PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Lin, EQ; Irvine, JC; Cao, AH; Alexander, AE; Love, JE; Patel, R; McMullen, JR; Kaye, DM; Kemp-Harper, BK; Ritchie, RH				Lin, Eliane Q.; Irvine, Jennifer C.; Cao, Anh H.; Alexander, Amy E.; Love, Jane E.; Patel, Ruchi; McMullen, Julie R.; Kaye, David M.; Kemp-Harper, Barbara K.; Ritchie, Rebecca H.			Nitroxyl (HNO) Stimulates Soluble Guanylyl Cyclase to Suppress Cardiomyocyte Hypertrophy and Superoxide Generation	PLOS ONE			English	Article							CARDIAC SARCOPLASMIC-RETICULUM; ADULT-RAT CARDIOMYOCYTES; II-INDUCED HYPERTROPHY; NITRIC-OXIDE; NATRIURETIC-PEPTIDE; ANTIHYPERTROPHIC ACTIONS; ANTIOXIDANT ACTIONS; OXIDATIVE STRESS; BLOOD-PRESSURE; ANGELIS SALT	Background: New therapeutic targets for cardiac hypertrophy, an independent risk factor for heart failure and death, are essential. HNO is a novel redox sibling of NON attracting considerable attention for the treatment of cardiovascular disorders, eliciting cGMP-dependent vasodilatation yet cGMP-independent positive inotropy. The impact of HNO on cardiac hypertrophy (which is negatively regulated by cGMP) however has not been investigated. Methods: Neonatal rat cardiomyocytes were incubated with angiotensin II (Ang II) in the presence and absence of the HNO donor Angeli's salt (sodium trioxodinitrate) or B-type natriuretic peptide, BNP (all 1 mu mol/L). Hypertrophic responses and its triggers, as well as cGMP signaling, were determined. Results: We now demonstrate that Angeli's salt inhibits Ang II-induced hypertrophic responses in cardiomyocytes, including increases in cardiomyocyte size, de novo protein synthesis and beta-myosin heavy chain expression. Angeli's salt also suppresses Ang II induction of key triggers of the cardiomyocyte hypertrophic response, including NADPH oxidase (on both Nox2 expression and superoxide generation), as well as p38 mitogen-activated protein kinase (p38MAPK). The antihypertrophic, superoxide-suppressing and cGMP-elevating effects of Angeli's salt were mimicked by BNP. We also demonstrate that the effects of Angeli's salt are specifically mediated by HNO (with no role for NO center dot or nitrite), with subsequent activation of cardiomyocyte soluble guanylyl cyclase (sGC) and cGMP signaling (on both cGMP-dependent protein kinase, cGK-I and phosphorylation of vasodilator-stimulated phosphoprotein, VASP). Conclusions: Our results demonstrate that HNO prevents cardiomyocyte hypertrophy, and that cGMP-dependent NADPH oxidase suppression contributes to these antihypertrophic actions. HNO donors may thus represent innovative pharmacotherapy for cardiac hypertrophy.	[Lin, Eliane Q.; Irvine, Jennifer C.; Cao, Anh H.; Alexander, Amy E.; Love, Jane E.; Patel, Ruchi; McMullen, Julie R.; Kaye, David M.; Ritchie, Rebecca H.] Baker IDI Heart & Diabet Inst, Melbourne, Vic, Australia; [Lin, Eliane Q.; Kemp-Harper, Barbara K.] Monash Univ, Dept Pharmacol, Clayton, Vic 3168, Australia; [Patel, Ruchi] Monash Univ, Dept Physiol, Clayton, Vic 3168, Australia; [Cao, Anh H.; Kaye, David M.; Ritchie, Rebecca H.] Monash Univ, Dept Med, Clayton, Vic 3168, Australia	Baker Heart and Diabetes Institute; Monash University; Monash University; Monash University	Lin, EQ (corresponding author), Baker IDI Heart & Diabet Inst, Melbourne, Vic, Australia.	rebecca.ritchie@bakeridi.edu.au	Ritchie, Rebecca H/E-7392-2011; Kaye, David/AAF-1202-2021	Kaye, David/0000-0003-4058-0372; Ritchie, Rebecca/0000-0002-8610-0058	National Health and Medical Research Council (NHMRC) [ID472642, ID472673]; Heart Foundation of Australia Postdoctoral Fellowship [PF09M4623]; Foundation for High Blood Pressure Research Postdoctoral Fellowship	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Heart Foundation of Australia Postdoctoral Fellowship; Foundation for High Blood Pressure Research Postdoctoral Fellowship	This work was supported by the National Health and Medical Research Council (NHMRC http://www.nhmrc.gov.au) of Australia (ID472642, ID472673) and in part by the Victorian State Government's Operational Infrastructure Support Program for Medical Research Institutes (http://www.business.vic.gov.au/BUSVIC/STANDARD/PC_60698.html). JCI was supported by a Heart Foundation of Australia Postdoctoral Fellowship (PF09M4623 http://www.heartfoundation.org.au) and BKK by a Foundation for High Blood Pressure Research Postdoctoral Fellowship (Australia http://www.hbprca.com.au/hbp-foundation/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernardo BC, 2010, PHARMACOL THERAPEUT, V128, P191, DOI 10.1016/j.pharmthera.2010.04.005; Bueno OF, 2000, EMBO J, V19, P6341, DOI 10.1093/emboj/19.23.6341; Bullen ML, 2011, ANTIOXID REDOX SIGN, V14, P1675, DOI 10.1089/ars.2010.3327; Cheong E, 2005, CELL CALCIUM, V37, P87, DOI 10.1016/j.ceca.2004.07.001; DUNN FG, 1990, J HYPERTENS, V8, P775, DOI 10.1097/00004872-199008000-00012; Evgenov OV, 2006, NAT REV DRUG DISCOV, V5, P755, DOI 10.1038/nrd2038; Favaloro JL, 2007, CARDIOVASC RES, V73, P587, DOI 10.1016/j.cardiores.2006.11.018; Fiedler B, 2002, P NATL ACAD SCI USA, V99, P11363, DOI 10.1073/pnas.162100799; Froehlich JP, 2008, BIOCHEMISTRY-US, V47, P13150, DOI 10.1021/bi801925p; FUKUTO JM, 1992, J PHARMACOL EXP THER, V263, P546; Goh SSC, 2007, ANTIOXID REDOX SIGN, V9, P101, DOI 10.1089/ars.2007.9.101; Hauselmann SP, 2011, FREE RADICAL BIO MED, V51, P609, DOI 10.1016/j.freeradbiomed.2011.05.007; Horowitz JD, 2003, J AM COLL CARDIOL, V41, P2001, DOI 10.1016/S0735-1097(03)00399-1; Irvine JC, 2003, HYPERTENSION, V41, P1301, DOI 10.1161/01.HYP.0000072010.54901.DE; Irvine JC, 2007, HYPERTENSION, V49, P885, DOI 10.1161/01.HYP.0000259328.04159.90; Irvine JC, 2011, ANTIOXID REDOX SIGN, V14, P1615, DOI 10.1089/ars.2010.3269; Irvine JC, 2008, TRENDS PHARMACOL SCI, V29, P601, DOI 10.1016/j.tips.2008.08.005; Ito H, 1997, HEART VESSELS, P15; Lancel S, 2009, CIRC RES, V104, P720, DOI 10.1161/CIRCRESAHA.108.188441; Laskowski A, 2006, CARDIOVASC RES, V72, P112, DOI 10.1016/j.cardiores.2006.07.006; LEVY D, 1990, NEW ENGL J MED, V322, P1561, DOI 10.1056/NEJM199005313222203; Li CG, 1999, BRIT J PHARMACOL, V127, P826, DOI 10.1038/sj.bjp.0702540; Lopez BE, 2007, FREE RADICAL BIO MED, V42, P482, DOI 10.1016/j.freeradbiomed.2006.11.015; MARAGOS CM, 1991, J MED CHEM, V34, P3242, DOI 10.1021/jm00115a013; Matsui T, 2003, CELL CYCLE, V2, P220, DOI 10.4161/cc.2.3.381; Miller TW, 2009, J BIOL CHEM, V284, P21788, DOI 10.1074/jbc.M109.014282; Miranda KM, 2002, ARCH BIOCHEM BIOPHYS, V401, P134, DOI 10.1016/S0003-9861(02)00031-0; MULSCH A, 1989, N-S ARCH PHARMACOL, V340, P119; Paolocci N, 2003, P NATL ACAD SCI USA, V100, P5537, DOI 10.1073/pnas.0937302100; Paolocci N, 2001, P NATL ACAD SCI USA, V98, P10463, DOI 10.1073/pnas.181191198; Purcell NH, 2007, P NATL ACAD SCI USA, V104, P14074, DOI 10.1073/pnas.0610906104; Ritchie RH, 2007, J MOL CELL CARDIOL, V42, P1119, DOI 10.1016/j.yjmcc.2007.03.900; Ritchie RH, 2009, PHARMACOL THERAPEUT, V124, P279, DOI 10.1016/j.pharmthera.2009.08.001; Ritchie RH, 2009, CURR MOL MED, V9, P814, DOI 10.2174/156652409789105499; Ritchie RH, 2004, AM J PHYSIOL-HEART C, V287, pH1179, DOI 10.1152/ajpheart.00725.2003; Ritchie RH, 1998, HYPERTENSION, V31, P39, DOI 10.1161/01.HYP.31.1.39; Ritchie RH, 1998, AM J PHYSIOL-HEART C, V275, pH1370, DOI 10.1152/ajpheart.1998.275.4.H1370; Rosenkranz AC, 2003, DIABETES, V52, P2389, DOI 10.2337/diabetes.52.9.2389; Rosenkranz AC, 2003, CARDIOVASC RES, V57, P515, DOI 10.1016/S0008-6363(02)00667-3; Rosenkranz AC, 2002, HYPERTENSION, V40, P498, DOI 10.1161/01.HYP.0000032854.74042.CF; Selvetella G, 2004, CARDIOVASC RES, V63, P373, DOI 10.1016/j.cardiores.2004.04.031; Sugden PH, 2006, ANTIOXID REDOX SIGN, V8, P2111, DOI 10.1089/ars.2006.8.2111; Supowit SC, 2005, HYPERTENSION, V45, P109, DOI 10.1161/01.HYP.0000151130.34874.fa; Tocchetti CG, 2007, CIRC RES, V100, P96, DOI 10.1161/01.RES.0000253904.53601.c9; Tocchetti CG, 2011, ANTIOXID REDOX SIGN, V14, P1687, DOI 10.1089/ars.2010.3859; Vleeming W, 1997, FOOD CHEM TOXICOL, V35, P615, DOI 10.1016/S0278-6915(97)00015-X; Wink DA, 1996, ARCH BIOCHEM BIOPHYS, V331, P241, DOI 10.1006/abbi.1996.0304; Xu Q, 2011, BRIT J PHARMACOL, V162, P1012, DOI 10.1111/j.1476-5381.2010.01043.x; Zeidan A, 2011, MOL CELL BIOCHEM, V352, P99, DOI 10.1007/s11010-011-0744-2; Zeller A, 2009, MOL PHARMACOL, V76, P1115, DOI 10.1124/mol.109.059915	50	41	41	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2012	7	4							e34892	10.1371/journal.pone.0034892	http://dx.doi.org/10.1371/journal.pone.0034892			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959FE	22506056	Green Submitted, Green Published, gold			2022-12-27	WOS:000305297500064
J	Stoppe, C; Fries, M; Rossaint, R; Grieb, G; Coburn, M; Simons, D; Brucken, D; Bernhagen, J; Pallua, N; Rex, S				Stoppe, Christian; Fries, Michael; Rossaint, Rolf; Grieb, Gerrit; Coburn, Mark; Simons, David; Bruecken, David; Bernhagen, Juergen; Pallua, Norbert; Rex, Steffen			Blood Levels of Macrophage Migration Inhibitory Factor after Successful Resuscitation from Cardiac Arrest	PLOS ONE			English	Article							AMERICAN-HEART-ASSOCIATION; MYOCARDIAL DYSFUNCTION; COUNCIL GUIDELINES; STROKE FOUNDATION; SERUM-LEVELS; MIF; CARDIOPULMONARY; CYTOKINE; CARE; STATEMENT	Introduction: Ischemia-reperfusion injury following cardiopulmonary resuscitation (CPR) is associated with a systemic inflammatory response, resulting in post-resuscitation disease. In the present study we investigated the response of the pleiotropic inflammatory cytokine macrophage migration inhibitory factor (MIF) to CPR in patients admitted to the hospital after out-of-hospital cardiac arrest (OHCA). To describe the magnitude of MIF release, we compared the blood levels from CPR patients with those obtained in healthy volunteers and with an aged-and gender-matched group of patients undergoing cardiac surgery with the use of extracorporeal circulation. Methods: Blood samples of 17 patients with return of spontaneous circulation (ROSC) after OHCA were obtained upon admission to the intensive care unit, and 6, 12, 24, 72 and 96 h later. Arrest and treatment related data were documented according to the Utstein style. Results: In patients after ROSC, MIF levels at admission (475.2 +/- 157.8 ng/ml) were significantly higher than in healthy volunteers (12.5 +/- 16.9 ng/ml, p<0.007) and in patients after cardiac surgery (78.2 +/- 41.6 ng/ml, p<0.007). Six hours after admission, MIF levels were decreased by more than 50% (150.5 +/- 127.2 ng/ml, p<0.007), but were not further reduced in the subsequent time course and remained significantly higher than the values observed during the ICU stay of cardiac surgical patients. In this small group of patients, MIF levels could not discriminate between survivors and non-survivors and were not affected by treatment with mild therapeutic hypothermia. Conclusion: MIF shows a rapid and pronounced increase following CPR, hence allowing a very early assessment of the inflammatory response. Further studies are warranted in larger patient groups to determine the prognostic significance of MIF.	[Stoppe, Christian; Rossaint, Rolf; Coburn, Mark; Rex, Steffen] Rhein Westfal TH Aachen, Univ Hosp, Dept Anaesthesiol, D-52062 Aachen, Germany; [Stoppe, Christian; Grieb, Gerrit; Simons, David; Bernhagen, Juergen] Rhein Westfal TH Aachen, Univ Hosp, Inst Biochem & Mol Cell Biol, D-52062 Aachen, Germany; [Fries, Michael] Rhein Westfal TH Aachen, Univ Hosp, Dept Intens Care, D-52062 Aachen, Germany; [Grieb, Gerrit; Simons, David; Pallua, Norbert] Rhein Westfal TH Aachen, Univ Hosp, Dept Plast Surg, Burn Unit, D-52062 Aachen, Germany; [Bruecken, David] Rhein Westfal TH Aachen, Univ Hosp, Dept Orthopaed & Trauma Surg Main Focus Trauma Su, D-52062 Aachen, Germany	RWTH Aachen University; RWTH Aachen University Hospital; RWTH Aachen University; RWTH Aachen University Hospital; RWTH Aachen University; RWTH Aachen University Hospital; RWTH Aachen University; RWTH Aachen University Hospital; RWTH Aachen University; RWTH Aachen University Hospital	Stoppe, C (corresponding author), Rhein Westfal TH Aachen, Univ Hosp, Dept Anaesthesiol, D-52062 Aachen, Germany.	christian.stoppe@gmail.com		Coburn, Mark/0000-0002-7930-0270; Rex, Steffen/0000-0002-3536-9321	Deutsche Forschungsgemeinschaft (DFG) [Be1977/4-2 (TP1 of DFG-FOR809), GRK1508/1 (project P13), Ra969/6-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This study was supported by the Deutsche Forschungsgemeinschaft (DFG) grants Be1977/4-2 (TP1 of DFG-FOR809), GRK1508/1 (project P13), and Ra969/6-1 to JB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrie C, 2002, CIRCULATION, V106, P562, DOI 10.1161/01.CIR.0000023891.80661.AD; Adrie Christophe, 2004, Curr Opin Crit Care, V10, P208, DOI 10.1097/01.ccx.0000126090.06275.fe; Beiser DG, 2009, RESUSCITATION, V80, P624, DOI 10.1016/j.resuscitation.2009.02.011; BERNHAGEN J, 1994, BIOCHEMISTRY-US, V33, P14144, DOI 10.1021/bi00251a025; Bernhagen J, 2007, NAT MED, V13, P587, DOI 10.1038/nm1567; CALANDRA T, 1994, J EXP MED, V179, P1895, DOI 10.1084/jem.179.6.1895; Calandra T, 2003, NAT REV IMMUNOL, V3, P791, DOI 10.1038/nri1200; Calandra T, 2000, NAT MED, V6, P164, DOI 10.1038/72262; CALANDRA T, 1995, NATURE, V377, P68, DOI 10.1038/377068a0; Chagnon F, 2005, CIRC RES, V96, P1095, DOI 10.1161/01.RES.0000168327.22888.4d; Cummins RO, 1997, CIRCULATION, V95, P2213, DOI 10.1161/01.CIR.95.8.2213; Derwall M, 2009, CRIT CARE, V13, DOI 10.1186/cc7785; Fink K, 2010, CRIT CARE, V14, DOI 10.1186/cc9050; Fries M, 2003, RESUSCITATION, V59, P105, DOI 10.1016/S0300-9572(03)00164-3; Fries M, 2009, J CRIT CARE, V24, P453, DOI 10.1016/j.jcrc.2008.10.012; de Mendonca HTF, 2006, CRIT CARE, V10, DOI 10.1186/cc4857; Gando S, 2000, INTENS CARE MED, V26, P38, DOI 10.1007/s001340050009; Gando S, 2001, INTENS CARE MED, V27, P1187, DOI 10.1007/s001340000818; Grenvik ASP., 1981, BRAIN FAILURE RESUSC, P155; Grieb G, 2010, BURNS, V36, P335, DOI 10.1016/j.burns.2009.04.019; Kim JJ, 2011, CRIT CARE, V15, DOI 10.1186/cc10019; Laurent I, 2002, J AM COLL CARDIOL, V40, P2110, DOI 10.1016/S0735-1097(02)02594-9; Laver S, 2004, INTENS CARE MED, V30, P2126, DOI 10.1007/s00134-004-2425-z; Leng L, 2003, J EXP MED, V197, P1467, DOI 10.1084/jem.20030286; Merk M, 2011, P NATL ACAD SCI USA, V108, pE577, DOI 10.1073/pnas.1102941108; Miller EJ, 2008, NATURE, V451, P578, DOI 10.1038/nature06504; Morand EF, 2006, NAT REV DRUG DISCOV, V5, P399, DOI 10.1038/nrd2029; NEGOVSKY VA, 1995, RESUSCITATION, V30, P23, DOI 10.1016/0300-9572(95)00861-M; Neumar RW, 2008, CIRCULATION, V118, P2452, DOI 10.1161/CIRCULATIONAHA.108.190652; Noels H, 2009, TRENDS CARDIOVAS MED, V19, P76, DOI 10.1016/j.tcm.2009.05.002; Nolan JP, 2010, RESUSCITATION, V81, P1219, DOI 10.1016/j.resuscitation.2010.08.021; Nolan JP, 2005, RESUSCITATION, V67, pS39, DOI 10.1016/j.resuscitation.2005.10.009; Qi D, 2009, J CLIN INVEST, V119, P3807, DOI 10.1172/JCI39738; Roger T, 2001, NATURE, V414, P920, DOI 10.1038/414920a; Sakuragi Tohru, 2007, Surg Infect (Larchmt), V8, P29, DOI 10.1089/sur.2006.031; Simons D, 2011, J CELL MOL MED, V15, P668, DOI 10.1111/j.1582-4934.2010.01041.x; Stoppe C, 2011, CRIT CARE MED, V39, P1879, DOI 10.1097/CCM.0b013e3182190d48; Trzeciak S, 2009, CRIT CARE MED, V37, P2895, DOI 10.1097/CCM.0b013e3181b01d8c; Yende S, 2009, FASEB J, V23, P2403, DOI 10.1096/fj.09-129445; Zernecke A, 2008, CIRCULATION, V117, P1594, DOI 10.1161/CIRCULATIONAHA.107.729125	40	21	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2012	7	4							e33512	10.1371/journal.pone.0033512	http://dx.doi.org/10.1371/journal.pone.0033512			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959FE	22506003	Green Published, Green Submitted, gold			2022-12-27	WOS:000305297500011
J	Narayan, SB; Master, SR; Sireci, AN; Bierl, C; Stanley, PE; Li, CH; Stanley, CA; Bennett, MJ				Narayan, Srinivas B.; Master, Stephen R.; Sireci, Anthony N.; Bierl, Charlene; Stanley, Paige E.; Li, Changhong; Stanley, Charles A.; Bennett, Michael J.			Short-Chain 3-Hydroxyacyl-Coenzyme A Dehydrogenase Associates with a Protein Super-Complex Integrating Multiple Metabolic Pathways	PLOS ONE			English	Article							CITRATE SYNTHASE; MALATE-DEHYDROGENASE; INSULIN-SECRETION; BETA-OXIDATION; MITOCHONDRIAL; HYPERINSULINISM; DEFICIENCY; ENZYMES; CELL; MUTATIONS	Proteins involved in mitochondrial metabolic pathways engage in functionally relevant multi-enzyme complexes. We previously described an interaction between short-chain 3-hydroxyacyl-coenzyme A dehydrogenase (SCHAD) and glutamate dehydrogenase (GDH) explaining the clinical phenotype of hyperinsulinism in SCHAD-deficient patients and adding SCHAD to the list of mitochondrial proteins capable of forming functional, multi-pathway complexes. In this work, we provide evidence of SCHAD's involvement in additional interactions forming tissue-specific metabolic super complexes involving both membrane-associated and matrix-dwelling enzymes and spanning multiple metabolic pathways. As an example, in murine liver, we find SCHAD interaction with aspartate transaminase (AST) and GDH from amino acid metabolic pathways, carbamoyl phosphate synthase I (CPS-1) from ureagenesis, other fatty acid oxidation and ketogenesis enzymes and fructose-bisphosphate aldolase, an extra-mitochondrial enzyme of the glycolytic pathway. Most of the interactions appear to be independent of SCHAD's role in the penultimate step of fatty acid oxidation suggesting an organizational, structural or non-enzymatic role for the SCHAD protein.	[Narayan, Srinivas B.; Stanley, Paige E.; Bennett, Michael J.] Childrens Hosp Philadelphia, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Master, Stephen R.; Bennett, Michael J.] Univ Penn, Dept Pathol & Lab Med, Perelman Sch Med, Philadelphia, PA 19104 USA; [Sireci, Anthony N.] Columbia Univ, Coll Phys & Surg, Dept Pathol & Cell Biol, New York, NY USA; [Bierl, Charlene] Cooper Univ Hosp, Dept Pathol, Camden, NJ USA; [Li, Changhong; Stanley, Charles A.] Childrens Hosp Philadelphia, Div Endocrinol, Philadelphia, PA 19104 USA; [Li, Changhong; Stanley, Charles A.] Univ Penn, Dept Pediat, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Columbia University; Cooper University Hospital; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine	Narayan, SB (corresponding author), Childrens Hosp Philadelphia, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA.	bennettmi@email.chop.edu	Abed, Farook Nehad/AAV-4188-2020	Abed, Farook Nehad/0000-0003-0338-0283; Master, Stephen/0000-0002-6808-631X; STANLEY, CHARLES/0000-0003-4881-9392	 [5R01 DK053012-11]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK056268, R01DK053012] Funding Source: NIH RePORTER	; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by 5R01 DK053012-11, to CAS. Molecular Basis of a New Form of Hyperinsulinism. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEECKMANS S, 1981, EUR J BIOCHEM, V117, P527; Bennett MJ, 2006, MOL GENET METAB, V89, P74, DOI 10.1016/j.ymgme.2006.04.004; BENNETT MJ, 1994, J INHERIT METAB DIS, V17, P283, DOI 10.1007/BF00711808; BUSTAMANTE E, 1977, P NATL ACAD SCI USA, V74, P3735, DOI 10.1073/pnas.74.9.3735; Clayton PT, 2001, J CLIN INVEST, V108, P457; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Enns GM, 2000, J PEDIATR-US, V136, P251, DOI 10.1016/S0022-3476(00)70111-9; FAHIEN LA, 1985, J BIOL CHEM, V260, P6069; FAHIEN LA, 1983, ARCH BIOCHEM BIOPHYS, V220, P386, DOI 10.1016/0003-9861(83)90428-9; Genda EN, 2011, J NEUROSCI, V31, P18275, DOI 10.1523/JNEUROSCI.3305-11.2011; HALPER LA, 1977, ARCH BIOCHEM BIOPHYS, V184, P529, DOI 10.1016/0003-9861(77)90462-3; Hardy OT, 2007, MOL ENDOCRINOL, V21, P765, DOI 10.1210/me.2006-0411; Hussain K, 2005, J PEDIATR-US, V146, P706, DOI 10.1016/j.jpeds.2005.01.032; Kapoor RR, 2009, J CLIN ENDOCR METAB, V94, P2221, DOI 10.1210/jc.2009-0423; KISPAL G, 1986, J BIOL CHEM, V261, P14209; Li CH, 2010, J BIOL CHEM, V285, P31806, DOI 10.1074/jbc.M110.123638; Martens GA, 2007, J BIOL CHEM, V282, P21134, DOI 10.1074/jbc.M700083200; Molven A, 2004, DIABETES, V53, P221, DOI 10.2337/diabetes.53.1.221; Narayan SB, 2011, CLIN CHEM LAB MED, V49, P1177, DOI 10.1515/CCLM.2011.200; Olsen LF, 2009, BIOPHYS J, V96, P3850, DOI 10.1016/j.bpj.2009.02.026; Parker A, 2000, BIOCHEM J, V345, P429, DOI 10.1042/0264-6021:3450429; Pearce EL, 2009, NATURE, V460, P103, DOI 10.1038/nature08097; Pepin E, 2010, J DIABETES, V2, P157, DOI 10.1111/j.1753-0407.2010.00076.x; Stanley CA, 1998, NEW ENGL J MED, V338, P1352, DOI 10.1056/NEJM199805073381904; SUMEGI B, 1984, J BIOL CHEM, V259, P5040; Vockley J, 2000, MOL GENET METAB, V71, P10, DOI 10.1006/mgme.2000.3066; Wang YD, 2010, J BIOL CHEM, V285, P29834, DOI 10.1074/jbc.M110.139493; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]	28	14	15	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2012	7	4							e35048	10.1371/journal.pone.0035048	http://dx.doi.org/10.1371/journal.pone.0035048			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JO	22496890	Green Published, gold, Green Submitted			2022-12-27	WOS:000305014500041
J	Noch, E; Sariyer, IK; Gordon, J; Khalili, K				Noch, Evan; Sariyer, Ilker Kudret; Gordon, Jennifer; Khalili, Kamel			JC Virus T-Antigen Regulates Glucose Metabolic Pathways in Brain Tumor Cells	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS TYPE-16; CANCER-CELLS; IN-VIVO; PYRUVATE-KINASE; DOWN-REGULATION; PROTEIN-KINASE; REPLICATION; EXPRESSION; TRANSCRIPTION; POLYOMAVIRUS	Recent studies have reported the detection of the human neurotropic virus, JCV, in a significant population of brain tumors, including medulloblastomas. Accordingly, expression of the JCV early protein, T-antigen, which has transforming activity in cell culture and in transgenic mice, results in the development of a broad range of tumors of neural crest and glial origin. Evidently, the association of T-antigen with a range of tumor-suppressor proteins, including p53 and pRb, and signaling molecules, such as b-catenin and IRS-1, plays a role in the oncogenic function of JCV T-antigen. We demonstrate that T-antigen expression is suppressed by glucose deprivation in medulloblastoma cells and in glioblastoma xenografts that both endogenously express T-antigen. Mechanistic studies indicate that glucose deprivation-mediated suppression of T-antigen is partly influenced by 5'-activated AMP kinase (AMPK), an important sensor of the AMP/ATP ratio in cells. In addition, glucose deprivation-induced cell cycle arrest in the G1 phase is blocked with AMPK inhibition, which also prevents T-antigen downregulation. Furthermore, T-antigen prevents G1 arrest and sustains cells in the G2 phase during glucose deprivation. On a functional level, T-antigen downregulation is partially dependent on reactive oxygen species (ROS) production during glucose deprivation, and T-antigen prevents ROS induction, loss of ATP production, and cytotoxicity induced by glucose deprivation. Additionally, we have found that T-antigen is downregulated by the glycolytic inhibitor, 2-deoxy-D-glucose (2-DG), and the pentose phosphate inhibitors, 6-aminonicotinamide and oxythiamine, and that T-antigen modulates expression of the glycolytic enzyme, hexokinase 2 (HK2), and the pentose phosphate enzyme, transaldolase-1 (TALDO1), indicating a potential link between T-antigen and metabolic regulation. These studies point to the possible involvement of JCV T-antigen in medulloblastoma proliferation and the metabolic phenotype and may enhance our understanding of the role of viral proteins in glycolytic tumor metabolism, thus providing useful targets for the treatment of virus-induced tumors.	[Noch, Evan] Temple Univ, Sch Med, Dept Neurosci, Philadelphia, PA 19122 USA; Temple Univ, Sch Med, Ctr Neurovirol, Philadelphia, PA 19122 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Noch, E (corresponding author), Temple Univ, Sch Med, Dept Neurosci, Philadelphia, PA 19122 USA.	kamel.khalili@temple.edu	Sariyer, Ilker/AAE-7677-2020		National Institutes of Health [1T32MH079785, R01NS35000]; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH092177, T32MH079785] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035000] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This investigation was partiallly supported by the National Institutes of Health under Ruth L. Kirchstein National Research Service Award (1T32MH079785) providing support to EN. Additional support for this work was made possible by grant number R01NS35000 awarded by NIH to KK. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Bollag B, 1996, VIROLOGY, V218, P81, DOI 10.1006/viro.1996.0168; BRAVARD A, 1992, CARCINOGENESIS, V13, P767, DOI 10.1093/carcin/13.5.767; Caldarelli-Stefano R, 2000, HUM PATHOL, V31, P394, DOI 10.1016/S0046-8177(00)80256-7; Caracciolo V, 2010, J CELL BIOCHEM, V110, P182, DOI 10.1002/jcb.22525; Cheng P, 2009, ONCOL REP, V22, P1101, DOI 10.3892/or_00000542; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Davy CE, 2002, J VIROL, V76, P9806, DOI 10.1128/JVI.76.19.9806-9818.2002; Del Valle L, 2001, CANCER RES, V61, P4287; Deshmane SL, 2009, J BIOL CHEM, V284, P11364, DOI 10.1074/jbc.M809266200; Dwarakanath BS, 2009, J CANCER RES THER, V5, P21, DOI 10.4103/0973-1482.55136; Gan DD, 2004, ONCOGENE, V23, P483, DOI 10.1038/sj.onc.1207018; Gan DD, 2001, ONCOGENE, V20, P4864, DOI 10.1038/sj.onc.1204670; Gentilella A, 2009, J CELL BIOCHEM, V108, P1117, DOI 10.1002/jcb.22343; Hernlund E, 2009, MOL CANCER THER, V8, P1916, DOI 10.1158/1535-7163.MCT-09-0179; HINDS PW, 1992, CELL, V70, P993, DOI 10.1016/0092-8674(92)90249-C; Izumi T, 2010, P NATL ACAD SCI USA, V107, P20798, DOI 10.1073/pnas.1008076107; JONES JS, 1993, J VIROL, V67, P67, DOI 10.1128/JVI.67.1.67-74.1993; Kasai D, 2009, J HEPATOL, V50, P883, DOI 10.1016/j.jhep.2008.12.029; Khalili K, 2003, ONCOGENE, V22, P5181, DOI 10.1038/sj.onc.1206559; Khalili K, 2003, ANTICANCER RES, V23, P2035; KITAGAWA K, 1985, BIOCHIM BIOPHYS ACTA, V821, P63, DOI 10.1016/0005-2736(85)90153-1; Krynska B, 1999, ONCOGENE, V18, P39, DOI 10.1038/sj.onc.1202278; Krynska B, 1997, J CELL BIOCHEM, V67, P223, DOI 10.1002/(SICI)1097-4644(19971101)67:2<223::AID-JCB7>3.0.CO;2-Z; Kumar SH, 2009, J VIROL, V83, P8565, DOI 10.1128/JVI.00603-09; Lachaise F, 2001, FREE RADICAL BIO MED, V30, P1365, DOI 10.1016/S0891-5849(01)00532-9; Laderoute KR, 2006, MOL CELL BIOL, V26, P5336, DOI 10.1128/MCB.00166-06; Liu BL, 2009, CELL CYCLE, V8, P2031, DOI 10.4161/cc.8.13.8814; Maehama T, 1998, INT J CANCER, V76, P639, DOI 10.1002/(SICI)1097-0215(19980529)76:5<639::AID-IJC5>3.0.CO;2-R; Manel N, 2003, CELL, V115, P449, DOI 10.1016/S0092-8674(03)00881-X; Maschek G, 2004, CANCER RES, V64, P31, DOI 10.1158/0008-5472.CAN-03-3294; NATH KA, 1995, AM J PHYSIOL-CELL PH, V268, pC227, DOI 10.1152/ajpcell.1995.268.1.C227; Orba Y, 2010, J BIOL CHEM, V285, P1544, DOI 10.1074/jbc.M109.064311; RAJ GV, 1995, INT J ONCOL, V7, P801; Safak M, 2001, J VIROL, V75, P1476, DOI 10.1128/JVI.75.3.1476-1486.2001; SATO H, 1989, J VIROL, V63, P3555, DOI 10.1128/JVI.63.8.3555-3559.1989; Spitz DR, 2000, ANN NY ACAD SCI, V899, P349, DOI 10.1111/j.1749-6632.2000.tb06199.x; Staib C, 1996, VIROLOGY, V219, P237, DOI 10.1006/viro.1996.0241; Uleri E, GENES CANC, V2, P728; Wang W, 2002, MOL CELL BIOL, V22, P3425, DOI 10.1128/MCB.22.10.3425-3436.2002; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; WOLD WSM, 1980, J VIROL, V33, P1225, DOI 10.1128/JVI.33.3.1225-1228.1980; Yamada M, 1999, CANCER CHEMOTH PHARM, V44, P59, DOI 10.1007/s002800050945; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505; Zhou J, 2009, ONCOGENE, V28, P1993, DOI 10.1038/onc.2009.63; Zhuang Yongxian, 2008, J Mol Signal, V3, P18, DOI 10.1186/1750-2187-3-18; Zwerschke W, 1999, P NATL ACAD SCI USA, V96, P1291, DOI 10.1073/pnas.96.4.1291	46	19	19	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2012	7	4							e35054	10.1371/journal.pone.0035054	http://dx.doi.org/10.1371/journal.pone.0035054			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JO	22496891	gold, Green Published, Green Submitted			2022-12-27	WOS:000305014500042
J	Hao, WL; Allen, VG; Jamieson, FB; Low, DE; Alexander, DC				Hao, Weilong; Allen, Vanessa G.; Jamieson, Frances B.; Low, Donald E.; Alexander, David C.			Phylogenetic Incongruence in E. coli O104: Understanding the Evolutionary Relationships of Emerging Pathogens in the Face of Homologous Recombination	PLOS ONE			English	Article							HEMOLYTIC-UREMIC SYNDROME; COMPLETE GENOME SEQUENCE; ESCHERICHIA-COLI; MOSAIC STRUCTURE; SPECIATION; DNA; INTEGRATION; POPULATIONS; DIVERSITY; INFERENCE	Escherichia coli O104:H4 was identified as an emerging pathogen during the spring and summer of 2011 and was responsible for a widespread outbreak that resulted in the deaths of 50 people and sickened over 4075. Traditional phenotypic and genotypic assays, such as serotyping, pulsed field gel electrophoresis (PFGE), and multilocus sequence typing (MLST), permit identification and classification of bacterial pathogens, but cannot accurately resolve relationships among genotypically similar but pathotypically different isolates. To understand the evolutionary origins of E. coli O104:H4, we sequenced two strains isolated in Ontario, Canada. One was epidemiologically linked to the 2011 outbreak, and the second, unrelated isolate, was obtained in 2010. MLST analysis indicated that both isolates are of the same sequence type (ST678), but whole-genome sequencing revealed differences in chromosomal and plasmid content. Through comprehensive phylogenetic analysis of five O104:H4 ST678 genomes, we identified 167 genes in three gene clusters that have undergone homologous recombination with distantly related E. coli strains. These recombination events have resulted in unexpectedly high sequence diversity within the same sequence type. Failure to recognize or adjust for homologous recombination can result in phylogenetic incongruence. Understanding the extent of homologous recombination among different strains of the same sequence type may explain the pathotypic differences between the ON2010 and ON2011 strains and help shed new light on the emergence of this new pathogen.	[Hao, Weilong; Allen, Vanessa G.; Jamieson, Frances B.; Low, Donald E.; Alexander, David C.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Hao, Weilong; Allen, Vanessa G.; Jamieson, Frances B.; Low, Donald E.] Mt Sinai Hosp, Toronto, ON M5G 1X5, Canada; [Hao, Weilong; Allen, Vanessa G.; Jamieson, Frances B.; Low, Donald E.; Alexander, David C.] Publ Hlth Ontario, Publ Hlth Labs, Toronto, ON, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto	Hao, WL (corresponding author), Wayne State Univ, Dept Biol Sci, Detroit, MI 48202 USA.	HaoW@wayne.edu	Jamieson, Frances/B-2040-2013; Hao, Weilong/C-4923-2009; Allen, Vanessa/AAE-2756-2022	Hao, Weilong/0000-0002-6337-7169; Allen, Vanessa/0000-0001-9802-9730	Public Health Ontario; Public Health Agency of Canada	Public Health Ontario; Public Health Agency of Canada	This work was supported by funding from Public Health Ontario and the Public Health Agency of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DC, 2012, EMERG INFEC IN PRESS; Alikhan NF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-402; Archer CT, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-9; Bae WK, 2006, YONSEI MED J, V47, P437, DOI 10.3349/ymj.2006.47.3.437; Bielaszewska M, 2011, LANCET INFECT DIS, V11, P671, DOI 10.1016/S1473-3099(11)70165-7; Bruen TC, 2006, GENETICS, V172, P2665, DOI 10.1534/genetics.105.048975; Brzuszkiewicz E, 2011, ARCH MICROBIOL, V193, P883, DOI 10.1007/s00203-011-0725-6; Budroni S, 2011, P NATL ACAD SCI USA, V108, P4494, DOI 10.1073/pnas.1019751108; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Chaudhuri RR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008801; Daubin V, 2004, GENOME RES, V14, P1036, DOI 10.1101/gr.2231904; Didelot X, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002191; Dobrindt U, 2001, CURR OPIN MICROBIOL, V4, P550, DOI 10.1016/S1369-5274(00)00250-2; DYKHUIZEN DE, 1991, J BACTERIOL, V173, P7257, DOI 10.1128/jb.173.22.7257-7268.1991; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Falush D, 2003, GENETICS, V164, P1567; Feil EJ, 2001, P NATL ACAD SCI USA, V98, P182, DOI 10.1073/pnas.98.1.182; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Gordon D, 2001, GENOME RES, V11, P614, DOI 10.1101/gr.171401; Guo H, 2009, GENOME, V52, P862, DOI [10.1139/G09-060, 10.1139/g09-060]; GUTTMAN DS, 1994, SCIENCE, V266, P1380, DOI 10.1126/science.7973728; Hacker J, 1997, MOL MICROBIOL, V23, P1089, DOI 10.1046/j.1365-2958.1997.3101672.x; Hao Weilong, 2011, Mob Genet Elements, V1, P256; Hao WL, 2011, GENOME BIOL EVOL, V3, P1406, DOI 10.1093/gbe/evr119; Hao WL, 2011, GENE, V481, P57, DOI 10.1016/j.gene.2011.04.012; Hao WL, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-114; Hao WL, 2006, GENOME RES, V16, P636, DOI 10.1101/gr.4746406; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Jolley KA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-595; KARLIN S, 1995, TRENDS GENET, V11, P283; Koski LB, 2001, J MOL EVOL, V52, P540, DOI 10.1007/s002390010184; Leigh JW, 2008, SYST BIOL, V57, P104, DOI 10.1080/10635150801910436; Lukjancenko O, 2010, MICROB ECOL, V60, P708, DOI 10.1007/s00248-010-9717-3; Luo CW, 2011, P NATL ACAD SCI USA, V108, P7200, DOI 10.1073/pnas.1015622108; Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140; Martin D, 2000, BIOINFORMATICS, V16, P562, DOI 10.1093/bioinformatics/16.6.562; MARTINEZ E, 1990, EMBO J, V9, P1275, DOI 10.1002/j.1460-2075.1990.tb08236.x; Mazel D, 1998, SCIENCE, V280, P605, DOI 10.1126/science.280.5363.605; McGraw EA, 1999, MOL BIOL EVOL, V16, P12, DOI 10.1093/oxfordjournals.molbev.a026032; Mellmann A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022751; Mossoro C, 2002, J CLIN MICROBIOL, V40, P3086, DOI 10.1128/JCM.40.8.3086-3088.2002; Ochman H, 1999, P NATL ACAD SCI USA, V96, P12638, DOI 10.1073/pnas.96.22.12638; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Ogura Y, 2009, P NATL ACAD SCI USA, V106, P17939, DOI 10.1073/pnas.0903585106; Oshima K, 2008, DNA RES, V15, P375, DOI 10.1093/dnares/dsn026; Posada D, 2002, J MOL EVOL, V54, P396, DOI 10.1007/s00239-001-0034-9; Posada D, 2002, ANNU REV GENET, V36, P75, DOI 10.1146/annurev.genet.36.040202.111115; Rasko DA, 2008, J BACTERIOL, V190, P6881, DOI 10.1128/JB.00619-08; Rasko DA, 2011, NEW ENGL J MED, V365, P709, DOI 10.1056/NEJMoa1106920; Retchless AC, 2007, SCIENCE, V317, P1093, DOI 10.1126/science.1144876; Retchless AC, 2010, P NATL ACAD SCI USA, V107, P11453, DOI 10.1073/pnas.1001291107; Rocha EPC, 2006, MOL BIOL EVOL, V23, P513, DOI 10.1093/molbev/msj052; Rohde H, 2011, NEW ENGL J MED, V365, P718, DOI 10.1056/NEJMoa1107643; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rowe-Magnus DA, 2003, GENOME RES, V13, P428, DOI 10.1101/gr.617103; Sims GE, 2011, P NATL ACAD SCI USA, V108, P8329, DOI 10.1073/pnas.1105168108; Sims GE, 2009, P NATL ACAD SCI USA, V106, P2677, DOI 10.1073/pnas.0813249106; Sonnhammer ELL, 1995, GENE, V167, pGC1, DOI 10.1016/0378-1119(95)00714-8; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; STOKES HW, 1989, MOL MICROBIOL, V3, P1669, DOI 10.1111/j.1365-2958.1989.tb00153.x; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Thompson JR, 2005, SCIENCE, V307, P1311, DOI 10.1126/science.1106028; Touchon M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000344; Vos M, 2009, ISME J, V3, P199, DOI 10.1038/ismej.2008.93; Welch RA, 2002, P NATL ACAD SCI USA, V99, P17020, DOI 10.1073/pnas.252529799; Wirth T, 2006, MOL MICROBIOL, V60, P1136, DOI 10.1111/j.1365-2958.2006.05172.x; Yomano LP, 1998, J IND MICROBIOL BIOT, V20, P132, DOI 10.1038/sj.jim.2900496; Zhou ZM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008700	68	20	21	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2012	7	4							e33971	10.1371/journal.pone.0033971	http://dx.doi.org/10.1371/journal.pone.0033971			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JA	22493677	Green Published, Green Submitted, gold			2022-12-27	WOS:000305012700019
J	Nehring, S; Budisa, N; Wiltschi, B				Nehring, Sebastian; Budisa, Nediljko; Wiltschi, Birgit			Performance Analysis of Orthogonal Pairs Designed for an Expanded Eukaryotic Genetic Code	PLOS ONE			English	Article							TRANSFER-RNA-SYNTHETASE; UNNATURAL AMINO-ACIDS; CU,ZN SUPEROXIDE-DISMUTASE; PROTEIN-COUPLED RECEPTOR; ESCHERICHIA-COLI; IN-VIVO; SACCHAROMYCES-CEREVISIAE; SUBSTRATE-SPECIFICITY; YEAST; EXPRESSION	Background: The suppression of amber stop codons with non-canonical amino acids (ncAAs) is used for the site-specific introduction of many unusual functions into proteins. Specific orthogonal aminoacyl-tRNA synthetase (o-aaRS)/amber suppressor tRNA(CUA) pairs (o-pairs) for the incorporation of ncAAs in S. cerevisiae were previously selected from an E. coli tyrosyl-tRNA synthetase/tRNA(CUA) mutant library. Incorporation fidelity relies on the specificity of the o-aaRSs for their ncAAs and the ability to effectively discriminate against their natural substrate Tyr or any other canonical amino acid. Methodology/Principal Findings: We used o-pairs previously developed for ncAAs carrying reactive alkyne-, azido-, or photocrosslinker side chains to suppress an amber mutant of human superoxide dismutase 1 in S. cerevisiae. We found worse incorporation efficiencies of the alkyne- and the photocrosslinker ncAAs than reported earlier. In our hands, amber suppression with the ncAA containing the azido group did not occur at all. In addition to the incorporation experiments in S. cerevisiae, we analyzed the catalytic properties of the o-aaRSs in vitro. Surprisingly, all o-aaRSs showed much higher preference for their natural substrate Tyr than for any of the tested ncAAs. While it is unclear why efficiently recognized Tyr is not inserted at amber codons, we speculate that metabolically inert ncAAs accumulate in the cell, and for this reason they are incorporated despite being weak substrates for the o-aaRSs. Conclusions/Significance: O-pairs have been developed for a whole plethora of ncAAs. However, a systematic and detailed analysis of their catalytic properties is still missing. Our study provides a comprehensive scrutiny of o-pairs developed for the site-specific incorporation of reactive ncAAs in S. cerevisiae. It suggests that future development of o-pairs as efficient biotechnological tools will greatly benefit from sound characterization in vivo and in vitro in parallel to monitoring intracellular ncAA levels.	[Nehring, Sebastian; Budisa, Nediljko] Tech Univ Berlin, Dept Biocatalysis, Berlin, Germany; [Wiltschi, Birgit] Univ Freiburg, BIOSS Ctr Biol Signalling Studies, D-79106 Freiburg, Germany; [Wiltschi, Birgit] Univ Freiburg, Fac Biol, D-79106 Freiburg, Germany	Technical University of Berlin; University of Freiburg; University of Freiburg	Nehring, S (corresponding author), Tech Univ Berlin, Dept Biocatalysis, Berlin, Germany.	birgit.wiltschi@acib.at	Budisa, Nediljko/AAA-4634-2022; Budisa, Nediljko/AAG-7291-2019; Budisa, Nediljko/T-4812-2017	Budisa, Nediljko/0000-0001-8437-7304; Budisa, Nediljko/0000-0001-8437-7304; Wiltschi, Birgit/0000-0001-5230-0951	Federal Ministry of Education and Research of Germany	Federal Ministry of Education and Research of Germany(Federal Ministry of Education & Research (BMBF))	The work was supported by the BioFuture Program of the Federal Ministry of Education and Research of Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai HW, 2010, ANGEW CHEM INT EDIT, V49, P935, DOI 10.1002/anie.200905590; Baruah M, 1996, SYNLETT, P1193; Beatty KE, 2008, BIOORG MED CHEM LETT, V18, P5995, DOI 10.1016/j.bmcl.2008.08.046; Beatty KE, 2006, ANGEW CHEM INT EDIT, V45, P7364, DOI 10.1002/anie.200602114; Beatty KE, 2010, CHEMBIOCHEM, V11, P2092, DOI 10.1002/cbic.201000419; Boer E, 2007, APPL MICROBIOL BIOT, V77, P513, DOI 10.1007/s00253-007-1209-0; Brustad E, 2008, BIOORG MED CHEM LETT, V18, P6004, DOI 10.1016/j.bmcl.2008.09.050; Chen HT, 2007, NAT STRUCT MOL BIOL, V14, P696, DOI 10.1038/nsmb1272; Chen PR, 2009, ANGEW CHEM INT EDIT, V48, P4052, DOI 10.1002/anie.200900683; Chen S, 2007, J MOL BIOL, V371, P112, DOI 10.1016/j.jmb.2007.05.017; Chin JW, 2003, SCIENCE, V301, P964, DOI 10.1126/science.1084772; Chin JW, 2003, CHEM BIOL, V10, P511, DOI 10.1016/S1074-5521(03)00123-6; Chin JW, 2002, J AM CHEM SOC, V124, P9026, DOI 10.1021/ja027007w; Coin I, 2011, ANGEW CHEM INT EDIT, V50, P8077, DOI 10.1002/anie.201102646; Cropp TA, 2007, NAT PROTOC, V2, P2590, DOI 10.1038/nprot.2007.378; Daggett KA, 2011, CURR OPIN CHEM BIOL, V15, P392, DOI 10.1016/j.cbpa.2011.03.010; Deiters A, 2003, J AM CHEM SOC, V125, P11782, DOI 10.1021/ja0370037; Deiters A, 2004, BIOORG MED CHEM LETT, V14, P5743, DOI 10.1016/j.bmcl.2004.09.059; Deiters A, 2006, UNNATURAL REACTIVE A; Dieterich DC, 2010, NAT NEUROSCI, V13, P897, DOI 10.1038/nn.2580; Francklyn CS, 2008, METHODS, V44, P100, DOI 10.1016/j.ymeth.2007.09.007; Furter R, 1998, PROTEIN SCI, V7, P419; Giese C, 2008, CHEMMEDCHEM, V3, P1449, DOI 10.1002/cmdc.200800108; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Grunbeck A, 2011, BIOCHEMISTRY-US, V50, P3411, DOI 10.1021/bi200214r; HAID A, 1983, METHOD ENZYMOL, V96, P192; HALLEWELL RA, 1987, BIO-TECHNOL, V5, P363, DOI 10.1038/nbt0487-363; Hans MA, 2001, APPL MICROBIOL BIOT, V56, P776, DOI 10.1007/s002530100708; Hoesl MG, 2011, CHEMBIOCHEM, V12, P552, DOI 10.1002/cbic.201000586; Huang LY, 2008, BIOCHEMISTRY-US, V47, P5638, DOI 10.1021/bi701866e; IBBA M, 1994, BIOCHEMISTRY-US, V33, P7107, DOI 10.1021/bi00189a013; IBBA M, 1995, FEBS LETT, V364, P272, DOI 10.1016/0014-5793(95)00408-2; Kamal A, 1997, CHEM COMMUN, P1015, DOI 10.1039/a701249g; KAST P, 1991, J MOL BIOL, V222, P99, DOI 10.1016/0022-2836(91)90740-W; Kiick KL, 2000, ANGEW CHEM INT EDIT, V39, P2148, DOI 10.1002/1521-3773(20000616)39:12<2148::AID-ANIE2148>3.0.CO;2-7; Kiick KL, 2000, TETRAHEDRON, V56, P9487, DOI 10.1016/S0040-4020(00)00833-4; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAWRENCE F, 1973, EUR J BIOCHEM, V36, P234, DOI 10.1111/j.1432-1033.1973.tb02905.x; Lee HS, 2009, J AM CHEM SOC, V131, P12921, DOI 10.1021/ja904896s; Lepthien S, 2010, ANGEW CHEM INT EDIT, V49, P5446, DOI 10.1002/anie.201000439; Lichty JJ, 2005, PROTEIN EXPRES PURIF, V41, P98, DOI 10.1016/j.pep.2005.01.019; Lindberg MJ, 2004, P NATL ACAD SCI USA, V101, P15893, DOI 10.1073/pnas.0403979101; Link AJ, 2006, P NATL ACAD SCI USA, V103, P10180, DOI 10.1073/pnas.0601167103; Liu CC, 2010, ANNU REV BIOCHEM, V79, P413, DOI 10.1146/annurev.biochem.052308.105824; Liu DR, 1999, P NATL ACAD SCI USA, V96, P4780, DOI 10.1073/pnas.96.9.4780; Liu WS, 2007, NAT METHODS, V4, P239, DOI 10.1038/NMETH1016; Meldal M, 2008, CHEM REV, V108, P2952, DOI 10.1021/cr0783479; Merkel L, 2008, CHEMBIOCHEM, V9, P1220, DOI 10.1002/cbic.200800050; Merkel L, 2007, CHEMBIOCHEM, V8, P2227, DOI 10.1002/cbic.200700540; Miyake-Stoner SJ, 2010, BIOCHEMISTRY-US, V49, P1667, DOI 10.1021/bi901947r; Mohibullah N, 2008, GENE DEV, V22, P2994, DOI 10.1101/gad.1724408; PARGE HE, 1992, P NATL ACAD SCI USA, V89, P6109, DOI 10.1073/pnas.89.13.6109; ROMANOS MA, 1992, YEAST, V8, P423, DOI 10.1002/yea.320080602; SAMPSON JR, 1989, SCIENCE, V243, P1363; Sharma N, 2000, FEBS LETT, V467, P37, DOI 10.1016/S0014-5793(00)01120-0; Takimoto JK, 2010, CHEMBIOCHEM, V11, P2268, DOI 10.1002/cbic.201000436; Takimoto JK, 2009, MOL BIOSYST, V5, P931, DOI 10.1039/b904228h; Tanrikulu IC, 2009, P NATL ACAD SCI USA, V106, P15285, DOI 10.1073/pnas.0905735106; Tippmann EM, 2007, TETRAHEDRON, V63, P6182, DOI 10.1016/j.tet.2007.02.125; Wan W, 2010, ANGEW CHEM INT EDIT, V49, P3211, DOI 10.1002/anie.201000465; Wang F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009354; Wang L, 2001, SCIENCE, V292, P498, DOI 10.1126/science.1060077; Wiltschi B, 2007, APPL MICROBIOL BIOT, V74, P739, DOI 10.1007/s00253-006-0823-6; Ye SX, 2008, J BIOL CHEM, V283, P1525, DOI 10.1074/jbc.M707355200; Ye SX, 2010, NATURE, V464, P1386, DOI 10.1038/nature08948; Ye SX, 2009, NAT CHEM BIOL, V5, P397, DOI 10.1038/nchembio.167; Young DD, 2011, BIOCHEMISTRY-US, V50, P1894, DOI 10.1021/bi101929e; Young TS, 2010, J BIOL CHEM, V285, P11039, DOI 10.1074/jbc.R109.091306; Young TS, 2010, J MOL BIOL, V395, P361, DOI 10.1016/j.jmb.2009.10.030; Young TS, 2009, BIOCHEMISTRY-US, V48, P2643, DOI 10.1021/bi802178k	70	44	46	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2012	7	4							e31992	10.1371/journal.pone.0031992	http://dx.doi.org/10.1371/journal.pone.0031992			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JA	22493661	Green Published, Green Submitted, gold			2022-12-27	WOS:000305012700003
J	Oh, J; Han, M; Peterson, BS; Jeong, J				Oh, Jihoon; Han, Mookyung; Peterson, Bradley S.; Jeong, Jaeseung			Spontaneous Eyeblinks Are Correlated with Responses during the Stroop Task	PLOS ONE			English	Article							EYE BLINKING; INTERFERENCE; FREQUENCY; WORK; GAZE; FMRI; EOG	The timing and frequency of spontaneous eyeblinking is thought to be influenced by ongoing internal cognitive or neurophysiological processes, but how precisely these processes influence the dynamics of eyeblinking is still unclear. This study aimed to better understand the functional role of eyeblinking during cognitive processes by investigating the temporal pattern of eyeblinks during the performance of attentional tasks. The timing of spontaneous eyeblinks was recorded from 28 healthy subjects during the performance of both visual and auditory versions of the Stroop task, and the temporal distributions of eyeblinks were estimated in relation to the timing of stimulus presentation and vocal response during the tasks. We found that the spontaneous eyeblink rate increased during Stroop task performance compared with the resting rate. Importantly, the subjects (17/28 during the visual Stroop, 20/28 during the auditory Stroop) were more likely to blink before a vocal response in both tasks (150-250 msec) and the remaining subjects were more likely to blink soon after the vocal response (200-300 msec), regardless of the stimulus type (congruent or incongruent) or task difficulty. These findings show that spontaneous eyeblinks are closely associated with responses during the performance of the Stroop task on a short time scale and suggest that spontaneous eyeblinks likely signal a shift in the internal cognitive or attentional state of the subjects.	[Oh, Jihoon; Han, Mookyung; Jeong, Jaeseung] Korea Adv Inst Sci & Technol, Dept Bio & Brain Engn, Taejon 305701, South Korea; [Oh, Jihoon] Catholic Univ Korea, Coll Med, Seoul, South Korea; [Peterson, Bradley S.; Jeong, Jaeseung] Columbia Univ, Coll Phys & Surg, Dept Psychiat, New York, NY USA	Korea Advanced Institute of Science & Technology (KAIST); Catholic University of Korea; Columbia University	Oh, J (corresponding author), Korea Adv Inst Sci & Technol, Dept Bio & Brain Engn, Taejon 305701, South Korea.	jsjeong@kaist.ac.kr	Jeong, Jaeseung/C-1620-2011		CHUNG Moon Soul Research Center for BioInformation and BioElectronics (CMSC) in KAIST; Korea Science and Engineering Foundation (KOSEF); Korea government (MOST) [R01-2003-000-10432-0, M10644000028-06N4400-02810]; KAIST [NNA0130]; NIMH [K02-74677]	CHUNG Moon Soul Research Center for BioInformation and BioElectronics (CMSC) in KAIST; Korea Science and Engineering Foundation (KOSEF)(Korea Science and Engineering Foundation); Korea government (MOST)(Ministry of Science & Technology (MOST), Republic of KoreaKorean Government); KAIST; NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by CHUNG Moon Soul Research Center for BioInformation and BioElectronics (CMSC) in KAIST, the Korea Science and Engineering Foundation (KOSEF) grant funded by the Korea government (MOST) (No. R01-2003-000-10432-0 and No. M10644000028-06N4400-02810) and grant No. NNA0130 from the KAIST, and NIMH grant K02-74677. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bacher LF, 2004, DEV PSYCHOBIOL, V44, P95, DOI 10.1002/dev.10162; Bentivoglio AR, 1997, MOVEMENT DISORD, V12, P1028, DOI 10.1002/mds.870120629; CAPLAN R, 1994, BIOL PSYCHIAT, V35, P228, DOI 10.1016/0006-3223(94)91253-X; Chung JY, 2006, NEUROSCI LETT, V395, P196, DOI 10.1016/j.neulet.2005.10.094; COHEN JD, 1990, PSYCHOL REV, V97, P332, DOI 10.1037/0033-295X.97.3.332; Colzato LS, 2008, NEUROPSYCHOLOGIA, V46, P3179, DOI 10.1016/j.neuropsychologia.2008.07.006; Colzato LS, 2007, NEUROPSYCHOLOGIA, V45, P2387, DOI 10.1016/j.neuropsychologia.2007.03.004; Dalley, 2008, GRANTS ATLAS ANATOMY; DEJONG PJ, 1990, INT J NEUROSCI, V51, P89, DOI 10.3109/00207459009000513; Doughty MJ, 2001, OPTOMETRY VISION SCI, V78, P712, DOI 10.1097/00006324-200110000-00011; EVINGER C, 1994, EXP BRAIN RES, V100, P337; FUKUDA K, 1994, PERCEPT MOTOR SKILL, V79, P1599, DOI 10.2466/pms.1994.79.3f.1599; Fukuda K, 2001, INT J PSYCHOPHYSIOL, V40, P239, DOI 10.1016/S0167-8760(00)00192-6; HOLLAND MK, 1975, PERCEPT MOTOR SKILL, V41, P403, DOI 10.2466/pms.1975.41.2.403; Ichikawa N, 2004, PERCEPT MOTOR SKILL, V98, P131; Kaneko K, 1999, PERCEPT MOTOR SKILL, V88, P1037, DOI 10.2466/pms.1999.88.3.1037; Kaneko K, 2001, PERCEPT MOTOR SKILL, V92, P234, DOI 10.2466/PMS.92.1.234-250; KARSON CN, 1981, PSYCHIAT RES, V5, P243, DOI 10.1016/0165-1781(81)90070-6; MACLEOD CM, 1991, PSYCHOL BULL, V109, P163, DOI 10.1037/0033-2909.109.2.163; MONSTER AW, 1978, BIOTELEM PAT MON, V5, P206; ORCHARD L N, 1991, Integrative Physiological and Behavioral Science, V26, P108, DOI 10.1007/BF02691032; PIETERS JM, 1981, CORTEX, V17, P369, DOI 10.1016/S0010-9452(81)80024-X; Siegle GJ, 2008, PSYCHOPHYSIOLOGY, V45, P679, DOI 10.1111/j.1469-8986.2008.00681.x; STERN JA, 1984, PSYCHOPHYSIOLOGY, V21, P22, DOI 10.1111/j.1469-8986.1984.tb02312.x; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Tada H, 1978, Fukushima J Med Sci, V25, P91; VONCRAMON D, 1980, NEUROPSYCHOLOGIA, V18, P603, DOI 10.1016/0028-3932(80)90164-5; WOOD CL, 1950, AM J PSYCHOL, V63, P584, DOI 10.2307/1418873; Yoon HW, 2005, NEUROSCI LETT, V381, P26, DOI 10.1016/j.neulet.2005.01.077; ZAKAY D, 1985, CAN J PSYCHOL, V39, P414, DOI 10.1037/h0080069	30	33	33	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2012	7	4							e34871	10.1371/journal.pone.0034871	http://dx.doi.org/10.1371/journal.pone.0034871			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	955JA	22493720	Green Published, gold, Green Submitted			2022-12-27	WOS:000305012700062
J	Ghosh, S; Hossain, MZ; Borges, M; Goggins, MG; Ingersoll, RG; Eshleman, JR; Klein, AP; Kern, SE				Ghosh, Soma; Hossain, M. Zulfiquer; Borges, Michael; Goggins, Michael G.; Ingersoll, Roxann G.; Eshleman, James R.; Klein, Alison P.; Kern, Scott E.			Analysis of Polymorphisms and Haplotype Structure of the Human Thymidylate Synthase Genetic Region: A Tool for Pharmacogenetic Studies	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISM; COLORECTAL-CANCER PATIENTS; 5-FLUOROURACIL INCORPORATION; MONONUCLEOTIDE REPEATS; POECILIA-RETICULATA; FUNCTIONAL-ANALYSIS; PREDICTS TOXICITY; DOSE ADJUSTMENT; DNA; RNA	5-fluorouracil (5FU), a widely used chemotherapeutic drug, inhibits the DNA replicative enzyme, thymidylate synthase (Tyms). Prior studies implicated a VNTR (variable numbers of tandem repeats) polymorphism in the 5'-untranslated region (5'-UTR) of the TYMS gene as a determinant of Tyms expression in tumors and normal tissues and proposed that these VNTR genotypes could help decide fluoropyrimidine dosing. Clinical associations between 5FU-related toxicity and the TYMS VNTR were reported, however, results were inconsistent, suggesting that additional genetic variation in the TYMS gene might influence Tyms expression. We thus conducted a detailed genetic analysis of this region, defining new polymorphisms in this gene including mononucleotide (poly A:T) repeats and novel single nucleotide polymorphisms (SNPs) flanking the VNTR in the TYMS genetic region. Our haplotype analysis of this region used data from both established and novel genetic variants and found nine SNP haplotypes accounting for more than 90% of the studied population. We observed non-exclusive relationships between the VNTR and adjacent SNP haplotypes, such that each type of VNTR commonly occurred on several haplotype backgrounds. Our results confirmed the expectation that the VNTR alleles exhibit homoplasy and lack the common ancestry required for a reliable marker of a linked adjacent locus that might govern toxicity. We propose that it may be necessary in a clinical trial to assay multiple types of genetic polymorphisms in the TYMS region to meaningfully model linkage of genetic markers to 5FU-related toxicity. The presence of multiple long (up to 26 nt), polymorphic monothymidine repeats in the promoter region of the sole human thymidylate synthetic enzyme is intriguing.	[Ghosh, Soma; Hossain, M. Zulfiquer; Goggins, Michael G.; Eshleman, James R.; Klein, Alison P.; Kern, Scott E.] Johns Hopkins Univ, Johns Hopkins Sch Med, Dept Oncol, Baltimore, MD 21218 USA; [Borges, Michael; Goggins, Michael G.; Eshleman, James R.; Klein, Alison P.] Johns Hopkins Univ, Johns Hopkins Sch Med, Dept Pathol, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine	Ghosh, S (corresponding author), Johns Hopkins Univ, Johns Hopkins Sch Med, Dept Oncol, Baltimore, MD 21218 USA.	sk@jhmi.edu		, Roxann/0000-0002-4266-613X	NIH [CA62924]; Everett and Marjorie Kovler Professorship in Pancreas Cancer Research; NATIONAL CANCER INSTITUTE [P50CA062924] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Everett and Marjorie Kovler Professorship in Pancreas Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was funded by NIH grant CA62924 and by the Everett and Marjorie Kovler Professorship in Pancreas Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AITMAN TJ, 1991, MAMM GENOME, V1, P206, DOI 10.1007/BF00352326; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Brody JR, 2009, CANCER RES, V69, P984, DOI 10.1158/0008-5472.CAN-08-3610; Brody JR, 2004, BIOTECHNIQUES, V37, P598, DOI 10.2144/04374ST04; de Bock CE, 2011, PHARMACOGENOMICS J, V11, P307, DOI 10.1038/tpj.2010.43; Fujii Ryuta, 2003, Int J Clin Oncol, V8, P72, DOI 10.1007/s101470300013; Fujishima M, 2010, ANTICANCER RES, V30, P4373; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gamelin E, 2008, J CLIN ONCOL, V26, P2099, DOI 10.1200/JCO.2007.13.3934; Ghosh S, 2011, CANCER BIOL THER, V12, P750, DOI 10.4161/cbt.12.8.16867; Gusella M, 2009, BRIT J CANCER, V100, P1549, DOI 10.1038/sj.bjc.6605052; HEIDELBERGER C, 1957, NATURE, V179, P663, DOI 10.1038/179663a0; HORIE N, 1995, CELL STRUCT FUNCT, V20, P191, DOI 10.1247/csf.20.191; Ichikawa W, 2006, CLIN CANCER RES, V12, P3928, DOI 10.1158/1078-0432.CCR-05-2665; Kakimoto M, 2005, CANCER LETT, V223, P103, DOI 10.1016/j.canlet.2004.09.020; KANEDA S, 1987, NUCLEIC ACIDS RES, V15, P1259, DOI 10.1093/nar/15.3.1259; Kawakami K, 2003, CANCER RES, V63, P6004; Kim SR, 2010, CHEMOTHERAPY, V56, P313, DOI 10.1159/000320032; Kline CL, 2011, CANCER BIOL THER, V12, P557, DOI 10.4161/cbt.12.7.18059; Kristensen MH, 2010, J INT MED RES, V38, P484, DOI 10.1177/147323001003800212; KUFE DW, 1981, J BIOL CHEM, V256, P8885; Lecomte T, 2004, CLIN CANCER RES, V10, P5880, DOI 10.1158/1078-0432.CCR-04-0169; Li WH, MOL EVOLUTION; Longley DB, 2003, NAT REV CANCER, V3, P330, DOI 10.1038/nrc1074; Lum PY, 2004, CELL, V116, P121, DOI 10.1016/S0092-8674(03)01035-3; LYSS AP, 1993, CANCER INVEST, V11, P239, DOI 10.3109/07357909309024846; MAJOR PP, 1982, CANCER RES, V42, P3005; Mandola MV, 2003, CANCER RES, V63, P2898; Noordhuis P, 2004, ANN ONCOL, V15, P1025, DOI 10.1093/annonc/mdh264; Ohta T, 2007, GENET RES, V89, P367, DOI 10.1017/S0016672308009531; Olsen KM, 1999, MOL BIOL EVOL, V16, P1406, DOI 10.1093/oxfordjournals.molbev.a026050; PARKER WB, 1990, PHARMACOL THERAPEUT, V48, P381, DOI 10.1016/0163-7258(90)90056-8; Pullarkat S. T., 2001, Pharmacogenomics Journal, V1, P65; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Saif MW, 2009, JNCI-J NATL CANCER I, V101, P1543, DOI 10.1093/jnci/djp328; SANTI DV, 1972, P NATL ACAD SCI USA, V69, P1855, DOI 10.1073/pnas.69.7.1855; Schwab M, 2008, J CLIN ONCOL, V26, P2131, DOI 10.1200/JCO.2006.10.4182; Schwartz S, 1999, CANCER RES, V59, P2995; Showalter SL, 2008, CANCER BIOL THER, V7, P986, DOI 10.4161/cbt.7.7.6181; Stephens M, 2005, AM J HUM GENET, V76, P449, DOI 10.1086/428594; Taylor JS, 1999, J MOL EVOL, V48, P245, DOI 10.1007/BF03356596; Taylor JS, 2000, GENETICS, V155, P1313; Ulrich CM, 2000, CANCER EPIDEM BIOMAR, V9, P1381; Vignoli M, 2011, PHARMACOL RES, V64, P242, DOI 10.1016/j.phrs.2011.04.006; Wenz HM, 1998, GENOME RES, V8, P69, DOI 10.1101/gr.8.1.69; Yawata A, 2005, CANCER CHEMOTH PHARM, V56, P465, DOI 10.1007/s00280-005-1018-z	46	7	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2012	7	4							e34426	10.1371/journal.pone.0034426	http://dx.doi.org/10.1371/journal.pone.0034426			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955IH	22496803	Green Published, gold, Green Submitted			2022-12-27	WOS:000305010500007
J	Hartling, L; Fernandes, RM; Seida, J; Vandermeer, B; Dryden, DM				Hartling, Lisa; Fernandes, Ricardo M.; Seida, Jennifer; Vandermeer, Ben; Dryden, Donna M.			From the Trenches: A Cross-Sectional Study Applying the GRADE Tool in Systematic Reviews of Healthcare Interventions	PLOS ONE			English	Review							QUALITY; STRENGTH	Background: GRADE was developed to address shortcomings of tools to rate the quality of a body of evidence. While much has been published about GRADE, there are few empirical and systematic evaluations. Objective: To assess GRADE for systematic reviews (SRs) in terms of inter-rater agreement and identify areas of uncertainty. Design: Cross-sectional, descriptive study. Methods: We applied GRADE to three SRs (n = 48, 66, and 75 studies, respectively) with 29 comparisons and 12 outcomes overall. Two reviewers graded evidence independently for outcomes deemed clinically important a priori. Inter-rater reliability was assessed using kappas for four main domains (risk of bias, consistency, directness, and precision) and overall quality of evidence. Results: For the first review, reliability was: kappa = 0.41 for risk of bias; 0.84 consistency; 0.18 precision; and 0.44 overall quality. Kappa could not be calculated for directness as one rater assessed all items as direct; assessors agreed in 41% of cases. For the second review reliability was: 0.37 consistency and 0.19 precision. Kappa could not be assessed for other items; assessors agreed in 33% of cases for risk of bias; 100% directness; and 58% overall quality. For the third review, reliability was: 0.06 risk of bias; 0.79 consistency; 0.21 precision; and 0.18 overall quality. Assessors agreed in 100% of cases for directness. Precision created the most uncertainty due to difficulties in identifying "optimal'' information size and "clinical decision threshold'', as well as making assessments when there was no meta-analysis. The risk of bias domain created uncertainty, particularly for nonrandomized studies. Conclusions: As researchers with varied levels of training and experience use GRADE, there is risk for variability in interpretation and application. This study shows variable agreement across the GRADE domains, reflecting areas where further guidance is required.	[Hartling, Lisa; Seida, Jennifer; Vandermeer, Ben; Dryden, Donna M.] Univ Alberta, Dept Pediat, Alberta Res Ctr Hlth Evidence, Edmonton, AB, Canada; [Hartling, Lisa] Univ Alberta, Dept Pediat, Cochrane Child Hlth Field, Edmonton, AB, Canada; [Fernandes, Ricardo M.] Hosp Santa Maria, Gulbenkian Programme Adv Med Educ, Lisbon, Portugal; [Fernandes, Ricardo M.] Hosp Santa Maria, Child & Family Dept, Lisbon, Portugal; [Fernandes, Ricardo M.] Inst Mol Med, Lab Farmacol Clin & Terapeut, Lisbon, Portugal	University of Alberta; University of Alberta; Universidade de Lisboa; Hospital Santa Maria; Universidade de Lisboa; Hospital Santa Maria; Universidade de Lisboa	Hartling, L (corresponding author), Univ Alberta, Dept Pediat, Alberta Res Ctr Hlth Evidence, Edmonton, AB, Canada.	hartling@ualberta.ca	Fernandes, Ricardo M/C-7501-2015	Fernandes, Ricardo M/0000-0002-7253-6475				Abou-Setta AM, 2011, ANN INTERN MED, V155, P234, DOI 10.7326/0003-4819-155-4-201108160-00346; Atkins D, 2004, BMJ-BRIT MED J, V328, P1490; Atkins D, 2005, BMC HEALTH SERV RES, V5, DOI 10.1186/1472-6963-5-25; Balshem H, 2011, J CLIN EPIDEMIOL, V64, P401, DOI 10.1016/j.jclinepi.2010.07.015; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1311, DOI [10.1016/j.jclinepi.2011.03.017, 10.1016/j.jclinepi.2011.06.004]; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1294, DOI 10.1016/j.jclinepi.2011.03.017; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1303, DOI 10.1016/j.jclinepi.2011.04.014; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1277, DOI 10.1016/j.jclinepi.2011.01.011; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1283, DOI 10.1016/j.jclinepi.2011.01.012; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P407, DOI 10.1016/j.jclinepi.2010.07.017; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P395, DOI 10.1016/j.jclinepi.2010.09.012; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P380, DOI 10.1016/j.jclinepi.2010.09.011; Hartling L, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1714; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; Institute of Medicine (IOM), 2011, FIND WHAT WORKS HLTH; Jamtvedt G, 2008, PHYS THER, V88, P123, DOI 10.2522/ptj.20070043; Kavanagh BP, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000094; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Owens DK, 2010, J CLIN EPIDEMIOL, V63, P513, DOI 10.1016/j.jclinepi.2009.03.009; Schunemann HJ, 2003, CAN MED ASSOC J, V169, P677; Schunemann HJ, 2009, GRADE HDB GRADING QU; Seida JC, 2010, ANN INTERN MED, V153, P246, DOI 10.7326/0003-4819-153-4-201008170-00263; Wells G, 2003, 11 COCHR C EV HLTH C	23	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2012	7	4							e34697	10.1371/journal.pone.0034697	http://dx.doi.org/10.1371/journal.pone.0034697			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955IH	22496843	gold, Green Published			2022-12-27	WOS:000305010500023
J	Bernardino, AF; Levin, LA; Thurber, AR; Smith, CR				Bernardino, Angelo F.; Levin, Lisa A.; Thurber, Andrew R.; Smith, Craig R.			Comparative Composition, Diversity and Trophic Ecology of Sediment Macrofauna at Vents, Seeps and Organic Falls	PLOS ONE			English	Review							GULF-OF-MEXICO; SEA WHALE-FALL; DEEP-SEA; COLD-SEEP; COMMUNITY STRUCTURE; METHANE SEEPS; SPATIAL HETEROGENEITY; NORTHEAST PACIFIC; SULFATE REDUCTION; MONTEREY CANYON	Sediments associated with hydrothermal venting, methane seepage and large organic falls such as whale, wood and plant detritus create deep-sea networks of soft-sediment habitats fueled, at least in part, by the oxidation of reduced chemicals. Biological studies at deep-sea vents, seeps and organic falls have looked at macrofaunal taxa, but there has yet to be a systematic comparison of the community-level attributes of sediment macrobenthos in various reducing ecosystems. Here we review key similarities and differences in the sediment-dwelling assemblages of each system with the goals of (1) generating a predictive framework for the exploration and study of newly identified reducing habitats, and (2) identifying taxa and communities that overlap across ecosystems. We show that deep-sea seep, vent and organic-fall sediments are highly heterogeneous. They sustain different geochemical and microbial processes that are reflected in a complex mosaic of habitats inhabited by a mixture of specialist (heterotrophic and symbiont-associated) and background fauna. Community-level comparisons reveal that vent, seep and organic-fall macrofauna are very distinct in terms of composition at the family level, although they share many dominant taxa among these highly sulphidic habitats. Stress gradients are good predictors of macrofaunal diversity at some sites, but habitat heterogeneity and facilitation often modify community structure. The biogeochemical differences across ecosystems and within habitats result in wide differences in organic utilization (i.e., food sources) and in the prevalence of chemosynthesis-derived nutrition. In the Pacific, vents, seeps and organic-falls exhibit distinct macrofaunal assemblages at broad-scales contributing to beta diversity. This has important implications for the conservation of reducing ecosystems, which face growing threats from human activities.	[Bernardino, Angelo F.] Univ Fed Espirito Santo, Dept Oceanog & Ecol, Vitoria, ES, Brazil; [Levin, Lisa A.] Univ Calif San Diego, Scripps Inst Oceanog, Integrat Oceanog Div, La Jolla, CA 92093 USA; [Levin, Lisa A.] Univ Calif San Diego, Scripps Inst Oceanog, Ctr Marine Biodivers & Conservat, La Jolla, CA 92093 USA; [Thurber, Andrew R.] Oregon State Univ, Coll Earth Ocean & Atmospher Sci, Corvallis, OR 97331 USA; [Smith, Craig R.] Univ Hawaii, Sch Ocean & Earth Sci & Technol, Dept Oceanog, Honolulu, HI 96822 USA	Universidade Federal do Espirito Santo; University of California System; University of California San Diego; Scripps Institution of Oceanography; University of California System; University of California San Diego; Scripps Institution of Oceanography; Oregon State University; University of Hawaii System	Bernardino, AF (corresponding author), Univ Fed Espirito Santo, Dept Oceanog & Ecol, Vitoria, ES, Brazil.	bernardino.ufes@gmail.com	Bernardino, Angelo Fraga/C-6921-2012	Bernardino, Angelo Fraga/0000-0002-1838-4597; Levin, Lisa/0000-0002-2858-8622	Nautilus Minerals Niugini (Manus Basin); National Undersea Research Center Alaska; West Coast and Polar Regions Undersea Research Center; National Science Foundation Division of Ocean Sciences [0096422]; Census of Marine Life; University of Sao Paulo; ChEss; NSF [OCE 04 35217, OCE 08 26254]	Nautilus Minerals Niugini (Manus Basin); National Undersea Research Center Alaska; West Coast and Polar Regions Undersea Research Center; National Science Foundation Division of Ocean Sciences(National Science Foundation (NSF)); Census of Marine Life; University of Sao Paulo; ChEss(Defence Research & Development Organisation (DRDO)); NSF(National Science Foundation (NSF))	A portion of the vent and seep studies reviewed here were supported in part by grants from Nautilus Minerals Niugini (Manus Basin), NSF OCE 04 35217 and OCE 08 26254 to LAL. Whale, wood and kelp-fall studies were funded by grants from the National Undersea Research Center Alaska, National Oceanic and Atmospheric Administration (now the West Coast and Polar Regions Undersea Research Center), and National Science Foundation Division of Ocean Sciences grant 0096422 to CRS. This synthesis was supported by the Census of Marine Life (www.coml.org) through the ChEss project. AFB was supported by travel grants from the University of Sao Paulo and ChEss. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersom MJ, 2008, PERMANOVA PRIMER GUI; Anderson MJ, 2006, BIOMETRICS, V62, P245, DOI 10.1111/j.1541-0420.2005.00440.x; Baco AR, 1999, MAR ECOL PROG SER, V182, P137, DOI 10.3354/meps182137; BAGARINAO T, 1992, AQUAT TOXICOL, V24, P21, DOI 10.1016/0166-445X(92)90015-F; Beal EJ, 2009, SCIENCE, V325, P184, DOI 10.1126/science.1169984; Bergquist DC, 2005, MAR ECOL PROG SER, V293, P99, DOI 10.3354/meps293099; Bernardino AF, 2009, WHALES WOOD KELP ISL; Bernardino AF, 2010, MAR ECOL-EVOL PERSP, V31, P608, DOI 10.1111/j.1439-0485.2010.00389.x; Bernardino AF, 2010, DEEP-SEA RES PT I, V57, P708, DOI 10.1016/j.dsr.2010.03.004; Bernhard JM, 2001, DEEP-SEA RES PT I, V48, P2233, DOI 10.1016/S0967-0637(01)00017-6; Boetius A, 2000, NATURE, V407, P623, DOI 10.1038/35036572; Boetius A, 2004, CHEM GEOL, V205, P291, DOI 10.1016/j.chemgeo.2003.12.034; Charlou JL, 2000, CHEM GEOL, V171, P49, DOI 10.1016/S0009-2541(00)00244-8; CHILDRESS JJ, 1992, OCEANOGR MAR BIOL, V30, P337; Conway N.M., 1994, P158; Cordes EE, 2007, DEEP-SEA RES PT I, V54, P637, DOI 10.1016/j.dsr.2007.01.001; Cordes EE, 2010, DEEP-SEA RES PT II, V57, P1870, DOI 10.1016/j.dsr2.2010.05.010; Cordes EE, 2010, MAR ECOL-EVOL PERSP, V31, P51, DOI 10.1111/j.1439-0485.2009.00334.x; Dando PR, 2008, DEEP-SEA RES PT I, V55, P966, DOI 10.1016/j.dsr.2008.04.002; Decker C, MARINE ECOL IN PRESS; Ding H, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2007JG000537; Domack E., 2005, EOS, V86, P269, DOI DOI 10.1029/2005EO290001; Dupont J, 2009, MYCOL RES, V113, P1351, DOI 10.1016/j.mycres.2009.08.015; Fisher C.R., 1995, GEOPHYS MONOGR SER, P297; FRY B, 1984, CONTRIB MAR SCI, V27, P13; Fujiwara Y, 2007, MAR ECOL-EVOL PERSP, V28, P219, DOI 10.1111/j.1439-0485.2007.00150.x; German CR, 2010, P NATL ACAD SCI USA, V107, P14020, DOI 10.1073/pnas.1009205107; German CR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023259; Glover AG, 2005, MAR ECOL-EVOL PERSP, V26, P223, DOI 10.1111/j.1439-0485.2005.00060.x; Goffredi SK, 2008, ISME J, V2, P204, DOI 10.1038/ismej.2007.103; Goffredi SK, 2004, DEEP-SEA RES PT I, V51, P1295, DOI 10.1016/j.dsr.2004.05.009; Gorley C.K., 2006, GETTING STARTED PRIM; Grassle J.F., 1985, Bulletin of the Biological Society of Washington, P443; Grassle JF, 1994, USGS B, V2022, P327; Hannides AK, 2008, ORGANIC MATTER CYCLI; Herzig PM, 2000, MARINE GEOCHEMISTRY, P398; Hugler M, 2011, ANNU REV MAR SCI, V3, P261, DOI 10.1146/annurev-marine-120709-142712; HURLBERT SH, 1971, ECOLOGY, V52, P577, DOI 10.2307/1934145; Jessen GL, CONTINENTAL IN PRESS; JORGENSEN BB, 1990, MAR ECOL PROG SER, V59, P39, DOI 10.3354/meps059039; Jorgensen BB, 1982, NAT REV MICROBIOL, V5, P770; JUNIPER SK, 1992, CAN J ZOOL, V70, P1792, DOI 10.1139/z92-247; JUNIPER SK, 1992, GEOLOGY, V20, P895, DOI 10.1130/0091-7613(1992)020<0895:IOATBP>2.3.CO;2; Krylova EM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009957; KVENVOLDEN KA, 1993, REV GEOPHYS, V31, P173, DOI 10.1029/93RG00268; Lessard-Pilon S, 2010, DEEP-SEA RES PT II, V57, P1891, DOI 10.1016/j.dsr2.2010.05.012; Levin LA, 2006, J EXP MAR BIOL ECOL, V330, P132, DOI 10.1016/j.jembe.2005.12.022; Levin LA, 2005, OCEANOGR MAR BIOL, V43, P1, DOI 10.1201/9781420037449.ch1; Levin LA, 2003, MAR ECOL PROG SER, V265, P123, DOI 10.3354/meps265123; Levin LA, 2002, LIMNOL OCEANOGR, V47, P1336, DOI 10.4319/lo.2002.47.5.1336; Levin LA, 2007, MAR ECOL-EVOL PERSP, V28, P1, DOI 10.1111/j.1439-0485.2007.00153.x; Levin LA, 2012, ANNU REV MAR SCI, V4, P79, DOI 10.1146/annurev-marine-120709-142714; Levin LA, 2010, MAR ECOL-EVOL PERSP, V31, P94, DOI 10.1111/j.1439-0485.2009.00335.x; Levin LA, 2009, TRENDS ECOL EVOL, V24, P606, DOI 10.1016/j.tree.2009.04.012; Levin LA, 2009, DEEP-SEA RES PT II, V56, P1632, DOI 10.1016/j.dsr2.2009.05.010; Li L., 1999, J OCEANOGR, V55, P635, DOI DOI 10.1023/A:1007897020042; Menot L, 2010, MAR ECOL-EVOL PERSP, V31, P78, DOI 10.1111/j.1439-0485.2009.00340.x; Murase J, 2007, ENVIRON MICROBIOL, V9, P3025, DOI 10.1111/j.1462-2920.2007.01414.x; Naganuma Takeshi, 1996, Journal of Oceanography, V52, P1, DOI 10.1007/BF02236529; Naudts L, 2010, MARINE GEOLOGY, P272; Nishimoto A, 2009, DEEP-SEA RES PT II, V56, P1683, DOI 10.1016/j.dsr2.2009.05.032; Orphan VJ, 2002, P NATL ACAD SCI USA, V99, P7663, DOI 10.1073/pnas.072210299; Orphan VJ, 2001, APPL ENVIRON MICROB, V67, P1922, DOI 10.1128/AEM.67.4.1922-1934.2001; Palacios C, 2009, MICROB ECOL, V58, P737, DOI 10.1007/s00248-009-9538-4; PAULL CK, 1984, SCIENCE, V226, P965, DOI 10.1126/science.226.4677.965; Pearson A, 2005, GEOCHIM COSMOCHIM AC, V69, P5477, DOI 10.1016/j.gca.2005.07.007; Pearson T.H., 1978, Oceanography and Marine Biology an Annual Review, V16, P229; Petrecca R. F., 1990, NOTES FAUNA SEVERAL, P279; Rathburn AE, 2003, GEOCHEM GEOPHY GEOSY, V4, DOI 10.1029/2003GC000595; Reeburgh WS, 2007, CHEM REV, V107, P486, DOI 10.1021/cr050362v; Ritt B, 2011, MAR BIOL, V158, P1187, DOI 10.1007/s00227-011-1679-6; Ritt B, 2010, DEEP-SEA RES PT I, V57, P1120, DOI 10.1016/j.dsr.2010.05.011; Robinson CA, 2004, MAR ECOL-P S Z N I, V25, P313, DOI 10.1111/j.1439-0485.2004.00034.x; Sahling H, 2005, LIMNOL OCEANOGR, V50, P598, DOI 10.4319/lo.2005.50.2.0598; Sahling H, 2003, DEEP-SEA RES PT I, V50, P1391, DOI 10.1016/j.dsr.2003.08.004; Sahling H, 2002, MAR ECOL PROG SER, V231, P121, DOI 10.3354/meps231121; Seyfried WE, 2004, GEOPHYS MONOGR SER, V148, P267, DOI 10.1029/148GM11; Sibuet M, 1998, DEEP-SEA RES PT II, V45, P517, DOI 10.1016/S0967-0645(97)00074-X; SMITH CR, 1983, DEEP-SEA RES, V30, P907, DOI 10.1016/0198-0149(83)90048-1; Smith CR, 2002, CAH BIOL MAR, V43, P293; Smith CR, 2003, OCEANOGR MAR BIOL, V41, P311; Smith CR, 1998, DEEP-SEA RES PT II, V45, P335, DOI 10.1016/S0967-0645(97)00043-X; SMITH CR, 1989, NATURE, V341, P27, DOI 10.1038/341027a0; Smith CR, GEOCHEMICAL MA UNPUB; Smith CR, 2009, CHEMOSYNTHETIC COMMU; Smith CR, 2008, TRENDS ECOL EVOL, V23, P518, DOI 10.1016/j.tree.2008.05.002; Smith CR, 2006, WHALES, WHALING, AND OCEAN ECOSYSTEMS, P286; SOMERO GN, 1989, CRC CRIT REV AQUAT S, V1, P591; Sommer S, 2010, MARINE GEOLOGY, P272; Tarasov VG, 2005, CHEM GEOL, V224, P5, DOI 10.1016/j.chemgeo.2005.07.021; Thornhill DJ, EVOLUTIONARY H UNPUB; Thurber AR, 2010, MAR GEOL, V272, P260, DOI 10.1016/j.margeo.2009.06.001; Thurber AR, 2010, MICROBE METAZOAN INT; THURBER AR, PLOS ONE IN PRESS; Thurber AR, ISME IN PRESS; Treude T, 2009, MAR ECOL PROG SER, V382, P1, DOI 10.3354/meps07972; Tryon MD, 2001, GEOPHYS RES LETT, V28, P2863, DOI 10.1029/2000GL012566; Tunnicliffe V, 2003, ECOSY WORLD, V28, P81; Tunnicliffe V, 1998, ADV MAR BIOL, V34, P353, DOI 10.1016/S0065-2881(08)60213-8; Turner R.D., 1977, Bulletin Am malac Union, V1977, P13; Van Dover C.L., 2000, ECOLOGY DEEP SEA HYD; Van Dover CL, 2003, DEEP-SEA RES PT I, V50, P281, DOI 10.1016/S0967-0637(02)00162-0; Van Dover CL, 2002, SCIENCE, V295, P1253, DOI 10.1126/science.1067361; VANDOVER CL, 1994, LIMNOL OCEANOGR, V39, P51, DOI 10.4319/lo.1994.39.1.0051; Vanreusel A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012449; Vrijenhoek RC, 2010, TOP GEOBIOL, V33, P15, DOI 10.1007/978-90-481-9572-5_2; Watanabe H, 2010, TOP GEOBIOL, V33, P379, DOI 10.1007/978-90-481-9572-5_12; Weber A, 2002, DEEP-SEA RES PT I, V49, P827, DOI 10.1016/S0967-0637(01)00079-6; WELHAN JA, 1988, CHEM GEOL, V71, P183, DOI 10.1016/0009-2541(88)90114-3; Wiklund H, 2009, ZOOTAXA, P43, DOI 10.11646/zootaxa.2228.1.3; Wiklund H, 2009, ZOOL J LINN SOC-LOND, V155, P774, DOI 10.1111/j.1096-3642.2008.00469.x; Ziebis W, 2005, COAST ESTUAR STUD, V60, P267	112	93	96	4	130	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e33515	10.1371/journal.pone.0033515	http://dx.doi.org/10.1371/journal.pone.0033515			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GO	22496753	Green Published, gold			2022-12-27	WOS:000304855200016
J	Bowler, MT; Buchanan-Smith, HM; Whiten, A				Bowler, Mark T.; Buchanan-Smith, Hannah M.; Whiten, Andrew			Assessing Public Engagement with Science in a University Primate Research Centre in a National Zoo	PLOS ONE			English	Article							VISITOR BEHAVIOR	Recent years have seen increasing encouragement by research institutions and funding bodies for scientists to actively engage with the public, who ultimately finance their work. Animal behaviour as a discipline possesses several features, including its inherent accessibility and appeal to the public, that may help it occupy a particularly successful niche within these developments. It has also established a repertoire of quantitative behavioural methodologies that can be used to document the public's responses to engagement initiatives. This kind of assessment is becoming increasingly important considering the enormous effort now being put into public engagement projects, whose effects are more often assumed than demonstrated. Here we report our first attempts to quantify relevant aspects of the behaviour of a sample of the hundreds of thousands of visitors who pass through the 'Living Links to Human Evolution Research Centre' in Edinburgh Zoo. This University research centre actively encourages the public to view ongoing primate research and associated science engagement activities. Focal follows of visitors and scan sampling showed substantial 'dwell times' in the Centre by common zoo standards and the addition of new engagement elements in a second year was accompanied by significantly increased overall dwell times, tripling for the most committed two thirds of visitors. Larger groups of visitors were found to spend more time in the Centre than smaller ones. Viewing live, active science was the most effective activity, shown to be enhanced by novel presentations of carefully constructed explanatory materials. The findings emphasise the importance and potential of zoos as public engagement centres for the biological sciences.	[Bowler, Mark T.; Whiten, Andrew] Univ St Andrews, Sch Psychol, Ctr Social Learning & Cognit Evolut, St Andrews, Fife, Scotland; [Bowler, Mark T.; Whiten, Andrew] Univ St Andrews, Sch Psychol, Scottish Primate Res Grp, St Andrews, Fife, Scotland; [Buchanan-Smith, Hannah M.] Univ Stirling, Sch Nat Sci, Stirling FK9 4LA, Scotland; [Buchanan-Smith, Hannah M.] Univ Stirling, Scottish Primate Res Grp, Stirling FK9 4LA, Scotland	University of St Andrews; University of St Andrews; University of Stirling; University of Stirling	Bowler, MT (corresponding author), Univ St Andrews, Sch Psychol, Ctr Social Learning & Cognit Evolut, St Andrews, Fife, Scotland.	mtb21@st-andrews.ac.uk	Buchanan-Smith, Hannah M/A-5350-2009	Buchanan-Smith, Hannah M/0000-0002-2516-7734; Whiten, Andrew/0000-0003-2426-5890; Bowler, Mark/0000-0001-5236-3477	Scottish Funding Council; Scottish Government; Wellcome Trust	Scottish Funding Council; Scottish Government; Wellcome Trust(Wellcome TrustEuropean Commission)	The Living Links to Human Evolution Research Centre was funded by a Strategic Research and Development Grant from the Scottish Funding Council. The research was funded by a Scottish Government Science Engagement Grant and a Wellcome Trust 'Investment in People' award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Anderson US, 2003, ENVIRON BEHAV, V35, P826, DOI 10.1177/0013916503254746; Bitgood S., 2000, J INTERPRETATION RES, V5, P31, DOI [https://doi.org/10.1177/109258720000500205, DOI 10.1177/109258720000500205]; Clayton S, 2009, ZOO BIOL, V28, P377, DOI 10.1002/zoo.20186; Falk J.H., 2007, WHY ZOOS AQUARIUMS M; Francis D, 2007, J INT ZOO ED ASS, V43, P20; Hart A, NCCPE BRIEFING SERIE; Leonardi R, 2010, AM J PRIMATOL, V72, P33, DOI 10.1002/ajp.20748; Louch J, 1999, DODO, V35, P134; Macdonald C., 2011, International Zoo Yearbook, V45, P7, DOI 10.1111/j.1748-1090.2010.00120.x; Moss A., 2010, J INTERPRETATION RES, V15, P11, DOI DOI 10.1177/109258721001500203; Moss A, 2008, VISIT STUD, V11, P26, DOI 10.1080/10645570801938418; Nakamichi M, 2007, ANTHROZOOS, V20, P155, DOI 10.2752/175303707X207945; Phillpot P, 1996, DODO, V32, P193; Randler C, 2007, VISIT STUD, V10, P205, DOI 10.1080/10645570701585343; Ross S. R., 2005, VISITOR STUDIES TODA, V8, P4; Ross SR, 2009, ZOO BIOL, V28, P462, DOI 10.1002/zoo.20220; Screven C, 1990, ILVS REV, V1, P33; Serrell B, 1999, PAYING ATTENTION VIS; Stoinski TS, 1998, ZOO BIOL, V17, P167, DOI 10.1002/(SICI)1098-2361(1998)17:3<167::AID-ZOO2>3.0.CO;2-7; Tanaka M, 2010, INT PRIM SOC C 2010; Whiten A, 2005, NATURE, V437, P737, DOI 10.1038/nature04047	22	24	24	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e34505	10.1371/journal.pone.0034505	http://dx.doi.org/10.1371/journal.pone.0034505			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GO	22496822	Green Submitted, Green Published, gold			2022-12-27	WOS:000304855200059
J	Tessema, M; Yingling, CM; Grimes, MJ; Thomas, CL; Liu, YS; Leng, SG; Joste, N; Belinsky, SA				Tessema, Mathewos; Yingling, Christin M.; Grimes, Marcie J.; Thomas, Cynthia L.; Liu, Yushi; Leng, Shuguang; Joste, Nancy; Belinsky, Steven A.			Differential Epigenetic Regulation of TOX Subfamily High Mobility Group Box Genes in Lung and Breast Cancers	PLOS ONE			English	Article							ABERRANT PROMOTER METHYLATION; CPG ISLAND; COLORECTAL-CANCER; HMGB PROTEINS; HUMAN TUMORS; DNA; IDENTIFICATION; EXPRESSION; CELLS; ADENOCARCINOMAS	Aberrant cytosine methylation affects regulation of hundreds of genes during cancer development. In this study, a novel aberrantly hypermethylated CpG island in cancer was discovered within the TOX2 promoter. TOX2 was unmethylated in normal cells but 28% lung (n = 190) and 23% breast (n = 80) tumors were methylated. Expression of two novel TOX2 transcripts identified was significantly reduced in primary lung tumors than distant normal lung (p<0.05). These transcripts were silenced in methylated lung and breast cancer cells and 5-Aza-2-deoxycytidine treatment re-expressed both. Extension of these assays to TOX, TOX3, and TOX4 genes that share similar genomic structure and protein homology with TOX2 revealed distinct methylation profiles by smoking status, histology, and cancer type. TOX was almost exclusively methylated in breast (43%) than lung (5%) cancer, whereas TOX3 was frequently methylated in lung (58%) than breast (30%) tumors. TOX4 was unmethylated in all samples and showed the highest expression in normal lung. Compared to TOX4, expression of TOX, TOX2 and TOX3 in normal lung was 25, 44, and 88% lower, respectively, supporting the premise that reduced promoter activity confers increased susceptibility to methylation during lung carcinogenesis. Genome-wide assays revealed that siRNA-mediated TOX2 knockdown modulated multiple pathways while TOX3 inactivation targeted neuronal development and function. Although these knockdowns did not result in further phenotypic changes of lung cancer cells in vitro, the impact on tissue remodeling, inflammatory response, and cell differentiation pathways suggest a potential role for TOX2 in modulating tumor microenvironment.	[Tessema, Mathewos; Yingling, Christin M.; Grimes, Marcie J.; Thomas, Cynthia L.; Liu, Yushi; Leng, Shuguang; Belinsky, Steven A.] Lovelace Resp Res Inst, Lung Canc Program, Albuquerque, NM USA; [Joste, Nancy] Univ New Mexico, Dept Internal Med, Albuquerque, NM 87131 USA	Lovelace Respiratory Research Institute; University of New Mexico	Tessema, M (corresponding author), Lovelace Resp Res Inst, Lung Canc Program, Albuquerque, NM USA.	sbelinsk@LRRI.org	Liu, Yushi/A-1533-2014	Liu, Yushi/0000-0003-4185-4187	National Institutes of Health [R01ES008801, ES015262, P50 CA58184]; NATIONAL CANCER INSTITUTE [P50CA058184] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015262, R01ES008801] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Institutes of Health Grant numbers [R01ES008801], [ES015262], and [P50 CA58184] to SAB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleman A, 2008, BRIT J CANCER, V98, P466, DOI 10.1038/sj.bjc.6604143; Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Belinsky SA, 2002, CANCER RES, V62, P2370; Belinsky SA, 2011, CANCER RES, V71, P454, DOI 10.1158/0008-5472.CAN-10-3184; Bewley CA, 1998, ANNU REV BIOPH BIOM, V27, P105, DOI 10.1146/annurev.biophys.27.1.105; Chakravarty G, 2011, EXP BIOL MED, V236, P145, DOI 10.1258/ebm.2010.010086; Ching TT, 2005, NAT GENET, V37, P645, DOI 10.1038/ng1563; Chung W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002079; Clark SJ, 2002, ONCOGENE, V21, P5380, DOI 10.1038/sj.onc.1205598; Deloukas P, 2001, NATURE, V414, P865, DOI 10.1038/414865a; Dittmer S, 2011, J CELL SCI, V124, P252, DOI 10.1242/jcs.068759; du Puch CBM, 2011, ARCH BIOCHEM BIOPHYS, V507, P296, DOI 10.1016/j.abb.2010.12.021; Hess JL, 1998, AM J CLIN PATHOL, V109, P251, DOI 10.1093/ajcp/109.3.251; Jia XP, 2011, J MOL CELL BIOL, V3, P230, DOI 10.1093/jmcb/mjr002; Jia Y, 2010, EPIGENETICS-US, V5, P743, DOI 10.4161/epi.5.8.13104; Kajitani T, 2004, ENDOCRINOLOGY, V145, P2307, DOI 10.1210/en.2003-1343; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marsit CJ, 2006, CANCER RES, V66, P10621, DOI 10.1158/0008-5472.CAN-06-1687; O'Flaherty E, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-13; Oyer JA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004832; Palmisano WA, 2003, CANCER RES, V63, P4620; Ramirez RD, 2004, CANCER RES, V64, P9027, DOI 10.1158/0008-5472.CAN-04-3703; Shiraishi M, 1999, P NATL ACAD SCI USA, V96, P2913, DOI 10.1073/pnas.96.6.2913; Shiraishi M, 2002, ONCOGENE, V21, P3659, DOI 10.1038/sj.onc.1205453; Smith LT, 2006, P NATL ACAD SCI USA, V103, P982, DOI 10.1073/pnas.0510171102; Soullier S, 1999, J MOL EVOL, V48, P517, DOI 10.1007/PL00006495; Stros M, 2010, BBA-GENE REGUL MECH, V1799, P101, DOI 10.1016/j.bbagrm.2009.09.008; Tallini G, 1999, ADV ANAT PATHOL, V6, P237, DOI 10.1097/00125480-199909000-00001; Tessema M, 2010, ONCOGENE, V29, P5159, DOI 10.1038/onc.2010.255; Tessema M, 2012, ONCOGENE        1212, DOI 101038/onc2011577; Tessema M, 2008, CANCER RES, V68, P1707, DOI 10.1158/0008-5472.CAN-07-6325; Thomas JO, 2001, TRENDS BIOCHEM SCI, V26, P167, DOI 10.1016/S0968-0004(01)01801-1; Toyota M, 1999, CANCER RES, V59, P2307; Toyota M, 1999, P NATL ACAD SCI USA, V96, P8681, DOI 10.1073/pnas.96.15.8681; Toyota M, 1999, CANCER RES, V59, P4535; Travers AA, 2003, EMBO REP, V4, P131, DOI 10.1038/sj.embor.embor741; Treff NR, 2004, ONCOGENE, V23, P777, DOI 10.1038/sj.onc.1207167; Ueki T, 2001, CANCER RES, V61, P8540; Wilkinson B, 2002, NAT IMMUNOL, V3, P272, DOI 10.1038/ni767; Yuan FH, 2004, J BIOL CHEM, V279, P20935, DOI 10.1074/jbc.M401931200; Yuan SH, 2009, P NATL ACAD SCI USA, V106, P2909, DOI 10.1073/pnas.0805555106; Zhang W, 2008, CANCER RES, V68, P2764, DOI 10.1158/0008-5472.CAN-07-6349	43	43	44	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e34850	10.1371/journal.pone.0034850	http://dx.doi.org/10.1371/journal.pone.0034850			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GO	22496870	Green Published, Green Submitted, gold			2022-12-27	WOS:000304855200085
J	Xie, MX; Zhu, XZ; Liu, ZF; Shrubsole, M; Varma, V; Mayer, IA; Dai, Q; Chen, Q; You, SJ				Xie, Mingxuan; Zhu, Xiangzhu; Liu, Zhaofan; Shrubsole, Martha; Varma, Vijay; Mayer, Ingrid A.; Dai, Qi; Chen, Qiong; You, Shaojin			Membrane Progesterone Receptor Alpha as a Potential Prognostic Biomarker for Breast Cancer Survival: A Retrospective Study	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; BASAL-LIKE; AMERICAN-SOCIETY; CELLS; EXPRESSION; CAVEOLIN-1; ESTROGEN; RECOMMENDATIONS; PHENOTYPE; HORMONES	Classically, the actions of progesterone (P4) are attributed to the binding of nuclear progesterone receptor (PR) and subsequent activation of its downstream target genes. These mechanisms, however, are not applicable to PR-or basal phenotype breast cancer (BPBC) due to lack of PR in these cancers. Recently, the function of membrane progesterone receptor alpha (mPR alpha) in human BPBC cell lines was studied in our lab. We proposed that the signaling cascades of P4 -> mPR alpha pathway may play an essential role in controlling cell proliferation and epithelial mesenchymal transition (EMT) of breast cancer. Using human breast cancer tissue microarrays, we found in this study that the average intensity of mPR alpha expression, but not percentage of breast cancer with high level of mPR alpha expression (mPR alpha-HiEx), was significantly lower in the TNM stage 4 patients compared to those with TNM 1-3 patients; and both average intensities of mPR alpha expression and mPR alpha-HiEx rates were significantly higher in cancers negative for ER, as compared with those cancers with ER+. However, after adjusting for age at diagnosis and/or TNM stage, only average intensities of mPR alpha expression were associated with ER status. In addition, we found that the rates of mPR alpha-HiEx were significantly higher in cancers with epithelial growth factor receptor-1 (EGFR+) and high level of Ki67 expression, indicating positive correlation between mPR alpha over expression and EGFR or Ki67. Further analysis indicated that both mPR alpha-HiEx rate and average intensity of mPR alpha expression were significantly higher in HER2+ subtype cancers (i.e. HER2+ER-PR-) as compared to ER+ subtype cancers. These data support our hypothesis that P4 modulates the activities of the PI3K and cell proliferation pathways through the caveolar membrane bound growth factor receptors such as mPR alpha and growth factor receptors. Future large longitudinal studies with larger sample size and survival outcomes are necessary to confirm our findings.	[Xie, Mingxuan; Liu, Zhaofan; You, Shaojin] Atlanta VA Med Ctr, Atlanta Res & Educ Fdn, Histopathol Core, Decatur, GA USA; [Zhu, Xiangzhu; Shrubsole, Martha; Dai, Qi] Vanderbilt Univ, Vanderbilt Epidemiol Ctr, Div Epidemiol, Nashville, TN USA; [Varma, Vijay] Atlanta VA Med Ctr, Dept Pathol, Decatur, GA USA; [Mayer, Ingrid A.] Sch Med, Div Hematol Oncol, Nashville, TN USA; [Xie, Mingxuan; Chen, Qiong] Cent S Univ, Xiangya Hosp, Dept Geriatr, Changsha, Hunan, Peoples R China	US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System; Atlanta VA Medical Center; Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System; Atlanta VA Medical Center; Central South University	Xie, MX (corresponding author), Atlanta VA Med Ctr, Atlanta Res & Educ Fdn, Histopathol Core, Decatur, GA USA.	qi.dai@Vanderbilt.Edu; Shaojin.You@va.gov	Shrubsole, Martha J/K-5052-2015; Zhu, Xiangzhu/ABB-5787-2021	Shrubsole, Martha J/0000-0002-5591-7575; Zhu, Xiangzhu/0000-0002-4462-8815	Atlanta Research and Education Foundation; Emory University; NATIONAL CANCER INSTITUTE [K23CA127469, R03CA112645] Funding Source: NIH RePORTER	Atlanta Research and Education Foundation; Emory University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was funded by Atlanta Research and Education Foundation Bridge Fund (SY) and Emory University Research Award (SY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bouman A, 2005, HUM REPROD UPDATE, V11, P411, DOI 10.1093/humupd/dmi008; Cheang MCU, 2009, JNCI-J NATL CANCER I, V101, P736, DOI 10.1093/jnci/djp082; D'Eon T, 2002, J WOMEN HEALTH GEN-B, V11, P225, DOI 10.1089/152460902753668439; Dressing GE, 2007, STEROIDS, V72, P111, DOI 10.1016/j.steroids.2006.10.006; Eliakim R, 2000, J REPROD MED, V45, P781; Elsheikh SE, 2008, BRIT J CANCER, V99, P327, DOI 10.1038/sj.bjc.6604463; Fadare O, 2008, NAT CLIN PRACT ONCOL, V5, P149, DOI 10.1038/ncponc1038; Falkenstein E, 2000, PHARMACOL REV, V52, P513; Flanagan MB, 2008, MODERN PATHOL, V21, P1255, DOI 10.1038/modpathol.2008.54; Flynn JF, 2009, J ONCOL, V2009, DOI 10.1155/2009/526963; Gellersen B, 2009, HUM REPROD UPDATE, V15, P119, DOI 10.1093/humupd/dmn044; Gialeli C, 2009, CURR MED CHEM, V16, P3797, DOI 10.2174/092986709789177984; Graham JD, 1997, ENDOCR REV, V18, P502, DOI 10.1210/er.18.4.502; Harris L, 2007, J CLIN ONCOL, V25, P5287, DOI 10.1200/JCO.2007.14.2364; Karteris E, 2006, MOL ENDOCRINOL, V20, P1519, DOI 10.1210/me.2005-0243; Lange CA, 1999, MOL ENDOCRINOL, V13, P829, DOI 10.1210/me.13.6.829; Liegl B, 2005, MODERN PATHOL, V18, P1283, DOI 10.1038/modpathol.3800437; Losel R, 2005, HORM METAB RES, V37, P10, DOI 10.1055/s-2005-861023; Losel R, 2003, NAT REV MOL CELL BIO, V4, P46, DOI 10.1038/nrm1009; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; McGowan EM, 2004, BREAST CANCER RES TR, V83, P211, DOI 10.1023/B:BREA.0000014041.58977.80; Medina PJ, 2008, CLIN THER, V30, P1426, DOI 10.1016/j.clinthera.2008.08.008; Morel AP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002888; Oettel M, 2004, Aging Male, V7, P236; Patel HH, 2008, ANNU REV PHARMACOL, V48, P359, DOI 10.1146/annurev.pharmtox.48.121506.124841; Pelekanou V, 2007, CANCER EPIDEM BIOMAR, V16, P2016, DOI 10.1158/1055-9965.EPI-06-1023; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Quinkler M, 2003, J CLIN ENDOCR METAB, V88, P2803, DOI 10.1210/jc.2002-021970; Pinilla SMR, 2006, BREAST CANCER RES TR, V99, P85, DOI 10.1007/s10549-006-9184-1; Schuffner AA, 2002, MOL HUM REPROD, V8, P722, DOI 10.1093/molehr/8.8.722; Sen A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2580; Sleiter N, 2009, ENDOCRINOLOGY, V150, P3833, DOI 10.1210/en.2008-0774; Thomas P, 2008, FRONT NEUROENDOCRIN, V29, P292, DOI 10.1016/j.yfrne.2008.01.001; Thomson TA, 2010, AM J CLIN PATHOL, V133, P909, DOI 10.1309/AJCP1IU7BTSAQGYZ; Viale G, 2007, J CLIN ONCOL, V25, P3846, DOI 10.1200/JCO.2007.11.9453; Weigel MT, 2010, ENDOCR-RELAT CANCER, V17, pR245, DOI 10.1677/ERC-10-0136; Williams TM, 2005, AM J PHYSIOL-CELL PH, V288, pC494, DOI 10.1152/ajpcell.00458.2004; Wolff AC, 2007, J CLIN ONCOL, V25, P118, DOI 10.1200/JCO.2006.09.2775; You S, 2010, J MOL HISTOL    0518; Zhu Y, 2003, P NATL ACAD SCI USA, V100, P2231, DOI 10.1073/pnas.0336132100; Zlobec I, 2006, MODERN PATHOL, V19, P1236, DOI 10.1038/modpathol.3800642; Zuo LA, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2588; Zuo L, 2009, CANCER CELL INT, V9, DOI 10.1186/1475-2867-9-8	43	27	28	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e35198	10.1371/journal.pone.0035198	http://dx.doi.org/10.1371/journal.pone.0035198			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GO	22496908	Green Published, gold, Green Submitted			2022-12-27	WOS:000304855200102
J	Zhang, YC; Limaye, PB; Lehman-McKeeman, LD; Klaassen, CD				Zhang, Youcai; Limaye, Pallavi B.; Lehman-McKeeman, Lois D.; Klaassen, Curtis D.			Dysfunction of Organic Anion Transporting Polypeptide 1a1 Alters Intestinal Bacteria and Bile Acid Metabolism in Mice	PLOS ONE			English	Article							SALT HYDROLASE; MOUSE; PURIFICATION; MICROFLORA; EXPRESSION; REVEALS; STRAINS; OBESITY	Organic anion transporting polypeptide 1a1 (Oatp1a1) is predominantly expressed in liver and is able to transport bile acids (BAs) in vitro. Male Oatp1a1-null mice have increased concentrations of taurodeoxycholic acid (TDCA), a secondary BA generated by intestinal bacteria, in both serum and livers. Therefore, in the present study, BA concentrations and intestinal bacteria in wild-type (WT) and Oatp1a1-null mice were quantified to investigate whether the increase of secondary BAs in Oatp1a1-null mice is due to alterations in intestinal bacteria. The data demonstrate that Oatp1a1-null mice : (1) have similar bile flow and BA concentrations in bile as WT mice; (2) have a markedly different BA composition in the intestinal contents, with a decrease in conjugated BAs and an increase in unconjugated BAs; (3) have BAs in the feces that are more deconjugated, desulfated, 7-dehydroxylated, 3-epimerized, and oxidized, but less 7-epimerized; (4) have 10-fold more bacteria in the small intestine, and 2-fold more bacteria in the large intestine which is majorly due to a 200% increase in Bacteroides and a 30% reduction in Firmicutes; and (5) have a different urinary excretion of bacteria-related metabolites than WT mice. In conclusion, the present study for the first time established that lack of a liver transporter (Oatp1a1) markedly alters the intestinal environment in mice, namely the bacteria composition.	[Zhang, Youcai; Limaye, Pallavi B.; Klaassen, Curtis D.] Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS 66103 USA; [Lehman-McKeeman, Lois D.] Bristol Myers Squibb Co, Pharmaceut Candidate Optimizat, Princeton, NJ USA	University of Kansas; University of Kansas Medical Center; Bristol-Myers Squibb	Zhang, YC (corresponding author), Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS 66103 USA.	cklaasse@kumc.edu	Zhang, Youcai/C-9085-2013; zhang, youcai/K-1303-2015		NIH [ES009649, RR021940]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR021940] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES009649] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by NIH grants ES009649 and RR021940. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMANN RI, 1990, APPL ENVIRON MICROB, V56, P1919, DOI 10.1128/AEM.56.6.1919-1925.1990; Bhathena SJ, 2002, AM J CLIN NUTR, V76, P1191, DOI 10.1093/ajcn/76.6.1191; Cheng QQ, 2008, MOL PHARMACEUT, V5, P77, DOI 10.1021/mp700114j; Cheng XG, 2005, DRUG METAB DISPOS, V33, P1062, DOI 10.1124/dmd.105.003640; Corzo G, 1999, J DAIRY SCI, V82, P472, DOI 10.3168/jds.S0022-0302(99)75256-2; DAVIS PJ, 1976, J BACTERIOL, V126, P544, DOI 10.1128/JB.126.1.544-546.1976; Eyssen HJ, 1999, APPL ENVIRON MICROB, V65, P3158; Fisher CD, 2009, EUR J PHARMACOL, V613, P119, DOI 10.1016/j.ejphar.2009.04.002; Garrett WS, 2010, CELL HOST MICROBE, V8, P292, DOI 10.1016/j.chom.2010.08.004; Gong LL, 2011, TOXICOL SCI; GOPALSRIVASTAVA R, 1988, J LIPID RES, V29, P1079; Guarner F, 2003, LANCET, V361, P512, DOI 10.1016/S0140-6736(03)12489-0; Hagenbuch B, 2008, XENOBIOTICA, V38, P778, DOI [10.1080/00498250801986951, 10.1080/00498250801986951 ]; Hagenbuch B, 2003, BBA-BIOMEMBRANES, V1609, P1, DOI 10.1016/S0005-2736(02)00633-8; Hagenbuch B, 2000, BIOCHEM J, V345, P115, DOI 10.1042/0264-6021:3450115; Hofmann AF, 2008, CELL MOL LIFE SCI, V65, P2461, DOI 10.1007/s00018-008-7568-6; HUIJGHEBAERT S, 1984, J STEROID BIOCHEM, V20, P907, DOI 10.1016/0022-4731(84)90404-7; Inagaki T, 2005, CELL METAB, V2, P217, DOI 10.1016/j.cmet.2005.09.001; KAWAMOTO K, 1989, J BIOCHEM-TOKYO, V106, P1049, DOI 10.1093/oxfordjournals.jbchem.a122962; Kinross James M, 2008, Curr Gastroenterol Rep, V10, P396, DOI 10.1007/s11894-008-0075-y; Kitahara M, 2000, INT J SYST EVOL MICR, V50, P971, DOI 10.1099/00207713-50-3-971; Klaassen CD, 2010, PHARMACOL REV, V62, P1, DOI 10.1124/pr.109.002014; Lepercq P, 2004, FEMS MICROBIOL LETT, V235, P65, DOI [10.1016/j.femsle.2004.04.011, 10.1111/j.1574-6968.2004.tb09568.x]; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Ley RE, 2008, NAT REV MICROBIOL, V6, P776, DOI 10.1038/nrmicro1978; MACDONALD IA, 1981, BIOCHIM BIOPHYS ACTA, V665, P262, DOI 10.1016/0005-2760(81)90011-4; MACDONALD IA, 1976, BIOCHIM BIOPHYS ACTA, V450, P142, DOI 10.1016/0005-2760(76)90086-2; MACDONALD IA, 1981, J LIPID RES, V22, P458; Martoni C, 2008, APPL MICROBIOL BIOT, V81, P225, DOI 10.1007/s00253-008-1642-8; Podschun R, 1998, CLIN MICROBIOL REV, V11, P589, DOI 10.1128/CMR.11.4.589; Ridlon JM, 2006, J LIPID RES, V47, P241, DOI 10.1194/jlr.R500013-JLR200; Riordan SM, 1998, AM J GASTROENTEROL, V93, P234, DOI 10.1016/S0002-9270(97)00051-8; Robertson DG, 2011, TOXICOL SCI, V120, pS146, DOI 10.1093/toxsci/kfq358; Salzman NH, 2002, MICROBIOL-SGM, V148, P3651, DOI 10.1099/00221287-148-11-3651; Son G, 2010, GASTROENT RES PRACT, V2010, DOI 10.1155/2010/453563; TAKAMINE F, 1985, MICROBIOL IMMUNOL, V29, P1247, DOI 10.1111/j.1348-0421.1985.tb00915.x; Wikoff WR, 2009, P NATL ACAD SCI USA, V106, P3698, DOI 10.1073/pnas.0812874106; Zhang Y, 2010, J LIPID RES, V51, P13; Zhang Y, 2011, TOXICOL SCI, V124, P251, DOI 10.1093/toxsci/kfr236	39	14	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e34522	10.1371/journal.pone.0034522	http://dx.doi.org/10.1371/journal.pone.0034522			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GO	22496825	Green Submitted, gold, Green Published			2022-12-27	WOS:000304855200061
J	Seifert, AW; Monaghan, JR; Voss, SR; Maden, M				Seifert, Ashley W.; Monaghan, James R.; Voss, S. Randal; Maden, Malcolm			Skin Regeneration in Adult Axolotls: A Blueprint for Scar-Free Healing in Vertebrates	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX; WOUND REPAIR; LIMB REGENERATION; KERATINOCYTE ACTIVATION; AMBYSTOMA-MEXICANUM; BASEMENT-MEMBRANE; FINE-STRUCTURE; FETAL; NEWT; CELL	While considerable progress has been made towards understanding the complex processes and pathways that regulate human wound healing, regenerative medicine has been unable to develop therapies that coax the natural wound environment to heal scar-free. The inability to induce perfect skin regeneration stems partly from our limited understanding of how scar-free healing occurs in a natural setting. Here we have investigated the wound repair process in adult axolotls and demonstrate that they are capable of perfectly repairing full thickness excisional wounds made on the flank. In the context of mammalian wound repair, our findings reveal a substantial reduction in hemostasis, reduced neutrophil infiltration and a relatively long delay in production of new extracellular matrix (ECM) during scar-free healing. Additionally, we test the hypothesis that metamorphosis leads to scarring and instead show that terrestrial axolotls also heal scar-free: albeit at a slower rate. Analysis of newly forming dermal ECM suggests that low levels of fibronectin and high levels of tenascin-C promote regeneration in lieu of scarring. Lastly, a genetic analysis during wound healing comparing epidermis between aquatic and terrestrial axolotls suggests that matrix metalloproteinases may regulate the fibrotic response. Our findings outline a blueprint to understand the cellular and molecular mechanisms coordinating scar-free healing that will be useful towards elucidating new regenerative therapies targeting fibrosis and wound repair.	[Seifert, Ashley W.; Monaghan, James R.; Maden, Malcolm] Univ Florida, Dept Biol, Gainesville, FL 32611 USA; [Voss, S. Randal] Univ Kentucky, Dept Biol, Lexington, KY USA; [Voss, S. Randal] Univ Kentucky, Spinal Cord & Brain Injury Res Ctr, Lexington, KY USA	State University System of Florida; University of Florida; University of Kentucky; University of Kentucky	Seifert, AW (corresponding author), Univ Florida, Dept Biol, Gainesville, FL 32611 USA.	seifert@ufl.edu		Seifert, Ashley/0000-0001-6576-3664	NIH-NCRR [R24-RR016344]; Army Research Office [MURI: W911NF-09-1-0305]; DFG Center for Regenerative Therapies; NIH-NIDCD [R01-DC005590-07S1]; National Science Foundation [DBI-0951484]; NIH [5RC2NS069480]; NIH-NIDDK [5T32DK074367]; University of Florida; NATIONAL CENTER FOR RESEARCH RESOURCES [R24RR016344] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK074367] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [RC2NS069480] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005590] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R24OD010435] Funding Source: NIH RePORTER	NIH-NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Army Research Office; DFG Center for Regenerative Therapies(German Research Foundation (DFG)); NIH-NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); National Science Foundation(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH-NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); University of Florida(University of Florida); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The Ambystoma Affymetrix Genechips were designed from a transcript assembly funded by NIH-NCRR (R24-RR016344). Most of the transcripts were generated under the NIH-NCRR grant and an Army Research Office grant (MURI: W911NF-09-1-0305) to Ken Muneoka, David Gardiner, and SRV. Additional transcripts were provided by Elly Tanaka through funding from the DFG Center for Regenerative Therapies, and Bernd Fritsch through funding from NIH-NIDCD (R01-DC005590-07S1). The axolotls were obtained from the Ambystoma Genetic Stock Center at the University of Kentucky, which is funded by the National Science Foundation (DBI-0951484). This study was supported by NIH 5RC2NS069480 to MM and AWS is funded by NIH-NIDDK 5T32DK074367. Publication of this article was funded in part by the University of Florida Open-Access Publishing Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarabi S, 2007, PLOS MED, V4, P1464, DOI 10.1371/journal.pmed.0040234; ADZICK NS, 1985, J PEDIATR SURG, V20, P315; Adzick NS, 1992, FETAL WOUND HEALING, Vxv; Annis DS, 2006, J THROMB HAEMOST, V4, P459, DOI 10.1111/j.1538-7836.2006.01723.x; ARMSTRONG JR, 1995, DEV BIOL, V169, P242, DOI 10.1006/dbio.1995.1141; Bayat A, 2003, BRIT MED J, V326, P88, DOI 10.1136/bmj.326.7380.88; Beare AHM, 2006, J ANAT, V209, P547, DOI 10.1111/j.1469-7580.2006.00641.x; BILLINGHAM RE, 1956, NATURE, V177, P791, DOI 10.1038/177791b0; BREEDIS C, 1954, CANCER RES, V14, P575; Brown BC, 2008, J PLAST RECONSTR AES, V61, P1049, DOI 10.1016/j.bjps.2008.03.020; Bullard KM, 2003, WORLD J SURG, V27, P54, DOI 10.1007/s00268-002-6737-2; Calve S, 2010, DEV BIOL, V344, P259, DOI 10.1016/j.ydbio.2010.05.007; Clark LD, 1998, CLIN IMMUNOL IMMUNOP, V88, P35, DOI 10.1006/clin.1998.4519; Clark R. A. F, 1996, MOL CELLULAR BIOL WO; CLARK RAF, 1990, J INVEST DERMATOL, V94, pS128, DOI 10.1111/1523-1747.ep12876104; Colwell AS, 2006, WOUND REPAIR REGEN, V14, P81, DOI 10.1111/j.1524-475X.2005.00092.x; Coolen NA, 2010, ARCH DERMATOL RES, V302, P47, DOI 10.1007/s00403-009-0989-8; Coulombe PA, 1997, BIOCHEM BIOPH RES CO, V236, P231, DOI 10.1006/bbrc.1997.6945; Dang CM, 2003, PLAST RECONSTR SURG, V111, P2273, DOI 10.1097/01.PRS.0000060102.57809.DA; Davis AK, 2008, FUNCT ECOL, V22, P760, DOI 10.1111/j.1365-2435.2008.01467.x; DONALDSON DJ, 1991, ANAT REC, V230, P451, DOI 10.1002/ar.1092300403; DONALDSON DJ, 1995, ANAT REC, V241, P49, DOI 10.1002/ar.1092410108; Dovi JV, 2004, THROMB HAEMOSTASIS, V92, P275, DOI 10.1160/TH03-11-0720; Dovi JV, 2003, J LEUKOCYTE BIOL, V73, P448, DOI 10.1189/jlb.0802406; Eppley BL, 2004, PLAST RECONSTR SURG, V114, P1502, DOI 10.1097/01.PRS.0000138251.07040.51; Ferguson MWJ, 2004, PHILOS T R SOC B, V359, P839, DOI 10.1098/rstb.2004.1475; Ferguson MWJ, 1991, FETAL WOUND HEALING, P92; Ferris DR, 2010, DEV GROWTH DIFFER, V52, P715, DOI 10.1111/j.1440-169X.2010.01208.x; FRANTZ FW, 1992, J PEDIATR SURG, V27, P945, DOI 10.1016/0022-3468(92)90537-H; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Godwin JW, 2006, J ANAT, V209, P423, DOI 10.1111/j.1469-7580.2006.00626.x; GOSS RJ, 1987, NEWS PHYSIOL SCI, V2, P112, DOI 10.1152/physiologyonline.1987.2.3.112; GRINNELL F, 1992, J CELL SCI, V101, P1; GRINNELL F, 1981, J INVEST DERMATOL, V76, P181, DOI 10.1111/1523-1747.ep12525694; GRINNELL F, 1994, J CELL BIOL, V124, P401, DOI 10.1083/jcb.124.4.401; GROSS J, 1995, P NATL ACAD SCI USA, V92, P5982, DOI 10.1073/pnas.92.13.5982; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Hasegawa H, 2007, ARCH HISTOL CYTOL, V70, P255, DOI 10.1679/aohc.70.255; HEMESATH TJ, 1994, J IMMUNOL, V152, P5199; Huggins P, COMP BIOCH PHYSL C; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Ito M, 2007, NATURE, V447, P316, DOI 10.1038/nature05766; JARIAL MS, 1989, J ANAT, V167, P95; KELLY DE, 1966, ANAT REC, V154, P685, DOI 10.1002/ar.1091540314; Kumar A, 2010, J ANAT, V217, P16, DOI 10.1111/j.1469-7580.2010.01239.x; KURKINEN M, 1980, LAB INVEST, V43, P47; Levesque M, 2010, J EXP ZOOL PART B, V314B, P684, DOI 10.1002/jez.b.21371; LIN RY, 1995, ANN SURG, V222, P146, DOI 10.1097/00000658-199508000-00006; MACKIE EJ, 1988, J CELL BIOL, V107, P2757, DOI 10.1083/jcb.107.6.2757; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; Martin P, 2005, TRENDS CELL BIOL, V15, P599, DOI 10.1016/j.tcb.2005.09.002; Martin P, 2003, CURR BIOL, V13, P1122, DOI 10.1016/S0960-9822(03)00396-8; MAST BA, 1992, SURG GYNECOL OBSTET, V174, P441; Mauch C, 2010, J INVEST DERMATOL, V130, P2120, DOI 10.1038/jid.2010.60; Mescher AL, 2005, ADV BIOCHEM ENG BIOT, V93, P39, DOI 10.1007/b99966; Mescher AL, 2006, THESCIENTIFICWORLDJO, V6, P1, DOI 10.1100/tsw.2006.323; Metcalfe AD, 2006, J ANAT, V209, P439, DOI 10.1111/j.1469-7580.2006.00632.x; Mori R, 2008, J EXP MED, V205, P43, DOI 10.1084/jem.20071412; Namazi MR, 2011, INT J DERMATOL, V50, P85, DOI 10.1111/j.1365-4632.2010.04678.x; Neufeld DA, 1996, ANAT RECORD, V245, P122; Neufeld DA, 1996, ANAT RECORD, V246, P155; OKADA Y, 1990, EUR J BIOCHEM, V194, P721, DOI 10.1111/j.1432-1033.1990.tb19462.x; ONDA H, 1990, DEVELOPMENT, V108, P657; Page RB, 2009, COLD SPRING HARB PRO; POLEZHAEV LV, 1972, ORGAN REGENERATION A; Rose SM, 1944, J EXP ZOOL, V95, P149, DOI 10.1002/jez.1400950202; Sanges R, 2007, BIOINFORMATICS, V23, P3406, DOI 10.1093/bioinformatics/btm469; Santosh N, 2011, DEV DYNAM, V240, P1127, DOI 10.1002/dvdy.22503; Schultz GS, 2011, WOUND REPAIR REGEN, V19, P134, DOI 10.1111/j.1524-475X.2011.00673.x; Schultz GS, 2009, WOUND REPAIR REGEN, V17, P153, DOI 10.1111/j.1524-475X.2009.00466.x; SHEEHAN HL, 1947, J PATHOL BACTERIOL, V59, P336, DOI 10.1002/path.1700590142; SIMPSON DM, 1972, J CLIN INVEST, V51, P2009, DOI 10.1172/JCI107007; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; Stramer BM, 2007, J INVEST DERMATOL, V127, P1009, DOI 10.1038/sj.jid.5700811; Sund B, 2000, NEW DEV WOUND CARE, P1; Szpaderska AM, 2003, J INVEST DERMATOL, V120, P1130, DOI 10.1046/j.1523-1747.2003.12253.x; Toriseva M, 2009, CELL MOL LIFE SCI, V66, P203, DOI 10.1007/s00018-008-8388-4; Vinarsky V, 2005, DEV BIOL, V279, P86, DOI 10.1016/j.ydbio.2004.12.003; Wallace, 1981, VERTEBRATE LIMB REGE; Werb Z, 1997, CELL, V91, P439, DOI 10.1016/S0092-8674(00)80429-8; WHITBY DJ, 1991, DEVELOPMENT, V112, P651; Yannas I.V., 2001, REGENERATION SKIN; Yannas Ioannis V., 1996, Wound Repair and Regeneration, V4, P29, DOI 10.1046/j.1524-475X.1996.40107.x	85	171	176	2	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2012	7	4							e32875	10.1371/journal.pone.0032875	http://dx.doi.org/10.1371/journal.pone.0032875			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952GU	22485136	Green Published, Green Submitted, gold			2022-12-27	WOS:000304780500012
J	Stathopoulou, A; Roukos, V; Petropoulou, C; Kotsantis, P; Karantzelis, N; Nishitani, H; Lygerou, Z; Taraviras, S				Stathopoulou, Athanasia; Roukos, Vassilis; Petropoulou, Chariklia; Kotsantis, Panagiotis; Karantzelis, Nickolas; Nishitani, Hideo; Lygerou, Zoi; Taraviras, Stavros			Cdt1 Is Differentially Targeted for Degradation by Anticancer Chemotherapeutic Drugs	PLOS ONE			English	Article							UBIQUITIN LIGASE; DNA-REPLICATION; TOPOISOMERASE-II; CELL-CYCLE; LICENSING FACTOR; GEMININ; CANCER; PCNA; PROTEOLYSIS; CHROMATIN	Background: Maintenance of genome integrity is crucial for the propagation of the genetic information. Cdt1 is a major component of the pre-replicative complex, which controls once per cell cycle DNA replication. Upon DNA damage, Cdt1 is rapidly targeted for degradation. This targeting has been suggested to safeguard genomic integrity and prevent re-replication while DNA repair is in progress. Cdt1 is deregulated in tumor specimens, while its aberrant expression is linked with aneuploidy and promotes tumorigenesis in animal models. The induction of lesions in DNA is a common mechanism by which many cytotoxic anticancer agents operate, leading to cell cycle arrest and apoptosis. Methodology/Principal Finding: In the present study we examine the ability of several anticancer drugs to target Cdt1 for degradation. We show that treatment of HeLa and HepG2 cells with MMS, Cisplatin and Doxorubicin lead to rapid proteolysis of Cdt1, whereas treatment with 5-Fluorouracil and Tamoxifen leave Cdt1 expression unaffected. Etoposide affects Cdt1 stability in HepG2 cells and not in HeLa cells. RNAi experiments suggest that Cdt1 proteolysis in response to MMS depends on the presence of the sliding clamp PCNA. Conclusion/Significance: Our data suggest that treatment of tumor cells with commonly used chemotherapeutic agents induces differential responses with respect to Cdt1 proteolysis. Information on specific cellular targets in response to distinct anticancer chemotherapeutic drugs in different cancer cell types may contribute to the optimization of the efficacy of chemotherapy.	[Stathopoulou, Athanasia; Petropoulou, Chariklia; Karantzelis, Nickolas; Taraviras, Stavros] Univ Patras, Sch Med, Dept Physiol, GR-26110 Patras, Greece; [Roukos, Vassilis; Kotsantis, Panagiotis; Lygerou, Zoi] Univ Patras, Sch Med, Dept Gen Biol, GR-26110 Patras, Greece; [Nishitani, Hideo] Univ Hyogo, Grad Sch Life Sci, Dept Biol Signaling, Kobe, Hyogo 6500044, Japan	University of Patras; University of Patras; University of Hyogo	Stathopoulou, A (corresponding author), Univ Patras, Sch Med, Dept Physiol, GR-26110 Patras, Greece.	taraviras@med.upatras.gr	Roukos, Vassilis/K-6248-2012; Kotsantis, Panagiotis/AGU-7131-2022; Kotsantis, Panagiotis/AGZ-3258-2022; Taraviras, Stavros/AAJ-4690-2020; Roukos, Vassilis/AAC-4827-2020	Kotsantis, Panagiotis/0000-0002-6131-4009; Kotsantis, Panagiotis/0000-0002-6131-4009; Taraviras, Stavros/0000-0002-7455-647X; Nishitani, Hideo/0000-0001-5907-9380; Karantzelis, Nikolaos/0000-0002-6582-6757; Stathopoulou, Athanasia/0000-0001-8579-7706; Roukos, Vassilis/0000-0002-5065-3937	Hellenic Anticancer Institute [11/2005]; Grants-in-Aid for Scientific Research [22019033] Funding Source: KAKEN	Hellenic Anticancer Institute; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by research funding from the Hellenic Anticancer Institute to S. Taraviras (11/2005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Achuthan S, 2011, J BIOL CHEM, V286, P37813, DOI 10.1074/jbc.M110.200675; Arentson E, 2002, ONCOGENE, V21, P1150, DOI 10.1038/sj.onc.1205175; Arias EE, 2006, NAT CELL BIOL, V8, P84, DOI 10.1038/ncb1346; Arias EE, 2005, GENE DEV, V19, P114, DOI 10.1101/gad.1255805; Bender RP, 2008, BIOCHEMISTRY-US, V47, P4501, DOI 10.1021/bi702019z; Bravou V, 2005, INT J ONCOL, V27, P1511; Davidson IF, 2006, MOL CELL, V24, P433, DOI 10.1016/j.molcel.2006.09.010; Gasnereau I, 2007, CYTOM PART A, V71A, P1, DOI 10.1002/cyto.a.20352; Guarino E, 2011, NUCLEIC ACIDS RES, V39, P5978, DOI 10.1093/nar/gkr222; Havens CG, 2009, MOL CELL, V35, P93, DOI 10.1016/j.molcel.2009.05.012; Higa LAA, 2003, NAT CELL BIOL, V5, P1008, DOI 10.1038/ncb1061; Higa LA, 2006, CELL CYCLE, V5, P1675, DOI 10.4161/cc.5.15.3149; Hu J, 2006, J BIOL CHEM, V281, P3753, DOI 10.1074/jbc.C500464200; Hu J, 2004, NAT CELL BIOL, V6, P1003, DOI 10.1038/ncb1172; Jin JP, 2006, MOL CELL, V23, P709, DOI 10.1016/j.molcel.2006.08.010; Karakaidos P, 2004, AM J PATHOL, V165, P1351, DOI 10.1016/S0002-9440(10)63393-7; Kondo T, 2004, J BIOL CHEM, V279, P27315, DOI 10.1074/jbc.M314023200; Li XH, 2003, J BIOL CHEM, V278, P30854, DOI 10.1074/jbc.C300251200; Liontos M, 2007, CANCER RES, V67, P10899, DOI 10.1158/0008-5472.CAN-07-2837; Liu EB, 2004, J BIOL CHEM, V279, P17283, DOI 10.1074/jbc.C300549200; Maiorano D, 2000, NATURE, V404, P622, DOI 10.1038/35007104; Musch T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010726; Nishitani H, 2006, EMBO J, V25, P1126, DOI 10.1038/sj.emboj.7601002; Nishitani H, 2000, NATURE, V404, P625, DOI 10.1038/35007110; Nishitani H, 2001, J BIOL CHEM, V276, P44905, DOI 10.1074/jbc.M105406200; Nitiss JL, 2009, NAT REV CANCER, V9, P338, DOI 10.1038/nrc2607; Petropoulou C, 2008, FRONT BIOSCI, V13, P4485, DOI 10.2741/3018; PINES J, 1990, NATURE, V346, P760, DOI 10.1038/346760a0; Ponti D, 2005, CANCER RES, V65, P5506, DOI 10.1158/0008-5472.CAN-05-0626; Ralph E, 2006, EMBO REP, V7, P1134, DOI 10.1038/sj.embor.7400827; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; Sansam CL, 2006, GENE DEV, V20, P3117, DOI 10.1101/gad.1482106; Senga T, 2006, J BIOL CHEM, V281, P6246, DOI 10.1074/jbc.M512705200; Seo J, 2005, ONCOGENE, V24, P8176, DOI 10.1038/sj.onc.1208881; Sharma SV, 2010, CELL, V141, P69, DOI 10.1016/j.cell.2010.02.027; Shibata E, 2011, MOL CELL BIOL, V31, P3136, DOI 10.1128/MCB.05496-11; Spella M, 2007, NEUROSCIENCE, V147, P373, DOI 10.1016/j.neuroscience.2007.03.050; Sugimoto N, 2004, J BIOL CHEM, V279, P19691, DOI 10.1074/jbc.M313175200; Tada S, 2001, NAT CELL BIOL, V3, P107, DOI 10.1038/35055000; Tatsumi Y, 2006, J CELL SCI, V119, P3128, DOI 10.1242/jcs.03031; Thomer M, 2004, DEVELOPMENT, V131, P4807, DOI 10.1242/dev.01348; Vaziri C, 2003, MOL CELL, V11, P997, DOI 10.1016/S1097-2765(03)00099-6; Wang D, 2005, NAT REV DRUG DISCOV, V4, P307, DOI 10.1038/nrd1691; Wang JZ, 2006, AM J PHYSIOL-RENAL, V291, pF1300, DOI 10.1152/ajprenal.00509.2005; Wilstermann AM, 2007, BIOCHEMISTRY-US, V46, P8217, DOI 10.1021/bi700272u; Wohlschlegel JA, 2000, SCIENCE, V290, P2309, DOI 10.1126/science.290.5500.2309; Wong PG, 2010, CELL CYCLE, V9, P4351, DOI 10.4161/cc.9.21.13596; Xouri G, 2004, EUR J BIOCHEM, V271, P3368, DOI 10.1111/j.1432-1033.2004.04271.x; Xouri G, 2007, EMBO J, V26, P1303, DOI 10.1038/sj.emboj.7601597; Zhong WW, 2003, NATURE, V423, P885, DOI 10.1038/nature01747; Zhou BBS, 2004, NAT REV CANCER, V4, P216, DOI 10.1038/nrc1296	51	23	23	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e34621	10.1371/journal.pone.0034621	http://dx.doi.org/10.1371/journal.pone.0034621			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479651	Green Published, gold, Green Submitted			2022-12-27	WOS:000305339100171
J	Furumura, K; Koide, T; Okada, T; Murase, S; Aleksic, B; Hayakawa, N; Shiino, T; Nakamura, Y; Tamaji, A; Ishikawa, N; Ohoka, H; Usui, H; Banno, N; Morita, T; Goto, S; Kanai, A; Masuda, T; Ozaki, N				Furumura, Kaori; Koide, Takayoshi; Okada, Takashi; Murase, Satomi; Aleksic, Branko; Hayakawa, Norika; Shiino, Tomoko; Nakamura, Yukako; Tamaji, Ai; Ishikawa, Naoko; Ohoka, Harue; Usui, Hinako; Banno, Naomi; Morita, Tokiko; Goto, Setsuko; Kanai, Atsuko; Masuda, Tomoko; Ozaki, Norio			Prospective Study on the Association between Harm Avoidance and Postpartum Depressive State in a Maternal Cohort of Japanese Women	PLOS ONE			English	Article							MAJOR DEPRESSION; POSTNATAL DEPRESSION; PERSONALITY; DISORDERS; MOOD; CHILDBEARING; TEMPERAMENT; CHARACTER; SCALE	Background: Recent studies have displayed increased interest in examining the relationship between personality traits and the onset, treatment response patterns, and relapse of depression. This study aimed to examine whether or not harm avoidance (HA) was a risk factor for postpartum depression measured by the Edinburgh Postnatal Depression Scale (EPDS) and the state dependency of HA. Methods: Pregnant women (n = 460; mean age 31.9 +/- 4.2 years) who participated in a prenatal program completed the EPDS as a measure of depressive state and the Temperament and Character Inventory (TCI) as a measure of HA during three periods: early pregnancy (T1), late pregnancy (around 36 weeks), and 1 month postpartum (T2). Changes in EPDS and HA scores from T1 to T2 were compared between the non depressive (ND) group and the postpartum depressive (PD) group. Results: There was no significant difference in the level of HA between the ND and PD groups at T1. In the ND group, EPDS and HA scores did not change significantly from T1 to T2. In the PD group, both scores increased significantly from T1 to T2 (EPDS, p<0.0001; HA, p<0.048). In the ND and PD groups, a significant positive correlation was observed in changes in EPDS and HA scores from T1 to T2 (r = 0.31, p = 0.002). Conclusions: These results suggest that HA cannot be considered a risk factor for the development of postpartum depression measured by EPDS. Furthermore, HA may be state dependent.	[Furumura, Kaori; Koide, Takayoshi; Okada, Takashi; Murase, Satomi; Aleksic, Branko; Hayakawa, Norika; Shiino, Tomoko; Nakamura, Yukako; Tamaji, Ai; Ishikawa, Naoko; Ohoka, Harue; Usui, Hinako; Banno, Naomi; Morita, Tokiko; Ozaki, Norio] Nagoya Univ, Dept Psychiat, Grad Sch Med, Nagoya, Aichi 4648601, Japan; [Hayakawa, Norika] Nanzan Univ, Fac Policy Studies, Seto, Aichi, Japan; [Goto, Setsuko] Sugiyama Jogakuen Univ, Dept Nursing, Nagoya, Aichi, Japan; [Kanai, Atsuko] Nagoya Univ, Grad Sch Educ & Human Dev, Nagoya, Aichi 4648601, Japan; [Masuda, Tomoko] Nagoya Univ, Grad Sch Law, Nagoya, Aichi 4648601, Japan	Nagoya University; Nagoya University; Nagoya University	Furumura, K (corresponding author), Nagoya Univ, Dept Psychiat, Grad Sch Med, Nagoya, Aichi 4648601, Japan.	okada@med.nagoya-u.ac.jp	nakamura, yukako/M-8889-2014; Shiino, Tomoko/ABA-7481-2020; Aleksic, Branko/G-1540-2011; Shiino, Tomoko/M-8903-2014; Ozaki, Norio/M-8908-2014; Aleksic, Branko/L-7851-2019; OKADA, Takashi/M-8902-2014	nakamura, yukako/0000-0002-3306-7127; Shiino, Tomoko/0000-0002-8750-0854; Aleksic, Branko/0000-0001-8982-4580; Shiino, Tomoko/0000-0002-8750-0854; Ozaki, Norio/0000-0002-7360-4898; Aleksic, Branko/0000-0001-8982-4580; OKADA, Takashi/0000-0001-5580-9913	Ministry of Education, Culture, Sports, Science and Technology of Japan; Ministry of Health, Labor and Welfare of Japan; Academic Frontier Project for Private Universities; Comparative Cognitive Science Institutes; Meijo University; National Center of Neurology and Psychiatry [21B-2]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Academic Frontier Project for Private Universities(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Comparative Cognitive Science Institutes; Meijo University; National Center of Neurology and Psychiatry(National Center for Neurology & Psychiatry - Japan)	Funding for this study was provided by research grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan (http://www.mext.go.jp/english/), the Ministry of Health, Labor and Welfare of Japan (http://www.mhlw.go.jp/english/), the Academic Frontier Project for Private Universities, Comparative Cognitive Science Institutes, Meijo University (http://www.meijo-u.ac.jp/english/index.html), and an Intramural Research Grant (21B-2) for Neurological and Psychiatric Disorders from the National Center of Neurology and Psychiatry (http://www.ncnp.go.jp/research/cost.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andriola E, 2011, DEPRESS RES TREAT, V2011, DOI [10.1155/2011/356428, DOI 10.1155/2011/356428]; Beck CT, 2001, NURS RES, V50, P275, DOI 10.1097/00006199-200109000-00004; Brockington I, 2004, LANCET, V363, P303, DOI 10.1016/S0140-6736(03)15390-1; BROWN SL, 1992, J PSYCHIAT RES, V26, P197, DOI 10.1016/0022-3956(92)90023-H; CLONINGER CR, 1987, ARCH GEN PSYCHIAT, V44, P573; CLONINGER CR, 1993, ARCH GEN PSYCHIAT, V50, P975, DOI 10.1001/archpsyc.1993.01820240059008; COX JL, 1987, BRIT J PSYCHIAT, V150, P782, DOI 10.1192/bjp.150.6.782; Cox JL, 1996, J AFFECT DISORDERS, V39, P185, DOI 10.1016/0165-0327(96)00008-0; Evans J, 2001, BRIT MED J, V323, P257, DOI 10.1136/bmj.323.7307.257; Hirano S, 2002, J AFFECT DISORDERS, V69, P31, DOI 10.1016/S0165-0327(00)00329-3; Ishikawa N, 2011, J PSYCHOSOM RES, V71, P264, DOI 10.1016/j.jpsychores.2011.02.001; JOFFE RT, 1993, AM J PSYCHIAT, V150, P959; Kendler KS, 2004, AM J PSYCHIAT, V161, P631, DOI 10.1176/appi.ajp.161.4.631; Kijima N., 1996, ARCH PSYCHIAT DIAGN, V7, P379, DOI DOI 10.1002/(SICI)1097-4679(199812)54:83.0.CO;2-A; Klein DN, 2011, ANNU REV CLIN PSYCHO, V7, P269, DOI 10.1146/annurev-clinpsy-032210-104540; KUMAR R, 1994, SOC PSYCH PSYCH EPID, V29, P250, DOI 10.1007/BF00802048; KUMAR R, 1984, BRIT J PSYCHIAT, V144, P35, DOI 10.1192/bjp.144.1.35; Lee K A, 1999, J Obstet Gynecol Neonatal Nurs, V28, P183, DOI 10.1111/j.1552-6909.1999.tb01983.x; Mulder RT, 2002, AM J PSYCHIAT, V159, P359, DOI 10.1176/appi.ajp.159.3.359; OHARA MW, 1990, J ABNORM PSYCHOL, V99, P3, DOI 10.1037/0021-843X.99.1.3; Okano TMM, 1996, ARCH PSYCHIAT DIAG C, P525; Riso LP, 2002, J AFFECT DISORDERS, V70, P103, DOI 10.1016/S0165-0327(01)00376-7; Sharma V, 2008, BIPOLAR DISORD, V10, P742, DOI 10.1111/j.1399-5618.2008.00606.x; Sharma V, 2009, AM J PSYCHIAT, V166, P1217, DOI 10.1176/appi.ajp.2009.08121902; Wisner KL, 2002, NEW ENGL J MED, V347, P194, DOI 10.1056/NEJMcp011542; Yoshida K, 1997, J AFFECT DISORDERS, V43, P69, DOI 10.1016/S0165-0327(96)01419-X	26	11	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2012	7	4							e34725	10.1371/journal.pone.0034725	http://dx.doi.org/10.1371/journal.pone.0034725			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959FE	22506046	gold, Green Submitted, Green Published			2022-12-27	WOS:000305297500054
J	Kurzweil, V; Tarangelo, A; Oliver, PM				Kurzweil, Vanessa; Tarangelo, Amy; Oliver, Paula M.			Gastrointestinal Microbiota Do Not Significantly Contribute to T Cell Activation or GI Inflammation in Ndfip1-cKO Mice	PLOS ONE			English	Article							BOWEL-DISEASE; ELEMENTAL DIET; EOSINOPHILIC ESOPHAGITIS; CROHNS-DISEASE; COLITIS; ELIMINATION; DEFICIENT; GENE	The bacteria inhabiting the mammalian gastrointestinal (GI) tract play a vital role in normal digestion and immune function. In a healthy host, the immune system is tolerant to gut bacteria and does not mount an effector response to bacteria-derived antigens. Loss of tolerance to intestinal microflora has been associated with inflammatory bowel disease (IBD) in both mice and humans. Mice lacking Ndfip1, an adaptor protein for E3 ubiquitin ligases of the Nedd4-family, in T cells (Ndfip1-cKO) develop a disease resembling IBD. Inflammation in these mice is characterized by increased activation of peripheral T cells, infiltration of eosinophils into the GI tract, and epithelial hypertrophy in the esophagus. We hypothesized that this intestinal inflammation in Ndfip1-cKO mice is caused by a loss of T-cell tolerance to bacterial antigens. Here, we show that treatment of Ndfip1-cKO mice with broad-spectrum antibiotics drastically reduced bacterial load in stool but had little effect on T-cell activation and did not affect eosinophil infiltration into the GI tract or epithelial hypertrophy in the esophagus. Thus, inflammation in Ndfip1-cKO mice is not caused by a loss of tolerance to intestinal microbiota. Rather, T cell activation and eosinophilia may instead be triggered by other environmental antigens.	[Kurzweil, Vanessa] Univ Penn, Perelman Sch Med, Cell & Mol Biol Grp, Philadelphia, PA 19104 USA; [Tarangelo, Amy] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; [Oliver, Paula M.] Univ Penn, Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Oliver, Paula M.] Univ Penn, Dept Pathol, Philadelphia, PA 19104 USA; [Oliver, Paula M.] Univ Penn, Lab Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; University of Pennsylvania	Kurzweil, V (corresponding author), Univ Penn, Perelman Sch Med, Cell & Mol Biol Grp, Philadelphia, PA 19104 USA.	paulao@mail.med.upenn.edu		Tarangelo, Amy/0000-0002-0571-3582	NIH [R01AI093566]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI093566] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the NIH grant R01AI093566. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beal AM, 2012, NAT IMMUNOL, V13, P77, DOI 10.1038/ni.2154; Borrelli O, 2006, CLIN GASTROENTEROL H, V4, P744, DOI 10.1016/j.cgh.2006.03.010; Duchmann R, 1995, CLIN EXP IMMUNOL, V102, P448; GORARD DA, 1993, GUT, V34, P1198, DOI 10.1136/gut.34.9.1198; Habtezion A, 2005, J CELL SCI, V118, P1971, DOI 10.1242/jcs.02316; HE Ramon, 2010, MUCOSAL IMMUNOLOGY, V69; Hill DA, 2010, MUCOSAL IMMUNOL, V3, P148, DOI 10.1038/mi.2009.132; Hill DA, 2010, ANNU REV IMMUNOL, V28, P623, DOI 10.1146/annurev-immunol-030409-101330; Kagalwalla AF, 2006, CLIN GASTROENTEROL H, V4, P1097, DOI 10.1016/j.cgh.2006.05.026; Madsen KL, 2000, GASTROENTEROLOGY, V118, P1094, DOI 10.1016/S0016-5085(00)70362-3; Markowitz JE, 2003, AM J GASTROENTEROL, V98, P777, DOI 10.1111/j.1572-0241.2003.07390.x; Mueller DL, 2004, NAT IMMUNOL, V5, P883, DOI 10.1038/ni1106; Oliver PM, 2006, IMMUNITY, V25, P929, DOI 10.1016/j.immuni.2006.10.012; Panwala CM, 1998, J IMMUNOL, V161, P5733; Rajendran N, 2010, WORLD J GASTROENTERO, V16, P1442, DOI 10.3748/wjg.v16.i12.1442; Suzuki H, 2005, DIGEST DIS SCI, V50, P1951, DOI 10.1007/s10620-005-2967-0	16	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2012	7	4							e34478	10.1371/journal.pone.0034478	http://dx.doi.org/10.1371/journal.pone.0034478			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959FE	22506022	gold, Green Published, Green Submitted			2022-12-27	WOS:000305297500030
J	Li, HG; Huang, SY; Guo, CC; Guan, HT; Xiong, CL				Li, Honggang; Huang, Shiyun; Guo, Cuicui; Guan, Huangtao; Xiong, Chengliang			Cell-Free Seminal mRNA and MicroRNA Exist in Different Forms	PLOS ONE			English	Article							MITOCHONDRIAL-TYPE RIBOSOMES; CIRCULATING MICRORNAS; CANCER-PATIENTS; HEALTHY-INDIVIDUALS; PROTEIN-COMPOSITION; MATERNAL PLASMA; BODY-FLUIDS; BIOMARKERS; SPERM; PROSTASOMES	Background: The great interest in cell-free mRNA, microRNA (miRNA) as molecular biomarkers for clinical applications, and as 'signaling' molecules for intercellular communication highlights the need to reveal their physical nature. Here this issue was explored in human cell-free seminal mRNA (cfs-mRNA) and miRNA (cfs-miRNA). Methodology/Principal Findings: Selected male reproductive organ-specific mRNAs, miRNAs, and piRNAs were quantified by quantitative real-time PCR in all experiments. While the stability of cfs-miRNA assessed by time-course analysis (up to 24 h at room temperature) was similar with cfs-mRNA, the reductive changes between cfs-miRNA and cfs-mRNA after filtration and Triton X-100 treatment on seminal plasma were very different, implying their different physical nature. Seminal microvesicles (SMVs) were then recovered and proportions of cfs-mRNA and cfs-miRNA within SMVs were quantified. The amounts of SMVs-sequestered cfs-mRNAs almost were the same as total cfs-mRNA, and were highly variable depending on the different sizes of SMVs. But most of cfs-miRNA was independent of SMVs and existed in the supernatant. The possible form of cfs-miRNA in the supernatant was further explored by filtration and protease K digestion. It passed through the 0.10-mu m pore, but was degraded dramatically after intense protease K digestion. Conclusions/Significance: The predominant cfs-mRNA is contained in SMVs, while most cfs-miRNA is bound with protein complexes. Our data explained the stability of extracellular RNAs in human semen, and shed light on their origins and potential functions in male reproduction, and strategy of developing them as biomarkers of male reproductive system.	[Li, Honggang; Huang, Shiyun; Guo, Cuicui; Guan, Huangtao; Xiong, Chengliang] Huazhong Univ Sci & Technol, Family Planning Res Inst, Ctr Reprod Med, Tongji Med Coll, Wuhan 430074, Peoples R China; [Li, Honggang; Guan, Huangtao; Xiong, Chengliang] Wuhan Tongji Reprod Med Hosp, Wuhan, Peoples R China; [Huang, Shiyun] Capital Univ Med Sci, Family Planning Dept, Beijing Obstet & Gynecol Hosp, Beijing, Peoples R China	Huazhong University of Science & Technology; Capital Medical University	Li, HG (corresponding author), Huazhong Univ Sci & Technol, Family Planning Res Inst, Ctr Reprod Med, Tongji Med Coll, Wuhan 430074, Peoples R China.	clxiongcn@yahoo.com.cn			National Natural Science Foundation [30801144]; Ph.D. Program Foundation of Education Ministry of China [200804871092, 20100142110077]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Ph.D. Program Foundation of Education Ministry of China	This work was supported by grant no. 30801144 from the National Natural Science Foundation and grants no. 200804871092 and 20100142110077 from the Ph.D. Program Foundation of Education Ministry of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amanai M, 2006, BIOL REPROD, V75, P877, DOI 10.1095/biolreprod.106.056499; Arroyo JD, 2011, P NATL ACAD SCI USA, V108, P5003, DOI 10.1073/pnas.1019055108; Aumuller G, 1997, ADV EXP MED BIOL, V424, P193; Burden HP, 2006, HUM REPROD UPDATE, V12, P283, DOI 10.1093/humupd/dmi052; Carlsson L, 2003, PROSTATE, V54, P322, DOI 10.1002/pros.10189; Chim SSC, 2008, CLIN CHEM, V54, P482, DOI 10.1373/clinchem.2007.097972; Cocucci E, 2009, TRENDS CELL BIOL, V19, P43, DOI 10.1016/j.tcb.2008.11.003; Cornwall GA, 2009, HUM REPROD UPDATE, V15, P213, DOI 10.1093/humupd/dmn055; Cortez MA, 2011, NAT REV CLIN ONCOL, V8, P467, DOI 10.1038/nrclinonc.2011.76; Dimmeler S, 2010, EUR HEART J, V31, P2705, DOI 10.1093/eurheartj/ehq221; Etheridge A, 2011, MUTAT RES-FUND MOL M, V717, P85, DOI 10.1016/j.mrfmmm.2011.03.004; Frenette G, 2003, BIOL REPROD, V69, P1586, DOI 10.1095/biolreprod.103.019216; Garcia JM, 2008, RNA, V14, P1424, DOI 10.1261/rna.755908; Gilad S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003148; Girouard J, 2009, BIOL REPROD, V80, P965, DOI 10.1095/biolreprod.108.073551; Go ATJI, 2011, HUM REPROD UPDATE, V17, P372, DOI 10.1093/humupd/dmq054; Gur Y, 2006, GENE DEV, V20, P411, DOI 10.1101/gad.367606; Gur Y, 2008, MOL CELL ENDOCRINOL, V282, P45, DOI 10.1016/j.mce.2007.11.015; Hanson EK, 2009, ANAL BIOCHEM, V387, P303, DOI 10.1016/j.ab.2009.01.037; Huang SY, 2009, CLIN CHEM, V55, P1967, DOI 10.1373/clinchem.2009.131128; Hunter MP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003694; Ji X, 2009, CLIN CHEM, V55, P1944, DOI 10.1373/clinchem.2009.125310; Jung M, 2010, CLIN CHEM, V56, P998, DOI 10.1373/clinchem.2009.141580; Kosaka Nobuyoshi, 2010, Silence, V1, P7, DOI 10.1186/1758-907X-1-7; Kosaka N, 2010, J BIOL CHEM, V285, P17442, DOI 10.1074/jbc.M110.107821; Laterza OF, 2009, CLIN CHEM, V55, P1977, DOI 10.1373/clinchem.2009.131797; Li J, 2009, ANAL CHEM, V81, P5446, DOI 10.1021/ac900598d; Lo YMD, 2007, NAT MED, V13, P218, DOI 10.1038/nm1530; McDonald JS, 2011, CLIN CHEM, V57, P833, DOI 10.1373/clinchem.2010.157198; Michael A, 2010, ORAL DIS, V16, P34, DOI 10.1111/j.1601-0825.2009.01604.x; MONESI V, 1964, J CELL BIOL, V22, P521, DOI 10.1083/jcb.22.3.521; Ng EKO, 2002, CLIN CHEM, V48, P1212; Oh JS, 2009, MOL CELLS, V28, P441, DOI 10.1007/s10059-009-0140-x; Ostermeier GC, 2004, NATURE, V429, P154, DOI 10.1038/429154a; Palmerini CA, 2003, FERTIL STERIL, V80, P1181, DOI 10.1016/S0015-0282(03)02160-5; Palmerini CA, 1999, CELL CALCIUM, V25, P291, DOI 10.1054/ceca.1999.0031; Park KH, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001595; Park NJ, 2006, CLIN CHEM, V52, P988, DOI 10.1373/clinchem.2005.063206; Poliakov A, 2009, PROSTATE, V69, P159, DOI 10.1002/pros.20860; Raimondo F, 2011, PROTEOMICS, V11, P709, DOI 10.1002/pmic.201000422; Reich CF, 2009, EXP CELL RES, V315, P760, DOI 10.1016/j.yexcr.2008.12.014; Sahin E, 2009, REPROD FERT DEVELOP, V21, P469, DOI 10.1071/RD08162; Sassone-Corsi P, 2002, SCIENCE, V296, P2176, DOI 10.1126/science.1070963; Schwarzenbach H, 2011, NAT REV CANCER, V11, P426, DOI 10.1038/nrc3066; Thimon V, 2008, HUM REPROD, V23, P1698, DOI 10.1093/humrep/den181; Turchinovich A, 2011, NUCLEIC ACIDS RES, V39, P7223, DOI 10.1093/nar/gkr254; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Wang K, 2010, NUCLEIC ACIDS RES, V38, P7248, DOI 10.1093/nar/gkq601; Wang K, 2009, P NATL ACAD SCI USA, V106, P4402, DOI 10.1073/pnas.0813371106; Weber JA, 2010, CLIN CHEM, V56, P1733, DOI 10.1373/clinchem.2010.147405; World Health Organization (WHO), 2021, WHO LAB MAN EX PROC, V6th, DOI DOI 10.HTTP://WHQLIBD0C.WH0.INT/PUBLICATI0NS/2010/9789241547789_; Yuan A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004722; Zampetaki A, 2010, CIRC RES, V107, P810, DOI 10.1161/CIRCRESAHA.110.226357; Zhao C, 2009, PROTEOMICS, V9, P1385, DOI 10.1002/pmic.200800353; Zubakov D, 2010, INT J LEGAL MED, V124, P217, DOI 10.1007/s00414-009-0402-3	55	171	182	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2012	7	4							e34566	10.1371/journal.pone.0034566	http://dx.doi.org/10.1371/journal.pone.0034566			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959FE	22506029	Green Published, Green Submitted, gold			2022-12-27	WOS:000305297500037
J	Li, L; Wei, Q; Li, HB; Wen, S; Teng, GJ				Li, Ling; Wei, Qiang; Li, Hong-Bo; Wen, Song; Teng, Gao-Jun			Evaluation of Microbubbles as Contrast Agents for Ultrasonography and Magnetic Resonance Imaging	PLOS ONE			English	Article							IN-VIVO; MR; PRESSURE	Background: Microbubbles (MBs) can serve as an ultrasound contrast agent, and has the potential for magnetic resonance imaging (MRI). Due to the relatively low effect of MBs on MRI, it is necessary to develop new MBs that are more suitable for MRI. In this study, we evaluate the properties of SonoVue (R) and custom-made Fe3O4-nanoparticle-embedded microbubbles (Fe3O4-MBs) in terms of contrast agents for ultrsonography (US) and MRI. Methodology/Principal Findings: A total of 20 HepG2 subcutaneous-tumor-bearing nude mice were randomly assigned to 2 groups (i.e., n = 10 mice each group), one for US test and the other for MRI test. Within each group, two tests were performed for each mouse. The contrast agent for the first test is SonoVue (R), and the second is Fe3O4-MBs. US was performed using a Technos(MPX) US system (Esaote, Italy) with a contrast-tuned imaging (CnTI (TM)) mode. MRI was performed using a 7.0T Micro-MRI (PharmaScan, Bruker Biospin GmbH, Germany) with an EPI-T-2* sequence. The data of signal-to-noise ratio (SNR) from the region-of-interest of each US and MR image was calculated by ImageJ (National Institute of Health, USA). In group 1, enhancement of SonoVue (R) was significantly higher than Fe3O4-MBs on US (P<0.001). In group 2, negative enhancement of Fe3O4-MBs was significantly higher than SonoVue (R) on MRI (P<0.001). The time to peak showed no significant differences between US and MRI, both of which used the same MBs (P>0.05). The SNR analysis of the enhancement process reveals a strong negative correlation in both cases (i.e., SonoVueH (R) = -0.733, Fe3O4-MBs r = -0.903, with P<0.05). Conclusions: It might be important to change the Fe3O4-MBs' shell structure and/or the imagining strategy of US to improve the imaging quality of Fe3O4-MBs on US. As an intriguing prospect that can be detected by US and MRI, MBs are worthy of further study.	[Li, Ling; Wen, Song; Teng, Gao-Jun] Southeast Univ, Jiangsu Key Lab Mol Imaging & Funct Imaging, Dept Radiol, Zhong Da Hosp, Nanjing, Jiangsu, Peoples R China; [Wei, Qiang; Li, Hong-Bo] Southeast Univ, Dept Ultrasound, Affiliated Hosp 2, Nanjing, Jiangsu, Peoples R China	Southeast University - China; Southeast University - China	Li, L (corresponding author), Southeast Univ, Jiangsu Key Lab Mol Imaging & Funct Imaging, Dept Radiol, Zhong Da Hosp, Nanjing, Jiangsu, Peoples R China.	gjteng@seu.edu.cn			National Natural Science Foundation of China (NSFC) [30870703]; Pilot Grant of NSFC of Southeast University [KJ2009390]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Pilot Grant of NSFC of Southeast University	This study was supported by the National Natural Science Foundation of China (NSFC No. 30870703) and the Pilot Grant of NSFC of Southeast University (No. KJ2009390). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander AL, 1996, MAGNET RESON MED, V35, P801, DOI 10.1002/mrm.1910350603; Cai WB, 2007, SMALL, V3, P1840, DOI 10.1002/smll.200700351; Cheung JS, 2009, NEUROIMAGE, V46, P658, DOI 10.1016/j.neuroimage.2009.02.037; Chow AM, 2010, MAGN RESON MED, V63, P224, DOI 10.1002/mrm.22184; Cosgrove D, 2006, EUR J RADIOL, V60, P324, DOI 10.1016/j.ejrad.2006.06.022; Dharmakumar R, 2005, PHYS MED BIOL, V50, P4745, DOI 10.1088/0031-9155/50/20/001; Dharmakumar R, 2002, MAGNET RESON MED, V47, P264, DOI 10.1002/mrm.10075; Folkman J, 2006, ANNU REV MED, V57, P1, DOI 10.1146/annurev.med.57.121304.131306; Francois DG, 2008, MAGN RESON MAT PHY, V21, P261; Kaur R, 2009, J BIOMED NANOTECHNOL, V5, P707, DOI 10.1166/jbn.2009.1087; Liu Z, 2011, BIOMATERIALS, V32, P6155, DOI 10.1016/j.biomaterials.2011.05.019; McDannold N, 2011, ULTRASOUND MED BIOL, V37, P1259, DOI 10.1016/j.ultrasmedbio.2011.04.019; Quaia E, 2007, EUR RADIOL, V17, P1995, DOI 10.1007/s00330-007-0623-0; Tung YS, 2010, PHYS MED BIOL, V55, P6141, DOI 10.1088/0031-9155/55/20/007; Ueguchi Takashi, 2006, Magn Reson Med Sci, V5, P147, DOI 10.2463/mrms.5.147; Vlachos F, 2010, PHYS MED BIOL, V55, P5451, DOI 10.1088/0031-9155/55/18/012; Voigt JU, 2009, METHODS, V48, P92, DOI 10.1016/j.ymeth.2009.03.011; Wong KK, 2004, MAGN RESON MED, V52, P445, DOI 10.1002/mrm.20181; Yang F, 2008, PHYS MED BIOL, V53, P6129, DOI 10.1088/0031-9155/53/21/016; Yang F, 2011, SMALL, V7, P902, DOI 10.1002/smll.201002185; Yang F, 2009, BIOMATERIALS, V30, P3882, DOI 10.1016/j.biomaterials.2009.03.051; Yankeelov TE, 2006, J ULTRAS MED, V25, P487, DOI 10.7863/jum.2006.25.4.487	22	2	2	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2012	7	4							e34644	10.1371/journal.pone.0034644	http://dx.doi.org/10.1371/journal.pone.0034644			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959FE	22506039	Green Submitted, Green Published, gold			2022-12-27	WOS:000305297500047
J	Teng, M; Jiang, XP; Zhang, Q; Zhang, JP; Zhang, DX; Liang, GP; Huang, YS				Teng, Miao; Jiang, Xu-pin; Zhang, Qiong; Zhang, Jia-ping; Zhang, Dong-xia; Liang, Guang-ping; Huang, Yue-sheng			Microtubular Stability Affects pVHL-Mediated Regulation of HIF-1alpha via the p38/MAPK Pathway in Hypoxic Cardiomyocytes	PLOS ONE			English	Article							LINDAU TUMOR-SUPPRESSOR; INDUCIBLE FACTOR-1 ALPHA; MYOCARDIAL INFARCT SIZE; TAXOL-INDUCED APOPTOSIS; RENAL-CELL CARCINOMA; MAP-KINASE PATHWAYS; NF-KAPPA-B; HIF-ALPHA; IN-VIVO; PROLINE HYDROXYLATION	Background: Our previous research found that structural changes of the microtubule network influence glycolysis in cardiomyocytes by regulating the hypoxia-inducible factor (HIF)-1 alpha during the early stages of hypoxia. However, little is known about the underlying regulatory mechanism of the changes of HIF-1 alpha caused by microtubule network alternation. The von Hippel-Lindau tumor suppressor protein (pVHL), as a ubiquitin ligase, is best understood as a negative regulator of HIF-1 alpha. Methodology/Principal Findings: In primary rat cardiomyocytes and H9c2 cardiac cells, microtubule-stabilization was achieved by pretreating with paclitaxel or transfection of microtubule-associated protein 4 (MAP4) overexpression plasmids and microtubule-depolymerization was achieved by pretreating with colchicine or transfection of MAP4 siRNA before hypoxia treatment. Recombinant adenovirus vectors for overexpressing pVHL or silencing of pVHL expression were constructed and transfected in primary rat cardiomyocytes and H9c2 cells. With different microtubule-stabilizing and depolymerizing treaments, we demonstrated that the protein levels of HIF-1 alpha were down-regulated through overexpression of pVHL and were up-regulated through knockdown of pVHL in hypoxic cardiomyocytes. Importantly, microtubular structure breakdown activated p38/MAPK pathway, accompanied with the upregulation of pVHL. In coincidence, we found that SB203580, a p38/MAPK inhibitor decreased pVHL while MKK6 (Glu) overexpression increased pVHL in the microtubule network altered-hypoxic cardiomyocytes and H9c2 cells. Conclusions/Significance: This study suggests that pVHL plays an important role in the regulation of HIF-1 alpha caused by the changes of microtubular structure and the p38/MAPK pathway participates in the process of pVHL change following microtubule network alteration in hypoxic cardiomyocytes.	[Teng, Miao; Jiang, Xu-pin; Zhang, Qiong; Zhang, Jia-ping; Zhang, Dong-xia; Liang, Guang-ping; Huang, Yue-sheng] Third Mil Med Univ, Southwest Hosp, State Key Lab Trauma Burns & Combined Injury, Inst Burn Res, Chongqing, Peoples R China	Army Medical University	Teng, M (corresponding author), Third Mil Med Univ, Southwest Hosp, State Key Lab Trauma Burns & Combined Injury, Inst Burn Res, Chongqing, Peoples R China.	yshuang.tmmu@gmail.com			National Natural Science Foundation of China [81101425, 81055748]; Key Project of China National Programs for Basic Research and Development [2012CB518101]; Science Foundation of the Third Military Medical University [2010XQN24]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Project of China National Programs for Basic Research and Development; Science Foundation of the Third Military Medical University	This work was supported by grants from the Program of National Natural Science Foundation of China (No. 81101425 and No. 81055748), Key Project of China National Programs for Basic Research and Development (No. 2012CB518101), and Science Foundation of the Third Military Medical University (No. 2010XQN24). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ampofo E, 2010, INT J BIOCHEM CELL B, V42, P1729, DOI 10.1016/j.biocel.2010.07.008; Bacus SS, 2001, ONCOGENE, V20, P147, DOI 10.1038/sj.onc.1204062; Cai QL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012636; Cai QL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009720; Caretti A, 2007, EXP BIOL MED, V232, P887; Cassimeris L, 1999, CURR OPIN CELL BIOL, V11, P134, DOI 10.1016/S0955-0674(99)80017-9; Cvetkovic I, 2004, CELL MOL LIFE SCI, V61, P1167, DOI 10.1007/s00018-004-3408-5; Czibik G, 2011, LIFE SCI, V88, P543, DOI 10.1016/j.lfs.2011.01.006; Czibik G, 2009, CTS-CLIN TRANSL SCI, V2, P33, DOI 10.1111/j.1752-8062.2008.00077.x; Czyzyk-Krzeska MF, 2004, TRENDS MOL MED, V10, P146, DOI 10.1016/j.molmed.2004.02.004; del Peso L, 2003, J BIOL CHEM, V278, P48690, DOI 10.1074/jbc.M308862200; Di Cristofano C, 2007, AM J SURG PATHOL, V31, P1875, DOI 10.1097/PAS.0b013e318094fed8; Fang YD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028052; Frew IJ, 2007, CURR OPIN CELL BIOL, V19, P685, DOI 10.1016/j.ceb.2007.10.001; Gundersen GG, 1999, CURR OPIN CELL BIOL, V11, P81, DOI 10.1016/S0955-0674(99)80010-6; Haase VH, 2006, KIDNEY INT, V69, P1302, DOI 10.1038/sj.ki.5000221; HESCHELER J, 1991, CIRC RES, V69, P1476, DOI 10.1161/01.RES.69.6.1476; HORWITZ LD, 1994, CIRCULATION, V89, P1792, DOI 10.1161/01.CIR.89.4.1792; Hu JY, 2010, CELL MOL LIFE SCI, V67, P321, DOI 10.1007/s00018-009-0187-z; Huang YS, 2003, BURNS, V29, P828, DOI 10.1016/S0305-4179(03)00204-3; HUANG YS, 2007, BURNS, V33, pS14; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Iwai K, 1999, P NATL ACAD SCI USA, V96, P12436, DOI 10.1073/pnas.96.22.12436; IWAI K, 1990, CIRC RES, V67, P694, DOI 10.1161/01.RES.67.3.694; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Jung YJ, 2003, J BIOL CHEM, V278, P7445, DOI 10.1074/jbc.M209804200; Kamura T, 2000, P NATL ACAD SCI USA, V97, P10430, DOI 10.1073/pnas.190332597; Ke QD, 2006, MOL PHARMACOL, V70, P1469, DOI 10.1124/mol.106.027029; Khandrika L, 2009, ONCOGENE, V28, P1248, DOI 10.1038/onc.2008.476; KYRIAKIDES ZS, 1991, AM J CARDIOL, V67, P687, DOI 10.1016/0002-9149(91)90522-M; Mabjeesh NJ, 2003, CANCER CELL, V3, P363, DOI 10.1016/S1535-6108(03)00077-1; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Min JH, 2002, SCIENCE, V296, P1886, DOI 10.1126/science.1073440; Miro-Murillo M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022589; Mole DR, 2001, IUBMB LIFE, V52, P43; Raingeaud J, 1996, MOL CELL BIOL, V16, P1247; Risinger AL, 2009, CANCER TREAT REV, V35, P255, DOI 10.1016/j.ctrv.2008.11.001; Sato H, 1997, J CELL BIOL, V139, P963, DOI 10.1083/jcb.139.4.963; Seidman R, 2001, EXP CELL RES, V268, P84, DOI 10.1006/excr.2001.5262; Semenza GL, 2000, GENE DEV, V14, P1983; Subbaramaiah K, 2000, J BIOL CHEM, V275, P14838, DOI 10.1074/jbc.275.20.14838; Sufan RI, 2009, EMBO MOL MED, V1, P66, DOI 10.1002/emmm.200900004; Suomalainen M, 2001, EMBO J, V20, P1310, DOI 10.1093/emboj/20.6.1310; Teng M, 2010, AM J PHYSIOL-HEART C, V298, pH1919, DOI 10.1152/ajpheart.01039.2009; Thomas SL, 2008, CELL CYCLE, V7, P2409, DOI 10.4161/cc.6410; Turcotte S, 2004, AM J PHYSIOL-RENAL, V286, pF338, DOI 10.1152/ajprenal.00254.2003; Vandroux D, 2004, MOL CELL BIOCHEM, V258, P99, DOI 10.1023/B:MCBI.0000012840.67616.cc; Webster DR, 1997, J MOL CELL CARDIOL, V29, P1747, DOI 10.1006/jmcc.1997.0421; Weidemann A, 2008, CELL DEATH DIFFER, V15, P621, DOI 10.1038/cdd.2008.12; Xiao JJ, 2011, J CELL MOL MED, V15, P1166, DOI 10.1111/j.1582-4934.2010.01106.x; Yang Y, 2007, EUR J PHARMACOL, V576, P26, DOI 10.1016/j.ejphar.2007.07.067; Yu F, 2001, P NATL ACAD SCI USA, V98, P9630, DOI 10.1073/pnas.181341498; Zhang JP, 2007, SHOCK, V28, P86, DOI 10.1097/SHK.0b013e31802f9d9a; Zordoky Beshay N. M., 2007, Journal of Pharmacological and Toxicological Methods, V56, P317, DOI 10.1016/j.vascn.2007.06.001	54	14	15	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2012	7	4							e35017	10.1371/journal.pone.0035017	http://dx.doi.org/10.1371/journal.pone.0035017			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959FE	22506063	Green Submitted, gold, Green Published			2022-12-27	WOS:000305297500070
J	Tetteh-Quarcoo, PB; Schmidt, CQ; Tham, WH; Hauhart, R; Mertens, HDT; Rowe, A; Atkinson, JP; Cowman, AF; Rowe, JA; Barlow, PN				Tetteh-Quarcoo, Patience B.; Schmidt, Christoph Q.; Tham, Wai-Hong; Hauhart, Richard; Mertens, Haydyn D. T.; Rowe, Arthur; Atkinson, John P.; Cowman, Alan F.; Rowe, J. Alexandra; Barlow, Paul N.			Lack of Evidence from Studies of Soluble Protein Fragments that Knops Blood Group Polymorphisms in Complement Receptor-Type 1 Are Driven by Malaria	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM; INVASION PATHWAYS; C3B/C4B RECEPTOR; ACTIVE-SITES; C3B BINDING; CR-1; CD35; MODULES; IDENTIFICATION; SUBSTITUTION	Complement receptor-type 1 (CR1, CD35) is the immune-adherence receptor, a complement regulator, and an erythroid receptor for Plasmodium falciparum during merozoite invasion and subsequent rosette formation involving parasitized and non-infected erythrocytes. The non-uniform geographical distribution of Knops blood group CR1 alleles Sl1/2 and McC(a/b) may result from selective pressures exerted by differential exposure to infectious hazards. Here, four variant short recombinant versions of CR1 were produced and analyzed, focusing on complement control protein modules (CCPs) 15-25 of its ectodomain. These eleven modules encompass a region (CCPs 15-17) key to rosetting, opsonin recognition and complement regulation, as well as the Knops blood group polymorphisms in CCPs 24-25. All four CR1 15-25 variants were monomeric and had similar axial ratios. Modules 21 and 22, despite their double-length inter-modular linker, did not lie side-by-side so as to stabilize a bent-back architecture that would facilitate cooperation between key functional modules and Knops blood group antigens. Indeed, the four CR1 15-25 variants had virtually indistinguishable affinities for immobilized complement fragments C3b (K-D = 0.8-1.1 mu M) and C4b (K-D = 5.0-5.3 mu M). They were all equally good co-factors for factor I-catalysed cleavage of C3b and C4b, and they bound equally within a narrow affinity range, to immobilized C1q. No differences between the variants were observed in assays for inhibition of erythrocyte invasion by P. falciparum or for rosette disruption. Neither differences in complement-regulatory functionality, nor interactions with P. falciparum proteins tested here, appear to have driven the non-uniform geographic distribution of these alleles.	[Tetteh-Quarcoo, Patience B.; Schmidt, Christoph Q.; Barlow, Paul N.] Univ Edinburgh, Inst Struct & Mol Biol, Edinburgh, Midlothian, Scotland; [Tham, Wai-Hong; Cowman, Alan F.] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia; [Hauhart, Richard; Atkinson, John P.] Washington Univ, Sch Med, Dept Med, Div Rheumatol, St Louis, MO 63110 USA; [Mertens, Haydyn D. T.] Australian Synchrotron, SAXS WAXS Beamline, Clayton, Vic, Australia; [Rowe, Arthur] Univ Nottingham, Sch Biosci, Leicester, Leics, England; [Rowe, J. Alexandra] Univ Edinburgh, Inst Immunol & Infect Res, Edinburgh, Midlothian, Scotland; [Barlow, Paul N.] Univ Edinburgh, Sch Chem, Edinburgh, Midlothian, Scotland	University of Edinburgh; Royal Melbourne Hospital; Walter & Eliza Hall Institute; Washington University (WUSTL); University of Nottingham; University of Edinburgh; University of Edinburgh	Tetteh-Quarcoo, PB (corresponding author), Univ Ghana, Dept Microbiol, Sch Med, Accra, Ghana.	Paul.Barlow@ed.ac.uk	Tham, Wai-Hong/P-6474-2019; Cowman, Alan F/C-7642-2013; Tham, Wai-Hong/L-3173-2018	Tham, Wai-Hong/0000-0001-7950-8699; Cowman, Alan F/0000-0001-5145-9004; Tham, Wai-Hong/0000-0001-7950-8699; Tetteh-Quarcoo (Nee Borketey), Patience Borkor/0000-0002-3344-4869; Mertens, Haydyn/0000-0002-5664-744X; Rowe, Alexandra/0000-0002-7702-1892; Atkinson, John/0000-0002-2514-3441	Darwin Trust of Edinburgh; Wellcome Trust (Senior Research Fellowship in Basic Biomedical Science) [084226]; National Institutes of Health [RO1 AI041592-13];  [WT 081179]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041592] Funding Source: NIH RePORTER	Darwin Trust of Edinburgh; Wellcome Trust (Senior Research Fellowship in Basic Biomedical Science)(Wellcome Trust); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	PBT-Q was funded by the Darwin Trust of Edinburgh; JAR was funded by the Wellcome Trust (Senior Research Fellowship in Basic Biomedical Science grant no. 084226); CQS was funded by WT 081179; and JPA and RH were funded by National Institutes of Health - RO1 AI041592-13. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awandare GA, 2011, MOL BIOCHEM PARASIT, V177, P57, DOI 10.1016/j.molbiopara.2011.01.005; BARLOW PN, 1991, BIOCHEMISTRY-US, V30, P997, DOI 10.1021/bi00218a016; BIRMINGHAM DJ, 1995, CRIT REV IMMUNOL, V15, P133, DOI 10.1615/CritRevImmunol.v15.i2.20; Bjorklund AK, 2006, PLOS COMPUT BIOL, V2, P959, DOI 10.1371/journal.pcbi.0020114; Corrigan RA, 2010, PARASITE IMMUNOL, V32, P512, DOI 10.1111/j.1365-3024.2010.01225.x; Doumbo OK, 2009, AM J TROP MED HYG, V81, P987, DOI 10.4269/ajtmh.2009.09-0406; Fearon D T, 1989, Prog Clin Biol Res, V297, P211; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Furtado PB, 2008, J MOL BIOL, V375, P102, DOI 10.1016/j.jmb.2007.09.085; Ghiran I, 2000, J EXP MED, V192, P1797, DOI 10.1084/jem.192.12.1797; Ghiran I, 2008, BLOOD, V112, P3465, DOI 10.1182/blood-2008-04-151845; Ghumra A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016414; GRZESIEK S, 1993, J BIOMOL NMR, V3, P185; Guinier A., 1939, ANN PHYS-LEIPZIG, DOI DOI 10.1051/ANPHYS/193911120161; Jallow M, 2009, NAT GENET, V41, P657, DOI 10.1038/ng.388; Kirkitadze MD, 1999, BIOCHEMISTRY-US, V38, P7019, DOI 10.1021/bi982453a; Kirkitadze MD, 1999, FEBS LETT, V459, P133, DOI 10.1016/S0014-5793(99)01205-3; KLICKSTEIN LB, 1987, J EXP MED, V165, P1095, DOI 10.1084/jem.165.4.1095; Klickstein LB, 1997, IMMUNITY, V7, P345, DOI 10.1016/S1074-7613(00)80356-8; KOCH MHJ, 1983, NUCL INSTRUM METHODS, V208, P461, DOI 10.1016/0167-5087(83)91169-9; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; KRYCH M, 1991, P NATL ACAD SCI USA, V88, P4353, DOI 10.1073/pnas.88.10.4353; KRYCH M, 1992, CURR OPIN IMMUNOL, V4, P8, DOI 10.1016/0952-7915(92)90116-V; Krych M, 1998, J BIOL CHEM, V273, P8623, DOI 10.1074/jbc.273.15.8623; KRYCH M, 1994, J BIOL CHEM, V269, P13273; Krych-Goldberg M, 2005, J IMMUNOL, V175, P4528, DOI 10.4049/jimmunol.175.7.4528; Krych-Goldberg M, 2001, IMMUNOL REV, V180, P112, DOI 10.1034/j.1600-065X.2001.1800110.x; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Moulds J M, 2010, Immunohematology, V26, P2; Moulds J M, 2002, Immunohematology, V18, P1; Moulds JM, 2001, BLOOD, V97, P2879, DOI 10.1182/blood.V97.9.2879; Murray CJL, 2012, LANCET, V379, P413, DOI 10.1016/S0140-6736(12)60034-8; NORMAN DG, 1991, J MOL BIOL, V219, P717, DOI 10.1016/0022-2836(91)90666-T; Noumsi GT, 2011, TRANSFUSION, V51, P2462, DOI 10.1111/j.1537-2995.2011.03161.x; Persson KEM, 2008, J CLIN INVEST, V118, P342, DOI 10.1172/JCI32138; Reid ME., 2012, BLOOD GROUP ANTIGEN; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Roessle MW, 2007, J APPL CRYSTALLOGR, V40, pS190, DOI 10.1107/S0021889806055506; Roversi P, 2011, P NATL ACAD SCI USA, V108, P12839, DOI 10.1073/pnas.1102167108; Rowe JA, 2009, CURR OPIN HEMATOL, V16, P480, DOI 10.1097/MOH.0b013e3283313de0; Rowe JA, 2000, J IMMUNOL, V165, P6341, DOI 10.4049/jimmunol.165.11.6341; Rowe JA, 2002, GENES IMMUN, V3, P497, DOI 10.1038/sj.gene.6363899; Rowe JA, 1997, NATURE, V388, P292, DOI 10.1038/40888; Schmidt CQ, 2008, J IMMUNOL, V181, P2610, DOI 10.4049/jimmunol.181.4.2610; Schmidt CQ, 2011, PROTEIN EXPRES PURIF, V76, P254, DOI 10.1016/j.pep.2010.12.002; Schmidt CQ, 2010, J MOL BIOL, V395, P105, DOI 10.1016/j.jmb.2009.10.010; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Soares DC, 2005, PROTEIN ENG DES SEL, V18, P379, DOI 10.1093/protein/gzi039; Spadafora C, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000968; Stoute JA, 2005, TRENDS PARASITOL, V21, P218, DOI 10.1016/j.pt.2005.03.004; Stoute JA, 2011, CELL MICROBIOL, V13, P1441, DOI 10.1111/j.1462-5822.2011.01648.x; Stubbs J, 2005, SCIENCE, V309, P1384, DOI 10.1126/science.1115257; Subramanian VB, 1996, J IMMUNOL, V157, P1242; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Tas SW, 1999, J IMMUNOL, V163, P5056; Tham WH, 2011, BLOOD, V118, P1923, DOI 10.1182/blood-2011-03-341305; Tham WH, 2010, P NATL ACAD SCI USA, V107, P17327, DOI 10.1073/pnas.1008151107; Tham WH, 2009, INFECT IMMUN, V77, P2427, DOI 10.1128/IAI.00048-09; Thathy V, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-54; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; WEISMAN HF, 1990, SCIENCE, V249, P146, DOI 10.1126/science.2371562; Wu J, 2009, NAT IMMUNOL, V10, P728, DOI 10.1038/ni.1755; Zimmerman PA, 2003, GENES IMMUN, V4, P368, DOI 10.1038/sj.gene.6363980	65	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2012	7	4							e34820	10.1371/journal.pone.0034820	http://dx.doi.org/10.1371/journal.pone.0034820			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959FE	22506052	Green Published, gold			2022-12-27	WOS:000305297500060
J	Bronze, M; Steegen, K; Wallis, CL; De Wolf, H; Papathanasopoulos, MA; Van Houtte, M; Stevens, WS; de Wit, TR; Stuyver, LJ				Bronze, Michelle; Steegen, Kim; Wallis, Carole L.; De Wolf, Hans; Papathanasopoulos, Maria A.; Van Houtte, Margriet; Stevens, Wendy S.; de Wit, Tobias Rinke; Stuyver, Lieven J.		ART-A Consortium	HIV-1 Phenotypic Reverse Transcriptase Inhibitor Drug Resistance Test Interpretation Is Not Dependent on the Subtype of the Virus Backbone	PLOS ONE			English	Article							ANTIRETROVIRAL DRUGS; SOUTH-AFRICA; SUSCEPTIBILITY; TYPE-1; ANTIVIROGRAM; PHENOSENSE; PROTEASE; ASSAYS; TOOL	To date, the majority of HIV-1 phenotypic resistance testing has been performed with subtype B virus backbones (e. g. HXB2). However, the relevance of using this backbone to determine resistance in non-subtype B HIV-1 viruses still needs to be assessed. From 114 HIV-1 subtype C clinical samples (36 ARV-naive, 78 ARV-exposed), pol amplicons were produced and analyzed for phenotypic resistance using both a subtype B-and C-backbone in which the pol fragment was deleted. Phenotypic resistance was assessed in resulting recombinant virus stocks (RVS) for a series of antiretroviral drugs (ARV's) and expressed as fold change (FC), yielding 1660 FC comparisons. These Antivirogram (R) derived FC values were categorized as having resistant or sensitive susceptibility based on biological cut-off values (BCOs). The concordance between resistance calls obtained for the same clinical sample but derived from two different backbones (i.e. B and C) accounted for 86.1% (1429/1660) of the FC comparisons. However, when taking the assay variability into account, 95.8% (1590/1660) of the phenotypic data could be considered as being concordant with respect to their resistance call. No difference in the capacity to detect resistance associated with M184V, K103N and V106M mutations was noted between the two backbones. The following was concluded: (i) A high level of concordance was shown between the two backbone phenotypic resistance profiles; (ii) Assay variability is largely responsible for discordant results (i. e. for FC values close to BCO); (iii) Confidence intervals should be given around the BCO's, when assessing resistance in HIV-1 subtype C; (iv) No systematic resistance under-or overcalling of subtype C amplicons in the B-backbone was observed; (v) Virus backbone subtype sequence variability outside the pol region does not contribute to phenotypic FC values. In conclusion the HXB2 virus backbone remains an acceptable vector for phenotyping HIV-1 subtype C pol amplicons.	[Bronze, Michelle; Wallis, Carole L.; Papathanasopoulos, Maria A.; Stevens, Wendy S.] Univ Witwatersrand, Dept Mol Med & Haematol, Johannesburg, South Africa; [Steegen, Kim; De Wolf, Hans; Van Houtte, Margriet; Stuyver, Lieven J.] Virco BVBA, Beerse, Belgium; [de Wit, Tobias Rinke] Univ Amsterdam, Acad Med Ctr, PharmAccess Fdn, CPCD, NL-1105 AZ Amsterdam, Netherlands	University of Witwatersrand; University of Amsterdam; Academic Medical Center Amsterdam	Bronze, M (corresponding author), Univ Witwatersrand, Dept Mol Med & Haematol, Johannesburg, South Africa.	michelle.bronze@gmail.com	Steegen, K/AAF-6512-2020; Steegen, Kim/ABH-4471-2020	Steegen, Kim/0000-0003-3226-7685; Wallis, Carole/0000-0001-8408-8772	NWO/WOTRO, The Hague, The Netherlands [W.07.05.204.00]; NOW/WOTRO -NACCAP; NWO: De Nederlandse Organisatie voor Wetenschappelij_ Onderzoek (Netherlands Organisation for Scientific Research); WOTRO: Wetenschappelijk Onderzoek van de Tropen an Ontwikkelingslanden (Netherelands Foundation for the advancement of Tropical Research)	NWO/WOTRO, The Hague, The Netherlands; NOW/WOTRO -NACCAP; NWO: De Nederlandse Organisatie voor Wetenschappelij_ Onderzoek (Netherlands Organisation for Scientific Research); WOTRO: Wetenschappelijk Onderzoek van de Tropen an Ontwikkelingslanden (Netherelands Foundation for the advancement of Tropical Research)	ART-A: Consortium to develop an Affordable Resistance Test for Africa, supported by NWO/WOTRO under the Netherlands African Partnership for Capacity Development and Clinical Interventions against Poverty related Diseases (NACCAP; grant: W.07.05.204.00), The Hague, The Netherlands. NWO: De Nederlandse Organisatie voor Wetenschappelij_ Onderzoek (Netherlands Organisation for Scientific Research). WOTRO: Wetenschappelijk Onderzoek van de Tropen an Ontwikkelingslanden (Netherelands Foundation for the advancement of Tropical Research). This research was conducted in the course of the authors' PhD programme. The funders had no direct or indirect influence on the results of the research. The funders (NOW/WOTRO -NACCAP) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arien KK, 2005, J VIROL, V79, P8979, DOI 10.1128/JVI.79.14.8979-8990.2005; Choe S, 15 INT HIV DRUG RES; Hamers R, 2011, INT J EPIDEMIOL 0421; Hamers RL, 2008, ANTIVIR THER, V13, P625; Hamers RL, 2010, JAIDS-J ACQ IMM DEF, V55, P95, DOI 10.1097/QAI.0b013e3181e544e0; Hamers RL, 2011, LANCET INFECT DI JUL; Hemelaar J, 2011, AIDS, V25, P679, DOI 10.1097/QAD.0b013e328342ff93; Hertogs K, 1998, ANTIMICROB AGENTS CH, V42, P269, DOI 10.1093/jac/42.2.269; Hunt GM, 2011, AIDS, V25, P1461, DOI 10.1097/QAD.0b013e3283492180; Johnson Victoria A, 2010, Top HIV Med, V18, P156; Murphy RA, 2010, AIDS, V24, P1007, DOI 10.1097/QAD.0b013e3283333639; Nauwelaers D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019643; Ndembi N, 2011, AIDS, V25, P905, DOI 10.1097/QAD.0b013e328346260f; Petropoulos CJ, 2000, ANTIMICROB AGENTS CH, V44, P920, DOI 10.1128/AAC.44.4.920-928.2000; Price MA, 2011, AIDS RES HUM RETROV, V27, P5, DOI 10.1089/aid.2010.0030; Qari SH, 2002, J CLIN MICROBIOL, V40, P31, DOI 10.1128/JCM.40.1.31-35.2002; Rhee SY, 2003, NUCLEIC ACIDS RES, V31, P298, DOI 10.1093/nar/gkg100; Steegen K, 2010, AIDS RES THER   1015, P38; Van Houtte M, 2009, J MED VIROL, V81, P1702, DOI 10.1002/jmv.21585; van Zyl GU, 2011, J MED VIROL, V83, P1764, DOI 10.1002/jmv.22189; Vergara IA, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-265; Virco B, VIRCO BIOL CUT OFFS; Wallis CL, 2010, J VIROL METHODS, V163, P505, DOI 10.1016/j.jviromet.2009.11.011; Wang K, 2004, ANTIVIR THER, V9, P703; World Health Organization, 2010, UN ACC SCAL PRIOR HI; Zhang J, 2005, JAIDS-J ACQ IMM DEF, V38, P439, DOI 10.1097/01.qai.0000147526.64863.53	26	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2012	7	4							e34708	10.1371/journal.pone.0034708	http://dx.doi.org/10.1371/journal.pone.0034708			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JO	22496845	gold, Green Published, Green Submitted			2022-12-27	WOS:000305014500027
J	Breen, MR; Camps, M; Carvalho-Simoes, F; Zorzano, A; Pilch, PF				Breen, Michael R.; Camps, Marta; Carvalho-Simoes, Francisco; Zorzano, Antonio; Pilch, Paul F.			Cholesterol Depletion in Adipocytes Causes Caveolae Collapse Concomitant with Proteosomal Degradation of Cavin-2 in a Switch-Like Fashion	PLOS ONE			English	Article							CONGENITAL GENERALIZED LIPODYSTROPHY; TRANSCRIPT RELEASE FACTOR; INSULIN-RESISTANCE; MICE SHOW; LIPID TRAFFICKING; PTRF MUTATIONS; ADIPOSE-TISSUE; KNOCKOUT MICE; RICH DOMAINS; POLYMERASE-I	Caveolae, little caves of cell surfaces, are enriched in cholesterol, a certain level of which is required for their structural integrity. Here we show in adipocytes that cavin-2, a peripheral membrane protein and one of 3 cavin isoforms present in caveolae from non-muscle tissue, is degraded upon cholesterol depletion in a rapid fashion resulting in collapse of caveolae. We exposed 3T3-L1 adipocytes to the cholesterol depleting agent methyl-beta-cyclodextrin, which results in a sudden and extensive degradation of cavin-2 by the proteasome and a concomitant movement of cavin-1 from the plasma membrane to the cytosol along with loss of caveolae. The recovery of cavin-2 at the plasma membrane is cholesterol-dependent and is required for the return of cavin-1 from the cytosol to the cell surface and caveolae restoration. Expression of shRNA directed against cavin-2 also results in a cytosolic distribution of cavin-1 and loss of caveolae. Taken together, these data demonstrate that cavin-2 functions as a cholesterol responsive component of caveolae that is required for cavin-1 localization to the plasma membrane, and caveolae structural integrity.	[Breen, Michael R.; Pilch, Paul F.] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA; [Camps, Marta; Carvalho-Simoes, Francisco; Zorzano, Antonio] Univ Barcelona, Fac Biol, Dept Bioquim & Biol Mol, Barcelona, Spain; [Camps, Marta; Carvalho-Simoes, Francisco; Zorzano, Antonio] Inst Salud Carlos III, CIBER Diabet & Enfermedades Metab Asociadas CIBER, Barcelona, Spain; [Camps, Marta; Carvalho-Simoes, Francisco] Univ Barcelona, IBUB Inst Biomed, Barcelona, Spain; [Zorzano, Antonio] Inst Res Biomed IRB Barcelona, Barcelona, Spain; [Pilch, Paul F.] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA	Boston University; University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Instituto de Salud Carlos III; University of Barcelona; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; Boston University	Breen, MR (corresponding author), Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA.	ppilch@bu.edu	Zorzano, Antonio/R-5479-2018; Camps, Marta/F-6557-2016	Camps, Marta/0000-0001-5392-1792; Pilch, Paul/0000-0003-1997-0499	U.S. National Institutes of Health [DK30425, DK56935, DK07201]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK030425, R01DK056935, T32DK007201] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the U.S. National Institutes of Health DK30425 and DK56935 to PFP and training grant DK07201 to MRB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboulaich N, 2004, BIOCHEM J, V383, P237, DOI 10.1042/BJ20040647; Bastiani M, 2010, J CELL SCI, V123, P3831, DOI 10.1242/jcs.070102; Bastiani M, 2009, J CELL BIOL, V185, P1259, DOI 10.1083/jcb.200903053; Bickel PE, 2009, BBA-MOL CELL BIOL L, V1791, P419, DOI 10.1016/j.bbalip.2009.04.002; Cao H, 2008, LIPIDS HEALTH DIS, V7, DOI 10.1186/1476-511X-7-3; Capozza F, 2005, AM J PHYSIOL-CELL PH, V288, pC1317, DOI 10.1152/ajpcell.00489.2004; Cohen AW, 2004, PHYSIOL REV, V84, P1341, DOI 10.1152/physrev.00046.2003; Cohen AW, 2003, AM J PHYSIOL-CELL PH, V285, pC222, DOI 10.1152/ajpcell.00006.2003; Drab M, 2001, SCIENCE, V293, P2449, DOI 10.1126/science.1062688; Dwianingsih EK, 2010, MOL GENET METAB, V101, P233, DOI 10.1016/j.ymgme.2010.06.016; Epand RM, 2008, BBA-BIOMEMBRANES, V1778, P1576, DOI 10.1016/j.bbamem.2008.03.016; Epand RM, 2005, J MOL BIOL, V345, P339, DOI 10.1016/j.jmb.2004.10.064; FOLCH J, 1957, J BIOL CHEM, V226, P497; Forbes A, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702117200; Galbiati F, 2001, J BIOL CHEM, V276, P21425, DOI 10.1074/jbc.M100828200; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; Gonzalez-Munoz E, 2009, ENDOCRINOLOGY, V150, P3493, DOI 10.1210/en.2008-1520; GREEN H, 1975, CELL, V5, P19, DOI 10.1016/0092-8674(75)90087-2; Guilherme A, 2008, NAT REV MOL CELL BIO, V9, P367, DOI 10.1038/nrm2391; Hailstones D, 1998, J LIPID RES, V39, P369; Hansen CG, 2010, TRENDS CELL BIOL, V20, P177, DOI 10.1016/j.tcb.2010.01.005; Hansen CG, 2009, NAT CELL BIOL, V11, P807, DOI 10.1038/ncb1887; Hansen CG, 2011, J CELL SCI, V124, P2777, DOI 10.1242/jcs.084319; Hayashi YK, 2009, J CLIN INVEST, V119, P2623, DOI 10.1172/JCI38660; Hayer A, 2010, J CELL BIOL, V191, P615, DOI 10.1083/jcb.201003086; Hayer A, 2010, TRAFFIC, V11, P361, DOI 10.1111/j.1600-0854.2009.01023.x; HEUSER JE, 1989, J CELL BIOL, V108, P389, DOI 10.1083/jcb.108.2.389; Hill MM, 2008, CELL, V132, P113, DOI 10.1016/j.cell.2007.11.042; Kim CA, 2008, J CLIN ENDOCR METAB, V93, P1129, DOI 10.1210/jc.2007-1328; KRAUSE BR, 1978, J LIPID RES, V19, P774; KRAUSE BR, 1984, J LIPID RES, V25, P97; Le Lay S, 2006, TRAFFIC, V7, P549, DOI 10.1111/j.1600-0854.2006.00406.x; Le Lay S, 2009, BBA-MOL CELL BIOL L, V1791, P514, DOI 10.1016/j.bbalip.2008.10.008; Liu LB, 2008, CELL METAB, V8, P310, DOI 10.1016/j.cmet.2008.07.008; Liu LB, 2008, J BIOL CHEM, V283, P4314, DOI 10.1074/jbc.M707890200; McMahon KA, 2009, EMBO J, V28, P1001, DOI 10.1038/emboj.2009.46; Meshulam T, 2006, BIOCHEMISTRY-US, V45, P2882, DOI 10.1021/bi051999b; Meshulam T, 2011, J LIPID RES, V52, P1526, DOI 10.1194/jlr.M015628; MURATA M, 1995, P NATL ACAD SCI USA, V92, P10339, DOI 10.1073/pnas.92.22.10339; Murphy S, 2009, BBA-MOL CELL BIOL L, V1791, P441, DOI 10.1016/j.bbalip.2008.07.004; Parpal S, 2001, J BIOL CHEM, V276, P9670, DOI 10.1074/jbc.M007454200; Pilch PF, 2007, J LIPID RES, V48, P2103, DOI 10.1194/jlr.R700009-JLR200; Pilch PF, 2011, TRENDS ENDOCRIN MET, V22, P318, DOI 10.1016/j.tem.2011.04.001; Pilch PF, 2011, CLIN LIPIDOL, V6, P49, DOI 10.2217/CLP.10.80; Radhakrishnan A, 2008, CELL METAB, V8, P512, DOI 10.1016/j.cmet.2008.10.008; Rajab A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000874; Razani B, 2001, J BIOL CHEM, V276, P38121; Rechsteiner M, 1996, TRENDS BIOCHEM SCI, V21, P267, DOI 10.1016/S0968-0004(96)10031-1; Ros-Baro A, 2001, P NATL ACAD SCI USA, V98, P12050, DOI 10.1073/pnas.211341698; ROTHBERG KG, 1992, CELL, V68, P673, DOI 10.1016/0092-8674(92)90143-Z; Shastry S, 2010, AM J MED GENET A, V152A, P2245, DOI 10.1002/ajmg.a.33578; Smart EJ, 2002, METHOD ENZYMOL, V353, P131; Thorn H, 2003, MOL BIOL CELL, V14, P3967, DOI 10.1091/mbc.E03-01-0050; Woodman SE, 2004, NEUROLOGY, V62, P538, DOI 10.1212/WNL.62.4.538; Zhao YY, 2002, P NATL ACAD SCI USA, V99, P11375, DOI 10.1073/pnas.172360799	55	47	48	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2012	7	4							e34516	10.1371/journal.pone.0034516	http://dx.doi.org/10.1371/journal.pone.0034516			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JA	22493697	Green Published, Green Submitted, gold			2022-12-27	WOS:000305012700039
J	Lozano, R; Ponce, O; Ramirez, M; Mostajo, N; Orjeda, G				Lozano, Roberto; Ponce, Olga; Ramirez, Manuel; Mostajo, Nelly; Orjeda, Gisella			Genome-Wide Identification and Mapping of NBS-Encoding Resistance Genes in Solanum tuberosum Group Phureja	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; DISEASE RESISTANCE; DEFENSE RESPONSES; REPEAT; PROTEINS; TOMATO; DOMAIN; INFECTION; EVOLUTION; PRODUCTS	The majority of disease resistance (R) genes identified to date in plants encode a nucleotide-binding site (NBS) and leucine-rich repeat (LRR) domain containing protein. Additional domains such as coiled-coil (CC) and TOLL/interleukin-1 receptor (TIR) domains can also be present. In the recently sequenced Solanum tuberosum group phureja genome we used HMM models and manual curation to annotate 435 NBS-encoding R gene homologs and 142 NBS-derived genes that lack the NBS domain. Highly similar homologs for most previously documented Solanaceae R genes were identified. A surprising similar to 41% (179) of the 435 NBS-encoding genes are pseudogenes primarily caused by premature stop codons or frameshift mutations. Alignment of 81.80% of the 577 homologs to S. tuberosum group phureja pseudomolecules revealed non-random distribution of the R-genes; 362 of 470 genes were found in high density clusters on 11 chromosomes.	[Lozano, Roberto; Ponce, Olga; Ramirez, Manuel; Mostajo, Nelly; Orjeda, Gisella] Univ Peruana Cayetano Heredia, Genom Res Unit, Fac Sci & Philosophy, Lima, Peru	Universidad Peruana Cayetano Heredia	Lozano, R (corresponding author), Univ Peruana Cayetano Heredia, Genom Res Unit, Fac Sci & Philosophy, Lima, Peru.	gisella.orjeda@upch.edu.pe		Ponce, Olga Patricia/0000-0001-9454-5797; Lozano, Roberto/0000-0003-0760-4977; Orjeda, Gisella/0000-0003-3013-5523	FINCyT [(099-FINCyT-EQUIP-2009)/(076-FINCyT-PIN-2008)]; IADB (Interamerican Development Bank) [1663/OC-PE]; Peruvian Ministry of Agriculture-Technical Secretariat of coordination; CGIAR; Peruvian National Council of Science and Technology (CONCYTEC); Inter-American Council for Integral Development (FEMCIDI)	FINCyT; IADB (Interamerican Development Bank); Peruvian Ministry of Agriculture-Technical Secretariat of coordination; CGIAR(CGIAR); Peruvian National Council of Science and Technology (CONCYTEC); Inter-American Council for Integral Development (FEMCIDI)	The authors acknowledge the funding made available by FINCyT (099-FINCyT-EQUIP-2009)/(076-FINCyT-PIN-2008), IADB (Interamerican Development Bank) Loan No 1663/OC-PE, Peruvian Ministry of Agriculture-Technical Secretariat of coordination with the CGIAR, Peruvian National Council of Science and Technology (CONCYTEC), Special Multilateral Fund of the Inter-American Council for Integral Development (FEMCIDI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameline-Torregrosa C, 2008, PLANT PHYSIOL, V146, P5, DOI 10.1104/pp.107.104588; Bailey T L, 1995, Proc Int Conf Intell Syst Mol Biol, V3, P21; Ballvora A, 2002, PLANT J, V30, P361, DOI 10.1046/j.1365-313X.2001.01292.x; Belkhadir Y, 2004, CURR OPIN PLANT BIOL, V7, P391, DOI 10.1016/j.pbi.2004.05.009; BENT AF, 1994, SCIENCE, V265, P1856, DOI 10.1126/science.8091210; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; Delorenzi M, 2002, BIOINFORMATICS, V18, P617, DOI 10.1093/bioinformatics/18.4.617; Dinesh-Kumar SP, 2000, P NATL ACAD SCI USA, V97, P1908, DOI 10.1073/pnas.020367497; Douchkov D, 2005, PLANT CELL ENVIRON, V28, P365, DOI 10.1111/j.1365-3040.2005.01273.x; Ernst K, 2002, PLANT J, V31, P127, DOI 10.1046/j.1365-313X.2002.01341.x; Fernandez D, 2004, MOL PLANT PATHOL, V5, P527, DOI [10.1111/j.1364-3703.2004.00250.x, 10.1111/J.1364-3703.2004.00250.X]; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Friedman AR, 2007, CURR OPIN GENET DEV, V17, P493, DOI 10.1016/j.gde.2007.08.014; Gassmann W, 2008, CURR TOP MICROBIOL, V326, P219; Gebhardt C, 2001, ANNU REV PHYTOPATHOL, V39, P79, DOI 10.1146/annurev.phyto.39.1.79; GRANT MR, 1995, SCIENCE, V269, P843, DOI 10.1126/science.7638602; Hirotsune S, 2003, NATURE, V423, P91, DOI 10.1038/nature01535; Hong JP, 2005, PLANTA, V220, P875, DOI 10.1007/s00425-004-1412-5; Hulbert SH, 2001, ANNU REV PHYTOPATHOL, V39, P285, DOI 10.1146/annurev.phyto.39.1.285; Kohler A, 2008, PLANT MOL BIOL, V66, P619, DOI 10.1007/s11103-008-9293-9; Kozik A, 2002, BIOINFORMATICS, V18, P335, DOI 10.1093/bioinformatics/18.2.335; Li XY, 2010, PLANT SYST EVOL, V289, P101, DOI 10.1007/s00606-010-0331-0; Liu J.-J., 2003, MGG Molecular Genetics and Genomics, V270, P432, DOI 10.1007/s00438-003-0940-1; Massa AN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026801; McDonnell AV, 2006, BIOINFORMATICS, V22, P356, DOI 10.1093/bioinformatics/bti797; McHale L, 2006, GENOME BIOL, V7, P212; Mestre P, 2006, PLANT CELL, V18, P491, DOI 10.1105/tpc.105.037234; Meyers BC, 2003, PLANT CELL, V15, P809, DOI 10.1105/tpc.009308; Meyers BC, 1999, PLANT J, V20, P317, DOI 10.1046/j.1365-313X.1999.t01-1-00606.x; Mlotshwa S, 2008, TRENDS PLANT SCI, V13, P375, DOI 10.1016/j.tplants.2008.04.009; Monosi B, 2004, THEOR APPL GENET, V109, P1434, DOI 10.1007/s00122-004-1758-x; Morrissey J, 2009, PLANT CELL, V21, P3326, DOI 10.1105/tpc.109.069401; Mun JH, 2009, MOL GENET GENOMICS, V282, P617, DOI 10.1007/s00438-009-0492-0; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Plocik A, 2004, MOL PHYLOGENET EVOL, V31, P153, DOI 10.1016/S1055-7903(03)00274-4; Poliseno L, 2010, NATURE, V465, P1033, DOI 10.1038/nature09144; Porter BW, 2009, MOL GENET GENOMICS, V281, P609, DOI 10.1007/s00438-009-0434-x; Radwan O, 2008, MOL GENET GENOMICS, V280, P111, DOI 10.1007/s00438-008-0346-1; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sanseverino W, 2010, NUCLEIC ACIDS RES, V38, pD814, DOI 10.1093/nar/gkp978; Schornack S, 2004, PLANT J, V37, P46, DOI 10.1046/j.1365-313X.2003.01937.x; Schuler GD, 1997, GENOME RES, V7, P541, DOI 10.1101/gr.7.5.541; Tameling WIL, 2002, PLANT CELL, V14, P2929, DOI 10.1105/tpc.005793; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tan XP, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-56; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TRAUT TW, 1994, EUR J BIOCHEM, V222, P9, DOI 10.1111/j.1432-1033.1994.tb18835.x; van der Biezen EA, 1998, CURR BIOL, V8, pR226, DOI 10.1016/S0960-9822(98)70145-9; van der Vossen EAG, 2005, PLANT J, V44, P208, DOI 10.1111/j.1365-313X.2005.02527.x; vanderVoort JR, 1997, THEOR APPL GENET, V95, P874, DOI 10.1007/s001220050638; Warren RF, 1998, PLANT CELL, V10, P1439, DOI 10.1105/tpc.10.9.1439; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wei FS, 2002, PLANT CELL, V14, P1903, DOI 10.1105/tpc.002238; Xu X, 2011, NATURE, V475, P189, DOI 10.1038/nature10158; Yang SH, 2008, MOL GENET GENOMICS, V280, P187, DOI 10.1007/s00438-008-0355-0; Zhou T, 2004, MOL GENET GENOMICS, V271, P402, DOI 10.1007/s00438-004-0990-z	56	85	94	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2012	7	4							e34775	10.1371/journal.pone.0034775	http://dx.doi.org/10.1371/journal.pone.0034775			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JA	22493716	gold, Green Submitted, Green Published			2022-12-27	WOS:000305012700058
J	Munoz, WA; Kloc, M; Cho, K; Lee, M; Hofmann, I; Sater, A; Vleminckx, K; McCrea, PD				Munoz, William A.; Kloc, Malgorzata; Cho, Kyucheol; Lee, Moonsup; Hofmann, Ilse; Sater, Amy; Vleminckx, Kris; McCrea, Pierre D.			Plakophilin-3 Is Required for Late Embryonic Amphibian Development, Exhibiting Roles in Ectodermal and Neural Tissues	PLOS ONE			English	Article							RHO-FAMILY GTPASES; DESMOSOMAL PLAQUE; P120 CATENIN; CELL-ADHESION; BETA-CATENIN; TRANSCRIPTION FACTOR; EPITHELIAL-CELLS; PROTEIN PLAKOPHILIN-2; ACTIN CYTOSKELETON; FRAGILITY-SYNDROME	The p120-catenin family has undergone a significant expansion during the evolution of vertebrates, resulting in varied functions that have yet to be discerned or fully characterized. Likewise, members of the plakophilins, a related catenin subfamily, are found throughout the cell with little known about their functions outside the desmosomal plaque. While the plakophilin-3 (Pkp3) knockout mouse resulted in skin defects, we find larger, including lethal effects following its depletion in Xenopus. Pkp3, unlike some other characterized catenins in amphibians, does not have significant maternal deposits of mRNA. However, during embryogenesis, two Pkp3 protein products whose temporal expression is partially complimentary become expressed. Only the smaller of these products is found in adult Xenopus tissues, with an expression pattern exhibiting distinctions as well as overlaps with those observed in mammalian studies. We determined that Xenopus Pkp3 depletion causes a skin fragility phenotype in keeping with the mouse knockout, but more novel, Xenopus tailbud embryos are hyposensitive to touch even in embryos lacking outward discernable phenotypes, and we additionally resolved disruptions in certain peripheral neural structures, altered establishment and migration of neural crest, and defects in ectodermal multiciliated cells. The use of two distinct morpholinos, as well as rescue approaches, indicated the specificity of these effects. Our results point to the requirement of Pkp3 in amphibian embryogenesis, with functional roles in a number of tissue types.	[Munoz, William A.; Kloc, Malgorzata; Cho, Kyucheol; Lee, Moonsup; McCrea, Pierre D.] Univ Texas MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Munoz, William A.; Cho, Kyucheol; Lee, Moonsup; McCrea, Pierre D.] Univ Texas Grad Sch Biomed Sci, Program Genes & Dev, Houston, TX USA; [Kloc, Malgorzata] Methodist Hosp, Res Inst, Dept Surg, Houston, TX 77030 USA; [Hofmann, Ilse] Univ Heidelberg, DKFZ, Med Fac Mannheim, Joint Res Div Vasc Biol, D-6800 Mannheim, Germany; [Sater, Amy] Univ Houston, Dept Biol & Biochem, Houston, TX USA; [Vleminckx, Kris] Flanders Inst Biotechnol VIB, Dept Mol Biomed Res, Ghent, Belgium	University of Texas System; UTMD Anderson Cancer Center; The Methodist Hospital System; The Methodist Hospital - Houston; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; University of Houston System; University of Houston; Flanders Institute for Biotechnology (VIB)	Munoz, WA (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Houston, TX 77030 USA.	pdmccrea@mdanderson.org	Kloc, Malgorzata/AAF-6982-2020; Vleminckx, Kris/J-5699-2013		NIH [RO1GM52112]; Cancer Prevention and Research Institute of Texas [RP101502]; National Cancer Institute [CA-16672]; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052112] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention and Research Institute of Texas; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported (P.D.M) by the NIH (RO1GM52112 and Research Supplement to Promote Diversity in Health-Related Research). W. A. M. was supported from a Cancer Prevention and Research Institute of Texas Research Training Award (RP101502). Assistance with DNA sequencing, high resolution electron microscopy and other core facilities was provided from a National Cancer Institute Core Grant (CA-16672) to MD Anderson Cancer Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACHTSTATTER T, 1989, DIFFERENTIATION, V40, P129, DOI 10.1111/j.1432-0436.1989.tb00822.x; Aho S, 2002, J CELL SCI, V115, P1391; Anastasiadis PZ, 2007, BBA-MOL CELL RES, V1773, P34, DOI 10.1016/j.bbamcr.2006.08.040; Anastasiadis PZ, 2001, CURR OPIN CELL BIOL, V13, P604, DOI 10.1016/S0955-0674(00)00258-1; Anastasiadis PZ, 2000, NAT CELL BIOL, V2, P637, DOI 10.1038/35023588; Awad MM, 2008, NAT CLIN PRACT CARD, V5, P258, DOI 10.1038/ncpcardio1182; Basch ML, 2006, ADV EXP MED BIOL, V589, P24; Bass-Zubek AE, 2009, CURR OPIN CELL BIOL, V21, P708, DOI 10.1016/j.ceb.2009.07.002; Beausoleil SA, 2004, P NATL ACAD SCI USA, V101, P12130, DOI 10.1073/pnas.0404720101; Bilinski SM, 2010, METHODS, V51, P11, DOI 10.1016/j.ymeth.2009.12.003; Bonne S, 2003, J CELL BIOL, V161, P403, DOI 10.1083/jcb.200303036; Bonne S, 1999, J CELL SCI, V112, P2265; Breuninger S, 2010, AM J PATHOL, V176, P2509, DOI 10.2353/ajpath.2010.090737; Brooke MA, 2012, J PATHOL, V226, P158, DOI 10.1002/path.3027; Carnahan RH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015747; Chen XY, 2002, J BIOL CHEM, V277, P10512, DOI 10.1074/jbc.M108765200; Chidgey M, 2001, J CELL BIOL, V155, P821, DOI 10.1083/jcb.200105009; Christiansen JH, 2000, CURR OPIN CELL BIOL, V12, P719, DOI 10.1016/S0955-0674(00)00158-7; Ciesiolka M, 2004, J CELL SCI, V117, P4325, DOI 10.1242/jcs.01298; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Daniel JM, 1999, MOL CELL BIOL, V19, P3614; Daniel JM, 2007, BBA-MOL CELL RES, V1773, P59, DOI 10.1016/j.bbamcr.2006.08.052; DEMARAIS AA, 1992, DEV BIOL, V153, P337, DOI 10.1016/0012-1606(92)90118-Z; Demirag GG, 2011, MED ONCOL; Demirag GG, 2011, DIAGN PATHOL, V6, DOI 10.1186/1746-1596-6-1; Fang X, 2004, J CELL BIOL, V165, P87, DOI 10.1083/jcb.200307109; Franke WW, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003061; FUNAYAMA N, 1995, J CELL BIOL, V128, P959, DOI 10.1083/jcb.128.5.959; Furukawa C, 2005, CANCER RES, V65, P7102, DOI 10.1158/0008-5472.CAN-04-1877; Gerull B, 2004, NAT GENET, V36, P1162, DOI 10.1038/ng1461; Godsel LM, 2010, MOL BIOL CELL, V21, P2844, DOI 10.1091/mbc.E10-02-0131; Green KJ, 2007, J INVEST DERMATOL, V127, P2499, DOI 10.1038/sj.jid.5701015; Grosheva I, 2001, J CELL SCI, V114, P695; Grossmann KS, 2004, J CELL BIOL, V167, P149, DOI 10.1083/jcb.200402096; Gu D, 2011, J BIOL CHEM; Gu DM, 2009, J CELL SCI, V122, P4049, DOI 10.1242/jcs.031948; Hartsock A, 2008, BBA-BIOMEMBRANES, V1778, P660, DOI 10.1016/j.bbamem.2007.07.012; Hatzfeld M, 2005, EUR J CELL BIOL, V84, P205, DOI 10.1016/j.ejcb.2004.12.016; Hatzfeld M, 2000, J CELL BIOL, V149, P209, DOI 10.1083/jcb.149.1.209; Hatzfeld M, 2007, BBA-MOL CELL RES, V1773, P69, DOI 10.1016/j.bbamcr.2006.04.009; HEID HW, 1994, DIFFERENTIATION, V58, P113; Hobbs RP, 2012, J INVEST DERMATOL; Hofmann I, 2006, MOL BIOL CELL, V17, P1388, DOI 10.1091/mbc.e05-08-0708; Hofmann I, 2000, J CELL SCI, V113, P2471; Hong JY, 2010, J CELL SCI, V123, P4351, DOI 10.1242/jcs.067199; Israely I, 2004, CURR BIOL, V14, P1657, DOI 10.1016/j.cub.2004.08.065; Keil R, 2007, CELL CYCLE, V6, P122, DOI 10.4161/cc.6.2.3741; Keirsebilck A, 1998, GENOMICS, V50, P129, DOI 10.1006/geno.1998.5325; Klaus A, 2008, NAT REV CANCER, V8, P387, DOI 10.1038/nrc2389; Klymkowsky MW, 1999, MICROSC RES TECHNIQ, V45, P43, DOI 10.1002/(SICI)1097-0029(19990401)45:1<43::AID-JEMT4>3.3.CO;2-3; Kowalczyk AP, 1999, J BIOL CHEM, V274, P18145, DOI 10.1074/jbc.274.26.18145; Kundu ST, 2008, INT J CANCER, V123, P2303, DOI 10.1002/ijc.23797; Kuriyama S, 2008, PHILOS T R SOC B, V363, P1349, DOI 10.1098/rstb.2007.2252; McCrea PD, 2007, BBA-MOL CELL RES, V1773, P17, DOI 10.1016/j.bbamcr.2006.06.009; McCrea PD, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002923; McCrea PD, 2010, J CELL SCI, V123, P637, DOI 10.1242/jcs.039842; McGrath JA, 1997, NAT GENET, V17, P240, DOI 10.1038/ng1097-240; McMillan JR, 2003, J INVEST DERMATOL, V121, P96, DOI 10.1046/j.1523-1747.2003.12324.x; Mertens C, 2001, P NATL ACAD SCI USA, V98, P7795, DOI 10.1073/pnas.141219498; Mertens C, 1996, J CELL BIOL, V135, P1009, DOI 10.1083/jcb.135.4.1009; Mo YY, 1996, CANCER RES, V56, P2633; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; Montross WT, 2000, J CELL SCI, V113, P1759; Nekrasova OE, 2011, J CELL BIOL, V195, P1185, DOI 10.1083/jcb.201106057; Noren NK, 2000, J CELL BIOL, V150, P567, DOI 10.1083/jcb.150.3.567; North AJ, 1999, J CELL SCI, V112, P4325; Papagerakis S, 2003, HUM PATHOL, V34, P565, DOI 10.1016/S0046-8177(03)00174-6; Paulson AF, 2000, J BIOL CHEM, V275, P30124, DOI 10.1074/jbc.M003048200; Perez-Moreno M, 2003, CELL, V112, P535, DOI 10.1016/S0092-8674(03)00108-9; Rickelt S, 2011, CELL TISSUE RES, V346, P65, DOI 10.1007/s00441-011-1260-0; Roberts BJ, 2011, EXP CELL RES, V317, P2814, DOI 10.1016/j.yexcr.2011.09.003; Schmidt A, 1999, DIFFERENTIATION, V64, P291, DOI 10.1046/j.1432-0436.1999.6450291.x; Schmidt A, 1997, CELL TISSUE RES, V290, P481, DOI 10.1007/s004410050956; SCHNEIDER S, 1993, DEVELOPMENT, V118, P629; Schwarz J, 2006, HUM PATHOL, V37, P613, DOI 10.1016/j.humpath.2006.01.013; Sive Hazel L., 2000, EARLY DEV XENOPUS LA; Sklyarova T, 2008, J INVEST DERMATOL, V128, P1375, DOI 10.1038/sj.jid.5701189; Smith EA, 1998, J CELL BIOL, V141, P1229, DOI 10.1083/jcb.141.5.1229; Snider P, 2007, THESCIENTIFICWORLDJO, V7, P1090, DOI 10.1100/tsw.2007.189; Sobolik-Delmaire T, 2006, J BIOL CHEM, V281, P16962, DOI 10.1074/jbc.M600570200; Sobolik-Delmaire T, 2010, J INVEST DERMATOL, V130, P2638, DOI 10.1038/jid.2010.191; South AP, 2003, J CELL SCI, V116, P3303, DOI 10.1242/jcs.00636; Sprecher E, 2004, J INVEST DERMATOL, V122, P647, DOI 10.1111/j.0022-202X.2004.22335.x; Thomason HA, 2010, BIOCHEM J, V429, P419, DOI 10.1042/BJ20100567; Wallingford JB, 2010, COLD SPRING HARB PRO; Wolf A, 2006, NAT CELL BIOL, V8, P1432, DOI 10.1038/ncb1504; Wolf A, 2010, J CELL BIOL, V188, P463, DOI 10.1083/jcb.200908135; Yin TF, 2004, SEMIN CELL DEV BIOL, V15, P665, DOI 10.1016/j.semcdb.2004.09.005	88	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2012	7	4							e34342	10.1371/journal.pone.0034342	http://dx.doi.org/10.1371/journal.pone.0034342			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955IH	22496792	gold, Green Published, Green Submitted			2022-12-27	WOS:000305010500006
J	Gorski, L				Gorski, Lisa			Selective Enrichment Media Bias the Types of Salmonella enterica Strains Isolated from Mixed Strain Cultures and Complex Enrichment Broths	PLOS ONE			English	Article							LISTERIA-MONOCYTOGENES; SEROTYPES; SAMPLES; IDENTIFICATION; LABORATORIES; TYPHIMURIUM; DIVERSITY; TRACKING; DIFFER	For foodborne outbreak investigations it can be difficult to isolate the relevant strain from food and/or environmental sources. If the sample is contaminated by more than one strain of the pathogen the relevant strain might be missed. In this study mixed cultures of Salmonella enterica were grown in one set of standard enrichment media to see if culture bias patterns emerged. Nineteen strains representing four serogroups and ten serotypes were compared in four-strain mixtures in Salmonella-only and in cattle fecal culture enrichment backgrounds using Salmonella enrichment media. One or more strain(s) emerged as dominant in each mixture. No serotype was most fit, but strains of serogroups C2 and E were more likely to dominate enrichment culture mixtures than strains of serogroups B or C1. Different versions of Rappaport-Vassiliadis (RV) medium gave different patterns of strain dominance in both Salmonella-only and fecal enrichment culture backgrounds. The fittest strains belonged to serogroups C1, C2, and E, and included strains of S. Infantis, S. Thompson S. Newport, S. 6,8:d:-, and S. Give. Strains of serogroup B, which included serotypes often seen in outbreaks such as S. Typhimurium, S. Saintpaul, and S. Schwarzengrund were less likely to emerge as dominant strains in the mixtures when using standard RV as part of the enrichment. Using a more nutrient-rich version of RV as part of the protocol led to a different pattern of strains emerging, however some were still present in very low numbers in the resulting population. These results indicate that outbreak investigations of food and/or other environmental samples should include multiple enrichment protocols to ensure isolation of target strains of Salmonella.	ARS, Produce Safety & Microbiol Res Unit, USDA, Albany, CA USA	United States Department of Agriculture (USDA)	Gorski, L (corresponding author), ARS, Produce Safety & Microbiol Res Unit, USDA, Albany, CA USA.	lisa.gorski@ars.usda.gov		Gorski, Lisa/0000-0003-2387-1012	United States Department of Agriculture (USDA), Agricultural Research Service CRIS [5325-42000-046-00D]; National Research Initiative from the USDA National Institute of Food and Agriculture [2006-55212-16927, 2007-35212-18239]	United States Department of Agriculture (USDA), Agricultural Research Service CRIS(United States Department of Agriculture (USDA)); National Research Initiative from the USDA National Institute of Food and Agriculture	This work was supported by the United States Department of Agriculture (USDA), Agricultural Research Service CRIS project 5325-42000-046-00D and, in part, by National Research Initiative Competitive Grant numbers 2006-55212-16927 and 2007-35212-18239 from the USDA National Institute of Food and Agriculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews W.H, 2007, SALMONELLA BACTERIOL; [Anonymous], ANONYMOUS METHOD 168; BARKER RM, 1980, J GEN MICROBIOL, V120, P21; Barkocy-Gallagher GA, 2002, J FOOD PROTECT, V65, P1527, DOI 10.4315/0362-028X-65.10.1527; Bruhn JB, 2005, APPL ENVIRON MICROB, V71, P961, DOI 10.1128/AEM.71.2.961-967.2005; CAMPOS L C, 1988, Memorias do Instituto Oswaldo Cruz, V83, P189; Carter MQ, 2011, APPL ENVIRON MICROB, V77, P3685, DOI 10.1128/AEM.02315-10; CDC, 2011, SALM ANN SUMM TABL 2; Cooley M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001159; Davies PR, 2000, J APPL MICROBIOL, V89, P169, DOI 10.1046/j.1365-2672.2000.01101.x; Fedorka-Cray PJ, 1998, J FOOD PROTECT, V61, P525, DOI 10.4315/0362-028X-61.5.525; Gorski L, 2006, APPL ENVIRON MICROB, V72, P776, DOI 10.1128/AEM.72.1.776-783.2006; Gorski L, 2011, APPL ENVIRON MICROB, V77, P2734, DOI 10.1128/AEM.02321-10; Haley BJ, 2009, APPL ENVIRON MICROB, V75, P1248, DOI 10.1128/AEM.01648-08; HARVEY RWS, 1967, J HYG-CAMB, V65, P423, DOI 10.1017/S0022172400045939; Hendriksen RS, 2011, FOODBORNE PATHOG DIS, V8, P887, DOI 10.1089/fpd.2010.0787; Jones TF, 2008, J INFECT DIS, V198, P109, DOI 10.1086/588823; MCGIBBON L, 1984, INT J FOOD MICROBIOL, V1, P171, DOI 10.1016/0168-1605(84)90013-8; Murray GL, 2003, MOL MICROBIOL, V47, P1395, DOI 10.1046/j.1365-2958.2003.03383.x; Palumbo JD, 2003, J CLIN MICROBIOL, V41, P564, DOI 10.1128/JCM.41.2.564-571.2003; Patankar C V, 1985, J Postgrad Med, V31, P46; Patchanee P, 2010, FOODBORNE PATHOG DIS, V7, P1113, DOI 10.1089/fpd.2010.0572; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Rostagno MH, 2005, J VET DIAGN INVEST, V17, P80, DOI 10.1177/104063870501700118; Rybolt ML, 2004, POULTRY SCI, V83, P1112, DOI 10.1093/ps/83.7.1112; Singer RS, 2009, J FOOD PROTECT, V72, P707, DOI 10.4315/0362-028X-72.4.707; VASSILIADIS P, 1983, J APPL BACTERIOL, V54, P69, DOI 10.1111/j.1365-2672.1983.tb01302.x; Voogt N, 2002, EUR J CLIN MICROBIOL, V21, P449, DOI 10.1007/s10096-002-0741-1	28	58	61	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e34722	10.1371/journal.pone.0034722	http://dx.doi.org/10.1371/journal.pone.0034722			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GO	22496847	Green Submitted, gold, Green Published			2022-12-27	WOS:000304855200070
J	Hsu, YC; Yu, L; Chen, HI; Lee, HL; Kuo, YM; Jen, CYJ				Hsu, Yuan-Chang; Yu, Lung; Chen, Hsiun-ing; Lee, Hui-Ling; Kuo, Yu-Min; Jen, Chauying J.			Blood Pressure Variations Real-Time Reflect the Conditioned Fear Learning and Memory	PLOS ONE			English	Article							SUBSTANCE-P; POTENTIATED STARTLE; AMYGDALA; HYPOTHALAMUS; BRAIN; RATS; ANXIETY; SYSTEM; CAT	The conditioned fear learning and memory occurs when a neutral conditioned stimulus (CS) is paired with an aversive unconditioned stimulus (US). This process is critically dependent on the amygdala and inevitably involves blood pressure (BP) alterations. We hypothesized that BP variations could instantaneously reveal individual steps during conditioned fear learning and memory. An implanted telemetric probe was used to monitor the BP real-time in rats during training and testing sessions of the fear-potentiated startle. Our results showed that (i) the conditioned fear learning during the training sessions was reflected by light (CS)-induced rapid BP elevations and by electric shock (US)-evoked sympathetic tone elevations; (ii) these two BP-related parameters were not only negatively correlated with each other but also coupled to each other in the training session trials; (iii) both parameters closely predicted the performance of fear-potentiated startle on the next day; and (iv) although local blocking of one of the two fear-conditioned pathways in the training session partially inhibited fear learning, the fear memory retrieval still used both pathways. Altogether, real-time blood pressure variations faithfully revealed the critical steps involved in conditioned fear learning and memory, and our results supported a coupling between the cued learning and the post-shock calmness.	[Hsu, Yuan-Chang; Chen, Hsiun-ing; Jen, Chauying J.] Natl Cheng Kung Univ, Inst Basic Med Sci, Tainan 70101, Taiwan; [Yu, Lung] Natl Cheng Kung Univ, Inst Behav Med, Tainan 70101, Taiwan; [Chen, Hsiun-ing; Jen, Chauying J.] Natl Cheng Kung Univ, Dept Physiol, Tainan 70101, Taiwan; [Lee, Hui-Ling] Natl Cheng Kung Univ, Inst Publ Hlth, Tainan 70101, Taiwan; [Kuo, Yu-Min] Natl Cheng Kung Univ, Dept Cell Biol & Anat, Tainan 70101, Taiwan	National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University	Hsu, YC (corresponding author), Natl Cheng Kung Univ, Inst Basic Med Sci, Tainan 70101, Taiwan.	jen@mail.ncku.edu.tw	Kuo, Yu-Min/A-9050-2013	Kuo, Yu-Min/0000-0003-4867-2482	National Science Council in Taiwan [NSC 98-2320-B-006-019-MY3, NSC 98-2320-B-006-028-MY3]	National Science Council in Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by grants from the National Science Council in Taiwan (Grant numbers NSC 98-2320-B-006-019-MY3, NSC 98-2320-B-006-028-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blair HT, 2001, LEARN MEMORY, V8, P229, DOI 10.1101/lm.30901; CERUTTI C, 1991, AM J PHYSIOL, V261, pH1292, DOI 10.1152/ajpheart.1991.261.4.H1292; COLPAERT FC, 1976, BEHAV BIOL, V16, P117, DOI 10.1016/S0091-6773(76)91225-6; Dalgleish T, 2004, NAT REV NEUROSCI, V5, P583, DOI 10.1038/nrn1432; DAVIS M, 1992, ANNU REV NEUROSCI, V15, P353, DOI 10.1146/annurev.neuro.15.1.353; Davis M, 2006, AM PSYCHOL, V61, P741, DOI 10.1037/0003-066X.61.8.741; deOliveira L, 1997, NEUROREPORT, V8, P3489, DOI 10.1097/00001756-199711100-00015; Dielenberg RA, 2001, NEUROSCIENCE, V104, P1085, DOI 10.1016/S0306-4522(01)00150-6; Fanselow MS, 1998, NEURON, V20, P625, DOI 10.1016/S0896-6273(00)81002-8; Fanselow MS, 2005, ANNU REV PSYCHOL, V56, P207, DOI 10.1146/annurev.psych.56.091103.070213; Han YC, 1996, BRAIN RES, V716, P59, DOI 10.1016/0006-8993(95)01586-8; Harris JA, 2011, J EXP PSYCHOL-ANIM B, V37, P277, DOI 10.1037/a0023079; Harris JA, 2011, J EXP PSYCHOL ANIM B, V37, P151, DOI 10.1037/a0021883; Hsu YC, 2011, J HYPERTENS, V29, P2339, DOI 10.1097/HJH.0b013e32834c628f; ITOI K, 1991, BRAIN RES, V558, P123, DOI 10.1016/0006-8993(91)90727-D; Lang PJ, 2006, PROG BRAIN RES, V156, P3, DOI 10.1016/S0079-6123(06)56001-7; LEDOUX J E, 1992, P339; Maren S, 2004, NAT REV NEUROSCI, V5, P844, DOI 10.1038/nrn1535; Roozendaal B, 2003, PROG NEURO-PSYCHOPH, V27, P1213, DOI 10.1016/j.pnpbp.2003.09.015; Roozendaal B, 2009, NAT REV NEUROSCI, V10, P423, DOI 10.1038/nrn2651; Sah P, 2008, ANN NY ACAD SCI, V1129, P88, DOI 10.1196/annals.1417.020; Sudakov K V, 1987, Neurosci Behav Physiol, V17, P74, DOI 10.1007/BF01186811; Zhao ZW, 2009, NEUROPSYCHOPHARMACOL, V34, P331, DOI 10.1038/npp.2008.55	23	5	5	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e32855	10.1371/journal.pone.0032855	http://dx.doi.org/10.1371/journal.pone.0032855			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	953GO	22496737	Green Published, gold, Green Submitted			2022-12-27	WOS:000304855200006
J	Pan, IC; Liao, DC; Wu, FH; Daniell, H; Singh, ND; Chang, C; Shih, MC; Chan, MT; Lin, CS				Pan, I-Chun; Liao, Der-Chih; Wu, Fu-Huei; Daniell, Henry; Singh, Nameirakpam Dolendro; Chang, Chen; Shih, Ming-Che; Chan, Ming-Tsair; Lin, Choun-Sea			Complete Chloroplast Genome Sequence of an Orchid Model Plant Candidate: Erycina pusilla Apply in Tropical Oncidium Breeding	PLOS ONE			English	Article							COMPLETE NUCLEOTIDE-SEQUENCE; GOWER RAMSEY; PHYLOGENETIC-RELATIONSHIPS; DIFFERENTIAL EXPRESSION; MITOCHONDRIAL-DNA; GENE-SEQUENCES; NDH GENES; IDENTIFICATION; EVOLUTION; BIOTECHNOLOGY	Oncidium is an important ornamental plant but the study of its functional genomics is difficult. Erycina pusilla is a fast-growing Oncidiinae species. Several characteristics including low chromosome number, small genome size, short growth period, and its ability to complete its life cycle in vitro make E. pusilla a good model candidate and parent for hybridization for orchids. Although genetic information remains limited, systematic molecular analysis of its chloroplast genome might provide useful genetic information. By combining bacterial artificial chromosome (BAC) clones and next-generation sequencing (NGS), the chloroplast (cp) genome of E. pusilla was sequenced accurately, efficiently and economically. The cp genome of E. pusilla shares 89 and 84% similarity with Oncidium Gower Ramsey and Phalanopsis aphrodite, respectively. Comparing these 3 cp genomes, 5 regions have been identified as showing diversity. Using PCR analysis of 19 species belonging to the Epidendroideae subfamily, a conserved deletion was found in the rps15-trnN region of the Cymbidieae tribe. Because commercial Oncidium varieties in Taiwan are limited, identification of potential parents using molecular breeding method has become very important. To demonstrate the relationship between taxonomic position and hybrid compatibility of E. pusilla, 4 DNA regions of 36 tropically adapted Oncidiinae varieties have been analyzed. The results indicated that trnF-ndhJ and trnH-psbA were suitable for phylogenetic analysis. E. pusilla proved to be phylogenetically closer to Rodriguezia and Tolumnia than Oncidium, despite its similar floral appearance to Oncidium. These results indicate the hybrid compatibility of E. pusilla, its cp genome providing important information for Oncidium breeding.	[Pan, I-Chun; Chan, Ming-Tsair] Natl Cheng Kung Univ, Inst Biotechnol, Tainan 70101, Taiwan; [Pan, I-Chun; Liao, Der-Chih; Wu, Fu-Huei; Shih, Ming-Che; Chan, Ming-Tsair; Lin, Choun-Sea] Acad Sinica, Agr Biotechnol Res Ctr, Taipei 115, Taiwan; [Pan, I-Chun; Chan, Ming-Tsair] Acad Sinica Biotechnol Ctr So Taiwan, Tainan, Taiwan; [Daniell, Henry; Singh, Nameirakpam Dolendro] Univ Cent Florida, Dept Mol Biol & Microbiol, Orlando, FL 32816 USA; [Chang, Chen] Natl Chung Hsing Univ, Dept Hort, Taichung 40227, Taiwan	National Cheng Kung University; Academia Sinica - Taiwan; State University System of Florida; University of Central Florida; National Chung Hsing University	Pan, IC (corresponding author), Natl Cheng Kung Univ, Inst Biotechnol, Tainan 70101, Taiwan.	mbmtchan@gate.sinica.edu.tw; cslin99@gate.sinica.edu.tw	Daniell, Henry/L-3655-2019; Pan, I-Chun/AFP-1078-2022; Shih, Ming-Che/V-1816-2019; Chan, Ming-Tsair/L-2465-2015	Daniell, Henry/0000-0003-4485-1176; Chan, Ming-Tsair/0000-0002-1942-9160; Lin, Choun-Sea/0000-0001-9566-2952	Agricultural Biotechnology Research Center, Academia Sinica, Taipei, Taiwan; Academia Sinica Biotechnology Center in Southern Taiwan, Tainan, Taiwan; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063879] Funding Source: NIH RePORTER	Agricultural Biotechnology Research Center, Academia Sinica, Taipei, Taiwan; Academia Sinica Biotechnology Center in Southern Taiwan, Tainan, Taiwan; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Agricultural Biotechnology Research Center, Academia Sinica, Taipei, Taiwan and Academia Sinica Biotechnology Center in Southern Taiwan, Tainan, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AYLIFFE MA, 1992, THEOR APPL GENET, V85, P229, DOI 10.1007/BF00222864; Bausher MG, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-21; Cameron KM, 2006, CLADISTICS, V22, P239, DOI 10.1111/j.1096-0031.2006.00102.x; Cameron KM, 2004, MOL PHYLOGENET EVOL, V31, P1157, DOI 10.1016/j.ympev.2003.10.010; Chang CC, 2006, MOL BIOL EVOL, V23, P279, DOI 10.1093/molbev/msj029; Chang YY, 2011, PLANT CELL PHYSIOL, V52, P1532, DOI 10.1093/pcp/pcr101; Chase M.W., 2003, ORCHID CONSERV, P69; Chase MW, 2009, ANN BOT-LONDON, V104, P387, DOI 10.1093/aob/mcp067; CHASE MW, 1986, SYST BOT, V11, P477, DOI 10.2307/2419085; Chase MW, 2005, ANN BOT-LONDON, V95, P191, DOI 10.1093/aob/mci012; Chen ChiaChung, 2003, Journal of Agriculture and Forestry, V52, P33; Chen YC, 2000, IN VITRO CELL DEV-PL, V36, P420; Chiou CY, 2008, PLANT MOL BIOL, V66, P379, DOI 10.1007/s11103-007-9275-3; Chiu YT, 2011, PROPAG ORNAM PLANTS, V11, P131; Chris BJ, 2011, PLANT MOL BIOL, P1; Damon Anne, 2007, Tropical Ecology, V48, P1; Daniell H, 2005, TRENDS BIOTECHNOL, V23, P238, DOI 10.1016/j.tibtech.2005.03.008; Daniell H, 2008, THEOR APPL GENET, V116, P723, DOI 10.1007/s00122-007-0706-y; DODSON C H, 1972, Phytologia, V24, P285; Felix LP, 1999, CARYOLOGIA, V52, P165, DOI 10.1080/00087114.1998.10589169; Fu CH, 2011, PLANT CELL PHYSIOL, V52, P238, DOI 10.1093/pcp/pcq201; Goremykin VV, 2009, MOL BIOL EVOL, V26, P99, DOI 10.1093/molbev/msn226; Hirai A., 1993, Plant Molecular Biology Reporter, V11, P98, DOI 10.1007/BF02670465; Hsiao YY, 2011, PLANT CELL PHYSIOL, V52, P1467, DOI 10.1093/pcp/pcr100; Hsu CT, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-60; Hsu HF, 2002, PLANT CELL PHYSIOL, V43, P1198, DOI 10.1093/pcp/pcf143; Jansen RK, 2008, MOL PHYLOGENET EVOL, V48, P1204, DOI 10.1016/j.ympev.2008.06.013; KERBAUY GB, 1984, PLANT SCI LETT, V35, P73, DOI 10.1016/0304-4211(84)90160-3; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Liao LJ, 2004, MOL BREEDING, V13, P229, DOI 10.1023/B:MOLB.0000022527.68551.30; Liau CH, 2003, PLANT CELL REP, V21, P993, DOI 10.1007/s00299-003-0614-9; Lin CS, 2011, SEED NURSERY, V13, P31; Mach JM, 2001, P NATL ACAD SCI USA, V98, P771, DOI 10.1073/pnas.021465298; Martin M, 2010, PLANT PHYSIOL BIOCH, V48, P636, DOI 10.1016/j.plaphy.2010.04.009; Mccoy SR, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-130; NAKAZONO M, 1993, MOL GEN GENET, V236, P341, DOI 10.1007/BF00277131; Neubig KM, 2009, PLANT SYST EVOL, V277, P75, DOI 10.1007/s00606-008-0105-0; Nock CJ, 2011, PLANT BIOTECHNOL J, V9, P328, DOI 10.1111/j.1467-7652.2010.00558.x; Pellegrino G, 2009, PLANT BIOLOGY, V11, P434, DOI 10.1111/j.1438-8677.2008.00135.x; Pinheiro F, 2010, MOL ECOL, V19, P3981, DOI 10.1111/j.1365-294X.2010.04780.x; Russell A, 2010, ANN BOT-LONDON, V106, P37, DOI 10.1093/aob/mcq092; Samson N, 2007, PLANT BIOTECHNOL J, V5, P339, DOI 10.1111/j.1467-7652.2007.00245.x; Sanjaya, 2007, ORCHID BIOTECHNOLOGY, P225; Saski C, 2005, PLANT MOL BIOL, V59, P309, DOI 10.1007/s11103-005-8882-0; Scarcelli N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019954; Sheu JJ, 1996, J BIOL CHEM, V271, P26998, DOI 10.1074/jbc.271.43.26998; STERN DB, 1982, NATURE, V299, P698, DOI 10.1038/299698a0; STERN DB, 1984, P NATL ACAD SCI-BIOL, V81, P1946, DOI 10.1073/pnas.81.7.1946; Su CL, 2011, PLANT CELL PHYSIOL, V52, P1501, DOI 10.1093/pcp/pcr097; Thiruvengadam M, 2009, PLANT CELL REP, V28, P1463, DOI 10.1007/s00299-009-0746-7; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tian Xin, 2002, Acta Botanica Yunnanica, V24, P170; Timmis JN, 2004, NAT REV GENET, V5, P123, DOI 10.1038/nrg1271; Verma D, 2007, PLANT PHYSIOL, V145, P1129, DOI 10.1104/pp.107.106690; WAKASUGI T, 1994, P NATL ACAD SCI USA, V91, P9794, DOI 10.1073/pnas.91.21.9794; Williams Norris H., 2001, Lindleyana, V16, P113; Wu CS, 2009, MOL PHYLOGENET EVOL, V52, P115, DOI 10.1016/j.ympev.2008.12.026; Wu FH, 2009, TREE PHYSIOL, V29, P847, DOI 10.1093/treephys/tpp015; Wu FH, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-68; Wyman SK, 2004, BIOINFORMATICS, V20, P3252, DOI 10.1093/bioinformatics/bth352; You SJ, 2003, PLANTA, V217, P60, DOI 10.1007/s00425-002-0970-7; Zhang Y, 2008, MAR BIOTECHNOL, V10, P358, DOI 10.1007/s10126-007-9071-8; Zhang YJ, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0021342, 10.1371/journal.pone.0020596]	63	48	49	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e34738	10.1371/journal.pone.0034738	http://dx.doi.org/10.1371/journal.pone.0034738			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GO	22496851	Green Published, gold, Green Submitted			2022-12-27	WOS:000304855200073
J	Lopez-Fernandez, H; Winemiller, KO; Montana, C; Honeycutt, RL				Lopez-Fernandez, Hernan; Winemiller, Kirk O.; Montana, Carmen; Honeycutt, Rodney L.			Diet-Morphology Correlations in the Radiation of South American Geophagine Cichlids (Perciformes: Cichlidae: Cichlinae)	PLOS ONE			English	Article							ECOMORPHOLOGICAL DIVERSIFICATION; MOLECULAR PHYLOGENY; ADAPTIVE RADIATION; ECOLOGICAL LIMITS; TELEOSTEI; EVOLUTION; GYMNOGEOPHAGUS; CONVERGENCE; MECHANICS; FISHES	Genera within the South American cichlid tribe Geophagini display specialized feeding and reproductive strategies, with some taxa specialized for both substrate sifting and mouth brooding. Several lineages within the clade also possess an epibranchial lobe (EBL), a unique pharyngeal structure that has been proposed to have a function in feeding and/or mouth brooding. A recently published genus-level phylogeny of Neotropical cichlids was used as the evolutionary framework for investigating the evolution of morphological features presumably correlated with diet and mouth brooding in the tribe Geophagini. We tested for possible associations between the geophagine epibranchial lobe and benthic feeding and mouth brooding. We also addressed whether the Eft.. may be associated with unique patterns of diversification in certain geophagine clades. Tests of binary character correlations revealed the EBL was significantly associated with mouth brooding. We also tested for a relationship between diet and morphology. We analyzed stomach contents and morphometric variation among 21 species, with data for two additional species obtained from the literature. Principal Components Analysis revealed axes of morphological variation significantly correlated with piscivory and benthivory, and both morphology and diet were significantly associated with phylogeny. These results suggest that the EBL could be an adaptation for either feeding or mouth brooding. The EBL, however, was not associated with species richness or accelerated rates of phyletic diversification.	[Lopez-Fernandez, Hernan] Royal Ontario Museum, Dept Nat Hist, Toronto, ON M5S 2C6, Canada; [Lopez-Fernandez, Hernan] Univ Toronto, Dept Ecol & Evolutionary Biol, Toronto, ON, Canada; [Winemiller, Kirk O.; Montana, Carmen] Texas A&M Univ, Dept Wildlife & Fisheries Sci, Sect Ecol Evolut & Systemat, College Stn, TX 77843 USA; [Honeycutt, Rodney L.] Pepperdine Univ, Div Nat Sci, Malibu, CA 90265 USA	Royal Ontario Museum; University of Toronto; Texas A&M University System; Texas A&M University College Station; Pepperdine University	Lopez-Fernandez, H (corresponding author), Royal Ontario Museum, Dept Nat Hist, Toronto, ON M5S 2C6, Canada.	hernanl@rom.on.ca	Montana, Carmen/H-1387-2012	Winemiller, Kirk/0000-0003-0236-5129; Lopez-Fernandez, Hernan/0000-0003-0270-1671	United States National Science Foundation [DEB 0516831]; Natural Sciences and Engineering Research Council of Canada	United States National Science Foundation(National Science Foundation (NSF)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	Funding for this project was provided by Grant DEB 0516831 from the United States National Science Foundation (www.nsf.gov) to KOW, RLH, and HLF and by a Discovery Grant from the Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca/Index_eng.asp) to HLF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abouheif E, 1999, EVOL ECOL RES, V1, P895; Albert JS, 2011, HISTORICAL BIOGEOGRAPHY OF NEOTROPICAL FRESHWATER FISHES, P21; Albert JS, 2011, HISTORICAL BIOGEOGRAPHY OF NEOTROPICAL FRESHWATER FISHES, P3; Albert JS, 2011, HISTORICAL BIOGEOGRAPHY OF NEOTROPICAL FRESHWATER FISHES, P1; BAREL CDN, 1983, NETH J ZOOL, V33, P357; Collar DC, 2009, EVOLUTION, V63, P1557, DOI 10.1111/j.1558-5646.2009.00626.x; DRUCKER EG, 1991, J MORPHOL, V210, P267, DOI 10.1002/jmor.1052100306; ESCALANTE A H, 1984, Limnobios, V2, P562; Farias IP, 1999, J MOL EVOL, V48, P703, DOI 10.1007/PL00006514; Farias IP, 2000, J EXP ZOOL, V288, P76, DOI 10.1002/(SICI)1097-010X(20000415)288:1&lt;76::AID-JEZ8&gt;3.0.CO;2-P; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; GARLAND T, 1992, SYST BIOL, V41, P18, DOI 10.2307/2992503; Gavrilets S, 2009, SCIENCE, V323, P732, DOI 10.1126/science.1157966; Glaser U, 1996, SOUTHAMERICAN CICHLI; GLASER U., 1996, SOUTHAMERICAN CICHLI; Glaser U, 1996, SOUTHAMERICAN CICHLI; Glor RE, 2010, ANNU REV ECOL EVOL S, V41, P251, DOI 10.1146/annurev.ecolsys.39.110707.173447; Gonzalez-Bergonzoni I, 2009, NEOTROP ICHTHYOL, V7, P19, DOI 10.1590/S1679-62252009000100003; Greenwood P.H., 1987, B BRIT MUS NAT HIST, V53, P139; Haseman JD, 1911, CARNEGIE MUS, V7, P315; Hoorn C, AMAZONIA LANDSCAPE S; Hulsey CD, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-279; Hulsey CD, 2004, MOL PHYLOGENET EVOL, V31, P754, DOI 10.1016/j.ympev.2003.08.024; Hulsey CD, 2005, FUNCT ECOL, V19, P487, DOI 10.1111/j.1365-2435.2005.00987.x; JACKSON DA, 1995, ECOSCIENCE, V2, P297, DOI 10.1080/11956860.1995.11682297; Kaufman L.S., 1982, Breviora, P1; KULLANDER S.O., 1989, CICHLIDS SURINAM; KULLANDER SO, 1989, J NAT HIST, V23, P225, DOI 10.1080/00222938900770131; Kullander SO, 1986, CICHLID FISHES AMAZO; Kullander Sven O., 1998, P461; LAUR DR, 1983, ENVIRON BIOL FISH, V8, P217, DOI 10.1007/BF00001087; LIEM KF, 1986, COPEIA, P311, DOI 10.2307/1444992; Lopez-Fernandez H, 2005, ZOOL SCR, V34, P627, DOI 10.1111/j.1463-6409.2005.00209.x; Lopez-Fernandez H, 2005, MOL PHYLOGENET EVOL, V34, P227, DOI 10.1016/j.ympev.2004.09.004; Lopez-Fernandez H, 2004, ZOOTAXA, P1; Lopez-Fernandez H, 2011, HISTORICAL BIOGEOGRAPHY OF NEOTROPICAL FRESHWATER FISHES, P105; Lopez-Fernandez H, 2010, MOL PHYLOGENET EVOL, V55, P1070, DOI 10.1016/j.ympev.2010.02.020; Lowe-McConnell RH, 1991, CICHLID FISHES BEHAV, P62; Lundberg John G., 1998, P13; Lundberg JG, 2010, AMAZONIA: LANDSCAPE AND SPECIES EVOLUTION: A LOOK INTO THE PAST, P281; Lundberg John G., 1998, P49; Maddison WP, 2019, MESQUITE MODULAR SYS; Malabarba MC, 2010, J VERTEBR PALEONTOL, V30, P341, DOI 10.1080/02724631003618348; Midford P. E., 2005, PDAP PACKAGE MESQUIT; MITTER C, 1988, AM NAT, V132, P107, DOI 10.1086/284840; Montana CG, 2009, NEOTROP ICHTHYOL, V7, P267, DOI 10.1590/S1679-62252009000200019; Moreira Sandra Socorro, 2002, Acta Amazonica, V32, P691; MULLER M, 1984, Transactions of the Zoological Society of London, V37, P51; Musilova Z, 2009, J ZOOL SYST EVOL RES, V47, P234, DOI 10.1111/j.1439-0469.2009.00528.x; Musilova Z, 2008, MOL PHYLOGENET EVOL, V46, P659, DOI 10.1016/j.ympev.2007.10.011; NORTON SF, 1993, J EXP BIOL, V176, P11; PAGEL M, 1994, P ROY SOC B-BIOL SCI, V255, P37, DOI 10.1098/rspb.1994.0006; Pavoine S, 2008, THEOR POPUL BIOL, V73, P79, DOI 10.1016/j.tpb.2007.10.001; Peres-Neto PR, 2001, OECOLOGIA, V129, P169, DOI 10.1007/s004420100720; Rabosky DL, 2008, P ROY SOC B-BIOL SCI, V275, P2363, DOI 10.1098/rspb.2008.0630; Rabosky DL, 2007, P ROY SOC B-BIOL SCI, V274, P2915, DOI 10.1098/rspb.2007.0924; Rabosky DL, 2009, ECOL LETT, V12, P735, DOI 10.1111/j.1461-0248.2009.01333.x; Rabosky DL, 2009, AM NAT, V173, P662, DOI 10.1086/597378; Reis RE., 2003, CLOFFSCA CHECK LIST; Relyea RA, 2004, ECOLOGY, V85, P172, DOI 10.1890/03-0169; Rican O, 2008, MOL PHYLOGENET EVOL, V49, P941, DOI 10.1016/j.ympev.2008.07.022; Smith WL, 2008, CLADISTICS, V24, P625, DOI 10.1111/j.1096-0031.2008.00210.x; STIASSNY M L J, 1987, Bulletin of the Museum of Comparative Zoology, V151, P269; Wainwright PC, 2001, J EXP BIOL, V204, P3039; Wainwright PC, 2006, FISH PHYSIOL, V23, P77, DOI 10.1016/S1546-5098(05)23003-0; Weidner T., 2000, S AM EARTHEATERS; WINEMILLER KO, 1990, ECOL MONOGR, V60, P331, DOI 10.2307/1943061; WINEMILLER KO, 1991, ECOL MONOGR, V61, P343, DOI 10.2307/2937046; WINEMILLER KO, 1995, ENVIRON BIOL FISH, V44, P235, DOI 10.1007/BF00005919	69	55	55	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2012	7	4							e33997	10.1371/journal.pone.0033997	http://dx.doi.org/10.1371/journal.pone.0033997			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952GU	22485154	Green Published, Green Submitted, gold			2022-12-27	WOS:000304780500030
J	McLachlan, NM; Marco, DJT; Wilson, SJ				McLachlan, Neil M.; Marco, David J. T.; Wilson, Sarah J.			Pitch Enumeration: Failure to Subitize in Audition	PLOS ONE			English	Article							DISCRIMINATION; TONES; NUMBER; MODEL	Background. Subitizing involves recognition mechanisms that allow effortless enumeration of up to four visual objects however despite ample resolution experimental data suggest that only one pitch can be reliably enumerated. This may be due to the grouping of tones according to harmonic relationships by recognition mechanisms prior to fine pitch processing. Poorer frequency resolution of auditory information available to recognition mechanisms may lead to unrelated tones being grouped, resulting in underestimation of pitch number. Methods, Results and Conclusion; We tested whether pitch enumeration is better for chords of full harmonic complex tones, where grouping errors are less likely, than for complexes with fewer and less accurately tuned harmonics. Chords of low familiarity were used to mitigate the possibility that participants would recognize the chord itself and simply recall the number of bitches. We found that accuracy of pitch enumeration was less than the visual system overall, and underestimation of pitch number increased for stimuli containing fewer harmonics. We conclude that harmonically related tones are first grouped at the poorer frequency resolution of the auditory nerve, leading to poor enumeration of more than one pitch.	[McLachlan, Neil M.; Marco, David J. T.; Wilson, Sarah J.] Univ Melbourne, Sch Psychol Sci, Melbourne, Vic, Australia	University of Melbourne	McLachlan, NM (corresponding author), Univ Melbourne, Sch Psychol Sci, Melbourne, Vic, Australia.	mcln@unimelb.edu.au		Wilson, Professor Sarah/0000-0002-2678-1576; Marco, David/0000-0001-8634-3036	Australian Research Council [DP0665494]	Australian Research Council(Australian Research Council)	This research was funded by an Australian Research Council (http://www.arc.gov.au/) Discovery grant (DP0665494). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alain C, 2007, HEARING RES, V229, P225, DOI 10.1016/j.heares.2007.01.011; Assmann PF, 1998, J ACOUST SOC AM, V103, P1150, DOI 10.1121/1.421249; DEWITT LA, 1987, PERCEPT PSYCHOPHYS, V41, P73, DOI 10.3758/BF03208216; HOUTSMA AJM, 1990, J ACOUST SOC AM, V87, P304, DOI 10.1121/1.399297; KAUFMAN EL, 1949, AM J PSYCHOL, V62, P498, DOI 10.2307/1418556; Krumhansl C.L., 1990, COGNITIVE FDN MUSICA, P77; McLachlan N, 2003, J ACOUST SOC AM, V114, P505, DOI 10.1121/1.1575748; McLachlan N, 2010, PSYCHOL REV, V117, P175, DOI 10.1037/a0018063; McLachlan N, 2009, HEARING RES, V249, P23, DOI 10.1016/j.heares.2009.01.003; MOORE BCJ, 1973, J ACOUST SOC AM, V54, P610, DOI 10.1121/1.1913640; Moore BCJ, 1996, J ACOUST SOC AM, V99, P542, DOI 10.1121/1.414512; Parncutt R., 1989, HARMONY PSYCHOACOUST; Piazza M, 2002, NEUROIMAGE, V15, P435, DOI 10.1006/nimg.2001.0980; Seither-Preisler A, 2007, J EXP PSYCHOL HUMAN, V33, P743, DOI 10.1037/0096-1523.33.3.743; TAKEUCHI AH, 1993, PSYCHOL BULL, V113, P345, DOI 10.1037/0033-2909.113.2.345; TERHARDT E, 1974, J ACOUST SOC AM, V55, P1061, DOI 10.1121/1.1914648; THURLOW WR, 1959, J ACOUST SOC AM, V31, P1332, DOI 10.1121/1.1907630; Vetter P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003269; Ward R, 1954, J ACOUST SOC AM, V26, P520; Wender KF, 2000, PSYCHOL RES-PSYCH FO, V64, P81, DOI 10.1007/s004260000021	20	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2012	7	4							e33661	10.1371/journal.pone.0033661	http://dx.doi.org/10.1371/journal.pone.0033661			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	952GU	22485148	Green Published, gold			2022-12-27	WOS:000304780500024
J	Schuessler, DL; Parish, T				Schuessler, Dorothee L.; Parish, Tanya			The Promoter of Rv0560c Is Induced by Salicylate and Structurally-Related Compounds in Mycobacterium tuberculosis	PLOS ONE			English	Article							INDUCIBLE GENE-REGULATION; EXPRESSION; IRON; IDENTIFICATION; SIDEROPHORE; RESISTANCE; INSIGHTS; GROWTH; TRANSPORT; VIRULENCE	Mycobacterium tuberculosis, the causative agent of tuberculosis (TB), is a major global health threat. During infection, bacteria are believed to encounter adverse conditions such as iron depletion. Mycobacteria synthesize iron-sequestering mycobactins, which are essential for survival in the host, via the intermediate salicylate. Salicylate is a ubiquitous compound which is known to induce a mild antibiotic resistance phenotype. In M. tuberculosis salicylate highly induces the expression of Rv0560c, a putative methyltransferase. We identified and characterized the promoter and regulatory elements of Rv0560c. P-Rv0560c activity was highly inducible by salicylate in a dose-dependent manner. The induction kinetics of P-Rv0560c were slow, taking several days to reach maximal activity, which was sustained over several weeks. Promoter activity could also be induced by compounds structurally related to salicylate, such as aspirin or para-aminosalicylic acid, but not by benzoate, indicating that induction is specific to a structural motif. The -10 and -35 promoter elements were identified and residues involved in regulation of Promoter activity were identified in close Proximity to an inverted repeat spanning the -35 promoter element. We conclude that Rv0560c expression is controlled by a yet unknown repressor via a highly inducible promoter.	[Schuessler, Dorothee L.; Parish, Tanya] Queen Mary Univ London, Barts & London Sch Med & Dent, London, England	University of London; Queen Mary University London	Schuessler, DL (corresponding author), MRC Natl Inst Med Res, London, England.	t.parish@qmul.ac.uk			European Union [LSHP-CT-2005-018923]	European Union(European Commission)	This work was funded by the European Union Project LSHP-CT-2005-018923. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal N, 2003, FEMS MICROBIOL LETT, V225, P75, DOI 10.1016/S0378-1097(03)00483-X; Agarwal N, 2006, MICROBIOL-SGM, V152, P2749, DOI 10.1099/mic.0.28924-0; Alekshun MN, 1997, ANTIMICROB AGENTS CH, V41, P2067, DOI 10.1128/AAC.41.10.2067; Amin AG, 2008, MICROBIOL-SGM, V154, P240, DOI 10.1099/mic.0.2007/012153-0; Bacon J, 2007, MICROBIOL-SGM, V153, P1435, DOI 10.1099/mic.0.2006/004317-0; Balazsi G, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.63; BARCLAY R, 1988, J GEN MICROBIOL, V134, P771; Bashyam MD, 1998, J BACTERIOL, V180, P2568, DOI 10.1128/JB.180.9.2568-2573.1998; Blokpoel MCJ, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni023; Blokpoel MCJ, 2003, J MICROBIOL METH, V54, P203, DOI 10.1016/S0167-7012(03)00044-7; Carroll P, 2005, APPL ENVIRON MICROB, V71, P3077, DOI 10.1128/AEM.71.6.3077-3084.2005; Carroll P, 2008, ASSAYING PROMOTER AC, P265; Carroll P, 2011, APPL ENVIRON MICROB, V77, P5040, DOI 10.1128/AEM.02880-10; Carroll P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009823; Chauhan S, 2011, NUCLEIC ACIDS RES, V39, P7400, DOI 10.1093/nar/gkr375; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; COLLINS MD, 1981, MICROBIOL REV, V45, P316, DOI 10.1128/MMBR.45.2.316-354.1981; COLLINS MD, 1977, J GEN MICROBIOL, V100, P221, DOI 10.1099/00221287-100-2-221; De Voss JJ, 2000, P NATL ACAD SCI USA, V97, P1252, DOI 10.1073/pnas.97.3.1252; Denkin S, 2005, ARCH MICROBIOL, V184, P152, DOI 10.1007/s00203-005-0037-9; Dussurget O, 1999, J BACTERIOL, V181, P3402, DOI 10.1128/JB.181.11.3402-3408.1999; Ehrt S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni013; Fivian-Hughes AS, 2010, J BACTERIOL, V192, P4348, DOI 10.1128/JB.00454-10; Forti F, 2009, J BIOTECHNOL, V140, P270, DOI 10.1016/j.jbiotec.2009.02.001; Garbe TR, 2004, CAN J MICROBIOL, V50, P771, DOI 10.1139/W04-067; Gustafson JE, 1999, ANTIMICROB AGENTS CH, V43, P990, DOI 10.1128/AAC.43.4.990; Harrison AJ, 2006, J BACTERIOL, V188, P6081, DOI 10.1128/JB.00338-06; Honaker RW, 2010, J BACTERIOL, V192, P6447, DOI 10.1128/JB.00978-10; Hotsclaw CM, 2008, ACS CHEM BIOL, V3, P619, DOI 10.1021/cb800145r; Kurosu M, 2009, MED CHEM, V5, P197, DOI 10.2174/157340609787582882; Manganelli R, 2004, J BACTERIOL, V186, P895, DOI 10.1128/JB.186.4.895-902.2004; Miller JH, EXPT MOL GENETICS; Papavinasasundaram KG, 2001, MICROBIOL-SGM, V147, P3271, DOI 10.1099/00221287-147-12-3271; Parish T, 1998, METH MOL B, V101, P129, DOI 10.1385/0-89603-471-2:129; Pomposiello PJ, 2001, J BACTERIOL, V183, P3890, DOI 10.1128/JB.183.13.3890-3902.2001; Price CTD, 2000, INT J BIOCHEM CELL B, V32, P1029, DOI 10.1016/S1357-2725(00)00042-X; Quadri LEN, 1998, CHEM BIOL, V5, P631, DOI 10.1016/S1074-5521(98)90291-5; Ratledge C, 2004, TUBERCULOSIS, V84, P110, DOI 10.1016/j.tube.2003.08.012; RATLEDGE C, 1962, BIOCHEM J, V84, P501, DOI 10.1042/bj0840501; Ratledge C, 1996, MICROBIOL-UK, V142, P2207, DOI 10.1099/13500872-142-8-2207; RATLEDGE C, 1972, BIOCHIM BIOPHYS ACTA, V279, P58, DOI 10.1016/0304-4165(72)90241-3; Rickman L, 2005, MOL MICROBIOL, V56, P1274, DOI 10.1111/j.1365-2958.2005.04609.x; Rodriguez GM, 2002, INFECT IMMUN, V70, P3371, DOI 10.1128/IAI.70.7.3371-3381.2002; ROSNER JL, 1985, P NATL ACAD SCI USA, V82, P8771, DOI 10.1073/pnas.82.24.8771; Russell DG, 2010, SCIENCE, V328, P852, DOI 10.1126/science.1184784; Schaller A, 2002, ANTIMICROB AGENTS CH, V46, P2636, DOI 10.1128/AAC.46.8.2636-2639.2002; Schnappinger D, 2003, J EXP MED, V198, P693, DOI 10.1084/jem.20030846; Shen ZQ, 2011, APPL ENVIRON MICROB, V77, P7128, DOI 10.1128/AEM.00763-11; Starck J, 2004, MICROBIOL-SGM, V150, P3821, DOI 10.1099/mic.0.27284-0; Stcovart OR, 2005, MYCOBACTERIUM MOL MI, P245; Sun ZH, 2001, FEMS MICROBIOL LETT, V203, P211, DOI 10.1111/j.1574-6968.2001.tb10843.x; Triccas JA, 2001, MICROBIOL-SGM, V147, P1253, DOI 10.1099/00221287-147-5-1253; Ulrichs T, 2006, J PATHOL, V208, P261, DOI 10.1002/path.1906; Weinberg ED, 1999, J EUKARYOT MICROBIOL, V46, P231, DOI 10.1111/j.1550-7408.1999.tb05119.x; Weinberg ED, 2009, BBA-GEN SUBJECTS, V1790, P600, DOI 10.1016/j.bbagen.2008.07.002; Weinstein EA, 2005, P NATL ACAD SCI USA, V102, P4548, DOI 10.1073/pnas.0500469102; World Health Organization, 2009, GLOB TUB CONTR EP ST; Young M., 2005, MYCOBACTERIUM MOL MI, P265; Zwahlen J, 2007, BIOCHEMISTRY-US, V46, P954, DOI 10.1021/bi060852x	59	21	27	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2012	7	4							e34471	10.1371/journal.pone.0034471	http://dx.doi.org/10.1371/journal.pone.0034471			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952GU	22485172	Green Published, gold			2022-12-27	WOS:000304780500047
J	Palanisamy, GS; Kirk, NM; Ackart, DF; Obregon-Henao, A; Shanley, CA; Orme, IM; Basaraba, RJ				Palanisamy, Gopinath S.; Kirk, Natalie M.; Ackart, David F.; Obregon-Henao, Andres; Shanley, Crystal A.; Orme, Ian M.; Basaraba, Randall J.			Uptake and Accumulation of Oxidized Low-Density Lipoprotein during Mycobacterium tuberculosis Infection in Guinea Pigs	PLOS ONE			English	Article							SCAVENGER RECEPTOR CD36; GLYCATION END-PRODUCTS; PULMONARY TUBERCULOSIS; FOAMY MACROPHAGES; LECTIN-LIKE; MICE; ATHEROSCLEROSIS; CHOLESTEROL; LDL; FAMILY	The typical host response to infection of humans and some animals by M. tuberculosis is the accumulation of reactive oxygen species generating inflammatory cells into discrete granulomas, which frequently develop central caseous necrosis. In previous studies we showed that infection of immunologically naive guinea pigs with M. tuberculosis leads to localized and systemic oxidative stress that results in a significant depletion of serum total antioxidant capacity and the accumulation of malondialdehyde, a bi-product of lipid peroxidation. Here we show that in addition, the generation of excessive reactive oxygen species in vivo resulted in the accumulation of oxidized low density lipoproteins (OxLDL) in pulmonary and extrapulmonary granulomas, serum and lung macrophages collected by bronchoalveolar lavage. Macrophages from immunologically naive guinea pigs infected with M. tuberculosis also had increased surface expression of the type 1 scavenger receptors CD36 and LOX1, which facilitate the uptake of oxidized host macromolecules including OxLDL. Vaccination of guinea pigs with Bacillus Calmette Guerin (BCG) prior to aerosol challenge reduced the bacterial burden as well as the intracellular accumulation of OxLDL and the expression of macrophage CD36 and LOX1. In vitro loading of guinea pig lung macrophages with OxLDL resulted in enhanced replication of bacilli compared to macrophages loaded with non-oxidized LDL. Overall, this study provides additional evidence of oxidative stress in M. tuberculosis infected guinea pigs and the potential role OxLDL laden macrophages have in supporting intracellular bacilli survival and persistence.	[Palanisamy, Gopinath S.; Kirk, Natalie M.; Ackart, David F.; Obregon-Henao, Andres; Shanley, Crystal A.; Orme, Ian M.; Basaraba, Randall J.] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA	Colorado State University	Palanisamy, GS (corresponding author), Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.	Randall.Basaraba@colostate.edu			National Institutes of Health [AI070456, AI083856]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI083856, U01AI070456] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by National Institutes of Health grants AI070456 (RJB) and AI083856 (IMO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basaraba RJ, 2008, TUBERCULOSIS, V88, P69, DOI 10.1016/j.tube.2007.09.002; Canetti G., 1955, TUBERCLE BACILLUS PU; Chen MJ, 2002, PHARMACOL THERAPEUT, V95, P89, DOI 10.1016/S0163-7258(02)00236-X; Chen XP, 2008, CELL BIOCHEM FUNCT, V26, P760, DOI 10.1002/cbf.1502; D'Avila H, 2008, CELL MICROBIOL, V10, P2589, DOI 10.1111/j.1462-5822.2008.01233.x; Esterbauer H, 1996, REV PHYSIOL BIOCH P, V127, P31, DOI 10.1007/BFb0048264; Febbraio M, 2000, J CLIN INVEST, V105, P1049, DOI 10.1172/JCI9259; Febbraio M, 2001, J CLIN INVEST, V108, P785, DOI 10.1172/JCI200114006; Galkina E, 2009, ANNU REV IMMUNOL, V27, P165, DOI 10.1146/annurev.immunol.021908.132620; Gatfield J, 2000, SCIENCE, V288, P1647, DOI 10.1126/science.288.5471.1647; Hunter RL, 2007, TUBERCULOSIS, V87, P267, DOI 10.1016/j.tube.2006.11.003; Kalayoglu MV, 1998, J INFECT DIS, V177, P725, DOI 10.1086/514241; Kwiatkowska S, 1999, RESP MED, V93, P272, DOI 10.1016/S0954-6111(99)90024-0; Larnsal Madhab, 2007, Southeast Asian Journal of Tropical Medicine and Public Health, V38, P695; Lenaerts AJ, 2007, ANTIMICROB AGENTS CH, V51, P3338, DOI 10.1128/AAC.00276-07; Matsunaga I, 2009, ANAL BIOCHEM, V393, P222, DOI 10.1016/j.ab.2009.06.032; McKinney JD, 2000, NATURE, V406, P735, DOI 10.1038/35021074; McMurray David N., 1994, P135; McNamara JR, 1996, J LIPID RES, V37, P1924; Mehta JL, 2007, CIRC RES, V100, P1634, DOI 10.1161/CIRCRESAHA.107.149724; Mehta JL, 2006, CARDIOVASC RES, V69, P36, DOI 10.1016/j.cardiores.2005.09.006; Miner MD, 2009, INDIAN J EXP BIOL, V47, P407; Ohgami N, 2001, J BIOL CHEM, V276, P3195, DOI 10.1074/jbc.M006545200; Ordway D, 2005, J IMMUNOL, V175, P3873, DOI 10.4049/jimmunol.175.6.3873; Ordway D, 2008, CLIN VACCINE IMMUNOL, V15, P1248, DOI 10.1128/CVI.00019-08; Ordway DJ, 2010, ANTIMICROB AGENTS CH, V54, P1820, DOI 10.1128/AAC.01521-09; Palanisamy GS, 2008, TUBERCULOSIS, V88, P295, DOI 10.1016/j.tube.2007.12.003; Palanisamy GS, 2011, PLOS ONE UNPUB; Pandey AK, 2008, P NATL ACAD SCI USA, V105, P4376, DOI 10.1073/pnas.0711159105; Peyron P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000204; Philips JA, 2005, SCIENCE, V309, P1251, DOI 10.1126/science.1116006; Podrez EA, 1999, J CLIN INVEST, V103, P1547, DOI 10.1172/JCI5549; Podrez EA, 2000, J CLIN INVEST, V105, P1095, DOI 10.1172/JCI8574; Podrez EA, 2007, NAT MED, V13, P1086, DOI 10.1038/nm1626; Rachman H, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000029; Rhoades ER, 1997, TUBERCLE LUNG DIS, V78, P57, DOI 10.1016/S0962-8479(97)90016-2; Rodriguez IR, 2004, INVEST OPHTH VIS SCI, V45, P2830, DOI 10.1167/iovs.04-0075; Russell DG, 2009, NAT IMMUNOL, V10, P943, DOI 10.1038/ni.1781; SMITH DW, 1970, AM REV RESPIR DIS, V102, P937; Steinberg D, 2005, MOL NUTR FOOD RES, V49, P995, DOI 10.1002/mnfr.200500081; TENG B, 1983, P NATL ACAD SCI-BIOL, V80, P6662, DOI 10.1073/pnas.80.21.6662; VIRCHOW R, 1989, NUTR REV, V47, P23; Wolschendorf F, 2011, P NATL ACAD SCI USA, V108, P1621, DOI 10.1073/pnas.1009261108; World Health Organization, 2009, GLOB TUB CONTR EP ST; Yam KC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000344	45	29	35	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e34148	10.1371/journal.pone.0034148	http://dx.doi.org/10.1371/journal.pone.0034148			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22493658	gold, Green Published, Green Submitted			2022-12-27	WOS:000305339100124
J	Ropero, AB; Alonso-Magdalena, P; Soriano, S; Juan-Pico, P; Roepke, TA; Kelly, MJ; Nadal, A				Ropero, Ana B.; Alonso-Magdalena, Paloma; Soriano, Sergi; Juan-Pico, Pablo; Roepke, Troy A.; Kelly, Martin J.; Nadal, Angel			Insulinotropic Effect of the Non-Steroidal Compound STX in Pancreatic beta-Cells	PLOS ONE			English	Article							ESTROGEN PLUS PROGESTIN; PLASMA-MEMBRANE RECEPTOR; ENERGY HOMEOSTASIS; POSTMENOPAUSAL WOMEN; PROTEIN-KINASE; AROMATASE DEFICIENCY; GLUCOSE-PRODUCTION; DIABETES-MELLITUS; RANDOMIZED-TRIAL; RESISTANCE	The non-steroidal compound STX modulates the hypothalamic control of core body temperature and energy homeostasis. The aim of this work was to study the potential effects of STX on pancreatic beta-cell function. 1-10 nM STX produced an increase in glucose-induced insulin secretion in isolated islets from male mice, whereas it had no effect in islets from female mice. This insulinotropic effect of STX was abolished by the anti-estrogen ICI 182,780. STX increased intracellular calcium entry in both whole islets and isolated beta-cells, and closed the K-ATP channel, suggesting a direct effect on beta-cells. When intraperitoneal glucose tolerance test was performed, a single dose of 100 mu g/kg body weight STX improved glucose sensitivity in males, yet it had a slight effect on females. In agreement with the effect on isolated islets, 100 mu g/kg dose of STX enhanced the plasma insulin increase in response to a glucose load, while it did not in females. Long-term treatment (100 mu g/kg, 6 days) of male mice with STX did not alter body weight, fasting glucose, glucose sensitivity or islet insulin content. Ovariectomized females were insensitive to STX (100 mu g/kg), after either an acute administration or a 6-day treatment. This long-term treatment was also ineffective in a mouse model of mild diabetes. Therefore, STX appears to have a gender-specific effect on blood glucose homeostasis, which is only manifested after an acute administration. The insulinotropic effect of STX in pancreatic beta-cells is mediated by the closure of the K-ATP channel and the increase in intracellular calcium concentration. The in vivo improvement in glucose tolerance appears to be mostly due to the enhancement of insulin secretion from beta-cells.	[Ropero, Ana B.; Alonso-Magdalena, Paloma; Soriano, Sergi; Juan-Pico, Pablo; Nadal, Angel] Univ Miguel Hernandez, Inst Bioingn, Elche, Spain; [Ropero, Ana B.; Alonso-Magdalena, Paloma; Soriano, Sergi; Juan-Pico, Pablo; Nadal, Angel] Univ Miguel Hernandez, CIBER Diabet & Enfermedades Metab Asociadas CIBER, Elche, Spain; [Roepke, Troy A.; Kelly, Martin J.] Oregon Hlth & Sci Univ, Dept Physiol & Pharmacol, Portland, OR 97201 USA	Universidad Miguel Hernandez de Elche; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Universidad Miguel Hernandez de Elche; Oregon Health & Science University	Ropero, AB (corresponding author), Univ Miguel Hernandez, Inst Bioingn, Elche, Spain.	ropero@umh.es	ROPERO, ANA B./AAK-8342-2021; Nadal, Angel/G-6721-2014; Alonso-Magdalena, Paloma/AAH-2076-2021; B, Ana/AAN-9680-2021; Soriano, Sergi/M-5255-2017; Roepke, Troy/C-8787-2017	ROPERO, ANA B./0000-0002-6503-7598; Nadal, Angel/0000-0003-4178-2152; Soriano, Sergi/0000-0001-9844-7027; ALONSO MAGDALENA, PALOMA/0000-0003-1065-5388; Roepke, Troy/0000-0001-5426-2266	Ministerio de Ciencia e Innovacion grants [BFU2008-01492]; Generalitat Valenciana grants [GV/2009/056]; UMH-Bancaja grant; US Public Health Service grant [DK 68098]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK068098] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038809] Funding Source: NIH RePORTER	Ministerio de Ciencia e Innovacion grants(Ministry of Science and Innovation, Spain (MICINN)); Generalitat Valenciana grants; UMH-Bancaja grant; US Public Health Service grant(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by Ministerio de Ciencia e Innovacion grants BFU2008-01492, by the Generalitat Valenciana grants GV/2009/056, by a UMH-Bancaja grant and by the US Public Health Service grant DK 68098. CIBERDEM is an initiative of Instituto de Salud Carlos III. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Ghani MA, 2007, DIABETES CARE, V30, P89, DOI 10.2337/dc06-1519; Alonso-Magdalena P, 2006, ENVIRON HEALTH PERSP, V114, P106, DOI [10.1289/ehp.8451, 10.1289/ehp.8062]; Alonso-Magdalena P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002069; Anderson GL, 2003, JAMA-J AM MED ASSOC, V290, P1739, DOI 10.1001/jama.290.13.1739; Barbosa RM, 1998, J PHYSIOL-LONDON, V510, P135, DOI 10.1111/j.1469-7793.1998.135bz.x; Barros RPA, 2006, TRENDS MOL MED, V12, P425, DOI 10.1016/j.molmed.2006.07.004; Belgorosky A, 2009, HORM RES, V72, P321, DOI 10.1159/000249159; Cooksey RC, 2004, ENDOCRINOLOGY, V145, P5305, DOI 10.1210/en.2004-0392; Gallagher CJ, 2007, DIABETES, V56, P2135, DOI 10.2337/db06-1017; Gardete-Correia L, 2010, DIABETIC MED, V27, P879, DOI 10.1111/j.1464-5491.2010.03017.x; GILON P, 1993, J BIOL CHEM, V268, P22265; Godsland IF, 2005, DIABETOLOGIA, V48, P2213, DOI 10.1007/s00125-005-1930-0; Kahn SE, 2009, DIABETOLOGIA, V52, P1003, DOI 10.1007/s00125-009-1321-z; Kanaya AM, 2003, ANN INTERN MED, V138, P1, DOI 10.7326/0003-4819-138-1-200301070-00005; Kim AM, 2010, NATURE, V465, P688, DOI 10.1038/465688a; Kuhl J, 2005, DIABETOLOGIA, V48, P35, DOI 10.1007/s00125-004-1614-1; Le May C, 2006, P NATL ACAD SCI USA, V103, P9232, DOI 10.1073/pnas.0602956103; Lebesgue D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008642; Manolopoulos VG, 2011, PHARMACOGENOMICS, V12, P1161, DOI [10.2217/PGS.11.65, 10.2217/pgs.11.65]; Margolis KL, 2004, DIABETOLOGIA, V47, P1175, DOI 10.1007/s00125-004-1448-x; Martensson UEA, 2009, ENDOCRINOLOGY, V150, P687, DOI 10.1210/en.2008-0623; Matsuyama-Yokono A, 2009, METABOLISM, V58, P379, DOI 10.1016/j.metabol.2008.10.012; Mauvais-Jarvis F, 2011, TRENDS ENDOCRIN MET, V22, P24, DOI 10.1016/j.tem.2010.10.002; Mittendorfer B, 2005, CURR OPIN CLIN NUTR, V8, P367, DOI 10.1097/01.mco.0000172574.64019.98; Nadal A, 1998, FASEB J, V12, P1341, DOI 10.1096/fasebj.12.13.1341; Nadal A, 2000, P NATL ACAD SCI USA, V97, P11603, DOI 10.1073/pnas.97.21.11603; Nadal A, 2011, FRONT BIOSCI-LANDMRK, V16, P251, DOI 10.2741/3686; Nadal A, 2009, J PHYSIOL-LONDON, V587, P5031, DOI 10.1113/jphysiol.2009.177188; Nadal A, 2009, MOL CELL ENDOCRINOL, V304, P63, DOI 10.1016/j.mce.2009.02.016; Nathan DM, 2009, DIABETES CARE, V32, P193, DOI 10.2337/dc08-9025; NUUTILA P, 1995, DIABETES, V44, P31, DOI 10.2337/diabetes.44.1.31; Obici S, 2002, NAT MED, V8, P1376, DOI 10.1038/nm798; Pocai A, 2005, NATURE, V434, P1026, DOI 10.1038/nature03439; Qiu J, 2003, J NEUROSCI, V23, P9529; Qiu J, 2008, STEROIDS, V73, P985, DOI 10.1016/j.steroids.2007.11.008; Qiu J, 2006, J NEUROSCI, V26, P5649, DOI 10.1523/JNEUROSCI.0327-06.2006; Roepke TA, 2009, J NEUROENDOCRINOL, V21, P263, DOI 10.1111/j.1365-2826.2009.01846.x; Roepke TA, 2008, ENDOCRINOLOGY, V149, P6113, DOI 10.1210/en.2008-0769; Roepke TA, 2010, ENDOCRINOLOGY, V151, P4926, DOI 10.1210/en.2010-0573; Ropero AB, 1999, J PHYSIOL-LONDON, V521, P397, DOI 10.1111/j.1469-7793.1999.00397.x; Ropero AB, STEROIDS; Ropero AB, 2008, STEROIDS, V73, P874, DOI 10.1016/j.steroids.2007.12.018; Ropero AB, 2010, ENDOCRINOLOGY, V151, P3665, DOI 10.1210/en.2010-0119; ROSSINI AA, 1977, P NATL ACAD SCI USA, V74, P2485, DOI 10.1073/pnas.74.6.2485; SAMANTA A, 1984, BRIT J CLIN PHARMACO, V18, P647, DOI 10.1111/j.1365-2125.1984.tb02522.x; Sandoval D, 2008, ANNU REV PHYSIOL, V70, P513, DOI 10.1146/annurev.physiol.70.120806.095256; Shi HF, 2010, PHYSIOL BEHAV, V100, P165, DOI 10.1016/j.physbeh.2010.02.018; Shumaker SA, 2003, JAMA-J AM MED ASSOC, V289, P2651, DOI 10.1001/jama.289.20.2651; Soria B, 2004, DIABETES, V53, pS86, DOI 10.2337/diabetes.53.2007.S86; Soriano S, 2009, MOL ENDOCRINOL, V23, P1973, DOI 10.1210/me.2009-0287; Soriguer F, 2012, DIABETOLOGIA, V55, P88, DOI 10.1007/s00125-011-2336-9; Tahara A, 2008, BASIC CLIN PHARMACOL, V103, P560, DOI 10.1111/j.1742-7843.2008.00321.x; Tobias SC, 2006, CHEMMEDCHEM, V1, P565, DOI 10.1002/cmdc.200500098; Wassertheil-Smoller S, 2003, JAMA-J AM MED ASSOC, V289, P2673, DOI 10.1001/jama.289.20.2673; Zhang CG, 2010, ENDOCRINOLOGY, V151, P4477, DOI 10.1210/en.2010-0177; Zierath JB, 1997, DIABETES, V46, P215, DOI 10.2337/diabetes.46.2.215; Zirilli L, 2008, J STEROID BIOCHEM, V109, P212, DOI 10.1016/j.jsbmb.2008.03.026	57	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2012	7	4							e34650	10.1371/journal.pone.0034650	http://dx.doi.org/10.1371/journal.pone.0034650			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959FE	22506040	Green Published, Green Submitted, gold			2022-12-27	WOS:000305297500048
J	Urra, H; Torres, VA; Ortiz, RJ; Lobos, L; Diaz, MI; Diaz, N; Hartel, S; Leyton, L; Quest, AFG				Urra, Hery; Torres, Vicente A.; Ortiz, Rina J.; Lobos, Lorena; Diaz, Maria I.; Diaz, Natalia; Haertel, Steffen; Leyton, Lisette; Quest, Andrew F. G.			Caveolin-1-Enhanced Motility and Focal Adhesion Turnover Require Tyrosine-14 but Not Accumulation to the Rear in Metastatic Cancer Cells	PLOS ONE			English	Article							ENDOTHELIAL-CELLS; RHO-GTPASES; PHOSPHORYLATED CAVEOLIN-1; DIRECTIONAL MIGRATION; SRC KINASE; POLARIZATION; DYNAMICS; PROTEIN; ADENOCARCINOMA; RECRUITMENT	Caveolin-1 is known to promote cell migration, and increased caveolin-1 expression is associated with tumor progression and metastasis. In fibroblasts, caveolin-1 polarization and phosphorylation of tyrosine-14 are essential to promote migration. However, the role of caveolin-1 in migration of metastatic cells remains poorly defined. Here, caveolin-1 participation in metastatic cell migration was evaluated by shRNA targeting of endogenous caveolin-1 in MDA-MB-231 human breast cancer cells and ectopic expression in B16-F10 mouse melanoma cells. Depletion of caveolin-1 in MDA-MB-231 cells reduced, while expression in B16-F10 cells promoted migration, polarization and focal adhesion turnover in a sequence of events that involved phosphorylation of tyrosine-14 and Rac-1 activation. In B16-F10 cells, expression of a non-phosphorylatable tyrosine-14 to phenylalanine mutant failed to recapitulate the effects observed with wild-type caveolin-1. Alternatively, treatment of MDA-MB-231 cells with the Src family kinase inhibitor PP2 reduced caveolin-1 phosphorylation on tyrosine-14 and cell migration. Surprisingly, unlike for fibroblasts, caveolin-1 polarization and re-localization to the trailing edge were not observed in migrating metastatic cells. Thus, expression and phosphorylation, but not polarization of caveolin-1 favor the highly mobile phenotype of metastatic cells.	[Urra, Hery; Torres, Vicente A.; Ortiz, Rina J.; Lobos, Lorena; Diaz, Maria I.; Diaz, Natalia; Leyton, Lisette; Quest, Andrew F. G.] Univ Chile, Fac Med, Ctr Mol Studies Cell, Lab Cellular Commun, Santiago 7, Chile; [Haertel, Steffen] Univ Chile, Fac Med, Inst Ciencias Biomed, Anat & Dev Biol Program, Santiago 7, Chile; [Haertel, Steffen; Leyton, Lisette] Univ Chile, Fac Med, Inst Ciencias Biomed, Biomed Neurosci Inst, Santiago 7, Chile; [Torres, Vicente A.] Univ Chile, Fac Dent, Dept Basic & Communitarian Sci, Santiago, Chile	Universidad de Chile; Universidad de Chile; Universidad de Chile; Universidad de Chile	Urra, H (corresponding author), Univ Chile, Fac Med, Ctr Mol Studies Cell, Lab Cellular Commun, Santiago 7, Chile.	lleyton@med.uchile.cl; aquest@med.uchile.cl	Härtel, Steffen/AAA-2336-2020; Diban, Rina Ortiz/T-6123-2019; Díaz-Valdivia, Natalia/Z-1893-2019; Torres, Vicente/I-2437-2013; Diban, Rina Ortiz/AAN-3414-2020	Härtel, Steffen/0000-0002-8913-1757; Díaz-Valdivia, Natalia/0000-0002-8063-2598; Torres, Vicente A/0000-0002-5973-7248	Fondo de Financiamiento de Centros de Excelencia en Investigacion [15010006]; National Fund for Scientific and Technological Development (FONDECYT) [1110149]; FONDECYT [1090071]; Biomedical Neuroscience Institute from Iniciativas Cientificas Milenio [P09-015-F]; Fogarty International Research Collaboration Award-National Institutes of Health [5R03TW007810]; National Commission for Science and Technology (CONICYT) [79090021]; FONDECYT Initiation [11100287]; CONICYT PhD fellowships; FOGARTY INTERNATIONAL CENTER [R03TW007810] Funding Source: NIH RePORTER	Fondo de Financiamiento de Centros de Excelencia en Investigacion; National Fund for Scientific and Technological Development (FONDECYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Biomedical Neuroscience Institute from Iniciativas Cientificas Milenio; Fogarty International Research Collaboration Award-National Institutes of Health; National Commission for Science and Technology (CONICYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); FONDECYT Initiation(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); CONICYT PhD fellowships; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This work was supported by Fondo de Financiamiento de Centros de Excelencia en Investigacion #15010006 (to AQ), National Fund for Scientific and Technological Development (FONDECYT) #1110149 (to L. Leyton), FONDECYT #1090071 (to AQ), Biomedical Neuroscience Institute P09-015-F from Iniciativas Cientificas Milenio (to L. Leyton and SH), Fogarty International Research Collaboration Award-National Institutes of Health 5R03TW007810 (to L. Leyton), National Commission for Science and Technology (CONICYT) #79090021 "Insertion of Young Postdoctoral Researches in the Academy" (to VT), FONDECYT Initiation #11100287 (to VT) and CONICYT PhD fellowships (to HU, ND, RO, MID and L. Lobos). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bastian P, 2006, MOL CANCER RES, V4, P411, DOI 10.1158/1541-7786.MCR-06-0030; Beardsley A, 2005, J BIOL CHEM, V280, P3541, DOI 10.1074/jbc.M409040200; Bender FC, 2000, CANCER RES, V60, P5870; Bishop AL, 2000, BIOCHEM J, V348, P241, DOI 10.1042/0264-6021:3480241; Caldieri G, 2009, J CELL MOL MED, V13, P1728, DOI 10.1111/j.1582-4934.2008.00568.x; Cao HM, 2004, EXP CELL RES, V294, P159, DOI 10.1016/j.yexcr.2003.11.010; Cao HM, 2002, J BIOL CHEM, V277, P8771, DOI 10.1074/jbc.C100661200; del Pozo MA, 2005, NAT CELL BIOL, V7, P901, DOI 10.1038/ncb1293; Dubash AD, 2009, INT REV CEL MOL BIO, V277, P1, DOI 10.1016/S1937-6448(09)77001-7; Etienne-Manneville S, 2004, J CELL SCI, V117, P1291, DOI 10.1242/jcs.01115; Ezratty EJ, 2005, NAT CELL BIOL, V7, P581, DOI 10.1038/ncb1262; Galvez BG, 2004, MOL BIOL CELL, V15, P678, DOI 10.1091/mbc.E03-07-0516; Ge SJ, 2004, J BIOL CHEM, V279, P6688, DOI 10.1074/jbc.M311769200; Giannone G, 2004, J BIOL CHEM, V279, P28715, DOI 10.1074/jbc.M404054200; Goetz JG, 2008, J CELL BIOL, V180, P1261, DOI 10.1083/jcb.200709019; Goetz JG, 2009, CELL ADHES MIGR, V3, P185, DOI 10.4161/cam.3.2.7295; Goetz JG, 2008, CANC METASTASIS REV; Gonzalez E, 2004, J BIOL CHEM, V279, P40659, DOI 10.1074/jbc.M407051200; Grande-Garcia A, 2008, EUR J CELL BIOL, V87, P641, DOI 10.1016/j.ejcb.2008.02.001; Grande-Garcia A, 2007, J CELL BIOL, V177, P683, DOI 10.1083/jcb.200701006; Hall A, 2005, BIOCHEM SOC T, V33, P891, DOI 10.1042/BST0330891; Hamadi A, 2005, J CELL SCI, V118, P4415, DOI 10.1242/jcs.02565; Hill MM, 2007, TRAFFIC, V8, P1695, DOI 10.1111/j.1600-0854.2007.00653.x; Ho CC, 2002, AM J PATHOL, V161, P1647, DOI 10.1016/S0002-9440(10)64442-2; Horwitz R, 2003, CURR BIOL, V13, pR756, DOI 10.1016/j.cub.2003.09.014; Isshiki M, 2002, J CELL SCI, V115, P475; Joshi B, 2008, CANCER RES, V68, P8210, DOI 10.1158/0008-5472.CAN-08-0343; Lentini D, 2008, J NEUROCHEM, V104, P514, DOI 10.1111/j.1471-4159.2007.05005.x; Li LK, 2001, CANCER RES, V61, P4386; Lin M, 2005, MOL CANCER, V4, DOI 10.1186/1476-4598-4-21; Luanpitpong S, 2010, J BIOL CHEM; Parat MO, 2003, MOL BIOL CELL, V14, P3156, DOI 10.1091/mbc.e02-11-0761; Peng X, 2010, J CELL SCI, V123, P567, DOI 10.1242/jcs.056432; QUEST A, 2008, J CELL MOL MED; Radel C, 2005, AM J PHYSIOL-HEART C, V288, pH936, DOI 10.1152/ajpheart.00519.2004; Ridley AJ, 2001, J CELL SCI, V114, P2713; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Shatz M, 2010, EXP CELL RES; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; Sun XH, 2007, J BIOL CHEM, V282, P7232, DOI 10.1074/jbc.M607396200; Sun XH, 2009, FEBS LETT, V583, P3681, DOI 10.1016/j.febslet.2009.10.055; Trimmer C, 2010, CANCER RES, V70, P7489, DOI 10.1158/0008-5472.CAN-10-0900; Tzima E, 2003, J BIOL CHEM, V278, P31020, DOI 10.1074/jbc.M301179200; Vicente-Manzanares M, 2005, J CELL SCI, V118, DOI 10.1242/jcs.02662; Yamaguchi H, 2009, CANCER RES, V69, P8594, DOI 10.1158/0008-5472.CAN-09-2305; Zhang W, 2000, J BIOL CHEM, V275, P20717, DOI 10.1074/jbc.M909895199	46	64	64	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2012	7	4							e33085	10.1371/journal.pone.0033085	http://dx.doi.org/10.1371/journal.pone.0033085			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959FE	22505999	Green Published, gold			2022-12-27	WOS:000305297500007
J	Koutinas, AA; Sypsas, V; Kandylis, P; Michelis, A; Bekatorou, A; Kourkoutas, Y; Kordulis, C; Lycourghiotis, A; Banat, IM; Nigam, P; Marchant, R; Giannouli, M; Yianoulis, P				Koutinas, Athanasios A.; Sypsas, Vasilios; Kandylis, Panagiotis; Michelis, Andreas; Bekatorou, Argyro; Kourkoutas, Yiannis; Kordulis, Christos; Lycourghiotis, Alexis; Banat, Ibrahim M.; Nigam, Poonam; Marchant, Roger; Giannouli, Myrsini; Yianoulis, Panagiotis			Nano-Tubular Cellulose for Bioprocess Technology Development	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; ETHANOL-PRODUCTION; YEAST; TEMPERATURE; IMMOBILIZATION; FERMENTATION; CATALYSIS	Delignified cellulosic material has shown a significant promotional effect on the alcoholic fermentation as yeast immobilization support. However, its potential for further biotechnological development is unexploited. This study reports the characterization of this tubular/porous cellulosic material, which was done by SEM, porosimetry and X-ray powder diffractometry. The results showed that the structure of nano-tubular cellulose (NC) justifies its suitability for use in "cold pasteurization'' processes and its promoting activity in bioprocessing (fermentation). The last was explained by a glucose pump theory. Also, it was demonstrated that crystallization of viscous invert sugar solutions during freeze drying could not be otherwise achieved unless NC was present. This effect as well as the feasibility of extremely low temperature fermentation are due to reduction of the activation energy, and have facilitated the development of technologies such as wine fermentations at home scale (in a domestic refrigerator). Moreover, NC may lead to new perspectives in research such as the development of new composites, templates for cylindrical nano-particles, etc.	[Koutinas, Athanasios A.; Sypsas, Vasilios; Kandylis, Panagiotis; Michelis, Andreas; Bekatorou, Argyro] Univ Patras, Dept Chem, Food Biotechnol Grp, Patras, Greece; [Kourkoutas, Yiannis] Democritus Univ Thrace, Dept Mol Biol, Alexandroupolis, Greece; [Kordulis, Christos; Lycourghiotis, Alexis] Univ Patras, Grp Catalysis & Interfacial Chem Environm Applica, Patras, Greece; [Kordulis, Christos] Inst Chem Engn & High Temp Chem Proc FORTH ICE HT, Patras, Greece; [Banat, Ibrahim M.; Nigam, Poonam; Marchant, Roger] Univ Ulster, Sch Biomed Sci, Coleraine BT52 1SA, Londonderry, North Ireland; [Giannouli, Myrsini; Yianoulis, Panagiotis] Univ Patras, Dept Phys, GR-26110 Patras, Greece	University of Patras; Democritus University of Thrace; University of Patras; Foundation for Research & Technology - Hellas (FORTH); Institute of Chemical Engineering Sciences (ICE-HT); Ulster University; University of Patras	Koutinas, AA (corresponding author), Univ Patras, Dept Chem, Food Biotechnol Grp, Patras, Greece.	a.a.koutinas@upatras.gr	Lycourghiotis, Alexis/G-1125-2010; Kourkoutas, Yiannis/AAM-8253-2021; bekatorou, argyro/AAT-5448-2020; Kandylis, Panagiotis/M-2338-2019; Banat, Ibrahim M/C-1910-2013; NIGAM, POONAM/AAV-4816-2021; Kandylis, Panagiotis/F-4403-2012; Kordulis, Christos/F-7982-2010	Banat, Ibrahim M/0000-0001-8964-2840; NIGAM, POONAM/0000-0001-8505-5382; Kordulis, Christos/0000-0002-4259-8624; Giannouli, Myrsini/0000-0002-9134-8146; Marchant, Roger/0000-0001-5213-229X; Kandylis, Panagiotis/0000-0002-3909-2139				Arinstein A, 2007, NAT NANOTECHNOL, V2, P59, DOI 10.1038/nnano.2006.172; Balat M, 2009, APPL ENERG, V86, P2273, DOI 10.1016/j.apenergy.2009.03.015; Bardi EP, 1996, J AGR FOOD CHEM, V44, P463, DOI 10.1021/jf9501406; BARDI EP, 1994, J AGR FOOD CHEM, V42, P221, DOI 10.1021/jf00037a040; Beecher JF, 2007, NAT NANOTECHNOL, V2, P466, DOI 10.1038/nnano.2007.239; Bourikas K, 2006, CATAL REV, V48, P363, DOI 10.1080/01614940600962321; Buick R, 2008, NATURE, V455, P569; Farrauto R. J., 2003, FUNDAMENTALS IND CAT; Franken J, 2008, CURR GENET, V53, P347, DOI 10.1007/s00294-008-0191-0; Girard B, 2000, CRIT REV BIOTECHNOL, V20, P109, DOI 10.1080/07388550008984168; Gonzalez MG, 1996, J AM SOC BREW CHEM, V54, P29; Huang J, 1998, U.S. Patent, Patent No. 5853647; ICONOMOU L, 1995, J FERMENT BIOENG, V79, P294, DOI 10.1016/0922-338X(95)90621-6; KANA K, 1989, J FERMENT BIOENG, V68, P213, DOI 10.1016/0922-338X(89)90140-2; KANA K, 1989, J FERMENT BIOENG, V68, P144, DOI 10.1016/0922-338X(89)90064-0; Kandylis P, 2008, J AGR FOOD CHEM, V56, P12037, DOI 10.1021/jf802476w; Kandylis P, 2008, J AGR FOOD CHEM, V56, P3317, DOI 10.1021/jf073273n; McClory C, 2009, AUST J CHEM, V62, P762, DOI 10.1071/CH09131; Mehdaoui S, 2009, MATER CHARACT, V60, P451, DOI 10.1016/j.matchar.2008.10.003; Mihranyan A, 2004, INT J PHARMACEUT, V269, P433, DOI 10.1016/j.ijpharm.2003.09.030; Yerga RMN, 2009, CHEMSUSCHEM, V2, P471, DOI 10.1002/cssc.200900018; Palkar VR, 1999, NANOSTRUCT MATER, V11, P369, DOI 10.1016/S0965-9773(99)00053-7; Resasco DE, 2008, NAT NANOTECHNOL, V3, P708, DOI 10.1038/nnano.2008.357; Scrosati B, 2007, NAT NANOTECHNOL, V2, P598, DOI 10.1038/nnano.2007.318; Zhang YHP, 2004, BIOTECHNOL BIOENG, V88, P797, DOI 10.1002/bit.20282	25	48	49	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2012	7	4							e34350	10.1371/journal.pone.0034350	http://dx.doi.org/10.1371/journal.pone.0034350			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JO	22496794	Green Published, gold			2022-12-27	WOS:000305014500022
J	Lopez, AA; Cespedes, ML; Vicente, T; Tomas, M; Bennasar-Veny, M; Tauler, P; Aguilo, A				Lopez, Angel A.; Cespedes, Mey L.; Vicente, Teofila; Tomas, Matias; Bennasar-Veny, Miguel; Tauler, Pedro; Aguilo, Antoni			Body Adiposity Index Utilization in a Spanish Mediterranean Population: Comparison with the Body Mass Index	PLOS ONE			English	Article							HEALTH-CARE COSTS; WAIST CIRCUMFERENCE; HERITAGE FAMILY; ECONOMIC COSTS; UNITED-STATES; DISEASE RISK; OBESITY; FAT; OVERWEIGHT; WOMEN	Background: Body fat content and fat distribution or adiposity are indicators of health risk. Several techniques have been developed and used for assessing and/or determining body fat or adiposity. Recently, the Body Adiposity Index (BAI), which is based on the measurements of hip circumference and height, has been suggested as a new index of adiposity. The aim of the study was to compare BAI and BMI measurements in a Caucasian population from a European Mediterranean area and to assess the usefulness of the BAI in men and women separately. Research Methodology/Principal Findings: A descriptive cross-sectional study was conducted in a Caucasian population. All participants in the study (1,726 women and 1,474 men, mean age 39.2 years, SD 10.8) were from Mallorca (Spain). Anthropometric data, including percentage of body fat mass obtained by Bioelectrical Impedance Analysis, were determined. Body Mass Index (BMI) and BAI were calculated. BAI and BMI showed a good correlation (r=0.64, p<0.001). A strong correlation was also found between BAI and the % fat determined using BIA (r=0.74, p<0.001), which is even stronger than the one between BMI and % fat (r=0.54, p<0.001). However, the ROC curve analysis showed a higher accuracy for BMI than for the BAI regarding the discriminatory capacity. Conclusion: The BAI could be a good tool to measure adiposity due, at least in part, to the advantages over other more complex mechanical or electrical systems. Probably, the most important advantage of BAI over BMI is that weight is not needed. However, in general it seems that the BAI does not overcome the limitations of BMI.	[Lopez, Angel A.; Cespedes, Mey L.] Balearic Isl Hlth Serv, Prevent Occupat Risks Hlth Serv, Palma De Mallorca, Spain; [Vicente, Teofila] Prevent Occupat Risks, Valencia, Spain; [Tomas, Matias] Balearic Isl Govt, Palma De Mallorca, Spain; [Bennasar-Veny, Miguel; Tauler, Pedro; Aguilo, Antoni] Univ Balearic Isl, Res Grp Evidence Lifestyles & Hlth, Palma De Mallorca, Spain	Universitat de les Illes Balears	Lopez, AA (corresponding author), Balearic Isl Hlth Serv, Prevent Occupat Risks Hlth Serv, Palma De Mallorca, Spain.	miquel.bennasar@uib.es	Tauler, Pedro/M-4126-2018; Bennasar-Veny, Miquel/C-5881-2008	Tauler, Pedro/0000-0003-0841-1720; Bennasar-Veny, Miquel/0000-0003-1668-2141; Tomas-Salva, Matias/0000-0002-5252-6974				Allison DB, 1999, JAMA-J AM MED ASSOC, V282, P1530, DOI 10.1001/jama.282.16.1530; Andreyeva T, 2004, OBES RES, V12, P1936, DOI 10.1038/oby.2004.243; [Anonymous], 1996, Am J Clin Nutr, V64, p524S, DOI 10.1093/ajcn/64.3.524S; Antal M, 2009, ANN NUTR METAB, V54, P171, DOI 10.1159/000217813; Behan D.F., 2010, OBESITY ITS RELATION; Bergman RN, 2011, OBESITY, V19, P1083, DOI 10.1038/oby.2011.38; Bouchard C, 2007, INT J OBESITY, V31, P1552, DOI 10.1038/sj.ijo.0803653; Buchanan TA, 1998, DIABETES, V47, P1302, DOI 10.2337/diabetes.47.8.1302; BURTON BT, 1985, INT J OBESITY, V9, P155; Camhi SM, 2011, OBESITY, V19, P402, DOI 10.1038/oby.2010.248; Deurenberg P, 1998, INT J OBESITY, V22, P1164, DOI 10.1038/sj/ijo/0800741; Dietz WH, 2005, NEW ENGL J MED, V352, P2100, DOI 10.1056/NEJMcp043052; Folmann NB, 2006, ADV HEALTH ECON HEAL, V17, P319, DOI 10.1016/S0731-2199(06)17012-0; Garrido-Chamorro RP, 2009, J SPORT MED PHYS FIT, V49, P278; He M, 2001, INT J OBESITY, V25, P748, DOI 10.1038/sj.ijo.0801612; Heymsfield SB, 2008, NUTR METAB, V5, DOI 10.1186/1743-7075-5-24; Hojgaard B, 2008, OBESITY FACTS, V1, P146, DOI 10.1159/000137822; Hojgaard B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002619; Jackson AS, 2002, INT J OBESITY, V26, P789, DOI 10.1038/sj.ijo.0802006; Katzmarzyk PT, 2004, CAN J APPL PHYSIOL, V29, P90, DOI 10.1139/h04-008; Katzmarzyk PT, 2001, MED SCI SPORT EXER, V33, P585; KEYS A, 1972, J CHRON DIS, V25, P329, DOI 10.1016/0021-9681(72)90027-6; Kotler DP, 1996, AM J CLIN NUTR, V64, P489; MCGINNIS JM, 1993, JAMA-J AM MED ASSOC, V270, P2207, DOI 10.1001/jama.270.18.2207; Must A, 1999, JAMA-J AM MED ASSOC, V282, P1523, DOI 10.1001/jama.282.16.1523; Organitzation WH, 2000, OBESITY PREVENTING M; Pateyjohns IR, 2006, OBESITY, V14, P2064, DOI 10.1038/oby.2006.241; Pietrobelli A, 2004, EUR J CLIN NUTR, V58, P1479, DOI 10.1038/sj.ejcn.1601993; Rahman M, 2010, OBSTET GYNECOL, V115, P982, DOI 10.1097/AOG.0b013e3181da9423; RAVUSSIN E, 1992, LANCET, V340, P404, DOI 10.1016/0140-6736(92)91480-V; Ross R, 2008, OBES REV, V9, P312, DOI 10.1111/j.1467-789X.2007.00411.x; SEGAL KR, 1987, J CLIN INVEST, V80, P1050, DOI 10.1172/JCI113159; Tanaka H, 1998, METABOLISM, V47, P1112, DOI 10.1016/S0026-0495(98)90286-4; Wee CC, 2005, AM J PUBLIC HEALTH, V95, P159, DOI 10.2105/AJPH.2003.027946	34	67	75	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2012	7	4							e35281	10.1371/journal.pone.0035281	http://dx.doi.org/10.1371/journal.pone.0035281			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JO	22496915	gold, Green Submitted, Green Published			2022-12-27	WOS:000305014500053
J	Alvarez-Garcia, O; Garcia-Lopez, E; Loredo, V; Gil-Pena, H; Mejia-Gaviria, N; Rodriguez-Suarez, J; Ordonez, FA; Santos, F				Alvarez-Garcia, Oscar; Garcia-Lopez, Enrique; Loredo, Vanessa; Gil-Pena, Helena; Mejia-Gaviria, Natalia; Rodriguez-Suarez, Julian; Ordonez, Flor A.; Santos, Fernando			Growth Hormone Improves Growth Retardation Induced by Rapamycin without Blocking Its Antiproliferative and Antiangiogenic Effects on Rat Growth Plate	PLOS ONE			English	Article							BONE-GROWTH; YOUNG-RATS; CHONDROCYTES; SIROLIMUS; MATURATION; ALLOGRAFTS; AUTOPHAGY; KINASE	Rapamycin, an immunosuppressant agent used in renal transplantation with antitumoral properties, has been reported to impair longitudinal growth in young individuals. As growth hormone (GH) can be used to treat growth retardation in transplanted children, we aimed this study to find out the effect of GH therapy in a model of young rat with growth retardation induced by rapamycin administration. Three groups of 4-week-old rats treated with vehicle (C), daily injections of rapamycin alone (RAPA) or in combination with GH (RGH) at pharmacological doses for 1 week were compared. GH treatment caused a 20% increase in both growth velocity and body length in RGH animals when compared with RAPA group. GH treatment did not increase circulating levels of insulin-like growth factor I, a systemic mediator of GH actions. Instead, GH promoted the maturation and hypertrophy of growth plate chondrocytes, an effect likely related to AKT and ERK1/2 mediated inactivation of GSK3 beta, increase of glycogen deposits and stabilization of beta-catenin. Interestingly, GH did not interfere with the antiproliferative and antiangiogenic activities of rapamycin in the growth plate and did not cause changes in chondrocyte autophagy markers. In summary, these findings indicate that GH administration improves longitudinal growth in rapamycin-treated rats by specifically acting on the process of growth plate chondrocyte hypertrophy but not by counteracting the effects of rapamycin on proliferation and angiogenesis.	[Alvarez-Garcia, Oscar; Mejia-Gaviria, Natalia; Rodriguez-Suarez, Julian; Santos, Fernando] Univ Oviedo, Dept Pediat, Oviedo, Spain; [Alvarez-Garcia, Oscar; Santos, Fernando] Inst Univ Oncol Principado Asturias, Lab Growth & Canc, Oviedo, Asturias, Spain; [Garcia-Lopez, Enrique; Loredo, Vanessa; Gil-Pena, Helena; Rodriguez-Suarez, Julian; Ordonez, Flor A.; Santos, Fernando] Hosp Univ Cent Asturias, Dept Pediat, Oviedo, Spain	University of Oviedo; University of Oviedo; Instituto Universitario de Oncologia de Asturias; Central University Hospital Asturias	Alvarez-Garcia, O (corresponding author), Univ Oviedo, Dept Pediat, Oviedo, Spain.	fsantos@uniovi.es	Rodríguez, Julián/W-2440-2019; Rodríguez, Julián/F-5900-2019	Rodríguez, Julián/0000-0003-4621-8905; Rodríguez, Julián/0000-0003-4621-8905; Mejia Gaviria, Natalia/0000-0003-3650-2785	Fondo de Investigacion Sanitaria (FIS) [PI08-1723]; Fondo Europeo de Desarrollo Regional (FEDER); Fundacion para el Fomento en Asturias de la Investigacion Cientifica Aplicada y Tecnologia (FICYT) [PC07-004]; Instituto Universitario de Oncologia del Principado de Asturias (IUOPA); Fundacion Nutricion y Crecimiento	Fondo de Investigacion Sanitaria (FIS)(Instituto de Salud Carlos III); Fondo Europeo de Desarrollo Regional (FEDER)(European Commission); Fundacion para el Fomento en Asturias de la Investigacion Cientifica Aplicada y Tecnologia (FICYT); Instituto Universitario de Oncologia del Principado de Asturias (IUOPA); Fundacion Nutricion y Crecimiento	This study was supported by Fondo de Investigacion Sanitaria (FIS, PI08-1723), Fondo Europeo de Desarrollo Regional (FEDER), Fundacion para el Fomento en Asturias de la Investigacion Cientifica Aplicada y Tecnologia (FICYT, PC07-004), Instituto Universitario de Oncologia del Principado de Asturias (IUOPA) and Fundacion Nutricion y Crecimiento. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Garcia O, 2007, PEDIATR NEPHROL, V22, P954, DOI 10.1007/s00467-007-0456-8; Alvarez-Garcia O, 2010, KIDNEY INT, V78, P561, DOI 10.1038/ki.2010.173; Bohensky J, 2010, PEDIATR NEPHROL, V25, P633, DOI 10.1007/s00467-009-1310-y; Cobo A, 1999, J AM SOC NEPHROL, V10, P971; Cohen P, 2001, NAT REV MOL CELL BIO, V2, P769, DOI 10.1038/35096075; Cravedi P, 2009, LANCET, V373, P1235, DOI 10.1016/S0140-6736(09)60709-1; Dharnidharka VR, 2008, PEDIATR TRANSPLANT, V12, P689, DOI 10.1111/j.1399-3046.2007.00881.x; Fine RN, 2007, NAT CLIN PRACT NEPHR, V3, P318, DOI 10.1038/ncpneph0502; Geissler EK, 2010, KIDNEY INT, V78, P1075, DOI 10.1038/ki.2010.324; Gillespie JR, 2011, ENDOCRINOLOGY, V152, P1755, DOI 10.1210/en.2010-1412; Gonzalez D, 2011, PEDIATR NEPHROL, V26, P961, DOI 10.1007/s00467-011-1811-3; Guo XZ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006067; Hudes G, 2007, NEW ENGL J MED, V356, P2271, DOI 10.1056/NEJMoa066838; Ibanez JP, 2005, TRANSPLANT P, V37, P682, DOI 10.1016/j.transproceed.2004.12.242; Kawasaki Y, 2008, J CLIN INVEST, V118, P2506, DOI 10.1172/JCI35243; Koehl GE, 2004, TRANSPLANTATION, V77, P1319, DOI 10.1097/00007890-200405150-00002; Le Roith D, 2001, ENDOCR REV, V22, P53, DOI 10.1210/er.22.1.53; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Molinos I, 2006, KIDNEY INT, V70, P1955, DOI 10.1038/sj.ki.5001949; Murakami S, 2004, GENE DEV, V18, P290, DOI 10.1101/gad.1179104; Phornphutkul C, 2009, J ORTHOP RES, V27, P1157, DOI 10.1002/jor.20894; Rangel GA, 2009, PEDIATR NEPHROL, V24, P2047, DOI 10.1007/s00467-009-1215-9; Sanchez CP, 2009, BMC PEDIATR, V9, DOI 10.1186/1471-2431-9-3; Srinivas V, 2009, CELLS TISSUES ORGANS, V189, P88, DOI 10.1159/000151428; van der Eerden BCJ, 2003, ENDOCR REV, V24, P782, DOI 10.1210/er.2002-0033; Wilsman NJ, 1996, J ORTHOP RES, V14, P927, DOI 10.1002/jor.1100140613; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016	27	12	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2012	7	4							e34788	10.1371/journal.pone.0034788	http://dx.doi.org/10.1371/journal.pone.0034788			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JA	22493717	gold, Green Published, Green Submitted			2022-12-27	WOS:000305012700059
J	Liang, GY; Nan, HM; Qureshi, AA; Han, JL				Liang, Geyu; Nan, Hongmei; Qureshi, Abrar A.; Han, Jiali			Pre-Diagnostic Plasma 25-Hydroxyvitamin D Levels and Risk of Non-Melanoma Skin Cancer in Women	PLOS ONE			English	Article							VITAMIN-D LEVELS; INCIDENT HYPERTENSION; POSTMENOPAUSAL WOMEN; BREAST-CANCER; UNITED-STATES; ELDERLY-MEN; BASAL-CELL; HEALTH; COHORT; 1,25-DIHYDROXYVITAMIN-D	Background: Recent reports have shown that vitamin D status was inversely associated with the risk of various cancers. However, few studies examined the association between vitamin D levels and risk of skin cancer. Methods: We prospectively evaluated the association between baseline plasma 25(OH)D levels and the risk of incident squamous cell carcinoma (SCC) and basal cell carcinoma (BCC) among 4,641 women from the Nurses' Health Study (NHS) and the NHS II with 510 incident BCC cases and 75 incident SCC cases. We used multivariate logistic regression models to calculate odds ratios (ORs) and 95% confidence intervals (CIs). Results: Plasma 25(OH)D levels were positively associated with risk of BCC after adjusting for age at blood draw, season of blood draw, lab batch, hair color, burning tendency, the number of sunburns, and ultra-violet B flux of residence at blood collection. Women in the highest quartile of 25(OH)D had more than 2-fold increased risk of BCC compared with women in the lowest quartile (OR = 2.07, 95% CI = 1.52-2.80, P for trend <0.0001). We also found a significantly positive association between plasma 25(OH)D levels and SCC risk after adjusting for the same covariates (OR, highest vs. lowest quartile = 3.77, 95% CI = 1.70-8.36, P for trend = 0.0002). Conclusion: In this prospective study of women, plasma vitamin D levels were positively associated with non-melanoma skin cancer risk. Considering that most circulating vitamin D is due to sun exposure, the positive association between plasma vitamin D and non-melanoma skin cancer is confounded by sun exposure. Our data suggest that one-time measurement of plasma vitamin D levels may reasonably reflect long-term sun exposure and predict the risk of non-melanoma skin cancer.	[Liang, Geyu] Southeast Univ, Sch Publ Hlth, Minist Educ, Key Lab Environm Med Engn, Nanjing, Jiangsu, Peoples R China; [Nan, Hongmei; Qureshi, Abrar A.; Han, Jiali] Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA USA; [Qureshi, Abrar A.; Han, Jiali] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Dermatol, Boston, MA 02115 USA; [Han, Jiali] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Nan, Hongmei] Univ Maryland, Sch Med, Dept Epidemiol & Publ Hlth, Div Canc Epidemiol, Baltimore, MD 21201 USA	Southeast University - China; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; University System of Maryland; University of Maryland Baltimore	Liang, GY (corresponding author), Southeast Univ, Sch Publ Hlth, Minist Educ, Key Lab Environm Med Engn, Nanjing, Jiangsu, Peoples R China.	jiali.han@channing.harvard.edu			NIH [CA50385, CA67262, CA87969, CA49449]; NATIONAL CANCER INSTITUTE [R01CA050385, R01CA049449, U01CA067262, P01CA087969, U01CA049449, R01CA067262] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is supported by NIH grants CA50385, CA67262, CA87969, and CA49449. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahonen MH, 2000, CANCER CAUSE CONTROL, V11, P847, DOI 10.1023/A:1008923802001; Asgari MM, 2010, J INVEST DERMATOL, V130, P1438, DOI 10.1038/jid.2009.402; Barake R, 2010, J AM COLL NUTR, V29, P25, DOI 10.1080/07315724.2010.10719813; Christenson LJ, 2005, JAMA-J AM MED ASSOC, V294, P681, DOI 10.1001/jama.294.6.681; COLDITZ GA, 1986, AM J EPIDEMIOL, V123, P894, DOI 10.1093/oxfordjournals.aje.a114319; Eide MJ, 2011, ARCH DERMATOL, V147, P1379, DOI 10.1001/archdermatol.2011.231; Eliassen AH, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2880; Feskanich D, 2004, CANCER EPIDEM BIOMAR, V13, P1502; Forman JP, 2008, HYPERTENSION, V52, P828, DOI 10.1161/HYPERTENSIONAHA.108.117630; Forman JP, 2007, HYPERTENSION, V49, P1063, DOI 10.1161/HYPERTENSIONAHA.107.087288; Garcia VC, 2010, NUTRIENTS, V2, P426, DOI 10.3390/nu2040426; Goodwin PJ, 2009, J CLIN ONCOL, V27, P3757, DOI 10.1200/JCO.2008.20.0725; Green AK, 2010, INT J CANCER, V127, P667, DOI 10.1002/ijc.25075; Holick MF, 2010, ENDOCRIN METAB CLIN, V39, P381, DOI [10.1016/j.rdc.2012.03.013, 10.1016/j.ecl.2010.02.016]; Hollis BW, 1996, CALCIFIED TISSUE INT, V58, P4, DOI 10.1007/s002239900002; Hollis BW, 1997, METHOD ENZYMOL, V282, P174; Hunter David J., 1990, Annals of Epidemiology, V1, P13; Karohl C, 2010, AM J CLIN NUTR, V92, P1393, DOI 10.3945/ajcn.2010.30176; Kotsopoulos J, 2010, CANCER EPIDEM BIOMAR, V19, P938, DOI 10.1158/1055-9965.EPI-09-1318; Linos E, 2009, J INVEST DERMATOL, V129, P1666, DOI 10.1038/jid.2008.423; MIETTINEN OS, 1976, AM J EPIDEMIOL, V104, P609, DOI 10.1093/oxfordjournals.aje.a112339; MILLER DL, 1994, J AM ACAD DERMATOL, V30, P774, DOI 10.1016/S0190-9622(08)81509-5; Seifert M, 2004, J STEROID BIOCHEM, V89-90, P375, DOI 10.1016/j.jsbmb.2004.03.002; Skinner HG, 2006, CANCER EPIDEM BIOMAR, V15, P1688, DOI 10.1158/1055-9965.EPI-06-0206; Tang JY, 2011, J CLIN ONCOL, V29, P3078, DOI 10.1200/JCO.2011.34.5967; Tang JY, 2011, CANCER PREV RES, V4, P744, DOI 10.1158/1940-6207.CAPR-10-0285; Tang JY, 2010, CANCER CAUSE CONTROL, V21, P387, DOI 10.1007/s10552-009-9470-4; Tworoger SS, 2007, CANCER EPIDEM BIOMAR, V16, P783, DOI 10.1158/1055-9965.EPI-06-0981; Wagner D, 2009, CLIN BIOCHEM, V42, P1549, DOI 10.1016/j.clinbiochem.2009.07.013; Wang YT, 2009, AM J EPIDEMIOL, V170, P88, DOI 10.1093/aje/kwp086; Weinstein SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020796; Wu K, 2007, J NATL CANCER I, V99, P1120, DOI 10.1093/jnci/djm038; Zhou W, 2005, CANCER EPIDEM BIOMAR, V14, P2303, DOI 10.1158/1055-9965.EPI-05-0335; Zinser GM, 2002, CARCINOGENESIS, V23, P2103, DOI 10.1093/carcin/23.12.2103	34	34	34	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2012	7	4							e35211	10.1371/journal.pone.0035211	http://dx.doi.org/10.1371/journal.pone.0035211			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JA	22493740	gold, Green Published, Green Submitted			2022-12-27	WOS:000305012700082
J	Walsh, CJ				Walsh, Charles J.			The Structure of the Mitotic Spindle and Nucleolus during Mitosis in the Amebo-Flagellate Naegleria	PLOS ONE			English	Article							GRUBERI; ACTIN; PROTEIN; CLONING	Mitosis in the amebo-flagellate Naegleria pringsheimi is acentrosomal and closed (the nuclear membrane does not break down). The large central nucleolus, which occupies about 20% of the nuclear volume, persists throughout the cell cycle. At mitosis, the nucleolus divides and moves to the poles in association with the chromosomes. The structure of the mitotic spindle and its relationship to the nucleolus are unknown. To identify the origin and structure of the mitotic spindle, its relationship to the nucleolus and to further understand the influence of persistent nucleoli on cellular division in acentriolar organisms like Naegleria, three-dimensional reconstructions of the mitotic spindle and nucleolus were carried out using confocal microscopy. Monoclonal antibodies against three different nucleolar regions and alpha-tubulin were used to image the nucleolus and mitotic spindle. Microtubules were restricted to the nucleolus beginning with the earliest prophase spindle microtubules. Early spindle microtubules were seen as short rods on the surface of the nucleolus. Elongation of the spindle microtubules resulted in a rough cage of microtubules surrounding the nucleolus. At metaphase, the mitotic spindle formed a broad band completely embedded within the nucleolus. The nucleolus separated into two discreet masses connected by a dense band of microtubules as the spindle elongated. At telophase, the distal ends of the mitotic spindle were still completely embedded within the daughter nucleoli. Pixel by pixel comparison of tubulin and nucleolar protein fluorescence showed 70% or more of tubulin co-localized with nucleolar proteins by early prophase. These observations suggest a model in which specific nucleolar binding sites for microtubules allow mitotic spindle formation and attachment. The fact that a significant mass of nucleolar material precedes the chromosomes as the mitotic spindle elongates suggests that spindle elongation drives nucleolar division.	Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Walsh, CJ (corresponding author), Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA.	cwalsh@pitt.edu			Department of Biological Sciences at the University of Pittsburgh	Department of Biological Sciences at the University of Pittsburgh	I am grateful to Christine Berliner, William Saunders and Betty Walsh for helpful comments on the manuscript. Tom Harper provided expert technical help with confocal microscopy. This work would not have been possible without the support of the Department of Biological Sciences at the University of Pittsburgh and the Department Chair, Professor Graham Hatfull. The expert technical help of David Salcido with this and previous work is especially appreciated.	Chung SL, 2002, GENE, V293, P77, DOI 10.1016/S0378-1119(02)00509-7; CLARK CG, 1987, MOL CELL BIOL, V7, P3027, DOI 10.1128/MCB.7.9.3027; CLARK CG, 1990, J PROTOZOOL, V37, P400, DOI 10.1111/j.1550-7408.1990.tb01164.x; De Jonckheere JF, 2004, PROTIST, V155, P89, DOI 10.1078/1434461000167; Fritz-Laylin LK, 2010, CELL, V140, P631, DOI 10.1016/j.cell.2010.01.032; FULTON C, 1971, J CELL BIOL, V51, P826, DOI 10.1083/jcb.51.3.826; Fulton C., 1970, Methods Cell Physiol., V4, P341; FULTON C, 1967, DEV BIOL, V15, P165, DOI 10.1016/0012-1606(67)90012-7; Gatlin JC, 2010, SEMIN CELL DEV BIOL, V21, P248, DOI 10.1016/j.semcdb.2010.01.015; Gonzalez-Robles A, 2009, EXP PARASITOL, V122, P212, DOI 10.1016/j.exppara.2009.03.016; Hernandez-Verdun D, 2011, NUCLEUS-PHILA, V2, P189, DOI 10.4161/nucl.2.3.16246; POMORSKI P, 1993, CELL BIOL INT, V17, P521, DOI 10.1006/cbir.1993.1093; Sandquist JC, 2011, DEV CELL, V21, P410, DOI 10.1016/j.devcel.2011.07.018; SCHUSTER FL, 1975, TISSUE CELL, V7, P1, DOI 10.1016/S0040-8166(75)80003-6; Trimbur GM, 1999, J CELL SCI, V112, P1159; TRIMBUR GM, 1993, J CELL BIOL, V122, P753, DOI 10.1083/jcb.122.4.753; TRIMBUR GM, 1992, J CELL SCI, V103, P167; Wadsworth P, 2011, PROTOPLASMA, V248, P439, DOI 10.1007/s00709-010-0205-x; WALSH C, 1984, J CELL BIOL, V98, P449, DOI 10.1083/jcb.98.2.449; Walsh CJ, 2007, EUR J CELL BIOL, V86, P85, DOI 10.1016/j.ejcb.2006.10.003	20	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2012	7	4							e34763	10.1371/journal.pone.0034763	http://dx.doi.org/10.1371/journal.pone.0034763			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JA	22493714	Green Accepted, Green Published, gold			2022-12-27	WOS:000305012700056
J	Kao, CH; Hsiang, CY; Ho, TY				Kao, Chia-Hung; Hsiang, Chien-Yun; Ho, Tin-Yun			Assessment of Chitosan-Affected Metabolic Response by Peroxisome Proliferator-Activated Receptor Bioluminescent Imaging-Guided Transcriptomic Analysis	PLOS ONE			English	Article							HOST-BIOMATERIAL INTERACTION; MOLECULAR-WEIGHT CHITOSAN; NUCLEAR RECEPTORS; APOLIPOPROTEIN-B; PPAR-GAMMA; MICE; DISEASE; CHITIN; OLIGOSACCHARIDES; THERAPY	Chitosan has been widely used in food industry as a weight-loss aid and a cholesterol-lowering agent. Previous studies have shown that chitosan affects metabolic responses and contributes to anti-diabetic, hypocholesteremic, and blood glucose-lowering effects; however, the in vivo targeting sites and mechanisms of chitosan remain to be clarified. In this study, we constructed transgenic mice, which carried the luciferase genes driven by peroxisome proliferator-activated receptor (PPAR), a key regulator of fatty acid and glucose metabolism. Bioluminescent imaging of PPAR transgenic mice was applied to report the organs that chitosan acted on, and gene expression profiles of chitosan-targeted organs were further analyzed to elucidate the mechanisms of chitosan. Bioluminescent imaging showed that constitutive PPAR activities were detected in brain and gastrointestinal tract. Administration of chitosan significantly activated the PPAR activities in brain and stomach. Microarray analysis of brain and stomach showed that several pathways involved in lipid and glucose metabolism were regulated by chitosan. Moreover, the expression levels of metabolism-associated genes like apolipoprotein B (apoB) and ghrelin genes were down-regulated by chitosan. In conclusion, these findings suggested the feasibility of PPAR bioluminescent imaging-guided transcriptomic analysis on the evaluation of chitosan-affected metabolic responses in vivo. Moreover, we newly identified that downregulated expression of apoB and ghrelin genes were novel mechanisms for chitosan-affected metabolic responses in vivo.	[Kao, Chia-Hung] China Med Univ Hosp, Dept Nucl Med, Taichung, Taiwan; [Hsiang, Chien-Yun] China Med Univ, Dept Microbiol, Taichung, Taiwan; [Ho, Tin-Yun] China Med Univ, Grad Inst Chinese Med, Taichung, Taiwan	China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan	Ho, TY (corresponding author), China Med Univ, Grad Inst Chinese Med, Taichung, Taiwan.	tyh@mail.cmu.edu.tw	Hsiang, Chien-Yun/O-3853-2015; Ho, Tin-Yun/O-3889-2015		National Science Council (NSC) [100-2324-B-039-001, NSC100-2320-B-039-020]; Committee on Chinese Medicine and Pharmacy at Department of Health [CCMP100-RD-048, CCMP101-RD-103]; China Medical University [CMU100-S-16, CMU100-S-34, CMU100-TS-14]	National Science Council (NSC)(Ministry of Science and Technology, Taiwan); Committee on Chinese Medicine and Pharmacy at Department of Health; China Medical University(China Medical University)	This work was supported by grants from National Science Council (NSC 100-2324-B-039-001 and NSC100-2320-B-039-020), Committee on Chinese Medicine and Pharmacy at Department of Health (CCMP100-RD-048 and CCMP101-RD-103), and China Medical University (CMU100-S-16, CMU100-S-34, and CMU100-TS-14). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker WL, 2009, ANN NUTR METAB, V55, P368, DOI 10.1159/000258633; Baldrick P, 2010, REGUL TOXICOL PHARM, V56, P290, DOI 10.1016/j.yrtph.2009.09.015; Benn M, 2009, ATHEROSCLEROSIS, V206, P17, DOI 10.1016/j.atherosclerosis.2009.01.004; Bensinger SJ, 2008, NATURE, V454, P470, DOI 10.1038/nature07202; Castaneda TR, 2010, FRONT NEUROENDOCRIN, V31, P44, DOI 10.1016/j.yfrne.2009.10.008; Chang CT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031808; Chang CT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023682; Cheng WY, 2009, BRIT J PHARMACOL, V157, P746, DOI 10.1111/j.1476-5381.2009.00223.x; Cho EJ, 2008, J MICROBIOL BIOTECHN, V18, P80; Cho MC, 2008, PPAR RES, V2008, DOI 10.1155/2008/679137; Ciana P, 2007, MOL ENDOCRINOL, V21, P388, DOI 10.1210/me.2006-0152; Coll Teresa, 2009, Curr Mol Pharmacol, V2, P46; Escher P, 2000, MUTAT RES-FUND MOL M, V448, P121, DOI 10.1016/S0027-5107(99)00231-6; Hayashi K, 2002, BIOL PHARM BULL, V25, P188, DOI 10.1248/bpb.25.188; Heneka MT, 2007, BBA-MOL CELL BIOL L, V1771, P1031, DOI 10.1016/j.bbalip.2007.04.016; Ho TY, 2007, BIOMATERIALS, V28, P4370, DOI 10.1016/j.biomaterials.2007.07.005; Hsiang CY, 2009, BIOMATERIALS, V30, P3042, DOI 10.1016/j.biomaterials.2009.02.016; Jarmila V, 2011, CURR PHARM DESIGN, V7, P3596; Jayakumar R, 2011, BIOTECHNOL ADV, V29, P322, DOI 10.1016/j.biotechadv.2011.01.005; Jayakumar R, 2010, CARBOHYD POLYM, V82, P227, DOI 10.1016/j.carbpol.2010.04.074; Jayakumar R, 2010, PROG MATER SCI, V55, P675, DOI 10.1016/j.pmatsci.2010.03.001; Jayakumar R, 2010, BIOTECHNOL ADV, V28, P142, DOI 10.1016/j.biotechadv.2009.11.001; Jayakumar R, 2010, CARBOHYD POLYM, V79, P1, DOI 10.1016/j.carbpol.2009.08.026; KANAUCHI O, 1995, BIOSCI BIOTECH BIOCH, V59, P786, DOI 10.1271/bbb.59.786; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Khor E, 2003, BIOMATERIALS, V24, P2339, DOI 10.1016/S0142-9612(03)00026-7; Kim E, 1998, J LIPID RES, V39, P703; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Kumar SG, 2009, PROTEOMICS, V9, P2149, DOI 10.1002/pmic.200800571; Kummer MP, 2008, PPAR RES, V2008, DOI 10.1155/2008/403896; LENICH C, 1988, J LIPID RES, V29, P755; Liu SH, 2010, J AGR FOOD CHEM, V58, P5795, DOI 10.1021/jf100662r; Lovett-Racke AE, 2004, J IMMUNOL, V172, P5790, DOI 10.4049/jimmunol.172.9.5790; Martin H, 2010, MUTAT RES-FUND MOL M, V690, P57, DOI 10.1016/j.mrfmmm.2009.09.009; Mhurchu CN, 2005, OBES REV, V6, P35, DOI 10.1111/j.1467-789X.2005.00158.x; Perissi V, 2005, NAT REV MOL CELL BIO, V6, P542, DOI 10.1038/nrm1680; Peters JM, 2008, CLIN SCI, V115, P107, DOI 10.1042/CS20080022; Rahman MA, 2008, PROTEOMICS, V8, P569, DOI 10.1002/pmic.200700888; Rosenson RS, 2009, ATHEROSCLEROSIS, V207, P328, DOI 10.1016/j.atherosclerosis.2009.05.020; Schintu N, 2009, EUR J NEUROSCI, V29, P954, DOI 10.1111/j.1460-9568.2009.06657.x; Shah A, 2010, ATHEROSCLEROSIS, V210, P35, DOI 10.1016/j.atherosclerosis.2009.11.010; Sniderman AD, 2005, CIRCULATION, V112, P3366, DOI 10.1161/CIRCULATIONAHA.105.583336; Sumiyoshi M, 2006, J PHARM PHARMACOL, V58, P201, DOI 10.1211/jpp.58.2.0007; Wu SL, 2009, J PHARMACOL EXP THER, V330, P370, DOI 10.1124/jpet.109.152835; Zambelli F, 2009, NUCLEIC ACIDS RES, V37, pW247, DOI 10.1093/nar/gkp464	45	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e34969	10.1371/journal.pone.0034969	http://dx.doi.org/10.1371/journal.pone.0034969			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GO	22496881	Green Submitted, gold, Green Published			2022-12-27	WOS:000304855200092
J	Karunanithi, S; Joshi, J; Chavel, C; Birkaya, B; Grell, L; Cullen, PJ				Karunanithi, Sheelarani; Joshi, Jyoti; Chavel, Colin; Birkaya, Barbara; Grell, Laura; Cullen, Paul J.			Regulation of Mat Responses by a Differentiation MAPK Pathway in Saccharomyces cerevisiae	PLOS ONE			English	Article							HAPLOID INVASIVE GROWTH; BUD-SITE-SELECTION; BIOFILM FORMATION; FILAMENTOUS GROWTH; PROTEIN-KINASE; SIGNALING SPECIFICITY; GENE DELETION; TRANSCRIPTION; FLO11; REPRESSION	Fungal species exhibit diverse behaviors when presented with extracellular challenges. Pathogenic fungi can undergo cell differentiation and biofilm formation in response to fluctuating nutrient levels, and these responses are required for virulence. In the model fungal eukaryote Saccharomyces cerevisiae, nutrient limitation induces filamentous growth and biofilm/mat formation. Both responses require the same signal transduction (MAPK) pathway and the same cell adhesion molecule (Flo11) but have been studied under different conditions. We found that filamentous growth and mat formation are aspects of a related response that is regulated by the MAPK pathway. Cells in yeast-form mats differentiated into pseudohyphae in response to nutrient limitation. The MAPK pathway regulated mat expansion (in the plane of the XY-axis) and substrate invasion (downward in the plane of the Z-axis), which optimized the mat's response to extracellular nutrient levels. The MAPK pathway also regulated an upward growth pattern (in the plane of the Z-axis) in response to nutrient limitation and changes in surface rigidity. Upward growth allowed for another level of mat responsiveness and resembled a type of colonial chemorepulsion. Together our results show that signaling pathways play critical roles in regulating social behaviors in which fungal cells participate. Signaling pathways may regulate similar processes in pathogens, whose highly nuanced responses are required for virulence.	[Karunanithi, Sheelarani; Joshi, Jyoti; Chavel, Colin; Birkaya, Barbara; Grell, Laura; Cullen, Paul J.] SUNY Buffalo, Dept Biol Sci, Buffalo, NY 14260 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Karunanithi, S (corresponding author), SUNY Buffalo, Dept Biol Sci, Buffalo, NY 14260 USA.	pjcullen@buffalo.edu			National Institutes of Health [1R03DE018425-01, GM098629, DE018425]; American Cancer Society [TBE-114083]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R03DE018425] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098629] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding was provided by the National Institutes of Health (1R03DE018425-01, GM098629, and DE018425) and the American Cancer Society (TBE-114083). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baillie GS, 1999, J MED MICROBIOL, V48, P671, DOI 10.1099/00222615-48-7-671; Bardwell L, 2006, BIOCHEM SOC T, V34, P837, DOI 10.1042/BST0340837; Bardwell L, 1998, P NATL ACAD SCI USA, V95, P15400, DOI 10.1073/pnas.95.26.15400; BAUDIN A, 1993, NUCLEIC ACIDS RES, V21, P3329, DOI 10.1093/nar/21.14.3329; Beauvais A, 2009, FEMS YEAST RES, V9, P411, DOI 10.1111/j.1567-1364.2009.00482.x; Blankenship JR, 2006, CURR OPIN MICROBIOL, V9, P588, DOI 10.1016/j.mib.2006.10.003; Chandra J, 2005, CURR DRUG TARGETS, V6, P887, DOI 10.2174/138945005774912762; CHANT J, 1995, J CELL BIOL, V129, P751, DOI 10.1083/jcb.129.3.751; Chavel CA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000883; Chen H, 2006, GENE DEV, V20, P1150, DOI 10.1101/gad.1411806; Cook JG, 1996, GENE DEV, V10, P2831, DOI 10.1101/gad.10.22.2831; COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431; Csank C, 1998, INFECT IMMUN, V66, P2713, DOI 10.1128/IAI.66.6.2713-2721.1998; Cullen PJ, 2000, P NATL ACAD SCI USA, V97, P13619, DOI 10.1073/pnas.240345197; Cullen PJ, 2004, GENE DEV, V18, P1695, DOI 10.1101/gad.1178604; Cullen PJ, 2002, MOL BIOL CELL, V13, P2990, DOI 10.1091/mbc.E02-03-0151; GIMENO CJ, 1992, CELL, V68, P1077, DOI 10.1016/0092-8674(92)90079-R; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Guo B, 2000, P NATL ACAD SCI USA, V97, P12158, DOI 10.1073/pnas.220420397; Halme A, 2004, CELL, V116, P405, DOI 10.1016/S0092-8674(04)00118-7; Karunanithi S, 2010, CURR BIOL, V20, P1389, DOI 10.1016/j.cub.2010.06.033; Kumamoto CA, 2005, ANNU REV MICROBIOL, V59, P113, DOI 10.1146/annurev.micro.59.030804.121034; Kumamoto CA, 2005, P NATL ACAD SCI USA, V102, P5576, DOI 10.1073/pnas.0407097102; Laffey SF, 2005, MICROBIOL-SGM, V151, P1073, DOI 10.1099/mic.0.27739-0; Lamb TM, 2003, MOL CELL BIOL, V23, P677, DOI 10.1128/MCB.23.2.677-686.2003; Lambrechts MG, 1996, P NATL ACAD SCI USA, V93, P8419, DOI 10.1073/pnas.93.16.8419; Leberer E, 1997, EMBO J, V16, P83, DOI 10.1093/emboj/16.1.83; LIU HP, 1993, SCIENCE, V262, P1741, DOI 10.1126/science.8259520; Lo HJ, 1997, CELL, V90, P939, DOI 10.1016/S0092-8674(00)80358-X; Lo WS, 1998, MOL BIOL CELL, V9, P161, DOI 10.1091/mbc.9.1.161; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Madhani HD, 1998, TRENDS CELL BIOL, V8, P348, DOI 10.1016/S0962-8924(98)01298-7; Madhani HD, 1997, SCIENCE, V275, P1314, DOI 10.1126/science.275.5304.1314; Madhani HD, 1997, CELL, V91, P673, DOI 10.1016/S0092-8674(00)80454-7; Malcher M, 2011, GENETICS, V187, P717, DOI 10.1534/genetics.110.125708; Martineau CN, 2007, GENETICS, V177, P1679, DOI 10.1534/genetics.107.081141; Mosch HU, 1996, P NATL ACAD SCI USA, V93, P5352, DOI 10.1073/pnas.93.11.5352; Murillo LA, 2005, EUKARYOT CELL, V4, P1562, DOI 10.1128/EC.4.9.1562-1573.2005; Nett JE, 2009, J INFECT DIS, V200, P307, DOI 10.1086/599838; Nobile CJ, 2005, CURR BIOL, V15, P1150, DOI 10.1016/j.cub.2005.05.047; Nobile CJ, 2006, EUKARYOT CELL, V5, P1604, DOI 10.1128/EC.00194-06; Nobile CJ, 2006, PLOS PATHOG, V2, P636, DOI 10.1371/journal.ppat.0020063; Norice CT, 2007, EUKARYOT CELL, V6, P2046, DOI 10.1128/EC.00314-07; O'Rourke SM, 1998, GENE DEV, V12, P2874, DOI 10.1101/gad.12.18.2874; Paramonova E, 2009, MICROBIOL-SGM, V155, P1997, DOI 10.1099/mic.0.021568-0; Parsek MR, 2005, TRENDS MICROBIOL, V13, P27, DOI 10.1016/j.tim.2004.11.007; Peter M, 1996, EMBO J, V15, P7046, DOI 10.1002/j.1460-2075.1996.tb01096.x; Ramage G, 2002, FEMS MICROBIOL LETT, V214, P95, DOI 10.1111/j.1574-6968.2002.tb11330.x; Reynolds TB, 2001, SCIENCE, V291, P878, DOI 10.1126/science.291.5505.878; Reynolds TB, 2006, EUKARYOT CELL, V5, P1266, DOI 10.1128/EC.00022-06; Richard ML, 2005, EUKARYOT CELL, V4, P1493, DOI 10.1128/EC.4.8.1493-1502.2005; ROBERTS RL, 1994, GENE DEV, V8, P2974, DOI 10.1101/gad.8.24.2974; Rose MD., 1990, METHODS YEAST GENETI; Rupp S, 1999, EMBO J, V18, P1257, DOI 10.1093/emboj/18.5.1257; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Sarode N, 2011, EUKARYOT CELL, V10, P1516, DOI 10.1128/EC.05078-11; Scherz R, 2001, J BACTERIOL, V183, P5402, DOI 10.1128/JB.183.18.5402-5413.2001; Schwartz MA, 2004, ANNU REV GENET, V38, P725, DOI 10.1146/annurev.genet.39.073003.112634; Smukalla S, 2008, CELL, V135, P726, DOI 10.1016/j.cell.2008.09.037; Vinod PK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001663	60	18	18	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e32294	10.1371/journal.pone.0032294	http://dx.doi.org/10.1371/journal.pone.0032294			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GO	22496730	gold, Green Published, Green Submitted			2022-12-27	WOS:000304855200003
J	Al-Mousa, F; Michelangeli, F				Al-Mousa, Fawaz; Michelangeli, Francesco			Some Commonly Used Brominated Flame Retardants Cause Ca2+-ATPase Inhibition, Beta-Amyloid Peptide Release and Apoptosis in SH-SY5Y Neuronal Cells	PLOS ONE			English	Article							TETRABROMOBISPHENOL-A TBBPA; POLYCHLORINATED-BIPHENYLS; SPONTANEOUS BEHAVIOR; ALZHEIMERS-DISEASE; NEONATAL EXPOSURE; DIPHENYL ETHERS; CALCIUM; HEXABROMOCYCLODODECANE; ADULT; DYSREGULATION	Brominated flame retardants (BFRs) are chemicals commonly used to reduce the flammability of consumer products and are considered pollutants since they have become widely dispersed throughout the environment and have also been shown to bio-accumulate within animals and man. This study investigated the cytotoxicity of some of the most commonly used groups of BFRs on SH-SY5Y human neuroblastoma cells. The results showed that of the BFRs tested, hexabromocyclododecane (HBCD), tetrabromobisphenol-A (TBBPA) and decabromodiphenyl ether (DBPE), all are cytotoxic at low micromolar concentrations (LC50 being 2.7 +/- 0.7 mu M, 15 +/- 4 mu M and 28 +/- 7 mu M, respectively). They induced cell death at least in part, by apoptosis through activation of caspases. They also increased intracellular [Ca2+] levels and reactive-oxygen-species within these neuronal cells. Furthermore, these BFRs also caused rapid depolarization of the mitochondria and cytochrome c release in these neuronal cells. Elevated intracellular [Ca2+] levels appear to occur through a mechanism involving microsomal Ca2+-ATPase inhibition and this maybe responsible for Ca2+-induced mitochondria dysfunction. In addition, mu M levels of these BFRs caused beta-amyloid peptide (A beta-42) processing and release from these cells with a few hours of exposure. These results therefore shows that these pollutants are both neurotoxic and amyloidogenic in-vitro.	[Al-Mousa, Fawaz; Michelangeli, Francesco] Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England	University of Birmingham	Al-Mousa, F (corresponding author), Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England.	F.Michelangeli@Bham.ac.uk			Medical Faculty of the University of Birmingham; The Ministry of Health, Saudi Arabia	Medical Faculty of the University of Birmingham; The Ministry of Health, Saudi Arabia	This project was funded through a Rowbottom bequest grant from the Medical Faculty of the University of Birmingham. The Ministry of Health, Saudi Arabia is thanked for a PhD scholarship to F. Al-Mousa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaee M, 2002, CHEMOSPHERE, V46, P579, DOI 10.1016/S0045-6535(01)00224-7; Berger AB, 2006, CELL RES, V2006, P1; Bezprozvanny I, 2008, TRENDS NEUROSCI, V31, P454, DOI 10.1016/j.tins.2008.06.005; Bi XH, 2007, ENVIRON SCI TECHNOL, V41, P5647, DOI 10.1021/es070346a; Camandola S, 2011, BBA-MOL CELL RES, V1813, P965, DOI 10.1016/j.bbamcr.2010.10.005; Darnerud PO, 2003, ENVIRON INT, V29, P841, DOI 10.1016/S0160-4120(03)00107-7; De Strooper B, 2000, J CELL SCI, V113, P1857; de Wit CA, 2002, CHEMOSPHERE, V46, P583, DOI 10.1016/S0045-6535(01)00225-9; Demuro A, 2005, J BIOL CHEM, V280, P17294, DOI 10.1074/jbc.M500997200; Demuro A, 2010, J BIOL CHEM, V285, P12463, DOI 10.1074/jbc.R109.080895; Eriksson P, 2002, TOXICOL SCI, V67, P98, DOI 10.1093/toxsci/67.1.98; Fonnum F, 2006, J TOXICOL ENV HEAL A, V69, P21, DOI 10.1080/15287390500259020; Franklin JL, 2011, ANTIOXID REDOX SIGN, V14, P1437, DOI 10.1089/ars.2010.3596; Green KN, 2008, J CELL BIOL, V181, P1107, DOI 10.1083/jcb.200706171; Hayden RE, 2010, HAEMATOL-HEMATOL J, V95, P1889, DOI 10.3324/haematol.2010.027821; He P, 2009, NEUROTOXICOLOGY, V30, P10, DOI 10.1016/j.neuro.2008.10.004; Jennings AM, 2006, FASEB J, V20, pA1158; Koyama Y, 2008, INVEST OPHTH VIS SCI, V49, P2376, DOI 10.1167/iovs.07-1067; Lai P, 2011, FEBS LETT, V585, P2291, DOI 10.1016/j.febslet.2011.05.058; Lai P, 2009, BIOSCIENCE REP, V29, P397, DOI 10.1042/BSR20090058; Leissring MA, 1999, J BIOL CHEM, V274, P32535, DOI 10.1074/jbc.274.46.32535; Liang B, 2010, J BIOL CHEM, V285, P27737, DOI 10.1074/jbc.M110.117960; Mattson MP, 2003, CELL CALCIUM, V34, P385, DOI 10.1016/S0143-4160(03)00128-3; Mattson MP, 2004, NATURE, V430, P631, DOI 10.1038/nature02621; McStay GP, 2008, CELL DEATH DIFFER, V15, P322, DOI 10.1038/sj.cdd.4402260; Michelangeli F, 2011, BIOCHEM SOC T, V39, P789, DOI 10.1042/BST0390789; Michelangeli F, 2008, CHEM-BIOL INTERACT, V176, P220, DOI 10.1016/j.cbi.2008.08.005; Nunez G, 1998, ONCOGENE, V17, P3237, DOI 10.1038/sj.onc.1202581; Ogunbayo OA, 2008, TOXICOL IN VITRO, V22, P943, DOI 10.1016/j.tiv.2008.01.015; Ogunbayo OA, 2007, BIOCHEM J, V408, P407, DOI 10.1042/BJ20070843; Ogunbayo OA, 2007, BBA-BIOMEMBRANES, V1768, P1559, DOI 10.1016/j.bbamem.2007.03.013; Querfurth HW, 1997, J NEUROCHEM, V69, P1580; Reistad T, 2006, ARCH TOXICOL, V80, P785, DOI 10.1007/s00204-006-0099-8; Stutzmann GE, 2004, J NEUROSCI, V24, P508, DOI 10.1523/JNEUROSCI.4386-03.2004; Stutzmann GE, 2007, NEUROSCIENTIST, V13, P546, DOI 10.1177/1073858407299730; Stutzmann GE, 2006, J NEUROSCI, V26, P5180, DOI 10.1523/JNEUROSCI.0739-06.2006; Szabo DT, 2010, TOXICOL SCI, V117, P282, DOI 10.1093/toxsci/kfq183; Tesco G, 2007, NEURON, V54, P721, DOI 10.1016/j.neuron.2007.05.012; Thomsen C, 2007, ENVIRON SCI TECHNOL, V41, P5210, DOI 10.1021/es0702622; Toescu EC, 2007, AGING CELL, V6, P267, DOI 10.1111/j.1474-9726.2007.00296.x; Viberg H, 2003, TOXICOL APPL PHARM, V192, P95, DOI 10.1016/S0041-008X(03)00217-5; Viberg H, 2006, TOXICOL SCI, V92, P211, DOI 10.1093/toxsci/kfj196; Viswanath V, 2001, J NEUROSCI, V21, P9519, DOI 10.1523/JNEUROSCI.21-24-09519.2001; Walsh DM, 2007, BIOCHEM SOC T, V35, P416, DOI 10.1042/BST0350416; Yoo AS, 2000, NEURON, V27, P561, DOI 10.1016/S0896-6273(00)00066-0	45	69	74	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2012	7	4							e33059	10.1371/journal.pone.0033059	http://dx.doi.org/10.1371/journal.pone.0033059			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952GU	22485137	Green Published, Green Submitted, gold			2022-12-27	WOS:000304780500013
J	Wang, K; Bodempudi, V; Liu, ZG; Borrego-Diaz, E; Yamoutpoor, F; Meyer, A; Woo, RA; Pan, W; Dudek, AZ; Olyaee, MS; Esfandyari, T; Farassati, F				Wang, Kun; Bodempudi, Vidya; Liu, Zhengian; Borrego-Diaz, Emma; Yamoutpoor, Farnaz; Meyer, Anna; Woo, Richard A.; Pan, Weihong; Dudek, Arkadiusz Z.; Olyaee, Mojtaba S.; Esfandyari, Tuba; Farassati, Faris			Inhibition of Mesothelin as a Novel Strategy for Targeting Cancer Cells	PLOS ONE			English	Article							RAF-MEK-ERK; HUMAN LUNG-CANCER; ENDOPLASMIC-RETICULUM; PANCREATIC-CANCER; OVARIAN-CANCER; MONOCLONAL-ANTIBODY; ANTITUMOR-ACTIVITY; TUMOR PROGRESSION; IMMUNOTOXIN SS1P; HIGH-AFFINITY	Mesothelin, a differentiation antigen present in a series of malignancies such as mesothelioma, ovarian, lung and pancreatic cancer, has been studied as a marker for diagnosis and a target for immunotherapy. We, however, were interested in evaluating the effects of direct targeting of Mesothelin on the viability of cancer cells as the first step towards developing a novel therapeutic strategy. We report here that gene specific silencing for Mesothelin by distinct methods (siRNA and microRNA) decreased viability of cancer cells from different origins such as mesothelioma (H2373), ovarian cancer (Skov3 and Ovcar-5) and pancreatic cancer (Miapaca2 and Panc-1). Additionally, the invasiveness of cancer cells was also significantly decreased upon such treatment. We then investigated pro-oncogenic signaling characteristics of cells upon mesothelin-silencing which revealed a significant decrease in phospho-ERK1 and PI3K/AKT activity. The molecular mechanism of reduced invasiveness was connected to the reduced expression of beta-Catenin, an important marker of EMT (epithelial-mesenchymal transition). Ero1, a protein involved in clearing unfolded proteins and a member of the ER-Stress (endoplasmic reticulum-stress) pathway was also markedly reduced. Furthermore, Mesothelin silencing caused a significant increase in fraction of cancer cells in S-phase. In next step, treatment of ovarian cancer cells (OVca429) with a lentivirus expressing anti-mesothelin microRNA resulted in significant loss of viability, invasiveness, and morphological alterations. Therefore, we propose the inhibition of Mesothelin as a potential novel strategy for targeting human malignancies.	[Wang, Kun; Liu, Zhengian; Borrego-Diaz, Emma; Yamoutpoor, Farnaz; Pan, Weihong; Olyaee, Mojtaba S.; Esfandyari, Tuba; Farassati, Faris] Univ Kansas, Med Ctr, Dept Med, Mol Med Lab,Div Gastroenterol, Kansas City, KS 66103 USA; [Wang, Kun; Liu, Zhengian; Borrego-Diaz, Emma; Yamoutpoor, Farnaz; Pan, Weihong; Olyaee, Mojtaba S.; Esfandyari, Tuba; Farassati, Faris] Univ Kansas, Med Ctr, Div Hematol Oncol, Dept Med, Kansas City, KS 66103 USA; [Bodempudi, Vidya; Meyer, Anna; Dudek, Arkadiusz Z.] Univ Minnesota, Dept Med, Minneapolis, MN 55455 USA; [Woo, Richard A.] So Illinois Univ, Med Ctr, Springfield, IL USA	University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; University of Minnesota System; University of Minnesota Twin Cities; Southern Illinois University System; Southern Illinois University	Wang, K (corresponding author), Univ Kansas, Med Ctr, Dept Med, Mol Med Lab,Div Gastroenterol, Kansas City, KS 66103 USA.	ffarassati@kumc.edu	Dudek, Arkadiusz Zbigniew/HGD-1339-2022; Wang, Kun/H-5227-2016	Dudek, Arkadiusz Zbigniew/0000-0002-9114-8945; 	Mesothelioma Applied Research Foundation (MARF); Marsha Rivkin Institute for Ovarian Cancer (MRC); Flight attendant Medical Research Institute (FAMRI); All in For Cure	Mesothelioma Applied Research Foundation (MARF); Marsha Rivkin Institute for Ovarian Cancer (MRC); Flight attendant Medical Research Institute (FAMRI); All in For Cure	Research at F. Farassati's laboratory is supported by "All in For Cure", "Mesothelioma Applied Research Foundation (MARF)", "Marsha Rivkin Institute for Ovarian Cancer (MRC)" and "Flight attendant Medical Research Institute (FAMRI)". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Azeez HA, 2010, ASIAN PAC J CANCER P, V11, P111; Alvarado Y, 2007, EXPERT OPIN EMERG DR, V12, P271, DOI 10.1517/14728214.12.2.271; Alves CC, 2009, FRONT BIOSCI-LANDMRK, V14, P3041, DOI 10.2741/3433; Araki K, 2011, J BIOL CHEM; Baba K, 2012, J SURG ONCOL, V105, P195, DOI 10.1002/jso.22024; Banhegyi G, 2007, ANN NY ACAD SCI, V1113, P58, DOI 10.1196/annals.1391.007; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bera TK, 2000, MOL CELL BIOL, V20, P2902, DOI 10.1128/MCB.20.8.2902-2906.2000; Bharadwaj U, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-106; Bharadwaj U, 2011, CARCINOGENESIS, V32, P1013, DOI 10.1093/carcin/bgr075; Bodempudi V, 2009, MOL CELL BIOL, V29, P3964, DOI 10.1128/MCB.01153-08; Boelens J, 2007, IN VIVO, V21, P215; Bolos V, 2003, J CELL SCI, V116, P499, DOI 10.1242/jcs.00224; Breidenbach M, 2005, GENE THER, V12, P187, DOI 10.1038/sj.gt.3302404; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Chang F, 2003, LEUKEMIA, V17, P590, DOI 10.1038/sj.leu.2402824; CHANG K, 1992, INT J CANCER, V50, P373, DOI 10.1002/ijc.2910500308; Chang K, 1996, P NATL ACAD SCI USA, V93, P136, DOI 10.1073/pnas.93.1.136; Chang MC, 2011, BIOCH J; Couto LB, 2010, CURR OPIN PHARMACOL, V10, P534, DOI 10.1016/j.coph.2010.06.007; Debacq-Chainiaux F, 2010, ADV EXP MED BIOL, V694, P126; Fan D, 2002, MOL CANCER THER, V1, P595; Glass JP, 2011, INT J SURG PATHOL; Gubbels JAA, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-50; Hall A, 2009, CANCER METAST REV, V28, P5, DOI 10.1007/s10555-008-9166-3; Hassan R, 1999, INT J CANCER, V80, P559, DOI 10.1002/(SICI)1097-0215(19990209)80:4<559::AID-IJC13>3.0.CO;2-Y; Hassan R, 2002, CLIN CANCER RES, V8, P3520; Hassan R, 2000, J IMMUNOTHER, V23, P473, DOI 10.1097/00002371-200007000-00011; Hassan R, 2007, CLIN CANCER RES, V13, P5144, DOI 10.1158/1078-0432.CCR-07-0869; Hassan R, 2006, CLIN CANCER RES, V12, P4983, DOI 10.1158/1078-0432.CCR-06-0441; Hassan R, 2010, CLIN CANCER RES, V16, P6132, DOI 10.1158/1078-0432.CCR-10-2275; Hellstrom Ingegerd, 2011, Expert Opin Med Diagn, V5, P227, DOI 10.1517/17530059.2011.559459; Hilger RA, 2002, ONKOLOGIE, V25, P511, DOI 10.1159/000068621; Ho M, 2007, CLIN CANCER RES, V13, P1571, DOI 10.1158/1078-0432.CCR-06-2161; Hokaiwado N, 2008, IDRUGS, V11, P274; Iacobuzio-Donahue CA, 2003, CANCER RES, V63, P8614; KARLAN BY, 1988, GYNECOL ONCOL, V31, P103, DOI 10.1016/0090-8258(88)90276-4; KOHNO K, 1993, MOL CELL BIOL, V13, P877, DOI 10.1128/MCB.13.2.877; Koumenis C, 2006, CURR MOL MED, V6, P55, DOI 10.2174/156652406775574604; Kreitman RJ, 2009, CLIN CANCER RES, V15, P5274, DOI 10.1158/1078-0432.CCR-09-0062; Lee AS, 2006, CANCER BIOL THER, V5, P721, DOI 10.4161/cbt.5.7.3120; Mak BC, 2003, J BIOL CHEM, V278, P5947, DOI 10.1074/jbc.C200473200; Micalizzi DS, 2010, J MAMMARY GLAND BIOL, V15, P117, DOI 10.1007/s10911-010-9178-9; Muminova ZE, 2004, BMC CANCER, V4, DOI 10.1186/1471-2407-4-19; Ni M, 2007, FEBS LETT, V581, P3641, DOI 10.1016/j.febslet.2007.04.045; Prieve Mary G, 2003, BMC Dev Biol, V3, P2, DOI 10.1186/1471-213X-3-2; Quintela-Fandino M, 2010, CLIN TRANSL ONCOL, V12, P662, DOI 10.1007/s12094-010-0575-8; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Rovira C, 2010, IUBMB LIFE, V62, P859, DOI 10.1002/iub.399; Rump A, 2004, J BIOL CHEM, V279, P9190, DOI 10.1074/jbc.M312372200; Scharovsky OG, 2000, J BIOMED SCI, V7, P292, DOI 10.1007/BF02253247; Singh A, 2010, ONCOGENE, V29, P4741, DOI 10.1038/onc.2010.215; Yamada S, 2011, CLIN CHEM LAB MED; Yamashita Y, 2000, BIOCHEM BIOPH RES CO, V275, P134, DOI 10.1006/bbrc.2000.3280; Yamoutpour F, 2008, MOL CANCER THER, V7, P3586, DOI 10.1158/1535-7163.MCT-08-0653; Yilmaz M, 2009, CANCER METAST REV, V28, P15, DOI 10.1007/s10555-008-9169-0; Zebisch A, 2007, CURR MED CHEM, V14, P601, DOI 10.2174/092986707780059670	57	36	40	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2012	7	4							e33214	10.1371/journal.pone.0033214	http://dx.doi.org/10.1371/journal.pone.0033214			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952GU	22485139	Green Submitted, gold, Green Published			2022-12-27	WOS:000304780500015
J	Avena, S; Via, M; Ziv, E; Perez-Stable, EJ; Gignoux, CR; Dejean, C; Huntsman, S; Torres-Mejia, G; Dutil, J; Matta, JL; Beckman, K; Burchard, EG; Parolin, ML; Goicoechea, A; Acreche, N; Boquet, M; Part, MDR; Fernandez, V; Rey, J; Stern, MC; Carnese, RF; Fejerman, L				Avena, Sergio; Via, Marc; Ziv, Elad; Perez-Stable, Eliseo J.; Gignoux, Christopher R.; Dejean, Cristina; Huntsman, Scott; Torres-Mejia, Gabriela; Dutil, Julie; Matta, Jaime L.; Beckman, Kenneth; Burchard, Esteban Gonzalez; Laura Parolin, Maria; Goicoechea, Alicia; Acreche, Noemi; Boquet, Mariel; Rios Part, Maria Del Carmen; Fernandez, Vanesa; Rey, Jorge; Stern, Mariana C.; Carnese, Raul F.; Fejerman, Laura			Heterogeneity in Genetic Admixture across Different Regions of Argentina	PLOS ONE			English	Article							POPULATION-STRUCTURE; BREAST-CANCER; BUENOS-AIRES; ANCESTRY; ASSOCIATION; SAMPLE; RISK; STRATIFICATION; URUGUAY; ASTHMA	The population of Argentina is the result of the intermixing between several groups, including Indigenous American, European and African populations. Despite the commonly held idea that the population of Argentina is of mostly European origin, multiple studies have shown that this process of admixture had an impact in the entire Argentine population. In the present study we characterized the distribution of Indigenous American, European and African ancestry among individuals from different regions of Argentina and evaluated the level of discrepancy between self-reported grandparental origin and genetic ancestry estimates. A set of 99 autosomal ancestry informative markers (AIMs) was genotyped in a sample of 441 Argentine individuals to estimate genetic ancestry. We used non-parametric tests to evaluate statistical significance. The average ancestry for the Argentine sample overall was 65% European (95% CI: 63-68%), 31% Indigenous American (28-33%) and 4% African (3-4%). We observed statistically significant differences in European ancestry across Argentine regions [Buenos Aires province (BA) 76%, 95% CI: 73-79%; Northeast (NEA) 54%, 95% CI: 49-58%; Northwest (NWA) 33%, 95% CI: 21-41%; South 54%, 95% CI: 49-59%; p<0.0001] as well as between the capital and immediate suburbs of Buenos Aires city compared to more distant suburbs [80% (95% CI: 75-86%) versus 68% (95% CI: 58-77%), p = 0.01]. European ancestry among individuals that declared all grandparents born in Europe was 91% (95% CI: 88-94%) compared to 54% (95% CI: 51-57%) among those with no European grandparents (p<0.001). Our results demonstrate the range of variation in genetic ancestry among Argentine individuals from different regions in the country, highlighting the importance of taking this variation into account in genetic association and admixture mapping studies in this population.	[Avena, Sergio; Dejean, Cristina; Laura Parolin, Maria; Goicoechea, Alicia; Carnese, Raul F.] Univ Buenos Aires, Dept Antropol, Buenos Aires, DF, Argentina; [Avena, Sergio; Dejean, Cristina; Laura Parolin, Maria] Univ Maimonides, Ctr Estudios Biomed Biotecnol Ambientales & Diagn, Buenos Aires, DF, Argentina; [Avena, Sergio; Dejean, Cristina; Laura Parolin, Maria; Goicoechea, Alicia] Consejo Nacl Invest Cient & Tecn, Buenos Aires, DF, Argentina; [Via, Marc; Burchard, Esteban Gonzalez] Univ Calif San Francisco, Div Pulm & Crit Care, San Francisco, CA 94143 USA; [Via, Marc] Univ Barcelona, Unit Anthropol, Dept Anim Biol, Barcelona, Spain; [Ziv, Elad; Perez-Stable, Eliseo J.; Huntsman, Scott] Univ Calif San Francisco, Div Gen Internal Med, San Francisco, CA 94143 USA; [Ziv, Elad; Gignoux, Christopher R.; Burchard, Esteban Gonzalez] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA; [Perez-Stable, Eliseo J.] Univ Calif San Francisco, Med Effectiveness Res Ctr Div Populat, San Francisco, CA 94143 USA; [Ziv, Elad; Perez-Stable, Eliseo J.] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA; [Gignoux, Christopher R.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Torres-Mejia, Gabriela] Inst Nacl Salud Publ, Ctr Invest Salud Poblac, Cuernavaca, Morelos, Mexico; [Dutil, Julie] Ponce Sch Med & Hlth Sci, Dept Biochem, Ponce, PR USA; [Matta, Jaime L.] Ponce Sch Med & Hlth Sci, Dept Physiol & Pharmacol, Ponce, PR USA; [Beckman, Kenneth] Univ Minnesota, Dept Genet Cell Biol & Dev Biol, Minneapolis, MN USA; [Burchard, Esteban Gonzalez] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA; [Acreche, Noemi] Univ Nacl Salta, Fac Ciencias Nat, Salta, Argentina; [Boquet, Mariel] Univ Nacl Patagonia, Fac Ciencias Nat, Esquel, Chubut, Argentina; [Rios Part, Maria Del Carmen] Banco Sangre Hosp Reg Comodoro Rivadavia, Comodoro Rivadavia, Chubut, Argentina; [Fernandez, Vanesa] Hosp Penna Bahia Blanca, Serv Hemoterapia, Bahia Blanca, Buenos Aires, Argentina; [Rey, Jorge] Univ Buenos Aires, Hosp Clin, Serv Hemoterapia, Buenos Aires, DF, Argentina; [Stern, Mariana C.] Univ Calif Los Angeles, Norris Comprehens Canc Ctr, Univ So Calif, Los Angeles, CA USA	University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of California System; University of California San Francisco; University of Barcelona; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of California System; University of California San Francisco; Instituto Nacional de Salud Publica; University of Minnesota System; University of Minnesota Twin Cities; University of California System; University of California San Francisco; Universidad Nacional de la Patagonia San Juan Bosco; University of Buenos Aires; University of California System; University of California Los Angeles; University of Southern California	Avena, S (corresponding author), Univ Buenos Aires, Dept Antropol, Buenos Aires, DF, Argentina.	Laura.fejerman@ucsf.edu	Via, Marc/L-6511-2014; Ziv, Elad/L-5396-2014; Dejean, Cristina/AAM-1408-2021	Via, Marc/0000-0002-9966-9921; Rey, Jorge/0000-0001-6148-9346; Parolin, Maria Laura/0000-0001-6726-2943; Fejerman, Laura/0000-0003-3179-1151	National Cancer Institute [R01CA120120, R25 CA112355, K01 CA160607, U56 CA126379]; Redes En Accion [U01-CA86117]; National Institutes of Health/National Institute of Child Health and Human Development (NIH/NICHHD) [5K12HD052163]; Beatriu de Pinos Program [2006 BP-A 10144, 2009 BP-B 00274]; UBACyT; Universidad Maimonides; CONICET; CONACyT [SALUD- 2002-C01-7462]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD052163] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R25CA112355, U56CA126379, U01CA086117, K01CA160607, R01CA120120] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL078885, R01HL088133] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI077439] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Redes En Accion; National Institutes of Health/National Institute of Child Health and Human Development (NIH/NICHHD); Beatriu de Pinos Program; UBACyT; Universidad Maimonides; CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Cancer Institute [R01CA120120 (EZ), R25 CA112355 (LF), K01 CA160607 (LF)], Redes En Accion, U01-CA86117 (EJPS), the BIRCWH K12 training grant sponsored by the National Institutes of Health/National Institute of Child Health and Human Development (NIH/NICHHD) [5K12HD052163 (LF)] and the Beatriu de Pinos Program [2006 BP-A 10144 and 2009 BP-B 00274 (MV)]. Other support came from the National Institutes of Health (HL078885, AI077439, HL088133), the Flight Attendant Medical Research Institute (FAMRI), American Asthma Foundation and the Sandler Foundation (EGB). Each of the participating studies was supported by the following grants: UBACyT, Universidad Maimonides and CONICET (SA), CONACyT (SALUD- 2002-C01-7462; GTM) and National Cancer Institute U56 CA126379 (JD & JLM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Angeles-Llerenas A, 2010, CANCER CAUSE CONTROL, V21, P577, DOI 10.1007/s10552-009-9487-8; Avena SA, 1999, REV ARGENTINA ANTROP, V2, P211; Avena SA, 2006, MEDICINA-BUENOS AIRE, V66, P113; Bazan A, 1995, HIST NOROESTE ARGENT; Bonilla C, 2005, AM J PHYS ANTHROPOL, V128, P861, DOI 10.1002/ajpa.20227; Bonilla C, 2004, AM J HUM BIOL, V16, P289, DOI 10.1002/ajhb.20025; Burchard EG, 2005, AM J PUBLIC HEALTH, V95, P2161, DOI 10.2105/AJPH.2005.068668; Carnese FR, 2011, RACIAL IDENTITIES, GENETIC ANCESTRY, AND HEALTH IN SOUTH AMERICA: ARGENTINA, BRAZIL, COLOMBIA, AND URUGUAY, P177; CHAKRABORTY R, 1986, AM J PHYS ANTHROPOL, V70, P489, DOI 10.1002/ajpa.1330700408; CHAKRABORTY R, 1991, Ethnicity and Disease, V1, P245; Choudhry S, 2008, HUM GENET, V123, P455, DOI 10.1007/s00439-008-0495-7; Corach D, 2010, ANN HUM GENET, V74, P65, DOI 10.1111/j.1469-1809.2009.00556.x; Corvol H, 2009, PHARMACOGENET GENOM, V19, P489, DOI 10.1097/FPC.0b013e32832c440e; Fejerman L, 2005, AM J PHYS ANTHROPOL, V128, P164, DOI 10.1002/ajpa.20083; Fejerman L, 2008, CANCER RES, V68, P9723, DOI 10.1158/0008-5472.CAN-08-2039; Fejerman L, 2010, CANCER EPIDEM BIOMAR, V19, P1074, DOI 10.1158/1055-9965.EPI-09-1193; Galanter J, 2008, AM J RESP CRIT CARE, V177, P1194, DOI 10.1164/rccm.200711-1644OC; Kim H, 2008, NEUROEPIDEMIOLOGY, V31, P224, DOI 10.1159/000160215; Lins TC, 2010, AM J HUM BIOL, V22, P187, DOI 10.1002/ajhb.20976; Lucaioli C, 2010, ESPACIOS FRONTERA CH, P21; Mao XY, 2007, AM J HUM GENET, V80, P1171, DOI 10.1086/518564; Marignac VLM, 2004, HUM BIOL, V76, P543, DOI 10.1353/hub.2004.0058; Martinez-Marignac VL, 2007, HUM GENET, V120, P807, DOI 10.1007/s00439-006-0273-3; Nelson MR, 2008, AM J HUM GENET, V83, P347, DOI 10.1016/j.ajhg.2008.08.005; Price AL, 2007, AM J HUM GENET, V80, P1024, DOI 10.1086/518313; Pritchard JK, 2000, GENETICS, V155, P945; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ramos JM, 2004, CANCER-AM CANCER SOC, V100, P1352, DOI 10.1002/cncr.20135; Risch N, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r132; Sans M, 2000, HUM BIOL, V72, P155; Sans M, 2006, AM J HUM BIOL, V18, P513, DOI 10.1002/ajhb.20520; Santos NPC, 2010, HUM MUTAT, V31, P184, DOI 10.1002/humu.21159; Seldin MF, 2007, AM J PHYS ANTHROPOL, V132, P455, DOI 10.1002/ajpa.20534; StataCorp, 2021, STATA STAT SOFTWARE; Suarez-Kurtz G, 2007, PHARMACOGENET GENOM, V17, P765, DOI 10.1097/FPC.0b013e3281c10e52; Tang H, 2005, GENET EPIDEMIOL, V28, P289, DOI 10.1002/gepi.20064; Tsai HJ, 2005, HUM GENET, V118, P424, DOI 10.1007/s00439-005-0067-z; Via M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016513; Wang S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000037; Yaeger R, 2008, CANCER EPIDEM BIOMAR, V17, P1329, DOI 10.1158/1055-9965.EPI-07-2505	41	101	105	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2012	7	4							e34695	10.1371/journal.pone.0034695	http://dx.doi.org/10.1371/journal.pone.0034695			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959FE	22506044	Green Published, Green Submitted, gold			2022-12-27	WOS:000305297500052
J	Goodin, P; Ciorciari, J; Baker, K; Carrey, AM; Harper, M; Kaufman, J				Goodin, Peter; Ciorciari, Joseph; Baker, Kate; Carrey, Anne-Marie; Harper, Michelle; Kaufman, Jordy			A High-Density EEG Investigation into Steady State Binaural Beat Stimulation	PLOS ONE			English	Article							FREQUENCY-FOLLOWING RESPONSE; WORKING-MEMORY; BRAIN ACTIVATION; BIPOLAR DISORDER; AUDITORY BEATS; FUNCTIONAL MRI; ENTRAINMENT; TECHNOLOGY; HUMANS; INJURY	Binaural beats are an auditory phenomenon that has been suggested to alter physiological and cognitive processes including vigilance and brainwave entrainment. Some personality traits measured by the NEO Five Factor Model have been found to alter entrainment using pulsing light stimuli, but as yet no studies have examined if this occurs using steady state presentation of binaural beats for a relatively short presentation of two minutes. This study aimed to examine if binaural beat stimulation altered vigilance or cortical frequencies and if personality traits were involved. Thirty-one participants were played binaural beat stimuli designed to elicit a response at either the Theta (7 Hz) or Beta (16 Hz) frequency bands while undertaking a zero-back vigilance task. EEG was recorded from a high-density electrode cap. No significant differences were found in vigilance or cortical frequency power during binaural beat stimulation compared to a white noise control period. Furthermore, no significant relationships were detected between the above and the Big Five personality traits. This suggests a short presentation of steady state binaural beats are not sufficient to alter vigilance or entrain cortical frequencies at the two bands examined and that certain personality traits were not more susceptible than others.	[Goodin, Peter; Ciorciari, Joseph; Baker, Kate; Carrey, Anne-Marie; Harper, Michelle; Kaufman, Jordy] Swinburne Univ Technol, Brain & Psychol Sci Res Ctr, Hawthorn, Vic 3122, Australia	Swinburne University of Technology	Goodin, P (corresponding author), Swinburne Univ Technol, Brain & Psychol Sci Res Ctr, Hawthorn, Vic 3122, Australia.	jciorciari@swin.edu.au	Kaufman, Jordy/A-5742-2008; Ciorciari, Joseph/J-9538-2012	Kaufman, Jordy/0000-0001-9881-371X; Ciorciari, Joseph/0000-0002-0751-0631; Goodin, Peter/0000-0003-1981-7363	Faculty of Life and Social Sciences	Faculty of Life and Social Sciences	This project was funded by the Faculty of Life and Social Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiken SJ, 2008, HEARING RES, V245, P35, DOI 10.1016/j.heares.2008.08.004; Bogdan VA, 2009, J COGN BEHAV PSYCHOT, V9, P67; Brady B, 2000, AM J CLIN HYPN, V43, P53, DOI 10.1080/00029157.2000.10404255; Costa P. T. J., 1992, PSYCHOL ASSESSMENT R, V4; Dabu-Bondoc S, 2010, ANESTH ANALG, V110, P208, DOI 10.1213/ANE.0b013e3181bea424; DeYoung CG, 2010, PSYCHOL SCI, V21, P820, DOI 10.1177/0956797610370159; Fitzpatrick DC, 2009, JARO-J ASSOC RES OTO, V10, P579, DOI 10.1007/s10162-009-0177-8; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; Gurrera RJ, 2001, BIOL PSYCHIAT, V49, P922, DOI 10.1016/S0006-3223(00)01067-2; Huang TL, 2008, ALTERN THER HEALTH M, V14, P38; Karino S, 2006, J NEUROPHYSIOL, V96, P1927, DOI 10.1152/jn.00859.2005; Kasprzak C, 2011, ACTA PHYS POL A, V119, P986, DOI 10.12693/APhysPolA.119.986; Kennerly R., 2004, J NEUROTHER, V8, P122; Krishnan A, 2004, HEARING RES, V189, P1, DOI 10.1016/S0378-5955(03)00402-7; Lane JD, 1998, PHYSIOL BEHAV, V63, P249, DOI 10.1016/S0031-9384(97)00436-8; Le Scouarnec RP, 2001, ALTERN THER HEALTH M, V7, P58; MARSH JT, 1970, SCIENCE, V169, P1222, DOI 10.1126/science.169.3951.1222; McAllister TW, 1999, NEUROLOGY, V53, P1300, DOI 10.1212/WNL.53.6.1300; MCCRAE RR, 1992, J PERS, V60, P175, DOI 10.1111/j.1467-6494.1992.tb00970.x; Monks PJ, 2004, BIPOLAR DISORD, V6, P550, DOI 10.1111/j.1399-5618.2004.00147.x; OSTER G, 1973, SCI AM, V229, P94, DOI 10.1038/scientificamerican1073-94; Persinger MA, 1997, PERCEPT MOTOR SKILL, V84, P527, DOI 10.2466/pms.1997.84.2.527; Rosenfeld JP, 1997, APPL PSYCHOPHYS BIOF, V22, P3, DOI 10.1023/A:1026233624772; Schwarz DWF, 2005, CLIN NEUROPHYSIOL, V116, P658, DOI 10.1016/j.clinph.2004.09.014; SILBERSTEIN R B, 1990, Brain Topography, V3, P337, DOI 10.1007/BF01135443; Smits M, 2009, HUM BRAIN MAPP, V30, P2789, DOI 10.1002/hbm.20709; Stevens L, 2003, AM J CLIN HYPN, V45, P295, DOI 10.1080/00029157.2003.10403543; Stough C, 2001, INT J PSYCHOPHYSIOL, V41, P87, DOI 10.1016/S0167-8760(00)00176-8; Szatkowska I, 2008, NEUROBIOL LEARN MEM, V90, P475, DOI 10.1016/j.nlm.2008.06.001; Thermenos HW, 2011, BIPOLAR DISORD, V13, P272, DOI 10.1111/j.1399-5618.2011.00920.x; von Stein A, 2000, INT J PSYCHOPHYSIOL, V38, P301, DOI 10.1016/S0167-8760(00)00172-0; Wahbeh H, 2007, J ALTERN COMPLEM MED, V13, P199, DOI 10.1089/acm.2006.6201; Wahbeh H, 2007, J ALTERN COMPLEM MED, V13, P25, DOI 10.1089/acm.2006.6196	33	40	44	4	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2012	7	4							e34789	10.1371/journal.pone.0034789	http://dx.doi.org/10.1371/journal.pone.0034789			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JO	22496862	Green Published, gold			2022-12-27	WOS:000305014500030
J	Scully, ED; Hoover, K; Carlson, J; Tien, M; Geib, SM				Scully, Erin D.; Hoover, Kelli; Carlson, John; Tien, Ming; Geib, Scott M.			Analysis of Fusarium solani Isolated from the Longhorned Beetle, Anoplophora glabripennis	PLOS ONE			English	Article							AMINO-ACID-SEQUENCE; LIGNIN DEGRADATION; PHANEROCHAETE-CHRYSOSPORIUM; LIGNOCELLULOSE DEGRADATION; EXTRACELLULAR PEROXIDASE; MICROBIAL-DEGRADATION; WOOD DECAY; PROTEINS; LACCASE; GUT	Wood is a highly intractable food source, yet many insects successfully colonize and thrive in this challenging niche. Overcoming the lignin barrier of wood is a key challenge in nutrient acquisition, but full depolymerization of intact lignin polymers has only been conclusively demonstrated in fungi and is not known to occur by enzymes produced by insects or bacteria. Previous research validated that lignocellulose and hemicellulose degradation occur within the gut of the wood boring insect, Anoplophora glabripennis (Asian longhorned beetle), and that a fungal species, Fusarium solani (ATCC MYA 4552), is consistently associated with the larval stage. While the nature of this relationship is unresolved, we sought to assess this fungal isolate's ability to degrade lignocellulose and cell wall polysaccharides and to extract nutrients from woody tissue. This gut-derived fungal isolate was inoculated onto a wood-based substrate and shotgun proteomics using Multidimensional Protein Identification Technology (MudPIT) was employed to identify 400 expressed proteins. Through this approach, we detected proteins responsible for plant cell wall polysaccharide degradation, including proteins belonging to 28 glycosyl hydrolase families and several cutinases, esterases, lipases, pectate lyases, and polysaccharide deacetylases. Proteinases with broad substrate specificities and ureases were observed, indicating that this isolate has the capability to digest plant cell wall proteins and recycle nitrogenous waste under periods of nutrient limitation. Additionally, several laccases, peroxidases, and enzymes involved in extracellular hydrogen peroxide production previously implicated in lignin depolymerization were detected. In vitro biochemical assays were conducted to corroborate MudPIT results and confirmed that cellulases, glycosyl hydrolases, xylanases, laccases, and Mn- independent peroxidases were active in culture; however, lignin- nd Mn- dependent peroxidase activities were not detected While little is known about the role of filamentous fungi and their associations with insects, these findings suggest that this isolate has the endogenous potential to degrade lignocellulose and extract nutrients from woody tissue.	[Scully, Erin D.] Penn State Univ, Huck Inst Life Sci, Intercoll Program Genet, University Pk, PA 16802 USA; [Hoover, Kelli] Penn State Univ, Ctr Chem Ecol, Dept Entomol, University Pk, PA 16802 USA; [Carlson, John] Penn State Univ, Sch Forest Resources, University Pk, PA 16802 USA; [Carlson, John] Chonnam Natl Univ, World Class Univ, Dept Bioenergy Sci & Technol, Kwangju, South Korea; [Tien, Ming] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; [Geib, Scott M.] USDA ARS, Trop Crop & Commod Protect Res Unit, Pacific Basin Agr Res Ctr, Hilo, HI USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Chonnam National University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; United States Department of Agriculture (USDA)	Scully, ED (corresponding author), Penn State Univ, Huck Inst Life Sci, Intercoll Program Genet, University Pk, PA 16802 USA.	scott.geib@ars.usda.gov		Geib, Scott/0000-0002-9511-5139	USDA-NRI-CRSEES [2008-35504-04464, 2009-35302-05286]; Alphawood Foundation, Chicago, Illinois; Pennsylvania State University College of Agricultural Sciences; World Class University from the Ministry of Education, Science and Technology of South Korea [R31-2009-000-20025-0]	USDA-NRI-CRSEES; Alphawood Foundation, Chicago, Illinois; Pennsylvania State University College of Agricultural Sciences; World Class University from the Ministry of Education, Science and Technology of South Korea	Funding for this project was provided by USDA-NRI-CRSEES grant 2008-35504-04464, USDA-NRI-CREES grant 2009-35302-05286, the Alphawood Foundation, Chicago, Illinois, a Seed Grant to Dr. Hoover from the Pennsylvania State University College of Agricultural Sciences. Dr. Carlson was partially supported by World Class University Project R31-2009-000-20025-0 grant from the Ministry of Education, Science and Technology of South Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas A, 2005, CURR GENET, V47, P49, DOI 10.1007/s00294-004-0550-4; ANDER P, 1976, ARCH MICROBIOL, V109, P1, DOI 10.1007/BF00425105; Bending GD, 1997, MYCOL RES, V101, P1348, DOI 10.1017/S0953756297004140; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bermek H, 1998, J BIOTECHNOL, V66, P117, DOI 10.1016/S0168-1656(98)00091-1; BERNFELD P, 1955, METHOD ENZYMOL, V1, P149, DOI 10.1016/0076-6879(55)01021-5; Bollag DM, 1996, PROTEIN METHODS, Vxvi; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bugg TDH, 2011, CURR OPIN BIOTECH, V22, P394, DOI 10.1016/j.copbio.2010.10.009; Calderon-Cortes N, 2010, INSECT MOL BIOL, V19, P323, DOI 10.1111/j.1365-2583.2010.00991.x; Camarero S, 1999, J BIOL CHEM, V274, P10324, DOI 10.1074/jbc.274.15.10324; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Chavez R, 2002, GENE, V293, P161, DOI 10.1016/S0378-1119(02)00720-5; Coleman JJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000618; Colombo JC, 1996, ENVIRON POLLUT, V94, P355, DOI 10.1016/S0269-7491(96)00044-9; Coy MR, 2010, INSECT BIOCHEM MOLEC, V40, P723, DOI 10.1016/j.ibmb.2010.07.004; CRAWFORD DL, 1980, ENZYME MICROB TECH, V2, P11, DOI 10.1016/0141-0229(80)90003-4; Davison A, 2005, MOL BIOL EVOL, V22, P1273, DOI 10.1093/molbev/msi107; DEJONG E, 1992, FEBS LETT, V299, P107, DOI 10.1016/0014-5793(92)80111-S; Dillon RJ, 2004, ANNU REV ENTOMOL, V49, P71, DOI 10.1146/annurev.ento.49.061802.123416; DOWD PF, 1992, J IND MICROBIOL, V9, P149, DOI 10.1007/BF01569619; Dunwell JM, 2004, PHYTOCHEMISTRY, V65, P7, DOI 10.1016/j.phytochem.2003.08.016; FALCON MA, 1995, SOIL BIOL BIOCHEM, V27, P121, DOI 10.1016/0038-0717(94)00174-Y; Ferris MJ, 1996, APPL ENVIRON MICROB, V62, P340, DOI 10.1128/AEM.62.2.340-346.1996; Geib SM, 2008, P NATL ACAD SCI USA, V105, P12932, DOI 10.1073/pnas.0805257105; Geib Scott M., 2012, Insects, V3, P141, DOI 10.3390/insects3010141; Geib SM, 2010, INSECT SCI, V17, P253, DOI 10.1111/j.1744-7917.2010.01323.x; Geib SM, 2009, ENVIRON ENTOMOL, V38, P686, DOI 10.1603/022.038.0320; Hammer K., 1997, Plant Genetic Resources Newsletter, P33; Hanks LM, 1999, ANNU REV ENTOMOL, V44, P483, DOI 10.1146/annurev.ento.44.1.483; Harazono K, 2003, BIOSCI BIOTECH BIOCH, V67, P889, DOI 10.1271/bbb.67.889; Hemingway RW, 1992, PLANT POLYPHENOLICS; HENRISSAT B, 1991, BIOCHEM J, V280, P309, DOI 10.1042/bj2800309; Her S, 1999, LETT APPL MICROBIOL, V29, P389, DOI 10.1046/j.1472-765X.1999.00651.x; HOLTZAPPLE M, 1990, BIOTECHNOL BIOENG, V36, P275, DOI 10.1002/bit.260360310; Hu JF, 2009, AGR FOREST ENTOMOL, V11, P359, DOI 10.1111/j.1461-9563.2009.00443.x; Kajikawa H, 2000, FEMS MICROBIOL LETT, V187, P15, DOI 10.1111/j.1574-6968.2000.tb09129.x; Kato K, 1998, BIOTECHNOL LETT, V20, P459, DOI 10.1023/A:1005432027603; Ke J, 2011, INT BIODETER BIODEGR, V65, P744, DOI 10.1016/j.ibiod.2010.12.016; KELLER B, 1989, P NATL ACAD SCI USA, V86, P1529, DOI 10.1073/pnas.86.5.1529; Kersten P, 2007, FUNGAL GENET BIOL, V44, P77, DOI 10.1016/j.fgb.2006.07.007; Kinter M, 2000, PROTEIN SEQUENCING I, Vxvi; KIRK TK, 1987, ANNU REV MICROBIOL, V41, P465, DOI 10.1146/annurev.mi.41.100187.002341; KUAN IC, 1993, P NATL ACAD SCI USA, V90, P1242, DOI 10.1073/pnas.90.4.1242; KUKOR JJ, 1988, PHYSIOL ZOOL, V61, P364, DOI 10.1086/physzool.61.4.30161254; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lingafelter S.W., 2002, REVISION ANOPLOPHORA; Lozovaya VV, 2006, PLANT DIS, V90, P77, DOI 10.1094/PD-90-0077; MAGNUSON TS, 1992, APPL ENVIRON MICROB, V58, P1070, DOI 10.1128/AEM.58.3.1070-1072.1992; Martinez D, 2004, NAT BIOTECHNOL, V22, P695, DOI 10.1038/nbt967; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Morales-Ramos JA, 2000, ANN ENTOMOL SOC AM, V93, P541, DOI 10.1603/0013-8746(2000)093[0541:SRBHHC]2.0.CO;2; Morozova OV, 2007, APPL BIOCHEM MICROB, V43, P12; Nowak DJ, 2001, J ECON ENTOMOL, V94, P116, DOI 10.1603/0022-0493-94.1.116; Ohta Y, 2001, MICROBIOL-SGM, V147, P31, DOI 10.1099/00221287-147-1-31; OSullivan AC, 1997, CELLULOSE, V4, P173, DOI 10.1023/A:1018431705579; PASTI MB, 1990, APPL ENVIRON MICROB, V56, P2213, DOI 10.1128/AEM.56.7.2213-2218.1990; Pauchet Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015635; Pauchet Y, 2009, INSECT BIOCHEM MOLEC, V39, P403, DOI 10.1016/j.ibmb.2009.04.001; Pazzagli L, 1999, J BIOL CHEM, V274, P24959, DOI 10.1074/jbc.274.35.24959; PETTERSEN RC, 1984, ADV CHEM SER, P57; Pinto PC, 2005, CARBOHYD POLYM, V60, P489, DOI 10.1016/j.carbpol.2005.03.001; Regalado V, 1999, APPL MICROBIOL BIOT, V51, P388, DOI 10.1007/s002530051407; REHMAN AU, 1992, J GEN MICROBIOL, V138, P1251, DOI 10.1099/00221287-138-6-1251; Rodriguez A, 1996, FEMS MICROBIOL ECOL, V21, P213, DOI 10.1016/S0168-6496(96)00057-8; Romero MC, 2002, ENVIRON POLLUT, V117, P159, DOI 10.1016/S0269-7491(01)00143-9; Sato S, 2007, MICROBIOL-SGM, V153, P3023, DOI 10.1099/mic.0.2006/000513-0; Sato S, 2009, CURR GENET, V55, P273, DOI 10.1007/s00294-009-0243-0; Scharf ME, 2008, BIOFUEL BIOPROD BIOR, V2, P540, DOI 10.1002/bbb.107; SCHWARZ WH, 1987, ANAL BIOCHEM, V164, P72, DOI 10.1016/0003-2697(87)90369-1; Shary S, 2007, APPL ENVIRON MICROB, V73, P6691, DOI 10.1128/AEM.01361-07; Soundararajan S, 2004, PLANT CELL, V16, P1564, DOI 10.1105/tpc.020677; Strope PK, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-80; Sun JZ, 2010, INSECT SCI, V17, P163, DOI 10.1111/j.1744-7917.2010.01348.x; SUTHERLAND JB, 1983, CAN J BOT, V61, P1194, DOI 10.1139/b83-126; TEETORBARSCH GH, 1983, MYCOPATHOLOGIA, V84, P3, DOI 10.1007/BF00436991; TIEN M, 1984, P NATL ACAD SCI-BIOL, V81, P2280, DOI 10.1073/pnas.81.8.2280; Ubiyvovk VM, 2006, CELL BIOL INT, V30, P665, DOI 10.1016/j.cellbi.2006.04.006; Varela E, 2003, ARCH MICROBIOL, V180, P251, DOI 10.1007/s00203-003-0583-y; Veignie E, 2004, ENVIRON POLLUT, V129, P1, DOI 10.1016/j.envpol.2003.11.007; Watanabe H, 2009, ANNU REV ENTOMOL, V55, P23; Willis JD, 2010, INSECT SCI, V17, P184, DOI 10.1111/j.1744-7917.2010.01322.x; Worrall JJ, 1997, MYCOLOGIA, V89, P199, DOI 10.2307/3761073; YOUN HD, 1995, FEMS MICROBIOL LETT, V132, P183, DOI 10.1111/j.1574-6968.1995.tb07831.x; ZAREMAIVAN H, 1988, MYCOLOGIA, V80, P365, DOI 10.2307/3807634; Zhang DH, 2011, INSECT BIOCHEM MOLEC, V41, P211, DOI 10.1016/j.ibmb.2010.12.006	86	31	31	0	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2012	7	4							e32990	10.1371/journal.pone.0032990	http://dx.doi.org/10.1371/journal.pone.0032990			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JO	22496740	Green Published, gold, Green Submitted			2022-12-27	WOS:000305014500008
J	Thangapandian, S; John, S; Arooj, M; Lee, KW				Thangapandian, Sundarapandian; John, Shalini; Arooj, Mahreen; Lee, Keun Woo			Molecular Dynamics Simulation Study and Hybrid Pharmacophore Model Development in Human LTA4H Inhibitor Design	PLOS ONE			English	Article							LEUKOTRIENE A(4) HYDROLASE; POTENT INHIBITORS; DISCOVERY; IDENTIFICATION; DOCKING; ENZYME; ATHEROSCLEROSIS; MECHANISMS	Human leukotriene A4 hydrolase (hLTA4H) is a bi-functional enzyme catalyzes the hydrolase and aminopeptidase functions upon the fatty acid and peptide substrates, respectively, utilizing the same but overlapping binding site. Particularly the hydrolase function of this enzyme catalyzes the rate-limiting step of the leukotriene (LT) cascade that converts the LTA4 to LTB4. This product is a potent pro-inflammatory activator of inflammatory responses and thus blocking this conversion provides a valuable means to design anti-inflammatory agents. Four structurally very similar chemical compounds with highly different inhibitory profile towards the hydrolase function of hLTA4H were selected from the literature. Molecular dynamics (MD) simulations of the complexes of hLTA4H with these inhibitors were performed and the results have provided valuable information explaining the reasons for the differences in their biological activities. Binding mode analysis revealed that the additional thiophene moiety of most active inhibitor helps the pyrrolidine moiety to interact the most important R563 and K565 residues. The hLTA4H complexes with the most active compound and substrate were utilized in the development of hybrid pharmacophore models. These developed pharmacophore models were used in screening chemical databases in order to identify lead candidates to design potent hLTA4H inhibitors. Final evaluation based on molecular docking and electronic parameters has identified three compounds of diverse chemical scaffolds as potential leads to be used in novel and potent hLTA4H inhibitor design.	[Thangapandian, Sundarapandian; John, Shalini; Arooj, Mahreen; Lee, Keun Woo] Gyeongsang Natl Univ, Res Inst Nat Sci, Div Appl Life Sci, SSAC,PMBBRC,Program BK21, Jinju, South Korea	Gyeongsang National University	Thangapandian, S (corresponding author), Gyeongsang Natl Univ, Res Inst Nat Sci, Div Appl Life Sci, SSAC,PMBBRC,Program BK21, Jinju, South Korea.	kwlee@gnu.ac.kr	Arooj, Mahreen/AAC-7565-2020	Arooj, Mahreen/0000-0003-1975-5289	National Research Foundation of Korea (NRF) [2009-0073267, 2009-0081539, 2010-0029084]; Ministry of Education, Science and Technology (MEST) of Republic of Korea; Rural Development Administration (RDA) of Republic of Korea [PJ008038]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology (MEST) of Republic of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea); Rural Development Administration (RDA) of Republic of Korea(Rural Development Administration (RDA), Republic of Korea)	This work was supported by the Basic Science Research Program (2009-0073267), Pioneer Research Center Program (2009-0081539), and Management of Climate Change Program (2010-0029084) through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (MEST) of Republic of Korea. This work was also supported by the Next-Generation BioGreen 21 Program (PJ008038) from Rural Development Administration (RDA) of Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Back M, 2005, P NATL ACAD SCI USA, V102, P17501, DOI 10.1073/pnas.0505845102; Barnes PJ, 2002, NAT REV DRUG DISCOV, V1, P437, DOI 10.1038/nrd820; Cheng F, 2008, PROTEINS, V70, P1228, DOI 10.1002/prot.21615; Davies DR, 2009, J MED CHEM, V52, P4694, DOI 10.1021/jm900259h; Delley B, 2000, COMP MATER SCI, V17, P122, DOI 10.1016/S0927-0256(00)00008-2; Drazen JM, 1999, NEW ENGL J MED, V340, P197, DOI 10.1056/NEJM199901213400306; Drazen JM, 1997, PHARMACOTHERAPY, V17, pS22; Enomoto H, 2009, BIOORG MED CHEM LETT, V19, P442, DOI 10.1016/j.bmcl.2008.11.042; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; Gompertz S, 2002, CHEST, V122, P289, DOI 10.1378/chest.122.1.289; Grice CA, 2008, J MED CHEM, V51, P4150, DOI 10.1021/jm701575k; GRIFFITHS RJ, 1995, P NATL ACAD SCI USA, V92, P517, DOI 10.1073/pnas.92.2.517; Haeggstrom JZ, 2004, J BIOL CHEM, V279, P50639, DOI 10.1074/jbc.R400027200; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; HOGG JH, 1995, BIOORGAN MED CHEM, V3, P1405, DOI 10.1016/0968-0896(95)00128-4; HOLMES MA, 1982, J MOL BIOL, V160, P623, DOI 10.1016/0022-2836(82)90319-9; Huey R, 2007, J COMPUT CHEM, V28, P1145, DOI 10.1002/jcc.20634; Iversen L, 1997, SKIN PHARMACOL, V10, P169, DOI 10.1159/000211501; Jiang XL, 2008, BIOORG MED CHEM LETT, V18, P6549, DOI 10.1016/j.bmcl.2008.10.044; Kirkland TA, 2008, BIOORGAN MED CHEM, V16, P4963, DOI 10.1016/j.bmc.2008.03.042; Langer T, 2004, Drug Discov Today Technol, V1, P203, DOI 10.1016/j.ddtec.2004.11.015; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Meng CQ, 2006, CURR TOP MED CHEM, V6, P93, DOI 10.2174/156802606775270260; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Penning TD, 2001, CURR PHARM DESIGN, V7, P163, DOI 10.2174/1381612013398248; Peters-Golden M, 2007, NEW ENGL J MED, V357, P1841, DOI 10.1056/NEJMra071371; Rinaldo-Matthis A, 2010, BIOCHIMIE, V92, P676, DOI 10.1016/j.biochi.2010.01.010; Rudberg PC, 2004, J BIOL CHEM, V279, P27376, DOI 10.1074/jbc.M401031200; Rudberg PC, 2002, J BIOL CHEM, V277, P1398, DOI 10.1074/jbc.M106577200; Sandanayaka V, 2010, BIOORG MED CHEM LETT, V20, P2851, DOI 10.1016/j.bmcl.2010.03.047; Sandanayaka V, 2010, J MED CHEM, V53, P573, DOI 10.1021/jm900838g; SHARON P, 1984, GASTROENTEROLOGY, V86, P453; Thangapandian S, 2011, EUR J MED CHEM, V46, P1593, DOI 10.1016/j.ejmech.2011.02.007; Thangapandian S, 2011, J CHEM INF MODEL, V51, P33, DOI 10.1021/ci1002813; Tholander F, 2005, J BIOL CHEM, V280, P33477, DOI 10.1074/jbc.M506821200; Thomsen R, 2006, J MED CHEM, V49, P3315, DOI 10.1021/jm051197e; Thunnissen MMGM, 2002, FASEB J, V16, P1648, DOI 10.1096/fj.01-1017fje; Thunnissen MMGM, 2001, NAT STRUCT BIOL, V8, P131, DOI 10.1038/84117; Tsuji F, 1998, LIFE SCI, V64, pPL51, DOI 10.1016/S0024-3205(98)00556-6; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Wagner AB, 2006, J CHEM INF MODEL, V46, P767, DOI 10.1021/ci050481b; Wang YL, 2010, NUCLEIC ACIDS RES, V38, pD255, DOI 10.1093/nar/gkp965; Wei DG, 2008, J MED CHEM, V51, P7882, DOI 10.1021/jm8010096	43	13	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2012	7	4							e34593	10.1371/journal.pone.0034593	http://dx.doi.org/10.1371/journal.pone.0034593			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955IH	22496831	Green Published, Green Submitted, gold			2022-12-27	WOS:000305010500019
J	Tobler, U; Borgula, A; Schmidt, BR				Tobler, Ursina; Borgula, Adrian; Schmidt, Benedikt R.			Populations of a Susceptible Amphibian Species Can Grow despite the Presence of a Pathogenic Chytrid Fungus	PLOS ONE			English	Article							EMERGING INFECTIOUS-DISEASE; BATRACHOCHYTRIUM-DENDROBATIDIS; CHYTRIDIOMYCOSIS; FROGS; DYNAMICS; SURVIVAL; EXTINCTION; VIRULENCE; DECLINE; HOST	Disease can be an important driver of host population dynamics and epizootics can cause severe host population declines. Batrachochytrium dendrobatidis (Bd), the pathogen causing amphibian chytridiomycosis, may occur epizootically or enzootically and can harm amphibian populations in many ways. While effects of Bd epizootics are well documented, the effects of enzootic Bd have rarely been described. We used a state-space model that accounts for observation error to test whether population trends of a species highly susceptible to Bd, the midwife toad Alytes obstetricans, are negatively affected by the enzootic presence of the pathogen. Unexpectedly, Bd had no negative effect on population growth rates from 2002-2008. This suggests that negative effects of disease on individuals do not necessarily translate into negative effects at the population level. Populations of amphibian species that are susceptible to the emerging disease chytridiomycosis can persist despite the enzootic presence of the pathogen under current environmental conditions.	[Tobler, Ursina; Schmidt, Benedikt R.] Univ Zurich, Inst Evolutionary Biol & Environm Studies, Zurich, Switzerland; [Borgula, Adrian] Bur Nat Schutzbiol, Luzern, Switzerland; [Schmidt, Benedikt R.] KARCH, Neuchatel, Switzerland	University of Zurich	Tobler, U (corresponding author), Univ Zurich, Inst Evolutionary Biol & Environm Studies, Zurich, Switzerland.	benedikt.schmidt@ieu.uzh.ch	Schmidt, Benedikt R./B-8491-2008	Schmidt, Benedikt R./0000-0002-4023-1001	Zoological Institute; Forschungskredit of the University of Zurich; Vontobel Stiftung; Janggen-Pohn Stiftung; Basler Stiftung fur biologische Forschung; Stiftung Dr. Joachim De Giacomi; Zoo Zurich; Grun Stadt Zurich; European Union of Aquarium Curators; Zurcher Tierschutz	Zoological Institute; Forschungskredit of the University of Zurich; Vontobel Stiftung; Janggen-Pohn Stiftung; Basler Stiftung fur biologische Forschung; Stiftung Dr. Joachim De Giacomi; Zoo Zurich; Grun Stadt Zurich; European Union of Aquarium Curators(European Commission); Zurcher Tierschutz	Funding was provided by the Zoological Institute and the Forschungskredit of the University of Zurich, Vontobel Stiftung, Janggen-Pohn Stiftung, Basler Stiftung fur biologische Forschung, Stiftung Dr. Joachim De Giacomi, Zoo Zurich, Grun Stadt Zurich, European Union of Aquarium Curators, and Zurcher Tierschutz. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altwegg R, 2003, OECOLOGIA, V136, P46, DOI 10.1007/s00442-003-1248-x; Amt fur Natur- und Landschaftsschutz, 2000, ART GEB 2000 2009; ANDERSON RM, 1979, NATURE, V280, P361, DOI 10.1038/280361a0; Bart J, 2004, WILDLIFE SOC B, V32, P1242, DOI 10.2193/0091-7648(2004)032[1242:DEIWS]2.0.CO;2; Berven KA, 2009, COPEIA, P328, DOI 10.1643/CH-08-052; Borgula A, 2010, ARTENHILFSPROGRAMM G; Borgula Adrian, 2003, Zeitschrift fuer Feldherpetologie, V10, P11; Bosch J, 2001, BIOL CONSERV, V97, P331, DOI 10.1016/S0006-3207(00)00132-4; Bosch J, 2007, P ROY SOC B-BIOL SCI, V274, P253, DOI 10.1098/rspb.2006.3713; Boyle DG, 2004, DIS AQUAT ORGAN, V60, P141, DOI 10.3354/dao060141; Briggs CJ, 2010, P NATL ACAD SCI USA, V107, P9695, DOI 10.1073/pnas.0912886107; Briggs CJ, 2005, ECOLOGY, V86, P3149, DOI 10.1890/04-1428; BURNHAM KP, 1984, ECOLOGY, V65, P105; Conroy SDS, 2003, POPUL ECOL, V45, P105, DOI 10.1007/s10144-003-0145-9; de Castro F, 2005, ECOL LETT, V8, P117, DOI 10.1111/j.1461-0248.2004.00693.x; De Valpine P, 2002, ECOL MONOGR, V72, P57, DOI 10.1890/0012-9615(2002)072[0057:FPMIPN]2.0.CO;2; Deem Sharon L., 2008, P304; Di Minin E, 2011, ECOGRAPHY, V34, P162, DOI 10.1111/j.1600-0587.2010.06263.x; DIGIACOMO RF, 1986, J AM VET MED ASSOC, V189, P22; Ebert D, 1996, TRENDS ECOL EVOL, V11, pA79; EBERT D, 1994, SCIENCE, V265, P1084, DOI 10.1126/science.265.5175.1084; Fisher MC, 2009, ANNU REV MICROBIOL, V63, P291, DOI 10.1146/annurev.micro.091208.073435; Garner TWJ, 2005, EMERG INFECT DIS, V11, P1639; Gelman A., 2007, DATA ANAL USING REGR; Grafe TU, 2004, OECOLOGIA, V141, P40, DOI 10.1007/s00442-004-1639-7; Hels T, 2002, ECOGRAPHY, V25, P730, DOI 10.1034/j.1600-0587.2002.250609.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Ibelings BW, 2004, J PHYCOL, V40, P437, DOI 10.1111/j.1529-8817.2004.03117.x; Jolles AE, 2006, AM NAT, V167, P745, DOI 10.1086/503055; Jolles AE, 2005, ECOLOGY, V86, P2358, DOI 10.1890/05-0038; Kery M, 2012, BAYESIAN POPULATION ANALYSIS USING WINBUGS: A HIERARCHICAL PERSPECTIVE, P1; Kery M, 2008, COMMUNITY ECOL, V9, P207, DOI 10.1556/ComEc.9.2008.2.10; Lampo M, 1998, ECOL APPL, V8, P388, DOI 10.2307/2641079; Laurance WF, 1996, CONSERV BIOL, V10, P406, DOI 10.1046/j.1523-1739.1996.10020406.x; Lebreton JD, 2005, AUST NZ J STAT, V47, P49, DOI 10.1111/j.1467-842X.2005.00371.x; Lips KR, 2006, P NATL ACAD SCI USA, V103, P3165, DOI 10.1073/pnas.0506889103; Longo AV, 2010, ECOHEALTH, V7, P185, DOI 10.1007/s10393-010-0327-9; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; Muths E, 2011, J APPL ECOL, V48, P873, DOI 10.1111/j.1365-2664.2011.02005.x; Patrick DA, 2008, ECOLOGY, V89, P2563, DOI 10.1890/07-0906.1; Peyer NF, 2010, THESIS U ZURICH ZURI; Pilliod DS, 2010, CONSERV BIOL, V24, P1259, DOI 10.1111/j.1523-1739.2010.01506.x; Puschendorf R, 2011, CONSERV BIOL, V25, P956, DOI 10.1111/j.1523-1739.2011.01728.x; R Core Team, 2018, R LANG ENV STAT COMP; Read Andrew F., 1994, Trends in Microbiology, V2, P73, DOI 10.1016/0966-842X(94)90537-1; Retallick RWR, 2004, PLOS BIOL, V2, P1965, DOI 10.1371/journal.pbio.0020351; Schmidt B.R., 2005, ROTE LISTE GEFAHRDET; SCHMIDT B. R., 2009, METHODEN FELDHERPETO, P229; Schmidt BR, 2009, AMPHIBIA-REPTILIA, V30, P313, DOI 10.1163/156853809788795245; SCHMIDT BR, 1993, TRENDS ECOL EVOL, V8, P271, DOI 10.1016/0169-5347(93)90252-K; Schmidt BR, 2005, AQUAT CONSERV, V15, P681, DOI 10.1002/aqc.740; Schmidt BR, 2004, HERPETOL J, V14, P167; Skelly D.C., 2009, AMPHIBIAN ECOLOGY CO, P55; Skerratt LF, 2007, ECOHEALTH, V4, P125, DOI 10.1007/s10393-007-0093-5; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Teacher AGF, 2010, ANIM CONSERV, V13, P514, DOI 10.1111/j.1469-1795.2010.00373.x; Tobler U, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010927; Tompkins D.M., 2001, ECOLOGY WILDLIFE DIS, P45; Tompkins DM, 1999, PARASITOL TODAY, V15, P311, DOI 10.1016/S0169-4758(99)01484-2; Vences Miguel, 2007, Zeitschrift fuer Feldherpetologie, V14, P153; Vredenburg VT, 2010, P NATL ACAD SCI USA, V107, P9689, DOI 10.1073/pnas.0914111107; Walker SF, 2010, ECOL LETT, V13, P372, DOI 10.1111/j.1461-0248.2009.01434.x; Woodhams DC, 2011, FRONT ZOOL, V8, DOI 10.1186/1742-9994-8-8	63	53	55	2	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2012	7	4							e34667	10.1371/journal.pone.0034667	http://dx.doi.org/10.1371/journal.pone.0034667			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955IH	22496836	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000305010500021
J	Moro, M; Crosti, M; Creo, P; Gallina, P; Curti, S; Sugliano, E; Scavelli, R; Cattaneo, D; Canidio, E; Marconi, M; Rebulla, P; Sarmientos, P; Viale, G; Pagani, M; Abrignani, S				Moro, Monica; Crosti, Mariacristina; Creo, Pasquale; Gallina, Pierangela; Curti, Serena; Sugliano, Elisa; Scavelli, Rossana; Cattaneo, Davide; Canidio, Elena; Marconi, Maurizio; Rebulla, Paolo; Sarmientos, Paolo; Viale, Giuseppe; Pagani, Massimiliano; Abrignani, Sergio			Identification of New Hematopoietic Cell Subsets with a Polyclonal Antibody Library Specific for Neglected Proteins	PLOS ONE			English	Article							GENE-EXPRESSION PROFILE; CD4(+)CD25(+) T-CELLS; B-CELLS; REGULATORY PROPERTIES; CD133(+) CELLS; BLOOD; EFFECTOR; MEMORY; DIFFERENTIATION; TRANSPLANTATION	The identification of new markers, the expression of which defines new phenotipically and functionally distinct cell subsets, is a main objective in cell biology. We have addressed the issue of identifying new cell specific markers with a reverse proteomic approach whereby approximately 1700 human open reading frames encoding proteins predicted to be transmembrane or secreted have been selected in silico for being poorly known, cloned and expressed in bacteria. These proteins have been purified and used to immunize mice with the aim of obtaining polyclonal antisera mostly specific for linear epitopes. Such a library, made of about 1600 different polyclonal antisera, has been obtained and screened by flow cytometry on cord blood derived CD34+CD45dim cells and on peripheral blood derived mature lymphocytes (PBLs). We identified three new proteins expressed by fractions of CD34+CD45dim cells and eight new proteins expressed by fractions of PBLs. Remarkably, we identified proteins the presence of which had not been demonstrated previously by transcriptomic analysis. From the functional point of view, looking at new proteins expressed on CD34+CD45dim cells, we identified one cell surface protein (MOSC-1) the expression of which on a minority of CD34+ progenitors marks those CD34+CD45dim cells that will go toward monocyte/granulocyte differentiation. In conclusion, we show a new way of looking at the membranome by assessing expression of generally neglected proteins with a library of polyclonal antisera, and in so doing we have identified new potential subsets of hematopoietic progenitors and of mature PBLs.	[Moro, Monica; Crosti, Mariacristina; Creo, Pasquale; Gallina, Pierangela; Curti, Serena; Sugliano, Elisa; Scavelli, Rossana; Abrignani, Sergio] Fdn Ist Nazl Genet Mol, INGM, Milan, Italy; [Cattaneo, Davide; Canidio, Elena; Sarmientos, Paolo; Pagani, Massimiliano; Abrignani, Sergio] PRIMM, Milan, Italy; [Marconi, Maurizio; Rebulla, Paolo; Pagani, Massimiliano; Abrignani, Sergio] IRCCS Ca Granda Osped Maggiore Policlin, Milan, Italy; [Viale, Giuseppe; Pagani, Massimiliano] IEO, Milan, Italy	IRCCS Ca Granda Ospedale Maggiore Policlinico; IRCCS European Institute of Oncology (IEO)	Moro, M (corresponding author), Fdn Ist Nazl Genet Mol, INGM, Milan, Italy.	pagani@primm.it	Creo, Pasquale/AAA-7572-2021; Viale, Giuseppe/AAE-8921-2019; Rebulla, Paolo/I-7684-2015	Creo, Pasquale/0000-0003-1545-3427; Rebulla, Paolo/0000-0002-3875-5754; Pagani, Massimiliano/0000-0002-7017-9304; Abrignani, Sergio/0000-0002-0794-3285	Italian Ministry of Health; CARIPLO Foundation [2007-5441]	Italian Ministry of Health(Ministry of Health, Italy); CARIPLO Foundation(Fondazione Cariplo)	This work was supported by the Italian Ministry of Health and partially by CARIPLO Foundation, grant no. 2007-5441. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anantharaman V, 2002, FEMS MICROBIOL LETT, V207, P55, DOI 10.1016/S0378-1097(01)00515-8; Annunziato F, 2007, J EXP MED, V204, P1849, DOI 10.1084/jem.20070663; Annunziato F, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2843; BACH FH, 1968, LANCET, V2, P1364; Bick D, 2011, CURR OPIN PEDIATR, V23, P594, DOI 10.1097/MOP.0b013e32834b20ec; Bluestone JA, 2009, NAT REV IMMUNOL, V9, P811, DOI 10.1038/nri2654; Chan WL, 2003, IMMUNOL LETT, V85, P159, DOI 10.1016/S0165-2478(02)00223-7; de Bruin AM, 2011, BLOOD; Dieckmann D, 2001, J EXP MED, V193, P1303, DOI 10.1084/jem.193.11.1303; Dorner T, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2780; Dogan I, 2009, NAT IMMUNOL, V10, P1292, DOI 10.1038/ni.1814; Eyerich S, 2009, J CLIN INVEST, V119, P3573, DOI 10.1172/JCI40202; Fischer D, 2006, CURR OPIN STRUC BIOL, V16, P178, DOI 10.1016/j.sbi.2006.03.004; Foster LJ, 2005, STEM CELLS, V23, P1367, DOI 10.1634/stemcells.2004-0372; Gluckman E, 2005, CYTOTHERAPY, V7, P219, DOI 10.1080/14653240510027136; Gonzaga-Jauregui C, 2012, ANNU REV MED, V63, P35, DOI 10.1146/annurev-med-051010-162644; Gratwohl A, 2002, BLOOD, V100, P2374, DOI 10.1182/blood-2002-03-0675; Grifantini R, 2011, J PROTEOMICS; Gross O, 2011, IMMUNOL REV, V243, P136, DOI 10.1111/j.1600-065X.2011.01046.x; Haberkorn U, 2002, EUR J NUCL MED, V29, P115, DOI 10.1007/s00259-001-0682-4; Harari A, 2006, IMMUNOL REV, V211, P236, DOI 10.1111/j.0105-2896.2006.00395.x; Hemmoranta H, 2006, STEM CELLS DEV, V15, P839, DOI 10.1089/scd.2006.15.839; Hinz U, 2010, CELL MOL LIFE SCI, V67, P1049, DOI 10.1007/s00018-009-0229-6; Hocquette J F, 2005, J Physiol Pharmacol, V56 Suppl 3, P37; Jaatinen T, 2006, STEM CELLS, V24, P631, DOI 10.1634/stemcells.2005-0185; Jonuleit H, 2001, J EXP MED, V193, P1285, DOI 10.1084/jem.193.11.1285; Kallies A, 2008, IMMUNOL CELL BIOL, V86, P325, DOI 10.1038/icb.2008.16; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; LANZAVECCHIA A, 1977, B I SIEROTER MILAN, V56, P217; Lemoine S, 2009, ANN NY ACAD SCI, V1173, P260, DOI 10.1111/j.1749-6632.2009.04651.x; Liu F, 2006, PROTEOMICS, V6, P2673, DOI 10.1002/pmic.200500032; Loyet KM, 2005, J PROTEOME RES, V4, P400, DOI 10.1021/pr049810q; Lyman GH, 2006, CLIN BREAST CANCER, V7, P372, DOI 10.3816/CBC.2006.n.053; Madras N, 2002, STEM CELLS, V20, P230, DOI 10.1634/stemcells.20-3-230; Nierhoff D, 2007, HEPATOLOGY; Oh JMC, 2001, PROTEOMICS, V1, P1303, DOI 10.1002/1615-9861(200110)1:10<1303::AID-PROT1303>3.0.CO;2-2; Sanz I, 2008, SEMIN IMMUNOL, V20, P67, DOI 10.1016/j.smim.2007.12.006; Turtle CJ, 2009, IMMUNITY, V31, P834, DOI 10.1016/j.immuni.2009.09.015; Weaver CT, 2009, NAT REV IMMUNOL, V9, P883, DOI 10.1038/nri2660; Xu Cunshuan, 2004, Genomics Proteomics & Bioinformatics, V2, P109; Zhao JH, 2011, CURR PHARM BIOTECHNO, V12, P293, DOI 10.2174/138920111794295729	41	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e34395	10.1371/journal.pone.0034395	http://dx.doi.org/10.1371/journal.pone.0034395			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GO	22496798	Green Submitted, Green Published, gold			2022-12-27	WOS:000304855200045
J	Zhang, QG; Laird, MD; Han, D; Nguyen, K; Scott, E; Dong, Y; Dhandapani, KM; Brann, DW				Zhang, Quan-Guang; Laird, Melissa D.; Han, Dong; Khoi Nguyen; Scott, Erin; Dong, Yan; Dhandapani, Krishnan M.; Brann, Darrell W.			Critical Role of NADPH Oxidase in Neuronal Oxidative Damage and Microglia Activation following Traumatic Brain Injury	PLOS ONE			English	Article							CONTROLLED CORTICAL IMPACT; AMYLOID PRECURSOR PROTEIN; CENTRAL-NERVOUS-SYSTEM; SUPEROXIDE-PRODUCTION; SYNAPTIC PROTEINS; ISCHEMIA; OXYGEN; EDEMA; NEUROPROTECTION; ATTENUATION	Background: Oxidative stress is known to play an important role in the pathology of traumatic brain injury. Mitochondria are thought to be the major source of the damaging reactive oxygen species (ROS) following TBI. However, recent work has revealed that the membrane, via the enzyme NADPH oxidase can also generate the superoxide radical (O-2(-)), and thereby potentially contribute to the oxidative stress following TBI. The current study thus addressed the potential role of NADPH oxidase in TBI. Methodology/Principal Findings:The results revealed that NADPH oxidase activity in the cerebral cortex and hippocampal CA1 region increases rapidly following controlled cortical impact in male mice, with an early peak at 1 h, followed by a secondary peak from 24-96 h after TBI. In situ localization using oxidized hydroethidine and the neuronal marker, NeuN, revealed that the O-2(-) induction occurred in neurons at 1 h after TBI. Pre- or post-treatment with the NADPH oxidase inhibitor, apocynin markedly inhibited microglial activation and oxidative stress damage. Apocynin also attenuated TBI-induction of the Alzheimer's disease proteins beta-amyloid and amyloid precursor protein. Finally, both pre- and post-treatment of apocynin was also shown to induce significant neuroprotection against TBI. In addition, a NOX2-specific inhibitor, gp91ds-tat was also shown to exert neuroprotection against TBI. Conclusions/Significance: As a whole, the study demonstrates that NADPH oxidase activity and superoxide production exhibit a biphasic elevation in the hippocampus and cortex following TBI, which contributes significantly to the pathology of TBI via mediation of oxidative stress damage, microglial activation, and AD protein induction in the brain following TBI.	[Zhang, Quan-Guang; Han, Dong; Khoi Nguyen; Scott, Erin; Dong, Yan; Brann, Darrell W.] Georgia Hlth Sci Univ, Dept Neurol, Inst Mol Med & Genet, Augusta, GA USA; [Laird, Melissa D.; Dhandapani, Krishnan M.] Georgia Hlth Sci Univ, Dept Neurosurg, Augusta, GA USA	University System of Georgia; Augusta University; University System of Georgia; Augusta University	Zhang, QG (corresponding author), Georgia Hlth Sci Univ, Dept Neurol, Inst Mol Med & Genet, Augusta, GA USA.	dbrann@georgiahealth.edu		Dhandapani, Krishnan/0000-0001-7044-1117				Afanas'ev IB, 2007, MOL BIOTECHNOL, V37, P2, DOI 10.1007/s12033-007-0056-7; Ansari MA, 2008, FREE RADICAL BIO MED, V45, P443, DOI 10.1016/j.freeradbiomed.2008.04.038; Ansari MA, 2008, J NEUROTRAUM, V25, P513, DOI 10.1089/neu.2007.0451; Beauchamp K, 2008, MOL MED, V14, P731, DOI 10.2119/2008-00050.Beauchamp; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Bergamini CM, 2004, CURR PHARM DESIGN, V10, P1611, DOI 10.2174/1381612043384664; Bindokas VP, 1996, J NEUROSCI, V16, P1324; Block ML, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-S2-S8; Bramlett HM, 1997, J NEUROPATH EXP NEUR, V56, P1132, DOI 10.1097/00005072-199710000-00007; Chen H, 2009, J CEREB BLOOD FLOW M; Chen H, 2009, J CEREBR BLOOD F MET, V29, P1262, DOI 10.1038/jcbfm.2009.47; Dohi K, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-41; Gaetz M, 2004, CLIN NEUROPHYSIOL, V115, P4, DOI 10.1016/S1388-2457(03)00258-X; Gilgun-Sherki Y, 2002, PHARMACOL REV, V54, P271, DOI 10.1124/pr.54.2.271; Harting MT, 2008, SURGERY, V144, P803, DOI 10.1016/j.surg.2008.05.017; Itoh T, 2009, NEUROL RES, V31, P103, DOI 10.1179/016164108X323771; Jackman KA, 2009, BRIT J PHARMACOL, V156, P680, DOI 10.1111/j.1476-5381.2008.00073.x; Jellinger KA, 2004, CURR OPIN NEUROL, V17, P719, DOI 10.1097/00019052-200412000-00012; Kelley BJ, 2007, J NEUROPATH EXP NEUR, V66, P989, DOI 10.1097/NEN.0b013e3181588245; Kiening KL, 2002, NEUROSCI LETT, V324, P105, DOI 10.1016/S0304-3940(02)00180-5; King MD, 2011, J NEUROSURG, V115, P116, DOI 10.3171/2011.2.JNS10784; Laird MD, 2010, J NEUROCHEM, V113, P637, DOI 10.1111/j.1471-4159.2010.06630.x; Lambert AJ, 2009, METHODS MOL BIOL, V554, P165, DOI 10.1007/978-1-59745-521-3_11; Lotocki G, 2009, J NEUROTRAUM, V26, P1123, DOI 10.1089/neu.2008.0802; MOUTON PR, 1994, J CHEM NEUROANAT, V7, P185, DOI 10.1016/0891-0618(94)90028-0; Murotomi K, 2011, MOL CELL NEUROSCI, V46, P681, DOI 10.1016/j.mcn.2011.01.009; Pun PBL, 2009, FREE RADICAL RES, V43, P348, DOI 10.1080/10715760902751902; Qin LY, 2002, J NEUROCHEM, V83, P973, DOI 10.1046/j.1471-4159.2002.01210.x; Raz L, 2010, PLAS ONE; Rey FE, 2001, CIRC RES, V89, P408, DOI 10.1161/hh1701.096037; Serrano F, 2003, BRAIN RES, V988, P193, DOI 10.1016/S0006-8993(03)03364-X; Sorce S, 2009, ANTIOXID REDOX SIGN, V11, P2481, DOI [10.1089/ars.2009.2578, 10.1089/ARS.2009.2578]; Tang LL, 2007, J INT MED RES, V35, P517, DOI 10.1177/147323000703500411; Toklu HZ, 2009, FREE RADICAL RES, V43, P658, DOI 10.1080/10715760902988843; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Van Den Heuvel C, 2007, PROG BRAIN RES, V161, P303, DOI 10.1016/S0079-6123(06)61021-2; Venkatesan C, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-32; Wada K, 1999, NEUROSURGERY, V45, P601, DOI 10.1097/00006123-199909000-00031; Wakade C, 2010, J NEUROSURG; Wakade C, 2008, ENDOCRINOLOGY, V149, P367, DOI 10.1210/en.2007-0899; Wang R, 2009, J NEUROSCIE IN PRESS; Zhang QG, 2008, J NEUROSCI, V28, P8430, DOI 10.1523/JNEUROSCI.2752-08.2008; Zhang QG, 2009, J NEUROSCI, V29, P13823, DOI 10.1523/JNEUROSCI.3574-09.2009; Zweckberger K, 2006, J NEUROTRAUM, V23, P1083, DOI 10.1089/neu.2006.23.1083	44	157	159	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2012	7	4							e34504	10.1371/journal.pone.0034504	http://dx.doi.org/10.1371/journal.pone.0034504			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952GU	22485176	Green Published, Green Submitted, gold			2022-12-27	WOS:000304780500051
J	Gerbitz, A; Sukumar, M; Helm, F; Wilke, A; Friese, C; Fahrenwaldt, C; Lehmann, FM; Loddenkemper, C; Kammertoens, T; Mautner, J; Schmitt, CA; Blankenstein, T; Bornkamm, GW				Gerbitz, Armin; Sukumar, Madhusudhanan; Helm, Florian; Wilke, Andrea; Friese, Christian; Fahrenwaldt, Cornelia; Lehmann, Frank M.; Loddenkemper, Christoph; Kammertoens, Thomas; Mautner, Josef; Schmitt, Clemens A.; Blankenstein, Thomas; Bornkamm, Georg W.			Stromal Interferon-gamma Signaling and Cross-Presentation Are Required to Eliminate Antigen-Loss Variants of B Cell Lymphomas in Mice	PLOS ONE			English	Article							THYMIC EPITHELIAL-CELLS; NON-HODGKIN-LYMPHOMA; T-CELLS; SUPPRESSOR-CELLS; BURKITT-LYMPHOMA; TUMOR STROMA; IN-VIVO; CANCER; LYMPHOCYTES; IMMUNITY	To study mechanisms of T cell-mediated rejection of B cell lymphomas, we developed a murine lymphoma model wherein three potential rejection antigens, human c-MYC, chicken ovalbumin (OVA), and GFP are expressed. After transfer into wild-type mice 60-70% of systemically growing lymphomas expressing all three antigens were rejected; lymphomas expressing only human c-MYC protein were not rejected. OVA expressing lymphomas were infiltrated by T cells, showed MHC class I and II upregulation, and lost antigen expression, indicating immune escape. In contrast to wild-type recipients, 80-100% of STAT1-, IFN-gamma-, or IFN-gamma receptor-deficient recipients died of lymphoma, indicating that host IFN-gamma signaling is critical for rejection. Lymphomas arising in IFN-gamma- and IFN-gamma-receptor-deficient mice had invariably lost antigen expression, suggesting that poor overall survival of these recipients was due to inefficient elimination of antigen-negative lymphoma variants. Antigen-dependent eradication of lymphoma cells in wild-type animals was dependent on cross-presentation of antigen by cells of the tumor stroma. These findings provide first evidence for an important role of the tumor stroma in T cell-mediated control of hematologic neoplasias and highlight the importance of incorporating stroma-targeting strategies into future immunotherapeutic approaches.	[Gerbitz, Armin; Helm, Florian; Wilke, Andrea; Friese, Christian; Fahrenwaldt, Cornelia; Kammertoens, Thomas; Blankenstein, Thomas] Charite, Dept Immunol, Berlin, Germany; [Sukumar, Madhusudhanan; Lehmann, Frank M.; Bornkamm, Georg W.] Helmholtz Ctr Munich, Inst Clin Mol Biol & Tumor Genet, Munich, Germany; [Loddenkemper, Christoph] Charite, Dept Pathol, Berlin, Germany; [Mautner, Josef] Tech Univ TU Munich, Dept Pediat, Munich, Germany; [Mautner, Josef] Tech Univ Munich, Clin Cooperat Grp Pediat Tumor Immunol, Munich, Germany; [Mautner, Josef] Helmholtz Ctr Munich, Munich, Germany; [Gerbitz, Armin; Fahrenwaldt, Cornelia] Univ Erlangen Nurnberg, Dept Hematol & Oncol, D-91054 Erlangen, Germany; [Schmitt, Clemens A.] Charite, Dept Hematol & Oncol, Berlin, Germany; [Blankenstein, Thomas] Max Delbruck Ctr Mol Med, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Erlangen Nuremberg; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Gerbitz, A (corresponding author), Charite, Dept Immunol, Berlin, Germany.	armin.gerbitz@uk-erlangen.de	Schmitt, Clemens A/S-9479-2017	Schmitt, Clemens A/0000-0002-4731-2226; Lehmann, Frank Michael/0000-0002-0381-9033	Deutsche Forschungsgemeinschaft [Ge999/5-3, SFB-TR36, SFB-TR54]; Wilhelm Sander Foundation; Rudolf-Bartling-Foundation	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Wilhelm Sander Foundation; Rudolf-Bartling-Foundation	This work was supported by grants from the Deutsche Forschungsgemeinschaft (Ge999/5-3, SFB-TR36, SFB-TR54), the Wilhelm Sander Foundation and the Rudolf-Bartling-Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aran JM, 1998, CANCER GENE THER, V5, P195; Bhattacharya D, 2006, J EXP MED, V203, P73, DOI 10.1084/jem.20051714; Zhang B, 2008, J CLIN INVEST, V118, P1398, DOI 10.1172/JCI33522; Bosetti C, 2008, INT J CANCER, V123, P1917, DOI 10.1002/ijc.23722; Clarke SRM, 2000, IMMUNOL CELL BIOL, V78, P110, DOI 10.1046/j.1440-1711.2000.00889.x; Cloosen S, 2007, CANCER RES, V67, P3919, DOI 10.1158/0008-5472.CAN-06-2112; Derbinski J, 2001, NAT IMMUNOL, V2, P1032, DOI 10.1038/ni723; Dierks C, 2007, NAT MED, V13, P944, DOI 10.1038/nm1614; DIGHE AS, 1994, IMMUNITY, V1, P447, DOI 10.1016/1074-7613(94)90087-6; Dunn GP, 2006, NAT REV IMMUNOL, V6, P836, DOI 10.1038/nri1961; Durbin JE, 1996, CELL, V84, P443, DOI 10.1016/S0092-8674(00)81289-1; Dyer CM, 2004, BLOOD, V103, P3073, DOI 10.1182/blood-2003-07-2305; Ehst BD, 2003, AM J TRANSPLANT, V3, P1355, DOI 10.1046/j.1600-6135.2003.00246.x; FalK MH, 1998, INT J CANCER, V75, P620, DOI 10.1002/(SICI)1097-0215(19980209)75:4<620::AID-IJC21>3.0.CO;2-B; Fisher SG, 2004, ONCOGENE, V23, P6524, DOI 10.1038/sj.onc.1207843; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; GHATTAS IR, 1991, MOL CELL BIOL, V11, P5848, DOI 10.1128/MCB.11.12.5848; Goldstone AH, 2009, BIOL BLOOD MARROW TR, V15, P7, DOI 10.1016/j.bbmt.2008.11.017; Grigg A, 2004, BIOL BLOOD MARROW TR, V10, P579, DOI 10.1016/j.bbmt.2004.05.008; Hamadani M, 2009, BIOL BLOOD MARROW TR, V15, P547, DOI 10.1016/j.bbmt.2009.01.010; Heslop HE, 1996, NAT MED, V2, P551, DOI 10.1038/nm0596-551; Heslop HE, 2009, BLOOD; Hurt EM, 2004, CANCER CELL, V5, P191, DOI 10.1016/S1535-6108(04)00019-4; Kolb HJ, 2004, BLOOD, V103, P767, DOI 10.1182/blood-2003-02-0342; KOLB HJ, 1990, BLOOD, V76, P2462, DOI 10.1182/blood.V76.12.2462.2462; Kovalchuk AL, 2000, J EXP MED, V192, P1183, DOI 10.1084/jem.192.8.1183; Kuppers R, 2009, NAT REV CANCER, V9, P15, DOI 10.1038/nrc2542; Lenz G, 2008, NEW ENGL J MED, V359, P2313, DOI 10.1056/NEJMoa0802885; Levi F, 2002, LEUKEMIA RES, V26, P903, DOI 10.1016/S0145-2126(02)00031-0; Mumberg D, 1996, Semin Immunol, V8, P289, DOI 10.1006/smim.1996.0037; Ostrand-Rosenberg S, 2009, J IMMUNOL, V182, P4499, DOI 10.4049/jimmunol.0802740; PREHN RT, 1957, J NATL CANCER I, V18, P769; Qin ZH, 2000, IMMUNITY, V12, P677, DOI 10.1016/S1074-7613(00)80218-6; Reimann M, CANC CELL, V17, P262; Schaefer BC, 2001, CELL IMMUNOL, V214, P110, DOI 10.1006/cimm.2001.1895; Schmitt CA, 2002, CELL, V109, P335, DOI 10.1016/S0092-8674(02)00734-1; Schuler T, 2003, J IMMUNOL, V170, P4427, DOI 10.4049/jimmunol.170.9.4427; Serody JS, 1999, BLOOD, V93, P43, DOI 10.1182/blood.V93.1.43.401k24_43_50; Spiotto MT, 2004, NAT MED, V10, P294, DOI 10.1038/nm999; Swift S, 2001, Curr Protoc Immunol, VChapter 10, DOI 10.1002/0471142735.im1017cs31; van Besien K, 2009, BIOL BLOOD MARROW TR, V15, P554, DOI 10.1016/j.bbmt.2009.01.012; Wagner HJ, 2004, CANCER GENE THER, V11, P81, DOI 10.1038/sj.cgt.7700664; WOLFEL T, 1995, SCIENCE, V269, P1281, DOI 10.1126/science.7652577; Zenz T, 2010, NAT REV CANCER, V10, P37, DOI 10.1038/nrc2764; Zhang B, 2008, CANCER RES, V68, P1563, DOI 10.1158/0008-5472.CAN-07-5324; Zhang B, 2007, J EXP MED, V204, P49, DOI 10.1084/jem.20062056	46	14	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e34552	10.1371/journal.pone.0034552	http://dx.doi.org/10.1371/journal.pone.0034552			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479645	Green Published, gold, Green Accepted			2022-12-27	WOS:000305339100168
J	Kriechbaumer, V; Nabok, A; Mustafa, MK; Al-Ammar, R; Tsargorodskaya, A; Smith, DP; Abell, BM				Kriechbaumer, Verena; Nabok, Alexei; Mustafa, Mohd K.; Al-Ammar, Rukaiah; Tsargorodskaya, Anna; Smith, David P.; Abell, Ben M.			Analysis of Protein Interactions at Native Chloroplast Membranes by Ellipsometry	PLOS ONE			English	Article							INTERNAL-REFLECTION ELLIPSOMETRY; SURFACE-PLASMON RESONANCE; RECEPTOR; IMPORT; TRANSLOCON; PRECURSOR	Membrane bound receptors play vital roles in cell signaling, and are the target for many drugs, yet their interactions with ligands are difficult to study by conventional techniques due to the technical difficulty of monitoring these interactions in lipid environments. In particular, the ability to analyse the behaviour of membrane proteins in their native membrane environment is limited. Here, we have developed a quantitative approach to detect specific interactions between low abundance chaperone receptors within native chloroplast membranes and their soluble chaperone partners. Langmuir-Schaefer film deposition was used to deposit native chloroplasts onto gold-coated glass slides, and interactions between the molecular chaperones Hsp70 and Hsp90 and their receptors in the chloroplast membranes were detected and quantified by total internal reflection ellipsometry (TIRE). We show that native chloroplast membranes deposited on gold-coated glass slides using Langmuir-Schaefer films retain functional receptors capable of binding chaperones with high specificity and affinity. Taking into account the low chaperone receptor abundance in native membranes, these binding properties are consistent with data generated using soluble forms of the chloroplast chaperone receptors, OEP61 and Toc64. Therefore, we conclude that chloroplasts have the capacity to selectively bind chaperones, consistent with the notion that chaperones play an important role in protein targeting to chloroplasts. Importantly, this method of monitoring by TIRE does not require any protein labelling. This novel combination of techniques should be applicable to a wide variety of membranes and membrane protein receptors, thus presenting the opportunity to quantify protein interactions involved in fundamental cellular processes, and to screen for drugs that target membrane proteins.	[Kriechbaumer, Verena; Smith, David P.; Abell, Ben M.] Sheffield Hallam Univ, Biomed Res Ctr, Sheffield S1 1WB, S Yorkshire, England; [Nabok, Alexei; Mustafa, Mohd K.; Al-Ammar, Rukaiah; Tsargorodskaya, Anna] Sheffield Hallam Univ, Mat & Engn Res Inst, Sheffield S1 1WB, S Yorkshire, England	Sheffield Hallam University; Sheffield Hallam University	Kriechbaumer, V (corresponding author), Sheffield Hallam Univ, Biomed Res Ctr, Sheffield S1 1WB, S Yorkshire, England.	v.kriechbaumer@shu.ac.uk	Kriechbaumer, Verena/AAW-9148-2020; Nabok, Alexei/AAW-5758-2020; ammmar, Rukaiah Al/AAB-1850-2019; Kriechbaumer, Verena/ABF-5534-2020; Mustafa, Mohd Kamarulzaki/AAO-9802-2021	Kriechbaumer, Verena/0000-0003-3782-5834; Mustafa, Mohd/0000-0003-2451-8595; Abell, Ben/0000-0002-0953-0046; Smith, David/0000-0001-5177-8574	EPSRC [EP/H000275/1, EP/I016473/1]; BBSRC [BB/E01559X/1]; Biotechnology and Biological Sciences Research Council [BB/E01559X/1] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/I016473/1, EP/J501621/1] Funding Source: researchfish	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by the EPSRC( www.epsrc.ac.uk) Engineering for Life research grant ( No. EP/H000275/1), the Feasibility Study grant ( No. EP/I016473/1), and a BBSRC( www.bbsrc.ac.uk/) research grant ( No. BB/E01559X/1, awarded to Dr. Abell. Consumables and salary of Dr. Kriechbaumer were paid off these grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abell BM, 2007, J CELL SCI, V120, P1743, DOI 10.1242/jcs.002410; Artigues A, 2002, J BIOL CHEM, V277, P25047, DOI 10.1074/jbc.M203474200; Arwin H, 2004, APPL OPTICS, V43, P3028, DOI 10.1364/AO.43.003028; Brinker A, 2002, J BIOL CHEM, V277, P19265, DOI 10.1074/jbc.M109002200; Chew O, 2004, FEBS LETT, V557, P109, DOI 10.1016/S0014-5793(03)01457-1; Gonzalez-Maeso J, 2010, NAT NEUROSCI, V13, P524, DOI 10.1038/nn0510-524; Hernandez MP, 2002, J BIOL CHEM, V277, P38294, DOI 10.1074/jbc.M206566200; Kriechbaumer V, 2011, BIOPHYS J, V101, P504, DOI 10.1016/j.bpj.2011.06.011; Liu X, 2003, ANAL BIOCHEM, V314, P301, DOI 10.1016/S0003-2697(02)00696-6; Maynard Jennifer A., 2009, Biotechnology Journal, V4, P1542, DOI 10.1002/biot.200900195; Nabok A, 2011, SENSOR ACTUAT B-CHEM, V154, P232, DOI 10.1016/j.snb.2010.02.005; Nabok A, 2008, THIN SOLID FILMS, V516, P8993, DOI 10.1016/j.tsf.2007.11.077; Nabok AV, 2005, APPL SURF SCI, V246, P381, DOI 10.1016/j.apsusc.2004.11.084; Odunuga OO, 2003, J BIOL CHEM, V278, P6896, DOI 10.1074/jbc.M206867200; Petty M.C., 1996, LANGMUIR BLODGETT FI, DOI 10.1017/CBO9780511622519; Prasad BD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012761; Qbadou S, 2006, EMBO J, V25, P1836, DOI 10.1038/sj.emboj.7601091; Scheufler C, 2000, CELL, V101, P199, DOI 10.1016/S0092-8674(00)80830-2; Schleiff E, 2003, J CELL BIOL, V160, P541, DOI 10.1083/jcb.200210060; Szekacs A, 2009, APPL OPTICS, V48, pB151, DOI 10.1364/AO.48.00B151; Vojta A, 2004, J BIOL CHEM, V279, P21401, DOI 10.1074/jbc.M401968200; von Loeffelholz O, 2011, BIOCHEM J, V438, P143, DOI 10.1042/BJ20110448; Wickner W, 2005, SCIENCE, V310, P1452, DOI 10.1126/science.1113752; Woollam J. A., 2002, GUIDE USING WVASE32	24	2	2	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2012	7	3							e34455	10.1371/journal.pone.0034455	http://dx.doi.org/10.1371/journal.pone.0034455			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948SR	22479632	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000304523400085
J	Muller, WEG; Wang, XH; Grebenjuk, VA; Korzhev, M; Wiens, M; Schlossmacher, U; Schroder, HC				Mueller, Werner E. G.; Wang, Xiaohong; Grebenjuk, Vlad A.; Korzhev, Michael; Wiens, Matthias; Schlossmacher, Ute; Schroeder, Heinz C.			Common Genetic Denominators for Ca++-Based Skeleton in Metazoa: Role of Osteoclast-Stimulating Factor and of Carbonic Anhydrase in a Calcareous Sponge	PLOS ONE			English	Article							CRYSTALLINE CALCIUM-CARBONATE; SUBERITES-DOMUNCULA; SILICEOUS SPICULES; AGGREGATION FACTOR; BONE-RESORPTION; PI-3 KINASE; SILICATEIN; PROTEINS; GROWTH; SYCON	Calcium-based matrices serve predominantly as inorganic, hard skeletal systems in Metazoa from calcareous sponges [phylum Porifera; class Calcarea] to proto- and deuterostomian multicellular animals. The calcareous sponges form their skeletal elements, the spicules, from amorphous calcium carbonate (ACC). Treatment of spicules from Sycon raphanus with sodium hypochlorite (NaOCl) results in the disintegration of the ACC in those skeletal elements. Until now a distinct protein/enzyme involved in ACC metabolism could not been identified in those animals. We applied the technique of phage display combinatorial libraries to identify oligopeptides that bind to NaOCl-treated spicules: those oligopeptides allowed us to detect proteins that bind to those spicules. Two molecules have been identified, the (putative) enzyme carbonic anhydrase and the (putative) osteoclast-stimulating factor (OSTF), that are involved in the catabolism of ACC. The complete cDNAs were isolated and the recombinant proteins were prepared to raise antibodies. In turn, immunofluorescence staining of tissue slices and qPCR analyses have been performed. The data show that sponges, cultivated under standard condition (10 mM CaCl2) show low levels of transcripts/proteins for carbonic anhydrase or OSTF, compared to those animals that had been cultivated under Ca2+-depletion condition (1 mM CaCl2). Our data identify with the carbonic anhydrase and the OSTF the first two molecules which remain conserved in cells, potentially involved in Ca-based skeletal dissolution, from sponges (sclerocytes) to human (osteoclast).	[Mueller, Werner E. G.; Wang, Xiaohong; Grebenjuk, Vlad A.; Korzhev, Michael; Wiens, Matthias; Schlossmacher, Ute; Schroeder, Heinz C.] Johannes Gutenberg Univ Mainz, ERC Adv Investigator Grant Res Grp, Inst Physiol Chem, Univ Med Ctr, Mainz, Germany; [Wang, Xiaohong] Chinese Acad Geol Sci, Natl Res Ctr Geoanal, CHN Beijing, Beijing, Peoples R China	Johannes Gutenberg University of Mainz; Chinese Academy of Geological Sciences	Muller, WEG (corresponding author), Johannes Gutenberg Univ Mainz, ERC Adv Investigator Grant Res Grp, Inst Physiol Chem, Univ Med Ctr, Mainz, Germany.	wmueller@uni-mainz.de	Müller, W. E. G./AAR-8651-2020; wang, jie/GRS-0942-2022; Wang, Xiaohong/AAR-5526-2020; Wang, Zhong Lin/E-2176-2011	Müller, W. E. G./0000-0002-8223-3689; Wang, Zhong Lin/0000-0002-5530-0380; Wiens, Matthias/0000-0001-9219-0478; Schroder, Heinz C./0000-0003-0992-6427	ERC Advanced Investigator Grant [268476 BIOSILICA]; German Bundesministerium fur Bildung und Forschung (project "Center of Excellence BIOTECmarin"); European Commission (seventh framework "The people programme"; Industry-Academia Partnerships and Pathways) [286059]; International Human Frontier Science Program; European Commission [031541 - BIO-LITHO]; Public Welfare Project of Ministry of Land and Resources of the People's Republic of China [201011005-06]; International S & T Cooperation Program of China [2008DFA00980]	ERC Advanced Investigator Grant; German Bundesministerium fur Bildung und Forschung (project "Center of Excellence BIOTECmarin"); European Commission (seventh framework "The people programme"; Industry-Academia Partnerships and Pathways); International Human Frontier Science Program(Human Frontier Science Program); European Commission(European CommissionEuropean Commission Joint Research Centre); Public Welfare Project of Ministry of Land and Resources of the People's Republic of China; International S & T Cooperation Program of China	WEGM is a holder of an ERC Advanced Investigator Grant (no 268476 BIOSILICA). This work was supported by grants from the German Bundesministerium fur Bildung und Forschung (project "Center of Excellence BIOTECmarin"), the European Commission (seventh framework "The people programme"; Industry-Academia Partnerships and Pathways; Grant No. 286059), the International Human Frontier Science Program, the European Commission (project no. 031541 - BIO-LITHO), the Public Welfare Project of Ministry of Land and Resources of the People's Republic of China (Grant No. 201011005-06) and the International S & T Cooperation Program of China (Grant No. 2008DFA00980). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADDADI L, 1987, P NATL ACAD SCI USA, V84, P2732, DOI 10.1073/pnas.84.9.2732; AIZENBERG J, 1995, FASEB J, V9, P262, DOI 10.1096/fasebj.9.2.7781928; Aizenberg J, 1996, ADV MATER, V8, P222, DOI 10.1002/adma.19960080307; Aizenberg J, 2003, CONNECT TISSUE RES, V44, P20, DOI 10.1080/03008200390152034; Aizenberg J, 2002, J AM CHEM SOC, V124, P32, DOI 10.1021/ja016990l; Aluma Y, 2011, J STRUCT BIOL, V175, P415, DOI 10.1016/j.jsb.2011.05.006; BADGER MR, 1994, ANNU REV PLANT PHYS, V45, P369, DOI 10.1146/annurev.pp.45.060194.002101; BAKER RWR, 1947, BIOCHEM J, V41, P337, DOI 10.1042/bj0410337; Bennett V, 2001, CURR OPIN CELL BIOL, V13, P61, DOI 10.1016/S0955-0674(00)00175-7; Bertucci A, 2011, MAR BIOTECHNOL, V13, P992, DOI 10.1007/s10126-011-9363-x; Borojevic Radovan, 2000, Zoosystema, V22, P203; Cha JN, 1999, P NATL ACAD SCI USA, V96, P361, DOI 10.1073/pnas.96.2.361; Coligan J.E., 2000, CURRENT PROTOCOLS PR; delaPena TC, 1997, PLANT J, V11, P407, DOI 10.1046/j.1365-313X.1997.11030407.x; Dufour C, 2008, BONE, V42, P1032, DOI 10.1016/j.bone.2008.02.009; Duplessis Kirk, 2000, Pacific Science, V54, P10; Eckert C, 2006, J HISTOCHEM CYTOCHEM, V54, P1031, DOI 10.1369/jhc.5A6903.2006; Ehrlich H, 2009, MICRON, V40, P169, DOI 10.1016/j.micron.2008.06.004; Felsenstein J., 1993, PHYLIP VERSION 3 5; Gaskin DJH, 2000, BIOTECHNOL LETT, V22, P1211, DOI 10.1023/A:1005603117023; GIRAUD MM, 1981, COMP BIOCHEM PHYS A, V69, P381, DOI 10.1016/0300-9629(81)92993-5; Grasso LC, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-540; Haeckel E, 1872, KALKSCHWAMME MONOGRA; HALL GE, 1987, CALCIFIED TISSUE INT, V40, P212, DOI 10.1007/BF02556624; HEYWOOD BR, 1994, ADV MATER, V6, P9, DOI 10.1002/adma.19940060103; Jackson DJ, 2007, SCIENCE, V316, P1893, DOI 10.1126/science.1141560; JONES WC, 1986, COMP BIOCHEM PHYS A, V84, P149, DOI 10.1016/0300-9629(86)90057-5; JONES WC, 1967, NATURE, V214, P365, DOI 10.1038/214365a0; Kirschvink J. L., 1992, PROTEROZOIC BIOSPHER, P51; KOVACS P, 1987, ACTA HISTOCHEM, V81, P95, DOI 10.1016/S0065-1281(87)80092-2; Krasko A, 2000, EUR J BIOCHEM, V267, P4878, DOI 10.1046/j.1432-1327.2000.01547.x; KUHNS WJ, 1974, ANN NY ACAD SCI, V234, P58, DOI 10.1111/j.1749-6632.1974.tb53021.x; KYHSEANDERSEN J, 1984, J BIOCHEM BIOPH METH, V10, P203, DOI 10.1016/0165-022X(84)90040-X; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lahiri S, 2003, INT J BIOCHEM CELL B, V35, P1413, DOI 10.1016/S1357-2725(03)00050-5; Le Pennec G, 2003, J BIOTECHNOL, V100, P93, DOI 10.1016/S0168-1656(02)00259-6; LEDGER PW, 1974, TISSUE CELL, V6, P385, DOI 10.1016/0040-8166(74)90032-9; LEDGER PW, 1977, CELL TISSUE RES, V181, P553; Love GD, 2009, NATURE, V457, P718, DOI 10.1038/nature07673; Margolis DS, 2008, CALCIFIED TISSUE INT, V82, P66, DOI 10.1007/s00223-007-9098-x; Meng FY, 1998, EMBO J, V17, P4391, DOI 10.1093/emboj/17.15.4391; Miao H, 2002, BIOCHEM BIOPH RES CO, V292, P892, DOI 10.1006/bbrc.2002.6750; Minchin E. A., 1909, Ergebnisse der Zoologie Jena, V2; MINKIN C, 1972, SCIENCE, V176, P1031, DOI 10.1126/science.176.4038.1031; Moscona AA, 1960, DEV CELL SYSTEMS THE, P173; Moya A, 2008, J BIOL CHEM, V283, P25475, DOI 10.1074/jbc.M804726200; Muller WEG, 2009, CELL MOL LIFE SCI, V66, P537, DOI 10.1007/s00018-008-8492-5; Muller WEG, 2008, FEBS J, V275, P362, DOI 10.1111/j.1742-4658.2007.06206.x; Muller WEG, 2006, SEMIN CELL DEV BIOL, V17, P481, DOI 10.1016/j.semcdb.2006.05.006; Muller WEG, 2011, ACTA BIOMATER, V7, P2661, DOI 10.1016/j.actbio.2011.03.007; Muller W.E.G., 1983, Coral Reefs, V1, P237, DOI 10.1007/BF00304421; Muller WEG, 2005, CELL TISSUE RES, V321, P285, DOI 10.1007/s00441-005-1141-5; Muller WEG, 2004, INT REV CYTOL, V235, P53, DOI 10.1016/S0074-7696(04)35002-3; MULLER WEG, 1977, J BIOL CHEM, V252, P3836; Muller WEG, 2002, IMMUNOGENETICS, V54, P48, DOI 10.1007/s00251-002-0441-0; MULLER WEG, 1982, INT REV CYTOL, V77, P129, DOI 10.1016/S0074-7696(08)62466-3; MULLER WEG, 1995, NATURWISSENSCHAFTEN, V82, P321; MULLER WEG, 1973, EXP CELL RES, V80, P95, DOI 10.1016/0014-4827(73)90279-6; Munugalavadla V, 2005, BLOOD, V106, P103, DOI 10.1182/blood-2004-10-4041; Naik RR, 2004, ADV FUNCT MATER, V14, P25, DOI 10.1002/adfm.200304501; NESBITT HW, 1991, J GEOL, V99, P429, DOI 10.1086/629504; Ng K. W., 2009, Endocrine Metabolic & Immune Disorders-Drug Targets, V9, P371; Ohradanova A, 2012, BIOORG MED CHEM LETT, V22, P1314, DOI 10.1016/j.bmcl.2011.12.085; Ojaniemi M, 1997, J BIOL CHEM, V272, P3780, DOI 10.1074/jbc.272.6.3780; PAWSON T, 1993, CURR BIOL, V3, P434, DOI 10.1016/0960-9822(93)90350-W; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Reddy S, 1998, J CELL PHYSIOL, V177, P636, DOI 10.1002/(SICI)1097-4652(199812)177:4<636::AID-JCP14>3.3.CO;2-8; Riihonen R, 2007, BONE, V40, P1021, DOI 10.1016/j.bone.2006.11.028; Rodi DJ, 1999, CURR OPIN BIOTECH, V10, P87, DOI 10.1016/S0958-1669(99)80016-0; Roodman GD, 1999, EXP HEMATOL, V27, P1229, DOI 10.1016/S0301-472X(99)00061-2; Roodman GD, 1996, ENDOCR REV, V17, P308, DOI 10.1210/er.17.4.308; Sachs L., 1984, ANGEW STAT; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schacke H, 1994, USE OF AQUATIC INVERTEBRATES AS TOOLS FOR MONITORING OF ENVIRONMENTAL HAZARDS, P201; Schlossmacher U, 2011, FEBS J, V278, P1145, DOI 10.1111/j.1742-4658.2011.08040.x; Schroder HC, 2003, PROG MOLEC, V33, P249; Schutze J, 1999, P ROY SOC B-BIOL SCI, V266, P63, DOI 10.1098/rspb.1999.0605; Shimizu K, 1998, P NATL ACAD SCI USA, V95, P6234, DOI 10.1073/pnas.95.11.6234; SIMPSON TL, 1985, ZOOMORPHOLOGY, V105, P375, DOI 10.1007/BF00312281; Supuran CT, 2008, NAT REV DRUG DISCOV, V7, P168, DOI 10.1038/nrd2467; Szymkiewicz I, 2004, FEBS LETT, V565, P33, DOI 10.1016/j.febslet.2004.03.100; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tripp BC, 2001, J BIOL CHEM, V276, P48615, DOI 10.1074/jbc.R100045200; TURNER RS, 1973, NATURE, V244, P509, DOI 10.1038/244509a0; Uriz MJ, 2006, CAN J ZOOL, V84, P322, DOI 10.1139/Z06-032; Wang XH, 2012, CURRENT OPI IN PRESS; Wang XH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020523; Wang XH, 2011, J EXP BIOL, V214, P2047, DOI 10.1242/jeb.056275; Weinschenk E., 1905, Zentralblatt fuer Mineralogie, P581; Wiens M, 2010, CALCIFIED TISSUE INT, V87, P513, DOI 10.1007/s00223-010-9408-6; Wiens M, 2010, BIOMATERIALS, V31, P7716, DOI 10.1016/j.biomaterials.2010.07.002; Wilson HV, 1907, J EXP ZOOL, V5, P245, DOI 10.1002/jez.1400050204; Zhang XY, 2004, BIOTECHNOL PROGR, V20, P151, DOI 10.1021/bp0341601	94	25	25	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2012	7	4							e34617	10.1371/journal.pone.0034617	http://dx.doi.org/10.1371/journal.pone.0034617			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959FE	22506035	Green Published, Green Submitted, gold			2022-12-27	WOS:000305297500043
J	Acar, N; Berdeaux, O; Gregoire, S; Cabaret, S; Martine, L; Gain, P; Thuret, G; Creuzot-Garcher, CP; Bron, AM; Bretillon, L				Acar, Niyazi; Berdeaux, Olivier; Gregoire, Stephane; Cabaret, Stephanie; Martine, Lucy; Gain, Philippe; Thuret, Gilles; Creuzot-Garcher, Catherine P.; Bron, Alain M.; Bretillon, Lionel			Lipid Composition of the Human Eye: Are Red Blood Cells a Good Mirror of Retinal and Optic Nerve Fatty Acids?	PLOS ONE			English	Article							DOMINANT RETINITIS-PIGMENTOSA; TANDEM MASS-SPECTROMETRY; DE-NOVO LIPOGENESIS; DOCOSAHEXAENOIC ACID; MACULAR DEGENERATION; MEMBRANE PHOSPHOLIPIDS; ADIPOSE-TISSUE; DIETARY-FAT; HUMAN-SERUM; AGE	Background: The assessment of blood lipids is very frequent in clinical research as it is assumed to reflect the lipid composition of peripheral tissues. Even well accepted such relationships have never been clearly established. This is particularly true in ophthalmology where the use of blood lipids has become very common following recent data linking lipid intake to ocular health and disease. In the present study, we wanted to determine in humans whether a lipidomic approach based on red blood cells could reveal associations between circulating and tissue lipid profiles. To check if the analytical sensitivity may be of importance in such analyses, we have used a double approach for lipidomics. Methodology and Principal Findings: Red blood cells, retinas and optic nerves were collected from 9 human donors. The lipidomic analyses on tissues consisted in gas chromatography and liquid chromatography coupled to an electrospray ionization source-mass spectrometer (LC-ESI-MS). Gas chromatography did not reveal any relevant association between circulating and ocular fatty acids except for arachidonic acid whose circulating amounts were positively associated with its levels in the retina and in the optic nerve. In contrast, several significant associations emerged from LC-ESI-MS analyses. Particularly, lipid entities in red blood cells were positively or negatively associated with representative pools of retinal docosahexaenoic acid (DHA), retinal very-long chain polyunsaturated fatty acids (VLC-PUFA) or optic nerve plasmalogens. Conclusions and Significance: LC-ESI-MS is more appropriate than gas chromatography for lipidomics on red blood cells, and further extrapolation to ocular lipids. The several individual lipid species we have identified are good candidates to represent circulating biomarkers of ocular lipids. However, further investigation is needed before considering them as indexes of disease risk and before using them in clinical studies on optic nerve neuropathies or retinal diseases displaying photoreceptors degeneration.	[Acar, Niyazi; Berdeaux, Olivier; Gregoire, Stephane; Cabaret, Stephanie; Martine, Lucy; Creuzot-Garcher, Catherine P.; Bron, Alain M.; Bretillon, Lionel] CNRS, Ctr Sci Gout & Alimentat UMR6265, Dijon, France; [Acar, Niyazi; Berdeaux, Olivier; Gregoire, Stephane; Cabaret, Stephanie; Martine, Lucy; Creuzot-Garcher, Catherine P.; Bron, Alain M.; Bretillon, Lionel] INRA, Ctr Sci Gout & Alimentat UMR1324, F-21034 Dijon, France; [Acar, Niyazi; Berdeaux, Olivier; Gregoire, Stephane; Cabaret, Stephanie; Martine, Lucy; Creuzot-Garcher, Catherine P.; Bron, Alain M.; Bretillon, Lionel] Univ Bourgogne, UMR Ctr Sci Gout & Alimentat, Dijon, France; [Gain, Philippe; Thuret, Gilles] Fac Med, Dept Ophthalmol, St Etienne, France; [Creuzot-Garcher, Catherine P.; Bron, Alain M.] Univ Hosp, Dept Ophthalmol, Dijon, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut Agro; AgroSup Dijon; Universite de Bourgogne; INRAE; Institut Agro; AgroSup Dijon; Universite de Bourgogne; Institut Agro; AgroSup Dijon; Centre National de la Recherche Scientifique (CNRS); Universite de Bourgogne; CHU Dijon Bourgogne	Acar, N (corresponding author), CNRS, Ctr Sci Gout & Alimentat UMR6265, Dijon, France.	acar@dijon.inra.fr	Bron, Alain/AAP-8010-2020	Bron, Alain/0000-0002-7265-931X; Bretillon, Lionel/0000-0002-6957-100X				Acar N, 2007, EXP EYE RES, V84, P143, DOI 10.1016/j.exer.2006.09.009; Acar N, 2009, EXP EYE RES, V89, P840, DOI 10.1016/j.exer.2009.07.008; Agbaga MP, 2008, P NATL ACAD SCI USA, V105, P12843, DOI 10.1073/pnas.0802607105; Agbaga MP, 2010, ADV EXP MED BIOL, V664, P233, DOI 10.1007/978-1-4419-1399-9_27; Ahn EJ, 2008, J CHROMATOGR A, V1194, P96, DOI 10.1016/j.chroma.2008.04.031; Albert CM, 2002, NEW ENGL J MED, V346, P1113, DOI 10.1056/NEJMoa012918; Ambati J, 2003, SURV OPHTHALMOL, V48, P257, DOI 10.1016/S0039-6257(03)00030-4; ANTONIS A, 1962, AM J CLIN NUTR, V11, P142, DOI 10.1093/ajcn/11.2.142; Arab L, 2003, J NUTR, V133, p925S, DOI 10.1093/jn/133.3.925S; Arneson KO, 2007, METHOD ENZYMOL, V433, P127, DOI 10.1016/S0076-6879(07)33007-3; AVELDANO MI, 1988, BIOCHEMISTRY-US, V27, P1229, DOI 10.1021/bi00404a024; Barrows BR, 2006, J CLIN ENDOCR METAB, V91, P1446, DOI 10.1210/jc.2005-1709; BARTLETT EM, 1970, ANAL BIOCHEM, V36, P159, DOI 10.1016/0003-2697(70)90343-X; Basu S, 2010, PROSTAG LEUKOTR ESS, V82, P219, DOI 10.1016/j.plefa.2010.02.031; Baylin A, 2006, CURR OPIN LIPIDOL, V17, P22, DOI 10.1097/01.mol.0000199814.46720.83; Bazan NG, 2005, BRAIN PATHOL, V15, P159; Bazan NG, 2007, INVEST OPHTH VIS SCI, V48, P4866, DOI 10.1167/iovs.07-0918; Berdeaux O, 2010, J CHROMATOGR A, V1217, P7738, DOI 10.1016/j.chroma.2010.10.039; Berry KAZ, 2004, J AM SOC MASS SPECTR, V15, P1499, DOI 10.1016/j.jasms.2004.07.009; BHATTACHARYYA AK, 1987, AM J CLIN NUTR, V46, P41, DOI 10.1093/ajcn/46.1.41; BIRCH EE, 1992, INVEST OPHTH VIS SCI, V33, P3242; Blodi BA, 2004, INSIGHT, V29, P17; Blodi Barbara A, 2004, Insight, V29, P15; Bretillon L, 2008, EXP EYE RES, V87, P521, DOI 10.1016/j.exer.2008.08.010; BROWN AJ, 1991, PROSTAG LEUKOTR ESS, V44, P103, DOI 10.1016/0952-3278(91)90191-7; Brugger B, 1997, P NATL ACAD SCI USA, V94, P2339, DOI 10.1073/pnas.94.6.2339; Brush RS, 2010, INVEST OPHTH VIS SCI, V51, P4422, DOI 10.1167/iovs.09-5134; Calder PC, 2009, BIOCHIMIE, V91, P791, DOI 10.1016/j.biochi.2009.01.008; CARLSON SE, 1986, J NUTR, V116, P718, DOI 10.1093/jn/116.5.718; Cho E, 2001, AM J CLIN NUTR, V73, P209; Chong MFF, 2008, AM J CLIN NUTR, V87, P817, DOI 10.1093/ajcn/87.4.817; Crowe FL, 2008, BRIT J NUTR, V99, P168, DOI 10.1017/S000711450779387X; DAS SK, 1978, LIPIDS, V13, P679, DOI 10.1007/BF02533745; DeLong CJ, 2001, J LIPID RES, V42, P1959; Di Marino L, 2000, METABOLISM, V49, P1164, DOI 10.1053/meta.2000.8616; EBAUGH FG, 1953, J CLIN INVEST, V32, P1260, DOI 10.1172/JCI102855; FARQUHAR JW, 1962, BIOCHIM BIOPHYS ACTA, V60, P80, DOI 10.1016/0006-3002(62)90374-8; FLIESLER SJ, 1983, PROG LIPID RES, V22, P79; FOLCH J, 1957, J BIOL CHEM, V226, P497; GORDON WC, 1993, INVEST OPHTH VIS SCI, V34, P2402; GORDON WC, 1990, J NEUROSCI, V10, P2190; GREINER CAM, 1995, INT J BIOCHEM CELL B, V27, P21, DOI 10.1016/1357-2725(94)00061-1; Ho L, 2011, ARCH OPHTHALMOL-CHIC, V129, P758, DOI 10.1001/archophthalmol.2011.141; Hodson L, 2008, PROG LIPID RES, V47, P348, DOI 10.1016/j.plipres.2008.03.003; HOFFMAN DR, 1995, INVEST OPHTH VIS SCI, V36, P1009; Hoffman DR, 2004, AM J OPHTHALMOL, V137, P704, DOI 10.1016/j.ajo.2003.10.045; HOFFMAN DR, 1995, EXP EYE RES, V60, P279, DOI 10.1016/S0014-4835(05)80110-1; HOFFMAN DR, 1993, EXP EYE RES, V57, P359, DOI 10.1006/exer.1993.1135; HOLMAN RT, 1979, AM J CLIN NUTR, V32, P2390, DOI 10.1093/ajcn/32.12.2390; Huang LL, 2008, INVEST OPHTH VIS SCI, V49, P3864, DOI 10.1167/iovs.07-1420; Hubbard LD, 2008, INVEST OPHTH VIS SCI, V49, P3269, DOI 10.1167/iovs.07-1267; Hudgins LC, 1996, J CLIN INVEST, V97, P2081, DOI 10.1172/JCI118645; Jacobson SG, 2010, NEW ENGL J MED, V363, P1669, DOI 10.1056/NEJMcibr1007685; JUANEDA P, 1985, LIPIDS, V20, P40, DOI 10.1007/BF02534360; Kashiwagi K, 2004, J GLAUCOMA, V13, P189, DOI 10.1097/00061198-200406000-00003; Knepper PA, 2010, EXPERT REV OPHTHALMO, V5, P731, DOI 10.1586/EOP.10.73; Koivusalo M, 2001, J LIPID RES, V42, P663; Lagreze WA, 2009, INVEST OPHTH VIS SCI, V50, P4223, DOI 10.1167/iovs.08-2683; LANDS WEM, 1995, AM J CLIN NUTR, V61, p721S, DOI 10.1093/ajcn/61.3.721S; Litman BJ, 1996, LIPIDS, V31, pS193, DOI 10.1007/BF02637075; Liu MM, 2011, BRIT J OPHTHALMOL, V95, P604, DOI 10.1136/bjo.2009.174912; MacDonald IM, 2004, BRIT J OPHTHALMOL, V88, P305, DOI 10.1136/bjo.2003.024299; MAKRIDES M, 1994, AM J CLIN NUTR, V60, P189, DOI 10.1093/ajcn/60.2.189; MARTINEZ M, 1992, J PEDIATR-US, V120, pS129, DOI 10.1016/S0022-3476(05)81247-8; MARTINEZ M, 1988, J NEUROSCI RES, V20, P484, DOI 10.1002/jnr.490200412; MOILANEN T, 1981, CLIN CHIM ACTA, V114, P111, DOI 10.1016/0009-8981(81)90235-7; MORRISON WR, 1964, J LIPID RES, V5, P600; Nagan N, 2001, PROG LIPID RES, V40, P199, DOI 10.1016/S0163-7827(01)00003-0; Nakagawa K, 2005, J LIPID RES, V46, P2514, DOI 10.1194/jlr.D500025-JLR200; NEURINGER M, 1988, ANNU REV NUTR, V8, P517, DOI 10.1146/annurev.nu.08.070188.002505; Nikolaidis MG, 2004, SPORTS MED, V34, P1051, DOI 10.2165/00007256-200434150-00004; Pawlosky RJ, 2007, J LIPID RES, V48, P935, DOI 10.1194/jlr.M600310-JLR200; Querques G, 2009, EUR J OPHTHALMOL, V19, P100, DOI 10.1177/112067210901900115; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Reed TT, 2011, FREE RADICAL BIO MED, V51, P1302, DOI 10.1016/j.freeradbiomed.2011.06.027; Ren HM, 2006, PROSTAG LEUKOTR ESS, V74, P157, DOI 10.1016/j.plefa.2005.11.007; Rodriguez Y, 2004, ANN NUTR METAB, V48, P335, DOI 10.1159/000081201; RodriguezPalmero M, 1997, EUR J CLIN NUTR, V51, P554, DOI 10.1038/sj.ejcn.1600445; ROMON M, 1995, METABOLISM, V44, P1139, DOI 10.1016/0026-0495(95)90006-3; SANDERS TAB, 1981, CLIN SCI, V61, P317, DOI 10.1042/cs0610317; SanGiovanni JP, 2008, ARCH OPHTHALMOL-CHIC, V126, P1274, DOI 10.1001/archopht.126.9.1274; SanGiovanni JP, 2007, ARCH OPHTHALMOL-CHIC, V125, P671, DOI 10.1001/archopht.125.5.671; SanGiovanni JP, 2005, PROG RETIN EYE RES, V24, P87, DOI 10.1016/j.preteyeres.2004.06.002; Sarkadi-Nagy E, 2004, J LIPID RES, V45, P71, DOI 10.1194/jlr.M300106-JLR200; SASTRY PS, 1985, PROG LIPID RES, V24, P69, DOI 10.1016/0163-7827(85)90011-6; Seddon JM, 2003, ARCH OPHTHALMOL-CHIC, V121, P1728, DOI 10.1001/archopht.121.12.1728; Seddon JM, 2001, ARCH OPHTHALMOL-CHIC, V119, P1191, DOI 10.1001/archopht.119.8.1191; Seddon JM, 2006, ARCH OPHTHALMOL-CHIC, V124, P995, DOI 10.1001/archopht.124.7.995; Shoji N, 2010, J LIPID RES, V51, P2445, DOI 10.1194/jlr.D004564; Simonelli F, 1996, OPHTHALMIC RES, V28, P93, DOI 10.1159/000267880; Smedman AEM, 1999, AM J CLIN NUTR, V69, P22; Stillwell W, 2003, CHEM PHYS LIPIDS, V126, P1, DOI 10.1016/S0009-3084(03)00101-4; Timlin MT, 2005, AM J CLIN NUTR, V81, P35; TYNAN MB, 1995, ATHEROSCLEROSIS, V117, P245, DOI 10.1016/0021-9150(95)05578-K; UAUY RD, 1990, PEDIATR RES, V28, P485, DOI 10.1203/00006450-199011000-00014; Vicario IM, 1998, ANN NUTR METAB, V42, P160, DOI 10.1159/000012729	96	82	82	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2012	7	4							e35102	10.1371/journal.pone.0035102	http://dx.doi.org/10.1371/journal.pone.0035102			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JO	22496896	Green Published, gold, Green Submitted			2022-12-27	WOS:000305014500045
J	Saravanan, S; Schrama, JW; Figueiredo-Silva, AC; Kaushik, SJ; Verreth, JAJ; Geurden, I				Saravanan, Subramanian; Schrama, Johan W.; Figueiredo-Silva, A. Claudia; Kaushik, Sadasivam J.; Verreth, Johan A. J.; Geurden, Inge			Constraints on Energy Intake in Fish: The Link between Diet Composition, Energy Metabolism, and Energy Intake in Rainbow Trout	PLOS ONE			English	Article							EUROPEAN SEA-BASS; VOLUNTARY FEED-INTAKE; SALMON SALMO-SALAR; ONCORHYNCHUS-MYKISS; FOOD-INTAKE; DIGESTIBLE ENERGY; GROWING-PIGS; UTILIZATION EFFICIENCY; OREOCHROMIS-NILOTICUS; DICENTRARCHUS-LABRAX	The hypothesis was tested that fish fed to satiation with iso-energetic diets differing in macronutrient composition will have different digestible energy intakes (DEI) but similar total heat production. Four iso-energetic diets (2 x 2 factorial design) were formulated having a contrast in i) the ratio of protein to energy (P/E): high (H-P/E) vs. low (L-P/E) and ii) the type of nonprotein energy (NPE) source: fat vs. carbohydrate which were iso-energetically exchanged. Triplicate groups (35 fish/tank) of rainbow trout were hand-fed each diet twice daily to satiation for 6 weeks under non-limiting water oxygen conditions. Feed intake (FI), DEI (kJ kg(-0.8) d(-1)) and growth (g kg(-0.8) d(-1)) of trout were affected by the interaction between P/E ratio and NPE source of the diet (P < 0.05). Regardless of dietary P/E ratio, the inclusion of carbohydrate compared to fat as main NPE source reduced DEI and growth of trout by similar to 20%. The diet-induced differences in FI and DEI show that trout did not compensate for the dietary differences in digestible energy or digestible protein contents. Further, changes in body fat store and plasma glucose did not seem to exert a homeostatic feedback control on DEI. Independent of the diet composition, heat production of trout did not differ (P > 0.05). Our data suggest that the control of DEI in trout might be a function of heat production, which in turn might reflect a physiological limit related with oxidative metabolism.	[Saravanan, Subramanian; Schrama, Johan W.; Verreth, Johan A. J.] Wageningen Univ, WIAS, Aquaculture & Fisheries Grp, Wageningen, Netherlands; [Saravanan, Subramanian; Figueiredo-Silva, A. Claudia; Kaushik, Sadasivam J.; Geurden, Inge] INRA, UR1067, Pole Hydrobiol INRA, St Pee Sur Nivelle, France	Wageningen University & Research; INRAE; Universite de Pau et des Pays de l'Adour	Saravanan, S (corresponding author), Wageningen Univ, WIAS, Aquaculture & Fisheries Grp, Wageningen, Netherlands.	inge.geurden@st-pee.inra.fr	Kaushik, Sadasivam J/B-9824-2009; Verreth, Johan/ABD-7198-2020	Kaushik, Sadasivam J/0000-0001-7856-8374; Verreth, Johan/0000-0001-7277-5129; Schrama, Johan/0000-0001-7156-8806	INRA (Institut National de Recherche Agronomique)	INRA (Institut National de Recherche Agronomique)	This study has been funded by institutional funds from INRA (Institut National de Recherche Agronomique) in the framework of the INRA/WUR (Wageningen University Research) Aquaculture Platform. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alanara A., 1996, Aquaculture Research, V27, P479, DOI 10.1111/j.1365-2109.1996.tb01277.x; Azevedo PA, 1998, AQUAT LIVING RESOUR, V11, P227, DOI 10.1016/S0990-7440(98)89005-0; Bendiksen EA, 2002, AQUAC RES, V33, P525, DOI 10.1046/j.1365-2109.2002.00737.x; Blundell John E., 1995, Nutrition Research Reviews, V8, P225, DOI 10.1079/NRR19950014; BOUJARD T, 1994, AQUAT LIVING RESOUR, V7, P211, DOI 10.1051/alr:1994023; BROBECK JOHN R., 1957, YALE JOUR BIOL AND MED, V29, P565; BROMLEY PJ, 1980, AQUACULTURE, V19, P359, DOI 10.1016/0044-8486(80)90084-8; Bureau Dominique P., 2002, P1; Bureau DP, 2003, N AM J AQUACULT, V65, P33, DOI 10.1577/1548-8454(2003)065&lt;0033:CCAPTE&gt;2.0.CO;2; Cho C.Y., 1985, P95; CHOUBERT G, 1982, AQUACULTURE, V29, P185, DOI 10.1016/0044-8486(82)90048-5; Dias J, 1999, CYBIUM, V23, P127; Dias J, 1998, AQUAT LIVING RESOUR, V11, P219, DOI 10.1016/S0990-7440(98)89004-9; Emmans GC, 1995, LIVEST PROD SCI, V44, P189, DOI 10.1016/0301-6226(95)00073-9; Encarnacao P, 2004, AQUACULTURE, V235, P569, DOI 10.1016/j.aquaculture.2004.01.001; Ferguson NS, 1997, ANIM SCI, V64, P365, DOI 10.1017/S1357729800015939; Ferguson NS, 2002, ANIM SCI, V74, P103, DOI 10.1017/S1357729800052267; Figueiredo-Silva AC, 2012, BRIT J NUTR, V107, P1714, DOI 10.1017/S0007114511004739; FOLCH J, 1957, J BIOL CHEM, V226, P497; Friedman MI, 1998, AM J CLIN NUTR, V67, p513S, DOI 10.1093/ajcn/67.3.513S; Gelineau A, 2001, REPROD NUTR DEV, V41, P487, DOI 10.1051/rnd:2001103; Geurden I, 2006, PHYSIOL BEHAV, V88, P325, DOI 10.1016/j.physbeh.2006.03.033; Glencross B, 2008, AQUACULT NUTR, V14, P129, DOI 10.1111/j.1365-2095.2007.00512.x; Glencross BD, 2009, AQUACULT NUTR, V15, P1, DOI 10.1111/j.1365-2095.2007.00562.x; Glencross B, 2007, AQUACULTURE, V265, P218, DOI 10.1016/j.aquaculture.2007.01.040; HE EQ, 1993, T AM FISH SOC, V122, P717, DOI 10.1577/1548-8659(1993)122<0717:AEMOGE>2.3.CO;2; Helland SJ, 1998, AQUACULTURE, V162, P1, DOI 10.1016/S0044-8486(98)00206-3; HEMRE GI, 1989, AQUACULTURE, V80, P261, DOI 10.1016/0044-8486(89)90174-9; HENRY Y, 1985, LIVEST PROD SCI, V12, P339, DOI 10.1016/0301-6226(85)90133-2; Hewson-Hughes AK, 2011, J EXP BIOL, V214, P1039, DOI 10.1242/jeb.049429; ISO, 1981, 5985 ISO; ISO, 2005, 15914 ISO; Johansen SJS, 2003, AQUAC RES, V34, P317; KAUSHIK SJ, 1984, Z TIERPHYSIOL TIERER, V51, P57; KENNEDY GC, 1953, PROC R SOC SER B-BIO, V140, P578, DOI 10.1098/rspb.1953.0009; Ketelaars JJMH, 1996, J ANIM SCI, V74, P3036; KIM JD, 1992, AQUACULTURE, V106, P161, DOI 10.1016/0044-8486(92)90200-5; Koh K, 1999, BRIT POULTRY SCI, V40, P511, DOI 10.1080/00071669987287; Langhans W, 2008, APPETITE, V51, P446, DOI 10.1016/j.appet.2008.06.014; Lekva A, 2010, AQUACULTURE, V300, P169, DOI 10.1016/j.aquaculture.2010.01.001; MAYER J, 1991, NUTR REV, V49, P46; Mayntz D, 2009, ANIM BEHAV, V77, P349, DOI 10.1016/j.anbehav.2008.09.036; MCLEAN JA, 1972, BRIT J NUTR, V27, P597, DOI 10.1079/BJN19720130; MORALES AE, 1994, AQUACULTURE, V124, P117, DOI 10.1016/0044-8486(94)90367-0; Nicolaidis S, 2011, PHYSIOL BEHAV, V104, P8, DOI 10.1016/j.physbeh.2011.04.058; NRC (National Research Council), 2011, NUTR REQ FISH SHRIMP; PAGE JW, 1973, J NUTR, V103, P1339, DOI 10.1093/jn/103.9.1339; Peres H, 1999, AQUACULTURE, V179, P325, DOI 10.1016/S0044-8486(99)00168-4; Polakof S, 2008, AM J PHYSIOL-REG I, V295, pR478, DOI 10.1152/ajpregu.00176.2008; Riche M, 2004, AQUACULTURE, V234, P657, DOI 10.1016/j.aquaculture.2003.12.012; Ruohonen K, 1996, J FISH BIOL, V49, P501, DOI 10.1111/j.1095-8649.1996.tb00045.x; SHARIATMADARI F, 1993, BRIT POULTRY SCI, V34, P959, DOI 10.1080/00071669308417656; Silverstein JT, 1999, AQUACULTURE, V177, P161, DOI 10.1016/S0044-8486(99)00076-9; Sorensen A, 2008, OBESITY, V16, P566, DOI 10.1038/oby.2007.58; Stubbs RJ, 2006, BRIT J NUTR, V95, P657, DOI 10.1079/BJN20041361; Tekinay AA, 2003, TURK J VET ANIM SCI, V27, P1077; Tran-Duy A, 2008, AQUACULTURE, V277, P213, DOI 10.1016/j.aquaculture.2008.03.004; Volkoff H, 2006, ZEBRAFISH, V3, P131, DOI 10.1089/zeb.2006.3.131; Woods SC, 1998, SCIENCE, V280, P1378, DOI 10.1126/science.280.5368.1378; Woods SC, 2011, PHYSIOL BEHAV, V104, P4, DOI 10.1016/j.physbeh.2011.04.026; Yamamoto T, 2000, FISHERIES SCI, V66, P528, DOI 10.1046/j.1444-2906.2000.00083.x	61	52	52	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2012	7	4							e34743	10.1371/journal.pone.0034743	http://dx.doi.org/10.1371/journal.pone.0034743			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JO	22496852	Green Published, gold, Green Submitted			2022-12-27	WOS:000305014500028
J	Daskalov, A; Paoletti, M; Ness, F; Saupe, SJ				Daskalov, Asen; Paoletti, Mathieu; Ness, Frederique; Saupe, Sven J.			Genomic Clustering and Homology between HET-S and the NWD2 STAND Protein in Various Fungal Genomes	PLOS ONE			English	Article							NON-SELF RECOGNITION; PROGRAMMED CELL-DEATH; PODOSPORA-ANSERINA; VEGETATIVE INCOMPATIBILITY; AMYLOID FIBRILS; PRION PROTEIN; HETEROKARYON INCOMPATIBILITY; HET-S(218-289) PRION; GENETIC-VARIATION; DOMAIN	Background: Prions are infectious proteins propagating as self-perpetuating amyloid polymers. The [Het-s] prion of Podospora anserina is involved in a cell death process associated with non-self recognition. The prion forming domain (PFD) of HET-s adopts a beta-solenoid amyloid structure characterized by the two fold repetition of an elementary triangular motif. [Het-s] induces cell death when interacting with HET-S, an allelic variant of HET-s. When templated by [Het-s], HET-S undergoes a trans-conformation, relocates to the cell membrane and induces toxicity. Methodology/Principal Findings: Here, comparing HET-s homologs from different species, we devise a consensus for the HET-s elementary triangular motif. We use this motif to screen genomic databases and find a match to the N-terminus of NWD2, a STAND protein, encoded by the gene immediately adjacent to het-S. STAND proteins are signal transducing ATPases which undergo ligand-induced oligomerisation. Homology modelling predicts that the NWD2 N-terminal region adopts a HET-s-like fold. We propose that upon NWD2 oligomerisation, these N-terminal extensions adopt the beta-solenoid fold and template HET-S to adopt the amyloid fold and trigger toxicity. We extend this model to a putative prion, the sigma infectious element in Nectria haematococca, because the s locus controlling propagation of sigma also encodes a STAND protein and displays analogous features. Comparative genomic analyses indicate evolutionary conservation of these STAND/prion-like gene pairs, identify a number of novel prion candidates and define, in addition to the HET-s PFD motif, two distinct, novel putative PFD-like motifs. Conclusions/Significance: We suggest the existence, in the fungal kingdom, of a widespread and evolutionarily conserved mode of signal transduction based on the transmission of an amyloid-fold from a NOD-like STAND receptor protein to an effector protein.	[Daskalov, Asen; Paoletti, Mathieu; Ness, Frederique; Saupe, Sven J.] Univ Bordeaux 2, CNRS, UMR 5095, Inst Biochim & Genet Cellulaire, F-33076 Bordeaux, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux	Daskalov, A (corresponding author), Univ Bordeaux 2, CNRS, UMR 5095, Inst Biochim & Genet Cellulaire, F-33076 Bordeaux, France.	sven.saupe@ibgc.u-bordeaux2.fr		saupe, sven/0000-0002-5589-721X				Aguzzi A, 2008, ANNU REV NEUROSCI, V31, P439, DOI 10.1146/annurev.neuro.31.060407.125620; Alexandrov IM, 2008, J BIOL CHEM, V283, P15185, DOI 10.1074/jbc.M802071200; Balguerie A, 2004, J CELL SCI, V117, P2599, DOI 10.1242/jcs.01116; Balguerie A, 2003, EMBO J, V22, P2071, DOI 10.1093/emboj/cdg213; Benkemoun L, 2011, MOL MICROBI IN PRESS; Blanco LP, 2012, TRENDS MICROBIOL, V20, P66, DOI 10.1016/j.tim.2011.11.005; Bratton SB, 2010, J CELL SCI, V123, P3209, DOI 10.1242/jcs.073643; Bryant C, 2009, TRENDS CELL BIOL, V19, P455, DOI 10.1016/j.tcb.2009.06.002; Chevanne D, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-134; Chevanne D, 2009, CURR GENET, V55, P93, DOI 10.1007/s00294-008-0227-5; Coustou V, 1997, P NATL ACAD SCI USA, V94, P9773, DOI 10.1073/pnas.94.18.9773; Crow ET, 2011, SEMIN CELL DEV BIOL, V22, P452, DOI 10.1016/j.semcdb.2011.03.003; Dalebroux ZD, 2010, MICROBIOL MOL BIOL R, V74, P171, DOI 10.1128/MMBR.00046-09; Dalstra HJP, 2003, P NATL ACAD SCI USA, V100, P6616, DOI 10.1073/pnas.1030058100; Danot O, 2009, STRUCTURE, V17, P172, DOI 10.1016/j.str.2009.01.001; DELEU C, 1990, NUCLEIC ACIDS RES, V18, P4901, DOI 10.1093/nar/18.16.4901; DELEU C, 1993, GENETICS, V135, P45; Derkatch IL, 2001, CELL, V106, P171, DOI 10.1016/S0092-8674(01)00427-5; Espagne E, 1997, MOL GEN GENET, V256, P620, DOI 10.1007/s004380050610; Espagne E, 2002, GENETICS, V161, P71; Gazit E, 2002, FASEB J, V16, P77, DOI 10.1096/fj.01-0442hyp; Glass NL, 2006, CURR OPIN MICROBIOL, V9, P553, DOI 10.1016/j.mib.2006.09.001; Graziani S, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-18; Greenwald J, 2010, STRUCTURE, V18, P1244, DOI 10.1016/j.str.2010.08.009; Greenwald J, 2010, MOL CELL, V38, P889, DOI 10.1016/j.molcel.2010.05.019; Halfmann R, 2012, NATURE, V482, P363, DOI 10.1038/nature10875; Halfmann R, 2011, MOL CELL, V43, P72, DOI 10.1016/j.molcel.2011.05.013; Halfmann R, 2010, TRENDS CELL BIOL, V20, P125, DOI 10.1016/j.tcb.2009.12.003; Hou FJ, 2011, CELL, V146, P448, DOI 10.1016/j.cell.2011.06.041; Kajava AV, 2010, FASEB J, V24, P1311, DOI 10.1096/fj.09-145979; Koonin EV, 2000, TRENDS BIOCHEM SCI, V25, P223, DOI 10.1016/S0968-0004(00)01577-2; Kubicek CP, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r40; Lange A, 2009, CHEMBIOCHEM, V10, P1657, DOI 10.1002/cbic.200900019; Larquet E, 2004, J MOL BIOL, V343, P1159, DOI 10.1016/j.jmb.2004.09.010; Lelpe DD, 2004, J MOL BIOL, V343, P1, DOI 10.1016/j.jmb.2004.08.023; Leveau JHJ, 2008, NEW PHYTOL, V177, P859, DOI 10.1111/j.1469-8137.2007.02325.x; Li LM, 2000, SCIENCE, V287, P661, DOI 10.1126/science.287.5453.661; Liu JJ, 1999, NATURE, V400, P573, DOI 10.1038/23048; Maddelein ML, 2002, P NATL ACAD SCI USA, V99, P7402, DOI 10.1073/pnas.072199199; Marshall KE, 2011, BIOCHEMISTRY-US, V50, P2061, DOI 10.1021/bi101936c; Mathur V, 2011, MOL CELLULA IN PRESS; Mattjus P, 2009, BBA-BIOMEMBRANES, V1788, P267, DOI 10.1016/j.bbamem.2008.10.003; McGlinchey RP, 2011, P NATL ACAD SCI USA, V108, P5337, DOI 10.1073/pnas.1102762108; Mitrophanov AY, 2008, BIOESSAYS, V30, P542, DOI 10.1002/bies.20769; Mizuno N, 2011, P NATL ACAD SCI USA, V108, P3252, DOI 10.1073/pnas.1011342108; Nakayashiki T, 2005, P NATL ACAD SCI USA, V102, P10575, DOI 10.1073/pnas.0504882102; Paoletti M, 2007, EUKARYOT CELL, V6, P2001, DOI 10.1128/EC.00129-07; Paoletti M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000283; Paoletti M, 2009, BIOESSAYS, V31, P1201, DOI 10.1002/bies.200900085; Pinan-Lucarre B, 2007, SEMIN CANCER BIOL, V17, P101, DOI 10.1016/j.semcancer.2006.11.009; Proell M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002119; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Reubold TF, 2011, STRUCTURE, V19, P1074, DOI 10.1016/j.str.2011.05.013; Riedl SJ, 2005, NATURE, V434, P926, DOI 10.1038/nature03465; Riedl SJ, 2007, NAT REV MOL CELL BIO, V8, P405, DOI 10.1038/nrm2153; Ritter C, 2005, NATURE, V435, P844, DOI 10.1038/nature03793; Ross ED, 2005, NAT CELL BIOL, V7, P1039, DOI 10.1038/ncb1105-1039; SAUPE S, 1995, GENE, V162, P135, DOI 10.1016/0378-1119(95)00272-8; SAUPE S, 1994, P NATL ACAD SCI USA, V91, P5927, DOI 10.1073/pnas.91.13.5927; Saupe S. J., 2011, SEMIN CELL DEV BIOL; Saupe SJ, 2000, MICROBIOL MOL BIOL R, V64, P489, DOI 10.1128/MMBR.64.3.489-502.2000; Saupe SJ, 2011, SEMIN CELL DEV BIOL, V22, P460, DOI 10.1016/j.semcdb.2011.02.019; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; Sen A, 2007, J BIOL CHEM, V282, P5545, DOI 10.1074/jbc.M611464200; Shi YG, 2006, CURR OPIN CELL BIOL, V18, P677, DOI 10.1016/j.ceb.2006.09.006; Ting JPY, 2008, NAT REV IMMUNOL, V8, P372, DOI 10.1038/nri2296; True HL, 2000, NATURE, V407, P477, DOI 10.1038/35035005; True HL, 2004, NATURE, V431, P184, DOI 10.1038/nature02885; Tsai HH, 2005, P NATL ACAD SCI USA, V102, P8174, DOI 10.1073/pnas.0408653102; Tuite MF, 2010, NAT REV MOL CELL BIO, V11, P823, DOI 10.1038/nrm3007; Van Melckebeke H, 2010, J AM CHEM SOC, V132, P13765, DOI [10.1021/ja104213J, 10.1021/ja104213j]; Van Ooijen G, 2008, J EXP BOT, V59, P1383, DOI 10.1093/jxb/ern045; Wasmer C, 2008, SCIENCE, V319, P1523, DOI 10.1126/science.1151839; Wasmer C, 2010, J MOL BIOL, V402, P311, DOI 10.1016/j.jmb.2010.06.053; Wasmer C, 2009, J MOL BIOL, V394, P119, DOI 10.1016/j.jmb.2009.09.015; WICKNER RB, 1994, SCIENCE, V264, P566, DOI 10.1126/science.7909170; Wickner RB, 1997, P NATL ACAD SCI USA, V94, P10012, DOI 10.1073/pnas.94.19.10012; Wickner RB, 2011, SEMIN CELL DEV BIOL; Yu XC, 2005, STRUCTURE, V13, P1725, DOI 10.1016/j.str.2005.09.006; Yuan SJ, 2011, STRUCTURE, V19, P1084, DOI 10.1016/j.str.2011.07.001	80	57	57	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2012	7	4							e34854	10.1371/journal.pone.0034854	http://dx.doi.org/10.1371/journal.pone.0034854			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JA	22493719	Green Published, Green Submitted, gold			2022-12-27	WOS:000305012700061
J	Huang, T; Wang, JJ; Cai, YD; Yu, H; Chou, KC				Huang, Tao; Wang, Junjie; Cai, Yu-Dong; Yu, Hanry; Chou, Kuo-Chen			Hepatitis C Virus Network Based Classification of Hepatocellular Cirrhosis and Carcinoma	PLOS ONE			English	Article							AMINO-ACID-COMPOSITION; PROTEIN STRUCTURAL CLASSES; CHRONIC LIVER-DISEASE; GENE-EXPRESSION; SUBCELLULAR-LOCALIZATION; DRUG-TARGET; NS3 PROTEIN; PREDICTION; HCV; INFECTION	Hepatitis C virus (HCV) is a main risk factor for liver cirrhosis and hepatocellular carcinoma, particularly to those patients with chronic liver disease or injury. The similar etiology leads to a high correlation of the patients suffering from the disease of liver cirrhosis with those suffering from the disease of hepatocellular carcinoma. However, the biological mechanism for the relationship between these two kinds of diseases is not clear. The present study was initiated in an attempt to investigate into the HCV infection protein network, in hopes to find good biomarkers for diagnosing the two diseases as well as gain insights into their progression mechanisms. To realize this, two potential biomarker pools were defined: (i) the target genes of HCV, and (ii) the between genes on the shortest paths among the target genes of HCV. Meanwhile, a predictor was developed for identifying the liver tissue samples among the following three categories: (i) normal, (ii) cirrhosis, and (iii) hepatocellular carcinoma. Interestingly, it was observed that the identification accuracy was higher with the tissue samples defined by extracting the features from the second biomarker pool than that with the samples defined based on the first biomarker pool. The identification accuracy by the jackknife validation for the between-genes approach was 0.960, indicating that the novel approach holds a quite promising potential in helping find effective biomarkers for diagnosing the liver cirrhosis disease and the hepatocellular carcinoma disease. It may also provide useful insights for in-depth study of the biological mechanisms of HCV-induced cirrhosis and hepatocellular carcinoma.	[Cai, Yu-Dong] Shanghai Univ, Inst Syst Biol, Shanghai, Peoples R China; [Huang, Tao] Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Syst Biol, Shanghai, Peoples R China; [Huang, Tao] Shanghai Ctr Bioinformat Technol, Shanghai, Peoples R China; [Huang, Tao] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China; [Cai, Yu-Dong] Fudan Univ, Ctr Computat Syst Biol, Shanghai 200433, Peoples R China; [Yu, Hanry] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Physiol, Singapore 117595, Singapore; [Yu, Hanry] ASTAR, Inst Bioengn & Nanotechnol, Singapore, Singapore; [Yu, Hanry] NUS Grad Sch Integrat Sci & Engn, Ctr Life Sci, Singapore, Singapore; [Wang, Junjie; Yu, Hanry] Natl Univ Singapore, Temasek Labs, Mechanobiol Inst Singapore, Singapore 117548, Singapore; [Wang, Junjie; Yu, Hanry] Singapore MIT Alliance, Computat & Syst Biol Program, Singapore, Singapore; [Yu, Hanry] Natl Univ Singapore, DSO Labs, NUS Tissue Engn Program, Singapore 117548, Singapore; [Yu, Hanry] Singapore MIT Alliance Res & Technol, Singapore, Singapore; [Yu, Hanry] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Cai, Yu-Dong; Chou, Kuo-Chen] Gordon Life Sci Inst, San Diego, CA USA	Shanghai University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Fudan University; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Bioengineering & Bioimaging (IBB); A*STAR - Institute of Bioengineering & Nanotechnology (IBN); National University of Singapore; National University of Singapore; Massachusetts Institute of Technology (MIT); Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Singapore-MIT Alliance for Research & Technology Centre (SMART); National University of Singapore; Singapore-MIT Alliance for Research & Technology Centre (SMART); Massachusetts Institute of Technology (MIT)	Cai, YD (corresponding author), Shanghai Univ, Inst Syst Biol, Shanghai, Peoples R China.	cai_yud@yahoo.com.cn; hanry_yu@nuhs.edu.sg; kcchou@gordonlifescience.org	Yu, Hanry/L-6050-2019; Yu, Hanry/C-7375-2011; Yu, Hanry/C-1031-2013; Chou, Kuo-Chen/A-8340-2009	Yu, Hanry/0000-0002-0339-3685; Yu, Hanry/0000-0002-0339-3685; cai, yudong/0000-0001-5664-7979	National Basic Research Program of China [2011CB510102, 2011CB510101]; Shanghai Municipal Education Commission [12ZZ087]; Institute of Bioengineering and Nanotechnology [R-185-000-182-592]; Singapore-MIT Alliance Computational and Systems Biology Flagship [C-382-641-001-091]; SMART (Singapore-MIT Alliance for Research and Technology) BioSyM and Mechanobiology Institute of Singapore [R-714-001-003-271]	National Basic Research Program of China(National Basic Research Program of China); Shanghai Municipal Education Commission(Shanghai Municipal Education Commission (SHMEC)); Institute of Bioengineering and Nanotechnology(Agency for Science Technology & Research (A*STAR)); Singapore-MIT Alliance Computational and Systems Biology Flagship(Singapore-MIT Alliance for Research & Technology Centre (SMART)); SMART (Singapore-MIT Alliance for Research and Technology) BioSyM and Mechanobiology Institute of Singapore(Singapore-MIT Alliance for Research & Technology Centre (SMART))	This work was supported by grants from National Basic Research Program of China (2011CB510102, 2011CB510101) and Innovation Program of Shanghai Municipal Education Commission (12ZZ087) to YDC and the Institute of Bioengineering and Nanotechnology Jassen Cilag Grant (R-185-000-182-592), (Singapore-MIT Alliance Computational and Systems Biology Flagship Project (C-382-641-001-091), SMART (Singapore-MIT Alliance for Research and Technology) BioSyM and Mechanobiology Institute of Singapore (R-714-001-003-271) to HY. JW is SMA (Singapore-MIT Alliance) scholar. The funders had no role in study desgin, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham G, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-277; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Carmona-Saez P, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r3; Casey LM, 2006, DEV DYNAM, V235, P1830, DOI 10.1002/dvdy.20821; Chartrand G, 1992, APPL ALGORITHMIC GRA; Chen SH, 2005, CURR MED CHEM, V12, P2317, DOI 10.2174/0929867054864769; CHOU KC, 1995, CRIT REV BIOCHEM MOL, V30, P275, DOI 10.3109/10409239509083488; CHOU KC, 1995, PROTEINS, V21, P319, DOI 10.1002/prot.340210406; Chou KC, 2008, NAT PROTOC, V3, P153, DOI 10.1038/nprot.2007.494; Chou KC, 2007, ANAL BIOCHEM, V370, P1, DOI 10.1016/j.ab.2007.07.006; Chou KC, 2012, MOL BIOSYST, V8, P629, DOI 10.1039/c1mb05420a; Chou KC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018258; Chou KC, 2011, J THEOR BIOL, V273, P236, DOI 10.1016/j.jtbi.2010.12.024; Chou KC, 2009, CURR PROTEOMICS, V6, P262, DOI 10.2174/157016409789973707; Cook GA, 2011, BIOPOLYMERS, V96, P32, DOI 10.1002/bip.21453; Cormen Thomas H., 2009, INTRO ALGORITHMS; COVER TM, 1967, IEEE T INFORM THEORY, V13, P21, DOI 10.1109/TIT.1967.1053964; Cubas R, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-253; de Chassey B, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.66; De Giorgi V, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-85; Deng L, 2006, J GEN VIROL, V87, P1703, DOI 10.1099/vir.0.81735-0; DENOEUX T, 1995, IEEE T SYST MAN CYB, V25, P804, DOI 10.1109/21.376493; Dijkstra E.W, 1959, NUMER MATH, V1, P269, DOI DOI 10.1007/BF01386390; El-Serag HB, 2008, GASTROENTEROLOGY, V134, P1752, DOI 10.1053/j.gastro.2008.02.090; El-Serag HB, 1999, NEW ENGL J MED, V340, P745, DOI 10.1056/NEJM199903113401001; Esmaeili M, 2010, J THEOR BIOL, V263, P203, DOI 10.1016/j.jtbi.2009.11.016; Farazi PA, 2006, NAT REV CANCER, V6, P674, DOI 10.1038/nrc1934; Frick DN, 2007, CURR ISSUES MOL BIOL, V9, P1; FRIEDMAN JH, 1975, IEEE T COMPUT, V24, P1000, DOI 10.1109/T-C.1975.224110; Gao M, 2010, NATURE, V465, P96, DOI 10.1038/nature08960; Garbi N, 2006, NAT IMMUNOL, V7, P93, DOI 10.1038/ni1288; He ZS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009603; Hoshida Y, 2008, NEW ENGL J MED, V359, P1995, DOI 10.1056/NEJMoa0804525; Hu LL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014556; Huang T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025297; Huang T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022940; Huang T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010972; Huang T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008126; Huber W, 2004, BIOINFORMATICS, V20, P1651, DOI 10.1093/bioinformatics/bth133; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Kiernan AE, 2005, DEVELOPMENT, V132, P4353, DOI 10.1242/dev.02002; Kudo M, 2011, DIGEST DIS, V29, P316, DOI 10.1159/000327568; Lemmer ER, 2006, SEMIN LIVER DIS, V26, P373, DOI 10.1055/s-2006-951604; Lenschow DJ, 2005, J VIROL, V79, P13974, DOI 10.1128/JVI.79.22.13974-13983.2005; Lin WZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024756; Mahalanobis P.C., 1936, P NATL I SCI INDIA, V2, P49, DOI DOI 10.1145/1390156.1390302; Mas VR, 2009, MOL MED, V15, P85, DOI 10.2119/molmed.2008.00110; Michiels S, 2005, LANCET, V365, P488, DOI 10.1016/S0140-6736(05)17866-0; Mohabatkar H, 2011, J THEOR BIOL, V281, P18, DOI 10.1016/j.jtbi.2011.04.017; Mousseau G, 2011, J GEN VIROL, V92, P101, DOI 10.1099/vir.0.023325-0; Nanni L, 2009, PROTEIN PEPTIDE LETT, V16, P163, DOI 10.2174/092986609787316199; Nogales-Cadenas R, 2009, NUCLEIC ACIDS RES, V37, pW317, DOI 10.1093/nar/gkp416; Nomoto S, 2010, ANN SURG ONCOL, V17, P923, DOI 10.1245/s10434-009-0790-0; Oppmann B, 2000, IMMUNITY, V13, P715, DOI 10.1016/S1074-7613(00)00070-4; Parham C, 2002, J IMMUNOL, V168, P5699, DOI 10.4049/jimmunol.168.11.5699; Peng HC, 2005, IEEE T PATTERN ANAL, V27, P1226, DOI 10.1109/TPAMI.2005.159; Pietras A, 2011, MOL CANCER RES, V9, P626, DOI 10.1158/1541-7786.MCR-10-0508; Pillai KCS, 1985, ENCY STATISTICAL SCI, P176; Piskin G, 2006, J IMMUNOL, V176, P1908, DOI 10.4049/jimmunol.176.3.1908; Romero-Gomez M, 2006, WORLD J GASTROENTERO, V12, P7075, DOI 10.3748/wjg.v12.i44.7075; Shang S, 2011, HEPATOLOGY; Shim EK, 2011, J IMMUNOL, V186, P2926, DOI 10.4049/jimmunol.1001785; Silva CM, 2004, ONCOGENE, V23, P8017, DOI 10.1038/sj.onc.1208159; Song EL, 2011, GYNECOL ONCOL, V121, P174, DOI 10.1016/j.ygyno.2010.11.004; Strosberg AD, 2010, VIRUSES-BASEL, V2, P1734, DOI 10.3390/v2081734; Su WH, 2007, NUCLEIC ACIDS RES, V35, pD727, DOI 10.1093/nar/gkl845; Tagger A, 1999, INT J CANCER, V81, P695, DOI 10.1002/(SICI)1097-0215(19990531)81:5<695::AID-IJC4>3.3.CO;2-N; TSUKUMA H, 1993, NEW ENGL J MED, V328, P1797, DOI 10.1056/NEJM199306243282501; Walker Michelle P., 2003, Antiviral Chemistry & Chemotherapy, V14, P1; Wang FJ, 2007, INT J ONCOL, V30, P33; Wang P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018476; Wang P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023505; Wang YH, 2010, DEV DYNAM, V239, P2522, DOI 10.1002/dvdy.22394; Wu TT, 1998, MOL BIOL CELL, V9, P1661, DOI 10.1091/mbc.9.7.1661; Wu ZC, 2012, PROTEIN PEPTIDE LETT, V19, P4, DOI 10.2174/092986612798472839; Wu ZC, 2011, MOL BIOSYST, V7, P3287, DOI 10.1039/c1mb05232b; Xiao X, 2011, J THEOR BIOL, V284, P42, DOI 10.1016/j.jtbi.2011.06.005; Xiao X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020592; Xiao XA, 2011, MOL BIOSYST, V7, P911, DOI 10.1039/c0mb00170h; Zhang LH, 2005, WORLD J GASTROENTERO, V11, P463, DOI 10.3748/wjg.v11.i4.463; Zhang ZJ, 2011, J CLIN LAB ANAL, V25, P402, DOI 10.1002/jcla.20491; Zhao C, 2005, P NATL ACAD SCI USA, V102, P10200, DOI 10.1073/pnas.0504754102	83	51	51	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2012	7	4							e34460	10.1371/journal.pone.0034460	http://dx.doi.org/10.1371/journal.pone.0034460			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JA	22493692	Green Published, gold, Green Submitted			2022-12-27	WOS:000305012700034
J	Valentine, LE; Reaveley, A; Johnson, B; Fisher, R; Wilson, BA				Valentine, Leonie E.; Reaveley, Alice; Johnson, Brent; Fisher, Rebecca; Wilson, Barbara A.			Burning in Banksia Woodlands: How Does the Fire-Free Period Influence Reptile Communities?	PLOS ONE			English	Article							WILDLAND-URBAN INTERFACE; SUCCESSION; REGIMES; CONSERVATION; LIZARDS; DISTURBANCE; MANAGEMENT; DIVERSITY; AUSTRALIA; RESPONSES	Fire is an important management tool for both hazard reduction burning and maintenance of biodiversity. The impact of time since last fire on fauna is an important factor to understand as land managers often aim for prescribed burning regimes with specific fire-free intervals. However, our current understanding of the impact of time since last fire on fauna is largely unknown and likely dependent on vegetation type. We examined the responses of reptiles to fire age in banksia woodlands, and the interspersed melaleuca damplands among them, north of Perth, Western Australia, where the current prescribed burning regime is targeting a fire-free period of 8-12 years. The response of reptiles to fire was dependent on vegetation type. Reptiles were generally more abundant (e.g. Lerista elegans and Ctenophorus adelaidensis) and specious in banksia sites. Several species (e.g. Menetia greyii, Cryptoblepharus buchananii) preferred long unburnt melaleuca sites (>16 years since last fire, YSLF) compared to recently burnt sites (<12 YSLF). Several of the small elapids (e.g. the WA priority listed species Neelaps calonotus) were only detected in older-aged banksia sites (>16 YSLF). The terrestrial dragon C. adelaidensis and the skink Morethia obscura displayed a strong response to fire in banksia woodlands only. Highest abundances of the dragon were detected in the recently burnt (<7 YSLF) and long unburnt (>35 YSLF) banksia woodlands, while the skink was more abundant in older sites. Habitats from a range of fire ages are required to support the reptiles we detected, especially the longer unburnt (>16 YSLF) melaleuca habitat. Current burning prescriptions are reducing the availability of these older habitats.	[Valentine, Leonie E.] Murdoch Univ, Sch Vet & Biomed Sci, Western Australian Ctr Excellence Climate Change, Perth, WA, Australia; [Reaveley, Alice; Johnson, Brent; Wilson, Barbara A.] Gnangara Sustainabil Strategy, Dept Environm & Conservat, Perth, WA, Australia; [Fisher, Rebecca] Univ Western Australia, Oceans Inst, Perth, WA 6009, Australia	Murdoch University; University of Western Australia	Valentine, LE (corresponding author), Murdoch Univ, Sch Vet & Biomed Sci, Western Australian Ctr Excellence Climate Change, Perth, WA, Australia.	l.valentine@murdoch.edu.au	Fisher, Rebecca/C-5459-2011; Valentine, Leonie Ellen/G-9963-2012	Fisher, Rebecca/0000-0001-5148-6731; Valentine, Leonie Ellen/0000-0003-1479-0755	Government of Western Australia	Government of Western Australia	Funding for the research was via the Gnangara Sustainability Strategy, Government of Western Australia. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	[Anonymous], 2004, HOTSPOTS REVISITED E; [Anonymous], 1981, FIRE AUSTR BIOTA; BEARD JS, 1984, KWONGAN PLANT LIFE S, P1; Behn G., 2001, Australian Forestry, V64, P80; Behn G., 2009, DEV REMOTELY SENSED; Bond W. J., 1996, FIRE PLANTS, DOI DOI 10.2307/2404797; BRAITHWAITE RW, 1987, J TROP ECOL, V3, P265, DOI 10.1017/S0266467400002145; Brawn JD, 2001, ANNU REV ECOL SYST, V32, P251, DOI 10.1146/annurev.ecolsys.32.081501.114031; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Burrows N., 2003, FIRE S W W AUSTR SYN; BURROWS ND, 1990, J ENVIRON MANAGE, V31, P229, DOI 10.1016/S0301-4797(05)80036-2; Caughley J., 1985, P31; Clarke MF, 2008, WILDLIFE RES, V35, P385, DOI 10.1071/WR07137; Colwell R.K., 2006, ESTIMATES STAT ESTIM; Craig MD, 2010, RESTOR ECOL, V18, P300, DOI 10.1111/j.1526-100X.2009.00526.x; Cunningham SC, 2002, BIOL CONSERV, V107, P193, DOI 10.1016/S0006-3207(02)00064-2; Dell J, 1995, BURNING OUR BUSHLAND, P35; DODD J, 1989, Journal of the Royal Society of Western Australia, V71, P89; Fernandes PM, 2003, INT J WILDLAND FIRE, V12, P117, DOI 10.1071/WF02042; Fox Barry J., 1996, P467, DOI 10.1016/B978-012178075-3/50016-7; FOX BJ, 1982, ECOLOGY, V63, P1332, DOI 10.2307/1938861; FOX BJ, 1979, AUST J BOT, V27, P157, DOI 10.1071/BT9790157; FRIEND GR, 1993, BIOL CONSERV, V65, P99, DOI 10.1016/0006-3207(93)90439-8; Galiana-Martin L, 2011, LANDSCAPE RES, V36, P151, DOI 10.1080/01426397.2010.549218; *GOV W AUSTR, 2000, BUSH FOR, V1; Government of Western Australia, 2009, GNANG SUST STRAT SIT; GREENBERG CH, 1994, CONSERV BIOL, V8, P1047, DOI 10.1046/j.1523-1739.1994.08041047.x; Hayward Matt W., 2008, Conservation Science Western Australia, V7, P35; Kitchener DJ, 1978, MAMMALS N SWAN COAST, P54; KRUSKAL JB, 1964, PSYCHOMETRIKA, V29, P1, DOI 10.1007/BF02289565; Letnic M, 2004, J ARID ENVIRON, V59, P85, DOI 10.1016/j.jaridenv.2004.01.014; Masters P, 1996, WILDLIFE RES, V23, P39, DOI 10.1071/WR9960039; Mattiske Consulting Pty Ltd, 2003, FLOR VEG STUD GNAN A; McCune B, 1999, MULTIVARIATE ANAL EC; McCune B., 2002, ANAL ECOLOGICAL COMM, DOI 10.1016/S0022-0981(03)00091-1; Mielke P.W., 1984, HDB STAT, V4, P813, DOI DOI 10.1016/S0169-7161(84)04036-0; Mitchell D, 2003, BIODIVERSITY AUDIT W; Muller C, 2010, FIRE MANAGEMENT OPER; Parr CL, 2006, CONSERV BIOL, V20, P1610, DOI 10.1111/j.1523-1739.2006.00492.x; Penman TD, 2011, INT J WILDLAND FIRE, V20, P721, DOI 10.1071/WF09131; PIANKA ER, 1989, AM NAT, V134, P344, DOI 10.1086/284985; Pianka ER, 2012, AUSTRAL ECOL, V37, P1, DOI 10.1111/j.1442-9993.2010.02234.x; PIELOU EC, 1966, J THEOR BIOL, V13, P131, DOI 10.1016/0022-5193(66)90013-0; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Radeloff VC, 2005, ECOL APPL, V15, P799, DOI 10.1890/04-1413; Russell-Smith J, 2003, INT J WILDLAND FIRE, V12, P283, DOI 10.1071/WF03015; SEMENIUK C A, 1990, Journal of the Royal Society of Western Australia, V72, P109; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Storr GM, 1978, FAUNAL STUDIES NO SW, P172; Taylor JE, 2001, AUSTRAL ECOL, V26, P193, DOI 10.1046/j.1442-9993.2001.01105.x; TRAINOR CR, 1994, WILDLIFE RES, V21, P131, DOI 10.1071/WR9940131; Underwood R.J., 1985, P S FIR EC MAN W AUS, P153; Valentine LE, 2007, BIOL CONSERV, V137, P90, DOI 10.1016/j.biocon.2007.01.018; Valentine LE, 2012, AUSTRAL ECOL, V37, P23, DOI 10.1111/j.1442-9993.2011.02244.x; Wallace Jeremy, 2006, Ecological Management & Restoration, V7, pS31, DOI 10.1111/j.1442-8903.2006.00289.x; Whelan R.J.., 1995, ECOLOGY FIRE; Whelan RJ, 2002, CONSERV BIOL, V16, P1659, DOI 10.1046/j.1523-1739.2002.02091.x; Wilson BA, 2009, BIOD VAL THREAT PROC; Wilson BA, 2010, GUIDELINES ECOLOGICA; Wittkuhn RS, 2011, FOREST ECOL MANAG, V261, P965, DOI 10.1016/j.foreco.2010.10.037; Woinarski JCZ, 1999, RANGELAND J, V21, P24, DOI 10.1071/RJ9990024; Yesertener C., 2007, ASSESSMENT DECLINING; Zar JH, 1999, BIOSTATISTICAL ANAL; Zuur Alain F., 2009, P1	64	32	36	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2012	7	4							e34448	10.1371/journal.pone.0034448	http://dx.doi.org/10.1371/journal.pone.0034448			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955IH	22496806	Green Published, gold			2022-12-27	WOS:000305010500008
J	Han, Y; Hou, GY; Jiang, WM; Han, CH; Liu, S; Chen, J; Li, JP; Zhang, P; Huang, BX; Liu, YH; Chen, JM				Han, Yan; Hou, Guangyu; Jiang, Wenming; Han, Chunhua; Liu, Shuo; Chen, Jie; Li, Jinping; Zhang, Peng; Huang, Baoxu; Liu, Yuehuan; Chen, Jiming			A Survey of Avian Influenza in Tree Sparrows in China in 2011	PLOS ONE			English	Article							WILD BIRDS; VIRUS SURVEILLANCE; PASSER-DOMESTICUS; EUROPEAN-UNION; H5N1; EPIDEMIOLOGY; GENERATION; POULTRY	Tree sparrows (Passer montanus) are widely distributed in all seasons in many countries. In this study, a survey and relevant experiments on avian influenza (AI) in tree sparrows were conducted. The results suggested that the receptor for avian influenza viruses (AIVs), SA alpha 2,3Gal,is abundant in the respiratory tract of tree sparrows, and most of the tree sparrows infected experimentally with two H5 subtype highly pathogenic avian influenza ( HPAI) viruses died within five days after inoculation. Furthermore, no AIVs were isolated from the rectum eluate of 1300 tree sparrows, but 94 serological positives of AI were found in 800 tree sparrows. The serological positives were more prevalent for H5 subtype HPAI (94/800) than for H7 subtype AI (0/800), more prevalent for clade 2.3.2.1 H5 subtype HPAI (89/800) than for clade 2.3.4 (1/800) and clade 7.2 (4/800) H5 subtype HPAI, more prevalent for clade 2.3.2.1 H5 subtype HPAI in a city in southern China (82/800) than in a city in northern China (8/800). The serological data are all consistent with the distribution of the subtypes or clades of AI in poultry in China. Previously, sparrows or other passerine birds were often found to be pathogenically negative for AIVs, except when an AIV was circulating in the local poultry, or the tested passerine birds were from a region near waterfowl-rich bodies of water. Taken together, the data suggest that tree sparrows are susceptible to infection of AIVs, and surveys targeting sparrows can provide good serological data about the circulation of AIVs in relevant regions.	[Han, Yan; Hou, Guangyu; Jiang, Wenming; Liu, Shuo; Chen, Jie; Li, Jinping; Zhang, Peng; Huang, Baoxu; Chen, Jiming] China Anim Hlth & Epidemiol Ctr, Qingdao, Peoples R China; [Han, Yan; Zhang, Peng] Qingdao Agr Univ, Coll Anim Sci & Vet Med, Qingdao, Peoples R China; [Han, Chunhua; Liu, Yuehuan] Beijing Acad Agr & Forestry Sci, Inst Anim & Husb Med, Beijing, Peoples R China	China Animal Health & Epidemiology Center; Qingdao Agricultural University; Beijing Academy of Agriculture & Forestry	Han, Y (corresponding author), China Anim Hlth & Epidemiol Ctr, Qingdao, Peoples R China.	jmchen66@yahoo.cn	Chen, Jiming/AAA-3575-2020; Chen, Ji-Ming/AHD-7398-2022	Chen, Jiming/0000-0003-3155-3145; Chen, Jiming/0000-0002-0404-0830	Ministry of Agriculture of People's Republic of China	Ministry of Agriculture of People's Republic of China	This work was supported by the Avian Influenza Surveillance Program of the Ministry of Agriculture of People's Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DJ, 2007, AVIAN DIS, V51, P161, DOI 10.1637/7602-041306R.1; Barbour Elie K, 2007, Vet Ital, V43, P33; Boon ACM, 2007, EMERG INFECT DIS, V13, P1720, DOI 10.3201/eid1311.070114; Boyce WM, 2009, COMP IMMUNOL MICROB, V32, P275, DOI 10.1016/j.cimid.2008.01.002; Breed AC, 2010, AVIAN DIS, V54, P399, DOI 10.1637/8950-053109-Reg.1; Brown JD, 2009, J VET DIAGN INVEST, V21, P437, DOI 10.1177/104063870902100404; Capua I, 2000, VET REC, V147, P640; Chen JM, 2007, AM J INFECT CONTROL, V35, P351, DOI 10.1016/j.ajic.2006.07.016; Dalessi S, 2007, AVIAN DIS, V51, P355, DOI 10.1637/7580-040106R.1; De Marco MA, 2003, VET RES COMMUN, V27, P107, DOI 10.1023/B:VERC.0000014126.72654.22; Forrest HL, 2010, J VIROL, V84, P3718, DOI 10.1128/JVI.02017-09; Fouchier RAM, 2009, REV SCI TECH OIE, V28, P49, DOI 10.20506/rst.28.1.1863; Fouchier RAM, 2003, AVIAN DIS, V47, P857, DOI 10.1637/0005-2086-47.s3.857; Gutierrez RA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028609; Hesterberg U, 2009, INFLUENZA OTHER RESP, V3, P1, DOI 10.1111/j.1750-2659.2008.00058.x; Hoffmann E, 2001, ARCH VIROL, V146, P2275, DOI 10.1007/s007050170002; Hoffmann E, 2002, VACCINE, V20, P3165, DOI 10.1016/S0264-410X(02)00268-2; Hoye BJ, 2010, EMERG INFECT DIS, V16, P1827, DOI 10.3201/eid1612.100589; Ito T, 1998, J VIROL, V72, P7367, DOI 10.1128/JVI.72.9.7367-7373.1998; Jiang WM, 2010, J GEN VIROL, V91, P2491, DOI 10.1099/vir.0.023168-0; Kang HM, 2010, J WILDLIFE DIS, V46, P878, DOI 10.7589/0090-3558-46.3.878; Kou Z, 2005, J VIROL, V79, P15460, DOI 10.1128/JVI.79.24.15460-15466.2005; Kou Z, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006926; Krauss S, 2010, AVIAN DIS, V54, P394, DOI 10.1637/8703-031609-Review.1; Li YB, 2006, VIRUS GENES, V33, P117, DOI 10.1007/s11262-005-0042-8; Liu QF, 2010, VIRUS RES, V147, P25, DOI 10.1016/j.virusres.2009.09.014; Liu S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005022; Liu YH, 2009, AVIAN PATHOL, V38, P263, DOI 10.1080/03079450903055363; Lvov DK, 2010, AVIAN DIS, V54, P483, DOI 10.1637/8893-042509-Review.1; Martin V, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001308; Morishita TY, 1999, AVIAN DIS, V43, P549, DOI 10.2307/1592655; Nemeth NM, 2010, AVIAN PATHOL, V39, P411, DOI 10.1080/03079457.2010.513043; NESTOROWICZ A, 1987, VIROLOGY, V160, P411, DOI 10.1016/0042-6822(87)90012-2; OIE (World Organization for Animal Health), 2011, TERR AN HLTH COD; Perez-Ramirez E, 2010, VET MICROBIOL, V146, P200, DOI 10.1016/j.vetmic.2010.05.008; Peterson AT, 2008, EMERG INFECT DIS, V14, P1644, DOI 10.3201/eid1410.080169; Poetranto ED, 2011, MICROBIOL IMMUNOL, V55, P666, DOI 10.1111/j.1348-0421.2011.00361.x; Samaan G, 2011, PREV VET MED, V100, P71, DOI 10.1016/j.prevetmed.2011.03.003; SIDORENKO EV, 1985, VOP VIRUSOL+, P657; Smith GJD, 2012, INFLUENZA OTHER RESP, V6, P1, DOI 10.1111/j.1750-2659.2011.00298.x; Summers-Smith JD, 2009, HDB BIRDS WORLD, V14, P759	42	11	12	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e33092	10.1371/journal.pone.0033092	http://dx.doi.org/10.1371/journal.pone.0033092			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GO	22496742	Green Published, Green Submitted, gold			2022-12-27	WOS:000304855200009
J	Padmanabhan, K; Wang, KY; Samatova, NF				Padmanabhan, Kanchana; Wang, Kuangyu; Samatova, Nagiza F.			Functional Annotation of Hierarchical Modularity	PLOS ONE			English	Article							GENE-EXPRESSION DATA; OXIDATIVE-STRESS; SACCHAROMYCES-CEREVISIAE; PROTEIN COMPLEXES; PLASMA-MEMBRANE; ONTOLOGY TERMS; YEAST RVS161; MODULES; TOOL; INFORMATION	In biological networks of molecular interactions in a cell, network motifs that are biologically relevant are also functionally coherent, or form functional modules. These functionally coherent modules combine in a hierarchical manner into larger, less cohesive subsystems, thus revealing one of the essential design principles of system-level cellular organization and function-hierarchical modularity. Arguably, hierarchical modularity has not been explicitly taken into consideration by most, if not all, functional annotation systems. As a result, the existing methods would often fail to assign a statistically significant functional coherence score to biologically relevant molecular machines. We developed a methodology for hierarchical functional annotation. Given the hierarchical taxonomy of functional concepts (e.g., Gene Ontology) and the association of individual genes or proteins with these concepts (e. g., GO terms), our method will assign a Hierarchical Modularity Score (HMS) to each node in the hierarchy of functional modules; the HMS score and its p-value measure functional coherence of each module in the hierarchy. While existing methods annotate each module with a set of "enriched'' functional terms in a bag of genes, our complementary method provides the hierarchical functional annotation of the modules and their hierarchically organized components. A hierarchical organization of functional modules often comes as a bi-product of cluster analysis of gene expression data or protein interaction data. Otherwise, our method will automatically build such a hierarchy by directly incorporating the functional taxonomy information into the hierarchy search process and by allowing multi-functional genes to be part of more than one component in the hierarchy. In addition, its underlying HMS scoring metric ensures that functional specificity of the terms across different levels of the hierarchical taxonomy is properly treated. We have evaluated our method using Saccharomyces cerevisiae data from KEGG and MIPS databases and several other computationally derived and curated datasets. The code and additional supplemental files can be obtained from http://code.google.com/p/functional-annotation-of-hierarchical-modularity/ (Accessed 2012 March 13).	[Padmanabhan, Kanchana; Samatova, Nagiza F.] N Carolina State Univ, Dept Comp Sci, Raleigh, NC 27695 USA; [Wang, Kuangyu] N Carolina State Univ, Bioinformat Res Ctr, Raleigh, NC 27695 USA; [Padmanabhan, Kanchana; Samatova, Nagiza F.] Oak Ridge Natl Lab, Oak Ridge, TN USA	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; United States Department of Energy (DOE); Oak Ridge National Laboratory	Padmanabhan, K (corresponding author), N Carolina State Univ, Dept Comp Sci, Raleigh, NC 27695 USA.	Samatova@csc.ncsu.edu			U.S. Department of Energy (DOE), Office of Science; Office of Advanced Scientific Computing Research (ASCR); Office of Biological and Environmental Research (BER); U.S. National Science Foundation (Expeditions in Computing); UT-Battelle for the LLC U.S. DOE [DEAC05-00OR22725]	U.S. Department of Energy (DOE), Office of Science(United States Department of Energy (DOE)); Office of Advanced Scientific Computing Research (ASCR)(Czech Academy of Sciences); Office of Biological and Environmental Research (BER); U.S. National Science Foundation (Expeditions in Computing)(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE)); UT-Battelle for the LLC U.S. DOE(United States Department of Energy (DOE))	This work was supported in part by the U.S. Department of Energy (DOE), Office of Science, the Office of Advanced Scientific Computing Research (ASCR) and the Office of Biological and Environmental Research (BER) and the U.S. National Science Foundation (Expeditions in Computing). Oak Ridge National Laboratory is managed by UT-Battelle for the LLC U.S. DOE under contract no. DEAC05-00OR22725. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Shahrour F, 2004, BIOINFORMATICS, V20, P578, DOI 10.1093/bioinformatics/btg455; Alexa A, 2006, BIOINFORMATICS, V22, P1600, DOI 10.1093/bioinformatics/btl140; Apostolico A, 2006, LECT NOTES COMPUTER, V3909, P85; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bauer S, 2008, BIOINFORMATICS, V24, P1650, DOI 10.1093/bioinformatics/btn250; Beissbarth T, 2004, BIOINFORMATICS, V20, P1464, DOI 10.1093/bioinformatics/bth088; Berriz GF, 2003, BIOINFORMATICS, V19, P2502, DOI 10.1093/bioinformatics/btg363; BEZDEK JC, 1984, COMPUT GEOSCI, V10, P191, DOI 10.1016/0098-3004(84)90020-7; Boyle EI, 2004, BIOINFORMATICS, V20, P3710, DOI 10.1093/bioinformatics/bth456; Breton AM, 2001, YEAST, V18, P1053, DOI 10.1002/yea.755; Budanitsky Alexander, 2001, WORKSH WORDNET OTH L, V2, P2; Carmona-Saez P, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r3; Castillo-Davis CI, 2003, BIOINFORMATICS, V19, P891, DOI 10.1093/bioinformatics/btg114; Chagoyen M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-444; Chen JC, 2006, BIOINFORMATICS, V22, P2283, DOI 10.1093/bioinformatics/btl370; DURRENS P, 1995, CURR GENET, V27, P213, DOI 10.1007/BF00326151; GARCIARUIZ C, 1995, MOL PHARMACOL, V48, P825; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; GERRITY JP, 1992, MON WEATHER REV, V120, P2709, DOI 10.1175/1520-0493(1992)120<2709:ANOGAM>2.0.CO;2; Geva AB, 1999, IEEE T FUZZY SYST, V7, P723, DOI 10.1109/91.811242; GRUNE T, 1995, J BIOL CHEM, V270, P2344, DOI 10.1074/jbc.270.5.2344; Guldener U, 2006, NUCLEIC ACIDS RES, V34, pD436, DOI 10.1093/nar/gkj003; Gulshan K, 2004, EUKARYOT CELL, V3, P318, DOI 10.1128/EC.3.2.318-330.2004; Hach A, 1999, MOL CELL BIOL, V19, P4324; Hand RA, 2003, EUKARYOT CELL, V2, P306, DOI 10.1128/EC.2.2.306-317.2003; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Heidke P., 1926, GEOGR ANN, V8; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Horng YJ, 2005, IEEE T FUZZY SYST, V13, P216, DOI 10.1109/TFUZZ.2004.840134; Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Jiang J.J., 1997, P INT C RES COMP LIN, P19; JOHNSTON M, 1987, MICROBIOL REV, V51, P458, DOI 10.1128/MMBR.51.4.458-476.1987; Jupiter D, 2010, INFORMS J COMPUT, V22, P210, DOI 10.1287/ijoc.1090.0356; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; KIKUCHI Y, 1994, MOL GEN GENET, V245, P107, DOI 10.1007/BF00279756; Kobayashi A, 2006, MOL CELL BIOL, V26, P221, DOI 10.1128/MCB.26.1.221-229.2006; Krogan NJ, 2004, MOL CELL, V13, P225, DOI 10.1016/S1097-2765(04)00003-6; LANCE GN, 1967, COMPUT J, V9, P373, DOI 10.1093/comjnl/9.4.373; Lavoie H, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000329; Lin D., 1998, Machine Learning. Proceedings of the Fifteenth International Conference (ICML'98), P296; Liu L, 2003, J BIOL CHEM, V278, P31998, DOI 10.1074/jbc.M303553200; Luo F, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S4-S8; Ma HW, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-199; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Masseroli M, 2004, NUCLEIC ACIDS RES, V32, pW293, DOI 10.1093/nar/gkh432; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Mistry M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-327; MUNN AL, 1995, MOL BIOL CELL, V6, P1721, DOI 10.1091/mbc.6.12.1721; Myer VE, 1998, J BIOL CHEM, V273, P27757, DOI 10.1074/jbc.273.43.27757; North BV, 2002, AM J HUM GENET, V71, P439, DOI 10.1086/341527; Pandey J, 2008, BIOINFORMATICS, V24, pI28, DOI 10.1093/bioinformatics/btn296; Pandey J, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S1-S35; Peirce C S, 1884, Science, V4, P453, DOI 10.1126/science.ns-4.93.453-a; Pilauri V, 2005, GENETICS, V169, P1903, DOI 10.1534/genetics.104.036723; Platt A, 1998, EMBO J, V17, P4086, DOI 10.1093/emboj/17.14.4086; Pu SY, 2009, NUCLEIC ACIDS RES, V37, P825, DOI 10.1093/nar/gkn1005; Quinn J., 2008, STRESS YEASTS FILAME, P67; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; Raychaudhuri S, 2003, BIOINFORMATICS, V19, P396, DOI 10.1093/bioinformatics/btg002; Raychaudhuri S, 2002, GENOME RES, V12, P1582, DOI 10.1101/gr.116402; Resnik P, 1999, J ARTIF INTELL RES, V11, P95, DOI 10.1613/jair.514; Rey FE, 2007, APPL ENVIRON MICROB, V73, P1665, DOI 10.1128/AEM.02565-06; Ruepp A, 2004, NUCLEIC ACIDS RES, V32, P5539, DOI 10.1093/nar/gkh894; Ruths T, 2009, BIOINFORMATICS, V25, P1178, DOI 10.1093/bioinformatics/btp128; Sallusto F, 2009, EUR J IMMUNOL, V39, P2076, DOI 10.1002/eji.200939722; Schaffrath R, 2000, FUNGAL GENET BIOL, V30, P173, DOI 10.1006/fgbi.2000.1221; SCHLESSER A, 1988, J BIOL CHEM, V263, P19480; SELLECK SB, 1987, MOL CELL BIOL, V7, P3260, DOI 10.1128/MCB.7.9.3260; Shah NH, 2004, BIOINFORMATICS, V20, P1196, DOI 10.1093/bioinformatics/bth056; SIVADON P, 1995, MOL GEN GENET, V246, P485, DOI 10.1007/BF00290452; Spirin V, 2003, P NATL ACAD SCI USA, V100, P12123, DOI 10.1073/pnas.2032324100; Stevens SW, 1999, P NATL ACAD SCI USA, V96, P7226, DOI 10.1073/pnas.96.13.7226; Tachihara K, 2005, J BIOL CHEM, V280, P12637, DOI 10.1074/jbc.M410778200; Tai SL, 2007, MOL BIOL CELL, V18, P5100, DOI 10.1091/mbc.E07-02-0131; Tsekouras G, 2005, FUZZY SET SYST, V150, P245, DOI 10.1016/j.fss.2004.04.013; Wang QQ, 2002, P NATL ACAD SCI USA, V99, P12853, DOI 10.1073/pnas.202115499; Wu CY, 2009, J BIOL CHEM, V284, P27544, DOI 10.1074/jbc.M109.042036; Young A, 2005, BIOINFORMATICS, V21, P275, DOI 10.1093/bioinformatics/bth495; Zeeberg BR, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-r28; Zhang B, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-16; Zheng B, 2007, GENOME BIOL, V8; Zhou H, 2006, YEAST PROTEIN PROTEI	88	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e33744	10.1371/journal.pone.0033744	http://dx.doi.org/10.1371/journal.pone.0033744			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GO	22496762	Green Submitted, Green Published, gold			2022-12-27	WOS:000304855200021
J	Wu, MY; Jiang, M; Zhai, XD; Beaudet, AL; Wu, RC				Wu, Mei-Yi; Jiang, Ming; Zhai, Xiaodong; Beaudet, Arthur L.; Wu, Ray-Chang			An Unexpected Function of the Prader-Willi Syndrome Imprinting Center in Maternal Imprinting in Mice	PLOS ONE			English	Article							ANGELMAN-SYNDROME; NECDIN GENE; ANTISENSE TRANSCRIPT; DNA METHYLATION; MURINE UBE3A; MOUSE MODEL; SNRPN GENE; MUTATIONS; DELETION; LETHALITY	Genomic imprinting is a phenomenon that some genes are expressed differentially according to the parent of origin. Prader-Willi syndrome (PWS) and Angelman syndrome (AS) are neurobehavioral disorders caused by deficiency of imprinted gene expression from paternal and maternal chromosome 15q11-q13, respectively. Imprinted genes at the PWS/AS domain are regulated through a bipartite imprinting center, the PWS-IC and AS-IC. The PWS-IC activates paternal-specific gene expression and is responsible for the paternal imprint, whereas the AS-IC functions in the maternal imprint by allele-specific repression of the PWS-IC to prevent the paternal imprinting program. Although mouse chromosome 7C has a conserved PWS/AS imprinted domain, the mouse equivalent of the human AS-IC element has not yet been identified. Here, we suggest another dimension that the PWS-IC also functions in maternal imprinting by negatively regulating the paternally expressed imprinted genes in mice, in contrast to its known function as a positive regulator for paternal-specific gene expression. Using a mouse model carrying a 4.8-kb deletion at the PWS-IC, we demonstrated that maternal transmission of the PWS-IC deletion resulted in a maternal imprinting defect with activation of the paternally expressed imprinted genes and decreased expression of the maternally expressed imprinted gene on the maternal chromosome, accompanied by alteration of the maternal epigenotype toward a paternal state spread over the PWS/AS domain. The functional significance of this acquired paternal pattern of gene expression was demonstrated by the ability to complement PWS phenotypes by maternal inheritance of the PWS-IC deletion, which is in stark contrast to paternal inheritance of the PWS-IC deletion that resulted in the PWS phenotypes. Importantly, low levels of expression of the paternally expressed imprinted genes are sufficient to rescue postnatal lethality and growth retardation in two PWS mouse models. These findings open the opportunity for a novel approach to the treatment of PWS.	[Wu, Mei-Yi; Jiang, Ming; Wu, Ray-Chang] George Washington Univ, Dept Biochem & Mol Biol, Washington, DC 20052 USA; [Zhai, Xiaodong; Beaudet, Arthur L.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA	George Washington University; Baylor College of Medicine	Wu, MY (corresponding author), George Washington Univ, Dept Biochem & Mol Biol, Washington, DC 20052 USA.	bcmmxw@gwumc.edu; bcmrxw@gwumc.edu	Wu, Ray-chang/X-2018-2019		George Washington University; National Institutes of Health [HD037283]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD037283] Funding Source: NIH RePORTER	George Washington University; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by a startup fund from George Washington University (to RW) and by a research grant HD037283 from the National Institutes of Health (to ALB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bielinska B, 2000, NAT GENET, V25, P74, DOI 10.1038/75629; Bischof JM, 2007, HUM MOL GENET, V16, P2713, DOI 10.1093/hmg/ddm225; Bressler J, 2001, NAT GENET, V28, P232, DOI 10.1038/90067; Buiting K, 2010, AM J MED GENET C, V154C, P365, DOI 10.1002/ajmg.c.30273; Cattanach BM, 1997, MAMM GENOME, V8, P472, DOI 10.1007/s003359900479; Chamberlain SJ, 2001, GENOMICS, V73, P316, DOI 10.1006/geno.2001.6543; Chamberlain SJ, 2010, NEUROBIOL DIS, V39, P13, DOI 10.1016/j.nbd.2010.03.011; de Smith AJ, 2009, HUM MOL GENET, V18, P3257, DOI 10.1093/hmg/ddp263; Dindot SV, 2009, GENOME RES, V19, P1374, DOI 10.1101/gr.089185.108; Ding F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001709; Dittrich B, 1996, NAT GENET, V14, P163, DOI 10.1038/ng1096-163; Dubose AJ, 2011, HUM MOL GENET; DUKER AL, 2010, EUR J HUM GENET; Farber C, 1999, HUM MOL GENET, V8, P337, DOI 10.1093/hmg/8.2.337; Gabriel JM, 1998, MAMM GENOME, V9, P788, DOI 10.1007/s003359900868; Gerard M, 1999, NAT GENET, V23, P199, DOI 10.1038/13828; Gray TA, 1999, P NATL ACAD SCI USA, V96, P5616, DOI 10.1073/pnas.96.10.5616; Hanel ML, 2001, MOL CELL BIOL, V21, P2384, DOI 10.1128/MCB.21.7.2384-2392.2001; Hershko A, 1999, GENE, V234, P323, DOI 10.1016/S0378-1119(99)00192-4; Horsthemke B, 2008, AM J MED GENET A, V146A, P2041, DOI 10.1002/ajmg.a.32364; Jay P, 1997, NAT GENET, V17, P357, DOI 10.1038/ng1197-357; Jiang YH, 1998, NEURON, V21, P799, DOI 10.1016/S0896-6273(00)80596-6; Johnstone KA, 2006, HUM MOL GENET, V15, P393, DOI 10.1093/hmg/ddi456; Kishino T, 1997, NAT GENET, V15, P70, DOI 10.1038/ng0197-70; Landers M, 2004, NUCLEIC ACIDS RES, V32, P3480, DOI 10.1093/nar/gkh670; Lau JCY, 2004, NUCLEIC ACIDS RES, V32, P3376, DOI 10.1093/nar/gkh671; MacDonald HR, 1997, HUM MOL GENET, V6, P1873, DOI 10.1093/hmg/6.11.1873; Matsuura T, 1997, NAT GENET, V15, P74, DOI 10.1038/ng0197-74; Muscatelli F, 2000, HUM MOL GENET, V9, P3101, DOI 10.1093/hmg/9.20.3101; Ohta T, 1999, AM J HUM GENET, V64, P385, DOI 10.1086/302232; Peery EG, 2007, MAMM GENOME, V18, P255, DOI 10.1007/s00335-007-9019-3; Perk J, 2002, EMBO J, V21, P5807, DOI 10.1093/emboj/cdf570; Relkovic D, 2011, BRAIN RES B; Rougeulle C, 1998, NAT GENET, V19, P15, DOI 10.1038/ng0598-15; Runte M, 2001, HUM MOL GENET, V10, P2687, DOI 10.1093/hmg/10.23.2687; Sahoo T, 2008, NAT GENET, V40, P719, DOI 10.1038/ng.158; Schaller F, 2010, HUM MOL GENET, V19, P4895, DOI 10.1093/hmg/ddq424; Shemer R, 2000, NAT GENET, V26, P440, DOI 10.1038/82571; Shemer R, 1997, P NATL ACAD SCI USA, V94, P10267, DOI 10.1073/pnas.94.19.10267; Skryabin BV, 2007, PLOS GENET, V3, P2529, DOI 10.1371/journal.pgen.0030235; Tsai TF, 1999, NAT GENET, V22, P15, DOI 10.1038/8722; Tsai TF, 1999, HUM MOL GENET, V8, P1357, DOI 10.1093/hmg/8.8.1357; Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598; Wu MY, 2006, GENESIS, V44, P12, DOI 10.1002/gene.20179; Yang T, 1998, NAT GENET, V19, P25, DOI 10.1038/ng0598-25	45	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e34348	10.1371/journal.pone.0034348	http://dx.doi.org/10.1371/journal.pone.0034348			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GO	22496793	Green Submitted, gold, Green Published			2022-12-27	WOS:000304855200041
J	Gong, Y; Li, YL; Abdolmaleky, HM; Li, LL; Zhou, JR				Gong, Yi; Li, Yanli; Abdolmaleky, Hamid M.; Li, Linglin; Zhou, Jin-Rong			Tanshinones Inhibit the Growth of Breast Cancer Cells through Epigenetic Modification of Aurora A Expression and Function	PLOS ONE			English	Article							TANDEM MASS-SPECTROMETRY; PROSTATE-CANCER; SALVIA-MILTIORRHIZA; KINASE INHIBITORS; CYCLE ARREST; RAT PLASMA; IIA; APOPTOSIS; CRYPTOTANSHINONE; CYTOTOXICITY	The objectives of this study were to evaluate the effects of tanshinones from a Chinese herb Salvia Miltiorrhiza on the growth of breast cancer cells, and to elucidate cellular and molecular mechanisms of action. Tanshinones showed the dose-dependent effect on the growth inhibition of breast cancer cells in vitro, with tanshinone I (T1) the most potent agent. T1 was also the only tanshinone to have potent activity in inhibiting the growth of the triple-negative breast cancer cell line MDA-MB231. T1 caused cell cycle arrests of both estrogen-dependent and estrogen-independent cell lines associated with alterations of cyclinD, CDK4 and cyclinB, and induced breast cancer cell apoptosis associated with upregulation of c-PARP and downregulation of survivin and Aurora A. Among these associated biomarkers, Aurora A showed the most consistent pattern with the anti-growth activity of tanshinones. Overexpression of Aurora A was also verified in breast tumors. The gene function assay showed that knockdown of Aurora A by siRNA dramatically reduced the growth-inhibition and apoptosis-induction activities of T1, suggesting Aurora A as an important functional target of T1 action. On the other hand, tanshinones had much less adverse effects on normal mammary epithelial cells. Epigenetic mechanism studies showed that overexpression of Aurora A gene in breast cancer cells was not regulated by gene promoter DNA methylation, but by histone acetylation. T1 treatment significantly reduced acetylation levels of histone H3 associated with Aurora A gene. Our results supported the potent activity of T1 in inhibiting the growth of breast cancer cells in vitro in part by downregulation of Aurora A gene function. Our previous studies also demonstrated that T1 had potent anti-angiogenesis activity and minimal side effects in vivo. Altogether, this study warrants further investigation to develop T1 as an effective and safe agent for the therapy and prevention of breast cancer.	[Gong, Yi; Li, Yanli; Abdolmaleky, Hamid M.; Li, Linglin; Zhou, Jin-Rong] Harvard Univ, Sch Med, Dept Surg, Nutr Metab Lab,Beth Israel Deaconess Med, Boston, MA 02115 USA; [Li, Yanli; Zhou, Jin-Rong] E China Normal Univ, Inst Mol & Expt Therapeut, Shanghai 200062, Peoples R China	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; East China Normal University	Gong, Y (corresponding author), Harvard Univ, Sch Med, Dept Surg, Nutr Metab Lab,Beth Israel Deaconess Med, Boston, MA 02115 USA.	jrzhou@bidmc.harvard.edu	li, yanli/AAT-2012-2021	li, yanli/0000-0002-2936-0339; Mostafavi Abdolmaleky, Hamid/0000-0002-8872-5174	National Cancer Institute [R21 CA133865]; Department of Defense [PC073988]; NATIONAL CANCER INSTITUTE [R21CA133865] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by grants to JRZ from the National Cancer Institute (R21 CA133865) and the Department of Defense (PC073988). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdolmaleky Hamid Mostafavi, 2008, V448, P187, DOI 10.1007/978-1-59745-205-2_9; American Cancer Society, 2010, OV BREST CANC MAN WO; Banerjee HN, 2009, BIOMARK MED, V3, P397, DOI 10.2217/BMM.09.26; Bi HC, 2007, BIOMED CHROMATOGR, V21, P473, DOI 10.1002/bmc.778; Buschhorn HM, 2005, PROSTATE, V64, P341, DOI 10.1002/pros.20247; Comperat E, 2007, VIRCHOWS ARCH, V450, P419, DOI 10.1007/s00428-007-0383-x; Comperat E, 2008, UROLOGY, V72, P873, DOI 10.1016/j.urology.2007.12.026; Cui Y, 2008, LIFE SCI, V82, P247, DOI 10.1016/j.lfs.2007.11.013; Dar AA, 2010, MOL CANCER THER, V9, P268, DOI 10.1158/1535-7163.MCT-09-0765; Davie JR, 2003, J NUTR, V133, p2485S, DOI 10.1093/jn/133.7.2485S; Dworkin AM, 2009, SEMIN CANCER BIOL, V19, P165, DOI 10.1016/j.semcancer.2009.02.007; Fang MZ, 2007, J NUTR, V137, p223S, DOI 10.1093/jn/137.1.223S; Giet R, 1999, J CELL SCI, V112, P3591; Gorgun G, 2010, BLOOD, V115, P5202, DOI 10.1182/blood-2009-12-259523; Gong Y, 2011, INT J CANCER, V129, P1042, DOI 10.1002/ijc.25678; Hao HP, 2006, J PHARMACEUT BIOMED, V40, P382, DOI 10.1016/j.jpba.2005.07.029; Kaestner P, 2009, MOL CANCER THER, V8, P2046, DOI 10.1158/1535-7163.MCT-09-0323; Keen N, 2004, NAT REV CANCER, V4, P927, DOI 10.1038/nrc1502; Lea MA, 2002, NUTR CANCER, V43, P90, DOI 10.1207/S15327914NC431_11; Lee CY, 2008, MOL CANCER THER, V7, P3527, DOI 10.1158/1535-7163.MCT-07-2288; Lee ECY, 2006, CANCER RES, V66, P4996, DOI 10.1158/0008-5472.CAN-05-2796; Lee WYW, 2008, FOOD CHEM TOXICOL, V46, P328, DOI 10.1016/j.fct.2007.08.013; Lentini L, 2008, ONCOL RES, V17, P115, DOI 10.3727/096504008785055521; Li DH, 2003, CLIN CANCER RES, V9, P991; Li J, 2005, J CHROMATOGR B, V826, P26, DOI 10.1016/j.jchromb.2005.07.048; Li Y, 2012, MOL CARCINO IN PRESS; Lima SC, 2010, CURR OPIN MOL THER, V12, P316; Liu JJ, 2009, ONCOL REP, V21, P1075, DOI 10.3892/or_00000326; Mai ZM, 2007, CARCINOGENESIS, V28, P1217, DOI 10.1093/carcin/bgm004; Marumoto T, 2005, NAT REV CANCER, V5, P42, DOI 10.1038/nrc1526; Matarasso N, 2007, NEOPLASIA, V9, P707, DOI 10.1593/neo.07322; Meraldi P, 2004, CURR OPIN GENET DEV, V14, P29, DOI 10.1016/j.gde.2003.11.006; Mosaddik MA, 2003, PHYTOMEDICINE, V10, P682, DOI 10.1078/0944-7113-00321; Nizamutdinova IT, 2008, CARCINOGENESIS, V29, P1885, DOI 10.1093/carcin/bgn151; Nizamutdinova IT, 2008, INT J ONCOL, V33, P485, DOI 10.3892/ijo_00000031; Qu Y, 2008, CANCER GENE THER, V15, P517, DOI 10.1038/cgt.2008.22; Qu Yi, 2008, Sichuan Da Xue Xue Bao Yi Xue Ban, V39, P1; Singh AV, 2006, CANCER RES, V66, P1851, DOI 10.1158/0008-5472.CAN-05-1332; Song M, 2005, J CHROMATOGR B, V827, P205, DOI 10.1016/j.jchromb.2005.09.014; Staff S, 2010, ONCOL REP, V23, P307, DOI 10.3892/or_00000637; Su CC, 2008, INT J MOL MED, V22, P357, DOI 10.3892/ijmm_00000030; Vankayalapati H, 2003, MOL CANCER THER, V2, P283; Veeck J, 2010, J MAMMARY GLAND BIOL, V15, P5, DOI 10.1007/s10911-010-9165-1; Wang J, 2007, J NEURO-ONCOL, V82, P11, DOI 10.1007/s11060-006-9242-x; Wang X, 1996, Zhonghua Zhong Liu Za Zhi, V18, P412; Wang XJ, 2005, INT J CANCER, V116, P799, DOI 10.1002/ijc.20880; Yuan S, 2002, HUA XI YI KE DA XUE, V33, P90; Yuan SL, 2004, WORLD J GASTROENTERO, V10, P2024, DOI 10.3748/wjg.v10.i14.2024; Yuan Shulan, 2002, Journal of West China University of Medical Sciences, V33, P84; Zhang P, 1999, Zhongguo Zhong Xi Yi Jie He Za Zhi, V19, P103	50	50	51	3	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2012	7	4							e33656	10.1371/journal.pone.0033656	http://dx.doi.org/10.1371/journal.pone.0033656			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952GU	22485147	Green Submitted, Green Published, gold			2022-12-27	WOS:000304780500023
J	Nanbara, H; Wara-aswapati, N; Nagasawa, T; Yoshida, Y; Yashiro, R; Bando, Y; Kobayashi, H; Khongcharoensuk, J; Hormdee, D; Pitiphat, W; Boch, JA; Izumi, Y				Nanbara, Hiromi; Wara-aswapati, Nawarat; Nagasawa, Toshiyuki; Yoshida, Yasuhiro; Yashiro, Reiko; Bando, Yukiko; Kobayashi, Hiroaki; Khongcharoensuk, Janjura; Hormdee, Doosadee; Pitiphat, Waranuch; Boch, Jason A.; Izumi, Yuichi			Modulation of Wnt5a Expression by Periodontopathic Bacteria	PLOS ONE			English	Article							OSTEOCLAST DIFFERENTIATION; PORPHYROMONAS-GINGIVALIS; OSTEOPROTEGERIN LIGAND; GENE-EXPRESSION; RHEUMATOID-ARTHRITIS; STEM-CELLS; PERIODONTITIS; ACTIVATION; WINGLESS; PROLIFERATION	Wingless proteins, termed Wnt, are involved in embryonic development, blood cell differentiation, and tumorigenesis. In mammalian hematopoiesis, Wnt signaling is essential for stem-cell homeostasis and lymphocyte differentiation. Recent studies have suggested that these molecules are associated with cardiovascular diseases, rheumatoid arthritis, and osteoarthritis. Furthermore, Wnt5a signaling is essential for the general inflammatory response of human macrophages. Periodontitis is a chronic inflammatory disease caused by gram-negative periodontopathic bacteria and the resultant host immune response. Periodontitis is characterized by loss of tooth-supporting structures and alveolar bone resorption. There have been no previous reports on Wnt5a expression in periodontitis tissue, and only few study reported the molecular mechanisms of Wnt5a expression in LPS-stimulated monocytic cells. Using RT-PCR, we demonstrated that Wnt5a mRNA expression was up-regulated in chronic periodontitis tissue as compared to healthy control tissue. P. gingivalis LPS induced Wnt5a mRNA in the human monocytic cell line THP-1 with a peak at 4 hrs after stimulation. P. gingivalis LPS induced higher up-regulation of Wnt5a mRNA than E. coli LPS. The LPS receptors TLR2 and TLR4 were equally expressed on the surface of THP-1 cells. P. gingivalis LPS induced l kappa B alpha degradation and was able to increase the NF-kappa B binding activity to DNA. P. gingivalis LPS-induced Wnt5a expression was inhibited by NF-kappa B inhibitors, suggesting NF-kappa B involvement. Furthermore, IFN-gamma synergistically enhanced the P. gingivalis LPS-induced production of Wnt5a. Pharmacological investigation and siRNA experiments showed that STAT1 was important for P. gingivalis LPS-induced Wnt5a expression. These results suggest that the modulation of Wnt5a expression by P. gingivalis may play an important role in the periodontal inflammatory process and serve a target for the development of new therapies.	[Nanbara, Hiromi; Nagasawa, Toshiyuki; Yashiro, Reiko; Bando, Yukiko; Kobayashi, Hiroaki; Izumi, Yuichi] Tokyo Med & Dent Univ, Dept Periodontol, Tokyo, Japan; [Nanbara, Hiromi; Izumi, Yuichi] Tokyo Med & Dent Univ, Global Ctr Excellence Program, Int Res Ctr Mol Sci Tooth & Bone Dis, Tokyo, Japan; [Wara-aswapati, Nawarat; Khongcharoensuk, Janjura; Hormdee, Doosadee] Khon Kaen Univ, Fac Dent, Dept Periodontol, Khon Kaen, Thailand; [Yoshida, Yasuhiro] Univ Occupat & Environm Hlth, Sch Med, Dept Immunol, Fukuoka, Japan; [Pitiphat, Waranuch] Khon Kaen Univ, Fac Dent, Dept Community Dent, Khon Kaen, Thailand; [Boch, Jason A.] Harvard Univ, Sch Dent Med, Dept Oral Med Infect & Immun, Boston, MA 02115 USA	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Khon Kaen University; University of Occupational & Environmental Health - Japan; Khon Kaen University; Harvard University; Harvard School of Dental Medicine	Nanbara, H (corresponding author), Tokyo Med & Dent Univ, Dept Periodontol, Tokyo, Japan.	freude@med.uoeh-u.ac.jp	Kobayashi, Hiroaki/AAG-6812-2019	Pitiphat, Waranuch/0000-0001-6628-0306; /0000-0003-1658-3119	Ministry of Education, Culture, Sports, Science, and Technology of Japan [21390553]; National Research Council of Thailand (NRCT); Japan Society for the Promotion of Science (JSPS); Khon Kaen University; Grants-in-Aid for Scientific Research [21390553] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Research Council of Thailand (NRCT)(National Research Council of Thailand (NRCT)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Khon Kaen University; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by Grant-in-Aid for Scientific Research 21390553, grant from Global Center of Excellence (GCOE) Program, International Research Center for Molecular Science in Tooth and Bone Diseases Program, from the Ministry of Education, Culture, Sports, Science, and Technology of Japan; the National Research Council of Thailand (NRCT); Japan Society for the Promotion of Science (JSPS) grant, JSPS Invitation Fellowship for Research in Japan (NW), and Khon Kaen University grant. http://www.mext.go.jp/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armitage G C, 1999, Ann Periodontol, V4, P1, DOI 10.1902/annals.1999.4.1.1; Bansal K, 2011, J BIOL CHEM, V286, P37032, DOI 10.1074/jbc.M111.260414; Bickel M, 2001, J CLIN PERIODONTOL, V28, P840, DOI 10.1034/j.1600-051x.2001.028009840.x; Blumenthal A, 2006, BLOOD, V108, P965, DOI 10.1182/blood-2005-12-5046; Burgess TL, 1999, J CELL BIOL, V145, P527, DOI 10.1083/jcb.145.3.527; Cheng CW, 2008, BIOCHEM BIOPH RES CO, V365, P285, DOI 10.1016/j.bbrc.2007.10.166; Christman MA, 2008, AM J PHYSIOL-HEART C, V294, pH2864, DOI 10.1152/ajpheart.00982.2007; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Darveau RP, 2002, INFECT IMMUN, V70, P1867, DOI 10.1128/IAI.70.4.1867-1873.2002; Dissanayake SK, 2008, CANCER RES, V68, P10205, DOI 10.1158/0008-5472.CAN-08-2149; Frank DA, 1999, NAT MED, V5, P444, DOI 10.1038/7445; Fujio Y, 2004, FEBS LETT, V573, P202, DOI 10.1016/j.febslet.2004.07.082; GAVIN BJ, 1992, MOL CELL BIOL, V12, P2418, DOI 10.1128/MCB.12.5.2418; Hofbauer LC, 1999, BONE, V25, P255, DOI 10.1016/S8756-3282(99)00162-3; Holt SC, 2005, PERIODONTOL 2000, V38, P72, DOI 10.1111/j.1600-0757.2005.00113.x; Hsu HL, 1999, P NATL ACAD SCI USA, V96, P3540, DOI 10.1073/pnas.96.7.3540; JAHNKE A, 1994, FEBS LETT, V354, P220, DOI 10.1016/0014-5793(94)01130-3; Kanaya S, 2004, EUR J IMMUNOL, V34, P1451, DOI 10.1002/eji.200324549; Katoh M, 2007, INT J MOL MED, V19, P273; KLINGENSMITH J, 1994, DEV BIOL, V166, P396, DOI 10.1006/dbio.1994.1325; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Loesche WJ, 2001, CLIN MICROBIOL REV, V14, P727, DOI 10.1128/CMR.14.4.727-752.2001; LOWENSTEIN CJ, 1993, P NATL ACAD SCI USA, V90, P9730, DOI 10.1073/pnas.90.20.9730; Masckauchan TNH, 2006, MOL BIOL CELL, V17, P5163, DOI 10.1091/mbc.E06-04-0320; Matsuzaki K, 1998, BIOCHEM BIOPH RES CO, V246, P199, DOI 10.1006/bbrc.1998.8586; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Nakashima T, 2000, BIOCHEM BIOPH RES CO, V275, P768, DOI 10.1006/bbrc.2000.3379; Nusse R, 2005, CELL RES, V15, P28, DOI 10.1038/sj.cr.7290260; Ohmori Y, 2001, J LEUKOCYTE BIOL, V69, P598; Pereira C, 2008, ARTERIOSCL THROM VAS, V28, P504, DOI 10.1161/ATVBAHA.107.157438; Plosker GL, 2003, DRUGS, V63, P2317, DOI 10.2165/00003495-200363210-00004; Pulendran B, 2001, J IMMUNOL, V167, P5067, DOI 10.4049/jimmunol.167.9.5067; Rasmussen L, 2000, J CLIN PERIODONTOL, V27, P41, DOI 10.1034/j.1600-051x.2000.027001041.x; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Reya T, 2000, IMMUNITY, V13, P15, DOI 10.1016/S1074-7613(00)00004-2; Sen M, 2000, P NATL ACAD SCI USA, V97, P2791, DOI 10.1073/pnas.050574297; SHARMA RP, 1976, DEV BIOL, V48, P461, DOI 10.1016/0012-1606(76)90108-1; Staal FJT, 2003, CURR OPIN IMMUNOL, V15, P204, DOI 10.1016/S0952-7915(03)00003-7; Wang D, 2005, ORAL MICROBIOL IMMUN, V20, P172, DOI 10.1111/j.1399-302X.2005.00208.x; Yang DH, 2009, CIRC RES, V104, P372, DOI 10.1161/CIRCRESAHA.108.185405; Yoshida Y, 2004, J BIOL CHEM, V279, P1768, DOI 10.1074/jbc.M311498200	41	43	47	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2012	7	4							e34434	10.1371/journal.pone.0034434	http://dx.doi.org/10.1371/journal.pone.0034434			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952GU	22485170	Green Published, Green Submitted, gold			2022-12-27	WOS:000304780500045
J	Woolston, A; Tu, YK; Baxter, PD; Gilthorpe, MS				Woolston, Andrew; Tu, Yu-Kang; Baxter, Paul D.; Gilthorpe, Mark S.			A Comparison of Different Approaches to Unravel the Latent Structure within Metabolic Syndrome	PLOS ONE			English	Article							EXPLORATORY FACTOR-ANALYSIS; CARDIOVASCULAR-DISEASE; ASSOCIATION; DEFINITION; COMPONENTS; ROTATION; RISK	Background: Exploratory factor analysis is a commonly used statistical technique in metabolic syndrome research to uncover latent structure amongst metabolic variables. The application of factor analysis requires methodological decisions that reflect the hypothesis of the metabolic syndrome construct. These decisions often raise the complexity of the interpretation from the output. We propose two alternative techniques developed from cluster analysis which can achieve a clinically relevant structure, whilst maintaining intuitive advantages of clustering methodology. Methods:Two advanced techniques of clustering in the VARCLUS and matroid methods are discussed and implemented on a metabolic syndrome data set to analyze the structure of ten metabolic risk factors. The subjects were selected from the normative aging study based in Boston, Massachusetts. The sample included a total of 847 men aged between 21 and 81 years who provided complete data on selected risk factors during the period 1987 to 1991. Results: Four core components were identified by the clustering methods. These are labelled obesity, lipids, insulin resistance and blood pressure. The exploratory factor analysis with oblique rotation suggested an overlap of the loadings identified on the insulin resistance and obesity factors. The VARCLUS and matroid analyses separated these components and were able to demonstrate associations between individual risk factors. Conclusions: An oblique rotation can be selected to reflect the clinical concept of a single underlying syndrome, however the results are often difficult to interpret. Factor loadings must be considered along with correlations between the factors. The correlated components produced by the VARCLUS and matroid analyses are not overlapped, which allows for a simpler application of the methodologies and interpretation of the results. These techniques encourage consistency in the interpretation whilst remaining faithful to the construct under study.	[Woolston, Andrew; Tu, Yu-Kang; Baxter, Paul D.; Gilthorpe, Mark S.] Univ Leeds, Div Biostat, Ctr Epidemiol & Biostat, Leeds, W Yorkshire, England	University of Leeds	Woolston, A (corresponding author), Univ Leeds, Div Biostat, Ctr Epidemiol & Biostat, Leeds, W Yorkshire, England.	cen5aw@leeds.ac.uk	Gilthorpe, Mark S/C-1240-2008	Gilthorpe, Mark S/0000-0001-8783-7695; Tu, Yu-Kang/0000-0002-2461-474X; Baxter, Paul/0000-0003-2699-3103; Woolston, Andrew/0000-0002-6175-4805	UK Medical Research Council; Leeds Teaching Hospitals Trust; United Kingdom government's Higher Education Funding Council for England (HEFCE)	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Leeds Teaching Hospitals Trust; United Kingdom government's Higher Education Funding Council for England (HEFCE)(UK Research & Innovation (UKRI)Higher Education Funding Council for England (HEFCE))	AW is funded by a UK Medical Research Council PhD studentship award. PDB is funded by the Leeds Teaching Hospitals Trust. YKT and MSG are funded by the United Kingdom government's Higher Education Funding Council for England (HEFCE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x; Anderberg MR, 1974, CLUSTER ANAL APPL; Chen J, 2004, ANN INTERN MED, V140, P167, DOI 10.7326/0003-4819-140-3-200402030-00007; Child D., 1990, ESSENTIALS FACTOR AN; Costello AB, PRACTICAL ASSESSMENT, V10, P173; CURETON EE, 1975, PSYCHOMETRIKA, V40, P183, DOI 10.1007/BF02291565; Darsow Tamara, 2006, Curr Diab Rep, V6, P357, DOI 10.1007/s11892-006-0006-y; Fabrigar LR, 1999, PSYCHOL METHODS, V4, P272, DOI 10.1037/1082-989X.4.3.272; Floyd FJ, 1995, PSYCHOL ASSESSMENT, V7, P286, DOI 10.1037/1040-3590.7.3.286; Ford ES, 2003, DIABETES CARE, V26, P575, DOI 10.2337/diacare.26.3.575; FORD JK, 1986, PERS PSYCHOL, V39, P291, DOI 10.1111/j.1744-6570.1986.tb00583.x; Gami AS, 2007, J AM COLL CARDIOL, V49, P403, DOI 10.1016/j.jacc.2006.09.032; Gorsuch R., 1983, FACTOR ANAL; GREENE T, 1990, COMPUT STAT DATA AN, V9, P251, DOI 10.1016/0167-9473(90)90108-T; GREENE T, 1991, DISCRETE MATH, V87, P149, DOI 10.1016/0012-365X(91)90044-3; Grundy SM, 2004, CIRCULATION, V109, P433, DOI 10.1161/01.CIR.0000111245.75752.C6; Guttman L., 1954, PSYCHOMETRIKA, V19, P149, DOI 10.1007/BF02289162; Joliffe IT, 2002, PRINCIPAL COMPONENT; Kahn R, 2007, CIRCULATION, V115, P1806, DOI 10.1161/CIRCULATIONAHA.106.658336; Kahn R, 2006, DIABETES CARE, V29, P1693, DOI 10.2337/dc06-0671; KAISER HF, 1960, EDUC PSYCHOL MEAS, V20, P141, DOI 10.1177/001316446002000116; KAISER HF, 1958, PSYCHOMETRIKA, V23, P187, DOI 10.1007/BF02289233; Kaufman L., 1990, FINDING GROUPS DATA, DOI 10.1002/9780470316801; Lafortuna CL, 2008, NUTR METAB CARDIOVAS, V18, P233, DOI 10.1016/j.numecd.2007.02.002; Lawlor DA, 2004, AM J EPIDEMIOL, V159, P1013, DOI 10.1093/aje/kwh150; Mannuicci E, 2007, NUTR METAB CARDIOVAS, V17, P719, DOI 10.1016/j.numecd.2006.09.003; McNeill AM, 2006, J AM GERIATR SOC, V54, P1317, DOI 10.1111/j.1532-5415.2006.00862.x; Niaura R, 2000, PSYCHOSOM MED, V62, P7, DOI 10.1097/00006842-200001000-00002; Pladevall M, 2006, DIABETES CARE, V29, P113, DOI 10.2337/diacare.29.1.113; R Core Team, 2018, R LANG ENV STAT COMP; SAS Institute Inc, 1999, SAS STAT US GUID VER; Shah S, 2006, EUR J EPIDEMIOL, V21, P343, DOI 10.1007/s10654-006-9004-2; Shen BJ, 2006, ANN EPIDEMIOL, V16, P131, DOI 10.1016/j.annepidem.2005.06.049; Shen BJ, 2003, AM J EPIDEMIOL, V157, P701, DOI 10.1093/aje/kwg045; STREINER DL, 1994, CAN J PSYCHIAT, V39, P135, DOI 10.1177/070674379403900303; Thomas G, 2011, CLIN J AM S IN PRESS; Thurstone LL, 1940, PSYCHOMETRIKA, V5, P153, DOI 10.1007/BF02287873; Welsh DJA, 1976, MATROID THEORY; Wilson PWF, 2005, CIRCULATION, V112, P3066, DOI 10.1161/CIRCULATIONAHA.105.539528; Yanai H, 2008, NUTR J, V7, DOI 10.1186/1475-2891-7-10	40	16	16	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2012	7	4							e34410	10.1371/journal.pone.0034410	http://dx.doi.org/10.1371/journal.pone.0034410			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	952GU	22485169	Green Published, Green Submitted, gold			2022-12-27	WOS:000304780500044
J	Pays, O; Fortin, D; Gassani, J; Duchesne, J				Pays, Olivier; Fortin, Daniel; Gassani, Jean; Duchesne, Jean			Group Dynamics and Landscape Features Constrain the Exploration of Herds in Fusion-Fission Societies: The Case of European Roe Deer	PLOS ONE			English	Article							ELK CERVUS-ELAPHUS; FRAGMENTED LANDSCAPE; SEXUAL SEGREGATION; GROUP-SIZE; SELECTION; AGGRESSION; BEHAVIOR; FOOD; CONNECTIVITY; INTENSITY	Despite the large number of movement studies, the constraints that grouping imposes on movement decisions remain essentially unexplored, even for highly social species. Such constraints could be key, however, to understanding the dynamics and spatial organisation of species living in group fusion-fission systems. We investigated the winter movements (speed and diffusion coefficient) of groups of free-ranging roe deer (Capreolus capreolus), in an agricultural landscape characterised by a mosaic of food and foodless patches. Most groups were short-lived units that merged and split up frequently during the course of a day. Deer groups decreased their speed and diffusion rate in areas where food patches were abundant, as well as when travelling close to main roads and crest lines and far from forests. While accounting for these behavioural adjustments to habitat features, our study revealed some constraints imposed by group foraging: large groups reached the limit of their diffusion rate faster than small groups. The ability of individuals to move rapidly to new foraging locations following patch depression thus decreases with group size. Our results highlight the importance of considering both habitat heterogeneity and group dynamics when predicting the movements of individuals in group fusion-fission societies. Further, we provide empirical evidence that group cohesion can restrain movement and, therefore, the speed at which group members can explore their environment. When maintaining cohesion reduces foraging gains because of movement constraints, leaving the group may become a fitness-rewarding decision, especially when individuals can join other groups located nearby, which would tend to maintain highly dynamical group fusion-fission systems. Our findings also provide the basis for new hypotheses explaining a broad range of ecological patterns, such as the broader diet and longer residency time reported for larger herbivore groups.	[Pays, Olivier] Univ Angers, Grp Ecol & Conservat, Angers, France; [Pays, Olivier] Univ Reims, Ctr Rech & Format Ecoethol, Boult Aux Bois, France; [Pays, Olivier] INRA, Comportement & Ecol Faune Sauvage, F-31326 Castanet Tolosan, France; [Fortin, Daniel] Univ Laval, Dept Biol, Quebec City, PQ G1K 7P4, Canada; [Gassani, Jean] Univ Djibouti, Djibouti, Djibouti; [Duchesne, Jean] Agrocampus Ouest, Unite Rech Paysage, Angers, France	Universite d'Angers; Universite de Reims Champagne-Ardenne; INRAE; Laval University; University Djibouti; Institut Agro; Agrocampus Ouest	Pays, O (corresponding author), Univ Angers, Grp Ecol & Conservat, Angers, France.	olivier.pays@univ-angers.fr	Fortin, Daniel/ABG-3554-2020		Communaute de Communes de l'Argonne Ardennaise; Conseil Regional de Champagne Ardenne	Communaute de Communes de l'Argonne Ardennaise(Region Grand-Est); Conseil Regional de Champagne Ardenne(Region Grand-Est)	The 'Communaute de Communes de l'Argonne Ardennaise' and the 'Conseil Regional de Champagne Ardenne,' provided financial supports to conduct the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DP, 2005, LANDSCAPE ECOL, V20, P257, DOI 10.1007/s10980-005-0062-8; Babin JS, 2011, ECOLOGY, V92, P240, DOI 10.1890/10-0252.1; Cargnelutti B, 2002, REV ECOL-TERRE VIE, V57, P29; Casellas E, 2008, J THEOR BIOL, V250, P424, DOI 10.1016/j.jtbi.2007.10.011; Coulon A, 2004, MOL ECOL, V13, P2841, DOI 10.1111/j.1365-294X.2004.02253.x; Farnsworth KD, 1998, FUNCT ECOL, V12, P74, DOI 10.1046/j.1365-2435.1998.00163.x; Fortin D, 2002, ECOLOGY, V83, P970, DOI 10.1890/0012-9658(2002)083[0970:TTSOFD]2.0.CO;2; Fortin D, 2008, J APPL ECOL, V45, P1392, DOI 10.1111/j.1365-2664.2008.01542.x; Fortin D, 2009, ECOLOGY, V90, P2480, DOI 10.1890/08-0345.1; Frair JL, 2008, J APPL ECOL, V45, P1504, DOI 10.1111/j.1365-2664.2008.01526.x; FREELAND WJ, 1990, ECOLOGY, V71, P589, DOI 10.2307/1940312; Frid A, 1997, ANIM BEHAV, V53, P799, DOI 10.1006/anbe.1996.0345; Goldberg JL, 2001, BEHAV ECOL, V12, P490, DOI 10.1093/beheco/12.4.490; GRANT JWA, 1993, MAR BEHAV PHYSIOL, V23, P137, DOI 10.1080/10236249309378862; Haskell DG, 1997, BEHAV ECOL, V8, P448, DOI 10.1093/beheco/8.4.448; Hebblewhite M, 2008, J APPL ECOL, V45, P834, DOI 10.1111/j.1365-2664.2008.01466.x; Houle M, 2010, LANDSCAPE ECOL, V25, P419, DOI 10.1007/s10980-009-9420-2; Johnson CA, 2004, BEHAV ECOL, V15, P412, DOI 10.1093/beheco/arh026; Kie JG, 2005, LANDSCAPE ECOL, V20, P289, DOI 10.1007/s10980-005-3165-3; Kie JG, 2002, ECOLOGY, V83, P530, DOI 10.1890/0012-9658(2002)083[0530:LHADSE]2.0.CO;2; Kutner M. H., 2004, APPL LINEAR REGRESSI; Laurian C, 2008, J WILDLIFE MANAGE, V72, P1550, DOI 10.2193/2008-063; Maindonald J, 2007, DATA ANAL GRAPHICS U; Marchal C, 1998, REV ECOL-TERRE VIE, V53, P59; Martin P., 1993, MEASURING BEHAV; McLoughlin PD, 2006, P ROY SOC B-BIOL SCI, V273, P1449, DOI 10.1098/rspb.2006.3486; Michelena P, 2004, ANIM BEHAV, V68, P1371, DOI 10.1016/j.anbehav.2004.04.008; MONAGHAN P, 1985, ANIM BEHAV, V33, P993, DOI 10.1016/S0003-3472(85)80033-6; Myers J.P., 1981, P135; Ramp D, 2002, OIKOS, V98, P393, DOI 10.1034/j.1600-0706.2002.980304.x; Robb SE, 1998, ANIM BEHAV, V56, P29, DOI 10.1006/anbe.1998.0735; Roever CL, 2010, ECOGRAPHY, V33, P1113, DOI 10.1111/j.1600-0587.2010.06077.x; Ruckstuhl KE, 2002, BIOL REV, V77, P77, DOI 10.1017/S1464793101005814; Ruckstuhl KE, 2002, ANIM BEHAV, V64, P909, DOI 10.1006/anbe.2002.2015; SMITH JNM, 1974, BEHAVIOUR, V49, P1, DOI 10.1163/156853974X00390; Stephens D.W., 1986, pi; Sueur C, 2011, OIKOS, V120, P1608, DOI 10.1111/j.1600-0706.2011.19685.x; Villerette N, 2006, CAN J ZOOL, V84, P787, DOI 10.1139/Z06-052; Wall J, 2006, CURR BIOL, V16, pR527, DOI 10.1016/j.cub.2006.06.049	39	20	20	0	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e34678	10.1371/journal.pone.0034678	http://dx.doi.org/10.1371/journal.pone.0034678			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479652	gold, Green Published, Green Submitted			2022-12-27	WOS:000305339100172
J	Agarwal, N; Pareek, M; Thakur, P; Pathak, V				Agarwal, Nisheeth; Pareek, Madhu; Thakur, Preeti; Pathak, Vibha			Functional Characterization of EngA(MS), a P-Loop GTPase of Mycobacterium smegmatis	PLOS ONE			English	Article							ESCHERICHIA-COLI; BINDING PROTEINS; NUCLEOTIDE-BINDING; SALMONELLA-TYPHIMURIUM; BACILLUS-SUBTILIS; BACTERIAL GTPASES; G-DOMAINS; ERA; EVOLUTION; SEQUENCES	Bacterial P-loop GTPases belong to a family of proteins that selectively hydrolyze a small molecule guanosine tri-phosphate (GTP) to guanosine di-phosphate (GDP) and inorganic phosphate, and regulate several essential cellular activities such as cell division, chromosomal segregation and ribosomal assembly. A comparative genome sequence analysis of different mycobacterial species indicates the presence of multiple P-loop GTPases that exhibit highly conserved motifs. However, an exact function of most of these GTPases in mycobacteria remains elusive. In the present study we characterized the function of a P-loop GTPase in mycobacteria by employing an EngA homologue from Mycobacterium smegmatis, encoded by an open reading frame, designated as MSMEG_3738. Amino acid sequence alignment and phylogenetic analysis suggest that MSMEG_3738 (termed as EngA(MS)) is highly conserved in mycobacteria. Homology modeling of EngA(MS) reveals a cloverleaf structure comprising of alpha/beta fold typical to EngA family of GTPases. Recombinant EngA(MS) purified from E. coli exhibits a GTP hydrolysis activity which is inhibited by the presence of GDP. Interestingly, the EngA(MS) protein is co-eluted with 16S and 23S ribosomal RNA during purification and exhibits association with 30S, 50S and 70S ribosomal subunits. Further studies demonstrate that GTP is essential for interaction of EngA(MS) with 50S subunit of ribosome and specifically C-terminal domains of EngA(MS) are required to facilitate this interaction. Moreover, EngA(MS) devoid of N-terminal region interacts well with 50S even in the absence of GTP, indicating a regulatory role of the N-terminal domain in EngA(MS)-50S interaction.	[Agarwal, Nisheeth; Pareek, Madhu; Thakur, Preeti; Pathak, Vibha] Translat Hlth Sci & Technol Inst, Vaccine & Infect Dis Res Ctr, Gurgaon, Haryana, India	Department of Biotechnology (DBT) India; Translational Health Science & Technology Institute (THSTI)	Agarwal, N (corresponding author), Translat Hlth Sci & Technol Inst, Vaccine & Infect Dis Res Ctr, Gurgaon, Haryana, India.	nisheeth@thsti.res.in			Department of Biotechnology, India; VIDRC at THSTI	Department of Biotechnology, India(Department of Biotechnology (DBT) India); VIDRC at THSTI	This work was supported by the Department of Biotechnology, India and VIDRC at THSTI. PT is thankful to Department of Biotechnology, India for a fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, WHO GLOB TUB CONTR 2; Bharat A, 2006, J BACTERIOL, V188, P7992, DOI 10.1128/JB.00959-06; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; Bregeon D, 2001, GENE DEV, V15, P2295, DOI 10.1101/gad.207701; Brown ED, 2005, BIOCHEM CELL BIOL, V83, P738, DOI 10.1139/O05-162; Caldon CE, 2003, CURR OPIN MICROBIOL, V6, P135, DOI 10.1016/S1369-5274(03)00037-7; Caldon CE, 2001, MOL MICROBIOL, V41, P289, DOI 10.1046/j.1365-2958.2001.02536.x; Daigle DM, 2004, J BACTERIOL, V186, P1381, DOI 10.1128/JB.186.5.1381-1387.2004; Hwang J, 2001, J BIOL CHEM, V276, P31415, DOI 10.1074/jbc.M104455200; Johnstone BH, 1999, MOL MICROBIOL, V33, P1118, DOI 10.1046/j.1365-2958.1999.01553.x; Koonin EV, 2000, ADV PROTEIN CHEM, V54, P245, DOI 10.1016/S0065-3233(00)54008-X; Lamb HK, 2007, PROTEIN SCI, V16, P2391, DOI 10.1110/ps.072900907; Leipe DD, 2002, J MOL BIOL, V317, P41, DOI 10.1006/jmbi.2001.5378; Meena LS, 2011, BIOLOGICALS, V39, P94, DOI 10.1016/j.biologicals.2011.01.005; Mehr IJ, 2000, GENETICS, V154, P523; MILNERWHITE EJ, 1991, J MOL BIOL, V221, P751; Mittenhuber G, 2001, J MOL MICROB BIOTECH, V3, P21; Morimoto T, 2002, MICROBIOL-SGM, V148, P3539, DOI 10.1099/00221287-148-11-3539; Muench SP, 2006, P NATL ACAD SCI USA, V103, P12359, DOI 10.1073/pnas.0602585103; Persky NS, 2009, MOL MICROBIOL, V73, P253, DOI 10.1111/j.1365-2958.2009.06767.x; PROSSNITZ E, 1988, J BIOL CHEM, V263, P17917; REMMERS AE, 1994, J BIOL CHEM, V269, P13771; Robinson VL, 2002, STRUCTURE, V10, P1649, DOI 10.1016/S0969-2126(02)00905-X; Sacchettini JC, 2008, NAT REV MICROBIOL, V6, P41, DOI 10.1038/nrmicro1816; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sambrook J., 2002, MOL CLONING LAB MANU; SARASTE M, 1990, TRENDS BIOCHEM SCI, V15, P430, DOI 10.1016/0968-0004(90)90281-F; Schaefer L, 2006, J BACTERIOL, V188, P8252, DOI 10.1128/JB.01213-06; Tan J, 2002, J BACTERIOL, V184, P2692, DOI 10.1128/JB.184.10.2692-2698.2002; Tomar SK, 2009, NUCLEIC ACIDS RES, V37, P2359, DOI 10.1093/nar/gkp107; Urbonavicius J, 2001, EMBO J, V20, P4863, DOI 10.1093/emboj/20.17.4863; VANVELDHOVEN PP, 1987, ANAL BIOCHEM, V161, P45, DOI 10.1016/0003-2697(87)90649-X; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; Yang AS, 2000, J MOL BIOL, V301, P665, DOI 10.1006/jmbi.2000.3973; Zhang JJ, 2002, J BACTERIOL, V184, P5323, DOI 10.1128/JB.184.19.5323-5329.2002	35	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2012	7	4							e34571	10.1371/journal.pone.0034571	http://dx.doi.org/10.1371/journal.pone.0034571			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959FE	22506030	Green Published, gold, Green Submitted			2022-12-27	WOS:000305297500038
J	Pan, XJ; Yuan, XL; Zheng, YX; Wang, WW; Shan, JP; Lin, FJ; Jiang, GR; Yang, YH; Wang, D; Xu, DK; Shen, LS				Pan, Xiujun; Yuan, Xiangliang; Zheng, Yingxia; Wang, Weiwei; Shan, Jianping; Lin, Fujun; Jiang, Gengru; Yang, Yuan H.; Wang, Die; Xu, Dakang; Shen, Lisong			Increased CD45RA(+) FoxP3(low) Regulatory T Cells with Impaired Suppressive Function in Patients with Systemic Lupus Erythematosus	PLOS ONE			English	Article							CD4(+)CD25(-)FOXP3(+) CELLS; RHEUMATOID-ARTHRITIS; AUTOIMMUNE-DISEASES; DENDRITIC CELLS; EXPRESSION; CD4(+)CD25(HIGH); ACTIVATION; TOLERANCE; EXPANSION; PATHWAY	Background: The role of naturally occurring regulatory T cells (Treg) in the control of the development of systemic lupus erythematosus (SLE) has not been well defined. Therefore, we dissect the phenotypically heterogeneous CD4(+)FoxP3(+) T cells into subpopulations during the dynamic SLE development. Methodlogy/Principal Findings: To evaluate the proliferative and suppressive capacities of different CD4(+) T cell subgroups between active SLE patients and healthy donors, we employed CD45RA and CD25 as surface markers and carboxyfluorescein diacetatesuccinimidyl ester (CFSE) dilution assay. In addition, multiplex cytokines expression in active SLE patients was assessed using Luminex assay. Here, we showed a significant increase in the frequency of CD45RA(+)FoxP3(low) naive Treg cells (nTreg cells) and CD45RA(-)2 FoxP3(low) (non-Treg) cells in patients with active SLE. In active SLE patients, the increased proportions of wCD45RA(+)FoxP3(low) nTreg cells were positively correlated with the disease based on SLE disease activity index (SLEDAI) and the status of serum anti-dsDNA antibodies. We found that the surface marker combination of CD25(+)CD45RA(+) can be used to defined CD45RA(+)FoxP3(low) nTreg cells for functional assays, wherein nTreg cells from active SLE patients demonstrated defective suppression function. A significant correlation was observed between inflammatory cytokines, such as IL-6, IL-12 and TNF alpha, and the frequency of nTreg cells. Furthermore, the CD45RA(+)FoxP3(low) nTreg cell subset increased when cultured with SLE serum compared to healthy donor serum, suggesting that the elevated inflammatory cytokines of SLE serum may promote nTreg cell proliferation/expansion. Conclusions/Significance: Our results indicate that impaired numbers of functional CD45RA(+)FoxP3(low) naive Treg cell and CD45RA(-)2 FoxP3(low) non-suppressive T cell subsets in inflammatory conditions may contribute to SLE development. Therefore, analysis of subsets of FoxP3(+) T cells, using a combination of FoxP3, CD25 and CD45RA, rather than whole FoxP3(+) T cells, will help us to better understand the pathogenesis of SLE and may lead to the development of new therapeutic strategies.	[Pan, Xiujun; Yuan, Xiangliang; Zheng, Yingxia; Wang, Weiwei; Shen, Lisong] Shanghai Jiao Tong Univ, Dept Clin Lab, Xinhua Hosp, Sch Med, Shanghai 200030, Peoples R China; [Shan, Jianping; Lin, Fujun; Jiang, Gengru] Shanghai Jiao Tong Univ, Dept Nephrol, Xinhua Hosp, Sch Med, Shanghai 200030, Peoples R China; [Yang, Yuan H.] Monash Univ, Ctr Inflammatory Dis, Dept Med, Melbourne, Vic 3004, Australia; [Wang, Die; Xu, Dakang] Monash Univ, Monash Inst Med Res, Melbourne, Vic 3004, Australia; [Xu, Dakang] Harbin Med Univ, Coll Basic Med Sci, Harbin, Peoples R China; [Xu, Dakang] Hangzhou Normal Univ, Inst Ageing Res, Sch Med, Hangzhou, Zhejiang, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Monash University; Monash University; Harbin Medical University; Hangzhou Normal University	Pan, XJ (corresponding author), Shanghai Jiao Tong Univ, Dept Clin Lab, Xinhua Hosp, Sch Med, Shanghai 200030, Peoples R China.	dakang.xu@monash.edu; lisongshen@hotmail.com	Wang, Die/H-8860-2017	Wang, Die/0000-0001-7628-7309; Xu, Dakang/0000-0003-2415-4920	National Natural Science Foundation of China [81072009, 21035004]; Shanghai Municipal Natural Science Foundation [10ZR1420000]; Key directional project of Shanghai Science and Technology Commission for Medical Devices [09DZ1907203]; National Health and Medical Research Council of Australia [606425]; "Longjiang Scholar'' (Chair Professor) award	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Natural Science Foundation; Key directional project of Shanghai Science and Technology Commission for Medical Devices; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); "Longjiang Scholar'' (Chair Professor) award	This work was supported by grants from National Natural Science Foundation of China (81072009) and (21035004), Shanghai Municipal Natural Science Foundation (10ZR1420000), and the Key directional project of Shanghai Science and Technology Commission for Medical Devices (09DZ1907203). This work also was supported by grants from the National Health and Medical Research Council of Australia (606425) and the Victorian Government's Operational Inftrastructure Support Program. DX is the recipient of a "Longjiang Scholar'' (Chair Professor) award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barath S, 2007, LUPUS, V16, P489, DOI 10.1177/0961203307080226; Belkaid Y, 2002, NATURE, V420, P502, DOI 10.1038/nature01152; BOMBARDIER C, 1992, ARTHRITIS RHEUM, V35, P630, DOI 10.1002/art.1780350606; Bonelli M, 2008, INT IMMUNOL, V20, P861, DOI 10.1093/intimm/dxn044; Bonelli M, 2009, J IMMUNOL, V182, P1689, DOI 10.4049/jimmunol.182.3.1689; Booth NJ, 2010, J IMMUNOL, V184, P4317, DOI 10.4049/jimmunol.0903781; Buckner JH, 2010, NAT REV IMMUNOL, V10, P849, DOI 10.1038/nri2889; Chavele KM, 2011, FEBS LETT, V585, P3603, DOI 10.1016/j.febslet.2011.07.043; Chen X, 2007, J IMMUNOL, V179, P154, DOI 10.4049/jimmunol.179.1.154; Gerli R, 2009, AUTOIMMUN REV, V8, P426, DOI 10.1016/j.autrev.2009.01.004; Hahn BH, 2008, ARTHRITIS RHEUM-US, V58, P2488, DOI 10.1002/art.23609; Hahn BH, 1998, NEW ENGL J MED, V338, P1359, DOI 10.1056/NEJM199805073381906; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Horwitz DA, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2894; Horwitz DA, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2511; Isomaki Pia, 2005, Current Drug Targets - Inflammation and Allergy, V4, P287, DOI 10.2174/1568010054022042; King IL, 2005, J IMMUNOL, V175, P641, DOI 10.4049/jimmunol.175.2.641; La Cava A, 2008, LUPUS, V17, P421, DOI 10.1177/0961203308090028; Miyara M, 2005, J IMMUNOL, V175, P8392, DOI 10.4049/jimmunol.175.12.8392; Miyara M, 2009, IMMUNITY, V30, P899, DOI 10.1016/j.immuni.2009.03.019; O'Sullivan BJ, 2006, J IMMUNOL, V176, P7278, DOI 10.4049/jimmunol.176.12.7278; Pasare C, 2003, SCIENCE, V299, P1033, DOI 10.1126/science.1078231; Prakken BJ, 2004, P NATL ACAD SCI USA, V101, P4228, DOI 10.1073/pnas.0400061101; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Sakaguchi S, 2008, EUR J IMMUNOL, V38, P901, DOI 10.1002/eji.200890012; Simonetta F, 2010, EUR J IMMUNOL, V40, P2528, DOI 10.1002/eji.201040531; Tang YJ, 2009, ARTHRITIS RHEUM-US, V60, P1065, DOI 10.1002/art.24436; Tran DQ, 2007, BLOOD, V110, P2983, DOI 10.1182/blood-2007-06-094656; Valencia X, 2006, BLOOD, V108, P253, DOI 10.1182/blood-2005-11-4567; Valencia X, 2007, J IMMUNOL, V178, P2579, DOI 10.4049/jimmunol.178.4.2579; Vargas-Rojas MI, 2008, LUPUS, V17, P289, DOI 10.1177/0961203307088307; Wan SG, 2007, J IMMUNOL, V178, P271, DOI 10.4049/jimmunol.178.1.271; Wang J, 2007, EUR J IMMUNOL, V37, P129, DOI 10.1002/eji.200636435; Wong CK, 2000, LUPUS, V9, P589, DOI 10.1191/096120300678828703; Yan B, 2008, ARTHRITIS RHEUM-US, V58, P801, DOI 10.1002/art.23268; Yang HX, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2829; Yuan XL, 2010, CLIN IMMUNOL, V134, P277, DOI 10.1016/j.clim.2009.10.005; Zhang B, 2008, ANN RHEUM DIS, V67, P1037, DOI 10.1136/ard.2007.083543	38	54	56	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2012	7	4							e34662	10.1371/journal.pone.0034662	http://dx.doi.org/10.1371/journal.pone.0034662			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959FE	22506043	Green Published, Green Submitted, gold			2022-12-27	WOS:000305297500051
J	Wang, Y; Li, L; Moore, BT; Peng, XH; Fang, X; Lappe, JM; Recker, RR; Xiao, P				Wang, Yang; Li, Ling; Moore, Benjamin T.; Peng, Xian-Hao; Fang, Xiang; Lappe, Joan M.; Recker, Robert R.; Xiao, Peng			MiR-133a in Human Circulating Monocytes: A Potential Biomarker Associated with Postmenopausal Osteoporosis	PLOS ONE			English	Article							BONE-MINERAL DENSITY; OSTEOGENIC DIFFERENTIATION; GENE-EXPRESSION; STEM-CELLS; CULTURE SUPERNATANTS; ADIPOSE-TISSUE; MICRORNA-1; MECHANISM; ZINC; MEN	Background: Osteoporosis mainly occurs in postmenopausal women, which is characterized by low bone mineral density (BMD) due to unbalanced bone resorption by osteoclasts and formation by osteoblasts. Circulating monocytes play important roles in osteoclastogenesis by acting as osteoclast precursors and secreting osteoclastogenic factors, such as IL-1, IL-6 and TNF-alpha. MicroRNAs (miRNAs) have been implicated as important biomarkers in various diseases. The present study aimed to find significant miRNA biomarkers in human circulating monocytes underlying postmenopausal osteoporosis. Methodology/Principal Findings: We used ABI TaqMan (R) miRNA array followed by qRT-PCR validation in circulating monocytes to identify miRNA biomarkers in 10 high and 10 low BMD postmenopausal Caucasian women. MiR-133a was upregulated (P = 0.007) in the low compared with the high BMD groups in the array analyses, which was also validated by qRT-PCR (P = 0.044). We performed bioinformatic target gene analysis and found three potential osteoclast-related target genes, CXCL11, CXCR3 and SLC39A1. In addition, we performed Pearson correlation analyses between the expression levels of miR-133a and the three potential target genes in the 20 postmenopausal women. We did find negative correlations between miR-133a and all the three genes though not significant. Conclusions/Significance: This is the first in vivo miRNA expression analysis in human circulating monocytes to identify novel miRNA biomarkers underlying postmenopausal osteoporosis. Our results suggest that miR-133a in circulating monocytes is a potential biomarker for postmenopausal osteoporosis.	[Wang, Yang; Li, Ling; Moore, Benjamin T.; Peng, Xian-Hao; Lappe, Joan M.; Recker, Robert R.; Xiao, Peng] Creighton Univ, Sch Med, Osteoporosis Res Ctr, Omaha, NE 68178 USA; [Fang, Xiang] Creighton Univ, Biostat Core, Off Res & Compliance, Omaha, NE 68178 USA	Creighton University; Creighton University	Wang, Y (corresponding author), Creighton Univ, Sch Med, Osteoporosis Res Ctr, Omaha, NE 68178 USA.	pxiao@creighton.edu			State of Nebraska [LB692, LB595]; NIH [R01AR04054496-02S1]	State of Nebraska; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by grants from the State of Nebraska (LB692 and LB595) and the NIH (R01AR04054496-02S1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atzmon G, 2002, HORM METAB RES, V34, P622, DOI 10.1055/s-2002-38250; Balasubramanyam M, 2011, MOL CELL BIOCHEM, V351, P197, DOI 10.1007/s11010-011-0727-3; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bostjancic E, 2010, CARDIOLOGY, V115, P163, DOI 10.1159/000268088; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Chen XD, 2010, J BONE MINER RES, V25, P339, DOI 10.1359/jbmr.090724; Coelho LFL, 2005, P NATL ACAD SCI USA, V102, P11917, DOI 10.1073/pnas.0502188102; Cohen-Solal ME, 1998, J CLIN ENDOCR METAB, V83, P1687, DOI 10.1210/jc.83.5.1687; COHENSOLAL ME, 1993, J CLIN ENDOCR METAB, V77, P1648, DOI 10.1210/jc.77.6.1648; Deng FY, 2007, J BONE MINER RES, V22, P808, DOI 10.1359/JBMR.070303; Deng FY, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.011700; Deng ZL, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-115; Eberle J, 1999, J TRACE ELEM MED BIO, V13, P21, DOI 10.1016/S0946-672X(99)80019-4; Eskildsen T, 2011, P NATL ACAD SCI USA, V108, P6139, DOI 10.1073/pnas.1016758108; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Fujikawa Y, 1996, ENDOCRINOLOGY, V137, P4058, DOI 10.1210/en.137.9.4058; Garcia DM, 2011, NAT STRUCT MOL BIOL, V18, P1139, DOI 10.1038/nsmb.2115; Grassi F, 2003, HISTOCHEM CELL BIOL, V120, P391, DOI 10.1007/s00418-003-0587-3; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Hassan MQ, 2010, P NATL ACAD SCI USA, V107, P19879, DOI 10.1073/pnas.1007698107; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Higuchi S, 1998, J BONE MINER RES, V13, P44, DOI 10.1359/jbmr.1998.13.1.44; Hsu YH, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000977; Huang J, 2010, STEM CELLS, V28, P357, DOI 10.1002/stem.288; Huang MB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029173; Inose H, 2009, P NATL ACAD SCI USA, V106, P20794, DOI 10.1073/pnas.0909311106; Kapinas K, 2010, J BIOL CHEM, V285, P25221, DOI 10.1074/jbc.M110.116137; Khadeer MA, 2005, BONE, V37, P296, DOI 10.1016/j.bone.2005.04.035; Kim YJ, 2009, J BONE MINER RES, V24, P816, DOI 10.1359/JBMR.081230; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li H, 2009, J CLIN INVEST, V119, P3666, DOI 10.1172/JCI39832; Li YW, 2010, CANCER RES, V70, P1486, DOI 10.1158/0008-5472.CAN-09-2792; Li Z, 2008, P NATL ACAD SCI USA, V105, P13906, DOI 10.1073/pnas.0804438105; Linder K, 2004, J LIPID RES, V45, P148, DOI 10.1194/jlr.M300256-JLR200; Liu N, 2007, P NATL ACAD SCI USA, V104, P20844, DOI 10.1073/pnas.0710558105; Liu YJ, 2006, J BONE MINER RES, V21, P1511, DOI 10.1359/JBMR.051002; Liu YZ, 2005, J BIOL CHEM, V280, P29011, DOI 10.1074/jbc.M501164200; Luzi E, 2008, J BONE MINER RES, V23, P287, DOI 10.1359/JBMR.071011; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Matayoshi A, 1996, P NATL ACAD SCI USA, V93, P10785, DOI 10.1073/pnas.93.20.10785; McCarthy JJ, 2007, J APPL PHYSIOL, V102, P306, DOI 10.1152/japplphysiol.00932.2006; Mitchell BD, 2000, J CLIN ENDOCR METAB, V85, P1362, DOI 10.1210/jc.85.4.1362; Mizuno Y, 2008, BIOCHEM BIOPH RES CO, V368, P267, DOI 10.1016/j.bbrc.2008.01.073; Nakasa T, 2011, ARTHRITIS RHEUM-US, V63, P1582, DOI 10.1002/art.30321; Nishi Y, 1996, J AM COLL NUTR, V15, P340; Pacifici R, 1996, J BONE MINER RES, V11, P1043; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; Purton LE, 1996, BLOOD, V87, P1802; Rajewsky N, 2006, NAT GENET, V38, pS8, DOI 10.1038/ng1798; Ralston SH, 2005, HUM MOL GENET, V14, P943, DOI 10.1093/hmg/ddi088; Rao PK, 2006, P NATL ACAD SCI USA, V103, P8721, DOI 10.1073/pnas.0602831103; Sugatani T, 2007, J CELL BIOCHEM, V101, P996, DOI 10.1002/jcb.21335; Thum T, 2008, NATURE, V456, P980, DOI 10.1038/nature07511; Torella D, 2011, CIRC RES, V109, P880, DOI 10.1161/CIRCRESAHA.111.240150; Villar AV, 2011, HEART, V97, P1132, DOI 10.1136/hrt.2010.220418; Wang XW, 2008, BIOINFORMATICS, V24, P325, DOI 10.1093/bioinformatics/btm595; Wang XW, 2008, RNA, V14, P1012, DOI 10.1261/rna.965408; Xiao P, 2008, J BONE MINER RES, V23, P644, DOI [10.1359/jbmr.080105, 10.1359/JBMR.080105]; Zerbini CAF, 2000, BRAZ J MED BIOL RES, V33, P1429, DOI 10.1590/S0100-879X2000001200005; Zhang J, 2011, J BONE MINER RES, V26, P1953, DOI 10.1002/jbmr.377; Zhang Y, 2011, P NATL ACAD SCI USA, V108, P9863, DOI 10.1073/pnas.1018493108; Zhou QA, 2011, BIOCHEM BIOPH RES CO, V404, P127, DOI 10.1016/j.bbrc.2010.11.079	62	138	152	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2012	7	4							e34641	10.1371/journal.pone.0034641	http://dx.doi.org/10.1371/journal.pone.0034641			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959FE	22506038	Green Published, gold, Green Submitted			2022-12-27	WOS:000305297500046
J	Zheng, YF; Lamoureux, EL; Ikram, MK; Mitchell, P; Wang, JJ; Younan, C; Anuar, AR; Tai, ES; Wong, TY				Zheng, Yingfeng; Lamoureux, Ecosse L.; Ikram, M. Kamran; Mitchell, Paul; Wang, Jie Jin; Younan, Christine; Anuar, Ainur Rahman; Tai, E-Shyong; Wong, Tien Y.			Impact of Migration and Acculturation on Prevalence of Type 2 Diabetes and Related Eye Complications in Indians Living in a Newly Urbanised Society	PLOS ONE			English	Article							POPULATION-BASED ASSESSMENT; RISK-FACTORS; RETINOPATHY; EPIDEMIOLOGY; METHODOLOGY; IMPAIRMENT; IMMIGRANTS; DISEASES; COHORT	Background: Health of migrants is a major public health challenge faced by governments and policy makers. Asian Indians are among the fastest growing migration groups across Asia and the world, but the impact of migration and acculturation on diabetes and diabetes-related eye complications among Indians living in urban Asia remains unclear. Methodologies/Principal Findings: We evaluated the influence of migration and acculturation (i.e., migration status and length of residence) on the prevalence of type-2 diabetes mellitus (T2DM) and diabetes-related eye complications (diabetic retinopathy (DR) and cataract), among first-generation (defined as participant born in India with both parents born in India, n = 781) and second-generation (participants born in Singapore with both parents born in India, n = 1,112) Indian immigrants from a population-based study of Adult Indians in Singapore. Diabetes was defined as HbA1c >= 6.5%, use of diabetic medication or a physician diagnosis of diabetes. Retinal and lens photographs were graded for the presence of DR and cataract. Compared to first generation immigrants, second generation immigrants had a higher age- and gender-standardized prevalence of T2DM (34.4% versus 29.0%, p<0.001), and, in those with T2DM, higher age-and gender-standardized prevalence of DR (31.7% versus 24.8%, p<0.001), nuclear cataract (13.6% versus 11.6%, p<0.001), and posterior sub-capsular cataract (6.4% versus 4.6%, p<0.001). Among first generation migrants, longer length of residence was associated with significantly younger age of diagnosis of diabetes and greater likelihood of having T2DM and diabetesrelated eye complications. Conclusion: Second generation immigrant Indians and longer length of residence are associated with higher prevalence of diabetes and diabetes-related complications (i.e., DR and cataract) among migrant Indians living in Singapore. These data highlight potential worldwide impacts of migration patterns on the risk and burden of diabetes.	[Zheng, Yingfeng; Lamoureux, Ecosse L.; Ikram, M. Kamran; Anuar, Ainur Rahman; Wong, Tien Y.] Singapore Natl Eye Ctr, Singapore Eye Res Inst, Singapore, Singapore; [Zheng, Yingfeng] Sun Yat Sen Univ, State Key Lab Ophthalmol, Zhongshan Ophthalm Ctr, Guangzhou 510275, Guangdong, Peoples R China; [Lamoureux, Ecosse L.; Wang, Jie Jin; Wong, Tien Y.] Univ Melbourne, Ctr Eye Res Australia, Royal Victorian Eye & Ear Hosp, Melbourne, Vic, Australia; [Ikram, M. Kamran] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [Ikram, M. Kamran] Erasmus MC, Dept Ophthalmol, Rotterdam, Netherlands; [Ikram, M. Kamran; Wong, Tien Y.] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117548, Singapore; [Mitchell, Paul; Wang, Jie Jin; Younan, Christine] Univ Sydney, Ctr Vis Res, Sydney, NSW 2006, Australia; [Anuar, Ainur Rahman] Univ Malaya, Fac Med, Eye Res Ctr, Kuala Lumpur, Malaysia; [Tai, E-Shyong] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Med, Singapore 117595, Singapore; [Wong, Tien Y.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Ophthalmol, Singapore 117595, Singapore	National University of Singapore; Singapore National Eye Center; Sun Yat Sen University; Centre for Eye Research Australia; Royal Victorian Eye & Ear Hospital; University of Melbourne; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; National University of Singapore; University of Sydney; Universiti Malaya; National University of Singapore; National University of Singapore	Zheng, YF (corresponding author), Singapore Natl Eye Ctr, Singapore Eye Res Inst, Singapore, Singapore.	ophwty@nus.edu.sg	Tai, E Shyong/J-9831-2013; Zheng, Yingfeng/CAE-9225-2022; wang, jie/GRS-0942-2022; ANUAR, AINUR RAHMAN/B-8192-2010; Lamoureux, Ecosse/Z-5482-2019; Mitchell, Paul/P-1498-2014; Wong, Tien Yin/AAC-9724-2020; Zheng, Yingfeng/AAE-2983-2022; Wang, Jie Jin/P-1499-2014	Zheng, Yingfeng/0000-0002-0914-7864; Wong, Tien Yin/0000-0002-8448-1264; Wang, Jie Jin/0000-0001-9491-4898; Ikram, Mohammad Kamran/0000-0003-0173-9571; Tai, E Shyong/0000-0003-2929-8966	Biomedical Research Council (BMRC) [08/1/35/19/550]; National Medical Research Council (NMRC), Singapore [STaR/0003/2008]	Biomedical Research Council (BMRC)(Agency for Science Technology & Research (A*STAR)); National Medical Research Council (NMRC), Singapore(National Medical Research Council, Singapore)	This study was funded by Biomedical Research Council (BMRC), 08/1/35/19/550 and National Medical Research Council (NMRC), STaR/0003/2008, Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS11, DOI 10.2337/dc10-S011; Chan JCN, 2009, JAMA-J AM MED ASSOC, V301, P2129, DOI 10.1001/jama.2009.726; Cheung N, 2010, LANCET, V376, P124, DOI 10.1016/S0140-6736(09)62124-3; Dandona L, 1999, BRIT J OPHTHALMOL, V83, P937, DOI 10.1136/bjo.83.8.937; Foong AWP, 2007, OPHTHAL EPIDEMIOL, V14, P25, DOI 10.1080/09286580600878844; Huang BJ, 1996, AM J EPIDEMIOL, V144, P674; Indian Consensus Group, 1996, J NUTR ENV MED, V6, P309, DOI DOI 10.3109/13590849609007257; Isharwal S, 2009, INDIAN J MED RES, V129, P485; Jaber LA, 2003, DIABETES CARE, V26, P2010, DOI 10.2337/diacare.26.7.2010; Jonnalagadda SS, 2002, J AM DIET ASSOC, V102, P1286, DOI 10.1016/S0002-8223(02)90283-X; Kandula NR, 2008, DIABETES CARE, V31, P1621, DOI 10.2337/dc07-2182; KLEIN BEK, 1990, OPHTHALMOLOGY, V97, P1428; Kramer U, 2010, ENVIRON HEALTH PERSP, V118, P1273, DOI 10.1289/ehp.0901689; Lamoureux EL, 2011, DIABETES CARE, V34, P1066, DOI 10.2337/dc11-0225; Lavanya R, 2009, BRIT J OPHTHALMOL, V93, P299, DOI 10.1136/bjo.2008.148650; Lavanya R, 2009, OPHTHAL EPIDEMIOL, V16, P325, DOI 10.3109/09286580903144738; Lee JWR, 2011, DIABETES CARE, V34, P353, DOI 10.2337/dc10-0746; Mohan V, 2007, INDIAN J MED RES, V125, P217; Namperumalsamy P, 2009, BRIT J OPHTHALMOL, V93, P429, DOI 10.1136/bjo.2008.147934; Raman R, 2009, OPHTHALMOLOGY, V116, P311, DOI 10.1016/j.ophtha.2008.09.010; Rema M, 2005, INVEST OPHTH VIS SCI, V46, P2328, DOI 10.1167/iovs.05-0019; Rigby RA, 2005, J R STAT SOC C-APPL, V54, P507, DOI 10.1111/j.1467-9876.2005.00510.x; Tuomilehto J, 2003, DIABETES CARE, V26, P1770; Varghese S, 2002, CAN J DIET PRACT RES, V63, P72, DOI 10.3148/63.2.2002.72; Whiting D, 2010, EQUITY, SOCIAL DETERMINANTS AND PUBLIC HEALTH PROGRAMMES, P77; Wong TY, 2008, OPHTHALMOLOGY, V115, P1869, DOI 10.1016/j.ophtha.2008.05.014; Wong TY, 2006, AM J OPHTHALMOL, V141, P446, DOI 10.1016/j.ajo.2005.08.063; Zheng YF, 2011, INVEST OPHTH VIS SCI, V52, P7634, DOI 10.1167/iovs.11-7725; Zheng YF, 2011, OPHTHALMOLOGY, V118, P1798, DOI 10.1016/j.ophtha.2011.02.014	29	29	29	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2012	7	4							e34829	10.1371/journal.pone.0034829	http://dx.doi.org/10.1371/journal.pone.0034829			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959FE	22506053	Green Published, gold			2022-12-27	WOS:000305297500061
J	Kim, B; Yang, MS; Choi, D; Kim, JH; Kim, HS; Seol, W; Choi, S; Jou, I; Kim, EY; Joe, EH				Kim, Beomsue; Yang, Myung-Soon; Choi, Dongjoo; Kim, Jong-Hyeon; Kim, Hye-Sun; Seol, Wongi; Choi, Sangdun; Jou, Ilo; Kim, Eun-Young; Joe, Eun-Hye			Impaired Inflammatory Responses in Murine Lrrk2-Knockdown Brain Microglia	PLOS ONE			English	Article							NF-KAPPA-B; ACTIVATED PROTEIN-KINASE; PARKIN DEFICIENCY INCREASES; CULTURED RAT MICROGLIA; NITRIC-OXIDE SYNTHASE; TRANSCRIPTIONAL ACTIVITY; NEURONAL TOXICITY; LRRK2 EXPRESSION; DNA-BINDING; IN-VITRO	LRRK2, a Parkinson's disease associated gene, is highly expressed in microglia in addition to neurons; however, its function in microglia has not been evaluated. Using Lrrk2 knockdown (Lrrk2-KD) murine microglia prepared by lentiviral-mediated transfer of Lrrk2-specific small inhibitory hairpin RNA (shRNA), we found that Lrrk2 deficiency attenuated lipopolysaccharide (LPS)-induced mRNA and/or protein expression of inducible nitric oxide synthase, TNF-alpha, IL-1 beta and IL-6. LPS-induced phosphorylation of p38 mitogen-activated protein kinase and stimulation of NF-kappa B-responsive luciferase reporter activity was also decreased in Lrrk2-KD cells. Interestingly, the decrease in NF-kappa B transcriptional activity measured by luciferase assays appeared to reflect increased binding of the inhibitory NF-kappa B homodimer, p50/p50, to DNA. In LPS-responsive HEK293T cells, overexpression of the human LRRK2 pathologic, kinase-active mutant G2019S increased basal and LPS-induced levels of phosphorylated p38 and JNK, whereas wild-type and other pathologic (R1441C and G2385R) or artificial kinase-dead (D1994A) LRRK2 mutants either enhanced or did not change basal and LPS-induced p38 and JNK phosphorylation levels. However, wild-type LRRK2 and all LRRK2 mutant variants equally enhanced NF-kappa B transcriptional activity. Taken together, these results suggest that LRRK2 is a positive regulator of inflammation in murine microglia, and LRRK2 mutations may alter the microenvironment of the brain to favor neuroinflammation.	[Kim, Beomsue; Yang, Myung-Soon; Jou, Ilo; Joe, Eun-Hye] Ajou Univ, Sch Med, Dept Pharmacol, Suwon 441749, South Korea; [Choi, Dongjoo; Kim, Jong-Hyeon; Kim, Hye-Sun; Jou, Ilo; Kim, Eun-Young; Joe, Eun-Hye] Ajou Univ, Sch Med, Grad Program Neurosci, Suwon 441749, South Korea; [Seol, Wongi] Wonkwang Univ, Sanbon Hosp, InAm Neurosci Res Ctr, Gunpo, South Korea; [Choi, Sangdun] Ajou Univ, Sch Med, Dept Mol Sci & Technol, Suwon 441749, South Korea; [Jou, Ilo; Kim, Eun-Young; Joe, Eun-Hye] Ajou Univ, Sch Med, Chron Inflammatory Dis Res Ctr, Suwon 441749, South Korea; [Kim, Eun-Young] Ajou Univ, Sch Med, Inst Med Sci, Suwon 441749, South Korea	Ajou University; Ajou University; Wonkwang University; Ajou University; Ajou University; Ajou University	Kim, B (corresponding author), Ajou Univ, Sch Med, Dept Pharmacol, Suwon 441749, South Korea.	ehjoe@ajou.ac.kr	Kim, Beomsue/X-3045-2019	Kim, Beomsue/0000-0003-1207-7876; Choi, Dongjoo/0000-0003-3222-7130	Korea Science and Engineering Foundation National Research Laboratory [2-2008025-0]; Korean government (Ministry of Education, Science and Technology); Brain Research Center of the Twenty-First Century Frontier Research Program [M103KV010011-06K2201-01110]; Ministry of Science and Technology, Republic of Korea; Korea Science and Engineering Foundation through the Chronic Inflammatory Disease Research Center at Ajou University [R13-2003-019]; National Research Foundation of Korea (NRF) [2009-00505, NRF-2008-521-C00220, NRF-2011-0012195]; Inje FIRST (Inje University, Korea)	Korea Science and Engineering Foundation National Research Laboratory(Korea Science and Engineering Foundation); Korean government (Ministry of Education, Science and Technology)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); Brain Research Center of the Twenty-First Century Frontier Research Program; Ministry of Science and Technology, Republic of Korea(Ministry of Science & Technology (MOST), Republic of Korea); Korea Science and Engineering Foundation through the Chronic Inflammatory Disease Research Center at Ajou University(Korea Science and Engineering Foundation); National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Inje FIRST (Inje University, Korea)	This work was supported by Korea Science and Engineering Foundation National Research Laboratory Program Grant 2-2008025-0, funded by the Korean government (Ministry of Education, Science and Technology), grant M103KV010011-06K2201-01110 from the Brain Research Center of the Twenty-First Century Frontier Research Program funded by the Ministry of Science and Technology, Republic of Korea, the Korea Science and Engineering Foundation through the Chronic Inflammatory Disease Research Center at Ajou University (Grant R13-2003-019) to EHJ, Global Partnership Program (2009-00505) through the National Research Foundation of Korea (NRF) and Inje FIRST program (Inje University, Korea) to WS, Basic Science Research Program (NRF-2008-521-C00220) through the National Research Foundation of Korea to EYK, and Basic Science Research Program (NRF-2011-0012195) through the National Research Foundation of Korea to BK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashwell JD, 2006, NAT REV IMMUNOL, V6, P532, DOI 10.1038/nri1865; Bachstetter AD, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-79; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; BLASI E, 1990, J NEUROIMMUNOL, V27, P229, DOI 10.1016/0165-5728(90)90073-V; Casarejos MJ, 2009, J NEUROCHEM, V110, P1523, DOI 10.1111/j.1471-4159.2009.06248.x; Chow JC, 1999, J BIOL CHEM, V274, P10689, DOI 10.1074/jbc.274.16.10689; Covy JP, 2009, MOVEMENT DISORD, V24, P32, DOI 10.1002/mds.22096; DING AH, 1988, ANAL BIOCHEM, V175, P22, DOI 10.1016/0003-2697(88)90355-7; Doyle SL, 2005, J BIOL CHEM, V280, P23496, DOI 10.1074/jbc.C500053200; Dusonchet J, 2011, J NEUROSCI, V31, P907, DOI 10.1523/JNEUROSCI.5092-10.2011; Frank-Cannon TC, 2008, J NEUROSCI, V28, P10825, DOI 10.1523/JNEUROSCI.3001-08.2008; Gardet A, 2010, J IMMUNOL, V185, P5577, DOI 10.4049/jimmunol.1000548; Gloeckner CJ, 2009, J NEUROCHEM, V109, P959, DOI 10.1111/j.1471-4159.2009.06024.x; Hamza TH, 2010, NAT GENET, V42, P781, DOI 10.1038/ng.642; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; He Y, 2003, J NEUROCHEM, V86, P1338, DOI 10.1046/j.1471-4159.2003.01938.x; Heo HY, 2010, EXP CELL RES, V316, P649, DOI 10.1016/j.yexcr.2009.09.014; Hou SH, 2003, J BIOL CHEM, V278, P45994, DOI 10.1074/jbc.M307971200; Hsu CH, 2010, J NEUROCHEM, V112, P1593, DOI 10.1111/j.1471-4159.2010.06568.x; Huang B, 2010, CELL SIGNAL, V22, P1282, DOI 10.1016/j.cellsig.2010.03.017; Kang JH, 2001, NEUROSCI LETT, V299, P205, DOI 10.1016/S0304-3940(01)01515-4; Lee BD, 2010, NAT MED, V16, P998, DOI 10.1038/nm.2199; Lee SB, 2007, BIOCHEM BIOPH RES CO, V358, P534, DOI 10.1016/j.bbrc.2007.04.156; Li XT, 2010, J NEUROSCI, V30, P1788, DOI 10.1523/JNEUROSCI.5604-09.2010; Li YP, 2009, NAT NEUROSCI, V12, P826, DOI 10.1038/nn.2349; Liberatore GT, 1999, NAT MED, V5, P1403; Liou AKF, 2008, NEUROBIOL DIS, V32, P116, DOI 10.1016/j.nbd.2008.06.016; Liu B, 2006, AAPS J, V8, pE606, DOI 10.1208/aapsj080369; Liu YG, 2001, CANCER RES, V61, P5402; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Madrid LV, 2001, J BIOL CHEM, V276, P18934, DOI 10.1074/jbc.M101103200; MCGEER PL, 1988, NEUROLOGY, V38, P1285, DOI 10.1212/WNL.38.8.1285; Medvedev AE, 2003, J ENDOTOXIN RES, V9, P60, DOI 10.1179/096805103125001360; Melrose HL, 2007, NEUROSCIENCE, V147, P1047, DOI 10.1016/j.neuroscience.2007.05.027; Melrose HL, 2010, NEUROBIOL DIS, V40, P503, DOI 10.1016/j.nbd.2010.07.010; Miklossy J, 2006, J NEUROPATH EXP NEUR, V65, P953, DOI 10.1097/01.jnen.0000235121.98052.54; Mutez E, 2011, NEUROBIOL AGING, V32, P1839, DOI 10.1016/j.neurobiolaging.2009.10.016; Paisan-Ruiz C, 2009, ANN HUM GENET, V73, P391, DOI 10.1111/j.1469-1809.2009.00524.x; Plowey ED, 2008, J NEUROCHEM, V105, P1048, DOI 10.1111/j.1471-4159.2008.05217.x; Potashkin J.A., 2010, PARKINSONS DIS, V2011; Godoy MCP, 2008, BRAIN, V131, P1880, DOI 10.1093/brain/awn101; Pyo H, 1998, NEUROREPORT, V9, P871, DOI 10.1097/00001756-199803300-00020; Pyo H, 1999, J BIOL CHEM, V274, P34584, DOI 10.1074/jbc.274.49.34584; Ryu J, 2002, J IMMUNOL, V168, P5805, DOI 10.4049/jimmunol.168.11.5805; Ryu J, 2000, J BIOL CHEM, V275, P29955, DOI 10.1074/jbc.M001220200; Saha RN, 2007, J IMMUNOL, V179, P7101, DOI 10.4049/jimmunol.179.10.7101; Schmidt S, 2011, HUM MOL GENET, V20, P1197, DOI 10.1093/hmg/ddq564; Shin N, 2008, EXP CELL RES, V314, P2055, DOI 10.1016/j.yexcr.2008.02.015; Smith WLW, 2006, NAT NEUROSCI, V9, P1231, DOI 10.1038/nn1776; Solano RM, 2008, J NEUROSCI, V28, P598, DOI 10.1523/JNEUROSCI.4609-07.2008; Tong YR, 2009, P NATL ACAD SCI USA, V106, P14622, DOI 10.1073/pnas.0906334106; Waak J, 2009, FASEB J, V23, P2478, DOI 10.1096/fj.08-125153; Wang L, 2010, NEUROSCI LETT, V468, P198, DOI 10.1016/j.neulet.2009.10.080; West AB, 2007, HUM MOL GENET, V16, P223, DOI 10.1093/hmg/ddl471; White LR, 2007, J NEUROSCI RES, V85, P1288, DOI 10.1002/jnr.21240; Whitton PS, 2007, BRIT J PHARMACOL, V150, P963, DOI 10.1038/sj.bjp.0707167; Wilms H, 2003, FASEB J, V17, P500, DOI 10.1096/fj.02-0314fje; Yang H, 2000, J BIOL CHEM, V275, P20861, DOI 10.1074/jbc.M002896200; Zhang FR, 2009, NEW ENGL J MED, V361, P2609, DOI 10.1056/NEJMoa0903753; Zheng Y, 2010, EUR J NEUROL; Zhong HH, 1997, CELL, V89, P413, DOI 10.1016/S0092-8674(00)80222-6	61	130	133	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2012	7	4							e34693	10.1371/journal.pone.0034693	http://dx.doi.org/10.1371/journal.pone.0034693			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JO	22496842	gold, Green Published			2022-12-27	WOS:000305014500026
J	Klemm, K; Mehta, A; Stadler, PF				Klemm, Konstantin; Mehta, Anita; Stadler, Peter F.			Landscape Encodings Enhance Optimization	PLOS ONE			English	Article								Hard combinatorial optimization problems deal with the search for the minimum cost solutions (ground states) of discrete systems under strong constraints. A transformation of state variables may enhance computational tractability. It has been argued that these state encodings are to be chosen invertible to retain the original size of the state space. Here we show how redundant non-invertible encodings enhance optimization by enriching the density of low-energy states. In addition, smooth landscapes may be established on encoded state spaces to guide local search dynamics towards the ground state.	[Klemm, Konstantin; Stadler, Peter F.] Univ Leipzig, Dept Comp Sci, Bioinformat Grp, Leipzig, Germany; [Klemm, Konstantin; Stadler, Peter F.] Univ Leipzig, Interdisciplinary Ctr Bioinformat, Leipzig, Germany; [Mehta, Anita] SN Bose Natl Ctr Basic Sci, Theory Dept, Kolkata 700064, W Bengal, India; [Stadler, Peter F.] Max Planck Inst Math Sci, Leipzig, Germany; [Stadler, Peter F.] Fraunhofer Inst Zelltherapie & Immunol, Leipzig, Germany; [Stadler, Peter F.] Univ Vienna, Dept Theoret Chem, Vienna, Austria; [Stadler, Peter F.] Santa Fe Inst, Santa Fe, NM 87501 USA	Leipzig University; Leipzig University; Department of Science & Technology (India); SN Bose National Centre for Basic Science (SNBNCBS); Max Planck Society; Fraunhofer Gesellschaft; University of Vienna; The Santa Fe Institute	Klemm, K (corresponding author), Univ Leipzig, Dept Comp Sci, Bioinformat Grp, Leipzig, Germany.	klemm@bioinf.uni-leipzig.de	Klemm, Konstantin/L-8426-2018; Stadler, Peter F. F/L-7857-2015; Klemm, Konstantin/GYU-3511-2022	Stadler, Peter F. F/0000-0002-5016-5191; 	Volkswagenstiftung [85 165/85 166]	Volkswagenstiftung(Volkswagen)	Volkswagenstiftung, project 85 165/85 166, http://www.volkswagenstiftung.de/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Applegate D.L., 2006, TRAVELING SALESMAN P, DOI DOI 10.1515/9781400841103; Banzhaf W, 2006, GENET PROGR SER, V9, P207, DOI 10.1007/0-387-28111-8_14; Bauer M, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.107202; Berg J, 2004, P NATL ACAD SCI USA, V101, P14689, DOI 10.1073/pnas.0305199101; BINDER K, 1986, REV MOD PHYS, V58, P801, DOI 10.1103/RevModPhys.58.801; Bollobas B., 2001, RANDOM GRAPHS; Caprara A, 1997, PROC INT C COMPUT MO, P75; Choi SS, 2008, IEEE T EVOLUT COMPUT, V12, P604, DOI 10.1109/TEVC.2007.913699; Fernandez P, 2007, J R SOC INTERFACE, V4, P41, DOI 10.1098/rsif.2006.0152; Flamm C., 2007, Foundations of Genetic Algorithms, P194; FRAENKEL AS, 1993, B MATH BIOL, V55, P1199, DOI 10.1007/BF02460704; Garey M.R., 1979, COMPUTERS INTRACTABI; HELD M, 1962, J SOC IND APPL MATH, V10, P196, DOI 10.1137/0110015; Holland J. H., 1992, ADAPTATION NATURAL A; Karmakar N, 1982, UCBCSD81113; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; Knowles J. D., 2002, Parallel Problem Solving from Nature - PPSN VII. 7th International Conference. Proceedings (Lecture Notes in Computer Science Vol.2439), P88; Koza JR, 1992, GENETIC PROGRAMMING; Mertens S, 1998, PHYS REV LETT, V81, P4281, DOI 10.1103/PhysRevLett.81.4281; Mezard M, 2002, SCIENCE, V297, P812, DOI 10.1126/science.1073287; Reidys C, 1997, B MATH BIOL, V59, P339, DOI 10.1016/S0092-8240(96)00089-4; Reidys CM, 2002, SIAM REV, V44, P3, DOI 10.1137/S0036144501395952; Ricci-Tersenghi F, 2010, SCIENCE, V330, P1639, DOI 10.1126/science.1189804; Rothlauf F, 2003, EVOL COMPUT, V11, P381, DOI 10.1162/106365603322519288; Rothlauf F., 2006, REPRESENTATIONS GENE; Rothlauf F, 2011, NAT COMPUT SER, P1, DOI 10.1007/978-3-540-72962-4; Ruml W, 1996, J OPTIMIZ THEORY APP, V89, P251, DOI 10.1007/BF02192530; Schulman LS, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.257202; SCHUSTER P, 1994, P ROY SOC B-BIOL SCI, V255, P279, DOI 10.1098/rspb.1994.0040; SHERRINGTON D, 1975, PHYS REV LETT, V35, P1792, DOI 10.1103/PhysRevLett.35.1792; Van Nimwegen E, 2000, B MATH BIOL, V62, P799, DOI 10.1006/bulm.2000.0180; YU T, 2002, LNCS, V2278, P13, DOI DOI 10.1007/3-540-45984-7_	32	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2012	7	4							e34780	10.1371/journal.pone.0034780	http://dx.doi.org/10.1371/journal.pone.0034780			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JO	22496860	gold, Green Submitted, Green Published			2022-12-27	WOS:000305014500029
J	Shariati, NH; Freeman, AW				Shariati, Nastaran Hesam; Freeman, Alan W.			A Multi-Stage Model for Fundamental Functional Properties in Primary Visual Cortex	PLOS ONE			English	Article							CATS STRIATE CORTEX; LATERAL GENICULATE-NUCLEUS; CELL RECEPTIVE-FIELDS; RETINAL GANGLION-CELLS; ORIENTATION SELECTIVITY; DIRECTION SELECTIVITY; COMPLEX CELLS; SPATIOTEMPORAL ORGANIZATION; CONTRAST SENSITIVITY; SPATIAL SUMMATION	Many neurons in mammalian primary visual cortex have properties such as sharp tuning for contour orientation, strong selectivity for motion direction, and insensitivity to stimulus polarity, that are not shared with their sub-cortical counterparts. Successful models have been developed for a number of these properties but in one case, direction selectivity, there is no consensus about underlying mechanisms. We here define a model that accounts for many of the empirical observations concerning direction selectivity. The model describes a single column of cat primary visual cortex and comprises a series of processing stages. Each neuron in the first cortical stage receives input from a small number of on-centre and off-centre relay cells in the lateral geniculate nucleus. Consistent with recent physiological evidence, the off-centre inputs to cortex precede the on-centre inputs by a small (similar to 4 ms) interval, and it is this difference that confers direction selectivity on model neurons. We show that the resulting model successfully matches the following empirical data: the proportion of cells that are direction selective; tilted spatiotemporal receptive fields; phase advance in the response to a stationary contrast-reversing grating stepped across the receptive field. The model also accounts for several other fundamental properties. Receptive fields have elongated subregions, orientation selectivity is strong, and the distribution of orientation tuning bandwidth across neurons is similar to that seen in the laboratory. Finally, neurons in the first stage have properties corresponding to simple cells, and more complex-like cells emerge in later stages. The results therefore show that a simple feed-forward model can account for a number of the fundamental properties of primary visual cortex.	[Shariati, Nastaran Hesam; Freeman, Alan W.] Univ Sydney, Discipline Biomed Sci, Lidcombe, NSW, Australia	University of Sydney	Shariati, NH (corresponding author), Univ Sydney, Discipline Biomed Sci, Lidcombe, NSW, Australia.	Alan.Freeman@sydney.edu.au	Freeman, Alan/A-6613-2008	Freeman, Alan/0000-0003-0563-526X				ADELSON EH, 1985, J OPT SOC AM A, V2, P284, DOI 10.1364/JOSAA.2.000284; Alonso JM, 1998, NAT NEUROSCI, V1, P395, DOI 10.1038/1609; Alonso JM, 2001, J NEUROSCI, V21, P4002, DOI 10.1523/JNEUROSCI.21-11-04002.2001; Alonso JM, 1996, NATURE, V383, P815, DOI 10.1038/383815a0; Anderson JS, 2000, J NEUROPHYSIOL, V84, P909, DOI 10.1152/jn.2000.84.2.909; BEAULIEU C, 1983, J COMP NEUROL, V217, P337, DOI 10.1002/cne.902170308; Carandini M, 2000, J NEUROSCI, V20, P470, DOI 10.1523/JNEUROSCI.20-01-00470.2000; Chance FS, 1999, NAT NEUROSCI, V2, P277, DOI 10.1038/6381; CREUTZFELDT O, 1968, EXP BRAIN RES, V6, P324; DEAN AF, 1983, J PHYSIOL-LONDON, V344, P305, DOI 10.1113/jphysiol.1983.sp014941; DEAN AF, 1981, J PHYSIOL-LONDON, V318, P413; DEANGELIS GC, 1993, J NEUROPHYSIOL, V69, P1118, DOI 10.1152/jn.1993.69.4.1118; DEANGELIS GC, 1993, J NEUROPHYSIOL, V69, P1091, DOI 10.1152/jn.1993.69.4.1091; ENROTHCUGELL C, 1966, J PHYSIOL-LONDON, V187, P517, DOI 10.1113/jphysiol.1966.sp008107; FRISHMAN LJ, 1987, J GEN PHYSIOL, V89, P599, DOI 10.1085/jgp.89.4.599; GABBOTT PLA, 1986, EXP BRAIN RES, V61, P323; Gardner JL, 1999, VISUAL NEUROSCI, V16, P1115, DOI 10.1017/S0952523899166112; GILBERT CD, 1979, NATURE, V280, P120, DOI 10.1038/280120a0; GIZZI MS, 1990, J NEUROPHYSIOL, V63, P1529, DOI 10.1152/jn.1990.63.6.1529; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; HUGHES A, 1976, VISION RES, V16, P149, DOI 10.1016/0042-6989(76)90091-2; Jagadeesh B, 1997, J NEUROPHYSIOL, V78, P2772, DOI 10.1152/jn.1997.78.5.2772; Jin JZ, 2011, J NEUROSCI, V31, P17471, DOI 10.1523/JNEUROSCI.2456-11.2011; Jin JZ, 2011, NAT NEUROSCI, V14, P232, DOI 10.1038/nn.2729; Jin JZ, 2008, NAT NEUROSCI, V11, P88, DOI 10.1038/nn2029; JONES JP, 1987, J NEUROPHYSIOL, V58, P1187, DOI 10.1152/jn.1987.58.6.1187; KAPLAN E, 1987, J PHYSIOL-LONDON, V391, P267, DOI 10.1113/jphysiol.1987.sp016737; Kuhlmann L, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00081; LUND JS, 1979, J COMP NEUROL, V184, P599, DOI 10.1002/cne.901840402; Martinez LM, 2005, NAT NEUROSCI, V8, P372, DOI 10.1038/nn1404; MOVSHON JA, 1978, J PHYSIOL-LONDON, V283, P53, DOI 10.1113/jphysiol.1978.sp012488; MOVSHON JA, 1978, J PHYSIOL-LONDON, V283, P101, DOI 10.1113/jphysiol.1978.sp012490; Murthy A, 1998, VISUAL NEUROSCI, V15, P239, DOI 10.1017/S0952523898152045; Peterson MR, 2004, J NEUROSCI, V24, P3583, DOI 10.1523/JNEUROSCI.5398-03.2004; REID RC, 1987, P NATL ACAD SCI USA, V84, P8740, DOI 10.1073/pnas.84.23.8740; REID RC, 1995, NATURE, V378, P281, DOI 10.1038/378281a0; Ringach DL, 2004, J NEUROPHYSIOL, V92, P468, DOI 10.1152/jn.01202.2003; Romo PA, 2011, J NEUROPHYSIOL, V106, P1688, DOI 10.1152/jn.00894.2010; ROSE D, 1974, EXP BRAIN RES, V20, P1; SAUL AB, 1990, J NEUROPHYSIOL, V64, P206, DOI 10.1152/jn.1990.64.1.206; SCLAR G, 1982, EXP BRAIN RES, V46, P457; SILLITO AM, 1975, J PHYSIOL-LONDON, V250, P305, DOI 10.1113/jphysiol.1975.sp011056; SOMERS DC, 1995, J NEUROSCI, V15, P5448; Sompolinsky H, 1997, CURR OPIN NEUROBIOL, V7, P514, DOI 10.1016/S0959-4388(97)80031-1; SOODAK RE, 1987, P NATL ACAD SCI USA, V84, P3936, DOI 10.1073/pnas.84.11.3936; Stein JJ, 1996, J COMP NEUROL, V372, P597, DOI 10.1002/(SICI)1096-9861(19960902)372:4<597::AID-CNE8>3.0.CO;2-#; STONE J, 1982, TRENDS NEUROSCI, V5, P441, DOI 10.1016/0166-2236(82)90237-5; TANAKA K, 1983, J NEUROPHYSIOL, V49, P1303, DOI 10.1152/jn.1983.49.6.1303; TUSA RJ, 1978, J COMP NEUROL, V177, P213, DOI 10.1002/cne.901770204; Ursino M, 2007, COMPUT BIOL MED, V37, P398, DOI 10.1016/j.compbiomed.2006.05.002; WASSLE H, 1981, PROC R SOC SER B-BIO, V212, P177, DOI 10.1098/rspb.1981.0033; WATSON AB, 1985, J OPT SOC AM A, V2, P322, DOI 10.1364/JOSAA.2.000322	52	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2012	7	4							e34466	10.1371/journal.pone.0034466	http://dx.doi.org/10.1371/journal.pone.0034466			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JO	22496811	Green Published, Green Submitted, gold			2022-12-27	WOS:000305014500023
J	Tabassum, R; Jaiswal, A; Chauhan, G; Dwivedi, OP; Ghosh, S; Marwaha, RK; Tandon, N; Bharadwaj, D				Tabassum, Rubina; Jaiswal, Alok; Chauhan, Ganesh; Dwivedi, Om Prakash; Ghosh, Saurabh; Marwaha, Raman K.; Tandon, Nikhil; Bharadwaj, Dwaipayan			Genetic Variant of AMD1 Is Associated with Obesity in Urban Indian Children	PLOS ONE			English	Article							PLASMA HOMOCYSTEINE LEVELS; CORONARY-HEART-DISEASE; METHYLENETETRAHYDROFOLATE REDUCTASE; INSULIN-RESISTANCE; METABOLIC SYNDROME; CHILDHOOD OBESITY; RISK-FACTORS; MTHFR C677T; HYPERHOMOCYSTEINEMIA; POLYMORPHISMS	Background: Hyperhomocysteinemia is regarded as a risk factor for cardiovascular diseases, diabetes and obesity. Manifestation of these chronic metabolic disorders starts in early life marked by increase in body mass index (BMI). We hypothesized that perturbations in homocysteine metabolism in early life could be a link between childhood obesity and adult metabolic disorders. Thus here we investigated association of common variants from homocysteine metabolism pathway genes with obesity in 3,168 urban Indian children. Methodology/Principal Findings: We genotyped 90 common variants from 18 genes in 1,325 children comprising of 862 normal-weight (NW) and 463 over-weight/obese (OW/OB) children in stage 1. The top signal obtained was replicated in an independent sample set of 1843 children (1,399 NW and 444 OW/OB) in stage 2. Stage 1 association analysis revealed association between seven variants and childhood obesity at P < 0.05, but association of only rs2796749 in AMD1 [OR = 1.41, P = 1.5x10(-4)] remained significant after multiple testing correction. Association of rs2796749 with childhood obesity was validated in stage 2 [OR = 1.28, P = 4.2x10(-3)] and meta-analysis [OR = 1.35, P = 1.9x10(-6)]. AMD1 variant rs2796749 was also associated with quantitative measures of adiposity and plasma leptin levels that was also replicated and corroborated in combined analysis. Conclusions/Significance: Our study provides first evidence for the association of AMD1 variant with obesity and plasma leptin levels in children. Further studies to confirm this association, its functional significance and mechanism of action need to be undertaken.	[Tabassum, Rubina; Jaiswal, Alok; Chauhan, Ganesh; Dwivedi, Om Prakash; Bharadwaj, Dwaipayan] Inst Genom & Integrat Biol, CSIR, Genom & Mol Med Unit, Delhi, India; [Ghosh, Saurabh] Indian Stat Inst, Human Genet Unit, Kolkata, India; [Marwaha, Raman K.] Inst Nucl Med & Allied Sci, Dept Endocrinol & Thyroid Res, Delhi, India; [Tandon, Nikhil] All India Inst Med Sci, Dept Endocrinol, New Delhi, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB); Indian Statistical Institute; Indian Statistical Institute Kolkata; Defence Research & Development Organisation (DRDO); Institute of Nuclear Medicine & Allied Sciences (INMAS); All India Institute of Medical Sciences (AIIMS) New Delhi	Tabassum, R (corresponding author), Inst Genom & Integrat Biol, CSIR, Genom & Mol Med Unit, Delhi, India.	nikhil_tandon@hotmail.com; db@igib.res.in	CHAUHAN, GANESH/AAI-5110-2021; Marwaha, Raman/AAQ-7475-2021	Marwaha, Raman/0000-0002-9698-4280; Bharadwaj, Dwaipayan/0000-0001-5268-8482; Tabassum, Rubina/0000-0002-3120-3041; Chauhan, Ganesh/0000-0002-8564-5021	Council of Scientific and Industrial Research (CSIR), Government of India [NWP0032-OB2]; Fogarty International Center; Eunice Kennedy Shriver National Institute of Child Health & Human Development at the National Institutes of Health [1 D43 HD065249]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [D43HD065249] Funding Source: NIH RePORTER	Council of Scientific and Industrial Research (CSIR), Government of India(Council of Scientific & Industrial Research (CSIR) - India); Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Eunice Kennedy Shriver National Institute of Child Health & Human Development at the National Institutes of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This study was supported by 'Diabetes mellitus-New drug discovery R&D, molecular mechanisms and genetic & epidemiological factors' (NWP0032-OB2) funded by Council of Scientific and Industrial Research (CSIR), Government of India. RT received postdoctoral fellowship from the Fogarty International Center and the Eunice Kennedy Shriver National Institute of Child Health & Human Development at the National Institutes of Health (1 D43 HD065249). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Bazzaz JT, 2010, MOL BIOL REP, V37, P105, DOI 10.1007/s11033-009-9545-z; Benes P, 2001, MOL GENET METAB, V73, P188, DOI 10.1006/mgme.2001.3188; Bhardwaj S, 2008, ASIA PAC J CLIN NUTR, V17, P172; Bhargava SK, 2004, NEW ENGL J MED, V350, P865, DOI 10.1056/NEJMoa035698; Biro FM, 2010, AM J CLIN NUTR, V91, p1499S, DOI 10.3945/ajcn.2010.28701B; Brahmachari SK, 2008, J GENET, V87, P3; Brooks WH, 2012, CLIN REV ALLERG IMMU, V42, P58, DOI [10.1007/s12016-011-8289-4, 10.1007/s12016-011-8290-y]; Brown KS, 2003, ARTERIOSCL THROM VAS, V23, P1014, DOI 10.1161/01.ATV.0000071348.70527.F4; Buysschaert M, 2000, DIABETES CARE, V23, P1816, DOI 10.2337/diacare.23.12.1816; Chauhan G, 2012, EXP DIABETES RES, DOI 10.1155/2012/960318; Codoner-Franch P, 2011, J CLIN ENDOCR METAB, V96, P2821, DOI 10.1210/jc.2011-0531; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Fernandez JR, 2012, INT J OBESITY, V36, P479, DOI 10.1038/ijo.2011.236; Finkelstein JD, 1998, EUR J PEDIATR, V157, pS40, DOI 10.1007/PL00014300; FROSST P, 1995, NAT GENET, V10, P111, DOI 10.1038/ng0595-111; Gupta R, 2008, HEART, V94, P16, DOI 10.1136/hrt.2007.132951; Gupta R, 2004, INT J CARDIOL, V97, P257, DOI 10.1016/j.ijcard.2003.11.003; Humphrey LL, 2008, MAYO CLIN PROC, V83, P1203, DOI 10.4065/83.11.1203; Kumar J, 2005, J HUM GENET, V50, P655, DOI 10.1007/s10038-005-0313-1; Kumar J, 2009, CIRC-CARDIOVASC GENE, V2, P599, DOI 10.1161/CIRCGENETICS.108.841411; Lai CQ, 2010, AM J CLIN NUTR, V91, P1377, DOI 10.3945/ajcn.2009.28923; Lobstein T., 2004, OBESITY REV OFFIC S1, V5, P4, DOI [10.1111/j.1467-789X.2004.00133.x, DOI 10.1111/J.1467-789X.2004.00133.X]; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Mehri S, 2010, CLIN BIOCHEM, V43, P259, DOI 10.1016/j.clinbiochem.2009.10.008; Meigs JB, 2001, DIABETES CARE, V24, P1403, DOI 10.2337/diacare.24.8.1403; Ntaios G, 2011, ATHEROSCLEROSIS, V214, P11, DOI 10.1016/j.atherosclerosis.2010.08.045; Park L. K., 2011, P NUTR SOC, V4, P1; Pirinen E, 2007, MOL CELL BIOL, V27, P4953, DOI 10.1128/MCB.02034-06; Rahimi M, 2010, CLIN BIOCHEM, V43, P1333, DOI 10.1016/j.clinbiochem.2010.08.019; Refsum H, 2001, AM J CLIN NUTR, V74, P233; SELHUB J, 1993, JAMA-J AM MED ASSOC, V270, P2693, DOI 10.1001/jama.270.22.2693; Soininen T, 1996, BIOCHEM J, V316, P273, DOI 10.1042/bj3160273; Souto JC, 2005, AM J HUM GENET, V76, P925, DOI 10.1086/430409; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Tabassum R, 2008, J HUM GENET, V53, P957, DOI 10.1007/s10038-008-0335-6; Tabassum R, 2012, DIABETES, V61, P626, DOI 10.2337/db11-1501; Terruzzi I, 2007, J ENDOCRINOL INVEST, V30, P747, DOI 10.1007/BF03350812; Vuohelainen S, 2010, J CELL MOL MED, V14, P1683, DOI 10.1111/j.1582-4934.2009.00808.x; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047	40	26	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2012	7	4							e33162	10.1371/journal.pone.0033162	http://dx.doi.org/10.1371/journal.pone.0033162			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JO	22496743	Green Published, gold, Green Submitted			2022-12-27	WOS:000305014500009
J	Lv, TF; Yuan, DM; Miao, XH; Lv, YL; Zhan, P; Shen, XK; Song, Y				Lv, Tangfeng; Yuan, Dongmei; Miao, Xiaohui; Lv, Yanling; Zhan, Ping; Shen, Xiaokun; Song, Yong			Over-Expression of LSD1 Promotes Proliferation, Migration and Invasion in Non-Small Cell Lung Cancer	PLOS ONE			English	Article								Background: Lysine specific demethylase 1 (LSD1) has been identified and biochemically characterized in epigenetics, but the pathological roles of its dysfunction in lung cancer remain to be elucidated. The aim of this study was to evaluate the prognostic significance of LSD1 expression in patients with non-small cell lung cancer (NSCLC) and to define its exact role in lung cancer proliferation, migration and invasion. Methods: The protein levels of LSD1 in surgically resected samples from NSCLC patients were detected by immunohistochemistry or Western blotting. The mRNA levels of LSD1 were detected by qRT-PCR. The correlation of LSD1 expression with clinical characteristics and prognosis was determined by statistical analysis. Cell proliferation rate was assessed by MTS assay and immunofluorescence. Cell migration and invasion were detected by scratch test, matrigel assay and transwell invasion assay. Results: LSD1 expression was higher in lung cancer tissue more than in normal lung tissue. Our results showed that overexpression of LSD1 protein were associated with shorter overall survival of NSCLC patients. LSD1 was localized mainly to the cancer cell nucleus. Interruption of LSD1 using siRNA or a chemical inhibitor, pargyline, suppressed proliferation, migration and invasion of A549, H460 and 293T cells. Meanwhile, over-expression of LSD1 enhanced cell growth. Finally, LSD1 was shown to regulate epithelial-to-mesenchymal transition in lung cancer cells. Conclusions: Over-expression of LSD1 was associated with poor prognosis in NSCLC, and promoted tumor cell proliferation, migration and invasion. These results suggest that LSD1 is a tumor-promoting factor with promising therapeutic potential for NSCLC.	[Lv, Tangfeng; Yuan, Dongmei; Miao, Xiaohui; Lv, Yanling; Shen, Xiaokun; Song, Yong] Nanjing Univ, Sch Med, Jinling Hosp, Dept Resp Med, Nanjing, Jiangsu, Peoples R China; [Zhan, Ping] Nanjing Chest Hosp, Dept Resp Med 1, Nanjing, Jiangsu, Peoples R China	Nanjing University	Lv, TF (corresponding author), Nanjing Univ, Sch Med, Jinling Hosp, Dept Resp Med, Nanjing, Jiangsu, Peoples R China.	yong_song6310@yahoo.com						Best JD, 2010, DRUG DISCOV TODAY, V15, P65, DOI 10.1016/j.drudis.2009.10.010; Chen PP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000534; Cole PA, 2008, NAT CHEM BIOL, V4, P590, DOI 10.1038/nchembio.111; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Hayami S, 2011, INT J CANCER, V128, P574, DOI 10.1002/ijc.25349; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Lim S, 2010, INT J CANCER, V127, P1991, DOI 10.1002/ijc.25538; Lim S, 2010, CARCINOGENESIS, V31, P512, DOI 10.1093/carcin/bgp324; Metzger E, 2005, NATURE, V437, P436, DOI 10.1038/nature04020; Piperi C, 2008, J CELL MOL MED, V12, P1495, DOI 10.1111/j.1582-4934.2008.00309.x; REMMELE W, 1987, PATHOLOGE, V8, P138; Risch A, 2008, INT J CANCER, V123, P1, DOI 10.1002/ijc.23605; Schulte JH, 2009, CANCER RES, V69, P2065, DOI 10.1158/0008-5472.CAN-08-1735; Scoumanne A, 2007, J BIOL CHEM, V282, P15471, DOI 10.1074/jbc.M701023200; Seligson DB, 2009, AM J PATHOL, V174, P1619, DOI 10.2353/ajpath.2009.080874; Shi Y, 2007, NAT REV GENET, V8, P829, DOI 10.1038/nrg2218; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Suikki HE, 2010, PROSTATE, V70, P889, DOI 10.1002/pros.21123; Ueda R, 2009, J AM CHEM SOC, V131, P17536, DOI 10.1021/ja907055q; Wang JX, 2007, NATURE, V446, P882, DOI 10.1038/nature05671; Wang Y, 2009, CELL, V138, P660, DOI 10.1016/j.cell.2009.05.050; Xiang B, 2006, METHOD ENZYMOL, V406, P692, DOI 10.1016/S0076-6879(06)06054-X	22	211	249	3	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2012	7	4							e35065	10.1371/journal.pone.0035065	http://dx.doi.org/10.1371/journal.pone.0035065			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JA	22493729	Green Submitted, Green Published, gold			2022-12-27	WOS:000305012700071
J	Pearson, HC; Dawson, LN; Breitkopf, CR				Pearson, Heidi C.; Dawson, Lauren N.; Breitkopf, Carmen Radecki			Recycling Attitudes and Behavior among a Clinic-Based Sample of Low-Income Hispanic Women in Southeast Texas	PLOS ONE			English	Article							ENVIRONMENTAL BEHAVIORS; ACCULTURATION; PARTICIPATION	We examined attitudes and behavior surrounding voluntary recycling in a population of low-income Hispanic women. Participants (N = 1,512) 18-55 years of age completed a self-report survey and responded to questions regarding household recycling behavior, recycling knowledge, recycling beliefs, potential barriers to recycling (transportation mode, time), acculturation, demographic characteristics (age, income, employment, marital status, education, number of children, birth country), and social desirability. Forty-six percent of participants (n = 810) indicated that they or someone else in their household recycled. In a logistic regression model controlling for social desirability, recycling behavior was related to increased age (P<0.05), lower acculturation (P<0.01), knowing what to recycle (P<0.01), knowing that recycling saves landfill space (P<0.05), and disagreeing that recycling takes too much time (P<0.001). A Sobel test revealed that acculturation mediated the relationship between recycling knowledge and recycling behavior (P<0.05). We offer new information on recycling behavior among Hispanic women and highlight the need for educational outreach and intervention strategies to increase recycling behavior within this understudied population.	[Pearson, Heidi C.] Univ Alaska SE, Dept Nat Sci, Juneau, AK USA; [Dawson, Lauren N.; Breitkopf, Carmen Radecki] Univ Texas Med Branch, Dept Obstet & Gynecol, Galveston, TX USA; [Breitkopf, Carmen Radecki] Mayo Clin, Dept Hlth Sci Res, Rochester, MN USA	University of Alaska System; University of Alaska Southeastern; University of Texas System; University of Texas Medical Branch Galveston; Mayo Clinic	Pearson, HC (corresponding author), Univ Alaska SE, Dept Nat Sci, Juneau, AK USA.	hcpearson@uas.alaska.edu	Pearson, Heidi/AAC-5309-2020		National Cancer Institute [R01 CA107015-01A1]; NATIONAL CANCER INSTITUTE [R01CA107015] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by a grant from the National Cancer Institute (R01 CA107015-01A1) awarded to CRB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afroz R, 2010, WASTE MANAGE RES, V28, P552, DOI 10.1177/0734242X09353434; Anderson GD, 2005, OBSTET GYNECOL, V105, P205, DOI 10.1097/01.AOG.0000146288.28195.27; ARBUTHNOT J, 1975, INT J PSYCHOL, V10, P275, DOI 10.1080/00207597508247339; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Berger IE, 1997, ENVIRON BEHAV, V29, P515, DOI 10.1177/001391659702900404; Bernstein R, 2009, CENSUS BUREAU ESTIMA; Berry J.W., 1992, CROSS CULTURAL PSYCH; Berry JW, 1997, APPL PSYCHOL-INT REV, V46, P5, DOI 10.1111/j.1464-0597.1997.tb01087.x; Bogner J, 2007, AR4 CLIMATE CHANGE 2007: MITIGATION OF CLIMATE CHANGE, P585; BOLDERO J, 1995, J APPL SOC PSYCHOL, V25, P440, DOI 10.1111/j.1559-1816.1995.tb01598.x; Budak F, 2008, J ENVIRON BIOL, V29, P923; CorralVerdugo V, 1996, ENVIRON BEHAV, V28, P665, DOI 10.1177/001391659602800505; DERKSEN L, 1993, AM SOCIOL REV, V58, P434, DOI 10.2307/2095910; DEYOUNG R, 1989, J ENVIRON SYST, V18, P341; Galanti Geri-Ann, 2003, J Transcult Nurs, V14, P180, DOI 10.1177/1043659603014003004; GAMBA RJ, 1994, ENVIRON BEHAV, V26, P587, DOI 10.1177/0013916594265001; HARTZLER K, 1985, HISPANIC J BEHAV SCI, V7, P333, DOI 10.1177/07399863850074002; Harvey SM, 2002, J SEX RES, V39, P284, DOI 10.1080/00224490209552152; HAYS RD, 1989, EDUC PSYCHOL MEAS, V49, P629, DOI 10.1177/001316448904900315; HERRERA RS, 1995, HISPANIC J BEHAV SCI, V17, P49, DOI 10.1177/07399863950171003; Hornik J., 1995, J SOCIO-ECON, V24, P105, DOI DOI 10.1016/1053-5357(95)90032-2; HOWENSTINE E, 1993, ENVIRON BEHAV, V25, P86, DOI 10.1177/0013916593251004; Johnson CY, 2004, ENVIRON BEHAV, V36, P157, DOI 10.1177/0013916503251478; Margai FL, 1997, ENVIRON BEHAV, V29, P769, DOI 10.1177/0013916597296003; MARIN G, 1987, HISPANIC J BEHAV SCI, V9, P183, DOI 10.1177/07399863870092005; Meneses GD, 2005, ENVIRON BEHAV, V37, P837, DOI 10.1177/0013916505276742; Mukherji J, 2005, ADV CONSUM RES, V32, P415; Olli E, 2001, ENVIRON BEHAV, V33, P181, DOI 10.1177/0013916501332002; OSKAMP S, 1991, ENVIRON BEHAV, V23, P494, DOI 10.1177/0013916591234005; Oskamp S, 1998, J ENVIRON EDUC, V29, P37, DOI [DOI 10.1080/10095896980959911, 10.1080/00958969809599111, DOI 10.1080/00958969809599111]; Owens J, 2000, ENVIRON BEHAV, V32, P637, DOI 10.1177/00139160021972711; Peretz JH, 2005, J ENVIRON PLANN MAN, V48, P627, DOI DOI 10.1080/0964056050018170; Pfeffer MJ, 2002, SOC SCI QUART, V83, P64, DOI 10.1111/1540-6237.00071; Preacher K, 2010, CALCULATION SOBEL TE; Schultz PW., 2000, J ENVIRON EDUC, V31, P22, DOI [DOI 10.1080/00958960009598635, 10.1080/00958960009598635]; Seacat JD, 2010, J ENVIRON PSYCHOL, V30, P393, DOI 10.1016/j.jenvp.2010.02.002; Telemundo Communications Group and Meredith Hispanic Ventures, 2009, WHAT LAT WANT STUD; U.S. Census Bureau, 2012, TEX QUICKFACTS; United States Environmental Protection Agency, 2008, MUN SOILD WAST GEN R; Vicente P, 2008, WASTE MANAGE RES, V26, P140, DOI 10.1177/0734242X07077371; VINING J, 1990, ENVIRON BEHAV, V22, P55, DOI 10.1177/0013916590221003	41	13	13	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2012	7	4							e34469	10.1371/journal.pone.0034469	http://dx.doi.org/10.1371/journal.pone.0034469			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	955JA	22493693	gold, Green Published, Green Submitted			2022-12-27	WOS:000305012700035
J	Tan, GG; Liao, WT; Dong, X; Yang, GJ; Zhu, ZY; Li, WH; Chai, YF; Lou, ZY				Tan, Guangguo; Liao, Wenting; Dong, Xin; Yang, Genjing; Zhu, Zhenyu; Li, Wuhong; Chai, Yifeng; Lou, Ziyang			Metabonomic Profiles Delineate the Effect of Traditional Chinese Medicine Sini Decoction on Myocardial Infarction in Rats	PLOS ONE			English	Article							FLIGHT MASS-SPECTROMETRY; FATTY-ACID OXIDATION; HEART-FAILURE; HPLC-MS; LIQUID-CHROMATOGRAPHY; H-1-NMR SPECTROSCOPY; SYSTEMS BIOLOGY; ISCHEMIC-HEART; FAILING HEART; HUMAN URINE	Background: In spite of great advances in target-oriented Western medicine for treating myocardial infarction (MI), it is still a leading cause of death in a worldwide epidemic. In contrast to Western medicine, Traditional Chinese medicine (TCM) uses a holistic and synergistic approach to restore the balance of Yin-Yang of body energy so the body's normal function can be restored. Sini decoction (SND) is a well-known formula of TCM which has been used to treat MI for many years. However, its holistic activity evaluation and mechanistic understanding are still lacking due to its complex components. Methodology/Principal Findings: A urinary metabonomic method based on nuclear magnetic resonance and ultra high-performance liquid chromatography coupled to mass spectrometry was developed to characterize MI-related metabolic profiles and delineate the effect of SND on MI. With Elastic Net for classification and selection of biomarkers, nineteen potential biomarkers in rat urine were screened out, primarily related to myocardial energy metabolism, including the glycolysis, citrate cycle, amino acid metabolism, purine metabolism and pyrimidine metabolism. With the altered metabolism pathways as possible drug targets, we systematically analyze the therapeutic effect of SND, which demonstrated that SND administration could provide satisfactory effect on MI through partially regulating the perturbed myocardial energy metabolism. Conclusions/Significance: Our results showed that metabonomic approach offers a useful tool to identify MI-related biomarkers and provides a new methodological cue for systematically dissecting the underlying efficacies and mechanisms of TCM in treating MI.	[Tan, Guangguo; Liao, Wenting; Dong, Xin; Yang, Genjing; Zhu, Zhenyu; Li, Wuhong; Chai, Yifeng; Lou, Ziyang] Second Mil Med Univ, Sch Pharm, Shanghai, Peoples R China; [Tan, Guangguo; Liao, Wenting; Zhu, Zhenyu; Li, Wuhong; Chai, Yifeng] Shanghai Key Lab Pharmaceut Metabolite Res, Shanghai, Peoples R China	Naval Medical University	Tan, GG (corresponding author), Second Mil Med Univ, Sch Pharm, Shanghai, Peoples R China.	louziyang@126.com			National Natural Science Fund of China [30873196]; Project of Modernization of Traditional Chinese Medicine of Shanghai [09dZ1975100]; Doctoral Innovation Foundation of Second Military Medical University	National Natural Science Fund of China(National Natural Science Foundation of China (NSFC)); Project of Modernization of Traditional Chinese Medicine of Shanghai; Doctoral Innovation Foundation of Second Military Medical University	The work was supported by the National Natural Science Fund of China (No. 30873196) and the Project of Modernization of Traditional Chinese Medicine of Shanghai (No. 09dZ1975100) as well as the Doctoral Innovation Foundation of Second Military Medical University (2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asl MN, 2008, PHYTOTHER RES, V22, P709, DOI 10.1002/ptr.2362; Bauer John Anthony, 2008, Congest Heart Fail, V14, P283, DOI 10.1111/j.1751-7133.2008.00011.x; Beckonert O, 2007, NAT PROTOC, V2, P2692, DOI 10.1038/nprot.2007.376; Bijlsma S, 2006, ANAL CHEM, V78, P567, DOI 10.1021/ac051495j; Butt MS, 2011, CRIT REV FOOD SCI, V51, P383, DOI 10.1080/10408391003624848; Dyck JRB, 2004, CIRC RES, V94, pE78, DOI 10.1161/01.RES.0000129255.19569.8f; Efferth T, 2007, TRENDS MOL MED, V13, P353, DOI 10.1016/j.molmed.2007.07.001; Fiehn O, 2002, PLANT MOL BIOL, V48, P155, DOI 10.1023/A:1013713905833; Gika HG, 2007, J PROTEOME RES, V6, P3291, DOI 10.1021/pr070183p; Giovane A, 2008, J CELL BIOCHEM, V105, P648, DOI 10.1002/jcb.21875; GORDON A, 1995, CARDIOVASC RES, V30, P413, DOI 10.1016/0008-6363(95)00062-3; GUTH BD, 1990, CIRCULATION, V81, P1948, DOI 10.1161/01.CIR.81.6.1948; Han J, 2009, BIOANALYSIS, V1, P1665, DOI 10.4155/BIO.09.158; Hodson MP, 2007, ANAL BIOCHEM, V362, P182, DOI 10.1016/j.ab.2006.12.037; Holmes E, 1997, J PHARMACEUT BIOMED, V15, P1647, DOI 10.1016/S0731-7085(97)00066-6; Janis MT, 2008, EXPERT OPIN DRUG MET, V4, P665, DOI [10.1517/17425255.4.6.665 , 10.1517/17425250802095565]; Jin Minghua, 2003, Zhong Yao Cai, V26, P71; KOBAYASHI M, 1988, J PHARMACOL EXP THER, V246, P667; Lenz EM, 2005, BIOMARKERS, V10, P173, DOI 10.1080/13547500500094034; Lindon JC, 2006, PHARM RES, V23, P1075, DOI 10.1007/s11095-006-0025-z; Lv YH, 2010, J PHARMACEUT BIOMED, V52, P129, DOI 10.1016/j.jpba.2009.12.016; Maier LS, 2000, CARDIOVASC RES, V45, P913, DOI 10.1016/S0008-6363(99)00387-9; McNulty PH, 2000, METABOLISM, V49, P1365, DOI 10.1053/meta.2000.9510; Mendes-Silva W, 2003, THROMB RES, V112, P93, DOI 10.1016/j.thromres.2003.10.014; Neubauer S, 2007, NEW ENGL J MED, V356, P1140, DOI 10.1056/NEJMra063052; Nicholson JK, 1999, XENOBIOTICA, V29, P1181, DOI 10.1080/004982599238047; Nielsen S, 1997, P NATL ACAD SCI USA, V94, P5450, DOI 10.1073/pnas.94.10.5450; Pechlivanis A, 2010, J PROTEOME RES, V9, P6405, DOI 10.1021/pr100684t; Roepke TK, 2009, NAT MED, V15, P1186, DOI 10.1038/nm.2029; Sabatine MS, 2005, CIRCULATION, V112, P3868, DOI 10.1161/CIRCULATIONAHA.105.569137; Sangster T, 2006, ANALYST, V131, P1075, DOI 10.1039/b604498k; Singhuber J, 2009, J ETHNOPHARMACOL, V126, P18, DOI 10.1016/j.jep.2009.07.031; Smith CA, 2006, ANAL CHEM, V78, P779, DOI 10.1021/ac051437y; Somjen D, 2004, J STEROID BIOCHEM, V91, P147, DOI 10.1016/j.jsbmb.2004.04.003; Sreekumar A, 2009, NATURE, V457, P910, DOI 10.1038/nature07762; Stanley WC, 2005, PHYSIOL REV, V85, P1093, DOI 10.1152/physrev.00006.2004; Stanley WC, 2005, HEART FAIL REV, V10, P275, DOI 10.1007/s10741-005-7542-4; Tan GG, 2011, BIOMED CHROMATOGR, V25, P913, DOI 10.1002/bmc.1544; Theodoridis G, 2008, TRAC-TREND ANAL CHEM, V27, P251, DOI 10.1016/j.trac.2008.01.008; Torabi A, 2008, EUR HEART J, V29, P859, DOI 10.1093/eurheartj/ehn096; Trygg J, 2007, J PROTEOME RES, V6, P469, DOI 10.1021/pr060594q; Tuunanen H, 2011, CARDIOVASC RES, V90, P251, DOI 10.1093/cvr/cvr052; Verpoorte R, 2005, J ETHNOPHARMACOL, V100, P53, DOI 10.1016/j.jep.2005.05.033; Wang M, 2005, PHYTOTHER RES, V19, P173, DOI 10.1002/ptr.1624; Weir Robin A P, 2006, Curr Heart Fail Rep, V3, P175, DOI 10.1007/s11897-006-0019-5; Wen ZN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018278; Williams RE, 2005, MOL BIOSYST, V1, P166, DOI 10.1039/b500852b; Williams RE, 2005, J PHARMACEUT BIOMED, V38, P465, DOI 10.1016/j.jpba.2005.01.013; Wu W, 1999, Zhongguo Zhong Xi Yi Jie He Za Zhi, V19, P23; Yamaguchi F, 1997, J MOL CELL CARDIOL, V29, P753, DOI 10.1006/jmcc.1996.0319; Yaoita H, 1993, Int J Card Imaging, V9, P273, DOI 10.1007/BF01137154; YU SM, 1995, BRIT J PHARMACOL, V114, P1587, DOI 10.1111/j.1476-5381.1995.tb14943.x; Zhao MQ, 2003, ZHONGGUO ZHONG XI YI, V23, P1; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	54	76	82	2	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2012	7	4							e34157	10.1371/journal.pone.0034157	http://dx.doi.org/10.1371/journal.pone.0034157			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JA	22493681	Green Published, Green Submitted, gold			2022-12-27	WOS:000305012700023
J	Long, Y; Qi, O; Wang, HL				Long Yan; Qi Ouyang; Hongli Wang			Dose-Response Aligned Circuits in Signaling Systems	PLOS ONE			English	Article							POSITIVE FEEDBACK LOOPS; NETWORK MOTIFS; YEAST; RECEPTOR; OSCILLATIONS; ROBUSTNESS; BINDING; DESIGN; CELLS; MODEL	Cells use biological signal transduction pathways to respond to environmental stimuli and the behavior of many cell types depends on precise sensing and transmission of external information. A notable property of signal transduction that was characterized in the Saccharomyces cerevisiae yeast cell and many mammalian cells is the alignment of dose-response curves. It was found that the dose response of the receptor matches closely the dose responses of the downstream. This dose-response alignment (DoRA) renders equal sensitivities and concordant responses in different parts of signaling system and guarantees a faithful information transmission. The experimental observations raise interesting questions about the nature of the information transmission through DoRA signaling networks and design principles of signaling systems with this function. Here, we performed an exhaustive computational analysis on network architectures that underlie the DoRA function in simple regulatory networks composed of two and three enzymes. The minimal circuits capable of DoRA were examined with Michaelis-Menten kinetics. Several motifs that are essential for the dynamical function of DoRA were identified. Systematic analysis of the topology space of robust DoRA circuits revealed that, rather than fine-tuning the network's parameters, the function is primarily realized by enzymatic regulations on the controlled node that are constrained in limiting regions of saturation or linearity.	[Long Yan; Qi Ouyang; Hongli Wang] Peking Univ, State Key Lab Mesoscop Phys, Beijing 100871, Peoples R China; [Long Yan; Qi Ouyang; Hongli Wang] Peking Univ, Sch Phys, Beijing 100871, Peoples R China; [Qi Ouyang; Hongli Wang] Peking Univ, Ctr Theoret Biol, Beijing 100871, Peoples R China; [Qi Ouyang] Sch Phys, Peking Tsinghua Ctr Life Sci, Beijing, Peoples R China	Peking University; Peking University; Peking University	Long, Y (corresponding author), Peking Univ, State Key Lab Mesoscop Phys, Beijing 100871, Peoples R China.	hlwang@pku.edu.cn			NSFC [10721403, 10774008, 11074009, 11174013]; MSTC [2009CB918500]	NSFC(National Natural Science Foundation of China (NSFC)); MSTC(Ministry of Science and Technology, China)	This work is partially supported by the NSFC (10721403, 10774008, 11074009, 11174013) and MSTC (2009CB918500). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alon U., 2007, INTRO SYSTEMS BIOL; Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; AMIR SM, 1973, J BIOL CHEM, V248, P4092; BLACK JW, 1983, PROC R SOC SER B-BIO, V220, P141, DOI 10.1098/rspb.1983.0093; Brandman O, 2005, SCIENCE, V310, P496, DOI 10.1126/science.1113834; Brent R, 2009, FEBS LETT, V583, P4019, DOI 10.1016/j.febslet.2009.11.029; Chang DE, 2010, P NATL ACAD SCI USA, V107, P175, DOI 10.1073/pnas.0908314107; Colman-Lerner A, 2005, NATURE, V437, P699, DOI 10.1038/nature03998; CUATRECASAS P, 1971, P NATL ACAD SCI USA, V68, P1264, DOI 10.1073/pnas.68.6.1264; Ferrell JE, 1998, SCIENCE, V280, P895, DOI 10.1126/science.280.5365.895; Goentoro L, 2009, MOL CELL, V36, P894, DOI 10.1016/j.molcel.2009.11.018; Hornung G, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040008; Huang CYF, 1996, P NATL ACAD SCI USA, V93, P10078, DOI 10.1073/pnas.93.19.10078; Iman R.L, 1980, LATIN HYPERCUBE SAMP; JACKSON CL, 1990, CELL, V63, P1039, DOI 10.1016/0092-8674(90)90507-B; KASAI M, 1971, J MEMBRANE BIOL, V6, P58, DOI 10.1007/BF01874114; KNAUER DJ, 1984, J BIOL CHEM, V259, P5623; LIN SY, 1970, AM J PHYSIOL, V218, P1319, DOI 10.1152/ajplegacy.1970.218.5.1319; Ma WZ, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100111; Ma WZ, 2009, CELL, V138, P760, DOI 10.1016/j.cell.2009.06.013; Marhl M, 2006, BIOPHYS CHEM, V120, P161, DOI 10.1016/j.bpc.2005.11.005; Marhl M, 2005, FEBS LETT, V579, P5461, DOI 10.1016/j.febslet.2005.09.007; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Novak B, 2008, NAT REV MOL CELL BIO, V9, P981, DOI 10.1038/nrm2530; NOVICK A, 1957, P NATL ACAD SCI USA, V43, P553, DOI 10.1073/pnas.43.7.553; SEGALL JE, 1993, P NATL ACAD SCI USA, V90, P8332, DOI 10.1073/pnas.90.18.8332; Shao DY, 2006, BIOPHYS J, V91, P3986, DOI 10.1529/biophysj.106.081661; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881; Shoval O, 2010, P NATL ACAD SCI USA, V107, P15995, DOI 10.1073/pnas.1002352107; Wagner A, 2005, P NATL ACAD SCI USA, V102, P11775, DOI 10.1073/pnas.0501094102; Yi TM, 2003, P NATL ACAD SCI USA, V100, P10764, DOI 10.1073/pnas.1834247100; Yu RC, 2008, NATURE, V456, P755, DOI 10.1038/nature07513	32	4	4	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2012	7	4							e34727	10.1371/journal.pone.0034727	http://dx.doi.org/10.1371/journal.pone.0034727			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955IH	22496849	Green Submitted, Green Published, gold			2022-12-27	WOS:000305010500026
J	Sabatier, R; Doyen, L; Tichit, M				Sabatier, Rodolphe; Doyen, Luc; Tichit, Muriel			Action versus Result-Oriented Schemes in a Grassland Agroecosystem: A Dynamic Modelling Approach	PLOS ONE			English	Article							AGRICULTURAL WET GRASSLANDS; LAPWINGS VANELLUS-VANELLUS; AGRI-ENVIRONMENT SCHEMES; BREEDING WADERS; VIABILITY MODEL; TRADE-OFFS; CONSERVATION; PERSPECTIVES; MANAGEMENT; BIRDS	Effects of agri-environment schemes (AES) on biodiversity remain controversial. While most AES are action-oriented, result-oriented and habitat-oriented schemes have recently been proposed as a solution to improve AES efficiency. The objective of this study was to compare action-oriented, habitat-oriented and result-oriented schemes in terms of ecological and productive performance as well as in terms of management flexibility. We developed a dynamic modelling approach based on the viable control framework to carry out a long term assessment of the three schemes in a grassland agroecosystem. The model explicitly links grazed grassland dynamics to bird population dynamics. It is applied to lapwing conservation in wet grasslands in France. We ran the model to assess the three AES scenarios. The model revealed the grazing strategies respecting ecological and productive constraints specific to each scheme. Grazing strategies were assessed by both their ecological and productive performance. The viable control approach made it possible to obtain the whole set of viable grazing strategies and therefore to quantify the management flexibility of the grassland agroecosystem. Our results showed that habitat and result-oriented scenarios led to much higher ecological performance than the action-oriented one. Differences in both ecological and productive performance between the habitat and result-oriented scenarios were limited. Flexibility of the grassland agroecosystem in the result-oriented scenario was much higher than in that of habitat-oriented scenario. Our model confirms the higher flexibility as well as the better ecological and productive performance of result-oriented schemes. A larger use of result-oriented schemes in conservation may also allow farmers to adapt their management to local conditions and to climatic variations.	[Sabatier, Rodolphe; Tichit, Muriel] INRA, UMR SADAPT 1048, Paris, France; [Sabatier, Rodolphe; Tichit, Muriel] AgroParisTech, UMR SADAPT 1048, Paris, France; [Doyen, Luc] MNHN, CNRS, UMR CERSP 7204, Paris, France	AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Museum National d'Histoire Naturelle (MNHN)	Sabatier, R (corresponding author), INRA, UMR SADAPT 1048, Paris, France.	rodolphe.sabatier@forst.uni-goettingen.de	Doyen, Luc/GXH-3424-2022	Doyen, Luc/0000-0001-8272-6187	ANR-Agence Nationale de la Recherche - The French National Research Agency [ANR-08-STRA-007]	ANR-Agence Nationale de la Recherche - The French National Research Agency(French National Research Agency (ANR))	This work was carried out with the financial support of the "ANR-Agence Nationale de la Recherche - The French National Research Agency'' under the "SYSTERRA program - Ecosystems and Sustainable Development,'' project "ANR-08-STRA-007, FARMBIRD - Coviability models of FARMing and BIRD biodiversity.'' The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aubin J.P., 1991, VIABILITY THEORY; Baumgartner S, 2009, ECOL ECON, V68, P2008, DOI 10.1016/j.ecolecon.2009.01.016; BEINTEMA AJ, 1987, J APPL ECOL, V24, P743, DOI 10.2307/2403978; Brunner A, 2005, AGRIENVIRONMENT SCHE; De Lara M., 2008, SUSTAINABLE MANAGEME; Devereux CL, 2004, IBIS, V146, P115, DOI 10.1111/j.1474-919X.2004.00355.x; Durant D, 2008, AGR ECOSYST ENVIRON, V128, P146, DOI 10.1016/j.agee.2008.05.013; Durant D, 2008, BIODIVERS CONSERV, V17, P2275, DOI 10.1007/s10531-007-9310-3; Groot JCJ, 2007, AGR ECOSYST ENVIRON, V120, P58, DOI 10.1016/j.agee.2006.03.037; Gunderson Lance, 1999, CONSERVATION ECOLOGY, V3; Kleijn D, 2006, ECOL LETT, V9, P243, DOI 10.1111/j.1461-0248.2005.00869.x; Klimek S, 2008, BIOL CONSERV, V141, P2888, DOI 10.1016/j.biocon.2008.08.025; Martin G, 2009, AGR ECOSYST ENVIRON, V129, P508, DOI 10.1016/j.agee.2008.11.005; Matzdorf B, 2010, LAND USE POLICY, V27, P535, DOI 10.1016/j.landusepol.2009.07.011; Melman TCP, 2010, WEB BASED TOOL TAILO; Mestelan P, 2007, RENCONTRES RECHERCHE; Musters CJM, 2001, CONSERV BIOL, V15, P363, DOI 10.1046/j.1523-1739.2001.015002363.x; NEAS, 2007, EX SUMM EC EV NAT CO; Sabatier R, 2010, ECOL MODEL, V221, P1292, DOI 10.1016/j.ecolmodel.2010.02.003; Sabatier R, 2010, MULTISCALE TRADE OFF; SABATIER R., 2010, RECONCILING PRODUCTI, P10; Sabatier R., 2011, P 3 FARM SYST DES C, P54; Sabatier R, 2008, ASSESSING EFFECT STO, P213; Schwarz G., 2008, ANAL POTENTIAL EFFEC; SNH, 2005, E SCOTTL GRASSL MAN; Sokal RR, 1995, BIOMETRY; Tichit M, 2007, ECOL MODEL, V206, P277, DOI 10.1016/j.ecolmodel.2007.03.043; Tichit M, 2004, ANIM RES, V53, P405, DOI 10.1051/animres:2004024; Tichit M, 2011, LIVEST SCI, V139, P161, DOI 10.1016/j.livsci.2011.03.006; Verhulst J, 2007, J APPL ECOL, V44, P70, DOI 10.1111/j.1365-2664.2006.01238.x; Wittig B, 2006, BIOL CONSERV, V133, P186, DOI 10.1016/j.biocon.2006.06.004; Zabel A, 2008, CONSERV BIOL, V22, P247, DOI 10.1111/j.1523-1739.2008.00898.x	32	30	30	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2012	7	4							e33257	10.1371/journal.pone.0033257	http://dx.doi.org/10.1371/journal.pone.0033257			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955IH	22496746	Green Published, gold, Green Submitted			2022-12-27	WOS:000305010500001
J	Banchereau, R; Jordan-Villegas, A; Ardura, M; Mejias, A; Baldwin, N; Xu, H; Saye, E; Rossello-Urgell, J; Nguyen, P; Blankenship, D; Creech, CB; Pascual, V; Banchereau, J; Chaussabel, D; Ramilo, O				Banchereau, Romain; Jordan-Villegas, Alejandro; Ardura, Monica; Mejias, Asuncion; Baldwin, Nicole; Xu, Hui; Saye, Elizabeth; Rossello-Urgell, Jose; Phuong Nguyen; Blankenship, Derek; Creech, Clarence B.; Pascual, Virginia; Banchereau, Jacques; Chaussabel, Damien; Ramilo, Octavio			Host Immune Transcriptional Profiles Reflect the Variability in Clinical Disease Manifestations in Patients with Staphylococcus aureus Infections	PLOS ONE			English	Article							JUVENILE IDIOPATHIC ARTHRITIS; SIGNATURE; EMERGENCE	Staphylococcus aureus infections are associated with diverse clinical manifestations leading to significant morbidity and mortality. To define the role of the host response in the clinical manifestations of the disease, we characterized whole blood transcriptional profiles of children hospitalized with community-acquired S. aureus infection and phenotyped the bacterial strains isolated. The overall transcriptional response to S. aureus infection was characterized by over-expression of innate immunity and hematopoiesis related genes and under-expression of genes related to adaptive immunity. We assessed individual profiles using modular fingerprints combined with the molecular distance to health (MDTH), a numerical score of transcriptional perturbation as compared to healthy controls. We observed significant heterogeneity in the host signatures and MDTH, as they were influenced by the type of clinical presentation, the extent of bacterial dissemination, and time of blood sampling in the course of the infection, but not by the bacterial isolate. System analysis approaches provide a new understanding of disease pathogenesis and the relation/interaction between host response and clinical disease manifestations.	[Banchereau, Romain; Jordan-Villegas, Alejandro] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA; [Baldwin, Nicole; Xu, Hui; Rossello-Urgell, Jose; Phuong Nguyen; Blankenship, Derek; Pascual, Virginia; Banchereau, Jacques; Chaussabel, Damien] Baylor Inst Immunol Res, Dallas, TX USA; [Ardura, Monica; Mejias, Asuncion; Ramilo, Octavio] Nationwide Childrens Hosp, Columbus, OH USA; [Saye, Elizabeth; Creech, Clarence B.] Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA; [Banchereau, Jacques] Hoffmann Laroche, Nutley, NJ USA; [Chaussabel, Damien] Benaroya Res Inst, Seattle, WA USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Baylor Scott & White Health; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Vanderbilt University; Benaroya Research Institute	Banchereau, R (corresponding author), Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA.	romain.banchereau@utsouthwestern.edu	Chaussabel, Damien/AAX-1909-2020; Mejias, Asuncion/AAC-5998-2019; Pascual, Virginia/ABD-3099-2020; Ardura, Monica/AHA-7339-2022	Mejias, Asuncion/0000-0002-5983-8006; Ardura, Monica/0000-0002-2853-2581; Chaussabel, Damien/0000-0002-6131-7242	National Institute of Allergy and Infectious Diseases; National Institutes of Arthritis and Musculo-Skeletal and Skin Diseases; Baylor Healthcare System Foundation [U01 AI082110, U19 AI089987, R01 ARO50770, U19 AI057234]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000090] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI057234, U19AI089987, U01AI082110] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050770] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Arthritis and Musculo-Skeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Baylor Healthcare System Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by the National Institute of Allergy and Infectious Diseases; the National Institutes of Arthritis and Musculo-Skeletal and Skin Diseases; and the Baylor Healthcare System Foundation [grant numbers U01 AI082110, U19 AI089987, R01 ARO50770, U19 AI057234]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allantaz F, 2007, J EXP MED, V204, P2131, DOI 10.1084/jem.20070070; Appelbaum PC, 2006, CLIN MICROBIOL INFEC, V12, P16, DOI 10.1111/j.1469-0691.2006.01344.x; Ardura MI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005446; Balamayooran G, 2010, AM J RESP CELL MOL, V43, P5, DOI 10.1165/rcmb.2009-0047TR; Begier EM, 2004, CLIN INFECT DIS, V39, P1446, DOI 10.1086/425313; Berry MPR, 2010, NATURE, V466, P973, DOI 10.1038/nature09247; Bullinger L, 2004, NEW ENGL J MED, V350, P1605, DOI 10.1056/NEJMoa031046; Campbell SJ, 2008, J CLIN MICROBIOL, V46, P678, DOI 10.1128/JCM.01822-07; Carleton HA, 2004, J INFECT DIS, V190, P1730, DOI 10.1086/425019; Chaussabel D, 2008, IMMUNITY, V29, P150, DOI 10.1016/j.immuni.2008.05.012; Chen C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017238; Crum NF, 2005, SCAND J INFECT DIS, V37, P651, DOI 10.1080/00365540510033636; DeLeo FR, 2010, LANCET, V375, P1557, DOI 10.1016/S0140-6736(09)61999-1; Deleo FR, 2009, INFECT DIS CLIN N AM, V23, P17, DOI 10.1016/j.idc.2008.10.003; Gonzalez BE, 2006, PEDIATRICS, V117, P1673, DOI 10.1542/peds.2005-2009; Have KLV, 2009, J PEDIATR ORTHOPED, V29, P927, DOI 10.1097/BPO.0b013e3181bd1e0c; Hinze CH, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3061; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Nagai T, 2003, J IMMUNOL, V171, P5233, DOI 10.4049/jimmunol.171.10.5233; Nairz M, 2011, IMMUNITY, V34, P61, DOI 10.1016/j.immuni.2011.01.002; Pankla R, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r127; Ramilo O, 2007, BLOOD, V109, P2066, DOI 10.1182/blood-2006-02-002477; Rubinstein E, 2008, INT J ANTIMICROB AG, V32, pS18, DOI 10.1016/j.ijantimicag.2008.06.006; Scumpia PO, 2010, J IMMUNOL, V184, P2247, DOI 10.4049/jimmunol.0903652; Sugar CA, 2003, J AM STAT ASSOC, V98, P750, DOI 10.1198/016214503000000666; Tanno T., 2010, ADV HEMATOL, V2010; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Thomsen I, 2011, PEDIATR INFECT DIS J, V30, P418, DOI 10.1097/INF.0b013e31820d7fd5; Vandenesch F, 2003, EMERG INFECT DIS, V9, P978; Wallin TR, 2008, EMERG MED CLIN N AM, V26, P431, DOI 10.1016/j.emc.2008.01.010	30	71	72	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e34390	10.1371/journal.pone.0034390	http://dx.doi.org/10.1371/journal.pone.0034390			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GO	22496797	Green Submitted, Green Published, gold			2022-12-27	WOS:000304855200044
J	Chaix, B; Bean, K; Daniel, M; Zenk, SN; Kestens, Y; Charreire, H; Leal, C; Thomas, F; Karusisi, N; Weber, C; Oppert, JM; Simon, C; Merlo, J; Pannier, B				Chaix, Basile; Bean, Kathy; Daniel, Mark; Zenk, Shannon N.; Kestens, Yan; Charreire, Helene; Leal, Cinira; Thomas, Frederique; Karusisi, Noella; Weber, Christiane; Oppert, Jean-Michel; Simon, Chantal; Merlo, Juan; Pannier, Bruno			Associations of Supermarket Characteristics with Weight Status and Body Fat: A Multilevel Analysis of Individuals within Supermarkets (RECORD Study)	PLOS ONE			English	Article							GEOGRAPHIC LIFE ENVIRONMENTS; HEALTH-CARE UTILIZATION; FOOD ENVIRONMENT; RISK-FACTORS; CARDIOVASCULAR MORTALITY; WAIST CIRCUMFERENCE; SOCIAL-FACTORS; NEIGHBORHOOD; STORES; AVAILABILITY	Purpose: Previous research on the influence of the food environment on weight status has often used impersonal measures food environment defined for residential neighborhoods, which ignore whether people actually use the food outlets near their residence. To assess whether supermarkets are relevant contexts for interventions, the present study explored between-residential neighborhood and between-supermarket variations in body mass index (BMI) and waist circumference (WC), and investigated associations between brands and characteristics of supermarkets and BMI or WC, after adjustment for individual and residential neighborhood characteristics. Methods: Participants in the RECORD Cohort Study (Paris Region, France, 2007-2008) were surveyed on the supermarket (brand and exact location) where they conducted their food shopping. Overall, 7 131 participants shopped in 1 097 different supermarkets. Cross-classified multilevel linear models were estimated for BMI and WC. Results: Just 11.4% of participants shopped for food primarily within their residential neighborhood. After accounting for participants' residential neighborhood, people shopping in the same supermarket had a more comparable BMI and WC than participants shopping in different supermarkets. After adjustment for individual and residential neighborhood characteristics, participants shopping in specific supermarket brands, in hard discount supermarkets (especially if they had a low education), and in supermarkets whose catchment area comprised low educated residents had a higher BMI/WC. Conclusion: A public health strategy to reduce excess weight may be to intervene on specific supermarkets to change food purchasing behavior, as supermarkets are where dietary preferences are materialized into definite purchased foods.	[Chaix, Basile; Leal, Cinira; Karusisi, Noella] Univ Paris 06, UMR S 707, Paris, France; [Chaix, Basile; Leal, Cinira; Karusisi, Noella] INSERM, U707, Paris, France; [Bean, Kathy; Thomas, Frederique; Pannier, Bruno] Ctr Invest Prevent & Clin, Paris, France; [Daniel, Mark] Univ S Australia, Sansom Inst Hlth Res, Social Epidemiol & Evaluat Res Unit, Adelaide, SA 5001, Australia; [Daniel, Mark] Univ Melbourne, St Vincents Hosp, Dept Med, Fitzroy, Vic 3065, Australia; [Zenk, Shannon N.] Univ Illinois, Dept Hlth Syst Sci, Chicago, IL USA; [Kestens, Yan] Univ Montreal, Social & Prevent Med Dept, Montreal, PQ, Canada; [Charreire, Helene] Univ Paris Est, LabUrba Inst Urbanisme Paris, Creteil, France; [Leal, Cinira] EHESP Sch Publ Hlth, Rennes, France; [Weber, Christiane] Strasbourg Univ, CNRS Image ERL7230, Strasbourg, France; [Oppert, Jean-Michel] Univ Paris 13, CNAM, Inserm U557, EA3200,Inra U1125, Bobigny, France; [Oppert, Jean-Michel] Univ Paris 06, Dept Nutr, CNRH IdF, Pitie Salpetriere Hosp,AP HP, Paris, France; [Simon, Chantal] Lyon Univ, Inra U1235, Inserm U870, CRNH Rhone Alpes, Pierre Benite, France; [Merlo, Juan] Lund Univ, Clin Res Ctr, Fac Med, Unit Social Epidemiol, Malmo, Sweden	UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); University of South Australia; St Vincent's Hospital Melbourne; University of Melbourne; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Universite de Montreal; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; heSam Universite; Conservatoire National Arts & Metiers (CNAM); INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris 13; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); Lund University	Chaix, B (corresponding author), Univ Paris 06, UMR S 707, Paris, France.	chaix@u707.jussieu.fr	Merlo, Juan/E-2136-2011; Kestens, Yan/D-1631-2012; Chaix, Basile/B-8625-2014; , simon/B-2895-2011; Oppert, Jean-Michel/F-2810-2017; Charreire, Helene/F-3037-2017; Zennk, Shannon/D-4096-2018; Daniel, Mark/A-1151-2009	Merlo, Juan/0000-0001-8379-9708; Kestens, Yan/0000-0003-2619-5750; , simon/0000-0002-7820-3233; Charreire, Helene/0000-0002-1260-9812; Zennk, Shannon/0000-0003-2409-7022; Daniel, Mark/0000-0001-9112-134X	Institute for Public Health Research (Institut de Recherche en Sante Publique); National Institute for Prevention and Health Education (Institut National de Prevention et d'Education pour la Sante) [074/07-DAS]; National Institute of Public Health Surveillance (Institut de Veille Sanitaire); French Ministries of Research and Health (Epidemiologic Cohorts); National Health Insurance Office for Salaried Workers (Caisse Nationale d'Assurance Maladie des Travailleurs Salaries); National Research Agency (Agence Nationale de la Recherche) [00153 05]; Ile-de-France Regional Health Agency (Agence Regionale de Sante d'Ile-de-France); City of Paris (Ville de Paris); Ile-de-France Regional Council (Conseil Regional d'Ile-de-France, DIM SEnT and CODDIM); Ile-de-France Youth, Sports, and Social Cohesion Regional Direction (Direction Regionale de la Jeunesse et des Sports et de la Cohesion Sociale); Swedish Research Council; Canadian Institutes for Health Research	Institute for Public Health Research (Institut de Recherche en Sante Publique); National Institute for Prevention and Health Education (Institut National de Prevention et d'Education pour la Sante); National Institute of Public Health Surveillance (Institut de Veille Sanitaire); French Ministries of Research and Health (Epidemiologic Cohorts); National Health Insurance Office for Salaried Workers (Caisse Nationale d'Assurance Maladie des Travailleurs Salaries); National Research Agency (Agence Nationale de la Recherche)(French National Research Agency (ANR)); Ile-de-France Regional Health Agency (Agence Regionale de Sante d'Ile-de-France)(Region Ile-de-France); City of Paris (Ville de Paris)(Region Ile-de-France); Ile-de-France Regional Council (Conseil Regional d'Ile-de-France, DIM SEnT and CODDIM)(Region Ile-de-France); Ile-de-France Youth, Sports, and Social Cohesion Regional Direction (Direction Regionale de la Jeunesse et des Sports et de la Cohesion Sociale)(Region Ile-de-France); Swedish Research Council(Swedish Research CouncilEuropean Commission); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR))	This work, as part of the RECORD project, was supported by the Institute for Public Health Research (Institut de Recherche en Sante Publique); the National Institute for Prevention and Health Education (Institut National de Prevention et d'Education pour la Sante) (Prevention Program 2007 074/07-DAS; 2010-2011 financial support; and 2011-2013 financial support); the National Institute of Public Health Surveillance (Institut de Veille Sanitaire) (Territory and Health Program); the French Ministries of Research and Health (Epidemiologic Cohorts Grant 2008); the National Health Insurance Office for Salaried Workers (Caisse Nationale d'Assurance Maladie des Travailleurs Salaries); the National Research Agency (Agence Nationale de la Recherche) (Health-Environment Program 2005 #00153 05); the Ile-de-France Regional Health Agency (Agence Regionale de Sante d'Ile-de-France); the City of Paris (Ville de Paris); the Ile-de-France Regional Council (Conseil Regional d'Ile-de-France, DIM SEnT and CODDIM); and the Ile-de-France Youth, Sports, and Social Cohesion Regional Direction (Direction Regionale de la Jeunesse et des Sports et de la Cohesion Sociale). The project was also supported by the Swedish Research Council (to JM), by the Canadian Institutes for Health Research (to YK), and by ANR-PNRA (to JMO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, PRODUITS BAS PRIX QU, P470; Beckman A, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-71; Benetos A, 2008, AM J CARDIOL, V102, P188, DOI 10.1016/j.amjcard.2008.03.037; Chaix B, 2008, J EPIDEMIOL COMMUN H, V62, P62, DOI 10.1136/jech.2006.056960; Chaix B, 2005, J EPIDEMIOL COMMUN H, V59, P517, DOI 10.1136/jech.2004.025478; Chaix B, 2005, AM J EPIDEMIOL, V162, P171, DOI 10.1093/aje/kwi175; Chaix B, 2012, INT J EPIDEMIOL, V41, P1283, DOI 10.1093/ije/dyr107; Chaix B, 2011, EPIDEMIOLOGY, V22, P18, DOI 10.1097/EDE.0b013e3181fd2961; Chaix B, 2010, HYPERTENSION, V55, P769, DOI 10.1161/HYPERTENSIONAHA.109.143206; Chaix B, 2010, EPIDEMIOLOGY, V21, P124, DOI 10.1097/EDE.0b013e3181c04e70; Chaix B, 2009, ANNU REV PUBL HEALTH, V30, P81, DOI 10.1146/annurev.publhealth.031308.100158; CNA, 2010, 67 CNA AV; Darmon N, 2009, PUBLIC HEALTH NUTR, V12, P808, DOI 10.1017/S1368980008003157; Drewnowski A, 2007, J AM DIET ASSOC, V107, P1028, DOI 10.1016/j.jada.2007.03.013; Farley TA, 2009, J URBAN HEALTH, V86, P672, DOI 10.1007/s11524-009-9390-3; Franco M, 2008, AM J PREV MED, V35, P561, DOI 10.1016/j.amepre.2008.07.003; Gittelsohn J, 2010, HEALTH EDUC BEHAV, V37, P390, DOI 10.1177/1090198109343886; Glanz K, 2005, AM J HEALTH PROMOT, V19, P330, DOI 10.4278/0890-1171-19.5.330; Glanz K, 2007, AM J PREV MED, V32, P282, DOI 10.1016/j.amepre.2006.12.019; Glanz K, 2009, AM J PREV MED, V36, pS93, DOI 10.1016/j.amepre.2009.01.010; Havard S, 2011, OCCUP ENVIRON MED, V68, P366, DOI 10.1136/oem.2010.060640; Inagami S, 2006, AM J PREV MED, V31, P10, DOI 10.1016/j.amepre.2006.03.019; Jeffery RW, 2006, INT J BEHAV NUTR PHY, V3, DOI 10.1186/1479-5868-3-2; Leal C, 2011, OBES REV, V12, P217, DOI 10.1111/j.1467-789X.2010.00726.x; Leal C, 2011, EPIDEMIOLOGY, V22, P694, DOI 10.1097/EDE.0b013e3182257784; Li F, 2009, AM J EPIDEMIOL, V169, P401, DOI 10.1093/aje/kwn398; Lytle LA, 2009, AM J PREV MED, V36, pS134, DOI 10.1016/j.amepre.2009.01.018; McKinnon RA, 2009, AM J PREV MED, V36, pS124, DOI 10.1016/j.amepre.2009.01.012; Mehta NK, 2008, AM J PREV MED, V34, P127, DOI 10.1016/j.amepre.2007.09.031; Michels S, 1995, LETT IFN, V35, P1; Morland K, 2006, AM J PREV MED, V30, P333, DOI 10.1016/j.amepre.2005.11.003; Mujahid MS, 2007, AM J EPIDEMIOL, V165, P858, DOI 10.1093/aje/kwm040; Muntaner C, 2006, HEALTH PLACE, V12, P688, DOI 10.1016/j.healthplace.2005.09.004; Oqali, 2010, RAPP ACT 2009; Powell LM, 2007, AM J PREV MED, V33, pS301, DOI 10.1016/j.amepre.2007.07.007; Rosmond R, 1996, INT J OBESITY, V20, P599; Roux AVD, 2003, J URBAN HEALTH, V80, P569, DOI 10.1093/jurban/jtg065; Thomas F, 2005, HYPERTENSION, V46, P654, DOI 10.1161/01.HYP.0000184282.51550.00; United Nations Development Programme, 2008, HUM DEV REP 2007 200; Wang MC, 2007, J EPIDEMIOL COMMUN H, V61, P491, DOI 10.1136/jech.2006.051680; Zenk SN, 2005, AM J PREV MED, V29, P1, DOI 10.1016/j.amepre.2005.03.002	41	63	63	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e32908	10.1371/journal.pone.0032908	http://dx.doi.org/10.1371/journal.pone.0032908			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	953GO	22496738	Green Accepted, Green Published, gold			2022-12-27	WOS:000304855200007
J	Chevalier, N; Vega, A; Bouskine, A; Siddeek, B; Michiels, JF; Chevallier, D; Fenichel, P				Chevalier, Nicolas; Vega, Aurelie; Bouskine, Adil; Siddeek, Benazir; Michiels, Jean-Francois; Chevallier, Daniel; Fenichel, Patrick			GPR30, the Non-Classical Membrane G Protein Related Estrogen Receptor, Is Overexpressed in Human Seminoma and Promotes Seminoma Cell Proliferation	PLOS ONE			English	Article							BREAST-CANCER CELLS; COUPLED RECEPTOR; OVARIAN-CANCER; ER-BETA; EXPRESSION; 17-BETA-ESTRADIOL; LINE; GPER; IDENTIFICATION; CONNEXIN-43	Background: Testicular germ cell tumours are the most frequent cancer of young men with an increasing incidence all over the world. Pathogenesis and reasons of this increase remain unknown but epidemiological and clinical data have suggested that fetal exposure to environmental endocrine disruptors (EEDs) with estrogenic effects, could participate to testicular germ cell carcinogenesis. However, these EEDs (like bisphenol A) are often weak ligands for classical nuclear estrogen receptors. Several research groups recently showed that the non classical membrane G-protein coupled estrogen receptor (GPER/GPR30) mediates the effects of estrogens and several xenoestrogens through rapid non genomic activation of signal transduction pathways in various human estrogen dependent cancer cells (breast, ovary, endometrium). The aim of this study was to demonstrate that GPER was overexpressed in testicular tumours and was able to trigger JKT-1 seminoma cell proliferation. Results: We report here for the first time a complete morphological and functional characterization of GPER in normal and malignant human testicular germ cells. In normal adult human testes, GPER was expressed by somatic (Sertoli cells) and germ cells (spermatogonia and spermatocytes). GPER was exclusively overexpressed in seminomas, the most frequent testicular germ cell cancer, localized at the cell membrane and triggered a proliferative effect on JKT-1 cells in vitro, which was completely abolished by G15 (a GPER selective antagonist) and by siRNA invalidation. Conclusion: These results demonstrate that GPER is expressed by human normal adult testicular germ cells, specifically overexpressed in seminoma tumours and able to trigger seminoma cell proliferation in vitro. It should therefore be considered rather than classical ERs when xeno-estrogens or other endocrine disruptors are assessed in testicular germ cell cancers. It may also represent a prognosis marker and/or a therapeutic target for seminomas.	[Chevalier, Nicolas; Vega, Aurelie; Bouskine, Adil; Siddeek, Benazir; Fenichel, Patrick] Ctr Mediterrane Med Mol C3M, UNS, INSERM,UMR 1065, Equipe Environm Reprod & Canc Hormonodependants 5, Nice, France; [Chevalier, Nicolas; Vega, Aurelie; Bouskine, Adil; Siddeek, Benazir; Fenichel, Patrick] Univ Nice Sophia Antipolis, Fac Med, Inst Signalisat & Pathol IFR 50, Nice, France; [Chevalier, Nicolas; Vega, Aurelie; Bouskine, Adil; Siddeek, Benazir; Fenichel, Patrick] Ctr Hosp Univ Nice, Hop Archet, Serv Endocrinol Diabet & Med Reprod, Nice, France; [Michiels, Jean-Francois] Ctr Hosp Univ Nice, Hop Pasteur, Lab Anat & Cytol Pathol, Nice, France; [Chevallier, Daniel] Ctr Hosp Univ Nice, Hop Pasteur, Serv Urol, Nice, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; UDICE-French Research Universities; Universite Cote d'Azur; CHU Nice; CHU Nice; CHU Nice	Chevalier, N (corresponding author), Ctr Mediterrane Med Mol C3M, UNS, INSERM,UMR 1065, Equipe Environm Reprod & Canc Hormonodependants 5, Nice, France.	fenichel.p@chu-nice.fr	VEGA, Aurelie/X-9434-2019	VEGA, Aurelie/0000-0002-9693-2173; , benazir/0000-0003-2764-6656; CHEVALIER, Nicolas/0000-0001-7160-4301; Patrick, FENICHEL/0000-0003-0509-175X				Albanito L, 2008, ENDOCRINOLOGY, V149, P3799, DOI 10.1210/en.2008-0117; Albanito L, 2007, CANCER RES, V67, P1859, DOI 10.1158/0008-5472.CAN-06-2909; Bourdon V, 1998, BIOL REPROD, V58, P591, DOI 10.1095/biolreprod58.2.591; Bouskine A, 2008, ENDOCRINOLOGY, V149, P565, DOI 10.1210/en.2007-1318; Bouskine A, 2010, INT J ANDROL, V33, P54, DOI 10.1111/j.1365-2605.2009.00950.x; Bouskine A, 2009, ENVIRON HEALTH PERSP, V117, P1053, DOI 10.1289/ehp.0800367; Carreau S, 2002, MOL CELL ENDOCRINOL, V193, P137, DOI 10.1016/S0303-7207(02)00107-7; Chang EC, 2006, ENDOCRINOLOGY, V147, P4831, DOI 10.1210/en.2006-0563; Cheng SB, 2011, STEROIDS, V76, P892, DOI 10.1016/j.steroids.2011.02.018; Chevalier N, 2012, INT J CANCER, V130, P241, DOI 10.1002/ijc.25972; Chimento A, 2010, MOL CELL ENDOCRINOL, V320, P136, DOI 10.1016/j.mce.2010.01.035; Dennis MK, 2009, NAT CHEM BIOL, V5, P421, DOI 10.1038/nchembio.168; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Esteller M, 2007, NAT REV GENET, V8, P286, DOI 10.1038/nrg2005; Filardo EJ, 2006, CLIN CANCER RES, V12, P6359, DOI 10.1158/1078-0432.CCR-06-0860; Filardo EJ, 2002, J STEROID BIOCHEM, V80, P231, DOI 10.1016/S0960-0760(01)00190-X; Filardo EJ, 2002, MOL ENDOCRINOL, V16, P70, DOI 10.1210/me.16.1.70; Franco R, 2011, CANCER BIOL THER, V11, P609, DOI 10.4161/cbt.11.6.14672; Giess M, 2010, J STEROID BIOCHEM, V118, P7, DOI 10.1016/j.jsbmb.2009.09.001; Hardell L, 2006, INT J ANDROL, V29, P228, DOI 10.1111/j.1365-2605.2005.00622.x; Iacobuzio-Donahue CA, 2009, ANNU REV PATHOL-MECH, V4, P229, DOI 10.1146/annurev.pathol.3.121806.151442; Jones MEE, 2000, BEST PRACT RES CL EN, V14, P505, DOI 10.1053/beem.2000.0094; Kang LG, 2010, MOL ENDOCRINOL, V24, P709, DOI 10.1210/me.2009-0317; Kinugawa K, 1998, Int J Urol, V5, P282, DOI 10.1111/j.1442-2042.1998.tb00604.x; Konstantinopoulos PA, 2003, EUR J CANCER, V39, P1251, DOI 10.1016/S0959-8049(03)00239-9; Lablack A, 1998, CELL TISSUE RES, V294, P279, DOI 10.1007/s004410051178; Langer G, 2010, STEROIDS, V75, P603, DOI 10.1016/j.steroids.2009.12.006; Lazennec G, 2001, ENDOCRINOLOGY, V142, P4120, DOI 10.1210/en.142.9.4120; Liu XC, 2009, BIOL REPROD, V80, P1253, DOI 10.1095/biolreprod.108.070250; Loomis AK, 2000, BIOL REPROD, V62, P995, DOI 10.1095/biolreprod62.4.995; Lucas TFG, 2010, BIOL REPROD, V83, P307, DOI 10.1095/biolreprod.110.084160; Maggiolini M, 2010, J ENDOCRINOL, V204, P105, DOI 10.1677/JOE-09-0242; Prossnitz ER, 2008, ANNU REV PHYSIOL, V70, P165, DOI 10.1146/annurev.physiol.70.113006.100518; Rago V, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-135; Revankar CM, 2005, SCIENCE, V307, P1625, DOI 10.1126/science.1106943; Roger C, 2005, J MOL ENDOCRINOL, V35, P191, DOI 10.1677/jme.1.01704; Roger C, 2004, J PATHOL, V202, P241, DOI 10.1002/path.1509; Sirianni R, 2008, ENDOCRINOLOGY, V149, P5043, DOI 10.1210/en.2007-1593; Skakkebaek NE, 1998, APMIS, V106, P3, DOI 10.1111/j.1699-0463.1998.tb01314.x; Smith HO, 2009, GYNECOL ONCOL, V114, P465, DOI 10.1016/j.ygyno.2009.05.015; Teng J, 2008, ENDOCRINOLOGY, V149, P4024, DOI 10.1210/en.2007-1669; Thomas P, 2006, STEROIDS, V71, P310, DOI 10.1016/j.steroids.2005.09.015; Thomas P, 2005, ENDOCRINOLOGY, V146, P624, DOI 10.1210/en.2004-1064; Thomas P, 2010, STEROIDS, V75, P595, DOI 10.1016/j.steroids.2009.11.005; Thomas P, 2006, J STEROID BIOCHEM, V102, P175, DOI 10.1016/j.jsbmb.2006.09.017; Vivacqua A, 2006, MOL ENDOCRINOL, V20, P631, DOI 10.1210/me.2005-0280; Zhao Chunyan, 2008, Nucl Recept Signal, V6, pe003, DOI 10.1621/nrs.06003	47	75	79	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e34672	10.1371/journal.pone.0034672	http://dx.doi.org/10.1371/journal.pone.0034672			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GO	22496838	Green Published, gold, Green Submitted			2022-12-27	WOS:000304855200067
J	Coutureau, E; Esclassan, F; Di Scala, G; Marchand, AR				Coutureau, Etienne; Esclassan, Frederic; Di Scala, Georges; Marchand, Alain R.			The Role of the Rat Medial Prefrontal Cortex in Adapting to Changes in Instrumental Contingency	PLOS ONE			English	Article							ACTION-OUTCOME CONTINGENCY; PRELIMBIC CORTEX; DIFFERENTIAL REINFORCEMENT; DORSOMEDIAL STRIATUM; ORBITOFRONTAL CORTEX; DOPAMINE; UNCERTAINTY; REWARD; TIME; INACTIVATION	In order to select actions appropriate to current needs, a subject must identify relationships between actions and events. Control over the environment is determined by the degree to which action consequences can be predicted, as described by action-outcome contingencies - i.e. performing an action should affect the probability of the outcome. We evaluated in a first experiment adaptation to contingency changes in rats with neurotoxic lesions of the medial prefrontal cortex. Results indicate that this brain region is not critical to adjust instrumental responding to a negative contingency where the rats must refrain from pressing a lever, as this action prevents reward delivery. By contrast, this brain region is required to reduce responding in a non-contingent situation where the same number of rewards is freely delivered and actions do not affect the outcome any more. In a second experiment, we determined that this effect does not result from a different perception of temporal relationships between actions and outcomes since lesioned rats adapted normally to gradually increasing delays in reward delivery. These data indicate that the medial prefrontal cortex is not directly involved in evaluating the correlation between action-and reward-rates or in the perception of reward delays. The deficit in lesioned rats appears to consist of an abnormal response to the balance between contingent and non-contingent rewards. By highlighting the role of prefrontal regions in adapting to the causal status of actions, these data contribute to our understanding of the neural basis of choice tasks.	[Coutureau, Etienne; Esclassan, Frederic; Di Scala, Georges; Marchand, Alain R.] Univ Bordeaux, INCIA, Talence, France; [Coutureau, Etienne; Esclassan, Frederic; Di Scala, Georges; Marchand, Alain R.] CNRS, UMR 5287, INCIA, Talence, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux	Coutureau, E (corresponding author), Univ Bordeaux, INCIA, Talence, France.	alain.marchand@u-bordeaux1.fr	INCIA, NeurexTeam/D-6197-2014	Coutureau, Etienne/0000-0001-6695-020X; Di Scala, Georges/0000-0001-7274-5499; Marchand, Alain/0000-0002-0231-5562	CNRS; ANR (National Research Agency); Conseil Regional d'Aquitaine	CNRS(Centre National de la Recherche Scientifique (CNRS)); ANR (National Research Agency)(French National Research Agency (ANR)); Conseil Regional d'Aquitaine(Region Nouvelle-Aquitaine)	This work was supported by grants from the CNRS (Programme interdisciplinaire Neuroinformatique), ANR (National Research Agency) (Programme Blanc SVSE 4, project LU2 "Learning under Uncertainty'') and Conseil Regional d'Aquitaine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander WH, 2011, NAT NEUROSCI, V14, P1338, DOI 10.1038/nn.2921; AZZI R, 1964, J EXP ANAL BEHAV, V7, P159, DOI 10.1901/jeab.1964.7-159; Balleine BW, 2010, NEUROPSYCHOPHARMACOL, V35, P48, DOI 10.1038/npp.2009.131; Balleine BW, 2005, PHYSIOL BEHAV, V86, P717, DOI 10.1016/j.physbeh.2005.08.061; Balleine BW, 1998, NEUROPHARMACOLOGY, V37, P407, DOI 10.1016/S0028-3908(98)00033-1; BITTERMAN ME, 1970, ANNU REV PSYCHOL, V21, P367, DOI 10.1146/annurev.ps.21.020170.002055; Corbit LH, 2003, BEHAV BRAIN RES, V146, P145, DOI 10.1016/j.bbr.2003.09.023; Coutureau E, 2003, BEHAV BRAIN RES, V146, P167, DOI 10.1016/j.bbr.2003.09.025; Coutureau E, 2009, BEHAV NEUROSCI, V123, P443, DOI 10.1037/a0014818; Dalley JW, 2004, NEUROSCI BIOBEHAV R, V28, P771, DOI 10.1016/j.neubiorev.2004.09.006; DAVIS J, 1971, J EXP ANAL BEHAV, V15, P237, DOI 10.1901/jeab.1971.15-237; Daw ND, 2005, NAT NEUROSCI, V8, P1704, DOI 10.1038/nn1560; DICKINSON A, 1985, PHILOS T ROY SOC B, V308, P67, DOI 10.1098/rstb.1985.0010; Dickinson A, 1998, Q J EXP PSYCHOL-B, V51, P271; Durstewitz D, 2008, BIOL PSYCHIAT, V64, P739, DOI 10.1016/j.biopsych.2008.05.015; Dutech A, 2011, J PHYSIOL-PARIS, V105, P36, DOI 10.1016/j.jphysparis.2011.07.017; Faure A, 2005, J NEUROSCI, V25, P2771, DOI 10.1523/JNEUROSCI.3894-04.2005; Fiorillo CD, 2003, SCIENCE, V299, P1898, DOI 10.1126/science.1077349; Fuster JM, 2001, NEURON, V30, P319, DOI 10.1016/S0896-6273(01)00285-9; Glascher J, 2010, NEURON, V66, P585, DOI 10.1016/j.neuron.2010.04.016; Hitchcott PK, 2007, CEREB CORTEX, V17, P2820, DOI 10.1093/cercor/bhm010; Ishikawa A, 2008, NEUROSCIENCE, V155, P573, DOI 10.1016/j.neuroscience.2008.06.037; Kargo WJ, 2007, J NEUROSCI, V27, P3548, DOI 10.1523/JNEUROSCI.3604-06.2007; Kheramin S, 2004, PSYCHOPHARMACOLOGY, V175, P206, DOI 10.1007/s00213-004-1813-y; Killcross S, 2003, CEREB CORTEX, V13, P400, DOI 10.1093/cercor/13.4.400; Lammel S, 2008, NEURON, V57, P760, DOI 10.1016/j.neuron.2008.01.022; Lex B, 2010, CEREB CORTEX, V20, P873, DOI 10.1093/cercor/bhp151; Maia TV, 2009, COGN AFFECT BEHAV NE, V9, P343, DOI 10.3758/CABN.9.4.343; Matsumoto K, 2004, CURR OPIN NEUROBIOL, V14, P178, DOI 10.1016/j.conb.2004.03.005; MAZALESKI JL, 1993, J APPL BEHAV ANAL, V26, P143, DOI 10.1901/jaba.1993.26-143; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Naneix F, 2009, J NEUROSCI, V29, P6599, DOI 10.1523/JNEUROSCI.1234-09.2009; Ostlund SB, 2005, J NEUROSCI, V25, P7763, DOI 10.1523/JNEUROSCI.1921-05.2005; Ostlund SB, 2009, J NEUROSCI, V29, P8280, DOI 10.1523/JNEUROSCI.1176-09.2009; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Ragozzino ME, 2007, ANN NY ACAD SCI, V1121, P355, DOI 10.1196/annals.1401.013; Rangel A, 2008, NAT REV NEUROSCI, V9, P545, DOI 10.1038/nrn2357; REYNOLDS GS, 1961, J EXP ANAL BEHAV, V4, P57, DOI 10.1901/jeab.1961.4-57; Ringdahl JE, 2001, J APPL BEHAV ANAL, V34, P1, DOI 10.1901/jaba.2001.34-1; Roesch MR, 2007, ANN NY ACAD SCI, V1104, P21, DOI 10.1196/annals.1390.001; Rushworth MFS, 2008, NAT NEUROSCI, V11, P389, DOI 10.1038/nn2066; SHANKS DR, 1991, MEM COGNITION, V19, P353, DOI 10.3758/BF03197139; Tanaka SC, 2008, J NEUROSCI, V28, P6750, DOI 10.1523/JNEUROSCI.1808-08.2008; Thompson RH, 2003, J APPL BEHAV ANAL, V36, P221, DOI 10.1901/jaba.2003.36-221; Tran-Tu-Yen DAS, 2009, EUR J NEUROSCI, V30, P464, DOI 10.1111/j.1460-9568.2009.06834.x; Vollmer TR, 1997, J APPL BEHAV ANAL, V30, P161, DOI 10.1901/jaba.1997.30-161; WILLIAMS BA, 1976, J EXP ANAL BEHAV, V26, P441, DOI 10.1901/jeab.1976.26-441; Yin HH, 2006, BEHAV BRAIN RES, V166, P189, DOI 10.1016/j.bbr.2005.07.012	48	13	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e33302	10.1371/journal.pone.0033302	http://dx.doi.org/10.1371/journal.pone.0033302			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	953GO	22496747	Green Published, gold, Green Submitted			2022-12-27	WOS:000304855200011
J	De Marco, D; Clementi, N; Mancini, N; Solforosi, L; Moreno, GJ; Sun, XJ; Tumpey, TM; Gubareva, LV; Mishin, V; Clementi, M; Burioni, R				De Marco, Donata; Clementi, Nicola; Mancini, Nicasio; Solforosi, Laura; Moreno, Guisella J.; Sun, Xiangjie; Tumpey, Terrence M.; Gubareva, Larisa V.; Mishin, Vasiliy; Clementi, Massimo; Burioni, Roberto			A Non-VH1-69 Heterosubtypic Neutralizing Human Monoclonal Antibody Protects Mice against H1N1 and H5N1 Viruses	PLOS ONE			English	Article							INFLUENZA-A; OSELTAMIVIR; HEMAGGLUTININ; RESISTANCE; EPITOPE; IDENTIFICATION; IMMUNIZATION; STRAIN	Influenza viruses are among the most important human pathogens and are responsible for annual epidemics and sporadic, potentially devastating pandemics. The humoral immune response plays an important role in the defense against these viruses, providing protection mainly by producing antibodies directed against the hemagglutinin (HA) glycoprotein. However, their high genetic variability allows the virus to evade the host immune response and the potential protection offered by seasonal vaccines. The emergence of resistance to antiviral drugs in recent years further limits the options available for the control of influenza. The development of alternative strategies for influenza prophylaxis and therapy is therefore urgently needed. In this study, we describe a human monoclonal antibody (PN-SIA49) that recognizes a highly conserved epitope located on the stem region of the HA and able to neutralize a broad spectrum of influenza viruses belonging to different subtypes (H1, H2 and H5). Furthermore, we describe its protective activity in mice after lethal challenge with H1N1 and H5N1 viruses suggesting a potential application in the treatment of influenza virus infections.	[De Marco, Donata; Clementi, Nicola; Mancini, Nicasio; Solforosi, Laura; Moreno, Guisella J.; Clementi, Massimo; Burioni, Roberto] Univ Vita Salute San Raffaele, Lab Microbiol & Virol, Milan, Italy; [Sun, Xiangjie; Tumpey, Terrence M.; Gubareva, Larisa V.; Mishin, Vasiliy] Ctr Dis Control & Prevent, Influenza Div, Natl Ctr Immunizat & Resp Dis, Atlanta, GA USA	Vita-Salute San Raffaele University; Centers for Disease Control & Prevention - USA	De Marco, D (corresponding author), Univ Vita Salute San Raffaele, Lab Microbiol & Virol, Milan, Italy.	burioni.roberto@hsr.it	Burioni, Roberto/F-2396-2012; Clementi, Nicola/G-8545-2014; Clementi, Massimo/F-6646-2013; Sun, Xiangjie/AAP-5409-2020; Mancini, Nicasio/AAN-6203-2020	Clementi, Nicola/0000-0002-1822-9861; Clementi, Massimo/0000-0002-7461-5898; MANCINI, Nicasio/0000-0003-0637-0910	UNIFLUVAC [10DF]	UNIFLUVAC	This study was supported by the Italian Minister of Health Universal Influenza Vaccine, UNIFLUVAC, grant n. 10DF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Smith Nicole M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Bright RA, 2006, JAMA-J AM MED ASSOC, V295, P891, DOI 10.1001/jama.295.8.joc60020; Burioni R, 2010, VIROLOGY, V399, P144, DOI 10.1016/j.virol.2009.12.014; Burioni R, 2009, NEW MICROBIOL, V32, P319; Burioni R, 2009, LANCET, V374, P1417, DOI 10.1016/S0140-6736(09)61853-5; Cheng PKC, 2009, EMERG INFECT DIS, V15, P966, DOI 10.3201/eid1506.081357; Clementi N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028001; Collins PJ, 2008, NATURE, V453, P1258, DOI 10.1038/nature06956; Corti D, 2010, J CLIN INVEST, V120, P1663, DOI 10.1172/JCI41902; CUNNINGHAM BC, 1989, SCIENCE, V244, P1081, DOI 10.1126/science.2471267; de Jong MD, 2005, NEW ENGL J MED, V353, P2667, DOI 10.1056/NEJMoa054512; Ekiert DC, 2011, SCIENCE, V333, P843, DOI 10.1126/science.1204839; Enserink M, 2009, SCIENCE, V323, P1162, DOI 10.1126/science.323.5918.1162; Ramirez-Gonzalez JE, 2011, EMERG INFECT DIS, V17, P283, DOI 10.3201/eid1702.100897; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Friesen RHE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009106; Hanson BJ, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-126; He GM, 2008, ANTIVIR RES, V77, P72, DOI 10.1016/j.antiviral.2007.08.007; Kashyap AK, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000990; KRYSTAL M, 1982, P NATL ACAD SCI-BIOL, V79, P4800, DOI 10.1073/pnas.79.15.4800; LAMARRE A, 1995, J IMMUNOL, V154, P3975; MA JKC, 1990, INFECT IMMUN, V58, P3407, DOI 10.1128/IAI.58.10.3407-3414.1990; Matthews BW, 1996, FASEB J, V10, P35, DOI 10.1096/fasebj.10.1.8566545; Monto AS, 2009, VACCINE, V27, P5043, DOI 10.1016/j.vaccine.2009.06.032; Moscona A, 2008, ANNU REV MED, V59, P397, DOI 10.1146/annurev.med.59.061506.213121; Moscona A, 2009, NEW ENGL J MED, V360, P953, DOI 10.1056/NEJMp0900648; Murphy Trudy V., 2008, Morbidity and Mortality Weekly Report, V57, P1; OKUNO Y, 1993, J VIROL, V67, P2552, DOI 10.1128/JVI.67.5.2552-2558.1993; Palese P, 2004, NAT MED, V10, pS82, DOI 10.1038/nm1141; Perotti M, 2008, J VIROL, V82, P1047, DOI 10.1128/JVI.01986-07; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566; Thompson WW, 2004, JAMA-J AM MED ASSOC, V292, P1333, DOI 10.1001/jama.292.11.1333; Throsby M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003942; Trifonov V, 2009, NEW ENGL J MED, V361, P115, DOI 10.1056/NEJMp0904572; Webster RG, 1999, P NATL ACAD SCI USA, V96, P1164, DOI 10.1073/pnas.96.4.1164; Weiss GA, 2000, P NATL ACAD SCI USA, V97, P8950, DOI 10.1073/pnas.160252097; WHO, 2002, GLOB SOL UV IND PRAC; YODEN S, 1985, ARCH VIROL, V85, P209, DOI 10.1007/BF01314232; Zhang MY, 2004, J VIROL, V78, P9233, DOI 10.1128/JVI.78.17.9233-9242.2004	39	46	49	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e34415	10.1371/journal.pone.0034415	http://dx.doi.org/10.1371/journal.pone.0034415			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GO	22496802	Green Published, gold, Green Submitted			2022-12-27	WOS:000304855200049
J	Kehn-Hall, K; Narayanan, A; Lundberg, L; Sampey, G; Pinkham, C; Guendel, I; Van Duyne, R; Senina, S; Schultz, KL; Stavale, E; Aman, MJ; Bailey, C; Kashanchi, F				Kehn-Hall, Kylene; Narayanan, Aarthi; Lundberg, Lindsay; Sampey, Gavin; Pinkham, Chelsea; Guendel, Irene; Van Duyne, Rachel; Senina, Svetlana; Schultz, Kimberly L.; Stavale, Eric; Aman, M. Javad; Bailey, Charles; Kashanchi, Fatah			Modulation of GSK-3 beta Activity in Venezuelan Equine Encephalitis Virus Infection	PLOS ONE			English	Article							GLYCOGEN-SYNTHASE KINASE-3; SMALL-MOLECULE INHIBITORS; DEPENDENT RNA-POLYMERASE; BLOOD-BRAIN-BARRIER; SIGNALING PATHWAYS; PROTEIN NSP2; MICE; CELLS; REPLICATION; GSK3-BETA	Alphaviruses, including Venezuelan Equine Encephalitis Virus (VEEV), cause disease in both equine and humans that exhibit overt encephalitis in a significant percentage of cases. Features of the host immune response and tissue-specific responses may contribute to fatal outcomes as well as the development of encephalitis. It has previously been shown that VEEV infection of mice induces transcription of pro-inflammatory cytokines genes (e. g., IFN-gamma, IL-6, IL-12, iNOS and TNF-alpha) within 6 h. GSK-3 beta is a host protein that is known to modulate pro-inflammatory gene expression and has been a therapeutic target in neurodegenerative disorders such as Alzheimer's. Hence inhibition of GSK-3 beta in the context of encephalitic viral infections has been useful in a neuroprotective capacity. Small molecule GSK-3 beta inhibitors and GSK-3 beta siRNA experiments indicated that GSK-3 beta was important for VEEV replication. Thirty-eight second generation BIO derivatives were tested and BIOder was found to be the most potent inhibitor, with an IC50 of similar to 0.5 mu M and a CC50 of >100 mu M. BIOder was a more potent inhibitor of GSK-3 beta than BIO, as demonstrated through in vitro kinase assays from uninfected and infected cells. Size exclusion chromatography experiments demonstrated that GSK-3 beta is found in three distinct complexes in VEEV infected cells, whereas GSK-3 beta is only present in one complex in uninfected cells. Cells treated with BIOder demonstrated an increase in the anti-apoptotic gene, survivin, and a decrease in the pro-apoptotic gene, BID, suggesting that modulation of pro-and anti-apoptotic genes contributes to the protective effect of BIOder treatment. Finally, BIOder partially protected mice from VEEV induced mortality. Our studies demonstrate the utility of GSK-3 beta inhibitors for modulating VEEV infection.	[Kehn-Hall, Kylene; Narayanan, Aarthi; Lundberg, Lindsay; Sampey, Gavin; Pinkham, Chelsea; Guendel, Irene; Van Duyne, Rachel; Senina, Svetlana; Bailey, Charles; Kashanchi, Fatah] George Mason Univ, Natl Ctr Biodef & Infect Dis, Manassas, VA USA; [Van Duyne, Rachel] George Washington Univ, Dept Microbiol Immunol & Trop Med, Washington, DC USA; [Schultz, Kimberly L.] Johns Hopkins Bloomberg Sch Publ Hlth, W Harry Feinstone Dept Mol Microbiol & Immunol, Baltimore, MD USA; [Stavale, Eric; Aman, M. Javad] Integrated Biotherapeut Inc, Gaithersburg, MD USA	George Mason University; George Washington University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Kehn-Hall, K (corresponding author), George Mason Univ, Natl Ctr Biodef & Infect Dis, Manassas, VA USA.	fkashanc@gmu.edu	Van Duyne, Rachel/I-7365-2019; Kehn-Hall, Kylene/I-5752-2013; Van Duyne, Rachel/ABI-2429-2020	Van Duyne, Rachel/0000-0003-2914-6874; Kehn-Hall, Kylene/0000-0001-8036-7213	National Institutes of Health (NIH) [AI0078859, AI0074410, NS070740]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI074410, R21AI078859] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS070740] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health (NIH) grants AI0078859, AI0074410 and NS070740 to FK. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal S, 2006, J EXP MED, V203, P1007, DOI 10.1084/jem.20051342; Aguilar PV, 2004, EMERG INFECT DIS, V10, P880, DOI 10.3201/eid1005.030634; Amanchy R, 2007, NAT BIOTECHNOL, V25, P285, DOI 10.1038/nbt0307-285; Atasheva S, 2008, J VIROL, V82, P4028, DOI 10.1128/JVI.02330-07; Atasheva S, 2010, J VIROL, V84, P4158, DOI 10.1128/JVI.02554-09; BERGE TO, 1961, AM J HYG, V73, P209, DOI 10.1093/oxfordjournals.aje.a120178; Beurel E, 2006, PROG NEUROBIOL, V79, P173, DOI 10.1016/j.pneurobio.2006.07.006; Beurel E, 2011, BIOL PSYCHIAT, V69, p34S; BEYAERT R, 1989, P NATL ACAD SCI USA, V86, P9494, DOI 10.1073/pnas.86.23.9494; Charles PC, 2001, VIROLOGY, V284, P190, DOI 10.1006/viro.2001.0878; CHARLES PC, 1995, VIROLOGY, V208, P662, DOI 10.1006/viro.1995.1197; Charvet C, 2011, MOL CELL, V42, P584, DOI 10.1016/j.molcel.2011.03.033; Chin PC, 2005, MOL BRAIN RES, V137, P193, DOI 10.1016/j.molbrainres.2005.03.004; Coghlan MP, 2000, CHEM BIOL, V7, P793, DOI 10.1016/S1074-5521(00)00025-9; Cross DAE, 2001, J NEUROCHEM, V77, P94, DOI 10.1046/j.1471-4159.2001.00251.x; de Cedron MG, 1999, FEBS LETT, V448, P19, DOI 10.1016/S0014-5793(99)00321-X; Ding QQ, 2007, MOL CELL BIOL, V27, P4006, DOI 10.1128/MCB.00620-06; Dolan PJ, 2010, CURR OPIN DRUG DISC, V13, P595; Eugenin EA, 2003, METHODS, V29, P351, DOI 10.1016/S1046-2023(02)00359-6; Frame S, 2001, BIOCHEM J, V359, P1, DOI 10.1042/0264-6021:3590001; Garmashova N, 2007, J VIROL, V81, P13552, DOI 10.1128/JVI.01576-07; Gould TD, 2006, CURR DRUG TARGETS, V7, P1399, DOI 10.2174/1389450110607011399; Griffin D, 1997, IMMUNOL REV, V159, P155, DOI 10.1111/j.1600-065X.1997.tb01013.x; Gubler DJ, 2002, ARCH MED RES, V33, P330, DOI 10.1016/S0188-4409(02)00378-8; Hanger DP, 2009, TRENDS MOL MED, V15, P112, DOI 10.1016/j.molmed.2009.01.003; Hoeflich KP, 2000, NATURE, V406, P86, DOI 10.1038/35017574; Huang WC, 2009, IMMUNOLOGY, V128, pe275, DOI 10.1111/j.1365-2567.2008.02959.x; Jackson AC, 1997, ACTA NEUROPATHOL, V93, P349, DOI 10.1007/s004010050626; JACKSON AC, 1991, VET PATHOL, V28, P410, DOI 10.1177/030098589102800509; Julander JG, 2008, ANTIVIR RES, V78, P230, DOI 10.1016/j.antiviral.2008.01.007; Kehn-Hall K, 2011, VIROLOGY, V415, P56, DOI 10.1016/j.virol.2011.03.025; KINNEY RM, 1993, J VIROL, V67, P1269, DOI 10.1128/JVI.67.3.1269-1277.1993; Konig R, 2010, NATURE, V463, P813, DOI 10.1038/nature08699; Kulasegaran-Shylini R, 2009, VIROLOGY, V387, P211, DOI 10.1016/j.virol.2009.02.027; LEON CA, 1975, INT J EPIDEMIOL, V4, P131, DOI 10.1093/ije/4.2.131; Li MT, 2000, MOL CELL BIOL, V20, P9356, DOI 10.1128/MCB.20.24.9356-9363.2000; Ludwig George V., 2001, American Journal of Tropical Medicine and Hygiene, V64, P49; MacAulay K, 2003, EUR J BIOCHEM, V270, P3829, DOI 10.1046/j.1432-1033.2003.03777.x; Magiatis P, 2010, NEUROTOXICOL TERATOL, V32, P212, DOI 10.1016/j.ntt.2009.12.005; Martin M, 2005, NAT IMMUNOL, V6, P777, DOI 10.1038/ni1221; Maurer MH, 2007, J PROTEOME RES, V6, P1198, DOI 10.1021/pr0605825; Maurer U, 2006, MOL CELL, V21, P749, DOI 10.1016/j.molcel.2006.02.009; Meijer L, 2003, CHEM BIOL, V10, P1255, DOI 10.1016/j.chembiol.2003.11.010; Morel C, 2009, MOL CELL BIOL, V29, P3845, DOI 10.1128/MCB.00279-09; Muehlenbein MP, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-19; Olival KJ, 2005, J NEUROVIROL, V11, P441, DOI 10.1080/13550280591002450; PARDIGON N, 1993, J VIROL, V67, P5003, DOI 10.1128/JVI.67.8.5003-5011.1993; Ramirez SH, 2010, AM J PATHOL, V176, P881, DOI 10.2353/ajpath.2010.090671; Reichert E, 2009, BIOSECUR BIOTERROR, V7, P413, DOI 10.1089/bsp.2009.0032; RIKKONEN M, 1994, J VIROL, V68, P5804, DOI 10.1128/JVI.68.9.5804-5810.1994; Rosenberg GA, 2002, NEUROSCIENTIST, V8, P586, DOI 10.1177/1073858402238517; Rubach JK, 2009, VIROLOGY, V384, P201, DOI 10.1016/j.virol.2008.10.030; Ryzhikov AB, 1995, ARCH VIROL, V140, P2243, DOI 10.1007/BF01323243; Schafer A, 2011, J VIROL, V85, P10682, DOI 10.1128/JVI.05032-11; Schafer A, 2009, J VIROL, V83, P4275, DOI 10.1128/JVI.02383-08; Schoneboom BA, 2000, J INTERF CYTOK RES, V20, P205, DOI 10.1089/107999000312621; Schoneboom BA, 2000, J NEUROIMMUNOL, V109, P132, DOI 10.1016/S0165-5728(00)00290-3; SHIRAKO Y, 1994, J VIROL, V68, P1874, DOI 10.1128/JVI.68.3.1874-1885.1994; Stamatovic SM, 2005, J CEREBR BLOOD F MET, V25, P593, DOI 10.1038/sj.jcbfm.9600055; Steele KE, 2010, VET PATHOL, V47, P790, DOI 10.1177/0300985810372508; Steele KE, 1998, VET PATHOL, V35, P386, DOI 10.1177/030098589803500508; STRAUSS JH, 1994, MICROBIOL REV, V58, P491, DOI 10.1128/MMBR.58.3.491-562.1994; Sutherland C., 2011, INT J ALZHEIMERS DIS, V2011; Thal MA, 2007, VIROLOGY, V358, P221, DOI 10.1016/j.virol.2006.08.022; Wang HZ, 2011, J IMMUNOL, V186, P5217, DOI 10.4049/jimmunol.1002513; Wang HZ, 2011, CYTOKINE, V53, P130, DOI 10.1016/j.cyto.2010.10.009; Weaver SC, 2004, ANNU REV ENTOMOL, V49, P141, DOI 10.1146/annurev.ento.49.061802.123422; Weaver SC, 1996, LANCET, V348, P436, DOI 10.1016/S0140-6736(96)02275-1; Zacks MA, 2010, VET MICROBIOL, V140, P281, DOI 10.1016/j.vetmic.2009.08.023	69	43	45	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e34761	10.1371/journal.pone.0034761	http://dx.doi.org/10.1371/journal.pone.0034761			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GO	22496857	Green Published, Green Submitted, gold			2022-12-27	WOS:000304855200078
J	Mondal, A; Roy, A; Sarkar, S; Mukherjee, J; Ganguly, T; Chattopadhyay, D				Mondal, Arindam; Roy, Arunava; Sarkar, Sandipto; Mukherjee, Jishnu; Ganguly, Tridib; Chattopadhyay, Dhrubajyoti			Interaction of Chandipura Virus N and P Proteins: Identification of Two Mutually Exclusive Domains of N Involved in Interaction with P	PLOS ONE			English	Article							VESICULAR-STOMATITIS-VIRUS; NUCLEOCAPSID PROTEIN; PHOSPHOPROTEIN NS; COMPLEX-FORMATION; RNA-SYNTHESIS; LEADER RNA; BINDING; NUCLEOPROTEIN; TRANSCRIPTION; CHAPERONE	The nucleocapsid protein (N) and the phosphoprotein (P) of nonsegmented negative-strand (NNS) RNA viruses interact with each other to accomplish two crucial events necessary for the viral replication cycle. First, the P protein binds to the aggregation prone nascent N molecules maintaining them in a soluble monomeric (N-0) form (N-0-P complex). It is this form that is competent for specific encapsidation of the viral genome. Second, the P protein binds to oligomeric N in the nucleoprotein complex (N-RNA-P complex), and thereby facilitates the recruitment of the viral polymerase (L) onto its template. All previous attempts to study these complexes relied on co-expression of the two proteins in diverse systems. In his study, we have characterised these different modes of N-P interaction in detail and for the first time have been able to reconstitute these complexes individually in vitro in the chandipura virus (CHPV), a human pathogenic NNS RNA virus. Using a battery of truncated mutants of the N protein, we have been able to identify two mutually exclusive domains of N involved in differential interaction with the P protein. An unique N-terminal binding site, comprising of amino acids (aa) 1-180 form the N-0-P interacting region, whereas, C-terminal residues spanning aa 320-390 is instrumental in N-RNA-P interactions. Significantly, the ex-vivo data also supports these observations. Based on these results, we suggest that the P Protein acts as N-specific chaperone and thereby Partially masking the N-N self-association region, which leads to the specific recognition of viral genome RNA by N-0.	[Mondal, Arindam; Roy, Arunava; Sarkar, Sandipto; Mukherjee, Jishnu; Chattopadhyay, Dhrubajyoti] Univ Calcutta, Dept Biotechnol, Kolkata, W Bengal, India; [Mondal, Arindam; Roy, Arunava; Sarkar, Sandipto; Mukherjee, Jishnu; Chattopadhyay, Dhrubajyoti] Univ Calcutta, Dr BC Guha Ctr Genet Engn & Biotechnol, Kolkata, W Bengal, India; [Ganguly, Tridib] IISER, Dept Biol Sci, Kolkata, W Bengal, India	University of Calcutta; University of Calcutta; Indian Institute of Science Education & Research (IISER) - Kolkata	Mondal, A (corresponding author), Univ Virginia, Dept Pathol, Hlth Syst, Charlottesville, VA 22903 USA.	djcbcg@caluniv.ac.in	Roy, Arunava/T-9494-2019; Mondal, Arindam/AAQ-5734-2021; ganguly, tridib/H-8767-2019	Roy, Arunava/0000-0002-8486-0539; ganguly, tridib/0000-0002-5283-5689; Mondal, Arindam/0000-0001-7991-5809	Department of Science and Technology, Ministry of Science and Technology, Government of India [SR/SO/BB-67/2008]; University Grants Commission CAS in the Department of Biochemistry	Department of Science and Technology, Ministry of Science and Technology, Government of India(Department of Science & Technology (India)); University Grants Commission CAS in the Department of Biochemistry	This work was supported by a research grant (SR/SO/BB-67/2008) from the Department of Science and Technology, Ministry of Science and Technology, Government of India and the University Grants Commission CAS programme in the Department of Biochemistry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertini AAV, 2006, SCIENCE, V313, P360, DOI 10.1126/science.1125280; Basak S, 2004, J MOL BIOL, V339, P1089, DOI 10.1016/j.jmb.2004.03.081; Basak S, 2003, VIROLOGY, V307, P372, DOI 10.1016/S0042-6822(02)00093-4; Basak S, 2007, BIOSCIENCE REP, V27, P275, DOI 10.1007/s10540-007-9054-z; BHATT PN, 1967, INDIAN J MED RES, V55, P1295; Bhattacharya R, 2006, VIROLOGY, V349, P197, DOI 10.1016/j.virol.2006.01.017; BLUMBERG BM, 1981, CELL, V23, P837, DOI 10.1016/0092-8674(81)90448-7; Chadha MS, 2005, AM J TROP MED HYG, V73, P566, DOI 10.4269/ajtmh.2005.73.566; Chattopadhyay D, 1997, VIROLOGY, V239, P11, DOI 10.1006/viro.1997.8838; CHATTOPADHYAY D, 1994, CELL MOL BIOL RES, V40, P693; Chen MZ, 2007, J VIROL, V81, P13478, DOI 10.1128/JVI.01244-07; CURRAN J, 1995, J VIROL, V69, P849, DOI 10.1128/JVI.69.2.849-855.1995; DAS T, 1993, VIROLOGY, V193, P340, DOI 10.1006/viro.1993.1130; DAVIS NL, 1986, J VIROL, V59, P751, DOI 10.1128/JVI.59.3.751-754.1986; DE BP, 1985, BIOCHEM BIOPH RES CO, V126, P40, DOI 10.1016/0006-291X(85)90568-6; De BP, 2000, J VIROL, V74, P5886, DOI 10.1128/JVI.74.13.5886-5895.2000; EMERSON SU, 1972, J VIROL, V10, P297, DOI 10.1128/JVI.10.2.297-309.1972; EMERSON SU, 1987, P NATL ACAD SCI USA, V84, P5655, DOI 10.1073/pnas.84.16.5655; EMERSON SU, 1975, J VIROL, V15, P1348, DOI 10.1128/JVI.15.6.1348-1356.1975; Green TJ, 2000, J VIROL, V74, P9515, DOI 10.1128/JVI.74.20.9515-9524.2000; Green TJ, 2006, SCIENCE, V313, P357, DOI 10.1126/science.1126953; Green TJ, 2009, P NATL ACAD SCI USA, V106, P11713, DOI 10.1073/pnas.0903228106; Gurav YK, 2010, INDIAN J MED RES, V132, P395; HOWARD M, 1989, J GEN VIROL, V70, P2683, DOI 10.1099/0022-1317-70-10-2683; Iseni F, 1998, J GEN VIROL, V79, P2909, DOI 10.1099/0022-1317-79-12-2909; Ivanov I, 2011, VIRUS RES, V162, P126, DOI 10.1016/j.virusres.2011.09.025; LAFERLA FM, 1989, J VIROL, V63, P3852, DOI 10.1128/JVI.63.9.3852-3857.1989; Leyrat C, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002248; Leyrat C, 2011, PROTEIN SCI, V20, P542, DOI 10.1002/pro.587; Majumdar A, 2004, BIOCHEMISTRY-US, V43, P2863, DOI 10.1021/bi035793r; Majumder A, 2001, J BIOL CHEM, V276, P30948, DOI 10.1074/jbc.M011705200; MASTERS PS, 1988, J VIROL, V62, P2658, DOI 10.1128/JVI.62.8.2658-2664.1988; MASTERS PS, 1988, J VIROL, V62, P2651, DOI 10.1128/JVI.62.8.2651-2657.1988; Mavrakis M, 2003, VIROLOGY, V305, P406, DOI 10.1006/viro.2002.1748; Mavrakis M, 2006, VIROLOGY, V349, P422, DOI 10.1016/j.virol.2006.01.030; Mondal A, 2010, VIROLOGY, V407, P33, DOI 10.1016/j.virol.2010.07.032; Omi-Furutani M, 2010, J VIROL, V84, P9793, DOI 10.1128/JVI.00339-10; PERLMAN SM, 1973, J VIROL, V12, P1395, DOI 10.1128/JVI.12.6.1395-1400.1973; Rao BL, 2004, LANCET, V364, P869, DOI 10.1016/S0140-6736(04)16982-1; Rao SN, 2008, J TROP PEDIATRICS, V54, P25, DOI 10.1093/tropej/fmm078; RODRIGUES JJ, 1983, INDIAN J MED RES, V77, P303; SORIA M, 1973, J MOL BIOL, V77, P449, DOI 10.1016/0022-2836(73)90450-6; TAKACS AM, 1993, P NATL ACAD SCI USA, V90, P10375, DOI 10.1073/pnas.90.21.10375; THORNTON GB, 1983, BIOCHEM BIOPH RES CO, V116, P1160, DOI 10.1016/S0006-291X(83)80264-2; WERTZ GW, 1973, J VIROL, V12, P253, DOI 10.1128/JVI.12.2.253-264.1973; Zhang X, 2008, J VIROL, V82, P674, DOI 10.1128/JVI.00935-07	46	28	29	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2012	7	4							e34623	10.1371/journal.pone.0034623	http://dx.doi.org/10.1371/journal.pone.0034623			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952GU	22485180	gold, Green Published, Green Submitted			2022-12-27	WOS:000304780500055
J	Posner, M; Kiss, AJ; Skiba, J; Drossman, A; Dolinska, MB; Hejtmancik, JF; Sergeev, YV				Posner, Mason; Kiss, Andor J.; Skiba, Jackie; Drossman, Amy; Dolinska, Monika B.; Hejtmancik, J. Fielding; Sergeev, Yuri V.			Functional Validation of Hydrophobic Adaptation to Physiological Temperature in the Small Heat Shock Protein alpha A-crystallin	PLOS ONE			English	Article							CHAPERONE-LIKE ACTIVITY; ZEBRAFISH DANIO-RERIO; TOOTHFISH DISSOSTICHUS-MAWSONI; DIFFERENT THERMAL ENVIRONMENTS; EYE LENS CRYSTALLINS; B-CRYSTALLIN; PHYLOGENETIC ANALYSIS; MOLECULAR CHAPERONE; MAXIMUM-LIKELIHOOD; SUBUNIT EXCHANGE	Small heat shock proteins (sHsps) maintain cellular homeostasis by preventing stress and disease-induced protein aggregation. While it is known that hydrophobicity impacts the ability of sHsps to bind aggregation-prone denaturing proteins, the complex quaternary structure of globular sHsps has made understanding the significance of specific changes in hydrophobicity difficult. Here we used recombinant protein of the lenticular sHsp alpha A-crystallin from six teleost fishes environmentally adapted to temperatures ranging from -2 degrees C to 40 degrees C to identify correlations between physiological temperature, protein stability and chaperone-like activity. Using sequence and structural modeling analysis we identified specific amino acid differences between the warm adapted zebrafish and cold adapted Antarctic toothfish that could contribute to these correlations and validated the functional consequences of three specific hydrophobicity-altering amino acid substitutions in alpha A-crystallin. Site directed mutagenesis of three residues in the zebrafish (V62T, C143S, T147V) confirmed that each impacts either protein stability or chaperone-like activity or both, with the V62T substitution having the greatest impact. Our results indicate a role for changing hydrophobicity in the thermal adaptation of alpha A-crystallin and suggest ways to produce sHsp variants with altered chaperone-like activity. These data also demonstrate that a comparative approach can provide new information about sHsp function and evolution.	[Posner, Mason; Skiba, Jackie; Drossman, Amy] Ashland Univ, Dept Biol, Ashland, OH USA; [Kiss, Andor J.] Miami Univ, Dept Zool, Oxford, OH 45056 USA; [Dolinska, Monika B.; Hejtmancik, J. Fielding; Sergeev, Yuri V.] NEI, Ophthalm Genet & Visual Funct Branch, NIH, Bethesda, MD 20892 USA	Ashland University; University System of Ohio; Miami University; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Posner, M (corresponding author), Ashland Univ, Dept Biol, Ashland, OH USA.	mposner@ashland.edu	Posner, Mason/J-9759-2019; Kiss, Andor J/E-9863-2016	Posner, Mason/0000-0003-2817-3395; Kiss, Andor J/0000-0002-7508-0485	National Eye Institute at the National Institutes of Health [R15 EY13535]; NATIONAL EYE INSTITUTE [R15EY013535, ZIAEY000272, ZIAEY000476, ZIAEY000281] Funding Source: NIH RePORTER	National Eye Institute at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This research was funded by grant R15 EY13535 from the National Eye Institute at the National Institutes of Health. http://grants.nih.gov/grants/funding/area.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abgar S, 2000, EUR J BIOCHEM, V267, P5916, DOI 10.1046/j.1432-1327.2000.01646.x; Aquilina JA, 2005, J BIOL CHEM, V280, P14485, DOI 10.1074/jbc.M500135200; Bagneris C, 2009, J MOL BIOL, V392, P1242, DOI 10.1016/j.jmb.2009.07.069; Benesch JLP, 2008, J BIOL CHEM, V283, P28513, DOI 10.1074/jbc.M804729200; Bhat SP, 1999, EUR J CELL BIOL, V78, P143, DOI 10.1016/S0171-9335(99)80016-8; BHAT SP, 1989, BIOCHEM BIOPH RES CO, V158, P319, DOI 10.1016/S0006-291X(89)80215-3; Bova MP, 1997, J BIOL CHEM, V272, P29511, DOI 10.1074/jbc.272.47.29511; Campbell KL, 2010, NAT GENET, V42, P536, DOI 10.1038/ng.574; Cheng C, 2010, J BIOL CHEM, V285, P41187, DOI 10.1074/jbc.M110.154534; Dahlman JM, 2005, MOL VIS, V11, P88; Derham BK, 2001, EUR J BIOCHEM, V268, P713, DOI 10.1046/j.1432-1327.2001.01929.x; Dong YW, 2009, J EXP BIOL, V212, P169, DOI 10.1242/jeb.024505; DUBIN RA, 1989, MOL CELL BIOL, V9, P1083, DOI 10.1128/MCB.9.3.1083; Eifert C, 2005, BBA-PROTEINS PROTEOM, V1748, P146, DOI 10.1016/j.bbapap.2004.12.015; Eyles SJ, 2010, P NATL ACAD SCI USA, V107, P2727, DOI 10.1073/pnas.0915160107; Gangadhariah MH, 2010, BBA-MOL BASIS DIS, V1802, P432, DOI 10.1016/j.bbadis.2010.01.010; Gangalum RK, 2009, INVEST OPHTH VIS SCI, V50, P3283, DOI 10.1167/iovs.08-3052; Geffeney SL, 2005, NATURE, V434, P759, DOI 10.1038/nature03444; Ghosh JG, 2007, INT J BIOCHEM CELL B, V39, P1804, DOI 10.1016/j.biocel.2007.04.027; GRAVES JE, 1982, EVOLUTION, V36, P97, DOI 10.1111/j.1558-5646.1982.tb05014.x; HallBarry G, PHYLOGENETIC TREES M; Hayes VH, 2008, J BIOL CHEM, V283, P10500, DOI 10.1074/jbc.M706453200; Hochachka PW, BIOCH ADAPTATION MEC; Holland LZ, 1997, BIOCHEMISTRY-US, V36, P3207, DOI 10.1021/bi962664k; HORWITZ J, 1992, P NATL ACAD SCI USA, V89, P10449, DOI 10.1073/pnas.89.21.10449; Horwitz J, 1998, METHOD ENZYMOL, V290, P365, DOI 10.1016/S0076-6879(98)90032-5; Horwitz J, 2009, EXP EYE RES, V88, P190, DOI 10.1016/j.exer.2008.07.007; IWAKI T, 1989, CELL, V57, P71, DOI 10.1016/0092-8674(89)90173-6; Jaenicke R, 2000, P NATL ACAD SCI USA, V97, P2962, DOI 10.1073/pnas.97.7.2962; Jaya N, 2009, P NATL ACAD SCI USA, V106, P15604, DOI 10.1073/pnas.0902177106; Kiss AJ, 2004, J EXP BIOL, V207, P4633, DOI 10.1242/jeb.01312; Kiss AJ, 2008, COMP BIOCHEM PHYS D, V3, P155, DOI 10.1016/j.cbd.2008.02.002; KLEMENZ R, 1991, P NATL ACAD SCI USA, V88, P3652, DOI 10.1073/pnas.88.9.3652; Kumar MS, 2005, J BIOL CHEM, V280, P21726, DOI 10.1074/jbc.M500405200; Laganowsky A, 2010, PROTEIN SCI, V19, P1978, DOI 10.1002/pro.471; Laganowsky A, 2010, PROTEIN SCI, V19, P1031, DOI 10.1002/pro.380; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LEE C, 1991, J MOL BIOL, V217, P373, DOI 10.1016/0022-2836(91)90550-P; LEE C, 1994, J MOL BIOL, V236, P918, DOI 10.1006/jmbi.1994.1198; Letunic I, 2009, NUCLEIC ACIDS RES, V37, pD229, DOI 10.1093/nar/gkn808; LEVITT M, 1992, J MOL BIOL, V226, P507, DOI 10.1016/0022-2836(92)90964-L; Liang JJN, 2000, MOL VIS, V6, P10; McClellan DA, 2005, MOL BIOL EVOL, V22, P437, DOI 10.1093/molbev/msi028; MCFALLNGAI MJ, 1990, EXP EYE RES, V50, P703, DOI 10.1016/0014-4835(90)90117-D; Mchaourab HS, 2009, BIOCHEMISTRY-US, V48, P3828, DOI 10.1021/bi900212j; Mchaourab HS, 2002, J BIOL CHEM, V277, P40557, DOI 10.1074/jbc.M206250200; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Nylander JAA, 2004, MRMODELTEST PROGRAM; Ousman SS, 2007, NATURE, V448, P474, DOI 10.1038/nature05935; PAULING L, 1949, SCIENCE, V110, P543, DOI 10.1126/science.110.2865.543; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Posner M, 1999, BBA-GENE STRUCT EXPR, V1447, P271, DOI 10.1016/S0167-4781(99)00155-4; Posner M, 2008, MOL VIS, V14, P806; Reddy GB, 2006, IUBMB LIFE, V58, P632, DOI 10.1080/15216540601010096; Reddy GB, 2000, J BIOL CHEM, V275, P4565, DOI 10.1074/jbc.275.7.4565; Runkle S, 2002, MOL VIS, V8, P45; Schrank TP, 2009, P NATL ACAD SCI USA, V106, P16984, DOI 10.1073/pnas.0906510106; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Schymkowitz J, 2005, NUCLEIC ACIDS RES, V33, pW382, DOI 10.1093/nar/gki387; Schymkowitz JWH, 2005, P NATL ACAD SCI USA, V102, P10147, DOI 10.1073/pnas.0501980102; Smith AA, 2006, FEBS J, V273, P481, DOI 10.1111/j.1742-4658.2005.05080.x; Stegh AH, 2008, P NATL ACAD SCI USA, V105, P10703, DOI 10.1073/pnas.0712034105; Stengel F, 2010, P NATL ACAD SCI USA, V107, P2007, DOI 10.1073/pnas.0910126107; Sun Y, 2005, CELL MOL LIFE SCI, V62, P2460, DOI 10.1007/s00018-005-5190-4; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Treweek TM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001046; Vicart P, 1998, NAT GENET, V20, P92, DOI 10.1038/1765; Waddell PJ, 1997, MOL PHYLOGENET EVOL, V8, P398, DOI 10.1006/mpev.1997.0452; Woolley S, 2003, BIOINFORMATICS, V19, P671, DOI 10.1093/bioinformatics/btg043; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088	71	16	17	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2012	7	3							e34438	10.1371/journal.pone.0034438	http://dx.doi.org/10.1371/journal.pone.0034438			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948SR	22479631	Green Published, Green Submitted, gold			2022-12-27	WOS:000304523400084
J	Hovey, RK; Van Niel, KP; Bellchambers, LM; Pember, MB				Hovey, Renae K.; Van Niel, Kimberly P.; Bellchambers, Lynda M.; Pember, Matthew B.			Modelling Deep Water Habitats to Develop a Spatially Explicit, Fine Scale Understanding of the Distribution of the Western Rock Lobster, Panulirus cygnus	PLOS ONE			English	Article							DEMERSAL FISH DISTRIBUTIONS; SPINY LOBSTER; FISHERIES MANAGEMENT; HOMARUS-AMERICANUS; POPULATION-DYNAMICS; BENTHIC HABITAT; ALACRANES REEF; TRAP ARRAYS; ABUNDANCE; ASSOCIATIONS	Background: The western rock lobster, Panulirus cygnus, is endemic to Western Australia and supports substantial commercial and recreational fisheries. Due to and its wide distribution and the commercial and recreational importance of the species a key component of managing western rock lobster is understanding the ecological processes and interactions that may influence lobster abundance and distribution. Using terrain analyses and distribution models of substrate and benthic biota, we assess the physical drivers that influence the distribution of lobsters at a key fishery site. Methods and Findings: Using data collected from hydroacoustic and towed video surveys, 20 variables (including geophysical, substrate and biota variables) were developed to predict the distributions of substrate type (three classes of reef, rhodoliths and sand) and dominant biota (kelp, sessile invertebrates and macroalgae) within a 40 km(2) area about 30 km off the west Australian coast. Lobster presence/absence data were collected within this area using georeferenced pots. These datasets were used to develop a classification tree model for predicting the distribution of the western rock lobster. Interestingly, kelp and reef were not selected as predictors. Instead, the model selected geophysical and geomorphic scalar variables, which emphasise a mix of terrain within limited distances. The model of lobster presence had an adjusted D-2 of 64 and an 80% correct classification. Conclusions: Species distribution models indicate that juxtaposition in fine scale terrain is most important to the western rock lobster. While key features like kelp and reef may be important to lobster distribution at a broad scale, it is the fine scale features in terrain that are likely to define its ecological niche. Determining the most appropriate landscape configuration and scale will be essential to refining niche habitats and will aid in selecting appropriate sites for protecting critical lobster habitats.	[Hovey, Renae K.; Van Niel, Kimberly P.] Univ Western Australia, UWA Oceans Inst, Perth, WA 6009, Australia; [Hovey, Renae K.; Van Niel, Kimberly P.] Univ Western Australia, Sch Earth & Environm, Fac Nat & Agr Sci, Perth, WA 6009, Australia; [Bellchambers, Lynda M.; Pember, Matthew B.] Govt Western Australia, Dept Fisheries, Western Australian Fisheries & Marine Res Labs, Perth, WA 6009, Australia	University of Western Australia; University of Western Australia; Western Australian Fisheries & Marine Research Laboratories	Hovey, RK (corresponding author), Univ Western Australia, UWA Oceans Inst, Perth, WA 6009, Australia.	renae.hovey@uwa.edu.au	Van Niel, Kimberly P/A-4953-2010; Hovey, Renae/F-8309-2011	Van Niel, Kimberly P/0000-0002-0312-4397; hovey, renae/0000-0003-0308-3609	Fisheries Research and Development Coporation (FRDC) [2008/013]; Western Australian Marine Science Institution (WAMSI)	Fisheries Research and Development Coporation (FRDC); Western Australian Marine Science Institution (WAMSI)	This work was undertaken as part of Fisheries Research and Development Coporation (FRDC) Project No. 2008/013. The Western Australian Marine Science Institution (WAMSI) provided financial support to MBP. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta CA, 1999, CONSERV BIOL, V13, P603, DOI 10.1046/j.1523-1739.1999.97477.x; Anderson MJ, 2004, J EXP MAR BIOL ECOL, V305, P191, DOI 10.1016/j.jembe.2003.12.011; Bellchambers LM, 2010, MAR FRESHWATER RES, V61, P279, DOI 10.1071/MF09031; Bello PJ, 2005, FISH RES, V73, P37, DOI 10.1016/j.fishres.2005.01.013; Breiman L., 1984, CLASSIFICATION REGRE; Cardinale M, 2011, FISH FISH, V12, P289, DOI 10.1111/j.1467-2979.2010.00393.x; CHAMBERS JM, 1993, STAT MODELS; Chatfield BS, 2010, J BIOGEOGR, V37, P593, DOI 10.1111/j.1365-2699.2009.02246.x; Cobb J, 1981, MARINE FRESHWATER RE, V32, P399; de Lestang S, 2010, W COAST ROCK LOBSTER, P39; De'ath G, 2000, ECOLOGY, V81, P3178, DOI 10.2307/177409; Dunnington MJ, 2005, NEW ZEAL J MAR FRESH, V39, P1253, DOI 10.1080/00288330.2005.9517391; Galparsoro I, 2009, ECOL MODEL, V220, P556, DOI 10.1016/j.ecolmodel.2008.11.003; Geraldi NR, 2009, CAN J FISH AQUAT SCI, V66, P460, DOI 10.1139/F09-011; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Halpern BS, 2010, P NATL ACAD SCI USA, V107, P18312, DOI 10.1073/pnas.0908503107; Harper SJM, 2010, OCEAN COAST MANAGE, V53, P615, DOI 10.1016/j.ocecoaman.2010.07.001; Holmes KW, 2008, CONT SHELF RES, V28, P1800, DOI 10.1016/j.csr.2008.04.016; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Laidig TE, 2009, ESTUAR COAST SHELF S, V83, P629, DOI 10.1016/j.ecss.2009.05.008; Lawton Peter, 1995, P47, DOI 10.1016/B978-012247570-2/50026-8; Legendre P, 2002, ECOGRAPHY, V25, P601, DOI 10.1034/j.1600-0587.2002.250508.x; LEGENDRE P, 1993, ECOLOGY, V74, P1659, DOI 10.2307/1939924; Levin PS, 2009, PLOS BIOL, V7, P23, DOI 10.1371/journal.pbio.1000014; Lotze HK, 2006, SCIENCE, V312, P1806, DOI 10.1126/science.1128035; Mai TT, 2007, MAR FRESHWATER RES, V58, P419, DOI 10.1071/MF06141; Marasco RJ, 2007, CAN J FISH AQUAT SCI, V64, P928, DOI 10.1139/F07-062; Maravelias CD, 2000, MAR ECOL PROG SER, V195, P249, DOI 10.3354/meps195249; MELVILLESMITH R, 1998, FISHERY INDEPENDENT; Moore CH, 2009, ICES J MAR SCI, V66, P2068, DOI 10.1093/icesjms/fsp205; O'Donnell KP, 2007, MAR ECOL PROG SER, V348, P249, DOI 10.3354/meps07009; Pandolfi JM, 2003, SCIENCE, V301, P955, DOI 10.1126/science.1085706; Parnell P. Ed, 2007, Bulletin Southern California Academy of Sciences, V106, P27, DOI 10.3160/0038-3872(2007)106[27:SATPOL]2.0.CO;2; Phillips BF, 2005, B MAR SCI, V76, P485; Pittman SJ, 2007, ECOL MODEL, V204, P9, DOI 10.1016/j.ecolmodel.2006.12.017; POLOVINA JJ, 1995, CRUSTACEANA, V68, P203, DOI 10.1163/156854095X00106; Rios-Lara V, 2007, FISH RES, V87, P35, DOI 10.1016/j.fishres.2007.06.021; Sala E, 2006, ANNU REV ENV RESOUR, V31, P93, DOI 10.1146/annurev.energy.31.020105.100235; Selgrath JC, 2007, J EXP MAR BIOL ECOL, V353, P253, DOI 10.1016/j.jembe.2007.09.012; Smith ADM, 2007, ICES J MAR SCI, V64, P633, DOI 10.1093/icesjms/fsm041; Tremblay MJ, 2009, ICES J MAR SCI, V66, P2060, DOI 10.1093/icesjms/fsp178; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294; Wynne SP, 2007, J APPL ECOL, V44, P488, DOI 10.1111/j.1365-2664.2007.01312.x; [No title captured]	44	15	16	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2012	7	4							e34476	10.1371/journal.pone.0034476	http://dx.doi.org/10.1371/journal.pone.0034476			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959FE	22506021	gold, Green Published, Green Submitted			2022-12-27	WOS:000305297500029
J	Fieder, M; Huber, S				Fieder, Martin; Huber, Susanne			The Association between Pro-Social Attitude and Reproductive Success Differs between Men and Women	PLOS ONE			English	Article							STRONG RECIPROCITY; RURAL GAMBIA; FERTILITY; HUMANS; COOPERATION; REPUTATION; EVOLUTION; WORK; LIFE; KIN	The evolution of pro-social attitude and cooperation in humans is under debate. Most of the knowledge on human cooperation results from laboratory experiments and theoretic modeling. Evolutionary explanations, however, rest upon fitness consequences. We therefore examined fitness correlates of pro-social behavior in a real life setting, analyzing data from the Wisconsin Longitudinal Study (n = 2545 men, 2967 women). We investigated whether pro-social attitude, proxied by self reported voluntary work, is associated with lifetime reproductive success. We find a sex difference in the association between pro-social attitude and offspring number. In men, a pro-social attitude was associated with higher offspring number, whereas in women, it was associated with lower offspring count. To our knowledge, this is the first study to demonstrate fitness consequences of pro-social behavior towards strangers. We conclude that analysing real life settings may help to explain the evolutionary forces leading to pro-social behavior in humans and speculate that these factors might differ between the sexes.	[Fieder, Martin; Huber, Susanne] Univ Vienna, Dept Anthropol, Vienna, Austria; [Huber, Susanne] Univ Vet Med Vienna, Res Inst Wildlife Ecol, Vienna, Austria	University of Vienna; University of Veterinary Medicine Vienna	Fieder, M (corresponding author), Univ Vienna, Dept Anthropol, Vienna, Austria.	martin.fieder@univie.ac.at			National Institute on Aging [AG-9775 AG-21079, AG-033285]; Vilas Estate Trust; National Science Foundation; Spencer Foundation; Graduate School of the University of Wisconsin-Madison; NATIONAL INSTITUTE ON AGING [R01AG009775, R01AG033285, P01AG021079] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Vilas Estate Trust; National Science Foundation(National Science Foundation (NSF)); Spencer Foundation; Graduate School of the University of Wisconsin-Madison; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Since 1991, the WLS has been supported principally by the National Institute on Aging (AG-9775 AG-21079 and AG-033285), with additional support from the Vilas Estate Trust, the National Science Foundation, the Spencer Foundation, and the Graduate School of the University of Wisconsin-Madison. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bereczkei T, 1998, EVOL HUM BEHAV, V19, P283, DOI 10.1016/S1090-5138(98)00027-0; Bereczkei T, 2007, EVOL HUM BEHAV, V28, P277, DOI 10.1016/j.evolhumbehav.2007.04.002; Bereczkei T, 2010, EVOL HUM BEHAV, V31, P95, DOI 10.1016/j.evolhumbehav.2009.07.004; Bernhard H, 2006, NATURE, V442, P912, DOI 10.1038/nature04981; Bowles S, 2004, THEOR POPUL BIOL, V65, P17, DOI 10.1016/j.tpb.2003.07.001; Crawley MJ, R BOOK JOHN; Day KM, 1997, APPL ECON, V29, P707, DOI 10.1080/000368497326642; Draper P, 2000, HUM NATURE-INT BIOS, V11, P117, DOI 10.1007/s12110-000-1016-0; Fehr E, 2002, HUM NATURE-INT BIOS, V13, P1, DOI 10.1007/s12110-002-1012-7; Fieder M, 2005, ETHOLOGY, V111, P940, DOI 10.1111/j.1439-0310.2005.01129.x; Fieder M, 2011, HUM NAT IN PRESS; Fieder M, 2007, EVOL HUM BEHAV, V28, P392, DOI 10.1016/j.evolhumbehav.2007.05.004; Gurven M, 2000, EVOL HUM BEHAV, V21, P263, DOI 10.1016/S1090-5138(00)00032-5; Gurven M, 2004, BEHAV BRAIN SCI, V27, P543, DOI 10.1017/S0140525X04000123; Hawkes K, 2002, EVOL ANTHROPOL, V11, P58, DOI 10.1002/evan.20005; Hopcroft RL, 2006, EVOL HUM BEHAV, V27, P104, DOI 10.1016/j.evolhumbehav.2005.07.004; Milinski M, 2002, P ROY SOC B-BIOL SCI, V269, P881, DOI 10.1098/rspb.2002.1964; Nettle D, 2008, AM NAT, V172, P658, DOI 10.1086/591690; O'Hara RB, 2010, METHODS ECOL EVOL, V1, P118, DOI 10.1111/j.2041-210X.2010.00021.x; Sear R, 2003, EVOL HUM BEHAV, V24, P25, DOI 10.1016/S1090-5138(02)00105-8; Sear R, 2002, DEMOGRAPHY, V39, P43, DOI 10.1353/dem.2002.0010; Sosis R, 2000, EVOL HUM BEHAV, V21, P223, DOI 10.1016/S1090-5138(00)00030-1; West SA, 2011, EVOL HUM BEHAV, V32, P231, DOI 10.1016/j.evolhumbehav.2010.08.001	23	3	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2012	7	4							e33489	10.1371/journal.pone.0033489	http://dx.doi.org/10.1371/journal.pone.0033489			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	955JO	22496750	Green Published, gold			2022-12-27	WOS:000305014500011
J	Oster, M; Murani, E; Metges, CC; Ponsuksili, S; Wimmers, K				Oster, Michael; Murani, Eduard; Metges, Cornelia C.; Ponsuksili, Siriluck; Wimmers, Klaus			A Gestational High Protein Diet Affects the Abundance of Muscle Transcripts Related to Cell Cycle Regulation throughout Development in Porcine Progeny	PLOS ONE			English	Article							FOLIC-ACID SUPPLEMENTATION; POLO-LIKE KINASES; SKELETAL-MUSCLE; GENE-EXPRESSION; GLUCOCORTICOID-RECEPTOR; GROWTH; RESTRICTION; FETAL; ALTERS; PERFORMANCE	Background: In various animal models pregnancy diets have been shown to affect offspring phenotype. Indeed, the underlying programming of development is associated with modulations in birth weight, body composition, and continual diet-dependent modifications of offspring metabolism until adulthood, producing the hypothesis that the offspring's transcriptome is permanently altered depending on maternal diet. Methodology/Principal Findings: To assess alterations of the offspring's transcriptome due to gestational protein supply, German Landrace sows were fed isoenergetic diets containing protein levels of either 30% (high protein - HP) or 12% (adequate protein - AP) throughout their pregnancy. Offspring muscle tissue (M. longissimus dorsi) was collected at 94 days post conception (dpc), and 1, 28, and 188 days post natum (dpn) for use with Affymetrix GeneChip Porcine Genome Arrays and subsequent statistical and Ingenuity pathway analyses. Numerous transcripts were found to have altered abundance at 94 dpc and 1 dpn; at 28 dpn no transcripts were altered, and at 188 dpn only a few transcripts showed a different abundance between diet groups. However, when assessing transcriptional changes across developmental time points, marked differences were obvious among the dietary groups. Depending on the gestational dietary exposure, short- and long-term effects were observed for mRNA expression of genes related to cell cycle regulation, energy metabolism, growth factor signaling pathways, and nucleic acid metabolism. In particular, the abundance of transcripts related to cell cycle remained divergent among the groups during development. Conclusion: Expression analysis indicates that maternal protein supply induced programming of the offspring's genome; early postnatal compensation of the slight growth retardation obvious at birth in HP piglets resulted, as did a permanently different developmental alteration and responsiveness to the common environment of the transcriptome. The transcriptome modulations are interpreted as the molecular equivalent of developmental plasticity of the offspring that necessitates adaptation and maintenance of the organismal phenotype.	[Oster, Michael; Murani, Eduard; Wimmers, Klaus] Leibniz Inst Farm Anim Biol FBN, Res Unit Mol Biol, Dummerstorf, Germany; [Metges, Cornelia C.] Leibniz Inst Farm Anim Biol FBN, Res Unit Nutr Physiol, Dummerstorf, Germany; [Ponsuksili, Siriluck] Leibniz Inst Farm Anim Biol FBN, Res Grp Funct Genom, Dummerstorf, Germany	Forschungsinstitut fur Nutztierbiologie (FBN); Forschungsinstitut fur Nutztierbiologie (FBN); Forschungsinstitut fur Nutztierbiologie (FBN)	Oster, M (corresponding author), Leibniz Inst Farm Anim Biol FBN, Res Unit Mol Biol, Dummerstorf, Germany.	wimmers@fbn-dummerstorf.de	Wimmers, Klaus/AAF-9434-2020	Wimmers, Klaus/0000-0002-9523-6790	German Federal Ministry of Education and Research, Bonn, Germany [FKZ 0315132A]	German Federal Ministry of Education and Research, Bonn, Germany	The study was part of the project FEPROeXPRESS (FUGATO plus, FKZ 0315132A) funded by the German Federal Ministry of Education and Research, Bonn, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertram C, 2001, ENDOCRINOLOGY, V142, P2841, DOI 10.1210/en.142.7.2841; Borengasser SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024068; Ciciarello M, 2007, CELL MOL LIFE SCI, V64, P1891, DOI 10.1007/s00018-007-6568-2; Coupe B, 2009, AM J PHYSIOL-REG I, V297, pR813, DOI 10.1152/ajpregu.00201.2009; D'Andrea M, 2011, ANIM GENET, V42, P501, DOI 10.1111/j.1365-2052.2010.02164.x; Desai M, 1996, BRIT J NUTR, V76, P591, DOI 10.1079/BJN19960065; Gallou-Kabani C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014398; Glover DM, 1998, GENE DEV, V12, P3777, DOI 10.1101/gad.12.24.3777; Gondret F, 2005, LIVEST PROD SCI, V93, P137, DOI 10.1016/j.livprodsci.2004.09.009; Jorgensen P, 2004, CURR BIOL, V14, pR1014, DOI 10.1016/j.cub.2004.11.027; Karunaratne J. F., 2006, Archiv fur Tierzucht, V49, P19; Karunaratne JF, 2005, J ANAT, V207, P763, DOI 10.1111/j.1469-7580.2005.00494.x; Li MZ, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0015168, 10.1371/journal.pone.0011541]; Lillycrop KA, 2005, J NUTR, V135, P1382, DOI 10.1093/jn/135.6.1382; Lillycrop KA, 2007, BRIT J NUTR, V97, P1064, DOI 10.1017/S000711450769196X; Lillycrop KA, 2010, BRIT J NUTR, V103, P1711, DOI 10.1017/S0007114509993795; MAHAN DC, 1977, J ANIM SCI, V45, P1061, DOI 10.2527/jas1977.4551061x; Maloney CA, 2005, BRIT J NUTR, V94, P12, DOI 10.1079/BJN20051447; Metges CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031390; Metzler-Zebeli B, 2012, BR J NUTR UNPUB; Micke GC, 2011, MOL CELL ENDOCRINOL, V332, P234, DOI 10.1016/j.mce.2010.10.018; Micke GC, 2011, REPRODUCTION, V141, P697, DOI 10.1530/REP-10-0332; Mortensen OH, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-S1-S38; Murani E, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-109; Naraballobh W, 2010, ARCH TIERZUCHT, V53, P230, DOI 10.5194/aab-53-230-2010; Nigg EA, 1998, CURR OPIN CELL BIOL, V10, P776, DOI 10.1016/S0955-0674(98)80121-X; Oster M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021691; Petrik J, 1999, ENDOCRINOLOGY, V140, P4861, DOI 10.1210/en.140.10.4861; Rehfeldt C, 2006, J Anim Sci, V84 Suppl, pE113; Rehfeldt C, 2012, J ANIM SCI, V90, P184, DOI 10.2527/jas.2011-4234; Rehfeldt C, 2011, J ANIM SCI, V89, P329, DOI 10.2527/jas.2010-2970; Rehfeldt C, 2011, EUR J NUTR; Ren J, 2010, J MOL MED, V88, P993, DOI 10.1007/s00109-010-0663-9; Ristow M, 2010, EXP GERONTOL, V45, P410, DOI 10.1016/j.exger.2010.03.014; Selak MA, 2003, AM J PHYSIOL-ENDOC M, V285, pE130, DOI 10.1152/ajpendo.00322.2002; Skulachev Vladimir P., 1999, Molecular Aspects of Medicine, V20, P139, DOI 10.1016/S0098-2997(99)00008-4; Sparre T, 2003, DIABETOLOGIA, V46, P1497, DOI 10.1007/s00125-003-1208-3; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Theil PK, 2011, J ANIM SCI, V89, P1805, DOI 10.2527/jas.2010-2856; Theys N, 2011, J NUTR BIOCHEM, V22, P985, DOI 10.1016/j.jnutbio.2010.08.015; Theys N, 2009, AM J PHYSIOL-REG I, V297, pR1516, DOI 10.1152/ajpregu.00280.2009; Towler MC, 2007, CIRC RES, V100, P328, DOI 10.1161/01.RES.0000256090.42690.05; Tzur A, 2009, SCIENCE, V325, P167, DOI 10.1126/science.1174294; Wallace DC, 2010, MITOCHONDRION, V10, P12, DOI 10.1016/j.mito.2009.09.006; Watkins AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028745; Wu G, 2006, J ANIM SCI, V84, P2316, DOI 10.2527/jas.2006-156; Zhu MJ, 2004, BIOL REPROD, V71, P1968, DOI 10.1095/biolreprod.104.034561	47	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2012	7	4							e34519	10.1371/journal.pone.0034519	http://dx.doi.org/10.1371/journal.pone.0034519			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JO	22496824	gold, Green Submitted, Green Published			2022-12-27	WOS:000305014500024
J	Bosiger, YJ; Lonnstedt, OM; McCormick, MI; Ferrari, MCO				Bosiger, Yoland J.; Lonnstedt, Oona M.; McCormick, Mark I.; Ferrari, Maud C. O.			Learning Temporal Patterns of Risk in a Predator-Diverse Environment	PLOS ONE			English	Article							CHEMICAL ALARM CUES; PREY INTERACTIONS; BEHAVIOR; MORTALITY; THREAT; RECOGNITION; AVOIDANCE; INTENSITY; ABUNDANCE; DYNAMICS	Predation plays a major role in shaping prey behaviour. Temporal patterns of predation risk have been shown to drive daily activity and foraging patterns in prey. Yet the ability to respond to temporal patterns of predation risk in environments inhabited by highly diverse predator communities, such as rainforests and coral reefs, has received surprisingly little attention. In this study, we investigated whether juvenile marine fish, Pomacentrus moluccensis (lemon damselfish), have the ability to learn to adjust the intensity of their antipredator response to match the daily temporal patterns of predation risk they experience. Groups of lemon damselfish were exposed to one of two predictable temporal risk patterns for six days. "Morning risk" treatment prey were exposed to the odour of Cephalopholis cyanostigma (rockcod) paired with conspecific chemical alarm cues (simulating a rockcod present and feeding) during the morning, and rockcod odour only in the evening (simulating a rockcod present but not feeding). "Evening risk" treatment prey had the two stimuli presented to them in the opposite order. When tested individually for their response to rockcod odour alone, lemon damselfish from the morning risk treatment responded with a greater antipredator response intensity in the morning than in the evening. In contrast, those lemon damselfish previously exposed to the evening risk treatment subsequently responded with a greater antipredator response when tested in the evening. The results of this experiment demonstrate that P. moluccensis have the ability to learn temporal patterns of predation risk and can adjust their foraging patterns to match the threat posed by predators at a given time of day. Our results provide the first experimental demonstration of a mechanism by which prey in a complex, multi-predator environment can learn and respond to daily patterns of predation risk.	[Bosiger, Yoland J.; Lonnstedt, Oona M.; McCormick, Mark I.] James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia; [Bosiger, Yoland J.; Lonnstedt, Oona M.; McCormick, Mark I.] James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia; [Ferrari, Maud C. O.] Univ Saskatchewan, WCVM, Dept Biomed Sci, Saskatoon, SK, Canada	James Cook University; James Cook University; University of Saskatchewan	Bosiger, YJ (corresponding author), James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia.	yoland.bosiger@my.jcu.edu.au	McCormick, Mark I/J-8301-2014	McCormick, Mark I/0000-0001-9289-1645	ARC Centre of Excellence for Coral Reef Studies [DP0985015]	ARC Centre of Excellence for Coral Reef Studies(Australian Research Council)	The work was supported by ARC Centre of Excellence for Coral Reef Studies Grant number: DP0985015. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almany GR, 2006, CORAL REEFS, V25, P19, DOI 10.1007/s00338-005-0044-y; Beukers JS, 1998, OECOLOGIA, V114, P50, DOI 10.1007/s004420050419; Beukers-Stewart BD, 2004, J EXP MAR BIOL ECOL, V299, P155, DOI 10.1016/j.jembe.2003.08.015; Brown GE, 2003, FISH FISH, V4, P227, DOI 10.1046/j.1467-2979.2003.00132.x; Chivers DP, 1998, ECOSCIENCE, V5, P338, DOI 10.1080/11956860.1998.11682471; CLARKE JA, 1983, BEHAV ECOL SOCIOBIOL, V13, P205, DOI 10.1007/BF00299924; Danilowicz BS, 1999, MAR BIOL, V133, P337, DOI 10.1007/s002270050472; Doherty PJ, 2004, ECOLOGY, V85, P2422, DOI 10.1890/04-0366; DOMM SB, 1973, PAC SCI, V27, P128; FEENER DH, 1988, BEHAV ECOL SOCIOBIOL, V22, P421, DOI 10.1007/BF00294980; Ferrari MCO, 2008, BEHAV ECOL, V19, P980, DOI 10.1093/beheco/arn056; Ferrari MCO, 2008, ETHOLOGY, V114, P238, DOI 10.1111/j.1439-0310.2007.01468.x; Ferrari MCO, 2006, ANIM BEHAV, V72, P927, DOI 10.1016/j.anbehav.2006.03.001; Ferrari MCO, 2010, CAN J ZOOL, V88, P698, DOI 10.1139/Z10-029; Ferrari MCO, 2010, BIOL LETTERS, V6, P308, DOI 10.1098/rsbl.2009.0798; Ferrari MCO, 2010, BEHAV ECOL SOCIOBIOL, V64, P549, DOI 10.1007/s00265-009-0870-y; Ferrari MCO, 2009, ANIM BEHAV, V78, P11, DOI 10.1016/j.anbehav.2009.03.016; GLADFELTER WB, 1979, MAR BIOL, V50, P109, DOI 10.1007/BF00397815; Green SJ, 2011, MAR ECOL PROG SER, V433, P159, DOI 10.3354/meps09208; HELFMAN G S, 1978, Environmental Biology of Fishes, V3, P129, DOI 10.1007/BF00006313; Helfman G.S., 1993, BEHAV TELEOST FISHES, P479, DOI DOI 10.1007/978-94-011-1578-0; HELFMAN GS, 1982, ANIM BEHAV, V30, P317, DOI 10.1016/S0003-3472(82)80042-0; HELFMAN GS, 1989, BEHAV ECOL SOCIOBIOL, V24, P47, DOI 10.1007/BF00300117; Hixon M.A., 1991, P475; Hobson E. S., 1965, Copeia, V1965, P291, DOI 10.2307/1440790; Holbrook SJ, 2002, ECOLOGY, V83, P2855, DOI 10.2307/3072021; Holmes TH, 2010, BEHAV PROCESS, V83, P299, DOI 10.1016/j.beproc.2010.01.013; Holmes TH, 2010, MAR ECOL PROG SER, V399, P273, DOI 10.3354/meps08337; Kelley JL, 2003, FISH FISH, V4, P216, DOI 10.1046/j.1467-2979.2003.00126.x; Kotler BP, 2002, EVOL ECOL RES, V4, P495; Kronfeld-Schor N, 2003, ANNU REV ECOL EVOL S, V34, P153, DOI 10.1146/annurev.ecolsys.34.011802.132435; Kusch RC, 2004, BEHAV ECOL SOCIOBIOL, V55, P551, DOI 10.1007/s00265-003-0743-8; Leis Jeffrey L., 2002, P171, DOI 10.1016/B978-012615185-5/50011-6; Lima SL, 1999, AM NAT, V153, P649, DOI 10.1086/303202; Lima SL, 2002, TRENDS ECOL EVOL, V17, P70, DOI 10.1016/S0169-5347(01)02393-X; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; Lonnstedt OM, 2011, ANIM BEHAV, V82, P213, DOI 10.1016/j.anbehav.2011.04.015; Mapstone BD, 1988, THESIS U SYDNEY SYDN; MATHIS A, 1993, ANIM BEHAV, V46, P645, DOI 10.1006/anbe.1993.1241; Milinski Manfred, 1993, Fish and Fisheries Series, V7, P285; Mitchell MD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015764; MUNZ FW, 1973, VISION RES, V13, P1829, DOI 10.1016/0042-6989(73)90060-6; Randall JE, 1997, FISHES GREAT BARRER; Reebs SG, 1999, ETHOLOGY, V105, P361, DOI 10.1046/j.1439-0310.1999.00390.x; Roth TC, 2007, AM NAT, V169, P264, DOI 10.1086/510605; SHPIGEL M, 1989, ENVIRON BIOL FISH, V24, P67, DOI 10.1007/BF00001611; SIH A, 1980, SCIENCE, V210, P1041, DOI 10.1126/science.210.4473.1041; SLOBODKIN LB, 1974, Q REV BIOL, V49, P181, DOI 10.1086/408082; Smith R. Jan F., 1997, P163; Sokal RR, 2003, BIOMETRY PRINCIPLES; Stephens DW, 1991, BEHAV ECOL, V2, P77, DOI 10.1093/beheco/2.1.77; Stewart BD, 2001, MAR BIOL, V138, P383, DOI 10.1007/s002270000468; SUBOSKI MD, 1990, PSYCHOL REV, V97, P271, DOI 10.1037/0033-295X.97.2.271; WATANUKI Y, 1986, AUK, V103, P14, DOI 10.1093/auk/103.1.14	54	23	23	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2012	7	4							e34535	10.1371/journal.pone.0034535	http://dx.doi.org/10.1371/journal.pone.0034535			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	955JA	22493699	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000305012700041
J	Breheny, P; Chalise, P; Batzler, A; Wang, LW; Fridley, BL				Breheny, Patrick; Chalise, Prabhakar; Batzler, Anthony; Wang, Liewei; Fridley, Brooke L.			Genetic Association Studies of Copy-Number Variation: Should Assignment of Copy Number States Precede Testing?	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; CIRCULAR BINARY SEGMENTATION; STRUCTURAL VARIATION; FINE-SCALE; CGH DATA; DISCOVERY; PHARMACOGENOMICS; CYTOTOXICITY; POLYMORPHISM; GEMCITABINE	Recently, structural variation in the genome has been implicated in many complex diseases. Using genomewide single nucleotide polymorphism (SNP) arrays, researchers are able to investigate the impact not only of SNP variation, but also of copy-number variants (CNVs) on the phenotype. The most common analytic approach involves estimating, at the level of the individual genome, the underlying number of copies present at each location. Once this is completed, tests are performed to determine the association between copy number state and phenotype. An alternative approach is to carry out association testing first, between phenotype and raw intensities from the SNP array at the level of the individual marker, and then aggregate neighboring test results to identify CNVs associated with the phenotype. Here, we explore the strengths and weaknesses of these two approaches using both simulations and real data from a pharmacogenomic study of the chemotherapeutic agent gemcitabine. Our results indicate that pooled marker-level testing is capable of offering a dramatic increase in power (>12-fold) over CNV-level testing, particularly for small CNVs. However, CNV-level testing is superior when CNVs are large and rare; understanding these tradeoffs is an important consideration in conducting association studies of structural variation.	[Breheny, Patrick] Univ Kentucky, Dept Biostat, Lexington, KY 40506 USA; [Chalise, Prabhakar] Univ Kansas, Med Ctr, Dept Biostat, Kansas City, KS 66103 USA; [Batzler, Anthony; Fridley, Brooke L.] Mayo Clin, Dept Hlth Sci Res, Rochester, MN USA; [Wang, Liewei] Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, Rochester, MN USA	University of Kentucky; University of Kansas; University of Kansas Medical Center; Mayo Clinic; Mayo Clinic	Breheny, P (corresponding author), Univ Kentucky, Dept Biostat, Lexington, KY 40506 USA.	patrick.breheny@uky.edu	Fridley, Brooke L/D-8315-2015	Fridley, Brooke L/0000-0001-7739-7956; Breheny, Patrick/0000-0002-0650-1119	National Institutes of Health [GM86689, CA140879, CA130828, CA138461, GM61388]; Minnesota Partnership for Biotechnology and Medical Genomics grant; Mayo Foundation; NATIONAL CANCER INSTITUTE [R21CA140879, K22CA130828, R01CA138461] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R21GM086689, U19GM061388, U01GM061388] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Minnesota Partnership for Biotechnology and Medical Genomics grant; Mayo Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by the National Institutes of Health (GM86689, CA140879, CA130828, CA138461, GM61388), Minnesota Partnership for Biotechnology and Medical Genomics grant, and the Mayo Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre AJ, 2004, P NATL ACAD SCI USA, V101, P9067, DOI 10.1073/pnas.0402932101; Baladandayuthapani V, 2010, J AM STAT ASSOC, V105, P1358, DOI 10.1198/jasa.2010.ap09250; Barnes C, 2008, NAT GENET, V40, P1245, DOI 10.1038/ng.206; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; CLEVELAND WS, 1979, J AM STAT ASSOC, V74, P829, DOI 10.2307/2286407; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; Davidian M., 1995, NONLINEAR MODELS REP; de Smith AJ, 2007, HUM MOL GENET, V16, P2783, DOI 10.1093/hmg/ddm208; Diskin SJ, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn556; Efron B, 2011, BIOMETRIKA, V98, P251, DOI 10.1093/biomet/asr018; Fellermann K, 2006, AM J HUM GENET, V79, P439, DOI 10.1086/505915; Fridlyand J, 2004, J MULTIVARIATE ANAL, V90, P132, DOI 10.1016/j.jmva.2004.02.008; Hollox EJ, 2008, NAT GENET, V40, P23, DOI 10.1038/ng.2007.48; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Ju YS, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq730; Kalari KR, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-357; Kidd JM, 2008, NATURE, V453, P56, DOI 10.1038/nature06862; Lai WR, 2005, BIOINFORMATICS, V21, P3763, DOI 10.1093/bioinformatics/bti611; LEHMANN E. L., 2005, TESTING STAT HYPOTHE; Li L, 2008, CANCER RES, V68, P7050, DOI 10.1158/0008-5472.CAN-08-0405; Li L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007765; Marenne G, 2011, HUM MUTAT, V32, P240, DOI 10.1002/humu.21398; Marioni JC, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r228; Matsuzaki H, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r125; McCarroll SA, 2006, NAT GENET, V38, P86, DOI 10.1038/ng1696; McKernan KJ, 2009, GENOME RES, V19, P1527, DOI 10.1101/gr.091868.109; Mills RE, 2006, GENOME RES, V16, P1182, DOI 10.1101/gr.4565806; Moreno De Luca D, 2011, AM J HUM GENET, V88, P121; Nadaraya E.A., 1964, THEOR PROBAB APPL+, V9, P141, DOI [10.1137/1110024, DOI 10.1137/1109020]; Niu NF, 2010, GENOME RES, V20, P1482, DOI 10.1101/gr.107672.110; Nowak G, 2011, BIOSTATISTICS, V12, P776, DOI 10.1093/biostatistics/kxr012; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Pang AW, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-r52; Peiffer DA, 2006, GENOME RES, V16, P1136, DOI 10.1101/gr.5402306; Perry GH, 2008, AM J HUM GENET, V82, P685, DOI 10.1016/j.ajhg.2007.12.010; Pinto D, 2007, HUM MOL GENET, V16, pR168, DOI 10.1093/hmg/ddm241; Pinto D, 2011, NAT BIOTECHNOL, V29, P512, DOI 10.1038/nbt.1852; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Shaikh TH, 2009, GENOME RES, V19, P1682, DOI 10.1101/gr.083501.108; Steemers FJ, 2006, NAT METHODS, V3, P31, DOI 10.1038/NMETH842; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Tibshirani R, 2005, J R STAT SOC B, V67, P91, DOI 10.1111/j.1467-9868.2005.00490.x; Tibshirani R, 2008, BIOSTATISTICS, V9, P18, DOI 10.1093/biostatistics/kxm013; Tuzun E, 2005, NAT GENET, V37, P727, DOI 10.1038/ng1562; Venkatraman ES, 2007, BIOINFORMATICS, V23, P657, DOI 10.1093/bioinformatics/btl646; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174; Wang K, 2007, AM J HUM GENET, V81, P1278, DOI 10.1086/522374; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Watson G.S, 1964, SANKHYA A, P359, DOI DOI 10.2307/25049340; Willenbrock H, 2005, BIOINFORMATICS, V21, P4084, DOI 10.1093/bioinformatics/bti677; Wong KK, 2007, AM J HUM GENET, V80, P91, DOI 10.1086/510560; Yang HC, 2008, GENETICS, V179, P1057, DOI 10.1534/genetics.107.084616; Zaykin DV, 2002, GENET EPIDEMIOL, V22, P170, DOI 10.1002/gepi.0042	57	6	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2012	7	4							e34262	10.1371/journal.pone.0034262	http://dx.doi.org/10.1371/journal.pone.0034262			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JA	22493684	Green Published, gold, Green Submitted			2022-12-27	WOS:000305012700026
J	Danko, MJ; Kozlowski, J; Vaupel, JW; Baudisch, A				Danko, Maciej Jan; Kozlowski, Jan; Vaupel, James Walton; Baudisch, Annette			Mutation Accumulation May Be a Minor Force in Shaping Life History Traits	PLOS ONE			English	Article							OPTIMAL ALLOCATION; GENE-EXPRESSION; AGE; EVOLUTION; GROWTH; SENESCENCE; MORTALITY; OPTIMIZATION; REPRODUCTION; PATTERNS	Is senescence the adaptive result of tradeoffs between younger and older ages or the nonadaptive burden of deleterious mutations that act at older ages? To shed new light on this unresolved question we combine adaptive and nonadaptive processes in a single model. Our model uses Penna's bit-strings to capture different age-specific mutational patterns. Each pattern represents a genotype and for each genotype we find the life history strategy that maximizes fitness. Genotypes compete with each other and are subject to selection and to new mutations over generations until equilibrium in gene-frequencies is reached. The mutation-selection equilibrium provides information about mutational load and the differential effects of mutations on a life history trait - the optimal age at maturity. We find that mutations accumulate only at ages with negligible impact on fitness and that mutation accumulation has very little effect on the optimal age at maturity. These results suggest that life histories are largely determined by adaptive processes. The non-adaptive process of mutation accumulation seems to be unimportant at evolutionarily relevant ages.	[Danko, Maciej Jan; Vaupel, James Walton; Baudisch, Annette] Max Planck Inst Demog Res, Rostock, Germany; [Kozlowski, Jan] Jagiellonian Univ, Inst Environm Sci, Krakow, Poland	Max Planck Society; Jagiellonian University	Danko, MJ (corresponding author), Max Planck Inst Demog Res, Rostock, Germany.	danko@demogr.mpg.de	Dańko, Maciej J./W-3099-2019; Baudisch, Annette/ABA-2290-2020; Kozlowski, Jan/K-5549-2012	Dańko, Maciej J./0000-0002-7924-9022; Kozlowski, Jan/0000-0002-7084-2030; Baudisch, Annette/0000-0002-4202-089X; Vaupel, James/0000-0003-0783-3905	Max Planck Institute for Demographic Research; Jagiellonian University [DS/WBiNoZ/INoS 757/08]	Max Planck Institute for Demographic Research; Jagiellonian University	MJD, AB and JWV are funded by Max Planck Institute for Demographic Research and JK is funded by Jagiellonian University (DS/WBiNoZ/INoS 757/08). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baudisch A, 2005, P NATL ACAD SCI USA, V102, P8263, DOI 10.1073/pnas.0502155102; Baudisch A, 2011, METHODS ECOLOGY EVOL, V2; Brown JH, 2006, P NATL ACAD SCI USA, V103, P17595, DOI 10.1073/pnas.0608522103; CHARLESWORTH B, 1990, EVOLUTION, V44, P520, DOI 10.1111/j.1558-5646.1990.tb05936.x; Charlesworth B, 1996, P NATL ACAD SCI USA, V93, P6140, DOI 10.1073/pnas.93.12.6140; Charlesworth B, 2001, J THEOR BIOL, V210, P47, DOI 10.1006/jtbi.2001.2296; Charnov EL, 2004, EVOL ECOL RES, V6, P307; CHARNOV EL, 1991, P NATL ACAD SCI USA, V88, P1134, DOI 10.1073/pnas.88.4.1134; Charnov EL, 2001, P NATL ACAD SCI USA, V98, P9460, DOI 10.1073/pnas.161294498; Charnov Eric L., 1993, P1; Cichon M, 2000, EVOL ECOL RES, V2, P857; Cichon M, 1999, ACTA OECOL, V20, P25, DOI 10.1016/S1146-609X(99)80012-5; Cooper VS, 2000, NATURE, V407, P736, DOI 10.1038/35037572; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; de Magalhaes JP, 2009, BIOINFORMATICS, V25, P875, DOI 10.1093/bioinformatics/btp073; Drake JW, 1999, ANN NY ACAD SCI, V870, P100, DOI 10.1111/j.1749-6632.1999.tb08870.x; Drake JW, 1998, GENETICS, V148, P1667; Flatt T, 2007, SCIENCE, V318, P1255, DOI 10.1126/science.1147491; Gibbs RA, 2004, NATURE, V428, P493, DOI 10.1038/nature02426; Golden TR, 2004, AGING CELL, V3, P111, DOI 10.1111/j.1474-9728.2004.00095.x; Gong Y, 2006, J GERONTOL A-BIOL, V61, P1246, DOI 10.1093/gerona/61.12.1246; GUSTAFSSON L, 1990, NATURE, V347, P279, DOI 10.1038/347279a0; HAMILTON WD, 1966, J THEOR BIOL, V12, P12, DOI 10.1016/0022-5193(66)90184-6; KAWECKI TJ, 1993, EVOL ECOL, V7, P155, DOI 10.1007/BF01239386; KIRKWOOD TBL, 1977, NATURE, V270, P301, DOI 10.1038/270301a0; KOZLOWSKI J, 1992, TRENDS ECOL EVOL, V7, P15, DOI 10.1016/0169-5347(92)90192-E; Kozlowski J, 2004, INTEGR COMP BIOL, V44, P480, DOI 10.1093/icb/44.6.480; KOZLOWSKI J, 1993, TRENDS ECOL EVOL, V8, P84, DOI 10.1016/0169-5347(93)90056-U; Kozlowski J, 1999, EVOL ECOL RES, V1, P423; KOZLOWSKI J, 1986, THEOR POPUL BIOL, V29, P16, DOI 10.1016/0040-5809(86)90003-1; Kozlowski J, 2006, POL J ECOL, V54, P585; McCarroll SA, 2004, NAT GENET, V36, P197, DOI 10.1038/ng1291; Medawar P., 1952, UNSOLVED PROBLEM BIO; Moorad JA, 2008, GENETICS, V179, P2061, DOI 10.1534/genetics.108.088526; Moorad JA, 2009, P ROY SOC B-BIOL SCI, V276, P2271, DOI 10.1098/rspb.2009.0183; Nekrutenko A, 2004, MOL BIOL EVOL, V21, P1278, DOI 10.1093/molbev/msh125; Nussey DH, 2008, P ROY SOC B-BIOL SCI, V275, P745, DOI 10.1098/rspb.2007.0986; Nussey DH, 2006, ECOL LETT, V9, P1342, DOI 10.1111/j.1461-0248.2006.00989.x; PARTRIDGE L, 1993, NATURE, V362, P305, DOI 10.1038/362305a0; PENNA TJP, 1995, J STAT PHYS, V78, P1629, DOI 10.1007/BF02180147; Pletcher SD, 2002, CURR BIOL, V12, P712, DOI 10.1016/S0960-9822(02)00808-4; Pletcher SD, 1998, GENETICS, V148, P287; Reid JM, 2003, J ANIM ECOL, V72, P765, DOI 10.1046/j.1365-2656.2003.00750.x; ROSE M, 1980, NATURE, V287, P141, DOI 10.1038/287141a0; Rose M.R., 1991, EVOLUTIONARY BIOL AG; Snoke MS, 2003, HEREDITY, V91, P546, DOI 10.1038/sj.hdy.6800353; Spencer CC, 2005, J HERED, V96, P513, DOI 10.1093/jhered/esi071; Stauffer D, 2007, ARXIV07063101V1; Stearns S.C., 1992, pi; Wachter KW, 2008, ARXIV08070483; WILLIAMS GC, 1957, EVOLUTION, V11, P398, DOI 10.1111/j.1558-5646.1957.tb02911.x; Yampolsky LY, 2000, GENETICA, V110, P11, DOI 10.1023/A:1017582625191; ZIOLKO M, 1983, MATH BIOSCI, V64, P127, DOI 10.1016/0025-5564(83)90032-9	54	14	14	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2012	7	4							e34146	10.1371/journal.pone.0034146	http://dx.doi.org/10.1371/journal.pone.0034146			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JA	22493680	Green Published, Green Submitted, gold			2022-12-27	WOS:000305012700022
J	Nicol, AF; Silva, JRLE; Cunha, CB; Amaro, SM; Oliveira, N; Grinsztejn, B; Khalil, R; Russomano, F; Pires, A; Golub, JE; Nuovo, GJ				Nicol, Alcina F.; Lapa e Silva, Jose R.; Cunha, Cynthia B.; Amaro-Filho, Sergio M.; Oliveira, Nathalia; Grinsztejn, Beatriz; Khalil, Ruth; Russomano, Fabio; Pires, Andrea; Golub, Jonathan E.; Nuovo, Gerard J.			Evaluation of MCM-2 Expression in TMA Cervical Specimens	PLOS ONE			English	Article							MINICHROMOSOME MAINTENANCE PROTEINS; HIV-POSITIVE MEN; INTRAEPITHELIAL NEOPLASIA; UTERINE CERVIX; HIV/HPV COINFECTION; CELL-CYCLE; BIOMARKERS; DYSPLASIA; MARKERS	Background: Minichromosome maintenance proteins (MCM) are highly expressed in actively replicating cells. The need for biological markers for cervical carcinoma and its precursor lesions is emerging. Our main aim was to determine the immunohistochemical expression of MCM-2 in HIV-positive and -negative dysplastic cervical specimens. Methods: Immunohistochemical analysis of MCM-2 was performed in a total of 352 cervical TMA specimens of normal control, low-grade CIN, high-grade CIN and invasive tumor. 38 specimens were from HIV-positive women. A receiver operating characteristic (ROC) curve was constructed to determine the best cutoff to diagnose high-grade CIN and invasive cervical cancer. Results: In the progression from normal epithelium to high-grade CIN and invasive tumor we found significant differences in the MCM-2 expression (p<0.05). Based on the ROC curve of 80% with an area under the curve (AUC) of 0.78, expression of MCM-2 to diagnose high-grade CIN and invasive tumor resulted in sensitivity of 81%, specificity of 66%, a positive predictive value (PPV) of 86% and a negative predictive value (NPV) of 57%. HIV-positive cervices revealed a decreasing expression of MCM-2 in both LGCIN and HGCIN compared with HIV-negative specimens (p<0.0001). Conclusions: The present study suggests that immunohistochemical MCM-2 may not be a promising biomarker for diagnosing high-grade CIN and invasive cancer.	[Nicol, Alcina F.; Amaro-Filho, Sergio M.; Oliveira, Nathalia] Inst Oswaldo Cruz, Lab Interdisciplinary Med Res, BR-20001 Rio De Janeiro, Brazil; [Lapa e Silva, Jose R.] Univ Fed Rio de Janeiro, Clementino Fraga Filho Univ Hosp, Lab Multidisciplinar, Rio De Janeiro, Brazil; [Cunha, Cynthia B.; Grinsztejn, Beatriz; Khalil, Ruth] Fundacao Oswaldo Cruz, Evandro Chagas Clin Res Inst, Dept Infect Dis, Rio De Janeiro, Brazil; [Russomano, Fabio] Fundacao Oswaldo Cruz, Fernandes Figueira Inst, Dept Cerv Pathol, Rio De Janeiro, Brazil; [Pires, Andrea] Fonte Med Diagnost Lab, Niteroi, RJ, Brazil; [Pires, Andrea] Univ Fed Fluminense, Niteroi, RJ, Brazil; [Golub, Jonathan E.] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Golub, Jonathan E.] Johns Hopkins Sch Med, Baltimore, MD USA; [Nuovo, Gerard J.] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA	Fundacao Oswaldo Cruz; Universidade Federal do Rio de Janeiro; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Universidade Federal Fluminense; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Medicine; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University	Nicol, AF (corresponding author), Inst Oswaldo Cruz, Lab Interdisciplinary Med Res, BR-20001 Rio De Janeiro, Brazil.	nicol@ioc.fiocruz.br	Oliveira, Nathália/M-8830-2019; Lapa e Silva, Jose R./AAS-4793-2020	Oliveira, Nathália/0000-0003-3733-0022; Lapa e Silva, Jose R./0000-0003-3116-0253; Amaro-Filho, Sergio/0000-0002-7374-4081	Fogarty International Center, National Institutes of Health [2 D 43 TW000010-23-AITRP]; Laboratory of Interdisciplinary Medical Research, Instituto Oswaldo Cruz, Brazil; Lewis Foundation (Dr. Gerard J Nuovo Laboratory); FOGARTY INTERNATIONAL CENTER [D43TW000010] Funding Source: NIH RePORTER	Fogarty International Center, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Laboratory of Interdisciplinary Medical Research, Instituto Oswaldo Cruz, Brazil; Lewis Foundation (Dr. Gerard J Nuovo Laboratory); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	AFN and SAF were scholars in the International AIDS Research and Training Program, supported by the Fogarty International Center, National Institutes of Health Research Grant 2 D 43 TW000010-23-AITRP. NO was a scholar in the Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro. This work was supported in part by grants from the Laboratory of Interdisciplinary Medical Research, Instituto Oswaldo Cruz, Brazil, and the Lewis Foundation (from the Dr. Gerard J Nuovo Laboratory). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benevolo M, 2010, HISTOPATHOLOGY, V57, P580, DOI 10.1111/j.1365-2559.2010.03674.x; Pires ARC, 2006, DIAGN PATHOL, V1, DOI 10.1186/1746-1596-1-14; Eng J, 2005, ACAD RADIOL, V12, P909, DOI 10.1016/j.acra.2005.04.005; Fan Jerome, 2006, CJEM, V8, P19; Freeman A, 1999, CLIN CANCER RES, V5, P2121; Galgano MT, 2010, AM J SURG PATHOL, V34, P1077, DOI 10.1097/PAS.0b013e3181e8b2c4; Giaginis C, 2010, HISTOL HISTOPATHOL, V25, P351, DOI 10.14670/HH-25.351; Gupta N, 2010, DIAGN CYTOPATHOL, V38, P618, DOI 10.1002/dc.21270; Kreuter A, 2008, J INVEST DERMATOL, V128, P2316, DOI 10.1038/jid.2008.72; Kreuter A, 2010, J AM ACAD DERMATOL, V63, P490, DOI 10.1016/j.jaad.2009.08.043; Mukherjee G, 2007, BRIT J CANCER, V96, P1107, DOI 10.1038/sj.bjc.6603679; Nicol AF, 2008, J CLIN PATHOL, V61, P84, DOI 10.1136/jcp.2007.047290; Nicol AF, DIAGN MOL PATHOL, V14, P39; Nicol AF, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-289; Nuovo GJ, 2010, METHODS, V52, P307, DOI 10.1016/j.ymeth.2010.08.009; Scarpini C, 2008, CANCER EPIDEM BIOMAR, V17, P2855, DOI 10.1158/1055-9965.EPI-08-0288; Tachibana KEK, 2005, J PATHOL, V205, P123, DOI 10.1002/path.1708	17	7	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2012	7	4							e32936	10.1371/journal.pone.0032936	http://dx.doi.org/10.1371/journal.pone.0032936			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JA	22493662	gold, Green Published, Green Submitted			2022-12-27	WOS:000305012700004
J	Njie, EG; Kantorovich, S; Astary, GW; Green, C; Zheng, T; Semple-Rowland, SL; Steindler, DA; Sarntinoranont, M; Streit, WJ; Borchelt, DR				Njie, EMalick G.; Kantorovich, Svetlana; Astary, Garrett W.; Green, Cameron; Zheng, Tong; Semple-Rowland, Susan L.; Steindler, Dennis A.; Sarntinoranont, Malisa; Streit, Wolfgang J.; Borchelt, David R.			A Preclinical Assessment of Neural Stem Cells as Delivery Vehicles for Anti-Amyloid Therapeutics	PLOS ONE			English	Article							ADULT HUMAN BRAIN; ALZHEIMER-DISEASE; PROGENITOR CELLS; RAT HIPPOCAMPUS; GAMMA-SECRETASE; IMPROVE MEMORY; NEURONAL LOSS; GENE-THERAPY; MOUSE MODEL; IN-VIVO	Transplantation of neural stems cells (NSCs) could be a useful means to deliver biologic therapeutics for late-stage Alzheimer's disease (AD). In this study, we conducted a small preclinical investigation of whether NSCs could be modified to express metalloproteinase 9 (MMP9), a secreted protease reported to degrade aggregated Ab peptides that are the major constituents of the senile plaques. Our findings illuminated three issues with using NSCs as delivery vehicles for this particular application. First, transplanted NSCs generally failed to migrate to amyloid plaques, instead tending to colonize white matter tracts. Second, the final destination of these cells was highly influenced by how they were delivered. We found that our injection methods led to cells largely distributing to white matter tracts, which are anisotropic conduits for fluids that facilitate rapid distribution within the CNS. Third, with regard to MMP9 as a therapeutic to remove senile plaques, we observed high concentrations of endogenous metalloproteinases around amyloid plaques in the mouse models used for these preclinical tests with no evidence that the NSC-delivered enzymes elevated these activities or had any impact. Interestingly, MMP9-expressing NSCs formed substantially larger grafts. Overall, we observed long-term survival of NSCs in the brains of mice with high amyloid burden. Therefore, we conclude that such cells may have potential in therapeutic applications in AD but improved targeting of these cells to disease-specific lesions may be required to enhance efficacy.	[Njie, EMalick G.; Kantorovich, Svetlana; Green, Cameron; Semple-Rowland, Susan L.; Streit, Wolfgang J.; Borchelt, David R.] Univ Florida, Dept Neurosci, McKnight Brain Inst, Gainesville, FL 32610 USA; [Astary, Garrett W.] Univ Florida, Dept Biomed Engn, Gainesville, FL USA; [Zheng, Tong; Steindler, Dennis A.] Univ Florida, Dept Neurosurg, Gainesville, FL USA; [Sarntinoranont, Malisa] Univ Florida, Dept Mech & Aerosp Engn, Gainesville, FL USA; [Borchelt, David R.] Univ Florida, SantaFe HealthCare Alzheimers Res Ctr, Gainesville, FL USA; [Borchelt, David R.] Univ Florida, Ctr Translat Res Neurodegenerat Dis, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Njie, EG (corresponding author), Columbia Univ, Dept Biol Sci, New York, NY 10027 USA.	borchelt@mbi.ufl.edu	Steindler, Dennis/AAJ-5811-2020	Njie, eMalick/0000-0002-7171-9237	National Institute of Aging National Research Service [T32 AG000196-16A1]; National Institutes of Health [NS047225, AG023665, NS055165, NS063360]; Johnnie B. Byrd Sr Alzheimer's Center and Research Institute; SantaFe Health Care Alzheimer's Disease Research Center; NATIONAL EYE INSTITUTE [P30EY021721] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS063360, R01NS047225] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG000196, R01AG023665] Funding Source: NIH RePORTER	National Institute of Aging National Research Service; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Johnnie B. Byrd Sr Alzheimer's Center and Research Institute; SantaFe Health Care Alzheimer's Disease Research Center; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by the National Institute of Aging National Research Service Award Training Grant [T32 AG000196-16A1 to Dr. Njie], National Institutes of Health [grant numbers NS047225 to Dr. Borchelt, AG023665 to Dr. Streit, NS055165 to Dr. Steindler, NS063360 to Dr. Sarntinoranont], a grant from the Johnnie B. Byrd Sr Alzheimer's Center and Research Institute [to Dr. Njie, Dr. Zheng, Dr. Steindler and Dr. Borchelt], and the SantaFe Health Care Alzheimer's Disease Research Center [Dr. Njie and Dr. Borchelt]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, SURG RADIOL ANAT, V30, P131, DOI 10.1007/s00276-007-0293-2; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Astary GW, 2010, J NEUROSCI METH, V187, P129, DOI 10.1016/j.jneumeth.2010.01.002; Blurton-Jones M, 2009, P NATL ACAD SCI USA, V106, P13594, DOI 10.1073/pnas.0901402106; Braak H, 1996, NEUROSCI LETT, V210, P87, DOI 10.1016/0304-3940(96)12668-9; Dolev I, 2004, P NATL ACAD SCI USA, V101, P13909, DOI 10.1073/pnas.0404458101; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Englund U, 2002, DEV BRAIN RES, V134, P123, DOI 10.1016/S0165-3806(01)00330-3; GAGE FH, 1995, P NATL ACAD SCI USA, V92, P11879, DOI 10.1073/pnas.92.25.11879; Golde TE, 2011, NEURON, V69, P203, DOI 10.1016/j.neuron.2011.01.002; Hemming ML, 2007, PLOS MED, V4, P1405, DOI 10.1371/journal.pmed.0040262; Hyman BT, 1997, J NEUROPATH EXP NEUR, V56, P1095, DOI 10.1097/00005072-199710000-00002; Imitola J, 2004, P NATL ACAD SCI USA, V101, P18117, DOI 10.1073/pnas.0408258102; Itoh T, 2009, NEUROL RES, V31, P90, DOI 10.1179/174313208X332995; Jankowsky JL, 2005, PLOS MED, V2, P1318, DOI 10.1371/journal.pmed.0020355; Jankowsky JL, 2004, HUM MOL GENET, V13, P159, DOI 10.1093/hmg/ddh019; Mazel T, 1998, NEUROREPORT, V9, P1299; Njie EG, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.05.008; Ohab JJ, 2006, J NEUROSCI, V26, P13007, DOI 10.1523/JNEUROSCI.4323-06.2006; Olstorn H, 2007, NEUROSURGERY, V60, P1089, DOI 10.1227/01.NEU.0000255461.91892.0D; Park KI, 2006, EXP NEUROL, V199, P179, DOI 10.1016/j.expneurol.2006.03.016; Pichavant Christophe, 2011, PLoS Curr, V3, pRRN1275, DOI 10.1371/currents.RRN1275; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Ryu JK, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-39; Semple-Rowland SL, 2007, MOL VIS, V13, P2001; Shagin DA, 2004, MOL BIOL EVOL, V21, P841, DOI 10.1093/molbev/msh079; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Tang J, 2008, NEUROSCI RES, V62, P86, DOI 10.1016/j.neures.2008.06.005; Tuszynski MH, 2005, NAT MED, V11, P551, DOI 10.1038/nm1239; Vorisek I, 1997, J NEUROPHYSIOL, V78, P912, DOI 10.1152/jn.1997.78.2.912; Walton NM, 2006, GLIA, V54, P815, DOI 10.1002/glia.20419; Walton NM, 2006, DEVELOPMENT, V133, P3671, DOI 10.1242/dev.02541; Wang A, 2011, J NEUROSCI, V31, P4124, DOI 10.1523/JNEUROSCI.5077-10.2011; Wong GT, 2004, J BIOL CHEM, V279, P12876, DOI 10.1074/jbc.M311652200; Yamasaki TR, 2007, J NEUROSCI, V27, P11925, DOI 10.1523/JNEUROSCI.1627-07.2007; Yan P, 2006, J BIOL CHEM, V281, P24566, DOI 10.1074/jbc.M602440200; Yin KJ, 2006, J NEUROSCI, V26, P10939, DOI 10.1523/JNEUROSCI.2085-06.2006; Yushkevich PA, 2006, NEUROIMAGE, V31, P1116, DOI 10.1016/j.neuroimage.2006.01.015; Zheng T, 2006, NEUROSCIENCE, V142, P175, DOI 10.1016/j.neuroscience.2006.05.051	39	17	18	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e34097	10.1371/journal.pone.0034097	http://dx.doi.org/10.1371/journal.pone.0034097			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GO	22496779	Green Published, gold, Green Submitted			2022-12-27	WOS:000304855200031
J	Prina, AM; Deeg, D; Brayne, C; Beekman, A; Huisman, M				Prina, A. Matthew; Deeg, Dorly; Brayne, Carol; Beekman, Aartjan; Huisman, Martijn			The Association between Depressive Symptoms and Non-Psychiatric Hospitalisation in Older Adults	PLOS ONE			English	Article							MYOCARDIAL-INFARCTION; PHYSICAL HEALTH; LATER-LIFE; CES-D; RISK; ONSET; DISABILITY; VALIDITY; OUTCOMES; DISEASE	Background: It is known that people who suffer from depression are more likely to have other physical illnesses, but the extent of the association between depression and non-psychiatric hospitalisation episodes has never been researched in great depth. We therefore aimed to investigate whether depressed middle-aged and older people were more likely to be hospitalised for causes other than mental illnesses, and whether the outcomes for this group of people were less favourable. Methods & Findings: Hospital events from 1995 to 2006 were obtained from the Dutch National Medical Register and linked to participants of the Longitudinal Aging Study Amsterdam (LASA). Linkage was accomplished in 97% of the LASA sample by matching gender, year of birth and postal code. Depression was measured at each wave point of the LASA study using the Centre for Epidemiologic Studies Depression (CES-D). Hospital outcomes including admission, length of stay, readmission and death while in hospital were recorded at 6, 12 and 24 months intervals after each LASA interview. Generalised Estimating Equation models were also used to investigate potential confounders. After 12 months, 14% of depressed people were hospitalised compared to 10% of non-depressed individuals. There was a 2-fold increase in deaths while in hospital amongst the depressed (0.8% vs 0.4%), who also had longer total length of stay (2.6 days vs 1.4 days). Chronic illnesses and functional limitations had major attenuating effects, but depression was found to be an independent risk factor for length of stay after full adjustment (OR = 1.33, 95% CI: 1.22-1.46 after 12 months). Conclusions: Depression in middle and old age is associated with non-psychiatric hospitalisation, longer length of stay and higher mortality in clinical settings. Targeting of this high-risk group could reduce the financial, medical and social burden related to hospital admission.	[Prina, A. Matthew; Brayne, Carol] Univ Cambridge, Inst Publ Hlth, Dept Publ Hlth & Primary Care, Cambridge, England; [Deeg, Dorly; Beekman, Aartjan; Huisman, Martijn] Vrije Univ Amsterdam, Med Ctr, Dept Epidemiol & Biostat, Amsterdam, Netherlands; [Deeg, Dorly; Beekman, Aartjan; Huisman, Martijn] Vrije Univ Amsterdam, Med Ctr, EMGO Inst Hlth & Care Res, Amsterdam, Netherlands; [Deeg, Dorly; Beekman, Aartjan; Huisman, Martijn] Vrije Univ Amsterdam, Med Ctr, Dept Psychiat, Amsterdam, Netherlands; [Huisman, Martijn] Vrije Univ Amsterdam, Dept Sociol, Amsterdam, Netherlands	University of Cambridge; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam	Prina, AM (corresponding author), Univ Cambridge, Inst Publ Hlth, Dept Publ Hlth & Primary Care, Cambridge, England.	amp68@medschl.cam.ac.uk	Prina, Matthew/B-4188-2013; Brayne, Carol/AAA-4285-2020; Huisman, Martijn/G-2873-2010	Prina, Matthew/0000-0001-6698-3263; Brayne, Carol/0000-0001-5307-663X; 	Ministry of Health, Welfare and Sports; National Institute for Health Research [NF-SI-0611-10084] Funding Source: researchfish	Ministry of Health, Welfare and Sports; National Institute for Health Research(National Institute for Health Research (NIHR))	The LASA study was primarily funded by the Ministry of Health, Welfare and Sports (to The Longitudinal Aging Study Amsterdam). The funders had no role in the study design, data collection, analysis, decision to publish or preparation of the manuscript. No additional external funding was received for this study.	American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Beekman A T, 1994, Tijdschr Gerontol Geriatr, V25, P95; Beekman ATF, 1997, PSYCHOL MED, V27, P231, DOI 10.1017/S0033291796003510; Beekman ATF, 1997, PSYCHOL MED, V27, P1397, DOI 10.1017/S0033291797005734; BERKMAN LF, 1986, AM J EPIDEMIOL, V124, P372, DOI 10.1093/oxfordjournals.aje.a114408; Braam AW, 2005, BRIT J PSYCHIAT, V187, P35, DOI 10.1192/bjp.187.1.35; Bromet E, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-90; (CBS) CBoS, 1993, STAT YB; Covinsky KE, 2010, J AM GERIATR SOC, V58, P551, DOI 10.1111/j.1532-5415.2010.02723.x; Deeg D., 2003, AUTONOMY WELL BEING; Department of Health, 2010, HOSP EP STAT HES; desBruin A., 2004, STAT J UN EC COMM EU, V21, P23; Eisner MD, 2005, ANN ALLERG ASTHMA IM, V94, P566, DOI 10.1016/S1081-1206(10)61135-0; FOELKER GA, 1992, J AM GERIATR SOC, V40, P259, DOI 10.1111/j.1532-5415.1992.tb02079.x; Frasure-Smith N, 2000, J PSYCHOSOM RES, V48, P471, DOI 10.1016/S0022-3999(99)00088-4; Garretsen H, PROBLEEMDRINKEN PREV; Hertzog C., 1990, PSYCHOL ASSESSMENT, V2, P64, DOI DOI 10.1037/1040-3590.2.1.64; HIMMELFARB S, 1983, J GERONTOL, V38, P333, DOI 10.1093/geronj/38.3.333; Hosaka T, 1999, PSYCHIAT CLIN NEUROS, V53, P491, DOI 10.1046/j.1440-1819.1999.00580.x; Huisman M, 2011, INT J EPIDEMIOL; Kato Naoko, 2009, J Card Fail, V15, P912, DOI 10.1016/j.cardfail.2009.06.442; Katon Wayne J, 2011, Dialogues Clin Neurosci, V13, P7; Knol MJ, 2006, DIABETOLOGIA, V49, P837, DOI 10.1007/s00125-006-0159-x; Kriegsman DMW, 1996, J CLIN EPIDEMIOL, V49, P1407, DOI 10.1016/S0895-4356(96)00274-0; Kronish IM, 2006, J GEN INTERN MED, V21, P1178, DOI 10.1111/j.1525-1497.2006.00586.x; LIANG KY, 1993, ANNU REV PUBL HEALTH, V14, P43, DOI 10.1146/annurev.pu.14.050193.000355; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Ormel J, 1999, PSYCHOL MED, V29, P847, DOI 10.1017/S0033291799008600; Paas G, 2002, RES VALIDITY LMR; Penninx BWJH, 2000, J AFFECT DISORDERS, V61, P1, DOI 10.1016/S0165-0327(00)00152-X; RADLOFF L S, 1986, Clinical Gerontologist, V5, P119; Seedat S, 2009, ARCH GEN PSYCHIAT, V66, P785, DOI 10.1001/archgenpsychiatry.2009.36; Smits CHM, 1997, J AGING HEALTH, V9, P204, DOI 10.1177/089826439700900204; Turner A, 2010, AUST NZ J PSYCHIAT, V44, P658, DOI 10.3109/00048671003646751; Twisk JWR, 1997, INT J SPORTS MED, V18, pS216, DOI 10.1055/s-2007-972718; van Sonsbeek JLA., 1988, MAANDBERICHT GEZONDH, V88, P4; Wolkowitz Owen M, 2011, Dialogues Clin Neurosci, V13, P25; Wulsin LR, 2003, PSYCHOSOM MED, V65, P201, DOI 10.1097/01.PSY.0000058371.50240.E3; Ziegelstein RC, 2000, ARCH INTERN MED, V160, P1818, DOI 10.1001/archinte.160.12.1818	39	37	39	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e34821	10.1371/journal.pone.0034821	http://dx.doi.org/10.1371/journal.pone.0034821			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	953GO	22496867	Green Published, gold			2022-12-27	WOS:000304855200083
J	Regev, L; Meningher, T; Hindiyeh, M; Mendelson, E; Mandelboim, M				Regev, Liora; Meningher, Tal; Hindiyeh, Musa; Mendelson, Ella; Mandelboim, Michal			Increase Human Metapneumovirus Mediated Morbidity following Pandemic Influenza Infection	PLOS ONE			English	Article							RESPIRATORY SYNCYTIAL VIRUS; GENETIC-VARIABILITY; TRACT INFECTIONS; CHILDREN; IMPACT	Human metapneumovirus (hMPV) is a recently discovered respiratory pathogen, infecting mainly young children. The infected patients suffer from influenza like symptoms (ILS). In Israel the virus is mainly circulating in February to March. Here we report on an increased rate of hMPV infection in the winter season of 2009-10. The 2009-10 infection had several unique characteristics when compared to previous seasons; it started around January and a large number of infants were infected by the virus. Genetic analysis based on the viral L and F genes of hMPV showed that only subtypes A2 and B2 circulated in Israel. Additionally, we have identified a novel variant of hMPV within subgroup A2b, which subdivide it into A2b1 and A2b2. Finally, we showed that the hMPV infection was detected in the country soon after the infection with the pandemic influenza virus had declined, that infection with the pandemic influenza virus was dominant and that it interfered with the infection of other respiratory viruses. Thus, we suggest that the unusual increase in hMPV infection observed in 2009-10 was due to the appearance of the pandemic influenza virus in the winter season prior to 2009-10.	[Regev, Liora; Meningher, Tal; Hindiyeh, Musa; Mendelson, Ella; Mandelboim, Michal] Chaim Sheba Med Ctr, Minist Hlth, Cent Virol Lab, Ramat Gan, Israel; [Meningher, Tal] Bar Ilan Univ, Fac Life Sci, Ramat Gan, Israel; [Mendelson, Ella] Tel Aviv Univ, Sackler Fac Med, Sch Publ Hlth, Dept Epidemiol & Prevent Med, IL-69978 Tel Aviv, Israel	Chaim Sheba Medical Center; Bar Ilan University; Tel Aviv University; Sackler Faculty of Medicine	Regev, L (corresponding author), Chaim Sheba Med Ctr, Minist Hlth, Cent Virol Lab, Ramat Gan, Israel.	michalman@sheba.health.gov.il						Aberle JH, 2010, PEDIATR INFECT DIS J, V29, P1016, DOI 10.1097/INF.0b013e3181e3331a; Agrawal AS, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-67; Arnott A, 2011, INFECT GENET EVOL; Bach N, 2004, ARCH PEDIATRIE, V11, P212, DOI 10.1016/j.arcped.2003.12.009; Bastien N, 2003, J CLIN MICROBIOL, V41, P4642, DOI 10.1128/JCM.41.10.4642-4646.2003; Biacchesi S, 2003, VIROLOGY, V315, P1, DOI 10.1016/S0042-6822(03)00528-2; Boivin G, 2003, EMERG INFECT DIS, V9, P634; Boivin G, 2002, J INFECT DIS, V186, P1330, DOI 10.1086/344319; Bosis S, 2005, J MED VIROL, V75, P101, DOI 10.1002/jmv.20243; Cane PA, 2003, BONE MARROW TRANSPL, V31, P309, DOI 10.1038/sj.bmt.1703849; Carr MJ, 2008, J MED VIROL, V80, P510, DOI 10.1002/jmv.21081; Engelhard D, 2011, EMERG INFECT DIS, V17, P1740, DOI 10.3201/eid1709.102022; Esper F, 2003, PEDIATRICS, V111, P1407, DOI 10.1542/peds.111.6.1407; Falsey AR, 2003, J INFECT DIS, V187, P785, DOI 10.1086/367901; Gaunt ER, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017427; Heim A, 2003, J MED VIROL, V70, P228, DOI 10.1002/jmv.10382; Hindiyeh M, 2010, J CLIN MICROBIOL, V48, P1884, DOI 10.1128/JCM.02540-09; Hu AZ, 2003, J CLIN MICROBIOL, V41, P149, DOI 10.1128/JCM.41.1.149-154.2003; Huck B, 2006, EMERG INFECT DIS, V12, P147, DOI 10.3201/eid1201.050772; Lazar I, 2004, EMERG INFECT DIS, V10, P1318, DOI 10.3201/eid1007.030983; Legrand L, 2011, J MED VIROL, V83, P517, DOI 10.1002/jmv.22002; Mackie P L, 2003, Paediatr Respir Rev, V4, P84, DOI 10.1016/S1526-0542(03)00031-9; Mammas IN, 2011, MOL MED REP, V4, P267, DOI 10.3892/mmr.2011.416; Matsuzaki Y, 2008, J MED VIROL, V80, P1084, DOI 10.1002/jmv.21194; O'Gorman C, 2006, EUR J CLIN MICROBIOL, V25, P190, DOI 10.1007/s10096-006-0116-0; Pabbaraju K, 2007, J CLIN VIROL, V40, P186, DOI 10.1016/j.jcv.2007.08.004; Peret TCT, 2004, J GEN VIROL, V85, P679, DOI 10.1099/vir.0.19504-0; Rafiefard F, 2008, J MED VIROL, V80, P1631, DOI 10.1002/jmv.21242; Regev L, 2006, J CLIN MICROBIOL, V44, P1484, DOI 10.1128/JCM.44.4.1484-1489.2006; Schildgen V, 2011, CLIN MICROBIOL REV, V24, P734, DOI 10.1128/CMR.00015-11; Shahda S, 2011, TRANSPL INFECT DIS, V13, P324, DOI 10.1111/j.1399-3062.2010.00575.x; Sumino KC, 2005, J INFECT DIS, V192, P1052, DOI 10.1086/432728; van den Hoogen BG, 2004, EMERG INFECT DIS, V10, P658, DOI 10.3201/eid1004.030393; Wang HC, 2008, ARCH VIROL, V153, P2207, DOI 10.1007/s00705-008-0242-3; Xiao NG, 2010, PEDIATR INFECT DIS J, V29, P131, DOI 10.1097/INF.0b013e3181b56009	35	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e34750	10.1371/journal.pone.0034750	http://dx.doi.org/10.1371/journal.pone.0034750			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GO	22496855	Green Submitted, Green Published, gold			2022-12-27	WOS:000304855200076
J	Voz, ML; Coppieters, W; Manfroid, I; Baudhuin, A; Von Berg, V; Charlier, C; Meyer, D; Driever, W; Martial, JA; Peers, B				Voz, Marianne L.; Coppieters, Wouter; Manfroid, Isabelle; Baudhuin, Ariane; Von Berg, Virginie; Charlier, Carole; Meyer, Dirk; Driever, Wolfgang; Martial, Joseph A.; Peers, Bernard			Fast Homozygosity Mapping and Identification of a Zebrafish ENU-Induced Mutation by Whole-Genome Sequencing	PLOS ONE			English	Article							PROTEIN COMPLEX SNAP(C); NUCLEAR-RNA GENES; SNRNA-ACTIVATING PROTEIN; BINDING PROTEIN; POLYMERASES II; DANIO-RERIO; TRANSCRIPTION; SUBUNIT; CLONING; DOMAIN	Forward genetics using zebrafish is a powerful tool for studying vertebrate development through large-scale mutagenesis. Nonetheless, the identification of the molecular lesion is still laborious and involves time-consuming genetic mapping. Here, we show that high-throughput sequencing of the whole zebrafish genome can directly locate the interval carrying the causative mutation and at the same time pinpoint the molecular lesion. The feasibility of this approach was validated by sequencing the m1045 mutant line that displays a severe hypoplasia of the exocrine pancreas. We generated 13 Gb of sequence, equivalent to an eightfold genomic coverage, from a pool of 50 mutant embryos obtained from a map-cross between the AB mutant carrier and the WIK polymorphic strain. The chromosomal region carrying the causal mutation was localized based on its unique property to display high levels of homozygosity among sequence reads as it derives exclusively from the initial AB mutated allele. We developed an algorithm identifying such a region by calculating a homozygosity score along all chromosomes. This highlighted an 8-Mb window on chromosome 5 with a score close to 1 in the m1045 mutants. The sequence analysis of all genes within this interval revealed a nonsense mutation in the snapc4 gene. Knockdown experiments confirmed the assertion that snapc4 is the gene whose mutation leads to exocrine pancreas hypoplasia. In conclusion, this study constitutes a proof-of-concept that whole-genome sequencing is a fast and effective alternative to the classical positional cloning strategies in zebrafish.	[Voz, Marianne L.; Manfroid, Isabelle; Baudhuin, Ariane; Von Berg, Virginie; Martial, Joseph A.; Peers, Bernard] Univ Liege, LBMGG, Sart Tilman Par Liege, Belgium; [Charlier, Carole] Univ Liege, GIGA R, Sart Tilman Par Liege, Belgium; [Meyer, Dirk] Leopold Franzens Univ Innsbruck, Inst Mol Biol, Innsbruck, Austria; [Driever, Wolfgang] Univ Freiburg, Fac Biol, Abt Entwicklungsbiol, D-79106 Freiburg, Germany	University of Liege; University of Liege; University of Innsbruck; University of Freiburg	Voz, ML (corresponding author), Univ Liege, LBMGG, Sart Tilman Par Liege, Belgium.	mvoz@ulg.ac.be; wouter.coppieters@ulg.ac.be	Coppieters, Wouter/AAF-5030-2021	Coppieters, Wouter/0000-0001-8109-7825; Charlier, Carole/0000-0002-9694-094X; Meyer, Dirk/0000-0002-4020-4484; Driever, Wolfgang/0000-0002-9551-9141	Belgian State's "Interuniversity Attraction Poles" Program (SSTC, PAI); European Union	Belgian State's "Interuniversity Attraction Poles" Program (SSTC, PAI); European Union(European Commission)	This work was funded by the Belgian State's "Interuniversity Attraction Poles" Program (SSTC, PAI,http://www.belspo.be/belspo/home/port_fr.stm) and by the 6th European Union Framework Program (http://ec.europa.eu/research/fp6)(BetaCellTherapy Integrated Project). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold CN, 2011, GENETICS, V187, P633, DOI 10.1534/genetics.110.124586; Biemar F, 2001, DEV BIOL, V230, P189, DOI 10.1006/dbio.2000.0103; Binot AC, 2010, DEV BIOL, V340, P397, DOI 10.1016/j.ydbio.2010.01.025; Blumenstiel JP, 2009, GENETICS, V182, P25, DOI 10.1534/genetics.109.101998; Christiane Nusslein-Volhard RD, ZEBRAFISH PRACTICAL; Detrich WW, ZEBRAFISH; Driever W, 1996, DEVELOPMENT, V123, P37; Fujita PA, 2011, NUCLEIC ACIDS RES, V39, pD876, DOI 10.1093/nar/gkq963; Godinho L, 2007, NEURON, V56, P597, DOI 10.1016/j.neuron.2007.09.036; Golling G, 2002, NAT GENET, V31, P135, DOI 10.1038/ng896; Haffter P, 1996, DEVELOPMENT, V123, P1; Henry RW, 1996, EMBO J, V15, P7129, DOI 10.1002/j.1460-2075.1996.tb01104.x; Henry RW, 1998, GENE DEV, V12, P2664, DOI 10.1101/gad.12.17.2664; Hesselson D, 2009, P NATL ACAD SCI USA, V106, P14896, DOI 10.1073/pnas.0906348106; Hubbard T, 2002, NUCLEIC ACIDS RES, V30, P38, DOI 10.1093/nar/30.1.38; Jawdekar GW, 2008, BBA-GENE REGUL MECH, V1779, P295, DOI 10.1016/j.bbagrm.2008.04.001; Jawdekar GW, 2006, J BIOL CHEM, V281, P31050, DOI 10.1074/jbc.M603810200; KANE DA, 1993, DEVELOPMENT, V119, P447; Konig H, 2007, CELL, V131, P718, DOI 10.1016/j.cell.2007.09.043; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Ma B, 2001, J BIOL CHEM, V276, P5027, DOI 10.1074/jbc.M009301200; Marcus RC, 1999, VISUAL NEUROSCI, V16, P417, DOI 10.1017/S095252389916303X; Mittal V, 1999, GENE DEV, V13, P1807, DOI 10.1101/gad.13.14.1807; Pendeville H, 2006, GENE EXPR PATTERNS, V6, P267, DOI 10.1016/j.modgep.2005.08.001; Pruitt KD, 2005, NUCLEIC ACIDS RES, V33, pD501, DOI 10.1093/nar/gki025; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Sadowski CL, 1996, P NATL ACAD SCI USA, V93, P4289, DOI 10.1073/pnas.93.9.4289; Sarin S, 2008, NAT METHODS, V5, P865, DOI 10.1038/NMETH.1249; Schilling TF, 1996, DEVELOPMENT, V123, P329; Shanmugam M, 2008, J BIOL CHEM, V283, P14845, DOI 10.1074/jbc.M800833200; SOLNICAKREZEL L, 1994, GENETICS, V136, P1401; Verbruggen V, 2010, J BIOL CHEM, V285, P13863, DOI 10.1074/jbc.M110.108019; Wehman AM, 2005, DEV BIOL, V281, P53, DOI 10.1016/j.ydbio.2005.02.010; Wong MW, 1998, MOL CELL BIOL, V18, P368, DOI 10.1128/MCB.18.1.368; Yoon JB, 1996, MOL CELL BIOL, V16, P1; YOON JB, 1995, MOL CELL BIOL, V15, P2019	37	31	32	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e34671	10.1371/journal.pone.0034671	http://dx.doi.org/10.1371/journal.pone.0034671			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GO	22496837	Green Published, gold, Green Submitted			2022-12-27	WOS:000304855200066
J	Lagadec, C; Dekmezian, C; Bauche, L; Pajonk, F				Lagadec, Chann; Dekmezian, Carmen; Bauche, Lucile; Pajonk, Frank			Oxygen Levels Do Not Determine Radiation Survival of Breast Cancer Stem Cells	PLOS ONE			English	Article							IN-VITRO PROPAGATION; INITIATING CELLS; TUMOR HYPOXIA; RADIOTHERAPY; HEAD; NECK; PREDICTOR; CARCINOMA; IMPACT; ALDH1	For more than a century oxygen has been known to be one of the most powerful radiosensitizers. However, despite decades of preclinical and clinical research aimed at overcoming tumor hypoxia, little clinical progress has been made so far. Ionizing radiation damages DNA through generation of free radicals. In the presence of oxygen these lesions are chemically modified, and thus harder to repair while hypoxia protects cells from radiation (Oxygen enhancement ratio (OER)). Breast cancer stem cells (BSCSs) are protected from radiation by high levels of free radical scavengers even in the presence of oxygen. This led us to hypothesize that BCSCs exhibit an OER of 1. Using four established breast cancer cell lines (MCF-7, T47D, MDA-MB-231, SUM159PT) and primary breast cancer samples, we determined the number of BCSCs using cancer stem cell markers (ALDH1, low proteasome activity), compared radiation clonogenic survival and mammosphere formation under normoxic and hypoxic conditions, and correlated these results to the expression levels of key members of the free radical scavenging systems. The number of BCSCs increased with increased aggressiveness of the cancer. This correlated with increased radioresistance (SF8Gy), and decreasing OERs. When cultured as mammospheres, breast cancer cell lines and primary samples were highly radioresistant and not further protected by hypoxia (OER similar to 1). We conclude that because BCSCs are protected from radiation through high expression levels of free radical scavengers, hypoxia does not lead to additional radioprotection of BCSCs.	[Lagadec, Chann; Dekmezian, Carmen; Bauche, Lucile; Pajonk, Frank] Univ Calif Los Angeles, David Geffen Sch Med, Dept Radiat Oncol, Los Angeles, CA 90095 USA; [Pajonk, Frank] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles	Lagadec, C (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Radiat Oncol, Los Angeles, CA 90095 USA.	fpajonk@mednet.ucla.edu	Lagadec, chann/E-4250-2010	Lagadec, chann/0000-0002-5182-2069	California Breast Cancer Research Program [15NB-0153]; National Cancer Institute [RO1 CA137110]; Army Medical Research and Material Command's Prostate Cancer Research Program [W81XWH-07-1-0065]; Ward Family Foundation; NATIONAL CANCER INSTITUTE [R01CA137110] Funding Source: NIH RePORTER	California Breast Cancer Research Program; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Army Medical Research and Material Command's Prostate Cancer Research Program; Ward Family Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	FP was supported by grants from the California Breast Cancer Research Program (15NB-0153), the National Cancer Institute (RO1 CA137110) and the Army Medical Research and Material Command's Prostate Cancer Research Program (W81XWH-07-1-0065). CL was supported by an award from the Ward Family Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Brizel DM, 1997, INT J RADIAT ONCOL, V38, P285, DOI 10.1016/S0360-3016(97)00101-6; Chen FH, 2009, CLIN CANCER RES, V15, P1721, DOI 10.1158/1078-0432.CCR-08-1471; De Bels D, 2011, NEW ENGL J MED, V365, P1845, DOI 10.1056/NEJMc1110602; Dewhirst MW, 2009, RADIAT RES, V172, P653, DOI 10.1667/RR1926.1; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; ELFadl D, 2011, BREAST, V20, P334, DOI 10.1016/j.breast.2011.02.017; Epperly MW, 2003, RADIAT RES, V160, P568, DOI 10.1667/RR3081; Fillmore CM, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1982; Frommhold H, 1998, STRAHLENTHER ONKOL, V174, P31; Fyles A, 2002, J CLIN ONCOL, V20, P680, DOI 10.1200/JCO.2002.20.3.680; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Heddleston JM, 2009, CELL CYCLE, V8, P3274, DOI 10.4161/cc.8.20.9701; Hemmati HD, 2003, P NATL ACAD SCI USA, V100, P15178, DOI 10.1073/pnas.2036535100; Henke M, 2003, LANCET, V362, P1255, DOI 10.1016/S0140-6736(03)14567-9; Hoff CM, 2011, ACTA ONCOL, V50, P1006, DOI 10.3109/0284186X.2011.592650; KONERDING MA, 1989, STRAHLENTHER ONKOL, V165, P503; Lagadec C, 2012, STEM CELLS IN PRESS; Lagadec C, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2479; Overgaard J, 2011, RADIOTHER ONCOL, V100, P22, DOI 10.1016/j.radonc.2011.03.004; Phillips TM, 2006, JNCI-J NATL CANCER I, V98, P1777, DOI 10.1093/jnci/djj495; Ponti D, 2005, CANCER RES, V65, P5506, DOI 10.1158/0008-5472.CAN-05-0626; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Ricardo S, 2011, J CLIN PATHOL, V64, P937, DOI 10.1136/jcp.2011.090456; Schwarz G, 1906, MUENCHNER MED WOCHEN, V56, P1217; TEICHER BA, 1981, CANCER RES, V41, P73; van Putten L M, 1968, Eur J Cancer, V4, P172; Vaupel P, 2002, Wien Med Wochenschr, V152, P334; Vlashi E, 2011, P NATL ACAD SCI USA, V108, P16062, DOI 10.1073/pnas.1106704108; Vlashi E, 2009, JNCI-J NATL CANCER I, V101, P350, DOI 10.1093/jnci/djn509; Woodward WA, 2007, P NATL ACAD SCI USA, V104, P618, DOI 10.1073/pnas.0606599104	31	27	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2012	7	3							e34545	10.1371/journal.pone.0034545	http://dx.doi.org/10.1371/journal.pone.0034545			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948SR	22479642	Green Published, gold, Green Submitted			2022-12-27	WOS:000304523400087
J	Jounai, K; Ikado, K; Sugimura, T; Ano, Y; Braun, J; Fujiwara, D				Jounai, Kenta; Ikado, Kumiko; Sugimura, Tetsu; Ano, Yasuhisa; Braun, Jonathan; Fujiwara, Daisuke			Spherical Lactic Acid Bacteria Activate Plasmacytoid Dendritic Cells Immunomodulatory Function via TLR9-Dependent Crosstalk with Myeloid Dendritic Cells	PLOS ONE			English	Article							PLACEBO-CONTROLLED TRIAL; CD8(+) T-CELLS; I INTERFERON; STAPHYLOCOCCUS-AUREUS; IFN-ALPHA; LACTOBACILLUS-RHAMNOSUS; CYTOKINE PRODUCTION; ATOPIC DISEASE; TLR AGONISTS; INDUCTION	Plasmacytoid dendritic cells (pDC) are a specialized sensor of viral and bacterial nucleic acids and a major producer of IFN-alpha that promotes host defense by priming both innate and acquired immune responses. Although synthetic Toll-like receptor (TLR) ligands, pathogenic bacteria and viruses activate pDC, there is limited investigation of non-pathogenic microbiota that are in wide industrial dietary use, such as lactic acid bacteria (LAB). In this study, we screened for LAB strains, which induce pDC activation and IFN-alpha production using murine bone marrow (BM)-derived Flt-3L induced dendritic cell culture. Microbial strains with such activity on pDC were absent in a diversity of bacillary strains, but were observed in certain spherical species (Lactococcus, Leuconostoc, Streptococcus and Pediococcus), which was correlated with their capacity for uptake by pDC. Detailed study of Lactococcus lactis subsp. lactis JCM5805 and JCM20101 revealed that the major type I and type III interferons were induced (IFN-alpha, -beta, and lambda). IFN-alpha induction was TLR9 and MyD88-dependent; a slight impairment was also observed in TLR4(-/-) cells. While these responses occurred with purified pDC, IFN-alpha production was synergistic upon co-culture with myeloid dendritic cells (mDC), an interaction that required direct mDC-pDC contact. L. lactis strains also stimulated expression of immunoregulatory receptors on pDC (ICOS-L and PD-L1), and accordingly augmented pDC induction of CD4(+)CD25(+)FoxP3(+) Treg compared to the Lactobacillus strain. Oral administration of L. lactis JCM5805 induced significant activation of pDC resident in the intestinal draining mesenteric lymph nodes, but not in a remote lymphoid site (spleen). Taken together, certain non-pathogenic spherical LAB in wide dietary use has potent and diverse immunomodulatory effects on pDC potentially relevant to anti-viral immunity and chronic inflammatory disease.	[Jounai, Kenta; Ikado, Kumiko; Sugimura, Tetsu; Ano, Yasuhisa; Fujiwara, Daisuke] Kirin Holdings Co Ltd, Cent Labs Frontier Technol, Kanazawa Ku, Yokohama, Kanagawa, Japan; [Jounai, Kenta] Koiwai Dairy Foods Co Ltd, Tech Dev Ctr, Sayama, Osaka, Japan; [Braun, Jonathan] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA	Kirin Holdings Co Ltd; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Jounai, K (corresponding author), Kirin Holdings Co Ltd, Cent Labs Frontier Technol, Kanazawa Ku, Yokohama, Kanagawa, Japan.	d-fujiwara@kirin.co.jp		Braun, Jonathan/0000-0003-1646-2974	NCATS NIH HHS [UL1 TR000124] Funding Source: Medline; NCRR NIH HHS [UL1 RR033176] Funding Source: Medline; NIAID NIH HHS [R01 AI078885] Funding Source: Medline; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR033176] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI078885] Funding Source: NIH RePORTER	NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Asselin-Paturel C, 2005, J EXP MED, V201, P1157, DOI 10.1084/jem.20041930; Asselin-Paturel C, 2001, NAT IMMUNOL, V2, P1144, DOI 10.1038/ni736; Banchereau J, 2006, IMMUNITY, V25, P383, DOI 10.1016/j.immuni.2006.08.010; BIRKE C, 1981, J IMMUNOL, V127, P94; Biron CA, 2001, IMMUNITY, V14, P661, DOI 10.1016/S1074-7613(01)00154-6; Cella M, 2000, NAT IMMUNOL, V1, P305, DOI 10.1038/79747; Dresing P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015567; DUCGOIRAN P, 1981, BIOMEDICINE, V34, P88; Fujiwara D, 2004, INT ARCH ALLERGY IMM, V135, P205, DOI 10.1159/000081305; Fujiwara D., 2005, ALLERGOL INT, V54, P143, DOI DOI 10.2332/ALLERGOLINT.54.143; Fujiwara D, 2008, J IMMUNOL, V180, P5843, DOI 10.4049/jimmunol.180.9.5843; Giacomini E, 2001, J IMMUNOL, V166, P7033, DOI 10.4049/jimmunol.166.12.7033; Greene JA, 2006, J IMMUNOL, V176, P5995, DOI 10.4049/jimmunol.176.10.5995; HESS CB, 1989, MICROB PATHOGENESIS, V7, P111, DOI 10.1016/0882-4010(89)90030-2; Hoene V, 2006, J LEUKOCYTE BIOL, V80, P1328, DOI 10.1189/jlb.0106011; Ito T, 2007, J EXP MED, V204, P105, DOI 10.1084/jem.20061660; Izumo T, 2011, BIOSCI BIOTECH BIOCH, V75, P370, DOI 10.1271/bbb.100696; Izumo T, 2010, INT IMMUNOPHARMACOL, V10, P1101, DOI 10.1016/j.intimp.2010.06.012; Jarnicki AG, 2008, J IMMUNOL, V180, P3797, DOI 10.4049/jimmunol.180.6.3797; Jego G, 2003, IMMUNITY, V19, P225, DOI 10.1016/S1074-7613(03)00208-5; Kalliomaki M, 2003, LANCET, V361, P1869, DOI 10.1016/S0140-6736(03)13490-3; Kalliomaki M, 2001, LANCET, V357, P1076, DOI 10.1016/S0140-6736(00)04259-8; Kamath AT, 2005, J IMMUNOL, V174, P767, DOI 10.4049/jimmunol.174.2.767; KITAZAWA H, 1994, FEMS MICROBIOL LETT, V120, P315, DOI 10.1016/0378-1097(94)90490-1; Kotenko SV, 2003, NAT IMMUNOL, V4, P69, DOI 10.1038/ni875; Kuwajima S, 2006, NAT IMMUNOL, V7, P740, DOI 10.1038/ni1348; Le Bon A, 2003, NAT IMMUNOL, V4, P1009, DOI 10.1038/ni978; Le Bon A, 2002, CURR OPIN IMMUNOL, V14, P432, DOI 10.1016/S0952-7915(02)00354-0; Le Bon A, 2001, IMMUNITY, V14, P461, DOI 10.1016/S1074-7613(01)00126-1; Levy DE, 2001, CYTOKINE GROWTH F R, V12, P143, DOI 10.1016/S1359-6101(00)00027-7; Lund JM, 2004, P NATL ACAD SCI USA, V101, P5598, DOI 10.1073/pnas.0400937101; Mao CM, 2011, J IMMUNOL, V186, P4734, DOI 10.4049/jimmunol.0904135; Megjugorac NJ, 2009, J LEUKOCYTE BIOL, V86, P1359, DOI 10.1189/jlb.0509347; Montoya M, 2002, BLOOD, V99, P3263, DOI 10.1182/blood.V99.9.3263; Murosaki S, 1998, J ALLERGY CLIN IMMUN, V102, P57, DOI 10.1016/S0091-6749(98)70055-7; Nagai S, 2007, P NATL ACAD SCI USA, V104, P8971, DOI 10.1073/pnas.0609014104; NAKANE A, 1981, J IMMUNOL, V126, P2139; Onoguchi K, 2007, J BIOL CHEM, V282, P7576, DOI 10.1074/jbc.M608618200; Parcina M, 2008, J IMMUNOL, V181, P3823, DOI 10.4049/jimmunol.181.6.3823; Pessi T, 2000, CLIN EXP ALLERGY, V30, P1804, DOI 10.1046/j.1365-2222.2000.00948.x; Piccioli D, 2009, BLOOD, V113, P4232, DOI 10.1182/blood-2008-10-186890; Pochard P, 2002, J ALLERGY CLIN IMMUN, V110, P617, DOI 10.1067/mai.2002.128528; Pott J, 2011, P NATL ACAD SCI USA, V108, P7944, DOI 10.1073/pnas.1100552108; Repa A, 2003, VACCINE, V22, P87, DOI 10.1016/S0264-410X(03)00528-0; Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314; Schroder NWJ, 2003, J BIOL CHEM, V278, P15587, DOI 10.1074/jbc.M212829200; Sharma MD, 2007, J CLIN INVEST, V117, P2570, DOI 10.1172/JCI31911; Shida K, 1998, INT ARCH ALLERGY IMM, V115, P278, DOI 10.1159/000069458; Siegemund S, 2009, J VIROL, V83, P9411, DOI 10.1128/JVI.02362-08; Svensson H, 1996, J INTERF CYTOK RES, V16, P7, DOI 10.1089/jir.1996.16.7; Varmanen P, 1998, APPL ENVIRON MICROB, V64, P1831; Wakabayashi H, 2008, INT ARCH ALLERGY IMM, V145, P141, DOI 10.1159/000108139; William V, 2003, J PATHOL, V200, P255; Wolk K, 2008, J LEUKOCYTE BIOL, V83, P1181, DOI 10.1189/jlb.0807525	54	69	73	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2012	7	4							e32588	10.1371/journal.pone.0032588	http://dx.doi.org/10.1371/journal.pone.0032588			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959FE	22505996	Green Published, gold, Green Submitted			2022-12-27	WOS:000305297500004
J	Blackler, R; Syer, S; Bolla, M; Ongini, E; Wallace, JL				Blackler, Rory; Syer, Stephanie; Bolla, Manlio; Ongini, Ennio; Wallace, John L.			Gastrointestinal-Sparing Effects of Novel NSAIDs in Rats with Compromised Mucosal Defence	PLOS ONE			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; ENTERIC-COATED ASPIRIN; PROTON PUMP INHIBITORS; SMALL-BOWEL INJURY; HYDROGEN-SULFIDE; NITRIC-OXIDE; GASTRIC-ULCERATION; CYCLOOXYGENASE 1; NO-NAPROXEN; ULCERS	Nonsteroidal antiand/orinflammatory drugs are among the most commonly used prescription and over-the-counter medications, but they often produce significant gastrointestinal ulceration and bleeding, particularly in elderly patients and patients with certain co-morbidities. Novel anti-inflammatory drugs are seldom tested in animal models that mimic the high risk human users, leading to an underestimate of the true toxicity of the drugs. In the present study we examined the effects of two novel NSAIDs and two commonly used NSAIDs in models in which mucosal defence was expected to be impaired. Naproxen, celecoxib, ATB-346 (a hydrogen sulfide- and naproxen-releasing compound) and NCX 429 (a nitric oxide- and naproxen-releasing compound) were evaluated in healthy, arthritic, obese, and hypertensive rats and in rats of advanced age (19 months) and rats co-administered low-dose aspirin and/or omeprazole. In all models except hypertension, greater gastric and/or intestinal damage was observed when naproxen was administered in these models than in healthy rats. Celecoxib-induced damage was significantly increased when co-administered with low-dose aspirin and/or omeprazole. In contrast, ATB-346 and NCX 429, when tested at doses that were as effective as naproxen and celecoxib in reducing inflammation and inhibiting cyclooxygenase activity, did not produce significant gastric or intestinal damage in any of the models. These results demonstrate that animal models of human co-morbidities display the same increased susceptibility to NSAID-induced gastrointestinal damage as observed in humans. Moreover, two novel NSAIDs that release mediators of mucosal defence (hydrogen sulfide and nitric oxide) do not induce significant gastrointestinal damage in these models of impaired mucosal defence.	[Blackler, Rory; Syer, Stephanie; Wallace, John L.] McMaster Univ, Farncombe Family Digest Hlth Res Inst, Hamilton, ON, Canada; [Bolla, Manlio; Ongini, Ennio] NicOx Res Inst, Milan, Italy	McMaster University	Blackler, R (corresponding author), McMaster Univ, Farncombe Family Digest Hlth Res Inst, Hamilton, ON, Canada.	jwalla@mcmaster.ca	Wallace, John/AAL-3763-2021		Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by a grant from the Canadian Institutes of Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aro P, 2006, AM J EPIDEMIOL, V163, P1025, DOI 10.1093/aje/kwj129; Augstein P, 2009, METHODS MOL BIOL, V560, P159, DOI 10.1007/978-1-59745-448-3_12; BJARNASON I, 1993, GASTROENTEROLOGY, V104, P1832, DOI 10.1016/0016-5085(93)90667-2; Brzozowski T, 2000, DIGEST LIVER DIS, V32, P583, DOI 10.1016/S1590-8658(00)80840-3; Cicala C, 2000, BRIT J PHARMACOL, V130, P1399, DOI 10.1038/sj.bjp.0703449; Davies NM, 1997, ALIMENT PHARM THER, V11, P69, DOI 10.1046/j.1365-2036.1997.115286000.x; Elliott SN, 1998, AM J PHYSIOL-GASTR L, V275, pG425, DOI 10.1152/ajpgi.1998.275.3.G425; ELLIOTT SN, 1995, GASTROENTEROLOGY, V109, P524, DOI 10.1016/0016-5085(95)90341-0; Fiorucci S, 2005, GASTROENTEROLOGY, V129, P1210, DOI 10.1053/j.gastro.2005.07.060; Fiorucci S, 2002, GASTROENTEROLOGY, V123, P1598, DOI 10.1053/gast.2002.36558; Fujimori S, 2010, EUR J CLIN INVEST, V40, P504, DOI 10.1111/j.1365-2362.2010.02290.x; Goldstein JL, 2005, CLIN GASTROENTEROL H, V3, P133, DOI 10.1016/S1542-3565(04)00619-6; Goto H, 2001, CLIN EXP PHARMACOL P, V28, P659, DOI 10.1046/j.1440-1681.2001.03497.x; Graham DY, 2011, AM J MED SCI, V342, P356, DOI 10.1097/MAJ.0b013e3182113658; Graham DY, 2005, CLIN GASTROENTEROL H, V3, P55, DOI 10.1016/S1542-3565(04)00603-2; Hernandez-Diaz S, 2002, J CLIN EPIDEMIOL, V55, P157, DOI 10.1016/S0895-4356(01)00461-9; Kearney PM, 2006, BMJ-BRIT MED J, V332, P1302, DOI 10.1136/bmj.332.7553.1302; KENT TH, 1969, AM J PATHOL, V54, P237; Laine L, 2004, GASTROENTEROLOGY, V127, P395, DOI 10.1053/j.gastro.2004.05.001; Maiden L, 2005, GASTROENTEROLOGY, V128, P1172, DOI 10.1053/j.gastro.2005.03.020; MCCAFFERTY DM, 1995, GASTROENTEROLOGY, V109, P1173, DOI 10.1016/0016-5085(95)90576-6; MIURA S, 1991, AM J PHYSIOL, V261, pG213, DOI 10.1152/ajpgi.1991.261.2.G213; Poullis A, 2003, EUR J GASTROEN HEPAT, V15, P573, DOI 10.1097/01.meg.0000059108.41030.23; PURKERSON ML, 1986, HYPERTENSION, V8, P1113, DOI 10.1161/01.HYP.8.12.1113; Reuter BK, 1997, GASTROENTEROLOGY, V112, P109, DOI 10.1016/S0016-5085(97)70225-7; Scheiman JM, 2006, AM J GASTROENTEROL, V101, P701, DOI 10.1111/j.1572-0241.2006.00499.x; Solomon DH, 1997, AM J MED, V102, P208; Uejima M, 1996, MICROBIOL IMMUNOL, V40, P553, DOI 10.1111/j.1348-0421.1996.tb01108.x; Vogiagis D, 2000, AM J PHYSIOL-GASTR L, V278, pG820, DOI 10.1152/ajpgi.2000.278.5.G820; Waldram A, 2009, J PROTEOME RES, V8, P2361, DOI 10.1021/pr8009885; WALLACE JL, 1990, AM J PHYSIOL, V259, pG462, DOI 10.1152/ajpgi.1990.259.3.G462; WALLACE JL, 1993, CAN J PHYSIOL PHARM, V71, P98, DOI 10.1139/y93-014; Wallace JL, 1998, GASTROENTEROLOGY, V115, P101, DOI 10.1016/S0016-5085(98)70370-1; Wallace JL, 2000, GASTROENTEROLOGY, V119, P512, DOI 10.1053/gast.2000.9304; Wallace JL, 2000, GASTROENTEROLOGY, V119, P706, DOI 10.1053/gast.2000.16510; Wallace JL, 2003, FUND CLIN PHARMACOL, V17, P11, DOI 10.1046/j.1472-8206.2003.00125.x; Wallace JL, 2008, PHYSIOL REV, V88, P1547, DOI 10.1152/physrev.00004.2008; Wallace JL, 2007, FASEB J, V21, P4070, DOI 10.1096/fj.07-8669com; Wallace JL, 2007, TRENDS PHARMACOL SCI, V28, P501, DOI 10.1016/j.tips.2007.09.003; Wallace JL, 2007, GASTROENTEROLOGY, V132, P261, DOI 10.1053/j.gastro.2006.11.042; Wallace JL, 2012, BRIT J PHARMACOL, V165, P67, DOI 10.1111/j.1476-5381.2011.01509.x; Wallace JL, 2011, GASTROENTEROLOGY, V141, P1314, DOI 10.1053/j.gastro.2011.06.075; Wallace JL, 2010, BRIT J PHARMACOL, V159, P1236, DOI 10.1111/j.1476-5381.2009.00611.x; Watanabe T, 2008, CLIN GASTROENTEROL H, V6, P1279, DOI 10.1016/j.cgh.2008.06.021; Zanardo RCO, 2006, FASEB J, V20, P2118, DOI 10.1096/fj.06-6270fje; ZUCKER LM, 1972, ENDOCRINOLOGY, V90, P1320, DOI 10.1210/endo-90-5-1320	46	32	34	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2012	7	4							e35196	10.1371/journal.pone.0035196	http://dx.doi.org/10.1371/journal.pone.0035196			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JO	22496907	Green Submitted, Green Published, gold			2022-12-27	WOS:000305014500049
J	Gish, M; Dafni, A; Inbar, M				Gish, Moshe; Dafni, Amots; Inbar, Moshe			Young Aphids Avoid Erroneous Dropping when Evading Mammalian Herbivores by Combining Input from Two Sensory Modalities	PLOS ONE			English	Article							ACYRTHOSIPHON-PISUM HARRIS; PEA APHID; ANTIPREDATOR BEHAVIOR; ESCAPE BEHAVIOR; PREDATOR AVOIDANCE; ALARM PHEROMONE; RESPONSES; RISK; CUES; COSTS	Mammalian herbivores may incidentally ingest plant-dwelling insects while foraging. Adult pea aphids (Acyrthosiphon pisum) avoid this danger by dropping off their host plant after sensing the herbivore's warm and humid breath and the vibrations it causes while feeding. Aphid nymphs may also drop (to escape insect enemies), but because of their slow movement, have a lower chance of finding a new plant. We compared dropping rates of first-instar nymphs with those of adults, after exposing pea aphids to different combinations of simulated mammalian breath and vibrations. We hypothesized that nymphs would compensate for the greater risk they face on the ground by interpreting more conservatively the mammalian herbivore cues they perceive. Most adults dropped in response to breath alone, but nymphs rarely did so. Breath stimulus accompanied by one concurrent vibrational stimulus, caused a minor rise in adult dropping rates. Adding a second vibration during breath had no additional effect on adults. The nymphs, however, relied on a combination of the two types of stimuli, with a threefold increase in dropping rates when the breath was accompanied by one vibration, and a further doubling of dropping rates when the second vibration was added. The age-specificity of the aphids' herbivore detection mechanism is probably an adaptation to the different cost of dropping for the different age groups. Relying on a combination of stimuli from two sensory modalities enables the vulnerable nymphs to avoid costly mistakes. Our findings emphasize the importance of the direct trophic effect of mammalian herbivory for plant-dwelling insects.	[Gish, Moshe; Dafni, Amots; Inbar, Moshe] Univ Haifa, Dept Evolutionary & Environm Biol, IL-31999 Haifa, Israel	University of Haifa	Gish, M (corresponding author), Univ Haifa, Dept Evolutionary & Environm Biol, IL-31999 Haifa, Israel.	minbar@research.haifa.ac.il		Inbar, Moshe/0000-0002-4707-9508	Israel Science Foundation [940/08]; Henk and Dorothy Schussheim Fund for Ecological Research in Mount Carmel	Israel Science Foundation(Israel Science Foundation); Henk and Dorothy Schussheim Fund for Ecological Research in Mount Carmel	This work was partly supported by the Israel Science Foundation (Grant Number 940/08 to MI) and by the Henk and Dorothy Schussheim Fund for Ecological Research in Mount Carmel. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Amo L, 2004, ANIM BEHAV, V67, P647, DOI 10.1016/j.anbehav.2003.08.005; Aoki S., 2010, Psyche: A Journal of Entomology, V2010, P380351, DOI 10.1155/2010/380351; Bernasconi ML, 1998, ENTOMOL EXP APPL, V87, P133, DOI 10.1023/A:1003200108763; Bouwma P, 2001, ANIM BEHAV, V61, P771, DOI 10.1006/anbe.2000.1649; Braam J, 2005, NEW PHYTOL, V165, P373, DOI 10.1111/j.1469-8137.2004.01263.x; BROADBENT L, 1951, ANN APPL BIOL, V38, P577, DOI 10.1111/j.1744-7348.1951.tb07829.x; Broom, 1981, BIOL BEHAV MECH FUNC; Caro Tim, 2005, pXIII; Castellanos I, 2006, ANIM BEHAV, V72, P461, DOI 10.1016/j.anbehav.2006.02.005; CLEGG JM, 1982, CAN J ZOOL, V60, P2245, DOI 10.1139/z82-289; Cooper WE, 1998, CAN J ZOOL, V76, P1507; Cromarty SI, 2000, BIOL BULL-US, V199, P265, DOI 10.2307/1543183; Dicke M, 2010, TRENDS PLANT SCI, V15, P167, DOI 10.1016/j.tplants.2009.12.002; DILL LM, 1990, OECOLOGIA, V83, P473, DOI 10.1007/BF00317197; DIXON A. F. G., 1958, TRANS ROY ENTOMOL SOC LONDON, V110, P319; FITZGIBBON CD, 1990, ANIM BEHAV, V40, P846, DOI 10.1016/S0003-3472(05)80985-6; Francke DL, 2008, ENTOMOL EXP APPL, V127, P118, DOI 10.1111/j.1570-7458.2008.00678.x; Frazer B.D., 1988, P217; FRAZER B D, 1976, Journal of the Entomological Society of British Columbia, V73, P33; Gish M, 2006, J INSECT BEHAV, V19, P143, DOI 10.1007/s10905-005-9009-9; Gish M, 2011, NATURWISSENSCHAFTEN, V98, P731, DOI 10.1007/s00114-011-0819-7; Gish M, 2010, CURR BIOL, V20, pR628, DOI 10.1016/j.cub.2010.06.065; Harrewijn, 1987, APHIDS THEIR BIOL A, V2A, P269; Hartbauer M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010417; Heil M, 2004, J CHEM ECOL, V30, P1289, DOI 10.1023/B:JOEC.0000030299.59863.69; HELFMAN GS, 1989, BEHAV ECOL SOCIOBIOL, V24, P47, DOI 10.1007/BF00300117; Kim JW, 2009, J FISH BIOL, V74, P1280, DOI 10.1111/j.1095-8649.2009.02199.x; Kunert G, 2010, ECOL ENTOMOL, V35, P147, DOI 10.1111/j.1365-2311.2009.01146.x; LANG F, 1977, SCIENCE, V197, P682, DOI 10.1126/science.197.4304.682; Levri EP, 1998, CAN J ZOOL, V76, P1878, DOI 10.1139/cjz-76-10-1878; Losey JE, 1998, ECOL ENTOMOL, V23, P53, DOI 10.1046/j.1365-2311.1998.00102.x; Losey JE, 1998, OECOLOGIA, V115, P245, DOI 10.1007/s004420050513; Martin J, 2005, CAN J ZOOL, V83, P1189, DOI 10.1139/Z05-114; MCALLISTER MK, 1987, NATURE, V328, P797, DOI 10.1038/328797b0; MONTGOMERY ME, 1978, ANN ENTOMOL SOC AM, V71, P788, DOI 10.1093/aesa/71.5.788; Nelson EH, 2007, OECOLOGIA, V151, P22, DOI 10.1007/s00442-006-0573-2; ODE PR, 1993, FRESHWATER BIOL, V30, P351, DOI 10.1111/j.1365-2427.1993.tb00819.x; Pavlovic A, 2010, ANN BOT-LONDON, V105, P37, DOI 10.1093/aob/mcp269; Peccoud J, 2009, P NATL ACAD SCI USA, V106, P7495, DOI 10.1073/pnas.0811117106; POLIS GA, 1989, ANNU REV ECOL SYST, V20, P297, DOI 10.1146/annurev.es.20.110189.001501; ROITBERG BD, 1978, J APPL ECOL, V15, P775, DOI 10.2307/2402774; ROITBERG BD, 1979, J ANIM ECOL, V48, P111, DOI 10.2307/4104; ROITBERG BD, 1978, CAN J ZOOL, V56, P103, DOI 10.1139/z78-014; ROITBERG BD, 1979, CAN ENTOMOL, V111, P515, DOI 10.4039/Ent111515-4; Roth ED, 2004, BEHAV ECOL, V15, P365, DOI 10.1093/beheco/arh024; SCHULTZ JC, 1981, EVOLUTION, V35, P175, DOI 10.1111/j.1558-5646.1981.tb04870.x; Shine R, 2002, COPEIA, P843; SOLUK DA, 1993, ECOLOGY, V74, P219, DOI 10.2307/1939516; Tokunaga E, 2008, POPUL ECOL, V50, P45, DOI 10.1007/s10144-007-0065-1; Volkov AG, 2011, J PLANT PHYSIOL, V168, P109, DOI 10.1016/j.jplph.2010.06.007; Warkentin KM, 2005, ANIM BEHAV, V70, P59, DOI 10.1016/j.anbehav.2004.09.019; Yamazaki K, 2008, NATURWISSENSCHAFTEN, V95, P263, DOI 10.1007/s00114-007-0318-z; ZAMORA R, 1993, OIKOS, V66, P223, DOI 10.2307/3544808	53	19	19	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2012	7	4							e32706	10.1371/journal.pone.0032706	http://dx.doi.org/10.1371/journal.pone.0032706			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JO	22496734	Green Published, gold, Green Submitted			2022-12-27	WOS:000305014500005
J	Nam, S; Park, T				Nam, Seungyoon; Park, Taesung			Pathway-Based Evaluation in Early Onset Colorectal Cancer Suggests Focal Adhesion and Immunosuppression along with Epithelial-Mesenchymal Transition	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; SIGNALING PATHWAYS; T-CELLS; TUMOR; METASTASIS; MECHANISMS; EXPRESSION; CARCINOMA; PROMOTION; BIOLOGY	Colorectal cancer (CRC) has one of the highest incidences among all cancers. The majority of CRCs are sporadic cancers that occur in individuals without family histories of CRC or inherited mutations. Unfortunately, whole-genome expression studies of sporadic CRCs are limited. A recent study used microarray techniques to identify a predictor gene set indicative of susceptibility to early-onset CRC. However, the molecular mechanisms of the predictor gene set were not fully investigated in the previous study. To understand the functional roles of the predictor gene set, in the present study we applied a subpathway-based statistical model to the microarray data from the previous study and identified mechanisms that are reasonably associated with the predictor gene set. Interestingly, significant subpathways belonging to 2 KEGG pathways (focal adhesion; natural killer cell-mediated cytotoxicity) were found to be involved in the early-onset CRC patients. We also showed that the 2 pathways were functionally involved in the predictor gene set using a text-mining technique. Entry of a single member of the predictor gene set triggered a focal adhesion pathway, which confers anti-apoptosis in the early-onset CRC patients. Furthermore, intensive inspection of the predictor gene set in terms of the 2 pathways suggested that some entries of the predictor gene set were implicated in immunosuppression along with epithelial-mesenchymal transition (EMT) in the early-onset CRC patients. In addition, we compared our subpathway-based statistical model with a gene set-based statistical model, MIT Gene Set Enrichment Analysis (GSEA). Our method showed better performance than GSEA in the sense that our method was more consistent with a well-known cancer-related pathway set. Thus, the biological suggestion generated by our subpathway-based approach seems quite reasonable and warrants a further experimental study on early-onset CRC in terms of dedifferentiation or differentiation, which is underscored in EMT and immunosuppression.	[Nam, Seungyoon] Natl Canc Ctr, Canc Genom Branch, Res Inst, Goyang, South Korea; [Nam, Seungyoon] Korea Inst Sci & Technol, Supercomp Ctr, Taejon, South Korea; [Park, Taesung] Seoul Natl Univ, Dept Stat, Seoul, South Korea; [Park, Taesung] Seoul Natl Univ, Interdisciplinary Program Bioinformat, Seoul, South Korea	National Cancer Center - Korea (NCC); Korea Institute of Science & Technology (KIST); Seoul National University (SNU); Seoul National University (SNU)	Nam, S (corresponding author), Natl Canc Ctr, Canc Genom Branch, Res Inst, Goyang, South Korea.	seungyoon.nam@ncc.re.kr; taesungp@gmail.com	Pillay, Nischalan/F-9536-2012		National Research Foundation of Korea; Korea government (MEST) [20080062618]; Korea Institute of Science and Technology Information [K-10-L05-C01-S13]	National Research Foundation of Korea(National Research Foundation of Korea); Korea government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); Korea Institute of Science and Technology Information(Korea Institute of Science & Technology Information (KISTI))	The work of TP was supported by a National Research Foundation of Korea grant funded by the Korea government (MEST) (20080062618). The work of SN was supported by K-10-L05-C01-S13 from the Korea Institute of Science and Technology Information. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Cancer Society, 2010, CANC FACTS FIG 2010; Bach JF, 2003, NAT REV IMMUNOL, V3, P189, DOI 10.1038/nri1026; Badvie S, 2006, J CLIN PATHOL, V59, P942, DOI 10.1136/jcp.2005.033431; Bates RC, 2003, MOL BIOL CELL, V14, P1790, DOI 10.1091/mbc.E02-09-0583; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Chai JY, 2010, LAB INVEST, V90, P1140, DOI 10.1038/labinvest.2010.101; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; Du CG, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-12; Dunn GP, 2006, NAT REV IMMUNOL, V6, P836, DOI 10.1038/nri1961; Dunn GP, 2004, IMMUNITY, V21, P137, DOI 10.1016/j.immuni.2004.07.017; Fernandez-Martinez AB, 2010, CANCER LETT, V299, P11, DOI 10.1016/j.canlet.2010.07.019; Fu S, 2004, AM J TRANSPLANT, V4, P1614, DOI 10.1111/j.1600-6143.2004.00566.x; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Ganea D, 2006, J NEUROIMMUNE PHARM, V1, P400, DOI 10.1007/s11481-006-9044-0; Gonzalez-Rey E, 2006, ARTHRITIS RHEUM-US, V54, P864, DOI 10.1002/art.21652; Gyorffy B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005645; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Haque I, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-8; Hong Y, 2007, CLIN CANCER RES, V13, P1107, DOI 10.1158/1078-0432.CCR-06-1633; Jenssen TK, 2001, NAT GENET, V28, P21, DOI 10.1038/88213; Jiang BH, 2008, BBA-PROTEINS PROTEOM, V1784, P150, DOI 10.1016/j.bbapap.2007.09.008; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Kim IY, 2005, J BIOCHEM MOL BIOL, V38, P1; Knutson KL, 2006, J IMMUNOL, V177, P1526, DOI 10.4049/jimmunol.177.3.1526; Kotelnikova E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009256; Li MO, 2006, ANNU REV IMMUNOL, V24, P99, DOI 10.1146/annurev.immunol.24.021605.090737; Markowitz SD, 2009, NEW ENGL J MED, V361, P2449, DOI 10.1056/NEJMra0804588; Monnier Y, 2008, CANCER RES, V68, P7323, DOI 10.1158/0008-5472.CAN-08-0841; Muller-Hermelink N, 2008, CANCER CELL, V13, P507, DOI 10.1016/j.ccr.2008.04.001; Murdoch C, 2008, NAT REV CANCER, V8, P618, DOI 10.1038/nrc2444; Nakayama F, 2001, J BIOL CHEM, V276, P16100, DOI 10.1074/jbc.M007272200; Niederkorn JY, 2009, PROG RETIN EYE RES, V28, P329, DOI 10.1016/j.preteyeres.2009.06.002; Oble Darryl A, 2009, Cancer Immun, V9, P3; Pai SI, 2006, GENE THER, V13, P464, DOI 10.1038/sj.gt.3302694; Parsons JT, 2008, CLIN CANCER RES, V14, P627, DOI 10.1158/1078-0432.CCR-07-2220; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Prasse A, 2010, AM J RESP CRIT CARE, V182, P540, DOI 10.1164/rccm.200909-1451OC; Reiman JM, 2007, SEMIN CANCER BIOL, V17, P275, DOI 10.1016/j.semcancer.2007.06.009; Reiman JM, 2010, CANCER RES, V70, P3005, DOI 10.1158/0008-5472.CAN-09-4041; Rocken M, 2010, J CLIN INVEST, V120, P1800, DOI 10.1172/JCI43424; Sansal I, 2004, J CLIN ONCOL, V22, P2954, DOI 10.1200/jco.2004.02.141; Schreiber RD, 2011, SCIENCE, V331, P1565, DOI 10.1126/science.1203486; Shimoyama M, 2001, J SURG ONCOL, V76, P63, DOI 10.1002/1096-9098(200101)76:1<63::AID-JSO1011>3.3.CO;2-3; Tarca AL, 2009, BIOINFORMATICS, V25, P75, DOI 10.1093/bioinformatics/btn577; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Yu HG, 2011, CANCER RES, V71, P360, DOI 10.1158/0008-5472.CAN-10-2894	46	31	31	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2012	7	4							e31685	10.1371/journal.pone.0031685	http://dx.doi.org/10.1371/journal.pone.0031685			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JO	22496728	Green Published, gold, Green Submitted			2022-12-27	WOS:000305014500002
J	Yuan, K; Lian, ZR; Sun, B; Clayton, MM; Ng, IOL; Feitelson, MA				Yuan, Ke; Lian, Zhaorui; Sun, Bill; Clayton, Marcia M.; Ng, Irene O. L.; Feitelson, Mark A.			Role of miR-148a in Hepatitis B Associated Hepatocellular Carcinoma	PLOS ONE			English	Article							VIRUS-X-PROTEIN; TUMOR-SUPPRESSOR GENE; NF-KAPPA-B; LIVER-CANCER; TRANSCRIPTIONAL ACTIVATION; DNA METHYLTRANSFERASE-1; NUCLEAR RECEPTOR; TARGETING PTEN; CELL-SURVIVAL; BETA-CATENIN	Hepatitis B virus encoded X antigen (HBx) is a trans-regulatory protein that alters the activity of selected transcription factors and cytoplasmic signal transduction pathways. HBx transcriptionally up-regulates the expression of a unique gene, URG11, which in turn transcriptionally up-regulates beta-catenin, thereby contributing importantly to hepatocarcinogenesis. HBx and URG11 also alter the expression of multiple microRNAs, and by miRNA array analysis, both were shown to promote the expression of miR-148a. Elevated miR-148a was also seen in HBx positive liver samples from infected patients. To study the function of miR-148a, anti-148a was introduced into HepG2 and Hep3B cells stably expressing HBx or stably over-expressing URG11. Anti-miR-148a suppressed cell proliferation, cell cycle progression, cell migration, anchorage independent growth in soft agar and subcutaneous tumor formation in SCID mice. Introduction of anti-miR-148a increased PTEN protein and mRNA expression, suggesting that PTEN was targeted by miR-148a. Anti-miR-148a failed to suppress PTEN expression when co-transfected with reporter gene mutants in the 3'UTR of PTEN mRNA. Introduction of anti-miR-148a also resulted in depressed Akt signaling by HBx and URG11, resulting in decreased expression of beta-catenin. Thus, miR-148a may play a central role in HBx/URG11 mediated HCC, and may be an early diagnostic marker and/or therapeutic target associated with this tumor type.	[Yuan, Ke; Lian, Zhaorui; Sun, Bill; Clayton, Marcia M.; Feitelson, Mark A.] Temple Univ, Dept Biol, Coll Sci & Technol, Philadelphia, PA 19122 USA; [Feitelson, Mark A.] Temple Univ, Ctr Biotechnol, Sbarro Hlth Res Org, Coll Sci & Technol, Philadelphia, PA 19122 USA; [Ng, Irene O. L.] Univ Hong Kong, Queen Mary Hosp, Dept Pathol, Pokfulam, Hong Kong, Peoples R China	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of Hong Kong	Yuan, K (corresponding author), Temple Univ, Dept Biol, Coll Sci & Technol, Philadelphia, PA 19122 USA.	feitelso@temple.edu	Lian, Zhaorui/AAW-2379-2020	Feitelson, Mark/0000-0002-4904-0498; Ng, Irene Oi-lin/0000-0001-7532-2029	National Institutes of Health [5R01CA104025, 5R01CA111427]; NATIONAL CANCER INSTITUTE [R01CA111427, R01CA104025] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health grants 5R01CA104025 and 5R01CA111427. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldus CD, 2003, BLOOD, V102, P1613, DOI 10.1182/blood-2003-02-0359; BENN J, 1994, P NATL ACAD SCI USA, V91, P10350, DOI 10.1073/pnas.91.22.10350; Blumberg B, 1998, GENE DEV, V12, P3195, DOI 10.1101/gad.12.20.3195; Braconi C, 2010, HEPATOLOGY, V51, P881, DOI 10.1002/hep.23381; Budhu A, 2008, HEPATOLOGY, V47, P897, DOI 10.1002/hep.22160; Calin GA, 2005, NEW ENGL J MED, V353, P1793, DOI 10.1056/NEJMoa050995; Calin GA, 2004, P NATL ACAD SCI USA, V101, P11755, DOI 10.1073/pnas.0404432101; Carruba G, 1999, ANN NY ACAD SCI, V886, P212, DOI 10.1111/j.1749-6632.1999.tb09419.x; Chalhoub N, 2009, ANNU REV PATHOL-MECH, V4, P127, DOI 10.1146/annurev.pathol.4.110807.092311; Cheng AM, 2005, NUCLEIC ACIDS RES, V33, P1290, DOI 10.1093/nar/gki200; Chirillo P, 1996, J VIROL, V70, P641, DOI 10.1128/JVI.70.1.641-646.1996; Chung TW, 2003, CANCER RES, V63, P3453; Cully M, 2006, NAT REV CANCER, V6, P184, DOI 10.1038/nrc1819; Duursma AM, 2008, RNA, V14, P872, DOI 10.1261/rna.972008; Fabregat I, 2007, LIVER INT, V27, P155, DOI 10.1111/j.1478-3231.2006.01409.x; FEITELSON MA, 1993, ONCOGENE, V8, P1109; Feitelson MA, 1997, AM J PATHOL, V150, P1141; Feitelson MA, 2009, CANCER LETT, V286, P69, DOI 10.1016/j.canlet.2008.12.010; Goodwin B, 1999, MOL PHARMACOL, V56, P1329, DOI 10.1124/mol.56.6.1329; Gramantieri L, 2007, CANCER RES, V67, P6092, DOI 10.1158/0008-5472.CAN-06-4607; Gramantieri L, 2008, J CELL MOL MED, V12, P2189, DOI 10.1111/j.1582-4934.2008.00533.x; He HL, 2005, P NATL ACAD SCI USA, V102, P19075, DOI 10.1073/pnas.0509603102; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Henkler F, 1996, J VIRAL HEPATITIS, V3, P109, DOI 10.1111/j.1365-2893.1996.tb00001.x; Jung JK, 2007, CANCER RES, V67, P5771, DOI 10.1158/0008-5472.CAN-07-0529; Kato M, 2009, NAT CELL BIOL, V11, P881, DOI 10.1038/ncb1897; Korkaya H, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000121; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; Lehmann JM, 1998, J CLIN INVEST, V102, P1016, DOI 10.1172/JCI3703; Lian ZR, 2006, HEPATOLOGY, V43, P415, DOI 10.1002/hep.21053; Lian ZR, 2003, NEOPLASIA, V5, P229, DOI 10.1016/S1476-5586(03)80055-6; Lian ZR, 1999, ONCOGENE, V18, P1677, DOI 10.1038/sj.onc.1202470; Liu CG, 2004, P NATL ACAD SCI USA, V101, P9740, DOI 10.1073/pnas.0403293101; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; LUCITO R, 1992, J VIROL, V66, P983, DOI 10.1128/JVI.66.2.983-991.1992; Lujambio A, 2008, P NATL ACAD SCI USA, V105, P13556, DOI 10.1073/pnas.0803055105; MAGUIRE HF, 1991, SCIENCE, V252, P842, DOI 10.1126/science.1827531; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; Murakami Y, 2006, ONCOGENE, V25, P2537, DOI 10.1038/sj.onc.1209283; Nijhara R, 2001, J VIROL, V75, P10348, DOI 10.1128/JVI.75.21.10348-10358.2001; Oishi N, 2007, CANCER SCI, V98, P1540, DOI 10.1111/j.1349-7006.2007.00579.x; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; QADRI I, 1995, P NATL ACAD SCI USA, V92, P1003, DOI 10.1073/pnas.92.4.1003; SETO E, 1990, NATURE, V344, P72, DOI 10.1038/344072a0; Shih WL, 2000, J BIOL CHEM, V275, P25858, DOI 10.1074/jbc.M003578200; Stambolic V, 2001, MOL CELL, V8, P317, DOI 10.1016/S1097-2765(01)00323-9; Sun BS, 1998, HEPATOLOGY, V27, P228, DOI 10.1002/hep.510270135; Szmuness W, 1978, Prog Med Virol, V24, P40; Takagi S, 2008, J BIOL CHEM, V283, P9674, DOI 10.1074/jbc.M709382200; Tang H, 2006, CANCER SCI, V97, P977, DOI 10.1111/j.1349-7006.2006.00299.x; Tanner SM, 2001, P NATL ACAD SCI USA, V98, P13901, DOI 10.1073/pnas.241525498; TIOLLAIS P, 1985, NATURE, V317, P489, DOI 10.1038/317489a0; UEDA H, 1995, NAT GENET, V9, P41, DOI 10.1038/ng0195-41; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; WANG XW, 1994, P NATL ACAD SCI USA, V91, P2230, DOI 10.1073/pnas.91.6.2230; Wen SH, 2001, P NATL ACAD SCI USA, V98, P4622, DOI 10.1073/pnas.081063798; Wu RC, 2000, MOL CELL BIOCHEM, V203, P59, DOI 10.1023/A:1007024624967; Yang H, 2008, CANCER RES, V68, P425, DOI 10.1158/0008-5472.CAN-07-2488	59	82	90	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2012	7	4							e35331	10.1371/journal.pone.0035331	http://dx.doi.org/10.1371/journal.pone.0035331			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JO	22496917	Green Published, gold, Green Submitted			2022-12-27	WOS:000305014500055
J	Wada, Y; Cardinale, I; Khatcherian, A; Chu, J; Kantor, AB; Gottlieb, AB; Tatsuta, N; Jacobson, E; Barsoum, J; Krueger, JG				Wada, Yumiko; Cardinale, Irma; Khatcherian, Artemis; Chu, John; Kantor, Aaron B.; Gottlieb, Alice B.; Tatsuta, Noriaki; Jacobson, Eric; Barsoum, James; Krueger, James G.			Apilimod Inhibits the Production of IL-12 and IL-23 and Reduces Dendritic Cell Infiltration in Psoriasis	PLOS ONE			English	Article							INTERLEUKIN-12/23 MONOCLONAL-ANTIBODY; C-REL; GENE-EXPRESSION; PROINFLAMMATORY PATHWAYS; DOUBLE-BLIND; THERAPY; SKIN; INFLAMMATION; USTEKINUMAB; VULGARIS	Psoriasis is characterized by hyperplasia of the epidermis and infiltration of leukocytes into both the dermis and epidermis. IL-23, a key cytokine that induces T(H)17 cells, has been found to play a critical role in the pathogenesis of psoriasis. Apilimod is a small-molecule compound that selectively suppresses synthesis of IL-12 and IL-23. An open-label clinical study of oral administration of apilimod was conducted in patients with psoriasis. Substantial improvements in histology and clinical measurements were observed in patients receiving 70mg QD. The expression of IL-23p19 and IL-12/IL-23p40 in skin lesions was significantly reduced in this dose group, with a simultaneous increase in IL-10 observed. A decrease in the levels of T(H)1 and T(H)17 cytokines/chemokines in skin lesions followed these p19 and p40 changes. In parallel, a reduction in skin-infiltrating CD11c(+) dendritic cells and CD3(+) T cells was seen, with a greater decrease in the CD11c(+) population. This was accompanied by increases in T and B cells, and decreases in neutrophils and eosinophils in the periphery. This study demonstrates the immunomodulatory activity of apilimod and provides clinical evidence supporting the inhibition of IL-12/IL-23 synthesis for the treatment of T(H)1- and T(H)17-mediated inflammatory diseases.	[Wada, Yumiko; Chu, John; Tatsuta, Noriaki; Jacobson, Eric; Barsoum, James] Synta Pharmaceut Corp, Lexington, MA USA; [Cardinale, Irma; Khatcherian, Artemis; Krueger, James G.] Rockefeller Univ, Invest Dermatol Lab, New York, NY 10021 USA; [Kantor, Aaron B.] Pharmaceutical Prod Dev Inc, Biomarker Discovery Sci, Menlo Pk, CA USA; [Gottlieb, Alice B.] Tufts Med Ctr, Dept Dermatol, Boston, MA USA	Rockefeller University; Tufts Medical Center	Wada, Y (corresponding author), Synta Pharmaceut Corp, Lexington, MA USA.	ywada@syntapharma.com			Synta Pharmaceuticals Corp.	Synta Pharmaceuticals Corp.	Synta Pharmaceuticals Corp. was the funding source of the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asadullah K, 2003, PHARMACOL REV, V55, P241, DOI 10.1124/pr.55.2.4; Asadullah K, 2001, J INVEST DERMATOL, V116, P721, DOI 10.1046/j.0022-202x.2001.01317.x; Asadullah K, 1999, ARCH DERMATOL, V135, P187, DOI 10.1001/archderm.135.2.187; Benson JM, 2011, NAT BIOTECHNOL, V29, P615, DOI 10.1038/nbt.1903; BOIARDI L, 1992, J RHEUMATOL, V19, P1933; Cargill M, 2007, AM J HUM GENET, V80, P273, DOI 10.1086/511051; Carmody RJ, 2007, J IMMUNOL, V178, P186, DOI 10.4049/jimmunol.178.1.186; Chamian F, 2005, P NATL ACAD SCI USA, V102, P2075, DOI 10.1073/pnas.0409569102; Chan JR, 2006, J EXP MED, V203, P2577, DOI 10.1084/jem.20060244; Friedrich M, 2002, J INVEST DERMATOL, V118, P672, DOI 10.1046/j.1523-1747.2002.01731.x; Gottlieb AB, 2011, BRIT J DERMATOL, V165, P652, DOI 10.1111/j.1365-2133.2011.10418.x; Gottlieb AB, 2005, J IMMUNOL, V175, P2721, DOI 10.4049/jimmunol.175.4.2721; Grigoriadis G, 1996, EMBO J, V15, P7099, DOI 10.1002/j.1460-2075.1996.tb01101.x; Grumont R, 2001, J EXP MED, V194, P1021, DOI 10.1084/jem.194.8.1021; Guttman-Yassky E, 2007, J ALLERGY CLIN IMMUN, V119, P1210, DOI 10.1016/j.jaci.2007.03.006; Hilliard BA, 2002, J CLIN INVEST, V110, P843, DOI 10.1172/JCI200215254; Kantor AB, 2004, CLIN IMMUNOL, V111, P186, DOI 10.1016/j.clim.2003.12.011; Kantor AB, 2004, BIOTECHNIQUES, V36, P520, DOI 10.2144/04363PF01; Korzenik JR, 2005, NEW ENGL J MED, V352, P2193, DOI 10.1056/NEJMoa041109; Krueger GG, 2007, NEW ENGL J MED, V356, P580, DOI 10.1056/NEJMoa062382; Kryczek I, 2008, J IMMUNOL, V181, P4733, DOI 10.4049/jimmunol.181.7.4733; LABORDA J, 1991, NUCLEIC ACIDS RES, V19, P3998, DOI 10.1093/nar/19.14.3998; Lebwohl M, 2003, LANCET, V361, P1197, DOI 10.1016/S0140-6736(03)12954-6; Lee E, 2004, J EXP MED, V199, P125, DOI 10.1084/jem.20030451; LEIGH IM, 1995, BRIT J DERMATOL, V133, P501, DOI 10.1111/j.1365-2133.1995.tb02696.x; Leonardi CL, 2008, LANCET, V371, P1665, DOI 10.1016/S0140-6736(08)60725-4; Lew W, 2004, TRENDS IMMUNOL, V25, P295, DOI 10.1016/j.it.2004.03.006; Lowes MA, 2005, P NATL ACAD SCI USA, V102, P19057, DOI 10.1073/pnas.0509736102; Lowes MA, 2008, J INVEST DERMATOL, V128, P1207, DOI 10.1038/sj.jid.5701213; Lowes MA, 2007, NATURE, V445, P866, DOI 10.1038/nature05663; Mason N, 2002, J IMMUNOL, V168, P2590, DOI 10.4049/jimmunol.168.6.2590; Papp KA, 2008, LANCET, V371, P1675, DOI 10.1016/S0140-6736(08)60726-6; Park AY, 2002, J IMMUNOL, V168, P5771, DOI 10.4049/jimmunol.168.11.5771; Sanjabi S, 2000, P NATL ACAD SCI USA, V97, P12705, DOI 10.1073/pnas.230436397; Schon MP, 2005, EXPERT OPIN THER TAR, V9, P225, DOI 10.1517/14728222.9.2.225; Strober BE, 2011, BRIT J DERMATOL, V165, P661, DOI 10.1111/j.1365-2133.2011.10419.x; Toichi E, 2006, J IMMUNOL, V177, P4917, DOI 10.4049/jimmunol.177.7.4917; Trepicchio WL, 1999, J CLIN INVEST, V104, P1527, DOI 10.1172/JCI6910; van Ruissen F, 1998, J INVEST DERMATOL, V110, P358, DOI 10.1046/j.1523-1747.1998.00155.x; Wada Y, 2007, BLOOD, V109, P1156, DOI 10.1182/blood-2006-04-019398; Wang HL, 2006, J CLIN INVEST, V116, P2105, DOI 10.1172/JCI27180; Yawalkar N, 1998, J INVEST DERMATOL, V111, P1053, DOI 10.1046/j.1523-1747.1998.00446.x; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505	43	487	511	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2012	7	4							e35069	10.1371/journal.pone.0035069	http://dx.doi.org/10.1371/journal.pone.0035069			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JA	22493730	Green Published, gold, Green Submitted			2022-12-27	WOS:000305012700072
J	Wang, M; Wang, QL; Wang, BM				Wang, Min; Wang, Qinglian; Wang, Baomin			Identification and Characterization of MicroRNAs in Asiatic Cotton (Gossypium arboreum L.)	PLOS ONE			English	Article							COMPUTATIONAL IDENTIFICATION; PLANT MICRORNA; TARGET GENES; CONSERVATION; RESISTANCE; EXPRESSION; SEQUENCE; HIRSUTUM; TIME	To date, no miRNAs have been identified in the important diploid cotton species although there are several reports on miRNAs in upland cotton. In this study, we identified 73 miRNAs, belonging to 49 families, from Asiatic cotton using a well-developed comparative genome-based homologue search. Several of the predicted miRNAs were validated using quantitative real time PCR (qRT-PCR). The length of miRNAs varied from 18 to 22 nt with an average of 20 nt. The length of miRNA precursors also varied from 46 to 684 nt with an average of 138 +/- 120 nt. For a majority of Asiatic cotton miRNAs, there is only one member per family; however, multiple members were identified for miRNA 156, 414, 837, 838, 1044, 1533, 2902, 2868, 5021 and 5142 families. Nucleotides A and U were dominant, accounted for 62.95%, in the Asiatic cotton pre-miRNAs. The Asiatic cotton pre-miRNAs had high negative minimal folding free energy (MFE) and adjusted MFE (AMFE) and high MFE index (MFEI). Many miRNAs identified in Asiatic cotton suggest that miRNAs also play a similar regulatory mechanism in diploid cotton.	[Wang, Min; Wang, Baomin] China Agr Univ, Coll Agron & Biotechnol, Beijing 100094, Peoples R China; [Wang, Qinglian] Henan Inst Sci & Technol, Xingxiang, Henan, Peoples R China	China Agricultural University; Henan Institute of Science & Technology	Wang, M (corresponding author), China Agr Univ, Coll Agron & Biotechnol, Beijing 100094, Peoples R China.	wangql@hist.edu.cn; wbaomin@263.net			National Natural Science Foundation of China [31170263]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This project is partially support by the grants from National Natural Science Foundation of China (31170263). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar KP, 2010, ANN APPL BIOL, V157, P135, DOI 10.1111/j.1744-7348.2010.00416.x; Altuvia Y, 2005, NUCLEIC ACIDS RES, V33, P2697, DOI 10.1093/nar/gki567; Aukerman MJ, 2003, PLANT CELL, V15, P2730, DOI 10.1105/tpc.016238; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen R, 2009, J INTEGR PLANT BIOL, V51, P1071, DOI 10.1111/j.1744-7909.2009.00887.x; Chen XM, 2004, SCIENCE, V303, P2022, DOI 10.1126/science.1088060; DHAWAN A K, 1991, Journal of Research Punjab Agricultural University, V28, P57; Frazier TP, 2010, PLANTA, V232, P1289, DOI 10.1007/s00425-010-1255-1; Glazinska P, 2009, J PLANT PHYSIOL, V166, P1801, DOI 10.1016/j.jplph.2009.05.011; Gleave AP, 2008, TREE GENET GENOMES, V4, P343, DOI 10.1007/s11295-007-0113-1; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Han YS, 2009, SCI CHINA SER C, V52, P1091, DOI 10.1007/s11427-009-0144-y; Kwak PB, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-457; Liu DQ, 2006, GENET RESOUR CROP EV, V53, P1145, DOI 10.1007/s10722-005-1304-y; Maqbool A, 2010, BIOTECHNOL PROGR, V26, P21, DOI 10.1002/btpr.306; Mlotshwa S, 2006, PLANT MOL BIOL, V61, P781, DOI 10.1007/s11103-006-0049-0; Nibouche S, 2008, PLANT BREEDING, V127, P376, DOI 10.1111/j.1439-0523.2008.01499.x; Pang MX, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r122; Pasquinelli AE, 2000, NATURE, V408, P86, DOI 10.1038/35040556; Pasquinelli AE, 2003, EVOL DEV, V5, P372, DOI 10.1046/j.1525-142X.2003.03044.x; Qiu CX, 2007, GENE, V395, P49, DOI 10.1016/j.gene.2007.01.034; Song CN, 2009, PLANTA, V230, P671, DOI 10.1007/s00425-009-0971-x; Tahir MS, 2011, CYTOLOGIA, V76, P193, DOI 10.1508/cytologia.76.193; Wheeler TA, 1999, PLANT DIS, V83, P831, DOI 10.1094/PDIS.1999.83.9.831; Xie FL, 2007, FEBS LETT, V581, P1464, DOI 10.1016/j.febslet.2007.02.074; Xie FL, 2011, GENE, V473, P8, DOI 10.1016/j.gene.2010.09.007; Xie FL, 2010, PLANTA, V232, P417, DOI 10.1007/s00425-010-1182-1; Yin ZJ, 2008, GENE, V414, P60, DOI 10.1016/j.gene.2008.02.007; Zhang BH, 2007, GENE, V397, P26, DOI 10.1016/j.gene.2007.03.020; Zhang BH, 2006, COMPUT BIOL CHEM, V30, P395, DOI 10.1016/j.compbiolchem.2006.08.006; Zhang BH, 2007, J CELL PHYSIOL, V210, P279, DOI 10.1002/jcp.20869; Zhang BH, 2006, FEBS LETT, V580, P3753, DOI 10.1016/j.febslet.2006.05.063; Zhang BH, 2009, MOL BIOTECHNOL, V42, P269, DOI 10.1007/s12033-009-9163-y; Zhang BH, 2008, PLANTA, V229, P161, DOI 10.1007/s00425-008-0818-x; Zhang BH, 2006, CELL MOL LIFE SCI, V63, P246, DOI 10.1007/s00018-005-5467-7; Zhang BH, 2006, DEV BIOL, V289, P3, DOI 10.1016/j.ydbio.2005.10.036; Zhang BH, 2005, CELL RES, V15, P336, DOI 10.1038/sj.cr.7290302; Zhang BH, 2006, PLANT J, V46, P243, DOI 10.1111/j.1365-313X.2006.02697.X; Zhang WW, 2009, COMPUT BIOL CHEM, V33, P84, DOI 10.1016/j.compbiolchem.2008.07.006	40	34	39	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2012	7	4							e33696	10.1371/journal.pone.0033696	http://dx.doi.org/10.1371/journal.pone.0033696			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JA	22493671	gold, Green Published, Green Submitted			2022-12-27	WOS:000305012700013
J	Lee, JY; Jeong, W; Lim, W; Kim, J; Bazer, FW; Han, JY; Song, G				Lee, Jin-Young; Jeong, Wooyoung; Lim, Whasun; Kim, Jinyoung; Bazer, Fuller W.; Han, Jae Yong; Song, Gwonhwa			Chicken Pleiotrophin: Regulation of Tissue Specific Expression by Estrogen in the Oviduct and Distinct Expression Pattern in the Ovarian Carcinomas	PLOS ONE			English	Article							GROWTH-ASSOCIATED MOLECULE; LAYING HEN; EPITHELIAL-CELLS; RETINOIC ACID; MIDKINE MK; HB-GAM; DIFFERENTIAL EXPRESSION; CANCER PATIENTS; MESSENGER-RNA; PROTEIN	Pleiotrophin (PTN) is a developmentally-regulated growth factor which is widely distributed in various tissues and also detected in many kinds of carcinomas. However, little is known about the PTN gene in chickens. In the present study, we found chicken PTN to be highly conserved with respect to mammalian PTN genes (91-92.6%) and its mRNA was most abundant in brain, heart and oviduct. This study focused on the PTN gene in the oviduct where it was detected in the glandular (GE) and luminal (LE) epithelial cells. Treatment of young chicks with diethylstilbesterol induced PTN mRNA and protein in GE and LE, but not in other cell types of the oviduct. Further, several microRNAs, specifically miR-499 and miR-1709 were discovered to influence PTN expression via its 3'-UTR which suggests that post-transcriptional regulation influences PTN expression in chickens. We also compared expression patterns and CpG methylation status of the PTN gene in normal and cancerous ovaries from chickens. Our results indicated that PTN is most abundant in the GE of adenocarcinoma of cancerous, but not normal ovaries of hens. Bisulfite sequencing revealed that 30- and 40% of -1311 and -1339 CpG sites are demethylated in ovarian cancer cells, respectively. Collectively, these results indicate that chicken PTN is a novel estrogen-induced gene expressed mainly in the oviductal epithelia implicating PTN regulation of oviduct development and egg formation, and also suggest that PTN is a biomarker for epithelial ovarian carcinoma that could be used for diagnosis and monitoring effects of therapies for the disease.	[Lee, Jin-Young; Jeong, Wooyoung; Lim, Whasun; Kim, Jinyoung; Bazer, Fuller W.; Han, Jae Yong; Song, Gwonhwa] Seoul Natl Univ, Dept Agr Biotechnol, WCU Biomodulat Major, Seoul, South Korea; [Bazer, Fuller W.] Texas A&M Univ, Dept Anim Sci, Ctr Anim Biotechnol & Genom, College Stn, TX 77843 USA	Seoul National University (SNU); Texas A&M University System; Texas A&M University College Station	Lee, JY (corresponding author), Seoul Natl Univ, Dept Agr Biotechnol, WCU Biomodulat Major, Seoul, South Korea.	ghsong@snu.ac.kr	Song, Gwonhwa/H-3647-2015; Bazer, Fuller/AAF-4317-2021; Lim, Whasun/AAP-3156-2020; Lim, Whasun/F-2060-2013; gwonhwa, song/H-3208-2015	Bazer, Fuller/0000-0002-5823-5086; Lim, Whasun/0000-0002-1328-0465; 	World Class University (WCU) [R31-10056]; National Research Foundation of Korea (NRF) [2010-0013078]; Ministry of Education, Science, and Technology; Rural Development Administration, Republic of Korea [PJ008142]	World Class University (WCU); National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Rural Development Administration, Republic of Korea(Rural Development Administration (RDA), Republic of Korea)	This research was funded by the World Class University (WCU) program (R31-10056) and by Basic Science Research Program (2010-0013078) through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science, and Technology, and also by a grant from the Next-Generation BioGreen 21 Program (No. PJ008142), Rural Development Administration, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publication, or preparation of the manuscript.	Ahn SE, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-100; Amet LEA, 2001, MOL CELL NEUROSCI, V17, P1014, DOI 10.1006/mcne.2001.0998; Anderson GL, 2010, JNCI-J NATL CANCER I, V102, P26, DOI 10.1093/jnci/djp438; Ansenberger K, 2009, GYNECOL ONCOL, V113, P362, DOI 10.1016/j.ygyno.2009.02.011; Askew DJ, 2007, J BIOL CHEM, V282, P24948, DOI 10.1074/jbc.M703182200; Auersperg N, 1998, SEMIN ONCOL, V25, P281; Auersperg N, 2001, ENDOCR REV, V22, P255, DOI 10.1210/er.22.2.255; Bar A, 2009, J POULT SCI, V46, P267, DOI 10.2141/jpsa.46.267; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Barua A, 2009, INT J GYNECOL CANCER, V19, P531, DOI 10.1111/IGC.0b013e3181a41613; Brigstock DR, 1996, J ENDOCRINOL, V148, P103, DOI 10.1677/joe.0.1480103; Brigstock DR, 1996, J REPROD FERTIL, V108, P313; CHAUHAN AK, 1993, P NATL ACAD SCI USA, V90, P679, DOI 10.1073/pnas.90.2.679; Choudhuri R, 1997, CANCER RES, V57, P1814; Cvetkovic Dusica, 2003, Reprod Biol Endocrinol, V1, P68; Dougherty DC, 2005, TRENDS ENDOCRIN MET, V16, P414, DOI 10.1016/j.tem.2005.09.001; Drummond A.J., 2010, GENEIOUS V5 04; FANG WJ, 1992, J BIOL CHEM, V267, P25889; Giles JR, 2004, GYNECOL ONCOL, V95, P530, DOI 10.1016/j.ygyno.2004.07.061; Goodman MT, 2003, CANCER, V97, P2648, DOI 10.1002/cncr.11347; Hakim AA, 2009, CANCER PREV RES, V2, P114, DOI 10.1158/1940-6207.CAPR-08-0065; Hienola A, 2004, MOL CELL NEUROSCI, V26, P75, DOI 10.1016/j.mcn.2004.01.018; Hincke MT, 2010, J POULT SCI, V47, P208, DOI 10.2141/jpsa.009122; Jackson E, 2007, GYNECOL ONCOL, V104, P192, DOI 10.1016/j.ygyno.2006.07.024; Jager R, 1997, INT J CANCER, V73, P537; Jager R, 2002, BRIT J CANCER, V86, P858, DOI 10.1038/sj.bjc.6600202; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Johnson KA, 2009, CANCER PREV RES, V2, P97, DOI 10.1158/1940-6207.CAPR-08-0244; Jung CG, 2004, FASEB J, V18, P1237, DOI 10.1096/fj.03-0927fje; Khalkhali-Ellis Z, 2006, CLIN CANCER RES, V12, P7279, DOI 10.1158/1078-0432.CCR-06-1589; Kim HS, 2011, 97 ANN C KOR SOC OBS; Klomp HJ, 2002, CLIN CANCER RES, V8, P823; KOHLER PO, 1968, SCIENCE, V160, P86, DOI 10.1126/science.160.3823.86; KOHLER PO, 1969, J CELL BIOL, V40, P8, DOI 10.1083/jcb.40.1.8; Kurman RJ, 2008, AM J OBSTET GYNECOL, V198, P351, DOI 10.1016/j.ajog.2008.01.005; Kurman RJ, 2008, INT J GYNECOL PATHOL, V27, P151, DOI 10.1097/PGP.0b013e318161e4f5; LAI SP, 1992, BIOCHEM BIOPH RES CO, V187, P1113, DOI 10.1016/0006-291X(92)91312-E; LAIRD PW, 1994, HUM MOL GENET, V3, P1487, DOI 10.1093/hmg/3.suppl_1.1487; Lee SI, 2009, POULTRY SCI, V88, P1003, DOI 10.3382/ps.2008-00197; LI YS, 1990, SCIENCE, V250, P1690, DOI 10.1126/science.2270483; Lim W, 2011, EXPT BIOL M IN PRESS; Lim W, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-137; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MCKNIGHT GS, 1978, CELL, V14, P403; Meng K, 2000, P NATL ACAD SCI USA, V97, P2603, DOI 10.1073/pnas.020487997; MILNER PG, 1989, BIOCHEM BIOPH RES CO, V165, P1096, DOI 10.1016/0006-291X(89)92715-0; MITSIADIS TA, 1995, DEVELOPMENT, V121, P37; Muramatsu H, 2006, GENES CELLS, V11, P1405, DOI 10.1111/j.1365-2443.2006.01028.x; Muramatsu T, 2002, J BIOCHEM, V132, P359, DOI 10.1093/oxfordjournals.jbchem.a003231; MURAMATSU T, 1993, INT J DEV BIOL, V37, P183; Murdoch WJ, 2005, EXP BIOL MED, V230, P429, DOI 10.1177/15353702-0323006-11; PALMITER RD, 1971, J CELL BIOL, V50, P598, DOI 10.1083/jcb.50.3.598; Pepe MS, 2001, J NATL CANCER I, V93, P1054, DOI 10.1093/jnci/93.14.1054; Perez-Pinera P, 2007, CELL CYCLE, V6, P2877, DOI 10.4161/cc.6.23.5090; RAULAIS D, 1991, BIOCHEM BIOPH RES CO, V174, P708, DOI 10.1016/0006-291X(91)91475-R; Rodriguez-Burford C, 2001, GYNECOL ONCOL, V81, P373, DOI 10.1006/gyno.2001.6191; Sakural H, 2001, DEVELOPMENT, V128, P3283; SANDERS MM, 1988, BIOCHEMISTRY-US, V27, P6550, DOI 10.1021/bi00417a053; Seo Bee Won, 2009, Journal of Animal Science and Technology, V51, P485; SOCHER SH, 1973, DEV BIOL, V30, P411, DOI 10.1016/0012-1606(73)90098-5; Song G, 2011, BIOL REPROD IN PRESS; Song G, 2007, REPRODUCTION, V133, P285, DOI 10.1530/REP-06-0092; Song GH, 2006, ENDOCRINOLOGY, V147, P3478, DOI 10.1210/en.2006-0122; Song G, 2011, BIOL REPROD, V85, P306, DOI 10.1095/biolreprod.110.089227; Soulie P, 2004, CANCER DETECT PREV, V28, P319, DOI 10.1016/j.cdp.2004.03.004; Souttou B, 1998, J NATL CANCER I, V90, P1468, DOI 10.1093/jnci/90.19.1468; Stakleff KDS, 2003, INT J GYNECOL CANCER, V13, P405, DOI 10.1046/j.1525-1438.2003.13317.x; Stammer K, 2008, GYNECOL ONCOL, V109, P115, DOI 10.1016/j.ygyno.2007.12.030; Suzuki K, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.195362; UEHARA K, 1992, J BIOCHEM-TOKYO, V111, P563, DOI 10.1093/oxfordjournals.jbchem.a123797; Vacherot F, 1999, PROSTATE, V38, P126, DOI 10.1002/(SICI)1097-0045(19990201)38:2<126::AID-PROS6>3.0.CO;2-C; Vanderhyden Barbara C, 2003, Reprod Biol Endocrinol, V1, P67, DOI 10.1186/1477-7827-1-67; VIGNY M, 1989, EUR J BIOCHEM, V186, P733, DOI 10.1111/j.1432-1033.1989.tb15267.x; Wong Alice S T, 2003, Reprod Biol Endocrinol, V1, P70, DOI 10.1186/1477-7827-1-70; Wu H, 2005, J CUTAN PATHOL, V32, P125, DOI 10.1111/j.0303-6987.2005.00282.x; Zhang N, 1997, J BIOL CHEM, V272, P16733, DOI 10.1074/jbc.272.27.16733	76	27	27	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e34215	10.1371/journal.pone.0034215	http://dx.doi.org/10.1371/journal.pone.0034215			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GO	22496782	Green Submitted, Green Published, gold			2022-12-27	WOS:000304855200034
J	Balanzat, AM; Hertlein, C; Apezteguia, C; Bonvehi, P; Camera, L; Gentile, A; Rizzo, O; Gomez-Carrillo, M; Coronado, F; Azziz-Baumgartner, E; Chavez, PR; Widdowson, MA				Balanzat, Ana M.; Hertlein, Christian; Apezteguia, Carlos; Bonvehi, Pablo; Camera, Luis; Gentile, Angela; Rizzo, Oscar; Gomez-Carrillo, Manuel; Coronado, Fatima; Azziz-Baumgartner, Eduardo; Chavez, Pollyanna R.; Widdowson, Marc-Alain			An Analysis of 332 Fatalities Infected with Pandemic 2009 Influenza A (H1N1) in Argentina	PLOS ONE			English	Article							HOSPITALIZED-PATIENTS; A(H1N1) INFECTION; DEFINITIONS; EXPERIENCE; VIRUS; DEATH; ARDS	Background: The apparent high number of deaths in Argentina during the 2009 pandemic led to concern that the influenza A H1N1pdm disease was different there. We report the characteristics and risk factors for influenza A H1N1pdm fatalities. Methods: We identified laboratory-confirmed influenza A H1N1pdm fatalities occurring during June-July 2009. Physicians abstracted data on age, sex, time of onset of illness, medical history, clinical presentation at admission, laboratory, treatment, and outcomes using standardize questionnaires. We explored the characteristics of fatalities according to their age and risk group. Results: Of 332 influenza A H1N1pdm fatalities, 226 (68%) were among persons aged <50 years. Acute respiratory failure was the leading cause of death. Of all cases, 249 (75%) had at least one comorbidity as defined by Advisory Committee on Immunization Practices. Obesity was reported in 32% with data and chronic pulmonary disease in 28%. Among the 40 deaths in children aged <5 years, chronic pulmonary disease (42%) and neonatal pathologies (35%) were the most common co-morbidities. Twenty (6%) fatalities were among pregnant or postpartum women of which only 47% had diagnosed comorbidities. Only 13% of patients received antiviral treatment within 48 hours of symptom onset. None of children aged <5 years or the pregnant women received antivirals within 48 h of symptom onset. As the pandemic progressed, the time from symptom-onset to medical care and to antiviral treatment decreased significantly among case-patients who subsequently died (p < 0.001). Conclusion: Persons with co-morbidities, pregnant and who received antivirals late were over-represented among influenza A H1N1pdm deaths in Argentina, though timeliness of antiviral treatment improved during the pandemic.	[Balanzat, Ana M.; Hertlein, Christian] Natl Minist Hlth Argentina, Buenos Aires, DF, Argentina; [Apezteguia, Carlos] Soc Argentina Terapia Intensiva, Buenos Aires, DF, Argentina; [Bonvehi, Pablo] Soc Argentina Infectol, Buenos Aires, Argentina; [Camera, Luis] Soc Argentina Med, Buenos Aires, DF, Argentina; [Gentile, Angela] Soc Argentina Pediat, Buenos Aires, DF, Argentina; [Rizzo, Oscar] Asociac Argentina Med Resp, Buenos Aires, DF, Argentina; [Gomez-Carrillo, Manuel] Asociac Argentina Microbiol, Buenos Aires, DF, Argentina; [Coronado, Fatima; Azziz-Baumgartner, Eduardo; Chavez, Pollyanna R.; Widdowson, Marc-Alain] Ctr Dis Control & Prevent, Influenza Div, Atlanta, GA USA	Centers for Disease Control & Prevention - USA	Balanzat, AM (corresponding author), Natl Minist Hlth Argentina, Buenos Aires, DF, Argentina.	balanzat@fibertel.com.ar		Widdowson, Marc-Alain/0000-0002-0682-6933	Pan American Health Organization (PAHO)-Argentina	Pan American Health Organization (PAHO)-Argentina	This work was supported by the Pan American Health Organization (PAHO)-Argentina. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANMAT, 2009, US OS ZAN MEN AN EMB; Archer BN, 2009, EUROSURVEILLANCE, V14, P11; BERNARD GR, 1994, AM J RESP CRIT CARE, V149, P818, DOI 10.1164/ajrccm.149.3.7509706; CDC, 2009, UPD INT REC HIV INF; CDC, 2009, PROT REALT RTPCR INF; Chile MdsSd, 2010, PLAN NAC PREP RESP P; Clarin, 2009, BEB TRES MES PRIM VI; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Dubnov-Raz G, 2011, PEDIATR INT, V53, P426, DOI 10.1111/j.1442-200X.2010.03271.x; Estenssoro E, 2002, CRIT CARE MED, V30, P2450, DOI 10.1097/00003246-200211000-00008; Estenssoro E, 2010, AM J RESP CRIT CARE, V182, P41, DOI [10.1164/rccm.201001-0037OC, 10.1164/201001-0037OC]; Farias JA, 2010, INTENS CARE MED, V36, P1015, DOI 10.1007/s00134-010-1853-1; Feiterna-Sperling C, 2010, CLIN INFECT DIS, V51, pE90, DOI 10.1086/657121; Ferring M, 1997, EUR RESPIR J, V10, P1297, DOI 10.1183/09031936.97.10061297; Giannattasio A, 2010, AIDS, V24, P2292, DOI 10.1097/QAD.0b013e32833d2096; Napolitano L. M., 2009, Morbidity and Mortality Weekly Report, V58, P749; Jain S, 2009, NEW ENGL J MED, V361, P1935, DOI 10.1056/NEJMoa0906695; Jamieson DJ, 2009, LANCET, V374, P451, DOI 10.1016/S0140-6736(09)61304-0; Kumar A, 2009, JAMA-J AM MED ASSOC, V302, P1872, DOI 10.1001/jama.2009.1496; Lee EH, 2010, CLIN INFECT DIS, V50, P1498, DOI 10.1086/652446; Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B; Libster R, 2010, NEW ENGL J MED, V362, P45, DOI 10.1056/NEJMoa0907673; Louie JK, 2010, NEW ENGL J MED, V362, P27, DOI 10.1056/NEJMoa0910444; Louie JK, 2009, JAMA-J AM MED ASSOC, V302, P1896, DOI 10.1001/jama.2009.1583; Meites E, 2011, INFECT CONT HOSP EP, V32, P87, DOI 10.1086/657667; Ministerio da Saude do Brasil, 2010, INFL PAND H1N1 2009; Ministerio de Salud Presidencia de la Nacion, 2010, CAMP NAC VAC NUEV VI; Ministerio de Salud Presidencia de la Nacion, 2009, B VIH SIDA ARG, V26; Ministerio de Salud Presidencia de la Nacion, 2006, PRIM ENC NAC FACT RI; Ministerio de Salud Publica, 2009, INF FIN INFL H1N1V U; Ministerio de Salud Publica y Bienestar Social, 2010, B SEM SIT EP; MONTGOMERY AB, 1985, AM REV RESPIR DIS, V132, P485; Morgan OW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009694; Nin N, 2011, J CRIT CARE, V26, P186, DOI 10.1016/j.jcrc.2010.05.031; *PAHO, 2006, PAHO CDC GEN PROT IN; PAHO, 2009, REG UPD PAND H1N1; Raffo L, 2009, MEDICINA-BUENOS AIRE, V69, P393; Riera M, 2010, AIDS, V24, P2460, DOI 10.1097/QAD.0b013e32833e508f; RODRIGUEZNORIEG.E, 2010, PLOS ONE, V0005; Secretaria de Salud M, 2010, SIT ACT PAND; Seppelt I, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1279; Siston AM, 2010, JAMA-J AM MED ASSOC, V303, P1517, DOI 10.1001/jama.2010.479; Ugarte S, 2010, CRIT CARE MED, V38, pE133, DOI 10.1097/CCM.0b013e3181c87716; Venkata C, 2010, MAYO CLIN PROC, V85, P798, DOI 10.4065/mcp.2010.0166; Webb SAR, 2009, NEW ENGL J MED, V361, P1925, DOI 10.1056/NEJMoa0908481	45	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2012	7	4							e33670	10.1371/journal.pone.0033670	http://dx.doi.org/10.1371/journal.pone.0033670			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959FE	22506006	gold, Green Published			2022-12-27	WOS:000305297500014
J	d'Alessandro, E; Hubert, D; Launay, O; Bassinet, L; Lortholary, O; Jaffre, Y; Sermet-Gaudelus, I				d'Alessandro, Eugenie; Hubert, Dominique; Launay, Odile; Bassinet, Laurence; Lortholary, Olivier; Jaffre, Yannick; Sermet-Gaudelus, Isabelle			Determinants of Refusal of A/H1N1 Pandemic Vaccination in a High Risk Population: A Qualitative Approach	PLOS ONE			English	Article							HEALTH-CARE WORKERS; INFLUENZA VACCINATION; H1N1; COVERAGE; CHILDREN; IMMUNIZATION; PERCEPTIONS; ACCEPTANCE; ATTITUDES; VACCINES	Background: Our study analyses the main determinants of refusal or acceptance of the 2009 A/H1N1 vaccine in patients with cystic fibrosis, a high-risk population for severe flu infection, usually very compliant for seasonal flu vaccine. Methodology/Principal Findings: We conducted a qualitative study based on semi-structured interviews in 3 cystic fibrosis referral centres in Paris, France. The study included 42 patients with cystic fibrosis: 24 who refused the vaccine and 18 who were vaccinated. The two groups differed quite substantially in their perceptions of vaccine-and disease-related risks. Those who refused the vaccine were motivated mainly by the fears it aroused and did not explicitly consider the 2009 A/H1N1 flu a potentially severe disease. People who were vaccinated explained their choice, first and foremost, as intended to prevent the flu's potential consequences on respiratory cystic fibrosis disease. Moreover, they considered vaccination to be an indirect collective prevention tool. Patients who refused the vaccine mentioned multiple, contradictory information sources and did not appear to consider the recommendation of their local health care provider as predominant. On the contrary, those who were vaccinated stated that they had based their decision solely on the clear and unequivocal advice of their health care provider. Conclusions/Significance: These results of our survey led us to formulate three main recommendations for improving adhesion to new pandemic vaccines. (1) it appears necessary to reinforce patient education about the disease and its specific risks, but also general population information about community immunity. (2) it is essential to disseminate a clear and effective message about the safety of novel vaccines. (3) this message should be conveyed by local health care providers, who should be involved in implementing immunization.	[d'Alessandro, Eugenie; Jaffre, Yannick] Univ Mediterranee, Fac Med Sect N, CNRS, UMI 3189, Marseille, France; [Hubert, Dominique] Univ Paris 05, Hop Cochin, Assistance Publ Hop Paris, Ctr Ressources & Competence Mucoviscidose, Paris, France; [Launay, Odile] Univ Paris 05, Hop Cochin, Assistance Publ Hop Paris, INSERM,Ctr Invest Clin BT505, Paris, France; [Bassinet, Laurence] Hop InterCommunal Creteil, Ctr Ressources & Competence Mucoviscidose, Creteil, France; [Lortholary, Olivier] Univ Paris 05, Hop Necker Enfants Malad, Assistance Publ Hop Paris, Serv Infectiol, Paris, France; [Sermet-Gaudelus, Isabelle] Univ Paris 05, Hop Necker Enfants Malad, Assistance Publ Hop Paris,Serv PneumoPediat, Ctr Ressources & Competence Mucoviscidose, Paris, France; [Sermet-Gaudelus, Isabelle] INSERM, U845, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Humanities & Social Sciences (INSHS); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); CHI Creteil; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm)	d'Alessandro, E (corresponding author), Univ Mediterranee, Fac Med Sect N, CNRS, UMI 3189, Marseille, France.	isabelle.sermet@nck.aphp.fr			Assistance Publique Hopitaux de Paris clinical research program	Assistance Publique Hopitaux de Paris clinical research program	This study was funded by Assistance Publique Hopitaux de Paris clinical research program. EudraCT: 2009-016662-90. The funders had no role in study design, data collection and analysis, decision to publish, or preparartion of the manuscript.	Balinska MA, 2009, J CLIN VIROL, V46, P202, DOI 10.1016/j.jcv.2009.07.024; Bish A, 2011, VACCINE, V29, P6472, DOI 10.1016/j.vaccine.2011.06.107; Blume S, 2005, SOC SCI MED, V2, P387; Brewer NT, 2007, HEALTH PSYCHOL, V26, P136, DOI 10.1037/0278-6133.26.2.136; Brown KF, 2010, VACCINE, V28, P4181, DOI 10.1016/j.vaccine.2010.04.012; Buchbinder SP, 2004, JAIDS-J ACQ IMM DEF, V36, P604, DOI 10.1097/00126334-200405010-00009; Bults M, 2011, BMC PUBLIC HEALTH, V11, DOI [10.1186/1471-2458-11-2, 10.1186/1471-2458-11-165]; Bults M, 2011, VACCINE, V29, P6226, DOI 10.1016/j.vaccine.2011.06.075; Caress AL, 2010, HEALTH TECHNOL ASSES, V14, P13, DOI 10.3310/hta14340-01; Cohen D, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c2912; Colombo C, 2011, THORAX, V66, P260, DOI 10.1136/thx.2010.157032; Commission d'enquete, 2010, 2698 COMM ENQ; CONWAY SP, 1992, THORAX, V47, P112, DOI 10.1136/thx.47.2.112; Cowling BJ, 2010, J INFECT DIS, V202, P867, DOI 10.1086/655811; Davis MM, 2002, J GEN INTERN MED, V17, P670, DOI 10.1046/j.1525-1497.2002.11040.x; Eastwood K, 2010, MED J AUSTRALIA, V192, P33, DOI 10.5694/j.1326-5377.2010.tb03399.x; EPSTEIN S, 1995, SCI TECHNOL HUM VAL, V20, P408, DOI 10.1177/016224399502000402; Fabry P, 2011, VACCINE, V29, P1824, DOI 10.1016/j.vaccine.2010.12.109; Fogarty AS, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-181; Frew PM, 2011, PEDIATRICS, V127, pS113, DOI 10.1542/peds.2010-1722Q; Giannattasio A, 2010, ITAL J PEDIATR, V36, DOI 10.1186/1824-7288-36-28; Gilligan Carol., 1982, DIFFERENT VOICE; Girard MP, 2010, VACCINE, V28, P4895, DOI [10.1016/j.vaccine.2010.05.031, 10.1016/j.vaccine.2010.07.034]; Glaser B.G., 1968, DISCOV GROUNDED THEO; Health I, 2009, BMJ-BRIT MED J, V338, P1241; Henrich N, 2009, Emerg Health Threats J, V2, pe8, DOI 10.3134/ehtj.09.008; Hidiroglu S, 2010, VACCINE, V28, P8120, DOI 10.1016/j.vaccine.2010.09.104; Jaffre Y, 2003, ENQUETE, V3, P55; Kraut A, 2011, VACCINE, V29, P8357, DOI 10.1016/j.vaccine.2011.08.084; Lau JTF, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4164; Lau JTF, 2009, J INFECTION, V59, P122, DOI 10.1016/j.jinf.2009.06.004; Leppin A, 2009, INT J BEHAV MED, V16, P7, DOI 10.1007/s12529-008-9002-8; Levy-Bruhl D, 2006, REV EPIDEMIOL SANTE, V54, p1S89; Liao QY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017713; Long N, 2007, ANTHR ENTRE RIGUEUR, P73; Madjid M, 2009, TEX HEART I J, V36, P546; Marshall BC, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.5.e80; Moulin A-M, 2006, REV EPIDEMIOL SANTE, V54, P1581; Moulin AM, 2007, M S-MED SCI, V23, P428; Murris-Espin M, 2008, VACCINE, V26, P5612, DOI 10.1016/j.vaccine.2008.07.095; Myers LB, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-15; Nan X, 2011, HLTH COMMUN; Neuzil KM, 2000, J PEDIATR-US, V137, P856, DOI 10.1067/mpd.2000.110445; Nguyen Trang, 2011, Infect Drug Resist, V4, P197, DOI 10.2147/IDR.S23174; Nichol KL, 2001, ARCH INTERN MED, V161, P2702, DOI 10.1001/archinte.161.22.2702; Nougairede A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011292; Olivier de Sardan J. P., 2005, ANTHR DEV UNDERSTAND; Omer SB, 2009, NEW ENGL J MED, V360, P1981, DOI 10.1056/NEJMsa0806477; Ompad DC, 2006, EPIDEMIOL REV, V28, P54, DOI 10.1093/epirev/mxj004; Poland GA, 2010, VACCINE, V28, pD3, DOI 10.1016/j.vaccine.2010.08.024; Pope C, 2000, BMJ-BRIT MED J, V320, P114, DOI 10.1136/bmj.320.7227.114; Rodriguez-Rieiro C, 2011, VACCINE, V29, P1332, DOI 10.1016/j.vaccine.2010.10.061; Salmon DA, 2005, ARCH PEDIAT ADOL MED, V159, P470, DOI 10.1001/archpedi.159.5.470; Schwarzinger M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010199; Seale H, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-99; Serino L, 2011, J Prev Med Hyg, V52, P144; Sinuff T, 2007, J CRIT CARE, V22, P104, DOI 10.1016/j.jcrc.2007.03.001; SteelFisher Gillian K, 2010, N Engl J Med, V362, pe65, DOI 10.1056/NEJMp1005102; Sypsa V, 2009, EUROSURVEILLANCE, V14; Torun SD, 2010, VACCINE, V28, P5703, DOI 10.1016/j.vaccine.2010.06.049; Velan B, 2011, VACCINE, V29, P1173, DOI 10.1016/j.vaccine.2010.12.006; Viviani L, 2011, J CYST FIBROS, V10, P370, DOI 10.1016/j.jcf.2011.06.004; Young ME, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003552	63	29	29	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2012	7	4							e34054	10.1371/journal.pone.0034054	http://dx.doi.org/10.1371/journal.pone.0034054			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959FE	22506011	Green Published, gold			2022-12-27	WOS:000305297500019
J	Hudson, PN; Self, J; Weiss, S; Braden, Z; Xiao, YH; Girgis, NM; Emerson, G; Hughes, C; Sammons, SA; Isaacs, SN; Damon, IK; Olson, VA				Hudson, Paul N.; Self, Joshua; Weiss, Sonja; Braden, Zachary; Xiao, Yuhong; Girgis, Natasha M.; Emerson, Ginny; Hughes, Christine; Sammons, Scott A.; Isaacs, Stuart N.; Damon, Inger K.; Olson, Victoria A.			Elucidating the Role of the Complement Control Protein in Monkeypox Pathogenicity	PLOS ONE			English	Article							ENHANCED NEUTRALIZATION; SMALLPOX INHIBITOR; IMMUNE-RESPONSES; ENZYMES SPICE; VIRUS; VACCINIA; ACTIVATION; CONGO; TRANSMISSION; EXPRESSION	Monkeypox virus (MPXV) causes a smallpox-like disease in humans. Clinical and epidemiological studies provide evidence of pathogenicity differences between two geographically distinct monkeypox virus clades: the West African and Congo Basin. Genomic analysis of strains from both clades identified a similar to 10 kbp deletion in the less virulent West African isolates sequenced to date. One absent open reading frame encodes the monkeypox virus homologue of the complement control protein (CCP). This modulatory protein prevents the initiation of both the classical and alternative pathways of complement activation. In monkeypox virus, CCP, also known as MOPICE, is a similar to 24 kDa secretory protein with sequence homology to this superfamily of proteins. Here we investigate CCP expression and its role in monkeypox virulence and pathogenesis. CCP was incorporated into the West African strain and removed from the Congo Basin strain by homologous recombination. CCP expression phenotypes were confirmed for both wild type and recombinant monkeypox viruses and CCP activity was confirmed using a C4b binding assay. To characterize the disease, prairie dogs were intranasally infected and disease progression was monitored for 30 days. Removal of CCP from the Congo Basin strain reduced monkeypox disease morbidity and mortality, but did not significantly decrease viral load. The inclusion of CCP in the West African strain produced changes in disease manifestation, but had no apparent effect on disease-associated mortality. This study identifies CCP as an important immuno-modulatory protein in monkeypox pathogenesis but not solely responsible for the increased virulence seen within the Congo Basin clade of monkeypox virus.	[Hudson, Paul N.; Self, Joshua; Weiss, Sonja; Braden, Zachary; Emerson, Ginny; Hughes, Christine; Sammons, Scott A.; Damon, Inger K.; Olson, Victoria A.] Ctr Dis Control & Prevent, Poxvirus & Rabies Branch, DHCPP, Atlanta, GA 30333 USA; [Hudson, Paul N.; Self, Joshua; Weiss, Sonja; Braden, Zachary; Emerson, Ginny; Hughes, Christine; Sammons, Scott A.; Damon, Inger K.; Olson, Victoria A.] Ctr Dis Control & Prevent, Biotechnol Core Facil Branch, DSR, NCEZID, Atlanta, GA USA; [Xiao, Yuhong; Girgis, Natasha M.; Isaacs, Stuart N.] Univ Penn, Sch Med, Dept Med, Div Infect Dis, Philadelphia, PA 19104 USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; University of Pennsylvania	Hudson, PN (corresponding author), Ctr Dis Control & Prevent, Poxvirus & Rabies Branch, DHCPP, Atlanta, GA 30333 USA.	fst6@cdc.gov	Isaacs, Stuart/HGA-3405-2022		NIH [U01 AI066333]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI066333] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by NIH grant U01 AI066333. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benhnia MREI, 2009, J VIROL, V83, P1201, DOI 10.1128/JVI.01797-08; Bernet J, 2004, J VIROL, V78, P9446, DOI 10.1128/JVI.78.17.9446-9457.2004; Bernet J, 2003, J BIOSCIENCES, V28, P249, DOI 10.1007/BF02970145; BOONE RF, 1977, J VIROL, V21, P475, DOI 10.1128/JVI.21.2.475-483.1977; BOYLE DB, 1988, GENE, V65, P123, DOI 10.1016/0378-1119(88)90424-6; Chakrabarti S, 1997, BIOTECHNIQUES, V23, P1094, DOI 10.2144/97236st07; Chen NH, 2005, VIROLOGY, V340, P46, DOI 10.1016/j.virol.2005.05.030; DeHaven BC, 2010, J VIROL, V84, P11245, DOI 10.1128/JVI.00372-10; Estep RD, 2011, J VIROL, V85, P9527, DOI 10.1128/JVI.00199-11; FALKNER FG, 1988, J VIROL, V62, P1849, DOI 10.1128/JVI.62.6.1849-1854.1988; Girgis NM, 2011, J VIROL, V85, P2547, DOI 10.1128/JVI.01474-10; Girgis NM, 2010, J VIROL; Guarner J, 2004, EMERG INFECT DIS, V10, P426, DOI 10.3201/eid1003.030878; HRUBY DE, 1979, J VIROL, V29, P705, DOI 10.1128/JVI.29.2.705-715.1979; Hutson CL, 2007, AM J TROP MED HYG, V76, P757, DOI 10.4269/ajtmh.2007.76.757; Hutson CL, 2009, J GEN VIROL, V90, P323, DOI 10.1099/vir.0.005108-0; Hutson CL, 2010, VIROLOGY; ISAACS SN, 1992, P NATL ACAD SCI USA, V89, P628, DOI 10.1073/pnas.89.2.628; Isaacs SN, 2003, J VIROL, V77, P8256, DOI 10.1128/JVI.77.15.8256-8262.2003; JEZEK Z, 1987, J INFECT DIS, V156, P293, DOI 10.1093/infdis/156.2.293; Jezek Z., 1988, MONOGRAPHS VIROLOGY; KOTWAL GJ, 1988, NATURE, V335, P176, DOI 10.1038/335176a0; KOTWAL GJ, 1990, SCIENCE, V250, P827, DOI 10.1126/science.2237434; Learned LA, 2005, AM J TROP MED HYG, V73, P428, DOI 10.4269/ajtmh.2005.73.428; Lehmann EL, 1975, NONPARAMETRICS STAT, pxvi; Leite JA, 2011, ARCH VIROL, V156, P617, DOI 10.1007/s00705-010-0900-0; Li Y, 2006, J CLIN VIROL, V36, P194, DOI 10.1016/j.jcv.2006.03.012; Likos AM, 2005, J GEN VIROL, V86, P2661, DOI 10.1099/vir.0.81215-0; Liszewski MK, 2008, J IMMUNOL, V181, P4199, DOI 10.4049/jimmunol.181.6.4199; Liszewski MK, 2006, J IMMUNOL, V176, P3725, DOI 10.4049/jimmunol.176.6.3725; Liszewski MK, 2009, J IMMUNOL, V183, P3150, DOI 10.4049/jimmunol.0901366; MCKENZIE R, 1992, J INFECT DIS, V166, P1245, DOI 10.1093/infdis/166.6.1245; Mehlhop E, 2006, J EXP MED, V203, P1371, DOI 10.1084/jem.20052388; Miller CG, 1997, VIROLOGY, V229, P126, DOI 10.1006/viro.1996.8396; Moulton EA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000249; Mullick J, 2005, J VIROL, V79, P12382, DOI 10.1128/JVI.79.19.12382-12393.2005; Mullick J, 2003, TRENDS IMMUNOL, V24, P500, DOI 10.1016/S1471-4906(03)00207-2; PATEL DD, 1986, VIROLOGY, V149, P174, DOI 10.1016/0042-6822(86)90119-4; Reed KD, 2004, NEW ENGL J MED, V350, P342, DOI 10.1056/NEJMoa032299; Rimoin AW, 2010, P NATL ACAD SCI USA, V107, P16262, DOI 10.1073/pnas.1005769107; Rosengard AM, 1999, MOL IMMUNOL, V36, P685, DOI 10.1016/S0161-5890(99)00081-4; Rosengard AM, 2002, P NATL ACAD SCI USA, V99, P8808, DOI 10.1073/pnas.112220499; Sfyroera G, 2005, J IMMUNOL, V174, P2143, DOI 10.4049/jimmunol.174.4.2143; Toapanta FR, 2006, IMMUNOL RES, V36, P197, DOI 10.1385/IR:36:1:197; Xu RH, 2008, J EXP MED, V205, P981, DOI 10.1084/jem.20071854	45	22	22	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2012	7	4							e35086	10.1371/journal.pone.0035086	http://dx.doi.org/10.1371/journal.pone.0035086			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JO	22496894	gold, Green Submitted, Green Published			2022-12-27	WOS:000305014500044
J	Lim, S; Choi, SH; Shin, H; Cho, BJ; Park, HS; Ahn, BY; Kang, SM; Yoon, JW; Jang, HC; Kim, YB; Park, KS				Lim, Soo; Choi, Sung Hee; Shin, Hayley; Cho, Bong Jun; Park, Ho Seon; Ahn, Byung Yong; Kang, Seon Mee; Yoon, Ji Won; Jang, Hak Chul; Kim, Young-Bum; Park, Kyong Soo			Effect of a Dipeptidyl Peptidase-IV Inhibitor, Des-Fluoro-Sitagliptin, on Neointimal Formation after Balloon Injury in Rats	PLOS ONE			English	Article							GLUCAGON-LIKE PEPTIDE-1; MONOCYTE CHEMOATTRACTANT PROTEIN-1; CORONARY-ARTERY-DISEASE; SMOOTH-MUSCLE-CELLS; MATRIX METALLOPROTEINASES; DIABETIC-PATIENTS; GROWTH-FACTOR; DPP-IV; HYPERPLASIA; MECHANISMS	Background: Recently, it has been suggested that enhancement of incretin effect improves cardiac function. We investigated the effect of a DPP-IV inhibitor, des-fluoro-sitagliptin, in reducing occurrence of restenosis in carotid artery in response to balloon injury and the related mechanisms. Methods and Findings: Otsuka Long-Evans Tokushima Fatty rats were grouped into four: control (normal saline) and sitagliptin 100, 250 and 500 mg/kg per day (n = 10 per group). Sitagliptin or normal saline were given orally from 1 week before to 2 weeks after carotid injury. After 3 weeks of treatment, sitagliptin treatment caused a significant and dose-dependent reduction in intima-media ratio (IMR) in obese diabetic rats. This effect was accompanied by improved glucose homeostasis, decreased circulating levels of high-sensitivity C-reactive protein (hsCRP) and increased adiponectin level. Moreover, decreased IMR was correlated significantly with reduced hsCRP, tumor necrosis factor-alpha and monocyte chemoattractant protein-1 levels and plasminogen activator inhibitor-1 activity. In vitro evidence with vascular smooth muscle cells (VSMCs) demonstrated that proliferation and migration were decreased significantly after sitagliptin treatment. In addition, sitagliptin increased caspase-3 activity and decreased monocyte adhesion and NF kappa B activation in VSMCs. Conclusions: Sitagliptin has protective properties against restenosis after carotid injury and therapeutic implications for treating macrovascular complications of diabetes.	[Lim, Soo; Choi, Sung Hee; Cho, Bong Jun; Kang, Seon Mee; Yoon, Ji Won; Jang, Hak Chul] Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Songnam, South Korea; [Lim, Soo; Choi, Sung Hee; Park, Ho Seon; Ahn, Byung Yong; Kang, Seon Mee; Yoon, Ji Won; Jang, Hak Chul; Park, Kyong Soo] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea; [Shin, Hayley] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Kim, Young-Bum] Beth Israel Deaconess Med Ctr, Dept Med, Div Endocrinol Diabet & Metab, Boston, MA 02215 USA; [Kim, Young-Bum] Harvard Univ, Sch Med, Boston, MA USA; [Park, Kyong Soo] Seoul Natl Univ, Grad Sch Convergence Sci & Technol, Dept Mol Med & Biopharmaceut Sci, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Seoul National University (SNU)	Lim, S (corresponding author), Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Songnam, South Korea.	kspark@snu.ac.kr	Jang, Hak Chul/D-9637-2012; Park, Kyong Soo/C-2265-2008; Ahn, Byungyong/AHB-6077-2022; Choi, Sung-hee/J-5689-2012; Lim, Soo/AAU-8107-2020	Jang, Hak Chul/0000-0002-4188-6536; Park, Kyong Soo/0000-0003-3597-342X; Lim, Soo/0000-0002-4137-1671; CHOI, SUNG HEE/0000-0003-0740-8116; Ahn, Byungyong/0000-0002-9871-5180; Park, Ho Seon/0000-0003-1200-4626	American Diabetes Association [1-09-RA-87]; Ministry of Education, Science and Technology; Korea Science and Engineering Foundation [R31-2008-000-10103-0]; Merck	American Diabetes Association(American Diabetes Association); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Korea Science and Engineering Foundation(Korea Science and Engineering Foundation); Merck(Merck & Company)	This work was supported by research grant from the American Diabetes Association (1-09-RA-87), the World Class University project of the Ministry of Education, Science and Technology and the Korea Science and Engineering Foundation (R31-2008-000-10103-0) and the investigator initiated studies programs of Merck. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was partly supported by the investigator initiated studies programs of Merck. The sitagliptin used in this study is a Merck product. There are no patents, products in development or other marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Ahren B, 2004, J CLIN ENDOCR METAB, V89, P2078, DOI 10.1210/jc.2003-031907; ANSARI B, 1993, J PATHOL, V170, P1, DOI 10.1002/path.1711700102; BENDECK MP, 1994, CIRC RES, V75, P539, DOI 10.1161/01.RES.75.3.539; Buteau J, 2004, DIABETOLOGIA, V47, P806, DOI 10.1007/s00125-004-1379-6; Buteau J, 2003, DIABETES, V52, P124, DOI 10.2337/diabetes.52.1.124; CLOWES AW, 1983, LAB INVEST, V49, P327; Cooper ME, 2001, AM J HYPERTENS, V14, P475, DOI 10.1016/S0895-7061(00)01323-6; Derosa G, 2007, DIABETES METAB, V33, P129, DOI 10.1016/j.diabet.2006.11.008; Drucker DJ, 2003, DIABETES CARE, V26, P2929, DOI 10.2337/diacare.26.10.2929; Drucker DJ, 2003, EXPERT OPIN INV DRUG, V12, P87, DOI 10.1517/13543784.12.1.87; Egashira K, 2002, CIRC RES, V90, P1167, DOI 10.1161/01.RES.0000020561.03244.7E; FALK E, 1995, CIRCULATION, V92, P657, DOI 10.1161/01.CIR.92.3.657; Ferns GAA, 2000, INT J EXP PATHOL, V81, P63, DOI 10.1046/j.1365-2613.2000.00143.x; GALIS ZS, 1994, CIRC RES, V75, P181, DOI 10.1161/01.RES.75.1.181; GALIS ZS, 1994, J CLIN INVEST, V94, P2493, DOI 10.1172/JCI117619; Holst JJ, 2003, ADV EXP MED BIOL, V524, P263; Klonoff DC, 2008, CURR MED RES OPIN, V24, P275, DOI 10.1185/030079908X253870; Lambeir AM, 2003, CRIT REV CL LAB SCI, V40, P209, DOI 10.1080/713609354; Lavrik IN, 2005, J CLIN INVEST, V115, P2665, DOI 10.1172/JCI26252; Li-Saw-Hee FL, 2000, INT J CARDIOL, V75, P43, DOI 10.1016/S0167-5273(00)00274-6; Liu HB, 2008, J ENDOCRINOL, V196, P57, DOI 10.1677/JOE-07-0387; Mari A, 2005, J CLIN ENDOCR METAB, V90, P4888, DOI 10.1210/jc.2004-2460; Marx N, 2003, ARTERIOSCL THROM VAS, V23, P283, DOI 10.1161/01.ATV.0000054195.35121.5E; Maxwell PR, 2001, DIABETIC MED, V18, P777, DOI 10.1046/j.1464-5491.2001.00542.x; Moreno PR, 1996, CIRCULATION, V94, P3098, DOI 10.1161/01.CIR.94.12.3098; Moreno PR, 1999, J AM COLL CARDIOL, V34, P1045, DOI 10.1016/S0735-1097(99)00338-1; Mori E, 2002, CIRCULATION, V105, P2905, DOI 10.1161/01.CIR.0000018603.67989.71; Nagase H, 1999, J BIOL CHEM, V274, P21491, DOI 10.1074/jbc.274.31.21491; Newby AC, 2000, J PATHOL, V190, P300, DOI 10.1002/(SICI)1096-9896(200002)190:3<300::AID-PATH596>3.0.CO;2-I; Nystrom T, 2005, REGUL PEPTIDES, V125, P173, DOI 10.1016/j.regpep.2004.08.024; Nystrom T, 2004, AM J PHYSIOL-ENDOC M, V287, pE1209, DOI 10.1152/ajpendo.00237.2004; Ohnuma K, 2007, J BIOL CHEM, V282, P10117, DOI 10.1074/jbc.M609157200; Pasceri V, 2000, CIRCULATION, V102, P2165; Petroff MGV, 2001, CIRC RES, V89, P445, DOI 10.1161/hh1701.095716; Pischon T, 2004, JAMA-J AM MED ASSOC, V291, P1730, DOI 10.1001/jama.291.14.1730; Read PA, 2010, DPP 4 INHIBITION SIT; Ristic S, 2005, DIABETES OBES METAB, V7, P692, DOI 10.1111/j.1463-1326.2005.00539.x; Rodriguez AE, 2007, EUR HEART J, V28, P2118, DOI 10.1093/eurheartj/ehm297; Rogers C, 1996, ARTERIOSCL THROM VAS, V16, P1312, DOI 10.1161/01.ATV.16.10.1312; Schulze MB, 2005, DIABETES, V54, P534, DOI 10.2337/diabetes.54.2.534; Song HK, 2008, AM J PHYSIOL-RENAL, V295, pF1485, DOI 10.1152/ajprenal.90231.2008; Tanaka H, 1996, ARTERIOSCL THROM VAS, V16, P12, DOI 10.1161/01.ATV.16.1.12; Welt FGP, 2000, ARTERIOSCL THROM VAS, V20, P2553, DOI 10.1161/01.ATV.20.12.2553; Yoon JS, 2011, DIABETES METAB J, V35, P437, DOI 10.4093/dmj.2011.35.5.437; Yu Y, 2004, J AM COLL CARDIOL, V44, P904, DOI 10.1016/j.jacc.2004.04.050	45	47	49	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2012	7	4							e35007	10.1371/journal.pone.0035007	http://dx.doi.org/10.1371/journal.pone.0035007			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JA	22493727	Green Published, Green Submitted, gold			2022-12-27	WOS:000305012700069
J	Shen, B; Han, XQ; Zhang, JP; Rossiter, SJ; Zhang, SY				Shen, Bin; Han, Xiuqun; Zhang, Junpeng; Rossiter, Stephen J.; Zhang, Shuyi			Adaptive Evolution in the Glucose Transporter 4 Gene Slc2a4 in Old World Fruit Bats (Family: Pteropodidae)	PLOS ONE			English	Article							DETECTING POSITIVE SELECTION; AMINO-ACID SITES; PARACELLULAR ABSORPTION; INSULIN-RESISTANCE; NATURAL-SELECTION; GLUCOSE; INFERENCE; MUSCLE; FUEL; ALGORITHM	Frugivorous and nectarivorous bats are able to ingest large quantities of sugar in a short time span while avoiding the potentially adverse side-effects of elevated blood glucose. The glucose transporter 4 protein (GLUT4) encoded by the Slc2a4 gene plays a critical role in transmembrane skeletal muscle glucose uptake and thus glucose homeostasis. To test whether the Slc2a4 gene has undergone adaptive evolution in bats with carbohydrate-rich diets in relation to their insect-eating sister taxa, we sequenced the coding region of the Slc2a4 gene in a number of bat species, including four Old World fruit bats (Pteropodidae) and three New World fruit bats (Phyllostomidae). Our molecular evolutionary analyses revealed evidence that Slc2a4 has undergone a change in selection pressure in Old World fruit bats with 11 amino acid substitutions detected on the ancestral branch, whereas, no positive selection was detected in the New World fruit bats. We noted that in the former group, amino acid replacements were biased towards either Serine or Isoleucine, and, of the 11 changes, six were specific to Old World fruit bats (A133S, A164S, V377F, V386I, V441I and G459S). Our study presents preliminary evidence that the Slc2a4 gene has undergone adaptive changes in Old World fruit bats in relation to their ability to meet the demands of a high sugar diet.	[Shen, Bin; Han, Xiuqun; Zhang, Junpeng; Zhang, Shuyi] E China Normal Univ, Inst Adv Interdisciplinary Res, Inst Mol Ecol & Evolut, Shanghai 200062, Peoples R China; [Rossiter, Stephen J.] Queen Mary Univ London, Sch Biol & Chem Sci, London, England	East China Normal University; University of London; Queen Mary University London	Shen, B (corresponding author), E China Normal Univ, Inst Adv Interdisciplinary Res, Inst Mol Ecol & Evolut, Shanghai 200062, Peoples R China.	syzhang@bio.ecnu.edu.cn	Rossiter, Stephen J/E-2111-2011	Rossiter, Stephen/0000-0002-3881-4515	Key Construction Program of the National "985" Project; "211" Project; Royal Society; Biotechnology and Biological Sciences Research Council (BBSRC)	Key Construction Program of the National "985" Project; "211" Project(Anhui UniversityMinistry of Education, China); Royal Society(Royal Society of London); Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This study was supported by grants awarded by the Key Construction Program of the National "985" Project and "211" Project to SZ. SJR was supported by a Royal Society Research Fellowship and a Biotechnology and Biological Sciences Research Council (BBSRC) Chinese Partnering award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel ED, 2001, NATURE, V409, P729, DOI 10.1038/35055575; Altringham J D, 1996, BATS BIOL BEHAV, P2; Amitai O, 2010, J EXP BIOL, V213, P2693, DOI 10.1242/jeb.043505; Anisimova M, 2002, MOL BIOL EVOL, V19, P950, DOI 10.1093/oxfordjournals.molbev.a004152; Betts M.J., 2007, BIOINFORMATICS GENET, DOI [10.1002/9780470059180.ch13, DOI 10.1002/0470867302.CH14]; Bielawski JP, 2003, J STRUCT FUNCT GENOM, V3, P201, DOI DOI 10.1007/978-94-010-0263-9_20; Brunner Y, 2009, J PROTEOMICS, V71, P576, DOI 10.1016/j.jprot.2008.10.002; Caviedes-Vidal E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001425; Caviedes-Vidal E, 2007, P NATL ACAD SCI USA, V104, P19132, DOI 10.1073/pnas.0703159104; Datzmann T, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-165; Davies K T J, 2012, Heredity (Edinb), V108, P480, DOI 10.1038/hdy.2011.119; Ding KY, 2005, MOL BIOL EVOL, V22, P148, DOI 10.1093/molbev/msh266; Haygood R, 2007, NAT GENET, V39, P1140, DOI 10.1038/ng2104; Huang SH, 2007, CELL METAB, V5, P237, DOI 10.1016/j.cmet.2007.03.006; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Kawahito S, 2009, WORLD J GASTROENTERO, V15, P4137, DOI 10.3748/wjg.15.4137; KEEGAN DJ, 1977, COMP BIOCHEM PHYS A, V58, P349, DOI 10.1016/0300-9629(77)90153-0; Kelm DH, 2011, P ROY SOC B-BIOL SCI, V278, P3490, DOI 10.1098/rspb.2011.0465; Klip A, 2009, APPL PHYSIOL NUTR ME, V34, P481, DOI 10.1139/H09-047; LASKA M, 1990, Z SAUGETIERKD, V55, P49; Li G, 2008, P NATL ACAD SCI USA, V105, P13959, DOI 10.1073/pnas.0802097105; Liu Y, 2011, MOL BIOL EV IN PRESS; Liu Y, 2012, MOL BIOL EVOL, V29, P1507, DOI 10.1093/molbev/mss013; Liu Y, 2010, CURR BIOL, V20, P1834, DOI 10.1016/j.cub.2010.09.008; Maddison WP, 2019, MESQUITE MODULAR SYS; Michelmore AJ, 1998, GEN COMP ENDOCR, V110, P319, DOI 10.1006/gcen.1998.7077; Murphy WJ, 2001, SCIENCE, V294, P2348, DOI 10.1126/science.1067179; Pond SLK, 2006, BIOINFORMATICS, V22, P3096, DOI 10.1093/bioinformatics/btl474; Pond SLK, 2011, MOL BIOL EVOL, V28, P3033, DOI 10.1093/molbev/msr125; Pond SLK, 2005, MOL BIOL EVOL, V22, P478, DOI 10.1093/molbev/msi031; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Protzek AOP, 2010, COMP BIOCHEM PHYS A, V157, P142, DOI 10.1016/j.cbpa.2010.05.016; Salas-Burgos A, 2004, BIOPHYS J, V87, P2990, DOI 10.1529/biophysj.104.047886; Shepherd PR, 1999, NEW ENGL J MED, V341, P248, DOI 10.1056/NEJM199907223410406; Suarez RK, 2009, COMP BIOCHEM PHYS A, V153, P136, DOI 10.1016/j.cbpa.2009.01.015; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tarazona-Santos E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009827; Teeling EC, 2005, SCIENCE, V307, P580, DOI 10.1126/science.1105113; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Thong FSL, 2005, PHYSIOLOGY, V20, P271, DOI 10.1152/physiol.00017.2005; Tracy CR, 2007, J EXP BIOL, V210, P1726, DOI 10.1242/jeb.02766; Voigt CC, 2007, FUNCT ECOL, V21, P913, DOI 10.1111/j.1365-2435.2007.01321.x; Welch KC, 2008, J EXP BIOL, V211, P310, DOI 10.1242/jeb.012252; Yang J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001472; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; YANG ZH, 1995, GENETICS, V141, P1641; Yang ZH, 2000, TRENDS ECOL EVOL, V15, P496, DOI 10.1016/S0169-5347(00)01994-7; Yang ZH, 1998, MOL BIOL EVOL, V15, P568, DOI 10.1093/oxfordjournals.molbev.a025957; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yuan LH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027189; Zisman A, 2000, NAT MED, V6, P924, DOI 10.1038/78693	52	19	22	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2012	7	4							e33197	10.1371/journal.pone.0033197	http://dx.doi.org/10.1371/journal.pone.0033197			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JA	22493665	gold, Green Published			2022-12-27	WOS:000305012700007
J	Zhou, J; Ju, WQ; Wang, DP; Wu, LW; Zhu, XF; Guo, ZY; He, XS				Zhou, Jian; Ju, Weiqiang; Wang, Dongping; Wu, Linwei; Zhu, Xiaofeng; Guo, Zhiyong; He, Xiaoshun			Down-Regulation of microRNA-26a Promotes Mouse Hepatocyte Proliferation during Liver Regeneration	PLOS ONE			English	Article							PARTIAL-HEPATECTOMY; STEM-CELLS; TARGETS; CANCER; TUMORIGENESIS; EXPRESSION; REPAIR; CYCLE	Background: Inadequate liver regeneration (LR) is still an unsolved problem in major liver resection and small-for-size syndrome post-living donor liver transplantation. A number of microRNAs have been shown to play important roles in cell proliferation. Herein, we investigated the role of miR-26a as a pivotal regulator of hepatocyte proliferation in LR. Methodology/Principal Findings: Adult male C57BL/6J mice, undergoing 70% partial hepatectomy (PH), were treated with Ad5-anti-miR-26a-LUC or Ad5-miR-26a-LUC or Ad5-LUC vector via portal vein. The animals were subjected to in vivo bioluminescence imaging. Serum and liver samples were collected to test liver function, calculate liver-to-body weight ratio (LBWR), document hepatocyte proliferation (Ki-67 staining), and investigate potential targeted gene expression of miR-26a by quantitative real-time PCR and Western blot. The miR-26a level declined during LR after 70% PH. Down-regulation of miR-26a by anti-miR-26a expression led to enhanced proliferation of hepatocytes, and both LBWR and hepatocyte proliferation (Ki-67(+) cells %) showed an increased tendency, while liver damage, indicated by aspartate aminotransferase (AST), alanine aminotransferase (ALT) and total bilirubin (T-Bil), was reduced. Furthermore, CCND2 and CCNE2, as possible targeted genes of miR-26a, were up-regulated. In addition, miR-26a over-expression showed converse results. Conclusions/Significance: MiR-26a plays crucial role in regulating the proliferative phase of LR, probably by repressing expressions of cell cycle proteins CCND2 and CCNE2. The current study reveals a novel miRNA-mediated regulation pattern during the proliferative phase of LR.	[Zhou, Jian; Ju, Weiqiang; Wang, Dongping; Wu, Linwei; Zhu, Xiaofeng; Guo, Zhiyong; He, Xiaoshun] Sun Yat Sen Univ, Organ Transplant Ctr, Affiliated Hosp 1, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University	Zhou, J (corresponding author), Sun Yat Sen Univ, Organ Transplant Ctr, Affiliated Hosp 1, Guangzhou 510275, Guangdong, Peoples R China.	rockyucsf1981@126.com; gdtrc@126.com			National High Technology Research and Development Program of China (863 Program) [2012AA021008]; Ministry of Health [2010159, 201002004]; National Natural Science Foundation of China [30972951, 81170448]	National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); Ministry of Health; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National High Technology Research and Development Program of China (863 Program) (2012AA021008), the Key Clinical Project from the Ministry of Health (2010159), National Natural Science Foundation of China (30972951 and 81170448), and special fund for science research by Ministry of Health (201002004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergmann A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3145re8; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Bockhorn M, 2007, J SURG RES, V138, P291, DOI 10.1016/j.jss.2006.07.027; Chang TC, 2008, NAT GENET, V40, P43, DOI 10.1038/ng.2007.30; Chen H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020238; Duncan AW, 2009, GASTROENTEROLOGY, V137, P466, DOI 10.1053/j.gastro.2009.05.044; Fausto N, 2004, HEPATOLOGY, V39, P1477, DOI 10.1002/hep.20214; Geng Y, 2003, CELL, V114, P431, DOI 10.1016/S0092-8674(03)00645-7; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Hammond SM, 2006, TRENDS MOL MED, V12, P99, DOI 10.1016/j.molmed.2006.01.004; Hardy J, 2004, SCIENCE, V303, P851, DOI 10.1126/science.1092712; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Jung J, 2011, INT IMMUNOPHARMACOL, V11, P976, DOI 10.1016/j.intimp.2011.02.012; Karp SJ, 2009, AM J TRANSPLANT, V9, P1973, DOI 10.1111/j.1600-6143.2009.02731.x; Kota J, 2009, CELL, V137, P1005, DOI 10.1016/j.cell.2009.04.021; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Kuramitsu K, 2011, HEPATOLOGY, V53, P2016, DOI 10.1002/hep.24317; Leeper NJ, 2011, J CELL PHYSIOL, V226, P1035, DOI 10.1002/jcp.22422; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu JA, 2011, CANCER RES, V71, P225, DOI 10.1158/0008-5472.CAN-10-1850; Luker GD, 2011, METHODS MOL BIOL, V680, P29, DOI 10.1007/978-1-60761-901-7_2; Lynn FC, 2009, TRENDS ENDOCRIN MET, V20, P452, DOI 10.1016/j.tem.2009.05.007; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; Marquez RT, 2010, AM J PHYSIOL-GASTR L, V298, pG535, DOI 10.1152/ajpgi.00338.2009; Matsuo R, 2011, ANN SURG, V253, P759, DOI 10.1097/SLA.0b013e318211caf8; Michalopoulos GK, 2007, J CELL PHYSIOL, V213, P286, DOI 10.1002/jcp.21172; Mitchell C, 2008, NAT PROTOC, V3, P1167, DOI 10.1038/nprot.2008.80; Ohtake Y, 2008, CELL BIOCHEM FUNCT, V26, P359, DOI 10.1002/cbf.1451; Pager CT, 2009, PROG MOL BIOL TRANSL, V90, P187, DOI 10.1016/S1877-1173(09)90005-9; Port JD, 2010, J CARDIOVASC PHARM, V56, P444, DOI 10.1097/FJC.0b013e3181f605b6; Shu JM, 2011, HEPATOLOGY, V54, P609, DOI 10.1002/hep.24421; Song GS, 2010, HEPATOLOGY, V51, P1735, DOI 10.1002/hep.23547; Sun SC, 2008, NEUROL INDIA, V56, P52; van der Meel R, 2010, DRUG DISCOV TODAY, V15, P102, DOI 10.1016/j.drudis.2009.12.003; Vermeulen K, 2003, CELL PROLIFERAT, V36, P131, DOI 10.1046/j.1365-2184.2003.00266.x; Weissleder R, 2008, NATURE, V452, P580, DOI 10.1038/nature06917; Wong CF, 2008, J BIOL CHEM, V283, P9836, DOI 10.1074/jbc.M709614200; Yang JD, 2010, WOUND REPAIR REGEN, V18, P524, DOI 10.1111/j.1524-475X.2010.00614.x; Yuan B, 2011, FEBS LETT, V585, P927, DOI 10.1016/j.febslet.2011.02.031; Zhang B, 2011, CARCINOGENESIS, V32, P2, DOI 10.1093/carcin/bgq209; Zhang N, 2004, BLOOD, V103, P617, DOI 10.1182/blood-2003-06-1820; Zimmermann A, 2004, NEPHROL DIAL TRANSPL, V19, P6, DOI 10.1093/ndt/gfh1034; Zinn KR, 2008, ILAR J, V49, P103, DOI 10.1093/ilar.49.1.103	43	55	64	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e33577	10.1371/journal.pone.0033577	http://dx.doi.org/10.1371/journal.pone.0033577			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GO	22496754	Green Submitted, Green Published, gold			2022-12-27	WOS:000304855200017
J	da Costa, LS; da Silva, APP; Da Poian, AT; El-Bacha, T				da Costa, Leandro Silva; Pereira da Silva, Ana Paula; Da Poian, Andrea T.; El-Bacha, Tatiana			Mitochondrial Bioenergetic Alterations in Mouse Neuroblastoma Cells Infected with Sindbis Virus: Implications to Viral Replication and Neuronal Death	PLOS ONE			English	Article							AGE-DEPENDENT RESISTANCE; OXIDATIVE STRESS; INDUCED APOPTOSIS; ACTIVATION; IDENTIFICATION; ENCEPHALITIS; DYSFUNCTION; RESPIRATION; INHIBITION; CALCIUM	The metabolic resources crucial for viral replication are provided by the host. Details of the mechanisms by which viruses interact with host metabolism, altering and recruiting high free-energy molecules for their own replication, remain unknown. Sindbis virus, the prototype of and most widespread alphavirus, causes outbreaks of arthritis in humans and serves as a model for the study of the pathogenesis of neurological diseases induced by alphaviruses in mice. In this work, respirometric analysis was used to evaluate the effects of Sindbis virus infection on mitochondrial bioenergetics of a mouse neuroblastoma cell lineage, Neuro 2a. The modulation of mitochondria] functions affected cellular ATP content and this was synchronous with Sindbis virus replication cycle and cell death. At 15 h, irrespective of effects on cell viability, viral replication induced a decrease in oxygen consumption uncoupled to ATP synthesis and a 36% decrease in maximum uncoupled respiration, which led to an increase of 30% in the fraction of oxygen consumption used for ATP synthesis. Decreased proton leak associated to complex I respiration contributed to the apparent improvement of mitochondrial function. Cellular ATP content was not affected by infection. After 24 h, mitochondria dysfunction was clearly observed as maximum uncoupled respiration reduced 65%, along with a decrease in the fraction of oxygen consumption used for ATP synthesis. Suppressed respiration driven by complexes I- and II-related substrates seemed to play a role in mitochondrial dysfunction. Despite the increase in glucose uptake and glycolytic flux, these changes were followed by a 30% decrease in ATP content and neuronal death. Taken together, mitochondrial bioenergetics is modulated during Sindbis virus infection in such a way as to favor ATP synthesis required to support active viral replication. These early changes in metabolism of Neuro 2a cells may form the molecular basis of neuronal dysfunction and Sindbis virus-induced encephalitis.	[da Costa, Leandro Silva; Pereira da Silva, Ana Paula; Da Poian, Andrea T.; El-Bacha, Tatiana] Univ Fed Rio de Janeiro, Inst Bioquim Med, Rio De Janeiro, Brazil; [Pereira da Silva, Ana Paula] Univ Fed Rio de Janeiro, Inst Ciencias Exatas, Dept Quim, Setor Bioquim, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	da Costa, LS (corresponding author), Univ Fed Rio de Janeiro, Inst Bioquim Med, Cidade Univ, Rio De Janeiro, Brazil.	elbachat@gmail.com	da Costa, Leandro Silva/X-9504-2019; da Silva, Ana/GXH-4851-2022; Da Poian, Andrea T./V-1699-2019; El-Bacha, Tatiana/ABH-1287-2020	da Costa, Leandro Silva/0000-0001-9697-4894; El-Bacha, Tatiana/0000-0003-0809-0218; Da Poian, Andrea/0000-0002-3969-704X	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-Brazilian Ministry of Science and Technology (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ); CNPq	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-Brazilian Ministry of Science and Technology (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-Brazilian Ministry of Science and Technology (CNPq), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) and Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ). L.S.C. is a recipient of a scholarship of CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAMATSU Y, 1994, YAKUGAKU ZASSHI, V114, P863, DOI 10.1248/yakushi1947.114.11_863; Andersen JK, 2004, NAT MED, V10, pS18, DOI 10.1038/nrn1434; Balachandran S, 2000, J VIROL, V74, P1513, DOI 10.1128/JVI.74.3.1513-1523.2000; Blas-Garcia A, 2010, HEPATOLOGY, V52, P115, DOI 10.1002/hep.23647; Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162; Caro C, 1998, INT J BIOCHEM CELL B, V30, P1031, DOI 10.1016/S1357-2725(98)00061-2; CHANCE B, 1956, ADV ENZYMOL REL S BI, V17, P65; Chapplain JM, 2011, HIV CLIN TRIALS, V12, P54, DOI 10.1310/hct1201-54; Chen HK, 2011, J BIOL CHEM, V286, P5215, DOI 10.1074/jbc.M110.151084; Despres P, 1996, J VIROL, V70, P4090; Einsiedel L, 2010, MITOCHONDRION, V10, P534, DOI 10.1016/j.mito.2010.05.010; El-Bacha T, 2004, MOL CELL BIOCHEM, V266, P191, DOI 10.1023/B:MCBI.0000049154.17866.00; El-Bacha T, 2007, BBA-MOL BASIS DIS, V1772, P1158, DOI 10.1016/j.bbadis.2007.08.003; Everett H, 2001, VIROLOGY, V288, P1, DOI 10.1006/viro.2001.1081; Fukui H, 2008, TRENDS NEUROSCI, V31, P251, DOI 10.1016/j.tins.2008.02.008; Galluzzi L, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000018; GARRY RF, 1986, VIROLOGY, V155, P378, DOI 10.1016/0042-6822(86)90201-1; Garry RF, 1994, J GEN VIROL 2, V75, P411; Gnaiger E, 2001, RESP PHYSIOL, V128, P277, DOI 10.1016/S0034-5687(01)00307-3; Gnaiger E, 2009, INT J BIOCHEM CELL B, V41, P1837, DOI 10.1016/j.biocel.2009.03.013; GRAY MA, 1983, J GEN VIROL, V64, P1449, DOI 10.1099/0022-1317-64-7-1449; Griffin DE, 2005, CURR TOP MICROBIOL, V289, P57; Griffin DE, 1997, ANNU REV MICROBIOL, V51, P565, DOI 10.1146/annurev.micro.51.1.565; Griffin DE, 2010, IMMUNOL RES, V47, P123, DOI 10.1007/s12026-009-8143-4; Halliwell B, 2006, J NEUROCHEM, V97, P1634, DOI 10.1111/j.1471-4159.2006.03907.x; Huang D, 2003, J CHROMATOGR B, V784, P101, DOI 10.1016/S1570-0232(02)00780-8; Hutter E, 2004, BIOCHEM J, V380, P919, DOI 10.1042/BJ20040095; JOHNSON RT, 1972, J INFECT DIS, V125, P257, DOI 10.1093/infdis/125.3.257; Kapadia SB, 2005, P NATL ACAD SCI USA, V102, P2561, DOI 10.1073/pnas.0409834102; Kowaltowski AJ, 1999, FREE RADICAL BIO MED, V26, P463, DOI 10.1016/S0891-5849(98)00216-0; Kowaltowski AJ, 2009, FREE RADICAL BIO MED, V47, P333, DOI 10.1016/j.freeradbiomed.2009.05.004; Labrada L, 2002, J VIROL, V76, P11688, DOI 10.1128/JVI.76.22.11688-11703.2002; Laine M, 2004, J INTERN MED, V256, P457, DOI 10.1111/j.1365-2796.2004.01413.x; LEVINE B, 1993, NATURE, V361, P739, DOI 10.1038/361739a0; Lewis J, 1999, NAT MED, V5, P832, DOI 10.1038/10556; Liang XH, 1998, J VIROL, V72, P8586, DOI 10.1128/JVI.72.11.8586-8596.1998; LIN KI, 1995, J CELL BIOL, V131, P1149, DOI 10.1083/jcb.131.5.1149; Lu TH, 2011, TOXICOL LETT, V204, P71, DOI 10.1016/j.toxlet.2011.04.013; Maity R, 2010, J CELL BIOCHEM, V109, P933, DOI 10.1002/jcb.22469; Maynard ND, 2010, BIOTECHNOL J, V5, P686, DOI 10.1002/biot.201000080; Munger J, 2008, NAT BIOTECHNOL, V26, P1179, DOI 10.1038/nbt.1500; Munger J, 2006, PLOS PATHOG, V2, P1165, DOI 10.1371/journal.ppat.0020132; Nagley R, 2009, BIOCHIM BIOPHYS ACTA, V1802, P167; Nicholls DG, 2008, ANN NY ACAD SCI, V1147, P53, DOI 10.1196/annals.1427.002; Ohta A, 2011, MITOCHONDRION, V11, P1, DOI 10.1016/j.mito.2010.08.006; Orvedahl A, 2010, CELL HOST MICROBE, V7, P115, DOI 10.1016/j.chom.2010.01.007; Parquet MD, 2001, FEBS LETT, V500, P17, DOI 10.1016/S0014-5793(01)02573-X; da Silva APP, 2009, BIOCHEM J, V417, P717, DOI 10.1042/BJ20080805; PETERHANS E, 1979, J VIROL, V29, P143, DOI 10.1128/JVI.29.1.143-152.1979; Renner K, 2003, BBA-MOL CELL RES, V1642, P115, DOI 10.1016/S0167-4889(03)00105-8; Ripoli M, 2010, J VIROL, V84, P647, DOI 10.1128/JVI.00769-09; Rodgers MA, 2009, J AM CHEM SOC, V131, P5030, DOI 10.1021/ja809949r; Rolfe DFS, 1997, PHYSIOL REV, V77, P731, DOI 10.1152/physrev.1997.77.3.731; SAWICKI DL, 1990, VIROLOGY, V174, P43, DOI 10.1016/0042-6822(90)90052-S; Scherbik SV, 2010, J VIROL, V84, P8721, DOI 10.1128/JVI.00144-10; Simmons JD, 2010, J VIROL, V84, P11429, DOI 10.1128/JVI.00577-10; Skulachev VP, 2006, APOPTOSIS, V11, P473, DOI 10.1007/s10495-006-5881-9; Sorbara LR, 1996, J VIROL, V70, P7275, DOI 10.1128/JVI.70.10.7275-7279.1996; Sumpter R, 2011, AUTOPHAGY, V7, P260, DOI 10.4161/auto.7.3.14281; Ubol S, 1996, J VIROL, V70, P2215, DOI 10.1128/JVI.70.4.2215-2220.1996; Vastag L, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002124; Verrier F, 2003, ANN NY ACAD SCI, V1010, P126, DOI 10.1196/annals.1299.022; WIDNELL CC, 1990, FASEB J, V4, P1634, DOI 10.1096/fasebj.4.6.2156742; Wishart DS, 2007, NUCLEIC ACIDS RES, V35, pD521, DOI 10.1093/nar/gkl923; Wojda U, 2008, IUBMB LIFE, V60, P575, DOI 10.1002/iub.91	65	30	30	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2012	7	4							e33871	10.1371/journal.pone.0033871	http://dx.doi.org/10.1371/journal.pone.0033871			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952GU	22485151	Green Submitted, gold, Green Published			2022-12-27	WOS:000304780500027
J	Valdez, G; Tapia, JC; Lichtman, JW; Fox, MA; Sanes, JR				Valdez, Gregorio; Tapia, Juan C.; Lichtman, Jeff W.; Fox, Michael A.; Sanes, Joshua R.			Shared Resistance to Aging and ALS in Neuromuscular Junctions of Specific Muscles	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; FRONTOTEMPORAL LOBAR DEGENERATION; AGE-RELATED-CHANGES; NEURODEGENERATIVE DISEASES; EXTRAOCULAR-MUSCLES; SUPEROXIDE-DISMUTASE; AXONAL-TRANSPORT; TRANSGENIC MICE; MOTOR-NEURONS; ONUFS NUCLEUS	Normal aging and neurodegenerative diseases both lead to structural and functional alterations in synapses. Comparison of synapses that are generally similar but respond differently to insults could provide the basis for discovering mechanisms that underlie susceptibility or resistance to damage. Here, we analyzed skeletal neuromuscular junctions (NMJs) in 16 mouse muscles to seek such differences. We find that muscles respond in one of three ways to aging. In some, including most limb and trunk muscles, age-related alterations to NMJs are progressive and extensive during the second postnatal year. NMJs in other muscles, such as extraocular muscles, are strikingly resistant to change. A third set of muscles, including several muscles of facial expression and the external anal sphinter, succumb to aging but not until the third postnatal year. We asked whether susceptible and resistant muscles differed in rostrocaudal or proximodistal position, source of innervation, motor unit size, or fiber type composition. Of these factors, muscle innervation by brainstem motor neurons correlated best with resistance to age-related decline. Finally, we compared synaptic alterations in normally aging muscles to those in a mouse model of amyotrophic lateral sclerosis (ALS). Patterns of resistance and susceptibility were strikingly correlated in the two conditions. Moreover, damage to NMJs in aged muscles correlated with altered expression and distribution of CRMP4a and TOP-43, which are both altered in motor neurons affected by ALS. Together, these results reveal novel structural regional and molecular parallels between aging and ALS.	[Valdez, Gregorio; Tapia, Juan C.; Lichtman, Jeff W.; Fox, Michael A.; Sanes, Joshua R.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Valdez, Gregorio; Tapia, Juan C.; Lichtman, Jeff W.; Fox, Michael A.; Sanes, Joshua R.] Harvard Univ, Ctr Brain Sci, Cambridge, MA 02138 USA; [Fox, Michael A.] Virginia Commonwealth Univ, Dept Anat & Neurobiol, Richmond, VA USA	Harvard University; Harvard University; Virginia Commonwealth University	Valdez, G (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.	sanesj@mcb.harvard.edu		Fox, Michael/0000-0002-1649-7782	NIH [R01AG032322]; NRSA from NINDS/NIH; NATIONAL INSTITUTE ON AGING [R01AG032322] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NRSA from NINDS/NIH; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grant R01AG032322 from the NIH to J.R.S. and J.W.L. G.V. was supported by a NRSA Postdoctoral Fellowship from NINDS/NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen BB, 2003, J COMP NEUROL, V466, P356, DOI 10.1002/cne.10884; Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093; Atkin JD, 2005, NEUROMUSCULAR DISORD, V15, P377, DOI 10.1016/j.nmd.2005.02.005; BERGMANN M, 1995, J NEUROL SCI, V129, P141, DOI 10.1016/0022-510X(94)00263-N; Briggs MM, 2002, J EXP BIOL, V205, P3133; Burke SN, 2010, TRENDS NEUROSCI, V33, P153, DOI 10.1016/j.tins.2009.12.003; Burke SN, 2006, NAT REV NEUROSCI, V7, P30, DOI 10.1038/nrn1809; Chakkalakal JV, 2010, DEVELOPMENT, V137, P3489, DOI 10.1242/dev.053348; Cohen TJ, 2011, TRENDS MOL MED, V17, P659, DOI 10.1016/j.molmed.2011.06.004; De Vos KJ, 2008, ANNU REV NEUROSCI, V31, P151, DOI 10.1146/annurev.neuro.31.061307.090711; Deschenes MR, 2011, CURR AGING SCI; Duan HL, 2003, CEREB CORTEX, V13, P950, DOI 10.1093/cercor/13.9.950; Duplan L, 2010, J NEUROSCI, V30, P785, DOI 10.1523/JNEUROSCI.5411-09.2010; ELKERDANY MK, 1993, ANAT REC, V237, P291, DOI 10.1002/ar.1092370215; FAHIM MA, 1983, J NEUROCYTOL, V12, P13, DOI 10.1007/BF01148085; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Fischer LR, 2004, EXP NEUROL, V185, P232, DOI 10.1016/j.expneurol.2003.10.004; Fox MA, 2011, J COMP NEUROL, V519, P2907, DOI 10.1002/cne.22700; Frolkis VV, 1997, EXP GERONTOL, V32, P441, DOI 10.1016/S0531-5565(96)00168-4; Goldberg SJ, 1999, PROG BRAIN RES, V123, P221, DOI 10.1016/S0079-6123(08)62859-9; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Hegedus J, 2007, NEUROBIOL DIS, V28, P154, DOI 10.1016/j.nbd.2007.07.003; Hof PR, 2004, TRENDS NEUROSCI, V27, P607, DOI 10.1016/j.tins.2004.07.013; KAMINSKI HJ, 1992, ANN NEUROL, V32, P586, DOI 10.1002/ana.410320418; KELLER EL, 1971, J NEUROPHYSIOL, V34, P908, DOI 10.1152/jn.1971.34.5.908; Keller-Peck CR, 2001, NEURON, V31, P381, DOI 10.1016/S0896-6273(01)00383-X; Kihira T, 1997, J NEUROL SCI, V147, P81, DOI 10.1016/S0022-510X(96)05313-0; LEXELL J, 1995, J GERONTOL A-BIOL, V50, P11; MANNEN T, 1982, ACTA NEUROPATHOL, V58, P255, DOI 10.1007/BF00688606; Mehler MF, 2000, TRENDS NEUROSCI, V23, P599, DOI 10.1016/S0166-2236(00)01705-7; Morrison BM, 1998, ANN NEUROL, V44, pS32, DOI 10.1002/ana.410440706; Mosier DR, 2000, NEUROLOGY, V54, P252, DOI 10.1212/WNL.54.1.252; Murray LM, 2008, HUM MOL GENET, V17, P949, DOI 10.1093/hmg/ddm367; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Page TL, 2002, NEUROSCI LETT, V317, P37, DOI 10.1016/S0304-3940(01)02428-4; PARDO CA, 1995, P NATL ACAD SCI USA, V92, P954, DOI 10.1073/pnas.92.4.954; Pette D, 2000, MICROSC RES TECHNIQ, V50, P500, DOI 10.1002/1097-0029(20000915)50:6<500::AID-JEMT7>3.0.CO;2-7; Porter JD, 2002, ANN NY ACAD SCI, V956, P7, DOI 10.1111/j.1749-6632.2002.tb02804.x; PORTER JD, 1989, INVEST OPHTH VIS SCI, V30, P1894; Prakash YS, 1998, MUSCLE NERVE, V21, P887, DOI 10.1002/(SICI)1097-4598(199807)21:7<887::AID-MUS6>3.0.CO;2-2; REINER A, 1995, EXP NEUROL, V131, P239, DOI 10.1016/0014-4886(95)90046-2; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Ryan S, 2007, ANAT SCI INT, V82, P1, DOI 10.1111/j.1447-073x.2006.00154.x; SARTORE S, 1987, J MUSCLE RES CELL M, V8, P161, DOI 10.1007/BF01753992; Saxena S, 2011, NEURON, V71, P35, DOI 10.1016/j.neuron.2011.06.031; Schaefer AM, 2005, J COMP NEUROL, V490, P209, DOI 10.1002/cne.20620; Schiaffino S, 2011, PHYSIOL REV, V91, P1447, DOI 10.1152/physrev.00031.2010; Stokin GB, 2006, ANNU REV BIOCHEM, V75, P607, DOI 10.1146/annurev.biochem.75.103004.142637; Valdez G, 2010, P NATL ACAD SCI USA, V107, P14863, DOI 10.1073/pnas.1002220107; Vandervoort AA, 2002, MUSCLE NERVE, V25, P17, DOI 10.1002/mus.1215; von Bohlen und Halbach O, 2006, J NEUROSCI RES, V83, P525, DOI 10.1002/jnr.20759; Wegorzewska I, 2009, P NATL ACAD SCI USA, V106, P18809, DOI 10.1073/pnas.0908767106; WIECZOREK DF, 1985, J CELL BIOL, V101, P618, DOI 10.1083/jcb.101.2.618	53	144	146	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2012	7	4							e34640	10.1371/journal.pone.0034640	http://dx.doi.org/10.1371/journal.pone.0034640			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952GU	22485182	Green Published, gold			2022-12-27	WOS:000304780500057
J	Berquist, RM; Gledhill, KM; Peterson, MW; Doan, AH; Baxter, GT; Yopak, KE; Kang, N; Walker, HJ; Hastings, PA; Frank, LR				Berquist, Rachel M.; Gledhill, Kristen M.; Peterson, Matthew W.; Doan, Allyson H.; Baxter, Gregory T.; Yopak, Kara E.; Kang, Ning; Walker, H. J.; Hastings, Philip A.; Frank, Lawrence R.			The Digital Fish Library: Using MRI to Digitize, Database, and Document the Morphological Diversity of Fish	PLOS ONE			English	Article							MAGNETIC-RESONANCE MICROSCOPY; HIGH-RESOLUTION; DIFFUSION PROPERTIES; COMPUTED-TOMOGRAPHY; CRANIAL ENDOTHERMY; VIRTUAL HISTOLOGY; MOUSE ATLAS; TISSUE; PHYLOGENY; TOOLS	Museum fish collections possess a wealth of anatomical and morphological data that are essential for documenting and understanding biodiversity. Obtaining access to specimens for research, however, is not always practical and frequently conflicts with the need to maintain the physical integrity of specimens and the collection as a whole. Non-invasive three-dimensional (3D) digital imaging therefore serves a critical role in facilitating the digitization of these specimens for anatomical and morphological analysis as well as facilitating an efficient method for online storage and sharing of this imaging data. Here we describe the development of the Digital Fish Library (DFL, http://www.digitalfishlibrary.org), an online digital archive of high-resolution, high-contrast, magnetic resonance imaging (MRI) scans of the soft tissue anatomy of an array of fishes preserved in the Marine Vertebrate Collection of Scripps Institution of Oceanography. We have imaged and uploaded MRI data for over 300 marine and freshwater species, developed a data archival and retrieval system with a web-based image analysis and visualization tool, and integrated these into the public DFL website to disseminate data and associated metadata freely over the web. We show that MRI is a rapid and powerful method for accurately depicting the in-situ soft-tissue anatomy of preserved fishes in sufficient detail for large-scale comparative digital morphology. However these 3D volumetric data require a sophisticated computational and archival infrastructure in order to be broadly accessible to researchers and educators.	[Berquist, Rachel M.; Gledhill, Kristen M.; Peterson, Matthew W.; Doan, Allyson H.; Baxter, Gregory T.; Yopak, Kara E.; Kang, Ning; Frank, Lawrence R.] Univ Calif San Diego, Ctr Sci Computat Imaging, La Jolla, CA 92093 USA; [Walker, H. J.; Hastings, Philip A.] Univ Calif San Diego, Scripps Inst Oceanog, Marine Vertebrate Collect & Marine Biol Res Div, La Jolla, CA 92093 USA; [Frank, Lawrence R.] Univ Calif San Diego, Ctr Funct Magnet Resonance Imaging, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Scripps Institution of Oceanography; University of California System; University of California San Diego	Berquist, RM (corresponding author), Univ Calif San Diego, Ctr Sci Computat Imaging, La Jolla, CA 92093 USA.	lfrank@ucsd.edu	Yopak, Kara E/A-5549-2012	Yopak, Kara E/0000-0002-7870-9066; Hastings, Philip/0000-0002-9867-6601	National Science Foundation (NSF) [DBI-0446389, EF-0850369]; Division Of Earth Sciences [0948842] Funding Source: National Science Foundation; Emerging Frontiers [0850369] Funding Source: National Science Foundation	National Science Foundation (NSF)(National Science Foundation (NSF)); Division Of Earth Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Emerging Frontiers(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The DFL received its primary funding from the Biological Infrastructure Program (Grant DBI-0446389) of the National Science Foundation (NSF: http://www.nsf.gov/div/index.jsp?div=DBI) with additional funding provided by NSF award EF-0850369. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI [10.1006/jmrb.1996.0086, 10.1016/j.jmr.2011.09.022]; Bernstein M.A., 2004, HDB MRI PULSE SEQUEN, DOI 10.1016/B978-012092861-3/50021-2; Betz O, 2007, J MICROSC-OXFORD, V227, P51, DOI 10.1111/j.1365-2818.2007.01785.x; BLACKBAND SJ, 1990, MAGN RESON IMAGING, V8, P191, DOI 10.1016/0730-725X(90)90253-X; Blits KC, 1999, ANAT REC, V257, P58; Bock C, 2002, MAGN RESON IMAGING, V20, P165, DOI 10.1016/S0730-725X(02)00482-4; Bookstein FL, 1996, B MATH BIOL, V58, P313, DOI 10.1016/0092-8240(95)00329-0; Bryson-Richardson RJ, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-34; Callaghan P., 1991, PRINCIPLES NUCL MAGN; Chakrabarty P, 2011, J MORPHOL, V272, P704, DOI 10.1002/jmor.10941; Chanet B, 2007, CYBIUM, V31, P107; Chanet B, 2009, CR BIOL, V332, P413, DOI 10.1016/j.crvi.2008.12.002; Clabaut C, 2007, EVOLUTION, V61, P560, DOI 10.1111/j.1558-5646.2007.00045.x; Cleary JO, 2011, NEUROIMAGE, V54, P769, DOI 10.1016/j.neuroimage.2010.07.039; CLOUTIER R, 1988, ENVIRON BIOL FISH, V23, P281, DOI 10.1007/BF00005239; Cnudde V, 2008, J MICROSC-OXFORD, V232, P476, DOI 10.1111/j.1365-2818.2008.02142.x; Corfield JR, 2008, NAT PROTOC, V3, P597, DOI 10.1038/nprot.2008.17; De Groof G, 2006, NEUROIMAGE, V29, P754, DOI 10.1016/j.neuroimage.2005.09.022; Dhenain M, 2001, DEV BIOL, V232, P458, DOI 10.1006/dbio.2001.0189; Dickinson ME, 2006, DEV DYNAM, V235, P2386, DOI 10.1002/dvdy.20889; Dinley J, 2010, J MICROSC-OXFORD, V238, P123, DOI 10.1111/j.1365-2818.2009.03335.x; Dogdas B, 2007, PHYS MED BIOL, V52, P577, DOI 10.1088/0031-9155/52/3/003; Driehuys B, 2008, ILAR J, V49, P35, DOI 10.1093/ilar.49.1.35; Fishbein KW, 2007, MAGN RESON MED, V57, P866, DOI 10.1002/mrm.21189; FISHELSON L, 1991, JPN J ICHTHYOL, V38, P17, DOI 10.1007/BF02910104; Forbes JG, 2006, MAGN RESON IMAGING, V24, P321, DOI 10.1016/j.mri.2005.10.036; Giribet G, 2010, ACTA ZOOL-STOCKHOLM, V91, P11, DOI 10.1111/j.1463-6395.2009.00420.x; Hart AG, 2003, J INSECT SCI, V3, DOI 10.1093/jis/3.1.5; Hastings PA, 2011, ZOOTAXA, P57, DOI 10.11646/zootaxa.2946.1.12; Hayat M. A, 1970, PRINCIPLES TECHNIQUE, V1; Heemskerk AM, 2007, CURR MED IMAGING REV, V3, P152, DOI 10.2174/157340507781386988; Herberholz J, 2004, J EXP BIOL, V207, P4543, DOI 10.1242/jeb.01328; Houle D, 2010, P NATL ACAD SCI USA, V107, P1793, DOI 10.1073/pnas.0906195106; Jacobs RE, 2003, NAT CELL BIOL, pSS10, DOI 10.1038/nrm1195; Jiang Y, 2004, MAGN RESON MED, V52, P453, DOI 10.1002/mrm.20191; Johnston P, 2011, J MORPHOL, V272, P1492, DOI 10.1002/jmor.10998; Kalat TM, 2010, APPL MAGN RESON, V38, P361, DOI 10.1007/s00723-010-0122-3; Kherlopian AR, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-74; Lauridsen H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017879; LIEM KF, 1991, AM ZOOL, V31, P759; Liste F, 2006, VET RADIOL ULTRASOUN, V47, P453, DOI 10.1111/j.1740-8261.2006.00167.x; Mathiassen JR, 2011, TRENDS FOOD SCI TECH, V22, P257, DOI 10.1016/j.tifs.2011.03.006; Metscher BD, 2009, DEV DYNAM, V238, P632, DOI 10.1002/dvdy.21857; MOK HK, 1982, JPN J ICHTHYOL, V29, P43; MOK HK, 1981, JPN J ICHTHYOL, V27, P281; Nelson JS, 2006, FISHES WORLD, DOI DOI 10.1002/9781119174844; Newman JD, 2009, BRAIN RES REV, V62, P1, DOI 10.1016/j.brainresrev.2009.09.001; Nott KP, 1999, FOOD SCI TECHNOL-LEB, V32, P261; Nott KP, 1999, MAGN RESON IMAGING, V17, P445, DOI 10.1016/S0730-725X(98)00189-1; Pena H, 2008, ICES J MAR SCI, V65, P1751, DOI 10.1093/icesjms/fsn190; Peng HC, 2010, NAT BIOTECHNOL, V28, P348, DOI 10.1038/nbt.1612; Perry CN, 2007, J MORPHOL, V268, P284, DOI 10.1002/jmor.10516; Petiet A, 2007, J MAGN RESON IMAGING, V25, P1192, DOI 10.1002/jmri.20932; Petiet AE, 2008, P NATL ACAD SCI USA, V105, P12331, DOI 10.1073/pnas.0805747105; Plyusnin I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001742; Prager RW, 2010, P I MECH ENG H, V224, P193, DOI 10.1243/09544119JEIM586; Prieto-Marquez A, 2007, J MORPHOL, V268, P1120; Pyle RL, 2008, ZOOTAXA, P3, DOI 10.11646/zootaxa.1671.1.2; Richtarski U, 2000, J FISH BIOL, V56, P22, DOI 10.1006/jfbi.1999.1137; Rogers BL, 2008, CAN J FISH AQUAT SCI, V65, P1245, DOI 10.1139/F08-102; Rowe T, 1999, J VERTEBR PALEONTOL, V19, P1, DOI 10.1080/02724634.1999.10011200; Rowe T, 2011, SCIENCE, V331, P712, DOI 10.1126/science.1202828; Ruffins SW, 2007, THESCIENTIFICWORLDJO, V7, P592, DOI 10.1100/tsw.2007.125; Runcie RM, 2009, J EXP BIOL, V212, P461, DOI 10.1242/jeb.022814; SCHULTZE HP, 1991, ENVIRON BIOL FISH, V32, P159, DOI 10.1007/BF00007451; Scotland RW, 2003, SYST BIOL, V52, P539, DOI 10.1080/10635150390223613; Seltman K, 2007, J MORPHOL, V268, P1132; Sepulveda CA, 2007, J FISH BIOL, V70, P1720, DOI 10.1111/j.1095-8649.2007.01446.x; Sharpe J, 2002, SCIENCE, V296, P541, DOI 10.1126/science.1068206; Shen L, 2009, EVOLUTION, V63, P1003, DOI 10.1111/j.1558-5646.2008.00557.x; Shepherd TM, 2009, MAGN RESON MED, V62, P26, DOI 10.1002/mrm.21977; SMEETS WJAJ, 1976, J COMP NEUROL, V165, P333, DOI 10.1002/cne.901650305; Sparks JS, 2008, B AM MUS NAT HIST, P5; Strijkers GJ, 2007, ANTI-CANCER AGENT ME, V7, P291, DOI 10.2174/187152007780618135; Suarez AV, 2004, BIOSCIENCE, V54, P66, DOI 10.1641/0006-3568(2004)054[0066:TVOMCF]2.0.CO;2; Taylor W. R., 1967, Proceedings of the United States National Museum, V122, P1; Thacker PD, 2003, BIOSCIENCE, V53, P544, DOI 10.1641/0006-3568(2003)053[0544:MTSOTT]2.0.CO;2; The Digital Fish Library Earthguide Module, DES DEEP FISH; Thelwall PE, 2006, MAGN RESON MED, V56, P282, DOI 10.1002/mrm.20962; THICKMAN DI, 1983, RADIOLOGY, V148, P183, DOI 10.1148/radiology.148.1.6856832; Tyszka JM, 2006, NEUROIMAGE, V29, P1058, DOI 10.1016/j.neuroimage.2005.08.037; Tyszka JM, 2005, CURR OPIN BIOTECH, V16, P93, DOI 10.1016/j.copbio.2004.11.004; Ullmann JFP, 2010, J MORPHOL, V271, P1446, DOI 10.1002/jmor.10887; Ullmann JFP, 2010, NMR BIOMED, V23, P341, DOI 10.1002/nbm.1465; Ullmann JFP, 2010, NEUROIMAGE, V51, P76, DOI 10.1016/j.neuroimage.2010.01.086; Van der Linden A, 2007, NMR BIOMED, V20, P522, DOI 10.1002/nbm.1131; Vasquez SX, 2008, ANAT REC, V291, P475, DOI 10.1002/ar.20670; Veliyulin E, 2006, MOD MAGN RESON, V1, P959, DOI [10.1007/1-4020-3910-7_111, DOI 10.1007/1-4020-3910-7_111]; Waller G, 1996, NATURE, V380, P209, DOI 10.1038/380209a0; WALLER GNH, 1994, MAGN RESON IMAGING, V12, P535, DOI 10.1016/0730-725X(94)92548-8; Walter T, 2010, NAT METHODS, V7, pS26, DOI [10.1038/nmeth.1431, 10.1038/NMETH.1431]; Weinmann HJ, 2003, EUR J RADIOL, V46, P33, DOI 10.1016/S0720-048X(02)00332-7; Westneat MW, 2008, ANNU REV PHYSIOL, V70, P119, DOI 10.1146/annurev.physiol.70.113006.100434; Winston JE, 2007, ZOOTAXA, P47, DOI 10.11646/zootaxa.1668.1.6; WINTERBOTTOM R, 1974, P ACAD NAT SCI PHILA, V125, P225; Yopak KE, 2009, BRAIN BEHAV EVOLUT, V74, P121, DOI 10.1159/000235962; Yopak KE, 2007, BRAIN BEHAV EVOLUT, V70, P210; Yushkevich PA, 2006, NEUROIMAGE, V31, P1116, DOI 10.1016/j.neuroimage.2006.01.015; Ziegler A, COMP MORPHOLOGY AXIA; Ziegler A, 2011, ZOOMORPHOLOGY, V130, P227, DOI 10.1007/s00435-011-0138-8; Ziegler A, 2011, METHODS MOL BIOL, V771, P633, DOI 10.1007/978-1-61779-219-9_32; Ziegler A, 2010, BIOL DIRECT, V5, DOI 10.1186/1745-6150-5-45; Ziegler A, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-33	103	41	43	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2012	7	4							e34499	10.1371/journal.pone.0034499	http://dx.doi.org/10.1371/journal.pone.0034499			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JA	22493695	Green Published, gold, Green Submitted			2022-12-27	WOS:000305012700037
J	Jenq, RR; Curran, MA; Goldberg, GL; Liu, C; Allison, JP; van den Brink, MRM				Jenq, Robert R.; Curran, Michael A.; Goldberg, Gabrielle L.; Liu, Chen; Allison, James P.; van den Brink, Marcel R. M.			Repertoire Enhancement with Adoptively Transferred Female Lymphocytes Controls the Growth of Pre-Implanted Murine Prostate Cancer	PLOS ONE			English	Article							VERSUS-HOST-DISEASE; BONE-MARROW-TRANSPLANTATION; ANDROGEN-REGULATED GENES; TRAMP MODEL; DONOR AGE; ANTIGEN; CELLS; EXPRESSION; BLOCKADE; RISK	Background: In prostate cancer, genes encoding androgen-regulated, Y-chromosome-encoded, and tissue-specific antigens may all be overexpressed. In the adult male host, however, most high affinity T cells targeting these potential tumor rejection antigens will be removed during negative selection. In contrast, the female mature T-cell repertoire should contain abundant precursors capable of recognizing these classes of prostate cancer antigens and mediating effective anti-tumor immune responses. Methodology/Principal Findings: We find that syngeneic TRAMP-C2 prostatic adenocarcinoma cells are spontaneously rejected in female hosts. Adoptive transfer of naive female lymphocytes to irradiated male hosts bearing pre-implanted TRAMP-C2 tumor cells slows tumor growth and mediates tumor rejection in some animals. The success of this adoptive transfer was dependent on the transfer of female CD4 T cells and independent of the presence of CD25-expressing regulatory T cells in the transferred lymphocytes. We identify in female CD4 T cells stimulated with TRAMP-C2 a dominant MHC II-restricted response to the Y-chromosome antigen DBY. Furthermore, CD8 T cell responses in female lymphocytes to the immunodominant MHC I-restricted antigen SPAS-1 are markedly increased compared to male mice. Finally, we find no exacerbation of graft-versus-host disease in either syngeneic or minor-antigen mismatched allogeneic lymphocyte adoptive transfer models by using female into male versus male into male cells. Conclusions/Significance: This study shows that adoptively transferred female lymphocytes, particularly CD4 T cells, can control the outgrowth of pre-implanted prostatic adenocarcinoma cells. This approach does not significantly worsen graft-versus-host responses suggesting it may be viable in the clinic. Further, enhancing the available immune repertoire with female-derived T cells may provide an excellent pool of prostate cancer reactive T cells for further augmentation by combination with either vaccination or immune regulatory blockade strategies.	[Jenq, Robert R.; Goldberg, Gabrielle L.; van den Brink, Marcel R. M.] Mem Sloan Kettering Canc Ctr, Dept Immunol & Med, New York, NY 10021 USA; [Jenq, Robert R.] Weill Cornell Med Coll, New York, NY USA; [Curran, Michael A.; Allison, James P.] Mem Sloan Kettering Canc Ctr, Dept Immunol, Howard Hughes Med Inst, New York, NY 10021 USA; [Liu, Chen] Univ Florida, Coll Med, Dept Pathol Immunol & Lab Med, Gainesville, FL USA	Memorial Sloan Kettering Cancer Center; Cornell University; Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center; State University System of Florida; University of Florida	Jenq, RR (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Immunol & Med, 1275 York Ave, New York, NY 10021 USA.	vandenbm@mskcc.org	van den Brink, Marcel R. M./HGB-9434-2022	Allison, James/0000-0001-8980-5697; Jenq, Robert/0000-0002-5434-439X; Curran, Michael/0000-0003-4996-7207	National Institutes of Health [R01-HL069929, R01-CA107096, R01-AI080455]; United States Department of Defense: USAMRAA [W81XWH-09-1-0294]; Radiation Effects Research Foundation (RERF-NIAID); Experimental Therapeutics Center of Memorial Sloan-Kettering Cancer Center; Lymphoma Foundation; Alex's Lemonade Stand; Geoffrey Beene Cancer Research Center at Memorial Sloan-Kettering Cancer Center; Peter Solomon Fund, Research and Therapeutics Program in Prostate Cancer; NATIONAL CANCER INSTITUTE [P30CA008748, R01CA107096] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069929] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080455] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Defense: USAMRAA; Radiation Effects Research Foundation (RERF-NIAID); Experimental Therapeutics Center of Memorial Sloan-Kettering Cancer Center; Lymphoma Foundation; Alex's Lemonade Stand; Geoffrey Beene Cancer Research Center at Memorial Sloan-Kettering Cancer Center; Peter Solomon Fund, Research and Therapeutics Program in Prostate Cancer; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by National Institutes of Health award numbers R01-HL069929 (MvdB), R01-CA107096 (MvdB), R01-AI080455 (MvdB). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Support was also received from the United States Department of Defense: USAMRAA Award W81XWH-09-1-0294 (MvdB), the Radiation Effects Research Foundation (RERF-NIAID) (MvdB), The Experimental Therapeutics Center of Memorial Sloan-Kettering Cancer Center funded by Mr. William H. Goodwin and Mrs. Alice Goodwin, The Lymphoma Foundation, Alex's Lemonade Stand, The Geoffrey Beene Cancer Research Center at Memorial Sloan-Kettering Cancer Center, The Peter Solomon Fund, Research and Therapeutics Program in Prostate Cancer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATKINSON K, 1986, BRIT J HAEMATOL, V63, P231; Barrett AJ, 2008, BRIT J HAEMATOL, V142, P877, DOI 10.1111/j.1365-2141.2008.07260.x; Chen H, 2009, P NATL ACAD SCI USA, V106, P2729, DOI 10.1073/pnas.0813175106; Cooke KR, 1996, BLOOD, V88, P3230, DOI 10.1182/blood.V88.8.3230.bloodjournal8883230; Curran MA, 2010, P NATL ACAD SCI USA, V107, P4275, DOI 10.1073/pnas.0915174107; Curran MA, 2009, CANCER RES, V69, P7747, DOI 10.1158/0008-5472.CAN-08-3289; Dasari VK, 2001, J UROLOGY, V165, P1335, DOI 10.1016/S0022-5347(01)69895-1; Fasso M, 2008, P NATL ACAD SCI USA, V105, P3509, DOI 10.1073/pnas.0712269105; FLOWERS MED, 1990, BRIT J HAEMATOL, V74, P492, DOI 10.1111/j.1365-2141.1990.tb06340.x; Fong L, 2009, CANCER RES, V69, P609, DOI 10.1158/0008-5472.CAN-08-3529; Foster BA, 1997, CANCER RES, V57, P3325; Garcia-Hernandez MDL, 2007, CANCER RES, V67, P1344, DOI 10.1158/0008-5472.CAN-06-2996; Gingrich JR, 1997, CANCER RES, V57, P4687; Gregory CW, 1998, CANCER RES, V58, P5718; Hill GR, 1997, BLOOD, V90, P3204, DOI 10.1182/blood.V90.8.3204; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Hurwitz Arthur A, 2001, Curr Protoc Immunol, VChapter 20, DOI 10.1002/0471142735.im2005s45; Jenq RR, 2009, BLOOD, V113, P1574, DOI 10.1182/blood-2008-05-155697; Kantoff PW, 2010, NEW ENGL J MED, V363, P411, DOI 10.1056/NEJMoa1001294; Kolb HJ, 2008, BLOOD, V112, P4371, DOI 10.1182/blood-2008-03-077974; Kollman C, 2001, BLOOD, V98, P2043, DOI 10.1182/blood.V98.7.2043; Kumar A, 2011, P NATL ACAD SCI USA, V108, P17087, DOI 10.1073/pnas.1108745108; Mapara MY, 2002, BLOOD, V100, P1903, DOI 10.1182/blood-2002-01-0023; Na IK, 2010, J CLIN INVEST, V120, P343, DOI 10.1172/JCI39395; Peggs KS, 2008, IMMUNOL REV, V224, P141, DOI 10.1111/j.1600-065X.2008.00649.x; Perez-Diez A, 2007, BLOOD, V109, P5346, DOI 10.1182/blood-2006-10-051318; SYKES M, 1988, BONE MARROW TRANSPL, V3, P379; Turcotte Simon, 2011, Adv Surg, V45, P341; Xu LL, 2001, INT J CANCER, V92, P322, DOI 10.1002/ijc.1196; Yanagisawa S, 1997, INT IMMUNOL, V9, P227, DOI 10.1093/intimm/9.2.227; Yi HF, 2011, CANCER IMMUNOL IMMUN, V60, P349, DOI 10.1007/s00262-010-0939-5	31	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2012	7	4							e35222	10.1371/journal.pone.0035222	http://dx.doi.org/10.1371/journal.pone.0035222			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JA	22493742	Green Submitted, Green Published, gold			2022-12-27	WOS:000305012700084
J	Kipfer, T; Wohlgemuth, T; van der Heijden, MGA; Ghazoul, J; Egli, S				Kipfer, Tabea; Wohlgemuth, Thomas; van der Heijden, Marcel G. A.; Ghazoul, Jaboury; Egli, Simon			Growth Response of Drought-Stressed Pinus sylvestris Seedlings to Single- and Multi-Species Inoculation with Ectomycorrhizal Fungi	PLOS ONE			English	Article							MYCORRHIZAL ASSOCIATIONS; ECOSYSTEM FUNCTION; ENZYME-ACTIVITIES; DIVERSITY; PRODUCTIVITY; BIODIVERSITY; PLANTS; RESISTANCE; SECRETION; NUTRITION	Many trees species form symbiotic associations with ectomycorrhizal (ECM) fungi, which improve nutrient and water acquisition of their host. Until now it is unclear whether the species richness of ECM fungi is beneficial for tree seedling performance, be it during moist conditions or drought. We performed a pot experiment using Pinus sylvestris seedlings inoculated with four selected ECM fungi (Cenococcum geophilum, Paxillus involutus, Rhizopogon roseolus and Suillus granulatus) to investigate (i) whether these four ECM fungi, in monoculture or in species mixtures, affect growth of P. sylvestris seedlings, and (ii) whether this effect can be attributed to species number per se or to species identity. Two different watering regimes (moist vs. dry) were applied to examine the context-dependency of the results. Additionally, we assessed the activity of eight extracellular enzymes in the root tips. Shoot growth was enhanced in the presence of S. granulatus, but not by any other ECM fungal species. The positive effect of S. granulatus on shoot growth was more pronounced under moist (threefold increase) than under dry conditions (twofold increase), indicating that the investigated ECM fungi did not provide additional support during drought stress. The activity of secreted extracellular enzymes was higher in S. granulatus than in any other species. In conclusion, our findings suggest that ECM fungal species composition may affect seedling performance in terms of aboveground biomass.	[Kipfer, Tabea; Wohlgemuth, Thomas; Egli, Simon] Swiss Fed Res Inst WSL, Birmensdorf, Switzerland; [Kipfer, Tabea; Ghazoul, Jaboury] ETH, Inst Terr Ecosyst, Zurich, Switzerland; [van der Heijden, Marcel G. A.] Agroscope Reckenholz Tanikon, Ecol Farming Syst, Zurich, Switzerland; [van der Heijden, Marcel G. A.] Univ Zurich, Inst Evolutionary Biol & Environm Studies, Zurich, Switzerland; [van der Heijden, Marcel G. A.] Univ Utrecht, Fac Sci, Inst Environm Biol, Utrecht, Netherlands	Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research; Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Research Station Agroscope; University of Zurich; Utrecht University	Kipfer, T (corresponding author), Swiss Fed Res Inst WSL, Birmensdorf, Switzerland.	tabea.kipfer@alumni.ethz.ch	van der Heijden, Marcel/AAY-1593-2021; Wohlgemuth, Thomas/E-6588-2016; van der Heijden, Marcel G.A./H-5243-2011; Ghazoul, Jaboury/B-2121-2018	Wohlgemuth, Thomas/0000-0002-4623-0894; van der Heijden, Marcel/0000-0001-7040-1924	Swiss National Foundation [31003A_118002]	Swiss National Foundation(Swiss National Science Foundation (SNSF))	This study was supported by the Swiss National Foundation grant no. 31003A_118002. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABUZINADAH RA, 1989, NEW PHYTOL, V112, P55, DOI 10.1111/j.1469-8137.1989.tb00308.x; Agerer R, 2001, MYCORRHIZA, V11, P107, DOI 10.1007/s005720100108; Baxter JW, 2001, NEW PHYTOL, V152, P139, DOI 10.1046/j.0028-646x.2001.00245.x; Brundrett MC, 2009, PLANT SOIL, V320, P37, DOI 10.1007/s11104-008-9877-9; Cairney JWG, 2007, CAN J FOREST RES, V37, P207, DOI 10.1139/X06-190; Chambers SM, 1999, ECTOMYCORRHIZAL FUNGI: KEY GENERA IN PROFILE, P1; Colpaert JV, 1999, NEW PHYTOL, V143, P589, DOI 10.1046/j.1469-8137.1999.00471.x; Courty PE, 2011, J EXP BOT, V62, P249, DOI 10.1093/jxb/erq274; Courty PE, 2005, NEW PHYTOL, V167, P309, DOI 10.1111/j.1469-8137.2005.01401.x; Courty PE, 2007, SOIL BIOL BIOCHEM, V39, P1655, DOI 10.1016/j.soilbio.2007.01.017; Crawley M. J., 2008, R BOOK; Cullings K, 2008, OECOLOGIA, V158, P77, DOI 10.1007/s00442-008-1119-6; DOSSKEY MG, 1991, NEW PHYTOL, V117, P327, DOI 10.1111/j.1469-8137.1991.tb04914.x; Dunabeitia MK, 2004, MYCORRHIZA, V14, P11, DOI 10.1007/s00572-003-0270-5; Erland S, 2002, ECOL STU AN, V157, P163; Fransson PMA, 2001, NEW PHYTOL, V152, P431, DOI 10.1046/j.0028-646X.2001.00276.x; Garbaye J, 2000, OUTLOOK AGR, V29, P63, DOI 10.5367/000000000101293068; Hector A, 1999, SCIENCE, V286, P1123, DOI 10.1126/science.286.5442.1123; Hector A, 1998, OIKOS, V82, P597, DOI 10.2307/3546380; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Huston MA, 1997, OECOLOGIA, V110, P449, DOI 10.1007/s004420050180; Johnson NC, 1997, NEW PHYTOL, V135, P575, DOI 10.1046/j.1469-8137.1997.00729.x; Jones MD, 2004, CAN J BOT, V82, P1089, DOI [10.1139/B04-110, 10.1139/b04-110]; Jones MD, 2009, FUNGAL ECOL, V2, P110, DOI [10.1016/j.funeco.2009.02.002, 10.1016/j.funeco.2008.09.003]; Jonsson LM, 2001, OIKOS, V93, P353, DOI 10.1034/j.1600-0706.2001.930301.x; Kennedy PG, 2007, PLANT SOIL, V291, P155, DOI 10.1007/s11104-006-9183-3; Kipfer T, 2011, OECOLOGIA, V167, P219, DOI 10.1007/s00442-011-1981-5; Koide RT, 2000, NEW PHYTOL, V147, P233, DOI 10.1046/j.1469-8137.2000.00710.x; LAMHAMEDI MS, 1992, TREE PHYSIOL, V10, P231, DOI 10.1093/treephys/10.3.231; Lehto T, 2011, MYCORRHIZA, V21, P71, DOI 10.1007/s00572-010-0348-9; Maherali H, 2007, SCIENCE, V316, P1746, DOI 10.1126/science.1143082; MARX DH, 1969, PHYTOPATHOLOGY, V59, P153; Molina R., 1992, Mycorrhizal functioning: an integrative plant-fungal process., P357; Morte A, 2001, BIOL PLANTARUM, V44, P263, DOI 10.1023/A:1010207610974; Moser B, 2010, EUR J FOREST RES, V129, P625, DOI 10.1007/s10342-010-0363-6; PARKE JL, 1983, NEW PHYTOL, V95, P83, DOI 10.1111/j.1469-8137.1983.tb03471.x; Parrent JL, 2006, ECOLOGY, V87, P2278, DOI 10.1890/0012-9658(2006)87[2278:CANAAE]2.0.CO;2; Peter M, 2001, NEW PHYTOL, V149, P311, DOI 10.1046/j.1469-8137.2001.00030.x; PIGOTT CD, 1982, NEW PHYTOL, V92, P513, DOI 10.1111/j.1469-8137.1982.tb03409.x; Pritsch K, 2011, ANN FOREST SCI, V68, P25, DOI 10.1007/s13595-010-0004-8; Simard SW, 1997, NATURE, V388, P579, DOI 10.1038/41557; Smith S.E., 2008, MYCORRHIZAL SYMBIOSI, V3rd ed; Tilman D, 2001, SCIENCE, V294, P843, DOI 10.1126/science.1060391; Trappe JM., 1962, THESIS U WASHINGTON; van der Heijden MGA, 1998, NATURE, V396, P69, DOI 10.1038/23932; Vogelsang KM, 2006, NEW PHYTOL, V172, P554, DOI 10.1111/j.1469-8137.2006.01854.x; Wagg C, 2011, ECOL LETT, V14, P1001, DOI 10.1111/j.1461-0248.2011.01666.x; Wardle DA, 1999, OIKOS, V87, P403, DOI 10.2307/3546757; Zhang BC, 2016, J BASIC MICROB, V56, P670, DOI 10.1002/jobm.201500751	49	46	52	6	100	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2012	7	4							e35275	10.1371/journal.pone.0035275	http://dx.doi.org/10.1371/journal.pone.0035275			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955IH	22496914	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000305010500036
J	Burchell, L; Chaugule, VK; Walden, H				Burchell, Lynn; Chaugule, Viduth K.; Walden, Helen			Small, N-Terminal Tags Activate Parkin E3 Ubiquitin Ligase Activity by Disrupting Its Autoinhibited Conformation	PLOS ONE			English	Article							RECESSIVE JUVENILE PARKINSONISM; PROTEIN LIGASE; PATHOGENIC MUTATIONS; DISEASE; MITOPHAGY; PINK1; GENE; PHOSPHORYLATION; MITOCHONDRIA; CELLS	Parkin is an E3 ubiquitin ligase, mutations in which cause Autosomal Recessive Parkinson's Disease. Many studies aimed at understanding Parkin function, regulation and dysfunction are performed using N-terminal epitope tags. We report here that the use of small tags such as FLAG, cMyc and HA, influence the physical stability and activity of Parkin in and out of cells, perturbing the autoinhibited native state of Parkin, resulting in an active-for-autoubiquitination species.	[Burchell, Lynn; Chaugule, Viduth K.; Walden, Helen] London Res Inst Canc Res UK, Lincolns Inn Fields Labs, Prot Struct & Funct Lab, London, England	University of London; Institute of Cancer Research - UK	Burchell, L (corresponding author), London Res Inst Canc Res UK, Lincolns Inn Fields Labs, Prot Struct & Funct Lab, London, England.	Helen.walden@cancer.org.uk	Chaugule, Viduth K./AAG-2753-2019	Chaugule, Viduth K./0000-0001-7814-5865	Cancer Research UK	Cancer Research UK(Cancer Research UK)	This work was funded by Cancer Research UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biasini E, 2004, J NEUROCHEM, V88, P545, DOI 10.1046/j.1471-4159.2003.02152.x; Bonifati Vincenzo, 2012, Parkinsonism Relat Disord, V18 Suppl 1, pS4, DOI 10.1016/S1353-8020(11)70004-9; Chaugule VK, 2011, EMBO J, V30, P2853, DOI 10.1038/emboj.2011.204; Chew KCM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019720; Cooper HJ, 2004, ANAL CHEM, V76, P6982, DOI 10.1021/ac0401063; Corti O, 2007, DRUG DISCOV TODAY, V4, P121; Dawson TM, 2010, MOVEMENT DISORD, V25, pS32, DOI 10.1002/mds.22798; Durcan TM, 2012, J BIOL CHEM, V287, P531, DOI 10.1074/jbc.M111.288449; Durcan TM, 2011, HUM MOL GENET, V20, P141, DOI 10.1093/hmg/ddq452; Finney N, 2003, J BIOL CHEM, V278, P16054, DOI 10.1074/jbc.C300051200; Gegg ME, 2010, HUM MOL GENET, V19, P4861, DOI 10.1093/hmg/ddq419; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Hardy J, 2010, NEURON, V68, P201, DOI 10.1016/j.neuron.2010.10.014; Henn IH, 2005, J NEUROCHEM, V92, P114, DOI 10.1111/j.1471-4159.2004.02854.x; Imai Y, 2000, J BIOL CHEM, V275, P35661, DOI 10.1074/jbc.C000447200; Imai Y, 2011, CURR OPIN NEUROBIOL, V21, P935, DOI 10.1016/j.conb.2011.10.016; Joch M, 2007, MOL BIOL CELL, V18, P3105, DOI 10.1091/mbc.E05-11-1027; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Ko HS, 2010, P NATL ACAD SCI USA, V107, P16691, DOI 10.1073/pnas.1006083107; LaVoie MJ, 2005, NAT MED, V11, P1214, DOI 10.1038/nm1314; Lucking CB, 1998, LANCET, V352, P1355, DOI 10.1016/S0140-6736(05)60746-5; Martin I, 2011, ANNU REV GENOM HUM G, V12, P301, DOI 10.1146/annurev-genom-082410-101440; Matsuda N, 2006, J BIOL CHEM, V281, P3204, DOI 10.1074/jbc.M510393200; Matsuda N, 2010, J CELL BIOL, V189, P211, DOI 10.1083/jcb.200910140; Rakovic A, 2010, HUM MOL GENET, V19, P3124, DOI 10.1093/hmg/ddq215; Rankin Carolyn A, 2011, Open Biochem J, V5, P9, DOI 10.2174/1874091X01105010009; Ren Y, 2011, HUM MOL GENET, V20, P1074, DOI 10.1093/hmg/ddq550; de la Torre ER, 2011, CURR MED CHEM, V18, P2477, DOI 10.2174/092986711795843254; Schlossmacher MG, 2002, AM J PATHOL, V160, P1655, DOI 10.1016/S0002-9440(10)61113-3; Sha D, 2010, HUM MOL GENET, V19, P352, DOI 10.1093/hmg/ddp501; Shimura H, 2000, NAT GENET, V25, P302, DOI 10.1038/77060; Shin JH, 2011, CELL, V144, P689, DOI 10.1016/j.cell.2011.02.010; Van Humbeeck C, 2008, EUR J NEUROSCI, V27, P284, DOI 10.1111/j.1460-9568.2007.06000.x; Vives-Bauza C, 2010, P NATL ACAD SCI USA, V107, P378, DOI 10.1073/pnas.0911187107; Wenzel DM, 2011, NATURE, V474, P105, DOI 10.1038/nature09966; West AB, 2003, NEUROSCI LETT, V341, P139, DOI 10.1016/S0304-3940(03)00188-5; Yao DD, 2004, P NATL ACAD SCI USA, V101, P10810, DOI 10.1073/pnas.0404161101; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028; Zhang Y, 2000, P NATL ACAD SCI USA, V97, P13354, DOI 10.1073/pnas.240347797	39	26	26	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e34748	10.1371/journal.pone.0034748	http://dx.doi.org/10.1371/journal.pone.0034748			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GO	22496854	Green Submitted, Green Published, gold			2022-12-27	WOS:000304855200075
J	Liu, SJ; Kong, CJ; Wu, J; Ying, H; Zhu, HZ				Liu, SiJie; Kong, ChuiJin; Wu, Jie; Ying, Hao; Zhu, HuanZhang			Effect of CCR5-Delta 32 Heterozygosity on HIV-1 Susceptibility: A Meta-Analysis	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; INFECTION; CCR5; TRANSMISSION; INDIVIDUALS; PROGRESSION; AIDS; RESISTANCE; DETERMINANTS; GENOTYPES	Background: So far, many studies have investigated the distribution of CCR5 genotype between HIV-1 infected patients and uninfected people. However, no definite results have been put forward about whether heterozygosity for a 32-basepair deletion in CCR5 gene (CCR5-Delta 32) can affect HIV-1 susceptibility. Methods: We performed a meta-analysis of 18 studies including more than 12000 subjects for whom the CCR5-Delta 32 polymorphism was genotyped. Odds ratio (OR) with 95% confidence interval (CI) were employed to assess the association of CCR5-Delta 32 polymorphism with HIV-1 susceptibility. Results: Compared with the wild-type CCR5 homozygotes, the pooled OR for CCR5-Delta 32 heterozygotes was 1.02 (95% CI, 0.88-1.19) for healthy controls (HC) and 0.95 (95% CI, 0.71-1.26) for exposed uninfected (EU) controls. Similar results were found in stratified analysis by ethnicity, sample size and method of CCR5-Delta 32 genotyping. Conclusions: The meta-analysis indicated that HIV-1 susceptibility is not significantly affected by heterozygosity for CCR5-Delta 32.	[Liu, SiJie; Kong, ChuiJin; Wu, Jie; Ying, Hao; Zhu, HuanZhang] Fudan Univ, Sch Life Sci, Inst Genet, State Key Lab Genet Engn, Shanghai 200433, Peoples R China	Fudan University	Liu, SJ (corresponding author), Fudan Univ, Sch Life Sci, Inst Genet, State Key Lab Genet Engn, Shanghai 200433, Peoples R China.	hzzhu@fudan.edu.cn			National Grand Program on Key Infectious Disease [2012ZX10001-003]; National Natural Science Funding of China [31171247]	National Grand Program on Key Infectious Disease; National Natural Science Funding of China(National Natural Science Foundation of China (NSFC))	This work is supported by National Grand Program on Key Infectious Disease (2012ZX10001-003), National Natural Science Funding of China (No.31171247). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allers K, 2011, BLOOD, V117, P2791, DOI 10.1182/blood-2010-09-309591; Battiloro E, 2000, AIDS RES HUM RETROV, V16, P181, DOI 10.1089/088922200309520; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Cochran WG, 1954, BIOMETRICS, V10, P9; Contopoulos-Ioannidis DG, 2003, JAIDS-J ACQ IMM DEF, V32, P70, DOI 10.1097/00126334-200301010-00010; Dean M, 1996, SCIENCE, V273, P1856, DOI 10.1126/science.273.5283.1856; Deng XL, 2004, CHIN J EPIDEMIOL, V25, P050; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Diaz FJ, 2000, MEM I OSWALDO CRUZ, V95, P237, DOI 10.1590/S0074-02762000000200018; Downer MV, 2002, GENES IMMUN, V3, P295, DOI 10.1038/sj.gene.6363884; Egger M, 1997, BMJ-BRIT MED J, V315, P29; Ghaffari G, 2005, J VIROL, V79, P13250, DOI 10.1128/JVI.79.21.13250-13261.2005; Grimaldi R, 2002, HUM GENET, V111, P102, DOI 10.1007/s00439-002-0747-x; Hladik F, 2005, J VIROL, V79, P11677, DOI 10.1128/JVI.79.18.11677-11684.2005; Hutter G, 2009, NEW ENGL J MED, V360, P692, DOI 10.1056/NEJMoa0802905; Husman AD, 1999, J IMMUNOL, V163, P4597; Ioannidis JPA, 2001, ANN INTERN MED, V135, P782, DOI 10.7326/0003-4819-135-9-200111060-00008; Isaacman-Beck J, 2009, J VIROL, V83, P8208, DOI 10.1128/JVI.00296-09; Kaur G, 2009, TISSUE ANTIGENS, V73, P289, DOI 10.1111/j.1399-0039.2009.01220.x; Li GH, 2003, CHIN J MICROBIOL IMM, V23, P65; Liu H, 2004, J INFECT DIS, V190, P055; Liu R, 1996, CELL, V86, P367, DOI 10.1016/S0092-8674(00)80110-5; Lockett SF, 1999, J INFECT DIS, V180, P614, DOI 10.1086/314918; MANTEL N, 1959, J NATL CANCER I, V22, P719; Marmor M, 2001, J ACQ IMMUN DEF SYND, V27, P472, DOI 10.1097/00126334-200108150-00009; O'Brien SJ, 2004, NAT GENET, V36, P565, DOI 10.1038/ng1369; O'Brien SJ, 2000, IMMUNOL REV, V177, P99, DOI 10.1034/j.1600-065X.2000.17710.x; Oh DY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002747; Papa A, 2000, FEMS IMMUNOL MED MIC, V28, P87, DOI 10.1111/j.1574-695X.2000.tb01461.x; Pasi KJ, 2000, BRIT J HAEMATOL, V111, P136, DOI 10.1046/j.1365-2141.2000.02325.x; Paz-y-Mino C, 2005, HUM BIOL, V77, P521, DOI 10.1353/hub.2005.0068; Philpott S, 2003, J INFECT DIS, V187, P569, DOI 10.1086/367995; SCHUITEMAKER H, 1991, J VIROL, V65, P356, DOI 10.1128/JVI.65.1.356-363.1991; Schuitemaker H, 2009, J TRANSL MED S1, pS5; Takacova M, 2008, ACTA VIROL, V52, P261; Tan XH, 2010, INFECT GENET EVOL, V10, P268, DOI 10.1016/j.meegid.2009.11.015; Tang H, 2010, J SHIHEZI U NATURAL, V28, P98; Trecarichi Enrico M, 2006, AIDS Res Ther, V3, P22, DOI 10.1186/1742-6405-3-22; Veloso S, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-63; Wang FS, 2003, J ACQ IMMUN DEF SYND, V32, P24; Wu LJ, 1997, J EXP MED, V185, P1681, DOI 10.1084/jem.185.9.1681	41	22	22	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e35020	10.1371/journal.pone.0035020	http://dx.doi.org/10.1371/journal.pone.0035020			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GO	22496885	gold, Green Published, Green Submitted			2022-12-27	WOS:000304855200094
J	Munemasa, Y; Chang, CS; Kwong, JMK; Kyung, H; Kitaoka, Y; Caprioli, J; Piri, N				Munemasa, Yasunari; Chang, Chang-Sheng; Kwong, Jacky M. K.; Kyung, Haksu; Kitaoka, Yasushi; Caprioli, Joseph; Piri, Natik			The Neuronal EGF-Related Gene Nell2 Interacts with Macf1 and Supports Survival of Retinal Ganglion Cells after Optic Nerve Injury	PLOS ONE			English	Article							IN-VIVO ELECTROPORATION; LONG-TERM POTENTIATION; GROWTH-FACTOR; PROTEIN; PROTECTION; MORPHOLOGY; GLAUCOMA; NUCLEUS; ACTIN; TRANSECTION	Nell2 is a neuron-specific protein containing six epidermal growth factor-like domains. We have identified Nell2 as a retinal ganglion cell (RGC)-expressed gene by comparing mRNA profiles of control and RGC-deficient rat retinas. The aim of this study was to analyze Nell2 expression in wild-type and optic nerve axotomized retinas and evaluate its potential role in RGCs. Nell2-positive in situ and immunohistochemical signals were localized to irregularly shaped cells in the ganglion cell layer (GCL) and colocalized with retrogradely-labeled RGCs. No Nell2-positive cells were detected in 2 weeks optic nerve transected (ONT) retinas characterized with approximately 90% RGC loss. RT-PCR analysis showed a dramatic decrease in the Nell2 mRNA level after ONT compared to the controls. Immunoblot analysis of the Nell2 expression in the retina revealed the presence of two proteins with approximate MW of 140 and 90 kDa representing glycosylated and non-glycosylated Nell2, respectively. Both products were almost undetectable in retinal protein extracts two weeks after ONT. Proteome analysis of Nell2-interacting proteins carried out with MALDI-TOF MS (MS) identified microtubule-actin crosslinking factor 1 (Macf1), known to be critical in CNS development. Strong Macf1 expression was observed in the inner plexiform layer and GCL where it was colocalizied with Thy-1 staining. Since Nell2 has been reported to increase neuronal survival of the hippocampus and cerebral cortex, we evaluated the effect of Nell2 overexpression on RGC survival. RGCs in the nasal retina were consistently more efficiently transfected than in other areas (49% vs. 13%; n = 5, p<0.05). In non-transfected or pEGFP-transfected ONT retinas, the loss of RGCs was approximately 90% compared to the untreated control. In the nasal region, Nell2 transfection led to the preservation of approximately 58% more cells damaged by axotomy compared to non-transfected (n = 5, p<0.01) or pEGFP-transfected controls (n = 5, p<0.01).	[Munemasa, Yasunari; Chang, Chang-Sheng; Kwong, Jacky M. K.; Kyung, Haksu; Caprioli, Joseph; Piri, Natik] Univ Calif Los Angeles, Jules Stein Eye Inst, Los Angeles, CA 90024 USA; [Caprioli, Joseph; Piri, Natik] Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90024 USA; [Munemasa, Yasunari; Kitaoka, Yasushi] St Marianna Univ, Sch Med, Dept Ophthalmol, Kawasaki, Kanagawa, Japan	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Saint Marianna University	Munemasa, Y (corresponding author), Univ Calif Los Angeles, Jules Stein Eye Inst, Los Angeles, CA 90024 USA.	piri@jsei.ucla.edu		Caprioli, Joseph/0000-0002-2383-7263	National Institutes of Health (NIH) [EY018644]; NATIONAL EYE INSTITUTE [R01EY018644] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the National Institutes of Health (NIH; http://www.nih.gov/) Grant EY018644 (NP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aihara K, 2003, MOL BRAIN RES, V116, P86, DOI 10.1016/S0169-328X(03)00256-0; Chen HJ, 2006, GENE DEV, V20, P1933, DOI 10.1101/gad.1411206; Choi EJ, 2010, J BIOL CHEM, V285, P25074, DOI 10.1074/jbc.M110.100545; DACEY DM, 1992, P NATL ACAD SCI USA, V89, P9666, DOI 10.1073/pnas.89.20.9666; Dacey DM, 1999, PROG RETIN EYE RES, V18, P737, DOI 10.1016/S1350-9462(98)00013-5; DACEY DM, 1993, J NEUROSCI, V13, P5334, DOI 10.1523/JNEUROSCI.13-12-05334.1993; DAVIS C G, 1990, New Biologist, V2, P410; Dezawa M, 2002, MICRON, V33, P1, DOI 10.1016/S0968-4328(01)00002-6; GLOVINSKY Y, 1991, INVEST OPHTH VIS SCI, V32, P484; Goryunov D, 2010, MOL CELL NEUROSCI, V44, P1, DOI 10.1016/j.mcn.2010.01.010; Haefliger IO, 1999, SURV OPHTHALMOL, V43, pS51, DOI 10.1016/S0039-6257(99)00026-0; Hwang EM, 2007, BIOCHEM BIOPH RES CO, V353, P805, DOI 10.1016/j.bbrc.2006.12.115; Ishii Y, 2003, INVEST OPHTH VIS SCI, V44, P1982, DOI 10.1167/iovs.02-0912; Ishikawa H, 2005, GENE THER, V12, P289, DOI 10.1038/sj.gt.3302277; Jeong JK, 2008, J NEUROCHEM, V106, P1604, DOI 10.1111/j.1471-4159.2008.05505.x; Jiang YL, 2009, MOL CELL NEUROSCI, V41, P113, DOI 10.1016/j.mcn.2009.02.006; Kielczewski JL, 2005, INVEST OPHTH VIS SCI, V46, P3188, DOI 10.1167/iovs.05-0321; Kim H, 2002, J NEUROCHEM, V83, P1389, DOI 10.1046/j.1471-4159.2002.01245.x; KIMURA H, 1993, P NATL ACAD SCI USA, V90, P2165, DOI 10.1073/pnas.90.6.2165; Kuroda S, 1999, BIOCHEM BIOPH RES CO, V265, P79, DOI 10.1006/bbrc.1999.1638; Leung CL, 1999, J CELL BIOL, V147, P1275, DOI 10.1083/jcb.147.6.1275; Martin KRG, 2003, INVEST OPHTH VIS SCI, V44, P4357, DOI 10.1167/iovs.02-1332; MATSUHASHI S, 1995, DEV DYNAM, V203, P212, DOI 10.1002/aja.1002030209; Matsuyama S, 2004, NEUROREPORT, V15, P417, DOI 10.1097/00001756-200403010-00007; Mo XF, 2002, INVEST OPHTH VIS SCI, V43, P2401; Munemasa Y, 2009, GENE THER, V16, P17, DOI 10.1038/gt.2008.126; Munemasa Y, 2008, INVEST OPHTH VIS SCI, V49, P3535, DOI 10.1167/iovs.08-1716; Munemasa Y, 2009, INVEST OPHTH VIS SCI, V50, P3869, DOI 10.1167/iovs.08-3138; Nelson BR, 2004, DEV BIOL, V270, P322, DOI 10.1016/j.ydbio.2004.03.004; Oyasu M, 2000, MOL BRAIN RES, V76, P151, DOI 10.1016/S0169-328X(99)00342-3; Paquet-Durand F, 2007, J NEUROSCI RES, V85, P693, DOI 10.1002/jnr.21151; Piri N, 2006, MOL VIS, V12, P1660; QUIGLEY HA, 1988, OPHTHALMOLOGY, V95, P357; RODIECK RW, 1993, J COMP NEUROL, V338, P289, DOI 10.1002/cne.903380211; Rosenblum K, 2002, J NEUROSCI, V22, P5432; SCHILLER PH, 1978, J NEUROPHYSIOL, V41, P788, DOI 10.1152/jn.1978.41.3.788; Schori H, 2001, P NATL ACAD SCI USA, V98, P3398, DOI 10.1073/pnas.041609498; SOMMER A, 1991, ARCH OPHTHALMOL-CHIC, V109, P77, DOI 10.1001/archopht.1991.01080010079037; Sonnenberg A, 2007, EXP CELL RES, V313, P2189, DOI 10.1016/j.yexcr.2007.03.039; Spencer AG, 1998, J BIOL CHEM, V273, P9886, DOI 10.1074/jbc.273.16.9886; Tahzib NG, 2004, BRAIN RES BULL, V62, P491, DOI 10.1016/S0361-9230(03)00083-2; Vereker E, 2000, J NEUROSCI, V20, P6811, DOI 10.1523/JNEUROSCI.20-18-06811.2000; Wang X, 2005, J NEUROSCI RES, V82, P674, DOI 10.1002/jnr.20679; Watanabe TK, 1996, GENOMICS, V38, P273, DOI 10.1006/geno.1996.0628; Yamada ES, 2001, VISION RES, V41, P119, DOI 10.1016/S0042-6989(00)00244-3	45	20	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e34810	10.1371/journal.pone.0034810	http://dx.doi.org/10.1371/journal.pone.0034810			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GO	22496866	Green Published, gold, Green Submitted			2022-12-27	WOS:000304855200082
J	Pinto, F; Pacheco, CC; Ferreira, D; Moradas-Ferreira, P; Tamagnini, P				Pinto, Filipe; Pacheco, Catarina C.; Ferreira, Daniela; Moradas-Ferreira, Pedro; Tamagnini, Paula			Selection of Suitable Reference Genes for RT-qPCR Analyses in Cyanobacteria	PLOS ONE			English	Article							REAL-TIME PCR; SYNECHOCYSTIS-SP PCC-6803; HOUSEKEEPING GENES; HETEROCYST DIFFERENTIATION; PROCHLOROCOCCUS MED4; EXPRESSION ANALYSIS; QUANTITATIVE PCR; MIQE GUIDELINES; HIGH LIGHT; RNA	Cyanobacteria are a group of photosynthetic prokaryotes that have a diverse morphology, minimal nutritional requirements and metabolic plasticity that has made them attractive organisms to use in biotechnological applications. The use of these organisms as cell factories requires the knowledge of their physiology and metabolism at a systems level. For the quantification of gene transcripts real-time quantitative polymerase chain reaction (RT-qPCR) is the standard technique. However, to obtain reliable RT-qPCR results the use and validation of reference genes is mandatory. Towards this goal we have selected and analyzed twelve candidate reference genes from three morphologically distinct cyanobacteria grown under routinely used laboratory conditions. The six genes exhibiting less variation in each organism were evaluated in terms of their expression stability using geNorm, NormFinder and BestKeeper. In addition, the minimum number of reference genes required for normalization was determined. Based on the three algorithms, we provide a list of genes for cyanobacterial RT-qPCR data normalization. To our knowledge, this is the first work on the validation of reference genes for cyanobacteria constituting a valuable starting point for future works.	[Pinto, Filipe; Pacheco, Catarina C.; Ferreira, Daniela; Moradas-Ferreira, Pedro; Tamagnini, Paula] Univ Porto, IBMC, P-4100 Oporto, Portugal; [Pinto, Filipe; Ferreira, Daniela; Tamagnini, Paula] Univ Porto, Fac Ciencias, Dept Biol, P-4100 Oporto, Portugal; [Moradas-Ferreira, Pedro] Univ Porto, ICBAS, P-4100 Oporto, Portugal	Universidade do Porto; Universidade do Porto; Universidade do Porto	Pinto, F (corresponding author), Univ Porto, IBMC, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	pmtamagn@ibmc.up.pt	Pinto, Filipe/J-9448-2013; Tamagnini, Paula/A-6613-2010; Tamagnini, Paula/AGF-3206-2022; MORADAS-FERREIRA, PEDRO/E-6357-2012; Pacheco, Catarina C/H-9718-2013	Pinto, Filipe/0000-0002-8554-6648; Tamagnini, Paula/0000-0003-4396-2122; Tamagnini, Paula/0000-0003-4396-2122; MORADAS-FERREIRA, PEDRO/0000-0003-2994-0314; Pacheco, Catarina C/0000-0002-0741-1529	Fundacao para a Ciencia e a Tecnologia (FCT) [SFRH/BD/36378/2007, SFRH/BD/16954/2004, SFRH/BPD/64095/2009, PTDC/BIA-MIC/100370/2008]; European Science Foundation (ESF) (III Quadro Comunitario de Apoio); Programa Operacional Factores de Competitividade (COMPETE) in it's FEDER (Fundo Europeu de Desenvolvimento Regional) component	Fundacao para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); European Science Foundation (ESF) (III Quadro Comunitario de Apoio)(European Science Foundation (ESF)); Programa Operacional Factores de Competitividade (COMPETE) in it's FEDER (Fundo Europeu de Desenvolvimento Regional) component	This work was financially supported by the Fundacao para a Ciencia e a Tecnologia (FCT) (SFRH/BD/36378/2007 (FP), SFRH/BD/16954/2004 (DF), SFRH/BPD/64095/2009 (CCP), PTDC/BIA-MIC/100370/2008), European Science Foundation (ESF) (III Quadro Comunitario de Apoio) and Programa Operacional Factores de Competitividade (COMPETE) in it's FEDER (Fundo Europeu de Desenvolvimento Regional) component. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Angermayr SA, 2009, CURR OPIN BIOTECH, V20, P257, DOI 10.1016/j.copbio.2009.05.011; Biogazelle website, GENORM PLUS MAN; Burja AM, 2003, TRENDS BIOTECHNOL, V21, P504, DOI 10.1016/j.tibtech.2003.08.008; Bustin SA, 2000, J MOL ENDOCRINOL, V25, P169, DOI 10.1677/jme.0.0250169; Bustin SA, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-74; Bustin SA, 2010, METHODS, V50, P217, DOI 10.1016/j.ymeth.2009.12.006; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Castenholz R.W., 2001, BERGEYS MANUAL SYSTE, V2nd ed., P474; Derveaux S, 2010, METHODS, V50, P227, DOI 10.1016/j.ymeth.2009.11.001; Dheda K, 2004, BIOTECHNIQUES, V37, P112, DOI 10.2144/04371RR03; Doblin MA, 2007, HARMFUL ALGAE, V6, P519, DOI 10.1016/j.hal.2006.05.007; Ducat DC, 2011, TRENDS BIOTECHNOL, V29, P95, DOI 10.1016/j.tibtech.2010.12.003; Ehira S, 2006, J BACTERIOL, V188, P8520, DOI 10.1128/JB.01314-06; El-Shehawy R, 2003, MICROBIOL-SGM, V149, P1139, DOI 10.1099/mic.0.26170-0; Elhai J, 2009, NUCLEIC ACIDS RES, V37, pW28, DOI 10.1093/nar/gkp354; Ferguson BS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015208; Fujimori T, 2005, PLANT PHYSIOL, V139, P408, DOI 10.1104/pp.105.064782; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Higo A, 2006, MICROBIOL-SGM, V152, P979, DOI 10.1099/mic.0.28583-0; Hihara Y, 2001, PLANT CELL, V13, P793, DOI 10.1105/tpc.13.4.793; Holtzendorff J, 2002, ENVIRON MICROBIOL, V4, P644, DOI 10.1046/j.1462-2920.2002.00347.x; Hruz T, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-156; Huang X, 2004, P NATL ACAD SCI USA, V101, P4848, DOI 10.1073/pnas.0400429101; Imamura S, 2006, J BIOL CHEM, V281, P2668, DOI 10.1074/jbc.M509639200; Lemeille S, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-18; Lemeille S, 2005, NUCLEIC ACIDS RES, V33, P3381, DOI 10.1093/nar/gki654; Mary I, 2004, MICROBIOL-SGM, V150, P1271, DOI 10.1099/mic.0.27014-0; Mary I, 2003, FEMS MICROBIOL LETT, V226, P135, DOI 10.1016/S0378-1097(03)00587-1; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Price GD, 2004, P NATL ACAD SCI USA, V101, P18228, DOI 10.1073/pnas.0405211101; Rinta-Kanto JM, 2005, ENVIRON SCI TECHNOL, V39, P4198, DOI 10.1021/es048249u; RIPPKA R, 1979, J GEN MICROBIOL, V111, P1, DOI 10.1099/00221287-111-1-1; Sambrook J., 2001, MOL CLONING LAB MANU; Schafer L, 2006, PLANT CELL ENVIRON, V29, P1349, DOI 10.1111/j.1365-3040.2006.01515.x; Silver N, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-33; Solanas M, 2001, ANAL BIOCHEM, V288, P99, DOI 10.1006/abio.2000.4889; STANIER RY, 1971, BACTERIOL REV, V35, P171, DOI 10.1128/MMBR.35.2.171-205.1971; Suzuki T, 2000, BIOTECHNIQUES, V29, P332, DOI 10.2144/00292rv02; Taylor S, 2010, METHODS, V50, pS1, DOI 10.1016/j.ymeth.2010.01.005; Thellin O, 1999, J BIOTECHNOL, V75, P291, DOI 10.1016/S0168-1656(99)00163-7; Tomitani A, 2006, P NATL ACAD SCI USA, V103, P5442, DOI 10.1073/pnas.0600999103; Tu CJ, 2004, J BACTERIOL, V186, P3889, DOI 10.1128/JB.186.12.3889-3902.2004; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; VanGuilder HD, 2008, BIOTECHNIQUES, V44, P619, DOI 10.2144/000112776; Woodger FJ, 2003, PLANT PHYSIOL, V133, P2069, DOI 10.1104/pp.103.029728	46	100	103	9	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e34983	10.1371/journal.pone.0034983	http://dx.doi.org/10.1371/journal.pone.0034983			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GO	22496882	Green Published, gold, Green Submitted			2022-12-27	WOS:000304855200093
J	Sharma, VK; Kumar, N; Prakash, T; Taylor, TD				Sharma, Vineet K.; Kumar, Naveen; Prakash, Tulika; Taylor, Todd D.			Fast and Accurate Taxonomic Assignments of Metagenomic Sequences Using MetaBin	PLOS ONE			English	Article							PHYLOGENETIC CLASSIFICATION; GENOME; GUT; FRAGMENTS	Taxonomic assignment of sequence reads is a challenging task in metagenomic data analysis, for which the present methods mainly use either composition- or homology-based approaches. Though the homology-based methods are more sensitive and accurate, they suffer primarily due to the time needed to generate the Blast alignments. We developed the MetaBin program and web server for better homology-based taxonomic assignments using an ORF-based approach. By implementing Blat as the faster alignment method in place of Blastx, the analysis time has been reduced by severalfold. It is benchmarked using both simulated and real metagenomic datasets, and can be used for both single and paired-end sequence reads of varying lengths (>= 45 bp). To our knowledge, MetaBin is the only available program that can be used for the taxonomic binning of short reads (<100 bp) with high accuracy and high sensitivity using a homology-based approach. The MetaBin web server can be used to carry out the taxonomic analysis, by either submitting reads or Blastx output. It provides several options including construction of taxonomic trees, creation of a composition chart, functional analysis using COGs, and comparative analysis of multiple metagenomic datasets. MetaBin web server and a standalone version for high-throughput analysis are available freely at http://metabin.riken.jp/.	[Sharma, Vineet K.; Kumar, Naveen; Prakash, Tulika; Taylor, Todd D.] RIKEN, Lab MetaSyst Res, Quantitat Biol Ctr, Yokohama, Kanagawa, Japan; [Sharma, Vineet K.] Indian Inst Sci Educ & Res, Dept Biol Sci, Bhopal, Madhya Pradesh, India	RIKEN; Indian Institute of Science Education & Research (IISER) - Bhopal	Sharma, VK (corresponding author), RIKEN, Lab MetaSyst Res, Quantitat Biol Ctr, Yokohama, Kanagawa, Japan.	taylor@riken.jp	Taylor, Todd/A-7121-2009	Taylor, Todd/0000-0003-4247-6253; Kumar, Naveen/0000-0001-7364-6601; K. Sharma, Vineet/0000-0002-2958-6215	RIKEN	RIKEN	This work was supported by the operational expenditure fund of RIKEN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brady A, 2009, NAT METHODS, V6, P673, DOI [10.1038/NMETH.1358, 10.1038/nmeth.1358]; Diaz NN, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-56; Gerlach W, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-430; Green Tringe Susannah, 2005, Nature Reviews Genetics, V6, P805, DOI 10.1038/nrg1709; Haque MM, 2009, BIOINFORMATICS, V25, P1722, DOI 10.1093/bioinformatics/btp317; Hongoh Y, 2008, SCIENCE, V322, P1108, DOI 10.1126/science.1165578; Hongoh Y, 2008, P NATL ACAD SCI USA, V105, P5555, DOI 10.1073/pnas.0801389105; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kurokawa K, 2007, DNA RES, V14, P169, DOI 10.1093/dnares/dsm018; McHardy AC, 2007, NAT METHODS, V4, P63, DOI 10.1038/NMETH976; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Richter DC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003373; Rosen GL, 2011, BIOINFORMATICS, V27, P127, DOI 10.1093/bioinformatics/btq619; Sayers EW, 2011, NUCLEIC ACIDS RES, V39, pD38, DOI 10.1093/nar/gkq1172; Sharma VK, 2010, NUCLEIC ACIDS RES, V38, pD468, DOI 10.1093/nar/gkp1001; Teeling H, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-163; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857	18	17	17	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e34030	10.1371/journal.pone.0034030	http://dx.doi.org/10.1371/journal.pone.0034030			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GO	22496776	gold, Green Published, Green Submitted			2022-12-27	WOS:000304855200029
J	Marei, HES; Ahmed, AE; Michetti, F; Pescatori, M; Pallini, R; Casalbore, P; Cenciarelli, C; Elhadidy, M				Marei, Hany E. S.; Ahmed, Abd-Elmaksoud; Michetti, Fabrizio; Pescatori, Mario; Pallini, Roberto; Casalbore, Patricia; Cenciarelli, Carlo; Elhadidy, Mohamed			Gene Expression Profile of Adult Human Olfactory Bulb and Embryonic Neural Stem Cell Suggests Distinct Signaling Pathways and Epigenetic Control	PLOS ONE			English	Article							NEURONAL DIFFERENTIATION; IN-VITRO; DNA METHYLATION; DE-NOVO; NERVOUS-SYSTEM; SELF-RENEWAL; PROGENITOR; PRECURSOR; METHYLTRANSFERASES; MAINTENANCE	Global gene expression profiling was performed using RNA from human embryonic neural stem cells (hENSC), and adult human olfactory bulb-derived neural stem cells (OBNSCs), to define a gene expression pattern and signaling pathways that are specific for each cell lineage. We have demonstrated large differences in the gene expression profile of human embryonic NSC, and adult human OBNSCs, but less variability between parallel cultures. Transcripts of genes involved in neural tube development and patterning (ALDH1A2, FOXA2), progenitor marker genes (LMX1a, ALDH1A1, SOX10), proliferation of neural progenitors (WNT1 and WNT3a), neuroplastin (NPTN), POU3F1 (OCT6), neuroligin (NLGN4X), MEIS2, and NPAS1 were up-regulated in both cell populations. By Gene Ontology, 325 out of 3875 investigated gene sets were scientifically different. 41 out of the 307 investigated Cellular Component (CC) categories, 45 out of the 620 investigated Molecular Function (MF) categories, and 239 out of the 2948 investigated Biological Process (BP) categories were significant. KEGG Pathway Class Comparison had revealed that 75 out of 171 investigated gene sets passed the 0.005 significance threshold. Levels of gene expression were explored in three signaling pathways, Notch, Wnt, and mTOR that are known to be involved in NS cell fates determination. The transcriptional signature also deciphers the role of genes involved in epigenetic modifications. SWI/SNF DNA chromatin remodeling complex family, including SMARCC1 and SMARCE1, were found specifically up-regulated in our OBNSC but not in hENSC. Differences in gene expression profile of transcripts controlling epigenetic modifications, and signaling pathways might indicate differences in the therapeutic potential of our examined two cell populations in relation to in cell survival, proliferation, migration, and differentiation following engraftments in different CNS insults.	[Marei, Hany E. S.; Ahmed, Abd-Elmaksoud] Mansoura Univ, Dept Cytol & Histol, Fac Vet Med, Mansoura, Egypt; [Elhadidy, Mohamed] Mansoura Univ, Dept Bacteriol, Fac Vet Med, Mansoura, Egypt; [Michetti, Fabrizio; Pescatori, Mario] Univ Cattolica Sacro Cuore, Inst Anat & Cell Biol, Rome, Italy; [Pallini, Roberto] Univ Cattolica Sacro Cuore, Inst Neurosurg, Rome, Italy; [Casalbore, Patricia] Natl Res Council Italy, Inst Cell Biol & Neurobiol, Rome, Italy; [Cenciarelli, Carlo] Natl Res Council Italy, Inst Translat Pharmacol, Rome, Italy	Egyptian Knowledge Bank (EKB); Mansoura University; Egyptian Knowledge Bank (EKB); Mansoura University; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia Cellulare e Neurobiologia (IBCN-CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto di Farmacologia Traslazionale (IFT-CNR)	Marei, HES (corresponding author), Mansoura Univ, Dept Cytol & Histol, Fac Vet Med, Mansoura, Egypt.	hany800@mans.edu.eg	Pallini, Roberto/AAA-3760-2019; CENCIARELLI, CARLO/AAC-1603-2019; PALLINI, Roberto/AAA-3747-2019; Marei, Hany E/AAC-7076-2019; pescatori, mario/H-3986-2012	CENCIARELLI, CARLO/0000-0001-7480-4608; PALLINI, Roberto/0000-0002-4611-8827; Marei, Hany E/0000-0002-0069-4212; 	Science and Technology Development Fund, Egypt (STDF) [99]	Science and Technology Development Fund, Egypt (STDF)(Science and Technology Development Fund (STDF))	This work was supported by the Science and Technology Development Fund, Egypt (STDF, ID 99). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arsenijevic Y, 2001, EXP NEUROL, V170, P48, DOI 10.1006/exnr.2001.7691; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Bjorklund A, 2000, NAT NEUROSCI, V3, P537, DOI 10.1038/75705; Borghese L, 2010, STEM CELLS, V28, P955, DOI 10.1002/stem.408; Bourc'his D, 2001, SCIENCE, V294, P2536, DOI 10.1126/science.1065848; BRILL G, 1992, DEVELOPMENT, V115, P1059; Brondani V, 2002, J MOL BIOL, V319, P715, DOI 10.1016/S0022-2836(02)00376-5; Cai JL, 2006, STEM CELLS DEV, V15, P232, DOI 10.1089/scd.2006.15.232; Casalbore P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004434; Cau E, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-36; Chiba S, 2006, STEM CELLS, V24, P2437, DOI 10.1634/stemcells.2005-0661; Curtis MA, 2007, SCIENCE, V315, P1243, DOI 10.1126/science.1136281; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Empson RM, 2006, J NEUROCHEM, V99, P850, DOI 10.1111/j.1471-4159.2006.04123.x; Episkopou V, 2005, TRENDS NEUROSCI, V28, P219, DOI 10.1016/j.tins.2005.03.003; Erlandsson A, 2001, J NEUROSCI, V21, P3483, DOI 10.1523/JNEUROSCI.21-10-03483.2001; Faedo A, 2010, J NEUROSCI, V30, P4015, DOI 10.1523/JNEUROSCI.0307-10.2010; Ferri ALM, 2007, DEVELOPMENT, V134, P2761, DOI 10.1242/dev.000141; Fu LJ, 2008, STEM CELLS DEV, V17, P1109, DOI 10.1089/scd.2008.0068; Futscher BW, 2002, NAT GENET, V31, P175, DOI 10.1038/ng886; Gowher H, 2000, EMBO J, V19, P6918, DOI 10.1093/emboj/19.24.6918; Grandbarbe L, 2003, DEVELOPMENT, V130, P1391, DOI 10.1242/dev.00374; Han J, 2008, MOL CELL NEUROSCI, V39, P118, DOI 10.1016/j.mcn.2008.06.003; Hata K, 2002, DEVELOPMENT, V129, P1983; HELIN K, 1993, GENE DEV, V7, P1850, DOI 10.1101/gad.7.10.1850; Hermann A, 2004, J CELL SCI, V117, P4411, DOI 10.1242/jcs.01307; Hermann A, 2006, J NEUROSCI RES, V83, P1502, DOI 10.1002/jnr.20840; Hermann A, 2006, J NEUROCHEM, V98, P629, DOI 10.1111/j.1471-4159.2006.03916.x; Horner PJ, 2000, NATURE, V407, P963, DOI 10.1038/35039559; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Imayoshi I, 2010, J NEUROSCI, V30, P3489, DOI 10.1523/JNEUROSCI.4987-09.2010; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jackson EL, 2006, NEURON, V51, P187, DOI 10.1016/j.neuron.2006.06.012; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Johansson CB, 1999, CELL, V96, P25, DOI 10.1016/S0092-8674(00)80956-3; Jones PA, 1999, NAT GENET, V21, P163, DOI 10.1038/5947; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Kageyama R, 2005, EXP CELL RES, V306, P343, DOI 10.1016/j.yexcr.2005.03.015; KIRSCHENBAUM B, 1994, CEREB CORTEX, V4, P576, DOI 10.1093/cercor/4.6.576; Kondo A, 2002, ACTA MED OKAYAMA, V56, P31; Kuhlbrodt K, 1998, J BIOL CHEM, V273, P16050, DOI 10.1074/jbc.273.26.16050; Kukekov VG, 1999, EXP NEUROL, V156, P333, DOI 10.1006/exnr.1999.7028; Lee SMK, 1997, DEVELOPMENT, V124, P959; Liu ZP, 2003, J COMP NEUROL, V459, P368, DOI 10.1002/cne.10664; Lyko F, 2000, NATURE, V408, P538, DOI 10.1038/35046205; Lyko F, 1999, NAT GENET, V23, P363, DOI 10.1038/15551; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Maisel M, 2007, STEM CELLS, V25, P1231, DOI 10.1634/stemcells.2006-0617; Marei HES, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028420; Martinez-Serrano A, 2001, GENE THER, V1, P279; Mattson M P, 2001, Expert Rev Neurother, V1, P267, DOI 10.1586/14737175.1.2.267; Mbikay M, 2001, BIOCHEM J, V357, P329, DOI 10.1042/0264-6021:3570329; Moe MC, 2005, NEUROSURGERY, V56, P1182, DOI 10.1227/01.NEU.0000159881.09663.6D; Munoz-Sanjuan I, 2002, NAT REV NEUROSCI, V3, P271, DOI 10.1038/nrn786; Nakashima K, 1999, J NEUROSCI, V19, P5429; Nemir M, 2006, CIRC RES, V98, P1471, DOI 10.1161/01.RES.0000226497.52052.2a; Nunes MC, 2003, NAT MED, V9, P439, DOI 10.1038/nm837; Nyfeler Y, 2005, EMBO J, V24, P3504, DOI 10.1038/sj.emboj.7600816; Ohsawa S, 2005, J NEUROSCI RES, V79, P451, DOI 10.1002/jnr.20365; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Okano M, 1998, NUCLEIC ACIDS RES, V26, P2536, DOI 10.1093/nar/26.11.2536; Owczarek S, 2010, FASEB J, V24, P1139, DOI 10.1096/fj.09-140509; Park KI, 2002, GENE THER, V9, P613, DOI 10.1038/sj.gt.3301721; Pavlidis P, 2004, NEUROCHEM RES, V29, P1213, DOI 10.1023/B:NERE.0000023608.29741.45; Reynolds BA, 1996, DEV BIOL, V175, P1, DOI 10.1006/dbio.1996.0090; Sato A, 2010, NEUROSCI LETT, V470, P115, DOI 10.1016/j.neulet.2009.12.067; Schaniel C, 2009, STEM CELLS, V27, P2979, DOI 10.1002/stem.223; Seo JH, 2011, HUM MOL GENET, V20, P4324, DOI 10.1093/hmg/ddr359; Shamir R, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-232; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Simon R, BRB ARRAYTOOLS USER; Slawny NA, 2011, MOL CELL NEUROSCI, V48, P205, DOI 10.1016/j.mcn.2011.07.010; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; Storch A, 2001, EXP NEUROL, V170, P317, DOI 10.1006/exnr.2001.7706; Sun MK, 2011, J NEUROSCI, V31, P687, DOI 10.1523/JNEUROSCI.3854-10.2011; SUZUKI N, 1990, EMBO J, V9, P3723, DOI 10.1002/j.1460-2075.1990.tb07585.x; Svendsen CN, 1999, TRENDS NEUROSCI, V22, P357, DOI 10.1016/S0166-2236(99)01428-9; Takebayashi H, 2002, CURR BIOL, V12, P1157, DOI 10.1016/S0960-9822(02)00926-0; Tanner SM, 2001, P NATL ACAD SCI USA, V98, P13901, DOI 10.1073/pnas.241525498; Toyota M, 1999, SEMIN CANCER BIOL, V9, P349, DOI 10.1006/scbi.1999.0135; Vescovi AL, 1999, BRAIN PATHOL, V9, P569, DOI 10.1111/j.1750-3639.1999.tb00542.x; Villa A, 2002, BRAIN RES BULL, V57, P789, DOI 10.1016/S0361-9230(01)00776-6; Villa A, 2001, BIOMED PHARMACOTHER, V55, P91, DOI 10.1016/S0753-3322(00)00032-9; Wang XM, 2004, BIOCHEM J, V383, P319, DOI 10.1042/BJ20040524; Westerlund U, 2003, EXP CELL RES, V289, P378, DOI 10.1016/S0014-4827(03)00291-X; Wiese C, 2004, CELL MOL LIFE SCI, V61, P2510, DOI 10.1007/s00018-004-4144-6; Woo SM, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-97; Wright GW, 2003, BIOINFORMATICS, V19, P2448, DOI 10.1093/bioinformatics/btg345; Wright LS, 2003, J NEUROCHEM, V86, P179, DOI 10.1046/j.1471-4159.2003.01826.x; Yu XB, 2008, CELL STEM CELL, V2, P461, DOI 10.1016/j.stem.2008.03.001; Zhang X, 2002, GENE DEV, V16, P2097, DOI 10.1101/gad.1007602; Zhang XD, 2004, EXP NEUROL, V186, P112, DOI 10.1016/j.expneurol.2003.10.022; Zhou JX, 2009, P NATL ACAD SCI USA, V106, P7840, DOI 10.1073/pnas.0901854106	93	29	31	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2012	7	4							e33542	10.1371/journal.pone.0033542	http://dx.doi.org/10.1371/journal.pone.0033542			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952GU	22485144	Green Published, gold, Green Submitted			2022-12-27	WOS:000304780500020
J	Nakao, T; Tsujikawa, M; Notomi, S; Ikeda, Y; Nishida, K				Nakao, Takeshi; Tsujikawa, Motokazu; Notomi, Shoji; Ikeda, Yasuhiro; Nishida, Kohji			The Role of Mislocalized Phototransduction in Photoreceptor Cell Death of Retinitis Pigmentosa	PLOS ONE			English	Article							BARDET-BIEDL-SYNDROME; RETINAL DEGENERATION; ADENYLYL-CYCLASE; BETA-SUBUNIT; GENE; RHODOPSIN; MUTATIONS; PROTEIN; MOUSE; LIGHT	Most of inherited retinal diseases such as retinitis pigmentosa (RP) cause photoreceptor cell death resulting in blindness. RP is a large family of diseases in which the photoreceptor cell death can be caused by a number of pathways. Among them, light exposure has been reported to induce photoreceptor cell death. However, the detailed mechanism by which photoreceptor cell death is caused by light exposure is unclear. In this study, we have shown that even a mild light exposure can induce ectopic phototransduction and result in the acceleration of rod photoreceptor cell death in some vertebrate models. In ovl, a zebrafish model of outer segment deficiency, photoreceptor cell death is associated with light exposure. The ovl larvae show ectopic accumulation of rhodopsin and knockdown of ectopic rhodopsin and transducin rescue rod photoreceptor cell death. However, knockdown of phosphodiesterase, the enzyme that mediates the next step of phototransduction, does not. So, ectopic phototransduction activated by light exposure, which leads to rod photoreceptor cell death, is through the action of transducin. Furthermore, we have demonstrated that forced activation of adenylyl cyclase in the inner segment leads to rod photoreceptor cell death. For further confirmation, we have also generated a transgenic fish which possesses a human rhodopsin mutation, Q344X. This fish and rd10 model mice show photoreceptor cell death caused by adenylyl cyclase. In short, our study indicates that in some RP, adenylyl cyclase is involved in photoreceptor cell death pathway; its inhibition is potentially a logical approach for a novel RP therapy.	[Nakao, Takeshi; Tsujikawa, Motokazu; Nishida, Kohji] Osaka Univ, Dept Ophthalmol, Grad Sch Med, Suita, Osaka, Japan; [Notomi, Shoji; Ikeda, Yasuhiro] Kyushu Univ, Dept Ophthalmol, Grad Sch Med Sci, Fukuoka 812, Japan	Osaka University; Kyushu University	Nakao, T (corresponding author), Osaka Univ, Dept Ophthalmol, Grad Sch Med, Suita, Osaka, Japan.	moto@ophthal.med.osaka-u.ac.jp		Nishida, Kohji/0000-0001-9069-3610	Ministry of Education, Culture, Sports, Science, and Technology	Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	These studies were supported by Grants-in-Aid from the Ministry of Education, Culture, Sports, Science, and Technology (MT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfinito PD, 2002, P NATL ACAD SCI USA, V99, P5655, DOI 10.1073/pnas.072557799; Allagnat F, 2008, J BIOL CHEM, V283, P5226, DOI 10.1074/jbc.M708181200; Azadi S, 2006, MOL CELL NEUROSCI, V31, P759, DOI 10.1016/j.mcn.2006.01.001; Azadi S, 2007, BRAIN RES, V1129, P116, DOI 10.1016/j.brainres.2006.10.031; Barhoum R, 2008, NEUROSCIENCE, V155, P698, DOI 10.1016/j.neuroscience.2008.06.042; Beales PL, 1999, J MED GENET, V36, P437; Berson EL, 1996, P NATL ACAD SCI USA, V93, P4526, DOI 10.1073/pnas.93.10.4526; BERSON EL, 1993, INVEST OPHTH VIS SCI, V34, P1659; Brand M, 1996, DEVELOPMENT, V123, P129; Chang B, 2007, VISION RES, V47, P624, DOI 10.1016/j.visres.2006.11.020; Chang B, 2002, VISION RES, V42, P517, DOI 10.1016/S0042-6989(01)00146-8; Concepcion F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010904; Defer N, 2000, AM J PHYSIOL-RENAL, V279, pF400, DOI 10.1152/ajprenal.2000.279.3.F400; Deretic D, 1998, P NATL ACAD SCI USA, V95, P10620, DOI 10.1073/pnas.95.18.10620; Deretic D, 1996, J BIOL CHEM, V271, P2279, DOI 10.1074/jbc.271.4.2279; DEVRIES GW, 1982, J NEUROCHEM, V38, P759; Doerre G, 2002, MECH DEVELOP, V110, P125, DOI 10.1016/S0925-4773(01)00571-8; Fariss RN, 1997, J COMP NEUROL, V387, P148, DOI 10.1002/(SICI)1096-9861(19971013)387:1<148::AID-CNE12>3.0.CO;2-Q; FARRAR GJ, 1991, NATURE, V354, P478, DOI 10.1038/354478a0; FEINSTEIN PG, 1991, P NATL ACAD SCI USA, V88, P10173, DOI 10.1073/pnas.88.22.10173; Gargini C, 2007, J COMP NEUROL, V500, P222, DOI 10.1002/cne.21144; GREEN JS, 1989, NEW ENGL J MED, V321, P1002, DOI 10.1056/NEJM198910123211503; Hamaoka T, 2002, GENESIS, V34, P215, DOI 10.1002/gene.10155; Hao WS, 2002, NAT GENET, V32, P254, DOI 10.1038/ng984; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; Hauck SM, 2006, MOL CELL PROTEOMICS, V5, P324, DOI 10.1074/mcp.M500217-MCP200; JACOBSON SG, 1991, AM J OPHTHALMOL, V112, P256, DOI 10.1016/S0002-9394(14)76726-1; Janssen S, 2011, HUM GENET, V129, P79, DOI 10.1007/s00439-010-0902-8; Johnson LE, 2005, CELL TISSUE RES, V320, P213, DOI 10.1007/s00441-004-1046-8; Johnson PT, 2003, INVEST OPHTH VIS SCI, V44, P4481, DOI 10.1167/iovs.03-0436; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kremmer S, 1997, GRAEF ARCH CLIN EXP, V235, P575, DOI 10.1007/BF00947087; Ludwig MG, 2002, J RECEPT SIGNAL TR R, V22, P79, DOI 10.1081/RRS-120014589; Malicki J, 1999, METHODS CELL BIOL, V59, P273; Malicki J, 2002, METHODS, V28, P427, DOI 10.1016/S1046-2023(02)00262-1; MCLAUGHLIN ME, 1993, NAT GENET, V4, P130, DOI 10.1038/ng0693-130; Nir I, 2001, EXP EYE RES, V73, P265, DOI 10.1006/exer.2001.1037; Paquet-Durand F, 2006, J NEUROCHEM, V96, P802, DOI 10.1111/j.1471-4159.2005.03628.x; Pazour GJ, 2000, J CELL BIOL, V151, P709, DOI 10.1083/jcb.151.3.709; Pierce EA, 1999, NAT GENET, V22, P248, DOI 10.1038/10305; Pujic Z, 2001, DEV BIOL, V234, P454, DOI 10.1006/dbio.2001.0251; Ravary A, 2003, J NEUROSCI, V23, P2228; Reme CE, 1998, PROG RETIN EYE RES, V17, P443, DOI 10.1016/S1350-9462(98)00009-3; Rex TS, 2004, MOL THER, V10, P855, DOI 10.1016/j.ymthe.2004.07.027; ROSENFELD PJ, 1992, NAT GENET, V1, P209, DOI 10.1038/ng0692-209; Smith LEH, 2004, J CLIN INVEST, V114, P755, DOI 10.1172/JCI200422930; Sohocki MM, 2001, HUM MUTAT, V17, P42, DOI 10.1002/1098-1004(2001)17:1<42::AID-HUMU5>3.0.CO;2-K; Sun ZX, 2004, DEVELOPMENT, V131, P4085, DOI 10.1242/dev.01240; SUNG CH, 1994, J NEUROSCI, V14, P5818; Tam BM, 2006, J NEUROSCI, V26, P203, DOI 10.1523/JNEUROSCI.3849-05.2006; Tam BM, 2000, J CELL BIOL, V151, P1369, DOI 10.1083/jcb.151.7.1369; Tan E, 2001, INVEST OPHTH VIS SCI, V42, P589; Tsujikawa M, 2004, NEURON, V42, P703, DOI 10.1016/S0896-6273(04)00268-5; Tsujikawa M, 2008, ARCH OPHTHALMOL-CHIC, V126, P337, DOI 10.1001/archopht.126.3.337; Wang M, 1997, VISUAL NEUROSCI, V14, P55, DOI 10.1017/S0952523800008750; WEISS ER, 1995, BIOCHEM BIOPH RES CO, V216, P755, DOI 10.1006/bbrc.1995.2686; Zaghloul NA, 2010, P NATL ACAD SCI USA, V107, P10602, DOI 10.1073/pnas.1000219107; Zhang LZ, 2004, J BIOL CHEM, V279, P20858, DOI 10.1074/jbc.M310643200; Zhang X, 2000, INVEST OPHTH VIS SCI, V41, P998	59	33	34	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2012	7	4							e32472	10.1371/journal.pone.0032472	http://dx.doi.org/10.1371/journal.pone.0032472			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952GU	22485131	Green Submitted, gold, Green Published			2022-12-27	WOS:000304780500007
J	Yanaba, K; Asano, Y; Tada, Y; Sugaya, M; Kadono, T; Sato, S				Yanaba, Koichi; Asano, Yoshihide; Tada, Yayoi; Sugaya, Makoto; Kadono, Takafumi; Sato, Shinichi			Proteasome Inhibitor Bortezomib Ameliorates Intestinal Injury in Mice	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; ULCERATIVE-COLITIS; MURINE COLITIS; CELL-CYCLE; KAPPA-B; CYCLOSPORINE; APOPTOSIS; 20S	Background: Bortezomib is a proteasome inhibitor that has shown impressive efficacy in the treatment of multiple myeloma. In mice, the addition of dextran sulfate sodium (DSS) to drinking water leads to acute colitis that can serve as an experimental animal model for human ulcerative colitis. Methodology/Principal Findings: Bortezomib treatment was shown to potently inhibit murine DSS-induced colitis. The attenuation of DSS-induced colitis was associated with decreased inflammatory cell infiltration in the colon. Specifically, bortezomib-treated mice showed significantly decreased numbers of CD4(+) and CD8(+) T cells in the colon and mesenteric lymph nodes. Bortezomib treatment significantly diminished interferon (IFN)-gamma expression in the colon and mesenteric lymph nodes. Furthermore, cytoplasmic IFN-gamma production by CD4(+) and CD8(+) T cells in mesenteric lymph nodes was substantially decreased by bortezomib treatment. Notably, bortezomib enhanced T cell apoptosis by inhibiting nuclear factor-kappa B activation during DSS-induced colitis. Conclusions/Significance: Bortezomib treatment is likely to induce T cell death, thereby suppressing DSS-induced colitis by reducing IFN-gamma production.	[Yanaba, Koichi; Asano, Yoshihide; Tada, Yayoi; Sugaya, Makoto; Kadono, Takafumi; Sato, Shinichi] Univ Tokyo, Fac Med, Dept Dermatol, Tokyo 113, Japan	University of Tokyo	Yanaba, K (corresponding author), Univ Tokyo, Fac Med, Dept Dermatol, Tokyo 113, Japan.	yanabak-der@h.u-tokyo.ac.jp	菅谷, 誠/GWC-3786-2022		Research on Intractable Diseases from the Ministry of Health, Labor and Welfare of Japan	Research on Intractable Diseases from the Ministry of Health, Labor and Welfare of Japan	This work was supported by a grant of Research on Intractable Diseases from the Ministry of Health, Labor and Welfare of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams J, 2004, NAT REV CANCER, V4, P349, DOI 10.1038/nrc1361; Baumeister W, 1998, CELL, V92, P367, DOI 10.1016/S0092-8674(00)80929-0; Blanco B, 2006, BLOOD, V107, P3575, DOI 10.1182/blood-2005-05-2118; Ciechanover A, 1998, P NATL ACAD SCI USA, V95, P2727, DOI 10.1073/pnas.95.6.2727; COOPER HS, 1993, LAB INVEST, V69, P238; Coux O, 1996, ANNU REV BIOCHEM, V65, P801, DOI 10.1146/annurev.bi.65.070196.004101; Egger B, 2000, DIGESTION, V62, P240, DOI 10.1159/000007822; Elliott PJ, 1999, J ALLERGY CLIN IMMUN, V104, P294, DOI 10.1016/S0091-6749(99)70369-6; Fiocchi C, 1998, GASTROENTEROLOGY, V115, P182, DOI 10.1016/S0016-5085(98)70381-6; Fissolo N, 2008, EUR J IMMUNOL, V38, P2401, DOI 10.1002/eji.200838413; Hibi T, 2006, J GASTROENTEROL, V41, P10, DOI 10.1007/s00535-005-1744-3; King RW, 1996, SCIENCE, V274, P1652, DOI 10.1126/science.274.5293.1652; Luo HY, 2001, TRANSPLANTATION, V72, P196, DOI 10.1097/00007890-200107270-00005; Meijerink J, 2001, J MOL DIAGN, V3, P55, DOI 10.1016/S1525-1578(10)60652-6; Melgar S, 2005, AM J PHYSIOL-GASTR L, V288, pG1328, DOI 10.1152/ajpgi.00467.2004; MURTHY SNS, 1993, DIGEST DIS SCI, V38, P1722, DOI 10.1007/BF01303184; Naujokat C, 2003, BIOCHEM BIOPH RES CO, V310, P347, DOI 10.1016/j.bbrc.2003.08.141; Naujokat C, 2002, LAB INVEST, V82, P965, DOI 10.1097/01.LAB.0000022226.23741.37; Neubert K, 2008, NAT MED, V14, P748, DOI 10.1038/nm1763; Obeng EA, 2006, BLOOD, V107, P4907, DOI 10.1182/blood-2005-08-3531; OKAYASU I, 1990, GASTROENTEROLOGY, V98, P694, DOI 10.1016/0016-5085(90)90290-H; Palombella VJ, 1998, P NATL ACAD SCI USA, V95, P15671, DOI 10.1073/pnas.95.26.15671; Richardson Paul G, 2003, Cancer Control, V10, P361; Sands BE, 2007, J GASTROENTEROL, V42, P16, DOI 10.1007/s00535-006-1995-7; Sato S, 1996, J IMMUNOL, V157, P4371; Schmidt N, 2010, GUT, V59, P896, DOI 10.1136/gut.2009.203554; Sun K, 2004, P NATL ACAD SCI USA, V101, P8120, DOI 10.1073/pnas.0401563101; Vanderlugt CL, 2000, J AUTOIMMUN, V14, P205, DOI 10.1006/jaut.2000.0370; Visekruna A, 2006, J CLIN INVEST, V116, P3195, DOI 10.1172/JCI28804; Visekruna A, 2009, INFLAMM BOWEL DIS, V15, P526, DOI 10.1002/ibd.20805; Wirtz S, 2007, NAT PROTOC, V2, P541, DOI 10.1038/nprot.2007.41; Yanaba K, 2010, J LEUKOCYTE BIOL, V88, P117, DOI 10.1189/jlb.1009666	32	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e34587	10.1371/journal.pone.0034587	http://dx.doi.org/10.1371/journal.pone.0034587			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479648	Green Published, Green Submitted			2022-12-27	WOS:000305339100170
J	Courbebaisse, M; Leroy, C; Bakouh, N; Salaun, C; Beck, L; Grandchamp, B; Planelles, G; Hall, RA; Friedlander, G; Prie, D				Courbebaisse, Marie; Leroy, Christine; Bakouh, Naziha; Salauen, Christine; Beck, Laurent; Grandchamp, Bernard; Planelles, Gabrielle; Hall, Randy A.; Friedlander, Gerard; Prie, Dominique			A New Human NHERF1 Mutation Decreases Renal Phosphate Transporter NPT2a Expression by a PTH-Independent Mechanism	PLOS ONE			English	Article							PARATHYROID-HORMONE; PROXIMAL TUBULE; COTRANSPORTER; IIA; ISOFORMS; RECEPTOR; CALCIUM; BETA	Background: The sodium-hydrogen exchanger regulatory factor 1 (NHERF1) binds to the main renal phosphate transporter NPT2a and to the parathyroid hormone (PTH) receptor. We have recently identified mutations in NHERF1 that decrease renal phosphate reabsorption by increasing PTH-induced cAMP production in the renal proximal tubule. Methods: We compared relevant parameters of phosphate homeostasis in a patient with a previously undescribed mutation in NHERF1 and in control subjects. We expressed the mutant NHERF1 protein in Xenopus Oocytes and in cultured cells to study its effects on phosphate transport and PTH-induced cAMP production. Results: We identified in a patient with inappropriate renal phosphate reabsorption a previously unidentified mutation (E68A) located in the PDZ1 domain of NHERF1. We report the consequences of this mutation on NHERF1 function. E68A mutation did not modify cAMP production in the patient. PTH-induced cAMP synthesis and PKC activity were not altered by E68A mutation in renal cells in culture. In contrast to wild-type NHERF1, expression of the E68A mutant in Xenopus oocytes and in human cells failed to increase phosphate transport. Pull down experiments showed that E68A mutant did not interact with NPT2a, which robustly interacted with wild type NHERF1 and previously identified mutants. Biotinylation studies revealed that E68A mutant was unable to increase cell surface expression of NPT2a. Conclusions: Our results indicate that the PDZ1 domain is critical for NHERF1-NPT2a interaction in humans and for the control of NPT2a expression at the plasma membrane. Thus we have identified a new mechanism of renal phosphate loss and shown that different mutations in NHERF1 can alter renal phosphate reabsorption via distinct mechanisms.	[Courbebaisse, Marie; Friedlander, Gerard; Prie, Dominique] Univ Paris 05, Fac Med, Paris, France; [Courbebaisse, Marie; Leroy, Christine; Bakouh, Naziha; Salauen, Christine; Beck, Laurent; Planelles, Gabrielle; Friedlander, Gerard; Prie, Dominique] INSERM U845, Res Ctr, Paris, France; [Courbebaisse, Marie; Prie, Dominique] Hop Necker Enfants Malad, Serv Physiol Explorat Fonct, Paris, France; [Grandchamp, Bernard] Univ Paris 05, Hop Bichat Claude Bernard, Inst Federatif Rech 02, INSERM, Paris, France; [Hall, Randy A.] Emory Univ, Sch Med, Dept Pharmacol, Atlanta, GA 30322 USA; [Friedlander, Gerard] Hop Europeen Georges Pompidou, Serv Physiol Explorat Fonct, Paris, France	UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Emory University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite	Courbebaisse, M (corresponding author), Univ Paris 05, Fac Med, Paris, France.	dominique.prie@inserm.fr	Planelles, Gabrielle/F-9603-2013; BECK, Laurent/P-2952-2014	Planelles, Gabrielle/0000-0002-7314-8837; BECK, Laurent/0000-0002-6730-2762; Hall, Randy/0000-0002-8318-8728; Salaun, Christine/0000-0003-3002-6810; Friedlander, Gerard/0000-0002-6854-4261	Inserm, Universite Paris Descartes, Assistance Publique - Hopitaux de Paris, Agence Nationale de la Recherche [ANR-07-PHYSIO_017_01]; Association Laboratoire de Recherches Physiologiques	Inserm, Universite Paris Descartes, Assistance Publique - Hopitaux de Paris, Agence Nationale de la Recherche(French National Research Agency (ANR)); Association Laboratoire de Recherches Physiologiques	This study was supported by grants from Inserm, Universite Paris Descartes, Assistance Publique - Hopitaux de Paris, Agence Nationale de la Recherche (grant NoANR-07-PHYSIO_017_01) and Association Laboratoire de Recherches Physiologiques. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beck L, 1998, P NATL ACAD SCI USA, V95, P5372, DOI 10.1073/pnas.95.9.5372; Biber J, 2004, AM J PHYSIOL-RENAL, V287, pF871, DOI 10.1152/ajprenal.00244.2004; Chau H, 2003, J BONE MINER RES, V18, P644, DOI 10.1359/jbmr.2003.18.4.644; Cunningham R, 2008, AM J PHYSIOL-RENAL, V294, pF1001, DOI 10.1152/ajprenal.00504.2007; Cunningham R, 2006, AM J PHYSIOL-RENAL, V291, pF896, DOI 10.1152/ajprenal.00036.2006; Gisler SM, 2001, J BIOL CHEM, V276, P9206, DOI 10.1074/jbc.M008745200; Hernando N, 2002, P NATL ACAD SCI USA, V99, P11957, DOI 10.1073/pnas.182412699; Karim Z, 2008, NEW ENGL J MED, V359, P1128, DOI 10.1056/NEJMc086284; Mahon MJ, 2003, MOL ENDOCRINOL, V17, P2355, DOI 10.1210/me.2003-0043; Mahon MJ, 2002, NATURE, V417, P858, DOI 10.1038/nature00816; Mahon MJ, 2004, J BIOL CHEM, V279, P23550, DOI 10.1074/jbc.M313229200; Prie D, 2002, NEW ENGL J MED, V347, P983, DOI 10.1056/NEJMoa020028; Prie D, 2001, KIDNEY INT, V60, P272, DOI 10.1046/j.1523-1755.2001.00796.x; Prie D, 2009, KIDNEY INT, V75, P882, DOI 10.1038/ki.2008.643; Shenolikar S, 2002, P NATL ACAD SCI USA, V99, P11470, DOI 10.1073/pnas.162232699; Villa-Bellosta R, 2008, KIDNEY INT, V73, P456, DOI 10.1038/sj.ki.5002703; Wade JB, 2003, AM J PHYSIOL-CELL PH, V285, pC1494, DOI 10.1152/ajpcell.00092.2003; Wade JB, 2001, AM J PHYSIOL-CELL PH, V280, pC192, DOI 10.1152/ajpcell.2001.280.1.C192; WALTON RJ, 1975, LANCET, V2, P309, DOI 10.1016/S0140-6736(75)92736-1; Weinman EJ, 2007, J CLIN INVEST, V117, P3412, DOI 10.1172/JCI32738; Weinman EJ, 2002, PATHOBIOLOGY, V70, P314, DOI 10.1159/000071271	21	33	36	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2012	7	4							e34764	10.1371/journal.pone.0034764	http://dx.doi.org/10.1371/journal.pone.0034764			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959FE	22506049	Green Published, gold			2022-12-27	WOS:000305297500057
J	Guan, HJ; Zhu, LH; Fu, MY; Yang, D; Tian, S; Guo, YY; Cui, CP; Wang, L; Jiang, H				Guan, Hongjing; Zhu, Lihua; Fu, Mingyue; Yang, Da; Tian, Song; Guo, Yuanyuan; Cui, Changping; Wang, Lang; Jiang, Hong			3,3 ' Diindolylmethane Suppresses Vascular Smooth Muscle Cell Phenotypic Modulation and Inhibits Neointima Formation after Carotid Injury	PLOS ONE			English	Article							PROSTATE-CANCER CELLS; DRUG-ELUTING STENTS; CARDIOVASCULAR-DISEASE; CYCLIN D1; PROLIFERATION; MIGRATION; APOPTOSIS; INDOLE-3-CARBINOL; KINASE; MICE	Background: 3, 3'diindolylmethane (DIM), a natural phytochemical, has shown inhibitory effects on the growth and migration of a variety of cancer cells; however, whether DIM has similar effects on vascular smooth muscle cells (VSMCs) remains unknown. The purpose of this study was to assess the effects of DIM on the proliferation and migration of cultured VSMCs and neointima formation in a carotid injury model, as well as the related cell signaling mechanisms. Methodology/Principal Findings: DIM dose-dependently inhibited the platelet-derived growth factor (PDGF)-BB-induced proliferation of VSMCs without cell cytotoxicity. This inhibition was caused by a G0/G1 phase cell cycle arrest demonstrated by fluorescence-activated cell-sorting analysis. We also showed that DIM-induced growth inhibition was associated with the inhibition of the expression of cyclin D1 and cyclin-dependent kinase (CDK) 4/6 as well as an increase in p27(Kip1) levels in PDGF-stimulated VSMCs. Moreover, DIM was also found to modulate migration of VSMCs and smooth muscle-specific contractile marker expression. Mechanistically, DIM negatively modulated PDGF-BB-induced phosphorylation of PDGF-recptor beta (PDGF-R beta) and the activities of downstream signaling molecules including Akt/glycogen synthase kinase(GSK) 3 beta, extracellular signal-regulated kinase1/2 (ERK1/2), and signal transducers and activators of transcription 3 (STAT3). Our in vivo studies using a mouse carotid arterial injury model revealed that treatment with 150 mg/kg DIM resulted in significant reduction of the neointima/media ratio and proliferating cell nuclear antigen (PCNA)-positive cells, without affecting apoptosis of vascular cells and reendothelialization. Infiltration of inflammatory cells was also inhibited by DIM administration. Conclusion: These results demonstrate that DIM can suppress the phenotypic modulation of VSMCs and neointima hyperplasia after vascular injury. These beneficial effects on VSMCs were at least partly mediated by the inhibition of PDGFR beta and the activities of downstream signaling pathways. The results suggest that DIM has the potential to be a candidate for the prevention of restenosis.	[Guan, Hongjing; Zhu, Lihua; Fu, Mingyue; Yang, Da; Tian, Song; Guo, Yuanyuan; Cui, Changping; Wang, Lang; Jiang, Hong] Wuhan Univ, Renmin Hosp, Dept Cardiol, Wuhan 430072, Peoples R China; [Guan, Hongjing; Zhu, Lihua; Fu, Mingyue; Yang, Da; Tian, Song; Guo, Yuanyuan; Cui, Changping; Wang, Lang; Jiang, Hong] Wuhan Univ, Cardiovasc Res Inst, Wuhan 430072, Peoples R China	Wuhan University; Wuhan University	Guan, HJ (corresponding author), Wuhan Univ, Renmin Hosp, Dept Cardiol, Wuhan 430072, Peoples R China.	hongjiangwuedu@gmail.com			National Natural Science Foundation of China [81000342]; Scientific Research Program for the Youth Scholars of Wuhan University [3082017]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Research Program for the Youth Scholars of Wuhan University	This work was supported by grants from National Natural Science Foundation of China (NO. 81000342); and Scientific Research Program for the Youth Scholars of Wuhan University (No. 3082017). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad A, 2009, J CELL BIOCHEM, V108, P916, DOI 10.1002/jcb.22323; Bauters C, 1996, CARDIOVASC RES, V31, P835; Besson A, 2004, GENE DEV, V18, P862, DOI 10.1101/gad.1185504; Bianchi M, 2005, BIOCHEM J, V391, P359, DOI 10.1042/BJ20050282; Chen DZ, 2001, J NUTR, V131, P3294, DOI 10.1093/jn/131.12.3294; Chinnakannu K, 2009, J CELL PHYSIOL, V219, P94, DOI 10.1002/jcp.21650; Dandre F, 2004, AM J PHYSIOL-HEART C, V286, pH2042, DOI 10.1152/ajpheart.00625.2003; Diehl JA, 1998, GENE DEV, V12, P3499, DOI 10.1101/gad.12.22.3499; Diez-Juan A, 2003, CIRC RES, V92, P402, DOI 10.1161/01.RES.0000059306.71961.ED; GEISTERFER AAT, 1988, CIRC RES, V62, P749, DOI 10.1161/01.RES.62.4.749; Genkinger JM, 2004, AM J EPIDEMIOL, V160, P1223, DOI 10.1093/aje/kwh339; Heldin CH, 1998, BBA-REV CANCER, V1378, pF79, DOI 10.1016/S0304-419X(98)00015-8; Joner M, 2006, J AM COLL CARDIOL, V48, P193, DOI 10.1016/j.jacc.2006.03.042; Karpurapu M, 2010, J BIOL CHEM, V285, P3510, DOI 10.1074/jbc.M109.063727; Kassie F, 2007, CANCER RES, V67, P6502, DOI 10.1158/0008-5472.CAN-06-4438; Kim EJ, 2009, J NUTR, V139, P2373, DOI 10.3945/jn.109.111864; Kovacic JC, 2010, J CLIN INVEST, V120, P303, DOI 10.1172/JCI40364; Kuhel DG, 2002, ARTERIOSCL THROM VAS, V22, P955, DOI 10.1161/01.ATV.0000017994.77066.75; Lagna G, 2007, J BIOL CHEM, V282, P37244, DOI 10.1074/jbc.M708137200; Leslie K, 2006, CANCER RES, V66, P2544, DOI 10.1158/0008-5472.CAN-05-2203; Li YW, 2007, J BIOL CHEM, V282, P21542, DOI 10.1074/jbc.M701978200; Li ZP, 2006, MOL CELL BIOL, V26, P4240, DOI 10.1128/MCB.02124-05; Malumbres M, 2001, NAT REV CANCER, V1, P222, DOI 10.1038/35106065; Mathers CD, 2009, BRIT MED BULL, V92, P7, DOI 10.1093/bmb/ldp028; Moreno R, 2005, J AM COLL CARDIOL, V45, P954, DOI 10.1016/j.jacc.2004.11.065; Moses JW, 2003, NEW ENGL J MED, V349, P1315, DOI 10.1056/NEJMoa035071; Oudit GY, 2004, J MOL CELL CARDIOL, V37, P449, DOI 10.1016/j.yjmcc.2004.05.015; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Rajoria S, PLOS ONE, V6; Safe S, 2008, CANCER LETT, V269, P326, DOI 10.1016/j.canlet.2008.04.021; Shibata R, 2003, HUM GENE THER, V14, P601, DOI 10.1089/104303403321618128; Sun J, 2001, CIRCULATION, V103, P2967, DOI 10.1161/01.CIR.103.24.2967; Takachi R, 2008, AM J EPIDEMIOL, V167, P59, DOI 10.1093/aje/kwm263; Tseng AS, 2006, CHEM BIOL, V13, P957, DOI 10.1016/j.chembiol.2006.08.004; Wang AB, 2007, J BIOMED SCI, V14, P357, DOI 10.1007/s11373-007-9150-x; Weintraub WS, 2007, AM J CARDIOL, V100, p3K, DOI 10.1016/j.amjcard.2007.06.002; Zhan YM, 2003, ARTERIOSCL THROM VAS, V23, P795, DOI 10.1161/01.ATV.0000066132.32063.F2	38	9	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2012	7	4							e34957	10.1371/journal.pone.0034957	http://dx.doi.org/10.1371/journal.pone.0034957			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959FE	22506059	Green Published, Green Submitted, gold			2022-12-27	WOS:000305297500066
J	Ling, IF; Bhongsatiern, J; Simpson, JF; Fardo, DW; Estus, S				Ling, I-Fang; Bhongsatiern, Jiraganya; Simpson, James F.; Fardo, David W.; Estus, Steven			Genetics of Clusterin Isoform Expression and Alzheimer's Disease Risk	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; SPLICING EFFICIENCY; IDENTIFIES VARIANTS; PLASMA CLUSTERIN; APOLIPOPROTEIN-J; CLU; PROSTATE; PROTEIN; PICALM; BRAIN	The minor allele of rs11136000 within CLU is strongly associated with reduced Alzheimer's disease (AD) risk. The mechanism underlying this association is unclear. Here, we report that CLU1 and CLU2 are the two primary CLU isoforms in human brain; CLU1 and CLU2 share exons 2-9 but differ in exon 1 and proximal promoters. The expression of both CLU1 and CLU2 was increased in individuals with significant AD neuropathology. However, only CLU1 was associated with the rs11136000 genotype, with the minor "protective" rs11136000T allele being associated with increased CLU1 expression. Since CLU1 and CLU2 are predicted to encode intracellular and secreted proteins, respectively, we compared their expression; for both CLU1 and CLU2 transfected cells, clusterin is present in the secretory pathway, accumulates in the extracellular media, and is similar in size to clusterin in human brain. Overall, we interpret these results as indicating that the AD-protective minor rs11136000T allele is associated with increased CLU1 expression. Since CLU1 and CLU2 appear to produce similar proteins and are increased in AD, the AD-protection afforded by the rs11136000T allele may reflect increased soluble clusterin throughout life.	[Ling, I-Fang; Bhongsatiern, Jiraganya; Simpson, James F.; Estus, Steven] Univ Kentucky, Dept Physiol, Lexington, KY 40506 USA; [Ling, I-Fang; Bhongsatiern, Jiraganya; Simpson, James F.; Estus, Steven] Univ Kentucky, Sanders Brown Ctr Aging, Lexington, KY 40536 USA; [Fardo, David W.] Univ Kentucky, Dept Biostat, Lexington, KY USA	University of Kentucky; University of Kentucky; University of Kentucky	Ling, IF (corresponding author), Univ Kentucky, Dept Physiol, Lexington, KY 40506 USA.	steve.estus@uky.edu	BHONGSATIERN, Jiraganya/ABB-9224-2020	BHONGSATIERN, Jiraganya/0000-0001-5384-9647; Fardo, David/0000-0002-7207-4696	NIH [P01AG030128, P30AG028383]; NATIONAL INSTITUTE ON AGING [P30AG028383, P01AG030128] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was funded by the NIH (P01AG030128 and P30AG028383). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksenov MY, 1999, NEUROCHEM RES, V24, P767, DOI 10.1023/A:1020783614031; Bell RD, 2007, J CEREBR BLOOD F MET, V27, P909, DOI 10.1038/sj.jcbfm.9600419; Bertram L, NAT REV NEUROL, V6, P11; Burchett ME, 2011, BIOCHEM BIOPH RES CO, V411, P323, DOI 10.1016/j.bbrc.2011.06.140; Calero M, 2000, MICROSC RES TECHNIQ, V50, P305, DOI 10.1002/1097-0029(20000815)50:4<305::AID-JEMT10>3.0.CO;2-L; Carrasquillo MM, 2010, ARCH NEUROL-CHICAGO, V67, P961, DOI 10.1001/archneurol.2010.147; CHOIMIURA NH, 1992, ACTA NEUROPATHOL, V83, P260, DOI 10.1007/BF00296787; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Cochrane DR, 2007, J BIOL CHEM, V282, P2278, DOI 10.1074/jbc.M608162200; Falgarone G, 2009, ADV CANCER RES, V104, P139, DOI 10.1016/S0065-230X(09)04008-1; Grear KE, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-46; Guerreiro RJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009510; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; Holtzman DM, 2004, J MOL NEUROSCI, V23, P247, DOI 10.1385/JMN:23:3:247; Jun G, 2010, ARCH NEUROL-CHICAGO, V67, P1473, DOI 10.1001/archneurol.2010.201; Kilgore M, 2010, NEUROPSYCHOPHARMACOL, V35, P870, DOI 10.1038/npp.2009.197; Kimura K, 1996, BBA-GENE STRUCT EXPR, V1307, P83, DOI 10.1016/0167-4781(96)00017-6; Lambert JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/ng.439; Leskov KS, 2003, J BIOL CHEM, V278, P11590, DOI 10.1074/jbc.M209233200; Ling IF, 2010, HUM MUTAT, V31, P702, DOI 10.1002/humu.21244; MAY PC, 1990, NEURON, V5, P831, DOI 10.1016/0896-6273(90)90342-D; Michel D, 1997, BIOCHEM J, V328, P45, DOI 10.1042/bj3280045; Nelson PT, 2009, J NEUROPATH EXP NEUR, V68, P1, DOI 10.1097/NEN.0b013e3181919a48; Nuutinen T, 2010, NEUROSCI LETT, V475, P64, DOI 10.1016/j.neulet.2010.03.041; Nuutinen T, 2009, BRAIN RES REV, V61, P89, DOI 10.1016/j.brainresrev.2009.05.007; Qing H, 2008, J EXP MED, V205, P2781, DOI 10.1084/jem.20081588; Reddy KB, 1996, BIOCHEMISTRY-US, V35, P6157, DOI 10.1021/bi952981b; Redondo M, 2009, ADV CANCER RES, V105, P21, DOI 10.1016/S0065-230X(09)05002-7; Rizzi F, 2010, ENDOCR-RELAT CANCER, V17, pR1, DOI 10.1677/ERC-09-0140; Sala A, 2009, ADV CANCER RES, V105, P115, DOI 10.1016/S0065-230X(09)05007-6; Schepeler Troels, 2007, J Mol Signal, V2, P6, DOI 10.1186/1750-2187-2-6; Schrijvers EMC, 2011, JAMA-J AM MED ASSOC, V305, P1322, DOI 10.1001/jama.2011.381; Thambisetty M, 2010, ARCH GEN PSYCHIAT, V67, P739, DOI 10.1001/archgenpsychiatry.2010.78; The National Institute on Aging and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease, 1997, NEUROBIOLOGY AGING, V18, pS1; van Es MA, 2009, NAT GENET, V41, P1047, DOI 10.1038/ng1009-1047; Yerbury JJ, 2007, FASEB J, V21, P2312, DOI 10.1096/fj.06-7986com; Zhang HL, 2005, NAT CELL BIOL, V7, P909, DOI 10.1038/ncb1291; Zhu H, 2007, HUM MOL GENET, V16, P1765, DOI 10.1093/hmg/ddm124; Zou FG, 2008, HUM MOL GENET, V17, P929, DOI 10.1093/hmg/ddm365	39	53	54	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2012	7	4							e33923	10.1371/journal.pone.0033923	http://dx.doi.org/10.1371/journal.pone.0033923			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959FE	22506010	Green Published, gold, Green Submitted			2022-12-27	WOS:000305297500018
J	Caserta, S; Nausch, N; Sawtell, A; Drummond, R; Barr, T; MacDonald, AS; Mutapi, F; Zamoyska, R				Caserta, Stefano; Nausch, Norman; Sawtell, Amy; Drummond, Rebecca; Barr, Tom; MacDonald, Andrew S.; Mutapi, Francisca; Zamoyska, Rose			Chronic Infection Drives Expression of the Inhibitory Receptor CD200R, and Its Ligand CD200, by Mouse and Human CD4 T Cells	PLOS ONE			English	Article							NEGLECTED TROPICAL DISEASES; SCHISTOSOMA-HAEMATOBIUM; SALMONELLA-TYPHIMURIUM; INFLUENZA INFECTION; MYELOID CELLS; IFN-GAMMA; IN-VIVO; RESPONSES; MICE; IMMUNITY	Certain parasites have evolved to evade the immune response and establish chronic infections that may persist for many years. T cell responses in these conditions become muted despite ongoing infection. Upregulation of surface receptors with inhibitory properties provides an immune cell-intrinsic mechanism that, under conditions of chronic infection, regulates immune responses and limits cellular activation and associated pathology. The negative regulator, CD200 receptor, and its ligand, CD200, have been shown to regulate macrophage activation and reduce pathology following infection. We show that CD4 T cells also increase expression of inhibitory CD200 receptors (CD200R) in response to chronic infection. CD200R was upregulated on murine effector T cells in response to infection with bacterial, Salmonella enterica, or helminth, Schistosoma mansoni, pathogens that respectively drive predominant Th1- or Th2-responses. In vitro chronic and prolonged stimuli were required for the sustained upregulation of CD200R, and its expression coincided with loss of multifunctional potential in T effector cells during infection. Importantly, we show an association between IL-4 production and CD200R expression on T effector cells from humans infected with Schistosoma haematobium that correlated effectively with egg burden and, thus infection intensity. Our results indicate a role of CD200R: CD200 in T cell responses to helminths which has diagnostic and prognostic relevance as a marker of infection for chronic schistosomiasis in mouse and man.	[Caserta, Stefano; Nausch, Norman; Sawtell, Amy; Drummond, Rebecca; Barr, Tom; MacDonald, Andrew S.; Mutapi, Francisca; Zamoyska, Rose] Univ Edinburgh, Inst Immunol & Infect Res, Edinburgh, Midlothian, Scotland	University of Edinburgh	Caserta, S (corresponding author), Univ Edinburgh, Inst Immunol & Infect Res, Edinburgh, Midlothian, Scotland.	rose.zamoyska@ed.ac.uk	Nausch, Norman/L-9276-2013; Drummond, Rebecca/I-3155-2019; Caserta, Stefano/AAP-5616-2020; Nausch, Norman/M-4526-2019	Nausch, Norman/0000-0002-9704-2148; Drummond, Rebecca/0000-0001-5424-7074; Caserta, Stefano/0000-0002-3674-2837; Nausch, Norman/0000-0002-9704-2148; Zamoyska, Rose/0000-0001-9816-2638; Mutapi, Francisca/0000-0002-2537-3466	Cancer Research UK [A8429]; Medical Research Council [G0701437]; Wellcome Trust [WT082028MA, WT082814]; MRC [G0701437] Funding Source: UKRI	Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Cancer Research UK (grant A8429) (SC RZ); Medical Research Council(grant G0701437) (ASM); The Wellcome Trust (grant WT082028MA) (NN FM) and (grant WT082814) (TB). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Barclay AN, 2002, TRENDS IMMUNOL, V23, P285, DOI 10.1016/S1471-4906(02)02223-8; Barr TA, 2010, J IMMUNOL, V185, P2783, DOI 10.4049/jimmunol.1001431; Caserta S, 2008, CANCER RES, V68, P3010, DOI 10.1158/0008-5472.CAN-07-5796; Caserta S, 2010, J IMMUNOL, V185, P6545, DOI 10.4049/jimmunol.1001867; Crompton DWT, 2002, ANNU REV NUTR, V22, P35, DOI 10.1146/annurev.nutr.22.120501.134539; Fife BT, 2008, IMMUNOL REV, V224, P166, DOI 10.1111/j.1600-065X.2008.00662.x; Han S, 2010, P NATL ACAD SCI USA, V107, P20453, DOI 10.1073/pnas.1008437107; Harari A, 2006, IMMUNOL REV, V211, P236, DOI 10.1111/j.0105-2896.2006.00395.x; Hess J, 1996, J IMMUNOL, V156, P3321; Hoek RM, 2000, SCIENCE, V290, P1768, DOI 10.1126/science.290.5497.1768; HOISETH SK, 1981, NATURE, V291, P238, DOI 10.1038/291238a0; Hotez PJ, 2008, J CLIN INVEST, V118, P1311, DOI 10.1172/JCI34261; Kawasaki BT, 2008, TRENDS IMMUNOL, V29, P464, DOI 10.1016/j.it.2008.07.005; Kretz-Rommel A, 2007, J IMMUNOL, V178, P5595, DOI 10.4049/jimmunol.178.9.5595; Kretz-Ronlmel A, 2008, J IMMUNOL, V180, P699, DOI 10.4049/jimmunol.180.2.699; LUCAS B, 1993, J IMMUNOL, V151, P4574; Mathers CD, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000114; Mihrshahi R, 2010, J IMMUNOL, V185, P7216, DOI 10.4049/jimmunol.1002858; Mihrshahi R, 2009, J IMMUNOL, V183, P4879, DOI 10.4049/jimmunol.0901531; Milner T, 2010, PARASITE IMMUNOL, V32, P710, DOI 10.1111/j.1365-3024.2010.01235.x; Mohrs M, 2001, IMMUNITY, V15, P303, DOI 10.1016/S1074-7613(01)00186-8; Murphy E, 1996, J EXP MED, V183, P901, DOI 10.1084/jem.183.3.901; MURPHY KM, 1990, SCIENCE, V250, P1720, DOI 10.1126/science.2125367; Mutapi F, 2002, LANCET INFECT DIS, V2, P219, DOI 10.1016/S1473-3099(02)00240-2; Mutapi F, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-139; Nishimura H, 1999, IMMUNITY, V11, P141, DOI 10.1016/S1074-7613(00)80089-8; Pearce EJ, 2002, NAT REV IMMUNOL, V2, P499, DOI 10.1038/nri843; Phythian-Adams AT, 2010, J EXP MED, V207, P2089, DOI 10.1084/jem.20100734; Rijkers ESK, 2008, MOL IMMUNOL, V45, P1126, DOI 10.1016/j.molimm.2007.07.013; Rygiel TP, 2009, J IMMUNOL, V183, P1990, DOI 10.4049/jimmunol.0900252; Snelgrove RJ, 2008, NAT IMMUNOL, V9, P1074, DOI 10.1038/ni.1637; Sprent J, 2002, ANNU REV IMMUNOL, V20, P551, DOI 10.1146/annurev.immunol.20.100101.151926; Taylor JJ, 2009, J CLIN INVEST, V119, P1019, DOI 10.1172/JCI36534; TIVOL EA, 1995, IMMUNITY, V3, P541, DOI 10.1016/1074-7613(95)90125-6; Vella A, 1997, J EXP MED, V186, P325, DOI 10.1084/jem.186.2.325; Wang J, 2005, P NATL ACAD SCI USA, V102, P11823, DOI 10.1073/pnas.0505497102; WATERHOUSE P, 1995, SCIENCE, V270, P985, DOI 10.1126/science.270.5238.985; WEBB M, 1984, J NEUROCHEM, V43, P1061, DOI 10.1111/j.1471-4159.1984.tb12844.x; Woolhouse MEJ, 1997, P NATL ACAD SCI USA, V94, P338, DOI 10.1073/pnas.94.1.338; Wright GJ, 2003, J IMMUNOL, V171, P3034, DOI 10.4049/jimmunol.171.6.3034; Wright GJ, 2001, IMMUNOLOGY, V102, P173, DOI 10.1046/j.1365-2567.2001.01163.x	41	30	31	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2012	7	4							e35466	10.1371/journal.pone.0035466	http://dx.doi.org/10.1371/journal.pone.0035466			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JO	22496920	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000305014500058
J	Jauhiainen, A; Thomsen, C; Strombom, L; Grundevik, P; Andersson, C; Danielsson, A; Andersson, MK; Nerman, O; Rorkvist, L; Stahlberg, A; Aman, P				Jauhiainen, Alexandra; Thomsen, Christer; Strombom, Linda; Grundevik, Pernilla; Andersson, Carola; Danielsson, Anna; Andersson, Mattias K.; Nerman, Olle; Rorkvist, Linda; Stahlberg, Anders; Aman, Pierre			Distinct Cytoplasmic and Nuclear Functions of the Stress Induced Protein DDIT3/CHOP/GADD153	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; C/EBP-HOMOLOGOUS PROTEIN; TRANSCRIPTION FACTOR CHOP; PANCREATIC BETA-CELLS; AMINO-ACID LIMITATION; MYXOID LIPOSARCOMA; BINDING-PROTEIN; GENE-EXPRESSION; IN-VITRO; INDUCED APOPTOSIS	DDIT3, also known as GADD153 or CHOP, encodes a basic leucine zipper transcription factor of the dimer forming C/EBP family. DDIT3 is known as a key regulator of cellular stress response, but its target genes and functions are not well characterized. Here, we applied a genome wide microarray based expression analysis to identify DDIT3 target genes and functions. By analyzing cells carrying tamoxifen inducible DDIT3 expression constructs we show distinct gene expression profiles for cells with cytoplasmic and nuclear localized DDIT3. Of 175 target genes identified only 3 were regulated by DDIT3 in both cellular localizations. More than two thirds of the genes were downregulated, supporting a role for DDIT3 as a dominant negative factor that could act by either cytoplasmic or nuclear sequestration of dimer forming transcription factor partners. Functional annotation of target genes showed cell migration, proliferation and apoptosis/survival as the most affected categories. Cytoplasmic DDIT3 affected more migration associated genes, while nuclear DDIT3 regulated more cell cycle controlling genes. Cell culture experiments confirmed that cytoplasmic DDIT3 inhibited migration, while nuclear DDIT3 caused a G1 cell cycle arrest. Promoters of target genes showed no common sequence motifs, reflecting that DDIT3 forms heterodimers with several alternative transcription factors that bind to different motifs. We conclude that expression of cytoplasmic DDIT3 regulated 94 genes. Nuclear translocation of DDIT3 regulated 81 additional genes linked to functions already affected by cytoplasmic DDIT3. Characterization of DDIT3 regulated functions helps understanding its role in stress response and involvement in cancer and degenerative disorders.	[Jauhiainen, Alexandra] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Thomsen, Christer; Strombom, Linda; Grundevik, Pernilla; Andersson, Carola; Andersson, Mattias K.; Rorkvist, Linda; Stahlberg, Anders; Aman, Pierre] Univ Gothenburg, Dept Pathol, Sahlgrenska Canc Ctr, Gothenburg, Sweden; [Danielsson, Anna] Univ Gothenburg, Sahlgrenska Univ Hosp, Inst Clin Sci, Dept Oncol, Gothenburg, Sweden; [Nerman, Olle] Chalmers, Dept Math Stat, S-41296 Gothenburg, Sweden; [Nerman, Olle] Univ Gothenburg, Dept Math Stat, Gothenburg, Sweden	Karolinska Institutet; University of Gothenburg; Sahlgrenska University Hospital; University of Gothenburg; Chalmers University of Technology; University of Gothenburg	Jauhiainen, A (corresponding author), Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden.	pierre.aman@llcr.med.gu.se		Stahlberg, Anders/0000-0003-4243-0191; Aman, Pierre/0000-0002-1482-8875; Danielsson, Anna/0000-0002-2827-7429	Swedish Cancer Society; Assar Gabrielssons Research Foundation; Johan Jansson Foundation for Cancer Research; Swedish Children's Cancer Society; University of Gothenburg; Wilhelm and Martina Lundgren Foundation for Scientific Research; Swedish Research Council; Gothenburg Stochastic Centre; Gothenburg Mathematical Modeling Centre; Swedish Foundation for Strategic Research	Swedish Cancer Society(Swedish Cancer Society); Assar Gabrielssons Research Foundation; Johan Jansson Foundation for Cancer Research; Swedish Children's Cancer Society; University of Gothenburg; Wilhelm and Martina Lundgren Foundation for Scientific Research; Swedish Research Council(Swedish Research CouncilEuropean Commission); Gothenburg Stochastic Centre; Gothenburg Mathematical Modeling Centre; Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research)	This work was supported by grants from the Swedish Cancer Society, Assar Gabrielssons Research Foundation, Johan Jansson Foundation for Cancer Research, Swedish Children's Cancer Society, BioCARE National Strategic Research Program at University of Gothenburg, Wilhelm and Martina Lundgren Foundation for Scientific Research, the Swedish Research Council, the Gothenburg Stochastic Centre, Gothenburg Mathematical Modeling Centre, and the Swedish Foundation for Strategic Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson ED, 2002, TUMOR BIOL, V23, P93, DOI 10.1159/000059711; Agresti A, 2002, CATEGORICAL DATA ANA, Vxv; Andersson MK, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-37; Araki E, 2003, EXP BIOL MED, V228, P1213, DOI 10.1177/153537020322801018; BARONE MV, 1994, GENE DEV, V8, P453, DOI 10.1101/gad.8.4.453; BATCHVAROVA N, 1995, EMBO J, V14, P4654, DOI 10.1002/j.1460-2075.1995.tb00147.x; Bento C, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-89; Chen BPC, 1996, MOL CELL BIOL, V16, P1157, DOI 10.1128/mcb.16.3.1157; Chen ZD, 1998, NUCLEIC ACIDS RES, V26, P1126, DOI 10.1093/nar/26.4.1126; Chiribau CB, 2010, MOL CELL BIOL, V30, P3722, DOI 10.1128/MCB.01507-09; CROZAT A, 1993, NATURE, V363, P640, DOI 10.1038/363640a0; Cui KY, 2000, J BIOL CHEM, V275, P7591, DOI 10.1074/jbc.275.11.7591; Diakogiannaki E, 2007, J ENDOCRINOL, V194, P283, DOI 10.1677/JOE-07-0082; Engstrom K, 2006, AM J PATHOL, V168, P1642, DOI 10.2353/ajpath.2006.050872; Fawcett TW, 1999, BIOCHEM J, V339, P135, DOI 10.1042/0264-6021:3390135; Gachon F, 2001, FEBS LETT, V502, P57, DOI 10.1016/S0014-5793(01)02646-1; GATELY DP, 1994, BRIT J CANCER, V70, P1102, DOI 10.1038/bjc.1994.455; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Goransson M, 2005, INT J CANCER, V115, P556, DOI 10.1002/ijc.20893; Goransson M, 2009, ONCOGENE, V28, P270, DOI 10.1038/onc.2008.378; Gotoh T, 2002, J BIOL CHEM, V277, P12343, DOI 10.1074/jbc.M107988200; Ishikawa F, 2009, J BIOCHEM, V146, P123, DOI 10.1093/jb/mvp052; JACKMAN J, 1994, CANCER RES, V54, P5656; Jousse C, 2001, NUCLEIC ACIDS RES, V29, P4341, DOI 10.1093/nar/29.21.4341; Jousse C, 1999, FEBS LETT, V448, P211, DOI 10.1016/S0014-5793(99)00373-7; Kel AE, 2003, NUCLEIC ACIDS RES, V31, P3576, DOI 10.1093/nar/gkg585; Krones-Herzig A, 2005, CANCER RES, V65, P5133, DOI 10.1158/0008-5472.CAN-04-3742; Li Y, 2008, J BIOL CHEM, V283, P22443, DOI 10.1074/jbc.M801046200; LITTLEWOOD TD, 1995, NUCLEIC ACIDS RES, V23, P1686, DOI 10.1093/nar/23.10.1686; Liu T, 2007, CELL DEATH DIFFER, V14, P411, DOI 10.1038/sj.cdd.4402022; Lorz C, 2004, J AM SOC NEPHROL, V15, P380, DOI 10.1097/01.ASN.0000111289.91206.B0; LUETHY JD, 1992, CANCER RES, V52, P5; Ma YJ, 2002, J MOL BIOL, V318, P1351, DOI 10.1016/S0022-2836(02)00234-6; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Maytin EV, 2001, EXP CELL RES, V267, P193, DOI 10.1006/excr.2001.5248; Mihailidou C, 2010, CELL PHYSIOL BIOCHEM, V25, P761, DOI 10.1159/000315096; Newman JRS, 2003, SCIENCE, V300, P2097, DOI 10.1126/science.1084648; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Oyadomari S, 2002, J CLIN INVEST, V109, P525, DOI 10.1172/JCI200214550; Pan YX, 2007, BIOCHEM J, V401, P299, DOI 10.1042/BJ20061261; Pereira RC, 2006, J CELL BIOCHEM, V97, P633, DOI 10.1002/jcb.20660; Persson F, 2008, CANCER LETT, V260, P37, DOI 10.1016/j.canlet.2007.10.032; RON D, 1992, GENE DEV, V6, P439, DOI 10.1101/gad.6.3.439; Shirakawa K, 2006, MOL CELL BIOL, V26, P6105, DOI 10.1128/MCB.02429-05; Singh VK, 2008, J MOL BIOL, V380, P313, DOI 10.1016/j.jmb.2008.04.069; Sok J, 1999, MOL CELL BIOL, V19, P495; Su N, 2008, J BIOL CHEM, V283, P35106, DOI 10.1074/jbc.M806874200; Tang JR, 2002, BIOCHEM BIOPH RES CO, V290, P1255, DOI 10.1006/bbrc.2002.6336; Thelin-Jarnum S, 2002, INT J CANCER, V97, P446, DOI 10.1002/ijc.1632; Thorp E, 2009, CELL METAB, V9, P474, DOI 10.1016/j.cmet.2009.03.003; Ubeda M, 1996, MOL CELL BIOL, V16, P1479; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang XZ, 1998, EMBO J, V17, P3619, DOI 10.1093/emboj/17.13.3619; WEDEL A, 1995, IMMUNOBIOLOGY, V193, P171, DOI 10.1016/S0171-2985(11)80541-3; Yu J, 2007, CELL DEATH DIFFER, V14, P436, DOI 10.1038/sj.cdd.4402029; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	57	71	78	6	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2012	7	4							e33208	10.1371/journal.pone.0033208	http://dx.doi.org/10.1371/journal.pone.0033208			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JO	22496745	gold, Green Published			2022-12-27	WOS:000305014500010
J	Ojuromi, OT; Izquierdo, F; Fenoy, S; Fagbenro-Beyioku, A; Oyibo, W; Akanmu, A; Odunukwe, N; Henriques-Gil, N; del Aguila, C				Ojuromi, Oladele Teslim; Izquierdo, Fernando; Fenoy, Soledad; Fagbenro-Beyioku, Adetayo; Oyibo, Wellington; Akanmu, Alani; Odunukwe, Nkiruka; Henriques-Gil, Nuno; del Aguila, Carmen			Identification and Characterization of Microsporidia from Fecal Samples of HIV-Positive Patients from Lagos, Nigeria	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; ENTEROCYTOZOON-BIENEUSI GENOTYPES; VIRUS-INFECTED PATIENTS; INTESTINAL MICROSPORIDIOSIS; ENCEPHALITOZOON-INTESTINALIS; SEPTATA-INTESTINALIS; NEGATIVE PATIENTS; PERSISTENT DIARRHEA; BIOPSY SPECIMENS; STOOL SAMPLES	Background: Microsporidia are obligate intracellular parasites that infect a broad range of vertebrates and invertebrates. They have been increasingly recognized as human pathogens in AIDS patients, mainly associated with a life-threatening chronic diarrhea and systemic disease. However, to date the global epidemiology of human microsporidiosis is poorly understood, and recent data suggest that the incidence of these pathogens is much higher than previously reported and may represent a neglected etiological agent of more common diseases indeed in immunocompetent individuals. To contribute to the knowledge of microsporidia molecular epidemiology in HIV-positive patients in Nigeria, the authors tested stool samples proceeding from patients with and without diarrhea. Methodology/Principal Findings: Stool samples from 193 HIV-positive patients with and without diarrhea (67 and 126 respectively) from Lagos (Nigeria) were investigated for the presence of microsporidia and Cryptosporidium using Weber's Chromotrope-based stain, Kinyoun stain, IFAT and PCR. The Weber stain showed 45 fecal samples (23.3%) with characteristic microsporidia spores, and a significant association of microsporidia with diarrhea was observed (O.R. = 18.2; CI: 95%). A similar result was obtained using Kinyoun stain, showing 44 (31,8%) positive samples with structures morphologically compatible with Cryptosporidium sp, 14 (31.8%) of them with infection mixed with microsporidia. The characterization of microsporidia species by IFAT and PCR allowed identification of Enterocytozoon bieneusi, Encephalitozoon intestinalis and E. cuniculi in 5, 2 and 1 samples respectively. The partial sequencing of the ITS region of the rRNA genes showed that the three isolates of E. bieneusi studied are included in Group I, one of which bears the genotype B. Conclusions/Significance: To our knowledge, this is the first report of microsporidia characterization in fecal samples from HIV-positive patients from Lagos, Nigeria. These results focus attention on the need to include microsporidial diagnosis in the management of HIV/AIDS infection in Nigeria, at the very least when other more common pathogens have not been detected.	[Ojuromi, Oladele Teslim] Lagos State Univ, Fac Sci, Dept Zool, Lagos, Nigeria; [Izquierdo, Fernando; Fenoy, Soledad; Henriques-Gil, Nuno; del Aguila, Carmen] CEU San Pablo, Fac Farm, Madrid, Spain; [Ojuromi, Oladele Teslim; Fagbenro-Beyioku, Adetayo; Oyibo, Wellington] Univ Lagos, Coll Med, Dept Med Microbiol & Parasitol, Lagos, Nigeria; [Akanmu, Alani] Univ Lagos, Coll Med, Dept Hematol, Lagos, Nigeria; [Odunukwe, Nkiruka] Nigerian Inst Med Res, Div Clin Res, Lagos, Nigeria	Lagos State University; San Pablo CEU University; University of Lagos; University of Lagos	Ojuromi, OT (corresponding author), Lagos State Univ, Fac Sci, Dept Zool, Lagos, Nigeria.	cagupue@ceu.es	del Aguila, Carmen/A-6063-2016; Arias, Fernando Izquierdo/AAE-3073-2019; Fenoy, Soledad/A-9633-2016	del Aguila, Carmen/0000-0003-0063-7899; Arias, Fernando Izquierdo/0000-0003-0367-007X; Fenoy, Soledad/0000-0002-5218-6308; Akanmu, Alani Sulaimon/0000-0001-7424-6060; Oyibo, Wellington/0000-0002-5730-5396	Fundacion San Pablo-CEU [USP-PC03/08]	Fundacion San Pablo-CEU	This work was supported by a grant from Fundacion San Pablo-CEU USP-PC03/08, and Lagos State University, Ojo, Nigeria, assisted for the visit of OTO to Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accoceberry I, 1999, J CLIN MICROBIOL, V37, P4107, DOI 10.1128/JCM.37.12.4107-4112.1999; ALDRAS AM, 1994, J CLIN MICROBIOL, V32, P608, DOI 10.1128/JCM.32.3.608-612.1994; Ayinmode A. B., 2011, Journal of Parasitology Research, V2011, P129542, DOI 10.1155/2011/129542; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bern C, 2005, J INFECT DIS, V191, P1658, DOI 10.1086/429674; BOOM R, 1990, J CLIN MICROBIOL, V28, P495, DOI 10.1128/JCM.28.3.495-503.1990; Bornay-Llinares FJ, 1998, J INFECT DIS, V178, P820, DOI 10.1086/515356; BRETAGNE S, 1993, B SOC PATHOL EXOT, V86, P351; Breton J, 2007, J CLIN MICROBIOL, V45, P2580, DOI 10.1128/JCM.02554-06; Carlson James R, 2004, Arch Pathol Lab Med, V128, pe41; Carville A, 1997, CLIN DIAGN LAB IMMUN, V4, P405, DOI 10.1128/CDLI.4.4.405-408.1997; Cegielski JP, 1999, CLIN INFECT DIS, V28, P314, DOI 10.1086/515131; Chabchoub N, 2009, AM J TROP MED HYG, V80, P24, DOI 10.4269/ajtmh.2009.80.24; Cisse OA, 2002, J CLIN MICROBIOL, V40, P1715, DOI 10.1128/JCM.40.5.1715-1718.2002; DaSilva AJ, 1996, J CLIN MICROBIOL, V34, P986, DOI 10.1128/JCM.34.4.986-987.1996; DaSilva AJ, 1997, MOL DIAGN, V2, P47, DOI 10.1016/S1084-8592(97)80010-0; Del Aguila C, 1999, J EUKARYOT MICROBIOL, V46, p8S; del Aguila C, 2001, J CLIN MICROBIOL, V39, P1105, DOI 10.1128/JCM.39.3.1105-1108.2001; Del Aguila C, 1997, J EUKARYOT MICROBIOL, V44, p84S, DOI 10.1111/j.1550-7408.1997.tb05798.x; delAguila C, 1997, J CLIN MICROBIOL, V35, P1862, DOI 10.1128/JCM.35.7.1862-1866.1997; Didier ES, 2005, ACTA TROP, V94, P61, DOI 10.1016/j.actatropica.2005.01.010; Didier ES, 2004, VET PARASITOL, V126, P145, DOI 10.1016/j.vetpar.2004.09.006; Endeshaw T, 2006, JPN J INFECT DIS, V59, P306; Espern A, 2007, J CLIN MICROBIOL, V45, P2999, DOI 10.1128/JCM.00684-07; FEDORKO DP, 1995, J CLIN MICROBIOL, V33, P1739, DOI 10.1128/JCM.33.7.1739-1741.1995; Ferreira FMB, 2001, MICROBES INFECT, V3, P1015, DOI 10.1016/S1286-4579(01)01465-4; Foster P, 2001, MOL BIOL EVOL, V18, P1864; Franzen C, 1999, CLIN MICROBIOL REV, V12, P243, DOI 10.1128/CMR.12.2.243; Gainzarain JC, 1998, CLIN INFECT DIS, V27, P394, DOI 10.1086/514660; GARCIA LS, 1994, J CLIN MICROBIOL, V32, P1739, DOI 10.1128/JCM.32.7.1739-1741.1994; Garcia LS, 2007, DIAGNOSTIC MED PARAS, V5th; Gumbo T, 1999, AIDS, V13, P819, DOI 10.1097/00002030-199905070-00011; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Haro M, 2005, APPL ENVIRON MICROB, V71, P3153, DOI 10.1128/AEM.71.6.3153-3157.2005; Haro M, 2003, J CLIN MICROBIOL, V41, P4166, DOI 10.1128/JCM.41.9.4166-4171.2003; Haro M, 2006, J EUKARYOT MICROBIOL, V53, pS58, DOI 10.1111/j.1550-7408.2006.00173.x; Henriques-Gil N, APPL ENV MICROBIOL, V76, P3333; Henriques-Gil N, 2010, APPL ENVIRON MICROB, V76, P3333, DOI 10.1128/AEM.03026-09; Ikeh E I, 2007, Niger Postgrad Med J, V14, P290; KELLY P, 1994, LANCET, V344, P271, DOI 10.1016/S0140-6736(94)93039-2; Kucerova-Pospisilova Z, 1998, FOLIA PARASIT, V45, P108; Latib MA, 2001, TRANSPLANT INT, V14, P274, DOI 10.1111/j.1432-2277.2001.tb00058.x; Lebbad M, 2001, ACTA TROP, V80, P45, DOI 10.1016/S0001-706X(01)00142-5; Leelayoova S, 2006, J CLIN MICROBIOL, V44, P3001, DOI 10.1128/JCM.00945-06; Liguory O, 1997, AIDS, V11, P723, DOI 10.1097/00002030-199706000-00004; Lores B, 2002, CLIN INFECT DIS, V34, P918, DOI 10.1086/339205; Lobo ML, 2006, APPL ENVIRON MICROB, V72, P7380, DOI 10.1128/AEM.01394-06; Maiga I, 1997, Sante, V7, P257; Mathis A, 1999, PARASITE, V6, P189, DOI 10.1051/parasite/1999062189; Metge S, 2000, EUR J CLIN MICROBIOL, V19, P221, DOI 10.1007/s100960050463; Mohindra A R, 2002, Transpl Infect Dis, V4, P102, DOI 10.1034/j.1399-3062.2002.01011.x; Mor SM, 2009, EMERG INFECT DIS, V15, P49, DOI 10.3201/eid1501.071536; MORALES MAG, 1995, TROP MED PARASITOL, V46, P109; Muller A, 2001, J CLIN MICROBIOL, V39, P1630, DOI 10.1128/JCM.39.4.1630-1632.2001; Nkinin SW, 2007, J CLIN MICROBIOL, V45, P2841, DOI 10.1128/JCM.00328-07; Notermans DW, 2005, J CLIN MICROBIOL, V43, P610, DOI 10.1128/JCM.43.2.610-614.2005; Okewole EA, 2008, ONDERSTEPOORT J VET, V75, P33; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Sadler F, 2002, J INFECTION, V44, P39, DOI 10.1053/jinf.2001.0934; Sak B, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001162; Samie A, 2007, T ROY SOC TROP MED H, V101, P547, DOI 10.1016/j.trstmh.2007.02.005; Santin M, 2005, PARASITOL RES, V97, P535, DOI 10.1007/s00436-005-1482-8; Santin M, 2009, J EUKARYOT MICROBIOL, V56, P34, DOI 10.1111/j.1550-7408.2008.00380.x; Sarfati C, 2006, AM J TROP MED HYG, V74, P162, DOI 10.4269/ajtmh.2006.74.162; SERWADDA D, 1985, LANCET, V2, P849, DOI 10.1016/S0140-6736(85)90122-9; Sianongo S, 2001, T ROY SOC TROP MED H, V95, P605, DOI 10.1016/S0035-9203(01)90093-8; Sing A, 2001, J CLIN MICROBIOL, V39, P2371, DOI 10.1128/JCM.39.6.2371-2372.2001; Stark D, 2009, CLIN MICROBIOL REV, V22, P634, DOI 10.1128/CMR.00017-09; Subrungruang I, 2004, J CLIN MICROBIOL, V42, P3490, DOI 10.1128/JCM.42.8.3490-3494.2004; Sulaiman IM, 2003, J EUKARYOT MICROBIOL, V50, P591, DOI 10.1111/j.1550-7408.2003.tb00642.x; Ten Hove RJ, 2009, J EUKARYOT MICROBIOL, V56, P388, DOI 10.1111/j.1550-7408.2009.00393.x; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tumwine JK, 2005, AM J TROP MED HYG, V73, P921, DOI 10.4269/ajtmh.2005.73.921; Tumwine JK, 2002, AM J TROP MED HYG, V67, P299, DOI 10.4269/ajtmh.2002.67.299; VANGOOL T, 1995, T ROY SOC TROP MED H, V89, P478, DOI 10.1016/0035-9203(95)90073-X; vanGool T, 1997, J INFECT DIS, V175, P1020, DOI 10.1086/513963; VISVESVARA GS, 1994, J CLIN MICROBIOL, V32, P2760, DOI 10.1128/JCM.32.11.2760-2768.1994; WEBER R, 1992, NEW ENGL J MED, V326, P161, DOI 10.1056/NEJM199201163260304; WEBER R, 1993, CLIN INFECT DIS, V17, P480, DOI 10.1093/clinids/17.3.480; Xiao L, 2004, SE ASIAN J TROP MED, V35, P40	80	34	35	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2012	7	4							e35239	10.1371/journal.pone.0035239	http://dx.doi.org/10.1371/journal.pone.0035239			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JO	22496910	Green Published, Green Submitted, gold			2022-12-27	WOS:000305014500050
J	Arun, P; Oguntayo, S; Alamneh, Y; Honnold, C; Wang, Y; Valiyaveettil, M; Long, JB; Nambiar, MP				Arun, Peethambaran; Oguntayo, Samuel; Alamneh, Yonas; Honnold, Cary; Wang, Ying; Valiyaveettil, Manojkumar; Long, Joseph B.; Nambiar, Madhusoodana P.			Rapid Release of Tissue Enzymes into Blood after Blast Exposure: Potential Use as Biological Dosimeters	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; LITHOTRIPTER SHOCK-WAVES; EXPLOSIVE BLAST; RATS; DAMAGE; PERMEABILIZATION; OVERPRESSURE; AFGHANISTAN; MEMBRANE; PROTEINS	Explosive blast results in multiple organ injury and polytrauma, the intensity of which varies with the nature of the exposure, orientation, environment and individual resilience. Blast overpressure alone may not precisely indicate the level of body or brain injury after blast exposure. Assessment of the extent of body injury after blast exposure is important, since polytrauma and systemic factors significantly contribute to blast-induced traumatic brain injury. We evaluated the activity of plasma enzymes including aspartate aminotransferase (AST), alanine aminotransferase (ALT), lactate dehydrogenase (LDH) and creatine kinase (CK) at different time points after blast exposure using a mouse model of single and repeated blast exposures to assess the severity of injury. Our data show that activities of all the enzymes in the plasma were significantly increased as early as 1 h after blast exposure. The elevated enzyme activity remained up to 6 h in an overpressure dose-dependent manner and returned close to normal levels at 24 h. Head-only blast exposure with body protection showed no increase in the enzyme activities suggesting that brain injury alone does not contribute to the systemic increase. In contrast to plasma increase, AST, ALT and LDH activity in the liver and CK in the skeletal muscle showed drastic decrease at 6 h after blast exposures. Histopathology showed mild necrosis at 6 h and severe necrosis at 24 h after blast exposures in liver and no changes in the skeletal muscle suggesting that the enzyme release from the tissue to plasma is probably triggered by transient cell membrane disruption from shockwave and not due to necrosis. Overpressure dependent transient release of tissue enzymes and elevation in the plasma after blast exposure suggest that elevated enzyme activities in the blood can be potentially used as a biological dosimeter to assess the severity of blast injury.	[Arun, Peethambaran; Oguntayo, Samuel; Alamneh, Yonas; Wang, Ying; Valiyaveettil, Manojkumar; Long, Joseph B.; Nambiar, Madhusoodana P.] Walter Reed Army Inst Res, Blast Induced Neurotrauma Branch, Ctr Mil Psychiat & Neurosci, Silver Spring, MD USA; [Honnold, Cary] Walter Reed Army Inst Res, Vet Serv Program, Div Pathol, Silver Spring, MD USA	United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR)	Arun, P (corresponding author), Walter Reed Army Inst Res, Blast Induced Neurotrauma Branch, Ctr Mil Psychiat & Neurosci, Silver Spring, MD USA.	madhusoodana.nambiar@amedd.army.mil			Congressionally Directed Medical Research Programs grant [W81XWH-08-2-0017]	Congressionally Directed Medical Research Programs grant	The study was supported by Congressionally Directed Medical Research Programs grant (Award Number W81XWH-08-2-0017) to JBL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armonda RA, 2006, NEUROSURGERY, V59, P1215, DOI 10.1227/01.NEU.0000249190.46033.94; Arun P, 2011, NEUROREPORT, V22, P379, DOI 10.1097/WNR.0b013e328346b138; Avidan V, 2005, AM J SURG, V190, P927, DOI 10.1016/j.amjsurg.2005.08.022; Bassit RA, 2010, EUR J APPL PHYSIOL, V108, P945, DOI 10.1007/s00421-009-1305-1; Bauman RA, 2009, J NEUROTRAUM, V26, P841, DOI [10.1089/neu.2008.0898, 10.1089/neu.2009-0898]; Bell RS, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2010.2.FOCUS1025; Cernak Ibolja, 2010, Front Neurol, V1, P151, DOI 10.3389/fneur.2010.00151; Chavko M, 2008, J TRAUMA, V65, P1140, DOI 10.1097/TA.0b013e3181870a8c; Chavko M, 2011, J NEUROSCI METH, V195, P61, DOI 10.1016/j.jneumeth.2010.11.019; Chavko M, 2009, SHOCK, V32, P325, DOI 10.1097/SHK.0b013e31819c38f1; Courtney AC, 2009, MED HYPOTHESES, V72, P76, DOI 10.1016/j.mehy.2008.08.015; Courtney MW, 2011, NEUROIMAGE, V54, pS55, DOI 10.1016/j.neuroimage.2010.05.025; Cullen DK, 2011, NEUROIMAGE, V54, pS37, DOI 10.1016/j.neuroimage.2010.10.076; Delius M, 1999, CANCER RES, V59, P5227; DePalma RG, 2005, NEW ENGL J MED, V352, P1335, DOI 10.1056/NEJMra042083; Devarajan P, 2011, CURR OPIN PEDIATR, V23, P194, DOI 10.1097/MOP.0b013e328343f4dd; DOUKAS AG, 1993, ULTRASOUND MED BIOL, V19, P137, DOI 10.1016/0301-5629(93)90006-A; Elsayed NM, 2000, TOXICOLOGY, V155, P91, DOI 10.1016/S0300-483X(00)00281-X; GAMBIHLER S, 1994, J MEMBRANE BIOL, V141, P267; GAMBIHLER S, 1992, NATURWISSENSCHAFTEN, V79, P328, DOI 10.1007/BF01138714; Garner Jeff, 2007, Anesthesiol Clin, V25, P147; Gorbunov NV, 2006, EXP MOL PATHOL, V80, P11, DOI 10.1016/j.yexmp.2005.06.007; Jeyaseelan K, 2008, STROKE, V39, P959, DOI 10.1161/STROKEAHA.107.500736; Kodama T, 2000, BIOPHYS J, V79, P1821, DOI 10.1016/S0006-3495(00)76432-0; Koliatsos VE, 2011, J NEUROPATH EXP NEUR, V70, P399, DOI 10.1097/NEN.0b013e3182189f06; Laterza OF, 2009, CLIN CHEM, V55, P1977, DOI 10.1373/clinchem.2009.131797; Ling G, 2009, J NEUROTRAUM, V26, P815, DOI 10.1089/neu.2007.0484; Long JB, 2009, J NEUROTRAUM, V26, P827, DOI 10.1089/neu.2008.0748; Morochovic R, 2009, EUR J NEUROL, V16, P1112, DOI 10.1111/j.1468-1331.2009.02653.x; Nakagawa A, 2011, J NEUROTRAUM, V28, P1101, DOI 10.1089/neu.2010.1442; Pun Pamela B L, 2011, Front Neurol, V2, P19, DOI 10.3389/fneur.2011.00019; Reagan WJ, 2010, TOXICOL PATHOL, V38, P1134, DOI 10.1177/0192623310382438; Redell JB, 2010, J NEUROTRAUM, V27, P2147, DOI 10.1089/neu.2010.1481; Shahshahani MM, 2011, J DERMATOL, V38, P1153, DOI 10.1111/j.1346-8138.2011.01278.x; Singab ANB, 2005, ARCH PHARM RES, V28, P791, DOI 10.1007/BF02977344; Sorichter S, 1999, EXERC IMMUNOL REV, V5, P5; Wallace D, 2009, AUSTRALAS PSYCHIATRY, V17, P218, DOI 10.1080/10398560902878679; Wang Y, 2011, J NEUROTRAUM, V28, P2171, DOI 10.1089/neu.2011.1990; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Wightman JM, 2001, ANN EMERG MED, V37, P664, DOI 10.1067/mem.2001.114906; Yamaguchi M, 2002, MOL CELL BIOCHEM, V241, P61, DOI 10.1023/A:1020822610085; Zurek J, 2012, ACTA NEUROCHIR, V154, P93, DOI 10.1007/s00701-011-1175-2	42	20	22	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2012	7	4							e33798	10.1371/journal.pone.0033798	http://dx.doi.org/10.1371/journal.pone.0033798			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JA	22493674	Green Published, gold, Green Submitted			2022-12-27	WOS:000305012700016
J	Cui, L; Li, T; Liu, YY; Zhou, L; Li, PH; Xu, BL; Huang, LF; Chen, Y; Liu, YZ; Tian, XY; Jee, WSS; Wu, T				Cui, Liao; Li, Ting; Liu, Yuyu; Zhou, Le; Li, Pinghua; Xu, Bilian; Huang, Lianfang; Chen, Yan; Liu, Yanzhi; Tian, Xiaoyan; Jee, Webster S. S.; Wu, Tie			Salvianolic Acid B Prevents Bone Loss in Prednisone-Treated Rats through Stimulation of Osteogenesis and Bone Marrow Angiogenesis	PLOS ONE			English	Article							TRABECULAR BONE; DIFFERENTIATION; OSTEOBLASTS; MILTIORRHIZA; CELLS; EXPRESSION; BEAGLE; HISTOMORPHOMETRY; GLUCOCORTICOIDS; OSTEONECROSIS	Glucocorticoid (GC) induced osteoporosis (GIO) is caused by the long-term use of GC for treatment of autoimmune and inflammatory diseases. The GC related disruption of bone marrow microcirculation and increased adipogenesis contribute to GIO development. However, neither currently available anti-osteoporosis agent is completely addressed to microcirculation and bone marrow adipogenesis. Salvianolic acid B (Sal B) is a polyphenolic compound from a Chinese herbal medicine, Salvia miltiorrhiza Bunge. The aim of this study was to determine the effects of Sal B on osteoblast bone formation, angiogenesis and adipogenesis-associated GIO by performing marrow adipogenesis and microcirculation dilation and bone histomorphometry analyses. (1) In vivo study: Bone loss in GC treated rats was confirmed by significantly decreased BMD, bone strength, cancellous bone mass and architecture, osteoblast distribution, bone formation, marrow microvessel density and diameter along with down-regulation of marrow BMPs expression and increased adipogenesis. Daily treatment with Sal B (40 mg/kg/d) for 12 weeks in GC male rats prevented GC-induced cancellous bone loss and increased adipogenesis while increasing cancellous bone formation rate with improved local microcirculation by capillary dilation. Treatment with Sal B at a higher dose (80 mg/kg/d) not only prevented GC-induced osteopenia, but also increased cancellous bone mass and thickness, associated with increase of marrow BMPs expression, inhibited adipogenesis and further increased microvessel diameters. (2) In vitro study: In concentration from 10(-6) mol/L to 10(-7) mol/L, Sal B stimulated bone marrow stromal cell (MSC) differentiation to osteoblast and increased osteoblast activities, decreased GC associated adipogenic differentiation by down-regulation of PPAR gamma mRNA expression, increased Runx2 mRNA expression without osteoblast inducement, and, furthermore, Sal B decreased Dickkopf-1 and increased beta-catenin mRNA expression with or without adipocyte inducement in MSC. We conclude that Sal B prevented bone loss in GC-treated rats through stimulation of osteogenesis, bone marrow angiogenesis and inhibition of adipogenesis.	[Cui, Liao; Li, Ting; Liu, Yuyu; Zhou, Le; Li, Pinghua; Xu, Bilian; Huang, Lianfang; Chen, Yan; Liu, Yanzhi; Wu, Tie] Guangdong Med Coll, Guangdong Key Lab Res & Dev Nat Drug, Dept Pharmacol, Zhanjiang City, Guangdong, Peoples R China; [Cui, Liao; Tian, Xiaoyan; Jee, Webster S. S.] Univ Utah, Sch Med, Div Radiobiol, Salt Lake City, UT 84112 USA	Guangdong Medical University; Utah System of Higher Education; University of Utah	Cui, L (corresponding author), Guangdong Med Coll, Guangdong Key Lab Res & Dev Nat Drug, Dept Pharmacol, Zhanjiang City, Guangdong, Peoples R China.	wutie2@163.com	Liu, Yanzhi/P-6387-2014; Li, Ping/GYV-4914-2022		National Science Foundation of China [30672470, 30973574]	National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Science Foundation of China (No: 30672470 and No: 30973574). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams James David, 2006, Chin Med, V1, P3, DOI 10.1186/1749-8546-1-3; Baron R, 1983, BONE HISTOMORPHOMETR, P22; Blair HC, 2007, ANN NY ACAD SCI, V1116, P165, DOI 10.1196/annals.1402.029; Brandi ML, 2006, J BONE MINER RES, V21, P183, DOI 10.1359/JBMR.050917; Branemark PI, 1958, SCAND J CLIN LAB S38, V11, P1; Canalis Ernesto, 2005, Curr Osteoporos Rep, V3, P98, DOI 10.1007/s11914-005-0017-7; Chinese Pharmacopoeia Commission, 2005, PHARM PEOPL REP CH 1; Cui L, 2001, ACTA PHARMACOL SIN, V22, P428; Cui L, 2009, ACTA PHARMACOL SIN, V30, P321, DOI 10.1038/aps.2009.9; Das A, 2011, TISSUE ENG PART B-RE, V17, P403, DOI [10.1089/ten.teb.2011.0190, 10.1089/ten.TEB.2011.0190]; Day TF, 2005, DEV CELL, V8, P739, DOI 10.1016/j.devcel.2005.03.016; Eghbali-Fatourechi GZ, 2005, NEW ENGL J MED, V352, P1959, DOI 10.1056/NEJMoa044264; Eriksen EF, 2007, J BONE MINER RES, V22, P1, DOI 10.1359/JBMR.060910; Ersoy A, 2006, NEPHROL DIAL TRANSPL, V21, P1452, DOI 10.1093/ndt/gfi342; Hamidouche Z, 2008, FASEB J, V22, P3813, DOI 10.1096/fj.08-106302; Hauge EM, 2001, J BONE MINER RES, V16, P1575, DOI 10.1359/jbmr.2001.16.9.1575; He HB, 2008, PHARMACOL REP, V60, P369; [胡长根 Hu Changgen], 2004, [中华骨科杂志, Chinese Journal of Orthopedics], V24, P359; Ito S, 2007, BONE, V40, P84, DOI 10.1016/j.bone.2006.07.012; Jee WSS, 1997, HDB BONE MORPHOLOGY, P87; Ji XY, 2000, ACTA PHARMACOL SIN, V21, P1089; Kang DG, 2003, PHYTOTHER RES, V17, P917, DOI 10.1002/ptr.1250; Kerachian MA, 2009, J STEROID BIOCHEM, V114, P121, DOI 10.1016/j.jsbmb.2009.02.007; Khan E, 2003, J LAB CLIN MED, V142, P29, DOI 10.1016/S0022-2143(03)00058-1; Kitajima M, 2007, MED MOL MORPHOL, V40, P150, DOI 10.1007/s00795-007-0367-6; Kuznetsov SA, 2001, J CELL BIOL, V153, P1133, DOI 10.1083/jcb.153.5.1133; Lam FFY, 2006, EUR J PHARMACOL, V553, P240, DOI 10.1016/j.ejphar.2006.09.030; Li GS, 2009, TOXICOL MECH METHOD, V19, P441, DOI 10.1080/15376510903150623; Li YG, 2009, J CHROMATOGR A, V1216, P1941, DOI 10.1016/j.chroma.2008.12.032; Liebschner MAK, 2005, ANN BIOMED ENG, V33, P26, DOI 10.1007/s10439-005-8960-0; Lu BY, 2010, CELL BIOL INT, V34, P1063, DOI 10.1042/CBI20090126; Luppen CA, 2008, GROWTH FACTORS, V26, P226, DOI 10.1080/08977190802277880; Marx N, 1998, CIRC RES, V83, P1097, DOI 10.1161/01.RES.83.11.1097; Miyanishi K, 2002, BONE, V30, P185, DOI 10.1016/S8756-3282(01)00663-9; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Ohnaka K, 2004, BIOCHEM BIOPH RES CO, V318, P259, DOI 10.1016/j.bbrc.2004.04.025; Ohnaka Keizo, 2006, Clin Calcium, V16, P1812; Padro T, 2000, BLOOD, V95, P2637, DOI 10.1182/blood.V95.8.2637.008k07_2637_2644; Parfitt AM, 1998, BONE, V23, P491, DOI 10.1016/S8756-3282(98)00140-9; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; PARFITT AM, 1995, CALCIFIED TISSUE INT, V56, pS5, DOI 10.1007/BF03354639; Partfitt AM, 2008, OSTEOPOROSIS, P71; REEVE J, 1988, J CLIN ENDOCR METAB, V66, P1124, DOI 10.1210/jcem-66-6-1124; Shah SK, 2006, J AM OSTEOPATH ASSOC, V106, P653; Sun Yu, 2008, Zhongguo Yaolixue Tongbao, V24, P377; Tian XY, 2010, BONE, V47, P529, DOI 10.1016/j.bone.2010.05.032; VAN DYKE DONALD, 1967, CLIN ORTHOP RELATED RES, V52, P37; [汪红 Wang Hong], 2002, [中国药科大学学报, Journal of China Pharmaceutical University], V33, P219; WEIDNER N, 1995, BREAST CANCER RES TR, V36, P169, DOI 10.1007/BF00666038; Weinstein RS, 2010, BONE, V46, P564, DOI 10.1016/j.bone.2009.06.030; WRONSKI TJ, 1981, CALCIFIED TISSUE INT, V33, P583, DOI 10.1007/BF02409495; WRONSKI TJ, 1980, RADIAT RES, V83, P74, DOI 10.2307/3575260; Yin L, 2006, CHINESE MED J-PEKING, V119, P581, DOI 10.1097/00029330-200604010-00012; Zhong Jing, 2007, Yaoxue Xuebao, V42, P716; Zhou LM, 2005, J CLIN PHARMACOL, V45, P1345, DOI 10.1177/0091270005282630	55	90	100	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2012	7	4							e34647	10.1371/journal.pone.0034647	http://dx.doi.org/10.1371/journal.pone.0034647			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JA	22493705	Green Published, gold, Green Submitted			2022-12-27	WOS:000305012700047
J	Gibson, NJ; Tolbert, LP; Oland, LA				Gibson, Nicholas J.; Tolbert, Leslie P.; Oland, Lynne A.			Activation of Glial FGFRs Is Essential in Glial Migration, Proliferation, and Survival and in Glia-Neuron Signaling during Olfactory System Development	PLOS ONE			English	Article							FIBROBLAST-GROWTH-FACTOR; MOTH MANDUCA-SEXTA; HEPARAN-SULFATE PROTEOGLYCANS; SENSORY AXON GUIDANCE; FACTOR RECEPTOR; ANTENNAL LOBES; EMBRYONIC-DEVELOPMENT; CELL-PROLIFERATION; NEURITE OUTGROWTH; NERVOUS-SYSTEM	Development of the adult olfactory system of the moth Manduca sexta depends on reciprocal interactions between olfactory receptor neuron (ORN) axons growing in from the periphery and centrally-derived glial cells. Early-arriving ORN axons induce a subset of glial cells to proliferate and migrate to form an axon-sorting zone, in which later-arriving ORN axons will change their axonal neighbors and change their direction of outgrowth in order to travel with like axons to their target areas in the olfactory (antennal) lobe. These newly fasciculated axon bundles will terminate in protoglomeruli, the formation of which induces other glial cells to migrate to surround them. Glial cells do not migrate unless ORN axons are present, axons fail to fasciculate and target correctly without sufficient glial cells, and protoglomeruli are not maintained without a glial surround. We have shown previously that Epidermal Growth Factor receptors and the IgCAMs Neuroglian and Fasciclin II play a role in the ORN responses to glial cells. In the present work, we present evidence for the importance of glial Fibroblast Growth Factor receptors in glial migration, proliferation, and survival in this developing pathway. We also report changes in growth patterns of ORN axons and of the dendrites of olfactory (antennal lobe) neurons following blockade of glial FGFR activation that suggest that glial FGFR activation is important in reciprocal communication between neurons and glial cells.	[Gibson, Nicholas J.; Tolbert, Leslie P.; Oland, Lynne A.] Univ Arizona, Dept Neurosci, Tucson, AZ 85721 USA	University of Arizona	Gibson, NJ (corresponding author), Univ Arizona, Dept Neurosci, Tucson, AZ 85721 USA.	njgibson@neurobio.arizona.edu			National Institutes of Health [DC008597]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC008597] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by National Institutes of Health DC008597 (http://nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auld V, 1999, CELL MOL LIFE SCI, V55, P1377, DOI 10.1007/s000180050378; Bashaw GJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001941; Baumann PM, 1996, J COMP NEUROL, V373, P118; Beiman M, 1996, GENE DEV, V10, P2993, DOI 10.1101/gad.10.23.2993; Biscardi JS, 1999, J BIOL CHEM, V274, P8335, DOI 10.1074/jbc.274.12.8335; Bryant MR, 2009, GLIA, V57, P935, DOI 10.1002/glia.20818; Chotard C, 2004, TRENDS NEUROSCI, V27, P655, DOI 10.1016/j.tins.2004.09.001; Chotard C, 2007, NEURON GLIA BIOL, V3, P17, DOI 10.1017/S1740925X07000592; Combet C, 2000, TRENDS BIOCHEM SCI, V25, P147, DOI 10.1016/S0968-0004(99)01540-6; Condron B, 1999, DEVELOPMENT, V126, P4635; Doherty P, 1996, MOL CELL NEUROSCI, V8, P99, DOI 10.1006/mcne.1996.0049; Dossenbach C, 2001, DEVELOPMENT, V128, P4563; EMORI Y, 1993, FEBS LETT, V332, P111, DOI 10.1016/0014-5793(93)80494-F; Eswarakumar VP, 2005, CYTOKINE GROWTH F R, V16, P139, DOI 10.1016/j.cytogfr.2005.01.001; Forni JJ, 2004, MOL CELL NEUROSCI, V26, P282, DOI 10.1016/j.mcn.2004.02.003; Franzdottir SR, 2009, NATURE, V460, P758, DOI 10.1038/nature08167; Freeman MR, 2006, CURR OPIN NEUROBIOL, V16, P119, DOI 10.1016/j.conb.2005.12.004; Garcia-Alonso L, 2000, NEURON, V28, P741, DOI 10.1016/S0896-6273(00)00150-1; Gdalyahu A, 2004, EMBO J, V23, P823, DOI 10.1038/sj.emboj.7600079; Gibson NJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007222; Gibson NJ, 2006, J COMP NEUROL, V495, P554, DOI 10.1002/cne.20890; Gibson NJ, 2001, DEV BIOL, V240, P326, DOI 10.1006/dbio.2001.0463; Gibson NJ, 2004, J COMP NEUROL, V476, P1, DOI 10.1002/cne.20178; Gisselbrecht S, 1996, GENE DEV, V10, P3003, DOI 10.1101/gad.10.23.3003; Gryzik T, 2004, CURR BIOL, V14, P659, DOI 10.1016/j.cub.2004.03.058; HAYASHI JH, 1990, J NEUROSCI, V10, P848; Heil JE, 2007, EUR J NEUROSCI, V26, P1227, DOI 10.1111/j.1460-9568.2007.05756.x; Hendzel MJ, 1997, CHROMOSOMA, V106, P348, DOI 10.1007/s004120050256; Hidalgo A, 2003, BIOCHEM SOC T, V31, P50, DOI 10.1042/bst0310050; Higgins MR, 2002, DEV BIOL, V244, P134, DOI 10.1006/dbio.2002.0583; Islam R, 2004, MOL BIOL CELL, V15, P2003, DOI 10.1091/mbc.e03-05-0333; Kadam S, 2009, DEVELOPMENT, V136, P739, DOI 10.1242/dev.027904; KADMON G, 1990, J CELL BIOL, V110, P193, DOI 10.1083/jcb.110.1.193; Kaneko M, 2003, J NEUROSCI, V23, P11523; Katsuma S, 2006, J VIROL, V80, P5474, DOI 10.1128/JVI.00248-06; KIRSCHENBAUM SR, 1995, J NEUROBIOL, V28, P234, DOI 10.1002/neu.480280209; Klambt C, 2009, NAT REV NEUROSCI, V10, P769, DOI 10.1038/nrn2720; KLAMBT C, 1992, GENE DEV, V6, P1668, DOI 10.1101/gad.6.9.1668; Klingseisen A, 2009, DEVELOPMENT, V136, P2393, DOI 10.1242/dev.035451; Kolodkin AL, 2010, CSH PERSPECT BIOL, V2; Kristiansen LV, 2005, MOL CELL NEUROSCI, V28, P141, DOI 10.1016/j.mcn.2004.09.003; LaVallee TM, 1998, J CELL BIOL, V141, P1647, DOI 10.1083/jcb.141.7.1647; Leadbeater WE, 2006, J NEUROCHEM, V96, P1189, DOI 10.1111/j.1471-4159.2005.03632.x; Lemke G, 2001, ANNU REV NEUROSCI, V24, P87, DOI 10.1146/annurev.neuro.24.1.87; Lin XH, 2000, MATRIX BIOL, V19, P303, DOI 10.1016/S0945-053X(00)00073-1; Lin XH, 1999, DEVELOPMENT, V126, P3715; Lohr C, 2005, GLIA, V50, P198, DOI 10.1002/glia.20163; Maher PA, 1996, J CELL BIOL, V134, P529, DOI 10.1083/jcb.134.2.529; Meaburn KJ, 2007, NATURE, V445, P379, DOI 10.1038/445379a; Michelson AM, 1998, DEV GENET, V22, P212, DOI 10.1002/(SICI)1520-6408(1998)22:3<212::AID-DVG4>3.0.CO;2-9; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Mohammadi M, 1998, EMBO J, V17, P5896, DOI 10.1093/emboj/17.20.5896; Niethammer P, 2002, J CELL BIOL, V157, P521, DOI 10.1083/jcb.200109059; OLAND LA, 1988, J NEUROSCI, V8, P353; OLAND LA, 1989, GLIA, V2, P10, DOI 10.1002/glia.440020103; OLAND LA, 1987, J COMP NEUROL, V255, P196, DOI 10.1002/cne.902550204; Oland LA, 2003, ANNU REV ENTOMOL, V48, P89, DOI 10.1146/annurev.ento.48.091801.112654; OLAND LA, 1988, J COMP NEUROL, V278, P377, DOI 10.1002/cne.902780307; Oland LA, 1998, J NEUROBIOL, V36, P41, DOI 10.1002/(SICI)1097-4695(199807)36:1<41::AID-NEU4>3.0.CO;2-A; Oland LA, 2011, GLIA IN PRESS; Ornitz DM, 2000, BIOESSAYS, V22, P108, DOI 10.1002/(SICI)1521-1878(200002)22:2<108::AID-BIES2>3.0.CO;2-M; Richardson TP, 2001, J CELL SCI, V114, P1613; Rossler W, 1999, J NEUROSCI, V19, P9865; Saffell JL, 1997, NEURON, V18, P231, DOI 10.1016/S0896-6273(00)80264-0; SANES JR, 1976, DEV BIOL, V51, P282, DOI 10.1016/0012-1606(76)90144-5; Schlessinger J, 2003, SCIENCE, V300, P750, DOI 10.1126/science.1082024; Sen A, 2005, BMC DEV BIOL, V5, DOI 10.1186/1471-213X-5-25; Sepp KJ, 2003, J NEUROSCI, V23, P8221; Shishido E, 1997, DEVELOPMENT, V124, P2119; SHISHIDO E, 1993, DEVELOPMENT, V117, P751; Silies M, 2010, NAT NEUROSCI, V13, P1357, DOI 10.1038/nn.2656; Skaper SD, 2000, J NEUROCHEM, V75, P1520, DOI 10.1046/j.1471-4159.2000.0751520.x; Stachowiak EK, 1997, ONCOGENE, V14, P2201, DOI 10.1038/sj.onc.1201057; Stachowiak MK, 2003, J CELL BIOCHEM, V90, P662, DOI 10.1002/jcb.10606; Stathopoulos A, 2004, GENE DEV, V18, P687, DOI 10.1101/gad.1166404; Thisse B, 2005, DEV BIOL, V287, P390, DOI 10.1016/j.ydbio.2005.09.011; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TOLBERT LP, 1990, J COMP NEUROL, V298, P69, DOI 10.1002/cne.902980106; TOLBERT LP, 1981, PROC R SOC SER B-BIO, V213, P279, DOI 10.1098/rspb.1981.0067; TOLBERT LP, 1983, J NEUROSCI, V3, P1158; Tolbert LP, 2004, PROG NEUROBIOL, V73, P73, DOI 10.1016/j.pneurobio.2004.04.004; Tsai LH, 2005, NEURON, V46, P383, DOI 10.1016/j.neuron.2005.04.013; WILLIAMS EJ, 1994, NEURON, V13, P583, DOI 10.1016/0896-6273(94)90027-2; Wright JW, 1999, DEVELOPMENT, V126, P3217; Xian W, 2007, MOL ENDOCRINOL, V21, P987, DOI 10.1210/me.2006-0518	85	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2012	7	4							e33828	10.1371/journal.pone.0033828	http://dx.doi.org/10.1371/journal.pone.0033828			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JA	22493675	Green Published, Green Submitted, gold			2022-12-27	WOS:000305012700017
J	Schmidt, C; Wiener, E; Hoffmann, J; Klingebiel, R; Schmidt, F; Hofmann, T; Harms, L; Kunte, H				Schmidt, Christoph; Wiener, Edzard; Hoffmann, Jan; Klingebiel, Randolf; Schmidt, Felix; Hofmann, Tobias; Harms, Lutz; Kunte, Hagen			Structural Olfactory Nerve Changes in Patients Suffering from Idiopathic Intracranial Hypertension	PLOS ONE			English	Article							QUALITY-OF-LIFE; BULB VOLUME; PENNSYLVANIA SMELL; DISORDERS; IDENTIFICATION; RHINORRHEA; UNIVERSITY	Background: Complications of idiopathic intracranial hypertension (IIH) are usually caused by elevated intracranial pressure (ICP). In a similar way as in the optic nerve, elevated ICP could also compromise the olfactory nerve system. On the other side, there is growing evidence that an extensive lymphatic network system around the olfactory nerves could be disturbed in cerebrospinal fluid disorders like IIH. The hypothesis that patients with IIH suffer from hyposmia has been suggested in the past. However, this has not been proven in clinical studies yet. This pilot study investigates whether structural changes of the olfactory nerve system can be detected in patients with IIH. Methodology/Principal Findings: Twenty-three patients with IIH and 23 matched controls were included. Olfactory bulb volume (OBV) and sulcus olfactorius (OS) depth were calculated by magnetic resonance techniques. While mean values of total OBV (128.7 +/- 38.4 vs. 130.0 +/- 32.6 mm(3), p = 0.90) and mean OS depth (8.5 +/- 1.2 vs. 8.6 +/- 1.1 mm, p = 0.91) were similar in both groups, Pearson correlation showed that patients with a shorter medical history IIH revealed a smaller OBV (r = 0.53, p<0.01). In untreated symptomatic patients (n = 7), the effect was greater (r = 0.76, p<0.05). Patients who suffered from IIH for less than one year (n = 8), total OBV was significantly smaller than in matched controls (116.6 +/- 24.3 vs. 149.3 +/- 22.2 mm(3), p = 0.01). IIH patients with visual disturbances (n = 21) revealed a lower OS depth than patients without (8.3 +/- 0.9 vs. 10.8 +/- 1.0 mm, p<0.01). Conclusions/Significance: The results suggest that morphological changes of the olfactory nerve system could be present in IIH patients at an early stage of disease.	[Schmidt, Christoph; Wiener, Edzard; Klingebiel, Randolf] Charite, Inst Radiol, D-13353 Berlin, Germany; [Hoffmann, Jan; Schmidt, Felix; Harms, Lutz; Kunte, Hagen] Charite, Dept Neurol, D-13353 Berlin, Germany; [Hofmann, Tobias] Charite, Dept Psychosomat Med, D-13353 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Schmidt, C (corresponding author), Charite, Inst Radiol, D-13353 Berlin, Germany.	hagen.kunte@charite.de	Hoffmann, Jan/AAP-8376-2020	Hofmann, Tobias/0000-0002-4002-3552; Csapo-Schmidt, Christoph/0000-0002-9021-8227				Abolmaali ND, 2002, AM J NEURORADIOL, V23, P157; Ball AK, 2006, LANCET NEUROL, V5, P433, DOI 10.1016/S1474-4422(06)70442-2; BRISMAN R, 1970, ARCH NEUROL-CHICAGO, V22, P245, DOI 10.1001/archneur.1970.00480210055007; Buschuter D, 2008, NEUROIMAGE, V42, P498, DOI 10.1016/j.neuroimage.2008.05.004; CLARK D, 1994, J NEUROL NEUROSUR PS, V57, P847, DOI 10.1136/jnnp.57.7.847; Curtis MA, 2007, SCIENCE, V315, P1243, DOI 10.1126/science.1136281; DEEMS DA, 1991, ARCH OTOLARYNGOL, V117, P519; Dhungana S, 2010, ACTA NEUROL SCAND, V121, P71, DOI 10.1111/j.1600-0404.2009.01172.x; DOTY RL, 1984, LARYNGOSCOPE, V94, P176, DOI 10.1288/00005537-198402000-00004; Duprez TP, 2010, EUR J RADIOL, V74, P288, DOI 10.1016/j.ejrad.2009.05.065; Friedman DI, 2002, NEUROLOGY, V59, P1492, DOI 10.1212/01.WNL.0000029570.69134.1B; GIUSEFFI V, 1991, NEUROLOGY, V41, P239, DOI 10.1212/WNL.41.2_Part_1.239; Goektas O, 2009, EUR J RADIOL, V71, P469, DOI 10.1016/j.ejrad.2008.10.039; Gomez C, 2006, NEUROSCIENCE, V141, P2117, DOI 10.1016/j.neuroscience.2006.05.046; Hummel T, 2005, ACTA OTO-LARYNGOL, V125, P116, DOI 10.1080/00016480410022787; Hummel T, 1997, CHEM SENSES, V22, P39, DOI 10.1093/chemse/22.1.39; Johnston Miles, 2004, Cerebrospinal Fluid Res, V1, P2, DOI 10.1186/1743-8454-1-2; Kapoor KG, 2008, MED HYPOTHESES, V71, P816, DOI 10.1016/j.mehy.2008.04.023; Miwa T, 2001, ARCH OTOLARYNGOL, V127, P497, DOI 10.1001/archotol.127.5.497; Rombaux P, 2010, EUR ARCH OTO-RHINO-L, V267, P1551, DOI 10.1007/s00405-010-1230-2; Rombaux P, 2009, RHINOLOGY, V47, P3; Schwob James E., 2002, Anatomical Record, V269, P33, DOI 10.1002/ar.10047; Sinclair AJ, 2008, J NEUROIMMUNOL, V201, P212, DOI 10.1016/j.jneuroim.2008.06.029; Temmel AFP, 2002, ARCH OTOLARYNGOL, V128, P635, DOI 10.1001/archotol.128.6.635; Wang J, 2011, AM J NEURORADIOL, V32, P677, DOI 10.3174/ajnr.A2350	25	26	27	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2012	7	4							e35221	10.1371/journal.pone.0035221	http://dx.doi.org/10.1371/journal.pone.0035221			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JA	22493741	Green Submitted, gold, Green Published			2022-12-27	WOS:000305012700083
J	Song, YT; Gunnarson, E				Song, Yutong; Gunnarson, Eli			Potassium Dependent Regulation of Astrocyte Water Permeability Is Mediated by cAMP Signaling	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; RETINAL MULLER CELLS; PROTEIN-KINASE-A; SPREADING DEPRESSION; EXTRACELLULAR POTASSIUM; HIPPOCAMPAL ASTROCYTES; GLUTAMATE UPTAKE; CALCIUM INFLUX; GLIAL-CELLS; CHANNELS	Astrocytes express potassium and water channels to support dynamic regulation of potassium homeostasis. Potassium kinetics can be modulated by aquaporin-4 (AQP4), the essential water channel for astrocyte water permeability regulation. We investigated whether extracellular potassium ([K+](o)) can regulate astrocyte water permeability and the mechanisms of such an effect. Studies were performed on rat primary astrocytes and a rat astrocyte cell line transfected with AQP4. We found that 10mM [K+](o) caused an immediate, more than 40%, increase in astrocyte water permeability which was sustained in 5min. The water channel AQP4 was a target for this regulation. Potassium induced a significant increase in intracellular cAMP as measured with a FRET based method and with enzyme immunoassay. We found that protein kinase A (PKA) could phosphorylate AQP4 in vitro. Further elevation of [K+](o) to 35mM induced a global intracellular calcium response and a transient water permeability increase that was abolished in 5min. When inwardly rectifying potassium (Kir)-channels were blocked, 10mM [K+](o) also induced a calcium increase and the water permeability increase no longer persisted. In conclusion, we find that elevation of extracellular potassium regulates AQP4 and astrocyte water permeability via intracellular signaling involving cAMP. A prolonged increase of astrocyte water permeability is Kir-channel dependent and this response can be impeded by intracellular calcium signaling. Our results support the concept of coupling between AQP4 and potassium handling in astrocytes.	[Song, Yutong; Gunnarson, Eli] Karolinska Inst, Dept Womens & Childrens Hlth, Astrid Lindgren Childrens Hosp, Stockholm, Sweden	Karolinska Institutet	Song, YT (corresponding author), Karolinska Inst, Dept Womens & Childrens Hlth, Astrid Lindgren Childrens Hosp, Stockholm, Sweden.	eli.gunnarson@ki.se			Jeanssons Stiftelse; Stiftelsen Frimurare Barnhuset i Stockholm; Sallskapet Barnavard	Jeanssons Stiftelse; Stiftelsen Frimurare Barnhuset i Stockholm; Sallskapet Barnavard	This work was supported by Jeanssons Stiftelse, Stiftelsen Frimurare Barnhuset i Stockholm, Sallskapet Barnavard, and the regional agreement on medical training and clinical research (ALF) between Stockholm County Council and Karolinska Institutet. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amiry-Moghaddam M, 2003, NAT REV NEUROSCI, V4, P991, DOI 10.1038/nrn1252; Amiry-Moghaddam M, 2003, P NATL ACAD SCI USA, V100, P13615, DOI 10.1073/pnas.2336064100; Binder DK, 2006, GLIA, V53, P631, DOI 10.1002/glia.20318; Bolton S, 2006, GLIA, V54, P316, DOI 10.1002/glia.20384; BOURKE RS, 1983, NEUROCHEM RES, V8, P5, DOI 10.1007/BF00965650; Butt AM, 2006, J CELL MOL MED, V10, P33, DOI 10.1111/j.1582-4934.2006.tb00289.x; Chever O, 2010, J NEUROSCI, V30, P15769, DOI 10.1523/JNEUROSCI.2078-10.2010; COGHLAN VM, 1995, SCIENCE, V267, P108, DOI 10.1126/science.7528941; Daly J W, 1977, Int Rev Neurobiol, V20, P105, DOI 10.1016/S0074-7742(08)60652-2; Djukic B, 2007, J NEUROSCI, V27, P11354, DOI 10.1523/JNEUROSCI.0723-07.2007; DUFFY S, 1994, NEUROSCIENCE, V61, P51, DOI 10.1016/0306-4522(94)90059-0; Duffy S, 1996, J NEUROSCI, V16, P71; Fort PE, 2008, GLIA, V56, P597, DOI 10.1002/glia.20633; Gunnarson E, 2005, NEUROSCIENCE, V136, P105, DOI 10.1016/j.neuroscience.2005.07.027; Gunnarson E, 2008, GLIA, V56, P587, DOI 10.1002/glia.20627; HENN FA, 1972, BRAIN RES, V43, P437, DOI 10.1016/0006-8993(72)90399-X; HERTZ L, 1965, NATURE, V206, P1091, DOI 10.1038/2061091a0; Hertz L, 1981, Prog Clin Biol Res, V59A, P45; Kang SJ, 2008, MOL CELLS, V25, P124; Klarenbeek JB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019170; Kofuji P, 2004, NEUROSCIENCE, V129, P1045, DOI 10.1016/j.neurscience.2004.06.008; Kucheryavykh YV, 2007, GLIA, V55, P274, DOI 10.1002/glia.20455; Leis JA, 2005, GLIA, V50, P407, DOI 10.1002/glia.20145; Lian XY, 2004, BRAIN RES, V1012, P177, DOI 10.1016/j.brainres.2004.04.011; MACVICAR BA, 1991, GLIA, V4, P448, DOI 10.1002/glia.440040504; MACVICAR BA, 1984, SCIENCE, V226, P1345, DOI 10.1126/science.6095454; Nagelhus EA, 1999, GLIA, V26, P47, DOI 10.1002/(SICI)1098-1136(199903)26:1<47::AID-GLIA5>3.0.CO;2-5; Olsen ML, 2008, J NEUROCHEM, V107, P589, DOI 10.1111/j.1471-4159.2008.05615.x; Paluzzi S, 2007, J NEUROCHEM, V103, P1196, DOI 10.1111/j.1471-4159.2007.04826.x; Risher WC, 2009, GLIA, V57, P207, DOI 10.1002/glia.20747; Ruiz-Ederra J, 2007, J BIOL CHEM, V282, P21866, DOI 10.1074/jbc.M703236200; Rutledge EM, 1996, J NEUROSCI, V16, P7803; SOMJEN GG, 1979, ANNU REV PHYSIOL, V41, P159, DOI 10.1146/annurev.ph.41.030179.001111; Strohschein S, 2011, GLIA, V59, P973, DOI 10.1002/glia.21169; Vinade L, 1997, DEV BRAIN RES, V104, P11, DOI 10.1016/S0165-3806(97)00114-4; VYSKOCIL F, 1972, BRAIN RES, V39, P255, DOI 10.1016/0006-8993(72)90802-5; WALZ W, 1983, PROG NEUROBIOL, V20, P133, DOI 10.1016/0301-0082(83)90013-8; Walz W, 2000, NEUROCHEM INT, V36, P291, DOI 10.1016/S0197-0186(99)00137-0; Zelenina M, 2000, EUR BIOPHYS J BIOPHY, V29, P165, DOI 10.1007/PL00006645; Zhang H, 2008, MOL CELL NEUROSCI, V37, P1, DOI 10.1016/j.mcn.2007.08.007; Zhou N, 2010, CEREB CORTEX, V20, P2614, DOI 10.1093/cercor/bhq018	41	32	35	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2012	7	4							e34936	10.1371/journal.pone.0034936	http://dx.doi.org/10.1371/journal.pone.0034936			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JA	22493723	Green Published, Green Submitted, gold			2022-12-27	WOS:000305012700065
J	Dai, JY; Wan, SG; Zhou, F; Myers, RE; Guo, X; Li, BS; Fu, XY; Palazzo, JP; Dou, KF; Yang, HS; Xing, JL				Dai, Jingyao; Wan, Shaogui; Zhou, Feng; Myers, Ronald E.; Guo, Xu; Li, Bingshan; Fu, Xiaoying; Palazzo, Juan P.; Dou, Kefeng; Yang, Hushan; Xing, Jinliang			Genetic Polymorphism in a VEGF-Independent Angiogenesis Gene ANGPT1 and Overall Survival of Colorectal Cancer Patients after Surgical Resection	PLOS ONE			English	Article							ENDOTHELIAL-GROWTH-FACTOR; TUMOR ANGIOGENESIS; TIE2 RECEPTOR; IN-VIVO; ANGIOPOIETIN-1; RISK; CHEMOTHERAPY; EXPRESSION; RS6983267; PATHWAYS	Background: The VEGF-independent angiogenic signaling plays an important role in the development of colorectal cancer (CRC). However, its implication in the clinical outcome of CRC has not been reported. This study aimed to investigate the association between genetic variations in several major VEGF-independent signaling pathway genes and the overall survival of CRC patients. Methods: Seven single nucleotide polymorphisms (SNPs) in four important VEGF-independent angiogenic genes (ANGPT1, AMOT, DLL4 and ENG) were genotyped in a Chinese population with 408 CRC patients. Results: One SNP, rs1954727 in ANGPT1, was significantly associated with CRC overall survival. Compared to patients with the homozygous wild-type genotype of rs1954727, those with heterozygous and homozygous variant genotypes exhibited a favorable overall survival with a hazard ratio (HR) of 0.89 (95% confidence interval [CI] 0.55-1.43, P = 0.623), and 0.32 (95% CI 0.15-0.71, P = 0.005), respectively (P trend = 0.008). In stratified analysis, this association remained significant in patients receiving chemotherapy (P trend = 0.012), but not in those without chemotherapy. We further evaluated the effects of chemotherapy on CRC survival that was stratified by rs1954727 genotypes. We found that chemotherapy resulted in a significantly better overall survival in the CRC patients (HR = 0.44, 95%CI 0.26-0.75, P = 0.002), which was especially prominent in those patients with the heterozygous genotype of rs1954727 (HR = 0.45, 95% CI 0.22-0.92, P = 0.028). Conclusion: Our data suggest that rs1954727 in ANGPT1 gene might be a prognostic biomarker for the overall survival of CRC patients, especially in those receiving chemotherapy, a finding that warrants validation in larger independent populations.	[Dai, Jingyao; Dou, Kefeng] Fourth Mil Med Univ, Xijing Hosp, Dept Hepatobiliary Surg, Xian 710032, Peoples R China; [Wan, Shaogui; Myers, Ronald E.; Fu, Xiaoying; Yang, Hushan] Thomas Jefferson Univ, Kimmel Canc Ctr, Dept Med Oncol, Div Populat Sci, Philadelphia, PA 19107 USA; [Zhou, Feng] Fourth Mil Med Univ, Tangdu Hosp, Dept Gen Surg, Xian 710032, Peoples R China; [Guo, Xu; Xing, Jinliang] Fourth Mil Med Univ, Cell Engn Res Ctr, State Key Lab Canc Biol, Xian 710032, Peoples R China; [Guo, Xu; Xing, Jinliang] Fourth Mil Med Univ, Dept Cell Biol, Xian 710032, Peoples R China; [Li, Bingshan] Vanderbilt Univ, Dept Mol Physiol & Biophys, Ctr Human Genet Res, Nashville, TN 37232 USA; [Palazzo, Juan P.] Thomas Jefferson Univ, Dept Pathol, Philadelphia, PA 19107 USA	Air Force Military Medical University; Jefferson University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Vanderbilt University; Jefferson University	Dai, JY (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Dept Hepatobiliary Surg, Xian 710032, Peoples R China.	hushan.yang@jefferson.edu; xingjl@fmmu.edu.cn	Wan, Shaogui/I-5047-2013; Li, Bingshan/H-1944-2011	Myers, Ronald E./0000-0002-8059-7390	Thomas Jefferson University; National Natural Science Foundation of China [30872927]; National Basic Research Program of China [2009CB521704]; NATIONAL CANCER INSTITUTE [R03CA162201] Funding Source: NIH RePORTER	Thomas Jefferson University; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The work reported here is supported by a start-up grant from Thomas Jefferson University, grant 2009CB521704 from The National Basic Research Program of China, and grant 30872927 from National Natural Science Foundation of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asahara T, 1998, CIRC RES, V83, P233, DOI 10.1161/01.RES.83.3.233; Bao L, 2007, NUCLEIC ACIDS RES, V35, pD51, DOI 10.1093/nar/gkl797; Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442; Cai J, 2011, FRONT BIOSCI-LANDMRK, V16, P803, DOI 10.2741/3721; Castro FA, 2011, EUR J CANCER, V47, P1203, DOI 10.1016/j.ejca.2010.12.011; Chen JF, 2009, CANCER BIOL THER, V8, P1424, DOI 10.4161/cbt.8.14.8889; Dassoulas K, 2009, MOL CARCINOGEN, V48, P563, DOI 10.1002/mc.20495; Dufraine J, 2008, ONCOGENE, V27, P5132, DOI 10.1038/onc.2008.227; El-Gohary YM, 2007, AM J CLIN PATHOL, V127, P572, DOI 10.1309/X6NXYE57DLUE2NQ8; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Ferrari P, 2007, INT J CANCER, V121, P2065, DOI 10.1002/ijc.22966; Goel A, 2010, CURR OPIN GASTROEN, V26, P47, DOI 10.1097/MOG.0b013e328332b850; Hansen TF, 2010, J CANCER RES CLIN, V136, P751, DOI 10.1007/s00432-009-0714-1; Hawighorst T, 2002, AM J PATHOL, V160, P1381, DOI 10.1016/S0002-9440(10)62565-5; Hayes AJ, 2000, BRIT J CANCER, V83, P1154, DOI 10.1054/bjoc.2000.1437; Hofmann G, 2008, J CANCER RES CLIN, V134, P591, DOI 10.1007/s00432-007-0322-x; Holash J, 1999, SCIENCE, V284, P1994, DOI 10.1126/science.284.5422.1994; Huang HH, 2010, NAT REV CANCER, V10, P575, DOI 10.1038/nrc2894; Koukourakis MI, 2004, LUNG CANCER, V46, P293, DOI 10.1016/j.lungcan.2004.04.037; Levchenko T, 2008, FASEB J, V22, P880, DOI 10.1096/fj.07-9509com; Loughna S, 2001, MATRIX BIOL, V20, P319, DOI 10.1016/S0945-053X(01)00149-4; Maisonpierre PC, 1997, SCIENCE, V277, P55, DOI 10.1126/science.277.5322.55; Mita AC, 2010, CLIN CANCER RES, V16, P3044, DOI 10.1158/1078-0432.CCR-09-3368; Papapetropoulos A, 2000, J BIOL CHEM, V275, P9102, DOI 10.1074/jbc.275.13.9102; Pomerantz MM, 2009, NAT GENET, V41, P882, DOI 10.1038/ng.403; Renner W, 2000, J VASC RES, V37, P443, DOI 10.1159/000054076; Rmali KA, 2007, COLORECTAL DIS, V9, P3, DOI 10.1111/j.1463-1318.2006.01089.x; Roberts KE, 2009, AM J RESP CRIT CARE, V179, P835, DOI 10.1164/rccm.200809-1472OC; Shibuya M, 2008, BMB REP, V41, P278, DOI 10.5483/BMBRep.2008.41.4.278; Shim WSN, 2007, MOL CANCER RES, V5, P655, DOI 10.1158/1541-7786.MCR-07-0072; Stoeltzing O, 2003, CANCER RES, V63, P3370; Thompson SD, 2010, ARTHRITIS RHEUM-US, V62, P3265, DOI 10.1002/art.27688; Tuupanen S, 2009, NAT GENET, V41, P885, DOI 10.1038/ng.406; Ulrich CM, 2003, NAT REV CANCER, V3, P912, DOI 10.1038/nrc1233; Xing JL, 2011, EUR J CANCER, V47, P1699, DOI 10.1016/j.ejca.2011.02.004; Yancopoulos GD, 2000, NATURE, V407, P242, DOI 10.1038/35025215; Yang BM, 2003, J DIABETES COMPLICAT, V17, P1, DOI 10.1016/S1056-8727(02)00181-2; Yu Q, 2001, AM J PATHOL, V158, P563, DOI 10.1016/S0002-9440(10)63998-3	38	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e34758	10.1371/journal.pone.0034758	http://dx.doi.org/10.1371/journal.pone.0034758			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GO	22496856	Green Published, gold			2022-12-27	WOS:000304855200077
J	Misu, H; Ishikura, K; Kurita, S; Takeshita, Y; Ota, T; Saito, Y; Takahashi, K; Kaneko, S; Takamura, T				Misu, Hirofumi; Ishikura, Kazuhide; Kurita, Seiichiro; Takeshita, Yumie; Ota, Tsuguhito; Saito, Yoshiro; Takahashi, Kazuhiko; Kaneko, Shuichi; Takamura, Toshinari			Inverse Correlation between Serum Levels of Selenoprotein P and Adiponectin in Patients with Type 2 Diabetes	PLOS ONE			English	Article							INSULIN-RESISTANCE; DEFICIENT MICE; SELENIUM; PLASMA; SENSITIVITY; OBESITY; ATHEROSCLEROSIS; PHOSPHORYLATION; EXPRESSION; DISEASE	Background: We recently identified selenoprotein P (SeP) as a liver-derived secretory protein that causes insulin resistance in the liver and skeletal muscle; however, it is unknown whether and, if so, how SeP acts on adipose tissue. The present study tested the hypothesis that SeP is related to hypoadiponectinemia in patients with type 2 diabetes. Methodology/Principal Findings: We compared serum levels of SeP with those of adiponectin and other clinical parameters in 36 patients with type 2 diabetes. We also measured levels of blood adiponectin in SeP knockout mice. Circulating SeP levels were positively correlated with fasting plasma glucose (r = 0.35, P = 0.037) and negatively associated with both total and high-molecular adiponectin in patients with type 2 diabetes (r = -0.355, P = 0.034; r = -0.367, P = 0.028). SeP was a predictor of both total and high-molecular adiponectin, independently of age, body weight, and quantitative insulin sensitivity index (beta = -0.343, P = 0.022; beta = -0.357, P = 0.017). SeP knockout mice exhibited an increase in blood adiponectin levels when fed regular chow or a high sucrose, high fat diet. Conclusions/Significance: These results suggest that overproduction of liver-derived secretory protein SeP is connected with hypoadiponectinemia in patients with type 2 diabetes.	[Misu, Hirofumi; Ishikura, Kazuhide; Kurita, Seiichiro; Takeshita, Yumie; Ota, Tsuguhito; Kaneko, Shuichi; Takamura, Toshinari] Kanazawa Univ, Grad Sch Med Sci, Dept Dis Control & Homeostasis, Kanazawa, Ishikawa, Japan; [Saito, Yoshiro] Doshisha Univ, Fac Med & Life Sci, Dept Med Life Syst, Kyoto 602, Japan; [Takahashi, Kazuhiko] Hokkaido Pharmaceut Univ, Dept Nutr Biochem, Otaru, Hokkaido, Japan	Kanazawa University; Doshisha University	Misu, H (corresponding author), Kanazawa Univ, Grad Sch Med Sci, Dept Dis Control & Homeostasis, Kanazawa, Ishikawa, Japan.	ttakamura@m-kanazawa.jp	Saito, Yoshiro/H-4597-2019	Saito, Yoshiro/0000-0002-0559-5889	Ministry of Education, Culture, Sports, Science, and Technology of Japan [C-23591301, B-23791022]; Grants-in-Aid for Scientific Research [23591301] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-Aid for Scientific Research (C-23591301 to TT), and a Grant-in-aid for Young Scientists (B-23791022 to HM) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Andoh A, 2005, NUTRITION, V21, P574, DOI 10.1016/j.nut.2004.08.025; Burk RF, 2005, ANNU REV NUTR, V25, P215, DOI 10.1146/annurev.nutr.24.012003.132120; Carlson BA, 2004, J BIOL CHEM, V279, P8011, DOI 10.1074/jbc.M310470200; Hill KE, 2003, J BIOL CHEM, V278, P13640, DOI 10.1074/jbc.M300755200; Hill KE, 1996, J NUTR, V126, P138, DOI 10.1093/jn/126.1.138; Iwaki M, 2003, DIABETES, V52, P1655, DOI 10.2337/diabetes.52.7.1655; Katz A, 2000, J CLIN ENDOCR METAB, V85, P2402, DOI 10.1210/jc.85.7.2402; Kern PA, 2003, DIABETES, V52, P1779, DOI 10.2337/diabetes.52.7.1779; Kubota N, 2006, J BIOL CHEM, V281, P8748, DOI 10.1074/jbc.M505649200; Lumeng CN, 2011, J CLIN INVEST, V121, P2111, DOI 10.1172/JCI57132; Maeda N, 2002, NAT MED, V8, P731, DOI 10.1038/nm724; Misu H, 2007, DIABETOLOGIA, V50, P268, DOI 10.1007/s00125-006-0489-8; Misu H, 2010, CELL METAB, V12, P483, DOI 10.1016/j.cmet.2010.09.015; Nakashima R, 2006, J CLIN ENDOCR METAB, V91, P3873, DOI 10.1210/jc.2006-1158; Okamoto Y, 2002, CIRCULATION, V106, P2767, DOI 10.1161/01.CIR.0000042707.50032.19; Pajvani UB, 2003, J BIOL CHEM, V278, P9073, DOI 10.1074/jbc.M207198200; Persson-Moschos M, 1998, EUR J CLIN NUTR, V52, P363, DOI 10.1038/sj.ejcn.1600565; Pischon T, 2004, JAMA-J AM MED ASSOC, V291, P1730, DOI 10.1001/jama.291.14.1730; Saito Y, 2001, J HEALTH SCI, V47, P346, DOI 10.1248/jhs.47.346; Schoenmakers E, 2010, J CLIN INVEST, V120, P4220, DOI 10.1172/JCI43653; Schomburg L, 2003, BIOCHEM J, V370, P397, DOI 10.1042/BJ20021853; Schulze MB, 2005, DIABETES, V54, P534, DOI 10.2337/diabetes.54.2.534; Speckmann B, 2008, HEPATOLOGY, V48, P1998, DOI 10.1002/hep.22526; Stefan N, 2002, DIABETES, V51, P1884, DOI 10.2337/diabetes.51.6.1884; Tschritter O, 2003, DIABETES, V52, P239, DOI 10.2337/diabetes.52.2.239; Waki H, 2003, J BIOL CHEM, V278, P40352, DOI 10.1074/jbc.M300365200; Walter PL, 2008, BIOCHEM BIOPH RES CO, V365, P316, DOI 10.1016/j.bbrc.2007.10.171; Weyer C, 2001, J CLIN ENDOCR METAB, V86, P1930, DOI 10.1210/jc.86.5.1930; Yamauchi T, 2003, J BIOL CHEM, V278, P2461, DOI 10.1074/jbc.M209033200; Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984; YANG JG, 1989, J NUTR, V119, P1010, DOI 10.1093/jn/119.7.1010; Yang SJ, 2011, J CLIN ENDOCR METAB, V96, pE1325, DOI 10.1210/jc.2011-0620	32	79	81	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e34952	10.1371/journal.pone.0034952	http://dx.doi.org/10.1371/journal.pone.0034952			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GO	22496878	Green Submitted, Green Published, gold			2022-12-27	WOS:000304855200089
J	Wuebben, EL; Mallanna, SK; Cox, JL; Rizzino, A				Wuebben, Erin L.; Mallanna, Sunil K.; Cox, Jesse L.; Rizzino, Angie			Musashi2 Is Required for the Self-Renewal and Pluripotency of Embryonic Stem Cells	PLOS ONE			English	Article							RNA-BINDING PROTEIN; MYELOID-LEUKEMIA; EXPRESSION; DIFFERENTIATION; MOUSE; REGULATOR; SCREEN; ROLES; MSI2; GENE	Recent studies have shown that the RNA binding protein Musashi 2 (Msi2) plays important roles during development. Msi2 has also been shown to be elevated in several leukemias and its elevated expression has been linked with poorer prognosis in these cancers. Additionally, in embryonic stem cells (ESC) undergoing the early stages of differentiation, Msi2 has been shown to associate with the transcription factor Sox2, which is required for the self-renewal of ESC. These findings led us to examine the effects of Msi2 on the behavior of ESC. We determined that ESC express two isoforms of Msi2, the larger canonical isoform (isoform 1) and a shorter, splice-variant isoform (isoform 2). Using multiple shRNA lentiviral vectors, we determined that knockdown of Msi2 disrupts the self-renewal of ESC and promotes their differentiation into cells that express markers associated with mesoderm, ectoderm, and trophectoderm. Moreover, our studies indicate that the extent of differentiation and the loss of self-renewal capacity correlate with the levels to which Msi2 levels were decreased. We extended these findings by engineering ESC to inducibly express either Msi2 isoform1 or isoform 2. We determined that ectopic expression of Msi2 isoform 1, but not isoform 2, enhances the cloning efficiency of ESC. In addition, we examined how Msi2 isoform 1 and isoform 2 affect the differentiation of ESC. Interestingly, ectopic expression of either Msi2 isoform 1 or isoform 2 does not affect the pattern of differentiation induced by retinoic acid. Finally, we show that ectopic expression of either isoform 1 or isoform 2 is not sufficient to block the differentiation that results from the knockdown of both isoforms of Msi2. Thus, it appears that both isoforms of Msi2 are required for the self-renewal of ESC.	[Wuebben, Erin L.; Mallanna, Sunil K.; Cox, Jesse L.; Rizzino, Angie] Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE USA	University of Nebraska System; University of Nebraska Medical Center	Wuebben, EL (corresponding author), Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE USA.	arizzino@unmc.edu			National Institutes of Health [GM 080751]; National Cancer Institute [CA009476]; NATIONAL CANCER INSTITUTE [T32CA009476] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080751] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a grant from National Institutes of Health (GM 080751); EW was supported by an National Cancer Institute training grant (CA009476). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbouti A, 2003, CANCER RES, V63, P1202; Boer B, 2007, NUCLEIC ACIDS RES, V35, P1773, DOI 10.1093/nar/gkm059; Cox JL, 2011, J CELL SCI, V124, P2654, DOI 10.1242/jcs.083238; de Andres-Aguayo L, 2011, BLOOD, V118, P554, DOI 10.1182/blood-2010-12-322081; DOETSCHMAN TC, 1985, J EMBRYOL EXP MORPH, V87, P27; Gao Z, 2012, J BIOL CHEM IN PRESS; Hope KJ, 2010, CELL STEM CELL, V7, P101, DOI 10.1016/j.stem.2010.06.007; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Imai T, 2001, MOL CELL BIOL, V21, P3888, DOI 10.1128/MCB.21.12.3888-3900.2001; Ito T, 2010, NATURE, V466, P765, DOI 10.1038/nature09171; Kharas MG, 2010, NAT MED, V16, P903, DOI 10.1038/nm.2187; Kopp JL, 2008, STEM CELLS, V26, P903, DOI 10.1634/stemcells.2007-0951; Mallanna SK, 2010, STEM CELLS, V28, P1715, DOI 10.1002/stem.494; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Sakakibara S, 2002, P NATL ACAD SCI USA, V99, P15194, DOI 10.1073/pnas.232087499; Sakakibara S, 2001, J NEUROSCI, V21, P8091, DOI 10.1523/JNEUROSCI.21-20-08091.2001; Varum S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020914; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040	19	35	39	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e34827	10.1371/journal.pone.0034827	http://dx.doi.org/10.1371/journal.pone.0034827			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GO	22496868	Green Submitted, Green Published, gold			2022-12-27	WOS:000304855200084
J	Badea, CT; Athreya, KK; Espinosa, G; Clark, D; Ghafoori, AP; Li, YF; Kirsch, DG; Johnson, GA; Annapragada, A; Ghaghada, KB				Badea, Cristian T.; Athreya, Khannan K.; Espinosa, Gabriela; Clark, Darin; Ghafoori, A. Paiman; Li, Yifan; Kirsch, David G.; Johnson, G. Allan; Annapragada, Ananth; Ghaghada, Ketan B.			Computed Tomography Imaging of Primary Lung Cancer in Mice Using a Liposomal-Iodinated Contrast Agent	PLOS ONE			English	Article							PULMONARY NODULES; CT; ALGORITHM	Purpose: To investigate the utility of a liposomal-iodinated nanoparticle contrast agent and computed tomography (CT) imaging for characterization of primary nodules in genetically engineered mouse models of non-small cell lung cancer. Methods: Primary lung cancers with mutations in K-ras alone (Kras(LA1)) or in combination with p53 (LSL-Kras(G12D);p53(FL/FL)) were generated. A liposomal-iodine contrast agent containing 120 mg Iodine/mL was administered systemically at a dose of 16 mu l/gm body weight. Longitudinal micro-CT imaging with cardio-respiratory gating was performed pre-contrast and at 0 hr, day 3, and day 7 post-contrast administration. CT-derived nodule sizes were used to assess tumor growth. Signal attenuation was measured in individual nodules to study dynamic enhancement of lung nodules. Results: A good correlation was seen between volume and diameter-based assessment of nodules (R-2>0.8) for both lung cancer models. The LSL-Kras(G12D);p53(FL/FL) model showed rapid growth as demonstrated by systemically higher volume changes compared to the lung nodules in Kras(LA1) mice (p<0.05). Early phase imaging using the nanoparticle contrast agent enabled visualization of nodule blood supply. Delayed-phase imaging demonstrated significant differential signal enhancement in the lung nodules of LSL-Kras(G12D);p53(FL/FL) mice compared to nodules in Kras(LA1) mice (p<0.05) indicating higher uptake and accumulation of the nanoparticle contrast agent in rapidly growing nodules. Conclusions: The nanoparticle iodinated contrast agent enabled visualization of blood supply to the nodules during the early-phase imaging. Delayed-phase imaging enabled characterization of slow growing and rapidly growing nodules based on signal enhancement. The use of this agent could facilitate early detection and diagnosis of pulmonary lesions as well as have implications on treatment response and monitoring.	[Badea, Cristian T.; Clark, Darin; Johnson, G. Allan] Duke Univ, Med Ctr, Ctr Vivo Microscopy, Durham, NC 27706 USA; [Athreya, Khannan K.] Univ Texas Hlth Sci Ctr Houston, Univ Texas, Med Sch Houston, Houston, TX USA; [Espinosa, Gabriela; Annapragada, Ananth; Ghaghada, Ketan B.] Texas Childrens Hosp, Edward B Singleton Dept Pediat Radiol, Houston, TX 77030 USA; [Espinosa, Gabriela] Univ Texas Hlth Sci Ctr Houston, Sch Biomed Informat, Houston, TX USA; [Ghafoori, A. Paiman; Li, Yifan; Kirsch, David G.] Duke Univ, Med Ctr, Dept Radiat Oncol, Durham, NC USA; [Kirsch, David G.] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC USA	Duke University; University of Texas System; University of Texas Health Science Center Houston; Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston; Duke University; Duke University	Badea, CT (corresponding author), Duke Univ, Med Ctr, Ctr Vivo Microscopy, Durham, NC 27706 USA.	cristian.badea@duke.edu; kbghagha@texaschildrens.org	Badea, Cristian T/M-3323-2019; Annapragada, Ananth/GOK-1576-2022; Ghaghada, Ketan/F-6825-2012; Badea, Cristian/B-6681-2011	Badea, Cristian T/0000-0002-1850-2522; Badea, Cristian/0000-0002-1850-2522; Annapragada, Ananth/0000-0002-3156-9617; Johnson, G.Allan/0000-0002-7606-5447	NIH/NCRR National Biomedical Technology Resource Center [P41 RR005959, NCI U24 CA092656]; Marval Biosciences Inc.; American Society of Clinical Oncology; NCI [K08 CA 114176]; NATIONAL CANCER INSTITUTE [K08CA114176, U24CA092656] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR005959] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K02AI093866] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB015897] Funding Source: NIH RePORTER	NIH/NCRR National Biomedical Technology Resource Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Marval Biosciences Inc.; American Society of Clinical Oncology; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported in part by NIH/NCRR National Biomedical Technology Resource Center grants (P41 RR005959, NCI U24 CA092656) (CTB, GAJ). Part of this work was supported by funding from Marval Biosciences Inc. (AA, KBG), American Society of Clinical Oncology, Young Investigator Award (APG) and NCI K08 CA 114176 (DGK). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, NEW ENGLAND J MED, V365, P395; Badea C, 2004, MED PHYS, V31, P3324, DOI 10.1118/1.1812604; Badea C. T., 2011, MED IMAGING 2011 PHY, P7961; Baden C, 2008, DUAL MICROCT SYSTEM; Boone John M, 2004, Mol Imaging, V3, P149, DOI 10.1162/1535350042380326; FELDKAMP LA, 1984, J OPT SOC AM A, V1, P612, DOI 10.1364/JOSAA.1.000612; Freedman M, 2009, ACAD RADIOL, V16, P627, DOI 10.1016/j.acra.2008.12.002; Garbow JR, 2004, CANCER RES, V64, P2740, DOI 10.1158/0008-5472.CAN-03-3258; Ghaghada KB, 2011, ACAD RADIOL, V18, P20, DOI 10.1016/j.acra.2010.09.003; Hallouard F, 2010, BIOMATERIALS, V31, P6249, DOI 10.1016/j.biomaterials.2010.04.066; Jackson EL, 2005, CANCER RES, V65, P10280, DOI 10.1158/0008-5472.CAN-05-2193; Jemal A, 2008, JNCI-J NATL CANCER I, V100, P1672, DOI 10.1093/jnci/djn389; Johnson L, 2001, NATURE, V410, P1111, DOI 10.1038/35074129; Johnston SM, 2010, MED IMAGING 2010 PHY, P7622; Kamba T, 2006, AM J PHYSIOL-HEART C, V290, pH560, DOI 10.1152/ajpheart.00133.2005; Karathanasis E, 2009, RADIOLOGY, V250, P398, DOI 10.1148/radiol.2502080801; Kim YR, 2000, ACCURATE MEASUREMENT; Kirsch DG, 2010, INT J RADIAT ONCOL, V76, P973, DOI 10.1016/j.ijrobp.2009.11.038; Klerk CPW, 2007, BIOTECHNIQUES, V43, P7, DOI 10.2144/000112515; MacMahon H, 2005, RADIOLOGY, V237, P395, DOI 10.1148/radiol.2372041887; Mozley PD, 2010, ANN ONCOL, V21, P1751, DOI 10.1093/annonc/mdq051; Niedre MJ, 2008, P NATL ACAD SCI USA, V105, P19126, DOI 10.1073/pnas.0804798105; Oliver TG, 2010, GENE DEV, V24, P837, DOI 10.1101/gad.1897010; Petkovska I, 2006, EUR J RADIOL, V59, P244, DOI 10.1016/j.ejrad.2006.03.005; Phillips WT, 2009, WIRES NANOMED NANOBI, V1, P69, DOI 10.1002/wnan.3; Quan E, 2009, PHYS MED BIOL, V54, P1061, DOI 10.1088/0031-9155/54/4/016; Rygh CB, 2011, CLIN CANCER RES, V17, P550, DOI 10.1158/1078-0432.CCR-10-2049; Samei E, 2009, INT J NANOMED, V4, P277; Schraufnagel DE, BREATHING AM DIS PRO; Strijkers GJ, 2010, ANGIOGENESIS, V13, P161, DOI 10.1007/s10456-010-9165-1; Turetschek K, 2004, J MAGN RESON IMAGING, V20, P138, DOI 10.1002/jmri.20049; X He, 2011, NOVEL PEPTIDE PROBE, pnull; Yi CA, 2004, RADIOLOGY, V233, P191, DOI 10.1148/radiol.2331031535; Zheng JZ, 2010, CONTRAST MEDIA MOL I, V5, P147, DOI 10.1002/cmmi.378	34	44	46	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2012	7	4							e34496	10.1371/journal.pone.0034496	http://dx.doi.org/10.1371/journal.pone.0034496			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952GU	22485175	Green Submitted, Green Published, gold			2022-12-27	WOS:000304780500050
J	Iamarino, A; de Melo, FL; Braconi, CT; Zanotto, PMD				Iamarino, Atila; de Melo, Fernando Lucas; Braconi, Carla Torres; de Andrade Zanotto, Paolo Marinho			BF Integrase Genes of HIV-1 Circulating in Sao Paulo, Brazil, with a Recurrent Recombination Region	PLOS ONE			English	Article							DRUG-RESISTANCE; PATIENTS NAIVE; SUBTYPE-B; VIRUS; IDENTIFICATION; INHIBITORS; JPHMM	Although some studies have shown diversity in HIV integrase (IN) genes, none has focused particularly on the gene evolving in epidemics in the context of recombination. The IN gene in 157 HIV-1 integrase inhibitor-naive patients from the Sao Paulo State, Brazil, were sequenced tallying 128 of subtype B (23 of which were found in non-B genomes), 17 of subtype F (8 of which were found in recombinant genomes), 11 integrases were BF recombinants, and 1 from subtype C. Crucially, we found that 4 BF recombinant viruses shared a recurrent recombination breakpoint region between positions 4900 and 4924 (relative to the HXB2) that includes 2 gRNA loops, where the RT may stutter. Since these recombinants had independent phylogenetic origin, we argue that these results suggest a possible recombination hotspot not observed so far in BF CRF in particular, or in any other HIV-1 CRF in general. Additionally, 40% of the drug-naive and 45% of the drug-treated patients had at least 1 raltegravir (RAL) or elvitegravir (EVG) resistance-associated amino acid change, but no major resistance mutations were found, in line with other studies. Importantly, V151I was the most common minor resistance mutation among B, F and BF IN genes. Most codon sites of the IN genes had higher rates of synonymous substitutions (dS) indicative of a strong negative selection. Nevertheless, several codon sites mainly in the subtype B were found under positive selection. Consequently, we observed a higher genetic diversity in the B portions of the mosaics, possibly due to the more recent introduction of subtype F on top of an ongoing subtype B epidemics and a fast spread of subtype F alleles among the B population.	[Iamarino, Atila; de Melo, Fernando Lucas; Braconi, Carla Torres; de Andrade Zanotto, Paolo Marinho] Univ Sao Paulo, Lab Mol Evolut & Bioinformat, Dept Microbiol, Biomed Sci Inst ICB 2, Sao Paulo, Brazil	Universidade de Sao Paulo	Iamarino, A (corresponding author), Univ Sao Paulo, Lab Mol Evolut & Bioinformat, Dept Microbiol, Biomed Sci Inst ICB 2, Sao Paulo, Brazil.	pzanotto@usp.br	Melo, Fernando Lucas/U-6535-2017; Braconi, Carla/B-3320-2014; de A. Zanotto, Paolo M./B-9286-2019	Melo, Fernando Lucas/0000-0002-9591-0239; Braconi, Carla/0000-0002-5370-8980; de A. Zanotto, Paolo M./0000-0002-8167-0625; Iamarino, Atila/0000-0003-3904-0248	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [10/19341-4, 00/04205-6, 08/58559-5, 07/01554-9, 09/16740-8]; CNPq	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was funded by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP; projects #10/19341-4, 00/04205-6 [VGDN program], 08/58559-5 [AI], 07/01554-9 [FLM], and 09/16740-8 [CTB]). PMAZ holds a CNPq-PQ scholarship. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arruda LB, 2010, AIDS RES HUM RETROV, V26, P105, DOI 10.1089/aid.2009.0179; Bello G, 2006, AIDS, V20, P763, DOI 10.1097/01.aids.0000216377.84313.52; Passaes CPB, 2009, AIDS RES HUM RETROV, V25, P1339, DOI 10.1089/aid.2009.0167; Bouyac-Bertoia M, 2001, MOL CELL, V7, P1025, DOI 10.1016/S1097-2765(01)00240-4; Bruselles A, 2009, AIDS RES HUM RETROV, V25, P937, DOI 10.1089/aid.2009.0083; Ceccherini-Silberstein F, 2009, AIDS REV, V11, P17; Pardini MI, 2008, PLOS BIOL, V6, P428, DOI 10.1371/journal.pbio.0060057; De Sa DJ, 2005, AIDS RES HUM RETROV, V21, P145, DOI 10.1089/aid.2005.21.145; De Sa DJ, 2006, AIDS RES HUM RETROV, V22, P1; DeJesus E, 2006, JAIDS-J ACQ IMM DEF, V43, P1, DOI 10.1097/01.qai.0000233308.82860.2f; ENGELMAN A, 1992, J VIROL, V66, P6361, DOI 10.1128/JVI.66.11.6361-6369.1992; Gonsalez CR, 2007, VIRUS RES, V129, P87, DOI 10.1016/j.virusres.2007.06.021; Grinsztejn B, 2007, LANCET, V369, P1261, DOI 10.1016/S0140-6736(07)60597-2; Pond SLK, 2006, MOL BIOL EVOL, V23, P1891, DOI 10.1093/molbev/msl051; KULKOSKY J, 1992, MOL CELL BIOL, V12, P2331, DOI 10.1128/MCB.12.5.2331; Lataillade M, 2007, ANTIVIR THER, V12, P563; Maertens GN, 2010, NATURE, V468, P326, DOI 10.1038/nature09517; Magiorkinis G, 2003, J GEN VIROL, V84, P2715, DOI 10.1099/vir.0.19180-0; Malet I, 2008, ANTIMICROB AGENTS CH, V52, P1351, DOI 10.1128/AAC.01228-07; de Souza ACMF, 2008, AIDS RES HUM RETROV, V24, P1521, DOI 10.1089/aid.2008.0089; McCutchan FE, 1999, EVOLUTION OF HIV, P41; Ministerio da Saude do Brasil Secretaria de Vigilancia em Saude Programa Nacional de DST e AIDS, 2010, MIN SAUD BRAS B EP, VVII; Pommier Y, 2005, NAT REV DRUG DISCOV, V4, P236, DOI 10.1038/nrd1660; Sanabani S, 2006, AIDS RES HUM RETROV, V22, P171, DOI 10.1089/aid.2006.22.171; Sanabani S, 2006, INFECT GENET EVOL, V6, P368, DOI 10.1016/j.meegid.2006.01.003; Schultz AK, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-265; Schultz AK, 2009, NUCLEIC ACIDS RES, V37, pW647, DOI 10.1093/nar/gkp371; Shafer RW, 2006, J INFECT DIS, V194, pS51, DOI 10.1086/505356; Thomson MM, 2005, AIDS REV, V7, P210; Van Laethem K, 2008, J VIROL METHODS, V153, P176, DOI 10.1016/j.jviromet.2008.07.008; Watts JM, 2009, NATURE, V460, P711, DOI 10.1038/nature08237; Zhang M, 2006, NUCLEIC ACIDS RES, V34, pW463, DOI 10.1093/nar/gkl255; Zhang M, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-25; Zwickl DJ., 2006, THESIS	34	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2012	7	4							e34324	10.1371/journal.pone.0034324	http://dx.doi.org/10.1371/journal.pone.0034324			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952GU	22485165	gold, Green Published, Green Submitted			2022-12-27	WOS:000304780500040
J	Rau, C; Hwang, M; Lee, WK; Richter, CP				Rau, Christoph; Hwang, Margaret; Lee, Wah-Keat; Richter, Claus-Peter			Quantitative X-ray Tomography of the Mouse Cochlea	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; TEMPORAL BONE; INNER-EAR; MICROSCOPY; MORPHOLOGY; MEMBRANE; TISSUE; MICE; MAP	Imaging with hard X-rays allows visualizing cochlear structures while maintaining intrinsic qualities of the tissue, including structure and size. With coherent X-rays, soft tissues, including membranes, can be imaged as well as cells making use of the so-called in-line phase contrast. In the present experiments, partially coherent synchrotron radiation has been used for micro-tomography. Three-dimensional reconstructions of the mouse cochlea have been created using the EM3D software and the volume has been segmented in the Amira Software Suite. The structures that have been reconstructed include scala tympani, scala media, scala vestibuli Reissner's membrane, basilar membrane, tectorial membrane, organ of Corti, spiral limbus, spiral ganglion and cochlear nerve. Cross-sectional areas of the scalae were measured. The results provide a realistic and quantitative reconstruction of the cochlea.	[Rau, Christoph] Diamond Light Source Ltd, Didcot, Oxon, England; [Rau, Christoph; Hwang, Margaret; Richter, Claus-Peter] Northwestern Univ, Dept Otolaryngol, Feinberg Sch Med, Chicago, IL 60611 USA; [Lee, Wah-Keat] Argonne Natl Lab, Adv Photon Source, Argonne, IL 60439 USA; [Richter, Claus-Peter] Northwestern Univ, Dept Biomed Engn, Evanston, IL 60208 USA; [Richter, Claus-Peter] Northwestern Univ, Dept Commun Sci & Disorders, Hugh Knowles Ctr, Evanston, IL USA	Diamond Light Source; Northwestern University; Feinberg School of Medicine; United States Department of Energy (DOE); Argonne National Laboratory; Northwestern University; Northwestern University	Rau, C (corresponding author), Diamond Light Source Ltd, Diamond House,Harwell Sci & Innovat Campus, Didcot, Oxon, England.	cri529@northwestern.edu	Lee, Wah-Keat/GRR-9734-2022		NSF [IBN-0415901]; Hugh Knowles Foundation; United States Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]	NSF(National Science Foundation (NSF)); Hugh Knowles Foundation; United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE))	CPR has been supported by a grant from the NSF (IBN-0415901) and the Hugh Knowles Foundation. Use of the Advanced Photon Source at Argonne National Laboratory was supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract No. DE-AC02-06CH11357. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brunschwig AS, 1997, HEARING RES, V114, P62, DOI 10.1016/S0378-5955(97)00153-6; BURDA H, 1988, J MORPHOL, V198, P269, DOI 10.1002/jmor.1051980303; BURDA H, 1988, HEARING RES, V36, P97, DOI 10.1016/0378-5955(88)90140-2; Choudhury N, 2006, HEARING RES, V220, P1, DOI 10.1016/j.heares.2006.06.006; Czerny C, 2003, RADIOLOGE, V43, P200, DOI 10.1007/s00117-003-0867-x; Dodt HU, 2007, NAT METHODS, V4, P331, DOI 10.1038/NMETH1036; Edge RM, 1998, HEARING RES, V124, P1, DOI 10.1016/S0378-5955(98)00090-2; EHRET G, 1977, J COMP PHYSIOL, V122, P65, DOI 10.1007/BF00611249; Fuchs E, 2002, OPT EXPRESS, V10, P145, DOI 10.1364/OE.10.000145; Glueckert R, 2010, AM J MED GENET A, V152A, P665, DOI 10.1002/ajmg.a.33321; Hallpike C S, 1938, Proc R Soc Med, V31, P1317; Huisken J, 2004, SCIENCE, V305, P1007, DOI 10.1126/science.1100035; Johnson SB, 2011, HEARING RES, V278, P34, DOI 10.1016/j.heares.2011.02.008; Keiler S, 2001, HEARING RES, V162, P91, DOI 10.1016/S0378-5955(01)00374-4; Lareida A, 2009, J MICROSC-OXFORD, V234, P95, DOI 10.1111/j.1365-2818.2009.03143.x; Lee CF, 2010, ANN BIOMED ENG, V38, P1719, DOI 10.1007/s10439-010-9961-1; LIM DJ, 1972, ARCHIV OTOLARYNGOL, V96, P199; Lin J, 2008, ANN OTO RHINOL LARYN, V117, P341, DOI 10.1177/000348940811700503; Muller M, 2005, HEARING RES, V202, P63, DOI 10.1016/j.heares.2004.08.011; Ou HC, 2000, HEARING RES, V145, P123, DOI 10.1016/S0378-5955(00)00082-4; Pau HW, 2008, LARYNGO RHINO OTOL, V87, P641, DOI 10.1055/s-2007-995725; Pau HW, 2007, ACTA OTO-LARYNGOL, V127, P907, DOI 10.1080/00016480601089408; Rau C, 2006, MICROSC RES TECHNIQ, V69, P660, DOI 10.1002/jemt.20336; Rau C, 2007, NIMB, DOI [10.1016/j.nimb.2007.1003.1053, DOI 10.1016/J.NIMB.2007.1003.1053]; Rau C, 2007, MICRO NANO IN PRESS; Rau C, 2006, SPIE, V6078; Reisser C, 1996, AM J OTOL, V17, P473; Richter CP, 2009, MICROSC RES TECHNIQ, V72, P902, DOI 10.1002/jemt.20728; Santi PA, 2011, J HISTOCHEM CYTOCHEM, V59, P129, DOI 10.1369/0022155410394857; Santi PA, 2009, BIOTECHNIQUES, V46, P287, DOI 10.2144/000113087; Siedentopf H, 1902, ANN PHYS, V315, P1, DOI [10.1002/andp.19023150102, DOI 10.1002/ANDP.19023150102]; Steel KP, 1996, CURR OPIN NEUROBIOL, V6, P520, DOI 10.1016/S0959-4388(96)80059-6; Subhash HM, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3456554; Thorne M, 1999, LARYNGOSCOPE, V109, P1661, DOI 10.1097/00005537-199910000-00021; Vogel U, 1999, ORL-J OTO-RHIN-LARYN, V61, P259, DOI 10.1159/000027683; VOIE AH, 1993, J MICROSC-OXFORD, V170, P229, DOI 10.1111/j.1365-2818.1993.tb03346.x; Voie AH, 1995, COMPUT MED IMAG GRAP, V19, P377, DOI 10.1016/0895-6111(95)00034-8; Voie AH, 2002, HEARING RES, V171, P119, DOI 10.1016/S0378-5955(02)00493-8; Wong BJF, 2000, J BIOMED OPT, V5, P367, DOI 10.1117/1.1310165; Wong BJF, 2004, OTOLARYNG HEAD NECK, V130, P334, DOI 10.1016/j.otohns.2003.11.007; Zheng QY, 1999, HEARING RES, V130, P94, DOI 10.1016/S0378-5955(99)00003-9	41	25	27	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2012	7	4							e33568	10.1371/journal.pone.0033568	http://dx.doi.org/10.1371/journal.pone.0033568			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952GU	22485145	Green Published, Green Submitted, gold			2022-12-27	WOS:000304780500021
J	Sawabe, M; Tanaka, N; Mieno, MN; Ishikawa, S; Kayaba, K; Nakahara, K; Matsushita, S				Sawabe, Motoji; Tanaka, Noriko; Mieno, Makiko Naka; Ishikawa, Shizukiyo; Kayaba, Kazunori; Nakahara, Ken-ichi; Matsushita, Satoru		J M S Cohort Study Grp	Low Lipoprotein(a) Concentration Is Associated with Cancer and All-Cause Deaths: A Population-Based Cohort Study (The JMS Cohort Study)	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; DEPENDENT TUMOR-GROWTH; HEPATOCELLULAR-CARCINOMA; HUMAN APOLIPOPROTEIN(A); LUNG-CANCER; RISK; ANGIOGENESIS; LP(A); CENTENARIANS; EXPRESSION	Background: Experimental studies support the anti-neoplastic effect of apo(a), but several clinical studies have reported contradictory results. The purpose of this study was to determine whether a low lipoprotein(a) [Lp(a)] concentration is related to mortality from major causes of death, especially cancer. Methods: The subjects were 10,413 participants (4,005 men and 6,408 women) from a multi-center population-based cohort study in Japan (The Jichi Medical School cohort study). The average age at registration was 55.0 years, and the median observation period was 4,559 days. As the estimated hazard ratio was high for both the low and very high Lp(a) levels, we defined two Lp(a) groups: a low Lp(a) group [Lp(a)<80 mg/L] and an intermediate-to-high Lp(a) group [Lp(a)>= 80]. Participants who died from malignant neoplasms (n=316), cardiovascular disease (202), or other causes (312) during the observation period were examined. Results: Cumulative incidence plots showed higher cumulative death rates for the low Lp(a) group than for the intermediate-to-high Lp(a) group for all-cause, cancer, and miscellaneous-cause deaths (p<0.001, p=0.03, and p=0.03, respectively). Cox proportional hazards analyses with the sex and age of the participants, body mass index, and smoking and drinking histories as covariates showed that a low Lp(a) level was a significant risk for all-cause, cancer, and miscellaneous-cause deaths (p<0.001, p=0.003, and p=0.01, respectively). The hazard ratio (95% CI) [1.48, 1.15-1.92] of a low Lp(a) level for cancer deaths was almost the same as that for a male sex (1.46, 1.00-2.13). Conclusions: This is the first report to describe the association between a low Lp(a) level and all-cause or cancer death, supporting the anti-neoplastic effect of Lp(a). Further epidemiological studies are needed to confirm the present results.	[Sawabe, Motoji] Tokyo Metropolitan Geriatr Hosp, Bioresource Ctr Geriatr Res, Tokyo 173, Japan; [Nakahara, Ken-ichi; Matsushita, Satoru] Tokyo Metropolitan Geriatr Hosp, Dept Internal Med, Tokyo 173, Japan; [Tanaka, Noriko] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Mieno, Makiko Naka] Jichi Med Univ, Dept Med Informat, Shimotsuke, Japan; [Ishikawa, Shizukiyo; Kayaba, Kazunori] Jichi Med Univ, Ctr Community Med, Shimotsuke, Japan	Tokyo Metropolitan Institute of Gerontology; Tokyo Metropolitan Institute of Gerontology; Harvard University; Harvard T.H. Chan School of Public Health; Jichi Medical University; Jichi Medical University	Sawabe, M (corresponding author), Tokyo Metropolitan Geriatr Hosp, Bioresource Ctr Geriatr Res, Tokyo 173, Japan.	i-shizu@jichi.ac.jp	Tanaka, Noriko/AAP-8984-2021; Tanaka, Noriko/J-7811-2018	Tanaka, Noriko/0000-0003-3025-1591; Tanaka, Noriko/0000-0003-3025-1591	Ministry of Education, Culture, Sports, Science and Technology in Japan [10470113, 13470096, 15390209, 18390198]	Ministry of Education, Culture, Sports, Science and Technology in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by the grants #10470113 to KK; #13470096, #15390209 and #18390198 to SI (http://kaken.nii.ac.jp/en/) from the Ministry of Education, Culture, Sports, Science and Technology in Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai Y, 2001, J AM GERIATR SOC, V49, P1434, DOI 10.1046/j.1532-5415.2001.4911234.x; Ariyo AA, 2003, NEW ENGL J MED, V349, P2108, DOI 10.1056/NEJMoa001066; Bennet A, 2008, ARCH INTERN MED, V168, P598, DOI 10.1001/archinte.168.6.598; Chien KL, 2008, CLIN CHEM, V54, P285, DOI 10.1373/clinchem.2007.090969; Danesh J, 2000, CIRCULATION, V102, P1082, DOI 10.1161/01.CIR.102.10.1082; Denti L, 1996, CLIN CHEM, V42, P1176; DURRLEMAN S, 1989, STAT MED, V8, P551, DOI 10.1002/sim.4780080504; Dursun A, 2006, CORONARY ARTERY DIS, V17, P159, DOI 10.1097/00019501-200603000-00010; Erqou S, 2009, JAMA-J AM MED ASSOC, V302, P412, DOI 10.1001/jama.2009.1063; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; GAW A, 1994, J CLIN INVEST, V93, P2526, DOI 10.1172/JCI117263; GRAY RJ, 1988, ANN STAT, V16, P1141, DOI 10.1214/aos/1176350951; Halton JM, 1998, CANCER, V83, P379, DOI 10.1002/(SICI)1097-0142(19980715)83:2<379::AID-CNCR24>3.0.CO;2-P; Hirose N, 2004, GERIATR GERONTOL INT, V4, P182, DOI [10.1111/j.1447-0594.2004.00194.x, DOI 10.1111/J.1447-0594.2004.00194.X]; Hoover-Plow J, 2009, EXP BIOL MED, V234, P28, DOI 10.3181/0804-RM-136; Ikai I, 2005, HEPATOL RES, V32, P163, DOI 10.1016/j.hepres.2005.04.005; Ishikawa S, 1999, J Epidemiol, V9, P32; Ishikawa Shizukiyo, 2002, J Epidemiol, V12, P408; Jaeger BR, 2009, NAT CLIN PRACT CARD, V6, P229, DOI 10.1038/ncpcardio1456; JENNER JL, 1993, CIRCULATION, V87, P1135, DOI 10.1161/01.CIR.87.4.1135; Kim JS, 2003, J BIOL CHEM, V278, P29000, DOI 10.1074/jbc.M301042200; KIYOSAWA K, 1990, HEPATOLOGY, V12, P671, DOI 10.1002/hep.1840120409; KOKOGLU E, 1994, CANCER BIOCHEM BIOPH, V14, P133; KUESEL AC, 1992, INT J CANCER, V52, P341, DOI 10.1002/ijc.2910520302; Kurup A, 2006, ANN ONCOL, V17, P97, DOI 10.1093/annonc/mdj055; Lee K, 2006, HEPATOLOGY, V43, P1063, DOI 10.1002/hep.21149; Lippi G, 2000, QJM-MON J ASSOC PHYS, V93, P75, DOI 10.1093/qjmed/93.2.75; Lippi G, 2007, CANCER TREAT REV, V33, P427, DOI 10.1016/j.ctrv.2007.02.006; Merki E, 2011, J AM COLL CARDIOL, V57, P1611, DOI 10.1016/j.jacc.2010.10.052; Motta M, 2001, Minerva Med, V92, P301; NAGO N, 1995, AM J EPIDEMIOL, V141, P815, DOI 10.1093/oxfordjournals.aje.a117516; NOMA A, 1994, CHEM PHYS LIPIDS, V67-8, P411, DOI 10.1016/0009-3084(94)90164-3; Nordestgaard BG, 2010, EUR HEART J, V31, P2844, DOI 10.1093/eurheartj/ehq386; Ohira T, 2006, STROKE, V37, P1407, DOI 10.1161/01.STR.0000222666.21482.b6; Parhofer KG, 2011, CURR PHARM DESIGN, V17, P871; Pepe G, 1998, ATHEROSCLEROSIS, V137, P407, DOI 10.1016/S0021-9150(97)00290-6; Samonakis DN, 2004, DIGEST DIS SCI, V49, P854, DOI 10.1023/B:DDAS.0000030099.13397.28; Sawabe M, 2009, HEART, V95, P1997, DOI 10.1136/hrt.2008.160879; Smolders B, 2007, STROKE, V38, P1959, DOI 10.1161/STROKEAHA.106.480657; Thillet J, 1998, ATHEROSCLEROSIS, V136, P389, DOI 10.1016/S0021-9150(97)00217-7; Trieu VN, 1999, BIOCHEM BIOPH RES CO, V257, P714, DOI 10.1006/bbrc.1999.0519; VANWERSCH JWJ, 1994, SCAND J CLIN LAB INV, V54, P559, DOI 10.3109/00365519409088568; Wahl ML, 2005, J CELL BIOCHEM, V96, P242, DOI 10.1002/jcb.20480; WRIGHT LC, 1989, INT J CANCER, V43, P241, DOI 10.1002/ijc.2910430212; Yang HH, 2009, CLIN CHEM LAB MED, V47, P452, DOI 10.1515/CCLM.2009.094; Yano Y, 1997, J HISTOCHEM CYTOCHEM, V45, P559, DOI 10.1177/002215549704500408; Yi ZF, 2009, INT J CANCER, V124, P843, DOI 10.1002/ijc.24027; Yu HK, 2004, CANCER RES, V64, P7092, DOI 10.1158/0008-5472.CAN-04-0364; Yu HK, 2005, J GENE MED, V7, P39, DOI 10.1002/jgm.638	49	28	30	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2012	7	4							e31954	10.1371/journal.pone.0031954	http://dx.doi.org/10.1371/journal.pone.0031954			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952GU	22485129	Green Published, gold, Green Submitted			2022-12-27	WOS:000304780500005
J	Belforte, N; Sande, PH; de Zavalia, N; Dorfman, D; Rosenstein, RE				Belforte, Nicolas; Sande, Pablo H.; de Zavalia, Nuria; Dorfman, Damian; Rosenstein, Ruth E.			Therapeutic Benefit of Radial Optic Neurotomy in a Rat Model of Glaucoma	PLOS ONE			English	Article							CENTRAL RETINAL VEIN; RETROGRADE AXOPLASMIC-TRANSPORT; GANGLION-CELL FATE; NERVE HEAD; LAMINA-CRIBROSA; INTRAOCULAR-PRESSURE; OCCLUSION; MONKEY; DEFORMATION; TISSUE	Radial optic neurotomy (RON) has been proposed as a surgical treatment to alleviate the neurovascular compression and to improve the venous outflow in patients with central retinal vein occlusion. Glaucoma is characterized by specific visual field defects due to the loss of retinal ganglion cells and damage to the optic nerve head (ONH). One of the clinical hallmarks of glaucomatous neuropathy is the excavation of the ONH. The aim of this work was to analyze the effect of RON in an experimental model of glaucoma in rats induced by intracameral injections of chondroitin sulfate (CS). For this purpose, Wistar rats were bilaterally injected with vehicle or CS in the eye anterior chamber, once a week, for 10 weeks. At 3 or 6 weeks of a treatment with vehicle or CS, RON was performed by a single incision in the edge of the neuro-retinal ring at the nasal hemisphere of the optic disk in one eye, while the contralateral eye was submitted to a sham procedure. Electroretinograms (ERGs) were registered under scotopic conditions and visual evoked potentials (VEPs) were registered with skull-implanted electrodes. Retinal and optic nerve morphology was examined by optical microscopy. RON did not affect the ocular hypertension induced by CS. In eyes injected with CS, a significant decrease of retinal (ERG a- and b- wave amplitude) and visual pathway (VEP N2-P2 component amplitude) function was observed, whereas RON reduced these functional alterations in hypertensive eyes. Moreover, a significant loss of cells in the ganglion cell layer, and Thy-1-, NeuN- and Brn3a- positive cells was observed in eyes injected with CS, whereas RON significantly preserved these parameters. In addition, RON preserved the optic nerve structure in eyes with chronic ocular hypertension. These results indicate that RON reduces functional and histological alterations induced by experimental chronic ocular hypertension.	[Belforte, Nicolas; Sande, Pablo H.; de Zavalia, Nuria; Dorfman, Damian; Rosenstein, Ruth E.] Univ Buenos Aires, Lab Retinal Neurochem & Expt Ophthalmol, Dept Human Biochem, Sch Med CEFyBO,CONICET, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	Belforte, N (corresponding author), Univ Buenos Aires, Lab Retinal Neurochem & Expt Ophthalmol, Dept Human Biochem, Sch Med CEFyBO,CONICET, Buenos Aires, DF, Argentina.	ruthr@fmed.uba.ar		Belforte, Nicolas/0000-0001-5857-8006	Agencia Nacional de Promocion Cientifica y Tecnologica [PICT 1623]; University of Buenos Aires [M062]; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET), Argentina [PIP 1911]	Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); University of Buenos Aires(University of Buenos Aires); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET), Argentina(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This research was supported by grants from the Agencia Nacional de Promocion Cientifica y Tecnologica (PICT 1623), the University of Buenos Aires (M062), and Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) (PIP 1911), Argentina. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arevalo JF, 2008, RETINA-J RET VIT DIS, V28, P1044, DOI 10.1097/IAE.0b013e3181744153; BARNSTABLE CJ, 1984, NEUROSCIENCE, V11, P847, DOI 10.1016/0306-4522(84)90195-7; Belforte N, 2010, INVEST OPHTH VIS SCI, V51, P5768, DOI 10.1167/iovs.10-5660; Belforte NA, 2011, RETINA-J RET VIT DIS, V31, P2115, DOI 10.1097/IAE.0b013e31820f4bcb; Bellezza AJ, 2003, INVEST OPHTH VIS SCI, V44, P623, DOI 10.1167/iovs.01-1282; Buckingham BP, 2008, J NEUROSCI, V28, P2735, DOI 10.1523/JNEUROSCI.4443-07.2008; Burgoyne CF, 2005, PROG RETIN EYE RES, V24, P39, DOI 10.1016/j.preteyeres.2004.06.001; Burgoyne CF, 2004, INVEST OPHTH VIS SCI, V45, P4388, DOI 10.1167/iovs.04-0022; Canola K, 2007, INVEST OPHTH VIS SCI, V48, P446, DOI 10.1167/iovs.06-0190; Dijk F, 2007, EXP EYE RES, V84, P858, DOI 10.1016/j.exer.2007.01.006; Downs JC, 2008, OPTOMETRY VISION SCI, V85, P425, DOI 10.1097/OPX.0b013e31817841cb; ERNEST JT, 1968, AM J OPHTHALMOL, V66, P373, DOI 10.1016/0002-9394(68)91520-1; Feltgen N, 2005, OPHTHALMOLOGE, V102, P802, DOI 10.1007/s00347-004-1060-y; Garcia-Arumi J, 2003, ARCH OPHTHALMOL-CHIC, V121, P1385, DOI 10.1001/archopht.121.10.1385; Hayreh SS, 2004, ARCH OPHTHALMOL-CHIC, V122, P1572, DOI 10.1001/archopht.122.10.1572-b; Horio N, 2005, AM J OPHTHALMOL, V139, P926, DOI 10.1016/j.ajo.2004.10.053; JOHANSSON JO, 1983, INVEST OPHTH VIS SCI, V24, P1552; Maia M, 2007, CLIN EXP OPHTHALMOL, V35, P672, DOI 10.1111/j.1442-9071.2007.01568.x; Martinez-Jardon CS, 2005, BRIT J OPHTHALMOL, V89, P558, DOI 10.1136/bjo.2004.048181; May CA, 2002, INVEST OPHTH VIS SCI, V43, P2206; May CA, 2008, OPEN OPHTHALMOL J, V2, P94, DOI 10.2174/1874364100802010094; MINCKLER DS, 1977, INVEST OPHTH VIS SCI, V16, P426; Moreno MC, 2004, FREE RADICAL BIO MED, V37, P803, DOI 10.1016/j.freeradbiomed.2004.06.001; MORRISON J, 1995, EXP EYE RES, V60, P127, DOI 10.1016/S0014-4835(95)80002-6; Opremcak EM, 2006, RETINA-J RET VIT DIS, V26, P297, DOI 10.1097/00006982-200603000-00008; Opremcak EM, 2001, RETINA-J RET VIT DIS, V21, P408, DOI 10.1097/00006982-200110000-00002; Pease ME, 2000, INVEST OPHTH VIS SCI, V41, P764; QUIGLEY HA, 1981, ARCH OPHTHALMOL-CHIC, V99, P635, DOI 10.1001/archopht.1981.03930010635009; Quina LA, 2005, J NEUROSCI, V25, P11595, DOI 10.1523/JNEUROSCI.2837-05.2005; Raymond ID, 2008, MOL VIS, V14, P1559; Roberts MD, 2010, INVEST OPHTH VIS SCI, V51, P5675, DOI 10.1167/iovs.10-5411; Samuel MA, 2003, RETINA-J RET VIT DIS, V23, P580, DOI 10.1097/00006982-200308000-00033; Schneider U, 2005, RETINA-J RET VIT DIS, V25, P704, DOI 10.1097/00006982-200509000-00004; Sigal IA, 2009, EXP EYE RES, V88, P799, DOI 10.1016/j.exer.2009.02.003; Soheilian M, 2010, OPHTHAL SURG LAS IM, V41, P157, DOI 10.3928/15428877-20100303-02; Wax MB, 2009, EXP EYE RES, V88, P825, DOI 10.1016/j.exer.2009.02.005; Weis E, 2008, CAN J OPHTHALMOL, V43, P73, DOI 10.3129/i07-180; Weizer JS, 2003, AM J OPHTHALMOL, V136, P814, DOI 10.1016/S0002-9394(03)00698-6; Williamson TH, 2003, BRIT J OPHTHALMOL, V87, P1126, DOI 10.1136/bjo.87.9.1126; Wolf HK, 1996, J HISTOCHEM CYTOCHEM, V44, P1167, DOI 10.1177/44.10.8813082; Yamamoto S, 2005, AM J OPHTHALMOL, V139, P206, DOI 10.1016/j.ajo.2004.07.031; Yamamoto T, 2009, RETINA-J RET VIT DIS, V29, P1167, DOI 10.1097/IAE.0b013e3181a46a5e; YAN DB, 1994, BRIT J OPHTHALMOL, V78, P643, DOI 10.1136/bjo.78.8.643; Yang HL, 2007, INVEST OPHTH VIS SCI, V48, P4597, DOI 10.1167/iovs.07-0349; Yang HL, 2011, INVEST OPHTH VIS SCI, V52, P345, DOI 10.1167/iovs.09-5122	45	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2012	7	3							e34574	10.1371/journal.pone.0034574	http://dx.doi.org/10.1371/journal.pone.0034574			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948SR	22479647	Green Published, Green Submitted, gold			2022-12-27	WOS:000304523400089
J	Dubut, V; Fouquet, A; Voisin, A; Costedoat, C; Chappaz, R; Gilles, A				Dubut, Vincent; Fouquet, Antoine; Voisin, Adrien; Costedoat, Caroline; Chappaz, Remi; Gilles, Andre			From Late Miocene to Holocene: Processes of Differentiation within the Telestes Genus (Actinopterygii: Cyprinidae)	PLOS ONE			English	Article							POPULATION GENETIC-STRUCTURE; MICROSATELLITE NULL ALLELES; VAIRONE LEUCISCUS-SOUFFIA; MULTILOCUS GENOTYPE DATA; BULLHEAD COTTUS-GOBIO; MUTICELLUS TELEOSTEI; EUROPEAN CYPRINIDS; COMPLEX TELEOSTEI; COMPUTER-PROGRAM; COUNTING ALLELES	Investigating processes and timing of differentiation of organisms is critical in the understanding of the evolutionary mechanisms involved in microevolution, speciation, and macroevolution that generated the extant biodiversity. From this perspective, the Telestes genus is of special interest: the Telestes species have a wide distribution range across Europe (from the Danubian district to Mediterranean districts) and have not been prone to translocation. Molecular data (mtDNA: 1,232 bp including the entire Cyt b gene; nuclear genome: 11 microsatellites) were gathered from 34 populations of the Telestes genus, almost encompassing the entire geographic range. Using several phylogenetic and molecular dating methods interpreted in conjunction with paleoclimatic and geomorphologic evidence, we investigated the processes and timing of differentiation of the Telestes lineages. The observed genetic structure and diversity were largely congruent between mtDNA and microsatellites. The Messinian Salinity Crisis (Late Miocene) seems to have played a major role in the speciation processes of the genus. Focusing on T. souffia, a species occurring in the Danube and Rhone drainages, we were able to point out several specific events from the Pleistocene to the Holocene that have likely driven the differentiation and the historical demography of this taxon. This study provides support for an evolutionary history of dispersal and vicariance with unprecedented resolution for any freshwater fish in this region.	[Dubut, Vincent; Fouquet, Antoine; Voisin, Adrien; Costedoat, Caroline; Chappaz, Remi; Gilles, Andre] Aix Marseille Univ, CNRS, Equipe Evolut Genome Environm, Ctr St Charles,IRD,UMR IMBE 7263, Marseille, France; [Fouquet, Antoine] CNRS Guyane, USR 3456, CNRS, Cayenne, French Guiana	UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD)	Dubut, V (corresponding author), Aix Marseille Univ, CNRS, Equipe Evolut Genome Environm, Ctr St Charles,IRD,UMR IMBE 7263, Case 36, Marseille, France.	v.dubut@gmail.com		Dubut, Vincent/0000-0002-5619-6909; Fouquet, Antoine/0000-0003-4060-0281				AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Avise JC, 1998, P ROY SOC B-BIOL SCI, V265, P1707, DOI 10.1098/rspb.1998.0492; Banarescu P., 1990, ZOOGEOGRAPHY FRESH W, V1; Banarescu PM, 1989, FRESHWATER FISHES EU, P88; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Belkhir K, 2004, GENETIX 4 05 LOGICIE; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bernatchez L, 1998, MOL ECOL, V7, P431, DOI 10.1046/j.1365-294x.1998.00319.x; Bianco P.G., 1990, Ichthyological Exploration of Freshwaters, V1, P167; BIANCO PG, 1988, J FISH BIOL, V32, P1, DOI 10.1111/j.1095-8649.1988.tb05331.x; Brito RM, 1997, MOL PHYLOGENET EVOL, V8, P435, DOI 10.1006/mpev.1997.0429; Bryja J, 2010, MOL ECOL, V19, P4708, DOI 10.1111/j.1365-294X.2010.04844.x; Burridge CP, 2008, MOL BIOL EVOL, V25, P624, DOI 10.1093/molbev/msm271; Campana MG, 2011, MOL ECOL RESOUR, V11, P349, DOI 10.1111/j.1755-0998.2010.02917.x; Carlsson J, 2008, J HERED, V99, P616, DOI 10.1093/jhered/esn048; CAVALLISFORZA LL, 1967, AM J HUM GENET, V19, P233, DOI 10.2307/2406616; CHANGEUX T, 1995, BIOL CONSERV, V72, P137, DOI 10.1016/0006-3207(94)00077-4; Chapuis MP, 2008, MOL ECOL, V17, P3640, DOI 10.1111/j.1365-294X.2008.03869.x; Chapuis MP, 2007, MOL BIOL EVOL, V24, P621, DOI 10.1093/molbev/msl191; Clark PU, 2009, SCIENCE, V325, P710, DOI 10.1126/science.1172873; Clebert JP, 1991, DURANCE; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Cornuet JM, 1996, GENETICS, V144, P2001; Cortey M, 2009, BIOL J LINN SOC, V97, P904, DOI 10.1111/j.1095-8312.2009.01220.x; Costedoat C, 2006, MOL PHYLOGENET EVOL, V41, P127, DOI 10.1016/j.ympev.2006.04.022; Costedoat Caroline, 2009, Open Conservation Biology Journal, V3, P36, DOI 10.2174/1874839200903010036; Coyne J.A., 2004, SPECIATION; CRACRAFT J, 1982, AM ZOOL, V22, P411; Dermitzakis M.D., 1991, Accademia Nazionale dei Lincei Atti Convegni Lincei (Rome), V85, P263; DIRIENZO A, 1994, P NATL ACAD SCI USA, V91, P3166, DOI 10.1073/pnas.91.8.3166; DOWLING TE, 1993, NATURE, V362, P444, DOI 10.1038/362444a0; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Dubut Vincent, 2010, BMC Res Notes, V3, P135, DOI 10.1186/1756-0500-3-135; Dubut V, 2009, MOL ECOL RESOUR, V9, P1001, DOI 10.1111/j.1755-0998.2009.02539.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EWENS WJ, 1972, THEOR POPUL BIOL, V3, P87, DOI 10.1016/0040-5809(72)90035-4; Excoffier L, 2008, TRENDS ECOL EVOL, V23, P347, DOI 10.1016/j.tree.2008.04.004; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Falush D, 2003, GENETICS, V164, P1567; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fogelqvist J, 2010, MOL ECOL RESOUR, V10, P314, DOI 10.1111/j.1755-0998.2009.02756.x; Forster P, 1996, AM J HUM GENET, V59, P935; Fu YX, 1997, GENETICS, V147, P915; Garcia-Castellanos D, 2009, NATURE, V462, P778, DOI 10.1038/nature08555; GIBBARD P.L., 2005, GEOLOGIC TIME SCALE, P441, DOI DOI 10.1017/CBO9780511536045.023; GIBBARD PL, 1988, PHILOS T ROY SOC B, V318, P559, DOI 10.1098/rstb.1988.0024; Gilles A, 1998, MOL PHYLOGENET EVOL, V10, P132, DOI 10.1006/mpev.1997.0480; Gilles A, 1998, CAN J FISH AQUAT SCI, V55, P2341, DOI 10.1139/cjfas-55-10-2341; Gilles A, 2010, ZOOL SCR, V39, P225, DOI 10.1111/j.1463-6409.2010.00417.x; Guinand B, 1996, BIOL J LINN SOC, V58, P173, DOI 10.1111/j.1095-8312.1996.tb01430.x; Head MJ, 2005, GEOL SOC SPEC PUBL, V247, P1, DOI 10.1144/GSL.SP.2005.247.01.01; Helgason A, 2003, ANN HUM GENET, V67, P281, DOI 10.1046/j.1469-1809.2003.00046.x; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hoffmann R.C., 1995, GUELPH ICHTHYOLOGY R, V3, P57; Hofreiter M, 2009, CURR BIOL, V19, pR584, DOI 10.1016/j.cub.2009.06.030; HSU KJ, 1977, NATURE, V267, P399, DOI 10.1038/267399a0; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Kalinowski ST, 2011, HEREDITY, V106, P625, DOI 10.1038/hdy.2010.95; Kalinowski ST, 2004, CONSERV GENET, V5, P539, DOI 10.1023/B:COGE.0000041021.91777.1a; Ketmaier V, 2004, MOL PHYLOGENET EVOL, V32, P1061, DOI 10.1016/j.ympev.2004.04.008; KIMURA M, 1964, GENETICS, V49, P725; KIMURA M, 1978, P NATL ACAD SCI USA, V75, P2868, DOI 10.1073/pnas.75.6.2868; Krijgsman W, 1999, NATURE, V400, P652, DOI 10.1038/23231; Lajbner Z, 2011, EVOL APPL, V4, P545, DOI 10.1111/j.1752-4571.2010.00174.x; Levy A, 2009, J BIOGEOGR, V36, P55, DOI 10.1111/j.1365-2699.2008.01969.x; Loczy D, 2008, LARGE RIVERS GEOMORP, P235; Machordom A, 2001, MOL PHYLOGENET EVOL, V18, P252, DOI 10.1006/mpev.2000.0876; MANTEL N, 1967, CANCER RES, V27, P209; Marchetto F, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-111; Muenzel FM, 2007, MOL ECOL NOTES, V7, P1048, DOI 10.1111/j.1471-8286.2007.01772.x; Muscheler R, 2008, NAT GEOSCI, V1, P263, DOI 10.1038/ngeo128; NEI M, 1975, EVOLUTION, V29, P1, DOI 10.2307/2407137; Nei M., 1987, MOL EVOLUTIONARY GEN; NELVA A, 1988, Cybium, V12, P287; Nelva A, 1997, B FR PECHE PISCIC, V344/345, P253; Neuenschwander S, 2008, MOL ECOL, V17, P757, DOI 10.1111/j.1365-294X.2007.03621.x; Olivier JM, 2009, RIVERS OF EUROPE, 1ST EDITION, P247, DOI 10.1016/B978-0-12-369449-2.00007-2; Otto-Bliesner BL, 2006, SCIENCE, V311, P1751, DOI 10.1126/science.1120808; PENNY D, 1985, SYST ZOOL, V34, P75, DOI 10.2307/2413347; Perea S, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-265; Petit RJ, 1998, CONSERV BIOL, V12, P844, DOI 10.1046/j.1523-1739.1998.96489.x; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Prichard J.K., 2010, DOCUMENTATION STRUCT; Pritchard JK, 2000, GENETICS, V155, P945; Provan J, 2008, TRENDS ECOL EVOL, V23, P564, DOI 10.1016/j.tree.2008.06.010; Rab P, 2008, CHROMOSOME RES, V16, P863, DOI 10.1007/s10577-008-1245-3; Rambaut A, 2007, TRACER VERSION 1 2; Reyjol Y, 2007, GLOBAL ECOL BIOGEOGR, V16, P65, DOI 10.1111/j.1466-8238.2006.00264.x; Rousset F, 1997, GENETICS, V145, P1219; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Rull V, 2009, J BIOGEOGR, V36, P481, DOI 10.1111/j.1365-2699.2008.02023.x; Saillard J, 2000, AM J HUM GENET, V67, P718, DOI 10.1086/303038; Salzburger W, 2003, MOL ECOL, V12, P2371, DOI 10.1046/j.1365-294X.2003.01911.x; Sastre C, 1997, B FR PECHE PISCIC, V344/345, P9; Schwarz M, 1998, BIOL MENACES PROTECT; Sediva A, 2008, MOL ECOL, V17, P1277, DOI 10.1111/j.1365-294X.2007.03656.x; Sirocko F, 2005, NATURE, V436, P833, DOI 10.1038/nature03905; Societe du Canal de Provence (SCP), 1995, CART AM HYDR; Solar II, 2009, REV AQUACULT, V1, P174, DOI 10.1111/j.1753-5131.2009.01013.x; Sommerwerk N, 2009, RIVERS OF EUROPE, 1ST EDITION, P59, DOI 10.1016/B978-0-12-369449-2.00003-5; Stepien CA, 2009, MOL ECOL, V18, P3411, DOI 10.1111/j.1365-294X.2009.04291.x; Szpiech ZA, 2008, BIOINFORMATICS, V24, P2498, DOI 10.1093/bioinformatics/btn478; TAJIMA F, 1989, GENETICS, V123, P585; TAJIMA F, 1983, GENETICS, V105, P437; TEMPLETON AR, 1992, GENETICS, V132, P619; Tishkoff SA, 2009, SCIENCE, V324, P1035, DOI 10.1126/science.1172257; Tougard C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003532; Uehlinger U, 2009, RIVERS OF EUROPE, 1ST EDITION, P199, DOI 10.1016/B978-0-12-369449-2.00006-0; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Volckaert FAM, 2002, J EVOLUTION BIOL, V15, P930, DOI 10.1046/j.1420-9101.2002.00469.x; Vonlanthen P, 2007, MOL ECOL, V16, P4572, DOI 10.1111/j.1365-294X.2007.03531.x; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Weir BS, 2002, ANNU REV GENET, V36, P721, DOI 10.1146/annurev.genet.36.050802.093940; WILGENBUSCH JC, 2004, AWTY SYSTEM GRAPHICA; Wocher H, 2006, ARCH HYDROBIOL, V165, P77, DOI 10.1127/0003-9136/2006/0165-0077; Won H, 2006, SYST BIOL, V55, P610, DOI 10.1080/10635150600812619; Zaccara S, 2007, ZOOL SCR, V36, P443, DOI 10.1111/j.1463-6409.2007.00294.x; Zardoya R, 1999, J MOL EVOL, V49, P227, DOI 10.1007/PL00006545	122	23	24	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2012	7	3							e34423	10.1371/journal.pone.0034423	http://dx.doi.org/10.1371/journal.pone.0034423			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948SR	22479629	Green Published, gold			2022-12-27	WOS:000304523400082
J	Glaizot, O; Fumagalli, L; Iritano, K; Lalubin, F; Van Rooyen, J; Christe, P				Glaizot, Olivier; Fumagalli, Luca; Iritano, Katia; Lalubin, Fabrice; Van Rooyen, Juan; Christe, Philippe			High Prevalence and Lineage Diversity of Avian Malaria in Wild Populations of Great Tits (Parus major) and Mosquitoes (Culex pipiens)	PLOS ONE			English	Article							CYTOCHROME-B LINEAGES; BLOOD MEAL IDENTIFICATION; QUINQUEFASCIATUS DIPTERA; PLASMODIUM; PARASITES; VECTOR; HOST; CULICIDAE; DNA; HAEMOSPORIDIANS	Avian malaria studies have taken a prominent place in different aspects of evolutionary ecology. Despite a recent interest in the role of vectors within the complex interaction system of the malaria parasite, they have largely been ignored in most epidemiological studies. Epidemiology of the disease is however strongly related to the vector's ecology and behaviour, and there is a need for basic investigations to obtain a better picture of the natural associations between Plasmodium lineages, vector species and bird hosts. The aim of the present study was to identify the mosquito species involved in the transmission of the haemosporidian parasites Plasmodium spp. in two wild populations of breeding great tits (Parus major) in western Switzerland. Additionally, we compared Plasmodium lineages, based on mitochondrial DNA cytochrome b sequences, between the vertebrate and dipteran hosts, and evaluated the prevalence of the parasite in the mosquito populations. Plasmodium spp. were detected in Culex pipiens only, with an overall 6.6% prevalence. Among the six cytochrome b lineages of Plasmodium identified in the mosquitoes, three were also present in great tits. The results provide evidence for the first time that C. pipiens can act as a natural vector of avian malaria in Europe and yield baseline data for future research on the epidemiology of avian malaria in European countries.	[Glaizot, Olivier] Museum Zool, Lausanne, Switzerland; [Fumagalli, Luca] Univ Lausanne, Dept Ecol & Evolut, Lab Conservat Biol, Lausanne, Switzerland	University of Lausanne	Glaizot, O (corresponding author), Museum Zool, Lausanne, Switzerland.	olivier.glaizot@unil.ch	Glaizot, Olivier/B-8627-2012; Lalubin, Fabrice/E-2708-2013; Christe, Philippe/X-4493-2018	Glaizot, Olivier/0000-0001-9116-3355; Lalubin, Fabrice/0000-0002-1115-7391; Fumagalli, Luca/0000-0002-6648-2570; Christe, Philippe/0000-0002-8605-7002	Swiss National Science Foundation [3100AO_120479, 31003A_138187]; Societe vaudoise d'entomologie	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Societe vaudoise d'entomologie	This study was supported by grants no 3100AO_120479 and 31003A_138187 from the Swiss National Science Foundation and a grant from the Societe vaudoise d'entomologie. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belo NO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017654; Bensch S, 2000, P ROY SOC B-BIOL SCI, V267, P1583, DOI 10.1098/rspb.2000.1181; Bensch S, 2007, J ANIM ECOL, V76, P112, DOI 10.1111/j.1365-2656.2006.01176.x; Bensch S, 2009, MOL ECOL RESOUR, V9, P1353, DOI 10.1111/j.1755-0998.2009.02692.x; Carlson JS, 2011, J VECTOR ECOL, V36, P213, DOI 10.1111/j.1948-7134.2011.00159.x; Cerny O, 2011, MED VET ENTOMOL, V25, P104, DOI 10.1111/j.1365-2915.2010.00875.x; Christe P, 2012, P ROY SOC B-BIOL SCI, V279, P1142, DOI 10.1098/rspb.2011.1546; D'Amico VL, 2010, J ORNITHOL, V151, P951, DOI 10.1007/s10336-010-0566-0; Ejiri H, 2008, J VET MED SCI, V70, P1205, DOI 10.1292/jvms.70.1205; Ejiri H, 2011, J MED ENTOMOL, V48, P904, DOI 10.1603/ME11053; Ejiri H, 2011, J MED ENTOMOL, V48, P600, DOI 10.1603/ME10197; Ejiri H, 2009, PARASITOL RES, V105, P629, DOI 10.1007/s00436-009-1434-9; Fonseca DM, 2000, MOL ECOL, V9, P1803, DOI 10.1046/j.1365-294x.2000.01070.x; Gager AB, 2008, MOL ECOL, V17, P2552, DOI 10.1111/j.1365-294X.2008.03764.x; Garnham PCC., 1966, MALARIA PARASITES OT; Hellgren O, 2007, J PARASITOL, V93, P889, DOI 10.1645/GE-1051R1.1; HUFF CG, 1965, EXP PARASITOL, V16, P107, DOI 10.1016/0014-4894(65)90036-6; Hughes T, 2010, J AM MOSQUITO CONTR, V26, P24, DOI 10.2987/09-5893.1; Ishtiaq F, 2008, MOL ECOL, V17, P4545, DOI 10.1111/j.1365-294X.2008.03935.x; Kim KS, 2010, MOL ECOL, V19, P5545, DOI 10.1111/j.1365-294X.2010.04897.x; Kim KS, 2009, PARASITOL RES, V105, P1351, DOI 10.1007/s00436-009-1568-9; Kimura M, 2010, J PARASITOL, V96, P144, DOI 10.1645/GE-2060.1; Knowles SCL, 2010, J EVOLUTION BIOL, V23, P557, DOI 10.1111/j.1420-9101.2009.01920.x; LaPointe DA, 2010, J PARASITOL, V96, P318, DOI 10.1645/GE-2290.1; LOURENCODEOLIVEIRA R, 1991, MEM I OSWALDO CRUZ, V86, P87, DOI 10.1590/S0074-02761991000100014; Martinez-de la Puente J, 2011, MOL ECOL, V20, P3275, DOI 10.1111/j.1365-294X.2011.05136.x; Martinsen ES, 2008, MOL PHYLOGENET EVOL, V47, P261, DOI 10.1016/j.ympev.2007.11.012; Massey B, 2007, J VECTOR ECOL, V32, P154, DOI 10.3376/1081-1710(2007)32[154:PDOPAB]2.0.CO;2; Megali A, 2011, MOL ECOL, V20, P1039, DOI 10.1111/j.1365-294X.2010.04905.x; MEYER CL, 1976, CAN J ZOOL, V54, P133, DOI 10.1139/z76-014; Njabo KY, 2011, MOL ECOL, V20, P1049, DOI 10.1111/j.1365-294X.2010.04904.x; Njabo KY, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-193; Palinauskas V, 2007, ZOOTAXA, P39, DOI 10.11646/zootaxa.1626.1.3; Reiter ME, 2007, J MED ENTOMOL, V44, P861, DOI 10.1603/0022-2585(2007)44[861:LFITSD]2.0.CO;2; Thiemann TC, 2012, J MED ENTOMOL, V49, P143, DOI 10.1603/ME11134; Tripet F, 2009, PARASITOLOGY, V136, P1935, DOI 10.1017/S0031182009006234; Valkinas G., 2005, AVIAN MALARIA PARASI; Valkiunas G, 2011, MOL ECOL, V20, P3084, DOI 10.1111/j.1365-294X.2011.05187.x; Vezilier J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-379; Vinogradova E.B., 2000, MOSQUITOES CULEX PIP; Waldenstrom J, 2002, MOL ECOL, V11, P1545, DOI 10.1046/j.1365-294X.2002.01523.x; Waldenstrom J, 2004, J PARASITOL, V90, P191, DOI 10.1645/GE-3221RN; Zehtindjiev P, 2012, EUR J WILDLIFE RES, V58, P335, DOI 10.1007/s10344-011-0586-y	43	59	59	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2012	7	4							e34964	10.1371/journal.pone.0034964	http://dx.doi.org/10.1371/journal.pone.0034964			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959FE	22506060	Green Published, Green Submitted, gold			2022-12-27	WOS:000305297500067
J	Satoh, T; Smith, A; Sarde, A; Lu, HC; Mian, S; Trouillet, C; Mufti, G; Emile, JF; Fraternali, F; Donadieu, J; Geissmann, F				Satoh, Takeshi; Smith, Alexander; Sarde, Aurelien; Lu, Hui-chun; Mian, Sophie; Trouillet, Celine; Mufti, Ghulam; Emile, Jean-Francois; Fraternali, Franca; Donadieu, Jean; Geissmann, Frederic			B-RAF Mutant Alleles Associated with Langerhans Cell Histiocytosis, a Granulomatous Pediatric Disease	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; BRAF; EXPRESSION; PROLIFERATION; ACTIVATION; CHILDHOOD; MUTATIONS; DYNAMICS; MELANOMA; LESIONS	Background: Langerhans cell histiocytosis (LCH) features inflammatory granuloma characterised by the presence of CD1a+ dendritic cells or 'LCH cells'. Badalian-Very et al. recently reported the presence of a canonical B-V600E-RAF mutation in 57% of paraffin-embedded biopsies from LCH granuloma. Here we confirm their findings and report the identification of two novel B-RAF mutations detected in LCH patients. Methods and Results: Mutations of B-RAF were observed in granuloma samples from 11 out of 16 patients using 'next generation' pyrosequencing. In 9 cases the mutation identified was B-V600E-RAF. In 2 cases novel polymorphisms were identified. A somatic B-600DLAT-RAF insertion mimicked the structural and functional consequences of the B-V600E-RAF mutant. It destabilized the inactive conformation of the B-RAF kinase and resulted in increased ERK activation in 293 T cells. The B-600DLAT-RAF and B-V600E-RAF mutations were found enriched in DNA and mRNA from the CD1a+ fraction of granuloma. They were absent from the blood and monocytes of 58 LCH patients, with a lower threshold of sequencing sensitivity of 1%-2% relative mutation abundance. A novel germ line B-T599A-RAF mutant allele was detected in one patient, at a relative mutation abundance close to 50% in the LCH granuloma, blood monocytes and lymphocytes. However, B-T599A-RAF did not destabilize the inactive conformation of the B-RAF kinase, and did not induce increased ERK phosphorylation or C-RAF transactivation. Conclusions: Our data confirmed presence of the B-V600E-RAF mutation in LCH granuloma of some patients, and identify two novel B-RAF mutations. They indicate that B-V600E-RAF and B-600DLAT-RAF mutations are somatic mutants enriched in LCH CD1a+ cells and absent from the patient blood. Further studies are needed to assess the functional consequences of the germ-line B-T599A-RAF allele.	[Satoh, Takeshi; Sarde, Aurelien; Trouillet, Celine; Geissmann, Frederic] Kings Coll London, Sch Med, CMCBI, London WC2R 2LS, England; [Smith, Alexander; Mian, Sophie; Mufti, Ghulam] Kings Coll London, Dept Haematol, London WC2R 2LS, England; [Lu, Hui-chun; Fraternali, Franca] Kings Coll London, Randall Div Mol Biophys, London WC2R 2LS, England; [Emile, Jean-Francois] Hop Ambroise Pare, AP HP, Dept Pathol, Paris, France; [Donadieu, Jean] Hop Enfants Armand Trousseau, AP HP, Ctr Reference Histiocytose, Pediat Hematol Unit, Paris, France	University of London; King's College London; University of London; King's College London; University of London; King's College London; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite	Satoh, T (corresponding author), Kings Coll London, Sch Med, CMCBI, London WC2R 2LS, England.	frederic.geissmann@kcl.ac.uk	Fraternali, Franca/D-4410-2011; Fraternali, Franca/C-8912-2009	geissmann, frederic/0000-0001-5029-2468; Mian, Syed Asif/0000-0001-8005-2860; Fraternali, Franca/0000-0002-3143-6574	Histiocytosis Research Trust (HRT); Medical Research Council (UK) [MRC G0900867]; MRC [G0900867] Funding Source: UKRI; Medical Research Council [G0900867] Funding Source: researchfish	Histiocytosis Research Trust (HRT); Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	TS is a fellow of the Japan Society for the Promotion of Science (JSPS) and FG is the Arthritis Research UK Chair of Inflammation Biology, at King's College London. This study was also funded by grants from the Histiocytosis Research Trust (HRT) and MRC G0900867 from the Medical Research Council (UK) to FG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen CE, 2010, J IMMUNOL, V184, P4557, DOI 10.4049/jimmunol.0902336; Annels NE, 2003, J EXP MED, V197, P1385, DOI 10.1084/jem.20030137; Arico M, 1999, BRIT J HAEMATOL, V107, P883, DOI 10.1046/j.1365-2141.1999.01777.x; Badalian-Very G, 2010, BLOOD; Blesa JMG, 2008, CLIN TRANSL ONCOL, V10, P688, DOI 10.1007/s12094-008-0275-9; CECI A, 1993, MED PEDIATR ONCOL, V21, P259, DOI 10.1002/mpo.2950210405; da Costa CET, 2005, J EXP MED, V201, P687, DOI 10.1084/jem.20041785; da Costa CET, 2009, GENE CHROMOSOME CANC, V48, P239, DOI 10.1002/gcc.20634; Dankort D, 2009, NAT GENET, V41, P544, DOI 10.1038/ng.356; de Chadarevian JP, 1998, MED PEDIATR ONCOL, V31, P559, DOI 10.1002/(SICI)1096-911X(199812)31:6<559::AID-MPO27>3.0.CO;2-V; Dhomen N, 2009, CANCER CELL, V15, P294, DOI 10.1016/j.ccr.2009.02.022; Donadieu J, 1996, ARCH DIS CHILD, V75, P17; Egeler RM, 2010, IMMUNOL REV, V234, P213, DOI 10.1111/j.0105-2896.2009.00883.x; Eswar Narayanan, 2008, V426, P145, DOI 10.1007/978-1-60327-058-8_8; Geissmann F, 2001, BLOOD, V97, P1241, DOI 10.1182/blood.V97.5.1241; Grois N, 2005, BRAIN, V128, P829, DOI 10.1093/brain/awh403; Guyot-Goubin A, 2008, PEDIATR BLOOD CANCER, V51, P71, DOI 10.1002/pbc.21498; Heidorn SJ, 2010, CELL, V140, P209, DOI 10.1016/j.cell.2009.12.040; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Kamata T, 2010, CANCER RES, V70, P8475, DOI 10.1158/0008-5472.CAN-10-0603; Madrigal-Martinez-Pereda C, 2009, MED ORAL PATOL ORAL, V14, pE222; Mercer K, 2005, CANCER RES, V65, P11493, DOI 10.1158/0008-5472.CAN-05-2211; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Pollock PM, 2003, NAT GENET, V33, P19, DOI 10.1038/ng1054; Pritchard C, 2007, BIOCHEM SOC T, V35, P1329, DOI 10.1042/BST0351329; Rolland A, 2005, J IMMUNOL, V174, P3067, DOI 10.4049/jimmunol.174.5.3067; Salotti JA, 2009, ARCH DIS CHILD, V94, P376, DOI 10.1136/adc.2008.144527; Senechal B, 2007, PLOS MED, V4, P1374, DOI 10.1371/journal.pmed.0040253; Simossis VA, 2005, NUCLEIC ACIDS RES, V33, pW289, DOI 10.1093/nar/gki390; Stalemark H, 2008, PEDIATR BLOOD CANCER, V51, P76, DOI 10.1002/pbc.21504; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6; Weitzmana S, 2008, CURR OPIN PEDIATR, V20, P23, DOI 10.1097/MOP.0b013e3282f45ba4; Wellbrock C, 2004, NAT REV MOL CELL BIO, V5, P875, DOI 10.1038/nrm1498; WILLMAN CL, 1994, NEW ENGL J MED, V331, P154, DOI 10.1056/NEJM199407213310303; YU RC, 1994, LANCET, V343, P767, DOI 10.1016/S0140-6736(94)91842-2; Zhang BH, 2000, EMBO J, V19, P5429, DOI 10.1093/emboj/19.20.5429	36	109	115	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2012	7	4							e33891	10.1371/journal.pone.0033891	http://dx.doi.org/10.1371/journal.pone.0033891			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959FE	22506009	Green Submitted, gold, Green Published			2022-12-27	WOS:000305297500017
J	Shaw, TA; McGonnell, IM; Driver, CJ; Rusbridge, C; Volk, HA				Shaw, Thomas A.; McGonnell, Imelda M.; Driver, Colin J.; Rusbridge, Clare; Volk, Holger A.			Increase in Cerebellar Volume in Cavalier King Charles Spaniels with Chiari-like Malformation and Its Role in the Development of Syringomyelia	PLOS ONE			English	Article							MACROCEPHALY-CAPILLARY MALFORMATION; OCCIPITAL BONE HYPOPLASIA; CAUDAL CRANIAL FOSSA; I MALFORMATION; PATHOGENESIS; DOGS; HYPOPLASIA/SYRINGOMYELIA; DISEASE; TYPE-1; GROWTH	Previous research in Cavalier King Charles Spaniels (CKCS) has found that Chiari-like malformation and syringomyelia (CM/SM) are associated with a volume mismatch between the caudal cranial fossa (CCF) and the brain parenchyma contained within. The objectives of this study were to i) compare cerebellar volume in CKCS (a 'high risk' group which frequently develops CM/SM), small breed dogs (medium risk - occasionally develop CM/SM), and Labradors (low risk -CM/SM not reported); ii) evaluate a possible association between increased cerebellar volume and CM/SM in CKCS; iii) investigate the relationship between increased cerebellar volume and crowding of the cerebellum in the caudal part of the CCF (i. e. the region of the foramen magnum). Volumes of three-dimensional, magnetic resonance imaging derived models of the CCF and cerebellum were obtained from 75 CKCS, 44 small breed dogs, and 31 Labradors. As SM is thought to be a late onset disease process, two subgroups were formed for comparison: 18 CKCS younger than 2 years with SM (CM/SM group) and 13 CKCS older than 5 years without SM (CM group). Relative cerebellar volume was defined as the volume of the cerebellum divided by the total volume of brain parenchyma. Our results show that the CKCS has a relatively larger cerebellum than small breed dogs and Labradors and provide evidence that increased cerebellar volume in CKCS is associated with crowding of cerebellum in the caudal part of the CCF. In CKCS there is an association between increased cerebellar volume and SM. These findings have implications for the understanding of the pathological mechanisms of CM/SM, and support the hypothesis that it is a multifactorial disease process governed by increased cerebellar volume and failure of the CCF to reach a commensurate size.	[Shaw, Thomas A.; Driver, Colin J.; Volk, Holger A.] Univ London Royal Vet Coll, Dept Vet Clin Sci, Hatfield, Herts, England; [McGonnell, Imelda M.] Univ London Royal Vet Coll, Dept Vet Basic Sci, London, England; [Rusbridge, Clare] Stone Lion Vet Hosp, London, England	University of London; University of London Royal Veterinary College; University of London; University of London Royal Veterinary College	Shaw, TA (corresponding author), Vet Emergency & Referral Grp, Brooklyn, NY USA.	hvolk@rvc.ac.uk	McGonnell, Imelda/AGG-3394-2022; Rusbridge, Clare/K-6560-2019; Rusbridge, Clare/A-3794-2019; Volk, Holger Andreas/B-9965-2011	McGonnell, Imelda/0000-0002-9800-7248; Rusbridge, Clare/0000-0002-3366-2110; Rusbridge, Clare/0000-0002-3366-2110; Volk, Holger Andreas/0000-0002-7312-638X; Driver, Colin/0000-0001-5419-7513	Cavalier Friends; Wellcome Trust	Cavalier Friends; Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by 'Cavalier Friends' and the 'Wellcome Trust'. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALL MJ, 1982, J NEUROL NEUROSUR PS, V45, P753; Bodensteiner JB, 1997, J CHILD NEUROL, V12, P365, DOI 10.1177/088307389701200605; Carrera I, 2009, AM J VET RES, V70, P340, DOI 10.2460/ajvr.70.3.340; Cerda-Gonzalez S, 2009, VET RADIOL ULTRASOUN, V50, P37, DOI 10.1111/j.1740-8261.2008.01487.x; Conway RL, 2007, AM J MED GENET A, V143A, P2981, DOI 10.1002/ajmg.a.32040; Couturier J, 2008, J SMALL ANIM PRACT, V49, P438, DOI 10.1111/j.1748-5827.2008.00578.x; Cross HR, 2009, J SMALL ANIM PRACT, V50, P399, DOI 10.1111/j.1748-5827.2009.00799.x; Dewey C, 2008, KIRKS CURRENT VET TH, P1102; Driver CJ, 2010, VET REC, V167, P978, DOI 10.1136/vr.c4109; Driver CJ, 2010, J SMALL ANIM PRACT, V51, P382, DOI 10.1111/j.1748-5827.2010.00952.x; Evans H. E., 2004, GUIDE DISSECTION DOG; Franklin B, 2009, BRAIN DEV-JPN, V31, P706, DOI 10.1016/j.braindev.2008.10.006; Griffiths PD, 2004, ACTA RADIOL, V45, P236, DOI 10.1080/02841850410003572; Gripp KW, 2010, AM J MED GENET A, V152A, P1161, DOI 10.1002/ajmg.a.33391; Gripp KW, 2009, AM J MED GENET A, V149A, P868, DOI 10.1002/ajmg.a.32732; Jeffery ND, 2011, VET RECORD, V168; Juranek J, 2010, CEREBELLUM, V9, P240, DOI 10.1007/s12311-010-0157-x; Kranioti EF, 2009, ANAT REC, V292, P1764, DOI 10.1002/ar.20997; Levine DN, 2004, J NEUROL SCI, V220, P3, DOI 10.1016/j.jns.2004.01.014; Lewis T, 2010, VET J, V183, P345, DOI 10.1016/j.tvjl.2009.10.022; Lu D, 2003, VET REC, V153, P260, DOI 10.1136/vr.153.9.260; MARINPADILLA M, 1981, J NEUROL SCI, V50, P29, DOI 10.1016/0022-510X(81)90040-X; McBratney-Owen B, 2008, DEV BIOL, V322, P121, DOI 10.1016/j.ydbio.2008.07.016; Milhorat TH, 1999, NEUROSURGERY, V44, P1005, DOI 10.1097/00006123-199905000-00042; Milhorat TH, 2010, ACTA NEUROCHIR, V152, P1117, DOI 10.1007/s00701-010-0636-3; Nishikawa M, 1997, J NEUROSURG, V86, P40, DOI 10.3171/jns.1997.86.1.0040; Noudel R, 2009, J NEUROSURG, V111, P1046, DOI 10.3171/2009.2.JNS08284; Olney Ann Haskins, 2007, Semin Pediatr Neurol, V14, P128, DOI 10.1016/j.spen.2007.07.004; Pareyson D, 2007, J NEUROL, V254, P18; Rusbridge C, 2007, J SMALL ANIM PRACT, V48, P432, DOI 10.1111/j.1748-5827.2007.00344.x; Rusbridge C, 2006, J SMALL ANIM PRACT, V47, P603, DOI 10.1111/j.1748-5827.2006.00048.x; Rusbridge C, 2005, J HERED, V96, P745, DOI 10.1093/jhered/esi074; Rusbridge C, 2004, J VET INTERN MED, V18, P673, DOI 10.1892/0891-6640(2004)18&lt;673:IOOBHC&gt;2.0.CO;2; Rusbridge C, 2003, VET REC, V153, P107, DOI 10.1136/vr.153.4.107; Rusbridge C, 2000, J AM ANIM HOSP ASSOC, V36, P34, DOI 10.5326/15473317-36-1-34; Rusbridge C, 2006, J VET INTERN MED, V20, P469, DOI 10.1892/0891-6640(2006)20[469:SCCIPD]2.0.CO;2; Schmidt MJ, 2009, AM J VET RES, V70, P508, DOI 10.2460/ajvr.70.4.508; Sherwood CC, 2011, P NATL ACAD SCI US; Thames RA, 2010, VET RADIOL ULTRASOUN, V51, P246, DOI 10.1111/j.1740-8261.2009.01655.x; Thomas B, 2007, NEURORADIOLOGY, V49, P733, DOI 10.1007/s00234-007-0241-1; Tidyman WE, 2009, CURR OPIN GENET DEV, V19, P230, DOI 10.1016/j.gde.2009.04.001; Tubbs RS, 2004, PEDIATR NEUROL, V30, P278, DOI 10.1016/j.pediatrneurol.2003.09.013; Yoon G, 2007, DEV MED CHILD NEUROL, V49, P894, DOI 10.1111/j.1469-8749.2007.00894.x	43	34	34	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2012	7	4							e33660	10.1371/journal.pone.0033660	http://dx.doi.org/10.1371/journal.pone.0033660			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959FE	22506005	Green Published, gold, Green Submitted			2022-12-27	WOS:000305297500013
J	Lin, WY; Lee, WC				Lin, Wan-Yu; Lee, Wen-Chung			Improving Power of Genome-Wide Association Studies with Weighted False Discovery Rate Control and Prioritized Subset Analysis	PLOS ONE			English	Article							TYPE-1 DIABETES-MELLITUS; D-RECEPTOR GENE; SINGLE-NUCLEOTIDE POLYMORPHISMS; PROMOTER POLYMORPHISM; RHEUMATOID-ARTHRITIS; ANTIGEN-4 GENE; CTLA4 GENE; PTPN22 POLYMORPHISMS; CELL-ACTIVATION; PD-1 GENE	The issue of large-scale testing has caught much attention with the advent of high-throughput technologies. In genomic studies, researchers are often confronted with a large number of tests. To make simultaneous inference for the many tests, the false discovery rate (FDR) control provides a practical balance between the number of true positives and the number of false positives. However, when few hypotheses are truly non-null, controlling the FDR may not provide additional advantages over controlling the family-wise error rate (e. g., the Bonferroni correction). To facilitate discoveries from a study, weighting tests according to prior information is a promising strategy. A 'weighted FDR control' (WEI) and a 'prioritized subset analysis' (PSA) have caught much attention. In this work, we compare the two weighting schemes with systematic simulation studies and demonstrate their use with a genome-wide association study (GWAS) on type 1 diabetes provided by the Wellcome Trust Case Control Consortium. The PSA and the WEI both can increase power when the prior is informative. With accurate and precise prioritization, the PSA can especially create substantial power improvements over the commonly-used whole-genome single-step FDR adjustment (i.e., the traditional un-weighted FDR control). When the prior is uninformative (true disease susceptibility regions are not prioritized), the power loss of the PSA and the WEI is almost negligible. However, a caution is that the overall FDR of the PSA can be slightly inflated if the prioritization is not accurate and precise. Our study highlights the merits of using information from mounting genetic studies, and provides insights to choose an appropriate weighting scheme to FDR control on GWAS.	[Lin, Wan-Yu; Lee, Wen-Chung] Natl Taiwan Univ, Coll Publ Hlth, Inst Epidemiol & Prevent Med, Taipei 10764, Taiwan; [Lin, Wan-Yu] Univ Alabama Birmingham, Dept Biostat, Birmingham, AL 35294 USA; [Lee, Wen-Chung] Natl Taiwan Univ, Res Ctr Genes Environm & Human Hlth, Taipei 10764, Taiwan	National Taiwan University; University of Alabama System; University of Alabama Birmingham; National Taiwan University	Lin, WY (corresponding author), Natl Taiwan Univ, Coll Publ Hlth, Inst Epidemiol & Prevent Med, Taipei 10764, Taiwan.	wlin@uab.edu		Lee, Wen-Chung/0000-0003-3171-7672; LIN, WAN-YU/0000-0002-3385-4702	Wellcome Trust [076113]; National Science Councils, Taiwan [NSC 99-2628-B-002-061-MY3]	Wellcome Trust(Wellcome Trust); National Science Councils, Taiwan(Ministry of Science and Technology, Taiwan)	Funding for the WTCCC project was provided by the Wellcome Trust under award 076113. This study was partly supported by National Science Councils, Taiwan (NSC 99-2628-B-002-061-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarnisalo J, 2008, J AUTOIMMUN, V31, P13, DOI 10.1016/j.jaut.2008.01.001; Abid HK, 2001, PATHOL BIOL, V49, P794, DOI 10.1016/S0369-8114(01)00246-2; Ahmedov G, 2006, PEDIATR DIABETES, V7, P88, DOI 10.1111/j.1399-543X.2006.00152.x; Alcina A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004137; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Anjos SM, 2004, J CLIN ENDOCR METAB, V89, P6257, DOI 10.1210/jc.2004-0881; Barone B, 2011, EXP CLIN ENDOCR DIAB, V119, P618, DOI 10.1055/s-0031-1280799; Bassuny WM, 2002, IMMUNOGENETICS, V54, P282, DOI 10.1007/s00251-002-0459-3; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bjornvold M, 2008, DIABETOLOGIA, V51, P589, DOI 10.1007/s00125-008-0932-0; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cinek O, 2004, Cas Lek Cesk, V143, P318; Conway BR, 2004, DIABETES, V53, P1162, DOI 10.2337/diabetes.53.4.1162; Dalmasso C, 2008, GENETICS, V180, P697, DOI 10.1534/genetics.108.089839; de Marquesini LGP, 2010, DIABETOLOGIA, V53, P1451, DOI 10.1007/s00125-010-1739-3; De Nanclares GP, 2003, ANN NY ACAD SCI, V1005, P319, DOI 10.1196/annals.1288.050; Dieude P, 2008, ANN RHEUM DIS, V67, P900, DOI 10.1136/ard.2007.077180; Douroudis K, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-11; Douroudis K, 2009, HUM IMMUNOL, V70, P536, DOI 10.1016/j.humimm.2009.04.023; Durrant C, 2004, AM J HUM GENET, V75, P35, DOI 10.1086/422174; Espino-Paisan L, 2011, AUTOIMMUNITY, V44, P624, DOI 10.3109/08916934.2011.592515; Fendler W, 2011, ENDOKRYNOL POL, V62, P436; Fichna M, 2010, INT J IMMUNOGENET, V37, P367, DOI 10.1111/j.1744-313X.2010.00935.x; Fichna M, 2011, TISSUE ANTIGENS; Genovese CR, 2006, BIOMETRIKA, V93, P509, DOI 10.1093/biomet/93.3.509; Guja C, 2004, Rom J Intern Med, V42, P313; Gupta M, 2003, HUM IMMUNOL, V64, P553, DOI 10.1016/S0198-8859(03)00035-1; Hakonarson H, 2007, NATURE, V448, P591, DOI 10.1038/nature06010; HOLM S, 1979, SCAND J STAT, V6, P65; Husain Z, 2008, J AUTOIMMUN, V30, P266, DOI 10.1016/j.jaut.2007.10.006; Ide A, 2003, ANN NY ACAD SCI, V1005, P436, DOI 10.1196/annals.1288.074; Ide A, 2004, J AUTOIMMUN, V22, P73, DOI 10.1016/j.jaut.2003.10.001; Ide A, 2002, HUM IMMUNOL, V63, P690, DOI 10.1016/S0198-8859(02)00417-2; Ihara K, 2001, IMMUNOGENETICS, V53, P447, DOI 10.1007/s002510100351; Iwata I, 1999, DIABETES, V48, P416, DOI 10.2337/diabetes.48.2.416; Jung MH, 2009, J KOREAN MED SCI, V24, P1004, DOI 10.3346/jkms.2009.24.6.1004; Kaas A, 2011, DIABET MED; Kawasaki E, 2006, AM J MED GENET A, V140A, P586, DOI 10.1002/ajmg.a.31124; Kawasaki E, 2008, DIABETES CARE, V31, P1608, DOI 10.2337/dc08-0280; Kikuoka N, 2001, CLIN ENDOCRINOL, V55, P597, DOI 10.1046/j.1365-2265.2001.01397.x; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Klinker MW, 2010, IMMUNOGENETICS, V62, P101, DOI 10.1007/s00251-009-0417-4; Kordonouri O, 2010, HUM IMMUNOL, V71, P731, DOI 10.1016/j.humimm.2010.04.002; Korolija M, 2009, DIABETES RES CLIN PR, V86, pE54, DOI 10.1016/j.diabres.2009.09.012; Ladner MB, 2005, HUM IMMUNOL, V66, P60, DOI 10.1016/j.humimm.2004.09.016; Lavery GG, 2002, EUR J ENDOCRINOL, V146, P553, DOI 10.1530/eje.0.1460553; Lavrikova EY, 2009, MOL BIOL+, V43, P968, DOI 10.1134/S0026893309060089; Lee YJ, 2000, CLIN ENDOCRINOL, V52, P153, DOI 10.1046/j.1365-2265.2000.00929.x; Li C, 2008, BIOINFORMATICS, V24, P140, DOI 10.1093/bioinformatics/btm549; Li C, 2008, HUM HERED, V65, P129, DOI 10.1159/000109730; Lin GT, 2009, STEM CELLS DEV, V18, P1399, DOI 10.1089/scd.2009.0010; Lin WY, 2011, COMPUT STAT DATA AN, V55, P903, DOI 10.1016/j.csda.2010.07.023; Lin Wan-Yu, 2010, BMC Res Notes, V3, P26, DOI 10.1186/1756-0500-3-26; Liu M, 2010, TRENDS ENDOCRIN MET, V21, P652, DOI 10.1016/j.tem.2010.07.001; Liu Q, 2009, INFECT IMMUN, V77, P5347, DOI 10.1128/IAI.01170-08; Maier LM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000322; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Marti G, 2004, MED CLIN-BARCELONA, V123, P286, DOI 10.1016/S0025-7753(04)74494-2; Maziarz M, 2010, GENES IMMUN, V11, P406, DOI 10.1038/gene.2010.12; Metcalfe KA, 1996, HUM IMMUNOL, V51, P41, DOI 10.1016/S0198-8859(96)00206-6; Millioni R, 2008, PROTEOM CLIN APPL, V2, P492, DOI 10.1002/prca.200780112; Millioni R, 2011, J DIABETES COMPLICAT, V25, P114, DOI 10.1016/j.jdiacomp.2010.07.005; Miyako K, 2004, ENDOCR J, V51, P493, DOI 10.1507/endocrj.51.493; Mochizuki M, 2003, DIABETES CARE, V26, P843, DOI 10.2337/diacare.26.3.843; Momin S, 2009, DIABETES RES CLIN PR, V83, P289, DOI 10.1016/j.diabres.2008.12.003; Nejentsev S, 2003, LANCET, V362, P1723, DOI 10.1016/S0140-6736(03)14847-7; Ni RH, 2007, HUM GENET, V121, P223, DOI 10.1007/s00439-006-0309-8; Nielsen C, 2003, TISSUE ANTIGENS, V62, P492, DOI 10.1046/j.1399-0039.2003.00136.x; Nielsen LB, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-41; Nikitin AG, 2010, MOL BIOL+, V44, P228, DOI 10.1134/S002689331002007X; Nishimura M, 2000, HUM IMMUNOL, V61, P507, DOI 10.1016/S0198-8859(00)00101-4; Nishino M, 2005, METABOLISM, V54, P628, DOI 10.1016/j.metabol.2004.12.006; Noso S, 2006, ANN NY ACAD SCI, V1079, P41, DOI 10.1196/annals.1375.006; Noso S, 2010, DIABETES, V59, P2579, DOI 10.2337/db10-0476; Ongagna JC, 2005, CLIN BIOCHEM, V38, P415, DOI 10.1016/j.clinbiochem.2004.12.013; Osei-Hyiaman D, 2001, DIABETES, V50, P2169, DOI 10.2337/diabetes.50.9.2169; Plagnol V, 2010, M S-MED SCI, V26, P236, DOI 10.1051/medsci/2010263236; Qu HQ, 2009, GENES IMMUN, V10, pS42, DOI 10.1038/gene.2009.90; Qu HQ, 2009, GENES IMMUN, V10, pS27, DOI 10.1038/gene.2009.88; Roeder K, 2006, AM J HUM GENET, V78, P243, DOI 10.1086/500026; Rohana A G, 2011, Med J Malaysia, V66, P133; Saccucci P, 2008, TISSUE ANTIGENS, V71, P234, DOI 10.1111/j.1399-0039.2007.00987.x; Saleh Hatem Mohamed, 2008, Indian J Hum Genet, V14, P92, DOI 10.4103/0971-6866.45001; San-Pedro JI, 2005, AUTOIMMUNITY, V38, P439, DOI 10.1080/08916930500288455; Sanda S, 2008, CLIN IMMUNOL, V127, P138, DOI 10.1016/j.clim.2007.12.003; Settin A, 2009, AUTOIMMUNITY, V42, P50, DOI 10.1080/08916930802292510; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Smyth DJ, 2008, DIABETES, V57, P1730, DOI 10.2337/db07-1131; Srinivasan S, 2008, DIABETES, V57, P484, DOI 10.2337/db07-0855; Stechova K, 2011, SCAND J IMMUNOL; Steck AK, 2009, GENES IMMUN, V10, pS21, DOI 10.1038/gene.2009.87; Steck AK, 2006, PEDIATR DIABETES, V7, P274, DOI 10.1111/j.1399-5448.2006.00202.x; Stene LC, 2011, PEDIATR DIABETES, V12, P91, DOI 10.1111/j.1399-5448.2010.00669.x; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Strimmer K, 2008, BIOINFORMATICS, V24, P1461, DOI 10.1093/bioinformatics/btn209; Strimmer K, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-303; Taniyama M, 2010, HUM IMMUNOL, V71, P795, DOI 10.1016/j.humimm.2010.05.016; Taverna MJ, 2005, J CLIN ENDOCR METAB, V90, P4803, DOI 10.1210/jc.2004-2407; Tessier MC, 2006, J MED GENET, V43, P129, DOI 10.1136/jmg.2005.035212; Thompson SD, 2010, ARTHRITIS RHEUM-US, V62, P3265, DOI 10.1002/art.27688; Vella A, 2005, AM J HUM GENET, V76, P773, DOI 10.1086/429843; Wang HJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011789; Wu XP, 2009, CLIN ENDOCRINOL, V71, P46, DOI 10.1111/j.1365-2265.2008.03437.x; Xie Y, 2005, BIOINFORMATICS, V21, P4280, DOI 10.1093/bioinformatics/bti685; Xing C, 2010, AM J HUM GENET, V86, P440, DOI 10.1016/j.ajhg.2010.01.025; Zeggini E, 2011, NAT GENET, V43, P287, DOI 10.1038/ng0411-287; Zhao JH, 2007, J STAT SOFTW, V23; Zhebrun D, 2011, AGING-US, V3, P368, DOI 10.18632/aging.100305; Zhernakova A, 2007, AM J HUM GENET, V81, P1284, DOI 10.1086/522037; Zhu HF, 2008, CELL MOL IMMUNOL, V5, P41, DOI 10.1038/cmi.2008.5	111	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2012	7	4							e33716	10.1371/journal.pone.0033716	http://dx.doi.org/10.1371/journal.pone.0033716			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JO	22496761	Green Published, gold, Green Submitted			2022-12-27	WOS:000305014500015
J	Mantri, N; Olarte, A; Li, CG; Xue, C; Pang, ECK				Mantri, Nitin; Olarte, Alexandra; Li, Chun Guang; Xue, Charlie; Pang, Edwin C. K.			Fingerprinting the Asterid Species Using Subtracted Diversity Array Reveals Novel Species-Specific Sequences	PLOS ONE			English	Article							DNA; PLANTS; MICROARRAY; PHYLOGENY	Background: Asterids is one of the major plant clades comprising of many commercially important medicinal species. One of the major concerns in medicinal plant industry is adulteration/contamination resulting from misidentification of herbal plants. This study reports the construction and validation of a microarray capable of fingerprinting medicinally important species from the Asterids clade. Methodology/Principal Findings: Pooled genomic DNA of 104 non-asterid angiosperm and non-angiosperm species was subtracted from pooled genomic DNA of 67 asterid species. Subsequently, 283 subtracted DNA fragments were used to construct an Asterid-specific array. The validation of Asterid-specific array revealed a high (99.5%) subtraction efficiency. Twenty-five Asterid species (mostly medicinal) representing 20 families and 9 orders within the clade were hybridized onto the array to reveal its level of species discrimination. All these species could be successfully differentiated using their hybridization patterns. A number of species-specific probes were identified for commercially important species like tea, coffee, dandelion, yarrow, motherwort, Japanese honeysuckle, valerian, wild celery, and yerba mate. Thirty-seven polymorphic probes were characterized by sequencing. A large number of probes were novel species-specific probes whilst some of them were from chloroplast region including genes like atpB, rpoB, and ndh that have extensively been used for fingerprinting and phylogenetic analysis of plants. Conclusions/Significance: Subtracted Diversity Array technique is highly efficient in fingerprinting species with little or no genomic information. The Asterid-specific array could fingerprint all 25 species assessed including three species that were not used in constructing the array. This study validates the use of chloroplast genes for bar-coding (fingerprinting) plant species. In addition, this method allowed detection of several new loci that can be explored to solve existing discrepancies in phylogenetics and fingerprinting of plants.	[Mantri, Nitin; Olarte, Alexandra; Pang, Edwin C. K.] RMIT Univ, Hlth Innovat Res Inst, Sch Appl Sci, Melbourne, Vic, Australia; [Li, Chun Guang; Xue, Charlie] RMIT Univ, Hlth Innovat Res Inst, Sch Hlth Sci, Div Chinese Med, Melbourne, Vic, Australia	Royal Melbourne Institute of Technology (RMIT); Royal Melbourne Institute of Technology (RMIT)	Mantri, N (corresponding author), RMIT Univ, Hlth Innovat Res Inst, Sch Appl Sci, Melbourne, Vic, Australia.	nitin.mantri@rmit.edu.au	Xue, Charlie C/F-1244-2014	Li, Chun Guang/0000-0002-7789-2209; Mantri, Nitin/0000-0002-7621-035X; Xue, Charlie/0000-0001-6937-9088	Rural Industries Research and Development Corporation [RMI-18A]	Rural Industries Research and Development Corporation	The authors thank Rural Industries Research and Development Corporation for supporting this research via grant number RMI-18A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albach DC, 2001, ANN MO BOT GARD, V88, P163, DOI 10.2307/2666224; Barthelson RA, 2006, AM J BOT, V93, P566, DOI 10.3732/ajb.93.4.566; Bremer B, 2002, MOL PHYLOGENET EVOL, V24, P274, DOI 10.1016/S1055-7903(02)00240-3; Bremer K, 2004, SYST BIOL, V53, P496, DOI 10.1080/10635150490445913; Chan K, 2003, CHEMOSPHERE, V52, P1361, DOI 10.1016/S0045-6535(03)00471-5; Coelho MRR, 2007, J MICROBIOL BIOTECHN, V17, P753; De Kochko A, 2010, ADV BOT RES, V53, P23, DOI 10.1016/S0065-2296(10)53002-7; Haston E, 2009, BOT J LINN SOC, V161, P128, DOI 10.1111/j.1095-8339.2009.00996.x; Heller-Uszynska K, 2010, MOL BREEDING, V28, P1; Henry RJ, 2001, CABI PUB, Vxiii; Jaccoud D, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.4.e25; James KE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001682; Jayasinghe R, 2007, PLANT BIOTECHNOL J, V5, P282, DOI 10.1111/j.1467-7652.2007.00240.x; Jayasinghe R, 2009, PLANTA MED, V75, P1180, DOI 10.1055/s-0029-1185484; Kapteyn JaS JE, 2002, USE RAPDS ASSESSMENT, P509; Kim W, 2008, J MED MICROBIOL, V57, P279, DOI 10.1099/jmm.0.47642-0; Leonti M, 2003, J ETHNOPHARMACOL, V88, P119, DOI 10.1016/S0378-8741(03)00188-0; Leonti M, 2009, J ETHNOPHARMACOL, V121, P55, DOI 10.1016/j.jep.2008.10.027; Lezar S, 2004, THEOR APPL GENET, V109, P1329, DOI 10.1007/s00122-004-1759-9; Li TX, 2006, J INTEGR PLANT BIOL, V48, P460, DOI 10.1111/j.1744-7909.2006.00249.x; Moerman DE, 1996, J ETHNOPHARMACOL, V52, P1, DOI 10.1016/0378-8741(96)01393-1; Niu LH, 2011, CHIN MED-UK, V6, DOI 10.1186/1749-8546-6-18; Olmstead RG, 2000, MOL PHYLOGENET EVOL, V16, P96, DOI 10.1006/mpev.1999.0769; Rao LS, 2007, GENET RESOUR CROP EV, V54, P1235, DOI 10.1007/s10722-006-9104-6; Techen N, 2004, CURR MED CHEM, V11, P1391, DOI 10.2174/0929867043365206; Tsui CKM, 2008, FEMS YEAST RES, V8, P651, DOI 10.1111/j.1567-1364.2007.00342.x; Vizcaino N, 2000, MICROBES INFECT, V2, P1089, DOI 10.1016/S1286-4579(00)01263-6; Yang SY, 2006, THEOR APPL GENET, V113, P585, DOI 10.1007/s00122-006-0317-z; Zhou JL, 2008, CHIN J CHROMATOGR, V26, P153, DOI 10.1016/S1872-2059(08)60011-5	29	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2012	7	4							e34873	10.1371/journal.pone.0034873	http://dx.doi.org/10.1371/journal.pone.0034873			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JO	22496874	Green Published, Green Submitted, gold			2022-12-27	WOS:000305014500035
J	Kittilsen, S; Johansen, IB; Braastad, BO; Overli, O				Kittilsen, Silje; Johansen, Ida Beitnes; Braastad, Bjarne Olai; Overli, Oyvind			Pigments, Parasites and Personalitiy: Towards a Unifying Role for Steroid Hormones?	PLOS ONE			English	Article							SALMON SALMO-SALAR; BRAIN MONOAMINERGIC ACTIVITY; TROUT ONCORHYNCHUS-MYKISS; ATLANTIC SALMON; RAINBOW-TROUT; LEPEOPHTHEIRUS-SALMONIS; SEA LICE; COHO SALMON; EXPERIMENTAL-INFECTION; STRESS RESPONSIVENESS	A surging interest in the evolution of consistent trait correlations has inspired research on pigment patterns as a correlate of behavioural syndromes, or "animal personalities". Associations between pigmentation, physiology and health status are less investigated as potentially conserved trait clusters. In the current study, lice counts performed on farmed Atlantic salmon Salmo salar naturally infected with ectoparasitic sea lice Lepeophtheirus salmonis showed that individual fish with high incidence of black melanin-based skin spots harboured fewer female sea lice carrying egg sacs, compared to less pigmented fish. There was no significant association between pigmentation and lice at other developmental stages, suggesting that host factors associated with melanin-based pigmentation may modify ectoparasite development to a larger degree than settlement. In a subsequent laboratory experiment a strong negative correlation between skin spots and post-stress cortisol levels was revealed, with less pigmented individuals showing a more pronounced cortisol response to acute stress. The observation that lice prevalence was strongly increased on a fraction of sexually mature male salmon which occurred among the farmed fish further supports a role for steroid hormones as mediators of reduced parasite resistance. The data presented here propose steroid hormones as a proximate cause for the association between melanin-based pigmentation and parasites. Possible fundamental and applied implications are discussed.	[Kittilsen, Silje; Braastad, Bjarne Olai; Overli, Oyvind] Norwegian Univ Life Sci, Dept Anim & Aquacultural Sci, As, Norway; [Johansen, Ida Beitnes] Univ Oslo, Dept Mol Biosci, Oslo, Norway	Norwegian University of Life Sciences; University of Oslo	Kittilsen, S (corresponding author), Norwegian Univ Life Sci, Dept Anim & Aquacultural Sci, As, Norway.	oyvind.overli@umb.no	Johansen, Ida Beitnes/W-3766-2019		Research Council of Norway [172609]	Research Council of Norway(Research Council of Norway)	Funding provided by the Research Council of Norway (www.rcn.no). Project no. 172609: Selection for reduced stress responsiveness in Atlantic salmon (Salmo salar). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almasi B, 2010, J EVOLUTION BIOL, V23, P987, DOI 10.1111/j.1420-9101.2010.01969.x; Bakke TA, 1998, CAN J FISH AQUAT SCI, V55, P247, DOI 10.1139/cjfas-55-S1-247; Barber I, 2010, PHILOS T R SOC B, V365, P4077, DOI 10.1098/rstb.2010.0182; BISBAL GA, 1991, J FISH BIOL, V39, P421, DOI 10.1111/j.1095-8649.1991.tb04373.x; Cesarini JP, 1996, ADV SPACE RES, V18, P35, DOI 10.1016/0273-1177(96)00025-7; Chakarov N, 2008, FUNCT ECOL, V22, P1062, DOI 10.1111/j.1365-2435.2008.01460.x; Clotfelter ED, 2007, BEHAV ECOL, V18, P1139, DOI 10.1093/beheco/arm090; Costello MJ, 2006, TRENDS PARASITOL, V22, P475, DOI 10.1016/j.pt.2006.08.006; Costello MJ, 2009, P ROY SOC B-BIOL SCI, V276, P3385, DOI 10.1098/rspb.2009.0771; Da Silva JAP, 1999, ANN NY ACAD SCI, V876, P102; Dawson LHJ, 1997, ICES J MAR SCI, V54, P1129, DOI 10.1016/S1054-3139(97)80018-5; Ruiz-Gomez MD, 2011, PHYSIOL BEHAV, V102, P317, DOI 10.1016/j.physbeh.2010.11.023; Denholm I, 2002, PEST MANAG SCI, V58, P528, DOI 10.1002/ps.482; DiBattista JD, 2005, J EXP BIOL, V208, P2707, DOI 10.1242/jeb.01690; Ducrest AL, 2008, TRENDS ECOL EVOL, V23, P502, DOI 10.1016/j.tree.2008.06.001; Fast MD, 2006, FISH SHELLFISH IMMUN, V21, P228, DOI 10.1016/j.fsi.2005.11.010; Fast MD, 2002, DIS AQUAT ORGAN, V52, P57, DOI 10.3354/dao052057; FITZPATRICK MS, 1986, GEN COMP ENDOCR, V62, P437, DOI 10.1016/0016-6480(86)90054-7; FOLSTAD I, 1992, AM NAT, V139, P603, DOI 10.1086/285346; Galeotti P, 2003, J ZOOL, V261, P91, DOI 10.1017/S0952836903003960; Garcia de Leaniz C, 2007, BIOL REV, V82, P173, DOI 10.1111/j.1469-185X.2006.00004.x; Gasparini J, 2009, J ANIM ECOL, V78, P608, DOI 10.1111/j.1365-2656.2008.01521.x; Gjerde B, 2011, AQUACULTURE, V314, P66, DOI 10.1016/j.aquaculture.2011.01.026; Harris J, 2000, VET IMMUNOL IMMUNOP, V77, P163, DOI 10.1016/S0165-2427(00)00235-X; HILL HZ, 1992, BIOESSAYS, V14, P49, DOI 10.1002/bies.950140111; Hoglund E, 2000, J EXP BIOL, V203, P1711; Horth L, 2003, P ROY SOC B-BIOL SCI, V270, P1033, DOI 10.1098/rspb.2003.2348; Hutchings JA, 1998, CAN J FISH AQUAT SCI, V55, P22, DOI 10.1139/cjfas-55-S1-22; Jacquin L, 2011, J AVIAN BIOL, V42, P11, DOI 10.1111/j.1600-048X.2010.05120.x; JARVI T, 1984, ANIM BEHAV, V32, P590, DOI 10.1016/S0003-3472(84)80296-1; Jawor JM, 2003, AUK, V120, P249, DOI 10.1642/0004-8038(2003)120[0249:MOHASS]2.0.CO;2; Johnson PTJ, 2007, P NATL ACAD SCI USA, V104, P15781, DOI 10.1073/pnas.0707763104; JOHNSON SC, 1991, CAN J ZOOL, V69, P929, DOI 10.1139/z91-138; JOHNSON SC, 1992, DIS AQUAT ORGAN, V14, P195, DOI 10.3354/dao014195; JOHNSON SC, 1992, DIS AQUAT ORGAN, V14, P179, DOI 10.3354/dao014179; Jones SRM, 2007, DIS AQUAT ORGAN, V75, P229, DOI 10.3354/dao075229; Kittilsen S, 2009, HORM BEHAV, V56, P292, DOI 10.1016/j.yhbeh.2009.06.006; Klein SL, 2004, PARASITE IMMUNOL, V26, P247, DOI 10.1111/j.0141-9838.2004.00710.x; Koolhaas JM, 1999, NEUROSCI BIOBEHAV R, V23, P925, DOI 10.1016/S0149-7634(99)00026-3; Korte SM, 2005, NEUROSCI BIOBEHAV R, V29, P3, DOI 10.1016/j.neubiorev.2004.08.009; Kortet R, 2010, ECOL LETT, V13, P1449, DOI 10.1111/j.1461-0248.2010.01536.x; Krkosek M, 2007, SCIENCE, V318, P1772, DOI 10.1126/science.1148744; Leclercq E, 2010, FISH FISH, V11, P159, DOI 10.1111/j.1467-2979.2009.00346.x; Lees F, 2008, J FISH DIS, V31, P947, DOI 10.1111/j.1365-2761.2008.00969.x; MacKinnon BM, 1998, ICES J MAR SCI, V55, P188, DOI 10.1006/jmsc.1997.0361; Mackintosh JA, 2001, J THEOR BIOL, V211, P101, DOI 10.1006/jtbi.2001.2331; Mafli A, 2011, ANIM BEHAV, V81, P859, DOI 10.1016/j.anbehav.2011.01.025; Maule AG, 1996, FISH SHELLFISH IMMUN, V6, P221, DOI 10.1006/fsim.1996.0022; MCBRIDE JR, 1986, J FISH BIOL, V29, P153, DOI 10.1111/j.1095-8649.1986.tb04934.x; McEwen BS, 1997, BRAIN RES REV, V23, P79, DOI 10.1016/S0165-0173(96)00012-4; McGraw KJ, 2008, PIGM CELL MELANOMA R, V21, P133, DOI 10.1111/j.1755-148X.2008.00454.x; McGraw KJ, 2003, AM NAT, V162, P704, DOI 10.1086/378904; McKenzie VJ, 2007, ECOHEALTH, V4, P384, DOI 10.1007/s10393-007-0131-3; McKinnon JS, 2010, MOL ECOL, V19, P5101, DOI 10.1111/j.1365-294X.2010.04846.x; Mommsen TP, 1999, REV FISH BIOL FISHER, V9, P211, DOI 10.1023/A:1008924418720; MOSER M, 1991, J PARASITOL, V77, P551, DOI 10.2307/3283158; NAPPI AJ, 1993, PIGM CELL RES, V6, P117, DOI 10.1111/j.1600-0749.1993.tb00590.x; Overli O, 2006, PHYSIOL BEHAV, V87, P506, DOI 10.1016/j.physbeh.2005.11.012; Overli O, 2002, J EXP BIOL, V205, P391; Overli O, 2002, HORM BEHAV, V42, P53, DOI 10.1006/hbeh.2002.1796; Overli O, 2001, BRAIN BEHAV EVOLUT, V57, P214, DOI 10.1159/000047238; Overli O, 2007, NEUROSCI BIOBEHAV R, V31, P396, DOI 10.1016/j.neubiorev.2006.10.006; Parejo D, 2011, J AVIAN BIOL, V42, P49, DOI 10.1111/j.1600-048X.2010.05235.x; Pfaff DW, 2009, HORMONES, BRAIN AND BEHAVIOR, VOLS 1-5, 2ND EDITION, P1; Pottinger TG, 1999, GEN COMP ENDOCR, V116, P122, DOI 10.1006/gcen.1999.7355; Pottinger TG, 2001, HORM BEHAV, V40, P419, DOI 10.1006/hbeh.2001.1707; Roulin A, 2001, BEHAV ECOL, V12, P103, DOI 10.1093/oxfordjournals.beheco.a000371; Roulin A, 2008, BEHAV ECOL SOCIOBIOL, V62, P507, DOI 10.1007/s00265-007-0475-2; Roulin A, 2004, BIOL REV, V79, P815, DOI 10.1017/S1464793104006487; Ruiz-Gomez MD, 2008, HORM BEHAV, V54, P534, DOI 10.1016/j.yhbeh.2008.05.005; Schjolden J, 2007, BRAIN BEHAV EVOLUT, V70, P227, DOI 10.1159/000105486; Schoech SJ, 2011, CURR ZOOL, V57, P514, DOI 10.1093/czoolo/57.4.514; Siva-Jothy MT, 2000, P ROY SOC B-BIOL SCI, V267, P2523, DOI 10.1098/rspb.2000.1315; Skugor S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-498; Tadiso TM, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-141; Taranger GL, 2010, GEN COMP ENDOCR, V165, P483, DOI 10.1016/j.ygcen.2009.05.004; Thorpe JE, 2007, MAR ECOL PROG SER, V335, P285, DOI 10.3354/meps335285; Tobler M, 2008, ENVIRON BIOL FISH, V81, P29, DOI 10.1007/s10641-006-9153-x; TULLY O, 1993, FISH RES, V17, P187, DOI 10.1016/0165-7836(93)90018-3; Vinkler M, 2010, NATURWISSENSCHAFTEN, V97, P19, DOI 10.1007/s00114-009-0595-9; von Schantz T, 1999, P ROY SOC B-BIOL SCI, V266, P1, DOI 10.1098/rspb.1999.0597; Wedekind C, 2008, P ROY SOC B-BIOL SCI, V275, P1737, DOI 10.1098/rspb.2008.0072; West PM, 2002, SCIENCE, V297, P1339, DOI 10.1126/science.1073257; Weyts FAA, 1999, FISH SHELLFISH IMMUN, V9, P1, DOI 10.1006/fsim.1998.0170; YOUNGSON AF, 1988, AQUACULTURE, V69, P145, DOI 10.1016/0044-8486(88)90193-7	85	42	43	1	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2012	7	4							e34281	10.1371/journal.pone.0034281	http://dx.doi.org/10.1371/journal.pone.0034281			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JA	22493685	Green Published, gold, Green Submitted			2022-12-27	WOS:000305012700027
J	Lahnakoski, JM; Salmi, J; Jaaskelainen, IP; Lampinen, J; Glerean, E; Tikka, P; Sams, M				Lahnakoski, Juha M.; Salmi, Juha; Jaaskelainen, Iiro P.; Lampinen, Jouko; Glerean, Enrico; Tikka, Pia; Sams, Mikko			Stimulus-Related Independent Component and Voxel-Wise Analysis of Human Brain Activity during Free Viewing of a Feature Film	PLOS ONE			English	Article							AUDITORY-CORTEX; NATURAL STIMULI; MOTION; PERCEPTION; NETWORKS; PREMOTOR; LANGUAGE; VISION; SYSTEM; ROBUST	Understanding how the brain processes stimuli in a rich natural environment is a fundamental goal of neuroscience. Here, we showed a feature film to 10 healthy volunteers during functional magnetic resonance imaging (fMRI) of hemodynamic brain activity. We then annotated auditory and visual features of the motion picture to inform analysis of the hemodynamic data. The annotations were fitted to both voxel-wise data and brain network time courses extracted by independent component analysis (ICA). Auditory annotations correlated with two independent components (IC) disclosing two functional networks, one responding to variety of auditory stimulation and another responding preferentially to speech but parts of the network also responding to non-verbal communication. Visual feature annotations correlated with four ICs delineating visual areas according to their sensitivity to different visual stimulus features. In comparison, a separate voxel-wise general linear model based analysis disclosed brain areas preferentially responding to sound energy, speech, music, visual contrast edges, body motion and hand motion which largely overlapped the results revealed by ICA. Differences between the results of IC- and voxel-based analyses demonstrate that thorough analysis of voxel time courses is important for understanding the activity of specific sub-areas of the functional networks, while ICA is a valuable tool for revealing novel information about functional connectivity which need not be explained by the predefined model. Our results encourage the use of naturalistic stimuli and tasks in cognitive neuroimaging to study how the brain processes stimuli in rich natural environments.	[Lahnakoski, Juha M.; Salmi, Juha; Jaaskelainen, Iiro P.; Lampinen, Jouko; Glerean, Enrico; Sams, Mikko] Aalto Univ, Sch Sci, Dept BECS, Brain & Mind Lab, Espoo, Finland; [Lahnakoski, Juha M.] Aalto Univ, Sch Sci, AMI Ctr, Espoo, Finland; [Tikka, Pia] Aalto Univ, Sch Arts Design & Architecture, Dept Mot Picture Televis & Prod Design, Helsinki, Finland	Aalto University; Aalto University; Aalto University	Lahnakoski, JM (corresponding author), Aalto Univ, Sch Sci, Dept BECS, Brain & Mind Lab, Espoo, Finland.	juha.lahnakoski@aalto.fi	Jaaskelainen, Iiro P/C-7392-2012; Lahnakoski, Juha/G-2072-2012; Salmi, Juha/G-7049-2012; Lahnakoski, Juha/AAB-1850-2022; Lampinen, Jouko/D-3927-2014; Tikka, Pia/J-1907-2012; Sams, Mikko E/G-7060-2012; Glerean, Enrico/C-6384-2011	Jaaskelainen, Iiro P/0000-0001-6001-6950; Lahnakoski, Juha/0000-0002-5223-7822; Salmi, Juha/0000-0001-5623-6598; Lahnakoski, Juha/0000-0002-5223-7822; Glerean, Enrico/0000-0003-0624-675X	Aalto University; Academy of Finland [129670, 130412, 138145]	Aalto University; Academy of Finland(Academy of Finland)	This work is supported by aivoAALTO research project of Aalto University (http://neuro.hut.fi/aivoaalto/contact.html), and Academy of Finland [grant numbers 129670, 130412, 138145] (http://www.aka.fi/eng). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartels A, 2008, CEREB CORTEX, V18, P705, DOI 10.1093/cercor/bhm107; Bartels A, 2004, NEUROIMAGE, V22, P419, DOI 10.1016/j.neuroimage.2004.01.007; BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; Brown S, 2008, CEREB CORTEX, V18, P837, DOI 10.1093/cercor/bhm131; Brown S, 2007, BRAIN COGNITION, V63, P59, DOI 10.1016/j.bandc.2006.08.006; Buccino G, 2004, BRAIN LANG, V89, P370, DOI 10.1016/S0093-934X(03)00356-0; Buccino G, 2001, EUR J NEUROSCI, V13, P400, DOI 10.1046/j.1460-9568.2001.01385.x; Calhoun VD, 2001, HUM BRAIN MAPP, V13, P43, DOI 10.1002/hbm.1024; Corbetta M, 2008, NEURON, V58, P306, DOI 10.1016/j.neuron.2008.04.017; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; David SV, 2009, J NEUROSCI, V29, P3374, DOI 10.1523/JNEUROSCI.5249-08.2009; Hari R, 2009, PHYSIOL REV, V89, P453, DOI 10.1152/physrev.00041.2007; Hart HC, 2002, HEARING RES, V171, P177, DOI 10.1016/S0378-5955(02)00498-7; Hasson U, 2004, SCIENCE, V303, P1634, DOI 10.1126/science.1089506; Hasson U, 2010, TRENDS COGN SCI, V14, P40, DOI 10.1016/j.tics.2009.10.011; Himberg J, 2003, 2003 IEEE XIII WORKSHOP ON NEURAL NETWORKS FOR SIGNAL PROCESSING - NNSP'03, P259, DOI 10.1109/NNSP.2003.1318025; Himberg J, 2004, NEUROIMAGE, V22, P1214, DOI 10.1016/j.neuroimage.2004.03.027; Hyvarinen A, 2000, NEURAL NETWORKS, V13, P411, DOI 10.1016/S0893-6080(00)00026-5; Jaaskelainen Iiro P, 2008, Open Neuroimag J, V2, P14, DOI 10.2174/1874440000802010014; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Kauppi J- P, 2010, INF TECHN APPL BIOM, P1, DOI [10.1109/ITAB.2010.5687650, DOI 10.1109/ITAB.2010.5687650]; Lartillot O., 2007, INT C DIG AUD EFF, P237; Lerner Y, 2011, J NEUROSCI, V31, P2906, DOI 10.1523/JNEUROSCI.3684-10.2011; Peeters R, 2009, J NEUROSCI, V29, P11523, DOI 10.1523/JNEUROSCI.2040-09.2009; Rauschecker JP, 2009, NAT NEUROSCI, V12, P718, DOI 10.1038/nn.2331; Salmi J, 2009, BRAIN RES, V1286, P155, DOI 10.1016/j.brainres.2009.06.083; Saur D, 2008, P NATL ACAD SCI USA, V105, P18035, DOI 10.1073/pnas.0805234105; Schon D, 2010, NEUROIMAGE, V51, P450, DOI 10.1016/j.neuroimage.2010.02.023; Schultz J, 2009, EXP BRAIN RES, V194, P465, DOI 10.1007/s00221-009-1721-9; Scott SK, 2003, TRENDS NEUROSCI, V26, P100, DOI 10.1016/S0166-2236(02)00037-1; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Spiers HJ, 2007, TRENDS COGN SCI, V11, P356, DOI 10.1016/j.tics.2007.06.002; Stephens GJ, 2010, P NATL ACAD SCI USA, V107, P14425, DOI 10.1073/pnas.1008662107; Woolrich MW, 2009, NEUROIMAGE, V45, pS173, DOI 10.1016/j.neuroimage.2008.10.055; Ylipaavalniemi J, 2009, NEUROIMAGE, V48, P176, DOI 10.1016/j.neuroimage.2009.03.056	36	41	41	3	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2012	7	4							e35215	10.1371/journal.pone.0035215	http://dx.doi.org/10.1371/journal.pone.0035215			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955IH	22496909	Green Published, gold, Green Submitted			2022-12-27	WOS:000305010500034
J	Lin, YT; Liu, CM; Chiu, MJ; Liu, CC; Chien, YL; Hwang, TJ; Jaw, FS; Shan, JC; Hsieh, MH; Hwu, HG				Lin, Yi-Ting; Liu, Chih-Min; Chiu, Ming-Jang; Liu, Chen-Chung; Chien, Yi-Ling; Hwang, Tzung-Jeng; Jaw, Fu-Shan; Shan, Jia-Chi; Hsieh, Ming H.; Hwu, Hai-Gwo			Differentiation of Schizophrenia Patients from Healthy Subjects by Mismatch Negativity and Neuropsychological Tests	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; OBSESSIVE-COMPULSIVE DISORDER; AUDITORY SENSORY MEMORY; ELECTROPHYSIOLOGICAL INDEXES; COGNITIVE IMPAIRMENT; SELECTIVE-ATTENTION; DEFICITS; BRAIN; DURATION; MMN	Background: Schizophrenia is a heterogeneous disorder with diverse presentations. The current and the proposed DSM-V diagnostic system remains phenomenologically based, despite the fact that several neurobiological and neuropsychological markers have been identified. A multivariate approach has better diagnostic utility than a single marker method. In this study, the mismatch negativity (MMN) deficit of schizophrenia was first replicated in a Han Chinese population, and then the MMN was combined with several neuropsychological measurements to differentiate schizophrenia patients from healthy subjects. Methodology/Principal Findings: 120 schizophrenia patients and 76 healthy controls were recruited. Each subject received examinations for duration MMN, Continuous Performance Test, Wisconsin Card Sorting Test, and Wechsler Adult Intelligence Scale Third Edition (WAIS-III). The MMN was compared between cases and controls, and important covariates were investigated. Schizophrenia patients had significantly reduced MMN amplitudes, and MMN decreased with increasing age in both patient and control groups. None of the neuropsychological indices correlated with MMN. Predictive multivariate logistic regression models using the MMN and neuropsychological measurements as predictors were developed. Four predictors, including MMN at electrode FCz and three scores from the WAIS-III (Arithmetic, Block Design, and Performance IQ) were retained in the final predictive model. The model performed well in differentiating patients from healthy subjects (percentage of concordant pairs: 90.5%). Conclusions/Significance: MMN deficits were found in Han Chinese schizophrenia patients. The multivariate approach combining biomarkers from different modalities such as electrophysiology and neuropsychology had a better diagnostic utility.	[Lin, Yi-Ting; Hsieh, Ming H.] Natl Taiwan Univ Hosp, Dept Psychiat, Yun Lin Branch, Dou Liou City, Yun Lin, Taiwan; [Liu, Chih-Min; Liu, Chen-Chung; Chien, Yi-Ling; Hwang, Tzung-Jeng; Shan, Jia-Chi; Hsieh, Ming H.; Hwu, Hai-Gwo] Natl Taiwan Univ Hosp, Dept Psychiat, Taipei, Taiwan; [Liu, Chih-Min; Liu, Chen-Chung; Chien, Yi-Ling; Hwang, Tzung-Jeng; Shan, Jia-Chi; Hsieh, Ming H.; Hwu, Hai-Gwo] Natl Taiwan Univ, Coll Med, Taipei 10764, Taiwan; [Liu, Chih-Min; Chiu, Ming-Jang; Liu, Chen-Chung; Hwang, Tzung-Jeng; Jaw, Fu-Shan; Hsieh, Ming H.; Hwu, Hai-Gwo] Natl Taiwan Univ, Neurobiol & Cognit Sci Ctr, Taipei 10764, Taiwan; [Chiu, Ming-Jang] Natl Taiwan Univ Hosp, Dept Neurol, Taipei, Taiwan; [Jaw, Fu-Shan; Hsieh, Ming H.] Natl Taiwan Univ, Inst Biomed Engn, Taipei 10764, Taiwan; [Shan, Jia-Chi] Cathay Gen Hosp, Dept Psychiat, Taipei, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; Cathay General Hospital	Lin, YT (corresponding author), Natl Taiwan Univ Hosp, Dept Psychiat, Yun Lin Branch, Dou Liou City, Yun Lin, Taiwan.	mingh@ntuh.gov.tw	Chiu, Ming-Jang/AAR-3940-2020; H.Hsieh, Ming/B-2970-2010; Hwang, TJ/K-4768-2019	Chiu, Ming-Jang/0000-0002-4158-4423; H.Hsieh, Ming/0000-0002-3585-7843; LIU, CHEN-CHUNG/0000-0002-9290-110X; HWU, HAI-GWO/0000-0002-2582-2807; CHIEN, YI-LING/0000-0002-3477-3015; LIU, CHIH-MIN/0000-0001-7016-8990; Shan, Jia-Chi/0000-0002-2852-8224; Hwang, Tzung-Jeng/0000-0001-7894-9484; Lin, Yi-Ting/0000-0003-3821-4744	National Science Council, Taiwan [NSC -98-2314-B-002-047-MY3, NSC-96-3112-B-002-039-]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by the National Science Council, Taiwan (NSC -98-2314-B-002-047-MY3, NSC-96-3112-B-002-039-). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson S, 2008, BIPOLAR DISORD, V10, P888, DOI 10.1111/j.1399-5618.2008.00638.x; Andreasen N C, 1990, Mod Probl Pharmacopsychiatry, V24, P73; Andreasen NC, 2010, BIOL PSYCHIAT, V67, P255, DOI 10.1016/j.biopsych.2009.08.040; Baldeweg T, 2004, SCHIZOPHR RES, V69, P203, DOI 10.1016/j.schres.2003.09.009; Bora E, 2010, SCHIZOPHRENIA BULL, V36, P36, DOI 10.1093/schbul/sbp094; Brockhaus-Dumke A, 2005, SCHIZOPHR RES, V73, P297, DOI 10.1016/j.schres.2004.05.016; CATTS SV, 1995, AM J PSYCHIAT, V152, P213; Chen WJ, 1998, SCHIZOPHRENIA BULL, V24, P163, DOI 10.1093/oxfordjournals.schbul.a033308; Chen WJ, 1998, AM J PSYCHIAT, V155, P1214, DOI 10.1176/ajp.155.9.1214; Cooper RJ, 2006, NEUROBIOL AGING, V27, P752, DOI 10.1016/j.neurobiolaging.2005.03.012; CZIGLER I, 1992, BIOL PSYCHOL, V33, P195, DOI 10.1016/0301-0511(92)90031-O; Dickinson D, 2007, ARCH GEN PSYCHIAT, V64, P532, DOI 10.1001/archpsyc.64.5.532; GEREZ M, 1995, BIOL PSYCHIAT, V38, P34, DOI 10.1016/0006-3223(94)00205-H; Heaton R.K., 1993, WISCONSIN CARD SORTI; Heinrichs RW, 1998, NEUROPSYCHOLOGY, V12, P426, DOI 10.1037/0894-4105.12.3.426; Hill SK, 2010, EXPERT REV NEUROTHER, V10, P43, DOI 10.1586/ERN.09.143; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Jansson-Verkasalo E, 2003, NEUROSCI LETT, V338, P197, DOI 10.1016/S0304-3940(02)01405-2; Javitt DC, 2000, ARCH GEN PSYCHIAT, V57, P1131, DOI 10.1001/archpsyc.57.12.1131; Kasai K, 2002, CLIN NEUROPHYSIOL, V113, P141, DOI 10.1016/S1388-2457(01)00710-6; Kawakubo Y, 2006, NEUROREPORT, V17, P1043, DOI 10.1097/01.wnr.0000221828.10846.ba; Keefe RSE, 1999, SCHIZOPHRENIA BULL, V25, P201, DOI 10.1093/oxfordjournals.schbul.a033374; Keshavan MS, 2008, SCHIZOPHR RES, V106, P89, DOI 10.1016/j.schres.2008.07.020; Kiang M, 2009, CLIN NEUROPHYSIOL, V120, P1949, DOI 10.1016/j.clinph.2009.08.019; Kisley MA, 2005, COGNITIVE BRAIN RES, V25, P913, DOI 10.1016/j.cogbrainres.2005.09.014; Korostenskaja M, 2005, PROG NEURO-PSYCHOPH, V29, P543, DOI 10.1016/j.pnpbp.2005.01.019; Lepisto T, 2006, CLIN NEUROPHYSIOL, V117, P2161, DOI 10.1016/j.clinph.2006.06.709; Lepisto T, 2007, NEUROSCI LETT, V414, P136, DOI 10.1016/j.neulet.2006.12.009; Leung S, 2007, PSYCHOPHARMACOLOGY, V194, P443, DOI 10.1007/s00213-007-0865-1; Light GA, 2005, AM J PSYCHIAT, V162, P1741, DOI 10.1176/appi.ajp.162.9.1741; Light GA, 2005, ARCH GEN PSYCHIAT, V62, P127, DOI 10.1001/archpsyc.62.2.127; Light Gregory A, 2010, Curr Protoc Neurosci, VChapter 6, DOI 10.1002/0471142301.ns0625s52; Lin SH, 2011, SCHIZOPHR B IN PRESS; Magno E, 2008, BIOL PSYCHIAT, V64, P385, DOI 10.1016/j.biopsych.2008.03.019; Michie PT, 2002, BIOL PSYCHIAT, V52, P749, DOI 10.1016/S0006-3223(02)01379-3; Murakami T, 2002, PROG NEURO-PSYCHOPH, V26, P651, DOI 10.1016/S0278-5846(01)00302-5; Naatanen R, 2007, CLIN NEUROPHYSIOL, V118, P2544, DOI 10.1016/j.clinph.2007.04.026; NAATANEN R, 1978, ACTA PSYCHOL, V42, P313, DOI 10.1016/0001-6918(78)90006-9; Naatanen R, 1999, PSYCHOL BULL, V125, P826, DOI 10.1037/0033-2909.125.6.826; Nakagome K, 1998, NEUROPSYCHOBIOLOGY, V38, P232, DOI 10.1159/000026547; Oades RD, 1997, BIOL PSYCHIAT, V41, P1196, DOI 10.1016/S0006-3223(96)00214-4; Oades RD, 1996, INT J PSYCHOPHYSIOL, V22, P185, DOI 10.1016/0167-8760(96)00026-8; Oranje B, 2008, INT J NEUROPSYCHOPH, V11, P453, DOI 10.1017/S1461145707008176; Palmer BW, 2009, NEUROPSYCHOL REV, V19, P365, DOI 10.1007/s11065-009-9109-y; Pardo PJ, 2006, SCHIZOPHR RES, V87, P297, DOI 10.1016/j.schres.2006.05.007; Pekkonen E, 1996, EXP AGING RES, V22, P171, DOI 10.1080/03610739608254005; Pekkonen E, 2000, AUDIOL NEURO-OTOL, V5, P216, DOI 10.1159/000013883; Price GW, 2006, BIOL PSYCHIAT, V60, P1, DOI 10.1016/j.biopsych.2005.09.010; Rosburg T, 2004, NEUROPSYCHOPHARMACOL, V29, P1723, DOI 10.1038/sj.npp.1300477; Rosner B., 2006, FUNDAMENTALS BIOSTAT; Ruzzoli M, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.03.021; Salisbury DF, 2007, ARCH GEN PSYCHIAT, V64, P521, DOI 10.1001/archpsyc.64.5.521; Salisbury DF, 2002, ARCH GEN PSYCHIAT, V59, P686, DOI 10.1001/archpsyc.59.8.686; Schall U, 1998, INT J NEUROPSYCHOP, V1, P19, DOI 10.1017/S146114579800100X; SEMLITSCH HV, 1986, PSYCHOPHYSIOLOGY, V23, P695, DOI 10.1111/j.1469-8986.1986.tb00696.x; Shinozaki N, 2002, BIOL PSYCHOL, V59, P105, DOI 10.1016/S0301-0511(01)00129-6; Takei Y, 2010, PROG NEURO-PSYCHOPH, V34, P903, DOI 10.1016/j.pnpbp.2010.04.014; Todd J, 2008, BIOL PSYCHIAT, V63, P58, DOI 10.1016/j.biopsych.2007.02.016; TOWEY JP, 1994, PSYCHOPHYSIOLOGY, V31, P535, DOI 10.1111/j.1469-8986.1994.tb02346.x; Toyomaki A, 2008, PROG NEURO-PSYCHOPH, V32, P95, DOI 10.1016/j.pnpbp.2007.07.020; Turetsky BI, 2007, SCHIZOPHRENIA BULL, V33, P69, DOI 10.1093/schbul/sbl060; Umbricht D, 1998, BIOL PSYCHIAT, V44, P716, DOI 10.1016/S0006-3223(97)00524-6; Umbricht D, 2005, SCHIZOPHR RES, V76, P1, DOI 10.1016/j.schres.2004.12.002; Umbricht D, 2003, BIOL PSYCHIAT, V53, P1120, DOI 10.1016/S0006-3223(02)01642-6; Umbricht D, 1999, INT J NEUROPSYCHOP, V2, P299, DOI 10.1017/S1461145799001595; Umbricht DSG, 2006, BIOL PSYCHIAT, V59, P762, DOI 10.1016/j.biopsych.2005.08.030; Weschler D., 2002, WAIS 3 CHINESE VERSI; Winkler I, 1996, BRAIN RES, V742, P239, DOI 10.1016/S0006-8993(96)01008-6; WOODS DL, 1992, ELECTROEN CLIN NEURO, V84, P456, DOI 10.1016/0168-5597(92)90033-8; Woodward ND, 2005, INT J NEUROPSYCHOPH, V8, P457, DOI 10.1017/S146114570500516X; Wynn JK, 2010, BIOL PSYCHIAT, V67, P940, DOI 10.1016/j.biopsych.2009.11.024	71	22	24	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2012	7	4							e34454	10.1371/journal.pone.0034454	http://dx.doi.org/10.1371/journal.pone.0034454			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	955IH	22496807	Green Submitted, Green Published, gold			2022-12-27	WOS:000305010500009
J	Li, BQ; Huang, T; Liu, L; Cai, YD; Chou, KC				Li, Bi-Qing; Huang, Tao; Liu, Lei; Cai, Yu-Dong; Chou, Kuo-Chen			Identification of Colorectal Cancer Related Genes with mRMR and Shortest Path in Protein-Protein Interaction Network	PLOS ONE			English	Article							AMINO-ACID-COMPOSITION; HUMAN TISSUE KALLIKREINS; GENOME-WIDE ASSOCIATION; SUBCELLULAR-LOCALIZATION; TRANSCRIPTION FACTOR; PREDICTION; EXPRESSION; ENZYME; COLON; BETA	One of the most important and challenging problems in biomedicine and genomics is how to identify the disease genes. In this study, we developed a computational method to identify colorectal cancer-related genes based on (i) the gene expression profiles, and (ii) the shortest path analysis of functional protein association networks. The former has been used to select differentially expressed genes as disease genes for quite a long time, while the latter has been widely used to study the mechanism of diseases. With the existing protein-protein interaction data from STRING (Search Tool for the Retrieval of Interacting Genes), a weighted functional protein association network was constructed. By means of the mRMR (Maximum Relevance Minimum Redundancy) approach, six genes were identified that can distinguish the colorectal tumors and normal adjacent colonic tissues from their gene expression profiles. Meanwhile, according to the shortest path approach, we further found an additional 35 genes, of which some have been reported to be relevant to colorectal cancer and some are very likely to be relevant to it. Interestingly, the genes we identified from both the gene expression profiles and the functional protein association network have more cancer genes than the genes identified from the gene expression profiles alone. Besides, these genes also had greater functional similarity with the reported colorectal cancer genes than the genes identified from the gene expression profiles alone. All these indicate that our method as presented in this paper is quite promising. The method may become a useful tool, or at least plays a complementary role to the existing method, for identifying colorectal cancer genes. It has not escaped our notice that the method can be applied to identify the genes of other diseases as well.	[Li, Bi-Qing; Huang, Tao; Liu, Lei] Chinese Acad Sci, Key Lab Syst Biol, Shanghai Inst Biol Sci, Shanghai, Peoples R China; [Li, Bi-Qing; Huang, Tao; Liu, Lei] Shanghai Ctr Bioinformat Technol, Shanghai, Peoples R China; [Cai, Yu-Dong] Shanghai Univ, Inst Syst Biol, Shanghai, Peoples R China; [Cai, Yu-Dong] Fudan Univ, Ctr Computat Syst Biol, Shanghai 200433, Peoples R China; [Cai, Yu-Dong; Chou, Kuo-Chen] Gordon Life Sci Inst, San Diego, CA USA	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai University; Fudan University	Li, BQ (corresponding author), Chinese Acad Sci, Key Lab Syst Biol, Shanghai Inst Biol Sci, Shanghai, Peoples R China.	liulei@sibs.ac.cn; cai_yud@yahoo.com.cn	Chou, Kuo-Chen/A-8340-2009	cai, yudong/0000-0001-5664-7979	National Basic Research Program of China [2011CB510102, 2011CB510101, 2011CB910200, 2010CB912702]; Natural Science Foundation of China [90913009]; Chinese Academy of Sciences [KSCX2-EW-R-04]; National High Tech Program [2012AA022802]; Innovation Program of Shanghai Municipal Education Commission [12ZZ087]	National Basic Research Program of China(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); National High Tech Program; Innovation Program of Shanghai Municipal Education Commission(Innovation Program of Shanghai Municipal Education Commission)	This work was supported by grants from the National Basic Research Program of China (2011CB510102, 2011CB510101, 2011CB910200 and 2010CB912702), the Natural Science Foundation of China (90913009), the Chinese Academy of Sciences (KSCX2-EW-R-04), a National High Tech Program Grant 2012AA022802 and the Innovation Program of Shanghai Municipal Education Commission (12ZZ087). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen WL, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-687; ALTHAUS IW, 1993, J BIOL CHEM, V268, P14875; Andraos J, 2008, CAN J CHEM, V86, P342, DOI 10.1139/V08-020; Bakall B, 2008, INVEST OPHTH VIS SCI, V49, P1563, DOI 10.1167/iovs.07-1338; Benjamini Y, 2001, ANN STAT, V29, P1165; Bogdanov P, 2010, IEEE ACM T COMPUT BI, V7, P208, DOI 10.1109/TCBB.2009.81; Borgono CA, 2004, NAT REV CANCER, V4, P876, DOI 10.1038/nrc1474; Cai Y., 2011, AMINO ACIDS; Castagnetta L, 2002, ANN NY ACAD SCI, V963, P322; Catalano MG, 2000, INT J CANCER, V86, P325, DOI 10.1002/(SICI)1097-0215(20000501)86:3<325::AID-IJC4>3.0.CO;2-G; Chen L, 2013, CURR BIOINFORM, V8, P200, DOI 10.2174/1574893611308020008; Chen L, 2012, PROTEIN PEPTIDE LETT, V19, P99, DOI 10.2174/092986612798472857; Chou K.C., 2011, NATUR SCI, V3, P862, DOI [10.4236/ns.2011.310111, DOI 10.4236/NS.2011.310111]; CHOU KC, 1994, ANAL BIOCHEM, V221, P217, DOI 10.1006/abio.1994.1405; CHOU KC, 1980, BIOCHEM J, V187, P829, DOI 10.1042/bj1870829; CHOU KC, 1989, J BIOL CHEM, V264, P12074; CHOU KC, 1990, BIOPHYS CHEM, V35, P1, DOI 10.1016/0301-4622(90)80056-D; CHOU KC, 1995, CRIT REV BIOCHEM MOL, V30, P275, DOI 10.3109/10409239509083488; Chou KC, 2008, NAT PROTOC, V3, P153, DOI 10.1038/nprot.2007.494; Chou KC, 2007, ANAL BIOCHEM, V370, P1, DOI 10.1016/j.ab.2007.07.006; Chou KC, 2012, MOL BIOSYST, V8, P629, DOI 10.1039/c1mb05420a; Chou KC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018258; Chou KC, 2011, J THEOR BIOL, V273, P236, DOI 10.1016/j.jtbi.2010.12.024; Chou KC, 2010, CURR DRUG METAB, V11, P369, DOI 10.2174/138920010791514261; Christensen BC, 2011, JNCI-J NATL CANCER I, V103, DOI 10.1093/jnci/djq497; Cui JA, 2011, NUCLEIC ACIDS RES, V39, P1197, DOI 10.1093/nar/gkq960; DENOEUX T, 1995, IEEE T SYST MAN CYB, V25, P804, DOI 10.1109/21.376493; Deves C, 2011, VIRCHOWS ARCH, V458, P421, DOI 10.1007/s00428-011-1053-6; Diamandis EP, 2002, CLIN CHEM, V48, P1198; DIAMANDIS EP, 1995, J CLIN ENDOCR METAB, V80, P1515, DOI 10.1210/jc.80.5.1515; Dijkstra E.W, 1959, NUMER MATH, V1, P269, DOI DOI 10.1007/BF01386390; Esmaeili M, 2010, J THEOR BIOL, V263, P203, DOI 10.1016/j.jtbi.2009.11.016; FRIEDMAN JH, 1975, IEEE T COMPUT, V24, P1000, DOI 10.1109/T-C.1975.224110; Gayther SA, 2000, NAT GENET, V24, P300, DOI 10.1038/73536; Georgiou DN, 2009, J THEOR BIOL, V257, P17, DOI 10.1016/j.jtbi.2008.11.003; Gu Q, 2010, PROTEIN PEPTIDE LETT, V17, P559, DOI 10.2174/092986610791112693; Hibi K, 2009, ANTICANCER RES, V29, P2215; Hinoue T., 2011, GENOME RES; Hiranuma C, 2004, INT J MOL MED, V13, P413; Hoeft B, 2010, CARCINOGENESIS, V31, P466, DOI 10.1093/carcin/bgp325; Howe GR, 1997, CANCER CAUSE CONTROL, V8, P215, DOI 10.1023/A:1018476414781; Hu LL, 2011, PROTEIN PEPTIDE LETT, V18, P552, DOI 10.2174/092986611795222795; Hu LL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014556; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang T, 2011, PROTEIN PEPTIDE LETT; Huang T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016036; Huang T, 2011, NEUROCOMPUTING, V74, P3677, DOI 10.1016/j.neucom.2011.07.019; Huang T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025297; Huang T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022940; Huang T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010972; Huang T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008126; Huang T, 2009, BIOCHEM BIOPH RES CO, V390, P1111, DOI 10.1016/j.bbrc.2009.08.131; Huret JL, 2003, NUCLEIC ACIDS RES, V31, P272, DOI 10.1093/nar/gkg126; Imai K, 2008, CLIN CANCER RES, V14, P6487, DOI 10.1158/1078-0432.CCR-08-1086; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Johnson SAS, 2003, MOL CELL BIOL, V23, P3043, DOI 10.1128/MCB.23.9.3043-3051.2003; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Karaoz U, 2004, P NATL ACAD SCI USA, V101, P2888, DOI 10.1073/pnas.0307326101; Katoh M, 2004, INT J ONCOL, V25, P1495; Kim IJ, 2006, CARCINOGENESIS, V27, P392, DOI 10.1093/carcin/bgi237; Kim MS, 2011, HISTOPATHOLOGY, V58, P660, DOI 10.1111/j.1365-2559.2011.03819.x; Kourmpetis YAI, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009293; Lagger G, 2003, MOL CELL BIOL, V23, P2669, DOI 10.1128/MCB.23.8.2669-2679.2003; Landi D, 2008, CARCINOGENESIS, V29, P579, DOI 10.1093/carcin/bgm304; Letovsky S, 2003, BIOINFORMATICS, V19, pi197, DOI 10.1093/bioinformatics/btg1026; LEVESQUE M, 1995, J CLIN LAB ANAL, V9, P123, DOI 10.1002/jcla.1860090209; Li JM, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2772; Lipkin SM, 2010, CANCER PREV RES, V3, P597, DOI 10.1158/1940-6207.CAPR-10-0007; Liu DJ, 2009, ANTICANCER RES, V29, P3777; Liu Q, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S11-S5; MacLean HE, 1997, J STEROID BIOCHEM, V62, P233, DOI 10.1016/S0960-0760(97)00049-6; Medina MW, 2010, DISCOV MED, V9, P495; Menendez D, 2009, NAT REV CANCER, V9, P724, DOI 10.1038/nrc2730; Mohabatkar H, 2011, J THEOR BIOL, V281, P18, DOI 10.1016/j.jtbi.2011.04.017; Mohabatkar H, 2010, PROTEIN PEPTIDE LETT, V17, P1207, DOI 10.2174/092986610792231564; Morikawa T, 2011, JAMA-J AM MED ASSOC, V305, P1685, DOI 10.1001/jama.2011.513; Nabieva E, 2005, BIOINFORMATICS, V21, pI302, DOI 10.1093/bioinformatics/bti1054; Nagaraj SH, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-35; Ng KL, 2010, COMPUT BIOL MED, V40, P300, DOI 10.1016/j.compbiomed.2010.01.001; Niittymaki I, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-23; OHKUBO I, 1995, INT J BIOCHEM CELL B, V27, P603, DOI 10.1016/1357-2725(95)00021-G; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Peng HC, 2005, IEEE T PATTERN ANAL, V27, P1226, DOI 10.1109/TPAMI.2005.159; Polakis P, 2000, GENE DEV, V14, P1837; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Reeves JR, 2005, BIOCHEM J, V385, P105, DOI 10.1042/BJ20040290; Sabates-Beliver J, 2007, MOL CANCER RES, V5, P1263, DOI 10.1158/1541-7786.MCR-07-0267; Sharan R, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100129; Slattery ML, 2005, CANCER EPIDEM BIOMAR, V14, P2936, DOI 10.1158/1055-9965.EPI-05-0514; Stohr H, 2002, EUR J HUM GENET, V10, P281, DOI 10.1038/sj.ejhg.5200796; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Talieri M, 2009, THROMB HAEMOSTASIS, V101, P741, DOI 10.1160/TH08-07-0471; Team RDC, 2019, R LANG ENV STAT COMP; Thangaraju M, 2009, BIOCHEM J, V417, P379, DOI 10.1042/BJ20081132; Thomas G, 2008, NAT GENET, V40, P310, DOI 10.1038/ng.91; Tsukahara H, 2001, PEDIATR INT, V43, P267, DOI 10.1046/j.1442-200x.2001.01393.x; van Criekinge W, 2007, International Application No: PCT/US2007/013803., Patent No. 2007013803; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Wu ZC, 2011, MOL BIOSYST, V7, P3287, DOI 10.1039/c1mb05232b; Xiao X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020592; Yang XY, 2010, PROTEIN PEPTIDE LETT, V17, P899, DOI 10.2174/092986610791306670; Yi XF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012495; Yu K, 2010, J CLIN INVEST, V120, P1722, DOI 10.1172/JCI41129; ZHOU GP, 1984, BIOCHEM J, V222, P169, DOI 10.1042/bj2220169; Zhou GP, 2011, PROTEIN PEPTIDE LETT, V18, P966, DOI 10.2174/0929866511107010966; Zhou GP, 2011, J THEOR BIOL, V284, P142, DOI 10.1016/j.jtbi.2011.06.006	106	155	157	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e33393	10.1371/journal.pone.0033393	http://dx.doi.org/10.1371/journal.pone.0033393			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GO	22496748	gold, Green Published, Green Submitted			2022-12-27	WOS:000304855200012
J	McEvoy, CRE; Cloete, R; Muller, B; Schurch, AC; van Helden, PD; Gagneux, S; Warren, RM; Gey van Pittius, NC				McEvoy, Christopher R. E.; Cloete, Ruben; Mueller, Borna; Schurch, Anita C.; van Helden, Paul D.; Gagneux, Sebastien; Warren, Robin M.; Gey van Pittius, Nicolaas C.			Comparative Analysis of Mycobacterium tuberculosis pe and ppe Genes Reveals High Sequence Variation and an Apparent Absence of Selective Constraints	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; T-CELL EPITOPES; PGRS PROTEINS; STRAIN DIFFERENTIATION; MOLECULAR EVOLUTION; POLYPROTEIN VACCINE; MULTIGENE FAMILIES; IMMUNE-RESPONSES; EXPRESSION; DNA	Mycobacterium tuberculosis complex (MTBC) genomes contain 2 large gene families termed pe and ppe. The function of pe/ppe proteins remains enigmatic but studies suggest that they are secreted or cell surface associated and are involved in bacterial virulence. Previous studies have also shown that some pe/ppe genes are polymorphic, a finding that suggests involvement in antigenic variation. Using comparative sequence analysis of 18 publicly available MTBC whole genome sequences, we have performed alignments of 33 pe (excluding pe_pgrs) and 66 ppe genes in order to detect the frequency and nature of genetic variation. This work has been supplemented by whole gene sequencing of 14 pe/ppe (including 5 pe_pgrs) genes in a cohort of 40 diverse and well defined clinical isolates covering all the main lineages of the M. tuberculosis phylogenetic tree. We show that nsSNP's in pe (excluding pgrs) and ppe genes are 3.0 and 3.3 times higher than in non-pe/ppe genes respectively and that numerous other mutation types are also present at a high frequency. It has previously been shown that non-pe/ppe M. tuberculosis genes display a remarkably low level of purifying selection. Here, we also show that compared to these genes those of the pe/ppe families show a further reduction of selection pressure that suggests neutral evolution. This is inconsistent with the positive selection pressure of "classical'' antigenic variation. Finally, by analyzing such a large number of genes we were able to detect large differences in mutation type and frequency between both individual genes and gene sub-families. The high variation rates and absence of selective constraints provides valuable insights into potential pe/ppe function. Since pe/ppe proteins are highly antigenic and have been studied as potential vaccine components these results should also prove informative for aspects of M. tuberculosis vaccine design.	[McEvoy, Christopher R. E.; Cloete, Ruben; Mueller, Borna; van Helden, Paul D.; Warren, Robin M.; Gey van Pittius, Nicolaas C.] Univ Stellenbosch, Med Res Council Ctr Mol & Cellular Biol, Natl Res Fdn Ctr Excellence Biomed TB Res, Dept Sci & Technol, Cape Town, South Africa; [Schurch, Anita C.] Natl Inst Publ Hlth & Environm, TB Reference Lab, CIb LIS, Ctr Infect Dis Control, NL-3720 BA Bilthoven, Netherlands; [Gagneux, Sebastien] Swiss Trop & Publ Hlth Inst, Dept Med Parasitol & Infect Biol, Basel, Switzerland; [Gagneux, Sebastien] Univ Basel, Basel, Switzerland; [Gagneux, Sebastien] Natl Inst Med Res, Med Res Council, Div Mycobacterial Res, London NW7 1AA, England	National Research Foundation - South Africa; Stellenbosch University; Netherlands National Institute for Public Health & the Environment; University of Basel; Swiss Tropical & Public Health Institute; University of Basel; MRC National Institute for Medical Research; UK Research & Innovation (UKRI); Medical Research Council UK (MRC)	McEvoy, CRE (corresponding author), Univ Melbourne, Dept Microbiol & Immunol, Melbourne, Vic, Australia.	cmcevoy@unimelb.edu.au	van Pittius, Nicolaas C Gey/D-3434-2015; Müller, Borna/AAS-9471-2020; Gagneux, Sebastien/ABE-7909-2020	van Pittius, Nicolaas C Gey/0000-0002-8807-4105; cloete, ruben/0000-0003-1966-0212; Warren, Robin/0000-0001-5741-7358; Gagneux, Sebastien/0000-0001-7783-9048; Schurch, Anita/0000-0003-1894-7545	South African National Research Foundation through the Centre of Excellence in Biomedical Tuberculosis Research	South African National Research Foundation through the Centre of Excellence in Biomedical Tuberculosis Research	Funding was provided by the South African National Research Foundation through the Centre of Excellence in Biomedical Tuberculosis Research http://www.tuberculosis.org.za/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah AM, 2009, MOL MICROBIOL, V73, P329, DOI 10.1111/j.1365-2958.2009.06783.x; Abdallah AM, 2006, MOL MICROBIOL, V62, P667, DOI 10.1111/j.1365-2958.2006.05409.x; Bachhawat Nandita, 2007, Genomics Proteomics & Bioinformatics, V5, P236, DOI 10.1016/S1672-0229(08)60010-8; Balaji KN, 2007, MICROBES INFECT, V9, P271, DOI 10.1016/j.micinf.2006.11.013; Banu S, 2002, MOL MICROBIOL, V44, P9, DOI 10.1046/j.1365-2958.2002.02813.x; Basu S, 2007, J BIOL CHEM, V282, P1039, DOI 10.1074/jbc.M604379200; Bonanni D, 2005, J MED MICROBIOL, V54, P443, DOI 10.1099/jmm.0.45960-0; Brandt L, 2004, INFECT IMMUN, V72, P6622, DOI 10.1128/IAI.72.11.6622-6632.2004; Brennan MJ, 2001, INFECT IMMUN, V69, P7326, DOI 10.1128/IAI.69.12.7326-7333.2001; Brudey K, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-23; BRUNHAM RC, 1993, INFECT IMMUN, V61, P2273, DOI 10.1128/IAI.61.6.2273-2276.1993; Cadieux N, 2011, MICROBIOL-SGM, V157, P793, DOI 10.1099/mic.0.041996-0; Campuzano J, 2007, VACCINE, V25, P3722, DOI 10.1016/j.vaccine.2006.12.042; Cascioferro A, 2007, MOL MICROBIOL, V66, P1536, DOI 10.1111/j.1365-2958.2007.06023.x; Chaitra MG, 2008, J MED MICROBIOL, V57, P1079, DOI 10.1099/jmm.0.47565-0; Chaitra MG, 2007, VACCINE, V25, P7168, DOI 10.1016/j.vaccine.2007.07.026; Chaitra MG, 2005, VACCINE, V23, P1265, DOI 10.1016/j.vaccine.2004.08.046; Chakhaiyar P, 2004, J INFECT DIS, V190, P1237, DOI 10.1086/423938; Cohen T, 2008, P NATL ACAD SCI USA, V105, P16302, DOI 10.1073/pnas.0808746105; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Comas I, 2010, NAT GENET, V42, P498, DOI 10.1038/ng.590; Comas I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007815; Daubin V, 2004, SCIENCE, V306; Delogu G, 2004, MOL MICROBIOL, V52, P725, DOI 10.1111/j.1365-2958.2004.04007.x; Delogu G, 2001, INFECT IMMUN, V69, P5606, DOI 10.1128/IAI.69.9.5606-5611.2001; Dheenadhayalan V, 2006, MICROBES INFECT, V8, P262, DOI 10.1016/j.micinf.2005.06.021; Dheenadhayalan V, 2006, J BACTERIOL, V188, P3721, DOI 10.1128/JB.188.10.3721-3725.2006; Espitia C, 1999, MICROBIOL-UK, V145, P3487, DOI 10.1099/00221287-145-12-3487; Fleischmann RD, 2002, J BACTERIOL, V184, P5479, DOI 10.1128/JB.184.19.5479-5490.2002; Flores J, 2003, GENE, V318, P75, DOI 10.1016/S0378-1119(03)00751-0; Fu Li M, 2009, Int J Microbiol, V2009, P879621, DOI 10.1155/2009/879621; Gao Q, 2005, MICROBIOL-SGM, V151, P5, DOI 10.1099/mic.0.27539-0; Garnier T, 2003, P NATL ACAD SCI USA, V100, P7877, DOI 10.1073/pnas.1130426100; Gey van Pittius NC, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-95; Goldstone RM, 2009, INFECT IMMUN, V77, P4654, DOI 10.1128/IAI.01495-08; Gutacker MM, 2002, GENETICS, V162, P1533; Gutierrez MC, 2005, PLOS PATHOG, V1, P55, DOI 10.1371/journal.ppat.0010005; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hebert AM, 2007, INFECT IMMUN, V75, P5798, DOI 10.1128/IAI.00335-07; HERMANS PWM, 1995, J INFECT DIS, V171, P1504, DOI 10.1093/infdis/171.6.1504; Hershberg R, 2008, PLOS BIOL, V6, P2658, DOI 10.1371/journal.pbio.0060311; Hughes AL, 2002, EMERG INFECT DIS, V8, P1342, DOI 10.3201/eid0811.020064; Jain SK, 2006, J INFECT DIS, V193, P1287, DOI 10.1086/502631; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Karboul A, 2008, J BACTERIOL, V190, P7838, DOI 10.1128/JB.00827-08; Karboul A, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-107; Koh KW, 2009, INFECT IMMUN, V77, P3337, DOI 10.1128/IAI.01175-08; Koh KW, 2009, MOL IMMUNOL, V46, P1312, DOI 10.1016/j.molimm.2008.11.008; Kryazhimskiy S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000304; LEVITSKAYA J, 1995, NATURE, V375, P685, DOI 10.1038/375685a0; Liu XM, 2006, J BACTERIOL, V188, P8169, DOI 10.1128/JB.01062-06; McEvoy CRE, 2009, TUBERCULOSIS, V89, P439, DOI 10.1016/j.tube.2009.08.001; McEvoy CRE, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-237; Mukherjee P, 2007, CLIN MICROBIOL INFEC, V13, P146, DOI 10.1111/j.1469-0691.2006.01660.x; Musser JM, 2000, GENETICS, V155, P7; Nair S, 2009, J IMMUNOL, V183, P6269, DOI 10.4049/jimmunol.0901367; Namouchi A, 2006, J MICROBIOL METH, V67, P202, DOI 10.1016/j.mimet.2006.03.021; Narayana Y, 2007, CLIN VACCINE IMMUNOL, V14, P1334, DOI 10.1128/CVI.00181-07; NEI M, 1986, MOL BIOL EVOL, V3, P418; Plotkin JB, 2004, NATURE, V428, P942, DOI 10.1038/nature02458; Reed SG, 2009, P NATL ACAD SCI USA, V106, P2301, DOI 10.1073/pnas.0712077106; Richardson M, 2002, J CLIN MICROBIOL, V40, P2750, DOI 10.1128/JCM.40.8.2750-2754.2002; Rindi L, 2007, FEMS IMMUNOL MED MIC, V51, P381, DOI 10.1111/j.1574-695X.2007.00315.x; Rodriguez GM, 2002, INFECT IMMUN, V70, P3371, DOI 10.1128/IAI.70.7.3371-3381.2002; Sampson S. L., 1999, Tubercle and Lung Disease, V79, P349, DOI 10.1054/tuld.1999.0218; Sampson SL, 2001, TUBERCULOSIS, V81, P305, DOI 10.1054/tube.2001.0304; Sassetti CM, 2003, P NATL ACAD SCI USA, V100, P12989, DOI 10.1073/pnas.2134250100; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Schurch AC, 2010, J CLIN MICROBIOL; Schurch AC, 2010, INFECT GENET EVOL, V10, P108, DOI 10.1016/j.meegid.2009.10.002; Singh PP, 2008, MICROBIOL-SGM, V154, P3469, DOI 10.1099/mic.0.2008/019968-0; Skeiky YAW, 2004, J IMMUNOL, V172, P7618, DOI 10.4049/jimmunol.172.12.7618; Sreevatsan S, 1997, P NATL ACAD SCI USA, V94, P9869, DOI 10.1073/pnas.94.18.9869; Srivastava R, 2006, J MED MICROBIOL, V55, P1071, DOI 10.1099/jmm.0.46379-0; Srivastava V, 2008, TUBERCULOSIS, V88, P171, DOI 10.1016/j.tube.2007.10.002; Stinear TP, 2008, GENOME RES, V18, P729, DOI 10.1101/gr.075069.107; Streicher EM, 2007, J CLIN MICROBIOL, V45, P237, DOI 10.1128/JCM.01429-06; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; Talaat AM, 2004, P NATL ACAD SCI USA, V101, P4602, DOI 10.1073/pnas.0306023101; Talarico S, 2005, J CLIN MICROBIOL, V43, P4954, DOI 10.1128/JCM.43.10.4954-4960.2005; Talarico S, 2008, TUBERCULOSIS, V88, P283, DOI 10.1016/j.tube.2008.01.001; Talarico S, 2007, TUBERCULOSIS, V87, P338, DOI 10.1016/j.tube.2007.03.003; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tsenova L, 2006, INFECT IMMUN, V74, P2392, DOI 10.1128/IAI.74.4.2392-2401.2006; Tundup S, 2006, FEBS LETT, V580, P1285, DOI 10.1016/j.febslet.2006.01.042; Vallecillo AJ, 2009, MICROB PATHOGENESIS, V46, P119, DOI 10.1016/j.micpath.2008.11.003; VANEMBDEN JDA, 1993, J CLIN MICROBIOL, V31, P406, DOI 10.1128/JCM.31.2.406-409.1993; Verver S, 2004, INT J EPIDEMIOL, V33, P351, DOI 10.1093/ije/dyh021; Vipond J, 2006, VACCINE, V24, P6340, DOI 10.1016/j.vaccine.2006.05.025; Voskuil MI, 2004, TUBERCULOSIS, V84, P256, DOI 10.1016/j.tube.2003.12.014; Warren RM, 2000, MOL MICROBIOL, V37, P1405, DOI 10.1046/j.1365-2958.2000.02090.x; Yesilkaya H, 2005, J BACTERIOL, V187, P6726, DOI 10.1128/JB.187.19.6726-6732.2005; Zhang Y, 2011, COMPUT BIOL CHEM, V35, P319, DOI 10.1016/j.compbiolchem.2011.08.001	93	62	63	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e30593	10.1371/journal.pone.0030593	http://dx.doi.org/10.1371/journal.pone.0030593			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GO	22496726	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000304855200001
J	Redmond, WL; Triplett, T; Floyd, K; Weinberg, AD				Redmond, William L.; Triplett, Todd; Floyd, Kevin; Weinberg, Andrew D.			Dual Anti-OX40/IL-2 Therapy Augments Tumor Immunotherapy via IL-2R-Mediated Regulation of OX40 Expression	PLOS ONE			English	Article							T-CELL RESPONSES; IN-VIVO; SELECTIVE STIMULATION; COMPETITIVE FITNESS; ANTITUMOR IMMUNITY; EFFECTOR FUNCTION; GENE-EXPRESSION; RECEPTOR; COSTIMULATION; INTERLEUKIN-2	The provision of T cell co-stimulation via members of the TNFR super-family, including OX40 (CD134) and 4-1BB (CD137), provides critical signals that promote T cell survival and differentiation. Recent studies have demonstrated that ligation of OX40 can augment T cell-mediated anti-tumor immunity in pre-clinical models and more importantly, OX40 agonists are under clinical development for cancer immunotherapy. OX40 is of particular interest as a therapeutic target as it is not expressed on naive T cells but rather, is transiently up-regulated following TCR stimulation. Although TCR engagement is necessary for inducing OX40 expression, the downstream signals that regulate OX40 itself remain unclear. In this study, we demonstrate that OX40 expression is regulated through a TCR and common gamma chain cytokine-dependent signaling cascade that requires JAK3-mediated activation of the downstream transcription factors STAT3 and STAT5. Furthermore, combined treatment with an agonist anti-OX40 mAb and IL-2 augmented tumor immunotherapy against multiple tumor types. Dual therapy was also able to restore the function of anergic tumor-reactive CD8 T cells in mice with long-term well-established (>5 wks) tumors, leading to increased survival of the tumor-bearing hosts. Together, these data reveal the ability of TCR/common gamma chain cytokine signaling to regulate OX40 expression and demonstrate a novel means of augmenting cancer immunotherapy by providing dual anti-OX40/common gamma chain cytokine-directed therapy.	[Redmond, William L.; Triplett, Todd; Floyd, Kevin; Weinberg, Andrew D.] Providence Portland Med Ctr, Earle A Chiles Res Inst, Robert W Franz Canc Res Ctr, Portland, OR USA; [Triplett, Todd; Weinberg, Andrew D.] Oregon Hlth & Sci Univ, Dept Mol Microbiol & Immunol, Portland, OR 97201 USA	Providence Portland Medical Center; Oregon Health & Science University	Redmond, WL (corresponding author), Providence Portland Med Ctr, Earle A Chiles Res Inst, Robert W Franz Canc Res Ctr, Portland, OR USA.	william.redmond@providence.org	triplett, todd/AAY-1204-2020	triplett, todd/0000-0001-5494-6510; Redmond, William/0000-0002-2572-1731	Providence Portland Medical Foundation; Safeway Foundation; American Cancer Society; Prostate Cancer Foundation; National Institute of Health (NIH) [4R00CA136678-02]; NATIONAL CANCER INSTITUTE [R01CA102577, R00CA136678] Funding Source: NIH RePORTER	Providence Portland Medical Foundation; Safeway Foundation; American Cancer Society(American Cancer Society); Prostate Cancer Foundation; National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Providence Portland Medical Foundation, the Safeway Foundation, an American Cancer Society Sam E. and Kathleen Henry post-doctoral fellowship; a Prostate Cancer Foundation Young Investigator Award; a National Institute of Health (NIH) Pathway to Independence Award (4R00CA136678-02; WLR); and grants from the NIH (ADW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiba H, 1999, J IMMUNOL, V162, P7058; Basham B, 2008, NUCLEIC ACIDS RES, V36, P3802, DOI 10.1093/nar/gkn271; Boyman O, 2006, SCIENCE, V311, P1924, DOI 10.1126/science.1122927; Changelian PS, 2008, BLOOD, V111, P2155, DOI 10.1182/blood-2007-09-115030; Croft M, 2003, NAT REV IMMUNOL, V3, P609, DOI 10.1038/nri1148; Croft M, 2010, ANNU REV IMMUNOL, V28, P57, DOI 10.1146/annurev-immunol-030409-101243; Evans DE, 2001, J IMMUNOL, V167, P6804, DOI 10.4049/jimmunol.167.12.6804; Gadina M, 2000, J BIOL CHEM, V275, P26959; Gaffen SL, 2001, CYTOKINE, V14, P63, DOI 10.1006/cyto.2001.0862; Gramaglia I, 1998, J IMMUNOL, V161, P6510; Gramaglia I, 2000, J IMMUNOL, V165, P3043, DOI 10.4049/jimmunol.165.6.3043; John S, 1999, MOL CELL BIOL, V19, P1910; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Kamimura D, 2007, J EXP MED, V204, P1803, DOI 10.1084/jem.20070543; Kish DD, 2007, J LEUKOCYTE BIOL, V82, P85, DOI 10.1189/jlb.0207089; Kitamura N, 2009, INT J CANCER, V125, P630, DOI 10.1002/ijc.24435; Klinger M, 2009, J IMMUNOL, V182, P4581, DOI 10.4049/jimmunol.0900010; Kovanen PE, 2004, IMMUNOL REV, V202, P67, DOI 10.1111/j.0105-2896.2004.00203.x; Krieg C, 2010, P NATL ACAD SCI USA, V107, P11906, DOI 10.1073/pnas.1002569107; Lathrop SK, 2004, J IMMUNOL, V172, P6735, DOI 10.4049/jimmunol.172.11.6735; Lees JR, 2006, IMMUNOLOGY, V117, P248, DOI 10.1111/j.1365-2567.2005.02293.x; Lenschow DJ, 1996, ANNU REV IMMUNOL, V14, P233, DOI 10.1146/annurev.immunol.14.1.233; Leonard WJ, 1998, ANNU REV IMMUNOL, V16, P293, DOI 10.1146/annurev.immunol.16.1.293; Lu LF, 2009, IMMUNITY, V30, P80, DOI 10.1016/j.immuni.2008.11.010; Moroz A, 2004, J IMMUNOL, V173, P900, DOI 10.4049/jimmunol.173.2.900; Nelson BH, 1998, ADV IMMUNOL, V70, P1, DOI 10.1016/S0065-2776(08)60386-7; Niedbala W, 2007, P NATL ACAD SCI USA, V104, P15478, DOI 10.1073/pnas.0703725104; Piconese S, 2010, EUR J IMMUNOL, V40, P2902, DOI 10.1002/eji.201040505; Rabinovich GA, 2007, ANNU REV IMMUNOL, V25, P267, DOI 10.1146/annurev.immunol.25.022106.141609; Redmond WL, 2007, J IMMUNOL, V179, P7244, DOI 10.4049/jimmunol.179.11.7244; Redmond WL, 2009, EUR J IMMUNOL, V39, P2184, DOI 10.1002/eji.200939348; Redmond WL, 2009, CRIT REV IMMUNOL, V29, P187, DOI 10.1615/CritRevImmunol.v29.i3.10; Rochman Y, 2009, NAT REV IMMUNOL, V9, P480, DOI 10.1038/nri2580; Rogers PR, 2001, IMMUNITY, V15, P445, DOI 10.1016/S1074-7613(01)00191-1; Sarkar S, 2008, J EXP MED, V205, P625, DOI 10.1084/jem.20071641; Shimoda M, 2006, J IMMUNOL, V176, P6503, DOI 10.4049/jimmunol.176.11.6503; SPIESS PJ, 1987, JNCI-J NATL CANCER I, V79, P1067; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Takeda I, 2004, J IMMUNOL, V172, P3580, DOI 10.4049/jimmunol.172.6.3580; Taraban VY, 2002, EUR J IMMUNOL, V32, P3617, DOI 10.1002/1521-4141(200212)32:12<3617::AID-IMMU3617>3.0.CO;2-M; Teglund S, 1998, CELL, V93, P841, DOI 10.1016/S0092-8674(00)81444-0; Toennies HM, 2004, J LEUKOCYTE BIOL, V75, P350, DOI 10.1189/jlb.0803401; Tone Y, 2007, J IMMUNOL, V179, P1760, DOI 10.4049/jimmunol.179.3.1760; Verdeil G, 2008, P NATL ACAD SCI US; Verdeil G, 2006, J IMMUNOL, V176, P4834, DOI 10.4049/jimmunol.176.8.4834; Walker LSK, 1999, J EXP MED, V190, P1115, DOI 10.1084/jem.190.8.1115; Watts TH, 2005, ANNU REV IMMUNOL, V23, P23, DOI 10.1146/annurev.immunol.23.021704.115839; Webster KE, 2009, J EXP MED, V206, P751, DOI 10.1084/jem.20082824; Weinberg AD, 2000, J IMMUNOL, V164, P2160, DOI 10.4049/jimmunol.164.4.2160; Williams CA, 2007, J IMMUNOL, V178, P7694, DOI 10.4049/jimmunol.178.12.7694; Xiao X, 2012, J IMMUNOL, V188, P892, DOI 10.4049/jimmunol.1101373; Yu CR, 1998, J LEUKOCYTE BIOL, V64, P245, DOI 10.1002/jlb.64.2.245	52	37	41	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e34467	10.1371/journal.pone.0034467	http://dx.doi.org/10.1371/journal.pone.0034467			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GO	22496812	Green Submitted, Green Published, gold			2022-12-27	WOS:000304855200054
J	Srinivasan, VB; Vaidyanathan, V; Mondal, A; Rajamohan, G				Srinivasan, Vijaya Bharathi; Vaidyanathan, Vasanth; Mondal, Amitabha; Rajamohan, Govindan			Role of the Two Component Signal Transduction System CpxAR in Conferring Cefepime and Chloramphenicol Resistance in Klebsiella pneumoniae NTUH-K2044	PLOS ONE			English	Article							BIOFILM FORMATION; ESCHERICHIA-COLI; LIVER-ABSCESS; EFFLUX PUMP; COLONIZATION; VIRULENCE; PATHWAY; KINASE; GENE	Background: Klebsiella pneumoniae is a Gram-negative, non-motile, facultative anaerobe belonging to the Enterobacteriaceae family of the gamma-Proteobacteria class in the phylum Proteobacteria. Multidrug resistant K. pneumoniae have caused major therapeutic problems worldwide due to emergence of extended-spectrum beta-lactamase producing strains. Two-component systems serve as a basic stimulus-response coupling mechanism to allow organisms to sense and respond to changes in many different environmental conditions including antibiotic stress. Principal Findings: In the present study, we investigated the role of an uncharacterized cpxAR operon in bacterial physiology and antimicrobial resistance by generating isogenic mutant (Delta cpxAR) deficient in the CpxA/CpxR component derived from the hyper mucoidal K1 strain K. pneumoniae NTUH-K2044. The behaviour of DcpxAR was determined under hostile conditions, reproducing stresses encountered in the gastrointestinal environment and deletion resulted in higher sensitivity to bile, osmotic and acid stresses. The Delta cpxAR was more susceptible to beta-lactams and chloramphenicol than the wild-type strain, and complementation restored the altered phenotypes. The relative change in expression of acrB, acrD, eefB efflux genes were decreased in cpxAR mutant as evidenced by qRT-PCR. Comparison of outer membrane protein profiles indicated a conspicuous difference in the knock out background. Gel shift assays demonstrated direct binding of CpxR(KP) to promoter region of ompC(KP) in a concentration dependent manner. Conclusions and Significance: The Cpx envelope stress response system is known to be activated by alterations in pH, membrane composition and misfolded proteins, and this systematic investigation reveals its direct involvement in conferring antimicrobial resistance against clinically significant antibiotics for the very first time. Overall results displayed in this report reflect the pleiotropic role of the CpxAR signaling system and diversity of the antibiotic resistome in hyper virulent K1 serotype K. pneumoniae NTUH-K2044.	[Srinivasan, Vijaya Bharathi; Vaidyanathan, Vasanth; Mondal, Amitabha; Rajamohan, Govindan] Inst Microbial Technol, Council Sci Ind Res, Chandigarh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH)	Srinivasan, VB (corresponding author), Inst Microbial Technol, Council Sci Ind Res, Sect 39 A, Chandigarh, India.	rmohan@imtech.res.in		Govindan, Rajamohan/0000-0002-0208-3546	Department of Biotechnology (DBT), Government of India; University Grants Commission (UGC); Council of Scientific and Industrial Research (CSIR), Diamond Jubilee scheme, Government of India; CSIR-Institute of Microbial Technology, India	Department of Biotechnology (DBT), Government of India(Department of Biotechnology (DBT) India); University Grants Commission (UGC)(University Grants Commission, India); Council of Scientific and Industrial Research (CSIR), Diamond Jubilee scheme, Government of India; CSIR-Institute of Microbial Technology, India	VBS, W, and AM are grateful to Department of Biotechnology (DBT), Innovative Young Biotechnologist Award, Government of India, University Grants Commission (UGC), and Council of Scientific and Industrial Research (CSIR), Diamond Jubilee scheme, Government of India, respectively, for their fellowships. The work was supported by CSIR-Institute of Microbial Technology, India; and a grant provided by Department of Biotechnology, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arnold RS, 2011, SOUTH MED J, V104, P40, DOI 10.1097/SMJ.0b013e3181fd7d5a; Chaba R, 2002, EUR J BIOCHEM, V269, P1078, DOI 10.1046/j.1432-1033.2002.02778.x; Chen JH, 2010, J ANTIMICROB CHEMOTH, V65, P986, DOI 10.1093/jac/dkq056; Cheng HY, 2010, J BACTERIOL, V192, P3144, DOI 10.1128/JB.00031-10; Clinical and Laboratory Standards Institute, 2010, M100S20U CLSI; Coudeyras S, 2008, INFECT IMMUN, V76, P4633, DOI 10.1128/IAI.00356-08; De Wulf P, 2000, J BACTERIOL, V182, P1423, DOI 10.1128/JB.182.5.1423-1426.2000; Di Martino P, 2003, RES MICROBIOL, V154, P9, DOI 10.1016/S0923-2508(02)00004-9; DiGiuseppe PA, 2003, J BACTERIOL, V185, P2432, DOI 10.1128/JB.185.8.2432-2440.2003; Dorel C, 2006, RES MICROBIOL, V157, P306, DOI 10.1016/j.resmic.2005.12.003; Fang CT, 2004, J EXP MED, V199, P697, DOI 10.1084/jem.20030857; Gunn JS, 2000, MICROBES INFECT, V2, P907, DOI 10.1016/S1286-4579(00)00392-0; Hennequin C, 2009, INFECT IMMUN, V77, P5449, DOI 10.1128/IAI.00837-09; Hirakawa H, 2003, J BACTERIOL, V185, P1851, DOI 10.1128/JB.185.6.1851-1856.2003; Hu WS, 2011, ANTIMICROB AGENTS CH, V55, P3829, DOI 10.1128/AAC.00216-11; Imlay JA, 2003, ANNU REV MICROBIOL, V57, P395, DOI 10.1146/annurev.micro.57.030502.090938; MacRitchie DM, 2008, ADV EXP MED BIOL, V631, P80, DOI 10.1007/978-0-387-78885-2_6; Maroncle N, 2002, INFECT IMMUN, V70, P4729, DOI 10.1128/IAI.70.8.4729-4734.2002; Pages JM, 2008, NAT REV MICROBIOL, V6, P893, DOI 10.1038/nrmicro1994; Piddock LJV, 2006, CLIN MICROBIOL REV, V19, P382, DOI 10.1128/CMR.19.2.382-402.2006; Podschun R, 1998, CLIN MICROBIOL REV, V11, P589, DOI 10.1128/CMR.11.4.589; Price NL, 2009, J BACTERIOL, V191, P1798, DOI 10.1128/JB.00798-08; Raffa RG, 2002, MOL MICROBIOL, V45, P1599, DOI 10.1046/j.1365-2958.2002.03112.x; Raivio TL, 2005, MOL MICROBIOL, V56, P1119, DOI 10.1111/j.1365-2958.2005.04625.x; Rajamohan G, 2010, J ANTIMICROB CHEMOTH, V65, P1919, DOI 10.1093/jac/dkq195; Shemesh M, 2010, J BACTERIOL, V192, P6352, DOI 10.1128/JB.01025-10; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Tran EEH, 2009, APPL ENVIRON MICROB, V75, P4007, DOI 10.1128/AEM.02658-08; Tsai YK, 2011, ANTIMICROB AGENTS CH, V55, P1485, DOI 10.1128/AAC.01275-10; Wu KM, 2009, J BACTERIOL, V191, P4492, DOI 10.1128/JB.00315-09	31	55	59	4	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e33777	10.1371/journal.pone.0033777	http://dx.doi.org/10.1371/journal.pone.0033777			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GO	22496764	Green Published, Green Submitted, gold			2022-12-27	WOS:000304855200023
J	Baker, DH; Wallis, SA; Georgeson, MA; Meese, TS				Baker, Daniel H.; Wallis, Stuart A.; Georgeson, Mark A.; Meese, Tim S.			The Effect of Interocular Phase Difference on Perceived Contrast	PLOS ONE			English	Article							PRIMARY VISUAL-CORTEX; BINOCULAR INTERACTIONS; STRIATE CORTEX; SUPPRESSION; COMBINATION; DISPARITY; SUMMATION; MASKING; RIVALRY; NEURONS	Binocular vision is traditionally treated as two processes: the fusion of similar images and the interocular suppression of dissimilar images (e.g. binocular rivalry). Recent work has demonstrated that interocular suppression is phase-insensitive, whereas binocular summation occurs only when stimuli are in phase. But how do these processes affect our perception of binocular contrast? We measured perceived contrast using a matching paradigm for a wide range of interocular phase offsets (0-180 degrees) and matching contrasts (2-32%). Our results revealed a complex interaction between contrast and interocular phase. At low contrasts, perceived contrast reduced monotonically with increasing phase offset, by up to a factor of 1.6. At higher contrasts the pattern was non-monotonic: perceived contrast was veridical for in-phase and antiphase conditions, and monocular presentation, but increased a little at intermediate phase angles. These findings challenge a recent model in which contrast perception is phase-invariant. The results were predicted by a binocular contrast gain control model. The model involves monocular gain controls with interocular suppression from positive and negative phase channels, followed by summation across eyes and then across space. Importantly, this model-applied to conditions with vertical disparity-has only a single (zero) disparity channel and embodies both fusion and suppression processes within a single framework.	[Baker, Daniel H.; Wallis, Stuart A.; Georgeson, Mark A.; Meese, Tim S.] Aston Univ, Sch Life & Hlth Sci, Birmingham B4 7ET, W Midlands, England	Aston University	Baker, DH (corresponding author), Aston Univ, Sch Life & Hlth Sci, Birmingham B4 7ET, W Midlands, England.	d.h.baker1@aston.ac.uk	Baker, Daniel H/A-1674-2009	Baker, Daniel H/0000-0002-0161-443X; Meese, Timothy S/0000-0003-3744-4679; Georgeson, Mark/0000-0002-8173-9522	Biotechnology and Biological Sciences Research Council (UK) [BBH00159X1]; Engineering and Physical Sciences Research Council (UK) [EP/H000038/1]; Biotechnology and Biological Sciences Research Council [BB/H00159X/1] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/H000038/1] Funding Source: researchfish; BBSRC [BB/H00159X/1] Funding Source: UKRI; EPSRC [EP/H000038/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council (UK)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council (UK)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	Supported by Grant BBH00159X1 from the Biotechnology and Biological Sciences Research Council (UK); www.bbsrc.ac.uk. Grant EP/H000038/1 from the Engineering and Physical Sciences Research Council (UK); www.epsrc.ac.uk. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker DH, 2008, VISION RES, V48, P1625, DOI 10.1016/j.visres.2008.04.017; Baker DH, 2007, VISION RES, V47, P3096, DOI 10.1016/j.visres.2007.08.013; Baker DH, 2007, SPATIAL VISION, V20, P397, DOI 10.1163/156856807781503622; CHINO YM, 1994, J NEUROSCI, V14, P5050; Cumming BG, 2002, NATURE, V418, P633, DOI 10.1038/nature00909; Ding J, 2006, P NATL ACAD SCI USA, V103, P1141, DOI 10.1073/pnas.0509629103; Ding J, 2007, COMPUTATIONAL VISION IN NEURAL AND MACHINE SYSTEMS, P257; Huang CB, 2011, J VISION, V11, DOI 10.1167/11.6.4; Huang CB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015075; LEVELT WJM, 1966, BRIT J PSYCHOL, V57, P225, DOI 10.1111/j.2044-8295.1966.tb01023.x; Meese TS, 2006, J VISION, V6, P1224, DOI 10.1167/6.11.7; Meese TS, 2011, J VISION, V11, DOI 10.1167/11.1.23; Meese TS, 2009, J VISION, V9, DOI 10.1167/9.4.7; Ohzawa I, 1994, COMPUTATIONAL VISION, V2054, P43; ROSE D, 1988, INVEST OPHTH VIS SCI, V29, P283; SENGPIEL F, 1995, VISION RES, V35, P179, DOI 10.1016/0042-6989(94)00125-6; Sengpiel F, 2006, CEREB CORTEX, V16, P1750, DOI 10.1093/cercor/bhj110; Simmons DR, 2005, PERCEPTION, V34, P1035, DOI 10.1068/p5279; Smith EL, 1997, J NEUROPHYSIOL, V78, P1353, DOI 10.1152/jn.1997.78.3.1353; Smith EL, 1997, J NEUROPHYSIOL, V78, P351, DOI 10.1152/jn.1997.78.1.351	20	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2012	7	4							e34696	10.1371/journal.pone.0034696	http://dx.doi.org/10.1371/journal.pone.0034696			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952GU	22485185	Green Submitted, gold, Green Accepted, Green Published			2022-12-27	WOS:000304780500060
J	Fong, B; Jin, R; Wang, XY; Safaee, M; Lisiero, DN; Yang, I; Li, G; Liau, LM; Prins, RM				Fong, Brendan; Jin, Richard; Wang, Xiaoyan; Safaee, Michael; Lisiero, Dominique N.; Yang, Isaac; Li, Gang; Liau, Linda M.; Prins, Robert M.			Monitoring of Regulatory T Cell Frequencies and Expression of CTLA-4 on T Cells, before and after DC Vaccination, Can Predict Survival in GBM Patients	PLOS ONE			English	Article							PULSED DENDRITIC CELLS; GLIOMA PATIENTS; ADJUVANT TEMOZOLOMIDE; RECURRENT GLIOMA; IMMUNE-RESPONSES; CD127 EXPRESSION; MURINE GLIOMA; SIPULEUCEL-T; GLIOBLASTOMA; IMMUNOTHERAPY	Purpose:Dendritic cell (DC) vaccines have recently emerged as an innovative therapeutic option for glioblastoma patients. To identify novel surrogates of anti-tumor immune responsiveness, we studied the dynamic expression of activation and inhibitory markers on peripheral blood lymphocyte (PBL) subsets in glioblastoma patients treated with DC vaccination at UCLA. Experimental Design: Pre-treatment and post-treatment PBL from 24 patients enrolled in two Phase I clinical trials of dendritic cell immunotherapy were stained and analyzed using flow cytometry. A univariate Cox proportional hazards model was utilized to investigate the association between continuous immune monitoring variables and survival. Finally, the immune monitoring variables were dichotomized and a recursive partitioning survival tree was built to obtain cut-off values predictive of survival. Results: The change in regulatory T cell (CD3(+)CD4(+)CD25(+)CD127(low)) frequency in PBL was significantly associated with survival (p = 0.0228; hazard ratio = 3.623) after DC vaccination. Furthermore, the dynamic expression of the negative co-stimulatory molecule, CTLA-4, was also significantly associated with survival on CD3(+)CD4(+) T cells (p =0.0191; hazard ratio = 2.840) and CD3(+)CD8(+) T cells (p = 0.0273; hazard ratio = 2.690), while that of activation markers (CD25, CD69) was not. Finally, a recursive partitioning tree algorithm was utilized to dichotomize the post/pre fold change immune monitoring variables. The resultant cut-off values from these immune monitoring variables could effectively segregate these patients into groups with significantly different overall survival curves. Conclusions: Our results suggest that monitoring the change in regulatory T cell frequencies and dynamic expression of the negative co-stimulatory molecules on peripheral blood T cells, before and after DC vaccination, may predict survival. The cut-off point generated from these data can be utilized in future prospective immunotherapy trials to further evaluate its predictive validity.	[Fong, Brendan; Jin, Richard; Safaee, Michael; Lisiero, Dominique N.; Yang, Isaac; Liau, Linda M.; Prins, Robert M.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurosurg, Los Angeles, CA 90095 USA; [Wang, Xiaoyan; Li, Gang] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biostat, Los Angeles, CA 90095 USA; [Yang, Isaac] Univ Calif Los Angeles, David Geffen Sch Med, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA; [Liau, Linda M.; Prins, Robert M.] Univ Calif Los Angeles, David Geffen Sch Med, Brain Res Inst, Los Angeles, CA 90095 USA; [Prins, Robert M.] Univ Calif Los Angeles, David Geffen Sch Med, Inst Mol Med, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Fong, B (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurosurg, Los Angeles, CA 90095 USA.	rprins@mednet.ucla.edu	Yang, Isaac/AAT-5897-2020; Prins, Robert/AAX-1155-2021	Yang, Isaac/0000-0002-5176-5615; Prins, Robert/0000-0002-6282-6583; Jin, Richard/0000-0002-1316-814X; Liau, Linda/0000-0002-4053-0052	NIH/NCI [K01-CA111402, RO1-CA123396, R01 CA 112358]; Brad Kaminsky Foundation; Cranium Crusaders; Miles for Hope Foundation; Northwest Biotherapeutics, Inc.; Eli & Edyth Broad Center of Regenerative Medicine and Stem Cell Research at UCLA; STOP Cancer Foundation; Ben & Catherine Ivy Foundation; American Brain Tumor Association; NIH [CA16042]; NATIONAL CANCER INSTITUTE [R01CA112358, R01CA123396, K01CA111402, P30CA016042] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR033176] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Brad Kaminsky Foundation; Cranium Crusaders; Miles for Hope Foundation; Northwest Biotherapeutics, Inc.; Eli & Edyth Broad Center of Regenerative Medicine and Stem Cell Research at UCLA; STOP Cancer Foundation; Ben & Catherine Ivy Foundation; American Brain Tumor Association; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported in part by NIH/NCI grants K01-CA111402 and RO1-CA123396 (to RMP), R01 CA 112358 (to LML), the Brad Kaminsky Foundation, Cranium Crusaders, the Miles for Hope Foundation, Northwest Biotherapeutics, Inc., the Eli & Edyth Broad Center of Regenerative Medicine and Stem Cell Research at UCLA (to RMP and LML), the STOP Cancer Foundation (RMP), the Ben & Catherine Ivy Foundation (to RMP), and the American Brain Tumor Association (to LL and BF). Flow cytometry was performed at the UCLA Jonsson Comprehensive Cancer Center (JCCC) Core Facility, which is supported by the NIH award CA16042. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardon H, 2010, J IMMUNOL METHODS, V352, P169, DOI 10.1016/j.jim.2009.10.007; Ardon H, 2010, J NEURO-ONCOL, V99, P261, DOI 10.1007/s11060-010-0131-y; Burton E C, 2000, Curr Treat Options Oncol, V1, P459, DOI 10.1007/s11864-000-0073-2; Cheever MA, 2011, CLIN CANCER RES, V17, P3520, DOI 10.1158/1078-0432.CCR-10-3126; Curran MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019499; Curtin JF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001983; De Vleeschouwer S, 2008, CLIN CANCER RES, V14, P3098, DOI 10.1158/1078-0432.CCR-07-4875; El Andaloussi A, 2006, NEURO-ONCOLOGY, V8, P234, DOI 10.1215/15228517-2006-006; El Andaloussi A, 2007, J NEURO-ONCOL, V83, P145, DOI 10.1007/s11060-006-9314-y; El Andaloussi A, 2006, J NEUROSURG, V105, P430, DOI 10.3171/jns.2006.105.3.430; Fecci PE, 2007, CLIN CANCER RES, V13, P2158, DOI 10.1158/1078-0432.CCR-06-2070; Fecci PE, 2006, CLIN CANCER RES, V12, P4294, DOI 10.1158/1078-0432.CCR-06-0053; Grauer OM, 2008, INT J CANCER, V122, P1794, DOI 10.1002/ijc.23284; Grauer OM, 2007, INT J CANCER, V121, P95, DOI 10.1002/ijc.22607; Heimberger AB, 2008, NEURO-ONCOLOGY, V10, P98, DOI 10.1215/15228517-2007-046; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Jackson C, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/732413; Kantoff PW, 2010, NEW ENGL J MED, V363, P411, DOI 10.1056/NEJMoa1001294; Kikuchi T, 2004, J IMMUNOTHER, V27, P452, DOI 10.1097/00002371-200411000-00005; Lee AW, 2002, VACCINE, V20, pA8, DOI 10.1016/S0264-410X(02)00382-1; Liau LM, 2005, CLIN CANCER RES, V11, P5515, DOI 10.1158/1078-0432.CCR-05-0464; Liu WH, 2006, J EXP MED, V203, P1701, DOI 10.1084/jem.20060772; Maes W, 2009, NEURO-ONCOLOGY, V11, P529, DOI 10.1215/15228517-2009-004; Mitchell DA, 2011, BLOOD; Nieder C, 2002, J CLIN ONCOL, V20, P3179, DOI 10.1200/JCO.2002.20.14.3179; Okada H, 2011, J CLIN ONCOL, V29, P330, DOI 10.1200/JCO.2010.30.7744; Pedicord VA, 2011, P NATL ACAD SCI USA, V108, P266, DOI 10.1073/pnas.1016791108; Peggs KS, 2009, J EXP MED, V206, P1717, DOI 10.1084/jem.20082492; Prins RM, 2008, NEW ENGL J MED, V359, P539, DOI 10.1056/NEJMc0804818; Prins RM, 2011, CLIN CANCER RES, V17, P1603, DOI 10.1158/1078-0432.CCR-10-2563; Quezada SA, 2008, J EXP MED, V205, P2125, DOI 10.1084/jem.20080099; Quezada SA, 2011, IMMUNOL REV, V241, P104, DOI 10.1111/j.1600-065X.2011.01007.x; Salama AK, 2011, CLIN CANC RES; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Surawicz TS, 1998, J NEURO-ONCOL, V40, P151, DOI 10.1023/A:1006091608586; Traynor K, 2011, AM J HEALTH-SYST PH, V68, P768, DOI 10.2146/news110025; Wainwright DA, 2011, NEUROONCOLOGY; Walker DG, 2008, J CLIN NEUROSCI, V15, P114, DOI 10.1016/j.jocn.2007.08.007; Wheeler CJ, 2008, CANCER RES, V68, P5955, DOI 10.1158/0008-5472.CAN-07-5973; Yamanaka R, 2003, BRIT J CANCER, V89, P1172, DOI 10.1038/sj.bjc.6601268; Yamanaka R, 2005, CLIN CANCER RES, V11, P4160, DOI 10.1158/1078-0432.CCR-05-0120; Yang Meng-Yin, 2006, Expert Rev Neurother, V6, P1481, DOI 10.1586/14737175.6.10.1481; Yu JS, 2001, CANCER RES, V61, P842; Yu JS, 2004, CANCER RES, V64, P4973, DOI 10.1158/0008-5472.CAN-03-3505; Yuan J, 2011, CANC IMMUNOL IMMUNOT	46	71	78	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2012	7	4							e32614	10.1371/journal.pone.0032614	http://dx.doi.org/10.1371/journal.pone.0032614			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952GU	22485134	gold, Green Published, Green Submitted			2022-12-27	WOS:000304780500010
J	Liang, ZX; Zhan, WQ; Zhu, AZ; Yoon, Y; Lin, SB; Sasaki, M; Klapproth, JMA; Yang, H; Grossniklaus, HE; Xu, JG; Rojas, M; Voll, RJ; Goodman, MM; Arrendale, RF; Liu, J; Yun, CC; Snyder, JP; Liotta, DC; Shim, H				Liang, Zhongxing; Zhan, Weiqiang; Zhu, Aizhi; Yoon, Younghyoun; Lin, Songbai; Sasaki, Maiko; Klapproth, Jan-Michael A.; Yang, Hua; Grossniklaus, Hans E.; Xu, Jianguo; Rojas, Mauricio; Voll, Ronald J.; Goodman, Mark M.; Arrendale, Richard F.; Liu, Jin; Yun, C. Chris; Snyder, James P.; Liotta, Dennis C.; Shim, Hyunsuk			Development of a Unique Small Molecule Modulator of CXCR4	PLOS ONE			English	Article							BREAST-CANCER METASTASIS; CHEMOKINE RECEPTOR; ACCURATE DOCKING; NECK-CANCER; STEM-CELLS; INVOLVEMENT; ANTAGONIST; ACTIVATION; EXPRESSION; AMD3100	Background: Metastasis, the spread and growth of tumor cells to distant organ sites, represents the most devastating attribute and plays a major role in the morbidity and mortality of cancer. Inflammation is crucial for malignant tumor transformation and survival. Thus, blocking inflammation is expected to serve as an effective cancer treatment. Among anti-inflammation therapies, chemokine modulation is now beginning to emerge from the pipeline. CXC chemokine receptor-4 (CXCR4) and its ligand stromal cell-derived factor-1 (CXCL12) interaction and the resulting cell signaling cascade have emerged as highly relevant targets since they play pleiotropic roles in metastatic progression. The unique function of CXCR4 is to promote the homing of tumor cells to their microenvironment at the distant organ sites. Methodology/Principal Findings: We describe the actions of N,N'-(1,4-phenylenebis(methylene))dipyrimidin-2-amine (designated MSX-122), a novel small molecule and partial CXCR4 antagonist with properties quite unlike that of any other reported CXCR4 antagonists, which was prepared in a single chemical step using a reductive amination reaction. Its specificity toward CXCR4 was tested in a binding affinity assay and a ligand competition assay using F-18-labeled MSX-122. The potency of the compound was determined in two functional assays, Matrigel invasion assay and cAMP modulation. The therapeutic potential of MSX-122 was evaluated in three different murine models for inflammation including an experimental colitis, carrageenan induced paw edema, and bleomycin induced lung fibrosis and three different animal models for metastasis including breast cancer micrometastasis in lung, head and neck cancer metastasis in lung, and uveal melanoma micrometastasis in liver in which CXCR4 was reported to play crucial roles. Conclusions/Significance: We developed a novel small molecule, MSX-122, that is a partial CXCR4 antagonist without mobilizing stem cells, which can be safer for long-term blockade of metastasis than other reported CXCR4 antagonists.	[Liang, Zhongxing; Zhu, Aizhi; Yoon, Younghyoun; Voll, Ronald J.; Goodman, Mark M.; Shim, Hyunsuk] Emory Univ, Dept Radiol & Imaging Sci, Atlanta, GA 30322 USA; [Zhan, Weiqiang; Liu, Jin; Snyder, James P.; Liotta, Dennis C.] Emory Univ, Dept Chem, Atlanta, GA 30322 USA; [Lin, Songbai; Sasaki, Maiko; Klapproth, Jan-Michael A.; Xu, Jianguo; Rojas, Mauricio; Yun, C. Chris] Emory Univ, Dept Med, Atlanta, GA 30322 USA; [Yang, Hua; Grossniklaus, Hans E.] Emory Univ, Dept Ophthalmol, Atlanta, GA 30322 USA; [Goodman, Mark M.; Liotta, Dennis C.; Shim, Hyunsuk] Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA; [Arrendale, Richard F.; Snyder, James P.; Liotta, Dennis C.] Emory Univ, Emory Inst Drug Discovery, Atlanta, GA 30322 USA	Emory University; Emory University; Emory University; Emory University; Emory University; Emory University	Liang, ZX (corresponding author), Emory Univ, Dept Radiol & Imaging Sci, Atlanta, GA 30322 USA.	jsnyder@emory.edu; dliotta@emory.edu; hshim@emory.edu			United States National Institutes of Health; NATIONAL CANCER INSTITUTE [R01CA165306] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071597] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	All the studies were funded by the United States National Institutes of Health. The NIH had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbdelMagid AF, 1996, J ORG CHEM, V61, P3849, DOI 10.1021/jo960057x; Andres PG, 2000, J IMMUNOL, V164, P6303, DOI 10.4049/jimmunol.164.12.6303; Balkwill F, 2004, SEMIN CANCER BIOL, V14, P171, DOI 10.1016/j.semcancer.2003.10.003; Boudeau J, 1999, INFECT IMMUN, V67, P4499, DOI 10.1128/IAI.67.9.4499-4509.1999; Calandra G, 2010, CURR TOP MICROBIOL, V341, P173, DOI 10.1007/82_2010_26; Castaneda FE, 2005, GASTROENTEROLOGY, V129, P1991, DOI 10.1053/j.gastro.2005.09.017; Crump MP, 1997, EMBO J, V16, P6996, DOI 10.1093/emboj/16.23.6996; Davis CB, 1997, J EXP MED, V186, P1793, DOI 10.1084/jem.186.10.1793; De Clercq E, 2003, NAT REV DRUG DISCOV, V2, P581, DOI 10.1038/nrd1134; Dorsam RT, 2007, NAT REV CANCER, V7, P79, DOI 10.1038/nrc2069; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; Fricker SP, 2006, BIOCHEM PHARMACOL, V72, P588, DOI 10.1016/j.bcp.2006.05.010; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Furusato B, 2010, PATHOL INT, V60, P497, DOI 10.1111/j.1440-1827.2010.02548.x; Gao C, 2007, TRANSPL P, V39, P268, DOI 10.1016/j.transproceed.2006.10.020; Graves AP, 2008, J MOL BIOL, V377, P914, DOI 10.1016/j.jmb.2008.01.049; Guimaraes CRW, 2008, J CHEM INF MODEL, V48, P958, DOI 10.1021/ci800004w; Gupta SK, 2001, IMMUNOL LETT, V78, P29, DOI 10.1016/S0165-2478(01)00228-0; Halgren TA, 2004, J MED CHEM, V47, P1750, DOI 10.1021/jm030644s; Imitola J, 2004, P NATL ACAD SCI USA, V101, P18117, DOI 10.1073/pnas.0408258102; Kajiyama H, 2007, CELL TISSUE RES, V330, P221, DOI 10.1007/s00441-007-0455-x; Kalatskaya I, 2009, MOL PHARMACOL, V75, P1240, DOI 10.1124/mol.108.053389; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kofuku Y, 2009, J BIOL CHEM, V284, P35240, DOI 10.1074/jbc.M109.024851; Kucia M, 2005, STEM CELLS, V23, P879, DOI 10.1634/stemcells.2004-0342; Lazennec G, 2010, TRENDS MOL MED, V16, P133, DOI 10.1016/j.molmed.2010.01.003; Liang Z, 2007, BIOCHEM BIOPH RES CO, V359, P716, DOI 10.1016/j.bbrc.2007.05.182; Liang ZX, 2004, CANCER RES, V64, P4302, DOI 10.1158/0008-5472.CAN-03-3958; Lin SB, 2010, GASTROENTEROLOGY, V138, P649, DOI 10.1053/j.gastro.2009.09.055; Liotta LA, 2001, NATURE, V411, P375, DOI 10.1038/35077241; Mikami S, 2008, J PHARMACOL EXP THER, V327, P383, DOI 10.1124/jpet.108.141085; Moyer RA, 2007, LAB INVEST, V87, P807, DOI 10.1038/labinvest.3700595; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Porta C, 2010, CANC LETT; Sanchez X, 1997, J BIOL CHEM, V272, P27529, DOI 10.1074/jbc.272.44.27529; Sasaki T, 2007, BIOL PHARM BULL, V30, P1599, DOI 10.1248/bpb.30.1599; Schiffer D, 2010, ANTICANCER RES, V30, P1977; Sherman W, 2006, J MED CHEM, V49, P534, DOI 10.1021/jm050540c; Shim H, 2009, SEMIN CANCER BIOL, V19, P123, DOI 10.1016/j.semcancer.2008.11.004; Strieter RM, 2009, J LEUKOCYTE BIOL, V86, P1111, DOI 10.1189/jlb.0309132; Thelen M, 2008, J NEUROIMMUNOL, V198, P9, DOI 10.1016/j.jneuroim.2008.04.020; Wang J, 2005, ONCOGENE, V24, P5897, DOI 10.1038/sj.onc.1208740; Wang JH, 2008, J BIOL CHEM, V283, P4283, DOI 10.1074/jbc.M707465200; Weinberg RA, 2007, BIOL CANC; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Xia XM, 2010, WORLD J GASTROENTERO, V16, P2873, DOI 10.3748/wjg.v16.i23.2873; Xui J, 2007, AM J RESP CELL MOL B; Yang H, 2008, MELANOMA RES, V18, P95, DOI 10.1097/CMR.0b013e3282f628df; Yang H, 2006, CURR EYE RES, V31, P557, DOI 10.1080/02713680600718962; Yoon Y, 2007, CANCER RES, V67, P7518, DOI 10.1158/0008-5472.CAN-06-2263; Zaitseva M, 1997, NAT MED, V3, P1369, DOI 10.1038/nm1297-1369; Zhan WQ, 2007, J MED CHEM, V50, P5655, DOI 10.1021/jm070679i; Zhu AZ, 2010, J MED CHEM, V53, P8556, DOI 10.1021/jm100786g; Zlotnik A, 2006, CONTRIB MICROBIOL, V13, P191, DOI 10.1159/000092973	55	96	106	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2012	7	4							e34038	10.1371/journal.pone.0034038	http://dx.doi.org/10.1371/journal.pone.0034038			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952GU	22485156	Green Submitted, Green Published, gold			2022-12-27	WOS:000304780500032
J	Naydenov, NG; Brown, B; Harris, G; Dohn, MR; Morales, VM; Baranwal, S; Reynolds, AB; Ivanov, AI				Naydenov, Nayden G.; Brown, Bryan; Harris, Gianni; Dohn, Michael R.; Morales, Victor M.; Baranwal, Somesh; Reynolds, Albert B.; Ivanov, Andrei I.			A Membrane Fusion Protein alpha SNAP Is a Novel Regulator of Epithelial Apical Junctions	PLOS ONE			English	Article							NUCLEOTIDE-EXCHANGE PROTEIN; CELL-CELL CONTACTS; E-CADHERIN; ENDOPLASMIC-RETICULUM; PLASMA-MEMBRANE; TIGHT JUNCTIONS; BARRIER FUNCTION; SECRETORY PATHWAY; ARF FAMILY; MDCK CELLS	Tight junctions (TJs) and adherens junctions (AJs) are key determinants of the structure and permeability of epithelial barriers. Although exocytic delivery to the cell surface is crucial for junctional assembly, little is known about the mechanisms controlling TJ and AJ exocytosis. This study was aimed at investigating whether a key mediator of exocytosis soluble N-ethylmaleimide sensitive factor (NSF) attachment protein alpha (alpha SNAP), regulates epithelial junctions. alpha SNAP was enriched at apical junctions in SK-CO15 and T84 colonic epithelial cells and in normal human intestinal mucosa. siRNA-mediated knockdown of alpha SNAP inhibited AJ/TJ assembly and establishment of the paracellular barrier in SK-CO15 cells which was accompanied by a significant down-regulation of p120-catenin and E-cadherin expression. A selective depletion of p120 catenin effectively disrupted AJ and TJ structure and compromised the epithelial barrier. However, overexpression of p120 catenin did not rescue the defects of junctional structure and permeability caused by alpha SNAP knockdown thereby suggesting the involvement of additional mechanisms. Such mechanisms did not depend on NSF functions or induction of cell death, but were associated with disruption of the Golgi complex and down regulation of a Golgi-associated guanidine nucleotide exchange factor, GBF1. These findings suggest novel roles for alpha SNAP in promoting the formation of epithelial AJs and TJs by controlling Golgi-dependent expression and trafficking of junctional proteins.	[Naydenov, Nayden G.; Brown, Bryan; Harris, Gianni; Morales, Victor M.; Baranwal, Somesh; Ivanov, Andrei I.] Univ Rochester, Dept Med, Rochester, NY 14627 USA; [Dohn, Michael R.; Reynolds, Albert B.] Vanderbilt Univ, Dept Canc Biol, Nashville, TN USA	University of Rochester; Vanderbilt University	Naydenov, NG (corresponding author), Univ Rochester, Dept Med, Rochester, NY 14627 USA.	Andrei_Ivanov@urmc.rochester.edu	Ivanov, Andrei/V-1672-2019; Baranwal, Somesh/F-4824-2012		National Institute of Health [RO1 DK083968, R01 DK084953, R01 CA111947, RO1 CA055724, P50 CA95103]; NATIONAL CANCER INSTITUTE [P50CA095103, R01CA055724, R01CA111947] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK084953, R01DK083968] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institute of Health grants RO1 DK083968, R01 DK084953 to All and R01 CA111947, RO1 CA055724, P50 CA95103 to ABR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JM, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002584; Andreeva AV, 2006, EXPERT OPIN THER TAR, V10, P723, DOI 10.1517/14728222.10.5.723; Andreeva AV, 2005, J BIOL CHEM, V280, P30376, DOI 10.1074/jbc.M502844200; Aoki T, 2008, BIOCHEM J, V410, P93, DOI 10.1042/BJ20071304; Barnard RJO, 1997, J CELL BIOL, V139, P875, DOI 10.1083/jcb.139.4.875; Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; Bryant DM, 2004, TRENDS CELL BIOL, V14, P427, DOI 10.1016/j.tcb.2004.07.007; Burgoyne RD, 1998, BIOESSAYS, V20, P328, DOI 10.1002/(SICI)1521-1878(199804)20:4<328::AID-BIES9>3.0.CO;2-L; BURGOYNE RD, 1993, BIOCHEM J, V293, P305, DOI 10.1042/bj2930305; Capaldo CT, 2007, MOL BIOL CELL, V18, P189, DOI 10.1091/mbc.E06-05-0471; Chae TH, 2004, NAT GENET, V36, P264, DOI 10.1038/ng1302; Citterio C, 2008, P NATL ACAD SCI USA, V105, P2877, DOI 10.1073/pnas.0712224105; Dancourt J, 2010, ANNU REV BIOCHEM, V79, P777, DOI 10.1146/annurev-biochem-061608-091319; Davis MA, 2006, DEV CELL, V10, P21, DOI 10.1016/j.devcel.2005.12.004; Davis MA, 2003, J CELL BIOL, V163, P525, DOI 10.1083/jcb.200307111; Delva E, 2009, TRAFFIC, V10, P259, DOI 10.1111/j.1600-0854.2008.00862.x; Diaz F, 2009, P NATL ACAD SCI USA, V106, P11143, DOI 10.1073/pnas.0811227106; Donaldson JG, 2005, BIOCHEM SOC T, V33, P639, DOI 10.1042/BST0330639; Ducharme NA, 2006, MOL BIOL CELL, V17, P3625, DOI 10.1091/mbc.E05-08-0736; Giepmans BNG, 2009, BBA-BIOMEMBRANES, V1788, P820, DOI 10.1016/j.bbamem.2008.07.015; Gillingham AK, 2007, ANNU REV CELL DEV BI, V23, P579, DOI 10.1146/annurev.cellbio.23.090506.123209; Gonzalez-Mariscal L, 2008, BBA-BIOMEMBRANES, V1778, P729, DOI 10.1016/j.bbamem.2007.08.018; Green KJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000125; Hartsock A, 2008, BBA-BIOMEMBRANES, V1778, P660, DOI 10.1016/j.bbamem.2007.07.012; Hong WJ, 2005, BBA-MOL CELL RES, V1744, P120, DOI 10.1016/j.bbamcr.2005.03.014; Hu W, 2005, MOL BIOL CELL, V16, P1555, DOI 10.1091/mbc.E04-07-0594; Ireton RC, 2002, J CELL BIOL, V159, P465, DOI 10.1083/jcb.200205115; Ivanov AI, 2005, BIOESSAYS, V27, P356, DOI 10.1002/bies.20203; Ivanov AI, 2004, MOL BIOL CELL, V15, P176, DOI 10.1091/mbc.E03-05-0319; Ivanov AI, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000658; Ivanov AI, 2010, AM J PATHOL, V177, P512, DOI 10.2353/ajpath.2010.100168; Ivanov AI, 2010, AM J PATHOL, V176, P134, DOI 10.2353/ajpath.2010.090220; Jackson C L, 2000, Subcell Biochem, V34, P233; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Kawamoto K, 2002, TRAFFIC, V3, P483, DOI 10.1034/j.1600-0854.2002.30705.x; LATTERICH M, 1995, CELL, V82, P885, DOI 10.1016/0092-8674(95)90268-6; Laukoetter MG, 2007, J EXP MED, V204, P3067, DOI 10.1084/jem.20071416; Le TL, 1999, J CELL BIOL, V146, P219, DOI 10.1083/jcb.146.1.219; LEBIVIC A, 1989, P NATL ACAD SCI USA, V86, P9313; Lin Y, 2005, J BIOL CHEM, V280, P12799, DOI 10.1074/jbc.M413968200; Lipschutz JH, 2003, J BIOL CHEM, V278, P20954, DOI 10.1074/jbc.M213210200; Lock JG, 2005, TRAFFIC, V6, P1142, DOI 10.1111/j.1600-0854.2005.00349.x; LOUVARD D, 1980, P NATL ACAD SCI-BIOL, V77, P4132, DOI 10.1073/pnas.77.7.4132; Low SH, 1998, J CELL BIOL, V141, P1503, DOI 10.1083/jcb.141.7.1503; Malsam J, 2008, CELL MOL LIFE SCI, V65, P2814, DOI 10.1007/s00018-008-8352-3; Marsden M, 2003, CURR BIOL, V13, P1182, DOI 10.1016/S0960-9822(03)00433-0; Martin HGS, 2006, J CELL BIOCHEM, V99, P1203, DOI 10.1002/jcb.20998; Martinez-Rico C, 2010, J CELL SCI, V123, P712, DOI 10.1242/jcs.047878; McCarter SD, 2010, TRAFFIC, V11, P856, DOI 10.1111/j.1600-0854.2010.01052.x; McNeil E, 2006, MOL BIOL CELL, V17, P1922, DOI 10.1091/mbc.E05-07-0650; Morimoto S, 2005, J BIOL CHEM, V280, P2220, DOI 10.1074/jbc.M406906200; Morinaga N, 1996, P NATL ACAD SCI USA, V93, P12856, DOI 10.1073/pnas.93.23.12856; Nakajima K, 2004, EMBO J, V23, P3216, DOI 10.1038/sj.emboj.7600333; Naydenov NG, 2010, MOL BIOL CELL, V21, P3506, DOI 10.1091/mbc.E10-03-0259; Nejsum LN, 2007, J CELL BIOL, V178, P323, DOI 10.1083/jcb.200705094; Niessen CM, 2008, BBA-BIOMEMBRANES, V1778, P562, DOI 10.1016/j.bbamem.2007.12.015; Niu TK, 2005, MOL BIOL CELL, V16, P1213, DOI 10.1091/mbc.E04-07-0599; Paris L, 2008, BBA-BIOMEMBRANES, V1778, P646, DOI 10.1016/j.bbamem.2007.08.004; Perez-Moreno M, 2006, CELL, V124, P631, DOI 10.1016/j.cell.2005.11.043; Peter F, 1998, J CELL SCI, V111, P2625; Pochec E, 2006, EUR J CELL BIOL, V85, P47, DOI 10.1016/j.ejcb.2005.08.010; Pokutta S, 2007, ANNU REV CELL DEV BI, V23, P237, DOI 10.1146/annurev.cellbio.22.010305.104241; Polishchuk R, 2004, NAT CELL BIOL, V6, P297, DOI 10.1038/ncb1109; Pulvirenti T, 2008, NAT CELL BIOL, V10, P912, DOI 10.1038/ncb1751; Rabouille C, 1998, CELL, V92, P603, DOI 10.1016/S0092-8674(00)81128-9; REYNOLDS AB, 1994, MOL CELL BIOL, V14, P8333, DOI 10.1128/MCB.14.12.8333; Reynolds AB, 2007, BBA-MOL CELL RES, V1773, P2, DOI 10.1016/j.bbamcr.2006.09.019; RIPLEY CR, 1993, J BIOL CHEM, V268, P3677; Rodriguez-Boulan E, 2005, NAT REV MOL CELL BIO, V6, P233, DOI 10.1038/nrm1593; Saenz JB, 2009, NAT CHEM BIOL, V5, P157, DOI 10.1038/nchembio.144; Sharma N, 2006, J CELL BIOL, V173, P937, DOI 10.1083/jcb.200603132; Sheen VL, 2004, NAT GENET, V36, P69, DOI 10.1038/ng1276; Shen L, 2006, AM J PHYSIOL-GASTR L, V290, pG577, DOI 10.1152/ajpgi.00439.2005; Smalley-Freed WG, 2010, J CLIN INVEST, V120, P1824, DOI 10.1172/JCI41414; Spang A, 2009, CURR OPIN CELL BIOL, V21, P531, DOI 10.1016/j.ceb.2009.03.003; Taulet N, 2009, J BIOL CHEM, V284, P23137, DOI 10.1074/jbc.M109.017665; Troyanovsky RB, 2006, MOL BIOL CELL, V17, P3484, DOI 10.1091/mbc.E06-03-0190; Tsukita S, 2001, NAT REV MOL CELL BIO, V2, P285, DOI 10.1038/35067088; Turner JR, 2009, NAT REV IMMUNOL, V9, P799, DOI 10.1038/nri2653; Ungar D, 2003, ANNU REV CELL DEV BI, V19, P493, DOI 10.1146/annurev.cellbio.19.110701.155609; Verrier SE, 2008, EUR J CELL BIOL, V87, P863, DOI 10.1016/j.ejcb.2008.07.003; Wang YZ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001647; Whiteheart SW, 2001, INT REV CYTOL, V207, P71; Winter U, 2009, J BIOL CHEM, V284, P31817, DOI 10.1074/jbc.M109.045286; Wirtz-Peitz F, 2009, CURR OPIN GENET DEV, V19, P350, DOI 10.1016/j.gde.2009.04.011; Wu J, 1998, HYBRIDOMA, V17, P175, DOI 10.1089/hyb.1998.17.175; Yamamoto Y, 2003, BIOCHEM BIOPH RES CO, V308, P270, DOI 10.1016/S0006-291X(03)01358-5; Yan HHN, 2008, CURR TOP DEV BIOL, V80, P57, DOI 10.1016/S0070-2153(07)80002-0; Yano T, 2011, J CELL BIOL, V193, P319, DOI 10.1083/jcb.201009100; Yap AS, 2007, CURR OPIN CELL BIOL, V19, P508, DOI 10.1016/j.ceb.2007.09.008; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	91	28	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2012	7	4							e34320	10.1371/journal.pone.0034320	http://dx.doi.org/10.1371/journal.pone.0034320			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952GU	22485163	gold, Green Published, Green Submitted			2022-12-27	WOS:000304780500038
J	Opitz, SEW; Boeve, JL; Nagy, ZT; Sonet, G; Koch, F; Muller, C				Opitz, Sebastian E. W.; Boeve, Jean-Luc; Nagy, Zoltan Tamas; Sonet, Gontran; Koch, Frank; Mueller, Caroline			Host Shifts from Lamiales to Brassicaceae in the Sawfly Genus Athalia	PLOS ONE			English	Article							INSECT PLANT INTERACTIONS; MOLECULAR PHYLOGENY; CHEMICAL DEFENSE; ROSAE-RUFICORNIS; HYMENOPTERA; EVOLUTION; SEQUESTRATION; SPECIALIZATION; CLERODENDRINS; LEPIDOPTERA	Plant chemistry can be a key driver of host shifts in herbivores. Several species in the salwfly genus Athalia are important economic Pests on Brassicaceae, whereas other Athalia species are specialized on Lamiales. These host. plants have glucosides in common which are sequestered by larvae. To disentangle the possible direction of host shifts in this genus, we examined the sequestration specificity and feeding deterrence of iridoid glucosides (IGs) and glucosinolates (GSs) in larvae of five species which either naturally sequester IGs from their hosts within the Plantaginaceae (Lamiales) or GSs from Brassicaceae, respectively. Furthermore, adults were tested for feeding stimulation by a neo-clerodane diterpenoid which occurs in Lamiales. Larvae of the Plantaginaceae-feeders did not sequester artificially administered p-hydroxybenzylGS and were more deterred by GSs than Brassicaceae-feeders were by IGs. In contrast, larvae of Brassicaceae-feeders were able to sequester artificially administered catalpol (IG), which points to an ancestral association with Lamiales. In line with this finding, adults of all tested species were stimulated by the neo-clerodarie diterpenoid. Finally, in a phylogenetic tree inferred from genetic marker sequences of 21 Athalia Species, the sister species of all remaining 20 Athalia species also turned out to be a Lamiales-feeder. Fundamental physiological pre-adaptations, such as the establishment of a glucoside transporter, and mechanisms to circumvent activation of glucosides by glucosidases are therefore necessary prerequisites for successful host shifts between Lamiales and Brassicaceae.	[Opitz, Sebastian E. W.; Mueller, Caroline] Univ Bielefeld, Dept Chem Ecol, D-33615 Bielefeld, Germany; [Boeve, Jean-Luc; Nagy, Zoltan Tamas; Sonet, Gontran] Royal Belgian Inst Nat Sci, IRSNB KBIN, Brussels, Belgium; [Koch, Frank] Humboldt Univ, Museum Nat Kunde, Leibniz Inst Evolut & Biodiversitatsforsch, D-10099 Berlin, Germany	University of Bielefeld; Royal Belgian Institute of Natural Sciences; Humboldt University of Berlin; Leibniz Institut fur Evolutions und Biodiversitatsforschung	Opitz, SEW (corresponding author), Univ Bielefeld, Dept Chem Ecol, D-33615 Bielefeld, Germany.	caroline.mueller@uni-bielefeld.de	Nagy, Zoltan T./C-6737-2011; Muller, Caroline/G-5073-2011; Opitz, Sebastian Ed Wieland/AAG-2898-2022; Opitz, Sebastian Ed Wieland/AFK-4118-2022	Nagy, Zoltan T./0000-0002-8455-040X; Muller, Caroline/0000-0002-8447-534X; 	Deutsche Forschungsgemeinschaft [MU1829/1-1]; Joint Experimental Molecular Unit, Belgian Science Policy Office; Belgian Directorate-General for Development Cooperation	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Joint Experimental Molecular Unit, Belgian Science Policy Office; Belgian Directorate-General for Development Cooperation	This work was funded mainly by the grant MU1829/1-1 of the Deutsche Forschungsgemeinschaft. The phylogenetic analyses were supported by the Joint Experimental Molecular Unit that is supported by the Belgian Science Policy Office. Athalia specimens from Ethiopia were collected in the frame of a Global Taxonomy Initiative project in collaboration with S. Mengistou (2437FRK2_T1_GTI-01_Boeve&Pauly_2010) and supported financially by the Belgian Directorate-General for Development Cooperation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABE M, 1988, Esakia, P91; Amano T, 1999, CHEMOECOLOGY, V9, P145, DOI 10.1007/s000490050046; Benson RB, 1962, B BRIT MUS NAT HIST, V11, P334; Berenbaum MR, 2001, ANN MO BOT GARD, V88, P45, DOI 10.2307/2666131; BERNAYS E, 1988, ECOLOGY, V69, P886, DOI 10.2307/1941237; Bernays E. A., 1994, Host-plant selection by phytophagous insects.; Byng JW, 2016, BOT J LINN SOC, V181, P1, DOI 10.1111/boj.12385; CHEVIN H, 1969, ANN SOC ENTOMOL FR, V5, P825; Dobler S, 2001, BASIC APPL ECOL, V2, P15, DOI 10.1078/1439-1791-00032; Dobler S, 1996, EVOLUTION, V50, P2373, DOI [10.2307/2410706, 10.1111/j.1558-5646.1996.tb03625.x]; Dobler S, 2011, PHYTOCHEMISTRY, V72, P1593, DOI 10.1016/j.phytochem.2011.04.015; EHRLICH PR, 1964, EVOLUTION, V18, P586, DOI 10.2307/2406212; FARRELL B, 1990, EVOLUTION, V44, P1389, DOI 10.1111/j.1558-5646.1990.tb03834.x; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Fordyce JA, 2010, P ROY SOC B-BIOL SCI, V277, P3735, DOI 10.1098/rspb.2010.0211; Futuyma DJ, 1996, PHILOS T R SOC B, V351, P1361, DOI 10.1098/rstb.1996.0119; FUTUYMA DJ, 1990, EVOLUTION, V44, P1885, DOI 10.1111/j.1558-5646.1990.tb04298.x; FUTUYMA DJ, 1992, HERBIVORES THEIR INT, P439; Futuyma DJ, 2009, P NATL ACAD SCI USA, V106, P18054, DOI 10.1073/pnas.0904106106; HANAZAWA M, 1995, DISCRETE APPL MATH, V56, P245, DOI 10.1016/0166-218X(94)00089-V; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; JAENIKE J, 1990, ANNU REV ECOL SYST, V21, P243, DOI 10.1146/annurev.es.21.110190.001331; Jahner JP, 2011, EVOLUTION, V65, P2719, DOI 10.1111/j.1558-5646.2011.01310.x; Janz N, 2001, EVOLUTION, V55, P783, DOI 10.1554/0014-3820(2001)055[0783:EDOHPS]2.0.CO;2; Janz N, 1998, EVOLUTION, V52, P486, DOI [10.2307/2411084, 10.1111/j.1558-5646.1998.tb01648.x]; Janz N, 2008, SPECIALIZATION, SPECIATION, AND RADIATION: THE EVOLUTIONARY BIOLOGY OF HERBIVOROUS INSECTS, P203; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Katoh K, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-212; Kim HY, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0024749, 10.1371/journal.pone.0019867]; Koch Frank, 2006, P297; Koch Frank, 2007, Mitteilungen Muenchener Entomologischen Gesellschaft, V97, P81; Lacourt Jean, 1999, Memoires de la SEF, V3, P1; Lauber K., 2007, FLORA HELVETICA; Malakov PY, 1998, PHYTOCHEMISTRY, V49, P811, DOI 10.1016/S0031-9422(97)01027-3; Menken SBJ, 1998, ENDLESS FORMS, P145; MERRITT AT, 1992, NAT PROD REP, V9, P243, DOI 10.1039/np9920900243; MITTER C, 1991, TRENDS ECOL EVOL, V6, P290, DOI 10.1016/0169-5347(91)90007-K; Morant AV, 2008, PHYTOCHEMISTRY, V69, P1795, DOI 10.1016/j.phytochem.2008.03.006; Muller C, 2009, PHYTOCHEM REV, V8, P121, DOI 10.1007/s11101-008-9115-3; Muller C, 2001, J CHEM ECOL, V27, P2505, DOI 10.1023/A:1013631616141; Murphy SM, 2004, P NATL ACAD SCI USA, V101, P18048, DOI 10.1073/pnas.0406490102; Narushima H, 1997, DISCRETE APPL MATH, V80, P231, DOI 10.1016/S0166-218X(97)00088-7; Nishida R, 2004, BIOCHEM SYST ECOL, V32, P15, DOI 10.1016/S0305-1978(03)00160-1; NISHIDA R, 1990, J CHEM ECOL, V16, P151, DOI 10.1007/BF01021276; NISHIDA R, 1989, AGR BIOL CHEM TOKYO, V53, P1641, DOI 10.1080/00021369.1989.10869500; Normark BB, 1999, P ROY SOC B-BIOL SCI, V266, P2253, DOI 10.1098/rspb.1999.0916; Nylin S, 2009, EVOL ECOL, V23, P137, DOI 10.1007/s10682-007-9205-5; Nyman T, 2006, SYST ENTOMOL, V31, P569, DOI 10.1111/j.1365-3113.2006.00336.x; Nyman T, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-266; Opitz SEW, 2011, CHEMBIOCHEM, V12, P1252, DOI 10.1002/cbic.201100053; Opitz SEW, 2010, J CHEM ECOL, V36, P148, DOI 10.1007/s10886-010-9740-3; Opitz SEW, 2009, CHEMOECOLOGY, V19, P117, DOI 10.1007/s00049-009-0018-6; Opitz SEW, 2011, THESIS BIELEFELD U G; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Rambaut A., 2009, TRACER MCMC TRACE AN; Schmidt S, 2006, ORG DIVERS EVOL, V6, P127, DOI 10.1016/j.ode.2005.07.002; SCHULTZ JC, 1988, ECOLOGY, V69, P896, DOI 10.2307/1941239; Speyer W., 1954, HDB PFLANZENKRANKHEI, P270; Swofford DL, 2002, PAUP 4 0B10 PHYLOGEN; Taeger A., 1998, PFLANZENWESPEN DEUTS, P49; Taeger A, 2010, ZOOTAXA, P1, DOI 10.11646/zootaxa.2580.1.1; Termonia A, 2002, P ROY SOC B-BIOL SCI, V269, P1, DOI 10.1098/rspb.2001.1859; Termonia A, 2001, P NATL ACAD SCI USA, V98, P3909, DOI 10.1073/pnas.061034598; Turner H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009933; Winkler IS, 2008, SPECIALIZATION, SPECIATION, AND RADIATION: THE EVOLUTIONARY BIOLOGY OF HERBIVOROUS INSECTS, P240; Winkler IS, 2009, P NATL ACAD SCI USA, V106, P18103, DOI 10.1073/pnas.0904852106	67	18	18	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2012	7	4							e33649	10.1371/journal.pone.0033649	http://dx.doi.org/10.1371/journal.pone.0033649			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952GU	22485146	Green Published, gold			2022-12-27	WOS:000304780500022
J	Frank, TD; Carmody, AM; Kholodenko, BN				Frank, Till D.; Carmody, Aimee M.; Kholodenko, Boris N.			Versatility of Cooperative Transcriptional Activation: A Thermodynamical Modeling Analysis for Greater-Than-Additive and Less-Than-Additive Effects	PLOS ONE			English	Article							COMBINATORIAL CIS-REGULATION; AMP RECEPTOR PROTEIN; COLI RNA-POLYMERASE; SYNERGISTIC ACTIVATION; BACTERIOPHAGE-LAMBDA; TYROSINE-HYDROXYLASE; PROMOTER RECOGNITION; BINDING-AFFINITY; DOPAMINE NEURONS; TERNARY COMPLEX	We derive a statistical model of transcriptional activation using equilibrium thermodynamics of chemical reactions. We examine to what extent this statistical model predicts synergy effects of cooperative activation of gene expression. We determine parameter domains in which greater-than-additive and less-than-additive effects are predicted for cooperative regulation by two activators. We show that the statistical approach can be used to identify different causes of synergistic greater-than-additive effects: nonlinearities of the thermostatistical transcriptional machinery and three-body interactions between RNA polymerase and two activators. In particular, our model-based analysis suggests that at low transcription factor concentrations cooperative activation cannot yield synergistic greater-than-additive effects, i.e., DNA transcription can only exhibit less-than-additive effects. Accordingly, transcriptional activity turns from synergistic greater-than-additive responses at relatively high transcription factor concentrations into less-than-additive responses at relatively low concentrations. In addition, two types of re-entrant phenomena are predicted. First, our analysis predicts that under particular circumstances transcriptional activity will feature a sequence of less-than-additive, greater-than-additive, and eventually less-than-additive effects when for fixed activator concentrations the regulatory impact of activators on the binding of RNA polymerase to the promoter increases from weak, to moderate, to strong. Second, for appropriate promoter conditions when activator concentrations are increased then the aforementioned re-entrant sequence of less-than-additive, greater-than-additive, and less-than-additive effects is predicted as well. Finally, our model-based analysis suggests that even for weak activators that individually induce only negligible increases in promoter activity, promoter activity can exhibit greater-than-additive responses when transcription factors and RNA polymerase interact by means of three-body interactions. Overall, we show that versatility of transcriptional activation is brought about by nonlinearities of transcriptional response functions and interactions between transcription factors, RNA polymerase and DNA.	[Frank, Till D.; Carmody, Aimee M.; Kholodenko, Boris N.] Univ Coll Dublin, Syst Biol Ireland, Dublin 2, Ireland; [Frank, Till D.] Univ Coll Dublin, Sch Phys, Dublin 2, Ireland	University College Dublin; University College Dublin	Frank, TD (corresponding author), Univ Coll Dublin, Syst Biol Ireland, Dublin 2, Ireland.	till.frank@ucd.ie	Admin, SBI/HGB-2738-2022	Shi, Qizhen/0000-0003-1548-0708; Kholodenko, Boris/0000-0002-9483-4975	Science Foundation Ireland [06/CE/B1129]	Science Foundation Ireland(Science Foundation IrelandEuropean Commission)	This work was funded by an award from Science Foundation Ireland - reference number: 06/CE/B1129. The funders have no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACKERS GK, 1982, P NATL ACAD SCI-BIOL, V79, P1129, DOI 10.1073/pnas.79.4.1129; Alon U, 2007, INTRO SYSTEMS BIOL D; [Anonymous], [No title captured]; AUBLE DT, 1986, J BIOL CHEM, V261, P1202; Ay A, 2011, CRIT REV BIOCHEM MOL, V46, P137, DOI 10.3109/10409238.2011.556597; Bintu L, 2005, CURR OPIN GENET DEV, V15, P125, DOI 10.1016/j.gde.2005.02.006; Bintu L, 2005, CURR OPIN GENET DEV, V15, P116, DOI 10.1016/j.gde.2005.02.007; Bonarek P, 2008, ACTA BIOCHIM POL, V55, P537, DOI 10.18388/abp.2008_3060; Buchler NE, 2003, P NATL ACAD SCI USA, V100, P5136, DOI 10.1073/pnas.0930314100; BUSBY S, 1994, J MOL BIOL, V241, P341, DOI 10.1006/jmbi.1994.1511; CAREY M, 1992, J VIROL, V66, P4803, DOI 10.1128/JVI.66.8.4803-4813.1992; Carey M, 1998, CELL, V92, P5, DOI 10.1016/S0092-8674(00)80893-4; Chi TH, 1996, GENE DEV, V10, P2540, DOI 10.1101/gad.10.20.2540; COUNTRYMAN JK, 1994, J VIROL, V68, P7628, DOI 10.1128/JVI.68.11.7628-7633.1994; Darling PJ, 2000, J MOL BIOL, V302, P625, DOI 10.1006/jmbi.2000.4050; Fakhouri WD, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2009.97; Frank T.D., 2005, SPRINGER SERIES SYNE; Frank TD, 2004, PHYSICA D, V189, P199, DOI 10.1016/j.physd.2003.08.010; Garcia HG, 2011, P NATL ACAD SCI USA, V108, P12173, DOI 10.1073/pnas.1015616108; GarciaOjalvo J, 1996, PHYS REV E, V54, P6918, DOI 10.1103/PhysRevE.54.6918; Gedeon T, 2008, B MATH BIOL, V70, P1660, DOI 10.1007/s11538-008-9313-6; Genovese W, 1998, PHYS REV E, V57, pR2495, DOI 10.1103/PhysRevE.57.R2495; Gertz J, 2009, MOL SYST BIOL, V5, DOI [10.1038/msb2009.1, 10.1038/msb.2009.1]; Gertz J, 2009, NATURE, V457, P215, DOI 10.1038/nature07521; He X, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000935; JOHNSON AD, 1981, NATURE, V294, P217, DOI 10.1038/294217a0; JOUNG JK, 1993, P NATL ACAD SCI USA, V90, P3083, DOI 10.1073/pnas.90.7.3083; JOUNG JK, 1994, SCIENCE, V265, P1863, DOI 10.1126/science.8091212; Kinney JB, 2010, P NATL ACAD SCI USA, V107, P9158, DOI 10.1073/pnas.1004290107; Kittappa R, 2007, PLOS BIOL, V5, P2875, DOI 10.1371/journal.pbio.0050325; Kuhlman T, 2007, P NATL ACAD SCI USA, V104, P6043, DOI 10.1073/pnas.0606717104; Lahiri A, 2009, STAT MECH ELEMENTARY; Lee HS, 2010, STEM CELLS, V28, P501, DOI 10.1002/stem.294; Levine M, 2010, CURR BIOL, V20, pR754, DOI 10.1016/j.cub.2010.06.070; Muller R, 1997, PHYS REV E, V56, P2658, DOI 10.1103/PhysRevE.56.2658; Nakakuki T, 2010, CELL, V141, P884, DOI 10.1016/j.cell.2010.03.054; Parker DS, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002077; Prakash N, 2006, J PHYSIOL-LONDON, V575, P403, DOI 10.1113/jphysiol.2006.113464; Ptashne M, 1997, NATURE, V386, P569, DOI 10.1038/386569a0; Reinitz John, 2003, ComPlexUs, V1, P54, DOI 10.1159/000070462; Sakurada K, 1999, DEVELOPMENT, V126, P4017; Segal E, 2008, NATURE, V451, P535, DOI 10.1038/nature06496; SHEA MA, 1985, J MOL BIOL, V181, P211, DOI 10.1016/0022-2836(85)90086-5; SZOKE PA, 1987, BIOCHEMISTRY-US, V26, P6188, DOI 10.1021/bi00393a035; VANDENBROECK C, 1994, PHYS REV LETT, V73, P3395, DOI 10.1103/PhysRevLett.73.3395; Veitia RA, 2003, BIOL REV, V78, P149, DOI 10.1017/S1464793102006036; Vogel SK, 2002, NUCLEIC ACIDS RES, V30, P4094, DOI 10.1093/nar/gkf519; Wang J, 1999, J MOL BIOL, V286, P315, DOI 10.1006/jmbi.1998.2489; Zhang T, 2007, NEUROSCI LETT, V423, P118, DOI 10.1016/j.neulet.2007.06.041; Zinzen RP, 2007, PLOS COMPUT BIOL, V3, P826, DOI 10.1371/journal.pcbi.0030084; Zinzen RP, 2006, CURR BIOL, V16, P1358, DOI 10.1016/j.cub.2006.05.044	51	10	10	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2012	7	4							e34439	10.1371/journal.pone.0034439	http://dx.doi.org/10.1371/journal.pone.0034439			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959FE	22506020	Green Published, Green Submitted, gold			2022-12-27	WOS:000305297500028
J	Liao, SF; Yang, HI; Lee, MH; Chen, CJ; Lee, WC				Liao, Shu-Fen; Yang, Hwai-I; Lee, Mei-Hsuan; Chen, Chien-Jen; Lee, Wen-Chung			Fifteen-Year Population Attributable Fractions and Causal Pies of Risk Factors for Newly Developed Hepatocellular Carcinomas in 11,801 Men in Taiwan	PLOS ONE			English	Article							CHRONIC HEPATITIS-B; C VIRUS-INFECTIONS; EPIDEMIOLOGIC CHARACTERISTICS; CIGARETTE-SMOKING; ALCOHOL; PREDICTORS; CIRRHOSIS	Development of hepatocellular carcinoma (HCC) is a multi-factorial process. Chronic infections with hepatitis B virus (HBV) and hepatitis C virus (HCV) are important risk factors of HCC. Host factors, such as alcohol drinking, may also play a role. This study aims to provide a synthesis view on the development of HCC by examining multiple risk factors jointly and collectively. Causal-pie modeling technique was applied to analyze a cohort of 11,801 male residents (followed up for 15 years) in Taiwan, during which a total of 298 incident HCC cases were ascertained. The rate ratios adjusted by age were further modeled by an additive Poisson regression. Population attributable fractions (PAFs) and causal-pie weights (CPWs) were calculated. A PAF indicates the magnitude of case-load reduction under a particular intervention scenario, whereas a CPW for a particular class of causal pies represents the proportion of HCC cases attributable to that class. Using PAF we observed a chance to reduce around 60% HCC risk moving from no HBV-related intervention to the total elimination of the ;virus. An additional similar to 15% (or similar to 5%) reduction can be expected, if the HBV-related intervention is coupled with an HCV-related intervention (or an anti-drinking campaign). Eight classes of causal pies were found to be significant, including four dose-response classes of HBV (total CPW = 52.7%), one independent-effect class of HCV (CPW = 14.4%), one HBV-alcohol interaction class (CPW = 4.2%), one HBV-HCV interaction class (CPW = 1.7%), and one all-unknown class (CPW = 27.0%). Causal-pie modeling for HCC helps clarify the relative importance of each viral and host factor, as well as their interactions.	[Liao, Shu-Fen; Lee, Wen-Chung] Natl Taiwan Univ, Res Ctr Genes Environm & Human Hlth, Taipei 10764, Taiwan; [Liao, Shu-Fen; Lee, Wen-Chung] Natl Taiwan Univ, Inst Epidemiol & Prevent Med, Coll Publ Hlth, Taipei 10764, Taiwan; [Yang, Hwai-I] China Med Univ, Mol & Genom Epidemiol Ctr, China Med Univ Hosp, Taichung, Taiwan; [Yang, Hwai-I] China Med Univ, Grad Inst Clin Med Sci, Taichung, Taiwan; [Lee, Mei-Hsuan; Chen, Chien-Jen] Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan	National Taiwan University; National Taiwan University; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; Academia Sinica - Taiwan	Liao, SF (corresponding author), Natl Taiwan Univ, Res Ctr Genes Environm & Human Hlth, Taipei 10764, Taiwan.	wenchung@ntu.edu.tw	Lee, Mei-Hsuan/J-8880-2015; Yang, Hwai-I/A-9470-2008; Chen, Chien-Jen/C-6976-2008; Huang, HsiaoYuan/F-5985-2012; Chen, Chien-Jen/N-4723-2019	Lee, Mei-Hsuan/0000-0002-0222-2251; Yang, Hwai-I/0000-0002-3433-942X; Lee, Wen-Chung/0000-0003-3171-7672; LIAO, SHU-FEN/0000-0003-0943-0667	National Science Council, Taiwan [NSC99-2628-B-002-061-MY3]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This study was partly supported by a grant from the National Science Council, Taiwan (NSC99-2628-B-002-061-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. These authors have no additional external support or funding to report.	Boshuizen HC, 2010, FITTING ADDITIVE POI; Chen CJ, 2011, J GASTROEN HEPATOL, V26, P628, DOI 10.1111/j.1440-1746.2011.06695.x; Chen CJ, 2009, HEPATOLOGY, V49, pS72, DOI 10.1002/hep.22884; Chen CJ, 1997, J GASTROEN HEPATOL, V12, pS294, DOI 10.1111/j.1440-1746.1997.tb00513.x; Chen CJ, 2002, HEPATOLOGY, V36, P1046, DOI 10.1053/jhep.2002.37084; Chen CJ, 2006, JAMA-J AM MED ASSOC, V295, P65, DOI 10.1001/jama.295.1.65; Cramp ME, 1999, GUT, V45, P168, DOI 10.1136/gut.45.2.168; Donato F, 1998, INT J CANCER, V75, P347, DOI 10.1002/(SICI)1097-0215(19980130)75:3&lt;347::AID-IJC4&gt;3.0.CO;2-2; Ferlay J, 2010, IARC CANCERBASE, V10; Gao B, 2002, ALCOHOL, V27, P69, DOI 10.1016/S0741-8329(02)00201-X; Huang YT, 2011, J CLIN ONCOL, V29, P3643, DOI 10.1200/JCO.2011.36.2335; Iloeje UH, 2007, CLIN GASTROENTEROL H, V5, P921, DOI 10.1016/j.cgh.2007.06.015; Lee MH, 2010, J CLIN ONCOL, V28, P4587, DOI 10.1200/JCO.2010.29.1500; Liang TJ, 2004, GASTROENTEROLOGY, V127, pS62, DOI 10.1053/j.gastro.2004.09.017; Liao SF, 2010, ANN EPIDEMIOL, V20, P568, DOI 10.1016/j.annepidem.2010.04.003; Liu JD, 1998, ALCOHOL CLIN EXP RES, V22, p164S, DOI 10.1111/acer.1998.22.s3_part1.164s; Liu Zhihua, 2006, Int J Med Sci, V3, P57; Mandayam S, 2004, SEMIN LIVER DIS, V24, P217, DOI 10.1055/s-2004-832936; McClune AC, 2010, CLIN LIVER DIS, V14, P461, DOI 10.1016/j.cld.2010.05.009; Mendy ME, 2010, J VIRAL HEPATITIS, V17, P115, DOI 10.1111/j.1365-2893.2009.01168.x; Morgan TR, 2004, GASTROENTEROLOGY, V127, pS87, DOI 10.1053/j.gastro.2004.09.020; Mori M, 2000, AM J EPIDEMIOL, V151, P131, DOI 10.1093/oxfordjournals.aje.a010180; Nguyen VTT, 2009, J VIRAL HEPATITIS, V16, P453, DOI 10.1111/j.1365-2893.2009.01117.x; Perz JF, 2006, J HEPATOL, V45, P529, DOI 10.1016/j.jhep.2006.05.013; Sun CA, 2003, AM J EPIDEMIOL, V157, P674, DOI 10.1093/aje/kwg041; Taiwan Cancer Registry, 2007, TAIW CANC REP; Tran G, 2008, BIOSCIENCE HORIZONS, V1, P167, DOI DOI 10.1093/BIOHORIZONS/HZN020; Wands J, 2007, NEW ENGL J MED, V357, P1974, DOI 10.1056/NEJMcibr075652; Wang LY, 2003, CANCER CAUSE CONTROL, V14, P241, DOI 10.1023/A:1023636619477; Yang HI, 2011, LANCET ONCOL, V12, P568, DOI 10.1016/S1470-2045(11)70077-8; Yeh SH, 2010, ONCOLOGY-BASEL, V78, P172, DOI 10.1159/000315247; YU MW, 1991, CANCER RES, V51, P5621	32	18	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2012	7	4							e34779	10.1371/journal.pone.0034779	http://dx.doi.org/10.1371/journal.pone.0034779			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959FE	22506050	gold, Green Published, Green Submitted			2022-12-27	WOS:000305297500058
J	Rabinovich, EI; Kapetanaki, MG; Steinfeld, I; Gibson, KF; Pandit, KV; Yu, GY; Yakhini, Z; Kaminski, N				Rabinovich, Einat I.; Kapetanaki, Maria G.; Steinfeld, Israel; Gibson, Kevin F.; Pandit, Kusum V.; Yu, Guoying; Yakhini, Zohar; Kaminski, Naftali			Global Methylation Patterns in Idiopathic Pulmonary Fibrosis	PLOS ONE			English	Article							GENE-EXPRESSION PROFILES; DNA METHYLATION; LUNG-CANCER; EPIGENETIC REGULATION; HYPERMETHYLATION; HYPOMETHYLATION; ACTIVATION; RETROTRANSPOSON; FIBROBLASTS; EPIGENOMICS	Background: Idiopathic Pulmonary Fibrosis (IPF) is characterized by profound changes in the lung phenotype including excessive extracellular matrix deposition, myofibroblast foci, alveolar epithelial cell hyperplasia and extensive remodeling. The role of epigenetic changes in determining the lung phenotype in IPF is unknown. In this study we determine whether IPF lungs exhibit an altered global methylation profile. Methodology/Principal Findings: Immunoprecipitated methylated DNA from 12 IPF lungs, 10 lung adenocarcinomas and 10 normal histology lungs was hybridized to Agilent human CpG Islands Microarrays and data analysis was performed using BRB-Array Tools and DAVID Bioinformatics Resources software packages. Array results were validated using the EpiTYPER MassARRAY platform for 3 CpG islands. 625 CpG islands were differentially methylated between IPF and control lungs with an estimated False Discovery Rate less than 5%. The genes associated with the differentially methylated CpG islands are involved in regulation of apoptosis, morphogenesis and cellular biosynthetic processes. The expression of three genes (STK17B, STK3 and HIST1H2AH) with hypomethylated promoters was increased in IPF lungs. Comparison of IPF methylation patterns to lung cancer or control samples, revealed that IPF lungs display an intermediate methylation profile, partly similar to lung cancer and partly similar to control with 402 differentially methylated CpG islands overlapping between IPF and cancer. Despite their similarity to cancer, IPF lungs did not exhibit hypomethylation of long interspersed nuclear element 1 (LINE-1) retrotransposon while lung cancer samples did, suggesting that the global hypomethylation observed in cancer was not typical of IPF. Conclusions/Significance: Our results provide evidence that epigenetic changes in IPF are widespread and potentially important. The partial similarity to cancer may signify similar pathogenetic mechanisms while the differences constitute IPF or cancer specific changes. Elucidating the role of these specific changes will potentially allow better understanding of the pathogenesis of IPF.	[Rabinovich, Einat I.; Kapetanaki, Maria G.; Gibson, Kevin F.; Pandit, Kusum V.; Yu, Guoying; Kaminski, Naftali] Univ Pittsburgh, Sch Med, Dorothy P & Richard P Simmons Ctr Interstitial Lu, Div Pulm Allergy & Crit Care Med, Pittsburgh, PA 15260 USA; [Steinfeld, Israel; Yakhini, Zohar] Technion Israel Inst Technol, Dept Comp Sci, IL-32000 Haifa, Israel; [Yakhini, Zohar] Agilent Labs, Tel Aviv, Israel	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Technion Israel Institute of Technology; Agilent Technologies	Rabinovich, EI (corresponding author), Univ Pittsburgh, Sch Med, Dorothy P & Richard P Simmons Ctr Interstitial Lu, Div Pulm Allergy & Crit Care Med, Pittsburgh, PA 15260 USA.	kaminskin@upmc.edu	Pandit, Kusum/E-7265-2018	Pandit, Kusum/0000-0001-7458-4705; Yakhini, Zohar/0000-0002-0420-5412; Kaminski, Naftali/0000-0001-5917-4601	NIH [R01HL095397, R01LM009657, RC2HL101715]; Dorothy P. and Richard P. Simmons Chair for Pulmonary Research; American Lung Association Senior Research Training Fellowship Grand; Agilent; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095397, RC2HL101715] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM009657] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dorothy P. and Richard P. Simmons Chair for Pulmonary Research; American Lung Association Senior Research Training Fellowship Grand; Agilent; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	NK, EIR, MK, KFG, KPV and GY were funded by NIH grants R01HL095397, R01LM009657, RC2HL101715 and the Dorothy P. and Richard P. Simmons Chair for Pulmonary Research. EIR was funded by American Lung Association Senior Research Training Fellowship Grand. The above funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: Dr. Yakhini is employed at Agilent Laboratories and his work on the manuscript was funded by Agilent. There are no patents, products in development or marketed products to declare. Dr Yakhini's employment at Agilent had no impact on the design of the study and does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Amer Thoracic Soc, 2000, AM J RESP CRIT CARE, V161, P646; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Boon K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005134; Chalitchagorn K, 2004, ONCOGENE, V23, P8841, DOI 10.1038/sj.onc.1208137; Choi JK, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-7-r70; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Collard HR, 2001, AM J MED, V110, P326, DOI 10.1016/S0002-9343(01)00622-2; Dolinoy DC, 2008, ENVIRON MOL MUTAGEN, V49, P4, DOI 10.1002/em.20366; Dudziec E, 2011, CLIN CANCER RES, V17, P1287, DOI 10.1158/1078-0432.CCR-10-2017; Ehrich M, 2005, P NATL ACAD SCI USA, V102, P15785, DOI 10.1073/pnas.0507816102; Estecio MRH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000399; Fattman CL, 2008, ANTIOXID REDOX SIGN, V10, P379, DOI 10.1089/ars.2007.1907; Faulkner GJ, 2009, NAT GENET, V41, P563, DOI 10.1038/ng.368; Gross TJ, 2001, NEW ENGL J MED, V345, P517, DOI 10.1056/NEJMra003200; Han JS, 2004, NATURE, V429, P268, DOI 10.1038/nature02536; Hecker L, 2009, NAT MED, V15, P1077, DOI 10.1038/nm.2005; Howard G, 2008, ONCOGENE, V27, P404, DOI 10.1038/sj.onc.1210631; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang SK, 2010, AM J PATHOL, V177, P2245, DOI 10.2353/ajpath.2010.100446; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Jones PA, 2001, SCIENCE, V293, P1068, DOI 10.1126/science.1063852; Katzenstein ALA, 1998, AM J RESP CRIT CARE, V157, P1301, DOI 10.1164/ajrccm.157.4.9707039; Keane MP, 1999, J IMMUNOL, V162, P5511; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kim JH, 2011, GENOME RES, V21, P1028, DOI 10.1101/gr.119347.110; Kim KK, 2006, P NATL ACAD SCI USA, V103, P13180, DOI 10.1073/pnas.0605669103; Kim KK, 2009, J CLIN INVEST, V119, P213, DOI 10.1172/JCI36940; Klug M, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-6-r63; Konishi K, 2009, AM J RESP CRIT CARE, V180, P167, DOI 10.1164/rccm.200810-1596OC; Lababede O, 1999, CHEST, V115, P233, DOI 10.1378/chest.115.1.233; Le Jeune I, 2007, RESP MED, V101, P2534, DOI 10.1016/j.rmed.2007.07.012; LI E, 1993, NATURE, V366, P362, DOI 10.1038/366362a0; Liu G, 2010, J EXP MED, V207, P1589, DOI 10.1084/jem.20100035; Liu TJ, 2009, AM J PATHOL, V174, P1745, DOI 10.2353/ajpath.2009.080618; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mohn Fabio, 2009, V507, P55, DOI 10.1007/978-1-59745-522-0_5; Ozawa Y, 2009, RESPIROLOGY, V14, P723, DOI 10.1111/j.1440-1843.2009.01547.x; Pandit KV, 2010, AM J RESP CRIT CARE, V182, P220, DOI 10.1164/rccm.200911-1698OC; Pang MY, 2010, J PHARMACOL EXP THER, V335, P266, DOI 10.1124/jpet.110.168385; Pfeifer GP, 2009, SEMIN CANCER BIOL, V19, P181, DOI 10.1016/j.semcancer.2009.02.008; Rajkumar R, 2010, AM J PHYSIOL-HEART C, V298, pH1235, DOI 10.1152/ajpheart.00254.2009; Rauch T, 2007, P NATL ACAD SCI USA, V104, P5527, DOI 10.1073/pnas.0701059104; Rauch TA, 2008, P NATL ACAD SCI USA, V105, P252, DOI 10.1073/pnas.0710735105; Rosas IO, 2008, PLOS MED, V5, P623, DOI 10.1371/journal.pmed.0050093; Sanders YY, 2008, AM J RESP CELL MOL, V39, P610, DOI 10.1165/rcmb.2007-0322OC; Sanjo H, 1998, J BIOL CHEM, V273, P29066, DOI 10.1074/jbc.273.44.29066; Schwartz David A, 2010, Proc Am Thorac Soc, V7, P123, DOI 10.1513/pats.200908-084RM; Scotton CJ, 2009, J CLIN INVEST, V119, P2550, DOI 10.1172/JCI33288; Segal E, 2004, NAT GENET, V36, P1090, DOI 10.1038/ng1434; Selman M, 2006, AM J RESP CRIT CARE, V173, P188, DOI 10.1164/rccm.200504-644OC; Selman M, 2001, ANN INTERN MED, V134, P136, DOI 10.7326/0003-4819-134-2-200101160-00015; Selman M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000482; Selman M, 2008, PLOS MED, V5, P373, DOI 10.1371/journal.pmed.0050062; Slotkin RK, 2007, NAT REV GENET, V8, P272, DOI 10.1038/nrg2072; Straussman R, 2009, NAT STRUCT MOL BIOL, V16, P564, DOI 10.1038/nsmb.1594; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; Taskar V, 2008, SEMIN RESP CRIT CARE, V29, P670, DOI 10.1055/s-0028-1101277; Taskar Varsha S, 2006, Proc Am Thorac Soc, V3, P293, DOI 10.1513/pats.200512-131TK; Thannickal Victor J, 2006, Proc Am Thorac Soc, V3, P350, DOI 10.1513/pats.200601-001TK; Ting AH, 2006, GENE DEV, V20, P3215, DOI 10.1101/gad.1464906; Toyota M, 2009, CANCER SCI, V100, P787, DOI 10.1111/j.1349-7006.2009.01095.x; Vancheri C, 2010, EUR RESPIR J, V35, P496, DOI 10.1183/09031936.00077309; Vuga LJ, 2009, AM J RESP CELL MOL, V41, P583, DOI 10.1165/rcmb.2008-0201OC; Waterland RA, 2004, NUTRITION, V20, P63, DOI 10.1016/j.nut.2003.09.011; Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598; Weisenberger DJ, 2005, NUCLEIC ACIDS RES, V33, P6823, DOI 10.1093/nar/gki987; Willis BC, 2007, AM J PHYSIOL-LUNG C, V293, pL525, DOI 10.1152/ajplung.00163.2007; Wilson AS, 2007, BBA-REV CANCER, V1775, P138, DOI 10.1016/j.bbcan.2006.08.007; Yamashita S, 2009, DNA RES, V16, P275, DOI 10.1093/dnares/dsp017	71	137	139	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2012	7	4							e33770	10.1371/journal.pone.0033770	http://dx.doi.org/10.1371/journal.pone.0033770			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959FE	22506007	Green Published, Green Accepted, gold			2022-12-27	WOS:000305297500015
J	Xiang, LS; Xie, GF; Ou, JJ; Wei, X; Pan, F; Liang, HJ				Xiang, Lisha; Xie, Ganfeng; Ou, Juanjuan; Wei, Xing; Pan, Feng; Liang, Houjie			The Extra Domain A of Fibronectin Increases VEGF-C Expression in Colorectal Carcinoma Involving the PI3K/AKT Signaling Pathway	PLOS ONE			English	Article							GROWTH-FACTOR-C; LYMPHATIC VESSEL DENSITY; TUMOR-METASTASIS; NODE METASTASIS; CANCER-CELLS; IN-VIVO; LYMPHANGIOGENESIS; MECHANISMS; ADENOCARCINOMA; VASCULATURE	The extra domain A (EDA)-containing fibronectin (EDA-FN), an alternatively spliced form of the extracellular matrix protein fibronectin, is predominantly expressed in various malignancies but not in normal tissues. In the present study, we investigated the potential pro-lymphangiogenesis effects of extra domain A (EDA)-mediated vascular endothelial growth factor-C (VEGF-C) secretion in colorectal carcinoma (CRC). We detected the expressions of EDA and VEGF-C in 52 human colorectal tumor tissues and their surrounding mucosae by immunohistochemical analysis, and further tested the correlation between the expressions of these two proteins in aforementioned CRC tissues. Both EDA and VEGF-C were abundantly expressed in the specimens of human CRC tissues. And VEGF-C was associated with increased expression of EDA in human CRC according to linear regression analysis. Besides, EDA expression was significantly correlated with lymph node metastasis, tumor differentiation and clinical stage by clinicopathological analysis of tissue microarrays containing tumor tissues of 115 CRC patients. Then, human CRC cell SW480 was transfected with lentivectors to elicit expression of shRNA against EDA (shRNA-EDA), and SW620 was transfected with a lentiviral vector to overexpress EDA (pGC-FU-EDA), respectively. We confirmed that VEGF-C was upregulated in EDA-overexpressed cells, and downregulated in shRNA-EDA cells. Moreover, a PI3K-dependent signaling pathway was found to be involved in EDA-mediated VEGF-C secretion. The in vivo result demonstrated that EDA could promote tumor growth and tumor-induced lymphangiogenesis in mouse xenograft models. Our findings provide evidence that EDA could play a role in tumor-induced lymphangiogenesis via upregulating autocrine secretion of VEGF-C in colorectal cancer, which is associated with the PI3K/Akt-dependent pathway.	[Xiang, Lisha] Third Mil Med Univ, Southwest Hosp, Dept Oncol, Chongqing, Peoples R China; Third Mil Med Univ, Southwest Hosp, SW Canc Ctr, Chongqing, Peoples R China	Army Medical University; Army Medical University	Xiang, LS (corresponding author), Third Mil Med Univ, Southwest Hosp, Dept Oncol, Chongqing, Peoples R China.	lianghoujie@sina.com						Achen MG, 2005, CANCER CELL, V7, P121, DOI 10.1016/j.ccr.2005.01.017; Avraamides CJ, 2008, NAT REV CANCER, V8, P604, DOI 10.1038/nrc2353; Bahram Fuad, 2010, Pathophysiology, V17, P253, DOI 10.1016/j.pathophys.2009.10.004; Barresi V, 2011, J CLIN PATHOL, V64, P6, DOI 10.1136/jcp.2010.083550; Beasley NJP, 2002, CANCER RES, V62, P1315; Caunt M, 2008, CANCER CELL, V13, P331, DOI 10.1016/j.ccr.2008.01.029; Chang L, 2002, ANN NY ACAD SCI, V979, P111, DOI 10.1111/j.1749-6632.2002.tb04872.x; Clasper S, 2008, CANCER RES, V68, P7293, DOI 10.1158/0008-5472.CAN-07-6506; Duan Guang-Jie, 2004, Zhonghua Bing Li Xue Za Zhi, V33, P518; Duff SE, 2003, INT J ONCOL, V22, P339; Enholm B, 1997, ONCOGENE, V14, P2475, DOI 10.1038/sj.onc.1201090; Girling JE, 2009, REPRODUCTION, V138, P883, DOI 10.1530/REP-09-0147; Goc A, 2011, INT J ONCOL, V38, P267, DOI 10.3892/ijo_00000847; Karpanen T, 2001, CANCER RES, V61, P1786; Kim JG, 2008, CLIN CANCER RES, V14, P62, DOI 10.1158/1078-0432.CCR-07-1537; Krishnan J, 2003, CANCER RES, V63, P713; Liu HT, 2009, INT J SURG PATHOL, V17, P426, DOI 10.1177/1066896909337505; Mandriota SJ, 2001, EMBO J, V20, P672, DOI 10.1093/emboj/20.4.672; McFadden JP, 2010, BRIT J DERMATOL, V163, P5, DOI 10.1111/j.1365-2133.2010.09737.x; Oliver G, 2002, GENE DEV, V16, P773, DOI 10.1101/gad.975002; Ou JJ, 2010, CANCER BIOL THER, V9, P186, DOI 10.4161/cbt.9.3.10651; Parr C, 2003, INT J ONCOL, V23, P533; Pepper MS, 2001, CLIN CANCER RES, V7, P462; Romberger DJ, 1997, INT J BIOCHEM CELL B, V29, P939, DOI 10.1016/S1357-2725(96)00172-0; Royston D, 2009, J PATHOL, V217, P608, DOI 10.1002/path.2517; Saad RS, 2009, AM J CLIN PATHOL, V131, P92, DOI 10.1309/AJCPKWUQSIPVG90H; Saintigny P, 2007, LUNG CANCER, V58, P205, DOI 10.1016/j.lungcan.2007.06.021; Saji M, 2010, MOL CELL ENDOCRINOL, V321, P20, DOI 10.1016/j.mce.2009.10.016; Skinner HD, 2004, J BIOL CHEM, V279, P45643, DOI 10.1074/jbc.M404097200; Su JL, 2008, CANCER CELL, V13, P557, DOI 10.1016/j.ccr.2008.04.021; Sundlisxter E, 2007, INT J CANCER, V121, P1401, DOI 10.1002/ijc.22996; Tammela T, 2010, CELL, V140, P460, DOI 10.1016/j.cell.2010.01.045; Tang YC, 2003, CANCER RES, V63, P1166; van der Straaten HM, 2004, J INVEST DERMATOL, V123, P1057, DOI 10.1111/j.0022-202X.2004.23474.x; Villa A, 2008, INT J CANCER, V122, P2405, DOI 10.1002/ijc.23408; West KA, 2002, DRUG RESIST UPDATE, V5, P234, DOI 10.1016/S1368-7646(02)00120-6	36	43	47	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2012	7	4							e35378	10.1371/journal.pone.0035378	http://dx.doi.org/10.1371/journal.pone.0035378			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JO	22496919	Green Published, gold, Green Submitted			2022-12-27	WOS:000305014500057
J	Chen, H; Gao, N; Fan, DY; Wu, JM; Zhu, JP; Li, JQ; Wang, J; Chen, YL; An, J				Chen, Hui; Gao, Na; Fan, Dongying; Wu, Jiangman; Zhu, Junping; Li, Jieqiong; Wang, Juan; Chen, Yanlei; An, Jing			Suppressive Effects on the Immune Response and Protective Immunity to a JEV DNA Vaccine by Co-administration of a GM-CSF-Expressing Plasmid in Mice	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; REGULATORY T-CELLS; TOLEROGENIC DENDRITIC CELLS; JAPANESE ENCEPHALITIS-VIRUS; AUTOIMMUNE-THYROIDITIS; RANDOMIZED-TRIAL; CANCER-PATIENTS; IN-VIVO; ANTIGEN; CYTOKINES	As a potential cytokine adjuvant of DNA vaccines, granulocyte-macrophage colony-stimulating factor (GM-CSF) has received considerable attention due to its essential role in the recruitment of antigen-presenting cells, differentiation and maturation of dendritic cells. However, in our recent study of a Japanese encephalitis virus (JEV) DNA vaccine, co-inoculation of a GM-CSF plasmid dramatically suppressed the specific IgG response and resulted in decreased protection against JEV challenge. It is known that GM-CSF has been used in clinic to treat neutropenia for repopulating myeloid cells, and as an adjuvant in vaccine studies; it has shown various effects on the immune response. Therefore, in this study, we characterized the suppressive effects on the immune response to a JEV DNA vaccine by the co-administration of the GM-CSF-expressing plasmid and clarified the underlying mechanisms of the suppression in mice. Our results demonstrated that co-immunization with GM-CSF caused a substantial dampening of the vaccine-induced antibody responses. The suppressive effect was dose-and timing-dependent and likely related to the immunogenicity of the antigen. The suppression was associated with the induction of immature dendritic cells and the expansion of regulatory T cells but not myeloid-derived suppressor cells. Collectively, our findings not only provide valuable information for the application of GM-CSF in clinic and using as a vaccine adjuvant but also offer further insight into the understanding of the complex roles of GM-CSF.	[Chen, Hui; Gao, Na; Fan, Dongying; Wu, Jiangman; Zhu, Junping; Li, Jieqiong; Wang, Juan; Chen, Yanlei; An, Jing] Capital Med Univ, Sch Basic Med Sci, Dept Microbiol, Beijing, Peoples R China	Capital Medical University	Chen, H (corresponding author), Capital Med Univ, Sch Basic Med Sci, Dept Microbiol, Beijing, Peoples R China.	anjing@ccmu.edu.cn	Li, jie/GXG-4583-2022		National Key Programs on Basic Research of China [2011CB504703]; National Natural Science Foundation of China [30872227]; Jurisdiction of Beijing Municipality [20090616119, 200907112]	National Key Programs on Basic Research of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jurisdiction of Beijing Municipality	This work was supported by grants from the National Key Programs on Basic Research of China (2011CB504703, http://www.973.gov.cn/English/Index.aspx), the National Natural Science Foundation of China (30872227, http://www.nsfc.gov.cn/) and the Funding Project for Academic Human Resources Development in Institutions of Higher Learning Under the Jurisdiction of Beijing Municipality (20090616119, 200907112, http://www.bjedu.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abaitua F, 2006, VIRUS RES, V116, P11, DOI 10.1016/j.virusres.2005.08.008; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Chakrabarti R, 2005, VACCINE, V23, P4553, DOI 10.1016/j.vaccine.2005.05.002; Chakrabarti R, 2004, VACCINE, V22, P1199, DOI 10.1016/j.vaccine.2003.09.023; Chang SY, 2004, INT J CANCER, V111, P86, DOI 10.1002/ijc.20232; Chen HW, 1999, J VIROL, V73, P10137, DOI 10.1128/JVI.73.12.10137-10145.1999; Chen HW, 2001, J IMMUNOL, V166, P7419, DOI 10.4049/jimmunol.166.12.7419; Dolcetti L, 2010, EUR J IMMUNOL, V40, P22, DOI 10.1002/eji.200939903; Ganesh BB, 2009, INT IMMUNOL, V21, P269, DOI 10.1093/intimm/dxn147; Gangi E, 2005, J IMMUNOL, V174, P7006, DOI 10.4049/jimmunol.174.11.7006; Gao N, 2010, IMMUNOL LETT, V129, P23, DOI 10.1016/j.imlet.2009.12.023; Gaudreau S, 2007, J IMMUNOL, V179, P3638, DOI 10.4049/jimmunol.179.6.3638; Gillessen S, 2003, P NATL ACAD SCI USA, V100, P8874, DOI 10.1073/pnas.1033098100; Grcevic D, 2006, CLIN EXP IMMUNOL, V146, P146, DOI 10.1111/j.1365-2249.2006.03181.x; Hirota K, 2010, SEMIN IMMUNOPATHOL, V32, P3, DOI 10.1007/s00281-009-0187-y; Jonuleit H, 2000, J EXP MED, V192, P1213, DOI 10.1084/jem.192.9.1213; Kared H, 2008, BLOOD, V112, P2575, DOI 10.1182/blood-2008-02-140681; Kaufman HL, 2002, VACCINE, V20, P1862, DOI 10.1016/S0264-410X(02)00032-4; Kusakabe K, 2000, J IMMUNOL, V164, P3102, DOI 10.4049/jimmunol.164.6.3102; Lahoud MH, 2006, J IMMUNOL, V177, P372, DOI 10.4049/jimmunol.177.1.372; Loudon PT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011021; Lutz MB, 2002, TRENDS IMMUNOL, V23, P445, DOI 10.1016/S1471-4906(02)02281-0; Mach N, 2000, CANCER RES, V60, P3239; Mahnke K, 2002, IMMUNOL CELL BIOL, V80, P477, DOI 10.1046/j.1440-1711.2002.01115.x; Mahnke K, 2007, CELL IMMUNOL, V250, P1, DOI 10.1016/j.cellimm.2008.01.004; Maldonado RA, 2010, ADV IMMUNOL, V108, P111, DOI [10.1016/B978-0-12-380995-7.00004-5, 10.1016/S0065-2776(10)08004_1]; Morales JK, 2010, BREAST CANCER RES TR, V123, P39, DOI 10.1007/s10549-009-0622-8; Nemunaitis J, 2005, EXPERT REV VACCINES, V4, P259, DOI 10.1586/14760584.4.3.259; Nimal S, 2006, VACCINE, V24, P3298, DOI 10.1016/j.vaccine.2006.01.020; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Parmiani G, 2007, ANN ONCOL, V18, P226, DOI 10.1093/annonc/mdl158; Qin L, 2007, J VIROL, V81, P10606, DOI 10.1128/JVI.01000-07; Ramanathan RK, 2002, J CLIN ONCOL, V20, P4313, DOI 10.1200/JCO.2002.02.041; Rutella S, 2004, IMMUNOL LETT, V94, P11, DOI 10.1016/j.imlet.2004.04.015; Serafini P, 2004, CANCER RES, V64, P6337, DOI 10.1158/0008-5472.CAN-04-0757; Serafini P, 2004, CANCER IMMUNOL IMMUN, V53, P64, DOI 10.1007/s00262-003-0443-2; Sheng JR, 2006, J IMMUNOL, V177, P5296, DOI 10.4049/jimmunol.177.8.5296; Shi YF, 2006, CELL RES, V16, P126, DOI 10.1038/sj.cr.7310017; Slingluff CL, 2009, CLIN CANCER RES, V15, P7036, DOI 10.1158/1078-0432.CCR-09-1544; Song XQ, 2009, VACCINE, V27, P690, DOI 10.1016/j.vaccine.2008.11.090; Wallet MA, 2005, CLIN MED RES, V3, P166, DOI 10.3121/cmr.3.3.166; Xu R, 2008, VACCINE, V26, P4819, DOI 10.1016/j.vaccine.2008.06.103; Yang B, 2008, VACCINE, V26, P5477, DOI 10.1016/j.vaccine.2008.07.060; Zhang XZ, 2007, VACCINE, V25, P1342, DOI 10.1016/j.vaccine.2006.09.089; Zheng Q, 2011, VACCINE, V29, P763, DOI 10.1016/j.vaccine.2010.11.014	45	13	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2012	7	4							e34602	10.1371/journal.pone.0034602	http://dx.doi.org/10.1371/journal.pone.0034602			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JA	22493704	Green Published, Green Submitted, gold			2022-12-27	WOS:000305012700046
J	Horvat, EA; Hanselmann, M; Hamprecht, FA; Zweig, KA				Horvat, Emoke-Agnes; Hanselmann, Michael; Hamprecht, Fred A.; Zweig, Katharina A.			One Plus One Makes Three (for Social Networks)	PLOS ONE			English	Article							COMMUNITY STRUCTURE; PREDICTION	Members of social network platforms often choose to reveal private information, and thus sacrifice some of their privacy, in exchange for the manifold opportunities and amenities offered by such platforms. In this article, we show that the seemingly innocuous combination of knowledge of confirmed contacts between members on the one hand and their email contacts to non-members on the other hand provides enough information to deduce a substantial proportion of relationships between non-members. Using machine learning we achieve an area under the (receiver operating characteristic) curve (AUC) of at least 0.85 for predicting whether two non-members known by the same member are connected or not, even for conservative estimates of the overall proportion of members, and the proportion of members disclosing their contacts.	[Horvat, Emoke-Agnes; Zweig, Katharina A.] Heidelberg Univ, Interdisciplinary Ctr Sci Comp IWR, Heidelberg, Germany; [Hanselmann, Michael; Hamprecht, Fred A.] Heidelberg Univ, Heidelberg Collaboratory Image Proc HCI, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Horvat, EA (corresponding author), Heidelberg Univ, Interdisciplinary Ctr Sci Comp IWR, Heidelberg, Germany.	nina@ninasnet.de		Zweig, Katharina Anna/0000-0002-4294-9017	Heidelberg Graduate School of Mathematical and Computational Methods for the Sciences, University of Heidelberg, Germany; German Excellence Initiative [GSC 220]; Marsilius Kolleg, University of Heidelberg	Heidelberg Graduate School of Mathematical and Computational Methods for the Sciences, University of Heidelberg, Germany; German Excellence Initiative; Marsilius Kolleg, University of Heidelberg	EAH and KAZ are supported by the Heidelberg Graduate School of Mathematical and Computational Methods for the Sciences (http://www.mathcomp.uni-heidelberg.de/), University of Heidelberg, Germany, which is funded by the German Excellence Initiative (GSC 220). FAH and KAZ were supported by a fellowship of the Marsilius Kolleg (http://www.marsilius-kolleg.uni-heidelberg.de/), University of Heidelberg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acquisti A, 2006, PRIVACY AND TECHNOLOGIES OF IDENTITY: A CROSS-DISCIPLINARY CONVERSATION, P15, DOI 10.1007/0-387-28222-X_2; Adamic L, 2005, SOC NETWORKS, V27, P187, DOI 10.1016/j.socnet.2005.01.007; Adamic L. A., 2003, First Monday, V8, DOI 10.5210/fm.v8i6.1057; [Anonymous], FAC STAT WEBS; Backstrom L, 2011, P 4 ACM INT C WEB SE, V11, P635; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Clauset A, 2008, NATURE, V453, P98, DOI 10.1038/nature06830; Crandall DJ, 2010, P NATL ACAD SCI USA, V107, P22436, DOI 10.1073/pnas.1006155107; Dietterich TG, 2008, MACH LEARN, V73, P3, DOI 10.1007/s10994-008-5079-1; GETOOR, 2005, ACM SIGKDD EXPLORATI, V7, P3, DOI DOI 10.1145/1117454.1117456; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Gross R, 2005, P 2005 ACM WORKSH PR, P71, DOI DOI 10.1145/1102199.1102214; Hasan MA, 2005, WORKSH LINK DISC ISS; Jernigan C., 2009, 1 MONDAY, V14; Kashima H, 2006, IEEE DATA MINING, P340; Kolaczyk ED, 2009, SPRINGER SER STAT, P1, DOI 10.1007/978-0-387-88146-1_1; Kumar R., 2006, P 12 ACM SIGKDD INT, P611; Leskovec J., 2010, P 19 INT C WORLD WID, P641, DOI [10.1145/1772690.1772756, DOI 10.1145/1772690.1772756]; Liben-Nowell D, 2007, J AM SOC INF SCI TEC, V58, P1019, DOI 10.1002/asi.20591; Lichtenwalter R.N., 2010, P 16 ACM SIGKDD INT, P243; Lindamood J., 2009, P 18 INT C WORLD WID, P1145, DOI DOI 10.1145/1526709.1526899; Liu WP, 2010, EPL-EUROPHYS LETT, V89, DOI 10.1209/0295-5075/89/58007; Mislove A., 2010, P 3 ACM INT C WEB SE, P251, DOI DOI 10.1145/1718487.1718519; Mislove A, 2007, IMC'07: PROCEEDINGS OF THE 2007 ACM SIGCOMM INTERNET MEASUREMENT CONFERENCE, P29; Newman MEJ, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.036122; Newman MEJ, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.208701; O'Madadhain J., 2005, ACM SIGKDD EXPLORATI, V7, P23, DOI DOI 10.1145/1117454.1117458; Pasek J., 2009, 1 MONDAY, V14; Rattigan M., 2005, SIGKDD EXPLORATIONS, V7, P41, DOI DOI 10.1145/1117454.1117460; Red V, 2011, SIAM REV, V53, P526, DOI 10.1137/080734315; Redner S, 2008, NATURE, V453, P47, DOI 10.1038/453047a; Ross C, 2009, COMPUT HUM BEHAV, V25, P578, DOI 10.1016/j.chb.2008.12.024; Toivonen R, 2009, SOC NETWORKS, V31, P240, DOI 10.1016/j.socnet.2009.06.004; Valenzuela S, 2009, J COMPUT-MEDIAT COMM, V14, P875, DOI 10.1111/j.1083-6101.2009.01474.x; Wang C, 2007, IEEE DATA MINING, P322, DOI 10.1109/ICDM.2007.108; Wang D., 2011, P 17 ACM SIGKDD INT, P1100, DOI DOI 10.1145/2020408.2020581; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Weiss G. M., 2004, SIGKDD EXPLORATIONS, V6, P7, DOI DOI 10.1145/1007730.1007734; Zheleva E., 2009, P 18 INT C WORLD WID, P531, DOI DOI 10.1145/1526709.1526781; Zhou T, 2009, EUR PHYS J B, V71, P623, DOI 10.1140/epjb/e2009-00335-8	40	20	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2012	7	4							e34740	10.1371/journal.pone.0034740	http://dx.doi.org/10.1371/journal.pone.0034740			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	955JA	22493713	Green Published, gold			2022-12-27	WOS:000305012700055
J	Li, JM; Jin, ZX; Song, WJ				Li, Junmin; Jin, Zexin; Song, Wenjing			Do Native Parasitic Plants Cause More Damage to Exotic Invasive Hosts Than Native Non-Invasive Hosts? An Implication for Biocontrol	PLOS ONE			English	Article							MIKANIA-MICRANTHA; SURFACE-AREA; RESISTANCE; IMPACTS; TRAITS; GROWTH; CARBON; ROOTS	Field studies have shown that native, parasitic plants grow vigorously on invasive plants and can cause more damage to invasive plants than native plants. However, no empirical test has been conducted and the mechanism is still unknown. We conducted a completely randomized greenhouse experiment using 3 congeneric pairs of exotic, invasive and native, non-invasive herbaceous plant species to quantify the damage caused by parasitic plants to hosts and its correlation with the hosts' growth rate and resource use efficiency. The biomass of the parasitic plants on exotic, invasive hosts was significantly higher than on congeneric native, non-invasive hosts. Parasites caused more damage to exotic, invasive hosts than to congeneric, native, non-invasive hosts. The damage caused by parasites to hosts was significantly positively correlated with the biomass of parasitic plants. The damage of parasites to hosts was significantly positively correlated with the relative growth rate and the resource use efficiency of its host plants. It may be the mechanism by which parasitic plants grow more vigorously on invasive hosts and cause more damage to exotic, invasive hosts than to native, non-invasive hosts. These results suggest a potential biological control effect of native, parasitic plants on invasive species by reducing the dominance of invasive species in the invaded community.	[Li, Junmin; Jin, Zexin; Song, Wenjing] Taizhou Univ, Inst Ecol, Linhai, Zhejiang, Peoples R China	Taizhou University	Li, JM (corresponding author), Taizhou Univ, Inst Ecol, Linhai, Zhejiang, Peoples R China.	lijmtzc@126.com	李, 钧敏/L-7390-2019		National Natural Science Foundation of China [30800133]; China Postdoctoral Science Foundation [20080440557]; National Natural Science Foundation of Zhejiang Province [Y5090253, Y5110227]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); National Natural Science Foundation of Zhejiang Province	Support for the project was provided through funding from the National Natural Science Foundation of China (No. 30800133), China Postdoctoral Science Foundation (No. 20080440557) and National Natural Science Foundation of Zhejiang Province (No. Y5090253; Y5110227). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aritua V, 1998, ANN APPL BIOL, V132, P399, DOI 10.1111/j.1744-7348.1998.tb05217.x; Barton KE, 2008, OIKOS, V117, P917, DOI 10.1111/j.0030-1299.2008.16324.x; Callaway RM, 2006, TRENDS ECOL EVOL, V21, P369, DOI 10.1016/j.tree.2006.04.008; Callaway RM, 2003, ECOLOGY, V84, P1115, DOI 10.1890/0012-9658(2003)084[1115:PPAIAP]2.0.CO;2; Callaway RM, 1999, ECOLOGY, V80, P1196, DOI 10.1890/0012-9658(1999)080[1196:BCHMIC]2.0.CO;2; Cogni R, 2010, BIOTROPICA, V42, P188, DOI 10.1111/j.1744-7429.2009.00570.x; Colautti RI, 2004, ECOL LETT, V7, P721, DOI 10.1111/j.1461-0248.2004.00616.x; Drenovsky RE, 2008, AM J BOT, V95, P681, DOI 10.3732/ajb.2007408; Edit Committee of Flora of China Chinese Academy of Science, 1985, FLORA CHINA, V14, P72; Egilla JN, 2001, PLANT SOIL, V229, P213, DOI 10.1023/A:1004883032383; EISSENSTAT DM, 1992, J PLANT NUTR, V15, P763, DOI 10.1080/01904169209364361; Elton C. S., 1958, ECOLOGY INVASIONS AN; Fu Gai-lan, 2007, Shengtaixue Zazhi, V26, P1590; Funk JL, 2007, NATURE, V446, P1079, DOI 10.1038/nature05719; Grime J. P., 1991, Plant root growth: an ecological perspective., P381; Gonzalez-Santana IH, 2012, PHYSIOL PLANTARUM, V144, P134, DOI 10.1111/j.1399-3054.2011.01527.x; Himmelbauer ML, 2004, PLANT SOIL, V260, P111, DOI 10.1023/B:PLSO.0000030171.28821.55; Jackson RB, 1997, P NATL ACAD SCI USA, V94, P7362, DOI 10.1073/pnas.94.14.7362; JESCHKE WD, 1994, J EXP BOT, V45, P801, DOI 10.1093/jxb/45.6.801; [郝建华 Jianhua Hao], 2009, [植物学报, Chinese Bulletin of Botany], V44, P656; Jogesh T, 2008, BIOL INVASIONS, V10, P797, DOI 10.1007/s10530-008-9236-z; Keane RM, 2002, TRENDS ECOL EVOL, V17, P164, DOI 10.1016/S0169-5347(02)02499-0; Kourtev PS, 2003, SOIL BIOL BIOCHEM, V35, P895, DOI 10.1016/S0038-0717(03)00120-2; Li YL, 2005, BOT BULL ACAD SINICA, V46, P127; NORBY RJ, 1994, PLANT SOIL, V165, P9, DOI 10.1007/BF00009958; Parker IM, 2007, ECOLOGY, V88, P1210, DOI 10.1890/06-1377; Pennings SC, 2002, OECOLOGIA, V131, P479, DOI 10.1007/s00442-002-0923-7; Press MC, 2005, NEW PHYTOL, V166, P737, DOI 10.1111/j.1469-8137.2005.01358.x; Prider J, 2009, ANN BOT-LONDON, V103, P107, DOI 10.1093/aob/mcn214; RAABE ZDZISLAW, 1965, ACTA PROTOZOOL, V3, P311; Reich PB, 1997, P NATL ACAD SCI USA, V94, P13730, DOI 10.1073/pnas.94.25.13730; Shen XY, 2011, BIOL INVASIONS, V13, P869, DOI 10.1007/s10530-010-9875-8; Suetsugu K, 2008, ANN BOT-LONDON, V102, P49, DOI 10.1093/aob/mcn065; van Kleunen M, 2010, ECOL LETT, V13, P235, DOI 10.1111/j.1461-0248.2009.01418.x; Vila M, 2004, OIKOS, V105, P229, DOI 10.1111/j.0030-1299.2004.12682.x; Wang Hui, 2008, Wuhan Zhiwuxue Yanjiu, V26, P134; Wang RK, 2012, ACTA ECOLOG IN PRESS, V6; Wang ZY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-726; Weiher E, 1999, J VEG SCI, V10, P609, DOI 10.2307/3237076; Wijesundara D. S. A., 2001, Annals of the Sri Lanka Department of Agriculture, V3, P343; Wu JR, 2006, ALLELOPATHY J, V17, P279; Yu H, 2008, BIOL CONSERV, V141, P2653, DOI 10.1016/j.biocon.2008.08.002; Yu H, 2011, BIOL INVASIONS, V13, P747, DOI 10.1007/s10530-010-9865-x; [昝启杰 Zan Qijie], 2002, [中山大学学报. 自然科学版, Acta Scientiarum Naturalium Universitatis Sunyatseni], V41, P60; Zhang LY, 2004, WEED RES, V44, P42, DOI 10.1111/j.1365-3180.2003.00371.x	45	23	26	3	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2012	7	4							e34577	10.1371/journal.pone.0034577	http://dx.doi.org/10.1371/journal.pone.0034577			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JA	22493703	Green Published, Green Submitted, gold			2022-12-27	WOS:000305012700045
J	Smallwood, J; Brown, KS; Baird, B; Mrazek, MD; Franklin, MS; Schooler, JW				Smallwood, Jonathan; Brown, Kevin S.; Baird, Benjamin; Mrazek, Michael D.; Franklin, Michael S.; Schooler, Jonathan W.			Insulation for Daydreams: A Role for Tonic Norepinephrine in the Facilitation of Internally Guided Thought	PLOS ONE			English	Article							STIMULUS-INDEPENDENT THOUGHT; LOCUS-COERULEUS; INTEGRATIVE THEORY; EXECUTIVE-CONTROL; WANDERING MINDS; WORKING-MEMORY; ADAPTIVE GAIN; EXPERIENCE; ATTENTION; BRAIN	Although consciousness can be brought to bear on both perceptual and internally generated information, little is known about how these different cognitive modes are coordinated. Here we show that between-participant variance in thoughts unrelated to the task being performed (known as task unrelated thought, TUT) is associated with longer response times (RT) when target presentation occurs during periods when baseline Pupil Diameter (PD) is increased. As behavioral interference due to high baseline PD can reflect increased tonic activity in the norepinephrine system (NE), these results might implicate high tonic NE activity in the facilitation of TUTs. Based on these findings, it is hypothesised that high tonic mode NE leads to a generalised de-amplification of task relevant information that prioritses internally generated thought and insulates it from the potentially disruptive events taking place in the external environment.	[Smallwood, Jonathan] Max Planck Inst Human Cognit Brain Sci, Dept Social Neurosci, Leipzig, Germany; [Brown, Kevin S.] Univ Calif Santa Barbara, Dept Phys, Santa Barbara, CA 93106 USA; [Baird, Benjamin; Mrazek, Michael D.; Franklin, Michael S.; Schooler, Jonathan W.] Univ Calif Santa Barbara, Dept Psychol & Brain Sci, Santa Barbara, CA 93106 USA	Max Planck Society; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara	Smallwood, J (corresponding author), Max Planck Inst Human Cognit Brain Sci, Dept Social Neurosci, Leipzig, Germany.	smallwood@cbs.mpg.de	Schooler, Jonathan/AAZ-3977-2020; Schooler, Jonathan/ABE-6434-2020; Smallwood, Jonathan/ABE-8365-2020	Brown, Kevin/0000-0003-2959-2401; Smallwood, Jonathan/0000-0002-7298-2459	Institute for Collaborative Biotechnologies through U.S. Army Research Office [W911NF-09-0001]; National Science Foundation [DGE-0707430]; United States Department of Education [R305A110277]	Institute for Collaborative Biotechnologies through U.S. Army Research Office; National Science Foundation(National Science Foundation (NSF)); United States Department of Education(US Department of Education)	K.S.B. is supported by the Institute for Collaborative Biotechnologies through grant W911NF-09-0001 from the U.S. Army Research Office (http://www.arl.army.mil/www/default.cfm?page=29). B.B. is supported by a National Science Foundation Graduate Research Fellowship under Grant No. DGE-0707430 (http://www.nsf.gov/). JWS, MDM and MSF are supported through United States Department of Education grant R305A110277 awarded to JWS and JS (http://www.ed.gov/). The content of the information does not necessarily reflect the position or policy of the U. S. Government, and no official endorsement should be inferred. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANTROBUS JS, 1970, T NEW YORK ACAD SCI, V32, P242, DOI 10.1111/j.2164-0947.1970.tb02056.x; Aston-Jones G, 2005, ANNU REV NEUROSCI, V28, P403, DOI 10.1146/annurev.neuro.28.061604.135709; Baars BJ, 2003, TRENDS NEUROSCI, V26, P671, DOI 10.1016/j.tins.2003.09.015; Baird B, 2011, BACK FUTURE AUTOBIOG; Barron E, 2011, PSYCHOL SCI, V22, P596, DOI 10.1177/0956797611404083; Chamberlain SR, 2007, BIOL PSYCHIAT, V62, P977, DOI 10.1016/j.biopsych.2007.03.003; Cheyne JA, 2009, COGNITION, V111, P98, DOI 10.1016/j.cognition.2008.12.009; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Gabay S, 2011, ATTEN PERCEPT PSYCHO, V73, P123, DOI 10.3758/s13414-010-0015-4; Gilzenrat MS, 2010, COGN AFFECT BEHAV NE, V10, P252, DOI 10.3758/CABN.10.2.252; Jepma M, 2011, J COGNITIVE NEUROSCI, V23, P1587, DOI 10.1162/jocn.2010.21548; Kam JWY, 2011, J COGNITIVE NEUROSCI, V23, P460, DOI 10.1162/jocn.2010.21443; Kane MJ, 2007, PSYCHOL SCI, V18, P614, DOI 10.1111/j.1467-9280.2007.01948.x; Killingsworth MA, 2010, SCIENCE, V330, P932, DOI 10.1126/science.1192439; Liberman N, 2008, SCIENCE, V322, P1201, DOI 10.1126/science.1161958; Mason MF, 2007, SCIENCE, V315, P393, DOI 10.1126/science.1131295; Mcvay JC, 2010, PSYCHOL BULL, V136, P188, DOI 10.1037/a0018298; McVay JC, 2009, J EXP PSYCHOL LEARN, V35, P196, DOI 10.1037/a0014104; Murphy PR, 2011, PSYCHOPHYSIOLOGY; Nieuwenhuis S, 2005, PSYCHOL BULL, V131, P510, DOI 10.1037/0033-2909.131.4.510; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Schooler JW, 2011, TRENDS COGN SCI, V15, P319, DOI 10.1016/j.tics.2011.05.006; Smallwood J, 2004, CONSCIOUS COGN, V13, P657, DOI 10.1016/j.concog.2004.06.003; Smallwood J, 2008, J COGNITIVE NEUROSCI, V20, P458, DOI 10.1162/jocn.2008.20037; Smallwood J, 2006, PSYCHOL BULL, V132, P946, DOI 10.1037/0033-2909.132.6.946; Smallwood J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018298; Smallwood J, 2009, CONSCIOUS COGN, V18, P118, DOI 10.1016/j.concog.2008.11.004; Smallwood J, 2009, EMOTION, V9, P271, DOI 10.1037/a0014855; TEASDALE JD, 1995, MEM COGNITION, V23, P551, DOI 10.3758/BF03197257; Usher M, 1999, SCIENCE, V283, P549, DOI 10.1126/science.283.5401.549	30	53	53	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2012	7	4							e33706	10.1371/journal.pone.0033706	http://dx.doi.org/10.1371/journal.pone.0033706			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	955JA	22493672	Green Submitted, Green Published, gold			2022-12-27	WOS:000305012700014
J	Hughes, S; Welsh, L; Katti, C; Gonzalez-Menendez, I; Turton, M; Halford, S; Sekaran, S; Peirson, SN; Hankins, MW; Foster, RG				Hughes, Steven; Welsh, Laura; Katti, Christiana; Gonzalez-Menendez, Irene; Turton, Michael; Halford, Stephanie; Sekaran, Sumathi; Peirson, Stuart N.; Hankins, Mark W.; Foster, Russell G.			Differential Expression of Melanopsin Isoforms Opn4L and Opn4S during Postnatal Development of the Mouse Retina	PLOS ONE			English	Article							GANGLION-CELL PHOTORECEPTORS; MAMMALIAN RETINA; DOPAMINE; PROJECTIONS; DIVERSITY; BIPOLAR; MICE; ROD	Photosensitive retinal ganglion cells (pRGCs) respond to light from birth and represent the earliest known light detection system to develop in the mouse retina. A number of morphologically and functionally distinct subtypes of pRGCs have been described in the adult retina, and have been linked to different physiological roles. We have previously identified two distinct isoforms of mouse melanopsin, Opn4L and Opn4S, which are generated by alternate splicing of the Opn4 locus. These isoforms are differentially expressed in pRGC subtypes of the adult mouse retina, with both Opn4L and Opn4S detected in M1 type pRGCs, and only Opn4L detected in M2 type pRGCs. Here we investigate the developmental expression of Opn4L and Opn4S and show a differential profile of expression during postnatal development. Opn4S mRNA is detected at relatively constant levels throughout postnatal development, with levels of Opn4S protein showing a marked increase between P0 and P3, and then increasing progressively over time until adult levels are reached by P10. By contrast, levels of Opn4L mRNA and protein are low at birth and show a marked increase at P14 and P30 compared to earlier time points. We suggest that these differing profiles of expression are associated with the functional maturation of M1 and M2 subtypes of pRGCs. Based upon our data, Opn4S expressing M1 type pRGCs mature first and are the dominant pRGC subtype in the neonate retina, whereas increased expression of Opn4L and the maturation of M2 type pRGCs occurs later, between P10 and P14, at a similar time to the maturation of rod and cone photoreceptors. We suggest that the distinct functions associated with these cell types will develop at different times during postnatal development.	[Hughes, Steven; Welsh, Laura; Katti, Christiana; Turton, Michael; Halford, Stephanie; Sekaran, Sumathi; Peirson, Stuart N.; Hankins, Mark W.; Foster, Russell G.] Univ Oxford, Nuffield Lab Ophthalmol, Oxford OX2 6AW, England; [Gonzalez-Menendez, Irene] Univ Oviedo, Dept Morfol & Biol Celular, E-33006 Oviedo, Spain	University of Oxford; University of Oviedo	Hughes, S (corresponding author), Univ Oxford, Nuffield Lab Ophthalmol, Walton St, Oxford OX2 6AW, England.	mark.hankins@eye.ox.ac.uk; russell.foster@eye.ox.ac.uk	Halford, Stephanie/AAJ-1375-2020	Halford, Stephanie/0000-0003-2179-907X; FOSTER, RUSSELL/0000-0001-6055-2067	Wellcome Trust; BBSRC (Biotechnology and Biological Sciences Research Council); BBSRC [BB/G003602/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G003602/1] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC (Biotechnology and Biological Sciences Research Council)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by a Wellcome Trust Programme Grant awarded to RGF, MWH, SNP, SH, SS. CK was funded by a BBSRC (Biotechnology and Biological Sciences Research Council) grant awarded to SS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baver SB, 2008, EUR J NEUROSCI, V27, P1763, DOI 10.1111/j.1460-9568.2008.06149.x; Belenky MA, 2003, J COMP NEUROL, V460, P380, DOI 10.1002/cne.10652; Berson DM, 2010, J COMP NEUROL, V518, P2405, DOI 10.1002/cne.22381; Cameron MA, 2009, EUR J NEUROSCI, V29, P761, DOI 10.1111/j.1460-9568.2009.06631.x; Chen SK, 2011, NATURE, V476, P92, DOI 10.1038/nature10206; Coombs JL, 2007, J COMP NEUROL, V503, P803, DOI 10.1002/cne.21429; Do MTH, 2010, PHYSIOL REV, V90, P1547, DOI 10.1152/physrev.00013.2010; Ecker JL, 2010, NEURON, V67, P49, DOI 10.1016/j.neuron.2010.05.023; Freedman MS, 1999, SCIENCE, V284, P502, DOI 10.1126/science.284.5413.502; Gonzalez-Menendez I, 2011, BRAIN RES; Gonzalez-Menendez I, 2009, FRONT CELL NEUROSCI, V3, DOI 10.3389/neuro.03.003.2009; Hankins MW, 2008, TRENDS NEUROSCI, V31, P27, DOI 10.1016/j.tins.2007.11.002; Hannibal J, 2004, CELL TISSUE RES, V316, P99, DOI 10.1007/s00441-004-0858-x; Hannibal L, 2005, J MOL NEUROSCI, V27, P147, DOI 10.1385/JMN:27:02:147; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; Hattar S, 2006, J COMP NEUROL, V497, P326, DOI 10.1002/cne.20970; Johnson J, 2010, P NATL ACAD SCI USA, V107, P17374, DOI 10.1073/pnas.1008533107; Li YC, 2012, CELL SIGNAL, V24, P685, DOI 10.1016/j.cellsig.2011.10.017; Mathes A, 2007, J NEUROENDOCRINOL, V19, P952, DOI 10.1111/j.1365-2826.2007.01608.x; McNeill DS, 2011, NEURAL DEV, V6, DOI 10.1186/1749-8104-6-8; NIR I, 1993, MOL BRAIN RES, V19, P47, DOI 10.1016/0169-328X(93)90147-H; Ostergaard J, 2007, INVEST OPHTH VIS SCI, V48, P3812, DOI 10.1167/iovs.06-1322; Pires SS, 2009, J NEUROSCI, V29, P12332, DOI 10.1523/JNEUROSCI.2036-09.2009; Provencio I, 2002, NATURE, V415, P493, DOI 10.1038/415493a; Ruan GX, 2006, P NATL ACAD SCI USA, V103, P9703, DOI 10.1073/pnas.0601940103; Sakamoto K, 2005, EUR J NEUROSCI, V22, P3129, DOI 10.1111/j.1460-9568.2005.04512.x; Schmidt TM, 2008, J NEUROPHYSIOL, V100, P371, DOI 10.1152/jn.00062.2008; Schmidt TM, 2011, TRENDS NEUROSCI, V34, P572, DOI 10.1016/j.tins.2011.07.001; Schmidt TM, 2011, J COMP NEUROL, V519, P1492, DOI 10.1002/cne.22579; Schmidt TM, 2010, J NEUROSCI, V30, P16262, DOI 10.1523/JNEUROSCI.3656-10.2010; Schmidt TM, 2009, J NEUROSCI, V29, P476, DOI 10.1523/JNEUROSCI.4117-08.2009; Sekaran S, 2005, CURR BIOL, V15, P1099, DOI 10.1016/j.cub.2005.05.053; Takada Y, 2004, INVEST OPHTH VIS SCI, V45, P3302, DOI 10.1167/iovs.04-0156; Tarttelin EE, 2003, EXP EYE RES, V76, P393, DOI 10.1016/S0014-4835(02)00300-7; Tian N, 2003, NEURON, V39, P85, DOI 10.1016/S0896-6273(03)00389-1; Tu DC, 2005, NEURON, V48, P987, DOI 10.1016/j.neuron.2005.09.031; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Viney TJ, 2007, CURR BIOL, V17, P981, DOI 10.1016/j.cub.2007.04.058; Vugler AA, 2007, J CHEM NEUROANAT, V33, P9, DOI 10.1016/j.jchemneu.2006.10.004; Vugler AA, 2007, EXP NEUROL, V205, P26, DOI 10.1016/j.expneurol.2007.01.032; Wong KY, 2007, J PHYSIOL-LONDON, V582, P279, DOI 10.1113/jphysiol.2007.133751; YOUNG RW, 1985, DEV BRAIN RES, V21, P229, DOI 10.1016/0165-3806(85)90211-1	42	26	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2012	7	4							e34531	10.1371/journal.pone.0034531	http://dx.doi.org/10.1371/journal.pone.0034531			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955IH	22496826	Green Submitted, Green Published, gold			2022-12-27	WOS:000305010500016
J	Huang, Y; Zheng, LS; Gong, XH; Jia, XL; Song, W; Liu, ML; Fan, YB				Huang, Yan; Zheng, Lisha; Gong, Xianghui; Jia, Xiaoling; Song, Wei; Liu, Meili; Fan, Yubo			Effect of Cyclic Strain on Cardiomyogenic Differentiation of Rat Bone Marrow Derived Mesenchymal Stem Cells	PLOS ONE			English	Article							STROMAL CELLS; IN-VITRO; MECHANICAL STRAIN; ENDOTHELIAL-CELLS; GROWTH-FACTORS; SHEAR-STRESS; CARDIOMYOCYTES; PROLIFERATION; EXPRESSION; STRETCH	Mesenchymal stem cells (MSCs) are a potential source of material for the generation of tissue-engineered cardiac grafts because of their ability to transdifferentiate into cardiomyocytes after chemical treatments or co-culture with cardiomyocytes. Cardiomyocytes in the body are subjected to cyclic strain induced by the rhythmic heart beating. Whether cyclic strain could regulate rat bone marrow derived MSC (rBMSC) differentiation into cardiomyocyte-like lineage was investigated in this study. A stretching device was used to generate the cyclic strain for rBMSCs. Cardiomyogenic differentiation was evaluated using quantitative real-time reverse transcription polymerase chain reaction (RT-PCR), immunocytochemistry and western-blotting. The results demonstrated that appropriate cyclic strain treatment alone could induce cardiomyogenic differentiation of rBMSCs, as confirmed by the expression of cardiomyocyte-related markers at both mRNA and protein levels. Furthermore, rBMSCs exposed to the strain stimulation expressed cardiomyocyte-related markers at a higher level than the shear stimulation. In addition, when rBMSCs were exposed to both strain and 5-azacytidine (5-aza), expression levels of cardiomyocyte-related markers significantly increased to a degree suggestive of a synergistic interaction. These results suggest that cyclic strain is an important mechanical stimulus affecting the cardiomyogenic differentiation of rBMSCs. This provides a new avenue for mechanistic studies of stem cell differentiation and a new approach to obtain more committed differentiated cells.	[Huang, Yan; Zheng, Lisha; Gong, Xianghui; Jia, Xiaoling; Song, Wei; Liu, Meili; Fan, Yubo] Beihang Univ, Sch Biol Sci & Med Engn, Minist Educ, Key Lab Biomech & Mechanobiol, Beijing, Peoples R China	Beihang University	Huang, Y (corresponding author), Beihang Univ, Sch Biol Sci & Med Engn, Minist Educ, Key Lab Biomech & Mechanobiol, Beijing, Peoples R China.	yubofan@buaa.edu.cn	Gong, Xianghui/AAW-1133-2020	Gong, Xianghui/0000-0002-6411-4272	National Basic Research Program of China (973 Program) [2011CB710901]; National Natural Science Foundation of China [10925208]; Specialized Research Fund for the Doctoral Program of Higher Education of China [20091102110031]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This project was supported by the National Basic Research Program of China (973 Program, No. 2011CB710901, www.most.gov.cn), the National Natural Science Foundation of China (No. 10925208, www.nsfc.gov.cn), and the Specialized Research Fund for the Doctoral Program of Higher Education of China (No. 20091102110031, www.cutech.edu.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abi-Char J, 2007, J PHYSIOL-LONDON, V582, P1205, DOI 10.1113/jphysiol.2007.134809; Amado LC, 2005, P NATL ACAD SCI USA, V102, P11474, DOI 10.1073/pnas.0504388102; Antonitsis Polychronis, 2007, Interact Cardiovasc Thorac Surg, V6, P593, DOI 10.1510/icvts.2007.157875; Arminan A, 2009, STEM CELLS DEV, V18, P907, DOI 10.1089/scd.2008.0292; Bai K, 2010, J BIOMECH, V43, P1176, DOI 10.1016/j.jbiomech.2009.11.030; Bartunek J, 2007, AM J PHYSIOL-HEART C, V292, pH1095, DOI 10.1152/ajpheart.01009.2005; Brand NJ, 2006, INT J BIOCHEM CELL B, V38, P30, DOI 10.1016/j.biocel.2005.06.018; BRAUNWALD E, 1988, HEART DISEASE, P383; Burlacu A, 2008, EUR J CELL BIOL, V87, P173, DOI 10.1016/j.ejcb.2007.09.003; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Feng C, 2009, EXP CELL RES, V315, P3044, DOI 10.1016/j.yexcr.2009.05.005; Fink C, 2000, FASEB J, V14, P669, DOI 10.1096/fasebj.14.5.669; Gomes ME, 2006, TISSUE ENG, V12, P177, DOI 10.1089/ten.2006.12.177; Gwak SJ, 2008, BIOMATERIALS, V29, P844, DOI 10.1016/j.biomaterials.2007.10.050; Hamilton DW, 2004, TISSUE ENG, V10, P361, DOI 10.1089/107632704323061726; Huang Y, 2010, ARCH MED RES, V41, P497, DOI 10.1016/j.arcmed.2010.10.002; Hwang NS, 2008, ADV DRUG DELIVER REV, V60, P199, DOI 10.1016/j.addr.2007.08.036; Inuernicia G, 2008, EXP CELL RES, V314, P366, DOI 10.1016/j.yexcr.2007.08.006; Jacot JG, 2010, J BIOMECH, V43, P93, DOI 10.1016/j.jbiomech.2009.09.014; Jang JY, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/860652; Kablar B, 2003, DEV BIOL, V258, P307, DOI 10.1016/S0012-1606(03)00139-8; Kasper G, 2007, STEM CELLS, V25, P903, DOI 10.1634/stemcells.2006-0432; Koike M, 2005, J BONE MINER METAB, V23, P219, DOI 10.1007/s00774-004-0587-y; Kreke MR, 2008, TISSUE ENG PT A, V14, P529, DOI 10.1089/tea.2007.0068; Kreke MR, 2005, BONE, V36, P1047, DOI 10.1016/j.bone.2005.03.008; Kreke MR, 2004, TISSUE ENG, V10, P780, DOI 10.1089/1076327041348455; Kurpinski K, 2006, P NATL ACAD SCI USA, V103, P16095, DOI 10.1073/pnas.0604182103; Lattanzi L, 1998, J CLIN INVEST, V101, P2119, DOI 10.1172/JCI1505; Li X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026029; Li XH, 2007, J MOL CELL CARDIOL, V42, P295, DOI 10.1016/j.yjmcc.2006.07.002; Martin-Rendon E, 2008, VOX SANG, V95, P137, DOI 10.1111/j.1423-0410.2008.01076.x; Martinez EC, 2011, J MOL CELL CARDIOL, V50, P312, DOI 10.1016/j.yjmcc.2010.08.009; McCloskey KE, 2006, J VASC RES, V43, P411, DOI 10.1159/000094791; Mouw JK, 2007, STEM CELLS, V25, P655, DOI 10.1634/stemcells.2006-0435; O'Cearbhaill ED, 2008, BIOMATERIALS, V29, P1610, DOI 10.1016/j.biomaterials.2007.11.042; Park JS, 2007, FRONT BIOSCI-LANDMRK, V12, P5098, DOI 10.2741/2551; Park JS, 2004, BIOTECHNOL BIOENG, V88, P359, DOI 10.1002/bit.20250; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Quinlan AMT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023272; Riddle RC, 2006, AM J PHYSIOL-CELL PH, V290, pC776, DOI 10.1152/ajpcell.00082.2005; SADOSHIMA J, 1992, J BIOL CHEM, V267, P10551; Saha S, 2006, J CELL PHYSIOL, V206, P126, DOI 10.1002/jcp.20441; Schmelter M, 2006, FASEB J, V20, P1182, DOI 10.1096/fj.05-4723fje; Shim WSN, 2004, BIOCHEM BIOPH RES CO, V324, P481, DOI 10.1016/j.bbrc.2004.09.087; Shimko VF, 2008, TISSUE ENG PT A, V14, P49, DOI 10.1089/ten.a.2007.0092; Simmons CA, 2003, J BIOMECH, V36, P1087, DOI 10.1016/S0021-9290(03)00110-6; Toma C, 2002, CIRCULATION, V105, P93, DOI 10.1161/hc0102.101442; Vandenburgh HH, 1996, AM J PHYSIOL-CELL PH, V270, pC1284, DOI 10.1152/ajpcell.1996.270.5.C1284; Wang FW, 2009, NEUROSCIENCE, V160, P319, DOI 10.1016/j.neuroscience.2009.02.068; Wang TZ, 2006, INT J CARDIOL, V109, P74, DOI 10.1016/j.ijcard.2005.05.072; Xie XJ, 2006, ACTA PHARMACOL SIN, V27, P1153, DOI 10.1111/j.1745-7254.2006.00436.x; Yamada K, 2005, CIRC RES, V97, P346, DOI 10.1161/01.RES.0000178788.76568.8a; Yang MC, 2009, BIOMATERIALS, V30, P3757, DOI 10.1016/j.biomaterials.2009.03.057; Zeng LF, 2006, J CELL BIOL, V174, P1059, DOI 10.1083/jcb.200605113	54	64	72	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e34960	10.1371/journal.pone.0034960	http://dx.doi.org/10.1371/journal.pone.0034960			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GO	22496879	Green Published, gold, Green Submitted			2022-12-27	WOS:000304855200090
J	Khakhalin, AS; Aizenman, CD				Khakhalin, Arseny S.; Aizenman, Carlos D.			GABAergic Transmission and Chloride Equilibrium Potential Are Not Modulated by Pyruvate in the Developing Optic Tectum of Xenopus laevis Tadpoles	PLOS ONE			English	Article							IN-VIVO; INTRINSIC EXCITABILITY; KETONE-BODIES; NEURONS; EXCITATION; CIRCUIT; GABA; AVAILABILITY; INHIBITION; METABOLISM	In the developing mammalian brain, gamma-aminobutyric acid (GABA) is thought to play an excitatory rather than an inhibitory role due to high levels of intracellular Cl- in immature neurons. This idea, however, has been questioned by recent studies which suggest that glucose-based artificial cerebrospinal fluid (ACSF) may be inadequate for experiments on immature and developing brains. These studies suggest that immature neurons may require alternative energy sources, such as lactate or pyruvate. Lack of these other energy sources is thought to result in artificially high intracellular Cl- concentrations, and therefore a more depolarized GABA receptor (GABAR) reversal potential. Since glucose metabolism can vary widely among different species, it is important to test the effects of these alternative energy sources on different experimental preparations. We tested whether pyruvate affects GABAergic transmission in isolated brains of developing wild type Xenopus tadpoles in vitro by recording the responsiveness of tectal neurons to optic nerve stimulation, and by measuring currents evoked by local GABA application in a gramicidin perforated patch configuration. We found that, in contrast with previously reported results, the reversal potential for GABAR-mediated currents does not change significantly between developmental stages 45 and 49. Partial substitution of glucose by pyruvate had only minor effects on both the GABA reversal potential, and the responsiveness of tectal neurons at stages 45 and 49. Total depletion of energy sources from the ACSF did not affect neural responsiveness. We also report a strong spatial gradient in GABA reversal potential, with immature cells adjacent to the lateral and caudal proliferative zones having more positive reversal potentials. We conclude that in this experimental preparation standard glucose-based ACSF is an appropriate extracellular media for in vitro experiments.	[Khakhalin, Arseny S.; Aizenman, Carlos D.] Brown Univ, Dept Neurosci, Providence, RI 02912 USA	Brown University	Khakhalin, AS (corresponding author), Brown Univ, Dept Neurosci, Providence, RI 02912 USA.	Carlos_Aizenman@brown.edu		Khakhalin, Arseny/0000-0002-0429-1728	National Eye Institute of the NIH [5R01 EYO19578-02]; NATIONAL EYE INSTITUTE [R01EY019578] Funding Source: NIH RePORTER	National Eye Institute of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by grant 5R01 EYO19578-02, from the National Eye Institute of the NIH [http://www.nei.nih.gov/]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizenman CD, 2007, J NEUROPHYSIOL, V97, P2949, DOI 10.1152/jn.00452.2006; Aizenman CD, 2003, NEURON, V39, P831, DOI 10.1016/S0896-6273(03)00527-0; Akerman CJ, 2007, TRENDS NEUROSCI, V30, P382, DOI 10.1016/j.tins.2007.06.002; Akerman CJ, 2006, J NEUROSCI, V26, P5117, DOI 10.1523/JNEUROSCI.0319-06.2006; Ben-Ari Y, 2007, PHYSIOL REV, V87, P1215, DOI 10.1152/physrev.00017.2006; Brumberg JC, 2000, J NEUROSCI, V20, P4829; Canepari M, 1997, BIOL CYBERN, V77, P153, DOI 10.1007/s004220050376; Casey JR, 2010, NAT REV MOL CELL BIO, V11, P50, DOI 10.1038/nrm2820; Church J, 1998, J PHYSIOL-LONDON, V511, P119, DOI 10.1111/j.1469-7793.1998.119bi.x; Clements JD, 1997, BIOPHYS J, V73, P220, DOI 10.1016/S0006-3495(97)78062-7; Dong W, 2009, J NEUROPHYSIOL, V101, P803, DOI 10.1152/jn.90848.2008; Dzhala VI, 2005, NAT MED, V11, P1205, DOI 10.1038/nm1301; Faber J., 1994, NORMAL TABLE XENOPUS, P2; Hahn G, 2010, J NEUROPHYSIOL, V104, P3312, DOI 10.1152/jn.00953.2009; Holmgren CD, 2010, J NEUROCHEM, V112, P900, DOI 10.1111/j.1471-4159.2009.06506.x; Juge N, 2010, NEURON, V68, P99, DOI 10.1016/j.neuron.2010.09.002; Khakhalin AS, 2011, J NEUROPHYSIOL, V106, P1065, DOI 10.1152/jn.00293.2011; Kirmse K, 2010, J NEUROSCI, V30, P16002, DOI 10.1523/JNEUROSCI.2534-10.2010; Kudela P, 2003, BIOL CYBERN, V88, P276, DOI 10.1007/s00422-002-0381-7; KYROZIS A, 1995, J NEUROSCI METH, V57, P27, DOI 10.1016/0165-0270(94)00116-X; LAZAR G, 1973, J ANAT, V116, P347; MERKLE S, 1988, COMP BIOCHEM PHYS B, V89, P719, DOI 10.1016/0305-0491(88)90314-8; Mukhtarov Marat, 2011, J Neurochem, V116, P316, DOI 10.1111/j.1471-4159.2010.07111.x; Nehlig A, 2004, PROSTAG LEUKOTR ESS, V70, P265, DOI 10.1016/j.plefa.2003.07.006; Pouille F, 2009, NAT NEUROSCI, V12, P1577, DOI 10.1038/nn.2441; Pratt KG, 2008, NAT NEUROSCI, V11, P467, DOI 10.1038/nn2076; Pratt KG, 2007, J NEUROSCI, V27, P8268, DOI 10.1523/JNEUROSCI.1738-07.2007; Pratt KG, 2009, J NEUROPHYSIOL, V102, P399, DOI 10.1152/jn.91317.2008; Rheims S, 2009, J NEUROCHEM, V110, P1330, DOI 10.1111/j.1471-4159.2009.06230.x; Richards Blake A, 2010, Front Synaptic Neurosci, V2, P7, DOI 10.3389/fnsyn.2010.00007; Ruusuvuori E, 2010, J NEUROSCI, V30, P15638, DOI 10.1523/JNEUROSCI.3355-10.2010; Schulz DJ, 2006, J EXP BIOL, V209, P4821, DOI 10.1242/jeb.02567; Simmons A, 2004, J COMP PHYSIOL A, V190, P747, DOI 10.1007/s00359-004-0534-3; Tyzio R, 2011, J NEUROSCI, V31, P34, DOI 10.1523/JNEUROSCI.3314-10.2011; Wright R, 2011, NEURAL PLAST, V2011, DOI 10.1155/2011/728395; Wu GY, 1996, SCIENCE, V274, P972, DOI 10.1126/science.274.5289.972; Zhang LI, 1998, NATURE, V395, P37, DOI 10.1038/25665; Zilberter Y, 2010, TRENDS PHARMACOL SCI, V31, P394, DOI 10.1016/j.tips.2010.06.005	38	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e34446	10.1371/journal.pone.0034446	http://dx.doi.org/10.1371/journal.pone.0034446			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GO	22496804	Green Published, Green Submitted, gold			2022-12-27	WOS:000304855200050
J	Sato, M; Kojima, K; Sakuma, C; Murakami, M; Aratani, E; Takenouchi, T; Tamada, Y; Kitani, H				Sato, Mitsuru; Kojima, Katsura; Sakuma, Chisato; Murakami, Maria; Aratani, Eriko; Takenouchi, Takato; Tamada, Yasushi; Kitani, Hiroshi			Production of scFv-Conjugated Affinity Silk Powder by Transgenic Silkworm Technology	PLOS ONE			English	Article							WISKOTT-ALDRICH-SYNDROME; RECOMBINANT PROTEINS; CELL LINES; FIBROIN; ANTIBODY; DIFFERENTIATION; NANOPARTICLES; GENERATION; SCAFFOLDS; SYSTEM	Bombyx mori (silkworm) silk proteins are being utilized as unique biomaterials for medical applications. Chemical modification or post-conjugation of bioactive ligands expand the applicability of silk proteins; however, the processes are elaborate and costly. In this study, we used transgenic silkworm technology to develop single-chain variable fragment (scFv)-conjugated silk fibroin. The cocoons of the transgenic silkworm contain fibroin L-chain linked with scFv as a fusion protein. After dissolving the cocoons in lithium bromide, the silk solution was dialyzed, concentrated, freeze-dried, and crushed into powder. Immunoprecipitation analyses demonstrate that the scFv domain retains its specific binding activity to the target molecule after multiple processing steps. These results strongly suggest the promise of scFv-conjugated silk fibroin as an alternative affinity reagent, which can be manufactured using transgenic silkworm technology at lower cost than traditional affinity carriers.	[Sato, Mitsuru; Sakuma, Chisato; Takenouchi, Takato; Kitani, Hiroshi] Natl Inst Agrobiol Sci, Anim Immune & Cell Biol Res Unit, Tsukuba, Ibaraki, Japan; [Kojima, Katsura; Murakami, Maria; Aratani, Eriko; Tamada, Yasushi] Natl Inst Agrobiol Sci, Silk Mat Res Unit, Tsukuba, Ibaraki, Japan	National Institute of Agrobiological Sciences - Japan; National Institute of Agrobiological Sciences - Japan	Sato, M (corresponding author), Natl Inst Agrobiol Sci, Anim Immune & Cell Biol Res Unit, Tsukuba, Ibaraki, Japan.	kitani@affrc.go.jp			Program for Promotion of Basic and Applied Research for Innovations in Bio-oriented Industry	Program for Promotion of Basic and Applied Research for Innovations in Bio-oriented Industry	This work was supported by the Program for Promotion of Basic and Applied Research for Innovations in Bio-oriented Industry (http://brain.naro.affrc.go.jp/index-e.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BIRD RE, 1988, SCIENCE, V242, P423, DOI 10.1126/science.3140379; Davies J, 1996, PROTEIN ENG, V9, P531, DOI 10.1093/protein/9.6.531; DERRY JMJ, 1994, CELL, V78, P635, DOI 10.1016/0092-8674(94)90528-2; Gotoh Y, 1997, BIOMATERIALS, V18, P267, DOI 10.1016/S0142-9612(96)00137-8; Gupta V, 2009, INT J NANOMED, V4, P115; Hino R, 2006, BIOMATERIALS, V27, P5715, DOI 10.1016/j.biomaterials.2006.07.028; HUSTON JS, 1988, P NATL ACAD SCI USA, V85, P5879, DOI 10.1073/pnas.85.16.5879; Iizuka M, 2009, FEBS J, V276, P5806, DOI 10.1111/j.1742-4658.2009.07262.x; Inoue S, 2005, INSECT BIOCHEM MOLEC, V35, P51, DOI 10.1016/j.ibmb.2004.10.002; Karageorgiou V, 2004, J BIOMED MATER RES A, V71A, P528, DOI 10.1002/jbm.a.30186; Kim UJ, 2004, BIOMACROMOLECULES, V5, P786, DOI 10.1021/bm0345460; Kojima K, 2007, BIOSCI BIOTECH BIOCH, V71, P2943, DOI 10.1271/bbb.70353; Mathur AB, 2010, NANOMEDICINE-UK, V5, P807, DOI [10.2217/nnm.10.51, 10.2217/NNM.10.51]; Meinel L, 2004, J BIOMED MATER RES A, V71A, P25, DOI 10.1002/jbm.a.30117; Murphy AR, 2008, BIOMATERIALS, V29, P2829, DOI 10.1016/j.biomaterials.2008.03.039; Nazarov R, 2004, BIOMACROMOLECULES, V5, P718, DOI 10.1021/bm034327e; Ogawa S, 2007, J BIOTECHNOL, V128, P531, DOI 10.1016/j.jbiotec.2006.10.019; RALPH P, 1977, J IMMUNOL, V119, P950; RASCHKE WC, 1978, CELL, V15, P261, DOI 10.1016/0092-8674(78)90101-0; Rockwood DN, 2011, NAT PROTOC, V6, P1612, DOI 10.1038/nprot.2011.379; Sato M, 2005, FEBS J, V272, P6131, DOI 10.1111/j.1742-4658.2005.05011.x; Sato M, 2001, J IMMUNOL, V167, P4701, DOI 10.4049/jimmunol.167.8.4701; Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7; Tamada Y, 2005, BIOMACROMOLECULES, V6, P3100, DOI 10.1021/bm050431f; Tamada Y, 2004, BIOMATERIALS, V25, P377, DOI 10.1016/S0142-9612(03)00533-7; Tamura T, 2000, NAT BIOTECHNOL, V18, P81, DOI 10.1038/71978; Thrasher AJ, 2002, NAT REV IMMUNOL, V2, P635, DOI 10.1038/nri884; WINTER G, 1991, NATURE, V349, P293, DOI 10.1038/349293a0	28	17	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e34632	10.1371/journal.pone.0034632	http://dx.doi.org/10.1371/journal.pone.0034632			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GO	22496833	gold, Green Submitted, Green Published			2022-12-27	WOS:000304855200064
J	Fischedick, G; Klein, DC; Wu, GM; Esch, D; Hoing, S; Han, DW; Reinhardt, P; Hergarten, K; Tapia, N; Scholer, HR; Sterneckert, JL				Fischedick, Gerrit; Klein, Diana C.; Wu, Guangming; Esch, Daniel; Hoeing, Susanne; Han, Dong Wook; Reinhardt, Peter; Hergarten, Kerstin; Tapia, Natalia; Schoeler, Hans R.; Sterneckert, Jared L.			Zfp296 Is a Novel, Pluripotent-Specific Reprogramming Factor	PLOS ONE			English	Article							NEURAL STEM-CELLS; ES; CONVERSION; CLONING; CYCLE	Expression of the four transcription factors Oct4, Sox2, Klf4, and c-Myc (OSKM) is sufficient to reprogram somatic cells into induced pluripotent stem (iPSCs). However, this process is slow and inefficient compared with the fusion of somatic cells with embryonic stem cells (ESCs), indicating that ESCs express additional factors that can enhance the efficiency of reprogramming We had previously developed a method to detect and isolate early neural induction intermediates during the differentiation of mouse ESCs. Using the gene expression profiles of these intermediates, we identified 23 ESC-specific transcripts and tested each for the ability to enhance iPSC formation. Of the tested factors, zinc finger protein 296 (Zfp296) led to the largest increase in mouse iPSC formation. We confirmed that Zfp296 was specifically expressed in pluripotent stem cells and germ cells. Zfp296 in combination with OSKM induced iPSC formation earlier and more efficiently than OSKM alone. Through mouse chimera and teratoma formation, we demonstrated that the resultant iPSCs were pluripotent. We showed that Zfp296 activates transcription of the Oct4 gene via the germ cell specific conserved region 4 (CR4), and when overexpressed in mouse ESCs leads to upregulation of Nanog expression and downregulation of the expression of differentiation markers, including Sox17, Eomes, and T, which is consistent with the observation that Zfp296 enhances the efficiency of reprogramming. In contrast, knockdown of Zfp296 in ESCs leads to the expression of differentiation markers. Finally, we demonstrated that expression of Zfp296 in ESCs inhibits, but does not block, differentiation into neural cells.	[Fischedick, Gerrit; Klein, Diana C.; Wu, Guangming; Esch, Daniel; Hoeing, Susanne; Reinhardt, Peter; Hergarten, Kerstin; Tapia, Natalia; Schoeler, Hans R.; Sterneckert, Jared L.] Max Planck Inst Mol Biomed, Dept Cell & Dev Biol, Munster, Germany; [Han, Dong Wook] Konkuk Univ, Dept Stem Cell Biol, Sch Med, Seoul, South Korea; [Schoeler, Hans R.] Univ Munster, Fac Med, Munster, Germany	Max Planck Society; Konkuk University; Konkuk University Medical Center; University of Munster	Fischedick, G (corresponding author), Max Planck Inst Mol Biomed, Dept Cell & Dev Biol, Munster, Germany.	office@mpi-muenster.mpg.de	Sterneckert, Jared/E-6802-2015; , HS/AAB-4434-2019; Tapia, Natalia/H-5500-2012	, HS/0000-0003-2643-5136; Sterneckert, Jared/0000-0002-7688-3124; Tapia, Natalia/0000-0003-0226-1952; Klein, Diana/0000-0002-1770-443X	Deutsche Forschungsgemeinschaft (DFG) [SCHO340/5-1, SPP 1356]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was generously supported by grant (SCHO340/5-1) from the Deutsche Forschungsgemeinschaft (DFG) Priority Program: Pluripotency and Cellular Reprogramming (SPP 1356). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aasen T, 2008, NAT BIOTECHNOL, V26, P1276, DOI 10.1038/nbt.1503; Anastassiadis K, 2002, GENE, V298, P159, DOI 10.1016/S0378-1119(02)00979-4; Bhutani N, 2010, NATURE, V463, P1042, DOI 10.1038/nature08752; Boland MJ, 2009, NATURE, V461, P91, DOI 10.1038/nature08310; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Cowan CA, 2004, NEW ENGL J MED, V350, P1353, DOI 10.1056/NEJMsr040330; Dear TN, 2000, MAMM GENOME, V11, P1037, DOI 10.1007/s003350010182; Do JT, 2006, STEM CELL REV, V2, P257, DOI 10.1007/BF02698052; Eminli S, 2009, NAT GENET, V41, P968, DOI 10.1038/ng.428; Han DW, 2008, STEM CELLS, V26, P445, DOI 10.1634/stemcells.2007-0553; Han DW, 2011, NAT CELL BIOL, V13, P66, DOI 10.1038/ncb2136; Hanna J, 2008, CELL, V133, P250, DOI 10.1016/j.cell.2008.03.028; HOGAN B, 1986, MANIPULATING MOUSE E; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Kang L, 2009, CELL STEM CELL, V5, P135, DOI 10.1016/j.stem.2009.07.001; Kim JB, 2008, NATURE, V454, P646, DOI 10.1038/nature07061; Kim JB, 2009, CELL, V136, P411, DOI 10.1016/j.cell.2009.01.023; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; Ko K, 2009, CELL STEM CELL, V5, P87, DOI 10.1016/j.stem.2009.05.025; Nagy A, 1993, GENE TARGETING PRACT; Nordhoff V, 2001, MAMM GENOME, V12, P309, DOI 10.1007/s003350010279; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Palermo A, 2009, FASEB J, V23, P1431, DOI 10.1096/fj.08-122903; Sebastiano V, 2010, DEVELOPMENT, V137, P3551, DOI 10.1242/dev.047027; Sterneckert J, 2010, STEM CELLS, V28, P1772, DOI 10.1002/stem.498; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tang FC, 2009, NAT METHODS, V6, P377, DOI [10.1038/NMETH.1315, 10.1038/nmeth.1315]; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Wu GM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001099; Yeom YI, 1996, DEVELOPMENT, V122, P881; Zhao XY, 2009, NATURE, V461, P86, DOI 10.1038/nature08267	31	26	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2012	7	4							e34645	10.1371/journal.pone.0034645	http://dx.doi.org/10.1371/journal.pone.0034645			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952GU	22485183	Green Published, gold, Green Submitted			2022-12-27	WOS:000304780500058
J	Lee, J; Sung, CO; Lee, EJ; Do, IG; Kim, HC; Yoon, SH; Lee, WY; Chun, HK; Kim, KM; Park, YS				Lee, Jeeyun; Sung, Chang Ohk; Lee, Eui J.; Do, In-Gu; Kim, Hee-Cheol; Yoon, Seong Hyeon; Lee, Woo Yong; Chun, Ho Kyung; Kim, Kyoung-Mee; Park, Young Suk			Metastasis of Neuroendocrine Tumors Are Characterized by Increased Cell Proliferation and Reduced Expression of the ATM Gene	PLOS ONE			English	Article							BREAST-CANCER PATIENTS; DNA-DAMAGE RESPONSE; ATAXIA-TELANGIECTASIA; CARCINOID-TUMORS; ENDOCRINE TUMORS; RISK; LYMPHOMA; RECTUM; LINES; RADIOSENSITIVITY	Purpose: Gastroenteropancreatic neuroendocrine tumors (GEP-NETs) are rare group of tumors with a wide spectrum of clinical behavior. However, there are no known clinically relevant biomarkers to predict metastasis. Experimental Design: To investigate differential gene expression signatures of metastatic vs non-metastatic NETs, we studied cell cycle regulatory genes in 19 metastatic and 22 non-metastatic colorectal NETs by PCR arrays. Immunohistochemistry (IHC) and quantitative real-time RT-PCR were performed to verify the results and another set of 38 GEP-NETs were further studied for validation. Results: We first delineated six candidate genes for metastasis including ATM, CCND2, RBL2, CDKN3, CCNB1, and GTSE1. ATM was negatively correlated with metastatic NETs (p<0.001) with more than 2-fold change compared to non-metastatic NETs. Overexpression of ATM protein by IHC was strongly correlated with high ATM mRNA levels and low Ki-67 labeling index. Patients with ATM-negativity by IHC showed significantly decreased overall survival than patients with ATM-positivity (median OS, metastatic vs non-metastatic NETs; 2.7 years vs not reached; p = 0.003) and 85.7% of metastatic NETs were ATM-negative. In another validation set of GEP-NETs, decreased mRNA of ATM gene was associated with metastasis and remained significant (p = 0.023). Conclusions: ATM down-regulation was strongly associated with metastatic NETs when compared with non-metastatic NETs and ATM may be a potential predictive marker for metastasis as well as a novel target in metastatic GEP-NETs.	[Lee, Jeeyun; Park, Young Suk] Sungkyunkwan Univ, Sch Med, Dept Med, Div Hematol Oncol, Seoul, South Korea; [Lee, Eui J.] Catholic Univ Korea, Incheon St Mary Hosp, Res Inst, Seoul, South Korea; [Do, In-Gu] Sungkyunkwan Univ, Sch Med, Samsung Canc Res Inst, Seoul, South Korea; [Kim, Hee-Cheol; Yoon, Seong Hyeon; Lee, Woo Yong; Chun, Ho Kyung] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Seoul, South Korea	Sungkyunkwan University (SKKU); Catholic University of Korea; Samsung; Sungkyunkwan University (SKKU); Sungkyunkwan University (SKKU); Samsung Medical Center	Lee, J (corresponding author), Sungkyunkwan Univ, Sch Med, Dept Med, Div Hematol Oncol, Seoul, South Korea.	kkmkys@skku.edu; pys27hmo@skku.edu	Lee, Jee Yun/C-9646-2011; Lee, Jeeyun/I-7171-2015	Sung, Chang Ohk/0000-0002-8567-456X				Ai LB, 2004, CANCER EPIDEM BIOMAR, V13, P150, DOI 10.1158/1055-9965.EPI-082-3; Atencio DP, 2001, ENVIRON MOL MUTAGEN, V38, P200, DOI 10.1002/em.1072; Bartek J, 2011, MOL ONCOL, V5, P303, DOI 10.1016/j.molonc.2011.07.006; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Chan JA, 2011, CURR TREAT OPTIONS O; COLE J, 1988, INT J RADIAT BIOL, V54, P929, DOI 10.1080/09553008814552331; Dahlberg WK, 1995, CLIN CANCER RES, V1, P785; De Falco G, 2007, BLOOD, V110, P1301, DOI 10.1182/blood-2006-12-064865; Fahy BN, 2007, ANN SURG ONCOL, V14, P1735, DOI 10.1245/s10434-006-9311-6; Gatti RA, 1999, MOL GENET METAB, V68, P419, DOI 10.1006/mgme.1999.2942; Hauso O, 2008, CANCER, V113, P2655, DOI 10.1002/cncr.23883; Hemminki K, 2001, CANCER, V92, P2204, DOI 10.1002/1097-0142(20011015)92:8&lt;2204::AID-CNCR1564&gt;3.0.CO;2-R; Iannuzzi CM, 2002, INT J RADIAT ONCOL, V52, P606, DOI 10.1016/S0360-3016(01)02684-0; Indra DM, 2011, HUM GENET, V130, P735, DOI 10.1007/s00439-011-1015-8; Ito T, 2010, J GASTROENTEROL, V45, P234, DOI 10.1007/s00535-009-0194-8; Khanna KK, 2000, JNCI-J NATL CANCER I, V92, P795, DOI 10.1093/jnci/92.10.795; Kim WJ, 2002, ONCOGENE, V21, P3864, DOI 10.1038/sj.onc.1205485; Klimstra DS, 2010, AM J SURG PATHOL, V34, P300, DOI 10.1097/PAS.0b013e3181ce1447; Kloppel G, 2004, ANN NY ACAD SCI, V1014, P13, DOI 10.1196/annals.1294.002; Koura AN, 1997, CANCER, V79, P1294, DOI 10.1002/(SICI)1097-0142(19970401)79:7<1294::AID-CNCR4>3.0.CO;2-H; Lavin MF, 2008, NAT REV MOL CELL BIO, V9, P759, DOI 10.1038/nrm2514; Lee SW, 2000, MOL CELL BIOL, V20, P1723, DOI 10.1128/MCB.20.5.1723-1732.2000; Lepage C, 2007, GASTROENTEROLOGY, V132, P899, DOI 10.1053/j.gastro.2007.01.006; Lobrich M, 2007, NAT REV CANCER, V7, P861, DOI 10.1038/nrc2248; Matsuoka S, 1998, SCIENCE, V282, P1893, DOI 10.1126/science.282.5395.1893; Mitui M, 2009, HUM MUTAT, V30, P12, DOI 10.1002/humu.20805; Modlin IM, 2003, CANCER-AM CANCER SOC, V97, P934, DOI 10.1002/cncr.11105; Schaffner C, 2000, P NATL ACAD SCI USA, V97, P2773, DOI 10.1073/pnas.050400997; Shields CJ, 2010, ANN SURG, V252, P750, DOI 10.1097/SLA.0b013e3181fb8df6; Soga J, 1998, J EXP CLIN CANC RES, V17, P139; Solcia EKG, 2000, WHO INT HISTOLOGICAL; Sterner JM, 1998, MOL CELL BIOL, V18, P2748, DOI 10.1128/MCB.18.5.2748; Stoppa-Lyonnet D, 1998, BLOOD, V91, P3920, DOI 10.1182/blood.V91.10.3920.3920_3920_3926; SWIFT M, 1991, NEW ENGL J MED, V325, P1831, DOI 10.1056/NEJM199112263252602; Taylor AMR, 2005, J CLIN PATHOL, V58, P1009, DOI 10.1136/jcp.2005.026062; Vorechovsky I, 1996, CANCER RES, V56, P2726; Weston VJ, 2010, BLOOD, V116, P4578, DOI 10.1182/blood-2010-01-265769; Williams GT, 2007, HISTOPATHOLOGY, V50, P30, DOI 10.1111/j.1365-2559.2006.02570.x; Williamson CT, 2010, MOL CANCER THER, V9, P347, DOI 10.1158/1535-7163.MCT-09-0872; Xie P, 2011, BIOCHEM BIOPH RES CO, V404, P413, DOI 10.1016/j.bbrc.2010.11.135; Yao JC, 2008, J CLIN ONCOL, V26, P3063, DOI 10.1200/JCO.2007.15.4377; Yao JC, 2011, NEW ENGL J MED, V364, P514, DOI 10.1056/NEJMoa1009290; Zhang L, 2004, MUTAT RES-GEN TOX EN, V557, P41, DOI 10.1016/j.mrgentox.2003.09.012; Zhang PL, 2003, CANCER BIOL THER, V2, P87	44	22	30	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2012	7	4							e34456	10.1371/journal.pone.0034456	http://dx.doi.org/10.1371/journal.pone.0034456			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952GU	22485171	gold, Green Submitted, Green Published			2022-12-27	WOS:000304780500046
J	Schmitt, V; Pankau, B; Fischer, J				Schmitt, Vanessa; Pankau, Birte; Fischer, Julia			Old World Monkeys Compare to Apes in the Primate Cognition Test Battery	PLOS ONE			English	Article							LONG-TAILED MACAQUES; BRAIN SIZE; NONHUMAN-PRIMATES; SOCIAL COGNITION; EVOLUTION; INTELLIGENCE; HUMANS; SKILLS; USAGE	Understanding the evolution of intelligence rests on comparative analyses of brain sizes as well as the assessment of cognitive skills of different species in relation to potential selective pressures such as environmental conditions and social organization. Because of the strong interest in human cognition, much previous work has focused on the comparison of the cognitive skills of human toddlers to those of our closest living relatives, i.e. apes. Such analyses revealed that apes and children have relatively similar competencies in the physical domain, while human children excel in the socio-cognitive domain; in particular in terms of attention sharing, cooperation, and mental state attribution. To develop a full understanding of the evolutionary dynamics of primate intelligence, however, comparative data for monkeys are needed. We tested 18 Old World monkeys (long-tailed macaques and olive baboons) in the so-called Primate Cognition Test Battery (PCTB) (Herrmann et al. 2007, Science). Surprisingly, our tests revealed largely comparable results between Old World monkeys and the Great apes. Single comparisons showed that chimpanzees performed only better than the macaques in experiments on spatial understanding and tool use, but in none of the socio-cognitive tasks. These results question the clear-cut relationship between cognitive performance and brain size and - prima facie - support the view of an accelerated evolution of social intelligence in humans. One limitation, however, is that the initial experiments were devised to tap into human specific skills in the first place, thus potentially underestimating both true nonhuman primate competencies as well as species differences.	[Schmitt, Vanessa; Pankau, Birte; Fischer, Julia] German Primate Ctr, Cognit Ethol Lab, Gottingen, Germany; [Schmitt, Vanessa; Fischer, Julia] Univ Gottingen, Courant Res Ctr Evolut Social Behav, Gottingen, Germany	Deutsches Primatenzentrum (DPZ); University of Gottingen	Schmitt, V (corresponding author), German Primate Ctr, Cognit Ethol Lab, Gottingen, Germany.	Schmitt@cog-ethol.de	Fischer, Julia/B-6674-2008	Fischer, Julia/0000-0002-5807-0074	German Initiative of Excellence; Leibniz Graduate School for Primate Neurobiology	German Initiative of Excellence; Leibniz Graduate School for Primate Neurobiology	This study was funded by the German Initiative of Excellence (http://www.uni-goettingen.de/and http://www.uni-goettingen.de/de/92425.html) and the Leibniz Graduate School for Primate Neurobiology (Neuroprim: www.dpz.eu/akn/neuroprim/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amici F, 2008, CURR BIOL, V18, P1415, DOI 10.1016/j.cub.2008.08.020; Amici F, 2010, AM J PHYS ANTHROPOL, V143, P188, DOI 10.1002/ajpa.21305; Barrett L, 2003, TRENDS COGN SCI, V7, P494, DOI 10.1016/j.tics.2003.09.005; Boesch C, 2007, J COMP PSYCHOL, V121, P227, DOI 10.1037/0735-7036.121.3.227; Byrne R., 1988, MACHIAVELLIAN INTELL; Byrne R.W., 1997, MACHIAVELLIAN INTELL, P289; Byrne RW, 2010, NEURON, V65, P815, DOI 10.1016/j.neuron.2010.03.010; Byrne RW, 2000, COGNITIVE SCI, V24, P543, DOI 10.1016/S0364-0213(00)00028-8; Call J, 2004, DEVELOPMENTAL SCI, V7, P488, DOI 10.1111/j.1467-7687.2004.00368.x; Call J, 2007, COGNITION, V105, P1, DOI 10.1016/j.cognition.2006.08.004; Carlson Neil R, 2007, PHYSIOL BEHAV; Chittka L, 2009, CURR BIOL, V19, pR995, DOI 10.1016/j.cub.2009.08.023; Deaner R. O., 2006, EVOL PSYCHOL, V4, DOI [10.1177/147470490600400114, DOI 10.1177/147470490600400114]; Deaner RO, 2007, BRAIN BEHAV EVOLUT, V70, P115, DOI 10.1159/000102973; Dunbar R, 2003, SCIENCE, V302, P1160, DOI 10.1126/science.1092116; Emery NJ, 2009, ANNU REV PSYCHOL, V60, P87, DOI 10.1146/annurev.psych.60.110707.163526; Frith U, 2010, PHILOS T R SOC B, V365, P165, DOI 10.1098/rstb.2009.0160; GALLUP GG, 1982, AM J PRIMATOL, V2, P237, DOI 10.1002/ajp.1350020302; Gumert MD, 2009, AM J PRIMATOL, V71, P594, DOI 10.1002/ajp.20694; HARVEY PH, 1980, P NATL ACAD SCI-BIOL, V77, P4387, DOI 10.1073/pnas.77.7.4387; Healy SD, 2007, P ROY SOC B-BIOL SCI, V274, P453, DOI 10.1098/rspb.2006.3748; Herrmann E, 2007, SCIENCE, V317, P1360, DOI 10.1126/science.1146282; Herrmann E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012438; Humphrey N., 1976, GROWING POINTS ETHOL, P303; InoueNakamura N, 1997, JPN PSYCHOL RES, V39, P266, DOI 10.1111/1468-5884.00059; Jerison HJ., 1973, EVOLUTION BRAIN INTE; Jolly A., 1972, EVOLUTION PRIMATE BE; MacLean EL, 2012, ANIM COGN, V15, P223, DOI 10.1007/s10071-011-0448-8; Malaivijitnond S, 2007, AM J PRIMATOL, V69, P227, DOI 10.1002/ajp.20342; Perelman P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001342; Pitt David, 2008, STANFORD ENCY PHILOS; Reader SM, 2002, P NATL ACAD SCI USA, V99, P4436, DOI 10.1073/pnas.062041299; Schmitt V, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1262; Schmitt V, 2009, J COMP PSYCHOL, V123, P316, DOI 10.1037/a0016218; Shettleworth SJ, 2010, TRENDS COGN SCI, V14, P477, DOI 10.1016/j.tics.2010.07.002; Shettleworth SJ, 2009, BEHAV PROCESS, V80, P210, DOI 10.1016/j.beproc.2008.09.001; Shultz S, 2010, J COMP PSYCHOL, V124, P252, DOI 10.1037/a0018894; Teufel C, 2010, DEVELOPMENTAL SCI, V13, P913, DOI 10.1111/j.1467-7687.2010.00956.x; Tinbergen, 1951, STUDY INSTINCT; Tomasello M, 2003, TRENDS COGN SCI, V7, P239, DOI 10.1016/S1364-6613(03)00107-4; Tomasello M, 2003, TRENDS COGN SCI, V7, P153, DOI 10.1016/S1364-6613(03)00035-4; Tomasello M, 1997, PRIMATE COGNITION; Wellman HM, 2011, DEVELOPMENTAL SCI, V14, P319, DOI 10.1111/j.1467-7687.2010.00977.x; Zalmout IS, 2010, NATURE, V466, P360, DOI 10.1038/nature09094; Zuberbuhler K, 2006, CURR BIOL, V16, pR786, DOI 10.1016/j.cub.2006.08.046	45	60	60	1	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2012	7	4							e32024	10.1371/journal.pone.0032024	http://dx.doi.org/10.1371/journal.pone.0032024			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952GU	22485130	Green Submitted, gold, Green Published			2022-12-27	WOS:000304780500006
J	Yi, YJ; Sutovsky, M; Kennedy, C; Sutovsky, P				Yi, Young-Joo; Sutovsky, Miriam; Kennedy, Chelsey; Sutovsky, Peter			Identification of the Inorganic Pyrophosphate Metabolizing, ATP Substituting Pathway in Mammalian Spermatozoa	PLOS ONE			English	Article							EXTRACELLULAR ADENOSINE 5'-TRIPHOSPHATE; CORTICAL GRANULE EXOCYTOSIS; PIG OOCYTES; MOUSE SPERMATOZOA; BOAR SPERMATOZOA; IN-VITRO; PROTEIN; FERTILIZATION; PHOSPHORYLATION; ANK	Inorganic pyrophosphate (PPi) is generated by ATP hydrolysis in the cells and also present in extracellular matrix, cartilage and bodily fluids. Fueling an alternative pathway for energy production in cells, PPi is hydrolyzed by inorganic pyrphosphatase (PPA1) in a highly exergonic reaction that can under certain conditions substitute for ATP-derived energy. Recombinant PPA1 is used for energy-regeneration in the cell-free systems used to study the zymology of ATP-dependent ubiquitin-proteasome system, including the role of sperm-borne proteasomes in mammalian fertilization. Inspired by an observation of reduced in vitro fertilization (IVF) rates in the presence of external, recombinant PPA1, this study reveals, for the first time, the presence of PPi, PPA1 and PPi transporter, progressive ankylosis protein ANKH in mammalian spermatozoa. Addition of PPi during porcine IVF increased fertilization rates significantly and in a dose-dependent manner. Fluorometric assay detected high levels of PPi in porcine seminal plasma, oviductal fluid and spermatozoa. Immunofluorescence detected PPA1 in the postacrosomal sheath (PAS) and connecting piece of boar spermatozoa; ANKH was present in the sperm head PAS and equatorial segment. Both ANKH and PPA1 were also detected in human and mouse spermatozoa, and in porcine spermatids. Higher proteasomal-proteolytic activity, indispensable for fertilization, was measured in spermatozoa preserved with PPi. The identification of an alternative, PPi dependent pathway for ATP production in spermatozoa elevates our understanding of sperm physiology and sets the stage for the improvement of semen extenders, storage media and IVF media for animal biotechnology and human assisted reproductive therapies.	[Yi, Young-Joo; Sutovsky, Miriam; Kennedy, Chelsey; Sutovsky, Peter] Univ Missouri, Div Anim Sci, Columbia, MO 65211 USA; [Sutovsky, Peter] Univ Missouri, Dept Obstet, Columbia, MO USA; [Sutovsky, Peter] Univ Missouri, Dept Gynecol, Columbia, MO USA; [Sutovsky, Peter] Univ Missouri, Dept Womens Hlth, Columbia, MO USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Yi, YJ (corresponding author), Univ Missouri, Div Anim Sci, Columbia, MO 65211 USA.	yiyo@missouri.edu		Sutovsky, Peter/0000-0002-9231-2823	University of Missouri-Columbia; United States Department of Agriculture (USDA) National Institute of Food and Agriculture [2007-35203-18274, 2011-67015-20025]	University of Missouri-Columbia; United States Department of Agriculture (USDA) National Institute of Food and Agriculture(United States Department of Agriculture (USDA))	This work was supported by funding from the Food for the 21st Century Program of the University of Missouri-Columbia, and the Competitive Grants no. 2007-35203-18274 and no. 2011-67015-20025 from the United States Department of Agriculture (USDA) National Institute of Food and Agriculture, to P.S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeydeera LR, 1998, BIOL REPROD, V58, P1316, DOI 10.1095/biolreprod58.5.1316; Baykov A A, 1999, Prog Mol Subcell Biol, V23, P127; Carr G, 2009, CELL PHYSIOL BIOCHEM, V24, P595, DOI 10.1159/000257515; CHEN J, 1990, J BACTERIOL, V172, P5686, DOI 10.1128/jb.172.10.5686-5689.1990; Chi A, 2000, J BIOL CHEM, V275, P35677, DOI 10.1074/jbc.C000581200; DASILVA LP, 1991, BIOCHEM BIOPH RES CO, V178, P1359, DOI 10.1016/0006-291X(91)91043-C; DAVIDSON AM, 1988, BIOCHEM J, V254, P379, DOI 10.1042/bj2540379; Edwards SE, 2007, REPROD SCI, V14, P655, DOI 10.1177/1933719107306227; Fairchild TA, 1999, BBA-GENE STRUCT EXPR, V1447, P133, DOI 10.1016/S0167-4781(99)00175-X; FLEISCH H, 1966, NATURE, V212, P901, DOI 10.1038/212901a0; FLEISCH H, 1962, AM J PHYSIOL, V203, P671, DOI 10.1152/ajplegacy.1962.203.4.671; GARNER DL, 1994, J ANDROL, V15, P620; Gurley KA, 2006, AM J HUM GENET, V79, P1017, DOI 10.1086/509881; Ho AM, 2000, SCIENCE, V289, P265, DOI 10.1126/science.289.5477.265; Hoelzle K, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-194; Islam MK, 2005, INFECT IMMUN, V73, P1995, DOI 10.1128/IAI.73.4.1995-2004.2005; Johnson K, 2000, ARTHRITIS RHEUM-US, V43, P1560, DOI 10.1002/1529-0131(200007)43:7<1560::AID-ANR21>3.3.CO;2-J; Johnson K, 1999, ARTHRITIS RHEUM-US, V42, P1986, DOI 10.1002/1529-0131(199909)42:9<1986::AID-ANR26>3.0.CO;2-O; Johnson LA, 2000, ANIM REPROD SCI, V62, P143, DOI 10.1016/S0378-4320(00)00157-3; KANO K, 1994, THERIOGENOLOGY, V42, P1061, DOI 10.1016/0093-691X(94)90128-6; Kim JC, 2008, MOL CELLS, V26, P558; Kim NH, 1996, J REPROD FERTIL, V107, P79, DOI 10.1530/jrf.0.1070079; LAHTI R, 1983, MICROBIOL REV, V47, P169, DOI 10.1128/MMBR.47.2.169-178.1983; LUNDIN M, 1991, J BIOL CHEM, V266, P12168; LUNDIN M, 1992, BIOCHIM BIOPHYS ACTA, V1098, P217, DOI 10.1016/S0005-2728(05)80339-1; Mohanty JG, 1997, J IMMUNOL METHODS, V202, P133, DOI 10.1016/S0022-1759(96)00244-X; Ozgocmen S, 2002, UROLOGY, V59, P919, DOI 10.1016/S0090-4295(02)01557-1; PELLER L, 1976, BIOCHEMISTRY-US, V15, P141, DOI 10.1021/bi00646a021; PEREIRADASILVA L, 1993, ARCH BIOCHEM BIOPHYS, V304, P310, DOI 10.1006/abbi.1993.1355; PURSEL VG, 1975, J ANIM SCI, V40, P99, DOI 10.2527/jas1975.40199x; Rodriguez-Miranda E, 2008, BIOL REPROD, V79, P164, DOI 10.1095/biolreprod.107.065565; Rosen F, 1997, ARTHRITIS RHEUM-US, V40, P1275, DOI 10.1002/art.12; Rosenthal AK, 1999, J RHEUMATOL, V26, P395; Rosenthal AK, 1996, CALCIFIED TISSUE INT, V59, P128, DOI 10.1007/s002239900099; Rossato M, 1999, HUM REPROD, V14, P694, DOI 10.1093/humrep/14.3.694; RUSSELL RGG, 1971, J CLIN INVEST, V50, P961, DOI 10.1172/JCI106589; Ryan LM, 1999, ARTHRITIS RHEUM, V42, P555, DOI 10.1002/1529-0131(199904)42:3<555::AID-ANR21>3.0.CO;2-Z; Sivula T, 1999, FEBS LETT, V454, P75, DOI 10.1016/S0014-5793(99)00779-6; SONNEWALD U, 1992, PLANT J, V2, P571; Sutovsky P, 2011, REPRODUCTION, V142, P1, DOI 10.1530/REP-11-0041; Terkeltaub RA, 2001, AM J PHYSIOL-CELL PH, V281, pC1, DOI 10.1152/ajpcell.2001.281.1.C1; VISCONTI PE, 1995, DEVELOPMENT, V121, P1139; VISCONTI PE, 1995, DEVELOPMENT, V121, P1129; Wang J, 2007, EXP CELL RES, V313, P4120, DOI 10.1016/j.yexcr.2007.09.008; Wang WH, 1997, J REPROD FERTIL, V109, P247, DOI 10.1530/jrf.0.1090247; Wang WH, 2003, MICROSC RES TECHNIQ, V61, P335, DOI 10.1002/jemt.10346; Wu ATH, 2007, DEV BIOL, V312, P471, DOI 10.1016/j.ydbio.2007.08.051; YANG ZH, 1992, J BIOL CHEM, V267, P24634; Yepes M, 2003, LAB INVEST, V83, P1025, DOI 10.1097/01.LAB.0000075640.49586.E6; Yi XJ, 2011, INT J ANDROL, DOI [10.111141365-2605.2011.01217.x, DOI 10.1111/J.1365.2011.01217.X]; Yi YJ, 2010, CELL TISSUE RES, V341, P325, DOI 10.1007/s00441-010-0988-2; Yi YJ, 2010, J REPROD IMMUNOL, V84, P154, DOI 10.1016/j.jri.2009.11.002; Yi YJ, 2009, SYST BIOL REPROD MED, V55, P85, DOI 10.1080/19396360802699074; Zhou MJ, 1997, ANAL BIOCHEM, V253, P162, DOI 10.1006/abio.1997.2391	54	27	29	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2012	7	4							e34524	10.1371/journal.pone.0034524	http://dx.doi.org/10.1371/journal.pone.0034524			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952GU	22485177	Green Submitted, Green Published, gold			2022-12-27	WOS:000304780500052
J	Bao, F; Wu, P; Xiao, N; Qiu, F; Zeng, QP				Bao, Fei; Wu, Pei; Xiao, Na; Qiu, Frank; Zeng, Qing-Ping			Nitric Oxide-Driven Hypoxia Initiates Synovial Angiogenesis, Hyperplasia and Inflammatory Lesions in Mice	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; RHEUMATOID-ARTHRITIS; MODEL; RESPONSES; SYNTHASE; STRESS; TARGET	Background: Rheumatoid arthritis (RA) is an inflammatory articular disease with cartilage and bone damage due to hyperplasic synoviocyte invasion and subsequent matrix protease digestion. Although monoclonal antibodies against tumor necrosis factor alpha (TNF alpha) have been approved for clinical use in patients with RA, desired therapeutic regimens suitable for non-responders are still unavailable because etiological initiators leading to RA remain enigmatic and unidentified. Methodology/Principal Findings: Bacteria-induced arthritis (BIA) that simulates collagen-induced arthritis (CIA) is developed in mice upon daily live bacterial feeding. The morphological lesions of paw erythema and edema together with the histological alterations of synovial hyperplasia and lymphocytic infiltration emerge as the early-phase manifestations of BIA and CIA. Bacteria- or collagen-mediated global upregulation of pro-inflammatory cytokines is accompanied by the burst of nitric oxide (NO). Elevation of the serum NO level is correlated with decline of the blood oxygen saturation percentage (SpO2), reflecting a hypoxic consequence during development towards arthritis. NO-driven hypoxia is further evident from a positive relationship between NO and lactic acid (LA), an end product from glycolysis. Upregulation of hypoxia inducible factor 1 alpha (HIF-1 alpha) and vascular endothelial growth factor (VEGF) validates hypoxia-induced angiogenesis in the inflamed synovium of modeling mice. Administration of the NO donor compound sodium nitroprusside (SNP) causes articular inflammation by inducing synovial hypoxia. Anti-bacteria by the antibiotic cefotaxime and/or the immunosuppressant rapamycin or artesunate that also inhibits nitric oxide synthase (NOS) can abrogate NO production, mitigate hypoxia, and considerably ameliorate or even completely abort synovitis, hence highlighting that NO may serve as an initiator of inflammatory arthritis. Conclusions/Significance: Like collagen, bacteria also enable synovial lesions via upregulating pro-inflammatory cytokines, triggering NO production, driving hypoxic responses, and inducing synovial angiogenesis and hyperplasia, suggesting that sustained infection might be, in part, responsible for the onset of synovitis and arthritis in mice.	[Bao, Fei; Wu, Pei; Xiao, Na; Zeng, Qing-Ping] Guangzhou Univ Chinese Med, Inst Trop Med, Guangzhou, Guangdong, Peoples R China; [Qiu, Frank] Simplex Biotechnol LLC, Clinton, NJ USA	Guangzhou University of Chinese Medicine	Bao, F (corresponding author), Guangzhou Univ Chinese Med, Inst Trop Med, Guangzhou, Guangdong, Peoples R China.	qpzeng@163.com			National Project for Talent Overseas Chinese Scholars; Guangdong Provincial Natural Science Foundation [9145624536-4000003]	National Project for Talent Overseas Chinese Scholars; Guangdong Provincial Natural Science Foundation(National Natural Science Foundation of Guangdong Province)	This work was supported by the National Project for Talent Overseas Chinese Scholars (2009) and Guangdong Provincial Natural Science Foundation (No. 9145624536-4000003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramson SB, 2004, J RHEUMATOL, V31, P70, DOI 10.1097/BOR.0b013e328349c2b1; Biniecka M, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3424; Brand DD, 2007, NAT PROTOC, V2, P1269, DOI 10.1038/nprot.2007.173; Bredt DS, 1999, FREE RADICAL RES, V31, P577, DOI 10.1080/10715769900301161; Cannon GW, 1996, ARTHRITIS RHEUM-US, V39, P1677, DOI 10.1002/art.1780391010; Cejka D, 2010, ARTHRITIS RHEUM-US, V62, P2294, DOI 10.1002/art.27504; COURTENAY JS, 1980, NATURE, V283, P666, DOI 10.1038/283666a0; Cua DJ, 2011, NAT MED, V17, P1055, DOI 10.1038/nm0911-1055; Eckmann L, 2005, SPRINGER SEMIN IMMUN, V27, P181, DOI 10.1007/s00281-005-0207-5; FARRELL AJ, 1992, ANN RHEUM DIS, V51, P1219, DOI 10.1136/ard.51.11.1219; Fermor B, 2007, EUR CELLS MATER, V13, P56, DOI 10.22203/eCM.v013a06; Gowers IR, 2010, RHEUMATOLOGY, V42, P508; Han TH, 2003, P NATL ACAD SCI USA, V100, P12504, DOI 10.1073/pnas.2133409100; Hultqvist M, 2006, PLOS MED, V3, P1625, DOI 10.1371/journal.pmed.0030348; Humby F, 2009, PLOS MED, V6, P59, DOI 10.1371/journal.pmed.0060001; Kasuno K, 2004, J BIOL CHEM, V279, P2550, DOI 10.1074/jbc.M308197200; Kelly D, 2012, IMMUNOL REV, V245, P27, DOI 10.1111/j.1600-065X.2011.01079.x; Kennedy A, 2010, ARTHRITIS RHEUM-US, V62, P711, DOI 10.1002/art.27287; Keunen O, 2011, P NATL ACAD SCI USA, V108, P3749, DOI 10.1073/pnas.1014480108; Lala PK, 2001, LANCET ONCOL, V2, P149, DOI 10.1016/S1470-2045(00)00256-4; Laragione T, 2010, MOL MED, V16, P352, DOI 10.2119/molmed.2010.00049; Luross JA, 2001, IMMUNOLOGY, V103, P407, DOI 10.1046/j.1365-2567.2001.01267.x; McDevitt H, 2000, ARTHRITIS RES, V2, P85, DOI 10.1186/ar72; Muntane J, 2010, WORLD J HEPATOL, V2, P337, DOI 10.4254/wjh.v2.i9.337; Nagy G, 2008, IMMUNOL LETT, V118, P55, DOI 10.1016/j.imlet.2008.02.009; Nagy G, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3045; Nagy G, 2007, IMMUNOL LETT, V111, P1, DOI 10.1016/j.imlet.2007.04.013; Natarajan R, 2003, FEBS LETT, V549, P99, DOI 10.1016/S0014-5793(03)00798-1; Ng CT, 2010, ANN RHEUM DIS, V69, P1389, DOI 10.1136/ard.2009.119776; Nisoli E, 2006, J CELL SCI, V119, P2855, DOI 10.1242/jcs.03062; Olson N, 2011, NITRIC OXIDE-BIOL CH, V25, P125, DOI 10.1016/j.niox.2010.12.010; Perkins DJ, 1998, ARTHRITIS RHEUM, V41, P2205, DOI 10.1002/1529-0131(199812)41:12<2205::AID-ART16>3.3.CO;2-H; Rahman Masmudur M, 2006, PLoS Pathog, V2, pe4; Sanchez-Pernaute O, 2003, ANN RHEUM DIS, V62, P1135, DOI 10.1136/ard.2003.011767; Schett G, 2011, ARTHRITIS RES THER, V13, DOI [10.1186/1478-6354-13-S1-S4, 10.1186/ar3095]; Sherbet G. V., 2009, British Journal of Medical Practitioners, V2, P6; Smith HS, 2011, PAIN PHYSICIAN, V14, pE427; Smith MM, 2008, RHEUMATOLOGY, V47, P1172, DOI 10.1093/rheumatology/ken219; Smolen JS, 2007, LANCET, V370, P1861, DOI 10.1016/S0140-6736(07)60784-3; Song XR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023453; Tak PP, 2011, ARTHRITIS RES THER, V13, DOI [10.1186/ar3096, 10.1186/1478-6354-13-S1-S5]; Tang W, 2011, SCIENCE, V332, P478, DOI 10.1126/science.1199214; Teachey DT, 2009, BRIT J HAEMATOL, V145, P101, DOI 10.1111/j.1365-2141.2009.07595.x; Toes REM, 2009, PLOS MED, V6, P15, DOI 10.1371/journal.pmed.1000009; van Zonneveld AJ, 2010, ANN RHEUM DIS, V69, P57, DOI 10.1136/ard.2009.119495; WALSH LJ, 1991, P NATL ACAD SCI USA, V88, P4220, DOI 10.1073/pnas.88.10.4220; Wang B, 2004, ARTHRITIS RHEUM-US, V50, P2995, DOI 10.1002/art.20459; Wang JX, 2008, BRIT J PHARMACOL, V153, P1303, DOI 10.1038/bjp.2008.11; Wheeler MA, 1997, J CLIN INVEST, V99, P110, DOI 10.1172/JCI119121; Wilder RL, 2002, ANN RHEUM DIS, V61, P96, DOI 10.1136/ard.61.suppl_2.ii96; Witthoft T, 1998, AM J PHYSIOL-GASTR L, V275, pG564, DOI 10.1152/ajpgi.1998.275.3.G564; Wu HJ, 2010, IMMUNITY, V32, P815, DOI 10.1016/j.immuni.2010.06.001; Xu WM, 2005, CELL RES, V15, P63, DOI 10.1038/sj.cr.7290267	53	16	19	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e34494	10.1371/journal.pone.0034494	http://dx.doi.org/10.1371/journal.pone.0034494			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479635	gold, Green Published			2022-12-27	WOS:000305339100161
J	Yarali, A; Nehrkorn, J; Tanimoto, H; Herz, AVM				Yarali, Ayse; Nehrkorn, Johannes; Tanimoto, Hiromu; Herz, Andreas V. M.			Event Timing in Associative Learning: From Biochemical Reaction Dynamics to Behavioural Observations	PLOS ONE			English	Article							SEQUENCE-DEPENDENT INTERACTIONS; MUSHROOM BODY NEURONS; LONG-TERM-MEMORY; ADENYLYL-CYCLASE; TRANSIENT CALCIUM; TRANSMITTER STIMULI; SENSORY NEURONS; ODOR AVOIDANCE; PROTEIN-KINASE; DROSOPHILA	Associative learning relies on event timing. Fruit flies for example, once trained with an odour that precedes electric shock, subsequently avoid this odour (punishment learning); if, on the other hand the odour follows the shock during training, it is approached later on (relief learning). During training, an odour-induced Ca++ signal and a shock-induced dopaminergic signal converge in the Kenyon cells, synergistically activating a Ca++-calmodulin-sensitive adenylate cyclase, which likely leads to the synaptic plasticity underlying the conditioned avoidance of the odour. In Aplysia, the effect of serotonin on the corresponding adenylate cyclase is bi-directionally modulated by Ca++, depending on the relative timing of the two inputs. Using a computational approach, we quantitatively explore this biochemical property of the adenylate cyclase and show that it can generate the effect of event timing on associative learning. We overcome the shortage of behavioural data in Aplysia and biochemical data in Drosophila by combining findings from both systems.	[Yarali, Ayse; Nehrkorn, Johannes; Tanimoto, Hiromu] Max Planck Inst Neurobiol, Martinsried, Germany; [Nehrkorn, Johannes; Herz, Andreas V. M.] Univ Munich, Dept Biol 2, Div Neurobiol, Martinsried, Germany; [Nehrkorn, Johannes; Herz, Andreas V. M.] Bernstein Ctr Computat Neurosci, Munich, Germany	Max Planck Society; University of Munich	Yarali, A (corresponding author), Max Planck Inst Neurobiol, Martinsried, Germany.	yarali@neuro.mpg.de	Tanimoto, Hiromu/J-6810-2016		Bundesministerium fuer Bildung und Forschung (BMBF) through the Bernstein Focus Neural Basis of Learning	Bundesministerium fuer Bildung und Forschung (BMBF) through the Bernstein Focus Neural Basis of Learning	This work was supported by the Bundesministerium fuer Bildung und Forschung (BMBF) through the Bernstein Focus Neural Basis of Learning (H. T. and A. V. M. H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams TW, 1998, LEARN MEMORY, V4, P496, DOI 10.1101/lm.4.6.496; ABRAMS TW, 1991, J NEUROSCI, V11, P2655; ABRAMS TW, 1985, CELL MOL NEUROBIOL, V5, P123, DOI 10.1007/BF00711089; Acevedo SF, 2007, MOL CELL NEUROSCI, V34, P378, DOI 10.1016/j.mcn.2006.11.011; Adams JA, 1998, J THEOR BIOL, V193, P543, DOI 10.1006/jtbi.1998.0721; Alberts B, 2002, MOL BIOL CELL, P868; Andreatta M, 2010, P ROY SOC B-BIOL SCI, V277, P2411, DOI 10.1098/rspb.2010.0103; Aso Y, 2010, CURR BIOL, V20, P1445, DOI 10.1016/j.cub.2010.06.048; ASZODI A, 1991, P NATL ACAD SCI USA, V88, P5832, DOI 10.1073/pnas.88.13.5832; Blum AL, 2009, CURR BIOL, V19, P1341, DOI 10.1016/j.cub.2009.07.016; Britton G, 1999, J NEUROSCI, V19, P9126, DOI 10.1523/JNEUROSCI.19-20-09126.1999; Cassenaer S, 2007, NATURE, V448, P709, DOI 10.1038/nature05973; Cassenaer S, 2012, NATURE, V482, P47, DOI 10.1038/nature10776; Chang RC, 2003, J EXP PSYCHOL ANIM B, V29, P171, DOI 10.1037/0097-7403.29.3.171; Claridge-Chang A, 2009, CELL, V139, P405, DOI 10.1016/j.cell.2009.08.034; Connolly JB, 1996, SCIENCE, V274, P2104, DOI 10.1126/science.274.5295.2104; Dougherty DP, 2005, P NATL ACAD SCI USA, V102, P10415, DOI 10.1073/pnas.0504099102; Drew PJ, 2006, P NATL ACAD SCI USA, V103, P8876, DOI 10.1073/pnas.0600676103; Galili DS, 2011, J NEUROSCI, V31, P7240, DOI 10.1523/JNEUROSCI.6667-10.2011; Gervasi N, 2010, NEURON, V65, P516, DOI 10.1016/j.neuron.2010.01.014; Halnes G, 2009, J COMPUT NEUROSCI, V27, P471, DOI 10.1007/s10827-009-0162-6; Hellstern F, 1998, LEARN MEMORY, V4, P429, DOI 10.1101/lm.4.5.429; Ito Iori, 2008, Communicative & Integrative Biology, V1, P170; Khurana S, 2009, J BIOSCIENCES, V34, P621, DOI 10.1007/s12038-009-0080-9; Kim YC, 2007, J NEUROSCI, V27, P7640, DOI 10.1523/JNEUROSCI.1167-07.2007; Lin AH, 1998, BRAIN RES, V800, P300, DOI 10.1016/S0006-8993(98)00536-8; Lin AH, 2010, P NATL ACAD SCI USA, V107, P15607, DOI 10.1073/pnas.1004451107; Lindskog M, 2006, PLOS COMPUT BIOL, V2, P1045, DOI 10.1371/journal.pcbi.0020119; LIVINGSTONE MS, 1984, CELL, V37, P205, DOI 10.1016/0092-8674(84)90316-7; MAIER SF, 1976, ANIM LEARN BEHAV, V4, P217, DOI 10.3758/BF03214039; Michels B, 2011, LEARN MEMORY, V18, P332, DOI 10.1101/lm.2101411; MOSCOVITCH A, 1968, J COMP PHYSIOL PSYCH, V66, P673, DOI 10.1037/h0026548; Muller U, 2000, NEURON, V27, P159, DOI 10.1016/S0896-6273(00)00017-9; Murakami S, 2010, J NEUROSCI METH, V188, P195, DOI 10.1016/j.jneumeth.2010.02.007; Murthy M, 2008, NEURON, V59, P1009, DOI 10.1016/j.neuron.2008.07.040; OCORR KA, 1985, P NATL ACAD SCI USA, V82, P2548, DOI 10.1073/pnas.82.8.2548; Onyike CU, 1998, J NEUROCHEM, V71, P1298; Pagani MR, 2009, CELL, V139, P186, DOI 10.1016/j.cell.2009.08.033; Pan YF, 2009, LEARN MEMORY, V16, P289, DOI 10.1101/lm.1331809; PLOTKIN HC, 1975, J COMP PHYSIOL PSYCH, V88, P586, DOI 10.1037/h0076426; Preat T, 1998, J NEUROSCI, V18, P8534; RESCORLA RA, 1988, ANNU REV NEUROSCI, V11, P329, DOI 10.1146/annurev.ne.11.030188.001553; Riemensperger T, 2005, CURR BIOL, V15, P1953, DOI 10.1016/j.cub.2005.09.042; Rospars JP, 2007, BIOSYSTEMS, V89, P101, DOI 10.1016/j.biosystems.2006.05.015; Schwaerzel M, 2003, J NEUROSCI, V23, P10495, DOI 10.1523/jneurosci.23-33-10495.2003; Sejourne J, 2011, NAT NEUROSCI, V14, P903, DOI 10.1038/nn.2846; Selcho M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005897; Seugnet L, 2008, CURR BIOL, V18, P1110, DOI 10.1016/j.cub.2008.07.028; Shuai YC, 2011, P NATL ACAD SCI USA, V108, P20201, DOI 10.1073/pnas.1107489109; SOLOMON RL, 1974, PSYCHOL REV, V81, P119, DOI 10.1037/h0036128; Sutton R.S., 1990, LEARNING COMPUTATION, P497; Tanimoto H, 2004, NATURE, V430, P983, DOI 10.1038/430983a; Tomchik SM, 2009, NEURON, V64, P510, DOI 10.1016/j.neuron.2009.09.029; TULLY T, 1985, J COMP PHYSIOL A, V157, P263, DOI 10.1007/BF01350033; Turner GC, 2008, J NEUROPHYSIOL, V99, P734, DOI 10.1152/jn.01283.2007; Wagner A.R., 1981, P5; Wang YL, 2008, J NEUROSCI, V28, P4368, DOI 10.1523/JNEUROSCI.2958-07.2008; Wang YL, 2004, J NEUROSCI, V24, P6507, DOI 10.1523/JNEUROSCI.3727-03.2004; Whitlock JR, 2006, SCIENCE, V313, P1093, DOI 10.1126/science.1128134; Yarali A, 2008, ANIM BEHAV, V76, P1173, DOI 10.1016/j.anbehav.2008.05.025; Yarali A, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00189; Yarali A, 2009, J NEUROGENET, V23, P235, DOI 10.1080/01677060802441372; YOVELL Y, 1992, P NATL ACAD SCI USA, V89, P6526, DOI 10.1073/pnas.89.14.6526; Yu DH, 2006, NEURON, V52, P845, DOI 10.1016/j.neuron.2006.10.030; Zars T, 2000, SCIENCE, V288, P672, DOI 10.1126/science.288.5466.672; Zhang JC, 2009, P NATL ACAD SCI USA, V106, P13028, DOI 10.1073/pnas.0900546106	66	18	18	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e32885	10.1371/journal.pone.0032885	http://dx.doi.org/10.1371/journal.pone.0032885			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22493657	Green Submitted, Green Published, gold			2022-12-27	WOS:000305339100021
J	Agnew, ZK; Wise, RJS; Leech, R				Agnew, Zarinah K.; Wise, Richard J. S.; Leech, Robert			Dissociating Object Directed and Non-Object Directed Action in the Human Mirror System; Implications for Theories of Motor Simulation	PLOS ONE			English	Article							PREMOTOR CORTEX; NEURON SYSTEM; SOCIAL COGNITION; PARIETAL CORTEX; TOOL USE; FMRI; BRAIN; RECOGNITION; IMITATION; AREAS	Mirror neurons are single cells found in macaque premotor and parietal cortices that are active during action execution and observation. In non-human primates, mirror neurons have only been found in relation to object-directed movements or communicative gestures, as non-object directed actions of the upper limb are not well characterized in non-human primates. Mirror neurons provide important evidence for motor simulation theories of cognition, sometimes referred to as the direct matching hypothesis, which propose that observed actions are mapped onto associated motor schemata in a direct and automatic manner. This study, for the first time, directly compares mirror responses, defined as the overlap between action execution and observation, during object directed and meaningless non-object directed actions. We present functional MRI data that demonstrate a clear dissociation between object directed and non-object directed actions within the human mirror system. A premotor and parietal network was preferentially active during object directed actions, whether observed or executed. Moreover, we report spatially correlated activity across multiple voxels for observation and execution of an object directed action. In contrast to predictions made by motor simulation theory, no similar activity was observed for non-object directed actions. These data demonstrate that object directed and meaningless non-object directed actions are subserved by different neuronal networks and that the human mirror response is significantly greater for object directed actions. These data have important implications for understanding the human mirror system and for simulation theories of motor cognition. Subsequent theories of motor simulation must account for these differences, possibly by acknowledging the role of experience in modulating the mirror response.	[Agnew, Zarinah K.] UCL, Inst Cognit Neurosci, London, England; [Wise, Richard J. S.] Univ London Imperial Coll Sci Technol & Med, Cognit Neuroimaging Grp, MRC, Ctr Clin Sci, London, England; [Wise, Richard J. S.; Leech, Robert] Univ London Imperial Coll Sci Technol & Med, Div Neurosci & Mental Hlth, London, England	University of London; University College London; Imperial College London; Imperial College London	Agnew, ZK (corresponding author), UCL, Inst Cognit Neurosci, London, England.	z.agnew@ucl.ac.uk	Leech, Robert/AAE-8254-2019	Leech, Robert/0000-0002-5801-6318	Medical Research Council; Research Councils UK (RCUK); MRC [MC_U120064975] Funding Source: UKRI; Medical Research Council [MC_U120064975] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Research Councils UK (RCUK)(UK Research & Innovation (UKRI)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded in the main by the Medical Research Council (http://www.mrc.ac.uk/index.htm) and to a much lesser degree Research Councils UK (RCUK) (http://www.rcuk.ac.uk/Pages/Home.aspx). The experiment was carried out by ZKA who, at the time, was funded by the Medical Research Council. RL, who contributed greatly to the pattern analysis and writing, was at the time funded by RCUK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Agnew Z, 2008, J NEUROSCI, V28, P12268, DOI 10.1523/JNEUROSCI.2836-08.2008; Aziz-Zadeh L, 2006, J NEUROSCI, V26, P2964, DOI 10.1523/JNEUROSCI.2921-05.2006; Aziz-Zadeh L, 2002, EXP BRAIN RES, V144, P127, DOI 10.1007/s00221-002-1037-5; Blakemore SJ, 1999, NEUROIMAGE, V10, P448, DOI 10.1006/nimg.1999.0478; Buccino G, 2004, J COGNITIVE NEUROSCI, V16, P114, DOI 10.1162/089892904322755601; Buccino G, 2001, EUR J NEUROSCI, V13, P400, DOI 10.1046/j.1460-9568.2001.01385.x; Caggiano V, 2009, SCIENCE, V324, P403, DOI 10.1126/science.1166818; Catmur C, 2008, EUR J NEUROSCI, V28, P1208, DOI 10.1111/j.1460-9568.2008.06419.x; Catmur C, 2007, CURR BIOL, V17, P1527, DOI 10.1016/j.cub.2007.08.006; Cornelissen FW, 2002, EXP BRAIN RES, V145, P270, DOI 10.1007/s00221-002-1136-3; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Culham JC, 2003, EXP BRAIN RES, V153, P180, DOI 10.1007/s00221-003-1591-5; Culham JC, 2006, NEUROPSYCHOLOGIA, V44, P2668, DOI 10.1016/j.neuropsychologia.2005.11.003; Dinstein I, 2008, J NEUROSCI, V28, P11231, DOI 10.1523/JNEUROSCI.3585-08.2008; Dinstein I, 2008, CURR BIOL, V18, pR13, DOI 10.1016/j.cub.2007.11.004; DIPELLEGRINO G, 1992, EXP BRAIN RES, V91, P176, DOI 10.1007/BF00230027; Downing PE, 2007, J NEUROSCI, V27, P226, DOI 10.1523/JNEUROSCI.3619-06.2007; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Etzel JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003690; FADIGA L, 1995, J NEUROPHYSIOL, V73, P2608, DOI 10.1152/jn.1995.73.6.2608; Ferrari PF, 2003, EUR J NEUROSCI, V17, P1703, DOI 10.1046/j.1460-9568.2003.02601.x; Fisher R. A., 1915, BIOMETRIKA, P507, DOI DOI 10.2307/2331838; Gallese V, 2004, TRENDS COGN SCI, V8, P396, DOI 10.1016/j.tics.2004.07.002; Gallese V, 1998, TRENDS COGN SCI, V2, P493, DOI 10.1016/S1364-6613(98)01262-5; Gallese V, 1996, BRAIN, V119, P593, DOI 10.1093/brain/119.2.593; Grezes J, 2003, NEUROIMAGE, V18, P928, DOI 10.1016/S1053-8119(03)00042-9; Heiser M, 2003, EUR J NEUROSCI, V17, P1123, DOI 10.1046/j.1460-9568.2003.02530.x; Heyes C, 2001, TRENDS COGN SCI, V5, P253, DOI 10.1016/S1364-6613(00)01661-2; Heyes C, 2010, NEUROSCI BIOBEHAV R, V34, P575, DOI 10.1016/j.neubiorev.2009.11.007; Hickok G, CURR BIOL, V20, pR593; Iacoboni M, 1999, SCIENCE, V286, P2526, DOI 10.1126/science.286.5449.2526; Iacoboni M, 2005, PLOS BIOL, V3, P529, DOI 10.1371/journal.pbio.0030079; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Keysers C, 2004, TRENDS COGN SCI, V8, P501, DOI 10.1016/j.tics.2004.09.005; Konen CS, 2004, NEUROIMAGE, V22, P304, DOI 10.1016/j.neuroimage.2003.12.039; Kriegeskorte N, 2006, P NATL ACAD SCI USA, V103, P3863, DOI 10.1073/pnas.0600244103; Leiguarda RC, 2000, BRAIN, V123, P860, DOI 10.1093/brain/123.5.860; Montgomery KJ, 2007, SOC COGN AFFECT NEUR, V2, P114, DOI 10.1093/scan/nsm004; Newman-Norlund R, 2010, BRAIN RES, V1315, P63, DOI 10.1016/j.brainres.2009.11.065; Obayashi S, 2002, NEUROREPORT, V13, P2349, DOI 10.1097/00001756-200212030-00036; Obayashi S, 2001, NEUROIMAGE, V14, P853, DOI 10.1006/nimg.2001.0878; Pazzaglia M, 2008, J NEUROSCI, V28, P3030, DOI 10.1523/JNEUROSCI.5748-07.2008; Pazzaglia M, 2008, CURR BIOL, V18, P1766, DOI 10.1016/j.cub.2008.09.061; RAPCSAK SZ, 1995, BRAIN COGNITION, V27, P213, DOI 10.1006/brcg.1995.1018; Rizzolatti G, 2001, NAT REV NEUROSCI, V2, P661, DOI 10.1038/35090060; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Rizzolatti G, 1996, COGNITIVE BRAIN RES, V3, P131, DOI 10.1016/0926-6410(95)00038-0; Rossi S, 2002, CLIN NEUROPHYSIOL, V113, P16, DOI 10.1016/S1388-2457(01)00725-8; Rothi LJ, 1991, COGNITIVE NEUROPSYCH, V8, P442; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Tkach D, 2007, J NEUROSCI, V27, P13241, DOI 10.1523/JNEUROSCI.2895-07.2007; Villarrea M, 2008, NEUROPSYCHOLOGIA, V46, P2371, DOI 10.1016/j.neuropsychologia.2008.03.004	52	31	33	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2012	7	4							e32517	10.1371/journal.pone.0032517	http://dx.doi.org/10.1371/journal.pone.0032517			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959FE	22505995	Green Published, Green Submitted, gold			2022-12-27	WOS:000305297500003
J	Marron, AO; Akam, M; Walker, G				Marron, Alan O.; Akam, Michael; Walker, Giselle			Nitrile Hydratase Genes Are Present in Multiple Eukaryotic Supergroups	PLOS ONE			English	Article							MOLECULAR PHYLOGENETICS; ORIGIN; DIVERSIFICATION; DIVERSITY; EVOLUTION; RELATIVES; TAXONOMY; DATABASE; CLUSTER; GENOME	Background: Nitrile hydratases are enzymes involved in the conversion of nitrile-containing compounds into ammonia and organic acids. Although they are widespread in prokaryotes, nitrile hydratases have only been reported in two eukaryotes: the choanoflagellate Monosiga brevicollis and the stramenopile Aureococcus anophagefferens. The nitrile hydratase gene in M. brevicollis was believed to have arisen by lateral gene transfer from a prokaryote, and is a fusion of beta and alpha nitrile hydratase subunits. Only the alpha subunit has been reported in A. anophagefferens. Methodology/Principal Findings: Here we report the detection of nitrile hydratase genes in five eukaryotic supergroups: opisthokonts, amoebozoa, archaeplastids, CCTH and SAR. Beta-alpha subunit fusion genes are found in the choanoflagellates, ichthyosporeans, apusozoans, haptophytes, rhizarians and stramenopiles, and potentially also in the amoebozoans. An individual alpha subunit is found in a dinoflagellate and an individual beta subunit is found in a haptophyte. Phylogenetic analyses recover a clade of eukaryotic-type nitrile hydratases in the Opisthokonta, Amoebozoa, SAR and CCTH; this is supported by analyses of introns and gene architecture. Two nitrile hydratase sequences from an animal and a plant resolve in the prokaryotic nitrile hydratase clade. Conclusions/Significance: The evidence presented here demonstrates that nitrile hydratase genes are present in multiple eukaryotic supergroups, suggesting that a subunit fusion gene was present in the last common ancestor of all eukaryotes. The absence of nitrile hydratase from several sequenced species indicates that subunits were lost in multiple eukaryotic taxa. The presence of nitrile hydratases in many other eukaryotic groups is unresolved due to insufficient data and taxon sampling. The retention and expression of the gene in distantly related eukaryotic species suggests that it plays an important metabolic role. The novel family of eukaryotic nitrile hydratases presented in this paper represents a promising candidate for research into their molecular biology and possible biotechnological applications.	[Marron, Alan O.; Akam, Michael] Univ Cambridge, Dept Zool, Cambridge, England; [Walker, Giselle] Univ Otago, Dept Bot, Dunedin, New Zealand	University of Cambridge; University of Otago	Marron, AO (corresponding author), Univ Cambridge, Dept Zool, Cambridge, England.	am543@cam.ac.uk	Walker, Giselle/I-3906-2012		Biotechnology and Biological Sciences Research Council Comparative Genomics training grant [BB/E527604/1]; Leathersellers' Company Scholarship; Fitzwilliam College, Cambridge; Biotechnology and Biological Sciences Research Council Capacity and Capability Challenge Programme [CCC-1-10]; BBSRC [BBS/E/T/000PR6193] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/T/000PR6193] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council Comparative Genomics training grant(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Leathersellers' Company Scholarship; Fitzwilliam College, Cambridge; Biotechnology and Biological Sciences Research Council Capacity and Capability Challenge Programme(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	AOM was supported by the Biotechnology and Biological Sciences Research Council Comparative Genomics training grant BB/E527604/1 and a Leathersellers' Company Scholarship awarded by Fitzwilliam College, Cambridge. Sequencing work carried out by The Genome Analysis Centre, Norwich, United Kingdom was supported by the Biotechnology and Biological Sciences Research Council Capacity and Capability Challenge Programme project number CCC-1-10. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Abedin M, 2010, TRENDS CELL BIOL, V20, P734, DOI 10.1016/j.tcb.2010.08.002; Adl SM, 2005, J EUKARYOT MICROBIOL, V52, P399, DOI 10.1111/j.1550-7408.2005.00053.x; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andersen RA, 2004, AM J BOT, V91, P1508, DOI 10.3732/ajb.91.10.1508; Andersson JO, 2005, CELL MOL LIFE SCI, V62, P1182, DOI 10.1007/s00018-005-4539-z; Banerjee A, 2002, APPL MICROBIOL BIOT, V60, P33, DOI 10.1007/s00253-002-1062-0; Basile LJ, 2008, APPL MICROBIOL BIOT, V80, P427, DOI 10.1007/s00253-008-1559-2; Bayer-Giraldi M, 2010, ENVIRON MICROBIOL, V12, P1041, DOI 10.1111/j.1462-2920.2009.02149.x; Bigey F, 1999, J APPL MICROBIOL, V86, P752, DOI 10.1046/j.1365-2672.1999.00723.x; Brandao PFB, 2003, APPL ENVIRON MICROB, V69, P5754, DOI 10.1128/AEM.69.10.5754-5766.2003; Cavalier-Smith T, 2010, PROTIST, V161, P549, DOI 10.1016/j.protis.2010.04.002; Chebrou H, 1996, BBA-PROTEIN STRUCT M, V1298, P285, DOI 10.1016/S0167-4838(96)00145-8; Coffey L, 2010, ANTON LEEUW INT J G, V98, P455, DOI 10.1007/s10482-010-9459-8; Doyle J. J., 1987, PHYTOCHEM B, P11; Duvick J, 2008, NUCLEIC ACIDS RES, V36, pD959, DOI 10.1093/nar/gkm1041; Faux NG, 2005, GENOME RES, V15, P537, DOI 10.1101/gr.3096505; Foerstner KU, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003976; Gobler CJ, 2011, P NATL ACAD SCI USA, V108, P4352, DOI 10.1073/pnas.1016106108; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Ivens AC, 2005, SCIENCE, V309, P436, DOI 10.1126/science.1112680; Keeling PJ, 2008, NAT REV GENET, V9, P605, DOI 10.1038/nrg2386; Kim E, 2006, MOL BIOL EVOL, V23, P2455, DOI 10.1093/molbev/msl120; Kobayashi M, 2000, CURR OPIN CHEM BIOL, V4, P95, DOI 10.1016/S1367-5931(99)00058-7; Komeda H, 1996, J BIOL CHEM, V271, P15796, DOI 10.1074/jbc.271.26.15796; Koonin EV, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-209; LEADBEATER BSC, 1979, PROTOPLASMA, V98, P241, DOI 10.1007/BF01281442; Miyanaga A, 2001, BIOCHEM BIOPH RES CO, V288, P1169, DOI 10.1006/bbrc.2001.5897; Nagaraj SH, 2007, BRIEF BIOINFORM, V8, P6, DOI 10.1093/bib/bbl015; Nakagaki T, 2000, NATURE, V407, P470, DOI 10.1038/35035159; Nedelcu AM, 2008, J EVOLUTION BIOL, V21, P1852, DOI 10.1111/j.1420-9101.2008.01605.x; NISHIYAMA M, 1991, J BACTERIOL, V173, P2465, DOI 10.1128/jb.173.8.2465-2472.1991; Nitsche F, 2011, J EUKARYOT MICROBIOL, V58, P452, DOI 10.1111/j.1550-7408.2011.00572.x; O'Brien EA, 2007, NUCLEIC ACIDS RES, V35, pD445, DOI 10.1093/nar/gkl770; Pace HC, 2001, GENOME BIOL, V2; Parfrey LW, 2011, P NATL ACAD SCI USA, V108, P13624, DOI 10.1073/pnas.1110633108; Piotrowski M, 2008, PHYTOCHEMISTRY, V69, P2655, DOI 10.1016/j.phytochem.2008.08.020; Prasad S, 2010, BIOTECHNOL ADV, V28, P725, DOI 10.1016/j.biotechadv.2010.05.020; Roger AJ, 2006, PHILOS T R SOC B, V361, P1039, DOI 10.1098/rstb.2006.1845; Rokas A, 2008, CURR OPIN GENET DEV, V18, P472, DOI 10.1016/j.gde.2008.09.004; Ruiz-Trillo I, 2008, MOL BIOL EVOL, V25, P664, DOI 10.1093/molbev/msn006; Sakashita T, 2008, J BACTERIOL, V190, P4210, DOI 10.1128/JB.00061-08; Sharma Monica, 2009, Reviews in Environmental Science and Bio/Technology, V8, P343, DOI 10.1007/s11157-009-9175-x; Sperling EA, 2010, GEOBIOLOGY, V8, P24, DOI 10.1111/j.1472-4669.2009.00225.x; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stiller JW, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-259; Sun GL, 2010, MOL BIOL EVOL, V27, P2879, DOI 10.1093/molbev/msq175; Torruella G, 2012, MOL BIOL EVOL, V29, P531, DOI 10.1093/molbev/msr185; Torruella G, 2009, J MOL EVOL, V69, P240, DOI 10.1007/s00239-009-9266-x; Walker G, 2011, PARASITOLOGY, V138, P1638, DOI 10.1017/S0031182010001708; Yamada H, 2001, CHEM REC, V1, P152	52	15	18	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2012	7	4							e32867	10.1371/journal.pone.0032867	http://dx.doi.org/10.1371/journal.pone.0032867			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959FE	22505998	gold, Green Published, Green Submitted			2022-12-27	WOS:000305297500006
J	Xu, LD; Qu, ZL				Xu, Lida; Qu, Zhilin			Roles of Protein Ubiquitination and Degradation Kinetics in Biological Oscillations	PLOS ONE			English	Article							CELL-CYCLE; NEGATIVE FEEDBACK; MODEL; DYNAMICS; ULTRASENSITIVITY; UBIQUITYLATION; ACCUMULATION; DESTRUCTION; HYSTERESIS; ORDER	Protein ubiquitination and degradation play important roles in many biological functions and are associated with many human diseases. It is well known that for biochemical oscillations to occur, proper degradation rates of the participating proteins are needed. In most mathematical models of biochemical reactions, linear degradation kinetics has been used. However, the degradation kinetics in real systems may be nonlinear, and how nonlinear degradation kinetics affects biological oscillations are not well understood. In this study, we first develop a biochemical reaction model of protein ubiquitination and degradation and calculate the degradation rate against the concentration of the free substrate. We show that the protein degradation kinetics mainly follows the Michaelis-Menten formulation with a time delay caused by ubiquitination and deubiquitination. We then study analytically how the Michaelis-Menten degradation kinetics affects the instabilities that lead to oscillations using three generic oscillation models: 1) a positive feedback mediated oscillator; 2) a positive-plus-negative feedback mediated oscillator; and 3) a negative feedback mediated oscillator. In all three cases, nonlinear degradation kinetics promotes oscillations, especially for the negative feedback mediated oscillator, resulting in much larger oscillation amplitudes and slower frequencies than those observed with linear kinetics. However, the time delay due to protein ubiquitination and deubiquitination generally suppresses oscillations, reducing the amplitude and increasing the frequency of the oscillations. These theoretical analyses provide mechanistic insights into the effects of specific proteins in the ubiquitination-proteasome system on biological oscillations.	[Xu, Lida; Qu, Zhilin] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med Cardiol, Los Angeles, CA 90095 USA; [Xu, Lida] Beijing Normal Univ, Dept Syst Sci, Beijing 100875, Peoples R China	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Beijing Normal University	Xu, LD (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Med Cardiol, Los Angeles, CA 90095 USA.	zqu@mednet.ucla.edu	xu, li/GNH-3667-2022		National Institute of Health [R01 HL101228]; China Scholarship Council; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL101228] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); China Scholarship Council(China Scholarship Council); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study is partially supported by National Institute of Health grant R01 HL101228, and a fellowship from the China Scholarship Council (LX). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Bhalla US, 2002, SCIENCE, V297, P1018, DOI 10.1126/science.1068873; BLISS RD, 1982, J THEOR BIOL, V97, P177, DOI 10.1016/0022-5193(82)90098-4; Buchler NE, 2005, P NATL ACAD SCI USA, V102, P9559, DOI 10.1073/pnas.0409553102; Busino L, 2007, SCIENCE, V316, P900, DOI 10.1126/science.1141194; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Gerard C, 2009, PHILOS T R SOC A, V367, P4665, DOI 10.1098/rsta.2009.0133; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Godinho SIH, 2007, SCIENCE, V316, P897, DOI 10.1126/science.1141138; GOLDBETER A, 1984, J BIOL CHEM, V259, P14441; GOLDBETER A, 1991, P NATL ACAD SCI USA, V88, P9107, DOI 10.1073/pnas.88.20.9107; Goldobin DS, 2009, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2009/01/P01009; GOODWIN BRIAN C., 1965, ADVANCE ENZYME REGULAT, V3, P425, DOI 10.1016/0065-2571(65)90067-1; GRIFFITH JS, 1968, J THEOR BIOL, V20, P202, DOI 10.1016/0022-5193(68)90189-6; Hersch GL, 2004, P NATL ACAD SCI USA, V101, P12136, DOI 10.1073/pnas.0404733101; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Hwang LH, 1998, SCIENCE, V279, P1041, DOI 10.1126/science.279.5353.1041; Kholodenko BN, 2000, EUR J BIOCHEM, V267, P1583, DOI 10.1046/j.1432-1327.2000.01197.x; Krishna S, 2006, P NATL ACAD SCI USA, V103, P10840, DOI 10.1073/pnas.0604085103; Leloup JC, 2003, P NATL ACAD SCI USA, V100, P7051, DOI 10.1073/pnas.1132112100; Liepe J, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000830; MORGAN DO, 1995, NATURE, V374, P131, DOI 10.1038/374131a0; Nakayama K, 2000, EMBO J, V19, P2069, DOI 10.1093/emboj/19.9.2069; Parry DH, 2001, CURR BIOL, V11, P671, DOI 10.1016/S0960-9822(01)00204-4; Pereg Y, 2010, NAT CELL BIOL, V12, P400, DOI 10.1038/ncb2041; Petroski MD, 2008, BMC BIOCHEM, V9, DOI 10.1186/1471-2091-9-S1-S7; Pfeuty B, 2009, PHYS BIOL, V6, DOI 10.1088/1478-3975/6/4/046013; Pierce NW, 2009, NATURE, V462, P615, DOI 10.1038/nature08595; Pomerening JR, 2003, NAT CELL BIOL, V5, P346, DOI 10.1038/ncb954; Popov N, 2010, NAT CELL BIOL, V12, P973, DOI 10.1038/ncb2104; Qu ZL, 2011, PROG BIOPHYS MOL BIO, V107, P21, DOI 10.1016/j.pbiomolbio.2011.06.004; Qu ZL, 2009, PHYS BIOL, V6, DOI 10.1088/1478-3975/6/1/016007; Qu ZL, 2003, BIOPHYS J, V85, P3600, DOI 10.1016/S0006-3495(03)74778-X; Qu ZL, 2003, AM J PHYSIOL-CELL PH, V284, pC349, DOI 10.1152/ajpcell.00066.2002; Schnell S, 2007, AM SCI, V95, P134, DOI 10.1511/2007.64.1018; Sha W, 2003, P NATL ACAD SCI USA, V100, P975, DOI 10.1073/pnas.0235349100; Strogatz SH, 2000, NONLINEAR DYNAMICS C, Vxi, P498; Tsai TYC, 2008, SCIENCE, V321, P126, DOI 10.1126/science.1156951; Tyson J.J., 2002, INTERD APPL, P230, DOI 10.1007/978-0-387-22459-6_9; Tyson JJ, 2003, CURR OPIN CELL BIOL, V15, P221, DOI 10.1016/S0955-0674(03)00017-6; TYSON JJ, 1991, P NATL ACAD SCI USA, V88, P7328, DOI 10.1073/pnas.88.16.7328; Vucic D, 2011, NAT REV MOL CELL BIO, V12, P439, DOI 10.1038/nrm3143; Wang J, 2011, P NATL ACAD SCI USA, V108, P8257, DOI 10.1073/pnas.1017017108; Wang YS, 1999, CURR BIOL, V9, P1191, DOI 10.1016/S0960-9822(00)80024-X; Westermark PO, 2003, BIOPHYS J, V85, P126, DOI 10.1016/S0006-3495(03)74460-9; Wong WW, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100172; Xiong W, 2003, NATURE, V426, P460, DOI 10.1038/nature02089; Yang L, 2004, BIOPHYS J, V86, P3432, DOI 10.1529/biophysj.103.036558	48	17	17	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2012	7	4							e34616	10.1371/journal.pone.0034616	http://dx.doi.org/10.1371/journal.pone.0034616			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959FE	22506034	gold, Green Published, Green Submitted			2022-12-27	WOS:000305297500042
J	Huang, WJ; Pach, D; Napadow, V; Park, K; Long, XY; Neumann, J; Maeda, Y; Nierhaus, T; Liang, FR; Witt, CM				Huang, Wenjing; Pach, Daniel; Napadow, Vitaly; Park, Kyungmo; Long, Xiangyu; Neumann, Jane; Maeda, Yumi; Nierhaus, Till; Liang, Fanrong; Witt, Claudia M.			Characterizing Acupuncture Stimuli Using Brain Imaging with fMRI - A Systematic Review and Meta-Analysis of the Literature	PLOS ONE			English	Article							NEURONAL SPECIFICITY; CORTICAL ACTIVATIONS; MANUAL ACUPUNCTURE; PLACEBO NEEDLE; DEFAULT MODE; CONNECTIVITY; CORTEX; ELECTROACUPUNCTURE; NETWORK; HYPOTHALAMUS	Background: The mechanisms of action underlying acupuncture, including acupuncture point specificity, are not well understood. In the previous decade, an increasing number of studies have applied fMRI to investigate brain response to acupuncture stimulation. Our aim was to provide a systematic overview of acupuncture fMRI research considering the following aspects: 1) differences between verum and sham acupuncture, 2) differences due to various methods of acupuncture manipulation, 3) differences between patients and healthy volunteers, 4) differences between different acupuncture points. Methodology/Principal Findings: We systematically searched English, Chinese, Korean and Japanese databases for literature published from the earliest available up until September 2009, without any language restrictions. We included all studies using fMRI to investigate the effect of acupuncture on the human brain (at least one group that received needle-based acupuncture). 779 papers were identified, 149 met the inclusion criteria for the descriptive analysis, and 34 were eligible for the meta-analyses. From a descriptive perspective, multiple studies reported that acupuncture modulates activity within specific brain areas, including somatosensory cortices, limbic system, basal ganglia, brain stem, and cerebellum. Meta-analyses for verum acupuncture stimuli confirmed brain activity within many of the regions mentioned above. Differences between verum and sham acupuncture were noted in brain response in middle cingulate, while some heterogeneity was noted for other regions depending on how such meta-analyses were performed, such as sensorimotor cortices, limbic regions, and cerebellum. Conclusions: Brain response to acupuncture stimuli encompasses a broad network of regions consistent with not just somatosensory, but also affective and cognitive processing. While the results were heterogeneous, from a descriptive perspective most studies suggest that acupuncture can modulate the activity within specific brain areas, and the evidence based on meta-analyses confirmed some of these results. More high quality studies with more transparent methodology are needed to improve the consistency amongst different studies.	[Huang, Wenjing; Pach, Daniel; Witt, Claudia M.] Charite Univ Med Ctr, Inst Social Med Epidemiol & Hlth Econ, Berlin, Germany; [Huang, Wenjing; Liang, Fanrong] Chengdu Univ Tradit Chinese Med, Chengdu, Peoples R China; [Witt, Claudia M.] Univ Maryland, Sch Med, Ctr Integrat Med, Baltimore, MD 21201 USA; [Napadow, Vitaly; Maeda, Yumi] Massachusetts Gen Hosp, Dept Radiol, Athinoula A Martinos Ctr Biomed Imaging, Charlestown, MA USA; [Napadow, Vitaly; Maeda, Yumi] Logan Coll Chiropract, Dept Radiol, Chesterfield, MO USA; [Park, Kyungmo] Kyung Hee Univ, Dept Biomed Engn, Yongin, South Korea; [Nierhaus, Till] Berlin Neuroimaging Ctr, Berlin, Germany; [Nierhaus, Till] Charite, Dept Neurol, Berlin, Germany; [Long, Xiangyu; Neumann, Jane; Nierhaus, Till] Max Planck Inst Human Cognit & Brain Sci, Leipzig, Germany; [Neumann, Jane] Univ Leipzig, Med Ctr, IFB Adipos Dis, Leipzig, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Chengdu University of Traditional Chinese Medicine; University System of Maryland; University of Maryland Baltimore; Harvard University; Massachusetts General Hospital; Kyung Hee University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Max Planck Society; Leipzig University	Huang, WJ (corresponding author), Charite Univ Med Ctr, Inst Social Med Epidemiol & Hlth Econ, Berlin, Germany.	claudia.witt@charite.de	Witt, Claudia M./AAX-2370-2021; Nierhaus, Till/ABG-8386-2020	Witt, Claudia M./0000-0002-5440-7805; Nierhaus, Till/0000-0003-0906-592X; Pach, Daniel/0000-0002-2459-6596; Liang, Fanrong/0000-0003-2210-2027; park, kyungmo/0000-0002-7689-8967; Napadow, Vitaly/0000-0003-1941-1750	Carstens Foundation; Chinese Scholarship Council	Carstens Foundation; Chinese Scholarship Council(China Scholarship Council)	Funding provided by Carstens Foundation and Chinese Scholarship Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai Lin, 2004, Chinese Journal of Medical Imaging Technology, V20, P1197; [Anonymous], 2002, ACUPUNCTURE REV ANAL, P4; Backer M, 2004, HEADACHE, V44, P95, DOI 10.1111/j.1526-4610.2004.04017.x; Bae E-j, 2003, J KOREAN ACUPUNCTURE, V20, P208; Bai L, 2007, P ANN INT IEEE EMBS, P2023, DOI 10.1109/IEMBS.2007.4352716; Bai LJ, 2009, HUM BRAIN MAPP, V30, P3445, DOI 10.1002/hbm.20769; Beissner F, 2009, EVID BASED COMPLEMEN; Brinkhaus B, 2006, ARCH INTERN MED, V166, P450; Cai K, 2007, INFORM MED EQUIPMENT, V22, P84; Campbell Anthony, 2006, Acupunct Med, V24, P118; Chae Y, 2007, NEUROL RES, V29, pS42, DOI 10.1179/016164107X172284; Chae Y, 2009, MOVEMENT DISORD, V24, P1794, DOI 10.1002/mds.22673; Chae Y, 2009, NEUROSCI LETT, V450, P80, DOI 10.1016/j.neulet.2008.11.048; [常静玲 CHANG Jingling], 2007, [中国康复医学杂志, Chinese Journal of Rehabilitation Medicine], V22, P13; Chang SX, 2002, LIN CHUANG FANG SHE, V21, P99; Chen HD, 2006, J ZHEJIANG U TRADIT, V30, P656; Chen Peng, 2008, Zhongguo Zhen Jiu, V28, P429; Chen Shang-jie, 2008, Zhen Ci Yan Jiu, V33, P267; [陈文君 CHEN Wenjun], 2007, [中华物理医学与康复杂志, Chinese Journal of Physical Medicine and Rehabilitation], V29, P774; [程华军 Cheng Hua-jun], 2009, [中国组织工程研究与临床康复, Journal of Clinical Rehabilitative Tissue Engineering Research], V13, P5020; Chi X, 2007, SHANGHAI J ACUMOX, V26, P30; Chi X, 2006, JCAM, V22, P37; Chi X, 2007, CHINESE ARCH TRADITI, V25, P843; Chi X, 2009, ACTA CHINESE MED PHA, V37, P37; Cho Z-h, 2001, J KOREAN ACUPUNCTURE, V18, P105; Cho ZH, 2006, ACTA NEUROL SCAND, V113, P370, DOI 10.1111/j.1600-0404.2006.00600.x; Choi N-g, 2009, J RADIOLOGICAL SCI T, V32, P183; Deng G, 2008, BMC COMPLEM ALTERN M, V8, DOI 10.1186/1472-6882-8-37; Dhond RP, 2008, PAIN, V136, P407, DOI 10.1016/j.pain.2008.01.011; Dhond RP, 2007, J ALTERN COMPLEM MED, V13, P603, DOI 10.1089/acm.2007.7040; Dhond RP, 2007, PAIN, V128, P8, DOI 10.1016/j.pain.2007.01.001; Dougherty DD, 2008, BEHAV BRAIN RES, V193, P63, DOI 10.1016/j.bbr.2008.04.020; Eickhoff SB, 2011, NEUROIMAGE, V57, P938, DOI 10.1016/j.neuroimage.2011.05.021; Eickhoff SB, 2009, HUM BRAIN MAPP, V30, P2907, DOI 10.1002/hbm.20718; FANG J, 2008, HUM BRAIN MAPP; [方继良 Fang Jiliang], 2005, [中国医学影像技术, Chinese Journal of Medical Imaging Technology], V21, P1332; Fang JL, 2004, NEURORADIOLOGY, V46, P359, DOI 10.1007/s00234-003-1125-7; Fang Song-hua, 2006, Zhongguo Zhong Xi Yi Jie He Za Zhi, V26, P965; [邓振生 Deng Zhensheng], 2005, [实用放射学杂志, The Journal of Practical Radiology], V21, P1240; Fu P, 2005, CHIN J NEUROL, V38, P118; Fu P, 2005, CHINESE J CLIN REHAB, V9, P92; Fu P, 2005, CHIN J CLIN REHABIL, V9, P120; Fu Ping, 2005, Zhongguo Zhen Jiu, V25, P784; Fukunaga M, 1999, B MEIJI U ORIENTAL M, V25, P7; Gareus IK, 2002, J MAGN RESON IMAGING, V15, P227, DOI 10.1002/jmri.10059; Gong HH, 2003, J DIAGNOSTIC IMAGING, V12, P133; Guan YQ, 2008, HEBEI J TCM, V30, P1065; Ha C-h, 2003, J KOREAN ACUPUNCTURE, V20, P187; Han JS, 2011, PAIN, V152, pS41, DOI 10.1016/j.pain.2010.10.012; He Yang-zi, 2006, Zhongguo Zhen Jiu, V26, P357; Hong K-e, 2003, J KOREAN ACUPUNCTURE, V20, P86; 박태균, 2004, Korean Journal of Acupuncture, V21, P29; [侯金文 Hou Jinwen], 2002, [中华放射学杂志, Chinese Journal of Radiology], V36, P206; [胡建平 HU Jianping], 2008, [第三军医大学学报, Acta Academiae Medicinae Militaris Tertiae], V30, P1878; Hu Ka-ming, 2006, Zhongguo Zhen Jiu, V26, P205; Hu Ka-ming, 2005, Zhongguo Zhen Jiu, V25, P860; Hu T, 2009, MED J W CHINA, V21, P1987; Huang Y, 2009, J CHINESE INTEGRATIV, V7, P527; Huang Y, 2009, J ANHUI TCM COLL, V28, P25; Huang Y, 2009, J SHANDONG U TCM, V33, P243; Huang Y, 2009, HEBEI J TCM, V31, P254; Huang Y, 2009, J CHENGDU U TRADIT C, V32, P3; Hui KKS, 2009, BRAIN RES, V1287, P84, DOI 10.1016/j.brainres.2009.06.061; Hui KKS, 2005, NEUROIMAGE, V27, P479, DOI 10.1016/j.neuroimage.2005.04.037; Hui KKS, 2000, HUM BRAIN MAPP, V9, P13, DOI 10.1002/(SICI)1097-0193(2000)9:1<13::AID-HBM2>3.0.CO;2-F; Jeun SS, 2005, AM J CHINESE MED, V33, P573, DOI 10.1142/S0192415X0500317X; Jiang C, 2010, J PRACTICAL TRADITIO, V26, P275; 조장희, 2004, Journal of Acupuncture Research, V21, P57; Kang J-h, 2003, J KOREAN ACUPUNCTURE, V20, P66; Kim J-h, 2003, J KOREAN ACUPUNCTURE, V20, P114; Kim Y-i, 2003, J KOREAN ACUPUNCTURE, V20, P133; Kong J, 2006, J NEUROSCI, V26, P381, DOI 10.1523/JNEUROSCI.3556-05.2006; Kong J, 2007, HUM BRAIN MAPP; Kong JA, 2002, J ALTERN COMPLEM MED, V8, P411, DOI 10.1089/107555302760253603; Kong J, 2007, NEUROIMAGE, V34, P1171, DOI 10.1016/j.neuroimage.2006.10.019; Kong J, 2009, NEUROIMAGE, V47, P1066, DOI 10.1016/j.neuroimage.2009.05.087; Kong J, 2009, NEUROIMAGE, V45, P940, DOI 10.1016/j.neuroimage.2008.12.025; Kwon C-h, 2004, J KOREAN ACUPUNCTURE, V21, P177; Lai XS, 2009, TIANJIN J TRADITIONA, V26, P113; Laird AR, 2005, HUM BRAIN MAPP, V25, P155, DOI 10.1002/hbm.20136; Lancaster JL, 2007, HUM BRAIN MAPP, V28, P1194, DOI 10.1002/hbm.20345; Lewith GT, 2005, EVID-BASED COMPL ALT, V2, P315, DOI 10.1093/ecam/neh110; Li DZ, 2000, ZHONGGUO ZHEN JIU, P491; Li G, 2004, MAGN RESON IMAGING, V22, P639, DOI 10.1016/j.mri.2004.01.074; Li G, 2003, HUM BRAIN MAPP, V18, P233, DOI 10.1002/hbm.10098; Li G, 2003, NEUROREPORT, V14, P669, DOI 10.1097/00001756-200304150-00002; Li G, 2006, J MAGN RESON IMAGING, V24, P1018, DOI 10.1002/jmri.20702; Li J., 2007, SHANGHAI ZHEN JIU ZA, V26, P3; Li K, 2006, J ALTERN COMPLEM MED, V12, P615, DOI 10.1089/acm.2006.12.615; [李可 Li Ke], 2005, [中国医学影像技术, Chinese Journal of Medical Imaging Technology], V21, P1329; Li L, 2008, J ALTERN COMPLEM MED, V14, P671, DOI 10.1089/acm.2008.0036; [李琳 LI Lin], 2008, [中国医学影像技术, Chinese Journal of Medical Imaging Technology], V24, P1001; Li XT, 2009, J ANHUI TCM COLL, V4, P78; Li XZ, 2008, NEURAL REGEN RES, V3, P777; Liang F., 2006, ACUPUNCTURE MOXIBUST; Linde K, 2005, JAMA-J AM MED ASSOC, V293, P2118, DOI 10.1001/jama.293.17.2118; [刘华 LIU Hua], 2006, [中国医学影像技术, Chinese Journal of Medical Imaging Technology], V22, P1165; Liu P, 2009, J MAGN RESON IMAGING, V30, P41, DOI 10.1002/jmri.21805; Liu P, 2009, NEUROSCI LETT, V462, P183, DOI 10.1016/j.neulet.2009.07.015; Liu S, 2007, NEUROSCI LETT, V421, P203, DOI 10.1016/j.neulet.2007.04.078; Liu WC, 2004, NEUROREPORT, V15, P1937, DOI 10.1097/00001756-200408260-00021; [龙玉 LONG Yu], 2009, [中国医学影像技术, Chinese Journal of Medical Imaging Technology], V25, P373; Lu N, 2008, CHIN J MED IMAGING T, V24, P46; MacPherson H, 2008, NEUROSCI LETT, V434, P144, DOI 10.1016/j.neulet.2008.01.058; Melchart D, 2005, BMJ-BRIT MED J, V331, P376, DOI 10.1136/bmj.38512.405440.8F; [王葳 MRI WANGWei], 2006, [中华放射学杂志, Chinese Journal of Radiology], V40, P29; Napadow V, 2007, PAIN, V130, P254, DOI 10.1016/j.pain.2006.12.003; Napadow V, 2005, HUM BRAIN MAPP, V24, P193, DOI 10.1002/hbm.20081; Napadow V, 2007, HUM BRAIN MAPP, V28, P159, DOI 10.1002/hbm.20261; Napadow V, 2009, NEUROIMAGE, V47, P1055, DOI 10.1016/j.neuroimage.2009.05.079; Napadow V, 2009, NEUROIMAGE, V47, P289, DOI 10.1016/j.neuroimage.2009.03.060; Park J-m, 2008, J KOREAN ACUPUNCTURE, V25, P151; Park K-y, 2003, J KOREAN ACUPUNCTURE, V20, P194; Parrish TB, 2005, IEEE ENG MED BIOL, V24, P35, DOI 10.1109/MEMB.2005.1411346; Poldrack RA, 2008, NEUROIMAGE, V40, P409, DOI 10.1016/j.neuroimage.2007.11.048; Qin Wei, 2006, Conf Proc IEEE Eng Med Biol Soc, V2006, P480; Qin W, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-55; [邱明国 QIU Mingguo], 2005, [第三军医大学学报, Acta Academiae Medicinae Militaris Tertiae], V27, P1970; Raichle ME, 2006, ANNU REV NEUROSCI, V29, P449, DOI 10.1146/annurev.neuro.29.051605.112819; Rheu K-h, 2006, KOREAN J MERIDIAN AC, V23, P89; Schaechter JD, 2007, J ALTERN COMPLEM MED, V13, P527, DOI 10.1089/acm.2007.6316; Schockert T, 2009, DTSCH Z AKUPUNKT, V52, P21, DOI 10.1016/j.dza.2009.01.003; Streitberger K, 1998, LANCET, V352, P364, DOI 10.1016/S0140-6736(97)10471-8; Sun G, 2008, BASIC THEROY TRADITI; Teng J, 2008, J SHANDONG U TCM, V32, P104; [田丽芳 TIAN Lifang], 2006, [针刺研究, Acupuncture Research], V31, P113; Turkeltaub PE, 2002, NEUROIMAGE, V16, P765, DOI 10.1006/nimg.2002.1131; [王爱成 WANG Aicheng], 2005, [针刺研究, Acupuncture Research], V30, P43; Wang Guang-Bin, 2009, Zhongguo Yi Xue Ke Xue Yuan Xue Bao, V31, P171; Wang SM, 2007, ANESTH ANALG, V105, P499, DOI 10.1213/01.ane.0000270216.71234.f5; Wang W, 2007, CHIN J INTEGR MED, V13, P10, DOI 10.1007/s11655-007-0010-3; [王葳 WANG Wei], 2006, [中国医学影像技术, Chinese Journal of Medical Imaging Technology], V22, P829; [王苇 Wang Wei], 2002, [中华放射学杂志, Chinese Journal of Radiology], V36, P211; [王苇 Wang Wei], 2004, [中华物理医学与康复杂志, Chinese Journal of Physical Medicine and Rehabilitation], V26, P472; [王伟 WANG Wei], 2009, [分子科学学报, Journal of Molecular Science], V25, P305; Wesolowski T, 2009, NEUROREPORT, V20, P116, DOI 10.1097/WNR.0b013e328321004d; Wu JX, 2009, CHINESE ARCH TRADITI, V27, P1625; Wu MT, 1999, RADIOLOGY, V212, P133, DOI 10.1148/radiology.212.1.r99jl04133; Wu MT, 2002, NEUROIMAGE, V16, P1028, DOI 10.1006/nimg.2002.1145; Wu Y, 2008, J CHILD NEUROL, V23, P1267, DOI 10.1177/0883073808318049; [吴志远 WU Zhiyuan], 2008, [中国医学影像学杂志, Chinese Journal of Medical Imaging], V16, P101; Wu ZY, 2007, CHINESE J TRADITIONA, V14, P305; Xiao Ye-yu, 2008, Zhongguo Zhong Xi Yi Jie He Za Zhi, V28, P122; [肖叶玉 Xiao Yeyu], 2004, [实用放射学杂志, The Journal of Practical Radiology], V20, P106; Xu Fang-Ming, 2007, Zhongguo Zhen Jiu, V27, P749; [徐放明 XU Fangming], 2007, [南京中医药大学学报, Journal of Nanjing University of Traditional Chinese Medicine], V23, P224; Xu J., 2004, CHINESE IMAGING J IN, V2, P85; [许建阳 Xu Jianyang], 2004, [中国针灸, Chinese Acupuncture and Moxibustion], V24, P263; Yan B, 2005, NEUROSCI LETT, V383, P236, DOI 10.1016/j.neulet.2005.04.021; Yan LP, 2005, JCAM, V21, P61; Yeo S, 2009, J MERIDIAN ACUPOINT, V26, P39; Yin L, 2002, CHINESE J REHABILITA, V8, P523; Yoo SS, 2007, COMPLEMENT THER MED, V15, P247, DOI 10.1016/j.ctim.2007.01.010; Yoo SS, 2004, NEUROIMAGE, V22, P932, DOI 10.1016/j.neuroimage.2004.02.017; Yoon J-h, 2001, J KOREAN ACUPUNCTURE, V18, P60; Zhang JH, 2007, ACUPUNCTURE ELECTRO, V32, P179, DOI 10.3727/036012907815844075; [张俊海 Zhang Junhai], 2005, [中国医学计算机成像杂志, Chinese Computed Medical Imaging], V11, P10; [张嵘 Zhang R], 2007, [中国组织工程研究与临床康复, Journal of Clinical Rehabilitative Tissue Engineering Research], V11, P4271; Zhang WT, 2004, NEUROSCI LETT, V354, P50, DOI 10.1016/j.neulet.2003.09.080; Zhang Y, 2008, NEUROSCI LETT; Zhang Y, 2009, NEUROSCI LETT, V458, P6, DOI 10.1016/j.neulet.2009.04.027; Zhen JP, 2008, CHINESE IMAGING J IN, V6, P325; [周诚 Zhou Cheng], 2005, [中华放射学杂志, Chinese Journal of Radiology], V39, P252; Zhou YL, 2008, ACUPUNCTURE ELECTRO, V33, P9, DOI 10.3727/036012908803861186; Zhu MJ, 2004, J HAINAN MED COLL, V10, P169; Zou YQ, 2008, J YUNNAN U TRADITION, V31, P44; 최보영, 2002, Journal of the Korean Magnetic Resonance Society, V6, P89; 赵凌, 2009, [时珍国医国药, Lishizhen Medicine and Materia Medica Research], V20, P1343	168	305	322	14	105	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2012	7	4							e32960	10.1371/journal.pone.0032960	http://dx.doi.org/10.1371/journal.pone.0032960			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JO	22496739	Green Published, gold			2022-12-27	WOS:000305014500007
J	Illingworth, RS; Botting, CH; Grimes, GR; Bickmore, WA; Eskeland, R				Illingworth, Robert S.; Botting, Catherine H.; Grimes, Graeme R.; Bickmore, Wendy A.; Eskeland, Ragnhild			PRC1 and PRC2 Are Not Required for Targeting of H2A.Z to Developmental Genes in Embryonic Stem Cells	PLOS ONE			English	Article							HISTONE VARIANT H2A.Z; POLYCOMB GROUP; CHROMATIN-STRUCTURE; DNA METHYLATION; GROUP PROTEINS; COMPLEX; RING1B; TRANSCRIPTION; PURIFICATION; REGULATORS	The essential histone variant H2A.Z localises to both active and silent chromatin sites. In embryonic stem cells (ESCs), H2A.Z is also reported to co-localise with polycomb repressive complex 2 (PRC2) at developmentally silenced genes. The mechanism of H2A.Z targeting is not clear, but a role for the PRC2 component Suz12 has been suggested. Given this association, we wished to determine if polycomb functionally directs H2A.Z incorporation in ESCs. We demonstrate that the PRC1 component Ring1B interacts with multiple complexes in ESCs. Moreover, we show that although the genomic distribution of H2A.Z co-localises with PRC2, Ring1B and with the presence of CpG islands, H2A.Z still blankets polycomb target loci in the absence of Suz12, Eed (PRC2) or Ring1B (PRC1). Therefore we conclude that H2A.Z accumulates at developmentally silenced genes in ESCs in a polycomb independent manner.	[Illingworth, Robert S.; Grimes, Graeme R.; Bickmore, Wendy A.; Eskeland, Ragnhild] Univ Edinburgh, MRC Human Genet Unit, MRC Inst Genet & Mol Med, Edinburgh, Midlothian, Scotland; [Botting, Catherine H.] Univ St Andrews, BMS Mass Spectrometry & Prote Facil, St Andrews, Fife, Scotland	University of Edinburgh; University of St Andrews	Illingworth, RS (corresponding author), Univ Edinburgh, MRC Human Genet Unit, MRC Inst Genet & Mol Med, Edinburgh, Midlothian, Scotland.	W.Bickmore@hgu.mrc.ac.uk; Ragnhild.Eskeland@imbv.uio.no	Eskeland, Ragnhild/AFM-2892-2022; Eskeland, Ragnhild/GSN-9383-2022; Eskeland, Ragnhild/K-7018-2014; Bickmore, Wendy/C-7314-2013	Eskeland, Ragnhild/0000-0003-2789-3171; Eskeland, Ragnhild/0000-0003-2789-3171; Illingworth, Rob/0000-0001-9275-1933; Bickmore, Wendy/0000-0001-6660-7735	Medical Research Council, UK; BBSRC [BB/H008500/1]; MRC [MC_PC_U127527202] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/H008500/1] Funding Source: researchfish; Medical Research Council [MC_PC_U127527202] Funding Source: researchfish	Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Medical Research Council, UK and by grant BB/H008500/1 from the BBSRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Buchwald G, 2006, EMBO J, V25, P2465, DOI 10.1038/sj.emboj.7601144; Chamberlain SJ, 2008, STEM CELLS, V26, P1496, DOI 10.1634/stemcells.2008-0102; Conerly ML, 2010, GENOME RES, V20, P1383, DOI 10.1101/gr.106542.110; Creyghton MP, 2008, CELL, V135, P649, DOI 10.1016/j.cell.2008.09.056; Dou YL, 2005, CELL, V121, P873, DOI 10.1016/j.cell.2005.04.031; Elderkin S, 2007, MOL CELL, V28, P107, DOI 10.1016/j.molcel.2007.08.009; Endoh M, 2008, DEVELOPMENT, V135, P1513, DOI 10.1242/dev.014340; Eskeland R, 2004, BIOCHEMISTRY-US, V43, P3740, DOI 10.1021/bi035964s; Eskeland R, 2010, MOL CELL, V38, P452, DOI 10.1016/j.molcel.2010.02.032; Fan JY, 2004, MOL CELL, V16, P655, DOI 10.1016/j.molcel.2004.10.023; Fazzio TG, 2008, CELL, V134, P162, DOI 10.1016/j.cell.2008.05.031; Fischle W, 2003, GENE DEV, V17, P1870, DOI 10.1101/gad.1110503; Fouse SD, 2008, CELL STEM CELL, V2, P160, DOI 10.1016/j.stem.2007.12.011; Fuchs M, 2001, CELL, V106, P297, DOI 10.1016/S0092-8674(01)00450-0; Gambetta MC, 2009, SCIENCE, V325, P93, DOI 10.1126/science.1169727; Garrick D, 2008, BLOOD, V112, P3889, DOI 10.1182/blood-2008-06-161901; Gearhart MD, 2006, MOL CELL BIOL, V26, P6880, DOI 10.1128/MCB.00630-06; Gevry N, 2007, GENE DEV, V21, P1869, DOI 10.1101/gad.1545707; Gevry N, 2009, GENE DEV, V23, P1522, DOI 10.1101/gad.1787109; Kim J, 2010, CELL, V143, P313, DOI 10.1016/j.cell.2010.09.010; Ku M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000242; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Leeb M, 2007, J CELL BIOL, V178, P219, DOI 10.1083/jcb.200612127; Leeb M, 2010, GENE DEV, V24, P265, DOI 10.1101/gad.544410; Levine SS, 2002, MOL CELL BIOL, V22, P6070, DOI 10.1128/MCB.22.17.6070-6078.2002; Lu JR, 2007, P NATL ACAD SCI USA, V104, P9381, DOI 10.1073/pnas.0610279104; Lu PYT, 2009, BIOCHEM CELL BIOL, V87, P799, DOI 10.1139/O09-062; Luger K, 1999, METH MOL B, V119, P1; Lynch MD, 2012, EMBO J, V31, P317, DOI 10.1038/emboj.2011.399; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Martinato F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003650; Mavrich TN, 2008, NATURE, V453, P358, DOI 10.1038/nature06929; Mendenhall EM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001244; Meneghini MD, 2003, CELL, V112, P725, DOI 10.1016/S0092-8674(03)00123-5; Myers SA, 2011, P NATL ACAD SCI US; Negishi M, 2007, BIOCHEM BIOPH RES CO, V353, P992, DOI 10.1016/j.bbrc.2006.12.166; Ogawa H, 2002, SCIENCE, V296, P1132, DOI 10.1126/science.1069861; Ollinger R, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000199; Pasini D, 2007, MOL CELL BIOL, V27, P3769, DOI 10.1128/MCB.01432-06; Raisner RM, 2005, CELL, V123, P233, DOI 10.1016/j.cell.2005.10.002; Rangasamy D, 2003, EMBO J, V22, P1599, DOI 10.1093/emboj/cdg160; Ruhf ML, 2001, DEVELOPMENT, V128, P1429; Ruhl DD, 2006, BIOCHEMISTRY-US, V45, P5671, DOI 10.1021/bi060043d; Sanchez C, 2007, MOL CELL PROTEOMICS, V6, P820, DOI 10.1074/mcp.M600275-MCP200; Sarcinella E, 2007, MOL CELL BIOL, V27, P6457, DOI 10.1128/MCB.00241-07; Shevchenko A, 1996, BIOCHEM SOC T, V24, P893, DOI 10.1042/bst0240893; Shia WJ, 2006, GENE DEV, V20, P2507, DOI 10.1101/gad.1439206; Simon JA, 2009, NAT REV MOL CELL BIO, V10, P697, DOI 10.1038/nrm2763; Sinclair DAR, 2009, P NATL ACAD SCI USA, V106, P13427, DOI 10.1073/pnas.0904638106; Stock JK, 2007, NAT CELL BIOL, V9, P1428, DOI 10.1038/ncb1663; Straub T, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000302; Strubbe G, 2011, P NATL ACAD SCI USA, V108, P5572, DOI 10.1073/pnas.1007916108; Swaminathan J, 2005, GENE DEV, V19, P65, DOI 10.1101/gad.1259105; Talbert PB, 2010, NAT REV MOL CELL BIO, V11, P264, DOI 10.1038/nrm2861; Trojer P, 2011, MOL CELL, V42, P438, DOI 10.1016/j.molcel.2011.04.004; van den Berg DLC, 2010, CELL STEM CELL, V6, P369, DOI 10.1016/j.stem.2010.02.014; Vidal M, 2009, INT J DEV BIOL, V53, P355, DOI 10.1387/ijdb.082690mv; Vogler C, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001234; Wamstad JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002814; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Wang L, 2004, MOL CELL, V14, P637, DOI 10.1016/j.molcel.2004.05.009; Wright KJ, 2006, P NATL ACAD SCI USA, V103, P12347, DOI 10.1073/pnas.0605499103; Wynder C, 2005, NAT CELL BIOL, V7, P1113, DOI 10.1038/ncb1312; Zilberman D, 2008, NATURE, V456, P125, DOI 10.1038/nature07324; Zlatanova J, 2008, STRUCTURE, V16, P166, DOI 10.1016/j.str.2007.12.008	69	33	35	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2012	7	4							e34848	10.1371/journal.pone.0034848	http://dx.doi.org/10.1371/journal.pone.0034848			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JO	22496869	Green Published, Green Submitted, gold			2022-12-27	WOS:000305014500033
J	Lai, JS; Cheng, CW; Sung, TY; Hsu, WL				Lai, Jhih-Siang; Cheng, Cheng-Wei; Sung, Ting-Yi; Hsu, Wen-Lian			Computational Comparative Study of Tuberculosis Proteomes Using a Model Learned from Signal Peptide Structures	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; AMINO-ACIDS; TRANSMEMBRANE TOPOLOGY; BIOMARKER DISCOVERY; MEMBRANE-PROTEINS; AFFECT VIRULENCE; IFN-GAMMA; PREDICTION; IDENTIFICATION; SEQUENCE	Secretome analysis is important in pathogen studies. A fundamental and convenient way to identify secreted proteins is to first predict signal peptides, which are essential for protein secretion. However, signal peptides are highly complex functional sequences that are easily confused with transmembrane domains. Such confusion would obviously affect the discovery of secreted proteins. Transmembrane proteins are important drug targets, but very few transmembrane protein structures have been determined experimentally; hence, prediction of the structures is essential. In the field of structure prediction, researchers do not make assumptions about organisms, so there is a need for a general signal peptide predictor. To improve signal peptide prediction without prior knowledge of the associated organisms, we present a machine-learning method, called SVMSignal, which uses biochemical properties as features, as well as features acquired from a novel encoding, to capture biochemical profile patterns for learning the structures of signal peptides directly. We tested SVMSignal and five popular methods on two benchmark datasets from the SPdb and UniProt/Swiss-Prot databases, respectively. Although SVMSignal was trained on an old dataset, it performed well, and the results demonstrate that learning the structures of signal peptides directly is a promising approach. We also utilized SVMSignal to analyze proteomes in the entire HAMAP microbial database. Finally, we conducted a comparative study of secretome analysis on seven tuberculosis-related strains selected from the HAMAP database. We identified ten potential secreted proteins, two of which are drug resistant and four are potential transmembrane proteins. SVMSignal is publicly available at http://bio-cluster.iis.sinica.edu.tw/SVMSignal. It provides user-friendly interfaces and visualizations, and the prediction results are available for download.	[Lai, Jhih-Siang; Cheng, Cheng-Wei; Sung, Ting-Yi; Hsu, Wen-Lian] Acad Sinica, Inst Informat Sci, Taipei, Taiwan	Academia Sinica - Taiwan	Lai, JS (corresponding author), Acad Sinica, Inst Informat Sci, Taipei, Taiwan.	tsung@iis.sinica.edu.tw; hsu@iis.sinica.edu.tw	Hsu, Wen-Lian/ABB-2851-2020; Sung, Ting-Yi/AAQ-5413-2021; CHENG, Cheng-Wei/G-2216-2019	Hsu, Wen-Lian/0000-0001-7061-3513; Sung, Ting-Yi/0000-0002-6028-0409; CHENG, Cheng-Wei/0000-0003-3491-8920; LAI, JHIH-SIANG/0000-0001-5677-5890	Academia Sinica [AS95ASIA03]; National Science Council [NSC 100-2319-B-010-002]	Academia Sinica(Academia Sinica - Taiwan); National Science Council(Ministry of Science and Technology, Taiwan)	This work was supported in part by the thematic program of Academia Sinica under grant AS95ASIA03 and the National Science Council under grant NSC 100-2319-B-010-002. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agranoff D, 1999, J EXP MED, V190, P717, DOI 10.1084/jem.190.5.717; Akhtar P, 2006, MICROBES INFECT, V8, P2855, DOI 10.1016/j.micinf.2006.09.004; Alderwick LJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001299; ANDERSSON H, 1991, P NATL ACAD SCI USA, V88, P9751, DOI 10.1073/pnas.88.21.9751; Argyrou A, 2004, J BIOL CHEM, V279, P52694, DOI 10.1074/jbc.M410704200; Banaiee N, 2006, J IMMUNOL, V176, P3019, DOI 10.4049/jimmunol.176.5.3019; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Boechat N, 2002, INFECT IMMUN, V70, P4124, DOI 10.1128/IAI.70.8.4124-4131.2002; Buttner K, 2001, ELECTROPHORESIS, V22, P2936; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chang F, 2010, J MACH LEARN RES, V11, P2935; Chang YH, 2009, J PROTEOME RES, V8, P5465, DOI 10.1021/pr900454e; Choo KH, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-249; Christie PJ, 2005, BIOGENESIS ARCHITECT, P451; Clausen T, 2011, NAT REV MOL CELL BIO, V12, P152, DOI 10.1038/nrm3065; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Courville P, 2004, J BIOL CHEM, V279, P3318, DOI 10.1074/jbc.M309913200; Darby CM, 2011, TUBERCULOSIS, V91, P343, DOI 10.1016/j.tube.2011.06.007; Domenech P, 2002, FEMS MICROBIOL LETT, V207, P81, DOI 10.1111/j.1574-6968.2002.tb11032.x; GIERASCH LM, 1989, BIOCHEMISTRY-US, V28, P923, DOI 10.1021/bi00429a001; Gronborg M, 2006, MOL CELL PROTEOMICS, V5, P157, DOI 10.1074/mcp.M500178-MCP200; Gu S, 2003, MOL CELL PROTEOMICS, V2, P1284, DOI 10.1074/mcp.M300060-MCP200; Herrmann JL, 2000, FEBS LETT, V473, P358, DOI 10.1016/S0014-5793(00)01553-2; Hessa T, 2007, NATURE, V450, P1026, DOI 10.1038/nature06387; HIKITA C, 1992, J BIOL CHEM, V267, P4882; Hiller K, 2004, NUCLEIC ACIDS RES, V32, pW375, DOI 10.1093/nar/gkh378; Jarjanazi H, 2008, PROTEINS, V70, P394, DOI 10.1002/prot.21548; Julenius K, 2005, GLYCOBIOLOGY, V15, P153, DOI 10.1093/glycob/cwh151; Kall L, 2004, J MOL BIOL, V338, P1027, DOI 10.1016/j.jmb.2004.03.016; KLEIN P, 1984, BIOCHIM BIOPHYS ACTA, V787, P221, DOI 10.1016/0167-4838(84)90312-1; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kulasingam V, 2008, NAT CLIN PRACT ONCOL, V5, P588, DOI 10.1038/ncponc1187; Leopold E, 2002, MACH LEARN, V46, P423, DOI 10.1023/A:1012491419635; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Lima T, 2009, NUCLEIC ACIDS RES, V37, pD471, DOI 10.1093/nar/gkn661; Loerger TR, 2009, PLOS ONE, V4; Luo XY, 2011, J PROTEOMICS, V74, P528, DOI 10.1016/j.jprot.2011.01.011; MacMicking JD, 2003, SCIENCE, V302, P654, DOI 10.1126/science.1088063; Malen H, 2007, PROTEOMICS, V7, P1702, DOI 10.1002/pmic.200600853; Malen H, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-132; Mattow J, 2007, PROTEOMICS, V7, P1687, DOI 10.1002/pmic.200600928; McDonough JA, 2008, J BACTERIOL, V190, P6428, DOI 10.1128/JB.00749-08; Mitaku S, 2002, BIOINFORMATICS, V18, P608, DOI 10.1093/bioinformatics/18.4.608; MohamedMohaideen NN, 2008, BIOCHEMISTRY-US, V47, P6092, DOI 10.1021/bi701929m; Nielsen H, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P122; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Nielsen H, 1996, PROTEINS, V24, P165, DOI 10.1002/(SICI)1097-0134(199602)24:2<165::AID-PROT4>3.0.CO;2-I; Paetzel M, 2002, CHEM REV, V102, P4549, DOI 10.1021/cr010166y; Pallen MJ, 2007, NATURE, V449, P835, DOI 10.1038/nature06248; Papp-Wallace KM, 2006, MANGANESE TRANSPORT, P187; Piersma SR, 2010, J PROTEOME RES, V9, P1913, DOI 10.1021/pr901072h; Plewczynski D, 2007, POLYMER, V48, P5493, DOI 10.1016/j.polymer.2007.07.039; Pontius J, 1996, J MOL BIOL, V264, P121, DOI 10.1006/jmbi.1996.0628; RADZICKA A, 1988, BIOCHEMISTRY-US, V27, P1664, DOI 10.1021/bi00405a042; Ramamurthi KS, 2002, TYPE 3 PROTEIN SECRE, P107; Reynolds SM, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000213; Singh N, 2011, ARCH BIOCHEM BIOPHYS, V516, P85, DOI 10.1016/j.abb.2011.10.007; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; Sreevatsan S, 1997, ANTIMICROB AGENTS CH, V41, P1677, DOI 10.1128/AAC.41.8.1677; Tseng TT, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-S1-S2; Tusnady GE, 2004, BIOINFORMATICS, V20, P2964, DOI 10.1093/bioinformatics/bth340; Vandal OH, 2008, NAT MED, V14, P849, DOI 10.1038/nm.1795; VONHEIJNE G, 1983, EUR J BIOCHEM, V133, P17; VONHEIJNE G, 1990, J MEMBRANE BIOL, V115, P195, DOI 10.1007/BF01868635; Walzl G, 2011, NAT REV IMMUNOL, V11, P343, DOI 10.1038/nri2960; Wu CH, 2006, NUCLEIC ACIDS RES, V34, pD187, DOI 10.1093/nar/gkj161; Xiong Y, 2005, J PROTEOME RES, V4, P855, DOI 10.1021/pr0500049; Zheng HJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002375	69	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2012	7	4							e35018	10.1371/journal.pone.0035018	http://dx.doi.org/10.1371/journal.pone.0035018			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JO	22496884	gold, Green Submitted, Green Published			2022-12-27	WOS:000305014500039
J	Carter, S; Miard, S; Roy-Bellavance, C; Boivin, L; Li, Z; Pibarot, P; Mathieu, P; Picard, F				Carter, Sophie; Miard, Stephanie; Roy-Bellavance, Catherine; Boivin, Louise; Li, Zhuo; Pibarot, Philippe; Mathieu, Patrick; Picard, Frederic			Sirt1 Inhibits Resistin Expression in Aortic Stenosis	PLOS ONE			English	Article							INCREASES LIPID-ACCUMULATION; VALVE STENOSIS; TRANSCRIPTIONAL ACTIVITY; SCAVENGER RECEPTOR; INSULIN-RESISTANCE; PPAR-GAMMA; TNF-ALPHA; MACROPHAGES; ATHEROSCLEROSIS; INFLAMMATION	The development of human calcified aortic stenosis (AS) includes age-dependent processes that have been involved in atherosclerosis, such as infiltration of macrophages in aortic valves, which then promote production of many pro-inflammatory cytokines, including resistin. However, the molecular mechanisms contributing to these processes are not established. Since Sirt1 has been shown to modulate macrophage biology and inflammation, we examined its levels in human AS and tested its impact on resistin expression. Sirt1 mRNA (p = 0.01) and protein (p < 0.05) levels were reduced in explanted valves from AS patients (n = 51) compared to those from control (n = 11) patients. Sirt1 mRNA levels were negatively associated with resistin mRNA levels quantified in AS valves (p = 0.02). Stimulation of Sirt1 by resveratrol or virus-driven overexpression robustly diminished resistin mRNA and protein expression in macrophages, whereas down-regulation of Sirt1 triggered a large increase in resistin expression. These effects were direct, as chromatin immunoprecipitation assays showed that Sirt1 physically interacted with the resistin promoter region at an AP-1 response element. Moreover, Sirt1 blocked c-jun-induced resistin transactivation in gene reporter assays. These findings demonstrate that, in calcified AS, levels of Sirt1 are reduced whereas those of resistin are increased within aortic valve leaflets. Our results also suggest that this loss of Sirt1 expression alleviates its inhibition of resistin transcription in macrophages. Although the overall contribution of this process to the underlying mechanisms for AS disease development remains unresolved, these observations suggest that modification of Sirt1 expression and/or activity could represent a novel approach against inflammation in AS.	[Carter, Sophie; Miard, Stephanie; Roy-Bellavance, Catherine; Boivin, Louise; Li, Zhuo; Pibarot, Philippe; Mathieu, Patrick; Picard, Frederic] Univ Laval, Quebec Heart & Lung Res Ctr, Quebec City, PQ, Canada	Laval University; Quebec Heart & Lung Institute	Carter, S (corresponding author), Univ Laval, Quebec Heart & Lung Res Ctr, Quebec City, PQ, Canada.	Frederic.Picard@criucpq.ulaval.ca	Pibarot, Philippe/ABD-5300-2021	Carter, Sophie/0000-0002-9817-0029	Institut de cardiologie et de pneumologie de Quebec (IUCPQ) Foundation; Canadian Institutes for Health Research (CIHR); International Chair on Cardiometabolic Risk; FRSQ	Institut de cardiologie et de pneumologie de Quebec (IUCPQ) Foundation; Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); International Chair on Cardiometabolic Risk; FRSQ(Fonds de la Recherche en Sante du Quebec)	This project was supported by grants from Institut de cardiologie et de pneumologie de Quebec (IUCPQ) Foundation and the Canadian Institutes for Health Research (CIHR). FP is a Junior 2 Investigator of the Fonds pour la recherche en sante du Quebec (FRSQ). SC was a recipient of a studentship from the International Chair on Cardiometabolic Risk and now holds a FRSQ PhD studentship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelmohsen K, 2007, MOL CELL, V25, P543, DOI 10.1016/j.molcel.2007.01.011; Agmon Y, 2001, J AM COLL CARDIOL, V38, P827, DOI 10.1016/S0735-1097(01)01422-X; Bosse Y, 2009, CIRC-CARDIOVASC GENE, V2, P489, DOI 10.1161/CIRCGENETICS.108.820795; Charest A, 2006, HEART, V92, P1844, DOI 10.1136/hrt.2005.086595; Chawla A, 2010, CIRC RES, V106, P1559, DOI 10.1161/CIRCRESAHA.110.216523; Cote C, 2008, HEART, V94, P1175, DOI 10.1136/hrt.2007.125740; de Kreutzenberg SV, 2010, DIABETES, V59, P1006, DOI 10.2337/db09-1187; Derbali H, 2010, AM J PATHOL, V176, P2638, DOI 10.2353/ajpath.2010.090541; Gao ZG, 2008, BIOCHEM BIOPH RES CO, V376, P793, DOI 10.1016/j.bbrc.2008.09.079; Guarente L, 2005, CELL, V120, P473, DOI 10.1016/j.cell.2005.01.029; Guarente L, 2011, NEW ENGL J MED, V364, P2235, DOI 10.1056/NEJMra1100831; Helske S, 2007, CURR OPIN LIPIDOL, V18, P483, DOI 10.1097/MOL.0b013e3282a66099; Hess J, 2004, J CELL SCI, V117, P5965, DOI 10.1242/jcs.01589; Hopkins RA, 2006, CIRCULATION, V114, P261, DOI 10.1161/CIRCULATIONAHA.106.639005; Jung HS, 2006, CARDIOVASC RES, V69, P76, DOI 10.1016/j.cardiores.2005.09.015; Kunnari AM, 2009, REGUL PEPTIDES, V157, P57, DOI 10.1016/j.regpep.2009.05.002; Lee TS, 2009, LIFE SCI, V84, P97, DOI 10.1016/j.lfs.2008.11.004; Lehrke M, 2004, PLOS MED, V1, P161, DOI 10.1371/journal.pmed.0010045; Li X, 2007, MOL CELL, V28, P91, DOI 10.1016/j.molcel.2007.07.032; LINDROOS M, 1993, J AM COLL CARDIOL, V21, P1220, DOI 10.1016/0735-1097(93)90249-Z; Liu K, 2010, BIOCHIMIE, V92, P789, DOI 10.1016/j.biochi.2010.02.024; Lorenzi I, 2008, J MOL MED, V86, P171, DOI 10.1007/s00109-007-0267-1; Lu SC, 2002, FEBS LETT, V530, P158, DOI 10.1016/S0014-5793(02)03450-6; Mathieu P, 2005, J HEART VALVE DIS, V14, P353; Mathieu P, 2006, VASC HEALTH RISK MAN, V2, P285, DOI 10.2147/vhrm.2006.2.3.285; Mercader J, 2011, J NUTR BIOCHEM, V22, P828, DOI 10.1016/j.jnutbio.2010.07.007; Miller JD, 2008, J AM COLL CARDIOL, V52, P843, DOI 10.1016/j.jacc.2008.05.043; Mohty D, 2010, INT J CARDIOL, V142, P126, DOI 10.1016/j.ijcard.2008.12.068; Nakamaru Y, 2009, FASEB J, V23, P2810, DOI 10.1096/fj.08-125468; Nollert G, 2003, J THORAC CARDIOV SUR, V126, P965, DOI 10.1016/S0022-5223(02)73619-2; Ohmori R, 2005, J AM COLL CARDIOL, V46, P379, DOI 10.1016/j.jacc.2005.04.022; Patel SD, 2004, SCIENCE, V304, P1154, DOI 10.1126/science.1093466; Picard F, 2004, NATURE, V429, P771, DOI 10.1038/nature02583; Picard F, 2002, CELL, V111, P931, DOI 10.1016/S0092-8674(02)01169-8; Rae C, 2006, DIABETOLOGIA, V49, P1112, DOI 10.1007/s00125-006-0187-6; Reilly MP, 2005, CIRCULATION, V111, P932, DOI 10.1161/01.CIR.0000155620.10387.43; Schwartz DR, 2011, TRENDS ENDOCRIN MET, V22, P259, DOI 10.1016/j.tem.2011.03.005; Shen Z, 2009, AM J PHYSIOL-GASTR L, V296, pG1047, DOI 10.1152/ajpgi.00016.2009; Shetty R, 2009, EUR J CLIN INVEST, V39, P471, DOI 10.1111/j.1365-2362.2009.02132.x; Shyu KG, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-50; Singh AK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009912; Stein S, 2010, EUR HEART J, V31, P2301, DOI 10.1093/eurheartj/ehq107; Takemura A, 2011, ARTERIOSCL THROM VAS, V31, P2054, DOI 10.1161/ATVBAHA.110.216739; Xu WB, 2006, BIOCHEM BIOPH RES CO, V351, P376, DOI 10.1016/j.bbrc.2006.10.051; Yetkin E, 2009, INT J CARDIOL, V135, P4, DOI 10.1016/j.ijcard.2009.03.108; Yoshizaki T, 2010, AM J PHYSIOL-ENDOC M, V298, pE419, DOI 10.1152/ajpendo.00417.2009; Zhang QJ, 2008, CARDIOVASC RES, V80, P191, DOI 10.1093/cvr/cvn224; Zhang R, 2010, J BIOL CHEM, V285, P7097, DOI 10.1074/jbc.M109.038604	48	23	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2012	7	4							e35110	10.1371/journal.pone.0035110	http://dx.doi.org/10.1371/journal.pone.0035110			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JA	22493735	Green Published, Green Submitted, gold			2022-12-27	WOS:000305012700077
J	Chua, AC; Leo, YS; Cavailler, P; Chu, C; Ng, A; Ng, OT; Krishnan, P				Chua, Arlene C.; Leo, Yee Sin; Cavailler, Philippe; Chu, Christine; Aloysius Ng; Oon Tek Ng; Krishnan, Prabha			Opt-out of Voluntary HIV Testing: A Singapore Hospital's Experience	PLOS ONE			English	Article							UNITED-STATES	Introduction: Since 2008, the Singapore Ministry of Health (MOH) has expanded HIV testing by increasing anonymous HIV test sites, as well as issuing a directive to hospitals to offer routine voluntary opt out inpatient HIV testing. We reviewed this program implemented at the end of 2008 at Tan Tock Seng Hospital (TTSH), the second largest acute care general hospital in Singapore. Methods and Findings: From January 2009 to December 2010, all inpatients aged greater or equal than 21 years were screened for HIV unless they declined or were not eligible for screening. We reviewed the implementation of the Opt Out testing policy. There were a total of 93,211 admissions; 41,543 patients were included based on HIV screening program eligibility criteria. Among those included, 79% (n = 32,675) opted out of HIV screening. The overall acceptance rate was 21%. Majority of eligible patients who were tested (63%) were men. The mean age of tested patients was 52 years. The opt out rate was significantly higher among females (OR: 1.5, 95% CI: 1.4-1.6), aged >60 years (OR: 2.3, 95% CI: 2.2-2.4) and Chinese ethnicity (OR: 1.7, 95% CI:1.6-1.8). The false positive rate of the HIV screening test is 0.56%. The proportion of patients with HIV infection among those who underwent HIV screening is 0.18%. All16 confirmed HIV patients were linked to care. Conclusion: The default opt-in rate of inpatient HIV testing was low at Tan Tock Seng Hospital, Singapore. Efforts to address individual HIV risk perception and campaigns against HIV stigma are needed to encourage more individuals to be tested for HIV.	[Chua, Arlene C.; Leo, Yee Sin; Oon Tek Ng] Tan Tock Seng Hosp, Dept Infect Dis, Singapore, Singapore; [Cavailler, Philippe] Reg Emerging Dis Intervent Ctr, Dept Epidemiol Res, Singapore, Singapore; [Chu, Christine; Aloysius Ng; Krishnan, Prabha] Tan Tock Seng Hosp, Dept Lab Med, Singapore, Singapore	Tan Tock Seng Hospital; Tan Tock Seng Hospital	Chua, AC (corresponding author), Tan Tock Seng Hosp, Dept Infect Dis, Singapore, Singapore.	Arlene_CHUA@ttsh.com.sg	Cavailler, Philippe/G-4138-2017	Chua, Arlene/0000-0001-6428-9083	Ministry of Health	Ministry of Health	This is a Ministry of Health funded screening program. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Action For AIDS, 2011, AFA AN TEST SIT PREV; Smith Nicole M., 2006, Morbidity and Mortality Weekly Report, V55, P1; [Anonymous], 2006, STRAITS TIMES; Calderon Y, 2011, CROI 2011; Health Promotion Board, 2007, NAT BEH SUR SURV 200; Mills CW, 2011, SEX TRANSM DIS, V38, P715, DOI 10.1097/OLQ.0b013e31820ead73; Ministry of Health, 2010, UPD HIV AIDS SIT SIN; Paltiel AD, 2006, ANN INTERN MED, V145, P797, DOI 10.7326/0003-4819-145-11-200612050-00004; Paltiel AD, 2005, NEW ENGL J MED, V352, P586, DOI 10.1056/NEJMsa042088; Sanders GD, 2005, NEW ENGL J MED, V352, P570, DOI 10.1056/NEJMsa042657; Siegel M, 2010, JAIDS-J ACQ IMM DEF, V55, P205, DOI 10.1097/QAI.0b013e3181e15bf4; WHO, 2008, EP FACT SHEET HIV AI; World Health Organization and the Joint United Nations Programme on HIV and AIDS (UNAIDS), 2011, UNGASS COUNTR PROGR	13	20	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2012	7	4							e34663	10.1371/journal.pone.0034663	http://dx.doi.org/10.1371/journal.pone.0034663			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JA	22493708	Green Submitted, gold, Green Published			2022-12-27	WOS:000305012700050
J	Duan, FB; Chapeau-Blondeau, F; Abbott, D				Duan, Fabing; Chapeau-Blondeau, Francois; Abbott, Derek			Fisher Information as a Metric of Locally Optimal Processing and Stochastic Resonance	PLOS ONE			English	Article							NON-GAUSSIAN NOISE; SYSTEMS; SIGNALS; DETECTORS; DISORDER	The origins of Fisher information are in its use as a performance measure for parametric estimation. We augment this and show that the Fisher information can characterize the performance in several other significant signal processing operations. For processing of a weak signal in additive white noise, we demonstrate that the Fisher information determines (i) the maximum output signal-to-noise ratio for a periodic signal; (ii) the optimum asymptotic efficacy for signal detection; (iii) the best cross-correlation coefficient for signal transmission; and (iv) the minimum mean square error of an unbiased estimator. This unifying picture, via inequalities on the Fisher information, is used to establish conditions where improvement by noise through stochastic resonance is feasible or not.	[Duan, Fabing] Qingdao Univ, Coll Automat Engn, Qingdao 266071, Peoples R China; [Chapeau-Blondeau, Francois] Univ Angers, LISA, Angers, France; [Abbott, Derek] Univ Adelaide, Sch Elect & Elect Engn, Adelaide, SA, Australia; [Abbott, Derek] Univ Adelaide, Ctr Biomed Engn CBME, Adelaide, SA, Australia	Qingdao University; Universite d'Angers; University of Adelaide; University of Adelaide	Duan, FB (corresponding author), Qingdao Univ, Coll Automat Engn, Qingdao 266071, Peoples R China.	fabing.duan@gmail.com	Abbott, Derek/E-8352-2011	Abbott, Derek/0000-0002-0945-2674; CHAPEAU-BLONDEAU, Francois/0000-0003-0536-7146	NSF of Shandong Province, China [ZR2010FM006]	NSF of Shandong Province, China	This work is sponsored by the NSF of Shandong Province, China (No. ZR2010FM006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENZI R, 1981, J PHYS A-MATH GEN, V14, pL453, DOI 10.1088/0305-4470/14/11/006; Bezrukov SM, 1997, NATURE, V385, P319, DOI 10.1038/385319a0; BROWN L. D., 1982, STAT PROBABILITY ESS, P141; CAPON J, 1961, IRE T INFORM THEOR, V7, P67, DOI 10.1109/TIT.1961.1057628; Chapeau-Blondeau F, 2009, J STAT MECH-THEORY E, V1; ChapeauBlondeau F, 1997, PHYS REV E, V55, P1478, DOI 10.1103/PhysRevE.55.1478; Chen HO, 2007, IEEE T SIGNAL PROCES, V55, P3172, DOI 10.1109/TSP.2007.893757; COLLINS JJ, 1995, NATURE, V376, P236, DOI 10.1038/376236a0; Cover T. M., 1991, ELEMENTS INFORM THEO; DEWEESE M, 1995, NUOVO CIMENTO D, V17, P733, DOI 10.1007/BF02451830; Duan FB, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.051107; Dykman MI, 1998, NATURE, V391, P344, DOI 10.1038/34812; Gammaitoni L, 1998, REV MOD PHYS, V70, P223, DOI 10.1103/RevModPhys.70.223; Gan CB, 2010, CHINESE PHYS B, V19, DOI 10.1088/1674-1056/19/4/040508; Gosak M, 2012, MOL CRYST LIQ CRYST, V553, P13, DOI 10.1080/15421406.2011.609343; Greenwood PE, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.051110; HANGGI P, 1993, J STAT PHYS, V70, P25, DOI 10.1007/BF01053952; Kassam S. A., 1988, SIGNAL DETECTION NON; Kay S, 2000, IEEE SIGNAL PROC LET, V7, P8, DOI 10.1109/97.809511; Kay S. M., 1998, FUNDAMENTALS STAT SI; LU NH, 1981, IEEE T INFORM THEORY, V27, P755, DOI 10.1109/TIT.1981.1056414; McDonnell MD, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000348; Perc M, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.066203; Perc M, 2008, SOFT MATTER, V4, P1861, DOI 10.1039/b804566f; Perc M, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.036105; POOR HV, 1978, J ACOUST SOC AM, V63, P75, DOI 10.1121/1.381698; SONG I, 1990, IEEE T INFORM THEORY, V36, P516, DOI 10.1109/18.54900; Stocks NG, 2000, PHYS REV LETT, V84, P2310, DOI 10.1103/PhysRevLett.84.2310; Wang QY, 2009, CHAOS, V19, DOI 10.1063/1.3133126; Ward LM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014371; WIESENFELD K, 1995, NATURE, V373, P33, DOI 10.1038/373033a0; Zaikin AA, 2000, PHYS REV LETT, V85, P227, DOI 10.1103/PhysRevLett.85.227; Zeng LZ, 2011, FLUCT NOISE LETT, V10, P223, DOI 10.1142/S0219477511000508; Zozor S, 2003, IEEE T SIGNAL PROCES, V51, P3177, DOI 10.1109/TSP.2003.818905	34	15	15	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2012	7	4							e34282	10.1371/journal.pone.0034282	http://dx.doi.org/10.1371/journal.pone.0034282			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JA	22493686	Green Published, gold, Green Submitted			2022-12-27	WOS:000305012700028
J	Duda, SN; Shepherd, BE; Gadd, CS; Masys, DR; McGowan, CC				Duda, Stephany N.; Shepherd, Bryan E.; Gadd, Cynthia S.; Masys, Daniel R.; McGowan, Catherine C.			Measuring the Quality of Observational Study Data in an International HIV Research Network	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; HIV-1-INFECTED PATIENTS; COHORT PROFILE; COLLABORATION; INCOME	Observational studies of health conditions and outcomes often combine clinical care data from many sites without explicitly assessing the accuracy and completeness of these data. In order to improve the quality of data in an international multi-site observational cohort of HIV-infected patients, the authors conducted on-site, Good Clinical Practice-based audits of the clinical care datasets submitted by participating HIV clinics. Discrepancies between data submitted for research and data in the clinical records were categorized using the audit codes published by the European Organization for the Research and Treatment of Cancer. Five of seven sites had error rates >10% in key study variables, notably laboratory data, weight measurements, and antiretroviral medications. All sites had significant discrepancies in medication start and stop dates. Clinical care data, particularly antiretroviral regimens and associated dates, are prone to substantial error. Verifying data against source documents through audits will improve the quality of databases and research and can be a technique for retraining staff responsible for clinical data collection. The authors recommend that all participants in observational cohorts use data audits to assess and improve the quality of data and to guide future data collection and abstraction efforts at the point of care.	[Duda, Stephany N.; Gadd, Cynthia S.; Masys, Daniel R.] Vanderbilt Univ, Sch Med, Dept Biomed Informat, Nashville, TN 37212 USA; [Shepherd, Bryan E.] Vanderbilt Univ, Sch Med, Dept Biostat, Nashville, TN 37212 USA; [McGowan, Catherine C.] Vanderbilt Univ, Sch Med, Dept Med, Div Infect Dis, Nashville, TN 37212 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University	Duda, SN (corresponding author), Vanderbilt Univ, Sch Med, Dept Biomed Informat, Nashville, TN 37212 USA.	stephany.duda@vanderbilt.edu			National Institute of Allergy and Infectious Diseases [5U01AI069923]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI069923] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institute of Allergy and Infectious Diseases [collaborative agreement 5U01AI069923-04, CCASAnet: Caribbean, Central and South America network for HIV epidemiology]. The manuscript was reviewed by the NIAID Project Scientist for CCASAnet, who recommended several clarifications to the text. The funders had no role in study design, data collection and analysis, or decision to publish the manuscript.	Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; CCASAnet, CAR CENTR S AM NETW; Dabis F, 2005, INT J EPIDEMIOL, V34, P979, DOI 10.1093/ije/dyi164; de Lusignan S, 2006, FAM PRACT, V23, P253, DOI 10.1093/fampra/cmi106; Egger M, 2002, LANCET, V360, P119, DOI 10.1016/S0140-6736(02)09411-4; Forster M, 2008, B WORLD HEALTH ORGAN, V86, P939, DOI 10.2471/BLT.07.049908; Hanna K., 2007, QUALITY ASSURANCE J, V11, P128, DOI DOI 10.1002/QAJ.420; ICH, 1996, ICH HARM TRIP GUID G; Kohn LT, 2000, ERR IS HUMAN BUILDIN; McFadden E, 2007, MANAGEMENT DATA CLIN; McGowan CC, 2007, INT J EPIDEMIOL, V36, P969, DOI 10.1093/ije/dym073; McKee M, 1993, Qual Health Care, V2, P104, DOI 10.1136/qshc.2.2.104; Nahm ML, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003049; Ottevanger PB, 2003, CRIT REV ONCOL HEMAT, V47, P213, DOI 10.1016/S1040-8428(03)00028-3; Rostami R, 2009, CLIN TRIALS, V6, P141, DOI 10.1177/1740774509102590; Shepherd BE, 2011, BIOMETRICS, V67, P1083, DOI 10.1111/j.1541-0420.2010.01543.x; TCHARI, 2008, T CAR HIV AIDS RES I; Van den Broeck J, 2007, CLIN TRIALS, V4, P572, DOI 10.1177/1740774507084106; VANTONGELEN K, 1989, EUR J CANCER CLIN ON, V25, P1241, DOI 10.1016/0277-5379(89)90421-5; Winchell T, 2007, QUAL ASSUR J, V11, P138, DOI DOI 10.1002/QAJ.412; Wolff WJ, 2005, JAIDS-J ACQ IMM DEF, V40, P551; Woolley P, 2004, QUAL ASSUR J, V8, P239, DOI [10.1002/qaj.293, DOI 10.1002/QAJ.293]; Zhou J, 2005, JAIDS-J ACQ IMM DEF, V38, P174, DOI 10.1097/01.qai.0000145351.96815.d5	23	26	26	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2012	7	4							e33908	10.1371/journal.pone.0033908	http://dx.doi.org/10.1371/journal.pone.0033908			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JA	22493676	Green Published, gold, Green Submitted			2022-12-27	WOS:000305012700018
J	Kox, M; Vaneker, M; van der Hoeven, JG; Scheffer, GJ; Hoedemaekers, CW; Pickkers, P				Kox, Matthijs; Vaneker, Michiel; van der Hoeven, Johannes G.; Scheffer, Gert-Jan; Hoedemaekers, Cornelia W.; Pickkers, Peter			Effects of Vagus Nerve Stimulation and Vagotomy on Systemic and Pulmonary Inflammation in a Two-Hit Model in Rats	PLOS ONE			English	Article							INDUCED LUNG INJURY; CHOLINERGIC ANTIINFLAMMATORY PATHWAY; VENTILATOR-INDUCED INJURY; MECHANICAL VENTILATION; IMPROVES SURVIVAL; HEALTHY MICE; IN-VIVO; SEPSIS; ENDOTOXEMIA; SUSCEPTIBILITY	Pulmonary inflammation contributes to ventilator-induced lung injury. Sepsis-induced pulmonary inflammation (first hit) may be potentiated by mechanical ventilation (MV, second hit). Electrical stimulation of the vagus nerve has been shown to attenuate inflammation in various animal models through the cholinergic anti-inflammatory pathway. We determined the effects of vagotomy (VGX) and vagus nerve stimulation (VNS) on systemic and pulmonary inflammation in a two-hit model. Male Sprague-Dawley rats were i.v. administered lipopolysaccharide (LPS) and subsequently underwent VGX, VNS or a sham operation. 1 hour following LPS, MV with low (8 mL/kg) or moderate (15 mL/kg) tidal volumes was initiated, or animals were left breathing spontaneously (SP). After 4 hours of MV or SP, rats were sacrificed. Cytokine and blood gas analysis was performed. MV with 15, but not 8 mL/kg, potentiated the LPS-induced pulmonary pro-inflammatory cytokine response (TNF-alpha, IL-6, KC: p<0.05 compared to LPS-SP), but did not affect systemic inflammation or impair oxygenation. VGX enhanced the LPS-induced pulmonary, but not systemic pro-inflammatory cytokine response in spontaneously breathing, but not in MV animals (TNF-alpha, IL-6, KC: p<0.05 compared to SHAM), and resulted in decreased pO(2) (p<0.05 compared to sham-operated animals). VNS did not affect any of the studied parameters in both SP and MV animals. In conclusion, MV with moderate tidal volumes potentiates the pulmonary inflammatory response elicited by systemic LPS administration. No beneficial effects of vagus nerve stimulation performed following LPS administration were found. These results questions the clinical applicability of stimulation of the cholinergic anti-inflammatory pathway in systemically inflamed patients admitted to the ICU where MV is initiated.	[Kox, Matthijs; van der Hoeven, Johannes G.; Hoedemaekers, Cornelia W.; Pickkers, Peter] Radboud Univ Nijmegen, Med Ctr, Dept Intens Care Med, NL-6525 ED Nijmegen, Netherlands; [Kox, Matthijs; Vaneker, Michiel; Scheffer, Gert-Jan] Radboud Univ Nijmegen, Med Ctr, Dept Anesthesiol, NL-6525 ED Nijmegen, Netherlands; [Kox, Matthijs; van der Hoeven, Johannes G.; Pickkers, Peter] Nijmegen Inst Infect Inflammat & Immun N4i, Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen	Kox, M (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Intens Care Med, NL-6525 ED Nijmegen, Netherlands.	m.kox@ic.umcn.nl	Scheffer, G.J./H-8086-2014; van der Hoeven, J.G./H-8048-2014; Hoedemaekers, C.W.E./L-4375-2015; Vaneker, M./L-4702-2015; Pickkers, P./H-8080-2014; Kox, Matthijs/L-4454-2015	Pickkers, P./0000-0002-1104-4303; 				Altemeier WA, 2004, AM J PHYSIOL-LUNG C, V287, pL533, DOI 10.1152/ajplung.00004.2004; Bernik TR, 2002, J EXP MED, V195, P781, DOI 10.1084/jem.20011714; Boland C, 2011, INFLAMMATION, V34, P29, DOI 10.1007/s10753-010-9204-5; Borovikova LV, 2000, NATURE, V405, P458, DOI 10.1038/35013070; Bregeon F, 2005, ANESTHESIOLOGY, V102, P331; Bregeon F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022386; Crimi E, 2006, AM J RESP CRIT CARE, V174, P178, DOI 10.1164/rccm.200507-1178OC; de Jonge WJ, 2005, NAT IMMUNOL, V6, P844, DOI 10.1038/ni1229; dos Santos CC, 2005, CRIT CARE, V9, P280, DOI 10.1186/cc3022; dos Santos CC, 2011, AM J RESP CRIT CARE, V183, P471, DOI 10.1164/rccm.201002-0314OC; Gattinoni L, 2010, CRIT CARE MED, V38, pS539, DOI 10.1097/CCM.0b013e3181f1fcf7; Guarini S, 2003, CIRCULATION, V107, P1189, DOI 10.1161/01.CIR.0000050627.90734.ED; Hofer S, 2008, CRIT CARE MED, V36, P404, DOI 10.1097/01.CCM.0B013E31816208B3; Hudson LD, 1999, JAMA-J AM MED ASSOC, V282, P77, DOI 10.1001/jama.282.1.77; Huston JM, 2007, CRIT CARE MED, V35, P2762, DOI 10.1097/01.CCM.0000288102.15975.BA; Huston JM, 2006, J EXP MED, V203, P1623, DOI 10.1084/jem.20052362; Imai Y, 1999, J APPL PHYSIOL, V87, P510, DOI 10.1152/jappl.1999.87.2.510; Jerng JS, 2007, THORAX, V62, P527, DOI 10.1136/thx.2006.061945; Jiang JS, 2010, RESPIRATION, V80, P246, DOI 10.1159/000279438; Karzai W, 2005, ANESTHESIOLOGY, V103, P996, DOI 10.1097/00000542-200511000-00014; Kox M, 2011, BR J ANAESTH; Lang JD, 2005, CLIN EXP IMMUNOL, V141, P211, DOI 10.1111/j.1365-2249.2005.02853.x; Lin SM, 2007, SHOCK, V28, P453, DOI 10.1097/shk.0b013e3180487fb5; Liu YY, 2008, CRIT CARE, V12, DOI 10.1186/cc6982; Niederbichler AD, 2009, BURNS, V35, P783, DOI 10.1016/j.burns.2008.08.023; Opal SM, 2010, INT J ANTIMICROB AG, V36, pS70, DOI 10.1016/j.ijantimicag.2010.11.008; Plotz FB, 2004, INTENS CARE MED, V30, P1865, DOI 10.1007/s00134-004-2363-9; Rieger-Fackeldey E, 2008, RESP PHYSIOL NEUROBI, V160, P341, DOI 10.1016/j.resp.2007.10.017; Rosas-Ballina M, 2008, P NATL ACAD SCI USA, V105, P11008, DOI 10.1073/pnas.0803237105; Schreiber T, 2006, ANESTHESIOLOGY, V104, P133, DOI 10.1097/00000542-200601000-00019; Sevransky Jonathan E, 2004, Crit Care Med, V32, pS548, DOI 10.1097/01.CCM.0000145947.19077.25; Terragni PP, 2009, ANESTHESIOLOGY, V111, P826, DOI 10.1097/ALN.0b013e3181b764d2; Tracey KJ, 2002, NATURE, V420, P853, DOI 10.1038/nature01321; Tremblay LN, 1998, P ASSOC AM PHYSICIAN, V110, P482; Vaneker M, 2007, ANESTHESIOLOGY, V107, P419, DOI 10.1097/01.anes.0000278908.22686.01; Wang H, 2003, NATURE, V421, P384, DOI 10.1038/nature01339; Wolthuis EK, 2009, CRIT CARE, V13, DOI 10.1186/cc7688; Wosten-van Asperen RM, 2010, AM J PATHOL, V176, P2219, DOI 10.2353/ajpath.2010.090565	38	34	36	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2012	7	4							e34431	10.1371/journal.pone.0034431	http://dx.doi.org/10.1371/journal.pone.0034431			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JA	22493690	Green Published, gold			2022-12-27	WOS:000305012700032
J	Krawczyk, SA; Haller, JF; Ferrante, T; Zoeller, RA; Corkey, BE				Krawczyk, Sarah A.; Haller, Jorge F.; Ferrante, Tom; Zoeller, Raphael A.; Corkey, Barbara E.			Reactive Oxygen Species Facilitate Translocation of Hormone Sensitive Lipase to the Lipid Droplet During Lipolysis in Human Differentiated Adipocytes	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASE; INSULIN-RESISTANT MICE; OXIDATIVE STRESS; ADIPOSE-TISSUE; IN-VITRO; NATRIURETIC PEPTIDES; NERVOUS-SYSTEM; CYCLIC-AMP; FAT-CELLS; PHOSPHORYLATION	In obesity, there is an increase in reactive oxygen species (ROS) within adipose tissue caused by increases in inflammation and overnutrition. Hormone sensitive lipase (HSL) is part of the canonical lipolytic pathway and critical for complete lipolysis. This study hypothesizes that ROS is a signal that integrates regulation of lipolysis by targeting HSL. Experiments were performed with human differentiated adipocytes from the subcutaneous depot. Antioxidants were employed as a tool to decrease ROS, and it was found that scavenging ROS with diphenyliodonium, N-acetyl cysteine, or resveratrol decreased lipolysis in adipocytes. HSL phosphorylation of a key serine residue, Ser552, as well as translocation of this enzyme from the cytosol to the lipid droplet upon lipolytic stimulation were both abrogated by scavenging ROS. The phosphorylation status of other serine residues on HSL were not affected. These findings are significant because they document that ROS contributes to the physiological regulation of lipolysis via an effect on translocation. Such regulation could be useful in developing new obesity therapies.	[Krawczyk, Sarah A.; Ferrante, Tom; Corkey, Barbara E.] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA; [Krawczyk, Sarah A.; Ferrante, Tom; Corkey, Barbara E.] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA; [Haller, Jorge F.; Zoeller, Raphael A.] Boston Univ, Sch Med, Dept Physiol & Biophys, Boston, MA 02118 USA	Boston University; Boston University; Boston University	Krawczyk, SA (corresponding author), Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA.	krawczyk@bu.edu		Zoeller, Raphael/0000-0002-6560-0993	National Institutes of Heatlh [DK056690, DK46200]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056690, P30DK046200, R01DK035914] Funding Source: NIH RePORTER	National Institutes of Heatlh; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding through the National Institutes of Heatlh, grants DK056690 and DK46200. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akassoglou K, 2005, MOL PHARMACOL, V68, P952, DOI 10.1124/mol.105.017277; Anthonsen MW, 1998, J BIOL CHEM, V273, P215, DOI 10.1074/jbc.273.1.215; Babich H, 2009, IN VITRO CELL DEV-AN, V45, P226, DOI 10.1007/s11626-008-9168-z; CAMPBELL PJ, 1994, AM J PHYSIOL, V266, pE600, DOI 10.1152/ajpendo.1994.266.4.E600; Contreras JA, 1998, PROTEIN EXPRES PURIF, V12, P93, DOI 10.1006/prep.1997.0821; Csaki LS, 2010, ANNU REV NUTR, V30, P257, DOI 10.1146/annurev.nutr.012809.104729; D'Autreaux B, 2007, NAT REV MOL CELL BIO, V8, P813, DOI 10.1038/nrm2256; Feil R, 2005, REV NEUROSCIENCE, V16, P23; Fischer-Posovszky P, 2001, AM J CLIN NUTR, V92, P5; Fiscus RR, 2002, NEUROSIGNALS, V11, P175, DOI 10.1159/000065431; Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI20042162S, 10.1172/JCI21625]; Galitzky J, 2001, J LIPID RES, V42, P536; Gaudiot N, 2000, AM J PHYSIOL-CELL PH, V279, pC1603, DOI 10.1152/ajpcell.2000.279.5.C1603; Gauthier MS, 2008, J BIOL CHEM, V283, P16514, DOI 10.1074/jbc.M708177200; GREENBERG AS, 1991, J BIOL CHEM, V266, P11341; Haemmerle G, 2006, SCIENCE, V312, P734, DOI 10.1126/science.1123965; Harada K, 2003, AM J PHYSIOL-ENDOC M, V285, pE1182, DOI 10.1152/ajpendo.00259.2003; Houslay MD, 2003, BIOCHEM J, V370, P1, DOI 10.1042/BJ20021698; KHOO JC, 1974, J CLIN INVEST, V53, P1124, DOI 10.1172/JCI107650; Krintel C, 2009, FEBS J, V276, P4752, DOI 10.1111/j.1742-4658.2009.07172.x; Krintel C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003756; Lampidonis AD, GENE, V477, P1; Lampidonis AD, 2011, GENE, V477, P1, DOI 10.1016/j.gene.2011.01.007; Martin S, 2009, J BIOL CHEM, V284, P32097, DOI 10.1074/jbc.M109.002675; Miyoshi H, 2006, J BIOL CHEM, V281, P15837, DOI 10.1074/jbc.M601097200; Peyot ML, 2004, DIABETES, V53, P1733, DOI 10.2337/diabetes.53.7.1733; Pi JB, 2007, DIABETES, V56, P1783, DOI 10.2337/db06-1601; Sekiya M, 2004, J BIOL CHEM, V279, P15084, DOI 10.1074/jbc.M310985200; Sengenes C, 2002, INT J OBESITY, V26, P24, DOI 10.1038/sj.ijo.0801845; Sengenes C, 2002, AM J PHYSIOL-REG I, V283, pR257, DOI 10.1152/ajpregu.00453.2001; Sengenes C, 2000, FASEB J, V14, P1345, DOI 10.1096/fj.14.10.1345; SENGUPTA K, 1981, J PHARMACOL EXP THER, V218, P128; Smith AJ, 2008, J BIOL CHEM, V283, P33536, DOI 10.1074/jbc.M806732200; Souza SC, 2002, J BIOL CHEM, V277, P8267, DOI 10.1074/jbc.M108329200; STRALFORS P, 1983, J BIOL CHEM, V258, P5146; STRALFORS P, 1984, P NATL ACAD SCI-BIOL, V81, P3317, DOI 10.1073/pnas.81.11.3317; Su CL, 2003, J BIOL CHEM, V278, P43615, DOI 10.1074/jbc.M301809200; Talior I, 2005, AM J PHYSIOL-ENDOC M, V288, pE405, DOI 10.1152/ajpendo.00378.2004; Talior I, 2003, AM J PHYSIOL-ENDOC M, V285, pE295, DOI 10.1152/ajpendo.00044.2003; Talmud PJ, 2001, BBA-MOL BASIS DIS, V1537, P239, DOI 10.1016/S0925-4439(01)00076-X; Wang T, 2010, OBESITY, V18, P1493, DOI 10.1038/oby.2009.456; Wang YL, 2004, OBES RES, V12, P1781, DOI 10.1038/oby.2004.221; Watt MJ, 2006, AM J PHYSIOL-ENDOC M, V290, pE500, DOI 10.1152/ajpendo.00361.2005; WOLFE RR, 1987, AM J PHYSIOL, V252, pE189, DOI 10.1152/ajpendo.1987.252.2.E189; Zhong J, 2010, J PROTEOME RES, V9, P5228, DOI 10.1021/pr100521c; Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747	46	40	41	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2012	7	4							e34904	10.1371/journal.pone.0034904	http://dx.doi.org/10.1371/journal.pone.0034904			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JA	22493722	Green Submitted, Green Published, gold			2022-12-27	WOS:000305012700064
J	Ogata, N; Yokoyama, T; Iwabuchi, K				Ogata, Norichika; Yokoyama, Takeshi; Iwabuchi, Kikuo			Transcriptome Responses of Insect Fat Body Cells to Tissue Culture Environment	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION ANALYSIS; RNA-SEQ; BOMBYX-MORI; SILKWORM; REVEALS; INVITRO; GROWTH; MOTH	Tissue culture is performed to maintain isolated portions of multicellular organisms in an artificial milieu that is outside the individual organism and for considerable periods of time; cells derived from cultured explants are, in general, different from cells of the corresponding tissue in a living organism. The changes in cultured tissues that precede and often explain the subsequent cell proliferation of explant-derived cells have been partially studied, but little is known about the molecular and genomic basis of these changes. Comparative transcriptomics of intact and cultured (90 hours in MGM-450 insect medium) Bombyx mori tissues revealed that fewer genes represented a larger portion of the transcriptome of intact fat body tissues than of cultured fat body tissues. This analysis also indicated that expression of genes encoding sugar transporters and immune response proteins increased during culture and that expression of genes encoding lipoproteins and cuticle proteins decreased during culture. These results provide support for hypotheses that cultured tissues respond immunologically to surgery, adapt to the medium by accelerating sugar uptake, and terminate their identity as part of an intact organism by becoming independent of that organism.	[Ogata, Norichika; Iwabuchi, Kikuo] Tokyo Univ Agr & Technol, Fac Agr, Appl Entomol Lab, Tokyo, Japan; [Yokoyama, Takeshi] Tokyo Univ Agr & Technol, Fac Agr, Sericultural Sci Lab, Tokyo, Japan	Tokyo University of Agriculture & Technology; Tokyo University of Agriculture & Technology	Ogata, N (corresponding author), Tokyo Univ Agr & Technol, Fac Agr, Appl Entomol Lab, Tokyo, Japan.	kikkuo@cc.tuat.ac.jp	Yokoyama, Takeshi/C-3854-2013; Iwabuchi, Kikuo/I-7530-2012	Ogata, Norichika/0000-0002-6856-6655				Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Carleton HM, 1923, BR J EXP BIOL, V1, P131; Celniker SE, 2009, NATURE, V459, P927, DOI 10.1038/459927a; Cherbas L, 2011, GENOME RES, V21, P301, DOI 10.1101/gr.112961.110; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Eppler A, 1980, INVERTEBRATE SYSTEMS, P59; Freshney R.I., 2005, CULTURE ANIMAL CELLS, DOI [10.1002/0471747599.CAC022, DOI 10.1002/0471747599.CAC022]; GRACE TDC, 1962, NATURE, V195, P788, DOI 10.1038/195788a0; GRACE TDC, 1959, ANN NY ACAD SCI, V77, P275, DOI 10.1111/j.1749-6632.1959.tb36908.x; Hosseini Parsa, 2010, BMC Res Notes, V3, P183, DOI 10.1186/1756-0500-3-183; IMANISHI S, 1992, JARQ-JPN AGR RES Q, V26, P196; IMANISHI S, 1988, Journal of Sericultural Science of Japan, V57, P184; Jing Tian-zhong, 2006, Journal of Forestry Research (Harbin), V17, P129, DOI 10.1007/s11676-006-0030-4; KURTTI TJ, 1975, IN VITRO CELL DEV B, V11, P274; Kurtti TJ, INSECT MITE NUTR, P387; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lynn DE, 2001, IN VITRO CELL DEV-AN, V37, P319, DOI 10.1007/BF02577564; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; MITSUHASHI J, 1988, APPL ENTOMOL ZOOL, V23, P488, DOI 10.1303/aez.23.488; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nordman J, 2011, GENOME RES, V21, P175, DOI 10.1101/gr.114611.110; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; SATO G, 1960, P NATL ACAD SCI USA, V46, P963, DOI 10.1073/pnas.46.7.963; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Shimomura M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-486; Shinoda T, 2003, P NATL ACAD SCI USA, V100, P11986, DOI 10.1073/pnas.2134232100; Stief P, 2006, J COMP PHYSIOL B, V176, P673, DOI 10.1007/s00360-006-0090-y; Tanaka H, 2008, INSECT BIOCHEM MOLEC, V38, P1087, DOI 10.1016/j.ibmb.2008.09.001; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; WEISS SA, 1982, BIOTECHNOL BIOENG, V24, P1145, DOI 10.1002/bit.260240511; WYATT GR, 1956, J GEN PHYSIOL, V39, P853, DOI 10.1085/jgp.39.6.853; Xia QY, 2008, INSECT BIOCHEM MOLEC, V38, P1036, DOI [10.1016/j.ibmb.2009.01.004, 10.1016/j.ibmb.2008.11.004]; Xiang H, 2010, NAT BIOTECHNOL, V28, P516, DOI 10.1038/nbt.1626; Yamashita M, 2001, J INSECT PHYSIOL, V47, P325, DOI 10.1016/S0022-1910(00)00144-X; Zhang JY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-611	38	10	11	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2012	7	4							e34940	10.1371/journal.pone.0034940	http://dx.doi.org/10.1371/journal.pone.0034940			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JA	22493724	gold, Green Published, Green Submitted			2022-12-27	WOS:000305012700066
J	Hundahl, CA; Fahrenkrug, J; Hay-Schmidt, A; Georg, B; Faltoft, B; Hannibal, J				Hundahl, Christian A.; Fahrenkrug, Jan; Hay-Schmidt, Anders; Georg, Birgitte; Faltoft, Birgitte; Hannibal, Jens			Circadian Behaviour in Neuroglobin Deficient Mice	PLOS ONE			English	Article							GASTRIN-RELEASING-PEPTIDE; SUPRACHIASMATIC NUCLEUS; MESSENGER-RNA; PROTEIN EXPRESSION; GENE-EXPRESSION; PHASE-SHIFT; C-FOS; CLOCK; RECEPTOR; LIGHT	Neuroglobin (Ngb), a neuron-specific oxygen-binding globin with an unknown function, has been proposed to play a key role in neuronal survival. We have previously shown Ngb to be highly expressed in the rat suprachiasmatic nucleus (SCN). The present study addresses the effect of Ngb deficiency on circadian behavior. Ngb-deficient and wild-type (wt) mice were placed in running wheels and their activity rhythms, endogenous period and response to light stimuli were investigated. The effect of Ngb deficiency on the expression of Period1 (Per1) and the immediate early gene Fos was determined after light stimulation at night and the neurochemical phenotype of Ngb expressing neurons in wt mice was characterized. Loss of Ngb function had no effect on overall circadian entrainment, but resulted in a significantly larger phase delay of circadian rhythm upon light stimulation at early night. A light-induced increase in Per1, but not Fos, gene expression was observed in Ngb-deficient mice. Ngb expressing neurons which co-stored Gastrin Releasing Peptide (GRP) and were innervated from the eye and the geniculo-hypothalamic tract expressed FOS after light stimulation. No PER1 expression was observed in Ngb-positive neurons. The present study demonstrates for the first time that the genetic elimination of Ngb does not affect core clock function but evokes an increased behavioural response to light concomitant with increased Per1 gene expression in the SCN at early night.	[Hundahl, Christian A.; Fahrenkrug, Jan; Georg, Birgitte; Faltoft, Birgitte; Hannibal, Jens] Univ Copenhagen, Bispebjerg Hosp, Fac Hlth Sci, Dept Clin Biochem, Copenhagen, Denmark; [Hay-Schmidt, Anders] Univ Copenhagen, Panum Inst, Dept Neurosci & Pharmacol, DK-2200 Copenhagen, Denmark	University of Copenhagen; Bispebjerg Hospital; University of Copenhagen	Hundahl, CA (corresponding author), Univ Copenhagen, Bispebjerg Hosp, Fac Hlth Sci, Dept Clin Biochem, Copenhagen, Denmark.	j.hannibal@dadlnet.dk	Hannibal, Jens/H-5482-2019; Hundahl, Christian Ansgar/H-3938-2015	Hannibal, Jens/0000-0001-9416-0125; 	Lundbeck Foundation [R44-A4267]; NOVO-Nordisk Foundation; King Christian the Xth Foundation; Foundation for Providing Medical Research; Danish Biotechnology Center for Cellular Communication; Lundbeck Foundation [R77-2010-7108] Funding Source: researchfish	Lundbeck Foundation(Lundbeckfonden); NOVO-Nordisk Foundation(Novo Nordisk Foundation); King Christian the Xth Foundation; Foundation for Providing Medical Research; Danish Biotechnology Center for Cellular Communication; Lundbeck Foundation(Lundbeckfonden)	This work was supported by the Lundbeck Foundation (R44-A4267), the NOVO-Nordisk Foundation, the King Christian the Xth Foundation, the Foundation for Providing Medical Research, and the Danish Biotechnology Center for Cellular Communication. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aida R, 2002, MOL PHARMACOL, V61, P26, DOI 10.1124/mol.61.1.26; Albrecht U, 1997, CELL, V91, P1055, DOI 10.1016/S0092-8674(00)80495-X; Antle MC, 2005, J NEUROSCI, V25, P2447, DOI 10.1523/JNEUROSCI.4696-04.2005; Antle MC, 2009, REV ENDOCR METAB DIS, V10, P279, DOI 10.1007/s11154-009-9116-6; Aton SJ, 2005, NAT NEUROSCI, V8, P476, DOI 10.1038/nn1419; Brewer JM, 2002, J BIOL RHYTHM, V17, P28, DOI 10.1177/074873002129002311; Brown TM, 2005, J NEUROSCI, V25, P11155, DOI 10.1523/JNEUROSCI.3821-05.2005; Brunori M, 2007, CELL MOL LIFE SCI, V64, P1259, DOI 10.1007/s00018-007-7090-2; Burmester T, 2000, NATURE, V407, P520, DOI 10.1038/35035093; DAAN S, 1976, J COMP PHYSIOL, V106, P253, DOI 10.1007/BF01417857; Dewilde S, 2001, J BIOL CHEM, V276, P38949, DOI 10.1074/jbc.M106438200; Fago A, 2004, J BIOL CHEM, V279, P44417, DOI 10.1074/jbc.M407126200; FAHRENKRUG J, 1995, REGUL PEPTIDES, V58, P89, DOI 10.1016/0167-0115(95)00052-D; Fahrenkrug J, 2006, ENDOCRINOLOGY, V147, P3769, DOI 10.1210/en.2006-0305; Gamble KL, 2007, J NEUROSCI, V27, P12078, DOI 10.1523/JNEUROSCI.1109-07.2007; Gamble KL, 2011, J BIOL RHYTHM, V26, P99, DOI 10.1177/0748730410396678; Georg B, 2007, BRAIN RES, V1135, P52, DOI 10.1016/j.brainres.2006.12.001; Golombek DA, 2010, PHYSIOL REV, V90, P1063, DOI 10.1152/physrev.00009.2009; Hannibal J, 2001, J NEUROSCI, V21, P4883, DOI 10.1523/JNEUROSCI.21-13-04883.2001; HANNIBAL J, 2006, ADV ANAT EMBRYOL CEL, V182, P1; Hannibal J, 2008, AM J PHYSIOL-REG I, V295, pR2050, DOI 10.1152/ajpregu.90563.2008; Harmar AJ, 2002, CELL, V109, P497, DOI 10.1016/S0092-8674(02)00736-5; Hundahl CA, 2010, J COMP NEUROL, V518, P1556, DOI 10.1002/cne.22290; Hundahl C, 2006, BRAIN RES, V1085, P19, DOI 10.1016/j.brainres.2006.02.040; Hundahl CA, 2008, NEUROENDOCRINOLOGY, V88, P183, DOI 10.1159/000135617; Hundahl CA, 2008, NEUROENDOCRINOLOGY, V88, P173, DOI 10.1159/000129698; Hundahl CA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028160; Hundahl CA, 2010, BRAIN RES, V1331, P58, DOI 10.1016/j.brainres.2010.03.056; Kallingal GJ, 2007, NEUROSCI LETT, V422, P59, DOI 10.1016/j.neulet.2007.06.003; Kallingal GJ, 2006, EUR J NEUROSCI, V24, P2853, DOI 10.1111/j.1460-9568.2006.05165.x; KNIGGE U, 1984, J CLIN ENDOCR METAB, V59, P310, DOI 10.1210/jcem-59-2-310; KORNHAUSER JM, 1990, NEURON, V5, P127, DOI 10.1016/0896-6273(90)90303-W; Kriegsfeld LJ, 2008, EUR J NEUROSCI, V27, P2907, DOI 10.1111/j.1460-9568.2008.06239.x; Maywood ES, 2007, COLD SPRING HARB SYM, V72, P85, DOI 10.1101/sqb.2007.72.005; Maywood ES, 2006, CURR BIOL, V16, P599, DOI 10.1016/j.cub.2006.02.023; Mohawk JA, 2011, TRENDS NEUROSCI; Morin LP, 2006, BRAIN RES REV, V51, P1, DOI 10.1016/j.brainresrev.2005.08.003; PIGGINS HD, 1995, J NEUROSCI, V15, P5612; Piggins HD, 2005, NEUROSCI LETT, V384, P205, DOI 10.1016/j.neulet.2005.03.072; Reppert SM, 2001, ANNU REV PHYSIOL, V63, P647, DOI 10.1146/annurev.physiol.63.1.647; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Shigeyoshi Y, 1997, CELL, V91, P1043, DOI 10.1016/S0092-8674(00)80494-8; Stadler F, 2010, CHRONOBIOL INT, V27, P68, DOI 10.3109/07420521003648554; Yan LL, 2004, EUR J NEUROSCI, V19, P1105, DOI 10.1111/j.1460-9568.2004.03189.x; Yannielli PC, 2001, J NEUROSCI, V21, P5367, DOI 10.1523/JNEUROSCI.21-14-05367.2001	45	28	28	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2012	7	4							e34462	10.1371/journal.pone.0034462	http://dx.doi.org/10.1371/journal.pone.0034462			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955IH	22496809	Green Published, Green Submitted, gold			2022-12-27	WOS:000305010500010
J	Lotsch, J; Walter, C; Felden, L; Noth, U; Deichmann, R; Oertel, BG				Loetsch, Joern; Walter, Carmen; Felden, Lisa; Noeth, Ulrike; Deichmann, Ralf; Oertel, Bruno G.			The Human Operculo-Insular Cortex Is Pain-Preferentially but Not Pain-Exclusively Activated by Trigeminal and Olfactory Stimuli	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; SENSORY DECISION-THEORY; HUMAN BRAIN; NASAL-MUCOSA; CORTICAL NETWORK; CO2 STIMULATION; FMRI; RESPONSES; PERCEPTION; SALIENCE	Increasing evidence about the central nervous representation of pain in the brain suggests that the operculo-insular cortex is a crucial part of the pain matrix. The pain-specificity of a brain region may be tested by administering nociceptive stimuli while controlling for unspecific activations by administering non-nociceptive stimuli. We applied this paradigm to nasal chemosensation, delivering trigeminal or olfactory stimuli, to verify the pain-specificity of the operculo-insular cortex. In detail, brain activations due to intranasal stimulation induced by non-nociceptive olfactory stimuli of hydrogen sulfide (5 ppm) or vanillin (0.8 ppm) were used to mask brain activations due to somatosensory, clearly nociceptive trigeminal stimulations with gaseous carbon dioxide (75% v/v). Functional magnetic resonance (fMRI) images were recorded from 12 healthy volunteers in a 3T head scanner during stimulus administration using an event-related design. We found that significantly more activations following nociceptive than non-nociceptive stimuli were localized bilaterally in two restricted clusters in the brain containing the primary and secondary somatosensory areas and the insular cortices consistent with the operculo-insular cortex. However, these activations completely disappeared when eliminating activations associated with the administration of olfactory stimuli, which were small but measurable. While the present experiments verify that the operculo-insular cortex plays a role in the processing of nociceptive input, they also show that it is not a pain-exclusive brain region and allow, in the experimental context, for the interpretation that the operculo-insular cortex splay a major role in the detection of and responding to salient events, whether or not these events are nociceptive or painful.	[Loetsch, Joern; Walter, Carmen; Felden, Lisa; Oertel, Bruno G.] Goethe Univ Frankfurt, Inst Clin Pharmacol, Pharmazentrum Frankfurt ZAFES, Frankfurt, Germany; [Noeth, Ulrike; Deichmann, Ralf] Goethe Univ Frankfurt, Brain Imaging Ctr, Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt	Lotsch, J (corresponding author), Goethe Univ Frankfurt, Inst Clin Pharmacol, Pharmazentrum Frankfurt ZAFES, Frankfurt, Germany.	j.loetsch@em.uni-frankfurt.de		Lotsch, Jorn/0000-0002-5818-6958	Deutsche Forschungsgemeinschaft, DFG [Lo 612/10-1]; Bundesministerium fur Bildung und Forschung [DLR 01GO0203]	Deutsche Forschungsgemeinschaft, DFG(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF))	Deutsche Forschungsgemeinschaft, DFG Lo 612/10-1, for study support (JL), and Bundesministerium fur Bildung und Forschung (DLR 01GO0203; RD) for support of the fMRI equipment. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht J, 2010, BRAIN RES REV, V62, P183, DOI 10.1016/j.brainresrev.2009.11.001; Andersson JLR, 2001, NEUROIMAGE, V13, P903, DOI 10.1006/nimg.2001.0746; Apkarian AV, 2005, EUR J PAIN, V9, P463, DOI 10.1016/j.ejpain.2004.11.001; Baliki MN, 2009, J NEUROPHYSIOL, V101, P875, DOI 10.1152/jn.91100.2008; Baumgartner U, 2010, J NEUROPHYSIOL, V104, P2863, DOI 10.1152/jn.00253.2010; Bingel U, 2008, PHYSIOLOGY, V23, P371, DOI 10.1152/physiol.00024.2008; Boly M, 2007, P NATL ACAD SCI USA, V104, P12187, DOI 10.1073/pnas.0611404104; Bornhovd K, 2002, BRAIN, V125, P1326, DOI 10.1093/brain/awf137; Boyle JA, 2007, NEUROSCIENCE, V149, P223, DOI 10.1016/j.neuroscience.2007.06.045; Boyle JA, 2007, CHEM SENSES, V32, P343, DOI 10.1093/chemse/bjm004; Brand G, 2006, NEUROSCI BIOBEHAV R, V30, P908, DOI 10.1016/j.neubiorev.2006.01.002; Bushnell MC, 1999, P NATL ACAD SCI USA, V96, P7705, DOI 10.1073/pnas.96.14.7705; CASEY KL, 1994, J NEUROPHYSIOL, V71, P802, DOI 10.1152/jn.1994.71.2.802; COGHILL RC, 1994, J NEUROSCI, V14, P4095; Coghill RC, 1999, J NEUROPHYSIOL, V82, P1934, DOI 10.1152/jn.1999.82.4.1934; CRAIG KD, 1978, J PERS SOC PSYCHOL, V36, P805, DOI 10.1037/0022-3514.36.8.805; Derbyshire SWG, 1997, PAIN, V73, P431, DOI 10.1016/S0304-3959(97)00138-3; DOTY RL, 1978, PHYSIOL BEHAV, V20, P175, DOI 10.1016/0031-9384(78)90070-7; Downar J, 2003, NEUROIMAGE, V20, P1540, DOI 10.1016/S1053-8119(03)00407-5; Downar J, 2002, J NEUROPHYSIOL, V87, P615, DOI 10.1152/jn.00636.2001; Downar J, 2000, NAT NEUROSCI, V3, P277, DOI 10.1038/72991; Eickhoff SB, 2006, CEREB CORTEX, V16, P254, DOI 10.1093/cercor/bhi105; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Eickhoff SB, 2007, NEUROIMAGE, V36, P511, DOI 10.1016/j.neuroimage.2007.03.060; Eickhoff SB, 2006, NEUROIMAGE, V32, P570, DOI 10.1016/j.neuroimage.2006.04.204; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; Frasnelli J, 2007, CEREB CORTEX, V17, P2268, DOI 10.1093/cercor/bhl135; FRIEDMAN DP, 1986, J COMP NEUROL, V252, P323, DOI 10.1002/cne.902520304; Friston KJ, 1998, NEUROIMAGE, V7, P30, DOI 10.1006/nimg.1997.0306; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Frot M, 2007, CEREB CORTEX, V17, P610, DOI 10.1093/cercor/bhk007; Garcia-Larrea L, 2010, BRAIN, V133, P2528, DOI 10.1093/brain/awq220; Geyer S, 1999, NEUROIMAGE, V10, P63, DOI 10.1006/nimg.1999.0440; Glascher J, 2009, NEUROINFORMATICS, V7, P73, DOI 10.1007/s12021-008-9042-x; Gluscher J., 2008, CONTRAST WEIGHTS FLE; Griswold MA, 2002, MAGN RESON MED, V47, P1202, DOI 10.1002/mrm.10171; Hari R, 1997, PAIN, V72, P145, DOI 10.1016/S0304-3959(97)00023-7; Howard JD, 2009, NAT NEUROSCI, V12, P932, DOI 10.1038/nn.2324; Hummel T, 2005, CHEM SENSES, V30, pI205, DOI 10.1093/chemse/bjh186; HUMMEL T, 1994, ELECTROEN CLIN NEURO, V92, P426, DOI 10.1016/0168-5597(94)90020-5; Hummel T, 2003, INT J PSYCHOPHYSIOL, V47, P147, DOI 10.1016/S0167-8760(02)00150-2; Hummel T, 2011, INT J PSYCHOPHYSIOL, V80, P69, DOI 10.1016/j.ijpsycho.2011.01.012; Hutton C, 2002, NEUROIMAGE, V16, P217, DOI 10.1006/nimg.2001.1054; HUTTUNEN J, 1986, ELECTROEN CLIN NEURO, V64, P347, DOI 10.1016/0013-4694(86)90159-8; Iannilli E, 2008, PAIN, V139, P376, DOI 10.1016/j.pain.2008.05.007; Iannilli E, 2007, BRAIN RES, V1139, P235, DOI 10.1016/j.brainres.2006.12.082; Ibanez A, 2010, BRAIN STRUCT FUNCT, V214, P397, DOI 10.1007/s00429-010-0256-y; KOBAL G, 1989, EXPERIENTIA, V45, P130, DOI 10.1007/BF01954845; KOBAL G, 1985, PAIN, V22, P151, DOI 10.1016/0304-3959(85)90175-7; Kobal G., 1996, Rhinology (Utrecht), V34, P222; Kobal G, 1998, LARYNGOSCOPE, V108, P1033, DOI 10.1097/00005537-199807000-00015; Kobal G, 1981, ELEKTROPHYSIOLOGISCH; Legrain V, 2003, PAIN, V103, P237, DOI 10.1016/S0304-3959(02)00451-7; Legrain V, 2002, PAIN, V99, P21, DOI 10.1016/S0304-3959(02)00051-9; Legrain V, 2011, PROG NEUROBIOL, V93, P111, DOI 10.1016/j.pneurobio.2010.10.005; Loring DW, 2002, EPILEPSY BEHAV, V3, P539, DOI 10.1016/S1525-5050(02)00558-9; Lotsch J, 2011, SOCIAL COGNITIVE AFF; Lui F, 2008, PAIN, V138, P362, DOI 10.1016/j.pain.2008.01.010; MALOW RM, 1989, PAIN, V38, P35, DOI 10.1016/0304-3959(89)90070-5; MALOW RM, 1987, J ABNORM PSYCHOL, V96, P184, DOI 10.1037/0021-843X.96.3.184; Mazzola L, 2006, CEREB CORTEX, V16, P960, DOI 10.1093/cercor/bhj038; Mazzola L, 2009, PAIN, V146, P99, DOI 10.1016/j.pain.2009.07.014; Menon V, 2010, BRAIN STRUCT FUNCT, V214, P655, DOI 10.1007/s00429-010-0262-0; MESULAM MM, 1982, J COMP NEUROL, V212, P38, DOI 10.1002/cne.902120104; Mouraux A, 2009, J NEUROPHYSIOL, V101, P3258, DOI 10.1152/jn.91181.2008; Mouraux A, 2011, NEUROIMAGE, V54, P2237, DOI 10.1016/j.neuroimage.2010.09.084; MUFSON EJ, 1981, NEUROSCIENCE, V6, P1231, DOI 10.1016/0306-4522(81)90184-6; MUGLER JP, 1991, JMRI-J MAGN RESON IM, V1, P561, DOI 10.1002/jmri.1880010509; Oertel BG, 2011, HUMAN BRAIN MAPPING; Peyron R, 2000, NEUROPHYSIOL CLIN, V30, P263, DOI 10.1016/S0987-7053(00)00227-6; Peyron R, 2002, NEUROIMAGE, V17, P1336, DOI 10.1006/nimg.2002.1315; Price DD, 2000, SCIENCE, V288, P1769, DOI 10.1126/science.288.5472.1769; Reeh P W, 2001, Curr Opin Pharmacol, V1, P45, DOI 10.1016/S1471-4892(01)00014-5; Schweinhardt P, 2006, NMR BIOMED, V19, P702, DOI 10.1002/nbm.1076; Starr CJ, 2009, J NEUROSCI, V29, P2684, DOI 10.1523/JNEUROSCI.5173-08.2009; STEEN KH, 1992, J NEUROSCI, V12, P86; TALBOT JD, 1991, SCIENCE, V251, P1355, DOI 10.1126/science.2003220; Tarun AS, 2003, CHEM SENSES, V28, P621, DOI 10.1093/chemse/bjg054; Tolle TR, 1999, ANN NEUROL, V45, P40, DOI 10.1002/1531-8249(199901)45:1<40::AID-ART8>3.0.CO;2-L; Treede RD, 1999, PAIN, V79, P105, DOI 10.1016/S0304-3959(98)00184-5; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Wang YYY, 2010, J NEUROSCI, V30, P12958, DOI 10.1523/JNEUROSCI.2715-10.2010; Weiskopf N, 2006, NEUROIMAGE, V33, P493, DOI 10.1016/j.neuroimage.2006.07.029; Wiech K, 2010, J NEUROSCI, V30, P16324, DOI 10.1523/JNEUROSCI.2087-10.2010; WORSLEY KJ, 1995, NEUROIMAGE, V2, P173, DOI 10.1006/nimg.1995.1023; WORSLEY KJ, 1994, ADV APPL PROBAB, V26, P13, DOI 10.2307/1427576; Wright IC, 1995, NEUROIMAGE, V2, P244, DOI 10.1006/nimg.1995.1032; YANG JC, 1985, PSYCHOSOM MED, V47, P461, DOI 10.1097/00006842-198509000-00006	88	24	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2012	7	4							e34798	10.1371/journal.pone.0034798	http://dx.doi.org/10.1371/journal.pone.0034798			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955IH	22496865	gold, Green Submitted, Green Published			2022-12-27	WOS:000305010500027
J	Bae, J; Sung, BH; Cho, IH; Song, WK				Bae, Jeomil; Sung, Bong Hwan; Cho, In Ha; Song, Woo Keun			F-Actin-Dependent Regulation of NESH Dynamics in Rat Hippocampal Neurons	PLOS ONE			English	Article							LONG-TERM POTENTIATION; DENDRITIC SPINES; SYNAPTIC PLASTICITY; EXCITATORY SYNAPSES; PROTEIN FAMILY; TRANSLOCATION; MECHANISMS; BRAIN; CELLS; LTP	Synaptic plasticity is an important feature of neurons essential for learning and memory. Postsynaptic organization and composition are dynamically remodeled in response to diverse synaptic inputs during synaptic plasticity. During this process, the dynamics and localization of postsynaptic proteins are also precisely regulated. NESH/Abi-3 is a member of the Abl interactor (Abi) protein family. Overexpression of NESH is associated with reduced cell motility and tumor metastasis. Strong evidence of a close relationship between NESH and the actin cytoskeleton has been documented. Although earlier studies have shown that NESH is prominently expressed in the brain, its function and characteristics are yet to be established. Data from the present investigation suggest that synaptic localization of NESH in hippocampal neurons is regulated in an F-actin-dependent manner. The dynamic fraction of NESH in the dendritic spine was analyzed using FRAP (fluorescence recovery after photobleaching). Interestingly, F-actin stabilization and disruption significantly affected the mobile fraction of NESH, possibly through altered interactions of NESH with the F-actin. In addition, NESH was synaptically targeted from the dendritic shaft to spine after induction of chemical LTP (long-term potentiation) and the translocation was dependent on F-actin. Our data collectively support the significance of the F-actin cytoskeleton in synaptic targeting of NESH as well as its dynamics.	[Bae, Jeomil; Cho, In Ha; Song, Woo Keun] Gwangju Inst Sci & Technol, Sch Life Sci, Cell Dynam & Bioimaging Res Ctr, Kwangju, South Korea; [Sung, Bong Hwan] Vanderbilt Univ, Med Ctr, Dept Canc Biol, Nashville, TN USA	Gwangju Institute of Science & Technology (GIST); Vanderbilt University	Bae, J (corresponding author), Gwangju Inst Sci & Technol, Sch Life Sci, Cell Dynam & Bioimaging Res Ctr, Kwangju, South Korea.	wksong@gist.ac.kr		Bae, Jeomil/0000-0001-9374-6802	Cell Dynamics and Bioimaging Research Center [20110001155]; Conversing Research Center [2011K000690]; Mid-Career Research Program [20110000095]; National Research Foundation of Korea	Cell Dynamics and Bioimaging Research Center; Conversing Research Center; Mid-Career Research Program; National Research Foundation of Korea(National Research Foundation of Korea)	This research was supported by grants from the Cell Dynamics and Bioimaging Research Center (20110001155), Conversing Research Center Program (2011K000690), Mid-Career Research Program (20110000095), and funding from the National Research Foundation of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bockers TM, 2001, J BIOL CHEM, V276, P40104, DOI 10.1074/jbc.M102454200; Bourne JN, 2008, ANNU REV NEUROSCI, V31, P47, DOI 10.1146/annurev.neuro.31.060407.125646; Ehrlich I, 2004, J NEUROSCI, V24, P916, DOI 10.1523/JNEUROSCI.4733-03.2004; Fortin DA, 2010, J NEUROSCI, V30, P11565, DOI 10.1523/JNEUROSCI.1746-10.2010; Fukazawa' Y, 2003, NEURON, V38, P447, DOI 10.1016/S0896-6273(03)00206-X; Hering H, 2003, J NEUROSCI, V23, P11759; Hirao N, 2006, FEBS LETT, V580, P6464, DOI 10.1016/j.febslet.2006.10.065; Holtmaat A, 2009, NAT REV NEUROSCI, V10, P647, DOI 10.1038/nrn2699; Hori K, 2005, J NEUROSCI, V25, P2670, DOI 10.1523/JNEUROSCI.3638-04.2005; Ichigotani Y, 2002, CANCER RES, V62, P2215; Innocenti M, 2005, NAT CELL BIOL, V7, P969, DOI 10.1038/ncb1304; Kasai H, 2003, TRENDS NEUROSCI, V26, P360, DOI 10.1016/S0166-2236(03)00162-0; Kasai H, 2010, TRENDS NEUROSCI, V33, P121, DOI 10.1016/j.tins.2010.01.001; Kopec CD, 2007, J NEUROSCI, V27, P13706, DOI 10.1523/JNEUROSCI.3503-07.2007; Kuriu T, 2006, J NEUROSCI, V26, P7693, DOI 10.1523/JNEUROSCI.0522-06.2006; Matsuda S, 2008, ANN ONCOL, V19, P1356, DOI 10.1093/annonc/mdn293; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; McGee AW, 2003, CURR OPIN NEUROBIOL, V13, P111, DOI 10.1016/S0959-4388(03)00008-4; Okamoto KI, 2004, NAT NEUROSCI, V7, P1104, DOI 10.1038/nn1311; Pak DTS, 2001, NEURON, V31, P289, DOI 10.1016/S0896-6273(01)00355-5; Renner M, 2008, CURR OPIN NEUROBIOL, V18, P532, DOI 10.1016/j.conb.2008.09.009; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Shen K, 1999, SCIENCE, V284, P162, DOI 10.1126/science.284.5411.162; Sheng M, 2002, SCIENCE, V298, P776, DOI 10.1126/science.1075333; Sheng M, 2007, ANNU REV BIOCHEM, V76, P823, DOI 10.1146/annurev.biochem.76.060805.160029; Shiraishi Y, 1999, J NEUROSCI, V19, P8389; Stein V, 2003, J NEUROSCI, V23, P5503; Stradal T, 2001, CURR BIOL, V11, P891, DOI 10.1016/S0960-9822(01)00239-1; Toni N, 1999, NATURE, V402, P421, DOI 10.1038/46574; Yang YL, 2008, J NEUROSCI, V28, P5740, DOI 10.1523/JNEUROSCI.3998-07.2008; Yuste R, 2001, ANNU REV NEUROSCI, V24, P1071, DOI 10.1146/annurev.neuro.24.1.1071	31	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e34514	10.1371/journal.pone.0034514	http://dx.doi.org/10.1371/journal.pone.0034514			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GO	22496823	Green Published, Green Submitted, gold			2022-12-27	WOS:000304855200060
J	Kayeyi, N; Fylkesnes, K; Michelo, C; Makasa, M; Sandoy, I				Kayeyi, Nkomba; Fylkesnes, Knut; Michelo, Charles; Makasa, Mpundu; Sandoy, Ingvild			Decline in HIV Prevalence among Young Women in Zambia: National-Level Estimates of Trends Mask Geographical and Socio-Demographic Differences	PLOS ONE			English	Article							POPULATION-BASED SURVEYS; TO-CHILD TRANSMISSION; SENTINEL SURVEILLANCE; PREVENTION; EPIDEMIC; PEOPLE; EXPERIENCE; MORTALITY; INFECTION; PATTERNS	Background: A decline in HIV incidence has been reported in Zambia and a number of other sub-Saharan countries. The trend of HIV prevalence among young people is a good marker of HIV incidence. In this study, different data sources are used to examine geographical and sub-population group differentials in HIV prevalence trends among men and women aged 15-24 years in Zambia. Design and Methods: We analysed ANC data for women aged 15-24 years from 22 sentinel sites consistently covered in the period 1994-2008, and HIV data for young men and women aged 15-24 years from the ZDHS 2001/2 and 2007. In addition, we systematically reviewed peer-reviewed articles that have reported findings on HIV prevalence and incidence among young people. Findings: Overall trends of the ANC surveillance data indicated a substantial HIV prevalence decline among young women in both urban and rural areas. However, provincial declines differed substantially, i.e. between 10% and 68% among urban women, and from stability to 86% among rural women. Prevalence declines were steeper among those with the highest educational attainments than among the least educated. The ZDHS data indicated a significant reduction in prevalence between the two survey rounds among young women only. Provincial-level ZDHS changes were difficult to assess because the sample sizes were small. ANC-based trend patterns were consistent with those observed in PMTCT-based data (2002-2006), whereas population-based surveys in a selected urban community (1995-2003) suggested that the ANC-based data underestimated the prevalence declines in the general populations of both young both men and women. Conclusion: The overall HIV prevalence declined substantially among young women in Zambia and this is interpreted as indicating a decline in HIV incidence. It is noteworthy that overall national trends masked substantial differences by place and by educational attainment, demonstrating critical limitations in the current focus on overall country-level trends in epidemiological reports.	[Kayeyi, Nkomba; Fylkesnes, Knut; Makasa, Mpundu; Sandoy, Ingvild] Univ Bergen, Ctr Int Hlth, Bergen, Norway; [Kayeyi, Nkomba; Michelo, Charles] Univ Zambia, Sch Med, Dept Publ Hlth, Lusaka, Zambia; [Makasa, Mpundu] Minist Hlth, Lusaka, Zambia	University of Bergen; University of Zambia	Kayeyi, N (corresponding author), Univ Bergen, Ctr Int Hlth, Bergen, Norway.	nkayeyi@yahoo.co.uk	Sandøy, Ingvild Fossgard/ABD-3557-2020	Kayeyi, Nkomba/0000-0002-4043-5872; Sandoy, Ingvild/0000-0001-5567-4588	Norwegian programme for development, research and education (NUFU); Norwegian Agency for Development Cooperation (NORAD); Swedish International Cooperation Agency (SIDA); Centers for Disease Control and Prevention (CDC); Demographic and Health Survey (DHS)	Norwegian programme for development, research and education (NUFU); Norwegian Agency for Development Cooperation (NORAD); Swedish International Cooperation Agency (SIDA); Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Demographic and Health Survey (DHS)	The authors would like to acknowledge the Norwegian programme for development, research and education (NUFU) for financing this study. Further acknowledgement is made to the funders of the surveys, in particular the ANC sentinel surveillance, which has been funded over the years by the Norwegian Agency for Development Cooperation (NORAD), the Swedish International Cooperation Agency (SIDA) and the Centers for Disease Control and Prevention (CDC). Other organisations include MEASURE DHS, which funds the Demographic and Health Survey (DHS). The funders of this study had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnighausen T, 2011, EPIDEMIOLOGY, V22, P27, DOI 10.1097/EDE.0b013e3181ffa201; Bello GA, 2006, SEX TRANSM INFECT, V82, pI9, DOI 10.1136/sti.2005.016030; Bond V, 2002, EVAL PROGRAM PLANN, V25, P347, DOI 10.1016/S0149-7189(02)00046-0; Bonell CP, 2007, AIDS S7, V21; Buve A, 2002, LANCET, V359, P2011, DOI 10.1016/S0140-6736(02)08823-2; Buve A, 2001, AIDS, V15, pS5, DOI 10.1097/00002030-200108004-00002; Central Statistical Office (CSO) [Zambia] Central Board of Health [Zambia] and ORC Macro, 2003, ZAMB DEM HLTH SURV 2; Chanem KG, 2008, AIDS, V22, P1145, DOI 10.1097/QAD.0b013e32830184df; Cheluget B, 2006, SEX TRANSM INFECT, V82, pI21, DOI 10.1136/sti.2005.015990; CSO MOH TDRC University of Zambia, 2009, ZAMB DEM HLTH SURV 2; Doherty T, 2006, B WORLD HEALTH ORGAN, V84, P90, DOI 10.2471/BLT.04.019448; Dzekedzeke K, 2006, BMC PUBLIC HLTH, V6; Fylkesnes K, 1997, AIDS, V11, P339, DOI 10.1097/00002030-199703110-00012; Fylkesnes K, 2001, AIDS, V15, P907, DOI 10.1097/00002030-200105040-00011; Fylkesnes K, 1998, AIDS, V12, P1227, DOI 10.1097/00002030-199810000-00015; Ghys DP, 2005, SEX TRANSM INFECT, V82, pi52; Glynn JR, 2001, AIDS, V15, P1717, DOI 10.1097/00002030-200109070-00016; Gouws E, 2010, EPI ALERT METHODS ES; Gouws E, 2008, AIDS, V22, pS5, DOI 10.1097/01.aids.0000341773.86500.9d; Hallett TB, 2010, AIDS, V24, P147, DOI 10.1097/QAD.0b013e32833062dc; Hargreaves JR, 2008, AIDS, V22, P403, DOI 10.1097/QAD.0b013e3282f2aac3; Hargreaves JR, 2010, AIDS, V24, P754, DOI 10.1097/QAD.0b013e328336672e; Hargrove JW, 2008, AIDS, V22, P511, DOI 10.1097/QAD.0b013e3282f2a960; Heffron R, 2011, LANCET          1004; Hladik W, 2006, SEX TRANSM INFECT, V82, pI32, DOI 10.1136/sti.2005.016592; Hladik W, 2005, AIDS, V19, pS19, DOI 10.1097/01.aids.0000172873.82509.5e; Janssen RS, 1998, JAMA-J AM MED ASSOC, V280, P42, DOI 10.1001/jama.280.1.42; Joesoef MR, 2003, INT J STD AIDS, V14, P193, DOI 10.1258/095646203762869214; Kapina M, 2010, SEX TRANSM DIS; Kayeyi N, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-310; Lopman B, 2008, INT J EPIDEMIOL, V37, P88, DOI 10.1093/ije/dym255; Mahomva A, 2006, SEX TRANSM INFECT, V82, pI42, DOI 10.1136/sti.2005.019174; Makasa M, 2011, SEX TRANSM DIS; Michelo C, 2008, TROP MED INT HEALTH, V13, P171, DOI 10.1111/j.1365-3156.2007.01987.x; Michelo C, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-279; Michelo C, 2006, AIDS, V20, P1031, DOI 10.1097/01.aids.0000222076.91114.95; Mishra V, 2006, B WORLD HEALTH ORGAN, V84, P537, DOI 10.2471/BLT.05.029520; MOH CBOH GRZ, 2005, ZAMB ANT CLIN SENT S; Mpairwe H, 2005, JAIDS-J ACQ IMM DEF, V39, P354, DOI 10.1097/01.qai.0000148081.38331.92; Myer L, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000229; NAC, 2009, ZAMB HIV PREV RESP M; NAC TDRC SIDA CDC, 2003, ZAMB ANT CLIN SENT S; Nyirenda M, 2007, AIDS, V21, pS73, DOI 10.1097/01.aids.0000299413.82893.2b; Ramjee G, 2008, JAIDS-J ACQ IMM DEF, V47, P93, DOI 10.1097/QAI.0b013e31815c71f7; Sandoy IF, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-60; Sandoy IF, 2006, TROP MED INT HEALTH, V11, P917, DOI 10.1111/j.1365-3156.2006.01629.x; Seguy N, 2006, CAN DATA PROGRAMS PR, P121; Smith J, 2007, AIDS, V21, pS81, DOI 10.1097/01.aids.0000299414.60022.1b; Stoneburner RL, 2004, SCIENCE, V304, P714, DOI 10.1126/science.1093166; Stringer ME, 2008, B WHO, V89; UNAIDS WHO, 2011, GLOB REP 2011 UNAIDS; Zaba B, 2000, AIDS, V14, P1633, DOI 10.1097/00002030-200007280-00020	52	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e33652	10.1371/journal.pone.0033652	http://dx.doi.org/10.1371/journal.pone.0033652			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GO	22496759	Green Submitted, Green Published, gold			2022-12-27	WOS:000304855200019
J	Neselius, S; Brisby, H; Theodorsson, A; Blennow, K; Zetterberg, H; Marcusson, J				Neselius, Sanna; Brisby, Helena; Theodorsson, Annette; Blennow, Kaj; Zetterberg, Henrik; Marcusson, Jan			CSF-Biomarkers in Olympic Boxing: Diagnosis and Effects of Repetitive Head Trauma	PLOS ONE			English	Article							CHRONIC BRAIN-DAMAGE; FIBRILLARY ACIDIC PROTEIN; DIFFUSE AXONAL INJURY; CEREBROSPINAL-FLUID; CONCUSSION; S100B; MILD; LEAD; FOOTBALL; SPORTS	Background: Sports-related head trauma is common but still there is no established laboratory test used in the diagnostics of minimal or mild traumatic brain injuries. Further the effects of recurrent head trauma on brain injury markers are unknown. The purpose of this study was to investigate the relationship between Olympic (amateur) boxing and cerebrospinal fluid (CSF) brain injury biomarkers. Methods: The study was designed as a prospective cohort study. Thirty Olympic boxers with a minimum of 45 bouts and 25 non-boxing matched controls were included in the study. CSF samples were collected by lumbar puncture 1-6 days after a bout and after a rest period for at least 14 days. The controls were tested once. Biomarkers for acute and chronic brain injury were analysed. Results: NFL (mean +/- SD, 5326 +/- 553 vs 135 +/- 51 ng/L p = 0.001), GFAP (496 +/- 238 vs 247 +/- 147 ng/L p<0.001), T-tau (58 +/- 26 vs 49 +/- 21 ng/L p<0.025) and S-100B (0.76 +/- 0.29 vs 0.60 +/- 0.23 ng/L p = 0.03) concentrations were significantly increased after boxing compared to controls. NFL (402 +/- 434 ng/L p = 0.004) and GFAP (369 +/- 113 ng/L p = 0.001) concentrations remained elevated after the rest period. Conclusion: Increased CSF levels of T-tau, NFL, GFAP, and S-100B in >80% of the boxers demonstrate that both the acute and the cumulative effect of head trauma in Olympic boxing may induce CSF biomarker changes that suggest minor central nervous injuries. The lack of normalization of NFL and GFAP after the rest period in a subgroup of boxers may indicate ongoing degeneration. The recurrent head trauma in boxing may be associated with increased risk of chronic traumatic brain injury.	[Neselius, Sanna; Brisby, Helena] Sahlgrens Univ Hosp, Dept Orthopaed, Gothenburg, Sweden; [Neselius, Sanna; Brisby, Helena] Univ Gothenburg, Sahlgrenska Acad, Inst Clin Sci, Gothenburg, Sweden; [Theodorsson, Annette] Linkoping Univ Hosp, Neurosurg Sect, S-58185 Linkoping, Sweden; [Theodorsson, Annette; Marcusson, Jan] Linkoping Univ, Inst Clin & Expt Med, Linkoping, Sweden; [Blennow, Kaj; Zetterberg, Henrik] Sahlgrens Univ Hosp, Clin Neurochem Lab, Dept Psychiat & Neurochem, Gothenburg, Sweden; [Blennow, Kaj; Zetterberg, Henrik] Univ Gothenburg, Inst Neurosci & Physiol, Sahlgrenska Acad, Gothenburg, Sweden; [Marcusson, Jan] Linkoping Univ Hosp, Geriatr Sect, S-58185 Linkoping, Sweden	Sahlgrenska University Hospital; University of Gothenburg; Linkoping University; Linkoping University; Sahlgrenska University Hospital; University of Gothenburg; Linkoping University	Neselius, S (corresponding author), Sahlgrens Univ Hosp, Dept Orthopaed, Gothenburg, Sweden.	sanna.neselius@vgregion.se			Marianne and Marcus Wallenberg Foundation, Sweden; County Council of Vastra Gotaland, Sweden; Sahlgrenska University Hospital, Gothenburg, Sweden; Gothenburg Medical Society, Sweden; County Council of Ostergotland, Sweden; Swedish Research Council	Marianne and Marcus Wallenberg Foundation, Sweden; County Council of Vastra Gotaland, Sweden; Sahlgrenska University Hospital, Gothenburg, Sweden; Gothenburg Medical Society, Sweden; County Council of Ostergotland, Sweden; Swedish Research Council(Swedish Research CouncilEuropean Commission)	This study has been funded by the Marianne and Marcus Wallenberg Foundation, Sweden; ALF Grants, County Council of Vastra Gotaland, Sweden; Sahlgrenska University Hospital, Gothenburg, Sweden; Gothenburg Medical Society, Sweden; ALF Grants, County Council of Ostergotland, Sweden and The Swedish Research Council. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Blennow K, 2010, NAT REV NEUROL, V6, P131, DOI 10.1038/nrneurol.2010.4; Brody DL, 2008, SCIENCE, V321, P1221, DOI 10.1126/science.1161591; Browne GJ, 2006, BRIT J SPORT MED, V40, P163, DOI 10.1136/bjsm.2005.021220; CHARNAS L, 1986, HOSP PRACT, V21, P30; Donato R, 2009, BBA-MOL CELL RES, V1793, P1008, DOI 10.1016/j.bbamcr.2008.11.009; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Franz G, 2003, NEUROLOGY, V60, P1457, DOI 10.1212/01.WNL.0000063313.57292.00; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; HAGLUND Y, 1990, ACTA NEUROL SCAND, V82, P353; HAGLUND Y, 1990, ACTA NEUROL SCAND, V82, P245; HAGLUND Y, 1990, ACTA NEUROL SCAND, V82, P297; Hamberger A, 2003, J NEUROTRAUM, V20, P169, DOI 10.1089/08977150360547080; Hasselblatt M, 2004, NEUROLOGY, V62, P1634, DOI 10.1212/01.WNL.0000123092.97047.B1; Hayakata T, 2004, SHOCK, V22, P102, DOI 10.1097/01.shk.0000131193.80038.f1; Honda M, 2010, J TRAUMA, V69, P104, DOI 10.1097/TA.0b013e3181bbd485; Ingebrigtsen T, 2000, J TRAUMA, V48, P760, DOI 10.1097/00005373-200004000-00029; Jagoda AS, 2010, PSYCHIAT CLIN N AM, V33, P797, DOI 10.1016/j.psc.2010.09.004; Jordan BD, 1996, AM J SPORT MED, V24, P704, DOI 10.1177/036354659602400526; Kane MJ, 2012, J NEUROSCI METH, V203, P41, DOI 10.1016/j.jneumeth.2011.09.003; KASTE M, 1982, LANCET, V2, P1186; Kay AD, 2003, J NEUROTRAUM, V20, P943, DOI 10.1089/089771503770195795; Kleindienst A, 2006, J NEUROTRAUM, V23, P1185, DOI 10.1089/neu.2006.23.1185; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; McCrory P, 2009, J SCI MED SPORT, V12, P340, DOI 10.1016/j.jsams.2009.02.004; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Michetti F, 2012, J NEUROCHEM, V120, P644, DOI 10.1111/j.1471-4159.2011.07612.x; Olsson A, 2005, CLIN CHEM, V51, P336, DOI 10.1373/clinchem.2004.039347; Omalu Bennet I, 2010, J Forensic Nurs, V6, P40, DOI 10.1111/j.1939-3938.2009.01064.x; Omalu BI, 2010, AM J FOREN MED PATH, V31, P130, DOI 10.1097/PAF.0b013e3181ca7f35; Pelsers MMAL, 2004, CLIN CHEM, V50, P1568, DOI 10.1373/clinchem.2003.030361; Petzold A, 2002, CRIT CARE MED, V30, P2705, DOI 10.1097/00003246-200212000-00015; Putukian M, 2011, CLIN SPORT MED, V30, P49, DOI 10.1016/j.csm.2010.09.005; Raftery AE, 1997, J AM STAT ASSOC, V92, P179, DOI 10.2307/2291462; ROSENGREN LE, 1994, J NEUROSCI METH, V51, P197, DOI 10.1016/0165-0270(94)90011-6; Rosengren LE, 1996, J NEUROCHEM, V67, P2013, DOI 10.1046/j.1471-4159.1996.67052013.x; Savola O, 2004, J TRAUMA, V56, P1229, DOI 10.1097/01.TA.0000096644.08735.72; Topal NB, 2008, NEUROL RES, V30, P974, DOI 10.1179/016164108X323799; Viano DC, 2005, NEUROSURGERY, V57, P1154, DOI 10.1227/01.NEU.0000187541.87937.D9; Zetterberg H, 2007, BRIT J SPORT MED, V41, DOI 10.1136/bjsm.2007.037143; Zetterberg H, 2006, ARCH NEUROL-CHICAGO, V63, P1277, DOI 10.1001/archneur.63.9.1277	41	184	186	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e33606	10.1371/journal.pone.0033606	http://dx.doi.org/10.1371/journal.pone.0033606			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GO	22496755	Green Published, gold, Green Submitted			2022-12-27	WOS:000304855200018
J	Yoshimura, M; Fisher, BL				Yoshimura, Masashi; Fisher, Brian L.			A Revision of Male Ants of the Malagasy Amblyoponinae (Hymenoptera: Formicidae) with Resurrections of the Genera Stigmatomma and Xymmer	PLOS ONE			English	Article							GENUS; DIVERSIFICATION; SYSTEMATICS; PHYLOGENY; TAXONOMY	In a male-based revision of ants of the subfamily Amblyoponinae from the Southwest Indian Ocean islands (SWIO: Comoros, Madagascar, Mauritius, Mayotte, Reunion, and Seychelles), we explore and reconsider male morphological characters that distinguish genera within the group. Our investigation redefines Amblyopone Erichson sensu Brown (1960), here referred to as Amblyopone sensu lato, into three genera: Xymmer Santschi stat. rev., Amblyopone sensu stricto, Stigmatomma Roger stat. rev. All species names under Amblyopone s. l. reassign into Xymmer and Amblyopone s. s., which are small, well-defined genera, and Stigmatomma, a large group with a generic delimitation that still needs further refinement. Based on a study of male mandible characters and our scenario for mandibular evolution of the worker caste within Amblyopone s. l, we conclude that Amblyopone s. s. nests outside of XMAS (Xymmer+Mystrium+Adetomyrma+Stigmatomma) clade. The following names are transferred from Amblyopone s. l. to Xymmer as comb. rev.: muticus. The following names are transferred from Amblyopone s. l. to Stigmatomma as comb. rev.: amblyops, armigerum, bellii, bierigi, bruni, celata, chilense, denticulatum, elongatum, emeryi, feae, impressifrons, luzonicum, minuta, normandi, oregonense, pallipes, quadratum, reclinatum, rothneyi, santschii, saundersi, silvestrii, zwaluwenburgi; as comb. nov.: agostii, annae, besucheti, boltoni, caliginosum, cleae, crenatum, degeneratum, egregium, electrinum, eminia, exiguum, falcatum, ferrugineum, fulvidum, gaetulicum, gingivalis, glauerti, gnoma, gracile, groehni, heraldoi, lucidum, lurilabes, monrosi, mystriops, noonadan, octodentatum, ophthalmicum, orizabanum, papuanum, pertinax, pluto, punctulatum, rubiginoum, sakaii, smithi, trigonignathum, trilobum, wilsoni, zaojun, and testaceum. A male-based key to the genera of Malagasy amblyoponine ants, their diagnoses, and a discussion of the evolution of the morphological character of males in the subfamily are given, and the distinguishing characters of each are illustrated. In addition, our results predict that Paraprionopelta belongs in the XMAS clade and that Concoctio should have males with two mandibular teeth.	[Yoshimura, Masashi; Fisher, Brian L.] Calif Acad Sci, Dept Entomol, San Francisco, CA 94118 USA	California Academy of Sciences	Yoshimura, M (corresponding author), Calif Acad Sci, Dept Entomol, San Francisco, CA 94118 USA.	myoshimura@ant-database.org; bfisher@calacademy.org	Fisher, Brian L./S-9374-2019; Yoshimura, Masashi/D-5096-2009	Fisher, Brian/0000-0002-4653-3270; Yoshimura, Masashi/0000-0003-1468-5541	National Science Foundation [DEB-0842395]; Division Of Environmental Biology [0842395] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the National Science Foundation under grant no. DEB-0842395 (http://www.nsf.gov/funding/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BINGHAM CT, 2003, FAUNA BRIT INDIA INC, V2; BOLTON B, 1990, J NAT HIST, V24, P53, DOI 10.1080/00222939000770051; Bolton B., 1994, Identification guide to the ant genera of the world.; Bolton Barry, 2003, Memoirs of the American Entomological Institute (Gainesville), V71, P1; Bolton Barry, 1995, P1; Brady SG, 2006, P NATL ACAD SCI USA, V103, P18172, DOI 10.1073/pnas.0605858103; Brown W. L jr., 1950, Transactions of the American Entomological Society, V75, P113; BROWN WILLIAM L., 1960, BULL MUS COMP ZOOL HARVARD UNIV, V122, P143; BROWN WILLIAM L., 1949, PSYCHE, V56, P81, DOI 10.1155/1949/67378; Clark J., 1934, Memoirs of the National Museum Melbourne, Vno. 8, P21; Clark J., 1928, Journal Royal Soc W Aust Sydney, V14, P29; Eguchi K, 2006, ZOOTAXA, P1; Emery C., 1919, Annales de la Societe Entomologique de Belgique Bruxelles, V59; ERICHSON WF, 1842, ARCH NATURGESCH, V8, P83, DOI DOI 10.5962/BHL.PART.21657; FISHER BL, 2005, P CALIFORNIA ACAD SC, V56, P78; Fisher BL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001787; Gauld I. D., 1988, HYMENOPTERA; Gotwald Jr WH, 1969, MEMOIR CORNELL U AGR; GOTWALD WH, 1972, ANN ENTOMOL SOC AM, V65, P383, DOI 10.1093/aesa/65.2.383; Huber John T., 1993, Agriculture Canada Publication, V1894E, P13; Hymenoptera Emery C, FAM FORMICIDAE SUBFA, P1; International Commission on Zoological Nomenclature, 1999, INT CODE ZOOLOGICAL, V4th; Kusnezov N., 1955, Zoologischer Anzeiger Leipzig, V154, P268; Mann W. M., 1919, Bulletin of the Museum at Harvard College, V63; Moreau CS, 2006, SCIENCE, V312, P101, DOI 10.1126/science.1124891; Nichols SW, TORRE BUENO GLOSSARY; OGATA K, 1987, Esakia, P97; Ouellette GD, 2006, MOL PHYLOGENET EVOL, V40, P359, DOI 10.1016/j.ympev.2006.03.017; Provancher L., 1881, NAT CAN, V12, P193; Roger J, 1859, BERL ENTOMOL Z, V3, P225; Santschi F., 1914, B LAB ZOOLOGIA GEN A, V8, P309, DOI DOI 10.5281/ZENODO.14385; Saux C, 2004, MOL PHYLOGENET EVOL, V33, P457, DOI 10.1016/j.ympev.2004.06.017; Serna F, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.11101; Serna F, 2011, ZOOTAXA, P67, DOI 10.11646/zootaxa.2923.1.5; Smith Marion R., 1943, AMER MIDLAND NAT, V30, P273, DOI 10.2307/2421283; SNODGRASS R. E., 1941, SMITHSONIAN MISC COLL, V99, P1; SNODGRASS R. E., 1957, SMITHSONIAN MISC COLL, V135, P1; Snodgrass RE., 1935, PRINCIPLES INSECT MO, P1; Ward PS, 2011, MYRMECOL NEWS, V15, P21; WARD PS, 1994, SYST ENTOMOL, V19, P159, DOI 10.1111/j.1365-3113.1994.tb00585.x; Wheeler W. M., 1922, Bulletin of the American Museum of Natural History, V45, P631; Wheeler WM, 1927, P AM ACAD ARTS SCI, V62, P1, DOI 10.2307/25130101; WOOTTON RJ, 1979, SYST ENTOMOL, V4, P81, DOI 10.1111/j.1365-3113.1979.tb00614.x; Yoshimura M, 2007, ZOOTAXA, P21, DOI 10.11646/zootaxa.1654.1.2; Yoshimura M, 2011, ZOOTAXA, P1; Yoshimura M, 2009, ZOOTAXA, P1	46	64	70	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2012	7	3							e33325	10.1371/journal.pone.0033325	http://dx.doi.org/10.1371/journal.pone.0033325			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948SR	22496722	Green Published, gold, Green Submitted			2022-12-27	WOS:000304523400020
J	Chen, JC; Chiu, LL; Lee, KL; Huang, WN; Chuang, JG; Liao, HK; Chow, LP				Chen, Jui-Chieh; Chiu, Li-Li; Lee, Kuang-Lun; Huang, Wei-Ning; Chuang, Jiing-Guang; Liao, Hsin-Kai; Chow, Lu-Ping			Identification of Critical Amino Acids in an Immunodominant IgE Epitope of Pen c 13, a Major Allergen from Penicillium citrinum	PLOS ONE			English	Article							BIRCH POLLEN ALLERGEN; MAGNETIC-RESONANCE STRUCTURE; AIRWAY EPITHELIAL-CELLS; DUST-MITE ALLERGEN; PEPTIDE IMMUNOTHERAPY; BLOCKING ANTIBODIES; STRUCTURAL-ANALYSIS; CRYSTAL-STRUCTURE; FUNGAL ALLERGENS; BINDING EPITOPES	Background: Pen c 13, identified as a 33-kDa alkaline serine protease, is a major allergen secreted by Penicillium citrinum. Detailed knowledge about the epitopes responsible for IgE binding would help inform the diagnosis/prognosis of fungal allergy and facilitate the rational design of hypoallergenic candidate vaccines. The goal of the present study was to characterize the IgE epitopes of Pen c 13. Methodology/Principal Findings: Serum samples were collected from 10 patients with mold allergy and positive Pen c 13 skin test results. IgE-binding epitopes on rPen c 13 were mapped using an enzymatic digestion and chemical cleavage method, followed by dot-blotting and mass spectrometry. A B-cell epitope-predicting server and molecular modeling were used to predict the residues most likely involved in IgE binding. Theoretically predicted IgE-binding regions were further confirmed by site-directed mutagenesis assays. At least twelve different IgE-binding epitopes located throughout Pen c 13 were identified. Of these, peptides S16 (A(148)-E-166) and S22 (A(243)-K-274) were recognized by sera from 90% and 100% of the patients tested, and were further confirmed by inhibition assays. Peptide S22 was selected for further analysis of IgE-binding ability. The results of serum screening showed that the majority of IgE-binding ability resided in the C-terminus. One Pen c 13 mutant, G270A (T-261-K-274), exhibited clearly enhanced IgE reactivity, whereas another, K274A, exhibited dramatically reduced IgE reactivity. Conclusions/Significance: Experimental analyses confirmed in silico-predicted residues involved in an important antigenic region of Pen c 13. The G270A mutant of Pen c 13 has the potential to serve as an additional tool for the diagnosis/ prognosis of mold allergy, and the K274A mutant, as a hypoallergenic form of the epitope, may provide a framework for the design and development of a safe and efficient therapeutic strategy for treating human allergic diseases.	[Chen, Jui-Chieh; Chiu, Li-Li; Chuang, Jiing-Guang; Liao, Hsin-Kai; Chow, Lu-Ping] Natl Taiwan Univ, Grad Inst Biochem & Mol Biol, Coll Med, Taipei 10764, Taiwan; [Lee, Kuang-Lun] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; [Huang, Wei-Ning] Yuanpei Univ, Dept Biotechnol, Hsinchu, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University Hospital	Chen, JC (corresponding author), Natl Taiwan Univ, Grad Inst Biochem & Mol Biol, Coll Med, Taipei 10764, Taiwan.	chowip@ntu.edu.tw	Liao, Hsin-Kai/H-9608-2015; é, çå/HCH-5712-2022	CHOW, LU-PING/0000-0002-4420-211X; Chen, Jui-Chieh/0000-0002-8854-9801	Program for Excellence Research Teams from the Ministry of Education; National Science Council of the Republic of China [NSC 99-2320-B-002-012]	Program for Excellence Research Teams from the Ministry of Education; National Science Council of the Republic of China(Ministry of Science and Technology, Taiwan)	This work was supported by the Program for Excellence Research Teams from the Ministry of Education and a grant (NSC 99-2320-B-002-012) from the National Science Council of the Republic of China (http://web1.nsc.gov.tw/mp.aspx?mp = 7). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Ball T, 2009, ALLERGY, V64, P569, DOI 10.1111/j.1398-9995.2008.01910.x; Beezhold DH, 2001, J ALLERGY CLIN IMMUN, V107, P1069, DOI 10.1067/mai.2001.115482; Breitenbach M, 2008, INT ARCH ALLERGY IMM, V145, P58, DOI 10.1159/000107578; Bui HH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-361; Campana R, 2010, J ALLERGY CLIN IMMUN, V126, P1024, DOI 10.1016/j.jaci.2010.05.023; Campbell JD, 2009, J EXP MED, V206, P1535, DOI 10.1084/jem.20082901; Chan SL, 2008, J IMMUNOL, V181, P2586, DOI 10.4049/jimmunol.181.4.2586; Chan SL, 2006, J IMMUNOL, V176, P4852, DOI 10.4049/jimmunol.176.8.4852; Chen JC, 2011, J BIOL CHEM, V286, P26667, DOI 10.1074/jbc.M110.193987; Chiu LL, 2008, PROTEOM CLIN APPL, V2, P33, DOI 10.1002/prca.200780050; Chiu LL, 2007, J IMMUNOL, V178, P5237, DOI 10.4049/jimmunol.178.8.5237; Chou H, 2011, MOL IMMUNOL, V48, P2130, DOI 10.1016/j.molimm.2011.07.004; Chou H, 2011, CLIN EXP ALLERGY, V41, P739, DOI 10.1111/j.1365-2222.2011.03698.x; Chow LP, 2000, BIOCHEM J, V346, P423, DOI 10.1042/0264-6021:3460423; Durham SR, 1998, J ALLERGY CLIN IMMUN, V102, P157, DOI 10.1016/S0091-6749(98)70079-X; Durham SR, 1999, NEW ENGL J MED, V341, P468, DOI 10.1056/NEJM199908123410702; Ferreira F, 1998, FASEB J, V12, P231, DOI 10.1096/fasebj.12.2.231; Gafvelin G, 2007, J BIOL CHEM, V282, P3778, DOI 10.1074/jbc.M607938200; Garcia-Casado G, 2003, J ALLERGY CLIN IMMUN, V112, P599, DOI 10.1037/mai.2003.1638; Hantusch B, 2004, J ALLERGY CLIN IMMUN, V114, P1294, DOI 10.1016/j.jaci.2004.06.048; Holm J, 2004, J IMMUNOL, V173, P5258, DOI 10.4049/jimmunol.173.8.5258; HORNER WE, 1995, CLIN MICROBIOL REV, V8, P161, DOI 10.1128/CMR.8.2.161; Ivanciuc O, 2009, REGUL TOXICOL PHARM, V54, pS11, DOI 10.1016/j.yrtph.2008.11.007; Kammerer R, 1997, CLIN EXP ALLERGY, V27, P1016, DOI 10.1111/j.1365-2222.1997.tb01253.x; Karamloo F, 2005, EUR J IMMUNOL, V35, P3268, DOI 10.1002/eji.200425522; Karisola P, 2004, J IMMUNOL, V172, P2621, DOI 10.4049/jimmunol.172.4.2621; Kouzaki H, 2009, J IMMUNOL, V183, P1427, DOI 10.4049/jimmunol.0900904; Kurup VP, 2000, MICROBES INFECT, V2, P1101, DOI 10.1016/S1286-4579(00)01264-8; Lai HY, 2004, CLIN EXP ALLERGY, V34, P1926, DOI 10.1111/j.1365-2222.2004.02115.x; Larche M, 2006, NAT REV IMMUNOL, V6, P761, DOI 10.1038/nri1934; Larsen Jens Erik Pontoppidan, 2006, Immunome Res, V2, P2, DOI 10.1186/1745-7580-2-2; Li M, 2008, J BIOL CHEM, V283, P22806, DOI 10.1074/jbc.M800937200; Liang LM, 2010, FASEB J, V24, P1391, DOI 10.1096/fj.09-136408; Moller C, 2002, J ALLERGY CLIN IMMUN, V109, P251, DOI 10.1067/mai.2002.121317; Mothes N, 2003, CLIN EXP ALLERGY, V33, P1198, DOI 10.1046/j.1365-2222.2003.01699.x; Muller U, 1998, J ALLERGY CLIN IMMUN, V101, P747, DOI 10.1016/S0091-6749(98)70402-6; Niemi M, 2007, STRUCTURE, V15, P1413, DOI 10.1016/j.str.2007.09.012; Niespodziana K, 2011, J ALLERGY CLIN IMMUN, V127, P1562, DOI 10.1016/j.jaci.2011.02.004; Norman PS, 1996, AM J RESP CRIT CARE, V154, P1623, DOI 10.1164/ajrccm.154.6.8970345; Nouri-Aria KT, 2004, J IMMUNOL, V172, P3252, DOI 10.4049/jimmunol.172.5.3252; Oldfield WLG, 2002, LANCET, V360, P47, DOI 10.1016/S0140-6736(02)09332-7; Oldfield WLG, 2001, J IMMUNOL, V167, P1734, DOI 10.4049/jimmunol.167.3.1734; Padavattan S, 2007, J MOL BIOL, V368, P742, DOI 10.1016/j.jmb.2007.02.036; Paul WE, 2010, NAT REV IMMUNOL, V10, P225, DOI 10.1038/nri2735; Pomes A, 2010, INT ARCH ALLERGY IMM, V152, P1, DOI 10.1159/000260078; Rapin N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009862; Razzera G, 2010, STRUCTURE, V18, P1011, DOI 10.1016/j.str.2010.05.012; Reisinger J, 2005, J ALLERGY CLIN IMMUN, V116, P347, DOI 10.1016/j.jaci.2005.04.003; Robotham JM, 2002, J ALLERGY CLIN IMMUN, V109, P143, DOI 10.1067/mai.2002.120558; Saarne T, 2011, ALLERGY, V66, P255, DOI 10.1111/j.1398-9995.2010.02468.x; Salimi N, 2010, IMMUNOGENETICS, V62, P185, DOI 10.1007/s00251-010-0435-2; Satoh R, 2010, INT ARCH ALLERGY IMM, V153, P133, DOI 10.1159/000312630; Sharma V, 2011, AM J RESP CELL MOL B; Sharma V, 2009, J PROTEOME RES, V8, P2650, DOI 10.1021/pr800784q; Shen HD, 1997, CLIN EXP ALLERGY, V27, P79; Shreffler WG, 2005, J ALLERGY CLIN IMMUN, V116, P893, DOI 10.1016/j.jaci.2005.06.033; Sokol CL, 2008, NAT IMMUNOL, V9, P310, DOI 10.1038/ni1558; Su NY, 1999, EUR J BIOCHEM, V261, P115, DOI 10.1046/j.1432-1327.1999.00242.x; Trevino MA, 2008, PROTEIN SCI, V17, P371, DOI 10.1110/ps.073230008; von Garnier C, 2000, EUR J IMMUNOL, V30, P1638, DOI 10.1002/1521-4141(200006)30:6<1638::AID-IMMU1638>3.0.CO;2-R; Vrtala S, 2000, J IMMUNOL, V165, P6653, DOI 10.4049/jimmunol.165.11.6653; Vrtala S, 1998, J IMMUNOL, V160, P6137; Vrtala S, 2011, VACCINE, V29, P2140, DOI 10.1016/j.vaccine.2010.12.080; Wachholz PA, 2004, CURR OPIN ALLERGY CL, V4, P313, DOI 10.1097/01.all.0000136753.35948.c0; Wiedermann U, 2001, INT ARCH ALLERGY IMM, V126, P68, DOI 10.1159/000049496; Yang XD, 2009, REV MED VIROL, V19, P77, DOI 10.1002/rmv.602; Yu CJ, 2002, BIOCHEM J, V363, P707, DOI 10.1042/bj3630707	68	11	11	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2012	7	4							e34627	10.1371/journal.pone.0034627	http://dx.doi.org/10.1371/journal.pone.0034627			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959FE	22506037	gold, Green Published, Green Submitted			2022-12-27	WOS:000305297500045
J	Gualdron-Lopez, M; Vapola, MH; Miinalainen, IJ; Hiltunen, JK; Michels, PAM; Antonenkov, VD				Gualdron-Lopez, Melisa; Vapola, Miia H.; Miinalainen, Ilkka J.; Hiltunen, J. Kalervo; Michels, Paul A. M.; Antonenkov, Vasily D.			Channel-Forming Activities in the Glycosomal Fraction from the Bloodstream Form of Trypanosoma brucei	PLOS ONE			English	Article							MAMMALIAN PEROXISOMAL MEMBRANE; SACCHAROMYCES-CEREVISIAE; IN-VITRO; GLYCOLYSIS; COMPARTMENTATION; ENZYMES; REVEALS; PROTEIN; LOCALIZATION; PURIFICATION	Background: Glycosomes are a specialized form of peroxisomes (microbodies) present in unicellular eukaryotes that belong to the Kinetoplastea order, such as Trypanosoma and Leishmania species, parasitic protists causing severe diseases of livestock and humans in subtropical and tropical countries. The organelles harbour most enzymes of the glycolytic pathway that is responsible for substrate-level ATP production in the cell. Glycolysis is essential for bloodstream-form Trypanosoma brucei and enzymes comprising this pathway have been validated as drug targets. Glycosomes are surrounded by a single membrane. How glycolytic metabolites are transported across the glycosomal membrane is unclear. Methods/Principal Findings: We hypothesized that glycosomal membrane, similarly to membranes of yeast and mammalian peroxisomes, contains channel-forming proteins involved in the selective transfer of metabolites. To verify this prediction, we isolated a glycosomal fraction from bloodstream-form T. brucei and reconstituted solubilized membrane proteins into planar lipid bilayers. The electrophysiological characteristics of the channels were studied using multiple channel recording and single channel analysis. Three main channel-forming activities were detected with current amplitudes 70-80 pA, 20-25 pA, and 8-11 pA, respectively (holding potential +10 mV and 3.0 M KCl as an electrolyte). All channels were in fully open state in a range of voltages +/- 150 mV and showed no sub-conductance transitions. The channel with current amplitude 20-25 pA is anion-selective (PK+/PCl-similar to 0.31), while the other two types of channels are slightly selective for cations (PK+/PCl- ratios similar to 1.15 and similar to 1.27 for the high-and low-conductance channels, respectively). The anion-selective channel showed an intrinsic current rectification that may suggest a functional asymmetry of the channel's pore. Conclusions/Significance: These results indicate that the membrane of glycosomes apparently contains several types of pore-forming channels connecting the glycosomal lumen and the cytosol.	[Gualdron-Lopez, Melisa; Michels, Paul A. M.] Catholic Univ Louvain, Trop Dis Res Unit, Duve Inst, B-1200 Brussels, Belgium; [Vapola, Miia H.; Hiltunen, J. Kalervo; Antonenkov, Vasily D.] Univ Oulu, Dept Biochem, Bioctr Oulu, Oulu, Finland; [Miinalainen, Ilkka J.] Univ Oulu, Dept Pathol, Oulu, Finland	Universite Catholique Louvain; Finland National Institute for Health & Welfare; University of Oulu; University of Oulu	Gualdron-Lopez, M (corresponding author), Catholic Univ Louvain, Trop Dis Res Unit, Duve Inst, B-1200 Brussels, Belgium.	paul.michels@uclouvain.be; vasily.antonenkov@oulu.fi	Michels, Paul A/A-5637-2009; Gualdrón-López, Melisa/A-4438-2016	Michels, Paul A/0000-0003-3726-6104; Gualdrón-López, Melisa/0000-0002-8202-6751; Miinalainen, Ilkka/0000-0002-3922-3442; Hiltunen, Kalervo/0000-0002-3073-9602; Salo, Miia/0000-0003-2085-7880	Academy of Finland; Sigrid Juselius Foundation (Finland); 'Fonds pour la formation a la Recherche dans l'Industrie et dans l'Agriculture' (FRIA); PAMM the 'Fonds de la Recherche Scientifique'; Belgian Interuniversity Attraction Poles-Federal Office for Scientific, Technical and Cultural Affairs	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation (Finland)(Sigrid Juselius Foundation); 'Fonds pour la formation a la Recherche dans l'Industrie et dans l'Agriculture' (FRIA)(Fonds de la Recherche Scientifique - FNRS); PAMM the 'Fonds de la Recherche Scientifique'; Belgian Interuniversity Attraction Poles-Federal Office for Scientific, Technical and Cultural Affairs	This work was supported by the Academy of Finland, and Sigrid Juselius Foundation (Finland). MGL acknowledges a PhD scholarship from the 'Fonds pour la formation a la Recherche dans l'Industrie et dans l'Agriculture' (FRIA) and PAMM the 'Fonds de la Recherche Scientifique' and the Belgian Interuniversity Attraction Poles-Federal Office for Scientific, Technical and Cultural Affairs for financial support of the research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonenkov VD, 2012, BBA-MOL BASIS DIS, V1822, P1374, DOI 10.1016/j.bbadis.2011.12.011; Antonenkov VD, 2010, ANTIOXID REDOX SIGN, V13, P525, DOI 10.1089/ars.2009.2996; Antonenkov VD, 2009, INT J BIOCHEM CELL B, V41, P2546, DOI 10.1016/j.biocel.2009.08.014; Antonenkov VD, 2005, CELL MOL LIFE SCI, V62, P2886, DOI 10.1007/s00018-005-5233-x; Antonenkov VD, 2004, J CELL SCI, V117, P5633, DOI 10.1242/jcs.01485; Antonenkov VD, 2004, AM J PHYSIOL-CELL PH, V287, pC1623, DOI 10.1152/ajpcell.00142.2004; Bakker BM, 2010, PARASITOLOGY, V137, P1333, DOI 10.1017/S0031182010000466; Bakker BM, 1997, J BIOL CHEM, V272, P3207, DOI 10.1074/jbc.272.6.3207; CHEN DP, 1993, BIOPHYS J, V64, P1405, DOI 10.1016/S0006-3495(93)81507-8; Colasante C, 2006, EUKARYOT CELL, V5, P1194, DOI 10.1128/EC.00096-06; Colasante C, 2006, PROTEOMICS, V6, P3275, DOI 10.1002/pmic.200500668; Colasante C, 2009, MOL BIOCHEM PARASIT, V167, P104, DOI 10.1016/j.molbiopara.2009.05.004; Furuya T, 2002, P NATL ACAD SCI USA, V99, P14177, DOI 10.1073/pnas.222454899; Ginger ML, 2010, PHILOS T R SOC B, V365, P831, DOI 10.1098/rstb.2009.0259; Grunau S, 2009, FEBS J, V276, P1698, DOI 10.1111/j.1742-4658.2009.06903.x; Gualdron-Lopez M, 2012, INT J PARASITOL, V42, P1, DOI 10.1016/j.ijpara.2011.10.007; Guerra-Giraidez C, 2002, J CELL SCI, V115, P2651; Haanstra JR, 2008, P NATL ACAD SCI USA, V105, P17718, DOI 10.1073/pnas.0806664105; Heiber T, 1995, BIOCHEMISTRY-US, V34, P15906, DOI 10.1021/bi00049a005; Hemmler R, 2006, J BIOL CHEM, V281, P12020, DOI 10.1074/jbc.M513586200; Hille B., 1992, IONIC CHANNELS EXCIT; Jones DC, 2005, J BIOL CHEM, V280, P35929, DOI 10.1074/jbc.M509130200; Kessler PS, 2005, J BIOL CHEM, V280, P9030, DOI 10.1074/jbc.M412033200; Kunkele KP, 1998, CELL, V93, P1009, DOI 10.1016/S0092-8674(00)81206-4; LANHAM SM, 1970, EXP PARASITOL, V28, P521, DOI 10.1016/0014-4894(70)90120-7; Lemercier G, 2002, J BIOL CHEM, V277, P37369, DOI 10.1074/jbc.M204744200; Maric D, 2010, CURR OPIN MICROBIOL, V13, P466, DOI 10.1016/j.mib.2010.06.001; Meinecke M, 2010, NAT CELL BIOL, V12, P273, DOI 10.1038/ncb2027; Michels PAM, 2006, BBA-MOL CELL RES, V1763, P1463, DOI 10.1016/j.bbamcr.2006.08.019; OPPERDOES FR, 1977, EUR J BIOCHEM, V76, P21, DOI 10.1111/j.1432-1033.1977.tb11566.x; OPPERDOES FR, 1977, EUR J BIOCHEM, V76, P29, DOI 10.1111/j.1432-1033.1977.tb11567.x; Opperdoes FR, 2006, MOL BIOCHEM PARASIT, V147, P193, DOI 10.1016/j.molbiopara.2006.02.010; Pabon MA, 2007, PARASITOL RES, V100, P803, DOI 10.1007/s00436-006-0351-4; Porcelli AM, 2005, BIOCHEM BIOPH RES CO, V326, P799, DOI 10.1016/j.bbrc.2004.11.105; Price N., 2001, PRINCIPLES PROBLEMS; Reumann S, 1998, EUR J BIOCHEM, V251, P359, DOI 10.1046/j.1432-1327.1998.2510359.x; Rokka A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005090; Rottensteiner H, 2003, MOL BIOL CELL, V14, P4316, DOI 10.1091/mbc.E03-03-0153; Schirmer T, 1998, J STRUCT BIOL, V121, P101, DOI 10.1006/jsbi.1997.3946; STEIGER RF, 1980, EUR J BIOCHEM, V105, P163, DOI 10.1111/j.1432-1033.1980.tb04486.x; Thoms S, 2005, FEBS J, V272, P5169, DOI 10.1111/j.1742-4658.2005.04939.x; Ujwal R, 2008, P NATL ACAD SCI USA, V105, P17742, DOI 10.1073/pnas.0809634105; van Roermund CWT, 2000, J CELL BIOL, V150, P489, DOI 10.1083/jcb.150.3.489; Vandersall-Nairn AS, 1998, GLYCOBIOLOGY, V8, P1183, DOI 10.1093/glycob/8.12.1183; VanVeldhoven PP, 1996, ANAL BIOCHEM, V237, P17, DOI 10.1006/abio.1996.0194; VISSER N, 1981, EUR J BIOCHEM, V118, P521, DOI 10.1111/j.1432-1033.1981.tb05550.x; VISSER N, 1980, EUR J BIOCHEM, V103, P623, DOI 10.1111/j.1432-1033.1980.tb05988.x; Voncken F, 2003, J BIOL CHEM, V278, P35299, DOI 10.1074/jbc.M301811200	48	39	39	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2012	7	4							e34530	10.1371/journal.pone.0034530	http://dx.doi.org/10.1371/journal.pone.0034530			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959FE	22506025	Green Published, gold, Green Submitted			2022-12-27	WOS:000305297500033
J	Kulnigg-Dabsch, S; Evstatiev, R; Dejaco, C; Gasche, C				Kulnigg-Dabsch, Stefanie; Evstatiev, Rayko; Dejaco, Clemens; Gasche, Christoph			Effect of Iron Therapy on Platelet Counts in Patients with Inflammatory Bowel Disease-Associated Anemia	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; PORTAL-VEIN THROMBOSIS; ULCERATIVE-COLITIS; DEFICIENCY ANEMIA; INTRAVENOUS IRON; FERRIC CARBOXYMALTOSE; THROMBOEMBOLIC EVENTS; CROHNS-DISEASE; THROMBOCYTOSIS; ERYTHROPOIETIN	Background and Aims: Secondary thrombocytosis is a clinical feature of unknown significance. In inflammatory bowel disease (IBD), thrombocytosis is considered a marker of active disease; however, iron deficiency itself may trigger platelet generation. In this study we tested the effect of iron therapy on platelet counts in patients with IBD-associated anemia. Methods: Platelet counts were analyzed before and after iron therapy from four prospective clinical trials. Further, changes in hemoglobin, transferrin saturation, ferritin, C-reactive protein, and leukocyte counts, before and after iron therapy were compared. In a subgroup the effect of erythropoietin treatment was tested. The results were confirmed in a large independent cohort (FERGIcor). Results: A total of 308 patient records were available for the initial analysis. A dose-depended drop in platelet counts (mean 425 G/L to 320 G/L; p<0.001) was found regardless of the type of iron preparation (iron sulphate, iron sucrose, or ferric carboxymaltose). Concomitant erythropoietin therapy as well as parameters of inflammation (leukocyte counts, C-reactive protein) had no effect on the change in platelet counts. This effect of iron therapy on platelets was confirmed in the FERGIcor study cohort (n = 448, mean platelet counts before iron therapy: 383 G/L, after: 310 G/L, p<0.001). Conclusion: Iron therapy normalizes elevated platelet counts in patients with IBD-associated anemia. Thus, iron deficiency is an important pathogenetic mechanism of secondary thrombocytosis in IBD.	[Kulnigg-Dabsch, Stefanie; Evstatiev, Rayko; Dejaco, Clemens; Gasche, Christoph] Med Univ Vienna, Dept Med 3, Vienna, Austria; [Evstatiev, Rayko; Gasche, Christoph] Med Univ Vienna, Christian Doppler Lab Mol Carcinoma Chemoprevent, Vienna, Austria	Medical University of Vienna; Medical University of Vienna	Kulnigg-Dabsch, S (corresponding author), Med Univ Vienna, Dept Med 3, Vienna, Austria.	christoph.gasche@meduniwien.ac.at	Gasche, Christoph W/A-5139-2013	Gasche, Christoph/0000-0002-3752-6685; Evstatiev, Rayko/0000-0002-6597-6034	Austrian Science Fund [FWF P21200]; Austrian Science Fund (FWF) [P 21200] Funding Source: researchfish	Austrian Science Fund(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	CG is supported by the Austrian Science Fund (FWF P21200). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basak R, 2008, Mymensingh Med J, V17, P74; Beguin Y, 1999, HAEMATOLOGICA, V84, P541; Benedict SL, 2004, J CHILD NEUROL, V19, P526, DOI 10.1177/08830738040190070901; CAPRON JP, 1979, DIGEST DIS SCI, V24, P232, DOI 10.1007/BF01308436; Ceresa IF, 2007, PLATELETS, V18, P579, DOI 10.1080/09537100701593601; Chow DKL, 2009, ALIMENT PHARM THER, V29, P843, DOI 10.1111/j.1365-2036.2009.03944.x; Danese S, 2004, GUT, V53, P1035, DOI 10.1136/gut.2003.026278; Danese S, 2004, AM J GASTROENTEROL, V99, P938, DOI 10.1111/j.1572-0241.2004.04129.x; Elalamy I., 2008, EUR REV MED PHARMACO, V121, P843; Evstatiev R, 2011, GASTROENTEROLOGY, V141, P846, DOI 10.1053/j.gastro.2011.06.005; Franchini M, 2008, ANN HEMATOL, V87, P167, DOI 10.1007/s00277-007-0416-1; Gasche C, 1997, ANN INTERN MED, V126, P782, DOI 10.7326/0003-4819-126-10-199705150-00006; Gasche C, 2004, GUT, V53, P1190, DOI 10.1136/gut.2003.035758; Gasche C, 2011, Z Gastroenterol, V49, P627, DOI 10.1055/s-0031-1273324; Gasche C, 2001, AM J GASTROENTEROL, V96, P2382; Gasche C, 1999, DIGESTION, V60, P262, DOI 10.1159/000007667; Gasche C, 2000, INFLAMM BOWEL DIS, V6, P142, DOI 10.1097/00054725-200005000-00013; Gasche C, 2007, INFLAMM BOWEL DIS, V13, P1545, DOI 10.1002/ibd.20285; Gomollon F, 2009, WORLD J GASTROENTERO, V15, P4659, DOI 10.3748/wjg.15.4659; HARRIES AD, 1983, BRIT MED J, V286, P1476, DOI 10.1136/bmj.286.6376.1476; Heits F, 1999, J INTERF CYTOK RES, V19, P757, DOI 10.1089/107999099313604; HOLMQUIST L, 1989, J PEDIATR GASTR NUTR, V9, P187, DOI 10.1097/00005176-198908000-00010; Houissa F, 2011, J CROHNS COLITIS, V5, P249, DOI 10.1016/j.crohns.2010.12.010; Rios JWH, 2009, REV ESP ENFERM DIG, V101, P163, DOI 10.4321/s1130-01082009000300002; Huang Pai-Hao, 2010, Acta Neurol Taiwan, V19, P125; Junge U, 2001, Z GASTROENTEROL, V39, P845, DOI 10.1055/s-2001-17864; Keung YK, 2004, CLIN APPL THROMB-HEM, V10, P387, DOI 10.1177/107602960401000412; Kinoshita Y, 2006, NEUROL MED-CHIR, V46, P589, DOI 10.2176/nmc.46.589; Kulnigg S, 2006, ALIMENT PHARM THER, V24, P1507, DOI 10.1111/j.1365-2036.2006.03146.x; Kulnigg S, 2008, AM J GASTROENTEROL, V103, P1182, DOI 10.1111/j.1572-0241.2007.01744.x; Larsen TB, 2002, PATHOPHYSIOL HAEMO T, V32, P92, DOI 10.1159/000065082; Lian L, 2009, DIS COLON RECTUM, V52, P1912, DOI 10.1007/DCR.0b013e3181b300f4; Linden MD, 2010, INT J BIOCH CELL BIO; Loo M, 1999, BLOOD, V93, P3286, DOI 10.1182/blood.V93.10.3286.410k29_3286_3293; McMorran BJ, 2009, SCIENCE, V323, P797, DOI 10.1126/science.1166296; Mijnhout GS, 2004, DIGEST LIVER DIS, V36, P296, DOI 10.1016/j.dld.2003.10.018; MUSIO F, 1993, AM J MED SCI, V305, P28, DOI 10.1097/00000441-199301000-00006; Okon A, 2005, AM SURGEON, V71, P821; Papa A, 2003, HEPATO-GASTROENTEROL, V50, P132; Richardson FL, 1904, J MED RES, V13, P99; Schafer AI, 2001, BLOOD REV, V15, P159, DOI 10.1054/blre.2001.0162; SCHNEIDERMAN JH, 1979, ANN NEUROL, V5, P331, DOI 10.1002/ana.410050405; Sethy Pradeepta Kumar, 2003, Indian J Gastroenterol, V22, P176; Simanek R, 2010, J THROMB HAEMOST, V8, P114, DOI 10.1111/j.1538-7836.2009.03680.x; Standridge S, 2008, J CHILD NEUROL, V23, P59, DOI 10.1177/0883073807308706; Stein J, 2010, NAT REV GASTRO HEPAT, V7, P599, DOI 10.1038/nrgastro.2010.151; Streja E, 2008, AM J KIDNEY DIS, V52, P727, DOI 10.1053/j.ajkd.2008.05.029; Thachil J, 2008, INTERNAL MED, V47, P1255, DOI 10.2169/internalmedicine.47.0875; Vaziri ND, 2009, AM J KIDNEY DIS, V53, P733, DOI 10.1053/j.ajkd.2008.12.030	49	44	46	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2012	7	4							e34520	10.1371/journal.pone.0034520	http://dx.doi.org/10.1371/journal.pone.0034520			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959FE	22506024	Green Submitted, Green Published, gold			2022-12-27	WOS:000305297500032
J	Liew, WC; Bartfai, R; Lim, ZJ; Sreenivasan, R; Siegfried, KR; Orban, L				Liew, Woei Chang; Bartfai, Richard; Lim, Zijie; Sreenivasan, Rajini; Siegfried, Kellee R.; Orban, Laszlo			Polygenic Sex Determination System in Zebrafish	PLOS ONE			English	Article							COPY NUMBER VARIATION; AMPLIFIED POLYMORPHIC DNA; COMPARATIVE GENOMIC HYBRIDIZATION; REARING TEMPERATURES; DANIO-RERIO; ROSY BARB; CHROMOSOMES; FISH; DIFFERENTIATION; MODEL	Background: Despite the popularity of zebrafish as a research model, its sex determination (SD) mechanism is still unknown. Most cytogenetic studies failed to find dimorphic sex chromosomes and no primary sex determining switch has been identified even though the assembly of zebrafish genome sequence is near to completion and a high resolution genetic map is available. Recent publications suggest that environmental factors within the natural range have minimal impact on sex ratios of zebrafish populations. The primary aim of this study is to find out more about how sex is determined in zebrafish. Methodology/Principal Findings: Using classical breeding experiments, we found that sex ratios across families were wide ranging (4.8% to 97.3% males). On the other hand, repeated single pair crossings produced broods of very similar sex ratios, indicating that parental genotypes have a role in the sex ratio of the offspring. Variation among family sex ratios was reduced after selection for breeding pairs with predominantly male or female offspring, another indication that zebrafish sex is regulated genetically. Further examinations by a PCR-based "blind assay" and array comparative genomic hybridization both failed to find universal sex-linked differences between the male and female genomes. Together with the ability to increase the sex bias of lines by selective breeding, these data suggest that zebrafish is unlikely to utilize a chromosomal sex determination (CSD) system. Conclusions/Significance: Taken together, our study suggests that zebrafish sex is genetically determined with limited, secondary influences from the environment. As we have not found any sign for CSD in the species, we propose that the zebrafish has a polygenic sex determination system.	[Liew, Woei Chang; Bartfai, Richard; Lim, Zijie; Sreenivasan, Rajini; Orban, Laszlo] Temasek Life Sci Lab, Reprod Genom Grp, Singapore, Singapore; [Liew, Woei Chang] Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore; [Bartfai, Richard; Lim, Zijie; Orban, Laszlo] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Siegfried, Kellee R.] Max Planck Inst Entwicklungsbiol, Dept Genet, D-72076 Tubingen, Germany; [Orban, Laszlo] Univ Pannonia, Dept Anim Sci & Anim Husb, Keszthely, Hungary	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National University of Singapore; Max Planck Society; University of Pannonia	Liew, WC (corresponding author), Temasek Life Sci Lab, Reprod Genom Grp, Singapore, Singapore.	laszlo@tll.org.sg	Orbán, László/A-3030-2009; Sreenivasan, Rajini/G-6930-2019; Bartfai, Richard/E-2083-2012	Orbán, László/0000-0001-5435-5948; Sreenivasan, Rajini/0000-0002-6357-5392; Bartfai, Richard/0000-0002-8460-6477; Siegfried, Kellee/0000-0002-7951-392X; Lim, ZiJie/0000-0002-3700-7586; Liew, Woei Chang/0000-0001-9354-1647	Ministry of National Development, Agri-Food and Veterinary Authority of Singapore; Temasek Life Sciences Laboratory; Human Frontiers in Science Program post doctoral fellowship; Max Planck Society	Ministry of National Development, Agri-Food and Veterinary Authority of Singapore(Ministry of National Development, Singapore); Temasek Life Sciences Laboratory(National University of Singapore); Human Frontiers in Science Program post doctoral fellowship; Max Planck Society(Max Planck SocietyFoundation CELLEX)	This study was supported by the Ministry of National Development, Agri-Food and Veterinary Authority of Singapore, and internal research funds from Temasek Life Sciences Laboratory. KRS was supported by a Human Frontiers in Science Program post doctoral fellowship and the Max Planck Society during the course of this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abozaid H, 2011, SEX DEV, V5, P259, DOI 10.1159/000330120; Albertson D, 1997, MOL BIOL CELL, V8, P736; Albertson DG, 2000, NAT GENET, V25, P144, DOI 10.1038/75985; Amores A, 1999, METHOD CELL BIOL, V60, P323; Arnold AP, 2012, TRENDS GENET, V28, P55, DOI 10.1016/j.tig.2011.10.004; Baroiller JF, 2009, COMP BIOCHEM PHYS A, V153, P30, DOI 10.1016/j.cbpa.2008.11.018; Baroiller JF, 2001, COMP BIOCHEM PHYS C, V130, P399, DOI 10.1016/S1532-0456(01)00267-8; Baron B, 2002, AQUAC RES, V33, P615, DOI 10.1046/j.1365-2109.2002.00699.x; Bello N, 1999, MOL ECOL, V8, P667, DOI 10.1046/j.1365-294x.1999.00549.x; Bradley KM, 2011, G3-GENES GENOM GENET, V1, P3, DOI 10.1534/g3.111.000190; Brown KH, 2012, P NATL ACAD SCI USA, V109, P529, DOI 10.1073/pnas.1112163109; BULMER MG, 1982, EVOLUTION, V36, P13, DOI 10.1111/j.1558-5646.1982.tb05005.x; Chang A, 2007, ELECTROPHORESIS, V28, P525, DOI 10.1002/elps.200600715; Charlesworth B, 2002, EVOLUTION CHROMOSOMA, P207; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; Daga RR, 1996, CHROMOSOME RES, V4, P29, DOI 10.1007/BF02254941; DeFalco T, 2009, ANNU REV CELL DEV BI, V25, P457, DOI 10.1146/annurev.cellbio.042308.13350; Devlin RH, 2002, AQUACULTURE, V208, P191, DOI 10.1016/S0044-8486(02)00057-1; Eimon PM, 2010, APOPTOSIS, V15, P331, DOI 10.1007/s10495-009-0432-9; ENDO A, 1968, J HERED, V59, P382, DOI 10.1093/oxfordjournals.jhered.a107755; Engeszer RE, 2007, ZEBRAFISH, V4, P21, DOI 10.1089/zeb.2006.9997; EWERT MA, 1991, COPEIA, P50, DOI 10.2307/1446248; Ezaz MT, 2004, MAR BIOTECHNOL, V6, P435, DOI 10.1007/s10126-004-3004-6; FERGUSON MWJ, 1982, NATURE, V296, P850, DOI 10.1038/296850a0; FONTANA F, 1970, CARYOLOGIA, V23, P549, DOI 10.1080/00087114.1970.10796394; FRANCO MG, 1982, GENET RES, V40, P279, DOI 10.1017/S0016672300019157; Godwin J, 2009, SEMIN CELL DEV BIOL, V20, P264, DOI 10.1016/j.semcdb.2008.12.003; Goidts V, 2006, HUM GENET, V119, P185, DOI 10.1007/s00439-005-0130-9; Gornung E, 1997, CHROMOSOME RES, V5, P40, DOI 10.1023/A:1018441402370; Graves JAM, 2006, CELL, V124, P901, DOI 10.1016/j.cell.2006.02.024; Graves JAM, 1995, PHILOS T R SOC B, V350, P305, DOI 10.1098/rstb.1995.0166; Grunwald DJ, 2002, NAT REV GENET, V3, P717, DOI 10.1038/nrg892; HARVEY PH, 1982, NATURE, V296, P807, DOI 10.1038/296807a0; Henrichsen CN, 2009, NAT GENET, V41, P424, DOI 10.1038/ng.345; Hoebeeck Jasmien, 2007, Methods Mol Biol, V353, P205; Hortopan GA, 2010, DIS MODEL MECH, V3, P144, DOI 10.1242/dmm.002139; Iturra P, 1997, GENETICA, V101, P209, DOI 10.1023/A:1018371623919; Kim HY, 2010, BMB REP, V43, P547, DOI 10.5483/BMBRep.2010.43.8.547; Kirankumar S, 2004, J EXP ZOOL PART A, V301A, P938, DOI 10.1002/jez.a.117; Kirankumar S, 2003, GEN COMP ENDOCR, V134, P62, DOI 10.1016/S0016-6480(03)00218-1; KOSSWIG C, 1964, EXPERIENTIA, V20, P190, DOI 10.1007/BF02135395; Kovacs B, 2000, GENETICA, V110, P267, DOI 10.1023/A:1012739318941; Krueger WH, 1999, ENVIRON BIOL FISH, V55, P381, DOI 10.1023/A:1007575600789; Lawrence C, 2008, ENVIRON BIOL FISH, V81, P239, DOI 10.1007/s10641-007-9195-8; Lee AS, 2008, HUM MOL GENET, V17, P1127, DOI 10.1093/hmg/ddn002; Lessells CM, 1998, MOL ECOL, V7, P187, DOI 10.1046/j.1365-294x.1998.00331.x; Li CH, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-44; Magerhans A, 2009, AQUACULTURE, V294, P25, DOI 10.1016/j.aquaculture.2009.05.001; Manolakou P, 2006, REPROD BIOL ENDOCRIN, V4, DOI 10.1186/1477-7827-4-59; Matsuda M, 2002, NATURE, V417, P559, DOI 10.1038/nature751; MICHELMORE RW, 1991, P NATL ACAD SCI USA, V88, P9828, DOI 10.1073/pnas.88.21.9828; Mione MC, 2010, DIS MODEL MECH, V3, P517, DOI 10.1242/dmm.004747; Modi WS, 2005, CURR OPIN GENET DEV, V15, P660, DOI 10.1016/j.gde.2005.09.009; Morrish BC, 2002, REPRODUCTION, V124, P447, DOI 10.1530/rep.0.1240447; NANDA I, 1990, J MOL EVOL, V30, P456, DOI 10.1007/BF02101117; Norton W, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-90; Orban L, 2009, MOL CELL ENDOCRINOL, V312, P35, DOI 10.1016/j.mce.2009.04.014; Ospina-Alvarez N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002837; Parichy DM, 2009, DEV DYNAM, V238, P2975, DOI 10.1002/dvdy.22113; Pelegri F, 1998, METHOD CELL BIOL, P1; Phillips RB, 2000, CHROMOSOME RES, V8, P27, DOI 10.1023/A:1009271017998; Pieau C, 1999, CELL MOL LIFE SCI, V55, P887, DOI 10.1007/s000180050342; PIJNACKER LP, 1995, GENOME, V38, P1052, DOI 10.1139/g95-140; Pinkel D, 1998, NAT GENET, V20, P207, DOI 10.1038/2524; POST ALFRED, 1965, Z ZOOL SYST EVOLUTIONS FORSCH, V3, P47; Quinn AE, 2009, MOL GENET GENOMICS, V281, P665, DOI 10.1007/s00438-009-0437-7; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; RISHI KK, 1976, NUCLEUS, V19, P95; Rozen S, 2000, Methods Mol Biol, V132, P365; Russell D. W., 2006, COLD SPRING HARB PRO; SCHREEB KH, 1993, J EXP ANIM SCI, V36, P27; Ser JR, 2010, EVOLUTION, V64, P486, DOI 10.1111/j.1558-5646.2009.00871.x; Shang EHH, 2007, COMP BIOCHEM PHYS A, V148, pS118, DOI 10.1016/j.cbpa.2007.06.294; Shang EHH, 2006, ENVIRON SCI TECHNOL, V40, P3118, DOI 10.1021/es0522579; Sharma K. K., 1998, Proceedings of the National Academy of Sciences India Section B (Biological Sciences), V68, P123; Siegfried KR, 2010, J FISH BIOL, V76, P1879, DOI 10.1111/j.1095-8649.2010.02594.x; Sola L, 2001, GENETICA, V111, P397, DOI 10.1023/A:1013776323077; Spence R, 2008, BIOL REV, V83, P13, DOI 10.1111/j.1469-185X.2007.00030.x; Tessema M, 2006, AQUACULTURE, V258, P270, DOI 10.1016/j.aquaculture.2006.04.041; Tong SK, 2010, DEV BIOL, V344, P849, DOI 10.1016/j.ydbio.2010.05.515; Traut W, 2001, CHROMOSOME RES, V9, P659, DOI 10.1023/A:1012956324417; Uchida D, 2004, COMP BIOCHEM PHYS A, V137, P11, DOI 10.1016/S1095-6433(03)00178-8; Ueda T, 1999, GENOME, V42, P531, DOI 10.1139/gen-42-3-531; Vandeputte M, 2007, GENETICS, V176, P1049, DOI 10.1534/genetics.107.072140; von Hofsten J, 2005, REPROD BIOL ENDOCRIN, V3, DOI 10.1186/1477-7827-3-63; Voordouw MJ, 2002, EVOLUTION, V56, P1754; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Wallace BMN, 2003, HEREDITY, V90, P136, DOI 10.1038/sj.hdy.6800184; Wellcome Trust Sanger Institute, 2008, ZV8 8 INT WHOL GEN A; WELSH J, 1990, NUCLEIC ACIDS RES, V18, P7213, DOI 10.1093/nar/18.24.7213; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE, P11; Wilhelm D, 2007, PHYSIOL REV, V87, P1, DOI 10.1152/physrev.00009.2006; WILLIAMS JGK, 1990, NUCLEIC ACIDS RES, V18, P6531, DOI 10.1093/nar/18.22.6531; Wilson MA, 2009, ANNU REV GENOM HUM G, V10, P333, DOI 10.1146/annurev-genom-082908-150105	94	159	167	4	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2012	7	4							e34397	10.1371/journal.pone.0034397	http://dx.doi.org/10.1371/journal.pone.0034397			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959FE	22506019	Green Published, Green Accepted, gold			2022-12-27	WOS:000305297500027
J	Trager, U; Sierro, S; Djordjevic, G; Bouzo, B; Khandwala, S; Meloni, A; Mortensen, M; Simon, AK				Traeger, Ulrike; Sierro, Sophie; Djordjevic, Gordana; Bouzo, Basma; Khandwala, Shivani; Meloni, Antonella; Mortensen, Monika; Simon, Anna Katharina			The Immune Response to Melanoma Is Limited by Thymic Selection of Self-Antigens	PLOS ONE			English	Article							AIRE-DEFICIENT MICE; CANDIDIASIS-ECTODERMAL DYSTROPHY; PROMISCUOUS GENE-EXPRESSION; PERIPHERAL TISSUE ANTIGENS; SYNDROME TYPE-I; T-CELLS; ESTABLISHED MELANOMA; EPITHELIAL-CELLS; TUMOR-IMMUNITY; AUTOIMMUNITY	The expression of melanoma-associated antigens (MAA) being limited to normal melanocytes and melanomas, MAAs are ideal targets for immunotherapy and melanoma vaccines. As MAAs are derived from self, immune responses to these may be limited by thymic tolerance. The extent to which self-tolerance prevents efficient immune responses to MAAs remains unknown. The autoimmune regulator (AIRE) controls the expression of tissue-specific self-antigens in thymic epithelial cells (TECs). The level of antigens expressed in the TECs determines the fate of auto-reactive thymocytes. Deficiency in AIRE leads in both humans (APECED patients) and mice to enlarged autoreactive immune repertoires. Here we show increased IgG levels to melanoma cells in APECED patients correlating with autoimmune skin features. Similarly, the enlarged T cell repertoire in AIRE(-/-) mice enables them to mount anti-MAA and anti-melanoma responses as shown by increased anti-melanoma antibodies, and enhanced CD4(+) and MAA-specific CD8(+) T cell responses after melanoma challenge. We show that thymic expression of gp100 is under the control of AIRE, leading to increased gp 100-specific CD8(+) T cell frequencies in AIRE(-/-) mice. TRP-2 (tyrosinase-related protein), on the other hand, is absent from TECs and consequently TRP-2 specific CD8(+) T cells were found in both AIRE(-/-) and AIRE(+/+) mice. This study emphasizes the importance of investigating thymic expression of self-antigens prior to their inclusion in vaccination and immunotherapy strategies.	[Traeger, Ulrike; Djordjevic, Gordana; Bouzo, Basma; Khandwala, Shivani; Mortensen, Monika; Simon, Anna Katharina] Univ Oxford, MRC, Immunol Unit, Weatherall Inst Mol Med,Nuffield Dept Med, Oxford, England; [Traeger, Ulrike; Djordjevic, Gordana; Bouzo, Basma; Khandwala, Shivani; Mortensen, Monika; Simon, Anna Katharina] NIHR Biomed Ctr, Oxford, England; [Sierro, Sophie] Ludwig Inst Canc Res, CH-1066 Epalinges, Switzerland; [Meloni, Antonella] Univ Cagliari, Pediat Clin 2, Osped Microcitem, Cagliari, Italy; [Meloni, Antonella] Univ Cagliari, Dept Biomed & Biotechnol Sci, Cagliari, Italy; [Mortensen, Monika] Danish Canc Soc, Apoptosis Dept, Copenhagen, Denmark; [Mortensen, Monika] Danish Canc Soc, Ctr Genotox Stress Res, Inst Canc Biol, Copenhagen, Denmark	University of Oxford; Ludwig Institute for Cancer Research; University of Cagliari; University of Cagliari; Danish Cancer Society; Danish Cancer Society	Trager, U (corresponding author), Univ Oxford, MRC, Immunol Unit, Weatherall Inst Mol Med,Nuffield Dept Med, Oxford, England.	katja.simon@ndm.ox.ac.uk		Trager, Ulrike/0000-0002-4493-1136; Simon, Anna Katharina/0000-0002-4077-7995	Association for International Cancer Research [05-134]; Medical Research Council; Andrew McMichael fund; Biotechnology and Biological Research Council; National Institute for Health Research	Association for International Cancer Research; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Andrew McMichael fund; Biotechnology and Biological Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); National Institute for Health Research(National Institute for Health Research (NIHR))	This study was supported by the Association for International Cancer Research (http://www.aicr.org.uk/), ref 05-134, Human Immunology Unit funded by the Medical Research Council, the Andrew McMichael fund, the Biotechnology and Biological Research Council, and the Biomedical Research Centre Oxford funded by the National Institute for Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad JD, 2008, J IMMUNOTHER, V31, P1, DOI 10.1097/CJI.0b013e31815c193f; Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; Bockle BC, 2010, J AM ACAD DERMATOL, V62, P864, DOI 10.1016/j.jaad.2009.06.061; Castelli C, 2000, J CELL PHYSIOL, V182, P323, DOI 10.1002/(SICI)1097-4652(200003)182:3<323::AID-JCP2>3.0.CO;2-#; Conteduca G, CLIN IMMUNOL; Derbinski J, 2005, J EXP MED, V202, P33, DOI 10.1084/jem.20050471; Derbinski J, 2001, NAT IMMUNOL, V2, P1032, DOI 10.1038/ni723; DeVoss J, 2006, J EXP MED, V203, P2727, DOI 10.1084/jem.20061864; Gallimore AM, 2008, ONCOGENE, V27, P5886, DOI 10.1038/onc.2008.269; Gavanescu I, 2008, P NATL ACAD SCI USA, V105, P13009, DOI 10.1073/pnas.0806874105; Gavanescu I, 2007, P NATL ACAD SCI USA, V104, P4583, DOI 10.1073/pnas.0700259104; Hassler S, 2006, BLOOD, V108, P1941, DOI 10.1182/blood-2006-04-019679; Hedstrand H, 1999, J INVEST DERMATOL, V113, P1054, DOI 10.1046/j.1523-1747.1999.00778.x; Jiang WY, 2005, J EXP MED, V202, P805, DOI 10.1084/jem.20050693; Jones Emma, 2002, Cancer Immun, V2, P1; Maddison P, 1999, LANCET, V353, P117, DOI 10.1016/S0140-6736(05)76153-5; Mathis D, 2009, ANNU REV IMMUNOL, V27, P287, DOI 10.1146/annurev.immunol.25.022106.141532; Miller AJ, 2006, NEW ENGL J MED, V355, P51, DOI 10.1056/NEJMra052166; Muranski P, 2008, BLOOD, V112, P362, DOI 10.1182/blood-2007-11-120998; Niki S, 2006, J CLIN INVEST, V116, P1292, DOI 10.1172/JCI26971; Overwijk WW, 2000, CRIT REV IMMUNOL, V20, P433; Perheentupa J, 2006, J CLIN ENDOCR METAB, V91, P2843, DOI 10.1210/jc.2005-2611; Peterson P, 2008, NAT REV IMMUNOL, V8, P948, DOI 10.1038/nri2450; Pittet MJ, 2002, TRENDS IMMUNOL, V23, P325, DOI 10.1016/S1471-4906(02)02244-5; Quezada SA, 2008, J EXP MED, V205, P2125, DOI 10.1084/jem.20080099; Ramsey C, 2002, HUM MOL GENET, V11, P397, DOI 10.1093/hmg/11.4.397; Rosatelli MC, 1998, HUM GENET, V103, P428, DOI 10.1007/s004390050846; Salio M, 2003, EUR J IMMUNOL, V33, P1052, DOI 10.1002/eji.200323676; Schreiber TH, 2009, BRIT J CANCER, V101, P381, DOI 10.1038/sj.bjc.6605198; Sierro SR, 2011, EUR J IMMUNOL, V41, P2217, DOI 10.1002/eji.201041235; Simon AK, 2002, CANCER CELL, V2, P315, DOI 10.1016/S1535-6108(02)00151-4; Singh V, 2009, J IMMUNOTHER, V32, P129, DOI 10.1097/CJI.0b013e31819144d7; Takase H, 2005, INT IMMUNOL, V17, P1131, DOI 10.1093/intimm/dxh275; Venanzi ES, 2008, P NATL ACAD SCI USA, V105, P15860, DOI 10.1073/pnas.0808070105; Yee C, 2000, J EXP MED, V192, P1637, DOI 10.1084/jem.192.11.1637; Yip LD, 2009, NAT IMMUNOL, V10, P1026, DOI 10.1038/ni.1773	37	36	37	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2012	7	4							e35005	10.1371/journal.pone.0035005	http://dx.doi.org/10.1371/journal.pone.0035005			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959FE	22506061	Green Submitted, Green Published, gold			2022-12-27	WOS:000305297500068
J	Pokrishevsky, E; Grad, LI; Yousefi, M; Wang, J; Mackenzie, IR; Cashman, NR				Pokrishevsky, Edward; Grad, Leslie I.; Yousefi, Masoud; Wang, Jing; Mackenzie, Ian R.; Cashman, Neil R.			Aberrant Localization of FUS and TDP43 Is Associated with Misfolding of SOD1 in Amyotrophic Lateral Sclerosis	PLOS ONE			English	Article							FRONTOTEMPORAL LOBAR DEGENERATION; TDP-43; ALS; MUTATIONS; PROTEIN; DISEASE; RNA; MUTANTS; NEURONS; NUCLEAR	Background: Amyotrophic lateral sclerosis (ALS) is incurable and characterized by progressive paralysis of the muscles of the limbs, speech and swallowing, and respiration due to the progressive degeneration of voluntary motor neurons. Clinically indistinguishable ALS can be caused by genetic mutations of Cu/Zn superoxide dismutase (SOD1), TAR-DNA binding protein 43 (TDP43), or fused in sarcoma/translocated in liposarcoma (FUS/TLS), or can occur in the absence of known mutation as sporadic disease. In this study, we tested the hypothesis that FUS/TLS and TDP43 gain new pathogenic functions upon aberrant accumulation in the cytosol that directly or indirectly include misfolding of SOD1. Methodology/Principal Findings: Patient spinal cord necropsy immunohistochemistry with SOD1 misfolding-specific antibodies revealed misfolded SOD1 in perikarya and motor axons of SOD1-familial ALS (SOD1-FALS), and in motor axons of R521C-FUS FALS and sporadic ALS (SALS) with cytoplasmic TDP43 inclusions. SOD1 misfolding and oxidation was also detected using immunocytochemistry and quantitative immunoprecipitation of human neuroblastoma SH-SY5Y cells as well as cultured murine spinal neural cells transgenic for human wtSOD1, which were transiently transfected with human cytosolic mutant FUS or TDP43, or wtTDP43. Conclusion/Significance: We conclude that cytosolic mislocalization of FUS or TDP43 in vitro and ALS in vivo may kindle wtSOD1 misfolding in non-SOD1 FALS and SALS. The lack of immunohistochemical compartmental co-localization of misfolded SOD1 with cytosolic TDP43 or FUS suggests an indirect induction of SOD1 misfolding followed by propagation through template directed misfolding beyond its site of inception. The identification of a final common pathway in the molecular pathogenesis of ALS provides a treatment target for this devastating disease.	[Pokrishevsky, Edward; Grad, Leslie I.; Yousefi, Masoud; Wang, Jing; Cashman, Neil R.] Univ British Columbia, Brain Res Ctr, Vancouver, BC V5Z 1M9, Canada; [Mackenzie, Ian R.] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V5Z 1M9, Canada	University of British Columbia; University of British Columbia	Pokrishevsky, E (corresponding author), Univ British Columbia, Brain Res Ctr, Vancouver, BC V5Z 1M9, Canada.	neil.cashman@vch.ca			Allen T. Lambert Neural Research Fund; PrioNet Canada; Canadian Institutes of Health Research (CIHR) [74580]; Pacific Alzheimer Research Foundation	Allen T. Lambert Neural Research Fund; PrioNet Canada; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Pacific Alzheimer Research Foundation	NRC is supported by donations from the Allen T. Lambert Neural Research Fund, as well as by grants from PrioNet Canada (http://www.prionetcanada.ca). EP receives the Frederick Banting and Charles Best Canada Graduate Award from Canadian Institutes of Health Research (CIHR) (http://www.cihr-irsc.gc.ca). IRM is supported by grants from CIHR (grant number 74580, IM) and the Pacific Alzheimer Research Foundation (IM; http://www.parf.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson KN, 2004, BRAIN RES PROTOC, V12, P132, DOI 10.1016/j.brainresprot.2003.10.001; Ash PEA, 2010, HUM MOL GENET, V19, P3206, DOI 10.1093/hmg/ddq230; Banci L, 2009, P NATL ACAD SCI USA, V106, P6980, DOI 10.1073/pnas.0809845106; Barmada SJ, 2010, J NEUROSCI, V30, P639, DOI 10.1523/JNEUROSCI.4988-09.2010; Bosco DA, 2010, NAT NEUROSCI, V13, P1396, DOI 10.1038/nn.2660; Bosco DA, 2010, HUM MOL GENET, V19, P4160, DOI 10.1093/hmg/ddq335; Boyault C, 2007, GENE DEV, V21, P2172, DOI 10.1101/gad.436407; Braun RJ, 2011, J BIOL CHEM, V286, P19958, DOI 10.1074/jbc.M110.194852; Cleveland DW, 1999, NEURON, V24, P515, DOI 10.1016/S0896-6273(00)81108-3; Crippa V, 2010, HUM MOL GENET, V19, P3440, DOI 10.1093/hmg/ddq257; Crow JP, 1997, J NEUROCHEM, V69, P1936; Dormann D, 2010, EMBO J, V29, P2841, DOI 10.1038/emboj.2010.143; Forsberg K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011552; Grad LI, 2011, P NATL ACAD SCI USA, V108, P16398, DOI 10.1073/pnas.1102645108; Guest WC, 2011, J TOXICOL ENV HEAL A, V74, P1433, DOI 10.1080/15287394.2011.618967; HUA XX, 1995, J BIOL CHEM, V270, P29422, DOI 10.1074/jbc.270.49.29422; Huang C, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002011; Ilieva H, 2009, J CELL BIOL, V187, P761, DOI 10.1083/jcb.200908164; Israelson A, 2010, NEURON, V67, P575, DOI 10.1016/j.neuron.2010.07.019; Keohane C., 1999, Clinical and Experimental Pathology, V47, P125; Kim SH, 2010, J BIOL CHEM, V285, P34097, DOI 10.1074/jbc.M110.154831; Koyama S, 2006, BIOCHEM BIOPH RES CO, V343, P719, DOI 10.1016/j.bbrc.2006.02.170; Kwiatkowski TJ, 2009, SCIENCE, V323, P1205, DOI 10.1126/science.1166066; Kwong LK, 2008, NEUROSIGNALS, V16, P41, DOI 10.1159/000109758; Lagier-Tourenne C, 2010, HUM MOL GENET, V19, pR46, DOI 10.1093/hmg/ddq137; Lagier-Tourenne C, 2009, CELL, V136, P1001, DOI 10.1016/j.cell.2009.03.006; Liu-Yesucevitz L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013250; Mackenzie IRA, 2010, LANCET NEUROL, V9, P995, DOI 10.1016/S1474-4422(10)70195-2; Moisse K, 2009, BRAIN RES, V1249, P202, DOI 10.1016/j.brainres.2008.10.021; Munch C, 2011, P NATL ACAD SCI USA, V108, P3548, DOI 10.1073/pnas.1017275108; Munoz DG, 2010, NEUROLOGY, V75, P584, DOI 10.1212/WNL.0b013e3181ed9ee4; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Neumann M, 2009, BRAIN, V132, P2922, DOI 10.1093/brain/awp214; Pesiridis GS, 2009, HUM MOL GENET, V18, pR156, DOI 10.1093/hmg/ddp303; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Rakhit R, 2007, NAT MED, V13, P754, DOI 10.1038/nm1559; Selkoe DJ, 2003, NATURE, V426, P900, DOI 10.1038/nature02264; Seyfried NT, 2010, MOL CELL PROTEOMICS, V9, P705, DOI 10.1074/mcp.M800390-MCP200; Vance C, 2009, SCIENCE, V323, P1208, DOI 10.1126/science.1165942; Ve Velde C., 2008, P NATL ACAD SCI USA, V105, P4022, DOI [DOI 10.1073/PNAS.0712209105, 10.1073/pnas.0712209105]; Wilson AC, 2011, INT J CLIN EXP PATHO, V4, P147; Winton MJ, 2008, J BIOL CHEM, V283, P13302, DOI 10.1074/jbc.M800342200; Xu YF, 2010, J NEUROSCI, V30, P10851, DOI 10.1523/JNEUROSCI.1630-10.2010	43	129	134	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2012	7	4							e35050	10.1371/journal.pone.0035050	http://dx.doi.org/10.1371/journal.pone.0035050			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JA	22493728	Green Published, Green Submitted, gold			2022-12-27	WOS:000305012700070
J	Sturdivant, SK; Diaz, RJ; Cutter, GR				Sturdivant, S. Kersey; Diaz, Robert J.; Cutter, George R.			Bioturbation in a Declining Oxygen Environment, in situ Observations from Wormcam	PLOS ONE			English	Article							BEHAVIORAL-RESPONSES; RAPPAHANNOCK RIVER; DEPOSIT-FEEDERS; REACTION-RATES; SEDIMENT; HYPOXIA; DEPLETION; BAY; ADAPTATIONS; POLYCHAETA	Bioturbation, the displacement and mixing of sediment particles by fauna or flora, facilitates life supporting processes by increasing the quality of marine sediments. In the marine environment bioturbation is primarily mediated by infaunal organisms, which are susceptible to perturbations in their surrounding environment due to their sedentary life history traits. Of particular concern is hypoxia, dissolved oxygen (DO) concentrations <= 2.8 mg l(-1), a prevalent and persistent problem that affects both pelagic and benthic fauna. A benthic observing system (Wormcam) consisting of a buoy, telemetering electronics, sediment profile camera, and water quality datasonde was developed and deployed in the Rappahannock River, VA, USA, in an area known to experience seasonal hypoxia from early spring to late fall. Wormcam transmitted a time series of in situ images and water quality data, to a website via wireless internet modem, for 5 months spanning normoxic and hypoxic periods. Hypoxia was found to significantly reduce bioturbation through reductions in burrow lengths, burrow production, and burrowing depth. Although infaunal activity was greatly reduced during hypoxic and near anoxic conditions, some individuals remained active. Low concentrations of DO in the water column limited bioturbation by infaunal burrowers and likely reduced redox cycling between aerobic and anaerobic states. This study emphasizes the importance of in situ observations for understanding how components of an ecosystem respond to hypoxia.	[Sturdivant, S. Kersey; Diaz, Robert J.] Coll William & Mary, Virginia Inst Marine Sci, Gloucester Pt, VA USA; [Sturdivant, S. Kersey] NOAA, Cordell Bank Natl Marine Sanctuaries Program, Point Reyes Stn, CA USA; [Cutter, George R.] NOAA, SW Fisheries Sci Ctr, La Jolla, CA USA	William & Mary; Virginia Institute of Marine Science; National Oceanic Atmospheric Admin (NOAA) - USA; National Oceanic Atmospheric Admin (NOAA) - USA	Sturdivant, SK (corresponding author), Coll William & Mary, Virginia Inst Marine Sci, Gloucester Pt, VA USA.	kersey.sturdivant@noaa.gov			National Science Foundation [0536572]; National Oceanic and Atmospheric Administration [NA05NOS4781202]	National Science Foundation(National Science Foundation (NSF)); National Oceanic and Atmospheric Administration(National Oceanic Atmospheric Admin (NOAA) - USA)	Supported in part by funding from National Science Foundation award 0536572 and National Oceanic and Atmospheric Administration Coastal Hypoxia Research Program grant NA05NOS4781202. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Aller RC, 1998, J MAR RES, V56, P905, DOI 10.1357/002224098321667413; ALLER RC, 1994, CHEM GEOL, V114, P331, DOI 10.1016/0009-2541(94)90062-0; ALLER RC, 1985, J MAR RES, V43, P615, DOI 10.1357/002224085788440349; ALLER RC, 1978, AM J SCI, V278, P1185, DOI 10.2475/ajs.278.9.1185; Andersen Frede Ostergaard, 1991, V63, P69; BAGARINAO T, 1992, AQUAT TOXICOL, V24, P21, DOI 10.1016/0166-445X(92)90015-F; Bartolomaeus Thomas, 1994, Microfauna Marina, V9, P171; Bernhard JM, 2000, NATURE, V403, P77, DOI 10.1038/47476; Childress JJ, 1998, J EXP BIOL, V201, P1223; DABORN GR, 1993, LIMNOL OCEANOGR, V38, P225; DAUER DM, 1985, MAR BIOL, V85, P143, DOI 10.1007/BF00397433; de Deckere EMGT, 2001, ESTUAR COAST SHELF S, V53, P665, DOI 10.1006/ecss.2001.0811; Diaz RJ, 1995, OCEANOGR MAR BIOL, V33, P245; Diaz RJ, 2001, BEL BAR LIB, P19; Diaz RJ, 2008, SCIENCE, V321, P926, DOI 10.1126/science.1156401; Dorgan KM, 2006, OCEANOGR MAR BIOL, V44, P85; FENCHEL T, 1969, Ophelia, V6, P1; Francois F, 2002, MAR ECOL PROG SER, V229, P127, DOI 10.3354/meps229127; Furukawa Y, 2001, J MAR RES, V59, P417, DOI 10.1357/002224001762842262; GILBERT F, 1994, CHEMOSPHERE, V29, P1, DOI 10.1016/0045-6535(94)90084-1; Gonzalez RR, 2000, ESTUAR COAST SHELF S, V51, P507, DOI 10.1006/ecss.2000.0693; Graco M, 2001, LIMNOL OCEANOGR, V46, P821, DOI 10.4319/lo.2001.46.4.0821; GRAF G, 1992, OCEANOGR MAR BIOL, V30, P149; GUINASSO NL, 1975, J GEOPHYS RES-OC ATM, V80, P3032, DOI 10.1029/JC080i021p03032; JORGENSEN BB, 1974, MAR BIOL, V24, P189, DOI 10.1007/BF00391893; JORGENSEN BB, 1980, OIKOS, V34, P68, DOI 10.2307/3544551; KUO AY, 1987, ESTUARIES, V10, P277, DOI 10.2307/1351884; Lamont PA, 2000, DEEP-SEA RES PT II, V47, P9, DOI 10.1016/S0967-0645(99)00102-2; Levin LA, 2003, OCEANOGR MAR BIOL, V41, P1; LLANSO RJ, 1992, ESTUAR COAST SHELF S, V35, P491, DOI 10.1016/S0272-7714(05)80027-7; Lohrer AM, 2004, NATURE, V431, P1092, DOI 10.1038/nature03042; MANGUM C, 1970, AM SCI, V58, P641; Meysman FJR, 2006, TRENDS ECOL EVOL, V21, P688, DOI 10.1016/j.tree.2006.08.002; NELSON DC, 1986, APPL ENVIRON MICROB, V52, P225, DOI 10.1128/AEM.52.2.225-233.1986; Nilsson HC, 2000, MAR ECOL PROG SER, V197, P139, DOI 10.3354/meps197139; Park KO, 1996, ESTUAR COAST SHELF S, V42, P563, DOI 10.1006/ecss.1996.0037; Pearson T.H., 1978, Oceanography and Marine Biology an Annual Review, V16, P229; RHOADS DC, 1971, LIMNOL OCEANOGR, V16, P110, DOI 10.4319/lo.1971.16.1.0110; Rhodes D., 1982, ANIMAL SEDIMENT RELA, P3, DOI DOI 10.1007/978-1-4757-1317-6; Riedel B, 2008, J EXP MAR BIOL ECOL, V367, P17, DOI 10.1016/j.jembe.2008.08.007; Rosenberg R, 2001, SCI MAR, V65, P107, DOI 10.3989/scimar.2001.65s2107; ROSENBERG R, 1991, MAR ECOL PROG SER, V79, P127, DOI 10.3354/meps079127; Rowden AA, 1998, CONT SHELF RES, V18, P1365, DOI 10.1016/S0278-4343(98)00048-X; Skipper M, 2010, NATURE, V465, P703, DOI 10.1038/465703a; SNELGROVE PVR, 1994, OCEANOGR MAR BIOL, V32, P111; Solan M, 2002, MAR ECOL PROG SER, V228, P179, DOI 10.3354/meps228179; THEEDE H, 1973, Netherlands Journal of Sea Research, V7, P244, DOI 10.1016/0077-7579(73)90048-3; Tyson RV, 1991, MODERN ANCIENT CONTI, P27; Van ENGEL W. A., 1958, COMMERCIAL FISH REV, V20, P6; Vaquer-Sunyer R, 2008, P NATL ACAD SCI USA, V105, P15452, DOI 10.1073/pnas.0803833105; Vinebrooke RD, 2004, OIKOS, V104, P451, DOI 10.1111/j.0030-1299.2004.13255.x; VISMANN B, 1990, MAR ECOL PROG SER, V59, P229, DOI 10.3354/meps059229; WEIGELT M, 1986, MEERESFORSCHUNG, V31, P124; WENNER C A, 1975, Chesapeake Science, V16, P62, DOI 10.2307/1351085	54	48	50	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2012	7	4							e34539	10.1371/journal.pone.0034539	http://dx.doi.org/10.1371/journal.pone.0034539			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JA	22493701	Green Submitted, Green Published, gold			2022-12-27	WOS:000305012700043
J	Taylor, JE; Swiderska, A; Artero, JB; Callow, P; Kneale, G				Taylor, James E.; Swiderska, Anna; Artero, Jean-Baptiste; Callow, Philip; Kneale, Geoff			Structural and Functional Analysis of the Symmetrical Type I Restriction Endonuclease R.EcoR124I(NT)	PLOS ONE			English	Article							DNA METHYLTRANSFERASE; MODIFICATION ENZYME; MODIFICATION METHYLASE; SCATTERING DATA; HSDR SUBUNIT; SYSTEMS; TRANSLOCATION; ORGANIZATION; RECOGNITION; EXPRESSION	Type I restriction-modification (RM) systems are comprised of two multi-subunit enzymes, the methyltransferase (similar to 160 kDa), responsible for methylation of DNA, and the restriction endonuclease (similar to 400 kDa), responsible for DNA cleavage. Both enzymes share a number of subunits. An engineered RM system, EcoR124I(NT), based on the N-terminal domain of the specificity subunit of EcoR124I was constructed that recognises the symmetrical sequence GAAN(7)TTC and is active as a methyltransferase. Here, we investigate the restriction endonuclease activity of R.EcoR124I(NT) in vitro and the subunit assembly of the multi-subunit enzyme. Finally, using small-angle neutron scattering and selective deuteration, we present a low-resolution structural model of the endonuclease and locate the motor subunits within the multi-subunit enzyme. We show that the covalent linkage between the two target recognition domains of the specificity subunit is not required for subunit assembly or enzyme activity, and discuss the implications for the evolution of Type I enzymes.	[Taylor, James E.; Swiderska, Anna; Kneale, Geoff] Univ Portsmouth, Inst Biomed & Biomol Sci, Portsmouth, Hants, England; [Artero, Jean-Baptiste; Callow, Philip] Inst Max Von Laue Paul Langevin, F-38042 Grenoble, France; [Artero, Jean-Baptiste] Keele Univ, Macromol Struct Res Grp, Keele, Staffs, England	University of Portsmouth; Institut Laue-Langevin (ILL); Keele University	Taylor, JE (corresponding author), Univ Portsmouth, Inst Biomed & Biomol Sci, Portsmouth, Hants, England.	geoff.kneale@port.ac.uk		Taylor, James/0000-0003-4285-6985	Wellcome Trust [080304/Z/06/Z]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was funded by the Wellcome Trust (grant number 080304/Z/06/Z awarded to GK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BICKLE TA, 1993, MICROBIOL REV, V57, P434, DOI 10.1128/MMBR.57.2.434-450.1993; Calisto RM, 2005, J MOL BIOL, V351, P749, DOI 10.1016/j.jmb.2005.06.050; Callow P, 2007, J MOL BIOL, V369, P177, DOI 10.1016/j.jmb.2007.03.012; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Firman K, 2000, EMBO J, V19, P2094, DOI 10.1093/emboj/19.9.2094; FOURNET G, 1950, J PHYS-PARIS, V11, P516, DOI 10.1051/jphysrad:01950001108-9051600; Gao P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017346; Janscak P, 1996, J MOL BIOL, V257, P977, DOI 10.1006/jmbi.1996.0217; Kennaway CK, 2012, GENE DEV, V26, P92, DOI 10.1101/gad.179085.111; Kennaway CK, 2009, NUCLEIC ACIDS RES, V37, P762, DOI 10.1093/nar/gkn988; Kim JS, 2005, P NATL ACAD SCI USA, V102, P3248, DOI 10.1073/pnas.0409851102; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Konarev PV, 2001, J APPL CRYSTALLOGR, V34, P527, DOI 10.1107/S0021889801006100; Lapkouski M, 2009, NAT STRUCT MOL BIOL, V16, P94, DOI 10.1038/nsmb.1523; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Mernagh DR, 1998, BIOL CHEM, V379, P497, DOI 10.1515/bchm.1998.379.4-5.497; Murray NE, 2000, MICROBIOL MOL BIOL R, V64, P412, DOI 10.1128/MMBR.64.2.412-434.2000; Obarska-Kosinska A, 2008, J MOL BIOL, V376, P438, DOI 10.1016/j.jmb.2007.11.024; Orthaber D, 2000, J APPL CRYSTALLOGR, V33, P218, DOI 10.1107/S0021889899015216; PATEL J, 1992, GENE, V112, P21, DOI 10.1016/0378-1119(92)90298-4; PRICE C, 1987, EMBO J, V6, P1493, DOI 10.1002/j.1460-2075.1987.tb02391.x; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Seidel R, 2004, NAT STRUCT MOL BIOL, V11, P838, DOI 10.1038/nsmb816; Smith MA, 2001, J MOL BIOL, V314, P41, DOI 10.1006/jmbi.2001.5123; Smith MA, 1998, BIOL CHEM, V379, P505, DOI 10.1515/bchm.1998.379.4-5.505; Svergun DI, 2000, J BIOL CHEM, V275, P14432, DOI 10.1074/jbc.275.19.14432; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Szczelkun MD, 1997, J MOL BIOL, V271, P112, DOI 10.1006/jmbi.1997.1172; TAYLOR I, 1993, NUCLEIC ACIDS RES, V21, P4929, DOI 10.1093/nar/21.21.4929; TAYLOR I, 1992, NUCLEIC ACIDS RES, V20, P179, DOI 10.1093/nar/20.2.179; Taylor JE, 2010, J MOL BIOL, V398, P391, DOI 10.1016/j.jmb.2010.03.008; Uyen NT, 2009, NUCLEIC ACIDS RES, V37, P6960, DOI 10.1093/nar/gkp603; Whitten AE, 2008, J APPL CRYSTALLOGR, V41, P222, DOI 10.1107/S0021889807055136; WILSON GG, 1991, NUCLEIC ACIDS RES, V19, P2539, DOI 10.1093/nar/19.10.2539	34	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2012	7	4							e35263	10.1371/journal.pone.0035263	http://dx.doi.org/10.1371/journal.pone.0035263			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JA	22493743	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000305012700085
J	Van Dongen, S; Sprengers, E; Helle, S				Van Dongen, Stefan; Sprengers, Ellen; Helle, Samuli			Hand Asymmetry Does Not Relate to Key Life History Traits in Post-Menopausal Contemporary Finnish Women	PLOS ONE			English	Article							FLUCTUATING ASYMMETRY; NATURAL-SELECTION; FACIAL ATTRACTIVENESS; BREAST ASYMMETRY; QUALITY; HUMANS; RATIO; SEX; 2ND	Associations between fluctuating asymmetry (FA, a putative marker of developmental instability, DI) and life history traits have received a great deal of attention in the non-human literature. However, the patterns found are very heterogeneous and generalizations are difficult to make. In humans, only a few studies have related FA to life histories and fitness. In this paper we study such relationships using hand FA and several key life history traits in 209 post-menopausal Finnish women born between 1946 and 1958. Asymmetry measurements were based on scans of the hands and the life histories of these women were collected using questionnaires. No significant associations were detected and trends were opposite to expectations. We did find evidence for directional asymmetry, as traits in the right hand were larger on average. This may be due to handedness, questioning the usefulness of hand FA as a measure of DI. We conclude that future studies in humans should carefully examine the usefulness of traits as measures of DI.	[Van Dongen, Stefan; Sprengers, Ellen] Univ Antwerp, Evolutionary Ecol Grp, Dept Biol, B-2020 Antwerp, Belgium; [Helle, Samuli] Univ Turku, Dept Biol, Sect Ecol, SF-20500 Turku, Finland	University of Antwerp; University of Turku	Van Dongen, S (corresponding author), Univ Antwerp, Evolutionary Ecol Grp, Dept Biol, B-2020 Antwerp, Belgium.	stefan.vandongen@ua.ac.be			research Foundation - Flanders (FWO) [G.0025.07]; Academy of Finland	research Foundation - Flanders (FWO)(FWO); Academy of Finland(Academy of Finland)	This study was supported by Research program G.0025.07 of the research Foundation - Flanders (FWO) and Academy of Finland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bridges Patricia S., 1995, Evolutionary Anthropology, V4, P112, DOI 10.1002/evan.1360040403; Byars SG, 2010, P NATL ACAD SCI USA, V107, P1787, DOI 10.1073/pnas.0906199106; Cochran C., 2009, 10000 YEAR EXPLOSION; Dongen SV, 2006, J EVOLUTION BIOL, V19, P1727, DOI 10.1111/j.1420-9101.2006.01175.x; Furlow FB, 1997, P ROY SOC B-BIOL SCI, V264, P823, DOI 10.1098/rspb.1997.0115; Gibson MA, 2003, P ROY SOC B-BIOL SCI, V270, pS108, DOI 10.1098/rsbl.2003.0031; Helle S, 2005, P ROY SOC B-BIOL SCI, V272, P29, DOI 10.1098/rspb.2004.2944; Helle S, 2008, AM J HUM BIOL, V20, P700, DOI 10.1002/ajhb.20796; Helle S, 2009, ARCH SEX BEHAV, V38, P1, DOI 10.1007/s10508-008-9419-9; Hume DK, 2001, EVOL HUM BEHAV, V22, P93, DOI 10.1016/S1090-5138(00)00065-9; Kirk KM, 2001, EVOLUTION, V55, P423; Klingenberg Christian Peter, 2003, P427; Kravdal O, 2008, AM SOCIOL REV, V73, P854, DOI 10.1177/000312240807300508; Manning JT, 1998, HUM REPROD, V13, P3000, DOI 10.1093/humrep/13.11.3000; Manning JT, 1997, EVOL HUM BEHAV, V18, P223, DOI 10.1016/S0162-3095(97)00002-0; Manning JT, P ROYAL SOC LONDON B, V255, P189; Milne BJ, 2003, EVOL HUM BEHAV, V24, P53, DOI 10.1016/S1090-5138(02)00120-4; MOLLER AP, 1995, ETHOL SOCIOBIOL, V16, P207, DOI 10.1016/0162-3095(95)00002-3; Pettay JE, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000606; Rasband W.S., 1997, IMAGE J; Scheib JE, 1999, P ROY SOC B-BIOL SCI, V266, P1913, DOI 10.1098/rspb.1999.0866; Van Dongen S, 2009, J EVOLUTION BIOL, V22, P612, DOI 10.1111/j.1420-9101.2008.01667.x; Van Dongen S, 2011, EVOLUTION H IN PRESS; Van Dongen S, ANN HUMAN BIOL, V38, P317; Whitlock M, 1998, P ROY SOC B-BIOL SCI, V265, P1429, DOI 10.1098/rspb.1998.0453; Zeller R, 2010, CURR OPIN GENET DEV, V20, P384, DOI 10.1016/j.gde.2010.04.014	26	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2012	7	4							e34661	10.1371/journal.pone.0034661	http://dx.doi.org/10.1371/journal.pone.0034661			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JA	22493707	Green Published, gold			2022-12-27	WOS:000305012700049
J	Villareal, TA; Brown, CG; Brzezinski, MA; Krause, JW; Wilson, C				Villareal, Tracy A.; Brown, Colbi G.; Brzezinski, Mark A.; Krause, Jeffrey W.; Wilson, Cara			Summer Diatom Blooms in the North Pacific Subtropical Gyre: 2008-2009	PLOS ONE			English	Article							SEA-SURFACE TEMPERATURE; ANNUAL SILICA CYCLE; RICHELIA-INTRACELLULARIS; CHLOROPHYLL BLOOMS; FIXATION; DIAZOTROPHS; FRONTS; OCEAN; ZONE; EDDY	The summertime North Pacific subtropical gyre has widespread phytoplankton blooms between Hawaii and the subtropical front (similar to 30 degrees N) that appear as chlorophyll (chl) increases in satellite ocean color data. Nitrogen-fixing diatom symbioses (diatom-diazotroph associations: DDAs) often increase 10(2)-10(3) fold in these blooms and contribute to elevated export flux. In 2008 and 2009, two cruises targeted satellite chlorophyll blooms to examine DDA species abundance, chlorophyll concentration, biogenic silica concentration, and hydrography. Generalized observations that DDA blooms occur when the mixed layer depth is < 70 m are supported, but there is no consistent relationship between mixed layer depth, bloom intensity, or composition; regional blooms between 22-34 degrees N occur within a broader temperature range (21-26 degrees C) than previously reported. In both years, the Hemiaulus-Richelia and Rhizosolenia-Richelia DDAs increased 10(2)-10(3) over background concentrations within satellite-defined bloom features. The two years share a common trend of Hemiaulus dominance of the DDAs and substantial increases in the >10 mu m chl a fraction (similar to 40-90+% of total chl a). Integrated diatom abundance varied 10-fold over <10 km. Biogenic silica concentration tracked diatom abundance, was dominated by the >10 mu m size fraction, and increased up to 5-fold in the blooms. The two years differed in the magnitude of the surface chl a increase (2009>2008), the abundance of pennate diatoms within the bloom (2009>2008), and the substantially greater mixed layer depth in 2009. Only the 2009 bloom had sufficient chl a in the >10 mu m fraction to produce the observed ocean color chl increase. Blooms had high spatial variability; ocean color images likely average over numerous small events over time and space scales that exceed the individual event scale. Summertime DDA export flux noted at the Hawaii time-series Sta. ALOHA is probably a generalized feature of the eastern N. Pacific north to the subtropical front.	[Villareal, Tracy A.; Brown, Colbi G.] Univ Texas Austin, Inst Marine Sci, Port Aransas, TX USA; [Villareal, Tracy A.; Brown, Colbi G.] Univ Texas Austin, Dept Marine Sci, Port Aransas, TX USA; [Brzezinski, Mark A.; Krause, Jeffrey W.] Univ Calif Santa Barbara, Inst Marine Sci, Santa Barbara, CA 93106 USA; [Brzezinski, Mark A.] Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA; [Wilson, Cara] NOAA NMFS SW Fisheries Sci Ctr, Div Environm Res, Pacific Grove, CA USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; National Oceanic Atmospheric Admin (NOAA) - USA	Villareal, TA (corresponding author), Univ Texas Austin, Inst Marine Sci, Port Aransas, TX USA.	t.villareal@mail.utexas.edu	Villareal, Tracy A/I-9462-2012; Wilson, Cara/A-8816-2009	Villareal, Tracy A/0000-0002-5717-8163; Wilson, Cara/0000-0001-9318-2322	National Science Foundation (NSF) [OCE-0726726, OCE-9414372, OCE-0094591, OCE-0648130]	National Science Foundation (NSF)(National Science Foundation (NSF))	This work was funded by National Science Foundation (NSF) (www.nsf.gov) grants OCE-0726726, OCE-9414372, and OCE-0094591 awarded to TAV and OCE, and OCE-0648130 to MAB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown SL, 2008, DEEP SEA RES 2, V55, P1133; Brzezinski MA, 1998, MAR ECOL PROG SER, V167, P89, DOI 10.3354/meps167089; BRZEZINSKI MA, 1995, DEEP-SEA RES PT I, V42, P1215, DOI 10.1016/0967-0637(95)93592-3; Brzezinski MA, 2011, DEEP-SEA RES PT I, V58, P988, DOI 10.1016/j.dsr.2011.08.001; Calil PHR, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2009JC005360; Calil PHR, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2010JC006704; Carpenter EJ, 1999, MAR ECOL PROG SER, V185, P273, DOI 10.3354/meps185273; Casey KS, 1999, J CLIMATE, V12, P1848, DOI 10.1175/1520-0442(1999)012<1848:ACOSAI>2.0.CO;2; Church MJ, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003418; Dore JE, 2008, PROG OCEANOGR, V76, P2, DOI 10.1016/j.pocean.2007.10.002; Fiore CL, 2010, TRENDS MICROBIOL, V18, P455, DOI 10.1016/j.tim.2010.07.001; Fong AA, 2008, ISME J, V2, P663, DOI 10.1038/ismej.2008.22; Foster RA, 2006, ENVIRON MICROBIOL, V8, P1913, DOI 10.1111/j.1462-2920.2006.01068.x; Foster RA, 2008, NITROGEN IN THE MARINE ENVIRONMENT, 2ND EDITION, P1197, DOI 10.1016/B978-0-12-372522-6.00027-X; Foster RA, 2009, ENVIRON MICROBIOL, V11, P741, DOI 10.1111/j.1462-2920.2008.01796.x; Fryxell GA, 2000, DIATOM RES, V15, P43; Gomez F, 2005, J PLANKTON RES, V27, P323, DOI 10.1093/plankt/fbi007; Hasle G.R., 1978, PHYTOPLANKTON MANUAL, VVolume 6, P88; HEINBOKEL JF, 1986, J PHYCOL, V22, P399, DOI 10.1111/j.1529-8817.1986.tb00043.x; Karl D, 2002, BIOGEOCHEMISTRY, V57, P47, DOI 10.1023/A:1015798105851; Karl DM, 2012, P NATL ACAD SCI USA, V109, P1842, DOI 10.1073/pnas.1120312109; Kilpatrick KA, 2001, J GEOPHYS RES-OCEANS, V106, P9179, DOI 10.1029/1999JC000065; Krause JW, 2010, LIMNOL OCEANOGR, V55, P2608, DOI 10.4319/lo.2010.55.6.2608; Levitus S, 1983, EOS T AM GEOPHYS UNI, V64, P962; LYNN RJ, 1986, J PHYS OCEANOGR, V16, P209, DOI 10.1175/1520-0485(1986)016<0209:TSANSF>2.0.CO;2; Mahaffey C, 2005, AM J SCI, V305, P546, DOI 10.2475/ajs.305.6-8.546; Montoya JP, 2004, NATURE, V430, P1027, DOI 10.1038/nature02824; Rii YM, 2008, DEEP-SEA RES PT II, V55, P1275, DOI 10.1016/j.dsr2.2008.01.013; RODEN GI, 1975, J PHYS OCEANOGR, V5, P557, DOI 10.1175/1520-0485(1975)005<0557:ONPTSS>2.0.CO;2; RODEN GI, 1980, J PHYS OCEANOGR, V10, P342, DOI 10.1175/1520-0485(1980)010<0342:OTSFZN>2.0.CO;2; Scharek R, 1999, MAR ECOL PROG SER, V182, P55, DOI 10.3354/meps182055; Scharek R, 1999, DEEP-SEA RES PT I, V46, P1051, DOI 10.1016/S0967-0637(98)00102-2; Sohm JA, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2010JG001513; Throndsen J., 1978, PHYTOPLANKTON MANUAL, P69; Vaillancourt RD, 2003, DEEP-SEA RES PT I, V50, P829, DOI 10.1016/S0967-0637(03)00059-1; VENRICK EL, 1974, LIMNOL OCEANOGR, V19, P437, DOI 10.4319/lo.1974.19.3.0437; VENRICK EL, 1988, J PLANKTON RES, V10, P987, DOI 10.1093/plankt/10.5.987; VILLAREAL TA, 1992, NATO ADV SCI I C-MAT, V362, P163; VILLAREAL TA, 1990, MAR ECOL-P S Z N I, V11, P117, DOI 10.1111/j.1439-0485.1990.tb00233.x; VILLAREAL TA, 1994, B MAR SCI, V54, P1; Villareal TA, 2007, DEEP-SEA RES PT I, V54, P1273, DOI 10.1016/j.dsr.2007.04.018; Villareal TA, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2010JC006268; Watkins-Brandt KS, 2011, MAR ECOL PROG SER, V432, P17, DOI 10.3354/meps09147; WELSCHMEYER NA, 1994, LIMNOL OCEANOGR, V39, P1985, DOI 10.4319/lo.1994.39.8.1985; White AE, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2007JC004129; Wilson C, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017770; Wilson C, 2011, GEOPHYS RES LETT, V38, P6, DOI [10.1029/2011GL1020, DOI 10.1029/2011GL1020]; Wilson C, 2008, PROG OCEANOGR, V78, P107, DOI 10.1016/j.pocean.2008.05.002; Wilson C, 2008, J MARINE SYST, V69, P164, DOI 10.1016/j.jmarsys.2005.09.018	49	49	50	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2012	7	4							e33109	10.1371/journal.pone.0033109	http://dx.doi.org/10.1371/journal.pone.0033109			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JA	22493663	Green Published, gold, Green Submitted			2022-12-27	WOS:000305012700005
J	Bernabe-Ortiz, A; Benziger, CP; Gilman, RH; Smeeth, L; Miranda, JJ				Bernabe-Ortiz, Antonio; Pastorius Benziger, Catherine; Gilman, Robert H.; Smeeth, Liam; Jaime Miranda, J.			Sex Differences in Risk Factors for Cardiovascular Disease: The PERU MIGRANT Study	PLOS ONE			English	Article							METABOLIC SYNDROME; PREVALENCE; MIGRATION; OBESITY; ASSOCIATION; URBAN	Introduction: Although men and women have similar risk factors for cardiovascular disease, many social behaviors in developing countries differ by sex. Rural-to-urban migrants have different cardiovascular risk profiles than rural or urban dwellers. The objective of this study was to evaluate the sex differences with specific cardiovascular risk factors in rural-to-urban migrants. Methods and Results: We used the rural-to-urban migrant group of the PERU MIGRANT cross-sectional study to investigate the sex differences in specific cardiovascular risk factors: obesity, hypertension, metabolic syndrome, as well as exposures of socioeconomic status, acculturation surrogates and behavioral characteristics. Logistic regression analysis was used to characterize strength of association between sex and our outcomes adjusting for potential confounders. The sample of migrants was 589 (mean age 46.5 years) and 52.4% were female. In the adjusted models, women were more likely to be obese (OR = 5.97; 95% CI: 3.21-11) and have metabolic syndrome (OR = 2.22; 95% CI: 1.39-3.55) than men, explaining the greatest variability for obesity and metabolic syndrome but not for hypertension. Conclusions: Our results suggest that interventions for CVD in Peru should be sex-specific and address the unique health needs of migrant populations living in urban shantytowns since the risk factors for obesity and metabolic syndrome differ between males and females.	[Bernabe-Ortiz, Antonio; Pastorius Benziger, Catherine; Gilman, Robert H.; Smeeth, Liam; Jaime Miranda, J.] Univ Peruana Cayetano Heredia, CRONICAS Ctr Excellence Chron Dis, Lima, Peru; [Bernabe-Ortiz, Antonio] Univ Peruana Cayetano Heredia, Sch Publ Hlth & Adm, Epidemiol Unit, Lima, Peru; [Pastorius Benziger, Catherine] Univ Minnesota, Sch Med, Minneapolis, MN 55455 USA; [Gilman, Robert H.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA; [Gilman, Robert H.] AB PRISMA, Area Invest & Desarrollo, Lima, Peru; [Smeeth, Liam; Jaime Miranda, J.] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London WC1, England; [Jaime Miranda, J.] Univ Peruana Cayetano Heredia, Sch Med, Dept Med, Lima, Peru	Universidad Peruana Cayetano Heredia; Universidad Peruana Cayetano Heredia; University of Minnesota System; University of Minnesota Twin Cities; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of London; London School of Hygiene & Tropical Medicine; Universidad Peruana Cayetano Heredia	Bernabe-Ortiz, A (corresponding author), Univ Peruana Cayetano Heredia, CRONICAS Ctr Excellence Chron Dis, Lima, Peru.	Jaime.Miranda@upch.pe	Miranda, J. Jaime/A-8482-2008; Benziger, Catherine/AAN-3344-2021; Smeeth, Liam/X-5862-2018	Miranda, J. Jaime/0000-0002-4738-5468; Benziger, Catherine/0000-0002-8992-6197; Smeeth, Liam/0000-0002-9168-6022; Bernabe-Ortiz, Antonio/0000-0002-6834-1376	National Heart, Lung and Blood Institute (NHLBI), National Institutes of Health, Department of Health and Human Services [HHSN268200900033C]; National Institutes of Health; Fogarty International Center through Vanderbilt University [R24 TW007988]; Wellcome Trust [GR074833MA]; National Institute for Health Research [NF-SI-0510-10090] Funding Source: researchfish; FOGARTY INTERNATIONAL CENTER [R24TW007988] Funding Source: NIH RePORTER	National Heart, Lung and Blood Institute (NHLBI), National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fogarty International Center through Vanderbilt University(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Wellcome Trust(Wellcome TrustEuropean Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	ABO, RHG, JJM and the CRONICAS Center of Excellence in Chronic Diseases at UPCH is funded by the National Heart, Lung and Blood Institute (NHLBI), National Institutes of Health, Department of Health and Human Services, under contract no. HHSN268200900033C. CPB was supported by the National Institutes of Health and Fogarty International Center through the International Clinical Research Fellows Program at Vanderbilt University (R24 TW007988). The PERU MIGRANT Study was funded by a Wellcome Trust Masters Research Training Fellowship and a Wellcome Trust PhD Studentship to JJM (GR074833MA). LS is supported by a Wellcome Trust Senior Research Fellowship in Clinical Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anonymous, 2006, Metabolic Syndrome and Related Disorders, V4, P1, DOI 10.1089/met.2006.4.1; Baracco Rossana, 2007, Metabolic Syndrome and Related Disorders, V5, P55, DOI 10.1089/met.2006.0019; Bautista LE, 2009, OBES REV, V10, P364, DOI 10.1111/j.1467-789X.2009.00591.x; Bernabe-Ortiz A, 2010, OBESITY, V18, P2199, DOI 10.1038/oby.2010.92; Quintana HC, 2009, REV ESP SALUD PUBLIC, V83, P257, DOI 10.1590/s1135-57272009000200009; Castanho VS, 2001, BMC PUBLIC HEALTH, V1, DOI 10.1186/1471-2458-1-3; Cecchini M, 2010, LANCET, V376, P1775, DOI 10.1016/S0140-6736(10)61514-0; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Ebrahim S, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000268; Epping-Jordan JE, 2005, LANCET, V366, P1667, DOI 10.1016/S0140-6736(05)67342-4; Escobedo J, 2009, CARDIOVASC DIABETOL, V8, DOI 10.1186/1475-2840-8-52; Filozof C, 2001, Obes Rev, V2, P99, DOI 10.1046/j.1467-789x.2001.00029.x; HE J, 1991, AM J EPIDEMIOL, V134, P1085, DOI 10.1093/oxfordjournals.aje.a116012; Hernandez AV, 2011, HEART; Herrera VM, 2009, INT J OBESITY, V33, P568, DOI 10.1038/ijo.2009.35; International Diabetes Federation, 2006, IDF CONS WORLDW DEF; Miranda JJ, 2011, HEART, V97, P787, DOI 10.1136/hrt.2010.218537; Málaga Germán, 2010, Rev. perú. med. exp. salud publica, V27, P557; Mancia G, 2007, EUR HEART J, V28, P1462, DOI [10.1093/eurheartj/eht151, 10.1093/eurheartj/ehm236]; Medina-Lezama J, 2007, DIABETES RES CLIN PR, V78, P270, DOI 10.1016/j.diabres.2007.04.004; Miranda JJ, 2009, BMC CARDIOVASC DISOR, V9, DOI 10.1186/1471-2261-9-23; Pastorius Benziger Catherine, 2011, Crit Pathw Cardiol, V10, P99, DOI 10.1097/HPC.0b013e318223e375; Patel RB, 2009, NEW ENGL J MED, V361, P741, DOI 10.1056/NEJMp0810878; Pedersen D, 2008, SOC SCI MED, V67, P205, DOI 10.1016/j.socscimed.2008.03.040; Pischon T, 2008, NEW ENGL J MED, V359, P2105, DOI 10.1056/NEJMoa0801891; POULTER NR, 1990, BMJ-BRIT MED J, V300, P967, DOI 10.1136/bmj.300.6730.967; SchenckGustafsson K, 1996, EUR HEART J, V17, P2, DOI 10.1093/eurheartj/17.suppl_D.2; Sokka T, 2008, CLIN EXP RHEUMATOL, V26, pS35, DOI 10.1161/CIRCULATIONAHA.109.192644; Takenaka A, 2010, LAT AM PERSPECT, V37, P29, DOI 10.1177/0094582X10379106; UNFPA, 2007, STAT WORLD POP 2007; Van Ginkel H., 2008, NATURE, V456, P32, DOI DOI 10.1038/TWAS08.32A; Wenger NK, 1995, AM J HYPERTENS, V8, pS94, DOI 10.1016/0895-7061(95)99306-1; WHO, 2011, GLOB STAT REP NONC D; WHO, 2002, RED RISKS PROM HLTH	34	20	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2012	7	4							e35127	10.1371/journal.pone.0035127	http://dx.doi.org/10.1371/journal.pone.0035127			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955IH	22496899	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000305010500030
J	Fruhwirth, S; Teich, K; Klug, G				Fruehwirth, Sebastian; Teich, Kristin; Klug, Gabriele			Effects of the Cryptochrome CryB from Rhodobacter sphaeroides on Global Gene Expression in the Dark or Blue Light or in the Presence of Singlet Oxygen	PLOS ONE			English	Article							PHOTOOXIDATIVE STRESS; HYDROGEN-PEROXIDE; PHOTOLYASE; DNA; PROTEIN; APPA; PUF; TRANSCRIPTOME; CAPSULATUS; MICROARRAY	Several regulators are controlling the formation of the photosynthetic apparatus in the facultatively photosynthetic bacterium Rhodobacter sphaeroides. Among the proteins affecting photosynthesis gene expression is the blue light photoreceptor cryptochrome CryB. This study addresses the effect of CryB on global gene expression. The data reveal that CryB does not only influence photosynthesis gene expression but also genes for the non-photosynthetic energy metabolism like citric acid cycle and oxidative phosphorylation. In addition several genes involved in RNA processing and in transcriptional regulation are affected by a cryB deletion. Although CryB was shown to undergo a photocycle it does not only affect gene expression in response to blue light illumination but also in response to singlet oxygen stress conditions. While there is a large overlap in these responses, some CryB-dependent effects are specific for blue-light or photooxidative stress. In addition to protein-coding genes some genes for sRNAs show CryB-dependent expression. These findings give new insight into the function of bacterial cryptochromes and demonstrate for the first time a function in the oxidative stress response.	[Fruehwirth, Sebastian; Teich, Kristin; Klug, Gabriele] Univ Giessen, Inst Mikrobiol & Mol Biol, Giessen, Germany	Justus Liebig University Giessen	Fruhwirth, S (corresponding author), Univ Giessen, Inst Mikrobiol & Mol Biol, Giessen, Germany.	Gabriele.Klug@mikro.bio.uni-giessen.de	Klug, Gabriele/K-5322-2014	Klug, Gabriele/0000-0002-3527-5093	Deutsche Forschungsgemeinschaft [Kl563/22-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft (Kl563/22-1). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berghoff BA, 2011, MOL MICROBIOL, V80, P1479, DOI 10.1111/j.1365-2958.2011.07658.x; Berghoff BA, 2009, MOL MICROBIOL, V74, P1497, DOI 10.1111/j.1365-2958.2009.06949.x; Braatsch S, 2004, PHOTOSYNTH RES, V79, P45, DOI 10.1023/B:PRES.0000011924.89742.f9; Braatsch S, 2002, MOL MICROBIOL, V45, P827, DOI 10.1046/j.1365-2958.2002.03058.x; Brennan RG, 2007, CURR OPIN MICROBIOL, V10, P125, DOI 10.1016/j.mib.2007.03.015; Brudler R, 2003, MOL CELL, V11, P59, DOI 10.1016/S1097-2765(03)00008-X; Chaves I, 2011, ANNU REV PLANT BIOL, V62, P335, DOI 10.1146/annurev-arplant-042110-103759; Devlin PF, 2000, PLANT CELL, V12, P2499, DOI 10.1105/tpc.12.12.2499; Drews G, 1983, MIKROBIOLOGISCHES PR; ERASO JM, 1994, J BACTERIOL, V176, P32, DOI 10.1128/JB.176.1.32-43.1994; Evguenieva-Hackenberg E, 2009, PROG MOL BIOL TRANSL, V85, P275, DOI 10.1016/S0079-6603(08)00807-6; Geisselbrecht Y, 2012, EMBO REPORT IN PRESS; Glaeser J, 2005, MICROBIOL-SGM, V151, P1927, DOI 10.1099/mic.0.27789-0; Glaeser J, 2011, ADV MICROB PHYSIOL, V58, P141, DOI 10.1016/B978-0-12-381043-4.00004-0; Glaeser J, 2007, J PROTEOME RES, V6, P2460, DOI 10.1021/pr060624p; Gomelsky M, 2002, TRENDS BIOCHEM SCI, V27, P497, DOI 10.1016/S0968-0004(02)02181-3; Gomelsky M, 2011, TRENDS MICROBIOL, V19, P441, DOI 10.1016/j.tim.2011.05.002; Griffin EA, 1999, SCIENCE, V286, P768, DOI 10.1126/science.286.5440.768; Han YC, 2007, MOL MICROBIOL, V64, P1090, DOI 10.1111/j.1365-2958.2007.05724.x; Happ HN, 2005, MOL MICROBIOL, V58, P903, DOI 10.1111/j.1365-2958.2005.04882.x; Heck C, 1999, J BACTERIOL, V181, P7621, DOI 10.1128/JB.181.24.7621-7625.1999; Hendrischk AK, 2007, MICROBIOL-SGM, V153, P1842, DOI 10.1099/mic.0.2006/004390-0; Hendrischk AK, 2009, MOL MICROBIOL, V74, P990, DOI 10.1111/j.1365-2958.2009.06912.x; Hitomi K, 2000, NUCLEIC ACIDS RES, V28, P2353, DOI 10.1093/nar/28.12.2353; Jager S, 2001, NUCLEIC ACIDS RES, V29, P4581, DOI 10.1093/nar/29.22.4581; JANZON L, 1986, FEMS MICROBIOL LETT, V33, P193; KLUG G, 1992, GENE, V121, P95, DOI 10.1016/0378-1119(92)90166-M; LEE JK, 1992, J BACTERIOL, V174, P1146, DOI 10.1128/jb.174.4.1146-1157.1992; Li QH, 2007, PHOTOCHEM PHOTOBIOL, V83, P94, DOI 10.1562/2006-02-28-IR-826; Lin CT, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-5-220; Liu HT, 2011, TRENDS PLANT SCI, V16, P684, DOI 10.1016/j.tplants.2011.09.002; Lopez L, 2011, PLANT CELL ENV, pno; Losi A, 2008, PHOTOCH PHOTOBIO SCI, V7, P1168, DOI 10.1039/b802472c; Losi A, 2007, PHOTOCHEM PHOTOBIOL, V83, P1283, DOI 10.1111/j.1751-1097.2007.00196.x; Mao LY, 2005, MICROBIOL-SGM, V151, P3197, DOI 10.1099/mic.0.28167-0; Metz S, 2010, PHOTOCHEM PHOTOBIOL, V86, P882, DOI 10.1111/j.1751-1097.2010.00749.x; Metz S, 2009, J BACTERIOL, V191, P4473, DOI 10.1128/JB.00262-09; Moon K, 2011, MOL MICROBIOL, V82, P1545, DOI 10.1111/j.1365-2958.2011.07907.x; Moskvin OV, 2007, J BIOL CHEM, V282, P28740, DOI 10.1074/jbc.M703261200; Moskvin OV, 2005, J BACTERIOL, V187, P2148, DOI 10.1128/JB.187.6.2148-2156.2005; Nuss AM, 2010, J BACTERIOL, V192, P2613, DOI 10.1128/JB.01605-09; Oberpichler I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026775; Pokorny R, 2008, P NATL ACAD SCI USA, V105, P21023, DOI 10.1073/pnas.0805830106; Purcell EB, 2008, CURR OPIN MICROBIOL, V11, P168, DOI 10.1016/j.mib.2008.02.014; Ritchie ME, 2007, BIOINFORMATICS, V23, P2700, DOI 10.1093/bioinformatics/btm412; Selby CP, 2006, P NATL ACAD SCI USA, V103, P17696, DOI 10.1073/pnas.0607993103; SHIMADA H, 1992, PLANT CELL PHYSIOL, V33, P471; Silva IJ, 2011, WIRES RNA, V2, P818, DOI 10.1002/wrna.94; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Somers DE, 1998, SCIENCE, V282, P1488, DOI 10.1126/science.282.5393.1488; Todo T, 1999, MUTAT RES-DNA REPAIR, V434, P89, DOI 10.1016/S0921-8777(99)00013-0; van der Horst GTJ, 1999, NATURE, V398, P627, DOI 10.1038/19323; Waters LS, 2009, CELL, V136, P615, DOI 10.1016/j.cell.2009.01.043; Zeller T, 2005, J BACTERIOL, V187, P7232, DOI 10.1128/JB.187.21.7232-7242.2005; Zeller T, 2007, J BACTERIOL, V189, P3784, DOI 10.1128/JB.01795-06	57	14	14	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2012	7	4							e33791	10.1371/journal.pone.0033791	http://dx.doi.org/10.1371/journal.pone.0033791			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955IH	22496766	Green Published, Green Submitted, gold			2022-12-27	WOS:000305010500002
J	Ma, LN; Huang, WW; Guo, CY; Wang, RZ; Xiao, CW				Ma, Linna; Huang, Wenwen; Guo, Chengyuan; Wang, Renzhong; Xiao, Chunwang			Soil Microbial Properties and Plant Growth Responses to Carbon and Water Addition in a Temperate Steppe: The Importance of Nutrient Availability	PLOS ONE			English	Article							ORGANIC-MATTER; COMMUNITY STRUCTURE; BACTERIAL BIOMASS; CLIMATE-CHANGE; NITROGEN LIMITATION; GRASSLAND; FUNGAL; MINERALIZATION; DECOMPOSITION; DYNAMICS	Background: Global climatic change is generally expected to stimulate net primary production, and consequently increase soil carbon (C) input. The enhanced C input together with potentially increased precipitation may affect soil microbial processes and plant growth. Methodology/Principal Findings: To examine the effects of C and water additions on soil microbial properties and plant growth, we conducted an experiment lasting two years in a temperate steppe of northeastern China. We found that soil C and water additions significantly affected microbial properties and stimulated plant growth. Carbon addition significantly increased soil microbial biomass and activity but had a limited effect on microbial community structure. Water addition significantly increased soil microbial activity in the first year but the response to water decreased in the second year. The water-induced changes of microbial activity could be ascribed to decreased soil nitrogen (N) availability and to the shift in soil microbial community structure. However, no water effect on soil microbial activity was visible under C addition during the two years, likely because C addition alleviated nutrient limitation of soil microbes. In addition, C and water additions interacted to affect plant functional group composition. Water addition significantly increased the ratio of grass to forb biomass in C addition plots but showed only minor effects under ambient C levels. Our results suggest that soil microbial activity and plant growth are limited by nutrient (C and N) and water availability, and highlight the importance of nutrient availability in modulating the responses of soil microbes and plants to potentially increased precipitation in the temperate steppe. Conclusions/Significance: Increased soil C input and precipitation would show significant effects on soil microbial properties and plant growth in the temperate steppe. These findings will improve our understanding of the responses of soil microbes and plants to the indirect and direct climate change effects.	[Ma, Linna; Huang, Wenwen; Guo, Chengyuan; Wang, Renzhong; Xiao, Chunwang] Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing, Peoples R China; [Ma, Linna; Huang, Wenwen; Guo, Chengyuan] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Ma, LN (corresponding author), Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing, Peoples R China.	wangrz@ibcas.ac.cn; cwxiao@ibcas.ac.cn	huang, wen/GXW-0661-2022; Huang, WW/GXH-0977-2022		State Key Laboratory of Vegetation and Environmental Change, Institute of Botany, Chinese Academy of Sciences (VEWALNE)	State Key Laboratory of Vegetation and Environmental Change, Institute of Botany, Chinese Academy of Sciences (VEWALNE)	This study was financially supported by the State Key Laboratory of Vegetation and Environmental Change, Institute of Botany, Chinese Academy of Sciences (VEWALNE-project). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alden L, 2001, APPL ENVIRON MICROB, V67, P1830, DOI 10.1128/AEM.67.4.1830-1838.2001; Avrahami S, 2003, ENVIRON MICROBIOL, V5, P691, DOI 10.1046/j.1462-2920.2003.00457.x; Balser TC, 2005, BIOGEOCHEMISTRY, V73, P395, DOI 10.1007/s10533-004-0372-y; Bardgett RD, 1999, FUNCT ECOL, V13, P650, DOI 10.1046/j.1365-2435.1999.00362.x; Bardgett RD, 1999, OIKOS, V85, P193, DOI 10.2307/3546486; Bossio DA, 1998, MICROBIAL ECOL, V35, P265, DOI 10.1007/s002489900082; Bossuyt H, 2001, APPL SOIL ECOL, V16, P195, DOI 10.1016/S0929-1393(00)00116-5; Bremner J. M., 1982, Methods of soil analysis. Part 2. Chemical and microbiological properties, P595; Busse MD, 2009, SOIL BIOL BIOCHEM, V41, P220, DOI 10.1016/j.soilbio.2008.10.012; Collins SL, 2008, J ECOL, V96, P413, DOI 10.1111/j.1365-2745.2008.01362.x; Drenovsky RE, 2004, MICROB ECOL, V48, P424, DOI 10.1007/s00248-003-1063-2; Elser JJ, 2007, ECOL LETT, V10, P1135, DOI 10.1111/j.1461-0248.2007.01113.x; Fierer N, 2003, SOIL BIOL BIOCHEM, V35, P167, DOI 10.1016/S0038-0717(02)00251-1; Frostegard A, 1996, BIOL FERT SOILS, V22, P59, DOI 10.1007/BF00384433; FROSTEGARD A, 1993, SOIL BIOL BIOCHEM, V25, P723, DOI 10.1016/0038-0717(93)90113-P; Gao XJ, 2001, ADV ATMOS SCI, V18, P1224; GONCALVES JLM, 1994, SOIL BIOL BIOCHEM, V26, P1557, DOI 10.1016/0038-0717(94)90098-1; Goyal S, 1999, BIOL FERT SOILS, V29, P196, DOI 10.1007/s003740050544; Harpole WS, 2007, GLOBAL CHANGE BIOL, V13, P2341, DOI 10.1111/j.1365-2486.2007.01447.x; Hol WHG, 2010, ECOL LETT, V13, P292, DOI 10.1111/j.1461-0248.2009.01424.x; Hooper DU, 1999, BIOGEOCHEMISTRY, V46, P247, DOI 10.1007/BF01007582; Houghton J. T., 2001, CLIMATE CHANGE 2001; Hu S, 2001, NATURE, V409, P188, DOI 10.1038/35051576; Hu S, 1997, MICROBIAL ECOL, V33, P134, DOI 10.1007/s002489900015; Jastrow JD, 1998, SOIL BIOL BIOCHEM, V30, P905, DOI 10.1016/S0038-0717(97)00207-1; Jin HM, 2010, J PLANT ECOL, V3, P209, DOI 10.1093/jpe/rtq001; Jones C, 2005, GLOBAL CHANGE BIOL, V11, P154, DOI 10.1111/j.1365-2486.2004.00885.x; Kim DG, 2011, BIOGEOSCIENCES, V8, P9847, DOI DOI 10.5194/BGD-8-9847-2011; Klanderud K, 2005, ECOLOGY, V86, P2047, DOI 10.1890/04-1563; Leiros MC, 1999, SOIL BIOL BIOCHEM, V31, P327, DOI 10.1016/S0038-0717(98)00129-1; Liski J, 2003, GLOBAL CHANGE BIOL, V9, P575, DOI 10.1046/j.1365-2486.2003.00605.x; LOVELL RD, 1995, SOIL BIOL BIOCHEM, V27, P969, DOI 10.1016/0038-0717(94)00241-R; LUND V, 1980, MICROBIAL ECOL, V6, P115, DOI 10.1007/BF02010550; Ma LN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027645; Marschner P, 2004, BIOL FERT SOILS, V40, P1, DOI 10.1007/s00374-004-0736-4; McIntyre RES, 2009, SOIL BIOL BIOCHEM, V41, P92, DOI 10.1016/j.soilbio.2008.09.021; Morris SJ, 1999, SOIL BIOL BIOCHEM, V31, P887, DOI 10.1016/S0038-0717(99)00002-4; Nelson D. W., 1982, Methods of soil analysis. Part 2. Chemical and microbiological properties, P539; Nemani RR, 2003, SCIENCE, V300, P1560, DOI 10.1126/science.1082750; Ni J, 2000, J ARID ENVIRON, V46, P313, DOI 10.1006/jare.2000.0667; Olsson PA, 1998, PLANT SOIL, V201, P9, DOI 10.1023/A:1004379404220; Panikov NS, 1999, APPL SOIL ECOL, V11, P161, DOI 10.1016/S0929-1393(98)00143-7; Peacock AD, 2001, SOIL BIOL BIOCHEM, V33, P1011, DOI 10.1016/S0038-0717(01)00004-9; Rodrigo A, 1997, ECOL MODEL, V102, P325, DOI 10.1016/S0304-3800(97)00067-7; SAKAMOTO K, 1994, BIOL FERT SOILS, V17, P39, DOI 10.1007/BF00418670; Schmidt MWI, 2011, NATURE, V478, P49, DOI 10.1038/nature10386; Shaver GR, 2000, BIOSCIENCE, V50, P871, DOI 10.1641/0006-3568(2000)050[0871:GWATEA]2.0.CO;2; Smith RS, 2003, J APPL ECOL, V40, P51, DOI 10.1046/j.1365-2664.2003.00780.x; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; SPARLING GP, 1995, AUST J SOIL RES, V33, P961, DOI 10.1071/SR9950961; Sylvia DM, 1999, PRINCIPLES APPL SOIL; Trujillo W, 2006, SOIL TILL RES, V87, P28, DOI 10.1016/j.still.2005.02.038; Tu C, 2006, SOIL BIOL BIOCHEM, V38, P247, DOI 10.1016/j.soilbio.2005.05.002; VANCE ED, 1987, SOIL BIOL BIOCHEM, V19, P703, DOI 10.1016/0038-0717(87)90052-6; Wardle DA, 1995, SOIL BIOL BIOCHEM, V27, P1601, DOI 10.1016/0038-0717(95)00093-T; Xiao CW, 2007, NEW PHYTOL, V174, P835, DOI 10.1111/j.1469-8137.2007.02054.x; Yang HJ, 2011, GLOBAL CHANGE BIOL, V17, P2936, DOI 10.1111/j.1365-2486.2011.02423.x; Yuan ZY, 2005, PLANT SOIL, V273, P257, DOI 10.1007/s11104-004-7941-7	58	40	47	11	90	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2012	7	4							e35165	10.1371/journal.pone.0035165	http://dx.doi.org/10.1371/journal.pone.0035165			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955IH	22496905	gold, Green Published, Green Submitted			2022-12-27	WOS:000305010500032
J	Park, HW; Cho, JS; Park, CK; Jung, SJ; Park, CH; Lee, SJ; Oh, SB; Park, YS; Chang, MS				Park, Hwan-Woo; Cho, Jung-Sun; Park, Chul-Kyu; Jung, Sung Jun; Park, Chang-Hwan; Lee, Shin-Jae; Oh, Seog Bae; Park, Young-Seok; Chang, Mi-Sook			Directed Induction of Functional Motor Neuron-Like Cells from Genetically Engineered Human Mesenchymal Stem Cells	PLOS ONE			English	Article							MARROW STROMAL CELLS; ADENOSINE-MONOPHOSPHATE STIMULATION; SPINAL-CORD-INJURY; BONE-MARROW; TRANSCRIPTION FACTORS; DIFFERENTIATION PROTOCOLS; AXONAL ELONGATION; SUBTYPE IDENTITY; IN-VITRO; SPECIFICATION	Cell replacement using stem cells is a promising therapeutic approach to treat degenerative motor neuron (MN) disorders, such as amyotrophic lateral sclerosis and spinal cord injury. Human bone marrow-derived mesenchymal stem cells (hMSCs) are a desirable cell source for autologous cell replacement therapy to treat nervous system injury due to their plasticity, low immunogenicity, and a lower risk of tumor formation than embryonic stem cells. However, hMSCs are inefficient with regards to differentiating into MN-like cells. To solve this limitation, we genetically engineered hMSCs to express MN-associated transcription factors, Olig2 and Hb9, and then treat the hMSCs expressing Olig2 and Hb9 with optimal MN induction medium (MNIM). This method of induction led to higher expression (>30% of total cells) of MN markers. Electrophysiological data revealed that the induced hMSCs had the excitable properties of neurons and were able to form functional connections with muscle fibers in vitro. Furthermore, when the induced hMSCs were transplanted into an injured organotypic rat spinal cord slice culture, an ex vivo model of spinal cord injury, they exhibited characteristics of MNs. The data strongly suggest that induced Olig2/Hb9-expressing hMSCs were clearly reprogrammed and directed toward a MN-like lineage. We propose that methods to induce Olig2 and Hb9, followed by further induction with MNIM have therapeutic potential for autologous cell replacement therapy to treat degenerative MN disorders.	[Park, Hwan-Woo; Cho, Jung-Sun; Park, Young-Seok; Chang, Mi-Sook] Seoul Natl Univ, Dent Res Inst, Dept Oral Anat, Seoul, South Korea; [Park, Hwan-Woo; Cho, Jung-Sun; Park, Chul-Kyu; Lee, Shin-Jae; Oh, Seog Bae; Park, Young-Seok; Chang, Mi-Sook] Seoul Natl Univ, Sch Dent, Seoul, South Korea; [Park, Chul-Kyu; Oh, Seog Bae] Seoul Natl Univ, Dent Res Inst, Dept Physiol, Seoul, South Korea; [Jung, Sung Jun] Hanyang Univ, Coll Med, Dept Physiol, Seoul 133791, South Korea; [Park, Chang-Hwan] Hanyang Univ, Coll Med, Grad Sch Biomed Sci & Engn, Seoul 133791, South Korea; [Park, Chang-Hwan] Hanyang Univ, Coll Med, Dept Microbiol, Seoul 133791, South Korea; [Lee, Shin-Jae] Seoul Natl Univ, Dent Res Inst, Dept Orthodont, Seoul, South Korea; [Chang, Mi-Sook] Seoul Natl Univ, Neurosci Res Inst, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Hanyang University; Hanyang University; Hanyang University; Seoul National University (SNU); Seoul National University (SNU)	Park, HW (corresponding author), Seoul Natl Univ, Dent Res Inst, Dept Oral Anat, Seoul, South Korea.	mschang@snu.ac.kr	Lee, Shin-Jae/D-5883-2012; Park, Hwan-Woo/D-2358-2014; OH, Seog Bae/AAQ-2478-2020; Park, Young-Seok/D-5762-2012	Lee, Shin-Jae/0000-0003-1861-1400; Park, Hwan-Woo/0000-0001-8029-2004; Oh, Seog Bae/0000-0001-7975-6895; Chang, Mi-Sook/0000-0002-4379-204X	National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [2011-0003075]; Ministry of Health & Welfare, Republic of Korea [A100823]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Ministry of Health & Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This research was supported by a grant from the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (M-SC, 2011-0003075) and a grant from the Korea Health Technology R&D Project, Ministry of Health & Welfare (M-SC, A100823), Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barzilay R, 2008, STEM CELLS DEV, V17, P547, DOI 10.1089/scd.2007.0172; Bianco P, 2001, STEM CELLS, V19, P180, DOI 10.1634/stemcells.19-3-180; Bohl D, 2008, STEM CELLS, V26, P2564, DOI 10.1634/stemcells.2008-0371; Boillee S, 2006, NEURON, V52, P39, DOI 10.1016/j.neuron.2006.09.018; Brejot T, 2006, EXP NEUROL, V198, P167, DOI 10.1016/j.expneurol.2005.11.026; Briscoe J, 2008, PHILOS T R SOC B, V363, P57, DOI 10.1098/rstb.2006.2012; Cho JS, 2009, NEUROSCI LETT, V454, P43, DOI 10.1016/j.neulet.2009.02.024; Cleveland DW, 2001, NAT REV NEUROSCI, V2, P806, DOI 10.1038/35097565; Diez del Corral R, 2003, NEURON, V40, P65; Ericson J, 1997, CELL, V90, P169, DOI 10.1016/S0092-8674(00)80323-2; Helmy KY, 2010, THER DELIV, V1, P693, DOI [10.4155/tde.10.57, 10.4155/TDE.10.57]; Lee SK, 2003, NEURON, V38, P731, DOI 10.1016/S0896-6273(03)00296-4; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; Li JY, 2008, TRENDS NEUROSCI, V31, P146, DOI 10.1016/j.tins.2007.12.001; Li XJ, 2005, NAT BIOTECHNOL, V23, P215, DOI 10.1038/nbt1063; Maden M, 2002, NAT REV NEUROSCI, V3, P843, DOI 10.1038/nrn963; Miles GB, 2004, J NEUROSCI, V24, P7848, DOI 10.1523/JNEUROSCI.1972-04.2004; Morrison SJ, 1999, CELL, V96, P737, DOI 10.1016/S0092-8674(00)80583-8; Munoz-Elias G, 2003, STEM CELLS, V21, P437, DOI 10.1634/stemcells.21-4-437; Nagoshi N, 2008, CELL STEM CELL, V2, P392, DOI 10.1016/j.stem.2008.03.005; Nayak MS, 2006, BBA-MOL BASIS DIS, V1762, P1128, DOI 10.1016/j.bbadis.2006.06.004; Neuhuber B, 2004, J NEUROSCI RES, V77, P192, DOI 10.1002/jnr.20147; Novitch BG, 2003, NEURON, V40, P81, DOI 10.1016/j.neuron.2003.08.006; Novitch BG, 2001, NEURON, V31, P773, DOI 10.1016/S0896-6273(01)00407-X; Nussbaum J, 2007, FASEB J, V21, P1345, DOI 10.1096/fj.06-6769com; Pang ZPP, 2011, NATURE, V476, P220, DOI 10.1038/nature10202; Park HW, 2010, GLIA, V58, P1118, DOI 10.1002/glia.20992; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Rameshwar P, 2009, MOL THER, V17, P216, DOI 10.1038/mt.2008.296; Reyes M, 2001, BLOOD, V98, P2615, DOI 10.1182/blood.V98.9.2615; ROELINK H, 1995, CELL, V81, P445, DOI 10.1016/0092-8674(95)90397-6; ROISEN FJ, 1972, SCIENCE, V175, P73, DOI 10.1126/science.175.4017.73; ROISEN FJ, 1972, SCIENCE, V177, P809, DOI 10.1126/science.177.4051.809; Sanchez-Ramos J, 2000, EXP NEUROL, V164, P247, DOI 10.1006/exnr.2000.7389; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; Shah NM, 1996, CELL, V85, P331, DOI 10.1016/S0092-8674(00)81112-5; Sherman LS, 2011, CTS-CLIN TRANSL SCI, V4, P380, DOI 10.1111/j.1752-8062.2011.00283.x; Shirasaki R, 2002, ANNU REV NEUROSCI, V25, P251, DOI 10.1146/annurev.neuro.25.112701.142916; Sockanathan S, 2003, NEURON, V40, P97, DOI 10.1016/S0896-6273(03)00532-4; Sockanathan S, 1998, CELL, V94, P503, DOI 10.1016/S0092-8674(00)81591-3; Takashima Y, 2007, CELL, V129, P1377, DOI 10.1016/j.cell.2007.04.028; Thaler JP, 2004, NEURON, V41, P337, DOI 10.1016/S0896-6273(04)00011-X; Thuret S, 2006, NAT REV NEUROSCI, V7, P628, DOI 10.1038/nrn1955; Trzaska KA, 2007, STEM CELLS, V25, P2797, DOI 10.1634/stemcells.2007-0212; Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8; Woodbury D, 2000, J NEUROSCI RES, V61, P364, DOI 10.1002/1097-4547(20000815)61:4<364::AID-JNR2>3.0.CO;2-C; Zhang XD, 2006, STEM CELLS, V24, P434, DOI 10.1634/stemcells.2005-0171	48	11	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2012	7	4							e35244	10.1371/journal.pone.0035244	http://dx.doi.org/10.1371/journal.pone.0035244			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955IH	22496912	Green Published, gold			2022-12-27	WOS:000305010500035
J	Enea-Drapeau, C; Carlier, M; Huguet, P				Enea-Drapeau, Claire; Carlier, Michele; Huguet, Pascal			Tracking Subtle Stereotypes of Children with Trisomy 21: From Facial-Feature-Based to Implicit Stereotyping	PLOS ONE			English	Article							DOWN-SYNDROME; ASSOCIATION TEST; INDIVIDUAL-DIFFERENCES; INTERGROUP CONTACT; SOCIAL COGNITION; RACIAL-ATTITUDES; THREAT; DISABILITIES; PERFORMANCE; PREJUDICE	Background: Stigmatization is one of the greatest obstacles to the successful integration of people with Trisomy 21 (T21 or Down syndrome), the most frequent genetic disorder associated with intellectual disability. Research on attitudes and stereotypes toward these people still focuses on explicit measures subjected to social-desirability biases, and neglects how variability in facial stigmata influences attitudes and stereotyping. Methodology/Principal Findings: The participants were 165 adults including 55 young adult students, 55 non-student adults, and 55 professional caregivers working with intellectually disabled persons. They were faced with implicit association tests (IAT), a well-known technique whereby response latency is used to capture the relative strength with which some groups of people-here photographed faces of typically developing children and children with T21-are automatically (without conscious awareness) associated with positive versus negative attributes in memory. Each participant also rated the same photographed faces (consciously accessible evaluations). We provide the first evidence that the positive bias typically found in explicit judgments of children with T21 is smaller for those whose facial features are highly characteristic of this disorder, compared to their counterparts with less distinctive features and to typically developing children. We also show that this bias can coexist with negative evaluations at the implicit level (with large effect sizes), even among professional caregivers. Conclusion: These findings support recent models of feature-based stereotyping, and more importantly show how crucial it is to go beyond explicit evaluations to estimate the true extent of stigmatization of intellectually disabled people.	[Enea-Drapeau, Claire] Aix Marseille Univ, Lab Psychol Cognit, Marseille, France; CNRS, Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS)	Enea-Drapeau, C (corresponding author), Aix Marseille Univ, Lab Psychol Cognit, Marseille, France.	claire.enea-drapeau@univ-amu.fr		Huguet, Pascal/0000-0002-0707-7655	Aix-Marseille University; Centre National de la Recherche Scientifique; "Fondation Jerome Lejeune" (France)	Aix-Marseille University; Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); "Fondation Jerome Lejeune" (France)	Support for this research was provided by Aix-Marseille University, the Centre National de la Recherche Scientifique, and the "Fondation Jerome Lejeune" (France). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambady N, 2001, PSYCHOL SCI, V12, P385, DOI 10.1111/1467-9280.00371; Bargh JA, 2006, CURR DIR PSYCHOL SCI, V15, P1, DOI 10.1111/j.0963-7214.2006.00395.x; Blair IV, 2004, J PERS SOC PSYCHOL, V87, P763, DOI 10.1037/0022-3514.87.6.763; Blair IV, 2002, J PERS SOC PSYCHOL, V83, P5, DOI 10.1037/0022-3514.83.1.5; Blair IV, 2004, PSYCHOL SCI, V15, P674, DOI 10.1111/j.0956-7976.2004.00739.x; Bodenhausen GV, 1997, ADV SOCIAL COGNITION, P1; Borthwick C, 1996, DISABIL SOC, V11, P403, DOI 10.1080/09687599627688; Brewer M.B., 1988, ADV SOCIAL COGNITION, P1, DOI DOI 10.2307/1423264; Carlier M., 2007, DEFICIENCES INTELLEC; Croizet JC, 1998, PERS SOC PSYCHOL B, V24, P588, DOI 10.1177/0146167298246003; Croizet JC, 2004, PERS SOC PSYCHOL B, V30, P721, DOI 10.1177/0146167204263961; Cunningham C., 2004, INT J DISABIL DEV ED, V51, P335, DOI [10.1080/1034912042000295017., DOI 10.1080/1034912042000295017]; Dasgupta N, 2000, J EXP SOC PSYCHOL, V36, P316, DOI 10.1006/jesp.1999.1418; DEVINE PG, 1989, J PERS SOC PSYCHOL, V56, P5, DOI 10.1037/0022-3514.56.1.5; Fidler DJ, 1999, AM J MENT RETARD, V104, P410, DOI 10.1352/0895-8017(1999)104<0410:CMAPPI>2.0.CO;2; Finlay WML, 2000, BRIT J SOC PSYCHOL, V39, P129, DOI 10.1348/014466600164372; FISKE ST, 1993, ANNU REV PSYCHOL, V44, P155, DOI 10.1146/annurev.psych.44.1.155; FISKE ST, 1990, ADV EXP SOC PSYCHOL, V23, P1, DOI 10.1016/S0065-2601(08)60317-2; Gilmore L., 2003, INT J DISABIL DEV ED, V50, P65, DOI [10.1080/1034912032000053340, DOI 10.1080/1034912032000053340]; Glenn S., 2004, INT J DISABIL DEV ED, V51, P363, DOI [10.1080/1034912042000295026., DOI 10.1080/1034912042000295026]; GREENWALD AG, 1995, PSYCHOL REV, V102, P4, DOI 10.1037/0033-295X.102.1.4; Greenwald AG, 1998, J PERS SOC PSYCHOL, V74, P1464, DOI 10.1037/0022-3514.74.6.1464; Greenwald AG, 2003, J PERS SOC PSYCHOL, V85, P197, DOI 10.1037/0022-3514.85.2.197; Greenwald AG, 2006, CALIF LAW REV, V94, P945, DOI 10.2307/20439056; Henry PJ, 2006, PSYCHOL SCI, V17, P862, DOI 10.1111/j.1467-9280.2006.01795.x; Huguet P, 2007, J EDUC PSYCHOL, V99, P545, DOI 10.1037/0022-0663.99.3.545; Huguet P, 2009, J EXP SOC PSYCHOL, V45, P1024, DOI 10.1016/j.jesp.2009.04.029; JULIANREYNIER C, 1995, J MED GENET, V32, P597, DOI 10.1136/jmg.32.8.597; Lawson KL, 2010, J APPL SOC PSYCHOL, V40, P554, DOI 10.1111/j.1559-1816.2010.00587.x; LEVY JM, 1993, J REHABIL, V59, P49; Maras P, 1996, J APPL SOC PSYCHOL, V26, P2113, DOI 10.1111/j.1559-1816.1996.tb01790.x; Mason MF, 2006, SOC COGNITION, V24, P540, DOI 10.1521/soco.2006.24.5.540; Mazerolles M, 2012, PSYCHOL SCI IN PRESS; McConnell AR, 2001, J EXP SOC PSYCHOL, V37, P435, DOI 10.1006/jesp.2000.1470; McKown C, 2003, CHILD DEV, V74, P498, DOI 10.1111/1467-8624.7402012; MENOLASCINO FJ, 1965, AM J MENT DEF, V69, P653; Mepsted J, 1988, SPECIAL CHILDREN, V17, P14; Morris JK, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b3794; Murthy SK, 2007, MED PRIN PRACT, V16, P25, DOI 10.1159/000096136; Nosek BA, 2009, P NATL ACAD SCI USA, V106, P10593, DOI 10.1073/pnas.0809921106; Olsen CL, 2003, HUM BIOL, V75, P503, DOI 10.1353/hub.2003.0059; Pace JE, 2010, AM J MED GENET A, V152A, P2185, DOI 10.1002/ajmg.a.33595; Peris TS, 2008, J NERV MENT DIS, V196, P752, DOI 10.1097/NMD.0b013e3181879dfd; Prestwich A, 2008, BRIT J SOC PSYCHOL, V47, P575, DOI 10.1348/014466607X267470; Regner I, 2010, PSYCHOL SCI, V21, P1646, DOI 10.1177/0956797610386619; Richetin J, 2007, INT J PSYCHOL, V42, P166, DOI 10.1080/00207590601067078; Robey KL, 2006, J DEV PHYS DISABIL, V18, P441, DOI 10.1007/s10882-006-9027-3; Rojahn J, 2008, J DEV PHYS DISABIL, V20, P389, DOI 10.1007/s10882-008-9108-6; Sirlopu D, 2008, J APPL SOC PSYCHOL, V38, P2710, DOI 10.1111/j.1559-1816.2008.00411.x; STEELE CM, 1995, J PERS SOC PSYCHOL, V69, P797, DOI 10.1037/0022-3514.69.5.797; Thomas A, 2007, J REHABIL, V73, P3; Turner RN, 2010, BRIT J SOC PSYCHOL, V49, P129, DOI 10.1348/014466609X419901; Unger D. D., 2002, FOCUS AUTISM DEV DIS, V17, P2, DOI [10.1177/108835760201700101, DOI 10.1177/108835760201700101]; White MJ, 2006, J REHABIL, V72, P33; Wilson TD, 2000, PSYCHOL REV, V107, P101, DOI 10.1037/0033-295X.107.1.101; Wishart JG, 1996, J INTELL DISABIL RES, V40, P56, DOI 10.1111/j.1365-2788.1996.tb00603.x	56	31	31	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e34369	10.1371/journal.pone.0034369	http://dx.doi.org/10.1371/journal.pone.0034369			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	953GO	22496796	gold, Green Published			2022-12-27	WOS:000304855200043
J	Khrameeva, EE; Mironov, AA; Fedonin, GG; Khaitovich, P; Gelfand, MS				Khrameeva, Ekaterina E.; Mironov, Andrey A.; Fedonin, Gennady G.; Khaitovich, Philipp; Gelfand, Mikhail S.			Spatial Proximity and Similarity of the Epigenetic State of Genome Domains	PLOS ONE			English	Article							INTEGRATIVE ANALYSIS; SEMANTIC SIMILARITY; CHROMATIN; MONOMETHYLATION; DISCOVERY	Recent studies demonstrate that the organization of the chromatin within the nuclear space might play a crucial role in the regulation of gene expression. The ongoing progress in determination of the 3D structure of the nuclear chromatin allows one to study correlations between spatial proximity of genome domains and their epigenetic state. We combined the data on three-dimensional architecture of the whole human genome with results of high-throughput studies of the chromatin functional state and observed that fragments of different chromosomes that are spatially close tend to have similar patterns of histone modifications, methylation state, DNAse sensitivity, expression level, and chromatin states in general. Moreover, clustering of genome regions by spatial proximity produced compact clusters characterized by the high level of histone modifications and DNAse sensitivity and low methylation level, and loose clusters with the opposite characteristics. We also associated the spatial proximity data with previously detected chimeric transcripts and the results of RNA-seq experiments and observed that the frequency of formation of chimeric transcripts from fragments of two different chromosomes is higher among spatially proximal genome domains. A fair fraction of these chimeric transcripts seems to arise post-transcriptionally via trans-splicing.	[Khrameeva, Ekaterina E.; Mironov, Andrey A.; Fedonin, Gennady G.; Gelfand, Mikhail S.] Russian Acad Sci, Inst Informat Transmiss Problems, Moscow, Russia; [Khrameeva, Ekaterina E.; Mironov, Andrey A.; Gelfand, Mikhail S.] Moscow MV Lomonosov State Univ, Fac Bioengn & Bioinformat, Moscow, Russia; [Khaitovich, Philipp] Shanghai Inst Biol Sci, Partner Inst Computat Biol, Shanghai, Peoples R China; [Khaitovich, Philipp] Max Planck Inst Evolutionary Anthropol, Leipzig, Germany	Kharkevich Institute for Information Transmission Problems of the RAS; Russian Academy of Sciences; Lomonosov Moscow State University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Max Planck Society	Khrameeva, EE (corresponding author), Russian Acad Sci, Inst Informat Transmiss Problems, Moscow, Russia.	khrameeva@genebee.msu.ru	Khrameeva, Ekaterina/I-3620-2015; Fedonin, Gennady/M-5786-2014; Gelfand, Mikhail S/F-3425-2012; Khaitovich, Philipp/HGC-8520-2022; Mironov, Andrey/C-8024-2012	Khrameeva, Ekaterina/0000-0001-6188-9139; Fedonin, Gennady/0000-0002-9427-8083; Gelfand, Mikhail/0000-0003-4181-0846	Russian Foundation of Basic Research [10-04-00783, 09-04-92745, 09-04-92742]; Russian Academy of Sciences;  [07.514.11.4007];  [14.740.11.0003]	Russian Foundation of Basic Research(Russian Foundation for Basic Research (RFBR)); Russian Academy of Sciences(Russian Academy of Sciences); ; 	This work was supported by State contracts [07.514.11.4007, 14.740.11.0003]; the Russian Foundation of Basic Research [10-04-00783 to EK, 09-04-92745 to MG, and 09-04-92742 to AM]; and the Russian Academy of Sciences ["Molecular and Cellular Biology", "Basic Science for Medicine"]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, R LANG ENV STAT COMP; Berger MF, 2010, GENOME RES, V20, P413, DOI 10.1101/gr.103697.109; Bernstein BE, 2007, CELL, V128, P669, DOI 10.1016/j.cell.2007.01.033; Bock C, 2008, BIOINFORMATICS, V24, P1, DOI 10.1093/bioinformatics/btm546; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Cocquet J, 2006, GENOMICS, V88, P127, DOI 10.1016/j.ygeno.2005.12.013; CREMER T, 1982, HUM GENET, V60, P46, DOI 10.1007/BF00281263; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Denoeud F, 2007, GENOME RES, V17, P746, DOI 10.1101/gr.5660607; Dorigo B, 2003, J MOL BIOL, V327, P85, DOI 10.1016/S0022-2836(03)00025-1; Ernst J, 2010, NAT BIOTECHNOL, V28, P817, DOI 10.1038/nbt.1662; Feingold EA, 2004, SCIENCE, V306, P636, DOI 10.1126/science.1105136; Gerstein MB, 2010, SCIENCE, V330, P1775, DOI 10.1126/science.1196914; Gingeras TR, 2009, NATURE, V461, P206, DOI 10.1038/nature08452; Houston SI, 2008, J BIOL CHEM, V283, P19478, DOI 10.1074/jbc.M710579200; Hubner MR, 2010, ANNU REV BIOPHYS, V39, P471, DOI 10.1146/annurev.biophys.093008.131348; Karolchik D, 2003, NUCLEIC ACIDS RES, V31, P51, DOI 10.1093/nar/gkg129; Kidd JM, 2008, NATURE, V453, P56, DOI 10.1038/nature06862; Kim P, 2010, NUCLEIC ACIDS RES, V38, pD81, DOI 10.1093/nar/gkp982; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Li X, 2009, J MOL EVOL, V68, P56, DOI 10.1007/s00239-008-9187-0; Li ZF, 2011, P NATL ACAD SCI USA, V108, P3116, DOI 10.1073/pnas.1009353108; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Liu W, 2010, NATURE, V466, P508, DOI 10.1038/nature09272; Lowe CB, 2007, P NATL ACAD SCI USA, V104, P8005, DOI 10.1073/pnas.0611223104; Maher CA, 2009, P NATL ACAD SCI USA, V106, P12353, DOI 10.1073/pnas.0904720106; Maher CA, 2009, NATURE, V458, P97, DOI 10.1038/nature07638; McManus CJ, 2010, P NATL ACAD SCI USA, V107, P12975, DOI 10.1073/pnas.1007586107; Obayashi T, 2011, NUCLEIC ACIDS RES, V39, pD1016, DOI 10.1093/nar/gkq1147; Roy S, 2010, SCIENCE, V330, P1787, DOI 10.1126/science.1198374; Schones DE, 2008, NAT REV GENET, V9, P179, DOI 10.1038/nrg2270; Schotta G, 2008, GENE DEV, V22, P2048, DOI 10.1101/gad.476008; Talasz H, 2005, J BIOL CHEM, V280, P38814, DOI 10.1074/jbc.M505563200; Tikhonov A. N., 1943, DOKL AKAD NAUK SSSR, V39, P195; Vakoc CR, 2006, MOL CELL BIOL, V26, P9185, DOI 10.1128/MCB.01529-06; Wang JZ, 2007, BIOINFORMATICS, V23, P1274, DOI 10.1093/bioinformatics/btm087; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Williams A, 2010, TRENDS GENET, V26, P188, DOI 10.1016/j.tig.2010.01.007; Xu AG, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000843; Yaffe E, 2011, NAT GENET, V43, P1059, DOI 10.1038/ng.947; Yu GC, 2010, BIOINFORMATICS, V26, P976, DOI 10.1093/bioinformatics/btq064; Yu H, 2008, GENOME RES, V18, P1314, DOI 10.1101/gr.073080.107	43	10	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e33947	10.1371/journal.pone.0033947	http://dx.doi.org/10.1371/journal.pone.0033947			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GO	22496774	Green Published, gold, Green Submitted			2022-12-27	WOS:000304855200027
J	Pryor, S; McCaffrey, G; Young, LR; Grimes, ML				Pryor, Shona; McCaffrey, Gretchen; Young, Lindsay R.; Grimes, Mark L.			NGF Causes TrkA to Specifically Attract Microtubules to Lipid Rafts	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; P75 NEUROTROPHIN RECEPTOR; SIGNALING ENDOSOMES; PC12 CELLS; ENDOCYTIC PATHWAY; POSTTRANSLATIONAL MODIFICATIONS; MEMBRANE TRAFFICKING; NEURONAL APOPTOSIS; TYROSINE KINASE; PLASMA-MEMBRANE	Membrane protein sorting is mediated by interactions between proteins and lipids. One mechanism that contributes to sorting involves patches of lipids, termed lipid rafts, which are different from their surroundings in lipid and protein composition. Although the nerve growth factor (NGF) receptors, TrkA and p75(NTR) collaborate with each other at the plasma membrane to bind NGF, these two receptors are endocytosed separately and activate different cellular responses. We hypothesized that receptor localization in membrane rafts may play a role in endocytic sorting. TrkA and p75(NTR) both reside in detergent-resistant membranes (DRMs), yet they responded differently to a variety of conditions. The ganglioside, GM1, caused increased association of NGF, TrkA, and microtubules with DRMs, but a decrease in p75(NTR). When microtubules were induced to polymerize and attach to DRMs by in vitro reactions, TrkA, but not p75(NTR), was bound to microtubules in DRMs and in a detergent-resistant endosomal fraction. NGF enhanced the interaction between TrkA and microtubules in DRMs, yet tyrosine phosphorylated TrkA was entirely absent in DRMs under conditions where activated TrkA was detected in detergent-sensitive membranes and endosomes. These data indicate that TrkA and p75(NTR) partition into membrane rafts by different mechanisms, and that the fraction of TrkA that associates with DRMs is internalized but does not directly form signaling endosomes. Rather, by attracting microtubules to lipid rafts, TrkA may mediate other processes such as axon guidance.	[Pryor, Shona; Young, Lindsay R.] Massey Univ, Inst Mol Biosci, Palmerston North, New Zealand; [McCaffrey, Gretchen; Young, Lindsay R.; Grimes, Mark L.] Univ Montana, Div Biol Sci, Missoula, MT 59812 USA; [Grimes, Mark L.] Univ Montana, Ctr Struct & Funct Neurosci, Missoula, MT 59812 USA	Massey University; University of Montana System; University of Montana; University of Montana System; University of Montana	Pryor, S (corresponding author), AgResearch Ltd, Ruakura Res Ctr, Hamilton, New Zealand.	Mark.Grimes@mso.umt.edu			Whitehall Foundation; NIH [NS070746-01, NS061303-01]; NIH COBRE NCRR [P20 RR015583]; NIH BRIN NCRR [PR-16455-02]; Health Research Council; Cancer Society; Neurological Foundation; Lottery Health; Real Kids Trust; Palmerston North Medical Research Foundation; Massey University; Lottery Science; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015583] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R15NS070746, R15NS061303] Funding Source: NIH RePORTER	Whitehall Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH COBRE NCRR; NIH BRIN NCRR; Health Research Council; Cancer Society; Neurological Foundation; Lottery Health; Real Kids Trust; Palmerston North Medical Research Foundation; Massey University; Lottery Science; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	MG was supported by the Whitehall Foundation (www.whitehall.org/), NIH NS070746-01, NS061303-01, NIH COBRE NCRR Grant # P20 RR015583, NIH BRIN NCRR Grant #PR-16455-02 and New Zealand Funding from: Health Research Council, Cancer Society, Neurological Foundation, Lottery Health, Lottery Science, Real Kids Trust, Palmerston North Medical Research Foundation, and Massey University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar RC, 2005, P NATL ACAD SCI USA, V102, P2679, DOI 10.1073/pnas.0500213102; Bamji SX, 1998, J CELL BIOL, V140, P911, DOI 10.1083/jcb.140.4.911; BANDTLOW C, 2004, SCI STKE, pPE24, DOI DOI 10.1126/STKE.2352004PE24; Bartheld von CS, 2011, PROG NEUROBIOL, DOI [10.1016/j.pneurobio.2011.01.003, DOI 10.1016/J.PNEUROBI0.2011.01.003]; Beattie EC, 2000, J NEUROSCI, V20, P7325; Bilderback TR, 1999, J BIOL CHEM, V274, P257, DOI 10.1074/jbc.274.1.257; Bronfman FC, 2003, J NEUROSCI, V23, P3209; Canossa M, 1996, EMBO J, V15, P3369, DOI 10.1002/j.1460-2075.1996.tb00702.x; Chen H, 2005, P NATL ACAD SCI USA, V102, P2766, DOI 10.1073/pnas.0409719102; de Pablo Y, 2008, J NEUROCHEM, V104, P124, DOI 10.1111/j.1471-4159.2007.05027.x; Dechant G, 2002, NAT NEUROSCI, V5, P1131, DOI 10.1038/nn1102-1131; Deinhardt K, 2007, TRAFFIC, V8, P1736, DOI 10.1111/j.1600-0854.2007.00645.x; del Pozo MA, 2004, SCIENCE, V303, P839, DOI 10.1126/science.1092571; Dixon SJ, 2006, BBA-MOL CELL RES, V1763, P366, DOI 10.1016/j.bbamcr.2006.02.009; DRUBIN D, 1988, J CELL BIOL, V106, P1583, DOI 10.1083/jcb.106.5.1583; DRUBIN DG, 1985, J CELL BIOL, V101, P1799, DOI 10.1083/jcb.101.5.1799; Esposito D, 2001, J BIOL CHEM, V276, P32687, DOI 10.1074/jbc.M011674200; Farooqui T, 1997, J NEUROCHEM, V68, P2348; FERRARI G, 1995, J BIOL CHEM, V270, P3074, DOI 10.1074/jbc.270.7.3074; Francois F, 2001, MOL CELL NEUROSCI, V18, P347, DOI 10.1006/mcne.2001.1035; Fukushima N, 2009, J NEUROCHEM, V109, P683, DOI 10.1111/j.1471-4159.2009.06013.x; Galjart N, 2003, CURR OPIN CELL BIOL, V15, P48, DOI 10.1016/S0955-0674(02)00007-8; Geetha T, 2008, TRAFFIC, V9, P1146, DOI 10.1111/j.1600-0854.2008.00751.x; Glebov OO, 2006, NAT CELL BIOL, V8, P46, DOI 10.1038/ncb1342; GREENE LA, 1987, METHOD ENZYMOL, V147, P207; Grimes ML, 1997, P NATL ACAD SCI USA, V94, P9909, DOI 10.1073/pnas.94.18.9909; Grimes ML, 1996, J NEUROSCI, V16, P7950; Grimes ML, 2003, J NEUROCHEM, V84, P905, DOI 10.1046/j.1471-4159.2003.01603.x; Haglund K, 2003, NAT CELL BIOL, V5, P461, DOI 10.1038/ncb983; HANTZOPOULOS PA, 1994, NEURON, V13, P187, DOI 10.1016/0896-6273(94)90469-3; Harrington AW, 2011, CELL, V146, P421, DOI 10.1016/j.cell.2011.07.008; Head BP, 2006, J BIOL CHEM, V281, P26391, DOI 10.1074/jbc.M602577200; Hibbert AP, 2006, MOL CELL NEUROSCI, V32, P387, DOI 10.1016/j.mcn.2006.06.001; Higuchi H, 2003, EMBO J, V22, P1790, DOI 10.1093/emboj/cdg177; Hoeller D, 2005, CURR OPIN CELL BIOL, V17, P107, DOI 10.1016/j.ceb.2005.01.001; Howe CL, 2001, NEURON, V32, P801, DOI 10.1016/S0896-6273(01)00526-8; Hryciw T, 2010, J NEUROCHEM, V112, P924, DOI 10.1111/j.1471-4159.2009.06503.x; Huang C, 1999, J BIOL CHEM, V274, P36707, DOI 10.1074/jbc.274.51.36707; HUBER LJ, 1995, J NEUROSCI RES, V40, P557, DOI 10.1002/jnr.490400415; Ibanez CF, 2004, NEURON, V42, P3, DOI 10.1016/S0896-6273(04)00194-1; Kamiguchi H, 2006, J NEUROCHEM, V98, P330, DOI 10.1111/j.1471-4159.2006.03888.x; Lakadamyali M, 2006, CELL, V124, P997, DOI 10.1016/j.cell.2005.12.038; Lasiecka ZM, 2011, MOL CELL NEUROSCI, V48, P278, DOI 10.1016/j.mcn.2011.06.013; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; MacCormick M, 2005, BIOCHEM J, V387, P155, DOI 10.1042/BJ20040272; Madshus IH, 2006, TRAFFIC, V7, P258, DOI 10.1111/j.1600-0854.2006.00393.x; Makkerh JPS, 2005, EMBO REP, V6, P936, DOI 10.1038/sj.embor.7400503; McCaffrey G, 2009, TRAFFIC, V10, P938, DOI 10.1111/j.1600-0854.2009.00909.x; Miller FD, 2001, CELL MOL LIFE SCI, V58, P1045, DOI 10.1007/PL00000919; MUTOH T, 1995, P NATL ACAD SCI USA, V92, P5087, DOI 10.1073/pnas.92.11.5087; Neumann-Giesen C, 2007, J CELL SCI, V120, P395, DOI 10.1242/jcs.03336; Nichols BJ, 2003, CURR BIOL, V13, P686, DOI 10.1016/S0960-9822(03)00209-4; Nishio M, 2004, J BIOL CHEM, V279, P33368, DOI 10.1074/jbc.M403816200; Palazzo AF, 2004, SCIENCE, V303, P836, DOI 10.1126/science.1091325; Paratcha G, 2002, CURR OPIN NEUROBIOL, V12, P542, DOI 10.1016/S0959-4388(02)00363-X; Perret E, 2005, CURR OPIN CELL BIOL, V17, P423, DOI 10.1016/j.ceb.2005.06.008; Philippidou P, 2011, P NATL ACAD SCI USA, V108, P852, DOI 10.1073/pnas.1015981108; Pike LJ, 2003, J LIPID RES, V44, P655, DOI 10.1194/jlr.R200021-JLR200; Polo S, 2006, CELL, V124, P897, DOI 10.1016/j.cell.2006.02.025; Polo S, 2002, NATURE, V416, P451, DOI 10.1038/416451a; RABIN SJ, 1995, J NEUROCHEM, V65, P347; Sadowski L, 2009, EXP CELL RES, V315, P1601, DOI 10.1016/j.yexcr.2008.09.021; Saxena S, 2005, MOL CELL NEUROSCI, V28, P571, DOI 10.1016/j.mcn.2004.11.011; Schwarz LA, 2012, MOL CELL NEUROSCI, V49, P387, DOI 10.1016/j.mcn.2011.08.006; Shao YF, 2002, J CELL BIOL, V157, P679, DOI 10.1083/jcb.200201063; Sigismund S, 2005, P NATL ACAD SCI USA, V102, P2760, DOI 10.1073/pnas.0409817102; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Simons K, 2010, NAT REV MOL CELL BIO, V11, P688, DOI 10.1038/nrm2977; Suzuki S, 2004, J CELL BIOL, V167, P1205, DOI 10.1083/jcb.200404106; Tsui-Pierchala BA, 2002, TRENDS NEUROSCI, V25, P412, DOI 10.1016/S0166-2236(02)02215-4; Ueda A, 2010, MOL CELL NEUROSCI, V45, P355, DOI 10.1016/j.mcn.2010.07.008; Valdez G, 2005, J NEUROSCI, V25, P5236, DOI 10.1523/JNEUROSCI.5104-04.2005; Valdez G, 2007, P NATL ACAD SCI USA, V104, P12270, DOI 10.1073/pnas.0702819104; Winckler B, 2011, TRAFFIC, V12, P1099, DOI 10.1111/j.1600-0854.2011.01213.x; Wloga D, 2010, J CELL SCI, V123, P3447, DOI 10.1242/jcs.063727; Wu CB, 2007, TRAFFIC, V8, P1503, DOI 10.1111/j.1600-0854.2007.00636.x; Yamashita T, 2005, MOL NEUROBIOL, V32, P105, DOI 10.1385/MN:32:2:105; Yu WY, 2004, FEBS LETT, V577, P87, DOI 10.1016/j.febslet.2004.09.068; Zheng J, 2008, J BIOL CHEM, V283, P13280, DOI 10.1074/jbc.M709930200; Zhou FQ, 2006, J CELL SCI, V119, P2787, DOI 10.1242/jcs.03016; Zhou FQ, 2004, NEURON, V42, P897, DOI 10.1016/j.neuron.2004.05.011; Zweifel LS, 2005, NAT REV NEUROSCI, V6, P615, DOI 10.1038/nrn1727	82	22	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e35163	10.1371/journal.pone.0035163	http://dx.doi.org/10.1371/journal.pone.0035163			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GO	22496904	Green Published, Green Submitted, gold			2022-12-27	WOS:000304855200101
J	Rahman, S; Quann, K; Pandya, D; Singh, S; Khan, ZK; Jain, P				Rahman, Saifur; Quann, Kevin; Pandya, Devanshi; Singh, Shruti; Khan, Zafar K.; Jain, Pooja			HTLV-1 Tax Mediated Downregulation of miRNAs Associated with Chromatin Remodeling Factors in T Cells with Stably Integrated Viral Promoter	PLOS ONE			English	Article							VIRUS TYPE-I; MYELOPATHY/TROPICAL SPASTIC PARAPARESIS; CENTRAL-NERVOUS-SYSTEM; LONG TERMINAL REPEAT; TYPE-1 TAX; TRANSCRIPTIONAL ACTIVATION; HISTONE ACETYLTRANSFERASE; ASYMPTOMATIC CARRIERS; 21-BASE-PAIR REPEATS; BASAL TRANSCRIPTION	RNA interference (RNAi) is a natural cellular mechanism to silence gene expression and is predominantly mediated by microRNAs (miRNAs) that target messenger RNA. Viruses can manipulate the cellular processes necessary for their replication by targeting the host RNAi machinery. This study explores the effect of human T-cell leukemia virus type 1 (HTLV-1) transactivating protein Tax on the RNAi pathway in the context of a chromosomally integrated viral long terminal repeat (LTR) using a CD4(+) T-cell line, Jurkat. Transcription factor profiling of the HTLV-1 LTR stably integrated T-cell clone transfected with Tax demonstrates increased activation of substrates and factors associated with chromatin remodeling complexes. Using a miRNA microarray and bioinformatics experimental approach, Tax was also shown to downregulate the expression of miRNAs associated with the translational regulation of factors required for chromatin remodeling. These observations were validated with selected miRNAs and an HTLV-1 infected T cells line, MT-2. miR-149 and miR-873 were found to be capable of directly targeting p300 and p/CAF, chromatin remodeling factors known to play critical role in HTLV-1 pathogenesis. Overall, these results are first in line establishing HTLV-1/Tax-miRNA-chromatin concept and open new avenues toward understanding retroviral latency and/or replication in a given cell type.	[Rahman, Saifur; Quann, Kevin; Pandya, Devanshi; Singh, Shruti; Khan, Zafar K.; Jain, Pooja] Drexel Univ, Coll Med, Drexel Inst Biotechnol & Virol Res, Dept Microbiol & Immunol, Philadelphia, PA 19104 USA	Drexel University	Rahman, S (corresponding author), Drexel Univ, Coll Med, Drexel Inst Biotechnol & Virol Res, Dept Microbiol & Immunol, Philadelphia, PA 19104 USA.	pjain@drexelmed.edu	Rahman, Saifur/D-8569-2012		United States Public Health Service/National Institutes of Health [AI077414, AI093172]; NATIONAL CANCER INSTITUTE [R01CA054559] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI077414, R21AI093172, R56AI077414] Funding Source: NIH RePORTER	United States Public Health Service/National Institutes of Health(United States Department of Health & Human ServicesUnited States Public Health ServiceNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	These studies were supported by the United States Public Health Service/National Institutes of Health grants: AI077414 to Dr. Jain and AI093172 to Dr. Khan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADYA N, 1995, J VIROL, V69, P1834, DOI 10.1128/JVI.69.3.1834-1841.1995; Azran Inbal, 2004, Retrovirology, V1, P20; Bangham CRM, 2003, J GEN VIROL, V84, P3177, DOI 10.1099/vir.0.19334-0; Bantignies F, 1996, MOL CELL BIOL, V16, P2174; Barnhart MK, 1997, J VIROL, V71, P337, DOI 10.1128/JVI.71.1.337-344.1997; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; BEIMLING P, 1992, ONCOGENE, V7, P257; Belandia B, 2003, CELL, V114, P277, DOI 10.1016/S0092-8674(03)00599-3; Bellon M, 2009, BLOOD, V113, P4914, DOI 10.1182/blood-2008-11-189845; Benkirane M, 1998, J BIOL CHEM, V273, P24898, DOI 10.1074/jbc.273.38.24898; Bennasser Y, 2005, IMMUNITY, V22, P607, DOI 10.1016/j.immuni.2005.03.010; Bennasser Yamina, 2004, Retrovirology, V1, P43, DOI 10.1186/1742-4690-1-43; Bodor J, 1995, FEBS LETT, V377, P413, DOI 10.1016/0014-5793(95)01299-0; Bogenberger JM, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-9; Cullen BR, 2006, NAT GENET, V38, pS25, DOI 10.1038/ng1793; de Vries W, 2008, GENE THER, V15, P545, DOI 10.1038/gt.2008.12; Derse D, 2007, J VIROL, V81, P6731, DOI 10.1128/JVI.02752-06; Doi K, 2005, BLOOD, V106, P1048, DOI 10.1182/blood-2004-11-4350; Doucas V, 1999, P NATL ACAD SCI USA, V96, P2633, DOI 10.1073/pnas.96.6.2633; Easley R, 2010, J VIROL, V84, P4755, DOI 10.1128/JVI.00851-09; Edlich RF, 2000, J EMERG MED, V18, P109, DOI 10.1016/S0736-4679(99)00173-0; El Kharroubi A, 1998, MOL CELL BIOL, V18, P2535, DOI 10.1128/MCB.18.5.2535; Elgin SCR, 1990, CURR OPIN CELL BIOL, V2, P437, DOI 10.1016/0955-0674(90)90125-X; Fazi F, 2007, CANCER CELL, V12, P457, DOI 10.1016/j.ccr.2007.09.020; Gallo RC, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-17; GESSAIN A, 1985, LANCET, V2, P407; Grant C, 2002, J CELL PHYSIOL, V190, P133, DOI 10.1002/JCP.10053; Grant C, 2006, J LEUKOCYTE BIOL, V80, P640, DOI 10.1189/jlb.1205723; Hakim ST, 2008, BIOCHEM BIOPH RES CO, V369, P357, DOI 10.1016/j.bbrc.2008.02.025; Harrod R, 2000, J BIOL CHEM, V275, P11852, DOI 10.1074/jbc.275.16.11852; Harrod R, 1998, MOL CELL BIOL, V18, P5052, DOI 10.1128/MCB.18.9.5052; Hayashi D, 2008, J NEUROVIROL, V14, P459, DOI 10.1080/13550280802178538; Hobert O, 2008, SCIENCE, V319, P1785, DOI 10.1126/science.1151651; HOLLSBERG P, 1993, NEW ENGL J MED, V328, P1173, DOI 10.1056/NEJM199304223281608; Huang JL, 2007, NAT MED, V13, P1241, DOI 10.1038/nm1639; Igakura T, 2003, SCIENCE, V299, P1713, DOI 10.1126/science.1080115; Jiang H, 1999, MOL CELL BIOL, V19, P8136; Johnnidis JB, 2008, NATURE, V451, P1125, DOI 10.1038/nature06607; Jones KS, 2008, NAT MED, V14, P429, DOI 10.1038/nm1745; Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329; Kashanchi F, 1998, J BIOL CHEM, V273, P34646, DOI 10.1074/jbc.273.51.34646; Kishimoto M, 2006, ENDOCR J, V53, P157, DOI 10.1507/endocrj.53.157; KIYOKAWA T, 1984, GANN, V75, P747; Koszewski NJ, 2003, J STEROID BIOCHEM, V87, P223, DOI 10.1016/j.jsbmb.2003.09.006; Kwok RPS, 1996, NATURE, V380, P642, DOI 10.1038/380642a0; Lecellier CH, 2005, SCIENCE, V308, P557, DOI 10.1126/science.1108784; LEHKY TJ, 1995, ANN NEUROL, V37, P167, DOI 10.1002/ana.410370206; Lenzmeier BA, 1998, MOL CELL BIOL, V18, P721, DOI 10.1128/MCB.18.2.721; Lin J, 2007, J VIROL, V81, P12218, DOI 10.1128/JVI.01390-07; Marzio G, 2001, P NATL ACAD SCI USA, V98, P6342, DOI 10.1073/pnas.111031498; Matsuoka M, 2007, NAT REV CANCER, V7, P270, DOI 10.1038/nrc2111; Meekings KN, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000027; Merkenschlager M, 2008, CURR OPIN IMMUNOL; Nagai M, 1998, J NEUROVIROL, V4, P586, DOI 10.3109/13550289809114225; Nagai M, 2001, BLOOD, V98, P1858, DOI 10.1182/blood.V98.6.1858; Newbound GC, 1996, J VIROL, V70, P2101, DOI 10.1128/JVI.70.4.2101-2106.1996; Nie ZQ, 2000, MOL CELL BIOL, V20, P8879, DOI 10.1128/MCB.20.23.8879-8888.2000; Okada M, 2002, J VIROL, V76, P12564, DOI 10.1128/JVI.76.24.12564-12573.2002; OSAME M, 1986, LANCET, V1, P1031; PACAUCCARALERTKUN S, 1994, MOL CELL BIOL, V14, P456, DOI 10.1128/MCB.14.1.456; Pais-Correia AM, 2010, NAT MED, V16, P83, DOI 10.1038/nm.2065; PALUTKE M, 1977, AM J CLIN PATHOL, V68, P429; Pandya D, 2007, FUTURE VIROL, V2, P481, DOI 10.2217/17460794.2.5.481; Persaud D, 2003, J VIROL, V77, P1659, DOI 10.1128/JVI.77.3.1659-1665.2003; Pichler K, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-100; POIESZ BJ, 1980, P NATL ACAD SCI-BIOL, V77, P7415, DOI 10.1073/pnas.77.12.7415; Quivy Vincent, 2007, Subcell Biochem, V41, P371; Richardson JH, 1997, BLOOD, V89, P3303, DOI 10.1182/blood.V89.9.3303; Rossi C, 1999, J MED VIROL, V58, P264, DOI 10.1002/(SICI)1096-9071(199907)58:3<264::AID-JMV12>3.0.CO;2-V; Rusinov V, 2005, NUCLEIC ACIDS RES, V33, pW696, DOI 10.1093/nar/gki364; SCHECHTER GP, 1977, BLOOD, V49, P651; Scoggin KES, 2001, MOL CELL BIOL, V21, P5520, DOI 10.1128/MCB.21.16.5520-5530.2001; SHINZATO O, 1991, BLOOD, V78, P2082; Silva MTT, 2007, CLIN INFECT DIS, V44, P689, DOI 10.1086/510679; SODROSKI JG, 1984, SCIENCE, V225, P381, DOI 10.1126/science.6330891; SUZUKI T, 1993, ONCOGENE, V8, P2391; Takatsuki K, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-16; TATENO M, 1984, J EXP MED, V159, P1105, DOI 10.1084/jem.159.4.1105; Tie F, 1996, J VIROL, V70, P8368, DOI 10.1128/JVI.70.12.8368-8374.1996; TOMITA M, 2009, INT J CANC; Triboulet R, 2007, SCIENCE, V315, P1579, DOI 10.1126/science.1136319; Uchiyama T, 1997, ANNU REV IMMUNOL, V15, P15, DOI 10.1146/annurev.immunol.15.1.15; Ureta-Vidal A, 2001, J INFECT DIS, V183, P857, DOI 10.1086/319264; Waziri A, 2000, J VIROL, V74, P2178, DOI 10.1128/JVI.74.5.2178-2185.2000; Yeung ML, 2008, CANCER RES, V68, P8976, DOI 10.1158/0008-5472.CAN-08-0769; Yeung ML, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-81; ZHAO LJ, 1992, P NATL ACAD SCI USA, V89, P7070, DOI 10.1073/pnas.89.15.7070	87	26	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e34490	10.1371/journal.pone.0034490	http://dx.doi.org/10.1371/journal.pone.0034490			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GO	22496815	Green Published, gold			2022-12-27	WOS:000304855200056
J	Brasme, JF; Grill, J; Doz, F; Lacour, B; Valteau-Couanet, D; Gaillard, S; Delalande, O; Aghakhani, N; Puget, S; Chalumeau, M				Brasme, Jean-Francois; Grill, Jacques; Doz, Francois; Lacour, Brigitte; Valteau-Couanet, Dominique; Gaillard, Stephan; Delalande, Olivier; Aghakhani, Nozar; Puget, Stephanie; Chalumeau, Martin			Long Time to Diagnosis of Medulloblastoma in Children Is Not Associated with Decreased Survival or with Worse Neurological Outcome	PLOS ONE			English	Article							HIGH-DOSE CHEMOTHERAPY; BRAIN-TUMORS; CHILDHOOD-CANCER; SYMPTOM ONSET; RISK MEDULLOBLASTOMA; DELAY; FRANCE; CLASSIFICATION; REGISTRIES; INTERVAL	Background: The long time to diagnosis of medulloblastoma, one of the most frequent brain tumors in children, is the source of painful remorse and sometimes lawsuits. We analyzed its consequences for tumor stage, survival, and sequelae. Patients and Methods: This retrospective population-based cohort study included all cases of pediatric medulloblastoma from a region of France between 1990 and 2005. We collected the demographic, clinical, and tumor data and analyzed the relations between the interval from symptom onset until diagnosis, initial disease stage, survival, and neuropsychological and neurological outcome. Results:The median interval from symptom onset until diagnosis for the 166 cases was 65 days (interquartile range 31-121, range 3-457). A long interval (defined as longer than the median) was associated with a lower frequency of metastasis in the univariate and multivariate analyses and with a larger tumor volume, desmoplastic histology, and longer survival in the univariate analysis, but not after adjustment for confounding factors. The time to diagnosis was significantly associated with IQ score among survivors. No significant relation was found between the time to diagnosis and neurological disability. In the 62 patients with metastases, a long prediagnosis interval was associated with a higher T stage, infiltration of the fourth ventricle floor, and incomplete surgical resection; it nonetheless did not influence survival significantly in this subgroup. Conclusions: We found complex and often inverse relations between time to diagnosis of medulloblastoma in children and initial severity factors, survival, and neuropsychological and neurological outcome. This interval appears due more to the nature of the tumor and its progression than to parental or medical factors. These conclusions should be taken into account in the information provided to parents and in expert assessments produced for malpractice claims.	[Brasme, Jean-Francois; Grill, Jacques; Valteau-Couanet, Dominique] Inst Gustave Roussy, Dept Pediat & Adolescent Oncol, Villejuif, France; [Brasme, Jean-Francois; Grill, Jacques; Valteau-Couanet, Dominique; Aghakhani, Nozar] Univ Paris Sud, Le Kremlin Bicetre, France; [Brasme, Jean-Francois; Grill, Jacques; Valteau-Couanet, Dominique; Aghakhani, Nozar] Hop St Vincent de Paul, INSERM, U953, Epidemiol Res Unit Perinatal Hlth & Womens & Chil, F-75674 Paris, France; [Doz, Francois] Inst Curie, Dept Pediat & Adolescent Oncol, Paris, France; [Doz, Francois; Puget, Stephanie; Chalumeau, Martin] Univ Paris 05, Paris, France; [Lacour, Brigitte] CHU Nancy, French Natl Registry Childhood Solid Tumors, Vandoeuvre Les Nancy, France; [Gaillard, Stephan] Hop Foch, Dept Neurosurg, Suresnes, France; [Gaillard, Stephan] Univ Paris Ile de France Ouest, Guyancourt, France; [Delalande, Olivier] Fdn Adolphe De Rothschild, Dept Pediat Neurosurg, Paris, France; [Aghakhani, Nozar] Ctr Hosp Bicetre, AP HP, Dept Neurosurg, Le Kremlin Bicetre, France; [Puget, Stephanie] Hop Necker Enfants Malad, AP HP, Dept Pediat Neurosurg, Paris, France; [Chalumeau, Martin] Hop Necker Enfants Malad, AP HP, Dept Pediat, Paris, France	UNICANCER; Gustave Roussy; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; Universite Paris Cite; CHU de Nancy; Hospital Foch; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	Brasme, JF (corresponding author), Inst Gustave Roussy, Dept Pediat & Adolescent Oncol, Villejuif, France.	jfbrasme@gmail.com	Doz, Francois P/K-8616-2012; aghakhani, nozar/ABF-7908-2021; Grill, Jacques/R-8093-2019; Chalumeau, Martin/F-4293-2017	Chalumeau, Martin/0000-0001-8175-3706; BRASME, jean-francois/0000-0003-1330-396X; aghakhani, nozar/0000-0001-8389-8167; Doz, Francois/0000-0001-9286-4831				Alston RD, 2003, DEV MED CHILD NEUROL, V45, P308, DOI 10.1017/S0012162203000586; Brasme JF, 2012, EUR J PEDIATR, V171, P25, DOI 10.1007/s00431-011-1480-z; CHANG CH, 1969, RADIOLOGY, V93, P1351, DOI 10.1148/93.6.1351; D'Agostino RB, 2007, CIRCULATION, V115, P2340, DOI 10.1161/CIRCULATIONAHA.105.594952; Dang-Tan T, 2008, PEDIATR BLOOD CANCER, V51, P468, DOI 10.1002/pbc.21600; Dang-Tan T, 2007, CANCER-AM CANCER SOC, V110, P703, DOI 10.1002/cncr.22849; Desandes E, 2004, PEDIATR BLOOD CANCER, V43, P749, DOI 10.1002/pbc.20148; Desandes E, 2008, EUR J CANCER, V44, P205, DOI 10.1016/j.ejca.2007.11.016; Dixon-Woods M, 2001, LANCET, V357, P670, DOI 10.1016/S0140-6736(00)04130-1; Dobrovoljac M, 2002, EUR J PEDIATR, V161, P663, DOI 10.1007/s00431-002-1088-4; Dufour C, 2008, NEURO-ONCOLOGY, V10, P488; Dufour C, 2008, NEURO-ONCOLOGY, V10, P423; Edgeworth J, 1996, ARCH DIS CHILD, V74, P148, DOI 10.1136/adc.74.2.148; FLORES LE, 1986, AM J DIS CHILD, V140, P684, DOI 10.1001/archpedi.1986.02140210082031; Frange P, 2009, J NEURO-ONCOL, V95, P271, DOI 10.1007/s11060-009-9927-z; Grill J, 1999, INT J RADIAT ONCOL, V45, P137, DOI 10.1016/S0360-3016(99)00177-7; Grill J, 2005, LANCET ONCOL, V6, P573, DOI 10.1016/S1470-2045(05)70252-7; Haimi M, 2004, PEDIATR HEMAT ONCOL, V21, P37, DOI 10.1080/08880010490263579; Halperin EC, 2001, CANCER, V91, P1444, DOI 10.1002/1097-0142(20010415)91:8<1444::AID-CNCR1151>3.0.CO;2-U; HARISIADIS L, 1977, INT J RADIAT ONCOL, V2, P833, DOI 10.1016/0360-3016(77)90181-X; Hoven E, 2008, J PEDIAT HEMATOL ONC, V30, P807, DOI 10.1097/MPH.0b013e31818a9553; Keene DL, 1999, PEDIATR NEUROL, V20, P198, DOI 10.1016/S0887-8994(98)00139-8; KLEIHUES P, 1993, BRAIN PATHOL, V3, P255, DOI 10.1111/j.1750-3639.1993.tb00752.x; Kleihues P, 2000, CANCER, V88, P2887, DOI 10.1002/1097-0142(20000615)88:12<2887::AID-CNCR32>3.0.CO;2-F; Klein-Geltink J, 2006, J PEDIAT HEMATOL ONC, V28, P433, DOI 10.1097/01.mph.0000212945.20480.26; Kukal K, 2009, EUR J PEDIATR, V168, P303, DOI 10.1007/s00431-008-0755-5; Lacour B, 2010, EUR J CANCER PREV, V19, P173, DOI 10.1097/CEJ.0b013e32833876c0; Lannering B, 2010, PEDIAT BLOOD CANC, V55; Loh AHP, 2009, J PEDIAT HEMATOL ONC, V31, P734, DOI 10.1097/MPH.0b013e3181b78725; Mehta V, 2002, NEUROSURGERY, V51, P365, DOI 10.1227/01.NEU.0000019779.27789.AC; Najaf-Zadeh A, 2011, ARCH DIS CHILD, V96, P127, DOI 10.1136/adc.2010.189209; Northcott PA, 2011, J CLIN ONCOL, V29, P1408, DOI 10.1200/JCO.2009.27.4324; Oyharcabal-Bourden V, 2005, J CLIN ONCOL, V23, P4726, DOI 10.1200/JCO.2005.00.760; POLLOCK BH, 1991, J PEDIATR-US, V119, P725, DOI 10.1016/S0022-3476(05)80287-2; Reulecke BC, 2008, J CHILD NEUROL, V23, P178, DOI 10.1177/0883073807308692; SAHA V, 1993, ARCH DIS CHILD, V68, P771, DOI 10.1136/adc.68.6.771; Sommelet D, 2005, ARCH PEDIATRIE, V12, P814, DOI 10.1016/j.arcped.2005.04.039; Thulesius H, 2000, ACTA ONCOL, V39, P873, DOI 10.1080/028418600750063640; Verlooy J, 2006, EUR J CANCER, V42, P3004, DOI 10.1016/j.ejca.2006.02.026; Wilne SH, 2006, ARCH DIS CHILD, V91, P502, DOI 10.1136/adc.2005.090266	40	27	27	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2012	7	4							e33415	10.1371/journal.pone.0033415	http://dx.doi.org/10.1371/journal.pone.0033415			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952GU	22485143	Green Published, gold, Green Submitted			2022-12-27	WOS:000304780500019
J	Michels, L; Martin, E; Klaver, P; Edden, R; Zelaya, F; Lythgoe, DJ; Luchinger, R; Brandeis, D; O'Gorman, RL				Michels, Lars; Martin, Ernst; Klaver, Peter; Edden, Richard; Zelaya, Fernando; Lythgoe, David J.; Luechinger, Rafael; Brandeis, Daniel; O'Gorman, Ruth L.			Frontal GABA Levels Change during Working Memory	PLOS ONE			English	Article							MAGNETIC-RESONANCE-SPECTROSCOPY; DORSOLATERAL PREFRONTAL CORTEX; HUMAN VISUAL-CORTEX; SHORT-TERM-MEMORY; IN-VIVO; NEURONAL-ACTIVITY; OXIDATIVE-METABOLISM; NMDA CHANNELS; BRAIN; STIMULATION	Functional neuroimaging metrics are thought to reflect changes in neurotransmitter flux, but changes in neurotransmitter levels have not been demonstrated in humans during a cognitive task, and the relationship between neurotransmitter dynamics and hemodynamic activity during cognition has not yet been established. We evaluate the concentration of the major inhibitory (GABA) and excitatory (glutamate + glutamine: Glx) neurotransmitters and the cerebral perfusion at rest and during a prolonged delayed match-to-sample working memory task. Resting GABA levels in the dorsolateral prefrontal cortex correlated positively with the resting perfusion and inversely with the change in perfusion during the task. Further, only GABA increased significantly during the first working memory run and then decreased continuously across subsequent task runs. The decrease of GABA over time was paralleled by a trend towards decreased reaction times and higher task accuracy. These results demonstrate a link between neurotransmitter dynamics and hemodynamic activity during working memory, indicating that functional neuroimaging metrics depend on the balance of excitation and inhibition required for cognitive processing.	[Michels, Lars; Martin, Ernst; Klaver, Peter; O'Gorman, Ruth L.] Univ Childrens Hosp, Ctr MR Res, Zurich, Switzerland; [Michels, Lars] Univ Zurich Hosp, Inst Neuroradiol, CH-8091 Zurich, Switzerland; [Martin, Ernst; Klaver, Peter; Brandeis, Daniel] Zurich Ctr Integrat Human Physiol, Zurich, Switzerland; [Klaver, Peter] Univ Zurich, Div Abnormal Psychol & Clin Intervent, Inst Psychol, Zurich, Switzerland; [Edden, Richard] Johns Hopkins Univ, Sch Med, Russell H Morgan Dept Radiol & Radiol Sci, Baltimore, MD USA; [Edden, Richard] Kennedy Krieger Inst, FM Kirby Ctr Funct Brain Imaging, Baltimore, MD USA; [Zelaya, Fernando; Lythgoe, David J.] Kings Coll London, Ctr Neuroimaging Sci, Inst Psychiat, London WC2R 2LS, England; [Luechinger, Rafael; Brandeis, Daniel] Univ Zurich, Dept Child & Adolescent Psychiat, Zurich, Switzerland; [Brandeis, Daniel] Heidelberg Univ, Dept Child & Adolescent Psychiat & Psychotherapy, Cent Inst Mental Hlth, Med Fac Mannheim, D-6800 Mannheim, Germany	University Children's Hospital Zurich; University of Zurich; University Zurich Hospital; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); University of Zurich; Johns Hopkins University; Kennedy Krieger Institute; University of London; King's College London; University of Zurich; Central Institute of Mental Health; Ruprecht Karls University Heidelberg	Michels, L (corresponding author), Univ Childrens Hosp, Ctr MR Res, Zurich, Switzerland.	lars.michels@kispi.uzh.ch	Zelaya, Fernando O/I-3125-2012; Edden, Richard A/G-5538-2012; Klaver, Peter/G-7988-2011; Michels, Lars/X-6939-2018; Klaver, Peter/M-9506-2019; Lythgoe, David J/E-5275-2010	Zelaya, Fernando O/0000-0002-9525-1560; Klaver, Peter/0000-0002-6541-9975; Klaver, Peter/0000-0002-6541-9975; O'Gorman, Ruth/0000-0001-5932-7786; Lythgoe, David/0000-0002-5078-9025; Michels, Lars/0000-0003-3750-1100; Edden, Richard/0000-0002-0671-7374	University of Zurich; Wellcome Trust	University of Zurich; Wellcome Trust(Wellcome Trust)	This work was supported by the University Research Priority Program "Integrative Human Physiology" at the University of Zurich. The authors also thank the Wellcome Trust for support to neuroimaging at the Centre for Neuroimaging Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altamura M, 2007, PSYCHIAT RES-NEUROIM, V154, P103, DOI 10.1016/j.pscychresns.2006.08.002; Attwell D, 2010, NATURE, V468, P232, DOI 10.1038/nature09613; Baddeley A, 1996, PHILOS T ROY SOC B, V351, P1461; Buzsaki G, 2007, NEURON, V56, P771, DOI 10.1016/j.neuron.2007.11.008; Compte A, 2000, CEREB CORTEX, V10, P910, DOI 10.1093/cercor/10.9.910; Cowan N, 2001, BEHAV BRAIN SCI, V24, P87, DOI 10.1017/S0140525X01003922; D'Esposito M, 2000, EXP BRAIN RES, V133, P3, DOI 10.1007/s002210000395; Dalby NO, 2001, CURR OPIN NEUROL, V14, P187, DOI 10.1097/00019052-200104000-00009; Donahue MJ, 2010, NEUROIMAGE; Edden RAE, 2007, MAGN RESON MED, V58, P1276, DOI 10.1002/mrm.21383; Evans CJ, 2011, REGIONAL VARIATIONS; Floyer-Lea A, 2006, J NEUROPHYSIOL, V95, P1639, DOI 10.1152/jn.00346.2005; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Frahm J, 1996, MAGNET RESON MED, V35, P143, DOI 10.1002/mrm.1910350202; FUSTER JM, 1982, J NEUROSCI, V2, P361; FUSTER JM, 1982, EXP NEUROL, V77, P679, DOI 10.1016/0014-4886(82)90238-2; Fuster JM, 2001, NEURON, V30, P319, DOI 10.1016/S0896-6273(01)00285-9; FUSTER JM, 1990, PROG BRAIN RES, V85, P313; GOLDMANRAKIC PS, 1995, NEURON, V14, P477, DOI 10.1016/0896-6273(95)90304-6; Gussew A, 2010, NEUROIMAGE, V49, P1895, DOI 10.1016/j.neuroimage.2009.09.007; Hyder F, 2001, NMR BIOMED, V14, P413, DOI 10.1002/nbm.733; Jansma JM, 2001, J COGNITIVE NEUROSCI, V13, P730, DOI 10.1162/08989290152541403; Jensen JE, 2005, NMR BIOMED, V18, P570, DOI 10.1002/nbm.994; Jensen O, 1996, LEARN MEMORY, V3, P264, DOI 10.1101/lm.3.2-3.264; Jensen O, 2002, EUR J NEUROSCI, V15, P1395, DOI 10.1046/j.1460-9568.2002.01975.x; Jensen O, 1996, LEARN MEMORY, V3, P243, DOI 10.1101/lm.3.2-3.243; Jentsch JD, 2009, NEUROPSYCHOPHARMACOL, V34, P2601, DOI 10.1038/npp.2009.90; JONIDES J, 1993, NATURE, V363, P623, DOI 10.1038/363623a0; Kegeles LS, 2007, P INT SOC MAG RESON; Kehrer C, 2008, FRONT MOL NEUROSCI, V1, DOI 10.3389/neuro.02/006.2008; Levy R, 1999, J NEUROSCI, V19, P5149; Levy R, 2000, EXP BRAIN RES, V133, P23, DOI 10.1007/s002210000397; Magistretti PJ, 1999, SCIENCE, V283, P496, DOI 10.1126/science.283.5401.496; Mangia S, 2007, J NEUROSCI RES, V85, P3340, DOI 10.1002/jnr.21371; Mangia S, 2007, J CEREBR BLOOD F MET, V27, P1055, DOI 10.1038/sj.jcbfm.9600401; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; McCarthy G, 1996, CEREB CORTEX, V6, P600, DOI 10.1093/cercor/6.4.600; Mescher M, 1998, NMR BIOMED, V11, P266, DOI 10.1002/(SICI)1099-1492(199810)11:6<266::AID-NBM530>3.0.CO;2-J; Michels L, 2008, NEUROIMAGE, V40, P1296, DOI 10.1016/j.neuroimage.2007.12.048; Michels L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010298; Morellini F, 2010, CEREB CORTEX, V20, P2712, DOI 10.1093/cercor/bhq017; MORRIS RGM, 1986, NATURE, V319, P774, DOI 10.1038/319774a0; Mullins PG, 2005, NEUROIMAGE, V26, P642, DOI 10.1016/j.neuroimage.2005.02.001; Muthukumaraswamy SD, 2009, P NATL ACAD SCI USA, V106, P8356, DOI 10.1073/pnas.0900728106; Northoff G, 2007, NAT NEUROSCI, V10, P1515, DOI 10.1038/nn2001; OLIVER MW, 1990, INT J DEV NEUROSCI, V8, P417, DOI 10.1016/0736-5748(90)90074-C; Owen AM, 1996, CEREB CORTEX, V6, P31, DOI 10.1093/cercor/6.1.31; Pang KC, 2011, HIPPOCAMPUS; Patel AB, 2005, P NATL ACAD SCI USA, V102, P5588, DOI 10.1073/pnas.0501703102; Peterson DA, 2002, NEUROSCI LETT, V328, P17, DOI 10.1016/S0304-3940(02)00429-9; Petrides M, 1996, PHILOS T ROY SOC B, V351, P1455, DOI 10.1098/rstb.1996.0130; Postle BR, 2005, J COGNITIVE NEUROSCI, V17, P1679, DOI 10.1162/089892905774589208; PRICHARD J, 1991, P NATL ACAD SCI USA, V88, P5829, DOI 10.1073/pnas.88.13.5829; PROVENCHER SW, 1993, MAGNET RESON MED, V30, P672, DOI 10.1002/mrm.1910300604; Puts NAJ, 2011, PROGR NUCL IN PRESS; Rothman DL, 1999, PHILOS T R SOC B, V354, P1165, DOI 10.1098/rstb.1999.0472; Rothman DL, 2003, ANNU REV PHYSIOL, V65, P401, DOI 10.1146/annurev.physiol.65.092101.142131; Rothman DL, 2002, IN VIVO MAGNETIC RES; Russell V, 2000, BEHAV BRAIN RES, V117, P69, DOI 10.1016/S0166-4328(00)00291-6; Rypma B, 2003, COGNITIVE BRAIN RES, V16, P162, DOI 10.1016/S0926-6410(02)00247-1; SAPPEYMARINIER D, 1992, J CEREBR BLOOD F MET, V12, P584, DOI 10.1038/jcbfm.1992.82; SAWAGUCHI T, 1988, BEHAV BRAIN RES, V31, P193, DOI 10.1016/0166-4328(88)90023-X; SHARMA AC, 1990, METHOD FIND EXP CLIN, V12, P175; Shulman RG, 2001, AM J PSYCHIAT, V158, P11, DOI 10.1176/appi.ajp.158.1.11; Sibson NR, 1998, P NATL ACAD SCI USA, V95, P316, DOI 10.1073/pnas.95.1.316; Smith EE, 1996, CEREB CORTEX, V6, P11, DOI 10.1093/cercor/6.1.11; Somogyi P, 1998, BRAIN RES REV, V26, P113, DOI 10.1016/S0165-0173(97)00061-1; SPEHLMANN R, 1976, LANCET, V1, P724; Stagg CJ, 2009, J NEUROPHYSIOL, V101, P2872, DOI 10.1152/jn.91060.2008; Stagg CJ, 2009, J NEUROSCI, V29, P5202, DOI 10.1523/JNEUROSCI.4432-08.2009; Thompson RB, 1998, MAGNET RESON MED, V39, P762, DOI 10.1002/mrm.1910390514; Waagepetersen H, 2007, HDB NEUROCHEMISTRY M; Wong EC, 1998, MAGNET RESON MED, V39, P702, DOI 10.1002/mrm.1910390506; Zahr NM, 2008, CEREB CORTEX, V18, P2241, DOI 10.1093/cercor/bhm250; Zhang JX, 2003, NEUROIMAGE, V20, P1531, DOI 10.1016/j.neuroimage.2003.07.016; Zhu H, 2011, MAGN RESON MED, V65, P603, DOI 10.1002/mrm.22671	76	75	76	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2012	7	4							e31933	10.1371/journal.pone.0031933	http://dx.doi.org/10.1371/journal.pone.0031933			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952GU	22485128	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000304780500004
J	Passot, JB; Sheynikhovich, D; Duvelle, E; Arleo, A				Passot, Jean-Baptiste; Sheynikhovich, Denis; Duvelle, Eleonore; Arleo, Angelo			Contribution of Cerebellar Sensorimotor Adaptation to Hippocampal Spatial Memory	PLOS ONE			English	Article							NMDA RECEPTOR-ACTIVITY; MORRIS WATER MAZE; PATH-INTEGRATION; PURKINJE-CELLS; PLACE CELLS; COGNITIVE MECHANISMS; DECLARATIVE MEMORY; VESTIBULAR NUCLEI; INTERNAL-MODEL; NAVIGATION	Complementing its primary role in motor control, cerebellar learning has also a bottom-up influence on cognitive functions where high-level representations build up from elementary sensorimotor memories. In this paper we examine the cerebellar contribution to both procedural and declarative components of spatial cognition. To do so, we model a functional interplay between the cerebellum and the hippocampal formation during goal-oriented navigation. We reinterpret and complete existing genetic behavioural observations by means of quantitative accounts that cross-link synaptic plasticity mechanisms, single cell and population coding properties, and behavioural responses. In contrast to earlier hypotheses positing only a purely procedural impact of cerebellar adaptation deficits, our results suggest a cerebellar involvement in high-level aspects of behaviour. In particular, we propose that cerebellar learning mechanisms may influence hippocampal place fields, by contributing to the path integration process. Our simulations Predict differences in place-cell discharge properties between normal mice and L7-PKCl mutant mice lacking long-term depression at cerebellar parallel fibre-Purkinje cell synapses. On the behavioural level, these results suggest that, by influencing the accuracy of hippocampal spatial codes, cerebellar deficits may impact the exploration-exploitation balance during spatial navigation.	[Passot, Jean-Baptiste; Sheynikhovich, Denis; Duvelle, Eleonore; Arleo, Angelo] Univ Paris 06, CNRS, Lab Neurobiol Adapt Proc, UMR 7102, Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite	Passot, JB (corresponding author), Univ Paris 06, CNRS, Lab Neurobiol Adapt Proc, UMR 7102, Paris, France.	angelo.arleo@upmc.fr	Arleo, Angelo/N-9255-2019; Sheynikhovich, Denis/K-3776-2013; Duvelle, Éléonore/ABC-1541-2020	Arleo, Angelo/0000-0002-1990-1971; Sheynikhovich, Denis/0000-0001-7737-8907; Duvelle, Éléonore/0000-0002-3514-8801	French Ministry of Higher Education and Research; French Defense Procurement Agency (DGA); French National Research Agency (ANR) [ANR-09-EMER-005-01]	French Ministry of Higher Education and Research; French Defense Procurement Agency (DGA); French National Research Agency (ANR)(French National Research Agency (ANR))	This manuscript was granted by the French Ministry of Higher Education and Research, the French Defense Procurement Agency (DGA), and the French National Research Agency (ANR) Project EvoNeuro, ANR-09-EMER-005-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBUS J S, 1971, Mathematical Biosciences, V10, P25, DOI 10.1016/0025-5564(71)90051-4; Angelaki DE, 2010, CEREBELLUM, V9, P174, DOI 10.1007/s12311-009-0147-z; Arleo A, 2000, BIOL CYBERN, V83, P287, DOI 10.1007/s004220000171; Arleo A, 2004, IEEE T NEURAL NETWOR, V15, P639, DOI 10.1109/TNN.2004.826221; Arleo Angelo, 2007, Journal of Integrative Neuroscience, V6, P327, DOI 10.1142/S0219635207001593; Attwell PJE, 2002, NEURON, V34, P1011, DOI 10.1016/S0896-6273(02)00719-5; Bell C, 1997, BRAIN BEHAV EVOLUT, V50, P17, DOI 10.1159/000113352; Bosco G, 2001, PHYSIOL REV, V81, P539, DOI 10.1152/physrev.2001.81.2.539; Brun VH, 2002, SCIENCE, V296, P2243, DOI 10.1126/science.1071089; Burgess N, 2002, NEURON, V35, P625, DOI 10.1016/S0896-6273(02)00830-9; Burguiere E, 2005, NAT NEUROSCI, V8, P1292, DOI 10.1038/nn1532; Cain DP, 1996, REV NEUROSCIENCE, V7, P215; Chadderton P, 2004, NATURE, V428, P856, DOI 10.1038/nature02442; Compoint C, 1997, NEUROSCI LETT, V238, P91, DOI 10.1016/S0304-3940(97)00864-1; D'Angelo E, 2009, TRENDS NEUROSCI, V32, P30, DOI 10.1016/j.tins.2008.09.007; DAHHAOUI M, 1992, BEHAV NEURAL BIOL, V58, P180, DOI 10.1016/0163-1047(92)90440-F; De Zeeuw CI, 1998, NEURON, V20, P495, DOI 10.1016/S0896-6273(00)80990-3; Eccles JC, 1967, CEREBELLUM NEURONAL; EICHENBAUM H, 1992, J COGNITIVE NEUROSCI, V4, P217, DOI 10.1162/jocn.1992.4.3.217; Eichenbaum H, 2001, BEHAV BRAIN RES, V127, P199, DOI 10.1016/S0166-4328(01)00365-5; EICHENBAUM H, 1990, J NEUROSCI, V10, P3531; Eichenbaum H, 1999, NEURON, V23, P209, DOI 10.1016/S0896-6273(00)80773-4; Ekstrom AD, 2003, NATURE, V425, P184, DOI 10.1038/nature01964; Etienne AS, 1998, NATURE, V396, P161, DOI 10.1038/24151; Etienne AS, 2004, HIPPOCAMPUS, V14, P180, DOI 10.1002/hipo.10173; Federico F, 2006, BRAIN RES BULL, V70, P356, DOI 10.1016/j.brainresbull.2006.06.005; Fonio E, 2009, P NATL ACAD SCI USA, V106, P21335, DOI 10.1073/pnas.0812513106; Foti F, 2010, CEREBELLUM, V9, P29, DOI 10.1007/s12311-009-0134-4; FUJITA M, 1982, BIOL CYBERN, V45, P195, DOI 10.1007/BF00336192; Fuster JM, 2001, NEURON, V30, P319, DOI 10.1016/S0896-6273(01)00285-9; Fyhn M, 2004, SCIENCE, V305, P1258, DOI 10.1126/science.1099901; Gandhi CC, 2000, BEHAV BRAIN RES, V109, P37, DOI 10.1016/S0166-4328(99)00160-6; GEORGOPOULOS AP, 1986, SCIENCE, V233, P1416, DOI 10.1126/science.3749885; Ghez C, 2000, CEREBELLUM, P832; Glickstein M, 2007, CURR BIOL, V17, pR824, DOI 10.1016/j.cub.2007.08.009; Glickstein M, 2008, CEREBELLUM, V7, P589, DOI 10.1007/s12311-008-0074-4; HARTIGAN JA, 1985, ANN STAT, V13, P70, DOI 10.1214/aos/1176346577; Hilber P, 1998, BEHAV GENET, V28, P299, DOI 10.1023/A:1021675514883; Hoh T, 1999, J Neurosci, V19, pRC2; Hok V, 2005, P NATL ACAD SCI USA, V102, P4602, DOI 10.1073/pnas.0407332102; Holmes G, 1939, BRAIN, V62, P1, DOI 10.1093/brain/62.1.1; Imamizu H, 2000, NATURE, V403, P192, DOI 10.1038/35003194; Ito M, 2005, PROG BRAIN RES, V148, P95, DOI 10.1016/S0079-6123(04)48009-1; Ito M, 1998, TRENDS COGN SCI, V2, P313, DOI 10.1016/S1364-6613(98)01222-4; ITO M, 1982, NEUROSCI LETT, V33, P253, DOI 10.1016/0304-3940(82)90380-9; ITO M, 1970, INT J NEUROL, V7, P162; Ito M, 1984, CEREBELLUM NEURAL CO; Ito M, 1974, CONTROL MECH CEREBEL, P293; Ito M, 2006, PROG NEUROBIOL, V78, P272, DOI 10.1016/j.pneurobio.2006.02.006; JAKAB RL, 1988, ANAT EMBRYOL, V179, P81, DOI 10.1007/BF00305102; Joyal CC, 2001, BEHAV BRAIN RES, V122, P131, DOI 10.1016/S0166-4328(00)00390-9; KAWATO M, 1987, BIOL CYBERN, V57, P169, DOI 10.1007/BF00364149; Koekkoek SKE, 2003, SCIENCE, V301, P1736, DOI 10.1126/science.1088383; KOLB B, 1983, BEHAV NEUROSCI, V97, P13, DOI 10.1037/0735-7044.97.1.13; Korelusova I, 2007, Prague Med Rep, V108, P37; KOTCHABHAKDI N, 1978, EXP BRAIN RES, V31, P591; LALONDE R, 1988, BRAIN RES, V455, P24, DOI 10.1016/0006-8993(88)90109-6; LALONDE R, 1987, J NEUROGENET, V4, P285, DOI 10.3109/01677068709102349; LALONDE R, 1986, BRAIN RES, V398, P175, DOI 10.1016/0006-8993(86)91264-3; Leggio MG, 2006, BRAIN RES BULL, V70, P347, DOI 10.1016/j.brainresbull.2006.06.006; Leggio MG, 1999, EXP BRAIN RES, V127, P1, DOI 10.1007/s002210050768; Lev-Ram V, 2002, P NATL ACAD SCI USA, V99, P8389, DOI 10.1073/pnas.122206399; Mandolesi L, 2003, EUR J NEUROSCI, V18, P2618, DOI 10.1046/j.1460-9568.2003.02990.x; Mandolesi L, 2001, EUR J NEUROSCI, V14, P2011, DOI 10.1046/j.0953-816x.2001.01819.x; MARR D, 1969, J PHYSIOL-LONDON, V202, P437, DOI 10.1113/jphysiol.1969.sp008820; Martinet LE, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002045; MCCORMICK DA, 1984, SCIENCE, V223, P296, DOI 10.1126/science.6701513; MCDONALD RJ, 1994, BEHAV NEURAL BIOL, V61, P260, DOI 10.1016/S0163-1047(05)80009-3; MCDONALD RJ, 1993, BEHAV NEUROSCI, V107, P3, DOI 10.1037/0735-7044.107.1.3; McNaughton BL, 2006, NAT REV NEUROSCI, V7, P663, DOI 10.1038/nrn1932; Medina JF, 2000, NAT NEUROSCI, V3, P1205, DOI 10.1038/81486; Medina JF, 2002, NAT REV NEUROSCI, V3, P122, DOI 10.1038/nrn728; Miall RC, 2007, PLOS BIOL, V5, P2733, DOI 10.1371/journal.pbio.0050316; Miall RC, 1998, NOVART FDN SYMP, V218, P272; Miall RC, 2001, NAT NEUROSCI, V4, P638, DOI 10.1038/88465; Michel O., 2004, International Journal of Advanced Robotic Systems, V1, P39; MITTELSTAEDT ML, 1980, NATURWISSENSCHAFTEN, V67, P566, DOI 10.1007/BF00450672; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Moser EI, 2008, ANNU REV NEUROSCI, V31, P69, DOI 10.1146/annurev.neuro.31.061307.090723; Mulliken GH, 2008, P NATL ACAD SCI USA, V105, P8170, DOI 10.1073/pnas.0802602105; OKEEFE J, 1978, EXP BRAIN RES, V31, P573; Packard MG, 1996, NEUROBIOL LEARN MEM, V65, P65, DOI 10.1006/nlme.1996.0007; Pasalar S, 2006, NAT NEUROSCI, V9, P1404, DOI 10.1038/nn1783; Petrosini L, 1998, PROG NEUROBIOL, V56, P191, DOI 10.1016/S0301-0082(98)00036-7; Petrosini L, 1996, EUR J NEUROSCI, V8, P1882, DOI 10.1111/j.1460-9568.1996.tb01332.x; Rochefort C, 2011, SCIENCE, V334, P385, DOI 10.1126/science.1207403; Rondi-Reig L, 2006, J NEUROSCI, V26, P4071, DOI 10.1523/JNEUROSCI.3408-05.2006; Rondi-Reig L, 2005, PROG BRAIN RES, V148, P201, DOI 10.1016/S0079-6123(04)48017-0; Safo P, 2008, NEUROPHARMACOLOGY, V54, P213, DOI 10.1016/j.neuropharm.2007.05.029; Schonewille M, 2010, NEURON, V67, P618, DOI 10.1016/j.neuron.2010.07.009; Schonewille M, 2011, NEURON, V70, P43, DOI 10.1016/j.neuron.2011.02.044; Schweighofer N, 1998, EUR J NEUROSCI, V10, P95, DOI 10.1046/j.1460-9568.1998.00007.x; Schweighofer N, 1996, BIOL CYBERN, V75, P29, DOI 10.1007/BF00238737; Shadmehr R, 2010, ANNU REV NEUROSCI, V33, P89, DOI 10.1146/annurev-neuro-060909-153135; Shaikh AG, 2004, J NEUROSCI, V24, P4491, DOI 10.1523/JNEUROSCI.0109-04.2004; Sheynikhovich D, 2009, PSYCHOL REV, V116, P540, DOI 10.1037/a0016170; Strick PL, 2009, ANNU REV NEUROSCI, V32, P413, DOI 10.1146/annurev.neuro.31.060407.125606; Thach WT, 1998, TRENDS COGN SCI, V2, P331, DOI 10.1016/S1364-6613(98)01223-6; THACH WT, 1992, ANNU REV NEUROSCI, V15, P403, DOI 10.1146/annurev.neuro.15.1.403; Timmann D, 2007, CEREBELLUM, V6, P159, DOI 10.1080/14734220701496448; TOLMAN EC, 1948, PSYCHOL REV, V55, P189, DOI 10.1037/h0061626; Wang YT, 2000, NEURON, V25, P635, DOI 10.1016/S0896-6273(00)81066-1; WHISHAW IQ, 1986, J COMP PSYCHOL, V100, P422, DOI 10.1037/0735-7036.100.4.422; WHISHAW IQ, 1991, Q J EXP PSYCHOL-B, V43, P83; WHISHAW IQ, 1985, BEHAV NEUROSCI, V99, P979, DOI 10.1037/0735-7044.99.5.979; White NM, 2002, NEUROBIOL LEARN MEM, V77, P125, DOI 10.1006/nlme.2001.4008; Wiener JM, 2011, EXP BRAIN RES, V208, P61, DOI 10.1007/s00221-010-2460-7; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520; Wolpert DM, 1998, NEURAL NETWORKS, V11, P1317, DOI 10.1016/S0893-6080(98)00066-5; Wolpert DM, 1998, TRENDS COGN SCI, V2, P338, DOI 10.1016/S1364-6613(98)01221-2; Yakusheva TA, 2007, NEURON, V54, P973, DOI 10.1016/j.neuron.2007.06.003; Yin HH, 2006, NAT REV NEUROSCI, V7, P464, DOI 10.1038/nrn1919	114	23	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2012	7	4							e32560	10.1371/journal.pone.0032560	http://dx.doi.org/10.1371/journal.pone.0032560			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952GU	22485133	Green Published, Green Submitted, gold			2022-12-27	WOS:000304780500009
J	Li, YH; Liu, SY; Zhang, ZY; Xu, QB; Xie, FK; Wang, JJ; Ping, SN; Li, C; Wang, ZJ; Zhang, M; Huang, JT; Chen, DD; Hu, LP; Li, CH				Li, Yuhuang; Liu, Shuying; Zhang, Zhengyu; Xu, Qingbo; Xie, Fukang; Wang, Jingjing; Ping, Suning; Li, Chen; Wang, Zhaojing; Zhang, Min; Huang, Jintao; Chen, Dadi; Hu, Liping; Li, Chaohong			RAGE Mediates Accelerated Diabetic Vein Graft Atherosclerosis Induced by Combined Mechanical Stress and AGEs via Synergistic ERK Activation	PLOS ONE			English	Article							GLYCATION END-PRODUCTS; SMOOTH-MUSCLE-CELLS; NEOINTIMAL FORMATION; NULL MICE; SIGNALING PATHWAY; OXIDATIVE STRESS; ANGIOTENSIN-II; BYPASS GRAFTS; RECEPTOR; ARTERIAL	Aims/Hypothesis: Diabetes with hypertension rapidly accelerates vascular disease, but the underlying mechanism remains unclear. We evaluated the hypothesis that the receptor of advanced glycation end products (RAGE) might mediate combined signals initiated by diabetes-related AGEs and hypertension-induced mechanical stress as a common molecular sensor. Methods: In vivo surgical vein grafts created by grafting vena cava segments from C57BL/6J mice into the common carotid arteries of streptozotocin (STZ)-treated and untreated isogenic mice for 4 and 8 weeks were analyzed using morphometric and immunohistochemical techniques. In vitro quiescent mouse vascular smooth muscle cells (VSMCs) with either knockdown or overexpression of RAGE were subjected to cyclic stretching with or without AGEs. Extracellular signal-regulated kinase (ERK) phosphorylation and Ki-67 expression were investigated. Results: Significant increases in neointimal formation, AGE deposition, Ki-67 expression, and RAGE were observed in the vein grafts of STZ-induced diabetic mice. The highest levels of ERK phosphorylation and Ki-67 expression in VSMCs were induced by simultaneous stretch stress and AGE exposure. The synergistic activation of ERKs and Ki-67 in VSMCs was significantly inhibited by siRNA-RAGE treatment and enhanced by over-expression of RAGE. Conclusion: RAGE may mediate synergistically increased ERK activation and VSMC proliferation induced by mechanical stretching with and without AGEs. It may serve as a common molecular bridge between the two, accelerating vascular remodeling. This study provides potential drug targets and novel therapeutic strategies for the treatment of vascular diseases resulting from diabetes with hypertension.	[Li, Yuhuang; Liu, Shuying; Zhang, Zhengyu; Xie, Fukang; Wang, Jingjing; Ping, Suning; Li, Chen; Wang, Zhaojing; Zhang, Min; Huang, Jintao; Chen, Dadi; Hu, Liping; Li, Chaohong] Sun Yat Sen Univ, Dept Histol & Embryol, Zhongshan Sch Med, Guangzhou 510275, Guangdong, Peoples R China; [Xu, Qingbo] Kings Coll London, British Heart Fdn Ctr, Div Cardiovasc, London WC2R 2LS, England	Sun Yat Sen University; University of London; King's College London	Li, YH (corresponding author), Sun Yat Sen Univ, Dept Histol & Embryol, Zhongshan Sch Med, Guangzhou 510275, Guangdong, Peoples R China.	lichaohongzq@yahoo.com	Zhang, Zhengyu/AAJ-3821-2020	Li, Chaohong/0000-0002-7979-1639	National Natural Science Foundation of China [30570762, 30871023, 81070124]; Natural Science Foundation of Guangdong Province [8151008901000044]; Doctoral Foundation of the Chinese Ministry of Education [20090171110049]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Doctoral Foundation of the Chinese Ministry of Education	This work was supported by grants 30570762, 30871023, and 81070124 from the National Natural Science Foundation of China, grant 8151008901000044 from the Natural Science Foundation of Guangdong Province, and grant 20090171110049 from the Doctoral Foundation of the Chinese Ministry of Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aronson D, 2003, J HYPERTENS, V21, P3, DOI 10.1097/00004872-200301000-00002; BENES AJ, 1985, J CELL SCI, V75, P35; Bierhaus A, 2009, DIABETOLOGIA, V52, P2251, DOI 10.1007/s00125-009-1458-9; BROWNLEE M, 1995, ANNU REV MED, V46, P223, DOI 10.1146/annurev.med.46.1.223; Bu DX, 2010, CIRC RES, V106, P1040, DOI 10.1161/CIRCRESAHA.109.201103; Bucciarelli LG, 2002, CIRCULATION, V106, P2827, DOI 10.1161/01.CIR.0000039325.03698.36; Cheng ZJ, 2007, J HUAZHONG U SCI-MED, V27, P393, DOI 10.1007/s11596-007-0411-8; Chien S, 2007, AM J PHYSIOL-HEART C, V292, pH1209, DOI 10.1152/ajpheart.01047.2006; Cooper ME, 2001, DIABETOLOGIA, V44, P1957, DOI 10.1007/s001250100000; Cooper SA, 2007, AM J PHYSIOL-HEART C, V293, pH2009, DOI 10.1152/ajpheart.00522.2007; DOBRIN PB, 1995, HYPERTENSION, V26, P38, DOI 10.1161/01.HYP.26.1.38; Galler A, 2003, DIABETES CARE, V26, P2609, DOI 10.2337/diacare.26.9.2609; Hilker M, 2002, CARDIOVASC PATHOL, V11, P284, DOI 10.1016/S1054-8807(02)00113-8; Hu YH, 2004, J CLIN INVEST, V113, P1258, DOI 10.1172/JCI200419628; Hu YH, 1998, FASEB J, V12, P1135, DOI 10.1096/fasebj.12.12.1135; Kim JY, 2008, INT J ONCOL, V33, P493, DOI 10.3892/ijo_00000032; Koka V, 2006, CIRCULATION, V113, P1353, DOI 10.1161/CIRCULATIONAHA.105.575589; Leitges M, 2001, J CLIN INVEST, V108, P1505; Lewko B, 2009, J CELL PHYSIOL, V221, P288, DOI 10.1002/jcp.21856; Li CH, 2000, CELL SIGNAL, V12, P435, DOI 10.1016/S0898-6568(00)00096-6; Li CH, 1999, J BIOL CHEM, V274, P25273, DOI 10.1074/jbc.274.36.25273; Li JH, 2004, AM J PATHOL, V164, P1389, DOI 10.1016/S0002-9440(10)63225-7; LOMBARD JH, 1990, AM J PHYSIOL, V259, pH29, DOI 10.1152/ajpheart.1990.259.1.H29; LOOP FD, 1986, NEW ENGL J MED, V314, P1, DOI 10.1056/NEJM198601023140101; Mayr U, 2002, CIRC RES, V90, P197, DOI 10.1161/hh0202.103715; Meloche J, 2011, ARTERIOSCL THROM VAS, V31, P2114, DOI 10.1161/ATVBAHA.111.230573; Nilsson PM, 2011, DIABETES CARE, V34, pS109, DOI 10.2337/dc11-s204; Park' L, 1998, NAT MED, V4, P1025, DOI 10.1038/2012; Prado CM, 2006, J HYPERTENS, V24, P503, DOI 10.1097/01.hjh.0000209987.51606.23; Rosen P, 2001, DIABETES-METAB RES, V17, P189, DOI 10.1002/dmrr.196; Sakaguchi T, 2003, J CLIN INVEST, V111, P959, DOI 10.1172/JCI200317115; Salzberg SP, 2006, CIRCULATION, V114, pI302, DOI 10.1161/CIRCULATIONAHA.105.001339; Schmidt AM, 1999, CIRC RES, V84, P489, DOI 10.1161/01.RES.84.5.489; Shi Y, 1996, CIRCULATION, V94, P1655, DOI 10.1161/01.CIR.94.7.1655; Soro-Paavonen A, 2008, DIABETES, V57, P2461, DOI 10.2337/db07-1808; Villacorta L, 2007, AM J PHYSIOL-HEART C, V293, pH770, DOI 10.1152/ajpheart.00261.2007; VLASSARA H, 1995, MOL MED, V1, P447, DOI 10.1007/BF03401582; Vlassara H, 2002, J INTERN MED, V251, P87, DOI 10.1046/j.1365-2796.2002.00932.x; Williams B, 1998, J HYPERTENS, V16, P1921, DOI 10.1097/00004872-199816121-00011; Yamagishi S, 2011, EXP GERONTOL, V46, P217, DOI 10.1016/j.exger.2010.11.007; Zauli G, 2010, DIABETES, V59, P1261, DOI 10.2337/db09-1771; Zhou ZM, 2003, CIRCULATION, V107, P2238, DOI 10.1161/01.CIR.0000063577.32819.23; Zou YP, 1998, AM J PATHOL, V153, P1301, DOI 10.1016/S0002-9440(10)65675-1; Zou YZ, 2004, NAT CELL BIOL, V6, P499, DOI 10.1038/ncb1137	44	37	43	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2012	7	4							e35016	10.1371/journal.pone.0035016	http://dx.doi.org/10.1371/journal.pone.0035016			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JO	22496883	gold, Green Published, Green Submitted			2022-12-27	WOS:000305014500038
J	Peng, F; Xu, ZM; Wang, J; Chen, YY; Li, Q; Zuo, YF; Chen, J; Hu, X; Zhou, QC; Wang, Y; Ma, HL; Bao, Y; Chen, M				Peng, Fang; Xu, Zumin; Wang, Jin; Chen, Yuanyuan; Li, Qiang; Zuo, Yufang; Chen, Jing; Hu, Xiao; Zhou, Qichao; Wang, Yan; Ma, Honglian; Bao, Yong; Chen, Ming			Recombinant Human Endostatin Normalizes Tumor Vasculature and Enhances Radiation Response in Xenografted Human Nasopharyngeal Carcinoma Models	PLOS ONE			English	Article							TYROSINE KINASE INHIBITOR; ENDOTHELIAL GROWTH-FACTOR; EPITHELIUM-DERIVED FACTOR; VESSEL NORMALIZATION; MATRIX METALLOPROTEINASES; ANTIANGIOGENIC THERAPY; LYMPHATIC METASTASIS; ANTI-ANGIOGENESIS; CANCER-THERAPY; SOLID TUMORS	Background: Hypoxic tumor cells can reduce the efficacy of radiation. Antiangiogenic therapy may transiently "normalize'' the tumor vasculature to make it more efficient for oxygen delivery. The aim of this study is to investigate whether the recombinant human endostatin (endostar) can create a "vascular normalization window'' to alleviate hypoxia and enhance the inhibitory effects of radiation therapy in human nasopharyngeal carcinoma (NPC) in mice. Methodology/Principal Findings: Transient changes in morphology of tumor vasculature and hypoxic tumor cell fraction in response to endostar were detected in mice bearing CNE-2 and 5-8F human NPC xenografts. Various treatment schedules were tested to assess the influence of endostar on the effect of radiation therapy. Several important factors relevant to the angiogenesis were identified through immunohistochemical staining. During endostar treatment, tumor vascularity decreased, while the basement membrane and pericyte coverage associated with endothelial cells increased, which supported the idea of vessel normalization. Hypoxic tumor cell fraction also decreased after the treatment. The transient modulation of tumor physiology caused by endostar improved the effect of radiation treatment compared with other treatment schedules. The expressions of vascular endothelial growth factor (VEGF), matrix metalloproteinase-2 (MMP-2), MMP-9, and MMP-14 decreased, while the level of pigment epithelium-derived factor (PEDF) increased. Conclusions: Endostar normalized tumor vasculature, which alleviated hypoxia and significantly sensitized the function of radiation in anti-tumor in human NPC. The results provide an important experimental basis for combining endostar with radiation therapy in human NPC.	[Peng, Fang; Xu, Zumin; Wang, Jin; Chen, Yuanyuan; Hu, Xiao; Zhou, Qichao; Wang, Yan; Ma, Honglian; Bao, Yong; Chen, Ming] Sun Yat Sen Univ, Ctr Canc, Dept Radiat Oncol, Guangzhou 510275, Guangdong, Peoples R China; [Peng, Fang; Xu, Zumin; Wang, Jin; Chen, Yuanyuan; Hu, Xiao; Zhou, Qichao; Wang, Yan; Ma, Honglian; Bao, Yong; Chen, Ming] State Key Lab Oncol S China, Guangzhou, Guangdong, Peoples R China; [Xu, Zumin; Zuo, Yufang] Guangdong Med Coll, Affiliated Hosp, Ctr Canc, Zhanjiang, Peoples R China; [Li, Qiang] Sun Yat Sen Univ, Affiliated Hosp 1, Organ Transplantat Ctr, Guangzhou 510275, Guangdong, Peoples R China; [Chen, Jing] Guangzhou Mil Command, Guangzhou Gen Hosp, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; Guangdong Medical University; Sun Yat Sen University; Southern Theater Command General Hospital	Peng, F (corresponding author), Sun Yat Sen Univ, Ctr Canc, Dept Radiat Oncol, Guangzhou 510275, Guangdong, Peoples R China.	baoyong@sysucc.org.cn; chenming@sysucc.org.cn	Chen, Ming/GVU-8412-2022; Chen, Yuanyuan/GXG-2130-2022; Chen, Ming/GYE-1379-2022; zuo, yufang/AAH-7155-2021	Chen, Ming/0000-0001-5041-9342; 	National Natural Science Foundation of China [30872974, 81172116]; Science and Technology Planning Project of Guangdong Province, China [2009B030801154]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Planning Project of Guangdong Province, China	This work was supported in part by National Natural Science Foundation of China (No. 30872974, 81172116) and Science and Technology Planning Project of Guangdong Province, China (No. 2009B030801154). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Brown JM, 1999, CANCER RES, V59, P5863; Brown JM, 2004, NAT REV CANCER, V4, P437, DOI 10.1038/nrc1367; Brown JM, 1998, CANCER RES, V58, P1408; Cao RH, 2004, CANCER CELL, V6, P333, DOI 10.1016/j.ccr.2004.08.034; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Carmeliet P, 2011, NAT REV DRUG DISCOV, V10, P417, DOI 10.1038/nrd3455; Cerniglia GJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006539; Chae SS, 2010, CLIN CANCER RES, V16, P3618, DOI 10.1158/1078-0432.CCR-09-3073; Chung YL, 2000, CLIN CANCER RES, V6, P1452; Dawson DW, 1999, SCIENCE, V285, P245, DOI 10.1126/science.285.5425.245; Dings RPM, 2007, CLIN CANCER RES, V13, P3395, DOI 10.1158/1078-0432.CCR-06-2441; Dvorak HF, 2002, J CLIN ONCOL, V20, P4368, DOI 10.1200/JCO.2002.10.088; Ek ETH, 2006, TRENDS MOL MED, V12, P497, DOI 10.1016/j.molmed.2006.08.009; Ferrara N, 2005, NATURE, V438, P967, DOI 10.1038/nature04483; FOLKMAN J, 1972, ANN SURG, V175, P409, DOI 10.1097/00000658-197203000-00014; Fukumura D, 2007, MICROVASC RES, V74, P72, DOI 10.1016/j.mvr.2007.05.003; Gao GQ, 2002, J BIOL CHEM, V277, P9492, DOI 10.1074/jbc.M108004200; Hardee M, 2009, CANCER CHEMOTH PHARM, V63, P219, DOI 10.1007/s00280-008-0729-3; Hedlund EM, 2009, P NATL ACAD SCI USA, V106, P17505, DOI 10.1073/pnas.0908026106; Jain RK, 2007, CANCER RES, V67, P2729, DOI 10.1158/0008-5472.CAN-06-4102; Jain Rakesh K., 2008, P261; Jain RK, 2001, NAT MED, V7, P987, DOI 10.1038/nm0901-987; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Lee AWM, 2011, EUR J CANCER, V47, P656, DOI 10.1016/j.ejca.2010.10.026; Lee NY, 2011, J CLIN ONCOL, V29, P5516; Liang Y, 2010, J BIOL CHEM, V285, P4931, DOI 10.1074/jbc.M109.048397; Ling Y, 2007, BIOCHEM BIOPH RES CO, V361, P79, DOI 10.1016/j.bbrc.2007.06.155; Lu N, 2008, EXP BIOL MED, V233, P1013, DOI 10.3181/0801-RM-7; Maione F, 2009, J CLIN INVEST, V119, P3356, DOI 10.1172/JCI36308; McGee MC, 2010, INT J RADIAT ONCOL, V76, P1537, DOI 10.1016/j.ijrobp.2009.12.010; Ni QG, 2009, EUR J PHARMACOL, V614, P1, DOI 10.1016/j.ejphar.2009.04.032; Nissen LJ, 2007, J CLIN INVEST, V117, P2766, DOI 10.1172/JCI32479; Ohta M, 2009, SURG TODAY, V39, P1046, DOI 10.1007/s00595-009-4020-y; OReilly MS, 1997, CELL, V88, P277, DOI 10.1016/S0092-8674(00)81848-6; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; Song LB, 2006, CANCER RES, V66, P6225, DOI 10.1158/0008-5472.CAN-06-0094; Sun Y, 2005, J CLIN ONCOL, V23, p654S; Taguchi E, 2008, CANCER SCI, V99, P623, DOI 10.1111/j.1349-7006.2007.00724.x; Winkler F, 2004, CANCER CELL, V6, P553, DOI 10.1016/S1535-6108(04)00305-8; Yang S, 2010, CURR CANCER DRUG TAR, V10, P611, DOI 10.2174/156800910791859506; ZHANG SH, 1983, INT J CANCER, V31, P587, DOI 10.1002/ijc.2910310509; Zhou QY, 2008, CLIN CANCER RES, V14, P1540, DOI 10.1158/1078-0432.CCR-07-4544	43	53	72	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2012	7	4							e34646	10.1371/journal.pone.0034646	http://dx.doi.org/10.1371/journal.pone.0034646			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JO	22496834	gold, Green Published, Green Submitted			2022-12-27	WOS:000305014500025
J	Tsukada, S; Nakashima, H; Torimitsu, K				Tsukada, Shingo; Nakashima, Hiroshi; Torimitsu, Keiichi			Conductive Polymer Combined Silk Fiber Bundle for Bioelectrical Signal Recording	PLOS ONE			English	Article							PEDOT; FIBROIN; TISSUE	Electrode materials for recording biomedical signals, such as electrocardiography (ECG), electroencephalography (EEG) and evoked potentials data, are expected to be soft, hydrophilic and electroconductive to minimize the stress imposed on living tissue, especially during long-term monitoring. We have developed and characterized string-shaped electrodes made from conductive polymer with silk fiber bundles (thread), which offer a new biocompatible stress free interface with living tissue in both wet and dry conditions. An electroconductive polyelectrolyte, poly(3,4-ethylenedioxythiophene) -poly(styrenesulfonate) (PEDOT-PSS) was electrochemically combined with silk thread made from natural Bombyx mori. The polymer composite 280 mu m thread exhibited a conductivity of 0.00117 S/cm (which corresponds to a DC resistance of 2.62 Mohm/cm). The addition of glycerol to the PEDOT-PSS silk thread improved the conductivity to 0.102 S/cm (20.6 kohm/cm). The wettability of PEDOT-PSS was controlled with glycerol, which improved its durability in water and washing cycles. The glycerol treated PEDOT-PSS silk thread showed a tensile strength of 1000 cN in both wet and dry states. Without using any electrolytes, pastes or solutions, the thread directly collects electrical signals from living tissue and transmits them through metal cables. ECG, EEG, and sensory evoked potential (SEP) signals were recorded from experimental animals by using this thread placed on the skin. PEDOT-PSS silk glycerol composite thread offers a new class of biocompatible electrodes in the field of biomedical and health promotion that does not induce stress in the subjects.	[Tsukada, Shingo; Nakashima, Hiroshi; Torimitsu, Keiichi] NTT Corp, NTT Basic Res Labs, Mat Sci Lab, Atsugi, Kanagawa, Japan	Nippon Telegraph & Telephone Corporation	Tsukada, S (corresponding author), NTT Corp, NTT Basic Res Labs, Mat Sci Lab, Atsugi, Kanagawa, Japan.	tsukada.shingo@lab.ntt.co.jp	Torimitsu, Keiichi/A-3078-2011; Torimitsu, Keiichi/AAE-4333-2019; TORIMITSU, KEIICHI/GQR-2299-2022		Nippon Telegraph and Telephone Corporation (NTT)	Nippon Telegraph and Telephone Corporation (NTT)	The authors have read the journal's policy and have the following conflicts. The authors, ST, HN and KT are employees at Basic Research Laboratory, which is a research institute funded by Nippon Telegraph and Telephone Corporation (NTT). The authors have been filing an application for a patent regarding this study. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Fabretto M, 2008, MACROMOL RAPID COMM, V29, P1403, DOI 10.1002/marc.200800270; Fabretto M, 2011, THIN SOLID FILMS, V519, P2544, DOI 10.1016/j.tsf.2010.12.016; Fabretto M, 2009, MACROMOL RAPID COMM, V30, P1846, DOI 10.1002/marc.200900371; Fabretto M, 2009, J MATER CHEM, V19, P7871, DOI 10.1039/b912324e; Fung MK, 2002, APPL PHYS LETT, V81, P1497, DOI 10.1063/1.1499519; Granlund T, 2001, J APPL PHYS, V89, P5897, DOI 10.1063/1.1350998; HEYWANG G, 1992, ADV MATER, V4, P116, DOI 10.1002/adma.19920040213; Jin HJ, 2003, NATURE, V424, P1057, DOI 10.1038/nature01809; Kim DH, 2010, NAT MATER, V9, P511, DOI [10.1038/NMAT2745, 10.1038/nmat2745]; Kim Dong-Hwan, 2008, P177; Kim JY, 2002, SYNTHETIC MET, V126, P311, DOI 10.1016/S0379-6779(01)00576-8; Kim WH, 2002, APPL PHYS LETT, V80, P3844, DOI 10.1063/1.1480100; Kim YH, 2011, ADV FUNCT MATER, V21, P1076, DOI 10.1002/adfm.201002290; Lang U, 2009, SYNTHETIC MET, V159, P473, DOI 10.1016/j.synthmet.2008.11.005; Lofhede J., 2010, P 10 IEEE INT C INF, P1; Marozas V, 2011, J ELECTROCARDIOL, V44, P189, DOI 10.1016/j.jelectrocard.2010.12.004; Marquez JC, 2009, IEEE ENG MED BIO, P4816, DOI 10.1109/IEMBS.2009.5332631; Miller K, 2002, J BIOMECH, V35, P483, DOI 10.1016/S0021-9290(01)00234-2; Muller C, 2011, ADV MATER, V23, P898, DOI 10.1002/adma.201003601; Muller C, 2011, J MATER CHEM, V21, P2909, DOI 10.1039/c0jm03270k; Nyberg T, 2007, J NEUROSCI METH, V160, P16, DOI 10.1016/j.jneumeth.2006.08.008; Okuzaki H, 2003, MACROMOL RAPID COMM, V24, P261, DOI 10.1002/marc.200390038; Richardson-Burns SM, 2007, BIOMATERIALS, V28, P1539, DOI 10.1016/j.biomaterials.2006.11.026; Serban MA, 2011, J BIOMED MATER RES A, V98A, P567, DOI 10.1002/jbm.a.33149; Winther-Jensen B, 2011, MACROMOL MATER ENG, V296, P185, DOI 10.1002/mame.201000292; Zhang FL, 2002, ADV MATER, V14, P662, DOI 10.1002/1521-4095(20020503)14:9<662::AID-ADMA662>3.0.CO;2-N	26	96	97	4	115	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2012	7	4							e33689	10.1371/journal.pone.0033689	http://dx.doi.org/10.1371/journal.pone.0033689			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JA	22493670	Green Published, gold, Green Submitted			2022-12-27	WOS:000305012700012
J	Disanto, G; Morahan, JM; Lacey, MV; DeLuca, GC; Giovannoni, G; Ebers, GC; Ramagopalan, SV				Disanto, Giulio; Morahan, Julia M.; Lacey, Melanie V.; DeLuca, Gabriele C.; Giovannoni, Gavin; Ebers, George C.; Ramagopalan, Sreeram V.			Seasonal Distribution of Psychiatric Births in England	PLOS ONE			English	Article							BIPOLAR DISORDER; NORTHERN-HEMISPHERE; ADULT DISEASE; SCHIZOPHRENIA; RISK; POPULATION; SIBLINGS; SUICIDE; ORIGINS	There is general consensus that season of birth influences the risk of developing psychiatric conditions later in life. We aimed to investigate whether the risk of schizophrenia (SC), bipolar affective disorder (BAD) and recurrent depressive disorder (RDD) is influenced by month of birth in England to a similar extent as other countries using the largest cohort of English patients collected to date (n = 57,971). When cases were compared to the general English population (n = 29,183,034) all diseases showed a seasonal distribution of births (SC p = 2.48E-05; BAD p = 0.019; RDD p = 0.015). This data has implications for future strategies of disease prevention.	[Disanto, Giulio; Morahan, Julia M.; DeLuca, Gabriele C.; Ebers, George C.; Ramagopalan, Sreeram V.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Disanto, Giulio; Morahan, Julia M.; DeLuca, Gabriele C.; Ebers, George C.; Ramagopalan, Sreeram V.] Univ Oxford, Dept Clin Neurol, Oxford, England; [Lacey, Melanie V.; Ramagopalan, Sreeram V.] London Sch Hyg & Trop Med, London WC1, England; [Giovannoni, Gavin; Ramagopalan, Sreeram V.] Queen Mary Univ London, Barts & London Sch Med & Dent, Blizard Inst Cell & Mol Sci, London, England	University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; University of London; London School of Hygiene & Tropical Medicine; University of London; Queen Mary University London	Disanto, G (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England.	s.ramagopalan@qmul.ac.uk		Ebers, George/0000-0003-4771-4177; De Luca, Gabriele/0000-0003-0342-5197; Morahan, Julia/0000-0001-9278-0603; McKeating, Jane/0000-0002-7229-5886	Medical Research Council [G0801976]; Wellcome Trust [075491/Z/04]; MRC [G0801976] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by the Medical Research Council [GRANT NUMBER G0801976] and the Wellcome Trust [075491/Z/04]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. All authors state that this research was carried out independently of the influence of funding bodies.	ADAMS W, 1993, BRIT J PSYCHIAT, V163, P522, DOI 10.1192/bjp.163.4.522; BARKER DJP, 1995, P ROY SOC B-BIOL SCI, V262, P37, DOI 10.1098/rspb.1995.0173; BUCK C, 1978, BRIT J PSYCHIAT, V133, P358, DOI 10.1192/bjp.133.4.358; Cohen AS, 2011, J PSYCHIATR RES, V45, P955, DOI 10.1016/j.jpsychires.2010.12.006; Davies G, 2003, SCHIZOPHRENIA BULL, V29, P587, DOI 10.1093/oxfordjournals.schbul.a007030; Disanto G, 2011, BRIT J PSYCHIAT, V198, P404, DOI 10.1192/bjp.bp.110.085944; Dome P, 2010, BIOL PSYCHIAT, V68, P148, DOI 10.1016/j.biopsych.2010.03.005; HARE EH, 1976, BRIT J PSYCHIAT, V129, P49, DOI 10.1192/bjp.129.1.49; Hoffman S, 2007, NEUROEPIDEMIOLOGY, V29, P89, DOI 10.1159/000109502; Joiner TE, 2002, PSYCHIAT RES, V112, P89, DOI 10.1016/S0165-1781(02)00183-X; Langley-Evans SC, 2010, MED PRIN PRACT, V19, P87, DOI 10.1159/000273066; Lichtenstein P, 2009, LANCET, V373, P234, DOI 10.1016/S0140-6736(09)60072-6; McGrath JJ, 2010, SCHIZOPHRENIA BULL, V36, P1073, DOI 10.1093/schbul/sbq101; McGrath JJ, 2010, ARCH GEN PSYCHIAT, V67, P889, DOI 10.1001/archgenpsychiatry.2010.110; Potash JB, 2009, NAT REV NEUROL, V5, P299, DOI 10.1038/nrneurol.2009.71; PULVER AE, 1992, BRIT J PSYCHIAT, V160, P71, DOI 10.1192/bjp.160.1.71; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Rihmer Z, 2011, J AFFECT DISORDERS, V132, P64, DOI 10.1016/j.jad.2011.01.015; Rothwell PM, 1999, BRIT MED J, V319, P887, DOI 10.1136/bmj.319.7214.887; Salib E, 2006, BRIT J PSYCHIAT, V188, P416, DOI 10.1192/bjp.bp.105.009118; Schwartz PJ, 2011, MED HYPOTHESES, V76, P785, DOI 10.1016/j.mehy.2011.02.019; Suvisaari JM, 2001, AM J PSYCHIAT, V158, P754, DOI 10.1176/appi.ajp.158.5.754; Torrey EF, 1996, SCHIZOPHR RES, V21, P141; Torrey EF, 1997, SCHIZOPHR RES, V28, P1, DOI 10.1016/S0920-9964(97)00092-3; Tsuchiya KJ, 2003, BIPOLAR DISORD, V5, P231, DOI 10.1034/j.1399-5618.2003.00038.x; WALTER SD, 1975, BRIT J PREV SOC MED, V29, P18	26	36	37	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e34866	10.1371/journal.pone.0034866	http://dx.doi.org/10.1371/journal.pone.0034866			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	953GO	22496872	gold, Green Published			2022-12-27	WOS:000304855200086
J	Gong, L; Ramm, G; Devenish, RJ; Prescott, M				Gong, Lan; Ramm, Georg; Devenish, Rodney J.; Prescott, Mark			HcRed, a Genetically Encoded Fluorescent Binary Cross-Linking Agent for Cross-Linking of Mitochondrial ATP Synthase in Saccharomyces cerevisiae	PLOS ONE			English	Article							F1F0-ATP SYNTHASE; IN-VIVO; MEMBRANE-PROTEIN; YEAST; IDENTIFICATION; COMPLEXES; DIMER; OSCP	Genetically encoded fluorescent cross-linking agents represent powerful tools useful both for visualising and modulating protein interactions in living cells. The far-red fluorescent protein HcRed, which is fluorescent only in a dimer form, can be used to promote the homo-dimerisation of target proteins, and thereby yield useful information about biological processes. We have in yeast cells expressed HcRed fused to a subunit of mitochondrial ATP synthase (mtATPase). This resulted in cross-linking of the large multi-subunit mtATPase complex within the inner-membrane of the mitochondrion. Fluorescence microscopy revealed aberrant mitochondrial morphology, and mtATPase complexes isolated from mitochondria were recovered as fluorescent dimers under conditions where complexes from control mitochondria were recovered as monomers. When viewed by electron microscopy normal cristae were absent from mitochondria in cells in which mATPase complexes were cross-linked. mtATPase dimers are believed to be the building blocks that are assembled into supramolecular mtATPase ribbons that promote the formation of mitochondrial cristae. We propose that HcRed cross-links mATPase complexes in the mitochondrial membrane hindering the normal assembly/disassembly of the supramolecular forms of mtATPase.	[Gong, Lan; Ramm, Georg; Devenish, Rodney J.; Prescott, Mark] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia; [Gong, Lan; Devenish, Rodney J.] Monash Univ, ARC Ctr Excellence Struct & Funct Microbial Genom, Clayton, Vic 3800, Australia	Monash University; Monash University	Gong, L (corresponding author), Monash Univ, Dept Biochem & Mol Biol, Clayton Campus, Clayton, Vic 3800, Australia.	Mark.Prescott@monash.edu	Gong, Lan/J-6368-2016; Gong, Lan/O-7886-2019	Gong, Lan/0000-0003-3136-1565; Gong, Lan/0000-0003-3136-1565; Ramm, Georg/0000-0003-3596-2288	Monash University; Australian Research Council	Monash University(Monash University); Australian Research Council(Australian Research Council)	This work was supported by Monash University (http://www.monash.edu.au/) and the Australian Research Council (http://www.arc.gov.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN RD, 1989, J CELL BIOL, V108, P2233, DOI 10.1083/jcb.108.6.2233; Arnold I, 1998, EMBO J, V17, P7170, DOI 10.1093/emboj/17.24.7170; Arnold I, 1998, J BIOL CHEM, V273, P1469, DOI 10.1074/jbc.273.3.1469; Bateson M, 1999, J BIOL CHEM, V274, P7462, DOI 10.1074/jbc.274.11.7462; Bevis BJ, 2002, NAT BIOTECHNOL, V20, P83, DOI 10.1038/nbt0102-83; Boyle GM, 1999, EUR J BIOCHEM, V262, P315, DOI 10.1046/j.1432-1327.1999.00345.x; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Chudakov DM, 2010, PHYSIOL REV, V90, P1103, DOI 10.1152/physrev.00038.2009; Couoh-Cardel SJ, 2010, J BIOL CHEM, V285, P36447, DOI 10.1074/jbc.M110.144907; Davies KM, 2011, P NATL ACAD SCI USA, V108, P14121, DOI 10.1073/pnas.1103621108; Devenish RJ, 2008, INT REV CEL MOL BIO, V267, P1, DOI 10.1016/S1937-6448(08)00601-1; Fenno L, 2011, ANNU REV NEUROSCI, V34, P389, DOI 10.1146/annurev-neuro-061010-113817; Fradkov AF, 2002, BIOCHEM J, V368, P17, DOI 10.1042/BJ20021191; Gavin P, 2002, BIOCHEM BIOPH RES CO, V298, P707, DOI 10.1016/S0006-291X(02)02552-4; Gavin PD, 2005, J BIOENERG BIOMEMBR, V37, P55, DOI 10.1007/s10863-005-4128-8; Gavin PD, 2004, J CELL SCI, V117, P2333, DOI 10.1242/jcs.01074; Gietz RD, 2007, NAT PROTOC, V2, P31, DOI 10.1038/nprot.2007.13; Griffith J, 2008, TRAFFIC, V9, P1060, DOI 10.1111/j.1600-0854.2008.00753.x; Gurskaya NG, 2001, FEBS LETT, V507, P16, DOI 10.1016/S0014-5793(01)02930-1; Liou W, 1996, HISTOCHEM CELL BIOL, V106, P41, DOI 10.1007/BF02473201; Lukyanov KA, 2005, NAT REV MOL CELL BIO, V6, P885, DOI 10.1038/nrm1741; Pastuszka MK, 2010, J DRUG DELIV SCI TEC, V20, P163, DOI 10.1016/S1773-2247(10)50025-X; Paumard P, 2002, EMBO J, V21, P221, DOI 10.1093/emboj/21.3.221; Prescott M, 2003, J BIOL CHEM, V278, P251, DOI 10.1074/jbc.M204556200; Prescott M, 1997, FEBS LETT, V411, P97, DOI 10.1016/S0014-5793(97)00670-4; Rosado CJ, 2008, AUTOPHAGY, V4, P205, DOI 10.4161/auto.5331; SCHAGGER H, 1994, ANAL BIOCHEM, V217, P220, DOI 10.1006/abio.1994.1112; Seelert H, 2011, BBA-BIOENERGETICS, V1807, P1185, DOI 10.1016/j.bbabio.2011.05.023; Stock D, 1999, SCIENCE, V286, P1700, DOI 10.1126/science.286.5445.1700; Straffon AFL, 1998, BBA-BIOMEMBRANES, V1371, P157, DOI 10.1016/S0005-2736(98)00034-0; Wilmann PG, 2005, J MOL BIOL, V349, P223, DOI 10.1016/j.jmb.2005.03.020	31	1	2	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e35095	10.1371/journal.pone.0035095	http://dx.doi.org/10.1371/journal.pone.0035095			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GO	22496895	gold, Green Published, Green Submitted			2022-12-27	WOS:000304855200099
J	Higaki, T; Higaki, S; Hirota, M; Akita, K; Hasezawa, S				Higaki, Takumi; Higaki, Shogo; Hirota, Masahiro; Akita, Kae; Hasezawa, Seiichiro			Radionuclide Analysis on Bamboos following the Fukushima Nuclear Accident	PLOS ONE			English	Article							RADIOCESIUM; SOIL	In response to contamination from the recent Fukushima nuclear accident, we conducted radionuclide analysis on bamboos sampled from six sites within a 25 to 980 km radius of the Fukushima Daiichi nuclear power plant. Maximum activity concentrations of radiocesium Cs-134 and Cs-137 in samples from Fukushima city, 65 km away from the Fukushima Daiichi plant, were in excess of 71 and 79 kBq/kg, dry weight (DW), respectively. In Kashiwa city, 195 km away from the Fukushima Daiichi, the sample concentrations were in excess of 3.4 and 4.3 kBq/kg DW, respectively. In Toyohashi city, 440 km away from the Fukushima Daiichi, the concentrations were below the measurable limits of up to 4.5 Bq/kg DW. In the radiocesium contaminated samples, the radiocesium activity was higher in mature and fallen leaves than in young leaves, branches and culms.	[Higaki, Takumi; Akita, Kae; Hasezawa, Seiichiro] Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Kashiwa, Chiba, Japan; [Higaki, Takumi; Hasezawa, Seiichiro] Japan Sci & Technol Agcy, Adv Measurement & Anal, Chiyoda Ku, Tokyo, Japan; [Higaki, Shogo] Univ Tokyo, Radioisotope Ctr, Bunkyo Ku, Tokyo, Japan; [Hirota, Masahiro] Univ Tokyo, Dept Nucl Engn & Management, Bunkyo Ku, Tokyo, Japan	University of Tokyo; Japan Science & Technology Agency (JST); University of Tokyo; University of Tokyo	Higaki, T (corresponding author), Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Kashiwa, Chiba, Japan.	takumi.higaki@gmail.com	Higaki, Shogo/N-8792-2019; Higaki, Shogo/G-5100-2013; Higaki, Takumi/N-1216-2015	Higaki, Shogo/0000-0002-5098-6475; Higaki, Shogo/0000-0002-5098-6475; 	Japanese Ministry of Education, Science, Culture, Sports and Technology [21027009]; Grants-in-Aid for Scientific Research [24114001] Funding Source: KAKEN	Japanese Ministry of Education, Science, Culture, Sports and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was financially supported in part by a Grant-in-Aid for Scientific Research on Priority Areas to SH (No. 21027009) from the Japanese Ministry of Education, Science, Culture, Sports and Technology. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bolsunovsky A, 2011, J ENVIRON RADIOACTIV, V102, P1062, DOI 10.1016/j.jenvrad.2011.06.007; Bowyer TW, 2011, J ENVIRON RADIOACTIV, V102, P681, DOI 10.1016/j.jenvrad.2011.04.009; Isagi Y, 1997, PLANT ECOL, V130, P41, DOI 10.1023/A:1009711814070; Lozano RL, 2011, ENVIRON INT, V37, P1259, DOI 10.1016/j.envint.2011.06.001; Manolopoulou M, 2011, J ENVIRON RADIOACTIV, V102, P796, DOI 10.1016/j.jenvrad.2011.04.010; Pittauerova D, 2011, J ENVIRON RADIOACTIV, V102, P877, DOI 10.1016/j.jenvrad.2011.06.003; Sinclair LE, 2011, J ENVIRON RADIOACTIV, V102, P1018, DOI 10.1016/j.jenvrad.2011.06.008; Smolders Erik, 2011, Integrated Environmental Assessment and Management, V7, P379, DOI 10.1002/ieam.236; Tagami K, 2011, J ENV RADIO IN PRESS; Tsukada H, 2002, ENVIRON POLLUT, V117, P403, DOI 10.1016/S0269-7491(01)00199-3	10	10	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e34766	10.1371/journal.pone.0034766	http://dx.doi.org/10.1371/journal.pone.0034766			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GO	22496858	Green Published, Green Submitted, gold			2022-12-27	WOS:000304855200079
J	Li, YY				Li, Yan-yan			Plasminogen Activator Inhibitor-1 4G/5G Gene Polymorphism and Coronary Artery Disease in the Chinese Han Population: A Meta-Analysis	PLOS ONE			English	Article							PLASMINOGEN-ACTIVATOR INHIBITOR-1; MYOCARDIAL-INFARCTION; RISK; ASSOCIATION; GENOTYPE; BIAS	Background: The polymorphism of plasminogen activator inhibitor-1 (PAI-1) 4G/5G gene has been indicated to be correlated with coronary artery disease (CAD) susceptibility, but study results are still debatable. Objective and Methods: The present meta-analysis was performed to investigate the association between PAI-1 4G/5G gene polymorphism and CAD in the Chinese Han population. A total of 879 CAD patients and 628 controls from eight separate studies were involved. The pooled odds ratio (OR) for the distribution of the 4G allele frequency of PAI-1 4G/5G gene and its corresponding 95% confidence interval (CI) was assessed by the random effect model. Results: The distribution of the 4 G allele frequency was 0.61 for the CAD group and 0.51 for the control group. The association between PAI-1 4G/5G gene polymorphism and CAD in the Chinese Han population was significant under an allelic genetic model (OR = 1.70, 95% CI = 1.18 to 2.44, P = 0.004). The heterogeneity test was also significant (P<0.0001). Meta-regression was performed to explore the heterogeneity source. Among the confounding factors, the heterogeneity could be explained by the publication year (P = 0.017), study region (P = 0.014), control group sample size (P = 0.011), total sample size (P = 0.011), and ratio of the case to the control group sample size (RR) (P = 0.019). In a stratified analysis by the total sample size, significantly increased risk was only detected in subgroup 2 under an allelic genetic model (OR = 1.93, 95% CI = 1.09 to 3.35, P = 0.02). Conclusions: In the Chinese Han population, PAI-1 4G/5G gene polymorphism was implied to be associated with increased CAD risk. Carriers of the 4G allele of the PAI-1 4G/5G gene might predispose to CAD.	Nanjing Med Univ, Dept Geriatr, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University	Li, YY (corresponding author), Nanjing Med Univ, Dept Geriatr, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China.	lyynjmu123@126.com			National Natural Science Foundation of China (NSFC) [81100073]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This work was funded by the National Natural Science Foundation of China (NSFC 81100073 to YL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abboud N, 2010, GENET TEST MOL BIOMA, V14, P23, DOI 10.1089/gtmb.2009.0039; Ashavaid TF, 2011, PLATELETS, V22, P85, DOI 10.3109/09537104.2010.522275; Binder BR, 2002, NEWS PHYSIOL SCI, V17, P56, DOI 10.1152/nips.01369.2001; Bottiger C, 2003, AM HEART J, V146, P855, DOI 10.1016/S0002-8703(03)00363-6; COCHRAN WG, 1968, BIOMETRICS, V24, P295, DOI 10.2307/2528036; Dai Y, 2001, CIRC J, V16, P275; DAWSON S, 1991, ARTERIOSCLER THROMB, V11, P183, DOI 10.1161/01.ATV.11.1.183; DAWSON SJ, 1993, J BIOL CHEM, V268, P10739; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; ERIKSSON P, 1995, P NATL ACAD SCI USA, V92, P1851, DOI 10.1073/pnas.92.6.1851; Franco RF, 2001, BRIT J HAEMATOL, V115, P491, DOI 10.1046/j.1365-2141.2001.03175.x; Fu Y, 2001, J CAPITAL U MED SCI, V22, P119; Guan Lixue, 2002, Zhonghua Yi Xue Yi Chuan Xue Za Zhi, V19, P393; HAMSTEN A, 1985, NEW ENGL J MED, V313, P1557, DOI 10.1056/NEJM198512193132501; Held C, 1997, J INTERN MED, V241, P59, DOI 10.1046/j.1365-2796.1997.84102000.x; Isordia-Salas I, 2009, REV ESP CARDIOL, V62, P365, DOI 10.1016/S0300-8932(09)70893-0; Iwai N, 1998, ATHEROSCLEROSIS, V136, P109, DOI 10.1016/S0021-9150(97)00191-3; Juhan-Vague I, 2003, J THROMB HAEMOST, V1, P2322, DOI 10.1046/j.1538-7836.2003.00458.x; Li XS, 2002, J GUANGZHOU U TRADIT, V19, P261; MANTEL N, 1959, J NATL CANCER I, V22, P719; Onalan O, 2008, J THROMB THROMBOLYS, V26, P211, DOI 10.1007/s11239-007-0083-z; Rallidis LS, 2010, J THROMB THROMBOLYS, V29, P497, DOI 10.1007/s11239-009-0398-z; Sampalo MF, 2007, CLIN CHIM ACTA, V377, P154, DOI 10.1016/j.cca.2006.09.013; Wang Y, 2003, NEW MED, V34, P674; [夏大胜 XIA Dasheng], 2006, [中国行为医学科学, Chinese Journal of Behavioral Medical Science], V15, P481; Ye Z, 2006, LANCET, V367, P651, DOI 10.1016/S0140-6736(06)68263-9; [尹士全 Yin Shiquan], 2003, [天津医药, Tianjin Medical Journal], V31, P131; Zhan M, 2003, CHINESE MED J-PEKING, V116, P1707	29	19	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e33511	10.1371/journal.pone.0033511	http://dx.doi.org/10.1371/journal.pone.0033511			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GO	22496752	gold, Green Submitted, Green Published			2022-12-27	WOS:000304855200015
J	Roy, S; Morse, D				Roy, Sougata; Morse, David			A Full Suite of Histone and Histone Modifying Genes Are Transcribed in the Dinoflagellate Lingulodinium	PLOS ONE			English	Article							PERIDINIUM-BALTICUM; DNA-REPLICATION; S-PHASE; CRYPTHECODINIUM-COHNII; PHYLOGENETIC ANALYSIS; GYRODINIUM-COHNII; NUCLEAR IMPORT; CELL-CYCLE; CHROMATIN; PROTEIN	Background: Dinoflagellates typically lack histones and nucleosomes are not observed in DNA spreads. However, recent studies have shown the presence of core histone mRNA sequences scattered among different dinoflagellate species. To date, the presence of all components required for manufacturing and modifying nucleosomes in a single dinoflagellate species has not been confirmed. Methodology and Results: Analysis of a Lingulodinium transcriptome obtained by Illumina sequencing of mRNA shows several different copies of each of the four core histones as well as a suite of histone modifying enzymes and histone chaperone proteins. Phylogenetic analysis shows one of each Lingulodinium histone copies belongs to the dinoflagellate clade while the second is more divergent and does not share a common ancestor. All histone mRNAs are in low abundance (roughly 25 times lower than higher plants) and transcript levels do not vary over the cell cycle. We also tested Lingulodinium extracts for histone proteins using immunoblotting and LC-MS/MS, but were unable to confirm histone expression at the protein level. Conclusion: We show that all core histone sequences are present in the Lingulodinium transcriptome. The conservation of these sequences, even though histone protein accumulation remains below currently detectable levels, strongly suggests dinoflagellates possess histones.	[Roy, Sougata; Morse, David] Univ Montreal, Dept Sci Biol, Inst Rech Biol Vegetale, Montreal, PQ H3C 3J7, Canada	Universite de Montreal	Roy, S (corresponding author), Univ Montreal, Dept Sci Biol, Inst Rech Biol Vegetale, CP 6128, Montreal, PQ H3C 3J7, Canada.	david.morse@umontreal.ca		Roy, Sougata/0000-0003-0168-5737; Morse, David/0000-0003-4131-4367; Roy, Sougata/0000-0001-9718-873X	National Science and Engineering Research Council of Canada [171382-03]	National Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	Research support from the National Science and Engineering Research Council of Canada to DM (Grant number 171382-03) is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AZEVEDO C, 1989, J PARASITOL, V75, P627, DOI 10.2307/3282915; Bannister AJ, 2011, CELL RES, V21, P381, DOI 10.1038/cr.2011.22; Baxevanis AD, 1996, NUCLEIC ACIDS RES, V24, P245, DOI 10.1093/nar/24.1.245; Bertomeu T, 2007, BIOL CELL, V99, P531, DOI 10.1042/BC20070018; BODANSKY S, 1979, BIOCHEM BIOPH RES CO, V88, P1329, DOI 10.1016/0006-291X(79)91126-4; Canela N, 2003, J BIOL CHEM, V278, P1158, DOI 10.1074/jbc.M207497200; Chan YH, 2007, NUCLEIC ACIDS RES, V35, P2573, DOI 10.1093/nar/gkm165; Chavez-Blanco A, 2005, MOL CANCER, V4, DOI 10.1186/1476-4598-4-22; Chow MH, 2010, EUKARYOT CELL, V9, P1577, DOI 10.1128/EC.00026-10; Chudnovsky Y, 2002, J PHYCOL, V38, P543, DOI 10.1046/j.1529-8817.2002.t01-1-01186.x; Costas E, 2005, CYTOGENET GENOME RES, V109, P268, DOI 10.1159/000082409; Dagenais-Bellefeuille S, 2008, J BIOL RHYTHM, V23, P400, DOI 10.1177/0748730408321749; de la Espina SMD, 2005, EUR J CELL BIOL, V84, P137, DOI 10.1016/j.ejcb.2005.01.002; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Dhillon N, 2006, MOL CELL BIOL, V26, P489, DOI 10.1128/MCB.26.2.489-501.2006; EHINGER A, 1990, MOL GEN GENET, V222, P416, DOI 10.1007/BF00633848; Frenkiel-Krispin D, 2001, EMBO J, V20, P1184, DOI 10.1093/emboj/20.5.1184; Fries T, 2007, J BIOL CHEM, V282, P19292, DOI 10.1074/jbc.M700217200; Frye RA, 2000, BIOCHEM BIOPH RES CO, V273, P793, DOI 10.1006/bbrc.2000.3000; Glozak MA, 2005, GENE, V363, P15, DOI 10.1016/j.gene.2005.09.010; GUILLARD RR, 1962, CAN J MICROBIOL, V8, P229, DOI 10.1139/m62-029; Hackett JD, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-80; HEINTZ N, 1983, MOL CELL BIOL, V3, P539, DOI 10.1128/MCB.3.4.539; HERZOG M, 1981, EUR J CELL BIOL, V23, P295; HOLMHANSEN O, 1969, SCIENCE, V163, P87, DOI 10.1126/science.163.3862.87; KAPROS T, 1995, PLANT MOL BIOL, V28, P901, DOI 10.1007/BF00042074; KELLOGG DR, 1995, J CELL BIOL, V130, P661, DOI 10.1083/jcb.130.3.661; KELLOGG DR, 1995, J CELL BIOL, V130, P675, DOI 10.1083/jcb.130.3.675; Krude T, 1999, EUR J BIOCHEM, V263, P1, DOI 10.1046/j.1432-1327.1999.00508.x; LaJeunesse TC, 2005, MOL BIOL EVOL, V22, P570, DOI 10.1093/molbev/msi042; Levi-Setti R, 2008, EUR J CELL BIOL, V87, P963, DOI 10.1016/j.ejcb.2008.06.002; Lin SJ, 2010, P NATL ACAD SCI USA, V107, P20033, DOI 10.1073/pnas.1007246107; LIVOLANT F, 1984, TISSUE CELL, V16, P535, DOI 10.1016/0040-8166(84)90029-6; Margueron R, 2005, CURR OPIN GENET DEV, V15, P163, DOI 10.1016/j.gde.2005.01.005; Martzen MR, 1999, SCIENCE, V286, P1153, DOI 10.1126/science.286.5442.1153; Mosammaparast N, 2002, J BIOL CHEM, V277, P862, DOI 10.1074/jbc.M106845200; Mosammaparast N, 2001, J CELL BIOL, V153, P251, DOI 10.1083/jcb.153.2.251; Okamoto OK, 2003, GENE, V321, P73, DOI 10.1016/j.gene.2003.07.003; Park YJ, 2006, P NATL ACAD SCI USA, V103, P1248, DOI 10.1073/pnas.0508002103; Pennini ME, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000995; Postberg J, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-259; RILL RL, 1989, CHROMOSOMA, V98, P280, DOI 10.1007/BF00327314; RIZZO PJ, 1981, BIOSYSTEMS, V14, P433, DOI 10.1016/0303-2647(81)90048-4; RIZZO PJ, 1972, SCIENCE, V176, P796, DOI 10.1126/science.176.4036.796; RIZZO PJ, 1982, BIOSYSTEMS, V15, P27, DOI 10.1016/0303-2647(82)90014-4; Rizzo PJ, 2003, CELL RES, V13, P215, DOI 10.1038/sj.cr.7290166; RIZZO PJ, 1977, SCIENCE, V198, P1258, DOI 10.1126/science.563104; ROBBINS E, 1967, P NATL ACAD SCI USA, V57, P409, DOI 10.1073/pnas.57.2.409; Robin P, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-12-r270; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Saldarriaga JF, 2003, INT J SYST EVOL MICR, V53, P355, DOI 10.1099/ijs.0.02328-0; Shechter D, 2007, NAT PROTOC, V2, P1445, DOI 10.1038/nprot.2007.202; SHUPE K, 1983, J PROTOZOOL, V30, P599, DOI 10.1111/j.1550-7408.1983.tb01429.x; Starai VJ, 2002, SCIENCE, V298, P2390, DOI 10.1126/science.1077650; Suganuma T, 2010, ANN REV BIOCH; TANIMOTO EY, 1993, PLANT PHYSIOL, V103, P1291, DOI 10.1104/pp.103.4.1291; Taoka K, 1998, PLANT CELL PHYSIOL, V39, P294, DOI 10.1093/oxfordjournals.pcp.a029370; THATCHER TH, 1994, NUCLEIC ACIDS RES, V22, P174, DOI 10.1093/nar/22.2.174; TOMAS RN, 1973, J PHYCOL, V9, P91, DOI 10.1111/j.0022-3646.1973.00091.x; Trievel RC, 2002, CELL, V111, P91, DOI 10.1016/S0092-8674(02)01000-0; VAQUERO A, 2003, SCI AGING KNOWLEDGE, pRE4, DOI DOI 10.1126/SAGEKE.2003.14.RE4; Velculescu VE, 1997, CELL, V88, P243, DOI 10.1016/S0092-8674(00)81845-0; Verdin E, 2003, TRENDS GENET, V19, P286, DOI 10.1016/S0168-9525(03)00073-8; VERNET G, 1990, BIOCHIM BIOPHYS ACTA, V1048, P281, DOI 10.1016/0167-4781(90)90068-D; WEST MHP, 1980, BIOCHEMISTRY-US, V19, P3238, DOI 10.1021/bi00555a022; WU RS, 1981, CELL, V27, P321, DOI 10.1016/0092-8674(81)90415-3; Zhang H, 2007, P NATL ACAD SCI USA, V104, P4618, DOI 10.1073/pnas.0700258104	67	42	43	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e34340	10.1371/journal.pone.0034340	http://dx.doi.org/10.1371/journal.pone.0034340			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GO	22496791	Green Published, gold, Green Submitted			2022-12-27	WOS:000304855200040
J	Vallejos, M; Carvajal, F; Pino, K; Navarrete, C; Ferres, M; Huidobro-Toro, JP; Sargueil, B; Lopez-Lastra, M				Vallejos, Maricarmen; Carvajal, Felipe; Pino, Karla; Navarrete, Camilo; Ferres, Marcela; Pablo Huidobro-Toro, Juan; Sargueil, Bruno; Lopez-Lastra, Marcelo			Functional and Structural Analysis of the Internal Ribosome Entry Site Present in the mRNA of Natural Variants of the HIV-1	PLOS ONE			English	Article							CAP-INDEPENDENT TRANSLATION; PROTEIN-SYNTHESIS; 5-UNTRANSLATED REGION; PROMOTES TRANSLATION; VIRUS LEADER; INITIATION; IRES; SEGMENT; EXPRESSION; MECHANISM	The 5'untranslated regions (UTR) of the full length mRNA of the HIV-1 proviral clones pNL4.3 and pLAI, harbor an internal ribosomal entry site (IRES). In this study we extend this finding by demonstrating that the mRNA 5'UTRs of natural variants of HIV-1 also exhibit IRES-activity. Cap-independent translational activity was demonstrated using bicistronic mRNAs in HeLa cells and in Xenopus laevis oocytes. The possibility that expression of the downstream cistron in these constructs was due to alternative splicing or to cryptic promoter activity was ruled out. The HIV-1 variants exhibited significant 5'UTR nucleotide diversity with respect to the control sequence recovered from pNL4.3. Interestingly, translational activity from the 5'UTR of some of the HIV-1 variants was enhanced relative to that observed for the 5'UTR of pNL4.3. In an attempt to explain these findings we probed the secondary structure of the variant HIV-1 5'UTRs using enzymatic and chemical approaches. Yet subsequent structural analyses did not reveal significant variations when compared to the pNL4.3-5'UTR. Thus, the increased IRES-activity observed for some of the HIV-1 variants cannot be ascribed to a specific structural modification. A model to explain these findings is proposed.	[Vallejos, Maricarmen; Carvajal, Felipe; Pino, Karla; Lopez-Lastra, Marcelo] Pontificia Univ Catolica Chile, Escuela Med, Inst Milenio Inmunol & Inmunoterapia, Lab Virol Mol,Ctr Invest Med, Santiago, Chile; [Navarrete, Camilo; Pablo Huidobro-Toro, Juan] Pontificia Univ Catolica Chile, Fac Ciencias Biol, Dept Fisiol, Ctr Envejecimiento & Regenerac,CARE, Santiago, Chile; [Ferres, Marcela] Univ Chile, Fac Med, Lab Infectol, Santiago 7, Chile; [Sargueil, Bruno] Univ Paris 05, CNRS, UMR 8015, Lab Cristallog & RMN Biol, Paris, France	Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile; Universidad de Chile; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite	Vallejos, M (corresponding author), Pontificia Univ Catolica Chile, Escuela Med, Inst Milenio Inmunol & Inmunoterapia, Lab Virol Mol,Ctr Invest Med, Alameda 340, Santiago, Chile.	malopez@med.puc.cl	Lopez-Lastra, Marcelo/HHM-9832-2022	sargueil, bruno/0000-0003-4483-355X; Carvajal Diaz, Felipe/0000-0002-4576-9310; Lopez-Lastra, Marcelo/0000-0002-7936-8478	Fondo Nacional de Ciencia y Tecnologia del Gobierno de Chile (FONDECYT) [1090318, 1110672]; Proyecto [P09/016-F]; de la Iniciativa Cientifica Milenio del Ministerio de Economia; Fomento y Turismo [PFB 12/2007]; SIDACTION [AI20-1-01577]; Agence Nationale de Recherche sur le Sida (ANRS) [2011-11188]; Centre National de la Recherche Scientifique (CNRS)-France [5283]; Comision Nacional de Investigacion Cientofica y Tecnologica (CONICYT)-Chile [5283]; Pontificia Universidad Catolica de Chile [PMD 10/09]; CONICYT	Fondo Nacional de Ciencia y Tecnologia del Gobierno de Chile (FONDECYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Proyecto; de la Iniciativa Cientifica Milenio del Ministerio de Economia; Fomento y Turismo; SIDACTION; Agence Nationale de Recherche sur le Sida (ANRS)(ANRSFrench National Research Agency (ANR)); Centre National de la Recherche Scientifique (CNRS)-France(Centre National de la Recherche Scientifique (CNRS)); Comision Nacional de Investigacion Cientofica y Tecnologica (CONICYT)-Chile(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); Pontificia Universidad Catolica de Chile; CONICYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT))	This study was supported by the Fondo Nacional de Ciencia y Tecnologia del Gobierno de Chile (FONDECYT 1090318) and Proyecto P09/016-F, de la Iniciativa Cientifica Milenio del Ministerio de Economia, Fomento y Turismo to MLL, PFB 12/2007, grants from SIDACTION (AI20-1-01577) and the Agence Nationale de Recherche sur le Sida (ANRS 2011-11188) to BS, and partial support from FONDECYT 1110672 to JPH-T, grant Projet International de Cooperation Scientifique (PICS 5283) between the Centre National de la Recherche Scientifique (CNRS)-France and the Comision Nacional de Investigacion Cientofica y Tecnologica (CONICYT)-Chile to BS and MLL, and funding from the Programa de Doctorado en Ciencias Medicas, Escuela de Medicina de la Pontificia Universidad Catolica de Chile (PMD 10/09) to MV. During her work on this project MV was supported by a CONICYT doctoral fellowship.	Acuna-Castillo C, 2002, BRIT J PHARMACOL, V136, P510, DOI 10.1038/sj.bjp.0704747; Altafaj Xavier, 2006, V322, P55; Alvarez E, 2006, BIOCHEM J, V396, P219, DOI 10.1042/BJ20060108; Attal J, 1996, FEBS LETT, V392, P220, DOI 10.1016/0014-5793(96)00815-0; Baird SD, 2006, RNA, V12, P1755, DOI 10.1261/rna.157806; Balvay L, 2007, NAT REV MICROBIOL, V5, P128, DOI 10.1038/nrmicro1599; Belsham GJ, 2000, TRENDS MICROBIOL, V8, P330, DOI 10.1016/S0966-842X(00)01788-1; Berkhout B, 1996, PROG NUCLEIC ACID RE, V54, P1, DOI 10.1016/S0079-6603(08)60359-1; Berkhout B., 2011, NUCL ACIDS IN PRESS; Berkhout B, 2011, NUCLEIC ACIDS RES, V39, P5232, DOI 10.1093/nar/gkr113; BERLIOZ C, 1995, J VIROL, V69, P6400, DOI 10.1128/JVI.69.10.6400-6407.1995; BERLIOZ C, 1995, J VIROL, V69, P2214, DOI 10.1128/JVI.69.4.2214-2222.1995; Bolinger C, 2010, NUCLEIC ACIDS RES, V38, P1686, DOI 10.1093/nar/gkp1075; Brasey A, 2003, J VIROL, V77, P3939, DOI 10.1128/JVI.77.7.3939-3949.2003; Buck CB, 2001, J VIROL, V75, P181, DOI 10.1128/JVI.75.1.181-191.2001; Cai A, 1999, BIOCHEMISTRY-US, V38, P8538, DOI 10.1021/bi9830213; Camerini V, 2008, J VIROL, V82, P3574, DOI 10.1128/JVI.02038-07; CARBERRY SE, 1989, BIOCHEMISTRY-US, V28, P8078, DOI 10.1021/bi00446a017; CARBERRY SE, 1990, BIOCHEMISTRY-US, V29, P3337, DOI 10.1021/bi00465a027; Castello A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007997; Chamond N, 2010, BIOCHEM SOC T, V38, P1548, DOI 10.1042/BST0381548; Charnay N, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-74; Cochrane A, 2009, RNA BIOL, V6, P169, DOI 10.4161/rna.6.2.8095; Cochrane AW, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-18; Damgaard CK, 2004, J MOL BIOL, V336, P369, DOI 10.1016/j.jmb.2003.12.010; DARZYNKIEWICZ E, 1988, NUCLEIC ACIDS RES, V16, P8953, DOI 10.1093/nar/16.18.8953; Deffaud C, 2000, J VIROL, V74, P11581, DOI 10.1128/JVI.74.24.11581-11588.2000; Fitzgerald KD, 2009, BBA-GENE REGUL MECH, V1789, P518, DOI 10.1016/j.bbagrm.2009.07.004; Gamarnik Andrea V., 2006, V322, P367; Gamarnik AV, 1996, EMBO J, V15, P5988, DOI 10.1002/j.1460-2075.1996.tb00985.x; Gendron K, 2011, NUCLEIC ACIDS RES, V39, P902, DOI 10.1093/nar/gkq885; Han BG, 2002, MOL CELL BIOL, V22, P7372, DOI 10.1128/MCB.22.21.7372-7384.2002; Herbreteau CH, 2005, NAT STRUCT MOL BIOL, V12, P1001, DOI 10.1038/nsmb1011; Barria MI, 2009, NUCLEIC ACIDS RES, V37, P957, DOI 10.1093/nar/gkn1022; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Jackson RJ, 1995, CURR TOP MICROBIOL, V203, P1; James L, 2008, NUCLEIC ACIDS RES, V36, P4653, DOI 10.1093/nar/gkn447; Kazadi K, 2008, NUCLEIC ACIDS RES, V36, P6918, DOI 10.1093/nar/gkn812; Keiper BD, 1997, NUCLEIC ACIDS RES, V25, P395, DOI 10.1093/nar/25.2.395; Kieft JS, 2008, TRENDS BIOCHEM SCI, V33, P274, DOI 10.1016/j.tibs.2008.04.007; Kozak M, 2003, GENE, V318, P1, DOI 10.1016/S0378-1119(03)00774-1; Liu JF, 2011, J NEUROIMMUNE PHARM, V6, P308, DOI 10.1007/s11481-011-9265-8; Locker N, 2011, NUCLEIC ACIDS RES, V39, P2367, DOI 10.1093/nar/gkq1118; Lopez-Lastra M, 2005, BIOL RES, V38, P121, DOI 10.4067/S0716-97602005000200003; Lopez-Lastra M, 1999, J VIROL, V73, P8393; Lopez-Lastra M, 2010, REV MED VIROL, V20, P177, DOI 10.1002/rmv.649; LopezLastra M, 1997, HUM GENE THER, V8, P1855, DOI 10.1089/hum.1997.8.16-1855; Meignin C, 2003, MOL CELL BIOL, V23, P8246, DOI 10.1128/MCB.23.22.8246-8254.2003; Monette A, 2009, J BIOL CHEM, V284, P31350, DOI 10.1074/jbc.M109.048736; Ohlmann T, 2002, J MOL BIOL, V318, P9, DOI 10.1016/S0022-2836(02)00070-0; Ohlmann T, 2000, J BIOL CHEM, V275, P11899, DOI 10.1074/jbc.275.16.11899; Ooms M, 2004, J VIROL, V78, P10814, DOI 10.1128/JVI.78.19.10814-10819.2004; Paillart JC, 2004, J BIOL CHEM, V279, P48397, DOI 10.1074/jbc.M408294200; Perales C, 2003, FEBS LETT, V533, P89, DOI 10.1016/S0014-5793(02)03764-X; Pfingsten JS, 2006, SCIENCE, V314, P1450, DOI 10.1126/science.1133281; Ricci EP, 2008, BIOCHEM SOC T, V36, P690, DOI 10.1042/BST0360690; Rivas-Aravena A, 2009, VIROLOGY, V392, P178, DOI 10.1016/j.virol.2009.06.050; Ronfort C, 2004, RNA, V10, P504, DOI 10.1261/rna.5185604; Rutkowska-Wlodarczyk I, 2008, BIOCHEMISTRY-US, V47, P2710, DOI 10.1021/bi701168z; Semler BL, 2008, TRENDS MICROBIOL, V16, P1, DOI 10.1016/j.tim.2007.11.001; Silvera D, 2009, NAT CELL BIOL, V11, P903, DOI 10.1038/ncb1900; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Thierry S, 2004, J VIROL, V78, P12198, DOI 10.1128/JVI.78.22.12198-12206.2004; VAGNER S, 1995, J BIOL CHEM, V270, P20376, DOI 10.1074/jbc.270.35.20376; Vallejos M, 2011, NUCLEIC ACIDS RES, V39, P6186, DOI 10.1093/nar/gkr189; Vallejos M, 2010, NUCLEIC ACIDS RES, V38, P618, DOI 10.1093/nar/gkp890; Ventoso I, 2001, P NATL ACAD SCI USA, V98, P12966, DOI 10.1073/pnas.231343498; Vopalensky V, 2008, RNA, V14, P1720, DOI 10.1261/rna.831808; Weill L, 2010, NUCLEIC ACIDS RES, V38, P1367, DOI 10.1093/nar/gkp1109; Wilkinson KA, 2008, PLOS BIOL, V6, P883, DOI 10.1371/journal.pbio.0060096; Wilson JE, 2000, MOL CELL BIOL, V20, P4990, DOI 10.1128/MCB.20.14.4990-4999.2000; Yedavalli VSRK, 2010, P NATL ACAD SCI USA, V107, P14787, DOI 10.1073/pnas.1009490107	72	29	29	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e35031	10.1371/journal.pone.0035031	http://dx.doi.org/10.1371/journal.pone.0035031			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GO	22496887	Green Published, Green Submitted, gold			2022-12-27	WOS:000304855200096
J	Burton-Chellew, MN; West, SA				Burton-Chellew, Maxwell N.; West, Stuart A.			Correlates of Cooperation in a One-Shot High-Stakes Televised Prisoners' Dilemma	PLOS ONE			English	Article							MEASURING SOCIAL PREFERENCES; EVOLUTION; BEHAVIOR; PEOPLE; GAME; RECIPROCITY; REPUTATION; ECONOMICS; LAUGHTER; MARKET	Explaining cooperation between non-relatives is a puzzle for both evolutionary biology and the social sciences. In humans cooperation is often studied in a laboratory setting using economic games such as the prisoners dilemma. However, such experiments are sometimes criticized for being played for low stakes and by misrepresentative student samples. Golden balls is a televised game show that uses the prisoners' dilemma, with a diverse range of participants, often playing for very large stakes. We use this non-experimental dataset to investigate the factors that influence cooperation when "playing" for considerably larger stakes than found in economic experiments. The game show has earlier stages that allow for an analysis of lying and voting decisions. We found that contestants were sensitive to the stakes involved, cooperating less when the stakes were larger in both absolute and relative terms. We also found that older contestants were more likely to cooperate, that liars received less cooperative behavior, but only if they told a certain type of lie, and that physical contact was associated with reduced cooperation, whereas laughter and promises were reliable signals or cues of cooperation, but were not necessarily detected.	[Burton-Chellew, Maxwell N.; West, Stuart A.] Univ Oxford, Dept Zool, Oxford OX1 3PS, England	University of Oxford	Burton-Chellew, MN (corresponding author), Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.	max.burton@zoo.ox.ac.uk	West, Stuart A/M-3608-2014; Burton-Chellew, Max/G-2760-2010	West, Stuart A/0000-0003-2152-3153; Burton-Chellew, Max/0000-0002-5330-0379	European Research Council [ATRQBY0]	European Research Council(European Research Council (ERC)European Commission)	This work was funded by the European Research Council Grant: ATRQBY0. http://erc.europa.eu/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Alexander R., 2008, ESSAYS PEDAGOGY; ANDREONI J, 1993, ECON J, V103, P570, DOI 10.2307/2234532; Ariely Daniel, 2008, PREDICTABLY IRRATION; AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; Belot M, 2010, J ECON BEHAV ORGAN, V73, P396, DOI 10.1016/j.jebo.2010.01.001; Benz M, 2008, EXP ECON, V11, P268, DOI 10.1007/s10683-007-9192-y; Bolton GE, 2000, AM ECON REV, V90, P166, DOI 10.1257/aer.90.1.166; Boone C, 1999, J ECON PSYCHOL, V20, P343, DOI 10.1016/S0167-4870(99)00012-4; Boone RT, 2003, J NONVERBAL BEHAV, V27, P163, DOI 10.1023/A:1025341931128; Bshary R, 2008, J EVOLUTION BIOL, V21, P405, DOI 10.1111/j.1420-9101.2007.01482.x; Camerer C.F., 2003, BEHAV GAME THEORY EX, DOI 10.1257/jep.9.2.209; Cameron LA, 1999, ECON INQ, V37, P47, DOI 10.1111/j.1465-7295.1999.tb01415.x; Carpenter J, 2005, ECON LETT, V86, P393, DOI 10.1016/j.econlet.2004.08.007; Charness G, 2002, Q J ECON, V117, P817, DOI 10.1162/003355302760193904; Clutton-Brock T, 2009, NATURE, V462, P51, DOI 10.1038/nature08366; Cooper R, 1996, GAME ECON BEHAV, V12, P187, DOI 10.1006/game.1996.0013; Crawley M.J., 2007, R BOOK; DANHEISER PR, 1982, J PERS SOC PSYCHOL, V42, P497, DOI 10.1037/0022-3514.42.3.497; dos Santos M, 2011, P ROY SOC B-BIOL SCI, V278, P371, DOI 10.1098/rspb.2010.1275; Dunbar RIM, 2010, NEUROSCI BIOBEHAV R, V34, P260, DOI 10.1016/j.neubiorev.2008.07.001; Fehr E, 2004, TRENDS COGN SCI, V8, P185, DOI 10.1016/j.tics.2004.02.007; Fehr E, 1999, Q J ECON, V114, P817, DOI 10.1162/003355399556151; Gachter S, 2009, PHILOS T R SOC B, V364, P791, DOI 10.1098/rstb.2008.0275; Gardner A, 2010, EVOLUTION, V64, P25, DOI 10.1111/j.1558-5646.2009.00842.x; GRAFEN A, 1990, J THEOR BIOL, V144, P517, DOI 10.1016/S0022-5193(05)80088-8; Hagen EH, 2006, THEOR POPUL BIOL, V69, P339, DOI 10.1016/j.tpb.2005.09.005; HAMILTON WD, 1963, AM NAT, V97, P354, DOI 10.1086/497114; HAMILTON WD, 1970, NATURE, V228, P1218, DOI 10.1038/2281218a0; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; HARDIN G, 1968, SCIENCE, V162, P1243, DOI 10.1126/science.162.3859.1243; Henrich J, 2010, BEHAV BRAIN SCI, V33, P111, DOI 10.1017/S0140525X10000725; Henrich J, 2010, NATURE, V466, P29, DOI 10.1038/466029a; Kocher MG, 2008, ECON LETT, V99, P508, DOI 10.1016/j.econlet.2007.09.048; Krebs JR, 1993, INTRO BEHAV ECOLOGY; Kummerli R, 2010, P NATL ACAD SCI USA, V107, P10125, DOI 10.1073/pnas.1000829107; Ledyard J., 1995, HDB EXPT EC, P253; Levitt SD, 2008, SCIENCE, V319, P909, DOI 10.1126/science.1153640; Levitt SD, 2007, J ECON PERSPECT, V21, P153, DOI 10.1257/jep.21.2.153; Levitt SD, 2007, CAN J ECON, V40, P347, DOI 10.1111/j.1365-2966.2007.00412.x; Liberman V, 2004, PERS SOC PSYCHOL B, V30, P1175, DOI 10.1177/0146167204264004; List JA, 2006, J POLIT ECON, V114, P1, DOI 10.1086/498587; Loewenstein G, 1999, ECON J, V109, pF25, DOI 10.1111/1468-0297.00400; Lusk JL, 2006, ECON LETT, V93, P285, DOI 10.1016/j.econlet.2006.05.016; MAYNARD-SMITH J., 2003, ANIMAL SIGNALS; Mehu M, 2008, FOLIA PRIMATOL, V79, P269, DOI 10.1159/000126928; Mehu M, 2007, EVOL HUM BEHAV, V28, P415, DOI 10.1016/j.evolhumbehav.2007.05.010; Mehu M, 2008, BEHAVIOUR, V145, P1747, DOI 10.1163/156853908786279619; Miller L, 2011, JENA EC RES PAPERS, V18, P1; Oda R, 2009, BIOL LETTERS, V5, P752, DOI 10.1098/rsbl.2009.0332; Oda R, 2009, HUM NATURE-INT BIOS, V20, P331, DOI 10.1007/s12110-009-9070-8; Owren MJ, 2001, EMO SOC BEH, P152; RAPOPORT A, 1988, J CONFLICT RESOLUT, V32, P457, DOI 10.1177/0022002788032003003; Sachs JL, 2004, Q REV BIOL, V79, P135, DOI 10.1086/383541; SALLY D, 1995, RATION SOC, V7, P58, DOI 10.1177/1043463195007001004; Schug J, 2010, EVOL HUM BEHAV, V31, P87, DOI 10.1016/j.evolhumbehav.2009.09.006; Slonim R, 1998, ECONOMETRICA, V66, P569, DOI 10.2307/2998575; SPENCE M, 1973, Q J ECON, V87, P355, DOI 10.2307/1882010; Szathmary E, 1995, MAJOR TRANSITIONS EV; van den Assem MJ, MANAGEMENT IN PRESS; WEISFELD GE, 1993, ETHOL SOCIOBIOL, V14, P141, DOI 10.1016/0162-3095(93)90012-7; West SA, 2007, CURR BIOL, V17, pR661, DOI 10.1016/j.cub.2007.06.004; West SA, 2010, SCIENCE, V327, P1341, DOI 10.1126/science.1178332; ZAHAVI A, 1975, J THEOR BIOL, V53, P205, DOI 10.1016/0022-5193(75)90111-3	64	8	8	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2012	7	4							e33344	10.1371/journal.pone.0033344	http://dx.doi.org/10.1371/journal.pone.0033344			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	952GU	22485141	Green Published, gold			2022-12-27	WOS:000304780500017
J	Doerks, T; van Noort, V; Minguez, P; Bork, P				Doerks, Tobias; van Noort, Vera; Minguez, Pablo; Bork, Peer			Annotation of the M. tuberculosis Hypothetical Orfeome: Adding Functional Information to More than Half of the Uncharacterized Proteins	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; ESCHERICHIA-COLI; COMPLETE GENOMES; GENE; DATABASE; PREDICTION; NETWORKS; SEQUENCE; TARGETS	The genome of Mycobacterium tuberculosis (H37Rv) contains 4,019 protein coding genes, of which more than thousand have been categorized as 'hypothetical' implying that for these not even weak functional associations could be identified so far. We here predict reliable functional indications for half of this large hypothetical orfeome: 497 genes can be annotated based on orthology, and another 125 can be linked to interacting proteins via integrated genomic context analysis and literature mining. The assignments include newly identified clusters of interacting proteins, hypothetical genes that are associated to well known pathways and putative disease-relevant targets. All together, we have raised the fraction of the proteome with at least some functional annotation to 88% which should considerably enhance the interpretation of large-scale experiments targeting this medically important organism.	[Doerks, Tobias; van Noort, Vera; Minguez, Pablo; Bork, Peer] European Mol Biol Lab, Heidelberg, Germany; [Bork, Peer] Max Delbrueck Ctr, Berlin, Germany	European Molecular Biology Laboratory (EMBL); Helmholtz Association; Max Delbruck Center for Molecular Medicine	Doerks, T (corresponding author), European Mol Biol Lab, Heidelberg, Germany.	doerks@embl.de	van Noort, Vera/E-1053-2011; Miguez, Pablo/D-4822-2013; van Noort, Vera/GWZ-9038-2022; Bork, Peer/F-1813-2013	van Noort, Vera/0000-0002-8436-6602; Miguez, Pablo/0000-0003-4099-9421; Bork, Peer/0000-0002-2627-833X; Ranganathan, Shoba/0000-0002-8290-813X	European Union (SysteMTb) [241587]	European Union (SysteMTb)	This work was supported by the European Union FP7 program (SysteMTb 241587). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anishetty S, 2005, COMPUT BIOL CHEM, V29, P368, DOI 10.1016/j.compbiolchem.2005.07.001; Beloqui A, 2006, J BIOL CHEM, V281, P22933, DOI 10.1074/jbc.M600577200; Bork P, 1998, NAT GENET, V18, P313, DOI 10.1038/ng0498-313; Boyle DS, 1997, MOL MICROBIOL, V24, P1263, DOI 10.1046/j.1365-2958.1997.4091773.x; Camus JC, 2002, MICROBIOL-SGM, V148, P2967, DOI 10.1099/00221287-148-10-2967; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Dandekar T, 1998, TRENDS BIOCHEM SCI, V23, P324, DOI 10.1016/S0968-0004(98)01274-2; Date SV, 2003, NAT BIOTECHNOL, V21, P1055, DOI 10.1038/nbt861; Doerks T, 2004, TRENDS GENET, V20, P126, DOI 10.1016/j.tig.2004.01.006; Eisen JA, 1998, GENOME RES, V8, P163, DOI 10.1101/gr.8.3.163; Enright AJ, 1999, NATURE, V402, P86, DOI 10.1038/47056; Galperin MY, 2004, NUCLEIC ACIDS RES, V32, P5452, DOI 10.1093/nar/gkh885; Goulding CW, 2005, J MOL BIOL, V349, P61, DOI 10.1016/j.jmb.2005.03.023; Honrubia MP, 2001, MOL GENET GENOMICS, V265, P1022, DOI 10.1007/s004380100497; Huynen M, 2000, GENOME RES, V10, P1204, DOI 10.1101/gr.10.8.1204; Huynen MA, 2003, CURR OPIN CELL BIOL, V15, P191, DOI 10.1016/S0955-0674(03)00009-7; Huynen MA, 1998, P NATL ACAD SCI USA, V95, P5849, DOI 10.1073/pnas.95.11.5849; Jackson M, 2000, J BIOL CHEM, V275, P30092, DOI 10.1074/jbc.M004658200; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Koonin EV, 2005, ANNU REV GENET, V39, P309, DOI 10.1146/annurev.genet.39.073003.114725; Kumar V., 2007, ROBBINS BASIC PATHOL, P516; Lew JM, 2011, TUBERCULOSIS, V91, P1, DOI 10.1016/j.tube.2010.09.008; Marcotte EM, 1999, NATURE, V402, P83, DOI 10.1038/47048; Mazandu GK, 2011, INFECT GENET EVOL; Mellor JC, 2002, NUCLEIC ACIDS RES, V30, P306, DOI 10.1093/nar/30.1.306; Muller J, 2010, NUCLEIC ACIDS RES, V38, pD190, DOI 10.1093/nar/gkp951; Overbeek R, 1999, P NATL ACAD SCI USA, V96, P2896, DOI 10.1073/pnas.96.6.2896; Pellegrini M, 1999, P NATL ACAD SCI USA, V96, P4285, DOI 10.1073/pnas.96.8.4285; Roberts RJ, 2004, PLOS BIOL, V2, P293, DOI 10.1371/journal.pbio.0020042; Roberts SA, 2002, P NATL ACAD SCI USA, V99, P2766, DOI 10.1073/pnas.052710499; Southwick F., 2007, INFECT DIS CLIN SHOR; Spraggon G, 2004, PROTEIN SCI, V13, P3187, DOI 10.1110/ps.04939904; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Tatusov RL, 2001, NUCLEIC ACIDS RES, V29, P22, DOI 10.1093/nar/29.1.22; von Mering C, 2003, P NATL ACAD SCI USA, V100, P15428, DOI 10.1073/pnas.2136809100; von Mering C, 2003, NUCLEIC ACIDS RES, V31, P258, DOI 10.1093/nar/gkg034; White EL, 2007, J BIOMOL SCREEN, V12, P100, DOI 10.1177/1087057106296484; *WHO, TUB FACT SHEET 104	38	42	42	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2012	7	4							e34302	10.1371/journal.pone.0034302	http://dx.doi.org/10.1371/journal.pone.0034302			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952GU	22485162	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000304780500037
J	Li, JG; Ren, LL; Guo, L; Xiang, ZC; Paranhos-Baccala, G; Vernet, G; Wang, JW				Li, Jianguo; Ren, Lili; Guo, Li; Xiang, Zichun; Paranhos-Baccala, Glaucia; Vernet, Guy; Wang, Jianwei			Evolutionary Dynamics Analysis of Human Metapneumovirus Subtype A2: Genetic Evidence for Its Dominant Epidemic	PLOS ONE			English	Article							RESPIRATORY SYNCYTIAL VIRUS; CIRCULATION PATTERNS; NATURAL-SELECTION; YOUNG-CHILDREN; VARIABILITY; INFECTION; TRACT; DIVERSITY; GENOTYPE; STRAINS	Human metapneumovirus (hMPV) is a respiratory viral pathogen in children worldwide. hMPV is divided into four subtypes: hMPV_A1, hMPV_A2, hMPV_B1, and hMPV_B2. hMPV_A2 can be further divided into hMPV_A2a and A2b based on phylogenetic analysis. The typical prevalence pattern of hMPV involves a shift of the predominant subtype within one or two years. However, hMPV_A2, in particular hMPV_A2b, has circulated worldwide with a several years long term high epidemic. To study this distinct epidemic behavior of hMPV_A2, we analyzed 294 sequences of partial G genes of the virus from different countries. Molecular evolutionary data indicates that hMPV_A2 evolved toward heterogeneity faster than the other subtypes. Specifically, a Bayesian skyline plot analysis revealed that hMPV_A2 has undergone a generally upward fluctuation since 1997, whereas the other subtypes experienced only one upward fluctuation. Although hMPV_A2 showed a lower value of mean dN/dS than the other subtypes, it had the largest number of positive selection sites. Meanwhile, various styles of mutation were observed in the mutation hotspots of hMPV_A2b. Bayesian phylogeography analysis also revealed two fusions of diffusion routes of hMPV_A2b in India (June 2006) and Beijing, China (June 2008). Sequences of hMPV_A2b retrieved from GenBank boosted simultaneously with the two fusions respectively, indicating that fusion of genetic transmission routes from different regions improved survival of hMPV_A2. Epidemic and evolutionary dynamics of hMPV_A2b were similar to those of hMPV_A2. Overall, our findings provide important molecular insights into hMPV epidemics and viral variation, and explain the occurrence of an atypical epidemic of hMPV_A2, particularly hMPV_A2b.	[Li, Jianguo; Ren, Lili; Guo, Li; Xiang, Zichun; Wang, Jianwei] Peking Union Med Coll, MOH Key Lab Syst Biol Pathogens, Beijing 100021, Peoples R China; [Li, Jianguo; Ren, Lili; Guo, Li; Xiang, Zichun; Wang, Jianwei] Peking Union Med Coll, Christophe Merieux Lab, IPB, CAMS Fdn Merieux, Beijing 100021, Peoples R China; [Li, Jianguo; Ren, Lili; Guo, Li; Xiang, Zichun; Wang, Jianwei] Chinese Acad Med Sci, Beijing 100730, Peoples R China; [Paranhos-Baccala, Glaucia; Vernet, Guy] Fdn Merieux, Lyon, France	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Pathogen Biology - CAMS; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College	Li, JG (corresponding author), Peking Union Med Coll, MOH Key Lab Syst Biol Pathogens, Beijing 100021, Peoples R China.	wangjw28@163.com	Li, Jianguo/T-3372-2019; Wang, Jianwei/W-5916-2019; Wang, Jianwei/AAW-9499-2020	Li, Jianguo/0000-0002-2251-8308; Wang, Jianwei/0000-0002-1116-4559	International Science and Technology Cooperation Program of China [2010DFB33270]; National Major Science & Technology Project for Control and Prevention of Major Infectious Diseases of China [2009ZX10004-206]	International Science and Technology Cooperation Program of China; National Major Science & Technology Project for Control and Prevention of Major Infectious Diseases of China	This study was supported in part by the International Science and Technology Cooperation Program of China (2010DFB33270) (http://www.cistc.gov.cn) and National Major Science & Technology Project for Control and Prevention of Major Infectious Diseases of China (2009ZX10004-206) (http://www.nmp.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Agapov E, 2006, J INFECT DIS, V193, P396, DOI 10.1086/499310; Ahumada-Ruiz S, 2008, AIDS RES HUM RETROV, V24, P1461, DOI 10.1089/aid.2008.0153; Bastien N, 2003, VIRUS RES, V93, P51, DOI 10.1016/S0168-1702(03)00065-0; Biacchesi S, 2005, J VIROL, V79, P12608, DOI 10.1128/JVI.79.19.12608-12613.2005; Biacchesi S, 2004, J VIROL, V78, P12877, DOI 10.1128/JVI.78.23.12877-12887.2004; Caracciolo S, 2008, PEDIATR INFECT DIS J, V27, P406, DOI 10.1097/INF.0b013e318162a164; Chung JY, 2008, J MED VIROL, V80, P902, DOI 10.1002/jmv.21129; de Graaf M, 2008, J GEN VIROL, V89, P2933, DOI 10.1099/vir.0.2008/006957-0; Dolz R, 2008, VIROLOGY, V374, P50, DOI 10.1016/j.virol.2007.12.020; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Gerna G, 2005, ARCH VIROL, V150, P2365, DOI 10.1007/s00705-005-0581-2; Holmes EC, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000505; Huck B, 2006, EMERG INFECT DIS, V12, P147, DOI 10.3201/eid1201.050772; Ishiguro N, 2004, J CLIN MICROBIOL, V42, P3406, DOI 10.1128/JCM.42.8.3406-3414.2004; Kahn JS, 2006, CLIN MICROBIOL REV, V19, P546, DOI 10.1128/CMR.00014-06; Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520; Liao YC, 2008, BIOINFORMATICS, V24, P505, DOI 10.1093/bioinformatics/btm638; Ludewick HP, 2005, EMERG INFECT DIS, V11, P1074, DOI 10.3201/eid1107.050050; Mackay IM, 2006, J INFECT DIS, V193, P1630, DOI 10.1086/504260; Noyola DE, 2005, J MED MICROBIOL, V54, P969, DOI 10.1099/jmm.0.46052-0; Oliveira DBL, 2009, J MED VIROL, V81, P915, DOI 10.1002/jmv.21436; Padhi A, 2008, VIRUS RES, V131, P121, DOI 10.1016/j.virusres.2007.08.014; Pan K, 2011, J R SOC INTERFACE, V8, P1644, DOI 10.1098/rsif.2011.0105; Peret TCT, 2004, J GEN VIROL, V85, P679, DOI 10.1099/vir.0.19504-0; Peret TCT, 1998, J GEN VIROL, V79, P2221, DOI 10.1099/0022-1317-79-9-2221; Peret TCT, 2000, J INFECT DIS, V181, P1891, DOI 10.1086/315508; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Pybus OG, 2009, NAT REV GENET, V10, P540, DOI 10.1038/nrg2583; Ren L, 2009, CLIN MICROBIOL INFEC, V15, P1146, DOI 10.1111/j.1469-0691.2009.02746.x; Ren LL, 2008, J CLIN VIROL, V43, P330, DOI 10.1016/j.jcv.2008.08.003; Sarasini A, 2006, J CLIN VIROL, V35, P59, DOI 10.1016/j.jcv.2005.05.010; Sloots TP, 2006, EMERG INFECT DIS, V12, P1263, DOI 10.3201/eid1708.051239; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tee KK, 2010, J VIROL, V84, P3339, DOI 10.1128/JVI.01019-09; van den Hoogen BG, 2001, NAT MED, V7, P719, DOI 10.1038/89098; Wilgenbusch James C, 2003, Curr Protoc Bioinformatics, VChapter 6, DOI 10.1002/0471250953.bi0604s00; Wolf Yuri I, 2010, PLoS Curr, V2, pRRN1200, DOI 10.1371/currents.RRN1200; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zaki ME, 2009, MICROBIOL IMMUNOL, V53, P603, DOI 10.1111/j.1348-0421.2009.00162.x; Zehender G, 2011, INFECT GENET EVOL, V11, P646, DOI 10.1016/j.meegid.2011.02.003	41	3	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e34544	10.1371/journal.pone.0034544	http://dx.doi.org/10.1371/journal.pone.0034544			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479641	gold, Green Published, Green Submitted			2022-12-27	WOS:000305339100166
J	Williams, CM; Marshall, KE; MacMillan, HA; Dzurisin, JDK; Hellmann, JJ; Sinclair, BJ				Williams, Caroline M.; Marshall, Katie E.; MacMillan, Heath A.; Dzurisin, Jason D. K.; Hellmann, Jessica J.; Sinclair, Brent J.			Thermal Variability Increases the Impact of Autumnal Warming and Drives Metabolic Depression in an Overwintering Butterfly	PLOS ONE			English	Article							CLIMATE-CHANGE; TEMPERATURE; RANGE; SIZE; POPULATIONS; PERFORMANCE; COLEOPTERA; ALLOCATION; EVOLUTION; SURVIVAL	Increases in thermal variability elevate metabolic rate due to Jensen's inequality, and increased metabolic rate decreases the fitness of dormant ectotherms by increasing consumption of stored energy reserves. Theory predicts that ectotherms should respond to increased thermal variability by lowering the thermal sensitivity of metabolism, which will reduce the impact of the warm portion of thermal variability. We examined the thermal sensitivity of metabolic rate of overwintering Erynnis propertius (Lepidoptera: Hesperiidae) larvae from a stable or variable environment reared in the laboratory in a reciprocal common garden design, and used these data to model energy use during the winters of 1973-2010 using meteorological data to predict the energetic outcomes of metabolic compensation and phenological shifts. Larvae that experienced variable temperatures had decreased thermal sensitivity of metabolic rate, and were larger than those reared at stable temperatures, which could partially compensate for the increased energetic demands. Even with depressed thermal sensitivity, the variable environment was more energy-demanding than the stable, with the majority of this demand occurring in autumn. Autumn phenology changes thus had disproportionate influence on energy consumption in variable environments, and variable-reared larvae were most susceptible to overwinter energy drain. Therefore the energetic impacts of the timing of entry into winter dormancy will strongly influence ectotherm fitness in northern temperate environments. We conclude that thermal variability drives the expression of metabolic suppression in this species; that phenological shifts will have a greater impact on ectotherms in variable thermal environments; and that E. propertius will be more sensitive to shifts in phenology in autumn than in spring. This suggests that increases in overwinter thermal variability and/or extended, warm autumns, will negatively impact all non-feeding dormant ectotherms which lack the ability to suppress their overwinter metabolic thermal sensitivity.	[Williams, Caroline M.; Marshall, Katie E.; MacMillan, Heath A.; Sinclair, Brent J.] Univ Western Ontario, Dept Biol, London, ON, Canada; [Dzurisin, Jason D. K.; Hellmann, Jessica J.] Univ Notre Dame, Dept Biol Sci, South Bend, IN USA	Western University (University of Western Ontario); University of Notre Dame	Williams, CM (corresponding author), Univ Florida, Dept Entomol & Nematol, Gainesville, FL 32611 USA.	bsincla7@uwo.ca	MacMillan, Heath/J-6943-2012; Williams, Caroline/B-4001-2012; Marshall, Katie/A-8200-2013	MacMillan, Heath/0000-0001-7598-3273; Williams, Caroline/0000-0003-3112-0286; Marshall, Katie/0000-0002-6991-4957; Sinclair, Brent/0000-0002-8191-9910	NSERC (Natural Sciences and Engineering Research Council of Canada); Canadian Foundation for Innovation; Ontario Ministry for Research and Innovation; U.S. Department of Energy Office of Science [DE-FG02-05ER]; Ontario NSERC	NSERC (Natural Sciences and Engineering Research Council of Canada)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Foundation for Innovation(Canada Foundation for Innovation); Ontario Ministry for Research and Innovation(Ministry of Research and Innovation, Ontario); U.S. Department of Energy Office of Science(United States Department of Energy (DOE)); Ontario NSERC	This study was supported by Ontario and NSERC (Natural Sciences and Engineering Research Council of Canada) Graduate Scholarships to C.M.W., H.A.M., and K.E.M.; grants from NSERC (Discovery), the Canadian Foundation for Innovation and Ontario Ministry for Research and Innovation to B.J.S; and U.S. Department of Energy Office of Science (Biological and Environmental Research) Grant no. DE-FG02-05ER to J.J.H. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angilletta MJ, 2006, J THERM BIOL, V31, P541, DOI 10.1016/j.jtherbio.2006.06.002; Angilletta MJ, 2009, BIO HABIT, P1, DOI 10.1093/acprof:oso/9780198570875.001.1; Boggs CL, 2009, FUNCT ECOL, V23, P27, DOI 10.1111/j.1365-2435.2009.01527.x; Bosch J, 2010, J INSECT PHYSIOL, V56, P1949, DOI 10.1016/j.jinsphys.2010.08.017; Chippindale AK, 1996, EVOLUTION, V50, P753, DOI [10.2307/2410848, 10.1111/j.1558-5646.1996.tb03885.x]; Clarke A, 2004, FUNCT ECOL, V18, P252, DOI 10.1111/j.0269-8463.2004.00842.x; Crawley M.J., 2007, R BOOK; Crozier L, 2004, ECOLOGY, V85, P231, DOI 10.1890/02-0607; Davidowitz G, 2004, INTEGR COMP BIOL, V44, P443, DOI 10.1093/icb/44.6.443; Dillon ME, 2010, NATURE, V467, P704, DOI 10.1038/nature09407; Estay SA, 2011, POPUL ECOL, V53, P53, DOI 10.1007/s10144-010-0216-7; Gillooly JF, 2001, SCIENCE, V293, P2248, DOI 10.1126/science.1061967; Hahn DA, 2011, ANNU REV ENTOMOL, V56, P103, DOI 10.1146/annurev-ento-112408-085436; Han EN, 1998, ECOL ENTOMOL, V23, P160, DOI 10.1046/j.1365-2311.1998.00111.x; Hellmann JJ, 2008, OECOLOGIA, V157, P583, DOI 10.1007/s00442-008-1112-0; Hochachka P. W., 2002, BIOCH ADAPTATION; Irwin JT, 2003, OIKOS, V100, P71, DOI 10.1034/j.1600-0706.2003.11738.x; Ishihara M, 2006, ENVIRON ENTOMOL, V35, P524, DOI 10.1603/0046-225X-35.2.524; Jepsen JU, 2008, J ANIM ECOL, V77, P257, DOI 10.1111/j.1365-2656.2007.01339.x; Kingsolver JG, 2009, EVOLUTION, V63, P537, DOI 10.1111/j.1558-5646.2008.00568.x; Makarieva AM, 2006, FUNCT ECOL, V20, P83, DOI 10.1111/j.1365-2435.2006.01070.x; Marshall KE, 2012, NATURWISSENSCHAFTEN, V99, P33, DOI 10.1007/s00114-011-0866-0; Nespolo RF, 2007, BIOL RES, V40, P5, DOI 10.4067/S0716-97602007000100001; Niehaus AC, 2011, J EXP BIOL, V214, P1965, DOI 10.1242/jeb.054478; NIJHOUT HF, 1975, BIOL BULL, V149, P214, DOI 10.2307/1540491; O'Brien DM, 2002, P NATL ACAD SCI USA, V99, P4413, DOI 10.1073/pnas.072346699; Paaijmans KP, 2010, P NATL ACAD SCI USA, V107, P15135, DOI 10.1073/pnas.1006422107; Pachauri Rajendra, 2007, AR4 CLIMATE CHANGE 2; Parajulee MN, 1997, ENVIRON ENTOMOL, V26, P135, DOI 10.1093/ee/26.2.135; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Pasztor L, 2000, TRENDS ECOL EVOL, V15, P117, DOI 10.1016/S0169-5347(99)01801-7; Pelini SL, 2009, P NATL ACAD SCI USA, V106, P11160, DOI 10.1073/pnas.0900284106; Pinheiro J., 2019, NLME LINEAR NONLINEA; Pinheiro J, 2001, MIXED EFFECTS MODELS; Prior KM, 2009, CAN ENTOMOL, V141, P161, DOI 10.4039/n08-019; R Core Development Team, 2009, R LANG ENV STAT COMP; Ruel JJ, 1999, TRENDS ECOL EVOL, V14, P361, DOI 10.1016/S0169-5347(99)01664-X; Schlenker W, 2009, P NATL ACAD SCI USA, V106, P15594, DOI 10.1073/pnas.0906865106; Schmidt Nielsen K, 1990, ANIMAL PHYSL ADAPTAT; Sunday JM, 2011, P ROY SOC B-BIOL SCI, V278, P1823, DOI 10.1098/rspb.2010.1295; Thackeray SJ, 2010, GLOBAL CHANGE BIOL, V16, P3304, DOI 10.1111/j.1365-2486.2010.02165.x; van Asch M, 2007, GLOBAL CHANGE BIOL, V13, P1596, DOI 10.1111/j.1365-2486.2007.01400.x; Williams CM, 2011, J INSECT PHYSIOL, V57, P1602, DOI 10.1016/j.jinsphys.2011.08.008; Williams CM, 2010, BIOL LETTERS, V6, P274, DOI 10.1098/rsbl.2009.0803; Zhang TJ, 2005, REV GEOPHYS, V43, DOI 10.1029/2004RG000157	45	93	94	0	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e34470	10.1371/journal.pone.0034470	http://dx.doi.org/10.1371/journal.pone.0034470			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479634	Green Submitted, gold, Green Published			2022-12-27	WOS:000305339100160
J	Zabransky, DJ; Nirschl, CJ; Durham, NM; Park, B; Ceccato, CM; Bruno, TC; Tam, AJ; Getnet, D; Drake, CG				Zabransky, Daniel J.; Nirschl, Christopher J.; Durham, Nicholas M.; Park, Ben V.; Ceccato, Christina M.; Bruno, Tullia C.; Tam, Ada J.; Getnet, Derese; Drake, Charles G.			Phenotypic and Functional Properties of Helios(+) Regulatory T Cells	PLOS ONE			English	Article							EXPRESSION; TOLERANCE; CD25(+); SELF; IMMUNITY	Helios, an Ikaros family transcription factor, is preferentially expressed at the mRNA and protein level in regulatory T cells. Helios expression previously appeared to be restricted to thymic-derived Treg. Consistent with recent data, we show here that Helios expression is inducible in vitro under certain conditions. To understand phenotypic and functional differences between Helios(+) and Helios(-) Treg, we profiled cell-surface markers of FoxP3(+) Treg using unmanipulated splenocytes. We found that CD103 and GITR are expressed at high levels on a subset of Helios(+) Treg and that a Helios(+) Treg population could be significantly enriched by FACS sorting using these two markers. Quantitative real-time PCR (qPCR) analysis revealed increased TGF-beta message in Helios(+) Treg, consistent with the possibility that this population possesses enhanced regulatory potential. In tumor-bearing mice, we found that Helios(+) Treg were relatively over-represented in the tumor-mass, and BrdU studies showed that, in vivo, Helios(+) Treg proliferated more than Helios(-) Treg. We hypothesized that Helios-enriched Treg might exert increased suppressive effects. Using in vitro suppression assays, we show that Treg function correlates with the absolute number of Helios(+) cells in culture. Taken together, these data show that Helios(+) Treg represent a functional subset with associated CD103 and GITR expression.	[Zabransky, Daniel J.; Nirschl, Christopher J.; Durham, Nicholas M.; Park, Ben V.; Ceccato, Christina M.; Bruno, Tullia C.; Tam, Ada J.; Getnet, Derese; Drake, Charles G.] Johns Hopkins Univ, Dept Oncol, Baltimore, MD 21218 USA; [Drake, Charles G.] James Buchanan Brady Urol Inst, Baltimore, MD USA	Johns Hopkins University	Zabransky, DJ (corresponding author), Johns Hopkins Univ, Dept Oncol, Baltimore, MD 21218 USA.	cdrake@jhmi.edu		Zabransky, Daniel/0000-0002-8184-3346; Nirschl, Christopher/0000-0002-7333-2757	National Institutes of Health [R01 CA127153, 1P50CA58236-15]; Patrick C. Walsh Fund; OneInSix Foundation; Prostate Cancer Foundation; NATIONAL CANCER INSTITUTE [P50CA058236, R01CA127153] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007247] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Patrick C. Walsh Fund; OneInSix Foundation; Prostate Cancer Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health R01 CA127153 and 1P50CA58236-15, the Patrick C. Walsh Fund (http://prostatecancerprogram.onc.jhmi.edu/PCW/), the OneInSix Foundation (www.oneinsix.org), and the Prostate Cancer Foundation (www.pcf.org). CGD is a Damon Runyon-Lilly Clinical Investigator. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alinikula J, 2010, EUR J IMMUNOL, V40, P2599, DOI 10.1002/eji.200940002; Anz D, 2011, INT J CANC IN PRESS; Belkaid Y, 2006, IMMUNOL REV, V212, P287, DOI 10.1111/j.0105-2896.2006.00409.x; Cai Q, 2009, J IMMUNOL, V183, P2303, DOI 10.4049/jimmunol.0901407; Chen X, 2008, J IMMUNOL, V180, P6467, DOI 10.4049/jimmunol.180.10.6467; Curiel TJ, 2008, CURR OPIN IMMUNOL, V20, P241, DOI 10.1016/j.coi.2008.04.008; Feuerer M, 2010, P NATL ACAD SCI USA, V107, P5919, DOI 10.1073/pnas.1002006107; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Getnet D, 2010, MOL IMMUNOL, V47, P1595, DOI 10.1016/j.molimm.2010.02.001; Getnet D, 2009, J IMMUNOL, V182, P4675, DOI 10.4049/jimmunol.0803400; Haribhai D, 2009, J IMMUNOL, V182, P3461, DOI 10.4049/jimmunol.0802535; Horwitz DA, 2008, TRENDS IMMUNOL, V29, P429, DOI 10.1016/j.it.2008.06.005; Huang CT, 2004, IMMUNITY, V21, P503, DOI 10.1016/j.immuni.2004.08.010; Huehn J, 2004, J EXP MED, V199, P303, DOI 10.1084/jem.20031562; Kronenberg M, 2005, NATURE, V435, P598, DOI 10.1038/nature03725; Lehmann J, 2002, P NATL ACAD SCI USA, V99, P13031, DOI 10.1073/pnas.192162899; Lin W, 2007, NAT IMMUNOL, V8, P359, DOI 10.1038/ni1445; Malek TR, 2004, NAT REV IMMUNOL, V4, P665, DOI 10.1038/nri1435; McHugh RS, 2002, IMMUNITY, V16, P311, DOI 10.1016/S1074-7613(02)00280-7; Sakaguchi S, 2005, NAT IMMUNOL, V6, P345, DOI 10.1038/ni1178; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Schon MP, 1999, J IMMUNOL, V162, P6641; Shevach EM, 2004, ARTHRITIS RHEUM, V50, P2721, DOI 10.1002/art.20500; Sugimoto N, 2006, INT IMMUNOL, V18, P1197, DOI 10.1093/intimm/dxl060; Thornton AM, 2004, J IMMUNOL, V172, P6519, DOI 10.4049/jimmunol.172.11.6519; Thornton AM, 2010, J IMMUNOL, V184, P3433, DOI 10.4049/jimmunol.0904028; Verhagen J, 2010, J IMMUNOL, V185, P7129, DOI 10.4049/jimmunol.1090105; Vignali DAA, 2008, NAT REV IMMUNOL, V8, P523, DOI 10.1038/nri2343; Zheng Y, 2007, NAT IMMUNOL, V8, P457, DOI 10.1038/ni1455	29	117	123	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e34547	10.1371/journal.pone.0034547	http://dx.doi.org/10.1371/journal.pone.0034547			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479644	gold, Green Published, Green Submitted			2022-12-27	WOS:000305339100167
J	Lee, SH; Yoon, J; Shin, SH; Zahoor, M; Kim, HJ; Park, PJ; Park, WS; Min, DS; Kim, HY; Choi, KY				Lee, Soung-Hoon; Yoon, Juyong; Shin, Seung Ho; Zahoor, Muhamad; Kim, Hyoung Jun; Park, Phil June; Park, Won-Seok; Min, Do Sik; Kim, Hyun-Yi; Choi, Kang-Yell			Valproic Acid Induces Hair Regeneration in Murine Model and Activates Alkaline Phosphatase Activity in Human Dermal Papilla Cells	PLOS ONE			English	Article							BETA-CATENIN; NEURONAL DIFFERENTIATION; FOLLICLE DEVELOPMENT; PROGENITOR CELLS; STEM-CELLS; WNT; INHIBITION; EXPRESSION; LITHIUM; PROLIFERATION	Background: Alopecia is the common hair loss problem that can affect many people. However, current therapies for treatment of alopecia are limited by low efficacy and potentially undesirable side effects. We have identified a new function for valproic acid (VPA), a GSK3 beta inhibitor that activates the Wnt/beta-catenin pathway, to promote hair re-growth in vitro and in vivo. Methodology/Principal Findings: Topical application of VPA to male C3H mice critically stimulated hair re-growth and induced terminally differentiated epidermal markers such as filaggrin and loricrin, and the dermal papilla marker alkaline phosphatase (ALP). VPA induced ALP in human dermal papilla cells by up-regulating the Wnt/beta-catenin pathway, whereas minoxidil (MNX), a drug commonly used to treat alopecia, did not significantly affect the Wnt/beta-catenin pathway. VPA analogs and other GSK3 beta inhibitors that activate the Wnt/beta-catenin pathway such as 4-phenyl butyric acid, LiCl, and BeCl2 also exhibited hair growth-promoting activities in vivo. Importantly, VPA, but not MNX, successfully stimulate hair growth in the wounds of C3H mice. Conclusions/Significance: Our findings indicate that small molecules that activate the Wnt/beta-catenin pathway, such as VPA, can potentially be developed as drugs to stimulate hair re-growth.	[Lee, Soung-Hoon; Yoon, Juyong; Shin, Seung Ho; Zahoor, Muhamad; Min, Do Sik; Kim, Hyun-Yi; Choi, Kang-Yell] Yonsei Univ, Translat Res Ctr Prot Funct Control, Dept Biotechnol, Coll Life Sci & Biotechnol, Seoul 120749, South Korea; [Kim, Hyoung Jun; Park, Phil June; Park, Won-Seok] Amore Pacific Corp, Ctr Res & Dev, Skin Res Inst, Skin Res Team, Kyonggi Do, South Korea; [Min, Do Sik] Pusan Natl Univ, Coll Nat Sci, Dept Mol Biol, Pusan, South Korea	Yonsei University; Pusan National University	Lee, SH (corresponding author), Yonsei Univ, Translat Res Ctr Prot Funct Control, Dept Biotechnol, Coll Life Sci & Biotechnol, Seoul 120749, South Korea.	kychoi@yonsei.ac.kr	Park, Phil June/S-3689-2018; Park, Phil June/AAU-5035-2020	Park, Phil June/0000-0002-8867-4602	National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology (MEST); Translational Research Center for Protein Function Control [2009-0083522]; Mid-career Researcher Program [2010-0026844]; Stem Cell Research Project [2010-0020235]; Ministry of Knowledge Economy (through the Korea Research Institute of Chemical Technology) [SI-095]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology (MEST)(Ministry of Education, Science & Technology (MEST), Republic of Korea); Translational Research Center for Protein Function Control; Mid-career Researcher Program; Stem Cell Research Project; Ministry of Knowledge Economy (through the Korea Research Institute of Chemical Technology)(Ministry of Trade, Industry & Energy (MOTIE), Republic of Korea)	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Ministry of Education, Science and Technology (MEST); Translational Research Center for Protein Function Control (2009-0083522), Mid-career Researcher Program (2010-0026844), and the Stem Cell Research Project (2010-0020235). This work was also partly supported by a grant from the Ministry of Knowledge Economy (through the Korea Research Institute of Chemical Technology [SI-095]). S. H. Lee, J. Yoon were supported by a BK21 studentship from the MEST. These funding sources had no role in the design of experiments, data collection, data analysis, data interpretation, or the preparation and submission of this manuscript.	Andl T, 2002, DEV CELL, V2, P643, DOI 10.1016/S1534-5807(02)00167-3; Bug G, 2007, HAEMATOLOGICA, V92, P542, DOI 10.3324/haematol.10758; Clement-Lacroix P, 2005, P NATL ACAD SCI USA, V102, P17406, DOI 10.1073/pnas.0505259102; Crabtree JS, 2010, ENDOCRINOLOGY, V151, P2373, DOI 10.1210/en.2009-1474; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P1269, DOI 10.1038/nbt.1502; DasGupta R, 1999, DEVELOPMENT, V126, P4557; Dewhurst S, 2007, J NEUROIMMUNE PHARM, V2, P93, DOI 10.1007/s11481-006-9051-1; Garza LA, 2011, J CLIN INVEST, V121, P613, DOI 10.1172/JCI44478; Gould TD, 2004, NEUROPSYCHOPHARMACOL, V29, P32, DOI 10.1038/sj.npp.1300283; Gould TD, 2002, NEUROSCIENTIST, V8, P497, DOI 10.1177/107385802237176; Gurvich N, 2002, PHARMACOL THERAPEUT, V96, P45, DOI 10.1016/S0163-7258(02)00299-1; Hall AC, 2002, MOL CELL NEUROSCI, V20, P257, DOI 10.1006/mcne.2002.1117; Han JH, 2004, J DERMATOL SCI, V34, P91, DOI 10.1016/j.jdermsci.2004.01.002; Hsieh J, 2004, P NATL ACAD SCI USA, V101, P16659, DOI 10.1073/pnas.0407643101; Huelsken J, 2001, CELL, V105, P533, DOI 10.1016/S0092-8674(01)00336-1; Iida M, 2007, DEV GROWTH DIFFER, V49, P185, DOI 10.1111/j.1440-169x.2007.00907.x; Ito M, 2001, J INVEST DERMATOL, V116, P956, DOI 10.1046/j.0022-202x.2001.01369.x; Ito M, 2007, NATURE, V447, P316, DOI 10.1038/nature05766; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jeong MR, 2003, FEBS LETT, V542, P74, DOI 10.1016/S0014-5793(03)00350-8; Jung GA, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-66; Kim JS, 2002, CANCER RES, V62, P2744; Kishimoto J, 2000, GENE DEV, V14, P1181; McElwee KJ, 2003, J INVEST DERMATOL, V121, P1267, DOI 10.1111/j.1523-1747.2003.12568.x; Millar SE, 2002, J INVEST DERMATOL, V118, P216, DOI 10.1046/j.0022-202x.2001.01670.x; Moon BS, 2009, EXP MOL MED, V41, P116, DOI 10.3858/emm.2009.41.2.014; Muller-Rover S, 2001, J INVEST DERMATOL, V117, P3, DOI 10.1046/j.0022-202x.2001.01377.x; Ohyama M, 2010, EXP DERMATOL, V19, P89, DOI 10.1111/j.1600-0625.2009.00935.x; Rendl M, 2008, GENE DEV, V22, P543, DOI 10.1101/gad.1614408; Reynolds MF, 2007, CURR MED CHEM, V14, P2799, DOI 10.2174/092986707782360088; Ridanpaa M, 2001, MECH DEVELOP, V109, P173, DOI 10.1016/S0925-4773(01)00563-9; Rosenberg G, 2007, CELL MOL LIFE SCI, V64, P2090, DOI 10.1007/s00018-007-7079-x; Shimshoni JA, 2007, MOL PHARMACOL, V71, P884, DOI 10.1124/mol.106.030601; Sick S, 2006, SCIENCE, V314, P1447, DOI 10.1126/science.1130088; Van Mater D, 2003, GENE DEV, V17, P1219, DOI 10.1101/gad.1076103; Yilmaz Y, 2009, EUR J PAEDIATR NEURO, V13, P439, DOI 10.1016/j.ejpn.2008.08.007	36	40	43	4	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2012	7	4							e34152	10.1371/journal.pone.0034152	http://dx.doi.org/10.1371/journal.pone.0034152			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959FE	22506014	Green Published, Green Submitted, gold			2022-12-27	WOS:000305297500022
J	Wagner, F; Rossi, V; Stahl, C; Bonal, D; Herault, B				Wagner, Fabien; Rossi, Vivien; Stahl, Clement; Bonal, Damien; Herault, Bruno			Water Availability Is the Main Climate Driver of Neotropical Tree Growth	PLOS ONE			English	Article							RAIN-FOREST TREE; TROPICAL FORESTS; EXPERIMENTAL DROUGHT; VEGETATION DYNAMICS; RESPONSES; MODEL; PATTERNS; BIOMASS; CO2; TEMPERATURE	Climate models for the coming century predict rainfall reduction in the Amazonian region, including change in water availability for tropical rainforests. Here, we test the extent to which climate variables related to water regime, temperature and irradiance shape the growth trajectories of neotropical trees. . We developed a diameter growth model explicitly designed to work with asynchronous climate and growth data. Growth trajectories of 205 individual trees from 54 neotropical species censused every 2 months over a 4-year period were used to rank 9 climate variables and find the best predictive model. . About 9% of the individual variation in tree growth was imputable to the seasonal variation of climate. Relative extractable water was the main predictor and alone explained more than 60% of the climate effect on tree growth, i.e. 5.4% of the individual variation in tree growth. Furthermore, the global annual tree growth was more dependent on the diameter increment at the onset of the rain season than on the duration of dry season. . The best predictive model included 3 climate variables: relative extractable water, minimum temperature and irradiance. The root mean squared error of prediction (0.035 mm.d(-1)) was slightly above the mean value of the growth (0.026 mm.d(-1)). . Amongst climate variables, we highlight the predominant role of water availability in determining seasonal variation in tree growth of neotropical forest trees and the need to include these relationships in forest simulators to test, in silico, the impact of different climate scenarios on the future dynamics of the rainforest.	[Wagner, Fabien; Herault, Bruno] Univ Antilles Guyane, UMR Ecol Forets Guyane, Kourou, France; [Rossi, Vivien] CIRAD, UMR Ecol Forets Guyane, Kourou, France; [Stahl, Clement] INRA, UMR Ecol Forets Guyane, Kourou, France; [Bonal, Damien] INRA, UMR Ecol & Ecophysiol Forestiere, Champenoux, France	AgroParisTech; CIRAD; Centre National de la Recherche Scientifique (CNRS); Universite des Antilles; AgroParisTech; CIRAD; Centre National de la Recherche Scientifique (CNRS); Universite des Antilles; AgroParisTech; CIRAD; Centre National de la Recherche Scientifique (CNRS); Universite des Antilles; INRAE; INRAE	Wagner, F (corresponding author), Univ Antilles Guyane, UMR Ecol Forets Guyane, BP 709, Kourou, France.	fabien.wagner@ecofog.gf	Hérault, Bruno/B-2765-2011; Rossi, Vivien/C-9721-2009; Wagner, Fabien FW/B-8364-2013	Hérault, Bruno/0000-0002-6950-7286; Rossi, Vivien/0000-0001-5458-1523; Wagner, Fabien FW/0000-0002-9623-1182	project Climfor (Fondation pour la Recherche sur la Biodiversite); project Guyasim (European structural fundings, PO-Feder)	project Climfor (Fondation pour la Recherche sur la Biodiversite); project Guyasim (European structural fundings, PO-Feder)	Funding came from the project Climfor (Fondation pour la Recherche sur la Biodiversite, www.fondationbiodiversite.fr/) and from the project Guyasim (European structural fundings, PO-Feder, http://www.europe-guyane.eu/index.php?option=com_content&task=view&id=14&Itemid=206). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anaya CA, 2007, OECOLOGIA, V150, P602, DOI 10.1007/s00442-006-0564-3; Arias PA, 2011, CLIM DYNAM, V37, P1151, DOI 10.1007/s00382-010-0903-2; Arneth A, 1998, TREE PHYSIOL, V18, P785; Baker TR, 2003, J TROP ECOL, V19, P109, DOI 10.1017/S0266467403003146; Bohrer G, 2005, WATER RESOUR RES, V41, DOI 10.1029/2005WR004181; Bonal D, 2008, GLOBAL CHANGE BIOL, V14, P1917, DOI 10.1111/j.1365-2486.2008.01610.x; Borchert R, 1998, CLIMATIC CHANGE, V39, P381, DOI 10.1023/A:1005383020063; Brando PM, 2008, PHILOS T R SOC B, V363, P1839, DOI 10.1098/rstb.2007.0031; Brando PM, 2010, P NATL ACAD SCI USA, V107, P14685, DOI 10.1073/pnas.0908741107; Braswell BH, 1997, SCIENCE, V278, P870, DOI 10.1126/science.278.5339.870; Brienen RJW, 2011, TREES-STRUCT FUNCT, V25, P103, DOI 10.1007/s00468-010-0474-1; Burke EJ, 2006, J HYDROMETEOROL, V7, P1113, DOI 10.1175/JHM544.1; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Calcagno V, 2010, J STAT SOFTW, V34, P1; Chambers JQ, 2004, PHILOS T R SOC B, V359, P463, DOI 10.1098/rstb.2003.1424; Chave J., 2009, BIOGEOSCI DISCUSS, V6, P7565, DOI [10.5194/bgd-6-7565-2009, DOI 10.5194/BGD-6-7565-2009]; Chen JQ, 2002, TREE PHYSIOL, V22, P169, DOI 10.1093/treephys/22.2-3.169; Clark DA, 2003, P NATL ACAD SCI USA, V100, P5852, DOI 10.1073/pnas.0935903100; Clark DA, 1999, ECOL APPL, V9, P981, DOI 10.1890/1051-0761(1999)009[0981:ATGOTR]2.0.CO;2; Clark DB, 2010, GLOBAL CHANGE BIOL, V16, P747, DOI 10.1111/j.1365-2486.2009.02004.x; Clark DA, 2011, BIOTROPICA, V43, P31, DOI 10.1111/j.1744-7429.2010.00654.x; Condit R, 2004, J TROP ECOL, V20, P51, DOI 10.1017/S0266467403001081; Doughty CE, 2008, J GEOPHYS RES-BIOGEO, V113, DOI [10.1029/2007JG000632, 10.1029/2007JG000590]; Enquist BJ, 2001, J TROP ECOL, V17, P41, DOI 10.1017/S0266467401001031; Feeley KJ, 2007, ECOL LETT, V10, P461, DOI 10.1111/j.1461-0248.2007.01033.x; Fonty E, 2009, GLOBAL CHANGE BIOL, V15, P2360, DOI 10.1111/j.1365-2486.2009.01923.x; Franks PJ, 1999, PLANT CELL ENVIRON, V22, P1337, DOI 10.1046/j.1365-3040.1999.00494.x; Goulden ML, 2004, ECOL APPL, V14, pS42, DOI 10.1890/02-6008; Gourlet-Fleury S., 2004, ECOLOGY MANAGEMENT N; Graham EA, 2003, P NATL ACAD SCI USA, V100, P572, DOI 10.1073/pnas.0133045100; Granier A, 1999, ECOL MODEL, V116, P269, DOI 10.1016/S0304-3800(98)00205-1; GRANIER A, 1992, ANN SCI FOREST, V49, P17, DOI 10.1051/forest:19920102; Harris PP, 2008, PHILOS T R SOC B, V363, P1753, DOI 10.1098/rstb.2007.0037; Herault B, 2011, J ECOL, V99, P1431, DOI 10.1111/j.1365-2745.2011.01883.x; Herault B, 2010, J APPL ECOL, V47, P821, DOI 10.1111/j.1365-2664.2010.01826.x; Houghton RA, 2005, GLOBAL CHANGE BIOL, V11, P945, DOI 10.1111/j.1365-2486.2005.00955.x; Huete AR, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025583; Hutyra LR, 2007, J GEOPHYS RES-BIOGEO, V112, DOI 10.1029/2006JG000365; Janott M, 2011, PLANT SOIL, V341, P233, DOI 10.1007/s11104-010-0639-0; Johns TC, 2003, CLIM DYNAM, V20, P583, DOI 10.1007/s00382-002-0296-y; KOZLOWSKI TT, 1992, BOT REV, V58, P107, DOI 10.1007/BF02858600; Krepkowski J, 2011, TREES-STRUCT FUNCT, V25, P59, DOI 10.1007/s00468-010-0460-7; Susan GWL, 2009, J VEG SCI, V20, P323, DOI 10.1111/j.1654-1103.2009.01044.x; Lloyd J, 2008, PHILOS T R SOC B, V363, P1811, DOI 10.1098/rstb.2007.0032; Loescher HW, 2003, GLOBAL CHANGE BIOL, V9, P396, DOI 10.1046/j.1365-2486.2003.00599.x; da Costa ACL, 2010, NEW PHYTOL, V187, P579, DOI 10.1111/j.1469-8137.2010.03309.x; Malhi Y, 2004, PHILOS T R SOC B, V359, P311, DOI 10.1098/rstb.2003.1433; Malhi Y, 2009, P NATL ACAD SCI USA, V106, P20610, DOI 10.1073/pnas.0804619106; MEINZER FC, 1993, PLANT CELL ENVIRON, V16, P429, DOI 10.1111/j.1365-3040.1993.tb00889.x; Myneni RB, 2007, P NATL ACAD SCI USA, V104, P4820, DOI 10.1073/pnas.0611338104; Nath CD, 2006, J BIOSCIENCES, V31, P651, DOI 10.1007/BF02708418; Nemani RR, 2003, SCIENCE, V300, P1560, DOI 10.1126/science.1082750; Nepstad D, 2004, GLOBAL CHANGE BIOL, V10, P704, DOI 10.1111/j.1529-8817.2003.00772.x; Nepstad DC, 2007, ECOLOGY, V88, P2259, DOI 10.1890/06-1046.1; Nepstad DC, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD000360; Orwig DA, 1997, TREES-STRUCT FUNCT, V11, P474, DOI 10.1007/s004680050110; Pennec A, 2011, REMOTE SENS LETT, V2, P337, DOI 10.1080/01431161.2010.507610; Phillips OL, 2009, SCIENCE, V323, P1344, DOI 10.1126/science.1164033; Reichstein M, 2002, FUNCT ECOL, V16, P27, DOI 10.1046/j.0269-8463.2001.00597.x; Rice AH, 2004, ECOL APPL, V14, pS55, DOI 10.1890/02-6006; Roche MA, 1982, ORSTOM SER HYDROL, V19, P37; Rozendaal DMA, 2011, TREES-STRUCT FUNCT, V25, P3, DOI 10.1007/s00468-010-0480-3; Ruger N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025330; Rutishauser E, 2010, J VEG SCI, V21, P672, DOI 10.1111/j.1654-1103.2010.01175.x; Saatchi SS, 2007, GLOBAL CHANGE BIOL, V13, P816, DOI 10.1111/j.1365-2486.2007.01323.x; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Solomon S, 2009, P NATL ACAD SCI USA, V106, P1704, DOI 10.1073/pnas.0812721106; Stahl C, 2010, J TROP ECOL, V26, P393, DOI 10.1017/S0266467410000155; ter Steege H, 2006, NATURE, V443, P444, DOI 10.1038/nature05134; Tian HQ, 1998, NATURE, V396, P664, DOI 10.1038/25328; Uriarte M, 2004, ECOL MONOGR, V74, P591, DOI 10.1890/03-4031; Wagner F, 2011, AGR FOREST METEOROL, V151, P1202, DOI 10.1016/j.agrformet.2011.04.012; Wagner F, 2010, BIOTROPICA, V42, P664, DOI 10.1111/j.1744-7429.2010.00644.x; Way DA, 2010, TREE PHYSIOL, V30, P669, DOI 10.1093/treephys/tpq015; WOFSY SC, 1993, SCIENCE, V260, P1314, DOI 10.1126/science.260.5112.1314; Wright SJ, 2010, ANN NY ACAD SCI, V1195, P1, DOI [10.1111/j.1749-6632.2009.05400.x, 10.1111/j.1749-6632.2010.05455.x]; Xiao XM, 2006, REMOTE SENS ENVIRON, V103, P465, DOI 10.1016/j.rse.2006.04.013; Zalamea M, 2008, BIOTROPICA, V40, P295, DOI 10.1111/j.1744-7429.2007.00389.x	78	65	69	0	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2012	7	4							e34074	10.1371/journal.pone.0034074	http://dx.doi.org/10.1371/journal.pone.0034074			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959FE	22506012	Green Published, gold, Green Submitted			2022-12-27	WOS:000305297500020
J	Zhang, YQ; Qiu, YF; Tan, YF; Guo, ZB; Yang, RF; Zhou, DS				Zhang, Yiquan; Qiu, Yefeng; Tan, Yafang; Guo, Zhaobiao; Yang, Ruifu; Zhou, Dongsheng			Transcriptional Regulation of opaR, qrr2-4 and aphA by the Master Quorum-Sensing Regulator OpaR in Vibrio parahaemolyticus	PLOS ONE			English	Article							CONTROLS BIOFILM FORMATION; VIRULENCE GENE-EXPRESSION; AMP RECEPTOR PROTEIN; GENOME SEQUENCE; ACTIVATOR APHA; III SECRETION; HARVEYI; CHOLERAE; LUXR; VULNIFICUS	Background: Vibrio parahaemolyticus is a leading cause of infectious diarrhea and enterogastritis via the fecal-oral route. V. harveyi is a pathogen of fishes and invertebrates, and has been used as a model for quorum sensing (QS) studies. LuxR is the master QS regulator (MQSR) of V. harveyi, and LuxR-dependent expression of its own gene, qrr2-4 and aphA have been established in V. harveyi. Molecular regulation of target genes by the V. parahaemolyticus MQSR OpaR is still poorly understood. Methodology/Principal Findings: The bioinformatics analysis indicated that V. parahaemolyticus OpaR, V. harveyi LuxR, V. vulnificu SmcR, and V. alginolyticus ValR were extremely conserved, and that these four MQSRs appeared to recognize the same conserved cis-acting signals, which was represented by the consensus constructs manifesting as a position frequency matrix and as a 20 bp box, within their target promoters. The MQSR box-like sequences were found within the upstream DNA regions of opaR, qrr2-4 and aphA in V. parahaemolyticus, and the direct transcriptional regulation of these target genes by OpaR were further confirmed by multiple biochemical experiments including primer extension assay, gel mobility shift assay, and DNase I footprinting analysis. Translation and transcription starts, core promoter elements for sigma factor recognition, Shine-Dalgarno sequences for ribosome recognition, and OpaR-binding sites were determined for the five target genes of OpaR, which gave a structural map of the OpaR-dependent promoters. Further computational promoter analysis indicated the above regulatory circuits were shared by several other closely related Vibrios but with slight exceptions. Conclusions/Significance: This study gave a comprehensive computational and characterization of the direct transcriptional regulation of five target genes, opaR, qrr2-4 and ahpA, by OpaR in V. parahaemolyticus. These characterized regulatory circuits were conserved in V. harveyi and V. parahaemolyticus.	[Zhang, Yiquan; Tan, Yafang; Guo, Zhaobiao; Yang, Ruifu; Zhou, Dongsheng] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China; [Qiu, Yefeng] Acad Mil Med Sci, Lab Anim Ctr, Beijing, Peoples R China	Beijing Institute of Microbiology & Epidemiology; Academy of Military Medical Sciences - China	Zhang, YQ (corresponding author), Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China.	dongshengzhou1977@gmail.com	Yang, Ruifu/A-2273-2011; Zhang, Yiquan/AAP-3311-2021	Yang, Ruifu/0000-0003-3219-7269; Zhang, Yiquan/0000-0003-3935-4079; Zhou, Dongsheng/0000-0003-3827-5969	National Natural Science Foundation of China [31170127, 30871370]; National Basic Research Program of China [2009CB522604]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China)	Financial support was provided by the National Natural Science Foundation of China (31170127, and 30871370), and by the National Basic Research Program of China (2009CB522604). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews GP, 1996, INFECT IMMUN, V64, P2180, DOI 10.1128/IAI.64.6.2180-2187.1996; BALBAS P, 1986, GENE, V50, P3, DOI 10.1016/0378-1119(86)90307-0; Casselli T, 2008, INFECT IMMUN, V76, P2202, DOI 10.1128/IAI.01704-07; Chatterjee J, 1996, MOL MICROBIOL, V20, P415, DOI 10.1111/j.1365-2958.1996.tb02628.x; Chen C, 2010, BIOFOULING, V26, P595, DOI 10.1080/08927014.2010.499511; Chen CY, 2003, GENOME RES, V13, P2577, DOI 10.1101/gr.1295503; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Croxatto A, 2004, MOL MICROBIOL, V52, P1677, DOI 10.1111/j.1365-2958.2004.04083.x; Faruque SM, 2006, P NATL ACAD SCI USA, V103, P6350, DOI 10.1073/pnas.0601277103; Fidopiastis PM, 2002, MOL MICROBIOL, V45, P131, DOI 10.1046/j.1365-2958.2002.02996.x; Gode-Potratz CJ, 2011, J BACTERIOL; Hammer BK, 2003, MOL MICROBIOL, V50, P101, DOI 10.1046/j.1365-2958.2003.03688.x; Hammer BK, 2007, P NATL ACAD SCI USA, V104, P11145, DOI 10.1073/pnas.0703860104; Hammer BK, 2009, J BACTERIOL, V191, P169, DOI 10.1128/JB.01307-08; Hasegawa H, 2009, APPL ENVIRON MICROB, V75, P7602, DOI 10.1128/AEM.01016-09; Heidelberg JF, 2000, NATURE, V406, P477, DOI 10.1038/35020000; Henke JM, 2004, J BACTERIOL, V186, P6902, DOI 10.1128/JB.186.20.6902-6914.2004; Henke JM, 2004, J BACTERIOL, V186, P3794, DOI 10.1128/JB.186.12.3794-3805.2004; Hiyoshi H, 2010, INFECT IMMUN, V78, P1772, DOI 10.1128/IAI.01051-09; Hussa EA, 2008, J BACTERIOL, V190, P4576, DOI 10.1128/JB.00130-08; Ishihama A, 2000, ANNU REV MICROBIOL, V54, P499, DOI 10.1146/annurev.micro.54.1.499; Jeong HS, 2003, J BIOL CHEM, V278, P45072, DOI 10.1074/jbc.M308184200; Kovacikova G, 2005, MOL MICROBIOL, V57, P420, DOI 10.1111/j.1365-2958.2005.04700.x; Kovacikova G, 2004, MOL MICROBIOL, V53, P129, DOI 10.1111/j.1365-2958.2004.04121.x; Kovacikova G, 2002, MOL MICROBIOL, V46, P1135, DOI 10.1046/j.1365-2958.2002.03229.x; Kovacikova G, 2001, MOL MICROBIOL, V41, P393, DOI 10.1046/j.1365-2958.2001.02518.x; Lee DH, 2008, J BIOL CHEM, V283, P23610, DOI 10.1074/jbc.M801480200; Lenz DH, 2004, CELL, V118, P69, DOI 10.1016/j.cell.2004.06.009; Li YL, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-143; Lim B, 2006, MOL MICROBIOL, V60, P331, DOI 10.1111/j.1365-2958.2006.05106.x; Lin BC, 2010, ENV MICROBIOL REP, V2, P81, DOI 10.1111/j.1758-2229.2009.00100.x; Lin W, 2005, J BACTERIOL, V187, P3013, DOI 10.1128/JB.187.9.3013-3019.2005; Lin W, 2007, MOL MICROBIOL, V64, P953, DOI 10.1111/j.1365-2958.2007.05693.x; Liu M, 2007, INFECT IMMUN, V75, P3282, DOI 10.1128/IAI.00045-07; Liu MQ, 2009, MOL MICROBIOL, V72, P491, DOI 10.1111/j.1365-2958.2009.06664.x; Long T, 2009, PLOS BIOL, V7, P640, DOI 10.1371/journal.pbio.1000068; Makino K, 2003, LANCET, V361, P743, DOI 10.1016/S0140-6736(03)12659-1; Mandel MJ, 2009, NATURE, V458, P215, DOI 10.1038/nature07660; McCarter LL, 1998, J BACTERIOL, V180, P3166, DOI 10.1128/JB.180.12.3166-3173.1998; Miyamoto CM, 2006, BBA-GENE STRUCT EXPR, V1759, P296, DOI 10.1016/j.bbaexp.2006.05.005; MIYAMOTO CM, 1994, MOL MICROBIOL, V14, P255, DOI 10.1111/j.1365-2958.1994.tb01286.x; Naka H, 2011, INFECT IMMUN, V79, P2889, DOI 10.1128/IAI.05138-11; Philippe N, 2004, PLASMID, V51, P246, DOI 10.1016/j.plasmid.2004.02.003; Pompeani AJ, 2008, MOL MICROBIOL, V70, P76, DOI 10.1111/j.1365-2958.2008.06389.x; Rutherford ST, 2011, GENE DEV, V25, P397, DOI 10.1101/gad.2015011; Sawabe T, 2007, J BACTERIOL, V189, P7932, DOI 10.1128/JB.00693-07; Shao CP, 2011, J BACTERIOL, V193, P2557, DOI 10.1128/JB.01259-10; Svenningsen SL, 2008, GENE DEV, V22, P226, DOI 10.1101/gad.1629908; Svenningsen SL, 2009, EMBO J, V28, P429, DOI 10.1038/emboj.2008.300; SWARTZMAN E, 1992, J BACTERIOL, V174, P7490, DOI 10.1128/jb.174.22.7490-7493.1992; Tamayo R, 2010, INFECT IMMUN, V78, P3560, DOI 10.1128/IAI.00048-10; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Teng SW, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.30; Thompson JD, 2002, CURR PROTOC BIOINFOR, V2, P23, DOI 10.1002/0471250953.bi0203s00; Tsou AM, 2010, INFECT IMMUN, V78, P461, DOI 10.1128/IAI.00590-09; Tu KC, 2008, MOL MICROBIOL, V70, P896, DOI 10.1111/j.1365-2958.2008.06452.x; Tu KC, 2007, GENE DEV, V21, P221, DOI 10.1101/gad.1502407; Tu KC, 2010, MOL CELL, V37, P567, DOI 10.1016/j.molcel.2010.01.022; van Helden J, 2003, NUCLEIC ACIDS RES, V31, P3593, DOI 10.1093/nar/gkg567; Waters CA, 2008, J BACTERIOL, V190, P2527, DOI 10.1128/JB.01756-07; Waters CM, 2006, GENE DEV, V20, P2754, DOI 10.1101/gad.1466506; Waters CM, 2010, APPL ENVIRON MICROB, V76, P4996, DOI 10.1128/AEM.00886-10; WRIGHT AC, 1991, INFECT IMMUN, V59, P192, DOI 10.1128/IAI.59.1.192-197.1991; Yang MH, 2010, INFECT IMMUN, V78, P697, DOI 10.1128/IAI.00429-09; Yeung P S Marie, 2004, Foodborne Pathog Dis, V1, P74, DOI 10.1089/153531404323143594; Zhan LJ, 2008, INFECT IMMUN, V76, P5028, DOI 10.1128/IAI.00370-08; Zhang YQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025484; Zhu J, 2002, P NATL ACAD SCI USA, V99, P3129, DOI 10.1073/pnas.052694299	68	54	63	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2012	7	4							e34622	10.1371/journal.pone.0034622	http://dx.doi.org/10.1371/journal.pone.0034622			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959FE	22506036	Green Submitted, Green Published, gold			2022-12-27	WOS:000305297500044
J	Avti, PK; Hu, S; Favazza, C; Mikos, AG; Jansen, JA; Shroyer, KR; Wang, LHV; Sitharaman, B				Avti, Pramod K.; Hu, Song; Favazza, Christopher; Mikos, Antonios G.; Jansen, John A.; Shroyer, Kenneth R.; Wang, Lihong V.; Sitharaman, Balaji			Detection, Mapping, and Quantification of Single Walled Carbon Nanotubes in Histological Specimens with Photoacoustic Microscopy	PLOS ONE			English	Article							NEAR-INFRARED FLUORESCENCE; IN-VIVO; RESOLUTION; BIOCOMPATIBILITY; CELLS	Aims: In the present study, the efficacy of multi-scale photoacoustic microscopy (PAM) was investigated to detect, map, and quantify trace amounts [nanograms (ng) to micrograms (mu g)] of SWCNTs in a variety of histological tissue specimens consisting of cancer and benign tissue biopsies (histological specimens from implanted tissue engineering scaffolds). Materials and Methods: Optical-resolution (OR) and acoustic-resolution (AR) - Photoacoustic microscopy (PAM) was employed to detect, map and quantify the SWCNTs in a variety of tissue histological specimens and compared with other optical techniques (bright-field optical microscopy, Raman microscopy, near infrared (NIR) fluorescence microscopy). Results: Both optical-resolution and acoustic-resolution PAM, allow the detection and quantification of SWCNTs in histological specimens with scalable spatial resolution and depth penetration. The noise-equivalent detection sensitivity to SWCNTs in the specimens was calculated to be as low as similar to 7 pg. Image processing analysis further allowed the mapping, distribution, and quantification of the SWCNTs in the histological sections. Conclusions: The results demonstrate the potential of PAM as a promising imaging technique to detect, map, and quantify SWCNTs in histological specimens, and could complement the capabilities of current optical and electron microscopy techniques in the analysis of histological specimens containing SWCNTs.	[Avti, Pramod K.; Sitharaman, Balaji] SUNY Stony Brook, Dept Biomed Engn, Stony Brook, NY 11794 USA; [Hu, Song; Favazza, Christopher; Wang, Lihong V.] Washington Univ, Dept Biomed Engn, Opt Imaging Lab, St Louis, MO USA; [Mikos, Antonios G.] Rice Univ, Dept Bioengn, Houston, TX USA; [Shroyer, Kenneth R.] SUNY Stony Brook, Sch Med, Dept Pathol, Med Ctr, Stony Brook, NY 11794 USA; [Jansen, John A.] Radboud Univ Nijmegen, Med Ctr, Dept Periodontol & Biomat, NL-6525 ED Nijmegen, Netherlands	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Washington University (WUSTL); Rice University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Radboud University Nijmegen	Avti, PK (corresponding author), SUNY Stony Brook, Dept Biomed Engn, Stony Brook, NY 11794 USA.	lhwang@biomed.wustl.edu; balaji.sitharaman@stonybrook.edu	Wang, Lihong V./A-7147-2009; Avti, Pramod/D-5303-2012; Hu, Song/ABD-6256-2021; Jansen, John A/H-8055-2014	Wang, Lihong V./0000-0001-9783-4383; Avti, Pramod/0000-0001-5603-4523; Hu, Song/0000-0002-5760-8012; Sitharaman, Balaji/0000-0001-8391-8076	Carol Baldwin Fund; National Institutes of Health [1DP2OD007394-01, R01 EB000712, EB000712A2S1, R01 EB00071207S2, R01 EB008085, R01 CA113453901, U54 CA136398, 5P60 DK02057933]; NATIONAL CANCER INSTITUTE [U54CA136398, R01CA134539] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [ZIAEB000071, R01EB008085, R01EB000712] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020579] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD007394] Funding Source: NIH RePORTER	Carol Baldwin Fund; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was sponsored by the Carol Baldwin Fund (BS), and National Institutes of Health (BS) grant (1DP2OD007394-01) and (LVW) grants R01 EB000712, EB000712A2S1, R01 EB00071207S2, R01 EB008085, R01 CA113453901, U54 CA136398, and 5P60 DK02057933. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barone PW, 2005, NAT MATER, V4, P86, DOI 10.1038/nmat1276; Carlson LJ, 2007, NANO LETT, V7, P3698, DOI 10.1021/nl072014+; Cherukuri P, 2004, J AM CHEM SOC, V126, P15638, DOI 10.1021/ja0466311; Cherukuri P, 2006, P NATL ACAD SCI USA, V103, P18882, DOI 10.1073/pnas.0609265103; Harrison BS, 2007, BIOMATERIALS, V28, P344, DOI 10.1016/j.biomaterials.2006.07.044; Hu S, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3281673; Hu S, 2009, MED PHYS, V36, P2320, DOI 10.1118/1.3137572; Jorio A, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.075401; Jorio A, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.075207; Leeuw TK, 2007, NANO LETT, V7, P2650, DOI 10.1021/nl0710452; Li L, 2009, OPT EXPRESS, V17, P16450, DOI 10.1364/OE.17.016450; Liu Z, 2008, P NATL ACAD SCI USA, V105, P1410, DOI 10.1073/pnas.0707654105; Liu Z, 2009, NANO RES, V2, P85, DOI 10.1007/s12274-009-9009-8; Maslov K, 2008, OPT LETT, V33, P929, DOI 10.1364/OL.33.000929; Miyawaki J, 2009, ACS NANO, V3, P1399, DOI 10.1021/nn9004846; Pramanik M, 2009, PHYS MED BIOL, V54, P3291, DOI 10.1088/0031-9155/54/11/001; Satishkumar BC, 2007, NAT NANOTECHNOL, V2, P560, DOI 10.1038/nnano.2007.261; Shi XF, 2007, BIOMATERIALS, V28, P4078, DOI 10.1016/j.biomaterials.2007.05.033; Sitharaman B, 2008, BONE, V43, P362, DOI 10.1016/j.bone.2008.04.013; Sitharaman B, 2007, J BIOMED NANOTECHNOL, V3, P342, DOI 10.1166/jbn.2007.043; Sitharaman B, 2011, TISSUE ENG PT A, V17, P1851, DOI [10.1089/ten.tea.2010.0710, 10.1089/ten.TEA.2010.0710]; Wang LV, 2009, NAT PHOTONICS, V3, P503, DOI 10.1038/NPHOTON.2009.157; Welsher K, 2008, NANO LETT, V8, P586, DOI 10.1021/nl072949q; Yang RH, 2008, J AM CHEM SOC, V130, P8351, DOI 10.1021/ja800604z; Zhang HF, 2006, NAT BIOTECHNOL, V24, P848, DOI 10.1038/nbt1220	25	27	27	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2012	7	4							e35064	10.1371/journal.pone.0035064	http://dx.doi.org/10.1371/journal.pone.0035064			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JO	22496892	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000305014500043
J	Safaeian, M; Hildesheim, A; Gonzalez, P; Yu, K; Porras, C; Li, QZ; Rodriguez, AC; Sherman, ME; Schiffman, M; Wacholder, S; Burk, R; Herrero, R; Burdette, L; Chanock, SJ; Wang, SS				Safaeian, Mahboobeh; Hildesheim, Allan; Gonzalez, Paula; Yu, Kai; Porras, Carolina; Li, Qizhai; Cecilia Rodriguez, Ana; Sherman, Mark E.; Schiffman, Mark; Wacholder, Sholom; Burk, Robert; Herrero, Rolando; Burdette, Laurie; Chanock, Stephen J.; Wang, Sophia S.			Single Nucleotide Polymorphisms in the PRDX3 and RPS19 and Risk of HPV Persistence and Cervical Precancer/Cancer	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS INFECTION; FAMILY-CANCER DATABASE; COSTA-RICA; NEOPLASIA; PROGRESSION; VARIANTS; GENES	Background: Host genetic factors might affect the risk of progression from infection with carcinogenic human papillomavirus (HPV), the etiologic agent for cervical cancer, to persistent HPV infection, and hence to cervical precancer and cancer. Methodology/Principal Findings: We assessed 18,310 tag single nucleotide polymorphisms (SNPs) from 1113 genes in 416 cervical intraepithelial neoplasia 3 (CIN3)/cancer cases, 356 women with persistent carcinogenic HPV infection (median persistence of 25 months) and 425 randomly selected women (non-cases and non-HPV persistent) from the 10,049 women from the Guanacaste, Costa Rica HPV natural history cohort. For gene and SNP associations, we computed age-adjusted odds ratio and p-trend. Three comparisons were made: 1) association with CIN3/cancer (compared CIN3/cancer cases to random controls), 2) association with persistence (compared HPV persistence to random controls), and 3) progression (compared CIN3/cancers with HPV-persistent group). Regions statistically significantly associated with CIN3/cancer included genes for peroxiredoxin 3 PRDX3, and ribosomal protein S19 RPS19. The single most significant SNPs from each gene associated with CIN3/cancer were PRDX3 rs7082598 (P-trend < 0.0001), and RPS19 rs2305809 (P-trend = 0.0007), respectively. Both SNPs were also associated with progression. Conclusions/Significance: These data suggest involvement of two genes, RSP19 and PRDX3, or other SNPs in linkage disequilibrium, with cervical cancer risk. Further investigation showed that they may be involved in both the persistence and progression transition stages. Our results require replication but, if true, suggest a role for ribosomal dysfunction, mitochondrial processes, and/or oxidative stress, or other unknown function of these genes in cervical carcinogenesis.	[Safaeian, Mahboobeh; Hildesheim, Allan; Yu, Kai; Sherman, Mark E.; Schiffman, Mark; Wacholder, Sholom] NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; [Gonzalez, Paula; Porras, Carolina; Cecilia Rodriguez, Ana; Herrero, Rolando] Fdn INCIENSA, Proyecto Epidemiol Guanacaste, San Jose, Costa Rica; [Li, Qizhai] Chinese Acad Sci, Acad Math & Syst Sci, Beijing, Peoples R China; [Burk, Robert] Albert Einstein Coll Med, Bronx, NY 10467 USA; [Burdette, Laurie; Chanock, Stephen J.] NCI Frederick, Core Genotyping Facil, Div Canc Epidemiol & Genet, Adv Technol Program,SAIC Frederick Inc, Frederick, MD USA; [Wang, Sophia S.] City Hope Natl Med Ctr, Dept Populat Sci, Div Etiol, Duarte, CA USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Chinese Academy of Sciences; Academy of Mathematics & System Sciences, CAS; Yeshiva University; Albert Einstein College of Medicine; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; City of Hope	Safaeian, M (corresponding author), NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA.	safaeianm@mail.nih.gov	Hildesheim, Allan/B-9760-2015; Schiffman, Mark/B-9766-2015	Hildesheim, Allan/0000-0003-0257-2363; WANG, SOPHIA/0000-0003-2597-9393	NCI; NIH Office of Research On Women's Health; National Young Science Foundation of China [10901155]; SAIC-Frederick Inc.; Information Management Services, Inc.; NATIONAL CANCER INSTITUTE [ZIACP010217] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH Office of Research On Women's Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Office of Research on Women's Health (ORWH)); National Young Science Foundation of China; SAIC-Frederick Inc.; Information Management Services, Inc.; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The study was funded by intramural NCI and the NIH Office of Research On Women's Health. The authors are grateful to Sabrina Chen from the Information Management Services, Inc. (IMS) for data management and programming support. They are also grateful to Amy Hutchinson and Belynda Hicks for their management of this genotyping effort at the NCI Core Genotyping Facility and for their scientific contributions to the authors' research efforts. Q. Li is partially supported by National Young Science Foundation of China No. 10901155. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Laurie Burdette and Stephen J. Chanock are employed by The Core Genotyping Facility (CGF) which is within the Division of Cancer Epidemiology and Genetics (DCEG) of the National Cancer Institute (NCI) and supported by SAIC-Frederick Inc. Information Management Services, Inc. also supported this study, along with Amy Hutchinson and Belynda Hicks with their management of this genotyping effort at the NCI Core Genotyping Facility and for their scientific contributions to the authors' research efforts. This does not alter the authors' adherence to all PloS ONE policies on sharing data and materials.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Carlson CS, 2004, AM J HUM GENET, V74, P106, DOI 10.1086/381000; Carrington M, 2005, J EXP MED, V201, P1069, DOI 10.1084/jem.20042158; Czene K, 2002, INT J CANCER, V99, P260, DOI 10.1002/ijc.10332; Gazda HT, 2006, BRIT J HAEMATOL, V135, P149, DOI 10.1111/j.1365-2141.2006.06268.x; Hemminki K, 1999, INT J CANCER, V82, P775, DOI 10.1002/(SICI)1097-0215(19990909)82:6<775::AID-IJC1>3.0.CO;2-V; Hemminki K, 2006, CANCER EPIDEM BIOMAR, V15, P1413, DOI 10.1158/1055-9965.EPI-05-0933; Herrero R, 2000, JNCI-J NATL CANCER I, V92, P464, DOI 10.1093/jnci/92.6.464; Herrero R, 2005, J INFECT DIS, V191, P1796, DOI 10.1086/428850; Herrero R, 1997, Rev Panam Salud Publica, V1, P362, DOI 10.1590/S1020-49891997000500005; Hildesheim A, 2002, VIRUS RES, V89, P229, DOI 10.1016/S0168-1702(02)00191-0; Hussain SK, 2008, INT J CANCER, V122, P1873, DOI 10.1002/ijc.23265; Kim K, 2009, ONCOL REP, V21, P1391, DOI 10.3892/or_00000366; Packer BR, 2006, NUCLEIC ACIDS RES, V34, pD617, DOI 10.1093/nar/gkj151; Peskin AV, 2010, BIOCHEM J, V432, P313, DOI 10.1042/BJ20101156; Schiffman M, 2000, JAMA-J AM MED ASSOC, V283, P87, DOI 10.1001/jama.283.1.87; Schiffman M, 2007, LANCET, V370, P890, DOI [10.1016/S0140-6736(07)61416-0, 10.1016/S0140-6736(13)60022-7]; Wang SS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008667; Wang SS, 2009, J INFECT DIS, V199, P20, DOI 10.1086/595563; Wang SS, 2002, J INFECT DIS, V186, P598, DOI 10.1086/342295; Yu K, 2009, GENET EPIDEMIOL	21	30	34	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2012	7	4							e33619	10.1371/journal.pone.0033619	http://dx.doi.org/10.1371/journal.pone.0033619			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JO	22496757	Green Published, gold, Green Submitted			2022-12-27	WOS:000305014500013
J	Greve, C; Gimnich, F; Hutterer, R; Misof, B; Haase, M				Greve, Carola; Gimnich, France; Hutterer, Rainer; Misof, Bernhard; Haase, Martin			Radiating on Oceanic Islands: Patterns and Processes of Speciation in the Land Snail Genus Theba (Risso 1826)	PLOS ONE			English	Article							MULTILOCUS GENOTYPE DATA; PHYLOGENETIC ANALYSIS; SYMPATRIC SPECIATION; TERRESTRIAL FAUNA; CANARY-ISLANDS; DIVERSIFICATION; INFERENCE; EVOLUTION; AFLP; COLONIZATION	Island radiations have played a major role in shaping our current understanding of allopatric, sympatric and parapatric speciation. However, the fact that species divergence correlates with island size emphasizes the importance of geographic isolation (allopatry) in speciation. Based on molecular and morphological data, we investigated the diversification of the land snail genus Theba on the two Canary Islands of Lanzarote and Fuerteventura. Due to the geological history of both islands, this study system provides ideal conditions to investigate the interplay of biogeography, dispersal ability and differentiation in generating species diversity. Our analyses demonstrated extensive cryptic diversification of Theba on these islands, probably driven mainly by non-adaptive allopatric differentiation and secondary gene flow. In a few cases, we observed a complete absence of gene flow among sympatrically distributed forms suggesting an advanced stage of speciation. On the Jandia peninsula genome scans suggested genotype-environment associations and potentially adaptive diversification of two closely related Theba species to different ecological environments. We found support for the idea that genetic differentiation was enhanced by divergent selection in different environments. The diversification of Theba on both islands is therefore best explained by a mixture of non-adaptive and adaptive speciation, promoted by ecological and geomorphological factors.	[Greve, Carola; Gimnich, France; Hutterer, Rainer; Misof, Bernhard] Zool Forsch Museum Alexander Koenig, Bonn, Germany; [Haase, Martin] Univ Greifswald, Inst Zool, Greifswald, Germany	Zoologisches Forschungsmuseum Alexander Koenig (ZFMK); Ernst Moritz Arndt Universitat Greifswald	Greve, C (corresponding author), Zool Forsch Museum Alexander Koenig, Bonn, Germany.	c.greve@uni-bonn.de	Haase, Martin/G-5034-2012	Haase, Martin/0000-0002-9281-8752	Deutsche Forschungsgemeinschaft (DFG) [MI 649/7-1, HU 430/2-2]; Alexander Koenig Gesellschaft (AKG)	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Alexander Koenig Gesellschaft (AKG)	This work was financially supported by grants of the Deutsche Forschungsgemeinschaft (DFG MI 649/7-1 and DFG HU 430/2-2) and the Alexander Koenig Gesellschaft (AKG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta J, 2003, MAR GEOPHYS RES, V24, P1, DOI 10.1007/s11001-004-1513-3; Bank RA, 2002, COLLECTANEA MALACOLO, P89; Beaumont MA, 2004, MOL ECOL, V13, P969, DOI 10.1111/j.1365-294X.2004.02125.x; Bierne N, 2011, MOL ECOL, V20, P2044, DOI 10.1111/j.1365-294X.2011.05080.x; Bonin A, 2007, MOL ECOL, V16, P3737, DOI 10.1111/j.1365-294X.2007.03435.x; Bonin A, 2004, MOL ECOL, V13, P3261, DOI 10.1111/j.1365-294X.2004.02346.x; Bonnet E, 2002, J STAT SOFTW, V7, P1, DOI DOI 10.18637/JSS.V007.I10; Bookstein F.L., 1991, MORPHOMETRIC TOOLS L; Butlin RK, 2010, GENETICA, V138, P409, DOI 10.1007/s10709-008-9321-3; Carracedo JC, 2002, CLASSIC GEOLOGY EURO; Carracedo JC, VOLCANES ISLAS CANAR; COELLO J, 1992, J VOLCANOL GEOTH RES, V53, P251, DOI 10.1016/0377-0273(92)90085-R; Cowie RH, 2008, PHILOS T R SOC B, V363, P3363, DOI 10.1098/rstb.2008.0061; Coyne J.A., 2004, SPECIATION; Davison A, 2000, BIOL J LINN SOC, V70, P697, DOI 10.1006/bijl.1999.0426; Dayrat B, 2011, MOL PHYLOGENET EVOL, V59, P425, DOI 10.1016/j.ympev.2011.02.014; Dyer RJ, 2004, MOL ECOL, V13, P1713, DOI 10.1111/j.1365-294X.2004.02177.x; Ehrich D, 2006, MOL ECOL NOTES, V6, P603, DOI 10.1111/j.1471-8286.2006.01380.x; Emerson BC, 2002, MOL ECOL, V11, P951, DOI 10.1046/j.1365-294X.2002.01507.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Falush D, 2003, GENETICS, V164, P1567; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; FERNANDEZPALACIOS JM, 1993, ECOGRAPHY, V16, P31, DOI 10.1111/j.1600-0587.1993.tb00056.x; Foll M, 2008, GENETICS, V180, P977, DOI 10.1534/genetics.108.092221; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Gavrilets Sergey, 2004, P1; GITTENBERGER E, 1991, BIOL J LINN SOC, V43, P263, DOI 10.1111/j.1095-8312.1991.tb00598.x; Gittenberger E., 1987, ZOOLOGISCHE VERHANDE, V241, P1; Glor RE, 2003, EVOLUTION, V57, P2383; Greve C, 2010, MOL PHYLOGENET EVOL, V57, P572, DOI 10.1016/j.ympev.2010.08.021; Haase M, 2009, J ZOOL SYST EVOL RES, V47, P105, DOI 10.1111/j.1439-0469.2008.00488.x; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hendry AP, 2007, FUNCT ECOL, V21, P455, DOI 10.1111/j.1365-2435.2007.01240.x; Herder F, 2008, EVOLUTION, V62, P2178, DOI 10.1111/j.1558-5646.2008.00447.x; Hey J, 2004, MOL ECOL, V13, P909, DOI 10.1046/j.1365-294X.2003.02031.x; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hutterer R, 1997, HELDIA 4 SONDERH, V5, P72; Juan C, 1998, P ROY SOC B-BIOL SCI, V265, P135, DOI 10.1098/rspb.1998.0274; Juan C, 2000, TRENDS ECOL EVOL, V15, P104, DOI 10.1016/S0169-5347(99)01776-0; Koopman WJM, 2005, SYST BIOL, V54, P197, DOI 10.1080/10635150590924181; Kozak KH, 2006, P ROY SOC B-BIOL SCI, V273, P539, DOI 10.1098/rspb.2005.3326; Losos JB, 2009, NATURE, V457, P830, DOI 10.1038/nature07893; Luikart G, 2003, NAT REV GENET, V4, P981, DOI 10.1038/nrg1226; MANTEL N, 1967, CANCER RES, V27, P209; Meco J, 2007, GLOBAL PLANET CHANGE, V57, P222, DOI 10.1016/j.gloplacha.2006.11.040; Meier R, 2006, SYST BIOL, V55, P715, DOI 10.1080/10635150600969864; Meudt HM, 2007, TRENDS PLANT SCI, V12, P106, DOI 10.1016/j.tplants.2007.02.001; NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269; Nosil P, 2008, EVOLUTION, V62, P316, DOI 10.1111/j.1558-5646.2007.00299.x; Nylander J.A.A, 2004, MRMODELTEST V2; Parent CE, 2008, PHILOS T R SOC B, V363, P3347, DOI 10.1098/rstb.2008.0118; Parent CE, 2006, EVOLUTION, V60, P2311, DOI 10.1554/06-366.1; Perez-Figueroa A, 2010, J EVOLUTION BIOL, V23, P2267, DOI 10.1111/j.1420-9101.2010.02093.x; Pfenninger M, 2002, EVOLUTION, V56, P1776, DOI 10.1111/j.0014-3820.2002.tb00191.x; Pompanon F, 2005, NAT REV GENET, V6, P847, DOI 10.1038/nrg1707; Pritchard JK, 2000, GENETICS, V155, P945; Rambaut A, 2008, TRACER V1 4 1; Risso A, 1826, HIST NATURELLE PRIN; Rohlf FJ, 2004, TPSDIG DIGITIZE LAND; Rohlf FJ, 2004, TPSUTIL FILE UTILITY; Rundell RJ, 2009, TRENDS ECOL EVOL, V24, P394, DOI 10.1016/j.tree.2009.02.007; Schilthuizen M, 2010, J ZOOL, V282, P191, DOI 10.1111/j.1469-7998.2010.00729.x; Schluter D, 2009, SCIENCE, V323, P737, DOI 10.1126/science.1160006; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Swofford D. L, 2002, PAUP PHYLOGENETIC AN; Thompson JD, 2002, CURR PROTOC BIOINFOR, V2, P23, DOI 10.1002/0471250953.bi0203s00; Via S, 2001, TRENDS ECOL EVOL, V16, P381, DOI 10.1016/S0169-5347(01)02188-7; Via S, 2009, P NATL ACAD SCI USA, V106, P9939, DOI 10.1073/pnas.0901397106; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; WRIGHT S, 1978, P580; Zelditch ML, 2004, GEOMETRIC MORPHOMETR	76	21	21	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2012	7	4							e34339	10.1371/journal.pone.0034339	http://dx.doi.org/10.1371/journal.pone.0034339			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JA	22493687	Green Published, gold, Green Submitted			2022-12-27	WOS:000305012700029
J	Silva-Rocha, R; de Lorenzo, V				Silva-Rocha, Rafael; de Lorenzo, Victor			A GFP-lacZ Bicistronic Reporter System for Promoter Analysis in Environmental Gram-Negative Bacteria	PLOS ONE			English	Article							STOCHASTIC GENE-EXPRESSION; PSEUDOMONAS-PUTIDA; TRANSCRIPTIONAL REGULATORS; CHROMOSOMAL INSERTION; NOISE-PROPAGATION; TOL PLASMID; BISTABILITY; DEGRADATION; NETWORKS; PATHWAYS	Here, we describe a bicistronic reporter system for the analysis of promoter activity in a variety of Gram-negative bacteria at both the population and single-cell levels. This synthetic genetic tool utilizes an artificial operon comprising the gfp and lacZ genes that are assembled in a suicide vector, which is integrated at specific sites within the chromosome of the target bacterium, thereby creating a monocopy reporter system. This tool was instrumental for the complete in vivo characterization of two promoters, Pb and Pc, that drive the expression of the benzoate and catechol degradation pathways, respectively, of the soil bacterium Pseudomonas putida KT2440. The parameterization of these promoters in a population (using beta-galactosidase assays) and in single cells (using flow cytometry) was necessary to examine the basic numerical features of these systems, such as the basal and maximal levels and the induction kinetics in response to an inducer (benzoate). Remarkably, GFP afforded a view of the process at a much higher resolution compared with standard lacZ tests; changes in fluorescence faithfully reflected variations in the transcriptional regimes of individual bacteria. The broad host range of the vector/reporter platform is an asset for the characterization of promoters in different bacteria, thereby expanding the diversity of genomic chasses amenable to Synthetic Biology methods.	[Silva-Rocha, Rafael; de Lorenzo, Victor] CSIC, Ctr Nacl Biotecnol, Syst Biol Program, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	Silva-Rocha, R (corresponding author), CSIC, Ctr Nacl Biotecnol, Syst Biol Program, Madrid, Spain.	vdlorenzo@cnb.csic.es	Silva-Rocha, Rafael/H-4929-2012	Silva-Rocha, Rafael/0000-0001-6319-631X; de Lorenzo, Victor/0000-0002-6041-2731	Spanish Ministry of Science and Innovation (MICINN); EU; Autonomous Community of Madrid	Spanish Ministry of Science and Innovation (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); EU(European Commission); Autonomous Community of Madrid	This work was funded by BIO and FEDER CONSOLIDER-INGENIO Program of the Spanish Ministry of Science and Innovation (MICINN), the BACSINE, MICROME and ST-FLOW Contracts of the EU, and the PROMT Program of the Autonomous Community of Madrid. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balleza E, 2009, FEMS MICROBIOL REV, V33, P133, DOI 10.1111/j.1574-6976.2008.00145.x; Becskei A, 2000, NATURE, V405, P590, DOI 10.1038/35014651; Cagatay T, 2009, CELL, V139, P512, DOI 10.1016/j.cell.2009.07.046; Cases I, 2003, TRENDS MICROBIOL, V11, P248, DOI 10.1016/S0966-842X(03)00103-3; Choi KH, 2005, NAT METHODS, V2, P443, DOI 10.1038/NMETH765; Cowles CE, 2000, J BACTERIOL, V182, P6339, DOI 10.1128/JB.182.22.6339-6346.2000; de las Heras A, 2010, FEMS MICROBIOL REV, V34, P842, DOI 10.1111/j.1574-6976.2010.00238.x; de Lorenzo V, 1992, Curr Opin Biotechnol, V3, P227, DOI 10.1016/0958-1669(92)90097-3; de Lorenzo V, 2008, CURR OPIN BIOTECH, V19, P579, DOI 10.1016/j.copbio.2008.10.004; DELORENZO V, 1991, EMBO J, V10, P1159, DOI 10.1002/j.1460-2075.1991.tb08056.x; DELORENZO V, 1993, J BACTERIOL, V175, P6902, DOI 10.1128/jb.175.21.6902-6907.1993; DELORENZO V, 1990, J BACTERIOL, V172, P6568, DOI 10.1128/jb.172.11.6568-6572.1990; DELORENZO V, 1994, METHOD ENZYMOL, V235, P386; Dublanche Y, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100081; Dubnau D, 2006, MOL MICROBIOL, V61, P564, DOI 10.1111/j.1365-2958.2006.05249.x; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Galvao TC, 2006, CURR OPIN BIOTECH, V17, P34, DOI 10.1016/j.copbio.2005.12.002; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Graumann PL, 2006, MOL MICROBIOL, V61, P560, DOI 10.1111/j.1365-2958.2006.05264.x; Harwood CS, 1996, ANNU REV MICROBIOL, V50, P553, DOI 10.1146/annurev.micro.50.1.553; Hasty J, 2002, NATURE, V420, P224, DOI 10.1038/nature01257; HERRERO M, 1990, J BACTERIOL, V172, P6557, DOI 10.1128/jb.172.11.6557-6567.1990; Hooshangi S, 2005, P NATL ACAD SCI USA, V102, P3581, DOI 10.1073/pnas.0408507102; Itzkovitz S, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-239; Jimenez JI, 2002, ENVIRON MICROBIOL, V4, P824, DOI 10.1046/j.1462-2920.2002.00370.x; KESSLER B, 1992, MOL GEN GENET, V233, P293, DOI 10.1007/BF00587591; KING JMH, 1990, SCIENCE, V249, P778, DOI 10.1126/science.249.4970.778; Konstantinidis KT, 2004, P NATL ACAD SCI USA, V101, P3160, DOI 10.1073/pnas.0308653100; KRISTENSEN CS, 1995, J BACTERIOL, V177, P52, DOI 10.1128/jb.177.1.52-58.1995; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Maamar H, 2005, MOL MICROBIOL, V56, P615, DOI 10.1111/j.1365-2958.2005.04592.x; Martin L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007569; Martinez-Antonio A, 2003, CURR OPIN MICROBIOL, V6, P482, DOI 10.1016/j.mib.2003.09.002; McAdams HH, 1999, TRENDS GENET, V15, P65, DOI 10.1016/S0168-9525(98)01659-X; McAdams HH, 2004, NAT REV GENET, V5, P169, DOI 10.1038/nrg1292; McAdams HH, 1997, P NATL ACAD SCI USA, V94, P814, DOI 10.1073/pnas.94.3.814; Miller WG, 1997, GENE, V191, P149, DOI 10.1016/S0378-1119(97)00051-6; Oppenheim AB, 2005, ANNU REV GENET, V39, P409, DOI 10.1146/annurev.genet.39.073003.113656; PARSEK MR, 1992, J BACTERIOL, V174, P7798, DOI 10.1128/JB.174.23.7798-7806.1992; PARSEK MR, 1995, MOL MICROBIOL, V15, P819, DOI 10.1111/j.1365-2958.1995.tb02352.x; Pedraza JM, 2005, SCIENCE, V307, P1965, DOI 10.1126/science.1109090; PEREZMARTIN J, 1995, J BACTERIOL, V177, P3758, DOI 10.1128/jb.177.13.3758-3763.1995; Qazi SNA, 2004, J BACTERIOL, V186, P1065, DOI 10.1128/JB.186.4.1065-1077.2004; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Santos PM, 2004, PROTEOMICS, V4, P2640, DOI 10.1002/pmic.200300793; Silva-Rocha R, 2010, ANNU REV MICROBIOL, V64, P257, DOI 10.1146/annurev.micro.091208.073229; Sprinzak D, 2005, NATURE, V438, P443, DOI 10.1038/nature04335; Teichmann SA, 2004, NAT GENET, V36, P492, DOI 10.1038/ng1340; Thieffry D, 1998, BIOESSAYS, V20, P433, DOI 10.1002/(SICI)1521-1878(199805)20:5<433::AID-BIES10>3.0.CO;2-2; Tropel D, 2004, MICROBIOL MOL BIOL R, V68, P474, DOI 10.1128/MMBR.68.3.474-500.2004; Visca P, 2002, MOL MICROBIOL, V45, P1177, DOI 10.1046/j.1365-2958.2002.03088.x; Voigt CA, 2006, CURR OPIN BIOTECH, V17, P548, DOI 10.1016/j.copbio.2006.09.001	54	16	16	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2012	7	4							e34675	10.1371/journal.pone.0034675	http://dx.doi.org/10.1371/journal.pone.0034675			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JA	22493710	Green Published, gold, Green Submitted			2022-12-27	WOS:000305012700052
J	Kuykendall, LD; Shao, JY; Hartung, JS				Kuykendall, L. David; Shao, Jonathan Y.; Hartung, John S.			Conservation of Gene Order and Content in the Circular Chromosomes of 'Candidatus Liberibacter asiaticus' and Other Rhizobiales	PLOS ONE			English	Article							GREENING DISEASE; PCR DETECTION; SPECIES TREE; CITRUS; IDENTIFICATION; COLONIZATION; EVOLUTIONARY; BACTERIUM; SEQUENCE; REVEALS	'Ca. Liberibacter asiaticus,' an insect-vectored, obligate intracellular bacterium associated with citrus-greening disease, also called "HLB," is a member of the Rhizobiales along with nitrogen-fixing microsymbionts Sinorhizobium meliloti and Bradyrhizobium japonicum, plant pathogen Agrobacterium tumefaciens and facultative intracellular mammalian pathogen Bartonella henselae. Comparative analyses of their circular chromosomes identified 514 orthologous genes shared among all five species. Shared among all five species are 50 identical blocks of microsyntenous orthologous genes (MOGs), containing a total of 283 genes. While retaining highly conserved genomic blocks of microsynteny, divergent evolution, horizontal gene transfer and niche specialization have disrupted macrosynteny among the five circular chromosomes compared. Highly conserved microsyntenous gene clusters help define the Rhizobiales, an order previously defined by 16S RNA gene similarity and herein represented by the three families: Bartonellaceae, Bradyrhizobiaceae and Rhizobiaceae. Genes without orthologs in the other four species help define individual species. The circular chromosomes of each of the five Rhizobiales species examined had genes lacking orthologs in the other four species. For example, 63 proteins are encoded by genes of 'Ca. Liberibacter asiaticus' not shared with other members of the Rhizobiales. Of these 63 proteins, 17 have predicted functions related to DNA replication or RNA transcription, and some of these may have roles related to low genomic GC content. An additional 17 proteins have predicted functions relevant to cellular processes, particularly modifications of the cell surface. Seventeen unshared proteins have specific metabolic functions including a pathway to synthesize cholesterol encoded by a seven-gene operon. The remaining 12 proteins encoded by 'Ca. Liberibacter asiaticus' genes not shared with other Rhizobiales are of bacteriophage origin. 'Ca. Liberibacter asiaticus' shares 11 genes with only Sinorhizobium meliloti and 12 genes are shared with only Bartonella henselae.	[Kuykendall, L. David; Shao, Jonathan Y.; Hartung, John S.] ARS, Mol Plant Pathol Lab, USDA, Beltsville, MD USA	United States Department of Agriculture (USDA)	Kuykendall, LD (corresponding author), ARS, Mol Plant Pathol Lab, USDA, Beltsville, MD USA.	John.Hartung@ars.usda.gov			United States Department of Agriculture	United States Department of Agriculture(United States Department of Agriculture (USDA))	This research was supported by intramural United States Department of Agriculture Funds funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsmark CM, 2004, P NATL ACAD SCI USA, V101, P9716, DOI 10.1073/pnas.0305659101; Ballouz S, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000672; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bove JM, 2006, J PLANT PATHOL, V88, P7; Carvalho FM, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-37; Castillo-Ramirez S, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-300; Chen J, 2011, [植物病理学报, Acta Phytopathologica Sinica], V41, P113; Da Graca J, 2004, DIS FRUITS VEGETABLE, VI, P229, DOI DOI 10.1007/1-4020-2606-4_4; Davis MJ, 2008, PLANT DIS, V92, P1547, DOI 10.1094/PDIS-92-11-1547; Dillingham MS, 1999, NUCLEIC ACIDS RES, V27, P3310, DOI 10.1093/nar/27.16.3310; Duan YP, 2009, MOL PLANT MICROBE IN, V22, P1011, DOI 10.1094/MPMI-22-8-1011; Durr H, 2006, NUCLEIC ACIDS RES, V34, P4160, DOI 10.1093/nar/gkl540; Engel P, 2009, GENOME DYNAM, V6, P158, DOI 10.1159/000235769; Flaus A, 2006, NUCLEIC ACIDS RES, V34, P2887, DOI 10.1093/nar/gkl295; Garnett HM, 1984, CITRUS SUBTROP FRUIT, V611, P4; GHOSH SK, 1971, CURR SCI INDIA, V40, P299; Guerrero G, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-55; Hamon MA, 2008, CELL HOST MICROBE, V4, P100, DOI 10.1016/j.chom.2008.07.009; Hartung JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023289; Hartung JS, 2010, PHYTOPATHOLOGY, V100, P756, DOI 10.1094/PHYTO-100-8-0756; Husain M. A., 1927, MEMOIRS DEP AGR INDI, V10, P1; JAGOUEIX S, 1994, INT J SYST BACTERIOL, V44, P379, DOI 10.1099/00207713-44-3-379; Jagoueix S, 1996, MOL CELL PROBE, V10, P43, DOI 10.1006/mcpr.1996.0006; Jagoueix S, 1997, INT J SYST BACTERIOL, V47, P224, DOI 10.1099/00207713-47-1-224; Jones KM, 2007, NAT REV MICROBIOL, V5, P619, DOI 10.1038/nrmicro1705; Kida Y, 2007, INFECT IMMUN, V75, P164, DOI 10.1128/IAI.01239-06; Kim JS, 2009, PHYTOPATHOLOGY, V99, P50, DOI 10.1094/PHYTO-99-1-0050; Konstantinidis KT, 2004, P NATL ACAD SCI USA, V101, P3160, DOI 10.1073/pnas.0308653100; Kuykendall L., 2006, INT J SYST EVOL MICR, V56, P1; Kuykendall L. D., 2005, BERGEYS MANUAL SYSTE, V2, P324; Kuykendall LD, PREDICTED ROLE UNPUB; Li WB, 2006, J MICROBIOL METH, V66, P104, DOI 10.1016/j.mimet.2005.10.018; Li WB, 2009, PHYTOPATHOLOGY, V99, P139, DOI 10.1094/PHYTO-99-2-0139; Li YX, 2007, MICROBIOL-SGM, V153, P719, DOI 10.1099/mic.0.2006/002311-0; LIN K. -H., 1956, Acta Phytopathologica Sinica, V2, P1; Merhej V, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-13; Moran NA, 2002, CELL, V108, P583, DOI 10.1016/S0092-8674(02)00665-7; Newman KL, 2004, P NATL ACAD SCI USA, V101, P1737, DOI 10.1073/pnas.0308399100; Newman KL, 2003, APPL ENVIRON MICROB, V69, P7319, DOI 10.1128/AEM.69.12.7319-7327.2003; Rocha EPC, 2002, TRENDS GENET, V18, P291, DOI 10.1016/S0168-9525(02)02690-2; Sechler A, 2009, PHYTOPATHOLOGY, V99, P480, DOI 10.1094/PHYTO-99-5-0480; Tatineni S, 2008, PHYTOPATHOLOGY, V98, P592, DOI 10.1094/PHYTO-98-5-0592; Teixeira DD, 2005, MOL CELL PROBE, V19, P173, DOI 10.1016/j.mcp.2004.011.002; Tyler HL, 2009, MOL PLANT MICROBE IN, V22, P1624, DOI 10.1094/MPMI-22-12-1624; Williams KP, 2007, J BACTERIOL, V189, P4578, DOI 10.1128/JB.00269-07; Wu H, 2005, P 2005 IEEE COMP SYS; Zhang SJ, 2011, MOL PLANT MICROBE IN, V24, P458, DOI 10.1094/MPMI-11-10-0256	47	10	10	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e34673	10.1371/journal.pone.0034673	http://dx.doi.org/10.1371/journal.pone.0034673			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GO	22496839	gold, Green Submitted, Green Published			2022-12-27	WOS:000304855200068
J	Mora-Rodriguez, R; Pallares, JG; Lopez-Samanes, A; Ortega, JF; Fernandez-Elias, VE				Mora-Rodriguez, Ricardo; Garcia Pallares, Jesus; Lopez-Samanes, Alvaro; Fernando Ortega, Juan; Fernandez-Elias, Valentin E.			Caffeine Ingestion Reverses the Circadian Rhythm Effects on Neuromuscular Performance in Highly Resistance-Trained Men	PLOS ONE			English	Article							ACUTE HORMONAL RESPONSES; DIURNAL-VARIATION; CYCLING PERFORMANCE; MAXIMAL STRENGTH; SKELETAL-MUSCLE; LEG EXTENSORS; SINGLE BOUT; EXERCISE; ENDURANCE; METABOLISM	Purpose: To investigate whether caffeine ingestion counteracts the morning reduction in neuromuscular performance associated with the circadian rhythm pattern. Methods: Twelve highly resistance-trained men underwent a battery of neuromuscular tests under three different conditions; i) morning (10:00 a.m.) with caffeine ingestion (i.e., 3 mg kg(-1); AM(CAFF) trial); ii) morning (10: 00 a.m.) with placebo ingestion (AM(PLAC) trial); and iii) afternoon (18:00 p.m.) with placebo ingestion (PMPLAC trial). A randomized, double-blind, crossover, placebo controlled experimental design was used, with all subjects serving as their own controls. The neuromuscular test battery consisted in the measurement of bar displacement velocity during free-weight full-squat (SQ) and bench press (BP) exercises against loads that elicit maximum strength (75% 1RM load) and muscle power adaptations (1 m s(-1) load). Isometric maximum voluntary contraction (MVCLEG) and isometric electrically evoked strength of the right knee (EVOKLEG) were measured to identify caffeine's action mechanisms. Steroid hormone levels (serum testosterone, cortisol and growth hormone) were evaluated at the beginning of each trial (PRE). In addition, plasma norepinephrine (NE) and epinephrine were measured PRE and at the end of each trial following a standardized intense (85% 1RM) 6 repetitions bout of SQ (POST). Results: In the PMPLAC trial, dynamic muscle strength and power output were significantly enhanced compared with AM(PLAC) treatment (3.0%-7.5%; p<0.05). During AM(CAFF) trial, muscle strength and power output increased above AM(PLAC) levels (4.6%-5.7%; p<0.05) except for BP velocity with 1 m s(-1) load (p = 0.06). During AM(CAFF), EVOKLEG and NE (a surrogate of maximal muscle sympathetic nerve activation) were increased above AM(PLAC) trial (14.6% and 96.8% respectively; p<0.05). Conclusions: These results indicate that caffeine ingestion reverses the morning neuromuscular declines in highly resistance-trained men, raising performance to the levels of the afternoon trial. Our electrical stimulation data, along with the NE values, suggest that caffeine increases neuromuscular performance having a direct effect in the muscle.	[Mora-Rodriguez, Ricardo; Garcia Pallares, Jesus; Lopez-Samanes, Alvaro; Fernando Ortega, Juan; Fernandez-Elias, Valentin E.] Univ Castilla La Mancha, Exercise Physiol Lab, Toledo, Spain	Universidad de Castilla-La Mancha	Mora-Rodriguez, R (corresponding author), Univ Castilla La Mancha, Exercise Physiol Lab, Toledo, Spain.	Ricardo.mora@uclm.es	Fernández-Elías, Valentín E./ABD-7398-2021; Ortega, Juan Fernando F/L-4973-2014; Mora-Rodriguez, Ricardo/AAC-9096-2022; Pallarés, Jesús G/J-3054-2016; PALLARES, JESUS G./AAW-3182-2020	Fernández-Elías, Valentín E./0000-0002-1459-5442; Ortega, Juan Fernando F/0000-0003-3884-923X; Pallarés, Jesús G/0000-0002-6087-1583; PALLARES, JESUS G./0000-0002-6087-1583; Lopez Samanes, Alvaro/0000-0003-0721-0150; Mora-Rodriguez, Ricardo/0000-0001-9252-4933				Astorino TA, 2008, EUR J APPL PHYSIOL, V102, P127, DOI 10.1007/s00421-007-0557-x; Astorino TA, 2011, J STRENGTH COND RES, V25, P1752, DOI 10.1519/JSC.0b013e3181ddf6db; Astorino TA, 2010, J STRENGTH COND RES, V24, P257, DOI 10.1519/JSC.0b013e3181c1f88a; Atkinson G, 2005, J SPORT SCI, V23, P321, DOI 10.1080/02640410410001729919; Atkinson G, 1998, PERCEPT MOTOR SKILL, V86, P1335, DOI 10.2466/pms.1998.86.3c.1335; Atkinson G, 1996, SPORTS MED, V21, P292, DOI 10.2165/00007256-199621040-00005; Beaven CM, 2008, INT J SPORT NUTR EXE, V18, P131, DOI 10.1123/ijsnem.18.2.131; Bird SP, 2004, CHRONOBIOL INT, V21, P131, DOI 10.1081/CBI-120027987; Bishop D, 2010, SPORTS MED, V40, P995, DOI 10.2165/11536870-000000000-00000; Bush JA, 1999, MED SCI SPORT EXER, V31, P554, DOI 10.1097/00005768-199904000-00010; Childs E, 2006, PSYCHOPHARMACOLOGY, V185, P514, DOI 10.1007/s00213-006-0341-3; Cohen J.E., 1988, STAT POWER ANAL BEHA; Conway KJ, 2003, J APPL PHYSIOL, V94, P1557, DOI 10.1152/japplphysiol.00911.2002; Cox GR, 2002, J APPL PHYSIOL, V93, P990, DOI 10.1152/japplphysiol.00249.2002; Davis JK, 2009, SPORTS MED, V39, P813, DOI 10.2165/11317770-000000000-00000; Davis JM, 2003, AM J PHYSIOL-REG I, V284, pR399, DOI 10.1152/ajpregu.00386.2002; Decostre V, 2005, P NATL ACAD SCI USA, V102, P13927, DOI 10.1073/pnas.0506795102; Del Coso J, 2008, MED SCI SPORT EXER, V40, P744, DOI 10.1249/MSS.0b013e3181621336; Del Coso J, 2011, EUR J SPORT SCI, V11, P95, DOI 10.1080/17461391.2010.487117; Desbrow B, 2007, INT J SPORT NUTR EXE, V17, P328, DOI 10.1123/ijsnem.17.4.328; Garcia-Pallares J, 2010, MED SCI SPORT EXER, V42, P1209, DOI 10.1249/MSS.0b013e3181c9228c; Garcia-Pallares J, 2009, EUR J APPL PHYSIOL, V106, P629, DOI 10.1007/s00421-009-1061-2; Glaister M, 2008, MED SCI SPORT EXER, V40, P1835, DOI 10.1249/MSS.0b013e31817a8ad2; Gonzalez-Badillo JJ, 2010, INT J SPORTS MED, V31, P347, DOI 10.1055/s-0030-1248333; Graham TE, 2001, SPORTS MED, V31, P785, DOI 10.2165/00007256-200131110-00002; Hayes LD, 2010, CHRONOBIOL INT, V27, P675, DOI 10.3109/07420521003778773; Izquierdo M, 2002, EUR J APPL PHYSIOL, V87, P264, DOI 10.1007/s00421-002-0628-y; Jasper I, 2009, CHRONOBIOL INT, V26, P576, DOI 10.1080/07420520902896590; Kline CE, 2007, J APPL PHYSIOL, V102, P641, DOI 10.1152/japplphysiol.00910.2006; Kraemer WJ, 2005, SPORTS MED, V35, P339, DOI 10.2165/00007256-200535040-00004; KRAEMER WJ, 1987, INT J SPORTS MED, V8, P247, DOI 10.1055/s-2008-1025663; Kraemer WJ, 1999, CAN J APPL PHYSIOL, V24, P524, DOI 10.1139/h99-034; Lane AR, 2010, EUR J APPL PHYSIOL, V108, P1125, DOI 10.1007/s00421-009-1220-5; Martin V, 2004, J APPL PHYSIOL, V97, P1923, DOI 10.1152/japplphysiol.00376.2004; Mohr T, 1998, J APPL PHYSIOL, V85, P979, DOI 10.1152/jappl.1998.85.3.979; Moussay S, 2003, CHRONOBIOL INT, V20, P879, DOI 10.1081/CBI-120024220; Racinais S, 2005, MED SCI SPORT EXER, V37, P2134, DOI 10.1249/01.mss.0000179099.81706.11; Racinais S, 2005, MED SCI SPORT EXER, V37, P256, DOI 10.1249/01.MSS.0000149885.82163.9F; Ratamess NA, 2009, MED SCI SPORT EXER, V41, P687, DOI 10.1249/MSS.0b013e3181915670; REILLY T, 1990, CRIT REV BIOMED ENG, V18, P165; Sanchez-Medina L, 2011, MED SCI SPORT EXER, V43, P1725, DOI 10.1249/MSS.0b013e318213f880; SAVARD G, 1987, ACTA PHYSIOL SCAND, V131, P507, DOI 10.1111/j.1748-1716.1987.tb08270.x; Schneiker KT, 2006, MED SCI SPORT EXER, V38, P578, DOI 10.1249/01.mss.0000188449.18968.62; Sedliak M, 2008, INT J SPORTS MED, V29, P217, DOI 10.1055/s-2007-965125; Sedliak M, 2008, J SPORT SCI, V26, P1005, DOI 10.1080/02640410801930150; Simmonds MJ, 2010, EUR J APPL PHYSIOL, V109, P287, DOI 10.1007/s00421-009-1351-8; Souissi N, 2007, CHRONOBIOL INT, V24, P739, DOI 10.1080/07420520701535811; Souissi N, 2010, CHRONOBIOL INT, V27, P640, DOI 10.3109/07420528.2010.483157; Starkie RL, 1999, EXP PHYSIOL, V84, P775, DOI 10.1017/S0958067099018151; Tarnopolsky M, 2000, J APPL PHYSIOL, V89, P1719, DOI 10.1152/jappl.2000.89.5.1719; Taylor K, 2011, INT J SPORTS MED, V32, P185, DOI 10.1055/s-0030-1268437; Teo WP, 2011, J STRENGTH COND RES, V25, P1538, DOI 10.1519/JSC.0b013e3181da77b0; Van Soeren MH, 1998, J APPL PHYSIOL, V85, P1493, DOI 10.1152/jappl.1998.85.4.1493; Warren GL, 2010, MED SCI SPORT EXER, V42, P1375, DOI 10.1249/MSS.0b013e3181cabbd8; Williams AD, 2008, J STRENGTH COND RES, V22, P464, DOI 10.1519/JSC.0b013e3181660320	55	61	62	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e33807	10.1371/journal.pone.0033807	http://dx.doi.org/10.1371/journal.pone.0033807			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GO	22496767	Green Published, Green Submitted, gold			2022-12-27	WOS:000304855200024
J	Lal, A; Hales, S; French, N; Baker, MG				Lal, Aparna; Hales, Simon; French, Nigel; Baker, Michael G.			Seasonality in Human Zoonotic Enteric Diseases: A Systematic Review	PLOS ONE			English	Review							ESCHERICHIA-COLI O157; CLIMATE-CHANGE; RISK-FACTORS; CRYPTOSPORIDIUM-PARVUM; CAMPYLOBACTER INFECTION; DIARRHEAL DISEASE; NEW-ZEALAND; DESCRIPTIVE ANALYSIS; AMBIENT-TEMPERATURE; TRANSMISSION CYCLES	Background: Although seasonality is a defining characteristic of many infectious diseases, few studies have described and compared seasonal patterns across diseases globally, impeding our understanding of putative mechanisms. Here, we review seasonal patterns across five enteric zoonotic diseases: campylobacteriosis, salmonellosis, vero-cytotoxigenic Escherichia coli (VTEC), cryptosporidiosis and giardiasis in the context of two primary drivers of seasonality: (i) environmental effects on pathogen occurrence and pathogen-host associations and (ii) population characteristics/behaviour. Methodology/Principal Findings: We systematically reviewed published literature from 1960-2010, resulting in the review of 86 studies across the five diseases. The Gini coefficient compared temporal variations in incidence across diseases and the monthly seasonality index characterised timing of seasonal peaks. Consistent seasonal patterns across transnational boundaries, albeit with regional variations was observed. The bacterial diseases all had a distinct summer peak, with identical Gini values for campylobacteriosis and salmonellosis (0.22) and a higher index for VTEC (Gini = 0.36). Cryptosporidiosis displayed a bi-modal peak with spring and summer highs and the most marked temporal variation (Gini = 0.39). Giardiasis showed a relatively small summer increase and was the least variable (Gini = 0.18). Conclusions/Significance:Seasonal variation in enteric zoonotic diseases is ubiquitous, with regional variations highlighting complex environment-pathogen-host interactions. Results suggest that proximal environmental influences and host population dynamics, together with distal, longer-term climatic variability could have important direct and indirect consequences for future enteric disease risk. Additional understanding of the concerted influence of these factors on disease patterns may improve assessment and prediction of enteric disease burden in temperate, developed countries.	[Lal, Aparna; Hales, Simon; Baker, Michael G.] Univ Otago, Dept Publ Hlth, Wellington, New Zealand; [French, Nigel] Massey Univ, Hopkirk Res Inst, Palmerston North, Manawatu, New Zealand	University of Otago; Massey University	Lal, A (corresponding author), Univ Otago, Dept Publ Hlth, Wellington, New Zealand.	lalap717@student.otago.ac.nz	hales, simon/E-5768-2010; French, Nigel/F-5725-2011	Hales, Simon/0000-0002-4529-7595; French, Nigel/0000-0002-6334-0657; lal, aparna/0000-0001-7062-1468	University of Otago	University of Otago	University of Otago, Postgraduate Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adlam SB, 2010, EPIDEMIOLOGY INFECT, P1; Altizer S, 2006, ECOL LETT, V9, P467, DOI 10.1111/j.1461-0248.2005.00879.x; Atwill ER, 1999, J AM VET MED ASSOC, V215, P1833; BARBOUR AG, 1976, AM J TROP MED HYG, V25, P384, DOI 10.4269/ajtmh.1976.25.384; Bates SJ, 2007, AM J EPIDEMIOL, V166, P1088, DOI 10.1093/aje/kwm184; Bi P, 2008, J INFECTION, V57, P317, DOI 10.1016/j.jinf.2008.08.004; Boysen L, 2011, FOOD MICROBIOL, V28, P1028, DOI 10.1016/j.fm.2011.02.010; Britton E, 2010, J WATER HEALTH, V8, P561, DOI 10.2166/wh.2010.049; Britton E, 2010, AUST NZ J PUBL HEAL, V34, P126, DOI 10.1111/j.1753-6405.2010.00495.x; Callaghan M, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-64; Carneiro I, 2010, PLOS ONE, V5, P1; Chalmers RM, 2011, EPIDEMIOL INFECT, V139, P700, DOI 10.1017/S0950268810001688; Chang M, 2009, EPIDEMIOL INFECT, V137, P810, DOI 10.1017/S0950268808001477; Clarke Rachel, 2004, N Z Med J, V117, pU1144; COOK SM, 1990, B WORLD HEALTH ORGAN, V68, P171; D'Souza RM, 2008, EPIDEMIOL INFECT, V136, P56, DOI 10.1017/S0950268807008229; D'Souza RM, 2004, EPIDEMIOLOGY, V15, P86, DOI 10.1097/01.ede.0000101021.03453.3e; Denno DM, 2009, J INFECT DIS, V199, P467, DOI 10.1086/596555; Doorduyn Y, 2010, EPIDEMIOL INFECT, V138, P1391, DOI 10.1017/S095026881000052X; Eisenberg JNS, 2007, ENV HLTH PERSPECT, P115; Ekdahl K, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-11; Ekdahl K, 2004, BMC INFECT DIS, V4, DOI 10.1186/1471-2334-4-54; Ekdahl K, 2005, CLIN MICROBIOL INFEC, V11, P138, DOI 10.1111/j.1469-0691.2004.01045.x; Elliott LJ, 2002, SEX TRANSM INFECT, V78, pI139, DOI 10.1136/sti.78.suppl_1.i139; Espelage W, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-41; Febriani Y, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-48; Fernandez D, 2009, J APPL MICROBIOL, V106, P1260, DOI 10.1111/j.1365-2672.2008.04088.x; FINCH MJ, 1985, AM J EPIDEMIOL, V122, P262, DOI 10.1093/oxfordjournals.aje.a114097; Fisman DN, 2007, ANNU REV PUBL HEALTH, V28, P127, DOI 10.1146/annurev.publhealth.28.021406.144128; George DB, 2010, EPIDEMIOL INFECT, V138, P1679, DOI 10.1017/S0950268810001639; Gini C., 1912, J R STAT SOC, V76, P326; Green Chris G, 2006, Int J Health Geogr, V5, P2, DOI 10.1186/1476-072X-5-2; Greer A, 2008, CAN MED ASSOC J, V178, P715, DOI 10.1503/cmaj.081325; Greig JD, 2001, CAN J PUBLIC HEALTH, V92, P361, DOI 10.1007/BF03404980; GRIFFITHS PL, 1990, J APPL BACTERIOL, V69, P281, DOI 10.1111/j.1365-2672.1990.tb01519.x; Grinberg A, 2005, NEW ZEAL VET J, V53, P315, DOI 10.1080/00480169.2005.36566; Hansson I, 2007, J APPL MICROBIOL, V103, P640, DOI 10.1111/j.1365-2672.2007.03291.x; Haus-Cheymol R, 2006, EPIDEMIOL INFECT, V134, P712, DOI 10.1017/S095026880500542X; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; Hoque Ekramul, 2004, N Z Med J, V117, pU1149; Horman A, 2004, INT J PARASITOL, V34, P1337, DOI 10.1016/j.ijpara.2004.08.009; IKRAM R, 1994, NEW ZEAL MED J, V107, P430; Jagai JS, 2009, ENVIRON RES, V109, P465, DOI 10.1016/j.envres.2009.02.008; Jore S, 2010, PREV VET MED, V93, P33, DOI 10.1016/j.prevetmed.2009.09.015; Jorgensen F, 2011, APPL ENVIRON MICROB, V77, P3741, DOI 10.1128/AEM.02444-10; Karanis P, 2007, J WATER HEALTH, V5, P1, DOI 10.2166/wh.2006.002; Kassenborg HD, 2004, CLIN INFECT DIS, V38, pS271, DOI 10.1086/381596; Keegan VA, 2009, CAN J INFECT DIS MED, V20, P79, DOI 10.1155/2009/978784; Kessel A S, 2001, Commun Dis Public Health, V4, P171; Kettlewell JS, 1998, J TRAVEL MED, V5, P127, DOI 10.1111/j.1708-8305.1998.tb00485.x; King AA, 2008, NATURE, V454, P877, DOI 10.1038/nature07084; Kistemann T, 2004, EPIDEMIOL INFECT, V132, P495, DOI 10.1017/S0950268803001729; Kosek M, 2003, B WORLD HEALTH ORGAN, V81, P197; Kovats RS, 2005, INT J BIOMETEOROL, V49, P207, DOI 10.1007/s00484-004-0241-3; Kovats RS, 2004, EPIDEMIOL INFECT, V132, P443, DOI 10.1017/S0950268804001992; Lake IR, 2009, EPIDEMIOL INFECT, V137, P1538, DOI 10.1017/S0950268809002477; Lake Iain R., 2005, Journal of Water and Health, V3, P469; Laupland KB, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-95; Learmonth J, 2001, J EUKARYOT MICROBIOL, p34S; Learmonth JJ, 2004, APPL ENVIRON MICROB, V70, P3973, DOI 10.1128/AEM.70.7.3973-3978.2004; Lee WC, 1997, STAT MED, V16, P729, DOI 10.1002/(SICI)1097-0258(19970415)16:7<729::AID-SIM491>3.0.CO;2-A; Levy K, 2009, INT J EPIDEMIOL, V38, P1487, DOI 10.1093/ije/dyn260; Llorca J, 2002, MED SCI MONITOR, V8, P193; Lorenz MO, 1905, J AM STAT ASSOC, V9, P209; Louis VR, 2005, APPL ENVIRON MICROB, V71, P85, DOI 10.1128/AEM.71.1.85-92.2005; Majowicz SE, 2001, CAN J PUBLIC HEALTH, V92, P62, DOI 10.1007/BF03404847; Mathieu E, 2004, AM J TROP MED HYG, V71, P582; McMichael AJ, 2001, ECOSYST HEALTH, V7, P107, DOI 10.1046/j.1526-0992.2001.007002107.x; McMichael AJ, 2007, LANCET, V370, P1253, DOI 10.1016/S0140-6736(07)61256-2; Mullner P, 2010, EPIDEMIOL INFECT, V138, P1372, DOI 10.1017/S0950268809991579; Naumova EN, 2007, EPIDEMIOL INFECT, V135, P281, DOI 10.1017/S0950268806006698; Naumova Elena N., 2005, Journal of Water and Health, V3, P185; Naumova EN, 2006, J PUBLIC HEALTH POL, V27, P2, DOI 10.1057/palgrave.jphp.3200061; Naumova EN, 2000, PUBLIC HEALTH REP, V115, P436, DOI 10.1093/phr/115.5.436; NEAL KR, 1995, J PUBLIC HEALTH MED, V17, P98; Nylen G, 2002, EPIDEMIOL INFECT, V128, P383, DOI 10.1017/S0950268802006830; O'Connor AM, 2008, PREV VET MED, V87, P213, DOI 10.1016/j.prevetmed.2008.06.017; Odoi Agricola, 2003, Int J Health Geogr, V2, P5, DOI 10.1186/1476-072X-2-5; Paiba GA, 2003, VET REC, V153, P347, DOI 10.1136/vr.153.12.347; Patz JA, 2004, ENVIRON HEALTH PERSP, V112, P1092, DOI 10.1289/ehp.6877; Patz JA, 2002, BMJ-BRIT MED J, V325, P1094, DOI 10.1136/bmj.325.7372.1094; Pearl DL, 2009, ZOONOSES PUBLIC HLTH, V56, P455, DOI 10.1111/j.1863-2378.2008.01193.x; PHILLIPS SC, 1981, NEW ENGL J MED, V305, P603, DOI 10.1056/NEJM198109103051102; Plowright RK, 2008, FRONT ECOL ENVIRON, V6, P420, DOI 10.1890/070086; Pruss A, 2002, ENV HLTH PERSPECTIVE, P110; Ravel A, 2010, FOODBORNE PATHOG DIS, V7, P785, DOI 10.1089/fpd.2009.0460; Rivero M, 2011, EUROPEAN J CLIN MICR, P1; Semenza JC, 2009, LANCET INFECT DIS, V9, P365, DOI 10.1016/S1473-3099(09)70104-5; Singh RBK, 2001, ENVIRON HEALTH PERSP, V109, P155, DOI 10.2307/3434769; Snel SJ, 2009, NEW ZEAL MED J, V122, P47; Sorvillo F, 1998, EPIDEMIOL INFECT, V121, P197, DOI 10.1017/S0950268898001009; Tacoli C, 2009, ENVIRON URBAN, V21, P513, DOI 10.1177/0956247809342182; Tierney WI, 1999, CONSTRUCT SEASONAL I, P1; Tirado MC, 2010, FOOD RES INT, V43, P1745, DOI 10.1016/j.foodres.2010.07.003; Tucker P, 2007, PUBLIC HEALTH, V121, P909, DOI 10.1016/j.puhe.2007.04.009; Unicomb LE, 2009, FOODBORNE PATHOG DIS, V6, P1241, DOI 10.1089/fpd.2009.0300; Valcour JE, 2002, EMERG INFECT DIS, V8, P252, DOI 10.3201/eid0803.010159; Verkerk G, 2003, THERIOGENOLOGY, V59, P553, DOI 10.1016/S0093-691X(02)01239-6; Welch T P, 2000, Int J Infect Dis, V4, P100, DOI 10.1016/S1201-9712(00)90102-4; WENIGER BG, 1983, AM J PUBLIC HEALTH, V73, P868, DOI 10.2105/AJPH.73.8.868; Word DP, 2010, COMPUT-AIDED CHEM EN, V28, P229	101	114	117	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2012	7	4							e31883	10.1371/journal.pone.0031883	http://dx.doi.org/10.1371/journal.pone.0031883			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952GU	22485127	gold, Green Published, Green Submitted			2022-12-27	WOS:000304780500003
J	Lim, S; MacIntyre, DA; Lee, YS; Khanjani, S; Terzidou, V; Teoh, TG; Bennett, PR				Lim, Sheri; MacIntyre, David A.; Lee, Yun S.; Khanjani, Shirin; Terzidou, Vasso; Teoh, T. G.; Bennett, Phillip R.			Nuclear Factor Kappa B Activation Occurs in the Amnion Prior to Labour Onset and Modulates the Expression of Numerous Labour Associated Genes	PLOS ONE			English	Article							HUMAN-FETAL MEMBRANES; ARACHIDONIC-ACID METABOLISM; EPIDERMAL GROWTH-FACTOR; OXYTOCIN RECEPTORS; HUMAN PARTURITION; PRETERM LABOR; EXPORT SIGNAL; RABBIT AMNION; CELLS; TERM	Background: Prior to the onset of human labour there is an increase in the synthesis of prostaglandins, cytokines and chemokines in the fetal membranes, particular the amnion. This is associated with activation of the transcription factor nuclear factor kappa B (NF kappa B). In this study we characterised the level of NF kappa B activity in amnion epithelial cells as a measure of amnion activation in samples collected from women undergoing caesarean section at 39 weeks gestation prior to the onset of labour. Methodology/Principal Findings: We found that a proportion of women exhibit low or moderate NF kappa B activity while other women exhibit high levels of NF kappa B activity (n=12). This activation process does not appear to involve classical pathways of NF kappa B activation but rather is correlated with an increase in nuclear p65-Rel-B dimers. To identify the full range of genes upregulated in association with amnion activation, microarray analysis was performed on carefully characterised non-activated amnion (n=3) samples and compared to activated samples (n=3). A total of 919 genes were upregulated in response to amnion activation including numerous inflammatory genes such cyclooxygenase-2 (COX-2, 44-fold), interleukin 8 (IL-8, 6-fold), IL-1 receptor accessory protein (IL-1 RAP, 4.5-fold), thrombospondin 1 (TSP-1, 3-fold) and, unexpectedly, oxytocin receptor (OTR, 24-fold). Ingenuity Pathway Analysis of the microarray data reveal the two main gene networks activated concurrently with amnion activation are i) cell death, cancer and morphology and ii) cell cycle, embryonic development and tissue development. Conclusions/Significance: Our results indicate that assessment of amnion NF kappa B activation is critical for accurate sample classification and subsequent interpretation of data. Collectively, our data suggest amnion activation is largely an inflammatory event that occurs in the amnion epithelial layer as a prelude to the onset of labour.	[Lim, Sheri; MacIntyre, David A.; Lee, Yun S.; Khanjani, Shirin; Terzidou, Vasso; Bennett, Phillip R.] Univ London Imperial Coll Sci Technol & Med, Inst Reprod & Dev Biol, Imperial Coll Parturit Res Grp, London, England; [Teoh, T. G.] St Marys Hosp, Dept Obstet & Gynaecol, London, England	Imperial College London; Imperial College London	Lim, S (corresponding author), Univ London Imperial Coll Sci Technol & Med, Inst Reprod & Dev Biol, Imperial Coll Parturit Res Grp, London, England.	pbennett@imperial.ac.uk	MacIntyre, David A/D-9267-2012	Bennett, Phillip/0000-0002-6253-4919; MacIntyre, David/0000-0002-4186-5567	Genesis Research Trust; National Institute for Health Research [ACF-2012-21-018] Funding Source: researchfish	Genesis Research Trust; National Institute for Health Research(National Institute for Health Research (NIHR))	This study was supported by funding from Genesis Research Trust. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman VE, 2004, BIOL REPROD, V71, P2079, DOI 10.1095/biolreprod.104.030841; Allport VC, 2001, MOL HUM REPROD, V7, P581, DOI 10.1093/molehr/7.6.581; Belt AR, 1999, AM J OBSTET GYNECOL, V181, P359, DOI 10.1016/S0002-9378(99)70562-4; BENNETT PR, 1987, AM J OBSTET GYNECOL, V156, P649, DOI 10.1016/0002-9378(87)90070-6; BENNETT PR, 1992, PROSTAGLANDINS, V43, P87, DOI 10.1016/0090-6980(92)90068-5; BENNETT PR, 1993, BRIT J OBSTET GYNAEC, V100, P1037, DOI 10.1111/j.1471-0528.1993.tb15143.x; Blanks AM, 2003, J CLIN ENDOCR METAB, V88, P3392, DOI 10.1210/jc.2002-021212; BROCKMAN JA, 1995, MOL CELL BIOL, V15, P2809; CHIBBAR R, 1993, J CLIN INVEST, V91, P185, DOI 10.1172/JCI116169; CONNOLLY JM, 1991, PROSTATE, V19, P173, DOI 10.1002/pros.2990190210; CONNOLLY JM, 1990, PROSTATE, V16, P209, DOI 10.1002/pros.2990160304; CROSTON GE, 1995, J BIOL CHEM, V270, P16514, DOI 10.1074/jbc.270.28.16514; Elliott CL, 2001, MOL HUM REPROD, V7, P787, DOI 10.1093/molehr/7.8.787; Elliott CL, 2001, AM J REPROD IMMUNOL, V46, P260, DOI 10.1034/j.1600-0897.2001.d01-11.x; FAN CM, 1991, NATURE, V354, P395, DOI 10.1038/354395a0; FUCHS AR, 1982, SCIENCE, V215, P1396, DOI 10.1126/science.6278592; HINKO A, 1992, ENDOCRINOLOGY, V130, P3547, DOI 10.1210/en.130.6.3547; Hsu CD, 2000, AM J REPROD IMMUNOL, V43, P255, DOI 10.1111/j.8755-8920.2000.430502.x; HSU HL, 1995, CELL, V81, P495, DOI 10.1016/0092-8674(95)90070-5; Huang TT, 2000, P NATL ACAD SCI USA, V97, P1014, DOI 10.1073/pnas.97.3.1014; Huang TT, 2001, MOL CELL BIOL, V21, P4737, DOI 10.1128/MCB.21.14.4737-4747.2001; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Ishikawa H, 1998, J EXP MED, V187, P985, DOI 10.1084/jem.187.7.985; JUNQUEIRA LCU, 1980, AM J OBSTET GYNECOL, V138, P273, DOI 10.1016/0002-9378(80)90248-3; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Kumagai K, 2001, MOL HUM REPROD, V7, P681, DOI 10.1093/molehr/7.7.681; Lee SH, 2002, J BIOL CHEM, V277, P23358, DOI 10.1074/jbc.M111559200; Lee Y, 2003, MOL HUM REPROD, V9, P213, DOI 10.1093/molehr/gag026; Lindstrom TM, 2005, REPRODUCTION, V130, P569, DOI 10.1530/rep.1.00197; Meteoglu I, 2008, J EXP CLIN CANC RES, V27, DOI 10.1186/1756-9966-27-53; OKITA JR, 1982, J BIOL CHEM, V257, P4029; OKITA JR, 1983, IN VITRO CELL DEV B, V19, P117; OSMERS R, 1992, AM J OBSTET GYNECOL, V166, P1455, DOI 10.1016/0002-9378(92)91619-L; RUBEN SM, 1992, GENE DEV, V6, P745, DOI 10.1101/gad.6.5.745; Sadovsky Y, 2000, AM J OBSTET GYNECOL, V182, P370, DOI 10.1016/S0002-9378(00)70226-2; SANGHA RK, 1994, J CLIN ENDOCR METAB, V78, P982, DOI 10.1210/jc.78.4.982; Sawdy RJ, 2000, PLACENTA, V21, P54, DOI 10.1053/plac.1999.0438; Slater D, 1999, J MOL ENDOCRINOL, V22, P125, DOI 10.1677/jme.0.0220125; SLATER DM, 1995, AM J OBSTET GYNECOL, V172, P77, DOI 10.1016/0002-9378(95)90087-X; SOLOFF MS, 1993, ANN NY ACAD SCI, V689, P207, DOI 10.1111/j.1749-6632.1993.tb55549.x; Terzidou V, 2011, BIOL REPROD, V84, P546, DOI 10.1095/biolreprod.110.086785; Thomson AJ, 1999, HUM REPROD, V14, P229, DOI 10.1093/humrep/14.1.229; WEIH F, 1994, ONCOGENE, V9, P3289; Xia YY, 1997, AM J PATHOL, V151, P375; Zanetti M, 2003, ANN NY ACAD SCI, V987, P249, DOI 10.1111/j.1749-6632.2003.tb06056.x	45	43	43	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2012	7	4							e34707	10.1371/journal.pone.0034707	http://dx.doi.org/10.1371/journal.pone.0034707			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952GU	22485186	gold, Green Published, Green Submitted			2022-12-27	WOS:000304780500061
J	Wasling, P; Strandberg, J; Hanse, E				Wasling, Pontus; Strandberg, Joakim; Hanse, Eric			AMPA Receptor Activation Causes Silencing of AMPA Receptor-Mediated Synaptic Transmission in the Developing Hippocampus	PLOS ONE			English	Article							LONG-TERM POTENTIATION; IONOTROPIC GLUTAMATE RECEPTORS; PYRAMIDAL NEURONS; DENDRITIC SPINES; CA1 REGION; SYNAPSES; PLASTICITY; DEPRESSION; LTP; TRAFFICKING	Agonist-induced internalization of transmembrane receptors is a widespread biological phenomenon that also may serve as a mechanism for synaptic plasticity. Here we show that the agonist AMPA causes a depression of AMPA receptor (AMPAR) signaling at glutamate synapses in the CA1 region of the hippocampus in slices from developing, but not from mature, rats. This developmentally restricted agonist-induced synaptic depression is expressed as a total loss of AMPAR signaling, without affecting NMDA receptor (NMDAR) signaling, in a large proportion of the developing synapses, thus creating AMPAR silent synapses. The AMPA-induced AMPAR silencing is induced independently of activation of mGluRs and NMDARs, and it mimics and occludes stimulus-induced depression, suggesting that this latter form of synaptic plasticity is expressed as agonist-induced removal of AMPARs. Induction of long-term potentiation (LTP) rendered the developing synapses resistant to the AMPA-induced depression, indicating that LTP contributes to the maturation-related increased stability of these synapses. Our study shows that agonist binding to AMPARs is a sufficient triggering stimulus for the creation of AMPAR silent synapses at developing glutamate synapses.	[Wasling, Pontus; Strandberg, Joakim; Hanse, Eric] Univ Gothenburg, Sahlgrenska Acad, Dept Physiol, Inst Neurosci & Physiol, Gothenburg, Sweden	University of Gothenburg	Wasling, P (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Dept Physiol, Inst Neurosci & Physiol, Gothenburg, Sweden.	pontus.wasling@physiol.gu.se	Strandberg, Joakim/B-4371-2009	Strandberg, Joakim/0000-0003-1483-6581	Swedish research council [12600, 01580]; Swedish Alzheimer foundation [2009-3033]; foundation of Wilhelm and Martina Lundgren [vet2-29/2010]	Swedish research council(Swedish Research CouncilEuropean Commission); Swedish Alzheimer foundation; foundation of Wilhelm and Martina Lundgren	This study was supported by the Swedish research council project nr 12600 and 01580 (www.vr.se), the Swedish Alzheimer foundation project nr 2009-3033 (www.alzheimerfonden.se), and the foundation of Wilhelm and Martina Lundgren project nr vet2-29/2010 (www.wmlundgren.se). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamsson T, 2005, J PHYSIOL-LONDON, V569, P737, DOI 10.1113/jphysiol.2005.097725; Abrahamsson T, 2008, J NEUROPHYSIOL, V100, P2605, DOI 10.1152/jn.90476.2008; Abrahamsson T, 2007, J NEUROPHYSIOL, V98, P2604, DOI 10.1152/jn.00602.2007; Carroll RC, 1999, P NATL ACAD SCI USA, V96, P14112, DOI 10.1073/pnas.96.24.14112; Collingridge GL, 2010, NAT REV NEUROSCI, V11, P459, DOI 10.1038/nrn2867; Derkach VA, 2007, NAT REV NEUROSCI, V8, P101, DOI 10.1038/nrn2055; Durand GM, 1996, NATURE, V381, P71, DOI 10.1038/381071a0; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; Groc L, 2006, TRENDS NEUROSCI, V29, P132, DOI 10.1016/j.tins.2006.01.005; Groc L, 2002, J NEUROSCI, V22, P5552; Hall BJ, 2008, TRENDS NEUROSCI, V31, P82, DOI 10.1016/j.tins.2007.11.010; Hanse E, 2009, TRENDS NEUROSCI, V32, P532, DOI 10.1016/j.tins.2009.07.003; Hsia AY, 1998, J NEUROPHYSIOL, V79, P2013, DOI 10.1152/jn.1998.79.4.2013; Hua JYY, 2004, NAT NEUROSCI, V7, P327, DOI 10.1038/nn1218; ISAAC JTR, 1995, NEURON, V15, P427, DOI 10.1016/0896-6273(95)90046-2; Jensen V, 2003, J PHYSIOL-LONDON, V553, P843, DOI 10.1113/jphysiol.2003.053637; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Kennedy MJ, 2006, ANNU REV NEUROSCI, V29, P325, DOI 10.1146/annurev.neuro.29.051605.112808; Kerchner GA, 2008, NAT REV NEUROSCI, V9, P813, DOI 10.1038/nrn2501; Lendvai B, 2000, NATURE, V404, P876, DOI 10.1038/35009107; LIAO DZ, 1995, NATURE, V375, P400, DOI 10.1038/375400a0; Lin JW, 2000, NAT NEUROSCI, V3, P1282, DOI 10.1038/81814; Lissin DV, 1999, J NEUROSCI, V19, P1263; Luscher C, 1999, NEURON, V24, P649, DOI 10.1016/S0896-6273(00)81119-8; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Meng K, 2010, NEUROSCIENCE, V165, P684, DOI 10.1016/j.neuroscience.2009.11.030; Montgomery JM, 2002, NEURON, V33, P765, DOI 10.1016/S0896-6273(02)00606-2; Morimoto-Tomita M, 2009, NEURON, V61, P101, DOI 10.1016/j.neuron.2008.11.009; Nishimune A, 1998, NEURON, V21, P87, DOI 10.1016/S0896-6273(00)80517-6; Park M, 2006, NEURON, V52, P817, DOI 10.1016/j.neuron.2006.09.040; Passafaro M, 2001, NAT NEUROSCI, V4, P917, DOI 10.1038/nn0901-917; Penzes P, 2011, NAT NEUROSCI, V14, P285, DOI 10.1038/nn.2741; RAKIC P, 1986, SCIENCE, V232, P232, DOI 10.1126/science.3952506; Riebe I, 2009, EUR J NEUROSCI, V29, P1870, DOI 10.1111/j.1460-9568.2009.06734.x; Scholz R, 2010, NEURON, V66, P768, DOI 10.1016/j.neuron.2010.05.003; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; Strandberg J, 2011, NEUROSCIENCE, V192, P54, DOI 10.1016/j.neuroscience.2011.06.081; Strandberg J, 2009, J NEUROPHYSIOL, V101, P2252, DOI 10.1152/jn.91210.2008; Tardin C, 2003, EMBO J, V22, P4656, DOI 10.1093/emboj/cdg463; Verhage M, 2000, SCIENCE, V287, P864, DOI 10.1126/science.287.5454.864; Xiao MY, 2004, NAT NEUROSCI, V7, P236, DOI 10.1038/nn1196; Yashiro K, 2008, NEUROPHARMACOLOGY, V55, P1081, DOI 10.1016/j.neuropharm.2008.07.046; Yasuda H, 2003, NAT NEUROSCI, V6, P15, DOI 10.1038/nn985	43	7	7	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2012	7	4							e34474	10.1371/journal.pone.0034474	http://dx.doi.org/10.1371/journal.pone.0034474			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952GU	22485173	gold, Green Published, Green Submitted			2022-12-27	WOS:000304780500048
J	Zhu, GJ; Wang, F; Chen, C; Xu, L; Zhang, WC; Fan, C; Peng, YJ; Chen, J; He, WQ; Guo, SY; Zuo, J; Gao, X; Zhu, MS				Zhu, Guang-Jie; Wang, Fang; Chen, Chen; Xu, Lin; Zhang, Wen-Cheng; Fan, Chi; Peng, Ya-Jing; Chen, Jie; He, Wei-Qi; Guo, Shi-Ying; Zuo, Jian; Gao, Xia; Zhu, Min-Sheng			Myosin Light-Chain Kinase Is Necessary for Membrane Homeostasis in Cochlear Inner Hair Cells	PLOS ONE			English	Article							SMOOTH-MUSCLE CONTRACTION; HEARING-LOSS; IN-VIVO; DEAFNESS; GENE; IDENTIFICATION; MUTATIONS; BINDING; MICE; EAR	The structural homeostasis of the cochlear hair cell membrane is critical for all aspects of sensory transduction, but the regulation of its maintenance is not well understood. In this report, we analyzed the cochlear hair cells of mice with specific deletion of myosin light chain kinase (MLCK) in inner hair cells. MLCK-deficient mice showed impaired hearing, with a 5- to 14-dB rise in the auditory brainstem response (ABR) thresholds to clicks and tones of different frequencies and a significant decrease in the amplitude of the ABR waves. The mutant inner hair cells produced several ball-like structures around the hair bundles in vivo, indicating impaired membrane stability. Inner hair cells isolated from the knockout mice consistently displayed less resistance to hypoosmotic solution and less membrane F-actin. Myosin light-chain phosphorylation was also reduced in the mutated inner hair cells. Our results suggest that MLCK is necessary for maintaining the membrane stability of inner hair cells.	[Zhu, Guang-Jie; Wang, Fang; Chen, Chen; Xu, Lin; Zhang, Wen-Cheng; Fan, Chi; Peng, Ya-Jing; Chen, Jie; He, Wei-Qi; Guo, Shi-Ying; Gao, Xia; Zhu, Min-Sheng] Nanjing Univ, Nanjing Drum Tower Hosp, MOE Key Lab Model Anim & Dis Studies, Nanjing, Jiangsu, Peoples R China; [Zhu, Guang-Jie; Wang, Fang; Chen, Chen; Xu, Lin; Zhang, Wen-Cheng; Fan, Chi; Peng, Ya-Jing; Chen, Jie; He, Wei-Qi; Guo, Shi-Ying; Gao, Xia; Zhu, Min-Sheng] Nanjing Univ, Model Anim Res Ctr, Nanjing, Jiangsu, Peoples R China; [Zhang, Wen-Cheng; Zhu, Min-Sheng] Wenzhou Med Coll, Sch Life Sci, Zhejiang Prov Key Lab Technol & Applicat Model Or, University Pk, Wenzhou, Peoples R China; [Zuo, Jian] St Jude Childrens Res Hosp, Dept Dev Neurobiol, Memphis, TN 38105 USA	Nanjing University; Nanjing University; Wenzhou Medical University; St Jude Children's Research Hospital	Zhu, GJ (corresponding author), Nanjing Univ, Nanjing Drum Tower Hosp, MOE Key Lab Model Anim & Dis Studies, Nanjing, Jiangsu, Peoples R China.	xiagao213@yahoo.com.cn; zhums@nju.edu.cn	Zhang, Wencheng/AAO-8445-2020; He, Weiqi/I-7935-2013; He, Weiqi/L-2502-2019	He, Weiqi/0000-0003-3137-8420; He, Weiqi/0000-0003-3137-8420; Chen, Chen/0000-0001-7075-8501	National Natural Science Funding of China [30973302]; National Basic Research Program of China (973) [2009CB942602, 2007CB947100]; Medically Important Development Project of Nanjing [ZKZ06019]; Medically Important People Project of Jiangsu Province [RC2007010]	National Natural Science Funding of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973)(National Basic Research Program of China); Medically Important Development Project of Nanjing; Medically Important People Project of Jiangsu Province	This work was supported by the National Natural Science Funding of China (grant number 30973302), the National Basic Research Program of China (973) (grant numbers 2009CB942602, and 2007CB947100), the Medically Important Development Project of Nanjing (ZKZ06019) and the Medically Important People Project of Jiangsu Province (RC2007010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashmore JF, 2000, P NATL ACAD SCI USA, V97, P11759, DOI 10.1073/pnas.97.22.11759; Bao R, 2008, J GEN PHYSIOL, V132, P145, DOI 10.1085/jgp.200709933; Bekesy G., 1960, EXPT HEARING; Belyantseva IA, 2003, P NATL ACAD SCI USA, V100, P13958, DOI 10.1073/pnas.2334417100; Breckenridge MT, 2009, MOL BIOL CELL, V20, P338, DOI 10.1091/mbc.E08-04-0372; BROWNELL WE, 1990, EAR HEARING, V11, P82, DOI 10.1097/00003446-199004000-00003; Cai S, 1998, AM J PHYSIOL-CELL PH, V275, pC1349, DOI 10.1152/ajpcell.1998.275.5.C1349; Clayburgh DR, 2004, J BIOL CHEM, V279, P55506, DOI 10.1074/jbc.M408822200; Ding HL, 2009, J BIOL CHEM, V284, P15541, DOI 10.1074/jbc.M900888200; Donaudy F, 2004, AM J HUM GENET, V74, P770, DOI 10.1086/383285; Etournay R, 2007, J CELL SCI, V120, P2838, DOI 10.1242/jcs.002568; Ferrari MB, 1998, J CELL BIOL, V141, P1349, DOI 10.1083/jcb.141.6.1349; Frolenkov GI, 2004, NAT REV GENET, V5, P489, DOI 10.1038/nrg1377; GOECKELER ZM, 1995, J CELL BIOL, V130, P613, DOI 10.1083/jcb.130.3.613; Grimm M, 2006, BRIT J PHARMACOL, V148, P991, DOI 10.1038/sj.bjp.0706803; Grimsley-Myers CM, 2009, J NEUROSCI, V29, P15859, DOI 10.1523/JNEUROSCI.3998-09.2009; He DZZ, 2000, HEARING RES, V145, P156, DOI 10.1016/S0378-5955(00)00084-8; He WQ, 2008, GASTROENTEROLOGY, V135, P610, DOI 10.1053/j.gastro.2008.05.032; He WQ, 2011, AM J PHYSIOL-HEART C, V301, pH584, DOI 10.1152/ajpheart.01212.2010; Heath KE, 2001, AM J HUM GENET, V69, P1033, DOI 10.1086/324267; Ingber DE, 2006, FASEB J, V20, P811, DOI 10.1096/fj.05-5424rev; Ishmael JE, 2008, ACTA HISTOCHEM, V110, P172, DOI 10.1016/j.acthis.2007.08.005; Jiang H, 2006, J NEUROSCI RES, V83, P1544, DOI 10.1002/jnr.20833; Judice TN, 2002, BRAIN RES PROTOC, V9, P65, DOI 10.1016/S1385-299X(01)00138-6; Kamm KE, 2001, J BIOL CHEM, V276, P4527, DOI 10.1074/jbc.R000028200; Kharkovets T, 2000, P NATL ACAD SCI USA, V97, P4333, DOI 10.1073/pnas.97.8.4333; Krendel M, 2005, PHYSIOLOGY, V20, P239, DOI 10.1152/physiol.00014.2005; Kudryashov DS, 1999, FEBS LETT, V463, P67, DOI 10.1016/S0014-5793(99)01591-4; Lalwani AK, 2000, AM J HUM GENET, V67, P1121, DOI 10.1016/S0002-9297(07)62942-5; Li J, 2001, J BIOL CHEM, V276, P31233, DOI 10.1074/jbc.M104368200; Li MY, 2004, GENESIS, V39, P173, DOI 10.1002/gene.20040; Li ZW, 2002, BIOPHYS J, V82, P1386, DOI 10.1016/S0006-3495(02)75493-3; LIM DJ, 1980, J ACOUST SOC AM, V67, P1686, DOI 10.1121/1.384295; Liu XZ, 1997, NAT GENET, V16, P188, DOI 10.1038/ng0697-188; Lynch ED, 1997, SCIENCE, V278, P1315, DOI 10.1126/science.278.5341.1315; Mermall V, 1998, SCIENCE, V279, P527, DOI 10.1126/science.279.5350.527; Mizuno Y, 2008, AM J PHYSIOL-CELL PH, V295, pC358, DOI 10.1152/ajpcell.90645.2007; Morton CC, 2002, HUM MOL GENET, V11, P1229, DOI 10.1093/hmg/11.10.1229; Nadol JB, 2001, INT J PEDIATR OTORHI, V61, P1, DOI 10.1016/S0165-5876(01)00546-8; Parker LL, 2006, BRAIN RES, V1091, P235, DOI 10.1016/j.brainres.2006.03.032; Parving A, 1999, ACTA PAEDIATR, V88, P69, DOI 10.1080/080352599750029439; Probst FJ, 1998, SCIENCE, V280, P1444, DOI 10.1126/science.280.5368.1444; ROBERTS WM, 1988, ANNU REV CELL BIOL, V4, P63, DOI 10.1146/annurev.cb.04.110188.000431; Seri M, 2002, HUM GENET, V110, P182, DOI 10.1007/s00439-001-0659-1; Smith L, 1999, J BIOL CHEM, V274, P29433, DOI 10.1074/jbc.274.41.29433; Smith L, 2002, J BIOL CHEM, V277, P35597, DOI 10.1074/jbc.M206483200; Somlyo AP, 2003, PHYSIOL REV, V83, P1325, DOI 10.1152/physrev.00023.2003; Takizawa N, 2007, J CELL SCI, V120, P3792, DOI 10.1242/jcs.008219; Willems PJ, 2000, NEW ENGL J MED, V342, P1101, DOI 10.1056/NEJM200004133421506; Wilson SM, 2001, GENOMICS, V74, P228, DOI 10.1006/geno.2001.6554; Yamamoto N, 2009, DEVELOPMENT, V136, P1977, DOI 10.1242/dev.030718; Yang CX, 2006, CELL RES, V16, P367, DOI 10.1038/sj.cr.7310047; Yang T, 2005, AM J MED GENET A, V139A, P9, DOI 10.1002/ajmg.a.30989; Zhang WC, 2008, FEBS J, V275, P2489, DOI 10.1111/j.1742-4658.2008.06393.x; Zhang WC, 2010, J BIOL CHEM, V285, P5522, DOI 10.1074/jbc.M109.062836	55	5	6	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2012	7	4							e34894	10.1371/journal.pone.0034894	http://dx.doi.org/10.1371/journal.pone.0034894			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952GU	22485190	Green Published, Green Submitted, gold			2022-12-27	WOS:000304780500064
J	Kwon, YH; Jung, SY; Kim, JW; Lee, SH; Lee, JH; Lee, BY; Kwon, SM				Kwon, Yi-Hong; Jung, Seok-Yun; Kim, Jae-Won; Lee, Sang-Hun; Lee, Jun-Hee; Lee, Boo-Yong; Kwon, Sang-Mo			Phloroglucinol Inhibits the Bioactivities of Endothelial Progenitor Cells and Suppresses Tumor Angiogenesis in LLC-Tumor-Bearing Mice	PLOS ONE			English	Article							GROWTH-FACTOR PATHWAY; IN-VITRO; ANTIANGIOGENIC THERAPY; ANTICANCER AGENTS; OXIDATIVE STRESS; VEGF EXPRESSION; METASTASIS; CARCINOMA; CANCER; VIVO	Background: There is increasing evidence that phloroglucinol, a compound from Ecklonia cava, induces the apoptosis of cancer cells, eventually suppressing tumor angiogenesis. Methodology/Principal Findings: This is the first report on phloroglucinol's ability to potentially inhibit the functional bioactivities of endothelial progenitor cells (EPCs) and thereby attenuate tumor growth and angiogenesis in the Lewis lung carcinoma (LLC)-tumor-bearing mouse model. Although Phloroglucinol did not affect their cell toxicity, it specifically inhibited vascular endothelial growth factor (VEGF) dependent migration and capillary-like tube formation of EPCs. Our matrigel plug assay clearly indicated that orally injected phloroglucinol effectively disrupts VEGF-induced neovessel formation. Moreover, we demonstrated that when phloroglucinol is orally administered, it significantly inhibits tumor growth and angiogenesis as well as CD45(-)/CD34(+) progenitor mobilization into peripheral blood in vivo in the LLC-tumor-bearing mouse model. Conclusions/Significance: These results suggest a novel role for phloroglucinol: Phloroglucinol might be a modulator of circulating EPC bioactivities, eventually suppressing tumorigenesis. Therefore, phloroglucinol might be a candidate compound for biosafe drugs that target tumor angiogenesis.	[Kwon, Yi-Hong; Kim, Jae-Won; Lee, Boo-Yong] CHA Univ, Dept Food Sci & Biotechnol, Lab Funct Foods & Nutrigenom, Dept Biomed Sci, Kyunggido, South Korea; [Jung, Seok-Yun; Lee, Sang-Hun; Lee, Jun-Hee; Kwon, Sang-Mo] Pusan Natl Univ, Med Res Inst, Sch Med, Lab Vasc Med & Stem Cell Biol,Dept Physiol, Gyeongsangnam Do, South Korea	Pochon Cha University; Pusan National University	Kwon, YH (corresponding author), CHA Univ, Dept Food Sci & Biotechnol, Lab Funct Foods & Nutrigenom, Dept Biomed Sci, Kyunggido, South Korea.	bylee@cha.ac.kr; smkwon323@pusan.ac.kr	lee, sang hun/Q-4650-2019	lee, sang hun/0000-0002-9005-5966; Lee, Junhee/0000-0001-6897-2824	National Research Foundation; Korea government [2010-0020260]; Ministry of Health and Welfare, Republic of Korea [A100322]	National Research Foundation; Korea government(Korean Government); Ministry of Health and Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This work was supported by a National Research Foundation grant funded by the Korea government (2010-0020260) and a grant of the Korean Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea (A100322). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asahara T, 1999, CIRC RES, V85, P221, DOI 10.1161/01.RES.85.3.221; Asahara T, 1999, EMBO J, V18, P3964, DOI 10.1093/emboj/18.14.3964; BANAI S, 1994, CIRCULATION, V89, P2183, DOI 10.1161/01.CIR.89.5.2183; Beckermann BM, 2008, BRIT J CANCER, V99, P622, DOI 10.1038/sj.bjc.6604508; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Cooney MM, 2006, NAT CLIN PRACT ONCOL, V3, P682, DOI 10.1038/ncponc0663; Cragg GM, 2005, J ETHNOPHARMACOL, V100, P72, DOI 10.1016/j.jep.2005.05.011; Deryugina EI, 2006, CANCER METAST REV, V25, P9, DOI 10.1007/s10555-006-7886-9; Dome B, 2006, CANCER RES, V66, P7341, DOI 10.1158/0008-5472.CAN-05-4654; Dona M, 2004, CANCER RES, V64, P6225, DOI 10.1158/0008-5472.CAN-04-0280; Ebos JML, 2009, CANCER CELL, V15, P232, DOI 10.1016/j.ccr.2009.01.021; Eccles SA, 1996, CANCER RES, V56, P2815; Fang J, 2007, CARCINOGENESIS, V28, P858, DOI 10.1093/carcin/bgl205; Fang ST, 2011, J MOL CELL CARDIOL, V50, P290, DOI 10.1016/j.yjmcc.2010.10.024; Gao DC, 2009, BBA-REV CANCER, V1796, P33, DOI 10.1016/j.bbcan.2009.05.001; Gupta P, 2010, BIOORG MED CHEM LETT, V20, P4427, DOI 10.1016/j.bmcl.2010.06.057; Hicklin DJ, 2005, J CLIN ONCOL, V23, P1011, DOI 10.1200/JCO.2005.06.081; Ho JWY, 2006, HEPATOLOGY, V44, P836, DOI 10.1002/hep.21353; Ingram DA, 2004, BLOOD, V104, P2752, DOI 10.1182/blood-2004-04-1396; Jung MH, 2009, CARCINOGENESIS, V30, P655, DOI 10.1093/carcin/bgp039; Kang KA, 2006, J CELL BIOCHEM, V97, P609, DOI 10.1002/jcb.20668; Kim MM, 2010, FOOD CHEM TOXICOL, V48, P2925, DOI 10.1016/j.fct.2010.07.029; Kwon SM, 2009, CIRC RES, V104, P969, DOI 10.1161/CIRCRESAHA.108.192856; Li Y, 2009, BIOORGAN MED CHEM, V17, P1963, DOI 10.1016/j.bmc.2009.01.031; LIOTTA LA, 1991, CELL, V64, P327, DOI 10.1016/0092-8674(91)90642-C; Lyden D, 2001, NAT MED, V7, P1194, DOI 10.1038/nm1101-1194; Napoli C, 2011, INT J CANCER, V128, P1505, DOI 10.1002/ijc.25743; Oh HK, 2007, CANCER RES, V67, P4851, DOI 10.1158/0008-5472.CAN-06-2979; OREILLY MS, 1994, CELL, V79, P315, DOI 10.1016/0092-8674(94)90200-3; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Paez-Ribes M, 2009, CANCER CELL, V15, P220, DOI 10.1016/j.ccr.2009.01.027; Patyna S, 2009, Birth Defects Res B Dev Reprod Toxicol, V86, P204, DOI 10.1002/bdrb.20194; Porta C, 2007, CLIN EXP MED, V7, P127, DOI 10.1007/s10238-007-0145-8; Rothley M, 2009, INT J CANCER, V125, P34, DOI 10.1002/ijc.24295; Schempp CM, 2005, PLANTA MED, V71, P999, DOI 10.1055/s-2005-871303; Singh IP, 2009, EXPERT OPIN THER PAT, V19, P847, DOI 10.1517/13543770902916614; Takahashi T, 1999, NAT MED, V5, P434, DOI 10.1038/7434; Tamaskar I, 2008, J UROLOGY, V179, P81, DOI 10.1016/j.juro.2007.08.127; Tonra JR, 2007, IMMUNOL INVEST, V36, P3, DOI 10.1080/08820130600991794; Yi TF, 2008, MOL CANCER THER, V7, P1789, DOI 10.1158/1535-7163.MCT-08-0124; Zhu W, 2006, EXP MOL PATHOL, V80, P267, DOI 10.1016/j.yexmp.2005.07.004	41	20	21	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2012	7	4							e33618	10.1371/journal.pone.0033618	http://dx.doi.org/10.1371/journal.pone.0033618			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JO	22496756	gold, Green Published, Green Submitted			2022-12-27	WOS:000305014500012
J	Liberman, AC; Antunica-Noguerol, M; Ferraz-de-Paula, V; Palermo-Neto, J; Castro, CN; Druker, J; Holsboer, F; Perone, MJ; Gerlo, S; De Bosscher, K; Haegeman, G; Arzt, E				Liberman, Ana C.; Antunica-Noguerol, Maria; Ferraz-de-Paula, Viviane; Palermo-Neto, Joao; Castro, Carla N.; Druker, Jimena; Holsboer, Florian; Perone, Marcelo J.; Gerlo, Sarah; De Bosscher, Karolien; Haegeman, Guy; Arzt, Eduardo			Compound A, a Dissociated Glucocorticoid Receptor Modulator, Inhibits T-bet (Th1) and Induces GATA-3 (Th2) Activity in Immune Cells	PLOS ONE			English	Article							NF-KAPPA-B; ACTIVATED PROTEIN-KINASE; TRANSCRIPTION FACTOR; DNA-BINDING; IN-VIVO; LINEAGE COMMITMENT; REGULATORY REGION; GENE-EXPRESSION; IL-5 PROMOTER; PLANT-ORIGIN	Background: Compound A (CpdA) is a dissociating non-steroidal glucocorticoid receptor (GR) ligand which has anti-inflammatory properties exerted by down-modulating proinflammatory gene expression. By favouring GR monomer formation, CpdA does not enhance glucocorticoid (GC) response element-driven gene expression, resulting in a reduced side effect profile as compared to GCs. Considering the importance of Th1/Th2 balance in the final outcome of immune and inflammatory responses, we analyzed how selective GR modulation differentially regulates the activity of T-bet and GATA-3, master drivers of Th1 and Th2 differentiation, respectively. Results: Using Western analysis and reporter gene assays, we show in murine T cells that, similar to GCs, CpdA inhibits T-bet activity via a transrepressive mechanism. Different from GCs, CpdA induces GATA-3 activity by p38 MAPK-induction of GATA-3 phosphorylation and nuclear translocation. CpdA effects are reversed by the GR antagonist RU38486, proving the involvement of GR in these actions. ELISA assays demonstrate that modulation of T-bet and GATA-3 impacts on cytokine production shown by a decrease in IFN-gamma and an increase in IL-5 production, respectively. Conclusions: Taken together, through their effect favoring Th2 over Th1 responses, particular dissociated GR ligands, for which CpdA represents a paradigm, hold potential for the application in Th1-mediated immune disorders.	[Liberman, Ana C.; Antunica-Noguerol, Maria; Castro, Carla N.; Druker, Jimena; Perone, Marcelo J.; Arzt, Eduardo] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Lab Fisiol & Biol Mol, Dept Fisiol & Biol Mol & Celular, Buenos Aires, DF, Argentina; [Liberman, Ana C.; Antunica-Noguerol, Maria; Castro, Carla N.; Druker, Jimena; Perone, Marcelo J.; Arzt, Eduardo] Consejo Nacl Invest Cient & Tecn, Partner Inst Max Planck Soc, Inst Invest Biomed Buenos Aires IBioBA, RA-1033 Buenos Aires, DF, Argentina; [Ferraz-de-Paula, Viviane; Palermo-Neto, Joao] FMVZ USP, Neuroimmunomodulat Res Grp, Sao Paulo, Brazil; [Holsboer, Florian; Arzt, Eduardo] Max Planck Inst Psychiat, D-80804 Munich, Germany; [Gerlo, Sarah; De Bosscher, Karolien; Haegeman, Guy] Univ Ghent, Lab Eukaryot Gene Express & Signal Transduct, B-9000 Ghent, Belgium; [Gerlo, Sarah; De Bosscher, Karolien] UGent, VIB Dept Med Prot Res, Ghent, Belgium	University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Max Planck Society; Universidade de Sao Paulo; Max Planck Society; Ghent University; Flanders Institute for Biotechnology (VIB); Ghent University	Liberman, AC (corresponding author), Univ Buenos Aires, Fac Ciencias Exactas & Nat, Lab Fisiol & Biol Mol, Dept Fisiol & Biol Mol & Celular, Buenos Aires, DF, Argentina.	earzt@fbmc.fcen.uba.ar		De Bosscher, Karolien/0000-0001-5059-9718; Castro, Carla Noemi/0000-0002-2689-9072	Max Planck Society, Germany; University of Buenos Aires (UBA); CONICET; Agencia Nacional de Promocion Cientifica y Tecnologica, Argentina; FWO Vlaanderen	Max Planck Society, Germany(Max Planck Society); University of Buenos Aires (UBA)(University of Buenos Aires); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Agencia Nacional de Promocion Cientifica y Tecnologica, Argentina(ANPCyT); FWO Vlaanderen(FWO)	This work was supported by Grants from the Max Planck Society, Germany; the University of Buenos Aires (UBA), the CONICET and Agencia Nacional de Promocion Cientifica y Tecnologica, Argentina; and the bilateral program of FWO Vlaanderen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; Beck IM, 2008, EMBO J, V27, P1682, DOI 10.1038/emboj.2008.95; Blaustein M, 2004, J BIOL CHEM, V279, P21029, DOI 10.1074/jbc.M314260200; Brancho D, 2003, GENE DEV, V17, P1969, DOI 10.1101/gad.1107303; Chen CH, 2000, J IMMUNOL, V165, P5597, DOI 10.4049/jimmunol.165.10.5597; DAY RN, 1989, J BIOL CHEM, V264, P431; De Bosscher K, 2005, P NATL ACAD SCI USA, V102, P15827, DOI 10.1073/pnas.0505554102; De Bosscher K, 2010, CURR OPIN PHARMACOL, V10, P497, DOI 10.1016/j.coph.2010.04.007; Dewint P, 2008, J IMMUNOL, V180, P2608, DOI 10.4049/jimmunol.180.4.2608; FOX HS, 1991, J IMMUNOL, V146, P4362; GIGUERE V, 1986, CELL, V46, P645, DOI 10.1016/0092-8674(86)90339-9; HECK S, 1994, EMBO J, V13, P4087, DOI 10.1002/j.1460-2075.1994.tb06726.x; HO IC, 1991, EMBO J, V10, P1187, DOI 10.1002/j.1460-2075.1991.tb08059.x; Hwang ES, 2005, SCIENCE, V307, P430, DOI 10.1126/science.1103336; Hwang ES, 2002, J IMMUNOL, V169, P248, DOI 10.4049/jimmunol.169.1.248; Kleiman A, 2007, MOL CELL ENDOCRINOL, V275, P98, DOI 10.1016/j.mce.2007.05.009; Klein-Hessling S, 2003, J IMMUNOL, V170, P2956, DOI 10.4049/jimmunol.170.6.2956; Klein-Hessling S, 2008, J BIOL CHEM, V283, P31030, DOI 10.1074/jbc.M805929200; LEE HJ, 1993, J IMMUNOL, V151, P6135; Liberman AC, 2007, FASEB J, V21, P1177, DOI 10.1096/fj.06-7452com; Liberman AC, 2007, CYTOKINE GROWTH F R, V18, P45, DOI 10.1016/j.cytogfr.2007.01.005; Liberman AC, 2009, FASEB J, V23, P1558, DOI 10.1096/fj.08-121236; Louw A, 1997, BIOCHEM PHARMACOL, V53, P189, DOI 10.1016/S0006-2952(96)00661-2; Maneechotesuwan K, 2007, J IMMUNOL, V178, P2491, DOI 10.4049/jimmunol.178.4.2491; Maneechotesuwan K, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000076; Mosmann TR, 1996, IMMUNOL TODAY, V17, P138, DOI 10.1016/0167-5699(96)80606-2; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; Mullen AC, 2001, SCIENCE, V292, P1907, DOI 10.1126/science.1059835; Nawijn MC, 2001, J IMMUNOL, V167, P724, DOI 10.4049/jimmunol.167.2.724; Neurath MF, 2002, J EXP MED, V195, P1129, DOI 10.1084/jem.20011956; Ouyang WJ, 2000, IMMUNITY, V12, P27, DOI 10.1016/S1074-7613(00)80156-9; Peng SL, 2006, CELL MOL IMMUNOL, V3, P87; Plaisance S, 1997, MOL CELL BIOL, V17, P3733, DOI 10.1128/MCB.17.7.3733; Quan A, 2001, J ALLERGY CLIN IMMUN, V108, P340; Rauch A, 2011, FASEB J, V25, P1323, DOI 10.1096/fj.10-173393; Reichardt HM, 1998, CELL, V93, P531, DOI 10.1016/S0092-8674(00)81183-6; Reichardt HM, 2001, EMBO J, V20, P7168, DOI 10.1093/emboj/20.24.7168; Robertson S, 2010, J BIOL CHEM, V285, P8061, DOI 10.1074/jbc.M109.087866; RUPPRECHT R, 1993, MOL ENDOCRINOL, V7, P597, DOI 10.1210/me.7.4.597; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Szabo SJ, 2002, SCIENCE, V295, P338, DOI 10.1126/science.1065543; Takemoto N, 2000, J IMMUNOL, V165, P6687, DOI 10.4049/jimmunol.165.12.6687; Tanos T, 2005, J BIOL CHEM, V280, P18842, DOI 10.1074/jbc.M500620200; Tao YX, 2001, J BIOL CHEM, V276, P2329, DOI 10.1074/jbc.C000526200; Usui T, 2006, J EXP MED, V203, P755, DOI 10.1084/jem.20052165; van Loo G, 2010, MOL ENDOCRINOL, V24, P310, DOI 10.1210/me.2009-0236; Wang XS, 1997, J BIOL CHEM, V272, P23668, DOI 10.1074/jbc.272.38.23668; Wust S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008202; Zhang DH, 1998, J IMMUNOL, V161, P3817; Zhang ZR, 2009, J IMMUNOL, V183, P3081, DOI 10.4049/jimmunol.0901088; Zhou M, 2003, IMMUNOL RES, V28, P25, DOI 10.1385/IR:28:1:25; Zhu JF, 2006, CELL RES, V16, P3, DOI 10.1038/sj.cr.7310002	52	31	32	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2012	7	4							e35155	10.1371/journal.pone.0035155	http://dx.doi.org/10.1371/journal.pone.0035155			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JO	22496903	Green Published, gold, Green Submitted			2022-12-27	WOS:000305014500048
J	Brown, NA; Antoniw, J; Hammond-Kosack, KE				Brown, Neil A.; Antoniw, John; Hammond-Kosack, Kim E.			The Predicted Secretome of the Plant Pathogenic Fungus Fusarium graminearum: A Refined Comparative Analysis	PLOS ONE			English	Article							POWDERY MILDEW FUNGI; TRICHOTHECENE 3-O-ACETYLTRANSFERASE; SUBCELLULAR-LOCALIZATION; GENOME SEQUENCE; USTILAGO-MAYDIS; PROTEIN; GENE; VIRULENCE; EFFECTOR; WHEAT	The fungus Fusarium graminearum forms an intimate association with the host species wheat whilst infecting the floral tissues at anthesis. During the prolonged latent period of infection, extracellular communication between live pathogen and host cells must occur, implying a role for secreted fungal proteins. The wheat cells in contact with fungal hyphae subsequently die and intracellular hyphal colonisation results in the development of visible disease symptoms. Since the original genome annotation analysis was done in 2007, which predicted the secretome using TargetP, the F. graminearum gene call has changed considerably through the combined efforts of the BROAD and MIPS institutes. As a result of the modifications to the genome and the recent findings that suggested a role for secreted proteins in virulence, the F. graminearum secretome was revisited. In the current study, a refined F. graminearum secretome was predicted by combining several bioinformatic approaches. This strategy increased the probability of identifying truly secreted proteins. A secretome of 574 proteins was predicted of which 99% was supported by transcriptional evidence. The function of the annotated and unannotated secreted proteins was explored. The potential role(s) of the annotated proteins including, putative enzymes, phytotoxins and antifungals are discussed. Characterisation of the unannotated proteins included the analysis of Pfam domains and features associated with known fungal effectors, for example, small size, cysteine-rich and containing internal amino acid repeats. A comprehensive comparative genomic analysis involving 57 fungal and oomycete genomes revealed that only a small number of the predicted F. graminearum secreted proteins can be considered to be either species or sequenced strain specific.	[Brown, Neil A.; Antoniw, John; Hammond-Kosack, Kim E.] Rothamsted Res, Dept Plant Pathol & Microbiol, Ctr Sustainable Pest & Dis Management, Harpenden, Herts, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research	Brown, NA (corresponding author), Rothamsted Res, Dept Plant Pathol & Microbiol, Ctr Sustainable Pest & Dis Management, Harpenden, Herts, England.	kim.hammond-kosack@rothamsted.ac.uk		Hammond-Kosack, kim/0000-0002-9699-485X; Brown, Neil/0000-0002-3555-5765	Biotechnology and Biological Sciences Research Council of the United Kingdom (BBSRC); BBSRC; Syngenta; Biotechnology and Biological Sciences Research Council [BBS/E/C/00005203, BBS/E/C/00004973] Funding Source: researchfish; BBSRC [BBS/E/C/00005203, BBS/E/C/00004973] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council of the United Kingdom (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Syngenta(Syngenta); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Rothamsted Research receives grant-aided support from the Biotechnology and Biological Sciences Research Council of the United Kingdom (BBSRC). Neil Brown was supported by BBSRC studentships with Syngenta as the CASE partner. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antoniw J, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-447; Baldwin TK, 2010, MOL PLANT MICROBE IN, V23, P566, DOI 10.1094/MPMI-23-5-0566; Beacham A, 2011, PATHOGENICITY FUSARI; BEACHAM AM, 2009, BIOLOGIST, V56, P98; Bhattacharjee Souvik, 2006, PLoS Pathogens, V2, DOI 10.1371/journal.ppat.0020050; Boenisch MJ, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-110; Brown NA, 2011, J PATHOG, V2011, DOI 10.4061/2011/626345; Brown NA, 2010, FUNGAL BIOL-UK, V114, P555, DOI 10.1016/j.funbio.2010.04.006; Cuomo CA, 2007, SCIENCE, V317, P1400, DOI 10.1126/science.1143708; Cuzick A, 2008, MOL PLANT PATHOL, V9, P697, DOI [10.1111/j.1364-3703.2008.00488.x, 10.1111/J.1364-3703.2008.00488.X]; Cuzick A, 2008, NEW PHYTOL, V177, P990, DOI 10.1111/j.1469-8137.2007.02333.x; de Jonge R, 2010, SCIENCE, V329, P953, DOI 10.1126/science.1190859; Dean RA, 2005, NATURE, V434, P980, DOI 10.1038/nature03449; Deller S, 2011, J PLANT PHYSIOL, V168, P63, DOI 10.1016/j.jplph.2010.05.024; Desmond OJ, 2008, MOL PLANT PATHOL, V9, P435, DOI 10.1111/J.1364-3703.2008.00475.X; Ding LN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019008; Doehlemann G, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000290; Dorman CJ, 2009, NUCLEIC ACIDS RES, V37, P672, DOI 10.1093/nar/gkn996; Dublin HJ, 1997, FUSARIUM HEAD SCAB G; Eisenhaber B, 2004, J MOL BIOL, V337, P243, DOI 10.1016/j.jmb.2004.01.025; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Fellbrich Guido, 2002, Plant Journal, V32, P375, DOI 10.1046/j.1365-313X.2002.01454.x; Gage MJ, 2001, MOL MICROBIOL, V41, P775, DOI 10.1046/j.1365-2958.2001.02554.x; Gale LR, 2005, GENETICS, V171, P985, DOI 10.1534/genetics.105.044842; Gan PHP, 2010, FUNCT PLANT BIOL, V37, P913, DOI 10.1071/FP10072; Godfrey D, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-317; Guldener U, 2006, FUNGAL GENET BIOL, V43, P316, DOI 10.1016/j.fgb.2006.01.005; Haas BJ, 2009, NATURE, V461, P393, DOI 10.1038/nature08358; Hall N, 1999, PHYSIOL MOL PLANT P, V55, P69, DOI 10.1006/pmpp.1999.0203; Hane JK, 2007, PLANT CELL, V19, P3347, DOI 10.1105/tpc.107.052829; Harris LJ, 1999, PLANT DIS, V83, P954, DOI 10.1094/PDIS.1999.83.10.954; Heger A, 2000, PROTEINS, V41, P224, DOI 10.1002/1097-0134(20001101)41:2<224::AID-PROT70>3.0.CO;2-Z; Hook S, 2007, GUIDELINES MINIMISE, P1; Horton P, 2006, SER ADV BIOINFORM, V3, P39, DOI 10.1142/9781860947292_0007; Howlett BJ, 2006, CURR OPIN PLANT BIOL, V9, P371, DOI 10.1016/j.pbi.2006.05.004; Jansen C, 2005, P NATL ACAD SCI USA, V102, P16892, DOI 10.1073/pnas.0508467102; Jeong JS, 2007, FEMS MICROBIOL LETT, V273, P157, DOI 10.1111/j.1574-6968.2007.00796.x; Kamper J, 2006, NATURE, V444, P97, DOI 10.1038/nature05248; Kale SD, 2010, CELL, V142, P284, DOI 10.1016/j.cell.2010.06.008; Khang CH, 2010, PLANT CELL, V22, P1388, DOI 10.1105/tpc.109.069666; Kimura M, 1998, J BIOL CHEM, V273, P1654, DOI 10.1074/jbc.273.3.1654; Kimura M, 2007, BIOSCI BIOTECH BIOCH, V71, P2105, DOI 10.1271/bbb.70183; Kloppholz S, 2011, CURR BIOL, V21, P1204, DOI 10.1016/j.cub.2011.06.044; KOLTIN Y, 1976, P NATL ACAD SCI USA, V73, P594, DOI 10.1073/pnas.73.2.594; Levdansky E, 2007, EUKARYOT CELL, V6, P1380, DOI 10.1128/EC.00229-06; Lievens B, 2009, FEMS MICROBIOL LETT, V300, P201, DOI 10.1111/j.1574-6968.2009.01783.x; Lutz MP, 2003, APPL ENVIRON MICROB, V69, P3077, DOI 10.1128/AEM.69.6.3077-3084.2003; Lysoe E, 2011, MOL PLANT MICROBE IN, V24, P995, DOI 10.1094/MPMI-02-11-0038; Maier FJ, 2006, MOL PLANT PATHOL, V7, P449, DOI 10.1111/j.1364-3703.2006.00351.x; Makandar R, 2010, MOL PLANT MICROBE IN, V23, P861, DOI 10.1094/MPMI-23-7-0861; Marshall R, 2011, PLANT PHYSIOL, V156, P756, DOI 10.1104/pp.111.176347; McCormick SP, 1999, APPL ENVIRON MICROB, V65, P5252; McCormick SP, 2002, APPL ENVIRON MICROB, V68, P2959, DOI 10.1128/AEM.68.6.2959-2964.2002; Menard R, 1997, NATURE, V385, P336, DOI 10.1038/385336a0; Motteram J, 2009, MOL PLANT MICROBE IN, V22, P790, DOI 10.1094/MPMI-22-7-0790; Muller O, 2008, MOL GENET GENOMICS, V279, P27, DOI 10.1007/s00438-007-0291-4; O Croinin T, 2006, MOL MICROBIOL, V62, P869, DOI 10.1111/j.1365-2958.2006.05416.x; Paper JM, 2007, PROTEOMICS, V7, P3171, DOI 10.1002/pmic.200700184; PARRY DW, 1995, PLANT PATHOL, V44, P207, DOI 10.1111/j.1365-3059.1995.tb02773.x; Pazzagli L, 1999, J BIOL CHEM, V274, P24959, DOI 10.1074/jbc.274.35.24959; PROCTOR RH, 1995, APPL ENVIRON MICROB, V61, P1923, DOI 10.1128/AEM.61.5.1923-1930.1995; PROCTOR RH, 1995, MOL PLANT MICROBE IN, V8, P593, DOI 10.1094/MPMI-8-0593; Qutob D, 2002, PLANT J, V32, P361, DOI 10.1046/j.1365-313X.2002.01439.x; Ridout CJ, 2006, PLANT CELL, V18, P2402, DOI 10.1105/tpc.106.043307; Rudd JJ, 2010, FUNGAL GENET BIOL, V47, P19, DOI 10.1016/j.fgb.2009.10.009; Sels J, 2008, PLANT PHYSIOL BIOCH, V46, P941, DOI 10.1016/j.plaphy.2008.06.011; Skibbe DS, 2010, SCIENCE, V328, P89, DOI 10.1126/science.1185775; Soanes DM, 2007, PLANT CELL, V19, P3318, DOI 10.1105/tpc.107.056663; Spanu PD, 2010, SCIENCE, V330, P1543, DOI 10.1126/science.1194573; Stergiopoulos I, 2009, ANNU REV PHYTOPATHOL, V47, P233, DOI 10.1146/annurev.phyto.112408.132637; Takahashi-Ando N, 2004, APPL ENVIRON MICROB, V70, P3239, DOI 10.1128/AEM.70.6.3239-3245.2004; Takahashi-Ando N, 2002, BIOCHEM J, V365, P1, DOI 10.1042/BJ20020450; Tan KC, 2010, FUNCT PLANT BIOL, V37, P907, DOI 10.1071/FP10067; Tyler BM, 2009, CELL MICROBIOL, V11, P13, DOI 10.1111/j.1462-5822.2008.01240.x; UENO Y, 1984, FUND APPL TOXICOL, V4, pS124, DOI 10.1016/0272-0590(84)90144-1; Valent B, 2010, CURR OPIN PLANT BIOL, V13, P434, DOI 10.1016/j.pbi.2010.04.012; van Esse HP, 2007, MOL PLANT MICROBE IN, V20, P1092, DOI 10.1094/MPMI-20-9-1092; Verstrepen KJ, 2005, NAT GENET, V37, P986, DOI 10.1038/ng1618; Voigt CA, 2005, PLANT J, V42, P364, DOI 10.1111/j.1365-313X.2005.02377.x; Wong P, 2011, NUCLEIC ACIDS RES, V39, pD637, DOI 10.1093/nar/gkq1016; Xu JR, 2000, FUNGAL GENET BIOL, V31, P137, DOI 10.1006/fgbi.2000.1237; Xue CY, 2002, PLANT CELL, V14, P2107, DOI 10.1105/tpc.003426	83	134	139	2	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2012	7	4							e33731	10.1371/journal.pone.0033731	http://dx.doi.org/10.1371/journal.pone.0033731			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JA	22493673	Green Published, Green Submitted, gold			2022-12-27	WOS:000305012700015
J	Loetscher, Y; Wieser, A; Lengefeld, J; Kaiser, P; Schubert, S; Heikenwalder, M; Hardt, WD; Stecher, B				Loetscher, Yvonne; Wieser, Andreas; Lengefeld, Jette; Kaiser, Patrick; Schubert, Soeren; Heikenwalder, Mathias; Hardt, Wolf-Dietrich; Stecher, Baerbel			Salmonella Transiently Reside in Luminal Neutrophils in the Inflamed Gut	PLOS ONE			English	Article							SEROVAR TYPHIMURIUM COLITIS; GREEN FLUORESCENT PROTEIN; IDENTIFICATION; RESISTANCE; MICROBIOTA; PATHOLOGY; DISRUPTS; PROVIDES; DISEASE; TRACT	Background: Enteric pathogens need to grow efficiently in the gut lumen in order to cause disease and ensure transmission. The interior of the gut forms a complex environment comprising the mucosal surface area and the inner gut lumen with epithelial cell debris and food particles. Recruitment of neutrophils to the intestinal lumen is a hallmark of non-typhoidal Salmonella enterica infections in humans. Here, we analyzed the interaction of gut luminal neutrophils with S. enterica serovar Typhimurium (S. Tm) in a mouse colitis model. Results: Upon S. Tm-wt infection, neutrophils transmigrate across the mucosa into the intestinal lumen. We detected a majority of pathogens associated with luminal neutrophils 20 hours after infection. Neutrophils are viable and actively engulf S. Tm, as demonstrated by live microscopy. Using S. Tm mutant strains defective in tissue invasion we show that pathogens are mostly taken up in the gut lumen at the epithelial barrier by luminal neutrophils. In these luminal neutrophils, S. Tm induces expression of genes typically required for its intracellular lifestyle such as siderophore production iroBCDE and the Salmonella pathogenicity island 2 encoded type three secretion system (TTSS-2). This shows that S. Tm at least transiently survives and responds to engulfment by gut luminal neutrophils. Gentamicin protection experiments suggest that the life-span of luminal neutrophils is limited and that S. Tm is subsequently released into the gut lumen. This "fast cycling" through the intracellular compartment of gut luminal neutrophils would explain the high fraction of TTSS-2 and iroBCDE expressing intra- and extracellular bacteria in the lumen of the infected gut. Conclusion: In conclusion, live neutrophils recruited during acute S. Tm colitis engulf pathogens in the gut lumen and may thus actively engage in shaping the environment of pathogens and commensals in the inflamed gut.	[Loetscher, Yvonne; Lengefeld, Jette; Kaiser, Patrick; Hardt, Wolf-Dietrich; Stecher, Baerbel] ETH, Inst Microbiol, CH-8092 Zurich, Switzerland; [Wieser, Andreas; Schubert, Soeren; Stecher, Baerbel] Univ Munich, Max Von Pettenkofer Inst, Munich, Germany; [Heikenwalder, Mathias] Tech Univ Munich, Helmholtz Ctr Munich, Inst Virol, Munich, Germany	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich	Loetscher, Y (corresponding author), ETH, Inst Agr Sci, Zurich, Switzerland.	stecher@mvp.uni-muenchen.de	Heikenwalder, Mathias/AAA-2269-2020; Stecher, Barbel/B-9940-2019; Stecher, Bärbel/A-2911-2015	Stecher, Bärbel/0000-0002-7445-5193; Hardt, Wolf-Dietrich/0000-0002-9892-6420; Lengfeld, Jette/0000-0001-6021-7613	UBS AG (Zurich); Swiss National Science Foundation (SNF) [310030-132997/1]; 17 DFG [STE 1971/2-1]	UBS AG (Zurich); Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF)); 17 DFG(German Research Foundation (DFG))	This work was supported by the UBS AG (Zurich) on behalf of a customer 16 (WDH), the Swiss National Science Foundation (SNF, 310030-132997/1 to WDH) and the 17 DFG (STE 1971/2-1 to BS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachman MA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000622; Barman M, 2008, INFECT IMMUN, V76, P907, DOI 10.1128/IAI.01432-07; Barthel M, 2003, INFECT IMMUN, V71, P2839, DOI 10.1128/IAI.71.5.2839-2858.2003; Baumler AJ, 1996, GENE, V183, P207, DOI 10.1016/S0378-1119(96)00560-4; Bongaerts RJM, 2002, METHOD ENZYMOL, V358, P43; BOYD JF, 1985, GUT, V26, P935, DOI 10.1136/gut.26.9.935; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; DAY DW, 1978, HISTOPATHOLOGY, V2, P117, DOI 10.1111/j.1365-2559.1978.tb01700.x; Faust N, 2000, BLOOD, V96, P719; Geddes K, 2007, PLOS PATHOG, V3, P2017, DOI 10.1371/journal.ppat.0030196; Hapfelmeier S, 2005, J IMMUNOL, V174, P1675, DOI 10.4049/jimmunol.174.3.1675; Hapfelmeier S, 2004, INFECT IMMUN, V72, P795, DOI 10.1128/IAI.72.2.795-809.2004; HAPFELMEIER S, 2005, TRENDS MICROBIOL; HOISETH SK, 1981, NATURE, V291, P238, DOI 10.1038/291238a0; JONES PW, 1988, VET REC, V123, P536, DOI 10.1136/vr.123.21.536; KJELDSEN L, 1994, BLOOD, V83, P799; LAWLEY TD, 2009, INFECT IMMUN; Luo Y, 1997, CURRENT PROTOCOLS IM, P32021; Lupp C, 2007, CELL HOST MICROBE, V2, P119, DOI 10.1016/j.chom.2007.06.010; MCGOVERN VJ, 1979, AM J SURG PATHOL, V3, P483, DOI 10.1097/00000478-197912000-00001; Pillay J, 2010, BLOOD, V116, P625, DOI 10.1182/blood-2010-01-259028; Raffatellu M, 2009, CELL HOST MICROBE, V5, P476, DOI 10.1016/j.chom.2009.03.011; Rollenhagen C, 2006, INFECT IMMUN, V74, P1649, DOI 10.1128/IAI.74.3.1649-1660.2006; SACHDEV HPS, 1993, J PEDIATR GASTR NUTR, V16, P33, DOI 10.1097/00005176-199301000-00006; Santos RL, 2009, TRENDS MICROBIOL, V17, P498, DOI 10.1016/j.tim.2009.08.008; Santos RL, 2001, MICROBES INFECT, V3, P1335, DOI 10.1016/S1286-4579(01)01495-2; Segal AW, 2005, ANNU REV IMMUNOL, V23, P197, DOI 10.1146/annurev.immunol.23.021704.115653; Sekirov I, 2010, GUT MICROBES, V1, P30, DOI 10.4161/gmic.1.1.10950; Stecher B, 2004, INFECT IMMUN, V72, P4138, DOI 10.1128/IAI.72.7.4138-4150.2004; Stecher B, 2010, CURR OPIN MICROBIOL; Stecher B, 2008, TRENDS MICROBIOL, V16, P107, DOI 10.1016/j.tim.2007.12.008; Stecher B, 2008, CELL MICROBIOL, V10, P1166, DOI 10.1111/j.1462-5822.2008.01118.x; Stecher B, 2007, PLOS BIOL, V5, P2177, DOI 10.1371/journal.pbio.0050244; Stecher B, 2006, INFECT IMMUN, V74, P5047, DOI 10.1128/IAI.00072-06; Stelter C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020749; Taylor CM, 2009, MICROB PATHOGENESIS, V46, P114, DOI 10.1016/j.micpath.2008.11.001; VANDERWAAIJ D, 1971, J HYG-CAMB, V69, P405, DOI 10.1017/S0022172400021653; Vijay-Kumar M, 2006, AM J PATHOL, V169, P1686, DOI 10.2353/ajpath.2006.060345; Wieser A, 2011, CELL MICROBIOL, V13, P742, DOI 10.1111/j.1462-5822.2011.01573.x; Winter SE, 2010, NATURE, V467, P426, DOI 10.1038/nature09415	40	43	43	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2012	7	4							e34812	10.1371/journal.pone.0034812	http://dx.doi.org/10.1371/journal.pone.0034812			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JA	22493718	gold, Green Published, Green Submitted			2022-12-27	WOS:000305012700060
J	Pritchard, L; Holden, NJ; Bielaszewska, M; Karch, H; Toth, IK				Pritchard, Leighton; Holden, Nicola J.; Bielaszewska, Martina; Karch, Helge; Toth, Ian K.			Alignment-Free Design of Highly Discriminatory Diagnostic Primer Sets for Escherichia coli O104:H4 Outbreak Strains	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; PCR; IDENTIFICATION; PATHOGENS	Background:An Escherichia coli O104:H4 outbreak in Germany in summer 2011 caused 53 deaths, over 4000 individual infections across Europe, and considerable economic, social and political impact. This outbreak was the first in a position to exploit rapid, benchtop high-throughput sequencing (HTS) technologies and crowdsourced data analysis early in its investigation, establishing a new paradigm for rapid response to disease threats. We describe a novel strategy for design of diagnostic PCR primers that exploited this rapid draft bacterial genome sequencing to distinguish between E. coli O104:H4 outbreak isolates and other pathogenic E. coli isolates, including the historical haemolytic uraemic syndrome (HUSEC) E. coli HUSEC041 O104:H4 strain, which possesses the same serotype as the outbreak isolates. Methodology/Principal Findings: Primers were designed using a novel alignment-free strategy against eleven draft whole genome assemblies of E. coli O104:H4 German outbreak isolates from the E. coli O104:H4 Genome Analysis Crowd-Sourcing Consortium website, and a negative sequence set containing 69 E. coli chromosome and plasmid sequences from public databases. Validation in vitro against 21 'positive' E. coli O104:H4 outbreak and 32 'negative' non-outbreak EHEC isolates indicated that individual primer sets exhibited 100% sensitivity for outbreak isolates, with false positive rates of between 9% and 22%. A minimal combination of two primers discriminated between outbreak and non-outbreak E. coli isolates with 100% sensitivity and 100% specificity. Conclusions/Significance: Draft genomes of isolates of disease outbreak bacteria enable high throughput primer design and enhanced diagnostic performance in comparison to traditional molecular assays. Future outbreak investigations will be able to harness HTS rapidly to generate draft genome sequences and diagnostic primer sets, greatly facilitating epidemiology and clinical diagnostics. We expect that high throughput primer design strategies will enable faster, more precise responses to future disease outbreaks of bacterial origin, and help to mitigate their societal impact.	[Pritchard, Leighton; Holden, Nicola J.; Toth, Ian K.] James Hutton Inst, Dundee, Scotland; [Bielaszewska, Martina; Karch, Helge] Univ Munster, Inst Hyg, Munster, Germany; [Bielaszewska, Martina; Karch, Helge] Univ Munster, Natl Consulting Lab Haemolyt Uraem Syndrome, Munster, Germany	James Hutton Institute; University of Munster; University of Munster	Pritchard, L (corresponding author), James Hutton Inst, Dundee, Scotland.	leighton.pritchard@hutton.ac.uk	Pritchard, Leighton/A-7331-2008; Holden, Nicola/B-3038-2009; Holden, Nicola/L-1653-2019; Bielaszewska, Martina/AAC-9812-2022	Pritchard, Leighton/0000-0002-8392-2822; Holden, Nicola/0000-0002-7904-4529; Holden, Nicola/0000-0002-7904-4529; 	Scottish Government Rural and Environment Science and Analytical Services Division (RESAS)	Scottish Government Rural and Environment Science and Analytical Services Division (RESAS)	This work was supported by the Scottish Government Rural and Environment Science and Analytical Services Division (RESAS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; [Anonymous], NCBI BACT GEN SEQ FT; [Anonymous], NCBI REFSEQ DAT NCBI; [Anonymous], E COL O104 PCR PRIM; [Anonymous], E COL O104 H4 GEN AN; Bielaszewska M, 2011, LANCET INFECT DIS, V11, P671, DOI 10.1016/S1473-3099(11)70165-7; Campagna D, 2009, BIOINFORMATICS, V25, P967, DOI 10.1093/bioinformatics/btp087; Cheung Man Kit, 2011, BMC Res Notes, V4, P533, DOI 10.1186/1756-0500-4-533; Grisham MP, 2007, PLANT DIS, V91, P430, DOI 10.1094/PDIS-91-4-0430; Gurtler V, 2001, INT J SYST EVOL MICR, V51, P3; Ho CC, 2011, J CLIN MICROBIOL, V49, P3714, DOI 10.1128/JCM.05062-11; Holden N, 2009, FEMS MICROBIOL REV, V33, P689, DOI 10.1111/j.1574-6976.2008.00153.x; Homer N, 2009, PLOS ONE, V4, pA95, DOI 10.1371/journal.pone.0007767; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Lindstedt BA, 2003, J CLIN MICROBIOL, V41, P1469, DOI 10.1128/JCM.41.4.1469-1479.2003; Maiden MCJ, 2006, ANNU REV MICROBIOL, V60, P561, DOI 10.1146/annurev.micro.59.030804.121325; Mellmann A, 2008, EMERG INFECT DIS, V14, P1287, DOI 10.3201/eid1408.071082; Mellmann A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022751; *NCBI, NCBI REF SEQ REFSEQ; Pallen MJ, 2007, NATURE, V449, P835, DOI 10.1038/nature06248; Phillippy AM, 2007, PLOS COMPUT BIOL, V3, P887, DOI 10.1371/journal.pcbi.0030098; Phillippy AM, 2009, NUCLEIC ACIDS RES, V37, pW229, DOI 10.1093/nar/gkp286; Rasko DA, 2011, NEW ENGL J MED, V365, P709, DOI 10.1056/NEJMoa1106920; Reinhardt JA, 2009, GENOME RES, V19, P294, DOI 10.1101/gr.083311.108; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rohde H, 2011, NEW ENGL J MED, V365, P718, DOI 10.1056/NEJMoa1107643; Rozen S, 2000, Methods Mol Biol, V132, P365; Satya RV, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-340; Satya RV, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-496; Schaad N, 2007, PLANT PATHOL; Schaad NW, 2002, PHYTOPATHOLOGY, V92, P721, DOI 10.1094/PHYTO.2002.92.7.721; Slezak Tom, 2003, Briefings in Bioinformatics, V4, P133, DOI 10.1093/bib/4.2.133; Tibayrenc M, 2009, METHODS MOL BIOL, V551, P13, DOI 10.1007/978-1-60327-999-4_2; Toth IK, 2006, ANNU REV PHYTOPATHOL, V44, P305, DOI 10.1146/annurev.phyto.44.070505.143444; Tsen HY, 1998, J APPL MICROBIOL, V84, P585, DOI 10.1046/j.1365-2672.1998.00385.x; Zhang DD, 2010, J FOOD SAFETY, V30, P832, DOI 10.1111/j.1745-4565.2010.00245.x; Zhu DS, 2009, J RAPID METH AUT MIC, V17, P67, DOI 10.1111/j.1745-4581.2009.00158.x	38	30	31	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2012	7	4							e34498	10.1371/journal.pone.0034498	http://dx.doi.org/10.1371/journal.pone.0034498			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955IH	22496820	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000305010500014
J	Maddox, SM; Coburn, PS; Shankar, N; Conway, T				Maddox, Scott M.; Coburn, Phillip S.; Shankar, Nathan; Conway, Tyrrell			Transcriptional Regulator PerA Influences Biofilm-Associated, Platelet Binding, and Metabolic Gene Expression in Enterococcus faecalis	PLOS ONE			English	Article							BIOSYNTHESIS-ACTIVATING PHEROMONE; SURFACE PROTEIN; AGGREGATION SUBSTANCE; STAPHYLOCOCCUS-AUREUS; PATHOGENICITY ISLAND; STREPTOCOCCUS-MITIS; SERINE-PROTEASE; PILUS LOCUS; VIRULENCE; ENDOCARDITIS	Enterococcus faecalis is an opportunistic pathogen and a leading cause of nosocomial infections, traits facilitated by the ability to quickly acquire and transfer virulence determinants. A 150 kb pathogenicity island (PAI) comprised of genes contributing to virulence is found in many enterococcal isolates and is known to undergo horizontal transfer. We have shown that the PAI-encoded transcriptional regulator PerA contributes to pathogenicity in the mouse peritonitis infection model. In this study, we used whole-genome microarrays to determine the PerA regulon. The PerA regulon is extensive, as transcriptional analysis showed 151 differentially regulated genes. Our findings reveal that PerA coordinately regulates genes important for metabolism, amino acid degradation, and pathogenicity. Further transcriptional analysis revealed that PerA is influenced by bicarbonate. Additionally, PerA influences the ability of E. faecalis to bind to human platelets. Our results suggest that PerA is a global transcriptional regulator that coordinately regulates genes responsible for enterococcal pathogenicity.	[Maddox, Scott M.; Conway, Tyrrell] Univ Oklahoma, Adv Ctr Genome Technol, Norman, OK 73019 USA; [Coburn, Phillip S.; Shankar, Nathan] Univ Oklahoma, Hlth Sci Ctr, Dept Pharmaceut Sci, Oklahoma City, OK USA	University of Oklahoma System; University of Oklahoma - Norman; University of Oklahoma System; University of Oklahoma Health Sciences Center	Maddox, SM (corresponding author), Univ Oklahoma, Adv Ctr Genome Technol, Norman, OK 73019 USA.	nathan-shankar@ouhsc.edu	Coburn, Phillip/V-6698-2019	Coburn, Phillip/0000-0003-3799-5251	National Institutes of Health [AI48945, GM095370]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI048945, R56AI048945] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095370] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants AI48945 and GM095370 from the National Institutes of Health (nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2002, INFECT IMMUN, V70, P3500, DOI 10.1128/IAI.70.7.3500-3509.2002; Abe H, 2008, DNA RES, V15, P25, DOI 10.1093/dnares/dsm033; Abuaita BH, 2009, INFECT IMMUN, V77, P4111, DOI 10.1128/IAI.00409-09; Allen A, 2005, AM J PHYSIOL-CELL PH, V288, pC1, DOI 10.1152/ajpcell.00102.2004; Baldassarri L, 2005, J INFECT DIS, V191, P1253, DOI 10.1086/428778; Barcelona-Andres B, 2002, J BACTERIOL, V184, P6289, DOI 10.1128/JB.184.22.6289-6300.2002; Bensing BA, 2001, INFECT IMMUN, V69, P1373, DOI 10.1128/IAI.69.3.1373-1380.2001; Booth MC, 1996, MOL MICROBIOL, V21, P1175, DOI 10.1046/j.1365-2958.1996.831449.x; Bourgogne A, 2006, J BACTERIOL, V188, P2875, DOI 10.1128/JB.188.8.2875-2884.2006; Bourgogne A, 2007, J BACTERIOL, V189, P6490, DOI 10.1128/JB.00594-07; Bourgogne A, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-17; Bustamante VH, 2008, P NATL ACAD SCI USA, V105, P14591, DOI 10.1073/pnas.0801205105; Chaussee MS, 2003, J BACTERIOL, V185, P6016, DOI 10.1128/JB.185.20.6016-6024.2003; CHOW JW, 1993, ANTIMICROB AGENTS CH, V37, P2474, DOI 10.1128/AAC.37.11.2474; Coburn PS, 2008, INFECT IMMUN, V76, P5668, DOI 10.1128/IAI.00930-08; Coburn PS, 2007, MOL MICROBIOL, V63, P530, DOI 10.1111/j.1365-2958.2006.05520.x; Coburn PS, 2010, PLASMID, V64, P18, DOI 10.1016/j.plasmid.2010.03.001; Coburn PS, 2004, SCIENCE, V306, P2270, DOI 10.1126/science.1103996; Coburn PS, 2003, CELL MICROBIOL, V5, P661, DOI 10.1046/j.1462-5822.2003.00310.x; Condon C, 2010, RNA BIOL, V7, P316, DOI 10.4161/rna.7.3.11913; COQUE TM, 1995, J INFECT DIS, V171, P1223, DOI 10.1093/infdis/171.5.1223; COSTERTON JW, 1987, ANNU REV MICROBIOL, V41, P435, DOI 10.1146/annurev.mi.41.100187.002251; CUNIN R, 1986, MICROBIOL REV, V50, P314, DOI 10.1128/MMBR.50.3.314-352.1986; Detmers FJM, 2001, RES MICROBIOL, V152, P245, DOI 10.1016/S0923-2508(01)01196-2; DURACK DT, 1975, J PATHOL, V115, P81, DOI 10.1002/path.1711150204; Edmond MB, 1999, CLIN INFECT DIS, V29, P239, DOI 10.1086/520192; Even S, 2005, NUCLEIC ACIDS RES, V33, P2141, DOI 10.1093/nar/gki505; Fitzgerald JR, 2006, NAT REV MICROBIOL, V4, P445, DOI 10.1038/nrmicro1425; Gallegos MT, 1997, MICROBIOL MOL BIOL R, V61, P393, DOI 10.1128/.61.4.393-410.1997; Gao P, 2010, J BACTERIOL, V192, P5489, DOI 10.1128/JB.00725-10; Garsin DA, 2001, P NATL ACAD SCI USA, V98, P10892, DOI 10.1073/pnas.191378698; GILMORE MS, 1994, J BACTERIOL, V176, P7335, DOI 10.1128/JB.176.23.7335-7344.1994; Griffith KL, 2002, J MOL BIOL, V322, P237, DOI 10.1016/S0022-2836(02)00782-9; HACKER J, 1983, J BACTERIOL, V154, P1145, DOI 10.1128/JB.154.3.1145-1152.1983; Hacker J, 2000, ANNU REV MICROBIOL, V54, P641, DOI 10.1146/annurev.micro.54.1.641; Hancock LE, 2004, J BACTERIOL, V186, P5629, DOI 10.1128/JB.186.17.5629-5639.2004; Hegstad K, 2010, CLIN MICROBIOL INFEC, V16, P541, DOI 10.1111/j.1469-0691.2010.03226.x; Hidalgo E, 1998, EMBO J, V17, P2629, DOI 10.1093/emboj/17.9.2629; Hills GM, 1940, BIOCHEM J, V34, P1057, DOI 10.1042/bj0341057; IKE Y, 1984, INFECT IMMUN, V45, P528, DOI 10.1128/IAI.45.2.528-530.1984; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kaunitz JD, 2006, ALIMENT PHARM THER, V24, P169, DOI 10.1111/j1365-2036.2006.00041.x; KREFT B, 1992, INFECT IMMUN, V60, P25, DOI 10.1128/IAI.60.1.25-30.1992; LOW D, 1984, INFECT IMMUN, V43, P353, DOI 10.1128/IAI.43.1.353-358.1984; Maccallum W G, 1899, J Exp Med, V4, P521, DOI 10.1084/jem.4.5-6.521; Mace C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003897; Mathy N, 2007, CELL, V129, P681, DOI 10.1016/j.cell.2007.02.051; McBride SM, 2009, J BACTERIOL, P00031; MEGRAN DW, 1992, CLIN INFECT DIS, V15, P63, DOI 10.1093/clinids/15.1.63; Mitchell J, 2007, MOL MICROBIOL, V64, P844, DOI 10.1111/j.1365-2958.2007.05703.x; Mohamed JA, 2007, J MED MICROBIOL, V56, P1581, DOI 10.1099/jmm.0.47331-0; MORISHITA T, 1981, J BACTERIOL, V148, P64, DOI 10.1128/JB.148.1.64-71.1981; Nakayama J, 2001, MOL MICROBIOL, V41, P145, DOI 10.1046/j.1365-2958.2001.02486.x; Nakayama J, 2006, J BACTERIOL, V188, P8321, DOI 10.1128/JB.00865-06; Nallapareddy SR, 2006, J CLIN INVEST, V116, P2799, DOI 10.1172/JCI29021; Nallapareddy SR, 2011, INFECT IMMUN, V79, P2911, DOI 10.1128/IAI.00039-11; OLMSTED SB, 1991, J BACTERIOL, V173, P7665, DOI 10.1128/jb.173.23.7665-7672.1991; OLMSTED SB, 1994, J INFECT DIS, V170, P1549, DOI 10.1093/infdis/170.6.1549; Palmer KL, 2010, MBIO, V1, DOI 10.1128/mBio.00227-10; Palmer KL, 2010, CURR OPIN MICROBIOL, V13, P632, DOI 10.1016/j.mib.2010.08.004; Paulsen IT, 2003, SCIENCE, V299, P2071, DOI 10.1126/science.1080613; Qin X, 2000, INFECT IMMUN, V68, P2579, DOI 10.1128/IAI.68.5.2579-2586.2000; Qin X, 2001, J BACTERIOL, V183, P3372, DOI 10.1128/JB.183.11.3372-3382.2001; Rasmussen M, 2010, MICROBES INFECT, V12, P295, DOI 10.1016/j.micinf.2010.01.005; Riboulet-Bisson E, 2008, INFECT IMMUN, V76, P3064, DOI 10.1128/IAI.00161-08; Richards MJ, 2000, INFECT CONT HOSP EP, V21, P510, DOI 10.1086/501795; Seo HS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001047; Shankar N, 2002, NATURE, V417, P746, DOI 10.1038/nature00802; Shankar N, 2001, INFECT IMMUN, V69, P4366, DOI 10.1128/IAI.69.7.4366-4372.2001; Shankar V, 1999, INFECT IMMUN, V67, P193, DOI 10.1128/IAI.67.1.193-200.1999; Shepard BD, 2002, INFECT IMMUN, V70, P4344, DOI 10.1128/IAI.70.8.4344-4352.2002; Singh KV, 2007, J INFECT DIS, V195, P1671, DOI 10.1086/517524; SLADE HD, 1952, J BACTERIOL, V64, P455, DOI 10.1128/JB.64.4.455-466.1952; Sullam PM, 1996, INFECT IMMUN, V64, P4915, DOI 10.1128/IAI.64.12.4915-4921.1996; Sussmuth SD, 2000, INFECT IMMUN, V68, P4900; Tendolkar PM, 2006, J BACTERIOL, V188, P2063, DOI 10.1128/JB.188.6.2063-2072.2006; Tendolkar PM, 2004, INFECT IMMUN, V72, P6032, DOI 10.1128/IAI.72.10.6032-6039.2004; Toledo-Arana A, 2001, APPL ENVIRON MICROB, V67, P4538, DOI 10.1128/AEM.67.10.4538-4545.2001; Traxler MF, 2008, MOL MICROBIOL, V68, P1128, DOI 10.1111/j.1365-2958.2008.06229.x; van Schaik W, 2010, CLIN MICROBIOL INFEC, V16, P527, DOI 10.1111/j.1469-0691.2010.03201.x; Waters CM, 2001, J BACTERIOL, V183, P5659, DOI 10.1128/JB.183.19.5659-5667.2001; Wren JD, 2006, OMICS, V10, P15, DOI 10.1089/omi.2006.10.15; Yang J, 2008, MOL MICROBIOL, V68, P314, DOI 10.1111/j.1365-2958.2008.06171.x; Yasmin A, 2010, J BACTERIOL, V192, P1122, DOI 10.1128/JB.01293-09; Zhu Y, 2007, INFECT IMMUN, V75, P4219, DOI 10.1128/IAI.00509-07	85	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e34398	10.1371/journal.pone.0034398	http://dx.doi.org/10.1371/journal.pone.0034398			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GO	22496800	Green Published, gold, Green Submitted			2022-12-27	WOS:000304855200047
J	Ribas, VT; Goncalves, BS; Linden, R; Chiarini, LB				Ribas, Vinicius Toledo; Goncalves, Bruno Souza; Linden, Rafael; Chiarini, Luciana Barreto			Activation of c-Jun N-Terminal Kinase (JNK) during Mitosis in Retinal Progenitor Cells	PLOS ONE			English	Article							PROTEIN-KINASE; NH2-TERMINAL KINASE; INHIBITOR SP600125; CYCLE PROGRESSION; NERVOUS-SYSTEM; GANGLION-CELL; NEURAL-TUBE; PHOSPHORYLATION; APOPTOSIS; PROLIFERATION	Most studies of c-Jun N-terminal Kinase (JNK) activation in retinal tissue were done in the context of neurodegeneration. In this study, we investigated the behavior of JNK during mitosis of progenitor cells in the retina of newborn rats. Retinal explants from newborn rats were kept in vitro for 3 hours and under distinct treatments. Sections of retinal explants or freshly fixed retinal tissue were used to detect JNK phosphorylation by immunohistochemistry, and were examined through both fluorescence and confocal microscopy. Mitotic cells were identified by chromatin morphology, histone-H3 phosphorylation, and location in the retinal tissue. The subcellular localization of proteins was analyzed by double staining with both a DNA marker and an antibody to each protein. Phosphorylation of JNK was also examined by western blot. The results showed that in the retina of newborn rats (P1), JNK is phosphorylated during mitosis of progenitor cells, mainly during the early stages of mitosis. JNK1 and/or JNK2 were preferentially phosphorylated in mitotic cells. Inhibition of JNK induced cell cycle arrest, specifically in mitosis. Treatment with the JNK inhibitor decreased the number of cells in anaphase, but did not alter the number of cells in either prophase/prometaphase or metaphase. Moreover, cells with aberrant chromatin morphology were found after treatment with the JNK inhibitor. The data show, for the first time, that JNK is activated in mitotic progenitor cells of developing retinal tissue, suggesting a new role of JNK in the control of progenitor cell proliferation in the retina.	[Ribas, Vinicius Toledo; Goncalves, Bruno Souza; Linden, Rafael; Chiarini, Luciana Barreto] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Rio de Janeiro, Brazil	Universidade Federal do Rio de Janeiro	Ribas, VT (corresponding author), Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Rio de Janeiro, Brazil.	chiarini@biof.ufrj.br	de Toledo Ribas, Vinicius/I-5780-2014; Ribas, Vinicius/ABG-2706-2020; Linden, Rafael/F-2275-2011; Chiarini, Luciana B/J-3644-2015; de Toledo Ribas, Vinicius/AAX-8713-2021	de Toledo Ribas, Vinicius/0000-0001-8161-786X; Ribas, Vinicius/0000-0001-8161-786X; Linden, Rafael/0000-0003-3287-336X; de Toledo Ribas, Vinicius/0000-0001-8161-786X	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ); Programa de Apoio a Nucleos de Excelencia-Rio (PRONEX-Rio); Pensa Rio	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Programa de Apoio a Nucleos de Excelencia-Rio (PRONEX-Rio); Pensa Rio	This study was supported by grants from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq - www.cnpq.br), Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ - www.faperj.br), Programa de Apoio a Nucleos de Excelencia-Rio (PRONEX-Rio), and Pensa Rio. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler R, 2000, PROG RETIN EYE RES, V19, P529, DOI 10.1016/S1350-9462(00)00008-2; Araujo Elizabeth Giestal De, 1993, European Journal of Neuroscience, V5, P1181, DOI 10.1111/j.1460-9568.1993.tb00972.x; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Bode AM, 2007, MOL CARCINOGEN, V46, P591, DOI 10.1002/mc.20348; Campos CBL, 2002, NEUROSCIENCE, V112, P583, DOI 10.1016/S0306-4522(02)00096-9; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Chang LF, 2003, DEV CELL, V4, P521, DOI 10.1016/S1534-5807(03)00094-7; Chen X, 2010, NEUROSCIENCE, V165, P705, DOI 10.1016/j.neuroscience.2009.11.007; Chuang JY, 2008, MOL BIOL CELL, V19, P1139, DOI 10.1091/mbc.E07-09-0881; Crocker SJ, 2006, J NEUROCHEM, V96, P489, DOI 10.1111/j.1471-4159.2005.03568.x; DEBRABANDER M, 1981, CELL BIOL INT REP, V5, P913, DOI 10.1016/0309-1651(81)90206-X; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; Du LH, 2004, J BIOL CHEM, V279, P11957, DOI 10.1074/jbc.M304935200; Giasson BI, 1997, J NEUROSCI, V17, P9466; Go HS, 2009, NEUROIMMUNOMODULAT, V16, P365, DOI 10.1159/000228911; Goss VL, 2003, CELL SIGNAL, V15, P709, DOI 10.1016/S0898-6568(03)00009-3; Gupta S, 1996, EMBO J, V15, P2760, DOI 10.1002/j.1460-2075.1996.tb00636.x; Gutierrez GJ, 2010, NAT CELL BIOL, V12, P686, DOI 10.1038/ncb2071; Gutierrez GJ, 2010, J BIOL CHEM, V285, P14217, DOI 10.1074/jbc.M110.121848; Hayes NL, 2000, DEV NEUROSCI-BASEL, V22, P44, DOI 10.1159/000017426; Hendzel MJ, 1997, CHROMOSOMA, V106, P348, DOI 10.1007/s004120050256; Hess P, 2002, NAT GENET, V32, P201, DOI 10.1038/ng946; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Hunot S, 2004, P NATL ACAD SCI USA, V101, P665, DOI 10.1073/pnas.0307453101; Kallunki T, 1996, CELL, V87, P929, DOI 10.1016/S0092-8674(00)81999-6; KALLUNKI T, 1994, GENE DEV, V8, P2996, DOI 10.1101/gad.8.24.2996; Kennedy NJ, 2003, CELL CYCLE, V2, P199, DOI 10.4161/cc.2.3.388; Kuan CY, 2003, P NATL ACAD SCI USA, V100, P15184, DOI 10.1073/pnas.2336254100; Kuan CY, 1999, NEURON, V22, P667, DOI 10.1016/S0896-6273(00)80727-8; Kuntzen C, 2005, CANCER RES, V65, P6780, DOI 10.1158/0008-5472.CAN-04-2618; Kwong JMK, 2006, EXP EYE RES, V82, P576, DOI 10.1016/j.exer.2005.08.017; KYRIAKIS JM, 1994, NATURE, V369, P156, DOI 10.1038/369156a0; Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807; Kyriakis JM, 1996, J BIOL CHEM, V271, P24313, DOI 10.1074/jbc.271.40.24313; Lee K, 2008, CELL CYCLE, V7, P216, DOI 10.4161/cc.7.2.5155; Levikocitch-Verbin H, 2007, EXP EYE RES, V85, P250; Linden R, 1999, PROG RETIN EYE RES, V18, P133, DOI 10.1016/S1350-9462(98)00020-2; MacCorkle RA, 2004, J BIOL CHEM, V279, P40112, DOI 10.1074/jbc.M405481200; Mielke K, 2000, PROG NEUROBIOL, V61, P45, DOI 10.1016/S0301-0082(99)00042-8; Mingo-Sion AM, 2004, ONCOGENE, V23, P596, DOI 10.1038/sj.onc.1207147; MOHIT AA, 1995, NEURON, V14, P67, DOI 10.1016/0896-6273(95)90241-4; Moon DO, 2009, EXP MOL MED, V41, P665, DOI 10.3858/emm.2009.41.9.073; Moon SW, 2009, BIOCHEM BIOPH RES CO, V388, P167, DOI 10.1016/j.bbrc.2009.07.144; Munemasa Y, 2005, BRAIN RES, V1044, P227, DOI 10.1016/j.brainres.2005.03.014; Nishina H, 2004, J BIOCHEM, V136, P123, DOI 10.1093/jb/mvh117; PERRY VH, 1983, J COMP NEUROL, V219, P356, DOI 10.1002/cne.902190309; Putcha GV, 2003, NEURON, V38, P899, DOI 10.1016/S0896-6273(03)00355-6; REESE BE, 1992, NEUROSCIENCE, V46, P419, DOI 10.1016/0306-4522(92)90062-7; Rehen SK, 1996, DEVELOPMENT, V122, P1439; Rehen SK, 1999, EUR J NEUROSCI, V11, P4349, DOI 10.1046/j.1460-9568.1999.00868.x; Ribas VT, 2011, NEUROSCIENCE, V180, P64, DOI 10.1016/j.neuroscience.2011.01.059; Ries V, 2008, J NEUROCHEM, V107, P1578, DOI 10.1111/j.1471-4159.2008.05713.x; Rusan NM, 2009, TRAFFIC, V10, P472, DOI 10.1111/j.1600-0854.2009.00880.x; Sabapathy K, 1999, MECH DEVELOP, V89, P115, DOI 10.1016/S0925-4773(99)00213-0; Sabapathy K, 2004, MOL CELL, V15, P713, DOI 10.1016/j.molcel.2004.08.028; Sakurai T, 2006, P NATL ACAD SCI USA, V103, P10544, DOI 10.1073/pnas.0603499103; Sauer FC, 1935, J COMP NEUROL, V62, P377, DOI 10.1002/cne.900620207; Tatebayashi Y, 2006, FASEB J, V20, P762, DOI 10.1096/fj.05-4362fje; Tezel G, 2004, BRAIN RES, V996, P202, DOI 10.1016/j.brainres.2003.10.029; Uhlirova M, 2005, P NATL ACAD SCI USA, V102, P13123, DOI 10.1073/pnas.0504170102; Wada T, 2004, NAT CELL BIOL, V6, P215, DOI 10.1038/ncb1098; Wang M, 2009, J PATHOL, V218, P95, DOI 10.1002/path.2521; Weston CR, 2004, P NATL ACAD SCI USA, V101, P14114, DOI 10.1073/pnas.0406061101; Yamamoto K, 1999, MOL CELL BIOL, V19, P8469; Yang DD, 1997, NATURE, V389, P865, DOI 10.1038/39899	65	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e34483	10.1371/journal.pone.0034483	http://dx.doi.org/10.1371/journal.pone.0034483			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GO	22496813	Green Published, Green Submitted, gold			2022-12-27	WOS:000304855200055
J	Flo, E; Pallesen, S; Mageroy, N; Moen, BE; Gronli, J; Nordhus, IH; Bjorvatn, B				Flo, Elisabeth; Pallesen, Stale; Mageroy, Nils; Moen, Bente Elisabeth; Gronli, Janne; Nordhus, Inger Hilde; Bjorvatn, Bjorn			Shift Work Disorder in Nurses - Assessment, Prevalence and Related Health Problems	PLOS ONE			English	Article							HOSPITAL ANXIETY; DEPRESSION SCALE; SLEEP DISORDERS; FATIGUE; POPULATION; VALIDATION	Background: This study investigates the prevalence of symptoms of shift work disorder in a sample of nurses, and its association to individual, health and work variables. Methodology/Principal Findings: We investigated three different shift work disorder assessment procedures all based on current diagnostic criteria and employing symptom based questions. Crude and adjusted logistic regression analyses were performed with symptoms of shift work disorder as the dependent variable. Participants (n=1968) reported age, gender, work schedule, commuting time, weekly work hours, children in household, number of nights and number of shifts separated by less than 11 hours worked the last year, use of bright light therapy, melatonin and sleep medication, and completed the Bergen Insomnia Scale, Epworth Sleepiness Scale, Global Sleep Assessment Questionnaire, Diurnal Scale, Revised Circadian Type Inventory, Dispositional Resilience (Hardiness) Scale - Revised, Fatigue Questionnaire, questions about alcohol and caffeine consumption, as well as the Hospital Anxiety and Depression Scale. Conclusions/Significance: Prevalence rates of symptoms of shift work disorder varied from 32.4-37.6% depending on the assessment method and from 4.8-44.3% depending on the work schedule. Associations were found between symptoms of shift work disorder and age, gender, circadian type, night work, number of shifts separated by less than 11 hours and number of nights worked the last year, insomnia and anxiety. The different assessment procedures yielded similar results (prevalence and logistic regression analyses). The prevalence of symptoms indicative of shift work disorder was high. We argue that three symptom-based questions used in the present study adequately assess shift work disorder in epidemiological studies.	[Flo, Elisabeth; Pallesen, Stale; Gronli, Janne; Nordhus, Inger Hilde; Bjorvatn, Bjorn] Haukeland Hosp, Norwegian Competence Ctr Sleep Disorders, N-5021 Bergen, Norway; [Flo, Elisabeth; Pallesen, Stale] Univ Bergen, Dept Psychosocial Sci, Bergen, Norway; [Mageroy, Nils] Uni Hlth, Occupat & Environm Med, Bergen, Norway; [Mageroy, Nils; Moen, Bente Elisabeth] Haukeland Hosp, Dept Occupat Med, N-5021 Bergen, Norway; [Moen, Bente Elisabeth; Bjorvatn, Bjorn] Univ Bergen, Dept Publ Hlth & Primary Hlth Care, Bergen, Norway; [Gronli, Janne] Univ Bergen, Dept Biol & Med Psychol, Bergen, Norway; [Nordhus, Inger Hilde] Univ Bergen, Dept Clin Psychol, Bergen, Norway	University of Bergen; Haukeland University Hospital; University of Bergen; University of Bergen; Haukeland University Hospital; University of Bergen; University of Bergen; University of Bergen	Flo, E (corresponding author), Haukeland Hosp, Norwegian Competence Ctr Sleep Disorders, N-5021 Bergen, Norway.	elisabeth.flo@psykp.uib.no	Moen, BE/P-9329-2017	Flo, Elisabeth/0000-0003-4312-3855	Western Norway Regional Health Authority [911386, 911540]; Norwegian Nurses Organisation	Western Norway Regional Health Authority; Norwegian Nurses Organisation	The project generating the data analyzed in the present study received a grant for practical administration and data collection from The Western Norway Regional Health Authority (no personal payment/salary). Grant number 911386. Elisabeth Flo received a PhD grant from The Western Norway Regional Health Authority, committing her to write three peer reviewed articles. Grant number 911540. The Western Norway Regional Health Authority webpage: http://helse-vest.no/english/Sider/side.aspx. Economic support (minor amount) was also received from The Norwegian Nurses Organisation for postal services related to mailing of questionnaires (no personal payment/salary). The funders (The Western Norway Regional Health Authority) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*AASM, 2005, INT CLASS SLEEP DIS; Akerstedt T, 2010, CHRONOBIOL INT, V27, P975, DOI 10.3109/07420528.2010.489001; APA, 2000, DIAGN STAT MAN MENT; Bartone TP, 1989, J OCCUP ENVIRON MED, V31, P657; Baruch Y, 1999, HUM RELAT, V52, P421, DOI 10.1023/A:1016905407491; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; Bush K, 1998, ARCH INTERN MED, V158, P1789, DOI 10.1001/archinte.158.16.1789; CHALDER T, 1993, J PSYCHOSOM RES, V37, P147, DOI 10.1016/0022-3999(93)90081-P; Di Milia L, 2005, PERS INDIV DIFFER, V39, P1293, DOI 10.1016/j.paid.2005.04.012; Dijk DJ, 1999, J PHYSIOL-LONDON, V516, P611, DOI 10.1111/j.1469-7793.1999.0611v.x; Drake CL, 2004, SLEEP, V27, P1453, DOI 10.1093/sleep/27.8.1453; Harma M, 2010, SCAND J WORK ENV HEA, V36, P81; Hystad SW, 2010, SCAND J PSYCHOL, V51, P237, DOI 10.1111/j.1467-9450.2009.00759.x; JOHNS NJ, 1991, SLEEP, V14, P540; Knudsen AK, 2010, AM J EPIDEMIOL, V172, P1306, DOI 10.1093/aje/kwq257; Kober T, 2010, ARBEIDSTID BLANT HEL; Loge JH, 1998, J PSYCHOSOM RES, V45, P53, DOI 10.1016/S0022-3999(97)00291-2; Munakata M, 2001, HYPERTENS RES, V24, P25, DOI 10.1291/hypres.24.25; Pallesen S, 2007, SLEEP, V30, P619, DOI 10.1093/sleep/30.5.619; Pallesen S, 2008, PERCEPT MOTOR SKILL, V107, P691, DOI 10.2466/PMS.107.3.691-706; Parent-Thirion A., 2007, 4 EUROPEAN WORKING C; Roth T, 2002, SLEEP MED, V3, P99, DOI 10.1016/S1389-9457(01)00131-9; Sack RL, 2007, SLEEP, V30, P1460, DOI 10.1093/sleep/30.11.1460; Saksvik IB, 2011, SLEEP MED REV, V15, P221, DOI 10.1016/j.smrv.2010.07.002; Shen JH, 2006, J SLEEP RES, V15, P1, DOI 10.1111/j.1365-2869.2006.00493.x; TORSVALL L, 1980, SCAND J WORK ENV HEA, V6, P283, DOI 10.5271/sjweh.2608; Waage S, 2009, SLEEP, V32, P558, DOI 10.1093/sleep/32.4.558; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	28	162	166	2	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2012	7	4							e33981	10.1371/journal.pone.0033981	http://dx.doi.org/10.1371/journal.pone.0033981			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	952GU	22485153	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000304780500029
J	Hysom, DA; Naraghi-Arani, P; Elsheikh, M; Carrillo, AC; Williams, PL; Gardner, SN				Hysom, David A.; Naraghi-Arani, Pejman; Elsheikh, Maher; Carrillo, A. Celena; Williams, Peter L.; Gardner, Shea N.			Skip the Alignment: Degenerate, Multiplex Primer and Probe Design Using K-mer Matching Instead of Alignments	PLOS ONE			English	Article							SOFTWARE	PriMux is a new software package for selecting multiplex compatible, degenerate primers and probes to detect diverse targets such as viruses. It requires no multiple sequence alignment, instead applying k-mer algorithms, hence it scales well for large target sets and saves user effort from curating sequences into alignable groups. PriMux has the capability to predict degenerate primers as well as probes suitable for TaqMan or other primer/probe triplet assay formats, or simply probes for microarray or other single-oligo assay formats. PriMux employs suffix array methods for efficient calculations on oligos 10-similar to 100 nt in length. TaqMan (R) primers and probes for each segment of Rift Valley fever virus were designed using PriMux, and lab testing comparing signatures designed using PriMux versus those designed using traditional methods demonstrated equivalent or better sensitivity for the PriMux-designed signatures compared to traditional signatures. In addition, we used PriMux to design TaqMan (R) primers and probes for unalignable or poorly alignable groups of targets: that is, all segments of Rift Valley fever virus analyzed as a single target set of 198 sequences, or all 2863 Dengue virus genomes for all four serotypes available at the time of our analysis. The PriMux software is available as open source from http:/sourceforge.net/projects/PriMux.	[Hysom, David A.; Naraghi-Arani, Pejman; Elsheikh, Maher; Carrillo, A. Celena; Gardner, Shea N.] Lawrence Livermore Natl Lab, Livermore, CA USA; [Williams, Peter L.] Lawrence Berkeley Natl Lab, Joint Genome Inst, Walnut Creek, CA USA	United States Department of Energy (DOE); Lawrence Livermore National Laboratory; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; Lawrence Berkeley National Laboratory	Hysom, DA (corresponding author), Lawrence Livermore Natl Lab, Livermore, CA USA.	gardner26@LLNL.gov			U.S. Department of Energy by Lawrence Livermore National Laboratory [DE-AC52-07NA27344]; Laboratory Directed Research and Development from Lawrence Livermore National Laboratory [08-SI-002]; Department of Homeland Security, Science and Technology Directorate [HSHQDC-07-X-00933]	U.S. Department of Energy by Lawrence Livermore National Laboratory(United States Department of Energy (DOE)); Laboratory Directed Research and Development from Lawrence Livermore National Laboratory; Department of Homeland Security, Science and Technology Directorate(United States Department of Homeland Security (DHS))	This work performed under the auspices of the U.S. Department of Energy by Lawrence Livermore National Laboratory under Contract DE-AC52-07NA27344. This work was supported by Laboratory Directed Research and Development grant number 08-SI-002 from Lawrence Livermore National Laboratory (https://www.llnl.gov/) and by the Department of Homeland Security, Science and Technology Directorate grant number HSHQDC-07-X-00933. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Gardner SN, 2009, NUCLEIC ACIDS RES, V37, P6291, DOI 10.1093/nar/gkp659; Gardner SN, 2004, J CLIN MICROBIOL, V42, P5472, DOI 10.1128/JCM.42.12.5472-5476.2004; Gardner SN, 2003, J CLIN MICROBIOL, V41, P2417, DOI 10.1128/JCM.41.6.2417-2427.2003; Jabado OJ, 2006, NUCLEIC ACIDS RES, V34, P6605, DOI 10.1093/nar/gkl966; Lemmon Gordon H, 2008, Ann Clin Microbiol Antimicrob, V7, P18, DOI 10.1186/1476-0711-7-18; Linhart Chaim, 2002, Bioinformatics, V18 Suppl 1, pS172; Mahony JO, 2000, INT J FOOD MICROBIOL, V61, P177, DOI 10.1016/S0168-1605(00)00378-0; Mandell R. B., 2011, Journal of Bioterrorism and Biodefense, V2, P108; Markham Nicholas R., 2008, V453, P3, DOI 10.1007/978-1-60327-429-6_1; MOE JB, 1981, J CLIN MICROBIOL, V13, P791, DOI 10.1128/JCM.13.4.791-793.1981; Najafabadi HS, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-55; Slezak Tom, 2003, Briefings in Bioinformatics, V4, P133, DOI 10.1093/bib/4.2.133; Souvenir R, 2003, LECT N BIOINFORMAT, V2812, P512; Victoria JG, 2010, J VIROL; Wagner EK, 2004, BASIC VIROLOGY, P136; Weidmann M, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-81	17	22	25	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2012	7	4							e34560	10.1371/journal.pone.0034560	http://dx.doi.org/10.1371/journal.pone.0034560			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952GU	22485178	Green Published, Green Submitted, gold			2022-12-27	WOS:000304780500053
J	Tsai, CC; Hung, HH; Liu, CP; Chen, YT; Pan, CY				Tsai, Chia-Chang; Hung, Hui-Hsing; Liu, Chien-Pang; Chen, Yit-Tsong; Pan, Chien-Yuan			Changes in Plasma Membrane Surface Potential of PC12 Cells as Measured by Kelvin Probe Force Microscopy	PLOS ONE			English	Article							PHOSPHATIDYLSERINE; MOLECULES; DOPAMINE; BIOMOLECULES; AGGREGATION; NEURONS; DEATH	The plasma membrane of a cell not only works as a physical barrier but also mediates the signal relay between the extracellular milieu and the cell interior. Various stimulants may cause the redistribution of molecules, like lipids, proteins, and polysaccharides, on the plasma membrane and change the surface potential (Ws). In this study, the Wss of PC12 cell plasma membranes were measured by atomic force microscopy in Kelvin probe mode (KPFM). The skewness values of the Wss distribution histogram were found to be mostly negative, and the incorporation of negatively charged phosphatidylserine shifted the average skewness values to positive. After being treated with H2O2, dopamine, or Zn2+, phosphatidylserine was found to be translocated to the membrane outer leaflet and the averaged skewness values were changed to positive values. These results demonstrated that KPFM can be used to monitor cell physiology status in response to various stimulants with high spatial resolution.	[Tsai, Chia-Chang; Liu, Chien-Pang; Chen, Yit-Tsong] Acad Sinica, Inst Atom & Mol Sci, Taipei, Taiwan; [Hung, Hui-Hsing; Pan, Chien-Yuan] Natl Taiwan Univ, Inst Zool, Taipei 10764, Taiwan; [Chen, Yit-Tsong] Natl Taiwan Univ, Dept Chem, Taipei 10764, Taiwan; [Pan, Chien-Yuan] Natl Taiwan Univ, Dept Life Sci, Taipei 10764, Taiwan	Academia Sinica - Taiwan; Academia Sinica - Taiwan; National Taiwan University; National Taiwan University; National Taiwan University	Tsai, CC (corresponding author), Acad Sinica, Inst Atom & Mol Sci, Taipei, Taiwan.	ytcchem@ntu.edu.tw; cypan@ntu.edu.tw	Chen, Yit-Tsong/F-7935-2012; Tsai, Chia Chang/C-6425-2008	Chen, Yit-Tsong/0000-0002-6204-8320; Tsai, Chia Chang/0000-0001-6279-0990; PAN, CHIEN-YUAN/0000-0002-6654-9309	National Science Council of Taiwan [NSC 95-2113-M-001-034-MY3, NSC 97-2627-M-002-019, NSC-97-2112-M-006-014-MY2, NSC 98-2627-B-006-020]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by the National Science Council of Taiwan (http://web1.nsc.gov.tw/mp.aspx?mp=7) under Grant Nos. NSC 95-2113-M-001-034-MY3, NSC 97-2627-M-002-019, NSC-97-2112-M-006-014-MY2, and NSC 98-2627-B-006-020. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadi FA, 2008, NEUROCHEM RES, V33, P886, DOI 10.1007/s11064-007-9532-5; Allison DP, 2010, WIRES NANOMED NANOBI, V2, P618, DOI 10.1002/wnan.104; Altman DG, 1996, BRIT MED J, V313, P1200, DOI 10.1136/bmj.313.7066.1200; Alves CS, 2010, J BIOL CHEM, V285, P27536, DOI 10.1074/jbc.M110.130955; Barnham KJ, 2008, CURR OPIN CHEM BIOL, V12, P222, DOI 10.1016/j.cbpa.2008.02.019; Dall'Olio F, 2012, FRONT BIOSCI-LANDMRK, V17, P670, DOI 10.2741/3951; Engel A, 2000, NAT STRUCT BIOL, V7, P715, DOI 10.1038/78929; FADOK VA, 1992, J IMMUNOL, V148, P2207; Fisher TE, 2000, NAT STRUCT BIOL, V7, P719; Fujihira M, 1999, ANNU REV MATER SCI, V29, P353, DOI 10.1146/annurev.matsci.29.1.353; Garai K, 2007, BIOCHEMISTRY-US, V46, P10655, DOI 10.1021/bi700798b; Garcia-Saez AJ, 2010, FEBS LETT, V584, P1653, DOI 10.1016/j.febslet.2009.12.036; Janas T, 2011, BBA-BIOMEMBRANES, V1808, P2923, DOI 10.1016/j.bbamem.2011.08.036; Kalinin SV, 2007, ANNU REV MATER RES, V37, P189, DOI 10.1146/annurev.matsci.37.052506.084323; Konat GW, 2003, J BIOSCIENCES, V28, P57, DOI 10.1007/BF02970132; Kontou M, 2009, BIOL CHEM, V390, P575, DOI 10.1515/BC.2009.058; Lee JD, 2008, MICROSC MICROANAL, V14, P507, DOI 10.1017/S1431927608080628; Leong SL, 2009, NEUROCHEM RES, V34, P1838, DOI 10.1007/s11064-009-9986-8; Leung C, 2009, NANO LETT, V9, P2769, DOI 10.1021/nl9012979; Leventis PA, 2010, ANNU REV BIOPHYS, V39, P407, DOI 10.1146/annurev.biophys.093008.131234; Li CX, 2007, BRAIN RES, V1139, P201, DOI 10.1016/j.brainres.2006.12.039; Lo HS, 2004, NEUROBIOL DIS, V17, P54, DOI 10.1016/j.nbd.2004.05.003; Marshall BT, 2003, NATURE, V423, P190, DOI 10.1038/nature01605; MCGEE R, 1980, MOL CELL BIOCHEM, V33, P121; Oh YJ, 2007, APPL PHYS LETT, V90, P3; Palermo V, 2006, ADV MATER, V18, P145, DOI 10.1002/adma.200501394; Schlegel RA, 2001, CELL DEATH DIFFER, V8, P551, DOI 10.1038/sj.cdd.4400817; Shatnyeva OM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019927; Sinensky AK, 2007, NAT NANOTECHNOL, V2, P653, DOI 10.1038/nnano.2007.293; Subczynski WK, 2000, ACTA BIOCHIM POL, V47, P613, DOI 10.18388/abp.2000_3983; Tsai CC, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/13/135503; Tsai CC, 2009, AM J PHYSIOL-CELL PH, V297, pC397, DOI 10.1152/ajpcell.00562.2008; Varki A, 2011, COLD SPRING HARB PER, V3; Yang Y, 2007, BIOPHYS J, V92, P1966, DOI 10.1529/biophysj.106.093328	34	16	16	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2012	7	4							e33849	10.1371/journal.pone.0033849	http://dx.doi.org/10.1371/journal.pone.0033849			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959FE	22506008	Green Submitted, Green Published, gold			2022-12-27	WOS:000305297500016
J	Kesic, MJ; Meyer, M; Bauer, R; Jaspers, I				Kesic, Matthew J.; Meyer, Megan; Bauer, Rebecca; Jaspers, Ilona			Exposure to Ozone Modulates Human Airway Protease/Antiprotease Balance Contributing to Increased Influenza A Infection	PLOS ONE			English	Article							BRONCHIAL EPITHELIAL-CELLS; SECRETORY LEUKOPROTEASE INHIBITOR; TRANSMEMBRANE SERINE PROTEASES; SOUTHWEST MEXICO-CITY; OXIDATIVE STRESS; CIGARETTE-SMOKE; VIRAL-INFECTION; ALPHA(1)-PROTEINASE INHIBITOR; INFLAMMATORY RESPONSE; GENE-EXPRESSION	Exposure to oxidant air pollution is associated with increased respiratory morbidities and susceptibility to infections. Ozone is a commonly encountered oxidant air pollutant, yet its effects on influenza infections in humans are not known. The greater Mexico City area was the primary site for the spring 2009 influenza A H1N1 pandemic, which also coincided with high levels of environmental ozone. Proteolytic cleavage of the viral membrane protein hemagglutinin (HA) is essential for influenza virus infectivity. Recent studies suggest that HA cleavage might be cell-associated and facilitated by the type II transmembrane serine proteases (TTSPs) human airway trypsin-like protease (HAT) and transmembrane protease, serine 2 (TMPRSS2), whose activities are regulated by antiproteases, such as secretory leukocyte protease inhibitor (SLPI). Based on these observations, we sought to determine how acute exposure to ozone may modulate cellular protease/antiprotease expression and function, and to define their roles in a viral infection. We utilized our in vitro model of differentiated human nasal epithelial cells (NECs) to determine the effects of ozone on influenza cleavage, entry, and replication. We show that ozone exposure disrupts the protease/antiprotease balance within the airway liquid. We also determined that functional forms of HAT, TMPRSS2, and SLPI are secreted from human airway epithelium, and acute exposure to ozone inversely alters their expression levels. We also show that addition of antioxidants significantly reduces virus replication through the induction of SLPI. In addition, we determined that ozone-induced cleavage of the viral HA protein is not cell-associated and that secreted endogenous proteases are sufficient to activate HA leading to a significant increase in viral replication. Our data indicate that pre-exposure to ozone disrupts the protease/antiprotease balance found in the human airway, leading to increased influenza susceptibility.	[Kesic, Matthew J.; Meyer, Megan; Bauer, Rebecca; Jaspers, Ilona] Univ N Carolina, Ctr Environm Med Asthma & Lung Biol, Chapel Hill, NC 27515 USA; [Bauer, Rebecca; Jaspers, Ilona] Univ N Carolina, Curriculum Toxicol, Chapel Hill, NC 27515 USA; [Jaspers, Ilona] Univ N Carolina, Dept Pediat, Chapel Hill, NC 27515 USA; [Meyer, Megan; Jaspers, Ilona] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27515 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Kesic, MJ (corresponding author), Univ N Carolina, Ctr Environm Med Asthma & Lung Biol, Chapel Hill, NC 27515 USA.	kesic@email.unc.edu	Jaspers, Ilona/AAZ-5035-2020		National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health [HL095163]; Flight Attendant Medical Research Institute (FAMRI); Environmental Protection Agency [CR829522]; National Institute of Environmental Health Sciences [T32 ES007126-26]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095163] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES013611, T32ES007126, P30ES010126] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Flight Attendant Medical Research Institute (FAMRI); Environmental Protection Agency(United States Environmental Protection Agency); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The project described was in part supported by grant number HL095163 from the National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health, a grant from the Flight Attendant Medical Research Institute (FAMRI), as well as a grant from the Environmental Protection Agency (CR829522) (all to IJ). This research was also supported by grant number T32 ES007126-26 National Institute of Environmental Health Sciences Curriculum of Toxicology Training Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abboud RT, 2008, INT J TUBERC LUNG D, V12, P361; Becker S, 1998, ENVIRON TOXICOL PHAR, V6, P257, DOI 10.1016/S1382-6689(98)00043-X; Bertram S, 2011, J VIROL, V85, P13363, DOI 10.1128/JVI.05300-11; Bertram S, 2010, J VIROL, V84, P10016, DOI 10.1128/JVI.00239-10; Bottcher-Friebertshauser E, 2011, J VIROL, V85, P1554, DOI 10.1128/JVI.01294-10; Bottcher-Friebertshauser E, 2010, J VIROL, V84, P5605, DOI 10.1128/JVI.00140-10; Bogadel'nikov I V, 1990, Pediatriia, P17; Borja-Aburto VH, 1998, ENVIRON HEALTH PERSP, V106, P849, DOI 10.2307/3434129; Bottcher E, 2006, J VIROL, V80, P9896, DOI 10.1128/JVI.01118-06; Cannell JJ, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-29; Cavarra E, 2001, AM J PHYSIOL-LUNG C, V281, pL412, DOI 10.1152/ajplung.2001.281.2.L412; Cavarra E, 2001, AM J RESP CRIT CARE, V164, P886, DOI 10.1164/ajrccm.164.5.2010032; Chandran K, 2005, SCIENCE, V308, P1643, DOI 10.1126/science.1110656; Cho HY, 2005, FREE RADICAL BIO MED, V38, P325, DOI 10.1016/j.freeradbiomed.2004.10.013; Cho HY, 2010, TOXICOL APPL PHARM, V244, P43, DOI 10.1016/j.taap.2009.07.024; Cho HY, 2009, AM J RESP CRIT CARE, V179, P138, DOI 10.1164/rccm.200804-535OC; Chowell G, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000436; Ciriolo MR, 1997, J BIOL CHEM, V272, P2700, DOI 10.1074/jbc.272.5.2700; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; DILLARD GHL, 1949, CANCER RES, V9, P665; FARAGMAHMOD FI, 1988, VACCINE, V6, P262, DOI 10.1016/0264-410X(88)90222-8; Fischer BM, 2011, INT J CHRONIC OBSTR, V6, P413, DOI 10.2147/COPD.S10770; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; FRIEDMAN M, 1992, ENVIRON HEALTH PERSP, V97, P95, DOI 10.2307/3431335; GABRIELSON EW, 1994, ENVIRON HEALTH PERSP, V102, P972, DOI 10.2307/3431921; Gagneux P, 2003, J BIOL CHEM, V278, P48245, DOI 10.1074/jbc.M309813200; Garcia-Sastre A, 2011, VIRUS RES, V162, P12, DOI 10.1016/j.virusres.2011.10.017; Garcia-Suastegui WA, 2011, MUTAGENESIS, V26, P385, DOI 10.1093/mutage/geq104; Gold DR, 1999, EPIDEMIOLOGY, V10, P8, DOI 10.1097/00001648-199901000-00004; HENNET T, 1992, J GEN VIROL, V73, P39, DOI 10.1099/0022-1317-73-1-39; Hernandez ML, 2010, J ALLERGY CLIN IMMUN, V126, P537, DOI 10.1016/j.jaci.2010.06.043; Hernandez ML, 2010, INHAL TOXICOL, V22, P648, DOI 10.3109/08958371003610966; Hooper JD, 2001, J BIOL CHEM, V276, P857, DOI 10.1074/jbc.R000020200; Iizuka T, 2005, GENES CELLS, V10, P1113, DOI 10.1111/j.1365-2443.2005.00905.x; Ishii Y, 2005, J IMMUNOL, V175, P6968, DOI 10.4049/jimmunol.175.10.6968; JAKAB GJ, 1995, ENVIRON HEALTH PERSP, V103, P77, DOI 10.2307/3432454; JAKAB GJ, 1990, AM REV RESPIR DIS, V141, P1307, DOI 10.1164/ajrccm/141.5_Pt_1.1307; Jaspers I, 2007, FREE RADICAL BIO MED, V42, P1826, DOI 10.1016/j.freeradbiomed.2007.03.017; Jaspers I, 2005, TOXICOL SCI, V85, P990, DOI 10.1093/toxsci/kfi141; Keller JN, 2006, ANTIOXID REDOX SIGN, V8, P119, DOI 10.1089/ars.2006.8.119; Kesic MJ, 2011, FREE RADICAL BIO MED, V51, P444, DOI 10.1016/j.freeradbiomed.2011.04.027; Kido H, 1999, BIOPOLYMERS, V51, P79, DOI 10.1002/(SICI)1097-0282(1999)51:1<79::AID-BIP9>3.0.CO;2-W; KIDO H, 1992, J BIOL CHEM, V267, P13573; Kido H, 2007, CURR PHARM DESIGN, V13, P405, DOI 10.2174/138161207780162971; Lambert LC, 2010, NEW ENGL J MED, V363, P2036, DOI 10.1056/NEJMra1002842; Liu CK, 1998, J VIROL, V72, P4643, DOI 10.1128/JVI.72.6.4643-4649.1998; Manicassamy B, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-75; Marsh GA, 2007, J VIROL, V81, P9727, DOI 10.1128/JVI.01144-07; Matsuyama S, 2010, J VIROL, V84, P12658, DOI 10.1128/JVI.01542-10; Matsuyama S, 2009, J VIROL, V83, P11133, DOI 10.1128/JVI.00959-09; Mauad T, 2010, AM J RESP CRIT CARE, V181, P72, DOI 10.1164/rccm.200909-1420OC; Mikerov AN, 2008, AM J PHYSIOL-LUNG C, V294, pL121, DOI 10.1152/ajplung.00288.2007; Monto AS, 2004, PEDIATR INFECT DIS J, V23, pS58, DOI 10.1097/01.inf.0000108193.91607.34; Mukhopadhyay S, 2010, AM J CLIN PATHOL, V133, P380, DOI 10.1309/AJCPXY17SULQKSWK; Na HK, 2008, FOOD CHEM TOXICOL, V46, P1271, DOI 10.1016/j.fct.2007.10.006; Nair S, 2010, ACTA PHARMACOL SIN, V31, P1223, DOI 10.1038/aps.2010.147; NAKAYAMA M, 1993, ANTIVIR RES, V21, P289, DOI 10.1016/0166-3542(93)90008-7; Neumann G, 1999, P NATL ACAD SCI USA, V96, P9345, DOI 10.1073/pnas.96.16.9345; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; O'Neill MS, 2004, J EXPO ANAL ENV EPID, V14, P429, DOI 10.1038/sj.jea.7500341; PRYOR WA, 1995, FREE RADICAL BIO MED, V19, P935, DOI 10.1016/0891-5849(95)02033-7; PURVIS MR, 1961, J INFECT DIS, V109, P238, DOI 10.1093/infdis/109.3.238; Qu F, 2009, CHEM-BIOL INTERACT, V179, P219, DOI 10.1016/j.cbi.2008.10.059; Quinlivan M, 2005, J VIROL, V79, P8431, DOI 10.1128/JVI.79.13.8431-8439.2005; Razani-Boroujerdi S, 2004, CELL IMMUNOL, V230, P1, DOI 10.1016/j.cellimm.2004.07.007; REDDEL RR, 1988, CANCER RES, V48, P1904; Reddy NM, 2007, AM J RESP CELL MOL, V37, P3, DOI 10.1165/rcmb.2007-0004RC; Reed KL, 1996, BIOL REPROD, V55, P469, DOI 10.1095/biolreprod55.2.469; SAKAI K, 1993, J HISTOCHEM CYTOCHEM, V41, P89, DOI 10.1177/41.1.8380186; Schwarz KB, 1996, FREE RADICAL BIO MED, V21, P641, DOI 10.1016/0891-5849(96)00131-1; Shinkai Y, 2006, FEBS LETT, V580, P1771, DOI 10.1016/j.febslet.2006.02.031; Shulla A, 2011, J VIROL, V85, P873, DOI 10.1128/JVI.02062-10; Simmons G, 2004, P NATL ACAD SCI USA, V101, P4240, DOI 10.1073/pnas.0306446101; Skrzydlewska E, 1997, Postepy Hig Med Dosw, V51, P443; Szabo R, 2003, THROMB HAEMOSTASIS, V90, P185, DOI 10.1160/TH03-02-0071; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Thompson WW, 2004, JAMA-J AM MED ASSOC, V292, P1333, DOI 10.1001/jama.292.11.1333; Cox LA, 2009, RISK ANAL, V29, P576, DOI 10.1111/j.1539-6924.2008.01152.x; Torres-Jardon R, 2009, J AIR WASTE MANAGE, V59, P1155, DOI 10.3155/1047-3289.59.10.1155; Van Amelsvoort JMM, 2001, XENOBIOTICA, V31, P891, DOI 10.1080/00498250110079149; Venkatasamy Radhakrishnan, 2007, Expert Rev Clin Immunol, V3, P365, DOI 10.1586/1744666X.3.3.365; Vogelmeier C, 1997, EUR RESPIR J, V10, P2114, DOI 10.1183/09031936.97.10092114; Wu CC, 2006, LIFE SCI, V78, P2889, DOI 10.1016/j.lfs.2005.11.013; Wu WD, 2011, FREE RADICAL BIO MED, V51, P522, DOI 10.1016/j.freeradbiomed.2011.05.006; Yasuoka S, 1997, AM J RESP CELL MOL, V16, P300, DOI 10.1165/ajrcmb.16.3.9070615; Ye LX, 2002, CLIN CHIM ACTA, V316, P43, DOI 10.1016/S0009-8981(01)00727-6; Ying QL, 2000, AM J RESP CELL MOL, V23, P506, DOI 10.1165/ajrcmb.23.4.3939; Zhu H, 2008, EXP BIOL MED, V233, P463, DOI 10.3181/0711-RM-304; Zhu M, 2000, PLANTA MED, V66, P444, DOI 10.1055/s-2000-8599	89	65	66	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2012	7	4							e35108	10.1371/journal.pone.0035108	http://dx.doi.org/10.1371/journal.pone.0035108			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JO	22496898	Green Published, Green Submitted, gold			2022-12-27	WOS:000305014500046
J	Yogo, K; Ogawa, T; Hayashi, M; Harada, Y; Nishizaka, T; Kinosita, K				Yogo, Katsunori; Ogawa, Taisaku; Hayashi, Masahito; Harada, Yoshie; Nishizaka, Takayuki; Kinosita, Kazuhiko, Jr.			Direct Observation of Strand Passage by DNA-Topoisomerase and Its Limited Processivity	PLOS ONE			English	Article							SINGLE-MOLECULE; II-ALPHA; SUPERCOILED DNA; MECHANISM; REPLICATION; TOPOLOGY	Type-II DNA topoisomerases resolve DNA entanglements such as supercoils, knots and catenanes by passing one segment of DNA duplex through a transient enzyme-bridged double-stranded break in another segment. The ATP-dependent passage reaction has previously been demonstrated at the single-molecule level, showing apparent processivity at saturating ATP. Here we directly observed the strand passage by human topoisomerase II alpha, after winding a pair of fluorescently stained DNA molecules with optical tweezers for 30 turns into an X-shaped braid. On average 0.51+/-0.33 mu m (11+/-6 turns) of a braid was unlinked in a burst of reactions taking 8+/-4 s, the unlinked length being essentially independent of the enzyme concentration between 0.25-37 pM. The time elapsed before the start of processive unlinking decreased with the enzyme concentration, being similar to 100 s at 3.7 pM. These results are consistent with a scenario where the enzyme binds to one DNA for a period of similar to 10 s, waiting for multiple diffusional encounters with the other DNA to transport it across the break similar to 10 times, and then dissociates from the binding site without waiting for the exhaustion of transportable DNA segments.	[Yogo, Katsunori; Ogawa, Taisaku; Kinosita, Kazuhiko, Jr.] Waseda Univ, Dept Phys, Fac Sci & Engn, Tokyo 169, Japan; [Hayashi, Masahito] KAST, Yasuda On Chip Mol Cell Phen Project, Kawasaki, Kanagawa, Japan; [Harada, Yoshie] Kyoto Univ, Inst Integrated Cell Mat Sci iCeMS, Kyoto, Japan; [Nishizaka, Takayuki] Gakushuin Univ, Dept Phys, Tokyo 171, Japan	Waseda University; Kanagawa Academy Science & Technology; Kyoto University; Gakushuin University	Yogo, K (corresponding author), Waseda Univ, Dept Phys, Fac Sci & Engn, Tokyo 169, Japan.	kazuhiko@waseda.jp		Yogo, Katsunori/0000-0001-9555-2147	Ministry of Education, Culture, Sports, Science and Technology of Japan [16002013, 21000011]; Grants-in-Aid for Scientific Research [21000011] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Specially Promoted Research (grant numbers 16002013, 21000011 to KK) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai Y, 1999, NATURE, V399, P446, DOI 10.1038/20894; Bromberg KD, 2003, J BIOL CHEM, V278, P7406, DOI 10.1074/jbc.M212056200; BROWN PO, 1979, SCIENCE, V206, P1081, DOI 10.1126/science.227059; BUSTAMANTE C, 1994, SCIENCE, V265, P1599, DOI 10.1126/science.8079175; Charvin G, 2003, P NATL ACAD SCI USA, V100, P9820, DOI 10.1073/pnas.1631550100; Harada Y, 2001, NATURE, V409, P113, DOI 10.1038/35051126; Hayashi M, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm529; Koster DA, 2006, P NATL ACAD SCI USA, V103, P1750, DOI 10.1073/pnas.0510509103; LIU LF, 1979, NATURE, V281, P456, DOI 10.1038/281456a0; Marko JF, 1997, PHYS REV E, V55, P1758, DOI 10.1103/PhysRevE.55.1758; McClendon AK, 2005, J BIOL CHEM, V280, P39337, DOI 10.1074/jbc.M503320200; MIZUUCHI K, 1980, P NATL ACAD SCI-BIOL, V77, P1847, DOI 10.1073/pnas.77.4.1847; Mueller-Planitz F, 2008, J BIOL CHEM, V283, P17463, DOI 10.1074/jbc.M710014200; Nollmann M, 2007, NAT STRUCT MOL BIOL, V14, P264, DOI 10.1038/nsmb1213; Renodon-Corniere A, 2002, BIOCHEMISTRY-US, V41, P13395, DOI 10.1021/bi0263614; Schoeffler AJ, 2008, Q REV BIOPHYS, V41, P41, DOI 10.1017/S003358350800468X; Smiley RD, 2007, P NATL ACAD SCI USA, V104, P4840, DOI 10.1073/pnas.0700342104; Stone MD, 2003, P NATL ACAD SCI USA, V100, P8654, DOI 10.1073/pnas.1133178100; Strick TR, 2000, NATURE, V404, P901, DOI 10.1038/35009144; Strick TR, 1998, BIOPHYS J, V74, P2016, DOI 10.1016/S0006-3495(98)77908-1; TANABE K, 1991, CANCER RES, V51, P4903; Wang JC, 1998, Q REV BIOPHYS, V31, P107, DOI 10.1017/S0033583598003424; Yasuda R, 2001, NATURE, V410, P898, DOI 10.1038/35073513; ZECHIEDRICH EL, 1990, EMBO J, V9, P4555, DOI 10.1002/j.1460-2075.1990.tb07908.x	24	14	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2012	7	4							e34920	10.1371/journal.pone.0034920	http://dx.doi.org/10.1371/journal.pone.0034920			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JO	22496876	gold, Green Published, Green Submitted			2022-12-27	WOS:000305014500036
J	Arjomandi, M; Haight, T; Sadeghi, N; Redberg, R; Gold, WM				Arjomandi, Mehrdad; Haight, Thaddeus; Sadeghi, Nasrat; Redberg, Rita; Gold, Warren M.			Reduced Exercise Tolerance and Pulmonary Capillary Recruitment with Remote Secondhand Smoke Exposure	PLOS ONE			English	Article							CABIN AIR-QUALITY; ENVIRONMENTAL TOBACCO-SMOKE; ACUTE CORONARY SYNDROMES; DIFFUSING-CAPACITY; SINGLE EXHALATION; DISEASE; HEALTH; ASSOCIATION; DIAGNOSIS; COTININE	Rationale: Flight attendants who worked on commercial aircraft before the smoking ban in flights (pre-ban FAs) were exposed to high levels of secondhand smoke (SHS). We previously showed never-smoking pre-ban FAs to have reduced diffusing capacity (Dco) at rest. Methods: To determine whether pre-ban FAs increase their Dco and pulmonary blood flow ((Q) over dotc) during exercise, we administered a symptom-limited supine-posture progressively increasing cycle exercise test to determine the maximum work (watts) and oxygen uptake ((V) over doto(2)) achieved by FAs. After 30 min rest, we then measured Dco and (Q) over dotc at 20, 40, 60, and 80 percent of maximum observed work. Results: The FAs with abnormal resting Dco achieved a lower level of maximum predicted work and (V) over doto(2) compared to those with normal resting Dco (mean +/- SEM; 88.7 +/- 2.9 vs. 102.5 +/- 3.1% predicted (V) over doto(2); p = 0.001). Exercise limitation was associated with the FAs' FEV1 (r = 0.33; p = 0.003). The Dco increased less with exercise in those with abnormal resting Dco (mean +/- SEM: 1.36 +/- 0.16 vs. 1.90 +/- 0.16 ml/min/mmHg per 20% increase in predicted watts; p = 0.020), and amongst all FAs, the increase with exercise seemed to be incrementally lower in those with lower resting Dco. Exercise-induced increase in (Q) over dotc was not different in the two groups. However, the FAs with abnormal resting Dco had less augmentation of their Dco with increase in (Q) over dotc during exercise (mean +/- SEM: 0.93 +/- 0.06 vs. 1.47 +/- 0.09 ml/min/mmHg per L/min; p<0.0001). The Dco during exercise was inversely associated with years of exposure to SHS in those FAs with >= 10 years of pre-ban experience (r = -0.32; p = 0.032). Conclusions: This cohort of never-smoking FAs with SHS exposure showed exercise limitation based on their resting Dco. Those with lower resting Dco had reduced pulmonary capillary recruitment. Exposure to SHS in the aircraft cabin seemed to be a predictor for lower Dco during exercise.	[Arjomandi, Mehrdad; Redberg, Rita; Gold, Warren M.] Univ Calif San Francisco, Flight Attendants Med Res Inst, Ctr Excellence, San Francisco, CA 94143 USA; [Gold, Warren M.] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA; [Arjomandi, Mehrdad; Gold, Warren M.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Arjomandi, Mehrdad; Redberg, Rita] San Francisco VA Med Ctr, San Francisco, CA USA; [Haight, Thaddeus] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA; [Sadeghi, Nasrat] Radboud Univ Nijmegen, Med Ctr, NL-6525 ED Nijmegen, Netherlands	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; University of California System; University of California Berkeley; Radboud University Nijmegen	Arjomandi, M (corresponding author), Univ Calif San Francisco, Flight Attendants Med Res Inst, Ctr Excellence, San Francisco, CA 94143 USA.	mehrdad.arjomandi@ucsf.edu	Arjomandi, Mehrdad/ABB-4327-2021	Arjomandi, Mehrdad/0000-0002-0116-9217	The Flight Attendants Medical Research Institute; The National Institutes of Health [K23 HL083099]; Northern California Institute for Research and Education; University of California San Francisco Cardiovascular Research Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL083099] Funding Source: NIH RePORTER	The Flight Attendants Medical Research Institute; The National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Northern California Institute for Research and Education; University of California San Francisco Cardiovascular Research Institute(University of California System); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding provided by The Flight Attendants Medical Research Institute, The National Institutes of Health (K23 HL083099), Northern California Institute for Research and Education and the University of California San Francisco Cardiovascular Research Institute Faculty Development Funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arjomandi M, 2009, J OCCUP ENVIRON MED, V51, P639, DOI 10.1097/JOM.0b013e3181a7f048; BELMAN MJ, 1991, CHEST, V99, P566, DOI 10.1378/chest.99.3.566; Benowitz NL, 2009, AM J EPIDEMIOL, V169, P236, DOI 10.1093/aje/kwn301; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; Celli BR, 2004, EUR RESPIR J, V23, P932, DOI 10.1183/09031936.04.00014304; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; CRAPO RO, 1981, AM REV RESPIR DIS, V123, P659; Eisner MD, 2007, ANN EPIDEMIOL, V17, P364, DOI 10.1016/j.annepidem.2006.10.008; Eisner Mark D, 2005, Environ Health, V4, P7, DOI 10.1186/1476-069X-4-7; Eisner MD, 2005, THORAX, V60, P814, DOI 10.1136/thx.2004.037283; First M, 1985, CONSTITUTENTS SIDEST, P195; Franciosi LG, 2006, PULM PHARMACOL THER, V19, P189, DOI 10.1016/j.pupt.2005.05.001; Gelb AF, 1996, CHEST, V109, P353, DOI 10.1378/chest.109.2.353; Goniewicz ML, 2011, NICOTINE TOB RES, V13, P202, DOI 10.1093/ntr/ntq237; Goniewicz Maciej Lukasz, 2009, Central European Journal of Public Health, V17, P220; HAMMOND SK, 1995, JAMA-J AM MED ASSOC, V274, P956, DOI 10.1001/jama.274.12.956; Hammond SK, 1999, ENVIRON HEALTH PERSP, V107, P329, DOI 10.2307/3434425; HUANG YCT, 1994, CHEST, V105, P501, DOI 10.1378/chest.105.2.501; Huang YCT, 2002, CHEST, V122, P177, DOI 10.1378/chest.122.1.177; Kawachi I, 1997, CIRCULATION, V95, P2374, DOI 10.1161/01.CIR.95.10.2374; Lam TH, 2005, TOB CONTROL, V14, P307, DOI 10.1136/tc.2005.011775; Lindgren T, 2000, AVIAT SPACE ENVIR MD, V71, P774; MARTONEN TB, 1982, J MATH BIOL, V14, P203, DOI 10.1007/BF01832845; Neilsen K, 2004, TOB CONTROL, V13, P20, DOI 10.1136/tc.2003.004721; NEWTH CJL, 1977, J APPL PHYSIOL, V43, P617, DOI 10.1152/jappl.1977.43.4.617; Nishimura K, 2002, CHEST, V121, P1434, DOI 10.1378/chest.121.5.1434; Pitsavos C, 2002, HEART VESSELS, V16, P127; Pitsavos C, 2002, TOB CONTROL, V11, P220, DOI 10.1136/tc.11.3.220; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; RAMAGE JE, 1987, CHEST, V92, P44, DOI 10.1378/chest.92.1.44; Rayman RB, 2002, AVIAT SPACE ENVIR MD, V73, P211; Repace J, 2004, TOB CONTROL, V13, P8, DOI 10.1136/tc.2003.003111; SAMET JM, 1987, AM REV RESPIR DIS, V136, P1486, DOI 10.1164/ajrccm/136.6.1486; SPENGLER JD, 1981, ATMOS ENVIRON, V15, P23, DOI 10.1016/0004-6981(81)90121-9; STOKES DL, 1981, J APPL PHYSIOL, V51, P858, DOI 10.1152/jappl.1981.51.4.858; TAYLOR AE, 1992, CIRCULATION, V86, P699, DOI 10.1161/01.CIR.86.2.699; Wan ES, 2011, AM J RESP CRIT CARE, V184, P57, DOI 10.1164/rccm.201101-0021OC; Wasserman K., 1999, PRINCIPLES EXERCISE; WILSON AF, 1994, THORAX, V49, P1121, DOI 10.1136/thx.49.11.1121	39	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2012	7	4							e34393	10.1371/journal.pone.0034393	http://dx.doi.org/10.1371/journal.pone.0034393			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JA	22493689	Green Published, Green Submitted, gold			2022-12-27	WOS:000305012700031
J	Nordlund, J; Milani, L; Lundmark, A; Lonnerholm, G; Syvanen, AC				Nordlund, Jessica; Milani, Lili; Lundmark, Anders; Lonnerholm, Gudmar; Syvanen, Ann-Christine			DNA Methylation Analysis of Bone Marrow Cells at Diagnosis of Acute Lymphoblastic Leukemia and at Remission	PLOS ONE			English	Article							ABERRANT METHYLATION; GENE-EXPRESSION; PREDICTION; MECHANISMS; CANCER; CLASSIFICATION; SUBTYPE; DISEASE; DBC1; MLL	To detect genes with CpG sites that display methylation patterns that are characteristic of acute lymphoblastic leukemia (ALL) cells, we compared the methylation patterns of cells taken at diagnosis from 20 patients with pediatric ALL to the methylation patterns in mononuclear cells from bone marrow of the same patients during remission and in non-leukemic control cells from bone marrow or blood. Using a custom-designed assay, we measured the methylation levels of 1,320 CpG sites in regulatory regions of 413 genes that were analyzed because they display allele-specific gene expression (ASE) in ALL cells. The rationale for our selection of CpG sites was that ASE could be the result of allele-specific methylation in the promoter regions of the genes. We found that the ALL cells had methylation profiles that allowed distinction between ALL cells and control cells. Using stringent criteria for calling differential methylation, we identified 28 CpG sites in 24 genes with recurrent differences in their methylation levels between ALL cells and control cells. Twenty of the differentially methylated genes were hypermethylated in the ALL cells, and as many as nine of them (AMICA1, CPNE7, CR1, DBC1, EYA4, LGALS8, RYR3, UQCRFS1, WDR35) have functions in cell signaling and/or apoptosis. The methylation levels of a subset of the genes were consistent with an inverse relationship with the mRNA expression levels in a large number of ALL cells from published data sets, supporting a potential biological effect of the methylation signatures and their application for diagnostic purposes.	[Nordlund, Jessica; Milani, Lili; Lundmark, Anders; Syvanen, Ann-Christine] Uppsala Univ, Dept Med Sci, Uppsala, Sweden; [Lonnerholm, Gudmar] Uppsala Univ, Dept Womens & Childrens Hlth, Uppsala, Sweden	Uppsala University; Uppsala University	Nordlund, J (corresponding author), Uppsala Univ, Dept Med Sci, Uppsala, Sweden.	Ann-Christine.Syvanen@medsci.uu.se	Nordlund, Jessica/A-9627-2011; Milani, Lili/C-8759-2011; Milani, Lili/N-1097-2019	Milani, Lili/0000-0002-5323-3102; Milani, Lili/0000-0002-5323-3102; Nordlund, Jessica/0000-0001-8699-9959	Swedish Foundation for Strategic Research [RBc08-008]; Swedish Cancer Society; Swedish Childhood Cancer Foundation; Swedish Research Council for Science and Technology [90559401]	Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Swedish Cancer Society(Swedish Cancer Society); Swedish Childhood Cancer Foundation(European Commission); Swedish Research Council for Science and Technology(Swedish Research Council)	This work was supported by grants from the Swedish Foundation for Strategic Research (#RBc08-008), the Swedish Cancer Society, the Swedish Childhood Cancer Foundation, and the Swedish Research Council for Science and Technology (#90559401). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal S, 2007, CANCER RES, V67, P1370, DOI 10.1158/0008-5472.CAN-06-1681; Andersson A, 2007, LEUKEMIA, V21, P1198, DOI 10.1038/sj.leu.2404688; Berdasco M, 2010, DEV CELL, V19, P698, DOI 10.1016/j.devcel.2010.10.005; Broske AM, 2009, NAT GENET, V41, P1207, DOI 10.1038/ng.463; Cerveira N, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-518; Chung W, 2011, CANCER EPIDEM BIOMAR, V20, P1483, DOI 10.1158/1055-9965.EPI-11-0067; Cleaver AL, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-105; Haferlach T, 2010, J CLIN ONCOL, V28, P2529, DOI 10.1200/JCO.2009.23.4732; Hansen KD, 2011, NAT GENET; Hogan LE, 2011, BLOOD; Issa JPJ, 2007, CLIN CANCER RES, V13, P1634, DOI 10.1158/1078-0432.CCR-06-2076; Izumi H, 2005, HUM MOL GENET, V14, P997, DOI 10.1093/hmg/ddi092; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Li YR, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000533; McCabe MT, 2009, CLIN CANCER RES, V15, P3927, DOI 10.1158/1078-0432.CCR-08-2784; Meyer C, 2009, LEUKEMIA, V23, P1490, DOI 10.1038/leu.2009.33; Milani L, 2010, BLOOD, V115, P1214, DOI 10.1182/blood-2009-04-214668; Milani L, 2009, GENOME RES, V19, P1, DOI 10.1101/gr.083931.108; Narayan G, 2011, GENE CHROMOSOME CANC; Osborn NK, 2006, CLIN GASTROENTEROL H, V4, P212, DOI 10.1016/j.cgh.2005.11.009; Pui C, 2004, NEW ENGL J MED, V350, P1535, DOI 10.1056/NEJMra023001; Pui CH, 2011, J CLIN ONCOL, V29, P551, DOI 10.1200/JCO.2010.30.7405; San Jose-Eneriz E, 2006, BRIT J HAEMATOL, V134, P137, DOI 10.1111/j.1365-2141.2006.06131.x; Schmiegelow K, 2010, LEUKEMIA, V24, P345, DOI 10.1038/leu.2009.251; Taylor KH, 2007, CANCER RES, V67, P2617, DOI 10.1158/0008-5472.CAN-06-3993; Testa U, 2011, ANN HEMATOL, V90, P245, DOI 10.1007/s00277-010-1118-7; Vilas-Zornoza A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017012; Wang MX, 2010, INT J CLIN EXP PATHO, V3, P265; Yeoh EJ, 2002, CANCER CELL, V1, P133, DOI 10.1016/S1535-6108(02)00032-6; Zou HZ, 2005, INT J CANCER, V116, P584, DOI 10.1002/ijc.21045	31	30	32	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2012	7	4							e34513	10.1371/journal.pone.0034513	http://dx.doi.org/10.1371/journal.pone.0034513			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JA	22493696	Green Published, Green Submitted, gold			2022-12-27	WOS:000305012700038
J	Chang, JH; Paik, SY; Mao, L; Eisner, W; Flannery, PJ; Wang, LM; Tang, YP; Mattocks, N; Hadjadj, S; Goujon, JM; Ruiz, P; Gurley, SB; Spurney, RF				Chang, Jae-Hyung; Paik, Seung-Yeol; Mao, Lan; Eisner, William; Flannery, Patrick J.; Wang, Liming; Tang, Yuping; Mattocks, Natalie; Hadjadj, Samy; Goujon, Jean-Michel; Ruiz, Phillip; Gurley, Susan B.; Spurney, Robert F.			Diabetic Kidney Disease in FVB/NJ Akita Mice: Temporal Pattern of Kidney Injury and Urinary Nephrin Excretion	PLOS ONE			English	Article							GLOMERULAR PODOCYTES; MOUSE; SUSCEPTIBILITY; NEPHROPATHY; EXPRESSION; APOPTOSIS; PROTEIN; NUMBER; GENE; CALCINEURIN	Akita mice are a genetic model of type 1 diabetes. In the present studies, we investigated the phenotype of Akita mice on the FVB/NJ background and examined urinary nephrin excretion as a marker of kidney injury. Male Akita mice were compared with non-diabetic controls for functional and structural characteristics of renal and cardiac disease. Podocyte number and apoptosis as well as urinary nephrin excretion were determined in both groups. Male FVB/NJ Akita mice developed sustained hyperglycemia and albuminuria by 4 and 8 weeks of age, respectively. These abnormalities were accompanied by a significant increase in systolic blood pressure in 10-week old Akita mice, which was associated with functional, structural and molecular characteristics of cardiac hypertrophy. By 20 weeks of age, Akita mice developed a 10-fold increase in albuminuria, renal and glomerular hypertrophy and a decrease in the number of podocytes. Mild-to-moderate glomerular mesangial expansion was observed in Akita mice at 30 weeks of age. In 4-week old Akita mice, the onset of hyperglycemia was accompanied by increased podocyte apoptosis and enhanced excretion of nephrin in urine before the development of albuminuria. Urinary nephrin excretion was also significantly increased in albuminuric Akita mice at 16 and 20 weeks of age and correlated with the albumin excretion rate. These data suggest that: 1. FVB/NJ Akita mice have phenotypic characteristics that may be useful for studying the mechanisms of kidney and cardiac injury in diabetes, and 2. Enhanced urinary nephrin excretion is associated with kidney injury in FVB/NJ Akita mice and is detectable early in the disease process.	[Chang, Jae-Hyung; Eisner, William; Flannery, Patrick J.; Wang, Liming; Tang, Yuping; Mattocks, Natalie; Gurley, Susan B.; Spurney, Robert F.] Duke Univ, Dept Med, Div Nephrol, Durham, NC 27706 USA; [Chang, Jae-Hyung; Eisner, William; Flannery, Patrick J.; Wang, Liming; Tang, Yuping; Mattocks, Natalie; Gurley, Susan B.; Spurney, Robert F.] Durham VA Med Ctr, Durham, NC USA; [Paik, Seung-Yeol] Chung Ang Univ, Sch Med, Seoul 156756, South Korea; [Mao, Lan] Duke Univ, Med Ctr, Dept Med, Div Cardiol, Durham, NC 27710 USA; [Goujon, Jean-Michel] CHU Poitiers, Pathol Unit, Poitiers, France; [Hadjadj, Samy; Goujon, Jean-Michel] INSERM, U927, Poitiers, France; [Hadjadj, Samy; Goujon, Jean-Michel] INSERM, CIC 0802, Poitiers, France; [Ruiz, Phillip] Univ Miami, Dept Surg & Pathol, Miami, FL USA	Duke University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Durham VA Medical Center; Chung Ang University; Chung Ang University Hospital; Duke University; CHU Poitiers; Universite de Poitiers; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Poitiers; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Poitiers; University of Miami	Chang, JH (corresponding author), Duke Univ, Dept Med, Div Nephrol, Durham, NC 27706 USA.	robert.spurney@dm.duke.edu			National Institutes of Health, National Institute of Diabetes, Digestive and Kidney Diseases [RO1-DK075688, 3R01DK075688-01A2S1]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK087707, R01DK075688] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000791] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of Diabetes, Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	These studies were supported by grants RO1-DK075688 (to RFS) and 3R01DK075688-01A2S1 (to RFS) from the National Institutes of Health, National Institute of Diabetes, Digestive and Kidney Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaltonen P, 2001, LAB INVEST, V81, P1185, DOI 10.1038/labinvest.3780332; Breyer MD, 2005, J AM SOC NEPHROL, V16, P27, DOI [10.1681/ASN.2009070721, 10.1681/ASN.2004080648]; Brosius FC, 2010, KIDNEY INT, V78, P431, DOI 10.1038/ki.2010.199; Brosius FC, 2009, J AM SOC NEPHROL, V20, P2503, DOI 10.1681/ASN.2009070721; Centers for Disease Control and Prevention, 2008, NAT DIAB FACT SHEET; Chua S, 2010, KIDNEY INT, V78, P453, DOI 10.1038/ki.2010.160; DEFRONZO RA, 2004, ELLENBERG RIFKINS DI, P723; Donoviel DB, 2001, MOL CELL BIOL, V21, P4829, DOI 10.1128/MCB.21.14.4829-4836.2001; Eisner C, 2010, KIDNEY INT, V77, P519, DOI 10.1038/ki.2009.501; Esposito G, 2000, AM J PHYSIOL-HEART C, V279, pH3101, DOI 10.1152/ajpheart.2000.279.6.H3101; Gooch JL, 2003, AM J PHYSIOL-RENAL, V284, pF144, DOI 10.1152/ajprenal.00158.2002; Gurley SB, 2006, AM J PHYSIOL-RENAL, V290, pF214, DOI 10.1152/ajprenal.00204.2005; Gurley SB, 2007, SEMIN NEPHROL, V27, P144, DOI 10.1016/j.semnephrol.2007.01.009; Gurley SB, 2010, AM J PHYSIOL-RENAL, V298, pF788, DOI 10.1152/ajprenal.90515.2008; Haseyama T, 2002, TOHOKU J EXP MED, V198, P233, DOI 10.1620/tjem.198.233; Hem A, 1998, LAB ANIM-UK, V32, P364, DOI 10.1258/002367798780599866; Holzman LB, 1999, KIDNEY INT, V56, P1481, DOI 10.1046/j.1523-1755.1999.00719.x; Hong EG, 2007, AM J PHYSIOL-ENDOC M, V293, pE1687, DOI 10.1152/ajpendo.00256.2007; Kestila M, 1998, MOL CELL, V1, P575, DOI 10.1016/S1097-2765(00)80057-X; Kim JJ, 2007, J AM SOC NEPHROL, V18, P2303, DOI 10.1681/ASN.2006101145; Kriz W, 1998, KIDNEY INT, V54, P687, DOI 10.1046/j.1523-1755.1998.00044.x; LANE PH, 1992, KIDNEY INT, V41, P1085, DOI 10.1038/ki.1992.165; Meyer TW, 1999, DIABETOLOGIA, V42, P1341, DOI 10.1007/s001250051447; Mundel P, 2002, J AM SOC NEPHROL, V13, P3005, DOI 10.1097/01.ASN.0000039661.06947.FD; Pagtalunan ME, 1997, J CLIN INVEST, V99, P342, DOI 10.1172/JCI119163; Patari A, 2003, DIABETES, V52, P2969, DOI 10.2337/diabetes.52.12.2969; Petermann AT, 2004, NEPHRON EXP NEPHROL, V98, pE114, DOI 10.1159/000081555; Qi ZH, 2005, DIABETES, V54, P2628, DOI 10.2337/diabetes.54.9.2628; Qi ZH, 2004, AM J PHYSIOL-RENAL, V286, pF590, DOI 10.1152/ajprenal.00324.2003; Ramage IJ, 2002, KIDNEY INT, V62, P895, DOI 10.1046/j.1523-1755.2002.00527.x; Rantanen M, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000016142.29721.22; Ruotsalainen V, 1999, P NATL ACAD SCI USA, V96, P7962, DOI 10.1073/pnas.96.14.7962; Steffes MW, 2001, KIDNEY INT, V59, P2104, DOI 10.1046/j.1523-1755.2001.0590062104.x; Susztak K, 2006, DIABETES, V55, P225, DOI 10.2337/diabetes.55.01.06.db05-0894; TAKETO M, 1991, P NATL ACAD SCI USA, V88, P2065, DOI 10.1073/pnas.88.6.2065; *US REN DAT SYST, 2007, ANN DAT REP ATL CHRO; Verzola D, 2007, KIDNEY INT, V72, P1262, DOI 10.1038/sj.ki.5002531; WALLENSTEIN S, 1980, CIRC RES, V47, P1, DOI 10.1161/01.RES.47.1.1; Wang G, 2008, EUR J ENDOCRINOL, V158, P317, DOI 10.1530/EJE-07-0708; Wang LM, 2008, KIDNEY BLOOD PRESS R, V31, P111, DOI 10.1159/000121531; Wang LM, 2011, MOL ENDOCRINOL, V25, P1376, DOI 10.1210/me.2011-0029; Wang LM, 2005, J AM SOC NEPHROL, V16, P3611, DOI 10.1681/ASN.2005020167; White KE, 2002, DIABETES, V51, P3083, DOI 10.2337/diabetes.51.10.3083; Whitesall SE, 2004, AM J PHYSIOL-HEART C, V286, pH2408, DOI 10.1152/ajpheart.01089.2003; Wiggins RC, 2007, KIDNEY INT, V71, P1205, DOI 10.1038/sj.ki.5002222; Wolf G, 2005, DIABETES, V54, P1626, DOI 10.2337/diabetes.54.6.1626; Xu JX, 2010, AM J PHYSIOL-RENAL, V299, pF487, DOI 10.1152/ajprenal.00018.2010; Yoshioka M, 1997, DIABETES, V46, P887, DOI 10.2337/diabetes.46.5.887	48	31	33	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e33942	10.1371/journal.pone.0033942	http://dx.doi.org/10.1371/journal.pone.0033942			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GO	22496773	Green Published, Green Submitted, gold			2022-12-27	WOS:000304855200026
J	Lethbridge, R; Hou, QL; Harley, CW; Yuan, Q				Lethbridge, Rebecca; Hou, Qinlong; Harley, Carolyn W.; Yuan, Qi			Olfactory Bulb Glomerular NMDA Receptors Mediate Olfactory Nerve Potentiation and Odor Preference Learning in the Neonate Rat	PLOS ONE			English	Article							LONG-TERM POTENTIATION; MITRAL CELLS; SYNAPTIC PLASTICITY; YOUNG-RATS; POSTNATAL-DEVELOPMENT; VISUAL-CORTEX; ACTIVATION; RESPONSES; SYNAPSES; MEMORY	Rat pup odor preference learning follows pairing of bulbar beta-adrenoceptor activation with olfactory input. We hypothesize that NMDA receptor (NMDAR)-mediated olfactory input to mitral cells is enhanced during training, such that increased calcium facilitates and shapes the critical cAMP pattern. Here, we demonstrate, in vitro, that olfactory nerve stimulation, at sniffing frequencies, paired with beta-adrenoceptor activation, potentiates olfactory nerve-evoked mitral cell firing. This potentiation is blocked by a NMDAR antagonist and by increased inhibition. Glomerular dishinhibtion also induces NMDAR-sensitive potentiation. In vivo, in parallel, behavioral learning is prevented by glomerular infusion of an NMDAR antagonist or a GABA(A) receptor agonist. A glomerular GABA(A) receptor antagonist paired with odor can induce NMDAR-dependent learning. The NMDA GluN1 subunit is phosphorylated in odor-specific glomeruli within 5 min of training suggesting early activation, and enhanced calcium entry, during acquisition. The GluN1 subunit is down-regulated 3 h after learning; and at 24 h post-training the GluN2B subunit is down-regulated. These events may assist memory stability. Ex vivo experiments using bulbs from trained rat pups reveal an increase in the AMPA/NMDA EPSC ratio post-training, consistent with an increase in AMPA receptor insertion and/or the decrease in NMDAR subunits. These results support a model of a cAMP/NMDA interaction in generating rat pup odor preference learning.	[Lethbridge, Rebecca; Hou, Qinlong; Yuan, Qi] Mem Univ Newfoundland, Fac Med, St John, NF, Canada; [Harley, Carolyn W.] Mem Univ Newfoundland, Dept Psychol, Fac Sci, St John, NF, Canada	Memorial University Newfoundland; Memorial University Newfoundland	Lethbridge, R (corresponding author), Mem Univ Newfoundland, Fac Med, St John, NF, Canada.	qi.yuan@med.mun.ca		Harley, Carolyn/0000-0001-8641-7998	Canadian Institutes of Health Research [MOP-102624]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	The work was supported by a Canadian Institutes of Health Research operating grant to QY (MOP-102624). http://www.cihr-irsc.gc.ca/e/193.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apicella A, 2010, J NEUROSCI, V30, P14255, DOI 10.1523/JNEUROSCI.2747-10.2010; Aroniadou-Anderjaska V, 1999, J NEUROPHYSIOL, V82, P489, DOI 10.1152/jn.1999.82.1.489; AroniadouAnderjaska V, 1997, NEUROSCIENCE, V79, P425, DOI 10.1016/S0306-4522(96)00706-3; Carlson GC, 2000, J NEUROSCI, V20, P2011; COOPERSMITH R, 1986, BRAIN RES, V371, P400, DOI 10.1016/0006-8993(86)90384-7; Cui W, 2007, LEARN MEMORY, V14, P126, DOI 10.1101/lm.496007; Cui W, 2011, LEARN MEMORY, V18, P283, DOI 10.1101/lm.1987711; Debanne D, 1996, REV NEUROSCIENCE, V7, P29; Egger V, 2007, J PHYSIOL-LONDON, V582, P7, DOI 10.1113/jphysiol.2007.136036; Ennis M, 1998, ANN NY ACAD SCI, V855, P457, DOI 10.1111/j.1749-6632.1998.tb10606.x; Flint AC, 1997, J NEUROSCI, V17, P2469; Franks KM, 2005, NEURON, V47, P101, DOI 10.1016/j.neuron.2005.05.024; Gire DH, 2008, J NEUROPHYSIOL, V99, P2021, DOI 10.1152/jn.01324.2007; Gire DH, 2009, J NEUROSCI, V29, P13454, DOI 10.1523/JNEUROSCI.2368-09.2009; Giustetto M, 1997, NEUROSCIENCE, V76, P787; Grimes MT, 2011, NEUROBIOL LEARN MEM, V95, P385, DOI 10.1016/j.nlm.2011.01.012; Grubb MS, 2008, J NEUROSCI, V28, P2919, DOI 10.1523/JNEUROSCI.5550-07.2008; GUTHRIE KM, 1993, P NATL ACAD SCI USA, V90, P3329, DOI 10.1073/pnas.90.8.3329; Hayar A, 2001, J NEUROPHYSIOL, V86, P2173, DOI 10.1152/jn.2001.86.5.2173; HOLLINGSWORTH EB, 1985, J NEUROSCI, V5, P2240; Ikegaya Y, 2004, SCIENCE, V304, P559, DOI 10.1126/science.1093173; Isaacson JS, 1998, NEURON, V20, P749, DOI 10.1016/S0896-6273(00)81013-2; JOHANSON IB, 1980, BEHAV NEURAL BIOL, V29, P132, DOI 10.1016/S0163-1047(80)92596-0; Johnson BA, 1996, J COMP NEUROL, V376, P557, DOI 10.1002/(SICI)1096-9861(19961223)376:4<557::AID-CNE5>3.0.CO;2-0; JOHNSON BA, 1995, BRAIN RES, V699, P192, DOI 10.1016/0006-8993(95)00896-X; KENDRICK KM, 1992, SCIENCE, V256, P833, DOI 10.1126/science.1589766; Kepecs A, 2006, CHEM SENSES, V31, P167, DOI 10.1093/chemsce/bjj016; Lin BJ, 2007, J PHYSIOL-LONDON, V582, P163, DOI 10.1113/jphysiol.2006.125963; Liu XB, 2004, J NEUROSCI, V24, P8885, DOI 10.1523/JNEUROSCI.2476-04.2004; Matsumoto H, 2009, J NEUROPHYSIOL, V101, P1890, DOI 10.1152/jn.91019.2008; McLean JH, 1999, LEARN MEMORY, V6, P608, DOI 10.1101/lm.6.6.608; MONYER H, 1992, SCIENCE, V256, P1217, DOI 10.1126/science.256.5060.1217; Mutoh H, 2005, J NEUROSCI, V25, P4252, DOI 10.1523/JNEUROSCI.4721-04.2005; Okutani F, 1999, NEUROSCIENCE, V93, P1297, DOI 10.1016/S0306-4522(99)00224-9; Quinlan EM, 2004, NEURON, V41, P185, DOI 10.1016/S0896-6273(03)00874-2; Quinlan EM, 1999, P NATL ACAD SCI USA, V96, P12876, DOI 10.1073/pnas.96.22.12876; Raineki C, 2010, BRAZ J MED BIOL RES, V43, P914, DOI 10.1590/S0100-879X2010001000001; Raman IM, 1996, NEURON, V16, P415, DOI 10.1016/S0896-6273(00)80059-8; Saint Jan DD, 2005, J NEUROSCI, V25, P2917, DOI 10.1523/JNEUROSCI.5042-04.2005; Satou M, 2006, J COMP PHYSIOL A, V192, P135, DOI 10.1007/s00359-005-0056-7; Satou M, 2005, J COMP PHYSIOL A, V191, P421, DOI 10.1007/s00359-005-0600-5; Schoppa NE, 1998, J NEUROSCI, V18, P6790; Sullivan RM, 2000, BEHAV NEUROSCI, V114, P957, DOI 10.1037/0735-7044.114.5.957; SULLIVAN RM, 1986, DEV BRAIN RES, V27, P278, DOI 10.1016/0165-3806(86)90256-7; SULLIVAN RM, 1991, DEV BRAIN RES, V60, P219, DOI 10.1016/0165-3806(91)90050-S; SULLIVAN RM, 1988, DEV PSYCHOBIOL, V21, P215, DOI 10.1002/dev.420210303; SULLIVAN RM, 1989, J NEUROSCI, V9, P3998; SULLIVAN RM, 1987, DEV BRAIN RES, V35, P307, DOI 10.1016/0165-3806(87)90056-3; Williams JM, 2003, NEUROSCIENCE, V118, P1003, DOI 10.1016/S0306-4522(03)00028-9; WILSON DA, 1988, J NEUROPHYSIOL, V59, P1770, DOI 10.1152/jn.1988.59.6.1770; Wilson DA, 1996, BRAIN RES, V719, P62, DOI 10.1016/0006-8993(96)00083-2; WOO CC, 1987, J COMP NEUROL, V263, P113, DOI 10.1002/cne.902630110; WOO CC, 1995, J COMP NEUROL, V352, P1, DOI 10.1002/cne.903520102; YOVELL Y, 1992, P NATL ACAD SCI USA, V89, P6526, DOI 10.1073/pnas.89.14.6526; Yuan Q, 2003, J NEUROSCI, V23, P4760; Yuan Q, 2006, J NEUROPHYSIOL, V95, P2417, DOI 10.1152/jn.00964.2005; Yuan Q, 2002, J NEUROPHYSIOL, V87, P3156, DOI 10.1152/jn.00917.2001; Yuan Q, 2003, LEARN MEMORY, V10, P5, DOI 10.1101/lm.54803; Yuan Q, 2000, LEARN MEMORY, V7, P413, DOI 10.1101/lm.35900; Yuan Q, 2012, LEARN MEMORY, V19, P50, DOI 10.1101/lm.024844.111; Yuan Q, 2009, LEARN MEMORY, V16, P676, DOI 10.1101/lm.1569309	61	31	31	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e35024	10.1371/journal.pone.0035024	http://dx.doi.org/10.1371/journal.pone.0035024			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	953GO	22496886	Green Accepted, Green Published, gold			2022-12-27	WOS:000304855200095
J	Payton, CA; Wilson, DA; Wesson, DW				Payton, Colleen A.; Wilson, Donald A.; Wesson, Daniel W.			Parallel Odor Processing by Two Anatomically Distinct Olfactory Bulb Target Structures	PLOS ONE			English	Article							PIRIFORM CORTEX; TUFTED CELLS; TUBERCLE; SYSTEM; RAT; ORGANIZATION; CONNECTIONS; INFORMATION; PROJECTIONS; ATTRACTION	The olfactory cortex encompasses several anatomically distinct regions each hypothesized to provide differential representation and processing of specific odors. Studies exploring whether or not the diversity of olfactory bulb input to olfactory cortices has functional meaning, however, are lacking. Here we tested whether two anatomically major olfactory cortical structures, the olfactory tubercle (OT) and piriform cortex (PCX), differ in their neural representation and processing dynamics of a small set of diverse odors by performing in vivo extracellular recordings from the OT and PCX of anesthetized mice. We found a wealth of similarities between structures, including odor-evoked response magnitudes, breadth of odor tuning, and odor-evoked firing latencies. In contrast, only few differences between structures were found, including spontaneous activity rates and odor signal-to-noise ratios. These results suggest that despite major anatomical differences in innervation by olfactory bulb mitral/tufted cells, the basic features of odor representation and processing, at least within this limited odor set, are similar within the OT and PCX. We predict that the olfactory code follows a distributed processing stream in transmitting behaviorally and perceptually-relevant information from low-level stations.	[Payton, Colleen A.; Wesson, Daniel W.] Case Western Reserve Univ, Sch Med, Dept Neurosci, Cleveland, OH 44106 USA; [Wilson, Donald A.; Wesson, Daniel W.] Nathan S Kline Inst Psychiat Res, Emot Brain Inst, Orangeburg, NY 10962 USA; [Wilson, Donald A.; Wesson, Daniel W.] NYU, Sch Med, Dept Child & Adolescent Psychiat, New York, NY USA	Case Western Reserve University; Nathan Kline Institute for Psychiatric Research; New York University	Payton, CA (corresponding author), Case Western Reserve Univ, Sch Med, Dept Neurosci, Cleveland, OH 44106 USA.	dww53@case.edu	Wesson, Daniel/AAJ-6719-2020; Payton, Colleen/AAS-9587-2020	Wesson, Daniel/0000-0002-3192-3866; Payton, Colleen/0000-0003-1398-6211	National Science Foundation [IOS-1121471]; National Institutes of Health [DC003906]; NATIONAL INSTITUTE ON AGING [R01AG037693] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC003906] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by National Science Foundation grant IOS-1121471 to D.W.W. and D.A.W. and DC003906 to D.A.W. from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALHEID GF, 1988, NEUROSCIENCE, V27, P1, DOI 10.1016/0306-4522(88)90217-5; Barnes DC, 2008, NAT NEUROSCI, V11, P1378, DOI 10.1038/nn.2217; Baum MJ, 2002, HORM BEHAV, V41, P213, DOI 10.1006/hbeh.2001.1749; Brennan PA, 2006, PHILOS T R SOC B, V361, P2061, DOI 10.1098/rstb.2006.1931; Brunjes PC, 2005, BRAIN RES REV, V50, P305, DOI 10.1016/j.brainresrev.2005.08.005; Carriero G, 2009, J NEUROPHYSIOL, V101, P1613, DOI 10.1152/jn.90792.2008; Chapuis J, 2012, NAT NEUROSCI, V15, P155, DOI 10.1038/nn.2966; Cury KM, 2010, NEURON, V68, P570, DOI 10.1016/j.neuron.2010.09.040; Davison IG, 2011, NEURON, V70, P82, DOI 10.1016/j.neuron.2011.02.047; Fallon JH, 1983, BRAIN RES B, V10, P179; Galizia CG, 2010, ANNU REV ENTOMOL, V55, P399, DOI 10.1146/annurev-ento-112408-085442; GERVAIS R, 1979, ELECTROEN CLIN NEURO, V46, P665, DOI 10.1016/0013-4694(79)90104-4; Ghosh S, 2011, NATURE, V472, P217, DOI 10.1038/nature09945; GILBERT CD, 1983, PROG BRAIN RES, V58, P209, DOI 10.1016/S0079-6123(08)60022-9; Gollisch T, 2008, SCIENCE, V319, P1108, DOI 10.1126/science.1149639; Gottfried JA, 2006, NEURON, V49, P467, DOI 10.1016/j.neuron.2006.01.007; HABERLY LB, 1978, J COMP NEUROL, V178, P711, DOI 10.1002/cne.901780408; HABERLY LB, 1977, BRAIN RES, V129, P152, DOI 10.1016/0006-8993(77)90978-7; Haberly LB, 1998, SYNAPTIC ORG BRAIN, P377; Heimer L, 1975, SUBCORTICAL PROJECTI; Howard JD, 2009, NAT NEUROSCI, V12, P932, DOI 10.1038/nn.2324; Ikemoto S, 2007, BRAIN RES REV; Imamura F, 2011, NAT NEUROSCI; Irvine DRF, AUDITORY BRAINSTEM, P1; Kadohisa M, 2006, P NATL ACAD SCI USA, V103, P15206, DOI 10.1073/pnas.0604313103; Kang N, 2009, EUR J NEUROSCI, V29, P624, DOI 10.1111/j.1460-9568.2009.06638.x; Kay LM, 1999, NAT NEUROSCI, V2, P1003, DOI 10.1038/14801; Lakatos P, 2008, SCIENCE, V320, P110, DOI 10.1126/science.1154735; Levy F, 2009, BEHAV BRAIN RES, V200, P336, DOI 10.1016/j.bbr.2008.12.017; Litaudon P, 2003, EUR J NEUROSCI, V17, P2457, DOI 10.1046/j.1460-9568.2003.02654.x; LUSKIN MB, 1983, J COMP NEUROL, V216, P292, DOI 10.1002/cne.902160306; Martel KL, 2007, EUR J NEUROSCI, V26, P463, DOI 10.1111/j.1460-9568.2007.05651.x; McNamara AM, 2004, CHEM SENSES, V29, P225, DOI 10.1093/chemse/bjh027; Miyamichi K, 2011, NATURE, V472, P191, DOI 10.1038/nature09714; Mombaerts P, 1999, ANNU REV NEUROSCI, V22, P487, DOI 10.1146/annurev.neuro.22.1.487; MOZELL MM, 1964, NATURE, V203, P1181, DOI 10.1038/2031181a0; Nagayama S, 2004, J NEUROPHYSIOL, V91, P2532, DOI 10.1152/jn.01266.2003; Nagayama S, 2010, FRONT NEURAL CIRCUIT, V4, DOI 10.3389/fncir.2010.00120; Neville K.R., 2004, SYNAPTIC ORG BRAIN, P415, DOI DOI 10.1093/ACPR0F:0S0/9780195159561.003.0010; Paxinos G, 2000, MOUSE BRAIN STEREOTA; PFAFF D, 1973, J COMP NEUROL, V151, P121, DOI 10.1002/cne.901510204; PFAFF DW, 1968, EXPERIENTIA, V24, P958, DOI 10.1007/BF02138682; PFAFFMANN C, 1959, AM PSYCHOL, V14, P226, DOI 10.1037/h0049324; PRICE JL, 1973, J COMP NEUROL, V150, P87, DOI 10.1002/cne.901500105; Rennaker RL, 2007, J NEUROSCI, V27, P1534, DOI 10.1523/JNEUROSCI.4072-06.2007; Rinberg D, 2006, J NEUROSCI, V26, P8857, DOI 10.1523/JNEUROSCI.0884-06.2006; SCHOENBAUM G, 1995, J NEUROPHYSIOL, V74, P733, DOI 10.1152/jn.1995.74.2.733; SCHWOB JE, 1984, J COMP NEUROL, V223, P177, DOI 10.1002/cne.902230204; SCOTT JW, 1986, EXPERIENTIA, V42, P223, DOI 10.1007/BF01942502; SCOTT JW, 1980, J COMP NEUROL, V194, P519, DOI 10.1002/cne.901940304; SCOTT JW, 1981, J NEUROPHYSIOL, V46, P918, DOI 10.1152/jn.1981.46.5.918; Shepherd G.M., 2004, SYNAPTIC ORG BRAIN, DOI [DOI 10.1093/ACPROF:OSO/9780195159561.001.1, 10.1093/acprof:oso/9780195159561.001.1]; SHIPLEY MT, 1984, BRAIN RES BULL, V12, P669, DOI 10.1016/0361-9230(84)90148-5; Sosulski DL, 2011, NATURE, V472, P213, DOI 10.1038/nature09868; Wesson DW, 2008, PLOS BIOL, V6, P717, DOI 10.1371/journal.pbio.0060082; Wesson DW, 2006, HORM BEHAV, V49, P580, DOI 10.1016/j.yhbeh.2005.12.013; Wesson DW, 2011, NEUROSCI BIOBEHAV R, V35, P655, DOI 10.1016/j.neubiorev.2010.08.004; WHITE LE, 1965, ANAT RECORD, V152, P465, DOI 10.1002/ar.1091520406; Wilson DA, 1998, J NEUROPHYSIOL, V79, P1425, DOI 10.1152/jn.1998.79.3.1425; Wilson DA, 2011, NEURON, V72, P506, DOI 10.1016/j.neuron.2011.10.027; YIN TCT, 1990, J NEUROPHYSIOL, V64, P465, DOI 10.1152/jn.1990.64.2.465	61	28	28	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e34926	10.1371/journal.pone.0034926	http://dx.doi.org/10.1371/journal.pone.0034926			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GO	22496877	Green Published, gold, Green Submitted			2022-12-27	WOS:000304855200088
J	Tsai, HY; Huang, YW				Tsai, Hung-Yin; Huang, Yen-Wen			Image Tracking Study on Courtship Behavior of Drosophila	PLOS ONE			English	Article							SLEEP ONSET; MAINTENANCE	Background: In recent years, there have been extensive studies aimed at decoding the DNA. Identifying the genetic cause of specific changes in a simple organism like Drosophila may help scientists recognize how multiple gene interactions may make some people more susceptible to heart disease or cancer. Investigators have devised experiments to observe changes in the gene networks in mutant Drosophila that responds differently to light, or have lower or higher locomotor activity. However, these studies focused on the behavior of the individual fly or on pair-wise interactions in the study of aggression or courtship. The behavior of these activities has been captured on film and inspected by a well-trained researcher after repeatedly watching the recorded film. Some studies also focused on ways to reduce the inspection time and increase the accuracy of the behavior experiment. Methodology: In this study, the behavior of drosophila during courtship was analyzed automatically by machine vision. We investigated the position and behavior discrimination during courtship using the captured images. Identification of the characteristics of drosophila, including sex, size, heading direction, and wing angles, can be computed using image analysis techniques that employ the Gaussian mixture model. The behavior of multiple drosophilae can also be analyzed simultaneously using the motion-prediction model and the variation constraint of heading direction. Conclusions: The overlapped fruit flies can be identified based on the relationship between body centers. Moreover, the behaviors and profiles can be correctly recognized by image processing based on the constraints of the wing angle and the size of the body. Therefore, the behavior of the male fruit flies can be discriminated when two or three fruit flies form a close cluster. In this study, the courtship behavior, including wing songs and attempts, can currently be distinguished with accuracies of 95.8% and 90%, respectively.	[Tsai, Hung-Yin; Huang, Yen-Wen] Natl Tsing Hua Univ, Dept Power Mech Engn, Hsinchu, Taiwan	National Tsing Hua University	Tsai, HY (corresponding author), Natl Tsing Hua Univ, Dept Power Mech Engn, Hsinchu, Taiwan.	hytsai@pme.nthu.edu.tw			National Science Council [NSC-98-2221-E-007-005-MY3]	National Science Council(Ministry of Science and Technology, Taiwan)	The authors would like to thank the National Science Council for supporting the research project under the contract No. NSC-98-2221-E-007-005-MY3 (http://www.nsc.gov.tw). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agosto J, 2008, NAT NEUROSCI, V11, P354, DOI 10.1038/nn2046; Branson K, 2009, NAT METHODS, V6, P451, DOI [10.1038/nmeth.1328, 10.1038/NMETH.1328]; Dankert H, 2009, NAT METHODS, V6, P297, DOI [10.1038/NMETH.1310, 10.1038/nmeth.1310]; Dickson BJ, 2008, SCIENCE, V322, P904, DOI 10.1126/science.1159276; Greenspan RJ, 2001, TRENDS NEUROSCI, V24, P142, DOI 10.1016/S0166-2236(00)01719-7; Lin HH, 2007, CELL, V128, P1205, DOI 10.1016/j.cell.2007.03.006; Liu T, 2008, J NEUROSCI, V28, P5539, DOI 10.1523/JNEUROSCI.5290-07.2008; Liu WJ, 2008, BIOCHEM BIOPH RES CO, V372, P798, DOI 10.1016/j.bbrc.2008.05.119; Martin JR, 2004, BEHAV PROCESS, V67, P207, DOI 10.1016/j.beproc.2004.04.003; Ramazani RB, 2007, J NEUROSCI METH, V162, P171, DOI 10.1016/j.jneumeth.2007.01.005	10	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e34784	10.1371/journal.pone.0034784	http://dx.doi.org/10.1371/journal.pone.0034784			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GO	22496861	gold, Green Published, Green Submitted			2022-12-27	WOS:000304855200081
J	Crumbley, C; Wang, YJ; Banerjee, S; Burris, TP				Crumbley, Christine; Wang, Yongjun; Banerjee, Subhashis; Burris, Thomas P.			Regulation of Expression of Citrate Synthase by the Retinoic Acid Receptor-Related Orphan Receptor alpha (ROR alpha)	PLOS ONE			English	Article							NUCLEAR RECEPTOR; GENE-EXPRESSION; TRANSCRIPTIONAL REGULATION; LIGAND; CHOLESTEROL; METABOLISM; COMPONENT	The retinoic acid receptor-related orphan receptor alpha (ROR alpha) is a member of the nuclear receptor superfamily of transcription factors that Plays an important role in regulation of the circadian rhythm and metabolism. Mice lacking a functional ROR alpha display a range of metabolic abnormalities including decreased serum cholesterol and plasma triglycerides. Citrate synthase (CS) is a key enzyme of the citric acid cycle that provides energy for cellular function. Additionally, CS plays a critical role in providing citrate derived acetyl-CoA for lipogenesis and cholesterologenesis. Here, we identified a functional ROR alpha response element (RORE) in the promoter of the CS gene. ChIP analysis demonstrates ROR alpha occupancy of the CS promoter and a putative RORE binds to ROR alpha effectively in an electrophoretic mobility shift assay and confers ROR alpha responsiveness to a reporter gene in a cotransfection assay. We also observed a decrease in CS gene expression and CS enzymatic activity in the staggerer mouse, which has a mutation of in the Rora gene resulting in nonfunctional ROR alpha. protein. Furthermore, we found that SR1001 a ROR alpha inverse agonist eliminated the circadian pattern of expression of CS mRNA in mice. These data suggest that CS is a direct ROR alpha target gene and one mechanism by which ROR alpha regulates lipid metabolism is via regulation of CS expression.	[Crumbley, Christine] Scripps Res Inst, Dept Mol Therapeut, Jupiter, FL USA; Scripps Res Inst, Ctr Diabet & Metab Dis, Jupiter, FL USA	Scripps Research Institute; Scripps Research Institute	Crumbley, C (corresponding author), Scripps Res Inst, Dept Mol Therapeut, Jupiter, FL USA.	tburris@scripps.edu	Burris, Thomas P/B-3886-2016	Burris, Thomas P/0000-0003-2922-4449	National Institutes of Health [DK080201, MH092769]; American Heart Association [10PRE4330013]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080201] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH092769] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by National Institutes of Health grants (DK080201 and MH092769 to TPB) and the American Heart Association (10PRE4330013 to CC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bass J, 2010, SCIENCE, V330, P1349, DOI 10.1126/science.1195027; Burris TP, 2008, MOL ENDOCRINOL, V22, P1509, DOI 10.1210/me.2007-0519; Chen YP, 2009, J PHARMACOL EXP THER, V329, P192, DOI 10.1124/jpet.108.148916; Chopra AR, 2008, SCIENCE, V322, P1395, DOI 10.1126/science.1164847; Crumbley C, 2010, J BIOL CHEM, V285, P35386, DOI 10.1074/jbc.M110.129288; GLATZ JFC, 1984, J BIOL CHEM, V259, P4295; Green CB, 2008, CELL, V134, P728, DOI 10.1016/j.cell.2008.08.022; Jetten Anton M, 2009, Nucl Recept Signal, V7, pe003, DOI 10.1621/nrs.07003; Kallen J, 2004, J BIOL CHEM, V279, P14033, DOI 10.1074/jbc.M400302200; Kallen JA, 2002, STRUCTURE, V10, P1697, DOI 10.1016/S0969-2126(02)00912-7; Kraft CS, 2006, AM J PHYSIOL-CELL PH, V290, pC1119, DOI 10.1152/ajpcell.00463.2005; Kumar N, 2011, ACS CHEM BIOL, V6, P218, DOI 10.1021/cb1002762; Kumar N, 2010, MOL PHARMACOL, V77, P228, DOI 10.1124/mol.109.060905; Lau P, 2008, J BIOL CHEM, V283, P18411, DOI 10.1074/jbc.M710526200; Mamontova A, 1998, CIRCULATION, V98, P2738, DOI 10.1161/01.CIR.98.24.2738; Ovcharenko I, 2004, NUCLEIC ACIDS RES, V32, pW280; Raspe E, 2001, J BIOL CHEM, V276, P2865, DOI 10.1074/jbc.M004982200; Sato TK, 2004, NEURON, V43, P527, DOI 10.1016/j.neuron.2004.07.018; Solt LA, 2011, NATURE, V472, P491, DOI 10.1038/nature10075; Solt LA, 2011, FUTURE MED CHEM, V3, P623, DOI [10.4155/FMC.11.9, 10.4155/fmc.11.9]; Takeda Y, 2011, NUCLEIC ACIDS RES, V39, P4769, DOI 10.1093/nar/gkq1335; VuDac N, 1997, J BIOL CHEM, V272, P22401, DOI 10.1074/jbc.272.36.22401; Wada T, 2008, EXP BIOL MED, V233, P1191, DOI 10.3181/0802-MR-50; Wang YJ, 2010, ACS CHEM BIOL, V5, P1029, DOI 10.1021/cb100223d; Wang YJ, 2010, BBA-MOL CELL BIOL L, V1801, P917, DOI 10.1016/j.bbalip.2010.02.012; Wang YJ, 2010, J BIOL CHEM, V285, P15668, DOI 10.1074/jbc.M110.102160; Wang YJ, 2010, J BIOL CHEM, V285, P5013, DOI 10.1074/jbc.M109.080614	27	18	18	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2012	7	4							e33804	10.1371/journal.pone.0033804	http://dx.doi.org/10.1371/journal.pone.0033804			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952GU	22485150	Green Published, gold			2022-12-27	WOS:000304780500026
J	Kelly, MA; Rees, SD; Hydrie, MZI; Shera, AS; Bellary, S; O'Hare, JP; Kumar, S; Taheri, S; Basit, A; Barnett, AH				Kelly, M. Ann; Rees, Simon D.; Hydrie, M. Zafar I.; Shera, A. Samad; Bellary, Srikanth; O'Hare, J. Paul; Kumar, Sudhesh; Taheri, Shahrad; Basit, Abdul; Barnett, Anthony H.		DIAGRAM Consortium; SAT2D Consortium	Circadian Gene Variants and Susceptibility to Type 2 Diabetes: A Pilot Study	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; PROSTATE-CANCER RISK; METABOLIC SYNDROME; SLEEP DURATION; SHIFT WORK; METAANALYSIS; LOCI; MELLITUS	Background: Disruption of endogenous circadian rhythms has been shown to increase the risk of developing type 2 diabetes, suggesting that circadian genes might play a role in determining disease susceptibility. We present the results of a pilot study investigating the association between type 2 diabetes and selected single nucleotide polymorphisms (SNPs) in/near nine circadian genes. The variants were chosen based on their previously reported association with prostate cancer, a disease that has been suggested to have a genetic link with type 2 diabetes through a number of shared inherited risk determinants. Methodology/Principal Findings:The pilot study was performed using two genetically homogeneous Punjabi cohorts, one resident in the United Kingdom and one indigenous to Pakistan. Subjects with (N = 1732) and without (N = 1780) type 2 diabetes were genotyped for thirteen circadian variants using a competitive allele-specific polymerase chain reaction method. Associations between the SNPs and type 2 diabetes were investigated using logistic regression. The results were also combined with in silico data from other South Asian datasets (SAT2D consortium) and white European cohorts (DIAGRAM+) using meta-analysis. The rs7602358G allele near PER2 was negatively associated with type 2 diabetes in our Punjabi cohorts (combined odds ratio [OR]= 0.75 [0.66-0.86], p = 3.18 x 10(-5)), while the BMAL1 rs11022775T allele was associated with an increased risk of the disease (combined OR = 1.22 [1.07-1.39], p = 0.003). Neither of these associations was replicated in the SAT2D or DIAGRAM+ datasets, however. Meta-analysis of all the cohorts identified disease associations with two variants, rs2292912 in CRY2 and rs12315175 near CRY1, although statistical significance was nominal (combined OR 1.05 [1.01-1.08], p = 0.008 and OR = 0.95 [0.91-0.99], p = 0.015 respectively). Conclusions/significance: None of the selected circadian gene variants was associated with type 2 diabetes with study-wide significance after meta-analysis. The nominal association observed with the CRY2 SNP, however, complements previous findings and confirms a role for this locus in disease susceptibility.	[Kelly, M. Ann; Rees, Simon D.; Taheri, Shahrad] Univ Birmingham, Coll Med & Dent Sci, Birmingham, W Midlands, England; [Kelly, M. Ann; Rees, Simon D.; Bellary, Srikanth; Taheri, Shahrad; Barnett, Anthony H.] Heart England NHS Fdn Trust, BioMed Res Ctr, Birmingham, W Midlands, England; [Hydrie, M. Zafar I.; Basit, Abdul] BIDE, Karachi, Pakistan; [Shera, A. Samad] Diabet Assoc Pakistan, Karachi, Pakistan; [Bellary, Srikanth] Aston Univ, Sch Life & Hlth Sci, Birmingham B4 7ET, W Midlands, England; [O'Hare, J. Paul; Kumar, Sudhesh] Univ Warwick, Warwick Med Sch, Coventry CV4 7AL, W Midlands, England	University of Birmingham; Heart of England NHS Foundation Trust; Aston University; University of Warwick	Kelly, MA (corresponding author), Univ Birmingham, Coll Med & Dent Sci, Birmingham, W Midlands, England.	m.a.kelly@bham.ac.uk	Benediktsson, Rafn/R-2457-2018; Roden, Michael/AAD-3843-2019; Hide, Winston/R-3815-2019; Walters, G. Bragi/L-4215-2013; Shah, Nabi/Q-1008-2016; Hydrie, Muhammad Zafar Iqbal/H-8490-2017; Rudan, Igor/I-1467-2012; Hide, Winston Hide/C-7217-2009; Bellary, Srikanth/ABA-1977-2020; Elliott, Amanda/G-5120-2012; Boehm, Bernhard Otto/F-8750-2015; Langenberg, Claudia/ABG-9067-2021; Taheri, Shahrad/O-9721-2016; Hide, Winston A/V-2727-2017; Meitinger, Thomas/O-1318-2015; FROGUEL, Philippe/O-6799-2017; kumar, sudhesh/D-6945-2013; Aulchenko, Yurii/M-8270-2013	Benediktsson, Rafn/0000-0002-2954-9801; Hide, Winston/0000-0002-8621-3271; Walters, G. Bragi/0000-0002-5415-6487; Shah, Nabi/0000-0003-2764-3615; Hydrie, Muhammad Zafar Iqbal/0000-0002-1317-6975; Rudan, Igor/0000-0001-6993-6884; Hide, Winston Hide/0000-0002-8621-3271; Bellary, Srikanth/0000-0002-5924-5278; Langenberg, Claudia/0000-0002-5017-7344; Taheri, Shahrad/0000-0001-8314-1500; Hide, Winston A/0000-0002-8621-3271; FROGUEL, Philippe/0000-0003-2972-0784; Jorgensen, Torben/0000-0001-9453-2830; Van Duijn, Cornelia/0000-0002-2374-9204; Hattersley, Andrew/0000-0001-5620-473X; Gloyn, Anna/0000-0003-1205-1844; Dina, Christian/0000-0002-7722-7348; kumar, sudhesh/0000-0003-4326-5941; Lindgren, Cecilia/0000-0002-4903-9374; Zeggini, Eleftheria/0000-0003-4238-659X; Aulchenko, Yurii/0000-0002-7899-1575; van Vliet-Ostaptchouk, Jana/0000-0002-7943-3153; bennett, amanda/0000-0003-2140-8710; Meitinger, Thomas/0000-0002-8838-8403; Katulanda, Prasad/0000-0003-4313-7528; Weedon, Michael/0000-0002-6174-6135; Couper, David/0000-0002-4313-9235; Bergman, Richard/0000-0003-1539-4471; Manickam, Chidambaram/0000-0001-8750-8576	Diabetes United Kingdom [07/0003512]; Pfizer; Sanofi-Aventis; Servier Laboratories United Kingdom; Merck Sharp and Dohme/Schering-Plough; Takeda UK; Roche; Merck Pharma; Daiichi-Sankyo United Kingdom; Boehringer Ingelheim; Eli Lilly; Novo Nordisk; Bristol-Myers Squibb; Solvay Health Care; Assurance Medical Society United Kingdom; British Heart Foundation [RG/08/014/24067] Funding Source: researchfish; Medical Research Council [G0600717B, MC_U106179471] Funding Source: researchfish; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG000024] Funding Source: NIH RePORTER	Diabetes United Kingdom(Diabetes UK); Pfizer(Pfizer); Sanofi-Aventis(Sanofi-Aventis); Servier Laboratories United Kingdom; Merck Sharp and Dohme/Schering-Plough(Merck & CompanySchering Plough Corporation); Takeda UK(Takeda Pharmaceutical Company Ltd); Roche(Roche Holding); Merck Pharma; Daiichi-Sankyo United Kingdom; Boehringer Ingelheim(Boehringer Ingelheim); Eli Lilly(Eli Lilly); Novo Nordisk(Novo Nordisk); Bristol-Myers Squibb(Bristol-Myers Squibb); Solvay Health Care(Solvay SA); Assurance Medical Society United Kingdom; British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	Collection of DNA and clinical data from the Pakistan-resident population was supported by Diabetes United Kingdom (project number 07/0003512, www.diabetes.org.uk). The United Kingdom Asian Diabetes Study (UKADS) was supported by Pfizer, Sanofi-Aventis, Servier Laboratories United Kingdom, Merck Sharp and Dohme/Schering-Plough, Takeda UK, Roche, Merck Pharma, Daiichi-Sankyo United Kingdom, Boehringer Ingelheim, Eli Lilly, Novo Nordisk, Bristol-Myers Squibb, Solvay Health Care and Assurance Medical Society United Kingdom. Funding for the genetic analyses was provided by Eli Lilly. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Bellary S, 2008, LANCET, V371, P1769, DOI 10.1016/S0140-6736(08)60764-3; Below JE, 2011, DIABETOLOGIA, V54, P2047, DOI 10.1007/s00125-011-2188-3; Chaput JP, 2007, DIABETOLOGIA, V50, P2298, DOI 10.1007/s00125-007-0786-x; Conlon M, 2007, EPIDEMIOLOGY, V18, P182, DOI 10.1097/01.ede.0000249519.33978.31; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Englund Ani, 2009, J Circadian Rhythms, V7, P5, DOI 10.1186/1740-3391-7-5; Gangwisch JE, 2007, SLEEP, V30, P1667, DOI 10.1093/sleep/30.12.1667; Garaulet M, 2010, J AM DIET ASSOC, V110, P917, DOI 10.1016/j.jada.2010.03.017; Karlsson B, 2005, SCAND J WORK ENV HEA, V31, P30, DOI 10.5271/sjweh.845; Karlsson B, 2001, OCCUP ENVIRON MED, V58, P747, DOI 10.1136/oem.58.11.747; Kasper JS, 2006, CANCER EPIDEM BIOMAR, V15, P2056, DOI 10.1158/1055-9965.EPI-06-0410; Kim ST, 2010, PROSTATE, V70, P1729, DOI 10.1002/pros.21208; Kooner JS, 2011, NAT GENET, V43, P984, DOI 10.1038/ng.921; Marcheva B, 2010, NATURE, V466, P627, DOI 10.1038/nature09253; Maury E, 2010, CIRC RES, V106, P447, DOI 10.1161/CIRCRESAHA.109.208355; Meyer TE, 2010, CANCER EPIDEM BIOMAR, V19, P558, DOI 10.1158/1055-9965.EPI-09-0902; Okano S, 2010, EUR J CLIN INVEST, V40, P1011, DOI 10.1111/j.1365-2362.2010.02359.x; Pierce BL, 2010, HUM HERED, V69, P193, DOI 10.1159/000289594; Prokopenko I, 2009, NAT GENET, V41, P77, DOI 10.1038/ng.290; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rees SD, 2011, DIABETOLOGIA, V54, P1368, DOI 10.1007/s00125-011-2063-2; Scheer FAJL, 2009, P NATL ACAD SCI USA, V106, P4453, DOI 10.1073/pnas.0808180106; Stevens VL, 2010, PROSTATE, V70, P601, DOI 10.1002/pros.21094; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Waters KM, 2011, CANCER EPIDEM BIOMAR, V20, P1979, DOI 10.1158/1055-9965.EPI-11-0019; Woon PY, 2007, P NATL ACAD SCI USA, V104, P14412, DOI 10.1073/pnas.0703247104; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; Zhang EE, 2010, NAT MED, V16, P1152, DOI 10.1038/nm.2214; Zhu Y, 2009, CANCER RES, V69, P9315, DOI 10.1158/0008-5472.CAN-09-0648	30	40	42	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2012	7	4							e32670	10.1371/journal.pone.0032670	http://dx.doi.org/10.1371/journal.pone.0032670			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952GU	22485135	Green Published, gold, Green Accepted			2022-12-27	WOS:000304780500011
J	St Gelais, C; Coleman, CM; Wang, JH; Wu, L				St Gelais, Corine; Coleman, Christopher M.; Wang, Jian-Hua; Wu, Li			HIV-1 Nef Enhances Dendritic Cell-Mediated Viral Transmission to CD4(+) T Cells and Promotes T-Cell Activation	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; DC-SIGN; PRIMATE LENTIVIRUSES; TYPE-1 REPLICATION; DOWN-REGULATION; ANTIGEN PRESENTATION; TRANS-ENHANCEMENT; INFECTION; PROTEIN; LYMPHOCYTES	HIV-1 Nef enhances dendritic cell (DC)-mediated viral transmission to CD4(+) T cells, but the underlying mechanism is not fully understood. It is also unknown whether HIV-1 infected DCs play a role in activating CD4(+) T cells and enhancing DC-mediated viral transmission. Here we investigated the role of HIV-1 Nef in DC-mediated viral transmission and HIV-1 infection of primary CD4(+) T cells using wild-type HIV-1 and Nef-mutated viruses. We show that HIV-1 Nef facilitated DC-mediated viral transmission to activated CD4(+) T cells. HIV-1 expressing wild-type Nef enhanced the activation and proliferation of primary resting CD4(+) T cells. However, when co-cultured with HIV-1-infected autologous DCs, there was no significant trend for infection- or Nef-dependent proliferation of resting CD4(+) T cells. Our results suggest an important role of Nef in DC-mediated transmission of HIV-1 to activated CD4(+) T cells and in the activation and proliferation of resting CD4(+) T cells, which likely contribute to viral pathogenesis.	[St Gelais, Corine; Coleman, Christopher M.; Wu, Li] Ohio State Univ, Ctr Retrovirus Res, Dept Vet Biosci, Columbus, OH 43210 USA; [Wang, Jian-Hua] Chinese Acad Sci, Key Lab Mol Virol & Immunol, Inst Pasteur Shanghai, Shanghai Inst Biol Sci, Shanghai, Peoples R China; [Wu, Li] Ohio State Univ, Med Ctr, Dept Microbial Infect & Immun, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Le Reseau International des Instituts Pasteur (RIIP); University System of Ohio; Ohio State University	St Gelais, C (corresponding author), Ohio State Univ, Ctr Retrovirus Res, Dept Vet Biosci, Columbus, OH 43210 USA.	wu.840@osu.edu	Wu, Li/ABB-2813-2020; Wu, Li/E-4330-2011	Wu, Li/0000-0002-5468-2487; Wu, Li/0000-0002-5468-2487; Coleman, Christopher/0000-0002-7306-8407	National Institutes of Health (NIH) [AI068493, AI078762, R21AI098524]; Public Health Preparedness for Infectious Diseases of The Ohio State University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068493, R21AI078762, R21AI102822, R21AI098524] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Public Health Preparedness for Infectious Diseases of The Ohio State University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a grant (AI068493) to LW from the National Institutes of Health (NIH) and by the program of Public Health Preparedness for Infectious Diseases of The Ohio State University. LW was supported in part by grants AI078762 and R21AI098524 from the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIKEN C, 1995, J VIROL, V69, P5048, DOI 10.1128/JVI.69.8.5048-5056.1995; Arhel NJ, 2009, CURR TOP MICROBIOL, V339, P147, DOI 10.1007/978-3-642-02175-6_8; Arrighi JF, 2004, J EXP MED, V200, P1279, DOI 10.1084/jem.20041356; Baribaud F, 2001, VIROLOGY, V286, P1, DOI 10.1006/viro.2001.0975; Boggiano C, 2007, J VIROL, V81, P2519, DOI 10.1128/JVI.01661-06; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Burleigh L, 2006, J VIROL, V80, P2949, DOI 10.1128/JVI.80.6.2949-2957.2006; Coleman CM, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-26; Coleman CM, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-51; CONNOR RI, 1995, VIROLOGY, V206, P935, DOI 10.1006/viro.1995.1016; DANIEL MD, 1992, SCIENCE, V258, P1938, DOI 10.1126/science.1470917; DEACON NJ, 1995, SCIENCE, V270, P988, DOI 10.1126/science.270.5238.988; Dong CS, 2007, J VIROL, V81, P11352, DOI 10.1128/JVI.01081-07; ENGLUND G, 1995, J VIROL, V69, P3216, DOI 10.1128/JVI.69.5.3216-3219.1995; Fackler OT, 2007, NAT REV IMMUNOL, V7, P310, DOI 10.1038/nri2041; Fackler OT, 2001, CURR BIOL, V11, P1294, DOI 10.1016/S0960-9822(01)00373-6; Finzi D, 1998, CELL, V93, P665, DOI 10.1016/S0092-8674(00)81427-0; Foskett SM, 2001, J VIROL, V75, P1220, DOI 10.1128/JVI.75.3.1220-1228.2001; Foster JL, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-84; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; Geyer M, 2001, EMBO REP, V2, P580, DOI 10.1093/embo-reports/kve141; Gummuluru S, 2003, J VIROL, V77, P12865, DOI 10.1128/JVI.77.23.12865-12874.2003; Gummuluru S, 2002, J VIROL, V76, P10692, DOI 10.1128/JVI.76.21.10692-10701.2002; Gurney KB, 2005, J VIROL, V79, P5762, DOI 10.1128/JVI.79.9.5762-5773.2005; Hrecka K, 2011, NATURE, V474, P658, DOI 10.1038/nature10195; Izquierdo-Useros N, 2007, J VIROL, V81, P7559, DOI 10.1128/JVI.02572-06; KESTLER HW, 1991, CELL, V65, P651, DOI 10.1016/0092-8674(91)90097-I; Kirchhoff F, 2008, CELL MOL LIFE SCI, V65, P2621, DOI 10.1007/s00018-008-8094-2; KIRCHHOFF F, 1995, NEW ENGL J MED, V332, P228, DOI 10.1056/NEJM199501263320405; Kirchhoff F, 2010, CELL HOST MICROBE, V8, P55, DOI 10.1016/j.chom.2010.06.004; Kwon DS, 2002, IMMUNITY, V16, P135, DOI 10.1016/S1074-7613(02)00259-5; Laguette N, 2011, NATURE, V474, P654, DOI 10.1038/nature10117; Lama J, 2000, J VIROL, V74, P9396, DOI 10.1128/JVI.74.20.9396-9402.2000; Lore K, 2005, J EXP MED, V201, P2023, DOI 10.1084/jem.20042413; Lundquist CA, 2004, J VIROL, V78, P6287, DOI 10.1128/JVI.78.12.6287-6296.2004; Lundquist CA, 2002, J VIROL, V76, P4625, DOI 10.1128/JVI.76.9.4625-4633.2002; Manel N, 2010, NATURE, V467, P214, DOI 10.1038/nature09337; McDonald D, 2003, SCIENCE, V300, P1295, DOI 10.1126/science.1084238; Messmer D, 2002, J IMMUNOL, V169, P4172, DOI 10.4049/jimmunol.169.8.4172; Messmer D, 2002, AIDS RES HUM RETROV, V18, P1043, DOI 10.1089/08892220260235407; Michel N, 2005, CURR BIOL, V15, P714, DOI 10.1016/j.cub.2005.02.058; Moris A, 2006, BLOOD, V108, P1643, DOI 10.1182/blood-2006-02-006361; Muratori C, 2009, CELL HOST MICROBE, V6, P218, DOI 10.1016/j.chom.2009.06.009; Neri F, 2011, VIROLOGY, V410, P316, DOI 10.1016/j.virol.2010.11.018; Nobile C, 2005, J VIROL, V79, P5386, DOI 10.1128/JVI.79.9.5386-5399.2005; Petit C, 2001, VIROLOGY, V286, P225, DOI 10.1006/viro.2001.0984; Piguet V, 1999, IMMUNOL REV, V168, P51, DOI 10.1111/j.1600-065X.1999.tb01282.x; Piguet V, 2007, TRENDS IMMUNOL, V28, P503, DOI 10.1016/j.it.2007.07.010; Ruiz A, 2010, CURR HIV RES, V8, P240, DOI 10.2174/157016210791111124; Sanders RW, 2002, J VIROL, V76, P7812, DOI 10.1128/JVI.76.15.7812-7821.2002; Schindler M, 2006, CELL, V125, P1055, DOI 10.1016/j.cell.2006.04.033; Schwartz O, 1996, NAT MED, V2, P338, DOI 10.1038/nm0396-338; Shen L, 2008, J ALLERGY CLIN IMMUN, V122, P22, DOI 10.1016/j.jaci.2008.05.033; Smed-Sorensen A, 2005, J VIROL, V79, P8861, DOI 10.1128/JVI.79.14.8861-8869.2005; Sol-Foulon N, 2002, IMMUNITY, V16, P145, DOI 10.1016/S1074-7613(02)00260-1; St Gelais C, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-55; Stumptner-Cuvelette P, 2001, P NATL ACAD SCI USA, V98, P12144, DOI 10.1073/pnas.221256498; Swigut T, 2001, EMBO J, V20, P1593, DOI 10.1093/emboj/20.7.1593; Trumpfheller C, 2003, INT IMMUNOL, V15, P289, DOI 10.1093/intimm/dxg030; Turville SG, 2004, BLOOD, V103, P2170, DOI 10.1182/blood-2003-09-3129; Unutmaz D, 1999, J EXP MED, V189, P1735, DOI 10.1084/jem.189.11.1735; Wang JH, 2007, J VIROL, V81, P8933, DOI 10.1128/JVI.00878-07; Wang JH, 2007, J VIROL, V81, P2497, DOI 10.1128/JVI.01970-06; Wu L, 2004, VIROLOGY, V318, P17, DOI 10.1016/j.virol.2003.09.028; Wu L, 2002, P NATL ACAD SCI USA, V99, P1568, DOI 10.1073/pnas.032654399; Wu L, 2002, J VIROL, V76, P5905, DOI 10.1128/JVI.76.12.5905-5914.2002; Wu L, 2008, CURR OPIN HIV AIDS, V3, P534, DOI 10.1097/COH.0b013e32830634c6; Wu L, 2006, NAT REV IMMUNOL, V6, P859, DOI 10.1038/nri1960; Wu YT, 2001, SCIENCE, V293, P1503, DOI 10.1126/science.1061548; Zhou J, 2001, J VIROL, V75, P5851, DOI 10.1128/JVI.75.13.5851-5859.2001; ZIEGLER SF, 1994, STEM CELLS, V12, P456, DOI 10.1002/stem.5530120502	71	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e34521	10.1371/journal.pone.0034521	http://dx.doi.org/10.1371/journal.pone.0034521			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479639	Green Published, Green Submitted, gold			2022-12-27	WOS:000305339100164
J	Levy, D; Davidovich, A; Zirkin, S; Frug, Y; Cohen, AM; Shalom, S; Don, J				Levy, Daphna; Davidovich, Ateret; Zirkin, Shahar; Frug, Yulia; Cohen, Amos M.; Shalom, Sara; Don, Jeremy			Activation of Cell Cycle Arrest and Apoptosis by the Proto-Oncogene Pim-2	PLOS ONE			English	Article							P73 INDUCES APOPTOSIS; C-MYC; CDC25A PHOSPHATASE; LYMPHOID TUMORS; TRANSGENIC MICE; DNA-DAMAGE; N-MYC; KINASES; INHIBITOR; GROWTH	Potent survival effects have been ascribed to the serine/threonine kinase proto-oncogene PIM-2. Elevated levels of PIM-2 are associated with various malignancies. In human cells, a single Pim-2 transcript gives rise mainly to two protein isoforms (34, 41 kDa) that share an identical catalytic site but differ at their N-terminus, due to in-frame alternative translation initiation sites. In this study we observed that the 34 kDa PIM-2 isoform has differential nuclear and cytoplasmic forms in all tested cell lines, suggesting a possible role for the balance between these forms for PIM-2's function. To further study the cellular role of the 34 kDa isoform of PIM-2, an N-terminally HA-tagged form of this isoform was transiently expressed in HeLa cells. Surprisingly, this resulted in increased level of G1 arrested cells, as well as of apoptotic cells. These effects could not be obtained by a Flag-tagged form of the 41 kDa isoform. The G1 arrest and apoptotic effects were associated with an increase in T14/Y15 phosphorylation of CDK2 and proteasom-dependent down-regulation of CDC25A, as well as with up-regulation of p57, E2F-1, and p73. No such effects were obtained upon over-expression of a kinase-dead form of the HA-tagged 34 kDa PIM-2. By either using a dominant negative form of p73, or by over-expressing the 34 kDa PIM-2 in p73-silenced cells, we demonstrated that these effects were p73-dependent. These results demonstrate that while PIM-2 can function as a potent survival factor, it can, under certain circumstances, exhibit pro-apoptotic effects as well.	[Levy, Daphna; Davidovich, Ateret; Zirkin, Shahar; Frug, Yulia; Shalom, Sara; Don, Jeremy] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, Ramat Gan, Israel; [Cohen, Amos M.] Rabin Med Ctr, Hematooncol Unit, Davidoff Ctr, Petah Tiqwa, Israel	Bar Ilan University; Rabin Medical Center	Levy, D (corresponding author), Chaim Sheba Med Ctr, Ella Inst Melanoma, IL-52621 Tel Hashomer, Israel.	jeremy.don@biu.ac.il	Don, Jeremy/AAS-1240-2021		Israel Cancer Association; Israeli Ministry of Health [3-00000-5049]; NICHD	Israel Cancer Association; Israeli Ministry of Health; NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This research was partially funded by the Israel Cancer Association through the "Ber-Lehmsdorf'' memorial fund in memory of the late John Furman, and by grant No. 3-00000-5049 of the Israeli Ministry of Health Chief Scientist Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.; The authors are grateful to Prof. Doron Ginsberg for generously providing us with a dominant negative construct of p73 and for reviewing the manuscript. The anti -beta-Tubulin monoclonal antibody, developed by Michael Klymkowsky, was obtained from the Developmental Studies Hybridoma Bank developed under the auspices of the NICHD and maintained by the University of Iowa, Department of Biological Sciences, Iowa City IA 52242.	Allen JD, 1997, ONCOGENE, V15, P1133, DOI 10.1038/sj.onc.1201288; Amaravadi R, 2005, J CLIN INVEST, V115, P2618, DOI 10.1172/JCI26273; Bachmann M, 2005, INT J BIOCHEM CELL B, V37, P726, DOI 10.1016/j.biocel.2004.11.005; Balint E, 2002, P NATL ACAD SCI USA, V99, P3529, DOI 10.1073/pnas.062491899; Bartek J, 2004, NAT REV MOL CELL BIO, V5, P792, DOI 10.1038/nrm1493; Baytel D, 1998, BBA-GENE STRUCT EXPR, V1442, P274, DOI 10.1016/S0167-4781(98)00185-7; Boutros R, 2006, CURR OPIN CELL BIOL, V18, P185, DOI 10.1016/j.ceb.2006.02.003; Busino L, 2004, ONCOGENE, V23, P2050, DOI 10.1038/sj.onc.1207394; Chen JL, 2008, BLOOD, V111, P1677, DOI 10.1182/blood-2007-04-083808; Chen LS, 2009, BLOOD, V114, P4150, DOI 10.1182/blood-2009-03-212852; Chen WW, 2005, MOL CANCER RES, V3, P443, DOI 10.1158/1541-7786.MCR-05-0007; Cohen AM, 2004, LEUKEMIA LYMPHOMA, V45, P951, DOI 10.1080/10428190310001641251; Coqueret O, 2000, J BIOL CHEM, V275, P18794, DOI 10.1074/jbc.M001601200; CUYPERS HT, 1984, CELL, V37, P141; Dai H, 2005, PROSTATE, V65, P276, DOI 10.1002/pros.20294; De Clercq A, 2006, CRIT REV BIOCHEM MOL, V41, P293, DOI 10.1080/10409230600856685; Delavaine L, 1999, ONCOGENE, V18, P5381, DOI 10.1038/sj.onc.1202923; Donzelli M, 2003, EMBO REP, V4, P671, DOI 10.1038/sj.embor.embor887; EPSTEIN MA, 1966, J NATL CANCER I, V37, P547; Fox CJ, 2003, GENE DEV, V17, P1841, DOI 10.1101/gad.1105003; Gil S, 2006, DEV BIOL, V298, P201, DOI 10.1016/j.ydbio.2006.06.029; Ginsberg D, 2002, FEBS LETT, V529, P122, DOI 10.1016/S0014-5793(02)03270-2; Golsteyn RM, 2005, CANCER LETT, V217, P129, DOI 10.1016/j.canlet.2004.08.005; Gonzalez S, 2005, CANCER RES, V65, P2186, DOI 10.1158/0008-5472.CAN-04-3047; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Guo G, 2010, ONCOGENE, V29, P3845, DOI 10.1038/onc.2010.149; Hammerman PS, 2004, CANCER RES, V64, P8341, DOI 10.1158/0008-5472.CAN-04-2284; Hershko T, 2005, CELL DEATH DIFFER, V12, P377, DOI 10.1038/sj.cdd.4401575; HIEBERT SW, 1995, MOL CELL BIOL, V15, P6864; Hiromura K, 2002, ONCOGENE, V21, P1750, DOI 10.1038/sj.onc.1205238; Ionov Y, 2003, ANTICANCER RES, V23, P167; Irwin M, 2000, NATURE, V407, P645, DOI 10.1038/35036614; KAIGHN ME, 1979, INVEST UROL, V17, P16; KOEFFLER HP, 1980, BLOOD, V56, P344; Kutchera W, 1996, P NATL ACAD SCI USA, V93, P4816, DOI 10.1073/pnas.93.10.4816; LAIRD PW, 1993, NUCLEIC ACIDS RES, V21, P4750, DOI 10.1093/nar/21.20.4750; Li GM, 2004, J IMMUNOL, V173, P2383, DOI 10.4049/jimmunol.173.4.2383; Lin YW, 2010, BLOOD, V115, P824, DOI 10.1182/blood-2009-07-233445; Macdonald A, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-1; Melino G, 2004, J BIOL CHEM, V279, P8076, DOI 10.1074/jbc.M307469200; Mikkers H, 2004, MOL CELL BIOL, V24, P6104, DOI 10.1128/MCB.24.13.6104-6115.2004; Mochizuki T, 1999, J BIOL CHEM, V274, P18659, DOI 10.1074/jbc.274.26.18659; Morishita D, 2008, CANCER RES, V68, P5076, DOI 10.1158/0008-5472.CAN-08-0634; Moroni MC, 2001, NAT CELL BIOL, V3, P552, DOI 10.1038/35078527; MOROY T, 1991, ONCOGENE, V6, P1941; Muraski JA, 2007, NAT MED, V13, P1467, DOI 10.1038/nm1671; Nawijn MC, 2011, NAT REV CANCER, V11, P23, DOI 10.1038/nrc2986; Peng C, 2007, J BIOCHEM, V141, P353, DOI 10.1093/jb/mvm040; Powers JT, 2004, MOL CANCER RES, V2, P203; PRATT SE, 1993, CANCER RES, V53, P5193; Ramadan S, 2005, BIOCHEM BIOPH RES CO, V331, P713, DOI 10.1016/j.bbrc.2005.03.156; Samuelsson MKR, 1999, MOL ENDOCRINOL, V13, P1811, DOI 10.1210/me.13.11.1811; Samuelsson MKR, 2002, BIOCHEM BIOPH RES CO, V296, P702, DOI 10.1016/S0006-291X(02)00912-9; Scandura JM, 2004, P NATL ACAD SCI USA, V101, P15231, DOI 10.1073/pnas.0406771101; TRAINER DL, 1988, INT J CANCER, V41, P287, DOI 10.1002/ijc.2910410221; VANDERLUGT NMT, 1995, EMBO J, V14, P2536, DOI 10.1002/j.1460-2075.1995.tb07251.x; VANLOHUIZEN M, 1989, CELL, V56, P673, DOI 10.1016/0092-8674(89)90589-8; Vigneron A, 2006, J BIOL CHEM, V281, P34742, DOI 10.1074/jbc.M602492200; Vlachos P, 2007, CELL DEATH DIFFER, V14, P1497, DOI 10.1038/sj.cdd.4402158; Wang Z, 2001, J Vet Sci, V2, P167; Yan B, 2003, J BIOL CHEM, V278, P45358, DOI 10.1074/jbc.M307933200; Yonezawa Y, 2007, INT J ONCOL, V30, P1197; Zhang Y, 2008, ONCOGENE, V27, P4809, DOI 10.1038/onc.2008.123	63	17	18	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2012	7	4							e34736	10.1371/journal.pone.0034736	http://dx.doi.org/10.1371/journal.pone.0034736			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959FE	22506047	Green Submitted, Green Published, gold			2022-12-27	WOS:000305297500055
J	Akhtar, MW; Kim, MS; Adachi, M; Morris, MJ; Qi, XX; Richardson, JA; Bassel-Duby, R; Olson, EN; Kavalali, ET; Monteggia, LM				Akhtar, M. Waseem; Kim, Mi-Sung; Adachi, Megumi; Morris, Michael J.; Qi, Xiaoxia; Richardson, James A.; Bassel-Duby, Rhonda; Olson, Eric N.; Kavalali, Ege T.; Monteggia, Lisa M.			In Vivo Analysis of MEF2 Transcription Factors in Synapse Regulation and Neuronal Survival	PLOS ONE			English	Article							ACTIVITY-DEPENDENT REGULATION; MATURATION; PROTEIN; MICE; DIFFERENTIATION; EXPRESSION; PLASTICITY; SYSTEM; SWITCH; GENES	MEF2 (A-D) transcription factors govern development, differentiation and maintenance of various cell types including neurons. The role of MEF2 isoforms in the brain has been studied using in vitro manipulations with only MEF2C examined in vivo. In order to understand specific as well as redundant roles of the MEF2 isoforms, we generated brain-specific deletion of MEF2A and found that Mef2aKO mice show normal behavior in a range of paradigms including learning and memory. We next generated Mef2a and Mef2d brain-specific double KO (Mef2a/dDKO) mice and observed deficits in motor coordination and enhanced hippocampal short-term synaptic plasticity, however there were no alterations in learning and memory, Schaffer collateral pathway long-term potentiation, or the number of dendritic spines. Since previous work has established a critical role for MEF2C in hippocampal plasticity, we generated a Mef2a, Mef2c and Mef2d brain-specific triple KO (Mef2a/c/dTKO). Mef2a/c/d TKO mice have early postnatal lethality with increased neuronal apoptosis, indicative of a redundant role for the MEF2 factors in neuronal survival. We examined synaptic plasticity in the intact neurons in the Mef2a/c/d TKO mice and found significant impairments in short-term synaptic plasticity suggesting that MEF2C is the major isoform involved in hippocampal synaptic function. Collectively, these data highlight the key in vivo role of MEF2C isoform in the brain and suggest that MEF2A and MEF2D have only subtle roles in regulating hippocampal synaptic function.	[Akhtar, M. Waseem; Adachi, Megumi; Morris, Michael J.; Monteggia, Lisa M.] Univ Texas SW Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA; [Kim, Mi-Sung; Qi, Xiaoxia; Bassel-Duby, Rhonda; Olson, Eric N.] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Richardson, James A.] Univ Texas SW Med Ctr Dallas, Dept Pathol, Dallas, TX 75390 USA; [Kavalali, Ege T.] Univ Texas SW Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA; [Kavalali, Ege T.] Univ Texas SW Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Akhtar, MW (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA.	lisa.monteggia@utsouthwestern.edu	Adachi, Megumi/M-7746-2017	Adachi, Megumi/0000-0003-3404-6640	National Institutes of Health [MH081060, MH066198]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH066198, R01MH081060] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by National Institutes of Health grants MH081060 (L. M. M.) and MH066198 (E. T. K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar MW, 2009, J NEUROSCI, V29, P8288, DOI 10.1523/JNEUROSCI.0097-09.2009; Barbosa AC, 2008, P NATL ACAD SCI USA, V105, P9391, DOI 10.1073/pnas.0802679105; Dittgen T, 2004, P NATL ACAD SCI USA, V101, P18206, DOI 10.1073/pnas.0407976101; Fernandez-Chacon R, 2004, NEURON, V42, P237, DOI 10.1016/S0896-6273(04)00190-4; Flavell SW, 2008, NEURON, V60, P1022, DOI 10.1016/j.neuron.2008.11.029; Flavell SW, 2006, SCIENCE, V311, P1008, DOI 10.1126/science.1122511; Kavalali ET, 1999, P NATL ACAD SCI USA, V96, P12893, DOI 10.1073/pnas.96.22.12893; Kim Y, 2008, J CLIN INVEST, V118, P124, DOI 10.1172/JCI33255; Li H, 2008, P NATL ACAD SCI USA, V105, P9397, DOI 10.1073/pnas.0802876105; LYONS GE, 1995, J NEUROSCI, V15, P5727, DOI 10.1523/jneurosci.15-08-05727.1995; Mao ZX, 1999, SCIENCE, V286, P785, DOI 10.1126/science.286.5440.785; Monteggia LM, 2004, P NATL ACAD SCI USA, V101, P10827, DOI 10.1073/pnas.0402141101; Naya FJ, 2002, NAT MED, V8, P1303, DOI 10.1038/nm789; Nelson ED, 2006, CURR BIOL, V16, P710, DOI 10.1016/j.cub.2006.02.062; Pfeiffer BE, 2010, NEURON, V66, P191, DOI 10.1016/j.neuron.2010.03.017; Potthoff MJ, 2007, DEVELOPMENT, V134, P4131, DOI 10.1242/dev.008367; Pulipparacharuvil S, 2008, NEURON, V59, P621, DOI 10.1016/j.neuron.2008.06.020; Shalizi A, 2006, SCIENCE, V311, P1012, DOI 10.1126/science.1122513; Shelton JM, 2000, J LIPID RES, V41, P532; Zhuo L, 2001, GENESIS, V31, P85, DOI 10.1002/gene.10008; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	21	75	76	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2012	7	4							e34863	10.1371/journal.pone.0034863	http://dx.doi.org/10.1371/journal.pone.0034863			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JO	22496871	Green Published, Green Submitted, gold			2022-12-27	WOS:000305014500034
J	Xu, YL; Liu, LZ; Zhang, LF; Fu, S; Hu, YX; Wang, YJ; Fu, HR; Wu, KN; Xiao, HW; Liu, SQ; Yu, XH; Zheng, WY; Feng, B; Huang, H				Xu, Yulin; Liu, Lizhen; Zhang, Lifei; Fu, Shan; Hu, Yongxian; Wang, Yingjia; Fu, Huarui; Wu, Kangni; Xiao, Haowen; Liu, Senquan; Yu, Xiaohong; Zheng, Weiyan; Feng, Bo; Huang, He			Efficient Commitment to Functional CD34+Progenitor Cells from Human Bone Marrow Mesenchymal Stem-Cell-Derived Induced Pluripotent Stem Cells	PLOS ONE			English	Article							HEMATOPOIETIC DIFFERENTIATION; HUMAN FIBROBLASTS; STROMAL CELLS; GROWTH-FACTOR; TRANSPLANTATION; GENERATION; COCULTURE	The efficient commitment of a specialized cell type from induced pluripotent stem cells (iPSCs) without contamination from unknown substances is crucial to their use in clinical applications. Here, we propose that CD34+ progenitor cells, which retain hematopoietic and endothelial cell potential, could be efficiently obtained from iPSCs derived from human bone marrow mesenchymal stem cells (hBMMSC-iPSCs) with defined factors. By treatment with a cocktail containing mesodermal, hematopoietic, and endothelial inducers (BMP4, SCF, and VEGF, respectively) for 5 days, hBMMSC-iPSCs expressed the mesodermal transcription factors Brachyury and GATA-2 at higher levels than untreated groups (P<0.05). After culturing with another hematopoietic and endothelial inducer cocktail, including SCF, Flt3L, VEGF and IL-3, for an additional 7-9 days, CD34+ progenitor cells, which were undetectable in the initial iPSC cultures, reached nearly 20% of the total culture. This was greater than the relative number of progenitor cells produced from human-skin-fibroblast-derived iPSCs (hFib-iPSCs) or from the spontaneous differentiation groups (P<0.05), as assessed by flow cytometry analysis. These induced cells expressed hematopoietic transcription factors TAL-1 and SCL. They developed into various hematopoietic colonies when exposed to semisolid media with hematopoietic cytokines such as EPO and G-CSF. Hematopoietic cell lineages were identified by phenotype analysis with Wright-Giemsa staining. The endothelial potential of the cells was also verified by the confirmation of the formation of vascular tube-like structures and the expression of endothelial-specific markers CD31 and VE-CADHERIN. Efficient induction of CD34+ progenitor cells, which retain hematopoietic and endothelial cell potential with defined factors, provides an opportunity to obtain patient-specific cells for iPSC therapy and a useful model for the study of the mechanisms of hematopoiesis and drug screening.	[Xu, Yulin; Liu, Lizhen; Zhang, Lifei; Fu, Shan; Hu, Yongxian; Wang, Yingjia; Fu, Huarui; Wu, Kangni; Xiao, Haowen; Liu, Senquan; Yu, Xiaohong; Zheng, Weiyan; Huang, He] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Bone Marrow Transplantat Ctr, Hangzhou 310003, Zhejiang, Peoples R China; [Feng, Bo] Chinese Univ Hong Kong, Sch Biomed Sci, Hong Kong, Hong Kong, Peoples R China	Zhejiang University; Chinese University of Hong Kong	Xu, YL (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 1, Bone Marrow Transplantat Ctr, Hangzhou 310003, Zhejiang, Peoples R China.	hehuang.zju@gmail.com	Feng, Bo/D-7831-2014	Feng, Bo/0000-0002-4018-3257	National Post Doctor Science Fund of China [20100471736]; Major Program of Technology Research and International co-operative research of Zhejiang Province [2009C14011]; Zhejiang Provincial Key Medical Discipline (Medical Tissue Engineering)	National Post Doctor Science Fund of China; Major Program of Technology Research and International co-operative research of Zhejiang Province; Zhejiang Provincial Key Medical Discipline (Medical Tissue Engineering)	This study was supported by research funding from National Post Doctor Science Fund of China to YX [20100471736], from Major Program of Technology Research and International co-operative research of Zhejiang Province to WZ (2009C14011) and from Zhejiang Provincial Key Medical Discipline (Medical Tissue Engineering) to HH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cerdan C, 2004, BLOOD, V103, P2504, DOI 10.1182/blood-2003-07-2563; Chadwick K, 2003, BLOOD, V102, P906, DOI 10.1182/blood-2003-03-0832; Chicha L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014733; Choi KD, 2009, STEM CELLS, V27, P559, DOI 10.1634/stemcells.2008-0922; Copelan EA, 2006, NEW ENGL J MED, V354, P1813, DOI 10.1056/NEJMra052638; Feng Q, 2010, STEM CELLS, V28, P704, DOI 10.1002/stem.321; Grewal SS, 2003, BLOOD, V101, P4233, DOI 10.1182/blood-2002-08-2510; Hassan HT, 1996, ACTA HAEMATOL-BASEL, V95, P257; Hinterberger W, 2002, BONE MARROW TRANSPL, V30, P753, DOI 10.1038/sj.bmt.1703686; Kaufman DS, 2001, P NATL ACAD SCI USA, V98, P10716, DOI 10.1073/pnas.191362598; KELLER G, 1993, MOL CELL BIOL, V13, P473, DOI 10.1128/MCB.13.1.473; Kennedy M, 2007, BLOOD, V109, P2679, DOI 10.1182/blood-2006-09-047704; Korbling M, 2001, BLOOD, V98, P2900, DOI 10.1182/blood.V98.10.2900; Le Blanc K, 2005, CYTOTHERAPY, V7, P36, DOI 10.1080/14653240510018118; Ledran MH, 2008, CELL STEM CELL, V3, P85, DOI 10.1016/j.stem.2008.06.001; Leger CS, 2004, CAN MED ASSOC J, V170, P1569, DOI 10.1503/cmaj.1011625; Lengerke C, 2009, ANN NY ACAD SCI, V1176, P219, DOI 10.1111/j.1749-6632.2009.04606.x; Lerou PH, 2005, BLOOD REV, V19, P321, DOI 10.1016/j.blre.2005.01.005; Lu M, 2009, EXP HEMATOL, V37, P924, DOI 10.1016/j.exphem.2009.05.007; LYMAN SD, 1993, CELL, V75, P1157, DOI 10.1016/0092-8674(93)90325-K; Murdoch B, 2002, EXP HEMATOL, V30, P598, DOI 10.1016/S0301-472X(02)00793-2; Nakano T, 1996, SCIENCE, V272, P722, DOI 10.1126/science.272.5262.722; Niibe K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017610; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Park SW, 2010, BLOOD, V116, P5762, DOI 10.1182/blood-2010-04-280719; Pick M, 2007, STEM CELLS, V25, P2206, DOI 10.1634/stemcells.2006-0713; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Qiu CH, 2005, EXP HEMATOL, V33, P1450, DOI 10.1016/j.exphem.2005.09.003; Seiler K, 2011, STEM CELLS DEV, V20, P1131, DOI 10.1089/scd.2010.0391; Szabo E, 2010, NATURE, V468, P521, DOI 10.1038/nature09591; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tian XH, 2004, EXP HEMATOL, V32, P1000, DOI 10.1016/j.exphem.2004.06.013; Vodyanik MA, 2005, BLOOD, V105, P617, DOI 10.1182/blood-2004-04-1649; Wang Y, 2005, P NATL ACAD SCI USA, V102, P19081, DOI 10.1073/pnas.0506127102; Woods NB, 2011, STEM CELLS, V29, P1158, DOI 10.1002/stem.657; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zambidis ET, 2005, BLOOD, V106, P860, DOI 10.1182/blood-2004-11-4522; Zhao YM, 2008, BIOCHEM BIOPH RES CO, V369, P1114, DOI 10.1016/j.bbrc.2008.03.011	40	33	34	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2012	7	4							e34321	10.1371/journal.pone.0034321	http://dx.doi.org/10.1371/journal.pone.0034321			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JO	22496789	Green Published, gold, Green Submitted			2022-12-27	WOS:000305014500021
J	Hovatta, I; de Mello, VDF; Kananen, L; Lindstrom, J; Eriksson, JG; Ilanne-Parikka, P; Keinanen-Kiukaanniemi, S; Peltonen, M; Tuomilehto, J; Uusitupa, M				Hovatta, Iiris; de Mello, Vanessa D. F.; Kananen, Laura; Lindstrom, Jaana; Eriksson, Johan G.; Ilanne-Parikka, Pirjo; Keinanen-Kiukaanniemi, Sirkka; Peltonen, Markku; Tuomilehto, Jaakko; Uusitupa, Matti			Leukocyte Telomere Length in the Finnish Diabetes Prevention Study	PLOS ONE			English	Article							IMPAIRED GLUCOSE-TOLERANCE; LIFE-STYLE; ASSOCIATION; MELLITUS; OBESITY; DISEASE	Leukocyte telomere length (TL) is considered a biomarker for biological aging. Shortened TL has been observed in many complex diseases, including type 2 diabetes (T2DM). Lifestyle intervention studies, e. g. the Diabetes Prevention Study (DPS), have shown a decrease in the incidence of T2DM by promoting healthy lifestyles in individuals with impaired glucose tolerance (IGT). Our aim was to study in the DPS the influence of the lifestyle intervention on TL. TL was measured by quantitative PCR-based method at two time points (N = 334 and 343) on average 4.5 years apart during the active intervention and post-intervention follow-up. TL inversely correlated with age. Our main finding was that TL increased in about two thirds of the individuals both in the intervention and in the control groups during follow-up; TL increased most in individuals with the shortest TL at the first measurement. TL was not associated with development of T2DM, nor did lifestyle intervention have an effect on TL. No association between insulin secretion or insulin resistance indices and TL was observed. We did not detect an association between TL and development of T2DM in the DPS participants. It could be due to all participants being overweight and having IGT at baseline, both of which have been found to be independently associated with shorter leukocyte TL in some earlier studies. TL had no substantial role in worsening of glucose tolerance in people with IGT. Our study confirms that leukocyte TL can increase with time even in obese people with impaired glucose metabolism.	[Hovatta, Iiris; Kananen, Laura] Univ Helsinki, Res Programs Unit, Biomedicum Helsinki, Helsinki, Finland; [Hovatta, Iiris; Kananen, Laura] Univ Helsinki, Dept Med Genet, Haartman Inst, Helsinki, Finland; [Hovatta, Iiris] Natl Inst Hlth & Welf, Mental Hlth Serv, Helsinki, Finland; [de Mello, Vanessa D. F.; Uusitupa, Matti] Univ Eastern Finland, Inst Publ Hlth & Clin Nutr, Kuopio, Finland; [Lindstrom, Jaana; Eriksson, Johan G.; Tuomilehto, Jaakko] Natl Inst Hlth & Welf, Dept Hlth Promot & Chron Dis Prevent, Helsinki, Finland; [Eriksson, Johan G.] Univ Helsinki, Dept Gen Practice & Primary Hlth Care, Helsinki, Finland; [Eriksson, Johan G.] Folkhalsan Res Ctr, Helsinki, Finland; [Eriksson, Johan G.] Univ Helsinki, Cent Hosp, Unit Gen Practice, Helsinki, Finland; [Eriksson, Johan G.] Vaasa Cent Hosp, Vaasa, Finland; [Ilanne-Parikka, Pirjo] Finnish Diabet Assoc, Ctr Diabet, Tampere, Finland; [Ilanne-Parikka, Pirjo] Tampere Univ Hosp, Pirkanmaa Hosp Dist, Ctr Sci, Tampere, Finland; [Keinanen-Kiukaanniemi, Sirkka] Univ Oulu, Inst Hlth Sci, Oulu, Finland; [Keinanen-Kiukaanniemi, Sirkka] Oulu Univ Hosp, Unit Gen Practice, Oulu, Finland; [Keinanen-Kiukaanniemi, Sirkka] Oulu Hlth Ctr, Oulu, Finland; [Peltonen, Markku] Natl Inst Hlth & Welf, Diabet Prevent Unit, Helsinki, Finland; [Tuomilehto, Jaakko] S Ostrobothnia Cent Hosp, Seinajoki, Finland; [Tuomilehto, Jaakko] Danube Univ Krems, Ctr Vasc Prevent, Krems, Austria; [Uusitupa, Matti] Kuopio Univ Hosp, Res Unit, SF-70210 Kuopio, Finland; [Hovatta, Iiris] Natl Inst Hlth & Welf, Substance Abuse Serv, Helsinki, Finland	University of Helsinki; University of Helsinki; Finland National Institute for Health & Welfare; University of Eastern Finland; Finland National Institute for Health & Welfare; University of Helsinki; Folkhalsan Research Center; University of Helsinki; Helsinki University Central Hospital; Vaasa Central Hospital; Pirkanmaa Hospital District; Tampere University; Tampere University Hospital; University of Oulu; University of Oulu; Finland National Institute for Health & Welfare; Danube University Krems; Kuopio University Hospital; University of Eastern Finland; Finland National Institute for Health & Welfare	Hovatta, I (corresponding author), Univ Helsinki, Res Programs Unit, Biomedicum Helsinki, Helsinki, Finland.	iiris.hovatta@helsinki.fi	Peltonen, Markku/F-3037-2015; Hovatta, Iiris/D-6871-2012; Uusitupa, Matti Ilmari Julius/AAX-4929-2020	Peltonen, Markku/0000-0002-3767-4223; Hovatta, Iiris/0000-0002-5990-7892; Eriksson, Johan/0000-0002-2516-2060; Kananen, Laura/0000-0003-3742-8927; Lindstrom, Jaana/0000-0001-9255-020X; de Mello, Vanessa/0000-0003-3414-6983	Academy of Finland; Peter and Patricia Gruber Foundation; Juho Vainio Foundation; Novo Nordisk Foundation; Kuopio University Hospital [5106, 5168, 5254]; Ministry of Education of Finland; Finnish Diabetes Research Foundation; Sigrid Juselius Foundation	Academy of Finland(Academy of Finland); Peter and Patricia Gruber Foundation; Juho Vainio Foundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Kuopio University Hospital; Ministry of Education of Finland; Finnish Diabetes Research Foundation; Sigrid Juselius Foundation(Sigrid Juselius Foundation)	Academy of Finland (IH, VDFM, JL, JGE, JT, MU, and SKK) www.aka.fi, Rosalind Franklin Young Investigator Award from the Peter and Patricia Gruber Foundation (IH) http://www.gruberprizes.org/, Juho Vainio Foundation (JL) http://www.juhovainionsaatio.fi, Novo Nordisk Foundation (JL) http://www.novonordiskfonden.dk/en/, EVO-fund of Kuopio University Hospital (5106, 5168, 5254 [MU]) www.kuh.fi, Ministry of Education of Finland (MU) www.minedu.fi, Finnish Diabetes Research Foundation (MU) www.diabetes.fi, and Sigrid Juselius Foundation (MU) www.sigridjuselius.fi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adaikalakoteswari A, 2007, ATHEROSCLEROSIS, V195, P83, DOI 10.1016/j.atherosclerosis.2006.12.003; Al-Attas OS, 2010, EUR J ENDOCRINOL, V163, P601, DOI 10.1530/EJE-10-0241; Aviv A, 2009, AM J EPIDEMIOL, V169, P323, DOI 10.1093/aje/kwn338; Bakaysa SL, 2007, AGING CELL, V6, P769, DOI 10.1111/j.1474-9726.2007.00340.x; Benetos A, 2001, HYPERTENSION, V37, P381, DOI 10.1161/01.HYP.37.2.381; Bischoff C, 2005, TWIN RES HUM GENET, V8, P433, DOI 10.1375/twin.8.5.433; Blasco MA, 2005, NAT REV GENET, V6, P611, DOI 10.1038/nrg1656; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Cherkas LF, 2008, ARCH INTERN MED, V168, P154, DOI 10.1001/archinternmed.2007.39; Clarke PM, 2004, DIABETOLOGIA, V47, P1747, DOI 10.1007/s00125-004-1527-z; Codd V, 2010, NAT GENET, V42, P197, DOI 10.1038/ng.532; de Mello VDF, 2012, DIABETES CARE, V35, P211, DOI 10.2337/dc11-1272; Fitzpatrick AL, 2007, AM J EPIDEMIOL, V165, P14, DOI [10.1093/aje/kw346, 10.1093/aje/kwj346]; Franco OH, 2007, ARCH INTERN MED, V167, P1145, DOI 10.1001/archinte.167.11.1145; Kananen L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010826; KAPRIO J, 1992, DIABETOLOGIA, V35, P1060, DOI 10.1007/BF02221682; Kim SM, 2009, CANCER EPIDEM BIOMAR, V18, P816, DOI 10.1158/1055-9965.EPI-08-0935; Kimura M, 2008, AM J EPIDEMIOL, V167, P799, DOI 10.1093/aje/kwm380; Kuhlow D, 2010, AGING-US, V2, P650, DOI 10.18632/aging.100200; Lindstrom J, 2003, DIABETES CARE, V26, P3230, DOI 10.2337/diacare.26.12.3230; Lindstrom J, 2006, LANCET, V368, P1673, DOI 10.1016/S0140-6736(06)69701-8; Nordfjall K, 2008, OBESITY, V16, P2682, DOI 10.1038/oby.2008.413; Nordfjall K, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000375; Olivieri F, 2009, ATHEROSCLEROSIS, V206, P588, DOI 10.1016/j.atherosclerosis.2009.03.034; Ornish D, 2008, LANCET ONCOL, V9, P1048, DOI 10.1016/S1470-2045(08)70234-1; Paulweber B, 2010, HORM METAB RES, V42, pS3, DOI 10.1055/s-0029-1240928; Salpea KD, 2010, ATHEROSCLEROSIS, V209, P42, DOI 10.1016/j.atherosclerosis.2009.09.070; Salpea KD, 2010, ATHEROSCLEROSIS, V209, P35, DOI 10.1016/j.atherosclerosis.2009.12.021; Sampson MJ, 2006, DIABETES CARE, V29, P283, DOI 10.2337/diacare.29.02.06.dc05-1715; SLAGBOOM PE, 1994, AM J HUM GENET, V55, P876; Svenson U, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021485; Tentolouris N, 2007, DIABETES CARE, V30, P2909, DOI 10.2337/dc07-0633; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; Valdes AM, 2005, LANCET, V366, P662, DOI 10.1016/S0140-6736(05)66630-5; Vasa-Nicotera M, 2005, AM J HUM GENET, V76, P147, DOI 10.1086/426734; von Zglinicki T, 2005, CURR MOL MED, V5, P197; Zee RYL, 2010, TRANSL RES, V155, P166, DOI 10.1016/j.trsl.2009.09.012	37	67	69	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2012	7	4							e34948	10.1371/journal.pone.0034948	http://dx.doi.org/10.1371/journal.pone.0034948			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JA	22493726	gold, Green Published, Green Submitted			2022-12-27	WOS:000305012700068
J	Kang, SH; Jeong, SJ; Kim, SH; Kim, JH; Jung, JH; Koh, W; Kim, JH; Kim, DK; Chen, CY; Kim, SH				Kang, Sang-Hun; Jeong, Soo-Jin; Kim, Sun-Hee; Kim, Ji-Hyun; Jung, Ji Hoon; Koh, Wonil; Kim, Jung Hyo; Kim, Dae Keun; Chen, Chang-Yan; Kim, Sung-Hoon			Icariside II Induces Apoptosis in U937 Acute Myeloid Leukemia Cells: Role of Inactivation of STAT3-Related Signaling	PLOS ONE			English	Article							TYROSINE-PHOSPHATASE SHP-1; STAT3 ACTIVATION; INHIBITION; PATHWAY	Background: The aim of this study is to determine anti-cancer effect of Icariside II purified from the root of Epimedium koreanum Nakai on human acute myeloid leukemia (AML) cell line U937. Methodology/Principal Findings: Icariside II blocked the growth U937 cells in a dose- and time-dependent manner. In this anti-proliferation process, this herb compound rendered the cells susceptible to apoptosis, manifested by enhanced accumulation of sub-G1 cell population and increased the terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL)-positive cells. Icariside II was able to activate caspase-3 and cleaved poly (ADP-ribose) polymerase (PARP) in a time-dependent manner. Concurrently, the anti-apoptotic proteins, such as bcl-x(L) and survivin in U937 cells, were downregulated by Icariside II. In addition, Icariside II could inhibit STAT3 phosphorylation and function and subsequently suppress the activation of Janus activated kinase 2 (JAK2), the upstream activators of STAT3, in a dose- and time-dependent manner. Icariside II also enhanced the expression of protein tyrosine phosphatase (PTP) SH2 domain-containing phosphatase (SHP)-1, and the addition of sodium pervanadate (a PTP inhibitor) prevented Icariside II-induced apoptosis as well as STAT3 inactivation in STAT3 positive U937 cells. Furthermore, silencing SHP-1 using its specific siRNA significantly blocked STAT3 inactivation and apoptosis induced by Icariside II in U937 cells. Conclusions/Significance: Our results demonstrated that via targeting STAT3-related signaling, Icariside II sensitizes U937 cells to apoptosis and perhaps serves as a potent chemotherapeutic agent for AML.	[Kang, Sang-Hun; Jeong, Soo-Jin; Kim, Sun-Hee; Kim, Ji-Hyun; Jung, Ji Hoon; Koh, Wonil; Kim, Sung-Hoon] Kyung Hee Univ, Coll Oriental Med, Seoul, South Korea; [Jeong, Soo-Jin] Korea Inst Oriental Med, Basic Herbal Res Grp, Taejon, South Korea; [Kim, Jung Hyo] Chosun Nursing Coll, Kwangju, South Korea; [Kim, Dae Keun] Woosuk Univ, Coll Pharm, Wonju, South Korea; [Chen, Chang-Yan] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Boston, MA 02215 USA	Kyung Hee University; Korea Institute of Oriental Medicine (KIOM); Chosun University; Woosuk University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Kang, SH (corresponding author), Kyung Hee Univ, Coll Oriental Med, Seoul, South Korea.	sungkim7@khu.ac.kr; sungkim7@khu.ac.kr	Kim, Sun/GSN-4867-2022; Jung, Jihoon/HHY-7803-2022	kim, sunghoon/0000-0002-1570-3230	Korea Science and Engineering Foundation (KOSEF); Korea government (MEST) [2011-0063466]	Korea Science and Engineering Foundation (KOSEF)(Korea Science and Engineering Foundation); Korea government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This work was supported by the Korea Science and Engineering Foundation (KOSEF) grant funded by the Korea government (MEST) (No. 2011-0063466). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn KS, 2008, CANCER RES, V68, P4406, DOI 10.1158/0008-5472.CAN-07-6696; Bishop JF, 1997, SEMIN ONCOL, V24, P57; Choi HJ, 2008, EUR J PHARMACOL, V579, P58, DOI 10.1016/j.ejphar.2007.10.010; Choi HJ, 2010, EUR J PHARMACOL, V636, P28, DOI 10.1016/j.ejphar.2010.03.023; Chung BH, 2008, BIOCHEM BIOPH RES CO, V376, P404, DOI 10.1016/j.bbrc.2008.09.001; Gao Z, 2007, J BIOL CHEM, V282, P30718, DOI 10.1074/jbc.M705258200; Han YJ, 2006, BLOOD, V108, P2796, DOI 10.1182/blood-2006-04-017434; Hassan HT, 2004, LEUKEMIA RES, V28, P667, DOI 10.1016/j.leukres.2003.10.008; Huang ST, 2010, PHYTOMEDICINE, V17, P47, DOI 10.1016/j.phymed.2009.06.005; JACOBSON MD, 1994, BIOCHEM SOC T, V22, P600, DOI 10.1042/bst0220600; Kee CH, 2000, PHARM CHINESE HERBS, P106; Kim H, 1999, MOL CELL BIOL, V19, P5326; Kim SH, 2011, EUR J PHARMACOL, V654, P10, DOI 10.1016/j.ejphar.2010.11.032; Kothakota S, 1997, SCIENCE, V278, P294, DOI 10.1126/science.278.5336.294; Lee JC, 2011, J CELL BIOCHEM, V112, P1552, DOI 10.1002/jcb.23077; Lee KS, 2009, CANCER LETT, V280, P93, DOI 10.1016/j.canlet.2009.02.024; Lund IK, 2005, J MOL ENDOCRINOL, V34, P339, DOI 10.1677/jme.1.01694; Mallick S, 2010, CANCER CHEMOTH PHARM, V66, P709, DOI 10.1007/s00280-009-1214-3; Oh MH, 2004, PHYTOMEDICINE, V11, P544, DOI 10.1016/j.phymed.2004.03.001; Park S, 2011, FOOD CHEM TOXICOL, V49, P1367, DOI 10.1016/j.fct.2011.03.021; Pathak AK, 2007, MOL CANCER RES, V5, P943, DOI 10.1158/1541-7786.MCR-06-0348; Redell MS, 2011, BLOOD, V117, P5701, DOI 10.1182/blood-2010-04-280123; Seki E, 2008, J HEPATOL, V48, P237, DOI 10.1016/j.jhep.2007.08.020; Sun S, 2002, J GEN VIROL, V83, P1651, DOI 10.1099/0022-1317-83-7-1651; Tenev T, 2000, EUR J CELL BIOL, V79, P261, DOI 10.1078/S0171-9335(04)70029-1; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Yamamoto T, 2002, BIOCHEM BIOPH RES CO, V297, P811, DOI 10.1016/S0006-291X(02)02291-X; Zhang Y, 2000, J BIOL CHEM, V275, P24935, DOI 10.1074/jbc.M002383200; Zhao W, 2011, ANTI-CANCER DRUG, V22, P79, DOI 10.1097/CAD.0b013e32833f44fd	29	70	73	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2012	7	4							e28706	10.1371/journal.pone.0028706	http://dx.doi.org/10.1371/journal.pone.0028706			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JA	22493659	Green Submitted, Green Published, gold			2022-12-27	WOS:000305012700001
J	Kirchberg, J; Buttner, D; Thiemer, B; Sawers, RG				Kirchberg, Janine; Buettner, Daniela; Thiemer, Barbara; Sawers, R. Gary			Aconitase B Is Required for Optimal Growth of Xanthomonas campestris pv. vesicatoria in Pepper Plants	PLOS ONE			English	Article							ESCHERICHIA-COLI ACONITASES; BACILLUS-SUBTILIS; POSTTRANSCRIPTIONAL REGULATION; OXIDATIVE STRESS; GENE-EXPRESSION; III SECRETION; RNA-BINDING; PATHOGENICITY; IRON; PROTEINS	The aerobic plant pathogenic bacterium Xanthomonas campestris pv. vesicatoria (Xcv) colonizes the intercellular spaces of pepper and tomato. One enzyme that might contribute to the successful proliferation of Xcv in the host is the iron-sulfur protein aconitase, which catalyzes the conversion of citrate to isocitrate in the tricarboxylic acid (TCA) cycle and might also sense reactive oxygen species (ROS) and changes in cellular iron levels. Xcv contains three putative aconitases, two of which, acnA and acnB, are encoded by a single chromosomal locus. The focus of this study is aconitase B (AcnB). acnB is co-transcribed with two genes, XCV1925 and XCV1926, encoding putative nucleic acid-binding proteins. In vitro growth of acnB mutants was like wild type, whereas in planta growth and symptom formation in pepper plants were impaired. While acnA, XCV1925 or XCV1926 mutants showed a wild-type phenotype with respect to bacterial growth and in planta symptom formation, proliferation of the acnB mutant in susceptible pepper plants was significantly impaired. Furthermore, the deletion of acnB led to reduced HR induction in resistant pepper plants and an increased susceptibility to the superoxide-generating compound menadione. As AcnB complemented the growth deficiency of an Escherichia coli aconitase mutant, it is likely to be an active aconitase. We therefore propose that optimal growth and survival of Xcv in pepper plants depends on AcnB, which might be required for the utilization of citrate as carbon source and could also help protect the bacterium against oxidative stress.	[Kirchberg, Janine; Thiemer, Barbara; Sawers, R. Gary] Univ Halle Wittenberg, Dept Microbiol, Inst Biol, Halle, Saale, Germany; [Buettner, Daniela] Univ Halle Wittenberg, Dept Genet, Inst Biol, Halle, Saale, Germany	Martin Luther University Halle Wittenberg; Martin Luther University Halle Wittenberg	Kirchberg, J (corresponding author), Univ Halle Wittenberg, Dept Microbiol, Inst Biol, Halle, Saale, Germany.	gary.sawers@mikrobiologie.uni-halle.de			Deutsche Forschungsgemeinschaft ['Sonderforschungsbereich' SFB 648]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft as part of a 'Sonderforschungsbereich' SFB 648 "Molecular Mechanisms of Information Transfer in Plants''. No official grant numbers exist but both DB and GS were recipients of grants providing financial support for their respective subprojects and the work described herein. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arcus VL, 2011, PROTEIN ENG DES SEL, V24, P33, DOI 10.1093/protein/gzq081; Ausubel FM., 1992, CURRENT PROTOCOLS MO, V3; Banerjee S, 2007, J BACTERIOL, V189, P4046, DOI 10.1128/JB.00026-07; BONAS U, 1989, MOL GEN GENET, V218, P127, DOI 10.1007/BF00330575; BONAS U, 1991, MOL PLANT MICROBE IN, V4, P81, DOI 10.1094/MPMI-4-081; Buttner D, 2010, FEMS MICROBIOL REV, V34, P107, DOI 10.1111/j.1574-6976.2009.00192.x; Buttner D, 2002, EMBO J, V21, P5313, DOI 10.1093/emboj/cdf536; Canteros BI, 1990, THESIS U FLA GAINESV; Cornelis P, 2011, METALLOMICS, V3, P540, DOI 10.1039/c1mt00022e; Craig JE, 1997, J BACTERIOL, V179, P7351, DOI 10.1128/jb.179.23.7351-7359.1997; Cunningham L, 1997, MICROBIOL-UK, V143, P3795, DOI 10.1099/00221287-143-12-3795; DANIELS MJ, 1984, EMBO J, V3, P3323, DOI 10.1002/j.1460-2075.1984.tb02298.x; Escolar L, 2001, MOL PLANT PATHOL, V2, P287, DOI 10.1046/j.1464-6722.2001.00077.x; FIGURSKI DH, 1979, P NATL ACAD SCI USA, V76, P1648, DOI 10.1073/pnas.76.4.1648; GARDNER PR, 1991, J BIOL CHEM, V266, P1478; Ghosh P, 2004, MICROBIOL MOL BIOL R, V68, P771, DOI 10.1128/MMBR.68.4.771-795.2004; Gruer MJ, 1997, MICROBIOL-UK, V143, P1837, DOI 10.1099/00221287-143-6-1837; Guo W, 2012, MICROBIOL-SGM, V158, P505, DOI 10.1099/mic.0.050419-0; Huguet E, 1998, MOL MICROBIOL, V29, P1379, DOI 10.1046/j.1365-2958.1998.01019.x; Jittawuttipoka T, 2010, ARCH MICROBIOL, V192, P331, DOI 10.1007/s00203-010-0558-8; Jittawuttipoka T, 2009, J BACTERIOL, V191, P7372, DOI 10.1128/JB.00788-09; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kitphati W, 2007, APPL ENVIRON MICROB, V73, P4760, DOI 10.1128/AEM.00531-07; Koebnik R, 2006, J BACTERIOL, V188, P7652, DOI 10.1128/JB.00795-06; Kousik CS, 1998, PLANT DIS, V82, P181, DOI 10.1094/PDIS.1998.82.2.181; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEYNS F, 1984, BOT REV, V50, P308, DOI 10.1007/BF02862635; Lorenz C, 2009, J BACTERIOL, V191, P1414, DOI 10.1128/JB.01446-08; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MENARD R, 1993, J BACTERIOL, V175, P5899; MINSAVAGE GV, 1990, MOL PLANT MICROBE IN, V3, P41, DOI 10.1094/MPMI-3-041; Murray EJ, 2009, J BACTERIOL, V191, P6822, DOI 10.1128/JB.00618-09; Noel L, 2001, MOL MICROBIOL, V41, P1271, DOI 10.1046/j.1365-2958.2001.02567.x; Potnis N, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-146; Qian W, 2005, GENOME RES, V15, P757, DOI 10.1101/gr.3378705; Rico A, 2008, MOL PLANT MICROBE IN, V21, P269, DOI 10.1094/MPMI-21-2-0269; Ronald P C, 1988, Mol Plant Microbe Interact, V1, P191, DOI 10.1094/MPMI-1-191; Rouault TA, 2006, NAT CHEM BIOL, V2, P406, DOI 10.1038/nchembio807; Ryan RP, 2011, NAT REV MICROBIOL, V9, P344, DOI 10.1038/nrmicro2558; Schmidtke C, 2012, NUCLEIC ACIDS RES, V40, P2020, DOI 10.1093/nar/gkr904; Somerville GA, 2002, INFECT IMMUN, V70, P6373, DOI 10.1128/IAI.70.11.6373-6382.2002; STRAUCH MA, 1989, EMBO J, V8, P1615, DOI 10.1002/j.1460-2075.1989.tb03546.x; STRAUCH MA, 1993, MOL MICROBIOL, V7, P337, DOI 10.1111/j.1365-2958.1993.tb01125.x; Sullivan DM, 2008, STRUCTURE, V16, P1702, DOI 10.1016/j.str.2008.08.014; Szczesny R, 2010, NEW PHYTOL, V187, P983, DOI 10.1111/j.1469-8137.2010.03312.x; Tamir-Ariel D, 2007, J BACTERIOL, V189, P6359, DOI 10.1128/JB.00320-07; Tamir-Ariel D, 2011, MOL PLANT PATHOL, V12, P57, DOI 10.1111/j.1364-3703.2010.00652.x; Tang Y, 1999, MICROBIOL-SGM, V145, P3069, DOI 10.1099/00221287-145-11-3069; Tang Y, 2005, MOL MICROBIOL, V56, P1149, DOI 10.1111/j.1365-2958.2005.04610.x; Tang Y, 2002, MICROBIOL-SGM, V148, P1027, DOI 10.1099/00221287-148-4-1027; Thieme F, 2005, J BACTERIOL, V187, P7254, DOI 10.1128/JB.187.21.7254-7266.2005; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Tsuchiya D, 2009, BIOCHEM BIOPH RES CO, V379, P485, DOI 10.1016/j.bbrc.2008.12.096; Varghese S, 2003, J BACTERIOL, V185, P221, DOI 10.1128/JB.185.1.221-230.2003; Walden WE, 2006, SCIENCE, V314, P1903, DOI 10.1126/science.1133116; Wengelnik K, 1999, J BACTERIOL, V181, P6828, DOI 10.1128/JB.181.21.6828-6831.1999; Wengelnik K, 1996, J BACTERIOL, V178, P3462, DOI 10.1128/jb.178.12.3462-3469.1996; Williams CH, 2002, NAT STRUCT BIOL, V9, P447, DOI 10.1038/nsb801; Wilson TJG, 1998, MOL MICROBIOL, V28, P961, DOI 10.1046/j.1365-2958.1998.00852.x; Winther KS, 2011, P NATL ACAD SCI USA, V108, P7403, DOI 10.1073/pnas.1019587108; Xu XQ, 2000, MOL MICROBIOL, V35, P407, DOI 10.1046/j.1365-2958.2000.01709.x	61	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2012	7	4							e34941	10.1371/journal.pone.0034941	http://dx.doi.org/10.1371/journal.pone.0034941			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JA	22493725	Green Submitted, Green Published, gold			2022-12-27	WOS:000305012700067
J	Pancsa, R; Tompa, P				Pancsa, Rita; Tompa, Peter			Structural Disorder in Eukaryotes	PLOS ONE			English	Article							INTRINSICALLY UNSTRUCTURED PROTEINS; AMINO-ACID-COMPOSITION; PREDICTION; REGIONS; EVOLUTION; SCAFFOLD; DOMAINS	Based on early bioinformatic studies on a handful of species, the frequency of structural disorder of proteins is generally thought to be much higher in eukaryotes than in prokaryotes. To refine this view, we present here a comparative prediction study and analysis of 194 fully described eukaryotic proteomes and 87 reference prokaryotes for structural disorder. We found that structural disorder does distinguish eukaryotes from prokaryotes, but its frequency spans a very wide range in the two superkingdoms that largely overlap. The number of disordered binding regions and different Pfam domain types also contribute to distinguish eukaryotes from prokaryotes. Unexpectedly, the highest levels - and highest variability - of predicted disorder is found in protists, i.e. single-celled eukaryotes, often surpassing more complex eukaryote organisms, plants and animals. This trend contrasts with that of the number of domain types, which increases rather monotonously toward more complex organisms. The level of structural disorder appears to be strongly correlated with lifestyle, because some obligate intracellular parasites and endosymbionts have the lowest levels, whereas host-changing parasites have the highest level of predicted disorder. We conclude that protists have been the evolutionary hot-bed of experimentation with structural disorder, in a period when structural disorder was actively invented and the major functional classes of disordered proteins established.	[Pancsa, Rita; Tompa, Peter] Vrije Univ Brussel VIB, Dept Biol Struct, B-1050 Brussels, Belgium; [Tompa, Peter] Hungarian Acad Sci, Inst Enzymol, Budapest, Hungary	Flanders Institute for Biotechnology (VIB); Vrije Universiteit Brussel; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences	Pancsa, R (corresponding author), Vrije Univ Brussel VIB, Dept Biol Struct, B-1050 Brussels, Belgium.	ptompa@vub.ac.be		Tompa, Peter/0000-0001-8042-9939	The Research Foundation-Flanders Odysseus [G.0029.12]	The Research Foundation-Flanders Odysseus	This work was supported by the The Research Foundation-Flanders Odysseus grant G.0029.12. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apweiler R, 2011, NUCLEIC ACIDS RES, V39, pD214, DOI 10.1093/nar/gkq1020; Balazs A, 2009, FEBS J, V276, P3744, DOI 10.1111/j.1742-4658.2009.07090.x; Brown CJ, 2011, CURR OPIN STRUC BIOL, V21, P441, DOI 10.1016/j.sbi.2011.02.005; Burra PV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012069; Csizmok V, 2005, BIOCHEMISTRY-US, V44, P3955, DOI 10.1021/bi047817f; Dafforn TR, 2004, EMBO REP, V5, P1046, DOI 10.1038/sj.embor.7400276; Davey NE, 2011, TRENDS BIOCHEM SCI, V36, P159, DOI 10.1016/j.tibs.2010.10.002; Diella F, 2008, FRONT BIOSCI-LANDMRK, V13, P6580, DOI 10.2741/3175; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Dosztanyi Z, 2005, J MOL BIOL, V347, P827, DOI 10.1016/j.jmb.2005.01.071; Dosztanyi Z, 2007, CURR PROTEIN PEPT SC, V8, P161, DOI 10.2174/138920307780363406; Dosztanyi Z, 2006, J PROTEOME RES, V5, P2985, DOI 10.1021/pr060171o; Dosztanyi Zsuzsanna, 2008, V426, P103, DOI 10.1007/978-1-60327-058-8_6; Dunker A K, 2000, Genome Inform Ser Workshop Genome Inform, V11, P161; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Feng ZP, 2006, MOL BIOCHEM PARASIT, V150, P256, DOI 10.1016/j.molbiopara.2006.08.011; Ferron F, 2006, PROTEINS, V65, P1, DOI 10.1002/prot.21075; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Fuxreiter M, 2007, BIOINFORMATICS, V23, P950, DOI 10.1093/bioinformatics/btm035; Goh GKM, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-69; Haynes C, 2006, PLOS COMPUT BIOL, V2, P890, DOI 10.1371/journal.pcbi.0020100; HERNANDEZ MA, 1986, EUR J BIOCHEM, V154, P41, DOI 10.1111/j.1432-1033.1986.tb09356.x; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Lu X, 2009, BIOCHEMISTRY-US, V48, P164, DOI 10.1021/bi801636y; Mark WY, 2005, J MOL BIOL, V345, P275, DOI 10.1016/j.jmb.2004.10.045; McCutcheon JP, 2012, NAT REV MICROBIOL, V10, P13, DOI 10.1038/nrmicro2670; Meszaros B, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000376; Minezaki Y, 2007, J MOL BIOL, V368, P902, DOI 10.1016/j.jmb.2007.02.033; Minezaki Y, 2006, J MOL BIOL, V359, P1137, DOI 10.1016/j.jmb.2006.04.016; Mohan A, 2008, MOL BIOSYST, V4, P328, DOI 10.1039/b719168e; Patel SS, 2007, CELL, V129, P83, DOI 10.1016/j.cell.2007.01.044; Pavlovic-Lazetic GM, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-66; Pruitt KD, 2009, NUCLEIC ACIDS RES, V37, pD32, DOI 10.1093/nar/gkn721; Rantalainen KI, 2011, J VIROL, V85, P2449, DOI 10.1128/JVI.02051-10; Renault L, 2008, TRENDS CELL BIOL, V18, P494, DOI 10.1016/j.tcb.2008.07.008; Schad E, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-12-r120; Schlessinger A, 2011, CURR OPIN STRUC BIOL, V21, P412, DOI 10.1016/j.sbi.2011.03.014; Sgarra R, 2009, BIOCHIM BIOPHYS ACTA, P37; Shoemaker BA, 2000, P NATL ACAD SCI USA, V97, P8868, DOI 10.1073/pnas.160259697; Singh GP, 2007, PROTEINS, V66, P761, DOI 10.1002/prot.21281; Szollosi E, 2008, J PROTEOME RES, V7, P2291, DOI 10.1021/pr700720c; Tompa P, 2005, TRENDS BIOCHEM SCI, V30, P484, DOI 10.1016/j.tibs.2005.07.008; Tompa P, 2003, BIOESSAYS, V25, P847, DOI 10.1002/bies.10324; Tompa P, 2011, CURR OPIN STRUC BIOL, V21, P419, DOI 10.1016/j.sbi.2011.03.012; Tompa P, 2010, J MOL BIOL, V403, P346, DOI 10.1016/j.jmb.2010.07.044; Tompa P, 2009, BIOESSAYS, V31, P328, DOI 10.1002/bies.200800151; Uversky VN, 2008, ANNU REV BIOPHYS, V37, P215, DOI 10.1146/annurev.biophys.37.032807.125924; Uversky VN, 2010, BBA-PROTEINS PROTEOM, V1804, P1231, DOI 10.1016/j.bbapap.2010.01.017; Vogel C, 2004, CURR OPIN STRUC BIOL, V14, P208, DOI 10.1016/j.sbi.2004.03.011; Vogel C, 2006, PLOS COMPUT BIOL, V2, P370, DOI 10.1371/journal.pcbi.0020048; Vucetic S, 2003, PROTEINS, V52, P573, DOI 10.1002/prot.10437; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; Wright PE, 2009, CURR OPIN STRUC BIOL, V19, P31, DOI 10.1016/j.sbi.2008.12.003; Xue B, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-S1-S1	54	131	130	0	84	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2012	7	4							e34687	10.1371/journal.pone.0034687	http://dx.doi.org/10.1371/journal.pone.0034687			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955IH	22496841	Green Published, gold			2022-12-27	WOS:000305010500022
J	Cheng, C; Wang, LS; Gall, JGD; Nason, M; Schwartz, RM; McElrath, J; DeRosa, SC; Hural, J; Corey, L; Buchbinder, SP; Nabel, GJ				Cheng, Cheng; Wang, LingShu; Gall, Jason G. D.; Nason, Martha; Schwartz, Richard M.; McElrath, Juliana; DeRosa, Steven C.; Hural, John; Corey, Lawrence; Buchbinder, Susan P.; Nabel, Gary J.			Decreased Pre-existing Ad5 Capsid and Ad35 Neutralizing Antibodies Increase HIV-1 Infection Risk in the Step Trial Independent of Vaccination	PLOS ONE			English	Article							ADENOVIRUS SEROTYPE 5; T-CELLS; SOLUBLE ANTIGENS; GENE-THERAPY; IMMUNITY; VECTORS; IMMUNIZATION; VOLUNTEERS; EXPANSION; HUMANS	Background: The Step trial raised the possibility that uncircumcised men with pre-existing Ad5 neutralizing antibodies carried an increased risk of HIV infection after vaccination. Thus, understanding Ad seropositivity in humans is important to the development of an AIDS vaccine. Here, we analyze the impact of different Ad5-specific neutralizing antibodies on immune function and clinical outcome. Methods and Findings: Ad seropositivity in the Step trial volunteers was analyzed using chimeric rAd5/35 vectors to characterize their specificity for Ad5 fiber and non-fiber external (capsid) proteins. Immune responses and HIV seropositivity were correlated with the specificity of Ad5-neutralizing antibodies. Neutralizing antibodies induced by the vaccine in Ad5 seronegative subjects were directed preferentially to Ad5 capsid proteins, although some fiber-neutralizing antibodies could be detected. Pre-vaccination Ad5 serostatus did not affect the capsid-directed response after three vaccinations. In contrast, anti-fiber antibody titers were significantly higher in volunteers who were Ad5 seropositive prior to vaccination. Those Ad5 seropositive subjects who generated anti-capsid responses showed a marked reduction in vaccine-induced CD8 responses. Unexpectedly, anti-vector immunity differed qualitatively in Ad5 seropositive participants who became HIV-1 infected compared to uninfected case controls; Ad5 seropositive participants who later acquired HIV had lower neutralizing antibodies to capsid. Moreover, Ad35 seropositivity was decreased in HIV-infected subjects compared with uninfected case controls, while seroprevalence for other serotypes including Ad14, Ad28 and Ad41 was similar in both groups. Conclusions: Together, these findings suggest that the case subjects were less immunologically responsive prior to infection. Subjects infected during the Step trial had qualitative differences in immunity that increased their risk of HIV-1 infection independent of vaccination.	[Cheng, Cheng; Wang, LingShu; Schwartz, Richard M.; Nabel, Gary J.] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA; [Nason, Martha] NIAID, Biostat Res Branch, NIH, Bethesda, MD 20892 USA; [Gall, Jason G. D.] GenVec Inc, Gaithersburg, MD USA; [McElrath, Juliana; DeRosa, Steven C.; Hural, John; Corey, Lawrence] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Seattle, WA 98104 USA; [McElrath, Juliana; DeRosa, Steven C.; Hural, John; Corey, Lawrence; Buchbinder, Susan P.] HIV Vaccine Trials Network, Seattle, WA USA; [Buchbinder, Susan P.] San Francisco Dept Publ Hlth, HIV Res Sect, San Francisco, CA USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Fred Hutchinson Cancer Center; San Francisco Department of Public Health	Cheng, C (corresponding author), NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	gnabel@nih.gov	Cheng, Cheng/AAE-8255-2019; Corey, Lawrence/AAE-1796-2020	Corey, Lawrence/0000-0002-2179-2436	National Institutes of Health intramural research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI068614, ZIBAI005074, U01AI068614] Funding Source: NIH RePORTER	National Institutes of Health intramural research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The study was funded by National Institutes of Health intramural research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BANKS PA, 1966, P SOC EXP BIOL MED, V121, P240, DOI 10.3181/00379727-121-30747; Benlahrech A, 2009, P NATL ACAD SCI USA, V106, P19940, DOI 10.1073/pnas.0907898106; Bradley RR, 2012, J VIROL, V86, P1267, DOI 10.1128/JVI.06165-11; Bradley RR, 2012, J VIROL, V86, P625, DOI 10.1128/JVI.06254-11; Brough DE, 1996, J VIROL, V70, P6497, DOI 10.1128/JVI.70.9.6497-6501.1996; Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; Carson SD, 2000, FEBS LETT, V484, P149, DOI 10.1016/S0014-5793(00)02144-X; Cheng C, 2010, J VIROL, V84, P630, DOI 10.1128/JVI.00866-09; Curlin ME, 2011, AIDS, V25, P153, DOI 10.1097/QAD.0b013e328342115c; Gahery-Segard H, 1998, J VIROL, V72, P2388; Hamilton MM, 2008, MOL VIS, V14, P2535; Hong SS, 2003, J VIROL, V77, P10366, DOI 10.1128/JVI.77.19.10366-10375.2003; Hutnick NA, 2009, NAT MED, V15, P876, DOI 10.1038/nm.1989; KASEL JA, 1964, P SOC EXP BIOL MED, V117, P186, DOI 10.3181/00379727-117-29531; Masek-Hammerman K, 2010, J VIROL, V84, P9810, DOI 10.1128/JVI.01157-10; McElrath MJ, 2008, LANCET, V372, P1894, DOI 10.1016/S0140-6736(08)61592-5; McVey D, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-276; Mittereder N, 1996, J VIROL, V70, P7498, DOI 10.1128/JVI.70.11.7498-7509.1996; O'Brien KL, 2009, NAT MED, V15, P873, DOI 10.1038/nm.1991; Perreau M, 2008, J EXP MED, V205, P2717, DOI 10.1084/jem.20081786; Roberts DM, 2006, NATURE, V441, P239, DOI 10.1038/nature04721; Segerman A, 2003, J VIROL, V77, P1157, DOI 10.1128/JVI.77.2.1157-1162.2003; Sprangers MC, 2003, J CLIN MICROBIOL, V41, P5046, DOI 10.1128/JCM.41.11.5046-5052.2003; Vasselon T, 1997, J IMMUNOL, V159, P4498; WOHLFART C, 1988, J VIROL, V62, P2321, DOI 10.1128/JVI.62.7.2321-2328.1988	25	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e33969	10.1371/journal.pone.0033969	http://dx.doi.org/10.1371/journal.pone.0033969			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GO	22496775	gold, Green Submitted, Green Published			2022-12-27	WOS:000304855200028
J	Clerc, P; Polster, BM				Clerc, Pascaline; Polster, Brian M.			Investigation of Mitochondrial Dysfunction by Sequential Microplate-Based Respiration Measurements from Intact and Permeabilized Neurons	PLOS ONE			English	Article							NEURODEGENERATIVE DISEASES; GLUTAMATE EXCITOTOXICITY; OXIDATIVE STRESS; COMPLEX I; MECHANISMS; APOPTOSIS; CAPACITY; SUSCEPTIBILITY; RESPIROMETRY; INHIBITION	Mitochondrial dysfunction is a component of many neurodegenerative conditions. Measurement of oxygen consumption from intact neurons enables evaluation of mitochondrial bioenergetics under conditions that are more physiologically realistic compared to isolated mitochondria. However, mechanistic analysis of mitochondrial function in cells is complicated by changing energy demands and lack of substrate control. Here we describe a technique for sequentially measuring respiration from intact and saponin-permeabilized cortical neurons on single microplates. This technique allows control of substrates to individual electron transport chain complexes following permeabilization, as well as side-by-side comparisons to intact cells. To illustrate the utility of the technique, we demonstrate that inhibition of respiration by the drug KB-R7943 in intact neurons is relieved by delivery of the complex II substrate succinate, but not by complex I substrates, via acute saponin permeabilization. In contrast, methyl succinate, a putative cell permeable complex II substrate, failed to rescue respiration in intact neurons and was a poor complex II substrate in permeabilized cells. Sequential measurements of intact and permeabilized cell respiration should be particularly useful for evaluating indirect mitochondrial toxicity due to drugs or cellular signaling events which cannot be readily studied using isolated mitochondria.	[Clerc, Pascaline] Univ Maryland, Sch Med, Dept Anesthesiol, Baltimore, MD 21201 USA; Univ Maryland, Sch Med, Ctr Shock Trauma & Anesthesiol Res, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Clerc, P (corresponding author), Univ Maryland, Sch Med, Dept Anesthesiol, Baltimore, MD 21201 USA.	bpolster@anes.umm.edu		Polster, Brian/0000-0003-2571-7510	National Institutes of Health [R01NS064978, P01HD016596]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD016596] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064978] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by National Institutes of Health grants R01NS064978 and P01HD016596. (http://grants.nih.gov/grants/oer.htm). The funders had no role in study design, data collection and analysis.	Abramov AY, 2008, BBA-BIOENERGETICS, V1777, P953, DOI 10.1016/j.bbabio.2008.04.017; Almeida A, 1997, BRAIN RES, V764, P167, DOI 10.1016/S0006-8993(97)00453-8; Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162; Brustovetsky T, 2011, BRIT J PHARMACOL, V162, P255, DOI 10.1111/j.1476-5381.2010.01054.x; Brustovetsky T, 2009, CELL CALCIUM, V46, P18, DOI 10.1016/j.ceca.2009.03.017; Chalmers S, 2003, J BIOL CHEM, V278, P19062, DOI 10.1074/jbc.M212661200; Dranka BP, 2010, FREE RADICAL BIO MED, V48, P905, DOI 10.1016/j.freeradbiomed.2010.01.015; FISKUM G, 1980, P NATL ACAD SCI-BIOL, V77, P3430, DOI 10.1073/pnas.77.6.3430; Fiskum G, 1999, J CEREBR BLOOD F MET, V19, P351, DOI 10.1097/00004647-199904000-00001; Gerencser AA, 2009, ANAL CHEM, V81, P6868, DOI 10.1021/ac900881z; Gerencser AA, 2009, J NEUROCHEM, V110, P990, DOI 10.1111/j.1471-4159.2009.06194.x; Iwamoto T, 1998, AM J PHYSIOL-CELL PH, V275, pC423, DOI 10.1152/ajpcell.1998.275.2.C423; Jones TT, 2010, BBA-BIOENERGETICS, V1797, P167, DOI 10.1016/j.bbabio.2009.09.009; Kristian T, 2006, J NEUROSCI METH, V152, P136, DOI 10.1016/j.jneumeth.2005.08.018; Kuznetsov AV, 2008, NAT PROTOC, V3, P965, DOI 10.1038/nprot.2008.61; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; MACDONALD MJ, 1989, ARCH BIOCHEM BIOPHYS, V269, P400, DOI 10.1016/0003-9861(89)90123-9; Nicholls DG, 2009, BIOCHEM SOC T, V37, P1385, DOI 10.1042/BST0371385; NICHOLLS DG, 1980, BIOCHEM J, V186, P833, DOI 10.1042/bj1860833; Patton C, 2004, CELL CALCIUM, V35, P427, DOI 10.1016/j.ceca.2003.10.006; Picard M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018317; Picard Martin, 2010, Aging Cell, V9, P1032, DOI 10.1111/j.1474-9726.2010.00628.x; Polster BM, 2004, J NEUROCHEM, V90, P1281, DOI 10.1111/j.1471-4159.2004.02572.x; Polster BM, 2001, J BIOL CHEM, V276, P37887; Safiulina D, 2004, J NEUROSCI METH, V137, P87, DOI 10.1016/j.jneumeth.2004.02.027; Santo-Domingo J, 2007, BRIT J PHARMACOL, V151, P647, DOI 10.1038/sj.bjp.0707260; Sauerbeck A, 2011, J NEUROSCI METH, V198, P36, DOI 10.1016/j.jneumeth.2011.03.007; Schuh RA, 2011, J NEUROSCI RES, V89, P1979, DOI 10.1002/jnr.22650; Sims NR, 2008, NAT PROTOC, V3, P1228, DOI 10.1038/nprot.2008.105; Stoica BA, 2005, MOL CELL NEUROSCI, V29, P355, DOI 10.1016/j.mcn.2005.02.009; Wu M, 2007, AM J PHYSIOL-CELL PH, V292, pC125, DOI 10.1152/ajpcell.00247.2006; Yakovlev AG, 2001, J NEUROSCI, V21, P7439, DOI 10.1523/JNEUROSCI.21-19-07439.2001	32	46	48	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e34465	10.1371/journal.pone.0034465	http://dx.doi.org/10.1371/journal.pone.0034465			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GO	22496810	Green Submitted, Green Published, gold			2022-12-27	WOS:000304855200053
J	Goel, M; Sienkiewicz, AE; Picciani, R; Wang, JH; Lee, RK; Bhattacharya, SK				Goel, Manik; Sienkiewicz, Adam E.; Picciani, Renata; Wang, Jianhua; Lee, Richard K.; Bhattacharya, Sanjoy K.			Cochlin, Intraocular Pressure Regulation and Mechanosensing	PLOS ONE			English	Article							TRABECULAR MESHWORK CELLS; VON-WILLEBRAND-FACTOR; CHANNEL TREK-1; AQUEOUS-HUMOR; PROFILIN-I; GLAUCOMA; OUTFLOW; EXPRESSION; MOUSE; MECHANOTRANSDUCTION	Fluid shear modulates many biological properties. How shear mechanosensing occurs in the extracellular matrix (ECM) and is transduced into cytoskeletal change remains unknown. Cochlin is an ECM protein of unknown function. Our investigation using a comprehensive spectrum of cutting-edge techniques has resulted in following major findings: (1) over-expression and down-regulation of cochlin increase and decrease intraocular pressure (IOP), respectively. The overexpression was achieved in DBA/2J-Gpnmb(+)/SjJ using lentiviral vectors, down-regulation was achieved in glaucomatous DBA/2J mice using targeted disruption (cochlin-null mice) and also using lentiviral vector mediated shRNA against cochlin coding region; (2) reintroduction of cochlin in cochlin-null mice increases IOP; (3) injection of exogenous cochlin also increased IOP; (4) increasing perfusion rates increased cochlin multimerization, which reduced the rate of cochlin proteolysis by trypsin and proteinase K; The cochlin multimerization in response to shear stress suggests its potential mechanosensing. Taken together with previous studies, we show cochlin is involved in regulation of intraocular pressure in DBA/2J potentially through mechanosensing of the shear stress.	[Goel, Manik; Sienkiewicz, Adam E.; Picciani, Renata; Wang, Jianhua; Lee, Richard K.; Bhattacharya, Sanjoy K.] Univ Miami, Bascom Palmer Eye Inst, Miami, FL USA	Bascom Palmer Eye Institute; University of Miami	Goel, M (corresponding author), Univ Miami, Bascom Palmer Eye Inst, Miami, FL USA.	Sbhattacharya@med.miami.edu			United States National Institute of Health [R01 EY016112, EY015266, EY021012, EY016775, EY014801]; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [R01EY016112, K08EY016775, R21EY021012, R03EY015266, P30EY014801] Funding Source: NIH RePORTER	United States National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was funded by United States National Institute of Health Grants R01 EY016112, EY015266, EY021012, EY016775, and EY014801 (www.nei.nih.gov); a career development and an unrestricted grant to the University of Miami from Research to Prevent Blindness (http://www.rpbusa.org/rpb/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of this manuscript.	Anderson Douglas R, 2003, Curr Opin Ophthalmol, V14, P86; Asrani S, 2000, J GLAUCOMA, V9, P134; Bhattacharya SK, 2009, INVEST OPHTH VIS SCI, V50, P551, DOI 10.1167/iovs.08-2632; Bhattacharya SK, 2005, EXP EYE RES, V80, P741, DOI 10.1016/j.exer.2005.01.028; Bhattacharya SK, 2005, J BIOL CHEM, V280, P6080, DOI 10.1074/jbc.M411233200; Borras T, 2003, PROG RETIN EYE RES, V22, P435, DOI 10.1016/S1350-9462(03)00018-1; Chemin J, 2005, EMBO J, V24, P44, DOI 10.1038/sj.emboj.7600494; Chow J, 2007, MOL VIS, V13, P1926; Fujiwara K, 2006, J INTERN MED, V259, P373, DOI 10.1111/j.1365-2796.2006.01623.x; Gabelt BT, 2005, PROG RETIN EYE RES, V24, P612, DOI 10.1016/j.preteyeres.2004.10.003; Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066; Goel M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023070; Gomez-Cabrero A, 2005, MOL VIS, V11, P1071; Gong HY, 2009, EXP EYE RES, V88, P729, DOI 10.1016/j.exer.2009.01.015; Heys JJ, 2001, J BIOMECH ENG-T ASME, V123, P540, DOI 10.1115/1.1411972; Janmey PA, 2004, TRENDS BIOCHEM SCI, V29, P364, DOI 10.1016/j.tibs.2004.05.003; John SWM, 1997, INVEST OPHTH VIS SCI, V38, P249; Kommareddi PK, 2007, JARO-J ASSOC RES OTO, V8, P435, DOI 10.1007/s10162-007-0099-2; Kung C, 2005, NATURE, V436, P647, DOI 10.1038/nature03896; Lambrechts A, 2006, J CELL SCI, V119, P1570, DOI 10.1242/jcs.02884; LARSSON LI, 1995, ARCH OPHTHALMOL-CHIC, V113, P283, DOI 10.1001/archopht.1995.01100030037018; Lauritzen I, 2005, EMBO REP, V6, P642, DOI 10.1038/sj.embor.7400449; Lee ES, 2010, INVEST OPHTH VIS SCI, V51, P2060, DOI 10.1167/iovs.09-4521; Lesage F, 2000, AM J PHYSIOL-RENAL, V279, pF793, DOI 10.1152/ajprenal.2000.279.5.F793; Libby RT, 2005, VISUAL NEUROSCI, V22, P637, DOI 10.1017/S0952523805225130; MAEPEA O, 1992, EXP EYE RES, V54, P879, DOI 10.1016/0014-4835(92)90151-H; Morales M, 2007, EUR J PHARMACOL, V567, P145, DOI 10.1016/j.ejphar.2007.04.020; Morrison JC, 2005, PROG RETIN EYE RES, V24, P217, DOI 10.1016/j.preteyeres.2004.08.003; Morrison JC, 2003, GLAUCOMA SCI PRACTIC; Patel AJ, 2001, CURR OPIN CELL BIOL, V13, P422, DOI 10.1016/S0955-0674(00)00231-3; Picciani R, 2007, PROG RETIN EYE RES, V26, P453, DOI 10.1016/j.preteyeres.2007.06.002; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Robertson NG, 2008, HUM MOL GENET, V17, P3426, DOI 10.1093/hmg/ddn236; Rodriguez CI, 2004, ENDOCRINOLOGY, V145, P1410, DOI 10.1210/en.2003-1361; Shankaran H, 2003, BLOOD, V101, P2637, DOI 10.1182/blood-2002-05-1550; Sharif-Naeini R, 2009, CELL, V139, P587, DOI 10.1016/j.cell.2009.08.045; Sit AJ, 2008, INVEST OPHTH VIS SCI, V49, P1473, DOI 10.1167/iovs.07-1139; Syriani E, 2008, FASEB J, V22, P1581, DOI 10.1096/fj.06-7654com; Tian B, 2009, EXP EYE RES, V88, P713, DOI 10.1016/j.exer.2008.08.008; Vass C., 2004, INVEST OPHTHALMOL VI, V45, P5030; Vogel V, 2006, ANNU REV BIOPH BIOM, V35, P459, DOI 10.1146/annurev.biophys.35.040405.102013; Wang J, 2010, EYE CONTACT IN PRESS; WuDunn D, 2009, EXP EYE RES, V88, P718, DOI 10.1016/j.exer.2008.11.008; Zhang YY, 2009, EXP EYE RES, V89, P748, DOI 10.1016/j.exer.2009.06.015	44	32	34	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e34309	10.1371/journal.pone.0034309	http://dx.doi.org/10.1371/journal.pone.0034309			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GO	22496787	Green Published, Green Submitted, gold			2022-12-27	WOS:000304855200038
J	Noh, NA; Fuggetta, G; Manganotti, P; Fiaschi, A				Noh, Nor Azila; Fuggetta, Giorgio; Manganotti, Paolo; Fiaschi, Antonio			Long Lasting Modulation of Cortical Oscillations after Continuous Theta Burst Transcranial Magnetic Stimulation	PLOS ONE			English	Article							HIGH-FREQUENCY; MOTOR CORTEX; THALAMOCORTICAL DYSRHYTHMIA; SYNAPTIC PLASTICITY; EEG; TMS; SYNCHRONIZATION; EXCITABILITY; SYSTEMS; TASK	Transcranial magnetic theta burst stimulation (TBS) differs from other high-frequency rTMS protocols because it induces plastic changes up to an hour despite lower stimulus intensity and shorter duration of stimulation. However, the effects of TBS on neuronal oscillations remain unclear. In this study, we used electroencephalography (EEG) to investigate changes of neuronal oscillations after continuous TBS (cTBS), the protocol that emulates long-term depression (LTD) form of synaptic plasticity. We randomly divided 26 healthy humans into two groups receiving either Active or Sham cTBS as control over the left primary motor cortex (M1). Post-cTBS aftereffects were assessed with behavioural measurements at rest using motor evoked potentials (MEPs) and at active state during the execution of a choice reaction time (RT) task in combination with continuous electrophysiological recordings. The cTBS-induced EEG oscillations were assessed using event-related power (ERPow), which reflected regional oscillatory activity of neural assemblies of theta (4-7.5 Hz), low alpha (8-9.5 Hz), mu (10-12.5 Hz), low beta (13-19.5 Hz), and high beta (20-30 Hz) brain rhythms. Results revealed 20-min suppression of MEPs and at least 30-min increase of ERPow modulation, suggesting that besides MEPs, EEG has the potential to provide an accurate cortical readout to assess cortical excitability and to investigate the interference of cortical oscillations in the human brain post-cTBS. We also observed a predominant modulation of beta frequency band, supporting the hypothesis that cTBS acts more on cortical level. Theta oscillations were also modulated during rest implying the involvement of independent cortical theta generators over the motor network post cTBS. This work provided more insights into the underlying mechanisms of cTBS, providing a possible link between synchronised neural oscillations and LTD in humans.	[Noh, Nor Azila; Fuggetta, Giorgio] Univ Leicester, Sch Psychol, Coll Med Biol Sci & Psychol, Leicester, Leics, England; [Noh, Nor Azila] USIM, Fac Med & Hlth Sci, Dept Basic Med Sci 1, Persiaran MPAJ, Kuala Lumpur, Malaysia; [Fuggetta, Giorgio; Manganotti, Paolo; Fiaschi, Antonio] Univ Verona, Dept Neurol Neuropsychol Morphol & Movement Sci, Sect Clin Neurol, GB Rossi Hosp, I-37100 Verona, Italy	University of Leicester; Universiti Sains Islam Malaysia; University of Verona; Azienda Ospedaliera Universitaria Integrata Verona	Noh, NA (corresponding author), Univ Leicester, Sch Psychol, Coll Med Biol Sci & Psychol, Leicester, Leics, England.	g.fuggetta@le.ac.uk	Manganotti, Paolo/L-1763-2018	Manganotti, Paolo/0000-0001-5305-6268				Aydin-Abidin S, 2008, EXP BRAIN RES, V188, P249, DOI 10.1007/s00221-008-1356-2; Azila Noh N, 2011, HUM BRAIN MAPP; Brignani D, 2008, HUM BRAIN MAPP, V29, P603, DOI 10.1002/hbm.20423; Caplan JB, 2001, J NEUROPHYSIOL, V86, P368, DOI 10.1152/jn.2001.86.1.368; Cardenas-Morales L, 2010, BRAIN TOPOGR, V22, P294, DOI 10.1007/s10548-009-0084-7; Di Lazzaro V, 2008, J PHYSIOL-LONDON, V586, P3871, DOI 10.1113/jphysiol.2008.152736; Di Lazzaro V, 2005, J PHYSIOL-LONDON, V565, P945, DOI 10.1113/jphysiol.2005.087288; Dutilh G, 2009, PSYCHON B REV, V16, P1026, DOI 10.3758/16.6.1026; Formaggio E, 2008, BRAIN TOPOGR, V21, P100, DOI 10.1007/s10548-008-0058-1; Fuggetta G, 2008, HUM BRAIN MAPP, V29, P1, DOI 10.1002/hbm.20371; Grossheinrich N, 2009, BIOL PSYCHIAT, V65, P778, DOI 10.1016/j.biopsych.2008.10.029; Hallett M, 2007, NEURON, V55, P187, DOI 10.1016/j.neuron.2007.06.026; Hernandez RV, 2005, BRAIN RES PROTOC, V15, P6, DOI 10.1016/j.brainresprot.2005.02.003; Huang CC, 2008, NEUROPHARMACOLOGY, V54, P1071, DOI 10.1016/j.neuropharm.2008.02.013; Huang YZ, 2008, CEREB CORTEX, V18, P563, DOI 10.1093/cercor/bhm087; Huang YZ, 2007, CLIN NEUROPHYSIOL, V118, P1028, DOI 10.1016/j.clinph.2007.01.021; Huang YZ, 2005, NEURON, V45, P201, DOI 10.1016/j.neuron.2004.12.033; Huerta PT, 2009, J NEUROENG REHABIL, V6, DOI 10.1186/1743-0003-6-7; Iyer MB, 2003, J NEUROSCI, V23, P10867; Jeanmonod D, 2003, NEUROSURG CLIN N AM, V14, P251, DOI 10.1016/S1042-3680(02)00116-X; Jurcak V, 2007, NEUROIMAGE, V34, P1600, DOI 10.1016/j.neuroimage.2006.09.024; Kahana MJ, 2001, CURR OPIN NEUROBIOL, V11, P739, DOI 10.1016/S0959-4388(01)00278-1; Komssi S, 2006, BRAIN RES REV, V52, P183, DOI 10.1016/j.brainresrev.2006.01.008; LEUNG LWS, 1987, BRAIN RES, V407, P68, DOI 10.1016/0006-8993(87)91220-0; Llinas R, 2005, TRENDS NEUROSCI, V28, P325, DOI 10.1016/j.tins.2005.04.006; Llinas RR, 1999, P NATL ACAD SCI USA, V96, P15222, DOI 10.1073/pnas.96.26.15222; Makeig S, 2002, SCIENCE, V295, P690, DOI 10.1126/science.1066168; Maki H, 2010, CLIN NEUROPHYSIOL, V121, P492, DOI 10.1016/j.clinph.2009.11.078; McAllister SM, 2011, EUR J NEUROSCI, V33, P1916, DOI 10.1111/j.1460-9568.2011.07673.x; Miniussi C, 2010, BRAIN TOPOGR, V22, P249, DOI 10.1007/s10548-009-0083-8; Mochizuki H, 2005, EXP BRAIN RES, V167, P414, DOI 10.1007/s00221-005-0047-5; Mochizuki H, 2007, EXP BRAIN RES, V180, P667, DOI 10.1007/s00221-007-0884-5; Niedermeyer E, 2004, CLIN EEG NEUROSCI, V35, P84, DOI 10.1177/155005940403500206; Nyffeler T, 2006, NEUROSCI LETT, V409, P57, DOI 10.1016/j.neulet.2006.09.011; Okamoto M, 2004, NEUROIMAGE, V21, P99, DOI 10.1016/j.neuroimage.2003.08.026; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pareti G, 2004, NEUROL SCI, V25, P41, DOI 10.1007/s10072-004-0235-2; Paulus W, 2005, NEURON, V45, P181, DOI 10.1016/j.neuron.2005.01.008; Perfetti B, 2011, J NEUROPHYSIOL, V105, P18, DOI 10.1152/jn.00778.2010; Pfurtscheller G, 2006, NEUROIMAGE, V31, P153, DOI 10.1016/j.neuroimage.2005.12.003; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; Pineda JA, 2005, BRAIN RES REV, V50, P57, DOI 10.1016/j.brainresrev.2005.04.005; Raghavachari S, 2006, J NEUROPHYSIOL, V95, P1630, DOI 10.1152/jn.00409.2005; Rengachary J, 2011, FRONT HUM NEUROSCI, V5, DOI [10.3389/fnhum.2011.00029, 10.3389/fnhum.2011.00069]; Ridding MC, 2007, NAT REV NEUROSCI, V8, P559, DOI 10.1038/nrn2169; Rosanova M, 2009, J NEUROSCI, V29, P7679, DOI 10.1523/JNEUROSCI.0445-09.2009; Rossi S, 2009, CLIN NEUROPHYSIOL, V120, P2008, DOI 10.1016/j.clinph.2009.08.016; Salenius S, 2003, CURR OPIN NEUROBIOL, V13, P678, DOI 10.1016/j.conb.2003.10.008; Sauseng P, 2008, NEUROSCI BIOBEHAV R, V32, P1001, DOI 10.1016/j.neubiorev.2008.03.014; Schindler K, 2008, NEUROSCI LETT, V436, P31, DOI 10.1016/j.neulet.2008.02.052; Siebner HR, 2003, EXP BRAIN RES, V148, P1, DOI 10.1007/s00221-002-1234-2; SILVA LR, 1991, SCIENCE, V251, P432, DOI 10.1126/science.1824881; Stefan K, 2008, NEUROIMAGE, V40, P265, DOI 10.1016/j.neuroimage.2007.11.037; Stinear CM, 2009, BRAIN STIMUL, V2, P152, DOI 10.1016/j.brs.2009.01.001; Suppa A, 2008, J PHYSIOL-LONDON, V586, P4489, DOI 10.1113/jphysiol.2008.156596; Taylor PCJ, 2008, BEHAV BRAIN RES, V191, P141, DOI 10.1016/j.bbr.2008.03.033; Thickbroom GW, 2007, EXP BRAIN RES, V180, P583, DOI 10.1007/s00221-007-0991-3; Thut G, 2010, BRAIN TOPOGR, V22, P219, DOI 10.1007/s10548-009-0115-4; Thut G, 2010, BRAIN TOPOGR, V22, P215, DOI 10.1007/s10548-009-0128-z; Thut G, 2009, TRENDS COGN SCI, V13, P182, DOI 10.1016/j.tics.2009.01.004; Trippe J, 2009, EXP BRAIN RES, V199, P411, DOI 10.1007/s00221-009-1961-8; Veniero D, 2011, PSYCHOPHYSIOLOGY, V48, P1381, DOI 10.1111/j.1469-8986.2011.01218.x; Zhang YC, 2009, FRONT NEURAL CIRCUIT, V3, DOI 10.3389/neuro.04.020.2009; Ziemann U, 2011, NEUROSCIENTIST, V17, P368, DOI 10.1177/1073858410390225	64	55	56	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e35080	10.1371/journal.pone.0035080	http://dx.doi.org/10.1371/journal.pone.0035080			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GO	22496893	Green Submitted, Green Published, gold			2022-12-27	WOS:000304855200098
J	Popic, J; Pesic, V; Milanovic, D; Todorovic, S; Kanazir, S; Jevtovic-Todorovic, V; Ruzdijic, S				Popic, Jelena; Pesic, Vesna; Milanovic, Desanka; Todorovic, Smilja; Kanazir, Selma; Jevtovic-Todorovic, Vesna; Ruzdijic, Sabera			Propofol-Induced Changes in Neurotrophic Signaling in the Developing Nervous System In Vivo	PLOS ONE			English	Article							PROTEIN-KINASE-B; GABA(A) RECEPTOR; NEONATAL EXPOSURE; CELL-DEATH; RAT-BRAIN; BDNF; ERK; ACTIVATION; INHIBITION; PHOSPHORYLATION	Several studies have revealed a role for neurotrophins in anesthesia-induced neurotoxicity in the developing brain. In this study we monitored the spatial and temporal expression of neurotrophic signaling molecules in the brain of 14-day-old (PND14) Wistar rats after the application of a single propofol dose (25 mg/kg i.p). The structures of interest were the cortex and thalamus as the primary areas of anesthetic actions. Changes of the protein levels of the brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF), their activated receptors tropomyosin-related kinase (TrkA and TrkB) and downstream kinases Akt and the extracellular signal regulated kinase (ERK) were assessed by Western immunoblot analysis at different time points during the first 24 h after the treatment, as well as the expression of cleaved caspase-3 fragment. Fluoro-Jade B staining was used to follow the appearance of degenerating neurons. The obtained results show that the treatment caused marked alterations in levels of the examined neurotrophins, their receptors and downstream effector kinases. However, these changes were not associated with increased neurodegeneration in either the cortex or the thalamus. These results indicate that in the brain of PND14 rats, the interaction between Akt/ERK signaling might be one of important part of endogenous defense mechanisms, which the developing brain utilizes to protect itself from potential anesthesia-induced damage. Elucidation of the underlying molecular mechanisms will improve our understanding of the age-dependent component of anesthesia-induced neurotoxicity.	[Popic, Jelena; Pesic, Vesna; Milanovic, Desanka; Todorovic, Smilja; Kanazir, Selma; Ruzdijic, Sabera] Univ Belgrade, Inst Biol Res, Dept Neurobiol, Belgrade, Serbia; [Milanovic, Desanka; Jevtovic-Todorovic, Vesna] Univ Virginia Hlth Syst, Dept Anesthesiol, Charlottesville, VA USA	University of Belgrade; University of Virginia	Popic, J (corresponding author), Univ Belgrade, Inst Biol Res, Dept Neurobiol, Belgrade, Serbia.	sabir@ibiss.bg.ac.rs	Kanazir, Selma/E-5495-2015	Kanazir, Selma/0000-0002-7229-5296; Pesic, Vesna/0000-0002-1415-5834; Milanovic, Desanka/0000-0001-9799-0335; Todorovic, Smilja/0000-0001-7155-4914; Popic, Jelena/0000-0002-0959-3856	Ministry of Education and Science of the Republic of Serbia [ON173056]	Ministry of Education and Science of the Republic of Serbia(Ministry of Education, Science & Technological Development, Serbia)	This work was suported by grant no. ON173056 from the Ministry of Education and Science of the Republic of Serbia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Altar CA, 1998, TRENDS NEUROSCI, V21, P433, DOI 10.1016/S0166-2236(98)01273-9; BARBACID M, 1994, J NEUROBIOL, V25, P1386, DOI 10.1002/neu.480251107; Ben-Ari Y, 2010, TRENDS NEUROSCI, V33, P485, DOI 10.1016/j.tins.2010.08.005; Bjornstrom K, 2008, J PHYSIOL PHARMACOL, V59, P617; Blum R, 2005, PHYSIOLOGY, V20, P70, DOI 10.1152/physiol.00042.2004; Briner A, 2010, ANESTHESIOLOGY, V112, P546, DOI 10.1097/ALN.0b013e3181cd7942; Cardone MH, 1998, SCIENCE, V282, P1318, DOI 10.1126/science.282.5392.1318; Cheung Eric C C, 2004, Sci STKE, V2004, pPE45; CURTIS R, 1995, NEURON, V14, P1201, DOI 10.1016/0896-6273(95)90267-8; DOBBING J, 1979, EARLY HUM DEV, V3, P79, DOI 10.1016/0378-3782(79)90022-7; Dolcet X, 1999, J NEUROCHEM, V73, P521, DOI 10.1046/j.1471-4159.1999.0730521.x; Dummler B, 2007, BIOCHEM SOC T, V35, P231, DOI 10.1042/BST0350231; Engelhard K, 2004, ANESTHESIOLOGY, V101, P912, DOI 10.1097/00000542-200410000-00016; Fredriksson A, 2007, ANESTHESIOLOGY, V107, P427, DOI 10.1097/01.anes.0000278892.62305.9c; Galetic I, 2003, J BIOL CHEM, V278, P4416, DOI 10.1074/jbc.M210578200; Gilman CP, 2002, NEUROMOL MED, V2, P197, DOI 10.1385/NMM:2:2:197; Grewal SS, 1999, CURR OPIN NEUROBIOL, V9, P544, DOI 10.1016/S0959-4388(99)00010-0; Hartmann M, 2001, EMBO J, V20, P5887, DOI 10.1093/emboj/20.21.5887; HEMPSTEAD BL, 1992, NEURON, V9, P883, DOI 10.1016/0896-6273(92)90241-5; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; JENSEN AG, 1994, ANESTHESIOLOGY, V81, P1220, DOI 10.1097/00000542-199411000-00016; Kaplan DR, 2000, CURR OPIN NEUROBIOL, V10, P381, DOI 10.1016/S0959-4388(00)00092-1; Kidambi Srivatsan, 2010, BMC Res Notes, V3, P201, DOI 10.1186/1756-0500-3-201; Kozinn J, 2006, ANESTHESIOLOGY, V105, P1182, DOI 10.1097/00000542-200612000-00018; Krasowski MD, 1999, CELL MOL LIFE SCI, V55, P1278, DOI 10.1007/s000180050371; Lewin GR, 1996, ANNU REV NEUROSCI, V19, P289, DOI 10.1146/annurev.ne.19.030196.001445; Liao Y, 2010, AM J TRANSL RES, V2, P19; Lu LX, 2006, APOPTOSIS, V11, P1603, DOI 10.1007/s10495-006-8762-3; Lu S, 2011, TOXICOLOGY, V279, P189, DOI 10.1016/j.tox.2010.10.011; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Marik PE, 2004, CURR PHARM DESIGN, V10, P3639, DOI 10.2174/1381612043382846; Muller DL, 2004, J PHARMACOL EXP THER, V310, P774, DOI 10.1124/jpet.104.066548; Nakao S, 2003, ACTA ANAESTH SCAND, V47, P284, DOI 10.1034/j.1399-6576.2003.00040.x; Nicholson KM, 2002, CELL SIGNAL, V14, P381, DOI 10.1016/S0898-6568(01)00271-6; Oscarsson A, 2007, ACTA ANAESTH SCAND, V51, P1184, DOI 10.1111/j.1399-6576.2007.01388.x; Pesic V, 2009, INT J DEV NEUROSCI, V27, P279, DOI 10.1016/j.ijdevneu.2008.12.005; Ponten E, 2011, BEHAV BRAIN RES, V223, P75, DOI 10.1016/j.bbr.2011.04.019; QIU MS, 1992, NEURON, V9, P705, DOI 10.1016/0896-6273(92)90033-A; Rajagopal R, 2004, J NEUROSCI, V24, P6650, DOI 10.1523/JNEUROSCI.0010-04.2004; Riccio A, 1997, SCIENCE, V277, P1097, DOI 10.1126/science.277.5329.1097; Riedl SJ, 2001, CELL, V104, P791, DOI 10.1016/S0092-8674(02)02036-6; Rommel C, 1999, SCIENCE, V286, P1738, DOI 10.1126/science.286.5445.1738; SEGER R, 1995, FASEB J, V9, P726, DOI 10.1096/fasebj.9.9.7601337; Tao X, 1998, NEURON, V20, P709, DOI 10.1016/S0896-6273(00)81010-7; Tsui-Pierchala BA, 1999, J NEUROSCI, V19, P8207; Turina D, 2008, BRIT J ANAESTH, V101, P374, DOI 10.1093/bja/aen185; Varju P, 2001, CELL TISSUE RES, V305, P239, DOI 10.1007/s004410100356; Vutskits L, 2005, ANESTHESIOLOGY, V102, P970, DOI 10.1097/00000542-200505000-00016; Wang C, 2002, DEV BRAIN RES, V139, P59, DOI 10.1016/S0165-3806(02)00536-9; Watson FL, 1999, J NEUROSCI, V19, P7889; Yang J, 2002, MOL CELL, V9, P1227, DOI 10.1016/S1097-2765(02)00550-6; Yon JH, 2005, NEUROSCIENCE, V135, P815, DOI 10.1016/j.neuroscience.2005.03.064; Zhang YY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027019; Zhang YZ, 2000, J NEUROSCI, V20, P5671, DOI 10.1523/JNEUROSCI.20-15-05671.2000	55	46	48	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e34396	10.1371/journal.pone.0034396	http://dx.doi.org/10.1371/journal.pone.0034396			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GO	22496799	Green Published, gold, Green Submitted			2022-12-27	WOS:000304855200046
J	Shah, NR; Braverman, ER				Shah, Nirav R.; Braverman, Eric R.			Measuring Adiposity in Patients: The Utility of Body Mass Index (BMI), Percent Body Fat, and Leptin	PLOS ONE			English	Article							BASE-LINE LEPTIN; SARCOPENIC OBESITY; WEIGHT; PREVALENCE; WOMEN; RESISTANCE; GHRELIN; TRENDS; AGE; OSTEOPOROSIS	Background:Obesity is a serious disease that is associated with an increased risk of diabetes, hypertension, heart disease, stroke, and cancer, among other diseases. The United States Centers for Disease Control and Prevention (CDC) estimates a 20% obesity rate in the 50 states, with 12 states having rates of over 30%. Currently, the body mass index (BMI) is most commonly used to determine adiposity. However, BMI presents as an inaccurate obesity classification method that underestimates the epidemic and contributes to failed treatment. In this study, we examine the effectiveness of precise biomarkers and duel-energy x-ray absorptiometry (DXA) to help diagnose and treat obesity. Methodology/Principal Findings: A cross-sectional study of adults with BMI, DXA, fasting leptin and insulin results were measured from 1998-2009. Of the participants, 63% were females, 37% were males, 75% white, with a mean age = 51.4 (SD = 14.2). Mean BMI was 27.3 (SD = 5.9) and mean percent body fat was 31.3% (SD = 9.3). BMI characterized 26% of the subjects as obese, while DXA indicated that 64% of them were obese. 39% of the subjects were classified as non-obese by BMI, but were found to be obese by DXA. BMI misclassified 25% men and 48% women. Meanwhile, a strong relationship was demonstrated between increased leptin and increased body fat. Conclusions/Significance: Our results demonstrate the prevalence of false-negative BMIs, increased misclassifications in women of advancing age, and the reliability of gender-specific revised BMI cutoffs. BMI underestimates obesity prevalence, especially in women with high leptin levels (>30 ng/mL). Clinicians can use leptin-revised levels to enhance the accuracy of BMI estimates of percentage body fat when DXA is unavailable.	[Shah, Nirav R.] NYU, Sch Med, Dept Med, New York, NY 10003 USA; [Braverman, Eric R.] PATH Fdn NY, New York, NY USA; [Braverman, Eric R.] Weill Cornell Med Coll, Dept Neurosurg, New York, NY USA	New York University; Cornell University	Shah, NR (corresponding author), NYU, Sch Med, Dept Med, New York, NY 10003 USA.	info@pathfounationny.org	Braverman, Eric new/ABC-1152-2021; Shah, Nirav R./B-6622-2008	Shah, Nirav R./0000-0003-2044-7865	Life Extension Foundation; PATH Foundation; NRS [1 R01 HS01 8589-01]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS018589] Funding Source: NIH RePORTER	Life Extension Foundation; PATH Foundation; NRS; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	The authors are grateful to the Life Extension Foundation for their generous financial support to PATH Foundation NY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: This work was supported by a research grant from the PATH Foundation. All research and financial support for this article preceded NRS's joining the New York State Department of Health. Similarly, except for minor editorial changes, the article was completed before that time. The views expressed in this article are solely those of the authors as individuals and do not represent the views or policies of the State of New York or the New York State Department of Health. During the period when the work was completed, NRS was also supported by grant 1 R01 HS01 8589-01. All authors have completed the Unified Competing Interest form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author and declare that (1) NRS has received grants from the PATH Foundation for the submitted work; ERB has received no personal compensation for the submitted work; (2) NRS has relationships with AstraZeneca, Pfizer, Merck, Ortho-McNeil, Roche, Shering-Plough, GlaxoSmithKline, Novartis, Partners Healthcare, Bellevue Hospital Association, NIH, AHRQ, CDC, Robert Wood Johnson Foundation, Cerner LifeSciences, Vemco MedEd, FAIR Health, Venebio Group, LLC, American Academy of Neurology, Pinnacle Health Geisinger Health System, MetaResearch, LLC, Johnson & Johnson, Takeda, Xcenda, Engage Healthcare, Medical Learning Institute, American Health & Drug Benefits, Center of Excellence Media LLC, Nassau University Medical Center, National Institute for Quality Improvement and Education and St. John's Episcopal Hospital. ERB has relationships with PATH Medical, Total Health Nutrients, Inc. and LLC, Life Extension Foundation, Weill-Cornell Medical College, the Stanley and Fiona Druckenmiller Fund, the American Academy of Anti-aging Medicine Fellowship in Anti-Aging, Regenerative, and Functional Medicine: Master's Degree in Metabolic & Nutritional Medicine in conjunction with the University of South Florida Medical School; the American Academy of Anti-aging Medicine Tarsus Medical Conference; and Douglas Labs, Life Extension Magazine; and has authored a book on weight loss; (3) Their spouses, partners, or children have no financial relationships that may be relevant to the submitted work; and (4) NRS and ERB have no non-financial interests that may be relevant to the submitted work. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Blew RM, 2002, OBES RES, V10, P799, DOI 10.1038/oby.2002.108; Chen K, 2006, NAT MED, V12, P425, DOI 10.1038/nm1372; Crujeiras AB, 2010, J CLIN ENDOCR METAB, V95, P5037, DOI 10.1210/jc.2009-2566; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; de Gonzalez AB, 2010, NEW ENGL J MED, V363, P2211, DOI 10.1056/NEJMoa1000367; De Lorenzo A, 2007, AM J CLIN NUTR, V85, P40, DOI 10.1093/ajcn/85.1.40; Di Monaco M, 2011, ARCH GERONTOL GERIAT, V52, P71, DOI 10.1016/j.archger.2010.02.002; FerroLuzzi A, 1995, WHO TECH REP SER, V854, P1; Flegal KM, 2010, INT J EPIDEMIOL, V39, P963, DOI 10.1093/ije/dyq124; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Flegal KM, 2009, AM J CLIN NUTR, V89, P500, DOI 10.3945/ajcn.2008.26847; Fleming TR, 1996, ANN INTERN MED, V125, P605, DOI 10.7326/0003-4819-125-7-199610010-00011; Gallagher D, 1996, AM J EPIDEMIOL, V143, P228, DOI 10.1093/oxfordjournals.aje.a008733; Gomez-Ambrosi J, 2011, OBESITY, V19, P1439, DOI 10.1038/oby.2011.36; Jia HM, 2010, AM J PREV MED, V38, P138, DOI 10.1016/j.amepre.2009.09.043; Kelesidis T, 2010, ANN INTERN MED, V152, P93, DOI 10.7326/0003-4819-152-2-201001190-00008; Koh KK, 2008, CIRCULATION, V117, P3238, DOI 10.1161/CIRCULATIONAHA.107.741645; Labayen I, 2011, J CLIN ENDOCR METAB, V96, pE996, DOI 10.1210/jc.2010-3006; Labruna G, 2011, OBESITY, V19, P1492, DOI 10.1038/oby.2010.309; Malnick SDH, 2006, QJM-INT J MED, V99, P565, DOI 10.1093/qjmed/hcl085; Mantzoros CS, 1999, ANN INTERN MED, V130, P671, DOI 10.7326/0003-4819-130-8-199904200-00014; Martin SS, 2008, J AM COLL CARDIOL, V52, P1201, DOI 10.1016/j.jacc.2008.05.060; *NHLBI, 1998, NIH PUBL; Okorodudu DO, 2010, INT J OBESITY, V34, P791, DOI 10.1038/ijo.2010.5; Prado CMM, 2008, LANCET ONCOL, V9, P629, DOI 10.1016/S1470-2045(08)70153-0; Rahman M, 2010, OBSTET GYNECOL, V115, P982, DOI 10.1097/AOG.0b013e3181da9423; Razak F, 2007, CIRCULATION, V115, P2111, DOI 10.1161/CIRCULATIONAHA.106.635011; Romero-Corral A, 2008, INT J OBESITY, V32, P959, DOI 10.1038/ijo.2008.11; Romero-Corral A, 2010, EUR HEART J, V31, P737, DOI 10.1093/eurheartj/ehp487; RUIZ JR, 2008, BMJ-BRIT MED J, V337, P439; Shea JL, 2011, NUTR METAB CARDIOVAS; Stenholm S, 2008, CURR OPIN CLIN NUTR, V11, P693, DOI 10.1097/MCO.0b013e328312c37d; Sun Q, 2010, AM J EPIDEMIOL, V172, P1442, DOI 10.1093/aje/kwq306; Sun Q, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b3796; Ursavas A, 2010, ANN THORAC MED, V5, P161, DOI 10.4103/1817-1737.65050; Walsh MC, 2006, OSTEOPOROSIS INT, V17, P61, DOI 10.1007/s00198-005-1900-x; Wormser D, 2011, LANCET, V377, P1085, DOI 10.1016/S0140-6736(11)60105-0; Zimmet P, 1996, BRIT MED J, V313, P965, DOI 10.1136/bmj.313.7063.965	38	327	337	6	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2012	7	4							e33308	10.1371/journal.pone.0033308	http://dx.doi.org/10.1371/journal.pone.0033308			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952GU	22485140	Green Published, gold			2022-12-27	WOS:000304780500016
J	Huang, DW				Huang, Danwei			Threatened Reef Corals of the World	PLOS ONE			English	Article							PHYLOGENETIC DIVERSITY; CONSERVATION PRIORITIES; BIODIVERSITY HOTSPOTS; SCLERACTINIAN CORALS; EVOLUTIONARY HISTORY; EXTINCTION RISK; CLIMATE-CHANGE; PHASE-SHIFTS; MATRIX REPRESENTATION; STONY CORALS	A substantial proportion of the world's living species, including one-third of the reef-building corals, are threatened with extinction and in pressing need of conservation action. In order to reduce biodiversity loss, it is important to consider species' contribution to evolutionary diversity along with their risk of extinction for the purpose of setting conservation priorities. Here I reconstruct the most comprehensive tree of life for the order Scleractinia (1,293 species) that includes all 837 living reef species, and employ a composite measure of phylogenetic distinctiveness and extinction risk to identify the most endangered lineages that would not be given top priority on the basis of risk alone. The preservation of these lineages, not just the threatened species, is vital for safeguarding evolutionary diversity. Tests for phylogeny-associated patterns show that corals facing elevated extinction risk are not clustered on the tree, but species that are susceptible, resistant or resilient to impacts such as bleaching and disease tend to be close relatives. Intensification of these threats or extirpation of the endangered lineages could therefore result in disproportionate pruning of the coral tree of life.	[Huang, Danwei] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; [Huang, Danwei] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore	University of California System; University of California San Diego; Scripps Institution of Oceanography; National University of Singapore	Huang, DW (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA.	huangdanwei@nus.edu.sg	Huang, Danwei/C-4525-2016		Ah Meng Memorial Conservation Fund (Wildlife Reserves Singapore); Friends of the International Center Scholarship (University of California San Diego)	Ah Meng Memorial Conservation Fund (Wildlife Reserves Singapore); Friends of the International Center Scholarship (University of California San Diego)	This work was supported by the Ah Meng Memorial Conservation Fund (Wildlife Reserves Singapore) and the Friends of the International Center Scholarship (University of California San Diego). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnarsson I, 2010, MOL PHYLOGENET EVOL, V54, P726, DOI 10.1016/j.ympev.2009.10.033; Almany GR, 2009, CORAL REEFS, V28, P339, DOI 10.1007/s00338-009-0484-x; ALTSCHUL SF, 1990, NATURE, V348, P493, DOI 10.1038/348493c0; BAUM BR, 1992, TAXON, V41, P3, DOI 10.2307/1222480; Beger M, 2003, BIOL CONSERV, V111, P53, DOI 10.1016/S0006-3207(02)00249-5; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Bellwood DR, 2001, SCIENCE, V292, P1532, DOI 10.1126/science.1058635; Benzoni F, 2007, CONTRIB ZOOL, V76, P35, DOI 10.1163/18759866-07601004; Benzoni F, 2010, ZOOL J LINN SOC-LOND, V160, P421, DOI 10.1111/j.1096-3642.2010.00622.x; Bininda-Emonds ORP, 2005, SYST BIOL, V54, P668, DOI 10.1080/10635150590947113; Bininda-Emonds ORP, 2004, TRENDS ECOL EVOL, V19, P315, DOI 10.1016/j.tree.2004.03.015; Bininda-Emonds ORP, 2002, ANNU REV ECOL SYST, V33, P265, DOI 10.1146/annurev.ecolsys.33.010802.150511; Blomberg SP, 2003, EVOLUTION, V57, P717, DOI 10.1111/j.0014-3820.2003.tb00285.x; Blum MGB, 2006, SYST BIOL, V55, P685, DOI 10.1080/10635150600889625; Borel Best M., 1987, Zoologische Mededelingen (Leiden), V61, P387; Brandt ME, 2009, ECOLOGY, V90, P2859, DOI 10.1890/08-0445.1; Bruno JF, 2007, PLOS BIOL, V5, P1220, DOI 10.1371/journal.pbio.0050124; Bruno JF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000711; Budd AF, 2005, PALEONTOLOGICAL SOC, V11, P103; Budd AF, 2010, INTEGR COMP BIOL, V50, P411, DOI 10.1093/icb/icq062; Cadotte MW, 2008, P NATL ACAD SCI USA, V105, P17012, DOI 10.1073/pnas.0805962105; Cadotte MW, 2010, DIVERS DISTRIB, V16, P376, DOI 10.1111/j.1472-4642.2010.00650.x; Cadotte MW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005695; Cairns S. D., 2009, COLD WATER CORALS BI; Cairns S. D., 1997, SMITHSONIAN CONTRIBU, V591, P1, DOI DOI 10.5479/SI.00810282.591; Cairns Stephen D., 2001, Smithsonian Contributions to Zoology, V615, P1; Carpenter KE, 2008, SCI E LETT; Carpenter KE, 2008, SCIENCE, V321, P560, DOI 10.1126/science.1159196; Carpenter Kent E., 2011, Journal of Marine Biology, V2011, P1; Chevalier JP, 1971, EXPEDITION FRANCAISE, V5, P1; Claereboudt M., 1990, Galaxea, V9, P1; Claereboudt MR, 2004, ZOOTAXA, P1; Collen B, 2011, PHILOS T R SOC B, V366, P2611, DOI 10.1098/rstb.2011.0109; Colless D.H., 1982, SYST ZOOL, V31, P100, DOI DOI 10.2307/2413420; Connolly J, 2011, ECOLOGY, V92, P1385, DOI 10.1890/10-2270.1; Daly M, 2003, ZOOL J LINN SOC-LOND, V139, P419, DOI 10.1046/j.1096-3642.2003.00084.x; Davies TJ, 2008, P NATL ACAD SCI USA, V105, P11556, DOI 10.1073/pnas.0801917105; De Queiroz K, 2011, BIOL J LINN SOC, V103, P19, DOI 10.1111/j.1095-8312.2011.01634.x; De'ath G, 2009, SCIENCE, V323, P116, DOI 10.1126/science.1165283; Diaz M, 2011, CORAL REEFS, V30, P73, DOI 10.1007/s00338-010-0668-4; Ditlev H., 2003, Zoologische Mededelingen (Leiden), V77, P193; Fabricius KE, 2011, NAT CLIM CHANGE, V1, P165, DOI 10.1038/NCLIMATE1122; Faith DP, 2010, CURR OPIN ENV SUST, V2, P66, DOI 10.1016/j.cosust.2010.04.002; Faith DP, 2008, CONSERV BIOL, V22, P1461, DOI 10.1111/j.1523-1739.2008.01068.x; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; FENNER DP, 1993, B MAR SCI, V53, P1099; Flynn DFB, 2011, ECOLOGY, V92, P1573, DOI 10.1890/10-1245.1; Forsman ZH, 2009, ZOOTAXA, P51; Fritz SA, 2010, CONSERV BIOL, V24, P1042, DOI 10.1111/j.1523-1739.2010.01455.x; Fritz SA, 2010, P ROY SOC B-BIOL SCI, V277, P2435, DOI 10.1098/rspb.2010.0030; Fukami H, 2004, NATURE, V427, P832, DOI 10.1038/nature02339; Fukami H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003222; Gittenberger A, 2011, CONTRIB ZOOL, V80, P107, DOI 10.1163/18759866-08002002; HEAD SM, 1983, J NAT HIST, V17, P419, DOI 10.1080/00222938300770281; Heard SB, 2000, P ROY SOC B-BIOL SCI, V267, P613, DOI 10.1098/rspb.2000.1046; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hoeksema B. W., 1993, Zoologische Mededelingen (Leiden), V67, P639; Hoeksema BW, 2009, RAFFLES B ZOOL, P81; Hoeksema BW, 1989, ZOOLOGISCHE VERHANDE, V254, P1; Hoffmann M., 2008, Endangered Species Research, V6, P113, DOI 10.3354/esr00087; Huang DW, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-37; Hughes TP, 2007, CURR BIOL, V17, P360, DOI 10.1016/j.cub.2006.12.049; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Hughes TP, 2002, ECOL LETT, V5, P775, DOI 10.1046/j.1461-0248.2002.00383.x; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; Isaac NJB, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000296; IUCN, 2012, IUCN RED LIST CATEGO, V2nd ed., P32; Jones KE, 2005, EVOLUTION, V59, P2243, DOI 10.1111/j.0014-3820.2005.tb00932.x; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Kembel SW, 2010, BIOINFORMATICS, V26, P1463, DOI 10.1093/bioinformatics/btq166; Kerr AM, 2005, BIOL REV, V80, P543, DOI 10.1017/S1464793105006780; Kitahara MV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011490; Knowlton N, 2008, SCI E LETT; Knowlton N, 2008, PLOS BIOL, V6, P215, DOI 10.1371/journal.pbio.0060054; Kuntner M, 2011, ZOOL SCR, V40, P1, DOI 10.1111/j.1463-6409.2010.00452.x; Lin MF, 2011, ZOOL STUD, V50, P513; Locke JM, 2007, P BIOL SOC WASH, V120, P214, DOI 10.2988/0006-324X(2007)120[214:ANDSOM]2.0.CO;2; Loya Y, 2001, ECOL LETT, V4, P122, DOI 10.1046/j.1461-0248.2001.00203.x; Mace GM, 2008, CONSERV BIOL, V22, P1424, DOI 10.1111/j.1523-1739.2008.01044.x; Mace GM, 2003, SCIENCE, V300, P1707, DOI 10.1126/science.1085510; Maddison W. P., 2007, TUATARA CONSERVATION; Maherali H, 2007, SCIENCE, V316, P1746, DOI 10.1126/science.1143082; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; Marshall PA, 2000, CORAL REEFS, V19, P155, DOI 10.1007/s003380000086; MAY RM, 1990, NATURE, V347, P129, DOI 10.1038/347129a0; May-Collado LJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022562; Maynard JA, 2008, CORAL REEFS, V27, P745, DOI 10.1007/s00338-008-0432-1; McCook LJ, 1999, CORAL REEFS, V18, P357, DOI 10.1007/s003380050213; McKinney ML, 1997, ANNU REV ECOL SYST, V28, P495, DOI 10.1146/annurev.ecolsys.28.1.495; Miller J, 2006, CORAL REEFS, V25, P418, DOI 10.1007/s00338-006-0125-6; Miller M.A., 2010, P GAT COMP ENV WORKS; MOLL H, 1984, Zoologische Mededelingen (Leiden), V58, P47; Mooers AO, 1997, Q REV BIOL, V72, P31, DOI 10.1086/419657; MOOERS AO, 1995, EVOLUTION, V49, P379, DOI [10.2307/2410349, 10.1111/j.1558-5646.1995.tb02251.x]; Mooers AO, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003700; Murdoch W, 2007, BIOL CONSERV, V139, P375, DOI 10.1016/j.biocon.2007.07.011; Myers Norman, 2000, Nature (London), V403, P853, DOI 10.1038/35002501; Nee S, 1997, SCIENCE, V278, P692, DOI 10.1126/science.278.5338.692; Nystrom M, 2008, CORAL REEFS, V27, P795, DOI 10.1007/s00338-008-0426-z; Orme D., 2008, CAIC COMP ANAL USING; Palmer CV, 2010, FASEB J, V24, P1935, DOI 10.1096/fj.09-152447; Pandolfi JM, 2005, SCIENCE, V308, P1742; PANDOLFI JM, 1992, J BIOGEOGR, V19, P593, DOI 10.2307/2845703; Pandolfi JM, 2011, SCIENCE, V333, P418, DOI 10.1126/science.1204794; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Parhar RK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023528; Pavoine S, 2005, ECOL LETT, V8, P579, DOI 10.1111/j.1461-0248.2005.00752.x; Pires D.O., 1997, P1581; Polidoro Beth A., 2011, Journal of Marine Biology, V2011, P1, DOI 10.1155/2011/247030; Purvis A, 2000, SCIENCE, V288, P328, DOI 10.1126/science.288.5464.328; Purvis A, 2002, SYST BIOL, V51, P844, DOI 10.1080/10635150290155809; Purvis A, 2011, PHILOS T R SOC B, V366, P2462, DOI 10.1098/rstb.2011.0025; Purvis A, 2008, ANNU REV ECOL EVOL S, V39, P301, DOI 10.1146/annurev-ecolsys-063008-102010; Ragan MA, 1992, MOL PHYLOGENET EVOL, V1, P53, DOI 10.1016/1055-7903(92)90035-F; Redding DW, 2008, J THEOR BIOL, V251, P606, DOI 10.1016/j.jtbi.2007.12.006; Redding DW, 2006, CONSERV BIOL, V20, P1670, DOI 10.1111/j.1523-1739.2006.00555.x; Redding DW, 2010, CONSERV BIOL, V24, P1052, DOI 10.1111/j.1523-1739.2010.01532.x; Roberts CM, 2002, SCIENCE, V295, P1280, DOI 10.1126/science.1067728; Rodolfo-Metalpa R, 2011, NAT CLIM CHANGE, V1, P308, DOI 10.1038/NCLIMATE1200; Rodrigues ASL, 2006, TRENDS ECOL EVOL, V21, P71, DOI 10.1016/j.tree.2005.10.010; Rodrigues ASL, 2004, BIOSCIENCE, V54, P1092, DOI 10.1641/0006-3568(2004)054[1092:GGAPRF]2.0.CO;2; Romano SL, 1997, J MOL EVOL, V45, P397, DOI 10.1007/PL00006245; Romano SL, 2000, B MAR SCI, V67, P1043; Romano SL, 1996, SCIENCE, V271, P640, DOI 10.1126/science.271.5249.640; Russell GJ, 1998, CONSERV BIOL, V12, P1365, DOI 10.1046/j.1523-1739.1998.96332.x; Scheer G., 1983, Zoologica (Stuttgart), P1; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Steel M, 2007, EVOL BIOINFORM, V3, P237; Swofford D, 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/J.0014-3820.2002.TB00191.X; van Woesik R, 2011, MAR ECOL PROG SER, V434, P67, DOI 10.3354/meps09203; VANEWRIGHT RI, 1991, BIOL CONSERV, V55, P235, DOI 10.1016/0006-3207(91)90030-D; Vaughan TW, 1901, B US FISH COMMISS, V2, P289; Veron, 2002, NEW SPECIES DESCRIBE; VERON J E N, 1990, Galaxea, V9, P95; Veron JEN, 2009, MAR POLLUT BULL, V58, P1428, DOI 10.1016/j.marpolbul.2009.09.009; Veron J.E.N., 2000, CORALS WORLD, V1-3; Veron J.E.N., 1986, CORALS AUSTR INDOPAC; Veron JEN, 2009, GALAXEA J CORAL REEF, V11, P91, DOI DOI 10.3755/GALAXEA.11.91; Veron JEN, 1980, SCLERACTINIA E AUS 3; Veron JEN, 1977, SCLERACTINIA E AUS 2; Wallace CC, 2007, CORAL REEFS, V26, P231, DOI 10.1007/s00338-007-0203-4; Wallace C.C., 1999, STAGHORN CORALS WORL, DOI 10.1071/9780643101388; Wallace CC, 2011, J NAT HIST, V45, P1905, DOI 10.1080/00222933.2011.573098; Weitzman ML, 1998, ECONOMETRICA, V66, P1279, DOI 10.2307/2999617; Wells J. W., 1937, Journal of Paleontology Menasha, V11, P73; WIJSMAN-BEST M, 1972, Bijdragen tot de Dierkunde, V42, P3; WITTING L, 1995, BIOL CONSERV, V71, P205, DOI 10.1016/0006-3207(94)00041-N; YABE HISAKATSU, 1941, SCI REPTS TOHOKU IMP UNIV SER 2 GEOL SPECIAL VOL, V2, P67; Yee SH, 2011, ECOL MODEL, V222, P1323, DOI 10.1016/j.ecolmodel.2011.01.009	152	92	94	1	109	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e34459	10.1371/journal.pone.0034459	http://dx.doi.org/10.1371/journal.pone.0034459			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479633	Green Submitted, gold, Green Published			2022-12-27	WOS:000305339100159
J	Popi, AF; Osugui, L; Perez, KR; Longo-Maugeri, IM; Mariano, M				Popi, Ana Flavia; Osugui, Lika; Perez, Katia Regina; Longo-Maugeri, Ieda Maria; Mariano, Mario			Could a B-1 Cell Derived Phagocyte "Be One" of the Peritoneal Macrophages during LPS-Driven Inflammation?	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; BIPHENOTYPIC B/MACROPHAGE CELLS; TRANSCRIPTION FACTOR PU.1; MONONUCLEAR PHAGOCYTE; B-LYMPHOCYTES; DIFFERENTIATION; MOUSE; MICE; OSTEOPETROSIS; POPULATIONS	The inflammatory response is driven by signals that recruit and elicit immune cells to areas of tissue damage or infection. The concept of a mononuclear phagocyte system postulates that monocytes circulating in the bloodstream are recruited to inflamed tissues where they give rise to macrophages. A recent publication demonstrated that the large increase in the macrophages observed during infection was the result of the multiplication of these cells rather than the recruitment of blood monocytes. We demonstrated previously that B-1 cells undergo differentiation to acquire a mononuclear phagocyte phenotype in vitro (B-1CDP), and we propose that B-1 cells could be an alternative origin for peritoneal macrophages. A number of recent studies that describe the phagocytic and microbicidal activity of B-1 cells in vitro and in vivo support this hypothesis. Based on these findings, we further investigated the differentiation of B-1 cells into phagocytes in vivo in response to LPS-induced inflammation. Therefore, we investigated the role of B-1 cells in the composition of the peritoneal macrophage population after LPS stimulation using osteopetrotic mice, BALB/Xid mice and the depletion of monocytes/macrophages by clodronate treatment. We show that peritoneal macrophages appear in op/op((-/-)) mice after LPS stimulation and exhibit the same Ig gene rearrangement (VH11) that is often found in B-1 cells. These results strongly suggest that op/op((-/-)) peritoneal "macrophages" are B-1CDP. Similarly, the LPS-induced increase in the macrophage population was observed even following monocyte/macrophage depletion by clodronate. After monocyte/macrophage depletion by clodronate, LPS-elicited macrophages were observed in BALB/Xid mice only following the transfer of B-1 cells. Based on these data, we confirmed that B-1 cell differentiation into phagocytes also occurs in vivo. In conclusion, the results strongly suggest that B-1 cell derived phagocytes are a component of the LPS-elicited peritoneal macrophage population.	[Popi, Ana Flavia; Osugui, Lika; Longo-Maugeri, Ieda Maria; Mariano, Mario] Univ Fed Sao Paulo, UNIFESP, Discipline Immunol, Dept Microbiol Immunol & Parasitol, Sao Paulo, Brazil; [Perez, Katia Regina] Univ Fed Sao Paulo, Dept Biophys, Sao Paulo, Brazil; [Mariano, Mario] Univ Estadual Paulista, Lab Mol & Cellular Biol, UNIP, Sao Paulo, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP); Universidade Estadual Paulista; Universidade Paulista	Popi, AF (corresponding author), Univ Fed Sao Paulo, UNIFESP, Discipline Immunol, Dept Microbiol Immunol & Parasitol, Sao Paulo, Brazil.	afpopi@unifesp.br	Popi, Ana Flavia/V-4437-2019; Popi, Ana/C-8828-2012; Perez, Katia/J-2312-2016; Mariano, Mario/L-2557-2015; Osugui, Lika/AFV-5288-2022; Longo-Maugeri, Ieda M/B-9764-2012	Popi, Ana Flavia/0000-0001-9814-4181; Popi, Ana/0000-0001-9814-4181; Osugui, Lika/0000-0002-2755-3487; Longo-Maugeri, Ieda M/0000-0003-4184-8414; Perez, Katia Regina/0000-0001-9612-1816	FAPESP - Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2002/01354-6, 2008/55526-9]	FAPESP - Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This research was supported by FAPESP - Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (2002/01354-6 and 2008/55526-9). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahao TB, 2003, IMMUNOBIOLOGY, V208, P401, DOI 10.1078/0171-2985-00287; Almeida SR, 2001, INT IMMUNOL, V13, P1193, DOI 10.1093/intimm/13.9.1193; Anderson KL, 1998, BLOOD, V91, P3702, DOI 10.1182/blood.V91.10.3702; Anthony RM, 2006, NAT MED, V12, P955, DOI 10.1038/nm1451; Bertrand JY, 2005, BLOOD, V106, P3004, DOI 10.1182/blood-2005-02-0461; Borrello MA, 1999, J IMMUNOL, V163, P3605; Borrello MA, 1996, IMMUNOL TODAY, V17, P471, DOI 10.1016/0167-5699(96)20031-B; BORRELLO MA, 1995, J IMMUNOL, V155, P4155; Getts DR, 2008, J EXP MED, V205, P2319, DOI 10.1084/jem.20080421; Graf BA, 1999, EUR J IMMUNOL, V29, P3793, DOI 10.1002/(SICI)1521-4141(199911)29:11<3793::AID-IMMU3793>3.0.CO;2-3; Hardy R R, 1992, Int Rev Immunol, V8, P189, DOI 10.3109/08830189209055573; HAYAKAWA K, 1985, J EXP MED, V161, P1554, DOI 10.1084/jem.161.6.1554; Jenkins SJ, 2011, SCIENCE, V332, P1284, DOI 10.1126/science.1204351; KANTOR AB, 1995, INT IMMUNOL, V7, P55, DOI 10.1093/intimm/7.1.55; KANTOR AB, 1992, P NATL ACAD SCI USA, V89, P3320, DOI 10.1073/pnas.89.8.3320; Katoh S, 1990, Dev Immunol, V1, P113, DOI 10.1155/1990/28760; Lepique AP, 2009, CLIN CANCER RES, V15, P4391, DOI 10.1158/1078-0432.CCR-09-0489; Li J, 2006, NAT IMMUNOL, V7, P1116, DOI 10.1038/ni1389; Lichanska AM, 1999, BLOOD, V94, P127, DOI 10.1182/blood.V94.1.127.413k07_127_138; McKercher SR, 1996, EMBO J, V15, P5647, DOI 10.1002/j.1460-2075.1996.tb00949.x; NAITO M, 1991, AM J PATHOL, V139, P657; Nakayama KI, 1997, INT J EXP PATHOL, V78, P245, DOI 10.1046/j.1365-2613.1997.250358.x; Novaes e Brito R.R., 2010, IMMUNOL IMMUNOGENETI, V2, P31; Ogiku M, 2009, J SURG RES; Parra D, 2011, J LEUKOC BIOL   1104; Plytycz B, 1997, IMMUNOL TODAY, V18, P505, DOI 10.1016/S0167-5699(97)82523-6; Popi AF, 2009, IMMUNOBIOLOGY, V214, P664, DOI 10.1016/j.imbio.2008.12.007; Popi AF, 2009, IMMUNOLOGY, V126, P114, DOI 10.1111/j.1365-2567.2008.02883.x; SCOTT EW, 1994, SCIENCE, V265, P1573, DOI 10.1126/science.8079170; Shepard JL, 2000, CURR OPIN HEMATOL, V7, P3, DOI 10.1097/00062752-200001000-00002; Smith P, 2007, J IMMUNOL, V178, P4557, DOI 10.4049/jimmunol.178.7.4557; SODHI A, 1993, INT J IMMUNOPHARMACO, V15, P327, DOI 10.1016/0192-0561(93)90043-X; Takahashi K, 1998, AM J PATHOL, V152, P445; Takahashi K, 1996, PATHOL INT, V46, P473, DOI 10.1111/j.1440-1827.1996.tb03641.x; Umeda S, 1996, AM J PATHOL, V149, P559; VANFURTH R, 1972, B WORLD HEALTH ORGAN, V46, P845; WIKTORJEDRZEJCZAK W, 1982, J EXP MED, V156, P1516, DOI 10.1084/jem.156.5.1516; WIKTORJEDRZEJCZAK W, 1992, EXP HEMATOL, V20, P1004; Yamashiro S, 1998, INT ARCH ALLERGY IMM, V115, P15, DOI 10.1159/000023825	39	30	30	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e34570	10.1371/journal.pone.0034570	http://dx.doi.org/10.1371/journal.pone.0034570			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479646	Green Submitted, Green Published, gold			2022-12-27	WOS:000305339100169
J	Diesing, AK; Nossol, C; Ponsuksili, S; Wimmers, K; Kluess, J; Walk, N; Post, A; Rothkotter, HJ; Kahlert, S				Diesing, Anne-Kathrin; Nossol, Constanze; Ponsuksili, Siriluck; Wimmers, Klaus; Kluess, Jeannette; Walk, Nicole; Post, Andreas; Rothkoetter, Hermann-Josef; Kahlert, Stefan			Gene Regulation of Intestinal Porcine Epithelial Cells IPEC-J2 Is Dependent on the Site of Deoxynivalenol Toxicological Action	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM; STRESS-RESPONSE; DEGRADATION; METABOLISM; MICROARRAY; MACROPHAGE; GRP78/BIP; INDUCTION; TRANSPORT; PROTEINS	The intestinal epithelial cell layer represents the border between the luminal and systemic side of the gut. The decision between absorption and exclusion of substances is the quintessential function of the gut and varies along the gut axis. Consequently, potentially toxic substances may reach the basolateral domain of the epithelial cell layer via blood stream. The mycotoxin deoxynivalenol (DON) is a Fusarium derived secondary metabolite known to enter the blood stream and displaying a striking toxicity on the basolateral side of polarised epithelial cell layers in vitro. Here we analysed potential mechanisms of apical and basolateral DON toxicity reflected in the gene expression. We used the jejunum-derived, polarised intestinal porcine epithelial cell line IPEC-J2 as an in vitro cell culture model. Luminal and systemic DON challenge of the epithelial cell layer was mimicked by a DON application from the apical or basolateral compartment of membrane inserts for 72 h. We compared the genome-wide gene expression of untreated and DON-treated IPEC-J2 cells with the GeneChip (R) Porcine Genome Array of Affymetrix. Low basolateral DON (200 ng/mL) application triggered 10 times more gene transcripts in comparison to the corresponding apical application (2539 versus 267) despite the intactness of the challenged cell layer as measured by transepithelial electrical resistance. Analysis of the regulated genes by bioinformatic resource DAVID identified several groups of biochemical pathways modulated by concentration and orientation of DON application. Selected genes representing pathways of the cellular metabolism, information processing and structural design were analysed in detail by quantitative PCR. Our findings clearly show that apical and basolateral challenge of epithelial cell layers trigger different gene response profiles paralleled with a higher susceptibility towards basolateral challenge. The evaluation of toxicological potentials of mycotoxins should take this difference in gene regulation dependent on route of application into account.	[Diesing, Anne-Kathrin; Nossol, Constanze; Kluess, Jeannette; Walk, Nicole; Post, Andreas; Rothkoetter, Hermann-Josef; Kahlert, Stefan] Univ Magdeburg, Inst Anat, D-39106 Magdeburg, Germany; [Ponsuksili, Siriluck; Wimmers, Klaus] Leibniz Inst Farm Anim Biol FBN, Dummerstorf, Germany	Otto von Guericke University; Forschungsinstitut fur Nutztierbiologie (FBN)	Diesing, AK (corresponding author), Univ Magdeburg, Inst Anat, D-39106 Magdeburg, Germany.	stefan.kahlert@med.ovgu.de	Wimmers, Klaus/AAF-9434-2020	Wimmers, Klaus/0000-0002-9523-6790	European Union [227549]; Deutsche For-schungsgemeinschaft (DFG) [RO 743/3-2]	European Union(European Commission); Deutsche For-schungsgemeinschaft (DFG)(German Research Foundation (DFG))	This research was financially supported by the European Union in the frame of the project "INTERPLAY" (grant agreement-no. 227549, http://cordis.europa.eu/projects/rcn/92294_en.html) and the Deutsche For-schungsgemeinschaft (DFG RO 743/3-2, http://www.dfg.de/en/index.jsp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Coe H, 2009, GEN PHYSIOL BIOPHYS, V28, pF96; Cole SPC, 2006, TRENDS PHARMACOL SCI, V27, P438, DOI 10.1016/j.tips.2006.06.008; Cuervo AM, 1996, SCIENCE, V273, P501, DOI 10.1126/science.273.5274.501; Danicke S, 2004, ARCH ANIM NUTR, V58, P169, DOI 10.1080/00039420410001667548; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Diesing AK, 2011, TOXICOL LETT, V200, P8, DOI 10.1016/j.toxlet.2010.10.006; Eskelinen EL, 2003, TRENDS CELL BIOL, V13, P137, DOI 10.1016/S0962-8924(03)00005-9; Iwahashi H, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-95; KAWAI K, 1984, APPL ENVIRON MICROB, V47, P481, DOI 10.1128/AEM.47.3.481-483.1984; Kitamura M, 2011, INT REV IMMUNOL, V30, P4, DOI 10.3109/08830185.2010.522281; KOCH G, 1986, J CELL SCI, V86, P217; Koenigs M, 2007, TOXICOLOGY, V240, P48, DOI 10.1016/j.tox.2007.07.016; Kouadio JH, 2005, TOXICOLOGY, V213, P56, DOI 10.1016/j.tox.2005.05.010; Li MX, 2008, TOXICOL SCI, V105, P67, DOI 10.1093/toxsci/kfn111; Liu BH, 2007, TOXICOL SCI, V95, P340, DOI 10.1093/toxsci/kfl156; Mariani V, 2009, VET IMMUNOL IMMUNOP, V131, P278, DOI 10.1016/j.vetimm.2009.04.006; Owusu-Ansah E, 2008, NAT GENET, V40, P356, DOI 10.1038/ng.2007.50; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; RHOADS JM, 1994, AM J PHYSIOL, V266, pG828, DOI 10.1152/ajpgi.1994.266.5.G828; Schierack P, 2006, HISTOCHEM CELL BIOL, V125, P293, DOI 10.1007/s00418-005-0067-z; Sergent T, 2006, TOXICOL LETT, V164, P167, DOI 10.1016/j.toxlet.2005.12.006; Shi Y, 2009, TOXICOL SCI, V109, P247, DOI 10.1093/toxsci/kfp060; Shifrin VI, 1999, J BIOL CHEM, V274, P13985, DOI 10.1074/jbc.274.20.13985; Steube KG, 2012, CYTOTECHNOLOGY, V64, P373, DOI 10.1007/s10616-011-9420-3; Tsai S, 2006, ANIM GENET, V37, P423, DOI 10.1111/j.1365-2052.2006.01460.x; Tuggle CK, 2007, INT J BIOL SCI, V3, P132; Vandenbroucke V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023871; Yang GH, 2000, TOXICOL APPL PHARM, V162, P207, DOI 10.1006/taap.1999.8842; Yang H, 2008, TOXICOLOGY, V243, P145, DOI 10.1016/j.tox.2007.10.002	30	26	27	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2012	7	4							e34136	10.1371/journal.pone.0034136	http://dx.doi.org/10.1371/journal.pone.0034136			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959FE	22506013	Green Published, Green Submitted, gold			2022-12-27	WOS:000305297500021
J	Waldenstrom, A; Genneback, N; Hellman, U; Ronquist, G				Waldenstrom, Anders; Genneback, Nina; Hellman, Urban; Ronquist, Gunnar			Cardiomyocyte Microvesicles Contain DNA/RNA and Convey Biological Messages to Target Cells	PLOS ONE			English	Article							EXTRACELLULAR ORGANELLES PROSTASOMES; ADENOSINE-TRIPHOSPHATASE; MEMBRANE-VESICLES; EPITHELIAL-CELLS; EXOSOMES; SECRETION; ASSOCIATION; SPERMATOZOA; ACTIVATION; FUSION	Background: Shedding microvesicles are membrane released vesicles derived directly from the plasma membrane. Exosomes are released membrane vesicles of late endosomal origin that share structural and biochemical characteristics with prostasomes. Microvesicles/exosomes can mediate messages between cells and affect various cell-related processes in their target cells. We describe newly detected microvesicles/exosomes from cardiomyocytes and depict some of their biological functions. Methodology/Principal Findings: Microvesicles/exosomes from media of cultured cardiomyocytes derived from adult mouse heart were isolated by differential centrifugation including preparative ultracentrifugation and identified by transmission electron microscopy and flow cytometry. They were surrounded by a bilayered membrane and flow cytometry revealed presence of both caveolin-3 and flotillin-1 while clathrin and annexin-2 were not detected. Microvesicle/exosome mRNA was identified and out of 1520 detected mRNA, 423 could be directly connected in a biological network. Furthermore, by a specific technique involving TDT polymerase, 343 different chromosomal DNA sequences were identified in the microvesicles/exosomes. Microvesicle/exosomal DNA transfer was possible into target fibroblasts, where exosomes stained for DNA were seen in the fibroblast cytosol and even in the nuclei. The gene expression was affected in fibroblasts transfected by microvesicles/exosomes and among 333 gene expression changes there were 175 upregulations and 158 downregulations compared with controls. Conclusions/Significance: Our study suggests that microvesicles/exosomes released from cardiomyocytes, where we propose that exosomes derived from cardiomyocytes could be denoted "cardiosomes", can be involved in a metabolic course of events in target cells by facilitating an array of metabolism-related processes including gene expression changes.	[Waldenstrom, Anders; Genneback, Nina; Hellman, Urban] Umea Univ, Dept Publ Hlth & Clin Med Med, Umea, Sweden; [Waldenstrom, Anders; Hellman, Urban] Umea Univ Hosp, Ctr Heart, S-90185 Umea, Sweden; [Ronquist, Gunnar] Univ Uppsala Hosp, Dept Med Sci, Uppsala, Sweden	Umea University; Umea University; Uppsala University; Uppsala University Hospital	Waldenstrom, A (corresponding author), Umea Univ, Dept Publ Hlth & Clin Med Med, Umea, Sweden.	anders.waldenstrom@medicin.umu.se	Hellman, Urban/L-7820-2019	Hellman, Urban/0000-0002-3822-0725; Waldenstrom, Anders/0000-0002-5304-0802	Swedish Heart and Lung Foundation [20070563]; Cutting-Edge Research Grant from the County Council of Vasterbotten; Norrlandska Hjartfonden; Swedish Research Council [K2009-64X-21036-01-3]	Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Cutting-Edge Research Grant from the County Council of Vasterbotten; Norrlandska Hjartfonden; Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported by grants from The Swedish Heart and Lung Foundation (20070563), www.hjart-lungfonden.se; Cutting-Edge Research Grant from the County Council of Vasterbotten, www.vll.se; Norrlandska Hjartfonden, www.hjartfonden.com; and The Swedish Research Council (K2009-64X-21036-01-3), www.vr.se. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Admyre C, 2007, J IMMUNOL, V179, P1969, DOI 10.4049/jimmunol.179.3.1969; Al-Nedawi K, 2009, CELL CYCLE, V8, P2014, DOI 10.4161/cc.8.13.8988; Arienti G, 1997, J MEMBRANE BIOL, V155, P89, DOI 10.1007/s002329900160; ARVIDSON G, 1989, BIOCHIM BIOPHYS ACTA, V984, P167, DOI 10.1016/0005-2736(89)90212-5; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blanchard N, 2002, J IMMUNOL, V168, P3235, DOI 10.4049/jimmunol.168.7.3235; Callahan KP, 2010, J BIOL CHEM, V285, P3540, DOI 10.1074/jbc.M109.058396; Claycomb WC, 1998, P NATL ACAD SCI USA, V95, P2979, DOI 10.1073/pnas.95.6.2979; FABIANI R, 1994, HUM REPROD, V9, P1485, DOI 10.1093/oxfordjournals.humrep.a138735; Faure J, 2006, MOL CELL NEUROSCI, V31, P642, DOI 10.1016/j.mcn.2005.12.003; Fevrier B, 2004, P NATL ACAD SCI USA, V101, P9683, DOI 10.1073/pnas.0308413101; Gazzerro E, 2010, EUR J HUM GENET, V18, P137, DOI 10.1038/ejhg.2009.103; Goldoni D, 2010, J CELL PHYSIOL, V225, P751, DOI 10.1002/jcp.22278; Gupta S, 2007, AM J PHYSIOL-HEART C, V292, pH3052, DOI 10.1152/ajpheart.01355.2006; Hayashi YK, 2009, J CLIN INVEST, V119, P2623, DOI 10.1172/JCI38660; Heijnen HFG, 1999, BLOOD, V94, P3791, DOI 10.1182/blood.V94.11.3791.423a22_3791_3799; JOHNSTONE RM, 1987, J BIOL CHEM, V262, P9412; KELLY RW, 1991, CLIN EXP IMMUNOL, V86, P550; Koga K, 2005, ANTICANCER RES, V25, P3703; Llorente A, 2004, J CELL SCI, V117, P5343, DOI 10.1242/jcs.01420; Minelli A, 1999, BIOL REPROD, V61, P802, DOI 10.1095/biolreprod61.3.802; Miranda KC, 2010, KIDNEY INT, V78, P191, DOI 10.1038/ki.2010.106; PAN BT, 1985, J CELL BIOL, V101, P942, DOI 10.1083/jcb.101.3.942; Poliakov A, 2009, PROSTATE, V69, P159, DOI 10.1002/pros.20860; Rabinowits G, 2009, CLIN LUNG CANCER, V10, P42, DOI 10.3816/CLC.2009.n.006; Raposo G, 1996, J EXP MED, V183, P1161, DOI 10.1084/jem.183.3.1161; Reiner A, 2003, BIOINFORMATICS, V19, P368, DOI 10.1093/bioinformatics/btf877; RONQUIST G, 1978, ANDROLOGIA, V10, P261; RONQUIST G, 1978, ANDROLOGIA, V10, P427; RONQUIST G, 1990, ARCH ANDROLOGY, V24, P147, DOI 10.3109/01485019008986874; RONQUIST G, 1977, BIOCHIM BIOPHYS ACTA, V483, P483, DOI 10.1016/0005-2744(77)90078-X; RONQUIST G, 1985, BIOCHIM BIOPHYS ACTA, V822, P203, DOI 10.1016/0304-4157(85)90008-5; Ronquist G, 2011, J INTERN MED; Ronquist G, 2001, P S HELD WENN GREN C, V81; Ronquist GK, 2011, MOL REPROD DEV, V78, P467, DOI 10.1002/mrd.21327; Ronquist KG, 2009, PROSTATE, V69, P737, DOI 10.1002/pros.20921; ROONEY IA, 1993, J EXP MED, V177, P1409, DOI 10.1084/jem.177.5.1409; Sahlen GE, 2002, PROSTATE, V53, P192, DOI 10.1002/pros.10126; Skokos D, 2001, J IMMUNOL, V166, P868, DOI 10.4049/jimmunol.166.2.868; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; van Niel G, 2001, GASTROENTEROLOGY, V121, P337, DOI 10.1053/gast.2001.26263; Wolfers J, 2001, NAT MED, V7, P297, DOI 10.1038/85438; Zitvogel L, 1998, NAT MED, V4, P594, DOI 10.1038/nm0598-594	44	273	283	2	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2012	7	4							e34653	10.1371/journal.pone.0034653	http://dx.doi.org/10.1371/journal.pone.0034653			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959FE	22506041	Green Published, Green Submitted, gold			2022-12-27	WOS:000305297500049
J	Abdoul, H; Perrey, C; Tubach, F; Amiel, P; Durand-Zaleski, I; Alberti, C				Abdoul, Hendy; Perrey, Christophe; Tubach, Florence; Amiel, Philippe; Durand-Zaleski, Isabelle; Alberti, Corinne			Non-Financial Conflicts of Interest in Academic Grant Evaluation: A Qualitative Study of Multiple Stakeholders in France	PLOS ONE			English	Article							PEER REVIEWERS; SYSTEM; RECOMMENDATIONS; PUBLICATION; DISCLOSURE; APPLICANTS; POLICIES; DECLINE; AUTHORS	Background: Peer review is the most widely used method for evaluating grant applications in clinical research. Criticisms of peer review include lack of equity, suspicion of biases, and conflicts of interest (CoI). CoIs raise questions of fairness, transparency, and trust in grant allocation. Few observational studies have assessed these issues. We report the results of a qualitative study on reviewers' and applicants' perceptions and experiences of CoIs in reviews of French academic grant applications. Methodology and Principal Findings: We designed a qualitative study using semi-structured interviews and direct observation. We asked members of assessment panels, external reviewers, and applicants to participate in semi-structured interviews. Two independent researchers conducted in-depth reviews and line-by-line coding of all transcribed interviews, which were also subjected to Tropes (R) software text analysis, to detect and qualify themes associated with CoIs. Most participants (73/98) spontaneously reported that non-financial CoIs predominated over financial CoIs. Non-financial CoIs mainly involved rivalry among disciplines, cronyism, and geographic and academic biases. However, none of the participants challenged the validity of peer review. Reviewers who felt they might be affected by CoIs said they reacted in a variety of ways: routine refusal to review, routine attempt to conduct an impartial review, or decision on a case-by-case basis. Multiple means of managing non-financial CoIs were suggested, including increased transparency throughout the review process, with public disclosure of non-financial CoIs, and careful selection of independent reviewers, including foreign experts and methodologists. Conclusions: Our study underscores the importance of considering non-financial CoIs when reviewing research grant applications, in addition to financial CoIs. Specific measures are needed to prevent a negative impact of non-financial CoIs on the fairness of resource allocation. Whether and how public disclosure of non-financial CoIs should be accomplished remains debatable.	[Abdoul, Hendy; Perrey, Christophe; Alberti, Corinne] Hop Robert Debre, AP HP, Unite Epidemiol Clin, F-75019 Paris, France; [Abdoul, Hendy; Tubach, Florence; Alberti, Corinne] Univ Paris Diderot, Unite Epidemiol Clin, Paris, France; [Abdoul, Hendy; Perrey, Christophe; Alberti, Corinne] INSERM, CIE 5, Paris, France; [Perrey, Christophe; Amiel, Philippe] Inst Cancerol Gustave Roussy, Unite Rech Sci Humaines & Sociales, Villejuif, France; [Tubach, Florence] Hop Bichat Claude Bernard, AP HP, Dept Epidemiol Biostat & Rech Clin, F-75877 Paris 18, France; [Durand-Zaleski, Isabelle] AP HP, Dept Rech Clin & Dev, Unite Rech Clin Econ Sante, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Gustave Roussy; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP)	Abdoul, H (corresponding author), Hop Robert Debre, AP HP, Unite Epidemiol Clin, F-75019 Paris, France.	hendy.abdoul@rdb.aphp.fr		AMIEL, Philippe/0000-0003-4557-9266	French Ministry of Heath; Departement a la Recherche Clinique et au Developpement, Assistance Publique-"Hopitaux de Paris [AOM 08 074]	French Ministry of Heath; Departement a la Recherche Clinique et au Developpement, Assistance Publique-"Hopitaux de Paris	This work was supported by a research grant from the French Ministry of Heath and sponsored by Departement a la Recherche Clinique et au Developpement, Assistance Publique-"Hopitaux de Paris (AOM 08 074). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, SUMM PEER REV PROJ G; Barbour V, 2008, PLOS MED, V5, P1299, DOI 10.1371/journal.pmed.0050199; Bero LA, 2005, TOB CONTROL, V14, P118; Bion J, 2009, CURR OPIN CRIT CARE, V15, P583, DOI 10.1097/MCC.0b013e328332f53a; Blum JA, 2009, JAMA-J AM MED ASSOC, V302, P2230, DOI 10.1001/jama.2009.1669; Bornmann L, 2011, ANNU REV INFORM SCI, V45, P199, DOI 10.1002/aris.2011.1440450112; Bornmann L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003480; Callaham ML, 2007, PLOS MED, V4, P32, DOI 10.1371/journal.pmed.0040040; Chollette VY, 2007, CANCER EPIDEM BIOMAR, V16, P2459, DOI 10.1158/1055-9965.EPI-06-1098; Clark J, 2003, QUALITATIVE RES REV; Comite d'ethique du CNRS (COMETS), 2010, AV ASP ETH FIN PUBL; Cooper RJ, 2006, J GEN INTERN MED, V21, P1248, DOI 10.1111/j.1525-1497.2006.00598.x; Davidoff F, 2004, BRIT MED J, V328, P657, DOI 10.1136/bmj.328.7441.657; Demicheli V, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000003.pub2; European Medical Research Councils, 2007, PRES STAT FUT STRAT; Field MJ., 2009, CONFLICT INTEREST ME; Finkel E, 2006, SCIENCE, V312, P176; Flynn KE, 2008, J EMPIR RES HUM RES, V3, P69, DOI 10.1525/jer.2008.3.3.69; FUHRER MJ, 1985, ARCH PHYS MED REHAB, V66, P318; Ghiglione Rodolphe, 1998, ANAL AUTOMATIQUE CON; Glaser B.G., 1968, DISCOV GROUNDED THEO; Godlee F, 1998, JAMA-J AM MED ASSOC, V280, P237, DOI 10.1001/jama.280.3.237; Groves T, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c6424; Haivas I, 2004, CAN MED ASSOC J, V171, P475, DOI 10.1503/cmaj.1031982; Hegde D, 2008, SCIENCE, V322, P1797, DOI 10.1126/science.1158562; HODGSON C, 1995, CAN J CARDIOL, V11, P864; Hodgson C, 1997, J CLIN EPIDEMIOL, V50, P1189, DOI 10.1016/S0895-4356(97)00167-4; Horrobin DF, 1999, BRIT MED J, V318, P466; Jaffe K, 2008, NATURE, V451, P395, DOI 10.1038/451395e; Jefferson T., 2003, PEER REV HLTH SCI; Justice AC, 1998, JAMA-J AM MED ASSOC, V280, P240, DOI 10.1001/jama.280.3.240; Kaiser J, 2005, SCIENCE, V309, P29, DOI 10.1126/science.309.5731.29; Kernick DP, 1999, LANCET, V354, P870, DOI 10.1016/S0140-6736(05)76210-3; Khan K, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c6425; Krimsky S, 1998, JAMA-J AM MED ASSOC, V280, P225, DOI 10.1001/jama.280.3.225; Lee M, 2000, SCIENTOMETRICS, V48, P99, DOI 10.1023/A:1005636503358; Levinsky NG, 2002, NEW ENGL J MED, V347, P759, DOI 10.1056/NEJMsb020853; Luty J, 2009, J MED ETHICS, V35, P200, DOI 10.1136/jme.2008.026740; Margottini L, 2008, SCIENCE, V320, P861, DOI 10.1126/science.320.5878.861a; Mervis J, 2007, SCIENCE, V317, P880, DOI 10.1126/science.317.5840.880; Miles M.B., 2019, QUALITATIVE DATA ANA, Vfourth; National Institute of Health, NIH GRANT REV PROC; O'Dowd A, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d3046; O'Dowd A, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d2858; Ross JS, 2006, JAMA-J AM MED ASSOC, V295, P1675, DOI 10.1001/jama.295.14.1675; Schroter S, 2006, JAMA-J AM MED ASSOC, V295, P314, DOI 10.1001/jama.295.3.314; Schroter S, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-62; Schwartz DA, 2006, ENVIRON HEALTH PERSP, V114, pA270, DOI 10.1289/ehp.114-a270; The International Committee of Medical Journal, 2010, INT COMMITTEE MED J; Tite L, 2007, J EPIDEMIOL COMMUN H, V61, P9, DOI 10.1136/jech.2006.049817; van Rooyen S, 1999, J GEN INTERN MED, V14, P622, DOI 10.1046/j.1525-1497.1999.09058.x; van Rooyen S, 1999, J CLIN EPIDEMIOL, V52, P625, DOI 10.1016/S0895-4356(99)00047-5; van Rooyen S, 1999, BRIT MED J, V318, P23; Wager E, 2006, BMC MED, V4, DOI 10.1186/1741-7015-4-13; Wessely S, 1998, LANCET, V352, P301, DOI 10.1016/S0140-6736(97)11129-1	55	23	24	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2012	7	4							e35247	10.1371/journal.pone.0035247	http://dx.doi.org/10.1371/journal.pone.0035247			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	955JO	22496913	gold, Green Submitted, Green Published			2022-12-27	WOS:000305014500052
J	Gesto, M; Castro, LFC; Reis-Henriques, MA; Santos, MM				Gesto, Manuel; Castro, L. Filipe C.; Reis-Henriques, Maria Armanda; Santos, Miguel Machado			Retinol Metabolism in the Mollusk Osilinus lineatus Indicates an Ancient Origin for Retinyl Ester Storage Capacity	PLOS ONE			English	Article							ENDOGENOUS RETINOIDS; HALOCYNTHIA-RORETZI; SIGNALING PATHWAYS; MASS-SPECTROMETRY; ACID; TISSUES; ADULT	Although retinoids have been reported to be present and active in vertebrates and invertebrates, the presence of mechanisms for retinoid storage in the form of retinyl esters, a key feature to maintain whole-organism retinoid homeostasis, have been considered to date a vertebrate innovation. Here we demonstrate for the first time the presence of retinol and retinyl esters in an invertebrate lophotrochozoan species, the gastropod mollusk Osilinus lineatus. Furthermore, through a pharmacological approach consisting of intramuscular injections of different retinoid precursors, we also demonstrate that the retinol esterification pathway is active in vivo in this species. Interestingly, retinol and retinyl esters were only detected in males, suggesting a gender-specific role for these compounds in the testis. Females, although lacking detectable levels of retinol or retinyl esters, also have the biochemical capacity to esterify retinol, but at a lower rate than males. The occurrence of retinyl ester storage capacity, together with the presence in males and females of active retinoids, i.e., retinoic acid isomers, indicates that O. lineatus has a well developed retinoid system. Hence, the present data strongly suggest that the capacity to maintain retinoid homeostasis has arisen earlier in Bilateria evolution than previously thought.	[Gesto, Manuel; Castro, L. Filipe C.; Reis-Henriques, Maria Armanda; Santos, Miguel Machado] Univ Porto, Interdisciplinary Ctr Marine & Environm Res, CIMAR CIIMAR, P-4100 Oporto, Portugal; [Santos, Miguel Machado] Univ Porto, Fac Sci, Dept Biol, P-4100 Oporto, Portugal	Universidade do Porto; Universidade do Porto	Gesto, M (corresponding author), Univ Vigo, Fac Biol, Dept Biol Func & Ciencias Saude, Vigo 36310, Spain.	manuelgesto@uvigo.es; filipe.castro@ciimar.up.pt; santos@ciimar.up.pt	Castro, Filipe/AAA-2197-2022; Gesto, Manuel/G-1032-2018; Santos, Miguel M./AAD-9267-2021	Castro, Filipe/0000-0001-7697-386X; Gesto, Manuel/0000-0002-9136-7857; Santos, Miguel/0000-0001-7347-0546; Reis Henriques, Maria Armanda/0000-0001-7602-9641	Fundacao para a Ciencia e a Tecnologia (Portugal) [PTDC/MAR/68106/2006, SFRH/BPD/47572/2008]; Xunta de Galicia (Spain) [IN809A 2010/360]	Fundacao para a Ciencia e a Tecnologia (Portugal)(Portuguese Foundation for Science and Technology); Xunta de Galicia (Spain)(Xunta de Galicia)	This work was supported by the project PTDC/MAR/68106/2006 from Fundacao para a Ciencia e a Tecnologia (Portugal, www.fct.pt). MG was the recipient of post-doctoral fellowships from Fundacao para a Ciencia e a Tecnologia (Portugal, SFRH/BPD/47572/2008) and Xunta de Galicia (Spain, Angeles Alvarino program, www.xunta.es), and a research grant (IN809A 2010/360, partly funded by European Social Fund) from Xunta de Galicia (Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albalat R, 2011, GENOME BIOL EVOL, V3, P985, DOI 10.1093/gbe/evr084; Albalat R, 2009, MOL CELL ENDOCRINOL, V313, P23, DOI 10.1016/j.mce.2009.08.029; Albalat R, 2009, CHEM-BIOL INTERACT, V178, P188, DOI 10.1016/j.cbi.2008.09.017; Alsop D, 2007, AQUAT TOXICOL, V82, P281, DOI 10.1016/j.aquatox.2007.03.001; BIESALSKI HK, 1992, ONCOGENE, V7, P1765; Blomhoff R, 2006, J NEUROBIOL, V66, P606, DOI 10.1002/neu.20242; Campo-Paysaa F, 2008, GENESIS, V46, P640, DOI 10.1002/dvg.20444; Castro LFC, 2007, AQUAT TOXICOL, V85, P57, DOI 10.1016/j.aquatox.2007.07.016; CRETON R, 1993, DEV GROWTH DIFFER, V35, P357; Crothers J. H., 2001, Field Studies, V10, P115; Dalfo D, 2002, DEV GENES EVOL, V212, P388, DOI 10.1007/s00427-002-0254-z; Desai B. N., 1966, Proceedings of the Malacological Society of London, V37, P1; Dmetrichuk JM, 2008, J NEUROSCI, V28, P13014, DOI 10.1523/JNEUROSCI.3192-08.2008; Gesto M, 2012, COMP BIOCHEM PHYS B, V161, P69, DOI 10.1016/j.cbpb.2011.09.006; Gundersen TE, 2007, RAPID COMMUN MASS SP, V21, P1176, DOI 10.1002/rcm.2946; Hopkins PM, 2008, COMP BIOCHEM PHYS A, V151, P602, DOI 10.1016/j.cbpa.2008.07.021; Irie T, 2004, COMP BIOCHEM PHYS B, V139, P597, DOI 10.1016/j.cbpc.2004.07.014; Irie T, 2003, COMP BIOCHEM PHYS B, V134, P221, DOI 10.1016/S1096-4959(02)00251-8; Irie T, 2010, COMP BIOCHEM PHYS B, V157, P113, DOI 10.1016/j.cbpb.2010.05.009; Kane MA, 2008, ANAL BIOCHEM, V378, P71, DOI 10.1016/j.ab.2008.03.038; KAWAMURA K, 1993, DEVELOPMENT, V117, P835; KURLANDSKY SB, 1995, J BIOL CHEM, V270, P17850, DOI 10.1074/jbc.270.30.17850; LEID M, 1992, TRENDS BIOCHEM SCI, V17, P427, DOI 10.1016/0968-0004(92)90014-Z; Malik MA, 2000, J NUTR BIOCHEM, V11, P2, DOI 10.1016/S0955-2863(99)00066-2; Marletaz F, 2006, INT J BIOL SCI, V2, P38; Nowickyj SM, 2008, P NATL ACAD SCI USA, V105, P9540, DOI 10.1073/pnas.0712132105; Ogino Y, 2001, ANN NY ACAD SCI, V948, P13; Romero R, 2001, INT J DEV BIOL, V45, P669; Simoes-Costa MS, 2008, J EXP ZOOL PART B, V310B, P54, DOI 10.1002/jez.b.21139; Suh MJ, 2006, ANAL CHEM, V78, P5719, DOI 10.1021/ac060492j; Theodosiou M, 2010, CELL MOL LIFE SCI, V67, P1423, DOI 10.1007/s00018-010-0268-z; Vernet N, 2006, ENDOCRINOLOGY, V147, P96, DOI 10.1210/en.2005-0953; Wingerath T, 1995, ARCH BIOCHEM BIOPHYS, V324, P385, DOI 10.1006/abbi.1995.0052; Wong CK, 2003, CHEMOSPHERE, V52, P1633, DOI 10.1016/S0045-6535(03)00503-4; Zega G, 2009, AQUAT TOXICOL, V91, P255, DOI 10.1016/j.aquatox.2008.11.015	35	19	19	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2012	7	4							e35138	10.1371/journal.pone.0035138	http://dx.doi.org/10.1371/journal.pone.0035138			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JA	22493737	Green Published, Green Submitted, gold			2022-12-27	WOS:000305012700079
J	Liu, G; Lei, B; Li, Y; Tong, KY; Ding, Y; Luo, LF; Xia, XY; Jiang, SW; Deng, CY; Xiong, YZ; Li, FG				Liu, Gang; Lei, Bin; Li, Yan; Tong, Keya; Ding, Yi; Luo, Lifan; Xia, Xuanyan; Jiang, Siwen; Deng, Changyan; Xiong, Yuanzhu; Li, Fenge			Discovery of Potential piRNAs from Next Generation Sequences of the Sexually Mature Porcine Testes	PLOS ONE			English	Article							SMALL RNAS; SPERMATOGENIC CELLS; GENE-EXPRESSION; NUAGE FORMATION; NONCODING RNAS; PIWI; MICRORNAS; GERMLINE; GENOME; IDENTIFICATION	Piwi-interacting RNAs (piRNAs), a new class of small RNAs discovered from mammalian testes, are involved in transcriptional silencing of retrotransposons and other genetic elements in germ line cells. In order to identify a full transcriptome set of piRNAs expressed in the sexually mature porcine testes, small RNA fractions were extracted and were subjected to a Solexa deep sequencing. We cloned 6,913,561 clean reads of Sus Scrofa small RNAs (18-30 nt) and performed functional characterization. Sus Scrofa small RNAs showed a bimodal length distribution with two peaks at 21 nt and 29 nt. Then from 938,328 deep-sequenced small RNAs (26-30 nt), 375,195 piRNAs were identified by a k-mer scheme and 326 piRNAs were identified by homology searches. All piRNAs predicted by the k-mer scheme were then mapped to swine genome by Short Oligonucleotide Analysis Package (SOAP), and 81.61% of all uniquely mapping piRNAs (197,673) were located to 1124 defined genomic regions (5.85 Mb). Within these regions, 536 and 501 piRNA clusters generally distributed across only minus or plus genomic strand, 48 piRNA clusters distributed on two strands but in a divergent manner, and 39 piRNA clusters distributed on two strands in an overlapping manner. Furthermore, expression pattern of 7 piRNAs identified by homology searches showed 5 piRNAs displayed a ubiquitous expression pattern, although 2 piRNAs were specifically expressed in the testes. Overall, our results provide new information of porcine piRNAs and their specific expression pattern in porcine testes suggests that piRNAs have a role in regulating spermatogenesis.	[Liu, Gang; Lei, Bin; Li, Yan; Tong, Keya; Ding, Yi; Luo, Lifan; Jiang, Siwen; Deng, Changyan; Xiong, Yuanzhu; Li, Fenge] Huazhong Agr Univ, Minist Agr, Key Lab Pig Genet & Breeding, Wuhan, Peoples R China; [Liu, Gang; Lei, Bin; Li, Yan; Tong, Keya; Ding, Yi; Luo, Lifan; Jiang, Siwen; Deng, Changyan; Xiong, Yuanzhu; Li, Fenge] Huazhong Agr Univ, Minist Educ, Key Lab Agr Anim Genet Breeding & Reprod, Wuhan, Peoples R China; [Xia, Xuanyan] Huazhong Agr Univ, Coll Sci, Wuhan, Peoples R China	Huazhong Agricultural University; Ministry of Agriculture & Rural Affairs; Huazhong Agricultural University; Huazhong Agricultural University	Liu, G (corresponding author), Huazhong Agr Univ, Minist Agr, Key Lab Pig Genet & Breeding, Wuhan, Peoples R China.	lifener@mail.hzau.edu.cn	Ding, Yi/U-3314-2019	Li, Yan/0000-0003-4537-7672	National Natural Science Foundation of China [31072011]; Trans-gene Key Project of China [2009ZX08009-148B]; Natural Science Foundation of Hubei Province of China [2009CDA127]; Fundamental Research Funds for the Central Universities [2011PY074]; Chinese education ministry [IRT-0831]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Trans-gene Key Project of China; Natural Science Foundation of Hubei Province of China(Natural Science Foundation of Hubei Province); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Chinese education ministry(Ministry of Education, China)	This work was supported financially by the National Natural Science Foundation of China (31072011), Trans-gene Key Project of China (2009ZX08009-148B), Natural Science Foundation of Hubei Province of China (2009CDA127), the Fundamental Research Funds for the Central Universities (2011PY074) and the creative team project of Chinese education ministry (IRT-0831). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aravin A, 2006, NATURE, V442, P203, DOI 10.1038/nature04916; Aravin AA, 2007, SCIENCE, V316, P744, DOI 10.1126/science.1142612; Aravin AA, 2011, DEV CELL, V20, P287, DOI 10.1016/j.devcel.2011.03.003; Aravin AA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000764; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen X, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-7-r78; Cheng J, 2012, CANCER LETT, V315, P12, DOI 10.1016/j.canlet.2011.10.004; de Kretser DM, 1998, HUM REPROD, V13, P1; Drabent B, 1997, BIOL REPROD, V57, P1375, DOI 10.1095/biolreprod57.6.1375; Esposito T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022727; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Girard A, 2006, NATURE, V442, P199, DOI 10.1038/nature04917; Grivna ST, 2006, P NATL ACAD SCI USA, V103, P13415, DOI 10.1073/pnas.0605506103; Grivna ST, 2006, GENE DEV, V20, P1709, DOI 10.1101/gad.1434406; Happel N, 2008, EXP GERONTOL, V43, P184, DOI 10.1016/j.exger.2007.11.008; HARAYAMA H, 1991, THERIOGENOLOGY, V36, P637, DOI 10.1016/0093-691X(91)90401-X; He ZP, 2009, REPRODUCTION, V137, P901, DOI 10.1530/REP-08-0494; Hochereau-de Reviers MT, 1999, REPROD DOMEST ANIM, V34, P213, DOI 10.1111/j.1439-0531.1999.tb01243.x; Houwing S, 2007, CELL, V129, P69, DOI 10.1016/j.cell.2007.03.026; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang HY, 2011, DEV CELL, V20, P376, DOI 10.1016/j.devcel.2011.01.004; Iguchi N, 2007, ANN NY ACAD SCI, V1120, P84, DOI 10.1196/annals.1411.002; Kawaoka S, 2011, RNA, V17, P1401, DOI 10.1261/rna.2709411; Klattenhoff C, 2009, CELL, V138, P1137, DOI 10.1016/j.cell.2009.07.014; Kleene KC, 2001, MECH DEVELOP, V106, P3, DOI 10.1016/S0925-4773(01)00413-0; Lakshmi SS, 2008, NUCLEIC ACIDS RES, V36, pD173, DOI 10.1093/nar/gkm696; Lau NC, 2006, SCIENCE, V313, P363, DOI 10.1126/science.1130164; Lee EJ, 2011, RNA, V17, P1090, DOI 10.1261/rna.2565011; LENNOX RW, 1984, DEV BIOL, V103, P80, DOI 10.1016/0012-1606(84)90009-5; Luo LF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011744; Ma L, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000635; Pang KC, 2007, NUCLEIC ACIDS RES, V35, pD178, DOI 10.1093/nar/gkl926; Papaioannou MD, 2010, J ANDROL, V31, P26, DOI 10.2164/jandrol.109.008128; Ro S, 2007, RNA, V13, P1693, DOI 10.1261/rna.640307; Rouget C, 2010, NATURE, V467, P1128, DOI 10.1038/nature09465; Saito K, 2006, GENE DEV, V20, P2214, DOI 10.1101/gad.1454806; Siomi MC, 2011, NAT REV MOL CELL BIO, V12, P246, DOI 10.1038/nrm3089; Sun XJ, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-111; Watanabe T, 2011, DEV CELL, V20, P364, DOI 10.1016/j.devcel.2011.01.005; Wei LQ, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r53; Xie SS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016235; Zamore PD, 2010, EMBO J, V29, P3219, DOI 10.1038/emboj.2010.232; Zhang Y, 2011, BIOINFORMATICS, V27, P771, DOI 10.1093/bioinformatics/btr016; Zhou XA, 2010, GENETICS, V186, P1175, DOI 10.1534/genetics.110.122234	45	16	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2012	7	4							e34770	10.1371/journal.pone.0034770	http://dx.doi.org/10.1371/journal.pone.0034770			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JA	22493715	Green Published, gold, Green Submitted			2022-12-27	WOS:000305012700057
J	Li, J; Guo, YF; Pei, YF; Deng, HW				Li, Jian; Guo, Yan-fang; Pei, Yufang; Deng, Hong-Wen			The Impact of Imputation on Meta-Analysis of Genome-Wide Association Studies	PLOS ONE			English	Article							DIABETES RISK LOCI; SUSCEPTIBILITY LOCI; GENOTYPES; DATASETS; DISEASE; TRAITS	Genotype imputation is often used in the meta-analysis of genome-wide association studies (GWAS), for combining data from different studies and/or genotyping platforms, in order to improve the ability for detecting disease variants with small to moderate effects. However, how genotype imputation affects the performance of the meta-analysis of GWAS is largely unknown. In this study, we investigated the effects of genotype imputation on the performance of meta-analysis through simulations based on empirical data from the Framingham Heart Study. We found that when fix-effects models were used, considerable between-study heterogeneity was detected when causal variants were typed in only some but not all individual studies, resulting in up to similar to 25% reduction of detection power. For certain situations, the power of the meta-analysis can be even less than that of individual studies. Additional analyses showed that the detection power was slightly improved when between-study heterogeneity was partially controlled through the random-effects model, relative to that of the fixed-effects model. Our study may aid in the planning, data analysis, and interpretation of GWAS meta-analysis results when genotype imputation is necessary.	[Li, Jian; Pei, Yufang; Deng, Hong-Wen] Tulane Univ, Sch Publ Hlth & Trop Med, New Orleans, LA 70118 USA; [Guo, Yan-fang] So Med Univ, Sch Biomed Engn, Guangzhou, Guangdong, Peoples R China; [Pei, Yufang; Deng, Hong-Wen] Shanghai Univ Sci & Technol, Ctr Syst Biomed Sci, Shanghai 201800, Peoples R China; [Deng, Hong-Wen] Hunan Normal Univ, Coll Life Sci, Minist Educ, Lab Mol & Stat Genet, Changsha, Hunan, Peoples R China; [Deng, Hong-Wen] Hunan Normal Univ, Coll Life Sci, Minist Educ, Key Lab Prot Chem & Dev Biol, Changsha, Hunan, Peoples R China	Tulane University; Southern Medical University - China; University of Shanghai for Science & Technology; Hunan Normal University; Hunan Normal University	Li, J (corresponding author), Tulane Univ, Sch Publ Hlth & Trop Med, New Orleans, LA 70118 USA.	hdeng2@tulane.edu	Li, Jian/G-4445-2015	Deng, Hong-Wen/0000-0002-0387-8818	National Institutes of Health [P50AR055081, R01AG026564, R01AR050496, RC2DE020756, R01AR057049, R03TW008221]; Tulane University; Shanghai Leading Academic Discipline Project [S30501]; University of Shanghai for Science and Technology; National Heart, Lung, and Blood Institute (NHLBI); Boston University [N01-HC-25195]; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC025195] Funding Source: NIH RePORTER; FOGARTY INTERNATIONAL CENTER [R03TW008221] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P50AR055081, R01AR057049, R01AR050496] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [RC2DE020756] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG026564] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tulane University; Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project); University of Shanghai for Science and Technology; National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Boston University; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The investigators of this work were partially supported by grants from the National Institutes of Health (http://www.nih.gov) (P50AR055081, R01AG026564, R01AR050496, RC2DE020756, R01AR057049, and R03TW008221). The study was also partially supported by a startup fund from Tulane University and by the Shanghai Leading Academic Discipline Project (S30501) and a startup fund from the University of Shanghai for Science and Technology. The Framingham Heart Study is conducted and supported by the National Heart, Lung, and Blood Institute (NHLBI) in collaboration with Boston University. This manuscript was not prepared in collaboration with investigators of the Framingham Heart Study and does not necessarily reflect the opinions or views of the Framingham Heart Study, Boston University, or the NHLBI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the reviewers' valuable comments to make the manuscript better. The Framingham Heart Study is conducted and supported by the National Heart, Lung, and Blood Institute (NHLBI) in collaboration with Boston University (Contract No. N01-HC-25195). This manuscript was not prepared in collaboration with investigators of the Framingham Heart Study and does not necessarily reflect the opinions or views of the Framingham Heart Study, Boston University, or NHLBI.	Anderson CA, 2008, AM J HUM GENET, V83, P112, DOI 10.1016/j.ajhg.2008.06.008; COCHRAN WG, 1954, BIOMETRICS, V10, P101, DOI 10.2307/3001666; Cooper JD, 2008, NAT GENET, V40, P1399, DOI 10.1038/ng.249; de Bakker PIW, 2008, HUM MOL GENET, V17, pR122, DOI 10.1093/hmg/ddn288; Evangelou E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000196; Ferreira MAR, 2008, NAT GENET, V40, P1056, DOI 10.1038/ng.209; Houlston RS, 2008, NAT GENET, V40, P1426, DOI 10.1038/ng.262; Iles MM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040033; Li MX, 2009, BIOINFORMATICS, V25, P1449, DOI 10.1093/bioinformatics/btp183; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; McCarthy MI, 2008, HUM MOL GENET, V17, pR156, DOI 10.1093/hmg/ddn289; Pei YF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010827; Raychaudhuri S, 2008, NAT GENET, V40, P1216, DOI 10.1038/ng.233; Sanghera DK, 2009, J HUM GENET, V54, P162, DOI 10.1038/jhg.2009.7; Staiger H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003019; Su Z, 2011, BIOINFORMATICS, V27, P2304, DOI 10.1093/bioinformatics/btr341; Xavier RJ, 2008, NAT REV IMMUNOL, V8, P631, DOI 10.1038/nri2361; Xiong DH, 2009, AM J HUM GENET, V84, P388, DOI 10.1016/j.ajhg.2009.01.025; Zeggini E, 2009, PHARMACOGENOMICS, V10, P191, DOI 10.2217/14622416.10.2.191; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; Zhao ZM, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-85	23	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2012	7	4							e34486	10.1371/journal.pone.0034486	http://dx.doi.org/10.1371/journal.pone.0034486			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955IH	22496814	Green Published, Green Submitted, gold			2022-12-27	WOS:000305010500011
J	Bae, J; Sung, BH; Cho, IH; Kim, SM; Song, WK				Bae, Jeomil; Sung, Bong Hwan; Cho, In Ha; Kim, Seon-Myung; Song, Woo Keun			NESH Regulates Dendritic Spine Morphology and Synapse Formation	PLOS ONE			English	Article							N-WASP; ACTIN POLYMERIZATION; POSTSYNAPTIC DENSITY; ALZHEIMERS-DISEASE; MENTAL-RETARDATION; BINDING PARTNER; ARP2/3 COMPLEX; MORPHOGENESIS; PROTEIN; PLASTICITY	Background: Dendritic spines are small membranous protrusions on the neuronal dendrites that receive synaptic input from axon terminals. Despite their importance for integrating the enormous information flow in the brain, the molecular mechanisms regulating spine morphogenesis are not well understood. NESH/Abi-3 is a member of the Abl interactor (Abi) protein family, and its overexpression is known to reduce cell motility and tumor metastasis. NESH is prominently expressed in the brain, but its function there remains unknown. Methodology/Principal Findings: NESH was strongly expressed in the hippocampus and moderately expressed in the cerebral cortex, cerebellum and striatum, where it co-localized with the postsynaptic proteins PSD95, SPIN90 and F-actin in dendritic spines. Overexpression of NESH reduced numbers of mushroom-type spines and synapse density but increased thin, filopodia-like spines and had no effect on spine density. siRNA knockdown of NESH also reduced mushroom spine numbers and inhibited synapse formation but it increased spine density. The N-terminal region of NESH co-sedimented with filamentous actin (F-actin), which is an essential component of dendritic spines, suggesting this interaction is important for the maturation of dendritic spines. Conclusions/Significance: NESH is a novel F-actin binding protein that likely plays important roles in the regulation of dendritic spine morphogenesis and synapse formation.	[Bae, Jeomil; Cho, In Ha; Song, Woo Keun] Gwangju Inst Sci & Technol, Sch Life Sci, Cell Dynam & Bioimaging Res Ctr, Kwangju, South Korea; [Sung, Bong Hwan] Vanderbilt Univ, Med Ctr, Dept Canc Biol, Nashville, TN USA; [Kim, Seon-Myung] Emory Univ, Sch Med, Dept Cell Biol & Neurol, Ctr Neurodegenerat Dis, Atlanta, GA USA	Gwangju Institute of Science & Technology (GIST); Vanderbilt University; Emory University	Bae, J (corresponding author), Gwangju Inst Sci & Technol, Sch Life Sci, Cell Dynam & Bioimaging Res Ctr, Kwangju, South Korea.	wksong@gist.ac.kr		Bae, Jeomil/0000-0001-9374-6802	Cell Dynamics and Bioimaging Research Center [20110001155]; Conversing Research Center [2011K000690]; Mid-Career Research Program [20110000095]; National Research Foundation of Korea	Cell Dynamics and Bioimaging Research Center; Conversing Research Center; Mid-Career Research Program; National Research Foundation of Korea(National Research Foundation of Korea)	This research was supported by grants from the Cell Dynamics and Bioimaging Research Center (20110001155), Conversing Research Center Program (2011K000690), Mid-Career Research Program (20110000095), and funding from the National Research Foundation of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen KM, 1998, NAT GENET, V20, P25, DOI 10.1038/1675; Boda B, 2008, HIPPOCAMPUS, V18, P857, DOI 10.1002/hipo.20451; Bourne JN, 2008, ANNU REV NEUROSCI, V31, P47, DOI 10.1146/annurev.neuro.31.060407.125646; Cheng DM, 2006, MOL CELL PROTEOMICS, V5, P1158, DOI 10.1074/mcp.D500009-MCP200; Cingolani LA, 2008, NAT REV NEUROSCI, V9, P344, DOI 10.1038/nrn2373; Craig AM, 2006, TRENDS NEUROSCI, V29, P8, DOI 10.1016/j.tins.2005.11.002; DAI ZH, 1995, GENE DEV, V9, P2569, DOI 10.1101/gad.9.21.2569; Durand CM, 2007, NAT GENET, V39, P25, DOI 10.1038/ng1933; Ethell IM, 2005, PROG NEUROBIOL, V75, P161, DOI 10.1016/j.pneurobio.2005.02.003; Fischer M, 2000, NAT NEUROSCI, V3, P887, DOI 10.1038/78791; Glantz LA, 2000, ARCH GEN PSYCHIAT, V57, P65, DOI 10.1001/archpsyc.57.1.65; Grove M, 2004, MOL CELL BIOL, V24, P10905, DOI 10.1128/MCB.24.24.10905-10922.2004; Haeckel A, 2008, J NEUROSCI, V28, P10031, DOI 10.1523/JNEUROSCI.0336-08.2008; Halpain S, 2000, TRENDS NEUROSCI, V23, P141, DOI 10.1016/S0166-2236(00)01576-9; Hering H, 2003, J NEUROSCI, V23, P11759; Hirao N, 2006, FEBS LETT, V580, P6464, DOI 10.1016/j.febslet.2006.10.065; Holtmaat A, 2009, NAT REV NEUROSCI, V10, P647, DOI 10.1038/nrn2699; Hotulainen P, 2009, J CELL BIOL, V185, P323, DOI 10.1083/jcb.200809046; Hutsler JJ, 2010, BRAIN RES, V1309, P83, DOI 10.1016/j.brainres.2009.09.120; HUTTNER WB, 1983, J CELL BIOL, V96, P1374, DOI 10.1083/jcb.96.5.1374; Ichigotani Y, 2002, CANCER RES, V62, P2215; Ichigotani Y, 2002, INT J MOL MED, V9, P591; Innocenti M, 2005, NAT CELL BIOL, V7, P969, DOI 10.1038/ncb1304; Ivanov A, 2009, J CELL SCI, V122, P524, DOI 10.1242/jcs.033464; Kasai H, 2003, TRENDS NEUROSCI, V26, P360, DOI 10.1016/S0166-2236(03)00162-0; Kasai H, 2010, TRENDS NEUROSCI, V33, P121, DOI 10.1016/j.tins.2010.01.001; Kim DJ, 2006, J BIOL CHEM, V281, P617, DOI 10.1074/jbc.M504450200; Kim SM, 2011, EXP CELL RES, V317, P2276, DOI 10.1016/j.yexcr.2011.06.018; Kim SM, 2009, J NEUROCHEM, V109, P1106, DOI 10.1111/j.1471-4159.2009.06039.x; Knobloch M, 2008, MOL NEUROBIOL, V37, P73, DOI 10.1007/s12035-008-8018-z; Lee S, 2006, EMBO J, V25, P4983, DOI 10.1038/sj.emboj.7601349; Liebau S, 2011, STARCH, V6; Matsuda S, 2008, ANN ONCOL, V19, P1356, DOI 10.1093/annonc/mdn293; Meng YH, 2002, NEURON, V35, P121, DOI 10.1016/S0896-6273(02)00758-4; Miyazaki K, 2000, BBA-GENE STRUCT EXPR, V1493, P237, DOI 10.1016/S0167-4781(00)00158-5; Newey SE, 2005, J NEUROBIOL, V64, P58, DOI 10.1002/neu.20153; Newpher TM, 2009, TRENDS CELL BIOL, V19, P218, DOI 10.1016/j.tcb.2009.02.004; Nimchinsky EA, 2002, ANNU REV PHYSIOL, V64, P313, DOI 10.1146/annurev.physiol.64.081501.160008; Okamoto KI, 2004, NAT NEUROSCI, V7, P1104, DOI 10.1038/nn1311; Pinyol R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000400; Proepper C, 2007, EMBO J, V26, P1397, DOI 10.1038/sj.emboj.7601569; Qualmann B, 2004, J NEUROSCI, V24, P2481, DOI 10.1523/JNEUROSCI.5479-03.2004; Renner M, 2008, CURR OPIN NEUROBIOL, V18, P532, DOI 10.1016/j.conb.2008.09.009; Schubert V, 2007, J CELL SCI, V120, P205, DOI 10.1242/jcs.03337; Sheng M, 2007, ANNU REV BIOCHEM, V76, P823, DOI 10.1146/annurev.biochem.76.060805.160029; Soderling SH, 2007, J NEUROSCI, V27, P355, DOI 10.1523/JNEUROSCI.3209-06.2006; Star EN, 2002, NAT NEUROSCI, V5, P239, DOI 10.1038/nn811; Stradal T, 2001, CURR BIOL, V11, P891, DOI 10.1016/S0960-9822(01)00239-1; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Tackenberg C, 2009, CURR ALZHEIMER RES, V6, P261, DOI 10.2174/156720509788486554; Terry-Lorenzo RT, 2005, MOL BIOL CELL, V16, P2349, DOI 10.1091/mbc.E04-12-1054; Yoshihara Y, 2009, CURR OPIN NEUROBIOL, V19, P146, DOI 10.1016/j.conb.2009.05.013; Yuste R, 2001, ANNU REV NEUROSCI, V24, P1071, DOI 10.1146/annurev.neuro.24.1.1071; Zhang HY, 2005, J NEUROSCI, V25, P3379, DOI 10.1523/JNEUROSCI.3553-04.2005	54	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2012	7	4							e34677	10.1371/journal.pone.0034677	http://dx.doi.org/10.1371/journal.pone.0034677			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952GU	22485184	gold, Green Submitted, Green Published			2022-12-27	WOS:000304780500059
J	Bojang, P; Gregg, RG				Bojang, Pasano, Jr.; Gregg, Ronald G.			Topological Analysis of Small Leucine-Rich Repeat Proteoglycan Nyctalopin	PLOS ONE			English	Article							STATIONARY NIGHT BLINDNESS; ROD BIPOLAR CELLS; SIGNAL-ANCHOR PROTEINS; GROWTH-FACTOR RECEPTOR; MEMBRANE-PROTEINS; CRYSTAL-STRUCTURE; SYNAPTIC-TRANSMISSION; GLUTAMATE RECEPTORS; SPLIT-UBIQUITIN; RAT RETINA	Nyctalopin is a small leucine rich repeat proteoglycan (SLRP) whose function is critical for normal vision. The absence of nyctalopin results in the complete form of congenital stationary night blindness. Normally, glutamate released by Photoreceptors binds to the metabotropic glutamate receptor type 6(GRM6), which through a G-protein cascade closes the non-specific cation channel, TRPM1, on the dendritic tips of depolarizing bipolar cells (DBCs) in the retina. Nyctalopin has been shown to interact with TRPM1 and expression of TRPM1 on the dendritic tips of the DBCs is dependent on nyctalopin expression. In the current study, we used yeast two hybrid and biochemical approaches to investigate whether murine nyctalopin was membrane bound, and if so by what mechanism, and also whether the functional form was as a homodimer. Our results show that murine nyctalopin is anchored to the plasma membrane by a single transmembrane domain, such that the LRR domain is located in the extracellular space.	[Bojang, Pasano, Jr.; Gregg, Ronald G.] Univ Louisville, Dept Biochem & Mol Biol, Louisville, KY 40292 USA	University of Louisville	Bojang, P (corresponding author), Univ Louisville, Dept Biochem & Mol Biol, Louisville, KY 40292 USA.	ron.gregg@louisville.edu		Gregg, Ronald/0000-0001-5805-224X	United States National Institutes of Health [R01EY12354]; NATIONAL EYE INSTITUTE [R01EY012354] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This research was supported by grant R01EY12354 from the United States National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appenzeller-Herzog C, 2006, J CELL SCI, V119, P2173, DOI 10.1242/jcs.03019; Bech-Hansen NT, 2000, NAT GENET, V26, P319, DOI 10.1038/81619; Bella J, 2008, CELL MOL LIFE SCI, V65, P2307, DOI 10.1007/s00018-008-8019-0; Brandan E, 2008, MATRIX BIOL, V27, P700, DOI 10.1016/j.matbio.2008.07.004; Brandstatter JH, 1997, J NEUROSCI, V17, P9298; Cao Y, 2011, J NEUROSCI, V31, P11521, DOI 10.1523/JNEUROSCI.1682-11.2011; Cheng W, 2010, PROTEIN CELL, V1, P802, DOI 10.1007/s13238-010-0108-9; CLAROS MG, 1994, COMPUT APPL BIOSCI, V10, P685; Cserzo M, 1997, PROTEIN ENG, V10, P673, DOI 10.1093/protein/10.6.673; Dalbey RE, 2011, ANNU REV BIOCHEM, V80, P161, DOI 10.1146/annurev-biochem-060409-092524; Dancourt J, 2010, ANNU REV BIOCHEM, V79, P777, DOI 10.1146/annurev-biochem-061608-091319; De Matteis MA, 2008, NAT REV MOL CELL BIO, V9, P273, DOI 10.1038/nrm2378; Denzer AJ, 1995, EMBO J, V14, P6311, DOI 10.1002/j.1460-2075.1995.tb00321.x; DeVries SH, 1999, NATURE, V397, P157, DOI 10.1038/16462; Egea PF, 2005, CURR OPIN STRUC BIOL, V15, P213, DOI 10.1016/j.sbi.2005.03.007; Eisenhaber B, 1999, J MOL BIOL, V292, P741, DOI 10.1006/jmbi.1999.3069; Felkl M, 2008, NEUROSCIENCE, V156, P344, DOI 10.1016/j.neuroscience.2008.07.033; Garnier C, 1996, MOL MICROBIOL, V21, P1061, DOI 10.1046/j.1365-2958.1996.621430.x; Gregg RG, 2003, INVEST OPHTH VIS SCI, V44, P378, DOI 10.1167/iovs.02-0501; Gregg RG, 2007, J NEUROPHYSIOL, V98, P3023, DOI 10.1152/jn.00608.2007; Hack I, 1999, P NATL ACAD SCI USA, V96, P14130, DOI 10.1073/pnas.96.24.14130; Hirokawa T, 1998, BIOINFORMATICS, V14, P378, DOI 10.1093/bioinformatics/14.4.378; HOFMANN K, 1993, BIOL CHEM HOPPESEYLE, V374, P166, DOI DOI 10.1515/BCHM3.1993.374.1-6.143; Iozzo RV, 1999, J BIOL CHEM, V274, P4489, DOI 10.1074/jbc.274.8.4489; Jiang LH, 2007, BIOCHEM SOC T, V35, P86, DOI 10.1042/BST0350086; JOHNSSON N, 1994, P NATL ACAD SCI USA, V91, P10340, DOI 10.1073/pnas.91.22.10340; Kobe B, 1996, J MOL BIOL, V264, P1028, DOI 10.1006/jmbi.1996.0694; Koike C, 2010, P NATL ACAD SCI USA, V107, P332, DOI 10.1073/pnas.0912730107; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Le Goff MM, 2003, J BIOL CHEM, V278, P45280, DOI 10.1074/jbc.M303117200; Lee JCM, 2004, BLOOD, V103, P1912, DOI 10.1182/blood-2003-03-0928; LIU J, 1994, J BIOL CHEM, V269, P28366; MEADOWS LA, 1994, J CELL SCI, V107, P321; Morgans CW, 2009, P NATL ACAD SCI USA, V106, P19174, DOI 10.1073/pnas.0908711106; NAWY S, 1991, NEURON, V7, P677, DOI 10.1016/0896-6273(91)90380-I; NOMURA A, 1994, CELL, V77, P361, DOI 10.1016/0092-8674(94)90151-1; O'Connor E, 2005, HUM MOL GENET, V14, P1877, DOI 10.1093/hmg/ddi194; Pearring JN, 2011, J NEUROSCI, V31, P10060, DOI 10.1523/JNEUROSCI.1014-11.2011; Perrimon N, 2001, SEMIN CELL DEV BIOL, V12, P65, DOI 10.1006/scdb.2000.0237; Pierleoni A, 2011, NUCLEIC ACIDS RES, V39, pW375, DOI 10.1093/nar/gkr282; Pusch CM, 2000, NAT GENET, V26, P324, DOI 10.1038/81627; SAKAGUCHI M, 1992, P NATL ACAD SCI USA, V89, P16, DOI 10.1073/pnas.89.1.16; Saraogi I, 2011, TRAFFIC, V12, P535, DOI 10.1111/j.1600-0854.2011.01171.x; Schaefer L, 2008, J BIOL CHEM, V283, P21305, DOI 10.1074/jbc.R800020200; Scott PG, 2006, J BIOL CHEM, V281, P13324, DOI 10.1074/jbc.M513470200; Scott PG, 2004, P NATL ACAD SCI USA, V101, P15633, DOI 10.1073/pnas.0402976101; Scott PG, 2003, J BIOL CHEM, V278, P18353, DOI 10.1074/jbc.M211936200; Shen Y, 2009, J NEUROSCI, V29, P6088, DOI 10.1523/JNEUROSCI.0132-09.2009; SHIELLS RA, 1990, P ROY SOC B-BIOL SCI, V242, P91, DOI 10.1098/rspb.1990.0109; Stagljar I, 1998, P NATL ACAD SCI USA, V95, P5187, DOI 10.1073/pnas.95.9.5187; Stagljar Igor, 2003, Sci STKE, V2003, ppe56; TAKAHASHI N, 1985, P NATL ACAD SCI USA, V82, P1906, DOI 10.1073/pnas.82.7.1906; TEHEESEN S, 1994, EUR J BIOCHEM, V224, P71, DOI 10.1111/j.1432-1033.1994.tb19996.x; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; Vardi N, 1997, VISUAL NEUROSCI, V14, P789, DOI 10.1017/S0952523800012736; Wahlberg JM, 1997, J CELL BIOL, V137, P555, DOI 10.1083/jcb.137.3.555; WINDISCH JM, 1995, J BIOL CHEM, V270, P28133; YAMASHITA M, 1991, J NEUROSCI, V11, P2372; Zeitz C, 2003, INVEST OPHTH VIS SCI, V44, P4184, DOI 10.1167/iovs.03-0251; Zhu JX, 2005, J BIOL CHEM, V280, P32468, DOI 10.1074/jbc.M503833200	60	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2012	7	4							e33137	10.1371/journal.pone.0033137	http://dx.doi.org/10.1371/journal.pone.0033137			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952GU	22485138	Green Published, Green Submitted, gold			2022-12-27	WOS:000304780500014
J	Ostwald, D; Porcaro, C; Mayhew, SD; Bagshaw, AP				Ostwald, Dirk; Porcaro, Camillo; Mayhew, Stephen D.; Bagshaw, Andrew P.			EEG-fMRI Based Information Theoretic Characterization of the Human Perceptual Decision System	PLOS ONE			English	Article							DORSOLATERAL PREFRONTAL CORTEX; FUNCTIONAL SOURCE SEPARATION; EVENT-RELATED POTENTIALS; SINGLE-TRIAL ANALYSIS; NEURAL SYSTEMS; HUMAN BRAIN; FACE RECOGNITION; PARIETAL CORTEX; FREE-ENERGY; ACTIVATION	The modern metaphor of the brain is that of a dynamic information processing device. In the current study we investigate how a core cognitive network of the human brain, the perceptual decision system, can be characterized regarding its spatiotemporal representation of task-relevant information. We capitalize on a recently developed information theoretic framework for the analysis of simultaneously acquired electroencephalography (EEG) and functional magnetic resonance imaging data (fMRI) (Ostwald et al. (2010), NeuroImage 49: 498-516). We show how this framework naturally extends from previous validations in the sensory to the cognitive domain and how it enables the economic description of neural spatiotemporal information encoding. Specifically, based on simultaneous EEG-fMRI data features from n=13 observers performing a visual perceptual decision task, we demonstrate how the information theoretic framework is able to reproduce earlier findings on the neurobiological underpinnings of perceptual decisions from the response signal features' marginal distributions. Furthermore, using the joint EEG-fMRI feature distribution, we provide novel evidence for a highly distributed and dynamic encoding of task-relevant information in the human brain.	[Ostwald, Dirk] Charite, Dept Neurol, D-13353 Berlin, Germany; [Ostwald, Dirk] Charite, Bernstein Ctr Computat Neurosci, D-13353 Berlin, Germany; [Porcaro, Camillo] Newcastle Univ, Inst Neurosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Ostwald, Dirk; Porcaro, Camillo; Mayhew, Stephen D.; Bagshaw, Andrew P.] Univ Birmingham, Sch Psychol, Birmingham B15 2TT, W Midlands, England; [Ostwald, Dirk; Porcaro, Camillo; Mayhew, Stephen D.; Bagshaw, Andrew P.] Univ Birmingham, BUIC, Birmingham B15 2TT, W Midlands, England; [Porcaro, Camillo] Osped Fatebenefratelli, LETs ISTC CNR, Rome, Italy	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Newcastle University - UK; University of Birmingham; University of Birmingham; Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze e Tecnologie della Cognizione (ISTC-CNR)	Ostwald, D (corresponding author), Charite, Dept Neurol, D-13353 Berlin, Germany.	dirk.ostwald@bccn-berlin.de	Mayhew, Stephen/ABB-6298-2021; Porcaro, Camillo/K-7864-2016	Mayhew, Stephen/0000-0003-1240-1488; Porcaro, Camillo/0000-0003-4847-163X; Ostwald, Dirk/0000-0002-3530-1845; Bagshaw, Andrew/0000-0001-6217-1292	UK Engineering and Physical Sciences Research Council (EPSRC) [EP/F023057/1]; Dr Hadwen Trust; EPSRC [EP/F023057/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/F023057/1] Funding Source: researchfish	UK Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Dr Hadwen Trust; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by grant number EP/F023057/1 from the UK Engineering and Physical Sciences Research Council (EPSRC) and the Dr Hadwen Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen PJ, 1998, NEUROIMAGE, V8, P229, DOI 10.1006/nimg.1998.0361; Allen PJ, 2000, NEUROIMAGE, V12, P230, DOI 10.1006/nimg.2000.0599; Barbati G, 2004, CLIN NEUROPHYSIOL, V115, P1220, DOI 10.1016/j.clinph.2003.12.015; Benar CG, 2007, HUM BRAIN MAPP, V28, P602, DOI 10.1002/hbm.20289; Chakeres DW, 2005, PROG BIOPHYS MOL BIO, V87, P255, DOI 10.1016/j.pbiomolbio.2004.08.012; Corbetta M, 2000, NAT NEUROSCI, V3, P292, DOI 10.1038/73009; Corbetta M, 2002, J COGNITIVE NEUROSCI, V14, P508, DOI 10.1162/089892902317362029; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Dakin SC, 2002, CURR BIOL, V12, pR476, DOI 10.1016/S0960-9822(02)00960-0; Debener S, 2005, J NEUROSCI, V25, P11730, DOI 10.1523/JNEUROSCI.3286-05.2005; Debener S, 2007, TRENDS COGN SCI, V11, P502, DOI 10.1016/j.tics.2007.09.005; Debener S, 2006, TRENDS COGN SCI, V10, P558, DOI 10.1016/j.tics.2006.09.010; Ditterich Jochen, 2006, Novartis Found Symp, V270, P114; Eichele T, 2005, P NATL ACAD SCI USA, V102, P17798, DOI 10.1073/pnas.0505508102; FRISON L, 1992, STAT MED, V11, P1685, DOI 10.1002/sim.4780111304; Friston K, 2007, STATISTICAL PARAMETRIC MAPPING: THE ANALYSIS OF FUNCTIONAL BRAIN IMAGES, P1; Friston KJ, 2007, SYNTHESE, V159, P417, DOI 10.1007/s11229-007-9237-y; Friston KJ, 2010, NAT REV NEUROSCI, V11, P127, DOI 10.1038/nrn2787; Friston KJ, 2009, SCIENCE, V326, P399, DOI 10.1126/science.1174521; Gazzaniga M. S., 2004, COGNITIVE NEUROSCIEN; Gold JI, 2007, ANNU REV NEUROSCI, V30, P535, DOI 10.1146/annurev.neuro.29.051605.113038; Haxby JV, 2002, BIOL PSYCHIAT, V51, P59, DOI 10.1016/S0006-3223(01)01330-0; Heekeren HR, 2006, P NATL ACAD SCI USA, V103, P10023, DOI 10.1073/pnas.0603949103; Heekeren HR, 2008, NAT REV NEUROSCI, V9, P467, DOI 10.1038/nrn2374; Heekeren HR, 2004, NATURE, V431, P859, DOI 10.1038/nature02966; Hopfinger JB, 2000, NAT NEUROSCI, V3, P284, DOI 10.1038/72999; Jasper H.H., 1958, CLIN NEUROPHYSIOL, V10, P371; Kastner S, 1999, NEURON, V22, P751, DOI 10.1016/S0896-6273(00)80734-5; Kilner JM, 2005, NEUROIMAGE, V28, P280, DOI 10.1016/j.neuroimage.2005.06.008; Kriegeskorte N, 2009, NAT NEUROSCI, V12, P535, DOI 10.1038/nn.2303; Luck S, 2000, OPERATION SELECTIVE, P687; Magri C, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-81; McClure KD, 2005, NEUROIMAGE, V27, P817, DOI 10.1016/j.neuroimage.2005.05.054; Mulert C, 2010, EEG FMRI; Mulert C, 2008, NEUROIMAGE, V42, P158, DOI 10.1016/j.neuroimage.2008.04.236; Mumford JA, 2009, NEUROIMAGE, V47, P1469, DOI 10.1016/j.neuroimage.2009.05.034; Noppeney U, 2010, J NEUROSCI, V30, P7434, DOI 10.1523/JNEUROSCI.0455-10.2010; Ostwald D, 2011, MAGN RESON IMAGING, V29, P1417, DOI 10.1016/j.mri.2011.07.013; Ostwald D, 2011, NEUROIMAGE, V55, P1270, DOI 10.1016/j.neuroimage.2010.12.029; Ostwald D, 2010, NEUROIMAGE, V49, P498, DOI 10.1016/j.neuroimage.2009.07.038; Panzeri S, 2008, MAGN RESON IMAGING, V26, P1015, DOI 10.1016/j.mri.2008.02.019; Panzeri S, 2007, J NEUROPHYSIOL, V98, P1064, DOI 10.1152/jn.00559.2007; Pessoa L, 2007, CEREB CORTEX, V17, P691, DOI 10.1093/cercor/bhk020; Philiastides MG, 2007, J NEUROSCI, V27, P13082, DOI 10.1523/JNEUROSCI.3540-07.2007; Philiastides MG, 2006, J NEUROSCI, V26, P8965, DOI 10.1523/JNEUROSCI.1655-06.2006; Philiastides MG, 2011, CURR BIOL, V21, P980, DOI 10.1016/j.cub.2011.04.034; Philiastides MG, 2006, CEREB CORTEX, V16, P509, DOI 10.1093/cercor/bhi130; Pola G, 2003, NETWORK-COMP NEURAL, V14, P35, DOI 10.1088/0954-898X/14/1/303; Pollmann S, 1998, NEUROIMAGE, V8, P327, DOI 10.1006/nimg.1998.0373; Porcaro C, 2010, NEUROIMAGE, V50, P112, DOI 10.1016/j.neuroimage.2009.12.002; Porcaro C, 2009, HUM BRAIN MAPP, V30, P660, DOI 10.1002/hbm.20533; Ratcliff R, 2009, PROCNATLACADSCIUSA; Ratcliff R, 2008, NEURAL COMPUT, V20, P873, DOI 10.1162/neco.2008.12-06-420; Rossion B, 2008, NEUROIMAGE, V39, P1959, DOI 10.1016/j.neuroimage.2007.10.011; Shadlen MN, 2001, J NEUROPHYSIOL, V86, P1916, DOI 10.1152/jn.2001.86.4.1916; Shulman GL, 2002, CEREB CORTEX, V12, P1124, DOI 10.1093/cercor/12.11.1124; Thielscher A, 2007, J NEUROSCI, V27, P2908, DOI 10.1523/JNEUROSCI.3024-06.2007; Troje NF, 1996, VISION RES, V36, P1761, DOI 10.1016/0042-6989(95)00230-8; Vandekerckhove J, 2007, PSYCHON B REV, V14, P1011, DOI 10.3758/BF03193087; Warbrick T, 2008, INT J PSYCHOPHYSIOL, V67, P169, DOI 10.1016/j.ijpsycho.2007.05.014	61	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2012	7	4							e33896	10.1371/journal.pone.0033896	http://dx.doi.org/10.1371/journal.pone.0033896			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952GU	22485152	Green Published, gold			2022-12-27	WOS:000304780500028
J	Palmberger, D; Wilson, IBH; Berger, I; Grabherr, R; Rendic, D				Palmberger, Dieter; Wilson, Iain B. H.; Berger, Imre; Grabherr, Reingard; Rendic, Dubravko			SweetBac: A New Approach for the Production of Mammalianised Glycoproteins in Insect Cells	PLOS ONE			English	Article							N-GLYCOSYLATION PATHWAY; BACULOVIRUS EXPRESSION SYSTEM; LEPIDOPTERA-NOCTUIDAE; PROTEIN; BETA-1,4-GALACTOSYLTRANSFERASE; GLYCOSYLTRANSFERASES; ANTIBODIES; VECTORS; GLYCANS; LINE	Recombinant production of therapeutically active proteins has become a central focus of contemporary life science research. These proteins are often produced in mammalian cells, in order to obtain products with post-translational modifications similar to their natural counterparts. However, in cases where a fast and flexible system for recombinant production of proteins is needed, the use of mammalian cells is limited. The baculoviral insect cell system has proven to be a powerful alternative for the expression of a wide range of recombinant proteins in short time frames. The major drawback of baculoviral systems lies in the inability to perform mammalian-like glycosylation required for the production of therapeutic glycoproteins. In this study we integrated sequences encoding Caenorhabditis elegans N-acetylglucosaminyltransferase II and bovine beta 1,4-galactosyltransferase I into the backbone of a baculovirus genome. The thereby generated SweetBac virus was subsequently used for the production of the human HIV anti-gp41 antibody 3D6 by integrating heavy and light chain open reading frames into the SweetBac genome. The parallel expression of target genes and glycosyltransferases reduced the yield of secreted antibody. However, the overall expression rate, especially in the recently established Tnao38 cell line, was comparable to that of transient expression in mammalian cells. In order to evaluate the ability of SweetBac to generate mammalian-like N-glycan structures on 3D6 antibody, we performed SDS-PAGE and tested for the presence of terminal galactose using Riccinus communis agglutinin I. The mammalianised variants of 3D6 showed highly specific binding to the lectin, indicating proper functionality. To confirm these results, PNGase A released N-glycans were analyzed by MALDI-TOF-MS and shown to contain structures with mainly one or two terminal galactose residues. Since the presence of specific N-glycans has an impact on antibodies ability to exert different effector functions, we tested the binding to human Fc gamma receptor I present on U937 cells.	[Palmberger, Dieter; Wilson, Iain B. H.; Grabherr, Reingard; Rendic, Dubravko] Univ Nat Resources & Life Sci, Vienna Inst BioTechnol VIBT, Vienna, Austria; [Berger, Imre] European Mol Biol Lab, F-38042 Grenoble, France	University of Natural Resources & Life Sciences, Vienna; European Molecular Biology Laboratory (EMBL)	Palmberger, D (corresponding author), Univ Nat Resources & Life Sci, Vienna Inst BioTechnol VIBT, Vienna, Austria.	reingard.grabherr@boku.ac.at	Rendic, Dubravko/A-9368-2010; Wilson, Iain/B-3326-2009	Grabherr, Reingard/0000-0002-4501-927X; Wilson, Iain/0000-0001-8996-1518; Palmberger, Dieter/0000-0002-2086-0396; Berger, Imre/0000-0001-7518-9045	Austrian Science Fund, FWF [TRP127-B11]; Austrian Science Fund (FWF) [TRP 127] Funding Source: researchfish	Austrian Science Fund, FWF(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was funded by the Austrian Science Fund, FWF (TRP127-B11), in the name of Austrian Ministry for Transport, Innovation and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmann F, 1999, GLYCOCONJUGATE J, V16, P109, DOI 10.1023/A:1026488408951; Aumiller JJ, 2003, GLYCOBIOLOGY, V13, P497, DOI 10.1093/glycob/cwg051; Aumiller JJ, 2012, GLYCOBIOLOGY; Berger I, 2004, NAT BIOTECHNOL, V22, P1583, DOI 10.1038/nbt1036; Bieniossek Christoph, 2008, Curr Protoc Protein Sci, VChapter 5, DOI 10.1002/0471140864.ps0520s51; Birch JR, 2006, ADV DRUG DELIVER REV, V58, P671, DOI 10.1016/j.addr.2005.12.006; Breitbach K, 2001, BIOTECHNOL BIOENG, V74, P230, DOI 10.1002/bit.1112; Chang GD, 2003, J BIOTECHNOL, V102, P61, DOI 10.1016/S0168-1656(02)00364-4; Chung CH, 2008, NEW ENGL J MED, V358, P1109, DOI 10.1056/NEJMoa074943; FELGENHAUER M, 1990, NUCLEIC ACIDS RES, V18, P4927, DOI 10.1093/nar/18.16.4927; Fitzgerald DJ, 2006, NAT METHODS, V3, P1021, DOI 10.1038/nmeth983; Hashimoto Y, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-50; Hollister J, 2002, BIOCHEMISTRY-US, V41, P15093, DOI 10.1021/bi026455d; Hollister JR, 1998, GLYCOBIOLOGY, V8, P473, DOI 10.1093/glycob/8.5.473; Hollister JR, 2001, GLYCOBIOLOGY, V11, P1; Huang LH, 2006, ANAL BIOCHEM, V349, P197, DOI 10.1016/j.ab.2005.11.012; Iskratsch T, 2009, ANAL BIOCHEM, V386, P133, DOI 10.1016/j.ab.2008.12.005; Jarvis DL, 1996, NAT BIOTECHNOL, V14, P1288, DOI 10.1038/nbt1096-1288; Jefferis R, 2009, TRENDS PHARMACOL SCI, V30, P356, DOI 10.1016/j.tips.2009.04.007; Kanda Y, 2007, GLYCOBIOLOGY, V17, P104, DOI 10.1093/glycob/cwl057; Kelley B, 2009, MABS-AUSTIN, V1, P443, DOI 10.4161/mabs.1.5.9448; Krammer F, 2010, MOL BIOTECHNOL, V45, P226, DOI 10.1007/s12033-010-9268-3; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Palmberger D, 2011, J BIOTECHNOL; Rendic D, 2007, ELECTROPHORESIS, V28, P4484, DOI 10.1002/elps.200700098; Sambrook J., 2002, MOL CLONING LAB MANU; Schiller JT, 2008, VACCINE, V26, pK53, DOI 10.1016/j.vaccine.2008.06.002; Summers MD, 1987, TEXAS AGR EXPT STATI; Trowitzsch S, 2010, J STRUCT BIOL, V172, P45, DOI 10.1016/j.jsb.2010.02.010; VAUGHN JL, 1977, IN VITRO CELL DEV B, V13, P213; Wagner R, 1996, GLYCOBIOLOGY, V6, P165, DOI 10.1093/glycob/6.2.165; WICKHAM TJ, 1993, BIOTECHNOL PROGR, V9, P25, DOI 10.1021/bp00019a004	32	59	63	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2012	7	4							e34226	10.1371/journal.pone.0034226	http://dx.doi.org/10.1371/journal.pone.0034226			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952GU	22485160	Green Published, Green Submitted, gold			2022-12-27	WOS:000304780500035
J	Puppala, M; Ponder, J; Suryanarayana, P; Reddy, GB; Petrash, JM; LaBarbera, DV				Puppala, Muthenna; Ponder, Jessica; Suryanarayana, Palla; Reddy, Geereddy Bhanuprakash; Petrash, J. Mark; LaBarbera, Daniel V.			The Isolation and Characterization of beta-Glucogallin as a Novel Aldose Reductase Inhibitor from Emblica officinalis	PLOS ONE			English	Article							DIABETIC-RETINOPATHY; TRANSGENIC MICE; KETO REDUCTASES; RAT RETINA; COMPLICATIONS; CATARACT; TANNINS; LENS; ACCUMULATION; DEFICIENCY	Diabetes mellitus is recognized as a leading cause of new cases of blindness. The prevalence of diabetic eye disease is expected to continue to increase worldwide as a result of the dramatic increase in the number of people with diabetes. At present, there is no medical treatment to delay or prevent the onset and progression of cataract or retinopathy, the most common causes of vision loss in diabetics. The plant Emblica officinalis (gooseberry) has been used for thousands of years as a traditional Indian Ayurvedic preparation for the treatment of diabetes in humans. Extracts from this plant have been shown to be efficacious against the progression of cataract in a diabetic rat model. Aldose reductase (ALR2) is implicated in the development of secondary complications of diabetes including cataract and, therefore, has been a major drug target for the development of therapies to treat diabetic disease. Herein, we present the bioassay-guided isolation and structure elucidation of 1-O-galloy1-beta-D-glucose (beta-glucogallin), a major component from the fruit of the gooseberry that displays selective as well as relatively potent inhibition (IC50=17 mu M) of AKR1B1 in vitro. Molecular modeling demonstrates that this inhibitor is able to favorably bind in the active site. Further, we show that beta-glucogallin effectively inhibits sorbitol accumulation by 73% at 30 mu M under hyperglycemic conditions in an ex-vivo organ culture model of lenses excised from transgenic mice overexpressing human ALR2 in the lens. This study supports the continued development of natural products such as beta-glucogallin as therapeutic leads in the development of novel therapies to treat diabetic complications such as cataract.	[Puppala, Muthenna; Suryanarayana, Palla; Reddy, Geereddy Bhanuprakash] Natl Inst Nutr, Dept Biochem, Hyderabad 500007, Andhra Pradesh, India; [Ponder, Jessica; Petrash, J. Mark; LaBarbera, Daniel V.] Univ Colorado, Skaggs Sch Pharm & Pharmaceut Sci, Dept Pharmaceut Sci, Aurora, CO USA; [Petrash, J. Mark] Univ Colorado, Dept Ophthalmol, Sch Med, Aurora, CO USA	Indian Council of Medical Research (ICMR); ICMR - National Institute of Nutrition (NIN); University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Puppala, M (corresponding author), Natl Inst Nutr, Dept Biochem, Hyderabad 500007, Andhra Pradesh, India.	daniel.labarbera@ucdenver.edu	Reddy, G Bhanuprakash/AAJ-3494-2020; Puppala, Muthenna/R-9629-2017	Reddy, G Bhanuprakash/0000-0003-4787-3944; Puppala, Muthenna/0000-0002-7035-749X	Department of Biotechnology; Life Sciences Research Board of Defense Research; Development Organization, Government of India (GBR); National Institutes of Health [EY005856, EY021498]; Skaggs School of Pharmacy and Pharmaceutical Sciences; University Grants Commission, India; BOYSCAST from the Department of Science and Technology, New Delhi, India; NATIONAL EYE INSTITUTE [R55EY005856, R01EY021498, R23EY005856, R01EY005856] Funding Source: NIH RePORTER	Department of Biotechnology; Life Sciences Research Board of Defense Research; Development Organization, Government of India (GBR); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Skaggs School of Pharmacy and Pharmaceutical Sciences; University Grants Commission, India(University Grants Commission, India); BOYSCAST from the Department of Science and Technology, New Delhi, India; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was funded in part by grants from the Department of Biotechnology (under 7th FP of Indo-EU collaborative program on functional foods) and Life Sciences Research Board of Defense Research and Development Organization, Government of India (GBR), National Institutes of Health grants EY005856 (JMP) and EY021498 (DVL and JMP), and through Skaggs School of Pharmacy and Pharmaceutical Sciences start up funds (DVL). MP was supported by a Senior Research Fellowship from the University Grants Commission, India. PS was supported by a BOYSCAST fellowship from the Department of Science and Technology, New Delhi, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiello LP, 1998, DIABETES CARE, V21, P143, DOI 10.2337/diacare.21.1.143; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Cheung AKH, 2005, DIABETES, V54, P3119, DOI 10.2337/diabetes.54.11.3119; DAS B, 1985, DIABETES, V34, P1145, DOI 10.2337/diabetes.34.11.1145; Diabetes Control and Complications Trial, 1995, ARCH OPHTHALMOL, V113, P36; EHRIG T, 1994, BIOCHEMISTRY-US, V33, P7157, DOI 10.1021/bi00189a019; El-Kabbani O, 2000, PROTEINS, V41, P407, DOI 10.1002/1097-0134(20001115)41:3<407::AID-PROT120>3.0.CO;2-9; El-Remessy AB, 2003, INVEST OPHTH VIS SCI, V44, P3135, DOI 10.1167/iovs.02-1022; ENGERMAN RL, 1993, DIABETES, V42, P820, DOI 10.2337/diabetes.42.6.820; Fischer E, 1918, BER DTSCH CHEM GES, V51, P45, DOI 10.1002/cber.19180510108; Ghosal S, 1996, INDIAN J CHEM B, V35, P941; Giannoukakis N, 2008, EXPERT OPIN INV DRUG, V17, P575, DOI [10.1517/13543784.17.4.575, 10.1517/13543784.17.4.575 ]; Gross G., 1999, COMPREHENSIVE NATURA; Gross GG, 1992, PLANT POLYHENOLS SYN; Haslam E, 2007, PHYTOCHEMISTRY, V68, P2713, DOI 10.1016/j.phytochem.2007.09.009; HAYMAN S, 1965, J BIOL CHEM, V240, P877; KADOR PF, 1985, J MED CHEM, V28, P841, DOI 10.1021/jm00145a001; KASHIWADA Y, 1984, CHEM PHARM BULL, V32, P3461; Klebe G, 2004, CELL MOL LIFE SCI, V61, P783, DOI 10.1007/s00018-003-3406-z; Latte KP, 2000, PHYTOCHEMISTRY, V54, P701, DOI 10.1016/S0031-9422(00)00176-X; LEE AYW, 1995, P NATL ACAD SCI USA, V92, P2780, DOI 10.1073/pnas.92.7.2780; Levin DS, 2007, J AM SOC MASS SPECTR, V18, P502, DOI 10.1016/j.jasms.2006.10.008; Montes M, 2007, PROTEINS, V68, P712, DOI 10.1002/prot.21405; Murata M, 2002, J DIABETES COMPLICAT, V16, P363, DOI 10.1016/S1056-8727(01)00171-4; Neuhauser W, 1997, BIOCHEM J, V326, P683, DOI 10.1042/bj3260683; Oates, 1999, Expert Opin Investig Drugs, V8, P2095, DOI 10.1517/13543784.8.12.2095; Penning TM, 2007, ARCH BIOCHEM BIOPHYS, V464, P241, DOI 10.1016/j.abb.2007.04.024; PETRASH JM, 1992, J BIOL CHEM, V267, P24833; Petrash JM, 2004, CELL MOL LIFE SCI, V61, P737, DOI 10.1007/s00018-003-3402-3; Quideau, 2009, CHEM BIOL ELLAGITANN; Quin GJ, 2007, PROTEOMICS, V7, P2636, DOI 10.1002/pmic.200600486; RAO PV, 1989, NUTR RES, V9, P1143, DOI 10.1016/S0271-5317(89)80049-1; Reddy GB, 2008, MOL VIS, V14, P593; Reddy GB, 2011, PYLLANTHUS SPECIES S, P235; ROBISON WG, 1990, EXP EYE RES, V50, P355, DOI 10.1016/0014-4835(90)90136-I; SARGES R, 1986, METABOLISM, V35, P101, DOI 10.1016/0026-0495(86)90196-4; Scartezzini P, 2000, J ETHNOPHARMACOL, V71, P23, DOI 10.1016/S0378-8741(00)00213-0; Shen Y, 2011, CHEM-BIOL INTERACT, V191, P192, DOI 10.1016/j.cbi.2011.02.004; Song ZT, 2003, MOL CELL NEUROSCI, V23, P638, DOI 10.1016/S1044-7431(03)00096-4; Suryanarayana P, 2007, MOL VIS, V13, P1291; Suryanarayana P, 2004, MOL VIS, V10, P148; Urzhumtsev A, 1997, STRUCTURE, V5, P601, DOI 10.1016/S0969-2126(97)00216-5; YAMAOKA T, 1995, DIABETOLOGIA, V38, P255, DOI 10.1007/s001250050278	44	65	68	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2012	7	4							e31399	10.1371/journal.pone.0031399	http://dx.doi.org/10.1371/journal.pone.0031399			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952GU	22485126	Green Published, gold, Green Submitted			2022-12-27	WOS:000304780500002
J	Garcia-Lastra, R; Leginagoikoa, I; Plazaola, JM; Ocabo, B; Aduriz, G; Nunes, T; Juste, RA				Garcia-Lastra, Rodrigo; Leginagoikoa, Iratxe; Plazaola, Jose M.; Ocabo, Blanca; Aduriz, Gorka; Nunes, Telmo; Juste, Ramon A.			Bluetongue Virus Serotype 1 Outbreak in the Basque Country (Northern Spain) 2007-2008. Data Support a Primary Vector Windborne Transport	PLOS ONE			English	Article							BREVITARSIS KIEFFER DIPTERA; CULICOIDES-IMICOLA; ARBOVIRUS VECTOR; RECENT EMERGENCE; AIR STREAMS; EUROPE; SPREAD; CERATOPOGONIDAE; DISPERSAL; DISEASE	Background: Bluetongue (BT) is a vector-borne disease of ruminants that has expanded its traditional global distribution in the last decade. Recently, BTV-1 emerged in Southern Spain and caused several outbreaks in livestock reaching the north of the country. The aim of this paper was to review the emergence of BTV-1 in the Basque Country (Northern Spain) during 2007 and 2008 analyzing the possibility that infected Culicoides were introduced into Basque Country by winds from the infected areas of Southern Spain. Methodology/Principal Findings: We use a complex HYSPLIT (Hybrid Single-Particle Lagrangian Integrated Trajectory) model to draw wind roses and backward wind trajectories. The analysis of winds showed September 28 to October 2 as the only period for the introduction of infected midges in the Basque Country. These wind trajectories crossed through the areas affected by serotype 1 on those dates in the South of the Iberian Peninsula. Additionally meteorological data, including wind speed and humidity, and altitude along the trajectories showed suitable conditions for Culicoides survival and dispersion. Conclusions/Significance: An active infection in medium-long distance regions, wind with suitable speed, altitude and trajectory, and appropriate weather can lead to outbreaks of BTV-1 by transport of Culicoides imicola, not only over the sea (as reported previously) but also over the land. This shows that an additional factor has to be taken into account for the control of the disease which is currently essentially based on the assumption that midges will only spread the virus in a series of short hops. Moreover, the epidemiological and serological data cannot rule out the involvement of other Culicoides species in the spread of the infection, especially at a local level.	[Garcia-Lastra, Rodrigo; Leginagoikoa, Iratxe; Aduriz, Gorka; Juste, Ramon A.] NEIKER Tecnalia, Dept Anim Hlth, Derio, Bizkaia, Spain; [Plazaola, Jose M.] Diputac Foral Gipuzkoa, Dept Desarrollo Rural, Donostia San Sebastian, Gipuzkoa, Spain; [Ocabo, Blanca] Diputac Foral Bizkaia, Dept Agr, Bilbao, Bizkaia, Spain; [Nunes, Telmo] Univ Tecn Lisboa, Fac Med Vet, Lisbon, Portugal	Universidade de Lisboa	Garcia-Lastra, R (corresponding author), NEIKER Tecnalia, Dept Anim Hlth, Derio, Bizkaia, Spain.	rjuste@neiker.net	Juste, Ramon A./C-3570-2008	Juste, Ramon A./0000-0001-6037-5873; LEGINAGOIKOA, IRATXE/0000-0002-4887-7472; Nunes, Telmo/0000-0003-4388-5366	Direccion de Agricultura of the Departmento de Medio Ambiente, Planificacion Territorial, Agricultura y Pesca of the Basque Governement	Direccion de Agricultura of the Departmento de Medio Ambiente, Planificacion Territorial, Agricultura y Pesca of the Basque Governement	Funding for this work has been provided by the Direccion de Agricultura of the Departmento de Medio Ambiente, Planificacion Territorial, Agricultura y Pesca of the Basque Governement. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agren ECC, 2010, VET REC, V167, P484, DOI 10.1136/vr.c3961; Alba A, 2004, VET REC, V155, P460, DOI 10.1136/vr.155.15.460; Allepuz A, 2010, PREV VET MED, V96, P263, DOI 10.1016/j.prevetmed.2010.06.005; Bishop AL, 2000, PREV VET MED, V47, P243, DOI 10.1016/S0167-5877(00)00175-6; Bishop AL, 2004, PREV VET MED, V65, P135, DOI 10.1016/j.prevetmed.2004.06.011; Braverman Y, 1996, REV SCI TECH OIE, V15, P1037, DOI 10.20506/rst.15.3.968; Burgin L, 2008, METEOROLOGICAL ANAL; Calvete C, 2008, MED VET ENTOMOL, V22, P124, DOI 10.1111/j.1365-2915.2008.00728.x; Calvete C, 2008, VET REC, V162, P255, DOI 10.1136/vr.162.8.255; Darpel KE, 2007, VET REC, V161, P253, DOI 10.1136/vr.161.8.253; Draxier RR, 1998, AUST METEOROL MAG, V47, P295; Ducheyne E, 2011, PREV VET MED, V99, P48, DOI 10.1016/j.prevetmed.2011.01.003; EUSKALMET, 2011, AG MET EUSK DAT EST; Feng HQ, 2007, AGR FOREST ENTOMOL, V9, P103, DOI 10.1111/j.1461-9563.2007.00326.x; Foxi C, 2010, MED VET ENTOMOL, V24, P199, DOI 10.1111/j.1365-2915.2010.00861.x; Gloster J, 2007, VET REC, V160, P54, DOI 10.1136/vr.160.2.54; Goldarazena A, 2008, VET REC, V162, P820, DOI 10.1136/vr.162.25.820; Hendrickx G, 2008, PREV VET MED, V87, P162, DOI 10.1016/j.prevetmed.2008.06.009; Hess GD, 2008, ENVIRON MODEL ASSESS, V13, P209, DOI 10.1007/s10666-007-9097-3; HYSPLIT, 2011, HYSPLIT HYBR SINGL P; Kedmi M, 2010, PREV VET MED, V96, P152, DOI 10.1016/j.prevetmed.2010.06.008; Lee LYL, 2004, ATMOS ENVIRON, V38, P7033, DOI 10.1016/j.atmosenv.2003.11.045; Lucientes J, 2008, 33 JORN CIENT 12 INT; Maan S, 2011, EMERG INFECT DIS, V17, P886, DOI 10.3201/eid1705.101742; Maclachlan NJ, 2009, J COMP PATHOL, V141, P1, DOI 10.1016/j.jcpa.2009.04.003; Maclachlan NJ, 2010, VET CLIN N AM-FOOD A, V26, P163, DOI 10.1016/j.cvfa.2009.10.012; Mehlhorn H, 2008, PARASITOL RES, V103, pS79, DOI 10.1007/s00436-008-1100-7; Mehlhorn H, 2009, PARASITOL RES, V105, P313, DOI 10.1007/s00436-009-1416-y; Meiswinkel R, 2008, PREV VET MED, V87, P55, DOI 10.1016/j.prevetmed.2008.06.005; Mellor PS, 2008, PREV VET MED, V87, P4, DOI 10.1016/j.prevetmed.2008.06.002; PERSSON C, 2009, 20092 SMHI; Polymenakou PN, 2008, ENVIRON HEALTH PERSP, V116, P292, DOI 10.1289/ehp.10684; Purse BV, 2005, NAT REV MICROBIOL, V3, P171, DOI 10.1038/nrmicro1090; Querol X, 1998, ATMOS ENVIRON, V32, P1963, DOI 10.1016/S1352-2310(97)00504-9; RASVE, 2011, INF LENG AZ AN 2009; Reynolds DR, 2006, ADV VIRUS RES, V67, P453, DOI 10.1016/S0065-3527(06)67012-7; Saegerman C, 2008, EMERG INFECT DIS, V14, P539, DOI 10.3201/eid1404.071441; Sellers R. F., 1992, Bluetongue, African horse sickness, and related orbiviruses: Proceedings of the Second International Symposium., P284; SELLERS RF, 1978, J HYG-CAMBRIDGE, V81, P189, DOI 10.1017/S0022172400025018; SELLERS RF, 1991, CAN J VET RES, V55, P367; SELLERS RF, 1989, CAN J VET RES, V53, P100; Sorooshian A, 2008, ATMOS CHEM PHYS, V8, P5489, DOI 10.5194/acp-8-5489-2008; Szmaragd C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007741; Westbrook JK, 2011, INT J BIOMETEOROL, V55, P585, DOI 10.1007/s00484-010-0359-4; Wilson A, 2009, PARASITOL RES, V104, P489, DOI 10.1007/s00436-008-1314-8; Yerramilli A, 2012, AIR QUAL ATMOS HLTH, V5, P401, DOI 10.1007/s11869-010-0132-1	46	33	33	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e34421	10.1371/journal.pone.0034421	http://dx.doi.org/10.1371/journal.pone.0034421			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479628	Green Published, Green Submitted, gold			2022-12-27	WOS:000305339100158
J	Swindell, WR; Xing, XY; Stuart, PE; Chen, CS; Aphale, A; Nair, RP; Voorhees, JJ; Elder, JT; Johnston, A; Gudjonsson, JE				Swindell, William R.; Xing, Xianying; Stuart, Philip E.; Chen, Cynthia S.; Aphale, Abhishek; Nair, Rajan P.; Voorhees, John J.; Elder, James T.; Johnston, Andrew; Gudjonsson, Johann E.			Heterogeneity of Inflammatory and Cytokine Networks in Chronic Plaque Psoriasis	PLOS ONE			English	Article							PERSONALIZED MEDICINE; EXPRESSION; INTERLEUKIN-13; SKIN; PHARMACOKINETICS; MECHANISMS; REVEALS; IL-13; KERATINOCYTES; EXACERBATION	The clinical features of psoriasis, characterized by sharply demarcated scaly erythematous plaques, are typically so distinctive that a diagnosis can easily be made on these grounds alone. However, there is great variability in treatment response between individual patients, and this may reflect heterogeneity of inflammatory networks driving the disease. In this study, whole-genome transcriptional profiling was used to characterize inflammatory and cytokine networks in 62 lesional skin samples obtained from patients with stable chronic plaque psoriasis. We were able to stratify lesions according to their inflammatory gene expression signatures, identifying those associated with strong (37% of patients), moderate (39%) and weak inflammatory infiltrates (24%). Additionally, we identified differences in cytokine signatures with heightened cytokine-response patterns in one sub-group of lesions (IL-13-strong; 50%) and attenuation of these patterns in a second sub-group (IL-13-weak; 50%). These sub-groups correlated with the composition of the inflammatory infiltrate, but were only weakly associated with increased risk allele frequency at some psoriasis susceptibility loci (e.g., REL, TRAF3IP2 and NOS2). Our findings highlight variable points in the inflammatory and cytokine networks known to drive chronic plaque psoriasis. Such heterogeneous aspects may shape clinical course and treatment responses, and can provide avenues for development of personalized treatments.	[Swindell, William R.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Xing, Xianying; Stuart, Philip E.; Chen, Cynthia S.; Aphale, Abhishek; Nair, Rajan P.; Voorhees, John J.; Elder, James T.; Johnston, Andrew; Gudjonsson, Johann E.] Univ Michigan, Sch Med, Dept Dermatol, Ann Arbor, MI USA	Harvard University; Harvard Medical School; University of Michigan System; University of Michigan	Swindell, WR (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA.	johanng@med.umich.edu	Johnston, Andrew/I-7904-2014; Voorhees, John/AAM-9966-2020	Johnston, Andrew/0000-0002-1313-9402; Voorhees, John/0000-0003-1856-785X	National Institutes of Health (NIH) [R01 AR054966]; Babcock Endowment Fund; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR054966, R01AR042742] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Babcock Endowment Fund; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by R01 AR054966 (JTE) from the National Institutes of Health (NIH) and the Babcock Endowment Fund. JEG has received support from the Dermatology Foundation and American Skin Association and is the Frances and Kenneth Eisenberg Emerging Scholar of the Taubman Medical Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hoqail IA, 2010, CURR VASC PHARMACOL, V8, P432; Balato N, 2009, J RHEUMATOL, V36, P24, DOI 10.3899/jrheum.090216; Bowcock AM, 2001, HUM MOL GENET, V10, P1793, DOI 10.1093/hmg/10.17.1793; Bowes J, 2011, ANN RHEUM DIS, V70, P1016, DOI 10.1136/ard.2010.143123; Cancino-Diaz JC, 2002, J INVEST DERMATOL, V119, P1114, DOI 10.1046/j.1523-1747.2002.19509.x; Chiricozzi A, 2011, J INVEST DERMATOL, V131, P677, DOI 10.1038/jid.2010.340; Di Cesare A, 2009, J INVEST DERMATOL, V129, P1339, DOI 10.1038/jid.2009.59; Duarte GV, 2010, AN BRAS DERMATOL, V85, P355, DOI 10.1590/S0365-05962010000300009; Duffin KC, 2009, J INVEST DERMATOL, V129, P2777, DOI 10.1038/jid.2009.169; Elewski B, 2007, BRIT J DERMATOL, V156, P138, DOI 10.1111/j.1365-2133.2006.07585.x; Filzmoser P, 2005, COMPUT GEOSCI-UK, V31, P579, DOI 10.1016/j.cageo.2004.11.013; Furlanut M, 1996, THER DRUG MONIT, V18, P544, DOI 10.1097/00007691-199610000-00004; Griffiths CEM, 2010, J EUR ACAD DERMATOL, V24, P10, DOI 10.1111/j.1468-3083.2010.03831.x; GRUBBS FE, 1950, ANN MATH STAT, V21, P27, DOI 10.1214/aoms/1177729885; Gudjonsson JE, 2004, CLIN EXP IMMUNOL, V135, P1, DOI 10.1111/j.1365-2249.2004.02310.x; Gudjonsson JE, 2010, J INVEST DERMATOL, V130, P1829, DOI 10.1038/jid.2010.36; Gudjonsson JE, 2009, J INVEST DERMATOL, V129, P2795, DOI 10.1038/jid.2009.173; Haider AS, 2008, J INVEST DERMATOL, V128, P606, DOI 10.1038/sj.jid.5701067; Hamid Q, 1996, J ALLERGY CLIN IMMUN, V98, P225, DOI 10.1016/S0091-6749(96)70246-4; HUFFMAN DH, 1973, CLIN PHARMACOL THER, V14, P572; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Itoh K, 2005, EXP DERMATOL, V14, P667, DOI 10.1111/j.0906-6705.2005.00338.x; Joham E, 2007, FITZPATRICKS DERMATO, P169; Joshi A, 2006, J CLIN PHARMACOL, V46, P10, DOI 10.1177/0091270005283282; Klotz U, 2007, CLIN PHARMACOKINET, V46, P645, DOI 10.2165/00003088-200746080-00002; Kulski JK, 2005, J MOL MED, V83, P964, DOI 10.1007/s00109-005-0721-x; LAMBERT WE, 1994, ACTA DERM-VENEREOL, V74, P122; Liu GY, 2003, NUCLEIC ACIDS RES, V31, P82, DOI 10.1093/nar/gkg121; Lowes MA, 2007, NATURE, V445, P866, DOI 10.1038/nature05663; Nair RP, 2009, NAT GENET, V41, P199, DOI 10.1038/ng.311; Nestle FO, 2009, NEW ENGL J MED, V361, P496, DOI 10.1056/NEJMra0804595; Papp K, 2011, BRIT J DERMATOL, V164, P434, DOI 10.1111/j.1365-2133.2010.10139.x; Papp KA, 2012, J AM ACAD DERMATOL, V67, pE11, DOI 10.1016/j.jaad.2011.02.032; R Development Core Team, 2010, R R LANG ENV STAT CO; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Schinke-Braun Martina, 2007, Methods Mol Biol, V366, P13; Shimoni Y, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000828; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Spadaro A, 2002, ANN RHEUM DIS, V61, P174, DOI 10.1136/ard.61.2.174; Suarez-Farinas M, 2010, BMC DERMATOL, V10, DOI 10.1186/1471-5945-10-1; Suarez-Farinas M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010247; Swindell WR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011861; Torii K, 2011, EXP DERMATOL, V20, P371, DOI 10.1111/j.1600-0625.2010.01224.x; van de Kerkhof PCM, 2009, J DERMATOL TREAT, V20, P253, DOI 10.1080/09546630903283352; VanderPloeg I, 1997, CLIN EXP IMMUNOL, V109, P526, DOI 10.1046/j.1365-2249.1997.4671365.x; Viguier M, 2009, EXPERT REV CLIN IMMU, V5, P421, DOI [10.1586/eci.09.18, 10.1586/ECI.09.18]; Wendling D, 2008, JOINT BONE SPINE, V75, P315, DOI 10.1016/j.jbspin.2007.06.011; Wongpiyabovorn J, 2003, J DERMATOL SCI, V33, P31, DOI 10.1016/S0923-1811(03)00148-8; Woolf RT, 2010, EXPERT REV CLIN IMMU, V6, P957, DOI 10.1586/ECI.10.74; Yao YH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002737; Zhou XH, 2003, PHYSIOL GENOMICS, V13, P69, DOI 10.1152/physiolgenomics.00157.2002; Zhu YW, 2009, J CLIN PHARMACOL, V49, P162, DOI 10.1177/0091270008329556; ZURAWSKI G, 1994, IMMUNOL TODAY, V15, P19, DOI 10.1016/0167-5699(94)90021-3	53	55	57	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2012	7	3							e34594	10.1371/journal.pone.0034594	http://dx.doi.org/10.1371/journal.pone.0034594			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948SR	22479649	gold, Green Submitted, Green Published			2022-12-27	WOS:000304523400090
J	Seavy, NE; Humple, DL; Cormier, RL; Gardali, T				Seavy, Nathaniel E.; Humple, Diana L.; Cormier, Renee L.; Gardali, Thomas			Establishing the Breeding Provenance of a Temperate-Wintering North American Passerine, the Golden-Crowned Sparrow, Using Light-Level Geolocation	PLOS ONE			English	Article							MIGRATORY CONNECTIVITY; ISOTOPES; PATTERNS; TRACKING; DUNLIN	The migratory biology and connectivity of passerines remains poorly known, even for those that move primarily within the temperate zone. We used light-level geolocators to describe the migratory geography of a North American temperate migrant passerine. From February to March of 2010, we attached geolocator tags to 33 Golden-crowned Sparrows (Zonotrichia atricapilla) wintering on the central coast of California, USA, and recovered four tags the following winter (October to December 2010). We used a Bayesian state-space model to estimate the most likely breeding locations. All four birds spent the breeding season on the coast of the Gulf of Alaska. These locations spanned approximately 1200 kilometers, and none of the individuals bred in the same location. Speed of migration was nearly twice as fast during spring than fall. The return rate of birds tagged the previous season (33%) was similar to that of control birds (39%), but comparing return rates was complicated because 7 of 11 returning birds had lost their tags. For birds that we recaptured before spring migration, we found no significant difference in mass change between tagged and control birds. Our results provide insight into the previously-unknown breeding provenance of a wintering population of Golden-crowned Sparrows and provide more evidence of the contributions that light-level geolocation can make to our understanding of the migratory geography of small passerines.	[Seavy, Nathaniel E.; Humple, Diana L.; Cormier, Renee L.; Gardali, Thomas] PRBO Conservat Sci, Petaluma, CA USA		Seavy, NE (corresponding author), PRBO Conservat Sci, Petaluma, CA USA.	nseavy@prbo.org			March Foundation; Point Reyes National Seashore; Golden Gate National Recreation Area; National Science Foundation [DBI-0533918]; Kimball Foundation; Karen A. & Kevin W. Kennedy Foundation; Schulz Donor Advised Fund	March Foundation; Point Reyes National Seashore; Golden Gate National Recreation Area; National Science Foundation(National Science Foundation (NSF)); Kimball Foundation; Karen A. & Kevin W. Kennedy Foundation; Schulz Donor Advised Fund	Funding for the deployment and recovery of geolocators was provided by the March Foundation and Don and Louise Johnston. Financial and logistical support for the Palomarin Field Station has been provided by the Point Reyes National Seashore, the Golden Gate National Recreation Area, the National Science Foundation (DBI-0533918), the Kimball Foundation, the Karen A. & Kevin W. Kennedy Foundation, Mrs. Marilyn M. Strand, the Schulz Donor Advised Fund, and the board members and directors of PRBO Conservation Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	arra P. P., 2006, CONNECTIVITY CONSERV, P157, DOI [10.1017/CBO9780511754821.008, DOI 10.1017/CBO9780511754821.008]; Bachler E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009566; Bishop Mary Anne, 2006, P545; Bowlin MS, 2010, METHODS ECOL EVOL, V1, P398, DOI 10.1111/j.2041-210X.2010.00043.x; Clegg SM, 2003, MOL ECOL, V12, P819, DOI 10.1046/j.1365-294X.2003.01757.x; Cox G.W., 2010, BIRD MIGRATION GLOBA; CRISSEY WALTER F., 1955, JOUR WILDLIFE MANAGEMENT, V19, P75, DOI 10.2307/3797556; DIEFENBACH DR, 1988, J WILDLIFE MANAGE, V52, P704, DOI 10.2307/3800934; Ekstrom Philip A., 2004, Memoirs of National Institute of Polar Research Special Issue, V58, P210; Farmer A, 2008, OECOLOGIA, V158, P183, DOI 10.1007/s00442-008-1143-6; Fudickar AM, 2012, METHODS ECOL EVOL, V3, P47, DOI 10.1111/j.2041-210X.2011.00136.x; Gill JA, 2001, NATURE, V412, P436, DOI 10.1038/35086568; Gill RE, 2009, P ROY SOC B-BIOL SCI, V276, P447, DOI 10.1098/rspb.2008.1142; Harrison XA, 2011, J ANIM ECOL, V80, P4, DOI 10.1111/j.1365-2656.2010.01740.x; Heckscher CM, 2011, AUK, V128, P531, DOI 10.1525/auk.2011.10280; Hitchcock CL, 1997, ECOLOGY, V78, P522; Hutto RL, 2000, STUD AVIAN BIOL-SER, P109; Lopes RJ, 2006, J ORNITHOL, V147, P385, DOI 10.1007/s10336-005-0048-y; Marra PP, 1998, SCIENCE, V282, P1884, DOI 10.1126/science.282.5395.1884; Norment C. J., 1998, BIRDS N AM; Norris DR, 2005, OIKOS, V109, P178, DOI 10.1111/j.0030-1299.2005.13671.x; North American Banding Council, 2001, N AM BAND STUD GUID; R Development Core Team, 2005, R LANG ENV STAT COMP; RAPPOLE JH, 1991, J FIELD ORNITHOL, V62, P335; Ruegg KC, 2002, P ROY SOC B-BIOL SCI, V269, P1375, DOI 10.1098/rspb.2002.2032; Ryder TB, 2011, AUK, V128, P448, DOI 10.1525/auk.2011.11091; Sillett TS, 2000, SCIENCE, V288, P2040, DOI 10.1126/science.288.5473.2040; Stutchbury BJM, 2009, SCIENCE, V323, P896, DOI 10.1126/science.1166664; Sumner M, 2010, TRIPESTIMATION METRO; Sumner MD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007324; Thiebot Jean-Baptiste, 2010, Endangered Species Research, V10, P341; Tottrup AP, 2012, P ROY SOC B-BIOL SCI, V279, P1008, DOI 10.1098/rspb.2011.1323; Warnock N, 2004, CAN J ZOOL, V82, P1687, DOI 10.1139/Z04-154; Webster MS, 2002, TRENDS ECOL EVOL, V17, P76, DOI 10.1016/S0169-5347(01)02380-1	34	28	31	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2012	7	4							e34886	10.1371/journal.pone.0034886	http://dx.doi.org/10.1371/journal.pone.0034886			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959FE	22506055	Green Published, gold			2022-12-27	WOS:000305297500063
J	Chowdhary, R; Tan, SL; Zhang, JF; Karnik, S; Bajic, VB; Liu, JS				Chowdhary, Rajesh; Tan, Sin Lam; Zhang, Jinfeng; Karnik, Shreyas; Bajic, Vladimir B.; Liu, Jun S.			Context-Specific Protein Network Miner - An Online System for Exploring Context-Specific Protein Interaction Networks from the Literature	PLOS ONE			English	Article							FILAGGRIN MUTATIONS; HAY-FEVER; GENE; KNOWLEDGE; ASTHMA; IDENTIFICATION; ONTOLOGY; DATABASE; LIBRARY; ECZEMA	Background: Protein interaction networks (PINs) specific within a particular context contain crucial information regarding many cellular biological processes. For example, PINs may include information on the type and directionality of interaction (e.g. phosphorylation), location of interaction (i.e. tissues, cells), and related diseases. Currently, very few tools are capable of deriving context-specific PINs for conducting exploratory analysis. Results: We developed a literature-base d online system, Context-specific Protein Network Miner (CPNM), which derives context-specific PINs in real-time from the PubMed database based on a set of user-input keywords and enhanced PubMed query system. CPNM reports enriched information on protein interactions (with type and directionality), their network topology with summary statistics (e.g. most densely connected proteins in the network; most densely connected protein-pairs; and proteins connected by most inbound/outbound links) that can be explored via a user-friendly interface. Some of the novel features of the CPNM system include PIN generation, ontology-based PubMed query enhancement, real-time, user-queried, up-to-date PubMed document processing, and prediction of PIN directionality. Conclusions: CPNM provides a tool for biologists to explore PINs. It is freely accessible at http://www.biotextminer.com/CPNM/.	[Chowdhary, Rajesh; Tan, Sin Lam; Karnik, Shreyas] Marshfield Clin Res Fdn, Biomed Informat Res Ctr, Marshfield Clin, Marshfield Ctr, Marshfield, WI USA; [Zhang, Jinfeng] Florida State Univ, Dept Stat, Tallahassee, FL 32306 USA; [Bajic, Vladimir B.] KAUST, Computat Biosci Res Ctr, Thuwal, Saudi Arabia; [Liu, Jun S.] Harvard Univ, Dept Stat, Cambridge, MA 02138 USA	Marshfield Clinic; State University System of Florida; Florida State University; King Abdullah University of Science & Technology; Harvard University	Chowdhary, R (corresponding author), Marshfield Clin Res Fdn, Biomed Informat Res Ctr, Marshfield Clin, Marshfield Ctr, Marshfield, WI USA.	chowdhary.rajesh@mcrf.mfldclin.edu	Bajic, Vladimir/D-2810-2009	Bajic, Vladimir/0000-0001-5435-4750				Agarwal S, 2010, BIOCREATIVE, V46-51; Apweiler R, 2004, NUCLEIC ACIDS RES, V32, pD115, DOI 10.1093/nar/gkh131; Aranda B, 2010, NUCLEIC ACIDS RES, V38, pD525, DOI 10.1093/nar/gkp878; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barbosa-Silva A, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-70; Beuming T, 2005, BIOINFORMATICS, V21, P827, DOI 10.1093/bioinformatics/bti098; Bjorne J, 2010, BIOINFORMATICS, V26, pi382, DOI 10.1093/bioinformatics/btq180; Bui QC, 2011, BIOINFORMATICS, V27, P259, DOI 10.1093/bioinformatics/btq620; Bunescu R, 2005, ARTIF INTELL MED, V33, P139, DOI 10.1016/j.artmed.2004.07.016; Ceol A, 2010, NUCLEIC ACIDS RES, V38, pD532, DOI 10.1093/nar/gkp983; Chowdhary R, 2011, INT J DATA IN PRESS; Chowdhary R, 2009, BIOINFORMATICS, V25, P1536, DOI 10.1093/bioinformatics/btp245; Croft D, 2011, NUCLEIC ACIDS RES, V39, pD691, DOI 10.1093/nar/gkq1018; Dogan RI, 2010, P BIOCR 3 WORKSH BET, P61; Du P, 2009, BIOINFORMATICS, V25, pI63, DOI 10.1093/bioinformatics/btp193; Fontaine JF, 2010, P BIOCR 3 WORKSH BET, P67; Gerner M., 2010, P WORKSH BIOM NAT LA, P72; Gremse M, 2011, NUCLEIC ACIDS RES, V39, pD507, DOI 10.1093/nar/gkq968; Hakenberg J, 2008, BIOINFORMATICS, V24, pI126, DOI 10.1093/bioinformatics/btn299; Hakenberg J, 2011, BIOINFORMATICS, V27, P2769, DOI 10.1093/bioinformatics/btr455; Hanisch D, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-S1-S14; Heguy A, 2006, J MOL MED, V84, P318, DOI 10.1007/s00109-005-0008-2; Hirschman L, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-S1-S11; Hoffmann R, 2004, NAT GENET, V36, P664, DOI 10.1038/ng0704-664; Huang ML, 2011, BIOINFORMATICS, V27, P1032, DOI 10.1093/bioinformatics/btr042; Hunter L, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-78; Iossifov I, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000559; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kim S, 2010, P BIOCR 3 13 15 SEPT, P83; Kim S, 2008, NUCLEIC ACIDS RES, V36, pW411, DOI 10.1093/nar/gkn281; Krallinger M, 2011, BMC BIOINFO IN PRESS; Kuhn M, 2008, NUCLEIC ACIDS RES, V36, pD684, DOI 10.1093/nar/gkm795; Leaman R, 2010, P BIOCR 3 WORKSH BET, P99; Leaman Robert, 2008, Pac Symp Biocomput, P652; Liu HF, 2006, BIOINFORMATICS, V22, P103, DOI 10.1093/bioinformatics/bti749; Lopes CT, 2010, BIOINFORMATICS, V26, P2347, DOI 10.1093/bioinformatics/btq430; Lourenco A, 2010, P BIOCR 3 WORKSH BET, P113; Maglott D, 2007, NUCLEIC ACIDS RES, V35, pD26, DOI 10.1093/nar/gkl993; Matos S, 2010, P BIOCR 3 WORKSH BET, P119; Mika S, 2004, NUCLEIC ACIDS RES, V32, pW634, DOI 10.1093/nar/gkh427; Morgan AA, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-S2-S3; Natale DA, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S9-S1; Neves ML, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-157; Okazaki N, 2010, P BIOCREATIVE, P125; Pagel P, 2005, BIOINFORMATICS, V21, P832, DOI 10.1093/bioinformatics/bti115; Palmer CNA, 2007, J ALLERGY CLIN IMMUN, V120, P64, DOI 10.1016/j.jaci.2007.04.001; Poninska J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016933; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Rebholz-Schuhmann D, 2008, BIOINFORMATICS, V24, P296, DOI 10.1093/bioinformatics/btm557; Rogers AJ, 2007, J ALLERGY CLIN IMMUN, V120, P1332, DOI 10.1016/j.jaci.2007.09.037; Rzhetsky A, 2008, CELL, V134, P9, DOI 10.1016/j.cell.2008.06.029; Saetre R., 2008, P 2 INT S LANG BIOL; Saetre R, 2010, IEEE ACM T COMPUT BI, V7, P442, DOI 10.1109/TCBB.2010.46; Sayers EW, 2010, NUCLEIC ACIDS RES, V38, P5, DOI DOI 10.1093/NAR/GKP967; Schaefer CF, 2009, NUCLEIC ACIDS RES, V37, pD674, DOI 10.1093/nar/gkn653; Schuttelaar MLA, 2009, ALLERGY, V64, P1758, DOI 10.1111/j.1398-9995.2009.02080.x; Smith B, 2007, NAT BIOTECHNOL, V25, P1251, DOI 10.1038/nbt1346; Smith L, 2008, GENOME BIOL, V9, DOI [10.1186/gb-2008-9-s2-s2, 10.1186/gb-2008-9-S2-S2]; Solt I, 2010, BIOCREATIVE 3 WORKSH, P143; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Tikk D, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000837; Tsuruoka Y, 2005, ADV INFORM; Wei CH, 2009, 2009 9 IEEE INT C BI, P461; Weidinger S, 2008, J ALLERGY CLIN IMMUN, V121, P1203, DOI 10.1016/j.jaci.2008.02.014; Wermter J, 2009, BIOINFORMATICS, V25, P815, DOI 10.1093/bioinformatics/btp071; Wong LS, 2010, J COMPUT SCI TECH-CH, V25, P124, DOI 10.1007/s11390-010-9310-8; Wren JD, 2004, BIOINFORMATICS, V20, P389, DOI 10.1093/bioinformatics/btg421; Xu H, 2007, BIOINFORMATICS, V23, P1015, DOI 10.1093/bioinformatics/btm056; Yu N, 2012, NUCLEIC ACIDS RES, V40, pD797, DOI 10.1093/nar/gkr1127; Zhou S, 2011, P NATL ACAD SCI USA, V108, P2100, DOI 10.1073/pnas.1014792108	71	20	20	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2012	7	4							e34480	10.1371/journal.pone.0034480	http://dx.doi.org/10.1371/journal.pone.0034480			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JA	22493694	Green Published, Green Submitted, gold			2022-12-27	WOS:000305012700036
J	Knights, AM; Firth, LB; Walters, K				Knights, Antony M.; Firth, Louise B.; Walters, Keith			Interactions between Multiple Recruitment Drivers: Post-Settlement Predation Mortality and Flow-Mediated Recruitment	PLOS ONE			English	Article							LARVAL DISPERSAL; MARINE ECOLOGY; LIMITATION; CONSEQUENCES; COMPETITION; COMPLEXITY; STRESSORS; ABUNDANCE; SELECTION; BEHAVIOR	Background: Dispersal is a primary driver in shaping the future distribution of species in both terrestrial and marine systems. Physical transport by advection can regulate the distance travelled and rate of propagule supply to a habitat but post-settlement processes such as predation can decouple supply from recruitment. The effect of flow-mediated recruitment and predation on the recruitment success of an intertidal species, the eastern oyster Crassostrea virginica was evaluated in two-replicated field experiments. Two key crab species were manipulated to test predator identity effects on oyster mortality. Findings: Recruitment was similar to 58% higher in high flow compared to low flow, but predation masked those differences. Predation mortality was primarily attributed to the blue crab Callinectes sapidus, whilst the mud crab Panopeus herbstii had no effect on recruit mortality. Recruit mortality from predation was high when recruit densities were high, but when recruit density was low, predation effects were not seen. Under high recruitment (supply), predation determined maximum population size and in low flow environments, recruitment success is likely determined by a combination of recruitment and resource limitation but not predation. Conclusions: Four processes are demonstrated: (1) Increases in flow rate positively affect recruitment success; (2) In high flow (recruitment) environments, resource availability is less important than predation; (3) predation is an important source of recruit mortality, but is dependent upon recruit density; and (4) recruitment and/or resource limitation is likely a major driver of population structure and functioning, modifying the interaction between predators and prey. Simultaneous testing of flow-mediated recruitment and predation was required to differentiate between the role of each process in determining population size. Our results reinforce the importance of propagule pressure, predation and post-settlement mortality as important determinants of population growth and persistence, but demonstrate that they should not be considered mutually exclusive.	[Knights, Antony M.; Firth, Louise B.; Walters, Keith] Coastal Carolina Univ, Dept Marine Sci, Conway, SC USA; [Knights, Antony M.] Univ Liverpool, Sch Environm Sci, Liverpool L69 3BX, Merseyside, England; [Firth, Louise B.] Natl Univ Ireland Galway, Ryan Inst, Dept Zool, Galway, Ireland	Coastal Carolina University; University of Liverpool; Ollscoil na Gaillimhe-University of Galway	Knights, AM (corresponding author), Coastal Carolina Univ, Dept Marine Sci, Conway, SC USA.	a.knights@liv.ac.uk	Walters, Keith/AAE-4802-2020	Walters, Keith/0000-0001-8709-9768; Knights, Antony/0000-0002-0916-3469	National Fish and Wildlife Foundation	National Fish and Wildlife Foundation	This study was funded by a grant from the National Fish and Wildlife Foundation through the Savannah-Pee Dee Resource Protection Fund to K. Walters and L. D. Coen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertness MD, 2002, ECOLOGY, V83, P3434, DOI 10.1890/0012-9658(2002)083[3434:DASCSE]2.0.CO;2; Blackburn TM, 2011, BIODIVERS CONSERV, V20, P2189, DOI 10.1007/s10531-011-0081-5; Boesch D, 2001, SCIENCE, V293, P1589; Bricker M, 2010, ECOLOGY, V91, P85, DOI 10.1890/08-1773.1; Burgess SC, 2011, J ANIM ECOL, V80, P681, DOI 10.1111/j.1365-2656.2010.01802.x; Caley MJ, 1996, ANNU REV ECOL SYST, V27, P477, DOI 10.1146/annurev.ecolsys.27.1.477; CONNELL JH, 1961, ECOL MONOGR, V31, P61, DOI 10.2307/1950746; CONNELL JH, 1961, ECOLOGY, V42, P710, DOI 10.2307/1933500; Cowen RK, 2006, SCIENCE, V311, P522, DOI 10.1126/science.1122039; Cowen RK, 2009, ANNU REV MAR SCI, V1, P443, DOI 10.1146/annurev.marine.010908.163757; Darling ES, 2008, ECOL LETT, V11, P1278, DOI 10.1111/j.1461-0248.2008.01243.x; Denny M. W., 1988, BIOL MECH WAVE SWEPT; DOHERTY P, 1994, SCIENCE, V263, P935, DOI 10.1126/science.263.5149.935; Ferner MC, 2009, MAR ECOL PROG SER, V374, P13, DOI 10.3354/meps07764; Finelli CM, 2000, ECOLOGY, V81, P784, DOI 10.1890/0012-9658(2000)081[0784:PCOEPA]2.0.CO;2; Firth LB, 2009, J EXP MAR BIOL ECOL, V375, P70, DOI 10.1016/j.jembe.2009.05.011; FRECHETTE M, 1989, LIMNOL OCEANOGR, V34, P19, DOI 10.4319/lo.1989.34.1.0019; Gaines SD, 2007, OCEANOGRAPHY, V20, P90, DOI 10.5670/oceanog.2007.32; GOTELLI NJ, 1991, AM NAT, V138, P768, DOI 10.1086/285249; Grabowski JH, 2005, ECOLOGY, V86, P1926, DOI 10.1890/04-0690; HOLLING C. S., 1959, CANADIAN ENT, V91, P293; HOLLING C. S., 1966, Memoirs of the Entomology Society of Canada; Holling C. S., 1965, Mem ent Soc Canada Ottawa, Vno. 45, P1; HUGHES RN, 1981, MAR ECOL PROG SER, V6, P83, DOI 10.3354/meps006083; Jackson JL, 2007, LIMNOL OCEANOGR, V52, P1883, DOI 10.4319/lo.2007.52.5.1883; Jenkins SR, 2005, J ANIM ECOL, V74, P893, DOI 10.1111/j.1365-2656.2005.00985.x; Knights AM, 2010, MAR ECOL PROG SER, V404, P79, DOI 10.3354/meps08480; Kritzer JP, 2004, FISH FISH, V5, P131, DOI 10.1111/j.1467-2979.2004.00131.x; Leonard GH, 1998, ECOLOGY, V79, P1395; Liu H, 2002, DATA MIN KNOWL DISC, V6, P393, DOI 10.1023/A:1016304305535; Lopez-Urrutia A, 2007, ECOLOGY, V88, P817, DOI 10.1890/06-1641; Miller LP, 2007, J EXP MAR BIOL ECOL, V344, P215, DOI 10.1016/j.jembe.2007.01.005; MORGAN S, 1995, ECOLOGY MARINE INVER; Morin X, 2009, ECOLOGY, V90, P1301, DOI 10.1890/08-0134.1; Nathan R, 2011, THEOR ECOL-NETH, V4, P113, DOI 10.1007/s12080-011-0115-3; O'Connor MI, 2007, P NATL ACAD SCI USA, V104, P1266, DOI 10.1073/pnas.0603422104; O'Connor NE, 2008, ECOLOGY, V89, P428, DOI 10.1890/06-2029.1; Oberle B, 2011, P NATL ACAD SCI USA, V108, P5655, DOI 10.1073/pnas.1012302108; OLAFSSON EB, 1994, OCEANOGR MAR BIOL, V32, P65; PAINE RT, 1966, AM NAT, V100, P65, DOI 10.1086/282400; PAWLIK JR, 1992, OCEANOGR MAR BIOL, V30, P273; Pernet F, 2003, MAR ECOL PROG SER, V260, P125, DOI 10.3354/meps260125; PIANKA ER, 1974, P NATL ACAD SCI USA, V71, P2141, DOI 10.1073/pnas.71.5.2141; Pineda J, 2007, OCEANOGRAPHY, V20, P22, DOI 10.5670/oceanog.2007.27; Porter ET, 2000, LIMNOL OCEANOGR, V45, P145, DOI 10.4319/lo.2000.45.1.0145; R Core Team, 2018, R LANG ENV STAT COMP; Regan HM, 2001, AM NAT, V157, P1, DOI 10.1086/317005; Roughgarden J., 1987, P491; Schmitz OJ, 2000, AM NAT, V155, P141, DOI 10.1086/303311; Shurin JB, 2002, ECOL LETT, V5, P785, DOI 10.1046/j.1461-0248.2002.00381.x; Silliman BR, 2004, ESTUARIES, V27, P188, DOI 10.1007/BF02803375; Smee DL, 2010, ECOLOGY, V91, P1391, DOI 10.1890/09-0017.1; Sokal RR, 1995, BIOMETRY; THOMPSON TL, 1994, LIMNOL OCEANOGR, V39, P1768, DOI 10.4319/lo.1994.39.7.1768; Tilman D, 1997, ECOLOGY, V78, P81, DOI 10.1890/0012-9658(1997)078[0081:CIRLAG]2.0.CO;2; Underwood A.J., 1998, GEN MODEL ANAL VARIA; Underwood A.J., 1997, EXPT ECOLOGY THEIR L, DOI DOI 10.1017/CBO9780511806407; UNDERWOOD AJ, 1989, TRENDS ECOL EVOL, V4, P16, DOI 10.1016/0169-5347(89)90008-6; Vitousek PM, 2010, ECOL APPL, V20, P5, DOI 10.1890/08-0127.1; WEISSBURG MJ, 1993, ECOLOGY, V74, P1428, DOI 10.2307/1940072; White JW, 2010, MAR ECOL PROG SER, V398, P49, DOI 10.3354/meps08327	61	32	32	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2012	7	4							e35096	10.1371/journal.pone.0035096	http://dx.doi.org/10.1371/journal.pone.0035096			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JA	22493734	Green Published, gold, Green Submitted			2022-12-27	WOS:000305012700076
J	Paulsen, A; Overgaard, S; Lauritsen, JM				Paulsen, Aksel; Overgaard, Soren; Lauritsen, Jens Martin			Quality of Data Entry Using Single Entry, Double Entry and Automated Forms Processing-An Example Based on a Study of Patient-Reported Outcomes	PLOS ONE			English	Article							TOTAL HIP-REPLACEMENT; TEXT; TELEFORM(TM); VALIDITY; ERRORS; SCALE	Background: The clinical and scientific usage of patient-reported outcome measures is increasing in the health services. Often paper forms are used. Manual double entry of data is defined as the definitive gold standard for transferring data to an electronic format, but the process is laborious. Automated forms processing may be an alternative, but further validation is warranted. Methods: 200 patients were randomly selected from a cohort of 5777 patients who had previously answered two different questionnaires. The questionnaires were scanned using an automated forms processing technique, as well as processed by single and double manual data entry, using the EpiData Entry data entry program. The main outcome measure was the proportion of correctly entered numbers at question, form and study level. Results: Manual double-key data entry (error proportion per 1000 fields = 0.046 (95% CI: 0.001-0.258)) performed better than single-key data entry (error proportion per 1000 fields = 0.370 (95% CI: 0.160-0.729), (p = 0.020)). There was no statistical difference between Optical Mark Recognition (error proportion per 1000 fields = 0.046 (95% CI: 0.001-0.258)) and double-key data entry (p = 1.000). With the Intelligent Character Recognition method, there was no statistical difference compared to single-key data entry (error proportion per 1000 fields = 6.734 (95% CI: 0.817-24.113), (p = 0.656)), as well as double-key data entry (error proportion per 1000 fields = 3.367 (95% CI: 0.085-18.616)), (p = 0.319)). Conclusions: Automated forms processing is a valid alternative to double manual data entry for highly structured forms containing only check boxes, numerical codes and no dates. Automated forms processing can be superior to single manual data entry through a data entry program, depending on the method chosen.	[Paulsen, Aksel; Overgaard, Soren; Lauritsen, Jens Martin] Odense Univ Hosp, Dept Orthopaed Surg & Traumatol, DK-5000 Odense, Funen, Denmark; [Paulsen, Aksel; Overgaard, Soren] Univ So Denmark, Inst Clin Res, Odense, Funen, Denmark; [Lauritsen, Jens Martin] Univ So Denmark, Inst Publ Hlth, Dept Biostat, Odense, Funen, Denmark	University of Southern Denmark; Odense University Hospital; University of Southern Denmark; University of Southern Denmark	Paulsen, A (corresponding author), Odense Univ Hosp, Dept Orthopaed Surg & Traumatol, DK-5000 Odense, Funen, Denmark.	Aksel.Paulsen@ouh.regionsyddanmark.dk	Overgaard, Søren/AAX-9407-2020; Paulsen, Aksel/E-7544-2013	Paulsen, Aksel/0000-0003-1292-4983; Lauritsen, Jens/0000-0001-9281-8990; Overgaard, Soren/0000-0001-6829-4787	Region of Southern Denmark [095382]; Danish Rheumatism Association [R63-A830-B373, R71-A1043, R69-A1427, R80-A1282-B373]; Odense University Hospital [2-41-4-00065-2010]	Region of Southern Denmark; Danish Rheumatism Association; Odense University Hospital	This study was supported by Region of Southern Denmark [095382] (http://www.regionsyddanmark.dk/wm228983), The Danish Rheumatism Association [R63-A830-B373, R71-A1043, R69-A1427, R80-A1282-B373] (http://www.gigtforeningen.dk), and Odense University Hospital [2-41-4-00065-2010](http://www.ouh.dk/wm259883). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abele L., 1981, P 2 SCAND C IM AN, P177; ASCHER RN, 1971, IEEE T COMPUT, VC 20, P1527, DOI 10.1109/T-C.1971.223166; Biondich PG, 2002, AMIA 2002 SYMPOSIUM, PROCEEDINGS, P56; Brooks R, 1996, HEALTH POLICY, V37, P53, DOI 10.1016/0168-8510(96)00822-6; Casey R., 1992, Machine Vision and Applications, V5, P143, DOI 10.1007/BF02626994; Ciardiello G., 1988, P 9 INT C PATT REC, P739; Dawson J, 1996, J BONE JOINT SURG BR, V78B, P185, DOI 10.1302/0301-620X.78B2.0780185; Esposito F., 1990, Proceedings. 10th International Conference on Pattern Recognition (Cat. No.90CH2898-5), P557, DOI 10.1109/ICPR.1990.118164; Goldberg Saveli I, 2008, AMIA Annu Symp Proc, P242; Hardin JM, 2005, PUBLIC HEALTH NURS, V22, P366, DOI 10.1111/j.0737-1209.2005.220410.x; Jinks C, 2003, COMPUT BIOL MED, V33, P425, DOI 10.1016/S0010-4825(03)00012-X; Jorgensen CK, 1998, COMPUT BIOL MED, V28, P659, DOI 10.1016/S0010-4825(98)00038-9; Kobak KA, 2000, DRUG INF J, V34, P145, DOI 10.1177/009286150003400120; Kubick WR, 1998, DRUG INF J, P861; Lampe AJ, 1998, DRUG INF J, V32, P871, DOI 10.1177/009286159803200403; Lawlor DA, 2010, INT J EPIDEMIOL, V39, P1133, DOI 10.1093/ije/dyq178; Masuda I., 1985, Proceedings CVPR '85: IEEE Computer Society Conference on Computer Vision and Pattern Recognition (Cat. No. 85CH2145-1), P550; NAGY G, 1968, COMMUN ACM, V11, P480, DOI 10.1145/363397.363417; Nagy G, 1990, P SSPR, V90, P293; Nahm ML, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003049; Nakano Y., 1986, Eighth International Conference on Pattern Recognition. Proceedings (Cat. No.86CH2342-4), P801; Nilsdotter AK, 2003, BMC MUSCULOSKEL DIS, V4, DOI 10.1186/1471-2474-4-10; OBOYLE CA, 1992, BRIT J SURG, V79, P395, DOI 10.1002/bjs.1800790506; Ohmann C, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-85; Paulsen A, 2012, ACTA ORTHOP IN PRESS; Protti Denis, 2006, Inform Prim Care, V14, P93; Rieder HL, 2011, INT J TUBERC LUNG D, V15, P296; Rolfson O, 2010, PATIENT REPORTED OUT; Toyoda J., 1982, Proceedings of the 6th International Conference on Pattern Recognition, P1113; Tsujimoto S., 1990, Proceedings. 10th International Conference on Pattern Recognition (Cat. No.90CH2898-5), P551, DOI 10.1109/ICPR.1990.118163; Wahi MM, 2008, J AM MED INFORM ASSN, V15, P386, DOI 10.1197/jamia.M2381; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; Weir CR, 2003, METHOD INFORM MED, V42, P61; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; WONG KY, 1982, IBM J RES DEV, V26, P647, DOI 10.1147/rd.266.0647	35	69	69	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2012	7	4							e35087	10.1371/journal.pone.0035087	http://dx.doi.org/10.1371/journal.pone.0035087			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	955JA	22493733	Green Published, Green Submitted, gold			2022-12-27	WOS:000305012700075
J	Tendulkar, SA; Koenen, KC; Dunn, EC; Buka, S; Subramanian, SV				Tendulkar, Shalini A.; Koenen, Karestan C.; Dunn, Erin C.; Buka, Stephen; Subramanian, S. V.			Neighborhood Influences on Perceived Social Support Among Parents: Findings from the Project on Human Development in Chicago Neighborhoods	PLOS ONE			English	Article							POVERTY AREA RESIDENCE; COLLECTIVE EFFICACY; CHILD; HEALTH; MULTILEVEL; DYNAMICS; VIOLENCE; MOTHERS; LEVEL; RISK	Background: Social support is frequently linked to positive parenting behavior. Similarly, studies increasingly show a link between neighborhood residential environment and positive parenting behavior. However, less is known about how the residential environment influences parental social support. To address this gap, we examine the relationship between neighborhood concentrated disadvantage and collective efficacy and the level and change in parental caregiver perceptions of non-familial social support. Methodology/Principal Findings: The data for this study came from three data sources, the Project on Human Development in Chicago Neighborhoods (PHDCN) Study's Longitudinal Cohort Survey of caregivers and their offspring, a Community Survey of adult residents in these same neighborhoods and the 1990 Census. Social support is measured at Wave 1 and Wave 3 and neighborhood characteristics are measured at Wave 1. Multilevel linear regression models are fit. The results show that neighborhood collective efficacy is a significant (beta = .04; SE = .02; p = .03), predictor of the positive change in perceived social support over a 7 year period, however, not of the level of social support, adjusting for key compositional variables and neighborhood concentrated disadvantage. In contrast concentrated neighborhood disadvantage is not a significant predictor of either the level or change in social support. Conclusion: Our finding suggests that neighborhood collective efficacy may be important for inducing the perception of support from friends in parental caregivers over time.	[Tendulkar, Shalini A.] Harvard Univ, Sch Med, Cambridge Hlth Alliance, Inst Community Hlth, Cambridge, MA 02138 USA; [Koenen, Karestan C.] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA; [Dunn, Erin C.; Subramanian, S. V.] Harvard Univ, Sch Publ Hlth, Dept Soc Human Dev & Hlth, Boston, MA 02115 USA; [Buka, Stephen] Brown Univ, Dept Community Hlth, Providence, RI 02912 USA	Harvard University; Cambridge Health Alliance; Columbia University; Harvard University; Harvard T.H. Chan School of Public Health; Brown University	Tendulkar, SA (corresponding author), Harvard Univ, Sch Med, Cambridge Hlth Alliance, Inst Community Hlth, Cambridge, MA 02138 USA.	stendulkar@challiance.org	Dunn, Erin C./AFM-9511-2022; Buka, Stephen/H-7335-2014; Koenen, Karestan/K-5402-2014	Dunn, Erin C./0000-0003-1413-3229; Buka, Stephen/0000-0002-8578-9308; Koenen, Karestan/0000-0003-3293-4281				ANDRESEN PA, 1992, AM J COMMUN PSYCHOL, V20, P753, DOI 10.1007/BF00942236; BELSKY J, 1984, CHILD DEV, V55, P83, DOI 10.2307/1129836; Berkman LF, 2000, SOC WORK HEALTH CARE, V31, P3, DOI 10.1300/J010v31n02_02; Brown GW, 1997, PSYCHOL MED, V27, P21, DOI 10.1017/S0033291796004060; Browning CR, 2002, J HEALTH SOC BEHAV, V43, P383, DOI 10.2307/3090233; Browning CR, 2002, J MARRIAGE FAM, V64, P833, DOI 10.1111/j.1741-3737.2002.00833.x; BRUHN JG, 1984, J BEHAV MED, V7, P151, DOI 10.1007/BF00845384; Ceballo R, 2002, CHILD DEV, V73, P1310, DOI 10.1111/1467-8624.00473; Cornwell B, 2003, SOC FORCES, V81, P953, DOI 10.1353/sof.2003.0029; Corse S, 1990, J COMMUNITY PSYCHOL, P18; Coulton CJ, 1999, CHILD ABUSE NEGLECT, V23, P1019, DOI 10.1016/S0145-2134(99)00076-9; Cunradi CB, 2000, ANN EPIDEMIOL, V10, P297, DOI 10.1016/S1047-2797(00)00052-1; DUBOWITZ H, 1987, AM J ORTHOPSYCHIAT, V57, P525, DOI 10.1111/j.1939-0025.1987.tb03568.x; DURKIN MS, 1994, AM J PUBLIC HEALTH, V84, P587, DOI 10.2105/AJPH.84.4.587; Earls F. J., 1997, ICPSR02766V3 HARV ME; GARBARINO J, 1980, CHILD DEV, V51, P188, DOI 10.2307/1129606; GARBARINO J, 1977, CHILD WELFARE, V56, P565; Garbarino J., 2005, PARENTING ECOLOGICAL, P297; Glymour MM, 2005, AM J EPIDEMIOL, V162, P267, DOI 10.1093/aje/kwi187; HAAN M, 1987, AM J EPIDEMIOL, V125, P989, DOI 10.1093/oxfordjournals.aje.a114637; Haber MG, 2007, AM J COMMUN PSYCHOL, V39, P133, DOI 10.1007/s10464-007-9100-9; KLEBANOV PK, 1994, J MARRIAGE FAM, V56, P441, DOI 10.2307/353111; Leventhal T, 2004, PARENT-SCI PRACT, V4, P211, DOI 10.1207/s15327922par0402&3_6; Maimon D, 2010, J HEALTH SOC BEHAV, V51, P307, DOI 10.1177/0022146510377878; Martin K, PROJECT HUMAN DEV CH; MARVELL TB, 1991, J QUANTITATIVE CRIMI, V0007; Molnar Beth E, 2003, Child Maltreat, V8, P84, DOI 10.1177/1077559502250822; Sampson RJ, 1999, AM SOCIOL REV, V64, P633, DOI 10.2307/2657367; Sampson RJ, 1997, SCIENCE, V277, P918, DOI 10.1126/science.277.5328.918; Simons RL, 2005, CRIMINOLOGY, V43, P989, DOI 10.1111/j.1745-9125.2005.00031.x; Singer J.D., 2003, APPL LONGITUDINAL DA, DOI 10.1093/acprof:oso/9780195152968.001.0001; Tendulkar SA, 2010, J COMMUNITY PSYCHOL, V38, P557, DOI 10.1002/jcop.20381; Turner RJ., 1983, RES COMMUNITY MENTAL, V3, P67; Uchino BN, 1996, PSYCHOL BULL, V119, P488, DOI 10.1037/0033-2909.119.3.488; United States Census, 1990, US CENS DAT DAT C90S; WEINRAUB M, 1983, CHILD DEV, V54, P1297, DOI 10.1111/j.1467-8624.1983.tb00548.x; Yen IH, 1999, INT J EPIDEMIOL, V28, P90, DOI 10.1093/ije/28.1.90; Yen IH, 1998, AM J PUBLIC HEALTH, V88, P1709, DOI 10.2105/AJPH.88.11.1709; Zolotor AJ, 2006, PEDIATRICS, V117, pE1124, DOI 10.1542/peds.2005-1913	39	11	11	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2012	7	4							e34235	10.1371/journal.pone.0034235	http://dx.doi.org/10.1371/journal.pone.0034235			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	955JA	22493683	Green Published, gold			2022-12-27	WOS:000305012700025
J	Van den Bergh, R; Morin, S; Sass, HJ; Grzesiek, S; Vekemans, M; Florence, E; Huyen, TTT; Imiru, RG; Heyndrickx, L; Vanham, G; De Baetselier, P; Raes, G				Van den Bergh, Rafael; Morin, Sebastien; Sass, Hans Juergen; Grzesiek, Stephan; Vekemans, Marc; Florence, Eric; Huyen Thanh Thi Tran; Imiru, Rosina Gabriel; Heyndrickx, Leo; Vanham, Guido; De Baetselier, Patrick; Raes, Geert			Monocytes Contribute to Differential Immune Pressure on R5 versus X4 HIV through the Adipocytokine Visfatin/NAMPT	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; T-CELLS; EVOLUTIONARY DYNAMICS; BIOSENSOR TECHNOLOGY; REPLICATIVE FITNESS; CORECEPTOR SWITCH; TYPE-1 INFECTION; IN-VITRO; MACROPHAGES; TRANSMISSION	Background: The immune system exerts a diversifying selection pressure on HIV through cellular, humoral and innate mechanisms. This pressure drives viral evolution throughout infection. A better understanding of the natural immune pressure on the virus during infection is warranted, given the clinical interest in eliciting and sustaining an immune response to HIV which can help to control the infection. We undertook to evaluate the potential of the novel HIV-induced, monocyte-derived factor visfatin to modulate viral infection, as part of the innate immune pressure on viral populations. Results: We show that visfatin is capable of selectively inhibiting infection by R5 HIV strains in macrophages and resting PBMC in vitro, while at the same time remaining indifferent to or even favouring infection by X4 strains. Furthermore, visfatin exerts a direct effect on the relative fitness of R5 versus X4 infections in a viral competition setup. Direct interaction of visfatin with the CCR5 receptor is proposed as a putative mechanism for this differential effect. Possible in vivo relevance of visfatin induction is illustrated by its association with the dominance of CXCR4-using HIV in the plasma. Conclusions: As an innate factor produced by monocytes, visfatin is capable of inhibiting infections by R5 but not X4 strains, reflecting a potential selective pressure against R5 viruses.	[Van den Bergh, Rafael; Huyen Thanh Thi Tran; Imiru, Rosina Gabriel; De Baetselier, Patrick; Raes, Geert] VIB, Dept Mol & Cellular Interact, Brussels, Belgium; [Van den Bergh, Rafael; Huyen Thanh Thi Tran; Imiru, Rosina Gabriel; De Baetselier, Patrick; Raes, Geert] Vrije Univ Brussel, Lab Cellular & Mol Immunol, Brussels, Belgium; [Morin, Sebastien; Sass, Hans Juergen; Grzesiek, Stephan] Univ Basel, Div Struct Biol, Biozentrum, Basel, Switzerland; [Vekemans, Marc; Florence, Eric] Inst Trop Med, Dept Clin Sci, HIV STD Unit, B-2000 Antwerp, Belgium; [Imiru, Rosina Gabriel; Heyndrickx, Leo; Vanham, Guido] Inst Trop Med, Dept Microbiol, HIV Virol Unit, B-2000 Antwerp, Belgium; [Vanham, Guido] Vrije Univ Brussel, Fac Med & Pharm, Brussels, Belgium; [Vanham, Guido] Univ Antwerp, Dept Biomed Sci, Fac Pharmaceut Biomed & Vet Sci, B-2020 Antwerp, Belgium	Flanders Institute for Biotechnology (VIB); Vrije Universiteit Brussel; University of Basel; Institute of Tropical Medicine (ITM); Institute of Tropical Medicine (ITM); Vrije Universiteit Brussel; University of Antwerp	Van den Bergh, R (corresponding author), VIB, Dept Mol & Cellular Interact, Brussels, Belgium.	rvdbergh@vub.ac.be	De Baetselier, Patrick/D-3866-2014; Raes, Geert M/H-5185-2013	Raes, Geert M/0000-0002-9065-1549; Grzesiek, Stephan/0000-0003-1998-4225; Florence, Eric/0000-0002-7004-9120; Van den Bergh, Rafael/0000-0001-6277-8713; Morin, Sebastien/0000-0003-4426-326X	Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen) [IWT SB474]; European Molecular Biology Organization (EMBO)	Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); European Molecular Biology Organization (EMBO)(European Molecular Biology Organization (EMBO))	This work was supported in part by a grant of the Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen) to RVdB (IWT SB474). The European Molecular Biology Organization (EMBO) is acknowledged for a postdoctoral fellowship to SM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aquaro S, 2002, J MED VIROL, V68, P479, DOI 10.1002/jmv.10245; Arien KK, 2006, VIROLOGY, V347, P65, DOI 10.1016/j.virol.2005.11.045; Beirnaert E, 1998, J VIROL METHODS, V73, P65, DOI 10.1016/S0166-0934(98)00044-5; Bewick S, 2011, B MATH BIOL; Carr JM, 1999, VIROLOGY, V265, P319, DOI 10.1006/viro.1999.0047; CROWE S, 1987, AIDS RES HUM RETROV, V3, P135, DOI 10.1089/aid.1987.3.135; Friebe D, 2011, DIABETOLOGIA, V54, P1200, DOI 10.1007/s00125-010-2042-z; Gordon SB, 2002, BRIT MED BULL, V61, P45, DOI 10.1093/bmb/61.1.45; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Hartley O, 2005, AIDS RES HUM RETROV, V21, P171, DOI 10.1089/aid.2005.21.171; Jiang SB, 2004, ANTIMICROB AGENTS CH, V48, P4349, DOI 10.1128/AAC.48.11.4349-4359.2004; Jones G, 2006, NEUROBIOL DIS, V21, P1, DOI 10.1016/j.nbd.2005.07.018; Jones KL, 2010, J BIOL CHEM, V285, P18603, DOI 10.1074/jbc.M109.090126; Kamp C, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-274; Kawashima Y, 2009, NATURE, V458, P641, DOI 10.1038/nature07746; Kedzierska K, 2002, CURR MED CHEM, V9, P1893, DOI 10.2174/0929867023368935; Korner A, 2007, J CLIN ENDOCR METAB, V92, P4783, DOI 10.1210/jc.2007-1304; Lemey P, 2006, AIDS REV, V8, P125; McMichael AJ, 1997, ANNU REV IMMUNOL, V15, P271, DOI 10.1146/annurev.immunol.15.1.271; Moncunill G, 2008, AIDS, V22, P23, DOI 10.1097/QAD.0b013e3282f303e6; Montaner LJ, 2006, J LEUKOCYTE BIOL, V80, P961, DOI 10.1189/jlb.0806488; Moore CB, 2002, SCIENCE, V296, P1439, DOI 10.1126/science.1069660; Moore JP, 2004, AIDS RES HUM RETROV, V20, P111, DOI 10.1089/088922204322749567; Moschen AR, 2010, CURR PHARM DESIGN, V16, P1913, DOI 10.2174/138161210791208947; Navratilova I, 2005, ANAL BIOCHEM, V339, P271, DOI 10.1016/j.ab.2004.12.017; Navratilova I, 2006, ANAL BIOCHEM, V355, P132, DOI 10.1016/j.ab.2006.04.021; Nisius L, 2008, PROTEIN EXPRES PURIF, V61, P155, DOI 10.1016/j.pep.2008.06.001; Oswald-Richter K, 2007, PLOS PATHOG, V3, P553, DOI 10.1371/journal.ppat.0030058; Pillai S, 2003, AIDS RES HUM RETROV, V19, P145, DOI 10.1089/088922203762688658; REED L. J., 1938, AMER JOUR HYG, V27, P493; Regoes RR, 2005, TRENDS MICROBIOL, V13, P269, DOI 10.1016/j.tim.2005.04.005; Richman DD, 2003, P NATL ACAD SCI USA, V100, P4144, DOI 10.1073/pnas.0630530100; Sguanci L, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-S2-S5; SMITH SD, 1984, CANCER RES, V44, P5657; Sonoli SS, 2011, EUR REV MED PHARMACO, V15, P9; Van den Bergh R, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-53; Van Herrewege Y, 2002, AIDS RES HUM RETROV, V18, P1091, DOI 10.1089/088922202320567833; Van Herrewege Y, 2008, J ANTIMICROB CHEMOTH, V61, P818, DOI 10.1093/jac/dkn042; Vyakarnam A, 2001, AIDS, V15, P1613, DOI 10.1097/00002030-200109070-00003; Wahl SM, 1997, J LEUKOCYTE BIOL, V62, P67, DOI 10.1002/jlb.62.1.67; Weber J, 2006, J VIROL METHODS, V136, P102, DOI 10.1016/j.jviromet.2006.04.004; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; WEISS A, 1984, J IMMUNOL, V133, P123; WILEY CA, 1986, P NATL ACAD SCI USA, V83, P7089, DOI 10.1073/pnas.83.18.7089	44	21	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2012	7	4							e35074	10.1371/journal.pone.0035074	http://dx.doi.org/10.1371/journal.pone.0035074			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JA	22493731	Green Submitted, Green Published, gold			2022-12-27	WOS:000305012700073
J	Anton, K; Banerjee, D; Glod, J				Anton, Kevin; Banerjee, Debabrata; Glod, John			Macrophage-Associated Mesenchymal Stem Cells Assume an Activated, Migratory, Pro-Inflammatory Phenotype with Increased IL-6 and CXCL10 Secretion	PLOS ONE			English	Article							MONOCYTE CHEMOTACTIC PROTEIN-1; BONE-MARROW; TUMOR STROMA; DELIVERY VEHICLES; TARGETED-DELIVERY; INFILTRATION; CANCER; KINASE; DIFFERENTIATION; PROLIFERATION	Mesenchymal stem cells (MSCs) exhibit tropism for sites of tissue injury and tumors. However, the influence of the microenvironment on MSC phenotype and localization remains incompletely characterized. In this study, we begin to define a macrophage-induced MSC phenotype. These MSCs secrete interleukin-6 (IL-6), CCL5, and interferon gamma-induced protein-10 (CXCL10) and exhibit increased mobility in response to multiple soluble factors produced by macrophages including IL-8, CCL2, and CCL5. The pro-migratory phenotype is dependent on activation of a c-Jun N-terminal kinase (JNK) pathway. This work begins to identify the influence of macrophages on MSC biology. These interactions are likely to play an important role in the tissue inflammatory response and may provide insight into the migratory potential of MSCs in inflammation and tissue injury.	[Anton, Kevin; Banerjee, Debabrata; Glod, John] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Canc Inst New Jersey, Dept Pharmacol, New Brunswick, NJ USA; [Banerjee, Debabrata] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Med, Canc Inst New Jersey, New Brunswick, NJ 08903 USA; [Glod, John] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pediat, Canc Inst New Jersey, New Brunswick, NJ 08903 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey	Anton, K (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Canc Inst New Jersey, Dept Pharmacol, New Brunswick, NJ USA.	glodjo@umdnj.edu	Anton, Kevin/P-1329-2018; Glod, John/U-9925-2019; Anton, Kevin/M-3147-2019	Anton, Kevin/0000-0003-1278-4626; Anton, Kevin/0000-0003-1278-4626	New Jersey Commission on Cancer Research [09-1959-CCR-E0]	New Jersey Commission on Cancer Research	This work was supported by a grant from the New Jersey Commission on Cancer Research (09-1959-CCR-E0. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson R, 2009, J Wound Care, V18, P349; Angst E, 2008, SURGERY, V144, P57, DOI 10.1016/j.surg.2008.03.024; Anton K, 2009, CURR PHARM BIOTECHNO, V10, P185, DOI 10.2174/138920109787315088; Arenberg DA, 2000, CANCER IMMUNOL IMMUN, V49, P63, DOI 10.1007/s002620050603; Bak XY, 2011, HUM GENE THER, V22, P1365, DOI 10.1089/hum.2010.212; Caplan AI, 2007, J CELL PHYSIOL, V213, P341, DOI 10.1002/jcp.21200; Chiou WF, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1093/ecam/nep140; Delavary BM, 2011, IMMUNOBIOLOGY, V216, P753, DOI 10.1016/j.imbio.2011.01.001; Dwyer RM, 2007, CLIN CANCER RES, V13, P5020, DOI 10.1158/1078-0432.CCR-07-0731; Fong ELS, 2011, BIOMATERIALS, V32, P395, DOI 10.1016/j.biomaterials.2010.08.101; Forte G, 2006, STEM CELLS, V24, P23, DOI 10.1634/stemcells.2004-0176; FREI K, 1992, J IMMUNOL, V148, P3140; FRIEDENSTEIN AJ, 1968, TRANSPLANTATION, V6, P230, DOI 10.1097/00007890-196803000-00009; Fu XB, 2009, WOUND REPAIR REGEN, V17, P185, DOI 10.1111/j.1524-475X.2009.00454.x; Hata N, 2010, NEUROSURGERY, V66, P144, DOI 10.1227/01.NEU.0000363149.58885.2E; Hedges JC, 1999, J BIOL CHEM, V274, P24211, DOI 10.1074/jbc.274.34.24211; Herrera MB, 2007, KIDNEY INT, V72, P430, DOI 10.1038/sj.ki.5002334; Heuertz RM, 1999, J BIOL CHEM, V274, P17968, DOI 10.1074/jbc.274.25.17968; Hsieh HL, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-88; Huang C, 2004, J CELL SCI, V117, P4619, DOI 10.1242/jcs.01481; Kanehira M, 2007, CANCER GENE THER, V14, P894, DOI 10.1038/sj.cgt.7701079; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Kim J, 2009, EXP HEMATOL, V37, P1445, DOI 10.1016/j.exphem.2009.09.004; Klemke RL, 1997, J CELL BIOL, V137, P481, DOI 10.1083/jcb.137.2.481; Leek RD, 1996, CANCER RES, V56, P4625; Loebinger MR, 2009, CANCER RES, V69, P8862, DOI 10.1158/0008-5472.CAN-09-1912; Maggini J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009252; Mendes KN, 2010, INT J ONCOL, V37, P143, DOI 10.3892/ijo_00000662; Menon LG, 2007, STEM CELLS, V25, P520, DOI 10.1634/stemcells.2006-0257; Meriane M, 2006, STEM CELLS, V24, P2557, DOI 10.1634/stemcells.2006-0209; Mishra PJ, 2008, CANCER RES, V68, P4331, DOI 10.1158/0008-5472.CAN-08-0943; Mishra PJ, 2011, METHODS MOL BIOL, V717, P245, DOI 10.1007/978-1-61779-024-9_14; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Nakamizo A, 2005, CANCER RES, V65, P3307, DOI 10.1158/0008-5472.CAN-04-1874; Novo E, 2011, J HEPATOL, V54, P964, DOI 10.1016/j.jhep.2010.09.022; Ren GW, 2008, CELL STEM CELL, V2, P141, DOI 10.1016/j.stem.2007.11.014; Romieu-Mourez R, 2009, J IMMUNOL, V182, P7963, DOI 10.4049/jimmunol.0803864; Russo FP, 2006, GASTROENTEROLOGY, V130, P1807, DOI 10.1053/j.gastro.2006.01.036; Ryu CH, 2011, HUM GENE THER, V22, P733, DOI 10.1089/hum.2010.187; Ryu CH, 2010, BIOCHEM BIOPH RES CO, V398, P105, DOI 10.1016/j.bbrc.2010.06.043; Shin EY, 2001, EXP MOL MED, V33, P276, DOI 10.1038/emm.2001.45; Spaeth E, 2008, GENE THER, V15, P730, DOI 10.1038/gt.2008.39; Studeny M, 2004, JNCI-J NATL CANCER I, V96, P1593, DOI 10.1093/jnci/djh299; Takanami I, 1999, ONCOLOGY-BASEL, V57, P138, DOI 10.1159/000012021; Varney ML, 2005, MELANOMA RES, V15, P417, DOI 10.1097/00008390-200510000-00010; Wang L, 2002, EXP HEMATOL, V30, P831, DOI 10.1016/S0301-472X(02)00829-9; Waterman RS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010088; Wei L, 2010, AM J PHYSIOL-LUNG C, V298, pL863, DOI 10.1152/ajplung.00281.2009; Wu S, 2011, BIOMATERIALS, V32, P7524, DOI 10.1016/j.biomaterials.2011.06.050; Xu F, 2010, ONCOL REP, V23, P1561, DOI 10.3892/or_00000796; Yan XL, 2011, DEV DYNAM, V240, P65, DOI 10.1002/dvdy.22490; Yang BJ, 2009, NEUROSURGERY, V65, P610, DOI 10.1227/01.NEU.0000350227.61132.A7; Yeh MC, 2010, J LEUKOCYTE BIOL, V87, P925, DOI 10.1189/jlb.0609399	53	97	107	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e35036	10.1371/journal.pone.0035036	http://dx.doi.org/10.1371/journal.pone.0035036			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GO	22496888	Green Published, gold, Green Submitted			2022-12-27	WOS:000304855200097
J	Leermakers, ETM; Taal, HR; Bakker, R; Steegers, EAP; Hofman, A; Jaddoe, VWV				Leermakers, Elisabeth T. M.; Taal, H. Rob; Bakker, Rachel; Steegers, Eric A. P.; Hofman, Albert; Jaddoe, Vincent W. V.			A Common Genetic Variant at 15q25 Modifies the Associations of Maternal Smoking during Pregnancy with Fetal Growth: The Generation R Study	PLOS ONE			English	Article							DIFFERENT PERIODS; BIRTH-WEIGHT; LUNG-CANCER; COTININE; ULTRASOUND; EXPOSURE; LENGTH; WOMEN; HEAD	Objective: Maternal smoking during pregnancy is associated with fetal growth retardation. We examined whether a common genetic variant at chromosome 15q25 (rs1051730), which is known to be involved in nicotine metabolism, modifies the associations of maternal smoking with fetal growth characteristics. Methods: This study was performed in 3,563 European mothers participating in a population-based prospective cohort study from early pregnancy onwards. Smoking was assessed by postal questionnaires and fetal growth characteristics were measured by ultrasound examinations in each trimester of pregnancy. Results: Among mothers who did not smoke during pregnancy (82.9%), maternal rs1051730 was not consistently associated with any fetal growth characteristic. Among mothers who continued smoking during pregnancy (17.1%), maternal rs1051730 was not associated with head circumference. The T-allele of maternal rs1051730 was associated with a smaller second and third trimester fetal femur length [differences -0.23 mm (95% CI -0.45 to -0.00) and -0.41 mm (95% CI -0.69 to -0.13), respectively] and a smaller birth length [difference -2.61 mm (95% CI -5.32 to 0.11)]. The maternal T-allele of rs1051730 was associated with a lower third trimester estimated fetal weight [difference -33 grams (95% CI -55 to -10)], and tended to be associated with birth weight [difference -38 grams (95% CI -89 to 13)]. This association persisted after adjustment for smoking quantity. Conclusions: Our results suggest that maternal rs1051730 genotype modifies the associations of maternal smoking during pregnancy with impaired fetal growth in length and weight. These results should be considered as hypothesis generating and indicate the need for large-scale genome wide association studies focusing on gene - fetal smoke exposure interactions.	[Leermakers, Elisabeth T. M.; Taal, H. Rob; Bakker, Rachel; Jaddoe, Vincent W. V.] Erasmus MC, Generat R Study Grp, Rotterdam, Netherlands; [Leermakers, Elisabeth T. M.; Taal, H. Rob; Hofman, Albert; Jaddoe, Vincent W. V.] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [Leermakers, Elisabeth T. M.; Taal, H. Rob; Jaddoe, Vincent W. V.] Erasmus MC, Dept Paediat, Rotterdam, Netherlands; [Bakker, Rachel; Steegers, Eric A. P.] Erasmus MC, Dept Obstet & Gynaecol, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Leermakers, ETM (corresponding author), Erasmus MC, Generat R Study Grp, Rotterdam, Netherlands.	v.jaddoe@erasmusmc.nl	Taal, Hendrik R/B-4847-2018		Erasmus Medical Center Rotterdam; Erasmus University Rotterdam; Netherlands Organization for Health Research and Development (ZonMw) [90700303, 916.10159]; Dutch Kidney Foundation [C08.2251]	Erasmus Medical Center Rotterdam; Erasmus University Rotterdam; Netherlands Organization for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development); Dutch Kidney Foundation	This work was supported by the Erasmus Medical Center Rotterdam, the Erasmus University Rotterdam and the Netherlands Organization for Health Research and Development (ZonMw), who financially supported the first phase of the Generation R Study. Additional grants were received from the Netherlands Organization for Health Research and Development (ZonMw) [90700303, 916.10159 to V.W.V.J.]; and the Dutch Kidney Foundation [C08.2251 to H. R. T.] The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1995, MULTILEVEL STAT METH; Ay L, 2009, BJOG-INT J OBSTET GY, V116, P953, DOI 10.1111/j.1471-0528.2009.02143.x; Bakker R, 2011, J NUTR, V141, P2172, DOI 10.3945/jn.111.142976; Breton CV, 2009, AM J RESP CRIT CARE, V180, P462, DOI 10.1164/rccm.200901-0135OC; Freathy RM, 2010, NAT GENET, V42, P430, DOI 10.1038/ng.567; Freathy RM, 2009, HUM MOL GENET, V18, P2922, DOI 10.1093/hmg/ddp216; Freathy RM, 2011, ULTRASOUND OBST GYN, V8, P178; Furberg H, 2010, NAT GENET, V42, P441, DOI 10.1038/ng.571; Geelhoed JJM, 2011, BJOG-INT J OBSTET GY, V118, P755, DOI 10.1111/j.1471-0528.2011.02900.x; HADDOW JE, 1987, BRIT J OBSTET GYNAEC, V94, P678, DOI 10.1111/j.1471-0528.1987.tb03174.x; HADLOCK FP, 1984, RADIOLOGY, V150, P535, DOI 10.1148/radiology.150.2.6691115; HEBEL JR, 1988, J CLIN EPIDEMIOL, V41, P483, DOI 10.1016/0895-4356(88)90050-9; Jaddoe VWV, 2007, EUR J EPIDEMIOL, V22, P917, DOI 10.1007/s10654-007-9209-z; Jaddoe VWV, 2008, PAEDIATR PERINAT EP, V22, P162, DOI 10.1111/j.1365-3016.2007.00916.x; Jaddoe VWV, 2007, AM J EPIDEMIOL, V165, P1207, DOI 10.1093/aje/kwm014; Jaddoe VWV, 2010, EUR J EPIDEMIOL, V25, P823, DOI 10.1007/s10654-010-9516-7; Klebanoff MA, 2001, PAEDIATR PERINAT EP, V15, P140, DOI 10.1046/j.1365-3016.2001.00321.x; Le Marchand L, 2008, CANCER RES, V68, P9137, DOI 10.1158/0008-5472.CAN-08-2271; NIKLASSON A, 1991, ACTA PAEDIATR SCAND, V80, P756, DOI 10.1111/j.1651-2227.1991.tb11945.x; Royal College of Obstetricians and Gynaecologists, 2000, ROUT ULTR SCREEN PRE; Timofeeva MN, 2011, CANCER EPIDEM BIOMAR, V20, P2250, DOI 10.1158/1055-9965.EPI-11-0496; Tunon K, 1996, ULTRASOUND OBST GYN, V8, P178, DOI 10.1046/j.1469-0705.1996.08030178.x; Varvarigou AA, 2010, J PERINAT MED, V38, P683, DOI [10.1515/JPM.2010.101, 10.1515/jpm.2010.101]; Verburg BO, 2008, ULTRASOUND OBST GYN, V31, P388, DOI 10.1002/uog.5225; Verburg BO, 2008, PRENATAL DIAG, V28, P323, DOI 10.1002/pd.1972; Wang XB, 1997, INT J EPIDEMIOL, V26, P978, DOI 10.1093/ije/26.5.978	26	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e34584	10.1371/journal.pone.0034584	http://dx.doi.org/10.1371/journal.pone.0034584			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GO	22496830	Green Published, Green Submitted, gold			2022-12-27	WOS:000304855200063
J	Moller, W; Heimbeck, I; Hofer, TPJ; Saba, GK; Neiswirth, M; Frankenberger, M; Ziegler-Heitbrock, L				Moeller, Winfried; Heimbeck, Irene; Hofer, Thomas P. J.; Saba, Guelnaz Khadem; Neiswirth, Margot; Frankenberger, Marion; Ziegler-Heitbrock, Loems			Differential Inflammatory Response to Inhaled Lipopolysaccharide Targeted Either to the Airways or the Alveoli in Man	PLOS ONE			English	Article							EXHALED BREATH CONDENSATE; ENDOTOXIN INHALATION; ULTRAFINE PARTICLES; HYDROGEN-PEROXIDE; HEALTHY-SUBJECTS; GENE-EXPRESSION; CHALLENGE; STANDARDIZATION; TRANSLOCATION; DEPOSITION	Endotoxin (Lipopolysaccharide, LPS) is a potent inducer of inflammation and there is various LPS contamination in the environment, being a trigger of lung diseases and exacerbation. The objective of this study was to assess the time course of inflammation and the sensitivities of the airways and alveoli to targeted LPS inhalation in order to understand the role of LPS challenge in airway disease. In healthy volunteers without any bronchial hyperresponsiveness we targeted sequentially 1, 5 and 20 mu g LPS to the airways and 5 mu g LPS to the alveoli using controlled aerosol bolus inhalation. Inflammatory parameters were assessed during a 72 h time period. LPS deposited in the airways induced dose dependent systemic responses with increases of blood neutrophils (peaking at 6 h), Interleukin-6 (peaking at 6 h), body temperature (peaking at 12 h), and CRP (peaking at 24 h). 5 mu g LPS targeted to the alveoli caused significantly stronger effects compared to 5 mg airway LPS deposition. Local responses were studied by measuring lung function (FEV1) and reactive oxygen production, assessed by hydrogen peroxide (H2O2) in fractionated exhaled breath condensate (EBC). FEV1 showed a dose dependent decline, with lowest values at 12 h post LPS challenge. There was a significant 2-fold H2O2 induction in airway-EBC at 2 h post LPS inhalation. Alveolar LPS targeting resulted in the induction of very low levels of EBC-H2O2. Targeting LPS to the alveoli leads to stronger systemic responses compared to airway LPS targeting. Targeted LPS inhalation may provide a novel model of airway inflammation for studying the role of LPS contamination of air pollution in lung diseases, exacerbation and anti-inflammatory drugs.	[Moeller, Winfried; Hofer, Thomas P. J.; Saba, Guelnaz Khadem; Frankenberger, Marion; Ziegler-Heitbrock, Loems] Comprehens Pneumol Ctr, Neuherberg, Germany; [Moeller, Winfried; Hofer, Thomas P. J.; Saba, Guelnaz Khadem; Frankenberger, Marion; Ziegler-Heitbrock, Loems] Comprehens Pneumol Ctr, Gauting, Germany; [Moeller, Winfried; Hofer, Thomas P. J.; Saba, Guelnaz Khadem; Frankenberger, Marion; Ziegler-Heitbrock, Loems] Comprehens Pneumol Ctr, Munich, Germany; [Moeller, Winfried; Hofer, Thomas P. J.; Saba, Guelnaz Khadem; Frankenberger, Marion; Ziegler-Heitbrock, Loems] Helmholtz Zentrum Munchen, Inst Lung Biol & Dis, Neuherberg, Germany; [Moeller, Winfried; Hofer, Thomas P. J.; Saba, Guelnaz Khadem; Frankenberger, Marion; Ziegler-Heitbrock, Loems] Helmholtz Zentrum Munchen, Inst Lung Biol & Dis, Gauting, Germany; [Moeller, Winfried; Hofer, Thomas P. J.; Saba, Guelnaz Khadem; Frankenberger, Marion; Ziegler-Heitbrock, Loems] Helmholtz Zentrum Munchen, Inst Lung Biol & Dis, Munich, Germany; [Heimbeck, Irene; Neiswirth, Margot] Asklepios Fachkliniken Munchen Gauting Ctr Pulm M, Gauting, Germany; [Ziegler-Heitbrock, Loems] Helmholtz Zentrum Munchen, EvA Study Ctr, Gauting, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Moller, W (corresponding author), Comprehens Pneumol Ctr, Neuherberg, Germany.	moeller@helmholtz-muenchen.de			Helmholtz Zentrum Munchen	Helmholtz Zentrum Munchen(Helmholtz Association)	The study was funded by the Helmholtz Zentrum Munchen. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander C, 2001, J ENDOTOXIN RES, V7, P167, DOI 10.1179/096805101101532675; Amrani Y, 2003, INT J BIOCHEM CELL B, V35, P272, DOI 10.1016/S1357-2725(02)00259-5; [Anonymous], 1994, Ann ICRP, V24, P1; Arbour NC, 2000, NAT GENET, V25, P187, DOI 10.1038/76048; ASANO S, 1991, AM J PEDIAT HEMATOL, V13, P400; Battin EE, 2009, CELL BIOCHEM BIOPHYS, V55, P1, DOI 10.1007/s12013-009-9054-7; BEESON PB, 1947, J EXP MED, V86, P29, DOI 10.1084/jem.86.1.29; Beutler B, 2003, NAT REV IMMUNOL, V3, P169, DOI 10.1038/nri1004; Bolte G, 2003, CLIN EXP ALLERGY, V33, P770, DOI 10.1046/j.1365-2222.2003.01665.x; Brand P, 2000, J PHARM SCI-US, V89, P724, DOI 10.1002/(SICI)1520-6017(200006)89:6<724::AID-JPS3>3.0.CO;2-B; Christopher MJ, 2007, CURR OPIN HEMATOL, V14, P3, DOI 10.1097/00062752-200701000-00003; DENTENER MA, 1993, J IMMUNOL, V150, P2885; Dinarello CA, 2004, J ENDOTOXIN RES, V10, P201, DOI 10.1179/096805104225006129; Doyen V, 2011, INFLAMMATIO IN PRESS, P1; FERRIS BG, 1978, AM REV RESPIR DIS, V118, P1; Gehring U, 2002, EUR RESPIR J, V19, P690, DOI 10.1183/09031936.02.01182001; Geiser M, 2005, ENVIRON HEALTH PERSP, V113, P1555, DOI 10.1289/ehp.8006; Gerritsen WB, 2005, RESP MED, V99, P1132, DOI 10.1016/j.rmed.2005.02.020; Hohlfeld JM, 2008, PULM PHARMACOL THER, V21, P616, DOI 10.1016/j.pupt.2008.02.002; HOLST H, 1994, J VET MED A, V41, P159, DOI 10.1111/j.1439-0442.1994.tb00079.x; Horvath I, 2005, EUR RESPIR J, V26, P523, DOI 10.1183/09031936.05.00029705; Jagielo PJ, 1996, CHEST, V110, P263, DOI 10.1378/chest.110.1.263; Kaminski N, 2000, P NATL ACAD SCI USA, V97, P1778, DOI 10.1073/pnas.97.4.1778; Kharitonov Sergei A., 2007, V14, P83, DOI 10.1159/000107056; Kitz R, 2006, J ENDOTOXIN RES, V12, P367, DOI 10.1179/096805106X153934; Lavigne MC, 2005, BIOCHEM BIOPH RES CO, V330, P194, DOI 10.1016/j.bbrc.2005.02.144; LEVINE SJ, 1993, AM J PHYSIOL, V265, pL360, DOI 10.1152/ajplung.1993.265.4.L360; Liebers V, 2008, ARCH TOXICOL, V82, P203, DOI 10.1007/s00204-008-0290-1; MACKIEWICZ A, 1991, J IMMUNOL, V146, P3032; Maris NA, 2006, EUR RESPIR J, V28, P622, DOI 10.1183/09031936.06.00010806; Maris NA, 2005, AM J RESP CRIT CARE, V172, P878, DOI 10.1164/rccm.200503-451OC; Michel O, 2001, J ALLERGY CLIN IMMUN, V107, P797, DOI 10.1067/mai.2001.114249; Michel O, 1997, AM J RESP CRIT CARE, V156, P1157, DOI 10.1164/ajrccm.156.4.97-02002; Moller W, 2010, J AEROSOL MED PULM D, V23, P129, DOI 10.1089/jamp.2009.0764; Moller W, 2008, AM J RESP CRIT CARE, V177, P426, DOI 10.1164/rccm.200602-301OC; Morris DG, 2003, NATURE, V422, P169, DOI 10.1038/nature01413; Mueller-Anneling L, 2004, ENVIRON HEALTH PERSP, V112, P583, DOI 10.1289/ehp.6552; Nauseef WM, 2004, HISTOCHEM CELL BIOL, V122, P277, DOI 10.1007/s00418-004-0679-8; Nightingale JA, 1998, THORAX, V53, P563, DOI 10.1136/thx.53.7.563; O'Byrne Paul M., 2007, V14, P1, DOI 10.1159/000107049; Peters M, 2006, THORAX, V61, P134, DOI 10.1136/thx.2005.049403; Prince HE, 1995, J IMMUNOL METHODS, V188, P129, DOI 10.1016/0022-1759(95)00210-3; QUANJER PH, 1993, EUR RESPIR J, V6, P5, DOI 10.1183/09041950.005s1693; Rahman Q, 1999, CRIT REV TOXICOL, V29, P543, DOI 10.1080/10408449991349276; Rietschel ET, 1999, SHOCK, V12, P21, DOI 10.1097/00024382-199911001-00064; Rochelle LG, 1998, FREE RADICAL BIO MED, V24, P863, DOI 10.1016/S0891-5849(97)00375-4; Rylander R, 2002, J ENDOTOXIN RES, V8, P241, DOI 10.1179/096805102125000452; Scheuch G, 2002, RESP DRUG DELIV, V8, P165; Shi J, 2010, ENVIRON HEALTH PERSP, V118, P1620, DOI 10.1289/ehp.0901178; STERK PJ, 1993, EUR RESPIR J, V6, P53, DOI 10.1183/09041950.053s1693; Tamagawa E, 2009, INNATE IMMUN-LONDON, V15, P251, DOI 10.1177/1753425909104782; Thorley AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021827; Thorn J, 2001, INFLAMM RES, V50, P254, DOI 10.1007/s000110050751; VANAS A, 1972, S AFR MED J, V46, P347; Wedzicha Jadwiga A, 2003, Respir Care, V48, P1204; Zhang P, 2000, IMMUNOL REV, V173, P39, DOI 10.1034/j.1600-065X.2000.917306.x; ZIEGLERHEITBROCK HWL, 1994, J BIOL CHEM, V269, P17001	58	32	33	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e33505	10.1371/journal.pone.0033505	http://dx.doi.org/10.1371/journal.pone.0033505			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GO	22496751	Green Submitted, gold, Green Published			2022-12-27	WOS:000304855200014
J	Son, S; Kang, AR; Kim, HC; Kwon, T; Park, J; Kim, HK				Son, Seokshin; Kang, Ah Reum; Kim, Hyun-chul; Kwon, Taekyoung; Park, Juyong; Kim, Huy Kang			Analysis of Context Dependence in Social Interaction Networks of a Massively Multiplayer Online Role-Playing Game	PLOS ONE			English	Article								Rapid advances in modern computing and information technology have enabled millions of people to interact online via various social network and gaming services. The widespread adoption of such online services have made possible analysis of large-scale archival data containing detailed human interactions, presenting a very promising opportunity to understand the rich and complex human behavior. In collaboration with a leading global provider of Massively Multiplayer Online Role-Playing Games (MMORPGs), here we present a network science-based analysis of the interplay between distinct types of user interaction networks in the virtual world. We find that their properties depend critically on the nature of the context-interdependence of the interactions, highlighting the complex and multilayered nature of human interactions, a robust understanding of which we believe may prove instrumental in the designing of more realistic future virtual arenas as well as provide novel insights to the science of collective human behavior.	[Son, Seokshin] Seoul Natl Univ, Multimedia & Mobile Commun Lab, Sch Comp Sci & Engn, Seoul, South Korea; [Kang, Ah Reum; Kim, Huy Kang] Korea Univ, Grad Sch Informat Secur, Seoul, South Korea; [Kim, Hyun-chul] Sangmyung Univ, Dept Comp Software Engn, Cheonan, South Korea; [Kwon, Taekyoung; Park, Juyong] Kyung Hee Univ, Dept Phys, Seoul, South Korea	Seoul National University (SNU); Korea University; Sang Myung University; Kyung Hee University	Son, S (corresponding author), Seoul Natl Univ, Multimedia & Mobile Commun Lab, Sch Comp Sci & Engn, Seoul, South Korea.	perturbation@gmail.com; cenda@korea.ac.kr	Park, Juyong/I-2290-2012; Kim, Huy Kang/R-5779-2016	Kim, Huy Kang/0000-0002-0760-8807; Kang, Ah Reum/0000-0002-0732-5313	Kyung Hee University [KHU-20110088]; National Research Foundation of Korea [KRF-20110005409]; Ministry of Knowledge Economy of Korea [NIPA-2012-C1090-1101-0004]; NAP of Korean Research Council of Fundamental Science and Technology	Kyung Hee University; National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Knowledge Economy of Korea(Ministry of Trade, Industry & Energy (MOTIE), Republic of Korea); NAP of Korean Research Council of Fundamental Science and Technology	Funding provided by Kyung Hee University (www.khu.ac.kr): KHU-20110088, National Research Foundation of Korea (www.nrf.re.kr) KRF-20110005409, Ministry of Knowledge Economy of Korea (www.mke.go.kr) NIPA-2012-C1090-1101-0004 and NAP of Korean Research Council of Fundamental Science and Technology (http://www.fif.kr/home.php). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahnert SE, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.036112; Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; [Anonymous], 2008, NATURE, V455, P1, DOI 10.1038/455001a; Cook K. S., 1991, MACROMICRO LINKAGES, P29; COOK KS, 1983, AM J SOCIOL, V89, P275, DOI 10.1086/227866; COOK KS, 1984, RES SOCIOLOGY ORG, V3, P1; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Kang A, 2011, ADV COMP SC IN PRESS; Kwak H, 2009, IMC'09: PROCEEDINGS OF THE 2009 ACM SIGCOMM INTERNET MEASUREMENT CONFERENCE, P301; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Newman M.E.J., 2010, NETWORKS INTRO; Newman MEJ, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.036122; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Onnela JP, 2007, P NATL ACAD SCI USA, V104, P7332, DOI 10.1073/pnas.0610245104; Park JY, 2007, P NATL ACAD SCI USA, V104, P17916, DOI 10.1073/pnas.0705081104; Son S, 2011, ACM SIGCOMM COMP COM, V41, P414, DOI 10.1145/2043164.2018496; Szell M, 2010, SOC NETWORKS, V32, P313, DOI 10.1016/j.socnet.2010.06.001; Szell M, 2010, P NATL ACAD SCI USA, V107, P13636, DOI 10.1073/pnas.1004008107; WASSERMAN S., 1994, SOCIAL NETWORK ANAL, DOI DOI 10.1017/CBO9780511815478	19	21	21	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e33918	10.1371/journal.pone.0033918	http://dx.doi.org/10.1371/journal.pone.0033918			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	953GO	22496771	Green Submitted, gold, Green Published			2022-12-27	WOS:000304855200025
J	Gelebart, P; Zak, Z; Anand, M; Belch, A; Lai, R				Gelebart, Pascal; Zak, Zoulika; Anand, Mona; Belch, Andrew; Lai, Raymond			Blockade of Fatty Acid Synthase Triggers Significant Apoptosis in Mantle Cell Lymphoma	PLOS ONE			English	Article							NF-KAPPA-B; PROSTATE-CANCER; LIPID-METABOLISM; ACTIVATION; INHIBITION; ONCOGENE; PATHWAYS; SURVIVAL; OVEREXPRESSION; PALMITOYLATION	Fatty acid synthase (FASN), a key player in the de novo synthetic pathway of long-chain fatty acids, has been shown to contribute to the tumorigenesis in various types of solid tumors. We here report that FASN is highly and consistently expressed in mantle cell lymphoma (MCL), an aggressive form of B-cell lymphoid malignancy. Specifically, the expression of FASN was detectable in all four MCL cell lines and 15 tumors examined. In contrast, benign lymphoid tissues and peripheral blood mononuclear cells from normal donors were negative. Treatment of MCL cell lines with orlistat, a FASN inhibitor, resulted in significant apoptosis. Knockdown of FASN expression using siRNA, which also significantly decreased the growth of MCL cells, led to a dramatic decrease in the cyclin D1 level. beta-catenin, which has been previously reported to be upregulated in a subset of MCL tumors, contributed to the high level of FASN in MCL cells, Interesting, siRNA knock-down of FASN in turn down-regulated beta-catenin. In conclusion, our data supports the concept that FASN contributes to the pathogenesis of MCL, by collaborating with beta-catenin. In view of its high and consistent expression in MCL, FASN inhibitors may hold promises for treating MCL.	[Gelebart, Pascal; Zak, Zoulika; Anand, Mona; Lai, Raymond] Univ Alberta, Dept Lab Med & Pathol, Edmonton, AB, Canada; [Gelebart, Pascal; Zak, Zoulika; Anand, Mona; Belch, Andrew; Lai, Raymond] Cross Canc Inst, Edmonton, AB T6G 1Z2, Canada; [Belch, Andrew; Lai, Raymond] Univ Alberta, Dept Oncol, Edmonton, AB, Canada	University of Alberta; University of Alberta; University of Alberta	Gelebart, P (corresponding author), Univ Alberta, Dept Lab Med & Pathol, Edmonton, AB, Canada.	rlai@ualberta.ca	Gelebart, Pascal/AAI-1439-2020	Gelebart, Pascal/0000-0003-2434-8987	Canadian Institute of Health Research; Alberta Cancer Foundation; Canadian Cancer Society Research Institute	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Cancer Foundation; Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS))	This study is supported by operating research grants from the Canadian Institute of Health Research, Alberta Cancer Foundation and the Canadian Cancer Society Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin HM, 2003, ARCH PATHOL LAB MED, V127, P424; Baron A, 2004, J CELL BIOCHEM, V91, P47, DOI 10.1002/jcb.10708; Cerne D, 2010, ARCH MED RES, V41, P405, DOI 10.1016/j.arcmed.2010.08.007; Delsol G, 2008, ANAPLASTIC LARGE CEL, V4th; Fiorentino M, 2008, LAB INVEST, V88, P1340, DOI 10.1038/labinvest.2008.97; Fu LC, 2006, BLOOD, V107, P4540, DOI 10.1182/blood-2005-10-4042; Gansler TS, 1997, HUM PATHOL, V28, P686, DOI 10.1016/S0046-8177(97)90177-5; Gelebart P, 2008, BLOOD, V112, P5171, DOI 10.1182/blood-2008-02-139212; Ghielmini M, 2009, BLOOD; Graner E, 2004, CANCER CELL, V5, P253, DOI 10.1016/S1535-6108(04)00055-8; Jares P, 2007, NAT REV CANCER, V7, P750, DOI 10.1038/nrc2230; JAYAKUMAR A, 1995, P NATL ACAD SCI USA, V92, P8695, DOI 10.1073/pnas.92.19.8695; Jin QR, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2777; Kridel SJ, 2004, CANCER RES, V64, P2070, DOI 10.1158/0008-5472.can-03-3645; Kridel SJ, 2007, EXPERT OPIN INV DRUG, V16, P1817, DOI 10.1517/13543784.16.11.1817; Kusakabe T, 2000, J HISTOCHEM CYTOCHEM, V48, P613, DOI 10.1177/002215540004800505; Kusakabe T, 2002, HISTOPATHOLOGY, V40, P71, DOI 10.1046/j.1365-2559.2002.01289.x; Maier T, 2010, Q REV BIOPHYS, V43, P373, DOI 10.1017/S0033583510000156; Martinez N, 2003, CANCER RES, V63, P8226; Mashima T, 2009, BRIT J CANCER, V100, P1369, DOI 10.1038/sj.bjc.6605007; Menendez JA, 2004, P NATL ACAD SCI USA, V101, P10715, DOI 10.1073/pnas.0403390101; Migita T, 2009, JNCI-J NATL CANCER I, V101, P519, DOI 10.1093/jnci/djp030; Pallasch CP, 2008, LEUKEMIA, V22, P585, DOI 10.1038/sj.leu.2405058; Pham LV, 2003, J IMMUNOL, V171, P88, DOI 10.4049/jimmunol.171.1.88; Rizzatti EG, 2008, LEUKEMIA LYMPHOMA, V49, P798, DOI 10.1080/10428190801910912; Rizzatti EG, 2005, BRIT J HAEMATOL, V130, P516, DOI 10.1111/j.1365-2141.2005.05630.x; Rudelius M, 2006, BLOOD, V108, P1668, DOI 10.1182/blood-2006-04-015586; Sandilands E, 2007, J CELL SCI, V120, P2555, DOI 10.1242/jcs.003657; SEMENKOVICH CF, 1995, J LIPID RES, V36, P1507; Shishodia S, 2005, BIOCHEM PHARMACOL, V70, P700, DOI 10.1016/j.bcp.2005.04.043; Smith MR, 2008, CURR OPIN HEMATOL, V15, P415, DOI 10.1097/MOH.0b013e328302c9c5; Swerdlow S, 2001, WHO CLASSIFICATION T; Tucker CA, 2008, MOL CANCER THER, V7, P749, DOI 10.1158/1535-7163.MCT-07-0302; Uddin S, 2008, J CLIN ENDOCR METAB, V93, P4088, DOI 10.1210/jc.2008-0503; Uddin S, 2010, MOL CANCER THER, V9, P1244, DOI 10.1158/1535-7163.MCT-09-1061; Wang WQ, 2008, J ZHEJIANG UNIV-SC B, V9, P441, DOI 10.1631/jzus.B0740640; Yoon S, 2007, J BIOL CHEM, V282, P26122, DOI 10.1074/jbc.M702854200	38	37	39	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2012	7	4							e33738	10.1371/journal.pone.0033738	http://dx.doi.org/10.1371/journal.pone.0033738			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952GU	22485149	Green Submitted, Green Published, gold			2022-12-27	WOS:000304780500025
J	Creighton, CJ; Hernandez-Herrera, A; Jacobsen, A; Levine, DA; Mankoo, P; Schultz, N; Du, Y; Zhang, YQ; Larsson, E; Sheridan, R; Xiao, WM; Spellman, PT; Getz, G; Wheeler, DA; Perou, CM; Gibbs, RA; Sander, C; Hayes, DN; Gunaratne, PH				Creighton, Chad J.; Hernandez-Herrera, Anadulce; Jacobsen, Anders; Levine, Douglas A.; Mankoo, Parminder; Schultz, Nikolaus; Du, Ying; Zhang, Yiqun; Larsson, Erik; Sheridan, Robert; Xiao, Weimin; Spellman, Paul T.; Getz, Gad; Wheeler, David A.; Perou, Charles M.; Gibbs, Richard A.; Sander, Chris; Hayes, D. Neil; Gunaratne, Preethi H.		Canc Genome Atlas Res Network	Integrated Analyses of microRNAs Demonstrate Their Widespread Influence on Gene Expression in High-Grade Serous Ovarian Carcinoma	PLOS ONE			English	Article							MESSENGER-RNAS; TARGETS; CANCER; PROFILES; REVEALS; SIGNATURES; 5'-UTR; MIRNAS; DICER	Background: The Cancer Genome Atlas (TCGA) Network recently comprehensively catalogued the molecular aberrations in 487 high-grade serous ovarian cancers, with much remaining to be elucidated regarding the microRNAs (miRNAs). Here, using TCGA ovarian data, we surveyed the miRNAs, in the context of their predicted gene targets. Methods and Results: Integration of miRNA and gene patterns yielded evidence that proximal pairs of miRNAs are processed from polycistronic primary transcripts, and that intronic miRNAs and their host gene mRNAs derive from common transcripts. Patterns of miRNA expression revealed multiple tumor subtypes and a set of 34 miRNAs predictive of overall patient survival. In a global analysis, miRNA:mRNA pairs anti-correlated in expression across tumors showed a higher frequency of in silico predicted target sites in the mRNA 3'-untranslated region (with less frequency observed for coding sequence and 5'-untranslated regions). The miR-29 family and predicted target genes were among the most strongly anti-correlated miRNA:mRNA pairs; over-expression of miR-29a in vitro repressed several anti-correlated genes (including DNMT3A and DNMT3B) and substantially decreased ovarian cancer cell viability. Conclusions: This study establishes miRNAs as having a widespread impact on gene expression programs in ovarian cancer, further strengthening our understanding of miRNA biology as it applies to human cancer. As with gene transcripts, miRNAs exhibit high diversity reflecting the genomic heterogeneity within a clinically homogeneous disease population. Putative miRNA:mRNA interactions, as identified using integrative analysis, can be validated. TCGA data are a valuable resource for the identification of novel tumor suppressive miRNAs in ovarian as well as other cancers.	[Creighton, Chad J.; Zhang, Yiqun] Baylor Coll Med, Dan L Duncan Canc Ctr, Houston, TX 77030 USA; [Creighton, Chad J.] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Levine, Douglas A.] Mem Sloan Kettering Canc Ctr, Dept Surg, Gynecol Serv, New York, NY 10021 USA; [Jacobsen, Anders; Mankoo, Parminder; Schultz, Nikolaus; Larsson, Erik; Sheridan, Robert; Sander, Chris] Mem Sloan Kettering Canc Ctr, Computat Biol Ctr, New York, NY 10021 USA; [Du, Ying; Perou, Charles M.; Hayes, D. Neil] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Hayes, D. Neil] Univ N Carolina, Div Med Oncol, Dept Internal Med, Chapel Hill, NC USA; [Spellman, Paul T.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA 94720 USA; [Getz, Gad] Broad Inst MIT & Harvard, Cambridge, MA USA; [Wheeler, David A.; Gibbs, Richard A.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Gunaratne, Preethi H.] Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA; [Hernandez-Herrera, Anadulce; Xiao, Weimin; Gunaratne, Preethi H.] Univ Houston, Dept Biol & Biochem, Houston, TX USA	Baylor College of Medicine; Baylor College of Medicine; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Baylor College of Medicine; Baylor College of Medicine; University of Houston System; University of Houston	Creighton, CJ (corresponding author), Baylor Coll Med, Dan L Duncan Canc Ctr, Houston, TX 77030 USA.	creighto@bcm.edu; phgunaratne@uh.edu	Perou, Charles M/H-9934-2014; Larsson Lekholm, Erik/HDM-8032-2022; Wheeler, David A/M-9740-2018; Larsson Lekholm, Erik/AHE-0932-2022; Skanderup, Anders Jacobsen/K-1081-2013; Schultz, Nikolaus/ABE-6347-2020; Zhang, YiQun/HCI-2427-2022	Perou, Charles M/0000-0001-9827-2247; Larsson Lekholm, Erik/0000-0003-1400-0119; Wheeler, David A/0000-0002-9056-6299; Larsson Lekholm, Erik/0000-0003-1400-0119; Skanderup, Anders Jacobsen/0000-0001-6847-4980; Hayes, D. Neil/0000-0001-6203-7771; Schultz, Nikolaus/0000-0002-0131-4904; Levine, Douglas/0000-0003-1038-8232	Ovarian Cancer Research Fund; National Institutes of Health (NIH) [P30CA125123]; TCGA GCC at Baylor: National Cancer Institue (NCI) [U24CA143843]; TCGA GCC at University of North Carolina [NCI-U24CA143848]; TCGA GDAC at Memorial Sloan-Kettering Cancer Center [NCI-U24CA143840]; Cullen Foundation; Mexican National Council for Science and Technology (CONACyT); Danish Research Council;  [CPRIT-RP110355]; NATIONAL CANCER INSTITUTE [P30CA016086, U24CA143840, U24CA143843, U24CA143848, P30CA125123] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003273] Funding Source: NIH RePORTER	Ovarian Cancer Research Fund; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); TCGA GCC at Baylor: National Cancer Institue (NCI); TCGA GCC at University of North Carolina; TCGA GDAC at Memorial Sloan-Kettering Cancer Center; Cullen Foundation; Mexican National Council for Science and Technology (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Danish Research Council(Det Frie Forskningsrad (DFF)); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported in part by the Ovarian Cancer Research Fund (CJC, PHG), National Institutes of Health (NIH) grant P30CA125123 (CJC, YZ), TCGA GCC at Baylor: National Cancer Institue (NCI) grant U24CA143843 (CJC, DAW, RAG), TCGA GCC at University of North Carolina: NCI-U24CA143848 (YD, CMP, DNH), TCGA GDAC at Memorial Sloan-Kettering Cancer Center: NCI-U24CA143840 (AJ, PM, NS, EL, RS, CS), CPRIT-RP110355 (PHG), a Cullen Foundation Grant (PHG), the Mexican National Council for Science and Technology (CONACyT) (AH), and the Danish Research Council (AJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baskerville S, 2005, RNA, V11, P241, DOI 10.1261/rna.7240905; Bearfoot JL, 2008, CLIN CANCER RES, V14, P7246, DOI 10.1158/1078-0432.CCR-08-1348; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Creighton CJ, 2008, RNA, V14, P2290, DOI 10.1261/rna.1188208; Creighton CJ, 2010, CANCER RES, V70, P1906, DOI 10.1158/0008-5472.CAN-09-3875; Fabbri M, 2007, P NATL ACAD SCI USA, V104, P15805, DOI 10.1073/pnas.0707628104; Forman JJ, 2008, P NATL ACAD SCI USA, V105, P14879, DOI 10.1073/pnas.0803230105; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Garzon R, 2009, BLOOD, V113, P6411, DOI 10.1182/blood-2008-07-170589; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Iorio MV, 2007, CANCER RES, V67, P8699, DOI 10.1158/0008-5472.CAN-07-1936; Iorio MV, 2009, J CLIN ONCOL, V27, P5848, DOI 10.1200/JCO.2009.24.0317; Jacobsen A, 2010, GENOME RES, V20, P1010, DOI 10.1101/gr.103259.109; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Lee I, 2009, GENOME RES, V19, P1175, DOI 10.1101/gr.089367.108; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Liang Y, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-166; Liu XX, 2011, FEBS LETT, V585, P1363, DOI 10.1016/j.febslet.2011.04.018; Lytle JR, 2007, P NATL ACAD SCI USA, V104, P9667, DOI 10.1073/pnas.0703820104; Mankoo PK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024709; Merritt WM, 2008, NEW ENGL J MED, V359, P2641, DOI 10.1056/NEJMoa0803785; Nam EJ, 2008, CLIN CANCER RES, V14, P2690, DOI 10.1158/1078-0432.CCR-07-1731; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Pollack JR, 2002, P NATL ACAD SCI USA, V99, P12963, DOI 10.1073/pnas.162471999; Rajewsky N, 2006, NAT GENET S, V38; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Shih KK, 2011, GYNECOL ONCOL, V121, P444, DOI 10.1016/j.ygyno.2011.01.025; Tay Y, 2008, NATURE, V455, P1124, DOI 10.1038/nature07299; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Wang YP, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-218; Wu L, 2008, MOL CELL, V29, P1, DOI 10.1016/j.molcel.2007.12.010; Wyman SK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005311; Zhang L, 2008, P NATL ACAD SCI USA, V105, P7004, DOI 10.1073/pnas.0801615105; Zhou X, 2011, ONCOL REP	35	93	96	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2012	7	3							e34546	10.1371/journal.pone.0034546	http://dx.doi.org/10.1371/journal.pone.0034546			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948SR	22479643	gold, Green Published, Green Submitted			2022-12-27	WOS:000304523400088
J	Simone-Finstrom, MD; Spivak, M				Simone-Finstrom, Michael D.; Spivak, Marla			Increased Resin Collection after Parasite Challenge: A Case of Self-Medication in Honey Bees?	PLOS ONE			English	Article							APIS-MELLIFERA; BRAZILIAN PROPOLIS; CHIMPANZEES; ANTIBACTERIAL; RESISTANCE; PATHOGEN; COLONIES; BEHAVIOR; DEFENSE; DISEASE	The constant pressure posed by parasites has caused species throughout the animal kingdom to evolve suites of mechanisms to resist infection. Individual barriers and physiological defenses are considered the main barriers against parasites in invertebrate species. However, behavioral traits and other non-immunological defenses can also effectively reduce parasite transmission and infection intensity. In social insects, behaviors that reduce colony-level parasite loads are termed "social immunity.'' One example of a behavioral defense is resin collection. Honey bees forage for plant-produced resins and incorporate them into their nest architecture. This use of resins can reduce chronic elevation of an individual bee's immune response. Since high activation of individual immunity can impose colony-level fitness costs, collection of resins may benefit both the individual and colony fitness. However the use of resins as a more direct defense against pathogens is unclear. Here we present evidence that honey bee colonies may self-medicate with plant resins in response to a fungal infection. Self-medication is generally defined as an individual responding to infection by ingesting or harvesting non-nutritive compounds or plant materials. Our results show that colonies increase resin foraging rates after a challenge with a fungal parasite (Ascophaera apis: chalkbrood or CB). Additionally, colonies experimentally enriched with resin had decreased infection intensities of this fungal parasite. If considered self-medication, this is a particularly unique example because it operates at the colony level. Most instances of self-medication involve pharmacophagy, whereby individuals change their diet in response to direct infection with a parasite. In this case with honey bees, resins are not ingested but used within the hive by adult bees exposed to fungal spores. Thus the colony, as the unit of selection, may be responding to infection through self-medication by increasing the number of individuals that forage for resin.	[Simone-Finstrom, Michael D.] N Carolina State Univ, Dept Entomol, Raleigh, NC 27695 USA; [Spivak, Marla] Univ Minnesota, Dept Entomol, St Paul, MN USA	University of North Carolina; North Carolina State University; University of Minnesota System; University of Minnesota Twin Cities	Simone-Finstrom, MD (corresponding author), N Carolina State Univ, Dept Entomol, Raleigh, NC 27695 USA.	mdsimone@ncsu.edu	Simone-Finstrom, Michael/D-3624-2012; Spivak, Marla/AAI-5088-2020	Simone-Finstrom, Michael/0000-0003-2938-9788	National Science Foundation [IOS-0717530]	National Science Foundation(National Science Foundation (NSF))	This research was supported by a grant from the National Science Foundation (IOS-0717530) awarded to MS and an NSF Graduate Student fellowship awarded to MSF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antunez K, 2008, VET MICROBIOL, V131, P324, DOI 10.1016/j.vetmic.2008.04.011; Aronstein KA, 2010, J INVERTEBR PATHOL, V103, pS20, DOI 10.1016/j.jip.2009.06.018; Bastos EMAF, 2008, J INVERTEBR PATHOL, V97, P273, DOI 10.1016/j.jip.2007.10.007; Bernays EA, 2005, NATURE, V436, P476, DOI 10.1038/436476a; BOPPRE M, 1984, J CHEM ECOL, V10, P1151, DOI 10.1007/BF00987520; Castella G, 2008, ECOL ENTOMOL, V33, P408, DOI 10.1111/j.1365-2311.2007.00983.x; Castella G, 2008, ANIM BEHAV, V75, P1591, DOI 10.1016/j.anbehav.2007.10.014; Chapuisat M, 2007, P ROY SOC B-BIOL SCI, V274, P2013, DOI 10.1098/rspb.2007.0531; Choe DH, 2007, ANN ENTOMOL SOC AM, V100, P320, DOI 10.1603/0013-8746(2007)100[320:UOPRBA]2.0.CO;2; Christe P, 2003, ECOL LETT, V6, P19, DOI 10.1046/j.1461-0248.2003.00395.x; Crane E., 1990, BEES BEEKEEPING, V1st; Cremer S, 2007, CURR BIOL, V17, pR693, DOI 10.1016/j.cub.2007.06.008; Evans JD, 2006, INSECT MOL BIOL, V15, P645, DOI 10.1111/j.1365-2583.2006.00682.x; Evans JD, 2010, J INVERTEBR PATHOL, V103, pS62, DOI 10.1016/j.jip.2009.06.019; Evans JD, 2005, EVOLUTION, V59, P2270, DOI 10.1111/j.0014-3820.2005.tb00935.x; Fearnley J., 2001, BEE PROPOLIS NATURAL; Fowler A, 2007, PRIMATES, V48, P73, DOI 10.1007/s10329-006-0001-6; GHISALBERTI EL, 1979, BEE WORLD, V60, P59, DOI 10.1080/0005772X.1979.11097738; GILLIAM M, 1988, J INVERTEBR PATHOL, V52, P314, DOI 10.1016/0022-2011(88)90141-3; GLINSKI Z., 2001, APIACATA, V36, P12, DOI DOI 10.1016/J.JACI.2016.04.024; GOMPPER ME, 1993, J TROP ECOL, V9, P533, DOI 10.1017/S0266467400007616; Gwinner H, 2000, ANIM BEHAV, V59, P301, DOI 10.1006/anbe.1999.1306; Huffman MA, 1996, INT J PRIMATOL, V17, P475, DOI 10.1007/BF02735188; Huffman MA, 2010, ANIM COGN, V13, P871, DOI 10.1007/s10071-010-0335-8; Hutchings MR, 2003, P NUTR SOC, V62, P361, DOI 10.1079/PNS2003243; Kanga LHB, 2003, J ECON ENTOMOL, V96, P1091, DOI 10.1603/0022-0493-96.4.1091; KONIG B, 1988, ENTOMOL GEN, V14, P145; Kujumgiev A, 1999, J ETHNOPHARMACOL, V64, P235, DOI 10.1016/S0378-8741(98)00131-7; Lee KP, 2006, P ROY SOC B-BIOL SCI, V273, P823, DOI 10.1098/rspb.2005.3385; Lozano GA, 1998, ADV STUD BEHAV, V27, P291; Manson JS, 2010, OECOLOGIA, V162, P81, DOI 10.1007/s00442-009-1431-9; Mennerat A, 2009, ANIM BEHAV, V77, P569, DOI 10.1016/j.anbehav.2008.11.008; Morse R.A., 1997, HONEY BEE PESTS PRED; Nakamura J, 2006, BEHAV ECOL SOCIOBIOL, V60, P339, DOI 10.1007/s00265-006-0170-8; Parker BJ, 2011, TRENDS ECOL EVOL, V26, P242, DOI 10.1016/j.tree.2011.02.005; Santos FA, 2003, PHYTOTHER RES, V17, P285, DOI 10.1002/ptr.1117; Schmid-Hempel P., 1998, Parasites in social insects.; Seeley TD, 1997, AM NAT, V150, pS22, DOI 10.1086/286048; SEELEY TD, 1989, AM SCI, V77, P546; SEELEY TD, 1976, INSECT SOC, V23, P495, DOI 10.1007/BF02223477; Simone M, 2009, EVOLUTION, V63, P3016, DOI 10.1111/j.1558-5646.2009.00772.x; Simone-Finstrom M, 2010, BEHAV ECOL SOCIOBIOL, V64, P1609, DOI 10.1007/s00265-010-0974-4; Simone-Finstrom M, 2010, APIDOLOGIE, V41, P295, DOI 10.1051/apido/2010016; Singer MS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004796; Smilanich AM, 2011, OECOLOGIA, V165, P995, DOI 10.1007/s00442-010-1803-1; Spivak M, 2001, APIDOLOGIE, V32, P555, DOI 10.1051/apido:2001103; Strand Michael R., 2008, Insect Science, V15, P1, DOI 10.1111/j.1744-7917.2008.00183.x; Swanson JAI, 2009, J CHEM ECOL, V35, P1108, DOI 10.1007/s10886-009-9683-8; Villalba JJ, 2006, ANIM BEHAV, V71, P1131, DOI 10.1016/j.anbehav.2005.09.012; Winston M. L. L., 1991, BIOL HONEY BEE; WRANGHAM RW, 1995, AM J PRIMATOL, V37, P297, DOI 10.1002/ajp.1350370404	51	121	124	2	124	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2012	7	3							e34601	10.1371/journal.pone.0034601	http://dx.doi.org/10.1371/journal.pone.0034601			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948SR	22479650	Green Published, Green Submitted, gold			2022-12-27	WOS:000304523400091
J	Galimberti, D; Dell'Osso, B; Fenoglio, C; Villa, C; Cortini, F; Serpente, M; Kittel-Schneider, S; Weigl, J; Neuner, M; Volkert, J; Leonhard, C; Olmes, DG; Kopf, J; Cantoni, C; Ridolfi, E; Palazzo, C; Ghezzi, L; Bresolin, N; Altamura, AC; Scarpini, E; Reif, A				Galimberti, Daniela; Dell'Osso, Bernardo; Fenoglio, Chiara; Villa, Chiara; Cortini, Francesca; Serpente, Maria; Kittel-Schneider, Sarah; Weigl, Johannes; Neuner, Maria; Volkert, Juliane; Leonhard, C.; Olmes, David G.; Kopf, Juliane; Cantoni, Claudia; Ridolfi, Elisa; Palazzo, Carlotta; Ghezzi, Laura; Bresolin, Nereo; Altamura, A. C.; Scarpini, Elio; Reif, Andreas			Progranulin Gene Variability and Plasma Levels in Bipolar Disorder and Schizophrenia	PLOS ONE			English	Article							FRONTOTEMPORAL LOBAR DEGENERATION; GENOME-WIDE ASSOCIATION; ALZHEIMERS-DISEASE; RISK GENES; DEMENTIA; GRN; MUTATION; FAMILIES; LINKAGE; PEOPLE	Basing on the assumption that frontotemporal lobar degeneration (FTLD), schizophrenia and bipolar disorder (BPD) might share common aetiological mechanisms, we analyzed genetic variation in the FTLD risk gene progranulin (GRN) in a German population of patients with schizophrenia (n=271) or BPD (n=237) as compared with 574 age-, gender-and ethnicity-matched controls. Furthermore, we measured plasma progranulin levels in 26 German BPD patients as well as in 61 Italian BPD patients and 29 matched controls. A significantly decreased allelic frequency of the minor versus the wild-type allele was observed for rs2879096 (23.2 versus 34.2%, P<0.001, OR: 0.63, 95% CI: 0.49-0.80), rs4792938 (30.7 versus 39.7%, P=0.005, OR: 0.70, 95% CI: 0.55-0.89) and rs5848 (30.3 versus 36.8, P=0.007, OR: 0.71, 95% CI: 0.56-0.91). Mean +/- SEM progranulin plasma levels were significantly decreased in BPD patients, either Germans or Italians, as compared with controls (89.69 +/- 3.97 and 116.14 +/- 5.80 ng/ml, respectively, versus 180.81 +/- 18.39 ng/ml P<0.001) and were not correlated with age. In conclusion, GRN variability decreases the risk to develop BPD and schizophrenia, and progranulin plasma levels are significantly lower in BPD patients than in controls. Nevertheless, a larger replication analysis would be needed to confirm these preliminary results.	[Galimberti, Daniela; Dell'Osso, Bernardo; Fenoglio, Chiara; Villa, Chiara; Cortini, Francesca; Serpente, Maria; Cantoni, Claudia; Ridolfi, Elisa; Palazzo, Carlotta; Ghezzi, Laura; Bresolin, Nereo; Altamura, A. C.; Scarpini, Elio] Univ Milan, Dept Neurol Sci, IRCCS Fdn Ca Granda, Osped Maggiore Policlin, Milan, Italy; [Kittel-Schneider, Sarah; Weigl, Johannes; Neuner, Maria; Volkert, Juliane; Leonhard, C.; Olmes, David G.; Kopf, Juliane; Reif, Andreas] Univ Wurzburg, Bipolar Disorder Program, Dept Psychiat Psychosomat & Psychotherapy, Wurzburg, Germany	IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; University of Wurzburg	Galimberti, D (corresponding author), Univ Milan, Dept Neurol Sci, IRCCS Fdn Ca Granda, Osped Maggiore Policlin, Milan, Italy.	daniela.galimberti@unimi.it	Ghezzi, Laura/J-2284-2018; Ghezzi, Laura/V-5280-2019; Dell'Osso, Bernardo/K-8030-2016; Galimberti, Daniela/N-7209-2019; Serpente, Maria/K-5792-2016; Cantoni, Claudia/Z-2529-2019; Scarpini, Elio/K-6547-2016	Ghezzi, Laura/0000-0001-8180-9730; Galimberti, Daniela/0000-0002-9284-5953; Serpente, Maria/0000-0003-0725-1403; Scarpini, Elio/0000-0002-6395-2119; Kittel-Schneider, Sarah/0000-0003-3057-6150; Palazzo, Mariacarlotta/0000-0002-6239-1807; dell'osso, bernardo/0000-0001-9370-5365; cortini, francesca/0000-0002-5417-4546; Bresolin, Nereo/0000-0001-6694-3595; Villa, Chiara/0000-0003-2730-5974	Monzino Foundation; Italian Ministry of Health; (DFG) German Research Foundation [RE1632/1-1, RE1632/1-3, RE1632/5, KFO 125, SFB TRR Z02 58, RTG 1252/2]	Monzino Foundation; Italian Ministry of Health(Ministry of Health, Italy); (DFG) German Research Foundation(German Research Foundation (DFG))	This work was supported by grants from Monzino Foundation, Italian Ministry of Health (Programma Strategico RF 2007, conv. PS39, to DG and ES) and the (DFG) German Research Foundation (Grant RE1632/1-1, /1-3 and /5 to AR, KFO 125 to AR, SFB TRR Z02 58 to AR, and RTG 1252/2, to AR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed Z, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-7; Boeve BF, 2008, ARCH NEUROL-CHICAGO, V65, P460, DOI 10.1001/archneur.65.4.460; Cantor RM, 2005, AM J HUM GENET, V76, P1050, DOI 10.1086/430278; Carecchio M, 2009, J NEUROL SCI, V287, P291, DOI 10.1016/j.jns.2009.07.011; Cerami C, 2011, J ALZHEIMERS DIS, V27, P791, DOI 10.3233/JAD-2011-110788; De Riz M, 2010, NEUROSCI LETT, V469, P234, DOI 10.1016/j.neulet.2009.12.002; Escamilla M, 2009, AM J PSYCHIAT, V166, P442, DOI 10.1176/appi.ajp.2008.08040612; Ewald H, 2005, AM J MED GENET B, V133B, P25, DOI 10.1002/ajmg.b.30106; Fenoglio C, 2009, J ALZHEIMERS DIS, V18, P603, DOI 10.3233/JAD-2009-1170; Ferreira MAR, 2008, NAT GENET, V40, P1056, DOI 10.1038/ng.209; Finch N, 2009, BRAIN, V132, P583, DOI 10.1093/brain/awn352; First MB, 2002, STRUCTURED CLIN INTE; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Galimberti D, 2010, J ALZHEIMERS DIS, V19, P171, DOI 10.3233/JAD-2010-1225; Gass J, 2006, HUM MOL GENET, V15, P2988, DOI 10.1093/hmg/ddl241; Ghidoni R, 2008, NEUROLOGY, V71, P1235, DOI 10.1212/01.wnl.0000325058.10218.fc; Graff-Radford NR, 2007, SEMIN NEUROL, V27, P48, DOI 10.1055/s-2006-956755; Howrigan DP, 2011, AM J MED GENET B, V156B, P462, DOI 10.1002/ajmg.b.31183; Kunz M, 2011, REV BRAS PSIQUIATR, V33, P268, DOI [10.1590/S1516-44462011005000009, 10.1590/S1516-44462011000300010]; McKhann GM, 2001, ARCH NEUROL-CHICAGO, V58, P1803, DOI 10.1001/archneur.58.11.1803; Neary D, 1998, NEUROLOGY, V51, P1546, DOI 10.1212/WNL.51.6.1546; Pietroboni AM, 2011, J ALZHEIMERS DIS, V24, P253, DOI 10.3233/JAD-2011-101704; Rademakers R, 2008, HUM MOL GENET, V17, P3631, DOI 10.1093/hmg/ddn257; Rainero I, 2011, BIOL PSYCHIAT, V70, pE43, DOI 10.1016/j.biopsych.2011.06.015; Reif A, 2006, MOL PSYCHIATR, V11, P286, DOI 10.1038/sj.mp.4001779; Ripke S, 2011, NAT GENET, V43, P969, DOI 10.1038/ng.940; Rollinson S, 2011, NEUROBIOL AGING, V32, P754, DOI 10.1016/j.neurobiolaging.2009.04.009; Schoder D, 2010, BRIT J PSYCHIAT, V197, P28, DOI 10.1192/bjp.bp.109.068981; Sklar P, 2011, NAT GENET, V43, P977, DOI 10.1038/ng.943; Stone JL, 2004, AM J HUM GENET, V75, P1117, DOI 10.1086/426034; Suvisaari J, 2011, PSYCHIAT RES, V189, P305, DOI 10.1016/j.psychres.2011.07.006; Velakoulis D, 2009, BRIT J PSYCHIAT, V194, P298, DOI 10.1192/bjp.bp.108.057034; Weber H, 2011, NEUROPSYCHOPHARMACOL, V36, P2076, DOI 10.1038/npp.2011.98; WILHELMSEN KC, 1994, AM J HUM GENET, V55, P1159; Williams HJ, 2011, HUM MOL GENET, V20, P387, DOI 10.1093/hmg/ddq471; Zhu J, 2002, CELL, V111, P867, DOI 10.1016/S0092-8674(02)01141-8	36	27	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2012	7	4							e32164	10.1371/journal.pone.0032164	http://dx.doi.org/10.1371/journal.pone.0032164			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959FE	22505994	Green Published, Green Submitted, gold			2022-12-27	WOS:000305297500002
J	Gautam, AKS; Balakrishnan, S; Venkatraman, P				Gautam, Amit Kumar Singh; Balakrishnan, Satish; Venkatraman, Prasanna			Direct Ubiquitin Independent Recognition and Degradation of a Folded Protein by the Eukaryotic Proteasomes-Origin of Intrinsic Degradation Signals	PLOS ONE			English	Article							HUMAN THYMIDYLATE SYNTHASE; EMPIRICAL PARAMETERS; SECONDARY STRUCTURE; FOLDING PROBLEM; STRUCTURAL-CHARACTERIZATION; APOMYOGLOBIN; PATHWAY; INTERMEDIATE; PEPTIDES; RESOLUTION	Eukaryotic 26S proteasomes are structurally organized to recognize, unfold and degrade globular proteins. However, all existing model substrates of the 26S proteasome in addition to ubiquitin or adaptor proteins require unstructured regions in the form of fusion tags for efficient degradation. We report for the first time that purified 26S proteasome can directly recognize and degrade apomyoglobin, a globular protein, in the absence of ubiquitin, extrinsic degradation tags or adaptor proteins. Despite a high affinity interaction, absence of a ligand and presence of only helices/loops that follow the degradation signal, apomyoglobin is degraded slowly by the proteasome. A short floppy F-helix exposed upon ligand removal and in conformational equilibrium with a disordered structure is mandatory for recognition and initiation of degradation. Holomyoglobin, in which the helix is buried, is neither recognized nor degraded. Exposure of the floppy F-helix seems to sensitize the proteasome and primes the substrate for degradation. Using peptide panning and competition experiments we speculate that initial encounters through the floppy helix and additional strong interactions with N-terminal helices anchors apomyoglobin to the proteasome. Stabilizing helical structure in the floppy F-helix slows down degradation. Destabilization of adjacent helices accelerates degradation. Unfolding seems to follow the mechanism of helix unraveling rather than global unfolding. Our findings while confirming the requirement for unstructured regions in degradation offers the following new insights: a) origin and identification of an intrinsic degradation signal in the substrate, b) identification of sequences in the native substrate that are likely to be responsible for direct interactions with the proteasome, and c) identification of critical rate limiting steps like exposure of the intrinsic degron and destabilization of an unfolding intermediate that are presumably catalyzed by the ATPases. Apomyoglobin emerges as a new model substrate to further explore the role of ATPases and protein structure in proteasomal degradation	[Gautam, Amit Kumar Singh; Balakrishnan, Satish; Venkatraman, Prasanna] Adv Ctr Treatment Res & Educ Canc, Kharghar, Navi Mumbai, India	Tata Memorial Centre (TMC); Advance Centre for Treatment, Research & Education in Cancer (ACTREC)	Gautam, AKS (corresponding author), Adv Ctr Treatment Res & Educ Canc, Kharghar, Navi Mumbai, India.	vprasanna@actrec.gov.in	GAUTAM, AMIT KUMAR SINGH/AAN-6296-2020	GAUTAM, AMIT KUMAR SINGH/0000-0001-9846-1945	Department of Biotechnology, India [BT/PR7977/BRB/10/509/2006]; ACTREC	Department of Biotechnology, India(Department of Biotechnology (DBT) India); ACTREC	The work was supported by BT/PR7977/BRB/10/509/2006 Department of Biotechnology, India and ACTREC. A.K.S.G. is funded by a fellowship from the Department of Biotechnology, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arcovito A, 2007, P NATL ACAD SCI USA, V104, P6211, DOI 10.1073/pnas.0608411104; Baugh JM, 2009, J MOL BIOL, V386, P814, DOI 10.1016/j.jmb.2008.12.081; Baumeister W, 1998, CELL, V92, P367, DOI 10.1016/S0092-8674(00)80929-0; Benaroudj N, 2003, MOL CELL, V11, P69, DOI 10.1016/S1097-2765(02)00775-X; Cashikar AG, 2002, MOL CELL, V9, P751, DOI 10.1016/S1097-2765(02)00499-9; Cavagnero S, 2001, BIOCHEMISTRY-US, V40, P14459, DOI 10.1021/bi011500n; Cogan EB, 1999, ANAL BIOCHEM, V271, P29, DOI 10.1006/abio.1999.4100; DEVERAUX Q, 1994, J BIOL CHEM, V269, P7059; Eliezer D, 2000, BIOCHEMISTRY-US, V39, P2894, DOI 10.1021/bi992545f; Eliezer D, 1996, J MOL BIOL, V263, P531, DOI 10.1006/jmbi.1996.0596; Feng ZY, 1999, BIOCHEMISTRY-US, V38, P14433, DOI 10.1021/bi991933e; Fontana A, 2004, ACTA BIOCHIM POL, V51, P299; Forsthoefel AM, 2004, BIOCHEMISTRY-US, V43, P1972, DOI 10.1021/bi035894p; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; GRIKO YV, 1988, J MOL BIOL, V202, P127, DOI 10.1016/0022-2836(88)90525-6; Groll M, 2000, NAT STRUCT BIOL, V7, P1062, DOI 10.1038/80992; Groll M, 1997, NATURE, V386, P463, DOI 10.1038/386463a0; Hagai T, 2010, P NATL ACAD SCI USA, V107, P2001, DOI 10.1073/pnas.0912335107; Hanna J, 2007, FEBS LETT, V581, P2854, DOI 10.1016/j.febslet.2007.03.053; HARRISON SC, 1965, J BIOL CHEM, V240, P299; Henderson A, 2011, J BIOL CHEM, V286, P17495, DOI 10.1074/jbc.M110.212027; HUGHSON FM, 1990, SCIENCE, V249, P1544, DOI 10.1126/science.2218495; Iakoucheva LM, 2004, NUCLEIC ACIDS RES, V32, P1037, DOI 10.1093/nar/gkh253; Jamin M, 2005, PROTEIN PEPTIDE LETT, V12, P229, DOI 10.2174/0929866053587174; Jamin M, 1996, NAT STRUCT BIOL, V3, P613, DOI 10.1038/nsb0796-613; Janse DM, 2004, J BIOL CHEM, V279, P21415, DOI 10.1074/jbc.M402954200; Kisselev AF, 1999, J BIOL CHEM, V274, P3363, DOI 10.1074/jbc.274.6.3363; Lam YA, 2002, NATURE, V416, P763, DOI 10.1038/416763a; Le Gall T, 2007, J BIOMOL STRUCT DYN, V24, P325; Lecomte JTJ, 1996, PROTEINS, V25, P267, DOI 10.1002/(SICI)1097-0134(199607)25:3<267::AID-PROT1>3.3.CO;2-8; Lee C, 2001, MOL CELL, V7, P627, DOI 10.1016/S1097-2765(01)00209-X; Liu CW, 2003, SCIENCE, V299, P408, DOI 10.1126/science.1079293; Lobley A, 2002, BIOINFORMATICS, V18, P211, DOI 10.1093/bioinformatics/18.1.211; MORRISET.JD, 1973, BIOCHEMISTRY-US, V12, P1290, DOI 10.1021/bi00731a008; MUNOZ V, 1995, J MOL BIOL, V245, P297, DOI 10.1006/jmbi.1994.0024; MUNOZ V, 1994, NAT STRUCT BIOL, V1, P399, DOI 10.1038/nsb0694-399; MUNOZ V, 1995, J MOL BIOL, V245, P275, DOI 10.1006/jmbi.1994.0023; Navon A, 2001, MOL CELL, V8, P1339, DOI 10.1016/S1097-2765(01)00407-5; Nishimura C, 2011, J MOL BIOL, V411, P248, DOI 10.1016/j.jmb.2011.05.028; Ogura T, 2003, MOL CELL, V11, P3, DOI 10.1016/S1097-2765(03)00004-2; Onufriev A, 2003, J MOL BIOL, V325, P555, DOI 10.1016/S0022-2836(02)01207-X; PALOMBELLA VJ, 1994, CELL, V78, P773, DOI 10.1016/S0092-8674(94)90482-0; Pena MMO, 2006, BIOCHEM J, V394, P355, DOI 10.1042/BJ20051479; PHILLIPS SEV, 1980, J MOL BIOL, V142, P531, DOI 10.1016/0022-2836(80)90262-4; Picotti P, 2004, PROTEIN SCI, V13, P1572, DOI 10.1110/ps.04635304; Prakash S, 2004, NAT STRUCT MOL BIOL, V11, P830, DOI 10.1038/nsmb814; Prakash S, 2009, NAT CHEM BIOL, V5, P29, DOI 10.1038/nchembio.130; Rape M, 2002, NAT CELL BIOL, V4, pE113, DOI 10.1038/ncb0502-e113; Samatova EN, 2010, BIOPHYS J, V98, P1694, DOI 10.1016/j.bpj.2009.12.4326; Shirley B A, 1995, Methods Mol Biol, V40, P177; Sickmeier M, 2007, NUCLEIC ACIDS RES, V35, pD786, DOI 10.1093/nar/gkl893; Sone T, 2004, J BIOL CHEM, V279, P28807, DOI 10.1074/jbc.M403165200; SPRINGER BA, 1987, P NATL ACAD SCI USA, V84, P8961, DOI 10.1073/pnas.84.24.8961; Venkatraman P, 2004, MOL CELL, V14, P95, DOI 10.1016/S1097-2765(04)00151-0; Venkatraman P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005700; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Wolf DH, 2004, BBA-MOL CELL RES, V1695, P19, DOI 10.1016/j.bbamcr.2004.10.007; Zhang Y, 2007, STRUCTURE, V15, P1141, DOI 10.1016/j.str.2007.07.012	58	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2012	7	4							e34864	10.1371/journal.pone.0034864	http://dx.doi.org/10.1371/journal.pone.0034864			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959FE	22506054	Green Published, Green Submitted, gold			2022-12-27	WOS:000305297500062
J	Parrino, C; Rossetti, P; Baratta, R; La Spina, N; La Delfa, L; Squatrito, S; Vigneri, R; Frittitta, L				Parrino, Cristina; Rossetti, Paola; Baratta, Roberto; La Spina, Nadia; La Delfa, Lavinia; Squatrito, Sebastiano; Vigneri, Riccardo; Frittitta, Lucia			Secular Trends in the Prevalence of Overweight and Obesity in Sicilian Schoolchildren Aged 11-13 Years During the Last Decade	PLOS ONE			English	Article							BODY-MASS INDEX; US CHILDREN; CHILDHOOD OVERWEIGHT; INTERNATIONAL SURVEY; WAIST CIRCUMFERENCE; PEDIATRIC OBESITY; EXCESS WEIGHT; HEIGHT RATIO; ADOLESCENTS; THINNESS	The present study evaluates trends in the prevalence of overweight and obesity in relation to gender and area of residence between two cohorts of students aged 11-13 years in Sicily. The analysis was performed on 1,839 schoolchildren, with 924 and 915 children being studied in 1999-2001 and 2009-2010, respectively. The children who were enrolled during 2009-2010 had significantly higher body mass indexes (BMI), BMI z-scores, and waist circumferences than the children who were studied during 1999-2001 (p<0.0001 for all); these differences was also observed when the cohort was subdivided according to gender or residence area The prevalence of obesity increased significantly from 7.9% in 1999-2001 to 13.7% in 2009-2010 (p<0.0001), whereas thinness decreased significantly from 10.1% to 2.3% (p<0.0001) in the same periods. The increase of trends in the prevalence of obesity was significantly higher in males (9.7% vs. 17.6%, p = 0.0006) than in females (6.3% vs. 9.8%, p = 0.04) and was slightly higher in urban areas (8.8% vs. 14.3%, p = 0.002) than in rural areas (7.8% vs. 13.0%, p = 0.012). The male gender was associated with a higher risk of being overweight or obese (odds ratio: 1.63; 95% confidence intervals: 1.24-2.15; p = 0.0005) in 2009-2010 than in 1999-2001, after adjusting for age and the residence area. In conclusion, this study showed an increasing trend in the prevalence of overweight and obesity in Sicilian schoolchildren during the last decade and that this trend was related to gender, age and the area of residence. More specifically, our data indicated that the prevalence of obesity increased by 5.8%, the prevalence of thinness decreased by 7.8% and the prevalence of normal-weight children did not change over the course of a decade. These results suggest a shift in the body weights of Sicilian children toward the upper percentiles.	[Parrino, Cristina; Rossetti, Paola; Baratta, Roberto; La Spina, Nadia; La Delfa, Lavinia; Squatrito, Sebastiano; Vigneri, Riccardo; Frittitta, Lucia] Univ Catania, Sch Med, Garibaldi Hosp, Dept Clin & Mol Biomed,Endocrinol Unit, Catania, Italy	University of Catania	Parrino, C (corresponding author), Univ Catania, Sch Med, Garibaldi Hosp, Dept Clin & Mol Biomed,Endocrinol Unit, Catania, Italy.	lfritti@unict.it	Parrino, Cristina/ABA-7496-2020; Parrino, Cristina/H-4009-2018; frittitta, lucia/AAA-4733-2019; frittitta, Lucia/J-2334-2012; Vigneri, Riccardo/M-3968-2017	Parrino, Cristina/0000-0002-1367-6208; Parrino, Cristina/0000-0002-1367-6208; frittitta, lucia/0000-0002-7941-5828; Baratta, Roberto/0000-0003-0524-4525; Vigneri, Riccardo/0000-0002-4401-3140	Italian Minister of Health (Center for Disease Control)	Italian Minister of Health (Center for Disease Control)	This study was supported by a grant of Italian Minister of Health (Center for Disease Control). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archenti Anna, 2008, Acta Biomed, V79, P151; August GP, 2008, J CLIN ENDOCR METAB, V93, P4576, DOI 10.1210/jc.2007-2458; Baratta R, 2006, NUTR METAB CARDIOVAS, V16, P249, DOI 10.1016/j.numecd.2005.07.009; Branca F, 2007, CHALLENGE OBESITY WH, pS4; Cacciari E, 2002, EUR J CLIN NUTR, V56, P171, DOI 10.1038/sj.ejcn.1601314; Cali AMG, 2008, J CLIN ENDOCR METAB, V93, pS31, DOI 10.1210/jc.2008-1363; Chrzanowska M, 2007, ECON HUM BIOL, V5, P370, DOI 10.1016/j.ehb.2007.08.004; Cole TJ, 2007, BMJ-BRIT MED J, V335, P194, DOI 10.1136/bmj.39238.399444.55; COLE TJ, 1990, EUR J CLIN NUTR, V44, P45; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; de Onis M, 2010, AM J CLIN NUTR, V92, P1257, DOI 10.3945/ajcn.2010.29786; Eagle TF, 2010, AM HEART J, V160, P1185, DOI 10.1016/j.ahj.2010.09.019; Esquivel M, 2010, MEDICC REV, V12, P13, DOI 10.37757/MR2010.V12.N2.5; Freedman DS, 2009, PEDIATRICS, V124, pS23, DOI 10.1542/peds.2008-3586E; Gupta DK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017221; Jackson-Leach R, 2006, INT J PEDIATR OBES, V1, P26, DOI 10.1080/17477160600586614; Kipping RR, 2008, BMJ-BRIT MED J, V337, P1824; Kolle E, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-389; Lazzeri G, 2008, J Prev Med Hyg, V49, P13; Li CY, 2006, PEDIATRICS, V118, pE1390, DOI 10.1542/peds.2006-1062; Maffeis C, 2008, J PEDIATR-US, V152, P207, DOI 10.1016/j.jpeds.2007.09.021; Martinez-Vizcaino V, 2009, PUBLIC HEALTH NUTR, V12, P1015, DOI 10.1017/S1368980008003571; McCarthy HD, 2006, INT J OBESITY, V30, P988, DOI 10.1038/sj.ijo.0803226; Ogden CL, 2008, JAMA-J AM MED ASSOC, V299, P2401, DOI 10.1001/jama.299.20.2401; Ogden CL, 2010, JAMA-J AM MED ASSOC, V303, P242, DOI 10.1001/jama.2009.2012; Papadimitriou A, 2006, OBESITY, V14, P1113, DOI 10.1038/oby.2006.127; Papandreou C, 2008, OBES REV, V9, P389, DOI 10.1111/j.1467-789X.2007.00466.x; Prokai A, 2007, ACTA PHYSIOL HUNG, V94, P267, DOI 10.1556/APhysiol.94.2007.3.11; Rokholm B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020816; Rolland-Cachera MF, 2002, INT J OBESITY, V26, P1610, DOI 10.1038/sj.ijo.0802146; Spinelli A, 2011, EPIDEMIOL PREV, V35, P82; Sundblom E, 2008, INT J OBESITY, V32, P1525, DOI 10.1038/ijo.2008.104; Wang Y, 2006, INT J PEDIATR OBES, V1, P11, DOI 10.1080/17477160600586747; Yanovski SZ, 2011, NEW ENGL J MED, V364, P987, DOI 10.1056/NEJMp1009229	34	21	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2012	7	4							e34551	10.1371/journal.pone.0034551	http://dx.doi.org/10.1371/journal.pone.0034551			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959FE	22506027	Green Published, gold, Green Submitted			2022-12-27	WOS:000305297500035
J	Rueegg, CS; von der Weid, NX; Rebholz, CE; Michel, G; Zwahlen, M; Grotzer, M; Kuehni, CE				Rueegg, Corina S.; von der Weid, Nicolas X.; Rebholz, Cornelia E.; Michel, Gisela; Zwahlen, Marcel; Grotzer, Michael; Kuehni, Claudia E.		SPOG	Daily Physical Activities and Sports in Adult Survivors of Childhood Cancer and Healthy Controls: A Population-Based Questionnaire Survey	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; BONE-MINERAL DENSITY; AMERICAN-COLLEGE; EXERCISE PROGRAM; BEHAVIORS; MORTALITY; PERFORMANCE; ADOLESCENT; MEDICINE; COHORT	Background: Healthy lifestyle including sufficient physical activity may mitigate or prevent adverse long-term effects of childhood cancer. We described daily physical activities and sports in childhood cancer survivors and controls, and assessed determinants of both activity patterns. Methodology/Principal Findings: The Swiss Childhood Cancer Survivor Study is a questionnaire survey including all children diagnosed with cancer 1976-2003 at age 0-15 years, registered in the Swiss Childhood Cancer Registry, who survived >= 5years and reached adulthood (>= 20years). Controls came from the population-based Swiss Health Survey. We compared the two populations and determined risk factors for both outcomes in separate multivariable logistic regression models. The sample included 1058 survivors and 5593 controls (response rates 78% and 66%). Sufficient daily physical activities were reported by 52% (n = 521) of survivors and 37% (n = 2069) of controls (p<0.001). In contrast, 62% (n = 640) of survivors and 65% (n = 3635) of controls reported engaging in sports (p = 0.067). Risk factors for insufficient daily activities in both populations were: older age (OR for >= 35years: 1.5, 95CI 1.2-2.0), female gender (OR 1.6, 95CI 1.3-1.9), French/Italian Speaking (OR 1.4, 95CI 1.1-1.7), and higher education (OR for university education: 2.0, 95CI 1.5-2.6). Risk factors for no sports were: being a survivor (OR 1.3, 95CI 1.1-1.6), older age (OR for >= 35years: 1.4, 95CI 1.1-1.8), migration background (OR 1.5, 95CI 1.3-1.8), French/Italian speaking (OR 1.4, 95CI 1.2-1.7), lower education (OR for compulsory schooling only: 1.6, 95CI 1.2-2.2), being married (OR 1.7, 95CI 1.5-2.0), having children (OR 1.3, 95CI 1.4-1.9), obesity (OR 2.4, 95CI 1.7-3.3), and smoking (OR 1.7, 95CI 1.5-2.1). Type of diagnosis was only associated with sports. Conclusions/Significance: Physical activity levels in survivors were lower than recommended, but comparable to controls and mainly determined by socio-demographic and cultural factors. Strategies to improve physical activity levels could be similar as for the general population.	[Rueegg, Corina S.; Rebholz, Cornelia E.; Michel, Gisela; Zwahlen, Marcel; Kuehni, Claudia E.] Univ Bern, Inst Social & Prevent Med, Swiss Childhood Canc Registry, Bern, Switzerland; [von der Weid, Nicolas X.] CHU Vaudois, Paediat Hematol Oncol Unit, CH-1011 Lausanne, Switzerland; [Grotzer, Michael] Univ Childrens Hosp Zurich, Dept Oncol, Zurich, Switzerland	University of Bern; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University Children's Hospital Zurich	Rueegg, CS (corresponding author), Univ Bern, Inst Social & Prevent Med, Swiss Childhood Canc Registry, Bern, Switzerland.	kuehni@ispm.unibe.ch	Michel, Gisela/G-1081-2018; Zwahlen, Marcel/AFF-8559-2022; Rueegg, Corina Silvia/H-7128-2019	Michel, Gisela/0000-0002-9589-0928; Zwahlen, Marcel/0000-0002-6772-6346; Rueegg, Corina Silvia/0000-0003-3720-4659; Leibundgut, Kurt/0000-0003-2514-6041; Kuehni, Claudia E./0000-0001-8957-2002	Swiss Cancer League [KLS-01605-10-2004, KLS-2215-02-2008]; Bernese Cancer League; Cancer League Zurich; Swiss Bridge; Stiftung zur Krebsbekampfung; Swiss National Science Foundation [PA001-117433/1, 3233069348]; Bernese Cancer League (Berner Krebsstipendium); Swiss Paediatric Oncology Group; Kinderkrebshilfe Schweiz; Stiftung fur krebskranke Kinder Regio Basiliensis; Novartis Oncology Switzerland; Axa Wintherthur; Glaxo Smithkline; Amgen; Bristol Myers Squibb	Swiss Cancer League; Bernese Cancer League; Cancer League Zurich; Swiss Bridge; Stiftung zur Krebsbekampfung; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Bernese Cancer League (Berner Krebsstipendium); Swiss Paediatric Oncology Group; Kinderkrebshilfe Schweiz; Stiftung fur krebskranke Kinder Regio Basiliensis; Novartis Oncology Switzerland; Axa Wintherthur; Glaxo Smithkline(GlaxoSmithKline); Amgen(Amgen); Bristol Myers Squibb(Bristol-Myers Squibb)	This study was supported by the Swiss Cancer League (Grant No KLS-01605-10-2004 and KLS-2215-02-2008; www.krebsliga.ch), Bernese Cancer League (www.bernischekrebsliga.ch), Cancer League Zurich (www.krebsliga-zh.ch), Swiss Bridge (www.swissbridge.ch), and Stiftung zur Krebsbekampfung (www.krebsbekaempfung.ch). GM and CEK were funded by the Swiss National Science Foundation (GM: Fellowship grant PA001-117433/1; CEK: PROSPER grant 3233069348; www.snf.ch). CR was funded by the Bernese Cancer League (Berner Krebsstipendium 2010; www.bernischekrebsliga.ch). The work of the Swiss Childhood Cancer Registry is supported by the Swiss Paediatric Oncology Group (www.spog.ch), Kinderkrebshilfe Schweiz (www.kinderkrebshilfe.ch), Stiftung fur krebskranke Kinder Regio Basiliensis (www.krebskrankekinder.ch), Novartis Oncology Switzerland (www.novartisoncology.ch), Interpharma (www.interpharma.ch), Axa Wintherthur (www.axa-winterthur.ch), Glaxo Smithkline (www.glaxosmithkline.ch), Amgen (www.amgen.ch), Bristol Myers Squibb (www.bms.ch) and numerous other sponsors. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez JA, 2007, CURR OPIN PEDIATR, V19, P23, DOI 10.1097/MOP.0b013e328013c89e; Barr-Anderson DJ, 2011, AM J PREV MED, V40, P76, DOI 10.1016/j.amepre.2010.09.033; Blaauwbroek R, 2009, SUPPORT CARE CANCER, V17, P1041, DOI 10.1007/s00520-008-0533-y; Butterfield RM, 2004, PSYCHO-ONCOLOGY, V13, P619, DOI 10.1002/pon.764; Cox CL, 2009, CANCER-AM CANCER SOC, V115, P642, DOI 10.1002/cncr.24043; Demark-Wahnefried W, 2005, J CLIN ONCOL, V23, P5814, DOI 10.1200/JCO.2005.01.230; Demark-Wahnefried W, 2005, CANCER, V103, P2171, DOI 10.1002/cncr.21009; Diller L, 2009, J CLIN ONCOL, V27, P2339, DOI 10.1200/JCO.2008.21.1953; Feller M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013156; Finnegan L, 2007, ONCOL NURS FORUM, V34, P201, DOI 10.1188/07.ONF.E60-E69; Florin TA, 2007, CANCER EPIDEM BIOMAR, V16, P1356, DOI 10.1158/1055-9965.EPI-07-0048; Gatta G, 2009, EUR J CANCER, V45, P992, DOI 10.1016/j.ejca.2008.11.042; Germann U, 2005, EIDGENOSSISCHE VOLKS; GODIN G, 1986, CAN J PUBLIC HEALTH, V77, P359; Hartman A, 2009, PEDIATR BLOOD CANCER, V53, P64, DOI 10.1002/pbc.21942; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI [10.1249/mss.0b013e3180616b27, 10.1161/CIRCULATIONAHA.107.185649]; Hawkins MM, 2008, PEDIATR BLOOD CANCER, V50, P1018, DOI 10.1002/pbc.21335; Jarvela LS, 2010, J CANCER SURVIV, V4, P339, DOI 10.1007/s11764-010-0131-0; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Juan AFS, 2008, INT J SPORTS MED, V29, P163, DOI 10.1055/s-2007-964908; Kuehni CE, 2011, INT J EPIDEMIOL, DOI [10.1093/ije/dyr1142, DOI 10.1093/IJE/DYR1142]; Kuehni CE, 2012, CANCER-AM CANCER SOC, V118, P1439, DOI 10.1002/cncr.26418; Liebherr R, 2010, NEUCHATEL BUNDESAMT; Mader U, 2006, MED SCI SPORT EXER, V38, P1255, DOI 10.1249/01.mss.0000227310.18902.28; Makinen T, 2010, EUR J PUBLIC HEALTH, V20, P346, DOI 10.1093/eurpub/ckp187; Mayer EIE, 2000, HORM RES, V53, P193, DOI 10.1159/000023566; Meacham LR, 2010, CANCER EPIDEM BIOMAR, V19, P170, DOI 10.1158/1055-9965.EPI-09-0555; Mertens AC, 2008, JNCI-J NATL CANCER I, V100, P1368, DOI 10.1093/jnci/djn310; Michel G, 2007, SWISS MED WKLY, V137, P502; Naylor AS, 2008, P NATL ACAD SCI USA, V105, P14632, DOI 10.1073/pnas.0711128105; Ness KK, 2009, J CLIN ONCOL, V27, P2382, DOI 10.1200/JCO.2008.21.1482; Ness KK, 2009, CANCER-AM CANCER SOC, V115, P1984, DOI 10.1002/cncr.24209; Oeffinger KC, 2004, CA-CANCER J CLIN, V54, P208, DOI 10.3322/canjclin.54.4.208; Oeffinger KC, 2006, NEW ENGL J MED, V355, P1572, DOI 10.1056/NEJMsa060185; Reeves M, 2007, AUST FAM PHYSICIAN, V36, P95; Reulen RC, 2010, JAMA-J AM MED ASSOC, V304, P172, DOI 10.1001/jama.2010.923; Robison LL, 2002, MED PEDIATR ONCOL, V38, P229, DOI 10.1002/mpo.1316; Samitz G, 2011, INT J EPIDEMIOL, V40, P1382, DOI 10.1093/ije/dyr112; San Juan AF, 2008, INT J SPORTS MED, V29, P439, DOI 10.1055/s-2007-965571; San Juan AF, 2007, MED SCI SPORT EXER, V39, P13, DOI 10.1249/01.mss.0000240326.54147.fc; Juan AFS, 2011, RECENT RESULTS CANC, V186, P319, DOI 10.1007/978-3-642-04231-7_14; Schmitz KH, 2010, MED SCI SPORT EXER, V42, P1409, DOI 10.1249/MSS.0b013e3181e0c112; Speck RM, 2010, J CANCER SURVIV, V4, P87, DOI 10.1007/s11764-009-0110-5; Steliarova-Foucher E, 2005, CANCER-AM CANCER SOC, V103, P1457, DOI 10.1002/cncr.20910; Stolley MR, 2010, ANN BEHAV MED, V39, P232, DOI 10.1007/s12160-010-9192-6; Thornton J, 1997, PHYSICIAN SPORTSMED, V25, P97, DOI 10.3810/psm.1997.11.1448; Tillmann V, 2002, J BONE MINER RES, V17, P1073, DOI 10.1359/jbmr.2002.17.6.1073; U.S. Department of Health and Human Services, 1996, PHYS ACT HLTH REP SU; US Department of Health and Human Services, 2010, HLTH PEOPL 2010, V2; van Brussel M, 2011, PEDIATR PHYS THER, V23, P2, DOI 10.1097/PEP.0b013e318208cb22; Westerterp KR, 2009, EUR J APPL PHYSIOL, V105, P823, DOI 10.1007/s00421-009-1000-2; Winter C, 2010, PEDIATR BLOOD CANCER, V54, P501, DOI 10.1002/pbc.22271; World Health Organization, 1995, PHYS STAT US INT ANT; WYNDER EL, 1990, J CLIN EPIDEMIOL, V43, P619, DOI 10.1016/0895-4356(90)90167-N	54	25	25	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2012	7	4							e34930	10.1371/journal.pone.0034930	http://dx.doi.org/10.1371/journal.pone.0034930			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959FE	22506058	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000305297500065
J	Wikgren, M; Karlsson, T; Lind, J; Nilbrink, T; Hultdin, J; Sleegers, K; Van Broeckhoven, C; Roos, G; Nilsson, LG; Nyberg, L; Adolfsson, R; Norrback, KF				Wikgren, Mikael; Karlsson, Thomas; Lind, Johanna; Nilbrink, Therese; Hultdin, Johan; Sleegers, Kristel; Van Broeckhoven, Christine; Roos, Goran; Nilsson, Lars-Goran; Nyberg, Lars; Adolfsson, Rolf; Norrback, Karl-Fredrik			Longer Leukocyte Telomere Length Is Associated with Smaller Hippocampal Volume among Non-Demented APOE epsilon 3/epsilon 3 Subjects	PLOS ONE			English	Article							APOLIPOPROTEIN-E EPSILON-4; ALZHEIMERS-DISEASE; PROSPECTIVE COHORT; MEMORY; RISK; HEALTH; NEUROGENESIS; DEMENTIA; CARRIERS; BETULA	Telomere length shortens with cellular division, and leukocyte telomere length is used as a marker for systemic telomere length. The hippocampus hosts adult neurogenesis and is an important structure for episodic memory, and carriers of the apolipoprotein E epsilon 4 allele exhibit higher hippocampal atrophy rates and differing telomere dynamics compared with non-carriers. The authors investigated whether leukocyte telomere length was associated with hippocampal volume in 57 cognitively intact subjects (29 epsilon 3/epsilon 3 carriers; 28 epsilon 4 carriers) aged 49-79 yr. Leukocyte telomere length correlated inversely with left (r(s) = -0.465; p = 0.011), right (r(s) = -0.414; p = 0.025), and total hippocampus volume (r(s) = -0.519; p = 0.004) among APOE epsilon 3/epsilon 3 carriers, but not among epsilon 4 carriers. However, the epsilon 4 carriers fit with the general correlation pattern exhibited by the epsilon 3/epsilon 3 carriers, as epsilon 4 carriers on average had longer telomeres and smaller hippocampi compared with epsilon 3/epsilon 3 carriers. The relationship observed can be interpreted as long telomeres representing a history of relatively low cellular proliferation, reflected in smaller hippocampal volumes. The results support the potential of leukocyte telomere length being used as a biomarker for tapping functional and structural processes of the aging brain.	[Wikgren, Mikael; Nilbrink, Therese; Adolfsson, Rolf; Norrback, Karl-Fredrik] Umea Univ, Dept Clin Sci, Div Psychiat, Umea, Sweden; [Karlsson, Thomas] Linkoping Univ, Dept Behav Sci & Learning, Linkoping, Sweden; [Lind, Johanna] Univ Oslo, Dept Psychol, Oslo, Norway; [Hultdin, Johan] Umea Univ, Dept Med Biosci, Div Clin Chem, Umea, Sweden; [Sleegers, Kristel; Van Broeckhoven, Christine] VIB, Dept Mol Genet, Neurodegenerat Brain Dis Grp, Antwerp, Belgium; [Sleegers, Kristel; Van Broeckhoven, Christine] Univ Antwerp, Neurogenet Lab, Inst Born Bunge, B-2020 Antwerp, Belgium; [Roos, Goran] Umea Univ, Dept Med Biosci, Div Pathol, Umea, Sweden; [Nilsson, Lars-Goran] Stockholm Univ, Dept Psychol, S-10691 Stockholm, Sweden; [Nilsson, Lars-Goran] Stockholm Brain Inst, Stockholm, Sweden; [Nyberg, Lars] Umea Univ, Dept Radiat Sci Radiol, Umea, Sweden; [Nyberg, Lars] Umea Univ, Dept Integrat Med Biol Physiol, Umea, Sweden	Umea University; Linkoping University; University of Oslo; Umea University; Flanders Institute for Biotechnology (VIB); University of Antwerp; Umea University; Stockholm University; Umea University; Umea University	Wikgren, M (corresponding author), Umea Univ, Dept Clin Sci, Div Psychiat, Umea, Sweden.	mikael.wikgren@psychiat.umu.se	Van Broeckhoven, Christine/M-7853-2019; Van Broeckhoven, Christine/G-8362-2017; Nyberg, Lars/M-5986-2019; Nyberg, Lars/C-2514-2009; Hultdin, Johan/AAD-4623-2021	Van Broeckhoven, Christine/0000-0003-0183-7665; Van Broeckhoven, Christine/0000-0003-0183-7665; Nyberg, Lars/0000-0002-3367-1746; Nyberg, Lars/0000-0002-3367-1746; Hultdin, Johan/0000-0002-9599-0961; Adolfsson, Rolf/0000-0001-9785-8473	Swedish Research Council [2006-4472, 2009-5269, 2009-3413, 345-2003-3883, 315-2004-6977]; Medical Faculty, Umea University; County Council of Vasterbotten, Sweden; County Council of Norrbotten, Sweden	Swedish Research Council(Swedish Research CouncilEuropean Commission); Medical Faculty, Umea University; County Council of Vasterbotten, Sweden; County Council of Norrbotten, Sweden	The research was funded by the Swedish Research Council (grants 2006-4472; 2009-5269; 2009-3413), the Medical Faculty, Umea University and the County Councils of Vasterbotten and Norrbotten, Sweden. The Betula Study is supported by grants 345-2003-3883 and 315-2004-6977 from the Swedish Research Council. The Apolipoprotein E genotyping was funded by the Fund for Scientific Research - Flanders (FWO-V). K. S. holds a postdoctoral fellowship of the FWO-V. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brouilette SW, 2007, LANCET, V369, P107, DOI 10.1016/S0140-6736(07)60071-3; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Chan SRWL, 2004, PHILOS T R SOC B, V359, P109, DOI 10.1098/rstb.2003.1370; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Deng W, 2010, NAT REV NEUROSCI, V11, P339, DOI 10.1038/nrn2822; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Fleisher A, 2005, ARCH NEUROL-CHICAGO, V62, P953, DOI 10.1001/archneur.62.6.953; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Friedrich U, 2000, MECH AGEING DEV, V119, P89, DOI 10.1016/S0047-6374(00)00173-1; Grodstein F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001590; JACK CR, 1992, NEUROLOGY, V42, P183, DOI 10.1212/WNL.42.1.183; Kimura M, 2010, EXP HEMATOL, V38, P854, DOI 10.1016/j.exphem.2010.06.010; Lind J, 2006, BRAIN, V129, P1240, DOI 10.1093/brain/awl054; Lind J, 2006, NEUROSCI LETT, V396, P23, DOI 10.1016/j.neulet.2005.11.070; Moffat SD, 2000, NEUROLOGY, V55, P134, DOI 10.1212/WNL.55.1.134; Nilsson LG, 2006, NEUROPSYCHOLOGY, V20, P645, DOI 10.1037/0894-4105.20.6.645; Nilsson LG, 1997, AGING NEUROPSYCHOL C, V4, P1, DOI 10.1080/13825589708256633; Nilsson LG, 2004, AGING NEUROPSYCHOL C, V11, P134, DOI 10.1080/13825580490511026; Nordfjall K, 2007, BIOCHEM BIOPH RES CO, V358, P215, DOI 10.1016/j.bbrc.2007.04.099; Persson J, 2006, CEREB CORTEX, V16, P907, DOI 10.1093/cercor/bhj036; Rufer N, 1998, NAT BIOTECHNOL, V16, P743, DOI 10.1038/nbt0898-743; Shay JW, 2005, CARCINOGENESIS, V26, P867, DOI 10.1093/carcin/bgh296; SRNT Subcommittee on Biochemical Verification, 2002, Nicotine Tob Res, V4, P149, DOI 10.1080/14622200210123581; Svenson U, 2009, BBA-MOL BASIS DIS, V1792, P317, DOI 10.1016/j.bbadis.2009.01.017; Takubo K, 2002, EXP GERONTOL, V37, P523, DOI 10.1016/S0531-5565(01)00218-2; Thomas P, 2008, MECH AGEING DEV, V129, P183, DOI 10.1016/j.mad.2007.12.004; Van Petten C, 2004, NEUROPSYCHOLOGIA, V42, P1394, DOI 10.1016/j.neuropsychologia.2004.04.006; Vitek MP, 2009, NEUROBIOL AGING, V30, P1350, DOI 10.1016/j.neurobiolaging.2007.11.014; von Zglinicki T, 2000, LAB INVEST, V80, P1739, DOI 10.1038/labinvest.3780184; Wikgren M, 2012, NEUROBIOL AGING, V33, P335, DOI 10.1016/j.neurobiolaging.2010.03.004	30	25	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2012	7	4							e34292	10.1371/journal.pone.0034292	http://dx.doi.org/10.1371/journal.pone.0034292			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959FE	22506016	Green Published, gold, Green Submitted			2022-12-27	WOS:000305297500024
J	Kaneko, T; Serikawa, T				Kaneko, Takehito; Serikawa, Tadao			Successful Long-Term Preservation of Rat Sperm by Freeze-Drying	PLOS ONE			English	Article							KNOCKOUT RATS; MOUSE SPERMATOZOA; IN-VITRO; EMBRYO MICROINJECTION; OOCYTES; FERTILIZATION; IMPROVEMENT; ACTIVATION; GENERATION; TOLERANCE	Background: Freeze-drying sperm has been developed as a new preservation method where liquid nitrogen is no longer necessary. An advantage of freeze-drying sperm is that it can be stored at 4 degrees C and transported at room temperature. Although the successful freeze-drying of sperm has been reported in a number of animals, the possibility of long-term preservation using this method has not yet been studied. Methodology/Principal Findings: Offspring were obtained from oocytes fertilized with rat epididymal sperm freeze-dried using a solution containing 10 mM Tris and 1 mM EDTA adjusted to pH 8.0. Tolerance of testicular sperm to freeze-drying was increased by pre-treatment with diamide. Offspring with normal fertility were obtained from oocytes fertilized with freeze-dried epididymal sperm stored at 4 degrees C for 5 years. Conclusions and Significance: Sperm with -SS- cross-linking in the thiol-disulfide of their protamine were highly tolerant to freeze-drying, and the fertility of freeze-dried sperm was maintained for 5 years without deterioration. This is the first report to demonstrate the successful freeze-drying of sperm using a new and simple method for long-term preservation.	[Kaneko, Takehito; Serikawa, Tadao] Kyoto Univ, Inst Lab Anim, Grad Sch Med, Kyoto, Japan	Kyoto University	Kaneko, T (corresponding author), Kyoto Univ, Inst Lab Anim, Grad Sch Med, Kyoto, Japan.	tkaneko@anim.med.kyoto-u.ac.jp			Grant-in-aid for National BioResource Project (NBRP) Fundamental Technologies Upgrading Program	Grant-in-aid for National BioResource Project (NBRP) Fundamental Technologies Upgrading Program	This study was supported in part by a Grant-in-aid for National BioResource Project (NBRP) Fundamental Technologies Upgrading Program. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitman TJ, 2008, NAT GENET, V40, P516, DOI 10.1038/ng.147; Charreau B, 1996, TRANSGENIC RES, V5, P223, DOI 10.1007/BF01972876; CHULAVATNATOL M, 1982, INT J ANDROL, V5, P425, DOI 10.1111/j.1365-2605.1982.tb00272.x; Geurts AM, 2009, SCIENCE, V325, P433, DOI 10.1126/science.1172447; Hirabayashi M, 2005, ZYGOTE, V13, P79, DOI 10.1017/S096719940500300X; Jacob HJ, 1999, GENOME RES, V9, P1013, DOI 10.1101/gr.9.11.1013; Kaneko T, 2007, THERIOGENOLOGY, V68, P1017, DOI 10.1016/j.theriogenology.2007.07.017; Kaneko T, 2005, COMPARATIVE MED, V55, P140; Kaneko T, 2003, BIOL REPROD, V69, P1859, DOI 10.1095/biolreprod.103.019729; Kaneko T, 2003, BIOL REPROD, V68, P136, DOI 10.1095/biolreprod.102.008706; Kaneko T, 2006, CRYOBIOLOGY, V53, P279, DOI 10.1016/j.cryobiol.2006.06.004; Kaneko T, 2011, J AM ASSOC LAB ANIM, V50, P33; Kaneko T, 2009, CRYOBIOLOGY, V58, P293, DOI 10.1016/j.cryobiol.2009.02.004; Kashiwazaki N, 2010, METHODS MOL BIOL, V597, P311, DOI 10.1007/978-1-60327-389-3_22; Keskintepe L, 2002, BIOL REPROD, V67, P409, DOI 10.1095/biolreprod67.2.409; KOSOWER NS, 1992, J ANDROL, V13, P342; Kwon IK, 2004, BIOL REPROD, V71, P1430, DOI 10.1095/biolreprod.104.031260; Liu JL, 2004, BIOL REPROD, V70, P1776, DOI 10.1095/biolreprod.103.025957; Maione B, 1997, DNA CELL BIOL, V16, P1087, DOI 10.1089/dna.1997.16.1087; Mashimo T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008870; MIYOSHI K, 1995, J REPROD FERTIL, V103, P27, DOI 10.1530/jrf.0.1030027; MULLINS JJ, 1990, NATURE, V344, P541, DOI 10.1038/344541a0; Nakatsukasa E, 2001, REPRODUCTION, V122, P463, DOI 10.1530/rep.0.1220463; NIWA K, 1974, BIOL REPROD, V11, P463, DOI 10.1095/biolreprod11.4.463; Sakamoto W, 2005, COMPARATIVE MED, V55, P136; Sakkas D, 2002, BIOL REPROD, V66, P1061, DOI 10.1095/biolreprod66.4.1061; Sanchez-Partida LG, 2008, FERTIL STERIL, V89, P742, DOI 10.1016/j.fertnstert.2007.02.066; Seita Y, 2009, BIOL REPROD, V80, P503, DOI 10.1095/biolreprod.108.072918; Serikawa T, 2009, EXP ANIM TOKYO, V58, P333, DOI 10.1538/expanim.58.333; Si W, 2006, CRYOBIOLOGY, V53, P336, DOI 10.1016/j.cryobiol.2006.09.001; Tesson L, 2011, NAT BIOTECHNOL, V29, P695, DOI 10.1038/nbt.1940; Wakayama T, 1998, NAT BIOTECHNOL, V16, P639, DOI 10.1038/nbt0798-639; Ward MA, 2003, BIOL REPROD, V69, P2100, DOI 10.1095/biolreprod.103.020529; Zan YH, 2003, NAT BIOTECHNOL, V21, P645, DOI 10.1038/nbt830	34	31	33	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2012	7	4							e35043	10.1371/journal.pone.0035043	http://dx.doi.org/10.1371/journal.pone.0035043			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JO	22496889	Green Submitted, Green Published, gold			2022-12-27	WOS:000305014500040
J	Lin, WC; Chou, KH; Chen, CC; Huang, CC; Chen, HL; Lu, CH; Li, SH; Wang, YL; Cheng, YF; Lin, CP				Lin, Wei-Che; Chou, Kun-Hsien; Chen, Chien-Chih; Huang, Chu-Chung; Chen, Hsiu-Ling; Lu, Cheng-Hsien; Li, Shau-Hsuan; Wang, Ya-Ling; Cheng, Yu-Fan; Lin, Ching-Po			White Matter Abnormalities Correlating with Memory and Depression in Heroin Users under Methadone Maintenance Treatment	PLOS ONE			English	Article							SPONGIFORM LEUKOENCEPHALOPATHY; DIFFUSION; DRUG; DAMAGE; ABUSE	Methadone maintenance treatment (MMT) has elevated rates of co-morbid memory deficit and depression that are associated with higher relapse rates for substance abuse. White matter (WM) disruption in MMT patients have been reported but their impact on these co-morbidities is unknown. This study aimed to investigate changes in WM integrity of MMT subjects using diffusion tensor image (DTI), and their relationship with history of heroin and methadone use in treated opiate-dependent individuals. The association between WM integrity changes from direct group comparisons and the severity of memory deficit and depression was also investigated. Differences in WM integrity between 35 MMT patients and 23 healthy controls were evaluated using DTI with tract-based spatial statistical analysis. Differences in DTI indices correlated with diminished memory function, Beck Depression Inventory, duration of heroin use and MMT, and dose of heroin and methadone administration. Changes in WM integrity were found in several WM regions, including the temporal and frontal lobes, pons, cerebellum, and cingulum bundles. The duration of MMT was associated with declining DTI indices in the superior longitudinal fasciculus and para-hippocampus. MMT patients had more memory and emotional deficits than healthy subjects. Worse scores in both depression and memory functions were associated with altered WM integrity in the superior longitudinal fasciculus, para-hippocampus, and middle cerebellar peduncle in MMT. Patients on MMT also had significant WM differences in the reward circuit and in depression-and memory-associated regions. Correlations among decreased DTI indices, disease severity, and accumulation effects of methadone suggest that WM alterations may be involved in the psychopathology and pathophysiology of co-morbidities in MMT.	[Lin, Wei-Che; Chen, Hsiu-Ling; Cheng, Yu-Fan] Chang Gung Univ, Coll Med, Kaohsiung Chang Gung Mem Hosp, Dept Diagnost Radiol, Kaohsiung, Taiwan; [Lin, Wei-Che; Huang, Chu-Chung; Chen, Hsiu-Ling; Lin, Ching-Po] Natl Yang Ming Univ, Dept Biomed Imaging & Radiol Sci, Taipei 112, Taiwan; [Chou, Kun-Hsien; Lin, Ching-Po] Natl Yang Ming Univ, Inst Neurosci, Taipei 112, Taiwan; [Chen, Chien-Chih; Wang, Ya-Ling] Chang Gung Univ, Coll Med, Kaohsiung Chang Gung Mem Hosp, Dept Psychiat, Kaohsiung, Taiwan; [Lu, Cheng-Hsien] Chang Gung Univ, Coll Med, Kaohsiung Chang Gung Mem Hosp, Dept Neurol, Kaohsiung, Taiwan; [Li, Shau-Hsuan] Chang Gung Univ, Coll Med, Kaohsiung Chang Gung Mem Hosp, Dept Internal Med, Kaohsiung, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University	Lin, WC (corresponding author), Chang Gung Univ, Coll Med, Kaohsiung Chang Gung Mem Hosp, Dept Diagnost Radiol, Kaohsiung, Taiwan.	cplin@ym.edu.tw	Huang, James/ADK-6342-2022	Huang, Chu-Chung/0000-0002-9096-9610	Chang Gung Medical Research Project [CGMH 880561, 870482]; National Health Research Institute [NHRI-EX100-9813EC]; National Science Council (NSC) [100-2628-E-010-002-MY3]	Chang Gung Medical Research Project; National Health Research Institute(National Health Research Institutes - Taiwan); National Science Council (NSC)(Ministry of Science and Technology, Taiwan)	This study was supported by grants from the Chang Gung Medical Research Project (CGMH 880561, 870482), National Health Research Institute (NHRI-EX100-9813EC) and National Science Council (NSC 100-2628-E-010-002-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI [10.1006/jmrb.1996.0086, 10.1016/j.jmr.2011.09.022]; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Beck A.T., 1996, PSYCHOL ASSESS, V10, DOI [10.1037/t00742-000, DOI 10.1037/T00742-000]; Benton A, 1978, PSYCHOL ASSESSMENT R; Benton A.L., 1974, REVISED VISUAL RETEN; Benton AL, 1968, TEST PRAXIE CONSTRUC; Boronat MA, 2001, BRIT J PHARMACOL, V134, P1263, DOI 10.1038/sj.bjp.0704364; Darke S, 2001, ADDICTION, V96, P1443, DOI 10.1046/j.1360-0443.2001.961014438.x; Galantucci S, 2011, BRAIN, V134, P3011, DOI 10.1093/brain/awr099; HATSUKAMI D, 1982, AM J PSYCHIAT, V139, P1563; Hepner IJ, 2002, PHYSIOL BEHAV, V76, P41, DOI 10.1016/S0031-9384(02)00695-9; Hua M.-S., 1986, WORD SEQUENCE UNPUB; Hua MS, 1997, NEUROPSYCHOLOGY, V11, P156, DOI 10.1037/0894-4105.11.1.156; Hua MS, 1986, RECENT REMOTE UNPUB; Huang H, 2011, NEUROBIOL AGING; Lee TMC, 2005, NEUROSCI LETT, V382, P211, DOI 10.1016/j.neulet.2005.03.053; Lim G, 2005, PAIN, V114, P81, DOI 10.1016/j.pain.2004.11.019; Lin WC, 2009, AM J NEURORADIOL, V30, P1248, DOI 10.3174/ajnr.A1517; Liu HH, 2009, PSYCHIAT CLIN NEUROS, V63, P563, DOI 10.1111/j.1440-1819.2009.01989.x; Lu CH, 2011, AM J NEURORADIOL, V32, P1333, DOI 10.3174/ajnr.A2489; Lyoo IK, 2006, PSYCHOPHARMACOLOGY, V184, P139, DOI 10.1007/s00213-005-0198-x; Madden GJ, 1997, EXP CLIN PSYCHOPHARM, V5, P256, DOI 10.1037/1064-1297.5.3.256; Maller JJ, 2010, BRAIN RES REV, V64, P213, DOI 10.1016/j.brainresrev.2010.04.003; Mintzer MZ, 2005, DRUG ALCOHOL DEPEN, V78, P225, DOI 10.1016/j.drugalcdep.2004.10.008; Mintzer MZ, 2002, DRUG ALCOHOL DEPEN, V67, P41, DOI 10.1016/S0376-8716(02)00013-3; Miquel Marta, 2009, Curr Drug Abuse Rev, V2, P26; MORONI F, 1977, N-S ARCH PHARMACOL, V299, P149, DOI 10.1007/BF00498556; Nakamura M, 2005, BIOL PSYCHIAT, V58, P468, DOI 10.1016/j.biopsych.2005.04.016; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Nobuhara K, 2006, J NEUROL NEUROSUR PS, V77, P120, DOI 10.1136/jnnp.2004.055129; Peles E, 2007, J AFFECT DISORDERS, V99, P213, DOI 10.1016/j.jad.2006.09.017; Phillips ML, 2003, BIOL PSYCHIAT, V54, P504, DOI 10.1016/S0006-3223(03)00168-9; Prosser J, 2006, DRUG ALCOHOL DEPEN, V84, P240, DOI 10.1016/j.drugalcdep.2006.02.006; Rapeli Pekka, 2007, BMC Clin Pharmacol, V7, P5, DOI 10.1186/1472-6904-7-5; Reitan RM, 1996, HALSTEAD REITAN NEUR; Rizzuto N, 1997, ACTA NEUROPATHOL, V94, P87, DOI 10.1007/s004010050676; Robbins TW, 2008, ANN NY ACAD SCI, V1141, P1, DOI 10.1196/annals.1441.020; Sapolsky RM, 2000, ARCH GEN PSYCHIAT, V57, P925, DOI 10.1001/archpsyc.57.10.925; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Song SK, 2005, NEUROIMAGE, V26, P132, DOI 10.1016/j.neuroimage.2005.01.028; Song SK, 2003, NEUROIMAGE, V20, P1714, DOI 10.1016/j.neuroimage.2003.07.005; Taylor WD, 2011, AM J GERIAT PSYCHIAT, V19, P43, DOI 10.1097/JGP.0b013e3181e70cec; Tramullas M, 2007, PSYCHOPHARMACOLOGY, V193, P107, DOI 10.1007/s00213-007-0751-x; Verdejo A, 2005, DRUG ALCOHOL DEPEN, V78, P283, DOI 10.1016/j.drugalcdep.2004.11.006; Wang YR, 2011, NEUROSCI LETT, V494, P49, DOI 10.1016/j.neulet.2011.02.053; Weber W, 1998, EUR RADIOL, V8, P749, DOI 10.1007/s003300050467; Wechsler D, 1981, WECHSLER ADAPT INTEL; Yuan Y, 2009, BRAIN COGNITION, V71, P223, DOI 10.1016/j.bandc.2009.08.014	50	22	26	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2012	7	4							e33809	10.1371/journal.pone.0033809	http://dx.doi.org/10.1371/journal.pone.0033809			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JO	22496768	Green Published, gold, Green Submitted			2022-12-27	WOS:000305014500017
J	Bai, VU; Hwang, O; Divine, GW; Barrack, ER; Menon, M; Reddy, GPV; Hwang, C				Bai, V. Uma; Hwang, Ok; Divine, George W.; Barrack, Evelyn R.; Menon, Mani; Reddy, G. Prem-Veer; Hwang, Clara			Averaged Differential Expression for the Discovery of Biomarkers in the Blood of Patients with Prostate Cancer	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; DORFIN LOCALIZES; GENE-EXPRESSION; LEWY BODIES; CELL-DEATH; SYNPHILIN-1; MORTALITY; SURVIVAL; PATHWAY; ANTIGEN	Background: The identification of a blood-based diagnostic marker is a goal in many areas of medicine, including the early diagnosis of prostate cancer. We describe the use of averaged differential display as an efficient mechanism for biomarker discovery in whole blood RNA. The process of averaging reduces the problem of clinical heterogeneity while simultaneously minimizing sample handling. Methodology/Principal Findings: RNA was isolated from the blood of prostate cancer patients and healthy controls. Samples were pooled and subjected to the averaged differential display process. Transcripts present at different levels between patients and controls were purified and sequenced for identification. Transcript levels in the blood of prostate cancer patients and controls were verified by quantitative RT-PCR. Means were compared using a t-test and a receiver-operating curve was generated. The Ring finger protein 19A (RNF19A) transcript was identified as having higher levels in prostate cancer patients compared to healthy men through the averaged differential display process. Quantitative RT-PCR analysis confirmed a more than 2-fold higher level of RNF19A mRNA levels in the blood of patients with prostate cancer than in healthy controls (p = 0.0066). The accuracy of distinguishing cancer patients from healthy men using RNF19A mRNA levels in blood as determined by the area under the receiving operator curve was 0.727. Conclusions/Significance: Averaged differential display offers a simplified approach for the comprehensive screening of body fluids, such as blood, to identify biomarkers in patients with prostate cancer. Furthermore, this proof-of-concept study warrants further analysis of RNF19A as a clinically relevant biomarker for prostate cancer detection.	[Bai, V. Uma; Barrack, Evelyn R.; Menon, Mani; Reddy, G. Prem-Veer] Henry Ford Hlth Syst, Dept Urol, Detroit, MI USA; [Bai, V. Uma; Barrack, Evelyn R.; Menon, Mani; Reddy, G. Prem-Veer] Henry Ford Hlth Syst, Vattikuti Inst Urol, Detroit, MI USA; [Hwang, Ok; Hwang, Clara] Henry Ford Hlth Syst, Dept Internal Med, Detroit, MI USA; [Divine, George W.] Henry Ford Hlth Syst, Dept Publ Hlth Sci, Detroit, MI USA; [Bai, V. Uma; Hwang, Ok; Divine, George W.; Barrack, Evelyn R.; Menon, Mani; Reddy, G. Prem-Veer; Hwang, Clara] Henry Ford Hlth Syst, Josephine Ford Canc Ctr, Detroit, MI USA	Henry Ford Health System; Henry Ford Hospital; Henry Ford Health System; Henry Ford Hospital; Henry Ford Health System; Henry Ford Hospital; Henry Ford Health System; Henry Ford Hospital; Henry Ford Health System; Henry Ford Hospital	Bai, VU (corresponding author), Henry Ford Hlth Syst, Dept Urol, Detroit, MI USA.	chwang2@hfhs.org	Hwang, Clara/AFJ-8520-2022; Hwang, Clara/AAF-5302-2022	Hwang, Clara/0000-0002-0998-323X; Hwang, Clara/0000-0002-0998-323X	Vattikuti Urology Institute	Vattikuti Urology Institute	This study was funded by the Vattikuti Urology Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andriole GL, 2009, NEW ENGL J MED, V360, P1310, DOI 10.1056/NEJMoa0810696; Bai VU, 2007, P NATL ACAD SCI USA, V104, P2343, DOI 10.1073/pnas.0610504104; Bhusari SS, 2010, EPIGENETICS-US, V5, P402, DOI 10.4161/epi.5.5.11853; Bill-Axelson A, 2011, NEW ENGL J MED, V364, P1708, DOI 10.1056/NEJMoa1011967; Bostwick DG, 2000, CANCER, V89, P123, DOI 10.1002/1097-0142(20000701)89:1<123::AID-CNCR17>3.0.CO;2-9; Catalona WJ, 1998, J UROLOGY, V160, P2428, DOI 10.1016/S0022-5347(01)62204-3; Dayyani F, 2011, JNCI-J NATL CANCER I, V103, P1665, DOI 10.1093/jnci/djr362; Eyre SJ, 2009, J UROLOGY, V182, P2653, DOI 10.1016/j.juro.2009.08.056; Giaime E, 2006, J BIOL CHEM, V281, P11515, DOI 10.1074/jbc.M508619200; Hishikawa N, 2003, AM J PATHOL, V163, P609, DOI 10.1016/S0002-9440(10)63688-7; Ito T, 2003, J BIOL CHEM, V278, P29106, DOI 10.1074/jbc.M302763200; Lee G, 2002, J NEUROCHEM, V83, P346, DOI 10.1046/j.1471-4159.2002.01136.x; Liang P, 2003, NAT REV CANCER, V3, P869, DOI 10.1038/nrc1214; LIANG P, 1994, METH MOL G, V5, P3; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Niwa J, 2002, J BIOL CHEM, V277, P36793, DOI 10.1074/jbc.M206559200; Ozsolak F, 2011, NAT REV GENET, V12, P87, DOI 10.1038/nrg2934; Parekh DJ, 2006, UROLOGY, V68, P1152, DOI 10.1016/j.urology.2006.10.022; Schroeder FH, 2009, NEW ENGL J MED, V360, P1320, DOI 10.1056/NEJMoa0810084; Shipley WU, 1999, JAMA-J AM MED ASSOC, V281, P1598, DOI 10.1001/jama.281.17.1598; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Takeuchi H, 2004, J NEUROCHEM, V89, P64, DOI 10.1046/j.1471-4159.2003.02289.x; Thompson IM, 2004, NEW ENGL J MED, V350, P2239, DOI 10.1056/NEJMoa031918; Thompson IM, 2005, JAMA-J AM MED ASSOC, V294, P66, DOI 10.1001/jama.294.1.66; Walsh P C, 1994, Important Adv Oncol, P211; Xu KX, 2009, CANCER CELL, V15, P270, DOI 10.1016/j.ccr.2009.02.021	26	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2012	7	4							e34875	10.1371/journal.pone.0034875	http://dx.doi.org/10.1371/journal.pone.0034875			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JA	22493721	Green Published, gold, Green Submitted			2022-12-27	WOS:000305012700063
J	Liu, Y; Pan, SD; Liu, L; Zhai, XJ; Liu, JB; Wen, J; Zhang, YX; Chen, JG; Shen, HB; Hu, ZB				Liu, Yao; Pan, Shandong; Liu, Li; Zhai, Xiangjun; Liu, Jibin; Wen, Juan; Zhang, Yixin; Chen, Jianguo; Shen, Hongbing; Hu, Zhibin			A Genetic Variant in Long Non-Coding RNA HULC Contributes to Risk of HBV-Related Hepatocellular Carcinoma in a Chinese Population	PLOS ONE			English	Article							CANCER; TRANSLOCATION	Background: Recently, several studies have demonstrated that two long non-coding RNAs (lncRNAs), HULC and MALAT1, may participate in hepatocellular carcinoma (HCC) development and progression. However, genetic variations in the two lncRNAs and their associations with HCC susceptibility have not been reported. In this study, we hypothesized that single nucleotide polymorphisms (SNPs) in HULC and MALAT1 may contribute to HCC risk. Methods: We conducted a case-control study and genotyped two SNPs, rs7763881 in HULC and rs619586 in MALAT1, in 1300 HBV positive HCC patients, 1344 HBV persistent carriers and 1344 subjects with HBV natural clearance to test the associations between the two SNPs and susceptibility to HCC and HBV chronic infection. Results: The variant genotypes of rs7763881 were significantly associated with decreased HCC risk in a dominant genetic model [AC/CC vs. AA: adjusted odds ration (OR) = 0.81, 95% confidence intervals (CIs) = 0.68-0.97, P = 0.022]. Furthermore, the variant genotypes of rs619586 was associated with decreased HCC risk with a borderline significance (AG/GG vs. AA: adjusted OR = 0.81, 95% CIs = 0.65-1.01, P = 0.057). However, no significant association was found between the two SNPs and HBV clearance. Conclusions: The variant genotypes of rs7763881 in HULC may contribute to decreased susceptibility to HCC in HBV persistent carriers.	[Liu, Yao; Pan, Shandong; Wen, Juan; Shen, Hongbing; Hu, Zhibin] Nanjing Med Univ, Sch Publ Hlth, MOE Key Lab Modern Toxicol, Dept Epidemiol & Biostat, Nanjing, Jiangsu, Peoples R China; [Liu, Li; Liu, Jibin; Zhang, Yixin] Nantong Tumor Hosp, Dept Hepatobiliary Surg, Nantong, Peoples R China; [Liu, Li] Nanjing Med Univ, Affiliated Hosp 2, Inst Digest Endoscopy, Nanjing, Jiangsu, Peoples R China; [Liu, Li] Nanjing Med Univ, Affiliated Hosp 2, Med Ctr Digest Dis, Nanjing, Jiangsu, Peoples R China; [Zhai, Xiangjun] Jiangsu Prov Ctr Dis Prevent & Control, Dept Infect Dis, Nanjing, Jiangsu, Peoples R China; [Chen, Jianguo] Qidong Liver Canc Res Inst, Qidong, Peoples R China; [Shen, Hongbing; Hu, Zhibin] Nanjing Med Univ, Ctr Canc, Jiangsu Key Lab Canc Biomarkers Prevent & Treatme, Clin Epidemiol Sect, Nanjing, Jiangsu, Peoples R China; [Shen, Hongbing; Hu, Zhibin] Nanjing Med Univ, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University	Liu, Y (corresponding author), Nanjing Med Univ, Sch Publ Hlth, MOE Key Lab Modern Toxicol, Dept Epidemiol & Biostat, Nanjing, Jiangsu, Peoples R China.	zhibin_hu@njmu.edu.cn	, 雷克思/ABG-3956-2020	, 雷克思/0000-0003-4102-8934	Priority Academic Program Development of Jiangsu Higher Education Institutions; Foundation for the Author of National Excellent Doctoral Dissertation [201081]; National Natural Science Foundation of China [30800946, 81072344]; Natural Science Foundation Jiangsu Ministry of Health [H200957]; Program for New Century Excellent Talents in University [NCET-10-0178]; National Major ST Projects [2011ZX10004-902]	Priority Academic Program Development of Jiangsu Higher Education Institutions; Foundation for the Author of National Excellent Doctoral Dissertation(Foundation for the Author of National Excellent Doctoral Dissertation of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation Jiangsu Ministry of Health; Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); National Major ST Projects	This work was supported in part by Priority Academic Program Development of Jiangsu Higher Education Institutions, Foundation for the Author of National Excellent Doctoral Dissertation (grant no.: 201081), National Natural Science Foundation of China (grant nos.: 30800946, 81072344), Natural Science Foundation Jiangsu Ministry of Health (grant no.: H200957), the Program for New Century Excellent Talents in University (NCET-10-0178) and National Major S&T Projects (grant no.: 2011ZX10004-902). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernard D, 2010, EMBO J, V29, P3082, DOI 10.1038/emboj.2010.199; Chuang SC, 2009, CANCER LETT, V286, P9, DOI 10.1016/j.canlet.2008.10.040; Davis IJ, 2003, P NATL ACAD SCI USA, V100, P6051, DOI 10.1073/pnas.0931430100; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Guffanti A, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-163; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Hu L., 2011, HEPATOLOGY; Hutchinson JN, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-39; Jin G, 2011, CARCINOGENESIS; Lin CP, 2010, WORLD J HEPATOL, V2, P16, DOI 10.4254/wjh.v2.i1.16; Lin R, 2007, ONCOGENE, V26, P851, DOI 10.1038/sj.onc.1209846; Matouk IJ, 2009, EUR J GASTROEN HEPAT, V21, P688, DOI 10.1097/MEG.0b013e328306a3a2; Panzitt K, 2007, GASTROENTEROLOGY, V132, P330, DOI 10.1053/j.gastro.2006.08.026; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Ponting CP, 2009, CELL, V136, P629, DOI 10.1016/j.cell.2009.02.006; Rajaram V, 2007, GENE CHROMOSOME CANC, V46, P508, DOI 10.1002/gcc.20437; Song Il Han, 2009, Korean J Hepatol, V15 Suppl 6, pS50, DOI 10.3350/kjhep.2009.15.S6.S50; Tripathi V, 2010, MOL CELL, V39, P925, DOI 10.1016/j.molcel.2010.08.011; Walter SR, 2011, J GASTROENTEROL HEPA; Wang Y, 2011, EXPERT REV ANTI-INFE, V9, P21, DOI [10.1586/eri.10.143, 10.1586/ERI.10.143]; Yang JD, 2010, NAT REV GASTRO HEPAT, V7, P448, DOI 10.1038/nrgastro.2010.100; Zhang S, 2010, INT J GYNECOL OBSTET, V109, P194, DOI 10.1016/j.ijgo.2010.01.002	22	146	158	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2012	7	4							e35145	10.1371/journal.pone.0035145	http://dx.doi.org/10.1371/journal.pone.0035145			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JA	22493738	gold, Green Published, Green Submitted			2022-12-27	WOS:000305012700080
J	Marconi, E; Nieus, T; Maccione, A; Valente, P; Simi, A; Messa, M; Dante, S; Baldelli, P; Berdondini, L; Benfenati, F				Marconi, Emanuele; Nieus, Thierry; Maccione, Alessandro; Valente, Pierluigi; Simi, Alessandro; Messa, Mirko; Dante, Silvia; Baldelli, Pietro; Berdondini, Luca; Benfenati, Fabio			Emergent Functional Properties of Neuronal Networks with Controlled Topology	PLOS ONE			English	Article							READILY RELEASABLE POOL; HIPPOCAMPAL-NEURONS; CONNECTIVITY; IDENTIFICATION; VESICLES; CIRCUIT; MODELS; MEA	The interplay between anatomical connectivity and dynamics in neural networks plays a key role in the functional properties of the brain and in the associated connectivity changes induced by neural diseases. However, a detailed experimental investigation of this interplay at both cellular and population scales in the living brain is limited by accessibility. Alternatively, to investigate the basic operational principles with morphological, electrophysiological and computational methods, the activity emerging from large in vitro networks of primary neurons organized with imposed topologies can be studied. Here, we validated the use of a new bio-printing approach, which effectively maintains the topology of hippocampal cultures in vitro and investigated, by patch-clamp and MEA electrophysiology, the emerging functional properties of these grid-confined networks. In spite of differences in the organization of physical connectivity, our bio-patterned grid networks retained the key properties of synaptic transmission, short-term plasticity and overall network activity with respect to random networks. Interestingly, the imposed grid topology resulted in a reinforcement of functional connections along orthogonal directions, shorter connectivity links and a greatly increased spiking probability in response to focal stimulation. These results clearly demonstrate that reliable functional studies can nowadays be performed on large neuronal networks in the presence of sustained changes in the physical network connectivity.	[Marconi, Emanuele; Nieus, Thierry; Maccione, Alessandro; Valente, Pierluigi; Simi, Alessandro; Messa, Mirko; Dante, Silvia; Baldelli, Pietro; Berdondini, Luca; Benfenati, Fabio] Fdn Ist Italiano Tecnol, Dept Neurosci & Brain Technol, Genoa, Italy; [Dante, Silvia] Fdn Ist Italiano Tecnol, Dept Nanophys, Genoa, Italy; [Marconi, Emanuele; Baldelli, Pietro; Benfenati, Fabio] Univ Genoa, Dept Expt Med, Physiol Sect, Genoa, Italy	Istituto Italiano di Tecnologia - IIT; Istituto Italiano di Tecnologia - IIT; University of Genoa	Marconi, E (corresponding author), Fdn Ist Italiano Tecnol, Dept Neurosci & Brain Technol, Genoa, Italy.	thierry.nieus@iit.it	Baldelli, Pietro/AAH-2493-2021; Berdondini, Luca/O-3201-2013; Valente, Pierluigi/AAF-2802-2021; dante, silvia/J-2996-2012; Baldelli, Pietro/AAA-6298-2020	Berdondini, Luca/0000-0001-9521-2812; maccione, alessandro/0000-0002-5044-9899; Dante, Silvia/0000-0001-6906-8482; Nieus, Thierry/0000-0001-8708-1015; Baldelli, Pietro/0000-0001-9599-3436; Simi, Alessandro/0000-0002-0427-8523	Italian Ministry of University and Research; Italian Ministry of Health Progetto Giovani Ricercatori; Compagnia di San Paolo, Torino; Telethon-Italy [GGP09134, GGP09066]	Italian Ministry of University and Research(Ministry of Education, Universities and Research (MIUR)); Italian Ministry of Health Progetto Giovani Ricercatori(Ministry of Health, Italy); Compagnia di San Paolo, Torino(Compagnia di San Paolo); Telethon-Italy(Fondazione Telethon)	This study was supported by research grants from the Italian Ministry of University and Research (PRIN to F. B.), the Italian Ministry of Health Progetto Giovani Ricercatori (to P. B.) and the Compagnia di San Paolo, Torino (to F. B. and P. B.). The support of Telethon-Italy (Grant GGP09134 to F. B. and GGP09066 to P. B.) is also acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arenas A, 2008, PHYS REP, V469, P93, DOI 10.1016/j.physrep.2008.09.002; Baldelli P, 2005, J NEUROSCI, V25, P3358, DOI 10.1523/JNEUROSCI.4227-04.2005; Baldelli P, 2007, J NEUROSCI, V27, P13520, DOI 10.1523/JNEUROSCI.3151-07.2007; BANKER G, 1998, CULTURING NERVE CELL; BEKKERS JM, 1991, P NATL ACAD SCI USA, V88, P7834, DOI 10.1073/pnas.88.17.7834; Berdondini L, 2006, SENSOR ACTUAT B-CHEM, V114, P530, DOI 10.1016/j.snb.2005.04.042; Berdondini L, 2009, LAB CHIP, V9, P2644, DOI 10.1039/b907394a; Binzegger T, 2004, J NEUROSCI, V24, P8441, DOI 10.1523/JNEUROSCI.1400-04.2004; Binzegger T, 2009, NEURAL NETWORKS, V22, P1071, DOI 10.1016/j.neunet.2009.07.011; Bologna LL, 2010, NEUROSCIENCE, V165, P692, DOI 10.1016/j.neuroscience.2009.11.018; Bonifazi P, 2005, EUR J NEUROSCI, V22, P2953, DOI 10.1111/j.1460-9568.2005.04464.x; Bonifazi P, 2009, SCIENCE, V326, P1419, DOI 10.1126/science.1175509; Buibas M, 2011, NEURAL COMPUT, V23, P183, DOI 10.1162/NECO_a_00065; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Buzsaki G, 2004, TRENDS NEUROSCI, V27, P186, DOI 10.1016/j.tins.2004.02.007; Chang JC, 2003, BIOMATERIALS, V24, P2863, DOI 10.1016/S0142-9612(03)00116-9; Chiappalone M, 2006, BRAIN RES, V1093, P41, DOI 10.1016/j.brainres.2006.03.049; Chiu DT, 2000, P NATL ACAD SCI USA, V97, P2408, DOI 10.1073/pnas.040562297; COREY JM, 1991, J NEUROSCI RES, V30, P300, DOI 10.1002/jnr.490300204; DULCEY CS, 1991, SCIENCE, V252, P551, DOI 10.1126/science.2020853; Erickson J, 2008, J NEUROSCI METH, V175, P1, DOI 10.1016/j.jneumeth.2008.07.023; Feinerman O, 2008, NAT PHYS, V4, P967, DOI 10.1038/nphys1099; Ferreira A, 2002, CELL MOL LIFE SCI, V59, P589, DOI 10.1007/s00018-002-8451-5; Garofalo M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006482; Grinstein G, 2005, P NATL ACAD SCI USA, V102, P9948, DOI 10.1073/pnas.0504127102; Grun S, 2010, SPRINGER SERIES COMP, V7, P443; Ivenshitz M, 2010, J NEUROPHYSIOL, V104, P1052, DOI 10.1152/jn.00914.2009; Jones E., 2001, LEAST SQUARE REGRESS; Jun SB, 2007, J NEUROSCI METH, V160, P317, DOI 10.1016/j.jneumeth.2006.09.009; Jungblut M, 2009, BIOMED MICRODEVICES, V11, P1269, DOI 10.1007/s10544-009-9346-0; Kitano K, 2007, J COMPUT NEUROSCI, V23, P237, DOI 10.1007/s10827-007-0030-1; KLEINFELD D, 1988, J NEUROSCI, V8, P4098; Liao DH, 1999, NAT NEUROSCI, V2, P37, DOI 10.1038/4540; Lichtman JW, 2000, NEURON, V25, P269, DOI 10.1016/S0896-6273(00)80893-4; Linkert M, 2010, J CELL BIOL, V189, P777, DOI 10.1083/jcb.201004104; Liu HS, 2009, J NEUROSCI, V29, P7395, DOI 10.1523/JNEUROSCI.1341-09.2009; Maccione A., 2010, FRONTIERS NEUROENGIN, V3, P12; Maccione A, 2009, J NEUROSCI METH, V177, P241, DOI 10.1016/j.jneumeth.2008.09.026; Mai J, 2009, J NEUROSCI, V29, P7450, DOI 10.1523/JNEUROSCI.1121-09.2009; Maiorano G, 2010, ACS NANO, V4, P7481, DOI 10.1021/nn101557e; MALLART A, 1967, J PHYSIOL-LONDON, V193, P679, DOI 10.1113/jphysiol.1967.sp008388; Morin F, 2006, BIOSENS BIOELECTRON, V21, P1093, DOI 10.1016/j.bios.2005.04.020; Muller-Linow M, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000190; Nam Y, 2006, BIOSENS BIOELECTRON, V22, P589, DOI 10.1016/j.bios.2006.01.027; Netoff TI, 2004, J NEUROSCI, V24, P8075, DOI 10.1523/JNEUROSCI.1509-04.2004; Rasband W, IMAGEJ; Rosenmund C, 1996, NEURON, V16, P1197, DOI 10.1016/S0896-6273(00)80146-4; Roupioz Y, 2009, SMALL, V5, P1493, DOI 10.1002/smll.200801941; Sanz-Arigita EJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013788; Schneggenburger R, 2002, TRENDS NEUROSCI, V25, P206, DOI 10.1016/S0166-2236(02)02139-2; Shein Idelson M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014443; Silberberg G, 2005, TRENDS NEUROSCI, V28, P541, DOI 10.1016/j.tins.2005.08.004; Sokal RR, BIOMETRY PRINCIPLES; Sporns O, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001049; Stenger DA, 1998, J NEUROSCI METH, V82, P167, DOI 10.1016/S0165-0270(98)00047-8; Stevenson IH, 2008, CURR OPIN NEUROBIOL, V18, P582, DOI 10.1016/j.conb.2008.11.005; Suzuki I, 2007, BIOCHEM BIOPH RES CO, V356, P470, DOI 10.1016/j.bbrc.2007.03.006; Taylor AM, 2005, NAT METHODS, V2, P599, DOI 10.1038/NMETH777; Vogt AK, 2005, BIOMATERIALS, V26, P2549, DOI 10.1016/j.biomaterials.2004.07.031; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wesseling JF, 2002, J NEUROSCI, V22, P9708; Wheeler BC, 2010, P IEEE, V98, P398, DOI 10.1109/JPROC.2009.2039029; Xu JT, 2004, BIOMED MICRODEVICES, V6, P117, DOI 10.1023/B:BMMD.0000031748.13353.10	63	83	84	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2012	7	4							e34648	10.1371/journal.pone.0034648	http://dx.doi.org/10.1371/journal.pone.0034648			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JA	22493706	Green Submitted, Green Published, gold			2022-12-27	WOS:000305012700048
J	Riou, M; Stroebel, D; Edwardson, JM; Paoletti, P				Riou, Morgane; Stroebel, David; Edwardson, J. Michael; Paoletti, Pierre			An Alternating GluN1-2-1-2 Subunit Arrangement in Mature NMDA Receptors	PLOS ONE			English	Article							CELL-SURFACE EXPRESSION; D-ASPARTATE RECEPTOR; DISULFIDE BONDS; TERMINAL DOMAIN; NR1 SUBUNIT; INHIBITION; ACTIVATION; MECHANISM; PROTEINS; PORE	NMDA receptors (NMDARs) form glutamate-gated ion channels that play a critical role in CNS physiology and pathology. Together with AMPA and kainate receptors, NMDARs are known to operate as tetrameric complexes with four membrane-embedded subunits associating to form a single central ion-conducting pore. While AMPA and some kainate receptors can function as homomers, NMDARs are obligatory heteromers composed of homologous but distinct subunits, most usually of the GluN1 and GluN2 types. A fundamental structural feature of NMDARs, that of the subunit arrangement around the ion pore, is still controversial. Thus, in a typical NMDAR associating two GluN1 and two GluN2 subunits, there is evidence for both alternating 1/2/1/2 and non-alternating 1/1/2/2 arrangements. Here, using a combination of electrophysiological and cross-linking experiments, we provide evidence that functional GluN1/GluN2A receptors adopt the 1/2/1/2 arrangement in which like subunits are diagonal to one another. Moreover, based on the recent crystal structure of an AMPA receptor, we show that in the agonist-binding and pore regions, the GluN1 subunits occupy a "proximal" position, closer to the central axis of the channel pore than that of GluN2 subunits. Finally, results obtained with reducing agents that differ in their membrane permeability indicate that immature (intracellular) and functional (plasma-membrane inserted) pools of NMDARs can adopt different subunit arrangements, thus stressing the importance of discriminating between the two receptor pools in assembly studies. Elucidating the quaternary arrangement of NMDARs helps to define the interface between the subunits and to understand the mechanism and pharmacology of these key signaling receptors.	[Riou, Morgane; Stroebel, David; Paoletti, Pierre] Ecole Normale Super, Inst Biol ENS, IBENS, F-75231 Paris, France; [Riou, Morgane; Stroebel, David; Paoletti, Pierre] INSERM, U1024, Paris, France; [Edwardson, J. Michael] Univ Cambridge, Dept Pharmacol, Cambridge CB2 1QJ, England; [Riou, Morgane; Stroebel, David; Paoletti, Pierre] CNRS, UMR 8197, Paris, France	UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Institut National de la Sante et de la Recherche Medicale (Inserm); University of Cambridge; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB)	Riou, M (corresponding author), Ecole Normale Super, Inst Biol ENS, IBENS, 24 Rue Lhomond, F-75231 Paris, France.	pierre.paoletti@ens.fr	Paoletti, Pierre/L-7358-2013	Paoletti, Pierre/0000-0002-3681-4845	Wellcome Trust; Central National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (INSERM); Fondation pour la Recherche Medicale (FRM, Equipe FRM); Direction Generale de l'Armement	Wellcome Trust(Wellcome TrustEuropean Commission); Central National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Fondation pour la Recherche Medicale (FRM, Equipe FRM); Direction Generale de l'Armement	This work supported by Wellcome Trust, Central National de la Recherche Scientifique (CNRS), Institut National de la Sante et de la Recherche Medicale (INSERM), Fondation pour la Recherche Medicale (FRM, Equipe FRM), and Direction Generale de l'Armement. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banke TG, 2003, NAT NEUROSCI, V6, P144, DOI 10.1038/nn1000; Blanke ML, 2008, MOL PHARMACOL, V74, P454, DOI 10.1124/mol.107.044115; Chang HR, 2008, J NEUROSCI, V28, P1546, DOI 10.1523/JNEUROSCI.3485-07.2008; Das U, 2010, P NATL ACAD SCI USA, V107, P8463, DOI 10.1073/pnas.1000838107; Farina AN, 2011, J NEUROSCI, V31, P3565, DOI 10.1523/JNEUROSCI.6041-10.2011; Furukawa H, 2005, NATURE, V438, P185, DOI 10.1038/nature04089; Gielen M, 2008, NEURON, V57, P80, DOI 10.1016/j.neuron.2007.11.021; Gielen M, 2009, NATURE, V459, P703, DOI 10.1038/nature07993; GLUSKER JP, 1991, ADV PROTEIN CHEM, V42, P1; HAZES B, 1988, PROTEIN ENG, V2, P119, DOI 10.1093/protein/2.2.119; Horak M, 2009, J BIOL CHEM, V284, P9683, DOI 10.1074/jbc.M807050200; Inanobe A, 2005, NEURON, V47, P71, DOI 10.1016/j.neuron.2005.05.022; Karakas E, 2011, NATURE, V475, P249, DOI 10.1038/nature10180; Krovetz HS, 1997, BIOPHYS J, V72, P117, DOI 10.1016/S0006-3495(97)78651-X; Kussius CL, 2009, NAT NEUROSCI, V12, P1114, DOI 10.1038/nn.2361; Lee CH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019180; Mayer ML, 2011, STRUCTURE, V19, P1370, DOI 10.1016/j.str.2011.08.009; Mayer ML, 2006, NATURE, V440, P456, DOI 10.1038/nature04709; McIlhinney RAJ, 1998, NEUROPHARMACOLOGY, V37, P1355, DOI 10.1016/S0028-3908(98)00121-X; Mony L, 2011, EMBO J, V30, P3134, DOI 10.1038/emboj.2011.203; Okabe S, 1999, J NEUROSCI, V19, P7781; Paoletti P, 1997, J NEUROSCI, V17, P5711; Paoletti P, 2011, EUR J NEUROSCI, V33, P1351, DOI 10.1111/j.1460-9568.2011.07628.x; Qiu S, 2005, J BIOL CHEM, V280, P24923, DOI 10.1074/jbc.M413915200; Rambhadran A, 2010, J BIOL CHEM, V285, P15296, DOI 10.1074/jbc.M109.085035; Salussolia CL, 2011, J NEUROSCI, V31, P11295, DOI 10.1523/JNEUROSCI.5612-10.2011; Schorge S, 2003, J NEUROSCI, V23, P1151, DOI 10.1523/JNEUROSCI.23-04-01151.2003; Sobolevsky AI, 2007, J GEN PHYSIOL, V129, P509, DOI 10.1085/jgp.200609718; Sobolevsky AI, 2009, NATURE, V462, P745, DOI 10.1038/nature08624; Stroebel D, 2011, NEUROPHARMACOLOGY, V60, P151, DOI 10.1016/j.neuropharm.2010.07.003; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; VIELES P, 1972, J CHIM PHYS PCB, V69, P869, DOI 10.1051/jcp/1972690869	33	28	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2012	7	4							e35134	10.1371/journal.pone.0035134	http://dx.doi.org/10.1371/journal.pone.0035134			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JA	22493736	Green Published, Green Submitted, gold			2022-12-27	WOS:000305012700078
J	Valentinova, L; Beer, NL; Stanik, J; Tribble, ND; van de Bunt, M; Huckova, M; Barrett, A; Klimes, I; Gasperikova, D; Gloyn, AL				Valentinova, Lucia; Beer, Nicola L.; Stanik, Juraj; Tribble, Nicholas D.; van de Bunt, Martijn; Huckova, Miroslava; Barrett, Amy; Klimes, Iwar; Gasperikova, Daniela; Gloyn, Anna L.			Identification and Functional Characterisation of Novel Glucokinase Mutations Causing Maturity-Onset Diabetes of the Young in Slovakia	PLOS ONE			English	Article							BETA-CELL GLUCOKINASE; HYPERINSULINEMIC HYPOGLYCEMIA; GCK GENE; MODY; HYPERGLYCEMIA; GLUCOSE; DIAGNOSIS; CHILDREN; HETEROGENEITY; HNF-1-ALPHA	Heterozygous glucokinase (GCK) mutations cause a subtype of maturity-onset diabetes of the young (GCK-MODY). Over 600 GCK mutations have been reported of which similar to 65% are missense. In many cases co-segregation has not been established and despite the importance of functional studies in ascribing pathogenicity for missense variants these have only been performed for <10% of mutations. The aim of this study was to determine the minimum prevalence of GCK-MODY amongst diabetic subjects in Slovakia by sequencing GCK in 100 Slovakian probands with a phenotype consistent with GCK-MODY and to explore the pathogenicity of identified variants through family and functional studies. Twenty-two mutations were identified in 36 families (17 missense) of which 7 (I110N, V200A, N204D, G258R, F419S, c.580-2A>C, c.1113-1114delGC) were novel. Parental DNA was available for 22 probands (covering 14/22 mutations) and co-segregation established in all cases. Bioinformatic analysis predicted all missense mutations to be damaging. Nine (I110N, V200A, N204D, G223S, G258R, F419S, V244G, L315H, I436N) mutations were functionally evaluated. Basic kinetic analysis explained pathogenicity for 7 mutants which showed reduced glucokinase activity with relative activity indices (RAI) between 0.6 to <0.001 compared to wild-type GCK (1.0). For the remaining 2 mutants additional molecular mechanisms were investigated. Differences in glucokinase regulatory protein (GKRP) -mediated-inhibition of GCK were observed for both L315H & I436N when compared to wild type (IC50 14.6 +/- 0.1 mM & 20.3 +/- 1.6 mM vs. 13.36 +/- 0.1 mM respectively [p<0.03]). Protein instability as assessed by thermal lability studies demonstrated that both L315H and I436N show marked thermal instability compared to wild-type GCK (RAI at 55 degrees C 8.8 +/- 0.8% & 3.1 +/- 0.4% vs. 42.56 +/- 3.9% respectively [p<0.001]). The minimum prevalence of GCK-MODY amongst Slovakian patients with diabetes was 0.03%. In conclusion, we have identified 22 GCK mutations in 36 Slovakian probands and demonstrate that combining family, bioinformatic and functional studies can aid the interpretation of variants identified by molecular diagnostic screening.	[Valentinova, Lucia; Stanik, Juraj; Huckova, Miroslava; Klimes, Iwar; Gasperikova, Daniela] Slovak Acad Sci, Inst Expt Endocrinol, Bratislava, Slovakia; [Valentinova, Lucia; Beer, Nicola L.; Tribble, Nicholas D.; van de Bunt, Martijn; Barrett, Amy; Gloyn, Anna L.] Univ Oxford, Oxford Ctr Diabet Endocrinol & Metab, Oxford, England; [Stanik, Juraj] Comenius Univ, Children Diabet Ctr, Dept Paediat 1, Bratislava, Slovakia; [Huckova, Miroslava; Klimes, Iwar; Gasperikova, Daniela] Slovak Acad Sci, Ctr Mol Med, Bratislava, Slovakia; [Gloyn, Anna L.] NIHR Oxford Biomed Res Ctr, Oxford, England	Slovak Academy of Sciences; University of Oxford; Comenius University Bratislava; Slovak Academy of Sciences; University of Oxford	Valentinova, L (corresponding author), Slovak Acad Sci, Inst Expt Endocrinol, Bratislava, Slovakia.	anna.gloyn@drl.ox.ac.uk	Stanik, Juraj/AAQ-6217-2021; Gasperikova, Daniela/E-7824-2018	Stanik, Juraj/0000-0002-0538-1274; Gasperikova, Daniela/0000-0002-5725-6424; van de Bunt, Martijn/0000-0002-6744-6125; Gloyn, Anna/0000-0003-1205-1844	Oxford by the Medical Research Council [81696]; European Foundation for the Study of Diabetes; Wellcome Trust [095101/Z/10/Z]; European Community [223211, CEED3]; Slovakia by the Slovak Diabetes Association; Scientific Grant Agency of the Ministry of Education, Science, Research and Sports of the Slovak Republic; Slovak Academy of Sciences [VEGA2/0151/11]; Research & Development Operational Programme [TRANSENDOGEN/26240220051]; European Regional Development Fund ERDF; Medical Research Council [G0700222] Funding Source: researchfish; MRC [G0700222] Funding Source: UKRI	Oxford by the Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Foundation for the Study of Diabetes; Wellcome Trust(Wellcome TrustEuropean Commission); European Community(European Commission); Slovakia by the Slovak Diabetes Association; Scientific Grant Agency of the Ministry of Education, Science, Research and Sports of the Slovak Republic; Slovak Academy of Sciences(Slovak Academy of Sciences); Research & Development Operational Programme; European Regional Development Fund ERDF(European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded in Oxford by the Medical Research Council (81696), the European Foundation for the Study of Diabetes (Albert Renold Travel Fellowship awarded to LV), and the Wellcome Trust (095101/Z/10/Z). The research leading to these results has also received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement no223211, CEED3. ALG is a Wellcome Trust Senior Fellow in Basic and Biomedical Science. This work was funded in Slovakia by the Slovak Diabetes Association and the Scientific Grant Agency of the Ministry of Education, Science, Research and Sports of the Slovak Republic, and the Slovak Academy of Sciences VEGA2/0151/11. This publication is also the result of the project implementation TRANSENDOGEN/26240220051/supported by the Research & Development Operational Programme funded by the European Regional Development Fund ERDF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arden C, 2007, DIABETES, V56, P1773, DOI 10.2337/db06-1151; Beer NL, 2011, J BIOL CHEM, V286, P19118, DOI 10.1074/jbc.M111.223362; Beer NL, 2009, HUM MOL GENET, V18, P4081, DOI 10.1093/hmg/ddp357; Boutin P, 2001, DIABETOLOGIA, V44, P775, DOI 10.1007/s001250051687; Brocklehurst KJ, 2004, BIOCHEM J, V378, P693, DOI 10.1042/BJ20031414; Burke CV, 1999, BIOCHEM J, V342, P345, DOI 10.1042/0264-6021:3420345; BYRNE MM, 1994, J CLIN INVEST, V93, P1120, DOI 10.1172/JCI117064; Costa A, 2000, EUR J ENDOCRINOL, V142, P380, DOI 10.1530/eje.0.1420380; Davis EA, 1999, DIABETOLOGIA, V42, P1175, DOI 10.1007/s001250051289; Ellard S, 2008, DIABETOLOGIA, V51, P546, DOI 10.1007/s00125-008-0942-y; Estalella I, 2007, CLIN ENDOCRINOL, V67, P538, DOI 10.1111/j.1365-2265.2007.02921.x; Feigerlova E, 2006, EUR J PEDIATR, V165, P446, DOI 10.1007/s00431-006-0106-3; FROGUEL P, 1992, NATURE, V356, P162, DOI 10.1038/356162a0; FROGUEL P, 1993, NEW ENGL J MED, V328, P697, DOI 10.1056/NEJM199303113281005; Gasperikova D, 2009, DIABETES, V58, P1929, DOI 10.2337/db09-0070; Gloyn AL, 2009, DIABETOLOGIA, V52, P172, DOI 10.1007/s00125-008-1188-4; Gloyn AL, 2004, FRONT DIABETES, V16, P92; Gloyn AL, 2005, J BIOL CHEM, V280, P14105, DOI 10.1074/jbc.M413146200; HAGER J, 1994, DIABETES, V43, P730, DOI 10.2337/diabetes.43.5.730; Johansen A, 2005, J CLIN ENDOCR METAB, V90, P4607, DOI 10.1210/jc.2005-0196; Kamata K, 2004, STRUCTURE, V12, P429, DOI 10.1016/j.str.2004.02.005; Kesavan P, 1997, BIOCHEM J, V322, P57, DOI 10.1042/bj3220057; Kropff J, 2011, DIABETOLOGIA, V54, P1261, DOI 10.1007/s00125-011-2090-z; LIANG Y, 1995, BIOCHEM J, V309, P167, DOI 10.1042/bj3090167; Lorini R, 2009, DIABETES CARE, V32, P1864, DOI 10.2337/dc08-2018; Mantovani Vilma, 2003, Hum Mutat, V22, P338, DOI 10.1002/humu.9179; Massa O, 2001, DIABETOLOGIA, V44, P898; Matschinsky FM, 2002, DIABETES, V51, pS394, DOI 10.2337/diabetes.51.2007.S394; Murphy R, 2008, NAT CLIN PRACT ENDOC, V4, P200, DOI 10.1038/ncpendmet0778; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; Osbak KK, 2009, HUM MUTAT, V30, P1512, DOI 10.1002/humu.21110; Pinterova D, 2007, CLIN GENET, V71, P95, DOI 10.1111/j.1399-0004.2006.00729.x; Pruhova S, 2003, DIABETOLOGIA, V46, P291, DOI 10.1007/s00125-002-1010-7; Pruhova S, 2010, PEDIATR DIABETES, V11, P529, DOI 10.1111/j.1399-5448.2010.00646.x; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Sagen JV, 2008, PEDIATR DIABETES, V9, P442, DOI 10.1111/j.1399-5448.2008.00399.x; Sagen JV, 2006, DIABETES, V55, P1713, DOI 10.2337/db05-1513; Schober E, 2009, DIABETIC MED, V26, P466, DOI 10.1111/j.1464-5491.2009.02720.x; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Shields BM, 2010, DIABETOLOGIA, V53, P2504, DOI 10.1007/s00125-010-1799-4; Shields BM, 2012, DIABET IN PRESS 0105; Steele AM, 2011, DIABETOLOGIA; STOFFEL M, 1992, P NATL ACAD SCI USA, V89, P7698, DOI 10.1073/pnas.89.16.7698; Stride A, 2002, DIABETOLOGIA, V45, P427, DOI 10.1007/s00125-001-0770-9; TAKEDA J, 1993, J BIOL CHEM, V268, P15200; Thomson K L, 2003, Hum Mutat, V22, P417, DOI 10.1002/humu.9186; Wabitsch M, 2007, DIABETIC MED, V24, P1393, DOI 10.1111/j.1464-5491.2007.02285.x; Ziemssen F, 2002, DIABETOLOGIA, V45, P286, DOI 10.1007/s00125-001-0738-9	48	15	15	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2012	7	4							e34541	10.1371/journal.pone.0034541	http://dx.doi.org/10.1371/journal.pone.0034541			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JA	22493702	gold, Green Submitted, Green Published			2022-12-27	WOS:000305012700044
J	Pinjari, AB; Novikov, B; Rezenom, YH; Russell, DH; Wales, ME; Siddavattam, D				Pinjari, Aleem Basha; Novikov, Boris; Rezenom, Yohannes H.; Russell, David H.; Wales, Melinda E.; Siddavattam, Dayananda			Mineralization of Acephate, a Recalcitrant Organophosphate Insecticide Is Initiated by a Pseudomonad in Environmental Samples	PLOS ONE			English	Article							UNITED-STATES; P-NITROPHENOL; BIODEGRADATION; METHAMIDOPHOS; DEGRADATION; HYDROLYSIS; PARATHION; TOXICITY; EXPOSURE; SULFUR	An aerobic bacterium capable of breaking down the pesticide acephate (O, S-dimethyl acetyl phosphoramidothioic acid) was isolated from activated sludge collected from a pesticide manufacturing facility. A phylogenetic tree based on the 16 S rRNA gene sequence determined that the isolate lies within the Pseudomonads. The isolate was able to grow in the presence of acephate at concentrations up to 80 mM, with maximum growth at 40 mM. HPLC and LC-MS/MS analysis of spent medium from growth experiments and a resting cell assay detected the accumulation of methamidophos and acetate, suggesting initial hydrolysis of the amide linkage found between these two moieties. As expected, the rapid decline in acephate was coincident with the accumulation of methamidophos. Methamidophos concentrations were maintained over a period of days, without evidence of further metabolism or cell growth by the cultures. Considering this limitation, strains such as described in this work can promote the first step of acephate mineralization in soil microbial communities.	[Pinjari, Aleem Basha; Siddavattam, Dayananda] Univ Hyderabad, Sch Life Sci, Dept Anim Sci, Hyderabad 500134, Andhra Pradesh, India; [Novikov, Boris; Wales, Melinda E.] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA; [Rezenom, Yohannes H.; Russell, David H.] Texas A&M Univ, Dept Chem, College Stn, TX 77843 USA	University of Hyderabad; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Pinjari, AB (corresponding author), Univ Hyderabad, Sch Life Sci, Dept Anim Sci, Hyderabad 500134, Andhra Pradesh, India.	sdsl@uohyd.ernet.in	Russell, David H/C-3618-2015	Russell, David H/0000-0003-0830-3914	DST, New Delhi [DST/INT/US/RPO-156/04]; National Science Foundation, USA (NSF OISE) [INT-0424002]	DST, New Delhi(Department of Science & Technology (India)); National Science Foundation, USA (NSF OISE)	DST, New Delhi (DST/INT/US/RPO-156/04) and National Science Foundation, USA (NSF OISE Grant, INT-0424002 to JRW) supported travel grant while executing the collaborative research work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDO M, 1985, ARCH ENVIRON CON TOX, V14, P535, DOI 10.1007/BF01055382; ANTONIOUS GF, 1994, B ENVIRON CONTAM TOX, V52, P141, DOI 10.1007/BF00197370; Battu RS, 2009, B ENVIRON CONTAM TOX, V82, P124, DOI 10.1007/s00128-008-9541-3; Blondell JM, 2007, CLIN TOXICOL, V45, P589, DOI 10.1080/15563650701397035; BOUCHARD DC, 1982, J ECON ENTOMOL, V75, P921, DOI 10.1093/jee/75.5.921; Bronstein AC, 2010, CLIN TOXICOL, V48, P979, DOI 10.3109/15563650.2010.543906; Buckley NA, 2004, BMJ-BRIT MED J, V329, P1231, DOI 10.1136/bmj.329.7476.1231; Calvert GM, 2008, AM J IND MED, V51, P883, DOI 10.1002/ajim.20623; CHAE MY, 1994, BIOORG MED CHEM LETT, V4, P1473, DOI 10.1016/S0960-894X(01)80516-3; Chai LK, 2010, CHEMOSPHERE, V79, P434, DOI 10.1016/j.chemosphere.2010.01.046; FAO, 2004, PEST RES FOOD 2003 1, V177; Farag AT, 2000, REPROD TOXICOL, V14, P241, DOI 10.1016/S0890-6238(00)00074-5; GARRETT NE, 1986, MUTAT RES, V168, P301, DOI 10.1016/0165-1110(86)90024-2; Graetz D. A., 1970, WATER POLLUT CONTROL, V42, pR76; Harari R, 2010, ENVIRON HEALTH PERSP, V118, P890, DOI 10.1289/ehp.0901582; Imhoff JF, 1998, INT J SYST BACTERIOL, V48, P1129, DOI 10.1099/00207713-48-4-1129; Jokanovic M, 2011, CLIN NEUROL NEUROSUR, V113, P7, DOI 10.1016/j.clineuro.2010.08.015; Kumar S, 1996, CRIT REV MICROBIOL, V22, P1, DOI 10.3109/10408419609106454; LAI K, 1995, ARCH BIOCHEM BIOPHYS, V318, P59, DOI 10.1006/abbi.1995.1204; Lee Hyun-Ho, 2002, Biotechnology and Bioprocess Engineering, V7, P375, DOI 10.1007/BF02933525; Litchfield Melville H, 2005, Toxicol Rev, V24, P271, DOI 10.2165/00139709-200524040-00006; Mahajna M, 1997, CHEM RES TOXICOL, V10, P64, DOI 10.1021/tx9601420; Mulet M, 2010, ENVIRON MICROBIOL, V12, P1513, DOI 10.1111/j.1462-2920.2010.02181.x; MUNNECKE DM, 1974, APPL MICROBIOL, V28, P212, DOI 10.1128/AEM.28.2.212-217.1974; Pakala SB, 2007, APPL MICROBIOL BIOT, V73, P1452, DOI 10.1007/s00253-006-0595-z; Prendergast MA, 1998, NEUROTOXICOL TERATOL, V20, P115, DOI 10.1016/S0892-0362(97)00098-6; Ragnarsdottir KV, 2000, J GEOL SOC LONDON, V157, P859, DOI 10.1144/jgs.157.4.859; ROSENBERG A, 1979, APPL ENVIRON MICROB, V37, P886, DOI 10.1128/AEM.37.5.886-891.1979; Schafer H, 2010, J EXP BOT, V61, P315, DOI 10.1093/jxb/erp355; SINGH AK, 1987, ENVIRON RES, V43, P342, DOI 10.1016/S0013-9351(87)80034-8; Singh BK, 2004, APPL ENVIRON MICROB, V70, P4855, DOI 10.1128/AEM.70.8.4855-4863.2004; Singh BK, 2009, NAT REV MICROBIOL, V7, P156, DOI 10.1038/nrmicro2050; Sudakin DL, 2007, J TOXICOL ENV HEAL A, V70, P141, DOI 10.1080/15287390600755224; SZETO SY, 1979, J ENVIRON SCI HEAL B, V14, P635, DOI 10.1080/03601237909372157; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tao CJ, 2010, ENVIRON MONIT ASSESS, V165, P685, DOI 10.1007/s10661-009-0979-5; Thundiyil JG, 2008, B WORLD HEALTH ORGAN, V86, P205, DOI [10.2471/BLT.08.041814, 10.2471/BLT.07.041814]; Wang L, 2011, CURR MICROBIOL, V62, P289, DOI 10.1007/s00284-010-9707-1; Wang L, 2010, BIODEGRADATION, V21, P513, DOI 10.1007/s10532-009-9320-9; Yen JH, 2000, ECOTOX ENVIRON SAFE, V45, P79, DOI 10.1006/eesa.1999.1846; Zhao RB, 2010, AGR SCI CHINA, V9, P695, DOI 10.1016/S1671-2927(09)60145-0	41	17	17	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e31963	10.1371/journal.pone.0031963	http://dx.doi.org/10.1371/journal.pone.0031963			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GO	22496729	Green Submitted, Green Published, gold			2022-12-27	WOS:000304855200002
J	Singh, VK; Rahman, MN; Munro, K; Uversky, VN; Smith, SP; Jia, ZC				Singh, Vinay K.; Rahman, Mona N.; Munro, Kim; Uversky, Vladimir N.; Smith, Steven P.; Jia, Zongchao			Free Cysteine Modulates the Conformation of Human C/EBP Homologous Protein	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; INTRINSICALLY DISORDERED PROTEINS; NATIVELY UNFOLDED PROTEINS; TRANSCRIPTION FACTOR CHOP; REDOX STATE; UNSTRUCTURED PROTEINS; OXIDATIVE STRESS; CELL-DEATH; MOLECULAR RECOGNITION; INDUCED APOPTOSIS	The C/EBP Homologous Protein (CHOP) is a nuclear protein that is integral to the unfolded protein response culminating from endoplasmic reticulum stress. Previously, CHOP was shown to comprise extensive disordered regions and to self-associate in solution. In the current study, the intrinsically disordered nature of this protein was characterized further by comprehensive in silico analyses. Using circular dichroism, differential scanning calorimetry and nuclear magnetic resonance, we investigated the global conformation and secondary structure of CHOP and demonstrated, for the first time, that conformational changes in this protein can be induced by the free amino acid L-cysteine. Addition of L-cysteine caused a significant dose-dependent decrease in the protein helicity - dropping from 69.1% to 23.8% in the presence of 1 mM of L-cysteine - and a sequential transition to a more disordered state, unlike that caused by thermal denaturation. Furthermore, the presence of small amounts of free amino acid (80 mu M, an 8: 1 cysteine: CHOP ratio) during CHOP thermal denaturation altered the molecular mechanism of its melting process, leading to a complex, multi-step transition. On the other hand, high levels (4 mM) of free L-cysteine seemed to cause a complete loss of rigid cooperatively melting structure. These results suggested a potential regulatory function of L-cysteine which may lead to changes in global conformation of CHOP in response to the cellular redox state and/or endoplasmic reticulum stress.	[Singh, Vinay K.; Rahman, Mona N.; Munro, Kim; Smith, Steven P.; Jia, Zongchao] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada; [Uversky, Vladimir N.] Univ S Florida, Dept Mol Med, Tampa, FL USA; [Uversky, Vladimir N.] Russian Acad Sci, Inst Biol Instrumentat, Pushchino 142292, Moscow Region, Russia	Queens University - Canada; State University System of Florida; University of South Florida; Russian Academy of Sciences	Singh, VK (corresponding author), Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada.	jia@queensu.ca	Uversky, Vladimir N./F-4515-2011; Rahman, Mona/GRF-6475-2022	Uversky, Vladimir N./0000-0002-4037-5857; Rahman, Mona Naeema/0000-0002-9782-0173; Smith, Steven/0000-0003-2710-4400	Canadian Institute of Health Research [MOP-77810]	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR))	This research was supported by Canadian Institute of Health Research (Grant #: MOP-77810, www.cihr-irsc.gc.ca). ZJ is a Killam Research Fellow and holds a Canada Research Chair in Structural Biology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alter J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029498; Anderson CL, 2007, AM J PHYSIOL-REG I, V293, pR1069, DOI 10.1152/ajpregu.00195.2007; Aridor M, 1999, NAT MED, V5, P745, DOI 10.1038/10466; Babu MM, 2011, CURR OPIN STRUC BIOL, V21, P432, DOI 10.1016/j.sbi.2011.03.011; Banjac A, 2008, ONCOGENE, V27, P1618, DOI 10.1038/sj.onc.1210796; Bates CJ, 2002, BRIT J NUTR, V87, P71, DOI 10.1079/BJN2001479; BOHM G, 1992, PROTEIN ENG, V5, P191, DOI 10.1093/protein/5.3.191; Bourhis JM, 2007, CURR PROTEIN PEPT SC, V8, P135, DOI 10.2174/138920307780363451; Bracken C, 2004, CURR OPIN STRUC BIOL, V14, P570, DOI 10.1016/j.sbi.2004.08.003; Bruhat A, 2002, J BIOL CHEM, V277, P48107, DOI 10.1074/jbc.M206149200; Bruylants G, 2005, CURR MED CHEM, V12, P2011, DOI 10.2174/0929867054546564; Bushmarina NA, 2001, CHEMBIOCHEM, V2, P813, DOI 10.1002/1439-7633(20011105)2:11<813::AID-CBIC813>3.0.CO;2-W; Campen A, 2008, PROTEIN PEPTIDE LETT, V15, P956, DOI 10.2174/092986608785849164; Chakravarthi S, 2006, EMBO REP, V7, P271, DOI 10.1038/sj.embor.7400645; Chigurupati S, 2009, J BIOL CHEM, V284, P18323, DOI 10.1074/jbc.M109.020891; Chiribau CB, 2010, MOL CELL BIOL, V30, P3722, DOI 10.1128/MCB.01507-09; Cunnea P, 2011, MULT SCLER J, V17, P808, DOI 10.1177/1352458511399114; D'Amico S, 2001, J BIOL CHEM, V276, P25791, DOI 10.1074/jbc.M102741200; DAUGHDRILL GW, 2004, HDB PROTEIN FOLDING, P271; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Demchenko AP, 2001, J MOL RECOGNIT, V14, P42, DOI 10.1002/1099-1352(200101/02)14:1<42::AID-JMR518>3.0.CO;2-8; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Dosztanyi Zsuzsanna, 2008, V426, P103, DOI 10.1007/978-1-60327-058-8_6; Dunker AK, 2008, NAT CHEM BIOL, V4, P229, DOI 10.1038/nchembio0408-229; Dunker AK, 2005, FEBS J, V272, P5129, DOI 10.1111/j.1742-4658.2005.04948.x; Dunker AK, 2001, NAT BIOTECHNOL, V19, P805, DOI 10.1038/nbt0901-805; Dunker AK, 2002, ADV PROTEIN CHEM, V62, P25; Dunker AK, 2002, BIOCHEMISTRY-US, V41, P6573, DOI 10.1021/bi012159+; Dunker AK, 2001, J MOL GRAPH MODEL, V19, P26, DOI 10.1016/S1093-3263(00)00138-8; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Dyson HJ, 2002, CURR OPIN STRUC BIOL, V12, P54, DOI 10.1016/S0959-440X(02)00289-0; Eizirik DL, 2008, ENDOCR REV, V29, P42, DOI 10.1210/er.2007-0015; Ferron F, 2006, PROTEINS, V65, P1, DOI 10.1002/prot.21075; Fink AL, 2005, CURR OPIN STRUC BIOL, V15, P35, DOI 10.1016/j.sbi.2005.01.002; Gogia R, 1998, CURR EYE RES, V17, P257, DOI 10.1076/ceyr.17.3.257.5213; Gow A, 2009, CURR OPIN NEUROBIOL, V19, P505, DOI 10.1016/j.conb.2009.08.007; Gsponer J, 2009, PROG BIOPHYS MOL BIO, V99, P94, DOI 10.1016/j.pbiomolbio.2009.03.001; Gunasekaran K, 2003, TRENDS BIOCHEM SCI, V28, P81, DOI 10.1016/S0968-0004(03)00003-3; He B, 2009, CELL RES, V19, P929, DOI 10.1038/cr.2009.87; HWANG C, 1992, SCIENCE, V257, P1496, DOI 10.1126/science.1523409; Iakoucheva LM, 2002, J MOL BIOL, V323, P573, DOI 10.1016/S0022-2836(02)00969-5; Iyer SS, 2009, AM J RESP CELL MOL, V40, P90, DOI 10.1165/rcmb.2007-0447OC; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Jones DP, 2004, FASEB J, V18, P1246, DOI 10.1096/fj.03-0971fje; Jones DP, 2002, FREE RADICAL BIO MED, V33, P1290, DOI 10.1016/S0891-5849(02)01040-7; Kaufman RJ, 2010, DIABETES OBES METAB, V12, P99, DOI 10.1111/j.1463-1326.2010.01281.x; Kumar A, 2006, BIOCHEM J, V396, P61, DOI 10.1042/BJ20051411; Kuznetsova IM, 2004, J PROTEOME RES, V3, P485, DOI 10.1021/pr034094y; Kuznetsova IM, 2002, BBA-PROTEIN STRUCT M, V1596, P138, DOI 10.1016/S0167-4838(02)00212-1; Li, 1999, Genome Inform Ser Workshop Genome Inform, V10, P30; Liu JG, 2006, BIOCHEMISTRY-US, V45, P6873, DOI 10.1021/bi0602718; Malhotra JD, 2007, SEMIN CELL DEV BIOL, V18, P716, DOI 10.1016/j.semcdb.2007.09.003; MATHEWSROTH MM, 1994, PHOTODERMATOL PHOTO, V10, P244; Matsumoto M, 1996, FEBS LETT, V395, P143, DOI 10.1016/0014-5793(96)01016-2; Maytin EV, 2001, EXP CELL RES, V267, P193, DOI 10.1006/excr.2001.5248; McCullough KD, 2001, MOL CELL BIOL, V21, P1249, DOI 10.1128/MCB.21.4.1249-1259.2001; Meares GP, 2011, EXP CELL RES, V317, P1621, DOI 10.1016/j.yexcr.2011.02.012; Miyazaki Y, 2011, ARTERIOSCL THROM VAS, V31, P1124, DOI 10.1161/ATVBAHA.111.224519; Moriarty SE, 2003, FREE RADICAL BIO MED, V35, P1582, DOI 10.1016/j.freeradbiomed.2003.09.006; Namba K, 2001, GENES CELLS, V6, P1, DOI 10.1046/j.1365-2443.2001.00384.x; Obeid OA, 2004, EUR J CLIN NUTR, V58, P105, DOI 10.1038/sj.ejcn.1601755; Ohoka N, 2005, EMBO J, V24, P1243, DOI 10.1038/sj.emboj.7600596; Oldfield CJ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S1-S1; Oldfield CJ, 2005, BIOCHEMISTRY-US, V44, P12454, DOI 10.1021/bi050736e; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Oyadomari S, 2002, J CLIN INVEST, V109, P525, DOI 10.1172/JCI200214550; Park SH, 2010, J BIOL CHEM, V285, P35330, DOI 10.1074/jbc.M110.136259; Peng K, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-208; PERMYAKOV EA, 1980, EUR J BIOCHEM, V109, P307, DOI 10.1111/j.1432-1033.1980.tb04796.x; Prilusky J, 2005, BIOINFORMATICS, V21, P3435, DOI 10.1093/bioinformatics/bti537; Radivojac P, 2007, BIOPHYS J, V92, P1439, DOI 10.1529/biophysj.106.094045; Radivojac Predrag, 2003, Pac Symp Biocomput, P216; Romero P, 2001, PROTEINS, V42, P38, DOI 10.1002/1097-0134(20010101)42:1<38::AID-PROT50>3.0.CO;2-3; RON D, 1992, GENE DEV, V6, P439, DOI 10.1101/gad.6.3.439; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4; Schroder M, 2008, CELL MOL LIFE SCI, V65, P862, DOI 10.1007/s00018-007-7383-5; Schulz GE, 1979, MOL MECH BIOL RECOGN, P79; Shao CL, 2010, J BIOL CHEM, V285, P19710, DOI 10.1074/jbc.M109.087486; Singh VK, 2008, J MOL BIOL, V380, P313, DOI 10.1016/j.jmb.2008.04.069; Tabas I, 2011, NAT CELL BIOL, V13, P184, DOI 10.1038/ncb0311-184; Tompa P, 2002, TRENDS BIOCHEM SCI, V27, P527, DOI 10.1016/S0968-0004(02)02169-2; Tsukano H, 2010, ARTERIOSCL THROM VAS, V30, P1925, DOI 10.1161/ATVBAHA.110.206094; Turoverov KK, 2010, PROG BIOPHYS MOL BIO, V102, P73, DOI 10.1016/j.pbiomolbio.2010.01.003; Ubeda M, 1996, MOL CELL BIOL, V16, P1479; Uversky VN, 2008, SCIENCE, V322, P1340, DOI 10.1126/science.1167453; Uversky VN, 2008, ANNU REV BIOPHYS, V37, P215, DOI 10.1146/annurev.biophys.37.032807.125924; Uversky VN, 2011, INT J BIOCHEM CELL B, V43, P1090, DOI 10.1016/j.biocel.2011.04.001; Uversky VN, 2011, BBA-PROTEINS PROTEOM, V1814, P693, DOI 10.1016/j.bbapap.2011.03.010; Uversky VN, 2010, BBA-PROTEINS PROTEOM, V1804, P1231, DOI 10.1016/j.bbapap.2010.01.017; Uversky VN, 2002, EUR J BIOCHEM, V269, P2, DOI 10.1046/j.0014-2956.2001.02649.x; Uversky VN, 2003, CELL MOL LIFE SCI, V60, P1852, DOI 10.1007/s00018-003-3096-6; Uversky VN, 1996, J MOL BIOL, V255, P215, DOI 10.1006/jmbi.1996.0018; Uversky VN, 2000, PROTEINS, V41, P415, DOI 10.1002/1097-0134(20001115)41:3<415::AID-PROT130>3.3.CO;2-Z; Uversky VN, 2002, PROTEIN SCI, V11, P739, DOI 10.1110/ps.4210102; Uversky VN, 2005, J MOL RECOGNIT, V18, P343, DOI 10.1002/jmr.747; Van Der Goot Francoise G., 1992, Trends in Cell Biology, V2, P343; Wang XZ, 1996, SCIENCE, V272, P1347, DOI 10.1126/science.272.5266.1347; Wang XZ, 1996, MOL CELL BIOL, V16, P4273; Wei YS, 2003, BIOPOLYMERS, V72, P345, DOI 10.1002/bip.10436; Xue B, 2010, BBA-PROTEINS PROTEOM, V1804, P996, DOI 10.1016/j.bbapap.2010.01.011; Xue B, 2009, FEBS LETT, V583, P1469, DOI 10.1016/j.febslet.2009.03.070; Yamaguchi H, 2004, J BIOL CHEM, V279, P45495, DOI 10.1074/jbc.M406933200; Yeh MY, 2007, AM J RESP CRIT CARE, V176, P270, DOI 10.1164/rccm.200611-1722OC; Yoshida H, 2007, FEBS J, V274, P630, DOI 10.1111/j.1742-4658.2007.05639.x; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982; Zou W, 2008, CANCER RES, V68, P7484, DOI 10.1158/0008-5472.CAN-08-1318	107	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e34680	10.1371/journal.pone.0034680	http://dx.doi.org/10.1371/journal.pone.0034680			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GO	22496840	Green Published, gold, Green Submitted			2022-12-27	WOS:000304855200069
J	Priyadarsini, RV; Kumar, N; Khan, I; Thiyagarajan, P; Kondaiah, P; Nagini, S				Priyadarsini, Ramamurthi Vidya; Kumar, Neeraj; Khan, Imran; Thiyagarajan, Paranthaman; Kondaiah, Paturu; Nagini, Siddavaram			Gene Expression Signature of DMBA-Induced Hamster Buccal Pouch Carcinomas: Modulation by Chlorophyllin and Ellagic Acid	PLOS ONE			English	Article							NF-KAPPA-B; GROWTH-FACTOR-BETA; THERAPEUTIC TARGET; DNA-DAMAGE; CANCER; CARCINOGENESIS; INHIBITION; MATRIX-METALLOPROTEINASE-9; RAT; ANTICARCINOGENS	Chlorophyllin (CHL), a water-soluble, semi synthetic derivative of chlorophyll and ellagic acid (EA), a naturally occurring polyplienolic compound in berries, grapes, and nuts have been reported to exert anticancer effects in various human cancer cell lines and in animal tumour models. The present study was undertaken to examine the mechanism underlying chemoprevention and changes in gene expression pattern induced by dietary supplementation of chlorophyllin and ellagic acid in the 7,12-diniethylbenz[a]anthracene (DMBA)-induced hamster buccal pouch (HBP) carcinogenesis model by whole genome profiling using pangenomic microarrays. In hamsters painted with DMBA, the expression of 1,700 genes was found to be altered significantly relative to control Dietary supplementation of chlorophyllin and ellagic acid modulated the expression profiles of 104 and 37 genes respectively. Microarray analysis also revealed changes in the expression of TGF beta receptors, NF-kappa B, cyclin D1, and matrix metalloproteinases (MMPs) that may play a crucial role in the transformation of the normal buccal pouch to a malignant phenotype. This gene expression signature was altered on treatment with chlorophyllin and ellagic acid. Our study has also revealed patterns of gene expression signature specific for chlorophyllin and ellagic acid exposure. Thus dietary chlorophyllin and ellagic acid that can reverse gene expression signature associated with carcinogenesis are novel candidates for cancer prevention and therapy.	[Priyadarsini, Ramamurthi Vidya; Thiyagarajan, Paranthaman; Nagini, Siddavaram] Annamalai Univ, Fac Sci, Dept Biochem & Biotechnol, Annamalainagar 608002, Tamil Nadu, India; [Kumar, Neeraj; Khan, Imran; Kondaiah, Paturu] Indian Inst Sci, Bengaluru, India	Annamalai University; Indian Institute of Science (IISC) - Bangalore	Priyadarsini, RV (corresponding author), Annamalai Univ, Fac Sci, Dept Biochem & Biotechnol, Annamalainagar 608002, Tamil Nadu, India.	s_nagini@yahoo.com	khan, imran/K-9921-2013	khan, imran/0000-0001-6888-7347	Department of Biotechnology, New Delhi, India, under Indo-EU	Department of Biotechnology, New Delhi, India, under Indo-EU	This work was supported by a grant from the Department of Biotechnology, New Delhi, India, under the 7th FP of the Indo-EU Joint Collaborative Project on 'FUNCFOOD'. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiyer HS, 2010, CANCER PREV RES, V3, P727, DOI 10.1158/1940-6207.CAPR-09-0260; Anitha P, 2011, EUR J NUTR IN PRESS; Baud V, 2009, NAT REV DRUG DISCOV, V8, P33, DOI 10.1038/nrd2781; Beltran E, 2011, P NATL ACAD SCI USA, V108, P12461, DOI 10.1073/pnas.1018941108; Binker MG, 2011, BIOCHEM BIOPH RES CO, V405, P140, DOI 10.1016/j.bbrc.2011.01.023; Carter O, 2004, J NUTR, V134, p3441S, DOI 10.1093/jn/134.12.3441S; Chaturvedi MM, 2011, ONCOGENE, V30, P1615, DOI 10.1038/onc.2010.566; Chiu LCM, 2005, INT J MOL MED, V16, P735; Chiu LCM, 2003, INT J ONCOL, V23, P729; Dashwood R, 1998, MUTAT RES-FUND MOL M, V399, P245, DOI 10.1016/S0027-5107(97)00259-5; Dashwood RH, 1997, INT J ONCOL, V10, P721; DIXIT R, 1986, P NATL ACAD SCI USA, V83, P8039, DOI 10.1073/pnas.83.21.8039; Egner PA, 2001, P NATL ACAD SCI USA, V98, P14601, DOI 10.1073/pnas.251536898; Elahi M, 2012, BIOMARKERS, V17, P21, DOI 10.3109/1354750X.2011.635804; Fujiwara Y, 2011, J HEPATO-BIL-PAN SCI, V18, P731, DOI 10.1007/s00534-011-0390-9; Gialeli C, 2011, FEBS J, V278, P16, DOI 10.1111/j.1742-4658.2010.07919.x; Gonzalez-Sarrias A, 2009, MOL NUTR FOOD RES, V53, P686, DOI 10.1002/mnfr.200800150; Gradecka-Meesters D, 2011, FOOD CHEM TOXICOL, V49, P1674, DOI 10.1016/j.fct.2011.02.021; Gupta SC, 2010, CANCER METAST REV, V29, P405, DOI 10.1007/s10555-010-9235-2; Hagiwara Y, 2010, INT J HEMATOL, V92, P136, DOI 10.1007/s12185-010-0627-4; Hawinkels LJAC, 2011, GROWTH FACTORS, V29, P140, DOI 10.3109/08977194.2011.595411; Hsieh HL, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-88; Hua H, 2011, CELL MOL LIFE SCI, V68, P3853, DOI 10.1007/s00018-011-0763-x; Huber MA, 2004, J CLIN INVEST, V114, P569, DOI 10.1172/JCI200421358; Kelly RJ, 2010, J IMMUNOTOXICOL, V7, P15, DOI 10.3109/15476910903389920; Lagerqvist A, 2011, FOOD CHEM TOXICOL, V49, P879, DOI 10.1016/j.fct.2010.12.011; LESCA P, 1983, CARCINOGENESIS, V4, P1651, DOI 10.1093/carcin/4.12.1651; Luqman S, 2010, PHYTOTHER RES, V24, P949, DOI 10.1002/ptr.3171; MadrigalBujaidar E, 1997, MUTAT RES-GEN TOX EN, V388, P79, DOI 10.1016/S1383-5718(96)00139-8; MANDAL S, 1987, CARCINOGENESIS, V8, P1651, DOI 10.1093/carcin/8.11.1651; Meulmeester E, 2011, J PATHOL, V223, P205, DOI 10.1002/path.2785; MUKHTAR H, 1986, CANCER RES, V46, P2262; Musgrove EA, 2011, NAT REV CANCER, V11, P558, DOI 10.1038/nrc3090; Nagini S, 2009, ANTI-CANCER AGENT ME, V9, P843, DOI 10.2174/187152009789124619; Nagini S, 2009, ORAL ONCOL, V45, pE31, DOI 10.1016/j.oraloncology.2009.01.006; Osowski A, 2010, J TOXICOL ENV HEAL A, V73, P1141, DOI 10.1080/15287394.2010.491044; Priyadarsini RV, 2012, CURR PHARM BIOTECHNO, V13, P125; Priyadarsini RV, 2011, NUTR CANCER, V63, P218, DOI 10.1080/01635581.2011.523503; Santibanez JF, 2011, CLIN SCI, V121, P233, DOI 10.1042/CS20110086; Simonich MT, 2008, FOOD CHEM TOXICOL, V46, P1014, DOI 10.1016/j.fct.2007.10.034; SINGLETARY K, 1989, In Vivo (Attiki), V3, P173; TANAKA T, 1993, CARCINOGENESIS, V14, P1321, DOI 10.1093/carcin/14.7.1321; TEEL RW, 1986, CANCER LETT, V30, P329, DOI 10.1016/0304-3835(86)90058-3; Tobar N, 2010, MOL CELL BIOCHEM, V340, P195, DOI 10.1007/s11010-010-0418-5; Umesalma S, 2010, BASIC CLIN PHARMACOL, V107, P650, DOI 10.1111/j.1742-7843.2010.00565.x; Wang R, 2006, MUTAT RES-FUND MOL M, V601, P11, DOI 10.1016/j.mrfmmm.2006.05.026; Witzel II, 2010, BIOCHEM SOC T, V38, P217, DOI 10.1042/BST0380217; Yang K, 2010, ONCOL REP, V23, P1619, DOI 10.3892/or_00000803; Yee JC, 2008, BIOTECHNOL BIOENG, V101, P1359, DOI 10.1002/bit.21984	49	26	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2012	7	4							e34628	10.1371/journal.pone.0034628	http://dx.doi.org/10.1371/journal.pone.0034628			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952GU	22485181	Green Published, gold, Green Submitted			2022-12-27	WOS:000304780500056
J	Zhou, CQ; Kandemir, I; Walsh, DB; Zalom, FG; Lavine, LC				Zhou, Changqing; Kandemir, Irfan; Walsh, Douglas B.; Zalom, Frank G.; Lavine, Laura Corley			Identification of Lygus hesperus by DNA Barcoding Reveals Insignificant Levels of Genetic Structure among Distant and Habitat Diverse Populations	PLOS ONE			English	Article							PLANT BUG HETEROPTERA; MIRIDAE; RESISTANCE; SOFTWARE	Background: The western tarnished plant bug Lygus hesperus is an economically important pest that belongs to a complex of morphologically similar species that makes identification problematic. The present study provides evidence for the use of DNA barcodes from populations of L. hesperus from the western United States of America for accurate identification. Methodology/Principal Findings: This study reports DNA barcodes for 134 individuals of the western tarnished plant bug from alfalfa and strawberry agricultural fields in the western United States of America. Sequence divergence estimates of <3% reveal that morphologically variable individuals presumed to be L. hesperus were accurately identified. Paired estimates of F-st and subsequent estimates of gene flow show that geographically distinct populations of L. hesperus are genetically similar. Therefore, our results support and reinforce the relatively recent (<100 years) migration of the western tarnished plant bug into agricultural habitats across the western United States. Conclusions/Significance: This study reveals that despite wide host plant usage and phenotypically plastic morphological traits, the commonly recognized western tarnished plant bug belongs to a single species, Lygus hesperus. In addition, no significant genetic structure was found for the geographically diverse populations of western tarnished plant bug used in this study.	[Zhou, Changqing; Walsh, Douglas B.; Lavine, Laura Corley] Washington State Univ, Dept Entomol, Pullman, WA 99164 USA; [Kandemir, Irfan] Ankara Univ, Dept Biol, TR-06100 Ankara, Turkey; [Walsh, Douglas B.] Irrigated Agr Res & Extens Ctr, Prosser, WA USA; [Zalom, Frank G.] Univ Calif Davis, Dept Entomol, Davis, CA 95616 USA	Washington State University; Ankara University; University of California System; University of California Davis	Zhou, CQ (corresponding author), Washington State Univ, Dept Entomol, Pullman, WA 99164 USA.	lavine@wsu.edu	kandemir, irfan/L-3944-2019	kandemir, irfan/0000-0002-2888-1044; Lavine, Laura/0000-0002-0262-359X	Washington Alfalfa Seed Commission; Washington State Commission on Pesticide Registration; California Strawberry Commission; WSU Department of Entomology	Washington Alfalfa Seed Commission; Washington State Commission on Pesticide Registration; California Strawberry Commission; WSU Department of Entomology	Funding for this study (covering collection and sequencing costs) was provided by the Washington Alfalfa Seed Commission (http://apps.leg.wa.gov/wac/default.aspx?cite = 16-529&full = true) and the Washington State Commission on Pesticide Registration (http://wscpr.org/) to DBW, California Strawberry Commission (http://www.calstrawberry.com/) to FGZ, and WSU Department of Entomology research and travel scholarships to CZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong K., 2010, Bulletin OEPP, V40, P91, DOI 10.1111/j.1365-2338.2009.02358.x; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; BUTTS RA, 1991, J ECON ENTOMOL, V84, P1591, DOI 10.1093/jee/84.5.1591; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Galloway D, 1999, 1182 US GEOL SURV; Geisler M, 2011, COMMODITY STRAWBERRY; Goodell PB, 2009, PEST MANAG SCI, V65, P1293, DOI 10.1002/ps.1859; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Jung S, 2011, MOL ECOL RESOUR, V11, P266, DOI 10.1111/j.1755-0998.2010.02945.x; Kelly LJ, 2010, TAXON, V59, P251, DOI 10.1002/tax.591023; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; LEIGH TF, 1970, CALIF AGR, V24, P12; Mueller SC, 2003, U CA AGR NATURAL RES; Park DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018749; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Putnam D, 1996, P 27 NAT ALF S 26 CA; Ronquist F, 2005, MRBAYES 3 1; Savolainen V, 2005, PHILOS T R SOC B, V360, P1805, DOI 10.1098/rstb.2005.1730; Schreiber AS, ALFALFA ALFALFA SEED; Schwartz M. D., 1998, Memoirs on Entomology, International, V10; Scott D.R., 1977, Bulletin Ent Soc Amer, V23, P19; Snodgrass GL, 1996, J ECON ENTOMOL, V89, P783, DOI 10.1093/jee/89.4.783; Snodgrass GL, 2000, J ECON ENTOMOL, V93, P441, DOI 10.1603/0022-0493-93.2.441; TEMPLETON AR, 1992, GENETICS, V132, P619; Waters TD, 2009, THESIS WASHINGTON ST; ZALOM FG, 1990, MONITORING AND INTEGRATED MANAGEMENT OF ARTHROPOD PESTS OF SMALL FRUIT CROPS, P239; Zalom FG, 2006, ENCY PEST MANAGEMENT, DOI 10.1081/E-EPM-120041243	30	13	13	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e34528	10.1371/journal.pone.0034528	http://dx.doi.org/10.1371/journal.pone.0034528			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479640	Green Published, gold, Green Submitted			2022-12-27	WOS:000305339100165
J	Waters, KM; Liu, T; Quesenberry, RD; Willse, AR; Bandyopadhyay, S; Kathmann, LE; Weber, TJ; Smith, RD; Wiley, HS; Thrall, BD				Waters, Katrina M.; Liu, Tao; Quesenberry, Ryan D.; Willse, Alan R.; Bandyopadhyay, Somnath; Kathmann, Loel E.; Weber, Thomas J.; Smith, Richard D.; Wiley, H. Steven; Thrall, Brian D.			Network Analysis of Epidermal Growth Factor Signaling Using Integrated Genomic, Proteomic and Phosphorylation Data	PLOS ONE			English	Article							MAMMARY EPITHELIAL-CELLS; CYSTEINYL-PEPTIDE ENRICHMENT; PROTEIN-INTERACTION NETWORK; GENE-EXPRESSION PATTERNS; HIGH-THROUGHPUT DATA; MICROARRAY TECHNOLOGY; MASS-SPECTROMETRY; SYSTEMS BIOLOGY; FACTOR RECEPTOR; QUANTITATIVE-ANALYSIS	To understand how integration of multiple data types can help decipher cellular responses at the systems level, we analyzed the mitogenic response of human mammary epithelial cells to epidermal growth factor (EGF) using whole genome microarrays, mass spectrometry-based proteomics and large-scale western blots with over 1000 antibodies. A time course analysis revealed significant differences in the expression of 3172 genes and 596 proteins, including protein phosphorylation changes measured by western blot. Integration of these disparate data types showed that each contributed qualitatively different components to the observed cell response to EGF and that varying degrees of concordance in gene expression and protein abundance measurements could be linked to specific biological processes. Networks inferred from individual data types were relatively limited, whereas networks derived from the integrated data recapitulated the known major cellular responses to EGF and exhibited more highly connected signaling nodes than networks derived from any individual dataset. While cell cycle regulatory pathways were altered as anticipated, we found the most robust response to mitogenic concentrations of EGF was induction of matrix metalloprotease cascades, highlighting the importance of the EGFR system as a regulator of the extracellular environment. These results demonstrate the value of integrating multiple levels of biological information to more accurately reconstruct networks of cellular response.	[Waters, Katrina M.; Wiley, H. Steven] Pacific NW Natl Lab, Environm Mol Sci Lab, Richland, WA 99352 USA	United States Department of Energy (DOE); Pacific Northwest National Laboratory	Waters, KM (corresponding author), Pacific NW Natl Lab, Environm Mol Sci Lab, Richland, WA 99352 USA.	katrina.waters@pnl.gov; steven.wiley@pnnl.gov; brian.thrall@pnnl.gov	Liu, Tao/A-9020-2013; Smith, Richard D/J-3664-2012	Liu, Tao/0000-0001-9529-6550; Smith, Richard D/0000-0002-2381-2349; Waters, Katrina/0000-0003-4696-5396; Wiley, Steven/0000-0003-0232-6867	Biomolecular Systems Initiative, Laboratory Directed Research and Development at Pacific Northwest National Laboratory (PNNL); National Institutes of Health (NIH) National Center for Research Resources at PNNL [RR018522]; U. S. Department of Energy; DOE [DE-ACO5-76RLO 1830]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR018522] Funding Source: NIH RePORTER	Biomolecular Systems Initiative, Laboratory Directed Research and Development at Pacific Northwest National Laboratory (PNNL); National Institutes of Health (NIH) National Center for Research Resources at PNNL; U. S. Department of Energy(United States Department of Energy (DOE)); DOE(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Support for this research was provided by the Biomolecular Systems Initiative, part of the Laboratory Directed Research and Development Program at Pacific Northwest National Laboratory (PNNL), and the National Institutes of Health (NIH) National Center for Research Resources (RR018522) at PNNL. Portions of this work were conducted at the Environmental Molecular Science Laboratory, a U. S. Department of Energy-funded national user facility. PNNL is operated by Battelle for DOE under contract DE-ACO5-76RLO 1830. The funding agencies had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Aderem A, 2005, CELL, V121, P511, DOI 10.1016/j.cell.2005.04.020; Amit I, 2007, NAT GENET, V39, P503, DOI 10.1038/ng1987; Anastassiou D, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100124; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Benjamini Y, 1995, J ROY STAT SOC, V57, P289; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bonneau R, 2007, CELL, V131, P1354, DOI 10.1016/j.cell.2007.10.053; Chen GA, 2002, MOL CELL PROTEOMICS, V1, P304, DOI 10.1074/mcp.M200008-MCP200; Chen WNU, 2004, J BIOL CHEM, V279, P18488, DOI 10.1074/jbc.M310874200; Chen WNU, 2003, PROTEOMICS, V3, P1647, DOI 10.1002/pmic.200300468; Cox B, 2005, METHODS, V35, P303, DOI 10.1016/j.ymeth.2004.08.021; Fischer OM, 2003, BIOCHEM SOC T, V31, P1203; Griffin TJ, 2002, MOL CELL PROTEOMICS, V1, P323, DOI 10.1074/mcp.M200001-MCP200; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; Gygi SP, 1999, NAT BIOTECHNOL, V17, P994, DOI 10.1038/13690; Hatzimanikatis V, 1999, METAB ENG, V1, P275, DOI 10.1006/mben.1999.0115; Hoheisel JD, 2006, NAT REV GENET, V7, P200, DOI 10.1038/nrg1809; Ideker T, 2001, SCIENCE, V292, P929, DOI 10.1126/science.292.5518.929; Ideker T, 2011, CELL, V144, P860, DOI 10.1016/j.cell.2011.03.007; Irish JM, 2006, NAT REV CANCER, V6, P146, DOI 10.1038/nrc1804; Jacobs JM, 2004, J PROTEOME RES, V3, P68, DOI 10.1021/pr034062a; Jones RB, 2006, NATURE, V439, P168, DOI 10.1038/nature04177; Kitano H, 2002, CURR GENET, V41, P1, DOI 10.1007/s00294-002-0285-z; Lettieri T, 2006, ENVIRON HEALTH PERSP, V114, P4, DOI 10.1289/ehp.8194; Liu T, 2005, PROTEOMICS, V5, P1263, DOI 10.1002/pmic.200401055; Liu T, 2004, ANAL CHEM, V76, P5345, DOI 10.1021/ac049485q; Maheshwari G, 2001, J CELL BIOL, V155, P1123, DOI 10.1083/jcb.200109060; McDermott JE, 2010, DIS MARKERS, V28, P253, DOI [10.1155/2010/708932, 10.3233/DMA-2010-0695]; Monaghan-Benson E, 2006, J BIOL CHEM, V281, P9450, DOI 10.1074/jbc.M501901200; Moro L, 2002, J BIOL CHEM, V277, P9405, DOI 10.1074/jbc.M109101200; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Nicholson JK, 2004, NAT BIOTECHNOL, V22, P1268, DOI 10.1038/nbt1015; Nishizuka S, 2003, P NATL ACAD SCI USA, V100, P14229, DOI 10.1073/pnas.2331323100; Oyama M, 2011, J BIOL CHEM, V286, P818, DOI 10.1074/jbc.M110.156877; Perou CM, 1999, P NATL ACAD SCI USA, V96, P9212, DOI 10.1073/pnas.96.16.9212; Petritis K, 2003, ANAL CHEM, V75, P1039, DOI 10.1021/ac0205154; Pines A, 2011, MOL CELL BIOL, V31, P4964, DOI 10.1128/MCB.05258-11; Pratt JM, 2002, MOL CELL PROTEOMICS, V1, P579, DOI 10.1074/mcp.M200046-MCP200; Qian WJ, 2005, MOL CELL PROTEOMICS, V4, P700, DOI 10.1074/mcp.M500045-MCP200; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; Shah AR, 2007, BIOINFORMATICS, V23, P906, DOI 10.1093/bioinformatics/btm031; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Smith RD, 2002, PROTEOMICS, V2, P513, DOI 10.1002/1615-9861(200205)2:5<513::AID-PROT513>3.0.CO;2-W; STAMPFER MR, 1993, CANCER SURV, V18, P7; STAMPFER MR, 1993, EXP CELL RES, V208, P175, DOI 10.1006/excr.1993.1236; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Tian Q, 2004, MOL CELL PROTEOMICS, V3, P960, DOI 10.1074/mcp.M400055-MCP200; Verhoeckx KCM, 2004, PROTEOMICS, V4, P1014, DOI 10.1002/pmic.200300669; Waters Katrina M., 2006, Briefings in Functional Genomics & Proteomics, V5, P261, DOI 10.1093/bfgp/ell019; Wiley HS, 2003, TRENDS CELL BIOL, V13, P43; Yamanishi Y, 2003, BIOINFORMATICS, V19, pi323, DOI 10.1093/bioinformatics/btg1045; Zangar RC, 2006, EXPERT REV PROTEOMIC, V3, P37, DOI 10.1586/14789450.3.1.37; Zhang Y, 2005, MOL CELL PROTEOMICS, V4, P1240, DOI 10.1074/mcp.M500089-MCP200	54	33	33	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2012	7	3							e34515	10.1371/journal.pone.0034515	http://dx.doi.org/10.1371/journal.pone.0034515			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948SR	22479638	gold, Green Published, Green Submitted			2022-12-27	WOS:000304523400086
J	Liu, R; Lin, SJ; Rallo, R; Zhao, Y; Damoiseaux, R; Xia, T; Lin, S; Nel, A; Cohen, Y				Liu, Rong; Lin, Sijie; Rallo, Robert; Zhao, Yan; Damoiseaux, Robert; Xia, Tian; Lin, Shuo; Nel, Andre; Cohen, Yoram			Automated Phenotype Recognition for Zebrafish Embryo Based In Vivo High Throughput Toxicity Screening of Engineered Nano-Materials	PLOS ONE			English	Article							SILVER NANOPARTICLES; ASSAY; NANOMATERIALS; ASSESSMENTS	A phenotype recognition model was developed for high throughput screening (HTS) of engineered Nano-Materials (eNMs) toxicity using zebrafish embryo developmental response classified, from automatically captured images and without manual manipulation of zebrafish positioning, by three basic phenotypes (i.e., hatched, unhatched, and dead). The recognition model was built with a set of vectorial descriptors providing image color and texture information. The best performing model was attained with three image descriptors (color histogram, representative color, and color layout) identified as most suitable from an initial pool of six descriptors. This model had an average recognition accuracy of 97.40 +/- 0.95% in a 10-fold cross-validation and 93.75% in a stress test of low quality zebrafish images. The present work has shown that a phenotyping model can be developed with accurate recognition ability suitable for zebrafish-based HTS assays. Although the present methodology was successfully demonstrated for only three basic zebrafish embryonic phenotypes, it can be readily adapted to incorporate more subtle phenotypes.	[Liu, Rong; Lin, Sijie; Rallo, Robert; Xia, Tian; Nel, Andre; Cohen, Yoram] Univ Calif Los Angeles, Calif Nanosyst Inst, Ctr Environm Implicat Nanotechnol, Los Angeles, CA 90024 USA; [Liu, Rong; Cohen, Yoram] Univ Calif Los Angeles, Dept Chem & Biomol Engn, Los Angeles, CA USA; [Rallo, Robert] Univ Rovira & Virgili, Dept Enginyeria Informat & Matemat, Tarragona, Catalunya, Spain; [Zhao, Yan; Lin, Shuo] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA USA; [Xia, Tian; Nel, Andre] Univ Calif Los Angeles, Dept Med, Div NanoMed, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Universitat Rovira i Virgili; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Liu, R (corresponding author), Univ Calif Los Angeles, Calif Nanosyst Inst, Ctr Environm Implicat Nanotechnol, Los Angeles, CA 90024 USA.	yoram@ucla.edu	xia, tian/C-3158-2013; Rallo, Robert/F-4703-2010; Nel, Andre E/J-2808-2012; Xiao, Jian/GYU-4351-2022; Damoiseaux, Robert/F-1086-2011; Cohen, Yoram/M-8802-2014; Lin, Sijie/E-7719-2011; Damoiseaux, Robert/S-6712-2019; Lin, Sijie/S-8428-2016	xia, tian/0000-0003-0123-1305; Rallo, Robert/0000-0003-3812-4458; Damoiseaux, Robert/0000-0002-7611-7534; Cohen, Yoram/0000-0002-0756-4699; Lin, Sijie/0000-0002-6970-8221; Damoiseaux, Robert/0000-0002-7611-7534; Lin, Sijie/0000-0002-6970-8221	National Science Foundation; Environmental Protection Agency [DBI-0830117]; U.S. Public Health Service [U19 ES019528]; CICYT [CTQ2009-14627]; Generalitat de Catalunya [2009SGR-01529]; EU Commission (OSIRIS) [037017]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U19ES019528] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); Environmental Protection Agency(United States Environmental Protection Agency); U.S. Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); CICYT(Consejo Interinstitucional de Ciencia y Tecnologia (CICYT)); Generalitat de Catalunya(Generalitat de Catalunya); EU Commission (OSIRIS)(European CommissionEuropean Commission Joint Research Centre); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This material is based upon work supported by the National Science Foundation and the Environmental Protection Agency under Cooperative Agreement Number DBI-0830117. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the author(s) and do not necessarily reflect the views of the National Science Foundation or the Environmental Protection Agency. This work has not been subjected to EPA review and no official endorsement should be inferred. Support was also provided by the U.S. Public Health Service Grants U19 ES019528. Robert Rallo also acknowledges support provided by CICYT (Project CTQ2009-14627), Generalitat de Catalunya (2009SGR-01529) and the EU Commission (OSIRIS, Contract No. 037017). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMED N, 1974, IEEE T COMPUT, VC 23, P90, DOI 10.1109/T-C.1974.223784; Asharani PV, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/25/255102; Bai W, 2010, J NANOPART RES, V12, P1645, DOI 10.1007/s11051-009-9740-9; Bai W, 2010, J NANOSCI NANOTECHNO, V10, P8670, DOI 10.1166/jnn.2010.2686; Bar-Ilan O, 2009, SMALL, V5, P1897, DOI 10.1002/smll.200801716; Bishop C. M., 2007, J ELECT IMAGING, V2nd, DOI 10.1117/1.2819119; Blackburn JS, 2011, NAT PROTOC, V6, P229, DOI 10.1038/nprot.2010.170; Burns CG, 2005, NAT CHEM BIOL, V1, P263, DOI 10.1038/nchembio732; Chang C.C., 2011, LIBSVM LIB SUPPORT V; Cheng JP, 2007, ENVIRON TOXICOL CHEM, V26, P708, DOI 10.1897/06-272R.1; Colvin VL, 2003, NAT BIOTECHNOL, V21, P1166, DOI 10.1038/nbt875; Cristianini Nello, 2000, INTRO SUPPORT VECTOR; d'Alencon CA, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-151; Damoiseaux R, 2011, NANOSCALE, V3, P1345, DOI 10.1039/c0nr00618a; Delvecchio C, 2011, ZEBRAFISH POWERFUL P; den Hertog J, 2005, BIOSCIENCE REP, V25, P289, DOI 10.1007/s10540-005-2891-8; Dunham M.H., 2003, DATA MINING INTRO AD; George S, 2011, ACS NANO, V5, P1805, DOI 10.1021/nn102734s; Guo Z, 2009, ART HSE NANO SCI ENG, P3; Hall JB, 2007, NANOMEDICINE-UK, V2, P789, DOI 10.2217/17435889.2.6.789; Han J, 2006, DATA MINING CONCEPTS; Haykin S., 1994, NEURAL NETWORKS, DOI 10.5555/521706; Hsu C.-W., 2010, PRACTICAL GUIDE SUPP; Hsu CW, 2002, IEEE T NEURAL NETWOR, V13, P415, DOI 10.1109/72.991427; Jones CF, 2009, ADV DRUG DELIVER REV, V61, P438, DOI 10.1016/j.addr.2009.03.005; King-Heiden TC, 2009, ENVIRON SCI TECHNOL, V43, P1605, DOI 10.1021/es801925c; Lee KJ, 2007, ACS NANO, V1, P133, DOI 10.1021/nn700048y; Lin SJ, 2011, ACS NANO, V5, P7284, DOI 10.1021/nn202116p; Liu H, 2005, IEEE T KNOWL DATA EN, V17, P491, DOI 10.1109/TKDE.2005.66; Liu Y, 2012, INTEGR BIOL-UK, V4, P285, DOI 10.1039/c2ib00130f; Love DR, 2004, CURR OPIN BIOTECH, V15, P564, DOI 10.1016/j.copbio.2004.09.004; Lux M, 2009, P 17 ACM INT C MULT, P925, DOI [DOI 10.1145/1631272.1631456, 10.1145/1631272.1631456]; Manjunath BS, 2001, IEEE T CIRC SYST VID, V11, P703, DOI 10.1109/76.927424; Meyer J, 2004, SPIES INT S OPTICSEA, P131; National Research Council, 2007, TOX TEST 21 CENT VIS; Nixon M., 2008, FEATURE EXTRACTION I; Parng C, 2005, CURR OPIN DRUG DISC, V8, P100; Rallo R, 2011, ENVIRON SCI TECHNOL, V45, P1695, DOI 10.1021/es103606x; Refaeilzadeh P., 2009, ENCY DATABASE SYSTEM, DOI [10.1007/978-1-4899-7993-3_565-2, DOI 10.1007/978-1-4899-7993-3_565-2]; Sikora T, 2001, IEEE T CIRC SYST VID, V11, P696, DOI 10.1109/76.927422; Teraoka Hiroki, 2003, Congenital Anomalies, V43, P123, DOI 10.1111/j.1741-4520.2003.tb01036.x; Thomas CR, 2011, ACS NANO, V5, P13, DOI 10.1021/nn1034857; Tran TC, 2007, CANCER RES, V67, P11386, DOI 10.1158/0008-5472.CAN-07-3126; Usenko CY, 2007, CARBON, V45, P1891, DOI 10.1016/j.carbon.2007.04.021; Vapnik V., 1998, STAT LEARNING THEORY, V3, DOI DOI 10.1007/978-1-4419-1428-6_5864; Vogt A, 2009, DEV DYNAM, V238, P656, DOI 10.1002/dvdy.21892; Won CS, 2002, ETRI J, V24, P23, DOI 10.4218/etrij.02.0102.0103; Woodrow Wilson International Center, 2010, PROJ EM NAN CONS PRO; Xia TA, 2011, ACS NANO, V5, P1223, DOI 10.1021/nn1028482; Xu XY, 2010, J BIOMOL SCREEN, V15, P1152, DOI 10.1177/1087057110379155; Zhu XS, 2008, J ENVIRON SCI HEAL A, V43, P278, DOI 10.1080/10934520701792779; Zhu XS, 2007, ENVIRON TOXICOL CHEM, V26, P976, DOI 10.1897/06-583.1; Zhu XS, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/19/195103; Zon LI, 2005, NAT REV DRUG DISCOV, V4, P35, DOI 10.1038/nrd1606	55	35	36	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2012	7	4							e35014	10.1371/journal.pone.0035014	http://dx.doi.org/10.1371/journal.pone.0035014			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959FE	22506062	Green Submitted, Green Published, gold			2022-12-27	WOS:000305297500069
J	Speybroeck, S; Kuppens, S; Van Damme, J; Van Petegem, P; Lamote, C; Boonen, T; de Bilde, J				Speybroeck, Sara; Kuppens, Sofie; Van Damme, Jan; Van Petegem, Peter; Lamote, Carl; Boonen, Tinneke; de Bilde, Jerissa			The Role of Teachers' Expectations in the Association between Children's SES and Performance in Kindergarten: A Moderated Mediation Analysis	PLOS ONE			English	Article							PHYSICAL-EDUCATION CLASSES; ACHIEVEMENT; PERCEPTIONS; CLASSROOM; STUDENTS; STEREOTYPES; COMPETENCE; ETHNICITY; ACCURACY; GENDER	This study examines the role of teachers' expectations in the association between children's socio-economic background and achievement outcomes. Furthermore, the role of children's ethnicity in moderating this mediated relation is investigated. In the present study, 3,948 children from kindergarten are examined. Data are analysed by means of structural equation modeling. First, results show that teachers' expectations mediate the relation between children's SES and their later language and math achievement, after controlling for children's ethnicity, prior achievement and gender. This result indicates that teachers may exacerbate individual differences between children. Second, children's ethnicity moderates the mediation effect of teachers' expectations with respect to math outcomes. The role of teachers' expectations in mediating the relation between SES and math outcomes is stronger for majority children than for minority children.	[Speybroeck, Sara; Van Damme, Jan; Lamote, Carl; Boonen, Tinneke; de Bilde, Jerissa] Katholieke Univ Leuven, Dept Educ Sci, Educ & Training Res Grp, Louvain, Belgium; [Kuppens, Sofie] Vrije Univ Amsterdam, EMGO Inst Hlth & Care Res, Amsterdam, Netherlands; [Kuppens, Sofie] Katholieke Univ Leuven, Dept Educ Sci, Methodol Educ Sci Res Grp, Louvain, Belgium; [Van Petegem, Peter] Univ Antwerp, Inst Educ & Informat Sci, Res Grp EduBROn, B-2020 Antwerp, Belgium	KU Leuven; Vrije Universiteit Amsterdam; KU Leuven; University of Antwerp	Speybroeck, S (corresponding author), Katholieke Univ Leuven, Dept Educ Sci, Educ & Training Res Grp, Louvain, Belgium.	sara.speybroeck@ped.kuleuven.be	Van Petegem, Peter/R-5494-2016; Akkal, Maureen/P-6919-2014; de Bilde, Jerissa/D-3752-2012	Van Petegem, Peter/0000-0002-4078-7800; Lamote, Carl/0000-0002-0000-0030	Ministry of the Flemish Government (Belgium)	Ministry of the Flemish Government (Belgium)	The study was financed by the Ministry of the Flemish Government (Belgium). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, STREAMS 3 0 USERS GU; Auwarter AE, 2008, J EDUC RES, V101, P243; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Blackwell LS, 2007, CHILD DEV, V78, P246, DOI 10.1111/j.1467-8624.2007.00995.x; Bollen K. A., 1993, TESTING STRUCTURAL E; Buyse E, 2009, ELEM SCHOOL J, V110, P119, DOI 10.1086/605768; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; de Boer H, 2010, J EDUC PSYCHOL, V102, P168, DOI 10.1037/a0017289; DUSEK JB, 1983, J EDUC PSYCHOL, V75, P327, DOI 10.1037/0022-0663.75.3.327; Edwards JR, 2007, PSYCHOL METHODS, V12, P1, DOI 10.1037/1082-989X.12.1.1; Farkas G, 2003, TEACH COLL REC, V105, P1119, DOI 10.1111/1467-9620.00279; Gill S, 1999, J SCHOOL PSYCHOL, V37, P403, DOI 10.1016/S0022-4405(99)00027-8; Gustafsson JE, 2000, STREAMS 2 5 USERS GU; Gutierrez-Dona B, 2009, APPL PSYCHOL-HLTH WE, V1, P91, DOI 10.1111/j.1758-0854.2008.01001.x; Hinnant JB, 2009, J EDUC PSYCHOL, V101, P662, DOI 10.1037/a0014306; Holmbeck GN, 1997, J CONSULT CLIN PSYCH, V65, P599, DOI 10.1037/0022-006X.65.4.599; Hughes JN, 2005, J SCHOOL PSYCHOL, V43, P303, DOI 10.1016/j.jsp.2005.07.001; James LR, 2006, ORGAN RES METHODS, V9, P233, DOI 10.1177/1094428105285144; Jussim L, 2005, PERS SOC PSYCHOL REV, V9, P131, DOI 10.1207/s15327957pspr0902_3; JUSSIM L, 1992, J PERS SOC PSYCHOL, V63, P947, DOI 10.1037/0022-3514.63.6.947; JUSSIM L, 1989, J PERS SOC PSYCHOL, V57, P469, DOI 10.1037/0022-3514.57.3.469; Jussim L, 1996, ADV EXP SOC PSYCHOL, V28, P281, DOI 10.1016/S0065-2601(08)60240-3; Kuklinski MR, 2001, CHILD DEV, V72, P1554, DOI 10.1111/1467-8624.00365; Lau RS, 2012, ORGAN RES METHODS, V15, P3, DOI 10.1177/1094428110391673; Little T. D., 2007, MODELING CONTEXTUAL; Madon S, 1997, J PERS SOC PSYCHOL, V72, P791, DOI 10.1037/0022-3514.72.4.791; Madon S, 1998, PERS SOC PSYCHOL B, V24, P1304, DOI 10.1177/01461672982412005; Maes F, 2003, 12 LOA SIBO STEUNP L; Maes F, 2002, 1 LOA SIBO STEUNP LO; Marshall GN, 2010, J ABNORM PSYCHOL, V119, P143, DOI 10.1037/a0018009; McKown C, 2002, J APPL SOC PSYCHOL, V32, P159, DOI 10.1111/j.1559-1816.2002.tb01425.x; McKown C, 2008, J SCHOOL PSYCHOL, V46, P235, DOI 10.1016/j.jsp.2007.05.001; MERTON RK, 1968, SCIENCE, V159, P56, DOI 10.1126/science.159.3810.56; Morgan PL, 2008, LEARN DISABILITY Q, V31, P187, DOI 10.2307/25474651; Muthen L, 2007, MUTH N MUTH N; Muthen LK., 2017, MPLUS, VEight; OECD, 2000, EARL CHILDH ED CAR P; Reynders T, 2004, 22 LOA SIBO STEUNP L; Rosenthal R., 1968, URBAN REV, P16, DOI [10.1007/BF02322211, DOI 10.1007/BF02322211]; Rubie-Davies C, 2006, BRIT J EDUC PSYCHOL, V76, P429, DOI 10.1348/000709905X53589; Rubie-Davies CM, 2010, BRIT J EDUC PSYCHOL, V80, P121, DOI 10.1348/000709909X466334; Rubie-Davies CM, 2006, PSYCHOL SCHOOLS, V43, P537, DOI 10.1002/pits.20169; Saft EW, 2001, SCHOOL PSYCHOL QUART, V16, P125, DOI 10.1521/scpq.16.2.125.18698; Satorra A, 2010, PSYCHOMETRIKA, V75, P243, DOI 10.1007/S11336-009-9135-Y; Scarborough HS, 2003, ANN DYSLEXIA, V53, P47, DOI 10.1007/s11881-003-0004-6; Schermelleh-Engel K, 2003, METHODS PSYCHOL RES, V8, P23, DOI DOI 10.1002/0470010940; Siongers J., 2009, BEROEP LERAAR DOORGE; SNOW RE, 1969, CONTEMP PSYCHOL, V14, P197, DOI 10.1037/0010293; THORNDIKE RL, 1968, AM EDUC RES J, V5, P708; Tomarken AJ, 2005, ANNU REV CLIN PSYCHO, V1, P31, DOI 10.1146/annurev.clinpsy.1.102803.144239; Trouilloud D, 2006, J EDUC PSYCHOL, V98, P75, DOI 10.1037/0022-0663.98.1.75; Trouilloud DO, 2002, EUR J SOC PSYCHOL, V32, P591, DOI 10.1002/ejsp.109; van den Bergh L, 2010, AM EDUC RES J, V47, P497, DOI 10.3102/0002831209353594; Verachtert P, 2003, 14 LOA SIBO STEUNP L; Verachtert P, 2009, SCH EFF SCH IMPROV, V20, P215, DOI 10.1080/09243450902883896; Verhaeghe JP, 2002, 5 LOA SIBO STEUNP LO; Vigoda E., 2003, INT J PUBLIC SECT MA, V16, P502, DOI DOI 10.1108/09513550310500382; WALBERG HJ, 1983, AM EDUC RES J, V20, P359, DOI 10.2307/1162605	58	32	32	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2012	7	4							e34502	10.1371/journal.pone.0034502	http://dx.doi.org/10.1371/journal.pone.0034502			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959FE	22506023	Green Published, gold, Green Submitted			2022-12-27	WOS:000305297500031
J	Thegerstrom, J; Jonsson, B; Brudin, L; Olsen, B; Wold, AE; Ernerudh, J; Friman, V				Thegerstrom, Johanna; Jonsson, Bodil; Brudin, Lars; Olsen, Bjorn; Wold, Agnes E.; Ernerudh, Jan; Friman, Vanda			Mycobacterium avium Subsp avium and Subsp hominissuis Give Different Cytokine Responses after in vitro Stimulation of Human Blood Mononuclear Cells	PLOS ONE			English	Article							CD4 T-CELLS; IFN-GAMMA; INFECTION; CHILDREN; IMMUNITY; LYMPHADENITIS; TUBERCULOSIS; COMPLEX; INTERLEUKIN-17; RESISTANCE	Background: Mycobacterium avium is the principal etiologic agent of non-tuberculous lymphadenitis in children. It is also a known pathogen for birds and other animals. Genetic typing of M. avium isolates has led to a proposal to expand the set of subspecies to include M. avium subsp. hominissuis. Isolates associated with disease in humans belong to this subspecies. Methodology/Principal Findings: Peripheral blood mononuclear cells from six healthy blood donors were stimulated in vitro with ten isolates of M. avium avium and 11 isolates of M. avium hominissuis followed by multiplex bead array quantification of cytokines in supernatants. M. avium hominissuis isolates induced significantly more IL-10 and significantly less IL-12p70, TNF, IFN-gamma and IL-17 when compared to M. avium avium isolates. All strains induced high levels of IL-17, but had very low levels of IL-12p70. Conclusion/Significance: The strong association between M. avium subsp. hominissuis and disease in humans and the clear differences in the human immune response to M. avium subsp. hominissuis compared to M. avium subsp. avium isolates, as demonstrated in this study, suggest that genetic differences between M. avium isolates play an important role in the pathogenicity in humans.	[Thegerstrom, Johanna; Ernerudh, Jan] Linkoping Univ, Fac Hlth Sci, Dept Clin & Expt Med, Linkoping, Sweden; [Thegerstrom, Johanna; Brudin, Lars] Kalmar Cty Hosp, Dept Clin Physiol, Kalmar, Sweden; [Jonsson, Bodil; Wold, Agnes E.] Univ Gothenburg, Inst Biomed, Dept Infect Med, Gothenburg, Sweden; [Brudin, Lars] Linkoping Univ, Dept Med & Hlth Sci, Linkoping, Sweden; [Olsen, Bjorn] Uppsala Univ, Dept Med Sci, Uppsala, Sweden; [Olsen, Bjorn] Acad Hosp, Uppsala, Sweden; [Friman, Vanda] Sahlgrens Univ Hosp, Dept Infect Dis, S-41345 Gothenburg, Sweden	Linkoping University; University of Gothenburg; Linkoping University; Uppsala University; Sahlgrenska University Hospital	Thegerstrom, J (corresponding author), Linkoping Univ, Fac Hlth Sci, Dept Clin & Expt Med, Linkoping, Sweden.	Johannathegerstrom@ltkalmar.se	Jonsson, Bodil/I-2133-2013	Jonsson, Bodil/0000-0002-0969-5975; Wold, Agnes/0000-0001-9196-5040; Olsen, Bjorn/0000-0002-4646-691X; Brudin, Lars/0000-0002-6278-1362	Medical Research Council of Southeast Sweden	Medical Research Council of Southeast Sweden(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The study was supported by grants from the Medical Research Council of Southeast Sweden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cooper AM, 2008, IMMUNOL REV, V226, P191, DOI 10.1111/j.1600-065X.2008.00702.x; Couper KN, 2008, J IMMUNOL, V180, P5771, DOI 10.4049/jimmunol.180.9.5771; Coury F, 2008, NAT MED, V14, P81, DOI 10.1038/nm1694; Cruz A, 2006, J IMMUNOL, V177, P1416, DOI 10.4049/jimmunol.177.3.1416; Danelishvilli L, 2003, CURR PHARM DESIGN, V9, P61, DOI 10.2174/1381612033392369; Emile JF, 1997, J PATHOL, V181, P25, DOI 10.1002/(SICI)1096-9896(199701)181:1<25::AID-PATH747>3.0.CO;2-Z; Evans MJ, 1998, J CLIN PATHOL, V51, P925, DOI 10.1136/jcp.51.12.925; FAIRCHOK MP, 1995, CLIN DIAGN LAB IMMUN, V2, P443, DOI 10.1128/CDLI.2.4.443-447.1995; Falkinham JO, 2002, CLIN CHEST MED, V23, P529, DOI 10.1016/S0272-5231(02)00014-X; Haverkamp MH, 2006, MICROBES INFECT, V8, P1157, DOI 10.1016/j.micinf.2005.10.029; Hessle CC, 2005, CYTOKINE, V30, P311, DOI 10.1016/j.cyto.2004.05.008; Kasperbauer SH, 2008, SEMIN RESP CRIT CARE, V29, P569, DOI 10.1055/s-0028-1085708; Khader SA, 2010, VIRULENCE, V1, P423, DOI 10.4161/viru.1.5.12862; LIND A, 1991, TUBERCLE, V72, P29, DOI 10.1016/0041-3879(91)90021-J; MASSON A M, 1956, Can Med Assoc J, V75, P798; Matsuzaki G, 2007, MICROBIOL IMMUNOL, V51, P1139, DOI 10.1111/j.1348-0421.2007.tb04008.x; Mijs W, 2002, INT J SYST EVOL MICR, V52, P1505, DOI [10.1099/ijs.0.02037-0, 10.1099/00207713-52-5-1505]; Ordway D, 2007, J LEUKOCYTE BIOL, V82, P1221, DOI 10.1189/jlb.0607426; Ottenhoff THM, 2002, NAT GENET, V32, P97, DOI 10.1038/ng0902-97; Ritacco V, 1998, INT J TUBERC LUNG D, V2, P242; Romani L, 1997, CLIN MICROBIOL REV, V10, P611, DOI 10.1128/CMR.10.4.611; ROMANUS V, 1995, TUBERCLE LUNG DIS, V76, P300, DOI 10.1016/S0962-8479(05)80028-0; SAUNDERS BM, 1995, INFECT IMMUN, V63, P4011, DOI 10.1128/IAI.63.10.4011-4015.1995; Scriba TJ, 2008, J IMMUNOL, V180, P1962, DOI 10.4049/jimmunol.180.3.1962; Sweet L, 2006, J LEUKOCYTE BIOL, V80, P415, DOI 10.1189/jlb.1205702; Thegerstrom J, 2005, SCAND J INFECT DIS, V37, P15, DOI 10.1080/00365540510026850; Torrado E, 2010, CYTOKINE GROWTH F R, V21, P455, DOI 10.1016/j.cytogfr.2010.10.004; Turenne CY, 2007, CLIN MICROBIOL REV, V20, P205, DOI 10.1128/CMR.00036-06; van Coppenraet LESB, 2008, EUR J CLIN MICROBIOL, V27, P293, DOI 10.1007/s10096-007-0440-z; WOLINSKY E, 1995, CLIN INFECT DIS, V20, P954, DOI 10.1093/clinids/20.4.954	30	13	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2012	7	4							e34391	10.1371/journal.pone.0034391	http://dx.doi.org/10.1371/journal.pone.0034391			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959FE	22506018	Green Submitted, Green Published, gold			2022-12-27	WOS:000305297500026
J	Shen, TH; Gladoun, N; Castillo-Martin, M; Bonal, D; Domingo-Domenech, J; Charytonowicz, D; Cordon-Cardo, C				Shen, Tian Huai; Gladoun, Nataliya; Castillo-Martin, Mireia; Bonal, Dennis; Domingo-Domenech, Josep; Charytonowicz, Daniel; Cordon-Cardo, Carlos			A BAC-Based Transgenic Mouse Specifically Expresses an Inducible Cre in the Urothelium	PLOS ONE			English	Article							GENE-EXPRESSION; MICE; INACTIVATION; GENOME; CELLS; TOOL; RAS	Cre-loxp mediated conditional knockout strategy has played critical roles for revealing functions of many genes essential for development, as well as the causal relationships between gene mutations and diseases in the postnatal adult mice. One key factor of this strategy is the availability of mice with tissue-or cell type-specific Cre expression. However, the success of the traditional molecular cloning approach to generate mice with tissue specific Cre expression often depends on luck. Here we provide a better alternative by using bacterial artificial chromosome (BAC)-based recombineering to insert iCreERT2 cDNA at the ATG start of the Upk2 gene. The BAC-based transgenic mice express the inducible Cre specifically in the urothelium as demonstrated by mRNA expression and staining for LacZ expression after crossing with a Rosa26 reporter mouse. Taking into consideration the size of the gene of interest and neighboring genes included in a BAC, this method should be widely applicable for generation of mice with tissue specific gene expression or deletions in a more specific manner than previously reported.	[Shen, Tian Huai; Gladoun, Nataliya; Castillo-Martin, Mireia; Bonal, Dennis; Domingo-Domenech, Josep; Charytonowicz, Daniel; Cordon-Cardo, Carlos] Columbia Univ, Herbert Irving Comprehens Canc Ctr, Med Ctr, New York, NY USA; [Shen, Tian Huai; Gladoun, Nataliya; Castillo-Martin, Mireia; Bonal, Dennis; Domingo-Domenech, Josep; Cordon-Cardo, Carlos] Columbia Univ, Dept Pathol, Med Ctr, New York, NY USA; [Castillo-Martin, Mireia; Bonal, Dennis; Domingo-Domenech, Josep; Cordon-Cardo, Carlos] Columbia Univ, Dept Urol, Med Ctr, New York, NY USA	Columbia University; Columbia University; Columbia University	Shen, TH (corresponding author), Albert Einstein Coll Med, Ruth L & David S Gottesman Inst Stem Cells & Rege, Dept Med, Bronx, NY 10467 USA.	carlos.cordon-cardo@mssm.edu	Castillo-Martin, Mireia/H-6152-2013		National Institutes of Health [P01 CA087497]; Alexander and Margaret Stewart Trust; NATIONAL CANCER INSTITUTE [P01CA087497] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alexander and Margaret Stewart Trust; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health grant P01 CA087497, and partially supported by an Alexander and Margaret Stewart Trust Award. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DJ, 2005, GENOMICS, V86, P753, DOI 10.1016/j.ygeno.2005.08.003; Ahmad I, 2011, DIS MODEL MECH, V4, P548, DOI 10.1242/dmm.006874; Blondeau B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030210; Copeland NG, 2001, NAT REV GENET, V2, P769, DOI 10.1038/35093556; Cordon-Cardo C, 2008, SCAND J UROL NEPHROL, V42, P154, DOI 10.1080/03008880802291915; Di Cristofano A, 1998, NAT GENET, V19, P348, DOI 10.1038/1235; Erdmann G, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-63; Heiman M, 2008, CELL, V135, P738, DOI 10.1016/j.cell.2008.10.028; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kerr DE, 1998, NAT BIOTECHNOL, V16, P75, DOI 10.1038/nbt0198-75; Kim JE, 2004, AM J PATHOL, V165, P1875, DOI 10.1016/S0002-9440(10)63240-3; LIN JH, 1995, P NATL ACAD SCI USA, V92, P679, DOI 10.1073/pnas.92.3.679; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marino S, 2000, GENE DEV, V14, P994; Miloud T, 2012, J IMMUNOL, V188, P1125, DOI 10.4049/jimmunol.1003920; Mo L, 2005, AM J PHYSIOL-RENAL, V289, pF562, DOI 10.1152/ajprenal.00368.2004; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Wallace HAC, 2007, CELL, V128, P197, DOI 10.1016/j.cell.2006.11.044; Warming S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni035; Wrann CD, 2012, J CLIN INVEST, V122, P1010, DOI 10.1172/JCI58431; WU XR, 1990, J BIOL CHEM, V265, P19170; Wu XR, 2009, KIDNEY INT, V75, P1153, DOI 10.1038/ki.2009.73; Yang XD, 2011, NAT MED, V17, P87, DOI 10.1038/nm.2278; Zhang ZT, 1999, CANCER RES, V59, P3512; Zhang ZT, 2001, ONCOGENE, V20, P1973, DOI 10.1038/sj.onc.1204315; Zhao SL, 2011, NAT METHODS, V8, P745, DOI 10.1038/nmeth.1668; Zhou HP, 2010, AM J PHYSIOL-RENAL, V299, pF387, DOI 10.1152/ajprenal.00185.2010	27	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2012	7	4							e35243	10.1371/journal.pone.0035243	http://dx.doi.org/10.1371/journal.pone.0035243			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JO	22496911	Green Published, gold, Green Submitted			2022-12-27	WOS:000305014500051
J	Eriksson, N; Tung, JY; Kiefer, AK; Hinds, DA; Francke, U; Mountain, JL; Do, CB				Eriksson, Nicholas; Tung, Joyce Y.; Kiefer, Amy K.; Hinds, David A.; Francke, Uta; Mountain, Joanna L.; Do, Chuong B.			Novel Associations for Hypothyroidism Include Known Autoimmune Risk Loci	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; THYROID-DISEASE; GRAVES-DISEASE; HASHIMOTOS-THYROIDITIS; SUSCEPTIBILITY LOCI; R620W POLYMORPHISM; GENE VARIANTS; VAV FAMILY; ALLELE; PHOSPHODIESTERASE	Hypothyroidism is the most common thyroid disorder, affecting about 5% of the general population. Here we present the current largest genome-wide association study of hypothyroidism, in 3,736 cases and 35,546 controls. Hypothyroidism was assessed via web-based questionnaires. We identify five genome-wide significant associations, three of which are well known to be involved in a large spectrum of autoimmune diseases: rs6679677 near PTPN22, rs3184504 in SH2B3, and rs2517532 in the HLA class I region (p-values 2.8.10(-13), 2.6.10(-12), and 1.3.10(-8), respectively). We also report associations with rs4915077 near VAV3 (p-value 7.5.10(-10)) and rs925489 near FOXE1 (p-value 2.4.10(-19)). VAV3 is involved in immune function, and FOXE1 and PTPN22 have previously been associated with hypothyroidism. Although the HLA class I region and SH2B3 have previously been linked with a number of autoimmune diseases, this is the first report of their association with thyroid disease. The VAV3 association is also novel. We also show suggestive evidence of association for hypothyroidism with a SNP in the HLA class II region (independent of the other HLA association) as well as SNPs in CAPZB, PDE8B, and CTLA4. CAPZB and PDE8B have been linked to TSH levels and CTLA4 to a variety of autoimmune diseases. These results suggest heterogeneity in the genetic etiology of hypothyroidism, implicating genes involved in both autoimmune disorders and thyroid function. Using a genetic risk profile score based on the top association from each of the five genome-wide significant regions in our study, the relative risk between the highest and lowest deciles of genetic risk is 2.0.	[Eriksson, Nicholas; Tung, Joyce Y.; Kiefer, Amy K.; Hinds, David A.; Francke, Uta; Mountain, Joanna L.; Do, Chuong B.] 23andMe Inc, Mountain View, CA USA		Eriksson, N (corresponding author), 23andMe Inc, Mountain View, CA USA.	nick@23andme.com		Hinds, David/0000-0002-4911-803X				Alcina A, 2010, GENES IMMUN, V11, P439, DOI 10.1038/gene.2010.30; Arnaud-Lopez L, 2008, AM J HUM GENET, V82, P1270, DOI 10.1016/j.ajhg.2008.04.019; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Bender AT, 2006, PHARMACOL REV, V58, P488, DOI 10.1124/pr.58.3.5; Betz RC, 2008, BRIT J DERMATOL, V158, P389, DOI 10.1111/j.1365-2133.2007.08312.x; Castanet M, 2010, HORM RES PAEDIAT, V73, P423, DOI 10.1159/000281438; Chen PL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016635; Cho JH, 2011, NEW ENGL J MED, V365, P1612, DOI 10.1056/NEJMra1100030; Chu X, 2011, NAT GENET, V43, P897, DOI 10.1038/ng.898; Coenen MJH, 2009, HUM MOL GENET, V18, P4195, DOI 10.1093/hmg/ddp365; Cotsapas C, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002254; Criswell LA, 2005, AM J HUM GENET, V76, P561, DOI 10.1086/429096; Denny JC, 2011, AM J HUM GENET, V89, P529, DOI 10.1016/j.ajhg.2011.09.008; Do CB, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002141; Donner H, 1997, J CLIN ENDOCR METAB, V82, P4130, DOI 10.1210/jc.82.12.4130; Eriksson N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000993; Falush D, 2003, GENETICS, V164, P1567; Fraser HI, 2010, J IMMUNOL, V184, P5075, DOI 10.4049/jimmunol.0903734; Fujikawa K, 2003, J EXP MED, V198, P1595, DOI 10.1084/jem.20030874; Giordano TJ, 2005, ONCOGENE, V24, P6646, DOI 10.1038/sj.onc.1208822; Gourh P, 2006, ARTHRITIS RHEUM-US, V54, P3945, DOI 10.1002/art.22196; Gregersen PK, 2009, ANNU REV IMMUNOL, V27, P363, DOI 10.1146/annurev.immunol.021908.132653; Gudmundsson J, 2009, NAT GENET, V41, P460, DOI 10.1038/ng.339; Hakonarson H, 2007, NATURE, V448, P591, DOI 10.1038/nature06010; Hayashi M, 1998, BIOCHEM BIOPH RES CO, V250, P751, DOI 10.1006/bbrc.1998.9379; Ikegami H, 2006, J CLIN ENDOCR METAB, V91, P1087, DOI 10.1210/jc.2005-1407; Landa I, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000637; Lee YH, 2007, RHEUMATOLOGY, V46, P49, DOI 10.1093/rheumatology/kel170; Lettre G, 2008, HUM MOL GENET, V17, pR116, DOI 10.1093/hmg/ddn246; Lowe JK, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000365; Menconi F, 2008, P NATL ACAD SCI USA, V105, P14034, DOI 10.1073/pnas.0806584105; Movilla N, 1999, MOL CELL BIOL, V19, P7870; Newby PR, 2010, EUR J HUM GENET, V18, P1021, DOI 10.1038/ejhg.2010.55; Newport M, 2007, NAT GENET, V39, P1329, DOI 10.1038/ng.2007.17; Newton-Cheh C, 2009, NAT GENET, V41, P666, DOI 10.1038/ng.361; Panicker V, 2010, AM J HUM GENET, V87, P430, DOI 10.1016/j.ajhg.2010.08.005; Park SM, 2005, J MED GENET, V42, P379, DOI 10.1136/jmg.2004.024158; Petrone A, 2001, THYROID, V11, P171, DOI 10.1089/105072501300042901; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Simmonds MJ, 2011, BRIEF FUNCT GENOMICS, V10, P77, DOI 10.1093/bfgp/elq036; Sirota M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000792; Smyth D, 2004, DIABETES, V53, P3020, DOI 10.2337/diabetes.53.11.3020; TANDON N, 1991, CLIN ENDOCRINOL, V34, P383; Teumer A, 2011, AM J HUM GENET, V88, P664, DOI 10.1016/j.ajhg.2011.04.015; Todd JA, 2007, NAT GENET, V39, P857, DOI 10.1038/ng2068; Tomer Y, 2010, THYROID, V20, P715, DOI 10.1089/thy.2010.1644; Velaga MR, 2004, J CLIN ENDOCR METAB, V89, P5862, DOI 10.1210/jc.2004-1108; Wigginton JE, 2005, AM J HUM GENET, V76, P887, DOI 10.1086/429864; Zeitlin AA, 2008, CLIN ENDOCRINOL, V68, P671, DOI 10.1111/j.1365-2265.2007.03075.x; Zhernakova A, 2010, AM J HUM GENET, V86, P970, DOI 10.1016/j.ajhg.2010.05.004	50	97	97	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2012	7	4							e34442	10.1371/journal.pone.0034442	http://dx.doi.org/10.1371/journal.pone.0034442			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JA	22493691	Green Published, gold, Green Submitted			2022-12-27	WOS:000305012700033
J	Lindenmayer, DB; Northrop-Mackie, AR; Montague-Drake, R; Crane, M; Michael, D; Okada, S; Gibbons, P				Lindenmayer, David B.; Northrop-Mackie, Amanda R.; Montague-Drake, Rebecca; Crane, Mason; Michael, Damian; Okada, Sachiko; Gibbons, Philip			Not All Kinds of Revegetation Are Created Equal: Revegetation Type Influences Bird Assemblages in Threatened Australian Woodland Ecosystems	PLOS ONE			English	Article							SOUTH-EASTERN AUSTRALIA; CANONICAL CORRESPONDENCE-ANALYSIS; AGRICULTURAL LANDSCAPES; REMNANT VEGETATION; SPECIES RICHNESS; CONSERVATION; FORESTS; RESTORATION; DIVERSITY; REGROWTH	The value for biodiversity of large intact areas of native vegetation is well established. The biodiversity value of regrowth vegetation is also increasingly recognised worldwide. However, there can be different kinds of revegetation that have different origins. Are there differences in the richness and composition of biotic communities in different kinds of revegetation? The answer remains unknown or poorly known in many ecosystems. We examined the conservation value of different kinds of revegetation through a comparative study of birds in 193 sites surveyed over ten years in four growth types located in semi-cleared agricultural areas of south-eastern Australia. These growth types were resprout regrowth, seedling regrowth, plantings, and old growth. Our investigation produced several key findings: (1) Marked differences in the bird assemblages of plantings, resprout regrowth, seedling regrowth, and old growth. (2) Differences in the number of species detected significantly more often in the different growth types; 29 species for plantings, 25 for seedling regrowth, 20 for resprout regrowth, and 15 for old growth. (3) Many bird species of conservation concern were significantly more often recorded in resprout regrowth, seedling regrowth or plantings but no species of conservation concern were recorded most often in old growth. We suggest that differences in bird occurrence among different growth types are likely to be strongly associated with growth-type differences in stand structural complexity. Our findings suggest a range of vegetation growth types are likely to be required in a given farmland area to support the diverse array of bird species that have the potential to occur in Australian temperate woodland ecosystems. Our results also highlight the inherent conservation value of regrowth woodland and suggest that current policies which allow it to be cleared or thinned need to be carefully re-examined.	[Lindenmayer, David B.] Australian Natl Univ, Fenner Sch Environm & Soc, ARC Ctr Excellence Environm Decis, Canberra, ACT, Australia; Australian Natl Univ, Natl Environm Res Program, Canberra, ACT, Australia	Australian National University; Australian National University	Lindenmayer, DB (corresponding author), Australian Natl Univ, Fenner Sch Environm & Soc, ARC Ctr Excellence Environm Decis, Canberra, ACT, Australia.	david.lindenmayer@anu.edu.au	Crane, Mason/AAQ-1810-2021; Lindenmayer, David B/P-7183-2017; Gibbons, Philip/I-8248-2012	Lindenmayer, David B/0000-0002-4766-4088; 	Murray Catchment Management Authority; Australian Research Council; Australian Government	Murray Catchment Management Authority; Australian Research Council(Australian Research Council); Australian Government(Australian GovernmentCGIAR)	This work was supported by major grants from the Murray Catchment Management Authority, the Australian Research Council and the Australian Government's Caring for our Country Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agresti A., 2013, CATEGORICAL DATA ANA, V3rd ed.; [Anonymous], 2010, TEMPERATE WOODLAND C; Antos MJ, 2008, EMU, V108, P201, DOI 10.1071/MU08005; Barlow J, 2007, BIOL CONSERV, V136, P212, DOI 10.1016/j.biocon.2006.11.021; Bowen ME, 2007, BIOL CONSERV, V140, P273, DOI 10.1016/j.biocon.2007.08.012; Bowen ME, 2009, BIOL CONSERV, V142, P3051, DOI 10.1016/j.biocon.2009.08.005; Briggs SV, 2008, AUST J BOT, V56, P590, DOI 10.1071/BT08046; Broome A, 2011, BIODIVERS CONSERV, V20, P729, DOI 10.1007/s10531-010-9974-y; Bunnell F., 2009, FORESTRY BIODIVERSIT; Chappell MJ, 2011, AGR HUM VALUES, V28, P3, DOI 10.1007/s10460-009-9251-4; Chazdon RL, 2009, CONSERV BIOL, V23, P1406, DOI 10.1111/j.1523-1739.2009.01338.x; Commonwealth of Australia, 2009, ENVL STEW STRAT FRAM; CONNELL JH, 1978, SCIENCE, V199, P1302, DOI 10.1126/science.199.4335.1302; Cribb J, 2010, COM FAM GLOB FOOD; Cunningham RB, 2008, CONSERV BIOL, V22, P742, DOI 10.1111/j.1523-1739.2008.00924.x; Cunningham RB, 2007, ECOL APPL, V17, P609, DOI 10.1890/05-1892; Dent DH, 2009, BIOL CONSERV, V142, P2833, DOI 10.1016/j.biocon.2009.05.035; Department of Environment Climate Change and Water, 2009, NSW ANN REP NAT VEG; Dhondt AA, 2007, BIRD STUDY, V54, P12, DOI 10.1080/00063650709461452; Doerr VAJ, 2006, EMU, V106, P93, DOI 10.1071/MU05020; Dorrough J, 2005, BIOL CONSERV, V123, P55, DOI 10.1016/j.biocon.2004.10.008; Dwass M., 1960, CONTRIBUTIONS PROBAB, P198; Egler FE, 1954, VEGETATIO ACTA GEOBO, V4, P412, DOI DOI 10.1007/BF00275587; Eldridge DJ, 2011, ECOL LETT, V14, P709, DOI 10.1111/j.1461-0248.2011.01630.x; Felton A, 2008, BIOL CONSERV, V141, P545, DOI 10.1016/j.biocon.2007.11.009; Field SA, 2002, AUSTRAL ECOL, V27, P624, DOI 10.1046/j.1442-9993.2002.01223.x; Fischer J, 2008, DIVERS DISTRIB, V14, P38, DOI 10.1111/j.1472-4642.2007.00411.x; Fischer J, 2009, P NATL ACAD SCI USA, V106, P10386, DOI 10.1073/pnas.0900110106; Ford HA, 2001, BIOL CONSERV, V97, P71, DOI 10.1016/S0006-3207(00)00101-4; Ford HA, 2009, BIOL CONSERV, V142, P3182, DOI 10.1016/j.biocon.2009.08.022; Foster DR, 2006, CONSERV BIOL, V20, P959, DOI 10.1111/j.1523-1739.2006.00495.x; Franklin J.F., 2000, CONSERVATION BIOL PR, V1, P9, DOI DOI 10.1111/J.1526-4629.2000.TB00155.X; Fuller RJ, 1998, FORESTRY, V71, P199, DOI 10.1093/forestry/71.3.199; Gibb H, 2010, BIOL CONSERV, V143, P677, DOI 10.1016/j.biocon.2009.12.005; Gibbons P, 2010, FOREST ECOL MANAG, V260, P2125, DOI 10.1016/j.foreco.2010.09.003; Gibson L, 2011, NATURE, V478, P378, DOI 10.1038/nature10425; Hobbs R.J., 2000, TEMPERATE EUCALYPT W; HOLLING CS, 1992, ECOL MONOGR, V62, P447, DOI 10.2307/2937313; Howes AL, 2009, WILDLIFE RES, V36, P617, DOI 10.1071/WR09054; Johnson EA, 2008, ECOL LETT, V11, P419, DOI 10.1111/j.1461-0248.2008.01173.x; Kavanagh RP, 2007, AUSTRAL ECOL, V32, P635, DOI 10.1111/j.1442-9993.2007.01746.x; Keith D.A., 2004, OCEAN SHORES DESERT; Laven NH, 1997, CORELLA, V22, P55; Legendre P., 2012, NUMERICAL ECOLOGY; Leps J, 2003, MULTIVARIATE ANAL EC; Lindenmayer DB, 2010, BIOL CONSERV, V143, P289, DOI 10.1016/j.biocon.2009.10.010; Lindenmayer D.B., 2002, CONSERVING FOREST BI; Lindenmayer D, 2010, CONSERV BIOL, V24, P1459, DOI 10.1111/j.1523-1739.2010.01544.x; Lindenmayer DB, 2008, ECOL MONOGR, V78, P567, DOI 10.1890/07-0945.1; Lindenmayer DB, 2009, EMU, V109, P100, DOI 10.1071/MU08029; Lindenmayer DB, 2008, ECOL APPL, V18, P1967, DOI 10.1890/07-1943.1; Lindenmayer DB, 2010, EFFECTIVE ECOLOGICAL MONITORING, P1; Mac Nally R, 2010, RESTOR ECOL, V18, P85, DOI 10.1111/j.1526-100X.2008.00430.x; MACARTHUR R, 1961, ECOLOGY, V42, P594, DOI 10.2307/1932254; MacFaden SW, 2002, FOREST SCI, V48, P243; Major RE, 2001, BIOL CONSERV, V102, P47, DOI 10.1016/S0006-3207(01)00090-8; Major RE, 1999, J APPL ECOL, V36, P901, DOI 10.1046/j.1365-2664.1999.00457.x; Manning AD, 2006, BIOL CONSERV, V132, P311, DOI 10.1016/j.biocon.2006.04.023; Martin TG, 2005, J APPL ECOL, V42, P400, DOI 10.1111/j.1365-2664.2005.01012.x; Michael DR, 2011, BIOL CONSERV, V144, P407, DOI 10.1016/j.biocon.2010.09.019; Millennium Ecosystem Assessment, 2005, EC HUM WELL BEING BI; Montague-Drake RM, 2009, BIOL CONSERV, V142, P2896, DOI 10.1016/j.biocon.2009.07.009; Montague-Drake RM, 2011, LANDSCAPE ECOL, V26, P1383, DOI 10.1007/s10980-011-9665-4; Munro N, 2011, PLANTING FOR WILDLIFE: A PRACTICAL GUIDE TO RESTORING NATIVE WOODLANDS, P1; Nelson P.R., 2005, ANAL MEANS GRAPHICAL; NSW Office of Environment and Heritage, 2011, NAT VEG MAN CLEAR; ODUM E. P, 1959, FUNDAMENTALS ECOLOGY; Oliver D, 2011, WOODLAND WANDERINGS, V8, P8; PALMER MW, 1993, ECOLOGY, V74, P2215, DOI 10.2307/1939575; Paton DC, 2000, TEMPERATE EUCALYPT WOODLANDS IN AUSTRALIA, P57; Pike DA, 2011, ECOL APPL, V21, P274, DOI 10.1890/09-2394.1; Posa MRC, 2006, BIOL CONSERV, V129, P256, DOI 10.1016/j.biocon.2005.10.041; Priday SD, 2010, EMU, V110, P118, DOI 10.1071/MU09051; PROBER SM, 1995, AUST J BOT, V43, P349, DOI 10.1071/BT9950349; Pyke G.H., 1983, METHODS CENSUSING BI, P55; Reid J., 1999, THREATENED DECLINING; Sekercioglu CH, 2006, TRENDS ECOL EVOL, V21, P464, DOI 10.1016/j.tree.2006.05.007; Selwood K, 2009, OECOLOGIA, V159, P435, DOI 10.1007/s00442-008-1221-9; Steel R.G.D., 1960, TECHNOMETRICS, VVol. 2, P197, DOI [DOI 10.1080/00401706.1960.10489894, 10.1080/00401706.1960.10489894]; STEEL RG, 1961, BIOMETRICS, V17, P539, DOI 10.2307/2527854; Swanson ME, 2011, FRONT ECOL ENVIRON, V9, P117, DOI 10.1890/090157; TERBRAAK CJF, 1986, ECOLOGY, V67, P1167; Titeux N, 2004, J BIOGEOGR, V31, P1841, DOI 10.1111/j.1365-2699.2004.01125.x; Tyre AJ, 2003, ECOL APPL, V13, P1790, DOI 10.1890/02-5078; Vesk PA, 2008, BIOL CONSERV, V141, P174, DOI 10.1016/j.biocon.2007.09.010; Watson J, 2001, CONSERV BIOL, V15, P1364, DOI 10.1046/j.1523-1739.2001.00166.x; Weinberg A, 2011, BIOL CONSERV, V144, P227, DOI 10.1016/j.biocon.2010.08.020; Wilkins S, 2003, RESTOR ECOL, V11, P489, DOI 10.1046/j.1526-100X.2003.rec0244.x; Woinarski JCZ, 2009, WILDLIFE RES, V36, P675, DOI 10.1071/WR08128; Zuur F. A., 2007, ANAL ECOLOGICAL DATA	90	50	50	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2012	7	4							e34527	10.1371/journal.pone.0034527	http://dx.doi.org/10.1371/journal.pone.0034527			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JA	22493698	Green Published, Green Submitted, gold			2022-12-27	WOS:000305012700040
J	Chim, SSC; Lee, WS; Ting, YH; Chan, OK; Lee, SWY; Leung, TY				Chim, Stephen S. C.; Lee, Wing S.; Ting, Yuen H.; Chan, Oi K.; Lee, Shara W. Y.; Leung, Tak Y.			Systematic Identification of Spontaneous Preterm Birth-Associated RNA Transcripts in Maternal Plasma	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; GENE POLYMORPHISMS; INTRAAMNIOTIC INFECTION; MESSENGER-RNA; FETAL; QUANTIFICATION; INTERLEUKIN-4; PARTURITION; MICRORNAS; PROTOCOLS	Background: Spontaneous preterm birth (SPB, before 37 gestational weeks) is a major cause of perinatal mortality and morbidity, but its pathogenesis remains unclear. Studies on SPB have been hampered by the limited availability of markers for SPB in predelivery clinical samples that can be easily compared with gestational age-matched normal controls. We hypothesize that SPB involves aberrant placental RNA expression, and that such RNA transcripts can be detected in predelivery maternal plasma samples, which can be compared with gestational age-matched controls. Principal Findings: Using gene expression microarray to profile essentially all human genes, we observed that 426 probe signals were changed by > 2.9-fold in the SPB placentas, compared with the spontaneous term birth (STB) placentas. Among the genes represented by those probes, we observed an over-representation of functions in RNA stabilization, extracellular matrix binding, and acute inflammatory response. Using RT-quantitative PCR, we observed differences in the RNA concentrations of certain genes only between the SPB and STB placentas, but not between the STB and term elective cesarean delivery placentas. Notably, 36 RNA transcripts were observed at placental microarray signals higher than a threshold, which indicated the possibility of their detection in maternal plasma. Among them, the IL1RL1 mRNA was tested in plasma samples taken from 37 women. It was detected in 6 of 10 (60%) plasma samples collected during the presentation of preterm labor (<= 32.9 weeks) in women eventually giving SPB, but was detected in only 1 of 27 (4%) samples collected during matched gestational weeks from women with no preterm labor (Fisher exact test, p = 0.00056). Conclusion: We have identified 36 SPB-associated RNA transcripts, which are possibly detectable in maternal plasma. We have illustrated that the IL1RL1 mRNA was more frequently detected in predelivery maternal plasma samples collected from women resulting in SPB than the gestational-age matched controls.	[Chim, Stephen S. C.; Lee, Wing S.; Ting, Yuen H.; Chan, Oi K.; Leung, Tak Y.] Chinese Univ Hong Kong, Dept Obstet & Gynaecol, Shatin, Hong Kong, Peoples R China; [Chim, Stephen S. C.] Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Ctr Res Circulating Fetal Nucle Acids, Shatin, Hong Kong, Peoples R China; [Lee, Wing S.; Lee, Shara W. Y.] Chinese Univ Hong Kong, Dept Chem Pathol, Shatin, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong	Chim, SSC (corresponding author), Chinese Univ Hong Kong, Dept Obstet & Gynaecol, Shatin, Hong Kong, Peoples R China.	sschim@cuhk.edu.hk	Chim, Stephen SC/O-6271-2016; Lee, Shara WY/G-1874-2014	Chim, Stephen SC/0000-0002-2152-7050; Lee, Shara WY/0000-0001-5257-2076	Research Grants Council of the Hong Kong Special Administrative Region, China [CUHK4484/06M]; University Grants Committee of the Government of the Hong Kong Special Administrative Region, China [AoE/M-04/06]	Research Grants Council of the Hong Kong Special Administrative Region, China(Hong Kong Research Grants Council); University Grants Committee of the Government of the Hong Kong Special Administrative Region, China	This study was supported by a grant from the Research Grants Council of the Hong Kong Special Administrative Region, China (Project No. CUHK4484/06M) and by the University Grants Committee of the Government of the Hong Kong Special Administrative Region, China, under the Areas of Excellence Scheme (AoE/M-04/06). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Aidoo M, 2001, GENET EPIDEMIOL, V21, P201, DOI 10.1002/gepi.1029; Amory JH, 2004, AM J OBSTET GYNECOL, V191, P1362, DOI 10.1016/j.ajog.2004.05.067; Annells MF, 2004, AM J OBSTET GYNECOL, V191, P2056, DOI 10.1016/j.ajog.2004.04.021; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Carbon S, 2009, BIOINFORMATICS, V25, P288, DOI 10.1093/bioinformatics/btn615; Chen Dafang, 2003, Beijing Da Xue Xue Bao Yi Xue Ban, V35, P377; Chim SSC, 2005, P NATL ACAD SCI USA, V102, P14753, DOI 10.1073/pnas.0503335102; Chim SSC, 2008, CLIN CHEM, V54, P482, DOI 10.1373/clinchem.2007.097972; Chiu RWK, 2001, CLIN CHEM, V47, P1607; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Esplin S, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.09.021; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Gravett MG, 2004, JAMA-J AM MED ASSOC, V292, P462, DOI 10.1001/jama.292.4.462; Haataja R, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001293; Haddad R, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.11.021; Hartel C, 2004, MOL HUM REPROD, V10, P911, DOI 10.1093/molehr/gah120; Heung MMS, 2009, PRENATAL DIAG, V29, P277, DOI 10.1002/pd.2191; Hitti J, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.03.037; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Iams JD, 1996, NEW ENGL J MED, V334, P567, DOI 10.1056/NEJM199602293340904; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kalish RB, 2004, AM J OBSTET GYNECOL, V190, P702, DOI 10.1016/j.ajog.2003.09.066; Li YP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007489; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lo YMD, 2007, NAT MED, V13, P218, DOI 10.1038/nm1530; LOCKWOOD CJ, 1991, NEW ENGL J MED, V325, P669, DOI 10.1056/NEJM199109053251001; Macones GA, 2004, AM J OBSTET GYNECOL, V190, P1504, DOI 10.1016/j.ajog.2004.01.001; Mayor-Lynn K, 2011, REPROD SCI, V18, P46, DOI 10.1177/1933719110374115; Moore S, 2004, BJOG-INT J OBSTET GY, V111, P125, DOI [10.1046/j.1471-0528.2003.00044.x, 10.1046/j.1471-0528.2003.00024.x-i1]; Ng EKO, 2003, P NATL ACAD SCI USA, V100, P4748, DOI 10.1073/pnas.0637450100; Olson PD, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001287; Pereira L, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2010.02.048; Plunkett J, 2008, ANN MED, V40, P167, DOI 10.1080/07853890701806181; Romero R, 2006, BJOG-INT J OBSTET GY, V113, P17, DOI 10.1111/j.1471-0528.2006.01120.x; Shah SJ, 2009, J PROTEOME RES, V8, P2407, DOI 10.1021/pr8010342; Shankar R, 2010, REPROD SCI, V17, P297, DOI 10.1177/1933719109353454; Simhan HN, 2003, OBSTET GYNECOL, V102, P162, DOI 10.1016/S0029-7844(03)00406-X; Slattery MM, 2002, LANCET, V360, P1489, DOI 10.1016/S0140-6736(02)11476-0; Snegovskikh VV, 2009, REPROD SCI, V16, P767, DOI 10.1177/1933719109336623; Tsui NBY, 2004, J MED GENET, V41, P461, DOI 10.1136/jmg.2003.016881; Tsui NBY, 2002, CLIN CHEM, V48, P1647; Wu WX, 1999, ENDOCRINOLOGY, V140, P2364, DOI 10.1210/en.140.5.2364	44	32	36	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2012	7	4							e34328	10.1371/journal.pone.0034328	http://dx.doi.org/10.1371/journal.pone.0034328			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955IH	22496790	Green Published, Green Submitted, gold			2022-12-27	WOS:000305010500005
J	Nham, T; Filali, S; Danne, C; Derbise, A; Carniel, E				Nham, Toan; Filali, Sofia; Danne, Camille; Derbise, Anne; Carniel, Elisabeth			Imaging of Bubonic Plague Dynamics by In Vivo Tracking of Bioluminescent Yersinia pestis	PLOS ONE			English	Article							SEPTICEMIC PLAGUE; ESCHERICHIA-COLI; INFECTION; DISEASE; MOUSE; MODEL; MICE; PATHOLOGY; VIRULENT; ANIMALS	Yersinia pestis dissemination in a host is usually studied by enumerating bacteria in the tissues of animals sacrificed at different times. This laborious methodology gives only snapshots of the infection, as the infectious process is not synchronized. In this work we used in vivo bioluminescence imaging (BLI) to follow Y. pestis dissemination during bubonic plague. We first demonstrated that Y. pestis CO92 transformed with pGEN-luxCDABE stably emitted bioluminescence in vitro and in vivo, while retaining full virulence. The light produced from live animals allowed to delineate the infected organs and correlated with bacterial loads, thus validating the BLI tool. We then showed that the first step of the infectious process is a bacterial multiplication at the injection site (linea alba), followed by a colonization of the draining inguinal lymph node(s), and subsequently of the ipsilateral axillary lymph node through a direct connection between the two nodes. A mild bacteremia and an effective filtering of the blood stream by the liver and spleen probably accounted for the early bacterial blood clearance and the simultaneous development of bacterial foci within these organs. The saturation of the filtering capacity of the spleen and liver subsequently led to terminal septicemia. Our results also indicate that secondary lymphoid tissues are the main targets of Y. pestis multiplication and that colonization of other organs occurs essentially at the terminal phase of the disease. Finally, our analysis reveals that the high variability in the kinetics of infection is attributable to the time the bacteria remain confined at the injection site. However, once Y. pestis has reached the draining lymph nodes, the disease progresses extremely rapidly, leading to the invasion of the entire body within two days and to death of the animals. This highlights the extraordinary capacity of Y. pestis to annihilate the host innate immune response.	[Nham, Toan; Filali, Sofia; Danne, Camille; Derbise, Anne; Carniel, Elisabeth] Inst Pasteur, Yersinia Res Unit, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Nham, T (corresponding author), Inst Pasteur, Yersinia Res Unit, Paris, France.	elisabeth.carniel@pasteur.fr		Danne, Camille/0000-0003-0971-8310				Andreu N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010777; Bina XR, 2010, PLASMID, V64, P156, DOI 10.1016/j.plasmid.2010.07.001; Bizanov G, 2007, J INFECTION, V54, P198, DOI 10.1016/j.jinf.2006.02.012; Bland DM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017352; Brock M, 2008, APPL ENVIRON MICROB, V74, P7023, DOI 10.1128/AEM.01288-08; Brubaker B, 2006, YERSINIA PESTIS BUBO, P399; CHEN TH, 1965, J INFECT DIS, V115, P456, DOI 10.1093/infdis/115.5.456; CONCHAS RF, 1990, GENE, V87, P133, DOI 10.1016/0378-1119(90)90505-L; Cook SH, 2003, J VIROL, V77, P5333, DOI 10.1128/JVI.77.9.5333-5338.2003; Demeure CE, 2012, J INFECT DIS, V205, P134, DOI 10.1093/infdis/jir696; Du YD, 1995, CONTRIB TO MICROBIOL, V13, P321; Flashner Y, 2010, FEMS IMMUNOL MED MIC, V59, P197, DOI 10.1111/j.1574-695X.2010.00687.x; Flexner S, 1901, AM J MED SCI, V122, P396; Francis KP, 2001, INFECT IMMUN, V69, P3350, DOI 10.1128/IAI.69.5.3350-3358.2001; Frank KM, 2011, NEW ENGL J MED, V364, P2563, DOI 10.1056/NEJMc1010939; Glomski IJ, 2007, PLOS PATHOG, V3, P699, DOI 10.1371/journal.ppat.0030076; Guarner J, 2005, HUM PATHOL, V36, P850, DOI 10.1016/j.humpath.2005.05.016; Guinet F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001688; Harrell MI, 2008, J IMMUNOL METHODS, V332, P170, DOI 10.1016/j.jim.2007.11.012; Henken S, 2010, ANTIMICROB AGENTS CH, V54, P3155, DOI 10.1128/AAC.00310-10; HOESSLY G F, 1955, Acta Trop, V12, P240; Isaksson EL, 2009, INFECT IMMUN, V77, P4740, DOI 10.1128/IAI.00333-09; Jawetz E, 1944, J INFECT DIS, V74, P1, DOI 10.1093/infdis/74.1.1; Lane MC, 2007, P NATL ACAD SCI USA, V104, P16669, DOI 10.1073/pnas.0607898104; Parkhill J, 2001, NATURE, V413, P523, DOI 10.1038/35097083; Pollitzer R, 1954, PLAGUE WHO MONOGRAPH; REED L. J., 1938, AMER JOUR HYG, V27, P493; Rocchetta HL, 2001, ANTIMICROB AGENTS CH, V45, P129, DOI 10.1128/AAC.45.1.129-137.2001; Russell WMS., 1959, MED J AUSTRALIA; SCHRAG SJ, 1995, TRENDS ECOL EVOL, V10, P319, DOI 10.1016/S0169-5347(00)89118-1; Sebbane F, 2005, AM J PATHOL, V166, P1427, DOI 10.1016/S0002-9440(10)62360-7; Simond, 1898, ANN I PASTEUR, P625; Trcek J, 2010, FEMS MICROBIOL LETT, V307, P201, DOI 10.1111/j.1574-6968.2010.01983.x; Uliczka F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020425; Xiong YQ, 2005, ANTIMICROB AGENTS CH, V49, P380, DOI 10.1128/AAC.49.1.380-387.2005; Yersin Alexandre, 1894, ANN I PASTEUR PARIS, V8, P662	36	27	28	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2012	7	4							e34714	10.1371/journal.pone.0034714	http://dx.doi.org/10.1371/journal.pone.0034714			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955IH	22496846	Green Published, gold, Green Submitted			2022-12-27	WOS:000305010500025
J	Bull, ND; Guidi, A; Goedert, M; Martin, KR; Spillantini, MG				Bull, Natalie D.; Guidi, Alessandra; Goedert, Michel; Martin, Keith R.; Spillantini, Maria Grazia			Reduced Axonal Transport and Increased Excitotoxic Retinal Ganglion Cell Degeneration in Mice Transgenic for Human Mutant P301S Tau	PLOS ONE			English	Article							FRONTOTEMPORAL DEMENTIA; NEUROTROPHIC FACTOR; MOUSE MODEL; PROTEIN; PHOSPHORYLATION; TAUOPATHY; FTDP-17; MUTATIONS; GLAUCOMA; BRAIN	The effects of tau hyperphosphorylation and aggregation on axonal transport were investigated in the optic nerve of mice transgenic for human mutant P301S tau. Transport was examined using cholera toxin B tracing. Retrograde transport was reduced in transgenic mice at 3 and 5 months of age, when compared to C57/Bl6 control mice. Anterograde axonal transport was also reduced in 3-month-old transgenic mice. Mild excitotoxic injury of retinal ganglion cells resulted in greater nerve cell loss in retinas from 3- and 5-month old P301S transgenic mice, when compared to controls. In conjunction with the detection of abnormal tau in the optic nerve in human and experimental glaucoma, the present findings suggest that tau hyperphosphorylation and aggregation may constitute targets for neuroprotective therapies in glaucoma as well as tauopathies.	[Bull, Natalie D.; Guidi, Alessandra; Martin, Keith R.; Spillantini, Maria Grazia] Univ Cambridge, Dept Clin Neurosci, Cambridge Ctr Brain Repair, Cambridge, England; [Martin, Keith R.] Univ Cambridge, Dept Ophthalmol, Cambridge, England; [Martin, Keith R.] Univ Cambridge, Biomed Res Ctr, Cambridge Natl Inst Hlth Res, Cambridge, England; [Goedert, Michel] Med Res Council Lab Mol Biol, Cambridge, England	University of Cambridge; University of Cambridge; University of Cambridge; MRC Laboratory Molecular Biology; UK Research & Innovation (UKRI); Medical Research Council UK (MRC)	Bull, ND (corresponding author), Univ Cambridge, Dept Clin Neurosci, Cambridge Ctr Brain Repair, Cambridge, England.	krgm2@cam.ac.uk; mgs11@cam.ac.uk			Fight for Sight United Kingdom; Cambridge University Hospitals' National Health Services Foundation Trust (Addenbrooke's Hospital); Glaucoma Foundation; Medical Research Council; National Institute for Health Research; Addenbrooke's Research Trust; Alzheimer's Research United Kingdom; MRC [MC_U105184291] Funding Source: UKRI; Alzheimers Research UK [ART-PG2011-20] Funding Source: researchfish; Medical Research Council [MC_U105184291] Funding Source: researchfish	Fight for Sight United Kingdom; Cambridge University Hospitals' National Health Services Foundation Trust (Addenbrooke's Hospital); Glaucoma Foundation; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research(National Institute for Health Research (NIHR)); Addenbrooke's Research Trust; Alzheimer's Research United Kingdom; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Fight for Sight United Kingdom; Cambridge University Hospitals' National Health Services Foundation Trust (Addenbrooke's Hospital); the Glaucoma Foundation; Medical Research Council; National Institute for Health Research; Addenbrooke's Research Trust; Alzheimer's Research United Kingdom. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen B, 2002, J NEUROSCI, V22, P9340; Arendt T, J NEUROSCI, V23, P6972; Delobel P, 2008, AM J PATHOL, V172, P123, DOI 10.2353/ajpath.2008.070627; Gasparini L, 2011, NEUROBIOL AGING, V32, P419, DOI 10.1016/j.neurobiolaging.2009.03.002; Goedert M, 1999, FEBS LETT, V450, P306, DOI 10.1016/S0014-5793(99)00508-6; GOEDERT M, 1993, P NATL ACAD SCI USA, V90, P5066, DOI 10.1073/pnas.90.11.5066; Goedert M, 2006, SCIENCE, V314, P777, DOI 10.1126/science.1132814; Gupta N, 2008, CAN J OPHTHALMOL, V43, P53, DOI 10.3129/i07-185; Hasegawa M, 1996, FEBS LETT, V384, P25, DOI 10.1016/0014-5793(96)00271-2; Hong M, 1998, SCIENCE, V282, P1914, DOI 10.1126/science.282.5395.1914; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; Ishihara T, 1999, NEURON, V24, P751, DOI 10.1016/S0896-6273(00)81127-7; Ittner LM, 2008, P NATL ACAD SCI USA, V105, P15997, DOI 10.1073/pnas.0808084105; Kanaan NM, 2011, J NEUROSCI, V31, P9858, DOI 10.1523/JNEUROSCI.0560-11.2011; Ko ML, 2001, NEUROSCI LETT, V305, P139, DOI 10.1016/S0304-3940(01)01830-4; LaPointe NE, 2009, J NEUROSCI RES, V87, P440, DOI 10.1002/jnr.21850; Magnani E, 2007, EMBO J, V26, P4546, DOI 10.1038/sj.emboj.7601878; Mandell JW, 1996, J NEUROSCI, V16, P5727; Martin KRG, 2006, EXP EYE RES, V83, P255, DOI 10.1016/j.exer.2005.11.025; Martin KRG, 2003, INVEST OPHTH VIS SCI, V44, P4357, DOI 10.1167/iovs.02-1332; Morfini G, 2007, J NEUROSCI RES, V85, P2620, DOI 10.1002/jnr.21154; Nacharaju P, 1999, FEBS LETT, V447, P195, DOI 10.1016/S0014-5793(99)00294-X; Nakanishi N, 2009, J NEUROSCI, V29, P5260, DOI 10.1523/JNEUROSCI.1067-09.2009; Pease ME, 2000, INVEST OPHTH VIS SCI, V41, P764; Poorkaj P, 1998, ANN NEUROL, V43, P815, DOI 10.1002/ana.410430617; Probst A, 2000, ACTA NEUROPATHOL, V99, P469, DOI 10.1007/s004010051148; Saxena S, 2011, NEURON, V71, P35, DOI 10.1016/j.neuron.2011.06.031; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P7737, DOI 10.1073/pnas.95.13.7737; Spittaels K, 1999, AM J PATHOL, V155, P2153, DOI 10.1016/S0002-9440(10)65533-2; Stamer K, 2002, J CELL BIOL, V156, P1051, DOI 10.1083/jcb.200108057; Utton MA, 2002, J NEUROSCI, V22, P6394; Velasco A, 2008, FEBS LETT, V582, P901, DOI 10.1016/j.febslet.2008.02.025; Yuan A, 2008, J NEUROSCI, V28, P1682, DOI 10.1523/JNEUROSCI.5242-07.2008; Zhang B, 2004, J NEUROSCI, V24, P4657, DOI 10.1523/JNEUROSCI.0797-04.2004	34	44	45	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e34724	10.1371/journal.pone.0034724	http://dx.doi.org/10.1371/journal.pone.0034724			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GO	22496848	Green Published, gold, Green Submitted			2022-12-27	WOS:000304855200071
J	Sottini, A; Capra, R; Zanotti, C; Chiarini, M; Serana, F; Ricotta, D; Caimi, L; Imberti, L				Sottini, Alessandra; Capra, Ruggero; Zanotti, Cinzia; Chiarini, Marco; Serana, Federico; Ricotta, Doris; Caimi, Luigi; Imberti, Luisa			Pre-Existing T- and B-Cell Defects in One Progressive Multifocal Leukoencephalopathy Patient	PLOS ONE			English	Article							JC VIRUS-DNA; CEREBRAL PERIVASCULAR SPACES; MULTIPLE-SCLEROSIS; THYMIC OUTPUT; GENE USAGE; NATALIZUMAB; BLOOD; BRAIN; TRANSPLANTATION; REACTIVATION	Progressive multifocal leukoencephalopathy (PML) usually occurs in patients with severe immunosuppression, hematological malignancies, chronic inflammatory conditions or receiving organ transplant. Recently, PML has also been observed in patients treated with monoclonal antibodies. By taking advantage of the availability of samples from a multiple sclerosis (MS) patient treated with natalizumab, the antibody anti-alpha 4 integrin, who developed PML and was monitored starting before therapy initiation, we investigated the fate of T and B lymphocytes in the onset of PML. Real-time PCR was used to measure new T- and B-cell production by means of T-cell receptor excision circle (TREC) and K-deleting recombination excision circle (KREC) analysis and to quantify transcripts for CD34, terminal-deoxynucleotidyltransferase, and V pre-B lymphocyte gene 1. T- and B-cell subsets and T-cell heterogeneity were measured by flow cytometry and spectratyping. The data were compared to those of untreated and natalizumab-treated MS patients and healthy donors. Before therapy, a patient who developed PML had a low TREC and KREC number; TRECs remained low, while KRECs and preB lymphocyte gene 1 transcripts peaked at 6 months of therapy and then decreased at PML diagnosis. Flow cytometry confirmed the deficient number of newly produced T lymphocytes, counterbalanced by an increase in TEMRA cells. The percentage of naive B cells increased by approximately 70% after 6 months of therapy, but B lymphocyte number remained low for the entire treatment period. T-cell heterogeneity and immunoglobulins were reduced. Although performed in a single patient, all results showed that an immune deficit, together with an increase in newly produced B cells a few months after therapy initiation, may predispose the patient to PML. These findings indicate the TREC/KREC assay is a potential tool to identify patients at risk of developing PML and may provide insights into the immunological involvement of monoclonal antibody-associated therapies.	[Sottini, Alessandra; Zanotti, Cinzia; Chiarini, Marco; Serana, Federico; Imberti, Luisa] Spedali Civil Brescia, Diagnost Dept, Biotechnol Lab, I-25125 Brescia, Italy; [Capra, Ruggero] Spedali Civil Brescia, Multiple Sclerosis Ctr, I-25125 Brescia, Italy; [Serana, Federico; Ricotta, Doris; Caimi, Luigi] Univ Brescia, Dept Biomed Sci & Biotechnol, Brescia, Italy	Hospital Spedali Civili Brescia; Hospital Spedali Civili Brescia; University of Brescia	Sottini, A (corresponding author), Spedali Civil Brescia, Diagnost Dept, Biotechnol Lab, I-25125 Brescia, Italy.	limberti@yahoo.it	; Chiarini, Marco/K-4983-2016	Imberti, Luisa/0000-0002-2075-8391; Serana, Federico/0000-0001-6740-4307; Chiarini, Marco/0000-0003-1000-0461; Caimi, Luigi/0000-0002-7163-9405				Akatsuka Y, 1999, TISSUE ANTIGENS, V53, P122, DOI 10.1034/j.1399-0039.1999.530202.x; BAUER SR, 1988, IMMUNOGENETICS, V28, P328, DOI 10.1007/BF00364231; Berger JR, 2006, ANN RHEUM DIS, V65, P48, DOI 10.1136/ard.2006.058404; Berger JR, 2011, CURR OPIN NEUROL, V24, P262, DOI 10.1097/WCO.0b013e328346d2a3; Berger JR, 2003, AIDS, V17, P1557, DOI 10.1097/00002030-200307040-00017; Boster A, 2009, ARCH NEUROL-CHICAGO, V66, P593, DOI 10.1001/archneurol.2009.31; Chapagain ML, 2010, J INFECT DIS, V202, P184, DOI 10.1086/653823; Chen YP, 2009, NEW ENGL J MED, V361, P1067, DOI 10.1056/NEJMoa0904267; CHESTERS PM, 1983, J INFECT DIS, V147, P676, DOI 10.1093/infdis/147.4.676; Clifford DB, 2010, LANCET NEUROL, V9, P438, DOI 10.1016/S1474-4422(10)70028-4; Coisne C, 2009, J IMMUNOL, V182, P5909, DOI 10.4049/jimmunol.0803418; Fox EJ, 2004, NEUROLOGY, V63, pS15, DOI 10.1212/WNL.63.12_suppl_6.S15; Geginat J, 2003, BLOOD, V101, P4260, DOI 10.1182/blood-2002-11-3577; Gorochov G, 1998, NAT MED, V4, P215, DOI 10.1038/nm0298-215; Gran B, 1998, J NEUROIMMUNOL, V85, P22, DOI 10.1016/S0165-5728(97)00250-6; HOUFF SA, 1988, NEW ENGL J MED, V318, P301, DOI 10.1056/NEJM198802043180507; Houff SA, 2010, J INFECT DIS, V202, P181, DOI 10.1086/653824; Jilek S, 2010, LANCET NEUROL, V9, P264, DOI 10.1016/S1474-4422(10)70006-5; Kalams SA, 1998, J EXP MED, V188, P2199, DOI 10.1084/jem.188.12.2199; Kappos L, 2011, LANCET NEUROL, V10, P745, DOI 10.1016/S1474-4422(11)70149-1; Koralnik IJ, 2006, ANN NEUROL, V60, P162, DOI 10.1002/ana.20933; Koralnik IJ, 2002, J NEUROVIROL, V8, P59, DOI 10.1080/13550280290167894; Koralnik IJ, 2002, J IMMUNOL, V168, P499, DOI 10.4049/jimmunol.168.1.499; Krumbholz M, 2008, NEUROLOGY, V71, P1350, DOI 10.1212/01.wnl.0000327671.91357.96; Lindberg RLP, 2008, J NEUROIMMUNOL, V194, P153, DOI 10.1016/j.jneuroim.2007.11.007; Major EO, 2010, ANNU REV MED, V61, P35, DOI 10.1146/annurev.med.080708.082655; Martin MD, 2009, ARCH NEUROL-CHICAGO, V66, P1016, DOI 10.1001/archneurol.2009.157; Martin MD, 2008, ARCH NEUROL-CHICAGO, V65, P1596, DOI 10.1001/archneur.65.12.noc80051; Mehling M, 2008, NEUROLOGY, V71, P1261, DOI 10.1212/01.wnl.0000327609.57688.ea; Monao MCG, 1998, J VIROL, V72, P9918, DOI 10.1128/JVI.72.12.9918-9923.1998; Muraro PA, 2005, J EXP MED, V201, P805, DOI 10.1084/jem.20041679; Naess H, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-32; Perez-Liz G, 2008, ANN NEUROL, V64, P379, DOI 10.1002/ana.21443; Rice GPA, 2005, NEUROLOGY, V64, P1336, DOI 10.1212/01.WNL.0000158329.30470.D0; Rudick RA, 2010, ANN NEUROL, V68, P304, DOI 10.1002/ana.22107; Sabath BF, 2002, J INFECT DIS, V186, pS180, DOI 10.1086/344280; Sandrock A, 2011, 63 AAN ANN M APR 9 1; Sarzotti-Kelsoe M, 2009, BLOOD, V114, P1445, DOI 10.1182/blood-2009-01-199323; Saure C, 2011, ARCH NEUROL-CHICAGO, V68, P1428, DOI 10.1001/archneurol.2011.238; Serana F, 2011, J CLIN IMMUNOL, V31, P540, DOI 10.1007/s10875-011-9526-6; Serana F, 2010, J IMMUNOL, V185, P7713, DOI 10.4049/jimmunol.1001770; Sottini A, 2010, CLIN IMMUNOL, V136, P217, DOI 10.1016/j.clim.2010.04.005; Stuve O, 2006, ANN NEUROL, V59, P743, DOI 10.1002/ana.20858; Sunyaev SR, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000368; Tan CS, 2010, LANCET NEUROL, V9, P425, DOI 10.1016/S1474-4422(10)70040-5; Thewissen M, 2005, ANN NY ACAD SCI, V1051, P255, DOI 10.1196/annals.1361.066; Warnke C, 2011, MULT SCLER J, V17, P151, DOI 10.1177/1352458510385834; Yao K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002028; YOGO Y, 1990, J VIROL, V64, P3139, DOI 10.1128/JVI.64.6.3139-3143.1990	49	19	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e34493	10.1371/journal.pone.0034493	http://dx.doi.org/10.1371/journal.pone.0034493			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GO	22496817	Green Published, Green Submitted, gold			2022-12-27	WOS:000304855200058
J	Vestberg, T; Gustafson, R; Maurex, L; Ingvar, M; Petrovic, P				Vestberg, Torbjorn; Gustafson, Roland; Maurex, Liselotte; Ingvar, Martin; Petrovic, Predrag			Executive Functions Predict the Success of Top-Soccer Players	PLOS ONE			English	Article							TALENT IDENTIFICATION; SPORT; EXPERTISE; SKILL	While the importance of physical abilities and motor coordination is non-contested in sport, more focus has recently been turned toward cognitive processes important for different sports. However, this line of studies has often investigated sport-specific cognitive traits, while few studies have focused on general cognitive traits. We explored if measures of general executive functions can predict the success of a soccer player. The present study used standardized neuropsychological assessment tools assessing players' general executive functions including on-line multi-processing such as creativity, response inhibition, and cognitive flexibility. In a first cross-sectional part of the study we compared the results between High Division players (HD), Lower Division players (LD) and a standardized norm group. The result shows that both HD and LD players had significantly better measures of executive functions in comparison to the norm group for both men and women. Moreover, the HD players outperformed the LD players in these tests. In the second prospective part of the study, a partial correlation test showed a significant correlation between the result from the executive test and the numbers of goals and assists the players had scored two seasons later. The results from this study strongly suggest that results in cognitive function tests predict the success of ball sport players.	[Vestberg, Torbjorn; Maurex, Liselotte; Ingvar, Martin; Petrovic, Predrag] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden; [Vestberg, Torbjorn; Gustafson, Roland] Univ Orebro, Sch Law Psychol & Social Work, Orebro, Sweden	Karolinska Institutet; Orebro University	Vestberg, T (corresponding author), Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden.	Predrag.Petrovic@ki.se	Petrovic, Predrag/AAS-6736-2020	Petrovic, Predrag/0000-0002-5536-945X; Ingvar, Martin/0000-0002-9041-5714; Vestberg, Torbjorn/0000-0003-0523-6621				Abernethy B, 2005, APPL COGNITIVE PSYCH, V19, P705, DOI 10.1002/acp.1102; ALLARD F, 1980, Journal of Sport Psychology, V2, P14; Anderson V, 2001, DEVELOMENTAL NEUROPS; Anderson VA, 2001, DEV NEUROPSYCHOL, V20, P385, DOI 10.1207/S15326942DN2001_5; Baddeley A.D., 1974, RECENT ADV LEARNING, V8; Baddeley A. D, 1986, WORKING MEMORY; Burgess PW, 2000, CONTROL OF COGNITIVE PROCESSES: ATTENTION AND PERFORMANCE XVIII, P465; Chan RCK, 2008, ARCH CLIN NEUROPSYCH, V23, P201, DOI 10.1016/j.acn.2007.08.010; Friedman NP, 2008, J EXP PSYCHOL GEN, V137, P201, DOI 10.1037/0096-3445.137.2.201; Friedman NP, 2006, NOT ALL EXECUTIVE FU, P17; Garganta J., 2009, REV PORTUGUESA CIENC, V9, P115, DOI [DOI 10.5628/RPCD.09.01.115, 10.5628/rpcd.09.01.115]; GOULD D, 1995, SPORT PSYCHOL, V9, P391, DOI 10.1123/tsp.9.4.391; Greene CM, 2008, BIOL PSYCHOL, V79, P30, DOI 10.1016/j.biopsycho.2007.11.009; Helsen W, 1993, COGNITIVE ISSUES MOT, V102, P109, DOI DOI 10.1016/S0166-4115(08)61468-5; Helsen WF, 1993, VISUAL SEARCH, VII, P177; Homack S, 2005, J CLIN EXP NEUROPSYC, V27, P599, DOI 10.1080/13803390490918444; Kovac T, 1996, STUD PSYCHOL, V38, P63; Mann DTY, 2007, J SPORT EXERCISE PSY, V29, P457, DOI 10.1123/jsep.29.4.457; McCrory P, 2004, BRIT J SPORT MED, V38, P516, DOI 10.1136/bjsm.2004.014811; Memmert D, 2011, J SPORT SCI, V29, P93, DOI 10.1080/02640414.2010.528014; Morris T, 2000, J SPORT SCI, V18, P715, DOI 10.1080/02640410050120096; Norman D.A., 1986, CONSCIOUSNESS SELF R, P1, DOI DOI 10.1007/978-1-4757-0629-1_1; Proteau L., 1980, PSYCHOL MOTOR BEHAV, P465; Reilly T, 2000, J SPORT SCI, V18, P695, DOI 10.1080/02640410050120050; Starkes J.L., 1984, COGNITIVE SPORT PSYC; Stratton G., 2004, YOUTH SOCCER SCI PER; Strauss E, 2006, COMPENDIUM NEURPSYCH; Swanson J, 2005, CAN J SCH PSYCHOL, V20, P117, DOI 10.1177/0829573506295469; Voss MW, 2010, APPL COGNITIVE PSYCH, V24, P812, DOI 10.1002/acp.1588; Ward P, 2003, J SPORT EXERCISE PSY, V25, P93, DOI 10.1123/jsep.25.1.93; Williams A.M., 2008, INT REV SPORT EXER P, V1, P4, DOI [https://doi.org/10.1080/17509840701836867, DOI 10.1080/17509840701836867, 10.1080/17509840701836867]; Williams AM, 2000, J SPORT SCI, V18, P737, DOI 10.1080/02640410050120113; Williams AM, 2000, J SPORT SCI, V18, P657, DOI 10.1080/02640410050120041; Williams AM, 2010, PERCEPTUAL CONITIVE, DOI [10.1002/acp.1710, DOI 10.1002/ACP.1710]; Williams JM, 2006, APPL SPORT PSYCHOL	35	242	245	6	121	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e34731	10.1371/journal.pone.0034731	http://dx.doi.org/10.1371/journal.pone.0034731			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	953GO	22496850	Green Submitted, Green Published, gold			2022-12-27	WOS:000304855200072
J	Xie, HJ; Noh, JH; Kim, JK; Jung, KH; Eun, JW; Bae, HJ; Kim, MG; Chang, YG; Lee, JY; Park, H; Nam, SW				Xie, Hong Jian; Noh, Ji Heon; Kim, Jeong Kyu; Jung, Kwang Hwa; Eun, Jung Woo; Bae, Hyun Jin; Kim, Min Gyu; Chang, Young Gyoon; Lee, Jung Young; Park, Hanna; Nam, Suk Woo			HDAC1 Inactivation Induces Mitotic Defect and Caspase-Independent Autophagic Cell Death in Liver Cancer	PLOS ONE			English	Article							HISTONE DEACETYLASE INHIBITOR; WAF1/CIP1 GENE PROMOTER; HYDROXAMIC ACID SAHA; HEPATOCELLULAR-CARCINOMA; SP1 SITES; CLASS-I; PROSTATE-CANCER; EXPRESSION; P53; PROLIFERATION	Histone deacetylases (HDACs) are known to play a central role in the regulation of several cellular properties interlinked with the development and progression of cancer. Recently, HDAC1 has been reported to be overexpressed in hepatocellular carcinoma (HCC), but its biological roles in hepatocarcinogenesis remain to be elucidated. In this study, we demonstrated overexpression of HDAC1 in a subset of human HCCs and liver cancer cell lines. HDAC1 inactivation resulted in regression of tumor cell growth and activation of caspase-independent autophagic cell death, via LC3B-II activation pathway in Hep3B cells. In cell cycle regulation, HDAC1 inactivation selectively induced both p21(WAF1/Cip1) and p27(Kip1) expressions, and simultaneously suppressed the expression of cyclin D1 and CDK2. Consequently, HDAC1 inactivation led to the hypophosphorylation of pRb in G1/S transition, and thereby inactivated E2F/DP1 transcription activity. In addition, we demonstrated that HDAC1 suppresses p21(WAF1/Cip1) transcriptional activity through Sp1-binding sites in the p21(WAF1/Cip1) promoter. Furthermore, sustained suppression of HDAC1 attenuated in vitro colony formation and in vivo tumor growth in a mouse xenograft model. Taken together, we suggest the aberrant regulation of HDAC1 in HCC and its epigenetic regulation of gene transcription of autophagy and cell cycle components. Overexpression of HDAC1 may play a pivotal role through the systemic regulation of mitotic effectors in the development of HCC, providing a particularly relevant potential target in cancer therapy.	[Xie, Hong Jian; Noh, Ji Heon; Kim, Jeong Kyu; Jung, Kwang Hwa; Eun, Jung Woo; Bae, Hyun Jin; Kim, Min Gyu; Chang, Young Gyoon; Lee, Jung Young; Park, Hanna; Nam, Suk Woo] Catholic Univ Korea, Coll Med, Dept Pathol, Seoul, South Korea; [Xie, Hong Jian; Noh, Ji Heon; Kim, Jeong Kyu; Jung, Kwang Hwa; Eun, Jung Woo; Bae, Hyun Jin; Kim, Min Gyu; Chang, Young Gyoon; Lee, Jung Young; Park, Hanna; Nam, Suk Woo] Catholic Univ Korea, Coll Med, Funct RNom Res Ctr, Seoul, South Korea	Catholic University of Korea; Catholic University of Korea	Xie, HJ (corresponding author), Catholic Univ Korea, Coll Med, Dept Pathol, Seoul, South Korea.	swnam@catholic.ac.kr	Eun, Jung Woo/ABB-5127-2020	Eun, Jung Woo/0000-0002-2461-6702	Korean Ministry of the Environment; National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [2010-0020764]; Korea government (MEST) [2011-0010705]	Korean Ministry of the Environment; National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Korea government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This work was supported by the Korean Ministry of the Environment via "The Eco-technopia 21 project" and by Public Welfare & Safety program, through the National Research Foundation of Korea (NRF), funded by the Ministry of Education, Science and Technology (2010-0020764); and by the National Research Foundation of Korea (NRF) grant, funded by the Korea government (MEST) (Grant No. 2011-0010705). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brehm A, 1998, NATURE, V391, P597, DOI 10.1038/35404; Glaser KB, 2003, BIOCHEM BIOPH RES CO, V310, P529, DOI 10.1016/j.bbrc.2003.09.043; Glozak MA, 2007, ONCOGENE, V26, P5420, DOI 10.1038/sj.onc.1210610; Gui CY, 2004, P NATL ACAD SCI USA, V101, P1241, DOI 10.1073/pnas.0307708100; Huang LL, 2000, ONCOGENE, V19, P5712, DOI 10.1038/sj.onc.1203963; Iakova P, 2011, SEMIN CANCER BIOL, V21, P28, DOI 10.1016/j.semcancer.2010.09.001; Keshelava N, 2007, JNCI-J NATL CANCER I, V99, P1107, DOI 10.1093/jnci/djm044; Kim NH, 2011, BIOCHEM BIOPH RES CO, V404, P915, DOI 10.1016/j.bbrc.2010.12.081; Lagger G, 2003, MOL CELL BIOL, V23, P2669, DOI 10.1128/MCB.23.8.2669-2679.2003; Liu YL, 2010, AUTOPHAGY, V6, P1057, DOI 10.4161/auto.6.8.13365; Luo JY, 2000, NATURE, V408, P377, DOI 10.1038/35042612; Marks PA, 2001, NAT REV CANCER, V1, P194, DOI 10.1038/35106079; Miyake K, 2008, PANCREAS, V36, pE1, DOI 10.1097/MPA.0b013e31815f2c2a; Nakano K, 1997, J BIOL CHEM, V272, P22199, DOI 10.1074/jbc.272.35.22199; Nam SW, 2005, HEPATOLOGY, V42, P809, DOI 10.1002/hep.20878; Nishioka C, 2008, LEUKEMIA RES, V32, P1382, DOI 10.1016/j.leukres.2008.02.018; Niyazi M, 2007, RADIAT ONCOL, V2, DOI 10.1186/1748-717X-2-4; Noh JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028103; Noonan EJ, 2009, ONCOGENE, V28, P1714, DOI 10.1038/onc.2009.19; Oh M, 2008, BIOCHEM BIOPH RES CO, V369, P1179, DOI 10.1016/j.bbrc.2008.03.019; Rikimaru T, 2007, ONCOLOGY-BASEL, V72, P69, DOI 10.1159/000111106; Ropero S, 2007, MOL ONCOL, V1, P19, DOI 10.1016/j.molonc.2007.01.001; Rundlett SE, 1996, P NATL ACAD SCI USA, V93, P14503, DOI 10.1073/pnas.93.25.14503; Scarlatti F, 2004, J BIOL CHEM, V279, P18384, DOI 10.1074/jbc.M313561200; Senese S, 2007, MOL CELL BIOL, V27, P4784, DOI 10.1128/MCB.00494-07; Shao YF, 2004, P NATL ACAD SCI USA, V101, P18030, DOI 10.1073/pnas.0408345102; Sowa Y, 1997, BIOCHEM BIOPH RES CO, V241, P142, DOI 10.1006/bbrc.1997.7786; Wang GL, 2008, J BIOL CHEM, V283, P26179, DOI 10.1074/jbc.M803545200; Weichert W, 2008, BRIT J CANCER, V98, P604, DOI 10.1038/sj.bjc.6604199; Weichert W, 2008, CLIN CANCER RES, V14, P1669, DOI 10.1158/1078-0432.CCR-07-0990; Weichert W, 2009, CANCER LETT, V280, P168, DOI 10.1016/j.canlet.2008.10.047; Whetstine JR, 2005, MOL CELL, V18, P483, DOI 10.1016/j.molcel.2005.04.006; Wilting RH, EMBO J, V2586-2597; Witt O, 2009, CANCER LETT, V277, P8, DOI 10.1016/j.canlet.2008.08.016; Yamamoto S, 2008, ANTICANCER RES, V28, P1585; Yang JD, 2010, NAT REV GASTRO HEPAT, V7, P448, DOI 10.1038/nrgastro.2010.100; Yarden RI, 1999, P NATL ACAD SCI USA, V96, P4983, DOI 10.1073/pnas.96.9.4983	37	75	80	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e34265	10.1371/journal.pone.0034265	http://dx.doi.org/10.1371/journal.pone.0034265			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GO	22496786	Green Published, gold, Green Submitted			2022-12-27	WOS:000304855200037
J	Devue, C; Belopolsky, AV; Theeuwes, J				Devue, Christel; Belopolsky, Artem V.; Theeuwes, Jan			Oculomotor Guidance and Capture by Irrelevant Faces	PLOS ONE			English	Article							HIGH-LEVEL POP; ATTENTIONAL CAPTURE; DETECTION ADVANTAGE; FLICKER PARADIGM; EXPERTISE; BLINDNESS; OBJECTS; VISION; ALWAYS; BLINK	Even though it is generally agreed that face stimuli constitute a special class of stimuli, which are treated preferentially by our visual system, it remains unclear whether faces can capture attention in a stimulus-driven manner. Moreover, there is a long-standing debate regarding the mechanism underlying the preferential bias of selecting faces. Some claim that faces constitute a set of special low-level features to which our visual system is tuned; others claim that the visual system is capable of extracting the meaning of faces very rapidly, driving attentional selection. Those debates continue because many studies contain methodological peculiarities and manipulations that prevent a definitive conclusion. Here, we present a new visual search task in which observers had to make a saccade to a uniquely colored circle while completely irrelevant objects were also present in the visual field. The results indicate that faces capture and guide the eyes more than other animated objects and that our visual system is not only tuned to the low-level features that make up a face but also to its meaning.	[Devue, Christel; Belopolsky, Artem V.; Theeuwes, Jan] Vrije Univ Amsterdam, Amsterdam, Netherlands; [Devue, Christel] Univ Liege, Dept Psychol Cognit & Behav, Liege, Belgium	Vrije Universiteit Amsterdam; University of Liege	Devue, C (corresponding author), Vrije Univ Amsterdam, Amsterdam, Netherlands.	cdevue@ulg.ac.be	Theeuwes, Jan/ABF-3771-2020; Devue, Christel/H-6252-2019; Theeuwes, Jan/B-6862-2008	Devue, Christel/0000-0001-7349-226X; Theeuwes, Jan/0000-0002-5849-7721; Belopolsky, Artem/0000-0003-3606-2134; Lauwereyns, Jan/0000-0003-0551-2550	FRS-F.N.R.S [A 4/5 - MCF/BIC - 11281]; Netherlands Organization for Scientific Research [NWO-Veni 451-08-017]	FRS-F.N.R.S(Fonds de la Recherche Scientifique - FNRS); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	This research was supported by a grant (A 4/5 - MCF/BIC - 11281) from the FRS-F.N.R.S to Dr. Devue who is a Postdoctoral Researcher within this institution (http://www1.frs-fnrs.be/) and the Netherlands Organization for Scientific Research (NWO-Veni 451-08-017) grant to Dr. Belopolsky (http://www.nwo.nl/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awh E, 2004, COGNITIVE PSYCHOL, V48, P95, DOI 10.1016/S0010-0285(03)00116-6; Bindemann M, 2005, PSYCHON B REV, V12, P1048, DOI 10.3758/BF03206442; Bindemann M, 2005, COGNITION, V98, P177, DOI 10.1016/j.cognition.2004.11.004; Bindemann M, 2007, J VISION, V7, DOI 10.1167/7.10.15; Bindemann M, 2008, VISION RES, V48, P2555, DOI 10.1016/j.visres.2008.09.001; Brown V, 1997, PERCEPTION, V26, P1555, DOI 10.1068/p261555; Cave KR, 2006, VIS COGN, V14, P629, DOI 10.1080/13506280500193107; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; David E, 2006, PSYCHOL BELG, V46, P253, DOI 10.5334/pb-46-4-253; Devue C, 2009, PERCEPTION, V38, P552, DOI 10.1068/p6049; Gauthier I, 2000, NAT NEUROSCI, V3, P191, DOI 10.1038/72140; Godijn R, 2002, J EXP PSYCHOL HUMAN, V28, P1039, DOI 10.1037//0096-1523.28.5.1039; Hershler O, 2005, VISION RES, V45, P1707, DOI 10.1016/j.visres.2004.12.021; Hershler O, 2006, VISION RES, V46, P3028, DOI 10.1016/j.visres.2006.03.023; Kirchner H, 2006, VISION RES, V46, P1762, DOI 10.1016/j.visres.2005.10.002; Landau AN, 2008, J EXP PSYCHOL HUMAN, V34, P818, DOI 10.1037/0096-1523.34.4.818; Langton SRH, 2008, COGNITION, V107, P330, DOI 10.1016/j.cognition.2007.07.012; Li FF, 2002, P NATL ACAD SCI USA, V99, P9596, DOI 10.1073/pnas.092277599; LOFTUS GR, 1994, PSYCHON B REV, V1, P476, DOI 10.3758/BF03210951; Mack A., 1998, INATTENTIONAL BLINDN; McKone E, 2007, TRENDS COGN SCI, V11, P8, DOI 10.1016/j.tics.2006.11.002; Palermo R, 2003, VIS COGN, V10, P683, DOI 10.1080/13506280344000059; Palermo R, 2007, NEUROPSYCHOLOGIA, V45, P75, DOI 10.1016/j.neuropsychologia.2006.04.025; Rhodes G, 2004, J COGNITIVE NEUROSCI, V16, P189, DOI 10.1162/089892904322984508; Ro T, 2001, PSYCHOL SCI, V12, P94, DOI 10.1111/1467-9280.00317; Theeuwes J, 2006, VIS COGN, V13, P657, DOI 10.1080/13506280500410949; Theeuwes J, 1998, PSYCHOL SCI, V9, P379, DOI 10.1111/1467-9280.00071; THEEUWES J, 1992, PERCEPT PSYCHOPHYS, V51, P599, DOI 10.3758/BF03211656; Theeuwes J, 1999, J EXP PSYCHOL HUMAN, V25, P1595, DOI 10.1037/0096-1523.25.6.1595; Theeuwes J, 2010, ACTA PSYCHOL, V135, P77, DOI 10.1016/j.actpsy.2010.02.006; VanRullen R, 2006, VISION RES, V46, P3017, DOI 10.1016/j.visres.2005.07.009; Vuilleumier P, 2000, NEUROPSYCHOLOGIA, V38, P693, DOI 10.1016/S0028-3932(99)00107-4; Weaver MD, 2011, PSYCHOL RES-PSYCH FO, V75, P10, DOI 10.1007/s00426-010-0284-5; Yang CT, 2009, VIS COGN, V17, P484, DOI 10.1080/13506280701822991; Yantis S, 1999, J EXP PSYCHOL HUMAN, V25, P661, DOI 10.1037/0096-1523.25.3.661	35	28	28	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2012	7	4							e34598	10.1371/journal.pone.0034598	http://dx.doi.org/10.1371/journal.pone.0034598			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959FE	22506033	Green Published, Green Submitted, gold			2022-12-27	WOS:000305297500041
J	Kerber, RA; O'Brien, E; Boucher, KM; Smith, KR; Cawthon, RM				Kerber, Richard A.; O'Brien, Elizabeth; Boucher, Kenneth M.; Smith, Ken R.; Cawthon, Richard M.			A Genome-Wide Study Replicates Linkage of 3p22-24 to Extreme Longevity in Humans and Identifies Possible Additional Loci	PLOS ONE			English	Article							PEDIGREE-MEMBER METHOD; GROWTH-FACTOR-BETA; EXTENDS LIFE-SPAN; GENE; ASSOCIATION; MORTALITY; SURVIVAL; METAANALYSIS; INHERITANCE; PHENOTYPES	Background: Although there is abundant evidence that human longevity is heritable, efforts to map loci responsible for variation in human lifespan have had limited success. Methodology/Principal Findings: We identified individuals from a large multigenerational population database (the Utah Population Database) who exhibited high levels of both familial longevity and individual longevity. This selection identified 325 related "affected individuals'', defined as those in the top quartile for both excess longevity (EL = observed lifespan expected lifespan) and familial excess longevity (FEL = weighted average EL across all relatives). A whole-genome scan for genetic linkage was performed on this sample using a panel of 1100 microsatellite markers. A strongly suggestive peak (Z = 4.2, Monte Carlo-adjusted p-value 0.09) was observed in the vicinity of D3S3547 on chromosome 3p24.1, at a point nearly identical to that reported recently by an independent team of researchers from Harvard Medical School (HMS) [1]. Meta-analysis of linkage scores on 3p from the two studies produced a minimum nominal p-value of 1.005x10(-9) at 55 cM. Other potentially noteworthy peaks in our data occur on 18q23-24, 8q23, and 17q21. Meta-analysis results from combined UPDB and HMS data yielded additional support, but not formal replication, for linkage on 8q, 9q, and 17q. Conclusions/Significance: Corroboration of the linkage of exceptional longevity to 3p22-24 greatly strengthens the case that genes in this region affect variation in longevity and suggest, therefore, an important role in the regulation of human lifespan. Future efforts should include intensive study of the 3p22-24 region.	[Kerber, Richard A.; Boucher, Kenneth M.] Univ Utah, Dept Oncol Sci, Salt Lake City, UT USA; [Kerber, Richard A.; O'Brien, Elizabeth; Boucher, Kenneth M.; Smith, Ken R.] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT USA; [Cawthon, Richard M.] Univ Utah, Dept Human Genet, Salt Lake City, UT USA; [Smith, Ken R.] Univ Utah, Dept Family & Consumer Studies, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Kerber, RA (corresponding author), Univ Louisville, Dept Epidemiol & Populat Hlth, Louisville, KY 40292 USA.	rich.kerber@louisville.edu	Smith, Ken/B-6451-2011	Smith, Ken/0000-0003-0682-3705; Boucher, Kenneth/0000-0003-2833-0127	National Institutes of Health (NIH) [R01-AG022095, R21-AG030034]; National Cancer Institute [P30 CA42014]; NATIONAL CANCER INSTITUTE [P30CA042014] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG030034, R01AG022095] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by National Institutes of Health (NIH) grant R01-AG022095 (K. Smith, P.I.), NIH grant R21-AG030034 (R. Cawthon, P.I.), and the Huntsman Cancer Foundation for database support provided to the Pedigree and Population Resource of the Huntsman Cancer Institute (HCI). Partial support for all datasets within the UPDB was provided by the University of Utah, HCI and the HCI Cancer Center Support Grant, P30 CA42014 from the National Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Azhar M, 2003, CYTOKINE GROWTH F R, V14, P391, DOI 10.1016/S1359-6101(03)00044-3; Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547; Beeton M, 1901, BIOMETRIKA, V1, P50, DOI 10.1093/biomet/1.1.50; Beeton M, 1899, P ROY SOC LONDON, VB67, P290; Blangero J, 1997, GENET EPIDEMIOL, V14, P959, DOI 10.1002/(SICI)1098-2272(1997)14:6<959::AID-GEPI66>3.0.CO;2-K; BOCQUETAPPEL JP, 1990, ANN HUM BIOL, V17, P81, DOI 10.1080/03014469000000832; Boyden SE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012432; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Campisi J, 2003, NAT REV CANCER, V3, P339, DOI 10.1038/nrc1073; CHURCHILL GA, 1994, GENETICS, V138, P963; COHEN BH, 1964, Q REV BIOL, V39, P130, DOI 10.1086/404164; Dempfle A, 2004, ANN HUM GENET, V68, P69, DOI 10.1046/j.1529-8817.2003.00061.x; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Gamazon ER, 2010, BIOINFORMATICS, V26, P259, DOI 10.1093/bioinformatics/btp644; Grady WM, 1999, CANCER RES, V59, P320; Gudbjartsson DF, 2005, NAT GENET, V37, P1015, DOI 10.1038/ng1005-1015; Gudmundsson H, 2000, EUR J HUM GENET, V8, P743, DOI 10.1038/sj.ejhg.5200527; Haldane JBS, 1919, J GENET, V8, P299; HARMAN D, 1992, ANN NY ACAD SCI, V673, P126, DOI 10.1111/j.1749-6632.1992.tb27444.x; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Heath SC, 1997, GENET EPIDEMIOL, V14, P1011, DOI 10.1002/(SICI)1098-2272(1997)14:6<1011::AID-GEPI75>3.3.CO;2-E; Kerber RA, 2001, J GERONTOL A-BIOL, V56, pB130, DOI 10.1093/gerona/56.3.B130; Kerber RA, 2009, AGING CELL, V8, P239, DOI 10.1111/j.1474-9726.2009.00467.x; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Lunetta KL, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S13; Malovini A, 2011, REJUV RES, V14, P283, DOI 10.1089/rej.2010.1114; Nebel A, 2011, MECH AGEING DEV, V132, P324, DOI 10.1016/j.mad.2011.06.008; Newman AB, 2010, J GERONTOL A-BIOL, V65, P478, DOI 10.1093/gerona/glq028; O'Brien E, 2007, J GERONTOL A-BIOL, V62, P803, DOI 10.1093/gerona/62.8.803; Perls T, 2000, J AM GERIATR SOC, V48, P1483, DOI 10.1111/jgs.2000.48.11.1483; Perls TT, 1998, LANCET, V351, P1560, DOI 10.1016/S0140-6736(05)61126-9; PHILIPPE P, 1978, AM J MED GENET, V2, P121, DOI 10.1002/ajmg.1320020203; Puca AA, 2001, P NATL ACAD SCI USA, V98, P10505, DOI 10.1073/pnas.181337598; SAGE, 2009, STAT ANAL GENETIC EP; SCHACHTER F, 1994, NAT GENET, V6, P29, DOI 10.1038/ng0194-29; Skolnick M, 1980, BANBURY REPORT, P285; Sobel E, 1996, AM J HUM GENET, V58, P1323; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; Ukraintseva SV, 2003, ANN NY ACAD SCI, V1010, P489, DOI 10.1196/annals.1299.089; WEEKS DE, 1988, AM J HUM GENET, V42, P315; WEEKS DE, 1992, AM J HUM GENET, V50, P859; Wilicox BJ, 2008, P NATL ACAD SCI USA, V105, P13987, DOI 10.1073/pnas.0801030105; Wylie JE, 2003, TRENDS BIOTECHNOL, V21, P113, DOI 10.1016/S0167-7799(02)00039-2; Yashin AI, 1999, AM J HUM GENET, V65, P1178, DOI 10.1086/302572	45	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2012	7	4							e34746	10.1371/journal.pone.0034746	http://dx.doi.org/10.1371/journal.pone.0034746			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959FE	22506048	Green Published, Green Submitted, gold			2022-12-27	WOS:000305297500056
J	Matthews, DR; Fruhwirth, GO; Weitsman, G; Carlin, LM; Ofo, E; Keppler, M; Barber, PR; Tullis, IDC; Vojnovic, B; Ng, T; Ameer-Beg, SM				Matthews, Daniel R.; Fruhwirth, Gilbert O.; Weitsman, Gregory; Carlin, Leo M.; Ofo, Enyinnaya; Keppler, Melanie; Barber, Paul R.; Tullis, Iain D. C.; Vojnovic, Borivoj; Ng, Tony; Ameer-Beg, Simon M.			A Multi-Functional Imaging Approach to High-Content Protein Interaction Screening	PLOS ONE			English	Article							RESONANCE ENERGY-TRANSFER; KINASE-C-ALPHA; FLUORESCENCE LIFETIME; SINGLE-CELL; FRET; MICROSCOPY; DOMAIN; ACTIVATION; BINDING; DYNAMIN	Functional imaging can provide a level of quantification that is not possible in what might be termed traditional high-content screening. This is due to the fact that the current state-of-the-art high-content screening systems take the approach of scaling-up single cell assays, and are therefore based on essentially pictorial measures as assay indicators. Such phenotypic analyses have become extremely sophisticated, advancing screening enormously, but this approach can still be somewhat subjective. We describe the development, and validation, of a prototype high-content screening platform that combines steady-state fluorescence anisotropy imaging with fluorescence lifetime imaging (FLIM). This functional approach allows objective, quantitative screening of small molecule libraries in protein-protein interaction assays. We discuss the development of the instrumentation, the process by which information on fluorescence resonance energy transfer (FRET) can be extracted from wide-field, acceptor fluorescence anisotropy imaging and cross-checking of this modality using lifetime imaging by time-correlated single-photon counting. Imaging of cells expressing protein constructs where eGFP and mRFP1 are linked with amino-acid chains of various lengths (7, 19 and 32 amino acids) shows the two methodologies to be highly correlated. We validate our approach using a small-scale inhibitor screen of a Cdc42 FRET biosensor probe expressed in epidermoid cancer cells (A431) in a 96 microwell-plate format. We also show that acceptor fluorescence anisotropy can be used to measure variations in hetero-FRET in protein-protein interactions. We demonstrate this using a screen of inhibitors of internalization of the transmembrane receptor, CXCR4. These assays enable us to demonstrate all the capabilities of the instrument, image processing and analytical techniques that have been developed. Direct correlation between acceptor anisotropy and donor FLIM is observed for FRET assays, providing an opportunity to rapidly screen proteins, interacting on the nano-meter scale, using wide-field imaging.	[Matthews, Daniel R.; Fruhwirth, Gilbert O.; Weitsman, Gregory; Carlin, Leo M.; Ofo, Enyinnaya; Keppler, Melanie; Barber, Paul R.; Vojnovic, Borivoj; Ng, Tony; Ameer-Beg, Simon M.] Kings Coll London, Div Canc Studies, Randall Div Cell & Mol Biophys, London WC2R 2LS, England; [Barber, Paul R.; Tullis, Iain D. C.; Vojnovic, Borivoj] Univ Oxford, Dept Oncol, Gray Inst Radiat Oncol & Biol, Oxford, England	University of London; King's College London; University of Oxford	Matthews, DR (corresponding author), Kings Coll London, Div Canc Studies, Randall Div Cell & Mol Biophys, London WC2R 2LS, England.	Simon.ameer-beg@kcl.ac.uk	Fruhwirth, Gilbert/AAP-5559-2021; Carlin, Leo Marc/E-3434-2012; Vojnovic, Borivoj/AAV-4756-2021	Fruhwirth, Gilbert/0000-0002-1438-2674; Carlin, Leo Marc/0000-0001-7172-5234; Vojnovic, Borivoj/0000-0001-9013-3816; Ng, Tony/0000-0003-3894-5619; Ameer-Beg, Simon/0000-0001-5227-575X; Tullis, Iain/0000-0001-5148-0161	Engineering and Physical Sciences Research Councils (EPSRC) [EP/C546105/1]; King's College London/University College London Comprehensive Cancer Imaging Centre (CCIC); Cancer Research UK (CRUK); CRUK Programme Grant [C133/A/1812]; Dimbleby Cancer Care to King's College London; EPSRC [EP/C546113/1] Funding Source: UKRI; Cancer Research UK [15677] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/C546113/1, EP/C546105/1] Funding Source: researchfish	Engineering and Physical Sciences Research Councils (EPSRC); King's College London/University College London Comprehensive Cancer Imaging Centre (CCIC); Cancer Research UK (CRUK)(Cancer Research UK); CRUK Programme Grant; Dimbleby Cancer Care to King's College London; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Cancer Research UK(Cancer Research UK); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	The work was supported by Engineering and Physical Sciences Research Councils (EPSRC) grant EP/C546105/1; the King's College London/University College London Comprehensive Cancer Imaging Centre (CCIC) funded by Cancer Research UK (CRUK) & EPSRC; a CRUK Programme Grant (C133/A/1812) and an endowment fund from Dimbleby Cancer Care to King's College London. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham VC, 2004, TRENDS BIOTECHNOL, V22, P15, DOI 10.1016/j.tibtech.2003.10.012; Anilkumar N, 2003, EMBO J, V22, P5390, DOI 10.1093/emboj/cdg521; AXELROD D, 1979, BIOPHYS J, V26, P557, DOI 10.1016/S0006-3495(79)85271-6; Bader AN, 2011, CHEMPHYSCHEM, V12, P475, DOI 10.1002/cphc.201000801; Barber PR, 2010, BIOMED OPT EXPRESS, V1, P1148, DOI 10.1364/BOE.1.001148; Barber PR, 2008, I S BIOMED IMAGING, P356, DOI 10.1109/ISBI.2008.4541006; Barber PR, 2009, J R SOC INTERFACE, V6, pS93, DOI 10.1098/rsif.2008.0451.focus; Barber PR, 2005, PROC SPIE, V5700, P171, DOI 10.1117/12.590510; Bastiaens PIH, 1999, TRENDS CELL BIOL, V9, P48, DOI 10.1016/S0962-8924(98)01410-X; Bleul CC, 1996, NATURE, V382, P829, DOI 10.1038/382829a0; Booth MJ, 2004, J MICROSC-OXFORD, V214, P36, DOI 10.1111/j.0022-2720.2004.01316.x; Bottomley MJ, 1999, CURR BIOL, V9, pR301, DOI 10.1016/S0960-9822(99)80184-5; Cade NI, 2010, BIOPHYS J, V98, P2752, DOI 10.1016/j.bpj.2010.03.016; Calleja V, 2003, BIOCHEM J, V372, P33, DOI 10.1042/BJ20030358; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Dadke S, 2007, NAT CELL BIOL, V9, P80, DOI 10.1038/ncb1522; DALE RE, 1979, BIOPHYS J, V26, P161, DOI 10.1016/S0006-3495(79)85243-1; DALE RE, 1976, P NATL ACAD SCI USA, V73, P271, DOI 10.1073/pnas.73.2.271; Dowling K, 1999, J MOD OPTIC, V46, P199, DOI 10.1080/09500349908231265; DUBRIDGE RB, 1987, MOL CELL BIOL, V7, P379, DOI 10.1128/MCB.7.1.379; Duncan RR, 2004, J MICROSC-OXFORD, V215, P1, DOI 10.1111/j.0022-2720.2004.01343.x; Eggert US, 2006, CURR OPIN CHEM BIOL, V10, P232, DOI 10.1016/j.cbpa.2006.04.010; Festy F, 2007, MOL BIOSYST, V3, P381, DOI 10.1039/b617204k; FORSTER T, 1948, ANN PHYS-BERLIN, V2, P55, DOI 10.1002/andp.19484370105; Fruhwirth GO, 2011, CHEMPHYSCHEM, V12, P442, DOI 10.1002/cphc.201000866; Fruhwirth GO, 2010, OPT EXPRESS, V18, P11148, DOI 10.1364/OE.18.011148; Fruhwirth GO, 2009, DEEP TISSUE MULTIPHO; Ganesan S, 2006, P NATL ACAD SCI USA, V103, P4089, DOI 10.1073/pnas.0509922103; Lopez MAG, 2009, CELL SIGNAL, V21, P1748, DOI 10.1016/j.cellsig.2009.07.010; GIARD DJ, 1973, J NATL CANCER I, V51, P1417, DOI 10.1093/jnci/51.5.1417; Glory E, 2007, DEV CELL, V12, P7, DOI 10.1016/j.devcel.2006.12.007; Heasman SJ, 2010, J CELL BIOL, V190, P553, DOI 10.1083/jcb.201002067; Held M, 2010, NAT METHODS, V7, P747, DOI 10.1038/nmeth.1486; Hille C, 2008, ANAL BIOANAL CHEM, V391, P1871, DOI 10.1007/s00216-008-2147-0; Hinshaw JE, 2000, ANNU REV CELL DEV BI, V16, P483, DOI 10.1146/annurev.cellbio.16.1.483; Itoh RE, 2005, EXP CELL RES, V307, P142, DOI 10.1016/j.yexcr.2005.02.026; Jares-Erijman EA, 2003, NAT BIOTECHNOL, V21, P1387, DOI 10.1038/nbt896; Khan A, 2009, J AM CHEM SOC, V131, P3416, DOI 10.1021/ja807921k; Koushik SV, 2006, BIOPHYS J, V91, pL99, DOI 10.1529/biophysj.106.096206; Krutzik PO, 2008, NAT CHEM BIOL, V4, P132, DOI 10.1038/nchembio.2007.59; Krutzik PO, 2006, NAT METHODS, V3, P361, DOI 10.1038/NMETH872; Kuimova MK, 2009, NAT CHEM, V1, P69, DOI [10.1038/nchem.120, 10.1038/NCHEM.120]; Kumar S, 2007, OPT EXPRESS, V15, P12548, DOI 10.1364/OE.15.012548; Lakowicz J.R., 2006, PRINCIPLES FLUORESCE; Legg JW, 2002, NAT CELL BIOL, V4, P399, DOI 10.1038/ncb797; Levitt JA, 2009, CURR OPIN BIOTECH, V20, P28, DOI 10.1016/j.copbio.2009.01.004; Lidke KA, 2005, IEEE T IMAGE PROCESS, V14, P1237, DOI 10.1109/TIP.2005.852458; Lu XS, 2008, COMPUT MED IMAG GRAP, V32, P202, DOI 10.1016/j.compmedimag.2007.12.001; Makrogianneli K, 2009, MOL CELL BIOL; Matthews DR, 2010, J MICROSC-OXFORD, V237, P51, DOI 10.1111/j.1365-2818.2009.03301.x; Mattheyses AL, 2004, BIOPHYS J, V87, P2787, DOI 10.1529/biophysj.103.036194; McRobbie G, 2007, DALTON T, P5008, DOI 10.1039/b705800d; Merzlyak EM, 2007, NAT METHODS, V4, P555, DOI 10.1038/NMETH1062; Morris JR, 2009, NATURE, V462, P886, DOI 10.1038/nature08593; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Nakamura T, 2006, METHOD ENZYMOL, V406, P315, DOI 10.1016/S0076-6879(06)06023-X; Newman W S, 1993, Q APPL MATH, V2, P160; Ng T, 1999, SCIENCE, V283, P2085, DOI 10.1126/science.283.5410.2085; Ng T, 1999, EMBO J, V18, P3909, DOI 10.1093/emboj/18.14.3909; Parsons M, 2005, MOL CELL BIOL, V25, P1680, DOI 10.1128/MCB.25.5.1680-1695.2005; Parsons M, 2002, MOL CELL BIOL, V22, P5897, DOI 10.1128/MCB.22.16.5897-5911.2002; Pelet S, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2203664; Pepperkok R, 2006, NAT REV MOL CELL BIO, V7, P690, DOI 10.1038/nrm1979; Peter M, 2005, BIOPHYS J, V88, P1224, DOI 10.1529/biophysj.104.050153; Peter M, 2004, BIOL CELL, V96, P231, DOI 10.1016/j.biolcel.2003.12.006; Piston DW, 2008, METHOD CELL BIOL, V85, P415, DOI 10.1016/S0091-679X(08)85018-2; Reynolds AR, 2003, NAT CELL BIOL, V5, P447, DOI 10.1038/ncb981; Rizzo MA, 2005, BIOPHYS J, V88, pL14, DOI 10.1529/biophysj.104.055442; Saxl T, 2009, BIOSENS BIOELECTRON, V24, P3229, DOI 10.1016/j.bios.2009.04.003; Schonle A, 2000, APPL OPTICS, V39, P6306, DOI 10.1364/AO.39.006306; Sharman KK, 1999, ANAL CHEM, V71, P947, DOI 10.1021/ac981050d; Signoret N, 1998, J CELL SCI, V111, P2819; Starkuviene V, 2007, BRIT J PHARMACOL, V152, P62, DOI 10.1038/sj.bjp.0707346; STRYER L, 1978, ANNU REV BIOCHEM, V47, P819, DOI 10.1146/annurev.bi.47.070178.004131; TOH Y, 1994, J BIOL CHEM, V269, P22958; Treanor B, 2006, J CELL BIOL, V174, P153, DOI 10.1083/jcb.200601108; Tregidgo C, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2937212; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Vanhecke D, 2005, DRUG DISCOV TODAY, V10, P205, DOI 10.1016/S1359-6446(04)03352-5; Verveer PJ, 2008, HISTOCHEM CELL BIOL, V130, P833, DOI 10.1007/s00418-008-0517-5; Verveer PJ, 2000, SCIENCE, V290, P1567, DOI 10.1126/science.290.5496.1567; WHITE SDM, 1986, SCIENTIST, V1, P23; Wlodarczyk J, 2008, BIOPHYS J, V94, P986, DOI 10.1529/biophysj.107.111773; WOODS RJ, 1984, ANAL CHEM, V56, P1395, DOI 10.1021/ac00272a043; Wouters FS, 2001, TRENDS CELL BIOL, V11, P203, DOI 10.1016/S0962-8924(01)01982-1; Wouters FS, 1999, CURR BIOL, V9, P1127, DOI 10.1016/S0960-9822(99)80484-9	86	28	28	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2012	7	4							e33231	10.1371/journal.pone.0033231	http://dx.doi.org/10.1371/journal.pone.0033231			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959FE	22506000	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000305297500008
J	Ronnberg, T; Jaaskelainen, K; Blot, G; Parviainen, V; Vaheri, A; Renkonen, R; Bouloy, M; Plyusnin, A				Ronnberg, Tuomas; Jaaskelainen, Kirsi; Blot, Guillaume; Parviainen, Ville; Vaheri, Antti; Renkonen, Risto; Bouloy, Michele; Plyusnin, Alexander			Searching for Cellular Partners of Hantaviral Nonstructural Protein NSs: Y2H Screening of Mouse cDNA Library and Analysis of Cellular Interactome	PLOS ONE			English	Article							RNA SILENCING SUPPRESSOR; UUKUNIEMI VIRUS; MEMBRANE-PROTEIN; TULA VIRUS; EXPRESSION; IDENTIFICATION; ALPHA-2HS-GLYCOPROTEIN; TRANSCRIPTION; GLYCOPROTEIN; REPLICATION	Hantaviruses (Bunyaviridae) are negative-strand RNA viruses with a tripartite genome. The small (S) segment encodes the nucleocapsid protein and, in some hantaviruses, also the nonstructural protein (NSs). The aim of this study was to find potential cellular partners for the hantaviral NSs protein. Toward this aim, yeast two-hybrid (Y2H) screening of mouse cDNA library was performed followed by a search for potential NSs protein counterparts via analyzing a cellular interactome. The resulting interaction network was shown to form logical, clustered structures. Furthermore, several potential binding partners for the NSs protein, for instance ACBD3, were identified and, to prove the principle, interaction between NSs and ACBD3 proteins was demonstrated biochemically.	[Ronnberg, Tuomas; Jaaskelainen, Kirsi; Vaheri, Antti; Plyusnin, Alexander] Univ Helsinki, Dept Virol, Haartman Inst, Helsinki, Finland; [Parviainen, Ville; Renkonen, Risto] Univ Helsinki, Transplantat Lab, Haartman Inst, Helsinki, Finland; [Ronnberg, Tuomas; Jaaskelainen, Kirsi; Parviainen, Ville; Vaheri, Antti; Renkonen, Risto; Plyusnin, Alexander] Univ Helsinki, Res Programs Unit, Infect Biol Res Program, Haartman Inst, Helsinki, Finland; [Blot, Guillaume; Bouloy, Michele] Inst Pasteur, Bunyaviridae Unit, Paris, France	University of Helsinki; University of Helsinki; University of Helsinki; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Ronnberg, T (corresponding author), Univ Helsinki, Dept Virol, Haartman Inst, Helsinki, Finland.	samu.ronnberg@helsinki.fi	Vaheri, Antti/AAV-1523-2020		Academy of Finland; Sigrid Juselius Foundation (Finland)	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation (Finland)(Sigrid Juselius Foundation)	The study was supported by research grants from The Academy of Finland and Sigrid Juselius Foundation (Finland). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; [Anonymous], VIRUS TAXONOMY CLASS; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Assenov Y, 2008, BIOINFORMATICS, V24, P282, DOI 10.1093/bioinformatics/btm554; Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2; Blakqori G, 2007, J VIROL, V81, P4991, DOI 10.1128/JVI.01933-06; Blanc M, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000598; Cerami EG, 2011, NUCLEIC ACIDS RES, V39, pD685, DOI 10.1093/nar/gkq1039; CHAN YM, 1994, GENE DEV, V8, P2574, DOI 10.1101/gad.8.21.2574; Church DM, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000112; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Cordell PA, 2010, BLOOD, V115, P2674, DOI 10.1182/blood-2009-08-231316; de Vries W, 2009, J GEN VIROL, V90, P1916, DOI 10.1099/vir.0.008284-0; Ehrhardt C, 2010, MICROBES INFECT, V12, P81, DOI 10.1016/j.micinf.2009.09.007; Fan JJ, 2010, PROG LIPID RES, V49, P218, DOI 10.1016/j.plipres.2009.12.003; Feller SM, 2001, ONCOGENE, V20, P6348, DOI 10.1038/sj.onc.1204779; Flick R, 2001, J VIROL, V75, P1643, DOI 10.1128/JVI.75.4.1643-1655.2001; Fontana J, 2008, CELL MICROBIOL, V10, P2012, DOI 10.1111/j.1462-5822.2008.01184.x; Greninger AL, 2012, J VIROL, V86, P3605, DOI 10.1128/JVI.06778-11; Habjan M, 2009, J VIROL, V83, P4365, DOI 10.1128/JVI.02148-08; Hale BG, 2008, J GEN VIROL, V89, P2359, DOI 10.1099/vir.0.2008/004606-0; Heikkinen LS, 2008, J BIOL CHEM, V283, P5719, DOI 10.1074/jbc.M707195200; Hennige AM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001765; Hrincius ER, 2010, CELL MICROBIOL, V12, P831, DOI 10.1111/j.1462-5822.2010.01436.x; Ikegami T, 2009, ANN NY ACAD SCI, V1171, P75; Jaaskelainen KM, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-3; Jaaskelainen KM, 2007, J MED VIROL, V79, P1527, DOI 10.1002/jmv.20948; Jersmann HPA, 2003, CLIN SCI, V105, P273, DOI 10.1042/CS20030126; Kalabay L, 2002, EUR J GASTROEN HEPAT, V14, P389, DOI 10.1097/00042737-200204000-00009; Klar M, 2005, MOL CELL BIOL, V25, P10159, DOI 10.1128/MCB.25.22.10159-10170.2005; Klingstrom J, 2006, MICROBES INFECT, V8, P728, DOI 10.1016/j.micinf.2005.09.010; Koegl Manfred, 2007, Briefings in Functional Genomics & Proteomics, V6, P302, DOI 10.1093/bfgp/elm035; Le May N, 2004, CELL, V116, P541, DOI 10.1016/S0092-8674(04)00132-1; Le May N, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040013; Lee CH, 2009, J CELL BIOL, V186, P409, DOI 10.1083/jcb.200810196; Leonard VHJ, 2006, J VIROL, V80, P9667, DOI 10.1128/JVI.00822-06; Li H, 2001, MOL ENDOCRINOL, V15, P2211, DOI 10.1210/me.15.12.2211; Lin X, 2000, J BIOL CHEM, V275, P36818, DOI 10.1074/jbc.C000580200; Lugassy J, 2008, J INVEST DERMATOL, V128, P1517, DOI 10.1038/sj.jid.5701187; LUNDKVIST A, 2002, MOL EPIDEMIOLOGY HUM, P351; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Mansuroglu Z, 2010, J VIROL, V84, P928, DOI 10.1128/JVI.01165-09; Medigeshi GR, 2008, TRAFFIC, V9, P121, DOI 10.1111/j.1600-0854.2007.00672.x; Palmer SR, 2011, ZOONOSES BIOL CLIN P, P307; Plyusnin A, 1995, VIRUS RES, V39, P237, DOI 10.1016/0168-1702(95)00086-0; Plyusnin A, 2002, ARCH VIROL, V147, P665, DOI 10.1007/s007050200017; PLYUSNIN A, 1994, J VIROL, V68, P7833, DOI 10.1128/JVI.68.12.7833-7839.1994; Ratushny V, 2008, BIOTECHNIQUES, V44, P655, DOI 10.2144/000112797; SAIKKU P, 1973, AM J TROP MED HYG, V22, P390, DOI 10.4269/ajtmh.1973.22.390; Sasaki J, 2012, EMBO J, V31, P754, DOI 10.1038/emboj.2011.429; Schnettler E, 2010, J VIROL, V84, P11542, DOI 10.1128/JVI.00595-10; Shen XT, 2000, NATURE, V406, P541, DOI 10.1038/35020123; Shen XT, 2003, MOL CELL, V12, P147, DOI 10.1016/S1097-2765(03)00264-8; Shi XH, 2010, J VIROL, V84, P8460, DOI 10.1128/JVI.00902-10; SIMONS JF, 1992, J VIROL, V66, P4233, DOI 10.1128/JVI.66.7.4233-4241.1992; Sohda M, 2001, J BIOL CHEM, V276, P45298, DOI 10.1074/jbc.M108961200; Soldan SS, 2005, J VIROL, V79, P234, DOI 10.1128/JVI.79.1.234-244.2005; Song JW, 2004, VIRUS GENES, V29, P239, DOI 10.1023/B:VIRU.0000036384.50102.cf; Stephens DJ, 1999, J BIOL CHEM, V274, P30080, DOI 10.1074/jbc.274.42.30080; Swallow CJ, 2004, CANCER RES, V64, P6402, DOI 10.1158/0008-5472.CAN-04-1117; Takeda A, 2002, FEBS LETT, V532, P75, DOI 10.1016/S0014-5793(02)03632-3; van Knippenberg I, 2010, J GEN VIROL, V91, P2002, DOI 10.1099/vir.0.021774-0; VAPALAHTI O, 1992, J GEN VIROL, V73, P829, DOI 10.1099/0022-1317-73-4-829; Virtanen JO, 2010, ARCH VIROL, V155, P117, DOI 10.1007/s00705-009-0546-y; Wang JM, 2000, TRAFFIC, V1, P713, DOI 10.1034/j.1600-0854.2000.010904.x; Warner DR, 2003, BIOCHEM BIOPH RES CO, V312, P1185, DOI 10.1016/j.bbrc.2003.11.049; Wilson D. E., 2005, MAMMAL SPECIES WORLD; Yan Q, 1999, J HISTOCHEM CYTOCHEM, V47, P1495, DOI 10.1177/002215549904701201; Zhou Y, 2007, CELL, V129, P163, DOI 10.1016/j.cell.2007.02.037	69	11	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2012	7	4							e34307	10.1371/journal.pone.0034307	http://dx.doi.org/10.1371/journal.pone.0034307			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959FE	22506017	Green Published, Green Submitted, gold			2022-12-27	WOS:000305297500025
J	Rubin, BER; Ree, RH; Moreau, CS				Rubin, Benjamin E. R.; Ree, Richard H.; Moreau, Corrie S.			Inferring Phylogenies from RAD Sequence Data	PLOS ONE			English	Article							MAXIMUM-LIKELIHOOD; DIVERGENCE TIMES; EVOLUTIONARY; IDENTIFICATION; MAMMALS; MARKERS; GENES; TREES; LOCI	Reduced-representation genome sequencing represents a new source of data for systematics, and its potential utility in interspecific phylogeny reconstruction has not yet been explored. One approach that seems especially promising is the use of inexpensive short-read technologies (e. g., Illumina, SOLiD) to sequence restriction-site associated DNA (RAD) - the regions of the genome that flank the recognition sites of restriction enzymes. In this study, we simulated the collection of RAD sequences from sequenced genomes of different taxa (Drosophila, mammals, and yeasts) and developed a proof-of-concept workflow to test whether informative data could be extracted and used to accurately reconstruct "known" phylogenies of species within each group. The workflow consists of three basic steps: first, sequences are clustered by similarity to estimate orthology; second, clusters are filtered by taxonomic coverage; and third, they are aligned and concatenated for "total evidence" phylogenetic analysis. We evaluated the performance of clustering and filtering parameters by comparing the resulting topologies with well-supported reference trees and we were able to identify conditions under which the reference tree was inferred with high support. For Drosophila, whole genome alignments allowed us to directly evaluate which parameters most consistently recovered orthologous sequences. For the parameter ranges explored, we recovered the best results at the low ends of sequence similarity and taxonomic representation of loci; these generated the largest supermatrices with the highest proportion of missing data. Applications of the method to mammals and yeasts were less successful, which we suggest may be due partly to their much deeper evolutionary divergence times compared to Drosophila (crown ages of approximately 100 and 300 versus 60 Mya, respectively). RAD sequences thus appear to hold promise for reconstructing phylogenetic relationships in younger clades in which sufficient numbers of orthologous restriction sites are retained across species.	[Rubin, Benjamin E. R.] Univ Chicago, Comm Evolutionary Biol, Chicago, IL 60637 USA; [Rubin, Benjamin E. R.; Moreau, Corrie S.] Field Museum Nat Hist, Dept Zool, Chicago, IL 60605 USA; [Ree, Richard H.] Field Museum Nat Hist, Dept Bot, Chicago, IL 60605 USA	University of Chicago; Field Museum of Natural History (Chicago); Field Museum of Natural History (Chicago)	Rubin, BER (corresponding author), Univ Chicago, Comm Evolutionary Biol, Chicago, IL 60637 USA.	brubin@fieldmuseum.org		Moreau, Corrie/0000-0003-1139-5792	U.S. National Science Foundation	U.S. National Science Foundation(National Science Foundation (NSF))	BERR was funded in part by a U.S. National Science Foundation Graduate Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Adkins RM, 2003, MOL PHYLOGENET EVOL, V26, P409, DOI 10.1016/S1055-7903(02)00304-4; Ane C, 2007, MOL BIOL EVOL, V24, P412; Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Bergsten J, 2005, CLADISTICS, V21, P163, DOI 10.1111/j.1096-0031.2005.00059.x; Bryant D, 2009, ARXIV09104193V1 QBIO; Burleigh JG, 2006, SYST BIOL, V55, P426, DOI 10.1080/10635150500541722; Carstens BC, 2007, SYST BIOL, V56, P400, DOI [10.1080/10635150701405560, 10.1080/10635150701701091]; Catchen JM, 2011, G3-GENES GENOM GENET, V1, P171, DOI 10.1534/g3.111.000240; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; Cutter AD, 2008, MOL BIOL EVOL, V25, P778, DOI 10.1093/molbev/msn024; de Villiers EP, 2010, VIROLOGY, V400, P128, DOI 10.1016/j.virol.2010.01.019; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Emerson KJ, 2010, P NATL ACAD SCI USA, V107, P16196, DOI 10.1073/pnas.1006538107; FELSENSTEIN J, 1978, SYST ZOOL, V27, P401, DOI 10.2307/2412923; Foster JT, 2009, J BACTERIOL, V191, P2864, DOI 10.1128/JB.01581-08; Fulton TM, 2002, PLANT CELL, V14, P1457, DOI 10.1105/tpc.010479; Glazko GV, 2003, MOL BIOL EVOL, V20, P424, DOI 10.1093/molbev/msg050; HILLIS DM, 1993, SYST BIOL, V42, P182, DOI 10.2307/2992540; Hohenlohe PA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000862; Kubatko LS, 2009, BIOINFORMATICS, V25, P971, DOI 10.1093/bioinformatics/btp079; Lewis ZA, 2007, GENETICS, V177, P1163, DOI 10.1534/genetics.107.078147; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Liu L, 2008, BIOINFORMATICS, V24, P2542, DOI 10.1093/bioinformatics/btn484; Metzker Michael L, 2010, Nat Rev Genet, V11, P31, DOI 10.1038/nrg2626; Miller MR, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r105; Miller MR, 2007, GENOME RES, V17, P240, DOI 10.1101/gr.5681207; Murphy WJ, 2007, GENOME RES, V17, P413, DOI 10.1101/gr.5918807; Philippe H, 2005, ANNU REV ECOL EVOL S, V36, P541, DOI 10.1146/annurev.ecolsys.35.112202.130205; Philippe H, 2004, MOL BIOL EVOL, V21, P1740, DOI 10.1093/molbev/msh182; Philippe H, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000602; Pollard DA, 2006, PLOS GENET, V2, P1634, DOI 10.1371/journal.pgen.0020173; Prasad AB, 2008, MOL BIOL EVOL, V25, P1795, DOI 10.1093/molbev/msn104; Rannala B, 2008, ANNU REV GENOM HUM G, V9, P217, DOI 10.1146/annurev.genom.9.081307.164407; Rokas A, 2003, NATURE, V425, P798, DOI 10.1038/nature02053; RUSSO CAM, 1995, MOL BIOL EVOL, V12, P391; Sims GE, 2009, P NATL ACAD SCI USA, V106, P17077, DOI 10.1073/pnas.0909377106; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Steppan SJ, 2004, SYST BIOL, V53, P533, DOI 10.1080/10635150490468701; Tamura K, 2004, MOL BIOL EVOL, V21, P36, DOI 10.1093/molbev/msg236; Taylor JW, 2006, MYCOLOGIA, V98, P838, DOI 10.3852/mycologia.98.6.838; Wiens JJ, 2003, SYST BIOL, V52, P528, DOI 10.1080/10635150390218330; Wiens JJ, 2011, SYST BIOL, V60, P719, DOI 10.1093/sysbio/syr025; Wu FN, 2006, GENETICS, V174, P1407, DOI 10.1534/genetics.106.062455	45	233	234	1	119	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2012	7	4							e33394	10.1371/journal.pone.0033394	http://dx.doi.org/10.1371/journal.pone.0033394			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JA	22493668	Green Submitted, gold, Green Published			2022-12-27	WOS:000305012700010
J	Yan, CF; Han, SJ; Zhou, YM; Wang, CG; Dai, GH; Xiao, WF; Li, MH				Yan, Cai-Feng; Han, Shi-Jie; Zhou, Yu-Mei; Wang, Cun-Guo; Dai, Guan-Hua; Xiao, Wen-Fa; Li, Mai-He			Needle-Age Related Variability in Nitrogen, Mobile Carbohydrates, and delta C-13 within Pinus koraiensis Tree Crowns	PLOS ONE			English	Article							CARBON-ISOTOPE DISCRIMINATION; LEAF GAS-EXCHANGE; SCOTS PINE; CANOPY POSITION; TROPICAL FOREST; CEMBRA TREES; DOUGLAS-FIR; LIGHT; NUTRIENT; AREA	For both ecologists and physiologists, foliar physioecology as a function of spatially and temporally variable environmental factors such as sunlight exposure within a tree crown is important for understanding whole tree physiology and for predicting ecosystem carbon balance and productivity. Hence, we studied concentrations of nitrogen (N), non-structural carbohydrates (NSC = soluble sugars + starch), and delta C-13 in different-aged needles within Pinus koraiensis tree crowns, to understand the needle age- and crown position-related physiology, in order to test the hypothesis that concentrations of N, NSC, and delta C-13 are needle-age and crown position dependent (more light, more photosynthesis affecting N, NSC, and delta C-13), and to develop an accurate sampling strategy. The present study indicated that the 1-yr-old needles had significantly higher concentration levels of mobile carbohydrates (both on a mass and an area basis) and N-area (on an area basis), as well as NSC-N ratios, but significantly lower levels of N-mass (on a mass basis) concentration and specific leaf area (SLA), compared to the current-year needles. Azimuthal (south-facing vs. north-facing crown side) effects were found to be significant on starch [both on a mass (STmass) and an area basis (STarea)], delta C-13 values, and N-area, with higher levels in needles on the S-facing crown side than the N-facing crown side. Needle N-mass concentrations significantly decreased but needle STmass, STarea, and delta C-13 values significantly increased with increasing vertical crown levels. Our results suggest that the sun-exposed crown position related to photosynthetic activity and water availability affects starch accumulation and carbon isotope discrimination. Needle age associated with physiological activity plays an important role in determining carbon and nitrogen physiology. The present study indicates that across-scale sampling needs to carefully select tissue samples with equal age from a comparable crown position.	[Yan, Cai-Feng; Han, Shi-Jie; Zhou, Yu-Mei; Wang, Cun-Guo; Li, Mai-He] Chinese Acad Sci, Inst Appl Ecol, State Key Lab Forest & Soil Ecol, Shenyang, Peoples R China; [Yan, Cai-Feng; Wang, Cun-Guo] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Dai, Guan-Hua] Chinese Acad Sci, Res Stn Changbai Mt Forest Ecosyst, Erdaobaihe, Peoples R China; [Xiao, Wen-Fa] Chinese Acad Forestry, Key Lab Forest Ecol & Environm, State Forestry Adm, Beijing, Peoples R China; [Li, Mai-He] Swiss Fed Res Inst WSL, Birmensdorf, Switzerland	Chinese Academy of Sciences; Shenyang Institute of Applied Ecology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Chinese Academy of Forestry; Research Institute of Forest Ecology, Environment and Protection, CAF; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research	Yan, CF (corresponding author), Chinese Acad Sci, Inst Appl Ecol, State Key Lab Forest & Soil Ecol, Shenyang, Peoples R China.	maihe.li@wsl.ch	Zhou, Yu/HHN-3071-2022; Li, Mai-He/L-6390-2013	Li, Mai-He/0000-0002-7029-2841	National Natural Science Foundation of China [40930107]; Key Laboratory of Forest Ecology and Environment, State Forestry Administration, Chinese Academy of Forestry [CAFIFEEPYBB2007001]; Major State Basic Research Development Program [2011CB403200]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Laboratory of Forest Ecology and Environment, State Forestry Administration, Chinese Academy of Forestry; Major State Basic Research Development Program(National Basic Research Program of China)	This study was supported by the National Natural Science Foundation of China (Project no. 40930107), Key Laboratory of Forest Ecology and Environment, State Forestry Administration, Chinese Academy of Forestry (CAFIFEEPYBB2007001), and the Major State Basic Research Development Program (2011CB403200). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attiwill PM, 2005, TREES-STRUCT FUNCT, V20, P79, DOI DOI 10.1007/S00468-005-0015-5; Barszczowska L, 2005, ACTA SOC BOT POL, V74, P93; Bond BJ, 1999, OECOLOGIA, V120, P183, DOI 10.1007/s004420050847; Bond BJ, 2000, TRENDS PLANT SCI, V5, P349, DOI 10.1016/S1360-1385(00)01691-5; Brendel O, 2003, ANN FOREST SCI, V60, P97, DOI 10.1051/forest:2003001; BROADMEADOW MSJ, 1992, OECOLOGIA, V89, P435, DOI 10.1007/BF00317423; Chevillat VS, 2005, BASIC APPL ECOL, V6, P519, DOI 10.1016/j.baae.2005.04.008; Chmura DJ, 2008, TREE PHYSIOL, V28, P729, DOI 10.1093/treephys/28.5.729; CONSTABLE GA, 1980, AUST J PLANT PHYSIOL, V7, P539, DOI 10.1071/PP9800539; CRAIG H, 1957, GEOCHIM COSMOCHIM AC, V12, P133, DOI 10.1016/0016-7037(57)90024-8; DALE MP, 1992, J ECOL, V80, P517, DOI 10.2307/2260695; El-Sharkawy MA, 2007, PHOTOSYNTHETICA, V45, P515, DOI 10.1007/s11099-007-0089-y; FISCHER C, 1991, TREES-STRUCT FUNCT, V5, P187, DOI 10.1007/BF00227524; GEBAUER G, 1994, PLANT SOIL, V164, P267, DOI 10.1007/BF00010079; GEBAUER G, 1991, OECOLOGIA, V87, P198, DOI 10.1007/BF00325257; GEIGER J, 1961, Z PHYS, V161, P243, DOI 10.1007/BF01338932; Gonzalez-Real MM, 2000, PLANT CELL ENVIRON, V23, P351, DOI 10.1046/j.1365-3040.2000.00559.x; Griffin KL, 2002, NEW PHYTOL, V154, P609, DOI 10.1046/j.1469-8137.2002.00410.x; GUTIERREZ MV, 1994, AUST J PLANT PHYSIOL, V21, P207, DOI 10.1071/PP9940207; Han QM, 2003, TREE PHYSIOL, V23, P851, DOI 10.1093/treephys/23.12.851; Hao ZQ, 2002, CHINESE J APPL ECOLO, V13, P785; HATCHER PE, 1990, OECOLOGIA, V85, P200, DOI 10.1007/BF00319402; Helle G, 2004, PLANT CELL ENVIRON, V27, P367, DOI 10.1111/j.0016-8025.2003.01159.x; Helmisaari Helja-Sisko, 1992, Silva Fennica, V26, P145; Hoch G, 2003, OECOLOGIA, V135, P10, DOI 10.1007/s00442-002-1154-7; Hollinger DY, 1996, TREE PHYSIOL, V16, P627; Holtum JAM, 2005, TREES-STRUCT FUNCT, V19, P545, DOI 10.1007/s00468-005-0413-8; Iio A, 2005, TREE PHYSIOL, V25, P533, DOI 10.1093/treephys/25.5.533; Ishii H, 2002, TREE PHYSIOL, V22, P31, DOI 10.1093/treephys/22.1.31; Ishii HT, 2008, OECOLOGIA, V156, P751, DOI 10.1007/s00442-008-1032-z; Jaggi M, 2002, OECOLOGIA, V131, P325, DOI 10.1007/s00442-002-0881-0; Johnson IR, 1996, AGR SYST, V50, P1, DOI 10.1016/0308-521X(95)00010-3; Koch GW, 2004, NATURE, V428, P851, DOI 10.1038/nature02417; Li CY, 2009, TREES-STRUCT FUNCT, V23, P1109, DOI 10.1007/s00468-009-0354-8; Li MH, 2008, PLANT CELL ENVIRON, V31, P1377, DOI 10.1111/j.1365-3040.2008.01848.x; Li MH, 2008, TREE PHYSIOL, V28, P1287, DOI 10.1093/treephys/28.8.1287; Li MH, 2006, TREES-STRUCT FUNCT, V20, P611, DOI 10.1007/s00468-006-0076-0; Li MH, 2002, TREES-STRUCT FUNCT, V16, P331, DOI 10.1007/s00468-002-0172-8; Li MH, 2001, PHYTON-ANN REI BOT A, V41, P203; Li MC, 2009, J FOREST RES-JPN, V14, P229, DOI 10.1007/s10310-009-0132-x; Livingston NJ, 1998, PLANT CELL ENVIRON, V21, P795, DOI 10.1046/j.1365-3040.1998.00314.x; LOWTHER WL, 1980, NEW ZEAL J EXP AGR, V8, P249, DOI 10.1080/03015521.1980.10426267; Ludovici KH, 2002, FOREST ECOL MANAG, V159, P261, DOI 10.1016/S0378-1127(01)00439-X; Maguire DA, 1996, CAN J FOREST RES, V26, P849, DOI 10.1139/x26-093; Marshall JD, 2003, CAN J FOREST RES, V33, P164, DOI 10.1139/X02-158; McGarvey RC, 2004, TREE PHYSIOL, V24, P1209, DOI 10.1093/treephys/24.11.1209; MEINZER FC, 1992, OECOLOGIA, V91, P305, DOI 10.1007/BF00317617; Mickelbart MV, 2010, HORTSCIENCE, V45, P428, DOI 10.21273/HORTSCI.45.3.428; Morecroft MD, 1996, NEW PHYTOL, V134, P471, DOI 10.1111/j.1469-8137.1996.tb04364.x; Niinemets U, 1997, TREE PHYSIOL, V17, P723; Niinemets U, 2003, ACTA OECOL, V24, P209, DOI 10.1016/S1146-609X(03)00094-8; Niinemets U, 2001, TREE PHYSIOL, V21, P1231, DOI 10.1093/treephys/21.17.1231; Nippert JB, 2003, TREE PHYSIOL, V23, P591, DOI 10.1093/treephys/23.9.591; O'Neal ME, 2002, J ECON ENTOMOL, V95, P1190, DOI 10.1603/0022-0493-95.6.1190; Ometto JPHB, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001462; Ozanne CMP, 2003, SCIENCE, V301, P183, DOI 10.1126/science.1084507; Perica S, 2001, J PLANT NUTR, V24, P779, DOI 10.1081/PLN-100103670; PERTERER J, 1990, FORSTWISS CENTRALBL, V109, P220, DOI 10.1007/BF02741637; Peters J, 2008, EUR J FOREST RES, V127, P293, DOI 10.1007/s10342-008-0205-y; Roux-Swarthout DL, 2001, PLANT SCI, V160, P563; Ryan MG, 2006, PLANT CELL ENVIRON, V29, P367, DOI 10.1111/j.1365-3040.2005.01478.x; Sabatier S, 1999, ANN BOT-LONDON, V84, P387, DOI 10.1006/anbo.1999.0939; SCHOETTLE AW, 1994, TREE PHYSIOL, V14, P1055, DOI 10.1093/treephys/14.7-8-9.1055; Schoettle AW, 1999, TREE PHYSIOL, V19, P13; SEIFTER S, 1950, P SOC EXP BIOL MED, V75, P46, DOI 10.3181/00379727-75-18095; Shi PL, 2006, BASIC APPL ECOL, V7, P370, DOI 10.1016/j.baae.2005.06.005; Suzuki M, 2003, ANN BOT-LONDON, V92, P339, DOI 10.1093/aob/mcg144; Takeuchi Y, 2001, PLANT CELL ENVIRON, V24, P1257, DOI 10.1046/j.0016-8025.2001.00787.x; Tateno R, 2002, ECOL RES, V17, P695, DOI 10.1046/j.1440-1703.2002.00526.x; Terwilliger VJ, 1997, AM J BOT, V84, P1693; VANHEES AFM, 1993, FOREST ECOL MANAG, V58, P19, DOI 10.1016/0378-1127(93)90128-A; Weiskittel AR, 2007, ANN FOREST SCI, V65, P103; Woodruff DR, 2007, PLANT CELL ENVIRON, V30, P559, DOI 10.1111/j.1365-3040.2007.01652.x; Wu Jing-Lian, 2009, Yingyong Shengtai Xuebao, V20, P235; Wurth MKR, 2005, OECOLOGIA, V143, P11, DOI 10.1007/s00442-004-1773-2; Wurth MKR, 1998, OECOLOGIA, V116, P18, DOI 10.1007/PL00013821; Xiao CW, 2006, TREES-STRUCT FUNCT, V20, P304, DOI 10.1007/s00468-005-0039-x; YODER BJ, 1994, FOREST SCI, V40, P513; Zha TS, 2002, NEW PHYTOL, V156, P33, DOI 10.1046/j.1469-8137.2002.00488.x	79	34	39	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2012	7	4							e35076	10.1371/journal.pone.0035076	http://dx.doi.org/10.1371/journal.pone.0035076			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JA	22493732	Green Published, Green Submitted, gold			2022-12-27	WOS:000305012700074
J	Xing, YZ; Samuvel, DJ; Stevens, SM; Dubno, JR; Schulte, BA; Lang, HN				Xing, Yazhi; Samuvel, Devadoss J.; Stevens, Shawn M.; Dubno, Judy R.; Schulte, Bradley A.; Lang, Hainan			Age-Related Changes of Myelin Basic Protein in Mouse and Human Auditory Nerve	PLOS ONE			English	Article							SPIRAL GANGLION NEURONS; PRODUCT OTOACOUSTIC EMISSIONS; HUMAN INNER-EAR; HUMAN COCHLEA; HEARING-LOSS; GLUTAMATE RECEPTORS; PERIPHERAL-NERVE; CORPUS-CALLOSUM; RHESUS-MONKEY; TEMPORAL BONE	Age-related hearing loss (presbyacusis) is the most common type of hearing impairment. One of the most consistent pathological changes seen in presbyacusis is the loss of spiral ganglion neurons (SGNs). Defining the cellular and molecular basis of SGN degeneration in the human inner ear is critical to gaining a better understanding of the pathophysiology of presbyacusis. However, information on age-related cellular and molecular alterations in the human spiral ganglion remains scant, owing to the very limited availably of human specimens suitable for high resolution morphological and molecular analysis. This study aimed at defining age-related alterations in the auditory nerve in human temporal bones and determining if immunostaining for myelin basic protein (MBP) can be used as an alternative approach to electron microscopy for evaluating myelin degeneration. For comparative purposes, we evaluated ultrastructural alternations and changes in MBP immunostaining in aging CBA/CaJ mice. We then examined 13 temporal bones from 10 human donors, including 4 adults aged 38-46 years (middle-aged group) and 6 adults aged 63-91 years (older group). Similar to the mouse, intense immunostaining of MBP was present throughout the auditory nerve of the middle-aged human donors. Significant declines in MBP immunoreactivity and losses of MBP+ auditory nerve fibers were observed in the spiral ganglia of both the older human and aged mouse ears. This study demonstrates that immunostaining for MBP in combination with confocal microscopy provides a sensitive, reliable, and efficient method for assessing alterations of myelin sheaths in the auditory nerve. The results also suggest that myelin degeneration may play a critical role in the SGN loss and the subsequent decline of the auditory nerve function in presbyacusis.	[Xing, Yazhi; Samuvel, Devadoss J.; Dubno, Judy R.; Schulte, Bradley A.; Lang, Hainan] Med Univ S Carolina, Dept Pathol & Lab Med, Charleston, SC 29425 USA; [Stevens, Shawn M.; Dubno, Judy R.; Schulte, Bradley A.] Med Univ S Carolina, Dept Otolaryngol Head & Neck Surg, Charleston, SC 29425 USA	Medical University of South Carolina; Medical University of South Carolina	Xing, YZ (corresponding author), Med Univ S Carolina, Dept Pathol & Lab Med, Charleston, SC 29425 USA.	langh@musc.edu	Xing, Yazhi/GVU-8191-2022; Xing, Yazhi/HDO-1842-2022	Lang, Hainan/0000-0003-2210-7856; Xing, Yazhi/0000-0001-8975-7242	National Institutes of Health (NIH) [NIH DC00422, NIH DC07506, DC00713]; South Carolina Clinical and Translational Research Institute (SCTR) [NIH/NCRR UL1RR029882]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000062] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029882] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC000713, R03DC007506, P01DC000422, P50DC000422] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); South Carolina Clinical and Translational Research Institute (SCTR); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by National Institutes of Health (NIH); Grant number: NIH DC00422 (HL, JRD, BAS); Grant number: NIH DC07506 (HL); Grant number: DC00713 (BAS); This work also benefitted from the South Carolina Clinical and Translational Research Institute (SCTR) Clinical and Translational Science Award (NIH/NCRR UL1RR029882). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNOLD W, 1987, ACTA OTO-LARYNGOL, P76; Bartzokis G, 2011, NEUROBIOL AGING, V32, P1341, DOI 10.1016/j.neurobiolaging.2009.08.007; BERGLUND AM, 1987, J COMP NEUROL, V255, P560, DOI 10.1002/cne.902550408; BLACK JA, 1982, BRAIN RES, V250, P1, DOI 10.1016/0006-8993(82)90948-9; Boggs JM, 2006, CELL MOL LIFE SCI, V63, P1945, DOI 10.1007/s00018-006-6094-7; Bowley MP, 2010, J COMP NEUROL, V518, P3046, DOI 10.1002/cne.22379; Braak H, 2004, NEUROBIOL AGING, V25, P19, DOI 10.1016/j.neurobiolaging.2003.04.001; CHAN KFJ, 1990, J NEUROSCI RES, V25, P535, DOI 10.1002/jnr.490250410; Conforti L, 2007, TRENDS NEUROSCI, V30, P159, DOI 10.1016/j.tins.2007.02.004; Cunningham CD, 2001, LARYNGOSCOPE, V111, P278, DOI 10.1097/00005537-200102000-00017; DOBROWOLSKI Z, 1986, EUR J CELL BIOL, V41, P65; DOBROWOLSKI Z, 1986, EUR J CELL BIOL, V42, P17; Driscoll M, 2003, NAT REV GENET, V4, P181, DOI 10.1038/nrg1018; El-Badry MM, 2007, EUR J NEUROSCI, V25, P1437, DOI 10.1111/j.1460-9568.2007.05401.x; Faddis BT, 1997, J NEUROCYTOL, V26, P625, DOI 10.1023/A:1018593710530; Fields RD, 2008, TRENDS NEUROSCI, V31, P361, DOI 10.1016/j.tins.2008.04.001; Gates GA, 2005, LANCET, V366, P1111, DOI 10.1016/S0140-6736(05)67423-5; GEREN BB, 1953, P NATL ACAD SCI USA, V39, P880, DOI 10.1073/pnas.39.8.880; Griffiths I, 1998, SCIENCE, V280, P1610, DOI 10.1126/science.280.5369.1610; Guimaraes P, 2004, HEARING RES, V192, P83, DOI 10.1016/j.heares.2004.01.013; Guipponi M, 2007, AM J PATHOL, V171, P608, DOI 10.2353/ajpath.2007.070068; Hansen MR, 2001, HEARING RES, V161, P87, DOI 10.1016/S0378-5955(01)00360-4; HENRY KR, 1980, AUDIOLOGY, V19, P369; Hequembourg S, 2001, JARO-J ASSOC RES OTO, V2, P118, DOI 10.1007/s101620010075; Hill CMD, 2005, BIOCHEMISTRY-US, V44, P16672, DOI 10.1021/bi050646+; HOEFFDING V, 1988, J COMP NEUROL, V276, P537, DOI 10.1002/cne.902760408; Hoopfer ED, 2006, NEURON, V50, P883, DOI 10.1016/j.neuron.2006.05.013; Hsu WJ, 1997, ORL J OTO-RHINO-LARY, V59, P258, DOI 10.1159/000276949; Ishiyama A, 2009, HEARING RES, V254, P1, DOI 10.1016/j.heares.2009.03.014; Jagger DJ, 2003, J PHYSIOL-LONDON, V552, P525, DOI 10.1111/j.1469-7793.2003.00525.x; Jimenez AM, 1999, HEARING RES, V138, P91, DOI 10.1016/S0378-5955(99)00154-9; JOHNSSON LG, 1974, ANN OTO RHINOL LARYN, V83, P294, DOI 10.1177/000348947408300303; Jyothi V, 2010, J COMP NEUROL, V518, P3254, DOI 10.1002/cne.22398; KEITHLEY EM, 1979, J COMP NEUROL, V188, P429, DOI 10.1002/cne.901880306; KEITHLEY EM, 1989, HEARING RES, V38, P125, DOI 10.1016/0378-5955(89)90134-2; Khalifa SAM, 2003, HEARING RES, V185, P35, DOI 10.1016/S0378-5955(03)00228-4; Knipper M, 1998, DEVELOPMENT, V125, P3709; Kujawa SG, 2006, J NEUROSCI, V26, P2115, DOI 10.1523/JNEUROSCI.4985-05.2006; Kujawa SG, 2009, J NEUROSCI, V29, P14077, DOI 10.1523/JNEUROSCI.2845-09.2009; Kusunoki T, 2004, OTOLARYNG HEAD NECK, V131, P897, DOI 10.1016/j.otohns.2004.05.022; Lang HN, 2010, JARO-J ASSOC RES OTO, V11, P419, DOI 10.1007/s10162-010-0214-7; Lang HN, 2006, J NEUROSCI, V26, P3541, DOI 10.1523/JNEUROSCI.2488-05.2006; LEE MK, 1994, CURR OPIN CELL BIOL, V6, P34, DOI 10.1016/0955-0674(94)90113-9; LI HS, 1991, ACTA OTO-LARYNGOL, V111, P827, DOI 10.3109/00016489109138418; Linthicum FH, 2009, OTOL NEUROTOL, V30, P418, DOI 10.1097/MAO.0b013e31819a8827; Liu W, 2011, CELL TISSUE RES, V345, P213, DOI 10.1007/s00441-011-1209-3; Liu W, 2010, CELL TISSUE RES, V342, P345, DOI 10.1007/s00441-010-1081-6; Liu W, 2009, HEARING RES, V250, P55, DOI 10.1016/j.heares.2009.01.010; Lopez I, 2005, J NEUROSCI METH, V145, P37, DOI 10.1016/j.jneumeth.2004.11.024; Lopez I, 2003, J NEUROSCI RES, V74, P666, DOI 10.1002/jnr.10813; Lopez IA, 2007, CELL TISSUE RES, V328, P453, DOI 10.1007/s00441-007-0380-z; Makary CA, 2011, JARO-J ASSOC RES OTO, V12, P711, DOI 10.1007/s10162-011-0283-2; Melcangi RC, 1998, NEUROSCIENCE, V85, P569, DOI 10.1016/S0306-4522(97)00628-3; Mills John H., 2006, Seminars in Hearing, V27, P228, DOI 10.1055/s-2006-954849; Mock B, 2011, JARO-J ASSOC RES OTO, V12, P173, DOI 10.1007/s10162-010-0247-y; Moscarello MA, 1997, ALTSCHUL SY, V4, P13; Nadol JB, 1996, OTOLARYNG HEAD NECK, V115, P298, DOI 10.1016/S0194-5998(96)70042-6; NADOL JB, 1990, HEARING RES, V49, P141, DOI 10.1016/0378-5955(90)90101-T; NADOL JB, 1979, OTOLARYNG HEAD NECK, V87, P818, DOI 10.1177/019459987908700617; Nave KA, 2008, ANNU REV NEUROSCI, V31, P535, DOI 10.1146/annurev.neuro.30.051606.094309; Nave KA, 2010, NAT REV NEUROSCI, V11, P275, DOI 10.1038/nrn2797; Newman TA, 2001, BRAIN, V124, P2203, DOI 10.1093/brain/124.11.2203; Ohlemiller KK, 2010, JARO-J ASSOC RES OTO, V11, P605, DOI 10.1007/s10162-010-0228-1; Ohlemiller KK, 2004, J COMP NEUROL, V479, P103, DOI 10.1002/cne.20326; OTA CY, 1980, ACTA OTO-LARYNGOL, V89, P53, DOI 10.3109/00016488009127108; Ouardouz M, 2009, ANN NEUROL, V65, P151, DOI 10.1002/ana.21533; Ouardouz M, 2009, ANN NEUROL, V65, P160, DOI 10.1002/ana.21539; PERKINS RE, 1975, J COMP NEUROL, V163, P129, DOI 10.1002/cne.901630202; Peters A, 2002, J COMP NEUROL, V442, P277, DOI 10.1002/cne.10099; Peters A, 1996, J COMP NEUROL, V371, P153, DOI 10.1002/(SICI)1096-9861(19960715)371:1<153::AID-CNE9>3.0.CO;2-2; Peters A, 2000, J COMP NEUROL, V419, P364, DOI 10.1002/(SICI)1096-9861(20000410)419:3<364::AID-CNE8>3.0.CO;2-R; Peters A, 2002, J NEUROCYTOL, V31, P581, DOI 10.1023/A:1025731309829; Pettingill LN, 2008, NEUROSCIENCE, V152, P821, DOI 10.1016/j.neuroscience.2007.11.057; Polverini E, 2004, J STRUCT BIOL, V148, P353, DOI 10.1016/j.jsb.2004.08.004; Prasad K, 1995, J BIOL CHEM, V270, P30551, DOI 10.1074/jbc.270.51.30551; Pun S, 2006, NAT NEUROSCI, V9, P408, DOI 10.1038/nn1653; Rask-Andersen H, 2000, HEARING RES, V141, P1, DOI 10.1016/S0378-5955(99)00179-3; Reid MA, 2004, J NEUROSCI, V24, P733, DOI 10.1523/JNEUROSCI.3923-03.2004; Robertson NG, 2006, HUM MOL GENET, V15, P1071, DOI 10.1093/hmg/ddl022; ROMAND MR, 1987, ACTA OTO-LARYNGOL, V104, P29, DOI 10.3109/00016488709109044; Romand R, 1984, ULTRASTRUCTURAL ATLA, P165; ROTH GA, 1993, NEUROCHEM INT, V23, P459, DOI 10.1016/0197-0186(93)90130-W; Sandell JH, 2001, J COMP NEUROL, V429, P541, DOI 10.1002/1096-9861(20010122)429:4<541::AID-CNE3>3.0.CO;2-5; Schiffmann R, 2004, CURR OPIN NEUROL, V17, P187, DOI 10.1097/00019052-200404000-00017; Schmiedt RA., 2009, SPRINGER HDB AUDITOR; SCHULNECHT H, 1968, Archives of Otolaryngology, V87, P129; Sekerkova G, 2008, J COMP NEUROL, V509, P661, DOI 10.1002/cne.21755; Sha SH, 2008, HEARING RES, V243, P87, DOI 10.1016/j.heares.2008.06.001; SPOENDLIN H, 1972, ACTA OTO-LARYNGOL, V73, P235, DOI 10.3109/00016487209138937; STORER JB, 1966, J GERONTOL, V21, P404, DOI 10.1093/geronj/21.3.404; Suter U, 2003, NAT REV NEUROSCI, V4, P714, DOI 10.1038/nrn1196; Trapp BD, 2008, ANNU REV NEUROSCI, V31, P247, DOI 10.1146/annurev.neuro.30.051606.094313; Tylstedt S, 1997, ACTA OTO-LARYNGOL, V117, P505, DOI 10.3109/00016489709113429; UCHIDA Y, 1986, J NEUROCHEM, V46, P1376, DOI 10.1111/j.1471-4159.1986.tb01750.x; Varghese GI, 2005, HEARING RES, V209, P60, DOI 10.1016/j.heares.2005.06.006; Verdu E, 2000, J PERIPHER NERV SYST, V5, P191, DOI 10.1046/j.1529-8027.2000.00026.x; Wang DS, 2004, NEUROSCI RES, V48, P93, DOI 10.1016/j.neures.2003.10.002; Wang SJ, 2009, J NEUROSCI RES, V87, P3428, DOI 10.1002/jnr.22164; Wang Y, 2005, J NEUROL SCI, V232, P59, DOI 10.1016/j.jns.2005.01.016; Weber PC, 2001, LARYNGOSCOPE, V111, P1156, DOI 10.1097/00005537-200107000-00006; Weisz C, 2009, NATURE, V461, P1126, DOI 10.1038/nature08487; Wise AK, 2005, J COMP NEUROL, V487, P147, DOI 10.1002/cne.20563; Wu T, 2003, JARO-J ASSOC RES OTO, V4, P353, DOI 10.1007/s10162-002-3026-6; Yin XH, 1998, J NEUROSCI, V18, P1953, DOI 10.1523/jneurosci.18-06-01953.1998; Zheng QY, 1999, HEARING RES, V130, P94, DOI 10.1016/S0378-5955(99)00003-9; ZHOU RZ, 1995, HEARING RES, V88, P87, DOI 10.1016/0378-5955(95)00104-C; ZHOU RZ, 1995, HEARING RES, V88, P98, DOI 10.1016/0378-5955(95)00105-D	107	54	55	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2012	7	4							e34500	10.1371/journal.pone.0034500	http://dx.doi.org/10.1371/journal.pone.0034500			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955IH	22496821	Green Submitted, Green Published, gold			2022-12-27	WOS:000305010500015
J	Yang, YL; Lin, CC; Chang, TP; Lauderdale, TL; Chen, HT; Lee, CF; Hsieh, CW; Chen, PC; Lo, HJ				Yang, Yun-Liang; Lin, Chih-Chao; Chang, Te-Pin; Lauderdale, Tsai-Ling; Chen, Hui-Ting; Lee, Ching-Fu; Hsieh, Chih-Wen; Chen, Pei-Chen; Lo, Hsiu-Jung			Comparison of Human and Soil Candida tropicalis Isolates with Reduced Susceptibility to Fluconazole	PLOS ONE			English	Article							AMPHOTERICIN-B; DRUG-RESISTANCE; ANTIFUNGAL SUSCEPTIBILITY; ASPERGILLUS-FUMIGATUS; SURVEILLANCE PROGRAM; GENETIC RELATEDNESS; AZOLE RESISTANCE; TRAILING GROWTH; NORTH-AMERICA; TAIWAN	Infections caused by treatment-resistant non-albicans Candida species, such as C. tropicalis, has increased, which is an emerging challenge in the management of fungal infections. Genetically related diploid sequence type (DST) strains of C. tropicalis exhibiting reduced susceptibility to fluconazole circulated widely in Taiwan. To identify the potential source of these wildly distributed DST strains, we investigated the possibility of the presence in soil of such C. tropicalis strains by pulsed field gel electrophoresis (PFGE) and DST typing methods. A total of 56 C. tropicalis isolates were recovered from 26 out of 477 soil samples. Among the 18 isolates with reduced susceptibility to fluconazole, 9 belonged to DST149 and 3 belonged to DST140. Both DSTs have been recovered from our previous studies on clinical isolates from the Taiwan Surveillance of Antimicrobial Resistance of Yeasts (TSARY) program. Furthermore, these isolates were more resistant to agricultural azoles. We have found genetically related C. tropicalis exhibiting reduced susceptibility to fluconazole from the human hosts and environmental samples. Therefore, to prevent patients from acquiring C. tropicalis with reduced susceptibility to azoles, prudent use of azoles in both clinical and agricultural settings is advocated.	[Yang, Yun-Liang] Natl Chiao Tung Univ, Dept Biol Sci & Technol, Hsinchu, Taiwan; [Yang, Yun-Liang; Chen, Hui-Ting] Natl Chiao Tung Univ, Inst Mol Med & Bioengn, Hsinchu, Taiwan; [Lin, Chih-Chao; Chang, Te-Pin; Lauderdale, Tsai-Ling; Chen, Hui-Ting; Chen, Pei-Chen; Lo, Hsiu-Jung] Natl Hlth Res Inst, Natl Inst Infect Dis & Vaccinol, Miaoli, Taiwan; [Lee, Ching-Fu; Hsieh, Chih-Wen] Natl Hsinchu Univ Educ, Dept Appl Sci, Hsinchu, Taiwan; [Lo, Hsiu-Jung] China Med Univ, Sch Dent, Taichung, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Health Research Institutes - Taiwan; National Tsing Hua University; China Medical University Taiwan	Yang, YL (corresponding author), Natl Chiao Tung Univ, Dept Biol Sci & Technol, Hsinchu, Taiwan.	hjlo@nhri.org.tw	Lauderdale, Tsai-Ling/B-2660-2010; Lo, Hsiu-Jung/B-2658-2010		National Health Research Institutes [99A1-ID-PP-04-014, 00A 1-ID-PP-04-014]; National Science Council in Taiwan [NSC 99-2320-B-400-006-MY3, NSC 99-2320-B-009-001-MY3]	National Health Research Institutes(National Health Research Institutes, Japan); National Science Council in Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by 99A1-ID-PP-04-014 and 00A 1-ID-PP-04-014 from National Health Research Institutes and NSC 99-2320-B-400-006-MY3 and NSC 99-2320-B-009-001-MY3 from National Science Council in Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akins RA, 2005, MED MYCOL, V43, P285, DOI 10.1080/13693780500138971; Arthington-Skaggs BA, 2002, ANTIMICROB AGENTS CH, V46, P2477, DOI 10.1128/AAC.46.8.2477-2481.2002; Barchiesi F, 2000, ANTIMICROB AGENTS CH, V44, P1578, DOI 10.1128/AAC.44.6.1578-1584.2000; Bard M, 1996, P NATL ACAD SCI USA, V93, P186, DOI 10.1073/pnas.93.1.186; BECKSAGUE CM, 1993, J INFECT DIS, V167, P1247, DOI 10.1093/infdis/167.5.1247; Calvet HM, 1997, ANTIMICROB AGENTS CH, V41, P535, DOI 10.1128/AAC.41.3.535; Chai LYA, 2010, CRIT REV MICROBIOL, V36, P282, DOI 10.3109/1040841X.2010.489506; Chen Feng-Jui, 2003, Journal of Microbiology Immunology and Infection, V36, P1; Chen KW, 2005, J MED MICROBIOL, V54, P249, DOI 10.1099/jmm.0.45829-0; Cheng MF, 2004, DIAGN MICR INFEC DIS, V48, P33, DOI 10.1016/j.diagmicrobio.2003.08.002; Chou HH, 2007, DIAGN MICR INFEC DIS, V58, P427, DOI 10.1016/j.diagmicrobio.2007.03.014; CLSI, 2008, M27A3 CLSI; Cowen LE, 2001, FEMS MICROBIOL LETT, V204, P1, DOI 10.1111/j.1574-6968.2001.tb10853.x; Cowen LE, 2000, J BACTERIOL, V182, P1515, DOI 10.1128/JB.182.6.1515-1522.2000; Hung CC, 2005, J CLIN MICROBIOL, V43, P1600, DOI 10.1128/JCM.43.4.1600-1603.2005; Iatta R, 2011, J CHEMOTHERAPY, V23, P92, DOI 10.1179/joc.2011.23.2.92; Lee CF, 2009, ANTON LEEUW INT J G, V95, P335, DOI 10.1007/s10482-009-9319-6; Lee MK, 2004, J ANTIMICROB CHEMOTH, V53, P217, DOI 10.1093/jac/dkh040; Li SY, 2009, MICROB DRUG RESIST, V15, P205, DOI 10.1089/mdr.2009.0915; Lo Hsiu-Jung, 2001, Journal of Microbiology Immunology and Infection, V34, P171; Lord ATK, 2010, ANN CLIN MICROB ANTI, V9, DOI 10.1186/1476-0711-9-11; McDonald LC, 2001, ANTIMICROB AGENTS CH, V45, P3084, DOI 10.1128/AAC.45.11.3084-3091.2001; Muller FMC, 2007, ANTIMICROB AGENTS CH, V51, P3014, DOI 10.1128/AAC.00459-07; Pfaller MA, 2008, J CLIN MICROBIOL, V46, P150, DOI 10.1128/JCM.01901-07; Pfaller MA, 2007, CLIN MICROBIOL REV, V20, P133, DOI 10.1128/CMR.00029-06; Pfaller MA, 2006, J CLIN MICROBIOL, V44, P3551, DOI 10.1128/JCM.00865-06; Pfaller MA, 2000, ANTIMICROB AGENTS CH, V44, P747, DOI 10.1128/AAC.44.3.747-751.2000; Pfaller MA, 2011, J CLIN MICROBIOL, V49, P396, DOI 10.1128/JCM.01398-10; Pfaller MA, 2010, CRIT REV MICROBIOL, V36, P1, DOI 10.3109/10408410903241444; Prasad KN, 1999, INDIAN J MED RES, V110, P11; Snelders E, 2008, PLOS MED, V5, P1629, DOI 10.1371/journal.pmed.0050219; Snelders E, 2009, APPL ENVIRON MICROB, V75, P4053, DOI 10.1128/AEM.00231-09; Verweij PE, 2009, LANCET INFECT DIS, V9, P789, DOI 10.1016/S1473-3099(09)70265-8; Vogel C, 2007, WATER RES, V41, P1915, DOI 10.1016/j.watres.2007.02.010; Wang JS, 2007, J MED MICROBIOL, V56, P650, DOI 10.1099/jmm.0.46664-0; Warnock David W, 2007, Nihon Ishinkin Gakkai Zasshi, V48, P1, DOI 10.3314/jjmm.48.1; White TC, 1998, CLIN MICROBIOL REV, V11, P382, DOI 10.1128/CMR.11.2.382; Xess I, 2007, INFECTION, V35, P256, DOI 10.1007/s15010-007-6144-6; Yang YL, 2010, MED MYCOL, V48, P328, DOI 10.3109/13693780903154070; Yang YL, 2004, INT J ANTIMICROB AG, V24, P294, DOI 10.1016/j.ijantimicag.2004.01.014; Yang YL, 2004, INFECT CONT HOSP EP, V25, P60, DOI 10.1086/502294; Yang YL, 2008, DIAGN MICR INFEC DIS, V61, P175, DOI 10.1016/j.diagmicrobio.2008.01.011; Yang Yun-Liang, 2004, Current Drug Targets - Infectious Disorders, V4, P295, DOI 10.2174/1568005043340623; Yang Yun-Liang, 2001, Journal of Microbiology Immunology and Infection, V34, P79	44	42	43	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2012	7	4							e34609	10.1371/journal.pone.0034609	http://dx.doi.org/10.1371/journal.pone.0034609			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955IH	22496832	Green Submitted, Green Published, gold			2022-12-27	WOS:000305010500020
J	Chintapalli, VR; Terhzaz, S; Wang, J; Al Bratty, M; Watson, DG; Herzyk, P; Davies, SA; Dow, JAT				Chintapalli, Venkateswara R.; Terhzaz, Selim; Wang, Jing; Al Bratty, Mohammed; Watson, David G.; Herzyk, Pawel; Davies, Shireen A.; Dow, Julian A. T.			Functional Correlates of Positional and Gender-Specific Renal Asymmetry in Drosophila	PLOS ONE			English	Article							VITELLIFORM MACULAR DYSTROPHY; NEUROPEPTIDE-F RECEPTOR; MULTIPOTENT STEM-CELLS; MALPIGHIAN TUBULES; OXIDATIVE STRESS; FLUID SECRETION; SITUS-INVERSUS; MELANOGASTER; CALCIUM; SEX	Background: In humans and other animals, the internal organs are positioned asymmetrically in the body cavity, and disruption of this body plan can be fatal in humans. The mechanisms by which internal asymmetry are established are presently the subject of intense study; however, the functional significance of internal asymmetry (outside the brain) is largely unexplored. Is internal asymmetry functionally significant, or merely an expedient way of packing organs into a cavity? Methodology/Principal Findings: Like humans, Drosophila shows internal asymmetry, with the gut thrown into stereotyped folds. There is also renal asymmetry, with the rightmost pair of renal (Malpighian) tubules always ramifying anteriorly, and the leftmost pair always sitting posteriorly in the body cavity. Accordingly, transcriptomes of anterior-directed (right-side) and posterior-directed (left-side) Malpighian (renal) tubules were compared in both adult male and female Drosophila. Although genes encoding the basic functions of the tubules (transport, signalling) were uniformly expressed, some functions (like innate immunity) showed positional or gender differences in emphasis; others, like calcium handling or the generation of potentially toxic ammonia, were reserved for just the right-side or left-side tubules, respectively. These findings correlated with the distinct locations of each tubule pair within the body cavity. Well known developmental genes (like dorsocross, dachshund and doublesex) showed continuing, patterned expression in adult tubules, implying that somatic tissues maintain both left-right and gender identities throughout life. Gender asymmetry was also noted, both in defence and in male-specific expression of receptors for neuropeptide F and sex-peptide: NPF elevated calcium only in male tubules. Conclusions/Significance: Accordingly, the physical asymmetry of the tubules in the body cavity is directly adaptive. Now that the detailed machinery underlying internal asymmetry is starting to be delineated, our work invites the investigation, not just of tissues in isolation, but in the context of their unique physical locations and milieux.	[Chintapalli, Venkateswara R.; Terhzaz, Selim; Wang, Jing; Herzyk, Pawel; Davies, Shireen A.; Dow, Julian A. T.] Univ Glasgow, Coll Med Vet & Life Sci, Inst Mol Cell & Syst Biol, Glasgow, Lanark, Scotland; [Al Bratty, Mohammed; Watson, David G.] Strathclyde Inst Pharm & Biomed Sci, Glasgow, Lanark, Scotland	University of Glasgow; University of Strathclyde	Chintapalli, VR (corresponding author), Univ Glasgow, Coll Med Vet & Life Sci, Inst Mol Cell & Syst Biol, Glasgow, Lanark, Scotland.	julian.dow@glasgow.ac.uk	Albratty, Mohammed/AHD-1350-2022; Dow, Julian/M-2371-2019	Dow, Julian/0000-0002-9595-5146; Terhzaz, Selim/0000-0002-6192-6558	United Kingdom (UK) Biotechnology and Biological Sciences Research Council (BBSRC); Universities of Glasgow and Strathclyde; Biotechnology and Biological Sciences Research Council [BB/F010397/1] Funding Source: researchfish; BBSRC [BB/F010397/1] Funding Source: UKRI	United Kingdom (UK) Biotechnology and Biological Sciences Research Council (BBSRC); Universities of Glasgow and Strathclyde; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by the United Kingdom (UK) Biotechnology and Biological Sciences Research Council (BBSRC) and by general funds of the Universities of Glasgow and Strathclyde. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldehni F, 2009, J AM SOC NEPHROL, V20, P1556, DOI 10.1681/ASN.2008090987; Allan AK, 2005, PHYSIOL GENOMICS, V22, P128, DOI 10.1152/physiolgenomics.00233.2004; Beyenbach KW, 2010, ANNU REV ENTOMOL, V55, P351, DOI 10.1146/annurev-ento-112408-085512; Broderick KE, 2003, AM J PHYSIOL-CELL PH, V285, pC1207, DOI 10.1152/ajpcell.00123.2003; Broeck JV, 2001, PEPTIDES, V22, P241, DOI 10.1016/S0196-9781(00)00376-4; Burn SF, 2009, BIOESSAYS, V31, P1026, DOI 10.1002/bies.200900056; Button D, 1996, MOL BIOL CELL, V7, P419, DOI 10.1091/mbc.7.3.419; Caldwell GM, 1999, GENOMICS, V58, P98, DOI 10.1006/geno.1999.5808; Chahine S, 2011, J EXP BIOL, V214, P462, DOI 10.1242/jeb.048884; Chahine S, 2010, ARCH INSECT BIOCHEM, V73, P128, DOI 10.1002/arch.20346; Chahine S, 2009, J INSECT PHYSIOL, V55, P927, DOI 10.1016/j.jinsphys.2009.06.005; Chapman R.F, 2012, INSECTS STRUCTURE FU, V5th; Chen YH, 2011, KIDNEY INT, V80, P369, DOI 10.1038/ki.2011.80; Chien LT, 2007, J GEN PHYSIOL, V130, P513, DOI 10.1085/jgp.200709795; Chintapalli VR, 2007, NAT GENET, V39, P715, DOI 10.1038/ng2049; Coast GM, 2009, J EXP BIOL, V212, P378, DOI 10.1242/jeb.024109; Coast GM, 2005, ANN NY ACAD SCI, V1040, P1, DOI 10.1196/annals.1327.001; Coast GM, 2001, J EXP BIOL, V204, P1795; Coutelis JB, 2008, SEMIN CELL DEV BIOL, V19, P252, DOI 10.1016/j.semcdb.2008.01.006; Davies SA, 1995, AM J PHYSIOL-REG I, V269, pR1321, DOI 10.1152/ajpregu.1995.269.6.R1321; Dow JAT, 2003, PHYSIOL REV, V83, P687, DOI 10.1152/physrev.00035.2002; DOW JAT, 1994, J EXP BIOL, V197, P421; Dow JAT, 2010, AM J PHYSIOL-RENAL, V299, pF1237, DOI 10.1152/ajprenal.00521.2010; Dow JAT, 2009, J EXP BIOL, V212, P435, DOI 10.1242/jeb.024224; Drago I, 2008, J BIOL CHEM, V283, P14384, DOI 10.1074/jbc.M800600200; Drake LL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015578; Dube K, 2000, J INSECT PHYSIOL, V46, P1449, DOI 10.1016/S0022-1910(00)00069-X; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Evans JM, 2005, J EXP BIOL, V208, P3771, DOI 10.1242/jeb.01829; Feng GP, 2003, EUR J NEUROSCI, V18, P227, DOI 10.1046/j.1460-9568.2003.02719.x; Fujii S, 2002, EMBO J, V21, P5353, DOI 10.1093/emboj/cdf556; Garczynski SF, 2002, PEPTIDES, V23, P773, DOI 10.1016/S0196-9781(01)00647-7; Hatton-Ellis E, 2007, P NATL ACAD SCI USA, V104, P169, DOI 10.1073/pnas.0606933104; Hewes RS, 2001, GENOME RES, V11, P1126, DOI 10.1101/gr.169901; Hofmann T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010519; Huang YQ, 2011, PEPTIDES, V32, P483, DOI 10.1016/j.peptides.2010.09.014; Iliadi KG, 2008, P NATL ACAD SCI USA, V105, P19986, DOI 10.1073/pnas.0810698105; Johnson EC, 2003, J BIOL CHEM, V278, P52172, DOI 10.1074/jbc.M306756200; Kahsai L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011480; Kamleh MA, 2008, FEBS LETT, V582, P2916, DOI 10.1016/j.febslet.2008.07.029; Kamleh MA, 2009, FEBS LETT IN PRESS; KARTAGENER M, 1962, ARCH PEDIATR, V79, P193; Kaufmann N, 2005, AM J PHYSIOL-CELL PH, V289, pC397, DOI 10.1152/ajpcell.00612.2004; Kim YJ, 2010, P NATL ACAD SCI USA, V107, P6520, DOI 10.1073/pnas.0914764107; Lee GH, 2006, P NATL ACAD SCI USA, V103, P12580, DOI 10.1073/pnas.0601171103; Lee KS, 2004, J BIOL CHEM, V279, P50781, DOI 10.1074/jbc.M407842200; Levin M, 2007, BIOESSAYS, V29, P271, DOI 10.1002/bies.20545; Lopez-Gracia ML, 2007, ADV ANAT EMBRYOL CEL, V188, P1; MacPherson MR, 2001, AM J PHYSIOL-CELL PH, V280, pC394, DOI 10.1152/ajpcell.2001.280.2.C394; Marmorstein AD, 2000, P NATL ACAD SCI USA, V97, P12758, DOI 10.1073/pnas.220402097; Marquez J, 2006, NEUROCHEM INT, V48, P465, DOI 10.1016/j.neuint.2005.10.015; McGettigan J, 2005, INSECT BIOCHEM MOLEC, V35, P741, DOI 10.1016/j.ibmb.2005.02.017; Mellroth P, 2006, BIOCHEM BIOPH RES CO, V350, P994, DOI 10.1016/j.bbrc.2006.09.139; Mertens I, 2002, BIOCHEM BIOPH RES CO, V297, P1140, DOI 10.1016/S0006-291X(02)02351-3; Metaxakis A, 2005, GENETICS, V171, P571, DOI 10.1534/genetics.105.041848; Nassel DR, 2011, PEPTIDES, V32, P1335, DOI 10.1016/j.peptides.2011.03.013; O'Donnell MJ, 1998, AM J PHYSIOL-REG I, V274, pR1039, DOI 10.1152/ajpregu.1998.274.4.R1039; ODonnell MJ, 1996, J EXP BIOL, V199, P1163; Overend G, 2011, PEPTIDES; Pifferi S, 2006, P NATL ACAD SCI USA, V103, P12929, DOI 10.1073/pnas.0604505103; Reim I, 2005, DEVELOPMENT, V132, P4911, DOI 10.1242/dev.02077; Rosay P, 1997, J CELL SCI, V110, P1683; Secca T, 2011, J INSECT PHYSIOL, V57, P521, DOI 10.1016/j.jinsphys.2011.02.002; Sharma N, 2008, CURR TOP DEV BIOL, V85, P371, DOI 10.1016/S0070-2153(08)00813-2; Singh SR, 2008, J AM SOC NEPHROL, V19, P660, DOI 10.1681/ASN.2007121307; Singh SR, 2007, CELL STEM CELL, V1, P191, DOI 10.1016/j.stem.2007.07.003; Singh SR, 2009, J EXP BIOL, V212, P413, DOI 10.1242/jeb.024216; Soderberg JAE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019866; Southall TD, 2006, PHYSIOL GENOMICS, V26, P35, DOI 10.1152/physiolgenomics.00038.2006; Sozen MA, 1997, P NATL ACAD SCI USA, V94, P5207, DOI 10.1073/pnas.94.10.5207; Stergiopoulos K, 2008, PHYSL GENOMICS; Sutherland MJ, 2009, AM J MED GENET C, V151C, P307, DOI 10.1002/ajmg.c.30228; Terhzaz S, 1999, J EXP BIOL, V202, P3667; Terhzaz S, 2010, CELL SIGNAL, V22, P737, DOI 10.1016/j.cellsig.2009.12.009; Terhzaz S, 2010, PHYSIOL GENOMICS, V41, P33, DOI 10.1152/physiolgenomics.00147.2009; Torrie LS, 2004, P NATL ACAD SCI USA, V101, P13689, DOI 10.1073/pnas.0403087101; Tzou P, 2002, CURR OPIN MICROBIOL, V5, P102, DOI 10.1016/S1369-5274(02)00294-1; Veenstra JA, 2009, CELL TISSUE RES, V336, P309, DOI 10.1007/s00441-009-0769-y; Wang J, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r69; Wen TQ, 2005, P NATL ACAD SCI USA, V102, P2141, DOI 10.1073/pnas.0406814102; Wessing A, 1999, J INSECT PHYSIOL, V45, P39, DOI 10.1016/S0022-1910(98)00097-3; Wheat CW, 2007, P NATL ACAD SCI USA, V104, P20427, DOI 10.1073/pnas.0706229104; Winterhalter WE, 2009, P ROY SOC B-BIOL SCI, V276, P1109, DOI 10.1098/rspb.2008.1559; Wolfner MF, 2003, CURR BIOL, V13, pR101, DOI 10.1016/S0960-9822(03)00038-1; Wu Q, 2003, NEURON, V39, P147, DOI 10.1016/S0896-6273(03)00396-9; Yang J, 2007, PHYSIOL GENOMICS, V30, P223, DOI 10.1152/physiolgenomics.00018.2007; Yapici N, 2008, NATURE, V451, P33, DOI 10.1038/nature06483; Zeng XK, 2010, J CELL PHYSIOL, V224, P766, DOI 10.1002/jcp.22179	88	42	42	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e32577	10.1371/journal.pone.0032577	http://dx.doi.org/10.1371/journal.pone.0032577			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GO	22496733	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000304855200004
J	Corti, A; Franzini, M; Cianchetti, S; Bergamini, G; Lorenzini, E; Melotti, P; Paolicchi, A; Paggiaro, P; Pompella, A				Corti, Alessandro; Franzini, Maria; Cianchetti, Silvana; Bergamini, Gabriella; Lorenzini, Evelina; Melotti, Paola; Paolicchi, Aldo; Paggiaro, Pierluigi; Pompella, Alfonso			Contribution by Polymorphonucleate Granulocytes to Elevated Gamma-Glutamyltransferase in Cystic Fibrosis Sputum	PLOS ONE			English	Article							HUMAN NEUTROPHILS; OXIDATIVE STRESS; CELL LINES; TRANSPEPTIDASE; GLUTATHIONE; CFTR; INFLAMMATION; TRANSPORT	Background: Cystic fibrosis (CF) is an autosomal recessive disorder characterized by a chronic neutrophilic airways inflammation, increasing levels of oxidative stress and reduced levels of antioxidants such as glutathione (GSH). Gammaglutamyltransferase (GGT), an enzyme induced by oxidative stress and involved in the catabolism of GSH and its derivatives, is increased in the airways of CF patients with inflammation, but the possible implications of its increase have not yet been investigated in detail. Principal Findings: The present study was aimed to evaluate the origin and the biochemical characteristics of the GGT detectable in CF sputum. We found GGT activity both in neutrophils and in the fluid, the latter significantly correlating with myeloperoxidase expression. In neutrophils, GGT was associated with intracellular granules. In the fluid, gel-filtration chromatography showed the presence of two distinct GGT fractions, the first corresponding to the human plasma b-GGT fraction, the other to the free enzyme. The same fractions were also observed in the supernatant of ionomycin and fMLP-activated neutrophils. Western blot analysis confirmed the presence of a single band of GGT immunoreactive peptide in the CF sputum samples and in isolated neutrophils. Conclusions: In conclusion, our data indicate that neutrophils are able to transport and release GGT, thus increasing GGT activity in CF sputum. The prompt release of GGT may have consequences on all GGT substrates, including major inflammatory mediators such as S-nitrosoglutathione and leukotrienes, and could participate in early modulation of inflammatory response.	[Corti, Alessandro; Lorenzini, Evelina; Paolicchi, Aldo; Pompella, Alfonso] Univ Pisa, Scuola Med, Dipartimento Patol Sperimentale, Pisa, Italy; [Franzini, Maria] Scuola Super Sant Anna, Pisa, Italy; [Franzini, Maria; Paolicchi, Aldo] CNR, Fdn Toscana G Monasterio, I-56100 Pisa, Regione Toscana, Italy; [Cianchetti, Silvana; Paggiaro, Pierluigi] Univ Pisa, Dipartimento Cardio Torac & Vasc, Pisa, Italy; [Bergamini, Gabriella; Melotti, Paola] Azienda Osped Verona, Ctr Fibrosi Cist, Verona, Italy; [Bergamini, Gabriella] Univ Verona, Dipartimento Patol & Diagnost, I-37100 Verona, Italy	University of Pisa; Scuola Superiore Sant'Anna; Consiglio Nazionale delle Ricerche (CNR); University of Pisa; University of Verona; Azienda Ospedaliera Universitaria Integrata Verona; University of Verona	Corti, A (corresponding author), Univ Pisa, Scuola Med, Dipartimento Patol Sperimentale, Pisa, Italy.	alessandro.corti@med.unipi.it	Paolicchi, Aldo/K-3946-2018; Franzini, Maria/L-5650-2013; Melotti, Paola/J-6205-2018; Pompella, Alfonso/G-6785-2012	Paolicchi, Aldo/0000-0002-9940-8481; Franzini, Maria/0000-0001-9496-9370; Melotti, Paola/0000-0002-5276-1595; Pompella, Alfonso/0000-0002-6435-9325	Fondazione per la Ricerca sulla Fibrosi Cistica-Onlus (Verona, Italy) [22/2009]	Fondazione per la Ricerca sulla Fibrosi Cistica-Onlus (Verona, Italy)	The present study was supported by a grant from Fondazione per la Ricerca sulla Fibrosi Cistica-Onlus (Verona, Italy; Project FFC#22/2009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergamini G, 2009, AM J RESP CELL MOL, V41, P199, DOI 10.1165/rcmb.2008-0013OC; BROM J, 1984, IMMUNOLOGY, V51, P571; Cantin AM, 2007, FREE RADICAL BIO MED, V42, P15, DOI 10.1016/j.freeradbiomed.2006.09.022; Cianchetti S, 2004, EUR RESPIR J, V24, P1018, DOI 10.1183/09031936.04.00139503; Cocucci E, 2009, TRENDS CELL BIOL, V19, P43, DOI 10.1016/j.tcb.2008.11.003; Corti A, 2005, ANTIOXID REDOX SIGN, V7, P911, DOI 10.1089/ars.2005.7.911; Corti A, 2010, ANTICANCER RES, V30, P1169; Elizur A, 2008, CHEST, V133, P489, DOI 10.1378/chest.07-1631; EVJEN G, 1992, CLIN CHIM ACTA, V209, P27, DOI 10.1016/0009-8981(92)90330-S; Franzini M, 2008, CLIN CHIM ACTA, V395, P188, DOI 10.1016/j.cca.2008.06.005; Franzini M, 2008, ANAL BIOCHEM, V374, P1, DOI 10.1016/j.ab.2007.10.025; Gao L, 1999, AM J PHYSIOL-LUNG C, V277, pL113, DOI 10.1152/ajplung.1999.277.1.L113; Gasser O, 2004, BLOOD, V104, P2543, DOI 10.1182/blood-2004-01-0361; GIARD DJ, 1973, J NATL CANCER I, V51, P1417, DOI 10.1093/jnci/51.5.1417; Hanigan MH, 1996, J HISTOCHEM CYTOCHEM, V44, P1101, DOI 10.1177/44.10.8813074; Hess C, 1999, J IMMUNOL, V163, P4564; Hogg N, 1997, BIOCHEM J, V323, P477, DOI 10.1042/bj3230477; Hudson VM, 2001, FREE RADICAL BIO MED, V30, P1440, DOI 10.1016/S0891-5849(01)00530-5; Hull J, 1997, THORAX, V52, P557, DOI 10.1136/thx.52.6.557; HUSEBY NE, 1974, SCAND J CLIN LAB INV, V34, P357, DOI 10.3109/00365517409049892; Hybertson BM, 2000, INFLAMMATION, V24, P289, DOI 10.1023/A:1007092529261; JOYCEBRADY M, 1994, J BIOL CHEM, V269, P14219; Karp DR, 1999, INT IMMUNOL, V11, P1791, DOI 10.1093/intimm/11.11.1791; KHALAF MR, 1987, HISTOCHEM J, V19, P385, DOI 10.1007/BF01680457; Kjeldsen L, 1999, J IMMUNOL METHODS, V232, P131, DOI 10.1016/S0022-1759(99)00171-4; Klebanoff SJ, 2005, J LEUKOCYTE BIOL, V77, P598, DOI 10.1189/jlb.1204697; KOLLER DY, 1995, AM J RESP CRIT CARE, V152, P629, DOI 10.1164/ajrccm.152.2.7633718; KUGELMAN A, 1994, AM J RESP CELL MOL, V11, P586, DOI 10.1165/ajrcmb.11.5.7946387; Linsdell P, 1998, AM J PHYSIOL-CELL PH, V275, pC323, DOI 10.1152/ajpcell.1998.275.1.C323; MORELL A, 1986, AM J HEMATOL, V21, P289, DOI 10.1002/ajh.2830210308; Paolicchi A, 2004, CIRCULATION, V109, P1440, DOI 10.1161/01.CIR.0000120558.41356.E6; Perez-Vilar J, 2004, FREE RADICAL BIO MED, V37, P1564, DOI 10.1016/j.freeradbiomed.2004.07.027; RAULF M, 1985, IMMUNOLOGY, V55, P135; ROUM JH, 1993, J APPL PHYSIOL, V75, P2419, DOI 10.1152/jappl.1993.75.6.2419; Rubin BK, 2007, PAEDIATR RESPIR REV, V8, P4, DOI 10.1016/j.prrv.2007.02.004; vanKlaveren RJ, 1997, FREE RADICAL BIO MED, V22, P525, DOI 10.1016/S0891-5849(96)00375-9; Witko-Sarsat V, 1999, MEDIAT INFLAMM, V8, P7, DOI 10.1080/09629359990658; ZEITLIN PL, 1991, AM J RESP CELL MOL, V4, P313, DOI 10.1165/ajrcmb/4.4.313	38	27	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e34772	10.1371/journal.pone.0034772	http://dx.doi.org/10.1371/journal.pone.0034772			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GO	22496859	Green Published, gold, Green Submitted			2022-12-27	WOS:000304855200080
J	Umezawa, T; Kato, A; Ogoshi, M; Ookata, K; Munakata, K; Yamamoto, Y; Islam, Z; Doi, H; Romero, MF; Hirose, S				Umezawa, Takahiro; Kato, Akira; Ogoshi, Maho; Ookata, Kayoko; Munakata, Keijiro; Yamamoto, Yoko; Islam, Zinia; Doi, Hiroyuki; Romero, Michael F.; Hirose, Shigehisa			O-2-Filled Swimbladder Employs Monocarboxylate Transporters for the Generation of O-2 by Lactate-Induced Root Effect Hemoglobin	PLOS ONE			English	Article							RETE-MIRABILE; MOLECULAR CHARACTERIZATION; PHENOTYPIC HETEROGENEITY; STRUCTURAL BASIS; LACTIC-ACID; EEL; SECRETION; FISH; ULTRASTRUCTURE; COTRANSPORTER	The swimbladder volume is regulated by O-2 transfer between the luminal space and the blood In the swimbladder, lactic acid generation by anaerobic glycolysis in the gas gland epithelial cells and its recycling through the rete mirabile bundles of countercurrent capillaries are essential for local blood acidification and oxygen liberation from hemoglobin by the "Root effect." While O-2 generation is critical for fish flotation, the molecular mechanism of the secretion and recycling of lactic acid in this critical process is not clear. To clarify molecules that are involved in the blood acidification and visualize the route of lactic acid movement, we analyzed the expression of 17 members of the H+/monocarboxylate transporter (MCT) family in the fugu genome and found that only MCT1b and MCT4b are highly expressed in the fugu swimbladder. Electrophysiological analyses demonstrated that MCT1b is a high-affinity lactate transporter whereas MCT4b is a low-affinity/high-conductance lactate transporter. Immunohistochemistry demonstrated that (i) MCT4b expresses in gas gland cells together with the glycolytic enzyme GAPDH at high level and mediate lactic acid secretion by gas gland cells, and (ii) MCT1b expresses in arterial, but not venous, capillary endothelial cells in rete mirabile and mediates recycling of lactic acid in the rete mirabile by solute-specific transcellular transport. These results clarified the mechanism of the blood acidification in the swimbladder by spatially organized two lactic acid transporters MCT4b and MCT1b.	[Umezawa, Takahiro; Kato, Akira; Ogoshi, Maho; Ookata, Kayoko; Munakata, Keijiro; Yamamoto, Yoko; Islam, Zinia; Hirose, Shigehisa] Tokyo Inst Technol, Dept Biol Sci, Yokohama, Kanagawa 227, Japan; [Kato, Akira; Romero, Michael F.] Mayo Clin Coll Med, Dept Physiol & Biomed Engn, Rochester, MN USA; [Ogoshi, Maho] Okayama Univ, Shimonoseki Marine Sci Museum, Ushimado Marine Lab, Setouchi, Japan; [Doi, Hiroyuki] Shimonoseki Acad Marine Sci, Shimonoseki, Yamaguchi, Japan	Tokyo Institute of Technology; Mayo Clinic; Okayama University	Umezawa, T (corresponding author), Tokyo Inst Technol, Dept Biol Sci, Midori Ku, Yokohama, Kanagawa 227, Japan.	akirkato@bio.titech.ac.jp	Kato, Akira/E-6328-2010	Kato, Akira/0000-0002-9083-1443	Ministry of Education, Culture, Sport, Science and Technology of Japan (MEXT) [14104002, 18059010, 22370029, 21770077, 23657054]; MEXT; Global Center of Excellence of MEXT; Grants-in-Aid for Scientific Research [22870020] Funding Source: KAKEN	Ministry of Education, Culture, Sport, Science and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Global Center of Excellence of MEXT; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Scientific Research 14104002, 18059010, 22370029, 21770077, and 23657054 from the Ministry of Education, Culture, Sport, Science and Technology of Japan (MEXT), and the 21st Century and Global Center of Excellence Programs of MEXT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aird WC, 2007, CIRC RES, V100, P158, DOI 10.1161/01.RES.0000255691.76142.4a; Aird WC, 2007, CIRC RES, V100, P174, DOI 10.1161/01.RES.0000255690.03436.ae; Albers JAA, 1806, GOTTINGEN GELEHRTE A, V2, P681; Aparicio S, 2002, SCIENCE, V297, P1301, DOI 10.1126/science.1072104; Berenbrink M, 2005, SCIENCE, V307, P1752, DOI 10.1126/science.1107793; Brittain T, 2005, J INORG BIOCHEM, V99, P120, DOI 10.1016/j.jinorgbio.2004.09.025; DAOUST BG, 1970, COMP BIOCHEM PHYSIOL, V32, P637, DOI 10.1016/0010-406X(70)90818-2; DENTON EJ, 1961, PROG BIOPHYS MOL BIO, V11, P177, DOI 10.1016/S0096-4174(18)30212-9; FANGE R, 1966, PHYSIOL REV, V46, P299, DOI 10.1152/physrev.1966.46.2.299; FANGE R, 1958, BIOL BULL, V115, P172, DOI 10.2307/1539023; Fox JEM, 2000, J PHYSIOL-LONDON, V529, P285, DOI 10.1111/j.1469-7793.2000.00285.x; GARCIA CK, 1994, CELL, V76, P865, DOI 10.1016/0092-8674(94)90361-1; GREEN SL, 1984, CELL TISSUE RES, V237, P277, DOI 10.1007/BF00217146; Halestrap AP, 2004, PFLUG ARCH EUR J PHY, V447, P619, DOI 10.1007/s00424-003-1067-2; Hall FG, 1924, BIOL BULL-US, V47, P79, DOI 10.2307/1536532; ITO N, 1995, J MOL BIOL, V250, P648, DOI 10.1006/jmbi.1995.0405; Jones TW, 1838, LONDON MED GAS, V21, P650; Kato A, 2011, AM J PHYSIOL-REG I, V300, pR284, DOI 10.1152/ajpregu.00725.2009; KOBAYASHI H, 1990, RESP PHYSIOL, V79, P231, DOI 10.1016/0034-5687(90)90129-M; KOBAYASHI H, 1989, RESP PHYSIOL, V78, P45, DOI 10.1016/0034-5687(89)90141-2; Kurita Y, 2008, AM J PHYSIOL-REG I, V294, pR1402, DOI 10.1152/ajpregu.00759.2007; Mylvaganam SE, 1996, NAT STRUCT BIOL, V3, P275, DOI 10.1038/nsb0396-275; Nakada T, 2007, FASEB J, V21, P1067, DOI 10.1096/fj.06-6834com; Pelster B, 2004, MICRON, V35, P73, DOI 10.1016/j.micron.2003.10.021; PELSTER B, 1995, AM J PHYSIOL-REG I, V269, pR793, DOI 10.1152/ajpregu.1995.269.4.R793; PELSTER B, 1993, J EXP BIOL, V185, P169; PELSTER B, 1991, J EXP BIOL, V156, P207; Plata C, 2007, J BIOL CHEM, V282, P11996, DOI 10.1074/jbc.M609313200; RASIO EA, 1977, CIRC RES, V41, P791, DOI 10.1161/01.RES.41.6.791; Romero MF, 1998, AM J PHYSIOL-RENAL, V274, pF425, DOI 10.1152/ajprenal.1998.274.2.F425; Root RW, 1931, BIOL BULL-US, V61, P427, DOI 10.2307/1536959; SCHOLANDER PF, 1953, BIOL BULL, V104, P75, DOI 10.2307/1538693; Siauve N, 1999, JMRI-J MAGN RESON IM, V9, P353, DOI 10.1002/(SICI)1522-2586(199902)9:2<353::AID-JMRI31>3.3.CO;2-L; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; WAGNER RC, 1987, MICROVASC RES, V34, P349, DOI 10.1016/0026-2862(87)90067-7; WAGNER RC, 1982, J ULTRA MOL STRUCT R, V81, P37, DOI 10.1016/S0022-5320(82)90039-9; Xie QH, 2002, AM J PHYSIOL-RENAL, V283, pF826, DOI 10.1152/ajprenal.00079.2002	38	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e34579	10.1371/journal.pone.0034579	http://dx.doi.org/10.1371/journal.pone.0034579			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GO	22496829	Green Published, gold, Green Submitted			2022-12-27	WOS:000304855200062
J	Valderrama, M; Crepon, B; Botella-Soler, V; Martinerie, J; Hasboun, D; Alvarado-Rojas, C; Baulac, M; Adam, C; Navarro, V; Le Van Quyen, M				Valderrama, Mario; Crepon, Benoit; Botella-Soler, Vicente; Martinerie, Jacques; Hasboun, Dominique; Alvarado-Rojas, Catalina; Baulac, Michel; Adam, Claude; Navarro, Vincent; Le Van Quyen, Michel			Human Gamma Oscillations during Slow Wave Sleep	PLOS ONE			English	Article							HIGH-FREQUENCY OSCILLATIONS; NEOCORTICAL NEURONS; HZ OSCILLATIONS; BAND RESPONSE; CORTEX; STATES; EEG; SYNCHRONIZATION; RIPPLES; NETWORK	Neocortical local field potentials have shown that gamma oscillations occur spontaneously during slow-wave sleep (SWS). At the macroscopic EEG level in the human brain, no evidences were reported so far. In this study, by using simultaneous scalp and intracranial EEG recordings in 20 epileptic subjects, we examined gamma oscillations in cerebral cortex during SWS. We report that gamma oscillations in low (30-50 Hz) and high (60-120 Hz) frequency bands recurrently emerged in all investigated regions and their amplitudes coincided with specific phases of the cortical slow wave. In most of the cases, multiple oscillatory bursts in different frequency bands from 30 to 120 Hz were correlated with positive peaks of scalp slow waves ("IN-phase'' pattern), confirming previous animal findings. In addition, we report another gamma pattern that appears preferentially during the negative phase of the slow wave ("ANTI-phase'' pattern). This new pattern presented dominant peaks in the high gamma range and was preferentially expressed in the temporal cortex. Finally, we found that the spatial coherence between cortical sites exhibiting gamma activities was local and fell off quickly when computed between distant sites. Overall, these results provide the first human evidences that gamma oscillations can be observed in macroscopic EEG recordings during sleep. They support the concept that these high-frequency activities might be associated with phasic increases of neural activity during slow oscillations. Such patterned activity in the sleeping brain could play a role in off-line processing of cortical networks.	[Valderrama, Mario; Crepon, Benoit; Martinerie, Jacques; Hasboun, Dominique; Alvarado-Rojas, Catalina; Baulac, Michel; Adam, Claude; Navarro, Vincent; Le Van Quyen, Michel] Univ Paris 06, Ctr Rech Inst Cerveau & Moelle Epiniere CRICM, INSERM,UMRS 975, Hop La Pitie Salpetriere,CNRS,UMR 7225, Paris, France; [Botella-Soler, Vicente] Univ Valencia, Dept Fis Teor, CSIC, Valencia, Spain; [Botella-Soler, Vicente] Univ Valencia, Inst Fis Corpuscular IFIC, CSIC, Valencia, Spain; [Crepon, Benoit; Hasboun, Dominique; Baulac, Michel; Adam, Claude; Navarro, Vincent] Grp Hosp Pitie Salpetriere, AP HP, Epilepsy Unit, F-75634 Paris, France; [Valderrama, Mario] Univ Los Andes, Dept Ingn Elect & Elect, Bogota, Colombia	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - UAM - Institut de Fisica Teorica (IFT); University of Valencia; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Fisica Corpuscular (IFIC); University of Valencia; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Universidad de los Andes (Colombia)	Valderrama, M (corresponding author), Univ Paris 06, Ctr Rech Inst Cerveau & Moelle Epiniere CRICM, INSERM,UMRS 975, Hop La Pitie Salpetriere,CNRS,UMR 7225, Paris, France.	quyen@t-online.de	Alvarado-Rojas, Catalina/AAR-8761-2021	Valderrama, Mario/0000-0001-8791-6078; Alvarado-Rojas, Catalina/0000-0002-2315-5692; Botella-Soler, Vicente/0000-0002-8790-1914; Navarro, Vincent/0000-0003-0077-8114	European Union [211713]; University of Los Andes; Administrative Department for Science, Technology and Innovation (COLCIENCIAS), Colombia; Generalitat Valenciana; INSERM	European Union(European Commission); University of Los Andes; Administrative Department for Science, Technology and Innovation (COLCIENCIAS), Colombia(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission)	This work was partially supported by the European Union-FP7 Project EPILEPSIAE (Evolving Platform for Improving Living Expectation of Subjects Suffering from IctAl Events, Grant No 211713). Mario Valderrama thanks the University of Los Andes and the Administrative Department for Science, Technology and Innovation (COLCIENCIAS), Colombia, for financial support. Vicente Botella-Soler thanks Generalitat Valenciana for financial support. Vincent Navarro was supported by Contrat d'Interface INSERM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achermann P, 1997, NEUROSCIENCE, V81, P213, DOI 10.1016/S0306-4522(97)00186-3; Alarcon G, 1997, BRAIN, V120, P2259, DOI 10.1093/brain/120.12.2259; ALLEN PJ, 1992, ELECTROEN CLIN NEURO, V82, P155, DOI 10.1016/0013-4694(92)90160-J; [Anonymous], 1913, P SOC PSYCHICAL RES; Cantero JL, 2004, NEUROIMAGE, V22, P1271, DOI 10.1016/j.neuroimage.2004.03.014; Cash SS, 2009, SCIENCE, V324, P1084, DOI 10.1126/science.1169626; Clemens Z, 2007, BRAIN, V130, P2868, DOI 10.1093/brain/awm146; Compte A, 2008, J NEUROSCI, V28, P13828, DOI 10.1523/JNEUROSCI.2684-08.2008; Crepon B, 2010, BRAIN, V133, P33, DOI 10.1093/brain/awp277; Crone NE, 2001, CLIN NEUROPHYSIOL, V112, P565, DOI 10.1016/S1388-2457(00)00545-9; Dalal SS, 2010, J NEUROSCI, V30, P14285, DOI 10.1523/JNEUROSCI.4275-10.2010; Dang-Vu TT, 2008, P NATL ACAD SCI USA, V105, P15160, DOI 10.1073/pnas.0801819105; Della Marca G, 2007, SLEEP MED, V8, P96, DOI 10.1016/j.sleep.2006.08.004; Destexhe A, 2007, TRENDS NEUROSCI, V30, P334, DOI 10.1016/j.tins.2007.04.006; Dickson CT, 2003, J NEUROPHYSIOL, V90, P39, DOI 10.1152/jn.01063.2002; Fell J, 2002, INT J NEUROSCI, V112, P893, DOI 10.1080/00207450290025905; Grenier F, 2003, J NEUROPHYSIOL, V89, P841, DOI 10.1152/jn.00420.2002; Grenier FO, 2001, J NEUROPHYSIOL, V86, P1884, DOI 10.1152/jn.2001.86.4.1884; Gross DW, 1999, NEUROSCIENCE, V94, P1005, DOI 10.1016/S0306-4522(99)00343-7; Haider B, 2009, NEURON, V62, P171, DOI 10.1016/j.neuron.2009.04.008; Isomura Y, 2006, NEURON, V52, P871, DOI 10.1016/j.neuron.2006.10.023; Jacobs J, 2009, J NEUROSCI, V29, P10203, DOI 10.1523/JNEUROSCI.2187-09.2009; Jensen O, 2007, TRENDS NEUROSCI, V30, P317, DOI 10.1016/j.tins.2007.05.001; Jerbi K, 2009, BRAIN TOPOGR, V22, P18, DOI 10.1007/s10548-009-0078-5; Jerbi K, 2009, HUM BRAIN MAPP, V30, P1758, DOI 10.1002/hbm.20750; Ji DY, 2007, NAT NEUROSCI, V10, P100, DOI 10.1038/nn1825; Lachaux JP, 2005, NEUROIMAGE, V25, P491, DOI 10.1016/j.neuroimage.2004.11.052; Lachaux JP, 1999, HUM BRAIN MAPP, V8, P194, DOI 10.1002/(SICI)1097-0193(1999)8:4<194::AID-HBM4>3.0.CO;2-C; Le Van Quyen M, 2010, J NEUROSCI, V30, P7770, DOI 10.1523/JNEUROSCI.5049-09.2010; Luczak A, 2007, P NATL ACAD SCI USA, V104, P347, DOI 10.1073/pnas.0605643104; Mallat S., 1999, WAVELET TOUR SIGNAL, DOI 10.1016/B978-012466606-1/50008-8; Maloney KJ, 1997, NEUROSCIENCE, V76, P541, DOI 10.1016/S0306-4522(96)00298-9; Massimini M, 2004, J NEUROSCI, V24, P6862, DOI 10.1523/JNEUROSCI.1318-04.2004; Mena-Segovia J, 2008, J PHYSIOL-LONDON, V586, P2947, DOI 10.1113/jphysiol.2008.153874; Menon V, 1996, ELECTROEN CLIN NEURO, V98, P89, DOI 10.1016/0013-4694(95)00206-5; Molle M, 2004, P NATL ACAD SCI USA, V101, P13963, DOI 10.1073/pnas.0402820101; Molle M, 2002, J NEUROSCI, V22, P10941; Montgomery SM, 2007, P NATL ACAD SCI USA, V104, P14495, DOI 10.1073/pnas.0701826104; Mukovski M, 2007, CEREB CORTEX, V17, P400, DOI 10.1093/cercor/bhj157; Murphy M, 2009, P NATL ACAD SCI USA, V106, P1608, DOI 10.1073/pnas.0807933106; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Ossandon T, 2011, J NEUROSCI, V31, P14521, DOI 10.1523/JNEUROSCI.2483-11.2011; Penttonen M, 2003, THALAMUS RELAT SYST, V48, P1; Sejnowski TJ, 2006, J NEUROSCI, V26, P1673, DOI 10.1523/JNEUROSCI.3737-05d.2006; Sejnowski TJ, 2000, BRAIN RES, V886, P208, DOI 10.1016/S0006-8993(00)03007-9; Siapas AG, 2005, NEURON, V46, P141, DOI 10.1016/j.neuron.2005.02.028; Staba RJ, 2002, J NEUROPHYSIOL, V88, P1743, DOI 10.1152/jn.2002.88.4.1743; Steriade M, 1996, J NEUROSCI, V16, P392, DOI 10.1523/jneurosci.16-01-00392.1996; STERIADE M, 1994, TRENDS NEUROSCI, V17, P199; STERIADE M, 1993, J NEUROSCI, V13, P3252, DOI 10.1523/jneurosci.13-08-03252.1993; TallonBaudry C, 1996, J NEUROSCI, V16, P4240; Trajanovic NN, 2007, SLEEP MED, V8, P111, DOI 10.1016/j.sleep.2006.08.013; Volgushev M, 2006, J NEUROSCI, V26, P5665, DOI 10.1523/JNEUROSCI.0279-06.2006; Wolansky T, 2006, J NEUROSCI, V26, P6213, DOI 10.1523/JNEUROSCI.5594-05.2006; Worrell GA, 2004, BRAIN, V127, P1496, DOI 10.1093/brain/awh149; Yuval-Greenberg S, 2008, NEURON, V58, P429, DOI 10.1016/j.neuron.2008.03.027	56	62	63	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e33477	10.1371/journal.pone.0033477	http://dx.doi.org/10.1371/journal.pone.0033477			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GO	22496749	Green Published, Green Submitted, gold			2022-12-27	WOS:000304855200013
J	Xiao, F; Wang, HX; Fu, XR; Li, YF; Wu, ZG				Xiao, Fang; Wang, Haixia; Fu, Xinrong; Li, Yanfeng; Wu, Zhenguo			TRAF6 Promotes Myogenic Differentiation via the TAK1/p38 Mitogen-Activated Protein Kinase and Akt Pathways	PLOS ONE			English	Article							I-KAPPA-B; P38-ALPHA/BETA MAPK; SIGNALING PATHWAY; TRANSCRIPTIONAL CONTROL; MOLECULAR REGULATION; P38; INSULIN; BINDING; PHOSPHORYLATION; COMPLEX	p38 mitogen-activated protein kinase (MAPK) is an essential kinase involved in myogenic differentiation. Although many substrates of p38 MAPK have been identified, little is known about its upstream activators during myogenic differentiation. TRAF6 is known to function in cytokine signaling during inflammatory responses. However, not much is known about its role in myogenic differentiation and muscle regeneration. We showed here that TRAF6 and its intrinsic ubiquitin E3 ligase activity are required for myogenic differentiation. In mouse myoblasts, knockdown of TRAF6 compromised the p38 MAPK and Akt pathways, while deliberate activation of either pathway rescued the differentiation defect caused by TRAF6 knockdown. TAK1 acted as a key signal transducer downstream of TRAF6 in myogenic differentiation. In vivo, knockdown of TRAF6 in mouse muscles compromised the injury-induced muscle regeneration without impairing macrophage infiltration and myoblast proliferation. Collectively, we demonstrated that TRAF6 promotes myogenic differentiation and muscle regeneration via the TAK1/p38 MAPK and Akt pathways.	[Xiao, Fang; Wang, Haixia; Fu, Xinrong; Li, Yanfeng; Wu, Zhenguo] Hong Kong Univ Sci & Technol, Div Life Sci, State Key Lab Mol Neurosci, Kowloon, Hong Kong, Peoples R China	Hong Kong University of Science & Technology	Xiao, F (corresponding author), Hong Kong Univ Sci & Technol, Div Life Sci, State Key Lab Mol Neurosci, Kowloon, Hong Kong, Peoples R China.	bczgwu@ust.hk	li, yan/GTI-4638-2022	Wu, Zhenguo/0000-0003-3049-8324	Hong Kong Research Grant Council [HKUST6496/06M, 663308, HKUST1/06C]; University Grants Council [AoE/B-15/01]	Hong Kong Research Grant Council(Hong Kong Research Grants Council); University Grants Council	This work was supported by grants from Hong Kong Research Grant Council (HKUST6496/06M, 663308, and HKUST1/06C to ZW) and an Area of Excellence Scheme (AoE/B-15/01) of the University Grants Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari A, 2007, ONCOGENE, V26, P3214, DOI 10.1038/sj.onc.1210413; Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Arnold L, 2007, J EXP MED, V204, P1057, DOI 10.1084/jem.20070075; Berkes CA, 2005, SEMIN CELL DEV BIOL, V16, P585, DOI 10.1016/j.semcdb.2005.07.006; Bhatnagar S, 2010, J BIOL CHEM, V285, P6401, DOI 10.1074/jbc.M109.064063; Black BL, 1998, ANNU REV CELL DEV BI, V14, P167, DOI 10.1146/annurev.cellbio.14.1.167; Blank JL, 1996, J BIOL CHEM, V271, P5361, DOI 10.1074/jbc.271.10.5361; Bois PRJ, 2003, EMBO J, V22, P1147, DOI 10.1093/emboj/cdg116; Buckingham M, 2001, CURR OPIN GENET DEV, V11, P440, DOI 10.1016/S0959-437X(00)00215-X; Cabane C, 2003, AM J PHYSIOL-CELL PH, V284, pC658, DOI 10.1152/ajpcell.00078.2002; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Chung JY, 2002, J CELL SCI, V115, P679; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Florini JR, 1996, ENDOCR REV, V17, P481, DOI 10.1210/edrv-17-5-481; Hribal ML, 2003, J CELL BIOL, V162, P535, DOI 10.1083/jcb.200212107; Jiang BH, 1999, P NATL ACAD SCI USA, V96, P2077, DOI 10.1073/pnas.96.5.2077; Kanayama A, 2004, MOL CELL, V15, P535, DOI 10.1016/j.molcel.2004.08.008; Kang JS, 2008, J CELL BIOL, V182, P497, DOI 10.1083/jcb.200801119; Keren A, 2006, MOL CELL ENDOCRINOL, V252, P224, DOI 10.1016/j.mce.2006.03.017; Landstrom M, 2010, INT J BIOCHEM CELL B, V42, P585, DOI 10.1016/j.biocel.2009.12.023; Liu SQ, 2011, CELL RES, V21, P6, DOI 10.1038/cr.2010.170; Lluis F, 2005, EMBO J, V24, P974, DOI 10.1038/sj.emboj.7600528; Lu M, 2010, P NATL ACAD SCI USA, V107, P4212, DOI 10.1073/pnas.0908883107; Molkentin JD, 1996, CURR OPIN GENET DEV, V6, P445, DOI 10.1016/S0959-437X(96)80066-9; Mueck T, 2011, DIFFERENTIATION, V81, P99, DOI 10.1016/j.diff.2010.11.002; Ninomiya-Tsuji J, 1999, NATURE, V398, P252, DOI 10.1038/18465; Palacios D, 2010, CELL STEM CELL, V7, P455, DOI 10.1016/j.stem.2010.08.013; Paul PK, 2010, J CELL BIOL, V191, P1395, DOI 10.1083/jcb.201006098; Perdiguero E, 2007, EMBO J, V26, P1245, DOI 10.1038/sj.emboj.7601587; Potthoff MJ, 2007, DEVELOPMENT, V134, P4131, DOI 10.1242/dev.008367; Puri PL, 2000, J CELL PHYSIOL, V185, P155, DOI 10.1002/1097-4652(200011)185:2<155::AID-JCP1>3.0.CO;2-Z; Rampalli S, 2007, NAT STRUCT MOL BIOL, V14, P1150, DOI 10.1038/nsmb1316; Sabourin LA, 2000, CLIN GENET, V57, P16, DOI 10.1034/j.1399-0004.2000.570103.x; Simone C, 2004, NAT GENET, V36, P738, DOI 10.1038/ng1378; Singhirunnusorn P, 2005, J BIOL CHEM, V280, P7359, DOI 10.1074/jbc.M407537200; Takaesu G, 2006, J CELL BIOL, V175, P383, DOI 10.1083/jcb.200608031; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tamir Y, 2000, J BIOL CHEM, V275, P34424, DOI 10.1074/jbc.M005815200; Wan J, 2004, MOL CELL BIOL, V24, P192, DOI 10.1128/MCB.24.1.192-199.2004; Wang HX, 2008, MOL BIOL CELL, V19, P1519, DOI 10.1091/mbc.E07-08-0817; Wu ZG, 2000, MOL CELL BIOL, V20, P3951, DOI 10.1128/MCB.20.11.3951-3964.2000; Xia ZP, 2009, NATURE, V461, P114, DOI 10.1038/nature08247; Xu Q, 2000, J BIOL CHEM, V275, P36750, DOI 10.1074/jbc.M005030200; Xu Q, 2002, MOL BIOL CELL, V13, P1940, DOI 10.1091/mbc.02-02-0016; YAMAGUCHI K, 1995, SCIENCE, V270, P2008, DOI 10.1126/science.270.5244.2008; Yang WL, 2009, SCIENCE, V325, P1134, DOI 10.1126/science.1175065; Zetser A, 1999, J BIOL CHEM, V274, P5193, DOI 10.1074/jbc.274.8.5193	48	21	23	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e34081	10.1371/journal.pone.0034081	http://dx.doi.org/10.1371/journal.pone.0034081			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GO	22496778	Green Published, Green Submitted, gold			2022-12-27	WOS:000304855200030
J	Zou, ZX; Denny, E; Brown, CE; Jensen, MC; Li, G; Fujii, T; Neman, J; Jandial, R; Chen, MK				Zou, Zhaoxia; Denny, Erin; Brown, Christine E.; Jensen, Michael C.; Li, Gang; Fujii, Tatsuhiro; Neman, Josh; Jandial, Rahul; Chen, Mike			Cytotoxic T Lymphocyte Trafficking and Survival in an Augmented Fibrin Matrix Carrier	PLOS ONE			English	Article							DELIVERY VEHICLE; INDUCIBLE PROTEIN-10; ADOPTIVE TRANSFER; IN-VIVO; CELLS; GLUE; TRANSPLANTATION; CHEMOTAXIS; CLOTS; INTERLEUKIN-2	Cell-based therapies have intriguing potential for the treatment of a variety of neurological disorders. One such example is genetically engineered cytotoxic T lymphocytes (CTLs) that are being investigated in brain tumor clinical trials. The development of methods for CTL delivery is critical to their use in the laboratory and clinical setting. In our study, we determined whether CTLs can migrate through fibrin matrices and if their migration, survival, and function could be modulated by adding chemokines to the matrix. Our results indicated that CTLs can freely migrate through fibrin matrices. As expected, the addition of the monocyte chemotactic protein-1 (MCP-1), also known as chemokine C-C motif ligand 2 (CCL2), to the surrounding media increased egress of the CTLs out of the fibrin clot. Interleukin (IL) -2 and/or IL-15 embedded in the matrix enhanced T cell survival and further promoted T cell migration. The interleukin-13 receptor alpha 2 specific (IL-13R alpha2) T cells that traveled out of the fibrin clot retained the capacity to kill U251 glioma cells. In summary, CTLs can survive and migrate robustly in fibrin matrices. These processes can be influenced by modification of matrix constituents. We conclude that fibrin matrices may be suitable T cell carriers and can be used to facilitate understanding of T cell interaction with the surrounding microenvironment.	[Zou, Zhaoxia; Denny, Erin; Li, Gang; Fujii, Tatsuhiro; Neman, Josh; Jandial, Rahul; Chen, Mike] City Hope Natl Med Ctr, Div Neurosurg, Duarte, CA 91010 USA; [Brown, Christine E.; Jensen, Michael C.] City Hope Natl Med Ctr, Dept Canc Immunotherapeut & Tumor Immunol, Duarte, CA 91010 USA	City of Hope; City of Hope	Zou, ZX (corresponding author), City Hope Natl Med Ctr, Div Neurosurg, 1500 E Duarte Rd, Duarte, CA 91010 USA.	mchen@coh.org	LI, GANG/O-1409-2016	LI, GANG/0000-0003-3203-8567; Brown, Christine/0000-0003-4915-8207				Andrades P, 2007, TRANSPL P, V39, P1607, DOI 10.1016/j.transproceed.2007.01.078; Blanco-Jerez C, 2002, J NEUROIMMUNOL, V128, P90, DOI 10.1016/S0165-5728(02)00146-7; Brown CE, 2007, J IMMUNOL, V179, P3332, DOI 10.4049/jimmunol.179.5.3332; Brown CE, 2009, CANCER RES, V69, P8886, DOI 10.1158/0008-5472.CAN-09-2687; CARR MW, 1994, P NATL ACAD SCI USA, V91, P3652, DOI 10.1073/pnas.91.9.3652; Chen SJ, 2010, STEM CELLS DEV, V19, P1757, DOI 10.1089/scd.2009.0452; Christman KL, 2004, J AM COLL CARDIOL, V44, P654, DOI 10.1016/j.jacc.2004.04.040; Cox S, 2004, TISSUE ENG, V10, P942, DOI 10.1089/1076327041348392; Currie LJ, 2001, PLAST RECONSTR SURG, V108, P1713, DOI 10.1097/00006534-200111000-00045; Dudley ME, 2001, J IMMUNOTHER, V24, P363, DOI 10.1097/00002371-200107000-00012; Falanga V, 2007, TISSUE ENG, V13, P1299, DOI 10.1089/ten.2006.0278; Gille J, 2005, TISSUE CELL, V37, P339, DOI 10.1016/j.tice.2005.05.004; Hafez AT, 2005, J UROLOGY, V174, P1663, DOI 10.1097/01.ju.0000177727.56790.98; Hanson AJ, 2002, J BIOMED MATER RES, V61, P474, DOI 10.1002/jbm.10196; Jung SN, 2010, J CRANIOFAC SURG, V21, P468, DOI 10.1097/SCS.0b013e3181cfea50; Kahlon KS, 2004, CANCER RES, V64, P9160, DOI 10.1158/0008-5472.CAN-04-0454; Kassam A, 2004, ENT-EAR NOSE THROAT, V83, P52; Kassam A, 2004, ENT-EAR NOSE THROAT, V83, P50; Kassam Amin, 2004, Ear Nose Throat J, V83, P246; Kinter AL, 2008, J IMMUNOL, V181, P6738, DOI 10.4049/jimmunol.181.10.6738; Kruse CA, 1997, CANCER IMMUNOL IMMUN, V45, P77, DOI 10.1007/s002620050405; LEE K-C, 1991, Yonsei Medical Journal, V32, P53; Mana M, 2006, WOUND REPAIR REGEN, V14, P72, DOI 10.1111/j.1524-475X.2005.00091.x; Muhammad AKMG, 1997, NEUROL RES, V19, P84; Nishimura F, 2006, CANCER RES, V66, P4478, DOI 10.1158/0008-5472.CAN-05-3825; Rainer C, 2001, J THORAC CARDIOV SUR, V121, P1187, DOI 10.1067/mtc.2001.113936; Rosenberg SA, 2009, CURR OPIN IMMUNOL, V21, P233, DOI 10.1016/j.coi.2009.03.002; Roth SJ, 1995, EUR J IMMUNOL, V25, P3482, DOI 10.1002/eji.1830251241; Roychowdhury S, 2004, CANCER RES, V64, P8062, DOI 10.1158/0008-5472.CAN-04-1860; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Stastny MJ, 2007, J PEDIAT HEMATOL ONC, V29, P669, DOI 10.1097/MPH.0b013e3181468c68; Wechselberger G, 2002, PLAST RECONSTR SURG, V110, P123, DOI 10.1097/00006534-200207000-00022; Wechselberger G, 1998, J UROLOGY, V160, P583, DOI 10.1016/S0022-5347(01)62962-8; Zheng M, 1999, CHINESE MED J-PEKING, V112, P493	34	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e34652	10.1371/journal.pone.0034652	http://dx.doi.org/10.1371/journal.pone.0034652			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GO	22496835	Green Published, gold, Green Submitted			2022-12-27	WOS:000304855200065
J	Johnstone, D; Milward, EA; Berretta, R; Moscato, P				Johnstone, Daniel; Milward, Elizabeth A.; Berretta, Regina; Moscato, Pablo		Alzheimer's Dis Neuroimaging Initi	Multivariate Protein Signatures of Pre-Clinical Alzheimer's Disease in the Alzheimer's Disease Neuroimaging Initiative (ADNI) Plasma Proteome Dataset	PLOS ONE			English	Article							APOLIPOPROTEIN-E POLYMORPHISM; E GENOTYPE; CEREBROSPINAL-FLUID; APOE POLYMORPHISM; E GENE; BIOMARKERS; ALLELE; ASSOCIATION; MARKERS; CLASSIFICATION	Background: Recent Alzheimer's disease (AD) research has focused on finding biomarkers to identify disease at the preclinical stage of mild cognitive impairment (MCI), allowing treatment to be initiated before irreversible damage occurs. Many studies have examined brain imaging or cerebrospinal fluid but there is also growing interest in blood biomarkers. The Alzheimer's Disease Neuroimaging Initiative (ADNI) has generated data on 190 plasma analytes in 566 individuals with MCI, AD or normal cognition. We conducted independent analyses of this dataset to identify plasma protein signatures predicting pre-clinical AD. Methods and Findings: We focused on identifying signatures that discriminate cognitively normal controls (n=54) from individuals with MCI who subsequently progress to AD (n=163). Based on p value, apolipoprotein E (APOE) showed the strongest difference between these groups (p=2.3 x 10(-13)). We applied a multivariate approach based on combinatorial optimization ((alpha,beta)-k Feature Set Selection), which retains information about individual participants and maintains the context of interrelationships between different analytes, to identify the optimal set of analytes (signature) to discriminate these two groups. We identified 11-analyte signatures achieving values of sensitivity and specificity between 65% and 86% for both MCI and AD groups, depending on whether APOE was included and other factors. Classification accuracy was improved by considering "meta-features," representing the difference in relative abundance of two analytes, with an 8-meta-feature signature consistently achieving sensitivity and specificity both over 85%. Generating signatures based on longitudinal rather than cross-sectional data further improved classification accuracy, returning sensitivities and specificities of approximately 90%. Conclusions: Applying these novel analysis approaches to the powerful and well-characterized ADNI dataset has identified sets of plasma biomarkers for pre-clinical AD. While studies of independent test sets are required to validate the signatures, these analyses provide a starting point for developing a cost-effective and minimally invasive test capable of diagnosing AD in its pre-clinical stages.	[Johnstone, Daniel; Milward, Elizabeth A.; Berretta, Regina; Moscato, Pablo] Univ Newcastle, Prior Res Ctr Bioinformat Biomarker Discovery & I, Callaghan, NSW 2308, Australia; [Johnstone, Daniel; Berretta, Regina; Moscato, Pablo] Univ Newcastle, Sch Elect Engn & Comp Sci, Callaghan, NSW 2308, Australia; [Milward, Elizabeth A.] Univ Newcastle, Sch Biomed Sci & Pharm, Callaghan, NSW 2308, Australia	University of Newcastle; University of Newcastle; University of Newcastle	Johnstone, D (corresponding author), Univ Newcastle, Prior Res Ctr Bioinformat Biomarker Discovery & I, Callaghan, NSW 2308, Australia.	Pablo.Moscato@newcastle.edu.au	Hsiung, Robin/AAT-1661-2021; MOSCATO, PABLO ALBERTO/G-7668-2013; Johnstone, Daniel/E-9929-2013; Levey, Allan/F-2104-2011; Preda, Adrian/K-8889-2013	Hsiung, Robin/0000-0002-8017-0856; Johnstone, Daniel/0000-0003-2876-3299; Levey, Allan/0000-0002-3153-502X; Preda, Adrian/0000-0003-3373-2438; Moscato, Pablo/0000-0003-2570-5966; Milward, Adrienne/0000-0002-1023-7795; Berretta, Regina/0000-0002-4420-3446	University of Newcastle; Hunter Medical Research Institute; Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health) [U01 AG024904]; National Institute on Aging; National Institute of Biomedical Imaging and Bioengineering; NIH [P30 AG010129, K01 AG030514]; Dana Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001998, UL1TR000117] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K01AG030514, P30AG013846, P30AG010129, U19AG010483, R01AG022374, U01AG024904, R01AG012101, P30AG019610] Funding Source: NIH RePORTER	University of Newcastle; Hunter Medical Research Institute; Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dana Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors of this study have only been funded by The University of Newcastle and the Hunter Medical Research Institute. Data collection and sharing for this project was funded by the Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant U01 AG024904). ADNI was funded by the National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering, and through generous contributions from the following: Abbott, AstraZeneca AB, Bayer Schering Pharma AG, Bristol-Myers Squibb, Eisai Global Clinical Development, Elan Corporation, Genentech, GE Healthcare, GlaxoSmithKilne, Innogenetics, Johnson and Johnson, Eli Lilly and Co., Medpace, Inc., Merck and Co., Inc., Novartis AD, Pfizer Inc, F. Hoffman-La Roche, Schering-Plough, Synarc, Inc., as well as non-profit partners the Alzheimer's Association and Alzheimer's Drug Discovery Foundation, with participation from the U.S. Food and Drug Administration. Private sector contributions to ADNI are facilitated by the Foundation for the National Institutes of Health (www.fnih.org). The grantee organization is the Northern California Institute for Research and Education, and the study is coordinated by the Alzheimer's Disease Cooperative Study at the University of California, San Diego. ADNI data are disseminated by the Laboratory for Neuro Imaging at the University of California, Los Angeles. This research was also supported by NIH grants P30 AG010129, K01 AG030514, and the Dana Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldi P, 2000, BIOINFORMATICS, V16, P412, DOI 10.1093/bioinformatics/16.5.412; Berretta Regina, 2008, V453, P363, DOI 10.1007/978-1-60327-429-6_19; Bertram L, 2007, NAT GENET, V39, P17, DOI 10.1038/ng1934; Blennow K, 2010, NAT REV NEUROL, V6, P131, DOI 10.1038/nrneurol.2010.4; BOERWINKLE E, 1988, AM J HUM GENET, V42, P104; Burman D, 2009, ATHEROSCLEROSIS, V203, P192, DOI 10.1016/j.atherosclerosis.2008.06.007; Campos F, 2011, CLIN SCI, V121, P11, DOI 10.1042/CS20100427; Caselli RJ, 2004, NEUROLOGY, V62, P1990, DOI 10.1212/01.WNL.0000129533.26544.BF; Castellano JM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002156; Corbo RM, 1999, ANN HUM GENET, V63, P301, DOI 10.1046/j.1469-1809.1999.6340301.x; CORDER EH, 1994, NAT GENET, V7, P180, DOI 10.1038/ng0694-180; Cotta C, 2004, LECT NOTES COMPUT SC, V3005, P21; Craig-Schapiro R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018850; de Paula MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017481; Eichner JE, 2002, AM J EPIDEMIOL, V155, P487, DOI 10.1093/aje/155.6.487; Eisenberg DTA, 2010, AM J PHYS ANTHROPOL, V143, P100, DOI 10.1002/ajpa.21298; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.1997.03550160069041; FAYYAD UM, 1993, IJCAI-93, VOLS 1 AND 2, P1022; Fiala M, 2010, EXP GERONTOL, V45, P57, DOI 10.1016/j.exger.2009.08.003; Fischer P, 1997, LIFE SCI, V60, P2273, DOI 10.1016/S0024-3205(97)00282-8; Frikke-Schmidt R, 2000, J LIPID RES, V41, P1812; Gerdes LU, 2000, GENET EPIDEMIOL, V19, P202, DOI 10.1002/1098-2272(200010)19:3<202::AID-GEPI2>3.0.CO;2-Q; Golledge J, 2010, ATHEROSCLEROSIS, V209, P487, DOI 10.1016/j.atherosclerosis.2009.09.027; Ravetti MG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010153; Hall M., 2009, SIGKDD EXPLORATIONS, V11; Hampel H, 2010, NAT REV DRUG DISCOV, V9, P560, DOI 10.1038/nrd3115; Hampel Harald, 2009, Dialogues Clin Neurosci, V11, P141; Han SH, 2011, J ALZHEIMERS DIS, V25, P77, DOI 10.3233/JAD-2011-102145; Hofer SM, 2002, PSYCHOL AGING, V17, P194, DOI 10.1037//0882-7974.17.2.194; Hu WT, 2010, ACTA NEUROPATHOL, V120, P385, DOI 10.1007/s00401-010-0723-9; Hubacek JA, 2010, HUM IMMUNOL, V71, P304, DOI 10.1016/j.humimm.2010.01.008; Hye A, 2006, BRAIN, V129, P3042, DOI 10.1093/brain/awl279; Laske C, 2011, INT J NEUROPSYCHOPH, P1; Leon AS, 2004, METABOLISM, V53, P108, DOI 10.1016/j.metabol.2003.08.013; Marksteiner J, 2011, NEUROBIOL AGING, V32, P539, DOI 10.1016/j.neurobiolaging.2009.03.011; Mattsson N, 2009, JAMA-J AM MED ASSOC, V302, P385, DOI 10.1001/jama.2009.1064; Mendes Alexandre, 2008, V141, P131; Morris JC, 2010, ANN NEUROL, V67, P122, DOI 10.1002/ana.21843; Moscato P, 2007, BIOSYSTEMS, V88, P56, DOI 10.1016/j.biosystems.2006.04.005; Neale MC, 2000, GENET EPIDEMIOL, V18, P331, DOI 10.1002/(SICI)1098-2272(200004)18:4<331::AID-GEPI6>3.0.CO;2-V; O'Bryant SE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028092; Ravetti MG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003111; Ray S, 2007, NAT MED, V13, P1359, DOI 10.1038/nm1653; Reiman EM, 2009, P NATL ACAD SCI USA, V106, P6820, DOI 10.1073/pnas.0900345106; Reitz C, 2011, ARCH NEUROL-CHICAGO, V68, P99, DOI 10.1001/archneurol.2010.346; Rogaeva E, 2007, NAT GENET, V39, P168, DOI 10.1038/ng1943; SCHMECHEL DE, 1993, P NATL ACAD SCI USA, V90, P9649, DOI 10.1073/pnas.90.20.9649; Shaw LM, 2009, ANN NEUROL, V65, P403, DOI 10.1002/ana.21610; SIEST G, 1995, CLIN CHEM, V41, P1068; SING CF, 1985, AM J HUM GENET, V37, P268; Slooter AJC, 1998, NEUROSCI LETT, V248, P21, DOI 10.1016/S0304-3940(98)00339-5; Soares HD, 2009, ANN NY ACAD SCI, V1180, P56, DOI 10.1111/j.1749-6632.2009.05066.x; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; Swan GE, 2005, J GERIATR PSYCH NEUR, V18, P196, DOI 10.1177/0891988705281864; Tarawneh R, 2009, CNS NEUROL DISORD-DR, V8, P144, DOI 10.2174/187152709787847324; Thambisetty M, 2010, J ALZHEIMERS DIS, V22, P1099, DOI 10.3233/JAD-2010-101350; Tiraboschi P, 2004, NEUROLOGY, V62, P1977, DOI 10.1212/01.WNL.0000128091.92139.0F; Vincent-Viry M, 1998, CLIN CHEM, V44, P957; Williams R, 2011, NATURE, V475, pS5, DOI 10.1038/475S5a; Wilson RS, 2002, ARCH NEUROL-CHICAGO, V59, P1154, DOI 10.1001/archneur.59.7.1154	60	50	51	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2012	7	4							e34341	10.1371/journal.pone.0034341	http://dx.doi.org/10.1371/journal.pone.0034341			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952GU	22485168	Green Published, gold			2022-12-27	WOS:000304780500043
J	Zhu, ML; Zheng, XC; Shu, QY; Li, H; Zhong, PX; Zhang, HJ; Xu, YJ; Wang, LJ; Wang, LS				Zhu, Manlan; Zheng, Xuchen; Shu, Qingyan; Li, Hui; Zhong, Peixing; Zhang, Huijin; Xu, Yanjun; Wang, Lijin; Wang, Liangsheng			Relationship between the Composition of Flavonoids and Flower Colors Variation in Tropical Water Lily (Nymphaea) Cultivars	PLOS ONE			English	Article							PERFORMANCE LIQUID-CHROMATOGRAPHY; PHENOLIC-COMPOUNDS; BLUE FLOWERS; ANTHOCYANINS; LEAVES; PETALS; COPIGMENTATION; DELPHINIDIN; POLYPHENOLS; IONIZATION	Water lily, the member of the Nymphaeaceae family, is the symbol of Buddhism and Brahmanism in India. Despite its limited researches on flower color variations and formation mechanism, water lily has background of blue flowers and displays an exceptionally wide diversity of flower colors from purple, red, blue to yellow, in nature. In this study, 34 flavonoids were identified among 35 tropical cultivars by high-performance liquid chromatography (HPLC) with photodiode array detection (DAD) and electrospray ionization mass spectrometry (ESI-MS). Among them, four anthocyanins: delphinidin 3-O-rhamnosyl-5-O-galactoside (Dp3Rh5Ga), delphinidin 3-O-(2 ''-O-galloyl-6 ''-O-oxalyl-rhamnoside) (Dp3galloyl-oxalylRh), delphinidin 3-O-(6 ''-O-acetyl-beta-glucopyranoside) (Dp3acetylG) and cyanidin 3-O-(2 ''-O-galloyl-galactopyranoside)-5-O-rhamnoside (Cy3galloylGa5Rh), one chalcone: chalcononaringenin 2'-O-galactoside (Chal2'Ga) and twelve flavonols: myricetin 7-O-rhamnosyl-(1 -> 2)-rhamnoside (My7RhRh), quercetin 7-O-galactosyl-(1 -> 2)-rhamnoside (Qu7GaRh), quercetin 7-O-galactoside (Qu7Ga), kaempferol 7-O-galactosyl-(1 -> 2)-rhamnoside (Km7GaRh), myricetin 3-O-galactoside (My3Ga), kaempferol 7-O-galloylgalactosyl-(1 -> 2)-rhamnoside (Km7galloylGaRh), myricetin 3-O-galloylrhamnoside (My3galloylRh), kaempferol 3-O-galactoside (Km3Ga), isorhamnetin 7-O-galactoside (Is7Ga), isorhamnetin 7-O-xyloside (Is7Xy), kaempferol 3-O-(3 ''-acetylrhamnoside) (Km3-3 '' acetylRh) and quercetin 3-O-acetylgalactoside (Qu3acetylGa) were identified in the petals of tropic water lily for the first time. Meanwhile a multivariate analysis was used to explore the relationship between pigments and flower color. By comparing, the cultivars which were detected delphinidin 3-galactoside (Dp3Ga) presented amaranth, and detected delphinidin 3'-galactoside (Dp3'Ga) presented blue. However, the derivatives of delphinidin and cyanidin were more complicated in red group. No anthocyanins were detected within white and yellow group. At the same time a possible flavonoid biosynthesis pathway of tropical water lily was presumed putatively. These studies will help to elucidate the evolution mechanism on the formation of flower colors and provide theoretical basis for outcross breeding and developing health care products from this plant.	[Zhu, Manlan; Zheng, Xuchen; Shu, Qingyan; Li, Hui; Zhong, Peixing; Zhang, Huijin; Wang, Lijin; Wang, Liangsheng] Chinese Acad Sci, Inst Bot, Key Lab Plant Resources, Beijing Bot Garden, Beijing, Peoples R China; [Zhu, Manlan; Zheng, Xuchen; Zhong, Peixing] Nanjing Agr Univ, Coll Hort, Nanjing, Jiangsu, Peoples R China; [Li, Hui; Wang, Lijin] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Xu, Yanjun] China Agr Univ, Dept Appl Chem, Beijing 100094, Peoples R China	Chinese Academy of Sciences; Institute of Botany, CAS; Nanjing Agricultural University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; China Agricultural University	Zhu, ML (corresponding author), Chinese Acad Sci, Inst Bot, Key Lab Plant Resources, Beijing Bot Garden, Beijing, Peoples R China.	shuqy@ibcas.ac.cn; wanglsh@ibcas.ac.cn			National Natural Science Foundation of China [31071824]; International Science & Technology Cooperation Program of China [2011DFA30560]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); International Science & Technology Cooperation Program of China	The authors appreciate the support of the National Natural Science Foundation of China, No. 31071824, as well as International Science & Technology Cooperation Program of China, no. 2011DFA30560. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad-Garcia B, 2009, J CHROMATOGR A, V1216, P5398, DOI 10.1016/j.chroma.2009.05.039; Abulajiang Ke yimu, 2006, STUDY MASS SPECTROME; Afaq F, 2007, J INVEST DERMATOL, V127, P222, DOI 10.1038/sj.jid.5700510; Androutsopoulos VP, 2010, PHARMACOL THERAPEUT, V126, P9, DOI 10.1016/j.pharmthera.2010.01.009; Bomser J, 1996, PLANTA MED, V62, P212, DOI 10.1055/s-2006-957862; Bown D., 1995, ENCY HERBS THEIR USE; Bravo L, 1998, NUTR REV, V56, P317, DOI 10.1111/j.1753-4887.1998.tb01670.x; Cuyckens F, 2004, J MASS SPECTROM, V39, P1, DOI [10.1002/jms.585, 10.1002/jms.622]; Du QZ, 2004, J CHROMATOGR A, V1045, P59, DOI 10.1016/j.chroma.2004.06.017; Elegami AA, 2003, PHYTOCHEMISTRY, V63, P727, DOI 10.1016/S0031-9422(03)00238-3; Fossen T, 1998, PHYTOCHEMISTRY, V49, P1997, DOI 10.1016/S0031-9422(98)00420-8; Fossen T, 2001, J HORTIC SCI BIOTECH, V76, P213; Fossen T, 1999, PHYTOCHEMISTRY, V50, P1185, DOI 10.1016/S0031-9422(98)00649-9; Fossen T, 1998, PHYTOCHEMISTRY, V48, P823, DOI 10.1016/S0031-9422(97)00918-7; Fossen T, 1997, PHYTOCHEMISTRY, V46, P353, DOI 10.1016/S0031-9422(97)00293-8; Fossen T, 1999, PHYTOCHEMISTRY, V51, P1133, DOI 10.1016/S0031-9422(99)00049-7; Gonnet JF, 1999, FOOD CHEM, V66, P387, DOI 10.1016/S0308-8146(99)00088-6; Gonnet JF, 1998, FOOD CHEM, V63, P409, DOI 10.1016/S0308-8146(98)00053-3; HARBORNE JB, 1958, BIOCHEM J, V70, P22, DOI 10.1042/bj0700022; HARBORNE JB, 1962, BIOCHEM J, V84, P100, DOI 10.1042/bj0840100; He QL, 2011, PLOS ONE, V6, P1; Hou DX, 2005, BIOCHEM PHARMACOL, V70, P417, DOI 10.1016/j.bcp.2005.05.003; Huang G., 2009, WATER LILY; Jambor J, 1992, ACTA SOC BOT POL, V60, P119; Jambor Jerzy, 1991, Acta Societatis Botanicorum Poloniae, V60, P119, DOI 10.5586/asbp.1991.010; Juranic Z, 2005, BIOFACTORS, V23, P207, DOI 10.1002/biof.5520230405; Li CH, 2009, J AGR FOOD CHEM, V57, P8496, DOI 10.1021/jf902103b; Li QQ, 2005, PRACTICAL FORESTRY T, V10, P45; Lin LZ, 2007, J AGR FOOD CHEM, V55, P1084, DOI 10.1021/jf062431s; Liu RN, 2007, J ASIAN NAT PROD RES, V9, P333, DOI 10.1080/10286020600727665; Ma YL, 2001, PHYTOCHEM ANALYSIS, V12, P159, DOI 10.1002/pca.573; Markham KR, 1982, FLAVONOIDS ADV RES, V5-6, P37; Marquina S, 2005, PHYTOCHEMISTRY, V66, P921, DOI 10.1016/j.phytochem.2005.02.027; Pedreschi R, 2007, FOOD CHEM, V100, P956, DOI 10.1016/j.foodchem.2005.11.004; Shi YF, 2009, CHINA FRUIT VEGETABL, V8, P40; Solomon A, 2006, J AGR FOOD CHEM, V54, P7717, DOI 10.1021/jf060497h; Springob K, 2003, NAT PROD REP, V20, P288, DOI 10.1039/b109542k; Tanaka Y, 2005, PLANT CELL TISS ORG, V80, P1, DOI 10.1007/s11240-004-0739-8; The Chinese Academy of Sciences Flora Reipublicae Popularis Sinicae Editorial Board, 1979, FLOR REIP POP SIN, V27, P8; Wang LS, 2001, J PLANT RES, V114, P33, DOI 10.1007/PL00013966; Yang RZ, 2009, J CHROMATOGR A, V1216, P106, DOI 10.1016/j.chroma.2008.11.046; Yoshida H, 2004, SCI HORTIC-AMSTERDAM, V99, P175, DOI 10.1016/S0304-4238(03)00093-1; Zafra-Stone S, 2007, MOL NUTR FOOD RES, V51, P675, DOI 10.1002/mnfr.200700002; Zhang JJ, 2007, SCI HORTIC-AMSTERDAM, V114, P104, DOI 10.1016/j.scienta.2007.05.009; Zhang ZZ, 2003, J NAT PROD, V66, P548, DOI 10.1021/np020442j	45	36	44	2	90	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2012	7	4							e34335	10.1371/journal.pone.0034335	http://dx.doi.org/10.1371/journal.pone.0034335			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952GU	22485167	gold, Green Published, Green Submitted			2022-12-27	WOS:000304780500042
J	Hoa, N; Tsui, S; Afifiyan, NF; Hikim, AS; Li, B; Douglas, RS; Smith, TJ				Hoa, Neil; Tsui, Shanli; Afifiyan, Nikoo F.; Hikim, Amiya Sinha; Li, Bin; Douglas, Raymond S.; Smith, Terry J.			Nuclear Targeting of IGF-1 Receptor in Orbital Fibroblasts from Graves' Disease: Apparent Role of ADAM17	PLOS ONE			English	Article							FACTOR-I RECEPTOR; ENDOPEROXIDE H SYNTHASE-2; GROWTH-FACTOR RECEPTOR-1; HUMAN-SKIN FIBROBLASTS; T-CELLS; GLYCOSAMINOGLYCAN SYNTHESIS; LEUKOREGULIN INDUCTION; HYALURONAN SYNTHESIS; EGF-RECEPTOR; B-CELLS	Insulin-like growth factor-1 receptor (IGF-1R) comprises two subunits, including a ligand binding domain on extra-cellular IGF-1R alpha and a tyrosine phosphorylation site located on IGF-1R beta. IGF-1R is over-expressed by orbital fibroblasts in the autoimmune syndrome, Graves' disease (GD). When activated by IGF-1 or GD-derived IgG (GD-IgG), these fibroblasts produce RANTES and IL-16, while those from healthy donors do not. We now report that IGF-1 and GD-IgG provoke IGF-1R accumulation in the cell nucleus of GD fibroblasts where it co-localizes with chromatin. Nuclear IGF-1R is detected with anti-IGF-1R alpha-specific mAb and migrates to approximately 110 kDa, consistent with its identity as an IGF-1R fragment. Nuclear IGF-1R migrating as a 200 kDa protein and consistent with an intact receptor was undetectable when probed with either anti-IGF-1R alpha or anti-IGF-1R beta mAbs. Nuclear redistribution of IGF-1R is absent in control orbital fibroblasts. In GD fibroblasts, it can be abolished by an IGF-1R-blocking mAb, 1H7 and by physiological concentrations of glucocorticoids. When cell-surface IGF-1R is cross-linked with I-125 IGF-1, I-125-IGF-1/IGF-1R complexes accumulate in the nuclei of GD fibroblasts. This requires active ADAM17, a membrane associated metalloproteinase, and the phosphorylation of IGF-1R. In contrast, virally encoded IGF-1R alpha/GFP fusion protein localizes equivalently in nuclei in both control and GD fibroblasts. This result suggests that generation of IGF-1R fragments may limit the accumulation of nuclear IGF-1R. We thus identify a heretofore-unrecognized behavior of IGF-1R that appears limited to GD-derived fibroblasts. Nuclear IGF-1R may play a role in disease pathogenesis.	[Hoa, Neil; Tsui, Shanli; Afifiyan, Nikoo F.; Hikim, Amiya Sinha; Douglas, Raymond S.; Smith, Terry J.] Harbor Univ Calif Los Angeles Med Ctr, Dept Med, Div Mol Med, Torrance, CA USA; [Hoa, Neil; Tsui, Shanli; Afifiyan, Nikoo F.; Hikim, Amiya Sinha; Douglas, Raymond S.; Smith, Terry J.] Harbor Univ Calif Los Angeles Med Ctr, Dept Med, Div Endocrinol, Torrance, CA USA; [Hoa, Neil; Tsui, Shanli; Afifiyan, Nikoo F.; Hikim, Amiya Sinha; Douglas, Raymond S.; Smith, Terry J.] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Hoa, Neil; Smith, Terry J.] Vet Affairs Med Ctr, Long Beach, CA USA; [Li, Bin; Douglas, Raymond S.; Smith, Terry J.] Univ Michigan, Sch Med, Dept Ophthalmol & Visual Sci, Ann Arbor, MI USA; [Li, Bin; Douglas, Raymond S.; Smith, Terry J.] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Long Beach Healthcare System; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Hoa, N (corresponding author), Harbor Univ Calif Los Angeles Med Ctr, Dept Med, Div Mol Med, Torrance, CA USA.	terrysmi@med.umich.edu	Smith, Terry/ABG-1360-2020	Douglas, Raymond S./0000-0002-3435-8161; Smith, Terry/0000-0002-6279-9685	National Institutes of Health [EY008976, EY011708, EY021197]; Core Center for Vision grant from the National Eye Institute [EY007003]; Merit Review award from the Research Service of the Department of Veterans Affairs [DK063121, RR00425]; unrestricted grant from Research to Prevent Blindness; Research to Prevent Blindness Career Development Award; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000425] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY007003, F31EY007003, R01EY021197, R01EY011708, R01EY008976] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK063121] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Core Center for Vision grant from the National Eye Institute; Merit Review award from the Research Service of the Department of Veterans Affairs(US Department of Veterans Affairs); unrestricted grant from Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Research to Prevent Blindness Career Development Award(Research to Prevent Blindness (RPB)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by National Institutes of Health grants EY008976, EY011708, and EY021197; Core Center for Vision grant EY007003 from the National Eye Institute; DK063121, RR00425, a Merit Review award from the Research Service of the Department of Veterans Affairs; an unrestricted grant from Research to Prevent Blindness; and a Research to Prevent Blindness Career Development Award. We gratefully acknowledge generous support from the Bell Charitable Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams TE, 2000, CELL MOL LIFE SCI, V57, P1050, DOI 10.1007/PL00000744; BASERGA R, 1994, CELL PROLIFERAT, V27, P63, DOI 10.1111/j.1365-2184.1994.tb01406.x; Baserga Renato, 1993, Critical Reviews in Eukaryotic Gene Expression, V3, P47; Bazley LA, 2005, ENDOCR-RELAT CANCER, V12, pS17, DOI 10.1677/erc.1.01032; Bell JH, 2007, J LEUKOCYTE BIOL, V82, P173, DOI 10.1189/jlb.0307193; Bryant DM, 2005, MOL BIOL CELL, V16, P14, DOI 10.1091/mbc.E04-09-0845; Cao HJ, 1998, J BIOL CHEM, V273, P29615, DOI 10.1074/jbc.273.45.29615; Chen QQ, 2005, CELL RES, V15, P504, DOI 10.1038/sj.cr.7290320; Collett-Solberg PF, 2000, ENDOCRINE, V12, P121, DOI 10.1385/ENDO:12:2:121; De Meyts P, 2002, NAT REV DRUG DISCOV, V1, P769, DOI 10.1038/nrd917; DECARLI M, 1993, J CLIN ENDOCR METAB, V77, P1120, DOI 10.1210/jc.77.5.1120; Dittmann K, 2005, J BIOL CHEM, V280, P31182, DOI 10.1074/jbc.M506591200; Douglas RS, 2008, J IMMUNOL, V181, P5768, DOI 10.4049/jimmunol.181.8.5768; Douglas RS, 2007, J IMMUNOL, V178, P3281, DOI 10.4049/jimmunol.178.5.3281; Douglas RS, 2010, J CLIN ENDOCR METAB, V95, P430, DOI 10.1210/jc.2009-1614; Dupont J, 2001, J BIOL CHEM, V276, P26699, DOI 10.1074/jbc.M102664200; Eckstein AK, 2004, BRIT J OPHTHALMOL, V88, P803, DOI 10.1136/bjo.2003.035915; Eckstein AK, 2006, J CLIN ENDOCR METAB, V91, P3464, DOI 10.1210/jc.2005-2813; Fang XH, 2005, J BIOL CHEM, V280, P28451, DOI 10.1074/jbc.M504400200; FRANCIS GL, 1993, BIOCHEM J, V293, P713, DOI 10.1042/bj2930713; Gerding MN, 2000, CLIN ENDOCRINOL, V52, P267, DOI 10.1046/j.1365-2265.2000.00959.x; Han R, 2002, J BIOL CHEM, V277, P16355, DOI 10.1074/jbc.M111246200; Hardy RR, 1986, HDB EXPT IMMUNOLOGY, V1; Hartl D, 2008, J BIOL CHEM, V283, P33472, DOI 10.1074/jbc.M805574200; Hikim APS, 2003, J STEROID BIOCHEM, V85, P175, DOI 10.1016/S0960-0760(03)00193-6; Hung LY, 2008, NUCLEIC ACIDS RES, V36, P4337, DOI 10.1093/nar/gkn417; Itoh M, 2002, CYTOKINE, V19, P107, DOI 10.1006/cyto.2002.1055; JAUME JC, 1994, J CLIN ENDOCR METAB, V78, P348, DOI 10.1210/jc.78.2.348; Kazim M, 2002, ARCH OPHTHALMOL-CHIC, V120, P380; Krolewski JJ, 2005, J CELL BIOCHEM, V95, P478, DOI 10.1002/jcb.20451; LI SL, 1993, BIOCHEM BIOPH RES CO, V196, P92, DOI 10.1006/bbrc.1993.2220; Lin SY, 2001, NAT CELL BIOL, V3, P802, DOI 10.1038/ncb0901-802; Lo HW, 2005, CANCER CELL, V7, P575, DOI 10.1016/j.ccr.2005.05.007; Morrione A, 1997, J BIOL CHEM, V272, P26382, DOI 10.1074/jbc.272.42.26382; Morrione A, 1999, J BIOL CHEM, V274, P24094, DOI 10.1074/jbc.274.34.24094; Moser C, 2008, EUR J CANCER, V44, P1577, DOI 10.1016/j.ejca.2008.04.003; Prabhakar BS, 2003, ENDOCR REV, V24, P802, DOI 10.1210/er.2002-0020; Pritchard J, 2003, J IMMUNOL, V170, P6348, DOI 10.4049/jimmunol.170.12.6348; Pritchard J, 2002, J IMMUNOL, V168, P942, DOI 10.4049/jimmunol.168.2.942; ROSENFELD RG, 1982, J CLIN ENDOCR METAB, V55, P434, DOI 10.1210/jcem-55-3-434; Sahin U, 2004, J CELL BIOL, V164, P769, DOI 10.1083/jcb.200307137; Sahin U, 2007, FEBS LETT, V581, P41, DOI 10.1016/j.febslet.2006.11.074; Sarfstein R, 2012, J BIOL CHEM, V287, P2766, DOI 10.1074/jbc.M111.281782; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Seol KC, 2003, BIOCHEM BIOPH RES CO, V306, P898, DOI 10.1016/S0006-291X(03)01046-5; Smith TJ, 2010, PHARMACOL REV, V62, P199, DOI 10.1124/pr.109.002469; Smith TJ, 2004, J CLIN ENDOCR METAB, V89, P5076, DOI 10.1210/jc.2004-0716; Smith TJ, 2002, J CLIN ENDOCR METAB, V87, P385, DOI 10.1210/jc.87.1.385; SMITH TJ, 1984, J CLIN INVEST, V74, P2157, DOI 10.1172/JCI111642; SMITH TJ, 1988, METABOLISM, V37, P179, DOI 10.1016/S0026-0495(98)90015-4; Tanno B, 2006, CLIN CANCER RES, V12, P6772, DOI 10.1158/1078-0432.CCR-06-1479; Tsui S, 2008, J IMMUNOL, V181, P4397, DOI 10.4049/jimmunol.181.6.4397; Tsui S, 2011, J BIOL CHEM, V286, P24487, DOI 10.1074/jbc.M111.241166; Vecchione A, 2003, MOL CELL BIOL, V23, P3363, DOI 10.1128/MCB.23.9.3363-3372.2003; Wang HS, 1996, J BIOL CHEM, V271, P22718, DOI 10.1074/jbc.271.37.22718; Weetman AP, 2000, NEW ENGL J MED, V343, P1236, DOI 10.1056/NEJM200010263431707; Yadav A, 2005, J BIOL CHEM, V280, P31830, DOI 10.1074/jbc.M501316200; Young DA, 1998, P NATL ACAD SCI USA, V95, P8904, DOI 10.1073/pnas.95.15.8904; ZAKARIJA M, 1988, J CLIN INVEST, V81, P879, DOI 10.1172/JCI113398; Zhang L, 2009, J BIOL CHEM, V284, P26447, DOI 10.1074/jbc.M109.003616	60	20	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2012	7	4							e34173	10.1371/journal.pone.0034173	http://dx.doi.org/10.1371/journal.pone.0034173			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959FE	22506015	gold, Green Published, Green Submitted			2022-12-27	WOS:000305297500023
J	Kim, KM; Baratta, MV; Yang, AM; Lee, D; Boyden, ES; Fiorillo, CD				Kim, Kyung Man; Baratta, Michael V.; Yang, Aimei; Lee, Doheon; Boyden, Edward S.; Fiorillo, Christopher D.			Optogenetic Mimicry of the Transient Activation of Dopamine Neurons by Natural Reward Is Sufficient for Operant Reinforcement	PLOS ONE			English	Article							INTRACRANIAL SELF-STIMULATION; PROGRESSIVE-RATIO SCHEDULE; NUCLEUS-ACCUMBENS; INCENTIVE SALIENCE; MIDBRAIN DOPAMINE; PREDICTION ERROR; D-AMPHETAMINE; BEHAVIOR; FOOD; GLUTAMATE	Activation of dopamine receptors in forebrain regions, for minutes or longer, is known to be sufficient for positive reinforcement of stimuli and actions. However, the firing rate of dopamine neurons is increased for only about 200 milliseconds following natural reward events that are better than expected, a response which has been described as a "reward prediction error'' (RPE). Although RPE drives reinforcement learning (RL) in computational models, it has not been possible to directly test whether the transient dopamine signal actually drives RL. Here we have performed optical stimulation of genetically targeted ventral tegmental area (VTA) dopamine neurons expressing Channelrhodopsin-2 (ChR2) in mice. We mimicked the transient activation of dopamine neurons that occurs in response to natural reward by applying a light pulse of 200 ms in VTA. When a single light pulse followed each self-initiated nose poke, it was sufficient in itself to cause operant reinforcement. Furthermore, when optical stimulation was delivered in separate sessions according to a predetermined pattern, it increased locomotion and contralateral rotations, behaviors that are known to result from activation of dopamine neurons. All three of the optically induced operant and locomotor behaviors were tightly correlated with the number of VTA dopamine neurons that expressed ChR2, providing additional evidence that the behavioral responses were caused by activation of dopamine neurons. These results provide strong evidence that the transient activation of dopamine neurons provides a functional reward signal that drives learning, in support of RL theories of dopamine function.	[Kim, Kyung Man; Lee, Doheon; Fiorillo, Christopher D.] Korea Adv Inst Sci & Technol, Dept Bio & Brain Engn, Taejon 305701, South Korea; [Baratta, Michael V.; Yang, Aimei; Boyden, Edward S.] MIT, Media Lab, McGovern Inst, Cambridge, MA 02139 USA	Korea Advanced Institute of Science & Technology (KAIST); Massachusetts Institute of Technology (MIT)	Kim, KM (corresponding author), Korea Adv Inst Sci & Technol, Dept Bio & Brain Engn, Taejon 305701, South Korea.	esb@media.mit.edu; fiorillo@kaist.ac.kr	Fiorillo, Christopher Dante/C-1718-2011; Lee, Doheon/B-7303-2011	Lee, Doheon/0000-0001-9070-4316; Fiorillo, Christopher/0000-0002-7232-9505	World Class University program through the National Research Foundation of Korea; Ministry of Education, Science and Technology [R32-2008-000-10218-0]; National Institutes of Health; National Science Foundation; Jerry and Marge Burnett; Massachusetts Institute of Technology McGovern Institute; Brain & Behavior Research Foundation; Sloan Foundation; Coulter Foundation	World Class University program through the National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Jerry and Marge Burnett; Massachusetts Institute of Technology McGovern Institute; Brain & Behavior Research Foundation(NARSAD); Sloan Foundation(Alfred P. Sloan Foundation); Coulter Foundation	Research was supported by a grant to CDF and DL from the World Class University program through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology (grant number R32-2008-000-10218-0), and grants to ESB from National Institutes of Health, National Science Foundation, Jerry and Marge Burnett, the Massachusetts Institute of Technology McGovern Institute, The Brain & Behavior Research Foundation, and Sloan and Coulter Foundations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamantidis AR, 2011, J NEUROSCI, V31, P10829, DOI 10.1523/JNEUROSCI.2246-11.2011; Atasoy D, 2008, J NEUROSCI, V28, P7025, DOI 10.1523/JNEUROSCI.1954-08.2008; Backman CM, 2006, GENESIS, V44, P383, DOI 10.1002/dvg.20228; Bayer HM, 2005, NEURON, V47, P129, DOI 10.1016/j.neuron.2005.05.020; Berridge KC, 1998, BRAIN RES REV, V28, P309, DOI 10.1016/S0165-0173(98)00019-8; Berridge KC, 2007, PSYCHOPHARMACOLOGY, V191, P391, DOI 10.1007/s00213-006-0578-x; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Brischoux F, 2009, P NATL ACAD SCI USA, V106, P4894, DOI 10.1073/pnas.0811507106; Brown MTC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015870; Cannon CM, 2003, J NEUROSCI, V23, P10827; CONOVER KL, 1994, BEHAV NEUROSCI, V108, P537, DOI 10.1037/0735-7044.108.3.537; de Vaca SC, 2004, PSYCHOPHARMACOLOGY, V175, P106, DOI 10.1007/s00213-003-1768-4; Depoortere R, 1999, PSYCHOPHARMACOLOGY, V142, P221, DOI 10.1007/s002130050883; Domingos AI, 2011, NAT NEUROSCI, V14, P1562, DOI 10.1038/nn.2977; Easterling KW, 2000, PSYCHOPHARMACOLOGY, V148, P263, DOI 10.1007/s002130050050; Fiorillo CD, 2003, SCIENCE, V299, P1898, DOI 10.1126/science.1077349; Fiorillo CD, 2008, NAT NEUROSCI, V11, P966, DOI 10.1038/nn.2159; HOLMES LJ, 1985, BRAIN RES, V326, P19, DOI 10.1016/0006-8993(85)91380-0; Horvitz JC, 2000, NEUROSCIENCE, V96, P651, DOI 10.1016/S0306-4522(00)00019-1; KEESEY RE, 1968, J EXP ANAL BEHAV, V11, P293, DOI 10.1901/jeab.1968.11-293; Matsumoto M, 2009, NATURE, V459, P837, DOI 10.1038/nature08028; Michaels CC, 2007, BRAIN RES BULL, V73, P310, DOI 10.1016/j.brainresbull.2007.04.008; Montague PR, 1996, J NEUROSCI, V16, P1936, DOI 10.1523/jneurosci.16-05-01936.1996; Morikawa H, 2003, J NEUROSCI, V23, P149; Morris G, 2004, NEURON, V43, P133, DOI 10.1016/j.neuron.2004.06.012; NAKAHARA D, 1992, BRAIN RES, V574, P164, DOI 10.1016/0006-8993(92)90813-O; Nakahara H, 2004, NEURON, V41, P269, DOI 10.1016/S0896-6273(03)00869-9; Nomoto K, 2010, J NEUROSCI, V30, P10692, DOI 10.1523/JNEUROSCI.4828-09.2010; OLDS J, 1954, J COMP PHYSIOL PSYCH, V47, P419, DOI 10.1037/h0058775; Pan WX, 2005, J NEUROSCI, V25, P6235, DOI 10.1523/JNEUROSCI.1478-05.2005; PHILLIPS AG, 1976, BRAIN RES, V104, P221, DOI 10.1016/0006-8993(76)90615-6; Redgrave P, 1999, TRENDS NEUROSCI, V22, P146, DOI 10.1016/S0166-2236(98)01373-3; Redgrave P, 2008, BRAIN RES REV, V58, P322, DOI 10.1016/j.brainresrev.2007.10.007; Redish AD, 2004, SCIENCE, V306, P1944, DOI 10.1126/science.1102384; Rescorla R. A., 1972, CLASSICAL CONDITIONI; Robinson S, 2005, BEHAV NEUROSCI, V119, P5, DOI 10.1037/0735-7044.119.1.5; Roesch MR, 2007, NAT NEUROSCI, V10, P1615, DOI 10.1038/nn2013; Roitman MF, 2004, J NEUROSCI, V24, P1265, DOI 10.1523/JNEUROSCI.3823-03.2004; ROUTTENBERG A, 1965, J COMP PHYSIOL PSYCH, V60, P158, DOI 10.1037/h0022365; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; SPYRAKI C, 1982, BRAIN RES, V253, P185, DOI 10.1016/0006-8993(82)90685-0; Stuber GD, 2010, J NEUROSCI, V30, P8229, DOI 10.1523/JNEUROSCI.1754-10.2010; Sutton R.S., 2015, REINFORCEMENT LEARNI, V2nd ed.; Tecuapetla F, 2010, J NEUROSCI, V30, P7105, DOI 10.1523/JNEUROSCI.0265-10.2010; Tobler PN, 2005, SCIENCE, V307, P1642, DOI 10.1126/science.1105370; Tsai HC, 2009, SCIENCE, V324, P1080, DOI 10.1126/science.1168878; Wellman PJ, 2008, PHYSIOL BEHAV, V93, P952, DOI 10.1016/j.physbeh.2007.12.018; Wise RA, 2004, NAT REV NEUROSCI, V5, P483, DOI 10.1038/nrn1406; WISE RA, 1987, PSYCHOL REV, V94, P469, DOI 10.1037/0033-295X.94.4.469; Zweifel LS, 2009, P NATL ACAD SCI USA, V106, P7281, DOI 10.1073/pnas.0813415106	50	71	75	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2012	7	4							e33612	10.1371/journal.pone.0033612	http://dx.doi.org/10.1371/journal.pone.0033612			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959FE	22506004	Green Published, gold, Green Submitted			2022-12-27	WOS:000305297500012
J	Plotz, M; Hossini, AM; Gillissen, B; Daniel, PT; Stockfleth, E; Eberle, J				Ploetz, Michael; Hossini, Amir M.; Gillissen, Bernhard; Daniel, Peter T.; Stockfleth, Eggert; Eberle, Juergen			Mutual Regulation of Bcl-2 Proteins Independent of the BH3 Domain as Shown by the BH3-Lacking Protein Bcl-x(AK)	PLOS ONE			English	Article							HUMAN-MELANOMA CELLS; HUMAN-MALIGNANT-MELANOMA; CONDITIONAL EXPRESSION; TRIGGERS APOPTOSIS; BH3-ONLY PROTEINS; BAX; FAMILY; MITOCHONDRIA; DEATH; BIM	The BH3 domain of Bcl-2 proteins was regarded as indispensable for apoptosis induction and for mutual regulation of family members. We recently described Bcl-x(AK), a proapoptotic splice product of the bcl-x gene, which lacks BH3 but encloses BH2, BH4 and a transmembrane domain. It remained however unclear, how Bcl-x(AK) may trigger apoptosis. For efficient overexpression, Bcl-x(AK) was subcloned in an adenoviral vector under Tet-OFF control. The construct resulted in significant apoptosis induction in melanoma and nonmelanoma cell lines with up to 50% apoptotic cells as well as decreased cell proliferation and survival. Disruption of mitochondrial membrane potential, and cytochrome c release clearly indicated activation of the mitochondrial apoptosis pathways. Both Bax and Bak were activated as shown by clustering and conformation analysis. Mitochondrial translocation of Bcl-x(AK) appeared as an essential and initial step. Bcl-x(AK) was critically dependent on either Bax or Bak, and apoptosis was abrogated in Bax/Bak double knockout conditions as well by overexpression of Bcl-2 or Bcl-x(L). A direct interaction with Bcl-2, Bax, Bad, Noxa or Puma was however not seen by immunoprecipitation. Thus besides BH3-mediated interactions, there exists an additional way for mutual regulation of Bcl-2 proteins, which is independent of the BH3. This pathway appears to play a supplementary role also for other proapoptotic family members, and its unraveling may help to overcome therapy resistance in cancer.	[Ploetz, Michael; Hossini, Amir M.; Stockfleth, Eggert; Eberle, Juergen] Univ Med Ctr, Charite, Skin Canc Ctr, Dept Dermatol & Allergy, Berlin, Germany; [Gillissen, Bernhard; Daniel, Peter T.] Univ Med Ctr, Charite, Dept Hematol Oncol & Tumor Immunol, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Plotz, M (corresponding author), Univ Med Ctr, Charite, Skin Canc Ctr, Dept Dermatol & Allergy, Berlin, Germany.	juergen.eberle@charite.de		Eberle, Jurgen/0000-0001-8533-1519; Gillissen, Bernhard/0000-0002-1815-2091	Sonnenfeld-Stiftung, Berlin	Sonnenfeld-Stiftung, Berlin	The study was supported by the Sonnenfeld-Stiftung, Berlin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akgul C, 2004, CELL MOL LIFE SCI, V61, P2189, DOI 10.1007/s00018-004-4001-7; Billen LP, 2008, ONCOGENE, V27, pS93, DOI 10.1038/onc.2009.47; BOISE LH, 1993, CELL, V74, P597, DOI 10.1016/0092-8674(93)90508-N; BRUGGEN J, 1983, CANCER IMMUNOL IMMUN, V15, P200; CAREY TE, 1976, P NATL ACAD SCI USA, V73, P3278, DOI 10.1073/pnas.73.9.3278; Cheng EHYA, 2001, MOL CELL, V8, P705, DOI 10.1016/S1097-2765(01)00320-3; Chipuk JE, 2006, CELL DEATH DIFFER, V13, P1396, DOI 10.1038/sj.cdd.4401963; Chipuk JE, 2008, TRENDS CELL BIOL, V18, P157, DOI 10.1016/j.tcb.2008.01.007; Chipuk JE, 2010, MOL CELL, V37, P299, DOI 10.1016/j.molcel.2010.01.025; Eberle J, 2003, ONCOGENE, V22, P9131, DOI 10.1038/sj.onc.1207228; Eberle J, 2008, CURR GENOMICS, V9, P409, DOI 10.2174/138920208785699571; Eberle J, 2007, DRUG RESIST UPDATE, V10, P218, DOI 10.1016/j.drup.2007.09.001; Ewings KE, 2007, CELL CYCLE, V6, P2236, DOI 10.4161/cc.6.18.4728; Fecker LF, 2011, HUM GENE THER, V22, P405, DOI 10.1089/hum.2010.108; Fischer U, 2003, CELL DEATH DIFFER, V10, P76, DOI 10.1038/sj.cdd.4401160; Gallenne T, 2009, J CELL BIOL, V185, P279, DOI 10.1083/jcb.200809153; Gillissen B, 2003, EMBO J, V22, P3580, DOI 10.1093/emboj/cdg343; Gillissen B, 2007, J CELL BIOL, V179, P701, DOI 10.1083/jcb.200703040; Gogvadze V, 2008, TRENDS CELL BIOL, V18, P165, DOI 10.1016/j.tcb.2008.01.006; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Hossini AM, 2006, ONCOGENE, V25, P2160, DOI 10.1038/sj.onc.1209253; Hossini AM, 2003, FEBS LETT, V553, P250, DOI 10.1016/S0014-5793(03)01017-2; Kim H, 2006, NAT CELL BIOL, V8, P1348, DOI 10.1038/ncb1499; Kim H, 2009, MOL CELL, V36, P487, DOI 10.1016/j.molcel.2009.09.030; Kim TH, 2004, MOL BIOL CELL, V15, P3061, DOI 10.1091/mbc.E03-12-0864; Krammer PH, 2007, NAT REV IMMUNOL, V7, P532, DOI 10.1038/nri2115; Lindenboim L, 2005, CELL DEATH DIFFER, V12, P713, DOI 10.1038/sj.cdd.4401638; Lomonosova E, 2008, ONCOGENE, V27, pS2, DOI 10.1038/onc.2009.39; Martinou JC, 2011, DEV CELL, V21, P92, DOI 10.1016/j.devcel.2011.06.017; Merino D, 2009, J CELL BIOL, V186, P355, DOI 10.1083/jcb.200905153; Mikhailov V, 2003, J BIOL CHEM, V278, P5367, DOI 10.1074/jbc.M203392200; Moore MJ, 2010, CELL, V142, P625, DOI 10.1016/j.cell.2010.07.019; Muchmore SW, 1996, NATURE, V381, P335, DOI 10.1038/381335a0; Oppermann M, 2005, ONCOGENE, V24, P7369, DOI 10.1038/sj.onc.1208890; Raisova M, 2001, J INVEST DERMATOL, V117, P333, DOI 10.1046/j.0022-202x.2001.01409.x; Riccardi C, 2006, NAT PROTOC, V1, P1458, DOI 10.1038/nprot.2006.238; Riedl SJ, 2004, NAT REV MOL CELL BIO, V5, P897, DOI 10.1038/nrm1496; Schmitt E, 2004, ONCOGENE, V23, P3915, DOI 10.1038/sj.onc.1207554; Shkreta L, 2010, J BIOL CHEM; Slee EA, 2000, CELL DEATH DIFFER, V7, P556, DOI 10.1038/sj.cdd.4400689; Tait SWG, 2010, NAT REV MOL CELL BIO, V11, P621, DOI 10.1038/nrm2952; van Delft MF, 2006, CELL RES, V16, P203, DOI 10.1038/sj.cr.7310028; Vande Velde C, 2000, MOL CELL BIOL, V20, P5454, DOI 10.1128/MCB.20.15.5454-5468.2000; Vogler M, 2009, CELL DEATH DIFFER, V16, P1030, DOI 10.1038/cdd.2009.48; Weber A, 2007, J CELL BIOL, V177, P625, DOI 10.1083/jcb.200610148; Willis SN, 2005, CURR OPIN CELL BIOL, V17, P617, DOI 10.1016/j.ceb.2005.10.001; Wolf J, 2010, J BIOL CHEM; Youle RJ, 2005, NAT REV MOL CELL BIO, V6, P657, DOI 10.1038/nrm1697; Zhai DY, 2008, J BIOL CHEM, V283, P9580, DOI 10.1074/jbc.M708426200	49	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2012	7	4							e34549	10.1371/journal.pone.0034549	http://dx.doi.org/10.1371/journal.pone.0034549			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959FE	22506026	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000305297500034
J	Hernandez-Lemus, E; Nicasio-Collazo, LA; Castaneda-Priego, R				Hernandez-Lemus, Enrique; Adriana Nicasio-Collazo, Luz; Castaneda-Priego, Ramon			Hysteresis in Pressure-Driven DNA Denaturation	PLOS ONE			English	Article							IRREVERSIBLE THERMODYNAMICS; CHARGE RENORMALIZATION; BASE COMPOSITION; STRESS; DYNAMICS; ENTROPY; DAMAGE; HELIX; ACID	In the past, a great deal of attention has been drawn to thermal driven denaturation processes. In recent years, however, the discovery of stress-induced denaturation, observed at the one-molecule level, has revealed new insights into the complex phenomena involved in the thermo-mechanics of DNA function. Understanding the effect of local pressure variations in DNA stability is thus an appealing topic. Such processes as cellular stress, dehydration, and changes in the ionic strength of the medium could explain local pressure changes that will affect the molecular mechanics of DNA and hence its stability. In this work, a theory that accounts for hysteresis in pressure-driven DNA denaturation is proposed. We here combine an irreversible thermodynamic approach with an equation of state based on the Poisson-Boltzmann cell model. The latter one provides a good description of the osmotic pressure over a wide range of DNA concentrations. The resulting theoretical framework predicts, in general, the process of denaturation and, in particular, hysteresis curves for a DNA sequence in terms of system parameters such as salt concentration, density of DNA molecules and temperature in addition to structural and configurational states of DNA. Furthermore, this formalism can be naturally extended to more complex situations, for example, in cases where the host medium is made up of asymmetric salts or in the description of the (helical-like) charge distribution along the DNA molecule. Moreover, since this study incorporates the effect of pressure through a thermodynamic analysis, much of what is known from temperature-driven experiments will shed light on the pressure-induced melting issue.	[Hernandez-Lemus, Enrique] Natl Inst Genom Med, Computat Genom Dept, Mexico City, DF, Mexico; [Hernandez-Lemus, Enrique] Univ Nacl Autonoma Mexico, Ctr Complex Sci, Mexico City 04510, DF, Mexico; [Adriana Nicasio-Collazo, Luz; Castaneda-Priego, Ramon] Univ Guanajuato, Div Sci & Engn, Leon, Guanajuato, Mexico	Instituto Nacional de Medicina Genomica; Universidad Nacional Autonoma de Mexico; Universidad de Guanajuato	Hernandez-Lemus, E (corresponding author), Natl Inst Genom Med, Computat Genom Dept, Mexico City, DF, Mexico.	ehernandez@inmegen.gob.mx; ramoncp@fisica.ugto.mx	Castaneda-Priego, Ramon/D-5043-2009	Hernandez-Lemus, Enrique/0000-0002-1872-1397	(PIFI) of the Secretaria de Educacion Publica (Mexico's Ministry of Education) [3.4]; Mexico's National Council of Science and Technology (CONACyT) [61418/2007, 102339/2008]; National Institute of Genomic Medicine (Mexico)	(PIFI) of the Secretaria de Educacion Publica (Mexico's Ministry of Education); Mexico's National Council of Science and Technology (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); National Institute of Genomic Medicine (Mexico)	Financial support from the Integral Program for Institutional Strengthening (PIFI for its Spanish acronym) of the Secretaria de Educacion Publica (Mexico's Ministry of Education) 3.4, and Mexico's National Council of Science and Technology (CONACyT for its Spanish acronym) (grant nos. 61418/2007 and 102339/2008), as well as federal funding from the National Institute of Genomic Medicine (Mexico) is acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER S, 1984, J CHEM PHYS, V80, P5776, DOI 10.1063/1.446600; Barbi M, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.061909; Belloni L, 2000, J PHYS-CONDENS MAT, V12, pR549, DOI 10.1088/0953-8984/12/46/201; Benham CJ, 1996, J MOL BIOL, V255, P425, DOI 10.1006/jmbi.1996.0035; Blake RD, 1999, BIOINFORMATICS, V15, P370, DOI 10.1093/bioinformatics/15.5.370; BRESLAUER KJ, 1992, METHOD ENZYMOL, V211, P533; Cattaneo C, 1949, ATT SEM MAT FIS U MO, V3, P83101; CHEN M, 1993, J MATH PHYS, V34, P3012, DOI 10.1063/1.530060; Choi CH, 2004, NUCLEIC ACIDS RES, V32, P1584, DOI 10.1093/nar/gkh335; Cocco S, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.011910; Cocco S, 2002, CR PHYS, V3, P569, DOI 10.1016/S1631-0705(02)01345-2; Dagdug L, 2004, REV MEX FIS, V50, P594; Daune M., 1999, MOL BIOPHYSICS STRUC; Denton AR, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/36/364108; Dobnikar J, 2006, NEW J PHYS, V8, DOI 10.1088/1367-2630/8/11/277; Dubins DN, 2001, J AM CHEM SOC, V123, P9254, DOI 10.1021/ja004309u; EssevazRoulet B, 1997, P NATL ACAD SCI USA, V94, P11935, DOI 10.1073/pnas.94.22.11935; Frank-Kamenestskii MD, 2006, SELF ASSEMBLY PATTER; GLASEL JA, 1995, BIOTECHNIQUES, V18, P62; Hansen L., 2001, PHYS REV E, V64, DOI [DOI 10.1103/PHYSREVE.64.021907), 10.1103/PhysRevE.64.021907]; Hennig D, 2006, ARXIVNLINPS0306019V1; Hernandez-Lemus E, 2002, REV MEX FIS, V48, P38; Ichijima Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008821; JOU D, 1985, PHYS REV A, V31, P2502, DOI 10.1103/PhysRevA.31.2502; Jou D, 1998, EXTENDED IRREVERSIBL; Kanduc M, 2009, SOFT MATTER, V5, P868, DOI 10.1039/b811795k; Kleckner N, 2004, P NATL ACAD SCI USA, V101, P12592, DOI 10.1073/pnas.0402724101; Kurki S, 2003, J CELL SCI, V116, P3917, DOI 10.1242/jcs.00714; Kurzynski M, 2000, PHYSICA A, V285, P29, DOI 10.1016/S0378-4371(00)00270-3; MacQuarrie D.A., 1976, STAT MECH; MARMUR J, 1962, J MOL BIOL, V5, P109, DOI 10.1016/S0022-2836(62)80066-7; MAYERGOYZ ID, 1986, PHYS REV LETT, V56, P1518, DOI 10.1103/PhysRevLett.56.1518; Peyrard M, 2004, NONLINEARITY, V17, pR1, DOI 10.1088/0951-7715/17/2/R01; Pianegonda S, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2387168; POLAND D, 1974, BIOPOLYMERS, V13, P1859, DOI 10.1002/bip.1974.360130916; Rayan G, 2005, J PHYS CHEM B, V109, P15558, DOI 10.1021/jp050899c; Reza Amiri A, 2010, THESIS U TORONTO; Rief M, 1999, NAT STRUCT BIOL, V6, P346; Rouzina I, 2001, BIOPHYS J, V80, P882, DOI 10.1016/S0006-3495(01)76067-5; Salim NS, 2009, ISOTHERMAL TITRATION; Smith SB, 1996, SCIENCE, V271, P795, DOI 10.1126/science.271.5250.795; Storm C, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.051906; Stroock DW, 1982, TATA I FUNDAMENTAL R; Trizac E, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.011401; Trizac E, 2003, LANGMUIR, V19, P4027, DOI 10.1021/la027056m; Vernotte P, 1958, CR HEBD ACAD SCI, V246; von Zglinicki T, 2001, EXP GERONTOL, V36, P1049, DOI 10.1016/S0531-5565(01)00111-5; Wannier GH, 1987, STAT PHYS; Whitelam S, 2008, BIOPHYS J, V94, P2452, DOI 10.1529/biophysj.107.117036; Williams MC, 2004, SPECTROSC-INT J, V18, P203, DOI 10.1155/2004/403203; Wilton DJ, 2008, NUCLEIC ACIDS RES, V36, P4032, DOI 10.1093/nar/gkn350; Zoli M, 2011, ARXIV11064207	52	3	3	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2012	7	4							e33789	10.1371/journal.pone.0033789	http://dx.doi.org/10.1371/journal.pone.0033789			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JO	22496765	Green Published, gold, Green Submitted			2022-12-27	WOS:000305014500016
J	Chen, HL; Huang, JY; Chen, CM; Chu, TH; Shih, C				Chen, Hung-Lin; Huang, Jyun-Yuan; Chen, Chun-Ming; Chu, Tien-Hua; Shih, Chiaho			MicroRNA-22 Can Reduce Parathymosin Expression in Transdifferentiated Hepatocytes	PLOS ONE			English	Article							CELL-PROLIFERATION; TRANSCRIPTION FACTORS; ZN2+-BINDING PROTEIN; RAT-TISSUES; IN-VIVO; LIVER; BINDING; VIRUS; DIFFERENTIATION; RECOGNITION	Pancreatic acinar cells AR42J-B13 can transdifferentiate into hepatocyte-like cells permissive for efficient hepatitis B virus (HBV) replication. Here, we profiled miRNAs differentially expressed in AR42J-B13 cells before and after transdifferentiation to hepatocytes, using chip-based microarray. Significant increase of miRNA expression, including miR-21, miR-22, and miR-122a, was confirmed by stem-loop real-time PCR and Northern blot analyses. In contrast, miR-93, miR-130b, and a number of other miRNAs, were significantly reduced after transdifferentiation. To investigate the potential significance of miR-22 in hepatocytes, we generated cell lines stably expressing miR-22. By 2D-DIGE, LC-MS/MS, and Western blot analyses, we identified several potential target genes of miR-22, including parathymosin. In transdifferentiated hepatocytes, miR-22 can inhibit both mRNA and protein expression of parathymosin, probably through a direct and an indirect mechanism. We tested two computer predicted miR-22 target sites at the 3' UTR of parathymosin, by the 3' UTR reporter gene assay. Treatment with anti-miR-22 resulted in significant elevation of the reporter activity. In addition, we observed an in vivo inverse correlation between miR-22 and parathymosin mRNA in their tissue distribution in a rat model. The phenomenon that miR-22 can reduce parathymosin protein was also observed in human hepatoma cell lines Huh7 and HepG2. So far, we detected no major effect on several transdifferentiation markers when AR42J-B13 cells were transfected with miR-22, or anti-miR-22, or a parathymosin expression vector, with or without dexamethasone treatment. Therefore, miR-22 appears to be neither necessary nor sufficient for transdifferentiation. We discussed the possibility that altered expression of some other microRNAs could induce cell cycle arrest leading to transdifferentiation.	[Chen, Hung-Lin; Chen, Chun-Ming; Shih, Chiaho] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Huang, Jyun-Yuan; Chu, Tien-Hua; Shih, Chiaho] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan	Academia Sinica - Taiwan; National Defense Medical Center	Chen, HL (corresponding author), Acad Sinica, Inst Biomed Sci, Taipei, Taiwan.	cshih@ibms.sinica.edu.tw	Shih, Chiaho/S-7017-2018	Chen, Hung-Lin/0000-0001-7900-3391	National Science Council; Academia Sinica; National Health Research Institute, Taiwan; Affymetrix Gene Expression Service Lab, Academia Sinica, Taiwan	National Science Council(Ministry of Science and Technology, Taiwan); Academia Sinica(Academia Sinica - Taiwan); National Health Research Institute, Taiwan(National Health Research Institutes - Taiwan); Affymetrix Gene Expression Service Lab, Academia Sinica, Taiwan	The authors acknowledge the funding from National Science Council, Academia Sinica, and National Health Research Institute, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the support from the Affymetrix Gene Expression Service Lab (http://ipmb.sinica.edu.tw/affy/), Academia Sinica, Taiwan. We thank Dr. Wen-Chang Lin for careful reading and discussion on this manuscript	ADEN DP, 1979, NATURE, V282, P615, DOI 10.1038/282615a0; Ambs S, 2008, CANCER RES, V68, P6162, DOI 10.1158/0008-5472.CAN-08-0144; Bar N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010859; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Behm-Ansmant I, 2006, GENE DEV, V20, P1885, DOI 10.1101/gad.1424106; BRAND IA, 1991, EUR J CELL BIOL, V54, P157; Chen JF, 2010, J CELL BIOL, V190, P867, DOI 10.1083/jcb.200911036; Esau C, 2006, CELL METAB, V3, P87, DOI 10.1016/j.cmet.2006.01.005; Girard M, 2008, J HEPATOL, V48, P648, DOI 10.1016/j.jhep.2008.01.019; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; HARITOS AA, 1985, P NATL ACAD SCI USA, V82, P1050, DOI 10.1073/pnas.82.4.1050; Hino K, 2008, RNA, V14, P1433, DOI 10.1261/rna.810208; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lal A, 2009, MOL CELL, V35, P610, DOI 10.1016/j.molcel.2009.08.020; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lewis AP, 2010, BIOCHEM SOC T, V38, P1553, DOI 10.1042/BST0381553; Martic G, 2005, J BIOL CHEM, V280, P16143, DOI 10.1074/jbc.M410175200; Meng FY, 2007, J BIOL CHEM, V282, P8256, DOI 10.1074/jbc.M607712200; NAKABAYASHI H, 1982, CANCER RES, V42, P3858; Nilsen TW, 2007, TRENDS GENET, V23, P243, DOI 10.1016/j.tig.2007.02.011; Okamoto K, 2005, J BIOL CHEM, V280, P36986, DOI 10.1074/jbc.M506056200; Pandey DP, 2009, MOL CELL BIOL, V29, P3783, DOI 10.1128/MCB.01875-08; Patel JB, 2011, ONCOGENE, V30, P1290, DOI 10.1038/onc.2010.510; RAO MS, 1988, BIOCHEM BIOPH RES CO, V156, P131, DOI 10.1016/S0006-291X(88)80814-3; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Savkovic V, 2004, DIGEST DIS, V22, P239, DOI 10.1159/000082795; Shen CN, 2000, NAT CELL BIOL, V2, P879, DOI 10.1038/35046522; SHIH CH, 1989, P NATL ACAD SCI USA, V86, P6323, DOI 10.1073/pnas.86.16.6323; Smith SB, 1999, MOL CELL BIOL, V19, P8272; Thomas M, 2010, NAT STRUCT MOL BIOL, V17, P1169, DOI 10.1038/nsmb.1921; Ting Y, 2010, BIOCHEM BIOPH RES CO, V394, P606, DOI 10.1016/j.bbrc.2010.03.030; Tosh D, 2007, BIOL CELL, V99, P37, DOI 10.1042/BC20060050; Wang J, 2011, J CELL BIOCH; Wang RYL, 2005, J VIROL, V79, P13116, DOI 10.1128/JVI.79.20.13116-13128.2005; Wingender E, 1996, NUCLEIC ACIDS RES, V24, P238, DOI 10.1093/nar/24.1.238; Xiong J, 2010, ONCOGENE, V29, P4980, DOI 10.1038/onc.2010.241; Xu H, 2010, HEPATOLOGY, V52, P1431, DOI 10.1002/hep.23818; Yeung ML, 2008, CANCER RES, V68, P8976, DOI 10.1158/0008-5472.CAN-08-0769; Zhang J, 2010, BRIT J CANCER, V103, P1215, DOI 10.1038/sj.bjc.6605895	42	6	7	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2012	7	4							e34116	10.1371/journal.pone.0034116	http://dx.doi.org/10.1371/journal.pone.0034116			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JA	22493679	Green Submitted, Green Published, gold			2022-12-27	WOS:000305012700021
J	Johns, SE; Hargrave, LA; Newton-Fisher, NE				Johns, Sarah E.; Hargrave, Lucy A.; Newton-Fisher, Nicholas E.			Red Is Not a Proxy Signal for Female Genitalia in Humans	PLOS ONE			English	Article							EXTERNAL GENITALIA; SEXUAL SWELLINGS; COLOR; WOMEN; PERFORMANCE; FERTILITY; EVOLUTION; DOMINANCE; VAGINITIS; PRIMATES	Red is a colour that induces physiological and psychological effects in humans, affecting competitive and sporting success, signalling and enhancing male social dominance. The colour is also associated with increased sexual attractiveness, such that women associated with red objects or contexts are regarded as more desirable. It has been proposed that human males have a biological predisposition towards the colour red such that it is 'sexually salient'. This hypothesis argues that women use the colour red to announce impending ovulation and sexual proceptivity, with this functioning as a proxy signal for genital colour, and that men show increased attraction in consequence. In the first test of this hypothesis, we show that contrary to the hypothesis, heterosexual men did not prefer redder female genitalia and, by extension, that red is not a proxy signal for genital colour. We found a relative preference for pinker genital images with redder genitalia rated significantly less sexually attractive. This effect was independent of raters' prior sexual experience and variation in female genital morphology. Our results refute the hypothesis that men's attraction to red is linked to an implied relationship to genital colour and women's signalling of fertility and sexual proceptivity.	[Johns, Sarah E.; Hargrave, Lucy A.; Newton-Fisher, Nicholas E.] Univ Kent, Sch Anthropol & Conservat, Canterbury, Kent, England	University of Kent	Johns, SE (corresponding author), Univ Kent, Sch Anthropol & Conservat, Canterbury, Kent, England.	s.e.johns@kent.ac.uk		Newton-Fisher, Nicholas/0000-0002-7657-2641; Johns, Sarah/0000-0002-7715-7351				Ackerman D, 1993, NATURAL HIST SENSES; ANDERSON CM, 1994, PRIMATES, V35, P283, DOI 10.1007/BF02382726; Attrill MJ, 2008, J SPORT SCI, V26, P577, DOI 10.1080/02640410701736244; Ayala ES, 2009, J PSYCHIATR RES, V43, P1235, DOI 10.1016/j.jpsychires.2009.04.008; Basaran M, 2008, CLIMACTERIC, V11, P416, DOI 10.1080/13697130802366670; BIELERT C, 1989, J ZOOL, V219, P569, DOI 10.1111/j.1469-7998.1989.tb02601.x; Brewer S, 2004, BLUFFERS GUIDE SEX; Buckley T, BLOOD MAGIC ANTHR ME; Crichton N, 2001, J CLIN NURS, V10, P706; Cuthill IC, 1997, P ROY SOC B-BIOL SCI, V264, P1093, DOI 10.1098/rspb.1997.0151; Edwards Libby, 2004, Dermatol Ther, V17, P102, DOI 10.1111/j.1396-0296.2004.04010.x; Elliot AJ, 2008, J PERS SOC PSYCHOL, V95, P1150, DOI 10.1037/0022-3514.95.5.1150; Farage Miranda, 2006, Archives of Gynecology and Obstetrics, V273, P195, DOI 10.1007/s00404-005-0079-x; Gangestad SW, 2010, EVOL HUM BEHAV, V31, P400, DOI 10.1016/j.evolhumbehav.2010.05.003; Greenfield A.B., 2006, PERFECT RED EMPIRE E; Heffner L.J., 2010, REPROD SYSTEM GLANCE; Hill RA, 2005, NATURE, V435, P293, DOI 10.1038/435293a; Howarth H, 2010, MED HUMANIT, V36, P75, DOI 10.1136/jmh.2009.003707; Huchard E, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-96; Huchard E, 2009, P ROY SOC B-BIOL SCI, V276, P1889, DOI 10.1098/rspb.2008.1923; Ilie A, 2008, CYBERPSYCHOL BEHAV, V11, P375, DOI 10.1089/cpb.2007.0122; Jung I., 2011, COMMUN COMPUT PHYS, V173, P284, DOI [DOI 10.1007/978-3-642-22098-2_57, 10.1007/978-3-642-22098-2_57]; Kayser DN, 2010, EUR J SOC PSYCHOL, V40, P901, DOI 10.1002/ejsp.757; Kinsey Alfred, 1953, SEXUAL BEHAV HUMAN F; Kissling EA, 2002, SEX ROLES, V46, P5, DOI 10.1023/A:1016029416750; Knight C., 1995, BLOOD RELATIONS MENS; Little A.C., 2007, J EVOLUTIONARY PSYCH, V5, P161, DOI [10. 1556/JEP. 2007. 1008, DOI 10.1556/JEP.2007.1008, https://doi.org/10.1556/JEP.2007.1008]; Lloyd J, 2005, BJOG-INT J OBSTET GY, V112, P643, DOI 10.1111/j.1471-0528.2004.00517.x; Low BS, 1979, EVOLUTIONARY BIOL HU, P462; Maier MA, 2008, PERS SOC PSYCHOL B, V34, P1530, DOI 10.1177/0146167208323104; Masters WH., 1966, HUMAN SEXUAL RESPONS; Morris D, 2005, NAKED WOMAN; Morris D., 1967, NAKED APE; MORTON RS, 1977, P ROY SOC MED, V70, P3, DOI 10.1177/00359157770700S402; Nunn CL, 1999, ANIM BEHAV, V58, P229, DOI 10.1006/anbe.1999.1159; Pallingston J, 1999, LIPSTICK CELEBRATION; Pryke SR, 2006, P ROY SOC B-BIOL SCI, V273, P949, DOI 10.1098/rspb.2005.3362; Roberts SC, 2010, EVOL PSYCHOL-US, V8, P350, DOI 10.1177/147470491000800304; Schick VR, 2011, J SEX RES, V48, P74, DOI 10.1080/00224490903308404; Schienle A, 2003, ANXIETY STRESS COPIN, V16, P185, DOI 10.1080/1061580021000030544; Setchell JM, 2005, ETHOLOGY, V111, P25, DOI 10.1111/j.1439-0310.2004.01054.x; Stephen ID, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005083; Stika CS, 2010, DERMATOL THER, V23, P514, DOI 10.1111/j.1529-8019.2010.01354.x; Tanfer K, 1996, SEX TRANSM DIS, V23, P395, DOI 10.1097/00007435-199609000-00009; VERKAUF BS, 1992, OBSTET GYNECOL, V80, P41; Waitt C, 2006, AM J PRIMATOL, V68, P738, DOI 10.1002/ajp.20264; WOLNER-HANSSEN P, 1989, Journal of the American Medical Association, V261, P571, DOI 10.1001/jama.261.4.571	47	5	6	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2012	7	4							e34669	10.1371/journal.pone.0034669	http://dx.doi.org/10.1371/journal.pone.0034669			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	955JA	22493709	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000305012700051
J	Azevedo, RVDM; Dias, DBS; Bretas, JAC; Mazzoni, CJ; Souza, NA; Albano, RM; Wagner, G; Davila, AMR; Peixoto, AA				Azevedo, Renata V. D. M.; Dias, Denise B. S.; Bretas, Jorge A. C.; Mazzoni, Camila J.; Souza, Nataly A.; Albano, Rodolpho M.; Wagner, Glauber; Davila, Alberto M. R.; Peixoto, Alexandre A.			The Transcriptome of Lutzomyia longipalpis (Diptera: Psychodidae) Male Reproductive Organs	PLOS ONE			English	Article							ACCESSORY-GLAND-PROTEINS; DENGUE VECTOR MOSQUITO; PHYSIOLOGICAL FUNCTIONS; VISCERAL LEISHMANIASIS; GENETIC-DIVERGENCE; SPECIES COMPLEX; SAND FLIES; DROSOPHILA; FEMALE; EXPRESSION	Background: It has been suggested that genes involved in the reproductive biology of insect disease vectors are potential targets for future alternative methods of control. Little is known about the molecular biology of reproduction in phlebotomine sand flies and there is no information available concerning genes that are expressed in male reproductive organs of Lutzomyia longipalpis, the main vector of American visceral leishmaniasis and a species complex. Methods/Principal Findings: We generated 2678 high quality ESTs ("Expressed Sequence Tags'') of L. longipalpis male reproductive organs that were grouped in 1391 non-redundant sequences (1136 singlets and 255 clusters). BLAST analysis revealed that only 57% of these sequences share similarity with a L. longipalpis female EST database. Although no more than 36% of the non-redundant sequences showed similarity to protein sequences deposited in databases, more than half of them presented the best-match hits with mosquito genes. Gene ontology analysis identified subsets of genes involved in biological processes such as protein biosynthesis and DNA replication, which are probably associated with spermatogenesis. A number of non-redundant sequences were also identified as putative male reproductive gland proteins (mRGPs), also known as male accessory gland protein genes (Acps). Conclusions: The transcriptome analysis of L. longipalpis male reproductive organs is one step further in the study of the molecular basis of the reproductive biology of this important species complex. It has allowed the identification of genes potentially involved in spermatogenesis as well as putative mRGPs sequences, which have been studied in many insect species because of their effects on female post-mating behavior and physiology and their potential role in sexual selection and speciation. These data open a number of new avenues for further research in the molecular and evolutionary reproductive biology of sand flies.	[Azevedo, Renata V. D. M.; Dias, Denise B. S.; Bretas, Jorge A. C.; Souza, Nataly A.; Wagner, Glauber; Davila, Alberto M. R.; Peixoto, Alexandre A.] Fiocruz MS, Inst Oswaldo Cruz, BR-21045900 Rio De Janeiro, Brazil; [Dias, Denise B. S.] Univ Estado Rio de Janeiro, Dept Biol Celular, BR-20550011 Rio De Janeiro, Brazil; [Mazzoni, Camila J.] Inst Zoo & Wildtierforsch, Berlin, Germany; [Mazzoni, Camila J.] Berlin Ctr Genom Biodivers Res, Berlin, Germany; [Albano, Rodolpho M.] Univ Estado Rio de Janeiro, Dept Bioquim, BR-20550011 Rio De Janeiro, Brazil; [Wagner, Glauber] Univ Oeste Santa Catarina, Area Ciencias Biol & Saude, Joacaba, SC, Brazil; [Davila, Alberto M. R.] Fiocruz MS, Polo Biol Computac & Sistemas, BR-21045900 Rio De Janeiro, Brazil	Fundacao Oswaldo Cruz; Universidade do Estado do Rio de Janeiro; Leibniz Institut fur Zoo und Wildtierforschung; Universidade do Estado do Rio de Janeiro; Universidade do Oeste de Santa Catarina; Fundacao Oswaldo Cruz	Azevedo, RVDM (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, BR-21045900 Rio De Janeiro, Brazil.	apeixoto@ioc.fiocruz.br	Wagner, Glauber GW/B-2369-2013; Mazzoni, Camila J/L-3441-2014; Mazzoni, Camila/AAJ-9702-2020; Dávila, Alberto M. R./AAJ-4647-2021	Wagner, Glauber GW/0000-0001-5003-6595; Mazzoni, Camila/0000-0001-6758-5427; Dávila, Alberto M. R./0000-0002-6918-7673; Albano, Rodolpho/0000-0002-0643-901X	Howard Hughes Medical Institute; CNPq; Faperj; FIOCRUZ	Howard Hughes Medical Institute(Howard Hughes Medical Institute); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Faperj(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); FIOCRUZ	This work was supported by grants from the Howard Hughes Medical Institute, CNPq, Faperj, and FIOCRUZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida FC, 2009, GENETICS, V181, P235, DOI 10.1534/genetics.108.096263; Anderson JM, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-52; Andrews J, 2000, GENOME RES, V10, P2030, DOI 10.1101/gr.10.12.2030; [Anonymous], 1991, BIOL BLOOD SUCKING I; Araki AS, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000365; Arner ESJ, 2000, EUR J BIOCHEM, V267, P6102, DOI 10.1046/j.1432-1327.2000.01701.x; Arrivillaga J, 2003, J MED ENTOMOL, V40, P615, DOI 10.1603/0022-2585-40.5.615; Baker DA, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-296; Barth R., 1961, Memorias do Instituto Oswaldo Cruz, V59, P23; Bauzer LGSR, 2007, MEM I OSWALDO CRUZ, V102, P1, DOI 10.1590/S0074-02762007000100001; Breugelmans B, 2009, PEPTIDES, V30, P622, DOI 10.1016/j.peptides.2008.07.026; Davies SJ, 2006, INSECT BIOCHEM MOLEC, V36, P846, DOI 10.1016/j.ibmb.2006.08.009; Davila AMR, 2005, BIOINFORMATICS, V21, P4302, DOI 10.1093/bioinformatics/bti705; Dillon RJ, 2006, GENOMICS, V88, P831, DOI 10.1016/j.ygeno.2006.06.011; Dottorini T, 2007, P NATL ACAD SCI USA, V104, P16215, DOI 10.1073/pnas.0703904104; DOWNE AER, 1975, J INSECT PHYSIOL, V21, P1835, DOI 10.1016/0022-1910(75)90250-4; Fausto AM, 2000, TISSUE CELL, V32, P228, DOI 10.1054/tice.2000.0110; Galindo K, 2001, GENETICS, V159, P1059; Gillott C, 2003, ANNU REV ENTOMOL, V48, P163, DOI 10.1146/annurev.ento.48.091801.112657; Guedes SD, 2005, BIOCHEM BIOPH RES CO, V328, P106, DOI 10.1016/j.bbrc.2004.12.135; Jochim RC, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-15; Krzywinska E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-300; Lainson R, 2005, MEM I OSWALDO CRUZ, V100, P811, DOI 10.1590/S0074-02762005000800001; LANZARO GC, 1993, AM J TROP MED HYG, V48, P839, DOI 10.4269/ajtmh.1993.48.839; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lins RMMA, 2008, MEM I OSWALDO CRUZ, V103, P736, DOI 10.1590/S0074-02762008000700019; Lung O, 2001, J INSECT PHYSIOL, V47, P617, DOI 10.1016/S0022-1910(00)00151-7; Maingon RDC, 2008, TRENDS PARASITOL, V24, P12, DOI 10.1016/j.pt.2007.10.003; MEIKLE DB, 1990, J INSECT PHYSIOL, V36, P93, DOI 10.1016/0022-1910(90)90179-J; MONSMA SA, 1990, DEV BIOL, V142, P465, DOI 10.1016/0012-1606(90)90368-S; Mueller JL, 2007, GENETICS, V175, P777, DOI 10.1534/genetics.106.065318; Mueller JL, 2004, P NATL ACAD SCI USA, V101, P13542, DOI 10.1073/pnas.0405579101; Nichol H, 2002, ANNU REV ENTOMOL, V47, P535, DOI 10.1146/annurev.ento.47.091201.145237; ODHIAMBO TR, 1971, TISSUE CELL, V3, P309, DOI 10.1016/S0040-8166(71)80025-3; Oliveira F, 2009, PARASITOL INT, V58, P1, DOI 10.1016/j.parint.2008.07.004; Panhuis TM, 2006, PHILOS T R SOC B, V361, P261, DOI 10.1098/rstb.2005.1793; Pitaluga AN, 2009, MOL GENET GENOMICS, V282, P307, DOI 10.1007/s00438-009-0466-2; Ram KR, 2007, INTEGR COMP BIOL, V47, P427, DOI 10.1093/icb/icm046; Ram KR, 2005, INSECT BIOCHEM MOLEC, V35, P1059, DOI 10.1016/j.ibmb.2005.05.001; Ram KR, 2006, P NATL ACAD SCI USA, V103, P18674, DOI 10.1073/pnas.0606228103; Rogers DW, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000272; Rogers DW, 2008, P NATL ACAD SCI USA, V105, P19390, DOI 10.1073/pnas.0809723105; SAMAKOVLIS C, 1991, EMBO J, V10, P163, DOI 10.1002/j.1460-2075.1991.tb07932.x; Simonet G, 2002, COMP BIOCHEM PHYS B, V132, P247, DOI 10.1016/S1096-4959(01)00530-9; Sirot LK, 2008, INSECT BIOCHEM MOLEC, V38, P176, DOI 10.1016/j.ibmb.2007.10.007; Sirot LK, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000989; Swanson WJ, 2001, P NATL ACAD SCI USA, V98, P7375, DOI 10.1073/pnas.131568198; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thailayil J, 2011, P NATL ACAD SCI USA, V108, P13677, DOI 10.1073/pnas.1104738108; Vogt RG, 2002, J EXP BIOL, V205, P719; Walker MJ, 2006, PROTEOME SCI, V4, DOI 10.1186/1477-5956-4-9; Ward PC, 1983, MEM I O CRUZ, V78, P269; Ward RD, 1988, BIOSYSTEMATICS HAEMA, P258; Wolfner MF, 2002, HEREDITY, V88, P85, DOI 10.1038/sj.hdy.6800017; Young David G., 1994, Memoirs of the American Entomological Institute (Gainesville), V54, P1	55	26	26	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2012	7	4							e34495	10.1371/journal.pone.0034495	http://dx.doi.org/10.1371/journal.pone.0034495			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955IH	22496818	Green Published, gold, Green Submitted			2022-12-27	WOS:000305010500012
J	Evans, KL; Newton, J; Mallord, JW; Markman, S				Evans, Karl L.; Newton, Jason; Mallord, John W.; Markman, Shai			Stable Isotope Analysis Provides New Information on Winter Habitat Use of Declining Avian Migrants That Is Relevant to Their Conservation	PLOS ONE			English	Article							MIGRATORY CONNECTIVITY; GEOGRAPHICAL-DISTRIBUTION; PHOTOSYNTHETIC PATHWAYS; SOUTHERN-AFRICA; WEST-AFRICA; APUS-APUS; ECOLOGY; CARBON; BIRDS; SURVIVAL	Winter habitat use and the magnitude of migratory connectivity are important parameters when assessing drivers of the marked declines in avian migrants. Such information is unavailable for most species. We use a stable isotope approach to assess these factors for three declining African-Eurasian migrants whose winter ecology is poorly known: wood warbler Phylloscopus sibilatrix, house martin Delichon urbicum and common swift Apus apus. Spatially segregated breeding wood warbler populations (sampled across a 800 km transect), house martins and common swifts (sampled across a 3,500 km transect) exhibited statistically identical intra-specific carbon and nitrogen isotope ratios in winter grown feathers. Such patterns are compatible with a high degree of migratory connectivity, but could arise if species use isotopically similar resources at different locations. Wood warbler carbon isotope ratios are more depleted than typical for African-Eurasian migrants and are compatible with use of moist lowland forest. The very limited variance in these ratios indicates specialisation on isotopically restricted resources, which may drive the similarity in wood warbler populations' stable isotope ratios and increase susceptibility to environmental change within its wintering grounds. House martins were previously considered to primarily use moist montane forest during the winter, but this seems unlikely given the enriched nature of their carbon isotope ratios. House martins use a narrower isotopic range of resources than the common swift, indicative of increased specialisation or a relatively limited wintering range; both factors could increase house martins' vulnerability to environmental change. The marked variance in isotope ratios within each common swift population contributes to the lack of population specific signatures and indicates that the species is less vulnerable to environmental change in sub-Saharan Africa than our other focal species. Our findings demonstrate how stable isotope research can contribute to understanding avian migrants' winter ecology and conservation status.	[Evans, Karl L.] Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England; [Newton, Jason] SUERC, UK NERC Life Sci Mass Spectrometry Facil, E Kilbride, Lanark, Scotland; [Mallord, John W.] Royal Soc Protect Birds, Sandy SG19 2DL, Beds, England; [Markman, Shai] Univ Haifa, Dept Biol, Tivon, Israel	University of Sheffield; Scottish Universities Research & Reactor Center; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); Royal Society for Protection of Birds; University of Haifa	Evans, KL (corresponding author), Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England.	karl.evans@sheffield.ac.uk	Newton, Jason/A-9536-2009	Newton, Jason/0000-0001-7594-3693	Natural Environment Research Council [EK-137-20/08]; Leverhulme Trust [ECF/2008/0018]; NERC [lsmsf010002] Funding Source: UKRI; Natural Environment Research Council [lsmsf010002] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Leverhulme Trust(Leverhulme Trust); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was funded by a Natural Environment Research Council Life Sciences Mass Spectrometry Facilities grant (EK-137-20/08) and the Leverhulme Trust (ECF/2008/0018). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMBROSE SH, 1986, OECOLOGIA, V69, P395, DOI 10.1007/BF00377062; Bearhop S, 2004, J ANIM ECOL, V73, P1007, DOI 10.1111/j.0021-8790.2004.00861.x; Bensch S, 2006, J AVIAN BIOL, V37, P323, DOI 10.1111/j.2006.0908-8857.03628.x; BURFIELD IJ, 2004, BIRDS EUROPE POPULAT; Cardillo M, 2008, P ROY SOC B-BIOL SCI, V275, P1441, DOI 10.1098/rspb.2008.0179; Chamberlain CP, 2000, P ROY SOC B-BIOL SCI, V267, P43, DOI 10.1098/rspb.2000.0964; Chantler P., 1995, SWIFTS GUIDE SWIFTS; Cooper N, 2008, GLOBAL ECOL BIOGEOGR, V17, P211, DOI 10.1111/j.1466-8238.2007.00355.x; Coplen TB, 2006, ANAL CHEM, V78, P2439, DOI 10.1021/ac052027c; EHLERINGER JR, 1988, OECOLOGIA, V76, P562, DOI 10.1007/BF00397870; ELLIS RP, 1980, S AFR J SCI, V76, P307; Eraud C, 2009, IBIS, V151, P186, DOI 10.1111/j.1474-919X.2008.00876.x; Evans KL, 2003, BIRD STUDY, V50, P294, DOI 10.1080/00063650309461322; FARQUHAR GD, 1982, AUST J PLANT PHYSIOL, V9, P121, DOI 10.1071/PP9820121; Fry CH., 1988, BIRDS AFRICA, V3; Gory G, 2008, REV ECOL-TERRE VIE, V63, P251; Grey J, 2004, LIMNOL OCEANOGR, V49, P239, DOI 10.4319/lo.2004.49.1.0239; Hernquist MB, 2009, J AVIAN BIOL, V40, P102; Hill LA, 2002, MIGRATION ATLAS, P465; Hobson KA, 2003, CAN J ZOOL, V81, P1630, DOI 10.1139/Z03-140; Inger R, 2008, IBIS, V150, P447, DOI 10.1111/j.1474-919X.2008.00839.x; Jenni L., 1994, BIOL MOULT BIRDS; Kelly JF, 2000, CAN J ZOOL, V78, P1, DOI 10.1139/cjz-78-1-1; Lack D., 1956, SWIFTS TOWER; Marra PP, 1998, SCIENCE, V282, P1884, DOI 10.1126/science.282.5395.1884; MOREL GJ, 1992, IBIS, V134, P83; Neto JM, 2006, J AVIAN BIOL, V37, P117; Newsome SD, 2007, FRONT ECOL ENVIRON, V5, P429, DOI 10.1890/060150.1; Newton I, 2008, MIGRATION ECOLOGY OF BIRDS, P1; Norman D., 2002, MIGRATION ATLAS, P565; Oatley TB, 1999, OSTRICH, V70, P236; Oppel S, 2011, J AVIAN BIOL, V42, P342, DOI 10.1111/j.1600-048X.2011.05252.x; Pain DJ, 2004, OECOLOGIA, V138, P168, DOI 10.1007/s00442-003-1416-z; Peach WJ, 1990, IBIS, V133, P300; PEARSON DJ, 1992, IBIS, V134, P89; Reichlin TS, 2010, DIVERS DISTRIB, V16, P643, DOI 10.1111/j.1472-4642.2010.00664.x; Risely K, 2011, 597 BRIT TRUST ORN; Robinson RA, 2010, ONLINE RINGING REPOR; Saino N, 2004, P ROY SOC B-BIOL SCI, V271, P681, DOI 10.1098/rspb.2003.2656; Sanderson FJ, 2006, BIOL CONSERV, V131, P93, DOI 10.1016/j.biocon.2006.02.008; Schaub M, 2005, J ANIM ECOL, V74, P656, DOI 10.1111/j.1365-2656.2005.00961.x; SEALY JC, 1987, GEOCHIM COSMOCHIM AC, V51, P2707, DOI 10.1016/0016-7037(87)90151-7; Shultz S, 2005, P ROY SOC B-BIOL SCI, V272, P2305, DOI 10.1098/rspb.2005.3250; SMITH BN, 1971, PLANT PHYSIOL, V47, P380, DOI 10.1104/pp.47.3.380; Stutchbury BJM, 2009, SCIENCE, V323, P896, DOI 10.1126/science.1166664; Svensson L., 1992, IDENTIFICATION GUIDE; Szep T, 2009, J ORNITHOL, V150, P621, DOI 10.1007/s10336-009-0382-6; SZEP T, 1995, IBIS, V137, P162, DOI 10.1111/j.1474-919X.1995.tb03235.x; VOGEL JC, 1978, S AFR J SCI, V74, P209; Webster MS, 2002, TRENDS ECOL EVOL, V17, P76, DOI 10.1016/S0169-5347(01)02380-1; WERGER MJA, 1981, FLORA, V171, P64; Wernham C., 2002, MIGRATION ATLAS, P443; Wernham CV, 2002, MIGRATION ATLAS; Wilcove DS, 2008, PLOS BIOL, V6, P1361, DOI 10.1371/journal.pbio.0060188; Yohannes E, 2007, J AVIAN BIOL, V38, P347, DOI 10.1111/j.2007.0908-8857.03927.x; Zwarts L., 2009, LIVING EDGE WETLANDS	56	15	15	0	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2012	7	4							e34542	10.1371/journal.pone.0034542	http://dx.doi.org/10.1371/journal.pone.0034542			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955IH	22496827	Green Published, Green Accepted, gold			2022-12-27	WOS:000305010500017
J	Martinell, J; Kowalewski, M; Domenech, R				Martinell, Jordi; Kowalewski, Michal; Domenech, Rosa			Drilling Predation on Serpulid Polychaetes (Ditrupa arietina) from the Pliocene of the Cope Basin, Murcia Region, Southeastern Spain	PLOS ONE			English	Article							WESTERN MEDITERRANEAN SEA; NATICID GASTROPODS; FOSSIL RECORD; BOTTOM ASSEMBLAGES; BORING PREDATION; MIDDLE MIOCENE; BRACHIOPODS; PREY; HOLES; PALEOECOLOGY	We report quantitative analyses of drilling predation on the free-living, tube-dwelling serpulid polychaete Ditrupa arietina from the Cope Cabo marine succession (Pliocene, Spain). Tubes of D. arietina are abundant in the sampled units: 9 bulk samples from 5 horizons yielded,5925 specimens of D. arietina. Except for fragmentation, tubes were well preserved. Complete specimens ranged from 3.1 to 13.4 mm in length and displayed allometric growth patterns, with larger specimens being relatively slimmer. Drilled Ditrupa tubes were observed in all samples. Drillholes, identified as Oichnus paraboloides, were characterized by circular to elliptical outline (drillhole eccentricity increased with its diameter), parabolic vertical profile, outer diameter larger than inner diameter, penetration of one tube wall only, narrow range of drill-hole sizes, and non-random (anterior) distribution of drillholes. A total of 233 drilled specimens were identified, with drilling frequencies varying across horizons from 2.7% to 21% (3.9% for pooled data). Many tube fragments were broken across a drillhole suggesting that the reported frequencies are conservative and that biologically-facilitated (drill-hole induced) fragmentation hampers fossil preservation of complete serpulid tubes. No failed or repaired holes were observed. Multiple complete drillholes were present (3.9%). Drilled specimens were significantly smaller than undrilled specimens and tube length and drill-hole diameter were weakly correlated. The results suggest that drillholes were produced by a size-selective, sitestereotypic predatory organism of unknown affinity. The qualitative and quantitative patterns reported here are mostly consistent with previous reports on recent and fossil Ditrupa and reveal parallels with drilling patterns documented for scaphopod mollusks, a group that is ecologically and morphologically similar to Ditrupa. Consistent with previous studies, the results suggest that free-dwelling serpulid polychaetes are preyed upon by drilling predators and may provide a viable source of data on biotic interactions in the fossil record.	[Martinell, Jordi; Domenech, Rosa] Univ Barcelona, Inst Recerca Biodiversitat, Barcelona, Spain; [Martinell, Jordi; Domenech, Rosa] Univ Barcelona, Fac Geol, Barcelona, Spain; [Kowalewski, Michal] Virginia Tech, Dept Geosci, Blacksburg, VA USA	University of Barcelona; University of Barcelona; Virginia Polytechnic Institute & State University	Martinell, J (corresponding author), Univ Barcelona, Inst Recerca Biodiversitat, Barcelona, Spain.	michalk@vt.edu	Martinell, Jordi/X-4501-2019; Kowalewski, Michal/B-4263-2008; Martinell, Jordi/K-2981-2014; Domènech, Rosa/M-6195-2013; Domènech, Rosa/X-5080-2019	Martinell, Jordi/0000-0003-2638-8106; Kowalewski, Michal/0000-0002-8575-4711; Martinell, Jordi/0000-0003-2638-8106; Domènech, Rosa/0000-0002-4174-8942; Domènech, Rosa/0000-0002-4174-8942	Spanish government [CGL2007-60507/BTE]; National Science Foundation [OCE-0602375, EAR-0920075, EAR-1053433]	Spanish government(Spanish GovernmentEuropean Commission); National Science Foundation(National Science Foundation (NSF))	This research project is supported by the grant CGL2007-60507/BTE funded by the Spanish government. In addition, MK acknowledges continuous support of his research program by the National Science Foundation grants (OCE-0602375, EAR-0920075, and EAR-1053433). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARDAJI T, 1995, GEODIN ACTA, V8, P112, DOI 10.1080/09853111.1995.11105383; Bardaji T, 1999, TEOR IMOV MAT STAT, P1; Baumiller TK, 1999, PALAEOGEOGR PALAEOCL, V147, P283, DOI 10.1016/S0031-0182(98)00165-5; BAUMILLER TK, 1990, PALAEONTOLOGY, V33, P743; Baumiller TK, 1996, PALAEOGEOGR PALAEOCL, V123, P343, DOI 10.1016/0031-0182(95)00124-7; BENGTSON S, 1992, SCIENCE, V257, P367, DOI 10.1126/science.257.5068.367; Berg JC, 1976, NAUTILUS, V90, P1; Bolam SG, 2002, J EXP MAR BIOL ECOL, V269, P197, DOI 10.1016/S0022-0981(02)00003-5; Bromley R.G., 1981, Acta Geologica Hispanica, V16, P55; Bromley RG, 1993, B GEOL SOC DENMARK, V40, P167; Cintra-Buenrostro CE, 2005, PALAIOS, V20, P296, DOI 10.2110/palo-2004.p04-21; Cosentino A, 2006, MAR ECOL-EVOL PERSP, V27, P170, DOI 10.1111/j.1439-0485.2006.00088.x; D'Alessandro A, 2004, SEDIMENT GEOL, V166, P89, DOI 10.1016/j.sedgeo.2003.11.017; Di Geronimo I, 1989, B ACC GIOENIA SC NAT, V20, P129; Di Geronimo Italo, 1992, Rivista Italiana di Paleontologia e Stratigrafia, V98, P229; Dietl GP, 1995, J SHELLFISH RES, V14, P307; Dominici S, 2001, PALAIOS, V16, P336, DOI 10.2307/3515575; EKDALE AA, 1985, PALAEOGEOGR PALAEOCL, V50, P63, DOI 10.1016/S0031-0182(85)80006-7; Gremare A, 1998, ESTUAR COAST SHELF S, V47, P447, DOI 10.1006/ecss.1998.0379; Guizien K, 2010, CONT SHELF RES, V30, P239, DOI 10.1016/j.csr.2009.11.010; Harper EM, 2005, PALAEONTOLOGY, V48, P197, DOI 10.1111/j.1475-4983.2004.00433.x; Harper EM, 2000, PALAEOGEOGR PALAEOCL, V158, P15, DOI 10.1016/S0031-0182(99)00164-9; Hoffman A, 1984, NEUES JB GEOLOGIE PA, P393; Hoffmeister AP, 2003, LETHAIA, V36, P107, DOI 10.1080/00241160310000408; Hua H, 2003, PALAIOS, V18, P454, DOI 10.1669/0883-1351(2003)018<0454:BICSCP>2.0.CO;2; Huntley JW, 2007, P NATL ACAD SCI USA, V104, P15006, DOI 10.1073/pnas.0704960104; Jager M., 1993, Contributions to Tertiary and Quaternary Geology, V29, P73; Jordana E, 2001, J EXP MAR BIOL ECOL, V266, P219, DOI 10.1016/S0022-0981(01)00357-4; KABAT AR, 1990, MALACOLOGIA, V32, P155; Kaplan P, 2000, PALAIOS, V15, P499, DOI 10.2307/3515614; Kelley PH, 1996, PALAIOS, V11, P437, DOI 10.2307/3515211; Kelley PH, 2001, PALAEOGEOGR PALAEOCL, V166, P165, DOI 10.1016/S0031-0182(00)00207-8; KITCHELL JA, 1981, PALEOBIOLOGY, V7, P533, DOI 10.1017/S0094837300025574; KITCHELL JA, 1986, MALACOLOGIA, V27, P291; Klompmaker AA, 2012, PALAEOGEOGR PALAEOCL, V321, P113, DOI 10.1016/j.palaeo.2012.01.024; Klompmaker AA, 2011, LETHAIA, V44, P429, DOI 10.1111/j.1502-3931.2010.00254.x; Kowalewski M, 2005, SCIENCE, V308, P1774, DOI 10.1126/science.1113408; Kowalewski M, 2000, J PALEONTOL, V74, P532, DOI 10.1666/0022-3360(2000)074<0532:DHISOP>2.0.CO;2; Kowalewski M, 2004, J MOLLUS STUD, V70, P359, DOI 10.1093/mollus/70.4.359; Kowalewski M, 1998, GEOLOGY, V26, P1091, DOI 10.1130/0091-7613(1998)026<1091:AFRFOH>2.3.CO;2; Kowalewski Michal, 2002, Paleontological Society Papers, V8, P3; Labrune C, 2007, J SEA RES, V58, P125, DOI 10.1016/j.seares.2007.02.006; Leighton LR, 2001, PALAEOGEOGR PALAEOCL, V165, P53, DOI 10.1016/S0031-0182(00)00153-X; Li Rong-Yu, 2011, Palaeoworld, V20, P296, DOI 10.1016/j.palwor.2011.04.001; Martinell J, 2010, PALAIOS, V25, P221, DOI 10.2110/palo.2009.p09-124r; MCCLINTOCK JB, 1993, B MAR SCI, V52, P1013; MCNAMARA KJ, 1994, ECHINODERMS THROUGH TIME, P785; Medernach L, 2000, MAR ECOL PROG SER, V199, P171, DOI 10.3354/meps199171; Morton B., 2009, ACOREANA S, V6, P157; Morton B., 2009, ACOREANA S, V6, P146; Muller OF, 1776, ZOOLOGIAE DANICAE PR, p[I, 1], DOI DOI 10.5962/BHL.TITLE.13268; Nebelsick JH, 1999, PALAIOS, V14, P127, DOI 10.2307/3515369; Nilsen KSS, 2008, ICHNOS, V8, P99; Picard J, 1965, RECL TRAV STN MAR EN, V52, P1; Pruss SB, 2011, PALAEOGEOGR PALAEOCL, V311, P74, DOI 10.1016/j.palaeo.2011.08.003; RICHARDS R P, 1969, Journal of Paleontology, V43, P838; Rodrigues SC, 2008, ACTA PALAEONTOL POL, V53, P657, DOI 10.4202/app.2008.0410; ROY K, 1994, PALAIOS, V9, P413, DOI 10.2307/3515059; Sanfilippo R, 1999, RIV ITAL PALEONTOL S, V105, P455, DOI 10.13130/2039-4942/5386; Sarda R, 2000, ICES J MAR SCI, V57, P1446, DOI 10.1006/jmsc.2000.0922; Savazzi Enrico, 1995, Palaeontologische Zeitschrift, V69, P73; SMITH SA, 1985, SCIENCE, V230, P1033, DOI 10.1126/science.230.4729.1033; SOHL NF, 1969, AM ZOOL, V9, P725; ten Hove H.A., 1990, Records of the Australian Museum, V42, P101; Ten Hove H.A., 2011, WORLD POLYCHAETA DAT; ten Hove HA, 1994, DEHOREN ZIJN ECHO, P65; Vermeij G.J, 1987, EVOLUTION ESCALATION; VERMEIJ GJ, 1980, PALEOBIOLOGY, V6, P352, DOI 10.1017/S0094837300006850; VERMEIJ GJ, 1983, PALAEONTOLOGY, V26, P455; Viseras C, 2004, CUENCAS NEOGENAS POS, P576; Wijnker E, 2008, NETH J GEOSCI, V87, P165, DOI 10.1017/S0016774600023209; WILSON JB, 1976, J MAR BIOL ASSOC UK, V56, P291, DOI 10.1017/S0025315400018919; Yochelson E.L., 1983, US GEOLOGICAL SURVEY, V1282, P1; Zlotnik M, 2005, ACTA PALAEONTOL POL, V50, P409; Zlotnik M, 2001, ACTA PALAEONTOL POL, V46, P87	75	20	22	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2012	7	4							e34576	10.1371/journal.pone.0034576	http://dx.doi.org/10.1371/journal.pone.0034576			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955IH	22496828	Green Published, gold, Green Submitted			2022-12-27	WOS:000305010500018
J	Turunen, SP; Kummu, O; Harila, K; Veneskoski, M; Soliymani, R; Baumann, M; Pussinen, PJ; Horkko, S				Turunen, S. Pauliina; Kummu, Outi; Harila, Kirsi; Veneskoski, Marja; Soliymani, Rabah; Baumann, Marc; Pussinen, Pirkko J.; Horkko, Sohvi			Recognition of Porphyromonas gingivalis Gingipain Epitopes by Natural IgM Binding to Malondialdehyde Modified Low-Density Lipoprotein	PLOS ONE			English	Article							E-DEFICIENT MICE; OXIDATION-SPECIFIC EPITOPES; CORONARY-ARTERY-DISEASE; LDL RECEPTOR-DEFICIENT; APOLIPOPROTEIN-E; MYOCARDIAL-INFARCTION; MONOCLONAL AUTOANTIBODIES; STREPTOCOCCUS-PNEUMONIAE; OXIDIZED PHOSPHOLIPIDS; PERIODONTITIS PATIENTS	Objective: Increased risk for atherosclerosis is associated with infectious diseases including periodontitis. Natural IgM antibodies recognize pathogen-associated molecular patterns on bacteria, and oxidized lipid and protein epitopes on low-density lipoprotein (LDL) and apoptotic cells. We aimed to identify epitopes on periodontal pathogen Porphyromonas gingivalis recognized by natural IgM binding to malondialdehyde (MDA) modified LDL. Methods and Results: Mouse monoclonal IgM (MDmAb) specific for MDA-LDL recognized epitopes on P. gingivalis on flow cytometry and chemiluminescence immunoassays. Immunization of C57BL/6 mice with P. gingivalis induced IgM, but not IgG, immune response to MDA-LDL and apoptotic cells. Immunization of LDLR-/- mice with P. gingivalis induced IgM, but not IgG, immune response to MDA-LDL and diminished aortic lipid deposition. On Western blot MDmAb bound to P. gingivalis fragments identified as arginine-specific gingipain (Rgp) by mass spectrometry. Recombinant domains of Rgp produced in E. coli were devoid of phosphocholine epitopes but contained epitopes recognized by MDmAb and human serum IgM. Serum IgM levels to P. gingivalis were associated with anti-MDA-LDL levels in humans. Conclusion: Gingipain of P. gingivalis is recognized by natural IgM and shares molecular identity with epitopes on MDA-LDL. These findings suggest a role for natural antibodies in the pathogenesis of two related inflammatory diseases, atherosclerosis and periodontitis.	[Turunen, S. Pauliina; Kummu, Outi; Harila, Kirsi; Veneskoski, Marja; Horkko, Sohvi] Univ Oulu, Inst Diagnost, Dept Med Microbiol & Immunol, Oulu, Finland; [Turunen, S. Pauliina; Kummu, Outi; Harila, Kirsi; Veneskoski, Marja; Horkko, Sohvi] Oulu Univ Hosp, Clin Res Ctr, Oulu, Finland; [Soliymani, Rabah; Baumann, Marc] Biomedicum Helsinki, Inst Biomed Anat, Prot Chem Unit, Helsinki, Finland; [Pussinen, Pirkko J.] Univ Helsinki, Inst Dent, Helsinki, Finland	University of Oulu; University of Oulu; University of Helsinki; University of Helsinki	Turunen, SP (corresponding author), Univ Oulu, Inst Diagnost, Dept Med Microbiol & Immunol, Oulu, Finland.	sohvi.horkko@oulu.fi		Pussinen, Pirkko/0000-0003-3563-1876; Kummu, Outi/0000-0003-0327-3496; Turunen, S. Pauliina/0000-0001-8060-9876; Soliymani, Rabah/0000-0003-0184-3352; Baumann, Marc/0000-0002-2991-889X	Academy of Finland [119012, 134763]; Finnish Foundation for Cardiovascular Research; Sigrid Juselius Foundation; Sohlberg Foundation; Finnish Cultural Foundation; Paavo Nurmi Foundation	Academy of Finland(Academy of Finland); Finnish Foundation for Cardiovascular Research; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Sohlberg Foundation; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Paavo Nurmi Foundation	The work was supported by Academy of Finland (119012 and 134763), Finnish Foundation for Cardiovascular Research, Sigrid Juselius Foundation, Sohlberg Foundation, Finnish Cultural Foundation, and Paavo Nurmi Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ait-Oufella H, 2010, J EXP MED, V207, P1579, DOI 10.1084/jem.20100155; Binder CJ, 2010, J CLIN IMMUNOL, V30, pS56, DOI 10.1007/s10875-010-9396-3; Binder CJ, 2003, NAT MED, V9, P736, DOI 10.1038/nm876; Booth V, 1997, J PERIODONTAL RES, V32, P54, DOI 10.1111/j.1600-0765.1997.tb01382.x; BRILES DE, 1992, INFECT IMMUN, V60, P1957, DOI 10.1128/IAI.60.5.1957-1962.1992; Chang MK, 1999, P NATL ACAD SCI USA, V96, P6353, DOI 10.1073/pnas.96.11.6353; Chou MY, 2009, J CLIN INVEST, V119, P1335, DOI 10.1172/JCI36800; Curtis MA, 1999, J PERIODONTAL RES, V34, P464, DOI 10.1111/j.1600-0765.1999.tb02282.x; de Faire U, 2010, J AUTOIMMUN, V34, P73, DOI 10.1016/j.jaut.2009.05.003; de Laat B, 2011, CURR RHEUMATOL REP, V13, P70, DOI 10.1007/s11926-010-0144-8; DESTEFANO F, 1993, BRIT MED J, V306, P688, DOI 10.1136/bmj.306.6879.688; DRAPER HH, 1990, METHOD ENZYMOL, V186, P421; Epstein SE, 2000, ARTERIOSCL THROM VAS, V20, P1417, DOI 10.1161/01.ATV.20.6.1417; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; Freigang S, 1998, ARTERIOSCL THROM VAS, V18, P1972, DOI 10.1161/01.ATV.18.12.1972; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Georges JL, 2003, AM J CARDIOL, V92, P515, DOI 10.1016/S0002-9149(03)00717-3; Gibson FC, 2004, CIRCULATION, V109, P2801, DOI 10.1161/01.CIR.0000129769.17895.F0; Gibson FC, 2001, INFECT IMMUN, V69, P7959, DOI 10.1128/IAI.69.12.7959-7963.2001; Gmur R, 1999, J DENT RES, V78, P77, DOI 10.1177/00220345990780011201; Guo YH, 2010, PERIODONTOL 2000, V54, P15, DOI 10.1111/j.1600-0757.2010.00377.x; HABEEB AFS, 1966, ANAL BIOCHEM, V14, P328, DOI 10.1016/0003-2697(66)90275-2; Hansson GK, 2011, NAT IMMUNOL, V12, P204, DOI 10.1038/ni.2001; HAVEL RJ, 1955, J CLIN INVEST, V34, P1345, DOI 10.1172/JCI103182; Hayashi C, 2011, ATHEROSCLEROSIS, V215, P52, DOI 10.1016/j.atherosclerosis.2010.12.009; Hazen SL, 2008, J BIOL CHEM, V283, P15527, DOI 10.1074/jbc.R700054200; Hill GE, 1998, ATHEROSCLEROSIS, V141, P107, DOI 10.1016/S0021-9150(98)00153-1; Horkko S, 2000, FREE RADICAL BIO MED, V28, P1771, DOI 10.1016/S0891-5849(00)00333-6; Horkko S, 1999, J CLIN INVEST, V103, P117, DOI 10.1172/JCI4533; Inagaki S, 2003, J PERIODONTOL, V74, P1432, DOI 10.1902/jop.2003.74.10.1432; ISHIBASHI S, 1994, J CLIN INVEST, V93, P1885, DOI 10.1172/JCI117179; KADOWAKI T, 1994, J BIOL CHEM, V269, P21371; Kaizuka K, 2003, J PERIODONTOL, V74, P38, DOI 10.1902/jop.2003.74.1.38; Karvonen J, 2003, CIRCULATION, V108, P2107, DOI 10.1161/01.CIR.0000092891.55157.A7; Kellokoski E, 2009, PEPTIDES, V30, P2292, DOI 10.1016/j.peptides.2009.09.008; Lalla E, 2003, ARTERIOSCL THROM VAS, V23, P1405, DOI 10.1161/01.ATV.0000082462.26258.FE; Lewis MJ, 2009, CIRCULATION, V120, P417, DOI 10.1161/CIRCULATIONAHA.109.868158; Li L, 2002, CIRCULATION, V105, P861, DOI 10.1161/hc0702.104178; Maekawa T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020240; MATTILA KJ, 1989, BRIT MED J, V298, P779, DOI 10.1136/bmj.298.6676.779; Mayr M, 2006, J AM COLL CARDIOL, V47, P2436, DOI 10.1016/j.jacc.2006.03.024; Miller YI, 2011, CIRC RES, V108, P235, DOI 10.1161/CIRCRESAHA.110.223875; Miyamoto T, 2006, INFECT IMMUN, V74, P1376, DOI 10.1128/IAI.74.2.1376-1380.2006; Palinski W, 1996, J CLIN INVEST, V98, P800, DOI 10.1172/JCI118853; PALINSKI W, 1990, ARTERIOSCLEROSIS, V10, P325, DOI 10.1161/01.ATV.10.3.325; PENGO V, 1995, THROMB HAEMOSTASIS, V73, P29; POTEMPA J, 1995, INFECT IMMUN, V63, P1176, DOI 10.1128/IAI.63.4.1176-1182.1995; Pussinen PJ, 2004, ARTERIOSCL THROM VAS, V24, P2174, DOI 10.1161/01.ATV.0000145979.82184.9f; Pussinen PJ, 2004, EUR J CARDIOV PREV R, V11, P408, DOI 10.1097/00149831-200410000-00008; Pussinen PJ, 2002, J CLIN MICROBIOL, V40, P512, DOI 10.1128/JCM.40.2.512-518.2002; Pussinen PJ, 2003, ARTERIOSCL THROM VAS, V23, P1250, DOI 10.1161/01.ATV.0000072969.71452.87; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Schenkein HA, 1999, INFECT IMMUN, V67, P4814, DOI 10.1128/IAI.67.9.4814-4818.1999; Schenkein HA, 2004, J PERIODONTOL, V75, P146, DOI 10.1902/jop.2004.75.1.146; Schenkein HA, 2003, J DENT RES, V82, P919, DOI 10.1177/154405910308201114; Schenkein HA, 2001, INFECT IMMUN, V69, P6612, DOI 10.1128/IAI.69.11.6612-6617.2001; Shaw PX, 2000, J CLIN INVEST, V105, P1731, DOI 10.1172/JCI8472; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; TANGIRALA RK, 1995, J LIPID RES, V36, P2320; Tsimikas S, 2007, J LIPID RES, V48, P425, DOI 10.1194/jlr.M600361-JLR200; Tuma DJ, 1996, HEPATOLOGY, V23, P872, DOI 10.1002/hep.510230431; Tuominen A, 2006, ARTERIOSCL THROM VAS, V26, P2096, DOI 10.1161/01.ATV.0000233333.07991.4a; Veneskoski M, 2011, FREE RADICAL BIO MED, V51, P834, DOI 10.1016/j.freeradbiomed.2011.05.029; von Nandelstadh P, 2011, BIOCHEM J, V436, P113, DOI 10.1042/BJ20101672; Yasaki-Inagaki Y, 2006, FEMS IMMUNOL MED MIC, V47, P287, DOI 10.1111/j.1574-695X.2006.00091.x; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9; ZHANG SH, 1992, SCIENCE, V258, P468, DOI 10.1126/science.1411543	67	46	46	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2012	7	4							e34910	10.1371/journal.pone.0034910	http://dx.doi.org/10.1371/journal.pone.0034910			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955IH	22496875	Green Published, Green Submitted, gold			2022-12-27	WOS:000305010500028
J	Hickson, RI; Mercer, GN; Lokuge, KM				Hickson, Roslyn I.; Mercer, Geoffry N.; Lokuge, Kamalini M.			A Metapopulation Model of Tuberculosis Transmission with a Case Study from High to Low Burden Areas	PLOS ONE			English	Article							DRUG-RESISTANCE; MATHEMATICAL-ANALYSIS; SENSITIVITY-ANALYSIS; COST-EFFECTIVENESS; HIV; UNCERTAINTY; DYNAMICS; STRATEGIES; TB	Tuberculosis (TB) is a growing problem worldwide, especially with the emergence and high prevalence of multidrug-resistant strains. We develop a metapopulation model for TB spread, which is particularly suited to investigating transmission between areas of high and low prevalence. A case study of cross-border transmission in the Torres Strait region of Australia and Papua New Guinea (PNG) is considered and a sensitivity analysis is conducted. We find that only 6 of the 50 parameters analysed are important to the cumulative number of clinically active TB patients in the entire region. Of these, only the detection rate in PNG is found to be an important intervention parameter. We therefore give insight into the extent the area with the high burden of TB (PNG in the case study) is dominating the TB dynamics of the entire region. Furthermore, the sensitivity analysis results give insight into the data that most important to collect and refine, which is found to be data relating to the PNG parameters.	[Hickson, Roslyn I.; Mercer, Geoffry N.; Lokuge, Kamalini M.] Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Canberra, ACT, Australia; [Hickson, Roslyn I.] Univ Newcastle, Sch Math & Phys Sci, Newcastle, NSW 2300, Australia	Australian National University; University of Newcastle	Hickson, RI (corresponding author), Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Canberra, ACT, Australia.	r.hickson@UNSWalumni.com	Hickson, R. I./B-3847-2011	Hickson, R. I./0000-0001-6453-7745; Lokuge, Kamalini/0000-0002-6287-1296	Australian National University	Australian National University(Australian National University)	The Australian National University has provided funding in the form of salary for the authors. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, WHO UNICEF ESTIMATES; [Anonymous], 2010, MATLAB VERS 7 10 0 4; [Anonymous], 2010, 2010 2011 TUB GLOB F; Baltussen R, 2005, BMJ-BRIT MED J, V331, P1364, DOI 10.1136/bmj.38645.660093.68; Basu S, 2008, EPIDEMIOL INFECT, V136, P1585, DOI 10.1017/S0950268808000964; Basu S, 2009, INT J TUBERC LUNG D, V13, P652; BLOWER SM, 1995, NAT MED, V1, P815, DOI 10.1038/nm0895-815; BLOWER SM, 1994, INT STAT REV, V62, P229, DOI 10.2307/1403510; Borgdorff MW, 2002, B WORLD HEALTH ORGAN, V80, P217; Bureau of Epidemiology, 2006, 5 MIN PUBL HLTH BUR; Centers for Disease Control & Prevention, 2009, PLAN COMB EXT DRUG R; Currie CSM, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-130; Department of Immigration and Citizenship Submissions received by the Committee, INQ MATT REL TORR ST; Hickson RI, 2011, 19TH INTERNATIONAL CONGRESS ON MODELLING AND SIMULATION (MODSIM2011), P926; Keeling MJ., 2008, MODELING INFECT DIS, DOI DOI 10.1515/9781400841035; Lumb R, 2008, COMMUN DIS INTELL, V32, P12; Marino S, 2008, J THEOR BIOL, V254, P178, DOI 10.1016/j.jtbi.2008.04.011; McCutcheon P, 2011, AUSTR GRAPPLES TUBER; McCutcheon P, 2011, INSIDER CRITICISES Q; Porco TC, 2001, J ACQ IMMUN DEF SYND, V28, P437, DOI 10.1097/00042560-200112150-00005; Rodrigues P, 2007, THEOR POPUL BIOL, V71, P196, DOI 10.1016/j.tpb.2006.10.004; Roeger LIW, 2009, MATH BIOSCI ENG, V6, P815, DOI 10.3934/mbe.2009.6.815; Sanchez MA, 1997, AM J EPIDEMIOL, V145, P1127; Schwartzman K, 2005, NEW ENGL J MED, V353, P1008, DOI 10.1056/NEJMsa043194; Sharomi O, 2008, MATH BIOSCI ENG, V5, P145; Tewa JJ, 2012, APPL MATH MODEL, V36, P2466, DOI 10.1016/j.apm.2011.09.004; Tewa JJ, 2011, MATH POPUL STUD, V18, P189, DOI 10.1080/08898480.2011.596757; The National Research Institute of Papua New Guinea, 2010, PAP NEW GUIN DISTR P; Thomas EG, 2010, ANZIAM J, V52, P26, DOI 10.1017/S1446181111000587; van Rie A, 1999, NEW ENGL J MED, V171, P1430; Verver S, 2005, AM J RESP CRIT CARE, V171, P1430, DOI 10.1164/rccm.200409-1200OC; *WHO, 2009, GLOB TUB CONTR SHORT; WHO, 2011, TUB CONTR W PAC REG; World Health Organisation, 2003, TUB CONTR WHO W PAC; World Health Organisation, 2009, TUB CONTR W PAC REG; World Health Organisation, 2009, TB COUNTR PROF PAP N; Wu P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010468	37	15	15	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e34411	10.1371/journal.pone.0034411	http://dx.doi.org/10.1371/journal.pone.0034411			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GO	22496801	Green Submitted, gold, Green Published			2022-12-27	WOS:000304855200048
J	Chan, YK; Huang, IC; Farzan, M				Chan, Ying Kai; Huang, I-Chueh; Farzan, Michael			IFITM Proteins Restrict Antibody-Dependent Enhancement of Dengue Virus Infection	PLOS ONE			English	Article							WEST NILE VIRUS; HEMORRHAGIC-FEVER; HUMAN-CELLS	Interferon-inducible transmembrane (IFITM) proteins restrict the entry processes of several pathogenic viruses, including the flaviviruses West Nile virus and dengue virus (DENV). DENV infects cells directly or via antibody-dependent enhancement (ADE) in Fc-receptor-bearing cells, a process thought to contribute to severe disease in a secondary infection. Here we investigated whether ADE-mediated DENV infection bypasses IFITM-mediated restriction or whether IFITM proteins can be protective in a secondary infection. We observed that IFITM proteins restricted ADE-mediated and direct infection with comparable efficiencies in a myelogenous leukemia cell line. Our data suggest that IFITM proteins can contribute to control of secondary DENV infections.	[Chan, Ying Kai; Huang, I-Chueh; Farzan, Michael] Harvard Univ, Sch Med, New England Primate Res Ctr, Dept Microbiol & Immunobiol, Southborough, MA 01772 USA	Harvard University	Chan, YK (corresponding author), Harvard Univ, Sch Med, New England Primate Res Ctr, Dept Microbiol & Immunobiol, Southborough, MA 01772 USA.	ykchan@fas.harvard.edu; farzan@hms.harvard.edu		Farzan, Michael/0000-0002-2990-5319	New England Regional Center for Excellence/Biodefense and Emerging Infectious Disease [U54 AI057159]; New England Primate Research Center [RR000168]; Burroughs Wellcome Fund; NATIONAL CENTER FOR RESEARCH RESOURCES [K26RR000168, P51RR000168] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R00AI093679, U54AI057159, K99AI093679] Funding Source: NIH RePORTER	New England Regional Center for Excellence/Biodefense and Emerging Infectious Disease; New England Primate Research Center; Burroughs Wellcome Fund(Burroughs Wellcome Fund); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the New England Regional Center for Excellence/Biodefense and Emerging Infectious Disease (U54 AI057159), by the New England Primate Research Center Base Grant (RR000168), and by the Burroughs Wellcome Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brass AL, 2009, CELL, V139, P1243, DOI 10.1016/j.cell.2009.12.017; Diamond MS, 2000, J VIROL, V74, P7814, DOI 10.1128/JVI.74.17.7814-7823.2000; Dowd KA, 2011, VIROLOGY, V411, P306, DOI 10.1016/j.virol.2010.12.020; FRIEDMAN RL, 1984, CELL, V38, P745, DOI 10.1016/0092-8674(84)90270-8; Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480; Guy B, 2004, VACCINE, V22, P3563, DOI 10.1016/j.vaccine.2004.03.042; HALSTEAD SB, 1970, YALE J BIOL MED, V42, P350; Halstead SB, 2007, LANCET, V370, P1644, DOI 10.1016/S0140-6736(07)61687-0; Huang IC, 2008, J VIROL, V82, P4834, DOI 10.1128/JVI.00079-08; Huang IC, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001258; Huang IC, 2006, J BIOL CHEM, V281, P3198, DOI 10.1074/jbc.M508381200; Jessie K, 2004, J INFECT DIS, V189, P1411, DOI 10.1086/383043; Jiang D, 2010, J VIROL, V84, P8332, DOI 10.1128/JVI.02199-09; KLIKS SC, 1988, AM J TROP MED HYG, V38, P411, DOI 10.4269/ajtmh.1988.38.411; LEWIN AR, 1991, EUR J BIOCHEM, V199, P417, DOI 10.1111/j.1432-1033.1991.tb16139.x; LITTAUA R, 1990, J IMMUNOL, V144, P3183; Liu SY, 2011, CURR OPIN IMMUNOL, V23, P57, DOI 10.1016/j.coi.2010.11.003; Lu J, 2011, J VIROL, V85, P2126, DOI 10.1128/JVI.01531-10; Moffatt P, 2008, J BONE MINER RES, V23, P1497, DOI 10.1359/JBMR.080412; Moreno-Altamirano MMB, 2007, INTERVIROLOGY, V50, P237, DOI 10.1159/000100567; Pierson Theodore C., 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000665; Rodenhuis-Zybert IA, 2011, TRENDS MICROBIOL, V19, P248, DOI 10.1016/j.tim.2011.02.002; Rodenhuis-Zybert IA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000718; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Tassaneetrithep B, 2003, J EXP MED, V197, P823, DOI 10.1084/jem.20021840; Ubol S, 2010, CLIN VACCINE IMMUNOL, V17, P1829, DOI 10.1128/CVI.00316-10	27	35	46	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e34508	10.1371/journal.pone.0034508	http://dx.doi.org/10.1371/journal.pone.0034508			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479637	Green Published, Green Submitted, gold			2022-12-27	WOS:000305339100163
J	Ghansah, A; Rockett, KA; Clark, TG; Wilson, MD; Koram, KA; Oduro, AR; Amenga-Etego, L; Anyorigiya, T; Hodgson, A; Milligan, P; Rogers, WO; Kwiatkowski, DP				Ghansah, Anita; Rockett, Kirk A.; Clark, Taane G.; Wilson, Michael D.; Koram, Kwadwo A.; Oduro, Abraham R.; Amenga-Etego, Lucas; Anyorigiya, Thomas; Hodgson, Abraham; Milligan, Paul; Rogers, William O.; Kwiatkowski, Dominic P.			Haplotype Analyses of Haemoglobin C and Haemoglobin S and the Dynamics of the Evolutionary Response to Malaria in Kassena-Nankana District of Ghana	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM MALARIA; RECENT POSITIVE SELECTION; LINKAGE DISEQUILIBRIUM; POPULATION-GENETICS; NORTHERN GHANA; HUMAN GENOME; RESISTANCE; CHILDREN; AFRICAN; RECOMBINATION	Background: Haemoglobin S (HbS) and C (HbC) are variants of the HBB gene which both protect against malaria. It is not clear, however, how these two alleles have evolved in the West African countries where they co-exist at high frequencies. Here we use haplotypic signatures of selection to investigate the evolutionary history of the malaria-protective alleles HbS and HbC in the Kassena-Nankana District (KND) of Ghana. Methodology/Principal Findings: The haplotypic structure of HbS and HbC alleles was investigated, by genotyping 56 SNPs around the HBB locus. We found that, in the KND population, both alleles reside on extended haplotypes (approximately 1.5 Mb for HbS and 650 Kb for HbC) that are significantly less diverse than those of the ancestral HbA allele. The extended haplotypes span a recombination hotspot that is known to exist in this region of the genome Significance: Our findings show strong support for recent positive selection of both the HbS and HbC alleles and provide insights into how these two alleles have both evolved in the population of northern Ghana.	[Ghansah, Anita; Wilson, Michael D.; Koram, Kwadwo A.] Univ Ghana, Noguchi Mem Inst Med Res, Accra, Ghana; [Rockett, Kirk A.; Amenga-Etego, Lucas; Kwiatkowski, Dominic P.] Wellcome Trust Ctr Human Genet, Oxford, England; [Clark, Taane G.; Anyorigiya, Thomas; Milligan, Paul] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; [Oduro, Abraham R.; Amenga-Etego, Lucas; Hodgson, Abraham] Navrongo Hlth Res Ctr, Navrongo, Ghana; [Rogers, William O.] Naval Med Res Unit 2, Jakarta, Indonesia; [Kwiatkowski, Dominic P.] Wellcome Trust Sanger Ctr, Hinxton, England	University of Ghana; University of Oxford; Wellcome Centre for Human Genetics; University of London; London School of Hygiene & Tropical Medicine; Navrongo Health Research Center; Naval Medical Research Center (NMRC); US Naval Medical Research Unit-2 (NAMRU-2); Wellcome Trust Sanger Institute	Ghansah, A (corresponding author), Univ Ghana, Noguchi Mem Inst Med Res, Accra, Ghana.	AGhansah@noguchi.mimcom.org	Milligan, Paul/D-8985-2017; Clark, Taane G./AAM-2570-2020	Milligan, Paul/0000-0003-3430-3395; Clark, Taane G./0000-0001-8985-9265; Kwiatkowski, Dominic/0000-0002-5023-0176; ODURO, ABRAHAM/0000-0002-4191-7419	US Naval Medical Research Centre; National Institute of Allergy and Infectious Diseases, National Institutes of Health [NO1 A195363]; Medical Research Council [G0600718, G0600230]; Wellcome Trust [090770/Z/09/Z, 075491/Z/04, 090532/Z/09/Z]; MRC [G0600230, G0600718] Funding Source: UKRI	US Naval Medical Research Centre; National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The original case-control study was supported by US Naval Medical Research Centre and National Institute of Allergy and Infectious Diseases, National Institutes of Health contract NO1 A195363. This research was supported by the Medical Research Council (G0600718; G0600230) and the Wellcome Trust (090770/Z/09/Z). The Wellcome Trust also provides a core award to the Wellcome Trust Centre for Human Genetics (075491/Z/04; 090532/Z/09/Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman H, 2005, ANN HUM GENET, V69, P559, DOI 10.1111/j.1529-8817.2005.00180.x; Agarwal A, 2000, BLOOD, V96, P2358, DOI 10.1182/blood.V96.7.2358.h8002358_2358_2363; ALLISON AC, 1954, ANN HUM GENET, V19, P39, DOI 10.1111/j.1469-1809.1954.tb01261.x; Bersaglieri T, 2004, AM J HUM GENET, V74, P1111, DOI 10.1086/421051; CHAKRAVARTI A, 1984, AM J HUM GENET, V36, P1239; Diallo DA, 2004, ACTA TROP, V90, P295, DOI 10.1016/j.actatropica.2004.02.005; Flint J, 1998, BAILLIERE CLIN HAEM, V11, P1, DOI 10.1016/S0950-3536(98)80069-3; FLINT J, 1993, BAILLIERE CLIN HAEM, V6, P215, DOI 10.1016/S0950-3536(05)80071-X; Haldane J.B.S., 1949, HEREDITAS, V35, P267; Hanchard NA, 2006, AM J HUM GENET, V78, P153, DOI 10.1086/499252; Hanchard N, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-52; Hedrick P, 2004, J EVOLUTION BIOL, V17, P221, DOI 10.1046/j.1420-9101.2003.00635.x; HILL AVS, 1991, NATURE, V352, P595, DOI 10.1038/352595a0; Jallow M, 2009, NAT GENET, V41, P657, DOI 10.1038/ng.388; Kwiatkowski DP, 2005, AM J HUM GENET, V77, P171, DOI 10.1086/432519; Li N, 2003, GENETICS, V165, P2213; Mockenhaupt FP, 2004, J INFECT DIS, V190, P1006, DOI 10.1086/422847; Modiano D, 2001, NATURE, V414, P305, DOI 10.1038/35104556; Modiano D, 2008, HUM MOL GENET, V17, P789, DOI 10.1093/hmg/ddm350; Nei M, MOL EVOLUTIONARY GEN; Oduro AR, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-96; Ohashi J, 2004, AM J HUM GENET, V74, P1198, DOI 10.1086/421330; Osafo-Addo AD, 2008, AM J TROP MED HYG, V78, P251, DOI 10.4269/ajtmh.2008.78.251; Rihet P, 2004, HUM MOL GENET, V13, P1, DOI 10.1093/hmg/ddh002; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; Tishkoff SA, 2001, SCIENCE, V293, P455, DOI 10.1126/science.1061573; Tishkoff SA, 2007, NAT GENET, V39, P31, DOI 10.1038/ng1946; Wilson JN, 2005, GENES IMMUN, V6, P462, DOI 10.1038/sj.gene.6364227; Wood ET, 2005, AM J HUM GENET, V77, P637, DOI 10.1086/491748; ZHANG L, 1992, P NATL ACAD SCI USA, V89, P5847, DOI 10.1073/pnas.89.13.5847	31	13	13	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2012	7	4							e34565	10.1371/journal.pone.0034565	http://dx.doi.org/10.1371/journal.pone.0034565			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959FE	22506028	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000305297500036
J	Vigelius, M; Meyer, B				Vigelius, Matthias; Meyer, Bernd			Multi-Dimensional, Mesoscopic Monte Carlo Simulations of Inhomogeneous Reaction-Drift-Diffusion Systems on Graphics-Processing Units	PLOS ONE			English	Article							EXACT STOCHASTIC SIMULATION; DIRECTIONAL GUIDANCE; MOTILITY REGULATION; MODELS; TRANSPORT; CHEMOTAXIS; MIGRATION; LIMIT	For many biological applications, a macroscopic (deterministic) treatment of reaction-drift-diffusion systems is insufficient. Instead, one has to properly handle the stochastic nature of the problem and generate true sample paths of the underlying probability distribution. Unfortunately, stochastic algorithms are computationally expensive and, in most cases, the large number of participating particles renders the relevant parameter regimes inaccessible. In an attempt to address this problem we present a genuine stochastic, multi-dimensional algorithm that solves the inhomogeneous, non-linear, drift-diffusion problem on a mesoscopic level. Our method improves on existing implementations in being multi-dimensional and handling inhomogeneous drift and diffusion. The algorithm is well suited for an implementation on data-parallel hardware architectures such as general-purpose graphics processing units (GPUs). We integrate the method into an operator-splitting approach that decouples chemical reactions from the spatial evolution. We demonstrate the validity and applicability of our algorithm with a comprehensive suite of standard test problems that also serve to quantify the numerical accuracy of the method. We provide a freely available, fully functional GPU implementation. Integration into Inchman, a user-friendly web service, that allows researchers to perform parallel simulations of reaction-drift-diffusion systems on GPU clusters is underway.	[Vigelius, Matthias; Meyer, Bernd] Monash Univ, FIT Ctr Res Intelligent Syst, Clayton, Vic, Australia	Monash University	Vigelius, M (corresponding author), Monash Univ, FIT Ctr Res Intelligent Syst, Clayton, Vic, Australia.	Matthias.Vigelius@monash.edu			Australian Research Council [ARC DP0879239]	Australian Research Council(Australian Research Council)	This research is funded by the Australian Research Council under ARC DP0879239. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews SS, 2004, PHYS BIOL, V1, P137, DOI 10.1088/1478-3967/1/3/001; [Anonymous], [No title captured]; Ballarini P, 2009, BRIEF BIOINFORM, V10, P278, DOI 10.1093/bib/bbp020; Bernstein D, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.041103; Broderick Gordon, 2006, ComPlexUs, V3, P217, DOI 10.1159/000106145; Buyya R, 2000, PROCEEDINGS OF THE INTERNATIONAL CONFERENCE ON PARALLEL AND DISTRIBUTED PROCESSING TECHNIQUES AND APPLICATIONS, VOLS I-V, P517; Cai AQ, 2006, B MATH BIOL, V68, P25, DOI 10.1007/s11538-005-9028-x; Codling EA, 2008, J R SOC INTERFACE, V5, P813, DOI 10.1098/rsif.2008.0014; Codling EA, 2010, ECOLOGY, V91, P3106, DOI 10.1890/09-1729.1; Dematte L., 2010, Proceedings 2010 9th International Workshop on Parallel & Distributed Methods in Verification and 2nd International Workshop on High Performance Computational Systems Biology (PDMC-HiBi 2010), P67, DOI 10.1109/PDMC-HiBi.2010.18; Dematte L, 2010, BRIEF BIOINFORM, V11, P323, DOI 10.1093/bib/bbq006; Donev A, 2010, J COMPUT PHYS, V229, P3214, DOI 10.1016/j.jcp.2009.12.038; Drozdov AN, 1996, PHYS REV E, V54, P931, DOI 10.1103/PhysRevE.54.931; Ducrot A, 2011, MATH MOD METH APPL S, V21, P871, DOI 10.1142/S0218202511005404; Elf J, 2003, P SOC PHOTO-OPT INS, V5110, P114, DOI 10.1117/12.497009; Engblom S, 2009, SIAM J SCI COMPUT, V31, P1774, DOI 10.1137/080721388; Erban R, 2009, PHYS BIOL, V6, DOI 10.1088/1478-3975/6/4/046001; Farkas Z, 2001, J PHYS A-MATH GEN, V34, P3191, DOI 10.1088/0305-4470/34/15/301; Ferm L, 2010, J COMPUT PHYS, V229, P343, DOI 10.1016/j.jcp.2009.09.030; Gardiner C, 2009, SPRINGER SERIES SYNE; Gauthier M, 2003, THESIS U OTTAWA; Gauthier M, 2004, PHYS REV E, V70, P6; Gauthier MG, 2002, CHEM PHYS, P117; Gibson MA, 2000, J PHYS CHEM A, V104, P1876, DOI 10.1021/jp993732q; Gillespie DT, 2001, J CHEM PHYS, V115, P1716, DOI 10.1063/1.1378322; Gillespie DT, 2000, J CHEM PHYS, V113, P297, DOI 10.1063/1.481811; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Hattne J, 2005, BIOINFORMATICS, V21, P2923, DOI 10.1093/bioinformatics/bti431; Helbing D, 1997, PHYS REV E, V56, P2527, DOI 10.1103/PhysRevE.56.2527; Hellander A, 2010, MULTISCALE MODEL SIM, V8, P1691, DOI 10.1137/100784709; Hellander S, 2011, J COMPUT PHYS, V230, P3948, DOI 10.1016/j.jcp.2011.02.020; Hillen T, 2000, SIAM J APPL MATH, V61, P751, DOI 10.1137/S0036139999358167; Hillen T, 2002, MATH MOD METH APPL S, V12, P1007, DOI 10.1142/S0218202502002008; Hughes B. D., 1995, RANDOM WALKS RANDOM, VI; Isaacson SA, 2009, SIAM J APPL MATH, V70, P77, DOI 10.1137/070705039; KELLER EF, 1971, J THEOR BIOL, V30, P225, DOI 10.1016/0022-5193(71)90050-6; Kokkendorff SL, 2010, SIAM J APPL MATH, V70, P2534, DOI 10.1137/070700693; Lampoudi S, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3074302; Lemerle C, 2005, FEBS LETT, V579, P1789, DOI 10.1016/j.febslet.2005.02.009; Li H, 2010, INT J HIGH PERFORM C, V24, P107, DOI 10.1177/1094342009106066; Lis M, 2009, BIOINFORMATICS, V25, P2289, DOI 10.1093/bioinformatics/btp387; Lysenko M, 2008, JASSS-J ARTIF SOC S, V11; Mason HA, 2001, J NEUROSCI, V21, P7654, DOI 10.1523/JNEUROSCI.21-19-07654.2001; Mayor R, 2010, TRENDS CELL BIOL, V20, P319, DOI 10.1016/j.tcb.2010.03.005; Merelli E, 2007, BRIEF BIOINFORM, V8, P45, DOI 10.1093/bib/bbl014; Nguyen H, 2007, GPU GEMS 3; Oppelstrup T, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.066701; Othmer HG, 1997, SIAM J APPL MATH, V57, P1044, DOI 10.1137/S0036139995288976; Othmer HG, 2002, SIAM J APPL MATH, V62, P1222, DOI 10.1137/S0036139900382772; OTHMER HG, 1988, J MATH BIOL, V26, P263, DOI 10.1007/BF00277392; Painter KJ, 2003, J THEOR BIOL, V225, P327, DOI 10.1016/S0022-5193(03)00258-3; Perthame B., 2007, FRONTIERS MATH, Patent No. pre05081225 MR 2270822; Redner S, 2001, GUIDE 1 PASSAGE PROC; Risken H., 1996, FOKKER PLANCK EQUATI; Rodriguez JV, 2006, BIOINFORMATICS, V22, P1895, DOI 10.1093/bioinformatics/btl271; Shahrezaei V, 2008, CURR OPIN BIOTECH, V19, P369, DOI 10.1016/j.copbio.2008.06.011; SLATER GW, 1993, ELECTROPHORESIS, V14, P1, DOI 10.1002/elps.1150140102; STRANG G, 1968, SIAM J NUMER ANAL, V5, P506, DOI 10.1137/0705041; Ullah M, 2010, WIRES SYST BIOL MED, V2, P385, DOI 10.1002/wsbm.78; Vigelius M, 2011, BIOINFORMATICS, V27, P288, DOI 10.1093/bioinformatics/btq622; Ward M, 2003, J NEUROSCI, V23, P5170; WATKINS JC, 1991, MATH BIOSCI, V104, P271, DOI 10.1016/0025-5564(91)90065-Q; Wu W, 1999, NATURE, V400, P331, DOI 10.1038/22477; Zhang DS, 1997, PHYS REV E, V56, P1197, DOI 10.1103/PhysRevE.56.1197	64	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2012	7	4							e33384	10.1371/journal.pone.0033384	http://dx.doi.org/10.1371/journal.pone.0033384			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959FE	22506001	gold, Green Published, Green Submitted			2022-12-27	WOS:000305297500009
J	Pinhal, D; Shivji, MS; Nachtigall, PG; Chapman, DD; Martins, C				Pinhal, Danillo; Shivji, Mahmood S.; Nachtigall, Pedro G.; Chapman, Demian D.; Martins, Cesar			A Streamlined DNA Tool for Global Identification of Heavily Exploited Coastal Shark Species (Genus Rhizoprionodon)	PLOS ONE			English	Article							MULTIPLEX PCR; GENETIC IDENTIFICATION; BODY PARTS; CONSERVATION; TRADE; CARCHARHINIDAE; LALANDII	Obtaining accurate species-specific landings data is an essential step toward achieving sustainable shark fisheries. Globally distributed sharpnose sharks (genus Rhizoprionodon) exhibit life-history characteristics (rapid growth, early maturity, annual reproduction) that suggests that they could be fished in a sustainable manner assuming an investment in monitoring, assessment and careful management. However, obtaining species-specific landings data for sharpnose sharks is problematic because they are morphologically very similar to one another. Moreover, sharpnose sharks may also be confused with other small sharks (either small species or juveniles of large species) once they are processed (i.e., the head and fins are removed). Here we present a highly streamlined molecular genetics approach based on seven species-specific PCR primers in a multiplex format that can simultaneously discriminate body parts from the seven described sharpnose shark species commonly occurring in coastal fisheries worldwide. The species-specific primers are based on nucleotide sequence differences among species in the nuclear ribosomal internal transcribed spacer 2 locus (ITS2). This approach also distinguishes sharpnose sharks from a wide range of other sharks (52 species) and can therefore assist in the regulation of coastal shark fisheries around the world.	[Pinhal, Danillo; Nachtigall, Pedro G.] UNESP Sao Paulo State Univ, Dept Genet, Sao Paulo, Brazil; [Shivji, Mahmood S.] Nova SE Univ, Save Our Seas Shark Ctr, Dania, FL USA; [Shivji, Mahmood S.] Nova SE Univ, Oceanog Ctr, Guy Harvey Res Inst, Dania, FL USA; [Chapman, Demian D.] SUNY Stony Brook, Sch Marine & Atmospher Sci, Stony Brook, NY 11794 USA; [Chapman, Demian D.] SUNY Stony Brook, Inst Ocean Conservat Sci, Stony Brook, NY 11794 USA; [Martins, Cesar] UNESP Sao Paulo State Univ, Dept Morphol, Sao Paulo, Brazil	Universidade Estadual Paulista; Nova Southeastern University; Nova Southeastern University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Universidade Estadual Paulista	Pinhal, D (corresponding author), UNESP Sao Paulo State Univ, Dept Genet, Sao Paulo, Brazil.	dlpinhal@ibb.unesp.br	Pinhal, Danillo/C-5983-2012; Adapta, Inct/J-8371-2013; Martins, Cesar/A-2594-2008; Nachtigall, Pedro Gabriel/M-5424-2017	Pinhal, Danillo/0000-0003-1075-0182; Martins, Cesar/0000-0003-3534-974X; Nachtigall, Pedro Gabriel/0000-0002-3196-0173	Sao Paulo Research Foundation (FAPESP) [07/03067-8, 07/03065-5]; Save Our Seas Foundation; Hai Stiftung/Shark Foundation	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Save Our Seas Foundation; Hai Stiftung/Shark Foundation	This work was supported by grants to DP and CM from the Sao Paulo Research Foundation (FAPESP - grant numbers 07/03067-8 and 07/03065-5) and grants from the Save Our Seas Foundation and Hai Stiftung/Shark Foundation to MSS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abercrombie DL, 2005, CONSERV GENET, V6, P775, DOI 10.1007/s10592-005-9036-2; AU DW, 2008, SHARKS OPEN OCEAN BI, P298, DOI DOI 10.1002/9781444302516.CH26; Chapman DD, 2003, CONSERV GENET, V4, P415, DOI 10.1023/A:1024771215616; Compagno Leonard, 2005, P1; Dubey B, 2009, CONSERV GENET, V10, P1861, DOI 10.1007/s10592-009-9835-y; FAO Food and Agriculture Organization, 2000, FISH MAN CONS S1; Heist Edward J., 2005, P27; Kibbe WA, 2007, NUCLEIC ACIDS RES, V35, pW43, DOI 10.1093/nar/gkm234; Lessa RPT, 2005, BRAZILIAN NATL PLAN; Lewin, 2004, GENES-BASEL; Magnussen JE, 2007, ANIM CONSERV, V10, P199, DOI 10.1111/j.1469-1795.2006.00088.x; Mendonca FF, 2011, CONSERV GENET, V12, P193, DOI 10.1007/s10592-010-0132-6; Mendonca FF, 2009, MOL ECOL RESOUR, V9, P771, DOI 10.1111/j.1755-0998.2009.02524.x; Motta FS, 2005, FISH RES, V74, P116, DOI 10.1016/j.fishres.2005.03.010; Mukherjee N, 2007, CONSERV GENET, V8, P1465, DOI 10.1007/s10592-007-9289-z; NMFS National Marine Fisheries Service, 2001, BIOL OP ONG KLAM PRO; Ogden Rob, 2010, Endangered Species Research, V9, P179, DOI 10.3354/esr00144; Pank M, 2001, MAR BIOTECHNOL, V3, P231, DOI 10.1007/s101260000071; Rosa RS, 2004, IUCN 2010 IUCN RED L; Shivji M, 2002, CONSERV BIOL, V16, P1036, DOI 10.1046/j.1523-1739.2002.01188.x; Shivji MS, 2010, CRC MAR BIOL SER, P593; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; Walker TI, 1998, MAR FRESHWATER RES, V49, P553, DOI 10.1071/MF98017; Wong EHK, 2009, MOL ECOL RESOUR, V9, P243, DOI 10.1111/j.1755-0998.2009.02653.x	25	14	14	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2012	7	4							e34797	10.1371/journal.pone.0034797	http://dx.doi.org/10.1371/journal.pone.0034797			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JO	22496864	gold, Green Published, Green Submitted			2022-12-27	WOS:000305014500032
J	Stradalova, V; Blazikova, M; Grossmann, G; Opekarova, M; Tanner, W; Malinsky, J				Stradalova, Vendula; Blazikova, Michaela; Grossmann, Guido; Opekarova, Miroslava; Tanner, Widmar; Malinsky, Jan			Distribution of Cortical Endoplasmic Reticulum Determines Positioning of Endocytic Events in Yeast Plasma Membrane	PLOS ONE			English	Article							NUCLEUS-VACUOLE JUNCTIONS; SACCHAROMYCES-CEREVISIAE; BUDDING YEAST; CELL; ER; COMPARTMENTATION; MICRODOMAINS; ORGANIZATION; PROTEINS; LIPIDS	In many eukaryotes, a significant part of the plasma membrane is closely associated with the dynamic meshwork of cortical endoplasmic reticulum (cortical ER). We mapped temporal variations in the local coverage of the yeast plasma membrane with cortical ER pattern and identified micron-sized plasma membrane domains clearly different in cortical ER persistence. We show that clathrin-mediated endocytosis is initiated outside the cortical ER-covered plasma membrane zones. These cortical ER-covered zones are highly dynamic but do not overlap with the immobile and also endocytosis-inactive membrane compartment of Can1 (MCC) and the subjacent eisosomes. The eisosomal component Pil1 is shown to regulate the distribution of cortical ER and thus the accessibility of the plasma membrane for endocytosis.	[Stradalova, Vendula; Blazikova, Michaela; Malinsky, Jan] Acad Sci Czech Republic, Inst Expt Med, Prague, Czech Republic; [Blazikova, Michaela] Charles Univ Prague, Fac Math & Phys, Prague, Czech Republic; [Grossmann, Guido] Carnegie Inst Sci, Dept Plant Biol, Stanford, CA USA; [Opekarova, Miroslava] Acad Sci Czech Republic, Inst Microbiol, Prague, Czech Republic; [Tanner, Widmar] Univ Regensburg, Inst Cell Biol & Plant Physiol, Regensburg, Germany	Czech Academy of Sciences; Institute of Experimental Medicine of the Czech Academy of Sciences; Charles University Prague; Carnegie Institution for Science; Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; University of Regensburg	Stradalova, V (corresponding author), Acad Sci Czech Republic, Inst Expt Med, Prague, Czech Republic.	malinsky@biomed.cas.cz	Malinsky, Jan/H-2484-2014; Efenberkova, Michaela/AAF-9968-2020; Grossmann, Guido/GQA-5985-2022; Stradalova, Vendula/H-2458-2014; Grossmann, Guido/D-3537-2014	Malinsky, Jan/0000-0002-1433-0989; Efenberkova, Michaela/0000-0003-1227-0393; Grossmann, Guido/0000-0001-7529-9244; Grossmann, Guido/0000-0001-7529-9244; Opekarova, Miroslava/0000-0002-2898-6014	Grant Agency of the Czech Republic [204/07/0133, P302/11/0146, 204/09/1924]; Grant Agency of the Academy of Sciences of the Czech Republic [KAN200520801]; Deutsche Forschungsgemeinschaft (DFG) [TA 36/18-1, TH, SFB699 Z2]; EMBO;  [AV0Z50390703];  [AV0Z50200510]	Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Grant Agency of the Academy of Sciences of the Czech Republic(Czech Academy of SciencesGrant Agency of the Czech Republic); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); EMBO(European Molecular Biology Organization (EMBO)); ; 	This work was financially supported by the Grant Agency of the Czech Republic (projects 204/07/0133, P302/11/0146 and 204/09/1924), the Grant Agency of the Academy of Sciences of the Czech Republic (KAN200520801), by the institutional grants (AV0Z50390703 and AV0Z50200510), and by the Deutsche Forschungsgemeinschaft (DFG projects TA 36/18-1; TH; SFB699 Z2). GG was supported by a EMBO long-term fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berchtold D, 2009, MOL BIOL CELL, V20, P1565, DOI 10.1091/mbc.E08-10-1001; Bevis BJ, 2002, NAT CELL BIOL, V4, P750, DOI 10.1038/ncb852; Brach T, 2011, J CELL SCI, V124, P328, DOI 10.1242/jcs.078519; Engqvist-Goldstein AEY, 2003, ANNU REV CELL DEV BI, V19, P287, DOI 10.1146/annurev.cellbio.19.111401.093127; Frohlich F, 2009, J CELL BIOL, V185, P1227, DOI 10.1083/jcb.200811081; Grossmann G, 2007, EMBO J, V26, P1, DOI 10.1038/sj.emboj.7601466; Grossmann G, 2008, J CELL BIOL, V183, P1075, DOI 10.1083/jcb.200806035; Idrissi FZ, 2008, J CELL BIOL, V180, P1219, DOI 10.1083/jcb.200708060; Kaksonen M, 2005, CELL, V123, P305, DOI 10.1016/j.cell.2005.09.024; Kleine-Vehn J, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.72; Kukulski W, 2011, J CELL BIOL, V192, P111, DOI 10.1083/jcb.201009037; Kvam E, 2007, AUTOPHAGY, V3, P85, DOI 10.4161/auto.3586; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Loewen CJR, 2007, J CELL BIOL, V179, P467, DOI 10.1083/jcb.200708205; Loibl M, 2010, EUKARYOT CELL, V9, P1184, DOI 10.1128/EC.00006-10; Malinska K, 2004, J CELL SCI, V117, P6031, DOI 10.1242/jcs.01493; Malinska K, 2003, MOL BIOL CELL, V14, P4427, DOI 10.1091/mbc.E03-04-0221; Malinsky J, 2010, YEAST, V27, P473, DOI 10.1002/yea.1772; Moreira KE, 2009, MOL BIOL CELL, V20, P809, DOI 10.1091/mbc.E08-03-0313; Olivera-Couto A, 2011, MOL BIOL CELL, V22, P2360, DOI 10.1091/mbc.E10-12-1021; Orci L, 2009, P NATL ACAD SCI USA, V106, P19358, DOI 10.1073/pnas.0911280106; Pan XZ, 2000, MOL BIOL CELL, V11, P2445, DOI 10.1091/mbc.11.7.2445; Perktold A, 2007, FEMS YEAST RES, V7, P629, DOI 10.1111/j.1567-1364.2007.00226.x; Pichler H, 2001, EUR J BIOCHEM, V268, P2351, DOI 10.1046/j.1432-1327.2001.02116.x; Prinz WA, 2000, J CELL BIOL, V150, P461, DOI 10.1083/jcb.150.3.461; Sparkes IA, 2009, BIOCHEM J, V423, P145, DOI 10.1042/BJ20091113; Stimpson HEM, 2009, MOL BIOL CELL, V20, P4640, DOI 10.1091/mbc.E09-05-0429; Stradalova V, 2009, J CELL SCI, V122, P2887, DOI 10.1242/jcs.051227; Toret CP, 2006, J CELL SCI, V119, P4585, DOI 10.1242/jcs.03251; Toshima JY, 2006, P NATL ACAD SCI USA, V103, P5793, DOI 10.1073/pnas.0601042103; Walther TC, 2006, NATURE, V439, P998, DOI 10.1038/nature04472; Walther TC, 2007, EMBO J, V26, P4946, DOI 10.1038/sj.emboj.7601933; West M, 2011, J CELL BIOL, V193, P333, DOI 10.1083/jcb.201011039; Zhang D, 2010, CURR BIOL, V20, P1029, DOI 10.1016/j.cub.2010.04.017; Ziolkowska NE, 2011, NAT STRUCT MOL BIOL, V18, P854, DOI 10.1038/nsmb.2080	35	33	33	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2012	7	4							e35132	10.1371/journal.pone.0035132	http://dx.doi.org/10.1371/journal.pone.0035132			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JO	22496901	Green Published, Green Submitted, gold			2022-12-27	WOS:000305014500047
J	Zha, DJ; Chen, FY; Ramamoorthy, S; Fridberger, A; Choudhury, N; Jacques, SL; Wang, RKK; Nuttall, AL				Zha, Dingjun; Chen, Fangyi; Ramamoorthy, Sripriya; Fridberger, Anders; Choudhury, Niloy; Jacques, Steven L.; Wang, Ruikang K.; Nuttall, Alfred L.			In Vivo Outer Hair Cell Length Changes Expose the Active Process in the Cochlea	PLOS ONE			English	Article							MECHANICAL WAVE-FORM; BASILAR-MEMBRANE; INNER-EAR; TECTORIAL MEMBRANE; MAMMALIAN COCHLEA; SUPPORTING CELLS; RESPONSES; MODEL; ORGAN; CORTI	In Background: Mammalian hearing is refined by amplification of the sound-evoked vibration of the cochlear partition. This amplification is at least partly due to forces produced by protein motors residing in the cylindrical body of the outer hair cell. To transmit power to the cochlear partition, it is required that the outer hair cells dynamically change their length, in addition to generating force. These length changes, which have not previously been measured in vivo, must be correctly timed with the acoustic stimulus to produce amplification. Methodology/Principal Findings: Using in vivo optical coherence tomography, we demonstrate that outer hair cells in living guinea pigs have length changes with unexpected timing and magnitudes that depend on the stimulus level in the sensitive cochlea. Conclusions/Significance: The level-dependent length change is a necessary condition for directly validating that power is expended by the active process presumed to underlie normal hearing.	[Zha, Dingjun; Chen, Fangyi; Ramamoorthy, Sripriya; Fridberger, Anders; Nuttall, Alfred L.] Oregon Hlth & Sci Univ, Oregon Hearing Res Ctr, Portland, OR 97201 USA; [Zha, Dingjun] Fourth Mil Med Univ, Xijing Hosp, Dept Otolaryngol Head & Neck Surg, Xian, Shaanxi, Peoples R China; [Jacques, Steven L.; Nuttall, Alfred L.] Oregon Hlth & Sci Univ, Dept Biomed Engn, Portland, OR 97201 USA; [Jacques, Steven L.] Oregon Hlth & Sci Univ, Dept Dermatol, Portland, OR 97201 USA; [Wang, Ruikang K.] Univ Washington, Dept Bioengn, Seattle, WA 98195 USA; [Fridberger, Anders] Karolinska Inst, M1 Karolinska Univ Hosp, Ctr Hearing & Commun Res, Dept Clin Sci Intervent & Technol, Stockholm, Sweden; [Choudhury, Niloy] Michigan Technol Univ, Dept Biomed Engn, Houghton, MI 49931 USA; [Nuttall, Alfred L.] Univ Michigan, Kresge Hearing Res Inst, Ann Arbor, MI 48109 USA	Oregon Health & Science University; Air Force Military Medical University; Oregon Health & Science University; Oregon Health & Science University; University of Washington; University of Washington Seattle; Karolinska Institutet; Karolinska University Hospital; Michigan Technological University; University of Michigan System; University of Michigan	Zha, DJ (corresponding author), Oregon Hlth & Sci Univ, Oregon Hearing Res Ctr, Portland, OR 97201 USA.	chenfa@ohsu.edu	Wang, Ruikang/L-3889-2019; Fridberger, Anders/E-8977-2010; Chen, Fangyi/I-3497-2018	Wang, Ruikang/0000-0001-5169-8822; Fridberger, Anders/0000-0002-7960-1559; Chen, Fangyi/0000-0002-5024-6215; Ramamoorthy, Sripriya/0000-0002-0782-1229	National Institute on Deafness and Other Communicable Disorders [R01 DC 000141, DC 010399]; Swedish Research Counctil [K2011-63X-14061-11-3]; Tysta Skolan foundation; Horselskadades Riksforbund; Chinese National Nature Science Foundation [30600702]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC010399, R01DC000141, P30DC005983] Funding Source: NIH RePORTER	National Institute on Deafness and Other Communicable Disorders; Swedish Research Counctil; Tysta Skolan foundation; Horselskadades Riksforbund; Chinese National Nature Science Foundation(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	Supported by National Institute on Deafness and Other Communicable Disorders grants R01 DC 000141 (ALN) and DC 010399 (ALN), Swedish Research Counctil grant K2011-63X-14061-11-3 (AF), grants from the Tysta Skolan foundation and Horselskadades Riksforbund (AF) and supported by Chinese National Nature Science Foundation, 30600702 (DZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN JB, 1980, J ACOUST SOC AM, V68, P1660, DOI 10.1121/1.385198; ANGELBORG C, 1972, ACTA OTO-LARYNGOL, P49; ASHMORE JF, 1987, J PHYSIOL-LONDON, V388, P323, DOI 10.1113/jphysiol.1987.sp016617; BROWNELL WE, 1985, SCIENCE, V227, P194, DOI 10.1126/science.3966153; BROWNELL WE, 1990, EAR HEARING, V11, P82, DOI 10.1097/00003446-199004000-00003; Chan DK, 2005, NAT NEUROSCI, V8, P149, DOI 10.1038/nn1385; Chen FY, 2011, NAT NEUROSCI, V14, P770, DOI 10.1038/nn.2827; Chen FY, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2717134; Choudhury N, 2006, HEARING RES, V220, P1, DOI 10.1016/j.heares.2006.06.006; CODY AR, 1987, J PHYSIOL-LONDON, V383, P551; Cooper NP, 1997, J NEUROPHYSIOL, V78, P261, DOI 10.1152/jn.1997.78.1.261; DALLOS P, 1991, NATURE, V350, P155, DOI 10.1038/350155a0; DAVIS H, 1983, HEARING RES, V9, P79, DOI 10.1016/0378-5955(83)90136-3; de Boer E, 2000, J ACOUST SOC AM, V107, P1487, DOI 10.1121/1.428435; de Boer E, 2000, J ACOUST SOC AM, V107, P1497, DOI 10.1121/1.428436; de Boer E., 2001, PHYSL PSYCHOL BASES, P1; Fridberger A, 2004, J NEUROSCI, V24, P10057, DOI 10.1523/JNEUROSCI.2711-04.2004; GEISLER CD, 1995, HEARING RES, V86, P132, DOI 10.1016/0378-5955(95)00064-B; GEISLER CD, 1986, HEARING RES, V24, P125, DOI 10.1016/0378-5955(86)90056-0; Grosh K, 2004, J ACOUST SOC AM, V115, P2178, DOI 10.1121/1.1695431; Gummer AW, 1996, P NATL ACAD SCI USA, V93, P8727, DOI 10.1073/pnas.93.16.8727; Hallworth R, 1995, J NEUROPHYSIOL, V74, P2319, DOI 10.1152/jn.1995.74.6.2319; He DZZ, 1999, P NATL ACAD SCI USA, V96, P8223, DOI 10.1073/pnas.96.14.8223; Jacob S, 2011, BIOPHYS J, V100, P2586, DOI 10.1016/j.bpj.2011.05.002; Kennedy HJ, 2005, NATURE, V433, P880, DOI 10.1038/nature03367; KHANNA SM, 1982, SCIENCE, V215, P305, DOI 10.1126/science.7053580; MAMMANO F, 1993, NATURE, V365, P838, DOI 10.1038/365838a0; MAMMANO F, 1995, PFLUG ARCH EUR J PHY, V430, P745, DOI 10.1007/BF00386170; MARKIN VS, 1995, BIOPHYS J, V69, P138, DOI 10.1016/S0006-3495(95)79883-6; NEELY ST, 1993, J ACOUST SOC AM, V94, P137, DOI 10.1121/1.407091; Nilsen KE, 1999, NAT NEUROSCI, V2, P642, DOI 10.1038/10197; Nobili R, 1996, J ACOUST SOC AM, V99, P2244, DOI 10.1121/1.415412; NUTTALL AL, 1991, HEARING RES, V51, P203, DOI 10.1016/0378-5955(91)90037-A; Ramamoorthy S, 2007, J ACOUST SOC AM, V121, P2758, DOI 10.1121/1.2713725; RHODE WS, 1971, J ACOUST SOC AM, V49, P1218, DOI 10.1121/1.1912485; ROBLES L, 1986, J ACOUST SOC AM, V80, P1364, DOI 10.1121/1.394389; RUGGERO MA, 1991, J NEUROSCI, V11, P1057; SANTOS-SACCHI J, 1988, HEARING RES, V35, P143, DOI 10.1016/0378-5955(88)90113-X; SANTOS-SACCHI J, 1992, J NEUROSCI, V12, P1906; SLEPECKY N, 1983, HEARING RES, V10, P359, DOI 10.1016/0378-5955(83)90098-9; ter Kuile E., 1900, PFLUGERS ARCH GES PH, V79, P146, DOI 10.1007/BF01796105; Tolomeo JA, 1997, BIOPHYS J, V73, P2241, DOI 10.1016/S0006-3495(97)78255-9; Tomo I, 2007, BIOPHYS J, V93, P3279, DOI 10.1529/biophysj.107.105072; ZENNER HP, 1985, HEARING RES, V18, P127, DOI 10.1016/0378-5955(85)90004-8; Zheng J, 2000, NATURE, V405, P149, DOI 10.1038/35012009; ZWISLOCKI JJ, 1979, SCIENCE, V204, P639, DOI 10.1126/science.432671	46	43	43	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2012	7	4							e32757	10.1371/journal.pone.0032757	http://dx.doi.org/10.1371/journal.pone.0032757			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JO	22496736	gold, Green Submitted, Green Published			2022-12-27	WOS:000305014500006
J	Castrezana, S; Bono, JM				Castrezana, Sergio; Bono, Jeremy M.			Host Plant Adaptation in Drosophila mettleri Populations	PLOS ONE			English	Article							SONORAN DESERT; TRADE-OFFS; CACTOPHILIC DROSOPHILA; ECOLOGICAL SPECIATION; LOCAL ADAPTATION; CYTOCHROME P450S; CACTUS ALKALOIDS; SPECIALIZATION; INVOLVEMENT; CACTACEAE	The process of local adaptation creates diversity among allopatric populations, and may eventually lead to speciation. Plant-feeding insect populations that specialize on different host species provide an excellent opportunity to evaluate the causes of ecological specialization and the subsequent consequences for diversity. In this study, we used geographically separated Drosophila mettleri populations that specialize on different host cacti to examine oviposition preference for and larval performance on an array of natural and non-natural hosts (eight total). We found evidence of local adaptation in performance on saguaro cactus (Carnegiea gigantea) for populations that are typically associated with this host, and to chemically divergent prickly pear species (Opuntia spp.) in a genetically isolated population on Santa Catalina Island. Moreover, each population exhibited reduced performance on the alternative host. This finding is consistent with trade-offs associated with adaptation to these chemically divergent hosts, although we also discuss alternative explanations for this pattern. For oviposition preference, Santa Catalina Island flies were more likely to oviposit on some prickly pear species, but all populations readily laid eggs on saguaro. Experiments with non-natural hosts suggest that factors such as ecological opportunity may play a more important role than host plant chemistry in explaining the lack of natural associations with some hosts.	[Castrezana, Sergio] Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ USA; [Bono, Jeremy M.] Univ Colorado, Dept Biol, Colorado Springs, CO 80907 USA	University of Arizona; University of Colorado System; University of Colorado at Colorado Springs	Castrezana, S (corresponding author), Univ Calif Los Angeles, Ecol & Evolutionary Biol Dept, Los Angeles, CA 90024 USA.	jbono@uccs.edu			National Science Foundation [INT-9402161, BED9510645]	National Science Foundation(National Science Foundation (NSF))	This research was supported by National Science Foundation Grants INT-9402161 and BED9510645. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AA, 2000, ECOLOGY, V81, P500, DOI 10.1890/0012-9658(2000)081[0500:HREAAT]2.0.CO;2; Bono JM, 2008, MOL ECOL, V17, P3211, DOI 10.1111/j.1365-294X.2008.03823.x; Castrezana SJ, 2008, BEHAV GENET, V38, P437, DOI 10.1007/s10519-008-9209-0; Coyne J.A., 2004, SPECIATION; Danielson PB, 1998, MOL GEN GENET, V259, P54, DOI 10.1007/s004380050788; Danielson PB, 1997, P NATL ACAD SCI USA, V94, P10797, DOI 10.1073/pnas.94.20.10797; FOGLEMAN JC, 1981, AM NAT, V118, P541, DOI 10.1086/283846; FOGLEMAN JC, 1982, COMP BIOCHEM PHYS A, V71, P413, DOI 10.1016/0300-9629(82)90427-3; Fogleman JC, 2001, AM ZOOL, V41, P877, DOI 10.1668/0003-1569(2001)041[0877:CIITCM]2.0.CO;2; Fogleman JC, 1990, ECOLOGICAL EVOLUTION; FOX LR, 1981, SCIENCE, V211, P887, DOI 10.1126/science.211.4485.887; FRANK MR, 1992, P NATL ACAD SCI USA, V89, P11998, DOI 10.1073/pnas.89.24.11998; FRY JD, 1996, AM NAT             S, V148, P84, DOI DOI 10.1086/285904; Funk DJ, 2002, GENETICA, V116, P251, DOI 10.1023/A:1021236510453; FUTUYMA DJ, 1988, ANNU REV ECOL SYST, V19, P207, DOI 10.1146/annurev.es.19.110188.001231; Griffith MP, 2009, INT J PLANT SCI, V170, P107, DOI 10.1086/593048; Hartmann S, 2002, AM J BOT, V89, P1085, DOI 10.3732/ajb.89.7.1085; Hereford J, 2009, AM NAT, V173, P579, DOI 10.1086/597611; Hurtado LA, 2004, MOL ECOL, V13, P1365, DOI 10.1111/j.1365-294X.2004.02169.x; JAENIKE J, 1990, ANNU REV ECOL SYST, V21, P243, DOI 10.1146/annurev.es.21.110190.001331; Kawecki TJ, 2004, ECOL LETT, V7, P1225, DOI 10.1111/j.1461-0248.2004.00684.x; Kircher H.W., 1982, P143; Markow TA, 2002, EVOLUTION, V56, P546, DOI 10.1111/j.0014-3820.2002.tb01365.x; Meyer BN, 1980, PHYTOCHEMISTRY, V19; MEYER JM, 1987, J CHEM ECOL, V13, P2069, DOI 10.1007/BF01012872; Newby BD, 1998, J INSECT BEHAV, V11, P691, DOI 10.1023/A:1022398809881; Rundle HD, 2005, ECOL LETT, V8, P336, DOI 10.1111/j.1461-0248.2004.00715.x; Scheirs J, 2005, EVOL ECOL, V19, P551, DOI 10.1007/s10682-005-2004-y; Schluter D, 2009, P NATL ACAD SCI USA, V106, P9955, DOI 10.1073/pnas.0901264106; Starmer W.T., 1982, P159; Starmer WT, 1990, ECOLOGICAL EVOLUTION; Stintzing FC, 2005, MOL NUTR FOOD RES, V49, P175, DOI 10.1002/mnfr.200400071; STROMBOM J, 1978, ACTA PHARM SUEC, V15, P127; VIA S, 1991, EVOLUTION, V45, P827, DOI 10.1111/j.1558-5646.1991.tb04353.x	34	6	6	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2012	7	4							e34008	10.1371/journal.pone.0034008	http://dx.doi.org/10.1371/journal.pone.0034008			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JA	22493678	Green Published, gold, Green Submitted			2022-12-27	WOS:000305012700020
J	Lin, IT; Yang, HC; Chen, JH				Lin, In-Tsang; Yang, Hong-Chang; Chen, Jyh-Horng			Whole Body Screening Using High-Temperature Superconducting MR Volume Resonators: Mice Studies	PLOS ONE			English	Article							RECEIVER COIL; MICROSCOPY; QUALITY; PROBES; SINGLE; MOUSE	High temperature superconducting (HTS) surface resonators have been used as a low loss RF receiver resonator for improving magnetic resonance imaging image quality. However, the application of HTS surface resonators is significantly limited by their filling factor. To maximize the filling factor, it is desirable to have the RF resonator wrapped around the sample so that more nuclear magnetic dipoles can contribute to the signal. In this study, a whole new Bi2Sr2Ca2Cu2O3 (Bi-2223) superconducting saddle resonator (width of 5 cm and length of 8 cm) was designed for the magnetic resonance image of a mouse's whole body in Bruker 3 T MRI system. The experiment was conducted with a professionally-made copper saddle resonator and a Bi-2223 saddle resonator to show the difference. Signal-to-noise ratio (SNR) with the HTS saddle resonator at 77 K was 2.1 and 2 folds higher than that of the copper saddle resonator at 300 K for a phantom and an in-vivo mice whole body imaging. Testing results were in accordance with predicted ones, and the difference between the predicted SNR gains and measured SNR gains were 2.4%similar to 2.7%. In summary, with this HTS saddle system, a mouse's whole body can be imaged in one scan and could reach a high SNR due to a 2 folds SNR gain over the professionally-made prototype of copper saddle resonator at 300 K. The use of HTS saddle resonator not only improves SNR but also enables a mouse's whole body screen in one scan.	[Lin, In-Tsang; Chen, Jyh-Horng] Natl Taiwan Univ, Grad Inst Biomed Elect & Bioinformat, Taipei 10764, Taiwan; [Lin, In-Tsang; Chen, Jyh-Horng] Natl Taiwan Univ, Dept Elect Engn, Interdisciplinary MRI MRS Lab, Taipei 10764, Taiwan; [Yang, Hong-Chang] Natl Taiwan Univ, Dept Phys, Taipei, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University	Lin, IT (corresponding author), Natl Taiwan Univ, Grad Inst Biomed Elect & Bioinformat, Taipei 10764, Taiwan.	hcyang@phys.ntu.edu.tw; jhchen@ntu.edu.tw			National Health Research Institutes [NHRI-EX100-10038]; National Science Council [NSC 100-2120-M002-015]	National Health Research Institutes(National Health Research Institutes, Japan); National Science Council(Ministry of Science and Technology, Taiwan)	The study is funded by National Health Research Institutes (http://www.nhri.org.tw), grant number NHRI-EX100-10038 and National Science Council (http://www.nhri.org.tw/), grant number NSC 100-2120-M002-015. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahl IJ, 2000, IEEE MICROW MAG, V1, P64, DOI 10.1109/6668.871190; BLACK RD, 1993, SCIENCE, V259, P793, DOI 10.1126/science.8430331; Cheng MC, 2005, SUPERCOND SCI TECH, V18, P1100, DOI 10.1088/0953-2048/18/8/013; Darrasse L, 2003, BIOCHIMIE, V85, P915, DOI 10.1016/j.biochi.2003.09.016; Ginefri JC, 1999, REV SCI INSTRUM, V70, P4730, DOI 10.1063/1.1150142; Ginefri JC, 2007, METHODS, V43, P54, DOI 10.1016/j.ymeth.2007.03.011; Grasso G, 2000, SUPERCOND SCI TECH, V13, pL15, DOI 10.1088/0953-2048/13/10/102; HALL AS, 1991, MAGNET RESON MED, V20, P340, DOI 10.1002/mrm.1910200218; Hoult DI, 2002, CONCEPT MAGNETIC RES, V15, P262, DOI 10.1002/cmr.10047; HOULT DI, 1976, J MAGN RESON, V24, P71, DOI 10.1016/0022-2364(76)90233-X; Hurlston SE, 1999, MAGNET RESON MED, V41, P1032, DOI 10.1002/(SICI)1522-2594(199905)41:5<1032::AID-MRM23>3.3.CO;2-O; Kwok WE, 2006, MAGN RESON IMAGING, V24, P819, DOI 10.1016/j.mri.2006.01.010; Lee HL, 2005, IEEE T APPL SUPERCON, V15, P1326, DOI 10.1109/TASC.2005.849582; Lee KH, 2004, IEEE T BIO-MED ENG, V51, P2024, DOI 10.1109/TBME.2004.831539; Lin IT, 2010, J APPL PHYS, V107, DOI 10.1063/1.3431538; Miller J, 1999, MAGNETIC RESONANCE M, V41; Mispelter J., NMR PROBEHEADS BIOPH; Nouls JC, 2008, J MAGN RESON, V191, P231, DOI 10.1016/j.jmr.2007.12.018; OKADA H, 1995, J MAGN RESON SER B, V107, P158, DOI 10.1006/jmrb.1995.1072; Quesson B, 2000, J MAGN RESON IMAGING, V12, P525, DOI 10.1002/1522-2586(200010)12:4<525::AID-JMRI3>3.0.CO;2-V; Wosik J, 2003, IEEE T APPL SUPERCON, V13, P1050, DOI 10.1109/TASC.2003.814148; Wright AC, 2000, MAGNET RESON MED, V43, P163, DOI 10.1002/(SICI)1522-2594(200002)43:2<163::AID-MRM1>3.0.CO;2-K; Yang HC, 2007, SUPERCOND SCI TECH, V20, P777, DOI 10.1088/0953-2048/20/8/009; Yi HP, 2004, PHYSICA C, V412, P1073, DOI 10.1016/j.physc.2004.01.114; Yuan J, 2004, SUPERCOND SCI TECH, V17, P333, DOI 10.1088/0953-2048/17/3/006	25	1	1	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2012	7	4							e33207	10.1371/journal.pone.0033207	http://dx.doi.org/10.1371/journal.pone.0033207			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JA	22493666	gold, Green Published, Green Submitted			2022-12-27	WOS:000305012700008
J	Machado, D; Couto, I; Perdigao, J; Rodrigues, L; Portugal, I; Baptista, P; Veigas, B; Amaral, L; Viveiros, M				Machado, Diana; Couto, Isabel; Perdigao, Joao; Rodrigues, Liliana; Portugal, Isabel; Baptista, Pedro; Veigas, Bruno; Amaral, Leonard; Viveiros, Miguel			Contribution of Efflux to the Emergence of Isoniazid and Multidrug Resistance in Mycobacterium tuberculosis	PLOS ONE			English	Article							CATALASE-PEROXIDASE GENE; DRUG-RESISTANCE; SUSCEPTIBILITY; MUTATIONS; MECHANISM; RIFAMPIN; PUMP; SPECIMENS; STRESS	Multidrug resistant (MDR) tuberculosis is caused by Mycobacterium tuberculosis resistant to isoniazid and rifampicin, the two most effective drugs used in tuberculosis therapy. Here, we investigated the mechanism by which resistance towards isoniazid develops and how overexpression of efflux pumps favors accumulation of mutations in isoniazid targets, thus establishing a MDR phenotype. The study was based on the in vitro induction of an isoniazid resistant phenotype by prolonged serial exposure of M. tuberculosis strains to the critical concentration of isoniazid employed for determination of drug susceptibility testing in clinical isolates. Results show that susceptible and rifampicin monoresistant strains exposed to this concentration become resistant to isoniazid after three weeks; and that resistance observed for the majority of these strains could be reduced by means of efflux pumps inhibitors. RT-qPCR assessment of efflux pump genes expression showed overexpression of all tested genes. Enhanced real-time efflux of ethidium bromide, a common efflux pump substrate, was also observed, showing a clear relation between overexpression of the genes and increased efflux pump function. Further exposure to isoniazid resulted in the selection and stabilization of spontaneous mutations and deletions in the katG gene along with sustained increased efflux activity. Together, results demonstrate the relevance of efflux pumps as one of the factors of isoniazid resistance in M. tuberculosis. These results support the hypothesis that activity of efflux pumps allows the maintenance of an isoniazid resistant population in a sub-optimally treated patient from which isoniazid genetically resistant mutants emerge. Therefore, the use of inhibitors of efflux should be considered in the development of new therapeutic strategies for preventing the emergence of MDR-TB during treatment.	[Machado, Diana; Couto, Isabel; Rodrigues, Liliana; Amaral, Leonard; Viveiros, Miguel] Univ Nova Lisboa, Inst Higiene & Med Trop, Unidade Microbiol Med, Grp Micobacterias, P-1200 Lisbon, Portugal; [Couto, Isabel] Univ Nova Lisboa, Fac Ciencias & Tecnol, Ctr Recursos Microbiol CREM, Caparica, Portugal; [Perdigao, Joao; Portugal, Isabel] Univ Lisbon, Fac Farm, Ctr Patogenese Mol URIA, P-1699 Lisbon, Portugal; [Baptista, Pedro; Veigas, Bruno] Univ Nova Lisboa, Fac Ciencias & Tecnol, Dept Ciencias Vida, CIGMH, Caparica, Portugal; [Amaral, Leonard; Viveiros, Miguel] COST ACT BM0701 ATENS, Brusells, Belgium	Universidade Nova de Lisboa; Institute of Hygiene & Tropical Medicine - UNL; Universidade Nova de Lisboa; Universidade de Lisboa; Universidade Nova de Lisboa	Machado, D (corresponding author), Univ Nova Lisboa, Inst Higiene & Med Trop, Unidade Microbiol Med, Grp Micobacterias, P-1200 Lisbon, Portugal.	mviveiros@ihmt.unl.pt	Viveiros, Miguel/A-7326-2008; Couto, Isabel/I-2640-2012; Baptista, Pedro/P-3182-2019; Veigas, Bruno M/I-1253-2012; Amaral, Leonard/I-2112-2012; Machado, Diana/L-7027-2013; Portugal, Isabel/B-1491-2008; Perdigão, João/L-6893-2013; Baptista, Pedro V/A-1237-2009; iMed.ULisboa, M2B/B-5277-2014; Rodrigues, Liliana/N-2463-2014	Viveiros, Miguel/0000-0001-9676-6251; Couto, Isabel/0000-0003-3536-2733; Amaral, Leonard/0000-0003-3127-1295; Machado, Diana/0000-0003-2375-2726; Portugal, Isabel/0000-0002-7843-0006; Perdigão, João/0000-0002-0339-1305; Baptista, Pedro V/0000-0001-5255-7095; iMed.ULisboa, M2B/0000-0002-1245-3715; Rodrigues, Liliana/0000-0002-2094-2666; Veigas, Bruno/0000-0002-9265-4591	Fundacao para a Ciencia e a Tecnologia (FCT), Portugal [EU-FSE/FEDER-PTDC/BIA-MIC/71280/2006, EU-QREN/COMPETE-PTDC/SAU-FCF/102807/2008, SFRH/BD/65060/2009, SFRH/BD/24931/2005]; Fundacao Calouste Gulbenkian (FCG), Portugal	Fundacao para a Ciencia e a Tecnologia (FCT), Portugal(Portuguese Foundation for Science and Technology); Fundacao Calouste Gulbenkian (FCG), Portugal	This work was supported by grant EU-FSE/FEDER-PTDC/BIA-MIC/71280/2006 and EU-QREN/COMPETE-PTDC/SAU-FCF/102807/2008 from Fundacao para a Ciencia e a Tecnologia (FCT), Portugal and Project "Early Molecular Detection of M/XDRTB in the Great Lisbon Healthcare Region", Refa SDH49, from Fundacao Calouste Gulbenkian (FCG), Portugal. Authors DM and LR were supported by grants SFRH/BD/65060/2009 and SFRH/BD/24931/2005 from FCT of Portugal. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	da Silva PEA, 2011, FEMS IMMUNOL MED MIC, V63, P1, DOI 10.1111/j.1574-695X.2011.00831.x; BANERJEE A, 1994, SCIENCE, V263, P227, DOI 10.1126/science.8284673; Bergval IL, 2009, J ANTIMICROB CHEMOTH, V64, P515, DOI 10.1093/jac/dkp237; Bianco MV, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-195; Bottger EC, 2011, CLIN MICROBIOL INFEC, V17, P1128, DOI 10.1111/j.1469-0691.2011.03551.x; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Costa SS, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-241; Cox JS, 1999, NATURE, V52, P2503; De Rossi Edda, 2002, Molecular Medicine (Baltimore), V8, P714; de Steenwinkel JEM, 2010, J ANTIMICROB CHEMOTH, V65, P2582, DOI 10.1093/jac/dkq374; DeMarco CE, 2007, ANTIMICROB AGENTS CH, V51, P3235, DOI 10.1128/AAC.00430-07; Doran JL, 1997, CLIN DIAGN LAB IMMUN, V4, P23, DOI 10.1128/CDLI.4.1.23-32.1997; Guo HL, 2006, J MED MICROBIOL, V55, P1527, DOI 10.1099/jmm.0.46718-0; Gupta AK, 2010, INDIAN J MED RES, V132, P176; Gupta AK, 2010, MICROB DRUG RESIST, V16, P21, DOI 10.1089/mdr.2009.0054; Hazbon MH, 2006, ANTIMICROB AGENTS CH, V50, P2640, DOI 10.1128/AAC.00112-06; HEYM B, 1995, MOL MICROBIOL, V15, P235, DOI 10.1111/j.1365-2958.1995.tb02238.x; Inderlied C. B., 1996, ANTIBIOTICS LAB MED, P127; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Louw GE, 2009, ANTIMICROB AGENTS CH, V53, P3181, DOI 10.1128/AAC.01577-08; Louw GE, 2011, AM J RESP CRIT CARE, V184, P269, DOI 10.1164/rccm.201011-1924OC; Martinez JL, 2000, ANTIMICROB AGENTS CH, V44, P1771, DOI 10.1128/AAC.44.7.1771-1777.2000; Martins A, 2009, INT J ANTIMICROB AG, V34, P602, DOI 10.1016/j.ijantimicag.2009.06.029; Paixao Laura, 2009, J Biol Eng, V3, P18, DOI 10.1186/1754-1611-3-18; Pasca MR, 2005, ANTIMICROB AGENTS CH, V49, P4775, DOI 10.1128/AAC.49.11.4775-4777.2005; Pasipanodya JG, 2011, CURR OPIN PHARMACOL, V11, P457, DOI 10.1016/j.coph.2011.07.001; Perdigao J, 2008, MICROB DRUG RESIST, V14, P133, DOI 10.1089/mdr.2008.0798; Portevin D, 2004, P NATL ACAD SCI USA, V101, P314, DOI 10.1073/pnas.0305439101; Rodrigues L, 2008, J ANTIMICROB CHEMOTH, V61, P1076, DOI 10.1093/jac/dkn070; Rodrigues L, 2012, INFECT GENET EVOL, V12, P695, DOI 10.1016/j.meegid.2011.08.009; Rodrigues Liliana, 2011, Recent Pat Antiinfect Drug Discov, V6, P118; Rodrigues L, 2009, INT J ANTIMICROB AG, V34, P529, DOI 10.1016/j.ijantimicag.2009.07.010; Siddiqi S, 2006, MGIT960 PROCEDURE MA; Silva PEA, 2001, ANTIMICROB AGENTS CH, V45, P800, DOI 10.1128/AAC.45.3.800-804.2001; Somoskovi A, 2001, RESP RES, V2, P164, DOI 10.1186/rr54; Springer B, 2009, J CLIN MICROBIOL, V47, P1773, DOI 10.1128/JCM.02501-08; Srivastava S, 2010, J INFECT DIS, V201, P1225, DOI 10.1086/651377; Supply P, 2006, J CLIN MICROBIOL, V44, P4498, DOI 10.1128/JCM.01392-06; TELENTI A, 1993, LANCET, V341, P647, DOI 10.1016/0140-6736(93)90417-F; Vijdea R, 2008, EUR J CLIN MICROBIOL, V27, P1079, DOI 10.1007/s10096-008-0548-9; Vilcheze C, 2007, ANNU REV MICROBIOL, V61, P35, DOI 10.1146/annurev.micro.61.111606.122346; Viveiros M, 2005, J CLIN MICROBIOL, V43, P4880, DOI 10.1128/JCM.43.9.4880-4884.2005; Viveiros M, 2003, INT J ANTIMICROB AG, V22, P274, DOI 10.1016/S0924-8579(03)00208-5; Viveiros M, 2002, ANTIMICROB AGENTS CH, V46, P2804, DOI 10.1128/AAC.46.9.2804-2810.2002; Viveiros M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000365; Viveiros M, 2010, METHODS MOL BIOL, V642, P159, DOI 10.1007/978-1-60327-279-7_12; Webber MA, 2003, J ANTIMICROB CHEMOTH, V51, P9, DOI 10.1093/jac/dkg050; *WHO, 2008, WHOHTMTB2008394; Wilson W, 1999, P NATL ACAD SCI USA, V96, P12833, DOI 10.1073/pnas.96.22.12833; World Health Organisation, 2011, WHOHTMTB201116; ZHANG Y, 1992, NATURE, V358, P591, DOI 10.1038/358591a0; Zumla A, 2011, TROP MED INT HEALTH, V16, P79, DOI 10.1111/j.1365-3156.2010.02665.x	52	161	166	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2012	7	4							e34538	10.1371/journal.pone.0034538	http://dx.doi.org/10.1371/journal.pone.0034538			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JA	22493700	Green Submitted, Green Published, gold			2022-12-27	WOS:000305012700042
J	Mulder, AM; Carragher, B; Towne, V; Meng, Y; Wang, Y; Dieter, L; Potter, CS; Washabaugh, MW; Sitrin, RD; Zhao, QJ				Mulder, Anke M.; Carragher, Bridget; Towne, Victoria; Meng, Yuan; Wang, Yang; Dieter, Lance; Potter, Clinton S.; Washabaugh, Michael W.; Sitrin, Robert D.; Zhao, Qinjian			Toolbox for Non-Intrusive Structural and Functional Analysis of Recombinant VLP Based Vaccines: A Case Study with Hepatitis B Vaccine	PLOS ONE			English	Article							VIRUS-LIKE PARTICLES; SURFACE-ANTIGEN PARTICLES; LINKED-IMMUNOSORBENT-ASSAY; AUSTRALIA-ANTIGEN; ENVELOPE PROTEINS; PAPILLOMAVIRUS; VISUALIZATION; ANTIBODIES; YEAST	Background: Fundamental to vaccine development, manufacturing consistency, and product stability is an understanding of the vaccine structure-activity relationship. With the virus-like particle (VLP) approach for recombinant vaccines gaining popularity, there is growing demand for tools that define their key characteristics. We assessed a suite of non-intrusive VLP epitope structure and function characterization tools by application to the Hepatitis B surface antigen (rHBsAg) VLP-based vaccine. Methodology: The epitope-specific immune reactivity of rHBsAg epitopes to a given monoclonal antibody was monitored by surface plasmon resonance (SPR) and quantitatively analyzed on rHBsAg VLPs in-solution or bound to adjuvant with a competitive enzyme-linked immunosorbent assay (ELISA). The structure of recombinant rHBsAg particles was examined by cryo transmission electron microscopy (cryoTEM) and in-solution atomic force microscopy (AFM). Principal Findings: SPR and competitive ELISA determined relative antigenicity in solution, in real time, with rapid turnaround, and without the need of dissolving the particulate aluminum based adjuvant. These methods demonstrated the nature of the clinically relevant epitopes of HBsAg as being responsive to heat and/or redox treatment. In-solution AFM and cryoTEM determined vaccine particle size distribution, shape, and morphology. Redox-treated rHBsAg enabled 3D reconstruction from CryoTEM images - confirming the previously proposed octahedral structure and the established lipid-to-protein ratio of HBsAg particles. Results from these non-intrusive biophysical and immunochemical analyses coalesced into a comprehensive understanding of rHBsAg vaccine epitope structure and function that was important for assuring the desired epitope formation, determinants for vaccine potency, and particle stability during vaccine design, development, and manufacturing. Significance: Together, the methods presented here comprise a novel suite of non-intrusive VLP structural and functional characterization tools for recombinant vaccines. Key VLP structural features were defined and epitope-specific antigenicity was quantified while preserving epitope integrity and particle morphology. These tools should facilitate the development of other VLP-based vaccines.	[Mulder, Anke M.; Carragher, Bridget; Potter, Clinton S.] NanoImaging Serv, Dept Res & Dev, La Jolla, CA USA; [Meng, Yuan; Wang, Yang; Washabaugh, Michael W.; Zhao, Qinjian] Merck Res Labs, Vaccine Analyt R&D, West Point, PA USA; [Dieter, Lance] Merck Res Labs, Vaccine Bioproc R&D, West Point, PA USA; [Towne, Victoria; Sitrin, Robert D.] Merck Mfg Div, Vaccine Mfg Sci & Commercializat, West Point, PA USA	Merck & Company; Merck & Company; Merck & Company	Mulder, AM (corresponding author), NanoImaging Serv, Dept Res & Dev, La Jolla, CA USA.	mulder@nanoimagingservices.com; qinjianzhao@gmail.com		Carragher, Bridget/0000-0002-0624-5020				BAYER ME, 1968, NATURE, V218, P1057, DOI 10.1038/2181057a0; Berkower I, 2011, J VIROL, V85, P2439, DOI 10.1128/JVI.02061-10; BRUSS V, 1991, P NATL ACAD SCI USA, V88, P1059, DOI 10.1073/pnas.88.3.1059; Carragher B, 2008, ADV TRANSMISSION ELE, P104; DANE DS, 1970, LANCET, V1, P695; DUBOCHET J, 2009, HDB CRYOPREPARATION, P1; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; GAVILANES F, 1990, BIOCHEM J, V265, P857, DOI 10.1042/bj2650857; Gilbert RJC, 2005, P NATL ACAD SCI USA, V102, P14783, DOI 10.1073/pnas.0505062102; Goddard TD, 2007, J STRUCT BIOL, V157, P281, DOI 10.1016/j.jsb.2006.06.010; GOMEZGUTIERREZ J, 1995, BBA-BIOMEMBRANES, V1233, P205, DOI 10.1016/0005-2736(94)00255-N; Greiner VJ, 2010, BIOCHIMIE, V92, P994, DOI 10.1016/j.biochi.2010.04.014; HARPAZ Y, 1994, STRUCTURE, V2, P641, DOI 10.1016/S0969-2126(00)00065-4; High K, 2005, ANAL BIOCHEM, V347, P159, DOI 10.1016/j.ab.2005.09.007; KIRNBAUER R, 1992, P NATL ACAD SCI USA, V89, P12180, DOI 10.1073/pnas.89.24.12180; Kuznetsov YG, 2011, MICROBIOL MOL BIOL R, V75, P268, DOI 10.1128/MMBR.00041-10; Lander GC, 2009, J STRUCT BIOL, V166, P95, DOI 10.1016/j.jsb.2009.01.002; Le Duff Y, 2009, J VIROL, V83, P12443, DOI 10.1128/JVI.01594-09; Li SW, 2005, VACCINE, V23, P2893, DOI 10.1016/j.vaccine.2004.11.064; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Mallick SP, 2005, ULTRAMICROSCOPY, V104, P8, DOI 10.1016/j.ultramic.2005.02.004; Mangold CMT, 1997, ARCH VIROL, V142, P2257, DOI 10.1007/s007050050240; MANGOLD CMT, 1995, VIROLOGY, V211, P535, DOI 10.1006/viro.1995.1435; Meng Y, 2005, ANAL BIOCHEM, V345, P227, DOI 10.1016/j.ab.2005.07.026; Milhiet PE, 2011, BIOCHIMIE, V93, P254, DOI 10.1016/j.biochi.2010.09.018; Rappuoli R, 2011, NATURE, V473, P463, DOI 10.1038/nature10124; Roldao A, 2010, EXPERT REV VACCINES, V9, P1149, DOI [10.1586/erv.10.115, 10.1586/ERV.10.115]; Roseman AM, 2004, J STRUCT BIOL, V145, P91, DOI 10.1016/j.jsb.2003.11.007; Salisse J, 2009, J VIROL, V83, P9321, DOI 10.1128/JVI.00678-09; SALUNKE DM, 1989, BIOPHYS J, V56, P887, DOI 10.1016/S0006-3495(89)82735-3; Satoh O, 2000, J BIOCHEM-TOKYO, V127, P543, DOI 10.1093/oxfordjournals.jbchem.a022639; Schofield T, 2002, Dev Biol (Basel), V111, P299; Shearer MH, 1998, MOL IMMUNOL, V35, P1149, DOI 10.1016/S0161-5890(98)00110-2; Short JM, 2009, J MOL BIOL, V390, P135, DOI 10.1016/j.jmb.2009.04.059; STIRK HJ, 1992, INTERVIROLOGY, V33, P148, DOI 10.1159/000150244; VALENZUELA P, 1982, NATURE, V298, P347, DOI 10.1038/298347a0; Voss NR, 2009, J STRUCT BIOL, V166, P205, DOI 10.1016/j.jsb.2009.01.004; WAMPLER DE, 1985, P NATL ACAD SCI USA, V82, P6830, DOI 10.1073/pnas.82.20.6830; WATERS J, 1986, J GEN VIROL, V67, P2467, DOI 10.1099/0022-1317-67-11-2467; Wolf M, 2010, P NATL ACAD SCI USA, V107, P6298, DOI 10.1073/pnas.0914604107; Zhao Q, 2012, VIROLOGY IN PRESS; Zhao QJ, 2011, VACCINE, V29, P7936, DOI 10.1016/j.vaccine.2011.08.070; Zhao QJ, 2011, BIOCHEM BIOPH RES CO, V408, P447, DOI 10.1016/j.bbrc.2011.04.048; Zhao QJ, 2006, HUM VACCINES, V2, P174, DOI 10.4161/hv.2.4.3015; Zhao QJ, 2005, J VIROL METHODS, V127, P133, DOI 10.1016/j.jviromet.2005.03.015; Zhu FC, 2010, LANCET, V376, P895, DOI 10.1016/S0140-6736(10)61030-6	46	42	46	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2012	7	4							e33235	10.1371/journal.pone.0033235	http://dx.doi.org/10.1371/journal.pone.0033235			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JA	22493667	Green Published, gold, Green Submitted			2022-12-27	WOS:000305012700009
J	Sharp, ME; Viswanathan, J; Lanyon, LJ; Barton, JJS				Sharp, Madeleine E.; Viswanathan, Jayalakshmi; Lanyon, Linda J.; Barton, Jason J. S.			Sensitivity and Bias in Decision-Making under Risk: Evaluating the Perception of Reward, Its Probability and Value	PLOS ONE			English	Article							DOPAMINE AGONISTS; PARKINSONS-DISEASE; NOVELTY-SEEKING; PROSPECT-THEORY; EXPECTED VALUE; PERSONALITY; IMPAIRMENT; DISORDERS; AVERSION; DISTINCT	Background: There are few clinical tools that assess decision-making under risk. Tests that characterize sensitivity and bias in decisions between prospects varying in magnitude and probability of gain may provide insights in conditions with anomalous reward-related behaviour. Objective: We designed a simple test of how subjects integrate information about the magnitude and the probability of reward, which can determine discriminative thresholds and choice bias in decisions under risk. Design/Methods: Twenty subjects were required to choose between two explicitly described prospects, one with higher probability but lower magnitude of reward than the other, with the difference in expected value between the two prospects varying from 3 to 23%. Results: Subjects showed a mean threshold sensitivity of 43% difference in expected value. Regarding choice bias, there was a 'risk premium' of 38%, indicating a tendency to choose higher probability over higher reward. An analysis using prospect theory showed that this risk premium is the predicted outcome of hypothesized non-linearities in the subjective perception of reward value and probability. Conclusions: This simple test provides a robust measure of discriminative value thresholds and biases in decisions under risk. Prospect theory can also make predictions about decisions when subjective perception of reward or probability is anomalous, as may occur in populations with dopaminergic or striatal dysfunction, such as Parkinson's disease and schizophrenia.	[Sharp, Madeleine E.; Viswanathan, Jayalakshmi; Lanyon, Linda J.; Barton, Jason J. S.] Univ British Columbia, Dept Med Neurol, Human Vis & Eye Movement Lab, Vancouver, BC V5Z 1M9, Canada; [Viswanathan, Jayalakshmi; Lanyon, Linda J.; Barton, Jason J. S.] Univ British Columbia, Dept Ophthalmol & Visual Sci, Vancouver, BC V5Z 1M9, Canada; [Barton, Jason J. S.] Univ British Columbia, Dept Psychol, Vancouver, BC, Canada	University of British Columbia; University of British Columbia; University of British Columbia	Sharp, ME (corresponding author), Univ British Columbia, Dept Med Neurol, Human Vis & Eye Movement Lab, Vancouver, BC V5Z 1M9, Canada.	madeleinesharp@gmail.com	Barton, Jason JS/A-6362-2012; Viswanathan, Jaya/AAW-1403-2021; Lanyon, Linda/L-9238-2019	Lanyon, Linda/0000-0002-0885-1825; Viswanathan, Jayalakshmi/0000-0001-5338-3170	Canadian Institute of Health Research: CIHR [MOP-81270]	Canadian Institute of Health Research: CIHR(Canadian Institutes of Health Research (CIHR))	This study was funded by the Canadian Institute of Health Research: CIHR grant number MOP-81270. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; Bechara A, 1996, CEREB CORTEX, V6, P215, DOI 10.1093/cercor/6.2.215; Blaukopf CL, 2006, EXP BRAIN RES, V174, P786, DOI 10.1007/s00221-006-0685-2; Bodi N, 2009, BRAIN, V132, P2385, DOI 10.1093/brain/awp094; Camerer C, 2000, NEUROECONOMICS DECIS; Camerer C, 1989, J RISK UNCERTAINTY; CANAVAN AGM, 1989, NEUROPSYCHOLOGIA, V27, P141, DOI 10.1016/0028-3932(89)90167-X; Christopoulos GI, 2009, J NEUROSCI, V29, P12574, DOI 10.1523/JNEUROSCI.2614-09.2009; d'Acremont M, 2008, COGN AFFECT BEHAV NE, V8, P363, DOI 10.3758/CABN.8.4.363; Daw ND, 2006, NATURE, V441, P876, DOI 10.1038/nature04766; Ding L, 2007, J NEUROPHYSIOL, V97, P57, DOI 10.1152/jn.00902.2006; Dodd ML, 2005, ARCH NEUROL-CHICAGO, V62, P1377, DOI 10.1001/archneur.62.9.noc50009; Dunn BD, 2006, NEUROSCI BIOBEHAV R, V30, P239, DOI 10.1016/j.neubiorev.2005.07.001; Fox CR, 2009, NEUROECONOMICS: DECISION MAKING AND THE BRAIN, P145, DOI 10.1016/B978-0-12-374176-9.00011-7; Glimcher PW, 2008, COGN AFFECT BEHAV NE, V8, P348, DOI 10.3758/CABN.8.4.348; Hikosaka O, 2006, J NEUROPHYSIOL, V95, P567, DOI 10.1152/jn.00458.2005; Holt C. A. K., 2002, AM EC REV, V92; Hsu M, 2009, J NEUROSCI, V29, P2231, DOI 10.1523/JNEUROSCI.5296-08.2009; Huettel SA, 2006, NEURON, V49, P765, DOI 10.1016/j.neuron.2006.01.024; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Kobayakawa M, 2008, MOVEMENT DISORD, V23, P547, DOI 10.1002/mds.21865; Lejuez CW, 2002, J EXP PSYCHOL-APPL, V8, P75, DOI 10.1037//1076-898X.8.2.75; LESIEUR HR, 1987, AM J PSYCHIAT, V144, P1184; Levy I, 2010, J NEUROPHYSIOL, V103, P1036, DOI 10.1152/jn.00853.2009; Liston DB, 2008, J NEUROSCI, V28, P13866, DOI 10.1523/JNEUROSCI.3120-08.2008; Markowitz H, 1952, J FINANC, V7, P77, DOI 10.1111/j.1540-6261.1952.tb01525.x; MENZA MA, 1993, NEUROLOGY, V43, P505, DOI 10.1212/WNL.43.3_Part_1.505; Milstein DM, 2007, J NEUROSCI, V27, P4810, DOI 10.1523/JNEUROSCI.0577-07.2007; O'Neill M, 2010, NEURON, V68, P789, DOI 10.1016/j.neuron.2010.09.031; Pagonabarraga J, 2007, MOVEMENT DISORD, V22, P1430, DOI 10.1002/mds.21457; Payzan-LeNestour E, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001048; Platt M, 2008, NAT NEUROSCI; Ragonese P, 2003, NEUROEPIDEMIOLOGY, V22, P297, DOI 10.1159/000071193; Roesch MR, 2004, SCIENCE, V304, P307, DOI 10.1126/science.1093223; Rolls ET, 2008, CEREB CORTEX, V18, P652, DOI 10.1093/cercor/bhm097; Ross M, 2011, NEUROSCIENCE, V196, P168, DOI 10.1016/j.neuroscience.2011.08.006; Savage L.J., 1954, FDN STAT; Schonberg T, 2011, TRENDS COGN SCI, V15, P11, DOI 10.1016/j.tics.2010.10.002; Schultz W, 2002, NEURON, V36, P241, DOI 10.1016/S0896-6273(02)00967-4; Schultz W, 2008, PHILOS T R SOC B, V363, P3801, DOI 10.1098/rstb.2008.0152; Shurman B, 2005, SCHIZOPHR RES, V72, P215, DOI 10.1016/j.schres.2004.03.020; SIMPSON TL, 1995, OPTOMETRY VISION SCI, V72, P371, DOI 10.1097/00006324-199506000-00004; Stanton SJ, 2011, PSYCHOL SCI, V22, P447, DOI 10.1177/0956797611401752; Stott HP, 2006, J RISK UNCERTAINTY, V32, P101, DOI 10.1007/s11166-006-8289-6; Stritzke M, 2009, J OPT SOC AM A, V26, P1; Symmonds M, 2010, J NEUROSCI, V30, P14380, DOI 10.1523/JNEUROSCI.1459-10.2010; Tobler PN, 2008, J NEUROSCI, V28, P11703, DOI 10.1523/JNEUROSCI.2870-08.2008; Tobler PN, 2007, J NEUROPHYSIOL, V97, P1621, DOI 10.1152/jn.00745.2006; Tobler PN, 2009, P NATL ACAD SCI USA, V106, P7185, DOI 10.1073/pnas.0809599106; Tomer R, 2004, J NEUROL NEUROSUR PS, V75, P972, DOI 10.1136/jnnp.2003.024885; Toplak ME, 2010, CLIN PSYCHOL REV, V30, P562, DOI 10.1016/j.cpr.2010.04.002; van Eimeren T, 2009, NEUROPSYCHOPHARMACOL, V34, P2758, DOI [10.1038/sj.npp.npp2009124, 10.1038/npp.2009.124]; Voon V, 2011, BRAIN, V134, P1438, DOI 10.1093/brain/awr080; Weber E, 2008, DECISIONS UNCERTAINT; Yechiam E, 2005, PSYCHOL SCI, V16, P973, DOI 10.1111/j.1467-9280.2005.01646.x	55	9	9	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2012	7	4							e33460	10.1371/journal.pone.0033460	http://dx.doi.org/10.1371/journal.pone.0033460			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	955JA	22493669	Green Submitted, Green Published, gold			2022-12-27	WOS:000305012700011
J	Dakshinamoorthy, G; Samykutty, AK; Munirathinam, G; Shinde, GB; Nutman, T; Reddy, MV; Kalyanasundaram, R				Dakshinamoorthy, Gajalakshmi; Samykutty, Abhilash Kumble; Munirathinam, Gnanasekar; Shinde, Gangadhar Bhaurao; Nutman, Thomas; Reddy, Maryada Venkatarami; Kalyanasundaram, Ramaswamy			Biochemical Characterization and Evaluation of a Brugia malayi Small Heat Shock Protein as a Vaccine against Lymphatic Filariasis	PLOS ONE			English	Article							WUCHERERIA-BANCROFTI; PROTECTIVE IMMUNITY; ANTIBODY-RESPONSES; DNA VACCINATION; ANTIGEN; IMMUNOGENICITY; TUBERCULOSIS; HEAT-SHOCK-PROTEIN-60; HYPORESPONSIVENESS; IMMUNIZATION	Filarial nematodes enjoy one of the longest life spans of any human pathogen due to effective immune evasion strategies developed by the parasite. Among the various immune evasion strategies exhibited by the parasite, Interleukin 10 (IL-10) productions and IL-10 mediated immune suppression has significant negative impact on the host immune system. Recently, we identified a small heat shock protein expressed by Brugia malayi (BmHsp12.6) that can bind to soluble human IL-10 receptor alpha (IL-10R) and activate IL-10 mediated effects in cell lines. In this study we show that the IL-10R binding region of BmHsp12.6 is localized to its N-terminal region. This region has significant sequence similarity to the receptor binding region of human IL-10. In vitro studies confirm that the N-terminal region of BmHsp12.6 (N-BmHsp12.6) has IL-10 like activity and the region containing the alpha crystalline domain and C-terminus of BmHsp12.6 (BmHsp12.6ac) has no IL-10 like activity. However, BmHsp12.6ac contains B cell, T cell and CTL epitopes. Members of the sHSP families are excellent vaccine candidates. Evaluation of sera samples from putatively immune endemic normal (EN) subjects showed IgG1 and IgG3 antibodies against BmHsp12.6ac and these antibodies were involved in the ADCC mediated protection. Subsequent vaccination trials with BmHsp12.6ac in a mouse model using a heterologous prime boost approach showed that 83% protection can be achieved against B. malayi L3 challenge. Results presented in this study thus show that the N-BmHsp12.6 subunit of BmHsp12.6 has immunoregulatory function, whereas, the BmHsp12.6ac subunit of BmHsp12.6 has significant vaccine potential.	[Dakshinamoorthy, Gajalakshmi; Samykutty, Abhilash Kumble; Munirathinam, Gnanasekar; Kalyanasundaram, Ramaswamy] Univ Illinois, Coll Med Rockford, Dept Biomed Sci, Rockford, IL USA; [Samykutty, Abhilash Kumble; Reddy, Maryada Venkatarami] Mahatma Gandhi Inst Med Sci, Dept Biochem, Sevagram, Maharashtra, India; [Shinde, Gangadhar Bhaurao] Rashtrasant Tukadoji Maharaj Nagpur Univ, Dept Biochem, Nagpur, Maharashtra, India; [Nutman, Thomas] NIH, Helminth Immunol Sect, Bethesda, MD 20892 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Rockford; Mahatma Gandhi Institute of Medical Sciences, Sevagram; Rashtrasant Tukadoji Maharaj Nagpur University; National Institutes of Health (NIH) - USA	Dakshinamoorthy, G (corresponding author), Univ Illinois, Coll Med Rockford, Dept Biomed Sci, Rockford, IL USA.	ramswamy@uic.edu	samykutty, Abhilash/J-6575-2019	samykutty, Abhilash/0000-0003-3551-045X	NIH [AI064745]; Department of Biotechnology, Ministry of Science and Technology, New Delhi [BT/INF/22/1/2007]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI064745, ZIAAI000512, R01AI064745] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Biotechnology, Ministry of Science and Technology, New Delhi(Department of Science & Technology (India)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was funded by an NIH RO1 grant (AI064745). Additional funding was received from the Department of Biotechnology, Ministry of Science and Technology, New Delhi (BT/INF/22/1/2007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAM D, 1989, AM J TROP MED HYG, V40, P598, DOI 10.4269/ajtmh.1989.40.598; Andley UP, 2002, J BIOL CHEM, V277, P10178, DOI 10.1074/jbc.M109211200; Aparicio-Burgos JE, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001050; Arizono N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018141; Bal M, 1999, ACTA TROP, V72, P259, DOI 10.1016/S0001-706X(98)00099-0; BLACHERE NE, 1993, J IMMUNOTHER, V14, P352, DOI 10.1097/00002371-199311000-00016; Brattig NW, 1997, TROP MED INT HEALTH, V2, P788, DOI 10.1046/j.1365-3156.1997.d01-384.x; CASPERS GJ, 1995, J MOL EVOL, V40, P238, DOI 10.1007/BF00163229; CHANDRASHEKAR R, 1985, PARASITE IMMUNOL, V7, P633, DOI 10.1111/j.1365-3024.1985.tb00107.x; Colaco CALS, 2004, BIOCHEM SOC T, V32, P626, DOI 10.1042/BST0320626; DA'Dara AA, 2003, PARASITE IMMUNOL, V25, P429, DOI 10.1111/j.1365-3024.2003.00651.x; Dabir P, 2006, CLIN MICROBIOL INFEC, V12, P361, DOI 10.1111/j.1469-0691.2006.01362.x; Doetze A, 2000, INT IMMUNOL, V12, P623, DOI 10.1093/intimm/12.5.623; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Ehrnsperger M., 1998, STRUCTURE FUNCTION S, P533; Estcourt MJ, 2002, INT IMMUNOL, V14, P31, DOI 10.1093/intimm/14.1.31; Ferrer E, 2005, EXP PARASITOL, V110, P1, DOI 10.1016/j.exppara.2004.11.014; Foon KA, 1998, CLIN CANCER RES, V4, P1117; Gnanasekar M, 2008, MOL BIOCHEM PARASIT, V159, P98, DOI 10.1016/j.molbiopara.2008.02.010; Gnanasekar M, 2009, BIOCHEM BIOPH RES CO, V386, P333, DOI 10.1016/j.bbrc.2009.06.028; Gregory WF, 2000, INFECT IMMUN, V68, P4174, DOI 10.1128/IAI.68.7.4174-4179.2000; Harnett W, 2008, PARASITE IMMUNOL, V30, P447, DOI 10.1111/j.1365-3024.2008.01045.x; Haslbeck M, 2005, NAT STRUCT MOL BIOL, V12, P842, DOI 10.1038/nsmb993; Hotez PJ, 2009, CLIN PHARMACOL THER, V136, P98; HUSSAIN R, 1995, CLIN DIAGN LAB IMMUN, V2, P726, DOI 10.1128/CDLI.2.6.726-732.1995; JAKOB U, 1994, TRENDS BIOCHEM SCI, V19, P205, DOI 10.1016/0968-0004(94)90023-X; Kalyanasundaram R, 2011, RES REP TROP MED, V2, P45, DOI 10.2147/RRTM.S13679; Kashala O, 2002, VACCINE, V20, P2263, DOI 10.1016/S0264-410X(02)00115-9; KENSIL CR, 1991, J IMMUNOL, V146, P431; KING CL, 1993, J CLIN INVEST, V92, P1667, DOI 10.1172/JCI116752; Koteiche HA, 2002, FEBS LETT, V519, P16, DOI 10.1016/S0014-5793(02)02688-1; Kurniawan-Atmadja A, 1998, PARASITE IMMUNOL, V20, P9, DOI 10.1046/j.1365-3024.1998.t01-1-00118.x; Lee JY, 2006, J PERIODONTAL RES, V41, P10, DOI 10.1111/j.1600-0765.2005.00832.x; Li BW, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-267; Lowrie DB, 1999, NATURE, V400, P269, DOI 10.1038/22326; Luder CGK, 1996, CLIN EXP IMMUNOL, V105, P245, DOI 10.1046/j.1365-2249.1996.d01-747.x; Maizels RM, 2003, NAT REV IMMUNOL, V3, P733, DOI 10.1038/nri1183; Mattos AMM, 2010, INT IMMUNOL, V22, P775, DOI 10.1093/intimm/dxq429; Michael E, 1997, PARASITOL TODAY, V13, P472, DOI 10.1016/S0169-4758(97)01151-4; Mohamed RM, 2003, VACCINE, V21, P2852, DOI [10.1016/S0264-410X(03)00157-9, 10.1016/s0264-410X(03)00157-9]; Norimine J, 2004, INFECT IMMUN, V72, P1096, DOI 10.1128/IAI.72.2.1096-1106.2003; Ofran Y, 2007, BIOINFORMATICS, V23, pE13, DOI 10.1093/bioinformatics/btl303; OTTESEN EA, 1977, IMMUNOLOGY, V33, P413; Qazi KR, 2005, VACCINE, V23, P1114, DOI 10.1016/j.vaccine.2004.08.033; Rajan B, 2005, J IMMUNOL, V175, P1827, DOI 10.4049/jimmunol.175.3.1827; RAJASEKARIAH GR, 1989, CLIN EXP IMMUNOL, V78, P292; Rao KVN, 2000, MOL BIOCHEM PARASIT, V107, P71, DOI 10.1016/S0166-6851(99)00231-5; Ravindran B, 2000, PARASITE IMMUNOL, V22, P633, DOI 10.1046/j.1365-3024.2000.00347.x; Reineke U, 1998, PROTEIN SCI, V7, P951; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; Scheckelhoff M, 2002, J IMMUNOL, V169, P5818, DOI 10.4049/jimmunol.169.10.5818; SHINNICK TM, 1988, INFECT IMMUN, V56, P446, DOI 10.1128/IAI.56.2.446-451.1988; Shiny C, 2011, MICROBES INFECT, V13, P1221, DOI 10.1016/j.micinf.2011.07.004; Singh H, 2001, BIOINFORMATICS, V17, P1236, DOI 10.1093/bioinformatics/17.12.1236; Steel C, 1996, J INFECT DIS, V174, P598, DOI 10.1093/infdis/174.3.598; Suzue K, 1997, P NATL ACAD SCI USA, V94, P13146, DOI 10.1073/pnas.94.24.13146; Tartz S, 2008, VACCINE, V26, P5935, DOI 10.1016/j.vaccine.2008.08.057; Tompa P, 2004, FASEB J, V18, P1169, DOI 10.1096/fj.04-1584rev; Veerapathran A, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000457; Vercauteren I, 2006, J PARASITOL, V92, P1244, DOI 10.1645/GE-871R.1; Vordermeier HM, 2003, VET MICROBIOL, V93, P349, DOI 10.1016/S0378-1135(03)00046-4	61	37	37	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2012	7	4							e34077	10.1371/journal.pone.0034077	http://dx.doi.org/10.1371/journal.pone.0034077			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955IH	22496777	Green Published, gold, Green Submitted			2022-12-27	WOS:000305010500004
J	Bate, N; Gingras, AR; Bachir, A; Horwitz, R; Ye, F; Patel, B; Goult, BT; Critchley, DR				Bate, Neil; Gingras, Alexandre R.; Bachir, Alexia; Horwitz, Rick; Ye, Feng; Patel, Bipin; Goult, Benjamin T.; Critchley, David R.			Talin Contains A C-Terminal Calpain2 Cleavage Site Important In Focal Adhesion Dynamics	PLOS ONE			English	Article							CELL-MIGRATION; MEDIATED PROTEOLYSIS; INTEGRIN ACTIVATION; BINDING-SITES; VINCULIN; DOMAIN; HEAD; REVEALS; IDENTIFICATION; CYTOSKELETON	Talin is a large (similar to 2540 residues) dimeric adaptor protein that associates with the integrin family of cell adhesion molecules in cell-extracellular matrix junctions (focal adhesions; FAs), where it both activates integrins and couples them to the actin cytoskeleton. Calpain2-mediated cleavage of talin between the head and rod domains has previously been shown to be important in FA turnover. Here we identify an additional calpain2-cleavage site that removes the dimerisation domain from the C-terminus of the talin rod, and show that an E2492G mutation inhibits calpain cleavage at this site in vitro, and increases the steady state levels of talin1 in vivo. Expression of a GFP-tagged talin1 E2492G mutant in CHO.K1 cells inhibited FA turnover and the persistence of cell protrusion just as effectively as a L432G mutation that inhibits calpain cleavage between the talin head and rod domains. Moreover, incorporation of both mutations into a single talin molecule had an additive effect clearly demonstrating that calpain cleavage at both the N- and C-terminal regions of talin contribute to the regulation of FA dynamics. However, the N-terminal site was more sensitive to calpain cleavage suggesting that lower levels of calpain are required to liberate the talin head and rod fragments than are needed to clip off the C-terminal dimerisation domain. The talin head and rod liberated by calpain2 cleavage have recently been shown to play roles in an integrin activation cycle important in FA turnover and in FAK-dependent cell cycle progression respectively. The half-life of the talin head is tightly regulated by ubiquitination and we suggest that removal of the C-terminal dimerisation domain from the talin rod may provide a mechanism both for terminating the signalling function of the talin rod and indeed for inactivating full-length talin thereby promoting FA turnover at the rear of the cell.	[Bate, Neil; Gingras, Alexandre R.; Patel, Bipin; Goult, Benjamin T.; Critchley, David R.] Univ Leicester, Dept Biochem, Leicester LE1 7RH, Leics, England; [Bachir, Alexia; Horwitz, Rick] Univ Virginia, Sch Med, Dept Cell Biol, Charlottesville, VA 22908 USA; [Ye, Feng] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA	University of Leicester; University of Virginia; University of California System; University of California San Diego	Bate, N (corresponding author), Univ Leicester, Dept Biochem, Leicester LE1 7RH, Leics, England.	drc@le.ac.uk	Gingras, Alexandre R/E-1867-2011; Goult, Benjamin T/B-3127-2009	Gingras, Alexandre R/0000-0002-5373-0176; Goult, Benjamin T/0000-0002-3438-2807	Wellcome Trust; Cancer Research United Kingdom; Cell Migration Consortium (National Institutes of Health (NIH)) [U54 GM64346]; NIH [GM23244]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM023244, R01GM023244, U54GM064346] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); Cancer Research United Kingdom(Cancer Research UK); Cell Migration Consortium (National Institutes of Health (NIH))(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding to DRC for staff and consumables was provided by the Wellcome Trust, Cancer Research United Kingdom and a grant from the Cell Migration Consortium (National Institutes of Health (NIH) Grant U54 GM64346), which also funded the work in RH's lab along with NIH grant GM23244. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthis NJ, 2009, EMBO J, V28, P3623, DOI 10.1038/emboj.2009.287; Anthis NJ, 2011, TRENDS BIOCH SCI; Barsukov IL, 2003, J BIOL CHEM, V278, P31202, DOI 10.1074/jbc.M303850200; Bolton SJ, 1997, CELL MOTIL CYTOSKEL, V36, P363; Calderwood DA, 1999, J BIOL CHEM, V274, P28071, DOI 10.1074/jbc.274.40.28071; Carragher NO, 2006, ONCOGENE, V25, P5726, DOI 10.1038/sj.onc.1209582; Chan KT, 2010, J BIOL CHEM, V285, P11418, DOI 10.1074/jbc.M109.090746; Cortesio CL, 2011, J BIOL CHEM, V286, P9998, DOI 10.1074/jbc.M110.187294; Critchley DR, 2008, J CELL SCI, V121, P1345, DOI 10.1242/jcs.018085; Critchley DR, 2009, ANNU REV BIOPHYS, V38, P235, DOI 10.1146/annurev.biophys.050708.133744; Debrand E, 2009, FEBS J, V276, P1610, DOI 10.1111/j.1742-4658.2009.06893.x; Di Paolo G, 2002, NATURE, V420, P85, DOI 10.1038/nature01147; Dourdin N, 2001, J BIOL CHEM, V276, P48382, DOI 10.1074/jbc.M108893200; Elliott PR, 2010, STRUCTURE, V18, P1289, DOI 10.1016/j.str.2010.07.011; Fabrice R, 2006, INT J BIOCHEM CELL B, V38, P404, DOI 10.1016/j.biocel.2005.09.020; Flevaris P, 2007, J CELL BIOL, V179, P553, DOI 10.1083/jcb.200703185; Franco SJ, 2004, NAT CELL BIOL, V6, P977, DOI 10.1038/ncb1175; Gingras AR, 2008, EMBO J, V27, P458, DOI 10.1038/sj.emboj.7601965; Gingras AR, 2010, J BIOL CHEM, V285, P29577, DOI 10.1074/jbc.M109.095455; Gingras AR, 2009, J BIOL CHEM, V284, P8857, DOI 10.1074/jbc.M805937200; Gingras AR, 2005, J BIOL CHEM, V280, P37217, DOI 10.1074/jbc.M508060200; Glading A, 2002, TRENDS CELL BIOL, V12, P46, DOI 10.1016/S0962-8924(01)02179-1; Goult BT, 2010, EMBO J, V29, P1069, DOI 10.1038/emboj.2010.4; Harburger DS, 2009, J CELL SCI, V122, P159, DOI 10.1242/jcs.018093; Hayashi M, 1999, ARCH BIOCHEM BIOPHYS, V371, P133, DOI 10.1006/abbi.1999.1427; Hemmings L, 1996, J CELL SCI, V109, P2715; Huang C, 2009, NAT CELL BIOL, V11, P624, DOI 10.1038/ncb1868; Humphries JD, 2007, J CELL BIOL, V179, P1043, DOI 10.1083/jcb.200703036; Jiang GY, 2003, NATURE, V424, P334, DOI 10.1038/nature01805; Kopp PM, 2010, EUR J CELL BIOL, V89, P661, DOI 10.1016/j.ejcb.2010.05.003; Lebart MC, 2006, FEBS J, V273, P3415, DOI 10.1111/j.1742-4658.2006.05350.x; Lee HS, 2004, J MOL BIOL, V343, P771, DOI 10.1016/j.jmb.2004.08.069; Legate KR, 2006, NAT REV MOL CELL BIO, V7, P20, DOI 10.1038/nrm1789; Legate KR, 2009, J CELL SCI, V122, P187, DOI 10.1242/jcs.041624; Leloup L, 2010, J BIOL CHEM, V285, P33549, DOI 10.1074/jbc.M110.123604; Moes M, 2007, J BIOL CHEM, V282, P17280, DOI 10.1074/jbc.M611846200; NIGGLI V, 1994, EUR J BIOCHEM, V224, P951, DOI 10.1111/j.1432-1033.1994.00951.x; Papagrigoriou E, 2004, EMBO J, V23, P2942, DOI 10.1038/sj.emboj.7600285; Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957; Priddle H, 1998, J CELL BIOL, V142, P1121, DOI 10.1083/jcb.142.4.1121; REES DJG, 1990, NATURE, V347, P685, DOI 10.1038/347685a0; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Saunders RM, 2006, EUR J CELL BIOL, V85, P487, DOI 10.1016/j.ejcb.2006.01.014; Senetar MA, 2007, CELL MOTIL CYTOSKEL, V64, P157, DOI 10.1002/cm.20173; Shattil SJ, 2010, NAT REV MOL CELL BIO, V11, P288, DOI 10.1038/nrm2871; Stabach PR, 1997, BIOCHEMISTRY-US, V36, P57, DOI 10.1021/bi962034i; Svensson L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015090; Swaney KF, 2010, ANNU REV BIOPHYS, V39, P265, DOI 10.1146/annurev.biophys.093008.131228; Vicente-Manzanares M, 2009, J CELL SCI, V122, P199, DOI 10.1242/jcs.018564; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Wang PB, 2011, J CELL BIOL, V195, P499, DOI 10.1083/jcb.201104128; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; Xu WM, 1998, DEVELOPMENT, V125, P327; Zaidel-Bar R, 2007, NAT CELL BIOL, V9, P858, DOI 10.1038/ncb0807-858; Zhang X, 2008, NAT CELL BIOL, V10, P1062, DOI 10.1038/ncb1765; Ziegler WH, 2006, TRENDS CELL BIOL, V16, P453, DOI 10.1016/j.tcb.2006.07.004	58	47	49	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e34461	10.1371/journal.pone.0034461	http://dx.doi.org/10.1371/journal.pone.0034461			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GO	22496808	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000304855200052
J	Bode, AS; Huberts, W; Bosboom, EMH; Kroon, W; van der Linden, WPM; Planken, RN; van de Vosse, FN; Tordoir, JHM				Bode, Aron S.; Huberts, Wouter; Bosboom, E. Marielle H.; Kroon, Wilco; van der Linden, Wim P. M.; Planken, R. Nils; van de Vosse, Frans N.; Tordoir, Jan H. M.			Patient-Specific Computational Modeling of Upper Extremity Arteriovenous Fistula Creation: Its Feasibility to Support Clinical Decision-Making	PLOS ONE			English	Article							HEMODIALYSIS VASCULAR ACCESS; ABDOMINAL AORTIC-ANEURYSM; CEPHALIC VEIN; RADIAL ARTERY; BLOOD-FLOW; HEMODYNAMICS; FAILURE; SIMULATION; ISCHEMIA; DISEASE	Introduction: Inadequate flow enhancement on the one hand, and excessive flow enhancement on the other hand, remain frequent complications of arteriovenous fistula (AVF) creation, and hamper hemodialysis therapy in patients with end-stage renal disease. In an effort to reduce these, a patient-specific computational model, capable of predicting postoperative flow, has been developed. The purpose of this study was to determine the accuracy of the patient-specific model and to investigate its feasibility to support decision-making in AVF surgery. Methods: Patient-specific pulse wave propagation models were created for 25 patients awaiting AVF creation. Model input parameters were obtained from clinical measurements and literature. For every patient, a radiocephalic AVF, a brachiocephalic AVF, and a brachiobasilic AVF configuration were simulated and analyzed for their postoperative flow. The most distal configuration with a predicted flow between 400 and 1500 ml/min was considered the preferred location for AVF surgery. The suggestion of the model was compared to the choice of an experienced vascular surgeon. Furthermore, predicted flows were compared to measured postoperative flows. Results: Taken into account the confidence interval (25th and 75th percentile interval), overlap between predicted and measured postoperative flows was observed in 70% of the patients. Differentiation between upper and lower arm configuration was similar in 76% of the patients, whereas discrimination between two upper arm AVF configurations was more difficult. In 3 patients the surgeon created an upper arm AVF, while model based predictions allowed for lower arm AVF creation, thereby preserving proximal vessels. In one patient early thrombosis in a radiocephalic AVF was observed which might have been indicated by the low predicted postoperative flow. Conclusions: Postoperative flow can be predicted relatively accurately for multiple AVF configurations by using computational modeling. This model may therefore be considered a valuable additional tool in the preoperative work-up of patients awaiting AVF creation.	[Bode, Aron S.; Tordoir, Jan H. M.] Maastricht Univ, Med Ctr, Dept Surg, Maastricht, Netherlands; [Huberts, Wouter; Bosboom, E. Marielle H.; Kroon, Wilco; van de Vosse, Frans N.] Eindhoven Univ Technol, Dept Biomed Engn, NL-5600 MB Eindhoven, Netherlands; [Huberts, Wouter; Bosboom, E. Marielle H.; Kroon, Wilco; van de Vosse, Frans N.] Maastricht Univ, Med Ctr, Dept Biomed Engn, Maastricht, Netherlands; [van der Linden, Wim P. M.] Philips Res Eindhoven, Healthcare Informat Management Grp, Eindhoven, Netherlands; [Planken, R. Nils] Univ Amsterdam, Acad Med Ctr, Dept Radiol, NL-1105 AZ Amsterdam, Netherlands	Maastricht University; Eindhoven University of Technology; Maastricht University; Philips; Philips Research; University of Amsterdam; Academic Medical Center Amsterdam	Bode, AS (corresponding author), Maastricht Univ, Med Ctr, Dept Surg, Maastricht, Netherlands.	aronbode@gmail.com	Tordoir, Jan/AAE-4083-2020; Planken, RN/GMX-0438-2022; van de Vosse, Frans N/I-4006-2013	van de Vosse, Frans N/0000-0002-4084-2064; Planken, R. Nils/0000-0003-3940-4670; Huberts, Wouter/0000-0002-0779-4785	European Commission [ICT-224390]; Profileringsfonds of the Maastricht University Medical Center	European Commission(European CommissionEuropean Commission Joint Research Centre); Profileringsfonds of the Maastricht University Medical Center	The current study, funded by the European Commission, was performed as part of the 'patient-specific image-based computational modeling for improvement of short-and long-term outcome of vascular access in patients on hemodialysis therapy' (ARCH) project, which is a 7th Framework European collaborative project with the aim to develop predictive tools and methodologies to aid clinical decision-making and to improve the success after AVF creation (ARCH Project, ICT-224390). Furthermore, the authors greatly acknowledge additional funding by the Profileringsfonds of the Maastricht University Medical Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allon M, 2002, KIDNEY INT, V62, P1109, DOI 10.1111/j.1523-1755.2002.kid551.x; [Anonymous], AM J KIDNEY DIS, V48, pS176; Bessems D, 2008, J BIOMECH, V41, P284, DOI 10.1016/j.jbiomech.2007.09.014; Bode A, 2012, MODELING CONTROL DIA; Bode A, J VASC ACCE IN PRESS; Bode AS, 2011, EUR J VASC IN PRESS; Breeuwer M, 2008, MED BIOL ENG COMPUT, V46, P1085, DOI 10.1007/s11517-008-0393-0; Cebral JR, 2005, AM J NEURORADIOL, V26, P2550; David T, 2008, MED ENG PHYS, V30, P1227, DOI 10.1016/j.medengphy.2008.09.008; Gijsen FJH, 2007, J BIOMECH, V40, P2349, DOI 10.1016/j.jbiomech.2006.12.007; Huberts W., 2011, MED ENG PHY IN PRESS; Huberts W, 2011, J BIOMECH UNPUB; Huberts W, 2011, SENSITIVITY ST UNPUB; Hunter PJ, 2003, ANNU REV BIOMED ENG, V5, P147, DOI 10.1146/annurev.bioeng.5.040202.121537; Kaiser DR, 2001, HYPERTENSION, V38, P1440, DOI 10.1161/hy1201.096539; Krueger, 2000, Int J Angiol, V9, P226, DOI 10.1007/s005470000039; Krueger U, 2002, ARTIF ORGANS, V26, P571, DOI 10.1046/j.1525-1594.2002.07078.x; Ku YM, 2006, NEPHROL DIAL TRANSPL, V21, P715, DOI 10.1093/ndt/gfi214; Lee T, CLIN J AM SOC NEPHRO; Malovrh M, 2002, AM J KIDNEY DIS, V39, P1218, DOI 10.1053/ajkd.2002.33394; Marchandise E, 2009, MED ENG PHYS, V31, P131, DOI 10.1016/j.medengphy.2008.04.015; McArdle WD, 1996, EXERCISE PHYSL ENERG; Mihmanli I, 2001, J ULTRAS MED, V20, P217; Mourad JJ, 1997, HYPERTENSION, V30, P1425, DOI 10.1161/01.HYP.30.6.1425; Pisoni RL, 2009, AM J KIDNEY DIS, V53, P475, DOI 10.1053/j.ajkd.2008.10.043; Planken RN, 2008, J VASC ACCESS, V9, P269, DOI 10.1177/112972980800900408; Planken RN, 2006, J VASC SURG, V44, P353, DOI 10.1016/j.jvs.2006.04.038; Reymond P, AM J PHYSL HEART CIR, V301, pH1173; Roy-Chaudhury P, 2007, J NEPHROL, V20, P150; Shemesh D, 2007, ULTRASOUND MED BIOL, V33, P727, DOI 10.1016/j.ultrasmedbio.2006.11.019; Sidawy AN, 2002, J VASC SURG, V35, P603, DOI 10.1067/mva.2002.122025; Silva MB, 1998, J VASC SURG, V27, P302, DOI 10.1016/S0741-5214(98)70360-X; Steele BN, 2003, IEEE T INF TECHNOL B, V7, P123, DOI 10.1109/TITB.2003.811880; STERGIOPULOS N, 1992, J BIOMECH, V25, P1477, DOI 10.1016/0021-9290(92)90060-E; Strandness DES, 1975, HEMODYNAMICS SURGEON; Tordoir J, 2007, NEPHROL DIAL TRANSPL, V22, P88, DOI 10.1093/ndt/gfm021; Tordoir JHM, 2003, NEPHROL DIAL TRANSPL, V18, P378, DOI 10.1093/ndt/18.2.378; Tordoir JHM, 2004, EUR J VASC ENDOVASC, V27, P1, DOI 10.1016/j.ejvs.2003.10.007; Vorp DA, 2007, J BIOMECH, V40, P1887, DOI 10.1016/j.jbiomech.2006.09.003; WESTERHOF N, 1969, J BIOMECH, V2, P121, DOI 10.1016/0021-9290(69)90024-4; Wijnen E, 2005, ARTIF ORGANS, V29, P960, DOI 10.1111/j.1525-1594.2005.00165.x; Zanow J, 2006, J VASC SURG, V44, P1273, DOI 10.1016/j.jvs.2006.08.010; Zanow J, 2008, J VASC SURG, V48, P1559, DOI 10.1016/j.jvs.2008.06.040	43	22	23	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e34491	10.1371/journal.pone.0034491	http://dx.doi.org/10.1371/journal.pone.0034491			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GO	22496816	Green Submitted, Green Published, gold			2022-12-27	WOS:000304855200057
J	Chartoumpekis, DV; Zaravinos, A; Ziros, PG; Iskrenova, RP; Psyrogiannis, AI; Kyriazopoulou, VE; Habeos, IG				Chartoumpekis, Dionysios V.; Zaravinos, Apostolos; Ziros, Panos G.; Iskrenova, Ralitsa P.; Psyrogiannis, Agathoklis I.; Kyriazopoulou, Venetsana E.; Habeos, Ioannis G.			Differential Expression of MicroRNAs in Adipose Tissue after Long-Term High-Fat Diet-Induced Obesity in Mice	PLOS ONE			English	Article							ADIPOCYTE DIFFERENTIATION; GENE-EXPRESSION; ABDOMINAL OBESITY; BETA(3)-ADRENOCEPTOR AGONIST; LIPID-METABOLISM; ADIPOGENESIS; IDENTIFICATION; ANTIOBESITY; INDUCTION; PROTEINS	Obesity is a major health concern worldwide which is associated with increased risk of chronic diseases such as metabolic syndrome, cardiovascular disease and cancer. The elucidation of the molecular mechanisms involved in adipogenesis and obesogenesis is of essential importance as it could lead to the identification of novel biomarkers and therapeutic targets for the development of anti-obesity drugs. MicroRNAs (miRNAs) have been shown to play regulatory roles in several biological processes. They have become a growing research field and consist of promising pharmaceutical targets in various fields such as cancer, metabolism, etc. The present study investigated the possible implication of miRNAs in adipose tissue during the development of obesity using as a model the C57BLJ6 mice fed a high-fat diet. C57BLJ6 wild type male mice were fed either a standard (SD) or a high-fat diet (HFD) for 5 months. Total RNA was prepared from white adipose tissue and was used for microRNA profiling and qPCR. Twenty-two of the most differentially expressed miRNAs, as identified by the microRNA profiling were validated using qPCR. The results of the present study confirmed previous results. The up-regulation of mmu-miR-222 and the down-regulation of mmu-miR-200b, mmu-miR-200c, mmu-miR-204, mmu-miR-30a*, mmu-miR-193, mmu-miR-378 and mmu-miR-30e* after HFD feeding has also been previously reported. On the other hand, we show for the first time the up-regulation of mmu-miR-342-3p, mmu-miR-142-3p, mmu-miR-142-5p, mmu-miR-21, mmu-miR-146a, mmu-miR-146b, mmu-miR-379 and the down-regulation of mmu-miR-122, mmu-miR-133b, mmu-miR-1, mmu-miR-30a*, mmu-miR-192 and mmu-miR-203 during the development of obesity. However, future studies are warranted in order to understand the exact role that miRNAs play in adipogenesis and obesity.	[Chartoumpekis, Dionysios V.; Ziros, Panos G.; Iskrenova, Ralitsa P.; Psyrogiannis, Agathoklis I.; Kyriazopoulou, Venetsana E.; Habeos, Ioannis G.] Univ Patras, Sch Med, Dept Internal Med, Div Endocrinol, GR-26110 Patras, Greece; [Zaravinos, Apostolos] Univ Crete, Sch Med, Lab Clin Virol, Iraklion, Greece	University of Patras; University of Crete	Chartoumpekis, DV (corresponding author), Univ Patras, Sch Med, Dept Internal Med, Div Endocrinol, GR-26110 Patras, Greece.	ihabeos@med.upatras.gr	Zaravinos, Apostolos/B-2528-2019; Chartoumpekis, Dionysios/L-8071-2017	Zaravinos, Apostolos/0000-0003-4625-5562; Chartoumpekis, Dionysios/0000-0002-6139-6067				Alexander R, 2011, EXPERT OPIN THER TAR, V15, P623, DOI 10.1517/14728222.2011.561317; Aronne LJ, 2007, AM J MED, V120, pS29, DOI 10.1016/j.amjmed.2006.11.015; Bengestrate L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021305; Bergman RN, 2007, AM J MED, V120, pS3, DOI 10.1016/j.amjmed.2006.11.012; Calle EE, 2004, NAT REV CANCER, V4, P579, DOI 10.1038/nrc1408; Chang Jinhong, 2004, RNA Biol, V1, P106, DOI 10.4161/rna.1.2.1066; Chartoumpekis DV, 2011, DIABETES, V60, P2465, DOI 10.2337/db11-0112; Chen Y, 2008, BLOOD, V111, P1217, DOI 10.1182/blood-2007-07-104133; Clarke IJ, 2010, CLIN EXP PHARMACOL P, V37, P121, DOI 10.1111/j.1440-1681.2009.05259.x; COUSIN B, 1992, J CELL SCI, V103, P931; Couzin J, 2008, SCIENCE, V319, P1782, DOI 10.1126/science.319.5871.1782; Day JW, 2009, NAT CHEM BIOL, V5, P749, DOI 10.1038/nchembio.209; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; DESPRES JP, 1993, NUTRITION, V9, P452; Dweep H, 2011, J BIOMED INFORM, V44, P839, DOI 10.1016/j.jbi.2011.05.002; Enomoto H, 2004, J CELL SCI, V117, P417, DOI 10.1242/jcs.00866; Esau C, 2006, CELL METAB, V3, P87, DOI 10.1016/j.cmet.2006.01.005; Feldmann HM, 2009, CELL METAB, V9, P203, DOI 10.1016/j.cmet.2008.12.014; Gerin I, 2010, AM J PHYSIOL-ENDOC M, V299, pE198, DOI 10.1152/ajpendo.00179.2010; GIMBLE JM, 1995, J CELL BIOCHEM, V58, P393, DOI 10.1002/jcb.240580312; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Heneghan HM, 2010, OBES REV, V11, P354, DOI 10.1111/j.1467-789X.2009.00659.x; Huang J, 2010, STEM CELLS, V28, P357, DOI 10.1002/stem.288; Huang ZH, 2009, AM J PHYSIOL-ENDOC M, V296, pE1110, DOI 10.1152/ajpendo.90964.2008; James P T, 2001, Obes Res, V9 Suppl 4, p228S, DOI 10.1038/oby.2001.123; Keller P, 2011, BMC ENDOCR DISORD, V11, DOI 10.1186/1472-6823-11-7; Kennell JA, 2008, P NATL ACAD SCI USA, V105, P15417, DOI 10.1073/pnas.0807763105; Kershaw EE, 2004, J CLIN ENDOCR METAB, V89, P2548, DOI 10.1210/jc.2004-0395; Kim YJ, 2009, STEM CELLS, V27, P3093, DOI 10.1002/stem.235; Kolfschoten IGM, 2009, DIABETES OBES METAB, V11, P118, DOI 10.1111/j.1463-1326.2009.01118.x; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McGregor RA, 2011, CURR MOL MED, V11, P304; Nishimura S, 2007, DIABETES, V56, P1517, DOI 10.2337/db06-1749; Ortega FJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009022; Osada H, 2007, CARCINOGENESIS, V28, P2, DOI 10.1093/carcin/bgl185; Radojicic J, 2011, CELL CYCLE, V10, P507, DOI 10.4161/cc.10.3.14754; Saykally JN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008460; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Tanaka T, 1997, EMBO J, V16, P7432, DOI 10.1093/emboj/16.24.7432; Umekawa T, 1997, EUR J ENDOCRINOL, V136, P429, DOI 10.1530/eje.0.1360429; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wajchenberg BL, 2000, ENDOCR REV, V21, P697, DOI 10.1210/er.21.6.697; Walden TB, 2009, J CELL PHYSIOL, V218, P444, DOI 10.1002/jcp.21621; Xie HM, 2009, DIABETES, V58, P1050, DOI 10.2337/db08-1299; Xu HY, 1999, J BIOL CHEM, V274, P26287, DOI 10.1074/jbc.274.37.26287; Yang BF, 2007, NAT MED, V13, P486, DOI 10.1038/nm1569; YOSHIDA T, 1994, LIFE SCI, V54, P491, DOI 10.1016/0024-3205(94)00408-0; Yun SJ, 2008, BIOCHEM BIOPH RES CO, V371, P138, DOI 10.1016/j.bbrc.2008.04.029; Yun Z, 2002, DEV CELL, V2, P331, DOI 10.1016/S1534-5807(02)00131-4; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475; Zhao EP, 2009, MAMM GENOME, V20, P476, DOI 10.1007/s00335-009-9217-2	55	163	174	0	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e34872	10.1371/journal.pone.0034872	http://dx.doi.org/10.1371/journal.pone.0034872			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GO	22496873	Green Submitted, Green Published, gold			2022-12-27	WOS:000304855200087
J	Mdzinarishvili, T; Sherman, S				Mdzinarishvili, Tengiz; Sherman, Simon			A Heuristic Solution of the Identifiability Problem of the Age-Period-Cohort Analysis of Cancer Occurrence: Lung Cancer Example	PLOS ONE			English	Article							TEMPORAL VARIATION; MORTALITY-RATES; OLD-AGE; MODELS; TIME	Background: The Age-Period-Cohort (APC) analysis is aimed at estimating the following effects on disease incidence: (i) the age of the subject at the time of disease diagnosis; (ii) the time period, when the disease occurred; and (iii) the date of birth of the subject. These effects can help in evaluating the biological events leading to the disease, in estimating the influence of distinct risk factors on disease occurrence, and in the development of new strategies for disease prevention and treatment. Methodology/Principal Findings: We developed a novel approach for estimating the APC effects on disease incidence rates in the frame of the Log-Linear Age-Period-Cohort (LLAPC) model. Since the APC effects are linearly interdependent and cannot be uniquely estimated, solving this identifiability problem requires setting four redundant parameters within a set of unknown parameters. By setting three parameters (one of the time-period and the birth-cohort effects and the corresponding age effect) to zero, we reduced this problem to the problem of determining one redundant parameter and, used as such, the effect of the time-period adjacent to the anchored time period. By varying this identification parameter, a family of estimates of the APC effects can be obtained. Using a heuristic assumption that the differences between the adjacent birth-cohort effects are small, we developed a numerical method for determining the optimal value of the identification parameter, by which a unique set of all APC effects is determined and the identifiability problem is solved. Conclusions/Significance: We tested this approach while estimating the APC effects on lung cancer occurrence in white men and women using the SEER data, collected during 1975-2004. We showed that the LLAPC models with the corresponding unique sets of the APC effects estimated by the proposed approach fit very well with the observational data.	[Mdzinarishvili, Tengiz; Sherman, Simon] Univ Nebraska Med Ctr, Eppley Inst, Omaha, NE USA	University of Nebraska System; University of Nebraska Medical Center	Mdzinarishvili, T (corresponding author), Univ Nebraska Med Ctr, Eppley Inst, Omaha, NE USA.	ssherm@unmc.edu			NCI NIH HHS [R01 CA140940] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA140940] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		[Anonymous], 1973, LTD US DAT 1973 2004; BARRETT JC, 1973, J HYG-CAMBRIDGE, V71, P253, DOI 10.1017/S0022172400022725; BARRETT JC, 1978, J EPIDEMIOL COMMUN H, V32, P314, DOI 10.1136/jech.32.4.314; Chatterjee S., 2015, REGRESSION ANAL EXAM; Chatterjee S., 1986, STAT SCI, V1, P379, DOI [10.1214/ss/1177013622, DOI 10.1214/SS/1177013622]; CLAYTON D, 1987, STAT MED, V6, P449, DOI 10.1002/sim.4780060405; CLAYTON D, 1987, STAT MED, V6, P469, DOI 10.1002/sim.4780060406; COOK PJ, 1969, INT J CANCER, V4, P93, DOI 10.1002/ijc.2910040113; Devore J., 2007, MODERN MATH STAT APP; Fienberg SE, 1978, SOCIOL METHODOL, V8, P1; Fu WJ, 2008, SOCIOL METHOD RES, V36, P327, DOI 10.1177/0049124107310637; Harding C, 2008, CANCER RES, V68, P4465, DOI 10.1158/0008-5472.CAN-07-1670; Harding C, 2012, CANCER-AM CANCER SOC, V118, P1371, DOI 10.1002/cncr.26376; HOLFORD TR, 1991, ANNU REV PUBL HEALTH, V12, P425, DOI 10.1146/annurev.pu.12.050191.002233; Holford TR, 2005, ENCY BIOSTATISTICS, P17; Jemal A, 2006, CA-CANCER J CLIN, V56, P106, DOI 10.3322/canjclin.56.2.106; Luebeck EG, 2002, P NATL ACAD SCI USA, V99, P15095, DOI 10.1073/pnas.222118199; Mdzinarishvili T, 2010, CANCER INFORM, V9, P179; Mdzinarishvili T, 2009, CANCER INFORM, V7, P271; Mdzinarishvili T, 2010, CANCER INFORM, V9, P67; Mdzinarishvili T, 2009, CANCER INFORM, V7, P183; Meza R, 2008, P NATL ACAD SCI USA, V105, P16284, DOI 10.1073/pnas.0801151105; Moolgavkar SH, 1998, MODERN EPIDEMIOLOGY, P482; Moolgavkar SH, 2009, CANCER CAUSE CONTROL, V20, P935, DOI 10.1007/s10552-009-9328-9; Pompei F, 2001, HUM ECOL RISK ASSESS, V7, P1619, DOI 10.1080/20018091095267; Pompei F, 2004, NAT REV CANCER, V3, P1474; Rosenberg PS, 2011, CANCER EPIDEM BIOMAR, V20, P1263, DOI 10.1158/1055-9965.EPI-11-0421; Selvin S, 2004, STORY WALLAH CELEBRA, P1; Tikhonov A.N., 1977, SOLUTION ILL POSED P, V54, P266, DOI 10.1137/1021044; Yang Y, 2004, SOCIOL METHODOL, V34, P75, DOI 10.1111/j.0081-1750.2004.00148.x	30	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e34362	10.1371/journal.pone.0034362	http://dx.doi.org/10.1371/journal.pone.0034362			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	953GO	22496795	Green Submitted, gold, Green Published			2022-12-27	WOS:000304855200042
J	Patel, R; Baker, SS; Liu, WS; Desai, S; Alkhouri, R; Kozielski, R; Mastrandrea, L; Sarfraz, A; Cai, WJ; Vlassara, H; Patel, MS; Baker, RD; Zhu, LX				Patel, Raza; Baker, Susan S.; Liu, Wensheng; Desai, Sonal; Alkhouri, Razan; Kozielski, Rafal; Mastrandrea, Lucy; Sarfraz, Adil; Cai, Weijing; Vlassara, Helen; Patel, Mulchand S.; Baker, Robert D.; Zhu, Lixin			Effect of Dietary Advanced Glycation End Products on Mouse Liver	PLOS ONE			English	Article							NONALCOHOLIC STEATOHEPATITIS; OXIDANT STRESS; UNITED-STATES; INSULIN-RESISTANCE; OXIDATIVE STRESS; LIFE-SPAN; DISEASE; MICE; PREVALENCE; RECEPTOR	The exact pathophysiology of non-alcoholic steatohepatitis (NASH) is not known. Previous studies suggest that dietary advanced glycation end products (AGEs) can cause oxidative stress in liver. We aim to study the effects of dietary AGEs on liver health and their possible role in the pathogenesis of NASH. METHODS: Two groups of mice were fed the same diet except the AGE content varied. One group was fed a high AGE diet and the second group was fed a regular AGE diet. Liver histology, alanine aminotransferase, aspartate aminotransferase, fasting glucose, fasting insulin, insulin resistance and glucose tolerance were assessed. RESULTS: Histology revealed that neutrophil infiltration occurred in the livers of the high AGE group at week 26; steatosis did not accompany liver inflammation. At week 39 livers from both groups exhibited macro-or micro-steatosis, yet no inflammation was detected. Higher insulin levels were detected in the regular AGE group at week 26 (P = 0.034), compared to the high AGE group. At week 39, the regular AGE group showed higher levels of alanine aminotransferase (P<0.01) and aspartate aminotransferase (P = 0.02) than those of the high AGE group. CONCLUSIONS: We demonstrate that a high AGE diet can cause liver inflammation in the absence of steatosis. Our results show that dietary AGEs could play a role in initiating liver inflammation contributing to the disease progression of NASH. Our observation that the inflammation caused by high AGE alone did not persist suggests interesting future directions to investigate how AGEs contribute to pro-oxidative and anti-oxidative pathways in the liver.	[Patel, Raza; Baker, Susan S.; Liu, Wensheng; Desai, Sonal; Alkhouri, Razan; Sarfraz, Adil; Baker, Robert D.; Zhu, Lixin] SUNY Buffalo, Digest Dis & Nutr Ctr, Dept Pediat, Women & Childrens Hosp Buffalo, Buffalo, NY 14260 USA; [Kozielski, Rafal] SUNY Buffalo, Women & Childrens Hosp Buffalo, Dept Pathol, Buffalo, NY 14260 USA; [Cai, Weijing; Vlassara, Helen] Mt Sinai Sch Med, Div Nephrol, New York, NY USA; [Patel, Mulchand S.] SUNY Buffalo, Dept Biochem, Buffalo, NY 14214 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Women & Children's Hospital of Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Women & Children's Hospital of Buffalo; Icahn School of Medicine at Mount Sinai; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Patel, R (corresponding author), SUNY Buffalo, Digest Dis & Nutr Ctr, Dept Pediat, Women & Childrens Hosp Buffalo, Buffalo, NY 14260 USA.	sbaker@upa.chob.edu; lixinzhu@buffalo.edu	liu, wen/HGE-3071-2022	Zhu, Lixin/0000-0001-7904-1769	Peter and Tommy Fund, Inc., Buffalo, NY	Peter and Tommy Fund, Inc., Buffalo, NY	This work was supported by an unrestricted grant from the Peter and Tommy Fund, Inc., Buffalo, NY http://www.thepeterandtommyfund.org (to Dr. Baker) and a departmental start-up fund (to Dr. Zhu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe R, 2004, J INVEST DERMATOL, V122, P461, DOI 10.1046/j.0022-202X.2004.22218.x; Anstee QM, 2006, INT J EXP PATHOL, V87, P1, DOI 10.1111/j.0959-9673.2006.00465.x; Baker SS, 2010, PLOS ONE, V5, pA82, DOI 10.1371/journal.pone.0009570; Birlouez-Aragon I, 2010, AM J CLIN NUTR, V91, P1220, DOI 10.3945/ajcn.2009.28737; Browning JD, 2004, HEPATOLOGY, V40, P1387, DOI 10.1002/hep.20466; Brunt EM, 2004, SEMIN LIVER DIS, V24, P3; Bugianesi Elisabetta, 2007, Curr Diab Rep, V7, P175, DOI 10.1007/s11892-007-0029-z; Cai WJ, 2008, AM J PATHOL, V173, P327, DOI 10.2353/ajpath.2008.080152; Cai WJ, 2007, AM J PATHOL, V170, P1893, DOI 10.2353/ajpath.2007.061281; Cerami C, 1997, P NATL ACAD SCI USA, V94, P13915, DOI 10.1073/pnas.94.25.13915; Charlton MR, 2011, GASTROENTEROLOGY, V141, P1249, DOI 10.1053/j.gastro.2011.06.061; Chuyen NV, 2005, ANN NY ACAD SCI, V1043, P467, DOI 10.1196/annals.1333.053; Clark JM, 2003, AM J GASTROENTEROL, V98, P960, DOI [10.1016/S0002-9270(03)00265-X, 10.1111/j.1572-0241.2003.07486.x]; Cope K, 2000, GASTROENTEROLOGY, V119, P1340, DOI 10.1053/gast.2000.19267; Day CP, 1998, GASTROENTEROLOGY, V114, P842, DOI 10.1016/S0016-5085(98)70599-2; GARCIARUIZ C, 1995, MOL PHARMACOL, V48, P825; Hensley K, 2000, CARCINOGENESIS, V21, P983, DOI 10.1093/carcin/21.5.983; Huttunen HJ, 2002, CANCER RES, V62, P4805; Hyogo H, 2008, CURR PHARM DESIGN, V14, P969, DOI 10.2174/138161208784139701; Hyogo H, 2007, J GASTROEN HEPATOL, V22, P1112, DOI 10.1111/j.1440-1746.2007.04943.x; Iwamoto K, 2008, J GASTROENTEROL, V43, P298, DOI 10.1007/s00535-007-2152-7; Kim CH, 2008, CLEV CLIN J MED, V75, P721, DOI 10.3949/ccjm.75.10.721; Kimura T, 1996, NEUROSCI LETT, V208, P53, DOI 10.1016/0304-3940(96)12537-4; Kojima H, 2007, ALCOHOL CLIN EXP RES, V31, p61S, DOI 10.1111/j.1530-0277.2006.00288.x; Lieber CS, 2004, HEPATOL RES, V28, P1, DOI 10.1016/j.hepres.2003.08.001; Lin HZ, 2000, NAT MED, V6, P998, DOI 10.1038/79697; Lindenmeier M, 2002, J AGR FOOD CHEM, V50, P6997, DOI 10.1021/jf020618n; Lindsey JB, 2009, DIABETES CARE, V32, P1218, DOI 10.2337/dc09-0053; Mannaerts GP, 2000, CELL BIOCHEM BIOPHYS, V32, P73, DOI 10.1385/CBB:32:1-3:73; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Perez-Carreras M, 2003, HEPATOLOGY, V38, P999, DOI 10.1053/jhep.2003.50398; Sandu O, 2005, DIABETES, V54, P2314, DOI 10.2337/diabetes.54.8.2314; Seki S, 2002, J HEPATOL, V37, P56, DOI 10.1016/S0168-8278(02)00073-9; Singh R, 2001, DIABETOLOGIA, V44, P129, DOI 10.1007/s001250051591; Tilg H, 2010, HEPATOLOGY, V52, P1836, DOI 10.1002/hep.24001; Vlassara H, 1997, DIABETES, V46, pS19, DOI 10.2337/diab.46.2.S19; Vlassara H, 2002, P NATL ACAD SCI USA, V99, P15596, DOI 10.1073/pnas.242407999; Wang MY, 2009, ACTA NEUROPATHOL, V118, P381, DOI 10.1007/s00401-009-0513-4; Yang SQ, 2000, ARCH BIOCHEM BIOPHYS, V378, P259, DOI 10.1006/abbi.2000.1829; Younossi ZM, 2011, CLIN GASTROENTEROL H, V9, P524, DOI 10.1016/j.cgh.2011.03.020	40	60	60	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e35143	10.1371/journal.pone.0035143	http://dx.doi.org/10.1371/journal.pone.0035143			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GO	22496902	gold, Green Published			2022-12-27	WOS:000304855200100
J	Resch, AM; Palakodeti, D; Lu, YC; Horowitz, M; Graveley, BR				Resch, Alissa M.; Palakodeti, Dasaradhi; Lu, Yi-Chien; Horowitz, Michael; Graveley, Brenton R.			Transcriptome Analysis Reveals Strain-Specific and Conserved Stemness Genes in Schmidtea mediterranea	PLOS ONE			English	Article							ALTERNATIVE SPLICING EVENTS; CELL FUNCTION; PLANARIAN; PROTEIN; REGENERATION; DIFFERENTIATION; EXPRESSION; DATABASE; GENOME; MODEL	The planarian Schmidtea mediterranea is a powerful model organism for studying stem cell biology due to its extraordinary regenerative ability mediated by neoblasts, a population of adult somatic stem cells. Elucidation of the S. mediterranea transcriptome and the dynamics of transcript expression will increase our understanding of the gene regulatory programs that regulate stem cell function and differentiation. Here, we have used RNA-Seq to characterize the S. mediterranea transcriptome in sexual and asexual animals and in purified neoblast and differentiated cell populations. Our analysis identified many uncharacterized genes, transcripts, and alternatively spliced isoforms that are differentially expressed in a strain or cell type-specific manner. Transcriptome profiling of purified neoblasts and differentiated cells identified neoblast-enriched transcripts, many of which likely play important roles in regeneration and stem cell function. Strikingly, many of the neoblast-enriched genes are orthologs of genes whose expression is enriched in human embryonic stem cells, suggesting that a core set of genes that regulate stem cell function are conserved across metazoan species.	[Resch, Alissa M.; Horowitz, Michael; Graveley, Brenton R.] Univ Connecticut, Ctr Hlth, Dept Genet & Dev Biol, Stem Cell Inst, Farmington, CT USA; [Palakodeti, Dasaradhi] Natl Ctr Biol Sci, Inst Stem Cell Biol & Regenerat Med, Bangalore, Karnataka, India; [Lu, Yi-Chien] Weill Cornell Med Coll, Dept Pathol & Lab Med, New York, NY USA	University of Connecticut; Department of Biotechnology (DBT) India; Institute for Stem Cell Biology & Regenerative Medicine - inStem; Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS); Cornell University	Resch, AM (corresponding author), Univ Connecticut, Ctr Hlth, Dept Genet & Dev Biol, Stem Cell Inst, Farmington, CT USA.	graveley@neuron.uchc.edu	Graveley, Brenton R/C-3108-2013	Graveley, Brenton/0000-0001-5777-5892	Raymond and Beverly Sackler Fund for the Arts and Sciences; Connecticut Stem Cell Fund	Raymond and Beverly Sackler Fund for the Arts and Sciences; Connecticut Stem Cell Fund	This work was generously supported by the Raymond and Beverly Sackler Fund for the Arts and Sciences and the State of Connecticut Stem Cell Fund (to Dr. Graveley). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abril JF, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-731; Adamidi C, 2011, GENOME RES, V21, P1193, DOI 10.1101/gr.113779.110; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Alvarado AS, 2004, PHILOS T R SOC B, V359, P759, DOI 10.1098/rstb.2004.1465; Alvarado AS, 2002, DEVELOPMENT, V129, P5659, DOI 10.1242/dev.00167; Alvarez-Presas M, 2008, MOL PHYLOGENET EVOL, V47, P555, DOI 10.1016/j.ympev.2008.01.032; Antin PB, 2010, DEV DYNAM, V239, P1879, DOI 10.1002/dvdy.22318; Archer TC, 2011, DEV BIOL, V350, P429, DOI 10.1016/j.ydbio.2010.12.013; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Berriman M, 2009, NATURE, V460, P352, DOI 10.1038/nature08160; Besset V, 1999, CELL GROWTH DIFFER, V10, P173; Blekhman R, 2010, GENOME RES, V20, P180, DOI 10.1101/gr.099226.109; Blythe MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015617; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Calvanese V, 2010, P NATL ACAD SCI USA, V107, P13736, DOI 10.1073/pnas.1001399107; Cebria F, 2005, DEVELOPMENT, V132, P3691, DOI 10.1242/dev.01941; Chapman JA, 2010, NATURE, V464, P592, DOI 10.1038/nature08830; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Eads BD, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-464; Eisenhoffer GT, 2008, CELL STEM CELL, V3, P327, DOI 10.1016/j.stem.2008.07.002; Fernandez-Taboada E, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-133; FRIEDEN C, 1989, TRENDS BIOCHEM SCI, V14, P283, DOI 10.1016/0968-0004(89)90065-0; Friedlander MR, 2008, NAT BIOTECHNOL, V26, P407, DOI 10.1038/nbt1394; Fu WY, 2011, NEUROSCIENCE, V180, P353, DOI 10.1016/j.neuroscience.2011.02.024; Gerstein MB, 2010, SCIENCE, V330, P1775, DOI 10.1126/science.1196914; Graveley BR, 2011, NATURE, V471, P473, DOI 10.1038/nature09715; Guth SIE, 2008, CELL MOL LIFE SCI, V65, P3000, DOI 10.1007/s00018-008-8138-7; Harris JE, 2006, DEV BIOL, V299, P105, DOI 10.1016/j.ydbio.2006.07.013; Hartmann B, 2011, RNA, V17, P453, DOI 10.1261/rna.2460411; Hayashi T, 2006, DEV GROWTH DIFFER, V48, P371, DOI 10.1111/j.1440-169x.2006.00876.x; Ho TH, 2004, EMBO J, V23, P3103, DOI 10.1038/sj.emboj.7600300; Hollenbach JP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021808; Holubcova Z, 2011, STEM CELLS, V29, P46, DOI 10.1002/stem.549; Huggins CE, 2008, J MOL CELL CARDIOL, V44, P270, DOI 10.1016/j.yjmcc.2007.11.020; Kalsotra A, 2008, P NATL ACAD SCI USA, V105, P20333, DOI 10.1073/pnas.0809045105; Kawamura K, 1999, MICROSC RES TECHNIQ, V44, P269, DOI 10.1002/(SICI)1097-0029(19990215)44:4<269::AID-JEMT6>3.0.CO;2-K; Koledova Z, 2010, STEM CELLS DEV, V19, P1663, DOI 10.1089/scd.2010.0136; Kondoh E, 2008, DEV GROWTH DIFFER, V50, P665, DOI 10.1111/j.1440-169X.2008.01064.x; LANGE CS, 1968, INT J RADIAT BIOL RE, V14, P119, DOI 10.1080/09553006814550931; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Laronda MM, 2011, ENDOCRINOLOGY, V152, P1606, DOI 10.1210/en.2010-1249; Lazaro EM, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-274; Lechler T, 2005, NATURE, V437, P275, DOI 10.1038/nature03922; Lu YC, 2009, RNA, V15, P1483, DOI 10.1261/rna.1702009; Magen A, 2005, NUCLEIC ACIDS RES, V33, P5574, DOI 10.1093/nar/gki858; Marchler-Bauer A, 2002, NUCLEIC ACIDS RES, V30, P281, DOI 10.1093/nar/30.1.281; Marthiens V, 2010, J CELL SCI, V123, P1613, DOI 10.1242/jcs.054312; Meier-Stiegen F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011481; Newmark PA, 2002, NAT REV GENET, V3, P210, DOI 10.1038/nrg759; Ng HH, 2011, NAT CELL BIOL, V13, P490, DOI 10.1038/ncb0511-490; Nilsen TW, 2010, NATURE, V463, P457, DOI 10.1038/nature08909; Orkin SH, 2011, CELL, V145, P835, DOI 10.1016/j.cell.2011.05.019; Palakodeti D, 2008, RNA, V14, P1174, DOI 10.1261/rna.1085008; Phillips K, 2000, J MOL BIOL, V302, P1023, DOI 10.1006/jmbi.2000.4107; Reddien PW, 2005, SCIENCE, V310, P1327, DOI 10.1126/science.1116110; Reddien PW, 2005, DEV CELL, V8, P635, DOI 10.1016/j.devcel.2005.02.014; Resch A, 2004, NUCLEIC ACIDS RES, V32, P1261, DOI 10.1093/nar/gkh284; Ritter AR, 2010, DEV DYNAM, V239, P2685, DOI 10.1002/dvdy.22407; Robb SMC, 2008, NUCLEIC ACIDS RES, V36, pD599, DOI 10.1093/nar/Gkm684; Rossi DJ, 2007, NATURE, V447, P725, DOI 10.1038/nature05862; Saiki Y, 2000, GENOMICS, V70, P387, DOI 10.1006/geno.2000.6385; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Sestan N, 1999, SCIENCE, V286, P741, DOI 10.1126/science.286.5440.741; Sundaram P, 2006, MOL BIOL CELL, V17, P3678, DOI 10.1091/mbc.E06-03-0192; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Vicente M, 2007, DIFFERENTIATION, V75, P427, DOI 10.1111/j.1432-0436.2006.00156.x; Wang YY, 2010, GENE DEV, V24, P2081, DOI 10.1101/gad.1951010; WOLFF ETIENNE, 1948, REV SUISSE ZOOL, V55, P218; Wu DY, 2009, NATURE, V462, P1056, DOI 10.1038/nature08656; Yeo GW, 2005, P NATL ACAD SCI USA, V102, P2850, DOI 10.1073/pnas.0409742102; Zayas RM, 2005, P NATL ACAD SCI USA, V102, P18491, DOI 10.1073/pnas.0509507102; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhou Y, 2009, NATURE, V460, P345, DOI 10.1038/nature08140	77	42	43	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e34447	10.1371/journal.pone.0034447	http://dx.doi.org/10.1371/journal.pone.0034447			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GO	22496805	Green Submitted, Green Published, gold			2022-12-27	WOS:000304855200051
J	van Boheemen, S; Bestebroer, TM; Verhagen, JH; Osterhaus, ADME; Pas, SD; Herfst, S; Fouchier, RAM				van Boheemen, Sander; Bestebroer, Theo M.; Verhagen, Josanne H.; Osterhaus, Albert D. M. E.; Pas, Suzan D.; Herfst, Sander; Fouchier, Ron A. M.			A Family-Wide RT-PCR Assay for Detection of Paramyxoviruses and Application to a Large-Scale Surveillance Study	PLOS ONE			English	Article							NIPAH VIRUS; IDENTIFICATION; CORONAVIRUS; GENE	Family-wide molecular diagnostic assays are valuable tools for initial identification of viruses during outbreaks and to limit costs of surveillance studies. Recent discoveries of paramyxoviruses have called for such assay that is able to detect all known and unknown paramyxoviruses in one round of PCR amplification. We have developed a RT-PCR assay consisting of a single degenerate primer set, able to detect all members of the Paramyxoviridae family including all virus genera within the subfamilies Paramyxovirinae and Pneumovirinae. Primers anneal to domain III of the polymerase gene, with the 39 end of the reverse primer annealing to the conserved motif GDNQ, which is proposed to be the active site for nucleotide polymerization. The assay was fully optimized and was shown to indeed detect all available paramyxoviruses tested. Clinical specimens from hospitalized patients that tested positive for known paramyxoviruses in conventional assays were also detected with the novel family-wide test. A high-throughput fluorescence-based RT-PCR version of the assay was developed for screening large numbers of specimens. A large number of samples collected from wild birds was tested, resulting in the detection of avian paramyxoviruses type 1 in both barnacle and white-fronted geese, and type 8 in barnacle geese. Avian metapneumovirus type C was found for the first time in Europe in mallards, greylag geese and common gulls. The single round family-wide RT-PCR assay described here is a useful tool for the detection of known and unknown paramyxoviruses, and screening of large sample collections from humans and animals.	[van Boheemen, Sander; Bestebroer, Theo M.; Verhagen, Josanne H.; Osterhaus, Albert D. M. E.; Pas, Suzan D.; Herfst, Sander; Fouchier, Ron A. M.] Erasmus MC, Dept Virol, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC	van Boheemen, S (corresponding author), Erasmus MC, Dept Virol, Rotterdam, Netherlands.	r.fouchier@erasmusmc.nl	Fouchier, Ron A/A-1911-2014; Pas, Suzan D/M-9863-2013	Fouchier, Ron A/0000-0001-8095-2869; Pas, Suzan D/0000-0003-1943-1217; Herfst, Sander/0000-0001-9866-8903; Osterhaus, Albert/0000-0002-6074-1172	European Community under European Commission [223498]	European Community under European Commission	This work was funded by the European Community's Seventh Framework Programme (FP7/2007-2013) under the project "European Management Platform for Emerging and Re-emerging Infectious Disease Entities" European Commission grant agreement no. 223498. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chua KB, 2000, SCIENCE, V288, P1432, DOI 10.1126/science.288.5470.1432; Chua KB, 1999, LANCET, V354, P1257, DOI 10.1016/S0140-6736(99)04299-3; Drosten C, 2003, NEW ENGL J MED, V348, P1967, DOI 10.1056/NEJMoa030747; Fauquet CM, 2005, VIRUS TAXONOMY 8 REP; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Kidd AH, 1996, J CLIN MICROBIOL, V34, P622, DOI 10.1128/JCM.34.3.622-627.1996; Kitchen A, 2011, P NATL ACAD SCI USA, V108, P238, DOI 10.1073/pnas.1011090108; Ksiazek TG, 2003, NEW ENGL J MED, V348, P1953, DOI 10.1056/NEJMoa030781; Lyles D. S., 2007, FIELDS VIROLOGY, V1, P1364; Malur AG, 2002, GENE EXPRESSION, V10, P93; Munster VJ, 2007, PLOS PATHOG, V3, P630, DOI 10.1371/journal.ppat.0030061; MURRAY K, 1995, SCIENCE, V268, P94, DOI 10.1126/science.7701348; Pierce J.R., 1980, INTRO INFORM THEORY; POCH O, 1990, J GEN VIROL, V71, P1153, DOI 10.1099/0022-1317-71-5-1153; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Scaramozzino N, 2001, J CLIN MICROBIOL, V39, P1922, DOI 10.1128/JCM.39.5.1922-1927.2001; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Svenda M, 1997, VIRUS RES, V48, P57, DOI 10.1016/S0168-1702(96)01426-8; Swofford DL, 2002, PAUP PHYLOGENETIC AN; Tong S, 2008, J CLIN MICROBIOL, V46, P2652, DOI 10.1128/JCM.00192-08; Tregoning JS, 2010, CLIN MICROBIOL REV, V23, P74, DOI 10.1128/CMR.00032-09	21	40	40	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e34961	10.1371/journal.pone.0034961	http://dx.doi.org/10.1371/journal.pone.0034961			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GO	22496880	Green Published, gold			2022-12-27	WOS:000304855200091
J	Weber, AL; Khan, GF; Magwire, MM; Tabor, CL; Mackay, TFC; Anholt, RRH				Weber, Allison L.; Khan, George F.; Magwire, Michael M.; Tabor, Crystal L.; Mackay, Trudy F. C.; Anholt, Robert R. H.			Genome-Wide Association Analysis of Oxidative Stress Resistance in Drosophila melanogaster	PLOS ONE			English	Article							GENE DISRUPTION PROJECT; LIFE-SPAN; SUPEROXIDE-DISMUTASE; ATAXIA-TELANGIECTASIA; TYROSINE KINASE; FREE-RADICALS; NITRIC-OXIDE; EXPRESSION; PROTEIN; ANTIOXIDANTS	Background: Aerobic organisms are susceptible to damage by reactive oxygen species. Oxidative stress resistance is a quantitative trait with population variation attributable to the interplay between genetic and environmental factors. Drosophila melanogaster provides an ideal system to study the genetics of variation for resistance to oxidative stress. Methods and Findings: We used 167 wild-derived inbred lines of the Drosophila Genetic Reference Panel for a genome-wide association study of acute oxidative stress resistance to two oxidizing agents, paraquat and menadione sodium bisulfite. We found significant genetic variation for both stressors. Single nucleotide polymorphisms (SNPs) associated with variation in oxidative stress resistance were often sex-specific and agent-dependent, with a small subset common for both sexes or treatments. Associated SNPs had moderately large effects, with an inverse relationship between effect size and allele frequency. Linear models with up to 12 SNPs explained 67-79% and 56-66% of the phenotypic variance for resistance to paraquat and menadione sodium bisulfite, respectively. Many genes implicated were novel with no known role in oxidative stress resistance. Bioinformatics analyses revealed a cellular network comprising DNA metabolism and neuronal development, consistent with targets of oxidative stress-inducing agents. We confirmed associations of seven candidate genes associated with natural variation in oxidative stress resistance through mutational analysis. Conclusions: We identified novel candidate genes associated with variation in resistance to oxidative stress that have context-dependent effects. These results form the basis for future translational studies to identify oxidative stress susceptibility/resistance genes that are evolutionary conserved and might play a role in human disease.	[Weber, Allison L.; Magwire, Michael M.; Tabor, Crystal L.; Mackay, Trudy F. C.; Anholt, Robert R. H.] N Carolina State Univ, Dept Genet, Raleigh, NC 27695 USA; [Weber, Allison L.; Khan, George F.; Magwire, Michael M.; Tabor, Crystal L.; Mackay, Trudy F. C.; Anholt, Robert R. H.] N Carolina State Univ, WM Keck Ctr Behav Biol, Raleigh, NC 27695 USA; [Khan, George F.; Anholt, Robert R. H.] N Carolina State Univ, Dept Biol, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University	Weber, AL (corresponding author), N Carolina State Univ, Dept Genet, Box 7614, Raleigh, NC 27695 USA.	allisonwebergenetics@gmail.com	Anholt, Robert/S-5977-2019		National Institutes of Health [F32 GM089010, 5RC1ES018255, GM045146]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [RC1ES018255] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045146, F32GM089010] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (www.nih.gov) grants F32 GM089010 (to ALW) and 5RC1ES018255 and GM045146 (to RRHA and TFCM). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen JK, 2004, NAT MED, V10, pS18, DOI 10.1038/nrn1434; Antonov A.V., 2010, NUCLEIC ACIDS RES, V38, pW118; ARKING R, 1991, DEV GENET, V12, P362, DOI 10.1002/dvg.1020120505; Arya GH, 2010, GENETICS, V186, P1475, DOI 10.1534/genetics.110.123166; Azumi H, 2002, ARTERIOSCL THROM VAS, V22, P1838, DOI 10.1161/01.ATV.0000037101.40667.62; Barnham KJ, 2004, NAT REV DRUG DISCOV, V3, P205, DOI 10.1038/nrd1330; Bellen HJ, 2004, GENETICS, V167, P761, DOI 10.1534/genetics.104.026427; Bellen HJ, 2011, GENETICS, V188, P731, DOI 10.1534/genetics.111.126995; BREWER GJ, 1967, AM J HUM GENET, V19, P674; Caceres L, 2011, GENE DEV, V25, P1476, DOI 10.1101/gad.2064111; Calabrese V, 2007, NAT REV NEUROSCI, V8, P766, DOI 10.1038/nrn2214; Chen DR, 2008, MOL BIOL CELL, V19, P308, DOI 10.1091/mbc.E07-08-0735; Dawes-Hoang RE, 2005, DEVELOPMENT, V132, P4165, DOI 10.1242/dev.01938; DeRosse P, 2008, SCHIZOPHRENIA BULL, V34, P1047, DOI 10.1093/schbul/sbn076; Falconer D. S., 1996, INTRO QUANTITATIVE G; Finkel T, 2005, NAT REV MOL CELL BIO, V6, P971, DOI 10.1038/nrm1763; Finkel T, 2003, CURR OPIN CELL BIOL, V15, P247, DOI 10.1016/S0955-0674(03)00002-4; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; GERTLER FB, 1995, GENE DEV, V9, P521, DOI 10.1101/gad.9.5.521; Ginsberg SD, 2012, NEUROBIOL DIS, V45, P99, DOI 10.1016/j.nbd.2011.07.013; Giorgio M, 2007, NAT REV MOL CELL BIO, V8, p722A; Girardot F, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-74; HARI KL, 1995, CELL, V82, P815, DOI 10.1016/0092-8674(95)90478-6; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; Helmersson J, 2002, CLIN SCI, V102, P39, DOI 10.1042/CS20010179; Holzenberger M, 2003, NATURE, V421, P182, DOI 10.1038/nature01298; Ide T, 2002, ARTERIOSCL THROM VAS, V22, P438, DOI 10.1161/hq0302.104515; Karaczyn A, 2010, NEURAL DEV, V5, DOI 10.1186/1749-8104-5-31; Khazaeli AA, 2007, MECH AGEING DEV, V128, P486, DOI 10.1016/j.mad.2007.06.005; Knowles JW, 2003, HUM GENET, V112, P62, DOI 10.1007/s00439-002-0834-z; Kopp A, 2003, GENETICS, V163, P771; Landis GN, 2004, P NATL ACAD SCI USA, V101, P7663, DOI 10.1073/pnas.0307605101; LARSEN PL, 1993, P NATL ACAD SCI USA, V90, P8905, DOI 10.1073/pnas.90.19.8905; Li WJ, 2005, DEV DYNAM, V234, P512, DOI 10.1002/dvdy.20496; Lin YJ, 1998, SCIENCE, V282, P943, DOI 10.1126/science.282.5390.943; Littleton JT, 2000, NEURON, V26, P35, DOI 10.1016/S0896-6273(00)81135-6; Loew O, 1900, SCIENCE, V11, P701, DOI 10.1126/science.11.279.701; Mackay TFC, 2012, NATURE, V482, P173, DOI 10.1038/nature10811; Madamanchi NR, 2005, ARTERIOSCL THROM VAS, V25, P950, DOI 10.1161/01.ATV.0000161050.77646.68; Magwere T, 2006, MECH AGEING DEV, V127, P356, DOI 10.1016/j.mad.2005.12.009; Maillet M, 2003, NAT CELL BIOL, V5, P633, DOI 10.1038/ncb1007; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; McGovern VL, 2003, MECH DEVELOP, V120, P1193, DOI 10.1016/s0925-4773(03)00159-X; Monaghan P, 2009, ECOL LETT, V12, P75, DOI 10.1111/j.1461-0248.2008.01258.x; Morton DB, 2004, MOL NEUROBIOL, V29, P97, DOI 10.1385/MN:29:2:097; O'Driscoll M, 2003, NAT GENET, V33, P497, DOI 10.1038/ng1129; O'Neal J, 2009, EXP HEMATOL, V37, P234, DOI 10.1016/j.exphem.2008.10.014; ORR EC, 1990, NUCLEIC ACIDS RES, V18, P3663, DOI 10.1093/nar/18.12.3663; ORR WC, 1994, SCIENCE, V263, P1128, DOI 10.1126/science.8108730; Palu E, 2002, J NEUROSCI RES, V69, P243, DOI 10.1002/jnr.10292; Pandey KN, 2011, FEBS J, V278, P1792, DOI 10.1111/j.1742-4658.2011.08081.x; Parkes TL, 1998, NAT GENET, V19, P171, DOI 10.1038/534; Patterson C, 1999, J BIOL CHEM, V274, P19814, DOI 10.1074/jbc.274.28.19814; Perry T, 2007, INSECT BIOCHEM MOLEC, V37, P184, DOI 10.1016/j.ibmb.2006.11.009; Popa-Nita O, 2008, ARTHRITIS RHEUM-US, V58, P1866, DOI 10.1002/art.23801; RITVO ER, 1988, ARCH GEN PSYCHIAT, V45, P600; Sartori-Valinotti JC, 2007, CLIN EXP PHARMACOL P, V34, P938, DOI 10.1111/j.1440-1681.2007.04643.x; Schwaerzel M, 2007, J NEUROSCI, V27, P1229, DOI 10.1523/JNEUROSCI.4622-06.2007; Sekelsky JJ, 2000, MUTAT RES-DNA REPAIR, V459, P219, DOI 10.1016/S0921-8777(99)00075-0; SETO NOL, 1987, NUCLEIC ACIDS RES, V15, P10601, DOI 10.1093/nar/15.24.10601; Shalaby NA, 2009, GENETICS, V182, P1061, DOI 10.1534/genetics.108.099986; Shamloula HK, 2002, GENETICS, V161, P693; SHIOMI T, 1994, MUTAT RES, V314, P167, DOI 10.1016/0921-8777(94)90080-9; Sun JT, 1999, MOL CELL BIOL, V19, P216; Swan LE, 2004, GENE DEV, V18, P223, DOI 10.1101/gad.287604; Thorpe GW, 2004, P NATL ACAD SCI USA, V101, P6564, DOI 10.1073/pnas.0305888101; Valko M, 2006, CHEM-BIOL INTERACT, V160, P1, DOI 10.1016/j.cbi.2005.12.009; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; van Kesteren PJM, 1998, THROMB HAEMOSTASIS, V79, P1029; VANFLETEREN JR, 1993, BIOCHEM J, V292, P605, DOI 10.1042/bj2920605; Volders K, 2011, CURR MOL MED, V11, P204, DOI 10.2174/156652411795243432; Wallace MA, 2005, CHEM RES TOXICOL, V18, P1279, DOI 10.1021/tx050050n; Walldorf U, 2000, MECH DEVELOP, V96, P141, DOI 10.1016/S0925-4773(00)00380-4; Wang Y, 2006, J HERED, V97, P355, DOI 10.1093/jhered/esl009; Wilson RJ, 2008, NUCLEIC ACIDS RES, V36, pD588, DOI 10.1093/nar/gkm930; Zhao HW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011701; Zuo H, 2010, CANCER RES, V70, P1389, DOI 10.1158/0008-5472.CAN-09-2812	77	78	80	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e34745	10.1371/journal.pone.0034745	http://dx.doi.org/10.1371/journal.pone.0034745			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GO	22496853	Green Published, gold, Green Submitted			2022-12-27	WOS:000304855200074
J	Li, ZQ; Cheng, DJ; Mon, H; Tatsuke, T; Zhu, L; Xu, J; Lee, JM; Xia, QY; Kusakabe, T				Li, Zhiqing; Cheng, Daojun; Mon, Hiroaki; Tatsuke, Tsuneyuki; Zhu, Li; Xu, Jian; Lee, Jae Man; Xia, Qingyou; Kusakabe, Takahiro			Genome-Wide Identification of Polycomb Target Genes Reveals a Functional Association of Pho with Scm in Bombyx mori	PLOS ONE			English	Article							METHYL-LYSINE-BINDING; DNA-BINDING; HISTONE METHYLTRANSFERASE; CHROMATIN BINDING; GROUP PROTEINS; CELL-CYCLE; SEX COMB; COMPLEXES; RECRUITMENT; REPRESSION	Polycomb group (PcG) proteins are evolutionarily conserved chromatin modifiers and act together in three multimeric complexes, Polycomb repressive complex 1 (PRC1), Polycomb repressive complex 2 (PRC2), and Pleiohomeotic repressive complex (PhoRC), to repress transcription of the target genes. Here, we identified Polycomb target genes in Bombyx mori with holocentric centromere using genome-wide expression screening based on the knockdown of BmSCE, BmESC, BmPHO, or BmSCM gene, which represent the distinct complexes. As a result, the expressions of 29 genes were up-regulated after knocking down 4 PcG genes. Particularly, there is a significant overlap between targets of BmPho (331 out of 524) and BmScm (331 out of 532), and among these, 190 genes function as regulator factors playing important roles in development. We also found that BmPho, as well as BmScm, can interact with other Polycomb components examined in this study. Further detailed analysis revealed that the C-terminus of BmPho containing zinc finger domain is involved in the interaction between BmPho and BmScm. Moreover, the zinc finger domain in BmPho contributes to its inhibitory function and ectopic overexpression of BmScm is able to promote transcriptional repression by Gal4-Pho fusions including BmScm-interacting domain. Loss of BmPho expression causes relocalization of BmScm into the cytoplasm. Collectively, we provide evidence of a functional link between BmPho and BmScm, and propose two Polycomb-related repression mechanisms requiring only BmPho associated with BmScm or a whole set of PcG complexes.	[Li, Zhiqing; Mon, Hiroaki; Tatsuke, Tsuneyuki; Zhu, Li; Xu, Jian; Lee, Jae Man; Kusakabe, Takahiro] Kyushu Univ, Grad Sch Bioresource & Bioenvironm Sci, Lab Silkworm Sci, Fukuoka 812, Japan; [Cheng, Daojun; Xia, Qingyou] Southwest Univ, State Key Lab Silkworm Genome Biol, Chongqing, Peoples R China	Kyushu University; Southwest University - China	Li, ZQ (corresponding author), Kyushu Univ, Grad Sch Bioresource & Bioenvironm Sci, Lab Silkworm Sci, Fukuoka 812, Japan.	kusakabe@agr.kyushu-u.ac.jp	Tatsuke, Tsuneyuki/I-3714-2019; Xu, Jian/G-6684-2015; Zhu, Li/S-7517-2018	Tatsuke, Tsuneyuki/0000-0003-2322-4528; Xu, Jian/0000-0003-1816-4129; Zhu, Li/0000-0002-4919-1894; Li, Zhiqing/0000-0001-8323-3245	Japan Society for the Promotion of Science [22248004, 23580077]; National Basic Research Program of China [2012CB114600]; Grants-in-Aid for Scientific Research [22248004] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); National Basic Research Program of China(National Basic Research Program of China); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-Aid for Scientific Research (KAKENHI) no. 22248004 and 23580077 from the Japan Society for the Promotion of Science to TK and JML, and also by a grant from the National Basic Research Program of China to QX: 2012CB114600. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boutros R, 2006, CURR OPIN CELL BIOL, V18, P185, DOI 10.1016/j.ceb.2006.02.003; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Brown JL, 1998, MOL CELL, V1, P1057, DOI 10.1016/S1097-2765(00)80106-9; Buchenau P, 1998, J CELL BIOL, V141, P469, DOI 10.1083/jcb.141.2.469; Cavalli G, 2011, J MOL BIOL, V409, P54, DOI 10.1016/j.jmb.2011.03.001; Chai CL, 2008, INSECT BIOCHEM MOLEC, V38, P1111, DOI 10.1016/j.ibmb.2008.06.008; Cheng D, 2008, INSECT BIOCHEM MOLEC, V38, P1130, DOI 10.1016/j.ibmb.2008.09.013; Finley RL, 1996, P NATL ACAD SCI USA, V93, P3011, DOI 10.1073/pnas.93.7.3011; Francis NJ, 2009, CELL CYCLE, V8, P3521, DOI 10.4161/cc.8.21.9876; Grimm C, 2007, EMBO REP, V8, P1031, DOI 10.1038/sj.embor.7401085; Grimm C, 2009, EMBO J, V28, P1965, DOI 10.1038/emboj.2009.147; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Jacobs JJL, 2002, BBA-REV CANCER, V1602, P151, DOI 10.1016/S0304-419X(02)00052-5; Kanhere A, 2010, MOL CELL, V38, P675, DOI 10.1016/j.molcel.2010.03.019; Klymenko T, 2006, GENE DEV, V20, P1110, DOI 10.1101/gad.377406; Lee JM, 2004, COMP BIOCHEM PHYS B, V139, P35, DOI 10.1016/j.cbpc.2004.06.004; Leeb M, 2010, GENE DEV, V24, P265, DOI 10.1101/gad.544410; LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0; Li ZQ, 2011, MOL BIOL RE IN PRESS; Majewski IJ, 2010, BLOOD, V116, P731, DOI 10.1182/blood-2009-12-260760; MESSMER S, 1992, GENE DEV, V6, P1241, DOI 10.1101/gad.6.7.1241; Mitsunobu H, 2012, INSECT MOL BIOL, V21, P9, DOI 10.1111/j.1365-2583.2011.01115.x; Mohd-Sarip A, 2002, MOL CELL BIOL, V22, P7473, DOI 10.1128/MCB.22.21.7473-7483.2002; Mon H, 2012, RNA BIOL, V9, P40, DOI 10.4161/rna.9.1.18084; Morey L, 2010, TRENDS BIOCHEM SCI, V35, P323, DOI 10.1016/j.tibs.2010.02.009; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; Oktaba K, 2008, DEV CELL, V15, P877, DOI 10.1016/j.devcel.2008.10.005; Pasini D, 2004, CELL CYCLE, V3, P396; Poux S, 2001, DEVELOPMENT, V128, P75; Prezioso C, 2011, FEBS LETT, V585, P2067, DOI 10.1016/j.febslet.2011.04.062; Roseman RR, 2001, GENETICS, V158, P291; Saurin AJ, 1998, J CELL BIOL, V142, P887, DOI 10.1083/jcb.142.4.887; Schwartz YB, 2006, NAT GENET, V38, P700, DOI 10.1038/ng1817; Shao ZH, 1999, CELL, V98, P37, DOI 10.1016/S0092-8674(00)80604-2; Simon JA, 2009, NAT REV MOL CELL BIO, V10, P697, DOI 10.1038/nrm2763; Simon JA, 2008, MUTAT RES-FUND MOL M, V647, P21, DOI 10.1016/j.mrfmmm.2008.07.010; Sparmann A, 2006, NAT REV CANCER, V6, P846, DOI 10.1038/nrc1991; STRUHL G, 1981, NATURE, V293, P36, DOI 10.1038/293036a0; Tolhuis B, 2006, NAT GENET, V38, P694, DOI 10.1038/ng1792; Wang L, 2004, MOL CELL, V14, P637, DOI 10.1016/j.molcel.2004.05.009; Wang LJ, 2010, MOL CELL BIOL, V30, P2584, DOI 10.1128/MCB.01451-09; Wilkinson FH, 2006, P NATL ACAD SCI USA, V103, P19296, DOI 10.1073/pnas.0603564103; Xia QY, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r162; Yap KL, 2010, MOL CELL, V38, P662, DOI 10.1016/j.molcel.2010.03.021	45	14	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2012	7	4							e34330	10.1371/journal.pone.0034330	http://dx.doi.org/10.1371/journal.pone.0034330			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952GU	22485166	Green Published, Green Submitted, gold			2022-12-27	WOS:000304780500041
J	Hewing, B; Stangl, V; Stangl, K; Enke-Melzer, K; Baumann, G; Ludwig, A				Hewing, Bernd; Stangl, Verena; Stangl, Karl; Enke-Melzer, Kathrin; Baumann, Gert; Ludwig, Antje			Circulating Angiogenic Factors in Patients with Thromboangiitis Obliterans	PLOS ONE			English	Article							ENDOTHELIAL PROGENITOR CELLS; PERIPHERAL ARTERIAL-DISEASE; BUERGERS-DISEASE; BONE-MARROW; GROWTH-FACTOR; TRANSPLANTATION; BLOOD; VEGF; ATHEROSCLEROSIS; GENE	Background: Thromboangiitis obliterans (TAO, also known as Buerger's disease) is a non-atherosclerotic inflammatory vascular disease that primarily affects arteries in the extremities of young adult smokers. Since the etiology of TAO is still unknown, therapeutic options are limited. Recent attempts in therapeutic angiogenesis have been promising. Therefore, the aim of our study was to evaluate angiogenic processes and factors including circulating progenitor cells in TAO. Methodology/Principal Findings: TAO patients with critical limb ischemia and age-and gender-matched nonsmokers and smokers without cardiovascular disease (n = 12 in each group) were enrolled in the study. Flow cytometric analysis of peripheral blood showed significantly decreased levels of circulating CD45(dim) CD34(+) progenitor cells in TAO patients and in smokers compared to nonsmokers. In contrast to both control groups, the proportion of CD45(dim) CD34(+) progenitor cells co-expressing VEGF receptor-2 (VEGFR2) was significantly elevated in TAO patients. Enzyme-linked immunosorbent assay (ELISA) of common angiogenic factors (such as VEGF) did not clearly point to pro-or antiangiogenic conditions in serum or plasma of TAO patients. Serum of TAO patients and controls was evaluated in proliferation, migration (scratch assay) and spheroid sprouting assays using human umbilical vein endothelial cells (HUVECs). Serum of TAO patients exhibited a diminished sprouting capacity of HUVECs compared to both control groups. Proliferation and migration of endothelial cells were impaired after treatment with serum of TAO patients. Conclusion: Levels of circulating progenitor cells were altered in TAO patients compared to healthy nonsmokers and smokers. Furthermore, serum of TAO patients exhibited an antiangiogenic activity (impaired endothelial cell sprouting, migration and proliferation) on endothelial cells, which may contribute to vascular pathology in this patient population.	[Hewing, Bernd; Stangl, Verena; Stangl, Karl; Baumann, Gert; Ludwig, Antje] Charite, Med Klin Schwerpunkt Kardiol & Angiol, D-13353 Berlin, Germany; [Enke-Melzer, Kathrin] Helios Klinikum Emil von Behring, Klin Gefassmed, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helios Kliniken	Hewing, B (corresponding author), Charite, Med Klin Schwerpunkt Kardiol & Angiol, Campus Mitte, D-13353 Berlin, Germany.	bernd.hewing@charite.de	, Antje Ludwig/ABF-6556-2021	Ludwig, Antje/0000-0002-8369-7020				Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Asahara T, 1999, EMBO J, V18, P3964, DOI 10.1093/emboj/18.14.3964; Baumann G, 2011, CLIN RES CARDIOL, V100, P683, DOI 10.1007/s00392-011-0298-z; Brodmann M, 2001, INT J CARDIOL, V80, P185, DOI 10.1016/S0167-5273(01)00492-2; Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651; Duda DG, 2007, NAT PROTOC, V2, P805, DOI 10.1038/nprot.2007.111; Durdu S, 2006, J VASC SURG, V44, P732, DOI 10.1016/j.jvs.2006.06.023; Espinoza LR, 2009, AM J MED SCI, V337, P285, DOI 10.1097/MAJ.0b013e318198d011; Fadini GP, 2006, STROKE, V37, P2277, DOI 10.1161/01.STR.0000236064.19293.79; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Idei N, 2011, HYPERTENSION, V57, P70, DOI 10.1161/HYPERTENSIONAHA.110.163683; Isner JM, 1998, J VASC SURG, V28, P964, DOI 10.1016/S0741-5214(98)70022-9; Katsuki Y, 2011, CLIN RES CARDIOL, V100, P21, DOI 10.1007/s00392-010-0198-7; Kim DI, 2006, STEM CELLS, V24, P1194, DOI 10.1634/stemcells.2005-0349; Kondo T, 2004, ARTERIOSCL THROM VAS, V24, P1442, DOI 10.1161/01.ATV.0000135655.52088.c5; Korff T, 1999, J CELL SCI, V112, P3249; Lawall H, 2011, J VASC SURG, V53, P445, DOI 10.1016/j.jvs.2010.08.060; Lazarides M K, 2006, Int J Low Extrem Wounds, V5, P89, DOI 10.1177/1534734606288817; Lopez-Novoa JM, 2010, AM J PHYSIOL-HEART C, V299, pH959, DOI 10.1152/ajpheart.01251.2009; Lorenz M, 2007, FASEB J, V21, P1556, DOI 10.1096/fj.06-7434com; Madeddu P, 2004, FASEB J, V18, P1737, DOI 10.1096/fj.04-2192fje; Massa M, 2005, BLOOD, V105, P199, DOI 10.1182/blood-2004-05-1831; Matsui K, 2003, CIRC J, V67, P660; Piazza G, 2010, CIRCULATION, V121, P1858, DOI 10.1161/CIRCULATIONAHA.110.942383; Pitchford SC, 2009, CELL STEM CELL, V4, P62, DOI 10.1016/j.stem.2008.10.017; Ribatti D, 2009, LEUKEMIA RES, V33, P638, DOI 10.1016/j.leukres.2008.11.019; Saito M, 2003, CANCER SCI, V94, P782, DOI 10.1111/j.1349-7006.2003.tb01519.x; Saito Y, 2007, CIRC J, V71, P1187, DOI 10.1253/circj.71.1187; Shantsila E, 2007, J AM COLL CARDIOL, V49, P741, DOI 10.1016/j.jacc.2006.09.050	29	10	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2012	7	4							e34717	10.1371/journal.pone.0034717	http://dx.doi.org/10.1371/journal.pone.0034717			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959FE	22506045	Green Published, Green Submitted, gold			2022-12-27	WOS:000305297500053
J	Mulligan, MK; Wang, XS; Adler, AL; Mozhui, K; Lu, L; Williams, RW				Mulligan, Megan K.; Wang, Xusheng; Adler, Adrienne L.; Mozhui, Khyobeni; Lu, Lu; Williams, Robert W.			Complex Control of GABA(A) Receptor Subunit mRNA Expression: Variation, Covariation, and Genetic Regulation	PLOS ONE			English	Article							ONSET ALZHEIMER-DISEASE; LIS1 MUTANT MICE; ALTERNATIVE POLYADENYLATION; HIPPOCAMPAL INTERNEURONS; INHIBITORY SYNAPSES; ANGELMAN-SYNDROME; NMDA RECEPTORS; NERVOUS-SYSTEM; 2 FORMS; NEURONS	GABA type-A receptors are essential for fast inhibitory neurotransmission and are critical in brain function. Surprisingly, expression of receptor subunits is highly variable among individuals, but the cause and impact of this fluctuation remains unknown. We have studied sources of variation for all 19 receptor subunits using massive expression data sets collected across multiple brain regions and platforms in mice and humans. Expression of Gabra1, Gabra2, Gabrb2, Gabrb3, and Gabrg2 is highly variable and heritable among the large cohort of BXD strains derived from crosses of fully sequenced parents-C57BL/6J and DBA/2J. Genetic control of these subunits is complex and highly dependent on tissue and mRNA region. Remarkably, this high variation is generally not linked to phenotypic differences. The single exception is Gabrb3, a locus that is linked to anxiety. We identified upstream genetic loci that influence subunit expression, including three unlinked regions of chromosome 5 that modulate the expression of nine subunits in hippocampus, and that are also associated with multiple phenotypes. Candidate genes within these loci include, Naaa, Nos1, and Zkscan1. We confirmed a high level of coexpression for subunits comprising the major channel-Gabra1, Gabrb2, and Gabrg2- and identified conserved members of this expression network in mice and humans. Gucy1a3, Gucy1b3, and Lis1 are novel and conserved associates of multiple subunits that are involved in inhibitory signaling. Finally, proximal and distal regions of the 3' UTRs of single subunits have remarkably independent expression patterns in both species. However, corresponding regions of different subunits often show congruent genetic control and coexpression (proximal-to-proximal or distal-to-distal), even in the absence of sequence homology. Our findings identify novel sources of variation that modulate subunit expression and highlight the extraordinary capacity of biological networks to buffer 4-100 fold differences in mRNA levels.	[Mulligan, Megan K.; Wang, Xusheng; Adler, Adrienne L.; Mozhui, Khyobeni; Lu, Lu; Williams, Robert W.] Univ Tennessee, Dept Anat & Neurobiol, Hlth Sci Ctr, Memphis, TN USA	University of Tennessee System; University of Tennessee Health Science Center	Mulligan, MK (corresponding author), Univ Tennessee, Dept Anat & Neurobiol, Hlth Sci Ctr, Memphis, TN USA.	mulliganmk@gmail.com	; Williams, Robert W./H-8789-2016	Mulligan, Megan/0000-0003-4909-635X; Williams, Robert W./0000-0001-8924-4447	Integrative Neuroscience Initiative on Alcoholism [U01AA13499, U24AA13513, U01AA014425]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [U01AA017590, U01AA016662, U01AA014425, U01AA013499] Funding Source: NIH RePORTER	Integrative Neuroscience Initiative on Alcoholism; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by Integrative Neuroscience Initiative on Alcoholism grants U01AA13499, U24AA13513, U01AA014425 (RWW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An JJ, 2008, CELL, V134, P175, DOI 10.1016/j.cell.2008.05.045; Behar TN, 2000, CEREB CORTEX, V10, P899, DOI 10.1093/cercor/10.9.899; Benovoy D, 2008, NUCLEIC ACIDS RES, V36, P4417, DOI 10.1093/nar/gkn409; Bing N, 2005, GENETICS, V170, P533, DOI 10.1534/genetics.105.041103; Blankenberg Daniel, 2010, Curr Protoc Mol Biol, VChapter 19, DOI 10.1002/0471142727.mb1910s89; Blankenberg D, 2010, BIOINFORMATICS, V26, P1783, DOI 10.1093/bioinformatics/btq281; Bottomly D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017820; Cacciagli P, 2010, EUR J HUM GENET, V18, P1360, DOI 10.1038/ejhg.2010.126; Chesler EJ, 2005, NAT GENET, V37, P233, DOI 10.1038/ng1518; Ciobanu DC, 2010, GENETICS, V184, P119, DOI 10.1534/genetics.109.107474; Clement AB, 2003, J NEUROSCI, V23, P3916; Coleman JA, 2009, J BIOL CHEM, V284, P32670, DOI 10.1074/jbc.M109.047415; Crestani F, 1999, NAT NEUROSCI, V2, P833, DOI 10.1038/12207; DAMERVAL C, 1994, GENETICS, V137, P289; de la Fuente A, 2004, BIOINFORMATICS, V20, P3565, DOI 10.1093/bioinformatics/bth445; DeLorey TM, 1998, J NEUROSCI, V18, P8505; Di Giammartino DC, 2011, MOL CELL, V43, P853, DOI 10.1016/j.molcel.2011.08.017; Friebe A, 2007, P NATL ACAD SCI USA, V104, P7699, DOI 10.1073/pnas.0609778104; Hajos N, 2000, EUR J NEUROSCI, V12, P3239, DOI 10.1046/j.1460-9568.2000.00217.x; Harvey BH, 2004, PSYCHOPHARMACOLOGY, V175, P494, DOI 10.1007/s00213-004-1836-4; Hashemi E, 2007, BRAIN RES, V1129, P191, DOI 10.1016/j.brainres.2006.10.050; Hofmann ME, 2011, J PHYSIOL-LONDON, V589, P3801, DOI 10.1113/jphysiol.2011.211482; Huang GJ, 2009, GENOME RES, V19, P1133, DOI 10.1101/gr.088120.108; Huen MSY, 2010, CELL CYCLE, V9, P2679, DOI 10.4161/cc.9.13.12151; Jin HC, 2007, P NATL ACAD SCI USA, V104, P12353, DOI 10.1073/pnas.0700153104; Jinno S, 2004, NEUROSCIENCE, V124, P797, DOI 10.1016/j.neuroscience.2004.01.027; Jones DL, 2007, J NEUROPHYSIOL, V98, P2737, DOI 10.1152/jn.00938.2007; Jones DL, 2009, J NEUROPHYSIOL, V102, P648, DOI 10.1152/jn.00392.2009; Katona I, 1999, J NEUROSCI, V19, P4544; Kholmanskikh SS, 2003, J NEUROSCI, V23, P8673; Kim J, 2010, NAT NEUROSCI, V13, P592, DOI 10.1038/nn.2517; Korostynski M, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-146; Krebs J, 2011, FRONT NEUROSCI-SWITZ, V5, DOI [10.3389/fnins.2011.00106, 10.3389/fnins.2011.00107]; Laughlin RE, 2011, BIOL PSYCHIAT, V69, P1109, DOI 10.1016/j.biopsych.2011.01.014; Li DP, 2002, J NEUROPHYSIOL, V88, P2664, DOI 10.1152/jn.00540.2002; Li ZS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012181; Liang X, 2006, MOL PSYCHIATR, V11, P280, DOI 10.1038/sj.mp.4001766; Liang XY, 2008, ANN HUM GENET, V72, P141, DOI 10.1111/j.1469-1809.2007.00394.x; LoTurco JJ, 2006, TRENDS NEUROSCI, V29, P407, DOI 10.1016/j.tins.2006.05.006; MCKINLEY DD, 1995, MOL BRAIN RES, V28, P175, DOI 10.1016/0169-328X(94)00228-7; Mercer TR, 2011, NUCLEIC ACIDS RES, V39, P2393, DOI 10.1093/nar/gkq1158; Miller JA, 2010, P NATL ACAD SCI USA, V107, P12698, DOI 10.1073/pnas.0914257107; Mozhui K, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000260; Musante L, 2004, GENE, V332, P119, DOI 10.1016/j.gene.2004.02.044; Nugent FS, 2007, NATURE, V446, P1086, DOI 10.1038/nature05726; Olsen RW, 2008, PHARMACOL REV, V60, P243, DOI 10.1124/pr.108.00505; Olsen RW, 2009, NEUROPHARMACOLOGY, V56, P141, DOI 10.1016/j.neuropharm.2008.07.045; Overall RW, 2009, FRONT NEUROSCI-SWITZ, V3, DOI 10.3389/neuro.15.003.2009; Park JB, 2005, NEURON, V45, P345, DOI 10.1016/j.neuron.2004.12.040; Philip VM, 2010, GENES BRAIN BEHAV, V9, P129, DOI 10.1111/j.1601-183X.2009.00540.x; Saba L, 2006, MAMM GENOME, V17, P669, DOI 10.1007/s00335-005-0190-0; Sacconi S, 2005, BIOCHEM BIOPH RES CO, V337, P832, DOI 10.1016/j.bbrc.2005.09.127; Sato S, 2004, MOL CELL, V14, P685, DOI 10.1016/j.molcel.2004.05.006; Seress L, 2002, EXP BRAIN RES, V147, P38, DOI 10.1007/s00221-002-1242-2; Sharma A, 2010, MOL BIOL CELL, V21, P650, DOI 10.1091/mbc.E09-02-0126; Shen QY, 2010, BIOL PSYCHIAT, V68, P512, DOI 10.1016/j.biopsych.2010.04.024; Stern JE, 2001, AM J PHYSIOL-REG I, V280, pR1815, DOI 10.1152/ajpregu.2001.280.6.R1815; Szabadits E, 2011, J NEUROSCI, V31, P5893, DOI 10.1523/JNEUROSCI.5938-10.2011; Thompson CL, 2008, NEURON, V60, P1010, DOI 10.1016/j.neuron.2008.12.008; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Tsou K, 1998, NEUROSCIENCE, V83, P393, DOI 10.1016/S0306-4522(97)00436-3; Tsuboi K, 2007, CHEM BIODIVERS, V4, P1914, DOI 10.1002/cbdv.200790159; Ueda N, 2001, J BIOL CHEM, V276, P35552, DOI 10.1074/jbc.M106261200; Ueda N, 2010, PROG LIPID RES, V49, P299, DOI 10.1016/j.plipres.2010.02.003; Walter NAR, 2007, NAT METHODS, V4, P679, DOI 10.1038/nmeth0907-679; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Webster JA, 2009, AM J HUM GENET, V84, P445, DOI 10.1016/j.ajhg.2009.03.011; WHITING P, 1990, P NATL ACAD SCI USA, V87, P9966, DOI 10.1073/pnas.87.24.9966; WILLIAMS CA, 1995, AM J MED GENET, V56, P237, DOI 10.1002/ajmg.1320560224; Wynn SL, 2000, GENOMICS, V68, P57, DOI 10.1006/geno.2000.6254; Yazdanpanah B, 2009, NATURE, V460, P1159, DOI 10.1038/nature08206; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475; Zhang HB, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-12-r100	73	40	42	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2012	7	4							e34586	10.1371/journal.pone.0034586	http://dx.doi.org/10.1371/journal.pone.0034586			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959FE	22506031	Green Published, gold, Green Submitted			2022-12-27	WOS:000305297500039
J	Shenoy, S; Shekhar, P; Heinrich, F; Daou, MC; Gericke, A; Ross, AH; Losche, M				Shenoy, Siddharth; Shekhar, Prabhanshu; Heinrich, Frank; Daou, Marie-Claire; Gericke, Arne; Ross, Alonzo H.; Loesche, Mathias			Membrane Association of the PTEN Tumor Suppressor: Molecular Details of the Protein-Membrane Complex from SPR Binding Studies and Neutron Reflection	PLOS ONE			English	Article							BILAYER-LIPID MEMBRANES; X-RAY; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; ELECTROSTATIC INTERACTIONS; AUTISM; PHOSPHATASE; MUTATIONS; ACTIVATION; HOMOLOG; INDIVIDUALS	The structure and function of the PTEN phosphatase is investigated by studying its membrane affinity and localization on in-plane fluid, thermally disordered synthetic membrane models. The membrane association of the protein depends strongly on membrane composition, where phosphatidylserine (PS) and phosphatidylinositol diphosphate (PI(4,5)P-2) act pronouncedly synergistic in pulling the enzyme to the membrane surface. The equilibrium dissociation constants for the binding of wild type (wt) PTEN to PS and PI(4,5)P-2 were determined to be K-d similar to 12 mu M and 0.4 mu M, respectively, and K-d similar to 50 nM if both lipids are present. Membrane affinities depend critically on membrane fluidity, which suggests multiple binding sites on the protein for PI(4,5)P-2. The PTEN mutations C124S and H93R show binding affinities that deviate strongly from those measured for the wt protein. Both mutants bind PS more strongly than wt PTEN. While C124S PTEN has at least the same affinity to PI(4,5)P-2 and an increased apparent affinity to PI(3,4,5) P-3, due to its lack of catalytic activity, H93R PTEN shows a decreased affinity to PI(4,5)P-2 and no synergy in its binding with PS and PI(4,5)P-2. Neutron reflection measurements show that the PTEN phosphatase "scoots'' along the membrane surface (penetration <5 angstrom) but binds the membrane tightly with its two major domains, the C2 and phosphatase domains, as suggested by the crystal structure. The regulatory C-terminal tail is most likely displaced from the membrane and organized on the far side of the protein similar to 60 angstrom away from the bilayer surface, in a rather compact structure. The combination of binding studies and neutron reflection allows us to distinguish between PTEN mutant proteins and ultimately may identify the structural features required for membrane binding and activation of PTEN.	[Shenoy, Siddharth; Shekhar, Prabhanshu; Heinrich, Frank; Loesche, Mathias] Carnegie Mellon Univ, Dept Phys, Pittsburgh, PA 15213 USA; [Heinrich, Frank; Loesche, Mathias] NIST, Ctr Neutron Res, Gaithersburg, MD 20899 USA; [Daou, Marie-Claire; Ross, Alonzo H.] Univ Massachusetts, Sch Med, Dept Mol Pharmacol & Biochem, Worcester, MA USA; [Gericke, Arne] Worcester Polytech Inst, Dept Chem & Biochem, Worcester, MA 01609 USA; [Loesche, Mathias] Carnegie Mellon Univ, Dept Biomed Engn, Pittsburgh, PA 15213 USA	Carnegie Mellon University; National Institute of Standards & Technology (NIST) - USA; University of Massachusetts System; University of Massachusetts Worcester; Worcester Polytechnic Institute; Carnegie Mellon University	Shenoy, S (corresponding author), Carnegie Mellon Univ, Dept Phys, Pittsburgh, PA 15213 USA.	quench@cmu.edu	Heinrich, Frank/A-5339-2010; Lösche, Mathias/J-2986-2013	Heinrich, Frank/0000-0002-8579-553X; Lösche, Mathias/0000-0001-6666-916X; Gericke, Arne/0000-0002-3682-0241	National Institutes of Health [1R01 NS021716, 1P01 AG032131]; National Science Foundation [CHE 0724082, 1216827]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS021716] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG032131] Funding Source: NIH RePORTER; Division Of Chemistry [1216827] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Division Of Chemistry(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported by the National Institutes of Health (1R01 NS021716 and 1P01 AG032131) and National Science Foundation (CHE 0724082 and 1216827). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boccone L, 2006, AM J MED GENET A, V140A, P1965, DOI 10.1002/ajmg.a.31396; Butler MG, 2005, J MED GENET, V42, P318, DOI 10.1136/jmg.2004.024646; Campbell RB, 2003, J BIOL CHEM, V278, P33617, DOI 10.1074/jbc.C300296200; Catmull Edwin, 1974, COMPUT AIDED GEOM D, P317, DOI 10.1016/B978-0-12-079050-0.50020-5; CONNOLLY ML, 1983, SCIENCE, V221, P709, DOI 10.1126/science.6879170; Cornell BA, 1997, NATURE, V387, P580, DOI 10.1038/42432; Curtis JE, 2012, COMPUT PHYS COMMUN, V183, P382, DOI 10.1016/j.cpc.2011.09.010; Das S, 2003, P NATL ACAD SCI USA, V100, P7491, DOI 10.1073/pnas.0932835100; Di Cristofano A, 1999, SCIENCE, V285, P2122, DOI 10.1126/science.285.5436.2122; Di Cristofano A, 2000, CELL, V100, P387, DOI 10.1016/S0092-8674(00)80674-1; Dura JA, 2006, REV SCI INSTRUM, V77, DOI 10.1063/1.2219744; Goffin A, 2001, AM J MED GENET, V105, P521, DOI 10.1002/ajmg.1477; Golebiewska U, 2006, BIOPHYS J, V91, P588, DOI 10.1529/biophysj.106.081562; Groszer M, 2001, SCIENCE, V294, P2186, DOI 10.1126/science.1065518; Gupta R, 2002, PLANT CELL, V14, P2495, DOI 10.1105/tpc.005702; Heinrich F, 2009, LANGMUIR, V25, P4219, DOI 10.1021/la8033275; Herman GE, 2007, AM J MED GENET A, V143A, P589, DOI 10.1002/ajmg.a.31619; Huang YH, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002428; Janetopoulos C, 2005, DEV CELL, V8, P467, DOI 10.1016/j.devcel.2005.02.010; Ji SP, 2006, NAT MED, V12, P324, DOI 10.1038/nm1349; Kirby BJ, 2012, CURR OPIN COLLOID IN, V17, P44, DOI 10.1016/j.cocis.2011.11.001; Lee JO, 1999, CELL, V99, P323, DOI 10.1016/S0092-8674(00)81663-3; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; Li L, 2007, J CELL BIOCHEM, V102, P1368, DOI 10.1002/jcb.21593; Lingwood D, 2008, P NATL ACAD SCI USA, V105, P10005, DOI 10.1073/pnas.0804374105; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; McBride KL, 2010, AUTISM RES, V3, P137, DOI 10.1002/aur.132; McGillivray DJ, 2007, BIOINTERPHASES, V2, P21, DOI 10.1116/1.2709308; McGillivray DJ, 2009, BIOPHYS J, V96, P1547, DOI 10.1016/j.bpj.2008.11.020; Mitra P, 2004, J CELL BIOL, V166, P205, DOI 10.1083/jcb.200404150; Mutti NS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022195; Nanda H, 2010, BIOPHYS J, V99, P2516, DOI 10.1016/j.bpj.2010.07.062; Narayan K, 2006, METHODS, V39, P122, DOI 10.1016/j.ymeth.2006.05.006; Ogg S, 1998, MOL CELL, V2, P887, DOI 10.1016/S1097-2765(00)80303-2; Orrico A, 2009, CLIN GENET, V75, P195, DOI 10.1111/j.1399-0004.2008.01074.x; Rahdar M, 2009, P NATL ACAD SCI USA, V106, P480, DOI 10.1073/pnas.0811212106; Redfern RE, 2008, BIOCHEMISTRY-US, V47, P2162, DOI 10.1021/bi702114w; Redfern RE, 2010, PROTEIN SCI, V19, P1948, DOI 10.1002/pro.483; Ross AH, 2009, P NATL ACAD SCI USA, V106, P1297, DOI 10.1073/pnas.0812473106; Russell T. P., 1990, Material Science Reports, V5, P171, DOI 10.1016/S0920-2307(05)80002-7; Schalke M, 2000, ADV COLLOID INTERFAC, V88, P243, DOI 10.1016/S0001-8686(00)00047-6; Schasfoort RBM, HDB SURFACE PLASMON; Shekhar P, 2011, J APPL PHYS, V110, DOI 10.1063/1.3661986; Shenoy S, 2010, SOFT MATTER, V6, P1263, DOI 10.1039/b919988h; Simpson L, 2001, EXP CELL RES, V264, P29, DOI 10.1006/excr.2000.5130; Stein MT, 2010, J DEV BEHAV PEDIATR, V31, P632, DOI 10.1097/DBP.0b013e3181ef422a; Stiles BL, 2009, INT J BIOCHEM CELL B, V41, P757, DOI 10.1016/j.biocel.2008.09.022; VAKNIN D, 1991, BIOPHYS J, V59, P1325, DOI 10.1016/S0006-3495(91)82347-5; Valincius G, 2006, J PHYS CHEM B, V110, P10213, DOI 10.1021/jp0616516; Vockenroth IK, 2008, BIOINTERPHASES, V3, pFA68, DOI 10.1116/1.2912097; Wacklin HP, 2010, CURR OPIN COLLOID IN, V15, P445, DOI 10.1016/j.cocis.2010.05.008; Wang JY, 2002, J BIOL CHEM, V277, P34401, DOI 10.1074/jbc.M203954200; WIENER MC, 1991, BIOPHYS J, V59, P174, DOI 10.1016/S0006-3495(91)82209-3	53	57	57	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2012	7	4							e32591	10.1371/journal.pone.0032591	http://dx.doi.org/10.1371/journal.pone.0032591			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959FE	22505997	Green Published, gold, Green Submitted			2022-12-27	WOS:000305297500005
J	de Goede, J; Verschuren, WMM; Boer, JMA; Kromhout, D; Geleijnse, JM				de Goede, Janette; Verschuren, W. M. Monique; Boer, Jolanda M. A.; Kromhout, Daan; Geleijnse, Johanna M.			Gender-Specific Associations of Marine n-3 Fatty Acids and Fish Consumption with 10-Year Incidence of Stroke	PLOS ONE			English	Article							FOOD FREQUENCY QUESTIONNAIRE; RELATIVE VALIDITY; CARDIOVASCULAR-DISEASE; RISK; REPRODUCIBILITY; MEN; OMEGA-3-FATTY-ACIDS; MORTALITY; COHORT; HEALTH	Background: There is some evidence that the association of fish and marine fatty acids with stroke risk differs between men and women. We investigated the gender-specific associations of habitual intake of the marine fatty acids eicosapentaenoic acid (EPA) plus docosahexaenoic acid (DHA) and fish on incident stroke in a population-based study in the Netherlands. Methods: We prospectively followed 20,069 men and women, aged 20-65 years, without cardiovascular diseases at baseline. Habitual diet was assessed with a validated 178-item food frequency questionnaire. Incidence of stroke was assessed through linkage with mortality and morbidity registers. Cox proportional hazards models were used to estimate multivariable-adjusted hazard ratios (HR) and 95% confidence intervals (95% CI). Results: During 8-13 years of follow-up, 221 strokes occurred. In women, an inverse dose-response relation (P-trend = 0.02) was observed between EPA-DHA intake and incident stroke, with an HR of 0.49 (95% CI: 0.27-0.91) in the top quartile of EPA-DHA (median 225 mg/d) as compared to the bottom quartile (median 36 mg/d). In men, the HR (95% CI) for the top quartile of EPA-DHA intake was 0.87 (0.51-1.48) (P-trend = 0.36). Similar results were observed for fish consumption and stroke incidence. Conclusion: A higher EPA-DHA and fish intake is related to a lower stroke risk in women, while for men an inverse association could not be demonstrated.	[de Goede, Janette; Kromhout, Daan; Geleijnse, Johanna M.] Wageningen Univ, Div Human Nutr, Wageningen, Netherlands; [Verschuren, W. M. Monique; Boer, Jolanda M. A.] Natl Inst Publ Hlth & Environm, NL-3720 BA Bilthoven, Netherlands	Wageningen University & Research; Netherlands National Institute for Public Health & the Environment	de Goede, J (corresponding author), Wageningen Univ, Div Human Nutr, Wageningen, Netherlands.	Marianne.geleijnse@wur.nl	Geleijnse, Johanna Marianna M/B-5749-2012; Kromhout, Daan/A-8566-2014	Geleijnse, Johanna Marianna M/0000-0001-7638-0589; 	Ministry of Health, Welfare and Sport of the Netherlands (The Hague); National Institute for Public Health and the Environment (Bilthoven, The Netherlands); European Union	Ministry of Health, Welfare and Sport of the Netherlands (The Hague); National Institute for Public Health and the Environment (Bilthoven, The Netherlands)(Netherlands Government); European Union(European Commission)	The Monitoring Project on Risk Factors for Chronic Diseases (MORGEN study) was financially supported by the Ministry of Health, Welfare and Sport of the Netherlands (The Hague) and the National Institute for Public Health and the Environment (Bilthoven, The Netherlands), and the Europe Against Cancer Program of the European Union. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	DEBRUIN A, 2003, LINKING DATA NATL AM; Feigin VL, 2003, LANCET NEUROL, V2, P43, DOI 10.1016/S1474-4422(03)00266-7; Folsom AR, 2004, AM J EPIDEMIOL, V160, P1005, DOI 10.1093/aje/kwh307; Gillum RF, 1996, ARCH INTERN MED, V156, P537, DOI 10.1001/archinte.156.5.537; Goldstein LB, 2011, STROKE, V42, P517, DOI 10.1161/STR.0b013e3181fcb238; He K, 2004, STROKE, V35, P1538, DOI 10.1161/01.STR.0000130856.31468.47; He K, 2002, JAMA-J AM MED ASSOC, V288, P3130, DOI 10.1001/jama.288.24.3130; HOEVENAARBLOM MP, 2010, EUR J CARDIOVASC PRE; Iso H, 2001, JAMA-J AM MED ASSOC, V285, P304, DOI 10.1001/jama.285.3.304; KELI SO, 1994, STROKE, V25, P328, DOI 10.1161/01.STR.25.2.328; Larsson SC, 2011, AM J CLIN NUTR, V93, P487, DOI 10.3945/ajcn.110.002287; Lichtenstein AH, 2006, CIRCULATION, V114, P82, DOI 10.1161/CIRCULATIONAHA.106.176158; Montonen J, 2009, BRIT J NUTR, V102, P750, DOI 10.1017/S0007114509274782; MORRIS MC, 1995, AM J EPIDEMIOL, V142, P166, DOI 10.1093/oxfordjournals.aje.a117615; Mozaffarian D, 2006, JAMA-J AM MED ASSOC, V296, P1885, DOI 10.1001/jama.296.15.1885; Murray CJL, 2008, GLOBAL BURDEN DIS 20; Myint PK, 2006, PUBLIC HEALTH NUTR, V9, P882, DOI 10.1017/PHN2006942; Ocke MC, 1997, INT J EPIDEMIOL, V26, pS37, DOI 10.1093/ije/26.suppl_1.S37; Ocke MC, 1997, INT J EPIDEMIOL, V26, pS49, DOI 10.1093/ije/26.suppl_1.S49; Orencia AJ, 1996, STROKE, V27, P204, DOI 10.1161/01.STR.27.2.204; Overby NC, 2009, BRIT J NUTR, V102, pS56, DOI 10.1017/S000711450999314X; Pols MA, 1997, INT J EPIDEMIOL, V26, pS181, DOI 10.1093/ije/26.suppl_1.S181; Reimer WJMSO, 2006, STROKE, V37, P1844, DOI 10.1161/01.STR.0000226463.17988.a3; Riboli E, 1997, INT J EPIDEMIOL, V26, pS6, DOI 10.1093/ije/26.suppl_1.S6; Sauvaget C, 2003, INT J EPIDEMIOL, V32, P536, DOI 10.1093/ije/dyg151; Verschuren WMM, 2008, INT J EPIDEMIOL, V37, P1236, DOI 10.1093/ije/dym292; Wang CC, 2006, AM J CLIN NUTR, V84, P5, DOI 10.1093/ajcn/84.1.5; Wennberg M, 2007, BRIT J NUTR, V98, P1038, DOI 10.1017/S0007114507756519; Yuan JM, 2001, AM J EPIDEMIOL, V154, P809, DOI 10.1093/aje/154.9.809	29	21	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2012	7	4							e33866	10.1371/journal.pone.0033866	http://dx.doi.org/10.1371/journal.pone.0033866			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JO	22496770	Green Published, gold			2022-12-27	WOS:000305014500019
J	Haspot, F; Lavault, A; Sinzger, C; Sampaio, KL; Stierhof, YD; Pilet, P; Bressolette-Bodin, C; Halary, F				Haspot, Fabienne; Lavault, Amelie; Sinzger, Christian; Sampaio, Kerstin Laib; Stierhof, York-Dieter; Pilet, Paul; Bressolette-Bodin, Celine; Halary, Franck			Human Cytomegalovirus Entry into Dendritic Cells Occurs via a Macropinocytosis-Like Pathway in a pH-Independent and Cholesterol-Dependent Manner	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; EPSTEIN-BARR-VIRUS; HEPATITIS-C VIRUS; DC-SIGN; ENDOTHELIAL-CELLS; TRANS-INFECTION; T-CELLS; ANTIGEN PRESENTATION; EPITHELIAL-CELLS; ANNEXIN-II	Human cytomegalovirus (HCMV) is a ubiquitous herpesvirus that is able to infect fibroblastic, epithelial, endothelial and hematopoietic cells. Over the past ten years, several groups have provided direct evidence that dendritic cells (DCs) fully support the HCMV lytic cycle. We previously demonstrated that the C-type lectin dendritic cell-specific intercellular adhesion molecule-3-grabbing non-integrin (DC-SIGN) has a prominent role in the docking of HCMV on monocyte-derived DCs (MDDCs). The DC-SIGN/HCMV interaction was demonstrated to be a crucial and early event that substantially enhanced infection in trans, i.e., from one CMV-bearing cell to another non-infected cell (or trans-infection), and rendered susceptible cells fully permissive to HCMV infection. Nevertheless, nothing is yet known about how HCMV enters MDDCs. In this study, we demonstrated that VHL/E HCMV virions (an endothelio/dendrotropic strain) are first internalized into MDDCs by a macropinocytosis-like process in an actin-and cholesterol-dependent, but pH-independent, manner. We observed the accumulation of virions in large uncoated vesicles with endosomal features, and the virions remained as intact particles that retained infectious potential for several hours. This trans-infection property was specific to MDDCs because monocyte-derived macrophages or monocytes from the same donor were unable to allow the accumulation of and the subsequent transmission of the virus. Together, these data allowed us to delineate the early mechanisms of the internalization and entry of an endothelio/dendrotropic HCMV strain into human MDDCs and to propose that DCs can serve as a "Trojan horse" to convey CMV from entry sites to other locations that may favor the occurrence of either latency or acute infection.	[Haspot, Fabienne; Lavault, Amelie; Halary, Franck] Inst Transplantat Urol & Nephrol ITUN, Inst Natl Sante & Rech Med, Unite Mixte Rech S 1064 Ex643, Nantes, France; [Haspot, Fabienne; Lavault, Amelie; Pilet, Paul; Bressolette-Bodin, Celine; Halary, Franck] Univ Nantes, Unite Format & Rech Med Pharmacie, Nantes, France; [Haspot, Fabienne; Lavault, Amelie; Bressolette-Bodin, Celine; Halary, Franck] CHU Nantes, F-44035 Nantes 01, France; [Sinzger, Christian; Sampaio, Kerstin Laib] Eberhard Karls Univ Tubingen, Inst Med Virol & Epidemiol Viral Dis, Tubingen, Germany; [Stierhof, York-Dieter] Eberhard Karls Univ Tubingen, Ctr Mol Biol Plants, Tubingen, Germany; [Pilet, Paul] Inst Natl Sante & Rech Med, Unite Mixte Rech 791, Nantes, France; [Bressolette-Bodin, Celine] Univ Nantes, Equipe Accueil 4271, Nantes, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; Nantes Universite; CHU de Nantes; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite	Haspot, F (corresponding author), Inst Transplantat Urol & Nephrol ITUN, Inst Natl Sante & Rech Med, Unite Mixte Rech S 1064 Ex643, Nantes, France.	franck.halary@univ-nantes.fr	HASPOT, Fabienne/AAD-5698-2021; halary, franck/AAR-9437-2020; Halary, Franck/B-3782-2017; Bressollette-Bodin, Celine/C-8780-2012	halary, franck/0000-0003-0336-9615; Halary, Franck/0000-0003-0336-9615; Haspot, Fabienne/0000-0003-0513-1387	Roche Organ Transplantation and Research Foundation (ROTRF, Basel, Switzerland) [705613444]; Region Pays de la Loire Aquitaine	Roche Organ Transplantation and Research Foundation (ROTRF, Basel, Switzerland); Region Pays de la Loire Aquitaine(Region Pays de la Loire)	This work was supported by the Roche Organ Transplantation and Research Foundation (Fabienne Haspot's salary; project no. 705613444, ROTRF, Basel, Switzerland) and by the Region Pays de la Loire Aquitaine (A. Lavault's salary). The funders had no role in the study design, the data collection and analysis, the decision to publish, or the preparation of the manuscript.	BEERSMA MFC, 1992, CURR EYE RES, V11, P141, DOI 10.3109/02713689208999524; BEERSMA MFC, 1991, J GEN VIROL, V72, P2757, DOI 10.1099/0022-1317-72-11-2757; Bodaghi B, 1999, INVEST OPHTH VIS SCI, V40, P2598; Bressollette-Bodin C, 2009, J MED VIROL, V81, P90, DOI 10.1002/jmv.21334; Cambi A, 2004, J CELL BIOL, V164, P145, DOI 10.1083/jcb.200306112; COMPTON T, 1992, VIROLOGY, V191, P387, DOI 10.1016/0042-6822(92)90200-9; COMPTON T, 1993, VIROLOGY, V193, P834, DOI 10.1006/viro.1993.1192; Cormier EG, 2004, P NATL ACAD SCI USA, V101, P14067, DOI 10.1073/pnas.0405695101; Dominguez-Soto A, 2007, BLOOD, V109, P5337, DOI 10.1182/blood-2006-09-048058; DOWRICK P, 1993, EUR J CELL BIOL, V61, P44; Engering A, 2002, J IMMUNOL, V168, P2118, DOI 10.4049/jimmunol.168.5.2118; Falcone S, 2006, J CELL SCI, V119, P4758, DOI 10.1242/jcs.03238; Feire AL, 2004, P NATL ACAD SCI USA, V101, P15470, DOI 10.1073/pnas.0406821101; Fleetwood AJ, 2009, J LEUKOCYTE BIOL, V86, P411, DOI 10.1189/jlb.1108702; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; Gerna G, 2005, J GEN VIROL, V86, P275, DOI 10.1099/vir.0.80474-0; Giugni TD, 1996, J INFECT DIS, V173, P1062, DOI 10.1093/infdis/173.5.1062; Halary F, 2002, IMMUNITY, V17, P653, DOI 10.1016/S1074-7613(02)00447-8; HEWLETT LJ, 1994, J CELL BIOL, V124, P689, DOI 10.1083/jcb.124.5.689; Isaacson MK, 2007, J VIROL, V81, P6241, DOI 10.1128/JVI.00169-07; Koopman M, 2004, FEBS LETT, V573, P6, DOI 10.1016/j.febslet.2004.07.035; Lakhan SE, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-93; Lim J. P., 2011, IMMUNOL CELL BIOL; Ludwig IS, 2004, J VIROL, V78, P8322, DOI 10.1128/jvi.78.15.8322-8332.2004; Marsh M, 2006, CELL, V124, P729, DOI 10.1016/j.cell.2006.02.007; MCGOOKEY DJ, 1983, J CELL BIOL, V96, P1273, DOI 10.1083/jcb.96.5.1273; MCKEATING JA, 1986, J MED VIROL, V18, P341, DOI 10.1002/jmv.1890180407; Mercer J, 2010, ANNU REV BIOCHEM, V79, P803, DOI 10.1146/annurev-biochem-060208-104626; Mercer J, 2009, NAT CELL BIOL, V11, P510, DOI 10.1038/ncb0509-510; NEMEROW GR, 1984, VIROLOGY, V132, P186, DOI 10.1016/0042-6822(84)90102-8; Neumann AK, 2008, J CELL SCI, V121, P634, DOI 10.1242/jcs.022418; Ogawa-Goto K, 2003, J VIROL, V77, P8541, DOI 10.1128/JVI.77.15.8541-8547.2003; Pietropaolo R, 1999, J GEN VIROL, V80, P1807, DOI 10.1099/0022-1317-80-7-1807; Plazolles N, 2010, J LEUKOC BIOL; Randolph GJ, 2005, NAT REV IMMUNOL, V5, P617, DOI 10.1038/nri1670; Riegler S, 2000, J GEN VIROL, V81, P393, DOI 10.1099/0022-1317-81-2-393; Rodal SK, 1999, MOL BIOL CELL, V10, P961, DOI 10.1091/mbc.10.4.961; Ryckman BJ, 2006, J VIROL, V80, P710, DOI 10.1128/JVI.80.2.710-722.2006; Ryckman BJ, 2008, P NATL ACAD SCI USA, V105, P14118, DOI 10.1073/pnas.0804365105; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Sampaio KL, 2005, J VIROL, V79, P2754, DOI 10.1128/JVI.79.5.2754-2767.2005; Sarkar K, 2005, IMMUNOLOGY, V116, P513, DOI 10.1111/j.1365-2567.2005.02253.x; Sathish N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000332; Savina A, 2007, IMMUNOL REV, V219, P143, DOI 10.1111/j.1600-065X.2007.00552.x; Savina A, 2006, CELL, V126, P205, DOI 10.1016/j.cell.2006.05.035; Savina A, 2009, IMMUNITY, V30, P544, DOI 10.1016/j.immuni.2009.01.013; Scrivano L, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001256; Segura E, 2009, P NATL ACAD SCI USA, V106, P20377, DOI 10.1073/pnas.0910295106; Singh SK, 2009, MOL IMMUNOL, V47, P164, DOI 10.1016/j.molimm.2009.09.026; Sinzger C, 2008, CURR TOP MICROBIOL, V325, P63; Sinzger C, 2008, J CLIN VIROL, V41, P174, DOI 10.1016/j.jcv.2007.12.002; Sodeik B, 1997, J CELL BIOL, V136, P1007, DOI 10.1083/jcb.136.5.1007; SODERBERG C, 1993, J VIROL, V67, P6576; Straschewski S, 2011, J VIROL, V85, P5150, DOI 10.1128/JVI.02100-10; Tabarani G, 2009, J BIOL CHEM, V284, P21229, DOI 10.1074/jbc.M109.021204; Tacken PJ, 2011, BLOOD, V118, P4111, DOI 10.1182/blood-2011-04-346957; TALBOT P, 1977, J GEN VIROL, V36, P345, DOI 10.1099/0022-1317-36-2-345; Verreck FAW, 2004, P NATL ACAD SCI USA, V101, P4560, DOI 10.1073/pnas.0400983101; WALDMAN WJ, 1989, J MED VIROL, V28, P223; Wang D, 2007, P NATL ACAD SCI USA, V104, P20037, DOI 10.1073/pnas.0709704104; Wang X, 2005, NAT MED, V11, P515, DOI 10.1038/nm1236; Wang X, 2003, NATURE, V424, P456, DOI 10.1038/nature01818; WEST MA, 1989, J CELL BIOL, V109, P2731, DOI 10.1083/jcb.109.6.2731; Wiley RD, 2006, P NATL ACAD SCI USA, V103, P738, DOI 10.1073/pnas.0507995103; Wille PT, 2010, J VIROL, V84, P2585, DOI 10.1128/JVI.02249-09; WRIGHT JF, 1995, J VIROL, V69, P4784, DOI 10.1128/JVI.69.8.4784-4791.1995; Yu HJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000134	67	58	61	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2012	7	4							e34795	10.1371/journal.pone.0034795	http://dx.doi.org/10.1371/journal.pone.0034795			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JO	22496863	Green Submitted, Green Published, gold			2022-12-27	WOS:000305014500031
J	Johnson, HM; Piper, ME; Baker, TB; Fiore, MC; Stein, JH				Johnson, Heather M.; Piper, Megan E.; Baker, Timothy B.; Fiore, Michael C.; Stein, James H.			Effects of Smoking and Cessation on Subclinical Arterial Disease: A Substudy of a Randomized Controlled Trial	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; CIGARETTE-SMOKING; RISK; PATHOPHYSIOLOGY; EVENTS	Background: The mechanisms by which smoking cessation reduces cardiovascular disease risk are unclear. We evaluated longitudinal changes in carotid intima-media thickness among current smokers enrolled in a prospective, randomized smoking cessation clinical trial. Methodology/Principal Findings: Subjects were enrolled in a randomized, double-blind, placebo-controlled trial of 5 smoking cessation pharmacotherapies and underwent carotid ultrasonography with carotid intima-media thickness measurement. Subjects were classified as continuously abstinent (biochemically confirmed abstinence at 6 months, 1 year, and 3 years post-quit attempt), intermittently abstinent (reported smoking at one of the three time points), or smoked continuously (reported smoking at all three time points). The primary endpoint was the absolute change (mm) in carotid intima-media thickness (Delta CIMTmax) before randomization and 3 years after the target quit date. Pearson correlations were calculated and multivariable regression models (controlling for baseline CIMTmax and research site) were analyzed. Among 795 subjects (45.2+/-10.6 years old, 58.5% female), 189 (23.8%) were continuously abstinent, 373 (46.9%) smoked continuously, and 233 (29.3%) were abstinent intermittently. There was a greater increase in carotid intima-media thickness among subjects who were continuously abstinent than among those who smoked continuously (p = 0.020), but not intermittently (p = 0.310). Antihypertensive medication use (p = 0.001) and research site (p, 0.001) independently predicted Delta CIMTmax -not smoking status. The greatest increase in carotid intima-media thickness among continuous abstainers was related to increases in body-mass index (p = 0.043). Conclusions/Significance: Smoking status did not independently predict Delta CIMTmax; increasing body-mass index and antihypertensive medication use were the most important independent predictors. The rapid reduction in cardiovascular disease events observed with smoking cessation is unlikely to be mediated by changes in subclinical atherosclerosis burden.	[Johnson, Heather M.; Piper, Megan E.; Baker, Timothy B.; Fiore, Michael C.; Stein, James H.] Univ Wisconsin, Dept Med, Sch Med & Publ Hlth, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Johnson, HM (corresponding author), Univ Wisconsin, Dept Med, Sch Med & Publ Hlth, Madison, WI 53706 USA.	jhs@medicine.wisc.edu		Johnson, Heather/0000-0002-4916-3519; Stein, James/0000-0002-2770-8223	National Institutes of Health [P50 DA019706, T32 HL07936, K05 CA139871]; Pfizer; GlaxoSmithKline; Nabi; NATIONAL CANCER INSTITUTE [K05CA139871] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025011] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL109031, T32HL007936] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P50DA019706] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pfizer(Pfizer); GlaxoSmithKline(GlaxoSmithKline); Nabi; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research was supported by the National Institutes of Health (P50 DA019706, T32 HL07936, and K05 CA139871). Medications were provided under a research agreement with GlaxoSmithKline. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; HJ, MP, TB, and JS have no conflicts to disclose. Over the last three years, MF has served as an investigator in research studies at the University of Wisconsin that were funded wholly or in part by Pfizer, GlaxoSmithKline and Nabi. From 1997 to 2010, MF held a University of Wisconsin named Chair for the Study of Tobacco Dependence, made possible by a gift to University of Wisconsin from GlaxoWellcome. Medications for the study were provided under a research agreement with GlaxoSmithKline. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Ambrose JA, 2004, J AM COLL CARDIOL, V43, P1731, DOI 10.1016/j.jacc.2003.12.047; Asthana A, 2010, AM HEART J, V160, P458, DOI 10.1016/j.ahj.2010.06.006; Bakhru A, 2005, PLOS MED, V2, P528, DOI 10.1371/journal.pmed.0020160; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Benowitz NL, 2003, PROG CARDIOVASC DIS, V46, P91, DOI 10.1016/S0033-0620(03)00087-2; Chow CK, 2010, CIRCULATION, V121, P750, DOI 10.1161/CIRCULATIONAHA.109.891523; Critchley JA, 2003, JAMA-J AM MED ASSOC, V290, P86, DOI 10.1001/jama.290.1.86; Gepner AD, 2011, AM HEART J, V161, DOI 10.1016/j.ahj.2010.09.023; Howard G, 1998, JAMA-J AM MED ASSOC, V279, P119, DOI 10.1001/jama.279.2.119; Johnson Heather M, 2010, Prev Cardiol, V13, P166, DOI 10.1111/j.1751-7141.2010.00068.x; Johnson HM, 2010, J AM COLL CARDIOL, V55, P1988, DOI 10.1016/j.jacc.2010.03.002; Kramer A, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-262; MacKinnon DP, 2002, PSYCHOL METHODS, V7, P83, DOI 10.1037/1082-989X.7.1.83; Piper ME, 2009, ARCH GEN PSYCHIAT, V66, P1253, DOI 10.1001/archgenpsychiatry.2009.142; Stein JH, 2008, J AM SOC ECHOCARDIOG, V21, P93, DOI 10.1016/j.echo.2007.11.011	15	13	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2012	7	4							e35332	10.1371/journal.pone.0035332	http://dx.doi.org/10.1371/journal.pone.0035332			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JO	22496918	gold, Green Published, Green Submitted			2022-12-27	WOS:000305014500056
J	Kaittanis, C; Boukhriss, H; Santra, S; Naser, SA; Perez, JM				Kaittanis, Charalambos; Boukhriss, Hamza; Santra, Santimukul; Naser, Saleh A.; Perez, J. Manuel			Rapid and Sensitive Detection of an Intracellular Pathogen in Human Peripheral Leukocytes with Hybridizing Magnetic Relaxation Nanosensors	PLOS ONE			English	Article							AVIUM SUBSPECIES PARATUBERCULOSIS; POLYMERASE-CHAIN-REACTION; CROHNS-DISEASE; MYCOBACTERIUM-PARATUBERCULOSIS; TISSUE; DNA; NANOTECHNOLOGY; NANOPARTICLES; TELOMERASE; BACTERIA	Bacterial infections are still a major global healthcare problem. The quick and sensitive detection of pathogens responsible for these infections would facilitate correct diagnosis of the disease and expedite treatment. Of major importance are intracellular slow-growing pathogens that reside within peripheral leukocytes, evading recognition by the immune system and detection by traditional culture methods. Herein, we report the use of hybridizing magnetic nanosensors (hMRS) for the detection of an intracellular pathogen, Mycobacterium avium spp. paratuberculosis (MAP). The hMRS are designed to bind to a unique genomic sequence found in the MAP genome, causing significant changes in the sample's magnetic resonance signal. Clinically relevant samples, including tissue and blood, were screened with hMRS and results were compared with traditional PCR analysis. Within less than an hour, the hMRS identified MAP-positive samples in a library of laboratory cultures, clinical isolates, blood and homogenized tissues. Comparison of the hMRS with culture methods in terms of prediction of disease state revealed that the hMRS outperformed established culture methods, while being significantly faster (1 hour vs 12 weeks). Additionally, using a single instrument and one nanoparticle preparation we were able to detect the intracellular bacterial target in clinical samples at the genomic and epitope levels. Overall, since the nanoparticles are robust in diverse environmental settings and substantially more affordable than PCR enzymes, the potential clinical and field-based use of hMRS in the multiplexed identification of microbial pathogens and other disease-related biomarkers via a single, deployable instrument in clinical and complex environmental samples is foreseen.	[Kaittanis, Charalambos; Boukhriss, Hamza; Santra, Santimukul; Perez, J. Manuel] Univ Cent Florida, NanoSci Technol Ctr, Orlando, FL 32816 USA; [Naser, Saleh A.; Perez, J. Manuel] Univ Cent Florida, Burnett Sch Biomed Sci, Coll Med, Orlando, FL 32816 USA; [Perez, J. Manuel] Univ Cent Florida, Dept Chem, Orlando, FL 32816 USA	State University System of Florida; University of Central Florida; State University System of Florida; University of Central Florida; State University System of Florida; University of Central Florida	Kaittanis, C (corresponding author), Univ Cent Florida, NanoSci Technol Ctr, Orlando, FL 32816 USA.	jmperez@ucf.edu			National Institute of General Medical Sciences [GM084331]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084331] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institute of General Medical Sciences GM084331 grant awarded to JMP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bancroft EA, 2007, JAMA-J AM MED ASSOC, V298, P1803, DOI 10.1001/jama.298.15.1803; Batt CA, 2007, SCIENCE, V316, P1579, DOI 10.1126/science.1140729; CHIODINI RJ, 1986, J CLIN MICROBIOL, V24, P357, DOI 10.1128/JCM.24.3.357-363.1986; CHIODINI RJ, 1989, CLIN MICROBIOL REV, V2, P90, DOI 10.1128/CMR.2.1.90-117.1989; COCITO C, 1994, CLIN MICROBIOL REV, V7, P328, DOI 10.1128/CMR.7.3.328-345.1994; Crohn BB, 1932, J AMER MED ASSOC, V99, P1323, DOI 10.1001/jama.1932.02740680019005; Cutler JI, 2011, J AM CHEM SOC, V133, P9254, DOI 10.1021/ja203375n; Dalziel TK, 1913, BRIT MED J, V1913, P1068; Engelberg-Kulka H, 2006, PLOS GENET, V2, P1518, DOI 10.1371/journal.pgen.0020135; Fang Y, 2002, J CLIN MICROBIOL, V40, P287, DOI 10.1128/JCM.40.1.287-291.2002; Ferrari M, 2005, NAT REV CANCER, V5, P161, DOI 10.1038/nrc1566; Gao JH, 2009, ACCOUNTS CHEM RES, V42, P1097, DOI 10.1021/ar9000026; Gao LZ, 2007, NAT NANOTECHNOL, V2, P577, DOI 10.1038/nnano.2007.260; Gaster RS, 2011, NAT NANOTECHNOL, V6, P314, DOI [10.1038/NNANO.2011.45, 10.1038/nnano.2011.45]; GREEN EP, 1989, NUCLEIC ACIDS RES, V17, P9063, DOI 10.1093/nar/17.22.9063; GREENSTEIN RJ, 1995, MOL MED TODAY, V1, P343, DOI 10.1016/S1357-4310(95)80034-4; Grimm J, 2004, CANCER RES, V64, P639, DOI 10.1158/0008-5472.CAN-03-2798; Grossman HL, 2004, P NATL ACAD SCI USA, V101, P129, DOI 10.1073/pnas.0307128101; Haun JB, SCI TRANSL MED, V3; Hiratsuka S, 2006, NAT CELL BIOL, V8, P1369, DOI 10.1038/ncb1507; Homolka S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000988; Jain KK, 2005, CLIN CHIM ACTA, V358, P37, DOI 10.1016/j.cccn.2005.03.014; Kaittanis C, 2007, NANO LETT, V7, P380, DOI 10.1021/nl062553z; Kaittanis C, 2011, J AM CHEM SOC, V133, P3668, DOI 10.1021/ja1109584; Kaittanis C, 2010, ADV DRUG DELIVER REV, V62, P408, DOI 10.1016/j.addr.2009.11.013; Kaittanis C, 2009, J AM CHEM SOC, V131, P12780, DOI 10.1021/ja9041077; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Laurent S, 2010, FUTURE MED CHEM, V2, P427, DOI [10.4155/fmc.09.164, 10.4155/FMC.09.164]; LISBY G, 1994, SCAND J GASTROENTERO, V29, P923, DOI 10.3109/00365529409094864; Morgan RA, 2006, SCIENCE, V314, P126, DOI 10.1126/science.1129003; Naser SA, 2004, LANCET, V364, P1039, DOI 10.1016/S0140-6736(04)17058-X; Naser SA, 2002, MOL CELL PROBE, V16, P41, DOI 10.1006/mcpr.2001.0395; Perez JM, 2008, NEOPLASIA, V10, P1066, DOI 10.1593/neo.08350; Pierce ES, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000234; Romero C, 2005, INFLAMM BOWEL DIS, V11, P116, DOI 10.1097/00054725-200502000-00004; Rosi NL, 2005, CHEM REV, V105, P1547, DOI 10.1021/cr030067f; SANDERSON JD, 1992, GUT, V33, P890, DOI 10.1136/gut.33.7.890; Seela F, 2007, NUCLEOS NUCLEOT NUCL, V26, P597, DOI 10.1080/15257770701490308; Taubes G, 2008, SCIENCE, V321, P356, DOI 10.1126/science.321.5887.356; Wang SX, 2008, IEEE T MAGN, V44, P1687, DOI 10.1109/TMAG.2008.920962	40	13	17	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2012	7	4							e35326	10.1371/journal.pone.0035326	http://dx.doi.org/10.1371/journal.pone.0035326			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JO	22496916	gold, Green Published, Green Submitted			2022-12-27	WOS:000305014500054
J	Balme, GA; Hunter, L; Braczkowski, AR				Balme, Guy Andrew; Hunter, Luke; Braczkowski, Alex Richard			Applicability of Age-Based Hunting Regulations for African Leopards	PLOS ONE			English	Article							CONSERVATION; RELIABILITY; POPULATION; DYNAMICS; IMPACT; LION	In species in which juvenile survival depends strongly on male tenure, excessive trophy hunting can artificially elevate male turnover and increase infanticide, potentially to unsustainable levels. Simulation models show that the likelihood of safe harvests can be improved by restricting offtakes to males old enough to have reared their first cohort of offspring to independence; in the case of African leopards, males were >= 7 years old. Here, we explore the applicability of an age-based approach for regulating trophy hunting of leopards. We conducted a structured survey comprising photographs of known-age leopards to assess the ability of wildlife practitioners to sex and age leopards. We also evaluated the utility of four phenotypic traits for use by trophy hunters to age male leopards in the field. Our logistic regression models showed that male leopard age affected the likelihood of survey respondents identifying the correct sex; notably, males <2 years were typically misidentified as females, while mature males (>= 4 years) were sexed correctly. Mature male leopards were also more likely to be aged correctly, as were portrait photographs. Aging proficiency was also influenced by the profession of respondents, with hunters recording the lowest scores. A discriminant model including dewlap size, the condition of the ears, and the extent of facial scarring accurately discriminated among male leopard age classes. Model classification rates were considerably higher than the respective scores attained by survey respondents, implying that the aging ability of hunters could theoretically improve with appropriate training. Dewlap size was a particularly reliable indicator of males >= 7 years and a review of online trophy galleries suggested its wider utility as an aging criterion. Our study demonstrated that an age-based hunting approach is practically applicable for leopards. However, implementation would require major reform within the regulatory framework and the hunting industry.	[Balme, Guy Andrew; Hunter, Luke] Panthera, New York, NY USA; [Braczkowski, Alex Richard] Univ Oxford, Dept Zool, Wildlife Conservat Res Unit, Oxford OX1 3PS, England	University of Oxford	Balme, GA (corresponding author), Panthera, New York, NY USA.	gbalme@panthera.org	Hunter, Luke T.B./H-3324-2019	Hunter, Luke T.B./0000-0001-9653-6544; Braczkowski, Alexander/0000-0002-0099-7803				[Anonymous], 2005, AFRICAN LEOPARD ECOL; Balme GA, 2012, S AFR J WIL IN PRESS; Balme GA, 2009, THESIS DURBAN U KWAZ; Balme GA, 2012, MAMM REV IN PRESS; Balme Guy A., 2010, P341; Balme GA, 2009, BIOL CONSERV, V142, P2681, DOI 10.1016/j.biocon.2009.06.020; Balme GA, 2009, J WILDLIFE MANAGE, V73, P433, DOI 10.2193/2007-368; Begg CM, 2007, TROPHY MONITORING NI; Booth V., 2009, COMPARISON PRICES HU; Caro TM, 2009, BIOL CONSERV, V142, P909, DOI 10.1016/j.biocon.2008.12.018; Caro TM, 1998, AFR J ECOL, V36, P321, DOI 10.1046/j.1365-2028.1998.00146.x; Cooley HS, 2009, ECOLOGY, V90, P2913, DOI 10.1890/08-1805.1; Costello CM, 2004, WILDLIFE SOC B, V32, P169, DOI 10.2193/0091-7648(2004)32[169:ROTCAT]2.0.CO;2; Crooks KR, 1998, CONSERV BIOL, V12, P889, DOI 10.1046/j.1523-1739.1998.97054.x; Daly B., 2005, CONSERVATION BREEDIN; Gaona P, 1998, ECOL MONOGR, V68, P349, DOI 10.1890/0012-9615(1998)068[0349:DAVOAM]2.0.CO;2; Garel M, 2005, WILDLIFE BIOL, V11, P229, DOI 10.2981/0909-6396(2005)11[229:ROMAUM]2.0.CO;2; Garel M, 2005, ACTA THERIOL, V50, P109, DOI 10.1007/BF03192623; Grant WM, 2008, INTO THORNS HUNTING; Harshyne WA, 1998, J WILDLIFE MANAGE, V62, P1281, DOI 10.2307/3801992; Henschel P, 2011, J ZOOL, V285, P11, DOI 10.1111/j.1469-7998.2011.00826.x; Henschel P., 2008, IUCN RED LIST THREAT; HOEFS M, 1984, J WILDLIFE MANAGE, V48, P980, DOI 10.2307/3801451; Hunter LTB, 2012, MAMMALS AFR IN PRESS, V5; LESSELLS CM, 1987, AUK, V104, P116, DOI 10.2307/4087240; Lindsey PA, 2007, BIOL CONSERV, V134, P455, DOI 10.1016/j.biocon.2006.09.005; Lindsey PA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029332; Logan K.A., 2001, DESERT PUMA EVOLUTIO; Loveridge AJ, 2007, BIOL CONSERV, V134, P548, DOI 10.1016/j.biocon.2006.09.010; Loveridge A.J., 2006, KEY TOPICS CONSERVAT, P224; Milner-Gulland E.J., 2009, RECREATIONAL HUNTING, P75, DOI 10.1002/9781444303179; Olifiers N, 2010, WILDLIFE BIOL, V16, P389, DOI 10.2981/09-104; Packer C, 2011, CONSERV BIOL, V25, P142, DOI 10.1111/j.1523-1739.2010.01576.x; Packer C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005941; Purchase G., 2008, STATE KNOWLEDGE REGA; Ray J.C., 2005, 24 WILDL CONS SOC; Smith RJ, 2003, NATURE, V426, P67, DOI 10.1038/nature02025; Soares FS, 2011, ASIAN AUSTRAL J ANIM, V24, P1587, DOI 10.5713/ajas.2011.11070; Spong Goran, 2000, Conservation Genetics, V1, P169, DOI 10.1023/A:1026543308136; Stander PE, 1997, AFR J ECOL, V35, P156, DOI 10.1111/j.1365-2028.1997.068-89068.x; Stein AB, 2011, AFR J ECOL, V49, P383, DOI 10.1111/j.1365-2028.2011.01267.x; Sunquist ME, 2002, WILD CATS WORLD; Whitman K, 2004, NATURE, V428, P175, DOI 10.1038/nature02395; Whitman K. L., 2007, HUNTERS GUIDE AGING; Whitman KL, 2007, CONSERV BIOL, V21, P591, DOI 10.1111/j.1523-1739.2007.00700.x; Zar J.H., 2009, BIOSTATISTICAL ANAL	46	59	59	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2012	7	4							e35209	10.1371/journal.pone.0035209	http://dx.doi.org/10.1371/journal.pone.0035209			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JA	22493739	Green Submitted, Green Published, gold			2022-12-27	WOS:000305012700081
J	Jensen, MA; Jauregui, L; Davis, RW				Jensen, Michael A.; Jauregui, Lauren; Davis, Ronald W.			A Rapid, Cost-Effective Method of Assembly and Purification of Synthetic DNA Probes > 100 bp	PLOS ONE			English	Article							LIGATION	Here we introduce a rapid, cost-effective method of generating molecular DNA probes in just under 15 minutes without the need for expensive, time-consuming gel-extraction steps. As an example, we enzymatically concatenated six variable strands (50 bp) with a common strand sequence (51 bp) in a single pool using Fast-Link DNA ligase to produce 101 bp targets (10 min). Unincorporated species were then filtered out by passing the crude reaction through a size-exclusion column (<5 min). We then compared full-length product yield of crude and purified samples using HPLC analysis; the results of which clearly show our method yields three-quarters that of the crude sample (50% higher than by gel-extraction). And while we substantially reduced the amount of unligated product with our filtration process, higher purity and yield, with an increase in number of stands per reaction (>12) could be achieved with further optimization. Moreover, for large-scale assays, we envision this method to be fully automated with the use of robotics such as the Biomek FX; here, potentially thousands of samples could be pooled, ligated and purified in either a 96, 384 or 1536-well platform in just minutes.	[Jensen, Michael A.; Jauregui, Lauren; Davis, Ronald W.] Stanford Genome Technol Ctr, Palo Alto, CA USA	Stanford University	Jensen, MA (corresponding author), Stanford Genome Technol Ctr, Palo Alto, CA USA.	m.a.jensen@stanford.edu			National Institutes of Health [PO1 HG000205, RC2 HG005570-01]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P01HG000205, RC2HG005570] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	Research for this manuscript was funded by the following grants from the National Institutes of Health (www.nih.gov): PO1 HG000205 to Michael Jensen and Ronald Davis and RC2 HG005570-01 to Lauren Jauregui and Ronald Davis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhras MS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000223; Borodina TA, 2003, ANAL BIOCHEM, V318, P309, DOI 10.1016/S0003-2697(03)00250-1; Dahl F, 2007, P NATL ACAD SCI USA, V104, P9387, DOI 10.1073/pnas.0702165104; Fredriksson S, 2007, NAT METHODS, V4, P327, DOI 10.1038/NMETH1020; Garcia-Canas V, 2011, J SEP SCI, V34, P1011, DOI 10.1002/jssc.201000826; Hardenbol P, 2003, NAT BIOTECHNOL, V21, P673, DOI 10.1038/nbt821; Natsoulis G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021088; Ritari Jarmo, 2009, BMC Res Notes, V2, P249, DOI 10.1186/1756-0500-2-249	8	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2012	7	4							e34373	10.1371/journal.pone.0034373	http://dx.doi.org/10.1371/journal.pone.0034373			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JA	22493688	Green Submitted, Green Published, gold			2022-12-27	WOS:000305012700030
J	Levinson, NM; Boxer, SG				Levinson, Nicholas M.; Boxer, Steven G.			Structural and Spectroscopic Analysis of the Kinase Inhibitor Bosutinib and an Isomer of Bosutinib Binding to the Abl Tyrosine Kinase Domain	PLOS ONE			English	Article							CHRONIC MYELOGENOUS LEUKEMIA; C-ABL; CLINICAL RESISTANCE; ELECTRIC-FIELDS; CHRONIC PHASE; ACTIVE-SITE; IMATINIB; SRC; COMPLEX; MUTATION	Chronic myeloid leukemia (CML) is caused by the kinase activity of the BCR-Abl fusion protein. The Abl inhibitors imatinib, nilotinib and dasatinib are currently used to treat CML, but resistance to these inhibitors is a significant clinical problem. The kinase inhibitor bosutinib has shown efficacy in clinical trials for imatinib-resistant CML, but its binding mode is unknown. We present the 2.4 angstrom structure of bosutinib bound to the kinase domain of Abl, which explains the inhibitor's activity against several imatinib-resistant mutants, and reveals that similar inhibitors that lack a nitrile moiety could be effective against the common T315I mutant. We also report that two distinct chemical compounds are currently being sold under the name "bosutinib", and report spectroscopic and structural characterizations of both. We show that the fluorescence properties of these compounds allow inhibitor binding to be measured quantitatively, and that the infrared absorption of the nitrile group reveals a different electrostatic environment in the conserved ATP-binding sites of Abl and Src kinases. Exploiting such differences could lead to inhibitors with improved selectivity.	[Levinson, Nicholas M.; Boxer, Steven G.] Stanford Univ, Dept Chem, Stanford, CA 94305 USA	Stanford University	Levinson, NM (corresponding author), Stanford Univ, Dept Chem, Stanford, CA 94305 USA.	nickl@stanford.edu		Boxer, Steven/0000-0001-9167-4286; Levinson, Nicholas/0000-0003-4338-8087	NIH [F32GM087896, GM27738]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM027738, F32GM087896, R37GM027738] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grants F32GM087896 and GM27738 (http://www.nigms.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Andrews SS, 2000, REV SCI INSTRUM, V71, P3567, DOI 10.1063/1.1287343; Andrews SS, 2000, J PHYS CHEM A, V104, P11853, DOI 10.1021/jp002242r; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Boschelli DH, 2001, J MED CHEM, V44, P3965, DOI 10.1021/jm0102250; Boschelli DH, 2001, J MED CHEM, V44, P822, DOI 10.1021/jm000420z; CAMPONE M, 2007, BREAST CANC RES TREA; Cools J, 2003, NEW ENGL J MED, V348, P1201, DOI 10.1056/NEJMoa025217; Cortes JE, 2010, J CLIN ONCOL, V28, P487; Cortes J, 2006, BLOOD, V108, p54A, DOI 10.1182/blood.V108.11.168.168; Dauter Z, 1999, J MOL BIOL, V289, P83, DOI 10.1006/jmbi.1999.2743; Demetri GD, 2002, NEW ENGL J MED, V347, P472, DOI 10.1056/NEJMoa020461; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Golas JM, 2003, CANCER RES, V63, P375; Gorre ME, 2001, SCIENCE, V293, P876, DOI 10.1126/science.1062538; Hubbard SR, 1997, EMBO J, V16, P5572, DOI 10.1093/emboj/16.18.5572; Kantarjian HM, 2007, BLOOD, V110, P3540, DOI 10.1182/blood-2007-03-080689; Karaman MW, 2008, NAT BIOTECHNOL, V26, P127, DOI 10.1038/nbt1358; le Coutre P, 2000, BLOOD, V95, P1758, DOI 10.1182/blood.V95.5.1758.005a41_1758_1766; Leslie AGW, 1992, JOINT CRYSTALLOGRAPH, V26; Levinson NM, 2006, PLOS BIOL, V4, P753, DOI 10.1371/journal.pbio.0040144; Nagar B, 2002, CANCER RES, V62, P4236; Nagar B, 2003, CELL, V112, P859, DOI 10.1016/S0092-8674(03)00194-6; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Puttini M, 2006, CANCER RES, V66, P11314, DOI 10.1158/0008-5472.CAN-06-1199; Redaelli S, 2009, J CLIN ONCOL, V27, P469, DOI 10.1200/JCO.2008.19.8853; Roumiantsev S, 2002, P NATL ACAD SCI USA, V99, P10700, DOI 10.1073/pnas.162140299; Sawyers CL, 1999, NEW ENGL J MED, V340, P1330, DOI 10.1056/NEJM199904293401706; Schindler T, 2000, SCIENCE, V289, P1938, DOI 10.1126/science.289.5486.1938; Seeliger MA, 2005, PROTEIN SCI, V14, P3135, DOI 10.1110/ps.051750905; Seeliger MA, 2007, STRUCTURE, V15, P299, DOI 10.1016/j.str.2007.01.015; Seeliger MA, 2009, CANCER RES, V69, P2384, DOI 10.1158/0008-5472.CAN-08-3953; Shah NP, 2007, J CLIN INVEST, V117, P2562, DOI 10.1172/JCI30890; Shah NP, 2002, CANCER CELL, V2, P117, DOI 10.1016/S1535-6108(02)00096-X; Shan YB, 2009, P NATL ACAD SCI USA, V106, P139, DOI 10.1073/pnas.0811223106; Stamos J, 2002, J BIOL CHEM, V277, P46265, DOI 10.1074/jbc.M207135200; Suydam IT, 2006, SCIENCE, V313, P200, DOI 10.1126/science.1127159; Suydam IT, 2003, BIOCHEMISTRY-US, V42, P12050, DOI 10.1021/bi0352926; Talpaz M, 2006, NEW ENGL J MED, V354, P2531, DOI 10.1056/NEJMoa055229; Tokarski JS, 2006, CANCER RES, V66, P5790, DOI 10.1158/0008-5472.CAN-05-4187; Toledo LM, 1999, CURR MED CHEM, V6, P775; Vultur A, 2008, MOL CANCER THER, V7, P1185, DOI 10.1158/1535-7163.MCT-08-0126; Wang WR, 2006, P NATL ACAD SCI USA, V103, P3563, DOI 10.1073/pnas.0600048103; Webb LJ, 2008, BIOCHEMISTRY-US, V47, P1588, DOI 10.1021/bi701708u; Wells SA, 2010, J CLIN ONCOL, V28, P767, DOI 10.1200/JCO.2009.23.6604; Yamaguchi H, 1996, NATURE, V384, P484, DOI 10.1038/384484a0; Yin XJ, 2010, MOLECULES, V15, P4261, DOI 10.3390/molecules15064261; Young MA, 2006, CANCER RES, V66, P1007, DOI 10.1158/0008-5472.CAN-05-2788; Yun CH, 2008, P NATL ACAD SCI USA, V105, P2070, DOI 10.1073/pnas.0709662105; Yun CH, 2007, CANCER CELL, V11, P217, DOI 10.1016/j.ccr.2006.12.017	51	94	97	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2012	7	4							e29828	10.1371/journal.pone.0029828	http://dx.doi.org/10.1371/journal.pone.0029828			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JA	22493660	Green Published, gold, Green Submitted			2022-12-27	WOS:000305012700002
J	Kindermans, PJ; Verstraeten, D; Schrauwen, B				Kindermans, Pieter-Jan; Verstraeten, David; Schrauwen, Benjamin			A Bayesian Model for Exploiting Application Constraints to Enable Unsupervised Training of a P300-based BCI	PLOS ONE			English	Article							BRAIN-COMPUTER-INTERFACE; MENTAL PROSTHESIS; COMPETITION 2003; P300 WAVE; CLASSIFICATION; COMMUNICATION; ALGORITHM; SPELLER	This work introduces a novel classifier for a P300-based speller, which, contrary to common methods, can be trained entirely unsupervisedly using an Expectation Maximization approach, eliminating the need for costly dataset collection or tedious calibration sessions. We use publicly available datasets for validation of our method and show that our unsupervised classifier performs competitively with supervised state-of-the-art spellers. Finally, we demonstrate the added value of our method in different experimental settings which reflect realistic usage situations of increasing difficulty and which would be difficult or impossible to tackle with existing supervised or adaptive methods.	[Kindermans, Pieter-Jan; Verstraeten, David; Schrauwen, Benjamin] Univ Ghent, Ghent, Belgium	Ghent University	Kindermans, PJ (corresponding author), Univ Ghent, Ghent, Belgium.	PieterJan.Kindermans@UGent.be			BOF-GOA; Ghent University	BOF-GOA; Ghent University(Ghent University)	This work was partially funded by the BOF-GOA Project Home-MATE funded by the Ghent University Special Research Fund. http://www.ugent.be. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bishop C. M., 2006, J ELECT IMAG, V16, P140; Blankertz B, 2004, IEEE T BIO-MED ENG, V51, P1044, DOI 10.1109/TBME.2004.826692; Blankertz B, 2006, IEEE T NEUR SYS REH, V14, P153, DOI 10.1109/TNSRE.2006.875642; Blankertz B, 2011, NEUROIMAGE, V56, P814, DOI 10.1016/j.neuroimage.2010.06.048; Cecotti H, 2010, IEEE T PATTERN ANAL, V99; Dahne S, 2011, 5 INT BRAIN COMP INT; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Donchin E, 2000, IEEE T REHABIL ENG, V8, P174, DOI 10.1109/86.847808; Dornhege G., 2007, BRAIN COMPUTER INTER; FARWELL LA, 1988, ELECTROEN CLIN NEURO, V70, P510, DOI 10.1016/0013-4694(88)90149-6; Fisher RA, 1936, ANN EUGENIC, V7, P179, DOI 10.1111/j.1469-1809.1936.tb02137.x; Hoffmann U, 2005, I IEEE EMBS C NEUR E, P97; Hoffmann U, 2008, J NEUROSCI METH, V167, P115, DOI 10.1016/j.jneumeth.2007.03.005; Kindermans PJ, 2011, 5 INT BRAIN COMP INT; Krauledat M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002967; Li YQ, 2008, PATTERN RECOGN LETT, V29, P1285, DOI 10.1016/j.patrec.2008.01.030; Liu Y, 2005, NEURAL NETWORKS BRAI, V3, P1535; Lu SJ, 2009, IEEE T NEUR SYS REH, V17, P135, DOI 10.1109/TNSRE.2009.2015197; Nijboer F, 2008, CLIN NEUROPHYSIOL, V119, P1909, DOI 10.1016/j.clinph.2008.03.034; Panicker RC, 2010, IEEE T BIO-MED ENG, V57, P2927, DOI 10.1109/TBME.2010.2058804; PICTON TW, 1992, J CLIN NEUROPHYSIOL, V9, P456, DOI 10.1097/00004691-199210000-00002; Rakotomarnonjy A, 2008, IEEE T BIO-MED ENG, V55, P1147, DOI 10.1109/TBME.2008.915728; Toh KA, 2008, NEURAL COMPUT, V20, P1565, DOI 10.1162/neco.2007.04-07-508; Vaughan TM, 2006, IEEE T NEUR SYS REH, V14, P229, DOI 10.1109/TNSRE.2006.875577; VIDAL JJ, 1973, ANNU REV BIOPHYS BIO, V2, P157, DOI 10.1146/annurev.bb.02.060173.001105; Wolpaw JR, 2002, CLIN NEUROPHYSIOL, V113, P767, DOI 10.1016/S1388-2457(02)00057-3; Xu N, 2004, IEEE T BIO-MED ENG, V51, P1067, DOI 10.1109/TBME.2004.826699; Xu P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014634; Yanez-Suarez O, P300 SPELLER PUBLICD	29	50	52	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e33758	10.1371/journal.pone.0033758	http://dx.doi.org/10.1371/journal.pone.0033758			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GO	22496763	Green Published, Green Submitted, gold			2022-12-27	WOS:000304855200022
J	Yu, X; Jiang, YF; Lu, L; Gong, X; Sun, XG; Xuan, ZP; Lu, LJ				Yu, Xin; Jiang, Yanfang; Lu, Lu; Gong, Xu; Sun, Xiguang; Xuan, Zhaopeng; Lu, Laijin			A Crucial Role of IL-17 and IFN-gamma during Acute Rejection of Peripheral Nerve Xenotransplantation in Mice	PLOS ONE			English	Article							T-CELL RESPONSES; TH17 CELLS; ALLOGRAFT-REJECTION; NEUROMA FORMATION; PORCINE ISLETS; EFFECTOR; LINEAGE; INFLAMMATION; DIFFERENTIATION; TRANSPLANTATION	Nerve injuries causing segmental loss require nerve grafting. However, autografts and allografts have limitations for clinical use. Peripheral nerve xenotransplantation has become an area of great interest in clinical surgery research as an alternative graft strategy. However, xenotransplant rejection is severe with cellular immunity, and Th1 cells play an important role in the process. To better understand the process of rejection, we used peripheral nerve xenografts from rats to mice and found that mononuclear cells expressing IFN-gamma and IL-17 infiltrated around the grafts, and IFN-gamma and IL-17 producing CD4+ and CD8+ T cells increased during the process of acute rejection. The changes of IL-4 level had no significant difference between xenotransplanted group and sham control group. The rejection of xenograft was significantly prevented after the treatment of IL-17 and IFN-gamma neutralizing antibodies. These data suggest that Th17 cells contribute to the acute rejection process of peripheral nerve xenotransplant in addition to Th1 cells.	[Yu, Xin; Lu, Lu; Gong, Xu; Sun, Xiguang; Xuan, Zhaopeng; Lu, Laijin] Jilin Univ, Dept Hand Surg, Hosp 1, Changchun 130023, Peoples R China; [Jiang, Yanfang] Jilin Univ, Dept Cent Lab, Second Part Hosp 1, Changchun 130023, Peoples R China	Jilin University; Jilin University	Yu, X (corresponding author), Jilin Univ, Dept Hand Surg, Hosp 1, Changchun 130023, Peoples R China.	lulaijin@yeah.net	lu, lu/HII-7530-2022; lu, lu/HGA-0894-2022		National Natural Science Foundation of China [81171145, 30972610]; Ph.D. Programs Foundation of Ministry of Education of China [20100061110057]; Graduate Innovation Foundation of Jilin University [20101032]; National High Technology Research and Development Program 863 [2011AA02A106]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ph.D. Programs Foundation of Ministry of Education of China(Ministry of Education, China); Graduate Innovation Foundation of Jilin University; National High Technology Research and Development Program 863(National High Technology Research and Development Program of China)	This study supported by grants from the National Natural Science Foundation of China (No. 81171145 and 30972610), Ph.D. Programs Foundation of Ministry of Education of China (20100061110057), Graduate Innovation Foundation of Jilin University(20101032), and National High Technology Research and Development Program 863 (2011AA02A106). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonysamy MA, 1999, J IMMUNOL, V162, P577; Bending D, 2009, J CLIN INVEST, V119, P565, DOI 10.1172/JCI37865; Berger A, 1999, UNFALLCHIRURG, V102, P59, DOI 10.1007/s001130050373; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Cardona K, 2006, NAT MED, V12, P304, DOI 10.1038/nm1375; Chen Y, 2008, TRANSPL P, V40, P2691, DOI 10.1016/j.transproceed.2008.08.014; Crome SQ, 2010, CLIN EXP IMMUNOL, V159, P109, DOI 10.1111/j.1365-2249.2009.04037.x; Davila E, 2006, XENOTRANSPLANTATION, V13, P31, DOI 10.1111/j.1399-3089.2005.00258.x; Dorling A, 1996, EUR J IMMUNOL, V26, P1378, DOI 10.1002/eji.1830260630; Fabrega E, 2009, LIVER TRANSPLANT, V15, P629, DOI 10.1002/lt.21724; Faust SM, 2009, J IMMUNOL, V183, P7297, DOI 10.4049/jimmunol.0902446; Fox IK, 2005, MUSCLE NERVE, V31, P59, DOI 10.1002/mus.20231; Galeano M, 2009, MICROSURG, V29, P568, DOI 10.1002/micr.20652; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; He D, 2006, J INVEST DERMATOL, V126, P110; Hebebrand D, 1997, J HAND SURG-BRIT EUR, V22B, P304, DOI 10.1016/S0266-7681(97)80391-9; Hering BJ, 2006, NAT MED, V12, P301, DOI 10.1038/nm1369; Honey K, 1999, J IMMUNOL, V163, P4805; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Jones ND, 2006, J IMMUNOL, V176, P2316, DOI 10.4049/jimmunol.176.4.2316; Khader SA, 2007, NAT IMMUNOL, V8, P369, DOI 10.1038/ni1449; Kim OS, 2002, MODERN PATHOL, V15, p133A; Kortylewski M, 2009, CANCER CELL, V15, P114, DOI 10.1016/j.ccr.2008.12.018; Kreisel D, 2002, NAT MED, V8, P233, DOI 10.1038/nm0302-233; Lee YK, 2009, IMMUNITY, V30, P92, DOI 10.1016/j.immuni.2008.11.005; Liang SC, 2006, J EXP MED, V203, P2271, DOI 10.1084/jem.20061308; Lu LJ, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/412598; Luger D, 2008, J EXP MED, V205, P799, DOI 10.1084/jem.20071258; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Martin-Orozco N, 2009, EUR J IMMUNOL, V39, P216, DOI 10.1002/eji.200838475; Novak CB, 2009, J HAND SURG-AM, V34A, P281, DOI 10.1016/j.jhsa.2008.11.017; O'Connor RA, 2008, J IMMUNOL, V181, P3750, DOI 10.4049/jimmunol.181.6.3750; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; SCHALLER E, 1987, PLAST RECONSTR SURG, V80, P870, DOI 10.1097/00006534-198712000-00043; Sinis N, 2007, PLAST RECONSTR SURG, V119, P960, DOI 10.1097/01.prs.0000242486.70919.82; Su SB, 2007, INVEST OPHTH VIS SCI, V48, P4616, DOI 10.1167/iovs.07-0233; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Trambley J, 1999, J CLIN INVEST, V104, P1715, DOI 10.1172/JCI8082; Trumble TE, 2000, HAND CLIN, V16, P105; Veldhoen M, 2006, NAT IMMUNOL, V7, P1151, DOI 10.1038/ni1391; Wei G, 2009, IMMUNITY, V30, P155, DOI 10.1016/j.immuni.2008.12.009; Yang YG, 2007, NAT REV IMMUNOL, V7, P519, DOI 10.1038/nri2099; Yuan XL, 2008, J EXP MED, V205, P3133, DOI 10.1084/jem.20081937	43	41	42	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e34419	10.1371/journal.pone.0034419	http://dx.doi.org/10.1371/journal.pone.0034419			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479627	Green Published, Green Submitted, gold			2022-12-27	WOS:000305339100157
J	Authier, M; Bentaleb, I; Ponchon, A; Martin, C; Guinet, C				Authier, Matthieu; Bentaleb, Ilham; Ponchon, Aurore; Martin, Celine; Guinet, Christophe			Foraging Fidelity as a Recipe for a Long Life: Foraging Strategy and Longevity in Male Southern Elephant Seals	PLOS ONE			English	Article							MULTIVARIATE DATA-ANALYSIS; MIROUNGA-LEONINA; STABLE-CARBON; INDIVIDUAL FITNESS; DECLINING POPULATION; LONGITUDINAL DATA; FUR SEALS; DELTA-C-13; NITROGEN; SURVIVAL	Identifying individual factors affecting life-span has long been of interest for biologists and demographers: how do some individuals manage to dodge the forces of mortality when the vast majority does not? Answering this question is not straightforward, partly because of the arduous task of accurately estimating longevity in wild animals, and of the statistical difficulties in correlating time-varying ecological covariables with a single number (time-to-event). Here we investigated the relationship between foraging strategy and life-span in an elusive and large marine predator: the Southern Elephant Seal (Mirounga leonina). Using teeth recovered from dead males on iles Kerguelen, Southern Ocean, we first aged specimens. Then we used stable isotopic measurements of carbon (delta C-13) in dentin to study the effect of foraging location on individual life-span. Using a joint change-point/survival modelling approach which enabled us to describe the ontogenetic trajectory of foraging, we unveiled how a stable foraging strategy developed early in life positively covaried with longevity in male Southern Elephant Seals. Coupled with an appropriate statistical analysis, stable isotopes have the potential to tackle ecological questions of long standing interest but whose answer has been hampered by logistic constraints.	[Authier, Matthieu; Guinet, Christophe] CNRS, UPR 1934, Ctr Etud Biol Chize, Villiers En Bois, France; [Authier, Matthieu] Univ Poitiers, Ecole Doctorale Sci Environm Gay Lussac, Poitiers, France; [Bentaleb, Ilham; Ponchon, Aurore; Martin, Celine] CNRS, UMR 5554, Inst Sci Evolut, Montpellier, France; [Ponchon, Aurore] CNRS, Ctr Ecol Fonct & Evolut, UMR 5175, F-34033 Montpellier, France	Centre National de la Recherche Scientifique (CNRS); Universite de Poitiers; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Institut Agro; Montpellier SupAgro; CIRAD; Institut de Recherche pour le Developpement (IRD); Universite Paul-Valery; Universite de Montpellier	Authier, M (corresponding author), CNRS, UPR 1934, Ctr Etud Biol Chize, Villiers En Bois, France.	authierm@gmail.com	Guinet, Christophe/AAR-8457-2020; Ponchon, Aurore/AAD-3674-2021; Bentaleb, Ilham/AAD-8137-2019; Ponchon, Aurore/AAD-3677-2021	Ponchon, Aurore/0000-0002-5126-6269; Ponchon, Aurore/0000-0002-5126-6269; Authier, Matthieu/0000-0001-7394-1993; Bentaleb, Ilham/0000-0002-6023-7929; Chiaradia, Andre/0000-0002-6178-4211	French Polar Institute (Institut Paul Emile Victor)	French Polar Institute (Institut Paul Emile Victor)	This study is part of a national research program (no. 109, H. Weimerskirch and the observatory Mammiferes Explorateurs du Milieu Oceanique, MEMO SOERE CTD 02) supported by the French Polar Institute (Institut Paul Emile Victor). The Territoire des Terres Australes et Antarctiques Francaises, the TOTAL Foundation and ANR-VMC 07 IPSOS-SEAL program contributed to this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMBROSE SH, 1990, J ARCHAEOL SCI, V17, P431, DOI 10.1016/0305-4403(90)90007-R; ANDERSON TW, 1987, SIAM J SCI STAT COMP, V8, P625, DOI 10.1137/0908055; Aubry LM, 2011, J ANIM ECOL, V80, P375, DOI 10.1111/j.1365-2656.2010.01784.x; Authier M, METHODS ECO IN PRESS; Authier M, 2011, POLAR BIOL, V34, P319, DOI 10.1007/s00300-010-0881-1; Bailleul F, 2007, DEEP-SEA RES PT II, V54, P343, DOI 10.1016/j.dsr2.2006.11.005; Bailleul F, 2010, ECOGRAPHY, V33, P709, DOI 10.1111/j.1600-0587.2009.06034.x; Balaisse M, 2001, J ARCHAEOL SCI, V28, P235, DOI 10.1006/jasc.1999.0535; Beauplet G, 2007, P R SOC B, V274, P1877, DOI 10.1098/rspb.2007.0454; Beckage B, 2007, NEW PHYTOL, V174, P456, DOI 10.1111/j.1469-8137.2007.01991.x; Beeton M, 1901, BIOMETRIKA, V1, P50, DOI 10.1093/biomet/1.1.50; Bentaleb I, 2011, MAR ECOL PROG SER, V438, P285, DOI 10.3354/meps09269; Bentaleb I, 1998, J MARINE SYST, V17, P39, DOI 10.1016/S0924-7963(98)00028-1; Bergeron P, 2011, J ANIM ECOL, V80, P361, DOI 10.1111/j.1365-2656.2010.01770.x; Berube CH, 1999, ECOLOGY, V80, P2555, DOI 10.1890/0012-9658(1999)080[2555:IDLARS]2.0.CO;2; Bradburn MJ, 2003, BRIT J CANCER, V89, P431, DOI 10.1038/sj.bjc.6601119; Bradburn MJ, 2003, BRIT J CANCER, V89, P605, DOI 10.1038/sj.bjc.6601120; Bradshaw CJA, 2004, ANIM BEHAV, V68, P1349, DOI 10.1016/j.anbehav.2003.12.013; Brodie CR, 2011, CHEM GEOL, V282, P67, DOI 10.1016/j.chemgeo.2011.01.007; Brommer JE, 2004, AM NAT, V163, P505, DOI 10.1086/382547; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Burton R, 1997, ANTARCTIC COMMUNITIE, P335; Cam E, 2002, AM NAT, V159, P96, DOI 10.1086/324126; Cam E, 2003, J ANIM ECOL, V72, P411, DOI 10.1046/j.1365-2656.2003.00708.x; CARLINI AR, 1994, POLAR BIOL, V14, P37, DOI 10.1007/BF00240270; Chaigne A, 2011, SHIFT FORAGING GROUN; Cowles MK, 1996, J AM STAT ASSOC, V91, P883, DOI 10.2307/2291683; COX DR, 1972, J R STAT SOC B, V34, P187; DENIRO MJ, 1977, SCIENCE, V197, P261, DOI 10.1126/science.327543; Descamps S, 2006, P ROY SOC B-BIOL SCI, V273, P2369, DOI 10.1098/rspb.2006.3588; EDNEY EB, 1968, NATURE, V220, P281, DOI 10.1038/220281a0; Gaillard JM, 2003, LIFE SPAN: EVOLUTIONARY, ECOLOGICAL, AND DEMOGRAPHIC PERSPECTIVES, P39; Gaillard JM, 2000, P ROY SOC B-BIOL SCI, V267, P471, DOI 10.1098/rspb.2000.1024; Galimberti F, 2002, CAN J ZOOL, V80, P1240, DOI 10.1139/Z02-117; Galimberti F, 2007, BEHAV ECOL SOCIOBIOL, V62, P159, DOI 10.1007/s00265-007-0450-y; Gao F, 2011, STAT METHOD APPL-GER, V20, P83, DOI 10.1007/s10260-010-0150-z; Gelman A, 2006, BAYESIAN ANAL, V1, P515, DOI 10.1214/06-BA117A; Gelman A, 2008, ANN APPL STAT, V2, P1360, DOI 10.1214/08-AOAS191; Ghosh P, 2007, STAT MED, V26, P2074, DOI 10.1002/sim.2671; Guo X, 2004, AM STAT, V58, P16, DOI 10.1198/0003130042854; Hamel S, 2009, J ANIM ECOL, V78, P143, DOI 10.1111/j.1365-2656.2008.01459.x; Hamel S, 2010, ECOL LETT, V13, P915, DOI 10.1111/j.1461-0248.2010.01478.x; Henderson R, 2001, STAT MED, V20, P3083, DOI 10.1002/sim.913; HINDELL MA, 1994, AUST J ZOOL, V42, P723, DOI 10.1071/ZO9940723; Hobson KA, 1998, MAR MAMMAL SCI, V14, P116, DOI 10.1111/j.1748-7692.1998.tb00694.x; Hoffman JI, 2010, J HERED, V101, P527, DOI 10.1093/jhered/esq045; Horrocks J, 2009, BAYESIAN ANAL, V4, P523, DOI 10.1214/09-BA419; Jackson CH, 2008, AM STAT, V62, P340, DOI 10.1198/000313008X370843; JONES E, 1981, AUST WILDLIFE RES, V8, P327; Kannisto V, 2001, GENUS, V47, P101; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kelly JF, 2000, CAN J ZOOL, V78, P1, DOI 10.1139/cjz-78-1-1; Kjellander P, 2004, P ROY SOC B-BIOL SCI, V271, pS338, DOI 10.1098/rsbl.2004.0177; Kruuk LEB, 2000, P NATL ACAD SCI USA, V97, P698, DOI 10.1073/pnas.97.2.698; Laws R, 1993, ANTARCTIC SEALS RES, P199; LAWS RM, 1952, NATURE, V169, P972, DOI 10.1038/169972b0; Liang LJ, 2010, J DRUG ISSUES, V40, P121, DOI 10.1177/002204261004000107; Lindstrom J, 1999, TRENDS ECOL EVOL, V14, P343, DOI 10.1016/S0169-5347(99)01639-0; Link WA, 2002, J APPL STAT, V29, P207, DOI 10.1080/02664760120108700a; Martin C, 2011, MAR ECOL PROG SER, V439, P295, DOI 10.3354/meps09331; MARTIN P, 1984, ANIM BEHAV, V32, P1257, DOI 10.1016/S0003-3472(84)80245-6; MCCANN TS, 1980, BIOL J LINN SOC, V14, P133, DOI 10.1111/j.1095-8312.1980.tb00102.x; McIntyre T, 2010, POLAR BIOL, V33, P1037, DOI 10.1007/s00300-010-0782-3; MCLAREN IA, 1993, BIOL REV, V68, P1, DOI 10.1111/j.1469-185X.1993.tb00731.x; McMahon CR, 2005, MAMMAL REV, V35, P82, DOI 10.1111/j.1365-2907.2005.00055.x; McMahon CR, 2003, J ANIM ECOL, V72, P61, DOI 10.1046/j.1365-2656.2003.00685.x; Mendes S, 2007, OECOLOGIA, V151, P605, DOI 10.1007/s00442-006-0612-z; METZGAR LH, 1967, J MAMMAL, V48, P387, DOI 10.2307/1377771; MILLAR JS, 1983, ECOLOGY, V64, P631, DOI 10.2307/1937181; MOYES AB, 1984, BRIT ANTARCT SURV B, P81; Muller HG, 2001, P ROY SOC B-BIOL SCI, V268, P445, DOI 10.1098/rspb.2000.1370; Newsome SD, 2010, MAR MAMMAL SCI, V26, P509, DOI 10.1111/j.1748-7692.2009.00354.x; Newsome SD, 2009, MAR ECOL PROG SER, V374, P229, DOI 10.3354/meps07747; Nguti R, 2005, GENET SEL EVOL, V37, P175, DOI 10.1051/gse:2004043; O'Hara RB, 2009, BAYESIAN ANAL, V4, P85, DOI 10.1214/09-BA403; ORSI AH, 1995, DEEP-SEA RES PT I, V42, P641, DOI 10.1016/0967-0637(95)00021-W; Pettorelli N, 2007, OIKOS, V116, P1879, DOI 10.1111/j.2007.0030-1299.16187.x; Pistorius PA, 1999, OECOLOGIA, V121, P201, DOI 10.1007/s004420050922; Pistorius PA, 1999, ANTARCT SCI, V11, P445, DOI 10.1017/S0954102099000577; Plummer M, 2008, CODA OUTPUT ANAL DIA; Polischuk SC, 2001, CAN J ZOOL, V79, P499, DOI 10.1139/cjz-79-3-499; R Core Team, 2020, R LANG ENV STAT COMP; RAU GH, 1989, NATURE, V341, P516, DOI 10.1038/341516a0; Schulting RJ, 2008, J ARCHAEOL SCI, V35, P763, DOI 10.1016/j.jas.2007.06.008; Shmueli G, 2010, STAT SCI, V25, P289, DOI 10.1214/10-STS330; Spiegelhalter D., 2003, WINBUGS USER MANUAL; Spiegelhalter D, 2011, SCIENCE, V333, P1393, DOI 10.1126/science.1191181; Sturtz S, 2005, J STAT SOFTW, V12, P1, DOI 10.18637/jss.v012.i03; Swindell WR, 2009, EXP GERONTOL, V44, P190, DOI 10.1016/j.exger.2008.10.005; Thomson DL, 2009, ENVIRON ECOL STAT SE, V3, P1, DOI 10.1007/978-0-387-78151-8; TIESZEN LL, 1983, OECOLOGIA, V57, P32, DOI 10.1007/BF00379558; Tokuda T., 2011, TECH REP; Trull TW, 2001, DEEP-SEA RES PT II, V48, P2655, DOI 10.1016/S0967-0645(01)00013-3; Turner EL, 2010, J R STAT SOC A STAT, V173, P483, DOI 10.1111/j.1467-985X.2010.00640.x; Valenzuela LO, 2009, MOL ECOL, V18, P782, DOI 10.1111/j.1365-294X.2008.04069.x; Vonesh EF, 2006, STAT MED, V25, P143, DOI 10.1002/sim.2249; Wainer H, 2007, AM SCI, V95, P249, DOI 10.1511/2007.65.249; Wasser DE, 2010, J ZOOL, V280, P103, DOI 10.1111/j.1469-7998.2009.00671.x; Weladji RB, 2006, P ROY SOC B-BIOL SCI, V273, P1239, DOI 10.1098/rspb.2005.3393; WERNER EE, 1984, ANNU REV ECOL SYST, V15, P393, DOI 10.1146/annurev.es.15.110184.002141; Wilske J, 1996, COMP BIOCHEM PHYS A, V114, P9, DOI 10.1016/0300-9629(95)02035-7; Wolf M, 2009, ECOGRAPHY, V32, P401, DOI 10.1111/j.1600-0587.2008.05626.x; Zhang ZY, 2007, INT J BEHAV DEV, V31, P374, DOI 10.1177/0165025407077764	103	34	34	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2012	7	4							e32026	10.1371/journal.pone.0032026	http://dx.doi.org/10.1371/journal.pone.0032026			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959FE	22505993	Green Published, gold			2022-12-27	WOS:000305297500001
J	McFerrin, LG; Atchley, WR				McFerrin, Lisa G.; Atchley, William R.			A Novel N-Terminal Domain May Dictate the Glucose Response of Mondo Proteins	PLOS ONE			English	Article							WILLIAMS-BEUREN-SYNDROME; ELEMENT-BINDING PROTEIN; CENTER-DOT-MLX; TRANSCRIPTION FACTOR; EVOLUTIONARY CONSERVATION; SUBCELLULAR-LOCALIZATION; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; GENE-EXPRESSION; CHREBP	Glucose is a fundamental energy source for both prokaryotes and eukaryotes. The balance between glucose utilization and storage is integral for proper energy homeostasis, and defects are associated with several diseases, e.g. type II diabetes. In vertebrates, the transcription factor ChREBP is a major component in glucose metabolism, while its ortholog MondoA is involved in glucose uptake. Both MondoA and ChREBP contain five Mondo conserved regions (MCRI-V) that affect their cellular localization and transactivation ability. While phosphorylation has been shown to affect ChREBP function, the mechanisms controlling glucose response of both ChREBP and MondoA remain elusive. By incorporating sequence analysis techniques, structure predictions, and functional annotations, we synthesized data surrounding Mondo family proteins into a cohesive, accurate, and general model involving the MCRs and two additional domains that determine ChREBP and MondoA glucose response. Paramount, we identified a conserved motif within the transactivation region of Mondo family proteins and propose that this motif interacts with the phosphorylated form of glucose. In addition, we discovered a putative nuclear receptor box in non-vertebrate Mondo and vertebrate ChREBP sequences that reveals a potentially novel interaction with nuclear receptors. These interactions are likely involved in altering ChREBP and MondoA conformation to form an active complex and induce transcription of genes involved in glucose metabolism and lipogenesis.	[McFerrin, Lisa G.; Atchley, William R.] N Carolina State Univ, Bioinformat Res Ctr, Raleigh, NC 27695 USA; [Atchley, William R.] N Carolina State Univ, Dept Genet, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University	McFerrin, LG (corresponding author), N Carolina State Univ, Bioinformat Res Ctr, Raleigh, NC 27695 USA.	Lisa.McFerrin@gmail.com						Aleshin AE, 2000, J MOL BIOL, V296, P1001, DOI 10.1006/jmbi.1999.3494; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Atchley WR, 1999, J MOL EVOL, V48, P501, DOI 10.1007/PL00006494; Billin AN, 2006, CURR TOP MICROBIOL, V302, P255; Billin AN, 2000, MOL CELL BIOL, V20, P8845, DOI 10.1128/MCB.20.23.8845-8854.2000; Burke SJ, 2009, FASEB J, V23, P2855, DOI 10.1096/fj.08-126631; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Capra JA, 2007, BIOINFORMATICS, V23, P1875, DOI 10.1093/bioinformatics/btm270; Chacinska A, 2009, CELL, V138, P628, DOI 10.1016/j.cell.2009.08.005; Combet C, 2000, TRENDS BIOCHEM SCI, V25, P147, DOI 10.1016/S0968-0004(99)01540-6; Cosgrove MS, 2000, BIOCHEMISTRY-US, V39, P15002, DOI 10.1021/bi0014608; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Davies M, 2010, AJP ENDOCRINOLOGY ME; Davies MN, 2008, J BIOL CHEM, V283, P24029, DOI 10.1074/jbc.M801539200; de Luis O, 2000, EUR J HUM GENET, V8, P215, DOI 10.1038/sj.ejhg.5200435; DiMaio F, 2011, NATURE, V473, P540, DOI 10.1038/nature09964; Dong XH, 2009, NATURE, V458, P1136, DOI 10.1038/nature07975; Eilers AL, 2002, MOL CELL BIOL, V22, P8514, DOI 10.1128/MCB.22.24.8514-8526.2002; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Escriva H, 1998, ANN NY ACAD SCI, V839, P143, DOI 10.1111/j.1749-6632.1998.tb10747.x; Fukasawa M, 2010, BIOCHEM BIOPH RES CO, V391, P1166, DOI 10.1016/j.bbrc.2009.11.115; Gattiker Alexandre, 2002, Appl Bioinformatics, V1, P107; Ginalski K, 2003, BIOINFORMATICS, V19, P1015, DOI 10.1093/bioinformatics/btg124; Gould CM, 2010, NUCLEIC ACIDS RES, V38, pD167, DOI 10.1093/nar/gkp1016; Guo L, 2007, P NATL ACAD SCI USA, V104, P4297, DOI 10.1073/pnas.0608041104; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Kabashima T, 2003, P NATL ACAD SCI USA, V100, P5107, DOI 10.1073/pnas.0730817100; Kamata K, 2004, STRUCTURE, V12, P429, DOI 10.1016/j.str.2004.02.005; Kawaguchi T, 2001, P NATL ACAD SCI USA, V98, P13710, DOI 10.1073/pnas.231370798; Kay BK, 2000, FASEB J, V14, P231, DOI 10.1096/fasebj.14.2.231; Kotaka M, 2005, ACTA CRYSTALLOGR D, V61, P495, DOI 10.1107/S0907444905002350; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Li M, 2010, BIOCH BIOPHYS RES CO; Li MV, 2008, MOL ENDOCRINOL, V22, P1658, DOI 10.1210/me.2007-0560; Li MV, 2006, DIABETES, V55, P1179, DOI 10.2337/db05-0822; Luo WB, 2011, CELL, V145, P732, DOI 10.1016/j.cell.2011.03.054; Ma L, 2005, J BIOL CHEM, V280, P12019, DOI 10.1074/jbc.M413063200; Ma L, 2006, J BIOL CHEM, V281, P28721, DOI 10.1074/jbc.M601576200; Maddocks ODK, 2011, J MOL MED, V89, P237, DOI 10.1007/s00109-011-0735-5; Magana MM, 1996, J BIOL CHEM, V271, P32689, DOI 10.1074/jbc.271.51.32689; Malmstrom L, 2007, PLOS BIOL, V5, P758, DOI 10.1371/journal.pbio.0050076; Mates JM, 2009, INT J BIOCHEM CELL B, V41, P2051, DOI 10.1016/j.biocel.2009.03.003; McFerrin LG, 2011, GENOME BIOL EVOL, V3, P915, DOI 10.1093/gbe/evr082; Merla G, 2004, HUM MOL GENET, V13, P1505, DOI 10.1093/hmg/ddh163; Mulichak AM, 1998, NAT STRUCT BIOL, V5, P555, DOI 10.1038/811; Nakaishi Y, 2009, FEBS LETT, V583, P163, DOI 10.1016/j.febslet.2008.11.041; Nolte RT, 1998, NATURE, V395, P137, DOI 10.1038/25931; Odom DT, 2004, SCIENCE, V303, P1378, DOI 10.1126/science.1089769; Ottmann C, 2007, EMBO J, V26, P902, DOI 10.1038/sj.emboj.7601530; Peterson CW, 2010, MOL CELL BIOL, V30, P2887, DOI 10.1128/MCB.01613-09; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pickett CL, 2007, DEV BIOL, V310, P226, DOI 10.1016/j.ydbio.2007.07.034; Piskacek S, 2007, GENOMICS, V89, P756, DOI 10.1016/j.ygeno.2007.02.003; Porollo A, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-316; Postic C, 2007, ANNU REV NUTR, V27, P179, DOI 10.1146/annurev.nutr.27.061406.093618; Poupeau A, BIOCH BIOPHYS ACTA; Raman M, 2007, ONCOGENE, V26, P3100, DOI 10.1038/sj.onc.1210392; Regni C, 2006, ACTA CRYSTALLOGR F, V62, P722, DOI 10.1107/S1744309106025887; Riffle M, 2005, NUCLEIC ACIDS RES, V33, pD378, DOI 10.1093/nar/gki073; Rohl CA, 2004, METHOD ENZYMOL, V383, P66; Rufo C, 2001, J BIOL CHEM, V276, P21969, DOI 10.1074/jbc.M100461200; Ryan JF, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r64; Sakiyama H, 2010, BIOCH BIOPHYS RES CO; Sakiyama H, 2008, J BIOL CHEM, V283, P24899, DOI 10.1074/jbc.M804308200; Sans CL, 2006, MOL CELL BIOL, V26, P4863, DOI 10.1128/MCB.00657-05; Schleiff E, 2000, J BIOENERG BIOMEMBR, V32, P55, DOI 10.1023/A:1005512412404; SHANNON CE, 1951, BELL SYST TECH J, V30, P50, DOI 10.1002/j.1538-7305.1951.tb01366.x; Sharrocks AD, 2000, TRENDS BIOCHEM SCI, V25, P448, DOI 10.1016/S0968-0004(00)01627-3; Solomons JTG, 2004, J MOL BIOL, V342, P847, DOI 10.1016/j.jmb.2004.07.085; Stoeckman AK, 2004, J BIOL CHEM, V279, P15662, DOI 10.1074/jbc.M311301200; Stoltzman CA, 2008, P NATL ACAD SCI USA, V105, P6912, DOI 10.1073/pnas.0712199105; Tabor DE, 1998, J BIOL CHEM, V273, P22052, DOI 10.1074/jbc.273.34.22052; Tanoue T, 2001, EMBO J, V20, P466, DOI 10.1093/emboj/20.3.466; Teplyakov A, 2001, J MOL BIOL, V313, P1093, DOI 10.1006/jmbi.2001.5094; Teplyakov A, 1999, PROTEIN SCI, V8, P596; Tong XM, 2009, P NATL ACAD SCI USA, V106, P21660, DOI 10.1073/pnas.0911316106; Tsatsos NG, 2006, BIOCHEM BIOPH RES CO, V340, P449, DOI 10.1016/j.bbrc.2005.12.029; Tsatsos NG, 2008, BIOCHEM J, V411, P261, DOI 10.1042/BJ20071156; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; Xu JH, 2006, J BIOL CHEM, V281, P18351, DOI 10.1074/jbc.M601277200; Yamashita H, 2001, P NATL ACAD SCI USA, V98, P9116, DOI 10.1073/pnas.161284298; Yuan J, 1998, ONCOGENE, V17, P1109, DOI 10.1038/sj.onc.1202036; Zhang GF, 2005, BIOCHEMISTRY-US, V44, P9404, DOI 10.1021/bi050558p; Zhang P, 2010, MOL ENDOCRINOL	84	33	37	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2012	7	4							e34803	10.1371/journal.pone.0034803	http://dx.doi.org/10.1371/journal.pone.0034803			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959FE	22506051	Green Published, Green Submitted, gold			2022-12-27	WOS:000305297500059
J	Raychaudhuri, S				Raychaudhuri, Santanu			MicroRNAs Overexpressed in Growth-Restricted Rat Skeletal Muscles Regulate the Glucose Transport in Cell Culture Targeting Central TGF-beta Factor SMAD4	PLOS ONE			English	Article							GLUT4 GENE-EXPRESSION; KINASE C-ZETA; INSULIN-RESISTANCE; 3T3-L1 ADIPOCYTES; MYOSTATIN GENE; MESSENGER-RNA; STEM-CELLS; IGF-I; MICE; GLUCOSE-TRANSPORTER-4	The micro-array profiling of micro-RNA has been performed in rat skeletal muscle tissues, isolated from male adult offspring of intrauterine plus postnatal growth restricted model (IPGR). Apparently, the GLUT4 mRNA expression in male sk. muscle was found to be unaltered in contrast to females. The over-expression of miR-29a and miR-23a in the experimental group of SMSP (Starved Mother Starved Pups) have been found to regulate the glucose transport activity with respect to their control counterparts CMCP (Control Mother Control Pups) as confirmed in rat L6 myoblast-myocyte cell culture system. The ex-vivo experimentation demonstrates an aberration in insulin signaling pathway in male sk. muscle that leads to the localization of the membrane-bound Glut4 protein. We have identified through a series of experiments one important protein factor SMAD4, a co-SMAD critical to the TGF-beta signaling pathway. This factor is targeted by miR-29a, as identified in an in vitro reporter-assay system in cell-culture experiment. The other micro-RNA, miR-23a, targets SMAD4 indirectly that seems to be critical in regulating insulin-dependent glucose transport activity. MicroRNA mimics, inhibitors and siRNA studies indicate the role of SMAD4 as inhibitory for glucose transport activities in normal physiological condition. The data demonstrate for the first time a critical function of microRNAs in fine-tuning the regulation of glucose transport in skeletal muscle. Chronic starved conditions (IPGR) in sk. muscle up-regulates microRNA changing the target protein expression patterns, such as SMAD4, to alter the glucose transport pathways for the survival. The innovative outcome of this paper identifies a critical pathway (TGF-beta) that may act negatively for the mammalian glucose transport machinery.	Univ Calif Los Angeles, David Geffen Sch Med, Dept Pediat, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Raychaudhuri, S (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Pediat, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA.	sraychau@ucla.edu			National Institutes of Health (NIH); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD041230] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD046979, R01HD033997] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY008976, R01EY011708] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK063121] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The National Institutes of Health (NIH) to Dr. Devaskar was used for performing this microRNA research. HD41230, HD46979, and HD33997. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Black BL, 1998, ANNU REV CELL DEV BI, V14, P167, DOI 10.1146/annurev.cellbio.14.1.167; Blot V, 2008, MOL BIOL CELL, V19, P3477, DOI 10.1091/mbc.E08-03-0236; Bogan JS, 2010, CURR OPIN CELL BIOL, V22, P506, DOI 10.1016/j.ceb.2010.03.012; BORNEMANN A, 1992, MUSCLE NERVE, V15, P14, DOI 10.1002/mus.880150104; Braiman L, 2001, MOL CELL BIOL, V21, P7852, DOI 10.1128/MCB.21.22.7852-7861.2001; Buchan JR, 2009, MOL CELL, V36, P932, DOI 10.1016/j.molcel.2009.11.020; Callis TE, 2007, DNA CELL BIOL, V26, P219, DOI 10.1089/dna.2006.0556; Cardinali B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007607; Carvalho E, 2005, AM J PHYSIOL-ENDOC M, V289, pE551, DOI 10.1152/ajpendo.00116.2005; Chen JF, 2009, J CELL SCI, V122, P13, DOI 10.1242/jcs.041723; Chen SA, 2011, CELL METAB, V13, P68, DOI 10.1016/j.cmet.2010.12.005; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Dugani CB, 2005, EMBO REP, V6, P1137, DOI 10.1038/sj.embor.7400584; Fazi F, 2008, CARDIOVASC RES, V79, P553, DOI 10.1093/cvr/cvn151; Gallagher IJ, 2010, GENOME MED, V2, DOI 10.1186/gm130; Garg M, 2009, AM J PHYSIOL-ENDOC M, V296, pE272, DOI 10.1152/ajpendo.90473.2008; Gatford KL, 2010, PLACENTA, V31, pS60, DOI 10.1016/j.placenta.2009.12.015; Grobet L, 2003, GENESIS, V35, P227, DOI 10.1002/gene.10188; HARDY RW, 1995, ENDOCRINOLOGY, V136, P431, DOI 10.1210/en.136.2.431; Hata A, 2009, CYTOKINE GROWTH F R, V20, P517, DOI 10.1016/j.cytogfr.2009.10.004; He AB, 2007, MOL ENDOCRINOL, V21, P2785, DOI 10.1210/me.2007-0167; Hoffman NJ, 2011, TRENDS ENDOCRIN MET, V22, P110, DOI 10.1016/j.tem.2010.12.001; Horie T, 2009, BIOCHEM BIOPH RES CO, V389, P315, DOI 10.1016/j.bbrc.2009.08.136; Hou R, 2006, J CELL BIOL, V173, P417, DOI 10.1083/jcb.200508121; Huang SL, 2008, INT J CANCER, V123, P972, DOI 10.1002/ijc.23580; Ida G, 2011, J PHYSL, V589.6, P1443; Juan AH, 2009, MOL CELL, V36, P61, DOI 10.1016/j.molcel.2009.08.008; Karlsson HKR, 2006, DIABETES, V55, P1283, DOI 10.2337/db05-0853; Kim JK, 2001, J CLIN INVEST, V108, P153, DOI 10.1172/JCI10294; Leeper NJ, 2011, J CELL PHYSIOL, V226, P1035, DOI 10.1002/jcp.22422; Leney SE, 2009, J ENDOCRINOL, V203, P1, DOI 10.1677/JOE-09-0037; Li-Zhong L, 2006, MOL BIOL CELL, V17, P2322; Lu H, 2010, CARDIOVASC RES, V86, P410, DOI 10.1093/cvr/cvq010; LUND S, 1994, AM J PHYSIOL, V267, pE461, DOI 10.1152/ajpendo.1994.267.3.E461; Lynn FC, 2009, TRENDS ENDOCRIN MET, V20, P452, DOI 10.1016/j.tem.2009.05.007; Mahoney DJ, 2008, AM J PHYSIOL-REG I, V294, pR1901, DOI 10.1152/ajpregu.00847.2007; Mariman ECM, 2008, J NUTRIGENET NUTRIGE, V1, P232, DOI 10.1159/000151237; Maurer B, 2010, ARTHRITIS RHEUM-US, V62, P1733, DOI 10.1002/art.27443; McPherron AC, 1997, P NATL ACAD SCI USA, V94, P12457, DOI 10.1073/pnas.94.23.12457; Michael LF, 2001, P NATL ACAD SCI USA, V98, P3820, DOI 10.1073/pnas.061035098; Mincione G, 2003, EXP CELL RES, V287, P411, DOI 10.1016/S0014-4827(03)00155-1; Moustakas A, 2005, J CELL SCI, V118, P3573, DOI 10.1242/jcs.02554; Neitzke U, 2008, PLACENTA, V29, P246, DOI 10.1016/j.placenta.2007.11.014; Oak SA, 2006, AM J PHYSIOL-ENDOC M, V290, pE1321, DOI 10.1152/ajpendo.00437.2005; Ploug T, 2002, MOL MEMBR BIOL, V19, P39, DOI 10.1080/09687680110119229; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; Raychaudhuri N, 2008, J BIOL CHEM, V283, P13611, DOI 10.1074/jbc.M800128200; Rossetti L, 1997, J CLIN INVEST, V100, P1831, DOI 10.1172/JCI119711; Rowland AF, 2011, TRAFFIC, V12, P672, DOI 10.1111/j.1600-0854.2011.01178.x; Saccone V, 2010, ORGANOGENESIS, V6, P48, DOI 10.4161/org.6.1.11293; SALATI LM, 1988, LIPIDS, V23, P36, DOI 10.1007/BF02535302; Schabort EJ, 2009, EXP CELL RES, V315, P373, DOI 10.1016/j.yexcr.2008.10.037; Song K, 2003, J BIOL CHEM, V278, P38342, DOI 10.1074/jbc.M304583200; Standaert ML, 1997, J BIOL CHEM, V272, P30075, DOI 10.1074/jbc.272.48.30075; Tang XQ, 2009, RNA, V15, P287, DOI 10.1261/rna.1211209; Thai MV, 1998, J BIOL CHEM, V273, P14285, DOI 10.1074/jbc.273.23.14285; Thamotharan M, 2007, AM J PHYSIOL-ENDOC M, V292, pE1270, DOI 10.1152/ajpendo.00462.2006; Tosh DN, 2010, AM J PHYSIOL-GASTR L, V299, pG1023, DOI 10.1152/ajpgi.00052.2010; Townley-Tilson WHD, 2010, INT J BIOCHEM CELL B, V42, P1252, DOI 10.1016/j.biocel.2009.03.002; Varvarigou AA, 2010, J PEDIATR ENDOCR MET, V23, P215, DOI 10.1515/JPEM.2010.23.3.215; Verleysdonk S, 2004, NEUROCHEM RES, V29, P127, DOI 10.1023/B:NERE.0000010441.08234.ca; Villeneuve LM, 2010, DIABETES, V59, P2904, DOI 10.2337/db10-0208; Wallberg-Henriksson H, 2001, MOL MEMBR BIOL, V18, P205; Wang H, 2009, CELL CYCLE, V8, P1833, DOI 10.4161/cc.8.12.8851; Williams AH, 2009, CURR OPIN CELL BIOL, V21, P461, DOI 10.1016/j.ceb.2009.01.029; Yumi N, 2008, J CELL BIOL, V182, P587; Zhang J, 2008, CANCER RES, V68, P1046, DOI 10.1158/0008-5472.CAN-07-1927; Zhao Y, 2005, NATURE, V436, P214, DOI 10.1038/nature03817; Zisman A, 2000, NAT MED, V6, P924, DOI 10.1038/78693	69	20	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2012	7	4							e34596	10.1371/journal.pone.0034596	http://dx.doi.org/10.1371/journal.pone.0034596			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959FE	22506032	Green Submitted, gold, Green Published			2022-12-27	WOS:000305297500040
J	Feng, CG; Stamatos, NM; Dragan, AI; Medvedev, A; Whitford, M; Zhang, L; Song, C; Rallabhandi, P; Cole, L; Nhu, QM; Vogel, SN; Geddes, CD; Cross, AS				Feng, Chiguang; Stamatos, Nicholas M.; Dragan, Anatoliy I.; Medvedev, Andrei; Whitford, Melissa; Zhang, Lei; Song, Chang; Rallabhandi, Prasad; Cole, Leah; Nhu, Quan M.; Vogel, Stefanie N.; Geddes, Chris D.; Cross, Alan S.			Sialyl Residues Modulate LPS-Mediated Signaling through the Toll-Like Receptor 4 Complex	PLOS ONE			English	Article							RECURRENT BACTERIAL-INFECTIONS; N-LINKED GLYCOSYLATIONS; CELL-SURFACE; SIALIDASE ACTIVITY; TLR4-MD-2 COMPLEX; HUMAN NEUTROPHILS; PLASMA-MEMBRANE; IN-VIVO; MD-2; TLR4	We previously reported that neuraminidase (NA) pretreatment of human PBMCs markedly increased their cytokine response to lipopolysaccharide (LPS). To study the mechanisms by which this occurs, we transfected HEK293T cells with plasmids encoding TLR4, CD14, and MD2 (three components of the LPS receptor complex), as well as a NF-kappa B luciferase reporting system. Both TLR4 and MD2 encoded by the plasmids are alpha-2,6 sialylated. HEK293T cells transfected with TLR4/MD2/CD14 responded robustly to the addition of LPS; however, omission of the MD2 plasmid abrogated this response. Addition of culture supernatants from MD2 (sMD2)-transfected HEK293T cells, but not recombinant, non-glycosylated MD2 reconstituted this response. NA treatment of sMD2 enhanced the LPS response as did NA treatment of the TLR4/CD14-transfected cell supplemented with untreated sMD2, but optimal LPS-initiated responses were observed with NA-treated TLR4/CD14-transfected cells supplemented with NA-treated sMD2. We hypothesized that removal of negatively charged sialyl residues from glycans on the TLR4 complex would hasten the dimerization of TLR4 monomers required for signaling. Co-transfection of HEK293T cells with separate plasmids encoding either YFP- or FLAG-tagged TLR4, followed by treatment with NA and stimulation with LPS, led to an earlier and more robust time-dependent dimerization of TLR4 monomers on co-immunoprecipitation, compared to untreated cells. These findings were confirmed by fluorescence resonance energy transfer (FRET) analysis. Overexpression of human Neu1 increased LPS-initiated TLR4-mediated NF-kappa B activation and a NA inhibitor suppressed its activation. We conclude that (1) sialyl residues on TLR4 modulate LPS responsiveness, perhaps by facilitating clustering of the homodimers, and that (2) sialic acid, and perhaps other glycosyl species, regulate MD2 activity required for LPS-mediated signaling. We speculate that endogenous sialidase activity mobilized during cell activation may play a role in this regulation.	[Feng, Chiguang; Whitford, Melissa; Zhang, Lei; Cross, Alan S.] Univ Maryland, Sch Med, Ctr Vaccine Dev, Baltimore, MD 21201 USA; [Stamatos, Nicholas M.] Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA; [Stamatos, Nicholas M.] Univ Maryland, Sch Med, Inst Human Virol, Baltimore, MD 21201 USA; [Dragan, Anatoliy I.; Geddes, Chris D.] Univ Maryland, Inst Fluorescence, Baltimore, MD 21201 USA; [Medvedev, Andrei; Song, Chang; Rallabhandi, Prasad; Cole, Leah; Nhu, Quan M.; Vogel, Stefanie N.] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University of Maryland Baltimore County; University System of Maryland; University of Maryland Baltimore	Feng, CG (corresponding author), Univ Maryland, Sch Med, Ctr Vaccine Dev, Baltimore, MD 21201 USA.	across@medicine.umaryland.edu			National Institutes of Health (NIH) [HL086933-01A1]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086933] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007540, R01AI018797] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	These studies were supported by National Institutes of Health (NIH) grant HL086933-01A1 to ASC. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amith SR, 2010, CELL SIGNAL, V22, P314, DOI 10.1016/j.cellsig.2009.09.038; Amith SR, 2009, GLYCOCONJUGATE J, V26, P1197, DOI 10.1007/s10719-009-9239-8; Bagriacik EU, 1999, GLYCOBIOLOGY, V9, P267, DOI 10.1093/glycob/9.3.267; Casanova JL, 2011, ANNU REV IMMUNOL, V29, P447, DOI 10.1146/annurev-immunol-030409-101335; Correia JD, 2002, J BIOL CHEM, V277, P1845, DOI 10.1074/jbc.M109910200; CROSS AS, 1991, J CLIN INVEST, V88, P2067, DOI 10.1172/JCI115536; Cross AS, 2003, J BIOL CHEM, V278, P4112, DOI 10.1074/jbc.M207591200; CROSS AS, 1989, J EXP MED, V169, P2021, DOI 10.1084/jem.169.6.2021; Dragan AI, 2004, J MOL BIOL, V343, P371, DOI 10.1016/j.jmb.2004.08.035; Dragan AI, 2008, METHOD ENZYMOL, V450, P185, DOI 10.1016/S0076-6879(08)03409-5; Feng CG, 2011, J LEUKOCYTE BIOL, V90, P313, DOI 10.1189/jlb.1210708; FOGEL M, 1983, J EXP MED, V157, P371, DOI 10.1084/jem.157.1.371; GALJART NJ, 1991, J BIOL CHEM, V266, P14754; Gioannini TL, 2004, P NATL ACAD SCI USA, V101, P4186, DOI 10.1073/pnas.0306906101; Hinek A, 2008, AM J PATHOL, V173, P1042, DOI 10.2353/ajpath.2008.071081; KEARSE KP, 1988, J IMMUNOL, V140, P1770; Kim HM, 2007, CELL, V130, P906, DOI 10.1016/j.cell.2007.08.002; Kobayashi M, 2006, J IMMUNOL, V176, P6211, DOI 10.4049/jimmunol.176.10.6211; Liang F, 2006, J BIOL CHEM, V281, P27526, DOI 10.1074/jbc.M605633200; Medvedev AE, 2005, J IMMUNOL, V174, P6587, DOI 10.4049/jimmunol.174.11.6587; Medvedev AE, 2003, J EXP MED, V198, P521, DOI 10.1084/jem.20030701; Medvedev AE, 2007, J BIOL CHEM, V282, P16042, DOI 10.1074/jbc.M606781200; Meng J, 2008, J BIOL CHEM, V283, P3376, DOI 10.1074/jbc.M707640200; Miyake K, 2006, J ENDOTOXIN RES, V12, P195, DOI 10.1179/096805106X118807; Monti E, 2002, NEUROCHEM RES, V27, P649, DOI 10.1023/A:1020276000901; Nagai Y, 2002, NAT IMMUNOL, V3, P667, DOI 10.1038/ni809; Nan XL, 2007, J LEUKOCYTE BIOL, V81, P284, DOI 10.1189/jlb.1105692; Nomura S, 2003, PROTEIN EXPRES PURIF, V28, P310, DOI 10.1016/S1046-5928(02)00705-2; OBRIEN AD, 1980, NATURE, V287, P440, DOI 10.1038/287440a0; Ohnishi T, 2003, CLIN DIAGN LAB IMMUN, V10, P405, DOI 10.1128/CDLI.10.3.405-410.2003; Ohnishi T, 2001, J IMMUNOL, V167, P3354, DOI 10.4049/jimmunol.167.6.3354; Overton MC, 2000, CURR BIOL, V10, P341, DOI 10.1016/S0960-9822(00)00386-9; Papini N, 2004, J BIOL CHEM, V279, P16989, DOI 10.1074/jbc.M400881200; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Patterson GH, 2000, ANAL BIOCHEM, V284, P438, DOI 10.1006/abio.2000.4708; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Rallabhandi P, 2008, J IMMUNOL, V180, P1139, DOI 10.4049/jimmunol.180.2.1139; Rallabhandi P, 2006, J IMMUNOL, V177, P322, DOI 10.4049/jimmunol.177.1.322; Rifat S, 2008, J LEUKOCYTE BIOL, V84, P1075, DOI 10.1189/jlb.0706462; ROGGENTIN P, 1993, MOL MICROBIOL, V9, P915, DOI 10.1111/j.1365-2958.1993.tb01221.x; Sakarya S, 2004, GLYCOBIOLOGY, V14, P481, DOI 10.1093/glycob/cwh065; SCHAUER R, 1985, TRENDS BIOCHEM SCI, V10, P357, DOI 10.1016/0968-0004(85)90112-4; Schromm AB, 2001, J EXP MED, V194, P79, DOI 10.1084/jem.194.1.79; SETOGUCHI M, 1989, BIOCHIM BIOPHYS ACTA, V1008, P213, DOI 10.1016/0167-4781(80)90012-3; Stamatos NM, 2010, J LEUKOCYTE BIOL, V88, P1227, DOI 10.1189/jlb.1209776; Stamatos NM, 2004, J LEUKOCYTE BIOL, V75, P307, DOI 10.1189/jlb.0503241; Stelter F, 1996, EUR J BIOCHEM, V236, P457, DOI 10.1111/j.1432-1033.1996.00457.x; Teghanemt A, 2008, J BIOL CHEM, V283, P21881, DOI 10.1074/jbc.M800672200; Vasl J, 2008, J IMMUNOL, V180, P6107, DOI 10.4049/jimmunol.180.9.6107; Vasta GR, 2009, NAT REV MICROBIOL, V7, P424, DOI 10.1038/nrmicro2146; Visentin A, 2001, PNAS, V98, P12156; Visintin A, 2006, J LEUKOCYTE BIOL, V80, P1584, DOI 10.1189/jlb.0606388; Wang Y, 2002, J BIOL CHEM, V277, P26252, DOI 10.1074/jbc.M110515200	53	35	35	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2012	7	4							e32359	10.1371/journal.pone.0032359	http://dx.doi.org/10.1371/journal.pone.0032359			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JO	22496731	Green Submitted, gold, Green Published			2022-12-27	WOS:000305014500003
J	Feverati, G; Achoch, M; Zrimi, J; Vuillon, L; Lesieur, C				Feverati, Giovanni; Achoch, Mounia; Zrimi, Jihad; Vuillon, Laurent; Lesieur, Claire			Beta-Strand Interfaces of Non-Dimeric Protein Oligomers Are Characterized by Scattered Charged Residue Patterns	PLOS ONE			English	Article							SIDE-CHAIN; BACTERIOPHAGE-T4 FIBRITIN; ALZHEIMERS-DISEASE; RECOGNITION SITES; CHOLERA-TOXIN; COILED COILS; ALPHA-HELIX; ASSEMBLIES; SEQUENCES; FORMS	Protein oligomers are formed either permanently, transiently or even by default. The protein chains are associated through intermolecular interactions constituting the protein interface. The protein interfaces of 40 soluble protein oligomers of stoechiometries above two are investigated using a quantitative and qualitative methodology, which analyzes the x-ray structures of the protein oligomers and considers their interfaces as interaction networks. The protein oligomers of the dataset share the same geometry of interface, made by the association of two individual beta-strands (beta-interfaces), but are otherwise unrelated. The results show that the beta-interfaces are made of two interdigitated interaction networks. One of them involves interactions between main chain atoms (backbone network) while the other involves interactions between side chain and backbone atoms or between only side chain atoms (side chain network). Each one has its own characteristics which can be associated to a distinct role. The secondary structure of the beta-interfaces is implemented through the backbone networks which are enriched with the hydrophobic amino acids favored in intramolecular beta-sheets (MCWIV). The intermolecular specificity is provided by the side chain networks via positioning different types of charged residues at the extremities (arginine) and in the middle (glutamic acid and histidine) of the interface. Such charge distribution helps discriminating between sequences of intermolecular beta-strands, of intramolecular beta-strands and of beta-strands forming beta-amyloid fibers. This might open new venues for drug designs and predictive tool developments. Moreover, the beta-strands of the cholera toxin B subunit interface, when produced individually as synthetic peptides, are capable of inhibiting the assembly of the toxin into pentamers. Thus, their sequences contain the features necessary for a beta-interface formation. Such beta-strands could be considered as 'assemblons', independent associating units, by homology to the foldons (independent folding unit). Such property would be extremely valuable in term of assembly inhibitory drug development.	[Feverati, Giovanni; Achoch, Mounia; Zrimi, Jihad; Lesieur, Claire] Univ Savoie, Annecy Le Vieux, France; [Achoch, Mounia; Zrimi, Jihad] Univ Cadi Ayyad, LCBM, Fac Sci & Tech Gueliz, Marrakech, Morocco; [Vuillon, Laurent] Univ Savoie, LAMA, Le Bourget Du Lac, France; [Lesieur, Claire] Univ Grenoble 1, AGIM, Archamps, France	Universite de Savoie; Cadi Ayyad University of Marrakech; Centre National de la Recherche Scientifique (CNRS); Universite de Savoie; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Feverati, G (corresponding author), Univ Savoie, Annecy Le Vieux, France.	lesieur@lapp.in2p3.fr	Vuillon, Laurent/AAR-6864-2020; Feverati, Giovanni/L-8248-2013		The system complex Rhone Alpes IXXI; University of Savoie	The system complex Rhone Alpes IXXI(Region Auvergne-Rhone-Alpes); University of Savoie	This work was supported by The system complex Rhone Alpes IXXI (5000 euros). Supported by the University of Savoie (4000 euros) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bode C, 2007, FEBS LETT, V581, P2776, DOI 10.1016/j.febslet.2007.05.021; Calladine CR, 2001, J MOL BIOL, V305, P603, DOI 10.1006/jmbi.2000.4320; Cazals F, 2006, PROTEIN SCI, V15, P2082, DOI 10.1110/ps.062245906; Chakrabarti P, 2002, PROTEINS, V47, P334, DOI 10.1002/prot.10085; Conrady DG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015153; CRICK FHC, 1953, ACTA CRYSTALLOGR, V6, P689, DOI 10.1107/S0365110X53001964; Dang LT, 2011, J BIOL CHEM; Davis FP, 2005, BIOINFORMATICS, V21, P1901, DOI 10.1093/bioinformatics/bti277; de la Paz ML, 2004, P NATL ACAD SCI USA, V101, P87, DOI 10.1073/pnas.2634884100; de la Paz ML, 2002, P NATL ACAD SCI USA, V99, P16052, DOI 10.1073/pnas.252340199; FarzadFard F, 2008, J STRUCT BIOL, V161, P101, DOI 10.1016/j.jsb.2007.09.024; Gan L, 2003, BIOCHEMISTRY-US, V42, P857, DOI 10.1021/bi0271401; Gao M, 2010, P NATL ACAD SCI USA, V107, P22517, DOI 10.1073/pnas.1012820107; GARRATT RC, 1991, FEBS LETT, V280, P141, DOI 10.1016/0014-5793(91)80223-P; Goodsell DS, 2000, ANNU REV BIOPH BIOM, V29, P105, DOI 10.1146/annurev.biophys.29.1.105; Grigoryan G, 2008, CURR OPIN STRUC BIOL, V18, P477, DOI 10.1016/j.sbi.2008.04.008; Grueninger D, 2008, SCIENCE, V319, P206, DOI 10.1126/science.1150421; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Guharoy M, 2007, BIOINFORMATICS, V23, P1909, DOI 10.1093/bioinformatics/btm274; Guidry Jesse J, 2003, BMC Biochem, V4, P14, DOI 10.1186/1471-2091-4-14; Hadley EB, 2008, P NATL ACAD SCI USA, V105, P530, DOI 10.1073/pnas.0709068105; Harrison RS, 2007, REV PHYSIOL BIOCH P, V159, P1, DOI 10.1007/112_2007_0701; Iacovache I, 2008, BIOCH BIOPHYS ACTA; Janin J, 2008, Q REV BIOPHYS, V41, P133, DOI 10.1017/S0033583508004708; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; Kirkitadze MD, 2002, J NEUROSCI RES, V69, P567, DOI 10.1002/jnr.10328; Klein WL, 2004, NEUROBIOL AGING, V25, P569, DOI 10.1016/j.neurobiolaging.2004.02.010; Krishnan A, 2008, CURR PROTEIN PEPT SC, V9, P28; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Larsen TA, 1998, STRUCT FOLD DES, V6, P421, DOI 10.1016/S0969-2126(98)00044-6; Lesieur C, 1997, MOL MEMBR BIOL, V14, P45, DOI 10.3109/09687689709068435; Lesieur C, 2002, J BIOL CHEM, V277, P16697, DOI 10.1074/jbc.M110561200; Lesieur C, 2010, PLOS ONE; Lo Conte L, 1999, J MOL BIOL, V285, P2177; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Lupas A, 1996, TRENDS BIOCHEM SCI, V21, P375, DOI 10.1016/0968-0004(96)10052-9; Ma B, 2007, CURR TOP MED CHEM, V7, P999, DOI 10.2174/156802607780906717; Ma BY, 2003, P NATL ACAD SCI USA, V100, P5772, DOI 10.1073/pnas.1030237100; Ma BY, 2000, J MOL BIOL, V296, P1091, DOI 10.1006/jmbi.2000.3518; Marshall KE, 2009, BIOCHEM SOC T, V37, P671, DOI 10.1042/BST0370671; Martin AJM, 2011, BIOINFORMATICS, V27, P2003, DOI 10.1093/bioinformatics/btr191; Merkel JS, 1999, STRUCT FOLD DES, V7, P1333, DOI 10.1016/S0969-2126(00)80023-4; Miller Y, 2010, POLYM ALZHEIMER AMYL; MINOR DL, 1994, NATURE, V367, P660, DOI 10.1038/367660a0; Mitraki A, 2005, METH MOL B, V300, P125; Moskaleva O, 2010, ACTA CRYSTALLOGR F, V66, P760, DOI 10.1107/S1744309110017331; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Nikulin A, 2005, ACTA CRYSTALLOGR D, V61, P141, DOI 10.1107/S0907444904030008; Panchenko AR, 1997, J MOL BIOL, V272, P95, DOI 10.1006/jmbi.1997.1205; Panchenko AR, 1996, P NATL ACAD SCI USA, V93, P2008, DOI 10.1073/pnas.93.5.2008; Papanikolopoulou K, 2004, J MOL BIOL, V342, P219, DOI 10.1016/j.jmb.2004.07.008; Papanikolopoulou K, 2004, J BIOL CHEM, V279, P8991, DOI 10.1074/jbc.M311791200; Penel S, 1999, J MOL BIOL, V287, P127, DOI 10.1006/jmbi.1998.2549; Richardson JS, 2002, P NATL ACAD SCI USA, V99, P2754, DOI 10.1073/pnas.052706099; Ruddock LW, 1996, J BIOL CHEM, V271, P19118, DOI 10.1074/jbc.271.32.19118; Shomura Y, 2004, J MOL BIOL, V335, P1265, DOI 10.1016/j.jmb.2003.11.028; Shulman-Peleg A, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-43; Soto C, 2003, NAT REV NEUROSCI, V4, P49, DOI 10.1038/nrn1007; Stein A, 2011, 3 DIMENSIONAL MODELI; Tacnet P, 2008, BBA-PROTEINS PROTEOM, V1784, P518, DOI 10.1016/j.bbapap.2007.12.005; Tsai CJ, 1996, J MOL BIOL, V260, P604, DOI 10.1006/jmbi.1996.0424; Tsai CJ, 1997, PROTEIN SCI, V6, P53; Tsai CJ, 1996, CRIT REV BIOCHEM MOL, V31, P127, DOI 10.3109/10409239609106582; Tuncbag N, 2009, BRIEF BIOINFORM, V10, P217, DOI 10.1093/bib/bbp001; Walshaw J, 2003, J STRUCT BIOL, V144, P349, DOI 10.1016/j.jsb.2003.10.014; Yan C, 2008, PROTEIN J, V27, P59, DOI 10.1007/s10930-007-9108-x; ZHANG RG, 1995, J MOL BIOL, V251, P563, DOI 10.1006/jmbi.1995.0456; Zrimi J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015347	68	9	9	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2012	7	4							e32558	10.1371/journal.pone.0032558	http://dx.doi.org/10.1371/journal.pone.0032558			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JO	22496732	Green Published, Green Submitted, gold			2022-12-27	WOS:000305014500004
J	Mota, NB; Vasconcelos, NAP; Lemos, N; Pieretti, AC; Kinouchi, O; Cecchi, GA; Copelli, M; Ribeiro, S				Mota, Natalia B.; Vasconcelos, Nivaldo A. P.; Lemos, Nathalia; Pieretti, Ana C.; Kinouchi, Osame; Cecchi, Guillermo A.; Copelli, Mauro; Ribeiro, Sidarta			Speech Graphs Provide a Quantitative Measure of Thought Disorder in Psychosis	PLOS ONE			English	Article							STRUCTURED CLINICAL INTERVIEW	Background: Psychosis has various causes, including mania and schizophrenia. Since the differential diagnosis of psychosis is exclusively based on subjective assessments of oral interviews with patients, an objective quantification of the speech disturbances that characterize mania and schizophrenia is in order. In principle, such quantification could be achieved by the analysis of speech graphs. A graph represents a network with nodes connected by edges; in speech graphs, nodes correspond to words and edges correspond to semantic and grammatical relationships. Methodology/Principal Findings: To quantify speech differences related to psychosis, interviews with schizophrenics, manics and normal subjects were recorded and represented as graphs. Manics scored significantly higher than schizophrenics in ten graph measures. Psychopathological symptoms such as logorrhea, poor speech, and flight of thoughts were grasped by the analysis even when verbosity differences were discounted. Binary classifiers based on speech graph measures sorted schizophrenics from manics with up to 93.8% of sensitivity and 93.7% of specificity. In contrast, sorting based on the scores of two standard psychiatric scales (BPRS and PANSS) reached only 62.5% of sensitivity and specificity. Conclusions/Significance: The results demonstrate that alterations of the thought process manifested in the speech of psychotic patients can be objectively measured using graph-theoretical tools, developed to capture specific features of the normal and dysfunctional flow of thought, such as divergence and recurrence. The quantitative analysis of speech graphs is not redundant with standard psychometric scales but rather complementary, as it yields a very accurate sorting of schizophrenics and manics. Overall, the results point to automated psychiatric diagnosis based not on what is said, but on how it is said.	[Mota, Natalia B.; Vasconcelos, Nivaldo A. P.; Lemos, Nathalia; Pieretti, Ana C.; Ribeiro, Sidarta] Univ Fed Rio Grande do Norte, Inst Brain, BR-59072970 Natal, RN, Brazil; [Mota, Natalia B.] Univ Fed Rio Grande do Norte, Hosp Onofre Lopes, BR-59072970 Natal, RN, Brazil; [Mota, Natalia B.] Edmond & Lily Safra Int Inst Neurosci Natal, Natal, RN, Brazil; [Vasconcelos, Nivaldo A. P.] Fac Natalense Desenvolvimento Rio Grande Norte, Natal, RN, Brazil; [Vasconcelos, Nivaldo A. P.] Univ Fed Campina Grande, Dept Syst & Computat, Campina Grande, Brazil; [Kinouchi, Osame] Univ Sao Paulo, Dept Phys, BR-14049 Ribeirao Preto, Brazil; [Cecchi, Guillermo A.] IBM Corp, Thomas J Watson Res Ctr, IBM Res Div, Biometaphor Comp,Computat Biol Ctr, Yorktown Hts, NY 10598 USA; [Copelli, Mauro] Univ Fed Pernambuco, Dept Phys, Recife, PE, Brazil	Universidade Federal do Rio Grande do Norte; Universidade Federal do Rio Grande do Norte; Universidade Federal de Campina Grande; Universidade de Sao Paulo; International Business Machines (IBM); Universidade Federal de Pernambuco	Mota, NB (corresponding author), Univ Fed Rio Grande do Norte, Inst Brain, BR-59072970 Natal, RN, Brazil.	sidartaribeiro@neuro.ufrn.br	Mota, Natália/O-4089-2019; Copelli, Mauro/C-6336-2009; Mota, Natalia B/J-6837-2012; de Vasconcelos, Nivaldo A P/M-6521-2019; Kinouchi, Osame/G-4074-2012; Copelli, Mauro/AAG-8110-2020; Ribeiro, Sidarta/C-5794-2016	Mota, Natália/0000-0003-2802-2001; Copelli, Mauro/0000-0001-7441-2858; de Vasconcelos, Nivaldo A P/0000-0002-0472-8205; Kinouchi, Osame/0000-0002-5876-3129; Ribeiro, Sidarta/0000-0001-9325-9545	FINEP [01.06.1092.00]; CNPq Universal [481506/2007-1]; CNPq; Capes; a'd Associacao Alberto Santos Dumont para Apoio a Pesquisa (AASDAP)	FINEP(Financiadora de Inovacao e Pesquisa (Finep)); CNPq Universal(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Capes(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); a'd Associacao Alberto Santos Dumont para Apoio a Pesquisa (AASDAP)	Support obtained from FINEP 01.06.1092.00, CNPq Universal 481506/2007-1, CNPq and Capes fellowships, a'd Associacao Alberto Santos Dumont para Apoio a Pesquisa (AASDAP); http://www.finep.gov.br/; http://www.cnpq.br/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bales ME, 2006, J BIOMED INFORM, V39, P451, DOI 10.1016/j.jbi.2005.10.007; BECH P, 1986, ACTA PSYCHIAT SCAND, V73, P1; Bishop C. M., 2006, J ELECT IMAG, V16, P140; Blei DM, 2003, J MACH LEARN RES, V3, P993, DOI 10.1162/jmlr.2003.3.4-5.993; Bollobas B, 1998, MODERN GRAPH THEORY, P103; Borner K, 2007, ANNU REV INFORM SCI, V41, P537, DOI 10.1002/aris.2007.1440410119; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Butts CT, 2009, SCIENCE, V325, P414, DOI 10.1126/science.1171022; Cancho RFI, 2001, P ROY SOC B-BIOL SCI, V268, P2261, DOI 10.1098/rspb.2001.1800; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Duda R.O., 2000, PATTERN CLASSIFICATI; Costa ME, 2009, FRONT INTEGR NEUROSC, V3, DOI 10.3389/neuro.07.019.2009; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; First MB, 1990, STRUCTURED CLIN INTE; Grinker RR, 2010, NATURE, V468, P168, DOI 10.1038/468168a; Hall M., 2009, SIGKDD EXPLORATIONS, V11; Hoffman RE, 2011, BIOL PSYCHIAT, V69, P997, DOI 10.1016/j.biopsych.2010.12.036; Holanda AJ, 2004, 1 WORKSH TECN INF LI, P530; Insel TR, 2010, NATURE, V468, P187, DOI 10.1038/nature09552; John G. H., 1995, Uncertainty in Artificial Intelligence. Proceedings of the Eleventh Conference (1995), P338; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Kotsiantis SB, 2007, FRONT ARTIF INTEL AP, V160, P3; Ma'ayan A, 2008, P NATL ACAD SCI USA, V105, P19235, DOI 10.1073/pnas.0805344105; Moretti F, 2011, NEW LEFT REV, P80; Sadock BJ, 2009, KAPLAN SADOCKS COMPR, V9th; Sigman M, 2002, P NATL ACAD SCI USA, V99, P1742, DOI 10.1073/pnas.022341799; Singh M., 1995, Machine Learning. Proceedings of the Twelfth International Conference on Machine Learning, P497; SKRE I, 1991, ACTA PSYCHIAT SCAND, V84, P167, DOI 10.1111/j.1600-0447.1991.tb03123.x; Turing A.M., 1950, MIND, P433, DOI DOI 10.1093/MIND/LIX.236.433; WILLIAMS JBW, 1992, ARCH GEN PSYCHIAT, V49, P630	30	106	112	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2012	7	4							e34928	10.1371/journal.pone.0034928	http://dx.doi.org/10.1371/journal.pone.0034928			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JO	22506057	gold, Green Published, Green Submitted			2022-12-27	WOS:000305014500037
J	Sardar, P; Kumar, A; Bhandari, A; Goswami, C				Sardar, Puspendu; Kumar, Abhishek; Bhandari, Anita; Goswami, Chandan			Conservation of Tubulin-Binding Sequences in TRPV1 throughout Evolution	PLOS ONE			English	Article							VANILLOID RECEPTOR TRPV1; ALPHA-BETA-TUBULIN; CAPSAICIN-RECEPTOR; DATABASE RESOURCES; MOLECULAR-BASIS; NATIONAL-CENTER; C-TERMINUS; CHANNEL; IDENTIFICATION; CYTOSKELETON	Background: Transient Receptor Potential Vanilloid sub type 1 (TRPV1), commonly known as capsaicin receptor can detect multiple stimuli ranging from noxious compounds, low pH, temperature as well as electromagnetic wave at different ranges. In addition, this receptor is involved in multiple physiological and sensory processes. Therefore, functions of TRPV1 have direct influences on adaptation and further evolution also. Availability of various eukaryotic genomic sequences in public domain facilitates us in studying the molecular evolution of TRPV1 protein and the respective conservation of certain domains, motifs and interacting regions that are functionally important. Methodology and Principal Findings: Using statistical and bioinformatics tools, our analysis reveals that TRPV1 has evolved about similar to 420 million years ago (MYA). Our analysis reveals that specific regions, domains and motifs of TRPV1 has gone through different selection pressure and thus have different levels of conservation. We found that among all, TRP box is the most conserved and thus have functional significance. Our results also indicate that the tubulin binding sequences (TBS) have evolutionary significance as these stretch sequences are more conserved than many other essential regions of TRPV1. The overall distribution of positively charged residues within the TBS motifs is conserved throughout evolution. In silico analysis reveals that the TBS-1 and TBS-2 of TRPV1 can form helical structures and may play important role in TRPV1 function. Conclusions and Significance: Our analysis identifies the regions of TRPV1, which are important for structure - function relationship. This analysis indicates that tubulin binding sequence-1 (TBS-1) near the TRP-box forms a potential helix and the tubulin interactions with TRPV1 via TBS-1 have evolutionary significance. This interaction may be required for the proper channel function and regulation and may also have significance in the context of Taxol (R)-induced neuropathy.	[Sardar, Puspendu; Goswami, Chandan] Natl Inst Sci Educ & Res, Bhubaneswar, Orissa, India; [Kumar, Abhishek] Univ Kiel, Abt Bot Genet & Mol Biol, Inst Bot, D-2300 Kiel, Germany; [Bhandari, Anita] Univ Kiel, Lehrstuhl Mol Phytopathol, Kiel, Germany; [Kumar, Abhishek] Univ Kiel, Bot Garten, Kiel, Germany	National Institute of Science Education & Research (NISER); University of Kiel; University of Kiel; University of Kiel	Sardar, P (corresponding author), Natl Inst Sci Educ & Res, Bhubaneswar, Orissa, India.	chandan@niser.ac.in	Kumar, Abhishek/A-8727-2012; Sardar, Puspendu/W-6727-2019	Kumar, Abhishek/0000-0003-4172-4059; Sardar, Puspendu/0000-0001-8011-2915	NISER, Bhubaneswar	NISER, Bhubaneswar	The support from all lab members is acknowledged. We acknowledge the financial support from NISER, Bhubaneswar.	Baxevanis AD, 1996, NUCLEIC ACIDS RES, V24, P245, DOI 10.1093/nar/24.1.245; Bhalla KN, 2003, ONCOGENE, V22, P9075, DOI 10.1038/sj.onc.1207233; Blagosklonny MV, 1999, INT J CANCER, V83, P151, DOI 10.1002/(SICI)1097-0215(19991008)83:2<151::AID-IJC1>3.0.CO;2-5; Canta A, 2009, CURR MED CHEM, V16, P1315, DOI 10.2174/092986709787846488; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Caterina MJ, 1999, NATURE, V398, P436, DOI 10.1038/18906; Chen JM, 2003, MOL BIOL EVOL, V20, P1767, DOI 10.1093/molbev/msg183; Cortright DN, 2004, EUR J BIOCHEM, V271, P1814, DOI 10.1111/j.1432-1033.2004.04082.x; Cotnoir-White D, 2011, MOL CELL ENDOCRINOL, V334, P76, DOI 10.1016/j.mce.2010.10.021; Denis V, 2002, J CELL BIOL, V156, P29, DOI 10.1083/jcb.200111004; Dickerson R E., 1971, Journal Molec Evol, V1, P26, DOI 10.1007/BF01659392; Dina OA, 2003, NEURON, V39, P613, DOI 10.1016/S0896-6273(03)00473-2; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Farid NR, 2004, ENDOCRINOLOGY, V145, P4048, DOI 10.1210/en.2004-0437; Flicek P, 2010, NUCLEIC ACIDS RES, V38, pD557, DOI 10.1093/nar/gkp972; Garcia-Sanz N, 2004, J NEUROSCI, V24, P5307, DOI 10.1523/JNEUROSCI.0202-04.2004; Geng J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028644; Gilbar Peter, 2009, J Oncol Pharm Pract, V15, P143, DOI 10.1177/1078155208100450; Goswami C, 2007, J NEUROCHEM, V103, P1319, DOI 10.1111/j.1471-4159.2007.04846.x; Goswami C, 2007, J NEUROCHEM, V101, P250, DOI 10.1111/j.1471-4159.2006.04338.x; Goswami C, 2007, FEBS J, V274, P760, DOI 10.1111/j.1742-4658.2006.05621.x; Goswami C, 2006, J NEUROCHEM, V96, P254, DOI 10.1111/j.1471-4159.2005.03551.x; Goswami C, 2004, J NEUROCHEM, V91, P1092, DOI 10.1111/j.1471-4159.2004.02795.x; Goswami C, 2008, FEBS J, V275, P4684, DOI 10.1111/j.1742-4658.2008.06617.x; Goswami C, 2011, J NEUROCHEM, V117, P995, DOI 10.1111/j.1471-4159.2011.07270.x; Goswami C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011654; Gracheva EO, 2011, NATURE, V476, P88, DOI 10.1038/nature10245; Gracheva EO, 2010, NATURE, V464, P1006, DOI 10.1038/nature08943; Hubbard TJP, 2009, NUCLEIC ACIDS RES, V37, pD690, DOI 10.1093/nar/gkn828; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jordt SE, 2002, CELL, V108, P421, DOI 10.1016/S0092-8674(02)00637-2; Jose-Estanyol M, 2004, PLANT PHYSIOL BIOCH, V42, P355, DOI 10.1016/j.plaphy.2004.03.009; KRUSKAL WH, 1952, J AM STAT ASSOC, V47, P583, DOI 10.1080/01621459.1952.10483441; Kumar A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022046; Kumar A, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-250; Lainez S, 2010, FASEB J, V24, P1958, DOI 10.1096/fj.09-151472; Lee JJ, 2006, J CLIN ONCOL, V24, P1633, DOI 10.1200/JCO.2005.04.0543; Lishko PV, 2007, NEURON, V54, P905, DOI 10.1016/j.neuron.2007.05.027; Lowe J, 2001, J MOL BIOL, V313, P1045, DOI 10.1006/jmbi.2001.5077; MASON JR, 1983, PHARMACOL BIOCHEM BE, V19, P857, DOI 10.1016/0091-3057(83)90093-X; Nogales E, 1998, NATURE, V391, P199, DOI 10.1038/34465; Numazaki M, 2003, P NATL ACAD SCI USA, V100, P8002, DOI 10.1073/pnas.1337252100; Phelps CB, 2008, BIOCHEMISTRY-US, V47, P2476, DOI 10.1021/bi702109w; Picazo-Juarez G, 2011, J BIOL CHEM, V286, P24966, DOI 10.1074/jbc.M111.237537; Planells-Cases R, 2005, PFLUG ARCH EUR J PHY, V451, P151, DOI 10.1007/s00424-005-1423-5; Prescott ED, 2003, SCIENCE, V300, P1284, DOI 10.1126/science.1083646; Ragg H, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-208; ROSSLER W, 1993, NEUROPEPTIDES, V25, P241, DOI 10.1016/0143-4179(93)90109-N; ROYTTA M, 1985, J NEUROCYTOL, V14, P157, DOI 10.1007/BF01150269; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tewksbury JJ, 2008, P NATL ACAD SCI USA, V105, P11808, DOI 10.1073/pnas.0802691105; Tominaga M, 1998, NEURON, V21, P531, DOI 10.1016/S0896-6273(00)80564-4; Valente P, 2008, FASEB J, V22, P3298, DOI 10.1096/fj.08-107425; Wheeler DL, 2007, NUCLEIC ACIDS RES, V35, pD5, DOI 10.1093/nar/gkl1031; Wheeler DL, 2006, NUCLEIC ACIDS RES, V34, pD173, DOI 10.1093/nar/gkj158; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; WHITE JG, 1982, BLOOD, V60, P474; Worby CA, 2002, NAT REV MOL CELL BIO, V3, P919, DOI 10.1038/nrm974; Zhang F, 2011, J BIOL CHEM, V286, P15308, DOI 10.1074/jbc.M111.223941; Zhou XL, 2003, P NATL ACAD SCI USA, V100, P7105, DOI 10.1073/pnas.1230540100	61	22	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2012	7	4							e31448	10.1371/journal.pone.0031448	http://dx.doi.org/10.1371/journal.pone.0031448			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JO	22496727	Green Published, Green Submitted, gold			2022-12-27	WOS:000305014500001
J	Pham, KT; Weiss, E; Soto, LFJ; Breithaupt, U; Haas, R; Fischer, W				Kieu Thuy Pham; Weiss, Evelyn; Soto, Luisa F. Jimenez; Breithaupt, Ute; Haas, Rainer; Fischer, Wolfgang			CagI Is an Essential Component of the Helicobacter pylori Cag Type IV Secretion System and Forms a Complex with CagL	PLOS ONE			English	Article							PATHOGENICITY ISLAND; PROTEIN; TRANSLOCATION; SURFACE; STABILIZATION; INDUCTION; SIGNAL; GENES; CELLS; VIRB5	Helicobacter pylori, the causative agent of type B gastritis, peptic ulcers, gastric adenocarcinoma and MALT lymphoma, uses the Cag type IV secretion system to induce a strong proinflammatory response in the gastric mucosa and to inject its effector protein CagA into gastric cells. CagA translocation results in altered host cell gene expression profiles and cytoskeletal rearrangements, and it is considered as a major bacterial virulence trait. Recently, it has been shown that binding of the type IV secretion apparatus to integrin receptors on target cells is a crucial step in the translocation process. Several bacterial proteins, including the Cag-specific components CagL and CagI, have been involved in this interaction. Here, we have examined the localization and interactions of CagI in the bacterial cell. Since the cagI gene overlaps and is co-transcribed with the cagL gene, the role of CagI for type IV secretion system function has been difficult to assess, and conflicting results have been reported regarding its involvement in the proinflammatory response. Using a marker-free gene deletion approach and genetic complementation, we show now that CagI is an essential component of the Cag type IV secretion apparatus for both CagA translocation and interleukin-8 induction. CagI is distributed over soluble and membrane-associated pools and seems to be partly surface-exposed. Deletion of several genes encoding essential Cag components has an impact on protein levels of CagI and CagL, suggesting that both proteins require partial assembly of the secretion apparatus. Finally, we show by co-immunoprecipitation that CagI and CagL interact with each other. Taken together, our results indicate that CagI and CagL form a functional complex which is formed at a late stage of secretion apparatus assembly.	[Kieu Thuy Pham; Weiss, Evelyn; Soto, Luisa F. Jimenez; Breithaupt, Ute; Haas, Rainer; Fischer, Wolfgang] Univ Munich, Max von Pettenkofer Inst Hyg & Med Mikrobiol, Munich, Germany	University of Munich	Pham, KT (corresponding author), Univ Munich, Max von Pettenkofer Inst Hyg & Med Mikrobiol, Munich, Germany.	fischer@mvp.uni-muenchen.de		Jimenez Soto, Luisa Fernanda/0000-0001-8551-5019	Deutsche Forschungsgemeinschaft [Ha2697/15-1]; Ministry of Education and Training of the Socialist Republic of Vietnam	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Ministry of Education and Training of the Socialist Republic of Vietnam	This work was supported by a research grant from the Deutsche Forschungsgemeinschaft (Ha2697/15-1) to RH. KTP received a research scholarship from the Ministry of Education and Training of the Socialist Republic of Vietnam. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Martinez CE, 2009, MICROBIOL MOL BIOL R, V73, P775, DOI 10.1128/MMBR.00023-09; Amieva MR, 2008, GASTROENTEROLOGY, V134, P306, DOI 10.1053/j.gastro.2007.11.009; Andrzejewska J, 2006, J BACTERIOL, V188, P5865, DOI 10.1128/JB.00060-06; Backert S, 2008, TRENDS MICROBIOL, V16, P409, DOI 10.1016/j.tim.2008.07.001; Basso D, 2008, GASTROENTEROLOGY, V135, P91, DOI 10.1053/j.gastro.2008.03.041; Busler VJ, 2006, J BACTERIOL, V188, P4787, DOI 10.1128/JB.00066-06; Cascales E, 2003, NAT REV MICROBIOL, V1, P137, DOI 10.1038/nrmicro753; Cendron L, 2009, J MOL BIOL, V386, P204, DOI 10.1016/j.jmb.2008.12.018; Censini S, 1996, P NATL ACAD SCI USA, V93, P14648, DOI 10.1073/pnas.93.25.14648; Dailidiene D, 2006, APPL ENVIRON MICROB, V72, P5908, DOI 10.1128/AEM.01135-06; Fernandez D, 1996, J BACTERIOL, V178, P3168, DOI 10.1128/jb.178.11.3168-3176.1996; Fischer W, 2004, J BACTERIOL, V186, P777, DOI 10.1128/JB.186.3.777-784.2004; Fischer W, 2001, MOL MICROBIOL, V42, P1337, DOI 10.1046/j.1365-2958.2001.02714.x; Fischer W, 2011, FEBS J, V278, P1203, DOI 10.1111/j.1742-4658.2011.08036.x; Fischer W, 2010, NUCLEIC ACIDS RES, V38, P6089, DOI 10.1093/nar/gkq378; HAAS R, 1993, MOL MICROBIOL, V8, P753, DOI 10.1111/j.1365-2958.1993.tb01618.x; Hapfelmeier S, 2000, J BACTERIOL, V182, P4505, DOI 10.1128/JB.182.16.4505-4511.2000; Hatakeyama M, 2008, CURR OPIN MICROBIOL, V11, P30, DOI 10.1016/j.mib.2007.12.003; Hohlfeld S, 2006, MOL MICROBIOL, V59, P1624, DOI 10.1111/j.1365-2958.2006.05050.x; Jimenez-Soto LF, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000684; Jurik A, 2010, INFECT IMMUN, V78, P5244, DOI 10.1128/IAI.00796-10; Kutter S, 2008, J BACTERIOL, V190, P2161, DOI 10.1128/JB.01341-07; Kwok T, 2007, NATURE, V449, P862, DOI 10.1038/nature06187; Odenbreit S, 2000, SCIENCE, V287, P1497, DOI 10.1126/science.287.5457.1497; Ohnishi N, 2008, P NATL ACAD SCI USA, V105, P1003, DOI 10.1073/pnas.0711183105; Pattis I, 2007, MICROBIOL-SGM, V153, P2896, DOI 10.1099/mic.0.2007/007385-0; Peek RM, 2002, NAT REV CANCER, V2, P28, DOI 10.1038/nrc703; Pinto-Santini DM, 2009, J BACTERIOL, V191, P7343, DOI 10.1128/JB.00946-09; Puls J, 2002, MOL MICROBIOL, V43, P961, DOI 10.1046/j.1365-2958.2002.02780.x; Rieder G, 2005, GASTROENTEROLOGY, V128, P1229, DOI 10.1053/j.gastro.2005.02.064; Rohde M, 2003, MOL MICROBIOL, V49, P219, DOI 10.1046/j.1365-2958.2003.03549.x; Sambrook J., 2001, MOL CLONING LAB MANU; Selbach M, 2002, INFECT IMMUN, V70, P665, DOI 10.1128/IAI.70.2.665-671.2002; Shaffer CL, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002237; Sharma CM, 2010, NATURE, V464, P250, DOI 10.1038/nature08756; Suerbaum S, 2002, NEW ENGL J MED, V347, P1175, DOI 10.1056/NEJMra020542; Tanaka J, 2003, CELL MICROBIOL, V5, P395, DOI 10.1046/j.1462-5822.2003.00286.x; Terradot L, 2011, FEBS J, V278, P1213, DOI 10.1111/j.1742-4658.2011.08037.x; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6	39	38	39	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2012	7	4							e35341	10.1371/journal.pone.0035341	http://dx.doi.org/10.1371/journal.pone.0035341			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JA	22493745	Green Published, Green Submitted, gold			2022-12-27	WOS:000305012700087
J	Bruder, JT; Semenova, E; Chen, P; Limbach, K; Patterson, NB; Stefaniak, ME; Konovalova, S; Thomas, C; Hamilton, M; King, CR; Richie, TL; Doolan, DL				Bruder, Joseph T.; Semenova, Elena; Chen, Ping; Limbach, Keith; Patterson, Noelle B.; Stefaniak, Maureen E.; Konovalova, Svetlana; Thomas, Charlie; Hamilton, Melissa; King, C. Richter; Richie, Thomas L.; Doolan, Denise L.			Modification of Ad5 Hexon Hypervariable Regions Circumvents Pre-Existing Ad5 Neutralizing Antibodies and Induces Protective Immune Responses	PLOS ONE			English	Article							ADENOVIRUS TYPE 5; CD8(+) T-CELLS; PLASMODIUM-YOELII; VACCINE VECTORS; HIV-1 VACCINE; GENE-TRANSFER; IMMUNOGENICITY; PROTEIN; VIRUS; IMMUNIZATION	The development of an effective malaria vaccine is a high global health priority. Vaccine vectors based on adenovirus type 5 are capable of generating robust and protective T cell and antibody responses in animal models and are currently being evaluated in clinical trials for HIV and malaria. They appear to be more effective in terms of inducing antigen-specific immune responses as compared with non-Ad5 serotype vectors. However, the high prevalence of neutralizing antibodies to Ad5 in the human population, particularly in the developing world, has the potential to limit the effectiveness of Ad5-based vaccines. We have generated novel Ad5-based vectors that precisely replace the hexon hypervariable regions with those derived from Ad43, a subgroup D serotype with low prevalence of neutralizing antibody in humans. We have demonstrated that these hexon-modified adenovectors are not neutralized efficiently by Ad5 neutralizing antibodies in vitro using sera from mice, rabbits and human volunteers. We have also generated hexon-modified adenovectors that express a rodent malaria parasite antigen, PyCSP, and demonstrated that they are as immunogenic as an unmodified vector. Furthermore, in contrast to the unmodified vector, the hexon-modified adenovectors induced robust T cell responses in mice with high levels of Ad5 neutralizing antibody. We also show that the hexon-modified vector can be combined with unmodified Ad5 vector in prime-boost regimens to induce protective responses in mice. Our data establish that these hexon-modified vectors are highly immunogenic even in the presence of pre-existing anti-adenovirus antibodies. These hexon-modified adenovectors may have advantages in sub-Saharan Africa where there is a high prevalence of Ad5 neutralizing antibody in the population.	[Bruder, Joseph T.; Semenova, Elena; Chen, Ping; Konovalova, Svetlana; Thomas, Charlie; Hamilton, Melissa; King, C. Richter] GenVec Inc, Res, Gaithersburg, MD USA; [Limbach, Keith; Patterson, Noelle B.; Stefaniak, Maureen E.; Richie, Thomas L.; Doolan, Denise L.] USN, Med Res Ctr, US Mil Malaria Vaccine Program, Silver Spring, MD USA; [Doolan, Denise L.] Queensland Inst Med Res, Brisbane, Qld 4006, Australia	United States Department of Defense; United States Navy; QIMR Berghofer Medical Research Institute	Bruder, JT (corresponding author), GenVec Inc, Res, Gaithersburg, MD USA.	jbruder@genvec.com	Doolan, Denise L/F-1969-2015	Doolan, Denise/0000-0001-7354-8817; Richie, Thomas/0000-0002-2946-5456	National Institutes of Health (NIH) [1R43AI077309-01]; US Army Medical Research and Material Command (work unit 6000.RAD1.F.A0309); US Army Medical Research and Material Command (work unit 62236N.4127.3696.A0258; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R43AI077309] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Army Medical Research and Material Command (work unit 6000.RAD1.F.A0309); US Army Medical Research and Material Command (work unit 62236N.4127.3696.A0258; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health (NIH) grant #1R43AI077309-01 and by funds allocated to NMRC by the US Army Medical Research and Material Command (work units 6000.RAD1.F.A0309 and 62236N.4127.3696.A0258). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbink P, 2007, J VIROL, V81, P4654, DOI 10.1128/JVI.02696-06; Abel B, 2010, AM J RESP CRIT CARE, V181, P1407, DOI 10.1164/rccm.200910-1484OC; Barouch DH, 2004, J IMMUNOL, V172, P6290, DOI 10.4049/jimmunol.172.10.6290; Brough DE, 1996, J VIROL, V70, P6497, DOI 10.1128/JVI.70.9.6497-6501.1996; Bruder JT, 2010, VACCINE, V28, P3201, DOI 10.1016/j.vaccine.2010.02.024; Bruder JT, 2010, HUM VACCINES, V6, P54, DOI 10.4161/hv.6.1.10463; Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; Casimiro DR, 2003, J VIROL, V77, P6305, DOI 10.1128/JVI.77.11.6305-6313.2003; Catanzaro AT, 2006, J INFECT DIS, V194, P1638, DOI 10.1086/509258; CHAROENVIT Y, 1991, J IMMUNOL, V146, P1020; Cheng C, 2007, PLOS PATHOG, V3, P239, DOI 10.1371/journal.ppat.0030025; Doolan DL, 2006, CURR MOL MED, V6, P169, DOI 10.2174/156652406776055249; EGAN JE, 1987, SCIENCE, V236, P453, DOI 10.1126/science.3551073; Epstein SL, 2005, VACCINE, V23, P5404, DOI 10.1016/j.vaccine.2005.04.047; Farina SF, 2001, J VIROL, V75, P11603, DOI 10.1128/JVI.75.23.11603-11613.2001; Fitzgerald JC, 2003, J IMMUNOL, V170, P1416, DOI 10.4049/jimmunol.170.3.1416; Gall J, 1996, J VIROL, V70, P2116, DOI 10.1128/JVI.70.4.2116-2123.1996; Gall JGD, 1998, J VIROL, V72, P10260, DOI 10.1128/JVI.72.12.10260-10264.1998; Gilbert SC, 2002, VACCINE, V20, P1039, DOI 10.1016/S0264-410X(01)00450-9; Hensley SE, 2007, MOL THER, V15, P393, DOI 10.1038/sj.mt.6300024; HIERHOLZER JC, 1991, ARCH VIROL, V121, P179, DOI 10.1007/BF01316753; Hong SS, 2003, J VIROL, V77, P10366, DOI 10.1128/JVI.77.19.10366-10375.2003; JACOBS SC, 1992, J VIROL, V66, P2086, DOI 10.1128/JVI.66.4.2086-2095.1992; Kostense S, 2004, AIDS, V18, P1213, DOI 10.1097/00002030-200405210-00019; Lasaro MO, 2009, MOL THER, V17, P1333, DOI 10.1038/mt.2009.130; Lemckert AAC, 2005, J VIROL, V79, P9694, DOI 10.1128/JVI.79.15.9694-9701.2005; Lubeck MD, 1997, NAT MED, V3, P651, DOI 10.1038/nm0697-651; McElrath MJ, 2008, LANCET, V372, P1894, DOI 10.1016/S0140-6736(08)61592-5; NORRBY E, 1969, J GEN VIROL, V5, P221, DOI 10.1099/0022-1317-5-2-221; Ophorst OJAE, 2006, INFECT IMMUN, V74, P313, DOI 10.1128/IAI.74.1.313-320.2006; Ophorst OJAE, 2004, VACCINE, V22, P3035, DOI 10.1016/j.vaccine.2004.02.011; Pinto AR, 2003, J IMMUNOL, V171, P6774, DOI 10.4049/jimmunol.171.12.6774; POTOCNJAK P, 1980, J EXP MED, V151, P1504, DOI 10.1084/jem.151.6.1504; Rasmussen H, 2002, CANCER GENE THER, V9, P951, DOI 10.1038/sj.cgt.7700518; Roberts DM, 2006, NATURE, V441, P239, DOI 10.1038/nature04721; ROBERTS MM, 1986, SCIENCE, V232, P1148, DOI 10.1126/science.3704642; Rodrigues EG, 2000, PARASITE IMMUNOL, V22, P157, DOI 10.1046/j.1365-3024.2000.00289.x; Rodrigues EG, 1997, J IMMUNOL, V158, P1268; Roederer M, 2011, CYTOM PART A, V79A, P167, DOI 10.1002/cyto.a.21015; Roy S, 1998, J VIROL, V72, P6875, DOI 10.1128/JVI.72.8.6875-6879.1998; Rux JJ, 2000, MOL THER, V1, P18, DOI 10.1006/mthe.1999.0001; Rux JJ, 2004, HUM GENE THER, V15, P1167, DOI 10.1089/hum.2004.15.1167; Rux JJ, 2003, J VIROL, V77, P9553, DOI 10.1128/JVI.77.17.9553-9566.2003; Sedegah M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024586; Sedegah M, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-241; Shiver JW, 2004, ANNU REV MED, V55, P355, DOI 10.1146/annurev.med.55.091902.104344; Shiver JW, 2002, NATURE, V415, P331, DOI 10.1038/415331a; Sprangers MC, 2003, J CLIN MICROBIOL, V41, P5046, DOI 10.1128/JCM.41.11.5046-5052.2003; Sridhar S, 2008, J VIROL, V82, P3822, DOI 10.1128/JVI.02568-07; Sullivan NJ, 2003, NATURE, V424, P681, DOI 10.1038/nature01876; Sumida SM, 2005, J IMMUNOL, V174, P7179, DOI 10.4049/jimmunol.174.11.7179; Tamminga C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025868; Tan YD, 2003, HUM GENE THER, V14, P1673, DOI 10.1089/104303403322542310; Thorner AR, 2006, J CLIN MICROBIOL, V44, P3781, DOI 10.1128/JCM.01249-06; TOOGOOD CIA, 1992, J GEN VIROL, V73, P1429, DOI 10.1099/0022-1317-73-6-1429; Tsuji M, 2003, TRENDS PARASITOL, V19, P88, DOI 10.1016/S1471-4922(02)00053-3; Vogels R, 2003, J VIROL, V77, P8263, DOI 10.1128/JVI.77.15.8263-8271.2003; Wang J, 2004, J IMMUNOL, V173, P6357, DOI 10.4049/jimmunol.173.10.6357; WANG RB, 1995, J IMMUNOL, V154, P2784; WOHLFART C, 1988, J VIROL, V62, P2321, DOI 10.1128/JVI.62.7.2321-2328.1988; Worgall S, 2005, J CLIN INVEST, V115, P1281, DOI 10.1172/JCI200523135; Xiang ZQ, 1996, VIROLOGY, V219, P220, DOI 10.1006/viro.1996.0239; Xiang ZQ, 2002, J VIROL, V76, P2667, DOI 10.1128/JVI.76.6.2667-2675.2002; Youil R, 2002, HUM GENE THER, V13, P311, DOI 10.1089/10430340252769824	64	24	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2012	7	4							e33920	10.1371/journal.pone.0033920	http://dx.doi.org/10.1371/journal.pone.0033920			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955IH	22496772	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000305010500003
J	Harris, GL; Creason, MB; Brulte, GB; Herr, DR				Harris, Greg L.; Creason, Michael B.; Brulte, Greg B.; Herr, Deron R.			In Vitro and In Vivo Antagonism of a G Protein-Coupled Receptor (S1P(3)) with a Novel Blocking Monoclonal Antibody	PLOS ONE			English	Article							SPHINGOSINE 1-PHOSPHATE RECEPTORS; ENDOTHELIAL-CELL MIGRATION; SIGNALING PATHWAYS; GROWTH-FACTOR; SPHINGOSINE-1-PHOSPHATE RECEPTORS; FINGOLIMOD FTY720; CANCER CELLS; EXPRESSION; PROLIFERATION; ANGIOGENESIS	Background: S1P(3) is a lipid-activated G protein-couple receptor (GPCR) that has been implicated in the pathological processes of a number of diseases, including sepsis and cancer. Currently, there are no available high-affinity, subtype-selective drug compounds that can block activation of S1P(3). We have developed a monoclonal antibody (7H9) that specifically recognizes S1P(3) and acts as a functional antagonist. Methodology/Principal Findings: Specific binding of 7H9 was demonstrated by immunocytochemistry using cells that over-express individual members of the S1P receptor family. We show, in vitro, that 7H9 can inhibit the activation of S1P(3)-mediated cellular processes, including arrestin translocation, receptor internalization, adenylate cyclase inhibiton, and calcium mobilization. We also demonstrate that 7H9 blocks activation of S1P(3) in vivo, 1) by preventing lethality due to systemic inflammation, and 2) by altering the progression of breast tumor xenografts. Conclusions/Significance: We have developed the first-reported monoclonal antibody that selectively recognizes a lipid-activated GPCR and blocks functional activity. In addition to serving as a lead drug compound for the treatment of sepsis and breast cancer, it also provides proof of concept for the generation of novel GPCR-specific therapeutic antibodies.	[Harris, Greg L.; Creason, Michael B.; Brulte, Greg B.; Herr, Deron R.] Express Drug Designs LLC, San Marcos, CA USA; [Harris, Greg L.; Herr, Deron R.] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA	California State University System; San Diego State University	Harris, GL (corresponding author), Express Drug Designs LLC, San Marcos, CA USA.	dherr@expressiondrugdesigns.com	Herr, Deron/AAB-7380-2020	Herr, Deron/0000-0001-5755-0896	National Institutes of Health (NIH) [1R43 CA132400, 1R43 CA156892]; NATIONAL CANCER INSTITUTE [R43CA156892, R43CA132400] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health (NIH) grants (1R43 CA132400, 1R43 CA156892) to DRH. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Arikawa K, 2003, J BIOL CHEM, V278, P32841, DOI 10.1074/jbc.M305024200; Benaud C, 2002, J BIOL CHEM, V277, P10539, DOI 10.1074/jbc.M109064200; Budde K, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V1341073; Choi JW, 2010, ANNU REV PHARMACOL, V50, P157, DOI 10.1146/annurev.pharmtox.010909.105753; Chun J, 2011, DISCOV MED, V12, P213; Czeloth N, 2005, J IMMUNOL, V175, P2960, DOI 10.4049/jimmunol.175.5.2960; Dolezalova H, 2003, J CELL BIOCHEM, V88, P732, DOI 10.1002/jcb.10394; Doll F, 2005, BBA-MOL CELL BIOL L, V1738, P72, DOI 10.1016/j.bbalip.2005.12.001; Ferguson Stephen S. G., 2003, V237, P121; Fieber CB, 2006, EXP CELL RES, V312, P1164, DOI 10.1016/j.yexcr.2006.01.022; Goetzl EJ, 1999, CANCER RES, V59, P4732; Hait NC, 2009, SCIENCE, V325, P1254, DOI 10.1126/science.1176709; Heringdorf DMZ, 2003, FEBS LETT, V554, P443, DOI 10.1016/S0014-5793(03)01219-5; Herr DR, 2007, CURR DRUG TARGETS, V8, P155, DOI 10.2174/138945007779315669; Ishii I, 2001, J BIOL CHEM, V276, P33697, DOI 10.1074/jbc.M104441200; Ishii I, 2002, J BIOL CHEM, V277, P25152, DOI 10.1074/jbc.M200137200; Jacobs E, 1999, BRIT J CANCER, V80, P352, DOI 10.1038/sj.bjc.6690362; Kappos L, 2006, NEW ENGL J MED, V355, P1124, DOI 10.1056/NEJMoa052643; Kato Y, 2007, CANCER BIOL THER, V6, P891, DOI 10.4161/cbt.6.6.4096; Kimura T, 2000, BIOCHEM J, V348, P71, DOI 10.1042/0264-6021:3480071; Kon J, 1999, J BIOL CHEM, V274, P23940, DOI 10.1074/jbc.274.34.23940; Kono M, 2004, J BIOL CHEM, V279, P29367, DOI 10.1074/jbc.M403937200; LaMontagne K, 2006, CANCER RES, V66, P221, DOI 10.1158/0008-5472.CAN-05-2001; Langlois S, 2004, BLOOD, V103, P3020, DOI 10.1182/blood-2003-08-2968; Le Stunff H, 2004, J BIOL CHEM, V279, P34290, DOI 10.1074/jbc.M404907200; Lee MJ, 1999, CELL, V99, P301, DOI 10.1016/S0092-8674(00)81661-X; Li ZS, 2009, BREAST CANCER RES TR, V118, P33, DOI 10.1007/s10549-008-0216-x; Licht T, 2003, BLOOD, V102, P2099, DOI 10.1182/blood-2002-12-3634; Liu YJ, 2000, J CLIN INVEST, V106, P951, DOI 10.1172/JCI10905; Maggon K, 2007, CURR MED CHEM, V14, P1978; Martin JL, 2009, J BIOL CHEM; Nava VE, 2002, EXP CELL RES, V281, P115, DOI 10.1006/excr.2002.5658; Niessen F, 2008, NATURE, V452, P654, DOI 10.1038/nature06663; Nixon GF, 2009, BRIT J PHARMACOL, V158, P982, DOI 10.1111/j.1476-5381.2009.00281.x; Oskouian B, 2004, SEMIN CELL DEV BIOL, V15, P529, DOI 10.1016/j.semcdb.2004.05.009; Oz-Arslan D, 2006, J LEUKOCYTE BIOL, V80, P287, DOI 10.1189/jlb.1205751; Paik JH, 2001, J BIOL CHEM, V276, P11830, DOI 10.1074/jbc.M009422200; Pchejetski D, 2010, CANCER RES, V70, P8651, DOI 10.1158/0008-5472.CAN-10-1388; Peters SLM, 2007, CURR OPIN PHARMACOL, V7, P186, DOI 10.1016/j.coph.2006.09.008; Radeff-Huang J, 2004, J CELL BIOCHEM, V92, P949, DOI 10.1002/jcb.20094; Roviezzo F, 2011, J PHARM EXPT THERAPE; Ruf W, 2009, J THROMB HAEMOST, V7, P118, DOI 10.1111/j.1538-7836.2009.03374.x; Sarkar S, 2005, FEBS LETT, V579, P5313, DOI 10.1016/j.febslet.2005.08.055; Singleton PA, 2007, AM J RESP CELL MOL, V37, P222, DOI 10.1165/rcmb.2006-0327OC; Singleton PA, 2006, J BIOL CHEM, V281, P34381, DOI 10.1074/jbc.M603680200; Skoura A, 2007, J CLIN INVEST, V117, P2506, DOI 10.1172/JCI31123; Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103; Sugimoto N, 2003, MOL CELL BIOL, V23, P1534, DOI 10.1128/MCB.23.5.1534-1545.2003; Sukocheva O, 2006, J CELL BIOL, V173, P301, DOI 10.1083/jcb.200506033; Visentin B, 2006, CANCER CELL, V9, P225, DOI 10.1016/j.ccr.2006.02.023; Wang F, 1999, J BIOL CHEM, V274, P35343, DOI 10.1074/jbc.274.50.35343; Watson C, 2010, AM J PATHOL, V177, P2205, DOI 10.2353/ajpath.2010.100220; Yamashita H, 2006, J SURG RES, V130, P80, DOI 10.1016/j.jss.2005.08.004; Zhang YH, 2006, J PHYSIOL-LONDON, V575, P101, DOI 10.1113/jphysiol.2006.111575	54	34	38	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2012	7	4							e35129	10.1371/journal.pone.0035129	http://dx.doi.org/10.1371/journal.pone.0035129			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955IH	22496900	Green Published, gold, Green Submitted			2022-12-27	WOS:000305010500031
J	Zhang, J; Xie, J; Hou, WL; Tu, XC; Xu, J; Song, FJ; Wang, ZH; Lu, ZX				Zhang, Juan; Xie, Jun; Hou, Wanli; Tu, Xiaochen; Xu, Jing; Song, Fujian; Wang, Zhihong; Lu, Zuxun			Mapping the Knowledge Structure of Research on Patient Adherence: Knowledge Domain Visualization Based Co-Word Analysis and Social Network Analysis	PLOS ONE			English	Article							SYSTEMATIC-REVIEWS; MEDICATION; SCIENTOMETRICS; ACIDIFICATION; INTERVENTIONS	Background: Patient adherence is an important issue for health service providers and health researchers. However, the knowledge structure of diverse research on treatment adherence is unclear. This study used co-word analysis and social network analysis techniques to analyze research literature on adherence, and to show their knowledge structure and evolution over time. Methods: Published scientific papers about treatment adherence were retrieved from Web of Science (2000 to May 2011). A total of 2308 relevant articles were included: 788 articles published in 2000-2005 and 1520 articles published in 2006-2011. The keywords of each article were extracted by using the software Biblexcel, and the synonym and isogenous words were merged manually. The frequency of keywords and their co-occurrence frequency were counted. High frequency keywords were selected to yield the co-words matrix. Finally the decomposition maps were used to comb the complex knowledge structures. Results: Research themes were more general in the first period (2000 to 2005), and more extensive with many more new terms in the second period (2006 to 2011). Research on adherence has covered more and more diseases, populations and methods, but other diseases/conditions are not as hot as HIV/AIDS and have not become specialty themes/sub-directions. Most studies originated from the United States. Conclusion: The dynamic of this field is mainly divergent, with increasing number of new sub-directions of research. Future research is required to investigate specific directions and converge as well to construct a general paradigm in this field.	[Zhang, Juan; Hou, Wanli; Tu, Xiaochen; Lu, Zuxun] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Wuhan 430074, Hubei Province, Peoples R China; [Zhang, Juan; Xie, Jun; Wang, Zhihong] Huazhong Univ Sci & Technol, Tongji Med Coll, Liyuan Hosp, Wuhan 430074, Hubei Province, Peoples R China; [Xu, Jing] Henan Univ Tradit Chinese Med, Sch Humanities, Zhengzhou, Henan Province, Peoples R China; [Song, Fujian] Univ E Anglia, Fac Med & Hlth Sci, Norwich Med Sch, Norwich NR4 7TJ, Norfolk, England	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Henan University of Traditional Chinese Medicine; University of East Anglia	Zhang, J (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Wuhan 430074, Hubei Province, Peoples R China.	lyyy_wzh@163.com; zuxunlu@yahoo.com	Song, Fujian/B-3516-2013		National Science Funding of China [70973041]	National Science Funding of China	This research was sponsored by the National Science Funding of China (no. 70973041). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amez L, 2010, 16 INT C CULT EC COP; An XY, 2011, SCIENTOMETRICS, V88, P133, DOI 10.1007/s11192-011-0374-1; Bain-Brickley D., 2011, COCHRANE DB SYST REV, V12; Bonaccorsi A, 2010, RES POLICY, V39, P1034, DOI 10.1016/j.respol.2010.05.002; Bonaccorso S, 2003, BRIT MED J, V327, P863, DOI 10.1136/bmj.327.7419.863; Callon M, 1986, MAPPING DYNAMICS SCI, P103, DOI DOI 10.1007/978-1-349-07408-2; CAMBROSIO A, 1993, SCIENTOMETRICS, V27, P119, DOI 10.1007/BF02016546; [陈悦 Chen Yue], 2005, [科学学研究, Studies in Science of Science], V23, P149; Courtial JP, 1997, SCIENTOMETRICS, V40, P333, DOI 10.1007/BF02457442; COURTIAL JP, 1994, SCIENTOMETRICS, V31, P251, DOI 10.1007/BF02016875; Davies HTO, 2009, WHAT IS SYSTEMATIC R; De Castro S, 2003, EUR J CARDIOVASC NUR, V2, P323; Ding Y, 2001, INFORM PROCESS MANAG, V37, P817, DOI 10.1016/S0306-4573(00)00051-0; Doggrell SA, 2010, DRUG AGING, V27, P239, DOI 10.2165/11532870-000000000-00000; Dowshen N, 2011, PEDIATRICS, V128, P762, DOI 10.1542/peds.2011-0068; FREEMAN LC, 1977, SOCIOMETRY, V40, P35, DOI 10.2307/3033543; Greenhalgh T, 1997, BRIT MED J, V315, P672, DOI 10.1136/bmj.315.7109.672; He Q, 1999, LIBR TRENDS, V48, P133; Huang Y, 2008, SCIENTOMETRICS, V77, P177, DOI 10.1007/s11192-007-1899-1; Ingersoll KS, 2008, J BEHAV MED, V31, P213, DOI 10.1007/s10865-007-9147-y; Kaczorowski J, 2009, CAN FAM PHYSICIAN, V55, P1155; Karamanidou C, 2008, BMC NEPHROL, V9, DOI 10.1186/1471-2369-9-2; Katy B, 2003, ANNU REV INFORM SCI, P179; La Rosa M, 2011, INT J IMMUNOPATH PH, V24, P69, DOI 10.1177/03946320110240S413; LAW J, 1992, SCIENTOMETRICS, V23, P417, DOI 10.1007/BF02029807; LAW J, 1988, SCIENTOMETRICS, V14, P251, DOI 10.1007/BF02020078; Liu J, 2004, IEEE CIRCUITS SYSTEM, P4; [刘则渊 LIU Zeyuan], 2007, [科学学研究, Studies in Science of Science], V25, P193; Mills EJ, 2006, PLOS MED, V3, P2039, DOI 10.1371/journal.pmed.0030438; Munro S, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-104; Osterberg L, 2005, NEW ENGL J MED, V353, P487, DOI 10.1056/NEJMra050100; PETERS HPF, 1993, RES POLICY, V22, P23, DOI 10.1016/0048-7333(93)90031-C; Puskas Cathy M, 2011, Curr HIV/AIDS Rep, V8, P277, DOI 10.1007/s11904-011-0098-0; Qiu H, 2009, SCIENTOMETRICS, V81, P601, DOI 10.1007/s11192-008-2207-4; Shi LZ, 2010, HEALTH QUAL LIFE OUT, V8, P12, DOI 10.1186/1477-7525-8-99; SMALL H, 1973, J AM SOC INFORM SCI, V24, P265, DOI 10.1002/asi.4630240406; SPENCE DP, 1990, J PSYCHOLINGUIST RES, V19, P317, DOI 10.1007/BF01074363; Su HN, 2010, SCIENTOMETRICS, V85, P65, DOI 10.1007/s11192-010-0259-8; Touchette DR, 2008, J MANAGE CARE PHARM, V14, pS2; Wang MH, 2010, SCIENTOMETRICS, V84, P813, DOI 10.1007/s11192-009-0112-0; Xie CX, 2005, J INFORM, V24, P69; Zhong WJ, 2008, J INFORM, V27, P70	42	45	53	2	122	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2012	7	4							e34497	10.1371/journal.pone.0034497	http://dx.doi.org/10.1371/journal.pone.0034497			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	955IH	22496819	Green Published, gold, Green Submitted			2022-12-27	WOS:000305010500013
J	Brouwer, L; Richardson, DS; Komdeur, J				Brouwer, Lyanne; Richardson, David S.; Komdeur, Jan			Helpers at the Nest Improve Late-Life Offspring Performance: Evidence from a Long-Term Study and a Cross-Foster Experiment	PLOS ONE			English	Article							WARBLER ACROCEPHALUS-SECHELLENSIS; COOPERATIVELY BREEDING BIRDS; SEYCHELLES WARBLER; REPRODUCTIVE SUCCESS; NATAL DISPERSAL; FITNESS CONSEQUENCES; GROUP-SIZE; SURVIVAL; SEX; EVOLUTION	Background: Conditions during an individual's rearing period can have far reaching consequences for its survival and reproduction later in life. Conditions typically vary due to variation in parental quality and/or the environment, but in cooperative breeders the presence of helpers adds an important component to this. Determining the causal effect of helpers on offspring fitness is difficult, since high-quality breeders or territories are likely to produce high-quality offspring, but are also more likely to have helpers because of past reproductive success. This problem is best resolved by comparing the effect of both helping and non-helping subordinates on offspring fitness, however species in which both type of subordinates commonly occur are rare. Methodology/Principal Findings: We used multi-state capture-recapture models on 20 years of data to investigate the effect of rearing conditions on survival and recruitment in the cooperatively breeding Seychelles warbler (Acrocephalus sechellensis), with both helping and non-helping subordinates. The number of helpers in the rearing territory, but not territory quality, group-or brood size, was positively associated with survival of offspring in their first year, and later in life. This was not a result of group size itself since the number of non-helpers was not associated with offspring survival. Furthermore, a nestling cross-foster experiment showed that the number of helpers on the pre-foster territory was not associated with offspring survival, indicating that offspring from territories with helpers do not differ in (genetic) quality. Conclusions/Significance: Our results suggest that the presence of helpers not only increase survival of offspring in their first year of life, but also subsequent adult survival, and therefore have important fitness consequences later in life. This means that when calculating the fitness benefits of helping not only short-term but also the late-life benefits have to be taken into account to fully understand the evolution of cooperative breeding.	[Brouwer, Lyanne; Komdeur, Jan] Univ Groningen, Anim Ecol Grp, Ctr Ecol & Evolutionary Studies, Groningen, Netherlands; [Brouwer, Lyanne] Australian Natl Univ, Res Sch Biol, Canberra, ACT, Australia; [Richardson, David S.] Univ E Anglia, Sch Biol Sci, Ctr Ecol Evolut & Conservat, Norwich NR4 7TJ, Norfolk, England; [Richardson, David S.] Nat Seychelles, Mahe, Seychelles	University of Groningen; Australian National University; University of East Anglia	Brouwer, L (corresponding author), Univ Groningen, Anim Ecol Grp, Ctr Ecol & Evolutionary Studies, Groningen, Netherlands.	L.Brouwer@MyScience.eu	Komdeur, Jan/X-1261-2019	Komdeur, Jan/0000-0002-9241-0124; Brouwer, Lyanne/0000-0001-6728-4851	Netherlands Organisation for Scientific Research [825.08.003]; Netherlands Foundation for the Advancement of Tropical Research [WOTRO, 84-519]; Marie Curie Fellowship [HPMF-CT-2000-01074]; NERC [NER/I/S/2002/00712]; Natural Environment Research Council [NER/I/S/2002/00712] Funding Source: researchfish	Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Netherlands Foundation for the Advancement of Tropical Research; Marie Curie Fellowship(European Commission); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	L.B. was supported by Rubicon fellowship of the Netherlands Organisation for Scientific Research (grant no. 825.08.003) and by a Netherlands Foundation for the Advancement of Tropical Research grant (WOTRO, 84-519) awarded to J.K. This work was further supported by a Marie Curie Fellowship (HPMF-CT-2000-01074) and a NERC fellowship (NER/I/S/2002/00712) awarded to D.S.R. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike H., 1971, P 2 INT S INF THEOR, P267, DOI DOI 10.2307/2334537; Beckerman AP, 2002, TRENDS ECOL EVOL, V17, P263, DOI 10.1016/S0169-5347(02)02469-2; Bennetts R. E., 2001, METHODS ESTIMATING D, P3; Brouwer L, 2007, MOL ECOL, V16, P3134, DOI 10.1111/j.1365-294X.2007.03370.x; Brouwer L, 2005, BEHAV ECOL, V16, P667, DOI 10.1093/beheco/ari042; Brouwer L, 2006, J ANIM ECOL, V75, P1321, DOI 10.1111/j.1365-2656.2006.01155.x; Brouwer L, 2009, ECOLOGY, V90, P729, DOI 10.1890/07-1437.1; Brown J.L., 1987, HELPING COMMUNAL BRE; BROWN JL, 1982, SCIENCE, V215, P421, DOI 10.1126/science.215.4531.421; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Cam E, 2000, J ANIM ECOL, V69, P380, DOI 10.1046/j.1365-2656.2000.00400.x; Cam E, 2003, J ANIM ECOL, V72, P411, DOI 10.1046/j.1365-2656.2003.00708.x; Cam E, 2011, J ORNITHOL, V152, P187, DOI 10.1007/s10336-011-0707-0; Caswell, 2000, MATRIX POPULATION MO; Charlesworth B., 1994, EVOLUTION AGE STRUCT, V2nd ed, edited by C. Cannings, F. C. Hoppensteadt, and L. A. Segel.; Clutton-Brock TH, 1988, REPROD SUCCESS STUDI; Cockburn A, 1998, ANNU REV ECOL SYST, V29, P141, DOI 10.1146/annurev.ecolsys.29.1.141; Cockburn A, 2008, J ANIM ECOL, V77, P430, DOI 10.1111/j.1365-2656.2007.01351.x; Cooch EG, WHITE GC PROGRAM MAR; DAVIES NB, 1992, J ANIM ECOL, V61, P259, DOI 10.2307/5319; Dickinson JL, 2004, FITNESS CONSEQUENCES; DRENT RH, 1980, ARDEA, V68, P225; Dugdale H., 2010, FITNESS CONSEQUENCES; Eikenaar C, 2008, J AVIAN BIOL, V39, P73, DOI 10.1111/j.0908-8857.2008.04124.x; Eikenaar C, 2009, BEHAV ECOL, V20, P207, DOI 10.1093/beheco/arn136; Eising CM, 2001, P ROY SOC B-BIOL SCI, V268, P839, DOI 10.1098/rspb.2001.1594; Emlen ST, 1991, EVOLUTION COOPERATIV, P301; Green DJ, 1995, P ROY SOC B-BIOL SCI, V262, P297, DOI 10.1098/rspb.1995.0209; Green DJ, 2001, J ANIM ECOL, V70, P505, DOI 10.1046/j.1365-2656.2001.00503.x; Griffin AS, 2003, SCIENCE, V302, P634, DOI 10.1126/science.1089402; Griffiths R, 1998, MOL ECOL, V7, P1071, DOI 10.1046/j.1365-294x.1998.00389.x; HAKKARAINEN H, 1994, OECOLOGIA, V97, P209, DOI 10.1007/BF00323151; Hatchwell BJ, 2004, BEHAV ECOL, V15, P1, DOI 10.1093/beheco/arg091; Hipfner JM, 2000, J AVIAN BIOL, V31, P112, DOI 10.1034/j.1600-048X.2000.310202.x; Hodge SJ, 2008, J ANIM ECOL, V77, P92, DOI 10.1111/j.1365-2656.2007.01318.x; Hodge SJ, 2005, P ROY SOC B-BIOL SCI, V272, P2479, DOI 10.1098/rspb.2005.3255; Ims RA, 2001, CONDITION DEPENDENT, P203; Kokko H, 2001, P ROY SOC B-BIOL SCI, V268, P187, DOI 10.1098/rspb.2000.1349; Komdeur J, 1996, BEHAV ECOL, V7, P326; Komdeur J, 2004, IBIS, V146, P298, DOI 10.1046/j.1474-919X.2004.00255.x; Komdeur J, 1996, P ROY SOC B-BIOL SCI, V263, P661, DOI 10.1098/rspb.1996.0099; KOMDEUR J, 1994, P ROY SOC B-BIOL SCI, V256, P47, DOI 10.1098/rspb.1994.0047; KOMDEUR J, 1994, BEHAV ECOL SOCIOBIOL, V34, P175, DOI 10.1007/BF00167742; KOMDEUR J, 1992, NATURE, V358, P493, DOI 10.1038/358493a0; Komdeur J, 1996, BEHAV ECOL, V7, P417, DOI 10.1093/beheco/7.4.417; Komdeur J, 1996, J BIOL RHYTHM, V11, P333, DOI 10.1177/074873049601100407; Komdeur J., 1991, THESIS U CAMBRIDGE C; Legge S, 2000, J ANIM ECOL, V69, P714, DOI 10.1046/j.1365-2656.2000.00429.x; Lindstrom J, 1999, TRENDS ECOL EVOL, V14, P343, DOI 10.1016/S0169-5347(99)01639-0; Lummaa V, 2002, TRENDS ECOL EVOL, V17, P141, DOI 10.1016/S0169-5347(01)02414-4; Lusk C, 2003, NATURE, V422, P580, DOI 10.1038/422580b; Magrath R. D., 1997, J ANIM ECOL, V66, P670; MAGRATH RD, 1991, J ANIM ECOL, V60, P335, DOI 10.2307/5464; MCNAMARA JM, 1992, EVOL ECOL, V6, P170, DOI 10.1007/BF02270710; Monaghan P, 2009, ECOL LETT, V12, P75, DOI 10.1111/j.1461-0248.2008.01258.x; Morris DW, 1998, OIKOS, V83, P518, DOI 10.2307/3546679; MUMME RL, 1992, BEHAV ECOL SOCIOBIOL, V31, P319; Newton, 1989, LIFETIME REPROD BIRD; Nichols JD, 1995, J APPL STAT, V22, P835, DOI 10.1080/02664769524658; Reid JM, 2003, J ANIM ECOL, V72, P36, DOI 10.1046/j.1365-2656.2003.00673.x; Richardson DS, 2007, EVOLUTION, V61, P2790, DOI 10.1111/j.1558-5646.2007.00222.x; Richardson DS, 2001, MOL ECOL, V10, P2263, DOI 10.1046/j.0962-1083.2001.01355.x; Richardson DS, 2004, EVOLUTION, V58, P2037, DOI 10.1111/j.0014-3820.2004.tb00488.x; Richardson DS, 2003, J EVOLUTION BIOL, V16, P854, DOI 10.1046/j.1420-9101.2003.00592.x; Richardson DS, 2002, EVOLUTION, V56, P2313; Ridley AR, 2007, J ANIM ECOL, V76, P750, DOI 10.1111/j.1365-2656.2007.01248.x; Russell AF, 2007, SCIENCE, V317, P941, DOI 10.1126/science.1146037; Russell AF, 2007, P R SOC B, V274, P513, DOI 10.1098/rspb.2006.3698; Saino N, 2003, P ROY SOC B-BIOL SCI, V270, P2485, DOI 10.1098/rspb.2003.2534; SEDINGER JS, 1995, ECOLOGY, V76, P2404, DOI 10.2307/2265816; Shreeves G, 2002, AM NAT, V159, P81, DOI 10.1086/324125; Sparkman AM, 2011, P ROY SOC B-BIOL SCI, V278, P1381, DOI 10.1098/rspb.2010.1921; Tinbergen JM, 2005, J ANIM ECOL, V74, P1112, DOI 10.1111/j.1365-2656.2005.01010.x; Van de Pol M, 2006, J ANIM ECOL, V75, P616, DOI 10.1111/j.1365-2656.2006.01079.x; Van der Jeugd HP, 1998, J ANIM ECOL, V67, P953, DOI 10.1046/j.1365-2656.1998.6760953.x; Verhulst S, 1997, ECOLOGY, V78, P864, DOI 10.1890/0012-9658(1997)078[0864:NDOGTI]2.0.CO;2; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239	77	25	27	1	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e33167	10.1371/journal.pone.0033167	http://dx.doi.org/10.1371/journal.pone.0033167			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GO	22496744	Green Published, gold, Green Submitted			2022-12-27	WOS:000304855200010
J	Petermann, K; Vordenbaumen, S; Maas, R; Braukmann, A; Bleck, E; Saenger, T; Schneider, M; Jose, J				Petermann, Klaudia; Vordenbaeumen, Stefan; Maas, Ruth; Braukmann, Achim; Bleck, Ellen; Saenger, Thorsten; Schneider, Matthias; Jose, Joachim			Autoantibodies to alpha S1-Casein Are Induced by Breast-Feeding	PLOS ONE			English	Article							CELLULAR-SURFACE DISPLAY; RECOMBINANT PROTEINS; ANTIBODY-PRODUCTION; MILK PROTEIN; AUTODISPLAY; ANTIGEN; SELECTION; INFANTS; ALLERGY; CASEIN	Background: The generation of antibodies is impaired in newborns due to an immature immune system and reduced exposure to pathogens due to maternally derived antibodies and placental functions. During nursing, the immune system of newborns is challenged with multiple milk-derived proteins. Amongst them, caseins are the main constituent. In particular, human alpha S1-casein (CSN1S1) was recently shown to possess immunomodulatory properties. We were thus interested to determine if auto-antibodies to CSN1S1 are induced by breast-feeding and may be sustained into adulthood. Methods: 62 sera of healthy adult individuals who were (n = 37) or were not ( n = 25) breast-fed against human CSN1S1 were investigated by a new SD ( surface display)-ELISA. For cross-checking, these sera were tested for anti Epstein-Barr virus (EBV) antibodies by a commercial ELISA. Results: IgG-antibodies were predominantly detected in individuals who had been nursed. At a cut-off value of 0.4, the SD-ELISA identified individuals with a history of having been breast-fed with a sensitivity of 80% and a specificity of 92%. Under these conditions, 35 out of 37 sera from healthy donors, who where breast-fed, reacted positively but only 5 sera of the 25 donors who were not breast-fed. The duration of breast-feeding was of no consequence to the antibody reaction as some healthy donors were only short term breast-fed ( 5 days minimum until 6 weeks maximum), but exhibited significant serum reaction against human CSN1S1 nonetheless. Conclusion: We postulate that human CSN1S1 is an autoantigen. The antigenicity is orally determined, caused by breast-feeding, and sustained into adulthood.	[Petermann, Klaudia; Maas, Ruth] Univ Dusseldorf, Inst Pharmaceut & Med Chem, D-40225 Dusseldorf, Germany; [Vordenbaeumen, Stefan; Bleck, Ellen; Schneider, Matthias] Univ Dusseldorf, Dept Endocrinol Diabetol & Rheumatol, D-40225 Dusseldorf, Germany; [Braukmann, Achim; Saenger, Thorsten; Jose, Joachim] Univ Munster, Inst Pharmaceut & Med Chem, Munster, Germany	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; University of Munster	Petermann, K (corresponding author), Univ Dusseldorf, Inst Pharmaceut & Med Chem, D-40225 Dusseldorf, Germany.	joachim.jose@uni-muenster.de		Jose, Joachim/0000-0002-0666-2676	"Hiller-Stiftung'', Dusseldorf; Deutsche Forschungsgemeinschaft; University of Muenster	"Hiller-Stiftung'', Dusseldorf; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); University of Muenster	The authors gratefully acknowledge unconditional financial support of this study by the "Hiller-Stiftung'', Dusseldorf. The authors also acknowledge support by Deutsche Forschungsgemeinschaft and Open Access Publication Fund of University of Muenster. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARBOUCHE R, 1992, SCAND J IMMUNOL, V35, P659, DOI 10.1111/j.1365-3083.1992.tb02972.x; Blanas E, 1999, Int Rev Immunol, V18, P217, DOI 10.3109/08830189909043026; Blanas E, 1996, SCIENCE, V274, P1707, DOI 10.1126/science.274.5293.1707; CARVER JD, 1991, PEDIATRICS, V88, P359; Chatchatee P, 2001, J ALLERGY CLIN IMMUN, V107, P379, DOI 10.1067/mai.2001.112372; Chucri TM, 2010, J REPROD IMMUNOL, V87, P14, DOI 10.1016/j.jri.2010.08.062; Franco OL, 2011, FEBS LETT, V585, P995, DOI 10.1016/j.febslet.2011.03.008; GREINER M, 1995, J IMMUNOL METHODS, V185, P123, DOI 10.1016/0022-1759(95)00121-P; HAHNZORIC M, 1990, ACTA PAEDIATR SCAND, V79, P1137; Hau J, 2005, ILAR J, V46, P294, DOI 10.1093/ilar.46.3.294; Hayward A R, 1983, Birth Defects Orig Artic Ser, V19, P289; Hvatum M, 2006, GUT, V55, P1240, DOI 10.1136/gut.2005.076901; JENNESS R, 1987, EXPERIENTIA, V43, P1015, DOI 10.1007/BF01952224; Jose J, 2006, APPL MICROBIOL BIOT, V69, P607, DOI 10.1007/s00253-005-0227-z; Jose J, 2003, CHEMBIOCHEM, V4, P396, DOI 10.1002/cbic.200200530; Jose J, 2002, J BIOTECHNOL, V95, P257, DOI 10.1016/S0168-1656(02)00030-5; Jose J, 2007, MICROBIOL MOL BIOL R, V71, P600, DOI 10.1128/MMBR.00011-07; Kapogiannis BG, 2001, J RHEUMATOL, V28, P2744; Kim TR, 1997, PROTEIN ENG, V10, P1339, DOI 10.1093/protein/10.11.1339; Lawton AR, 1999, PEDIATR INFECT DIS J, V18, P462, DOI 10.1097/00006454-199905000-00012; Meffre E, 2007, J CLIN INVEST, V117, P598, DOI 10.1172/JCI31578; Merbl Y, 2007, J CLIN INVEST, V117, P712, DOI 10.1172/JCI29943; MERCIER JC, 1993, J DAIRY SCI, V76, P3079, DOI 10.3168/jds.S0022-0302(93)77647-X; MILLER MJS, 1990, P SOC EXP BIOL MED, V195, P143, DOI 10.3181/00379727-195-43129; PABST HF, 1990, LANCET, V336, P269, DOI 10.1016/0140-6736(90)91802-H; Petermann K, 2010, ANAL BIOCHEM, V407, P72, DOI 10.1016/j.ab.2010.07.030; REJNEK J, 1974, FOLIA MICROBIOL, V19, P520, DOI 10.1007/BF02872919; Sampson HA, 1999, J ALLERGY CLIN IMMUN, V103, P717, DOI 10.1016/S0091-6749(99)70411-2; SILVERSTEIN AM, 1963, J EXP MED, V117, P799, DOI 10.1084/jem.117.5.799; VANFURTH R, 1965, J EXP MED, V122, P1173, DOI 10.1084/jem.122.6.1173; Vidor E, 2007, J COMP PATHOL, V137, pS42, DOI 10.1016/j.jcpa.2007.04.011; Vordenbaumen S, 2011, J IMMUNOL, V186, P592, DOI 10.4049/jimmunol.1001461; Wang X, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-247; WEINER HL, 1994, ANNU REV IMMUNOL, V12, P809, DOI 10.1146/annurev.immunol.12.1.809; Wilson CB, 2008, NESTLE NUTR WORKS SE, V61, P183, DOI 10.1159/0000113493; Zou KH, 2007, CIRCULATION, V115, P654, DOI 10.1161/CIRCULATIONAHA.105.594929	36	10	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e32716	10.1371/journal.pone.0032716	http://dx.doi.org/10.1371/journal.pone.0032716			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GO	22496735	Green Published, gold, Green Submitted			2022-12-27	WOS:000304855200005
J	Besseling, RMH; Jansen, JFA; Overvliet, GM; Vaessen, MJ; Braakman, HMH; Hofman, PAM; Aldenkamp, AP; Backes, WH				Besseling, Rene M. H.; Jansen, Jacobus F. A.; Overvliet, Geke M.; Vaessen, Maarten J.; Braakman, Hilde M. H.; Hofman, Paul A. M.; Aldenkamp, Albert P.; Backes, Walter H.			Tract Specific Reproducibility of Tractography Based Morphology and Diffusion Metrics	PLOS ONE			English	Article							WHITE-MATTER; SPHERICAL DECONVOLUTION; FRACTIONAL ANISOTROPY; MRI DATA; BRAIN	Introduction:The reproducibility of tractography is important to determine its sensitivity to pathological abnormalities. The reproducibility of tract morphology has not yet been systematically studied and the recently developed tractography contrast Tract Density Imaging (TDI) has not yet been assessed at the tract specific level. Materials and Methods: Diffusion tensor imaging (DTI) and probabilistic constrained spherical deconvolution (CSD) tractography are performed twice in 9 healthy subjects. Tractography is based on common space seed and target regions and performed for several major white matter tracts. Tractograms are converted to tract segmentations and inter-session reproducibility of tract morphology is assessed using Dice similarity coefficient (DSC). The coefficient of variation (COV) and intraclass correlation coefficient (ICC) are calculated of the following tract metrics: fractional anisotropy (FA), apparent diffusion coefficient (ADC), volume, and TDI. Analyses are performed both for proximal (deep white matter) and extended (including subcortical white matter) tract segmentations. Results: Proximal DSC values were 0.70-0.92. DSC values were 5-10% lower in extended compared to proximal segmentations. COV/ICC values of FA, ADC, volume and TDI were 1-4%/0.65-0.94, 2-4%/0.62-0.94, 3-22%/0.53-0.96 and 8-31%/0.48-0.70, respectively, with the lower COV and higher ICC values found in the proximal segmentations. Conclusion: For all investigated metrics, reproducibility depended on the segmented tract. FA and ADC had relatively low COV and relatively high ICC, indicating clinical potential. Volume had higher COV but its moderate to high ICC values in most tracts still suggest subject-differentiating power. Tract TDI had high COV and relatively low ICC, which reflects unfavorable reproducibility.	[Besseling, Rene M. H.; Jansen, Jacobus F. A.; Vaessen, Maarten J.; Hofman, Paul A. M.; Backes, Walter H.] Maastricht Univ, Med Ctr, Dept Radiol, Maastricht, Netherlands; [Overvliet, Geke M.; Braakman, Hilde M. H.; Aldenkamp, Albert P.] Maastricht Univ, Med Ctr, Dept Neurol, Maastricht, Netherlands; [Besseling, Rene M. H.; Jansen, Jacobus F. A.; Overvliet, Geke M.; Vaessen, Maarten J.; Braakman, Hilde M. H.; Hofman, Paul A. M.; Aldenkamp, Albert P.; Backes, Walter H.] Maastricht Univ, Med Ctr, Sch Mental Hlth & Neurosci, Maastricht, Netherlands; [Besseling, Rene M. H.; Overvliet, Geke M.; Vaessen, Maarten J.; Braakman, Hilde M. H.; Hofman, Paul A. M.; Aldenkamp, Albert P.] Epilepsy Ctr Kempenhaeghe, Heeze, Netherlands	Maastricht University; Maastricht University; Maastricht University	Besseling, RMH (corresponding author), Maastricht Univ, Med Ctr, Dept Radiol, Maastricht, Netherlands.	w.backes@mumc.nl	Jansen, Jacobus F.A./C-4098-2009	Jansen, Jacobus F.A./0000-0002-5271-8060; Backes, Walter H/0000-0001-7905-0681	Dutch Epilepsy Foundation (NEF); Netherlands Organization for Scientific Research (NWO) [916.11.059]; Netherlands Organization for Health Research and Development (ZonMw)	Dutch Epilepsy Foundation (NEF); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Netherlands Organization for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development)	This project was funded by the Dutch Epilepsy Foundation (NEF). The author JJ was funded by VENI research grant 916.11.059 from the Netherlands Organization for Scientific Research (NWO) and the Netherlands Organization for Health Research and Development (ZonMw). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afzali M, 2011, COMPUT BIOL MED; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Behrens TEJ, 2003, MAGN RESON MED, V50, P1077, DOI 10.1002/mrm.10609; Bernal B, 2009, BRAIN, V132, P2309, DOI 10.1093/brain/awp206; Calamante F, 2010, NEUROIMAGE, V53, P1233, DOI 10.1016/j.neuroimage.2010.07.024; Catani M, 2008, CORTEX, V44, P1105, DOI 10.1016/j.cortex.2008.05.004; Ciccarelli O, 2003, NEUROIMAGE, V18, P348, DOI 10.1016/S1053-8119(02)00042-3; Clatworthy PL, 2010, NEUROIMAGE, V49, P2001, DOI 10.1016/j.neuroimage.2009.10.083; CORY DG, 1990, MAGNET RESON MED, V14, P435, DOI 10.1002/mrm.1910140303; Dancause N, 2005, J NEUROSCI, V25, P10167, DOI 10.1523/JNEUROSCI.3256-05.2005; Davis DP, 2006, J EMERG MED, V31, P269, DOI 10.1016/j.jemermed.2005.10.003; Dice L. R., 1945, ECOLOGY, V26, P207; Eriksson SH, 2001, BRAIN, V124, P617, DOI 10.1093/brain/124.3.617; Farrell JAD, 2007, J MAGN RESON IMAGING, V26, P756, DOI 10.1002/jmri.21053; Heiervang E, 2006, NEUROIMAGE, V33, P867, DOI 10.1016/j.neuroimage.2006.07.037; Jeurissen B, 2011, HUM BRAIN MAPP, V32, P461, DOI 10.1002/hbm.21032; Jones DK, 2010, NMR BIOMED, V23, P803, DOI 10.1002/nbm.1543; Jones DK, 1999, MAGNET RESON MED, V42, P515, DOI 10.1002/(SICI)1522-2594(199909)42:3<515::AID-MRM14>3.0.CO;2-Q; Lachin John M, 2004, Clin Trials, V1, P553, DOI 10.1191/1740774504cn057oa; Leemans A, 2009, MAGN RESON MED, V61, P1336, DOI 10.1002/mrm.21890; May A, 2006, CURR OPIN NEUROL, V19, P407, DOI 10.1097/01.wco.0000236622.91495.21; Pagani E, 2005, NEUROIMAGE, V26, P258, DOI 10.1016/j.neuroimage.2005.01.008; Pannek K, 2011, NEUROIMAGE, V55, P133, DOI 10.1016/j.neuroimage.2010.12.010; Parker GJM, 2002, IEEE T MED IMAGING, V21, P505, DOI 10.1109/TMI.2002.1009386; Parsey RV, 2000, J CEREBR BLOOD F MET, V20, P1111, DOI 10.1097/00004647-200007000-00011; Pierpaoli C, 2001, NEUROIMAGE, V13, P1174, DOI 10.1006/nimg.2001.0765; Roberts TPL, 2005, AM J NEURORADIOL, V26, P2183; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Tournier J. D., 2009, P INT SOC MAG RESON; Tournier JD, 2007, NEUROIMAGE, V35, P1459, DOI 10.1016/j.neuroimage.2007.02.016; Tournier JD, 2004, NEUROIMAGE, V23, P1176, DOI 10.1016/j.neuroimage.2004.07.037; Tuch DS, 2004, MAGN RESON MED, V52, P1358, DOI 10.1002/mrm.20279; Wakana S, 2007, NEUROIMAGE, V36, P630, DOI 10.1016/j.neuroimage.2007.02.049	33	43	43	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2012	7	4							e34125	10.1371/journal.pone.0034125	http://dx.doi.org/10.1371/journal.pone.0034125			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952GU	22485157	Green Published, gold, Green Submitted			2022-12-27	WOS:000304780500033
J	Garg, AD; Bose, M; Ahmed, MI; Bonass, WA; Wood, SR				Garg, Abhishek D.; Bose, Muthiah; Ahmed, Mohammed I.; Bonass, William A.; Wood, Simon R.			In Vitro Studies on Erythrosine-Based Photodynamic Therapy of Malignant and Pre-Malignant Oral Epithelial Cells	PLOS ONE			English	Article							SINGLET OXYGEN; CANCER; APOPTOSIS; MECHANISMS; PHOTOSENSITIZERS; DEPOLARIZATION; PATHWAYS; EXPOSURE; NECROSIS; DAMAGE	Photodynamic Therapy (PDT) involves the administration of a tumor localizing photosensitizing agent, which upon activation with light of an appropriate wavelength leads to the destruction of the tumor cells. The aim of the present study was to determine the efficacy of erythrosine as a photosensitizer for the PDT of oral malignancies. The drug uptake kinetics of erythrosine in malignant (H357) and pre-malignant (DOK) oral epithelial cells and their susceptibility to erythrosine-based PDT was studied along with the determination of the subcellular localization of erythrosine. This was followed by initial investigations into the mechanism of cell killing induced following PDT involving both high and low concentrations of erythrosine. The results showed that at 37 degrees C the uptake of erythrosine by both DOK and H357 cells increased in an erythrosine dose dependent manner. However, the percentage of cell killing observed following PDT differed between the 2 cell lines; a maximum of similar to 80% of DOK cell killing was achieved as compared to similar to 60% killing for H357 cells. Both the DOK and H357 cell types exhibited predominantly mitochondrial accumulation of erythrosine, but the mitochondrial transmembrane potential (Delta Psi(m)) studies showed that the H357 cells were far more resistant to the changes in Delta Psi(m). when compared to the DOK cells and this might be a factor in the apparent relative resistance of the H357 cells to PDT. Finally, cell death morphology and caspase activity analysis studies demonstrated the occurrence of extensive necrosis with high dose PDT in DOK cells, whereas apoptosis was observed at lower doses of PDT for both cell lines. For H357 cells, high dose PDT produced both apoptotic as well as necrotic responses. This is the first instance of erythrosine-based PDT's usage for cancer cell killing.	[Garg, Abhishek D.; Bose, Muthiah; Ahmed, Mohammed I.; Bonass, William A.; Wood, Simon R.] Univ Leeds, Fac Med & Hlth, Leeds Dent Inst, Dept Oral Biol, Leeds, W Yorkshire, England; [Garg, Abhishek D.; Bose, Muthiah; Ahmed, Mohammed I.] Univ Leeds, Fac Biol Sci, Leeds, W Yorkshire, England	University of Leeds; University of Leeds	Garg, AD (corresponding author), Univ Leeds, Fac Med & Hlth, Leeds Dent Inst, Dept Oral Biol, Leeds, W Yorkshire, England.	s.r.wood@leeds.ac.uk	Ahmed, Mohammed/AAU-7535-2021; Ahmed, Mohamed/N-8174-2019; Garg, Abhishek/D-5230-2012; Ahmed, Mohammed/T-5898-2019	Ahmed, Mohammed/0000-0002-9051-7681; Ahmed, Mohamed/0000-0002-1921-0724; Garg, Abhishek/0000-0002-9976-9922; 				Agostinis P, 2004, PHOTOCH PHOTOBIO SCI, V3, P721, DOI 10.1039/b315237e; Agostinis P, 2011, CA-CANCER J CLIN, V61, P250, DOI 10.3322/caac.20114; Allaker RP, 2009, INT J ANTIMICROB AG, V33, P8, DOI 10.1016/j.ijantimicag.2008.07.014; Allison RR, 2004, PHOTODIAGN PHOTODYN, V1, P27, DOI 10.1016/S1572-1000(04)00007-9; Argiris A, 2004, HEAD NECK CANC, P14; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; British Dental Association, 2000, 6 BRIT DENT ASS; Bruce A., 2002, MOL BIOL CELL, V4th ed.; Buytaert E, 2007, BBA-REV CANCER, V1776, P86, DOI 10.1016/j.bbcan.2007.07.001; Castro A, 2005, PLOS MED, V2, P1217, DOI 10.1371/journal.pmed.0020338; Chaloupka R, 1999, FEBS LETT, V462, P295, DOI 10.1016/S0014-5793(99)01538-0; CHANG SE, 1992, INT J CANCER, V52, P896, DOI 10.1002/ijc.2910520612; Chiu SM, 2001, BRIT J CANCER, V84, P1099, DOI 10.1054/bjoc.2000.1714; Dougherty TJ, 1998, JNCI-J NATL CANCER I, V90, P889, DOI 10.1093/jnci/90.12.889; Estevez JP, 2010, PHOTODIAGN PHOTODYN, V7, P251, DOI 10.1016/j.pdpdt.2010.07.007; Friberg EG, 2003, CANCER LETT, V195, P73, DOI 10.1016/S0304-3835(03)00150-2; GANDIN E, 1979, ARCH INT PHYSIOL BIO, V87, P1046; Garg AD, 2011, PHOTOCH PHOTOBIO SCI, V10, P670, DOI 10.1039/c0pp00294a; Garg AD, 2012, EMBO J, V31, P1062, DOI 10.1038/emboj.2011.497; Garg AD, 2012, CANCER IMMUNOL IMMUN, V61, P215, DOI 10.1007/s00262-011-1184-2; Garg AD, 2010, APOPTOSIS, V15, P1050, DOI 10.1007/s10495-010-0479-7; Garg AD, 2010, BBA-REV CANCER, V1805, P53, DOI 10.1016/j.bbcan.2009.08.003; Geserick C, 2006, MECH AGEING DEV, V127, P579, DOI 10.1016/j.mad.2006.01.017; Gottesman MM, 2002, ANNU REV MED, V53, P615, DOI 10.1146/annurev.med.53.082901.103929; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; He YY, 2008, PHOTOCHEM PHOTOBIOL, V84, P69, DOI 10.1111/j.1751-1097.2007.00199.x; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Indran IR, 2011, CANCER RES, V71, P266, DOI 10.1158/0008-5472.CAN-10-1588; Josefsen LB, 2008, BRIT J PHARMACOL, V154, P1, DOI 10.1038/bjp.2008.98; Kim R, 2006, J PATHOL, V208, P319, DOI 10.1002/path.1885; Kobayashi W, 2006, ORAL ONCOL, V42, P46, DOI 10.1016/j.oraloncology.2005.05.009; Konopka K, 2007, J DENT RES, V86, P694, DOI 10.1177/154405910708600803; Loebinger MR, 2010, BRIT J CANCER, V103, P1692, DOI 10.1038/sj.bjc.6605952; Luo Y, 1997, PHOTOCHEM PHOTOBIOL, V66, P479, DOI 10.1111/j.1751-1097.1997.tb03176.x; Moan J, 2003, COMP SER PHOTOCHEM, V2, P1; MOAN J, 1991, PHOTOCHEM PHOTOBIOL, V53, P549, DOI 10.1111/j.1751-1097.1991.tb03669.x; Moor ACE, 2003, COMP SER PHOTOCHEM, V2, P19; Nagel W, 2001, AM J PHYSIOL-CELL PH, V281, pC1223, DOI 10.1152/ajpcell.2001.281.4.C1223; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Plaetzer K, 2003, MED LASER APPL, V18, P7, DOI DOI 10.1078/1615-1615-00082; PRIME SS, 1994, INT J CANCER, V56, P406, DOI 10.1002/ijc.2910560320; Schuler M, 2000, J BIOL CHEM, V275, P7337, DOI 10.1074/jbc.275.10.7337; Shah GM, 1996, BIOCHEM BIOPH RES CO, V229, P838, DOI 10.1006/bbrc.1996.1889; Sharman WM, 2004, ADV DRUG DELIVER REV, V56, P53, DOI 10.1016/j.addr.2003.08.015; Siboni G, 2002, PHOTOCH PHOTOBIO SCI, V1, P483, DOI 10.1039/b202884k; Usuda J, 2010, LUNG CANCER, V67, P198, DOI 10.1016/j.lungcan.2009.04.002; Vazifeh D, 1999, ANTIMICROB AGENTS CH, V43, P246, DOI 10.1128/AAC.43.2.246; Wood S, 2006, J ANTIMICROB CHEMOTH, V57, P680, DOI 10.1093/jac/dkl021	48	40	40	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2012	7	4							e34475	10.1371/journal.pone.0034475	http://dx.doi.org/10.1371/journal.pone.0034475			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952GU	22485174	Green Submitted, Green Published, gold			2022-12-27	WOS:000304780500049
J	Sato, Y; Kameya, M; Fushinobu, S; Wakagi, T; Arai, H; Ishii, M; Igarashi, Y				Sato, Yuya; Kameya, Masafumi; Fushinobu, Shinya; Wakagi, Takayoshi; Arai, Hiroyuki; Ishii, Masaharu; Igarashi, Yasuo			A Novel Enzymatic System against Oxidative Stress in the Thermophilic Hydrogen-Oxidizing Bacterium Hydrogenobacter thermophilus	PLOS ONE			English	Article							TRICARBOXYLIC-ACID CYCLE; SULFOLOBUS-TOKODAII STRAIN-7; RUBRERYTHRIN-LIKE PROTEIN; DESULFOVIBRIO-VULGARIS; SUPEROXIDE-DISMUTASE; CLOSTRIDIUM-ACETOBUTYLICUM; OBLIGATORY ANAEROBE; PYROCOCCUS-FURIOSUS; PEROXIDASE-ACTIVITY; RUBREDOXIN	Rubrerythrin (Rbr) is a non-heme iron protein composed of two distinctive domains and functions as a peroxidase in anaerobic organisms. A novel Rbr-like protein, ferriperoxin (Fpx), was identified in Hydrogenobacter thermophilus and was found not to possess the rubredoxin-like domain that is present in typical Rbrs. Although this protein is widely distributed among aerobic organisms, its function remains unknown. In this study, Fpx exhibited ferredoxin:NADPH oxidoreductase (FNR)-dependent peroxidase activity and reduced both hydrogen peroxide (H2O2) and organic hydroperoxide in the presence of NADPH and FNR as electron donors. The calculated K-m and V-max values of Fpx for organic hydroperoxides were comparable to that for H2O2, demonstrating a multiple reactivity of Fpx towards hydroperoxides. An fpx gene disruptant was unable to grow under aerobic conditions, whereas its growth profiles were comparable to those of the wild-type strain under anaerobic and microaerobic conditions, clearly indicating the indispensability of Fpx as an antioxidant of H. thermophilus in aerobic environments. Structural analysis suggested that domain-swapping occurs in Fpx, and this domain-swapped structure is well conserved among thermophiles, implying the importance of structural stability of domain-swapped conformation for thermal environments. In addition, Fpx was located on a deep branch of the phylogenetic tree of Rbr and Rbr-like proteins. This finding, taken together with the wide distribution of Fpx among Bacteria and Archaea, suggests that Fpx is an ancestral type of Rbr homolog that functions as an essential antioxidant and may be part of an ancestral peroxide-detoxification system.	[Sato, Yuya; Fushinobu, Shinya; Wakagi, Takayoshi; Arai, Hiroyuki; Ishii, Masaharu; Igarashi, Yasuo] Univ Tokyo, Dept Biotechnol, Bunkyo Ku, Tokyo, Japan; [Kameya, Masafumi] Toyama Prefectural Univ, Biotechnol Res Ctr, Toyama, Japan; [Kameya, Masafumi] Toyama Prefectural Univ, Dept Biotechnol, Toyama, Japan	University of Tokyo; Toyama Prefectural University; Toyama Prefectural University	Sato, Y (corresponding author), Univ Tokyo, Dept Biotechnol, Bunkyo Ku, Tokyo, Japan.	amishii@mail.ecc.u-tokyo.ac.jp	Sato, Yuya/M-4921-2018; Fushinobu, Shinya/E-4987-2011; Wakagi, Takayoshi/AAJ-4145-2021	Sato, Yuya/0000-0003-2959-9603; Fushinobu, Shinya/0000-0003-1346-6435; Kameya, Masafumi/0000-0003-1987-4296	Japan Society for the Promotion of Science [21248010]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	Grant-in-Aid for Scientific Research (A) from Japan Society for the Promotion of Science KAKENHI (21248010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alban PS, 1998, J APPL MICROBIOL, V85, P875, DOI 10.1046/j.1365-2672.1998.00602.x; Andrews SC, 2010, BBA-GEN SUBJECTS, V1800, P691, DOI 10.1016/j.bbagen.2010.05.010; Arai H, 2010, J BACTERIOL, V192, P2651, DOI 10.1128/JB.00158-10; BEH M, 1993, ARCH MICROBIOL, V160, P306, DOI 10.1007/BF00292082; Berg IA, 2011, APPL ENVIRON MICROB, V77, P1925, DOI 10.1128/AEM.02473-10; Bonomi F, 1996, J BIOL INORG CHEM, V1, P67, DOI 10.1007/s007750050024; Cooley RB, 2011, J MOL BIOL; Cooley RB, 2011, SCIENCE, V332, P929, DOI 10.1126/science.1205687; Coulter ED, 1999, BIOCHEM BIOPH RES CO, V255, P317, DOI 10.1006/bbrc.1999.0197; Coulter ED, 2001, ARCH BIOCHEM BIOPHYS, V394, P76, DOI 10.1006/abbi.2001.2531; Das A, 2001, J BACTERIOL, V183, P1560, DOI 10.1128/JB.183.5.1560-1567.2001; Fushinobu S, 2003, BIOCHEMISTRY-US, V42, P11707, DOI 10.1021/bi034220b; Hoseki J, 1999, J BIOCHEM-TOKYO, V126, P951, DOI 10.1093/oxfordjournals.jbchem.a022539; Ikeda T, 2009, FEMS MICROBIOL LETT, V297, P124, DOI 10.1111/j.1574-6968.2009.01667.x; ISHII M, 1987, J BACTERIOL, V169, P2380, DOI 10.1128/jb.169.6.2380-2384.1987; Iyer RB, 2005, J BIOL INORG CHEM, V10, P407, DOI 10.1007/s00775-005-0650-8; JACOB F, 1977, SCIENCE, V196, P1161, DOI 10.1126/science.860134; Kawasaki S, 2004, FEBS LETT, V571, P21, DOI 10.1016/j.febslet.2004.06.047; Kawasaki S, 2007, FEBS LETT, V581, P2460, DOI 10.1016/j.febslet.2007.04.050; Kawasaki S, 2009, APPL ENVIRON MICROB, V75, P1021, DOI 10.1128/AEM.01425-08; KEELE BB, 1970, J BIOL CHEM, V245, P6176; Kurtz DM, 2006, J INORG BIOCHEM, V100, P679, DOI 10.1016/j.jinorgbio.2005.12.017; Lanzilotta WN, 2011, J BIOL INORG CHEM, V16, P949; LEGALL J, 1988, BIOCHEMISTRY-US, V27, P1636, DOI 10.1021/bi00405a037; Lehmann Y, 1996, J BACTERIOL, V178, P7152, DOI 10.1128/jb.178.24.7152-7158.1996; MCCORD JM, 1969, J BIOL CHEM, V244, P6056; PESCHEK GA, 1989, BIOCHEMISTRY-US, V28, P3057, DOI 10.1021/bi00433a048; Picrik AJ, 1993, EUR J BIOCHEM, V212, P237; PITULLE C, 1994, INT J SYST BACTERIOL, V44, P620, DOI 10.1099/00207713-44-4-620; RICHTER OMH, 1994, J BIOL CHEM, V269, P23079; SCHAUDER R, 1987, ARCH MICROBIOL, V148, P218, DOI 10.1007/BF00414815; SHIBA H, 1982, AGR BIOL CHEM TOKYO, V46, P2341, DOI 10.1080/00021369.1982.10865433; SHIBA H, 1985, ARCH MICROBIOL, V141, P198, DOI 10.1007/BF00408058; Sztukowska M, 2002, MOL MICROBIOL, V44, P479, DOI 10.1046/j.1365-2958.2002.02892.x; Tempel W, 2004, PROTEINS, V57, P878, DOI 10.1002/prot.20280; Ukeda H, 1997, ANAL BIOCHEM, V251, P206, DOI 10.1006/abio.1997.2273; Wahlund TM, 1997, J BACTERIOL, V179, P4859, DOI 10.1128/jb.179.15.4859-4867.1997; Wakagi T, 2003, FEMS MICROBIOL LETT, V222, P33, DOI 10.1016/S0378-1097(03)00233-7; Weinberg MV, 2004, J BACTERIOL, V186, P7888, DOI 10.1128/JB.186.23.7888-7895.2004; WOLFF SP, 1994, METHOD ENZYMOL, V233, P182; Yamamoto M, 2006, FEMS MICROBIOL LETT, V263, P189, DOI 10.1111/j.1574-6968.2006.00415.x; Zhao WX, 2007, MOL MICROBIOL, V66, P1219, DOI 10.1111/j.1365-2958.2007.05994.x	42	10	10	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2012	7	4							e34825	10.1371/journal.pone.0034825	http://dx.doi.org/10.1371/journal.pone.0034825			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952GU	22485188	Green Published, gold, Green Submitted			2022-12-27	WOS:000304780500062
J	Shen, XF; Ruan, XG; Zhao, H				Shen, Xuefeng; Ruan, Xiaoguo; Zhao, Hua			Stimulation of Midbrain Dopaminergic Structures Modifies Firing Rates of Rat Lateral Habenula Neurons	PLOS ONE			English	Article							VENTRAL TEGMENTAL AREA; PREFRONTAL CORTEX; SUBSTANTIA-NIGRA; NUCLEUS; BRAIN; TRANSMISSION; PATHWAY; ORIGIN; SYSTEM; D1	Ventral tegmental area (VTA) and substantia nigra pars compacta SNpc) are midbrain structures known to be involved in mediating reward in rodents. Lateral habenula (LHb) is considered as a negative reward source and it is reported that stimulation of the LHb rapidly induces inhibition of firing in midbrain dopamine neurons. Interestingly, the phasic fall in LHb neuronal activity may follow the excitation of dopamine neurons in response to reward-predicting stimuli. The VTA and SNpc give rise to dopaminergic projections that innervate the LHb, which is also known to be involved in processing painful stimuli. But it's unclear what physiological effects these inputs have on habenular function. In this study we distinguished the LHb pain activated neurons of the Wistar rats and assessed their electrophysiological responsiveness to the stimulation of the VTA and SNpc with either single-pulse stimulation (300 mu A, 0.5 Hz) or tetanic stimulation (80 mu A, 25 Hz). Single-pulse stimulation that was delivered to either midbrain structure triggered transient inhibition of firing of similar to 90% of the LHb pain-activated neurons. However, tetanic stimulation of the VTA tended to evoke an elevation in neuronal firing rate. W conclude that LHb pain-activated neurons can receive diverse reward-related signals originating from midbrain dopaminergic structures, and thus participate in the regulation of the brain reward system via both positive and negative feedback mechanisms.	[Shen, Xuefeng; Ruan, Xiaoguo; Zhao, Hua] Jilin Univ, Norman Bethune Coll Med, Dept Physiol, Changchun 130023, Jilin, Peoples R China	Jilin University	Shen, XF (corresponding author), Jilin Univ, Norman Bethune Coll Med, Dept Physiol, Changchun 130023, Jilin, Peoples R China.	zhua@jlu.edu.cn		Shen, Xuefeng/0000-0003-4401-3025	National Natural Science Foundation of China [30670670, 30970956]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (No. 30670670 and No. 30970956). The funders had no role in study design,data collection and analysis,decision to publish,or preparation of the manuscript.	AKISKAL HS, 1973, SCIENCE, V182, P20, DOI 10.1126/science.182.4107.20; ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; Carlezon WA, 2009, NEUROPHARMACOLOGY, V56, P122, DOI 10.1016/j.neuropharm.2008.06.075; CHERGUI K, 1994, NEUROSCIENCE, V62, P641, DOI 10.1016/0306-4522(94)90465-0; CHRISTOPH GR, 1986, J NEUROSCI, V6, P613; Ellison G, 2002, EUR NEUROPSYCHOPHARM, V12, P287, DOI 10.1016/S0924-977X(02)00020-2; FREMEAU RT, 1991, P NATL ACAD SCI USA, V88, P3772, DOI 10.1073/pnas.88.9.3772; Gao DM, 1996, EUR J NEUROSCI, V8, P1474, DOI 10.1111/j.1460-9568.1996.tb01609.x; GARRIS PA, 1994, J NEUROSCI, V14, P442; Gruber C, 2007, NEUROSCI LETT, V427, P165, DOI 10.1016/j.neulet.2007.09.016; Gurden H, 1999, NEUROSCIENCE, V94, P1019, DOI 10.1016/S0306-4522(99)00395-4; Hauptman JS, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC/2008/25/7/E3; Ikemoto S, 2007, BRAIN RES REV, V56, P27, DOI 10.1016/j.brainresrev.2007.05.004; Ji HF, 2007, J NEUROSCI, V27, P6923, DOI 10.1523/JNEUROSCI.0958-07.2007; Juckel G, 2009, EUR ARCH PSY CLIN N, V259, P1, DOI 10.1007/s00406-008-0826-7; Kao C Q, 1985, Sheng Li Xue Bao, V37, P24; KAWAGOE KT, 1992, NEUROSCIENCE, V51, P55, DOI 10.1016/0306-4522(92)90470-M; Kowski AB, 2009, NEUROSCIENCE, V161, P1154, DOI 10.1016/j.neuroscience.2009.04.026; Lecourtier L, 2008, EUR J NEUROSCI, V27, P1755, DOI 10.1111/j.1460-9568.2008.06130.x; LI YQ, 1993, J COMP NEUROL, V333, P118, DOI 10.1002/cne.903330110; Matsumoto M, 2007, NATURE, V447, P1111, DOI 10.1038/nature05860; Matsumoto M, 2009, NAT NEUROSCI, V12, P77, DOI 10.1038/nn.2233; Meshul CK, 1998, SYNAPSE, V30, P211, DOI 10.1002/(SICI)1098-2396(199810)30:2<211::AID-SYN11>3.0.CO;2-4; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; PHILLIPSON OT, 1982, EXP BRAIN RES, V45, P89; REISINE TD, 1984, BRAIN RES, V308, P281, DOI 10.1016/0006-8993(84)91067-9; Sartorius A, 2010, BIOL PSYCHIAT, V67, pE9, DOI 10.1016/j.biopsych.2009.08.027; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Seymour B, 2005, NAT NEUROSCI, V8, P1234, DOI 10.1038/nn1527; SKAGERBERG G, 1984, BRAIN RES, V307, P99, DOI 10.1016/0006-8993(84)90465-7; Smith WJ, 1997, PHYSIOL BEHAV, V61, P717, DOI 10.1016/S0031-9384(96)00524-0; Surmeier DJ, 2007, TRENDS NEUROSCI, V30, P228, DOI 10.1016/j.tins.2007.03.008; Tobler PN, 2005, SCIENCE, V307, P1642, DOI 10.1126/science.1105370; Ullsperger M, 2003, J NEUROSCI, V23, P4308, DOI 10.1523/jneurosci.23-10-04308.2003; Ungless MA, 2004, SCIENCE, V303, P2040, DOI 10.1126/science.1093360; Watanabe Y, 2009, NEUROREPORT, V20, P875, DOI 10.1097/WNR.0b013e32832c5e98; WEINER DM, 1991, P NATL ACAD SCI USA, V88, P1859, DOI 10.1073/pnas.88.5.1859; Yang LM, 2008, BEHAV BRAIN RES, V188, P84, DOI 10.1016/j.bbr.2007.10.022; Zhang Chun-xiao, 2007, Zhongguo Ying Yong Sheng Li Xue Za Zhi, V23, P442; Zhao H, 1995, Sheng Li Xue Bao, V47, P292	40	37	38	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2012	7	4							e34323	10.1371/journal.pone.0034323	http://dx.doi.org/10.1371/journal.pone.0034323			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952GU	22485164	Green Published, Green Submitted, gold			2022-12-27	WOS:000304780500039
J	Wolburg, H; Mogk, S; Acker, S; Frey, C; Meinert, M; Schonfeld, C; Lazarus, M; Urade, Y; Kubata, BK; Duszenko, M				Wolburg, Hartwig; Mogk, Stefan; Acker, Sven; Frey, Claudia; Meinert, Monika; Schoenfeld, Caroline; Lazarus, Michael; Urade, Yoshihiro; Kubata, Bruno Kilunga; Duszenko, Michael			Late Stage Infection in Sleeping Sickness	PLOS ONE			English	Article							TRYPANOSOMA-BRUCEI-BRUCEI; BLOOD-BRAIN-BARRIER; PROGRAMMED CELL-DEATH; VIRCHOW-ROBIN SPACES; CEREBROSPINAL-FLUID; TRANSENDOTHELIAL MIGRATION; AFRICAN TRYPANOSOMIASIS; IMMUNE-COMPLEXES; TIGHT JUNCTIONS; PIA MATER	At the turn of the 19th century, trypanosomes were identified as the causative agent of sleeping sickness and their presence within the cerebrospinal fluid of late stage sleeping sickness patients was described. However, no definitive proof of how the parasites reach the brain has been presented so far. Analyzing electron micrographs prepared from rodent brains more than 20 days after infection, we present here conclusive evidence that the parasites first enter the brain via the choroid plexus from where they penetrate the epithelial cell layer to reach the ventricular system. Adversely, no trypanosomes were observed within the parenchyma outside blood vessels. We also show that brain infection depends on the formation of long slender trypanosomes and that the cerebrospinal fluid as well as the stroma of the choroid plexus is a hostile environment for the survival of trypanosomes, which enter the pial space including the Virchow-Robin space via the subarachnoid space to escape degradation. Our data suggest that trypanosomes do not intend to colonize the brain but reside near or within the glia limitans, from where they can re-populate blood vessels and disrupt the sleep wake cycles.	[Wolburg, Hartwig] Univ Tubingen, Inst Pathol & Neuropathol, Tubingen, Germany; [Mogk, Stefan; Acker, Sven; Frey, Claudia; Schoenfeld, Caroline; Duszenko, Michael] Univ Tubingen, Interfac Inst Biochem, Tubingen, Germany; [Meinert, Monika] Univ Tubingen, Inst Evolut Biol Invertebrates, Tubingen, Germany; [Lazarus, Michael; Urade, Yoshihiro] Osaka Biosci Inst, Dept Mol Behav Biol, Osaka, Japan; [Kubata, Bruno Kilunga] African Union New Partnership Africas Dev Agcy Re, Nairobi, Kenya	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; African Union (AU)	Wolburg, H (corresponding author), Univ Tubingen, Inst Pathol & Neuropathol, Tubingen, Germany.	michael.duszenko@uni-tuebingen.de	Lazarus, Michael/G-3130-2010	Lazarus, Michael/0000-0003-3863-4474; Lazarus, Michael/0000-0003-4700-7894	German Research Foundation [DU 136/15-1]; Takeda Science Foundation; Japan Society for the Progress of Science; Government of Canada provided through the Canadian International Development Agency; Grants-in-Aid for Scientific Research [21300133] Funding Source: KAKEN	German Research Foundation(German Research Foundation (DFG)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Japan Society for the Progress of Science; Government of Canada provided through the Canadian International Development Agency; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work has been supported by the German Research Foundation, grant DU 136/15-1. The authors are grateful to the Takeda Science Foundation for a fellowship to SM and the Japan Society for the Progress of Science for a travel grant to MD. This study received also financial support of the Government of Canada provided through the Canadian International Development Agency to New Partnership for Africa's Development. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	BLACK SJ, 1982, PARASITE IMMUNOL, V4, P233, DOI 10.1111/j.1365-3024.1982.tb00435.x; Bruce D., 1895, PRELIMINARY REPORT T; Brun R, 2010, LANCET, V375, P148, DOI 10.1016/S0140-6736(09)60829-1; Castellant A, 1903, BRIT MED J, V1903, P1431, DOI 10.1136/bmj.1.2216.1431; Claes F, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000486; Cox FEG, 2004, INFECT DIS CLIN N AM, V18, P231, DOI 10.1016/j.idc.2004.01.004; Cross GAM, 1998, MOL BIOCHEM PARASIT, V91, P77, DOI 10.1016/S0166-6851(97)00186-2; de Sousa KP, 2010, PROTEIN J, V29, P283, DOI 10.1007/s10930-010-9250-8; Denninger V, 2008, METHOD ENZYMOL, V451, P373, DOI 10.1016/S0076-6879(08)03225-4; Duszenko M, 2006, TRENDS PARASITOL, V22, P536, DOI 10.1016/j.pt.2006.08.010; Engelhardt B, 2004, EUR J IMMUNOL, V34, P2955, DOI 10.1002/eji.200425327; FERGUSON MAJ, 1985, J BIOL CHEM, V260, P4547; Figarella K, 2006, CELL DEATH DIFFER, V13, P1802, DOI 10.1038/sj.cdd.4401862; Figarella K, 2005, CELL DEATH DIFFER, V12, P335, DOI 10.1038/sj.cdd.4401564; Frankmann S, 1987, NEW APPROACH REPEATE; GREENWOOD BM, 1980, T ROY SOC TROP MED H, V74, P716, DOI 10.1016/0035-9203(80)90184-4; Haag J, 1998, MOL BIOCHEM PARASIT, V91, P37, DOI 10.1016/S0166-6851(97)00185-0; Hayaishi O, 2004, ARCH ITAL BIOL, V142, P533; HIRUMI H, 1994, PARASITOL TODAY, V10, P80, DOI 10.1016/0169-4758(94)90402-2; Iadecola C, 2004, NAT REV NEUROSCI, V5, P347, DOI 10.1038/nrn1387; Kibona SN, 2006, TROP MED INT HEALTH, V11, P144, DOI 10.1111/j.1365-3156.2005.01545.x; Kreier J, 1977, PARASITIC PROTOZOA, V1, P205; Kristensson K, 2010, PROG NEUROBIOL, V91, P152, DOI 10.1016/j.pneurobio.2009.12.001; Kubata BK, 2007, TRENDS PARASITOL, V23, P325, DOI 10.1016/j.pt.2007.05.005; Kwee RM, 2007, RADIOGRAPHICS, V27, P1071, DOI 10.1148/rg.274065722; LAMBERT PH, 1981, J CLIN INVEST, V67, P77, DOI 10.1172/JCI110035; LANHAM SM, 1968, NATURE, V218, P1273, DOI 10.1038/2181273a0; Leggat PA, 2001, TRAVEL MED INFECT DI, V1, P137; Lentner C, 1981, GEIGY SCI TABLES, V1; Lyck R, 2003, BLOOD, V102, P3675, DOI 10.1182/blood-2003-02-0358; Masocha W, 2007, PHYSIOL BEHAV, V92, P110, DOI 10.1016/j.physbeh.2007.05.045; MORSE DE, 1972, AM J ANAT, V133, P349, DOI 10.1002/aja.1001330309; Mulenga C, 2001, NEUROPATH APPL NEURO, V27, P77, DOI 10.1046/j.0305-1846.2001.00306.x; ONOE H, 1988, P NATL ACAD SCI USA, V85, P4082, DOI 10.1073/pnas.85.11.4082; ORMEROD WE, 1986, T ROY SOC TROP MED H, V80, P626, DOI 10.1016/0035-9203(86)90161-6; Osterauer R, 2010, EVOL DEV, V12, P474, DOI 10.1111/j.1525-142X.2010.00433.x; PATZOLD U, 1980, J NEUROL, V222, P249, DOI 10.1007/BF00313154; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; PENTREATH VW, 1990, T ROY SOC TROP MED H, V84, P795, DOI 10.1016/0035-9203(90)90085-S; PENTREATH VW, 1995, T ROY SOC TROP MED H, V89, P9, DOI 10.1016/0035-9203(95)90637-1; PENTREATH VW, 1992, ANN TROP MED PARASIT, V86, P29, DOI 10.1080/00034983.1992.11812627; POLTERA AA, 1980, CLIN EXP IMMUNOL, V40, P496; Ransohoff RM, 2003, NAT REV IMMUNOL, V3, P569, DOI 10.1038/nri1130; Rodgers J, 2011, AM J TROP MED HYG, V84, P344, DOI 10.4269/ajtmh.2011.10-0487; Rubin LL, 1999, ANNU REV NEUROSCI, V22, P11, DOI 10.1146/annurev.neuro.22.1.11; SCHMIDT H, 1985, AM J TROP MED HYG, V34, P64, DOI 10.4269/ajtmh.1985.34.64; SCHMIDT H, 1983, VIRCHOWS ARCH A, V399, P333, DOI 10.1007/BF00612951; Steverding D, 2008, PARASITE VECTOR, V1, DOI 10.1186/1756-3305-1-3; Turner CMR, 1997, FEMS MICROBIOL LETT, V153, P227, DOI 10.1111/j.1574-6968.1997.tb10486.x; Wastling SL, 2011, TRENDS PARASITOL, V27, P394, DOI 10.1016/j.pt.2011.04.005; Wewer C, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-51; WHO, 2011, AFR TRYP SLEEP SICKN; Wolburg H, 2002, VASC PHARMACOL, V38, P323, DOI 10.1016/S1537-1891(02)00200-8; Wolburg H, 2001, NEUROSCI LETT, V307, P77, DOI 10.1016/S0304-3940(01)01927-9; Wolburg H, 2010, ACTA NEUROPATHOL, V119, P75, DOI 10.1007/s00401-009-0627-8; Yang Y, 2011, PROG MOL BIOL TRANSL, V99, P241, DOI 10.1016/S1877-1173(11)99006-1; ZHANG ET, 1990, J ANAT, V170, P111	57	32	32	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2012	7	3							e34304	10.1371/journal.pone.0034304	http://dx.doi.org/10.1371/journal.pone.0034304			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940MY	22496723	Green Published, Green Submitted, gold			2022-12-27	WOS:000303894900079
J	Herencia, C; Martinez-Moreno, JM; Herrera, C; Corrales, F; Santiago-Mora, R; Espejo, I; Barco, M; Almaden, Y; de la Mata, M; Rodriguez-Ariza, A; Munoz-Castaneda, JR				Herencia, Carmen; Martinez-Moreno, Julio M.; Herrera, Concepcion; Corrales, Fernando; Santiago-Mora, Raquel; Espejo, Isabel; Barco, Monserrat; Almaden, Yolanda; de la Mata, Manuel; Rodriguez-Ariza, Antonio; Munoz-Castaneda, Juan R.			Nuclear Translocation of beta-Catenin during Mesenchymal Stem Cells Differentiation into Hepatocytes Is Associated with a Tumoral Phenotype	PLOS ONE			English	Article							HUMAN HEPATOCELLULAR-CARCINOMA; HEPATIC DIFFERENTIATION; PROTEOME ANALYSIS; BONE-MARROW; CANCER-CELLS; IN-VITRO; LIVER; EXPRESSION; HEPATOBLASTOMAS; IDENTIFICATION	Wnt/beta-catenin pathway controls biochemical processes related to cell differentiation. In committed cells the alteration of this pathway has been associated with tumors as hepatocellular carcinoma or hepatoblastoma. The present study evaluated the role of Wnt/beta-catenin activation during human mesenchymal stem cells differentiation into hepatocytes. The differentiation to hepatocytes was achieved by the addition of two different conditioned media. In one of them, beta-catenin nuclear translocation, up-regulation of genes related to the Wnt/beta-catenin pathway, such as Lrp5 and Fzd3, as well as the oncogenes c-myc and p53 were observed. While in the other protocol there was a Wnt/beta-catenin inactivation. Hepatocytes with nuclear translocation of beta-catenin also had abnormal cellular proliferation, and expressed membrane proteins involved in hepatocellular carcinoma, metastatic behavior and cancer stem cells. Further, these cells had also increased auto-renewal capability as shown in spheroids formation assay. Comparison of both differentiation protocols by 2D-DIGE proteomic analysis revealed differential expression of 11 proteins with altered expression in hepatocellular carcinoma. Cathepsin B and D, adenine phosphoribosyltransferase, triosephosphate isomerase, inorganic pyrophosphatase, peptidyl-prolyl cis-trans isomerase A or lactate dehydrogenase beta-chain were up-regulated only with the protocol associated with Wnt signaling activation while other proteins involved in tumor suppression, such as transgelin or tropomyosin beta-chain were downregulated in this protocol. In conclusion, our results suggest that activation of the Wnt/beta-catenin pathway during human mesenchymal stem cells differentiation into hepatocytes is associated with a tumoral phenotype.	[Herencia, Carmen; Martinez-Moreno, Julio M.; Almaden, Yolanda; Rodriguez-Ariza, Antonio; Munoz-Castaneda, Juan R.] Univ Cordoba, Maimonides Inst Biomed Res IMIBIC, Reina Sofia Univ Hosp, Cordoba, Spain; [Herrera, Concepcion] Reina Sofia Univ Hosp, Cellular Therapy Unit, IMIBIC, Cordoba, Spain; [Corrales, Fernando] Univ Navarra, Ctr Appl Med Res, Prote Lab, E-31080 Pamplona, Spain; [Santiago-Mora, Raquel; Espejo, Isabel; Barco, Monserrat] Reina Sofia Univ Hosp, Serv Clin Anal, Cordoba, Spain; [de la Mata, Manuel] Reina Sofia Univ Hosp, Liver Res Unit, CIBERehd, IMIBIC, Cordoba, Spain	Universidad de Cordoba; University of Navarra; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD	Herencia, C (corresponding author), Univ Cordoba, Maimonides Inst Biomed Res IMIBIC, Reina Sofia Univ Hosp, Cordoba, Spain.	juanr.munoz.exts@juntadeandalucia.es	Herencia, Carmen/AAA-6843-2020; Muñoz-Castañeda, Juan R./AFQ-3443-2022; Arroyo, InmaculadaConcepcion Herrera/C-7346-2008; Rodriguez-Ariza, Antonio/U-4854-2017; Martínez, Julio Manuel/AAA-6724-2020	Arroyo, InmaculadaConcepcion Herrera/0000-0003-0055-2270; Rodriguez-Ariza, Antonio/0000-0001-5304-5745; Martínez, Julio Manuel/0000-0002-1945-5078; Corrales, Fernando/0000-0002-0231-5159; Munoz-Castaneda, Juan R/0000-0002-9341-0724	Consejeria de Economia, Ciencia y Empresa, Junta de Andalucia (Proyecto de Excelencia) [P06-CTS-02137]	Consejeria de Economia, Ciencia y Empresa, Junta de Andalucia (Proyecto de Excelencia)	This study was supported by a grant from Consejeria de Economia, Ciencia y Empresa, Junta de Andalucia (Proyecto de Excelencia: P06-CTS-02137). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armengol C, 2011, INT J BIOCHEM CELL B, V43, P265, DOI 10.1016/j.biocel.2009.07.012; Basma H, 2009, GASTROENTEROLOGY, V136, P990, DOI 10.1053/j.gastro.2008.10.047; Beaujouin M, 2008, ADV EXP MED BIOL, V617, P453, DOI 10.1007/978-0-387-69080-3_44; Bhagwat SV, 2001, BLOOD, V97, P652, DOI 10.1182/blood.V97.3.652; Bharadwaj S, 2002, CANCER LETT, V183, P205, DOI 10.1016/S0304-3835(02)00119-2; Burns JS, 2005, CANCER RES, V65, P3126, DOI 10.1158/0008-5472.CAN-04-2218; Cao L, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-71; Chafey P, 2009, PROTEOMICS, V9, P3889, DOI 10.1002/pmic.200800609; Chen S, 2008, CANCER CHEMOTH PHARM, V61, P459, DOI 10.1007/s00280-007-0491-y; Chen XH, 2008, ONCOL REP, V20, P979, DOI 10.3892/or_00000099; Fan HZ, 2009, J CANCER RES CLIN, V135, P591, DOI 10.1007/s00432-008-0493-0; Fantin VR, 2006, CANCER CELL, V9, P425, DOI 10.1016/j.ccr.2006.04.023; Fu BH, 2010, MOL BIOL REP, V37, P1665, DOI 10.1007/s11033-009-9790-1; Haegebarth A, 2009, AM J PATHOL, V174, P715, DOI 10.2353/ajpath.2009.080758; Hamidouche Z, 2008, FASEB J, V22, P3813, DOI 10.1096/fj.08-106302; Haraguchi N, 2010, J CLIN INVEST, V120, P3326, DOI 10.1172/JCI42550; Hirasawa Y, 2006, ONCOLOGY-BASEL, V71, P77, DOI 10.1159/000100475; Huang JF, 2011, J CLIN PATHOL, V64, P343, DOI 10.1136/jcp.2010.085142; Ishii K, 2008, HEPATOLOGY, V48, P597, DOI 10.1002/hep.22362; Iwamuro M, 2010, CELL TRANSPLANT, V19, P841, DOI 10.3727/096368910X508960; Jeng YM, 2000, CANCER LETT, V152, P45, DOI 10.1016/S0304-3835(99)00433-4; Ke ZF, 2008, BIOCHEM BIOPH RES CO, V367, P342, DOI 10.1016/j.bbrc.2007.12.134; Kotobuki N, 2004, ARTIF ORGANS, V28, P33, DOI 10.1111/j.1525-1594.2004.07320.x; Laudes M, 2011, J MOL ENDOCRINOL, V46, pR65, DOI 10.1530/JME-10-0169; Lee KD, 2004, HEPATOLOGY, V40, P1275, DOI 10.1002/hep.20469; Li L, 2008, J PROTEOME RES, V7, P611, DOI 10.1021/pr070525r; Liang RCMY, 2002, J CHROMATOGR B, V771, P303, DOI 10.1016/S1570-0232(02)00041-7; Lim SO, 2002, BIOCHEM BIOPH RES CO, V291, P1031, DOI 10.1006/bbrc.2002.6547; Liu ZH, 2011, OMICS, V15, P61, DOI 10.1089/omi.2010.0061; Llovet JM, 2008, HEPATOLOGY, V48, P1312, DOI 10.1002/hep.22506; Malanchi I, 2008, NATURE, V452, P650, DOI 10.1038/nature06835; Marquardt JU, 2010, J HEPATOL, V53, P568, DOI 10.1016/j.jhep.2010.05.003; Martin J, 2008, WORLD J GASTROENTERO, V14, P1720, DOI 10.3748/wjg.14.1720; Mishra L, 2009, HEPATOLOGY, V49, P318, DOI 10.1002/hep.22704; MONGA SP, 2009, INT J BIOCHEM CELL B, V43, P1021; Monga SPS, 2006, CELL TISSUE RES, V323, P71, DOI 10.1007/s00441-005-0045-8; Nusse R, 2005, CELL RES, V15, P28, DOI 10.1038/sj.cr.7290260; Petrovic N, 2007, BLOOD, V110, P142, DOI 10.1182/blood-2006-02-002931; Piao LS, 2012, CANCER LETT, V315, P129, DOI 10.1016/j.canlet.2011.10.012; Ranganathan S, 2005, PEDIATR DEVEL PATHOL, V8, P435, DOI 10.1007/s10024-005-0028-5; Rubio D, 2005, CANCER RES, V65, P3035, DOI 10.1158/0008-5472.CAN-04-4194; Serakinci N, 2004, ONCOGENE, V23, P5095, DOI 10.1038/sj.onc.1207651; Shen HL, 2006, PROTEOMICS, V6, P528, DOI 10.1002/pmic.200500232; Shen Yi, 2012, Front Biosci (Elite Ed), V4, P1157; Si-Tayeb K, 2010, HEPATOLOGY, V51, P297, DOI 10.1002/hep.23354; Srisomsap C, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/437143; Tang N, 2009, J CELL MOL MED, V13, P2448, DOI 10.1111/j.1582-4934.2008.00569.x; TERAMOTO T, 1994, CANCER RES, V54, P231; Tian J, 1999, BRIT J CANCER, V81, P814, DOI 10.1038/sj.bjc.6690769; Uchida Y, 2010, ONCOL REP, V24, P1147, DOI 10.3892/or_00000966; Wei Y, 2000, ONCOGENE, V19, P498, DOI 10.1038/sj.onc.1203356; Weiswald LB, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-106; Wu XZ, 2008, ANN SURG ONCOL, V15, P407, DOI 10.1245/s10434-007-9695-y; Yamada S, 2004, ONCOGENE, V23, P5901, DOI 10.1038/sj.onc.1207782; Yeo M, 2006, PROTEOMICS, V6, P1158, DOI 10.1002/pmic.200500390; Yokoyama Y, 2004, PROTEOMICS, V4, P2111, DOI 10.1002/pmic.200300712; Yoshida Y, 2007, AM J PHYSIOL-GASTR L, V293, pG1089, DOI 10.1152/ajpgi.00187.2007; Zimmermann A, 2005, EUR J CANCER, V41, P1503, DOI 10.1016/j.ejca.2005.02.035; Zulehner G, 2010, AM J PATHOL, V176, P472, DOI 10.2353/ajpath.2010.090300	59	39	43	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2012	7	4							e34656	10.1371/journal.pone.0034656	http://dx.doi.org/10.1371/journal.pone.0034656			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959FE	22506042	Green Published, gold			2022-12-27	WOS:000305297500050
J	Shen, X; Zeng, H; Xie, L; He, J; Li, J; Xie, XJ; Luo, CL; Xu, HP; Zhou, M; Nie, QH; Zhang, XQ				Shen, Xu; Zeng, Hua; Xie, Liang; He, Jun; Li, Jian; Xie, Xiujuan; Luo, Chenglong; Xu, Haiping; Zhou, Min; Nie, Qinghua; Zhang, Xiquan			The GTPase Activating Rap/RanGAP Domain-Like 1 Gene Is Associated with Chicken Reproductive Traits	PLOS ONE			English	Article							VASOACTIVE-INTESTINAL-PEPTIDE; GENOME-WIDE ASSOCIATION; HORMONE BETA-SUBUNIT; HIGH EGG-PRODUCTION; PITUITARY-GLAND; DOMESTIC HEN; BODY-WEIGHT; INCUBATION BEHAVIOR; PROLACTIN SECRETION; CANDIDATE GENES	Background: Abundant evidence indicates that chicken reproduction is strictly regulated by the hypothalamic-pituitary-gonad (HPG) axis, and the genes included in the HPG axis have been studied extensively. However, the question remains as to whether any other genes outside of the HPG system are involved in regulating chicken reproduction. The present study was aimed to identify, on a genome-wide level, novel genes associated with chicken reproductive traits. Methodology/Principal Finding: Suppressive subtractive hybridization (SSH), genome-wide association study (GWAS), and gene-centric GWAS were used to identify novel genes underlying chicken reproduction. Single marker-trait association analysis with a large population and allelic frequency spectrum analysis were used to confirm the effects of candidate genes. Using two full-sib Ningdu Sanhuang (NDH) chickens, GARNL1 was identified as a candidate gene involved in chicken broodiness by SSH analysis. Its expression levels in the hypothalamus and pituitary were significantly higher in brooding chickens than in non-brooding chickens. GWAS analysis with a NDH two tail sample showed that 2802 SNPs were significantly associated with egg number at 300 d of age (EN300). Among the 2802 SNPs, 2 SNPs composed a block overlapping the GARNL1 gene. The gene-centric GWAS analysis with another two tail sample of NDH showed that GARNL1 was strongly associated with EN300 and age at first egg (AFE). Single marker-trait association analysis in 1301 female NDH chickens confirmed that variation in this gene was related to EN300 and AFE. The allelic frequency spectrum of the SNP rs15700989 among 5 different populations supported the above associations. Western blotting, RT-PCR, and qPCR were used to analyze alternative splicing of the GARNL1 gene. RT-PCR detected 5 transcripts and revealed that the transcript, which has a 141 bp insertion, was expressed in a tissue-specific manner. Conclusions/Significance: Our findings demonstrate that the GARNL1 gene contributes to chicken reproductive traits.	[Shen, Xu; Zeng, Hua; Xie, Liang; He, Jun; Li, Jian; Xie, Xiujuan; Xu, Haiping; Nie, Qinghua; Zhang, Xiquan] S China Agr Univ, Coll Anim Sci, Dept Anim Genet Breeding & Reprod, Guangzhou, Guangdong, Peoples R China; [Shen, Xu; He, Jun; Li, Jian; Xie, Xiujuan; Xu, Haiping; Nie, Qinghua; Zhang, Xiquan] Guangdong Prov Key Lab Agroanim Genom & Mol Breed, Guangzhou, Guangdong, Peoples R China; [Xie, Liang] Hainan Acad Agr Sci, Inst Anim Sci & Vet, Haikou, Hainan, Peoples R China; [Luo, Chenglong] Guangdong Acad Agr Sci, Inst Anim Sci, Guangzhou, Guangdong, Peoples R China; [Zhou, Min] Jiang Xi Educ Coll, Inst Biotechnol, Nanchang, Jiangxi, Peoples R China	South China Agricultural University; Guangdong Academy of Agricultural Sciences	Shen, X (corresponding author), S China Agr Univ, Coll Anim Sci, Dept Anim Genet Breeding & Reprod, Guangzhou, Guangdong, Peoples R China.	xqzhang@scau.edu.cn	xu, haiping/GSJ-1374-2022		China Agriculture Research System [CARS-42-G05]; National Natural Scientific Foundation of China [31000544]	China Agriculture Research System; National Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by China Agriculture Research System (CARS-42-G05) and the National Natural Scientific Foundation of China, project (No. 31000544). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abasht B, 2007, ANIM GENET, V38, P491, DOI 10.1111/j.1365-2052.2007.01642.x; Ahn JS, 2010, STEM CELLS DEV, V19, P1249, DOI 10.1089/scd.2009.0265; Bao B, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-224; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Basheer A, 2010, 32 C INT SOC AN GEN; Bhatt R, 2003, GEN COMP ENDOCR, V130, P41, DOI 10.1016/S0016-6480(02)00533-6; Bouatia-Naji N, 2009, NAT GENET, V41, P89, DOI 10.1038/ng.277; BUNTIN JD, 1988, J ENDOCRINOL, V118, P33, DOI 10.1677/joe.0.1180033; Chaiseha Y, 2003, NEUROENDOCRINOLOGY, V77, P105, DOI 10.1159/000068649; Chen CF, 2007, THERIOGENOLOGY, V68, P1305, DOI 10.1016/j.theriogenology.2007.08.032; Chen LR, 2007, ANIM REPROD SCI, V100, P172, DOI 10.1016/j.anireprosci.2006.07.005; Ciccone NA, 2004, J NEUROENDOCRINOL, V16, P999, DOI 10.1111/j.1365-2826.2005.01260.x; Cui JX, 2006, POULTRY SCI, V85, P26, DOI 10.1093/ps/85.1.26; Dunn IC, 2009, ANIM GENET, V40, P110, DOI 10.1111/j.1365-2052.2008.01794.x; Dunn IC, 1999, J NEUROENDOCRINOL, V11, P371; Dunn IC, 2004, HEREDITY, V92, P128, DOI 10.1038/sj.hdy.6800396; El Halawani ME, 2000, POULTRY SCI, V79, P349, DOI 10.1093/ps/79.3.349; ELHALAWANI ME, 1993, POULTRY SCI, V72, P906, DOI 10.3382/ps.0720906; Elkin RG, 2003, POULTRY SCI, V82, P517, DOI 10.1093/ps/82.4.517; GARWOOD VA, 1975, POULTRY SCI, V54, P1765; Gorni C, 2011, ANIM GENET, V42, P161, DOI 10.1111/j.1365-2052.2010.02098.x; HALAWANI ME, 1980, BIOL REPROD, V23, P118, DOI 10.1095/biolreprod23.1.118; Han B, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000456; Hansen C, 2005, ANIM BIOTECHNOL, V16, P67, DOI 10.1081/ABIO-200055016; Hasenstein JR, 2008, DEV BIOLOGICALS, V132, P213, DOI 10.1159/000317162; HATTORI M, 1995, MOL CELL BIOL, V15, P552, DOI 10.1128/MCB.15.1.552; Hemminger BM, 2006, BIOINFORMATICS, V22, P626, DOI 10.1093/bioinformatics/btk025; Heng JIT, 2002, J BIOL CHEM, V277, P43152, DOI 10.1074/jbc.M204858200; Jiang RS, 2005, POULTRY SCI, V84, P839, DOI 10.1093/ps/84.6.839; Jiang RunShen, 2007, Journal of China Agricultural University, V12, P46; Jorgenson E, 2006, NAT REV GENET, V7, P885, DOI 10.1038/nrg1962; Klenke U, 2010, ENDOCRINOLOGY, V151, P2736, DOI 10.1210/en.2009-1198; Kuo YM, 2005, THERIOGENOLOGY, V64, P1490, DOI 10.1016/j.theriogenology.2005.03.020; Liang Y, 2006, DOMEST ANIM ENDOCRIN, V30, P1, DOI 10.1016/j.domaniend.2005.05.006; LIU G, 1995, POULTRY SCI, V74, P1259, DOI 10.3382/ps.0741259; MAURO LJ, 1989, ENDOCRINOLOGY, V125, P1795, DOI 10.1210/endo-125-4-1795; Mochizuki N, 1999, NATURE, V400, P891, DOI 10.1038/23738; Onagbesan OM, 2006, POULTRY SCI, V85, P1245, DOI 10.1093/ps/85.7.1245; Richard-Yris MA, 1998, BRIT POULTRY SCI, V39, P309, DOI 10.1080/00071669888836; Rioux JD, 2007, NAT GENET, V39, P596, DOI 10.1038/ng2032; Romanov MN, 2002, POULTRY SCI, V81, P928, DOI 10.1093/ps/81.7.928; Sasaki O, 2004, ANIM GENET, V35, P188, DOI 10.1111/j.1365-2052.2004.01133.x; Schreiweis MA, 2006, ANIM GENET, V37, P106, DOI 10.1111/j.1365-2052.2005.01394.x; Schulze TG, 2009, MOL PSYCHIATR, V14, P487, DOI 10.1038/mp.2008.134; Schutz K, 2002, BEHAV GENET, V32, P423, DOI 10.1023/A:1020880211144; Schwarzbraun T, 2004, GENOMICS, V84, P577, DOI 10.1016/j.ygeno.2004.04.013; Sharp PJ, 2005, ANN NY ACAD SCI, V1040, P189, DOI 10.1196/annals.1327.024; SHARP PJ, 1993, POULTRY SCI, V72, P897, DOI 10.3382/ps.0720897; SHARP PJ, 1989, J ENDOCRINOL, V122, P5, DOI 10.1677/joe.0.1220005; SHARP PJ, 1984, J EXP ZOOL, V232, P475, DOI 10.1002/jez.1402320314; SHARP PJ, 2004, GENES PERSISTENCY EG, P38; Shimojima K, 2009, GENOMICS, V94, P414, DOI 10.1016/j.ygeno.2009.08.015; Shiue YL, 2006, THERIOGENOLOGY, V66, P1274, DOI 10.1016/j.theriogenology.2006.03.037; Tuiskula-Haavisto M, 2004, GENET RES, V84, P57, DOI 10.1017/S0016672304006950; Tuiskula-Haavisto M, 2002, POULTRY SCI, V81, P919, DOI 10.1093/ps/81.7.919; Uemoto Y, 2009, POULTRY SCI, V88, P2512, DOI 10.3382/ps.2009-00331; Wardecka Barbara, 2002, Journal of Applied Genetics, V43, P319; Xu HP, 2010, POULTRY SCI, V89, P428, DOI 10.3382/ps.2009-00428; Xu HP, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-33; Xu HP, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-17; Yang N, 2005, WORLD POULTRY SCI J, V61, P373, DOI [10.1079/WPS200463, 10.1079/WPS200563]; Youngren OM, 1998, NEUROENDOCRINOLOGY, V68, P319, DOI 10.1159/000054380; ZHANG K, 1991, SCIENCE, V254, P1630, DOI 10.1126/science.1749934; Zhou M, 2008, POULTRY SCI, V87, P893, DOI 10.3382/ps.2007-00495; Zhou M, 2010, BRIT POULTRY SCI, V51, P195, DOI 10.1080/00071661003745786	65	19	24	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2012	7	4							e33851	10.1371/journal.pone.0033851	http://dx.doi.org/10.1371/journal.pone.0033851			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JO	22496769	Green Published, Green Submitted, gold			2022-12-27	WOS:000305014500018
J	Buchi, L; Vuilleumier, S				Buechi, Lucie; Vuilleumier, Severine			Dispersal Strategies, Few Dominating or Many Coexisting: The Effect of Environmental Spatial Structure and Multiple Sources of Mortality	PLOS ONE			English	Article							METAPOPULATION PERSISTENCE; PATCHY ENVIRONMENTS; LOCAL ADAPTATION; SEED DISPERSAL; EVOLUTION; COMPETITION; LANDSCAPES; DISTANCE; POPULATIONS; HABITATS	Interspecific competition, life history traits, environmental heterogeneity and spatial structure as well as disturbance are known to impact the successful dispersal strategies in metacommunities. However, studies on the direction of impact of those factors on dispersal have yielded contradictory results and often considered only few competing dispersal strategies at the same time. We used a unifying modeling approach to contrast the combined effects of species traits (adult survival, specialization), environmental heterogeneity and structure (spatial autocorrelation, habitat availability) and disturbance on the selected, maintained and coexisting dispersal strategies in heterogeneous metacommunities. Using a negative exponential dispersal kernel, we allowed for variation of both species dispersal distance and dispersal rate. We showed that strong disturbance promotes species with high dispersal abilities, while low local adult survival and habitat availability select against them. Spatial autocorrelation favors species with higher dispersal ability when adult survival and disturbance rate are low, and selects against them in the opposite situation. Interestingly, several dispersal strategies coexist when disturbance and adult survival act in opposition, as for example when strong disturbance regime favors species with high dispersal abilities while low adult survival selects species with low dispersal. Our results unify apparently contradictory previous results and demonstrate that spatial structure, disturbance and adult survival determine the success and diversity of coexisting dispersal strategies in competing metacommunities.	[Buechi, Lucie; Vuilleumier, Severine] Univ Lausanne, Dept Ecol & Evolut, Lausanne, Switzerland; [Buechi, Lucie] Agroscope Changins Wadenswil Res Stn ACW, Nyon, Switzerland	University of Lausanne; Swiss Federal Research Station Agroscope	Buchi, L (corresponding author), Univ Lausanne, Dept Ecol & Evolut, Lausanne, Switzerland.	Lucie.Buchi@gmail.com	; Buchi, Lucie/E-5677-2012	Vuilleumier, Severine/0000-0002-0131-3186; Buchi, Lucie/0000-0002-1935-6176	Swiss National Science Foundation [31003A-112511/2, PZ00P3-121702, PZ00P3_139421 / 1, 31003A-130065]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was funded by the Swiss National Science Foundation, grant #31003A-112511/2 and for SV, grants #PZ00P3-121702, #PZ00P3_139421 / 1 and #31003A-130065. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achter JD, 2006, EVOL ECOL RES, V8, P1377; ASMUSSEN MA, 1983, THEOR POPUL BIOL, V23, P281, DOI 10.1016/0040-5809(83)90019-9; BALKAU BJ, 1973, GENETICS, V74, P171; BENGTSSON BO, 1978, J THEOR BIOL, V73, P439, DOI 10.1016/0022-5193(78)90151-0; Blanquart F, 2011, AM NAT, V177, P188, DOI 10.1086/657953; Bonte D, 2010, OIKOS, V119, P560, DOI 10.1111/j.1600-0706.2009.17943.x; Buchi L, 2009, ECOL MODEL, V220, P2857, DOI 10.1016/j.ecolmodel.2009.08.005; Cadotte MW, 2006, AM NAT, V167, P913, DOI 10.1086/504850; Chase JM, 2005, FUNCT ECOL, V19, P182, DOI 10.1111/j.0269-8463.2005.00937.x; Clark JS, 1999, ECOLOGY, V80, P1475, DOI 10.1890/0012-9658(1999)080[1475:SDNAFP]2.0.CO;2; COHEN D, 1991, THEOR POPUL BIOL, V39, P63, DOI 10.1016/0040-5809(91)90041-D; COMINS HN, 1980, J THEOR BIOL, V82, P205, DOI 10.1016/0022-5193(80)90099-5; CONNELL JH, 1978, SCIENCE, V199, P1302, DOI 10.1126/science.199.4335.1302; Conrad KF, 1999, ECOGRAPHY, V22, P524, DOI 10.1111/j.1600-0587.1999.tb00541.x; Devictor V, 2009, DIVERS DISTRIB, V15, P122, DOI 10.1111/j.1472-4642.2008.00510.x; Doebeli M, 1997, EVOLUTION, V51, P1730, DOI 10.1111/j.1558-5646.1997.tb05097.x; FRANK SA, 1986, J THEOR BIOL, V122, P303, DOI 10.1016/S0022-5193(86)80122-9; GADGIL M, 1971, ECOLOGY, V52, P253, DOI 10.2307/1934583; Gandon S, 1999, J THEOR BIOL, V199, P275, DOI 10.1006/jtbi.1999.0960; Goodnight CJ, 2011, PHILOS T R SOC B, V366, P1401, DOI 10.1098/rstb.2010.0290; Gros A, 2006, OIKOS, V114, P544, DOI 10.1111/j.2006.0030-1299.14909.x; HAMILTON WD, 1977, NATURE, V269, P578, DOI 10.1038/269578a0; Hanski I, 2004, ECOL LETT, V7, P958, DOI 10.1111/j.1461-0248.2004.00654.x; HASTINGS A, 1983, THEOR POPUL BIOL, V24, P244, DOI 10.1016/0040-5809(83)90027-8; Heino M, 2001, AM NAT, V157, P495, DOI 10.1086/319927; Hiebeler D, 2004, THEOR POPUL BIOL, V66, P205, DOI 10.1016/j.tpb.2004.06.004; Hiebeler DE, 2007, J MATH BIOL, V54, P337, DOI 10.1007/s00285-006-0054-6; Higgins SI, 2002, J ECOL, V90, P616, DOI 10.1046/j.1365-2745.2002.00694.x; Hovestadt T, 2001, P ROY SOC B-BIOL SCI, V268, P385, DOI 10.1098/rspb.2000.1379; Hubbell Stephen P., 2001, V32, pi; Jansen VAA, 2007, EVOLUTION, V61, P2386, DOI 10.1111/j.1558-5646.2007.00201.x; JOHNSON ML, 1990, ANNU REV ECOL SYST, V21, P449, DOI 10.1146/annurev.ecolsys.21.1.449; Johst K, 2002, OIKOS, V98, P263, DOI 10.1034/j.1600-0706.2002.980208.x; Kallimanis AS, 2006, EVOL ECOL RES, V8, P529; Kisdi E, 2002, AM NAT, V159, P579, DOI 10.1086/339989; Kneitel JM, 2004, ECOL LETT, V7, P69, DOI 10.1046/j.1461-0248.2003.00551.x; LEVIN SA, 1984, THEOR POPUL BIOL, V26, P165, DOI 10.1016/0040-5809(84)90028-5; Levin SA, 2003, ANNU REV ECOL EVOL S, V34, P575, DOI 10.1146/annurev.ecolsys.34.011802.132428; Massol F, 2011, EVOLUTION, V65, P490, DOI 10.1111/j.1558-5646.2010.01143.x; Mathias A, 2001, EVOLUTION, V55, P246; MCPEEK MA, 1992, AM NAT, V140, P1010, DOI 10.1086/285453; MORRIS DW, 1991, AM NAT, V137, P907, DOI 10.1086/285200; Mouquet N., 2005, METACOMMUNITIES SPAT, P237; Muneepeerakul R, 2011, J THEOR BIOL, V269, P256, DOI 10.1016/j.jtbi.2010.11.003; Murrell DJ, 2002, OIKOS, V97, P229, DOI 10.1034/j.1600-0706.2002.970209.x; Nichols J., 2001, DISPERSAL; North A, 2007, OIKOS, V116, P1106, DOI 10.1111/j.2007.0030-1299.15366.x; OLIVIERI I, 1995, AM NAT, V146, P202, DOI 10.1086/285795; Paradis E, 1998, EVOL ECOL, V12, P235, DOI 10.1023/A:1006539930788; Parvinen K, 2003, J EVOLUTION BIOL, V16, P143, DOI 10.1046/j.1420-9101.2003.00478.x; Parvinen K, 2006, B MATH BIOL, V68, P655, DOI 10.1007/s11538-005-9040-1; Payne JL, 2011, J THEOR BIOL, V273, P147, DOI 10.1016/j.jtbi.2010.12.036; Perrin N, 1999, AM NAT, V154, P282, DOI 10.1086/303236; Poethke HJ, 2003, AM NAT, V161, P631, DOI 10.1086/368224; R Core Team, 2020, R LANG ENV STAT COMP; Ronce O, 2000, AM NAT, V155, P485, DOI 10.1086/303341; Ronce O, 2007, ANNU REV ECOL EVOL S, V38, P231, DOI 10.1146/annurev.ecolsys.38.091206.095611; Rousset F, 2002, J EVOLUTION BIOL, V15, P515, DOI 10.1046/j.1420-9101.2002.00430.x; Snyder RE, 2011, P ROY SOC B-BIOL SCI, V278, P739, DOI 10.1098/rspb.2010.1549; Streiff R, 1999, MOL ECOL, V8, P831, DOI 10.1046/j.1365-294X.1999.00637.x; TILMAN D, 1994, ECOLOGY, V75, P2, DOI 10.2307/1939377; Travis JMJ, 1999, P ROY SOC B-BIOL SCI, V266, P723, DOI 10.1098/rspb.1999.0696; Travis JMJ, 2001, ECOL RES, V16, P157, DOI 10.1046/j.1440-1703.2001.00381.x; Urban MC, 2008, TRENDS ECOL EVOL, V23, P311, DOI 10.1016/j.tree.2008.02.007; Van Valen Leigh, 1971, Evolution, V25, P591, DOI [10.1111/j.1558-5646.1971.tb01919.x, 10.2307/2406942]; Vuilleumier S, 2007, THEOR POPUL BIOL, V72, P77, DOI 10.1016/j.tpb.2006.11.001; WASER PM, 1986, AM NAT, V128, P529, DOI 10.1086/284585; With KA, 1999, LANDSCAPE ECOL, V14, P73, DOI 10.1023/A:1008030215600	68	13	13	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2012	7	4							e34733	10.1371/journal.pone.0034733	http://dx.doi.org/10.1371/journal.pone.0034733			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JA	22493712	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000305012700054
J	Cheng, WY; Kandel, JJ; Yamashiro, DJ; Canoll, P; Anastassiou, D				Cheng, Wei-Yi; Kandel, Jessica J.; Yamashiro, Darrell J.; Canoll, Peter; Anastassiou, Dimitris			A Multi-Cancer Mesenchymal Transition Gene Expression Signature Is Associated with Prolonged Time to Recurrence in Glioblastoma	PLOS ONE			English	Article							TUMOR PROGRESSION; STEM-CELLS; INVASION; DISEASE; GROWTH	A stage-associated gene expression signature of coordinately expressed genes, including the transcription factor Slug (SNAI2) and other epithelial-mesenchymal transition (EMT) markers has been found present in samples from publicly available gene expression datasets in multiple cancer types, including nonepithelial cancers. The expression levels of the co-expressed genes vary in a continuous and coordinate manner across the samples, ranging from absence of expression to strong co-expression of all genes. These data suggest that tumor cells may pass through an EMT-like process of mesenchymal transition to varying degrees. Here we show that, in glioblastoma multiforme (GBM), this signature is associated with time to recurrence following initial treatment. By analyzing data from The Cancer Genome Atlas (TCGA), we found that GBM patients who responded to therapy and had long time to recurrence had low levels of the signature in their tumor samples (P = 3 x 10(-7)). We also found that the signature is strongly correlated in gliomas with the putative stem cell marker CD44, and is highly enriched among the differentially expressed genes in glioblastomas vs. lower grade gliomas. Our results suggest that long delay before tumor recurrence is associated with absence of the mesenchymal transition signature, raising the possibility that inhibiting this transition might improve the durability of therapy in glioma patients.	[Cheng, Wei-Yi; Anastassiou, Dimitris] Columbia Univ, Ctr Computat Biol & Bioinformat, New York, NY 10027 USA; [Kandel, Jessica J.; Yamashiro, Darrell J.] Columbia Univ, Inst Canc Genet, New York, NY USA; [Kandel, Jessica J.] Columbia Univ, Dept Surg, New York, NY USA; [Kandel, Jessica J.; Yamashiro, Darrell J.] Columbia Univ, Dept Pediat, New York, NY 10027 USA; [Yamashiro, Darrell J.; Canoll, Peter] Columbia Univ, Dept Pathol & Cell Biol, New York, NY USA; [Canoll, Peter] Columbia Univ, Columbia Stem Cell Initiat, New York, NY USA; [Cheng, Wei-Yi; Anastassiou, Dimitris] Columbia Univ, Dept Elect Engn, New York, NY 10027 USA	Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; Columbia University	Cheng, WY (corresponding author), Columbia Univ, Ctr Computat Biol & Bioinformat, New York, NY 10027 USA.	da8@columbia.edu			Columbia University; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS066955] Funding Source: NIH RePORTER	Columbia University; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was funded from Columbia University's inventor's patent royalty proceeds. The patent is unrelated to the research described in the paper. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alison MR, 2011, J PATHOL, V223, P147, DOI 10.1002/path.2793; Anastassiou D, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-529; Anido J, 2010, CANCER CELL, V18, P655, DOI 10.1016/j.ccr.2010.10.023; Buck E, 2007, MOL CANCER THER, V6, P532, DOI 10.1158/1535-7163.MCT-06-0462; Cooper LAD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012548; Cover T. M., 2006, ELEMENTS INFORM THEO, p[xxiii, 74]; Creighton CJ, 2009, P NATL ACAD SCI USA, V106, P13820, DOI 10.1073/pnas.0905718106; Dabney AR, 2005, BIOINFORMATICS, V21, P4148, DOI 10.1093/bioinformatics/bti681; Jechlinger M, 2003, ONCOGENE, V22, P7155, DOI 10.1038/sj.onc.1206887; Kim H, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-51; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Mikheeva SA, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-194; Morel AP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002888; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Scheel C, 2011, INT J CANCER, V129, P2310, DOI 10.1002/ijc.26311; Singh A, 2010, ONCOGENE, V29, P4741, DOI 10.1038/onc.2010.215; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Taube JH, 2010, P NATL ACAD SCI USA, V107, P15449, DOI 10.1073/pnas.1004900107; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Xu Y, 2010, CANCER RES, V70, P2455, DOI 10.1158/0008-5472.CAN-09-2505; Yang HW, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-301; Zoller M, 2011, NAT REV CANCER, V11, P254, DOI 10.1038/nrc3023	25	89	94	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2012	7	4							e34705	10.1371/journal.pone.0034705	http://dx.doi.org/10.1371/journal.pone.0034705			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JA	22493711	gold, Green Submitted, Green Published			2022-12-27	WOS:000305012700053
J	Ma, Y; Zhang, L; Edwards, JN; Launikonis, BS; Chen, C				Ma, Yi; Zhang, Lin; Edwards, Joshua N.; Launikonis, Bradley S.; Chen, Chen			Growth Hormone Secretagogues Protect Mouse Cardiomyocytes from in vitro Ischemia/Reperfusion Injury through Regulation of Intracellular Calcium	PLOS ONE			English	Article							SARCOPLASMIC-RETICULUM; RAT-HEART; VENTRICULAR MYOCYTES; ISCHEMIA-REPERFUSION; NA+-CA2+ EXCHANGER; CARDIAC ISCHEMIA; GH-SECRETAGOGUES; GHRELIN; RECEPTOR; EXPRESSION	Background: Ischemic heart disease is a leading cause of mortality. To study this disease, ischemia/reperfusion (I/R) models are widely used to mimic the process of transient blockage and subsequent recovery of cardiac coronary blood supply. We aimed to determine whether the presence of the growth hormone secretagogues, ghrelin and hexarelin, would protect/improve the function of heart from I/R injury and to examine the underlying mechanisms. Methodology/Principal Findings: Isolated hearts from adult male mice underwent 20 min global ischemia and 30 min reperfusion using a Langendorff apparatus. Ghrelin (10 nM) or hexarelin (1 nM) was introduced into the perfusion system either 10 min before or after ischemia, termed pre- and post-treatments. In freshly isolated cardiomyocytes from these hearts, single cell shortening, intracellular calcium ([Ca2+](i)) transients and caffeine-releasable sarcoplasmic reticulum (SR) Ca2+ were measured. In addition, RT-PCR and Western blots were used to examine the expression level of GHS receptor type 1a (GHS-R1a), and phosphorylated phospholamban (p-PLB), respectively. Ghrelin and hexarelin pre- or post-treatments prevented the significant reduction in the cell shortening, [Ca2+](i) transient amplitude and caffeine-releasable SR Ca2+ content after I/R through recovery of p-PLB. GHS-R1a antagonists, [D-Lys3]-GHRP-6 (200 nM) and BIM28163 (100 nM), completely blocked the effects of GHS on both cell shortening and [Ca2+](i) transients. Conclusion/Significance: Through activation of GHS-R1a, ghrelin and hexarelin produced a positive inotropic effect on ischemic cardiomyocytes and protected them from I/R injury probably by protecting or recovering p-PLB (and therefore SR Ca2+ content) to allow the maintenance or recovery of normal cardiac contractility. These observations provide supporting evidence for the potential therapeutic application of ghrelin and hexarelin in patients with cardiac I/R injury.	[Ma, Yi; Edwards, Joshua N.; Launikonis, Bradley S.; Chen, Chen] Univ Queensland, Sch Biomed Sci, Brisbane, Qld, Australia; [Zhang, Lin] Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand	University of Queensland; University of Auckland	Ma, Y (corresponding author), Univ Queensland, Sch Biomed Sci, Brisbane, Qld, Australia.	chen.chen@uq.edu.au	Launikonis, Bradley/K-6256-2015; CHEN, CHEN/HDM-6657-2022; Chen, Chen/B-4284-2010; chen, chen/GRY-7085-2022	Launikonis, Bradley/0000-0003-0700-4867; Chen, Chen/0000-0003-2104-534X; Ma, Yi/0000-0002-7226-8327	Australian National Health and Medical Research Council; University of Queensland	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); University of Queensland(University of Queensland)	This work was supported by funding from the Australian National Health and Medical Research Council and the University of Queensland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asakawa A, 2003, GUT, V52, P947, DOI 10.1136/gut.52.7.947; Baldanzi G, 2002, J CELL BIOL, V159, P1029, DOI 10.1083/jcb.200207165; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Berti F, 1998, GROWTH HORM IGF RES, V8, P149, DOI 10.1016/S1096-6374(98)80041-5; Bodart V, 2002, CIRC RES, V90, P844, DOI 10.1161/01.RES.0000016164.02525.B4; Bulgarelli I, 2009, J NEUROSCI RES, V87, P2718, DOI 10.1002/jnr.22088; Cassoni P, 2001, J CLIN ENDOCR METAB, V86, P1738, DOI 10.1210/jc.86.4.1738; Ceylan-Isik AF, 2011, J MOL CELL CARDIOL, V50, P107, DOI 10.1016/j.yjmcc.2010.10.023; Chambers DJ, 2010, PHARMACOL THERAPEUT, V127, P41, DOI 10.1016/j.pharmthera.2010.04.001; Chang L, 2004, J CARDIOVASC PHARM, V43, P165, DOI 10.1097/00005344-200402000-00001; del Monte F, 2004, P NATL ACAD SCI USA, V101, P5622, DOI 10.1073/pnas.0305778101; Feng DD, 2011, EUR J NEUROSCI, V34, P732, DOI 10.1111/j.1460-9568.2011.07787.x; Frascarelli S, 2003, BASIC RES CARDIOL, V98, P401, DOI 10.1007/s00395-003-0434-7; Fung Jenny N. T., 2010, Hormones & Cancer, V1, P245, DOI 10.1007/s12672-010-0047-1; FURMAN E, 1985, CARDIOVASC RES, V19, P606, DOI 10.1093/cvr/19.10.606; Gnanapavan S, 2002, J CLIN ENDOCR METAB, V87, P2988, DOI 10.1210/jc.87.6.2988; Halem HA, 2004, EUR J ENDOCRINOL, V151, pS71, DOI 10.1530/eje.0.151S071; Headrick JP, 2001, EXP PHYSIOL, V86, P703, DOI 10.1111/j.1469-445X.2001.tb00035.x; Iwasaki E, 2011, DIG DIS SCI; Kawamura K, 2003, ENDOCRINOLOGY, V144, P2623, DOI 10.1210/en.2003-0033; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Kuster GM, 2010, FREE RADICAL BIO MED, V48, P1182, DOI 10.1016/j.freeradbiomed.2010.01.038; Launikonis BS, 1997, J PHYSIOL-LONDON, V504, P425, DOI 10.1111/j.1469-7793.1997.425be.x; McDonough JL, 1999, CIRC RES, V84, P9; Murphy E, 2008, PHYSIOL REV, V88, P581, DOI 10.1152/physrev.00024.2007; Ogawa A, 2011, AM J PHYSL REGUL INT; OSTADAL B, 1999, CARDIAC ISCHEMIA INJ; Santiago DJ, 2010, BIOPHYS J, V98, P2111, DOI 10.1016/j.bpj.2010.01.042; Sax B, 2011, PEPTIDES, V32, P362, DOI 10.1016/j.peptides.2010.11.020; Seehase M, 2006, BIOL NEONATE, V90, P174, DOI 10.1159/000092888; Sun Q, 2010, ENDOCRINOLOGY, V151, P4446, DOI 10.1210/en.2009-1432; Sun YX, 2007, ENDOCRINOLOGY, V148, P1323, DOI 10.1210/en.2006-0782; Torsello A, 2003, ENDOCRINOLOGY, V144, P1787, DOI 10.1210/en.2002-221048; Xu XB, 2003, ENDOCRINOLOGY, V144, P5050, DOI 10.1210/en.2003-0025; Xu XL, 2008, PHARMACOLOGY, V81, P325, DOI 10.1159/000121335; Yang CG, 2011, MOL MED REP, V4, P1061, DOI 10.3892/mmr.2011.571; Yu Wei, 2010, Zhonghua Xin Xue Guan Bing Za Zhi, V38, P225; Zhang GG, 2009, PEPTIDES, V30, P1109, DOI 10.1016/j.peptides.2009.03.024; Zima AV, 2010, J PHYSIOL-LONDON, V588, P4743, DOI 10.1113/jphysiol.2010.197913	39	26	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2012	7	4							e35265	10.1371/journal.pone.0035265	http://dx.doi.org/10.1371/journal.pone.0035265			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JA	22493744	Green Published, Green Submitted, gold			2022-12-27	WOS:000305012700086
J	Sousa-Figueiredo, JC; Gamboa, D; Pedro, JM; Fancony, C; Langa, AJ; Magalhaes, RJS; Stothard, JR; Nery, SV				Sousa-Figueiredo, Jose Carlos; Gamboa, Dina; Pedro, Joao Mario; Fancony, Claudia; Langa, Antonio Justino; Magalhaes, Ricardo J. Soares; Stothard, J. Russell; Nery, Susana Vaz			Epidemiology of Malaria, Schistosomiasis, Geohelminths, Anemia and Malnutrition in the Context of a Demographic Surveillance System in Northern Angola	PLOS ONE			English	Article							NUTRITIONAL-STATUS; CHILDREN; HEALTH; MORBIDITY; INFECTION; COUNTRIES; DISEASES; ASCARIS; IMPACT; RISK	Background: Malaria, schistosomiasis and geohelminth infection are linked to maternal and child morbidity and mortality in sub-Saharan Africa. Knowing the prevalence levels of these infections is vital to guide governments towards the implementation of successful and cost-effective disease control initiatives. Methodology/Principal Findings: A cross-sectional study of 1,237 preschool children (0-5 year olds), 1,142 school-aged children (6-15 year olds) and 960 women (>15 year olds) was conducted to understand the distribution of malnutrition, anemia, malaria, schistosomiasis (intestinal and urinary) and geohelminths in a north-western province of Angola. We used a recent demographic surveillance system (DSS) database to select and recruit suitable households. Malnutrition was common among children (23.3% under-weight, 9.9% wasting and 32.2% stunting), and anemia was found to be a severe public health problem (i.e., >40%). Malaria prevalence was highest among preschool children reaching 20.2%. Micro-hematuria prevalence levels reached 10.0% of preschool children, 16.6% of school-aged children and 21.7% of mothers. Geohelminth infections were common, affecting 22.3% of preschool children, 31.6% of school-aged children and 28.0% of mothers. Conclusions: Here we report prevalence levels of malaria, schistosomiasis and geohelminths; all endemic in this poorly described area where a DSS has been recently established. Furthermore we found evidence that the studied infections are associated with the observed levels of anemia and malnutrition, which can justify the implementation of integrated interventions for the control of these diseases and morbidities.	[Sousa-Figueiredo, Jose Carlos; Stothard, J. Russell] Univ Liverpool, Liverpool Sch Trop Med, Ctr Trop & Infect Dis, Liverpool L3 5QA, Merseyside, England; [Sousa-Figueiredo, Jose Carlos] Univ London London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1E 7HT, England; [Gamboa, Dina; Pedro, Joao Mario; Fancony, Claudia; Langa, Antonio Justino; Nery, Susana Vaz] Hlth Res Ctr Angola, CISA Project, Caxito, Bengo, Angola; [Pedro, Joao Mario] Escola Super Tecnol Saude Lisboa, Lisbon, Portugal; [Magalhaes, Ricardo J. Soares] Univ Queensland, Sch Populat Hlth, Herston, Qld, Australia	Liverpool School of Tropical Medicine; University of Liverpool; University of London; London School of Hygiene & Tropical Medicine; Universidade de Lisboa; University of Queensland	Sousa-Figueiredo, JC (corresponding author), Univ Liverpool, Liverpool Sch Trop Med, Ctr Trop & Infect Dis, Liverpool L3 5QA, Merseyside, England.	susana.nery@cisacaxito.org	Pedro, Joao M/A-6556-2013; Magalhaes, Ricardo J. Soares/A-5316-2010; Nery, Susana Vaz/P-4518-2014; Stothard, John Russell/AAK-4829-2021	Pedro, Joao M/0000-0003-2405-521X; Magalhaes, Ricardo J. Soares/0000-0001-9157-8470; Stothard, John Russell/0000-0002-9370-3420; Fancony, Claudia/0000-0003-4421-1769; Vaz Nery, Susana/0000-0002-2399-7785	Portuguese Institute for Development Assistance (Ministry of Foreign Affairs); Calouste Gulbenkian Foundation; Angolan Ministry of Health; Bengo Provincial Government	Portuguese Institute for Development Assistance (Ministry of Foreign Affairs); Calouste Gulbenkian Foundation; Angolan Ministry of Health; Bengo Provincial Government	This work has been funded by the Portuguese Institute for Development Assistance (Ministry of Foreign Affairs) and the Calouste Gulbenkian Foundation, and was supported by the Angolan Ministry of Health and the Bengo Provincial Government. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Agadjanian V, 2003, SOC SCI MED, V56, P2515, DOI 10.1016/S0277-9536(02)00286-1; Akaike H, 1973, INFORM THEORY EXTENS, P267, DOI DOI 10.1007/978-1-4612-1694-0_15; [Anonymous], 2001, IRON DEFICIENCY ANAE; Armitage P., 2001, STAT METHODS MED RES; Avogo WA, 2010, SOC SCI MED, V70, P53, DOI 10.1016/j.socscimed.2009.09.057; Bejon P, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000164; BRESLOW NE, 1993, J AM STAT ASSOC, V88, P9, DOI 10.1080/01621459.1993.10594284; CHOPRA J G, 1965, J Trop Pediatr Afr Child Health, V11, P18; COSEP, 2006, ANG MAL IND SURV; Costa MJ, SETTING DEMOGR UNPUB; deOnis M, 1996, AM J CLIN NUTR, V64, P650, DOI 10.1093/ajcn/64.4.650; DIRREN H, 1994, EUR J CLIN NUTR, V48, P625; Filippi V, 2006, LANCET, V368, P1535, DOI 10.1016/S0140-6736(06)69384-7; Fleischer B, 2004, TROP MED INT HEALTH, V9, P755, DOI 10.1111/j.1365-3156.2004.01278.x; Giugliani C, 2010, ARCH DIS CHILD, V95, P198, DOI 10.1136/adc.2009.169227; Glinz D, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000754; Goodman D, 2007, AM J TROP MED HYG, V76, P725, DOI 10.4269/ajtmh.2007.76.725; Hall A, 2007, LANCET INFECT DIS, V7, P297, DOI 10.1016/S1473-3099(07)70084-1; Hotez PJ, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000270; Katz N, 1972, Rev Inst Med Trop Sao Paulo, V14, P397; Kennedy G, 2006, PUBLIC HEALTH NUTR, V9, P187, DOI 10.1079/PHN2005835; Kirkwood BR, 2003, ESSENTIAL MED STAT; Lwambo NJS, 1997, B WORLD HEALTH ORGAN, V75, P247; Lwanga SK, 1991, SAMPLE SIZE DETERMIN; Magalhaes RJS, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000438; Martin-Prevel Y, 2000, B WORLD HEALTH ORGAN, V78, P108; MINSA WFP WHO UNICEF, 2005, BAS SURV HELM CONTR; Molyneux DH, 2009, LANCET, V373, P296, DOI 10.1016/S0140-6736(09)60089-1; Muller O, 2003, LANCET, V361, P86, DOI 10.1016/S0140-6736(03)12154-X; Petney TN, 1998, INT J PARASITOL, V28, P377, DOI 10.1016/S0020-7519(97)00189-6; PMI, 2011, COUNTR PROF ANG; Richter J, 2003, ACTA TROP, V86, P161, DOI 10.1016/S0001-706X(03)00032-9; Rollinson D, 2005, J HELMINTHOL, V79, P199, DOI 10.1079/JOH2005305; Sacko M, 2010, ACTA TROP, DOI [10.1016/j.actatropica.2010.1012.1009, DOI 10.1016/J.ACTATROPICA.2010.1012.1009]; Savioli L., 1998, GUIDELINES EVALUATIO; Shapiro AE, 2005, T ROY SOC TROP MED H, V99, P18, DOI 10.1016/j.trstmh.2004.02.006; STEPHENSON LS, 1980, PARASITOLOGY, V81, P221, DOI 10.1017/S0031182000055177; THEINHLAING, 1991, T ROY SOC TROP MED H, V85, P523, DOI 10.1016/0035-9203(91)90242-Q; Tohon ZB, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000241; UNICEF, 2011, CHILDINFO MON SIT CH; Walker SP, 2007, LANCET, V369, P145, DOI 10.1016/S0140-6736(07)60076-2; WHO, 2006, WHO GLOB DAT AN; World Health Organization, 2008, COMM DIR INT MAJ HLT; World Health Organization, 2002, WHO TRADITIONAL MED, P1; World Health Organization, 2008, WORLD MAL REP; Yamey G, 2002, BRIT MED J, V325, P176, DOI 10.1136/bmj.325.7357.176	46	66	69	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2012	7	4							e33189	10.1371/journal.pone.0033189	http://dx.doi.org/10.1371/journal.pone.0033189			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JA	22493664	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000305012700006
J	Walker, SI; Grover, MA; Hud, NV				Walker, Sara Imari; Grover, Martha A.; Hud, Nicholas V.			Universal Sequence Replication, Reversible Polymerization and Early Functional Biopolymers: A Model for the Initiation of Prebiotic Sequence Evolution	PLOS ONE			English	Article							TEMPLATE-DIRECTED SYNTHESIS; MOLECULAR EVOLUTION; EUTECTIC PHASE; ORIGIN; EMERGENCE; SELECTION; DNA; OLIGONUCLEOTIDES; INTERCALATION; AMPLIFICATION	Many models for the origin of life have focused on understanding how evolution can drive the refinement of a preexisting enzyme, such as the evolution of efficient replicase activity. Here we present a model for what was, arguably, an even earlier stage of chemical evolution, when polymer sequence diversity was generated and sustained before, and during, the onset of functional selection. The model includes regular environmental cycles (e.g. hydration-dehydration cycles) that drive polymers between times of replication and functional activity, which coincide with times of different monomer and polymer diffusivity. Template-directed replication of informational polymers, which takes place during the dehydration stage of each cycle, is considered to be sequence-independent. New sequences are generated by spontaneous polymer formation, and all sequences compete for a finite monomer resource that is recycled via reversible polymerization. Kinetic Monte Carlo simulations demonstrate that this proposed prebiotic scenario provides a robust mechanism for the exploration of sequence space. Introduction of a polymer sequence with monomer synthetase activity illustrates that functional sequences can become established in a preexisting pool of otherwise non-functional sequences. Functional selection does not dominate system dynamics and sequence diversity remains high, permitting the emergence and spread of more than one functional sequence. It is also observed that polymers spontaneously form clusters in simulations where polymers diffuse more slowly than monomers, a feature that is reminiscent of a previous proposal that the earliest stages of life could have been defined by the collective evolution of a system-wide cooperation of polymer aggregates. Overall, the results presented demonstrate the merits of considering plausible prebiotic polymer chemistries and environments that would have allowed for the rapid turnover of monomer resources and for regularly varying monomer/polymer diffusivities.	[Walker, Sara Imari; Grover, Martha A.; Hud, Nicholas V.] Georgia Inst Technol, NSF NASA Ctr Chem Evolut, Atlanta, GA 30332 USA; [Walker, Sara Imari; Grover, Martha A.] Georgia Inst Technol, Sch Chem & Biomol Engn, Atlanta, GA 30332 USA; [Walker, Sara Imari; Hud, Nicholas V.] Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA	National Aeronautics & Space Administration (NASA); University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology	Walker, SI (corresponding author), Arizona State Univ, BEYOND Ctr Fundamental Concepts Sci, Tempe, AZ 85287 USA.	hud@chemistry.gatech.edu	Walker, Sara/J-5829-2015; Hud, Nicholas V/T-7017-2017	Walker, Sara/0000-0001-5779-2772; Hud, Nicholas/0000-0001-7711-6472	NSF [CHE-1004570]; NASA under the NSF Center for Chemical Evolution [CHE-1004570]; NASA Astrobiology Institute through the NASA	NSF(National Science Foundation (NSF)); NASA under the NSF Center for Chemical Evolution; NASA Astrobiology Institute through the NASA	This work was jointly supported by NSF and the NASA Astrobiology Program, under the NSF Center for Chemical Evolution, CHE-1004570. SIW additionally acknowledges support from the NASA Astrobiology Institute through the NASA Postdoctoral Fellowship Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfonsi A, 2004, RR5435 INRIA; Apel CL, 2005, ORIGINS LIFE EVOL B, V35, P323, DOI 10.1007/s11084-005-2046-8; Bean HD, 2006, ORIGINS LIFE EVOL B, V36, P39, DOI 10.1007/s11084-005-2082-4; Bernstein D, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.041103; BOERLIJST MC, 1991, PHYSICA D, V48, P17, DOI 10.1016/0167-2789(91)90049-F; Cairns-Smith A.G., 1982, GENETIC TAKEOVER MIN; CHACON P, 1995, PHYSICA D, V81, P398, DOI 10.1016/0167-2789(94)00214-B; Chatterjee A, 2007, J COMPUT-AIDED MATER, V14, P253, DOI 10.1007/s10820-006-9042-9; Commeyras A, 2002, POLYM INT, V51, P661, DOI 10.1002/pi.1027; Corliss J. B., 1981, Oceanologica Acta, V4, P59; Czaran T, 2000, GEOMETRY SPATIAL INT; Deck C, 2011, NAT CHEM, V3, P603, DOI [10.1038/NCHEM.1086, 10.1038/nchem.1086]; Dobson CM, 2000, P NATL ACAD SCI USA, V97, P11864, DOI 10.1073/pnas.200366897; EIGEN M, 1977, NATURWISSENSCHAFTEN, V64, P541, DOI 10.1007/BF00450633; EIGEN M, 1971, NATURWISSENSCHAFTEN, V58, P465, DOI 10.1007/BF00623322; EIGEN M, 1988, J PHYS CHEM-US, V92, P6881, DOI 10.1021/j100335a010; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Engelhart AE, 2010, COLD SPRING HARB PER, V2; Eschenmoser A, 2007, TETRAHEDRON, V63, P12821, DOI 10.1016/j.tet.2007.10.012; Fishkis M, 2011, ORIGINS LIFE EVOL B, V41, P261, DOI 10.1007/s11084-010-9220-3; Gesteland R, 2006, RNA WORLD COLD SPRIN; GILLESPIE DT, 1976, J COMPUT PHYS, V22, P403, DOI 10.1016/0021-9991(76)90041-3; Hazen R. M., 2010, COLD SPRING HARB PER, V2; Hazen RM, 2007, P NATL ACAD SCI USA, V104, P8574, DOI 10.1073/pnas.0701744104; Hazen RM, 2009, INT J DEV BIOL, V53, P683, DOI 10.1387/ijdb.092936rh; Hogeweg P, 2003, ORIGINS LIFE EVOL B, V33, P375, DOI 10.1023/A:1025754907141; Horowitz ED, 2010, P NATL ACAD SCI USA, V107, P5288, DOI 10.1073/pnas.0914172107; Huber C, 1998, SCIENCE, V281, P670, DOI 10.1126/science.281.5377.670; Hud NV, 2007, CHEM BIODIVERS, V4, P768, DOI 10.1002/cbdv.200790063; Hud NV, 2000, J THEOR BIOL, V205, P543, DOI 10.1006/jtbi.2000.2084; Jain SS, 2004, ANGEW CHEM INT EDIT, V43, P2004, DOI 10.1002/anie.200353155; Joyce GF, 2002, NATURE, V420, P278, DOI 10.1038/420278a; Joyce GF, 2002, NATURE, V418, P214, DOI 10.1038/418214a; KACIAN DL, 1972, P NATL ACAD SCI USA, V69, P3038, DOI 10.1073/pnas.69.10.3038; Kauffman S.A., 1993, ORIGINS ORDER; KING GAM, 1986, J THEOR BIOL, V123, P493, DOI 10.1016/S0022-5193(86)80216-8; KING GAM, 1982, BIOSYSTEMS, V15, P89, DOI 10.1016/0303-2647(82)90022-3; Konnyu B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020931; Konnyu B, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-267; LAHAV N, 1978, SCIENCE, V201, P67, DOI 10.1126/science.663639; Lee DH, 1996, NATURE, V382, P525, DOI 10.1038/382525a0; Lehman N, 2011, ENTROPY-SWITZ, V13, P17, DOI 10.3390/e13010017; Leitzel JC, 2001, CHEM REC, V1, P53; Li XY, 2011, HETEROCYCLES, V82, P1477, DOI 10.3987/COM-10-S(E)99; Luther A, 1998, NATURE, V396, P245, DOI 10.1038/24343; Ma W, 2007, RNA, V13, P2012, DOI 10.1261/rna.658507; Ma WT, 2007, BIOSYSTEMS, V90, P28, DOI 10.1016/j.biosystems.2006.06.005; Ma WT, 2010, ASTROBIOLOGY, V10, P437, DOI 10.1089/ast.2009.0385; Manapat ML, 2010, J THEOR BIOL, V263, P317, DOI 10.1016/j.jtbi.2009.12.020; Monnard PA, 2003, J AM CHEM SOC, V125, P13734, DOI 10.1021/ja036465h; Monnard PA, 2008, CHEM BIODIVERS, V5, P1521, DOI 10.1002/cbdv.200890141; NIELSEN PE, 1993, ORIGINS LIFE EVOL B, V23, P323, DOI 10.1007/BF01582083; Pedersen K, 2000, FEMS MICROBIOL LETT, V185, P9, DOI 10.1016/S0378-1097(00)00061-6; Pross A, 2005, ORIGINS LIFE EVOL B, V35, P151, DOI 10.1007/s11084-005-5272-1; Pross A, 2003, J THEOR BIOL, V220, P393, DOI 10.1006/jtbi.2003.3178; ROBERTSON MP, 1995, NATURE, V375, P772, DOI 10.1038/375772a0; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; STRIBLING R, 1991, J MOL EVOL, V32, P289, DOI 10.1007/BF02102186; Szabo P, 2002, NATURE, V420, P340, DOI 10.1038/nature01187; SZATHMARY E, 1987, J THEOR BIOL, V128, P463, DOI 10.1016/S0022-5193(87)80191-1; SZATHMARY E, 1989, TRENDS ECOL EVOL, V4, P200, DOI 10.1016/0169-5347(89)90073-6; SZATHMARY E, 1997, MAJOR TRANSITIONS EV; Takeuchi N, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000542; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Turk RM, 2010, P NATL ACAD SCI USA, V107, P4585, DOI 10.1073/pnas.0912895107; Ura Y, 2009, SCIENCE, V325, P73, DOI 10.1126/science.1174577; Vetsigian K, 2006, P NATL ACAD SCI USA, V103, P10696, DOI 10.1073/pnas.0603780103; WACHTERSHAUSER G, 1992, PROG BIOPHYS MOL BIO, V58, P85, DOI 10.1016/0079-6107(92)90022-X; Wochner A, 2011, SCIENCE, V332, P209, DOI 10.1126/science.1200752; Woese CR, 2002, P NATL ACAD SCI USA, V99, P8742, DOI 10.1073/pnas.132266999; Wu M, 2011, ASTROBIOLOGY, V11, P895, DOI 10.1089/ast.2011.0679; Wu M, 2009, J MOL EVOL, V69, P541, DOI 10.1007/s00239-009-9276-8; Zhan ZYJ, 1997, J AM CHEM SOC, V119, P12420, DOI 10.1021/ja972870v	73	45	48	0	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2012	7	4							e34166	10.1371/journal.pone.0034166	http://dx.doi.org/10.1371/journal.pone.0034166			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JA	22493682	Green Published, Green Submitted, gold			2022-12-27	WOS:000305012700024
J	Cheng, Y; Sk, UH; Zhang, Y; Ren, XC; Zhang, L; Huber-Keener, KJ; Sun, YW; Liao, J; Amin, S; Sharma, AK; Yang, JM				Cheng, Yan; Sk, Ugir Hossain; Zhang, Yi; Ren, Xingcong; Zhang, Li; Huber-Keener, Kathryn J.; Sun, Yuan-Wan; Liao, Jason; Amin, Shantu; Sharma, Arun K.; Yang, Jin-Ming			Rational Incorporation of Selenium into Temozolomide Elicits Superior Antitumor Activity Associated with Both Apoptotic and Autophagic Cell Death	PLOS ONE			English	Article							MALIGNANT GLIOMA; CANCER; MELANOMA; ISOSELENOCYANATES; SENSITIVITY; BECLIN; AGENTS; MGMT	Background: The DNA alkylating agent temozolomide (TMZ) is widely used in the treatment of human malignancies such as glioma and melanoma. On the basis of previous structure-activity studies, we recently synthesized a new TMZ selenium analog by rationally introducing an N-ethylselenocyanate extension to the amide functionality in TMZ structure. Principal Findings: This TMZ-Se analog showed a superior cytotoxicity to TMZ in human glioma and melanoma cells and a more potent tumor-inhibiting activity than TMZ in mouse glioma and melanoma xenograft model. TMZ-Se was also effective against a TMZ-resistant glioma cell line. To explore the mechanism underlying the superior antitumor activity of TMZ-Se, we compared the effects of TMZ and TMZ-Se on apoptosis and autophagy. Apoptosis was significantly increased in tumor cells treated with TMZ-Se in comparison to those treated with TMZ. TMZ-Se also triggered greater autophagic response, as compared with TMZ, and suppressing autophagy partly rescued cell death induced by TMZ-Se, indicating that TMZ-Se-triggered autophagy contributed to cell death. Although mRNA level of the key autophagy gene, Beclin 1, was increased, Beclin 1 protein was down-regulated in the cells treated with TMZ-Se. The decrease in Beclin 1 following TMZ-Se treatment were rescued by the calpain inhibitors and the calpain-mediated degradation of Beclin1 had no effect on autophagy but promoted apoptosis in cells treated with TMZ-Se. Conclusions: Our study indicates that incorporation of Se into TMZ can render greater potency to this chemotherapeutic drug.	[Cheng, Yan] Penn State Univ, Coll Med, Dept Pharmacol, Hershey, PA 17033 USA; Penn State Univ, Coll Med, Penn State Hershey Canc Inst, Hershey, PA USA; Milton S Hershey Med Ctr, Hershey, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Cheng, Y (corresponding author), Penn State Univ, Coll Med, Dept Pharmacol, Hershey, PA 17033 USA.	aks14@psu.edu; juy16@psu.edu		Sharma, Arun/0000-0002-7679-7779; Huber-Keener, Kathryn/0000-0002-1981-7251	US Public Health Service [R01CA135038, R03CA143999]; NATIONAL CANCER INSTITUTE [R01CA135038, R03CA143999] Funding Source: NIH RePORTER	US Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the US Public Health Service R01CA135038 (Yang) and R03CA143999 (Sharma). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Bael TE, 2008, MELANOMA RES, V18, P147, DOI 10.1097/CMR.0b013e3282f2a7ae; Combs GF, 1998, PHARMACOL THERAPEUT, V79, P179, DOI 10.1016/S0163-7258(98)00014-X; Dalby KN, 2010, AUTOPHAGY, V6, P322, DOI 10.4161/auto.6.3.11625; Daniel F, 2006, WORLD J GASTROENTERO, V12, P2895, DOI 10.3748/wjg.v12.i18.2895; Desai D, 2010, CHEM-BIOL INTERACT, V188, P446, DOI 10.1016/j.cbi.2010.09.021; Desai D, 2010, INT J CANCER, V127, P230, DOI 10.1002/ijc.25033; Desai D, 2010, BIOORG MED CHEM LETT, V20, P2044, DOI 10.1016/j.bmcl.2009.07.068; Friedman HS, 2000, CLIN CANCER RES, V6, P2585; Gasparian AV, 2002, MOL CANCER THER, V1, P1079; Hoyer-Hansen M, 2008, AUTOPHAGY, V4, P574, DOI 10.4161/auto.5921; Jariwalla RJ, 2009, BRIT J NUTR, V101, P182, DOI 10.1017/S0007114508998305; Kaina B, 2007, DNA REPAIR, V6, P1079, DOI 10.1016/j.dnarep.2007.03.008; Kanzawa T, 2004, CELL DEATH DIFFER, V11, P448, DOI 10.1038/sj.cdd.4401359; Kim T, 2001, CARCINOGENESIS, V22, P559, DOI 10.1093/carcin/22.4.559; Liang XH, 1998, J VIROL, V72, P8586, DOI 10.1128/JVI.72.11.8586-8596.1998; Natsumeda M, 2011, NEUROPATHOLOGY, V31, P486, DOI 10.1111/j.1440-1789.2010.01197.x; Naumann SC, 2009, BRIT J CANCER, V100, P322, DOI 10.1038/sj.bjc.6604856; Nguyen N, 2011, CANCER PREV RES, V4, P248, DOI 10.1158/1940-6207.CAPR-10-0106; Niu TK, 2010, FEBS LETT, V584, P3519, DOI 10.1016/j.febslet.2010.07.018; Ochs K, 2000, CANCER RES, V60, P5815; Rayman MP, 2005, P NUTR SOC, V64, P527, DOI 10.1079/PNS2005467; Reiling JH, 2006, ONCOGENE, V25, P6373, DOI 10.1038/sj.onc.1209889; Sharma A, 2009, CLIN CANCER RES, V15, P1674, DOI 10.1158/1078-0432.CCR-08-2214; Sharma AK, 2011, CLIN CANCER RES, V17, P4474, DOI 10.1158/1078-0432.CCR-10-2370; Sharma AK, 2008, J MED CHEM, V51, P7820, DOI 10.1021/jm800993r; Yoo BH, 2010, J BIOL CHEM, V285, P5438, DOI 10.1074/jbc.M109.046789; Zhang WB, 2010, J BIOL CHEM, V285, P40461, DOI 10.1074/jbc.M110.164046; Zhou N, 2003, J BIOL CHEM, V278, P29532, DOI 10.1074/jbc.M301877200	28	24	24	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2012	7	4							e35104	10.1371/journal.pone.0035104	http://dx.doi.org/10.1371/journal.pone.0035104			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955IH	22496897	Green Published, gold, Green Submitted			2022-12-27	WOS:000305010500029
J	Orton, E; Kendrick, D; West, J; Tata, LJ				Orton, Elizabeth; Kendrick, Denise; West, Joe; Tata, Laila J.			Independent Risk Factors for Injury in Pre-School Children: Three Population-Based Nested Case-Control Studies Using Routine Primary Care Data	PLOS ONE			English	Article							ALCOHOL-USE DISORDERS; CHILDHOOD FRACTURES; GENERAL-PRACTICE; YOUNG-CHILDREN; SOCIAL-CLASS; ACCIDENTS; FAMILY; AGE; DRINKING; ENGLAND	Background: Injuries in childhood are largely preventable yet an estimated 2,400 children die every day because of injury and violence. Despite this, the factors that contribute to injury occurrence have not been quantified at the population scale using primary care data. We used The Health Improvement Network (THIN) database to identify risk factors for thermal injury, fractures and poisoning in pre-school children in order to inform the optimal delivery of preventative strategies. Methods: We used a matched, nested case-control study design. Cases were children under 5 with a first medically recorded injury, comprising 3,649 thermal injury cases, 4,050 fracture cases and 2,193 poisoning cases, matched on general practice to 94,620 control children. Results: Younger maternal age and higher birth order increased the odds of all injuries. Children's age of highest injury risk varied by injury type; compared with children under 1 year, thermal injuries were highest in those age 1-2 (OR = 2.43, 95%CI 2.23-2.65), poisonings in those age 2-3 (OR = 7.32, 95%CI 6.26-8.58) and fractures in those age 3-5 (OR = 3.80, 95%CI 3.42-4.23). Increasing deprivation was an important modifiable risk factor for poisonings and thermal injuries (tests for trend p <= 0.001) as were hazardous/harmful alcohol consumption by a household adult (OR = 1.73, 95%CI 1.26-2.38 and OR = 1.39, 95%CI 1.07-1.81 respectively) and maternal diagnosis of depression (OR = 1.45, 95%CI 1.24-1.70 and OR = 1.16, 95%CI 1.02-1.32 respectively). Fracture was not associated with these factors, however, not living in single-adult household reduced the odds of fracture (OR = 0.88, 95%CI 0.82-0.95). Conclusions: Maternal depression, hazardous/harmful adult alcohol consumption and socioeconomic deprivation represent important modifiable risk factors for thermal injury and poisoning but not fractures in preschool children. Since these risk factors can be ascertained from routine primary care records, pre-school children's frequent visits to primary care present an opportunity to reduce injury risk by implementing effective preventative interventions from existing national guidelines.	[Orton, Elizabeth; Kendrick, Denise] Univ Nottingham, Div Primary Care, Nottingham NG7 2RD, England; [West, Joe; Tata, Laila J.] Univ Nottingham, City Hosp Nottingham, Div Epidemiol & Publ Hlth, Nottingham NG7 2RD, England	University of Nottingham; Nottingham University Hospital NHS Trust; Nottingham City Hospital; University of Nottingham	Orton, E (corresponding author), Univ Nottingham, Div Primary Care, Univ Pk, Nottingham NG7 2RD, England.	elizabeth.orton@nottingham.ac.uk	Orton, Elizabeth/AAI-1377-2021; Orton, Elizabeth/J-6550-2013; West, Joe/M-3867-2019; West, Joe/I-6637-2012; Tata, Laila/J-5227-2012	Orton, Elizabeth/0000-0002-2531-8846; West, Joe/0000-0002-1135-9356; West, Joe/0000-0002-1135-9356; Kendrick, Denise/0000-0003-3603-6542; Tata, Laila/0000-0002-6404-8658				Agran PF, 2003, PEDIATRICS, V111, pE683, DOI 10.1542/peds.111.6.e683; Audit Commission, 2007, BETT SAF SORR PREV U; BEAUTRAIS AL, 1981, AUST PAEDIATR J, V17, P104; BIJUR PE, 1992, JAMA-J AM MED ASSOC, V267, P3166, DOI 10.1001/jama.267.23.3166; Bourke Alison, 2004, Inform Prim Care, V12, P171; Branche C., 2008, WORLD REPORT CHILD I; BROWN GW, 1978, LANCET, V1, P378; Centre TI, 2009, HOSP EP STAT EXT CAU; Cheeta S, 2008, ADDICTION, V103, P766, DOI 10.1111/j.1360-0443.2008.02198.x; Collett, 2003, MODELLING SURVIVAL D; Cooper C, 2004, J BONE MINER RES, V19, P1976, DOI 10.1359/JBMR.040902; Crandall M, 2006, J SURG RES, V133, P7, DOI 10.1016/j.jss.2006.02.027; Damashek A, 2009, J PEDIATR PSYCHOL, V34, P344, DOI 10.1093/jpepsy/jsn097; Dawson DA, 2005, DRUG ALCOHOL DEPEN, V77, P139, DOI 10.1016/j.drugalcdep.2004.07.012; Flavin MP, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-187; Groom L, 2006, INJURY PREV, V12, P166, DOI 10.1136/ip.2005.011254; Haynes R, 2003, SOC SCI MED, V57, P625, DOI 10.1016/S0277-9536(02)00446-X; Hippisley-Cox J, 2002, BRIT MED J, V324, P1132, DOI 10.1136/bmj.324.7346.1132; Joffe Ari R, 2006, J Intensive Care Med, V21, P227, DOI 10.1177/0885066606288944; JOLLY DL, 1993, J PAEDIATR CHILD H, V29, P438; Kendrick D, 2005, SOC SCI MED, V61, P1905, DOI 10.1016/j.socscimed.2005.04.003; Kendrick D, 2001, PUBLIC HEALTH, V115, P103, DOI 10.1016/S0033-3506(01)00427-9; Kendrick D, 2012, BRIT J GEN PRACT, V62, P62, DOI 10.3399/bjgp12X625012; Lalloo R, 2003, INJURY, V34, P261, DOI 10.1016/S0020-1383(02)00277-2; LANDIN LA, 1983, ACTA ORTHOP SCAND, V54, P1; Laursen B, 2008, EUR J PUBLIC HEALTH, V18, P366, DOI 10.1093/eurpub/ckn034; Lyons RA, 2000, BRIT MED J, V320, P149, DOI 10.1136/bmj.320.7228.149; MacInnes K, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-120; NICE, 2010, STRAT PREV UN INJ 15; NICE, 2007, AN POSTN MENT HLTH; NICE, 2009, DEPR TREATM MAN DEPR; NICE, 2010, ALC US DIS PREV DEV, P1; O'Connor TG, 2000, PEDIATRICS, V106, DOI 10.1542/peds.106.5.e68; ONS, 2009, MORT STAT DEATHS REG; Pomerantz WJ, 2001, J URBAN HEALTH, V78, P141, DOI 10.1093/jurban/78.1.141; Reading R, 1999, SOC SCI MED, V48, P321, DOI 10.1016/S0277-9536(98)00311-6; Reading R, 2008, SOC SCI MED, V67, P915, DOI 10.1016/j.socscimed.2008.05.018; Reid MC, 1999, ARCH INTERN MED, V159, P1681, DOI 10.1001/archinte.159.15.1681; Rewers A, 2005, PEDIATRICS, V115, pE543, DOI 10.1542/peds.2004-1064; Roberts I, 1997, J EPIDEMIOL COMMUN H, V51, P334, DOI 10.1136/jech.51.3.334; ROSPA, 2002, HOM LEIS ACC SURV SY; Ruckinger S, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-7; Russell K M, 1998, J Community Health Nurs, V15, P179, DOI 10.1207/s15327655jchn1503_5; Schmertmann M, 2008, INJURY PREV, V14, P30, DOI 10.1136/ip.2007.016253; Schwebel DC, 2008, J PEDIATR PSYCHOL, V33, P1108, DOI 10.1093/jpepsy/jsn046; Shenassa ED, 2004, AM J PUBLIC HEALTH, V94, P633, DOI 10.2105/AJPH.94.4.633; Smith L, 2009, DRINKING UK EXPLORAT; Stark AD, 2002, BRIT MED J, V324, P457, DOI 10.1136/bmj.324.7335.457; Tata LJ, 2008, THORAX, V63, P981, DOI 10.1136/thx.2008.098244; Townsend PP., 1988, HLTH DEPRIVATION INE; UNICEF, 2001, LEAG TABL CHILD DEAT; Villalba-Cota J, 2004, ANN TROP PAEDIATR, V24, P53, DOI 10.1179/027249304225013259; Winqvist S, 2007, BRAIN INJURY, V21, P1079, DOI 10.1080/02699050701553221	53	45	47	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2012	7	4							e35193	10.1371/journal.pone.0035193	http://dx.doi.org/10.1371/journal.pone.0035193			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	955IH	22496906	Green Published, gold			2022-12-27	WOS:000305010500033
J	John, S; Thiebach, L; Frie, C; Mokkapati, S; Bechtel, M; Nischt, R; Rosser-Davies, S; Paulsson, M; Smyth, N				John, Susan; Thiebach, Lars; Frie, Christian; Mokkapati, Sharada; Bechtel, Manuela; Nischt, Roswitha; Rosser-Davies, Sally; Paulsson, Mats; Smyth, Neil			Epidermal Transglutaminase (TGase 3) Is Required for Proper Hair Development, but Not the Formation of the Epidermal Barrier	PLOS ONE			English	Article							CORNIFIED CELL-ENVELOPE; PROTEIN CROSS-LINKING; PROLINE-RICH PROTEINS; TISSUE TRANSGLUTAMINASE; LAMELLAR ICHTHYOSIS; KERATINOCYTE TRANSGLUTAMINASE; PACHYONYCHIA-CONGENITA; BINDING-PROTEIN; MICE LACKING; SKIN	Transglutaminases (TGase), a family of cross-linking enzymes present in most cell types, are important in events as diverse as cell-signaling and matrix stabilization. Transglutaminase 1 is crucial in developing the epidermal barrier, however the skin also contains other family members, in particular TGase 3. This isoform is highly expressed in the cornified layer, where it is believed to stabilize the epidermis and its reduction is implicated in psoriasis. To understand the importance of TGase 3 in vivo we have generated and analyzed mice lacking this protein. Surprisingly, these animals display no obvious defect in skin development, no overt changes in barrier function or ability to heal wounds. In contrast, hair lacking TGase 3 is thinner, has major alterations in the cuticle cells and hair protein cross-linking is markedly decreased. Apparently, while TGase 3 is of unique functional importance in hair, in the epidermis loss of TGase 3 can be compensated for by other family members.	[John, Susan; Thiebach, Lars; Frie, Christian; Paulsson, Mats; Smyth, Neil] Univ Cologne, Ctr Biochem, D-50931 Cologne, North Rhine Wes, Germany; [John, Susan] Univ Cologne, Ctr Mol Med CMMC, D-50931 Cologne, North Rhine Wes, Germany; [Mokkapati, Sharada; Bechtel, Manuela; Nischt, Roswitha] Univ Cologne, Dept Dermatol, D-50931 Cologne, North Rhine Wes, Germany; [Rosser-Davies, Sally; Smyth, Neil] Univ Southampton, Sch Biol Sci, Southampton, Hants, England; [Paulsson, Mats] Cologne Excellence Cluster Cellular Stress Respon, Cologne, North Rhine Wes, Germany	University of Cologne; University of Cologne; University of Cologne; University of Southampton; University of Cologne	John, S (corresponding author), Univ Cologne, Ctr Biochem, D-50931 Cologne, North Rhine Wes, Germany.	susan.john@uni-koeln.de		Smyth, Neil/0000-0002-3734-2149	Deutsche Forschungsgemeinschaft [SFB 589, SFB 829]; MRC [G0501515]; Medical Research Council [G0501515] Funding Source: researchfish	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The authors acknowledge the financial support by the Deutsche Forschungsgemeinschaft (SFB 589, SFB 829) and the MRC by grant number G0501515. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aeschlimann D, 2000, CONNECT TISSUE RES, V41, P1, DOI 10.3109/03008200009005638; AESCHLIMANN D, 1994, THROMB HAEMOSTASIS, V71, P402; Aeschlimann Daniel, 1996, Seminars in Thrombosis and Hemostasis, V22, P437; Ahvazi B, 2003, EXP MOL MED, V35, P228, DOI 10.1038/emm.2003.31; Akimov SS, 2000, J CELL BIOL, V148, P825, DOI 10.1083/jcb.148.4.825; Appel B, 1942, NEW ENGL J MED, V226, P912, DOI 10.1056/NEJM194206042262303; BOWNESS JM, 1988, BIOCHIM BIOPHYS ACTA, V967, P234; BUXMAN MM, 1975, J INVEST DERMATOL, V65, P107, DOI 10.1111/1523-1747.ep12598072; Candi E, 2005, NAT REV MOL CELL BIO, V6, P328, DOI 10.1038/nrm1619; Candi E, 1998, P NATL ACAD SCI USA, V95, P2067, DOI 10.1073/pnas.95.5.2067; CANDI E, 1995, J BIOL CHEM, V270, P26382, DOI 10.1074/jbc.270.44.26382; Candi E, 2001, J BIOL CHEM, V276, P35014, DOI 10.1074/jbc.M010157200; Cheng T, 2006, J BIOL CHEM, V281, P15893, DOI 10.1074/jbc.M600694200; CLEMENTI M, 1986, BRIT J DERMATOL, V114, P367, DOI 10.1111/j.1365-2133.1986.tb02829.x; Djian P, 2000, J CELL BIOL, V151, P381, DOI 10.1083/jcb.151.2.381; FOLK JE, 1965, J BIOL CHEM, V240, P2951; Grenard P, 2001, J BIOL CHEM, V276, P33066, DOI 10.1074/jbc.M102553200; Hardman MJ, 1998, DEVELOPMENT, V125, P1541; Haroon ZA, 1999, FASEB J, V13, P1787, DOI 10.1096/fasebj.13.13.1787; Hitomi K, 2001, INT J BIOCHEM CELL B, V33, P491, DOI 10.1016/S1357-2725(01)00033-4; HUBER M, 1995, SCIENCE, V267, P525, DOI 10.1126/science.7824952; Inada R, 2000, AM J PATHOL, V157, P1875, DOI 10.1016/S0002-9440(10)64826-2; Kalinin AE, 2002, BIOESSAYS, V24, P789, DOI 10.1002/bies.10144; KIM HC, 1990, J BIOL CHEM, V265, P21971; Koch PJ, 2000, J CELL BIOL, V151, P389, DOI 10.1083/jcb.151.2.389; Kuramoto N, 2002, J CLIN INVEST, V109, P243, DOI 10.1172/JCI200213563; LEE SC, 1993, J BIOL CHEM, V268, P12164; Lee YJ, 2006, MOL CELL PROTEOMICS, V5, P789, DOI 10.1074/mcp.M500278-MCP200; Matsuki M, 1998, P NATL ACAD SCI USA, V95, P1044, DOI 10.1073/pnas.95.3.1044; McGowan KM, 1998, J CELL BIOL, V143, P469, DOI 10.1083/jcb.143.2.469; McGowan KM, 2002, GENE DEV, V16, P1412, DOI 10.1101/gad.979502; MCLEAN WHI, 1995, NAT GENET, V9, P273, DOI 10.1038/ng0395-273; Medland SE, 2009, AM J HUM GENET, V85, P750, DOI 10.1016/j.ajhg.2009.10.009; MYCEK MJ, 1959, ARCH BIOCHEM BIOPHYS, V84, P528, DOI 10.1016/0003-9861(59)90613-7; Nunes I, 1997, J CELL BIOL, V136, P1151, DOI 10.1083/jcb.136.5.1151; OKEEFE EJ, 1993, J INVEST DERMATOL, V101, pS65, DOI 10.1111/1523-1747.ep12362866; Pinkas DM, 2007, PLOS BIOL, V5, P2788, DOI 10.1371/journal.pbio.0050327; Raghunath M, 1996, J CLIN INVEST, V98, P1174, DOI 10.1172/JCI118901; Rice RH, 1996, ANAT RECORD, V246, P433, DOI 10.1002/(SICI)1097-0185(199612)246:4<433::AID-AR2>3.0.CO;2-W; RUSSELL LJ, 1995, NAT GENET, V9, P279, DOI 10.1038/ng0395-279; Sardy M, 2002, J EXP MED, V195, P747, DOI 10.1084/jem.20011299; Sevilla LM, 2007, J CELL BIOL, V179, P1599, DOI 10.1083/jcb.200706187; Siegel M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001861; Steinert PM, 2003, J BIOL CHEM, V278, P41409, DOI 10.1074/jbc.M302037200; Steinert PM, 1998, J BIOL CHEM, V273, P11758, DOI 10.1074/jbc.273.19.11758; Stephens P, 2004, J CELL SCI, V117, P3389, DOI 10.1242/jcs.01188; Tarcsa E, 1997, J BIOL CHEM, V272, P27893, DOI 10.1074/jbc.272.44.27893; Thibaut S, 2005, J INVEST DERMATOL, V125, P581, DOI 10.1111/j.0022-202X.2005.23868.x; Vader LW, 2002, J EXP MED, V195, P643, DOI 10.1084/jem.20012028; Verderio EAM, 2005, PROG EXP TUMOR RES, V38, P89; Wang ZL, 2003, J INVEST DERMATOL, V121, P1276, DOI 10.1111/j.1523-1747.2003.12644.x; Yamada K, 1997, HUM MOL GENET, V6, P2223, DOI 10.1093/hmg/6.13.2223; Yamane A, 2010, FEBS J, V277, P3564, DOI 10.1111/j.1742-4658.2010.07765.x; Zhang H, 2005, CELL RES, V15, P105, DOI 10.1038/sj.cr.7290274	54	34	35	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e34252	10.1371/journal.pone.0034252	http://dx.doi.org/10.1371/journal.pone.0034252			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GO	22496784	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000304855200035
J	Lee, H; Song, M; Shin, N; Shin, CH; Min, BS; Kim, HS; Yoo, JS; Kim, H				Lee, Hanna; Song, Meiying; Shin, Nara; Shin, Chang Hoon; Min, Byung Soh; Kim, Hyon-Suk; Yoo, Jong Shin; Kim, Hoguen			Diagnostic Significance of Serum HMGB1 in Colorectal Carcinomas	PLOS ONE			English	Article							MOBILITY GROUP BOX-1; CELL LUNG-CANCER; COLON-CANCER; PROSTATE-CANCER; BETA GENE; PROTEIN; SECRETION; RELEASE; CEA; EXPRESSION	High mobility group box 1 protein (HMGB1), a nuclear protein, can be translocated to the cytoplasm and secreted in colon cancer cells. However, the diagnostic significance of HMGB1 has not been evaluated in colorectal carcinomas. For this purpose, we have screened the expression and secretion of HMGB1 in 10 colon cancer cell lines and 1 control cell line and found that HMGB1 was detected in the culture medium. To evaluate the diagnostic value of HMGB1, we performed an enzyme-linked immunosorbent assay to measure HMGB1 levels and compared them to carcinoembryonic antigen (CEA) levels in the serum samples of 219 colorectal carcinoma patients and 75 healthy control subjects. We found that the serum HMGB1 level was increased by 1.5-fold in patients with colorectal carcinoma compared to those in healthy controls. When HMGB1 and CEA levels were compared, HMGB1 had similar efficacy as CEA regarding cancer detection (the sensitivity was 20.1% for HMGB1 vs. 25.6% for CEA, and the specificity was 96% for HMGB1 vs. 90.7% for CEA). Moreover, the diagnostic accuracy of HMGB1 for stage I cancer was significantly higher than that of CEA (sensitivity: 41.2% vs. 5.9%; specificity: 96% vs. 90.7). When we combined HMGB1 and CEA, the overall diagnostic sensitivity was higher than that of CEA alone (42% vs. 25.6%), and the diagnostic sensitivity for stage I was also elevated (47% vs. 5.9%). However, the prognosis of patients was not related with serum HMGB1 concentrations. Our findings indicate that serum HMGB1 levels are increased in a subset of colorectal carcinomas, suggesting their potential utility as a supportive diagnostic marker for colorectal carcinomas.	[Lee, Hanna; Song, Meiying; Shin, Nara; Shin, Chang Hoon; Kim, Hoguen] Yonsei Univ, Coll Med, Dept Pathol, Seoul, South Korea; [Lee, Hanna; Song, Meiying; Shin, Nara; Shin, Chang Hoon; Kim, Hoguen] Yonsei Univ, Coll Med, Brain Korea Project Med Sci 21, Seoul, South Korea; [Min, Byung Soh] Yonsei Univ, Coll Med, Dept Surg, Seoul, South Korea; [Kim, Hyon-Suk] Yonsei Univ, Coll Med, Dept Lab Med, Seoul, South Korea; [Yoo, Jong Shin] Korea Basic Sci Inst, Div Mass Spectrometr Anal, Cheongwon, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Korea Basic Science Institute (KBSI)	Lee, H (corresponding author), Yonsei Univ, Coll Med, Dept Pathol, Seoul, South Korea.	hkyonsei@yuhs.ac	Kim, Hyon-Suk/R-4113-2017	Kim, Hyon-Suk/0000-0001-5662-7740; Shin, Nara/0000-0002-9910-4971	Korean Ministry of Education, Science, and Technology [FPR08A2-100]; Converging Research Center through the National Research Foundation of Korea [2010K001115]; Ministry of Education, Science, and Technology; Ministry for Health & Welfare Affairs, Republic of Korea [A085136]	Korean Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Converging Research Center through the National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Ministry for Health & Welfare Affairs, Republic of Korea	This research was supported by a grant (FPR08A2-100) from the 21C Frontier Functional Proteomics Project from the Korean Ministry of Education, Science, and Technology, by the Converging Research Center Program (2010K001115) through the National Research Foundation of Korea funded by the Ministry of Education, Science, and Technology, and by a grant from the Korea Healthcare technology R&D Project, Ministry for Health & Welfare Affairs, Republic of Korea (A085136). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apetoh L, 2007, NAT MED, V13, P1050, DOI 10.1038/nm1622; Baldassarre G, 2003, MOL CELL BIOL, V23, P2225, DOI 10.1128/MCB.23.7.2225-2238.2003; Bast RC, 2001, J CLIN ONCOL, V19, P1865, DOI 10.1200/JCO.2001.19.6.1865; Bianchi ME, 2007, IMMUNOL REV, V220, P35, DOI 10.1111/j.1600-065X.2007.00574.x; Bonaldi T, 2003, EMBO J, V22, P5551, DOI 10.1093/emboj/cdg516; Bustin M, 1999, MOL CELL BIOL, V19, P5237; Candolfi M, 2009, CLIN CANCER RES, V15, P4401, DOI 10.1158/1078-0432.CCR-09-0155; Chen YD, 2004, CLIN CANCER RES, V10, P8380, DOI 10.1158/1078-0432.CCR-1162-03; Cheng BQ, 2008, DIGEST LIVER DIS, V40, P446, DOI 10.1016/j.dld.2007.11.024; Chung HW, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-38; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Dolde CE, 2002, BREAST CANCER RES TR, V71, P181, DOI 10.1023/A:1014444114804; Dudek AZ, 2005, CANCER INVEST, V23, P193, DOI 10.1081/CNV-200055949; Ellerman JE, 2007, CLIN CANCER RES, V13, P2836, DOI 10.1158/1078-0432.CCR-06-1953; Evans A, 2004, J SURG ONCOL, V88, P86, DOI 10.1002/jso.20136; Fakih MG, 2006, ONCOLOGY-NY, V20, P579; FASHENA SJ, 1992, MOL CELL BIOL, V12, P894, DOI 10.1128/MCB.12.2.894; GOODWIN GH, 1973, EUR J BIOCHEM, V38, P14, DOI 10.1111/j.1432-1033.1973.tb03026.x; Holten-Andersen MN, 2002, CLIN CANCER RES, V8, P156; Ito N, 2007, J LEUKOCYTE BIOL, V81, P75, DOI 10.1189/jlb.0306169; Kang HJ, 2009, LAB INVEST, V89, P948, DOI 10.1038/labinvest.2009.47; Kim HJ, 2008, BMB REP, V41, P685, DOI 10.5483/BMBRep.2008.41.10.685; Kuniyasu H, 2003, ONCOL REP, V10, P1863; Leconte A, 1999, BRIT J CANCER, V80, P1373, DOI 10.1038/sj.bjc.6690531; Lee H, 2010, J PROTEOME RES, V9, P4661, DOI 10.1021/pr100386r; Leman ES, 2003, J CELL BIOCHEM, V88, P599, DOI 10.1002/jcb.10368; Lim SC, 2007, INT J MOL MED, V20, P187; Lotze MT, 2005, NAT REV IMMUNOL, V5, P331, DOI 10.1038/nri1594; Maeda S, 2007, BIOCHEM BIOPH RES CO, V360, P394, DOI 10.1016/j.bbrc.2007.06.065; MOERTEL CG, 1993, JAMA-J AM MED ASSOC, V270, P943, DOI 10.1001/jama.270.8.943; Naumnik W, 2009, FOLIA HISTOCHEM CYTO, V47, P703, DOI 10.2478/v10042-009-0025-z; Poser I, 2003, MOL CELL BIOL, V23, P2991, DOI 10.1128/MCB.23.8.2991-2998.2003; Rovere-Querini P, 2004, EMBO REP, V5, P825, DOI 10.1038/sj.embor.7400205; Semino C, 2005, BLOOD, V106, P609, DOI 10.1182/blood-2004-10-3906; Shang GH, 2009, RESP MED, V103, P1949, DOI 10.1016/j.rmed.2009.05.019; Sheng XG, 2009, CROAT MED J, V50, P455, DOI 10.3325/cmj.2009.50.455; Sung JJY, 2005, LANCET ONCOL, V6, P871, DOI 10.1016/S1470-2045(05)70422-8; Taguchi A, 2000, NATURE, V405, P354, DOI 10.1038/35012626; Tang DL, 2010, BBA-GENE REGUL MECH, V1799, P131, DOI 10.1016/j.bbagrm.2009.11.014; Tarbe N, 2001, ANTICANCER RES, V21, P3221; THANOS D, 1992, CELL, V71, P777, DOI 10.1016/0092-8674(92)90554-P; Volp K, 2006, GUT, V55, P234, DOI 10.1136/gut.2004.062729; WANEBO HJ, 1978, NEW ENGL J MED, V299, P448, DOI 10.1056/NEJM197808312990904; WEIR HM, 1993, EMBO J, V12, P1311, DOI 10.1002/j.1460-2075.1993.tb05776.x; Yao XJ, 2010, J CANCER RES CLIN, V136, P677, DOI 10.1007/s00432-009-0706-1; Youn JH, 2006, J IMMUNOL, V177, P7889, DOI 10.4049/jimmunol.177.11.7889	46	44	51	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e34318	10.1371/journal.pone.0034318	http://dx.doi.org/10.1371/journal.pone.0034318			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GO	22496788	Green Submitted, gold, Green Published			2022-12-27	WOS:000304855200039
J	Skopelitou, K; Dhavala, P; Papageorgiou, AC; Labrou, NE				Skopelitou, Katholiki; Dhavala, Prathusha; Papageorgiou, Anastassios C.; Labrou, Nikolaos E.			A Glutathione Transferase from Agrobacterium tumefaciens Reveals a Novel Class of Bacterial GST Superfamily	PLOS ONE			English	Article							HYDROPHOBIC STAPLE MOTIF; CATALYTIC MECHANISM; S-TRANSFERASE; SECONDARY-STRUCTURE; DISULFIDE BOND; H-SITE; ENZYMES; BINDING; P1-1; STABILITY	In the present work, we report a novel class of glutathione transferases (GSTs) originated from the pathogenic soil bacterium Agrobacterium tumefaciens C58, with structural and catalytic properties not observed previously in prokaryotic and eukaryotic GST isoenzymes. A GST-like sequence from A. tumefaciens C58 (Atu3701) with low similarity to other characterized GST family of enzymes was identified. Phylogenetic analysis showed that it belongs to a distinct GST class not previously described and restricted only in soil bacteria, called the Eta class (H). This enzyme (designated as AtuGSTH1-1) was cloned and expressed in E. coli and its structural and catalytic properties were investigated. Functional analysis showed that AtuGSTH1-1 exhibits significant transferase activity against the common substrates aryl halides, as well as very high peroxidase activity towards organic hydroperoxides. The crystal structure of AtuGSTH1-1 was determined at 1.4 angstrom resolution in complex with S-(p-nitrobenzyl)-glutathione (Nb-GSH). Although AtuGSTH1-1 adopts the canonical GST fold, sequence and structural characteristics distinct from previously characterized GSTs were identified. The absence of the classic catalytic essential residues (Tyr, Ser, Cys) distinguishes AtuGSTH1-1 from all other cytosolic GSTs of known structure and function. Site-directed mutagenesis showed that instead of the classic catalytic residues, an Arg residue (Arg34), an electron-sharing network, and a bridge of a network of water molecules may form the basis of the catalytic mechanism. Comparative sequence analysis, structural information, and site-directed mutagenesis in combination with kinetic analysis showed that Phe22, Ser25, and Arg187 are additional important residues for the enzyme's catalytic efficiency and specificity.	[Skopelitou, Katholiki; Labrou, Nikolaos E.] Agr Univ Athens, Dept Agr Biotechnol, Lab Enzyme Technol, Athens, Greece; [Dhavala, Prathusha; Papageorgiou, Anastassios C.] Abo Akad Univ, Univ Turku, Turku Ctr Biotechnol, Turku, Finland	Agricultural University of Athens; Abo Akademi University; University of Turku	Skopelitou, K (corresponding author), Agr Univ Athens, Dept Agr Biotechnol, Lab Enzyme Technol, Athens, Greece.	lambrou@aua.gr	Labrou, Nikolaos/B-1089-2011; Papageorgiou, Anastassios C./AAL-5274-2020	Labrou, Nikolaos/0000-0003-1925-9867; Papageorgiou, Anastassios C./0000-0002-7980-1120	grant THALES; European Social Fund; Academy of Finland [121278]; European Community [226716]	grant THALES(Thales Group); European Social Fund(European Social Fund (ESF)); Academy of Finland(Academy of Finland); European Community(European Commission)	This work was partially supported by the grant THALES. The grant THALES falls under the Operational Programme "Education and Lifelong Learning" and is co-financed by the European Social Fund and National Resources. Dr. Papageorgiou thanks the Academy of Finland for financial support (grant number 121278). Access to EMBL Hamburg (c/o DESY) was provided by the European Community's Seventh Framework Programme (FP7/2007-2012) under grant agreement no. 226716. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Allocati N, 2006, BIOCHEM J, V394, P11, DOI 10.1042/BJ20051367; Allocati N, 2008, PROTEINS, V71, P16, DOI 10.1002/prot.21835; Allocati N, 2009, FEBS J, V276, P58, DOI 10.1111/j.1742-4658.2008.06743.x; Armstrong RN, 1997, CHEM RES TOXICOL, V10, P2, DOI 10.1021/tx960072x; Axarli IA, 2004, BIOCHEM J, V382, P885, DOI 10.1042/BJ20040298; Axarli I, 2009, J MOL BIOL, V385, P984, DOI 10.1016/j.jmb.2008.10.084; Axarli I, 2010, BBA-PROTEINS PROTEOM, V1804, P662, DOI 10.1016/j.bbapap.2009.10.016; Axarli I, 2009, BIOCHEM J, V422, P247, DOI 10.1042/BJ20090224; Balogh LM, 2010, BIOCHEMISTRY-US, V49, P1541, DOI 10.1021/bi902038u; Cocco R, 2001, J BIOL CHEM, V276, P32177, DOI 10.1074/jbc.M104057200; Diederichs K, 1997, NAT STRUCT BIOL, V4, P269, DOI 10.1038/nsb0497-269; Dixon DP, 2010, PHYTOCHEMISTRY, V71, P338, DOI 10.1016/j.phytochem.2009.12.012; Dourado DFAR, 2008, CHEM-EUR J, V14, P9591, DOI 10.1002/chem.200800946; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Federici L, 2010, PROTEIN ENG DES SEL, V23, P743, DOI 10.1093/protein/gzq048; Grahn E, 2006, ACTA CRYSTALLOGR D, V62, P197, DOI 10.1107/S0907444905039296; Gupta MN, 2011, CURR SCI INDIA, V100, P1152; Hayes JD, 1999, FREE RADICAL RES, V31, P273, DOI 10.1080/10715769900300851; Hayes JD, 2005, ANNU REV PHARMACOL, V45, P51, DOI 10.1146/annurev.pharmtox.45.120403.095857; Hegazy UM, 2006, CHEM BIOL, V13, P929, DOI 10.1016/j.chembiol.2006.07.005; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Holm L, 1997, NUCLEIC ACIDS RES, V25, P231, DOI 10.1093/nar/25.1.231; Honaker MT, 2011, J BIOL CHEM, V286, P42770, DOI 10.1074/jbc.M111.304386; Hurd TR, 2005, ANTIOXID REDOX SIGN, V7, P999, DOI 10.1089/ars.2005.7.999; JOHNSON WW, 1993, J BIOL CHEM, V268, P11508; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Mannervik B, 1996, BIOCHEM SOC T, V24, P878, DOI 10.1042/bst0240878; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Micaloni C, 2003, J MOL BIOL, V325, P111, DOI 10.1016/S0022-2836(02)01178-6; Morris RJ, 2003, METHOD ENZYMOL, V374, P229, DOI 10.1016/S0076-6879(03)74011-7; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Norrgard MA, 2011, J BIOL CHEM, V286, P16871, DOI 10.1074/jbc.M111.230078; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pemble SE, 1996, BIOCHEM J, V319, P749, DOI 10.1042/bj3190749; Pitzschke A, 2010, EMBO J, V29, P1021, DOI 10.1038/emboj.2010.8; Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716; Ricci G, 1996, J BIOL CHEM, V271, P16187, DOI 10.1074/jbc.271.27.16187; Rossjohn J, 1998, STRUCT FOLD DES, V6, P721, DOI 10.1016/S0969-2126(98)00074-4; SAMPSON NS, 1992, BIOCHEMISTRY-US, V31, P8488, DOI 10.1021/bi00151a015; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Sies H, 1998, CHEM-BIOL INTERACT, V112, P177, DOI 10.1016/S0009-2797(97)00160-9; Skopelitou K, 2012, FUNCT INTEGR GENOMIC, V12, P157, DOI 10.1007/s10142-011-0248-x; Stenberg G, 2000, J BIOL CHEM, V275, P10421, DOI 10.1074/jbc.275.14.10421; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Wadington MC, 2009, BIOCHEMISTRY-US, V48, P6559, DOI 10.1021/bi9008825; Wiktelius E, 2007, BIOCHEM J, V406, P115, DOI 10.1042/BJ20070328; Winayanuwattikun P, 2005, J BIOL CHEM, V280, P31776, DOI 10.1074/jbc.M502612200; Wolf AV, HDB CHEM PHYS, pD; Wood DW, 2001, SCIENCE, V294, P2317, DOI 10.1126/science.1066804	56	22	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e34263	10.1371/journal.pone.0034263	http://dx.doi.org/10.1371/journal.pone.0034263			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GO	22496785	Green Published, gold, Green Submitted			2022-12-27	WOS:000304855200036
J	An, A; Sun, MR; Wang, Y; Wang, F; Ding, YL; Song, Y				An, An; Sun, Meirong; Wang, Yun; Wang, Fang; Ding, Yulong; Song, Yan			The N2pc Is Increased by Perceptual Learning but Is Unnecessary for the Transfer of Learning	PLOS ONE			English	Article							OBLIQUE ORIENTATION; SPECIFICITY; DISCRIMINATION; ATTENTION; IMPROVEMENT	Background: Practice improves human performance in many psychophysical paradigms. This kind of improvement is thought to be the evidence of human brain plasticity. However, the changes that occur in the brain are not fully understood. Methodology/Principal Findings: The N2pc component has previously been associated with visuo-spatial attention. In this study, we used event-related potentials (ERPs) to investigate whether the N2pc component changed during long-term visual perceptual learning. Thirteen subjects completed several days of training in an orientation discrimination task, and were given a final test 30 days later. The results showed that behavioral thresholds significantly decreased across training sessions, and this decrement was also present in the untrained visual field. ERPs showed training significantly increased the N2pc amplitude, and this effect could be maintained for up to 30 days. However, the increase in N2pc was specific to the trained visual field. Conclusion/Significance: Training caused spatial attention to be increasingly focused on the target positions. However, this process was not transferrable from the trained to the untrained visual field, which suggests that the increase in N2pc may be unnecessary for behavioral improvements in the untrained visual field.	[An, An; Sun, Meirong; Wang, Yun; Wang, Fang; Song, Yan] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China; [Ding, Yulong] Sun Yat Sen Univ, Dept Psychol, Guangzhou 510275, Guangdong, Peoples R China	Beijing Normal University; Sun Yat Sen University	An, A (corresponding author), Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China.	songyan@bnu.edu.cn		Ding, Yulong/0000-0002-4094-1601; Wang, Yun/0000-0002-2648-4467; Ding, Yulong/0000-0002-3112-6867; Song, Yan/0000-0002-5923-7673	National Natural Science Foundation of China [31070899, 31070983]; National Basic Research Program of China [2011CB711000]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China)	This research was supported by the National Natural Science Foundation of China (31070899), the National Basic Research Program of China (2011CB711000), and the National Natural Science Foundation of China (31070983). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberg KC, 2009, VISION RES, V49, P2087, DOI 10.1016/j.visres.2009.05.020; AHISSAR M, 1993, P NATL ACAD SCI USA, V90, P5718, DOI 10.1073/pnas.90.12.5718; BALL K, 1982, SCIENCE, V218, P697, DOI 10.1126/science.7134968; BALL K, 1987, VISION RES, V27, P953, DOI 10.1016/0042-6989(87)90011-3; BERARDI N, 1987, J PHYSIOL-LONDON, V384, P633, DOI 10.1113/jphysiol.1987.sp016474; Braun J, 1998, PERCEPT PSYCHOPHYS, V60, P1, DOI 10.3758/BF03211915; Crist RE, 1997, J NEUROPHYSIOL, V78, P2889, DOI 10.1152/jn.1997.78.6.2889; Eimer M, 1996, ELECTROEN CLIN NEURO, V99, P225, DOI 10.1016/0013-4694(96)95711-9; Fahle M, 2005, CURR OPIN NEUROBIOL, V15, P154, DOI 10.1016/j.conb.2005.03.010; FAHLE M, 1994, PERCEPTION, V23, P411, DOI 10.1068/p230411; Gutnisky DA, 2009, CURR BIOL, V19, P555, DOI 10.1016/j.cub.2009.01.063; Hamame CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019221; Kahnt T, 2011, NEURON, V70, P549, DOI 10.1016/j.neuron.2011.02.054; KARNI A, 1991, P NATL ACAD SCI USA, V88, P4966, DOI 10.1073/pnas.88.11.4966; Luck SJ, 1997, COGNITIVE PSYCHOL, V33, P64, DOI 10.1006/cogp.1997.0660; LUCK SJ, 1994, J EXP PSYCHOL HUMAN, V20, P1000, DOI 10.1037/0096-1523.20.5.1000; LUCK SJ, 1994, PSYCHOPHYSIOLOGY, V31, P291, DOI 10.1111/j.1469-8986.1994.tb02218.x; Luck SJ, 1998, P NATL ACAD SCI USA, V95, P825, DOI 10.1073/pnas.95.3.825; Mukai I, 2011, J VISION, V11, DOI 10.1167/11.1.25; POGGIO T, 1992, SCIENCE, V256, P1018, DOI 10.1126/science.1589770; Qu Z, 2010, NEUROPSYCHOLOGIA, V48, P1869, DOI 10.1016/j.neuropsychologia.2010.01.008; SCHOUPS AA, 1995, J PHYSIOL-LONDON, V483, P797, DOI 10.1113/jphysiol.1995.sp020623; Schwartz S, 2002, P NATL ACAD SCI USA, V99, P17137, DOI 10.1073/pnas.242414599; Seitz AR, 2009, NEURON, V61, P700, DOI 10.1016/j.neuron.2009.01.016; Song Y, 2010, INT J PSYCHOPHYSIOL, V75, P241, DOI 10.1016/j.ijpsycho.2009.11.007; Tartaglia EM, 2009, CURR BIOL, V19, P2081, DOI 10.1016/j.cub.2009.10.060; TREISMAN A, 1992, AM J PSYCHOL, V105, P341, DOI 10.2307/1423032; Tsushima Y, 2008, CURR BIOL, V18, pR516, DOI 10.1016/j.cub.2008.04.029; VOGELS R, 1985, VISION RES, V25, P1679, DOI 10.1016/0042-6989(85)90140-3; Woodman GF, 2003, J EXP PSYCHOL HUMAN, V29, P121, DOI 10.1037/0096-1523.29.1.121; Zhang E, 2010, P NATL ACAD SCI USA, V107, P15969, DOI 10.1073/pnas.1003547107; Zhang T, 2010, VISION RES, V50, P368, DOI 10.1016/j.visres.2009.08.024	32	22	22	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2012	7	4							e34826	10.1371/journal.pone.0034826	http://dx.doi.org/10.1371/journal.pone.0034826			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	952GU	22485189	gold, Green Published, Green Submitted			2022-12-27	WOS:000304780500063
J	Hogan, L; Bhuju, S; Jones, DC; Laing, K; Trowsdale, J; Butcher, P; Singh, M; Vordermeier, M; Allen, RL				Hogan, Louise; Bhuju, Sabin; Jones, Des C.; Laing, Ken; Trowsdale, John; Butcher, Philip; Singh, Mahavir; Vordermeier, Martin; Allen, Rachel L.			Characterisation of Bovine Leukocyte Ig-like Receptors	PLOS ONE			English	Article							IMMUNOGLOBULIN-LIKE RECEPTORS; DENDRITIC CELLS; KILLER-CELL; MULTIPLE-SCLEROSIS; INHIBITION MOTIFS; FC-RECEPTOR; KIR GENES; SUPERFAMILY; ACTIVATION; EVOLUTION	Leukocyte Immunoglobulin-like receptors (LILR) are innate immune receptors involved in regulating both innate and adaptive immune functions. LILR show more interspecies conservation than the closely related Killer Ig-like receptors, and homologues have been identified in rodents, primates, seals and chickens. The murine equivalents, paired Ig-like receptors PIR), contain two additional immunoglobulin domains, but show strong sequence and functional similarities to human LILR. The bovine genome was recently sequenced, with preliminary annotations indicating that LILR were present in this species. We therefore sought to identify and characterize novel LILR within the Bos taurus genome, compare these phylogenetically with LILR from other species and determine whether they were expressed in vivo. Twenty six potential bovine LILR were initially identified using BLAST and BLAT software. Phylogenetic analysis constructed using the neighbour joining method, incorporating pairwise deletion and confidence limits estimated from 1000 replicates using bootstrapping, indicated that 16 of these represent novel bovine LILR. Protein structures defined using protein BLAST predict that the bovine LILR family comprises seven putative inhibitory, four activating and five soluble receptors. Preliminary expression analysis was performed by mapping the predicted sequences with raw data from total transcript sequence generated using Genome Analyzer Ilx (Illumina) to provide evidence that all 16 of these receptors are expressed in vivo. The bovine receptor family appears to contain receptors which resemble the six domain rodent PIR as well as the four domain LILR found in other species.	[Hogan, Louise; Laing, Ken; Butcher, Philip; Allen, Rachel L.] Univ London, Div Clin Sci, Ctr Infect, London, England; [Hogan, Louise; Vordermeier, Martin] AHVLA, TB Res Grp, Weybridge, New Haw, England; [Bhuju, Sabin; Singh, Mahavir] Helmholtz Zentrum Infekt Forsch, Dept Gene Regulat & Differentiat, Braunschweig, Germany; [Jones, Des C.; Trowsdale, John] Univ Cambridge, Dept Pathol, Div Immunol, Cambridge CB2 1QP, England; [Bhuju, Sabin; Singh, Mahavir] LIONEX Diagnost & Therapeut, Braunschweig, Germany	University of London; Helmholtz Association; Helmholtz-Center for Infection Research; University of Cambridge; Lionex Diagnostics & Therapeutics GmbH	Hogan, L (corresponding author), Univ London, Div Clin Sci, Ctr Infect, Cranmer Terrace, London, England.	p0904768@sgul.ac.uk		Hogan, Louise/0000-0001-5526-954X; Laing, Ken/0000-0003-1883-3433; Allen, Rachel/0000-0001-9834-8475; Butcher, Philip/0000-0003-1223-9097	St George's University of London; Animal Health and Veterinary Laboratories Agency; MRC [G0901682] Funding Source: UKRI; Medical Research Council [G0901682] Funding Source: researchfish	St George's University of London; Animal Health and Veterinary Laboratories Agency; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This project was funded by St George's University of London and the Animal Health and Veterinary Laboratories Agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson KJ, 2009, IMMUNOLOGY, V127, P8, DOI 10.1111/j.1365-2567.2009.03097.x; Barrow AD, 2006, EUR J IMMUNOL, V36, P1646, DOI 10.1002/eji.200636195; Beinhauer BG, 2004, EUR J IMMUNOL, V34, P74, DOI 10.1002/eji.200324550; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Bleharski JR, 2003, SCIENCE, V301, P1527, DOI 10.1126/science.1087785; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Burshtyn DN, 1997, J BIOL CHEM, V272, P13066, DOI 10.1074/jbc.272.20.13066; Canavez F, 2001, J IMMUNOL, V167, P5786, DOI 10.4049/jimmunol.167.10.5786; CASTELLS MC, 1994, J BIOL CHEM, V269, P8393; Cella M, 1997, J EXP MED, V185, P1743, DOI 10.1084/jem.185.10.1743; Chang CC, 2002, NAT IMMUNOL, V3, P237, DOI 10.1038/ni760; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Cosman D, 1997, IMMUNITY, V7, P273, DOI 10.1016/S1074-7613(00)80529-4; Daeron M, 2008, IMMUNOL REV, V224, P11, DOI 10.1111/j.1600-065X.2008.00666.x; Elsik CG, 2009, SCIENCE, V324, P522, DOI 10.1126/science.1169588; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Guethlein LA, 2007, IMMUNOGENETICS, V59, P517, DOI 10.1007/s00251-007-0214-x; Hammond JA, 2009, J IMMUNOL, V182, P3618, DOI 10.4049/jimmunol.0803026; HARPAZ Y, 1994, J MOL BIOL, V238, P528, DOI 10.1006/jmbi.1994.1312; Hayami K, 1997, J BIOL CHEM, V272, P7320, DOI 10.1074/jbc.272.11.7320; Hirayasu K, 2008, AM J HUM GENET, V82, P1075, DOI 10.1016/j.ajhg.2008.03.012; Huang J, 2010, J VIROL; Huang JH, 2009, J EXP MED, V206, P2959, DOI 10.1084/jem.20091386; Jones DC, 2009, EUR J IMMUNOL; Jones DC, 2011, J IMMUNOL, V186, P2990, DOI 10.4049/jimmunol.1003078; Kabalak G, 2009, ARTHRITIS RHEUM-US, V60, P2923, DOI 10.1002/art.24804; Katz HR, 1996, P NATL ACAD SCI USA, V93, P10809, DOI 10.1073/pnas.93.20.10809; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Koch S, 2005, GENES IMMUN, V6, P445, DOI 10.1038/sj.gene.6364187; Kollnberger S, 2004, J IMMUNOL, V173, P1699, DOI 10.4049/jimmunol.173.3.1699; Kubagawa H, 1997, P NATL ACAD SCI USA, V94, P5261, DOI 10.1073/pnas.94.10.5261; Lee DJ, 2007, J IMMUNOL, V179, P8128, DOI 10.4049/jimmunol.179.12.8128; Liang SY, 2002, EUR J IMMUNOL, V32, P2418, DOI 10.1002/1521-4141(200209)32:9<2418::AID-IMMU2418>3.0.CO;2-L; Lomsadze A, 2005, NUCLEIC ACIDS RES, V33, P6494, DOI 10.1093/nar/gki937; Martin AM, 2002, TRENDS IMMUNOL, V23, P81, DOI 10.1016/S1471-4906(01)02155-X; McQueen KL, 2002, EUR J IMMUNOL, V32, P810, DOI 10.1002/1521-4141(200203)32:3<810::AID-IMMU810>3.0.CO;2-P; Nakajima H, 1999, J IMMUNOL, V162, P5; Nikolaidis N, 2005, P NATL ACAD SCI USA, V102, P4057, DOI 10.1073/pnas.0501040102; Nikolaidis N, 2005, IMMUNOGENETICS, V57, P151, DOI 10.1007/s00251-004-0764-0; Olcese L, 1996, J IMMUNOL, V156, P4531; Ordonez D, 2009, GENES IMMUN, V10, P579, DOI 10.1038/gene.2009.34; Pilsbury LE, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/536478; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Samaridis J, 1997, EUR J IMMUNOL, V27, P660, DOI 10.1002/eji.1830270313; Sloane DE, 2004, BLOOD, V104, P2832, DOI 10.1182/blood-2004-01-0268; Storset AK, 2003, EUR J IMMUNOL, V33, P980, DOI 10.1002/eji.200323710; Takai T, 2001, IMMUNOL REV, V181, P215, DOI 10.1034/j.1600-065X.2001.1810118.x; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Torkar M, 2000, EUR J IMMUNOL, V30, P3655, DOI 10.1002/1521-4141(200012)30:12<3655::AID-IMMU3655>3.0.CO;2-Y; Tun T, 2003, TISSUE ANTIGENS, V61, P220, DOI 10.1034/j.1399-0039.2003.00042.x; Vely F, 1997, EUR J IMMUNOL, V27, P1994, DOI 10.1002/eji.1830270825; Viertlboeck BC, 2005, J IMMUNOL, V175, P385, DOI 10.4049/jimmunol.175.1.385; Vivier E, 1997, IMMUNOL TODAY, V18, P286, DOI 10.1016/S0167-5699(97)80025-4; Willcox BE, 2003, NAT IMMUNOL, V4, P913, DOI 10.1038/ni961; Willcox Benjamin E, 2002, BMC Struct Biol, V2, P6, DOI 10.1186/1472-6807-2-6; Wilson MJ, 2000, P NATL ACAD SCI USA, V97, P4778, DOI 10.1073/pnas.080588597; Young NT, 2008, BLOOD, V111, P3090, DOI 10.1182/blood-2007-05-089771	58	16	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2012	7	4							e34291	10.1371/journal.pone.0034291	http://dx.doi.org/10.1371/journal.pone.0034291			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952GU	22485161	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000304780500036
J	Lim, EJ; Hong, DY; Park, JH; Joung, YH; Darvin, P; Kim, SY; Na, YM; Hwang, TS; Ye, SK; Moon, ES; Cho, BW; Park, KD; Lee, HK; Park, T; Yang, YM				Lim, Eun Joung; Hong, Dae Young; Park, Jin Hee; Joung, Youn Hee; Darvin, Pramod; Kim, Sang Yoon; Na, Yoon Mi; Hwang, Tae Sook; Ye, Sang-Kyu; Moon, Eon-Soo; Cho, Byung Wook; Park, Kyung Do; Lee, Hak Kyo; Park, Taekyu; Yang, Young Mok			Methylsulfonylmethane Suppresses Breast Cancer Growth by Down-Regulating STAT3 and STAT5b Pathways	PLOS ONE			English	Article							DIMETHYL SULFONE; SIGNAL TRANSDUCER; ESTROGEN-RECEPTORS; IGF-1 EXPRESSION; TRANSCRIPTION 5B; VEGF EXPRESSION; CYCLIN D1; IN-VIVO; CELLS; PROGESTERONE	Breast cancer is the most aggressive form of all cancers, with high incidence and mortality rates. The purpose of the present study was to investigate the molecular mechanism by which methylsulfonylmethane (MSM) inhibits breast cancer growth in mice xenografts. MSM is an organic sulfur-containing natural compound without any toxicity. In this study, we demonstrated that MSM substantially decreased the viability of human breast cancer cells in a dose-dependent manner. MSM also suppressed the phosphorylation of STAT3, STAT5b, expression of IGF-1R, HIF-1 alpha, VEGF, BrK and p-IGF-1R and inhibited triple-negative receptor expression in receptor-positive cell lines. Moreover, expression in receptor-positive cell-lines. Moreover, MSM decreased the DNA-binding activities of STAT5b and STAT3, to the target gene promoters in MDA-MB 231 or co-transfected COS-7 cells. We confirmed that MSM significantly decreased the relative luciferase activities indicating crosstalk between STAT5b/IGF-1R, STAT5b/HSP90 alpha, and STAT3/VEGF. To confirm these findings in vivo, xenografts were established in Balb/c athymic nude mice with MDA-MB 231 cells and MSM was administered for 30 days. Concurring to our in vitro analysis, these xenografts showed decreased expression of STAT3, STAT5b, IGF-1R and VEGF. Through in vitro and in vivo analysis, we confirmed that MSM can effectively regulate multiple targets including STAT3/VEGF and STAT5b/IGF-1R. These are the major molecules involved in tumor development, progression, and metastasis: Thus, we strongly recommend the use of MSM as a trial drug for treating all types of breast cancers including triple-negative cancers.	[Lim, Eun Joung; Park, Jin Hee; Joung, Youn Hee; Darvin, Pramod; Kim, Sang Yoon; Na, Yoon Mi; Hwang, Tae Sook; Yang, Young Mok] Konkuk Univ, Dept Pathol, Sch Med, Seoul, South Korea; [Lim, Eun Joung; Park, Jin Hee; Joung, Youn Hee; Darvin, Pramod; Kim, Sang Yoon; Na, Yoon Mi; Hwang, Tae Sook; Yang, Young Mok] Konkuk Univ, Inst Biomed Sci & Technol, Seoul, South Korea; [Hong, Dae Young] Konkuk Univ Hosp, Dept Emergency Med, Seoul, South Korea; [Ye, Sang-Kyu] Seoul Natl Univ, Coll Med, Dept Pharmacol, Seoul, South Korea; [Moon, Eon-Soo] Konkuk Univ, Sch Med, Dept Internal Med, Chungju, South Korea; [Cho, Byung Wook] Pusan Natl Univ, Coll Life Sci, Dept Anim Sci, Pusan, South Korea; [Park, Kyung Do; Lee, Hak Kyo] Hankyong Natl Univ, Genom Informat Ctr, Anseong, South Korea; [Park, Taekyu] Konkuk Univ, Coll Biomed & Hlth Sci, Dept Biotechnol, Chungju, South Korea	Konkuk University; Konkuk University Medical Center; Konkuk University; Konkuk University; Konkuk University Medical Center; Seoul National University (SNU); Konkuk University; Konkuk University Medical Center; Pusan National University; Hankyong National University; Konkuk University	Lim, EJ (corresponding author), Konkuk Univ, Dept Pathol, Sch Med, Glocal Campus, Seoul, South Korea.	ymyang@kku.ac.kr	Ye, Sang Kyu/J-2768-2012; Darvin, Pramod/M-1730-2019	Darvin, Pramod/0000-0003-3746-109X	Next generation BioGreen 21 Program [PJ0081062011]; Rural Development Administration; Ministry of Commerce, Industry and Energy through the Bio-Food and Drug Research Center at Konkuk University, Glocal Campus, South Korea	Next generation BioGreen 21 Program(Rural Development Administration (RDA), Republic of Korea); Rural Development Administration(Rural Development Administration (RDA), Republic of Korea); Ministry of Commerce, Industry and Energy through the Bio-Food and Drug Research Center at Konkuk University, Glocal Campus, South Korea	This work was supported by a grant from the Next generation BioGreen 21 Program (No. PJ0081062011), by the Rural Development Administration, and partially supported by the Ministry of Commerce, Industry and Energy through the Bio-Food and Drug Research Center at Konkuk University, Glocal Campus, South Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders CK, 2009, CLIN BREAST CANCER, V9, pS73, DOI 10.3816/CBC.2009.s.008; Arpino G, 2005, JNCI-J NATL CANCER I, V97, P1254, DOI 10.1093/jnci/dji249; Barrager E, 2002, J ALTERN COMPLEM MED, V8, P167, DOI 10.1089/107555302317371451; Battle T. E., 2002, Current Molecular Medicine (Hilversum), V2, P381, DOI 10.2174/1566524023362456; BEILKE MA, 1987, J LAB CLIN MED, V110, P91; Bernaciak TM, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2341; BLACK R, 1983, CLIN ONCOL, V9, P311; Buettner R, 2002, CLIN CANCER RES, V8, P945; Caron JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011788; Chapman RS, 2000, ADV EXP MED BIOL, V480, P129; Chen JQ, 2009, BBA-REV CANCER, V1796, P162, DOI 10.1016/j.bbcan.2009.06.003; CHILDS SJ, 1994, UROL CLIN N AM, V21, P85; Dabrosin C, 2003, INT J CANCER, V107, P535, DOI 10.1002/ijc.11398; Dolled-Filhart M, 2003, CLIN CANCER RES, V9, P594; Engelke UFH, 2005, NMR BIOMED, V18, P331, DOI 10.1002/nbm.966; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Ferreira ACS, 2003, J AGR FOOD CHEM, V51, P727, DOI 10.1021/jf025934g; Fisher BJ, 1998, INT J RADIAT ONCOL, V42, P117, DOI 10.1016/S0360-3016(98)00177-1; Fowler AM, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1748; Gluz O, 2009, ANN ONCOL, V20, P1913, DOI 10.1093/annonc/mdp492; Graham JD, 2000, J STEROID BIOCHEM, V74, P255, DOI 10.1016/S0960-0760(00)00101-1; Hopp TA, 2004, CLIN CANCER RES, V10, P2751, DOI 10.1158/1078-0432.CCR-03-0141; Horvath K, 2002, FOOD CHEM TOXICOL, V40, P1459, DOI 10.1016/S0278-6915(02)00086-8; Hwang PH, 2005, EXP MOL MED, V37, P391, DOI 10.1038/emm.2005.49; Ismail-Khan R, 2010, CANCER CONTROL, V17, P173, DOI 10.1177/107327481001700305; Jacob SW, 2003, MSM DEFINITIVE GUIDE, P107; Joung YH, 2005, EXP MOL MED, V37, P353, DOI 10.1038/emm.2005.45; Joung YH, 2008, INT J ONCOL, V33, P477, DOI 10.3892/ijo_00000030; Joung YH, 2007, BIOCHEM BIOPH RES CO, V358, P733, DOI 10.1016/j.bbrc.2007.04.201; Jung JE, 2005, FASEB J, V19, P1296, DOI 10.1096/fj.04-3099fje; KASTNER P, 1990, EMBO J, V9, P1603, DOI 10.1002/j.1460-2075.1990.tb08280.x; Kim LS, 2006, OSTEOARTHR CARTILAGE, V14, P286, DOI 10.1016/j.joca.2005.10.003; Kimura H, 2001, J BIOL CHEM, V276, P2292, DOI 10.1074/jbc.M008398200; Klagsbrun Michael, 1996, Cytokine and Growth Factor Reviews, V7, P259, DOI 10.1016/S1359-6101(96)00027-5; KRAUS WL, 1993, ENDOCRINOLOGY, V132, P2371, DOI 10.1210/en.132.6.2371; Lim EJ, 2010, INT J ONCOL, V36, P1243, DOI 10.3892/ijo_00000608; Liu XW, 1997, GENE DEV, V11, P179, DOI 10.1101/gad.11.2.179; LYDON JP, 1995, GENE DEV, V9, P2266, DOI 10.1101/gad.9.18.2266; Matsumoto T, 2001, Sci STKE, V2001, pre21, DOI 10.1126/stke.2001.112.re21; Mitsiades CS, 2004, CANCER CELL, V5, P221, DOI 10.1016/S1535-6108(04)00050-9; Moasser MM, 2007, ONCOGENE, V26, P6469, DOI 10.1038/sj.onc.1210477; MORTON JI, 1986, P SOC EXP BIOL MED, V183, P227; Nahta R, 2005, CANCER RES, V65, P11118, DOI 10.1158/0008-5472.CAN-04-3841; Niu GL, 2002, ONCOGENE, V21, P2000, DOI 10.1038/sj.onc.1205260; Park SH, 2001, MOL ENDOCRINOL, V15, P2157, DOI 10.1210/me.15.12.2157; Podo F, 2010, MOL ONCOL, V4, P209, DOI 10.1016/j.molonc.2010.04.006; RAVDIN PM, 1992, J CLIN ONCOL, V10, P1284, DOI 10.1200/JCO.1992.10.8.1284; Rose SE, 2000, MAGN RESON IMAGING, V18, P95, DOI 10.1016/S0730-725X(99)00110-1; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Tian XB, 2007, J NUCL MED, V48, P1699, DOI 10.2967/jnumed.107.042499; Tweardy D, 2011, J CLIN ONCOL, V29, P2443, DOI 10.1200/JCO.2010.34.2014; Weaver AM, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1794; Werner H, 1996, P NATL ACAD SCI USA, V93, P8318, DOI 10.1073/pnas.93.16.8318; Yamashita H, 2004, CANCER SCI, V95, P662, DOI 10.1111/j.1349-7006.2004.tb03326.x; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Yi HK, 2001, EUR J CANCER, V37, P2257, DOI 10.1016/S0959-8049(01)00269-6; ZHANG HJ, 1984, BREAST CANCER RES TR, V4, P221, DOI 10.1007/BF01806488	57	53	54	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2012	7	4							e33361	10.1371/journal.pone.0033361	http://dx.doi.org/10.1371/journal.pone.0033361			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952GU	22485142	Green Published, Green Submitted, gold			2022-12-27	WOS:000304780500018
J	Martin, LJ; Kissebah, AH; Olivier, M				Martin, Lisa J.; Kissebah, Ahmed H.; Olivier, Michael			Accounting for a Quantitative Trait Locus for Plasma Triglyceride Levels: Utilization of Variants in Multiple Genes	PLOS ONE			English	Article							HOLT-ORAM-SYNDROME; GENOME-WIDE SCAN; CHOLESTEROL LEVELS; NUCLEAR FAMILIES; COMBINED LINKAGE; TBX5 MUTATIONS; ASSOCIATION; OBESITY; PHENOTYPES; GENETICS	Background: For decades, research efforts have tried to uncover the underlying genetic basis of human susceptibility to a variety of diseases. Linkage studies have resulted in highly replicated findings and helped identify quantitative trait loci (QTL) for many complex traits; however identification of specific alleles accounting for linkage remains elusive. The purpose of this study was to determine whether with a sufficient number of variants a linkage signal can be fully explained. Method: We used comprehensive fine-mapping using a dense set of single nucleotide polymorphisms (SNPs) across the entire quantitative trait locus (QTL) on human chromosome 7q36 linked to plasma triglyceride levels. Analyses included measured genotype and combined linkage association analyses. Results: Screening this linkage region, we found an over representation of nominally significant associations in five genes (MLL3, DPP6, PAXIP1, HTR5A, INSIG1). However, no single genetic variant was sufficient to account for the linkage. On the other hand, multiple variants capturing the variation in these five genes did account for the linkage at this locus. Permutation analyses suggested that this reduction in LOD score was unlikely to have occurred by chance (p=0.008). Discussion: With recent findings, it has become clear that most complex traits are influenced by a large number of genetic variants each contributing only a small percentage to the overall phenotype. We found that with a sufficient number of variants, the linkage can be fully explained. The results from this analysis suggest that perhaps the failure to identify causal variants for linkage peaks may be due to multiple variants under the linkage peak with small individual effect, rather than a single variant of large effect.	[Martin, Lisa J.] Cincinnati Childrens Hosp Med Ctr, Div Human Genet, Cincinnati, OH USA; [Martin, Lisa J.] Univ Cincinnati, Dept Pediat, Sch Med, Cincinnati, OH 45221 USA; [Martin, Lisa J.] Cincinnati Childrens Hosp Med Ctr, Div Biostat & Epidemiol, Cincinnati, OH USA; [Kissebah, Ahmed H.; Olivier, Michael] Med Coll Wisconsin, Human & Mol Genet Ctr, Milwaukee, WI 53226 USA; [Kissebah, Ahmed H.] Med Coll Wisconsin, Dept Med, Milwaukee, WI 53226 USA; [Olivier, Michael] Med Coll Wisconsin, Biotechnol & Bioengn Ctr, Milwaukee, WI 53226 USA; [Olivier, Michael] Med Coll Wisconsin, Dept Physiol, Milwaukee, WI 53226 USA	Cincinnati Children's Hospital Medical Center; University of Cincinnati; Cincinnati Children's Hospital Medical Center; Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin	Martin, LJ (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Human Genet, Cincinnati, OH USA.	Lisa.martin@cchmc.org	Martin, Lisa/E-2425-2016	Martin, Lisa/0000-0001-8702-9946	Take Off Pounds Sensibly organization;  [R01 HL74168];  [R01 DK071895]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL074168] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071895] Funding Source: NIH RePORTER	Take Off Pounds Sensibly organization; ; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The Take Off Pounds Sensibly organization provided financial support. This work was supported in part by R01 HL74168 (MO) and R01 DK071895 (AHK). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almasy L, 2004, BEHAV GENET, V34, P173, DOI 10.1023/B:BEGE.0000013731.03827.69; Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; Banas SM, 2009, CELL MOL NEUROBIOL, V29, P157, DOI 10.1007/s10571-008-9307-9; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Boes E, 2009, EXP GERONTOL, V44, P136, DOI 10.1016/j.exger.2008.11.003; Carlton VEH, 2005, AM J HUM GENET, V77, P567, DOI 10.1086/468189; Cecil JE, 2005, DIABETOLOGIA, V48, P1496, DOI 10.1007/s00125-005-1817-0; Chen DL, 1999, J LIPID RES, V40, P1735; Chen MH, 2010, HUM HERED, V69, P104, DOI 10.1159/000264448; Cho YW, 2009, CELL METAB, V10, P27, DOI 10.1016/j.cmet.2009.05.010; Chung RH, 2007, GENET EPIDEMIOL, V31, P134, DOI 10.1002/gepi.20196; Das SK, 2004, DIABETES, V53, P3300, DOI 10.2337/diabetes.53.12.3300; Debeer P, 2007, CLIN ORTHOP RELAT R, P20, DOI 10.1097/BLO.0b013e3181123ffe; Dehghan A, 2011, CIRCULATION, V123, P731, DOI 10.1161/CIRCULATIONAHA.110.948570; Dong XY, 2010, PEPTIDES, V31, P2145, DOI 10.1016/j.peptides.2010.07.020; Duggirala R, 2000, AM J HUM GENET, V66, P1237, DOI 10.1086/302849; Ehret GB, 2009, EUR J HUM GENET, V17, P1650, DOI 10.1038/ejhg.2009.94; Elbein SC, 2009, DIABETES, V58, P268, DOI 10.2337/db08-0931; Falconer D. S., 1989, Introduction to quantitative genetics.; Fan RZ, 2003, EUR J HUM GENET, V11, P125, DOI 10.1038/sj.ejhg.5200941; Florez JC, 2008, J CLIN ENDOCR METAB, V93, P4633, DOI 10.1210/jc.2008-1345; Frazer KA, 2009, NAT REV GENET, V10, P241, DOI 10.1038/nrg2554; Fulker DW, 1999, AM J HUM GENET, V64, P259, DOI 10.1086/302193; Hebebrand J, 2010, OBESITY FACTS, V3, P294, DOI 10.1159/000321537; Hinney A, 2010, EUR CHILD ADOLES PSY, V19, P297, DOI 10.1007/s00787-010-0096-6; Kaulin YA, 2009, J NEUROSCI, V29, P3242, DOI 10.1523/JNEUROSCI.4767-08.2009; Kissebah AH, 2000, P NATL ACAD SCI USA, V97, P14478, DOI 10.1073/pnas.97.26.14478; Lee J, 2008, P NATL ACAD SCI USA, V105, P19229, DOI 10.1073/pnas.0810100105; Levin AM, 2008, CANCER RES, V68, P6492, DOI 10.1158/0008-5472.CAN-08-0348; Li WD, 2005, J LIPID RES, V46, P432, DOI 10.1194/jlr.M400391-JLR200; Lillioja S, 2009, DIABETOLOGIA, V52, P1061, DOI 10.1007/s00125-009-1324-9; Lin JP, 2003, BMC GENET, V4, DOI 10.1186/1471-2156-4-S1-S47; Lommatzsch ST, 2009, SEMIN RESP CRIT CARE, V30, P531, DOI 10.1055/s-0029-1238911; Love-Gregory L, 2007, CURR OPIN CLIN NUTR, V10, P397, DOI 10.1097/MCO.0b013e3281e3888d; Marx J, 2002, SCIENCE, V296, P686, DOI 10.1126/science.296.5568.686; McCarthy S, 2005, HUM GENET, V117, P545, DOI 10.1007/s00439-005-1328-6; Mori AD, 2004, CURR OPIN CARDIOL, V19, P211, DOI 10.1097/00001573-200405000-00004; Nadin BM, 2010, J NEUROSCI, V30, P8551, DOI 10.1523/JNEUROSCI.5489-09.2010; Pullinger Clive R, 2003, Expert Rev Cardiovasc Ther, V1, P107, DOI 10.1586/14779072.1.1.107; Shearman AM, 2000, HUM MOL GENET, V9, P1315, DOI 10.1093/hmg/9.9.1315; Siegmund KD, 2001, GENET EPIDEMIOL, V21, pS358, DOI 10.1002/gepi.2001.21.s1.s358; Smith EM, 2010, J LIPID RES, V51, P701, DOI 10.1194/jlr.M001404; Sonnenberg GE, 2004, J LIPID RES, V45, P610, DOI 10.1194/jlr.M300474-JLR200; Sun X, 2011, AM J PHYSL GASTROINT; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; The International HapMap Consortium, 2005, NATURE, V437, P1299, DOI DOI 10.1038/NATURE04226; Zhang Y, 2010, PHYSL GENOMICS	47	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2012	7	4							e34614	10.1371/journal.pone.0034614	http://dx.doi.org/10.1371/journal.pone.0034614			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952GU	22485179	Green Published, Green Submitted, gold			2022-12-27	WOS:000304780500054
J	Sandoval-Comte, A; Pineda, E; Aguilar-Lopez, JL				Sandoval-Comte, Adriana; Pineda, Eduardo; Aguilar-Lopez, Jose L.			In Search of Critically Endangered Species: The Current Situation of Two Tiny Salamander Species in the Neotropical Mountains of Mexico	PLOS ONE			English	Article							PLETHODONTID SALAMANDERS; POPULATIONS; DECLINES; CONSERVATION; TRENDS; TOOL	Worldwide, one in every three species of amphibian is endangered, 39 species have gone extinct in the last 500 years and another 130 species are suspected to have gone extinct in recent decades. Of the amphibians, salamanders have the highest portion of their species in one of the risk categories, even higher than the frogs. To date there have been few studies that have used recent field data to examine the status of populations of endangered salamanders. In this study we evaluate the current situation of two tiny salamanders, Parvimolge townsendi and Thorius pennatulus, both of which are distributed at intermediate elevations in the mountains of the northern Neotropics and are considered to be critically endangered; the first has been proposed as possibly extinct. By carrying out exhaustive surveys in both historical and potentially suitable sites for these two species, we evaluated their abundance and the characteristics of their habitats, and estimated their potential geographic distribution. We visited 22 sites, investing 672 person-hours of sampling effort in he surveys, and found 201 P. townsendi salamanders in 11 sites and only 13 T. pennatulus salamanders in 5 sites. Both species were preferentially found in cloud forest fragments that were well conserved or only moderately transformed, and some of the salamanders were found in shade coffee plantations. The potential distribution area of both species is markedly fragmented and we estimate that it has decreased by more than 48%. The results of this study highlight the importance of carrying out exhaustive, systematic field surveys to obtain accurate information about the current situation of critically endangered species, and help us better understand the crisis that amphibians are facing worldwide.	[Sandoval-Comte, Adriana; Pineda, Eduardo; Aguilar-Lopez, Jose L.] AC, Inst Ecol, Xalapa, Veracruz, Mexico	Instituto de Ecologia - Mexico	Sandoval-Comte, A (corresponding author), AC, Inst Ecol, Xalapa, Veracruz, Mexico.	eduardo.pineda@inecol.edu.mx	Pineda, Eduardo/N-5254-2014; Sandoval-Comte, Adriana/R-4575-2018	Pineda, Eduardo/0000-0002-1997-9576; Sandoval-Comte, Adriana/0000-0002-2265-465X	CONACyT (Consejo Nacional de Ciencia y Tecnologia) [336197, 23588]; CONABIO (Comision Nacional para el Conocimiento y Uso de la Biodiversidad) [HK006]; INECOL	CONACyT (Consejo Nacional de Ciencia y Tecnologia)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); CONABIO (Comision Nacional para el Conocimiento y Uso de la Biodiversidad); INECOL	Adriana Sandoval-Comte was supported by CONACyT (Consejo Nacional de Ciencia y Tecnologia) (grant 336197). Fondo SEMARNAT-CONACyT (project 23588) and CONABIO (Comision Nacional para el Conocimiento y Uso de la Biodiversidad) (project HK006) provided support for this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We gratefully acknowledge the contributions of Octavio Rojas-Soto, Luis Canseco-Marquez and Sean M. Rovito who made valuable comments on this study. Rene. Murrieta, Matthias Ros and Jose Manuel Serrano provided the geographic references for some of the specimens collected. Flor Vazquez, Carolina Madero, Antonio Vazquez, Policarpo Ronzon, Luis Carrillo, Nelson Ceron, Ricardo Luria and all who helped with the field work. Roberto Monroy provided advice on editing the maps. Bianca Delfosse translated the text of the manuscript from the original in Spanish and offered valuable suggestions, and one anonymous reviewer offered comments that improved the manuscript. The owners of several properties (Finca Kassandra, Rancho Alamor, Rancho San Gabriel, Granja Avicola Los Naranjos and Rancho La Mesa) kindly allowed us to sample on their land. To the Graduate Studies program of the INECOL for support provided.	[Anonymous], 2004, STATISTICA VERS 7 DA; Ash AN, 1997, CONSERV BIOL, V11, P983, DOI 10.1046/j.1523-1739.1997.96172.x; Bailey LL, 2004, ECOL APPL, V14, P692, DOI 10.1890/03-5012; Canseco-MuYrquez L., 2006, INVENTARIOS HERPETOF, P180; Castillo-Campos G, 2011, BIODIVERSIDAD ESTADO, P159; Cheng TL, 2011, P NATL ACAD SCI USA, V108, P9502, DOI 10.1073/pnas.1105538108; Conservation International, 2011, GLOB SEARCH LOST FRO; COPE ED, 1869, P ACAD NAT SCI PHILA, V21, P93; Dunn E. R., 1922, Proceedings of the Biological Society of Washington, V35, P5; ESRI, 1998, AREVIEW GIS VERS 3 2; Frias-Alvarez P, 2010, BIODIVERS CONSERV, V19, P3699, DOI 10.1007/s10531-010-9923-9; Frost DR, 2011, AMPHIBIAN SPECIES WO; Hanken J, 1998, COPEIA, P312; Herbeck LA, 1999, CONSERV BIOL, V13, P623, DOI 10.1046/j.1523-1739.1999.98097.x; Hijmans R.J., WORLDCLIM; Korhonen L, 2006, SILVA FENN, V40, P577, DOI 10.14214/sf.315; Lips KR, 2006, P NATL ACAD SCI USA, V103, P3165, DOI 10.1073/pnas.0506889103; Martinez-Gordillo D, 2010, J EVOLUTION BIOL, V23, P259, DOI 10.1111/j.1420-9101.2009.01897.x; Murrieta-Galindo R, 2007, DIVERSIDAD ANFIBIOS; Ochoa-Ochoa L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006878; Ochoa-Ochoa LM, 2011, BIOL CONSERV, V144, P2710, DOI 10.1016/j.biocon.2011.07.032; Papenfuss TJ, 2010, FROGLOG, V93, P1; Parra-Olea G, 1999, REV BIOL TROP, V47, P217; Parra-Olea G, 2008, THORIUS PENNATULUS, V2008; Parra-Olea G, 2008, PARVIMOLGE TOWNSENDI; PECHMANN JHK, 1991, SCIENCE, V253, P892, DOI 10.1126/science.253.5022.892; Phillips S.J, 2004, P 21 INT C MACH LEAR, P83, DOI [10.1145/1015330.1015412, DOI 10.1145/1015330.1015412]; Raffaclli J, 2007, URODELES MONDE; Rasband W., 2006, IMAGEJ; Rivera M., 2021, IUCN RED LIST THREAT, DOI DOI 10.2305/IUCN.UK.2020-3.RLTS.T22678711A183481909.EN; Rojas-Soto OR, 2008, J FIELD ORNITHOL, V79, P245, DOI 10.1111/j.1557-9263.2008.00170.x; Rovito SM, 2009, P NATL ACAD SCI USA, V106, P3231, DOI 10.1073/pnas.0813051106; Scheffers BR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022531; SEDESMA, 2006, PROGR MAN AR NAT MAR; SEMARNAT (Secretaria del Medio Ambiente y Recursos Naturales), 2010, NORM OF MEX NOM 059; Stuart S. N., 2008, THREATENED AMPHIBIAN; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Wake D.B., 1976, NAT HIST MUS LOS ANG, V25, P1; Wake David B., 1992, Tulane Studies in Zoology and Botany Supplementary Publication, V1, P303; WAKE DB, 1987, ANN MO BOT GARD, V74, P242, DOI 10.2307/2399397; Welsh HH, 2001, CONSERV BIOL, V15, P558, DOI 10.1046/j.1523-1739.2001.015003558.x; Whitfield SM, 2007, P NATL ACAD SCI USA, V104, P8352, DOI 10.1073/pnas.0611256104; Zar JH., 1999, BIOL STAT	43	11	13	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2012	7	4							e34023	10.1371/journal.pone.0034023	http://dx.doi.org/10.1371/journal.pone.0034023			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952GU	22485155	Green Published, Green Submitted, gold			2022-12-27	WOS:000304780500031
J	Thornton, E; Vink, R				Thornton, Emma; Vink, Robert			Treatment with a Substance P Receptor Antagonist Is Neuroprotective in the Intrastriatal 6-Hydroxydopamine Model of Early Parkinson's Disease	PLOS ONE			English	Article							NEUROKININ-3 RECEPTORS; BASAL GANGLIA; IN-VIVO; MICROGLIAL ACTIVATION; FUNCTIONAL DEFICITS; OXIDATIVE STRESS; DOPAMINE; DEGENERATION; ASTROCYTES; NIGRA	Neuroinflammation and blood brain barrier (BBB) dysfunction have been implicated in the pathogenesis of Parkinson's disease (PD). The neuropeptide substance P (SP) is an important mediator of both neuroinflammation and BBB dysfunction through its NK1 receptor in a process known as neurogenic inflammation. Increased SP content has previously been reported following 6-OHDA treatment in vitro, with the levels of SP correlating with cell death. The present study used an in vivo 6-OHDA lesion model to determine if dopaminergic degeneration was associated with increased SP in the substantia nigra and whether this degeneration could be prevented by using a SP, NK1 receptor antagonist Unilateral, intrastriatal 6-OHDA lesions were induced and SP (10 mu g/2 mu L) or the NK1 receptor antagonists, N-acetyl-L-tryptophan (2 mu L at 50 nM) or L-333,060 (2 mu L at 100 nM), administered immediately after the neurotoxin. Nigral SP content was then determined using immunohistochemical and ELISA methods, neuroinflammation and barrier integrity was assessed using Iba-1, ED-1, GFAP and albumin immunohistochemistry, while dopaminergic cell loss was assessed with tyrosine hydroxylase immunohistochemistry. Motor function in all animals was assessed using the rotarod task. Intrastriatal 6-OHDA lesioning produced an early and sustained increase in ipsilateral nigral SP content, along with a breakdown of the BBB and activation of microglia and astrocytes. Further exacerbation of SP levels accelerated disease progression, whereas NK1 receptor antagonist treatment protected dopaminergic neurons, preserved barrier integrity, reduced neuroinflammation and significantly improved motor function. We propose that neurogenic inflammation contributes to dopaminergic degeneration in early experimental PD and demonstrate that an NK1 receptor antagonist may represent a novel neuroprotective therapy.	[Thornton, Emma; Vink, Robert] Univ Adelaide, Sch Med Sci, Adelaide Ctr Neurosci Res, Adelaide, SA, Australia	University of Adelaide	Thornton, E (corresponding author), Univ Adelaide, Sch Med Sci, Adelaide Ctr Neurosci Res, Adelaide, SA, Australia.	Robert.Vink@adelaide.edu.au	Vink, Robert/S-5616-2019; Vink, Robert/J-7351-2012; Emery, Kitty/B-5850-2011; Speller, Camilla/D-2830-2014	Vink, Robert/0000-0002-4885-0667; Vink, Robert/0000-0002-4885-0667; Emery, Kitty/0000-0002-4031-1968; Speller, Camilla/0000-0001-7128-9903	Neurosurgical Research Foundation, Adelaide, Australia	Neurosurgical Research Foundation, Adelaide, Australia	This study was funded, in part, by the Neurosurgical Research Foundation, Adelaide, Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Alves G, 2008, J NEUROL, V255, P18, DOI 10.1007/s00415-008-5004-3; BANNON MJ, 1995, BRAIN RES, V695, P19, DOI 10.1016/0006-8993(95)00791-N; Bartels AL, 2008, J NEURAL TRANSM, V115, P1001, DOI 10.1007/s00702-008-0030-y; BEAL MF, 1992, FASEB J, V6, P3338, DOI 10.1096/fasebj.6.15.1464368; Bevan MD, 1996, NEUROSCIENCE, V75, P5, DOI 10.1016/0306-4522(96)00377-6; Bishop C, 2004, BRAIN RES, V1023, P126, DOI 10.1016/j.brainres.2004.07.039; Block ML, 2006, FASEB J, V20, P251, DOI 10.1096/fj.05-4553com; Blum D, 2001, PROG NEUROBIOL, V65, P135, DOI 10.1016/S0301-0082(01)00003-X; Brahmachari S, 2006, J NEUROSCI, V26, P4930, DOI 10.1523/JNEUROSCI.5480-05.2006; Brochard V, 2009, J CLIN INVEST, V119, P182, DOI 10.1172/JCI36470; Carson MJ, 2006, CLIN NEUROSCI RES, V6, P237, DOI 10.1016/j.cnr.2006.09.004; Chen LW, 2004, CURR DRUG TARGETS, V5, P197, DOI 10.2174/1389450043490596; Chung YC, 2010, BMB REP, V43, P225, DOI 10.5483/BMBRep.2010.43.4.225; De Ceballos ML, 1999, PEPTIDES, V20, P249, DOI 10.1016/S0196-9781(98)00177-6; Depino AM, 2003, EUR J NEUROSCI, V18, P2731, DOI 10.1111/j.1460-9568.2003.03014.x; Deumens R, 2002, EXP NEUROL, V175, P303, DOI 10.1006/exnr.2002.7891; Donkin JJ, 2009, J CEREBR BLOOD F MET, V29, P1388, DOI 10.1038/jcbfm.2009.63; FERNANDEZ A, 1994, NEUROSCIENCE, V61, P73, DOI 10.1016/0306-4522(94)90061-2; Gao HM, 2002, J NEUROCHEM, V81, P1285, DOI 10.1046/j.1471-4159.2002.00928.x; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; Harrison S, 2001, INT J BIOCHEM CELL B, V33, P555, DOI 10.1016/S1357-2725(01)00031-0; Helps SC, 2012, APPL IMMUNOHISTO M M, V20, P82, DOI 10.1097/PAI.0b013e31821fc8cd; Hirsch EC, 2000, J NEUROL, V247, P58, DOI 10.1007/PL00007762; Ionov ID, 2008, INT J NEUROSCI, V118, P1763, DOI 10.1080/00207450802330561; Ji KA, 2008, GLIA, V56, P1039, DOI 10.1002/glia.20677; Kortekaas R, 2005, ANN NEUROL, V57, P176, DOI 10.1002/ana.20369; Lee CS, 1996, NEUROSCIENCE, V72, P641, DOI 10.1016/0306-4522(95)00571-4; Levesque M, 2007, NEUROSCI RES, V57, P362, DOI 10.1016/j.neures.2006.11.002; Lin RCS, 1995, NEUROREPORT, V7, P310, DOI 10.1097/00001756-199512000-00074; Liu B, 2003, J PHARMACOL EXP THER, V304, P1, DOI 10.1124/jpet.102.035048; MANTYH PW, 1989, P NATL ACAD SCI USA, V86, P5193, DOI 10.1073/pnas.86.13.5193; Marriott I, 2004, FRONT BIOSCI-LANDMRK, V9, P2153, DOI 10.2741/1377; Marti M, 2005, J NEUROCHEM, V93, P195, DOI 10.1111/j.1471-4159.2005.03015.x; MAUBORGNE A, 1983, BRAIN RES, V268, P167, DOI 10.1016/0006-8993(83)90403-1; McGeer PL, 2008, MOVEMENT DISORD, V23, P474, DOI 10.1002/mds.21751; Mosley RL, 2006, CLIN NEUROSCI RES, V6, P261, DOI 10.1016/j.cnr.2006.09.006; Nimmo AJ, 2004, NEUROPEPTIDES, V38, P40, DOI 10.1016/j.npep.2003.12.003; NISBET AP, 1995, NEUROSCIENCE, V66, P361, DOI 10.1016/0306-4522(94)00606-6; Ogura T, 2005, NEUROSCI RES, V51, P299, DOI 10.1016/j.neures.2004.12.006; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; REID MS, 1990, EXP BRAIN RES, V82, P293; Rite I, 2007, J NEUROCHEM, V101, P1567, DOI 10.1111/j.1471-4159.2007.04567.x; Rock RB, 2006, J NEUROIMMUNE PHARM, V1, P117, DOI 10.1007/s11481-006-9012-8; Rodriguez MC, 1998, ANN NEUROL, V44, pS175, DOI 10.1002/ana.410440726; Schwarting RKW, 1996, PROG NEUROBIOL, V49, P215, DOI 10.1016/S0301-0082(96)00015-9; Shults CW, 2004, MITOCHONDRION, V4, P641, DOI 10.1016/j.mito.2004.07.028; SIVAM SP, 1991, NEUROPEPTIDES, V18, P201, DOI 10.1016/0143-4179(91)90148-C; Takagi S, 2007, J NEURAL TRANSM, V114, P1553, DOI 10.1007/s00702-007-0790-9; Teismann P, 2004, CELL TISSUE RES, V318, P149, DOI 10.1007/s00441-004-0944-0; TENOVUO O, 1984, BRAIN RES, V303, P113, DOI 10.1016/0006-8993(84)90217-8; Thornton E, 2010, NEUROSCI LETT, V481, P64, DOI 10.1016/j.neulet.2010.06.057; Turner RJ, 2011, BRAIN RES, V1393, P84, DOI 10.1016/j.brainres.2011.03.066; UKAI M, 1995, PHARMACOL BIOCHEM BE, V51, P705, DOI 10.1016/0091-3057(95)00010-T; Vink R, 2010, NEUROTHERAPEUTICS, V7, P74, DOI 10.1016/j.nurt.2009.10.018; Wojtera M, 2005, FOLIA NEUROPATHOL, V43, P311	56	67	71	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2012	7	4							e34138	10.1371/journal.pone.0034138	http://dx.doi.org/10.1371/journal.pone.0034138			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952GU	22905156	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000304780500034
J	Savory, EA; Zou, C; Adhikari, BN; Hamilton, JP; Buell, CR; Shiu, SH; Day, B				Savory, Elizabeth A.; Zou, Cheng; Adhikari, Bishwo N.; Hamilton, John P.; Buell, C. Robin; Shiu, Shin-Han; Day, Brad			Alternative Splicing of a Multi-Drug Transporter from Pseudoperonospora cubensis Generates an RXLR Effector Protein That Elicits a Rapid Cell Death	PLOS ONE			English	Review							PHYTOPHTHORA-SOJAE; GENOME SEQUENCE; AVIRULENCE; ARABIDOPSIS; EXPRESSION; EVOLUTION; GENES; LOCUS; POLYMORPHISMS; MECHANISMS	Pseudoperonospora cubensis, an obligate oomycete pathogen, is the causal agent of cucurbit downy mildew, a foliar disease of global economic importance. Similar to other oomycete plant pathogens, Ps. cubensis has a suite of RXLR and RXLR-like effector proteins, which likely function as virulence or avirulence determinants during the course of host infection. Using in silico analyses, we identified 271 candidate effector proteins within the Ps. cubensis genome with variable RXLR motifs. In extending this analysis, we present the functional characterization of one Ps. cubensis effector protein, RXLR protein 1 (PscRXLR1), and its closest Phytophthora infestans ortholog, PITG_17484, a member of the Drug/Metabolite Transporter (DMT) superfamily. To assess if such effector-non-effector pairs are common among oomycete plant pathogens, we examined the relationship(s) among putative ortholog pairs in Ps. cubensis and P. infestans. Of 271 predicted Ps. cubensis effector proteins, only 109 (41%) had a putative ortholog in P. infestans and evolutionary rate analysis of these orthologs shows that they are evolving significantly faster than most other genes. We found that PscRXLR1 was up-regulated during the early stages of infection of plants, and, moreover, that heterologous expression of PscRXLR1 in Nicotiana benthamiana elicits a rapid necrosis. More interestingly, we also demonstrate that PscRXLR1 arises as a product of alternative splicing, making this the first example of an alternative splicing event in plant pathogenic oomycetes transforming a non-effector gene to a functional effector protein. Taken together, these data suggest a role for PscRXLR1 in pathogenicity, and, in total, our data provide a basis for comparative analysis of candidate effector proteins and their non-effector orthologs as a means of understanding function and evolutionary history of pathogen effectors.	[Savory, Elizabeth A.; Day, Brad] Michigan State Univ, Dept Plant Pathol, E Lansing, MI 48824 USA; [Zou, Cheng; Adhikari, Bishwo N.; Hamilton, John P.; Buell, C. Robin; Shiu, Shin-Han] Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA	Michigan State University; Michigan State University	Savory, EA (corresponding author), Michigan State Univ, Dept Plant Pathol, E Lansing, MI 48824 USA.	bday@msu.edu	Shiu, Shin-Han/R-6117-2016; Hamilton, John P/G-1379-2016	Shiu, Shin-Han/0000-0001-6470-235X; Hamilton, John P/0000-0002-8682-5526; Buell, C Robin/0000-0002-6727-4677; Adhikari, Bishwo/0000-0003-4840-9609; Savory, Elizabeth/0000-0002-6016-9962; zou, cheng/0000-0001-9325-9465; Day, Brad/0000-0002-9880-4319; Vaillancourt, Brieanne/0000-0002-6795-5173	National Science Foundation [IOS-0641319]; United States Department of Agriculture Agriculture and Food Research Initiative (AFRI)	National Science Foundation(National Science Foundation (NSF)); United States Department of Agriculture Agriculture and Food Research Initiative (AFRI)	Work in the laboratory of BD is supported by a grant from the National Science Foundation (IOS-0641319). EAS is supported by a United States Department of Agriculture Agriculture and Food Research Initiative (AFRI) pre-doctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen RL, 2004, SCIENCE, V306, P1957, DOI 10.1126/science.1104022; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Armstrong MR, 2005, P NATL ACAD SCI USA, V102, P7766, DOI 10.1073/pnas.0500113102; Baxter L, 2010, SCIENCE, V330, P1549, DOI 10.1126/science.1195203; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bos JIB, 2006, PLANT J, V48, P165, DOI 10.1111/j.1365-313X.2006.02866.x; Cantarel BL, 2008, GENOME RES, V18, P188, DOI 10.1101/gr.6743907; Chandran D, 2009, PLANT PHYSIOL, V149, P1435, DOI 10.1104/pp.108.132985; Chaparro-Garcia A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016608; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; Costanzo S, 2007, CURR GENET, V52, P115, DOI 10.1007/s00294-007-0144-z; de Wit PJGM, 2009, MOL PLANT PATHOL, V10, P735, DOI 10.1111/j.1364-3703.2009.00591.x; Dong SM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005556; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Franke I, 2003, J BACTERIOL, V185, P1161, DOI 10.1128/JB.185.4.1161-1166.2003; Gurlebeck D, 2009, MOL PLANT PATHOL, V10, P175, DOI 10.1111/j.1364-3703.2008.00519.x; Haas BJ, 2009, NATURE, V461, P393, DOI 10.1038/nature08358; Halterman DA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010536; Huang SW, 2009, NAT GENET, V41, P1275, DOI 10.1038/ng.475; Jack DL, 2001, EUR J BIOCHEM, V268, P3620, DOI 10.1046/j.1432-1327.2001.02265.x; Jacobs KA, 1997, GENE, V198, P289, DOI 10.1016/S0378-1119(97)00330-2; Jiang RHY, 2008, P NATL ACAD SCI USA, V105, P4874, DOI 10.1073/pnas.0709303105; Jin P, 2003, PLANT PHYSIOL, V133, P1072, DOI 10.1104/pp.103.025999; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kamoun S, 2006, ANNU REV PHYTOPATHOL, V44, P41, DOI 10.1146/annurev.phyto.44.070505.143436; Keren H, 2010, NAT REV GENET, V11, P345, DOI 10.1038/nrg2776; Knepper C, 2011, PLANT PHYSIOL, V156, P286, DOI 10.1104/pp.110.169656; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Levesque CA, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-7-r73; Liu TL, 2011, PLANT PHYSIOL, V155, P490, DOI 10.1104/pp.110.166470; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Mansfield JW, 2009, MOL PLANT PATHOL, V10, P721, DOI 10.1111/j.1364-3703.2009.00576.x; Matlin AJ, 2005, NAT REV MOL CELL BIO, V6, P386, DOI 10.1038/nrm1645; Nelson BK, 2007, PLANT J, V51, P1126, DOI 10.1111/j.1365-313X.2007.03212.x; Oh SK, 2009, PLANT CELL, V21, P2928, DOI 10.1105/tpc.109.068247; Qutob D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005066; Rafiqi M, 2010, PLANT CELL, V22, P2017, DOI 10.1105/tpc.109.072983; Rehmany AP, 2005, PLANT CELL, V17, P1839, DOI 10.1105/tpc.105.031807; Salamov AA, 2000, GENOME RES, V10, P516, DOI 10.1101/gr.10.4.516; Savory EA, 2011, MOL PLANT PATHOL, V12, P217, DOI 10.1111/j.1364-3703.2010.00670.x; Schornack S, 2010, P NATL ACAD SCI USA, V107, P17421, DOI 10.1073/pnas.1008491107; Schornack S, 2009, MOL PLANT PATHOL, V10, P795, DOI 10.1111/j.1364-3703.2009.00593.x; Shan LB, 2000, PLANT CELL, V12, P2323, DOI 10.1105/tpc.12.12.2323; Shan WX, 2004, MOL PLANT MICROBE IN, V17, P394, DOI 10.1094/MPMI.2004.17.4.394; Shen DY, 2011, CAN J MICROBIOL, V57, P84, DOI [10.1139/W10-103, 10.1139/w10-103]; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tang HB, 2008, GENOME RES, V18, P1944, DOI 10.1101/gr.080978.108; Tian MY, 2011, MOL PLANT MICROBE IN, V24, P543, DOI 10.1094/MPMI-08-10-0185; Torto TA, 2003, GENOME RES, V13, P1675, DOI 10.1101/gr.910003; Tyler BM, 2006, SCIENCE, V313, P1261, DOI 10.1126/science.1128796; Whisson SC, 2007, NATURE, V450, P115, DOI 10.1038/nature06203; Win J, 2006, FUNGAL GENET BIOL, V43, P20, DOI 10.1016/j.fgb.2005.10.003; Win J, 2007, PLANT CELL, V19, P2349, DOI 10.1105/tpc.107.051037; Win J, 2011, METHODS MOL BIOL, V712, P181, DOI 10.1007/978-1-61737-998-7_15; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	60	45	46	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2012	7	4							e34701	10.1371/journal.pone.0034701	http://dx.doi.org/10.1371/journal.pone.0034701			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955IH	22545137	Green Published, gold, Green Submitted			2022-12-27	WOS:000305010500024
J	Moriya, J; Sugiura, Y				Moriya, Jun; Sugiura, Yoshinori			Impaired Attentional Disengagement from Stimuli Matching the Contents of Working Memory in Social Anxiety	PLOS ONE			English	Article							THREAT-RELATED STIMULI; SELECTIVE ATTENTION; TRAIT ANXIETY; VISUAL-ATTENTION; COGNITIVE CONTROL; INDIVIDUAL-DIFFERENCES; PROCESSING EFFICIENCY; NEURAL MECHANISMS; PERCEPTUAL LOAD; EMOTIONAL FACES	Although many cognitive models in anxiety propose that an impaired top-down control enhances the processing of task-irrelevant stimuli, few studies have paid attention to task-irrelevant stimuli under a cognitive load task. In the present study, we investigated the effects of the working memory load on attention to task-irrelevant stimuli in trait social anxiety. The results showed that as trait social anxiety increased, participants were unable to disengage from task-irrelevant stimuli identical to the memory cue under low and high working memory loads. Impaired attentional disengagement was positively correlated with trait social anxiety. This impaired attentional disengagement was related to trait social anxiety, but not state anxiety. Our findings suggest that socially anxious people have difficulty in disengaging attention from a task-irrelevant memory cue owing to an impaired top-down control under a working memory load.	[Moriya, Jun; Sugiura, Yoshinori] Hiroshima Univ, Sch Integrated Arts & Sci, Hiroshima, Japan; [Moriya, Jun] Univ Ghent, Dept Expt Clin & Hlth Psychol, B-9000 Ghent, Belgium	Hiroshima University; Ghent University	Moriya, J (corresponding author), Hiroshima Univ, Sch Integrated Arts & Sci, Hiroshima, Japan.	Jun.Moriya@UGent.be		Moriya, Jun/0000-0001-5148-0014	JSPS Fellowship [10J06078]; Grants-in-Aid for Scientific Research [23530901, 10J06078] Funding Source: KAKEN	JSPS Fellowship(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for JSPS Fellowship (10J06078). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez GA, 2004, PSYCHOL SCI, V15, P106, DOI 10.1111/j.0963-7214.2004.01502006.x; Amir N, 2003, BEHAV RES THER, V41, P1325, DOI 10.1016/S0005-7967(03)00039-1; Amir N, 2011, J ABNORM PSYCHOL, V120, P504, DOI 10.1037/a0022849; Awh E, 2007, PSYCHOL SCI, V18, P622, DOI 10.1111/j.1467-9280.2007.01949.x; Bar-Haim Y, 2007, PSYCHOL BULL, V133, P1, DOI 10.1037/0033-2909.133.1.1; Bar-Haim Y, 2011, J CHILD PSYCHOL PSYC, V52, P861, DOI 10.1111/j.1469-7610.2011.02368.x; Berggren N, 2012, J COGN PSYCHOL, V24, P79, DOI 10.1080/20445911.2011.618450; Bishop S, 2004, NAT NEUROSCI, V7, P184, DOI 10.1038/nn1173; Bishop SJ, 2004, J NEUROSCI, V24, P10364, DOI 10.1523/JNEUROSCI.2550-04.2004; Bishop SJ, 2008, ANN NY ACAD SCI, V1129, P141, DOI 10.1196/annals.1417.016; Bishop SJ, 2007, TRENDS COGN SCI, V11, P307, DOI 10.1016/j.tics.2007.05.008; Bishop SJ, 2007, CEREB CORTEX, V17, P1595, DOI 10.1093/cercor/bhl070; Bishop SJ, 2009, NAT NEUROSCI, V12, P92, DOI 10.1038/nn.2242; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Carlisle NB, 2011, J COGNITIVE NEUROSCI, V23, P2650, DOI 10.1162/jocn.2011.21602; Cisler JM, 2010, CLIN PSYCHOL REV, V30, P203, DOI 10.1016/j.cpr.2009.11.003; Cisler JM, 2009, COGNITIVE THER RES, V33, P221, DOI 10.1007/s10608-007-9161-y; Dalvit S, 2011, VIS COGN, V19, P145, DOI 10.1080/13506285.2010.543441; de Fockert JW, 2001, SCIENCE, V291, P1803, DOI 10.1126/science.1056496; Derakshan N., BIOL PSYCHOL; Derakshan N, 2010, BEHAV RES THER, V48, P1180, DOI 10.1016/j.brat.2010.08.009; Derakshan N, 2009, EUR PSYCHOL, V14, P168, DOI 10.1027/1016-9040.14.2.168; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Downing PE, 2000, PSYCHOL SCI, V11, P467, DOI 10.1111/1467-9280.00290; Eysenck MW, 2007, EMOTION, V7, P336, DOI 10.1037/1528-3542.7.2.336; Fales CL, 2010, COGNITION EMOTION, V24, P200, DOI 10.1080/02699930903384691; Fox E, 2002, COGNITION EMOTION, V16, P355, DOI 10.1080/02699930143000527; Fox E, 2001, J EXP PSYCHOL GEN, V130, P681, DOI 10.1037/0096-3445.130.4.681; Fox E, 2010, BIOL PSYCHIAT, V67, P371, DOI 10.1016/j.biopsych.2009.11.018; Fukuda K, 1973, Seishin Shinkeigaku Zasshi, V75, P673; Georgiou GA, 2005, VIS COGN, V12, P145, DOI 10.1080/13506280444000076; Han SW, 2009, J EXP PSYCHOL HUMAN, V35, P1292, DOI 10.1037/a0016452; Kanai Y., 2004, JPN J PSYCHOSOM MED, V44, P841, DOI DOI 10.15064/JJPM.44.11_; Kastner S, 2000, ANNU REV NEUROSCI, V23, P315, DOI 10.1146/annurev.neuro.23.1.315; Koster EHW, 2004, BEHAV RES THER, V42, P1183, DOI 10.1016/j.brat.2003.08.001; Koster EHW, 2006, BEHAV RES THER, V44, P1757, DOI 10.1016/j.brat.2005.12.011; Ladouceur CD, 2009, EMOTION, V9, P855, DOI 10.1037/a0017747; Lavie N, 2005, TRENDS COGN SCI, V9, P75, DOI 10.1016/j.tics.2004.12.004; Lavie N, 2004, J EXP PSYCHOL GEN, V133, P339, DOI 10.1037/0096-3445.133.3.339; Lavie N, 2006, VIS COGN, V14, P863, DOI 10.1080/13506280500195953; Lavie N, 2010, CURR DIR PSYCHOL SCI, V19, P143, DOI 10.1177/0963721410370295; LEARY MR, 1983, PERS SOC PSYCHOL B, V9, P371, DOI 10.1177/0146167283093007; Luck SJ, 1997, NATURE, V390, P279, DOI 10.1038/36846; MacLeod C, 2002, J ABNORM PSYCHOL, V111, P107, DOI 10.1037//0021-843X.111.1.107; Mattick RP, 1998, BEHAV RES THER, V36, P455, DOI 10.1016/S0005-7967(97)10031-6; Mogg K, 1998, BEHAV RES THER, V36, P809, DOI 10.1016/S0005-7967(98)00063-1; Moriya J, 2008, PERS INDIV DIFFER, V44, P1348, DOI 10.1016/j.paid.2007.12.003; Moriya J, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0034244, 10.1371/journal.pone.0047221]; Moriya J, 2011, ACTA PSYCHOL, V138, P162, DOI 10.1016/j.actpsy.2011.05.019; Moriya J, 2010, COGNITION EMOTION, V24, P1329, DOI 10.1080/02699930903378503; Moriya J, 2011, J BEHAV THER EXP PSY, V42, P122, DOI 10.1016/j.jbtep.2010.08.001; Moriya J, 2009, EMOTION, V9, P739, DOI 10.1037/a0016817; Moser JS, 2012, EMOTION, V12, P213, DOI 10.1037/a0026156; Notebaert L, 2010, BEHAV RES THER, V48, P1150, DOI 10.1016/j.brat.2010.07.013; Olivers CNL, 2011, TRENDS COGN SCI, V15, P327, DOI 10.1016/j.tics.2011.05.004; Olivers CNL, 2009, J EXP PSYCHOL HUMAN, V35, P1275, DOI 10.1037/a0013896; Pan Y, 2010, VISION RES, V50, P1437, DOI 10.1016/j.visres.2009.10.016; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Pacheco-Unguetti AP, 2011, J ANXIETY DISORD, V25, P888, DOI 10.1016/j.janxdis.2011.04.010; Pacheco-Unguetti AP, 2010, PSYCHOL SCI, V21, P298, DOI 10.1177/0956797609359624; Sadeh N, 2011, COGNITION EMOTION, V25, P747, DOI 10.1080/02699931.2010.500566; Salemink E, 2007, BEHAV RES THER, V45, P607, DOI 10.1016/j.brat.2006.04.004; Sasagawa S., 2004, JPN J BEHAV THER, V30, P87, DOI DOI 10.24468/JJBT.30.2_; See J, 2009, J ABNORM PSYCHOL, V118, P65, DOI 10.1037/a0014377; Shackman AJ, 2006, EMOTION, V6, P40, DOI 10.1037/1528-3542.6.1.40; Shimizu H., 1981, JAPANESE J ED PSYCHO, V29, P348, DOI DOI 10.5926/JJEP1953.29.4_348; Sorro D, 2008, PERCEPT PSYCHOPHYS, V70, P924, DOI 10.3758/PP.70.5.924; Soto D, 2005, J EXP PSYCHOL HUMAN, V31, P248, DOI 10.1037/0096-1523.31.2.248; Soto D, 2008, TRENDS COGN SCI, V12, P342, DOI 10.1016/j.tics.2008.05.007; Soto D, 2006, NEUROPSYCHOLOGIA, V44, P1282, DOI 10.1016/j.neuropsychologia.2006.01.029; Soto D, 2012, CEREB CORTEX, V22, P1159, DOI 10.1093/cercor/bhr190; Spielberger C.D., 1983, MANUAL STATE TRAIT A; Theeuwes J, 2010, ACTA PSYCHOL, V135, P77, DOI 10.1016/j.actpsy.2010.02.006; Van Damme S, 2008, EMOTION, V8, P820, DOI 10.1037/a0014149; Visu-Petra L, 2011, INT J BEHAV DEV, V35, P38, DOI 10.1177/0165025410368945; Vogel EK, 2004, NATURE, V428, P748, DOI 10.1038/nature02447; Woodman GF, 2007, J EXP PSYCHOL HUMAN, V33, P363, DOI 10.1037/0096-1523.33.2.363; Yiend J, 2001, Q J EXP PSYCHOL-A, V54, P665, DOI 10.1080/02724980042000462; Zhang B, 2011, VISION RES, V51, P2356, DOI 10.1016/j.visres.2011.09.008; ZUNG WWK, 1965, ARCH GEN PSYCHIAT, V12, P63, DOI 10.1001/archpsyc.1965.01720310065008	80	56	58	3	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2012	7	10							e47221	10.1371/journal.pone.0047221	http://dx.doi.org/10.1371/journal.pone.0047221			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	020LH	22496783	Green Published, Green Submitted, gold			2022-12-27	WOS:000309809500038
J	Xu, D; Gao, ZQ; Zhang, XW; Fan, X; Wang, YT; Li, DM; Wang, W; Zhuang, ZM; Ye, NH				Xu, Dong; Gao, Zhengquan; Zhang, Xiaowen; Fan, Xiao; Wang, Yitao; Li, Demao; Wang, Wei; Zhuang, Zhimeng; Ye, Naihao			Allelopathic Interactions between the Opportunistic Species Ulva prolifera and the Native Macroalga Gracilaria lichvoides	PLOS ONE			English	Article							RED SEAWEED; GROWTH; EPIPHYTES; CONFERTA; CHLOROPHYTA; RHODOPHYTA; INVASION; LACTUCA	Allelopathy, one type of direct plant competition, can be a potent mechanism through which plant communities are structured. The aim of this study was to determine whether allelopathic interactions occur between the opportunistic green tide-forming species Ulva prolifera and the native macroalga Gracilaria lichvoides, both of which were collected from the coastline of East China sea. In laboratory experiments, the presence of G. lichvoides at 1.25 g wet weight L-1 significantly inhibited growth and photosynthesis of U. prolifera at concentrations of 1.25, 2.50, and 3.75 g wet weight L-1 (p < 0.05) in both semi-continuous co-culture assays and in co-culture assays without nutrient supplementation. In contrast, although U. prolifera had a density effect on G. lichvoides, the differences among treatments were not significant (p > 0.05). Culture medium experiments further confirmed that some allelochemicals may be released by both of the tested macroalgae, and these could account for the observed physiological inhibition of growth and photosynthesis. Moreover, the native macroalgae G. lichvoides was a stronger competitor than the opportunistic species U. prolifera. Collectively, the results of the present study represent a significant advance in exploring ecological questions about the effects of green tide blooms on the macroalgal community.	[Xu, Dong; Zhang, Xiaowen; Fan, Xiao; Wang, Wei; Zhuang, Zhimeng; Ye, Naihao] Chinese Acad Fishery Sci, Yellow Sea Fisheries Res Inst, Qingdao, Peoples R China; [Gao, Zhengquan] Shandong Univ Technol, Sch Life Sci, Zibo, Peoples R China; [Wang, Yitao] Qingdao Agr Univ, Coll Anim Sci & Technol, Qingdao, Peoples R China; [Li, Demao] Chinese Acad Sci, Tianjin Inst Ind Biotechnol, Tianjin Key Lab Ind Biol Syst & Bioproce Engn, Tianjin, Peoples R China	Chinese Academy of Fishery Sciences; Yellow Sea Fisheries Research Institute, CAFS; Shandong University of Technology; Qingdao Agricultural University; Chinese Academy of Sciences; Tianjin Institute of Industrial Biotechnology, CAS	Xu, D (corresponding author), Chinese Acad Fishery Sci, Yellow Sea Fisheries Res Inst, Qingdao, Peoples R China.	yenh@ysfri.ac.cn			Shandong Science and Technology plan project [2011GHY11528]; Hi-Tech Research and Development Program (863) of China [2012AA052103]; Specialized Fund for the Basic Research Operating expenses Program [20603022012004, 2010-ts-03]; National Natural Science Foundation of China [41176153]; Natural Science Foundation of Shandong Province [2009ZRA02075]; Qingdao Municipal Science and Technology plan project [11-3-1-5-hy]; National Marine Public Welfare Research Project [200805069]; National Science & Technology Pillar Program [2008BAD95B11, 2010BAC68B03]	Shandong Science and Technology plan project; Hi-Tech Research and Development Program (863) of China(National High Technology Research and Development Program of China); Specialized Fund for the Basic Research Operating expenses Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province); Qingdao Municipal Science and Technology plan project; National Marine Public Welfare Research Project; National Science & Technology Pillar Program	This work was supported by Shandong Science and Technology plan project (2011GHY11528), the Hi-Tech Research and Development Program (863) of China (2012AA052103), the Specialized Fund for the Basic Research Operating expenses Program (20603022012004, 2010-ts-03), National Natural Science Foundation of China (41176153), Natural Science Foundation of Shandong Province (2009ZRA02075), Qingdao Municipal Science and Technology plan project (11-3-1-5-hy), National Marine Public Welfare Research Project (200805069), and the National Science & Technology Pillar Program, (2008BAD95B11, 2010BAC68B03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amsler CD, 2006, ADV BOT RES, V43, P1, DOI 10.1016/S0065-2296(05)43001-3; Blunt JW, 2010, NAT PROD REP, V27, P165, DOI 10.1039/b906091j; Charlier Roger H., 2007, Environmental Research, Engineering and Management, V41, P52; Fletcher RL., 1996, MARINE BENTHIC VEGET, P7, DOI [10.1007/978-3-642-61398-2_2, DOI 10.1007/978-3-642-61398-2_2]; Frankenstein G., 2000, BLOOMS ULVOIDS PUGET; Friedlander M, 1996, J APPL PHYCOL, V8, P21, DOI 10.1007/BF02186217; FRIEDLANDER M, 1991, BOT MAR, V34, P161, DOI 10.1515/botm.1991.34.3.161; Huo YZ, 2011, HARMFUL ALGAE, V10, P411, DOI 10.1016/j.hal.2011.02.003; Jarchow ME, 2009, PLANT ECOL, V204, P113, DOI 10.1007/s11258-009-9573-8; Ji XQ, 2011, CHIN J OCEANOL LIMN, V29, P840, DOI 10.1007/s00343-011-0512-x; Klein J, 2005, MAR ECOL PROG SER, V290, P79, DOI 10.3354/meps290079; Lapointe BE, 2010, HARMFUL ALGAE, V9, P1, DOI 10.1016/j.hal.2009.06.001; Leliaert F, 2008, MARINE POLLUTION B, V56, P15; Leliaert F, 2009, PHYCOL RES, V57, P147, DOI 10.1111/j.1440-1835.2009.00532.x; Liu DY, 2009, MAR POLLUT BULL, V58, P888, DOI 10.1016/j.marpolbul.2009.01.013; Liu F, 2010, J APPL PHYCOL, V22, P531, DOI 10.1007/s10811-009-9489-7; Lundholm N, 2005, MAR ECOL PROG SER, V288, P21, DOI 10.3354/meps288021; Macias Francisco A., 2008, Phytochemistry Reviews, V7, P155, DOI 10.1007/s11101-007-9065-1; Mineur F, 2008, J MAR BIOL ASSOC UK, V88, P693, DOI 10.1017/S0025315408001409; Nan CR, 2008, AQUAT BOT, V89, P9, DOI 10.1016/j.aquabot.2008.01.005; Pang SJ, 2010, MAR ENVIRON RES, V69, P207, DOI 10.1016/j.marenvres.2009.10.007; Pereira R. C., 2008, P25, DOI 10.1007/978-3-540-74181-7_2; Raffaelli DG, 1998, OCEANOGR MAR BIOL<D>, V36, P97; Schmidt LE, 2001, MAR ECOL PROG SER, V216, P67, DOI 10.3354/meps216067; SVIRSKI E, 1993, HYDROBIOLOGIA, V261, P391; Tait LW, 2011, MAR ECOL PROG SER, V421, P97, DOI 10.3354/meps08909; Tang YZ, 2011, HARMFUL ALGAE, V10, P480, DOI 10.1016/j.hal.2011.03.003; Valentine JP, 2003, J EXP MAR BIOL ECOL, V295, P63, DOI 10.1016/S0022-0981(03)00272-7; Valiela I, 1997, LIMNOL OCEANOGR, V42, P1105, DOI 10.4319/lo.1997.42.5_part_2.1105; Walters LJ, 2006, FRONT ECOL ENVIRON, V4, P75, DOI 10.1890/1540-9295(2006)004[0075:EACUDO]2.0.CO;2; Wang RJ, 2007, J SEA RES, V58, P189, DOI 10.1016/j.seares.2007.03.002; Wang Y, 2007, AQUAT BOT, V86, P139, DOI 10.1016/j.aquabot.2006.09.013; Wang Y, 2009, J APPL PHYCOL, V21, P375, DOI 10.1007/s10811-008-9380-y; Wasson K, 2005, BIOL INVASIONS, V7, P935, DOI 10.1007/s10530-004-2995-2; White LF, 2011, J EXP MAR BIOL ECOL, V405, P111, DOI 10.1016/j.jembe.2011.05.024; Williams SL, 2007, ANNU REV ECOL EVOL S, V38, P327, DOI 10.1146/annurev.ecolsys.38.091206.095543; Wonham MJ, 2006, ECOL LETT, V9, P663, DOI 10.1111/j.1461-0248.2006.00913.x; Worm B, 2001, OECOLOGIA, V128, P281, DOI 10.1007/s004420100648; Ye NH, 2011, ECOL RES, V26, P477, DOI 10.1007/s11284-011-0821-8; Zhang XW, 2011, LIMNOL OCEANOGR, V56, P233, DOI 10.4319/lo.2011.56.1.0233; Zhang XW, 2010, J APPL PHYCOL, V22, P173, DOI 10.1007/s10811-009-9437-6	41	66	68	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2012	7	4							e33648	10.1371/journal.pone.0033648	http://dx.doi.org/10.1371/journal.pone.0033648			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JO	22496758	gold, Green Published, Green Submitted			2022-12-27	WOS:000305014500014
J	Moriya, J; Sugiura, Y				Moriya, Jun; Sugiura, Yoshinori			High Visual Working Memory Capacity in Trait Social Anxiety	PLOS ONE			English	Article							SHORT-TERM-MEMORY; PREDICTS INDIVIDUAL-DIFFERENCES; FLUID INTELLIGENCE; SELECTIVE ATTENTION; PERCEPTUAL LOAD; THREAT; PERFORMANCE; PRESSURE; CHOKING; MECHANISMS	Working memory capacity is one of the most important cognitive functions influencing individual traits, such as attentional control, fluid intelligence, and also psychopathological traits. Previous research suggests that anxiety is associated with impaired cognitive function, and studies have shown low verbal working memory capacity in individuals with high trait anxiety. However, the relationship between trait anxiety and visual working memory capacity is still unclear. Considering that people allocate visual attention more widely to detect danger under threat, visual working memory capacity might be higher in anxious people. In the present study, we show that visual working memory capacity increases as trait social anxiety increases by using a change detection task. When the demand to inhibit distractors increased, however, high visual working memory capacity diminished in individuals with social anxiety, and instead, impaired filtering of distractors was predicted by trait social anxiety. State anxiety was not correlated with visual working memory capacity. These results indicate that socially anxious people could potentially hold a large amount of information in working memory. However, because of an impaired cognitive function, they could not inhibit goal-irrelevant distractors and their performance decreased under highly demanding conditions.	[Moriya, Jun] Univ Ghent, Dept Expt Clin & Hlth Psychol, B-9000 Ghent, Belgium; [Moriya, Jun; Sugiura, Yoshinori] Hiroshima Univ, Grad Sch Integrated Arts & Sci, Hiroshima, Japan	Ghent University; Hiroshima University	Moriya, J (corresponding author), Univ Ghent, Dept Expt Clin & Hlth Psychol, B-9000 Ghent, Belgium.	Jun.Moriya@UGent.be		Moriya, Jun/0000-0001-5148-0014	Grants-in-Aid for Scientific Research [23530901, 10J06078] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Alvarez GA, 2004, PSYCHOL SCI, V15, P106, DOI 10.1111/j.0963-7214.2004.01502006.x; Amir N, 2011, J ABNORM PSYCHOL, V120, P504, DOI 10.1037/a0022849; Awh E, 2007, PSYCHOL SCI, V18, P622, DOI 10.1111/j.1467-9280.2007.01949.x; Beilock SL, 2005, PSYCHOL SCI, V16, P101, DOI 10.1111/j.0956-7976.2005.00789.x; Beilock SL, 2004, J EXP PSYCHOL GEN, V133, P584, DOI 10.1037/0096-3445.133.4.584; Birk JL, 2011, EMOTION, V11, P1291, DOI 10.1037/a0026152; Bishop SJ, 2007, TRENDS COGN SCI, V11, P307, DOI 10.1016/j.tics.2007.05.008; Bishop SJ, 2009, NAT NEUROSCI, V12, P92, DOI 10.1038/nn.2242; Chun MM, 2011, NEUROPSYCHOLOGIA, V49, P1407, DOI 10.1016/j.neuropsychologia.2011.01.029; Clark D. M., 1995, SOCIALPHOBIA DIAGNOS, P69, DOI DOI 10.1017/S1352465808004487; Conway ARA, 2003, TRENDS COGN SCI, V7, P547, DOI 10.1016/j.tics.2003.10.005; Cowan N, 2001, BEHAV BRAIN SCI, V24, P87, DOI 10.1017/S0140525X01003922; DeCaro MS, 2008, COGNITION, V107, P284, DOI 10.1016/j.cognition.2007.07.001; Derakshan N, 2010, BEHAV RES THER, V48, P1180, DOI 10.1016/j.brat.2010.08.009; Engle RW, 1999, J EXP PSYCHOL GEN, V128, P309, DOI 10.1037/0096-3445.128.3.309; Eysenck MW, 2007, EMOTION, V7, P336, DOI 10.1037/1528-3542.7.2.336; Fukuda K, 2010, PSYCHON B REV, V17, P673, DOI 10.3758/17.5.673; Fukuda K, 2009, J NEUROSCI, V29, P8726, DOI 10.1523/JNEUROSCI.2145-09.2009; Gamer M, 2011, COGNITION EMOTION, V25, P756, DOI 10.1080/02699931.2010.503117; Gimmig D, 2006, PSYCHON B REV, V13, P1005, DOI 10.3758/BF03213916; Hayes S, 2008, J ABNORM PSYCHOL, V117, P712, DOI 10.1037/a0012908; Holmes EA, 2010, CLIN PSYCHOL REV, V30, P349, DOI 10.1016/j.cpr.2010.01.001; Imae K., 1981, JAPANESE J ED PSYCHO, V29, P62; Jaeggi SM, 2008, P NATL ACAD SCI USA, V105, P6829, DOI 10.1073/pnas.0801268105; Klingberg T, 2010, TRENDS COGN SCI, V14, P317, DOI 10.1016/j.tics.2010.05.002; Lavie N, 2005, TRENDS COGN SCI, V9, P75, DOI 10.1016/j.tics.2004.12.004; LAVIE N, 1995, J EXP PSYCHOL HUMAN, V21, P451, DOI 10.1037/0096-1523.21.3.451; LEARY MR, 1983, PERS SOC PSYCHOL B, V9, P371, DOI 10.1177/0146167283093007; Leigh E, 2011, BEHAV RES THER, V49, P99, DOI 10.1016/j.brat.2010.11.005; Luck SJ, 1997, NATURE, V390, P279, DOI 10.1038/36846; Machizawa MG, 2011, NEUROPSYCHOLOGIA, V49, P1518, DOI 10.1016/j.neuropsychologia.2010.11.032; Mcnab F, 2008, NAT NEUROSCI, V11, P103, DOI 10.1038/nn2024; Mogg K, 2004, J ABNORM PSYCHOL, V113, P160, DOI 10.1037/0021-843X.113.1.160; Moriya J, 2011, ACTA PSYCHOL, V138, P162, DOI 10.1016/j.actpsy.2011.05.019; Moriya J, 2010, COGNITION EMOTION, V24, P1329, DOI 10.1080/02699930903378503; Moriya J, 2009, EMOTION, V9, P739, DOI 10.1037/a0016817; Okajima I., 2008, SEISHIN IGAKU, V50, P801; Olesen PJ, 2004, NAT NEUROSCI, V7, P75, DOI 10.1038/nn1165; PASHLER H, 1988, PERCEPT PSYCHOPHYS, V44, P369, DOI 10.3758/BF03210419; Pacheco-Unguetti AP, 2010, PSYCHOL SCI, V21, P298, DOI 10.1177/0956797609359624; Pishyar R, 2004, ANXIETY STRESS COPIN, V17, P23, DOI 10.1080/10615800310001601458; Rapee RM, 1997, BEHAV RES THER, V35, P741, DOI 10.1016/S0005-7967(97)00022-3; Regner I, 2010, PSYCHOL SCI, V21, P1646, DOI 10.1177/0956797610386619; Robinson OJ, 2011, COGN AFFECT BEHAV NE, V11, P217, DOI 10.3758/s13415-011-0030-5; Sadeh N, 2011, COGNITION EMOTION, V25, P747, DOI 10.1080/02699931.2010.500566; Sasagawa S., 2004, JPN J BEHAV THER, V30, P87, DOI DOI 10.24468/JJBT.30.2_; Schmader T, 2003, J PERS SOC PSYCHOL, V85, P440, DOI 10.1037/0022-3514.85.3.440; Soto D, 2008, TRENDS COGN SCI, V12, P342, DOI 10.1016/j.tics.2008.05.007; Spielberger C. D., 1970, MANNUAL STATE TRAIT; Stober J, 1998, BEHAV RES THER, V36, P751, DOI 10.1016/S0005-7967(98)00027-8; Stober J, 2002, COGNITIVE THER RES, V26, P89, DOI 10.1023/A:1013845821848; Stout DM, 2010, COGNITION EMOTION, V24, P1293, DOI 10.1080/02699930903309334; Todd JJ, 2005, COGN AFFECT BEHAV NE, V5, P144, DOI 10.3758/CABN.5.2.144; TURNER ML, 1989, J MEM LANG, V28, P127, DOI 10.1016/0749-596X(89)90040-5; Visu-Petra L, 2011, INT J BEHAV DEV, V35, P38, DOI 10.1177/0165025410368945; Vogel EK, 2005, NATURE, V438, P500, DOI 10.1038/nature04171; Vogel EK, 2004, NATURE, V428, P748, DOI 10.1038/nature02447; Xu YD, 2006, NATURE, V440, P91, DOI 10.1038/nature04262; Zhang WW, 2008, NATURE, V453, P233, DOI 10.1038/nature06860	59	56	58	3	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2012	7	4							e34244	10.1371/journal.pone.0034244	http://dx.doi.org/10.1371/journal.pone.0034244			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	955JO	22496783	Green Published, gold, Green Submitted			2022-12-27	WOS:000305014500020
J	Xu, JY; Qi, X; Gong, JF; Yu, MY; Zhang, FX; Sha, HB; Gao, X				Xu, Jingyue; Qi, Xin; Gong, Jianfeng; Yu, Mingyan; Zhang, Fangxiong; Sha, Haibo; Gao, Xiang			Fstl1 Antagonizes BMP Signaling and Regulates Ureter Development	PLOS ONE			English	Article							BONE MORPHOGENETIC PROTEIN-4; URINARY-TRACT DEVELOPMENT; SONIC-HEDGEHOG; CONGENITAL-ANOMALIES; MOUSE URETER; BRANCHING MORPHOGENESIS; PERISTALTIC MACHINERY; VESICOURETERAL REFLUX; KIDNEY DEVELOPMENT; EXPRESSION	Bone morphogenetic protein (BMP) signaling pathway plays important roles in urinary tract development although the detailed regulation of its activity in this process remains unclear. Here we report that follistatiri-like 1 (Fstl1), encoding a secreted extracellular glycoprotein, is expressed in developing ureter and antagonizes BMP signaling activity. Mouse embryos carrying disrupted Fstl1 gene displayed prominent hydroureter arising from proximal segment and tireterovesical junction defects. These defects were associated with significant reduction in ureteric epithelial cell proliferation at E15.5 and E16.5 as well as absence of subepithelial ureteral mesenchymal cells in the urinary tract at E16.5 and E18.5. At the molecular level, increased BMP signaling was found in Fstl1 deficient ureters, indicated by elevated pSmad1/5/8 activity. in vitro study also indicated that Fstl1 can directly bind to ALK6 which is specifically expressed in ureteric epithelial cells in developing ureter. Furthermore, Sonic hedgehog (SHH) signaling, which is crucial for differentiation of ureteral subepithelial cell proliferation, was also impaired in Fstl1(-/-) ureter. Altogether, our data suggest that Fstl1 is essential in maintaining normal ureter development by antagonizing BMP signaling.	[Xu, Jingyue; Qi, Xin; Gong, Jianfeng; Yu, Mingyan; Sha, Haibo; Gao, Xiang] Nanjing Univ, Model Anim Res Ctr, MOE Key Lab Model Anim Dis Study, Nanjing, Jiangsu, Peoples R China; [Gao, Xiang] Wenzhou Med Coll, Sch Life Sci, Zhejiang Prov Key Lab Technol & Applicat Model Or, Wenzhou, Peoples R China; [Zhang, Fangxiong] Chinese Acad Sci, Inst Neurosci, Shanghai Inst Life Sci, Shanghai, Peoples R China	Nanjing University; Wenzhou Medical University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Xu, JY (corresponding author), Nanjing Univ, Model Anim Res Ctr, MOE Key Lab Model Anim Dis Study, Nanjing, Jiangsu, Peoples R China.	gaoxiang@nju.edu.cn			MOST (The Ministry of Science and Technology) [2011CB944104, 2011BAI15B02, 2011ZX09307-302-02]; NSFC (The National Science Foundation of China) [30825024]	MOST (The Ministry of Science and Technology); NSFC (The National Science Foundation of China)	This work is supported in part by grants from MOST (The Ministry of Science and Technology) (2011CB944104, 2011BAI15B02, 2011ZX09307-302-02) and NSFC (The National Science Foundation of China) (30825024). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams D, 2007, GENE EXPR PATTERNS, V7, P491, DOI 10.1016/j.modgep.2006.10.009; Airik R, 2006, J CLIN INVEST, V116, P663, DOI 10.1172/JCI26027; Batourina E, 2005, NAT GENET, V37, P1082, DOI 10.1038/ng1645; Bellusci S, 1996, DEVELOPMENT, V122, P1693; BLESSING M, 1993, GENE DEV, V7, P204, DOI 10.1101/gad.7.2.204; BOBER E, 1994, DEVELOPMENT, V120, P603; Botchkarev VA, 2001, FASEB J, V15, P2205, DOI 10.1096/fj.01-0207com; Bush KT, 2006, DEV BIOL, V298, P571, DOI 10.1016/j.ydbio.2006.07.006; Chang CP, 2004, J CLIN INVEST, V113, P1051, DOI 10.1172/JCI200420049; Chia I, 2011, DEVELOPMENT, V138, P2089, DOI 10.1242/dev.056838; Dal-Pra S, 2006, DEV BIOL, V298, P514, DOI 10.1016/j.ydbio.2006.07.002; Ding J, 2009, ENDOCRINOLOGY, V150, P2136, DOI 10.1210/en.2008-1006; DRESSLER GR, 1990, DEVELOPMENT, V109, P787; DUDLEY AT, 1995, GENE DEV, V9, P2795, DOI 10.1101/gad.9.22.2795; Dudley AT, 1997, DEV DYNAM, V208, P349; Geng Y, 2011, P NATL ACAD SCI USA, V108, P7058, DOI 10.1073/pnas.1007293108; Goodrich LV, 1997, SCIENCE, V277, P1109, DOI 10.1126/science.277.5329.1109; Hambrock HO, 2004, J BIOL CHEM, V279, P11727, DOI 10.1074/jbc.M309318200; Hoshino T, 2008, GENES CELLS, V13, P159, DOI 10.1111/j.1365-2443.2007.01158.x; Hu P, 2000, J CELL BIOL, V151, P961, DOI 10.1083/jcb.151.5.961; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Lamm MLG, 2001, DEV BIOL, V232, P301, DOI 10.1006/dbio.2001.0187; Li KC, 2011, NEURON, V69, P974, DOI 10.1016/j.neuron.2011.01.022; Liem KF, 2000, DEVELOPMENT, V127, P4855; LUO G, 1995, GENE DEV, V9, P2808, DOI 10.1101/gad.9.22.2808; Mahoney ZX, 2006, P NATL ACAD SCI USA, V103, P19872, DOI 10.1073/pnas.0609326103; MAURER P, 1995, J MOL BIOL, V253, P347, DOI 10.1006/jmbi.1995.0557; Mendelsohn C, 2004, J CLIN INVEST, V113, P957, DOI 10.1172/JCI21402; Mendelsohn C, 2009, ORGANOGENESIS, V5, P306; Michos O, 2004, DEVELOPMENT, V131, P3401, DOI 10.1242/dev.01251; Michos O, 2007, DEVELOPMENT, V134, P2397, DOI 10.1242/dev.02861; Mitchell EKL, 2006, GENE EXPR PATTERNS, V6, P519, DOI 10.1016/j.modgep.2005.10.008; Miyazaki Y, 1998, J CLIN INVEST, V102, P1489, DOI 10.1172/JCI4401; Miyazaki Y, 2003, PEDIATR INT, V45, P598, DOI 10.1046/j.1442-200X.2003.01777.x; Miyazaki Y, 2003, KIDNEY INT, V63, P835, DOI 10.1046/j.1523-1755.2003.00834.x; Miyazaki Y, 2000, J CLIN INVEST, V105, P863, DOI 10.1172/JCI8256; Monsoro-Burq AH, 2001, MOL CELL, V7, P789, DOI 10.1016/S1097-2765(01)00223-4; Murawski IJ, 2007, AM J PHYSIOL-RENAL, V293, pF1736, DOI 10.1152/ajprenal.00221.2007; Nishimura H, 1999, MOL CELL, V3, P1, DOI 10.1016/S1097-2765(00)80169-0; Okabayashi K, 1999, BIOCHEM BIOPH RES CO, V254, P42, DOI 10.1006/bbrc.1998.9892; Oshima Y, 2008, CIRCULATION, V117, P3099, DOI 10.1161/CIRCULATIONAHA.108.767673; Ouchi N, 2008, J BIOL CHEM, V283, P32802, DOI 10.1074/jbc.M803440200; Pope JC, 1999, J AM SOC NEPHROL, V10, P2018; Roberts DJ, 1998, DEVELOPMENT, V125, P2791; ROBERTS DJ, 1995, DEVELOPMENT, V121, P3163; Schedl A, 2000, CURR OPIN GENET DEV, V10, P543, DOI 10.1016/S0959-437X(00)00125-8; Schilling TF, 1999, DEV BIOL, V210, P277, DOI 10.1006/dbio.1999.9214; Sylva M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022616; Tanaka M, 2010, FEBS J, V277, P4278, DOI 10.1111/j.1742-4658.2010.07816.x; Towers P, 1999, DEV BIOL, V214, P298, DOI 10.1006/dbio.1999.9421; Uetani N, 2009, CLIN GENET, V75, P307, DOI 10.1111/j.1399-0004.2009.01175.x; Uetani N, 2009, J CLIN INVEST, V119, P924, DOI 10.1172/JCI37196; Umezu T, 2010, P NATL ACAD SCI USA, V107, P4601, DOI 10.1073/pnas.0909501107; Vainio S, 2002, NAT REV GENET, V3, P533, DOI 10.1038/nrg842; Yu J, 2002, DEVELOPMENT, V129, P5301; Zhang YD, 2000, DEVELOPMENT, V127, P1431; Zhao J, 2009, HUM MOL GENET, V18, P3090, DOI 10.1093/hmg/ddp250; Zhou YH, 1998, EMBO J, V17, P6689, DOI 10.1093/emboj/17.22.6689	58	56	60	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2012	7	4							e32554	10.1371/journal.pone.0032554	http://dx.doi.org/10.1371/journal.pone.0032554			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952GU	22808012	Green Submitted, Green Published, gold			2022-12-27	WOS:000304780500008
J	Lin, ZJ; Lu, J; Zhou, WH; Shen, YQ				Lin, Zhijie; Lu, Jing; Zhou, Weihong; Shen, Yuequan			Structural Insights into TIR Domain Specificity of the Bridging Adaptor Mal in TLR4 Signaling	PLOS ONE			English	Article							KAPPA-B ACTIVATION; CRYSTAL-STRUCTURE; RECEPTOR DOMAIN; GENETIC-VARIATIONS; TRANSDUCTION; REVEALS; MOLECULE; SEPSIS; DIMERIZATION; TUBERCULOSIS	MyD88 adaptor-like protein (Mal) is a crucial adaptor that acts as a bridge to recruit the MyD88 molecule to activated TLR4 receptors in response to invading pathogens. The specific assembly of the Toll/interleukin-1 receptor (TIR) domains of TLR4, Mal and MyD88 is responsible for proper signal transduction in the TLR4 signaling pathway. However, the molecular mechanism for the specificity of these TIR domains remains unclear. Here, we present the crystal structure of the TIR domain of the human Mal molecule (Mal-TIR) at a resolution of 2.4 angstrom. Unexpectedly, Mal-TIR exhibits an extraordinarily long AB loop, but no alpha B helix or BB loop, distinguishing it from other TIR domains. More importantly, the Mal-TIR AB loop is capable of mediating direct binding to the TIR domains of TLR4 and MyD88 simultaneously. We also found that Mal-TIR can form a back-to-back dimer that may resemble the dimeric assembly of the entire Mal molecule. Our data demonstrate the bridge role of the Mal-TIR domain and provide important information about TIR domain specificity.	[Lin, Zhijie; Lu, Jing; Zhou, Weihong; Shen, Yuequan] Nankai Univ, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China; [Lin, Zhijie; Lu, Jing; Zhou, Weihong; Shen, Yuequan] Nankai Univ, Coll Life Sci, Tianjin 300071, Peoples R China	Nankai University; Nankai University	Shen, YQ (corresponding author), Nankai Univ, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China.	yuequan74@yahoo.com	Shen, Yuequan/C-8950-2013; Lin, Zhijie/Y-4836-2019	Shen, Yuequan/0000-0002-3775-0900; LU, JINJIAN/0000-0001-6703-3120; yuanjia, Hu/0000-0001-5244-8577	973 Program [2007CB914301, 2009CB825504]; NSFC [31170684]; TBR [08QTPTJC28200, 08SYSYTC00200]	973 Program(National Basic Research Program of China); NSFC(National Natural Science Foundation of China (NSFC)); TBR	This work was funded by the 973 Program (grants 2007CB914301 and 2009CB825504), NSFC (grant 31170684) and the TBR program (grants 08QTPTJC28200 and 08SYSYTC00200). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; An Y, 2011, INT J MOL MED, V27, P795, DOI 10.3892/ijmm.2011.645; [Anonymous], ACTA CRYSTALLOGR D, V50, P760; Barton GM, 2009, NAT REV IMMUNOL, V9, P535, DOI 10.1038/nri2587; Bernoux M, 2011, CELL HOST MICROBE, V9, P200, DOI 10.1016/j.chom.2011.02.009; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Castiblanco J, 2008, INFECT GENET EVOL, V8, P541, DOI 10.1016/j.meegid.2008.03.001; Chan SL, 2010, PROTEIN SCI, V19, P155, DOI 10.1002/pro.275; Chan SL, 2009, J BIOL CHEM, V284, P21386, DOI 10.1074/jbc.C109.007591; Choe J, 2005, SCIENCE, V309, P581, DOI 10.1126/science.1115253; Dissanayeke SR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006698; Dunne A, 2003, J BIOL CHEM, V278, P41443, DOI 10.1074/jbc.M301742200; Durrani O, 2011, RHEUMATOLOGY, V50, P1760, DOI 10.1093/rheumatology/ker200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ferwerda B, 2009, P NATL ACAD SCI USA, V106, P10272, DOI 10.1073/pnas.0811273106; Fitzgerald KA, 2001, NATURE, V413, P78, DOI 10.1038/35092578; George J, 2010, J IMMUNOL, V184, P3025, DOI 10.4049/jimmunol.0901156; Gray P, 2006, J BIOL CHEM, V281, P10489, DOI 10.1074/jbc.M508892200; Horng T, 2002, NATURE, V420, P329, DOI 10.1038/nature01180; Horng T, 2001, NAT IMMUNOL, V2, P835, DOI 10.1038/ni0901-835; Jiang ZF, 2006, P NATL ACAD SCI USA, V103, P10961, DOI 10.1073/pnas.0603804103; Jin MS, 2007, CELL, V130, P1071, DOI 10.1016/j.cell.2007.09.008; Kagan JC, 2006, CELL, V125, P943, DOI 10.1016/j.cell.2006.03.047; Kawamoto T, 2008, EUR J PHARMACOL, V584, P40, DOI 10.1016/j.ejphar.2008.01.026; Khan JA, 2004, J BIOL CHEM, V279, P31664, DOI 10.1074/jbc.M403434200; Khor CC, 2007, NAT GENET, V39, P523, DOI 10.1038/ng1976; Kumpf O, 2010, CRIT CARE, V14, DOI 10.1186/cc9047; Li CS, 2005, J BIOL CHEM, V280, P26152, DOI 10.1074/jbc.M503262200; Liu L, 2008, SCIENCE, V320, P379, DOI 10.1126/science.1155406; Loiarro M, 2005, J BIOL CHEM, V280, P15809, DOI 10.1074/jbc.C400613200; Mansell A, 2004, J BIOL CHEM, V279, P37227, DOI 10.1074/jbc.C400289200; Matsunaga N, 2011, MOL PHARMACOL, V79, P34, DOI 10.1124/mol.110.068064; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Miggin SM, 2007, P NATL ACAD SCI USA, V104, P3372, DOI 10.1073/pnas.0608100104; Miguel RN, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000788; Nagpal K, 2009, J BIOL CHEM, V284, P25742, DOI 10.1074/jbc.M109.014886; Nejentsev S, 2008, NAT GENET, V40, P261, DOI 10.1038/ng0308-261; Nyman T, 2008, J BIOL CHEM, V283, P11861, DOI 10.1074/jbc.C800001200; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Ohnishi H, 2009, P NATL ACAD SCI USA, V106, P10260, DOI 10.1073/pnas.0812956106; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Piao W, 2008, J BIOL CHEM, V283, P3109, DOI 10.1074/jbc.M707400200; Song ZJ, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-168; Takashima K, 2009, BRIT J PHARMACOL, V157, P1250, DOI 10.1111/j.1476-5381.2009.00297.x; Toshchakov VY, 2011, J IMMUNOL, V186, P4819, DOI 10.4049/jimmunol.1002424; Toshchakov VU, 2005, J IMMUNOL, V175, P494, DOI 10.4049/jimmunol.175.1.494; Valkov E, 2011, P NATL ACAD SCI USA, V108, P14879, DOI 10.1073/pnas.1104780108; Watters TM, 2007, IMMUNOL CELL BIOL, V85, P411, DOI 10.1038/sj.icb.7100095; Xu YW, 2000, NATURE, V408, P111, DOI 10.1038/35040600; Yamamoto M, 2002, NATURE, V420, P324, DOI 10.1038/nature01182; Zwart Peter H., 2008, V426, P419, DOI 10.1007/978-1-60327-058-8_28	52	129	129	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2012	7	4							e34202	10.1371/journal.pone.0034202	http://dx.doi.org/10.1371/journal.pone.0034202			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087PX	22485159	Green Published, gold, Green Submitted			2022-12-27	WOS:000314775500001
J	Zhang, L; Li, YG; Li, YH; Qi, L; Liu, XG; Yuan, CZ; Hus, NW; Ma, DX; Li, ZF; Yang, Q; Li, W; Li, JM				Zhang, Lei; Li, Yong-gang; Li, Yu-hua; Qi, Lei; Liu, Xin-guang; Yuan, Cun-zhong; Hus, Nai-wen; Ma, Dao-xin; Li, Zhen-feng; Yang, Qiang; Li, Wei; Li, Jian-min			Increased Frequencies of Th22 Cells as well as Th17 Cells in the Peripheral Blood of Patients with Ankylosing Spondylitis and Rheumatoid Arthritis	PLOS ONE			English	Article							COLLAGEN-INDUCED ARTHRITIS; GROWTH-FACTOR-BETA; MEMORY T-CELLS; DISEASE-ACTIVITY; PROINFLAMMATORY CYTOKINE; AUTOIMMUNE INFLAMMATION; INFLAMED JOINTS; CROHNS-DISEASE; INTERLEUKIN 22; DISTINCT	Background: T-helper (Th) 22 is involved in the pathogenesis of inflammatory diseases. The roles of Th22 cells in the pathophysiological of ankylosing spondylitis (AS) and rheumatoid arthritis (RA) remain unsettled. So we examined the frequencies of Th22 cells, Th17 cells and Th1 cells in peripheral blood (PB) from patients with AS and patients with RA compared with both healthy controls as well as patients with osteoarthritis. Design and Methods: We studied 32 AS patients, 20 RA patients, 10 OA patients and 20 healthy controls. The expression of IL-22, IL-17 and IFN-gamma were examined in AS, RA, OA patients and healthy controls by flow cytometry. Plasma IL-22 and IL-17 levels were examined by enzyme-linked immunosorbent assay. Results: Th22 cells, Th17 cells and interleukin-22 were significantly elevated in AS and RA patients compared with OA patients and healthy controls. Moreover, Th22 cells showed positive correlation with Th17 cells as well as interleukin-22 in AS and RA patients. However, positive correlation between IL-22 and Th17 cells was only found in AS patients not in RA patients. In addition, the percentages of both Th22 cells and Th17 cells correlated positively with disease activity only in RA patients not in AS patients. Conclusions:The frequencies of both Th22 cells and Th17 cells were elevated in PB from patients with AS and patients with RA. These findings suggest that Th22 cells and Th17 cells may be implicated in the pathogenesis of AS and RA, and Th22 cells and Th17 cells may be reasonable cellular targets for therapeutic intervention.	[Zhang, Lei; Li, Yong-gang; Qi, Lei; Li, Zhen-feng; Yang, Qiang; Li, Jian-min] Shandong Univ, Dept Orthoped, Qilu Hosp, Jinan 250100, Peoples R China; [Li, Yu-hua] Shandong Univ, Dept Emergency, Qilu Hosp, Jinan 250100, Peoples R China; [Liu, Xin-guang; Ma, Dao-xin] Shandong Univ, Qilu Hosp, Dept Hematol, Jinan 250100, Peoples R China; [Yuan, Cun-zhong] Shandong Univ, Dept Obstet & Gynecol, Qilu Hosp, Jinan 250100, Peoples R China; [Hus, Nai-wen] Shandong Univ, Prov Hosp, Dept Rheumatol, Jinan 250100, Peoples R China; [Li, Wei] Shandong Univ, Qilu Hosp, Dept Clin Lab, Jinan 250100, Peoples R China	Shandong University; Shandong University; Shandong University; Shandong University; Shandong University; Shandong University	Zhang, L (corresponding author), Shandong Univ, Dept Orthoped, Qilu Hosp, Jinan 250100, Peoples R China.	daoxinma@hotmail.com; jianminli123456@163.com	Li, yu/HHZ-5236-2022	Zhang, Lurong/0000-0002-0829-4942; Liang, Guoqiang/0000-0002-2355-444X; Liu, Haiyan/0000-0002-4652-469X; Liu, Xin Guang/0000-0001-9033-9099; Yao, Fei/0000-0002-6936-4553; Li, Yonggang/0000-0001-8280-4827	National Natural Science Foundation [30600680, 81070407, 30973018]; Shandong Technological Development Project [2005BS03022, Q2008C07, BS2009SW014]; Graduate Independent Innovation Foundation of Shandong University, GIIFSDU [yzc21300071613082, yzc10147]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Shandong Technological Development Project; Graduate Independent Innovation Foundation of Shandong University, GIIFSDU	This study was partially supported by research funding from the National Natural Science Foundation (30600680, 81070407 and 30973018), the Shandong Technological Development Project (2005BS03022, Q2008C07, and BS2009SW014), and Graduate Independent Innovation Foundation of Shandong University, GIIFSDU (yzc21300071613082, yzc10147). (http://www.nsfc.gov.cn/Portal0/default152.htm) (http://www.art.sdu.edu.cn/2011/0321/931.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Bettelli E, 2008, NATURE, V453, P1051, DOI 10.1038/nature07036; Bettelli E, 2007, NAT IMMUNOL, V8, P345, DOI 10.1038/ni0407-345; Brand S, 2006, AM J PHYSIOL-GASTR L, V290, pG827, DOI 10.1152/ajpgi.00513.2005; Chabaud M, 1999, ARTHRITIS RHEUM-US, V42, P963, DOI 10.1002/1529-0131(199905)42:5<963::AID-ANR15>3.0.CO;2-E; Cheng F, 2009, ANN RHEUM DIS, V68, P604, DOI 10.1136/ard.2008.097089; Colin EM, 2010, ARTHRITIS RHEUM-US, V62, P132, DOI 10.1002/art.25043; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Dolhain RJEM, 1996, ARTHRITIS RHEUM-US, V39, P1961, DOI 10.1002/art.1780391204; Duhen T, 2009, NAT IMMUNOL, V10, P857, DOI 10.1038/ni.1767; Eyerich S, 2009, J CLIN INVEST, V119, P3573, DOI 10.1172/JCI40202; Fitch Erin, 2007, Curr Rheumatol Rep, V9, P461, DOI 10.1007/s11926-007-0075-1; Flytlie HA, 2010, CYTOKINE, V49, P24, DOI 10.1016/j.cyto.2009.10.005; GARRETT S, 1994, J RHEUMATOL, V21, P2286; Gaston JSH, 2008, RHEUMATOLOGY, V47, P8, DOI 10.1093/rheumatology/kem203; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Hirota K, 2007, J EXP MED, V204, P2803, DOI 10.1084/jem.20071397; Hirota K, 2007, J EXP MED, V204, P41, DOI 10.1084/jem.20062259; Ikeuchi H, 2005, ARTHRITIS RHEUM-US, V52, P1037, DOI 10.1002/art.20965; Kagami S, 2010, J INVEST DERMATOL, V130, P1373, DOI 10.1038/jid.2009.399; Kebir H, 2007, NAT MED, V13, P1173, DOI 10.1038/nm1651; Leipe J, 2011, ANN RHEUM DIS, V70, P1453, DOI 10.1136/ard.2011.152074; Leipe J, 2010, ARTHRITIS RHEUM-US, V62, P2876, DOI 10.1002/art.27622; Lejeune D, 2002, J BIOL CHEM, V277, P33676, DOI 10.1074/jbc.M204204200; Lo YH, 2010, J DERMATOL SCI, V58, P225, DOI 10.1016/j.jdermsci.2010.03.018; Lubberts E, 2004, ARTHRITIS RHEUM-US, V50, P650, DOI 10.1002/art.20001; Lubberts E, 2001, J IMMUNOL, V167, P1004, DOI 10.4049/jimmunol.167.2.1004; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Mei Y, 2011, CLIN RHEUMATOL, V30, P269, DOI 10.1007/s10067-010-1647-4; Miossec P, 2003, ARTHRITIS RHEUM-US, V48, P594, DOI 10.1002/art.10816; Miossec P, 2007, ARTHRITIS RHEUM-US, V56, P2111, DOI 10.1002/art.22733; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; Murphy CA, 2003, J EXP MED, V198, P1951, DOI 10.1084/jem.20030896; Okey Allan B, 2005, Toxicol Appl Pharmacol, V207, P43, DOI 10.1016/j.taap.2004.12.028; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Parsonage G, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2406; PREVOO MLL, 1995, ARTHRITIS RHEUM, V38, P44, DOI 10.1002/art.1780380107; Renauld JC, 2003, NAT REV IMMUNOL, V3, P667, DOI 10.1038/nri1153; Schmechel S, 2008, INFLAMM BOWEL DIS, V14, P204, DOI 10.1002/ibd.20315; Shahrara S, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2477; Shen H, 2009, ARTHRITIS RHEUM-US, V60, P1647, DOI 10.1002/art.24568; Trifari S, 2009, NAT IMMUNOL, V10, P864, DOI 10.1038/ni.1770; VANDERLINDEN S, 1984, ARTHRITIS RHEUM, V27, P361; Volpe E, 2008, NAT IMMUNOL, V9, P650, DOI 10.1038/ni.1613; Wedderburn LR, 2000, ARTHRITIS RHEUM-US, V43, P765, DOI 10.1002/1529-0131(200004)43:4<765::AID-ANR7>3.0.CO;2-B; Wolk K, 2002, J IMMUNOL, V168, P5397, DOI 10.4049/jimmunol.168.11.5397; Zenewicz LA, 2007, IMMUNITY, V27, P647, DOI 10.1016/j.immuni.2007.07.023; Zhang L, 2011, J CLIN IMMUNOL, V31, P606, DOI 10.1007/s10875-011-9540-8; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505	49	187	202	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2012	7	4							e31000	10.1371/journal.pone.0031000	http://dx.doi.org/10.1371/journal.pone.0031000			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952GU	22485125	gold, Green Published, Green Submitted			2022-12-27	WOS:000304780500001
J	Anderson, AM; Carter, KW; Anderson, D; Wise, MJ				Anderson, Alison M.; Carter, Kim W.; Anderson, Denise; Wise, Michael J.			Coexpression of Nuclear Receptors and Histone Methylation Modifying Genes in the Testis: Implications for Endocrine Disruptor Modes of Action	PLOS ONE			English	Article							NEONATAL EXPOSURE; MECHANISMS; DNA; METHYLTRANSFERASES; NOMENCLATURE; ACTIVATION; EXPRESSION; CHEMICALS; MLL3; MARK	Background: Endocrine disruptor chemicals elicit adverse health effects by perturbing nuclear receptor signalling systems. It has been speculated that these compounds may also perturb epigenetic mechanisms and thus contribute to the early origin of adult onset disease. We hypothesised that histone methylation may be a component of the epigenome that is susceptible to perturbation. We used coexpression analysis of publicly available data to investigate the combinatorial actions of nuclear receptors and genes involved in histone methylation in normal testis and when faced with endocrine disruptor compounds. Methodology/Principal Findings: The expression patterns of a set of genes were profiled across testis tissue in human, rat and mouse, plus control and exposed samples from four toxicity experiments in the rat. Our results indicate that histone methylation events are a more general component of nuclear receptor mediated transcriptional regulation in the testis than previously appreciated. Coexpression patterns support the role of a gatekeeper mechanism involving the histone methylation modifiers Kdm1, Prdm2, and Ehmt1 and indicate that this mechanism is a common determinant of transcriptional integrity for genes critical to diverse physiological endpoints relevant to endocrine disruption. Coexpression patterns following exposure to vinclozolin and dibutyl phthalate suggest that coactivity of the demethylase Kdm1 in particular warrants further investigation in relation to endocrine disruptor mode of action. Conclusions/Significance: This study provides proof of concept that a bioinformatics approach that profiles genes related to a specific hypothesis across multiple biological settings can provide powerful insight into coregulatory activity that would be difficult to discern at an individual experiment level or by traditional differential expression analysis methods.	[Anderson, Alison M.; Carter, Kim W.; Anderson, Denise] Univ Western Australia, Telethon Inst Child Hlth Res, Ctr Child Hlth Res, Perth, WA 6009, Australia	Telethon Kids Institute; University of Western Australia	Anderson, AM (corresponding author), Univ Western Australia, Telethon Inst Child Hlth Res, Ctr Child Hlth Res, Perth, WA 6009, Australia.	alisona@ichr.uwa.edu.au	Anderson, Alison/J-6786-2014; Wise, Michael/B-5676-2012	Anderson, Alison/0000-0002-1490-2262; Wise, Michael/0000-0001-6559-4303; Anderson, Denise/0000-0003-0643-4136	William and Marlene Schrader Trust [F6787]	William and Marlene Schrader Trust	AA was supported by a William and Marlene Schrader Postgraduate Scholarship [F6787] awarded by the William and Marlene Schrader Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allis CD, 2007, CELL, V131, P633, DOI 10.1016/j.cell.2007.10.039; Allocco DJ, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-18; Ansari KI, 2011, BIOCHEMISTRY-US, V50, P3517, DOI 10.1021/bi102037t; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bjornstrom L, 2005, MOL ENDOCRINOL, V19, P833, DOI 10.1210/me.2004-0486; Brykczynska U, 2010, NAT STRUCT MOL BIOL, V17, P679, DOI 10.1038/nsmb.1821; Bulynko YA, 2011, BIOCHEMISTRY-US, V50, P313, DOI 10.1021/bi101762x; Cloos PAC, 2008, GENE DEV, V22, P1115, DOI 10.1101/gad.1652908; Crawford BD, 2006, ACS CHEM BIOL, V1, P495, DOI 10.1021/cb600367v; De Santa F, 2007, CELL, V130, P1083, DOI 10.1016/j.cell.2007.08.019; Diamanti-Kandarakis E, 2009, ENDOCR REV, V30, P293, DOI 10.1210/er.2009-0002; Dreijerink KMA, 2006, CANCER RES, V66, P4929, DOI 10.1158/0008-5472.CAN-05-4461; Dreijerink KMA, 2009, MOL CELL BIOL, V29, P5060, DOI 10.1128/MCB.01001-08; Foster PMD, 2006, INT J ANDROL, V29, P140, DOI 10.1111/j.1365-2605.2005.00563.x; Garcia-Bassets I, 2007, CELL, V128, P505, DOI 10.1016/j.cell.2006.12.038; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Germain P, 2006, PHARMACOL REV, V58, P685, DOI 10.1124/pr.58.4.2; Hemberger M, 2009, NAT REV MOL CELL BIO, V10, P526, DOI 10.1038/nrm2727; Hiroi H, 2004, MOL ENDOCRINOL, V18, P791, DOI 10.1210/me.2003-0305; Hotchkiss AK, 2010, REPROD TOXICOL, V30, P261, DOI 10.1016/j.reprotox.2010.06.001; Hublitz P, 2009, INT J DEV BIOL, V53, P335, DOI 10.1387/ijdb.082717ph; Issaeva I, 2007, MOL CELL BIOL, V27, P1889, DOI 10.1128/MCB.01506-06; Kim SM, 2010, NUCLEIC ACIDS RES, V38, P6389, DOI 10.1093/nar/gkq491; LeBaron MJ, 2010, MUTAT RES-REV MUTAT, V705, P83, DOI 10.1016/j.mrrev.2010.04.003; Lee S, 2008, MOL ENDOCRINOL, V22, P1312, DOI 10.1210/me.2008-0012; Lee S, 2009, MOL ENDOCRINOL, V23, P610, DOI 10.1210/me.2008-0455; Metzger E, 2005, NATURE, V437, P436, DOI 10.1038/nature04020; Mo R, 2006, J BIOL CHEM, V281, P15714, DOI 10.1074/jbc.M513245200; Narita M, 2007, ADDICT BIOL, V12, P167, DOI 10.1111/j.1369-1600.2007.00048.x; Newbold RR, 2011, AM J CLIN NUTR, V94, p1939S, DOI 10.3945/ajcn.110.001057; Newbold RR, 2009, MOL CELL ENDOCRINOL, V304, P84, DOI 10.1016/j.mce.2009.02.024; Okada Y, 2010, J ANDROL, V31, P75, DOI 10.2164/jandrol.109.008052; Vicent GP, 2011, GENE DEV, V25, P845, DOI 10.1101/gad.621811; Sato K, 2009, ENDOCR J, V56, P131, DOI 10.1507/endocrj.K08E-239; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Sun LC, 2008, CANCER RES, V68, P2726, DOI 10.1158/0008-5472.CAN-07-6654; Viswakarma N, 2010, PPAR RES; Wang J, 2009, NAT GENET, V41, P125, DOI 10.1038/ng.268; Wilson VS, 2008, INT J ANDROL, V31, P178, DOI 10.1111/j.1365-2605.2007.00861.x; Wysocka J, 2005, CELL, V121, P859, DOI 10.1016/j.cell.2005.03.036; Yang J, 2010, CANCER RES, V70, P6456, DOI 10.1158/0008-5472.CAN-10-0413; Zhang XA, 2011, J MOL ENDOCRINOL, V46, pR11, DOI 10.1677/JME-10-0053	42	24	26	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e34158	10.1371/journal.pone.0034158	http://dx.doi.org/10.1371/journal.pone.0034158			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GO	22496781	Green Published, Green Submitted, gold			2022-12-27	WOS:000304855200033
J	Johnson, RM; Mao, WF; Pollock, HS; Niu, GD; Schuler, MA; Berenbaum, MR				Johnson, Reed M.; Mao, Wenfu; Pollock, Henry S.; Niu, Guodong; Schuler, Mary A.; Berenbaum, May R.			Ecologically Appropriate Xenobiotics Induce Cytochrome P450s in Apis mellifera	PLOS ONE			English	Article							HELICOVERPA-ARMIGERA HUBNER; DRUG-METABOLIZING-ENZYMES; FALL ARMYWORM LARVAE; HONEY-BEE; DROSOPHILA-MELANOGASTER; PYRETHROID INSECTICIDE; MOLECULAR-CLONING; DETOXIFYING ENZYMES; RESISTANT STRAINS; MICROARRAY DATA	Background: Honey bees are exposed to phytochemicals through the nectar, pollen and propolis consumed to sustain the colony. They may also encounter mycotoxins produced by Aspergillus fungi infesting pollen in beebread. Moreover, bees are exposed to agricultural pesticides, particularly in-hive acaricides used against the parasite Varroa destructor. They cope with these and other xenobiotics primarily through enzymatic detoxificative processes, but the regulation of detoxificative enzymes in honey bees remains largely unexplored. Methodology/Principal Findings: We used several approaches to ascertain effects of dietary toxins on bee susceptibility to synthetic and natural xenobiotics, including the acaricide tau-fluvalinate, the agricultural pesticide imidacloprid, and the naturally occurring mycotoxin aflatoxin. We administered potential inducers of cytochrome P450 enzymes, the principal biochemical system for Phase 1 detoxification in insects, to investigate how detoxification is regulated. The drug phenobarbital induces P450s in many insects, yet feeding bees with phenobarbital had no effect on the toxicity of taufluvalinate, a pesticide known to be detoxified by bee P450s. Similarly, no P450 induction, as measured by tau-fluvalinate tolerance, occurred in bees fed xanthotoxin, salicylic acid, or indole-3-carbinol, all of which induce P450s in other insects. Only quercetin, a common pollen and honey constituent, reduced tau-fluvalinate toxicity. In microarray comparisons no change in detoxificative gene expression was detected in phenobarbital-treated bees. However, northern blot analyses of guts of bees fed extracts of honey, pollen and propolis showed elevated expression of three CYP6AS P450 genes. Diet did not influence tau-fluvalinate or imidacloprid toxicity in bioassays; however, aflatoxin toxicity was higher in bees consuming sucrose or high-fructose corn syrup than in bees consuming honey. Conclusions/Significance: These results suggest that regulation of honey bee P450s is tuned to chemicals occurring naturally in the hive environment and that, in terms of toxicological capacity, a diet of sugar is not equivalent to a diet of honey.	[Johnson, Reed M.; Mao, Wenfu; Pollock, Henry S.; Niu, Guodong; Berenbaum, May R.] Univ Illinois, Dept Entomol, Urbana, IL USA; [Schuler, Mary A.] Univ Illinois, Dept Cell & Dev Biol, Urbana, IL USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Johnson, RM (corresponding author), Ohio State Univ, Ohio Agr Res & Dev Ctr, Dept Entomol, Wooster, OH 44691 USA.	johnson.5005@osu.edu	Johnson, Reed M./H-3742-2011; Niu, Guodong/E-5846-2012	Johnson, Reed M./0000-0002-2431-0180; Niu, Guodong/0000-0002-1406-6698; Johnson, Rebecca/0000-0003-2249-2643	United States Department of Agriculture, Agriculture and Food Research Initiative (USDA-AFRI)	United States Department of Agriculture, Agriculture and Food Research Initiative (USDA-AFRI)(United States Department of Agriculture (USDA))	United States Department of Agriculture, Agriculture and Food Research Initiative (USDA-AFRI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGOSIN M, 1976, MOL CELL BIOCHEM, V12, P33, DOI 10.1007/BF01731901; Amichot M, 1998, COMP BIOCHEM PHYS C, V121, P311, DOI 10.1016/S0742-8413(98)10052-X; Anspaugh DD, 2005, J INSECT PHYSIOL, V51, P523, DOI 10.1016/j.jinsphys.2004.12.008; Berenbaum M.R., 1990, P257; BRATTSTEN LB, 1975, BIOCHEM J, V150, P97, DOI 10.1042/bj1500097; Brodschneider R, 2010, APIDOLOGIE, V41, P278, DOI 10.1051/apido/2010012; Brown D, 2003, ARCH INSECT BIOCHEM, V53, P119, DOI 10.1002/arch.10089; Brun A, 1996, INSECT BIOCHEM MOLEC, V26, P697, DOI 10.1016/S0965-1748(96)00036-7; BULL DL, 1986, J CHEM ECOL, V12, P885, DOI 10.1007/BF01020258; Calderone, 2000, BEE CULT, V128, P1, DOI DOI 10.3896/IBRA.1.49.1.01; Campos M, 1997, PHYTOCHEM ANALYSIS, V8, P181, DOI 10.1002/(SICI)1099-1565(199707)8:4&lt;181::AID-PCA359&gt;3.0.CO;2-A; CARINO FA, 1994, INSECT BIOCHEM MOLEC, V24, P411, DOI 10.1016/0965-1748(94)90034-5; Claudianos C, 2006, INSECT MOL BIOL, V15, P615, DOI 10.1111/j.1365-2583.2006.00672.x; COHEN MB, 1992, P NATL ACAD SCI USA, V89, P10920, DOI 10.1073/pnas.89.22.10920; Cresswell JE, 2011, ECOTOXICOLOGY, V20, P149, DOI 10.1007/s10646-010-0566-0; Danielson PB, 1997, P NATL ACAD SCI USA, V94, P10797, DOI 10.1073/pnas.94.20.10797; DENISON MS, 1995, J BIOL CHEM, V270, P18175, DOI 10.1074/jbc.270.31.18175; Dunkov BC, 1997, DNA CELL BIOL, V16, P1345, DOI 10.1089/dna.1997.16.1345; Felsenstein J, PHYLIP PHYLOGENY INF; Feyereisen R., 2005, P1; ffrench-Constant RH, 2004, TRENDS GENET, V20, P163, DOI 10.1016/j.tig.2004.01.003; Finney D.J., 1971, PROBIT ANAL; Fisher T, 2003, ECOTOX ENVIRON SAFE, V54, P1, DOI 10.1016/S0147-6513(02)00031-3; Furgala B., 1992, HIVE HONEY BEE, P829; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gonzalez G, 2005, INT J FOOD MICROBIOL, V105, P1, DOI 10.1016/j.ijfoodmicro.2005.05.001; GUIRGUIS GN, 1976, ENVIRON ENTOMOL, V5, P590, DOI 10.1093/ee/5.3.590; Hardstone MC, 2010, PEST MANAG SCI, V66, P1171, DOI 10.1002/ps.2001; Johansen C.A., 1990, POLLINATOR PROTECTIO; Johnson RM, 2006, J ECON ENTOMOL, V99, P1046, DOI 10.1603/0022-0493-99.4.1046; Johnson RM, 2010, APIDOLOGIE, V41, P312, DOI 10.1051/apido/2010018; Johnson RM, 2009, J ECON ENTOMOL, V102, P474, DOI 10.1603/029.102.0202; Kasai S, 2001, INSECT BIOCHEM MOLEC, V32, P1, DOI 10.1016/S0965-1748(01)00073-X; Kenjeric D, 2007, FOOD CHEM, V102, P683, DOI 10.1016/j.foodchem.2006.05.055; KEZIC N, 1992, APIDOLOGIE, V23, P217, DOI 10.1051/apido:19920304; King-Jones K, 2005, NAT REV GENET, V6, P311, DOI 10.1038/nrg1581; Le Goff G, 2006, INSECT BIOCHEM MOLEC, V36, P674, DOI 10.1016/j.ibmb.2006.05.009; LeBlanc BW, 2009, J AGR FOOD CHEM, V57, P7369, DOI 10.1021/jf9014526; Lewis DFV, 2002, J CHEM TECHNOL BIOT, V77, P1095, DOI 10.1002/jctb.648; Li XC, 2002, NATURE, V419, P712, DOI 10.1038/nature01003; Li XC, 2000, INSECT BIOCHEM MOLEC, V30, P75, DOI 10.1016/S0965-1748(99)00102-2; Li XC, 2007, ANNU REV ENTOMOL, V52, P231, DOI 10.1146/annurev.ento.51.110104.151104; Liu FL, 2006, BEHAV ECOL SOCIOBIOL, V59, P582, DOI 10.1007/s00265-005-0084-x; Liu XN, 2006, PESTIC BIOCHEM PHYS, V84, P127, DOI 10.1016/j.pestbp.2005.06.002; Mao WF, 2006, J CHEM ECOL, V32, P523, DOI 10.1007/s10886-005-9018-3; Mao WF, 2011, P NATL ACAD SCI USA, V108, P12657, DOI 10.1073/pnas.1109535108; Mao WF, 2009, COMP BIOCHEM PHYS B, V154, P427, DOI 10.1016/j.cbpb.2009.08.008; Medina A, 2004, SYST APPL MICROBIOL, V27, P261, DOI 10.1078/072320204322881880; Mullin CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009754; Natsuhara K, 2004, PESTIC BIOCHEM PHYS, V79, P33, DOI 10.1016/j.pestbp.2004.04.002; NEBERT DW, 1987, ANNU REV BIOCHEM, V56, P945, DOI 10.1146/annurev.biochem.56.1.945; Niu GD, 2011, APIDOLOGIE, V42, P79, DOI 10.1051/apido/2010039; Oakeshott JG, 2010, INSECT MOL BIOL, V19, P147, DOI 10.1111/j.1365-2583.2009.00961.x; Oshlack A, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r2; PILLING ED, 1995, PESTIC BIOCHEM PHYS, V51, P1, DOI 10.1006/pest.1995.1001; PILLING ED, 1993, PESTIC SCI, V39, P293, DOI 10.1002/ps.2780390407; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Ranasinghe C, 1999, INSECT MOL BIOL, V8, P443, DOI 10.1046/j.1365-2583.1999.00135.x; Reiner A, 2003, BIOINFORMATICS, V19, P368, DOI 10.1093/bioinformatics/btf877; REMMER H, 1963, SCIENCE, V142, P1657, DOI 10.1126/science.142.3600.1657; RISKALLAH MR, 1986, PESTIC BIOCHEM PHYS, V25, P233, DOI 10.1016/0048-3575(86)90050-7; Ritchie ME, 2007, BIOINFORMATICS, V23, P2700, DOI 10.1093/bioinformatics/btm412; Schell R, 2005, AM BEE J, V145, P392; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; SCOTT JG, 1993, INSECT BIOCHEM MOLEC, V23, P729, DOI 10.1016/0965-1748(93)90047-V; Sen Zeng R, 2007, J CHEM ECOL, V33, P449, DOI 10.1007/s10886-006-9238-1; Simone-Finstrom M, 2010, APIDOLOGIE, V41, P295, DOI 10.1051/apido/2010016; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; SNYDER MJ, 1995, ARCH BIOCHEM BIOPHYS, V321, P13, DOI 10.1006/abbi.1995.1362; Stevens JL, 2000, INSECT BIOCHEM MOLEC, V30, P559, DOI 10.1016/S0965-1748(00)00024-2; Suchail S, 2000, ENVIRON TOXICOL CHEM, V19, P1901, DOI [10.1897/1551-5028(2000)019&lt;1901:COITIT&gt;2.3.CO;2, 10.1002/etc.5620190726]; Suchail S, 2004, PEST MANAG SCI, V60, P291, DOI 10.1002/ps.772; Sun W, 2006, INSECT MOL BIOL, V15, P455, DOI 10.1111/j.1365-2583.2006.00662.x; Tanaka E, 1999, J CLIN PHARM THER, V24, P87, DOI 10.1046/j.1365-2710.1999.00201.x; TERRIERE LC, 1974, J AGR FOOD CHEM, V22, P366, DOI 10.1021/jf60193a057; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Treutter D, 2005, PLANT BIOLOGY, V7, P581, DOI 10.1055/s-2005-873009; Tushar T, 2007, BASIC CLIN PHARMACOL, V100, P269, DOI 10.1111/j.1742-7843.2006.00039.x; VanEngelsdorp D, 2007, AM BEE J, V147, P603; Venables WN., 2002, MODERN APPL STAT S 4; Wanner KW, 2007, P NATL ACAD SCI USA, V104, P14383, DOI 10.1073/pnas.0705459104; Weinstock GM, 2006, NATURE, V443, P931, DOI 10.1038/nature05260; WIERMANN R, 1968, BER DEUT BOT GES, V81, P3; WILKINSON CF, 1972, DRUG METAB REV, V1, P153, DOI 10.3109/03602537208993912; Willoughby L, 2006, INSECT BIOCHEM MOLEC, V36, P934, DOI 10.1016/j.ibmb.2006.09.004; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15; YU SJ, 1983, PESTIC BIOCHEM PHYS, V19, P330, DOI 10.1016/0048-3575(83)90061-5; YU SJ, 1984, PESTIC BIOCHEM PHYS, V22, P360, DOI 10.1016/0048-3575(84)90029-4; YU SJ, 1984, COMP BIOCHEM PHYS C, V78, P145, DOI 10.1016/0742-8413(84)90062-8; YU SJ, 1995, ARCH INSECT BIOCHEM, V28, P365, DOI 10.1002/arch.940280406	90	153	158	2	126	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2012	7	2							e31051	10.1371/journal.pone.0031051	http://dx.doi.org/10.1371/journal.pone.0031051			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917LO	22319603	Green Published, gold, Green Submitted			2022-12-27	WOS:000302178400026
